Record B-SMOKER O
date: O O
2069-04-07 O O
Mr. O O
Villegas O O
is O O
seen O O
today. O O
I O O
have O O
not O O
seen O O
him O O
since O O
November. O O
About O O
three O O
weeks O O
ago O O
he O O
stopped O O
his O O
Prednisone O O
on O O
his O O
own O O
because O O
he O O
was O O
gaining O O
weight. O O
He O O
does O O
feel O O
that O O
his O O
shoulders O O
are O O
definitely O O
improved. O O
It O O
is O O
unclear O O
what O O
he O O
is O O
actually O O
taking, O O
but O O
I O O
think O O
based O O
on O O
the O O
color O O
of O O
his O O
pills O O
and O O
the O O
timing O O
of O O
the O O
medication O O
that O O
he O O
continues O O
taking O O
his O O
Atenolol B-MEDICATION B-MEDICATION
for O O
hypertension B-HYPERTENSION O
and O O
1 O O
Hydroxychloroquine O O
tablet. O O
He O O
is O O
concerned O O
because O O
of O O
the O O
relatively O O
recent O O
onset O O
of O O
difficulties O O
turning O O
his O O
head O O
to O O
the O O
right. O O
When O O
he O O
does O O
this, O O
he O O
will O O
note O O
that O O
he O O
feels O O
as O O
though O O
he O O
is O O
going O O
to O O
pass O O
out O O
although O O
this O O
has O O
not O O
actually O O
happened. O O
This O O
only O O
occurs O O
when O O
he O O
turns O O
to O O
the O O
right O O
and O O
not O O
to O O
the O O
left. O O
He O O
has O O
no O O
visual O O
changes O O
otherwise O O
and O O
denies O O
any O O
headache O O
or O O
other O O
cranial O O
complaints. O O
On O O
examination O O
today, O O
BP O O
120/80. O O
He O O
has O O
no O O
bruits O O
over O O
the O O
carotid. O O
He O O
has O O
no O O
tenderness O O
in O O
this O O
region O O
either. O O
He O O
has O O
good O O
peripheral O O
pulses O O
at O O
the O O
arms. O O
His O O
joint O O
examination O O
is O O
much O O
improved O O
with O O
better O O
ROM O O
of O O
the O O
shoulders O O
and O O
no O O
peripheral O O
joint O O
synovitis. O O
Clinical O O
Impression: O O
#1: O O
Inflammatory O O
arthritis O O
- O O
possibly O O
RA O O
- O O
with O O
response O O
noted O O
to O O
Hydroxychloroquine O O
along O O
with O O
Prednisone. O O
He O O
has O O
stopped O O
the O O
Prednisone, O O
and O O
I O O
would O O
not O O
restart O O
it O O
yet. O O
#2: O O
New O O
onset O O
of O O
symptoms O O
suspicious O O
for O O
right-sided O O
carotid O O
disease. O O
Will O O
arrange O O
for O O
carotid O O
ultrasound O O
studies. O O
Patient O O
advised O O
to O O
call O O
me O O
if O O
he O O
develops O O
any O O
worsening O O
symptoms. O O
He O O
has O O
been O O
taking O O
1 O O
aspirin B-MEDICATION B-MEDICATION
per O O
day O O
prophylaxis O O
long-term, O O
and O O
I O O
stressed O O
that O O
he O O
continue O O
to O O
do O O
so. O O
He O O
will O O
follow-up O O
with O O
me O O
shortly O O
after O O
the O O
ultrasound O O
study. O O
Xzavian O O
G. O O
Tavares, O O
M.D. O O
XGT:holmes O O
DD: O O
04/07/69 O O
DT: O O
04/15/69 O O
DV: O O
04/07/69 O O
******** O O
Approved O O
but O O
not O O
reviewed O O
by O O
Attending O O
Provider O O
******** O O

Record O O
date: O O
2075-01-07 O O
NAME: O O
Villegas, O O
Yosef O O
MRN: O O
8249813 O O
S: O O
Here O O
for O O
follow O O
up O O
of O O
his O O
colonic O O
polyps. O O
He O O
wants O O
to O O
know O O
the O O
results O O
from O O
them. O O
He O O
is O O
not O O
taking O O
hydrochlorothiazide O O
and O O
is O O
curious O O
about O O
his O O
blood O O
pressure. O O
He O O
said O O
he O O
has O O
cut O O
his O O
alcohol O O
back O O
to O O
6 O O
pack O O
once O O
a O O
week. O O
He O O
has O O
cut B-SMOKER O
back I-SMOKER O
his I-SMOKER O
cigarettes B-SMOKER O
to I-SMOKER O
one I-SMOKER O
time I-SMOKER O
per I-SMOKER O
week. I-SMOKER O
He O O
does O O
say O O
he O O
has O O
had O O
some O O
problems O O
with O O
his O O
memory O O
recently, O O
although O O
no O O
other O O
manifestations O O
of O O
dementia O O
and O O
no O O
difficulty O O
with O O
ADLs. O O
He O O
says O O
he O O
uses O O
Viagra O O
occasionally O O
and O O
it O O
works O O
for O O
him. O O
O: O O
Well-appearing O O
male. O O
Blood O O
pressure O O
142/74. B-HYPERTENSION O
Chest O O
clear. O O
COR: O O
No O O
murmur. O O
A: O O
(1) O O
Alcohol O O
excess O O
discussed. O O
I O O
told O O
him O O
to O O
cut O O
it O O
out O O
entirely. O O
(2) O O
Cigarette B-SMOKER O
smoking. I-SMOKER O
Discussed. O O
(3) O O
Hypertension. B-HYPERTENSION O
Under O O
good O O
control. O O
(4) O O
Elevated O O
lipids. O O
Will O O
check O O
FLP. O O
(5) O O
Worried O O
about O O
dementia. O O
Will O O
check O O
B12, O O
TSH, O O
RPR O O
for O O
now. O O
(6) O O
Status-post O O
knee O O
replacement. O O
Gets O O
occasional O O
Vicodin O O
from O O
his O O
orthopedist. O O
Says O O
he O O
wanted O O
8 O O
Percocet O O
for O O
the O O
next O O
month O O
or O O
two O O
that O O
he O O
will O O
take O O
on O O
rare O O
occasions O O
when O O
his O O
pain O O
is O O
more O O
severe, O O
and O O
I O O
did O O
give O O
him O O
8 O O
Percocet. O O
P: O O
Follow O O
up O O
with O O
Dr. O O
Hobbs O O
in O O
3 O O
months. O O
Gilbert O O
P. O O
Perez, O O
M.D. O O
GPP/church/olinger O O

Record O O
date: O O
2080-02-18 O O
SDU O O
JAR O O
Admission O O
Note O O
Name: O O
Yosef O O
Villegas O O
MR: O O
8249813 O O
DOA: O O
2/17/80 O O
PCP: O O
Gilbert O O
Perez O O
Attending: O O
YBARRA O O
CODE: O O
FULL O O
HPI: O O
70 O O
yo O O
M O O
with O O
NIDDM B-DIABETES O
admitted O O
for O O
cath O O
after O O
positive B-CAD O
MIBI. I-CAD O
Pt O O
has O O
had O O
increasing O O
CP O O
and O O
SOB O O
on O O
exertion O O
for O O
past O O
two O O
months, O O
seen O O
at O O
PCP O O
on O O
2/03 O O
with O O
EKG O O
showing O O
RBBB. O O
Pt O O
was O O
scheduled O O
for O O
stress O O
MIBI O O
today O O
to O O
eval O O
for O O
cardiac O O
ischemia. O O
MIBI O O
was O O
reportedly O O
stopped O O
2/2 O O
to O O
chest O O
pain, O O
though O O
pt O O
denies O O
having O O
pain O O
during O O
procedure. O O
MIBI B-CAD O
was I-CAD O
read I-CAD O
as I-CAD O
positive I-CAD O
for I-CAD O
moderate I-CAD O
to I-CAD O
severe B-CAD O
inferior I-CAD O
ischemia I-CAD O
and O O
pt O O
was O O
referred O O
to O O
the O O
ED O O
for O O
admission O O
and O O
catheterization. O O
PMH: O O
Seronegative O O
Rheumatoid O O
Arthritis O O
HTN B-HYPERTENSION O
Right O O
Carotid O O
Artery O O
Dz O O
Obesity B-OBESE O
Hyperlipidemia B-HYPERLIPIDEMIA B-MEDICATION
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Home O O
Medications: O O
Acetylsalicylic O B-MEDICATION
Acid O O
(Aspirin) B-MEDICATION O
PO O O
81 O O
MG O O
QD O O
Xanax O O
(Alprazolam) O O
PO O O
BID O O
Atenolol B-MEDICATION B-MEDICATION
PO O O
50 O O
MG O O
QD O O
Enalapril B-MEDICATION O
Maleate I-MEDICATION O
PO O O
10 O O
MG O O
QD O O
Hctz B-MEDICATION B-MEDICATION
(Hydrochlorothiazide) B-MEDICATION O
PO O O
QD O O
Metformin B-MEDICATION B-MEDICATION
PO O O
850 O O
MG O O
BID O O
Allergies: O O
NKDA O O
Social O O
History: O O
Smokes B-SMOKER O
2 I-SMOKER O
packs I-SMOKER O
per I-SMOKER O
month, I-SMOKER O
drinks O O
1 O O
case O O
of O O
beer O O
per O O
month O O
Exam: O O
VS: O O
T: O O
98.1 O O
HR: O O
59 O O
BP: B-HYPERTENSION O
158/72 I-HYPERTENSION O
RR: O O
20 O O
Sat: O O
97% O O
RA O O
General: O O
Obese B-OBESE O
gentleman O O
lying O O
comfortably O O
in O O
bed O O
HEENT: O O
Pupils O O
equal, O O
round, O O
and O O
reactive O O
to O O
light, O O
extra O O
ocular O O
muscles O O
intact, O O
pharynx O O
clear O O
Pulmonary: O O
Clear O O
to O O
auscultation O O
bilaterally, O O
no O O
wheezes, O O
rubs O O
or O O
rales O O
Cardiac: O O
Irregular, O O
no O O
m/r/g, O O
no O O
jugular O O
venous O O
distension O O
Abdomen: O O
soft, O O
nt, O O
nd, O O
normal O O
bowl O O
sounds O O
Extr: O O
Positive O O
pedal O O
pulses O O
bilaterally, O O
no O O
cyanosis, O O
clubbing, O O
or O O
edema O O
Neuro: O O
Alert O O
and O O
oriented O O
to O O
person O O
place O O
and O O
time. O O
No O O
focal O O
weakness O O
or O O
paresthesias. O O
DATA: O O
NA O O
138 O O
K O O
3.9 O O
CL O O
99(L) O O
CO2 O O
27.8 O O
BUN O O
16 O O
CRE O O
0.9 O O
GLU O O
95 O O
WBC O O
9.9 O O
RBC O O
5.14 O O
HGB O O
15.7 O O
HCT O O
44.5 O O
MCV O O
87 O O
MCH O O
30.6 O O
MCHC O O
35.4 O O
PLT O O
243 O O
RDW O O
13.4 O O
PT O O
12.2 O O
PT-INR O O
1.1 O O
PTT O O
24.8 O O
MIBI: O O
The O O
patient O O
has O O
reduced O O
exercise O O
capacity O O
(5 O O
METS). O O
The O O
ECG B-CAD O
is I-CAD O
positive I-CAD O
for I-CAD O
ischemia. I-CAD O
LV O O
contractile O O
function O O
is O O
normal. O O
Findings O O
are O O
consistent O O
with O O
moderate B-CAD O
to I-CAD O
severe I-CAD O
ischemia I-CAD O
in I-CAD O
the I-CAD O
inferior I-CAD O
and I-CAD O
inferolateral I-CAD O
ischemia I-CAD O
at O O
low O O
work O O
load O O
(1.5 O O
min O O
EX). O O
The O O
LVEF O O
is O O
52%. O O
EKG: O O
Sinus O O
arrhythmia O O
with O O
RBBB O O
ASSESSMENT O O
AND O O
PLAN: O O
70 O O
yo O O
M O O
with O O
multiple O O
cardiac O O
risk O O
factors O O
and O O
2 B-CAD O
mo I-CAD O
escalating I-CAD O
angina I-CAD O
sx O O
presents O O
with O O
MIBI B-CAD O
positive I-CAD O
for I-CAD O
interior I-CAD O
and I-CAD O
inferiolateral I-CAD O
ischemia. I-CAD O
CV: O O
Ischemia: O O
Hx B-CAD O
angina, I-CAD O
MIBI B-CAD O
positive I-CAD O
for I-CAD O
inferior I-CAD O
and I-CAD O
inferiolateral I-CAD O
ischemia. I-CAD O
Cycle O O
enzymes, O O
plan O O
for O O
cath O O
2/18 O O
to O O
eval O O
for O O
reversible O O
coronary O O
defect. O O
ASA. B-MEDICATION B-MEDICATION
Pump: O O
EF O O
estimated O O
at O O
52% O O
Cont O O
enalapril, B-MEDICATION O
hctz B-MEDICATION O
Rhythm: O O
Sinus O O
arrythmia O O
and O O
RBBB O O
Hold B-MEDICATION O
atenolol I-MEDICATION B-MEDICATION
for I-MEDICATION O
bradycardia I-MEDICATION O
DM O O
RISS O O
Prophy: O O
DVT O O
prophylaxis: O O
ambulatory O O
GI O O
prophylaxis: O O
Zantac O O
_______________________ O O
Mike O O
Ivan, O O
MD, O O
EHMS O O
pager O O
84710 O O

Record B-SMOKER O
date: O O
2080-10-01 O O
Reason O O
for O O
Visit O O
Sternal O O
pain. O O
History O O
of O O
Present O O
Illness O O
71 O O
yo O O
M O O
with O O
CAD, B-CAD O
s/p B-CAD O
CABG B-CAD B-MEDICATION
x I-CAD O
4 I-CAD O
in I-CAD O
3/80. I-CAD O
He O O
presents O O
with O O
pain O O
over O O
the O O
lower O O
part O O
of O O
his O O
chest O O
since O O
Monday-- O O
came O O
on O O
when O O
he O O
was O O
in O O
bed. O O
The O O
pain O O
is O O
located O O
in O O
a O O
specific O O
spot O O
over O O
his O O
breast O O
bone, O O
and O O
is O O
present O O
all O O
the O O
time, O O
worse O O
with O O
coughing, O O
sneezing, O O
or O O
sudden O O
deep O O
breath. O O
No O O
change O O
with O O
exertion-- O O
did O O
his O O
usual O O
exercises O O
(stretching, O O
leg O O
lifts, O O
crunching) O O
yesterday O O
without O O
a O O
problem. O O
No O O
variation O O
with O O
food. O O
No O O
change O O
with O O
position O O
(e.g., O O
leaning O O
forward). O O
Denies O O
productive O O
cough, O O
fever, O O
chills, O O
nausea, O O
diaphoresis, O O
palpitations. O O
No O O
radiation O O
to O O
the O O
jaw O O
or O O
arm. O O
The O O
pain O O
does O O
not O O
remind O O
him O O
of O O
his O O
sx O O
prior O O
to O O
CABG O O
(which O O
he O O
says O O
was O O
exertional O O
SOB), O O
but O O
does O O
feel O O
like O O
his O O
incisional O O
pain O O
after O O
the O O
surgery O O
(which O O
eventually O O
went O O
away O O
completely). O O
ROS O O
as O O
above, O O
otherwise O O
negative O O
in O O
detail. O O
He O O
says O O
his O O
pain O O
is O O
currently O O
gone, O O
and O O
he O O
feels O O
fine O O
lying O O
back O O
in O O
the O O
exam O O
room. O O
Problems O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
: O O
s/p O O
CABG O O
x O O
4 O O
in O O
3/80 O O
SERONEGATIVE O O
RA O O
HYPERTENSION B-HYPERTENSION B-HYPERTENSION
?CARPAL O O
TUNNEL O O
SYNDROME O O
?RT O O
CAROTID O O
DISEASE O O
obesity B-OBESE O
hyperlipidemia B-HYPERLIPIDEMIA O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Medications O O
AMIODARONE O O
200 O O
MG O O
(200MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Aspirin B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
Acid) O O
325MG O O
TABLET O O
PO O O
QD O O
x O O
30 O O
days O O
ATENOLOL B-MEDICATION B-MEDICATION
50 O O
MG O O
(50MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Enalapril B-MEDICATION O
Maleate O O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
x O O
30 O O
days O O
Hctz B-MEDICATION B-MEDICATION
(HYDROCHLOROTHIAZIDE) B-MEDICATION O
25MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) B-MEDICATION O
80 O O
MG O O
(80MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
METFORMIN B-MEDICATION B-MEDICATION
850 O O
MG O O
(850MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
Viagra O O
(SILDENAFIL) O O
100MG O O
TABLET O O
take O O
0.5 O O
Tablet(s) O O
PO O O
x1 O O
Vicodin O B-MEDICATION
Es O O
7.5/750 O O
(HYDROCODONE O O
7.5mg O O
+ O O
Apap O O
750mg) O O
1 O O
TAB O O
PO O O
BID O O
PRN O O
, O O
Mailing O O
hard O O
copy O O
to O O
you. O O
Xanax O O
(ALPRAZOLAM) O O
0.5MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
Allergies O O
NKA O O
Vital O O
Signs O O
PULSE O O
66 O O
TEMPERATURE O O
98.7 O O
F O O
O2 O O
SAT O O
97 O O
BLOOD O O
PRESSURE O O
135/60 O O
Right O O
arm. O O
BLOOD O O
PRESSURE O O
132/60 O O
L O O
arm. O O
Physical O O
Exam O O
General O O
Appearance O O
Alert, O O
no O O
acute O O
distress, O O
comfortable O O
lying O O
flat O O
on O O
exam O O
table. O O
HEENT O O
PERRL. O O
Moist O O
mucous O O
membranes. O O
Neck O O
No O O
visible O O
JVD. O O
No O O
cervical O O
nodes. O O
Chest O O
Lungs O O
clear, O O
good O O
air O O
movement, O O
no O O
crackles, O O
wheezes. O O
No O O
focal O O
rhonchi. O O
No O O
pleural O O
rub. O O
+ O O
focal O O
tenderness O O
approx O O
2-3 O O
cm O O
above O O
the O O
xiphoid-- O O
subcutaneous O O
tissue O O
feels O O
a O O
little O O
thicker O O
here, O O
but O O
no O O
fluctuance, O O
erythema, O O
warmth. O O
No O O
sternal O O
movement O O
wiht O O
palpation. O O
No O O
palpable O O
sternal O O
wire. O O
Cor/Cardiac O O
RRR, O O
+ O O
systolic O O
murmur, O O
no O O
rub. O O
?S4. O O
Abdomen O O
Soft, O O
ND, O O
NT. O O
+ O O
bowel O O
sounds. O O
Extremity O O
Warm. O O
No O O
edema. O O
Lab O O
Test O O
ECG O O
(today): O O
sinus O O
at O O
60 O O
bpm, O O
nl O O
axis. O O
IVCD O O
(toward O O
RBBB, O O
but O O
does O O
not O O
meet O O
criteria); O O
inverted O O
Ts O O
in O O
II, O O
III, O O
AVF. O O
Compared O O
with O O
8/79-- O O
the O O
QRS O O
complex O O
is O O
slightly O O
narrower. O O
Impression O O
Sternal O O
pain-- O O
non-exertional, O O
reproducible O O
by O O
palpation, O O
and O O
not O O
accompanied O O
by O O
ECG O O
changes-- O O
in O O
pt O O
who O O
is O O
s/p O O
CABG O O
seven O O
months O O
ago. O O
Sx O O
are O O
different O O
from O O
his O O
original O O
anginal O O
pain-- O O
and O O
I O O
suspect O O
he O O
has O O
some O O
sort O O
of O O
focal O O
inflammation O O
/ O O
contusion O O
over O O
the O O
lower O O
part O O
of O O
the O O
sternotomy O O
site. O O
No O O
sign, O O
currently, O O
of O O
local O O
or O O
systemic O O
infection. O O
Doubt O O
pneumonia O O
(no O O
cough O O
or O O
fever, O O
lungs O O
clear) O O
or O O
GI O O
cause. O O
Pericarditis O O
a O O
possibility O O
(he O O
had O O
post-op O O
pericarditis O O
after O O
his O O
CABG), O O
but O O
no O O
signs O O
on O O
ECG, O O
and O O
the O O
pain O O
is O O
not O O
positional. O O
Discussed O O
the O O
case O O
with O O
the O O
pt's O O
cardiologist, O O
Dr. O O
Xavier O O
Rush-- O O
and O O
we O O
came O O
up O O
with O O
the O O
following O O
plan: O O
Plan O O
- O O
will O O
send O O
CK/MB/Tn O O
x O O
1-- O O
although O O
cards O O
agrees O O
that O O
likelihood O O
that O O
this O O
is O O
cardiac O O
seems O O
low O O
- O O
check O O
CXR O O
- O O
send O O
ESR, O O
CBC/Diff O O
- O O
OK O O
for O O
pt O O
to O O
go O O
home O O
after O O
labs O O
drawn O O
and O O
CXR O O
done O O
- O O
will O O
contact O O
Dr. O O
Thorne's O O
service O O
(cardiac O O
surgery) O O
and O O
Dr. O O
Perez O O
(PCP) O O
to O O
make O O
them O O
aware O O
- O O
instructed O O
pt O O
to O O
go O O
to O O
the O O
ED O O
immediately O O
for O O
increased O O
pain, O O
SOB, O O
fever, O O
or O O
swelling/redness O O
over O O
the O O
lower O O
sternum O O
______________________________ O O
Owen O O
M O O
Gallagher, O O
M.D. O O

Record B-SMOKER O
date: O O
2083-07-20 O O
SILVER O O
RIDGE O O
EMERGENCY O O
DEPT O O
VISIT O O
OROZCO,KYLE O O
560-40-78-5 O O
VISIT O O
DATE: O O
07/20/83 O O
PRESENTING O O
COMPLAINT: O O
Groin O O
abscess. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
is O O
a O O
58 O O
year-old O O
male O O
who O O
had O O
a O O
renal O O
catheterization O O
via O O
the O O
right O O
groin O O
for O O
renal O O
artery O O
stenosis O O
on O O
8-09-83, O O
who O O
now O O
comes O O
in O O
with O O
progressive O O
redness, O O
swelling O O
and O O
some O O
drainage O O
over O O
the O O
last O O
two O O
days. O O
Some O O
low O O
grade O O
fever, O O
no O O
chills, O O
no O O
rigors, O O
no O O
cough, O O
no O O
chest O O
pain. O O
PAST O O
MEDICAL O O
HISTORY: O O
Angioplasty O O
of O O
his O O
renal O O
artery, O O
insulin B-DIABETES O
dependent I-DIABETES O
diabetes B-DIABETES O
mellitus, I-DIABETES O
hypertension. B-HYPERTENSION O
MEDICATIONS: O O
Zestril, B-MEDICATION B-MEDICATION
Zocor, B-MEDICATION B-MEDICATION
hydrochlorothiazide, B-MEDICATION B-MEDICATION
insulin. O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
PHYSICAL O O
EXAMINATION: O O
This O O
is O O
a O O
well-nourished, O O
well-developed O O
male. O O
SKIN: O O
Warm O O
and O O
dry O O
without O O
rash O O
or O O
diaphoresis. O O
HEENT: O O
Normocephalic, O O
atraumatic, O O
pupils O O
are O O
equal, O O
round O O
and O O
reactive O O
to O O
light. O O
NECK: O O
Supple, O O
full O O
range O O
of O O
motion. O O
LUNGS: O O
Clear. O O
HEART: O O
Regular O O
rate O O
and O O
rhythm. O O
ABDOMEN: O O
Soft O O
and O O
nontender. O O
The O O
right O O
groin O O
has O O
a O O
purulent O O
abscess O O
which O O
is O O
extremely O O
tender. O O
It O O
is O O
not O O
pulsatile. O O
There O O
is O O
purulent O O
drainage O O
from O O
it. O O
There O O
is O O
some O O
surrounding O O
erythema O O
that O O
extends O O
on O O
to O O
the O O
testicles. O O
The O O
testicles O O
are O O
nontender. O O
CONSULTATIONS O O
(including O O
PCP): O O
I O O
have O O
discussed O O
the O O
case O O
with O O
the O O
primary O O
care O O
physician. O O
FINAL O O
DIAGNOSIS: O O
Groin O O
abscess. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
is O O
admitted O O
to O O
the O O
operating O O
room O O
in O O
stable O O
condition. O O
___________________________________ O O
XW277/90683 O O
FILBERT O O
BRIGHT, O O
M.D. O O
FB59 O O
D:07/20/83 O O
T:07/20/83 O O
Dictated O O
by: O O
FILBERT O O
BRIGHT, O O
M.D. O O
FB59 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2083-08-26 O O
SILVER O O
RIDGE O O
EMERGENCY O O
DEPT O O
VISIT O O
OROZCO,KYLE O O
560-40-78-5 O O
VISIT O O
DATE: O O
08/26/83 O O
This O O
is O O
a O O
preliminary O O
dictation. O O
PRESENTING O O
COMPLAINT O O
and O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
patient O O
is O O
a O O
58-year-old O O
male O O
with O O
a O O
history O O
of O O
hypertension B-HYPERTENSION O
and O O
diabetes B-DIABETES O
who O O
presents O O
with O O
fever O O
and O O
chills. O O
He O O
is O O
four O O
weeks O O
status O O
post O O
revision O O
of O O
an O O
aorto-bifemoral O O
bypass O O
graft, O O
which O O
got O O
infected O O
and O O
had O O
to O O
be O O
revised. O O
He O O
has O O
been O O
doing O O
well, O O
but O O
now O O
presents O O
here O O
with O O
a O O
low-grade O O
fever O O
to O O
100.9 O O
degrees O O
F. O O
(he O O
states O O
his O O
maximum O O
temperature O O
at O O
home O O
was O O
101 O O
degrees O O
F., O O
while O O
he O O
was O O
taking O O
Advil O O
for O O
the O O
fever). O O
He O O
presents O O
for O O
evaluation. O O
He O O
has O O
had O O
no O O
drainage O O
from O O
the O O
site, O O
and O O
has O O
been O O
home O O
on O O
IV O O
Nafcillin O O
for O O
the O O
past O O
two O O
months O O
secondary O O
to O O
his O O
graft O O
infection. O O
PAST O O
MEDICAL O O
HISTORY: O O
As O O
above. O O
MEDICATIONS: O O
IV O O
Nafcillin, O O
Lasix, O O
Zocor, B-MEDICATION O
and O O
insulin. B-MEDICATION O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
PHYSICAL O O
EXAMINATION: O O
The O O
vital O O
signs O O
include O O
a O O
blood O O
pressure O O
of O O
179/85, B-HYPERTENSION O
a O O
pulse O O
of O O
91, O O
respirations O O
of O O
20, O O
and O O
a O O
fever O O
to O O
100.9 O O
degrees O O
F. O O
The O O
HEENT O O
examination O O
is O O
normal. O O
There O O
are O O
some O O
crackles O O
at O O
the O O
left O O
base, O O
but O O
the O O
lungs O O
are O O
otherwise O O
normal. O O
The O O
heart O O
has O O
a O O
regular O O
rate O O
and O O
rhythm. O O
The O O
abdomen O O
is O O
soft O O
and O O
non-tender, O O
with O O
good O O
bowel O O
sounds. O O
There O O
is O O
a O O
right O O
groin O O
mass, O O
questionably O O
a O O
hematoma, O O
with O O
good O O
pulses O O
however. O O
The O O
extremities O O
are O O
well-perfused. O O
LABORATORY O O
EVALUATION: O O
The O O
electrolytes, O O
BUN, O O
and O O
creatinine O O
are O O
normal. O O
The O O
blood B-DIABETES O
sugar I-DIABETES O
is I-DIABETES O
180. B-DIABETES O
The O O
white O O
count O O
is O O
normal O O
at O O
3.7. O O
The O O
hematocrit O O
is O O
29. O O
The O O
PT/PTT O O
are O O
pending. O O
The O O
urinalysis O O
is O O
negative O O
so O O
far, O O
with O O
microscopic O O
pending. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
was O O
seen O O
by O O
Surgery. O O
The O O
consensus O O
was O O
to O O
order O O
a O O
CT O O
scan O O
of O O
the O O
abdomen, O O
since O O
the O O
patient O O
had O O
a O O
fever O O
at O O
that O O
point, O O
and O O
so O O
the O O
CT O O
scan O O
is O O
pending. O O
Thus, O O
the O O
assessment O O
was O O
that O O
this O O
was O O
a O O
58-year-old O O
male O O
with O O
a O O
history O O
of O O
a O O
recent O O
revision O O
of O O
an O O
aorto-bifemoral O O
bypass O O
graft, O O
who O O
had O O
been O O
on O O
two O O
months O O
of O O
IV O O
Nafcillin, O O
and O O
who O O
presented O O
with O O
a O O
fever. O O
Laboratory O O
studies O O
are O O
done O O
and O O
cultures O O
sent. O O
A O O
Surgery O O
consultation O O
and O O
abdominal O O
CT O O
scan O O
were O O
ordered, O O
and O O
results O O
were O O
pending. O O
The O O
patient O O
was O O
admitted O O
to O O
the O O
Emergency O O
Department O O
Observation O O
Unit O O
awaiting O O
the O O
scan, O O
full O O
evaluation, O O
and O O
disposition. O O
The O O
patient O O
was O O
signed O O
out O O
to O O
the O O
3 O O
p.m. O O
attending. O O
CONSULTATIONS O O
(INCLUDING O O
PCP): O O
Surgery. O O
FINAL O O
DIAGNOSIS: O O
Fever. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
is O O
admitted O O
to O O
the O O
Emergency O O
Department O O
Observation O O
Unit O O
in O O
stable O O
condition. O O
___________________________________ O O
VF918/05141 O O
PERRY O O
UPSHAW, O O
M.D. O O
PU38 O O
D:08/26/83 O O
T:08/27/83 O O
Dictated O O
by: O O
PERRY O O
UPSHAW, O O
M.D. O O
PU38 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2086-12-08 O O
Silver O O
Ridge O O
Internal O O
Medicine O O
3 O O
Eaton O O
Place O O
OROZCO, O O
KYLE O O
Mansfield, O O
NV O O
29473 O O
56040785 O O
----------- O O
12/08/86 O O
INTERVAL O O
HISTORY: O O
The O O
patient O O
is O O
status O O
post O O
one O O
lumbar O O
epidural O O
injection. O O
He O O
is O O
61 O O
years O O
old O O
with O O
previous O O
history O O
of O O
diabetes, B-DIABETES O
as O O
well O O
as O O
bilateral O O
fem-pop O O
surgery. O O
He O O
has O O
pain O O
radiating O O
to O O
both O O
legs O O
up O O
to O O
calves O O
and O O
thighs. O O
He O O
has O O
moderate-to-severe O O
spinal O O
stenosis. O O
He O O
had O O
good O O
response O O
to O O
L5-S1 O O
epidural O O
steroid O O
injection O O
once, O O
about O O
3 O O
months O O
ago. O O
He O O
states O O
that O O
he O O
is O O
reasonably O O
symptom O O
free O O
but O O
the O O
pain O O
is O O
coming O O
back. O O
Today, O O
we O O
are O O
going O O
to O O
repeat O O
the O O
injection. O O
PHYSICAL O O
EXAMINATION: O O
Essentially O O
unchanged O O
from O O
prior. O O
PROCEDURE O O
NOTE: O O
After O O
obtaining O O
informed O O
consent, O O
the O O
patient O O
placed O O
in O O
sitting O O
position. O O
Lower O O
back O O
prepped O O
and O O
draped O O
in O O
usual O O
sterile O O
fashion. O O
A O O
17-gauge, O O
Weiss O O
needle O O
used O O
to O O
access O O
epidural O O
space O O
at O O
L5-S1. O O
Three O O
cc O O
of O O
Depo-Medrol O O
and O O
3 O O
cc O O
of O O
0.5% O O
lidocaine O O
were O O
allowed O O
to O O
drip O O
in O O
via O O
gravity. O O
No O O
complications. O O
No O O
heme, O O
no O O
CSF. O O
No O O
paresthesia. O O
FOLLOW-UP O O
PLAN: O O
The O O
patient O O
to O O
report O O
for O O
further O O
injection O O
in O O
case O O
needed O O
in O O
the O O
next O O
2 O O
or O O
3 O O
months. O O
______________________________ O O
Hardy O O
Ostrowski, O O
M.D. O O
Dictated O O
By: O O
Hardy O O
Ostrowski O O
eScription O O
document:1-1277442 O O
EMSSten O O
Tel O O
DD: O O
12/08/86 O O
DT: O O
12/09/86 O O
DV: O O
12/08/86 O O

Record O O
date: O O
2090-02-14 O O
EDVISIT^56040785^OROZCO, O O
KYLE^02/14/90^CHANEY, O O
QUENTIN O O
CHIEF O O
COMPLAINT: O O
Chest O O
pain. O O
I O O
confirm O O
that O O
I O O
have O O
interviewed O O
and O O
examined O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation O O
on O O
the O O
patient's O O
chart, O O
and O O
discussed O O
the O O
evaluation, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
In O O
essence, O O
this O O
is O O
a O O
pleasant O O
65-year-old O O
male O O
with O O
known O O
history B-CAD O
of I-CAD O
CAD I-CAD O
who O O
presents O O
complaining O O
of O O
some O O
chest O O
discomfort O O
that O O
began O O
tonight O O
while O O
walking, O O
took O O
2 O O
nitro B-CAD O
and O O
the O O
pain O O
got O O
better. O O
Then, O O
had O O
a O O
repeat O O
episode O O
relived O O
by O O
nitro O O
again. O O
Picked O O
up O O
by O O
EMS. O O
Given O O
aspirin B-MEDICATION B-MEDICATION
as O O
well. O O
He O O
describes O O
the O O
pain O O
as O O
8/10, O O
sharp, O O
left O O
sided, O O
substernal, O O
and O O
deep. O O
No O O
diaphoresis, O O
no O O
nausea, O O
no O O
vomiting, O O
and O O
some O O
shortness O O
of O O
breath O O
associated O O
with O O
it. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension, B-HYPERTENSION O
diabetes, B-DIABETES O
CAD, O O
and O O
peripheral O O
vascular O O
disease. O O
SOCIAL O O
HISTORY: O O
He O O
is O O
a O O
past B-SMOKER O
smoker, I-SMOKER O
occasional O O
drinker. O O
Lives O O
with O O
family. O O
FAMILY O O
HISTORY: O O
Noncontributory. O O
PAST O O
SURGICAL O O
HISTORY: O O
Angioplasty B-CAD O
with I-CAD O
multiple I-CAD O
stents I-CAD O
and O O
an O O
A-fem O O
bypass O O
in O O
2074. O O
REVIEW O O
OF O O
SYSTEMS: O O
Per O O
HPI. O O
ALLERGIES: O O
Does O O
not O O
have O O
any O O
allergies. O O
MEDICATIONS: O O
He O O
is O O
on O O
multiple O O
medications O O
which O O
include O O
Plavix, B-MEDICATION B-MEDICATION
Zocor, B-MEDICATION B-MEDICATION
aspirin, O B-MEDICATION
Norvasc, B-MEDICATION B-MEDICATION
enalapril, B-MEDICATION O
NovoLog, B-MEDICATION B-MEDICATION
Lasix, O O
Neurontin, O O
and O O
Lantus. B-MEDICATION O
PHYSICAL O O
EXAMINATION: O O
Pulse O O
of O O
90, O O
respirations O O
16, O O
blood O O
pressure O O
186/56, B-HYPERTENSION O
oxygen O O
saturation O O
97%, O O
and O O
temperature O O
is O O
97.4. O O
HEENT O O
is O O
atraumatic, O O
normal O O
to O O
inspection, O O
normal O O
pharynx. O O
Neck O O
is O O
supple. O O
Lungs O O
are O O
clear. O O
Cardiovascular: O O
Regular O O
rate O O
and O O
rhythm O O
with O O
no O O
murmurs O O
or O O
gallops. O O
Abdomen O O
is O O
soft, O O
nontender O O
with O O
no O O
organomegaly O O
or O O
masses. O O
Skin O O
is O O
warm, O O
dry, O O
and O O
intact. O O
LABORATORY O O
DATA: O O
White O O
count O O
6.8, O O
hematocrit O O
34.1, O O
and O O
platelet O O
count O O
of O O
229,000. O O
BUN O O
45, O O
creatinine O O
1.7 O O
up O O
from O O
1.3, O O
and O O
glucose B-DIABETES O
420. I-DIABETES O
Cardiac O O
enzymes O O
were O O
negative. O O
INR O O
is O O
1. O O
EKG O O
shows O O
no O O
acute O O
ST-T O O
changes. O O
Chest O O
x-ray O O
was O O
normal. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
At O O
this O O
time, O O
we O O
have O O
spoken O O
with O O
the O O
patient's O O
primary O O
physician O O
and O O
given O O
the O O
patient's O O
cardiac O O
history, O O
his O O
hypertension, B-HYPERTENSION O
and O O
worsening O O
kidney O O
function, O O
we O O
believe O O
that O O
he O O
will O O
be O O
better O O
served O O
as O O
an O O
inpatient. O O
PRIMARY O O
DIAGNOSIS: O O
Chest O O
pain, O O
rule O O
out O O
acute O O
coronary O O
syndrome. O O
DISPOSITION: O O
Admit O O
to O O
hospital. O O
CONDITION: O O
Stable O O
______________________________ O O
CHANEY, O O
QUENTIN O O
M.D. O O
D: O O
02/15/90 O O
T: O O
02/15/90 O O
Dictated O O
By: O O
CHANEY, O O
QUENTIN O O
eScription O O
document:7-9617124 O O
SJZvdbs O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2060-10-11 O O
BCH O O
EMERGENCY O O
DEPT O O
VISIT O O
HESS,CLARENCE O O
H O O
643-65-59-5 O O
VISIT O O
DATE: O O
10/11/60 O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
46 O O
year O O
old O O
male O O
with O O
complaints O O
of O O
chest O O
pain O O
and O O
throat O O
tightness. O O
The O O
patient O O
reported O O
that O O
he O O
was O O
stuck O O
in O O
traffic O O
for O O
about O O
12 O O
hours O O
last O O
night O O
and O O
apparently O O
got O O
very O O
tense. O O
He O O
felt O O
some O O
heat O O
from O O
his O O
car, O O
thought O O
that O O
it O O
was O O
overheating, O O
and O O
then O O
developed O O
some O O
chest O O
pain O O
and O O
throat O O
tightness. O O
He O O
really O O
described O O
what O O
seems O O
to O O
be O O
fleeting O O
chest O O
tightness O O
and O O
no O O
diaphoresis, O O
no O O
shortness O O
of O O
breath, O O
and O O
no O O
arm O O
numbness O O
or O O
tingling. O O
However, O O
he O O
did O O
have O O
one O O
associated O O
symptom O O
of O O
some O O
throat O O
tightness. O O
PAST O O
MEDICAL O O
HISTORY: O O
The O O
patient O O
has O O
had O O
a O O
stress O O
test O O
one O O
year O O
ago O O
that O O
was O O
normal. O O
He O O
had O O
an O O
echocardiogram O O
at O O
that O O
time O O
that O O
was O O
also O O
normal. O O
MEDICATIONS: O O
Claritin, O O
Proventil, O O
and O O
cimetidine. O O
ALLERGIES: O O
Morphine O O
sulfate. O O
PHYSICAL O O
EXAMINATION: O O
VITAL O O
SIGNS: O O
The O O
patient O O
is O O
afebrile. O O
Vital O O
signs O O
are O O
normal. O O
HEENT: O O
Normal. O O
NECK: O O
Supple. O O
LUNGS: O O
Clear O O
bilaterally. O O
CARDIAC: O O
Regular O O
rate O O
and O O
rhythm O O
without O O
murmur. O O
ABDOMEN: O O
Soft O O
and O O
non-tender. O O
EXTREMITIES: O O
Negative. O O
No O O
CVA O O
tenderness. O O
LABORATORY O O
EVALUATION: O O
EKG O O
shows O O
normal O O
sinus O O
rhythm. O O
There O O
is O O
no O O
change O O
in O O
his O O
electrocardiogram. O O
Chest O O
x-ray O O
is O O
clear. O O
CK O O
is O O
155. O O
Troponin O O
is O O
0.13. O O
Electrolytes O O
are O O
normal. O O
BUN O O
and O O
creatinine O O
are O O
20 O O
and O O
1.0. O O
Hematocrit O O
is O O
39, O O
white O O
count O O
normal. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
is O O
a O O
46 O O
year O O
old O O
male O O
with O O
a O O
fleeting O O
episode O O
of O O
chest O O
pain O O
and O O
throat O O
tightness O O
while O O
stuck O O
in O O
traffic. O O
He O O
was O O
seen O O
at O O
Southwest O O
Texas O O
Medical O O
Center O O
and O O
then O O
sent O O
here O O
appearing O O
somewhat O O
anxious, O O
with O O
a O O
normal O O
physical O O
examination, O O
normal O O
EKG, O O
normal O O
chest O O
x-ray, O O
and O O
normal O O
metabolic O O
panel. O O
Most O O
likely O O
low O O
probability O O
for O O
ischemia. O O
Risk O O
factors O O
are O O
also O O
very O O
low. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
is O O
going O O
to O O
be O O
admitted O O
to O O
the O O
Short O O
Stay O O
Unit O O
for O O
a O O
rule O O
out O O
MI O O
protocol O O
and O O
possibly O O
for O O
another O O
ETT. O O
___________________________________ O O
NE270/9072 O O
VICTOR O O
T. O O
BONNER, O O
M.D. O O
VB07 O O
D:10/11/60 O O
T:10/11/60 O O
Dictated O O
by: O O
VICTOR O O
T. O O
BONNER, O O
M.D. O O
VB07 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2060-02-26 O O
BCH O O
Cardiovascular O O
Division O O
CVD O O
R12 O O
86 O O
Cote O O
Avenue O O
HESS, O O
CLARENCE O O
Pinehurst, O O
OH O O
19792 O O
64365595 O O
(680) O O
317-3494 O O
02/26/60 O O
Yariel O O
Law, O O
M.D. O O
Wheatland O O
Memorial O O
Nursing O O
Home/Bangdung O O
Office O O
870 O O
Newburgh O O
Street O O
Pinehurst, O O
OH O O
35594 O O
Dear O O
Dr. O O
Law: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
Mr. O O
Hess O O
in O O
followup O O
in O O
Cardiology O O
today. O O
As O O
you O O
know, O O
he O O
is O O
a O O
53-year-old O O
gentleman O O
who O O
underwent O O
implantation O O
of O O
a O O
permanent O O
pacemaker O O
on O O
02/11/60 O O
for O O
presyncope O O
and O O
pauses O O
on O O
Holter O O
monitoring. O O
His O O
past O O
medical O O
history O O
is O O
significant O O
for O O
hyperlipidemia, B-HYPERLIPIDEMIA O
gastroesophageal O O
reflux O O
disease, O O
and O O
asthma. O O
Prior O O
to O O
his O O
pacemaker O O
placement, O O
an O O
exercise O O
stress O O
test O O
was O O
performed O O
because O O
of O O
his O O
history O O
of O O
exertional O O
chest O O
pain. O O
He O O
was O O
able O O
to O O
exercise O O
for O O
8 O O
minutes O O
and O O
4 O O
seconds. O O
The O O
test O O
was O O
terminated O O
for O O
7/10 O O
substernal O O
chest O O
pain, O O
but O O
no O O
hypotension O O
and O O
no O O
overt O O
EKG O O
changes O O
were O O
noted, O O
so O O
we O O
proceeded O O
with O O
the O O
pacemaker O O
implant. O O
Since O O
the O O
implant O O
Mr. O O
Hess O O
describes O O
that O O
his O O
intermittent O O
symptoms O O
of O O
lightheadedness O O
and O O
shortness O O
of O O
breath O O
have O O
vanished, O O
however, O O
he O O
has O O
noticed O O
that O O
he O O
is O O
sleeping O O
less O O
well O O
and O O
occasionally O O
has O O
nocturnal O O
palpitations, O O
which O O
potentially O O
could O O
represent O O
pacing O O
from O O
his O O
pacemaker. O O
Interrogation O O
today O O
of O O
his O O
Medtronic O O
Kappa O O
QQ O O
626 O O
pacemaker O O
reveals O O
that O O
his O O
underlying O O
rhythm O O
is O O
sinus O O
tachycardia O O
with O O
intact O O
AV O O
conduction. O O
His O O
estimated O O
battery O O
longevity O O
is O O
89 O O
months. O O
The O O
atrial O O
impedance O O
is O O
569 O O
ohms, O O
the O O
ventricular O O
impedance O O
is O O
529 O O
ohms. O O
The O O
P-wave O O
is O O
5.6 O O
mV. O O
The O O
R-wave O O
is O O
31.3 O O
mV. O O
The O O
threshold O O
in O O
the O O
atrium O O
is O O
0.75 O O
V O O
at O O
0.4 O O
mV, O O
and O O
the O O
threshold O O
in O O
the O O
ventricle O O
is O O
0.75 O O
V O O
at O O
0.4 O O
msec. O O
In O O
summary, O O
Mr. O O
Hess O O
is O O
doing O O
extremely O O
well O O
after O O
his O O
pacemaker O O
placement. O O
His O O
pacemaker O O
incision O O
is O O
extremely O O
well O O
healed. O O
There O O
is O O
no O O
sign O O
of O O
erythema O O
or O O
hematoma. O O
However, O O
his O O
sinus O O
tachycardia O O
is O O
mildly O O
perplexing. O O
Looking O O
at O O
his O O
heart O O
rate O O
histogram, O O
it O O
appears O O
that O O
this O O
sinus O O
rates O O
have O O
varied O O
from O O
80-120 O O
beats O O
per O O
minute O O
for O O
the O O
most O O
part O O
aside O O
from O O
some O O
low O O
heart O O
rate O O
that O O
potentially O O
are O O
nocturnal. O O
I O O
have O O
performed O O
some O O
pacing O O
maneuvers O O
today O O
in O O
clinic O O
to O O
attempt O O
to O O
determine O O
whether O O
the O O
mechanism O O
of O O
his O O
current O O
tachycardia O O
is O O
sinus O O
and O O
it O O
appears O O
that O O
this O O
is O O
sinus O O
tachycardia. O O
For O O
this O O
reason, O O
I O O
have O O
performed O O
a O O
TSH O O
today, O O
which O O
is O O
normal, O O
however, O O
I O O
suggest O O
to O O
you O O
that O O
potentially O O
a O O
cursory O O
endocrine O O
workup O O
and O O
potentially O O
a O O
repeat O O
echocardiogram O O
at O O
your O O
facility O O
might O O
be O O
indicated. O O
I O O
am O O
available O O
to O O
discuss O O
these O O
findings O O
with O O
you O O
at O O
any O O
time. O O
I O O
plan O O
to O O
see O O
Mr. O O
Hess O O
in O O
followup O O
in O O
three O O
months' O O
time, O O
and O O
if O O
any O O
issues O O
arise O O
in O O
the O O
interim, O O
please O O
do O O
not O O
hesitate O O
to O O
contact O O
me. O O
Sincerely, O O
______________________________ O O
Una O O
Trujillo, O O
MD O O
Dictated O O
By: O O
Una O O
Trujillo O O
eScription O O
document:9-1748355 O O
UFFocus O O
CC: O O
Robert O O
Yousif O O
Gordon O O
MD O O
803 O O
FAIRHAVEN O O
ROAD O O
OLNEY, O O
OH O O
23751 O O
DD: O O
02/27/60 O O
DT: O O
02/27/60 O O
DV: O O
02/26/60 O O

Record B-SMOKER O
date: O O
2060-05-21 O O
HESS, O O
CLARENCE O O
64365595 O O
05/21/2060 O O
Robert O O
Y. O O
Gordon, O O
M.D. O O
WMNH O O
Internal O O
Medicine O O
Olney O O
494 O O
Fairhaven O O
Road O O
Olney, O O
OH O O
23751 O O
Dear O O
Dr. O O
Gordon: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
Mr. O O
Hess O O
in O O
followup O O
in O O
Cardiology O O
today. O O
As O O
you O O
know, O O
he O O
is O O
a O O
54-year-old O O
gentleman O O
who O O
underwent O O
implantation O O
of O O
a O O
permanent O O
pacemaker O O
on O O
02/11/2060 O O
for O O
his O O
presyncope O O
and O O
pauses O O
on O O
Holter O O
monitoring. O O
His O O
past O O
medical O O
history O O
is O O
significant O O
for O O
hyperlipidemia, B-HYPERLIPIDEMIA O
gastroesophageal O O
reflux O O
disease, O O
and O O
asthma. O O
Prior O O
to O O
his O O
pacemaker O O
placement, O O
an O O
exercise O O
stress O O
test O O
was O O
performed O O
because O O
of O O
a O O
history O O
of O O
exertional O O
chest O O
pain. O O
He O O
was O O
able O O
to O O
exercise O O
for O O
8 O O
minutes O O
and O O
4 O O
seconds. O O
The O O
test O O
was O O
terminated B-CAD O
for I-CAD O
7/10 I-CAD O
substernal I-CAD O
chest I-CAD O
pain, I-CAD O
but O O
no O O
hypotension O O
or O O
overt O O
ECG O O
changes O O
were O O
noted. O O
We O O
proceeded O O
to O O
pacemaker O O
implant O O
and O O
Mr. O O
Hess O O
has O O
done O O
well O O
since O O
that O O
time. O O
He O O
remarks O O
that O O
his O O
intermittent O O
symptoms O O
of O O
lightheadedness O O
have O O
resolved. O O
However, O O
he O O
occasionally O O
still O O
has O O
nocturnal O O
palpitations O O
as O O
well O O
as O O
occasional O O
exertional O O
chest O O
discomfort. O O
He O O
tells O O
me O O
that O O
he O O
underwent O O
testing O O
at O O
Wheatland O O
Memorial O O
consisting O O
of O O
a O O
stress B-CAD O
test I-CAD O
with I-CAD O
MIBI I-CAD O
imaging I-CAD O
that I-CAD O
perhaps I-CAD O
showed I-CAD O
an I-CAD O
abnormality, I-CAD O
though O O
the O O
report O O
of O O
this O O
test O O
is O O
not O O
available O O
to O O
me O O
today O O
for O O
review. O O
Interrogation O O
today O O
of O O
his O O
Medtronic O O
Kappa O O
CTE O O
226 O O
pacemaker O O
reveals O O
that O O
his O O
underlying O O
rhythm O O
is O O
sinus O O
tachycardia O O
with O O
intact O O
AV O O
conduction. O O
The O O
estimated O O
longevity O O
on O O
the O O
battery O O
life O O
is O O
95 O O
months. O O
The O O
atrial O O
impedance O O
is O O
544 O O
ohms O O
and O O
the O O
ventricular O O
impedance O O
is O O
519 O O
ohms. O O
The O O
P-wave O O
in O O
the O O
atrium O O
is O O
5.6 O O
mV O O
and O O
the O O
R-wave O O
in O O
the O O
ventricle O O
is O O
31 O O
mV. O O
The O O
threshold O O
in O O
the O O
atrium O O
is O O
stable O O
at O O
0.5 O O
V O O
at O O
0.4 O O
msec, O O
and O O
the O O
threshold O O
in O O
the O O
ventricle O O
is O O
also O O
stable O O
at O O
0.5 O O
V O O
at O O
0.4 O O
msec. O O
In O O
summary, O O
the O O
pacemaker O O
appears O O
to O O
be O O
working O O
quite O O
well. O O
However, O O
Mr. O O
Hess O O
persists O O
in O O
a O O
perplexing O O
sinus O O
tachycardia O O
that O O
has O O
been O O
present O O
since O O
his O O
last O O
pacemaker O O
interrogation. O O
I O O
have O O
therefore O O
ordered O O
an O O
echocardiogram O O
to O O
rule O O
out O O
any O O
ill O O
effects O O
of O O
the O O
sinus O O
tachycardia O O
or O O
any O O
structural O O
heart O O
disease O O
that O O
may O O
be O O
causing O O
the O O
sinus O O
tachycardia. O O
In O O
addition, O O
I O O
have O O
performed O O
a O O
12-lead O O
ECG, O O
which O O
appears O O
to O O
show O O
sinus O O
mechanism O O
rather O O
than O O
an O O
atrial O O
tachycardia. O O
Today O O
in O O
the O O
office, O O
his O O
sinus O O
rate O O
is O O
109 O O
beats O O
per O O
minute O O
with O O
stable O O
blood O O
pressure. O O
Mr. O O
Hess O O
and O O
I O O
have O O
checked O O
thyroid O O
studies O O
in O O
the O O
recent O O
past O O
and O O
those O O
have O O
been O O
unremarkable. O O
I O O
have O O
discussed O O
this O O
case O O
with O O
Dr. O O
Quatrell O O
Swanson O O
who O O
has O O
agreed O O
to O O
assist O O
in O O
Cardiology O O
care O O
for O O
Mr. O O
Hess O O
in O O
the O O
near O O
future, O O
since O O
Dr. O O
Law O O
is O O
moving O O
his O O
practice O O
to O O
the O O
NCHC. O O
I O O
plan O O
to O O
see O O
Mr. O O
Hess O O
in O O
followup O O
in O O
three O O
months' O O
time O O
for O O
his O O
pacemaker. O O
If O O
any O O
issues O O
arise O O
in O O
the O O
interim, O O
please O O
do O O
not O O
hesitate O O
to O O
contact O O
me. O O
Sincerely, O O
______________________________ O O
Una O O
Trujillo, O O
MD O O
eScription O O
document:4-3989721 O O
UFFocus O O
transcriptionists O O
DD: O O
06/02/60 O O
DT: O O
06/02/60 O O
DV: O O
05/21/60 O O

Record B-SMOKER O
date: O O
2060-08-05 O O
5 O O
August O O
2060 O O
Quatrell O O
Swanson, O O
MD O O
Division O O
of O O
Cardiology O O
Barney O O
Convalescent O O
Hospital O O
Re: O O
Clarence O O
H. O O
HESS O O
BCH O O
643-65-59-5 O O
Dear O O
Dr. O O
Swanson: O O
I O O
had O O
the O O
pleasure O O
of O O
caring O O
for O O
Clarence O O
Hess O O
at O O
BCH O O
08/04-03/07. O O
He O O
is O O
a O O
54-year-old O O
man O O
with O O
obesity, B-OBESE O
dyslipidemia B-HYPERLIPIDEMIA O
and O O
hypertension, B-HYPERTENSION O
S/P O O
dual-chamber O O
pacemaker O O
placement O O
by O O
Dr. O O
Una O O
Trujillo O O
in O O
February, O O
2060. O O
He O O
complained O O
of O O
fatigue O O
and O O
exertional O O
throat O O
tightness O O
and O O
a O O
nuclear B-CAD O
stress I-CAD O
test I-CAD O
in I-CAD O
June, I-CAD O
2060, I-CAD O
revealed I-CAD O
apical I-CAD O
ischemia I-CAD O
and O O
an O O
ejection O O
fraction O O
of O O
70 O O
percent. O O
Cardiac B-CAD O
catheterization I-CAD O
performed I-CAD O
by I-CAD O
Dr. I-CAD O
Leslie I-CAD O
Campbell I-CAD O
on I-CAD O
08/04/60 I-CAD O
via I-CAD O
the I-CAD O
right I-CAD O
radial I-CAD O
artery I-CAD O
revealed I-CAD O
a I-CAD O
right I-CAD O
dominant I-CAD O
system, I-CAD O
a I-CAD O
tight I-CAD O
lesion I-CAD O
in I-CAD O
the I-CAD O
proximal I-CAD O
LAD, I-CAD O
and I-CAD O
no I-CAD O
other I-CAD O
focally I-CAD O
occlusive I-CAD O
disease. I-CAD O
He I-CAD O
received I-CAD O
a I-CAD O
3mm I-CAD O
stent, I-CAD O
postdilated I-CAD O
to I-CAD O
3.5mm, I-CAD O
with I-CAD O
an I-CAD O
excellent I-CAD O
angiographic I-CAD O
result. I-CAD O
He O O
spent O O
an O O
uneventful O O
night O O
without O O
complaints, O O
ambulating O O
and O O
voiding O O
without O O
difficulty. O O
His O O
right O O
wrist O O
was O O
stable, O O
and O O
his O O
hand O O
warm O O
and O O
well O O
perfused. O O
Morning O O
labs O O
included O O
a O O
BUN O O
of O O
16, O O
creatinine O O
0.9, O O
negative O O
cardiac O O
enzymes, O O
hematocrit O O
36.4, O O
platelets O O
238,000, O O
cholesterol O O
182, O O
HDL O O
37, O O
LDL O O
91 O O
and O O
triglycerides O O
269. O O
He O O
was O O
discharged O O
home O O
on O O
aspirin, B-MEDICATION B-MEDICATION
325mg O O
po O O
qd; O O
Plavix, B-MEDICATION B-MEDICATION
75mg O O
po O O
qd, O O
to O O
be O O
continued O O
for O O
at O O
least O O
six O O
months O O
according O O
to O O
the O O
research O O
trial O O
protocol; O O
atenolol, B-MEDICATION B-MEDICATION
50mg O O
po O O
qd; O O
Lipitor, B-MEDICATION B-MEDICATION
80mg O O
po O O
qd; O O
Prilosec, O O
20mg O O
po O O
qd; O O
Proventil, O O
two O O
puffs O O
qid; O O
and O O
sublingual O O
nitroglycerin, B-MEDICATION O
prn O O
chest O O
pain. O O
We've O O
asked O O
him O O
to O O
see O O
you O O
in O O
the O O
next O O
couple O O
of O O
weeks, O O
and O O
to O O
call O O
if O O
he O O
has O O
questions O O
before O O
then. O O
He O O
also O O
will O O
follow O O
up O O
with O O
the O O
research O O
staff O O
per O O
protocol O O
guidelines. O O
Thank O O
you O O
for O O
allowing O O
us O O
to O O
participate O O
in O O
his O O
care. O O
Please O O
don't O O
hesitate O O
to O O
call O O
with O O
questions. O O
Sincerely, O O
Brittany O O
Witt, O O
MD O O
BW/brown O O
cc: O O
Robert O O
Y. O O
Gordon, O O
MD, O O
301 O O
Fairhaven O O
Road, O O
Olney, O O
OH O O
23751 O O
Una O O
Trujillo, O O
MD, O O
BCH O O
Cardiology O O
DS: O O
08/05/60 O O
DD: O O
08/05/60 O O
DT: O O
08/2150 O O

Record B-SMOKER O
date: O O
2060-07-08 O O
HESS, O O
CLARENCE O O
64365595 O O
07/08/2060 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
He O O
has O O
not O O
had O O
recurrent O O
angina. O O
Unfortunately, O O
we O O
did O O
not O O
connect O O
back O O
in O O
December O O
following O O
the O O
receipt O O
of O O
his O O
lipid O O
data O O
that O O
included O O
a O O
marked O O
and O O
unacceptable O O
LDL O O
elevation. O O
We O O
had O O
left O O
a O O
message O O
with O O
his O O
daughter, O O
Lea. O O
Additional O O
laboratory O O
data O O
at O O
that O O
time O O
included O O
a O O
hemoglobin O O
A1c O O
of O O
6.2%. O O
He O O
is O O
seeking O O
to O O
establish O O
a O O
new O O
relationship O O
with O O
a O O
primary O O
care O O
physician O O
through O O
Barney O O
Convalescent O O
Hospital. O O
He O O
has O O
also O O
had O O
problems O O
of O O
at O O
least O O
2 O O
years O O
duration O O
with O O
erectile O O
dysfunction O O
and O O
decreased O O
libido. O O
MEDICATIONS: O O
His O O
medications O O
are O O
atenolol B-MEDICATION B-MEDICATION
50 O O
mg O O
b.i.d., O O
atorvastatin B-MEDICATION B-MEDICATION
80 O O
mg O O
daily, O O
ezetimibe B-MEDICATION O
10 O O
mg O O
daily, O O
Ecotrin B-MEDICATION B-MEDICATION
325 O O
mg O O
daily, O O
Prilosec O O
20 O O
mg O O
daily. O O
He O O
apparently O O
ran B-MEDICATION O
out I-MEDICATION O
of I-MEDICATION O
his I-MEDICATION O
clopidogrel B-MEDICATION O
some O O
time O O
ago O O
and O O
did O O
not O O
renew O O
the O O
prescription. O O
It O O
was O O
his O O
understanding O O
that O O
he O O
was O O
to O O
remain O O
on O O
this O O
medication O O
for O O
only O O
six O O
months O O
following O O
the O O
PCI O O
procedure. O O
PHYSICAL O O
EXAMINATION: O O
His O O
heart O O
rate O O
at O O
rest O O
is O O
105. O O
His O O
initial O O
blood O O
pressure O O
149/96, B-HYPERTENSION O
but I-HYPERTENSION O
then I-HYPERTENSION O
150/82 B-HYPERTENSION O
on I-HYPERTENSION O
repeat, I-HYPERTENSION O
using O O
a O O
large O O
cuff. O O
His O O
weight O O
is O O
down O O
4 O O
pounds O O
to O O
193. O O
His O O
venous O O
pressure O O
and O O
carotid O O
upstrokes O O
are O O
normal. O O
His O O
lung O O
fields O O
are O O
clear. O O
He O O
has O O
no O O
cardiac O O
murmur. O O
There O O
are O O
no O O
pulse O O
deficits O O
or O O
peripheral O O
edema. O O
His O O
ECG O O
shows O O
a O O
sinus O O
tachycardia O O
(after O O
rushing O O
into O O
the O O
office) O O
and O O
an O O
incomplete O O
right O O
bundle-branch O O
block O O
pattern O O
with O O
a O O
normal O O
QRS O O
duration. O O
In O O
comparison O O
with O O
his O O
tracing O O
from O O
12/24/2060, O O
his O O
resting O O
heart O O
rate O O
has O O
increased. O O
ASSESSMENT O O
AND O O
PLAN: O O
He O O
will O O
keep O O
a O O
diary O O
of O O
blood O O
pressure O O
and O O
heart O O
rate O O
recordings O O
over O O
the O O
next O O
month O O
on O O
the O O
basis O O
of O O
which O O
we O O
will O O
determine O O
next O O
steps. O O
It O O
is O O
possible O O
that O O
the O O
higher O O
dose O O
beta-blocker O O
contributes O O
to O O
his O O
erectile O O
dysfunction, O O
though O O
the O O
problem O O
may O O
have O O
antedated O O
this O O
medication O O
altogether. O O
We O O
will O O
refer O O
him O O
to O O
the O O
practice O O
of O O
Dr. O O
Ohara O O
and O O
Dr. O O
Xiao, O O
as O O
well O O
as O O
to O O
Dr. O O
Sutherland, O O
the O O
latter O O
specifically O O
to O O
help O O
us O O
evaluate O O
his O O
longstanding O O
erectile O O
dysfunction. O O
He O O
will O O
continue O O
his O O
efforts O O
at O O
weight O O
loss. O O
He O O
is O O
working O O
out O O
at O O
the O O
gym O O
2-3 O O
times O O
per O O
week. O O
______________________________ O O
Quatrell O O
Swanson, O O
M.D. O O
eScription O O
document:5-9051404 O O
AFFocus O O
DD: O O
07/08/60 O O
DT: O O
07/09/60 O O
DV: O O
07/08/60 O O

Record B-SMOKER O
date: O O
2087-02-21 O O
DAMERON O O
EMERGENCY O O
DEPT O O
VISIT O O
VALENZUELA,BRIAN O O
036-89-96-4 O O
VISIT O O
DATE: O O
02/21/87 O O
The O O
patient O O
was O O
seen O O
by O O
me O O
in O O
the O O
emergency O O
department O O
on O O
02/21/87 O O
with O O
the O O
resident. O O
The O O
resident's O O
notes O O
were O O
reviewed O O
and O O
the O O
patient O O
interviewed O O
was O O
examined O O
by O O
me. O O
The O O
patient's O O
complete O O
history O O
is O O
limited O O
by O O
change O O
in O O
mental O O
status O O
and O O
multiple O O
sclerosis. O O
The O O
patient O O
was O O
transferred O O
from O O
an O O
Ellijay O O
home. O O
PRESENTING O O
COMPLAINT: O O
Nausea O O
and O O
vomiting. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
49-year-old O O
with O O
nausea O O
and O O
vomiting O O
for O O
the O O
past O O
24 O O
hours, O O
rigid O O
abdomen O O
and O O
no O O
bowel O O
sounds. O O
He O O
has O O
had O O
some O O
feculent O O
emesis O O
over O O
the O O
last O O
day. O O
REVIEW O O
OF O O
SYSTEMS: O O
No O O
fevers O O
or O O
chills, O O
no O O
bright O O
red O O
blood O O
per O O
rectum O O
or O O
melena O O
but O O
did O O
have O O
liquid O O
stool O O
earlier O O
today. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension, B-HYPERTENSION O
multiple O O
sclerosis O O
and O O
anemia. O O
PHYSICAL O O
EXAMINATION: O O
GENERAL: O O
The O O
patient O O
is O O
awake. O O
LUNGS: O O
Scattered O O
rhonchi, O O
otherwise O O
clear. O O
HEART: O O
Regular O O
rate O O
and O O
rhythm. O O
ABDOMEN: O O
Distended O O
with O O
absent O O
bowel O O
sounds, O O
nontender. O O
NEUROLOGICAL: O O
Nonfocal. O O
LABORATORY O O
EVALUATION: O O
Remarkable O O
for O O
a O O
glucose O O
of O O
100, O O
BUN O O
13, O O
creatinine O O
0.6, O O
sodium O O
141, O O
potassium O O
3.9, O O
chloride O O
108, O O
bicarb O O
25, O O
lipase O O
144, O O
calcium O O
9.4. O O
White O O
count O O
10.4, O O
hematocrit O O
41, O O
platelet O O
count O O
250. O O
KUB O O
reviewed O O
by O O
me O O
shows O O
distended O O
small O O
bowel O O
and O O
large O O
bowel O O
consistent O O
with O O
a O O
large O O
bowel O O
obstruction O O
versus O O
an O O
ileus. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
A O O
nasogastric O O
tube O O
was O O
placed. O O
CONSULTATIONS O O
(including O O
PCP): O O
Surgery. O O
FINAL O O
DIAGNOSIS: O O
Large O O
bowel O O
obstruction. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
will O O
be O O
admitted. O O
Surgery O O
was O O
consulted. O O
The O O
patient O O
was O O
admitted O O
in O O
stable O O
condition. O O
___________________________________ O O
GJ089/08607 O O
HAROLD O O
OSBORNE, O O
M.D. O O
HO97 O O
D:02/21/87 O O
T:02/21/87 O O
Dictated O O
by: O O
HAROLD O O
OSBORNE, O O
M.D. O O
HO97 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2088-08-03 O O
DAMERON O O
EMERGENCY O O
DEPT O O
VISIT O O
VALENZUELA,BRIAN O O
036-89-96-4 O O
The O O
patient O O
was O O
seen O O
by O O
the O O
resident, O O
seen O O
and O O
examined O O
by O O
me. O O
I O O
have O O
taken O O
the O O
history O O
and O O
reviewed O O
the O O
medical O O
record O O
as O O
well O O
as O O
the O O
vital O O
signs, O O
medication O O
and O O
allergy O O
list O O
as O O
well O O
as O O
the O O
past O O
medical O O
history. O O
PRESENTING O O
COMPLAINT: O O
Fever O O
of O O
unknown O O
cause O O
with O O
mental O O
status O O
change. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
is O O
a O O
51-year-old O O
man O O
with O O
a O O
history O O
of O O
multiple O O
sclerosis, O O
initially O O
diagnosed O O
in O O
2063 O O
and O O
also O O
a O O
history O O
of O O
hypertension, B-HYPERTENSION O
history O O
of O O
anemia O O
and O O
has O O
sacral O O
decubitus O O
that O O
has O O
been O O
debrided O O
in O O
the O O
past O O
who O O
was O O
transferred O O
to O O
the O O
emergency O O
department O O
today O O
from O O
a O O
nursing O O
facility. O O
The O O
patient O O
is O O
bedridden O O
for O O
the O O
last O O
few O O
years O O
and O O
today O O
the O O
nursing O O
home O O
personnel O O
noted O O
confusion O O
and O O
the O O
patient O O
had O O
a O O
fever. O O
The O O
nursing O O
personnel O O
at O O
the O O
nursing O O
home O O
also, O O
after O O
speaking O O
with O O
them O O
states O O
that O O
he O O
has O O
chronic O O
abdominal O O
distention O O
at O O
baseline. O O
REVIEW O O
OF O O
SYSTEMS: O O
Positive O O
for O O
fevers O O
and O O
chills. O O
Negative O O
for O O
abdominal O O
pain, O O
nausea, O O
vomiting, O O
chest O O
pain O O
or O O
palpitations. O O
The O O
patient O O
also O O
has O O
no O O
urinary O O
symptoms. O O
He O O
also O O
denies O O
a O O
cough, O O
denies O O
neck O O
stiffness O O
and O O
denies O O
a O O
headache. O O
PAST O O
MEDICAL O O
HISTORY: O O
The O O
patient O O
wears O O
a O O
condom O O
cath O O
at O O
baseline. O O
MEDICATIONS: O O
Baclofen, O O
atenolol, B-MEDICATION B-MEDICATION
Lactulose O O
and O O
Lasix O O
as O O
well O O
as O O
vitamin O O
E. O O
PHYSICAL O O
EXAMINATION: O O
VITAL O O
SIGNS: O O
Here O O
his O O
temperature O O
is O O
101.8. O O
He O O
is O O
tachycardic O O
with O O
a O O
pulse O O
rate O O
of O O
112, O O
respiratory O O
rate O O
24 O O
but O O
he O O
is O O
maintaining O O
a O O
normal O O
blood O O
pressure O O
of O O
131/79. O O
His O O
oxygen O O
saturation O O
is O O
also O O
99%. O O
GENERAL: O O
He O O
is O O
awake O O
and O O
alert, O O
in O O
no O O
distress. O O
He O O
is O O
communicative O O
but O O
some O O
times O O
difficult O O
to O O
understand. O O
He O O
is O O
oriented O O
x2. O O
He O O
is O O
somewhat O O
dysarthric. O O
His O O
dysarthria O O
is O O
at O O
his O O
baseline O O
according O O
to O O
nursing O O
personnel. O O
HEENT: O O
Otherwise O O
normal. O O
He O O
has O O
no O O
evidence O O
of O O
an O O
ear O O
infection. O O
His O O
oropharyngeal O O
examination O O
is O O
normal. O O
He O O
has O O
no O O
lymphadenopathy. O O
NECK: O O
Supple O O
and O O
nontender. O O
There O O
is O O
no O O
cervical O O
adenopathy. O O
No O O
signs O O
of O O
meningitis. O O
Full O O
range O O
of O O
motion. O O
Normal O O
flexion O O
and O O
extension. O O
LUNGS: O O
Clear. O O
No O O
rhonchi O O
heard. O O
No O O
wheezes O O
or O O
rales O O
heard. O O
Good O O
air O O
movement O O
bilaterally. O O
CARDIAC: O O
Tachycardic O O
but O O
no O O
murmurs O O
or O O
rubs O O
appreciated. O O
No O O
friction O O
rub. O O
The O O
patient O O
is O O
well O O
perfused. O O
Pulses O O
are O O
normal O O
throughout. O O
Good O O
capillary O O
refill. O O
SKIN: O O
Warm O O
to O O
the O O
touch O O
indicating O O
good O O
perfusion. O O
Warm O O
and O O
dry. O O
No O O
lesions O O
seen. O O
He O O
has O O
a O O
right O O
gluteal O O
ulcer O O
but O O
is O O
healing. O O
ABDOMEN: O O
Somewhat O O
distended O O
and O O
mildly O O
tympanitic O O
but O O
no O O
tenderness, O O
no O O
guarding, O O
rebound O O
or O O
masses. O O
No O O
liver O O
edge O O
palpated. O O
No O O
spleen O O
edge O O
palpated O O
and O O
no O O
evidence O O
of O O
a O O
hernia. O O
Bowel O O
sounds O O
are O O
normal. O O
Again, O O
it O O
is O O
soft O O
and O O
nontender. O O
GENITOURINARY: O O
He O O
has O O
a O O
condom O O
cath. O O
Cloudy O O
urine O O
in O O
the O O
Foley. O O
MUSCULOSKELETAL: O O
Normal O O
examination. O O
He O O
is O O
somewhat O O
contracted O O
in O O
his O O
lower O O
extremities O O
but O O
for O O
the O O
most O O
part, O O
no O O
evidence O O
of O O
ulceration O O
and O O
no O O
pedal O O
edema. O O
There O O
is O O
no O O
evidence O O
of O O
trauma. O O
NEUROLOGICAL: O O
Grossly O O
intact. O O
Oriented O O
x2 O O
with O O
some O O
dysarthria O O
at O O
baseline. O O
RECTAL: O O
Heme O O
negative O O
with O O
good O O
rectal O O
tone. O O
LABORATORY O O
EVALUATION: O O
Chest O O
x-ray O O
was O O
done O O
which O O
showed O O
no O O
evidence O O
of O O
an O O
infection, O O
no O O
evidence O O
of O O
a O O
pneumonia. O O
Because O O
of O O
his O O
abdominal O O
distention, O O
a O O
KUB O O
was O O
done O O
but O O
there O O
was O O
no O O
evidence O O
of O O
air O O
fluid O O
levels O O
and O O
no O O
evidence O O
of O O
intestinal O O
obstruction. O O
He O O
had O O
a O O
lot O O
of O O
gas O O
but O O
otherwise O O
normal. O O
There O O
was O O
also O O
no O O
evidence O O
of O O
constipation. O O
Electrocardiogram O O
showed O O
a O O
sinus O O
rhythm O O
with O O
some O O
nonspecific O O
ST O O
and O O
T-wave O O
changes. O O
Old O O
electrocardiogram O O
was O O
compared O O
with O O
new O O
one O O
and O O
there O O
was O O
no O O
significant O O
change. O O
His O O
white O O
count O O
was O O
14,000 O O
with O O
a O O
hematocrit O O
of O O
36. O O
His O O
electrolytes, O O
BUN O O
and O O
creatinine O O
as O O
well O O
as O O
blood O O
sugar O O
was O O
normal. O O
Amylase O O
and O O
lipase, O O
also O O
normal. O O
Liver O O
function O O
tests, O O
normal. O O
Urinalysis O O
showed O O
too O O
numerous O O
to O O
count O O
white O O
cells O O
and O O
also O O
has O O
bacteria. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
Management O O
in O O
the O O
emergency O O
department O O
consisted O O
of O O
IV O O
fluids. O O
Blood O O
cultures O O
and O O
urine O O
cultures O O
were O O
sent. O O
The O O
patient O O
was O O
immediately O O
started O O
on O O
intravenous O O
antibiotics, O O
was O O
given O O
Tylenol, O O
placed O O
on O O
oxygen O O
and O O
was O O
being O O
hydrated. O O
Again, O O
a O O
urine O O
culture O O
was O O
sent O O
as O O
well O O
as O O
blood O O
cultures. O O
A O O
51-year-old O O
man O O
with O O
a O O
history O O
of O O
multiple O O
sclerosis, O O
bedridden, O O
also O O
has O O
a O O
history O O
of O O
hypertension O O
who O O
has O O
been O O
experiencing O O
fever, O O
chills, O O
tachycardia, O O
tachypnea O O
and O O
mental O O
status O O
change O O
over O O
the O O
last O O
twenty-four O O
hours O O
at O O
his O O
nursing O O
home O O
who O O
presents O O
now O O
with O O
urosepsis. O O
Cultures O O
done, O O
antibiotics O O
given, O O
IV O O
fluids O O
given, O O
Tylenol O O
given. O O
Vital O O
signs O O
are O O
normalizing. O O
CONSULTATIONS O O
(including O O
PCP): O O
Medical. O O
FINAL O O
DIAGNOSIS: O O
Urosepsis. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
is O O
going O O
to O O
be O O
admitted O O
to O O
the O O
medical O O
service. O O
The O O
patient O O
is O O
admitted O O
to O O
the O O
medical O O
service O O
in O O
stable O O
condition. O O
Primary O O
care O O
physician O O
is O O
aware. O O
___________________________________ O O
VI752/79442 O O
KEITH O O
TOLLIVER, O O
M.D. O O
KT40 O O
D:08/05/88 O O
T:08/05/88 O O
Dictated O O
by: O O
KEITH O O
TOLLIVER, O O
M.D. O O
KT40 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2092-10-15 O O
EDVISIT^03689964^VALENZUELA, O O
BRIAN^10/15/92^BENSON, O O
KAILEE O O
I O O
saw O O
this O O
patient O O
in O O
conjunction O O
with O O
Dr. O O
Otis. O O
I O O
confirm O O
that O O
I O O
have O O
interviewed O O
and O O
examined O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation O O
on O O
the O O
patient's O O
chart, O O
and O O
discussed O O
the O O
evaluation, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient. O O
CHIEF O O
COMPLAINT: O O
A O O
55-year-old O O
male O O
with O O
vomiting. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
with O O
end-stage O O
multiple O O
sclerosis O O
as O O
well O O
as O O
neurogenic O O
bladder O O
and O O
chronic O O
indwelling O O
Foley O O
who O O
presents O O
from O O
the O O
nursing O O
home O O
after O O
4 O O
episodes O O
of O O
vomiting O O
since O O
10:00 O O
a.m. O O
He O O
has O O
had O O
also O O
progressive O O
abdominal O O
distention, O O
he O O
reports O O
over O O
the O O
last O O
3-4 O O
weeks. O O
Nursing O O
note O O
also O O
reports O O
decreased O O
urine O O
output O O
for O O
the O O
last O O
2 O O
days. O O
He O O
had O O
a O O
KUB O O
done O O
at O O
the O O
referring O O
facility O O
that O O
demonstrated O O
a O O
question O O
of O O
a O O
small O O
bowel O O
obstruction O O
but O O
this O O
film O O
was O O
not O O
sent O O
with O O
him. O O
He O O
also O O
had O O
a O O
fever O O
today O O
per O O
report. O O
The O O
patient O O
denies O O
any O O
abdominal O O
pain, O O
shortness O O
of O O
breath, O O
chest O O
pain, O O
or O O
other O O
complaints. O O
He O O
does O O
have O O
a O O
history O O
of O O
an O O
ileus O O
and O O
prior O O
admissions O O
for O O
urosepsis O O
with O O
levofloxacin O O
resistant O O
E. O O
coli. O O
He O O
reports O O
a O O
mild O O
cough. O O
PAST O O
MEDICAL O O
HISTORY: O O
Remarkable O O
for O O
hypertension, B-HYPERTENSION O
multiple O O
sclerosis, O O
anemia, O O
decubitus O O
ulcers, O O
neurogenic O O
bladder, O O
and O O
urethral O O
strictures. O O
PAST O O
SURGICAL O O
HISTORY: O O
He O O
is O O
status O O
post O O
urethral O O
stenting. O O
Social O O
history, O O
family O O
history, O O
and O O
review O O
of O O
systems O O
are O O
as O O
per O O
written O O
note. O O
MEDICATIONS: O O
Prozac, O B-MEDICATION
Actonel, O O
ferrous O O
sulfate, O O
aspirin, B-MEDICATION B-MEDICATION
multivitamins, O O
lisinopril, B-MEDICATION B-MEDICATION
Lipitor, B-MEDICATION B-MEDICATION
and O O
Prilosec. O O
ALLERGIES: O O
None. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
awake O O
and O O
alert, O O
generally O O
chronically O O
ill O O
appearing, O O
quite O O
pleasant. O O
Vital O O
signs O O
are O O
within O O
normal O O
limits O O
as O O
documented O O
except O O
for O O
an O O
elevated O O
pulse O O
rate O O
of O O
120 O O
beats O O
per O O
minute, O O
respiratory O O
rate O O
of O O
24, O O
room O O
air O O
saturations O O
of O O
93% O O
and O O
a O O
temperature O O
of O O
99.2. O O
For O O
full O O
physical O O
exam O O
findings, O O
please O O
see O O
the O O
resident's O O
written O O
note. O O
Specifically, O O
HEENT O O
exam O O
is O O
atraumatic. O O
There O O
is O O
a O O
1-cm O O
ulcer O O
on O O
roof O O
of O O
his O O
mouth. O O
He O O
has O O
synechiae O O
of O O
his O O
pupils O O
that O O
are O O
2 O O
mm O O
and O O
nonreactive. O O
His O O
extraocular O O
movements O O
are O O
not O O
alignment. O O
Neck O O
exam O O
is O O
normal O O
as O O
documented. O O
Respiratory O O
exam O O
reveals O O
scattered O O
bronchi. O O
There O O
is O O
no O O
chest O O
wall O O
tenderness. O O
Cardiovascular O O
exam O O
reveals O O
tachycardia O O
without O O
murmur. O O
Abdominal O O
exam O O
is O O
distinctly O O
distended O O
and O O
slightly O O
firm O O
with O O
hypoactive O O
bowel O O
sounds O O
but O O
no O O
tenderness, O O
no O O
rebound O O
or O O
guarding. O O
Skin O O
is O O
intact, O O
warm, O O
and O O
dry O O
on O O
my O O
exam. O O
Musculoskeletal O O
exam O O
is O O
nontender O O
with O O
no O O
edema O O
or O O
bony O O
point O O
tenderness. O O
Neurologically, O O
the O O
patient O O
has O O
increased O O
tone O O
in O O
his O O
lower O O
extremities O O
and O O
weakness O O
of O O
all O O
of O O
his O O
extremities. O O
His O O
mood O O
and O O
affect O O
is O O
normal O O
but O O
he O O
is O O
dysarthric. O O
He O O
is O O
neurologically, O O
however, O O
appears O O
to O O
be O O
at O O
his O O
baseline. O O
LABORATORY O O
DATA: O O
CBC O O
and O O
electrolytes O O
remarkable O O
for O O
white O O
blood O O
count O O
16.2, O O
BUN O O
and O O
creatinine O O
ratio O O
of O O
40 O O
and O O
1.0 O O
respectively. O O
Last O O
creatinine O O
was O O
0.5. O O
LFTs O O
and O O
lipase O O
are O O
within O O
normal O O
limits O O
as O O
documented. O O
INR O O
is O O
1.1. O O
IMAGING O O
STUDIES: O O
EKG O O
demonstrates O O
sinus O O
rhythm O O
with O O
nonspecific O O
ST-T O O
wave O O
changes. O O
Plain O O
films O O
of O O
the O O
abdomen O O
demonstrates O O
scattered O O
dilated O O
loops O O
of O O
small O O
bowel O O
but O O
no O O
clear O O
obstruction O O
consistent O O
with O O
possible O O
ileus O O
versus O O
early O O
obstruction. O O
Chest O O
x-ray O O
shows O O
low O O
lung O O
volumes O O
without O O
any O O
focal O O
consolidation. O O
IMPRESSION: O O
This O O
is O O
a O O
patient O O
with O O
abdominal O O
distention, O O
is O O
quite O O
impressive O O
as O O
well O O
as O O
a O O
firm O O
belly O O
with O O
dilated O O
loops O O
of O O
bowel O O
on O O
his O O
KUB O O
as O O
well O O
as O O
history O O
of O O
vomiting O O
earlier O O
this O O
evening. O O
He O O
has O O
had O O
no O O
vomiting O O
here O O
and O O
does O O
not O O
feel O O
nauseated, O O
however, O O
does O O
not O O
have O O
an O O
appetite. O O
He O O
has O O
had O O
decreased O O
urine O O
output O O
and O O
managed O O
to O O
put O O
out O O
a O O
total O O
25 O O
cc O O
of O O
urine O O
through O O
his O O
Foley O O
since O O
2:00 O O
p.m. O O
today. O O
Presently, O O
he O O
was O O
not O O
tender O O
over O O
his O O
bladder. O O
Upon O O
flushing O O
the O O
Foley, O O
there O O
is O O
a O O
large O O
amount O O
of O O
debris. O O
They O O
came O O
out O O
and O O
followed O O
by O O
high O O
pressure O O
urine O O
that O O
had O O
malodorous O O
character O O
to O O
it. O O
I O O
think O O
this O O
patient O O
likely O O
has O O
an O O
ileus O O
and O O
urinary O O
tract O O
infection. O O
He O O
received O O
antibiotics O O
wide O O
spectrum O O
including O O
vancomycin, O O
levofloxacin O O
and O O
Flagyl O O
initially O O
followed O O
by O O
gentamicin O O
given O O
his O O
prior O O
levofloxacin O O
resistance. O O
PRIMARY O O
DIAGNOSIS: O O
Urinary O O
tract O O
infection. O O
SECONDARY O O
DIAGNOSIS: O O
Ileus O O
versus O O
SBO. O O
The O O
patient O O
was O O
admitted O O
to O O
the O O
ED O O
Observation O O
Area O O
for O O
CT O O
imaging, O O
however O O
will O O
eventually O O
require O O
admission O O
for O O
this O O
problem O O
likely O O
to O O
Medicine O O
Service. O O
DISPOSITION: O O
Admitted O O
to O O
ED O O
Observation O O
Unit. O O
______________________________ O O
BENSON, O O
KAILEE O O
MD O O
D: O O
10/15/92 O O
T: O O
10/15/92 O O
Dictated O O
By: O O
BENSON, O O
KAILEE O O
eScription O O
document:7-8396761 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2093-08-09 O O
EDVISIT^03689964^VALENZUELA, O O
BRIAN^08/09/93^BOYER, O O
DAWN O O
CHIEF O O
COMPLAINT: O O
Fever. O O
I O O
saw O O
this O O
patient O O
with O O
Dr. O O
Edwards. O O
Please O O
see O O
his O O
note O O
for O O
further O O
details. O O
I O O
confirm O O
that O O
I O O
have O O
interviewed O O
and O O
examined O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation, O O
and O O
discussed, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient. O O
History O O
is O O
obtained O O
through O O
discussion O O
with O O
the O O
patient O O
who O O
says O O
yes O O
or O O
no, O O
as O O
well O O
as O O
transporting O O
paramedics. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
56-year-old O O
gentleman O O
with O O
end-stage O O
MS O O
at O O
nursing O O
home. O O
He O O
has O O
indwelling O O
Foley O O
catheter. O O
He O O
was O O
transported O O
from O O
nursing O O
home O O
to O O
ED O O
as O O
he O O
has O O
had O O
a O O
fever O O
today O O
to O O
approximately O O
100.5. O O
Per O O
EMS, O O
they O O
were O O
told O O
that O O
the O O
patient O O
has O O
also O O
been O O
more O O
lethargic O O
with O O
decreased O O
POs O O
today. O O
He O O
received O O
Tylenol O O
and O O
defervesced O O
somewhat. O O
He O O
then O O
received O O
400 O O
mL O O
of O O
fluid O O
en O O
route O O
and O O
he O O
has O O
become O O
more O O
awake O O
and O O
alert. O O
He O O
is O O
telling O O
the O O
paramedics O O
that O O
he O O
is O O
at O O
his O O
baseline. O O
He O O
denies O O
to O O
me O O
any O O
headaches, O O
neck O O
pain. O O
No O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
no O O
abdominal O O
pain, O O
no O O
cough, O O
no O O
fevers O O
or O O
chills. O O
He O O
reports O O
that O O
he O O
is O O
able O O
to O O
discern O O
when O O
he O O
has O O
abdominal O O
pain. O O
He O O
has O O
intact O O
sensation. O O
PAST O O
MEDICAL O O
HISTORY: O O
As O O
per O O
HPI. O O
In O O
addition, O O
CAD, B-CAD O
diabetes, B-DIABETES O
hypertension, B-HYPERTENSION O
CHF. O O
Please O O
see O O
resident O O
note O O
for O O
list O O
of O O
medication O O
and O O
allergies. O O
SOCIAL O O
HISTORY: O O
He B-SMOKER O
does B-SMOKER O
not I-SMOKER O
smoke. I-SMOKER O
He O O
does O O
not O O
drink. O O
He O O
is O O
at O O
a O O
nursing O O
home. O O
He O O
is O O
married. O O
FAMILY O O
HISTORY: O O
Noncontributory. O O
REVIEW O O
OF O O
SYSTEMS: O O
As O O
per O O
resident O O
note O O
and O O
my O O
HPI. O O
PHYSICAL O O
EXAMINATION: O O
He O O
is O O
awake, O O
alert, O O
and O O
nontoxic, O O
in O O
no O O
distress. O O
Afebrile, O O
pulse O O
in O O
90s, O O
respiratory O O
18, O O
blood O O
pressure O O
102/66, O O
O2 O O
saturation O O
99% O O
on O O
room O O
air. O O
HEENT O O
exam: O O
Normocephalic O O
and O O
atraumatic. O O
Neck: O O
Supple. O O
He O O
has O O
coarse O O
upper O O
airway O O
sounds O O
bilaterally O O
anteriorly. O O
Heart O O
is O O
regular O O
rate O O
and O O
rhythm. O O
His O O
abdomen O O
is O O
slightly O O
distended. O O
He O O
is O O
nontender. O O
He O O
has O O
sacral O O
decubitus O O
ulcers O O
that O O
are O O
well O O
healing, O O
no O O
evidence O O
of O O
acute O O
infection, O O
contractures O O
in O O
his O O
lower O O
extremities. O O
He O O
is O O
alert O O
and O O
does O O
say O O
yes O O
or O O
no O O
to O O
questions. O O
The O O
most O O
likely O O
etiology O O
in O O
this O O
patient O O
for O O
an O O
infection O O
is O O
his O O
urinary O O
tract O O
infection. O O
His O O
urine O O
and O O
his O O
catheter O O
was O O
cloudy. O O
Prior O O
to O O
sending O O
the O O
urine O O
for O O
evaluation O O
for O O
urinalysis O O
to O O
the O O
lab, O O
the O O
patient O O
had O O
his O O
catheter O O
changed. O O
He O O
then O O
began O O
to O O
no O O
longer O O
drain O O
urine. O O
Accordingly, O O
a O O
bladder O O
probe O O
was O O
put O O
on O O
using O O
ultrasound O O
and O O
clearly O O
showed O O
a O O
distended O O
bladder. O O
Attempts O O
were O O
made O O
to O O
change O O
the O O
catheter, O O
but O O
they O O
were O O
unsuccessful. O O
There O O
was O O
pus O O
found O O
at O O
the O O
meatus. O O
At O O
this O O
point, O O
the O O
patient O O
is O O
awaiting O O
a O O
CT O O
scan O O
of O O
his O O
abdomen O O
and O O
urology O O
evaluation. O O
He O O
is O O
also O O
receiving O O
antibiotics O O
for O O
presumed O O
UTI O O
and/or O O
abscess. O O
LABORATORY O O
DATA: O O
Include O O
sodium O O
136, O O
K O O
4.5, O O
chloride O O
102, O O
bicarbonate O O
22, O O
BUN O O
22, O O
creatinine O O
0.45, O O
and O O
glucose O O
136. O O
LFTs O O
within O O
normal O O
limits. O O
Normal O O
lipase. O O
White O O
count O O
of O O
5.7, O O
hematocrit O O
35.5, O O
and O O
platelet O O
count O O
306,000. O O
Coags O O
within O O
normal O O
limits. O O
UA O O
again O O
is O O
pending O O
at O O
this O O
time. O O
He O O
will O O
be O O
admitted O O
to O O
the O O
hospital. O O
I O O
attempted O O
to O O
reach O O
the O O
patient's O O
primary O O
care O O
physician, O O
Dr. O O
Earle O O
to O O
contact O O
from O O
the O O
WBM O O
office, O O
however, O O
my O O
calls O O
went O O
unanswered. O O
At O O
this O O
point, O O
I O O
am O O
signing O O
out O O
the O O
patient O O
and O O
he O O
is O O
awaiting O O
his O O
CT O O
scan O O
and O O
urology O O
evaluation. O O
DIAGNOSIS: O O
Urinary O O
infection, O O
mild O O
dehydration, O O
end-stage O O
MS. O O
CONDITION: O O
Stable. O O
DISPOSITION: O O
Will O O
be O O
admitted. O O
______________________________ O O
BOYER, O O
DAWN O O
MD O O
D: O O
08/09/93 O O
T: O O
08/10/93 O O
Dictated O O
By: O O
BOYER, O O
DAWN O O
eScription O O
document:6-1950972 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2094-10-23 O O
Patient: O O
VALENZUELA,BRIAN O O
03689964Date O O
of O O
Admission: O O
10/23/2094 O O
Attending: O O
Davila O O
Internal O O
Medicine O O
Intern O O
Admit O O
Note O O
CC: O O
fever, O O
lethargy, O O
confusion O O
HPI: O O
57M O O
who O O
lives O O
in O O
NH O O
and O O
has O O
h/o O O
severe O O
MS-partially O O
verbal O O
at O O
baseline, O O
bedridden- O O
recurrent O O
UTIs O O
and O O
urosepsis O O
with O O
chronic O O
indwelling O O
foley, O O
HTN, B-HYPERTENSION O
CAD,and B-CAD O
CHF O O
(EF O O
35-40%) O O
who O O
presents O O
from O O
NH O O
with O O
confusion, O O
lethargy, O O
and O O
fever O O
to O O
102. O O
Per O O
patient's O O
daughter, O O
he O O
becomes O O
lethargic O O
and O O
confused O O
whenever O O
he O O
has O O
fevers. O O
Patient O O
was O O
doing O O
well O O
at O O
NH O O
until O O
day O O
prior O O
to O O
admission O O
when O O
he O O
became O O
lethargic. O O
The O O
day O O
of O O
admission O O
he O O
had O O
fever O O
and O O
was O O
confused O O
so O O
daughter O O
brought O O
him O O
to O O
ED. O O
ED O O
vitals O O
notable O O
for O O
T101.8, O O
HR O O
140s, O O
BP O O
110/80s, O O
98% O O
RA. O O
WBC O O
notable O O
for O O
13.3. O O
Patient O O
was O O
given O O
tylenol, O O
1LNS, O O
Blood O O
and O O
urine O O
cultures O O
were O O
sent. O O
Pt O O
given O O
IV O O
vanc O O
and O O
ceftriaxone. O O
Per O O
daughter O O
patient's O O
foley O O
is O O
supposed O O
to O O
be O O
changed O O
every O O
15 O O
days O O
at O O
NH, O O
but O O
she O O
does O O
not O O
believe O O
that O O
it O O
has O O
been O O
changed. O O
Last O O
documented O O
changed O O
at O O
the O O
WBM O O
was O O
12/93 O O
by O O
urology. O O
Patient O O
is O O
able O O
to O O
nod O O
and O O
answer O O
questions O O
although O O
he O O
is O O
difficult O O
to O O
understand. O O
He O O
is O O
cooperative O O
and O O
responds O O
to O O
commands. O O
Pt O O
reports O O
feeling O O
fatigued, O O
lethargic O O
x O O
2 O O
days, O O
but O O
denies O O
fevers, O O
chills, O O
chest O O
pain, O O
SOB, O O
dysuria, O O
suprapublic O O
pain, O O
n/v/diarrhea, O O
or O O
CVA O O
tenderness. O O
PMHX: O O
severe/end-stage O O
MS O O
DM B-DIABETES O
atonic O O
colon O O
with O O
history O O
of O O
constipation O O
neurogenic O O
bladder O O
with O O
chronic O O
indwelling O O
foley O O
chronic O O
urethral O O
strictures O O
and O O
bladder O O
calculi O O
(including O O
staghorn O O
calculi) O O
CAD O O
s/p B-CAD O
STEMI I-CAD O
in I-CAD O
2091 I-CAD O
in O O
setting O O
of O O
sepsis/pressors O O
CHF O O
(EF O O
35-40%) O O
recurrent O O
UTIs O O
and O O
urosepsis O O
decubitus O O
ulcers O O
ulcers O O
toes/heels O O
chronic O O
sinus O O
tachycardia O O
Medications: O O
(from O O
NH) O O
Acetaminophen O O
(tylenol) O O
1000mg O O
PO O O
Q6H O O
prn O O
headache O O
Acetylsalicylic B-MEDICATION O
Acid I-MEDICATION O
81mg O O
PO O O
QD O O
Albuterol O O
Neb O O
1.25MG O O
INH O O
Q6H O O
prn O O
Wheezing O O
Alendronate O O
(Fosamax) O O
70mg O O
PO O O
Qweek O O
on O O
Wednesdays O O
Artificial O O
Tears O O
Ascorbic O B-MEDICATION
Acid O O
(vit O O
C) O O
500mg O O
PO O O
BID O O
Baclofen O O
10mg O O
PO O O
TID O O
Bisacodyl O O
Rectal O O
10 O O
MG O O
PR O O
QOD O O
prn O O
Constipation O O
Docusate O O
Sodium O O
100mg O O
PO O O
BID O O
Caltrate O O
500 O O
(calcitrate) O O
2 O O
tab O O
PO O O
TID O O
Insulin B-MEDICATION O
Aspart I-MEDICATION O
Sliding I-MEDICATION O
Scale I-MEDICATION O
SC O O
AC O O
Lacri-Lube O O
Ointment O O
1 O O
Appl O O
OU O O
QHS O O
Latulose O O
15mL O O
PO O O
QD O O
prn O O
constipation O O
Metformin B-MEDICATION B-MEDICATION
500mg I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
Metroprol B-MEDICATION O
25mg O O
PO O O
BID O O
Naphazoline O O
0.012% O O
Ophthalmic O O
Solution O O
1 O O
drop O O
OD O O
BID O O
prn O O
redness O O
drainage O O
Omeprazole O O
20mg O O
PO O O
QD O O
Sennosides O O
2 O O
TAB O O
PO O O
BID O O
Simethicone O O
80 O O
mg O O
PO O O
BID O O
Simvastatin B-MEDICATION B-MEDICATION
80mg O O
PO O O
QD O O
Therapeutic O O
MV O O
5 O O
ML O O
PO O O
BID O O
Tolteroidine O O
Tartrate O O
Long O O
Acting O O
4mg O O
PO O O
QHS O O
Allergies O O
NKA O O
Studies: O O
10/22/94 O O
CXR O O
PA O O
view: O O
Single O O
frontal O O
portable O O
upright O O
radiograph O O
of O O
the O O
chest O O
is O O
reviewed O O
with O O
comparison O O
made O O
to O O
prior O O
PA O O
and O O
lateral O O
study O O
dated O O
December O O
03, O O
2093. O O
Lungs O O
are O O
clear O O
without O O
focal O O
consolidation. O O
Lung O O
volumes O O
are O O
low. O O
Cardiomediastinal O O
silhouette O O
is O O
stable. O O
There O O
is O O
no O O
pleural O O
effusion O O
or O O
pneumothorax. O O
LABS: O O
10/22/94: O O
NA O O
155 O O
(*#), O O
K O O
4.3, O O
CL O O
118 O O
(*), O O
CO2 O O
27, O O
BUN O O
48 O O
(*#), O O
CRE O O
0.53 O O
(*#), O O
EGFR O O
160, O O
GLU O O
164 O O
(*) O O
ANION O O
10 O O
CA O O
9.3, O O
PHOS O O
2.6, O O
MG O O
3.2 O O
(*#), O O
TBILI O O
0.3, O O
TP O O
8.1 O O
(*), O O
ALB O O
3.3 O O
(*), O O
GLOB O O
4.8 O O
(*), O O
LACT O O
1.6 O O
bPO2 O O
72, O O
bPCO2 O O
38, O O
bPH O O
7.46 O O
(*), O O
UBASEX O O
2, O O
O2 O O
Sat O O
96.1, O O
CO2-PL O O
27, O O
HGB O O
BG O O
14.9, O O
HCT-BG O O
44 O O
ALT/SGPT O O
11, O O
AST/SGOT O O
9, O O
ALKP O O
116, O O
TBILI O O
0.3 O O
WBC O O
13.30 O O
(*), O O
RBC O O
5.30 O O
(#), O O
HGB O O
13.6 O O
(#), O O
HCT O O
43.6 O O
(#), O O
MCV O O
82.4, O O
MCH O O
25.7 O O
(*), O O
MCHC O O
31.2 O O
(*), O O
PLT O O
373 O O
RDW O O
15.7 O O
(*#) O O
%BAND-M O O
1, O O
%POLY-M O O
77 O O
(*#), O O
%LYMPH-M O O
16 O O
(*#), O O
%ATYPS O O
0, O O
%MONO-M O O
6, O O
%EOS-M O O
0 O O
(#), O O
%BASO-M O O
0 O O
PLT-EST O O
NL O O
PT O O
15.7 O O
(*), O O
PT-INR O O
1.2 O O
(*), O O
PTT O O
33.9 O O
UA-COLOR O O
LT O O
BROWN, O O
UA-GLUC O O
NEG, O O
UA-BILI O O
TRACE, O O
UA-KET O O
NEG, O O
UA-SPGR O O
1.010, O O
UA-BLD O O
3+ O O
(*), O O
UA-PH O O
8.5 O O
(*), O O
UA-PROT O O
2+ O O
(*) O O
UA-UROBI O O
NEG, O O
UA-NIT O O
POS, O O
UA-WBC O O
3+ O O
(*) O O
UAS-RBC O O
4-10 O O
(*), O O
UAS-WBC O O
&gt;200 O O
(*), O O
UAS-BACT O O
4+, O O
UAS-SQHI O O
1+, O O
OCAST O O
NEG, O O
HCAST O O
0, O O
UAS-CRYS O O
1+, O O
UAS-COM O O
NEG O O
UA-EPIS O O
NEG O O
Physical O O
Exam:T O O
98.6 O O
HR O O
150 O O
BP O O
113/83 O O
18-20 O O
97% O O
RA O O
Gen: O O
pleasant O O
elderly O O
gentleman, O O
trying O O
to O O
speak O O
but O O
is O O
not O O
understandable; O O
HEENT: O O
mucous O O
membranes O O
dry O O
Neck: O O
JVP O O
flat O O
Chest: O O
CTA O O
anteriorly; O O
pt O O
was O O
unable O O
to O O
roll O O
or O O
sit O O
up O O
CV: O O
RRR O O
no O O
m/r/g O O
Abd: O O
+ O O
BS, O O
soft, O O
NT, O O
ND, O O
no O O
grimace O O
to O O
palpation, O O
no O O
rebound O O
or O O
guarding O O
Extr: O O
no O O
edema, O O
thin O O
frail O O
with O O
multiple O O
ulcers O O
on O O
big O O
toes, O O
small O O
toes O O
and O O
R O O
heel O O
SKIN: O O
several O O
large O O
decub O O
ulcers O O
below O O
buttocks O O
Neuro: O O
Alert O O
&amp; O O
Oriented O O
x O O
3, O O
CN O O
II-XII O O
appear O O
intact O O
no O O
focal O O
deficits O O
A/P: O O
57M O O
h/o O O
severe O O
MS O O
who O O
is O O
bedridden O O
and O O
partially O O
non-verban O O
with O O
PMHx O O
significant O O
for O O
atonic O O
bladder O O
with O O
indwelling O O
foley O O
and O O
recurrent O O
UTI O O
and O O
urosepsis O O
who O O
presents O O
with O O
urosepsis/UTI O O
picture. O O
1) O O
UTI/urosepsis- O O
Urology O O
changed O O
foley O O
which O O
had O O
notable O O
purple O O
growth O O
on O O
both O O
foley O O
and O O
bag, O O
suggestive O O
of O O
Psuedomonas. O O
Patient O O
will O O
be O O
double O O
covered O O
for O O
Pseudomonas O O
with O O
ceftaz O O
and O O
cipro. O O
-follow O O
blood O O
cultures O O
-follow O O
up O O
urine O O
culture O O
-new O O
foley O O
2) O O
decub O O
ulcers O O
and O O
toe O O
ulcers O O
-do O O
not O O
appear O O
infected, O O
dressings O O
c/d/i O O
-vascular O O
wound O O
care O O
consult O O
-order O O
special O O
bed O O
for O O
ulcers O O
-order O O
for O O
heels O O
to O O
be O O
wrapped/padded O O
3) O O
DM- O O
d/c B-MEDICATION O
metformin I-MEDICATION B-MEDICATION
and O O
use O O
ISS B-MEDICATION O
4) O O
holding O O
antihypertensives O O
given O O
possibly O O
septic O O
5) O O
Continue O O
1/2NS O O
to O O
bring O O
down O O
hyernatremia O O
NA O O
155 O O
6) O O
Contine O O
pureed, O O
netcar O O
thick O O
consistency O O
with O O
encourage O O
PO O O
intakes O O
between O O
meals O O
7) O O
enoxaparan O O
40SC O O
prophylaxis O O
8) O O
Full O O
code O O
____________________________________ O O
Heather O O
T. O O
Quinonez, O O
M.D. O O

Record O O
date: O O
2132-10-01 O O
Personal O O
Data O O
and O O
Overall O O
Health O O
75 O O
year O O
old O O
right O O
handed O O
man O O
with O O
pure O O
motor O O
hemiparesis O O
synrdrome O O
on O O
right O O
from O O
L O O
IC O O
stroke O O
in O O
6/32. O O
History O O
of O O
Present O O
Illness O O
Mr. O O
Slater O O
comes O O
to O O
the O O
stroke O O
clinic O O
today O O
for O O
an O O
initial O O
visit O O
and O O
second O O
opinion O O
for O O
left-sided O O
weakness O O
starting O O
in O O
6/25/32. O O
He O O
was O O
golfing O O
at O O
the O O
time, O O
and O O
suddenly O O
developed O O
weakness O O
with O O
no O O
sensory O O
changes. O O
The O O
weakness O O
involved O O
the O O
face, O O
arm O O
and O O
leg O O
on O O
the O O
left O O
side O O
only. O O
He O O
went O O
to O O
Gilmore O O
Hospital, O O
where O O
they O O
checked O O
his O O
blood O O
pressure, O O
and O O
found O O
it O O
to O O
be O O
220/140 B-HYPERTENSION O
(per O O
his O O
report). O O
A O O
CT O O
scan O O
was O O
performed, O O
and O O
he O O
was O O
informed O O
that O O
it O O
was O O
normal. O O
He O O
became O O
frustrated O O
with O O
the O O
ER O O
there O O
and O O
signed O O
out O O
AMA. O O
He O O
went O O
to O O
the O O
HCH O O
at O O
Easton O O
2 O O
days O O
later, O O
his O O
BP O O
was O O
still O O
elevated, O O
and O O
they O O
started O O
him O O
on O O
clonidine. O O
They O O
attempted O O
to O O
arrange O O
for O O
a O O
renal O O
angiogram O O
to O O
work O O
up O O
his O O
hypertension, B-HYPERTENSION O
but O O
he O O
declined. O O
No O O
further O O
stroke/TIA O O
workup O O
was O O
performed. O O
He O O
comes O O
to O O
me O O
for O O
a O O
second O O
opinion O O
regarding O O
his O O
workup. O O
His O O
weakness O O
has O O
greatly O O
improved, O O
but O O
not O O
back O O
to O O
normal. O O
He O O
has O O
never O O
had O O
sensory O O
changes, O O
and O O
no O O
speech O O
difficulties, O O
anosognosia, O O
neglect, O O
or O O
gait O O
instability. O O
He O O
did O O
have O O
'flashing O O
lights O O
in O O
both O O
eyes' O O
for O O
fifteen O O
minutes O O
at O O
the O O
onset O O
of O O
the O O
symptoms O O
on O O
the O O
golf O O
course, O O
but O O
none O O
since O O
then. O O
He O O
has O O
never O O
had O O
transient O O
monocular O O
blindness, O O
diplopia, O O
or O O
suddenly O O
blurry O O
vision. O O
Past O O
Medical O O
History O O
Hypertension. B-HYPERTENSION O
He O O
is O O
being O O
worked O O
up O O
for O O
possible O O
renal O O
artery O O
stenosis. O O
He O O
has O O
not O O
had O O
his O O
cholesterol O O
checked. O O
Medications O O
PROPRANOLOL B-MEDICATION O
(PROPRANOLOL O O
HCL) O O
40MG O O
PO O O
BID O O
Start O O
Date: O O
10/1/32 O O
HCTZ B-MEDICATION O
(HYDROCHLOROTHIAZIDE) B-MEDICATION O
12.5MG O O
PO O O
QD O O
Start O O
Date: O O
10/1/32 O O
CLONIDINE O O
HCL O O
0.2MG O O
PO O O
BID O O
Start O O
Date: O O
10/1/32 O O
ZESTRIL B-MEDICATION B-MEDICATION
(LISINOPRIL) I-MEDICATION O
40MG O O
PO O O
QD O O
Start O O
Date: O O
10/1/32 O O
ASA B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC I-MEDICATION O
ACID) I-MEDICATION O
81MG O O
PO O O
QD O O
Start O O
Date: O O
10/1/32 O O
Allergies O O
NKDA O O
Social O O
History O O
lives O O
in O O
Avenal. O O
Retired O O
journalist. O O
Widowed. O O
quit B-SMOKER O
smoking I-SMOKER O
in I-SMOKER O
June, I-SMOKER O
former I-SMOKER O
1 I-SMOKER O
ppd I-SMOKER O
x I-SMOKER O
60 I-SMOKER O
years. I-SMOKER O
EtOH: O O
couple O O
of O O
drinks O O
1-2 O O
times O O
per O O
week. O O
Family O O
History O O
HTN O O
in O O
mother, O O
aunt. O O
Father O O
died O O
of O O
cancer. O O
No O O
stroke O O
Review O O
of O O
Systems O O
denies O O
chest O O
pain, O O
SOB, O O
palpitations. O O
Exam O O
HEENT: O O
NC/AT, O O
O/P O O
clear. O O
Neck O O
supple, O O
no O O
bruits. O O
Lungs: O O
CTA O O
bilaterally. O O
CV: O O
RRR, O O
no O O
M/R/G. O O
Abd: O O
soft, O O
NT/ND, O O
+ O O
BS. O O
EXT: O O
no O O
CCE O O
Neuro: O O
A, O O
Ox3. O O
Speech O O
fluent, O O
non-dysarthric. O O
Naming, O O
repetition O O
intact. O O
STM O O
3/3 O O
at O O
5 O O
min. O O
Follows O O
3-step O O
R/L O O
commands. O O
CN: O O
VFFTC, O O
EOMI O O
without O O
nystagmus. O O
PERRL O O
facial O O
sensation, O O
symmetry O O
and O O
strength O O
intact. O O
Hearing O O
intact O O
bilaterally. O O
Palate O O
moves O O
symmetrically. O O
SCM O O
strength O O
full O O
bilaterally. O O
Tongue O O
midline. O O
Motor: O O
nl O O
bulk O O
and O O
tone. O O
Power O O
5/5 O O
throughout. O O
No O O
drift. O O
Sensation: O O
intact O O
to O O
LT, O O
PP, O O
temp, O O
vib, O O
PS O O
throughout. O O
Coord: O O
nl O O
FNF, O O
HKS O O
bilaterally. O O
Gait O O
normal-based, O O
good O O
toe, O O
heel O O
and O O
tandem O O
walk. O O
DTR's: O O
2 O O
throughout, O O
toes O O
downgoing. O O
Plan O O
I O O
have O O
reviewed O O
Mr. O O
Slater's O O
CT O O
scan, O O
and O O
he O O
has O O
a O O
lacunar O O
infarct O O
of O O
the O O
left O O
posterior O O
internal O O
capsule, O O
which O O
explains O O
his O O
pure O O
motor O O
hemiparesis O O
syndrome. O O
I O O
have O O
counseled O O
him O O
that O O
most O O
likely O O
the O O
best O O
treatment O O
for O O
this O O
type O O
of O O
stroke O O
is O O
to O O
control O O
his O O
hypertension, O O
and O O
to O O
use O O
antiplatelet O O
agents. O O
I O O
have O O
asked O O
that O O
he O O
increase O O
his O O
dose O O
of O O
ASA O B-MEDICATION
to O O
325 O O
mg O O
per O O
day. O O
In O O
addition, O O
he O O
needs O O
a O O
work O O
up. O O
I O O
have O O
arranged O O
for O O
him O O
to O O
have O O
CNIS, O O
24 O O
hour O O
Holter O O
monitoring, O O
and O O
TTE O O
with O O
bubble O O
study. O O
Additionally, O O
we O O
should O O
check O O
fasting O O
lipids. O O
He O O
wishes O O
to O O
have O O
a O O
PCP O O
at O O
FPC, O O
and O O
I O O
have O O
requested O O
that O O
he O O
have O O
the O O
next O O
available O O
appointment O O
with O O
Dr. O O
Harry O O
Tolliver O O
of O O
the O O
cardiology O O
department, O O
who O O
could O O
also O O
be O O
instrumental O O
in O O
adjusting O O
his O O
hypertension O O
meds. O O
He O O
will O O
return O O
to O O
clinic O O
in O O
2-3 O O
months, O O
and O O
is O O
to O O
page O O
me O O
immediately O O
with O O
any O O
new O O
symptoms O O
or O O
concerns. O O
CC O O
Dr. O O
Harry O O
Tolliver, O O
FPC O O
cardiology O O
unit. O O

Record B-SMOKER O
date: O O
2132-12-31 O O
Personal O O
Data O O
and O O
Overall O O
Health O O
75-year-old O O
S/P O O
L O O
internal O O
capsule O O
stroke O O
6/32. O O
Reason O O
for O O
Visit O O
Mr. O O
Slater O O
returns O O
to O O
clinic O O
today O O
for O O
routine O O
follow O O
up. O O
I O O
last O O
saw O O
him O O
on O O
10/1/2132, O O
and O O
he O O
has O O
continued O O
to O O
improvesince O O
that O O
time. O O
He O O
remains O O
on O O
ASA B-MEDICATION B-MEDICATION
325mg O O
po O O
qd O O
for O O
stroke O O
prevention, O O
and O O
continues O O
to O O
be O O
worked O O
up O O
for O O
renovascular O O
hypertension. B-HYPERTENSION O
He O O
has O O
had O O
no O O
new O O
stroke-like O O
symptoms, O O
and O O
only O O
very O O
infrequently O O
feels O O
that O O
the O O
right O O
leg O O
is O O
weak, O O
usually O O
at O O
the O O
end O O
of O O
the O O
day O O
when O O
he O O
is O O
fatigued. O O
He O O
was O O
recently O O
seen O O
by O O
Dr. O O
Harry O O
Tolliver O O
of O O
the O O
department O O
of O O
Cardiology. O O
He O O
underwent O O
a O O
24-hour O O
holter O O
monitor, O O
which O O
showed O O
no O O
evidence O O
for O O
atrial O O
fibrillation O O
or O O
other O O
significant O O
dysrhythmia. O O
His O O
CNIS O O
have O O
no O O
evidence O O
for O O
disease. O O
He O O
is O O
to O O
go O O
for O O
his O O
TTE O O
with O O
bubble O O
study O O
later O O
today. O O
Medications O O
PROPRANOLOL B-MEDICATION O
(PROPRANOLOL O O
HCL) O O
40MG O O
PO O O
BID O O
x O O
87 O O
days O O
Start O O
Date: O O
10/1/32 O O
Stop O O
Date: O O
12/27/32 O O
ATENOLOL B-MEDICATION B-MEDICATION
50MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
Start O O
Date: O O
12/31/32 O O
NORVASC B-MEDICATION B-MEDICATION
(AMLODIPINE) O O
2.5MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
Start O O
Date: O O
12/31/32 O O
Exam O O
Alert, O O
Ox3. O O
Speech O O
fluent, O O
non-dysarthric. O O
EOM's O O
full, O O
no O O
nystagmus. O O
Face O O
symmetric, O O
full O O
power O O
x O O
4. O O
No O O
drift. O O
Gait O O
steady, O O
narrow-based. O O
Plan O O
I O O
am O O
pleased O O
with O O
his O O
negative O O
results O O
so O O
far O O
(24 O O
hour O O
holter, O O
CNIS), O O
and O O
I O O
doubt O O
the O O
TTE O O
will O O
change O O
our O O
management. O O
We O O
are O O
likely O O
left O O
with O O
small O O
vessel O O
disease O O
causing O O
a O O
lacune O O
in O O
the O O
internal O O
capsule. O O
The O O
best O O
for O O
of O O
treatment O O
would O O
be O O
continued O O
antiplatelet O O
therapy O O
with O O
the O O
ASA O B-MEDICATION
325mg O O
per O O
day, O O
and O O
continued O O
treatment O O
for O O
his O O
hypertension, O O
as O O
per O O
Dr. O O
Tolliver. O O
I O O
will O O
see O O
him O O
again O O
in O O
3 O O
months O O
time, O O
and O O
he O O
will O O
call O O
me O O
in O O
the O O
interim O O
with O O
any O O
problems O O
or O O
questions. O O
CC O O
Dr. O O
Harry O O
Tolliver, O O
FPC O O
Cardiology O O
Unit O O

Record O O
date: O O
2138-06-14 O O
Patient O O
Name: O O
SLATER, O O
OWEN; O O
MRN: O O
8635779 O O
Dictated O O
on: O O
06/14/2138 O O
by O O
URIEL O O
T. O O
ZIRKLE, O O
MD O O
ATTENDING O O
CONSULTATION O O
NOTE O O
DIAGNOSIS: O O
Recurrent O O
renal O O
cell O O
carcinoma. O O
HISTORY: O O
Mr. O O
Slater O O
is O O
a O O
delightful O O
and O O
active O O
80-year-old O O
man O O
who O O
was O O
incidentally O O
found O O
to O O
have O O
a O O
renal O O
mass O O
in O O
2133. O O
At O O
that O O
time O O
Dr. O O
Updike O O
performed O O
a O O
left O O
partial O O
nephrectomy, O O
and O O
the O O
final O O
pathology O O
showed O O
a O O
1.5 O O
cm O O
clear O O
cell O O
renal O O
cell O O
carcinoma. O O
Since O O
that O O
date O O
he O O
has O O
remained O O
well O O
with O O
no O O
clinical O O
evidence O O
of O O
recurrent O O
disease O O
and O O
has O O
had O O
interval O O
CT O O
scans. O O
For O O
the O O
last O O
2 O O
years, O O
enhancing O O
nodules O O
have O O
been O O
noted O O
within O O
the O O
region O O
of O O
the O O
partial O O
nephrectomy. O O
A O O
biopsy O O
performed O O
approximately O O
1 O O
year O O
ago O O
did O O
not O O
demonstrate O O
any O O
cancer O O
within O O
modestly O O
enlarged O O
retroperitoneal O O
lymph O O
nodes. O O
CT O O
scan O O
was O O
repeated O O
in O O
December O O
of O O
2137. O O
This O O
again O O
showed O O
some O O
enlarged O O
retroperitoneal O O
adenopathy O O
and O O
also O O
enlargement O O
of O O
the O O
soft O O
tissue O O
nodules. O O
Biopsy O O
in O O
March O O
of O O
this O O
year O O
showed O O
probable O O
recurrent O O
renal O O
cell O O
carcinoma O O
of O O
the O O
clear O O
cell O O
type O O
within O O
the O O
nodules. O O
Biopsy O O
of O O
an O O
adjacent O O
adrenal O O
gland O O
showed O O
no O O
cancer. O O
His O O
metastatic O O
workup O O
has O O
included O O
CT O O
scans O O
of O O
the O O
chest, O O
which O O
have O O
demonstrated O O
small O O
pulmonary O O
nodules O O
of O O
uncertain O O
significance. O O
He O O
has O O
met O O
with O O
Drs. O O
Eagle O O
and O O
Yzaguirre. O O
Both O O
have O O
recommended O O
completion O O
of O O
the O O
nephrectomy O O
and O O
resection O O
of O O
any O O
visible O O
tumor, O O
perhaps O O
with O O
intraoperative O O
radiation O O
as O O
well. O O
PAST O O
MEDICAL O O
HISTORY: O O
1. O O
Hypertension. B-HYPERTENSION O
2. O O
CVA O O
with O O
residual O O
weakness O O
on O O
the O O
right O O
side. O O
He O O
is, O O
however, O O
still O O
able O O
to O O
walk O O
with O O
a O O
cane. O O
3. O O
High B-HYPERLIPIDEMIA O
cholesterol. I-HYPERLIPIDEMIA O
CURRENT O O
MEDICATIONS: O O
Atenolol, B-MEDICATION B-MEDICATION
hydrochlorothiazide, B-MEDICATION B-MEDICATION
lisinopril, B-MEDICATION B-MEDICATION
Norvasc, B-MEDICATION B-MEDICATION
Avapro, B-MEDICATION B-MEDICATION
clonidine, O O
Lipitor, B-MEDICATION B-MEDICATION
and O O
allopurinol. O O
DRUG O O
ALLERGIES: O O
None O O
known. O O
SOCIAL O O
HISTORY: O O
He O O
is O O
a O O
long O O
retired O O
news O O
writer O O
with O O
a O O
heavy B-SMOKER O
smoking I-SMOKER O
history. I-SMOKER O
He B-SMOKER O
last I-SMOKER O
smoked I-SMOKER O
in I-SMOKER O
2132. I-SMOKER O
He O O
is O O
a O O
widow O O
and O O
came O O
today O O
to O O
the O O
appointment O O
with O O
1 O O
of O O
his O O
daughters. O O
REVIEW O O
OF O O
SYSTEMS: O O
No O O
respiratory O O
symptoms O O
suggesting O O
progressive O O
pulmonary O O
metastases, O O
no O O
abdominal O O
or O O
GI O O
symptoms. O O
PHYSICAL O O
EXAM: O O
No O O
anemia, O O
jaundice, O O
cyanosis, O O
or O O
clubbing O O
No O O
gynecomastia O O
Respiration O O
comfortable O O
Mild O O
right-sided O O
motor O O
weakness, O O
walks O O
with O O
a O O
cane. O O
No O O
skeletal O O
deformity O O
or O O
tenderness O O
Head, O O
eyes, O O
ears, O O
and O O
nose O O
normal O O
Abdomen O O
soft O O
with O O
no O O
hepatomegaly, O O
splenomegaly, O O
nor O O
any O O
additional O O
masses. O O
No O O
hernias. O O
RADIOLOGY: O O
CT O O
scans O O
demonstrate O O
multiple O O
soft O O
tissue O O
nodules O O
within O O
the O O
partial O O
nephrectomy O O
bed, O O
the O O
largest O O
being O O
15 O O
mm O O
across. O O
He O O
also O O
has O O
prominent O O
lymph O O
nodes O O
within O O
the O O
retroperitoneum, O O
the O O
largest O O
of O O
which O O
is O O
14 O O
mm, O O
and O O
an O O
enlarged O O
left O O
common O O
iliac O O
lymph O O
node O O
of O O
18 O O
mm. O O
Chest O O
CT O O
shows O O
scattered O O
2 O O
mm O O
nodules O O
of O O
uncertain O O
significance. O O
IMPRESSION O O
AND O O
PLAN: O O
Confirmed O O
local O O
recurrence O O
of O O
renal O O
cell O O
cancer O O
- O O
for O O
completion O O
nephrectomy O O
and O O
resection O O
of O O
tumor O O
bed. O O
Lymph O O
nodes O O
will O O
be O O
also O O
be O O
sampled. O O
For O O
intraoperative O O
radiation O O
if O O
appropriate O O
and O O
possibly O O
adjuvant O O
radiation O O
to O O
follow. O O
Consent O O
obtained O O
today. O O
URIEL O O
T. O O
ZIRKLE, O O
MD O O
cc: O O
Dr. O O
Francis O O
Eagle O O
Dr. O O
Vonnie O O
Yzaguirre O O
Dr. O O
Fernando O O
Gregg O O
Internal O O
Medicine, O O
FPC O O
DD:06/14/2138 O O
DT:06/15/2138 O O
CI:100417 O O
:7153 O O

Record O O
date: O O
2141-08-31 O O
Internal O O
Medicine O O
Intern O O
Admission O O
Note O O
PATIENT: O O
Slater, O O
Owen O O
MRN: O O
8635779 O O
DATE: O O
31 O O
August O O
41 O O
TIME: O O
816 O O
ATTENDING O O
PHYSICIAN: O O
Gregg O O
HCP/FAMILY O O
CONTACT: O O
Talissa O O
Irish O O
(daughter) O O
(215)579-9664 O O
CHIEF O O
COMPLAINT O O
: O O
hyperglycemia O O
HISTORY O O
OF O O
THE O O
PRESENT O O
ILLNESS O O
Mr. O O
Slater O O
is O O
an O O
83 O O
yo O O
w/ O O
h/o O O
bullous O O
pemphigoid, O O
chronic O O
kidney O O
disease, O O
HTN, B-HYPERTENSION O
dyslipidemia, B-HYPERLIPIDEMIA O
and O O
multiple O O
vasculopathies O O
presenting O O
with O O
hyperglycemia. O O
His O O
dermatologist O O
started O O
prednisone O O
(60 O O
mg O O
daily) O O
three O O
weeks O O
ago O O
for O O
a O O
pemphigiod O O
flair. O O
Mr O O
Slater&#8217;s O O
sugars O O
were O O
initially O O
well O O
controlled O O
off O O
insulin, B-MEDICATION O
but O O
a O O
week O O
and O O
a O O
half O O
ago O O
he O O
began O O
to O O
develop O O
lower O O
extremity O O
edema, O O
DOE, O O
and O O
general O O
fatigue. O O
He O O
began O O
to O O
taper O O
the O O
prednisone O O
(to O O
40 O O
mg O O
daily) O O
and O O
then O O
stopped O O
them O O
altogether O O
yesterday. O O
He O O
presented O O
to O O
the O O
FPC O O
ED O O
complaining O O
of O O
fatigue O O
and O O
weakness O O
and O O
was O O
found O O
to O O
have O O
a O O
FSBG&gt;500. B-DIABETES O
His O O
initial O O
labs O O
were O O
notable O O
for O O
a O O
glucose B-DIABETES O
of I-DIABETES O
804. I-DIABETES O
An O O
EKG O O
showed O O
a-fib O O
(rate O O
70s). O O
His O O
blood O O
pressure, O O
oxygenation, O O
and O O
respiratory O O
were O O
the O O
normal O O
range O O
and O O
he O O
was O O
given O O
2 O O
L O O
of O O
NS O O
and O O
regular B-MEDICATION O
insulin. I-MEDICATION O
Repeat O O
labs O O
showed O O
Glu B-DIABETES O
479 I-DIABETES O
w/ O O
partial O O
resolution O O
of O O
other O O
electrolyte O O
abnormalities. O O
He O O
was O O
admitted O O
to O O
the O O
hospital O O
for O O
further O O
evaluation O O
and O O
management. O O
On O O
arrival O O
to O O
the O O
floor, O O
he O O
reports O O
feeling O O
tired, O O
but O O
that O O
his O O
weakness O O
and O O
fatigue O O
have O O
improved O O
since O O
he O O
arrived O O
in O O
the O O
ED. O O
He O O
continues O O
to O O
have O O
LE O O
edema, O O
which O O
has O O
worsened O O
in O O
the O O
last O O
day. O O
He O O
denies O O
recent O O
weight O O
loss, O O
fevers, O O
cough, O O
dyspnea O O
or O O
PND, O O
syncope, O O
N/V, O O
diarrhea, O O
constipation, O O
melena, O O
urinary O O
symptoms, O O
joint O O
pain, O O
bruising, O O
worsening O O
rash, O O
skin O O
lesions, O O
double O O
vision, O O
dysarthria, O O
headache, O O
or O O
focal O O
weakness O O
or O O
numbness. O O
PAST O O
MEDICAL O O
HISTORY: O O
&#183; O O
Bullous O O
pemphigoid O O
2/2 O O
simvastatin O B-MEDICATION
&#183; O O
Chronic O O
kidney O O
disease O O
&#183; O O
RAS O O
&#183; O O
History O O
of O O
CVA O O
with O O
residual O O
minor O O
weakness O O
and O O
numbness O O
on O O
the O O
right O O
side O O
&#8216;00 O O
&#183; O O
Hypertension B-HYPERTENSION O
&#183; O O
Hypercholesterolemia B-HYPERLIPIDEMIA B-MEDICATION
&#183; O O
PVD O O
(ABI O O
0.43/0.20 O O
after O O
exercise) O O
&#183; O O
AAA O O
2.8 O O
cm O O
&#8216;06 O O
PAST O O
SURGICAL O O
HISTORY: O O
&#183; O O
Stage O O
III O O
renal O O
cell O O
carcinoma O O
status O O
post O O
L O O
nephrectomy O O
in O O
2133, O O
now O O
w/ O O
metastatic O O
disease O O
(+ O O
retroperitoneal O O
LN O O
8/41) O O
MEDICATIONS O O
ON O O
ADMISSION: O O
Amlodipine B-MEDICATION B-MEDICATION
5 O O
mg O O
PO O O
daily O O
Allopurinol O O
200 O O
mg O O
daily O O
ASA B-MEDICATION B-MEDICATION
325 O O
daily O O
Doxazosin O O
2 O O
mg O O
qHS O O
HCTZ B-MEDICATION O
12.5 O O
PO O O
daily O O
Aliskiren/HCTZ B-MEDICATION O
12.5 O O
mg O O
daily O O
Clonidine O O
0.2 O O
mg O O
PO O O
BID O O
ALLERGIES: O O
simvastatin O B-MEDICATION
(pemphigoid); O O
ezetimibe O O
(rash) O O
SOCIAL O O
HISTORY: O O
Retired O O
political O O
journalist. O O
60 B-SMOKER O
pk I-SMOKER O
year I-SMOKER O
smoking I-SMOKER O
history, I-SMOKER O
but B-SMOKER O
none I-SMOKER O
currently. I-SMOKER O
Occasional O O
EtOH, O O
No O O
illicits. O O
FAMILY O O
HISTORY: O O
non-contributory O O
PHYSICAL O O
EXAM O O
ON O O
ADMISSION: O O
VITALS: O O
T O O
98.4 O O
; O O
BP O O
140/72 O O
, O O
HR O O
72 O O
, O O
RR O O
18 O O
, O O
97% O O
O2 O O
Sat O O
RA O O
General O O
&#8211; O O
NAD O O
, O O
AOx3 O O
HEENT O O
&#8211; O O
PERRL, O O
EOMI; O O
sclerae O O
anicteric, O O
no O O
conjunctival O O
injection; O O
oropharynx O O
dry O O
w/o O O
erythema O O
or O O
exudate O O
Neck O O
- O O
no O O
lymphadenopathy, O O
JVP O O
5 O O
cm; O O
carotid O O
pulses O O
2+ O O
bilaterally; O O
? O O
R O O
carotid O O
bruit; O O
trachea O O
midline O O
Pulmonary O O
&#8211; O O
rhonci O O
at O O
L O O
base, O O
otherwise O O
CTAB O O
Cardiac O O
&#8211; O O
irregularly O O
irregular, O O
no O O
murmurs O O
Abdomen O O
&#8211; O O
S/NT O O
+BS O O
Extremity O O
&#8211; O O
warm, O O
2-3+ O O
pitting O O
edema O O
bilaterally O O
Neurology O O
&#8211; O O
CN O O
II-XII O O
grossly O O
intact, O O
good O O
strength O O
bilaterally, O O
normal O O
sensation O O
bilaterally O O
Skin O O
&#8211; O O
legs O O
2-5 O O
cm O O
flat O O
red O O
patches O O
w/o O O
bullae; O O
arms, O O
legs, O O
and O O
chest, O O
2-6 O O
cm, O O
multiple O O
excoriated O O
red O O
urticarial O O
patches O O
w/o O O
bullae O O
LABORATORIES O O
1533 O O
Lytes: O O
Na O O
123 O O
K O O
4.1 O O
Cl O O
85 O O
HCO3 O O
26 O O
BUN O O
51 O O
Cr O O
2.5 O O
Glu O O
804 O O
Ca O O
8.5 O O
Mg O O
1.7 O O
Phos O O
2.8 O O
1942 O O
Lytes: O O
Na O O
128 O O
K O O
3.5 O O
Cl O O
93 O O
HCO3 O O
26 O O
BUN O O
45 O O
Cr O O
2.37 O O
Glu O O
479 O O
Ca O O
7.9 O O
CBC: O O
WBC O O
7.7 O O
Hct O O
32 O O
Plt O O
193 O O
LFTs: O O
WNL O O
alb O O
3.3 O O
U/A: O O
no O O
ketones, O O
3+ O O
glucose O O
BNP: O O
7500 O O
(no O O
previous O O
measured) O O
2133: O O
Troponin: O O
0.05 O O
MICROBIOLOGY O O
8/30 O O
urine O O
cultures: O O
negative O O
RADIOLOGICAL O O
STUDIES O O
1/40: O O
Per O O
cardiology O O
note, O O
echo O O
showed O O
LVEF O O
60% O O
w/ O O
e/o O O
diastolic O O
dysfunction O O
and O O
? O O
PFO/ASD O O
8/31/41 O O
CXR O O
: O O
Small O O
left-sided O O
pleural O O
effusion. O O
Patchy O O
atelectasis O O
versus O O
pneumonia O O
in O O
the O O
left O O
lower O O
lobe. O O
EKG O O
a-fib O O
rate O O
90, O O
normal O O
axis, O O
normal O O
intervals, O O
no O O
TWI O O
A/P O O
: O O
Mr. O O
Slater O O
is O O
an O O
83 O O
yo O O
w/ O O
h/o O O
bullous O O
pemphigoid, O O
chronic O O
kidney O O
disease, O O
HTN, O O
dyslipidemia, O O
and O O
multiple O O
vasculopathies O O
presenting O O
with O O
hyperglycemia O O
#) O O
Hyperglycemia: O O
Elevated O O
glucose, O O
serum O O
osm, O O
lack O O
of O O
anion O O
gap, O O
and O O
absence O O
of O O
urine O O
ketones O O
suggest O O
HHS. O O
Most O O
likely O O
etiology O O
is O O
steroid-induced O O
hyperglycemia O O
superimposed O O
on O O
? O O
underlying O O
DM O O
(HgbA1c B-DIABETES O
6.80 I-DIABETES O
in I-DIABETES O
the I-DIABETES O
past). I-DIABETES O
No O O
e/o O O
infectious-trigger O O
(urine O O
culture O O
negative O O
and O O
CXR O O
equivocal). O O
Rapidly O O
improving O O
after O O
IVF O O
in O O
ED O O
and O O
insulin. O O
Current O O
FSBG O O
330. O O
Diagnostic O O
evaluation: O O
will O O
send O O
repeat O O
HgbA1c, O O
FSBG O O
before O O
meals, O O
qd O O
electrolytes. O O
Therapeutic O O
intervention: O O
will O O
hold O O
IVF O O
given O O
new O O
a-fib O O
and O O
signs O O
of O O
volume O O
overload O O
(see O O
below); O O
give O O
10 B-MEDICATION O
U I-MEDICATION O
regular I-MEDICATION O
insulin I-MEDICATION O
now I-MEDICATION O
and O O
SSI B-MEDICATION O
with I-MEDICATION O
meals I-MEDICATION O
(convert I-MEDICATION O
daily I-MEDICATION O
usage I-MEDICATION O
to I-MEDICATION O
NPH); I-MEDICATION O
potassium O O
repletion O O
PRN O O
#) O O
A-fib: O O
New O O
onset O O
a-fib. O O
Differential O O
includes O O
fluid O O
overload, O O
hyperthyroidism, O O
pre-existing O O
structural O O
heart O O
disease O O
(LAH, O O
mitral O O
regurg/stenosis). O O
CHADS2 O O
score: O O
12.5% O O
risk O O
of O O
stroke O O
over O O
the O O
next O O
year O O
if O O
not O O
on O O
anticoagulation. O O
Currently O O
rate-controlled O O
80s. O O
Diagnostic O O
evaluation: O O
echocardiogram, O O
TSH, O O
cardiac O O
monitor. O O
Therapeutic O O
intervention: O O
d/c O O
amlodipine O O
(given O O
LE O O
edema) O O
and O O
start O O
low O O
dose O O
dilt B-MEDICATION O
(30 I-MEDICATION O
mg I-MEDICATION O
TID) I-MEDICATION O
for O O
continued O O
rate O O
control. O O
On O O
ASA. O O
Will O O
discuss O O
risks/benefits O O
of O O
coumadin O O
w/ O O
patient O O
and O O
PCP. O O
#) O O
Troponin O O
leak: O O
In O O
the O O
absence O O
of O O
chest O O
pain/angina O O
or O O
concerning O O
EKG O O
changes, O O
this O O
likely O O
represents O O
heart O O
strain O O
in O O
the O O
context O O
of O O
chronic O O
kidney O O
disease. O O
Will O O
trend O O
enzyme, O O
repeat O O
EKG, O O
and O O
monitor O O
for O O
changes O O
in O O
clinical O O
status. O O
#) O O
Edema O O
: O O
differential O O
includes O O
congestive O O
heart O O
failure O O
vs O O
worsening O O
kidney O O
disease O O
vs O O
iatrogenic O O
volume O O
overload O O
vs O O
capillary O O
leak O O
syndrome O O
(from O O
steroids, O O
norvasc). O O
Given O O
duration, O O
clinical O O
picture, O O
and O O
elevated O O
BNP O O
(although O O
no O O
baseline O O
comparison), O O
concerning O O
for O O
CHF. O O
Diagnostic O O
evaluation: O O
echocardiogram, O O
TSH, O O
etc. O O
w/ O O
more O O
extensive O O
evaluation O O
as O O
needed. O O
Therapeutic O O
intervention: O O
will O O
hold O O
lasix O O
given O O
underlying O O
kidney O O
function, O O
continue O O
HCTZ, O O
monitor O O
I/Os. O O
#) O O
Bullous O O
pemphigoid O O
: O O
Will O O
restart O O
prednisone O O
taper O O
at O O
40 O O
mg O O
daily O O
per O O
dermatology O O
outpatient O O
note O O
w/ O O
goal O O
of O O
one O O
additional O O
week, O O
then O O
20 O O
mg O O
daily O O
for O O
three O O
weeks. O O
Will O O
contact O O
dermatology O O
regarding O O
modifications O O
to O O
the O O
regimen, O O
if O O
any. O O
#) O O
HTN O O
: O O
Currently O O
well-controlled. O O
Continue O O
doxazosin O O
2 O O
mg O O
qHS, O O
HCTZ O O
12.5 O O
PO O O
daily O O
Aliskiren/HCTZ O O
12.5 O O
mg O O
daily, O O
and O O
clonidine O O
0.2 O O
mg O O
PO O O
BID. O O
Monitor O O
and O O
add O O
additional O O
agents O O
as O O
needed O O
#) O O
Chronic O O
kidney O O
disease: O O
Cr O O
slightly O O
above O O
baseline, O O
but O O
improving O O
with O O
hydration. O O
Will O O
monitor. O O
No O O
current O O
indications O O
for O O
renal O O
replacement O O
therapy. O O
#) O O
? O O
PNA: O O
Afebrile O O
and O O
asymptomatic O O
(no O O
cough, O O
chest O O
pain, O O
tachycardia, O O
tachypnea, O O
leukocytosis, O O
or O O
left O O
shift). O O
Will O O
hold O O
antibiotics. O O
#) O O
Gout: O O
cont. O O
allopurinol O O
(redosed O O
for O O
renal O O
function) O O
#) O O
FEN: O O
Diabetic O O
diet O O
#) O O
PPX: O O
GI: O O
PPI; O O
PCP: O O
bactrim; O O
Bowel: O O
none; O O
Steroids: O O
vit O O
D; O O
DVT: O O
heparin O O
_____________________________ O O
Umar O O
Barton, O O
MD, O O
PhD O O
pager O O
5-4228 O O
Internal O O
Medicine O O
PGY1 O O

Record B-SMOKER O
date: O O
2107-10-24 O O
TOOLE O O
COUNTY O O
HOSPITAL O O
Cardiology O O
871 O O
Westerdale O O
Drive O O
Werner, O O
Nancy O O
West O O
Liberty, O O
AL O O
54854 O O
2-05-09 O O
Routine O O
Visit O O
Taking O O
Diabeta B-DIABETES O
10 O O
b.i.d. O O
as O O
well O O
as O O
other O O
medications O O
and O O
has O O
now O O
added O O
Pravachol B-MEDICATION B-MEDICATION
40 O O
mg. O O
at O O
bedtime. O O
She O O
is O O
tolerating O O
the O O
Pravachol O B-MEDICATION
well. O O
Blood O O
sugars O O
at O O
home, O O
morning O O
and O O
at O O
bedtime, O O
are O O
in O O
the O O
130-155 O O
range. O O
No O O
side O O
effects O O
of O O
the O O
medication. O O
No O O
evidence O O
of O O
hypoglycemia. O O
No O O
polyuria, O O
polydipsia. O O
Trying O O
to O O
walk O O
on O O
a O O
treadmill O O
inside O O
the O O
house O O
20 O O
minutes O O
at O O
a O O
time O O
several O O
times O O
a O O
week. O O
Trying O O
to O O
watch O O
diet. O O
Physical O O
Exam: O O
Blood O O
pressure: O O
150/86, B-HYPERTENSION O
148/84. B-HYPERTENSION O
Pulse O O
78. O O
PERRL. O O
Carotids O O
1+, O O
no O O
bruits. O O
No O O
peripheral O O
edema. O O
Assessment: O O
Blood O O
pressure O O
adequately O O
controlled. O O
Sounds O O
like O O
diabetes B-DIABETES O
is O O
moderately O O
well O O
controlled. O O
Check O O
hemoglobin O O
A1 O O
today. O O
She O O
will O O
call O O
me O O
for O O
these O O
results O O
in O O
10 O O
days. O O
Adjust O O
Diabeta O O
if O O
necessary. O O
Return O O
here O O
in O O
three O O
months. O O
_________________________ O O
Paul O O
D. O O
Quaglia, O O
M.D. O O
mzy:KX:7901 O O
DD:2-15-09 O O

Record B-SMOKER O
date: O O
2114-11-26 O O
November O O
26, O O
2114 O O
Wanda O O
Flaherty, O O
M.D. O O
Saint O O
Annes O O
Hospital O O
98 O O
Greeley O O
Street O O
Sturgis, O O
AL O O
52345 O O
Re: O O
Nancy O O
Werner O O
MRN O O
57274347 O O
Dear O O
Wanda: O O
Nancy O O
Werner O O
is O O
doing O O
better O O
than O O
the O O
last O O
time O O
I O O
saw O O
her O O
in O O
May O O
in O O
that O O
the O O
triglycerides O O
have O O
decreased O O
to O O
460, O O
pretty O O
much O O
where O O
they O O
had O O
usually O O
been. O O
The O O
LDL O O
is O O
now O O
quite O O
low O O
at O O
93 O O
but O O
the O O
HDL O O
has O O
declined O O
to O O
34. O O
All O O
in O O
all, O O
the O O
results O O
are O O
compatible O O
with O O
better O O
glucose O O
control O O
and O O
the O O
action O O
of O O
Atorvastatin B-MEDICATION B-MEDICATION
10 O O
mg O O
is O O
likely O O
responsible O O
for O O
the O O
very O O
low O O
LDL O O
but O O
on O O
the O O
other O O
hand O O
discontinuation B-MEDICATION O
of I-MEDICATION O
the I-MEDICATION O
gemfibrozil I-MEDICATION O
probably O O
lowered O O
the O O
HDL. O O
The O O
effect O O
on O O
triglycerides O O
of O O
the O O
low O O
dose O O
of O O
the O O
Atorvastatin O B-MEDICATION
is O O
minimal O O
and O O
overall O O
the O O
triglyceride O O
lowering O O
effect O O
is O O
overrated O O
except O O
at O O
the O O
high O O
dose O O
of O O
80 O O
mg. O O
Even O O
at O O
80 O O
mg O O
Atorvastatin O B-MEDICATION
could O O
not O O
compare O O
to O O
the O O
fibrates O O
in O O
the O O
triglyceride O O
lowering O O
action. O O
Her O O
current O O
medications O O
are O O
Atorvastatin O B-MEDICATION
10 O O
mg, O O
Lopressor B-MEDICATION B-MEDICATION
25 O O
mg, O O
Procardia B-MEDICATION B-MEDICATION
60 O O
mg O O
b.i.d., O O
Capoten B-MEDICATION O
50 O O
mg O O
t.i.d., O O
and O O
Insulin B-MEDICATION O
22 O O
units O O
A.M. O O
Labs: O O
Cholesterol O O
220, O O
TG. O O
460, O O
HDL O O
34, O O
LDL O O
93. O O
Blood O O
pressure O O
is O O
120/80. O O
I O O
restarted B-MEDICATION O
the I-MEDICATION O
Gemfibrozil, B-MEDICATION O
600 O O
mg O O
b.i.d. O O
and O O
left O O
her O O
on O O
the O O
Atorvastatin O B-MEDICATION
10 O O
mg. O O
Although O O
I O O
don't O O
expect O O
any O O
side O O
effects O O
with O O
this O O
low O O
dose O O
of O O
Atorvastatin O B-MEDICATION
and O O
Gemfibrozil O O
I O O
warned O O
Mrs. O O
Werner O O
and O O
her O O
husband O O
that O O
if O O
she O O
should O O
have O O
generalized O O
muscle O O
aches O O
or O O
weakness O O
she O O
should O O
contact O O
us O O
and O O
discontinue O O
medication. O O
I O O
think O O
that O O
aggressive O O
therapy O O
is O O
warranted O O
in O O
Mrs. O O
Werner. O O
page O O
2 O O
Nancy O O
Werner O O
November O O
26, O O
2114 O O
Please O O
feel O O
free O O
to O O
call O O
or O O
e-mail O O
me O O
if O O
you O O
have O O
questions. O O
Best O O
Wishes. O O
Sincerely, O O
Isaac O O
Q. O O
Whitman, O O
M.D. O O
/quiggle O O
******** O O
Approved O O
but O O
not O O
reviewed O O
by O O
Attending O O
Provider O O
******** O O

Record B-SMOKER O
date: O O
2120-07-12 O O
EDVISIT^57274347^Werner, O O
Nancy^07/12/20^WILLIAMSON, O O
PAUL O O
I O O
saw O O
this O O
patient O O
with O O
the O O
resident. O O
Resident's O O
history O O
reviewed. O O
Patient O O
interviewed O O
and O O
examined O O
by O O
me. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
78-year-old O O
woman O O
comes O O
in O O
with O O
shortness O O
of O O
breath, O O
midabdominal O O
pain, O O
and O O
left O O
hip O O
pain O O
for O O
2 O O
weeks. O O
REVIEW O O
OF O O
SYSTEMS: O O
Includes O O
some O O
constipation O O
and O O
decreased O O
appetite. O O
She O O
has O O
had O O
some O O
trauma O O
about O O
10 O O
days O O
ago. O O
She O O
was O O
seen O O
at O O
the O O
Ihle O O
Central O O
Clinic O O
earlier O O
today. O O
The O O
Emergency O O
Department O O
was O O
overcrowded, O O
and O O
she O O
was O O
in O O
the O O
waiting O O
room O O
for O O
almost O O
6 O O
hours. O O
PHYSICAL O O
EXAMINATION: O O
She O O
is O O
obese B-OBESE O
with O O
some O O
minimal O O
tenderness O O
around O O
the O O
umbilicus. O O
No O O
bony O O
tenderness. O O
Several O O
lesions O O
on O O
the O O
legs. O O
Rales O O
at O O
bases. O O
See O O
the O O
written O O
notes O O
for O O
details. O O
DISPOSITION: O O
Admitted O O
to O O
hospital. O O
CONDITION: O O
Satisfactory. O O
DIAGNOSIS: O O
Congestive O O
heart O O
failure, O O
Abdominal O O
pain, O O
Diabetes, B-DIABETES O
Contusions O O
from O O
falls. O O
______________________________ O O
WILLIAMSON, O O
PAUL O O
M.D. O O
D: O O
07/12/20 O O
T: O O
07/13/20 O O
Dictated O O
By: O O
WILLIAMSON, O O
PAUL O O
eScription O O
document:2-0605694 O O
BFFocus O O

Record O O
date: O O
2123-05-01 O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
PENDER O O
CARE O O
CENTER O O
Personal O O
data O O
and O O
overall O O
health O O
A O O
75-year-old O O
married O O
woman O O
with O O
two O O
adult O O
sons, O O
three O O
granddaughers. O O
Was O O
a O O
Personnel O O
Officer. O O
Primary O O
care O O
physician O O
in O O
Polson, O O
VA O O
is O O
Dr. O O
David O O
Mccall O O
at O O
207-155-2827. O O
Reason O O
for O O
visit O O
Extended O O
followup, O O
multiple O O
medical O O
problems. O O
Problem O O
List O O
(reviewed) O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
MAJOR O O
Squamous O O
cell O O
carcinoma O O
of O O
skin O O
MAJOR O O
Atrial O O
fibrillation O O
MAJOR O O
Restless O O
leg O O
syndrome O O
MAJOR O O
Family O O
history O O
risk O O
factors O O
MAJOR O O
Hyperuricemia O O
MAJOR O O
Hyperlipidemia B-HYPERLIPIDEMIA O
MAJOR O O
Anemia O O
MAJOR O O
Hypertension B-HYPERTENSION B-HYPERTENSION
MAJOR O O
Dysthymia O O
MAJOR O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
MAJOR O O
Hyperhomocysteinemia O O
MAJOR O O
Permanent O O
pacemaker O O
MAJOR O O
Health O O
maintenance O O
Major O O
Problems O O
Diabetes O O
mellitus O O
/insulin B-MEDICATION O
dependent. O O
Saw O O
Dr. O O
Miles O O
today. O O
DM O O
is O O
under O O
excellent O O
control. O O
He O O
lowered O O
Lantus B-MEDICATION B-MEDICATION
by O O
5 O O
units. O O
Squamous O O
cell O O
carcinoma O O
of O O
skin O O
/status O O
post O O
foot. O O
The O O
patient O O
had O O
to O O
have O O
skin O O
grafting O O
following O O
Kohs O O
surgery O O
for O O
severe O O
extensive O O
squamous O O
cell O O
carcinoma O O
on O O
the O O
dorsum O O
of O O
her O O
right O O
foot O O
in O O
2118. O O
Is O O
followed O O
by O O
Dr. O O
Colleen O O
Quinonez O O
in O O
Milliken O O
for O O
skin O O
exams. O O
Atrial O O
fibrillation O O
tachy O O
brady O O
syndrome O O
now O O
with O O
pacemaker O O
and O O
beta O O
blockade. O O
Restless O O
leg O O
syndrome O O
Is O O
dependent O O
on O O
daily O O
narcotics O O
for O O
pain O O
control, O O
but O O
has O O
not O O
escalated O O
dose. O O
Family O O
history O O
risk O O
factors O O
/high O O
risk O O
colon O O
carcinoma. O O
Is O O
up O O
to O O
date O O
on O O
screening. O O
Hyperuricemia O O
No O O
symptoms O O
of O O
gout O O
on O O
allopurinol O O
200 O O
mg O O
daily. O O
Hyperlipidemia O O
Dr. O O
Whiteman O O
left O O
meds O O
the O O
same O O
last O O
week, O O
and O O
told O O
her O O
that O O
he O O
was O O
very O O
pleased O O
with O O
her O O
lipids O O
control. O O
Anemia O O
CBC O O
ordered O O
today. O O
Hypertension O O
BP O O
has O O
been O O
well-controlled O O
in O O
VA, O O
usually O O
in O O
the O O
128 O O
systolic O O
range. O O
Dysthymia O O
/posttraumatic O O
stress O O
disorder. O O
Much O O
better O O
after O O
6 O O
months O O
on O O
the O O
ocean O O
in O O
Virginia. O O
I O O
suspect O O
she O O
is O O
feeling O O
better O O
with O O
rate O O
control O O
on O O
meds O O
+ O O
pacemaker. O O
Coronary O O
artery O O
disease O O
No O O
angina O O
or O O
SOB. O O
After O O
exam O O
last O O
November, O O
I O O
asked O O
Dr. O O
Nielson O O
to O O
see O O
her O O
regarding O O
her O O
rapid O O
VR. O O
He O O
increased O O
beta B-MEDICATION O
blocker I-MEDICATION O
and O O
she O O
developed O O
what O O
sounds O O
like O O
heart O O
block O O
in O O
VA. O O
Had O O
a O O
pacemaker O O
placed O O
and O O
has O O
been O O
asymptomatic O O
since O O
then. O O
Hyperhomocysteinemia O O
Taking O O
folic O O
acid O O
and O O
b O O
vitamins. O O
Permanent O O
pacemaker O O
Dual O O
Chamber O O
Pacemaker O O
placed O O
3/23 O O
for O O
bradycardia. O O
P/G O O
model O O
5435, O O
serial O O
4712198, O O
implanted O O
12/27/22. O O
RAL O O
5167DH/20 O O
Serial O O
SQ462162. O O
RVL O O
0049EO/46. O O
Serial O O
LX39426. O O
Placed O O
in O O
Polson, O O
VA O O
3/23 O O
for O O
bradycardia. O O
Cardiologist O O
there O O
Dr. O O
Quenton O O
Qiu, O O
203-942-9207. O O
Other O O
Problems O O
Pneumonia O O
- O O
Inactivated O O
Menopausal O O
syndrome O O
- O O
Inactivated O O
Abnormal O O
mammogram O O
- O O
Inactivated O O
Health O O
maintenance O O
Pap O O
due O O
in O O
August. O O
Mamm O O
resulted O O
in O O
benign O O
bx O O
11/22. O O
Normal O O
DEXA O O
11/22. O O
Next O O
colonoscopy O O
due O O
in O O
4/25. O O
Regular O O
dental O O
and O O
eye O O
exams. O O
Close O O
skin O O
surveillance. O O
Active O O
Medications O O
allopurinol O O
100 O O
mg O O
2 O O
tab O O
PO O O
qd O O
amitriptyline O O
10 O O
mg O O
po O O
qhs O O
increase O O
gradually O O
to O O
3 O O
at O O
bedtime O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
1 O O
tab O O
PO O O
QD O O
Coumadin O O
2.5 O O
mg O O
po O O
qpm O O
adjust O O
per O O
inr O O
Demadex O O
20 O O
mg O O
PO O O
qd O O
digoxin O O
0.125 O O
mg O O
po O O
qd O O
Diovan B-MEDICATION O
160mg O O
po O O
qd O O
fenofibrate B-MEDICATION B-MEDICATION
145mg O O
po O O
qd O O
Fish O O
oil O O
1000mg O O
po O O
5 O O
times O O
per O O
day O O
folic O O
acid O O
1 O O
mg O O
po O O
qd O O
glucagon O B-MEDICATION
1 O O
mg O O
PRN O O
for O O
hypoglycemia O O
Humalog B-MEDICATION B-MEDICATION
sliding I-MEDICATION O
scale I-MEDICATION O
sc I-MEDICATION O
tid I-MEDICATION O
Imdur B-MEDICATION B-MEDICATION
30 O O
mg O O
po O O
1bid O O
Lantus O B-MEDICATION
55 O O
units O O
sc O O
qhs O O
do O O
not O O
mix O O
with O O
other O O
insulins O O
in O O
same O O
syringe O O
Mirapex O O
0.125 O O
mg O O
po O O
bid O O
take O O
at O O
5 O O
pm O O
and O O
at O O
bedtime O O
multivitamins O O
1 O O
tab O O
PO O O
QD O O
omeprazole O O
20mg O O
po O O
qd O O
take O O
before O O
meals O O
percocet O O
7.5/500mg O O
po O O
1 O O
tab.qhs.prn O O
potassium O O
chloride O O
20 O O
mg O O
1/2 O O
PO O O
three O O
times O O
weekly O O
pravastatin B-MEDICATION B-MEDICATION
80mg O O
po O O
qd O O
take O O
with O O
evening O O
meal O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
100 O O
mg O O
po O O
qd O O
Zetia B-MEDICATION O
10mg O O
po O O
qd O O
Change O O
in O O
therapies O O
and O O
Renewals O O
potassium O O
chloride O O
20 O O
mg O O
1/2 O O
PO O O
three O O
times O O
weekly O O
QTY:45 O O
Refills:3 O O
Start: O O
9/23/2120 O O
Demadex O O
20 O O
mg O O
PO O O
qd O O
QTY:135 O O
Refills:3 O O
Start: O O
9/23/2120 O O
percocet O O
7.5/500mg O O
po O O
1 O O
tab.qhs.prn O O
QTY:90 O O
Refills:0 O O
Start: O O
9/23/2120 O O
Mirapex O O
0.125 O O
mg O O
po O O
bid O O
take O O
at O O
5 O O
pm O O
and O O
at O O
bedtime O O
QTY:60 O O
Refills:3 O O
Start: O O
05/01/2123 O O
Fish O O
oil O O
1000mg O O
po O O
5 O O
times O O
per O O
day O O
Start: O O
05/01/2123 O O
Humalog O B-MEDICATION
sliding O O
scale O O
sc O O
tid O O
Start: O O
6/28/2122 O O
Lantus O B-MEDICATION
55 O O
units O O
sc O O
qhs O O
do O O
not O O
mix O O
with O O
other O O
insulins O O
in O O
same O O
syringe O O
QTY:3-month O O
supply O O
Refills:3 O O
Start: O O
6/28/2122 O O
Toprol O B-MEDICATION
XL O O
100 O O
mg O O
po O O
qd O O
Start: O O
05/01/2123 O O
omeprazole O O
20mg O O
po O O
qd O O
take O O
before O O
meals O O
Start: O O
05/01/2123 O O
Past O O
medical O O
history O O
Hospitalized O O
2115 O O
TCH O O
for O O
ROMI O O
2120 O O
TCH O O
new O O
onset O O
A O O
Fib O O
with O O
CHF O O
2120 O O
PCC O O
for O O
atypical O O
pneumonia O O
Surgery: O O
Appendectomy O O
2064 O O
C-section O O
x O O
2 O O
Breast O O
biopsies O O
2090 O O
and O O
2097 O O
Koh's O O
surgery O O
dorsum O O
foot O O
DFCI O O
2118 O O
Family O O
history O O
Both O O
parents O O
died O O
of O O
sudden O O
death O O
in O O
their O O
82nd O O
year. O O
Brother O O
had O O
SCD O O
at O O
66. O O
Mother O O
had O O
breast O O
cancer O O
at O O
80 O O
as O O
did O O
mother's O O
sister O O
in O O
her O O
50's. O O
Father O O
had O O
hpt, O O
gout O O
and O O
glaucoma. O O
Social O O
history O O
Patient O O
was O O
born O O
and O O
raised O O
in O O
rural O O
Finland. O O
She O O
was O O
hidden O O
by O O
an O O
uncle O O
in O O
a O O
farm O O
house O O
during O O
the O O
war, O O
which O O
was O O
frightening, O O
lonely O O
and O O
phsycially O O
taxing. O O
After O O
liberation, O O
she O O
came O O
to O O
Algeria O O
where O O
she O O
met O O
her O O
husband. O O
She O O
was O O
going O O
to O O
school O O
when O O
she O O
married O O
and O O
started O O
her O O
family. O O
She O O
is O O
very O O
happily O O
married O O
and O O
lives O O
in O O
Polson, O O
VA O O
half O O
the O O
year. O O
Habits/Risk O O
Screening O O
Activity O O
level: O O
sedentary O O
Smoking B-SMOKER O
status: I-SMOKER O
never I-SMOKER O
smoked I-SMOKER O
Alcohol O O
use O O
status: O O
moderate O O
Averages O O
1 O O
drink O O
per O O
week. O O
Drug O O
use O O
status: O O
opiates O O
One O O
percocet O O
qhs O O
for O O
restless O O
less O O
syndrome O O
Advance O O
directives O O
Living O O
will O O
on O O
file O O
with O O
attorney. O O
Son O O
is O O
heath O O
care O O
proxy. O O
His O O
name O O
is O O
Norman O O
Werner O O
at O O
515-562-2325. O O
Procedures O O
and O O
Immunizations O O
Urine O O
dip O O
stick O O
negative O O
x O O
6. O O
Review O O
of O O
systems O O
General: O O
chronic O O
fatigue, O O
anxiety O O
and O O
struggling O O
with O O
weight; O O
in O O
general, O O
feeling O O
much O O
better. O O
. O O
HEENT: O O
neg O O
except O O
for O O
hearing O O
loss. O O
Resp, O O
negative. O O
Cor, O O
see O O
problems. O O
GI, O O
negative. O O
GU, O O
negative. O O
GYN, O O
negative. O O
Endocr, O O
see O O
problem O O
DM. O O
Neuro, O O
negative. O O
Mood, O O
stable. O O
Skin, O O
see O O
problems. O O
MS, O O
mild O O
OA O O
sxs. O O
Physical O O
examination O O
Blood O O
pressure O O
130/60 O O
large O O
cuff O O
Weight O O
204 O O
Height O O
61.5 O O
General O O
appearance O O
Nancy O O
looks O O
well O O
and O O
happy. O O
Skin O O
No O O
rashes, O O
anicteric. O O
Extensive O O
solar O O
damage O O
with O O
many O O
actinic O O
keratoses O O
Heent O O
NC/AT, O O
PERRL, O O
EOMI, O O
O/P O O
clear O O
without O O
erythema O O
or O O
exudates. O O
Hearing O O
diminished O O
with O O
cerumin O O
bilaterally O O
Neck O O
supple; O O
carotid O O
upstroke O O
normal O O
without O O
bruits; O O
no O O
JVD; O O
thyroid O O
small, O O
smooth, O O
midline O O
and O O
symmetric O O
Nodes O O
no O O
palpable O O
lymphadenopathy O O
in O O
cervical, O O
axillary O O
or O O
groin O O
lymph O O
nodes O O
Breasts O O
no O O
nodule, O O
lump, O O
skin O O
or O O
nipple O O
change; O O
axilla O O
negative O O
Chest O O
no O O
skeletal O O
abnormalities O O
spine O O
and O O
thorax; O O
lungs O O
clear O O
to O O
percussion O O
and O O
auscultation O O
Cor O O
Apical O O
impulse, O O
quiet. O O
S1 O O
and O O
S2 O O
are O O
normal. O O
Regular O O
rhythm O O
at O O
62. O O
No O O
murmur O O
or O O
gallop. O O
Abdomen O O
NT/ND, O O
no O O
HSM. O O
No O O
masses O O
Rectal O O
exam O O
Deferred O O
to O O
gyn. O O
Genitalia O O
Deferred O O
to O O
gyn O O
Extrem O O
No O O
clubbing, O O
cyanosis, O O
edema. O O
Palpable O O
pedal O O
pulses. O O
Minimal O O
OA O O
changes. O O
Foot O O
exam O O
Negative O O
Selected O O
recent O O
labs O O
4/9/23 O O
in O O
VA: O O
BUN/Creat, O O
56/1.6 O O
K+, O O
4.2 O O
A1c, B-DIABETES O
6.8 I-DIABETES O
HGB/HCT O O
11.1/32 O O
with O O
normal O O
Fe++ O O
studies O O
Microalb O O
urine, O O
0.7 O O
(normal) O O
with O O
alb/creat O O
ratio O O
35 O O
(normal O O
&lt; O O
30). O O
Assessment O O
and O O
plan O O
See O O
problem O O
related O O
assessment O O
and O O
plans. O O
CBC, O O
TSH, O O
homocysteine O O
Disposition O O
Return O O
in O O
3 O O
months O O
or O O
prn. O O
Signed O O
electronically O O
by O O
Flaherty, O O
Wanda O O
H O O
on O O
May O O
04, O O
2123 O O

Record B-SMOKER O
date: O O
2081-06-22 O O
AH O O
EMERGENCY O O
DEPT O O
VISIT O O
BRANCH,EARNEST O O
530-23-69-1 O O
VISIT O O
DATE: O O
06/22/81 O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
patient O O
was O O
examined O O
and O O
treated O O
in O O
conjunction O O
with O O
a O O
resident. O O
Briefly, O O
the O O
history O O
is O O
as O O
follows: O O
The O O
patient O O
is O O
a O O
47 O O
year O O
old O O
male O O
with O O
end O O
stage O O
renal O O
disease O O
on O O
hemodialysis O O
who O O
was O O
referred O O
for O O
abdominal O O
discomfort O O
and O O
fever. O O
His O O
abdominal O O
discomfort O O
had O O
begun O O
within O O
the O O
preceding O O
24 O O
hours O O
and O O
had O O
gradually O O
worsened. O O
He O O
had O O
pain O O
in O O
the O O
left O O
lower O O
quadrant O O
radiating O O
to O O
the O O
rectal O O
area. O O
He O O
did O O
have O O
one O O
diarrheal O O
bowel O O
movement. O O
He O O
specifically O O
denied O O
bleeding. O O
PHYSICAL O O
EXAMINATION: O O
GENERAL O O
APPEARANCE: O O
The O O
patient O O
was O O
awake O O
and O O
alert, O O
although O O
somewhat O O
sluggish O O
and O O
apparently O O
uncomfortable. O O
VITAL O O
SIGNS: O O
Blood O O
pressure O O
was O O
177/90, B-HYPERTENSION O
pulse O O
117, O O
initial O O
temperature O O
103.3, O O
respiratory O O
rate O O
20. O O
HEENT: O O
Pupils O O
were O O
equal. O O
Sclerae O O
were O O
anicteric. O O
The O O
oropharynx O O
showed O O
normal O O
architecture. O O
NECK: O O
Supple. O O
CARDIOVASCULAR: O O
Regular O O
rate O O
and O O
rhythm. O O
LUNGS: O O
The O O
breath O O
sounds O O
were O O
essentially O O
clear. O O
ABDOMEN: O O
There O O
was O O
mild O O
to O O
moderate O O
diffuse O O
tenderness. O O
No O O
definite O O
mass O O
can O O
be O O
appreciated. O O
Bowel O O
sounds O O
were O O
diminished. O O
RECTAL: O O
Stool O O
is O O
guaiac-negative, O O
per O O
the O O
resident's O O
examination. O O
EXTREMITIES: O O
Examination O O
of O O
the O O
left O O
thigh O O
showed O O
slight O O
drainage O O
at O O
a O O
recent O O
surgical O O
incision O O
site. O O
LABORATORY O O
EVALUATION: O O
Electrolytes O O
showed O O
sodium O O
139, O O
potassium O O
4.3, O O
chloride O O
99, O O
CO2 O O
27, O O
BUN O O
12, O O
creatinine O O
2.2, O O
glucose B-DIABETES O
230. I-DIABETES O
White O O
blood O O
cell O O
count O O
was O O
30,000, O O
hematocrit O O
38. O O
Chest O O
x-ray O O
showed O O
no O O
definite O O
infiltrate. O O
Abdominal O O
x-ray O O
showed O O
dilated O O
loops O O
of O O
small O O
bowel. O O
EKG O O
showed O O
no O O
change O O
from O O
previous O O
tracings. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
assessment O O
and O O
plan O O
were O O
reviewed O O
with O O
the O O
resident. O O
FINAL O O
DIAGNOSIS: O O
I O O
confirm O O
the O O
provisional O O
diagnosis O O
of O O
abdominal O O
pain O O
with O O
question O O
of O O
deep O O
venous O O
thrombosis O O
versus O O
sepsis O O
from O O
as O O
yet O O
unidentified O O
source. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
care O O
plan O O
was O O
reviewed. O O
The O O
patient O O
was O O
started O O
on O O
antibiotics O O
and O O
ultimately O O
admitted O O
to O O
the O O
hospital O O
for O O
definitive O O
evaluation O O
and O O
further O O
care. O O
___________________________________ O O
RD883/1008 O O
FRANK O O
E. O O
BENDER, O O
M.D. O O
FB25 O O
D:07/25/81 O O
T:07/25/81 O O
Dictated O O
by: O O
FRANK O O
E. O O
BENDER, O O
M.D. O O
FB25 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2081-07-07 O O
July O O
8, O O
2081 O O
Francis O O
Xayarath, O O
M.D. O O
Integra O O
Health O O
Center O O
487 O O
Jackson O O
Street O O
La O O
Grulla, O O
ME O O
21614 O O
RE: O O
Branche, O O
Earnest O O
MRN: O O
53023691 O O
Dear O O
Dr. O O
Xayarath: O O
Your O O
patient O O
Mr. O O
Earnest O O
Branche O O
returned O O
to O O
the O O
office O O
today O O
for O O
a O O
follow O O
up O O
visit. O O
As O O
you O O
know, O O
Mr. O O
Branche O O
underwent O O
a O O
left O O
femoral O O
to O O
posterior O O
tibial O O
bypass O O
one O O
month O O
ago O O
followed O O
by O O
amputation O O
of O O
a O O
gangrenous O O
first O O
toe. O O
After O O
being O O
discharged O O
from O O
our O O
service O O
he O O
was O O
readmitted O O
to O O
the O O
Medical O O
Service O O
with O O
a O O
severe O O
case O O
of O O
C. O O
difficile O O
colitis. O O
Ultimately O O
this O O
resolved O O
and O O
he O O
was O O
discharged. O O
Today O O
he O O
reports O O
that O O
the O O
diarrhea O O
has O O
again O O
resumed O O
and O O
he O O
was O O
placed O O
back O O
on O O
an O O
oral O O
antibiotic O O
yesterday. O O
He O O
complains O O
of O O
only O O
mild O O
incisional O O
discomfort O O
in O O
his O O
left O O
leg. O O
On O O
examination, O O
there O O
is O O
a O O
strong O O
pulse O O
easily O O
palpated O O
over O O
the O O
left O O
lower O O
extremity O O
bypass O O
graft. O O
The O O
old O O
right O O
lower O O
extremity O O
bypass O O
graft O O
was O O
also O O
palpable. O O
The O O
left O O
foot O O
itself O O
is O O
warm. O O
The O O
great O O
toe O O
incision O O
site, O O
however, O O
has O O
developed O O
necrotic O O
tissue O O
all O O
along O O
the O O
incision, O O
which O O
was O O
sharply O O
debrided O O
to O O
clean O O
margins. O O
This O O
will O O
now O O
need O O
to O O
be O O
treated O O
as O O
an O O
open O O
wound. O O
The O O
calf O O
portion O O
of O O
the O O
left O O
lower O O
extremity O O
incision O O
also O O
has O O
a O O
narrow O O
zone O O
of O O
superficial O O
skin O O
slough O O
which O O
was O O
gently O O
debrided. O O
The O O
graft O O
is O O
not O O
exposed O O
and O O
there O O
are O O
no O O
deep O O
wounds O O
in O O
the O O
leg. O O
Mr. O O
Branche's O O
left O O
lower O O
extremity O O
bypass O O
graft O O
is O O
functioning O O
well. O O
However, O O
he O O
will O O
require O O
significant O O
ongoing O O
wound O O
care O O
for O O
the O O
immediate O O
future. O O
Daily O O
dressing O O
changes O O
will O O
be O O
arranged O O
with O O
visiting O O
nurse O O
services. O O
We O O
plan O O
to O O
follow O O
him O O
closely O O
and O O
an O O
appointment O O
was O O
given O O
for O O
two O O
weeks. O O
Thanks O O
again O O
for O O
allowing O O
us O O
to O O
participate O O
in O O
the O O
care O O
of O O
this O O
delightful O O
and O O
challenging O O
patient O O
and O O
please O O
don't O O
hesitate O O
to O O
contact O O
me O O
at O O
any O O
time O O
if O O
I O O
can O O
RE: O O
Branche, O O
Earnest O O
MRN: O O
53023691 O O
7-8-81 O O
Page O O
2 O O
be O O
of O O
further O O
assistance. O O
Sincerely, O O
Luis O O
J. O O
Nicholas, O O
M.D. O O
NU:UJ:4653/DD:7-8-81/DT:7-13-81/DV:7-8-81 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2082-01-10 O O
AH O O
EMERGENCY O O
DEPT O O
VISIT O O
BRANCH,EARNEST O O
530-23-69-1 O O
VISIT O O
DATE: O O
01/10/82 O O
The O O
patient O O
was O O
seen O O
by O O
me O O
in O O
the O O
emergency O O
department O O
with O O
Dr. O O
Whittaker. O O
The O O
resident's O O
note O O
was O O
reviewed O O
and O O
the O O
patient O O
was O O
interviewed O O
and O O
examined O O
by O O
me. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
very O O
pleasant, O O
50 O O
year-old O O
gentleman O O
who O O
presents O O
with O O
gross O O
hematemesis O O
and O O
coffee-ground O O
emesis. O O
He O O
had O O
it O O
during O O
the O O
night O O
and O O
then O O
this O O
morning O O
developed O O
coffee-grounds O O
turned O O
to O O
red O O
blood O O
emesis. O O
He O O
denies O O
any O O
light-headedness, O O
chest O O
pain O O
or O O
abdominal O O
pain. O O
He O O
has O O
had O O
some O O
diarrhea O O
over O O
the O O
last O O
seven O O
months, O O
of O O
unclear O O
etiology. O O
No O O
melena. O O
PAST O O
MEDICAL O O
HISTORY: O O
Chronic O O
renal O O
failure, O O
myocardial B-CAD O
infarction, I-CAD O
insulin B-DIABETES O
dependent I-DIABETES O
diabetes. I-DIABETES O
PHYSICAL O O
EXAMINATION: O O
GENERAL: O O
The O O
patient O O
was O O
hemodynamically O O
stable, O O
well-appearing, O O
nontoxic. O O
LUNGS: O O
Clear. O O
HEART: O O
Regular O O
rate O O
and O O
rhythm. O O
ABDOMEN: O O
Soft O O
with O O
tenderness O O
to O O
palpation O O
in O O
the O O
bilateral O O
lower O O
quadrants. O O
NG O O
tube O O
lavage O O
showed O O
200 O O
cc O O
of O O
pink O O
tinged O O
fluid, O O
cleared O O
after O O
50 O O
cc. O O
LABORATORY O O
EVALUATION: O O
Hematocrit O O
was O O
46, O O
white O O
count O O
11, O O
potassium O O
6.6, O O
moderately O O
hemolyzed. O O
BUN O O
was O O
62, O O
creatinine O O
6.9. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
will O O
be O O
seen O O
by O O
the O O
renal O O
service O O
and O O
admitted O O
to O O
the O O
medical O O
service. O O
The O O
patient O O
will O O
need O O
dialysis O O
and O O
endoscopy O O
tomorrow. O O
See O O
resident's O O
note O O
for O O
details. O O
FINAL O O
DIAGNOSIS: O O
Upper O O
GI O O
bleed. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
was O O
admitted O O
in O O
satisfactory O O
condition. O O
___________________________________ O O
ED832/1818 O O
CHRISTOPHER O O
LEMUS, O O
M.D. O O
CL58 O O
D:01/10/82 O O
T:01/11/82 O O
Dictated O O
by: O O
CHRISTOPHER O O
LEMUS, O O
M.D. O O
CL58 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2082-03-08 O O
March O O
8, O O
2082 O O
Francis O O
Xayarath, O O
M.D. O O
Integra O O
Health O O
Center O O
Derry O O
Street O O
La O O
Grulla, O O
ME O O
21614 O O
RE:Branch, O O
Earnest O O
MRN:53023691 O O
Dear O O
Dr. O O
Xayarath: O O
Your O O
patient O O
Earnest O O
Branch O O
came O O
in O O
the O O
office O O
today O O
for O O
a O O
follow O O
up O O
visit. O O
Mr. O O
Branch O O
is O O
now O O
two O O
years O O
out O O
from O O
a O O
right O O
femoral- O O
tibial O O
bypass O O
and O O
nine O O
months O O
out O O
from O O
a O O
left O O
femoral-tibial O O
bypass O O
with O O
subsequent O O
transmetatarsal O O
amputation O O
of O O
the O O
left O O
foot O O
and O O
split-thickness O O
skin O O
grafting. O O
Over O O
the O O
last O O
several O O
months, O O
he O O
has O O
been O O
undergoing O O
dressing O O
changes O O
to O O
remaining, O O
small, O O
superficial, O O
open O O
wounds O O
on O O
the O O
dorsum O O
of O O
the O O
left O O
foot. O O
Over O O
the O O
last O O
one O O
to O O
two O O
weeks, O O
he O O
began O O
to O O
note O O
the O O
development O O
of O O
a O O
new O O
area O O
of O O
dark O O
skin O O
on O O
the O O
lateral O O
aspect O O
of O O
the O O
left O O
foot O O
and O O
recently O O
has O O
noted O O
some O O
drainage. O O
He O O
denies O O
any O O
fevers. O O
In O O
addition O O
and O O
of O O
note, O O
he O O
complains O O
of O O
recent O O
onset O O
of O O
pain O O
in O O
the O O
right O O
eye O O
and O O
has O O
an O O
appointment O O
at O O
the O O
Ophthalmology O O
Clinic O O
immediately O O
following O O
his O O
visit O O
with O O
us. O O
He O O
last O O
underwent O O
vascular O O
lab O O
studies O O
in O O
September O O
at O O
which O O
time O O
both O O
lower O O
extremity O O
bypass O O
grafts O O
were O O
widely O O
patent O O
and O O
without O O
stenoses. O O
On O O
examination O O
today, O O
there O O
are O O
strong, O O
easily O O
palpable O O
pulses O O
over O O
both O O
lower O O
extremity O O
bypass O O
grafts. O O
The O O
right O O
foot O O
is O O
warm O O
and O O
without O O
any O O
new O O
ischemic O O
skin O O
changes O O
or O O
lesions. O O
On O O
examination O O
of O O
the O O
left O O
foot, O O
there O O
is O O
a O O
large O O
area O O
of O O
full- O O
thickness O O
skin O O
necrosis O O
on O O
the O O
lateral O O
aspect O O
of O O
the O O
foot O O
where O O
there O O
had O O
never O O
been O O
any O O
previous O O
open O O
wounds. O O
This O O
area O O
encompasses O O
a O O
significant O O
proportion O O
of O O
the O O
lateral O O
aspect O O
of O O
the O O
foot O O
from O O
the O O
end O O
of O O
the O O
transmetatarsal O O
incision O O
to O O
the O O
proximal O O
mid O O
foot. O O
On O O
probing, O O
purulent O O
material O O
drains O O
from O O
the O O
margins O O
and O O
there O O
is O O
obvious O O
significant O O
sepsis. O O
The O O
foot O O
itself O O
is O O
warm O O
and O O
there O O
is O O
a O O
good O O
posterior O O
tibial O O
Doppler O O
signal O O
at O O
the O O
ankle. O O
Unfortunately, O O
Mr. O O
Branch O O
has O O
developed O O
a O O
new, O O
large O O
wound O O
on O O
the O O
left O O
foot O O
which O O
likely O O
began O O
as O O
a O O
pressure O O
(decubitus) O O
ulceration O O
due O O
to O O
his O O
severe O O
neuropathy. O O
This O O
is O O
now O O
complicated O O
by O O
significant O O
local O O
sepsis O O
and O O
there O O
is O O
a O O
large O O
area O O
of O O
soft O O
tissue O O
loss O O
on O O
the O O
foot. O O
He O O
will O O
require O O
urgent O O
admission O O
and O O
operative O O
debridement O O
today. O O
In O O
addition, O O
given O O
the O O
extent O O
of O O
the O O
problem, O O
it O O
is O O
likely O O
that O O
he O O
will O O
ultimately O O
come O O
to O O
below-knee O O
amputation O O
in O O
the O O
end. O O
Immediately O O
following O O
his O O
visit O O
to O O
the O O
Ophthalmology O O
Clinic, O O
he O O
will O O
be O O
admitted O O
to O O
the O O
RE:Branch, O O
Earnest O O
MRN:53023691 O O
3-8-82 O O
Page O O
2 O O
hospital O O
with O O
the O O
hopes O O
of O O
performing O O
debridement O O
and O O
drainage O O
later O O
today. O O
I O O
will O O
certainly O O
continue O O
to O O
keep O O
you O O
apprised O O
of O O
his O O
progress. O O
Sincerely, O O
Luis O O
J. O O
Nicholas, O O
M.D. O O
RH:KU:0156/DD:3-8-82/DT:3-14-82 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2082-12-31 O O
AH O O
EMERGENCY O O
DEPT O O
VISIT O O
BRANCH,EARNEST O O
530-23-69-1 O O
VISIT O O
DATE: O O
12/31/82 O O
This O O
patient O O
was O O
seen O O
primarily O O
by O O
Dr. O O
Xavier O O
Whittaker. O O
I O O
also O O
saw O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
note, O O
and O O
discussed O O
evaluation O O
and O O
plan. O O
PRESENTING O O
COMPLAINT: O O
Shortness O O
of O O
breath O O
and O O
nausea. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
49-year-old O O
man O O
has O O
been O O
complaining O O
of O O
shortness O O
of O O
breath O O
for O O
the O O
last O O
24 O O
hours. O O
He O O
came O O
in O O
complaining O O
of O O
that O O
plus O O
some O O
nausea O O
and O O
was O O
found O O
to O O
have O O
a O O
highly O O
elevated O O
glucose O O
and O O
was O O
sent O O
over O O
here. O O
The O O
patient O O
denies O O
any O O
chest O O
pain O O
or O O
pain O O
any O O
place O O
else, O O
but O O
he O O
does O O
state O O
that O O
he O O
feels O O
poorly. O O
Of O O
note, O O
on O O
transport O O
and O O
on O O
arrival O O
here, O O
his O O
blood B-DIABETES O
sugar I-DIABETES O
was I-DIABETES O
noted I-DIABETES O
to I-DIABETES O
be I-DIABETES O
greater I-DIABETES O
than I-DIABETES O
600. I-DIABETES O
The O O
patient O O
does O O
not O O
complain O O
of O O
blurry O O
vision O O
and O O
does O O
not O O
complain O O
of O O
light-headedness, O O
just O O
the O O
nausea O O
and O O
the O O
shortness O O
of O O
breath. O O
REVIEW O O
OF O O
SYSTEMS: O O
As O O
per O O
the O O
resident's O O
note. O O
PAST O O
MEDICAL O O
HISTORY: O O
Cardiomyopathy. O O
Otherwise, O O
as O O
per O O
the O O
resident's O O
note. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
As O O
per O O
the O O
resident's O O
note. O O
PHYSICAL O O
EXAMINATION: O O
Significant O O
findings O O
include O O
a O O
pulse O O
of O O
76, O O
respirations O O
22. O O
The O O
patient O O
appears O O
to O O
be O O
in O O
no O O
acute O O
distress. O O
The O O
lungs O O
display O O
crackles O O
bilaterally O O
to O O
the O O
mid O O
lung. O O
There O O
is O O
jugular O O
venous O O
distention O O
elevation O O
to O O
the O O
angle O O
of O O
the O O
jaw. O O
Cardiac O O
examination O O
is O O
otherwise O O
normal. O O
Abdominal O O
examination O O
is O O
within O O
normal O O
limits. O O
The O O
patient O O
has O O
a O O
colostomy. O O
The O O
patient O O
has O O
a O O
left O O
below-knee O O
amputation O O
and O O
toe-digit-toe O O
amputation O O
on O O
the O O
right O O
side. O O
Otherwise, O O
there O O
are O O
no O O
musculoskeletal O O
abnormalities. O O
There O O
are O O
some O O
decubitus O O
ulcers O O
which O O
are O O
stable. O O
LABORATORY O O
EVALUATION: O O
Laboratories O O
are O O
significant O O
for O O
a O O
glucose B-DIABETES O
of I-DIABETES O
934, I-DIABETES O
sodium O O
127, O O
anion O O
gap O O
17, O O
bicarb O O
19, O O
creatinine O O
and O O
BUN O O
5.8 O O
and O O
37, O O
hematocrit O O
30, O O
which O O
is O O
not O O
too O O
different O O
from O O
his O O
usual. O O
His O O
pH O O
is O O
7.42. O O
CK O O
is O O
54, O O
but O O
troponin O O
is O O
1.45. O O
Of O O
note, O O
however, O O
the O O
patient O O
does O O
have O O
renal O O
conditions. O O
EKG O O
shows O O
new O O
deep O O
Qs O O
in O O
2, O O
3, O O
and O O
F O O
compared O O
to O O
one O O
done O O
a O O
month O O
ago. O O
Chest O O
x-ray O O
shows O O
some O O
excess O O
interstitial O O
markings O O
indicative O O
of O O
increased O O
fluid. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
This O O
patient O O
appears O O
to O O
have O O
congestive O O
heart O O
failure. O O
He O O
may O O
be O O
having O O
new O O
cardiac O O
event, O O
although O O
after O O
a O O
consultation O O
with O O
the O O
Integra O O
Health O O
cardiologist, O O
he O O
felt O O
that O O
perhaps O O
this O O
might O O
not O O
be O O
a O O
new O O
event, O O
but O O
rather O O
due O O
to O O
axis O O
deviation. O O
The O O
patient O O
is O O
being O O
treated O O
for O O
his O O
hyperglycemia O O
and O O
is O O
being O O
admitted. O O
FINAL O O
DIAGNOSES: O O
1. O O
Rule O O
out O O
myocardial O O
infarction. O O
2. O O
Hyperglycemia. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
was O O
admitted O O
to O O
the O O
hospital O O
in O O
stable O O
condition. O O
___________________________________ O O
ZI623/55469 O O
FAITH O O
GALINDO, O O
M.D. O O
FG9 O O
D:12/31/82 O O
T:12/31/82 O O
Dictated O O
by: O O
FAITH O O
GALINDO, O O
M.D. O O
FG9 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2065-09-20 O O
Melissa O O
Cummings O O
HGH O O
Unit O O
No: O O
265-01-73 O O
SAINT O O
VINCENT O O
HOSPITAL O O
ADULT O O
MEDICINE O O
Date: O O
September O O
20, O O
2065 O O
Weight: O O
125. O O
The O O
patient O O
returns O O
from O O
Paraguay. O O
States O O
while O O
there, O O
had O O
problems O O
with O O
her O O
stomach. O O
Was O O
treated O O
by O O
MD O O
there O O
with O O
what O O
sounds O O
like O O
GERD O O
but O O
was O O
? O O
attempted O O
to O O
be O O
treated O O
for O O
H. O O
pylori. O O
Brings O O
in O O
medicines, O O
all O O
of O O
which O O
she O O
took O O
for O O
one O O
week. O O
They O O
are O O
Flagyl O O
500 O O
mg O O
b.i.d., O O
Metoclopramide O B-MEDICATION
10 O O
mg O O
q.i.d. O O
PC, O O
Patoprazol O B-MEDICATION
40 O O
mg O O
q.d. O O
All O O
have O O
been O O
completed. O O
CURRENT O O
MEDICATIONS: O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
mg O O
b.i.d., O O
atenolol B-MEDICATION B-MEDICATION
25 O O
mg O O
b.i.d., O O
Zestril B-MEDICATION B-MEDICATION
20 O O
mg O O
q.d., O O
Glyburide B-MEDICATION B-MEDICATION
25 O O
mg O O
tablets O O
2 O O
tabs O O
b.i.d. O O
(Patient O O
occasionally O O
does O O
not O O
take O O
pills O O
at O O
supper O O
as O O
she O O
is O O
still O O
fearful O O
of O O
hypoglycemia), O O
clonazepam O O
1 O O
mg O O
b.i.d., O O
NTG B-MEDICATION O
p.r.n., O O
Bayer O O
aspirin B-MEDICATION B-MEDICATION
and O O
eye O O
drops. O O
(1) O O
Abdominal O O
pain: O O
Off O O
medicine. O O
Symptoms O O
have O O
resolved. O O
Currently O O
on O O
no O O
treatment O O
for O O
GI O O
symptoms. O O
(2) O O
Diabetes B-DIABETES O
mellitus: I-DIABETES O
FBS B-DIABETES O
126, I-DIABETES O
137, I-DIABETES O
149, I-DIABETES O
120, I-DIABETES O
139, I-DIABETES O
135, I-DIABETES O
116. I-DIABETES O
10:00 I-DIABETES O
p.m. I-DIABETES O
226, I-DIABETES O
8:00 I-DIABETES O
p.m. I-DIABETES O
201, I-DIABETES O
8:00 I-DIABETES O
p.m. I-DIABETES O
151. I-DIABETES O
The O O
patient O O
does O O
not O O
check O O
prior O O
to O O
supper. O O
States O O
she O O
is O O
fearful O O
she O O
will O O
die O O
during O O
night O O
if O O
sugar O O
gets O O
too O O
low, O O
therefore, O O
occasionally O O
does O O
not O O
take O O
pills O O
before O O
supper O O
and O O
gets O O
higher O O
readings O O
at O O
night O O
in O O
the O O
240's B-DIABETES O
to I-DIABETES O
260's. I-DIABETES O
Generally O O
avoids O O
sweets O O
in O O
diet. O O
Takes O O
evening O O
pills O O
with O O
dinner O O
at O O
approximately O O
4:00 O O
or O O
5:00. O O
(3) O O
RHCM: O O
Was O O
scheduled O O
Dr. O O
Yelverton O O
for O O
a O O
sigmoidoscopy O O
9/16. O O
Apparently O O
is O O
office O O
called O O
and O O
cancelled O O
it O O
and O O
patient O O
is O O
waiting O O
to O O
be O O
rescheduled. O O
(4) O O
HTN: B-HYPERTENSION O
No O O
chest O O
pain, O O
shortness O O
of O O
breath O O
or O O
palpations. O O
PE: O O
Blood O O
pressure, O O
right O O
arm: B-HYPERTENSION O
142/80. I-HYPERTENSION O
Chest O O
is O O
clear. O O
Cardiac O O
regular O O
rhythm O O
at O O
66, O O
no O O
murmur O O
or O O
gallop. O O
Extremities: O O
No O O
edema. O O
Labs O O
from O O
7/27: B-DIABETES O
Hemoglobin I-DIABETES O
A1C I-DIABETES O
8.5 I-DIABETES O
(197), O O
BUN O O
13, O O
creatinine O O
0.6, O O
lytes O O
normal, O O
SGOT O O
normal. O O
CBC O O
normal. O O
Melissa O O
Cummings O O
HGH O O
Unit O O
No: O O
265-01-73 O O
SAINT O O
VINCENT O O
HOSPITAL O O
ADULT O O
MEDICINE O O
Date: O O
September O O
20, O O
2065 O O
Page O O
2 O O
A/P: O O
(1) O O
Diabetes O O
mellitus: O O
Irregular O O
control O O
secondary O O
to O O
patient O O
s O O
self-adjustment O O
of O O
medicine. O O
Have O O
asked O O
patient O O
to O O
check O O
blood O O
sugar O O
pre-breakfast/pre-dinner. O O
If O O
sugar O O
below O O
100 O O
pre-dinner, O O
may O O
decrease O O
Glyburide O B-MEDICATION
evening O O
dose. O O
If O O
sugar O O
100 O O
or O O
greater, O O
continue O O
the O O
10 O O
mg O O
dose O O
with O O
supper. O O
(2) O O
HTN: O O
Reasonable O O
control. O O
Continue O O
current O O
treatment. O O
(3) O O
Epigastric O O
pain: O O
Currently O O
stable, O O
monitor. O O
(4) O O
Routine O O
health O O
maintenance: O O
UTD. O O
Mammogram O O
normal. O O
(5) O O
Return O O
to O O
clinic O O
in O O
three O O
months O O
to O O
Dr. O O
Eng. O O
Kimberly O O
I O O
Kidd, O O
RNC, O O
ANP O O
KI/espinoza/nolen O O

Record O O
date: O O
2066-05-23 O O
Hinds O O
General O O
Hospital O O
Preadmission O O
Testing O O
Area O O
History O O
& O O
Physical O O
Examination O O
and O O
Anesthesia O O
Assessment O O
Ulonda O O
Jablonski, O O
N.P. O O
Patricia O O
Wynn, O O
N.P. O O
Frances O O
Strickland, O O
N.P. O O
Mark O O
C. O O
Xian, O O
M.D. O O
Medical O O
Director O O
May O O
22, O O
2066 O O
Medical O O
Record O O
Number: O O
2650173 O O
Cummings, O O
Melissa O O
Procedure: O O
The O O
patient O O
is O O
a O O
71 O O
year O O
old O O
Spanish-speaking O O
female O O
scheduled O O
for O O
right O O
colectomy. O O
Surgery O O
is O O
scheduled O O
on O O
May O O
31, O O
2066 O O
by O O
Dr. O O
Patrick O O
Frantz. O O
Chief O O
Complaint O O
& O O
Present O O
Illness: O O
Patient O O
reports O O
that O O
she O O
was O O
having O O
difficulty O O
with O O
constipation O O
and O O
colonoscopy O O
was O O
scheduled O O
5/07/66. O O
Colonoscopy O O
showed O O
a O O
malignant O O
appearing O O
tumor O O
or O O
possibly O O
a O O
villous O O
adenoma O O
in O O
the O O
cecum. O O
Pathology O O
revealed O O
adenocarcinoma. O O
Patient O O
reports O O
a O O
history B-CAD O
of I-CAD O
angina B-CAD O
stating O O
that O O
it O O
is O O
usually O O
precipitated O O
by O O
stress O O
or O O
anxiety O O
as O O
well O O
as O O
exertion. O O
Describes O O
angina O O
as O O
left-sided O O
anterior O O
chest O O
pain O O
that O O
is O O
stabbing O O
in O O
nature O O
and O O
constant. O O
Sometimes O O
she O O
gets O O
relief O O
from O O
this O O
pain O O
by O O
applying O O
pressure O O
to O O
chest O O
with O O
her O O
hand. O O
However, O O
if O O
pain O O
is O O
severe O O
enough O O
she O O
usually O O
takes O O
one O O
nitroglycerin B-MEDICATION O
tablet. O O
Occasionally O O
nausea O O
will O O
accompany O O
chest O O
pain. O O
States O O
pain O O
occurs O O
most O O
frequently O O
at O O
night O O
and O O
she O O
usually O O
confines O O
herself O O
to O O
taking O O
nitroglycerin O B-MEDICATION
tablets O O
only O O
at O O
night, O O
not O O
with O O
daytime O O
pain. O O
Most O O
recent O O
stress O O
test O O
done O O
11/63 O O
showed O O
that O O
patient O O
had O O
a O O
normal O O
exercise O O
capacity, O O
METS=8, O O
EKG O O
that O O
was O O
negative O O
for O O
ischemia O O
in O O
response O O
to O O
stress, O O
and O O
myocardial O B-MEDICATION
scans O O
were O O
within O O
normal O O
limits O O
and O O
did O O
not O O
show O O
evidence O O
of O O
ischemia O O
or O O
infarction. O O
Cardiac O O
ultrasound O O
done O O
10/62 O O
showed O O
a O O
normal O O
left O O
ventricular O O
size O O
and O O
systolic O O
function, O O
no O O
segmental O O
wall O O
motion O O
abnormalities, O O
and O O
an O O
EF O O
of O O
62%. O O
Patient O O
reports O O
that O O
she O O
developed O O
a O O
cough O O
approximately O O
two O O
weeks O O
ago O O
productive O O
of O O
white/tan O O
sputum. O O
She O O
also O O
has O O
nasal O O
discharge O O
that O O
is O O
yellowish O O
in O O
color. O O
Was O O
evaluated O O
at O O
the O O
urgent O O
care O O
clinic O O
5/20/66 O O
no O O
antibiotics O O
were O O
started. O O
Patient O O
denies O O
fever, O O
chills, O O
nausea, O O
vomiting, O O
diarrhea. O O
Past O O
Medical O O
History: O O
Significant O O
medical O O
problems O O
include: O O
1. O O
Diabetes B-DIABETES O
(insulin-dependent, B-MEDICATION O
3/66 B-DIABETES O
HBA1C B-DIABETES O
was I-DIABETES O
8.90) I-DIABETES O
2. O O
Hypercholesterolemia B-HYPERLIPIDEMIA O
3. O O
Hypertension B-HYPERTENSION O
4. O O
History B-CAD O
of I-CAD O
angina I-CAD O
5. O O
History O O
of O O
cyst O O
near O O
scapular, O O
upper O O
left O O
back O O
6. O O
Normal O O
spontaneous O O
vaginal O O
delivery O O
x O O
5 O O
Past O O
Surgical O O
History: O O
Prior O O
surgery O O
includes: O O
1. O O
Status O O
post O O
bilateral O O
cataract O O
surgery O O
2. O O
Status O O
post O O
surgery O O
to O O
remove O O
lesion O O
from O O
head O O
and O O
right O O
flank O O
3. O O
Status O O
post O O
myomectomy O O
4. O O
Status O O
post O O
bowel O O
resection O O
secondary O O
to O O
infection O O
5. O O
Status O O
post O O
gallbladder O O
surgery, O O
most O O
likely O O
cholecystectomy O O
Family O O
History: O O
There O O
is O O
no O O
family O O
history O O
of O O
adverse O O
reactions O O
to O O
general O O
anesthesia. O O
Family O O
history O O
positive O O
for O O
MI, O O
diabetes B-DIABETES O
Medications: O O
Humalog B-MEDICATION B-MEDICATION
insulin I-MEDICATION O
75/25 I-MEDICATION O
22 O O
units O O
qAM, O O
8 O O
units O O
qPM O O
nitroglycerin O B-MEDICATION
tablets O O
.3 O O
mg O O
prn O O
atenolol B-MEDICATION B-MEDICATION
25 O O
mg O O
b.i.d. O O
Zestril B-MEDICATION B-MEDICATION
20 O O
mg O O
q.d. O O
Claritin O O
10 O O
mg O O
q.d. O O
clonazepam O O
1 O O
mg O O
q.d. O O
Correctol O O
5 O O
mg O O
Bayer O O
aspirin B-MEDICATION B-MEDICATION
Livostmo O O
0.5 O O
mg O O
eye O O
drops O O
Robitussin O O
ginger O O
supplements O O
(told O O
to O O
stop O O
5/23/66) O O
green O O
tea O O
(told O O
to O O
stop O O
5/23/66) O O
Allergies: O O
NKDA O O
Social O O
History: O O
Smoking: B-SMOKER O
denies I-SMOKER O
Alcohol O O
use: O O
denies O O
Substance O O
Abuse: O O
denies O O
Allergen O O
Exposure O O
(blood O O
products/pregnancy): O O
none O O
in O O
last O O
3 O O
months O O
Exercise: O O
no O O
formal O O
routine, O O
active O O
by O O
style O O
caring O O
for O O
self, O O
caring O O
for O O
home, O O
cooking, O O
cleaning O O
Occupation: O O
Customs O O
Broker O O
Marital O O
Status: O O
married, O O
five O O
children O O
Review O O
of O O
Systems: O O
General: O O
see O O
HPI O O
HEENT: O O
negative O O
Cardiovascular: O O
see O O
HPI; O O
hypertension; B-HYPERTENSION O
hypercholesterolemia B-HYPERLIPIDEMIA O
which O O
she O O
had B-MEDICATION O
been I-MEDICATION O
taking I-MEDICATION O
Lipitor I-MEDICATION B-MEDICATION
for O O
however O O
this O O
was O O
stopped O O
(per O O
patient) O O
after O O
patient O O
noted O O
to O O
have O O
elevated O O
LFTs O O
Respiratory: O O
negative O O
Neurological: O O
negative O O
Gastrointestinal: O O
reports O O
having O O
occasional O O
difficulty O O
with O O
reflux O O
in O O
the O O
past O O
and O O
was O O
treated O O
with O O
medication O O
however, O O
she O O
is O O
not O O
on O O
any O O
medication O O
now O O
and O O
states O O
she O O
rarely O O
has O O
reflux O O
Hepatobiliary: O O
negative O O
Renal/Genitourinary: O O
negative O O
Musculoskeletal: O O
joint O O
pain O O
especially O O
in O O
her O O
hips O O
and O O
knees O O
Peripheral O O
Vascular: O O
negative O O
Endocrine/metabolic: O O
diabetes O O
Heme/Onc: O O
negative O O
Psychiatric: O O
negative O O
Skin: O O
negative O O
Vital O O
Signs: O O
BP: B-HYPERTENSION O
148/84 B-HYPERTENSION O
mm O O
Hg O O
P: O O
74 O O
bpm O O
SaO2: O O
98% O O
Temp: O O
96 O O
degrees O O
F O O
Resp: O O
16 O O
rpm O O
Ht: O O
59 O O
inches O O
Wt: O O
124.2 O O
pounds O O
Exam: O O
General: O O
well O O
developed, O O
well O O
nourished O O
female O O
HEEN&T: O O
good O O
range O O
of O O
motion, O O
no O O
masses, O O
neck O O
veins O O
flat, O O
no O O
bruits O O
Airway: O O
Mallampatti O O
Class O O
II O O
Teeth: O O
in O O
good O O
repair O O
Lungs: O O
clear O O
to O O
auscultation O O
Heart: O O
regular O O
rhythm, O O
no O O
murmurs, O O
S1=S2, O O
no O O
gallop O O
Abdomen: O O
soft, O O
non-tender, O O
not O O
distended, O O
normal O O
bowel O O
sounds, O O
no O O
organomegaly O O
or O O
palpable O O
masses O O
GU/Rectal: O O
no O O
CVA O O
tenderness O O
Lymphatics: O O
no O O
lymphadenopathy O O
(periauricular, O O
occipital, O O
supraclavicular, O O
clavicular) O O
Peripheral O O
Vascular: O O
carotids: O O
2+ O O
bilateral O O
no O O
bruits O O
radials: O O
2+ O O
bilateral O O
Neurological: O O
cranial O O
nerves: O O
II-XII O O
intact O O
motor: O O
strength O O
5/5 O O
upper O O
and O O
lower O O
extremities, O O
good O O
range O O
of O O
motion O O
Extremities: O O
no O O
edema O O
Skin: O O
no O O
ulcers O O
or O O
rashes O O
observed O O
Assessment: O O
ASA O O
Physical O O
Status O O
II O O
71 O O
year O O
old O O
female O O
with O O
a O O
history O O
of O O
diabetes, O O
hypercholesterolemia, O O
hypertension, O O
and O O
angina O O
who O O
presents O O
for O O
right O O
colectomy O O
secondary O O
to O O
adenocarcinoma O O
of O O
the O O
cecum. O O
Patient O O
does O O
describes O O
episodes O O
of O O
angina O O
that O O
are O O
at O O
times O O
related O O
to O O
exertion. O O
These O O
episodes O O
have O O
not O O
increased O O
over O O
time O O
and O O
are O O
controlled O O
with O O
rest O O
or O O
occasionally, O O
nitroglycerin O O
tablets. O O
Stress O O
test O O
done O O
in O O
2063 O O
was O O
negative O O
for O O
ischemia. O O
Patient O O
does O O
have O O
some O O
symptoms O O
of O O
a O O
respiratory O O
infection, O O
no O O
fever, O O
lungs O O
clear, O O
to O O
be O O
re-evaluated O O
the O O
day O O
of O O
surgery O O
by O O
anesthesia. O O
Case O O
presented O O
to O O
Dr. O O
Emma-Wendy O O
Alcala O O
who O O
agreed O O
that O O
further O O
cardiac O O
testing O O
not O O
indicated O O
at O O
presence. O O
Also O O
agreed O O
that O O
patient O O
should O O
be O O
evaluated O O
data O O
surgery O O
for O O
any O O
symptoms O O
of O O
respiratory O O
infection. O O
Dr. O O
Alcala O O
met O O
with O O
patient O O
to O O
discuss O O
general O O
anesthesia, O O
answer O O
questions, O O
address O O
concerns, O O
and O O
obtain O O
signature O O
on O O
anesthesia O O
consent O O
form. O O
Plan: O O
Proposed O O
Anesthetic: O O
general O O
endotracheal O O
anesthesia O O
Monitors: O O
standard, O O
possible O O
arterial O O
line O O
Pain O O
Management: O O
epidural O O
or O O
IVPCA O O
Autologous O O
blood: O O
none O O
Premedication: O O
none O O
Usual O O
Medications: O O
TNG, B-MEDICATION O
atenolol, O B-MEDICATION
Zestril, O B-MEDICATION
Claritin, O O
clonazepam, O O
insulin, O O
aspirin, O B-MEDICATION
eye O O
drops, O O
Correctol, O O
Robitussin, O O
green O O
tea, O O
ginger O O
Medications O O
to O O
be O O
held O O
on O O
day O O
of O O
surgery: O O
insulin, O O
aspirin, O B-MEDICATION
eye O O
drops, O O
Correctol, O O
Robitussin O O
green O O
tea, O O
ginger O O
Diabetic O O
medications: O O
do O O
not O O
take O O
any O O
insulin O O
that O O
day O O
of O O
surgery O O
NSAIDS: O O
avoid O O
for O O
3 O O
days O O
prior O O
to O O
surgery O O
Aspirin: O B-MEDICATION
avoid O O
for O O
1 O O
week O O
prior O O
to O O
surgery O O
NPO: O O
after O O
midnight O O
the O O
evening O O
before O O
surgery O O
Ancillary O O
Studies: O O
_______________________________________________ O O
Patricia O O
C. O O
Wynn, O O
MSN, O O
RN, O O
CS O O
PATA O O
Medical O O
Director O O
Note: O O
I O O
have O O
reviewed O O
this O O
preanesthetic O O
assessment O O
and O O
concur O O
with O O
the O O
assessment O O
and O O
recommended O O
plan O O
with O O
the O O
following O O
exceptions: O O
signed: O O
____________________________________________________________ O O
Attending O O
Surgeon O O
Reassessment O O
Note: O O
I O O
have O O
reviewed O O
the O O
above O O
history O O
and O O
physical O O
exam O O
and O O
agree O O
with O O
the O O
findings. O O
Additional O O
comments: O O
signed: O O
___________________________________________________________ O O

Record O O
date: O O
2117-03-10 O O
SDU O O
Admission O O
PATIENT: O O
Usrey, O O
Anthony O O
MR: O O
6444877 O O
ADMIT O O
DATE: O O
March O O
10, O O
2117 O O
CODE O O
STATUS: O O
Full O O
ATTENDING: O O
Dr. O O
Updyke O O
(Ward) O O
PCP: O O
Iacono, O O
Cruz O O
CC: O O
syncope, O O
AS O O
HPI: O O
54 O O
y/o O O
Columbian O O
speaking O O
male O O
with O O
HTN, B-HYPERTENSION O
HL B-HYPERLIPIDEMIA O
who O O
was O O
in O O
Columbia O O
and O O
had O O
syncopal O O
episode O O
2 O O
days O O
ago O O
after O O
climbing O O
4 O O
flights O O
of O O
stairs. O O
There O O
are O O
conflicting O O
stories O O
of O O
his O O
prodrome O O
some O O
notes O O
mention O O
that O O
his O O
syncope O O
was O O
precipitated O O
by O O
chest O O
pain, O O
however O O
he O O
denies O O
this O O
and O O
only O O
reports O O
some O O
dyspnea O O
and O O
fatigue O O
as O O
he O O
was O O
climbing O O
the O O
stairs. O O
He O O
believes O O
he O O
was O O
unconscious O O
for O O
a O O
few O O
minutes. O O
On O O
waking O O
up, O O
he O O
reported O O
some O O
nausea O O
and O O
vomiting. O O
He O O
was O O
taken O O
to O O
a O O
hospital O O
in O O
Columbia O O
where O O
he O O
had O O
EKG O O
changes O O
and O O
CK O O
was O O
308 O O
and O O
troponin O O
was O O
0.19. O O
Echo O O
at O O
the O O
OSH O O
in O O
Columbia O O
was O O
showed O O
AS O O
with O O
peak O O
AV O O
gradient O O
62, O O
mean O O
38. O O
Valve O O
size O O
was O O
not O O
commented O O
upon. O O
He O O
was O O
offered O O
surgery O O
however O O
he O O
elected O O
to O O
come O O
back O O
to O O
America O O
and O O
now O O
presents O O
to O O
the O O
ER. O O
He O O
has O O
been O O
asymptomatic O O
since O O
this O O
episode O O
and O O
presently O O
denies O O
chest O O
pain, O O
dizziness, O O
SOB, O O
palpitations. O O
Denies O O
any O O
history O O
of O O
syncope O O
in O O
past. O O
Denies O O
history O O
of O O
seizures O O
in O O
past. O O
ER: O O
97.6, O O
77, O O
161/84, B-HYPERTENSION O
20, O O
97% O O
on O O
RA. O O
Got O O
ASA, B-MEDICATION B-MEDICATION
lopressor B-MEDICATION B-MEDICATION
25. O O
PMH: O O
HTN O O
HL O O
L O O
Achilles O O
repair O O
L O O
Medial O O
mensical O O
repair O O
MEDS: O O
Lisinopril B-MEDICATION B-MEDICATION
20mg O O
PO O O
QD O O
Lipitor B-MEDICATION B-MEDICATION
40mg O O
PO O O
QD O O
In O O
Columbia O O
was O O
started O O
on O O
the O O
following O O
but O O
is O O
not O O
taking: O O
Propranolol O O
10mg O O
PO O O
TID O O
Diovan O O
Asa B-MEDICATION B-MEDICATION
81mg O O
PO O O
QD O O
Simvastatin B-MEDICATION B-MEDICATION
Enoxaparin O B-MEDICATION
70mg O O
BID O O
ALLERGIES: O O
NKDA O O
SOCIAL O O
HISTORY: O O
No B-SMOKER O
tobacco, I-SMOKER O
Occ O O
Etoh, O O
Spanish O O
speaking, O O
originally O O
from O O
Columbia, O O
Divorced O O
lives O O
alone O O
in O O
Johnson O O
City. O O
Works O O
for O O
Pilgrim's O O
Pride. O O
FAMILY O O
HISTORY: O O
Brother-MI O O
in O O
50s O O
PHYSICAL O O
EXAM O O
VITALS: O O
98.2 O O
59, O O
145/88, B-HYPERTENSION O
16, O O
98% O O
Gen: O O
awake, O O
alert, O O
NAD O O
HEENT: O O
EOMI O O
OP: O O
OP O O
Clear O O
Neck: O O
No O O
JVD, O O
murmur O O
radiated O O
to O O
B O O
carotids, O O
No O O
LAD, O O
parvus O O
carotids O O
, O O
no O O
tardus O O
CV: O O
RRR O O
nl O O
s1 O O
s2 O O
harsh O O
III/VI O O
SEM O O
heard O O
throughout O O
precordium, O O
no O O
LV O O
heave O O
Pulm: O O
CTA O O
B O O
Abd: O O
+ O O
b.s, O O
NT, O O
ND, O O
soft O O
Ext: O O
1+ O O
DP, O O
no O O
edema O O
Neuro: O O
grossly O O
intact O O
LABS: O O
Chemistry O O
: O O
Sodium O O
(Stat O O
Lab) O O
137 O O
(135-145) O O
mmol/L O O
Potassium O O
(Stat O O
Lab) O O
4.5 O O
(3.4-4.8) O O
mmol/L O O
Chloride O O
(Stat O O
Lab) O O
106 O O
(100-108) O O
mmol/L O O
CO2 O O
(Stat O O
Lab) O O
24.8 O O
(23.0-31.9) O O
mmol/L O O
BUN O O
(Stat O O
Lab) O O
17 O O
(8-25) O O
mg/dl O O
Creatinine O O
(Stat O O
Lab) O O
1.0 O O
(0.6-1.5) O O
mg/dl O O
Glucose O O
(Stat O O
Lab) O O
101 O O
(70-110) O O
mg/dl O O
Hematology: O O
WBC O O
7.7 O O
(4.5-11.0) O O
th/cmm O O
HCT O O
37.7 O O
L O O
(41.0-53.0) O O
% O O
HGB O O
13.0 O O
L O O
(13.5-17.5) O O
gm/dl O O
RBC O O
4.22 O O
L O O
(4.50-5.90) O O
mil/cmm O O
PLT O O
185 O O
(150-350) O O
th/cumm O O
MCV O O
89 O O
(80-100) O O
fl O O
MCH O O
30.8 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
34.5 O O
(31.0-37.0) O O
g/dl O O
RDW O O
13.6 O O
(11.5-14.5) O O
% O O
PT O O
12.4 O O
(10.3-13.2) O O
sec O O
PT-INR O O
1.1 O O
APTT O O
26.6 O O
(22.1-34.0) O O
sec O O
Cardiac O O
Creatine O O
Kinase O O
Isoenzymes O O
NEGATIVE O O
(NEG) O O
Troponin-I O O
NEGATIVE O O
(NEG) O O
Echo: O O
At O O
OSH O O
in O O
Columbia: O O
LVH, O O
nl O O
fxn, O O
AV O O
calcified. O O
Max O O
gradient O O
62, O O
mean O O
38mmHg. O O
Mild O O
Aortic O O
regurg. O O
EKG: O O
Sinus O O
brady O O
at O O
55 O O
bpm, O O
nl O O
axis, O O
1st O O
degree O O
AV O O
block, O O
STD/TWI O O
in O O
I, O O
II, O O
III, O O
aVF, O O
V5, O O
V6. O O
LVH O O
pattern O O
w/ O O
J O O
pt O O
elevation O O
in O O
V1-V3. O O
ASSESSMENT O O
& O O
PLAN O O
54 O O
y/o O O
Spanish O O
speaking O O
male O O
with O O
HTN, O O
HL O O
presents O O
to O O
PNC O O
after O O
syncopal O O
episode O O
2 O O
days O O
ago O O
and O O
was O O
found O O
to O O
have O O
AS O O
at O O
OSH. O O
Mean O O
gradient O O
of O O
38mmHg O O
indicates O O
moderate O O
disease. O O
Prognosis O O
after O O
syncopal O O
episode O O
due O O
to O O
AS O O
is O O
3 O O
years. O O
AS: O O
Monitor O O
for O O
syncope, O O
CHF, O O
ischemia O O
Repeat O O
Echo O O
to O O
assess O O
valve O O
area, O O
gradients O O
Afterload O O
reduction--start O O
on O O
ACE B-MEDICATION O
Cont O O
statin, O O
check O O
lipid O O
panel O O
Avoid O O
nitrates, O O
diuretics O O
His O O
symptomatic O O
AS O O
warrants O O
w/u O O
for O O
AVR O O
Ischemia: O O
EKG O O
changes O O
c/w O O
LVH O O
although O O
doesn O O
t O O
quite O O
LVH O O
meet O O
criteria. O O
Did O O
have O O
+ O O
enzymes O O
at O O
OSH, O O
although O O
denies O O
hx O O
of O O
chest O O
pain. O O
Positive O O
biomarkers O O
? O O
due O O
to O O
coronary O O
insufficiency O O
in O O
the O O
setting O O
of O O
AS. O O
Cont O O
ASA, O O
lipitor B-MEDICATION O
Cycle O O
enzymes O O
Will O O
likely O O
need O O
coronary O O
angiography O O
before O O
AVR O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Lipitor O O
Prophylaxis O O
Nexium O O
Enoxaparin O O
Code O O
Full O O
__________________________________ O O
Jennifer O O
Yuan, O O
MD O O
67404 O O

Record B-SMOKER O
date: O O
2117-07-12 O O
Date O O
of O O
Consult: O O
7/16/17 O O
Anthony O O
Usrey O O
MRN: O O
644-48-77 O O
Admit O O
date: O O
7/12/17 O O
Heather O O
O. O O
Shelton, O O
N.P. O O
INDICATIONS O O
FOR O O
TPN: O O
Pancreatitis O O
CLASSIFICATION O O
OF O O
MALNUTRITION: O O
NSPCM O O
HPI: O O
Patient O O
is O O
a O O
54- O O
year O O
old O O
male O O
w/pancreatitis, O O
NPO, O O
was O O
on O O
TPN O O
@ O O
OSH. O O
Transferred O O
to O O
PNC O O
for O O
further O O
management. O O
TPN O O
off O O
for O O
2 O O
days O O
(7/14-7/15), O O
noPO's O O
for O O
about O O
15 O O
days O O
per O O
pt. O O
Anticipate O O
NPO O O
&gt; O O
1wk. O O
PMH: O O
CHF, O O
HTN, B-HYPERTENSION O
hyperlipidemia. B-HYPERLIPIDEMIA O
PSH: O O
Aortic O O
valve O O
replacement O O
3/17, O O
ERCP O O
with O O
sphincterotomy O O
(7/07), O O
CABG. B-CAD O
ROS: O O
CV: O O
Stable O O
PULM: O O
On O O
RA, O O
O2 O O
sats O O
96% O O
on O O
nebs. O O
GI: O O
abdominal O O
pain, O O
pancreatitis, O O
flatus, O O
no O O
BM, O O
no O O
N/V. O O
MEDICATIONS: O O
Rantidine, O O
Abx, O O
Heparin, O O
Sliding O O
scale. O O
ALLERGIES: O O
NKDA O O
PERTINENT O O
LAB O O
DATA: O O
Na: O O
138 O O
K: O O
3.3 O O
CL: O O
102 O O
HC03: O O
26.3 O O
BUN: O O
12 O O
CREAT: O O
0.8 O O
Glucose: O O
121 O O
Ca: O O
7.8 O O
PHOS: O O
2.6 O O
MG: O O
1.5 O O
Alb: O O
2.3 O O
Amy/Lips O O
162/34.9 O O
Check O O
Trigs. O O
Last O O
157 O O
@ O O
7/14. O O
ANTHROPMETRICS O O
HT: O O
5' O O
11' O O
WT: O O
215 O O
lbs. O O
/98 O O
Kg O O
IBW: O O
172lbs. O O
/ O O
78 O O
Kg O O
126 O O
% O O
IBW O O
ABW: O O
183 O O
lbs O O
./ O O
83 O O
Kg O O
Wt. O O
Change O O
stable O O
Body O O
Mass O O
Index O O
(BMI) O O
30 O O
(30-34.9 O O
obese) O O
Estimated O O
Nutritional O O
Requirements: O O
Maintenance O O
FLUID: O O
25-30cc/Kg O O
= O O
2075-2490cc/day O O
Kcal/Kg O O
Range: O O
25Kcal/Kg O O
= O O
2075 O O
Kcal O O
Protein O O
Requirements: O O
(1- O O
1.5 O O
gms/Kg/day) O O
= O O
83 O O
- O O
125 O O
gms/day. O O
PHYSICAL O O
EXAM: O O
General: O O
Large O O
male O O
lying O O
in O O
bed O O
in O O
mild O O
distress. O O
HR: O O
89 O O
BP: O O
130/62 O O
RR O O
18 O O
T O O
98? O O
CV: O O
RRR O O
Resp: O O
(B) O O
expiratory O O
wheezes. O O
GI/GU: O O
Abdomen O O
distended, O O
firm, O O
tenderness, O O
BS. O O
Skin: O O
Warm, O O
dry, O O
no O O
rashes. O O
ASSESSMENT O O
& O O
PLAN O O
Patient O O
will O O
be O O
started O O
on O O
70/100/25 O O
per O O
liter O O
at O O
50 O O
cc/hr. O O
This O O
will O O
provide O O
the O O
patient O O
with O O
84 O O
gms O O
of O O
protein O O
and O O
1044 O O
Kcals/day. O O
Adjust O O
to O O
goal. O O
TPN O O
Goal: O O
2075 O O
Kcal O O
(=25 O O
Kcal/Kg) O O
/ O O
protein O O
125 O O
gm O O
(= O O
1.5 O O
gm/kg) O O
VENOUS O O
ACCESS O O
(x) O O
PICC O O
LINE O O
( O O
) O O
HICKMAN O O
( O O
) O O
PA O O
LINE O O
( O O
) O O
TLC O O
( O O
) O O
PORTCATH O O
Triple O O
lumen O O
PICC O O
confirmed O O
in O O
PNC. O O
Charles O O
Zylstra, O O
RPH, O O
BCNSP/NSU O O
Iman O O
Anders, O O
(65985) O O
___________________ O O
Signature O O
of O O
Examiner O O
______________________________________________ O O
Gianna O O
Irish, O O
M.D. O O

Record B-SMOKER O
date: O O
2117-08-26 O O
Usrey, O O
Anthony O O
MRN: O O
6444877 O O
DOB: O O
8/11/2062 O O
August O O
26, O O
2117 O O
Sisters O O
Of O O
Providence O O
Hospital O O
CC: O O
f/u O O
pancreatitis O O
HPI: O O
55 O O
y.o. O O
male O O
Columbian O O
speaking O O
(hospital O O
interpreter O O
present) O O
presents O O
for O O
follow O O
up. O O
He O O
was O O
admitted O O
to O O
PNC O O
on O O
7/12/17 O O
for O O
further O O
management O O
of O O
his O O
pancreatitis O O
secondary O O
to O O
an O O
ERCP/spincterotomy O O
that O O
was O O
preformed O O
at O O
an O O
outside O O
hospital. O O
He O O
had O O
a O O
prolonged O O
stay O O
that O O
included O O
NPO, O O
IVF, O O
antibiotics, O O
and O O
TPN. O O
Further O O
management O O
included O O
management O O
of O O
pulmonary O O
edema O O
and O O
anticoagulation O O
as O O
the O O
patient O O
is O O
on O O
Coumadin O O
at O O
baseline O O
secondary O O
to O O
a O O
heart O O
valve. O O
He O O
was O O
eventually O O
transitioned O O
to O O
a O O
diet O O
and O O
the O O
TPN O O
stopped. O O
He O O
represents O O
today O O
for O O
follow O O
up O O
c/o O O
epigastric O O
pain O O
'nails' O O
intermittently O O
at O O
night. O O
Pain O O
noted O O
on O O
going O O
to O O
sleep O O
but O O
does O O
not O O
stop O O
sleep O O
and O O
he O O
does O O
not O O
awaken O O
in O O
the O O
night O O
from O O
it. O O
He O O
continues O O
on O O
his O O
antibiotic O O
and O O
will O O
complete O O
its O O
course. O O
ROS: O O
no O O
fever/chills, O O
no O O
nausea/vomiting, O O
taking O O
in O O
good O O
oral O O
solids/liquids, O O
occ O O
abdominal O O
pain O O
at O O
present O O
none, O O
no O O
change O O
in O O
bowel O O
or O O
urinary O O
habits. O O
Exam: O O
Temp: O O
98.2F O O
Abdo: O O
slightly O O
round, O O
soft, O O
nondistended, O O
minimal O O
tenderness O O
LUQ, O O
no O O
masses, O O
+BS O O
Plan: O O
1. O O
continue O O
oral O O
antibiotics O O
til O O
course O O
is O O
complete O O
2. O O
return O O
in O O
1-2 O O
weeks O O
for O O
follow O O
3. O O
return O O
sooner O O
fever/chills, O O
n/v, O O
abdominal O O
pain O O
Case O O
discussed O O
with O O
and O O
seen O O
by O O
Dr O O
Hugh O O
Delarosa O O
Helen O O
Ochs O O
NP O O

Record B-SMOKER O
date: O O
2118-01-08 O O
Garner O O
Medical O O
Clinic O O
Internal O O
Medicine O O
Attending: O O
Dr O O
Mariusz O O
Soto, O O
MD O O
Senior: O O
Gregory O O
Xing, O O
MD O O
Intern: O O
Frances O O
Justus, O O
MD O O
Medical O O
Students: O O
Robert O O
Joshi, O O
Sylvia O O
Cordova. O O
Patient O O
Name: O O
Usrey, O O
Anthony O O
MR#: O O
6444877 O O
Date: O O
01/08/2118 O O
-- O O
CC: O O
scheduled O O
for O O
surgery O O
on O O
1/13/18 O O
HPI: O O
Patient O O
is O O
a O O
54 O O
y.o. O O
male O O
with O O
h/o O O
aortic O O
valve O O
replacement, O O
CHF, O O
and O O
HTN B-HYPERTENSION O
who O O
presented O O
to O O
PNC O O
as O O
a O O
transfer O O
from O O
Montebello O O
Convalescent O O
Hospital O O
with O O
a O O
diagnosis O O
of O O
post-ERCP O O
pancreatitis. O O
The O O
patient O O
was O O
admitted O O
to O O
Montebello O O
Convalescent O O
with O O
a O O
history O O
of O O
RUQ O O
pain O O
that O O
began O O
on O O
July O O
3rd. O O
He O O
was O O
found O O
to O O
have O O
choledochal O O
stones O O
and O O
underwent O O
an O O
ERCP O O
with O O
sphincterotomy O O
on O O
July O O
07. O O
Subsequent O O
to O O
this O O
he O O
developed O O
a O O
bout O O
of O O
generalized O O
abdominal O O
pain O O
two O O
days O O
later O O
and O O
he O O
was O O
noted O O
to O O
have O O
a O O
marked O O
and O O
new O O
increase O O
in O O
his O O
amylase O O
and O O
lipase O O
levels O O
(3191 O O
and O O
2171, O O
respectively), O O
diagnosed O O
as O O
acute O O
post O O
ERCP O O
pancreatitis O O
and O O
transferred O O
to O O
PNC O O
for O O
further O O
management. O O
Dr O O
Gregory O O
Xing O O
explained O O
to O O
him O O
via O O
an O O
interpreter O O
and O O
with O O
images O O
of O O
his O O
CT O O
scan O O
that O O
he O O
has O O
gallstones O O
and O O
pancreatic O O
pseudocysts O O
that O O
have O O
persisted O O
as O O
compared O O
to O O
his O O
last O O
CT O O
in O O
July O O
2117. O O
The O O
procedure O O
of O O
open O O
cholecystectomy O O
with O O
Roux O O
en O O
Y O O
drainage O O
of O O
pancreatic O O
psudocyst O O
was O O
explained O O
to O O
him O O
and O O
he O O
was O O
consented. O O
He O O
will O O
be O O
an O O
inpatient O O
3 O O
days O O
prior O O
to O O
surgery O O
for O O
transition O O
from O O
Coumadin O O
to O O
heparin O O
/ O O
lovenox O O
therapy. O O
He O O
is O O
presently O O
doing O O
well, O O
with O O
no O O
fevers O O
or O O
abd O O
pain. O O
He O O
is O O
eating O O
well O O
and O O
has O O
returned O O
to O O
his O O
normal O O
life. O O
PMH: O O
S/p O O
mechanical O O
aortic O O
valve O O
replacement, O O
CHF, O O
HTN, O O
hyperlipidemia B-HYPERLIPIDEMIA B-MEDICATION
-- O O
PSH: O O
CABG, B-CAD O
AVR O O
-- O O
Meds: O O
Lisinopril B-MEDICATION B-MEDICATION
40 O O
MG O O
QD O O
Coumadin O O
5 O O
MG O O
QHS O O
Lipitor B-MEDICATION B-MEDICATION
40 O O
mg O O
QD. O O
Allergies: O O
NKDA O O
-- O O
Physical O O
Exam: O O
CV: O O
RRR O O
(+) O O
S1/S2, O O
2+ O O
radial O O
pulses, O O
audible O O
mechanical O O
valve O O
click O O
Pulm: O O
CTAB O O
Abdomen: O O
Abdomen O O
soft. O O
He O O
is O O
completely O O
nontender. O O
Ext: O O
No O O
e/c/c. O O
-- O O
Imaging: O O
1. O O
CXR: O O
Bilateral O O
pleural O O
effusions, O O
no O O
free O O
air O O
under O O
the O O
diaphragm O O
seen. O O
2. O O
CT O O
scan O O
from O O
OSH O O
of O O
abdomen: O O
reveals O O
phlegmon O O
in O O
the O O
lesser O O
sac O O
and O O
gas O O
in O O
both O O
the O O
biliary O O
tree O O
as O O
well O O
as O O
the O O
portal O O
vein. O O
3. O O
CT O O
scan O O
from O O
10/10/17 O O
at O O
PNC: O O
Overall O O
decrease O O
in O O
abdominal O O
phlegmonous O O
change, O O
with O O
interval O O
development O O
of O O
a O O
13 O O
x O O
5.4 O O
x O O
4.8 O O
cm O O
well O O
defined O O
collection O O
anterior O O
to O O
the O O
pancreas. O O
4. O O
CT O O
from O O
1/02/18: O O
No O O
significant O O
change O O
in O O
hypodense O O
lesions O O
anterior O O
to O O
the O O
pancreatic O O
body/tail O O
and O O
tail O O
most O O
consistent O O
with O O
pseudocysts. O O
Cholelithiasis. O O
Diverticulosis O O
without O O
diverticulitis. O O
Assessment/Plan: O O
54 O O
y.o. O O
male O O
with O O
post-ERCP O O
pancreatitis O O
which O O
is O O
not O O
responding O O
to O O
conservative O O
management O O
-Cardiology O O
consult. O O
-Anesthesia O O
pre-op O O
clearance O O
-Home O O
meds. O O
-d/c O O
Coumadin O O
-Start O O
heparin O O
drip O O
after O O
stat O O
labs O O
(check O O
PTT, O O
INR) O O
-Regular O O
diet. O O
Patient O O
has O O
been O O
seen O O
by O O
Gregory O O
Xing, O O
senior O O
resident O O
SOPH O O
Internal O O
Medicine O O
Frances O O
Justus, O O
MD O O
PNC O O
Surgery O O

Record B-SMOKER O
date: O O
2118-04-15 O O
CARDIOLOGY O O
PARK O O
NICOLLET O O
CLINIC O O
Reason O O
for O O
visit: O O
55 O O
y/o O O
Columbian O O
male O O
with O O
a O O
history O O
of O O
HTN, B-HYPERTENSION O
hyperlipidemia, B-HYPERLIPIDEMIA O
severe O O
AS O O
s/p O O
AVR O O
(St. O O
Judes) O O
in O O
3/17 O O
and O O
recent O O
composite O O
arortic O O
homograft O O
replacement O O
for O O
MRSA/VISA O O
endocarditis O O
presenting O O
for O O
follow-up. O O
Interval O O
History: O O
The O O
patient's O O
complicated O O
cardiac O O
history O O
dates O O
back O O
to O O
3/17 O O
when O O
he O O
underwent O O
mechanical O O
AVR O O
for O O
symptomatic O O
severe O O
AS. O O
He O O
had O O
preserved O O
LV O O
function O O
and O O
pre-operative O O
cardiac O O
catheterization B-CAD O
showed I-CAD O
multi I-CAD O
vessel I-CAD O
non-obstructive I-CAD O
CAD. B-CAD O
He O O
initially O O
did O O
well, O O
but O O
had O O
a O O
prolonged O O
hospitalization O O
in O O
7/17. O O
At O O
that O O
time, O O
he O O
developed O O
acute O O
cholecystitis O O
and O O
post-ERCP O O
pancreatitis O O
which O O
was O O
complicated O O
by O O
phlegmon O O
and O O
pseudocyst O O
formation. O O
He O O
was O O
admitted O O
to O O
PNC O O
in O O
1/18 O O
for O O
elective O O
open O O
cholecystectomy O O
and O O
roux-en-Y O O
cyst-jejunostomy. O O
He O O
underwent O O
the O O
GI O O
surgery O O
on O O
1/11/18. O O
His O O
post-operative O O
course O O
was O O
complicated O O
by O O
recurrent O O
GIB O O
upon O O
re-initiation O O
of O O
anti-coagulation O O
for O O
the O O
mechanical O O
AVR O O
that O O
prolonged O O
his O O
hospital O O
stay. O O
Unfortunately, O O
he O O
developed O O
line-associated O O
bactermeia O O
and O O
sepsis O O
4 O O
weeks O O
into O O
the O O
hospitalization. O O
He O O
developed O O
high O O
fevers O O
on O O
2/07/18 O O
ad O O
he O O
had O O
serial O O
cultures O O
positive O O
for O O
MRSA O O
that O O
had O O
intermediate O O
sensitivity O O
to O O
Vancomycin. O O
He O O
was O O
initially O O
treated O O
with O O
Vancomycin O O
and O O
Gentamicin O O
with O O
addition O O
of O O
Rifampin O O
later O O
in O O
the O O
course O O
of O O
treatment. O O
He O O
developed O O
progressive O O
PR O O
prolongation O O
on O O
ECG O O
and O O
a O O
TTE O O
on O O
2/10/18 O O
and O O
TEE O O
on O O
2/11/18 O O
showed O O
vegetations O O
on O O
the O O
aortic O O
prosthesis O O
with O O
evidence O O
of O O
annular O O
involvement O O
with O O
abscess. O O
A O O
follow-up O O
TEE O O
on O O
2/17/18 O O
showed O O
worsening O O
aortic O O
root O O
abscess O O
and O O
he O O
was O O
ultimately O O
taken O O
to O O
the O O
OR O O
by O O
Dr. O O
Elrod O O
on O O
2/17/18. O O
The O O
intraoperative O O
findings O O
were O O
notable O O
were O O
notable O O
for O O
severe O O
aortic O O
root O O
involvement O O
and O O
he O O
underwent O O
composite O O
aortic O O
homograft O O
replacement O O
that O O
was O O
complicated O O
by O O
severe O O
RV O O
failure. O O
On O O
POD O O
0, O O
he O O
had O O
recurrent O O
malignant O O
arrhythmias O O
(VT/VF) O O
which O O
required O O
~ O O
50 O O
defibrillations O O
and O O
open O O
cardiac O O
massage. O O
A O O
TEE O O
done O O
after O O
stabilization O O
showed O O
global O O
akinesis O O
and O O
severe O O
TR, O O
and O O
preserved O O
LV O O
function. O O
Emergent O O
coronary O O
angiogram O O
showed O O
evidence O O
of O O
RCA O O
vasospasm. O O
An O O
IABP O O
was O O
placed O O
and O O
he O O
was O O
treated O O
with O O
beta O O
blockade O O
and O O
for O O
vasospasm. O O
HE O O
was O O
taken O O
to O O
the O O
OR O O
for O O
closure O O
on O O
2/22/18. O O
His O O
course O O
was O O
subsequently O O
notable O O
for O O
ARF O O
which O O
transiently O O
required O O
CVVH, O O
development O O
of O O
HIT, O O
and O O
vascular O O
emboli O O
to O O
the O O
right O O
lower O O
extremity O O
which O O
led O O
to O O
dry O O
gangrene O O
og O O
the O O
right O O
3rd O O
digit. O O
ABI O O
testing O O
revealed O O
no O O
evidence O O
of O O
PAD. O O
He O O
was O O
followed O O
by O O
ID O O
and O O
was O O
placed O O
on O O
daptomycin O O
and O O
Bactrim. O O
He O O
was O O
seen O O
by O O
Vascular O O
surgery O O
and O O
was O O
not O O
deemed O O
to O O
require O O
any O O
surgical O O
intervention O O
and O O
was O O
scheduled O O
for O O
outpatient O O
follow O O
up. O O
With O O
supportive O O
care, O O
he O O
was O O
successfully O O
weaned O O
off O O
IABP O O
and O O
ventilatory O O
support O O
and O O
transferred O O
to O O
the O O
step O O
down O O
unit. O O
His O O
course O O
there O O
was O O
notable O O
for O O
mild O O
hyperkalemia O O
that O O
was O O
felt O O
to O O
be O O
related O O
to O O
Bactrim O O
induced O O
RTA. O O
He O O
also O O
had O O
severe O O
depression O O
that O O
was O O
felt O O
to O O
be O O
related O O
an O O
adjustment O O
disorder. O O
He O O
was O O
discharged O O
to O O
a O O
rehab O O
facility O O
on O O
3/22/18 O O
and O O
was O O
discharged O O
from O O
rehab O O
12 O O
dyas O O
ago. O O
Since O O
discharge, O O
he O O
reports O O
doing O O
relatively O O
well. O O
He O O
reports O O
fatigue O O
and O O
DOE O O
after O O
walking O O
up O O
a O O
flight O O
of O O
stairs. O O
He O O
is O O
able O O
to O O
walk O O
up O O
to O O
15-20 O O
minutes O O
continuously. O O
He O O
denies O O
any O O
chest O O
pain, O O
dyspnea O O
at O O
rest, O O
PND, O O
orthopnea, O O
LE O O
edema, O O
palpitations, O O
syncope, O O
or O O
pre-syncope. O O
He O O
also O O
denies O O
any O O
fevers, O O
chills, O O
or O O
weight O O
loss. O O
He O O
has O O
been O O
seen O O
in O O
follow O O
up O O
by O O
Dr. O O
Infant-Nickel O O
in O O
ID O O
earlier O O
this O O
month. O O
He O O
was O O
noted O O
to O O
be O O
doing O O
relatively O O
well O O
but O O
still O O
had O O
an O O
elevated O O
ESR O O
and O O
CRP. O O
The O O
plan O O
is O O
continue O O
a O O
prolonged O O
oral O O
taper O O
of O O
Bactrim. O O
He O O
has O O
completed O O
a O O
6 O O
week O O
course O O
of O O
daptomycin. O O
Past O O
medical O O
history: O O
1. O O
MRSA/VISA O O
prosthetic O O
aortic O O
valve O O
endocarditis. O O
Originally O O
underwent O O
AVR O O
for O O
severe O O
AS O O
on O O
03/13/2117. O O
Developed O O
aortic O O
endocarditis O O
and O O
aortic O O
root O O
abscess O O
as O O
a O O
complication O O
of O O
line O O
sepsis O O
in O O
2/18 O O
and O O
underwent O O
composite O O
aortic O O
homograft O O
replacement O O
on O O
2/19/18. O O
Intraoperatively O O
developed O O
severe O O
RV O O
failure. O O
2. O O
RV O O
failure. O O
Complication O O
of O O
aortic O O
homograft O O
surgery. O O
TEE O O
on O O
2/20/18 O O
showed O O
severe O O
RV O O
hypokinesis O O
and O O
severe O O
TR. O O
3. O O
HIT. O O
Developed O O
HIT O O
post-operatively O O
after O O
aortic O O
homograft O O
replacement O O
in O O
2/18. O O
4. O O
Coronary B-CAD O
artery I-CAD O
disease. I-CAD O
Preoperative O O
cardiac B-CAD O
catheterization I-CAD O
on I-CAD O
03/11/2117 I-CAD O
demonstrated I-CAD O
30% I-CAD O
focal I-CAD O
narrowing I-CAD O
in I-CAD O
the I-CAD O
left I-CAD O
main; I-CAD O
proximal I-CAD O
30% I-CAD O
lesion I-CAD O
in I-CAD O
the I-CAD O
LAD; B-CAD O
50% I-CAD O
lesion I-CAD O
in I-CAD O
D1; I-CAD O
mid I-CAD O
50% I-CAD O
lesion I-CAD O
in I-CAD O
the I-CAD O
left I-CAD O
circumflex, I-CAD O
and O O
normal O O
RCA. O O
5. O O
Dry O O
gangrene O O
of O O
right O O
3rd O O
digit O O
of O O
right O O
foot O O
thought O O
to O O
be O O
secondary O O
to O O
an O O
embolic O O
complication O O
of O O
IABP O O
versus O O
HITT. O O
6. O O
Hypertension. B-HYPERTENSION O
7. O O
Hyperlipidemia. B-HYPERLIPIDEMIA O
Changes O O
to O O
Allergies O O
Heparin O O
- O O
reaction: O O
Thrombocytopenia O O
or O O
Anemia O O
[reviewed] O O
Medications O O
(Confirmed): O O
ascorbic O B-MEDICATION
acid O O
250mg O O
po O O
daily O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
po O O
daily O O
atenolol B-MEDICATION B-MEDICATION
25mg O O
po O O
BID O O
Bactrim O O
DS O O
tablets O O
Coumadin O O
5 O O
mg O O
PO O O
at O O
bedtime O O
Lasix O O
40mg O O
po O O
BID O O
Lipitor B-MEDICATION B-MEDICATION
40 O O
mg O O
PO O O
daily O O
Protonix O O
40mg O O
po O O
daily O O
Silvadene O O
zinc O O
Review O O
of O O
systems: O O
As O O
per O O
HPI. O O
Physical O O
examination: O O
-BMI: O O
-Pulse: O O
72 O O
-resp. O O
rate: O O
16 O O
-weight: O O
178 O O
lbs. O O
-General: O O
No O O
acute O O
distress. O O
-Heent: O O
Oropharynx O O
clear O O
-Neck: O O
2+ O O
symmetric O O
carotid O O
pulses O O
with O O
no O O
bruits. O O
JVP O O
of O O
12-14 O O
cm O O
with O O
prominent O O
V O O
waves. O O
-Chest: O O
Decreased O O
BS O O
and O O
dullness O O
to O O
percussion O O
over O O
the O O
right O O
base. O O
Otherwise O O
CTAB. O O
-Cardiac: O O
Discrete O O
non-displaced O O
PMI. O O
No O O
clear O O
RV O O
heave. O O
Sternal O O
wound O O
well O O
healed O O
with O O
no O O
sternal O O
click. O O
RRR. O O
Normal O O
S1 O O
and O O
widely O O
split O O
S2. O O
Soft O O
1-2/6 O O
SEM. O O
No O O
diastolic O O
murmur. O O
-Abdomen: O O
Soft, O O
non-tender, O O
non-distended O O
with O O
pulsatile O O
liver. O O
-Extremities: O O
No O O
lower O O
extremity O O
edema. O O
Tip O O
of O O
3rd O O
toe O O
on O O
right O O
foot O O
has O O
dry O O
gangrene O O
but O O
no O O
exudate O O
or O O
open O O
ulceration. O O
1+ O O
DP O O
on O O
the O O
right O O
and O O
2+ O O
DP O O
on O O
left. O O
-Neuro: O O
A&amp;O O O
x3 O O
-BP: O O
107/60 O O
EKG: O O
NSR O O
75 O O
with O O
1st O O
degree O O
AV O O
block, O O
RBBB, O O
and O O
LAFB. O O
Selected O O
recent O O
labs: O O
Assessment O O
and O O
plan: O O
55 O O
y/o O O
Columbian O O
male O O
with O O
a O O
history O O
of O O
HTN, O O
hyperlipidemia, O O
severe O O
AS O O
s/p O O
AVR O O
(St. O O
Judes) O O
in O O
3/17 O O
and O O
recent O O
composite O O
arortic O O
homograft O O
replacement O O
for O O
MRSA/VISA O O
endocarditis. O O
The O O
patient O O
had O O
a O O
prolonged O O
hospitalization O O
with O O
a O O
complicated O O
post-operative O O
course O O
that O O
was O O
notable O O
for O O
RV O O
failure, O O
ARF, O O
HIT, O O
vascular O O
emboli O O
to O O
the O O
right O O
foot, O O
and O O
mild O O
hyperkalemia. O O
At O O
this O O
point, O O
he O O
appears O O
close O O
to O O
euvolemia O O
by O O
exam O O
and O O
has O O
no O O
evidence O O
of O O
decompensated O O
CHF. O O
HE O O
has O O
evidence O O
of O O
severe O O
TR O O
on O O
exam. O O
From O O
an O O
ID O O
perspective O O
although O O
all O O
recent O O
cultures O O
have O O
been O O
negative, O O
the O O
resistance O O
pattern O O
of O O
his O O
MRSA O O
and O O
persistent O O
elevation O O
of O O
ESR O O
and O O
CRP O O
are O O
concerning, O O
and O O
he O O
will O O
require O O
a O O
prolonged O O
course O O
of O O
anti-biotics O O
as O O
outlined O O
by O O
Dr. O O
Infant-Nickel. O O
His O O
ARF O O
has O O
resolved O O
and O O
his O O
vascular O O
embolic O O
events O O
to O O
the O O
right O O
foot O O
are O O
not O O
an O O
active, O O
acute O O
issue O O
as O O
he O O
only O O
has O O
dry O O
gangrene O O
and O O
no O O
evidence O O
of O O
infection. O O
PLAN: O O
1. O O
PVE O O
endocarditis. O O
He O O
is O O
s/p O O
composite O O
aortic O O
homograft O O
replacement. O O
He O O
will O O
need O O
a O O
prolonged O O
Bactrim O O
taper O O
per O O
ID. O O
We O O
will O O
obtain O O
CBC, O O
chem O O
panel, O O
LFTs, O O
ESR, O O
CRP O O
per O O
ID O O
today. O O
He O O
is O O
currently O O
on O O
coumadin O O
and O O
will O O
likely O O
need O O
this O O
for O O
a O O
total O O
of O O
~6-8 O O
weeks O O
post-operatively. O O
We O O
will O O
continue O O
coumadin O O
pending O O
his O O
visit O O
with O O
Dr. O O
Elrod O O
next O O
week. O O
2. O O
RV O O
failure. O O
Currently O O
well O O
compensated O O
with O O
no O O
evidence O O
of O O
systemic O O
congestion. O O
We O O
will O O
continue O O
his O O
current O O
dose O O
of O O
lasix. O O
Dry O O
weight O O
~175-178 O O
lbs. O O
I O O
will O O
obtain O O
a O O
repeat O O
TTE O O
to O O
reassess O O
RV O O
and O O
TR O O
severity. O O
We O O
anticipate O O
some O O
recovery O O
of O O
RV O O
function. O O
3. O O
ARF. O O
Resolved. O O
We O O
will O O
check O O
a O O
follow O O
up O O
chem O O
panel O O
today. O O
4. O O
Right O O
foot O O
gangrene. O O
Involvement O O
of O O
the O O
right O O
3rd O O
toe O O
with O O
no O O
wet O O
gangrene O O
or O O
signs O O
of O O
infection. O O
ABI O O
testing O O
in O O
3/18 O O
showed O O
no O O
PAD. O O
He O O
will O O
need O O
outpatient O O
follow O O
up O O
with O O
Dr. O O
Werner O O
in O O
vascular O O
surgery. O O
5. O O
CAD. O O
Non-obstructive O O
disease. O O
Continue O O
ASA, B-MEDICATION B-MEDICATION
atenolol O B-MEDICATION
and O O
lipitor. B-MEDICATION B-MEDICATION
We O O
will O O
hold O O
on O O
ACE-inhibitor O O
given O O
hyperkalemia O O
issues. O O
6. O O
Hyperkalemia. O O
Likely O O
secondary O O
to O O
RTA O O
related O O
to O O
Bactrim. O O
Ww O O
will O O
check O O
follow O O
up O O
chem O O
panel O O
today. O O
He O O
will O O
need O O
monitoring O O
of O O
K O O
and O O
we O O
can O O
consider O O
kayexlate O O
therapy O O
if O O
he O O
has O O
persistent O O
elevations O O
for O O
the O O
duration O O
of O O
therapy O O
with O O
Bactrim. O O
Patient O O
will O O
return O O
to O O
clinic O O
in O O
3 O O
months O O
for O O
follow-up. O O
Patient O O
seen O O
with O O
Dr. O O
Calhoun. O O
Changes O O
to O O
Medications O O
this O O
visit O O
Coumadin O O
3 O O
mg O O
PO O O
at O O
bedtime O O
Jonathan O O
Forrester, O O
Fellow O O
pager O O
#08374 O O
Signed O O
electronically O O
by O O
Jonathan O O
Forrester, O O
Fellow O O
Document O O
Status: O O
Final O O

Record B-SMOKER O
date: O O
2088-05-21 O O
Patient O O
Name: O O
CURTIS, O O
OM; O O
MRN: O O
7682941 O O
Dictated O O
at: O O
05/21/88 O O
by O O
VICTOR O O
R. O O
GOMES, O O
M.D. O O
Mr. O O
Curtis O O
returns O O
with O O
a O O
history O O
of O O
ureteral O O
stones, O O
BPH, O O
and O O
dysuria. O O
He O O
has O O
not O O
had O O
any O O
stone O O
passage O O
in O O
the O O
last O O
six O O
months. O O
He O O
has O O
passed O O
some O O
tissue, O O
and O O
had O O
some O O
gross O O
hematuria O O
with O O
his O O
last O O
visit, O O
but O O
has O O
not O O
had O O
any O O
symptoms O O
since O O
then. O O
With O O
his O O
BPH, O O
he O O
has O O
not O O
had O O
any O O
significant O O
worsening O O
of O O
his O O
nocturia O O
or O O
daytime O O
frequency. O O
He O O
feels O O
as O O
if O O
he O O
is O O
emptying O O
his O O
bladder O O
well O O
now O O
on O O
the O O
Cardura. O O
He O O
did O O
have O O
some O O
dysuria, O O
and O O
Dr. O O
Geiger O O
gave O O
him O O
a O O
pill O O
which O O
seems O O
to O O
have O O
helped O O
him. O O
His O O
review O O
of O O
systems O O
today O O
is O O
negative. O O
His O O
past O O
medical O O
history O O
is O O
unchanged, O O
and O O
he O O
is O O
continuing O O
with O O
a O O
cholesterol O O
medication, O O
a O O
pill O O
for O O
burning, O O
Cardura, O O
and O O
Atenolol. B-MEDICATION B-MEDICATION
On O O
physical O O
examination, O O
his O O
vital O O
signs O O
show O O
him O O
to O O
be O O
well-nourished O O
and O O
well-developed. O O
His O O
respirations O O
are O O
14. O O
His O O
pulse O O
is O O
regular. O O
A O O
general O O
examination O O
shows O O
his O O
neck O O
to O O
be O O
supple. O O
He O O
is O O
alert O O
and O O
oriented O O
x O O
3. O O
He O O
has O O
no O O
labored O O
breathing. O O
He O O
has O O
no O O
palpable O O
groin O O
adenopathy. O O
His O O
skin O O
has O O
normal O O
turgor, O O
and O O
his O O
cardiovascular O O
exam O O
shows O O
no O O
JVD. O O
A O O
complete O O
GU O O
examination O O
shows O O
his O O
epididymis O O
to O O
be O O
without O O
masses. O O
A O O
rectal O O
exam O O
shows O O
his O O
anus O O
to O O
be O O
without O O
masses. O O
His O O
scrotum O O
is O O
without O O
lesions. O O
His O O
urethral O O
meatus O O
has O O
no O O
discharge. O O
His O O
prostate O O
has O O
some O O
BPH, O O
but O O
no O O
nodularity. O O
His O O
penis O O
has O O
no O O
foreskin O O
lesions. O O
His O O
testes O O
have O O
no O O
masses. O O
His O O
seminal O O
vesicles O O
have O O
no O O
masses. O O
His O O
sphincter O O
tone O O
is O O
normal. O O
An O O
independent O O
review O O
of O O
a O O
urinalysis O O
today O O
is O O
negative. O O
A O O
review O O
of O O
clinical O O
lab O O
testes O O
shows O O
a O O
nuclear O O
matrix O O
protein O O
less O O
than O O
10 O O
on O O
11/14/87. O O
This O O
was O O
done O O
via O O
PCIS. O O
A O O
post-void O O
residual O O
today O O
is O O
14 O O
cc. O O
For O O
his O O
BPH, O O
I O O
believe O O
he O O
should O O
continue O O
with O O
Cardura O O
2 O O
mg O O
p.o. O O
q.d. O O
His O O
stone O O
disease O O
is O O
quiescent, O O
and O O
he O O
will O O
let O O
me O O
know O O
if O O
there O O
are O O
any O O
recurrences O O
with O O
symptoms O O
of O O
these. O O
We O O
will O O
consider O O
checking O O
a O O
KUB O O
in O O
one O O
year's O O
time. O O
He O O
will O O
let O O
me O O
know O O
if O O
there O O
are O O
any O O
difficulties O O
in O O
the O O
interim. O O
_______________________________ O O
Victor O O
R. O O
Gomes, O O
M.D. O O
cc: O O
William O O
Geiger, O O
M.D., O O
Allina O O
Medical O O
Clinic O O
At O O
Hinckley, O O
Internal O O
Medicine O O
DD:05/21/88 O O
DT:05/21/88 O O
UL:30614 O O
:7550 O O

Record B-SMOKER O
date: O O
2089-08-24 O O
NAME: O O
Curtis, O O
Om O O
MRN: O O
7682941 O O
He O O
is O O
feeling O O
quite O O
fine O O
today. O O
He O O
has O O
no O O
specific O O
problems O O
to O O
being O O
to O O
my O O
attention. O O
He O O
says O O
that O O
he O O
is O O
having O O
no O O
problems O O
with O O
chest O O
pains O O
whatsoever O O
and O O
that O O
includes O O
with O O
exertion. O O
His O O
breathing O O
has O O
been O O
fine O O
as O O
well. O O
No O O
shortness O O
of O O
breath. O O
Otherwise O O
he O O
denies O O
any O O
abdominal O O
pains, O O
joint O O
pains, O O
bowel O O
or O O
bladder O O
difficulties. O O
The O O
remainder O O
of O O
the O O
review O O
of O O
systems O O
is O O
negative O O
in O O
detail. O O
PHYSICAL O O
EXAM: O O
On O O
exam, O O
he O O
looks O O
well. O O
Skin O O
is O O
clear. O O
HEENT O O
- O O
PERRLA. O O
EOMI. O O
TMs O O
and O O
throat O O
clear. O O
Neck O O
supple. O O
No O O
thyromegaly. O O
No O O
lymphadenopathy. O O
Lungs O O
are O O
clear. O O
Heart O O
is O O
regular O O
rate O O
and O O
rhythm. O O
No O O
murmurs, O O
gallops O O
or O O
rubs. O O
Abdomen O O
is O O
soft O O
and O O
nontender. O O
No O O
masses. O O
No O O
HSM. O O
Extremities O O
with O O
no O O
edema. O O
Neurologically O O
fully O O
intact. O O
ASSESSMENT O O
AND O O
PLAN: O O
(1) O O
Angina/hypertension/hyperlipidemia. B-CAD O
He O O
is O O
doing O O
quite O O
well O O
and O O
very O O
stable. O O
Since O O
his O O
cholesterol O O
was O O
in O O
such O O
great O O
shape O O
just O O
a O O
few O O
months O O
ago, O O
no O O
need O O
to O O
recheck O O
here O O
today. O O
(2) O O
Bladder O O
stone. O O
He O O
had O O
this O O
dealt O O
with O O
by O O
Dr. O O
Gomes O O
of O O
Urology. O O
(3) O O
Diabetes B-DIABETES O
mellitus. I-DIABETES O
Very O O
stable. O O
Check O O
glycosylated O O
hemoglobin. O O
He O O
is O O
up O O
to O O
date O O
on O O
his O O
eye O O
exams. O O
Follow-up O O
with O O
me O O
in O O
three O O
months. O O
William O O
V. O O
Geiger, O O
M.D. O O
WVG/xin/quilici O O

Record B-SMOKER O
date: O O
2090-07-16 O O
NAME: O O
Curtis, O O
Om O O
MRN: O O
7682941 O O
He O O
is O O
feeling O O
great. O O
He O O
is O O
all O O
done O O
with O O
his O O
radiation O O
to O O
the O O
left O O
axilla O O
for O O
metastatic O O
squamous O O
cell O O
cancer. O O
He O O
is O O
following O O
closely O O
with O O
the O O
radiation O O
oncologist O O
and O O
the O O
medical O O
oncologist. O O
He O O
is O O
seeing O O
them O O
both O O
later O O
this O O
month. O O
He O O
has O O
had O O
no O O
problems O O
with O O
chest O O
pains O O
or O O
shortness O O
of O O
breath. O O
All O O
in O O
all, O O
things O O
are O O
going O O
well. O O
PHYSICAL O O
EXAM: O O
On O O
exam, O O
no O O
acute O O
distress. O O
Lungs O O
are O O
clear. O O
Heart O O
is O O
regular O O
rate O O
and O O
rhythm. O O
No O O
murmurs, O O
gallops O O
or O O
rubs. O O
He O O
does O O
have O O
some O O
skin O O
discoloration O O
around O O
the O O
left O O
axilla O O
but O O
I O O
feel O O
no O O
mass. O O
He O O
has O O
a O O
well-healed O O
incision. O O
There O O
is O O
no O O
hair O O
noted O O
in O O
or O O
around O O
the O O
axilla. O O
Extremities O O
with O O
no O O
edema. O O
ASSESSMENT O O
AND O O
PLAN: O O
(1) O O
CAD/hypertension/diabetes B-DIABETES O
mellitus. I-DIABETES O
This O O
is O O
stable. O O
Check O O
glycosylated O O
hemoglobin. O O
(2) O O
Metastatic O O
squamous O O
cell O O
cancer. O O
He O O
is O O
being O O
followed O O
closely O O
by O O
Oncology O O
for O O
this. O O
Follow-up O O
with O O
me O O
in O O
the O O
spring. O O
William O O
V. O O
Geiger, O O
M.D. O O
WVG/xin/quilici O O

Record B-SMOKER O
date: O O
2092-03-26 O O
Reason O O
for O O
Visit O O
Here O O
for O O
Angina/BP/DM B-DIABETES O
check, O O
no O O
chest O O
pains. O O
Taking O O
meds O O
without O O
problems. O O
No O O
problems O O
c O O
L O O
axilla O O
(site O O
of O O
squam O O
cell O O
ca), O O
has O O
been O O
going O O
to O O
f/u O O
for O O
this. O O
Medications O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
Acid) O O
325MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
: O O
Take O O
as O O
directed O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
: O O
Take O O
as O O
directed O O
Zocor B-MEDICATION B-MEDICATION
(SIMVASTATIN) O O
10MG, O O
1 O O
Tablet(s) O O
PO O O
QHS O O
: O O
Take O O
as O O
directed O O
Cardura O O
(DOXAZOSIN) O O
2MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
: O O
Take O O
as O O
directed O O
Imdur B-MEDICATION B-MEDICATION
(ISOSORBIDE O O
MONONIT.(SR)) O O
30MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
: O O
Take O O
as O O
directed O O
LISINOPRIL B-MEDICATION B-MEDICATION
20MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Allergies O O
Sulfa O O
- O O
Unknown O O
Problems O O
Visual O O
impairment O O
: O O
Diplopia O O
due O O
to O O
6th O O
nn O O
palsy, O O
2091 O O
Angina O B-MEDICATION
: O O
STABLE O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Elevated O O
cholesterol O O
Hypertension B-HYPERTENSION O
Hearing O O
impairment O O
: O O
HEARING O O
aids O O
S/P O O
urolithiasis O O
S/P O O
Squamous O O
cell O O
cancer O O
: O O
metastatic O O
to O O
L O O
axilla O O
Dr. O O
Jessup O O
Med O O
onc, O O
Dr. O O
Enright O O
XRT O O
Benign O O
prostatic O O
hypertrophy O O
: O O
urinary O O
retenetion O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
118/60 O O
PULSE O O
64 O O
WEIGHT O O
188 O O
lb O O
Exam O O
NAD O O
Lungs: O O
Clear O O
Cor: O O
RRR O O
Ext: O O
no O O
edema/lesions O O
Assessment O O
and O O
Plan O O
1. O O
Angina/HTN B-HYPERTENSION O
- O O
Better O O
control O O
c O O
increase O O
of O O
lisinopril B-MEDICATION B-MEDICATION
to O O
20mg O O
qd. O O
Cont. O O
low O O
Na O O
diet. O O
2. O O
DM O O
- O O
No O O
changes, O O
cont. O O
low O O
fat O O
diet, O O
check O O
HgbA1c. O O
3. O O
Squam O O
cell O O
skin O O
ca O O
- O O
Saw O O
Dr. O O
Jeffries O O
and O O
had O O
repeat O O
CT O O
and O O
PET O O
scan O O
that O O
showed O O
no O O
tumor. O O
Cont O O
f/u O O
c O O
Dr. O O
Jeffries. O O
4. O O
R O O
Cranial O O
6 O O
nn O O
palsy O O
- O O
Resolved. O O
Follow O O
-up O O
in O O
3-4 O O
months. O O

Record B-SMOKER O
date: O O
2093-04-30 O O
Reason O O
for O O
Visit O O
Here O O
for O O
CHF/Angina/BP/DM B-DIABETES O
check, O O
no O O
chest O O
pains. O O
Taking O O
meds O O
without O O
problems. O O
Breathing O O
still O O
is O O
fine O O
and O O
no O O
ankle O O
swelling. O O
Medications O O
FUROSEMIDE O O
20MG, O O
1 O O
PO O O
QD O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
Acid) O O
325MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
, O O
Take O O
as O O
directed O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
, O O
Take O O
as O O
directed O O
LISINOPRIL B-MEDICATION B-MEDICATION
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Zocor B-MEDICATION B-MEDICATION
(SIMVASTATIN) O O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QHS O O
Imdur B-MEDICATION B-MEDICATION
(ISOSORBIDE O O
MONONIT.(SR)) O O
30MG O O
TABLET O O
CR O O
24HR O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Cardura O O
(DOXAZOSIN) O O
4MG O O
TABLET O O
PO O O
QD O O
Allergies O O
Sulfa O O
- O O
Unknown O O
Problems O O
Angina O O
: O O
STABLE O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Elevated O O
cholesterol O O
Hypertension B-HYPERTENSION O
Hearing O O
impairment O O
: O O
HEARING O O
aids O O
S/P O O
urolithiasis O O
S/P O O
Squamous O O
cell O O
cancer O O
: O O
metastatic O O
to O O
L O O
axilla O O
Dr. O O
Jessup O O
Med O O
onc, O O
Dr. O O
Enright O O
XRT O O
Benign O O
prostatic O O
hypertrophy O O
: O O
urinary O O
retenetion O O
Visual O O
impairment O O
: O O
Diplopia O O
due O O
to O O
6th O O
nn O O
palsy, O O
2091 O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
130/60 O O
PULSE O O
68 O O
WEIGHT O O
184 O O
lb O O
Exam O O
NAD O O
Lungs: O O
Clear O O
Cor: O O
RRR O O
Ext: O O
no O O
edema/lesions O O
Assessment O O
and O O
Plan O O
1. O O
CHF/Angina/HTN B-HYPERTENSION O
- O O
Good O O
control O O
but O O
BP O O
could O O
be O O
a O O
bit O O
better, O O
increase O O
lisinopril B-MEDICATION B-MEDICATION
to O O
40mg O O
qd. O O
Cont. O O
low O O
Na O O
diet. O O
Check O O
BUN/Cr/lytes/BNP. O O
2. O O
DM O O
- O O
No O O
changes, O O
cont. O O
low O O
fat O O
diet. O O
3. O O
Squam O O
cell O O
skin O O
ca O O
- O O
Stable. O O
Cont O O
f/u O O
c O O
Dr. O O
Jeffries. O O
4. O O
BPH O O
- O O
Stable. O O
Follow O O
-up O O
in O O
2 O O
months. O O

Record O O
date: O O
2084-10-19 O O
Mae O O
Paul O O
LMC# O O
100-57-08 O O
LMC O O
SURGERY O O
CLINIC O O
NOTE O O
October O O
19, O O
2084 O O
CC: O O
Consult O O
for O O
hemorrhoids. O O
HPI: O O
This O O
is O O
a O O
73-year-old O O
female. O O
Five- O O
to O O
six-year O O
history O O
constant O O
anal O O
protrusion O O
and O O
bloody O O
discharge O O
and O O
mucus O O
nearly O O
constantly O O
(wears O O
a O O
pad). O O
No O O
anal O O
pain. O O
Usually O O
has O O
1-2 O O
BMs O O
a O O
day, O O
solid O O
or O O
liquid O O
(her O O
chronic O O
pattern). O O
No O O
abdominal O O
pain O O
or O O
weight O O
loss. O O
No O O
history O O
STD. O O
No O O
rectal O O
surgery. O O
Status O O
post O O
left O O
and O O
right O O
kidney O O
transplants O O
2078 O O
and O O
2075, O O
which O O
have O O
failed. O O
Status O O
post O O
supracervical O O
hysterectomy O O
(no O O
BSO) O O
for O O
benign O O
disease. O O
Status O O
post O O
appendectomy. O O
4/82 O O
underwent O O
left O O
salpingo-oophorectomy O O
for O O
serous O O
cyst O O
(Dr. O O
Sutton). O O
No O O
other O O
abdominal O O
OPs. O O
8/81 O O
she O O
was O O
treated O O
for O O
CMV O O
colitis. O O
No O O
FH O O
colon O O
neoplasms. O O
PFSH: O O
Chronic O O
renal O O
failure O O
from O O
glomerulonephritis. O O
Has O O
had O O
two O O
failed O O
transplants O O
as O O
above. O O
Now O O
on O O
dialysis O O
every O O
Monday, O O
Wednesday O O
and O O
Friday. O O
On O O
waiting O O
list O O
for O O
another O O
transplant O O
at O O
EHCC. O O
Hypertension. B-HYPERTENSION O
Spinal O O
stenosis O O
and O O
sciatica. O O
Lower O O
extremity O O
PVD. O O
This O O
was O O
shown O O
on O O
angio O O
9/83 O O
(Dr. O O
Xayasane), O O
but O O
she O O
denies O O
claudication. O O
Right O O
foot-drop O O
due O O
to O O
shingles. O O
Hypercholesterolemia. B-HYPERLIPIDEMIA O
Ectopic O O
beats O O
as O O
below. O O
Nonsmoker. B-SMOKER O
She O O
takes O O
Pravachol B-MEDICATION B-MEDICATION
40 O O
mg O O
q.p.m., O O
PhosLo O O
1300 O O
mg O O
t.i.d.-q.i.d., O O
Sensipar O O
30 O O
mg O O
daily O O
(for O O
calcium), O O
Restoril O O
30 O O
mg O O
q.h.s., O O
Neurontin O O
900 O O
mg O O
every O O
Monday, O O
Wednesday, O O
Friday, O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
mg O O
b.i.d., O O
Nephrocaps O O
one O O
tablet O O
daily, O O
plus O O
vitamins. O O
No O O
allergies. O O
Retired O O
Mathematician O O
at O O
Vassar. O O
Widow. O O
Lives O O
alone. O O
Has O O
daughter O O
in O O
the O O
area O O
(an O O
surgeon). O O
PE: O O
Appears O O
a O O
little O O
frail. O O
No O O
neck O O
masses O O
or O O
bruits. O O
Chest O O
clear. O O
Heart: O O
Frequent O O
ectopic O O
beats. O O
4/6 O O
systolic O O
murmur. O O
Mild O O
abdominal O O
adiposity. O O
Palpable O O
LLQ O O
kidney. O O
No O O
other O O
masses O O
or O O
organomegaly. O O
Groins O O
normal. O O
No O O
pedal O O
edema. O O
3/4 O O
femoral O O
pulses, O O
with O O
nothing O O
below. O O
Large O O
non-thrombosed O O
permanently O O
prolapsed O O
right O O
anterior O O
internal O O
hemorrhoid O O
and O O
associated O O
large O O
external O O
hemorrhoid. O O
Moderate O O
external O O
hemorrhoids O O
elsewhere. O O
Digital O O
rectal O O
exam O O
normal. O O
Anoscopy O O
shows O O
large O O
internal O O
hemorrhoids. O O
Mae O O
Paul O O
LMC# O O
100-57-08 O O
Flexible O O
sigmoidoscopy O O
to O O
25 O O
cm O O
(sigmoid) O O
normal O O
except O O
mild O O
diverticulosis. O O
IMPRESSION: O O
Large O O
symptomatic O O
hemorrhoids. O O
They O O
are O O
too O O
big O O
for O O
office O O
treatment. O O
Therefore O O
discussed O O
the O O
option O O
of O O
hemorrhoidectomy, O O
which O O
would O O
probably O O
give O O
her O O
a O O
nice O O
result. O O
She O O
wishes O O
to O O
think O O
about O O
it O O
for O O
now, O O
however, O O
which O O
is O O
fine. O O
In O O
the O O
meantime, O O
gave O O
her O O
info O O
brochure O O
plus O O
instructions O O
in O O
conservative O O
RX O O
hemorrhoids. O O
Thomas O O
Y. O O
Ontiveros, O O
M.D. O O
cc: O O
Jack O O
John, O O
M.D., O O
LMC O O
Harvey O O
Ethridge, O O
M.D., O O
LMC O O
E. O O
K. O O
Sutton, O O
M.D., O O
LMC O O
Herman O O
Lemus, O O
M.D., O O
EHCC O O
TYO/ellington O O
04-14609701.doc O O

Record O O
date: O O
2084-12-27 O O
JAR O O
Night-float O O
Admission O O
Note O O
Internal O O
Medicine O O
Patient: O O
Mae O O
Paul O O
MRN: O O
1005708 O O
Date O O
of O O
admission: O O
12/27/2084 O O
Renal O O
Attending: O O
Dr. O O
John O O
Cc: O O
cough, O O
SOB, O O
failed O O
Z-pk O O
x2 O O
HPI: O O
Pt O O
is O O
a O O
73yo O O
female O O
with O O
ESRD O O
on O O
HS O O
s/p O O
kidney O O
transplant O O
x2. O O
She O O
has O O
had O O
a O O
cough O O
for O O
over O O
the O O
past O O
week. O O
No O O
fever; O O
no O O
sputum O O
production. O O
Also O O
reports O O
1 O O
day O O
of O O
sore O O
throat, O O
now O O
resolved O O
and O O
nasal O O
congestion O O
forh O O
te O O
past O O
week. O O
Her O O
grandson O O
(age O O
4) O O
has O O
had O O
a O O
cough/head O O
cold. O O
Her O O
daughter O O
is O O
a O O
surgeon O O
and O O
has O O
prescribed O O
her O O
a O O
Z-pk O O
x O O
2 O O
which O O
she O O
has O O
failed O O
and O O
yesterday O O
gave O O
her O O
a O O
dose O O
of O O
levaquin O O
500mg O O
on O O
12/26/2084. O O
Last O O
HD O O
on O O
12/22; O O
missed O O
on O O
12/25. O O
On O O
presentation O O
to O O
the O O
ED O O
her O O
Vs O O
were: O O
T=97.9 O O
P=118 O O
BP=173/93 B-HYPERTENSION O
sat=91%RA. O O
Saturations O O
decreased O O
to O O
91%on O O
4L O O
in O O
setting O O
of O O
SBP O O
to O O
221/119. O O
She O O
was O O
treated O O
with O O
IV O O
lopressor B-MEDICATION B-MEDICATION
2.5 O O
x2 O O
and O O
lopressor O B-MEDICATION
12.5 O O
po. O O
Saturation O O
improved O O
to O O
95%4L. O O
Renal O O
team O O
evaluated O O
her O O
and O O
she O O
will O O
have O O
dialysis O O
this O O
am. O O
She O O
was O O
admitted O O
to O O
floor O O
for O O
further O O
evaluation. O O
ROS: O O
as O O
above. O O
No O O
chest O O
pain.? O O
Wheezing O O
today. O O
+ O O
SOB. O O
No O O
N/V/D. O O
No O O
rashes. O O
No O O
HA, O O
muscle O O
aches. O O
+ O O
fatigue/generalized O O
weakness. O O
PMH: O O
1. O O
ESRD O O
2/2 O O
GN O O
on O O
HD; O O
Status O O
post O O
left O O
and O O
right O O
kidney O O
transplants O O
2078 O O
and O O
2075, O O
which O O
have O O
failed. O O
Off O O
immunosuppressive O O
for O O
the O O
past O O
4 O O
years. O O
2. O O
Htn B-HYPERTENSION O
3. O O
PVD: O O
Lower O O
extremity O O
PVD. O O
This O O
was O O
shown O O
on O O
angio O O
9/83 O O
(Dr. O O
Xayasane), O O
but O O
she O O
denies O O
claudication. O O
4. O O
R O O
foot O O
drop O O
due O O
to O O
shingles O O
5. O O
hemorrhoids: O O
Five- O O
to O O
six-year O O
history O O
constant O O
anal O O
protrusion O O
and O O
bloody O O
discharge O O
and O O
mucus O O
nearly O O
constantly O O
(wears O O
a O O
pad). O O
No O O
anal O O
pain. O O
No O O
rectal O O
surgeries. O O
6. O O
Status O O
post O O
supracervical O O
hysterectomy O O
(no O O
BSO) O O
for O O
benign O O
disease. O O
4/82 O O
underwent O O
left O O
salpingo-oophorectomy O O
for O O
serous O O
cyst O O
(Dr. O O
Sutton). O O
7. O O
Status O O
post O O
appendectomy. O O
8. O O
8/81 O O
she O O
was O O
treated O O
for O O
CMV O O
colitis. O O
9. O O
Spinal O O
stenosis O O
and O O
sciatica. O O
Current O O
Meds: O O
daughter O O
not O O
present; O O
need O O
to O O
verigy O O
meds/doses O O
Pravachol B-MEDICATION B-MEDICATION
Norvasc B-MEDICATION B-MEDICATION
Phoslo O O
Nephrocaps O O
Neurontin O O
Allergies: O O
Vasotec O O
tape O O
Fam O O
Hx: O O
NC O O
Social O O
History: O O
Retired O O
Mathematician O O
at O O
Vassar. O O
Widow. O O
Lives O O
alone. O O
Has O O
daughter O O
in O O
the O O
area O O
(a O O
surgeon). O O
No B-SMOKER O
smoking. I-SMOKER O
Physical O O
Examination: O O
Exam: O O
VS: O O
T=99.7 O O
HR=101 O O
BP=159/88 B-HYPERTENSION O
RR=22 O O
SaO2= O O
92%6LRA O O
General: O O
HEENT: O O
NC/AT, O O
PERRL, O O
anicteric. O O
OP O O
w/ O O
DMM, O O
no O O
erythema O O
or O O
injection. O O
Skin: O O
No O O
rashes O O
Neck: O O
Supple, O O
2+ O O
carotids O O
w/o O O
bruits, O O
no O O
thyromegaly O O
or O O
nodules, O O
no O O
nodes O O
Chest: O O
inspiratory O O
crackles O O
in O O
right O O
lower O O
and O O
mid O O
lung O O
fields, O O
left O O
side O O
clear, O O
no O O
wheezing O O
CVS: O O
RRR O O
nl O O
S1 O O
S2, O O
no O O
m/r/g O O
Abd: O O
nl O O
BS, O O
soft, O O
non-tender O O
Extr: O O
no O O
c/c/e O O
2+ O O
DP's O O
bilaterally O O
Neuro: O O
AAOX3, O O
MS O O
nl O O
Data: O O
Chemistries: O O
12/27/84 O O
12/26/84 O O
00:46 O O
16:08 O O
NA O O
139 O O
138 O O
K O O
4.9(H) O O
5.6(H) O O
CL O O
100 O O
95(L) O O
CO2 O O
24.4 O O
21.8(L) O O
BUN O O
122(H) O O
110(H) O O
CRE O O
12.7(H) O O
11.7(H) O O
GLU O O
100 O O
109 O O
12/26/84 O O
16:08 O O
CA O O
10.1 O O
PHOS O O
4.0 O O
MG O O
2.1(H) O O
TBILI O O
0.3 O O
DBILI O O
0.1 O O
TP O O
8.1 O O
ALB O O
3.7 O O
GLOB O O
4.4(H) O O
AMY O O
114(H) O O
LIPS O O
3.9 O O
12/26/84 O O
16:08 O O
ALT/SGPT O O
12 O O
AST/SGOT O O
21 O O
ALKP O O
221(H) O O
TBILI O O
0.3 O O
DBILI O O
0.1 O O
12/26/84 O O
16:08 O O
CHOL O O
189(T) O O
TRIG O O
224(H) O O
HDL O O
65 O O
Heme: O O
12/26/84 O O
15:52 O O
WBC O O
8.1 O O
HCT O O
37.7 O O
MCV O O
81 O O
PLT O O
326 O O
METHOD O O
Auto O O
%NEUT O O
81(H) O O
Studies: O O
CXR: O O
PA O O
and O O
lateral O O
chest O O
12/26/2084 O O
Comparison: O O
6/15/84. O O
There O O
are O O
small O O
bilateral O O
pleural O O
effusions. O O
There O O
is O O
a O O
new O O
right O O
lower O O
the O O
lobe O O
opacity O O
which O O
appears O O
to O O
the O O
heart O O
border. O O
This O O
likely O O
represents O O
a O O
right O O
middle O O
lobe O O
pneumonia. O O
There O O
is O O
atherosclerotic O O
calcification O O
of O O
a O O
tortuous O O
aorta. O O
The O O
heart O O
is O O
enlarged. O O
The O O
mediastinal O O
flow O O
is O O
unremarkable. O O
There O O
is O O
stable O O
mild O O
wedge O O
compression O O
deformity O O
and O O
sclerosis O O
of O O
the O O
thoracic O O
spine. O O
EKG: O O
NSR, O O
nl O O
interval, O O
nl O O
axis, O O
resolved O O
TWI O O
isolated O O
to O O
III O O
Assessment/Plan: O O
73yo O O
female O O
with O O
ESRD O O
presents O O
with O O
SB/ O O
cough O O
and O O
RML O O
pna O O
on O O
CXR. O O
1) O O
PNA: O O
levo O O
250 O O
qod; O O
RML O O
lobe O O
on O O
CXR. O O
Check O O
sputum/blood O O
Cx. O O
Rapid O O
flu O O
neg; O O
on O O
precautions O O
until O O
final. O O
2) O O
ESRD: O O
Renal O O
aware; O O
HD O O
in O O
am O O
12/27; O O
CA-phos O O
product&lt;50; O O
cont O O
phoslo. O O
3) O O
CV: O O
Ischemia: O O
? O O
dynamic O O
TWI: O O
cycle O O
enzymes, O O
asa/ O B-MEDICATION
lopressor/ O B-MEDICATION
pravachol B-MEDICATION B-MEDICATION
Pump: O O
EF=66%; O O
HD O O
in O O
am; O O
lopressor/ O B-MEDICATION
norvac O O
for O O
BP O O
4) O O
FEN: O O
s/p O O
kayexcelate O O
in O O
ed; O O
watch O O
K O O
5) O O
Proph: O O
Nexium, O O
heparin O O
6) O O
CODE: O O
full O O
_____________________________ O O
Elinor O O
Keenan O O
#10985 O O

Record O O
date: O O
2087-03-06 O O
Ravenna O O
Medical O O
Clinic O O
RMC O O
7785 O O
Marlowe O O
Street O O
PAUL, O O
MAE O O
Barnesville, O O
TN O O
13351 O O
83288425 O O
(665) O O
578-7821 O O
03/06/2087 O O
CHIEF O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
75-year-old O O
woman, O O
new O O
patient O O
who O O
comes O O
in O O
to O O
establish O O
primary O O
care O O
and O O
for O O
followup O O
of O O
multiple O O
medical O O
problems O O
including O O
end-stage O O
renal O O
disease, O O
hypertension, B-HYPERTENSION O
peripheral O O
vascular O O
disease, O O
history O O
of O O
foot O O
drop, O O
etc. O O
PAST O O
MEDICAL O O
HISTORY: O O
1. O O
End-stage O O
renal O O
disease. O O
Because O O
of O O
her O O
original O O
end-stage O O
renal O O
disease O O
was O O
reportedly O O
FSGS, O O
she O O
had O O
a O O
preemptive O O
transplant O O
in O O
2068, O O
which O O
was O O
complicated O O
by O O
rejection O O
and O O
ultimate O O
loss O O
of O O
the O O
graft. O O
She O O
resumed O O
dialysis O O
in O O
2072. O O
She O O
had O O
a O O
second O O
transplant O O
in O O
2075, O O
which O O
was O O
also O O
complicated O O
and O O
ultimately O O
rejected. O O
She O O
resumed O O
hemodialysis O O
in O O
2082. O O
She O O
does O O
have O O
a O O
match O O
with O O
her O O
only O O
daughter, O O
but O O
apparently O O
the O O
Transplant O O
Service O O
feels O O
that O O
she O O
would O O
not O O
be O O
a O O
good O O
candidate O O
and O O
I O O
think O O
she O O
would O O
be O O
reluctant O O
to O O
go O O
through O O
two O O
surgeries, O O
which O O
would O O
be O O
required, O O
one O O
to O O
remove O O
the O O
old O O
graft O O
and O O
one O O
for O O
the O O
new O O
transplant. O O
She O O
currently O O
is O O
dialyzed O O
at O O
the O O
Overbrook O O
Hospital. O O
Her O O
dialysis O O
physician O O
is O O
Dr. O O
Lemus. O O
2. O O
Hypertension. O O
3. O O
Peripheral O O
vascular O O
disease. O O
She O O
had O O
an O O
angiogram O O
in O O
2083 O O
at O O
LMC O O
and O O
an O O
MRA O O
in O O
2085, O O
which O O
showed O O
bilateral O O
iliac O O
and O O
femoral O O
artery O O
stenoses. O O
She O O
apparently O O
does O O
not O O
have O O
claudication O O
despite O O
this. O O
4. O O
History O O
of O O
right O O
foot-drop. O O
She O O
had O O
a O O
severe O O
episode O O
of O O
shingles O O
in O O
2077 O O
with O O
associated O O
sciatica O O
and O O
foot-drop. O O
5. O O
History O O
of O O
hemorrhoids O O
for O O
at O O
least O O
six O O
years O O
with O O
occasional O O
bleeding O O
and O O
with O O
anal O O
protrusion. O O
6. O O
History O O
of O O
CMV O O
colitis O O
in O O
08/2081. O O
7. O O
Secondary O O
hyperparathyroidism. O O
She O O
is O O
on O O
Sensipar O O
and O O
has O O
been O O
on O O
this O O
since O O
early O O
2085. O O
PAST O O
SURGICAL O O
HISTORY: O O
She O O
had O O
a O O
supracervical O O
hysterectomy O O
for O O
benign O O
disease O O
in O O
2061 O O
and O O
a O O
left O O
salpingo-oophorectomy O O
for O O
a O O
serous O O
cyst O O
in O O
04/2082. O O
She O O
is O O
status O O
post O O
appendectomy. O O
She O O
is O O
status O O
post O O
bilateral O O
cataract O O
surgery. O O
MEDICATIONS: O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
mg O O
per O O
day, O O
lisinopril B-MEDICATION B-MEDICATION
20 O O
mg O O
per O O
day, O O
metoprolol B-MEDICATION B-MEDICATION
50 O O
mg O O
b.i.d., O O
Lipitor B-MEDICATION B-MEDICATION
40 O O
mg O O
per O O
day, O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
per O O
day, O O
Nephrocaps O O
1 O O
mg O O
per O O
day, O O
Restoril O O
15 O O
mg O O
nightly, O O
Hectorol O O
4 O O
mcg O O
per O O
2 O O
mL O O
three O O
times O O
per O O
week, O O
B6 O O
200 O O
mg O O
per O O
day, O O
vitamin O O
E O O
400 O O
mg O O
per O O
day, O O
flaxseed O O
oil O O
1000 O O
mg O O
per O O
day O O
and O O
B12 O O
4000 O O
mcg O O
per O O
day. O O
FAMILY O O
HISTORY: O O
Significant O O
for O O
diabetes O O
in O O
her O O
father O O
and O O
grandfather, O O
negative O O
for O O
cancer. O O
SOCIAL O O
HISTORY: O O
She O O
is O O
a O O
widow. O O
She O O
is O O
a B-SMOKER O
lifetime B-SMOKER O
nonsmoker. I-SMOKER O
She O O
does O O
not O O
drink O O
alcohol O O
or O O
use O O
drugs. O O
She O O
is O O
a O O
retired O O
mathematician O O
at O O
Vassar. O O
She O O
came O O
from O O
Turlock O O
10 O O
years O O
ago O O
to O O
Pecos O O
to O O
be O O
with O O
her O O
daughter O O
who O O
is O O
a O O
surgeon O O
in O O
the O O
area. O O
She O O
never O O
has O O
felt O O
the O O
Pecos O O
as O O
home O O
and O O
is O O
home O O
sick O O
for O O
Turlock. O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
REVIEW O O
OF O O
SYSTEMS: O O
She O O
has O O
had O O
some O O
problems O O
with O O
left O O
shoulder O O
pain O O
and O O
immobility. O O
She O O
generally O O
seems O O
to O O
be O O
somewhat O O
overwhelmed O O
and O O
a O O
little O O
bit O O
sad. O O
She O O
seems O O
never O O
to O O
have O O
adjusted O O
to O O
life O O
in O O
Pecos. O O
She O O
has O O
had O O
the O O
loss O O
of O O
two O O
the O O
kidney O O
transplants O O
and O O
then O O
the O O
foot-drop, O O
which O O
has O O
made O O
walking O O
difficult. O O
She O O
did O O
have O O
a O O
brace O O
at O O
one O O
time, O O
which O O
helped O O
her O O
to O O
walk, O O
but O O
it O O
was O O
irritating. O O
She O O
had O O
seen O O
Dr. O O
Yim O O
to O O
get O O
another O O
one, O O
but O O
that O O
never O O
worked O O
out. O O
She O O
did O O
not O O
complain O O
of O O
any O O
chest O O
pain O O
or O O
shortness O O
of O O
breath, O O
no O O
constipation. O O
She O O
does O O
have O O
hemorrhoids O O
that O O
are O O
active O O
as O O
above. O O
PHYSICAL O O
EXAMINATION: O O
She O O
is O O
a O O
well-developed, O O
well-nourished, O O
very O O
pleasant, O O
but O O
somewhat O O
sad-appearing O O
white O O
female. O O
Her O O
blood O O
pressure O O
is O O
140/60. O O
HEENT, O O
pupils O O
equal, O O
round O O
and O O
reactive O O
to O O
light. O O
Extraocular O O
movements O O
are O O
intact. O O
Throat O O
is O O
clear. O O
Neck, O O
supple, O O
no O O
adenopathy O O
or O O
thyromegaly. O O
Heart, O O
regular O O
rate O O
and O O
rhythm. O O
Lungs, O O
clear. O O
Abdomen, O O
soft, O O
nontender, O O
no O O
organomegaly. O O
Extremities, O O
no O O
edema. O O
Neuro, O O
absent O O
reflex O O
in O O
the O O
right O O
patella O O
and O O
2+ O O
in O O
the O O
left O O
patella. O O
ASSESSMENT O O
AND O O
PLAN: O O
1. O O
End-stage O O
renal O O
disease O O
on O O
dialysis, O O
not O O
considered O O
to O O
be O O
a O O
transplant O O
candidate O O
at O O
this O O
time O O
as O O
she O O
has O O
had O O
two O O
rejections. O O
2. O O
Hypertension, O O
well O O
controlled O O
on O O
medications. O O
3. O O
Hyperlipidemia, B-HYPERLIPIDEMIA O
on O O
Lipitor. O B-MEDICATION
Last O O
cholesterol O O
was O O
checked O O
in O O
10/2086 O O
with O O
normal O O
ALT O O
and O O
AST, O O
but O O
elevated O O
alkaline O O
phosphatase. O O
4. O O
Peripheral O O
vascular O O
disease, O O
currently O O
asymptomatic. O O
5. O O
Right O O
foot-drop. O O
We O O
may O O
look O O
into O O
getting O O
her O O
another O O
brace O O
perhaps O O
another O O
consult O O
with O O
Dr. O O
Yim. O O
6. O O
Left O O
shoulder O O
pain. O O
It O O
did O O
mention O O
in O O
her O O
physical, O O
but O O
she O O
can O O
only O O
abduct O O
her O O
left O O
shoulder O O
to O O
about O O
90 O O
degrees O O
without O O
pain. O O
We O O
may O O
look O O
into O O
this O O
further O O
and O O
perhaps O O
get O O
some O O
physical O O
therapy O O
for O O
possible O O
rotator O O
cuff O O
tendinitis. O O
7. O O
Hemorrhoids. O O
8. O O
Secondary O O
hyperparathyroidism O O
on O O
Sensipar. O O
9. O O
Health O O
maintenance. O O
Mammogram O O
was O O
done O O
in O O
06/2086. O O
Pap O O
smear O O
was O O
done O O
in O O
04/2083. O O
Colonoscopy O O
was O O
done O O
in O O
08/2081. O O
10. O O
? O O
Depression. O O
She O O
seemed O O
a O O
little O O
sad. O O
Has O O
had O O
a O O
tough O O
time O O
with O O
her O O
medical O O
problems O O
and O O
never O O
adjusted O O
that O O
well O O
to O O
Pecos. O O
Will O O
have O O
her O O
come O O
back O O
and O O
discuss O O
further. O O
______________________________ O O
Qiana O O
Solomon, O O
MD O O
eScription O O
document:9-2784353 O O
KUQlhv O O
Egq O O
DD: O O
03/06/87 O O
DT: O O
03/07/87 O O
DV: O O
03/06/87 O O

Record O O
date: O O
2089-03-29 O O
Internal O O
Medicine O O
INTERN O O
ADMISSION O O
NOTE O O
PATIENT O O
FH O O
MRN: O O
57585291 O O
ATTENDING: O O
Dr. O O
Olivia O O
Perry O O
PRIMARY O O
CARE: O O
Dr. O O
Qiana O O
Solomon, O O
Emmons O O
Health O O
Counseling O O
Center, O O
665-578-7821 O O
HCP: O O
Quanita-Ella O O
Paul-Doyle O O
(daughter),: O O
448-876-4285 O O
CC: O O
Left O O
thigh O O
pain, O O
inability O O
to O O
ambulate O O
HPI: O O
77F O O
with O O
ESRD O O
(secondary O O
to O O
FSGS) O O
on O O
HD O O
(Monday,Wednesday,Friday) O O
s/p O O
two O O
failed O O
renal O O
transplants O O
(2068, O O
2075), O O
severe O O
lumbar O O
spinal O O
stenosis O O
and O O
left O O
thigh O O
tendonitis O O
presenting O O
with O O
worsening O O
of O O
chronic O O
left O O
thigh O O
pain O O
and O O
inability O O
to O O
ambulate O O
x3 O O
days. O O
Patient O O
with O O
a O O
history O O
of O O
left O O
thigh O O
pain O O
since O O
6/2088. O O
MRI O O
showed O O
tendinosis O O
with O O
parial O O
tears O O
of O O
the O O
hangstrings. O O
Patient O O
did O O
not O O
follow O O
up O O
with O O
ortho O O
or O O
PT O O
and O O
managed O O
pain O O
at O O
home O O
with O O
NSAIDs O O
and O O
Tylenol O O
3. O O
Admitted O O
again O O
on O O
12/2088 O O
with O O
increasing O O
pain. O O
MRI O O
showed O O
severe O O
lumbar O O
spinal O O
stenosis O O
at O O
L4-S1. O O
Orthopedics O O
consult O O
recommended O O
epidural O O
steroids O O
and O O
physiatry O O
follow O O
up O O
given O O
that O O
patient O O
is O O
a O O
poor O O
surgical O O
candidate. O O
Neuro O O
posited O O
possible O O
uremic O O
neuroapthy. O O
She O O
had O O
one O O
epidural O O
steroid O O
injection O O
along O O
with O O
low O O
dose O O
gabapentin, O O
lidocain O B-MEDICATION
patch, O O
and O O
oxycontin O O
and O O
oxycodone O O
prn O O
which O O
relieved O O
her O O
pain. O O
She O O
was O O
to O O
follow O O
up O O
with O O
the O O
Pain O O
Clinic O O
at O O
EHCC O O
but O O
did O O
not O O
and O O
had O O
no O O
further O O
epidural O O
steroid O O
injections. O O
Patient O O
managing O O
well O O
at O O
home O O
on O O
oxycontin O O
and O O
oxycodone O O
when O O
she O O
developed O O
acute O O
worsening O O
of O O
her O O
left O O
thigh O O
pain O O
on O O
3/27. O O
She O O
denied O O
any O O
prior O O
trauma. O O
Noticed O O
onset O O
of O O
pain O O
while O O
lying O O
flat O O
at O O
dialysis O O
on O O
3/27. O O
No O O
numbness O O
or O O
tingling. O O
No O O
bowel O O
incontinence. O O
Pain O O
is O O
a O O
stabbing, O O
10/10 O O
pain. O O
No O O
redness O O
in O O
area O O
of O O
pain. O O
Worsening O O
over O O
past O O
3 O O
days. O O
Patient O O
seen O O
after O O
HD O O
on O O
3/27 O O
for O O
ulcer O O
over O O
left O O
AVF O O
found O O
at O O
HD O O
on O O
3/27. O O
Completed O O
HD O O
without O O
incident O O
and O O
got O O
a O O
dose O O
of O O
vancomycin. O O
Wound O O
culture O O
sent O O
and O O
growing O O
staph O O
aureus. O O
Started O O
on O O
PO O O
Keflex O O
and O O
discharged O O
home. O O
Pain O O
worsened O O
at O O
home. O O
Patient O O
took O O
20mg O O
oxycodone O O
IR, O O
10mg O O
oxycontin, O O
and O O
2mg O O
dildaudid O O
with O O
minimal O O
relief O O
of O O
pain. O O
No O O
f/c/n/v/abdominal O O
pain/BRBPR/diarrhea. O O
Patient O O
is O O
anuric. O O
ED O O
Course: O O
Vitals O O
notable O O
for O O
BP B-HYPERTENSION O
164/100 I-HYPERTENSION O
(patient O O
had O O
not O O
taken O O
her O O
BP O O
meds). O O
No O O
medications O O
administered. O O
Labs O O
notable O O
for O O
creatinine O O
of O O
7.7. O O
PAST O O
MEDICAL O O
HISTORY: O O
-ESRD O O
(FSGS) O O
on O O
HD O O
Mon,Wed,Fri O O
s/p O O
failed O O
renal O O
transplants O O
in O O
2068 O O
and O O
2075 O O
- O O
HTN B-HYPERTENSION O
- O O
PVD O O
- O O
HLD B-HYPERLIPIDEMIA O
- O O
Foot O O
drop O O
on O O
R O O
side O O
(11yrs O O
ago) O O
- O O
Secondary O O
Hyperparathyroidism O O
- O O
Hemorrhoids O O
- O O
Spinal O O
stenosis O O
L4-L5 O O
- O O
s/p O O
appendectomy O O
- O O
s/p O O
TAH O O
- O O
s/p O O
cataract O O
surgery O O
- O O
s/p O O
ovarian O O
cyst O O
removal O O
- O O
carpal O O
tunnel O O
syndrome O O
ALLERGIES: O O
Enalapril O O
CURRENT O O
MEDICATIONS: O O
Amlodipine B-MEDICATION B-MEDICATION
10 O O
MG O O
(10MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#1 O O
Month(s) O O
Supply, O O
QSun,Mon,Wed,Fri O O
Aspirin B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
81 O O
MG O O
(81MG O O
TABLET O O
Take O O
1) O O
PO O O
Dilaudid O O
(HYDROMORPHONE O O
HCL) O O
1 O O
MG O O
(2MG O O
TABLET O O
Take O O
0.5) O O
PO O O
Q6H O O
PRN O O
pain O O
x O O
30 O O
days, O O
note O O
to O O
pharmacist: O O
please O O
provide O O
pt O O
with O O
brand-name O O
version. O O
#60 O O
Tablet(s) O O
Keflex O O
(CEPHALEXIN) O O
250 O O
MG O O
(250MG O O
CAPSULE O O
Take O O
1) O O
PO O O
as O O
directed O O
, O O
please O O
take O O
250mg O O
orally O O
after O O
dialysis O O
for O O
10d. O O
#6 O O
Capsule(s) O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
40 O O
MG O O
(40MG O O
TABLET O O
Take O O
1) O O
PO O O
QHS O O
#3 O O
Month(s) O O
Supply O O
Lisinopril B-MEDICATION B-MEDICATION
20 O O
MG O O
(20MG O O
TABLET O O
Take O O
1) O O
PO O O
QHS, O O
40mg O O
QAM O O
Nephrocaps O O
1 O O
CAPSULE O O
PO O O
QD O O
Oxycodone O O
5 O O
MG O O
(5MG O O
TABLET O O
Take O O
1) O O
PO O O
4-6 O O
hrs O O
PRN O O
#540 O O
Tablet(s) O O
Oxycontin O O
(OXYCODONE O O
CONTROLLED O O
RELEASE) O O
10 O O
MG O O
(10MG O O
TAB.SR O O
12H O O
Take O O
1) O O
PO O O
BID O O
#20 O O
TAB.SR O O
Restoril O O
(TEMAZEPAM) O O
30 O O
MG O O
(15MG O O
CAPSULE O O
Take O O
2) O O
PO O O
QHS O O
PRN O O
#180 O O
Capsule(s) O O
Sensipar O O
(CINACALCET) O O
30 O O
MG O O
PO O O
BID O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
(METOPROLOL O O
SUCCINATE O O
EXTENDED O O
RELEASE) O O
150 O O
MG O O
(50MG O O
TAB.SR O O
24H O O
) O O
PO O O
QD O O
x O O
90 O O
days O O
#3 O O
month(s) O O
Supply O O
FH:- O O
DM: O O
father, O O
brother- O O
HTN: O O
mother, O O
father, O O
brother- O O
PVD: O O
father, O O
brother- O O
CAD/CABG: O O
brothers O O
x2, O O
in O O
60s- O O
no O O
cancer, O O
sudden O O
cardiac O O
deathSH:- O O
lives O O
with O O
daughter, O O
who O O
is O O
a O O
surgeon- O O
formerly O O
worked O O
in O O
mathmatics- O O
does B-SMOKER O
not I-SMOKER O
smoke, I-SMOKER O
drink O O
etoh, O O
or O O
use O O
any O O
illicit O O
drugsADMISSION O O
EXAM: O O
VS: O O
T O O
95.4 O O
P O O
71, O O
BP O O
132/60, O O
RR O O
18, O O
97% O O
on O O
2L O O
GENERAL: O O
Frail, O O
elderly O O
woman O O
in O O
NAD O O
HEENT: O O
MM O O
dry, O O
no O O
cervical O O
or O O
supraclavicular O O
lymphadenopathy, O O
OP O O
clear O O
CARDIO: O O
RRR. O O
Mid-peaking O O
II/VI O O
cres-decres O O
murmur O O
at O O
RUSB O O
radiating O O
to O O
clavicles O O
bilaterally, O O
Holosystolic O O
II/VI O O
murmur O O
at O O
apex O O
PULM: O O
CTAB O O
ABD: O O
Soft, O O
NT, O O
ND, O O
+BSEXTREM: O O
No O O
c/c/e. O O
Left O O
arm O O
fistula O O
with O O
shallow O O
ulcer, O O
no O O
discharge O O
or O O
odor. O O
NEURO: O O
5/5 O O
strength O O
in O O
LE O O
with O O
sensation O O
to O O
light O O
touch O O
in O O
tact. O O
Right O O
foot O O
drop. O O
Pain O O
on O O
abduction O O
and O O
straight O O
leg O O
raise O O
of O O
40 O O
degrees. O O
No O O
tenderness O O
along O O
trochanteric O O
bursa. O O
Near O O
full O O
ROM O O
at O O
the O O
hip. O O
ADMISSION O O
LABS:03/29/2089 O O
NA O O
142, O O
K O O
4.6, O O
CL O O
99, O O
CO2 O O
31, O O
BUN O O
65 O O
(H), O O
CRE O O
7.7 O O
(H), O O
GLU O O
9403/29/2089 O O
CA O O
9.1, O O
TBILI O O
0.4, O O
TP O O
7.2, O O
ALB O O
2.9 O O
(L)03/27/2089 O O
CA O O
9.9, O O
PHOS O O
3.9, O O
MG O O
1.903/29/2089 O O
ALT/SGPT O O
24, O O
AST/SGOT O O
15, O O
ALKP O O
130, O O
TBILI O O
0.403/29/2089 O O
WBC O O
7.7, O O
RBC O O
4.84, O O
HGB O O
11.0 O O
(L), O O
HCT O O
38.1, O O
MCV O O
79 O O
(L), O O
MCH O O
22.7 O O
(L), O O
MCHC O O
28.8 O O
(L), O O
PLT O O
444 O O
(H)03/29/2089 O O
RDW O O
19.1 O O
(H)03/29/2089 O O
%NEUT O O
66.6, O O
%MONO O O
5.2, O O
%EOS O O
3.1, O O
%BASO O O
0.6, O O
%LYMPH-M O O
24.5 O O
(L)03/29/2089 O O
ANISO O O
++, O O
HYPO O O
+++, O O
MICRO O O
++03/29/2089 O O
PT O O
17.2 O O
(H), O O
PT-INR O O
1.5 O O
(H), O O
PTT O O
30.4 O O
(H)Microbiology O O
Specimen: O O
82:F9402026Y O O
Collected O O
27-Mar-89 O O
09:23 O O
Received O O
27-Mar-89 O O
09:23 O O
Ordering O O
Provider: O O
LEMUS, O O
HERMAN O O
DR O O
MD O O
Specimen O O
Group: O O
BLOOD/SERUM O O
Specimen O O
Type: O O
BLOOD O O
BLOOD O O
CULTURE O O
- O O
Preliminary O O
Reported: O O
28-Mar-89 O O
09:00 O O
NO O O
GROWTH O O
TO O O
DATE O O
Specimen: O O
38:Z8912708G O O
Collected O O
27-Mar-89 O O
09:23 O O
Received O O
27-Mar-89 O O
09:23 O O
Ordering O O
Provider: O O
LEMUS, O O
HERMAN O O
DR O O
MD O O
Specimen O O
Group: O O
TISSUE/BIOPSY/WOUND O O
Specimen O O
Type: O O
FISTULA O O
Specimen O O
Comment: O O
WOUND O O
CULTURE O O
FROM O O
AV O O
FISTULA O O
GRAM O O
STAIN O O
- O O
Final O O
Reported: O O
28-Mar-89 O O
16:02 O O
GRAM O O
STAIN O O
RESULTS O O
RARE O O
POLYS O O
MODERATE O O
GRAM O O
POSITIVE O O
COCCI O O
WOUND O O
CULTURE O O
- O O
Preliminary O O
Reported: O O
28-Mar-89 O O
11:56 O O
MANY O O
Staph O O
aureus O O
COMMENTS O O
SUSCEPTIBILITY O O
TO O O
FOLLOW O O
ASSESSMENT O O
AND O O
PLAN: O O
77F O O
with O O
ESRD O O
on O O
HD O O
and O O
severe O O
spinal O O
stenosis, O O
tendinosis, O O
and O O
left O O
thigh O O
muscle O O
tears O O
presenting O O
with O O
acute O O
worsening O O
of O O
her O O
chronic O O
left O O
thigh O O
pain. O O
#) O O
Left O O
thigh O O
pain: O O
No O O
recent O O
trauma O O
or O O
clear O O
trigger O O
for O O
exacerbation. O O
No O O
fevers O O
or O O
fluctuance O O
on O O
exam O O
concerning O O
for O O
infection. O O
-doubt O O
imaging O O
will O O
change O O
management O O
as O O
this O O
is O O
most O O
likely O O
secondary O O
to O O
known O O
spinal O O
stenosis O O
-augment O O
PO O O
pain O O
regimen O O
and, O O
accordingly, O O
bowel O O
regimen O O
-PT O O
consult, O O
will O O
likely O O
need O O
rehab O O
#) O O
ESRD-Due O O
for O O
HD O O
tomorrow O O
-HD O O
in O O
the O O
AM O O
-continue O O
renal O O
meds O O
#) O O
AVF O O
ulcer: O O
Growing O O
staph O O
aureus O O
-f/u O O
sensitivities O O
-continue O O
PO O O
Keflex O O
#) O O
HTN O O
-continue O O
lisinopril, O B-MEDICATION
BB, O O
#) O O
CV: O O
-continue O O
ASA, O O
BB, O O
statin O O
#) O O
PPX: O O
heparin O O
sc O O
#) O O
CODE: O O
FULL O O
__________________________ O O
Collette O O
M. O O
Kirkland, O O
MD O O
EHCC O O
Intern O O

Record O O
date: O O
2090-04-30 O O
EDVISIT^83288425^PAUL, O O
MAE^04/30/90^CORTES, O O
ODESSA O O
The O O
patient O O
was O O
seen O O
in O O
conjunction O O
with O O
resident, O O
Dr. O O
Peacock. O O
Resident's O O
note O O
was O O
reviewed. O O
The O O
patient O O
was O O
seen O O
and O O
examined O O
by O O
me. O O
Please O O
see O O
the O O
resident's O O
note O O
for O O
details O O
of O O
the O O
patient's O O
past O O
medical, O O
social, O O
family O O
history, O O
review O O
of O O
systems, O O
and O O
physical O O
exam. O O
CHIEF O O
COMPLAINT: O O
Bleeding O O
fistula. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
is O O
a O O
78-year-old O O
woman O O
with O O
end-stage O O
renal O O
disease, O O
on O O
hemodialysis, O O
who O O
is O O
here O O
with O O
bleeding O O
of O O
her O O
left O O
upper O O
arm O O
AV O O
fistula O O
that O O
she O O
uses O O
for O O
dialysis O O
that O O
started O O
today O O
at O O
dialysis. O O
When O O
the O O
patient O O
pulled O O
up O O
her O O
sleeve, O O
she O O
scratched O O
herself O O
and O O
it O O
began O O
to O O
bleed. O O
Blood O O
pressure O O
is O O
112/60. O O
The O O
bleeding O O
can O O
be O O
controlled O O
with O O
compression O O
and O O
so O O
she O O
presented O O
to O O
the O O
Emergency O O
Department O O
where O O
she O O
was O O
seen O O
by O O
the O O
Internal O O
Medicine O O
for O O
repair. O O
PAST O O
MEDICAL O O
HISTORY: O O
The O O
patient O O
has O O
a O O
history O O
of O O
severe O O
aortic O O
stenosis O O
with O O
0.7 O O
cm O O
greater O O
diameter, O O
mitral O O
regurg O O
and O O
tricuspid O O
regurg, O O
end-stage O O
renal O O
disease O O
on O O
hemodialysis, O O
PVD, O O
foot O O
drop, O O
anemia, O O
sciatica, O O
left O O
thigh O O
pain, O O
hyperlipidemia, B-HYPERLIPIDEMIA O
secondary O O
hyperparathyroidism, O O
hemorrhoids, O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
status B-CAD O
post I-CAD O
non-ST I-CAD O
elevation I-CAD O
MI, I-CAD O
CHF O O
with O O
an O O
EF O O
of O O
35-40%. O O
PAST O O
SURGICAL O O
HISTORY: O O
Includes O O
a O O
TAH, O O
appendectomy, O O
cataract O O
surgery, O O
ovarian O O
cyst O O
removal. O O
SOCIAL O O
HISTORY: O O
Never B-SMOKER O
smoked, I-SMOKER O
does O O
not O O
drink O O
or O O
use O O
drugs. O O
She O O
is O O
retired, O O
lives O O
with O O
her O O
daughter O O
who O O
is O O
a O O
surgeon. O O
FAMILY O O
HISTORY: O O
Shows O O
an O O
extensive O O
vascular O O
history. O O
REVIEW O O
OF O O
SYSTEMS: O O
Otherwise, O O
negative. O O
PHYSICAL O O
EXAMINATION: O O
She O O
is O O
afebrile, O O
normal O O
and O O
stable O O
vital O O
signs. O O
She O O
has O O
bilaterally O O
faintly O O
scattered O O
rales O O
on O O
chest O O
examination O O
and O O
she O O
has O O
a O O
small O O
laceration O O
on O O
the O O
left O O
arm O O
over O O
the O O
fistula O O
with O O
an O O
excoriation O O
and O O
this O O
squirting O O
blood O O
would O O
not O O
controlled O O
with O O
pressure. O O
LABORATORY O O
DATA: O O
CBC O O
is O O
normal O O
with O O
a O O
hematocrit O O
of O O
43. O O
Chem-7 O O
is O O
otherwise O O
normal. O O
Coags O O
reveal O O
an O O
INR O O
of O O
1.4. O O
Chest O O
x-ray O O
shows O O
no O O
acute O O
disease. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
She O O
was O O
seen O O
by O O
surgery O O
who O O
repair O O
her O O
fistula. O O
She O O
is O O
due O O
to O O
go O O
to O O
dialysis O O
now O O
and O O
due O O
to O O
sickle O O
nature O O
of O O
her O O
disease, O O
I O O
think O O
it O O
is O O
best O O
that O O
she O O
keep O O
her O O
dialysis O O
appointment O O
and O O
so O O
she O O
is O O
transferred O O
from O O
here O O
with O O
her O O
daughter O O
to O O
the O O
EHCC O O
Dialysis O O
Unit O O
to O O
undergo O O
full O O
dialysis. O O
PRIMARY O O
DIAGNOSES: O O
Bleeding O O
aVF O O
and O O
end-stage O O
renal O O
disease. O O
DISPOSITION: O O
She O O
is O O
discharged O O
in O O
satisfactory O O
condition. O O
______________________________ O O
CORTES, O O
ODESSA O O
M.D. O O
D: O O
04/30/90 O O
T: O O
04/30/90 O O
Dictated O O
By: O O
CORTES, O O
ODESSA O O
eScription O O
document:5-52221754 O O
FVQtwry O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2091-07-11 O O
Reason O O
for O O
Visit O O
Comprehensive O O
evaluation O O
of O O
all O O
problems. O O
Problems O O
hypertension B-HYPERTENSION O
PRESENT O O
SINCE O O
MID O O
2060'S. O O
FOLLOWED O O
BY O O
DR. O O
THACKER O O
AT O O
DARDANELLE O O
HOSPITAL. O O
ETT O O
5/12/82 O O
TO O O
98% O O
PRMHR O O
SHOWED O O
ST O O
CHANGES O O
WHICH O O
WERE O O
SUGGESTIVE O O
BUT O O
NOT O O
DIAGNOSTIC O O
AND O O
THERE O O
WAS O O
BASELINE O O
LVH O O
WITH O O
STRAIN O O
BUT O O
THALLIUM O O
WAS O O
NEG. O O
THERE O O
WERE O O
OCCASIONAL O O
PVC'S O O
AND O O
COUPLETS O O
AND O O
TWO O O
3 O O
BEAT O O
RUNS O O
OF O O
VT. O O
HAD O O
BEEN O O
ACCEPTABLE O O
ALBEIT O O
ON O O
AN O O
ELABORATE O O
REGIMEN O O
THAT O O
HAD O O
EVOLVED. O O
SUBOPTIMAL O O
WITH O O
ADDITIONAL O O
WEIGHT O O
GAIN O O
5/23/86. O O
WILL O O
RECHECK O O
6-8 O O
WEEKS O O
AFTER O O
8-10 O O
LB O O
WEIGHT O O
LOSS. O O
ETT O O
THAL O O
SCHEDULED, O O
GIVEN O O
ABNL O O
ECG, O O
RISK O O
FACTORS, O O
AND O O
HIS O O
CONTINUING O O
DESIRE O O
TO O O
EXERCISE. O O
5/86 O O
EXCELLENT O O
EXERCISE O O
CAPACITY O O
TO O O
9 O O
METS, O O
ECG O O
NONDIAGNOSTIC O O
DUE O O
TO O O
BASELINE O O
ABNORMALITIES O O
BUT O O
THALLIUM O O
NL. O O
150/74 O O
7/86 O O
AND O O
WILL O O
ACCEPT O O
THIS O O
FOR O O
NOW O O
BUT O O
STILL O O
NEEDS O O
TO O O
LOSE O O
WEIGHT. O O
140/78 O O
9/86 O O
WO O O
WEIGHT O O
LOSS. O O
REDISCUSSED O O
IT O O
WOULD O O
MAKE O O
IT O O
POSSIBLE O O
TO O O
SIMPLIFY O O
HIS O O
REGIMEN O O
CONSIDERABLY. O O
HE O O
REMAINS O O
ON O O
VERY O O
ELABORATE O O
REGIMEN O O
THAT O O
HE O O
HAD O O
BEEN O O
ON O O
FOR O O
YEARS O O
BY O O
DR. O O
TITUS. O O
(8/8/87) O O
[28-Aug-2088] O O
REASONABLE O O
CONTROL O O
ON O O
REGIMEN, O O
BUT O O
STILL O O
NEEDS O O
WEIGHT O O
LOSS. O O
78-9 O O
really O O
not O O
adequate O O
control O O
with O O
his O O
mild B-DIABETES O
diabetes; B-DIABETES O
increased O O
Cardura O O
to O O
8 O O
mg O O
without O O
help. O O
Change B-MEDICATION O
Procardia I-MEDICATION O
XL I-MEDICATION O
to B-MEDICATION O
Norvasc I-MEDICATION B-MEDICATION
with O O
increase O O
from O O
15 O O
to O O
20 O O
mg. O O
BP O O
control O O
acceptable. O O
7/91 O O
still O O
a O O
bit O O
suboptima O O
and O O
Lisinopril B-MEDICATION B-MEDICATION
increased O O
from O O
40mg O O
to O O
60mg O O
per O O
day. O O
Continue O O
to O O
emphasize O O
weight O O
loss. O O
hyperglycemia O O
BS O O
WAS O O
APPARENTLY O O
190 O O
FASTING O O
2/82 O O
BUT O O
THEN O O
LOST O O
10 O O
LBS. O O
3 O O
HR O O
PC O O
BS O O
IS O O
91 O O
3/3/82. O O
RBS O O
118 O O
AND O O
HBA1C O O
5.06 O O
= O O
83 O O
4/22/83. O O
121 O O
4/84. O O
DAUGHTER O O
DID O O
RBG O O
9/18/84 O O
ABOUT O O
2 O O
HR O O
PP O O
AND O O
WAS O O
208. O O
134 O O
IN O O
OFFICE O O
9/22/84 B-DIABETES O
AND I-DIABETES O
HBA1C I-DIABETES O
8.16. I-DIABETES O
5.59 O O
4/85. O O
2-1/2 O O
HR O O
PC O O
179 O O
5/86. O O
FBS O O
120 O O
7/86. O O
12/86 O O
FBS O O
145 O O
AND O O
HGB O O
A1C O O
4.57 O O
= O O
66. O O
FBS O O
154 O O
AND O O
HBA1C O O
6.44 O O
= O O
129 O O
ON O O
4/87, O O
DONE O O
BY O O
HPLC O O
METHODS O O
SINCE O O
THERE O O
HAD O O
BEEN O O
A O O
DISCREPANCY O O
BETWEEN O O
BLOOD O O
SUGARS O O
AND O O
HBA1C O O
LEVELS, O O
AND O O
THIS O O
WAS O O
IN O O
AGREEMENT O O
WITH O O
RESULT O O
BY O O
AFFINITY. O O
DISCUSSED O O
DIETARY O O
CHANGE O O
AT O O
LENGTH. O O
8/87 O O
VISIT. O O
(8/8/87) O O
A1C O O
6.10 O O
= O O
117. O O
BLOOD O O
SUGARS O O
BECAME O O
HIGHER, O O
HE O O
DID O O
EXCEPT O O
NUTRITION O O
REFERRAL, O O
BEGUN O O
ON O O
METFORMIN B-MEDICATION B-MEDICATION
500 O O
BID O O
WITH O O
GI O O
SXS O O
WHEN O O
3RD O O
DOSE O O
ADDED. O O
5/88 B-DIABETES O
A1C I-DIABETES O
7.04 I-DIABETES O
= I-DIABETES O
149. I-DIABETES O
AT O O
THAT O O
POINT O O
HAD O O
LOST O O
14 O O
POUNDS. O O
[28-Aug-2088] O O
STARTED O O
ON O O
METFORMIN B-MEDICATION B-MEDICATION
WITH I-MEDICATION O
A1C O O
NORMAL O O
AT O O
500 O O
BID. O O
1/90 B-DIABETES O
A1C I-DIABETES O
6.60. I-DIABETES O
Urine O O
microalbumin O O
is O O
high O O
and O O
this O O
was O O
discussed. O O
Already O O
on O O
good O O
dose O O
ACEI O O
and O O
try O O
to O O
control O O
BP. O O
Gets O O
regular O O
eye O O
exams. O O
4/91 O O
A1C O O
6.00 O O
on O O
Metformin O B-MEDICATION
500mg O O
tid. O O
FBS O O
and O O
A1C O O
done. O O
Spell O O
4/4/90 O O
at O O
Gym O O
while O O
lying O O
down O O
with O O
his O O
head O O
back, O O
he O O
had O O
dizziness O O
and O O
then O O
weakness. O O
Seen O O
in O O
Educare-Pullman O O
ER O O
with O O
vital O O
signs O O
and O O
sugar O O
fine. O O
ECG O O
unchanged O O
and O O
not O O
reproducible. O O
Turns O O
out O O
he's O O
had O O
similar O O
sxs O O
for O O
about O O
30 O O
years, O O
always O O
with O O
his O O
head O O
back. O O
TCDs O O
here O O
okay O O
except O O
? O O
of O O
middle O O
cerebral O O
artery, O O
resolved O O
with O O
spinal O O
CT O O
angio. O O
7/91 O O
no O O
further O O
episodes. O O
gout O O
HAS O O
HAD O O
VARIOUS O O
ACUTE O O
JOINT O O
SWELLINGS, O O
INCL O O
ELBOW O O
AND O O
ANKLE. O O
APPARENTLY O O
DX O O
OF O O
GOUT O O
WAS O O
MADE. O O
HE O O
HAS O O
NOTED O O
THIS O O
OCCURS O O
ESPECIALLY O O
IF O O
HE O O
EATS O O
LOTS O O
OF O O
CHOCOLATE, O O
WHICH O O
HE O O
TENDS O O
TO O O
DO O O
FREQUENTLY. O O
LAST O O
EPISODE O O
WAS O O
ABT O O
A O O
YR O O
AGO. O O
NO O O
HO O O
UROLITHIASIS. O O
DISCUSSED O O
POSSIBLE O O
ROLE O O
OF O O
FUROSEMIDE, O O
AND O O
SINCE O O
IT O O
IS O O
NOT O O
ENTIRELY O O
CLR O O
TO O O
ME O O
WHY O O
HE O O
NEEDS O O
TO O O
BE O O
ON O O
A O O
HIGH O O
DOSE O O
OF O O
FUROSEMIDE O O
IT O O
MAY O O
BE O O
POSSIBLE O O
FOR O O
THIS O O
TO O O
BE O O
ADJUSTED. O O
HOWEVER, O O
NO O O
FURTHER O O
EPISODES. O O
UNTIL O O
POSTOP O O
3/86 O O
ATTACK. O O
HAVE O O
REDUCED O O
FUROSEMIDE. O O
SPRING O O
2088 O O
HAVING O O
SOME O O
MILD O O
SXS O O
THAT O O
COULD O O
BE O O
PODAGRA O O
AND O O
SOME O O
ANKLE O O
SXS, O O
THOUGH O O
W/O O O
OVERT O O
INFLAMMATION. O O
WONDER O O
WHETHER O O
LEFT O O
OLECRANON O O
COULD O O
BE O O
TOPHUS. O O
HIS O O
RIGHT O O
FOURTH O O
TOE O O
ALSO O O
HAS O O
A O O
LONGSTANDING O O
DEFORMITY O O
WHICH O O
IS O O
NOT O O
TYPICAL O O
FOR O O
TOPHUS O O
BUT O O
COULD O O
BE. O O
URIC O O
ACID O O
7.8 O O
1/88. O O
URIC O O
ACID O O
DONE O O
TODAY. O O
STARTED O O
ON O O
0.6 O O
COLCHICINE O O
DAILY. O O
IF O O
URIC O O
ACID O O
HIGH O O
WILL O O
START O O
ON O O
LOW O O
DOSE O O
ALLOPURINOL O O
IN O O
VIEW O O
OF O O
PHOSPHO-TOPHI. O O
[28-Aug-2088] O O
? O O
TOFUS O O
ON O O
4TH O O
TOE, O O
BUT O O
URIC O O
ACID O O
LEVEL O O
IS O O
NORMAL. O O
NO O O
ATTACKS O O
ON O O
COLCHICINE. O O
URIC O O
ACID O O
LEVEL O O
DONE. O O
elevated B-HYPERLIPIDEMIA O
serum I-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
211/45/4.69 O O
4/84. O O
181/39/112 B-HYPERLIPIDEMIA O
WITH I-HYPERLIPIDEMIA O
TG I-HYPERLIPIDEMIA O
149 I-HYPERLIPIDEMIA O
11/85. I-HYPERLIPIDEMIA O
194/42/123/4.6 B-HYPERLIPIDEMIA O
WITH O O
TG O O
147 O O
7/86. O O
12/88 O O
188/42/118/4.5. B-HYPERLIPIDEMIA O
Fasting O O
lipids O O
done O O
today. O O
skin O O
lesion O O
ACTINIC O O
LEFT O O
CHEEK O O
LESION O O
AND O O
WILL O O
REFER O O
TO O O
DR. O O
TOMLIN O O
AS O O
IT O O
MAY O O
BE O O
SQUAMOUS O O
CELL. O O
ALSO O O
MANY O O
OTHER O O
KINDS O O
OF O O
SKIN O O
LESIONS, O O
BUT O O
NONE O O
SUSPICIOUS. O O
4/84 O O
VISIT O O
NOTED O O
THAT O O
HE O O
NEVER O O
SAW O O
DR. O O
TOMLIN O O
BUT O O
IN O O
FACT O O
THIS O O
LESION O O
IS O O
NEARLY O O
GONE. O O
[26-Apr-2084] O O
Many O O
actinic O O
lesions. O O
BCE O O
excised O O
12/89 O O
at O O
ST O O
FRANCIS. O O
Note O O
that O O
brother O O
has O O
had O O
melanoma. O O
No O O
suspicious O O
lesions. O O
HEALTH O O
MAINTENANCE O O
SCREENING O O
FLEX O O
SIG O O
DONE O O
7/84 O O
NEG O O
BY O O
XIAN. O O
REFERRED O O
TO O O
QUINLIVAN O O
FOR O O
SCREENING O O
FLEX O O
SIG. O O
STOOL O O
CARDS O O
GIVEN. O O
Past O O
Medical O O
History O O
Stopped B-SMOKER O
smoking I-SMOKER O
about I-SMOKER O
2061. I-SMOKER O
No O O
ETOH. O O
No O O
known O O
med O O
allergies. O O
Family O O
History O O
Mother O O
died O O
age O O
89. O O
Father O O
died O O
37, O O
pneumonia. O O
Two O O
full O O
brothers, O O
one O O
with O O
DM, O O
who O O
is O O
S/P O O
THR, O O
1 O O
A&W. O O
Two O O
half O O
brothers O O
and O O
one O O
half O O
sister, O O
all O O
A&W. O O
One O O
of O O
his O O
brothers O O
had O O
had O O
melanoma. O O
Social O O
History O O
INSURANCE O O
CLAIMS O O
EXAMINER O O
WITH O O
DESK O O
JOB O O
IN O O
NEW O O
MARLBOROUGH. O O
MARRIED O O
WITH O O
4 O O
CHILDREN. O O
CURRENTLY O O
ONE O O
OF O O
HIS O O
SONS O O
IS O O
LIVING O O
AT O O
HOME. O O
HE O O
IS O O
RETIRED. O O
GOES O O
TO O O
GYM O O
EVERY O O
DAY. O O
Plays O O
alot O O
of O O
golf. O O
Review O O
of O O
Systems O O
Negative O O
except O O
for O O
extensive O O
problem O O
list. O O
Vital O O
Signs O O
Weight: O O
218 O O
Pounds O O
Blood B-HYPERTENSION O
Pressure: I-HYPERTENSION O
150/75 B-HYPERTENSION O
Pulse: O O
60 O O
Physical O O
Exam O O
Skin O O
Many O O
seborrheic O O
keratoses, O O
large O O
hyperpigmented O O
area O O
on O O
R O O
shoulder. O O
Multiple O O
viral O O
warts O O
under O O
arms O O
and O O
on O O
neck. O O
No O O
suspicious O O
lesions. O O
HEENT O O
Oropharynx O O
benign. O O
TMs O O
clear. O O
Gets O O
routine O O
eye O O
exams. O O
Neck O O
No O O
thyromegaly, O O
increased O O
JVP, O O
bruits O O
or O O
adenopathy. O O
Chest O O
Clear. O O
Cor/Cardiac O O
II/VI O O
SEM O O
at O O
apex O O
without O O
change. O O
No O O
gallop. O O
Abdomen O O
Obese B-OBESE O
without O O
organomegaly O O
or O O
tenderness. O O
No O O
bruits. O O
Rectal O O
Exam O O
Prostate O O
3+ O O
enlarged, O O
smooth O O
and O O
without O O
nodules. O O
No O O
change. O O
Extremity O O
1+ O O
edema O O
left, O O
trace O O
right. O O
Pulses O O
full. O O
Medications O O
lisinopril O B-MEDICATION
20MG O O
PO O O
QD O O
Disposition O O
and O O
Plans O O
3 O O
months O O
fasting O O
or O O
sooner O O
prn. O O
VN O O
Dr. O O
Gregory O O
Quinlivan O O
with O O
Case O O
Summary. O O

Record O O
date: O O
2094-07-28 O O
Reason O O
for O O
Visit O O
Comprehensive O O
evaluation O O
and O O
follow-up O O
of O O
problems. O O
Problems O O
Shortness O O
of O O
breath O O
11/93 O O
after O O
starting O O
atenolol B-MEDICATION B-MEDICATION
(and O O
wt O O
gain) O O
devel O O
DOE O O
w/o O O
wheezing. O O
Resolved O O
off O O
it O O
(and O O
w O O
inc O O
lasix O O
60 O O
--&gt; O O
80). O O
ETT O O
12/93 O O
neg O O
to O O
7 O O
METS, O O
echo O O
12/93 O O
mild/mod O O
MR, O O
Ao O O
scle O O
w/o O O
sten, O O
LV O O
mild O O
dil O O
55, O O
LA O O
mod O O
dil, O O
EF O O
72%, O O
no O O
RWMA, O O
mod O O
sym O O
LVH, O O
all O O
c/w O O
diastolic O O
dysfunction. O O
Lumbar O O
disc O O
disease O O
4/94 O O
seen O O
for O O
9 O O
days O O
L O O
buttock--&gt; O O
post O O
thigh O O
pain O O
w/o O O
trauma. O O
No O O
improvement O O
at O O
2 O O
weeks O O
and O O
MRI O O
done--&gt; O O
mild O O
L4-5 O O
and O O
L5-S1 O O
disc O O
disease, O O
facet O O
DJD O O
and O O
B O O
foraminal O O
encroachment O O
L5-S1. O O
Sx O O
resolved. O O
Spell O O
4/4/90 O O
at O O
Gym O O
while O O
lying O O
down O O
with O O
his O O
head O O
back, O O
he O O
had O O
dizziness O O
and O O
then O O
weakness. O O
Seen O O
in O O
Cedars O O
ER O O
with O O
vital O O
signs O O
and O O
sugar O O
fine. O O
ECG O O
unchanged O O
and O O
not O O
reproducible. O O
Turns O O
out O O
he's O O
had O O
similar O O
sxs O O
for O O
about O O
30 O O
years, O O
always O O
with O O
his O O
head O O
back. O O
TCDs O O
here O O
okay O O
except O O
? O O
of O O
middle O O
cerebral O O
artery, O O
resolved O O
with O O
spinal O O
CT O O
angio. O O
No O O
further O O
episodes. O O
hypertension B-HYPERTENSION O
PRESENT O O
SINCE O O
MID O O
2060'S. O O
HAD O O
BEEN O O
FOLLOWED O O
BY O O
DR. O O
TITUS O O
AT O O
DARDANELLE O O
HOSPITAL. O O
ETT O O
5/12/82 O O
TO O O
98% O O
PRMHR O O
SHOWED O O
ST O O
CHANGES O O
WHICH O O
WERE O O
SUGGESTIVE O O
BUT O O
NOT O O
DIAGNOSTIC O O
AND O O
THERE O O
WAS O O
BASELINE O O
LVH O O
WITH O O
STRAIN O O
BUT O O
THALLIUM O O
WAS O O
NEG. O O
THERE O O
WERE O O
OCCASIONAL O O
PVC'S O O
AND O O
COUPLETS O O
AND O O
TWO O O
3 O O
BEAT O O
RUNS O O
OF O O
VT. O O
HAD O O
BEEN O O
ACCEPTABLE O O
ALBEIT O O
ON O O
AN O O
ELABORATE O O
REGIMEN O O
THAT O O
HAD O O
EVOLVED. O O
SUBOPTIMAL O O
WITH O O
ADDITIONAL O O
WEIGHT O O
GAIN O O
5/23/86. O O
WILL O O
RECHECK O O
6-8 O O
WEEKS O O
AFTER O O
8-10 O O
LB O O
WEIGHT O O
LOSS. O O
ETT O O
THAL O O
SCHEDULED, O O
GIVEN O O
ABNL O O
ECG, O O
RISK O O
FACTORS, O O
AND O O
HIS O O
CONTINUING O O
DESIRE O O
TO O O
EXERCISE. O O
5/86 O O
EXCELLENT O O
EXERCISE O O
CAPACITY O O
TO O O
9 O O
METS, O O
ECG O O
NONDIAGNOSTIC O O
DUE O O
TO O O
BASELINE O O
ABNORMALITIES O O
BUT O O
THALLIUM O O
NL. O O
150/74 B-HYPERTENSION O
7/86 O O
AND O O
WILL O O
ACCEPT O O
THIS O O
FOR O O
NOW O O
BUT O O
STILL O O
NEEDS O O
TO O O
LOSE O O
WEIGHT. O O
140/78 O O
9/86 O O
WO O O
WEIGHT O O
LOSS. O O
REDISCUSSED O O
IT O O
WOULD O O
MAKE O O
IT O O
POSSIBLE O O
TO O O
SIMPLIFY O O
HIS O O
REGIMEN O O
CONSIDERABLY. O O
HE O O
REMAINS O O
ON O O
VERY O O
ELABORATE O O
REGIMEN O O
THAT O O
HE O O
HAD O O
BEEN O O
ON O O
FOR O O
YEARS O O
BY O O
DR. O O
TITUS. O O
(8/8/87) O O
[28-Aug-2088] O O
REASONABLE O O
CONTROL O O
ON O O
REGIMEN, O O
BUT O O
STILL O O
NEEDS O O
WEIGHT O O
LOSS. O O
78-9 O O
really O O
not O O
adequate O O
control O O
with O O
his O O
mild B-DIABETES O
diabetes; I-DIABETES O
increased O O
Cardura O O
to O O
8 O O
mg O O
without O O
help. O O
Change B-MEDICATION O
Procardia B-MEDICATION O
XL I-MEDICATION O
to B-MEDICATION O
Norvasc B-MEDICATION B-MEDICATION
with O O
increase O O
from O O
15 O O
to O O
20 O O
mg. O O
BP O O
control O O
acceptable. O O
7/91 O O
still O O
a O O
bit O O
suboptimal, O O
and O O
has O O
continued O O
so O O
w O O
wt O O
gain. O O
Lisinopril B-MEDICATION B-MEDICATION
increased O O
from O O
40mg O O
qd O O
to O O
bid, O O
lasix O O
from O O
40 O O
to O O
60 O O
qd. O O
7/92 O O
still O O
140/70. O O
Wt O O
down O O
5.5 O O
from O O
peak., O O
at O O
228# O O
Not O O
improved, O O
so O O
dec O O
lisinopril B-MEDICATION B-MEDICATION
to O O
40 O O
mg O O
and O O
added O O
Irbesartan B-MEDICATION O
w O O
good O O
response, O O
though O O
7/93 O O
suboptimal O O
140/70 O O
and O O
subsequent O O
~ O O
135. O O
Inc B-HYPERTENSION O
160--&gt;240 I-HYPERTENSION O
7/94. I-HYPERTENSION O
Following O O
chems. O O
Continue O O
to O O
emphasize O O
weight O O
loss. O O
hyperglycemia O O
BS O O
WAS O O
APPARENTLY O O
190 O O
FASTING O O
2/82 O O
BUT O O
THEN O O
LOST O O
10 O O
LBS. O O
3 O O
HR O O
PC O O
BS O O
IS O O
91 O O
3/3/82. O O
RBS O O
118 O O
AND O O
HBA1C O O
5.06 O O
= O O
83 O O
4/22/83. O O
121 O O
4/84. O O
DAUGHTER O O
DID O O
RBG O O
9/18/84 B-DIABETES O
ABOUT I-DIABETES O
2 I-DIABETES O
HR I-DIABETES O
PP I-DIABETES O
AND I-DIABETES O
WAS I-DIABETES O
208. I-DIABETES O
134 O O
IN O O
OFFICE O O
9/22/84 O O
AND O O
HBA1C B-DIABETES O
8.16. I-DIABETES O
5.59 O O
4/85. O O
2-1/2 O O
HR O O
PC O O
179 O O
5/86. O O
FBS O O
120 O O
7/86. O O
12/86 O O
FBS O O
145 O O
AND O O
HGB O O
A1C O O
4.57 O O
= O O
66. O O
FBS O O
154 O O
AND O O
HBA1C O O
6.44 O O
= O O
129 O O
ON O O
4/87, O O
DONE O O
BY O O
HPLC O O
METHODS O O
SINCE O O
THERE O O
HAD O O
BEEN O O
A O O
DISCREPANCY O O
BETWEEN O O
BLOOD O O
SUGARS O O
AND O O
HBA1C O O
LEVELS, O O
AND O O
THIS O O
WAS O O
IN O O
AGREEMENT O O
WITH O O
RESULT O O
BY O O
AFFINITY. O O
DISCUSSED O O
DIETARY O O
CHANGE O O
AT O O
LENGTH. O O
8/87 O O
VISIT. O O
(8/8/87) O O
A1C O O
6.10 O O
= O O
117. O O
BLOOD O O
SUGARS O O
BECAME O O
HIGHER, O O
HE O O
DID O O
ACCEPT O O
NUTRITION O O
REFERRAL, O O
BEGUN O O
ON O O
METFORMIN B-MEDICATION O
500 O O
BID O O
WITH O O
GI O O
SXS O O
WHEN O O
3RD O O
DOSE O O
ADDED. O O
5/88 B-DIABETES O
A1C B-DIABETES O
7.04 I-DIABETES O
= O O
149. O O
AT O O
THAT O O
POINT O O
HAD O O
LOST O O
14 O O
POUNDS. O O
[28-Aug-2088] O O
Gets O O
regular O O
eye O O
f/u. O O
Have O O
emphasized O O
importance O O
of O O
caring O O
for O O
feet. O O
7/94 O O
beginning O O
to O O
get O O
slight O O
neuropathic O O
pain. O O
STARTED O O
ON O O
METFORMIN O O
WITH O O
A1C O O
NORMAL O O
AT O O
500 O O
BID. O O
1/90 B-DIABETES O
A1C I-DIABETES O
6.60. I-DIABETES O
Urine O O
microalbumin O O
is O O
high O O
and O O
this O O
was O O
discussed. O O
Already O O
on O O
good O O
dose O O
ACEI O O
and O O
try O O
to O O
control O O
BP. O O
Gets O O
regular O O
eye O O
exams. O O
4/91 O O
A1C O O
6.00 O O
on O O
Metformin O O
500mg O O
tid. O O
However, O O
weight O O
gained O O
up O O
to O O
234 O O
1/92. O O
A1c B-DIABETES O
3/92 I-DIABETES O
7.40. I-DIABETES O
Metformin O B-MEDICATION
tolerated O O
at O O
1000 O O
BID. O O
Is O O
aware O O
of O O
centrality O O
of O O
diet O O
and O O
wt O O
loss. O O
Have O O
discussed O O
mulidisciplinary O O
referral O O
for O O
wt O O
loss, O O
but O O
he O O
defers. O O
11/92 B-DIABETES O
A1c I-DIABETES O
7.60 I-DIABETES O
and O O
glyburide B-MEDICATION B-MEDICATION
added. O O
4/93 O O
5.50 O O
and O O
dec O O
to O O
1/2 O O
of O O
2.5mg O O
pill. O O
11/93 O O
w O O
creat O O
metformin B-MEDICATION O
D/C. I-MEDICATION O
A1c B-DIABETES O
off I-DIABETES O
it I-DIABETES O
3/94 I-DIABETES O
8.5 I-DIABETES O
and O O
Glipizide O B-MEDICATION
inc O O
to O O
10 O O
mg, O O
rec O O
insulin O O
but O O
he O O
deferred. O O
Walks O O
playing O O
golf O O
but O O
stopped O O
other O O
exercise; O O
discussed. O O
FBS O O
and O O
A1C O O
done. O O
gout O O
HAS O O
HAD O O
VARIOUS O O
ACUTE O O
JOINT O O
SWELLINGS, O O
INCL O O
ELBOW O O
AND O O
ANKLE. O O
APPARENTLY O O
DX O O
OF O O
GOUT O O
WAS O O
MADE. O O
HE O O
HAS O O
NOTED O O
THIS O O
OCCURS O O
ESPECIALLY O O
IF O O
HE O O
EATS O O
LOTS O O
OF O O
CHOCOLATE, O O
WHICH O O
HE O O
TENDS O O
TO O O
DO O O
FREQUENTLY. O O
LAST O O
EPISODE O O
WAS O O
ABT O O
A O O
YR O O
AGO. O O
NO O O
HO O O
UROLITHIASIS. O O
DISCUSSED O O
POSSIBLE O O
ROLE O O
OF O O
FUROSEMIDE, O O
AND O O
SINCE O O
IT O O
IS O O
NOT O O
ENTIRELY O O
CLR O O
TO O O
ME O O
WHY O O
HE O O
NEEDS O O
TO O O
BE O O
ON O O
A O O
HIGH O O
DOSE O O
OF O O
FUROSEMIDE O O
IT O O
MAY O O
BE O O
POSSIBLE O O
FOR O O
THIS O O
TO O O
BE O O
ADJUSTED. O O
HOWEVER, O O
NO O O
FURTHER O O
EPISODES. O O
UNTIL O O
POSTOP O O
3/86 O O
ATTACK. O O
HAVE O O
REDUCED O O
FUROSEMIDE. O O
Spring O O
2088 O O
HAVING O O
SOME O O
MILD O O
SXS O O
THAT O O
COULD O O
BE O O
PODAGRA O O
AND O O
SOME O O
ANKLE O O
SXS, O O
THOUGH O O
W/O O O
OVERT O O
INFLAMMATION. O O
WONDER O O
WHETHER O O
LEFT O O
OLECRANON O O
COULD O O
BE O O
TOPHUS. O O
HIS O O
RIGHT O O
FOURTH O O
TOE O O
ALSO O O
HAS O O
A O O
LONGSTANDING O O
DEFORMITY O O
WHICH O O
IS O O
NOT O O
TYPICAL O O
FOR O O
TOPHUS O O
BUT O O
COULD O O
BE. O O
URIC O O
ACID O O
7.8 O O
1/88. O O
URIC O O
ACID O O
DONE O O
TODAY. O O
STARTED O O
ON O O
0.6 O O
COLCHICINE O O
DAILY. O O
IF O O
URIC O O
ACID O O
HIGH O O
WILL O O
START O O
ON O O
LOW O O
DOSE O O
ALLOPURINOL O O
IN O O
VIEW O O
OF O O
PHOSPHO-TOPHI. O O
[28-Aug-2088] O O
MAY O O
WELL O O
BE O O
TOPHUS O O
ON O O
4TH O O
TOE, O O
BUT O O
URIC O O
ACID O O
LEVEL O O
IS O O
NORMAL. O O
NO O O
ATTACKS O O
ON O O
COLCHICINE. O O
7/94 O O
dec O O
to O O
1 O O
QOD. O O
URIC O O
ACID O O
LEVEL O O
DONE. O O
elevated B-HYPERLIPIDEMIA O
serum I-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
On O O
atorva B-MEDICATION O
10 O O
mg O O
LDL O O
&lt;100. O O
Fasting O O
lipids O O
done O O
today. O O
benign O O
prostatic O O
hypertrophy O O
SIGNIFICANT O O
SX O O
FROM O O
BPH, O O
HELPED O O
SOME O O
BY O O
CARDURA, O O
BUT O O
RETENTION O O
AND O O
TURP O O
3/86 O O
BY O O
FONSECA. O O
RESIDUAL O O
PROSTATE O O
1 O O
TO O O
2+ O O
W/O O O
NODULES. O O
CURRENTLY O O
ON O O
PROSCAR O O
W O O
SX O O
BENEFIT. O O
HEALTH O O
MAINTENANCE O O
SCREENING O O
FLEX O O
SIG O O
DONE O O
7/84 O O
NEG O O
BY O O
XIAN. O O
QUINLIVAN O O
SCREENING O O
FLEX O O
SIG O O
10/30 O O
neg O O
x O O
tics. O O
STOOL O O
CARDS O O
GIVEN. O O
skin O O
lesion O O
Many O O
actinic O O
lesions. O O
BCE O O
excised O O
12/89 O O
at O O
ST O O
FRANCIS. O O
Note O O
that O O
brother O O
has O O
had O O
melanoma. O O
DR. O O
TOMLIN O O
excised O O
SSC O O
from O O
scalp O O
3/93--&gt;reexcision. O O
7/94 O O
will O O
see O O
him O O
again.. O O
Allergies O O
* O O
NKDA O O
Past O O
Medical O O
History O O
Stopped B-SMOKER O
smoking I-SMOKER O
about I-SMOKER O
2061. I-SMOKER O
No O O
ETOH. O O
No O O
known O O
med O O
allergies. O O
Family O O
History O O
Mother O O
died O O
age O O
90. O O
Father O O
died O O
37, O O
pneumonia. O O
Two O O
full O O
brothers, O O
one O O
with O O
DM, O O
who O O
is O O
S/P O O
THR, O O
1 O O
A&W. O O
Two O O
half O O
brothers O O
and O O
one O O
half O O
sister, O O
all O O
A&W. O O
One O O
of O O
his O O
brothers O O
had O O
had O O
melanoma. O O
Social O O
History O O
INSURANCE O O
CLAIMS O O
EXAMINER O O
WITH O O
DESK O O
JOB O O
IN O O
NEW O O
MARLBOROUGH. O O
MARRIED O O
WITH O O
4 O O
CHILDREN. O O
CURRENTLY O O
ONE O O
OF O O
HIS O O
SONS O O
IS O O
LIVING O O
AT O O
HOME. O O
HE O O
IS O O
RETIRED. O O
GOES O O
TO O O
GYM O O
EVERY O O
DAY. O O
Plays O O
alot O O
of O O
golf. O O
Wife O O
with O O
some O O
memory O O
lapses, O O
which O O
worries O O
him O O
because O O
her O O
mother O O
had O O
Alzheimer's. O O
Review O O
of O O
Systems O O
L O O
basal O O
jt O O
(thumb) O O
discomfort O O
and O O
mild O O
tenderness, O O
and O O
10/91 O O
discussed O O
could O O
be O O
referred O O
for O O
injection O O
if O O
bothersome O O
enough. O O
Otherwise O O
negative O O
except O O
for O O
extensive O O
problem O O
list. O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
135/70 O O
PULSE O O
70 O O
WEIGHT O O
231 O O
lb O O
Physical O O
Exam O O
Skin O O
Many O O
seborrheic O O
keratoses, O O
large O O
hyperpigmented O O
area O O
on O O
R O O
shoulder. O O
Multiple O O
viral O O
warts O O
under O O
arms O O
and O O
on O O
neck. O O
Actinic O O
areas O O
on O O
scalp. O O
HEENT O O
Oropharynx O O
benign. O O
TMs O O
clear. O O
Gets O O
routine O O
eye O O
exams. O O
Neck O O
No O O
thyromegaly, O O
increased O O
JVP, O O
bruits O O
or O O
adenopathy. O O
Chest O O
Clear. O O
Cor/Cardiac O O
II/VI O O
SEM O O
at O O
apex O O
without O O
change. O O
No O O
gallop. O O
Abdomen O O
Obese B-OBESE O
without O O
organomegaly O O
or O O
tenderness. O O
No O O
bruits. O O
Rectal O O
Exam O O
Prostate O O
2+ O O
enlarged, O O
smooth O O
and O O
without O O
nodules. O O
No O O
change. O O
Genito-Urinary O O
Normal. O O
Extremity O O
trace O O
edema O O
left. O O
Pulses O O
full. O O
Medications O O
Norvasc O B-MEDICATION
10MG O O
PO O O
BID O O
enteric B-MEDICATION O
coated I-MEDICATION O
aspirin I-MEDICATION B-MEDICATION
TAB O O
PO O O
QD O O
Potassium O O
chloride O O
10MEQ O O
PO O O
QAM O O
lisinopril O B-MEDICATION
20MG O O
PO O O
QD O O
PROSCAR O B-MEDICATION
(FINASTERIDE) O O
5MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
LIPITOR B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10mg O O
PO O O
QD O O
colchicine O O
0.6 O O
MG O O
PO O O
QOD O O
Avapro B-MEDICATION B-MEDICATION
(IRBESARTAN) B-MEDICATION O
150MG, O O
1.5 O O
Tablet(s) O O
PO O O
QD O O
ALLOPURINOL O O
100MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
furosemide O O
40 O O
MG O O
PO O O
2 O O
QD O O
Cardura O O
8 O O
MG O O
PO O O
QD O O
GLIPIZIDE B-MEDICATION B-MEDICATION
10MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Disposition O O
and O O
Plans O O
3 O O
months O O
fasting O O
or O O
sooner O O
prn. O O

Record O O
date: O O
2096-06-07 O O
Chief O O
Complaint O O
Admission O O
note- O O
Internal O O
Medicine O O
Kenneth O O
Weeks- O O
1205466 O O
History O O
of O O
Present O O
Illness O O
Mr. O O
Weeks O O
is O O
a O O
78 O O
yr. O O
old O O
male O O
who O O
was O O
admitted O O
for O O
further O O
cardiac O O
testing. O O
His O O
PMH O O
includes O O
hypertension, B-HYPERTENSION B-HYPERTENSION
hyperlipidemia, B-HYPERLIPIDEMIA O
diabetes B-DIABETES B-MEDICATION
mellitus, I-DIABETES O
atrial O O
fibrillation O O
and O O
mitral O O
regurgitation. O O
He O O
has O O
been O O
experiencing O O
increasing O O
dyspnea O O
with O O
exertion O O
over O O
the O O
past O O
5 O O
weeks. O O
He O O
has O O
especially O O
noted O O
this O O
when O O
he O O
climbs O O
stairs O O
or O O
walking O O
up O O
an O O
incline. O O
He O O
also O O
notes O O
this O O
SOB O O
when O O
he O O
is O O
walking O O
the O O
golf O O
course. O O
He O O
denies O O
any O O
chest O O
pain O O
or O O
orthopnea, O O
although O O
he O O
states O O
that O O
he O O
has O O
been O O
experiencing O O
some O O
'indigestion' O O
the O O
past O O
few O O
days. O O
It O O
usually O O
occurs O O
in O O
the O O
morning. O O
He O O
was O O
given O O
sublingual B-MEDICATION O
nitroglycerin I-MEDICATION O
and O O
notes O O
improvement O O
in O O
his O O
symptoms O O
His O O
Lasix O O
dose O O
was O O
increased O O
on O O
4/3/96 O O
(from O O
80 O O
mg O O
to O O
120 O O
mg). O O
This O O
increase O O
did O O
help O O
his O O
symptoms O O
a O O
little, O O
but O O
he O O
still O O
felt O O
his O O
exercise O O
capacity O O
had O O
decreased. O O
An O O
ECHO O O
was O O
done O O
on O O
4/10 O O
which O O
was O O
not O O
significantly O O
changed O O
from O O
1/95. O O
His O O
EF O O
was O O
74%, O O
mild O O
MR, O O
dilated O O
LA, O O
symmetric O O
LV O O
hypertrophy O O
without O O
any O O
obvious O O
segmental O O
wall O O
motion O O
abnormalities O O
and O O
RVSP O O
43 O O
mmHg. O O
A O O
Sestamibi B-CAD O
stress I-CAD O
test I-CAD O
was I-CAD O
done I-CAD O
on I-CAD O
5/19. I-CAD O
The I-CAD O
patient I-CAD O
exercised I-CAD O
for I-CAD O
3 I-CAD O
minutes I-CAD O
21 I-CAD O
seconds I-CAD O
reaching I-CAD O
84% I-CAD O
of I-CAD O
predicted I-CAD O
HR. I-CAD O
His I-CAD O
EKG I-CAD O
had I-CAD O
STD I-CAD O
AVF, I-CAD O
V4-V6. I-CAD O
The B-CAD O
perfusion I-CAD O
scans I-CAD O
showed I-CAD O
a I-CAD O
moderate, I-CAD O
reversible I-CAD O
mid-distal I-CAD O
anterior, I-CAD O
septal I-CAD O
and I-CAD O
apical I-CAD O
defect I-CAD O
indicative I-CAD O
of I-CAD O
moderate I-CAD O
ischemia. I-CAD O
LV O O
function O O
preserved. O O
He O O
was O O
admitted O O
electively O O
today O O
for O O
further O O
evaluation. O O
He O O
arrives O O
to O O
Internal O O
Medicine O O
chest O O
pain O O
free O O
and O O
hemodynamically O O
stable. O O
Allergies O O
NKDA O O
Past O O
Medical O O
History O O
Hypertension O B-HYPERTENSION
Hyperlipidemia O B-HYPERTENSION
Diabetes B-DIABETES O
Mellitus I-DIABETES O
- I-DIABETES O
since I-DIABETES O
2070's I-DIABETES O
Atrial O O
Fibrillation O O
- O O
for O O
1 O O
1/2 O O
yrs- O O
on O O
chronic O O
Coumadin- O O
followed O O
by O O
FWO O O
at O O
VMC O O
Gout O O
Left O O
Olecranon O O
bursitis O O
Umbilical O O
hernia O O
Benign O O
Prostatic O O
Hypertrophy- O O
s/p O O
TURP O O
3/86 O O
at O O
VMC O O
(Fonseca) O O
Family O O
History O O
Mother: O O
Died O O
at O O
age O O
89 O O
- O O
'old O O
age' O O
Father: O O
Died O O
at O O
age O O
37 O O
with O O
Pneumonia O O
Siblings: O O
one O O
brother O O
with O O
DM- O O
s/p O O
amputation O O
for O O
PVD O O
Social O O
History O O
Married- O O
4 O O
children O O
Lives O O
with O O
his O O
wife O O
Retired O O
claims O O
examiner O O
Habits O O
ETOH: O O
None O O
Tobacco: B-SMOKER O
Quit I-SMOKER O
in I-SMOKER O
2070's I-SMOKER O
- I-SMOKER O
smoked I-SMOKER O
1 I-SMOKER O
ppd I-SMOKER O
x I-SMOKER O
30 I-SMOKER O
yrs I-SMOKER O
Diet: O O
Poor O O
diet O O
habits O O
Exercise: O O
Last O O
5 O O
wks O O
minimal O O
exercise O O
due O O
to O O
DOE- O O
prior O O
to O O
that O O
walked O O
2 O O
miles, O O
5x/week O O
Caffeine: O O
2 O O
cups O O
of O O
coffee/day O O
Review O O
of O O
Systems O O
Neuro: O O
No O O
recent O O
fever, O O
chills, O O
night O O
sweats, O O
unintentional O O
weight O O
loss/gain O O
Neuro: O O
+ O O
Labrinythitis- O O
on O O
Meclizine O O
prn, O O
No O O
lightheadedness O O
pre-syncope O O
or O O
syncope, O O
No O O
HA/Sz/CVA, O O
No O O
visual O O
or O O
speech O O
changes O O
Cardiac: O O
see O O
HPI, O O
denies O O
palpatations O O
Endo: O O
+ O O
diabetes, O O
no O O
thyroid O O
disease O O
Resp: O O
see O O
HPI, O O
no O O
SOB O O
at O O
rest, O O
no O O
orthopnea, O O
PND, O O
No O O
COPD/asthma. O O
GI: O O
No O O
constipation. O O
No O O
BRBPR. O O
No O O
N/V/D. O O
No O O
hepatitis/jaundice/gall O O
bladder O O
disease. O O
Last O O
colonscopy O O
5 O O
yrs O O
ago O O
Heme: O O
+ O O
chronically O O
low O O
plts- O O
no O O
work-up O O
done O O
per O O
pt, O O
No O O
bleeding O O
problems, O O
no O O
clotting O O
problems, O O
no O O
DVT/PE O O
MS: O O
+ O O
pedal O O
edema, O O
No O O
claudication O O
symptoms O O
Physical O O
Exam O O
Height: O O
5'9' O O
Weight: O O
220 O O
;bs O O
VS: O O
afebrile O O
HR: O O
60 O O
AF O O
BP: O O
130/70 O O
General: O O
well O O
appearing O O
male, O O
sitting O O
in O O
bed, O O
in O O
NAD O O
Neuro: O O
alert, O O
oriented O O
x O O
3, O O
speech O O
clear O O
and O O
articulate, O O
CN O O
II-XII O O
intact. O O
Strength O O
5/5 O O
BUE O O
and O O
BLE, O O
No O O
focal O O
motor O O
or O O
sensory O O
deficits O O
Neck:supple, O O
thyroid O O
midline O O
without O O
nodularity, O O
JVP O O
flat, O O
no O O
HJR. O O
Carotid O O
pulses O O
2+, O O
no O O
bruits O O
noted. O O
No O O
adenopathy O O
appreciated. O O
Cor: O O
Irreg, O O
Irreg, O O
S1, O O
S2, O O
2/6 O O
systolic O O
murmur O O
at O O
apex O O
radiating O O
to O O
axilla, O O
PMI O O
not O O
displaced O O
Resp: O O
clear O O
to O O
auscultation O O
bilaterally O O
Abd: O O
soft, O O
non-tender, O O
non-distended. O O
No O O
HSM/masses/bruits. O O
Bowel O O
sounds O O
in O O
all O O
quads. O O
Ext: O O
Femoral O O
arteries: O O
2+ O O
bilaterally, O O
no O O
bruits. O O
Lower O O
ext: O O
warm, O O
dry O O
without O O
edema O O
Pulses O O
2+ O O
bilaterally O O
Medications O O
At O O
home: O O
ECASA B-MEDICATION B-MEDICATION
81 O O
mg O O
QD O O
Lisinopril B-MEDICATION B-MEDICATION
40 O O
mg O O
BID O O
Norvasc B-MEDICATION B-MEDICATION
5 O O
mg O O
QD O O
Avapro B-MEDICATION B-MEDICATION
300 O O
mg O O
QD O O
Coumadin O O
5 O O
mg O O
QD- O O
except O O
Wednesday O O
takes O O
7.5 O O
mg O O
Atenolol B-MEDICATION B-MEDICATION
25 I-MEDICATION O
mg I-MEDICATION O
BID I-MEDICATION O
Colchicine O O
0.6 O O
mg O O
prn O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
mg O O
QD O O
Glipizide B-MEDICATION B-MEDICATION
10 O O
mg O O
QD O O
Folgard O O
1 O O
tablet O O
QD O O
Quinine O O
260 O O
mg O O
QHS O O
Lasix O O
120 O O
mg O O
QD O O
- O O
recently O O
increased O O
NPH B-MEDICATION B-MEDICATION
insulin I-MEDICATION B-MEDICATION
30 O O
units O O
SQ O O
prior O O
to O O
breakfast O O
Cardura O O
8 O O
mg O O
QD O O
Proscar O O
5 O O
mg O O
QD O O
Allopurinol O O
100 O O
mg O O
QD O O
TNG B-MEDICATION O
prn I-MEDICATION O
sublingual I-MEDICATION O
Meclizine O O
prn O O
dizziness O O
Lab O O
Test O O
Labs: O O
EKG: O O
Impression O O
Impression: O O
Mr. O O
Weeks O O
is O O
a O O
78 O O
yr O O
old O O
with O O
PMH O O
significant O O
for O O
HTN, O O
hyperlipidemia, O O
diabetes O O
mellitus, O O
MR O O
and O O
AF O O
who O O
is O O
admitted O O
for O O
an O O
elective O O
cardiac O O
catheterization. O O
He O O
has O O
been O O
experiencing O O
increasing O O
DOE O O
and O O
had O O
a O O
+ B-CAD O
ETT. I-CAD O
His O O
stress O O
test O O
showed O O
anterior, O O
septal O O
and O O
apical O O
defect. O O
Plan: O O
1. O O
Cardiac: O O
Currently O O
pain O O
free O O
and O O
hemodynamically O O
stable O O
-- O O
Admit O O
to O O
Internal O O
Medicine/telemetry O O
-- O O
NPO O O
after O O
MN O O
for O O
cardiac O O
cath O O
in O O
the O O
am O O
-- O O
Will O O
begin O O
ECASA O B-MEDICATION
-- O O
Continue O O
Atenolol- O B-MEDICATION
pt. O O
recently O O
changed B-MEDICATION O
from I-MEDICATION O
Cardiazem I-MEDICATION O
to I-MEDICATION O
Atenolol I-MEDICATION B-MEDICATION
given O O
ETT O O
results. O O
HR O O
well O O
controlled O O
at O O
present. O O
-- O O
Continue O O
Norvasc O B-MEDICATION
and O O
Avapro- O B-MEDICATION
SBP O O
currently O O
well O O
controlled. O O
-- O O
Pt O O
euvolemic O O
on O O
exam- O O
will O O
continue O O
Lasix O O
- O O
holding O O
tomorrow O O
pre-cath. O O
Follow O O
strict O O
I/O's O O
and O O
daily O O
weights- O O
will O O
adjust O O
Lasix O O
dose O O
as O O
needed O O
depending O O
on O O
fluid O O
status O O
and O O
renal O O
function. O O
-- O O
Pt O O
in O O
AF- O O
last O O
Coumadin O O
dose O O
on O O
Friday- O O
will O O
begin O O
Heparin O O
pre O O
cath. O O
Will O O
need O O
to O O
resume O O
coumadin O O
once O O
all O O
interventions O O
completed. O O
2. O O
Renal: O O
Pre O O
cath O O
creatinine O O
2.1. O O
Pt O O
had O O
renal O O
angiogram O O
in O O
4/95 O O
which O O
showed O O
patent O O
renal O O
arteries. O O
-- O O
Will O O
give O O
Mucomyst O O
and O O
NaHCO3 O O
protocol O O
pre O O
cath. O O
-- O O
Monitor O O
urine O O
output. O O
-- O O
Follow O O
renal O O
function O O
closely O O
post O O
dye O O
load O O
-- O O
Will O O
hold O O
ARB O O
and O O
diuretic O O
pre- O O
cath- O O
will O O
reassess O O
post O O
cath. O O
3. O O
DM: O O
Long O O
hx O O
of O O
DM- O O
per O O
pt. O O
well O O
controlled O O
on O O
present O O
regimine O O
Will O O
continue O O
NPH O B-MEDICATION
and O O
Glipizide- O B-MEDICATION
holding O O
in O O
am O O
of O O
cath. O O
Will O O
check O O
fingersticks O O
QID O O
and O O
cover O O
with O O
RISS. O O
Diabetic O O
diet. O O
Pt. O O
also O O
reports O O
poor O O
dietary O O
compliance- O O
will O O
obtain O O
nutrition O O
consult. O O
4. O O
Thrombocytopenia: O O
Pt O O
with O O
long O O
history O O
of O O
low O O
platelets- O O
per O O
pt. O O
he O O
has O O
never O O
had O O
this O O
worked O O
up. O O
Will O O
follow O O
closely. O O
? O O
need O O
for O O
hematology O O
consult O O
at O O
some O O
point- O O
will O O
discuss O O
with O O
Dr. O O
Felder. O O
Watch O O
CBC O O
closely O O
while O O
on O O
Heparin. O O
Further O O
plans O O
per O O
Dr. O O
Felder O O
Florence O O
Urquhart, O O
APRN-BC O O
32954 O O

Record O O
date: O O
2096-09-09 O O
Cardiac O O
Surgery O O
Consult O O
Weeks, O O
Kenneth O O
9/09/96 O O
1205466 O O
CC: O O
3 O O
days O O
of O O
increased O O
shortness O O
of O O
breath. O O
HPI: O O
78 O O
yom O O
s/p B-CAD O
2-cabg I-CAD O
on I-CAD O
Jul I-CAD O
20, I-CAD O
2096. I-CAD O
Had O O
pleural O O
effusions, O O
tapped O O
for O O
1.5 O O
liter O O
on O O
August O O
31, O O
2096, O O
felt O O
better. O O
Was O O
put O O
on O O
Lasix, O O
excreted O O
28 O O
lbs O O
of O O
fluids. O O
3 O O
days O O
ago O O
started O O
having O O
increased O O
DOE O O
and O O
SOB. O O
No O O
CP. O O
Now O O
able O O
to O O
walk O O
only O O
10-15 O O
ft O O
w/o O O
sob. O O
Able O O
to O O
walk O O
up O O
1 O O
flt O O
of O O
stairs O O
or O O
less. O O
Needs O O
only O O
1 O O
pillow O O
to O O
sleep O O
at O O
night. O O
Has O O
committed O O
some O O
dietary O O
indiscretions O O
lately O O
(chicken O O
sausage). O O
No O O
CP, O O
night O O
sweats, O O
chills. O O
PMH: O O
Gout O O
IDDM2 B-DIABETES O
Thrombocytopenia O O
Atrial O O
Fibrillation O O
BPH O O
Chronic O O
Renal O O
Insufficiency O O
Hypercholesterolemia B-HYPERLIPIDEMIA O
Hyperhomocysteinemia O O
Hypertension B-HYPERTENSION O
Patent O O
Foramen O O
Ovale O O
(PFO) O O
Basal O O
Cell O O
Carcinoma O O
Bursitis, O O
Coronary B-CAD O
Artery I-CAD O
Disease, I-CAD O
Labyrinthitis O O
Squamous O O
Cell O O
Carcinoma O O
Umbilical O O
Hernia O O
PSH: O O
CABG O O
Bone O O
marrow O O
Biopsy O O
SCC O O
removed O O
from O O
head O O
2094 O O
Turp O O
2086 O O
FH: O O
Brother O O
s/p O O
stent O O
placement O O
at O O
age O O
78, O O
CHF O O
Another O O
brother O O
had O O
diabetes O O
and O O
peripheral O O
vascular O O
disease. O O
SH: O O
SMOH: B-SMOKER O
30 B-SMOKER O
pack I-SMOKER O
yrs; I-SMOKER O
Date I-SMOKER O
quit: I-SMOKER O
2065 I-SMOKER O
ETOH: O O
Amount: O O
about O O
10 O O
drinks O O
in O O
his O O
lifetime O O
No O O
IV O O
drug O O
use. O O
Occupation: O O
Retired O O
Insurance O O
Claims O O
Examiner O O
for O O
Prudential O O
Notes: O O
Lives O O
in O O
New O O
Iberia, O O
MN O O
with O O
his O O
wife O O
of O O
54 O O
years. O O
His O O
wife O O
is O O
in O O
the O O
early O O
stages O O
of O O
Alzheimers. O O
Meds: O O
ATENOLOL B-MEDICATION B-MEDICATION
50 O O
MG O O
QAM, O O
25 O O
MG O O
QPM O O
ASPIRIN B-MEDICATION B-MEDICATION
ENTERIC I-MEDICATION O
COATED I-MEDICATION O
(ASA O O
ENTERIC O O
COATED) O O
325 O O
MG O O
PO O O
QD O O
FINASTERIDE O O
(PROSCAR) O O
5 O O
MG O O
PO O O
QD O O
FOLIC O O
ACID O O
(FOLATE) O O
1 O O
MG O O
PO O O
QD O O
ALLOPURINOL O O
100 O O
MG O O
PO O O
QD O O
QUININE O O
SULFATE O O
(QUININE) O O
325 O O
MG O O
PO O O
QHS O O
FUROSEMIDE O O
(LASIX) O O
120 O O
MG O O
PO O O
QD O O
LORAZEPAM O B-MEDICATION
(ATIVAN) O O
1 O O
MG O O
PO O O
PRN O O
ATORVASTATIN B-MEDICATION B-MEDICATION
(LIPITOR) O O
20 O O
MG O O
PO O O
QD O O
WARFARIN O O
SODIUM O O
5 O O
MG O O
QD O O
EXCEPT O O
THU: O O
7.5 O O
MG O O
INSULIN B-MEDICATION B-MEDICATION
NPH I-MEDICATION B-MEDICATION
HUMAN I-MEDICATION O
15 O O
UNITS O O
SC O O
QAM O O
BEFORE O O
BREAKFAST O O
AMBIEN O O
25 O O
MG O O
PO O O
QHS O O
All: O O
NKDA O O
PE: O O
VS: O O
96.8 O O
153/95 B-HYPERTENSION O
89 O O
18 O O
97% O O
RA O O
Gen: O O
NAD, O O
A+OX3 O O
HEENT: O O
Multiple O O
AK's O O
on O O
head, O O
lentiginous O O
lesions O O
present. O O
Scar O O
from O O
SCC O O
present O O
at O O
right O O
vertex. O O
JVP O O
5 O O
Heart: O O
Irreg. O O
Irreg. O O
2/6 O O
systolic O O
ejection O O
murmur O O
present. O O
Chest: O O
clear O O
on O O
Right O O
with O O
fine O O
crackles O O
at O O
bases, O O
Loss O O
of O O
breath O O
sounds O O
from O O
midfield O O
down O O
on O O
Left. O O
ABD: O O
Protuberant, O O
non-distended, O O
non-tender. O O
+ O O
shifting O O
dullness. O O
No O O
fluid O O
wave. O O
Extr: O O
Trace O O
pitting O O
edema O O
on O O
right O O
leg. O O
2+ O O
pulses O O
Labs: O O
WBC O O
4.6 O O
(4.5-11.0) O O
th/cmm O O
HCT O O
33.5 O O
L O O
(41.0-53.0) O O
% O O
HGB O O
11.6 O O
L O O
(13.5-17.5) O O
gm/dl O O
RBC O O
3.81 O O
L O O
(4.50-5.90) O O
mil/cmm O O
PLT O O
142 O O
L O O
(150-350) O O
th/cumm O O
MCV O O
88 O O
(80-100) O O
fl O O
MCH O O
30.4 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
34.6 O O
(31.0-37.0) O O
g/dl O O
RDW O O
14.0 O O
(11.5-14.5) O O
% O O
DIFFERENTIAL O O
REQUEST O O
RECEIVED O O
Diff O O
Method O O
Auto O O
Poly O O
65 O O
(40-70) O O
% O O
Lymphs O O
21 O O
L O O
(22-44) O O
% O O
Monos O O
9 O O
(4-11) O O
% O O
EOS O O
4 O O
(0-8) O O
% O O
Basos O O
1 O O
(0-3) O O
% O O
Absolute O O
Neuts O O
3.01 O O
(1.8-7.7) O O
th/cmm O O
Absolute O O
Lymphs O O
0.95 O O
L O O
(1.0-4.8) O O
th/cmm O O
Absolute O O
Monos O O
0.39 O O
(0.2-0.4) O O
th/cmm O O
Absolute O O
EOS O O
0.20 O O
(0.1-0.3) O O
th/cmm O O
Absolute O O
Basos O O
0.04 O O
(0.0-0.3) O O
th/cmm O O
Aniso O O
None O O
(NORMAL) O O
Hypo O O
None O O
(NORMAL) O O
Macrocytes O O
None O O
Microcytes O O
None O O
Sodium O O
(Stat O O
Lab) O O
140 O O
(135-145) O O
mmol/L O O
Potassium O O
(Stat O O
Lab) O O
4.7 O O
(3.4-4.8) O O
mmol/L O O
Chloride O O
(Stat O O
Lab) O O
110 O O
H O O
(100-108) O O
mmol/L O O
CO2 O O
(Stat O O
Lab) O O
27.3 O O
(23.0-31.9) O O
mmol/L O O
BUN O O
(Stat O O
Lab) O O
55 O O
H O O
(8-25) O O
mg/dl O O
Creatinine O O
(Stat O O
Lab) O O
2.4 O O
H O O
(0.6-1.5) O O
mg/dl O O
Glucose O O
(Stat O O
Lab) O O
116 O O
H O O
(70-110) O O
mg/dl O O
Imaging: O O
CXR O O
9/09/96 O O
Moderate O O
left O O
CP O O
angle O O
blunting O O
increasing O O
since O O
previous O O
study O O
9/11/96. O O
No O O
other O O
change. O O
EKG: O O
Low O O
amplitude O O
EKG. O O
PR O O
interval O O
200ms, O O
borderline O O
1st O O
degree O O
AV O O
Block O O
Impression/Plan: O O
78 O O
yo O O
male O O
with O O
increased O O
SOB O O
and O O
DOE, O O
with O O
increased O O
left O O
pleural O O
effusion. O O
1. O O
Coags O O
2. O O
BS O O
fingersticks O O
qid O O
3. O O
RISS O O
4. O O
OK O O
to O O
diurese O O
5. O O
Consider O O
IR O O
drainage O O
6. O O
Cardiac O O
Surgery O O
Team O O
will O O
follow O O
Pt O O
seen O O
with O O
Dr O O
Stone. O O
Dr O O
Mickey O O
Kyle, O O
DMD, O O
MD O O

Record O O
date: O O
2097-01-04 O O
CARDIOLOGY O O
VICTOR O O
MEDICAL O O
CLINIC O O
Thomas O O
N O O
Ramos O O
M.D. O O
Victor O O
Medical O O
Clinic O O
55 O O
Harbor O O
Avenue, O O
BUL-773 O O
Pullman, O O
MN O O
74618 O O
Dear O O
Thomas: O O
Thank O O
you O O
very O O
much O O
for O O
referring O O
Mr. O O
Weeks O O
for O O
evaluation O O
of O O
coronary B-CAD O
disease, I-CAD O
mitral O O
insufficiency, O O
atrial O O
fibrillation, O O
and O O
congestive O O
heart O O
failure. O O
As O O
you O O
know, O O
he O O
is O O
a O O
78-year-old O O
gentleman O O
who O O
underwent O O
coronary B-CAD O
artery I-CAD O
bypass I-CAD O
grafting I-CAD O
on I-CAD O
07/20/2096 I-CAD O
and O O
had O O
two-vessel O O
CABG O O
at O O
that O O
time O O
with O O
a O O
LIMA O O
to O O
mid O O
LAD O O
and O O
a O O
saphenous O O
vein O O
graft O O
to O O
the O O
right O O
coronary O O
artery. O O
Left O O
atrial O O
appendage O O
was O O
amputated O O
and O O
he O O
had O O
a O O
closure O O
of O O
a O O
PFO O O
as O O
well O O
as O O
a O O
CryoMAZE O O
procedure. O O
The O O
patient O O
had O O
symptoms O O
of O O
dyspnea O O
on O O
exertion O O
prior O O
to O O
coronary O O
artery O O
bypass O O
grafting. O O
After O O
the O O
coronary O O
artery O O
bypass O B-CAD
grafting, O O
he O O
had O O
done O O
well O O
but O O
now O O
is O O
noting O O
that O O
the O O
shortness O O
of O O
breath O O
and O O
dyspnea O O
on O O
exertion O O
has O O
recurred. O O
It O O
has O O
been O O
progressive O O
over O O
the O O
last O O
several O O
months. O O
He O O
had O O
been O O
seen O O
by O O
GI O O
and O O
also O O
by O O
Pulmonary O O
and O O
has O O
been O O
treated O O
for O O
gastroesophageal O O
reflux. O O
He O O
was O O
found O O
to O O
have O O
a O O
pleural O O
effusion O O
which O O
has O O
been O O
drained O O
and O O
he O O
has O O
had O O
sclerosing O O
of O O
that. O O
He O O
has O O
also O O
had O O
an O O
admission O O
for O O
renal O O
failure O O
this O O
spring. O O
Past O O
medical O O
history: O O
Notable O O
for O O
insulin-dependent B-DIABETES O
diabetes. I-DIABETES O
Hypertension. B-HYPERTENSION B-HYPERTENSION
Hypercholesterolemia. B-HYPERLIPIDEMIA B-HYPERTENSION
Hyperhomocysteinemia. O O
Paroxysmal O O
atrial O O
fibrillation. O O
Benign O O
prostatic O O
hypertrophy. O O
Gout. O O
Renal O O
insufficiency. O O
Mild O O
thrombocytopenia. O O
Current O O
Medications: O O
atenolol B-MEDICATION B-MEDICATION
25 O O
mg O O
BID O O
Coumadin; O O
Dir: O O
as O O
directed O O
Ecotrin B-MEDICATION B-MEDICATION
325 O O
mg O O
qd O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
mg O O
qd O O
Lasix O O
120 O O
mg O O
qd O O
folate O O
1 O O
mg O O
qd O O
allopurinol O O
100 O O
mg O O
qd O O
Ativan O O
Proscar O O
free O O
text O O
medications; O O
Dir: O O
Insulin B-MEDICATION O
Protonix O O
Allergies: O O
No O O
known O O
drug O O
allergy O O
or O O
IV O O
contrast O O
dye. O O
Family O O
history: O O
Positive O O
for O O
brother O O
who O O
is O O
status O O
post O O
stent O O
placement O O
at O O
the O O
age O O
of O O
78 O O
and O O
another O O
brother O O
with O O
congestive O O
heart O O
failure. O O
There O O
is O O
also O O
peripheral O O
vascular O O
disease O O
and O O
diabetes O O
in O O
his O O
family. O O
Social O O
history: O O
The O O
patient O O
has O O
a B-SMOKER O
25-pack-year I-SMOKER O
history I-SMOKER O
of I-SMOKER O
smoking, I-SMOKER O
quit I-SMOKER O
in I-SMOKER O
2065. I-SMOKER O
He O O
does O O
not O O
drink O O
alcohol. O O
He O O
lives O O
independently O O
with O O
his O O
wife O O
and O O
comes O O
to O O
the O O
interview O O
with O O
his O O
daughter O O
who O O
works O O
at O O
Casco O O
Bay O O
Shipping. O O
Review O O
of O O
systems: O O
Negative O O
for O O
fevers, O O
chills, O O
weight O O
loss O O
or O O
gain. O O
He O O
has O O
not O O
had O O
any O O
visual O O
loss O O
or O O
hearing O O
loss. O O
He O O
denies O O
hematochezia. O O
He O O
has O O
not O O
had O O
difficulty O O
swallowing, O O
change O O
in O O
bowel O O
habits, O O
constipation, O O
diarrhea, O O
or O O
hematemesis. O O
He O O
denies O O
chest O O
pain, O O
PND, O O
orthopnea, O O
or O O
pedal O O
edema. O O
He O O
denies O O
dysuria O O
or O O
hematuria. O O
He O O
has O O
not O O
had O O
any O O
rashes O O
or O O
poor O O
healing O O
wound O O
lesions. O O
Physical O O
examination: O O
-Pulse: O O
55 O O
and O O
regular O O
-BP: B-HYPERTENSION O
160/80 I-HYPERTENSION O
in I-HYPERTENSION O
the O O
right O O
and O O
left O O
arm O O
in O O
seated O O
position O O
-resp. O O
rate: O O
12 O O
and O O
unlabored O O
-Heent: O O
No O O
xanthelasma, O O
scleral O O
icterus, O O
proptosis, O O
or O O
lid O O
lag. O O
Mucous O O
membranes O O
are O O
moist. O O
Trachea O O
is O O
midline O O
-Neck: O O
Thyroid O O
is O O
not O O
palpable. O O
Carotids O O
are O O
2+ O O
without O O
bruits. O O
Have O O
a O O
normal O O
upstroke. O O
JVP O O
is O O
less O O
than O O
7 O O
cm O O
of O O
water O O
-Chest: O O
Clear O O
without O O
rales, O O
rhonchi, O O
or O O
wheezes. O O
He O O
does O O
have O O
low O O
dullness O O
in O O
both O O
bases O O
-Cardiac: O O
Remarkable O O
for O O
well-healed O O
midline O O
incision O O
of O O
the O O
sternum. O O
He O O
has O O
a O O
normal O O
S1 O O
and O O
S2 O O
and O O
a O O
grade O O
1/6 O O
holosystolic O O
murmur O O
radiating O O
to O O
the O O
apex O O
and O O
a O O
grade O O
1/6 O O
high-pitched O O
holosystolic O O
murmur O O
at O O
the O O
left O O
sternal O O
border O O
which O O
is O O
different O O
from O O
the O O
other O O
murmur O O
-Abdomen: O O
Normal O O
bowel O O
sounds. O O
No O O
organomegaly. O O
No O O
pulsatile O O
masses O O
-Extremities: O O
Peripheral O O
pulses O O
are O O
2+ O O
and O O
symmetric. O O
He O O
has O O
no O O
pedal O O
edema. O O
He O O
has O O
no O O
clubbing O O
or O O
cyanosis O O
Procedures: O O
Tc O O
MIBI O O
STATUS O O
POST O O
The O O
patient O O
underwent O O
adenosine O O
MIBI O O
testing O O
on. O O
His O O
heart O O
rate O O
from O O
67 O O
to O O
90 O O
which O O
was O O
only O O
62% O O
of O O
the O O
maximal O O
predicted O O
heart O O
rate. O O
Peak O O
blood O O
pressure O O
was O O
158/80. O O
He O O
had O O
no O O
chest O O
pain. O O
Nuclear O O
imaging O O
showed O O
distal O O
anterior O O
wall O O
and O O
apical O O
septal O O
defect O O
consistent O O
with O O
mild-to-moderate O O
ischemia O O
in O O
that O O
distribution. O O
The O O
patient O O
has O O
also O O
had O O
an O O
event O O
monitor O O
but O O
we O O
do O O
not O O
have O O
the O O
results O O
of O O
that O O
in O O
hand. O O
EKG: O O
today O O
shows O O
atrial O O
fibrillation O O
with O O
a O O
fairly O O
regular O O
rate O O
at O O
about O O
55, O O
leftward O O
axis, O O
and O O
IVCD O O
with O O
nonspecific O O
ST-T O O
wave O O
abnormalities. O O
Selected O O
recent O O
labs: O O
Laboratory O O
results O O
recently O O
have O O
shown O O
plasma O O
creatinine O O
of O O
2.4, O O
BUN O O
of O O
42, O O
hematocrit O O
of O O
30.4, O O
white O O
count O O
of O O
5.4, O O
and O O
platelet O O
count O O
of O O
92,000 O O
all O O
done O O
on O O
12/22/2096 O O
and O O
12/26/2096. O O
Assessment O O
and O O
plan: O O
In O O
summary, O O
this O O
is O O
a O O
78-year-old O O
gentleman O O
who O O
has O O
a O O
history O O
of O O
coronary O O
artery O O
bypass O O
grafting, O O
closure O O
of O O
PFO, O O
and O O
ligation O O
of O O
the O O
left O O
atrial O O
appendage O O
and O O
Maze O O
procedure O O
which O O
was O O
done O O
in O O
July O O
2096. O O
His O O
anginal O O
equivalent O O
prior O O
to O O
that O O
was O O
dyspnea O O
on O O
exertion O O
and O O
he O O
did O O
well O O
for O O
a O O
period O O
of O O
time O O
but O O
now O O
has O O
dyspnea O O
on O O
exertion O O
again. O O
There O O
are O O
a O O
number O O
of O O
factors O O
involved O O
here. O O
He O O
has O O
atrial O O
fibrillation O O
which O O
is O O
now O O
recurrent O O
but O O
the O O
rate O O
seems O O
to O O
be O O
reasonably O O
well O O
controlled. O O
I O O
doubt O O
that, O O
that O O
is O O
playing O O
a O O
role O O
in O O
his O O
shortness O O
of O O
breath. O O
He O O
also O O
has O O
a O O
history O O
of O O
plural O O
effusions O O
which O O
could O O
have O O
been O O
contributing O O
to O O
shortness O O
of O O
breath O O
as O O
well O O
and O O
that O O
has O O
been O O
dealt O O
with O O
corrosion O O
of O O
the O O
pleura. O O
He O O
has O O
mitral O O
regurgitation O O
which O O
in O O
the O O
past O O
was O O
said O O
to O O
be O O
moderate O O
and O O
he O O
has O O
had O O
the O O
closure O O
of O O
PFO. O O
He O O
has O O
insulin-dependent O O
diabetes O O
and O O
hypertension. O O
He O O
also O O
has O O
low O O
platelets. O O
The O O
recurrence O O
of O O
the O O
exertional O O
dyspnea O O
is O O
certainly O O
worrisome O O
for O O
recurrence O O
of O O
coronary O O
disease O O
particularly O O
with O O
the O O
exercise O O
test O O
showing O O
anterior O O
wall O O
ischemia. O O
It O O
may O O
be O O
that O O
there O O
are O O
other O O
issues O O
contributing O O
to O O
this, O O
the O O
atrial O O
fibrillation O O
and O O
mitral O O
regurgitation. O O
He O O
has O O
murmur O O
consistent O O
with O O
mitral O O
regurgitation, O O
but O O
he O O
has O O
no O O
evidence O O
of O O
decompensated O O
congestive O O
failure O O
at O O
this O O
time. O O
Blood O O
pressure O O
is O O
elevated O O
somewhat O O
and O O
I O O
think O O
that O O
increase O O
in O O
his O O
Avapro O O
might O O
be O O
worthwhile. O O
He O O
also O O
has O O
chronic O O
renal O O
insufficiency O O
which O O
makes O O
things O O
more O O
complicated O O
as O O
well. O O
My O O
feeling O O
is O O
that O O
we O O
are O O
dealing O O
with O O
recurrence O O
of O O
coronary O O
disease O O
and O O
I O O
spoke O O
with O O
the O O
patient O O
about O O
this. O O
He O O
is O O
clearly O O
limited O O
in O O
his O O
exercise O O
capacity O O
and O O
wants O O
to O O
have O O
something O O
done. O O
I O O
would O O
like O O
to O O
get O O
an O O
echocardiogram O O
to O O
be O O
sure O O
we O O
are O O
dealing O O
with O O
constrictive O O
disease, O O
but O O
I O O
think O O
he O O
will O O
probably O O
need O O
to O O
have O O
a O O
cardiac O O
catheterization. O O
I O O
would O O
like O O
to O O
get O O
the O O
echocardiogram, O O
bring O O
him O O
in O O
for O O
cardiac O O
catheterization, O O
and O O
see O O
if O O
there O O
are O O
narrowings O O
either O O
in O O
the O O
graft O O
or O O
in O O
his O O
native O O
arteries O O
that O O
may O O
be O O
contributing O O
to O O
the O O
anterior O O
wall O O
ischemia. O O
Starting O O
him O O
on O O
an O O
antiarrhythmic O O
to O O
see O O
if O O
we O O
can O O
reestablish O O
sinus O O
rhythm O O
may O O
be O O
worth O O
considering O O
or O O
perhaps O O
cardioversion O O
after O O
the O O
cardiac O O
catheterization. O O
Because O O
of O O
renal O O
insufficiency, O O
cardiac O O
catheterization O O
is O O
a O O
little O O
bit O O
more O O
complicated O O
and O O
that O O
the O O
low O O
platelets O O
are O O
also O O
an O O
issue O O
we O O
need O O
to O O
address. O O
Changes O O
to O O
Medications O O
this O O
visit O O
atenolol O B-MEDICATION
25 O O
mg O O
BID O O
Coumadin O O
as O O
directed O O
Ecotrin O B-MEDICATION
325 O O
mg O O
qd O O
Lipitor O B-MEDICATION
20 O O
mg O O
qd O O
Lasix O O
120 O O
mg O O
qd O O
folate O O
1 O O
mg O O
qd O O
allopurinol O O
100 O O
mg O O
qd O O
Ativan O O
Proscar O O
free O O
text O O
medications O O
Insulin O O
Protonix O O
Thank O O
you O O
very O O
much O O
for O O
referring O O
this O O
very O O
pleasant O O
gentleman O O
to O O
Wayne O O
Dental O O
Clinic O O
for O O
evaluation O O
and O O
management O O
of O O
coronary O O
disease, O O
mitral O O
regurgitation, O O
PFO, O O
atrial O O
fibrillation, O O
and O O
congestive O O
failure. O O
Best O O
personal O O
regards. O O
Sincerely O O
yours, O O
Henry O O
Mays O O
MD, O O
PhD O O
Signed O O
electronically O O
by O O
Henry O O
Mays O O
MD, O O
PhD O O
on O O
Jan O O
6, O O
2097 O O

Record O O
date: O O
2071-08-21 O O
August O O
21, O O
2071 O O
Aiden O O
Geiger, O O
M.D. O O
Friendship O O
Villa O O
Care O O
Center O O
58 O O
Hyannis O O
Street O O
Sioux O O
City, O O
FL O O
76546 O O
RE: O O
Vivian O O
Lea O O
Jorgenson O O
MR#471-90-84-7 O O
Dear O O
Dr. O O
Geiger: O O
Thank O O
you O O
for O O
referring O O
your O O
patient, O O
Victoria O O
Carina O O
Jorgenson O O
to O O
me O O
for O O
a O O
preoperative O O
evaluation O O
for O O
thyroidectomy O O
on O O
September O O
17, O O
2071. O O
As O O
you O O
know, O O
she O O
is O O
a O O
64 O O
year O O
old O O
woman O O
with O O
hypertension, B-HYPERTENSION O
hyperlipidemia B-HYPERLIPIDEMIA O
and O O
a B-FAMILY_HIST O
positive I-FAMILY_HIST O
family I-FAMILY_HIST O
history I-FAMILY_HIST O
of I-FAMILY_HIST O
coronary I-FAMILY_HIST O
disease. I-FAMILY_HIST O
She O O
noticed O O
a O O
nodule O O
in O O
her O O
neck O O
in O O
April O O
or O O
May O O
of O O
this O O
year O O
and O O
brought O O
it O O
to O O
the O O
attention O O
of O O
her O O
doctors O O
and O O
given O O
that O O
it O O
has O O
increased O O
in O O
size, O O
it O O
is O O
felt O O
to O O
be O O
a O O
potential O O
malignancy O O
and O O
she O O
is O O
currently O O
scheduled O O
to O O
undergo O O
thyroidectomy O O
in O O
September O O
of O O
this O O
year. O O
In O O
terms O O
of O O
her O O
cardiac O O
history, O O
she O O
was O O
well O O
until O O
four O O
years O O
ago O O
when O O
she O O
developed O O
acute O O
shortness O O
of O O
breath O O
and O O
was O O
admitted O O
to O O
Lake O O
Park O O
Hospital O O
for O O
congestive O O
heart O O
failure. O O
At O O
that O O
time, O O
she O O
had O O
an O O
exercise O O
Thallium O O
scan O O
which O O
revealed O O
a O O
low O O
work O O
load O O
at O O
only O O
3 O O
minutes O O
stopping O O
secondary O O
to O O
shortness O O
of O O
breath O O
with O O
a O O
large O O
fixed O O
anterolateral O O
defect O O
and O O
a O O
dilated O O
left O O
ventricle. O O
In O O
addition, O O
she O O
had O O
an O O
echo O O
in O O
June O O
of O O
2071, O O
which O O
shows O O
an O O
ejection O O
fraction O O
of O O
25% O O
with O O
1+ O O
mitral O O
regurgitation, O O
left O O
atrial O O
enlargement O O
and O O
diastolic O O
dysfunction. O O
She O O
has O O
never O O
been O O
hospitalized O O
since O O
that O O
time O O
for O O
her O O
congestive O O
heart O O
failure O O
and O O
has O O
been O O
treated O O
medically O O
with O O
good O O
result. O O
She O O
currently O O
denies O O
any O O
orthopnea, O O
PND, O O
angina O B-MEDICATION
or O O
claudication. O O
She O O
does O O
have O O
chronic O O
mild O O
lower O O
extremity O O
edema. O O
In O O
fact, O O
she O O
has O O
never O O
had O O
chest O O
pain O O
or O O
chest O O
pressure O O
to O O
her O O
recollection. O O
She O O
is O O
able O O
to O O
walk O O
up O O
the O O
10 O O
stairs O O
to O O
her O O
house O O
and O O
can O O
unload O O
groceries O O
from O O
her O O
car, O O
up O O
those O O
stairs. O O
She O O
is O O
able O O
to O O
shop, O O
walk O O
through O O
the O O
grocery O O
store O O
without O O
difficulty O O
from O O
chest O O
Jorgenson, O O
Vivian O O
Lea O O
MR O O
#471-90-84-7 O O
-2- O O
August O O
21, O O
2071 O O
pains O O
or O O
shortness O O
of O O
breath, O O
although O O
she O O
occasionally O O
stops O O
secondary O O
to O O
fatigue. O O
Her O O
past O O
medical O O
history O O
includes O O
hypertension, O O
hyperlipidemia, O O
CHF, O O
chronic O O
anxiety O O
and O O
this O O
thyroid O O
nodule. O O
She O O
has O O
never O O
had O O
surgery. O O
Her O O
family O O
history O O
is O O
significant O O
for O O
a O O
mother O O
who O O
died O O
of O O
myocardial O O
infarction O O
at O O
the O O
age O O
of O O
55. O O
Her O O
social O O
history, O O
she B-SMOKER O
smoked I-SMOKER O
1-2 I-SMOKER O
packs I-SMOKER O
of I-SMOKER O
cigarettes I-SMOKER O
a I-SMOKER O
day I-SMOKER O
for I-SMOKER O
40 I-SMOKER O
years I-SMOKER O
and I-SMOKER O
quit I-SMOKER O
four I-SMOKER O
years I-SMOKER O
ago. I-SMOKER O
She O O
denies O O
alcohol, O O
intravenous O O
drugs O O
or O O
cocaine O O
use. O O
She O O
lives O O
with O O
her O O
husband O O
and O O
briefly O O
worked O O
in O O
Amy's O O
Baking O O
Company O O
but O O
for O O
the O O
past O O
20 O O
years O O
is O O
an O O
electrical O O
engineer. O O
She O O
has O O
no O O
known O O
drug O O
allergies. O O
Her O O
current O O
medications O O
include O O
Labetalol B-MEDICATION B-MEDICATION
100mg O O
po O O
BID, O O
Captopril B-MEDICATION B-MEDICATION
50 O O
po O O
TID, O O
Digoxin O O
0.25mg O O
po O O
QD, O O
Coumadin O O
5 O O
po O O
QD, O O
Lipitor B-MEDICATION B-MEDICATION
10 O O
po O O
QD, O O
Lasix O O
40 O O
po O O
QD, O O
Coreg B-MEDICATION O
12.5 O O
po O O
BID, O O
Nitroglycerin B-MEDICATION B-MEDICATION
patch O O
daily O O
and O O
Gemfibrozil B-MEDICATION O
600mg O O
BID. O O
On O O
physical O O
exam O O
in O O
my O O
office, O O
her O O
blood O O
pressure O O
was O O
170/85 B-HYPERTENSION O
in I-HYPERTENSION O
her I-HYPERTENSION O
left I-HYPERTENSION O
arm I-HYPERTENSION O
and I-HYPERTENSION O
165/70 I-HYPERTENSION O
in I-HYPERTENSION O
her I-HYPERTENSION O
right. I-HYPERTENSION O
Her O O
heart O O
rate O O
was O O
104 O O
when O O
I O O
saw O O
her, O O
although O O
it O O
was O O
80 O O
on O O
her O O
EKG O O
today. O O
Her O O
JVP O O
was O O
7 O O
centimeters. O O
Her O O
carotids O O
were O O
brisk O O
upstrokes O O
without O O
carotid O O
bruits. O O
Her O O
chest O O
is O O
clear O O
to O O
auscultation O O
without O O
crackles. O O
Her O O
heart O O
has O O
a O O
non O O
displaced O O
PMI O O
with O O
a O O
regular O O
rate O O
and O O
rhythm O O
with O O
occasional O O
ectopic O O
beats. O O
She O O
has O O
a O O
normal O O
S1 O O
and O O
S2 O O
with O O
a O O
2/6 O O
systolic O O
ejection O O
murmur O O
at O O
the O O
left O O
upper O O
sternal O O
border O O
without O O
radiation. O O
Her O O
abdomen O O
is O O
soft O O
with O O
positive O O
bowel O O
sounds. O O
Her O O
extremities O O
have O O
2+ O O
distal O O
pulses O O
and O O
trace O O
peripheral O O
edema. O O
Her O O
EKG O O
today O O
is O O
normal O O
sinus O O
rhythm O O
at O O
a O O
rate O O
of O O
80. O O
She O O
has O O
a O O
diffuse O O
ST O O
and O O
T O O
wave O O
abnormality O O
consistent O O
with O O
Digoxin O O
effects. O O
She O O
has O O
poor O O
R O O
wave O O
progression O O
consistent O O
with O O
an B-CAD O
old I-CAD O
anterior I-CAD O
septal I-CAD O
MI I-CAD O
but O O
no O O
acute O O
ischemic O O
changes. O O
In O O
summary, O O
Ms. O O
Jorgenson O O
is O O
a O O
64 O O
year O O
old O O
woman O O
with O O
hypertension, O B-HYPERTENSION
hyperlipidemia O O
and O O
a O O
positive O O
family O O
history O O
of O O
coronary O O
disease O O
with O O
congestive O O
heart O O
failure O O
with O O
an O O
ejection O O
fraction O O
of O O
25%, O O
likely O O
secondary O O
to O O
coronary O O
disease O O
from O O
an O O
anterior O O
myocardial O O
infarction, O O
although O O
she O O
has O O
never O O
undergone O O
heart O O
catheterization. O O
She O O
is O O
currently O O
undergoing O O
evaluation O O
for O O
a O O
thyroidectomy O O
for O O
a O O
thyroid O O
nodule. O O
Jorgenson, O O
Vivian O O
Lea O O
MR O O
#471-90-84-7 O O
-3- O O
August O O
21, O O
2071 O O
Issue O O
number O O
one, O O
preoperative O O
cardiovascular O O
risk O O
assessment: O O
given O O
that O O
she O O
has O O
not O O
had O O
an O O
assessment O O
of O O
her O O
ischemic O O
burden O O
since O O
2067, O O
I O O
have O O
scheduled O O
her O O
for O O
a O O
repeat O O
exercise O O
test O O
with O O
imaging. O O
If O O
this O O
is O O
similar O O
to O O
her O O
previous O O
study O O
showing O O
only O O
fixed O O
defects O O
and O O
no O O
reversible O O
ischemia, O O
then O O
I O O
feel O O
that O O
she O O
will O O
be O O
of O O
low O O
to O O
moderate O O
risk O O
for O O
surgery O O
for O O
perioperative O O
myocardial O O
infarction O O
and O O
that O O
her O O
congestive O O
heart O O
failure O O
is O O
well O O
treated O O
and O O
therefore, O O
will O O
not O O
preclude O O
her O O
from O O
having O O
surgery. O O
Issue O O
number O O
two, O O
is O O
her O O
anticoagulation O O
for O O
low O O
ejection O O
fraction. O O
She O O
is O O
currently O O
on O O
Coumadin O O
for O O
low O O
ejection O O
fraction. O O
As O O
far O O
as O O
I O O
know, O O
she O O
has O O
never O O
had O O
atrial O O
fibrillation O O
and O O
she O O
has O O
never O O
been O O
told O O
that O O
she O O
had O O
an O O
irregular O O
rate O O
or O O
rhythm. O O
Therefore, O O
I O O
recommend O O
that O O
she O O
stop O O
her O O
Coumadin O O
6 O O
days O O
prior O O
to O O
surgery O O
and O O
it O O
can O O
be O O
restarted O O
several O O
days O O
after O O
surgery O O
without O O
Heparin O O
overlap O O
at O O
the O O
discretion O O
of O O
the O O
surgeons O O
as O O
to O O
how O O
may O O
days O O
she O O
should O O
wait O O
after O O
surgery O O
before O O
restarting O O
that O O
medication. O O
She O O
will O O
otherwise O O
remain O O
on O O
her O O
current O O
medical O O
regimen O O
as O O
determined O O
by O O
her O O
cardiologist O O
and O O
primary O O
care O O
physician, O O
Dr. O O
Charles O O
Van. O O
If O O
her O O
stress O O
test O O
is O O
without O O
reversible O O
defects, O O
she O O
need O O
not O O
follow O O
up O O
with O O
me O O
for O O
further O O
evaluation. O O
Thank O O
you O O
for O O
referring O O
this O O
interesting O O
patient. O O
She O O
was O O
seen O O
and O O
examined O O
with O O
Dr. O O
Voss. O O
Sincerely, O O
Pamela O O
Imperial, O O
M.D. O O
PI/waldron O O
cc: O O
Charles O O
Van, O O
M.D. O O
Jordan, O O
FL O O
83712 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2071-11-24 O O
Thyroid O O
Division O O
Jeanes O O
Memorial O O
Hospital O O
89 O O
Buck O O
St O O
Sioux O O
City, O O
FL O O
76546 O O
VivianLee O O
Jorgenson O O
MR# O O
471-90-84-7 O O
November O O
24, O O
2071 O O
This O O
is O O
the O O
first O O
visit O O
for O O
Ms. O O
Jorgenson O O
who O O
is O O
a O O
64 O O
year O O
old O O
woman O O
who O O
presents O O
for O O
management O O
of O O
papillary O O
thyroid O O
cancer. O O
Her O O
symptoms O O
began O O
in O O
May, O O
2071, O O
when O O
she O O
felt O O
a O O
prominence O O
in O O
her O O
neck. O O
She O O
did O O
not O O
experience O O
any O O
dysphagia O O
or O O
voice O O
changes, O O
but O O
presumably O O
was O O
felt O O
to O O
have O O
an O O
abnormality O O
on O O
thyroid O O
examination. O O
She O O
underwent O O
a O O
thyroid O O
biopsy O O
in O O
June, O O
2071, O O
at O O
a O O
local O O
hospital. O O
The O O
pathology O O
which O O
was O O
read O O
at O O
JMH O O
revealed O O
numerous O O
follicular O O
cells O O
with O O
chromatin O O
grooves O O
suspicious O O
for O O
papillary O O
carcinoma. O O
She O O
was O O
subsequently O O
referred O O
to O O
Dr. O O
Geiger O O
at O O
JMH O O
for O O
thyroidectomy O O
and O O
underwent O O
thyroidectomy O O
on O O
9/17/71. O O
The O O
thyroidectomy O O
was O O
uncomplicated O O
though O O
there O O
was O O
inadvertent O O
displacement O O
of O O
a O O
parathyroid O O
gland O O
and O O
this O O
gland O O
was O O
then O O
reimplanted. O O
According O O
to O O
the O O
operative O O
report, O O
the O O
carcinoma O O
was O O
felt O O
to O O
be O O
locally O O
extensive O O
though O O
no O O
laryngo-tracheal O O
nerve O O
invasion O O
was O O
present. O O
The O O
pathology O O
revealed O O
a O O
(R) O O
6 O O
cm O O
papillary O O
carcinoma O O
with O O
capsular O O
and O O
lymphovascular O O
invasion. O O
There O O
was O O
an O O
additional O O
focus O O
of O O
papillary O O
carcinoma, O O
follicular O O
variant, O O
in O O
the O O
(L) O O
thyroid O O
lobe O O
that O O
was O O
0.3 O O
cm. O O
Of O O
note, O O
the O O
tissue O O
was O O
stained O O
for O O
calcitonin O O
and O O
this O O
was O O
negative. O O
The O O
tumor O O
did O O
stain O O
positively O O
for O O
thyroglobulin. O O
Since O O
undergoing O O
thyroidectomy, O O
Ms. O O
Jorgenson O O
has O O
done O O
fairly O O
well. O O
She O O
has O O
been O O
maintained O O
on O O
75 O O
mcg O O
daily O O
of O O
Levoxyl. O O
She O O
says O O
that O O
she O O
feels O O
generally O O
well O O
on O O
this O O
dose O O
though O O
she O O
does O O
endorse O O
slight O O
fatigue. O O
She O O
denies O O
any O O
changes O O
in O O
her O O
sleep, O O
hair, O O
skin O O
or O O
bowels. O O
She O O
does O O
endorse O O
a O O
one O O
pound O O
weight O O
gain O O
over O O
the O O
last O O
two O O
months. O O
She O O
denies O O
any O O
paresthesias O O
or O O
other O O
symptoms O O
consistent O O
with O O
hypocalcemia. O O
She O O
denies O O
any O O
history O O
of O O
thyroid O O
disturbances O O
prior O O
to O O
her O O
diagnosis O O
of O O
cancer. O O
She O O
is O O
now O O
referred O O
for O O
consideration O O
of O O
radioiodine O O
ablation. O O
Past O O
Medical O O
History:Notable O O
for O O
congestive O O
heart O O
failure. O O
She O O
has O O
an O O
ejection O O
fraction O O
of O O
25%. O O
She O O
also O O
has O O
a O O
history O O
of O O
hypercholesterolemia, B-HYPERLIPIDEMIA O
hypertension, B-HYPERTENSION O
and O O
anxiety. O O
No O O
history O O
of O O
childhood O O
irradiation. O O
Current O O
Medications:Digoxin O O
0.25 O O
daily; O O
Coreg B-MEDICATION O
12.5 O O
mg O O
daily; O O
Levoxyl O O
75 O O
mcg O O
daily; O O
Lipitor B-MEDICATION B-MEDICATION
10 O O
mg O O
daily; O O
Coumadin O O
5 O O
mg O O
daily; O O
Lasix O O
40 O O
mg O O
daily; O O
captopril B-MEDICATION B-MEDICATION
50 O O
mg, O O
tid; O O
labetolol B-MEDICATION B-MEDICATION
100, O O
bid; O O
nitroglycerine. B-MEDICATION B-MEDICATION
Allergies:No O O
known O O
drug O O
allergies. O O
Social O O
History:Remote B-SMOKER O
history I-SMOKER O
of I-SMOKER O
tobacco. I-SMOKER O
She I-SMOKER O
quit I-SMOKER O
4 I-SMOKER O
years I-SMOKER O
ago. I-SMOKER O
She O O
endorses O O
rare O O
alcohol O O
use. O O
She O O
is O O
married O O
with O O
four O O
children. O O
Family O O
History:Negative O O
for O O
thyroid O O
cancer. O O
Physical O O
Exam:Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
elevated I-HYPERTENSION O
at I-HYPERTENSION O
188/92. I-HYPERTENSION O
Weight O O
208. O O
Pulse O O
88. O O
In O O
general O O
this O O
is O O
a O O
somewhat O O
tired, O O
slightly O O
pale-appearing O O
woman O O
in O O
NAD. O O
HEENT: O O
PERRLA. O O
EOMI. O O
No O O
proptosis O O
or O O
lid O O
lag. O O
Neck: O O
supple O O
with O O
a O O
large O O
well-healed O O
thyroidectomy O O
scar. O O
No O O
VivianLee O O
Jorgenson O O
MR# O O
471-90-84-7 O O
November O O
24, O O
2071 O O
Page O O
2 O O
remaining O O
thyroid O O
tissue O O
or O O
lymphadenopathy O O
is O O
appreciated. O O
Lungs: O O
clear O O
to O O
auscultation O O
bilaterally. O O
Cardiovascular: O O
normal O O
S1, O O
S2, O O
regular O O
rate O O
and O O
rhythm. O O
Abdomen: O O
soft, O O
slightly O O
distended, O O
non-tender, O O
moderately O O
obese. B-OBESE O
Extremities: O O
trace O O
pedal O O
edema, O O
1+ O O
distal O O
pulses. O O
Neurologic: O O
reflexes O O
are O O
slightly O O
delayed. O O
There O O
is O O
no O O
tremor O O
of O O
outstretched O O
hands. O O
Review O O
of O O
Labs:Of O O
note, O O
include O O
a O O
TSH O O
of O O
1.65 O O
from O O
August, O O
2071, O O
that O O
was O O
prior O O
to O O
surgery. O O
Free O O
T4 O O
at O O
that O O
time O O
was O O
normal O O
at O O
1.1. O O
Calcium O O
prior O O
to O O
surgery O O
was O O
slightly O O
elevated O O
at O O
10.6 O O
though O O
several O O
calciums O O
drawn O O
after O O
her O O
surgery O O
were O O
in O O
the O O
mid-8 O O
range. O O
Impression:This O O
is O O
a O O
64 O O
year O O
old O O
woman O O
with O O
a O O
history O O
of O O
congestive O O
heart O O
failure O O
who O O
is O O
now O O
s/p O O
total O O
thyroidectomy O O
for O O
papillary O O
thyroid O O
cancer. O O
Ms. O O
Jorgenson O O
is O O
potentially O O
at O O
higher O O
risk O O
for O O
recurrence O O
given O O
the O O
fact O O
that O O
she O O
is O O
older O O
at O O
the O O
time O O
of O O
diagnosis, O O
she O O
had O O
a O O
large-size O O
tumor, O O
and O O
she O O
had O O
multifocal O O
disease. O O
Plan:Check O O
a O O
TSH O O
and O O
thyroglobulin O O
today O O
for O O
a O O
baseline. O O
We O O
suspect O O
that O O
she O O
may O O
be O O
undertreated O O
on O O
her O O
current O O
dose O O
of O O
Levoxyl. O O
I O O
have O O
recommended O O
131I O O
treatment. O O
Benefits O O
and O O
risks O O
were O O
discussed. O O
In O O
addition, O O
I O O
think O O
she O O
would O O
tolerate O O
thyroid O O
hormone O O
withdrawal. O O
TSH O O
and O O
calcium O O
were O O
drawn O O
today. O O
We O O
will O O
plan O O
to O O
arrange O O
for O O
131I O O
for O O
January. O O
Hilda O O
Vincent, O O
M.D. O O
Brittany O O
Farrar, O O
M.D. O O
BF/cooley O O
cc:Aiden O O
Geiger, O O
M.D. O O
_______________________________ O O
Hilda O O
Vincent O O
DD: O O
11/24/71 O O
DT: O O
12/31/71 O O
DV: O O
11/24/71 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2074-06-20 O O
HHH O O
Cardiovascular O O
Division O O
CVD O O
Rm O O
5 O O
89 O O
Buck O O
St O O
JORGENSON, O O
VIVIANLEE O O
Sioux O O
City, O O
FL O O
76546 O O
47190847 O O
(179) O O
732-8159 O O
06/20/74 O O
Charles O O
F. O O
Van, O O
M.D. O O
66 O O
Kessler O O
Farm O O
Drive, O O
Puite O O
#9488 O O
Jordan, O O
FL O O
83712 O O
Dear O O
Dr. O O
Van: O O
I O O
had O O
the O O
pleasure O O
of O O
participating O O
in O O
the O O
care O O
of O O
VivianLee O O
Jorgenson O O
during O O
her O O
recent O O
hospitalization O O
at O O
Goulds O O
Hospital. O O
This O O
lovely O O
67-year-old O O
female O O
ended O O
up O O
having O O
no O O
discernable O O
coronary O O
artery O O
disease O O
on O O
catheterization. O O
At O O
the O O
time O O
of O O
the O O
cath, O O
her O O
pulmonary O O
capillary O O
wedge O O
pressure O O
was O O
12. O O
During O O
the O O
course O O
of O O
her O O
hospitalization, O O
we O O
noted O O
as O O
well O O
that O O
she O O
had O O
had O O
runs O O
of O O
nonsustained O O
VT O O
and O O
asked O O
our O O
EP O O
colleagues O O
to O O
comment O O
on O O
the O O
appropriateness O O
of O O
an O O
ICD. O O
They O O
felt O O
that O O
this O O
could O O
certainly O O
be O O
rediscussed O O
in O O
the O O
future, O O
but O O
at O O
the O O
present O O
time, O O
there O O
was O O
no O O
compelling O O
indication O O
for O O
her O O
to O O
receive O O
an O O
ICD. O O
Her O O
medications O O
at O O
discharge O O
include O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
mg O O
p.o. O O
q.d., O O
digoxin O O
0.25 O O
mg O O
p.o. O O
q.d., O O
captopril B-MEDICATION B-MEDICATION
50 O O
mg O O
p.o. O O
t.i.d., O O
Lasix O O
40 O O
mg O O
p.o. O O
b.i.d., O O
enteric-coated B-MEDICATION O
aspirin I-MEDICATION B-MEDICATION
81 O O
mg O O
p.o. O O
q.d., O O
Nexium O O
20 O O
mg O O
p.o. O O
q.d., O O
Synthroid O O
300 O O
mcg O O
p.o. O O
q.d., O O
Aldactone O O
25 O O
mg O O
p.o. O O
q.d., O O
Coreg B-MEDICATION O
25 O O
mg O O
p.o. O O
b.i.d., O O
and O O
Norvasc B-MEDICATION B-MEDICATION
5 O O
mg O O
p.o. O O
q.d. O O
It O O
has O O
been O O
a O O
delight O O
to O O
participate O O
in O O
the O O
care O O
of O O
this O O
lovely O O
woman. O O
If O O
there O O
is O O
any O O
questions O O
or O O
issues, O O
please O O
feel O O
free O O
to O O
call. O O
Sincerely, O O
______________________________ O O
Vickie O O
Frank-Jarvis, O O
M.D. O O
Dictated O O
By: O O
Vickie O O
Frank-Jarvis O O
eScription O O
document:9-9294537 O O
RFFocus O O
DD: O O
06/20/74 O O
DT: O O
06/20/74 O O
DV: O O
06/20/74 O O

Record O O
date: O O
2078-03-17 O O
Patient O O
Name: O O
JORGENSON,VIVIANLEE O O
[ O O
47190847(JMH) O O
] O O
Date O O
of O O
Visit: O O
03/17/2078 O O
CC: O O
Syncope, O O
Afib O O
HPI: O O
71 O O
year O O
old O O
lady O O
with O O
a O O
history O O
of O O
A O O
fib O O
was O O
seen O O
in O O
clinic O O
today O O
for O O
complaints O O
of O O
DOE O O
and O O
increased O O
wt. O O
She O O
was O O
found O O
to O O
be O O
in O O
mild O O
to O O
moderate O O
CHF O O
and O O
an O O
increase O O
in O O
her O O
torsemide O O
dose O O
was O O
recommended. O O
On O O
her O O
way O O
to O O
a O O
blood O O
draw, O O
while O O
in O O
the O O
elevator, O O
she O O
had O O
syncope O O
and O O
hit O O
her O O
head. O O
The O O
fall O O
was O O
witnessed O O
by O O
her O O
daughter. O O
There O O
was O O
no O O
prodrome, O O
no O O
nausea, O O
no O O
incontinence O O
with O O
the O O
fall. O O
The O O
pt O O
does O O
not O O
have O O
any O O
seizure O O
or O O
hypoglycemia O O
history. O O
She O O
notes O O
an O O
8 O O
lb O O
wt O O
gain O O
over O O
2-3 O O
weeks O O
and O O
denies O O
dietary O O
indiscretions. O O
She O O
takes O O
her O O
medications O O
faithfully O O
which O O
include O O
an O O
escalating O O
dose O O
of O O
torsemide O O
in O O
over O O
the O O
last O O
several O O
months. O O
She's O O
been O O
hospitalized O O
twice O O
for O O
CHF O O
- O O
once O O
in O O
2075 O O
and O O
again O O
in O O
11/77. O O
The O O
pt O O
was O O
brought O O
to O O
the O O
ED. O O
In O O
the O O
ED O O
the O O
patient O O
had O O
a O O
head O O
CT O O
was O O
done O O
which O O
did O O
not O O
reveal O O
any O O
acute O O
pathology. O O
PMH:Cardiomyopathy O O
: O O
Nonischemic, O O
6/19/74 O O
cath O O
no O O
significant O O
coronary O O
disease, O O
11/26/77 O O
EF O O
20% O O
with O O
and O O
global O O
hypokinesis O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
: O O
6/19/74 O O
cath: O O
RCA O O
30% O O
Thyroid O O
cancer O O
: O O
Papillary O O
nodule O O
Ca, O O
2071, O O
a/p O O
thyroidectomy O O
Diabetes: B-DIABETES O
Had O O
been O O
on O O
glyburide, B-MEDICATION B-MEDICATION
currently O O
diet O O
controlled, O O
11/25 O O
A1c O O
6.3 O O
Hypothyroidism: O O
11/25: O O
1.4 O O
normal O O
Elevated B-HYPERLIPIDEMIA O
cholesterol: I-HYPERLIPIDEMIA O
11/26: O O
LDL O O
of O O
36 O O
and O O
an O O
HDL O O
of O O
26 O O
Hypertension B-HYPERTENSION O
Atrial O O
fibrillation O O
on O O
Coumadin O O
Non O O
sustained O O
ventricular O O
tachycardia O O
Medications O O
Ambien O O
(ZOLPIDEM O O
TARTRATE) O O
5 O O
MG O O
(5MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
PRN O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
81 O O
MG O O
(81MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Celexa O O
(CITALOPRAM) O O
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Coreg B-MEDICATION O
(CARVEDILOL) O O
12.5 O O
MG O O
(12.5MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
Coumadin O O
(WARFARIN O O
SODIUM) O O
1 O O
MG O O
(2.5MG O O
TABLET O O
take O O
1) O O
PO O O
QPM O O
Digoxin O O
0.0612 O O
MG O O
(125MCG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Lisinopril B-MEDICATION B-MEDICATION
40 O O
MG O O
PO O O
QD O O
Potassium O O
CHLORIDE O O
SLOW O O
REL. O O
(KCL O O
SLOW O O
RELEASE) O O
20 O O
MEQ O O
(20MEQ O O
TAB O O
PRT O O
SR O O
take O O
1) O O
PO O O
BID O O
Synthroid O O
(LEVOTHYROXINE O O
SODIUM) O O
150MCG O O
TABLET O O
PO O O
variable O O
Torsemide O O
200 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Allergies O O
NKA O O
FH: O O
Mom B-FAMILY_HIST O
had I-FAMILY_HIST O
MI, I-FAMILY_HIST O
age I-FAMILY_HIST O
50 I-FAMILY_HIST O
SH: O O
Lives O O
with O O
husband O O
(Blacksmith, O O
recently O O
had O O
CABG) O O
and O O
has O O
4 O O
grown O O
children. O O
Health-Related O O
Behaviors O O
Alcohol-social O O
only O O
Tobacco-prior B-SMOKER O
use, I-SMOKER O
60 I-SMOKER O
ppy, I-SMOKER O
quit B-SMOKER O
2067Drug I-SMOKER O
use-no O O
illicit O O
drugs O O
PE: O O
T O O
98, O O
BP O O
100/65, O O
HR O O
131, O O
RR O O
18, O O
96%RA O O
GEN: O O
NAD O O
HEENT: O O
PERRL, O O
EOMI, O O
mm O O
moist O O
CV: O O
irreg O O
irreg, O O
no O O
murmurs O O
appreciated. O O
JVP O O
15 O O
cm O O
LUNG: O O
Rales O O
in O O
bases O O
bilaterally O O
ABD: O O
soft, O O
non-tender, O O
non-distended O O
EXT: O O
no O O
c/c/e O O
Neuro: O O
A&amp;Ox3, O O
moves O O
all O O
extremiteis. O O
CXR: O O
enlarged O O
heart. O O
Minimal O O
pulmonary O O
infiltrate O O
EKG: O O
A O O
fib, O O
no O O
ischemic O O
changes, O O
poor O O
RWP. O O
Unchanged O O
from O O
previous. O O
Labs O O
ResultsDate/Time O O
NA O O
K O O
CL O O
CO2 O O
03/17/2078 O O
[1] O O
139 O O
4.6 O O
103 O O
28 O O
03/17/2078 O O
139 O O
4.2 O O
102 O O
26 O O
Date/Time O O
BUN O O
CRE O O
EGFR O O
GLU O O
03/17/2078 O O
[2] O O
50 O O
(*) O O
1.73 O O
(*) O O
29 O O
[3] O O
110 O O
03/17/2078 O O
50 O O
(*) O O
1.66 O O
(*#) O O
30 O O
[4] O O
106 O O
Date/Time O O
ANION O O
03/17/2078 O O
[5] O O
8 O O
03/17/2078 O O
11 O O
Date/Time O O
CA O O
MG O O
TBILI O O
TP O O
03/17/2078 O O
[6] O O
9.7 O O
3.0 O O
(*) O O
6.9 O O
03/17/2078 O O
9.7 O O
2.2 O O
2.9 O O
(*) O O
7.0 O O
Date/Time O O
ALB O O
GLOB O O
LIPS O O
03/17/2078 O O
[7] O O
4.0 O O
2.9 O O
62 O O
(*)[8] O O
03/17/2078 O O
4.0 O O
3.0 O O
Date/Time O O
ALT/SGPT O O
AST/SGOT O O
ALKP O O
TBILI O O
03/17/2078 O O
[9] O O
8 O O
24 O O
106 O O
3.0 O O
(*) O O
03/17/2078 O O
8 O O
(#) O O
22 O O
106 O O
2.9 O O
(*) O O
Date/Time O O
CK O O
CK-MB O O
TROP-I O O
03/17/2078 O O
[10] O O
56 O O
2.1 O O
SEE O O
DETAIL[11] O O
Date/Time O O
TSH O O
03/17/2078 O O
4.091 O O
Date/Time O O
WBC O O
RBC O O
HGB O O
HCT O O
03/17/2078 O O
[12] O O
5.68 O O
(#) O O
4.67 O O
15.2 O O
45.8 O O
Date/Time O O
MCV O O
MCH O O
MCHC O O
PLT O O
03/17/2078 O O
[13] O O
98.2 O O
(*#) O O
32.6 O O
(*#) O O
33.1 O O
136 O O
(*) O O
Date/Time O O
RDW O O
03/17/2078 O O
[14] O O
14.6 O O
(*) O O
Date/Time O O
%POLY-A O O
%LYMPH-A O O
%MONO-A O O
%EOS-A O O
03/17/2078 O O
[15] O O
76.4 O O
(*) O O
15.4 O O
(*) O O
6.6 O O
1.3 O O
Date/Time O O
%BASO-A O O
03/17/2078 O O
[16] O O
0.3 O O
Date/Time O O
ANEUT-A O O
ALYMP-A O O
AMONO-A O O
AEOS-A O O
03/17/2078 O O
[17] O O
4.34 O O
.88 O O
0.37 O O
0.07 O O
Date/Time O O
ABASO-A O O
03/17/2078 O O
[18] O O
0.02 O O
Date/Time O O
HYPO O O
MACRO O O
03/17/2078 O O
[19] O O
+ O O
+ O O
Date/Time O O
PT O O
PT-INR O O
PTT O O
03/17/2078 O O
[20] O O
24.1 O O
(*) O O
2.1 O O
(*) O O
39.2 O O
(*) O O
A/P: O O
71 O O
year O O
old O O
lady O O
with O O
syncope O O
of O O
unclear O O
eitiology O O
with O O
CHF/Afib. O O
Ddx O O
includes O O
cardiac O O
arrhythmia, O O
hypovolemia, O O
vaso-vagal. O O
Neurologic O O
causes O O
less O O
likely O O
from O O
history. O O
#CV O O
- O O
i. O O
Low O O
suspicion O O
ACS- O O
Rule O O
out O O
with O O
serial O O
CE O O
- O O
Continue O O
asa, O O
statin#CV O O
- O O
p. O O
Decompensated O O
CHF- O O
Diuresis O O
with O O
IV O O
lasix. O O
Consider O O
lasix O O
drip O O
if O O
inadequate O O
response. O O
- O O
Daily O O
wt. O O
Strict O O
I/O.- O O
Cont. O O
digoxin- O O
Will O O
start O O
amiodarone O O
400 O O
bid- O O
Discuss O O
possible O O
role O O
of O O
AICD O O
with O O
patient O O
and O O
family.#CV O O
- O O
r. O O
- O O
Telemetry#AFR O O
- O O
acute O O
on O O
chronic O O
- O O
likely O O
from O O
poor O O
forward O O
flow- O O
reduce O O
lisinopril- O B-MEDICATION
urine O O
electrolytes, O O
eos. O O
#Psych O O
- O O
continue O O
celexa O O
#Endocrine O O
- O O
continue O O
home O O
thyroid O O
regimen O O
#FEN O O
- O O
low O O
sodium, O O
2L O O
fluid O O
restricted O O
diet#CODE: O O
Full O O
____________________________________ O O
Xavier O O
B. O O
Nix, O O
M.D., O O
Ph.D. O O

Record B-SMOKER O
date: O O
2078-05-29 O O
EDVISIT^47190847^JORGENSON, O O
VIVIANLEE^05/29/78^XUEREB, O O
VESTER O O
I O O
saw O O
this O O
patient O O
with O O
Dr. O O
Wendy O O
Wu, O O
resident. O O
CHIEF O O
COMPLAINT: O O
Chief O O
complaint O O
on O O
the O O
chart O O
is O O
ataxia, O O
when O O
I O O
speak O O
with O O
the O O
patient O O
chief O O
complaint O O
is O O
weakness. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
71-year-old O O
female O O
with O O
a O O
history O O
of O O
atrial O O
fibrillation O O
on O O
Coumadin. O O
She O O
presents O O
with O O
episodes O O
of O O
gait O O
instability, O O
diffuse O O
weakness, O O
multiple O O
falls. O O
She O O
was O O
brought O O
in O O
by O O
her O O
family O O
for O O
further O O
evaluation. O O
She O O
also O O
had O O
dark O O
stools O O
over O O
the O O
past O O
few O O
weeks. O O
She O O
denies O O
any O O
associated O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
lightheadedness, O O
any O O
syncope, O O
any O O
nausea O O
or O O
vomiting. O O
She O O
does O O
have O O
a O O
bruise O O
on O O
her O O
chin. O O
She O O
denies O O
any O O
focal O O
weakness, O O
numbness, O O
or O O
tingling. O O
No O O
hematuria, O O
no O O
epistaxis O O
or O O
gum O O
bleeding. O O
PAST O O
MEDICAL O O
HISTORY: O O
Congestive O O
heart O O
failure, O O
atrial O O
fibrillation, O O
hypertension, B-HYPERTENSION B-HYPERTENSION
coronary B-CAD O
artery I-CAD O
disease, I-CAD O
hypercholesterolemia, B-HYPERLIPIDEMIA B-HYPERTENSION
and O O
thyroid O O
disease. O O
SOCIAL O O
HISTORY: O O
She O O
lives O O
with O O
family. O O
REVIEW O O
OF O O
SYSTEMS: O O
As O O
noted O O
in O O
the O O
written O O
chart O O
and O O
the O O
HPI, O O
otherwise O O
negative. O O
MEDICATIONS: O O
Include O O
ranitidine, O O
baby B-MEDICATION O
aspirin, B-MEDICATION B-MEDICATION
Coumadin, O O
Lasix, O O
and O O
digoxin. O O
ALLERGIES: O O
None. O O
PHYSICAL O O
EXAMINATION: O O
Temperature O O
96.5, O O
pulse O O
60, O O
respiratory O O
rate O O
20, O O
blood O O
pressure O O
136/60, O O
and O O
oxygen O O
95% O O
on O O
room O O
air. O O
General: O O
This O O
is O O
a O O
pleasant O O
female, O O
elderly; O O
she O O
has O O
got O O
a O O
3-cm O O
ecchymosis O O
over O O
her O O
mid O O
left O O
chin O O
as O O
well O O
as O O
over O O
her O O
left O O
shoulder. O O
Her O O
pupils O O
are O O
reactive. O O
Neck O O
is O O
supple. O O
Respiratory: O O
Clear O O
to O O
auscultation. O O
Cardiovascular: O O
Regular O O
rate. O O
Abdomen O O
is O O
soft. O O
Rectal O O
is O O
heme-positive, O O
heme-positive O O
melena O O
per O O
the O O
resident. O O
Skin O O
is O O
otherwise O O
with O O
bruises O O
over O O
the O O
left O O
arm O O
as O O
well O O
as O O
a O O
bruise O O
over O O
the O O
right O O
thumb O O
that O O
appears O O
healing. O O
Extremities O O
are O O
with O O
good O O
range O O
of O O
motion. O O
No O O
focal O O
tenderness. O O
She O O
is O O
oriented O O
x3. O O
Mood O O
and O O
affect O O
are O O
normal. O O
She O O
is O O
moving O O
all O O
extremities O O
equally. O O
LABORATORY O O
DATA: O O
Chest O O
x-ray O O
shows O O
no O O
acute O O
cardiomediastinal O O
process O O
and O O
head O O
CT O O
preliminary O O
shows O O
no O O
intracranial O O
abnormalities. O O
Laboratory O O
studies O O
are O O
remarkable O O
for O O
hematocrit O O
of O O
16, O O
creatinine O O
of O O
1.5, O O
BUN O O
of O O
95, O O
troponin O O
less O O
than O O
0.04, O O
and O O
platelets O O
of O O
358. O O
INR O O
of O O
2. O O
Urinalysis O O
with O O
2+ O O
ketones, O O
no O O
blood. O O
INITIAL O O
IMPRESSION O O
AND O O
PLAN: O O
This O O
71-year-old O O
female O O
presents O O
with O O
generalized O O
weakness O O
and O O
gait O O
instability O O
and O O
frequent O O
falls, O O
concerning O O
for O O
either O O
an O O
evolving O O
intracranial O O
process O O
such O O
as O O
a O O
subdural O O
or O O
stroke. O O
This O O
has O O
been O O
going O O
on O O
for O O
several O O
weeks, O O
however, O O
but O O
also O O
presents O O
with O O
melena O O
over O O
the O O
past O O
several O O
weeks O O
and O O
profound O O
anemia O O
for O O
which O O
she O O
required O O
transfusion O O
in O O
the O O
Emergency O O
Department. O O
We O O
did O O
order O O
a O O
CT O O
of O O
the O O
brain O O
to O O
evaluate O O
for O O
intracranial O O
injury O O
or O O
abnormality O O
both O O
given O O
the O O
frequent O O
falls O O
and O O
as O O
the O O
cause O O
of O O
the O O
falls. O O
This O O
does O O
not O O
show O O
any O O
large O O
subdural O O
or O O
mass O O
lesion. O O
She O O
is O O
quite O O
anemic O O
has O O
melanotic O O
heme-positive O O
stool. O O
I O O
suspect O O
this O O
is O O
the O O
etiology, O O
but O O
it O O
seems O O
like O O
it O O
has O O
been O O
a O O
slow O O
progression, O O
and O O
concerned O O
given O O
her O O
cardiac O O
history O O
also O O
the O O
weakness O O
and O O
could O O
represent O O
coronary O O
insufficiency. O O
She O O
does O O
not O O
have O O
an O O
elevated O O
troponin O O
at O O
present. O O
She O O
will O O
need O O
to O O
be O O
further O O
monitored. O O
She O O
was O O
transfused O O
here O O
in O O
the O O
Emergency O O
Department O O
given O O
her O O
profoundly O O
low O O
hematocrit O O
after O O
consent O O
was O O
obtained. O O
Clinically, O O
feels O O
better. O O
I O O
discussed O O
with O O
the O O
patient's O O
family O O
because O O
of O O
the O O
bleeding O O
he O O
will O O
need O O
to O O
be O O
evaluated O O
as O O
____ O O
further O O
cardiac O O
biomarkers O O
and O O
further O O
monitoring O O
as O O
well O O
as O O
physical O O
therapy O O
evaluation O O
once O O
the O O
patient's O O
acute O O
medical O O
issues O O
have O O
been O O
addressed. O O
She O O
will O O
be O O
admitted O O
to O O
the O O
medical O O
service O O
with O O
diagnosis O O
of O O
symptomatic O O
anemia, O O
gastrointestinal O O
bleeding, O O
congestive O O
heart O O
failure, O O
and O O
atrial O O
fibrillation O O
in O O
stable O O
condition. O O
______________________________ O O
XUEREB, O O
VESTER O O
M.D. O O
D: O O
05/29/78 O O
T: O O
05/30/78 O O
Dictated O O
By: O O
XUEREB, O O
VESTER O O
eScription O O
document:9-7189367 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2088-01-20 O O
PCC O O
Internal O O
Medicine O O
PRIMARY O O
CARE O O
630 O O
Poliquin O O
Drive, O O
642 O O
Asmara, O O
PA O O
96931 O O
RE: O O
Jarvis, O O
Amador O O
PCC#: O O
090-73-07 O O
January O O
20, O O
2088 O O
Reason O O
for O O
visit: O O
Mr. O O
Jarvis O O
comes O O
to O O
follow O O
up O O
on O O
his O O
hypertension, B-HYPERTENSION O
hyperglycemia, O O
renal O O
insufficiency O O
and O O
elevated O O
PSA. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
He O O
has O O
seen O O
Dr. O O
Jose O O
Quirk O O
and O O
a O O
prostate O O
biopsy O O
has O O
been O O
recommended. O O
This O O
is O O
scheduled O O
for O O
next O O
week O O
and O O
Mr. O O
Jarvis O O
is O O
quite O O
anxious O O
about O O
it. O O
He O O
began O O
the O O
Captopril B-MEDICATION B-MEDICATION
and O O
HCTZ B-MEDICATION O
(? O O
or O O
Maxide) O O
and O O
has O O
noted O O
good O O
blood O O
pressure O O
control O O
as O O
checked O O
at O O
BH. O O
At O O
first O O
he O O
developed O O
a O O
considerable O O
cough O O
but O O
in O O
the O O
last O O
two O O
weeks O O
this O O
has O O
largely O O
resolved. O O
He O O
states O O
that O O
the O O
cough O O
is O O
productive O O
of O O
thick O O
phlegm O O
and O O
may O O
reflect O O
a O O
respiratory O O
infection O O
rather O O
than O O
the O O
Captopril O B-MEDICATION
itself. O O
His O O
blood O O
sugars O O
when O O
checked O O
at O O
home O O
have O O
averaged O O
between O O
the O O
140 O O
to O O
150 O O
range O O
fasting. O O
On O O
one O O
occasion O O
a O O
three O O
hour O O
postprandial O O
was O O
170. O O
He O O
has O O
had O O
no O O
attacks O O
of O O
gout O O
or O O
gout O O
like O O
arthritis O O
in O O
the O O
past O O
six O O
weeks O O
and O O
is O O
quite O O
pleased O O
about O O
this. O O
He O O
has O O
continued O O
actively O O
managing O O
production O O
and O O
is O O
planning O O
a O O
trip O O
to O O
Italy O O
next O O
month. O O
PHYSICAL O O
EXAMINATION: O O
On O O
examination O O
today O O
he O O
looks O O
well O O
and O O
comfortable. O O
His O O
blood O O
pressure O O
is O O
140/76 O O
right O O
arm O O
sitting O O
with O O
regular O O
pulse O O
of O O
68. O O
His O O
weight O O
is O O
173 O O
(stable). O O
IMPRESSION: O O
Doing O O
reasonably O O
well O O
on O O
the O O
new O O
blood O O
pressure O O
program. O O
Since O O
the O O
cough O O
is O O
resolving O O
it O O
would O O
seem O O
reasonable O O
to O O
continue O O
the O O
present O O
program. O O
We O O
will O O
look O O
forward O O
to O O
seeing O O
the O O
results O O
of O O
the O O
prostate O O
biopsy O O
and O O
we O O
will O O
check O O
glucose O O
and O O
glycosylated O O
hemoglobin O O
today. O O
He O O
will O O
return O O
in O O
four O O
months O O
for O O
follow O O
up. O O
Orvell O O
Oliver, O O
M.D. O O
Labs: O O
Hemolyzed O O
sample O O
shows O O
K O O
of O O
6.0. O O
Will O O
check O O
re O O
HCTZ O O
vs O O
Maxide. O O
If O O
the O O
latter, O O
will O O
change O O
it. O O
O O O
Plasma O O
Sodium O O
138 O O
135-145 O O
mmol/L O O
Plasma O O
Potassium O O
6.0 O O
H O O
3.4-4.8 O O
mmol/L O O
Result O O
Text: O O
HEMOLYZED O O
Plasma O O
Chloride O O
98 O O
L O O
100-108 O O
mmol/L O O
Plasma O O
Carbon O O
Dioxide O O
25.9 O O
24.0-30.0 O O
mmol/L O O
Plasma O O
Urea O O
Nitrogen O O
29 O O
H O O
8-25 O O
mg/dl O O
Plasma O O
Creatinine O O
2.1 O O
H O O
0.6-1.5 O O
mg/dl O O
Plasma O O
Glucose O O
167 O O
H O O
70-110 O O
mg/dl O O
Transaminase-SGOT O O
26 O O
10-40 O O
U/L O O

Record B-SMOKER O
date: O O
2089-05-11 O O
Patient O O
Name: O O
JARVIS,AMADOR O O
[ O O
MRN: O O
0907307PCC O O
] O O
Date O O
of O O
Visit: O O
05/11/2089 O O
REASON O O
FOR O O
VISIT: O O
Mr. O O
Jarvis O O
comes O O
for O O
a O O
regular O O
6-month O O
followup O O
visit. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
He O O
has O O
been O O
feeling O O
extremely O O
well O O
without O O
any O O
illness O O
or O O
any O O
unpleasant O O
symptoms. O O
He O O
is O O
working O O
hard O O
as O O
a O O
production O O
manager, O O
and O O
he O O
will O O
have O O
some O O
time O O
off O O
this O O
spring. O O
He O O
and O O
his O O
wife O O
are O O
planning O O
a O O
trip O O
to O O
Italy O O
and O O
Greece, O O
and O O
following O O
this, O O
they O O
will O O
spend O O
mostly O O
long O O
weekends O O
in O O
New O O
Mexico. O O
He O O
has O O
not O O
had O O
shortness O O
of O O
breath, O O
orthopnea, O O
or O O
edema. O O
The O O
pains O O
in O O
his O O
hips O O
and O O
legs O O
have O O
not O O
been O O
bothering O O
him. O O
When O O
he O O
tests O O
his O O
blood O O
glucose O O
level, O O
he O O
gets O O
results O O
that O O
range O O
between O O
170 O O
and O O
120. O O
He O O
has O O
not O O
been O O
specifically O O
exercising, O O
but O O
does O O
try O O
to O O
park O O
his O O
car O O
at O O
some O O
distance O O
from O O
shops O O
and O O
stores O O
and O O
walk O O
the O O
intervening O O
distance. O O
He O O
continues O O
on O O
1/2 O O
tablet O O
of O O
atenolol B-MEDICATION B-MEDICATION
50 O O
mg O O
per O O
day O O
along O O
with O O
1 O O
Hyzaar B-MEDICATION O
tablet O O
per O O
day. O O
Otherwise, O O
the O O
review O O
of O O
systems O O
is O O
unremarkable. O O
PHYSICAL O O
EXAMINATION: O O
He O O
looks O O
cheerful O O
and O O
fit. O O
Blood O O
pressure O O
in O O
the O O
right O O
arm, O O
sitting O O
140/86 O O
with O O
regular O O
pulse O O
64. O O
Chest O O
is O O
clear O O
to O O
P&A. O O
Heart O O
sounds O O
are O O
very O O
faint, O O
but O O
appear O O
normal O O
with O O
normal O O
rate O O
and O O
rhythm. O O
Neck O O
veins O O
are O O
not O O
distended. O O
Abdomen O O
is O O
nontender. O O
Extremities O O
have O O
good O O
dorsalis O O
pedis O O
pulses. O O
Sensation O O
in O O
feet O O
is O O
intact O O
to O O
light O O
touch O O
and O O
vibration. O O
IMPRESSION: O O
Very O O
stable O O
with O O
regards O O
to O O
hypertension. B-HYPERTENSION O
He O O
remains O O
moderately O O
hyperglycemic. O O
He O O
has O O
an O O
appointment O O
to O O
be O O
followed O O
by O O
the O O
urologist, O O
Dr. O O
Jose O O
Quirk, O O
in O O
the O O
next O O
month O O
for O O
his O O
elevated O O
prostatic- O O
specific O O
antigen O O
(the O O
prostate O O
biopsy O O
showed O O
intraepithelial O O
neoplasia O O
considered O O
only O O
a O O
risk O O
factor). O O
PLAN: O O
We O O
will O O
check O O
the O O
usual O O
laboratory O O
work, O O
and O O
we O O
will O O
let O O
him O O
know O O
when O O
the O O
results O O
are O O
available. O O
He O O
should O O
return O O
in O O
6 O O
months. O O
Orvell O O
Oliver, O O
M.D. O O
Test O O
Description O O
Result O O
Abnormal O O
Flag O O
Ref. O O
Range O O
Ref. O O
Units O O
Plasma O O
Sodium O O
140 O O
135-145 O O
mmol/L O O
Plasma O O
Potassium O O
4.7 O O
3.4-4.8 O O
mmol/L O O
Plasma O O
Chloride O O
103 O O
100-108 O O
mmol/L O O
Plasma O O
Carbon O O
Dioxide O O
25.0 O O
24.0-30.0 O O
mmol/L O O
Calcium O O
9.0 O O
8.5-10.5 O O
mg/dl O O
Plasma O O
Urea O O
Nitrogen O O
39 O O
H O O
8-25 O O
mg/dl O O
Plasma O O
Creatinine O O
2.4 O O
H O O
0.6-1.5 O O
mg/dl O O
Plasma O O
Glucose O O
244 O O
H O O
70-110 O O
mg/dl O O
Cholesterol O O
245 O O
mg/dl O O
Test O O
Description O O
Result O O
Abnormal O O
Flag O O
Ref. O O
Range O O
Ref. O O
Units O O
Hemoglobin B-DIABETES O
A1C I-DIABETES O
7.70 I-DIABETES O
H I-DIABETES O
3.80-6.40 O O
% O O
Calc O O
Mean O O
Bld O O
Glucose O O
171 O O
mg% O O
Mr O O
Jarvis: O O
The O O
glucose O O
when O O
you O O
were O O
here O O
was O O
244 O O
and O O
the O O
average O O
calclated O O
from O O
the O O
HbA1c O O
is O O
171; O O
despite O O
your O O
efforts O O
and O O
exercise O O
and O O
diet. O O
I O O
think O O
it O O
would O O
be O O
wise O O
to O O
start O O
on O O
a O O
low O O
dose O O
of O O
a O O
glucose-lowering O O
medicine, O O
glipizide B-MEDICATION B-MEDICATION
(Glucotrol). O O
I O O
would O O
start O O
on O O
1/2 O O
of O O
a O O
5 O O
mg O O
pill O O
twice O O
a O O
day O O
and O O
continue O O
checking O O
your O O
blood O O
sugar O O
levels O O
from O O
time O O
to O O
time. O O
If O O
they O O
stay O O
a O O
bit O O
up, O O
then O O
increase O O
to O O
one O O
whole O O
pill O O
(5 O O
mg) O O
twice O O
a O O
day. O O
Then O O
we O O
will O O
see O O
how O O
that O O
effects O O
the O O
blood O O
sugar. O O
I O O
don't O O
think O O
this O O
will O O
interfere O O
with O O
your O O
trip. O O
Call O O
me O O
in O O
a O O
week O O
to O O
tell O O
me O O
how O O
it O O
is O O
going. O O
Best O O
wishes, O O
O O O

Record O O
date: O O
2091-09-18 O O
Reason O O
for O O
Visit O O
Mr. O O
Amador O O
Jarvis O O
comes O O
for O O
an O O
annual O O
visit O O
and O O
physical O O
exam, O O
and O O
to O O
follow-up O O
on O O
his O O
diabetes, B-DIABETES O
hypertension B-HYPERTENSION B-HYPERTENSION
and O O
elevated O O
serum O O
creatinine O O
Problems O O
Hyperexpanded O O
lungs O O
Hypertension O B-HYPERTENSION
Elevated O O
creatinine O O
Elevated O O
glucose O O
Elevated O O
prostate O O
specific O O
antigen O O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Narrative O O
History O O
He O O
has O O
been O O
generally O O
healthy O O
since O O
last O O
visit. O O
He O O
notes O O
that O O
his B-DIABETES O
morning B-DIABETES O
fasting I-DIABETES O
glucose I-DIABETES O
values I-DIABETES O
usually I-DIABETES O
range I-DIABETES O
between I-DIABETES O
130 I-DIABETES O
and I-DIABETES O
140 I-DIABETES O
mg I-DIABETES O
percent. I-DIABETES O
He O O
has O O
not O O
checked O O
his O O
blood O O
pressure O O
frequently O O
but O O
feels O O
that O O
it O O
is O O
under O O
reasonable O O
control. O O
He O O
has O O
been O O
followed O O
by O O
Dr. O O
Quirk O O
for O O
his O O
prostate O O
and O O
has O O
regular O O
ophthalmological O O
visits O O
for O O
his O O
eyes. O O
He O O
also O O
has O O
regular O O
dermatology O O
visits. O O
He O O
does O O
not O O
notice O O
any O O
unusual O O
shortness O O
of O O
breath O O
with O O
exertion, O O
and O O
in O O
fact O O
since O O
he O O
has O O
been O O
exercising O O
regularly O O
he O O
feels O O
that O O
his O O
breathing O O
has O O
improved. O O
Review O O
of O O
Systems O O
General O O
- O O
Neg; O O
Weight O O
stable. O O
Eyes O O
- O O
Neg; O O
No O O
problems O O
with O O
vision. O O
Ears O O
- O O
Neg; O O
Hearing O O
not O O
impaired O O
in O O
a O O
quiet O O
room O O
though O O
some O O
difficulty O O
in O O
a O O
noisy O O
environment. O O
Nose O O
- O O
Neg; O O
No O O
nasal O O
allergies O O
Mouth O O
- O O
Neg; O O
Teeth, O O
throat, O O
chewing O O
normal. O O
Heart O O
- O O
Neg. O O
No O O
pain O O
or O O
abnormal O O
heart O O
beats. O O
Lungs O O
- O O
Neg; O O
No O O
cough O O
or O O
sortness O O
of O O
breath. O O
GI O O
- O O
Neg; O O
No O O
heartburn, O O
abdominal O O
pain,constipation, O O
diarrhea, O O
rectal O O
bleeding. O O
GU O O
- O O
Neg; O O
No O O
pain O O
or O O
difficulty O O
with O O
urination. O O
t O O
Musc-skel O O
- O O
Neg; O O
No O O
painful O O
or O O
swollen O O
joints. O O
Skin O O
- O O
Neg; O O
No O O
rashes, O O
severe O O
acne, O O
abnormal O O
moles. O O
Neuro O O
- O O
Neg; O O
No O O
weakness, O O
numbness, O O
shakiness. O O
Emotional O O
- O O
Neg; O O
No O O
unusual O O
sadness O O
or O O
anxiety. O O
Exam O O
Mr. O O
Jarvis O O
is O O
a O O
healthy, O O
comfortable O O
appearing O O
man. O O
Blood O O
pressure O O
right O O
arm, O O
sitting O O
is O O
136/70 O O
with O O
regular O O
pulse O O
72. O O
Weight O O
is O O
174 O O
lbs. O O
Ears, O O
drums, O O
canals, O O
hearing O O
within O O
normal O O
limits. O O
(Eyes O O
are O O
regularly O O
examined). O O
Mouth, O O
teeth, O O
tongue O O
and O O
throat O O
normal. O O
Neck, O O
thyroid, O O
nodes, O O
carotids O O
normal. O O
JVP O O
fills O O
below O O
the O O
sternal O O
angle. O O
Chest O O
is O O
clear O O
to O O
percussion O O
and O O
to O O
auscultation O O
both O O
quiet O O
breathing O O
and O O
forced O O
maximal O O
expiration. O O
Diaphragms O O
are O O
somewhat O O
low. O O
Heart O O
is O O
normal O O
size O O
and O O
has O O
normal O O
rate, O O
rhythm O O
and O O
sounds O O
with O O
no O O
murmurs O O
or O O
gallops. O O
Abdomen O O
has O O
no O O
tenderness, O O
masses O O
or O O
enlarged O O
organs. O O
There O O
is O O
an O O
area O O
of O O
muscular O O
weakness O O
in O O
the O O
anterior O O
abdomen O O
producing O O
a O O
partial O O
ventral O O
hernia. O O
Extremities O O
have O O
good O O
pedal O O
pulses O O
and O O
no O O
edema. O O
Skin O O
has O O
many O O
keratoses O O
of O O
various O O
sizes O O
and O O
shapes O O
but O O
is O O
free O O
of O O
suspicious O O
lesions. O O
Rectal O O
and O O
prostate O O
examination O O
have O O
been O O
done O O
by O O
the O O
urologist. O O
Assessment O O
Mr. O O
Jarvis O O
appears O O
to O O
be O O
in O O
stable O O
health O O
with O O
hypertension O O
and O O
diabetes O O
under O O
good O O
control. O O
His O O
elevated O O
serum O O
creatinine O O
seems O O
to O O
be O O
causing O O
no O O
problems. O O
His O O
prostate O O
is O O
being O O
carefully O O
followed O O
and O O
shows O O
no O O
signs O O
of O O
progression. O O
Disposition O O
and O O
Plans O O
We O O
will O O
check O O
laboratory O O
work O O
today O O
and O O
let O O
Mr. O O
Jarvis O O
know O O
the O O
results O O
when O O
they're O O
available. O O
He O O
will O O
keep O O
in O O
touch O O
and O O
return O O
as O O
necessary O O
but O O
should O O
return O O
for O O
a O O
regular O O
follow-up O O
visit O O
in O O
six O O
months. O O
Medications O O
Centrum O O
Vitamins O O
PO O O
QD O O
Hyzaar B-MEDICATION B-MEDICATION
(25 O O
Mg/100 O O
Mg) O O
(HCTZ O O
25mg O O
+ O O
Losart... O O
1 O O
TAB O O
PO O O
QD O O
GLIPIZIDE B-MEDICATION B-MEDICATION
5MG, O O
1 O O
Tablet(s) O O
PO O O
BID O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
ATENOLOL B-MEDICATION B-MEDICATION
50 O O
MG O O
PO O O
QD O O
Allergies O O
CAPTOPRIL O B-MEDICATION
- O O
possible O O
rash O O
Health O O
Maintenance O O
Influenza O O
Vaccine O O
11/28/2090 O O
Aventis O O
lot O O
GL735LM O O
exp. O O
7/08/2091 O O
VHS O O
given O O
11/26/90 O O
VHS O O
Pub. O O
7/04/90 O O
adm O O
by O O
A. O O
Torres, O O
RN O O
Cholesterol O O
09/21/2090 O O
179 O O
M-alb/creat O O
ratio O O
03/13/2091 O O
34.4 O O
Stool O O
Guaiac O O
10/18/2090 O O
times O O
three O O
Done O O
- O O
negative O O
Pneumovax O O
03/13/2091 O O
adm. O O
0.5ml O O
into O O
r.arm O O
UA-Protein O O
06/17/87 O O
1+ O O
Colonoscopy O O
08/21/2091 O O
tubular O O
adenoma O O
at O O
Brewster O O
Hospital O O
HBA1C O O
03/14/2091 O O
6.50 O O
Triglycerides O O
05/15/2090 O O
131 O O
Cholesterol-LDL B-HYPERLIPIDEMIA O
05/15/2090 I-HYPERLIPIDEMIA O
165 I-HYPERLIPIDEMIA O
Microalbumin O O
03/13/2091 O O
2.2 O O
Hct O O
(Hematocrit) O O
03/13/2091 O O
43.2 O O
Cholesterol-HDL O O
05/15/2090 O O
51 O O
Hgb O O
(Hemoglobin) O O
03/13/2091 O O
15.2 O O
Past O O
Medical O O
History O O
Former O O
patient O O
of O O
Dr. O O
Michael O O
Jett. O O
Known O O
hyperglycemia O O
and O O
hypertension O O
for O O
many O O
years. O O
Elevated O O
blood O O
creatinine O O
level O O
for O O
many O O
years O O
dating O O
back O O
to O O
a O O
creatinine O O
of O O
1.7 O O
in O O
2068. O O
Hypertension O O
noted O O
in O O
2063. O O
PSA O O
tests O O
gradually O O
rising O O
from O O
2.9 O O
and O O
2080 O O
to O O
4.8 O O
in O O
2091 O O
Social B-SMOKER O
History O O
Mr. O O
Jarvis O O
continues O O
work O O
as O O
a O O
production O O
manager, O O
working O O
seven O O
days O O
a O O
week. O O
He O O
does O O
manage O O
two O O
months O O
of O O
vacation O O
during O O
the O O
spring O O
Lab O O
Tests O O
Amador: O O
the O O
lab O O
results O O
show O O
good O O
levels O O
of O O
glucose O O
and O O
stasble O O
prostate O O
antigen O O
and O O
creatinine. O O
You O O
look O O
good, O O
and O O
lets O O
stick O O
with O O
the O O
present O O
plan. O O
O O O

Record O O
date: O O
2095-12-11 O O
SECTIONS O O
OF O O
THIS O O
NOTE O O
WERE O O
CREATED O O
WITH O O
A O O
'COPY O O
AND O O
PASTE' O O
ACTION. O O
THESE O O
SECTIONS O O
MAY O O
NOT O O
HAVE O O
COPIED O O
COMPLETELY. O O
PLEASE O O
USE O O
CAUTION O O
WHEN O O
RENDERING O O
CLINICAL O O
JUDGMENT O O
BASED O O
ON O O
THE O O
INFORMATION O O
IN O O
THIS O O
NOTE. O O
CCU O O
JAR O O
ADMIT O O
NOTE O O
Name: O O
Amador O O
Jarvis O O
MR O O
#: O O
0907307 O O
Date O O
of O O
admission: O O
12/11/95 O O
JAR: O O
Larry O O
Oates O O
MD O O
PhD O O
Attending: O O
Dr. O O
Ickes O O
PCP: O O
Orvell O O
Oliver O O
MD O O
CC/ID: O O
82M O O
w/ O O
h/o O O
HTN, B-HYPERTENSION O
CRI, O O
DM2 B-DIABETES O
and O O
+ O O
h/o B-SMOKER O
smoking I-SMOKER O
w/ O O
no O O
known O O
CAD O O
p/w O O
syncope O O
and O O
an B-CAD O
inferior I-CAD O
STEMI I-CAD O
HPI: O O
82M O O
w/ O O
h/o O O
HTN, O O
CRI, O O
DM2 O O
and O O
+ O O
h/o O O
smoking O O
w/ O O
no O O
known O O
CAD O O
p/w O O
syncope O O
and O O
an O O
inferior O O
STEMI. O O
Pt O O
has O O
been O O
in O O
his O O
USOH. O O
This O O
AM O O
while O O
shoveling O O
snow O O
he O O
started O O
to O O
feel O O
&#8220;unwell&#8221; O O
c/o O O
dizziness, O O
slightly O O
nauseous O O
and O O
sweaty. O O
He O O
denied O O
CP, O O
SOB/V/diaphoresis. O O
He O O
may O O
have O O
had O O
a O O
similar O O
event O O
3 O O
years O O
ago O O
during O O
heavy O O
exertion O O
(1 O O
episode). O O
He O O
felt O O
this O O
was O O
like O O
prior O O
hypoglycemic O O
episodes. O O
Pt O O
went O O
inside, O O
called O O
for O O
his O O
wife O O
and O O
then O O
syncopized. O O
Estimated O O
total O O
LOC O O
~5 O O
min. O O
He O O
awoke O O
as O O
his O O
wife O O
returned O O
to O O
give O O
him O O
the O O
OJ O O
and O O
felt O O
completely O O
better O O
after O O
drinking O O
it. O O
arrived O O
to O O
find O O
the O O
pt O O
with O O
STEMI O O
in O O
inf O O
leads. O O
Pt O O
was O O
given O O
asa B-MEDICATION B-MEDICATION
and O O
was O O
taken O O
to O O
the O O
ED O O
for O O
further O O
management. O O
ED O O
course: O O
Pt O O
was O O
bradycardic O O
but O O
hemodynamically O O
stable O O
P59, O O
BP112/63). O O
He O O
was O O
found O O
to O O
have O O
a O O
new O O
RBBB O O
and O O
new O O
STE O O
in O O
2, O O
3, O O
avf O O
and O O
V3-V6 O O
with O O
depressions O O
in O O
1, O O
avl. O O
Pt O O
had O O
no O O
chest O O
pain O O
through O O
out O O
the O O
entire O O
duration, O O
but O O
felt O O
generally O O
unwell. O O
Was O O
started O O
on O O
heparin, O O
lipitor, B-MEDICATION B-MEDICATION
NAC O O
and O O
cardiology O O
was O O
called. O O
Pt O O
was O O
taken O O
to O O
the O O
cath B-CAD O
lab I-CAD O
and I-CAD O
found I-CAD O
to I-CAD O
have I-CAD O
3VD I-CAD O
w/ I-CAD O
severe I-CAD O
proximal I-CAD O
LAD I-CAD O
lesion, I-CAD O
a I-CAD O
diffusely I-CAD O
diseased I-CAD O
Cx/OM2, I-CAD O
and I-CAD O
a I-CAD O
severe I-CAD O
RCA I-CAD O
lesion, I-CAD O
which O O
was O O
felt O O
to O O
be O O
the O O
culprit. O O
A O O
BMS B-CAD O
to O O
RCA O O
lesion. O O
Pt O O
was O O
plavix B-MEDICATION B-MEDICATION
loaded O O
and O O
started O O
on O O
a O O
bicarb O O
drip. O O
ROS: O O
Per O O
HPI. O O
No O O
F/C/NS. O O
No O O
SOB/cough/hemoptysis/wheezing/sore O O
throat/rash. O O
No O O
GI/GU O O
complaints. O O
PMH: O O
Hypertension O O
CRI O O
b/l O O
2.5 O O
DM2 O O
Elevated O O
PSA O O
HL B-HYPERLIPIDEMIA O
Colonic O O
tubular O O
adenomas O O
- O O
8/2091 O O
Gout O O
Depression O O
Medications O O
on O O
admission: O O
ATENOLOL B-MEDICATION B-MEDICATION
50 O O
MG O O
QD O O
Centrum O O
Vitamins O O
QD O O
CITALOPRAM O O
40 O O
MG O O
(40MG O O
TABLET O O
take O O
1) O O
QD O O
Enteric B-MEDICATION O
Coated I-MEDICATION O
Aspirin I-MEDICATION B-MEDICATION
(ASPIRIN O O
Enteric O O
Coated) O O
81 O O
MG O O
(81MG O O
TABLET O O
take O O
1) O O
QD O O
Hyzaar B-MEDICATION O
(25 O O
Mg/100 O O
Mg) O O
(HCTZ O O
25mg O O
+ O O
Losart... O O
1 O O
TAB O O
QD O O
Prandin O O
(REPAGLINIDE) O O
0.5 O O
MG O O
(0.5MG O O
TABLET O O
take O O
1) O O
as O O
directed O O
x O O
90 O O
days, O O
1 O O
tab O O
before O O
breakfast O O
and O O
lunch. O O
2 O O
before O O
dinner. O O
Pravachol B-MEDICATION B-MEDICATION
(PRAVASTATIN) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
ALL: O O
captopril O B-MEDICATION
- O O
possible O O
rash, O O
cough O O
SH: O O
Lives O O
with O O
wife O O
of O O
57 O O
years. O O
Has O O
several O O
kids O O
all O O
grown. O O
Former B-SMOKER O
smoker I-SMOKER O
7 I-SMOKER O
years, I-SMOKER O
30 I-SMOKER O
years I-SMOKER O
ago. I-SMOKER O
No O O
IVDU O O
or O O
ETOH. O O
FH: O O
M O O
&#8211; O O
CAD O B-MEDICATION
60s, O O
F O O
&#8211; O O
CAD O O
80s O O
Physical O O
Exam: O O
V: O O
HR: O O
55 O O
BP O O
131/50 O O
100% O O
2l O O
Gen: O O
AAox3 O O
NAD O O
well O O
appearing O O
elderly O O
man O O
HEENT: O O
PERRL, O O
EOMI, O O
sclera O O
anicteric. O O
Neck: O O
Supple, O O
no O O
thyromegaly, O O
no O O
carotid O O
bruits, O O
JVP O O
8-9 O O
Nodes: O O
No O O
cervical O O
or O O
supraclavicular O O
LAN O O
Cor: O O
RRR O O
S1, O O
S2 O O
nl. O O
No O O
m/r/g. O O
Chest: O O
CTA O O
laterally O O
Abdomen: O O
+BS O O
Soft, O O
NT, O O
ND. O O
No O O
HSM, O O
No O O
CVA O O
tenderness. O O
Ext: O O
No O O
C/C/E. O O
Pulses: O O
Carotids O O
2+, O O
no O O
bruits, O O
+2 O O
DP/PT, O O
2+ O O
radial. O O
Venous O O
and O O
art O O
sheath O O
in O O
right O O
groin. O O
B/l O O
no O O
fem O O
bruits O O
w/ O O
2+ O O
pulses. O O
Skin: O O
No O O
rashes. O O
Neuro: O O
non-focal O O
Labs O O
and O O
Studies: O O
12/11/95 O O
11:50 O O
NA O O
137 O O
K O O
5.1(H) O O
CL O O
103 O O
CO2 O O
26.5 O O
BUN O O
54(H) O O
CRE O O
2.5(H) O O
GLU O O
184(H) O O
12/11/95 O O
11:53 O O
CA O O
9.6 O O
PHOS O O
3.0 O O
MG O O
1.6 O O
12/11/95 O O
12:03 O O
CK-MB O O
Negative O O
TROP-I O O
Negative O O
12/11/95 O O
11:50 O O
WBC O O
7.1 O O
RBC O O
3.99(L) O O
HGB O O
12.9(L) O O
HCT O O
39.8(L) O O
MCV O O
100(T) O O
MCH O O
32.3 O O
MCHC O O
32.5 O O
PLT O O
267 O O
RDW O O
13.8 O O
DIFFR O O
Received O O
METHOD O O
Auto O O
%NEUT O O
66 O O
%LYMPH O O
25 O O
%MONO O O
5 O O
%EOS O O
4 O O
%BASO O O
0 O O
ANEUT O O
4.64 O O
ALYMP O O
1.76 O O
AMONS O O
0.38 O O
AEOSN O O
0.25 O O
ABASOP O O
0.02 O O
ANISO O O
None O O
HYPO O O
None O O
MACRO O O
1+(H) O O
MICRO O O
None O O
12/11/95 O O
11:50 O O
PT O O
12.4 O O
PT-INR O O
1.1 O O
PTT O O
23.7 O O
CXR: O O
No O O
acute O O
process O O
EKGs: O O
2085: O O
sinus O O
brady, O O
nl O O
PR, O O
LAHB O O
12/11 O O
11:25A O O
sinus O O
1st O O
degree O O
AVB, O O
LAHB, O O
w/ O O
RBBB O O
~0.5-2 O O
mm O O
STE O O
in O O
III. O O
TWF O O
in O O
aVL O O
12/11 O O
11:35A O O
1st O O
degree O O
AVB, O O
LAHB, O O
RBBB, O O
4 O O
mm O O
inf O O
STE, O O
3-4 O O
mm O O
STE O O
in O O
V3-5 O O
12/11 O O
3:35P O O
CCU O O
admit O O
/ O O
post O O
cath: O O
1st O O
degree O O
avb, O O
LAHB, O O
RBBB O O
Resolving O O
inf O O
STE. O O
A/P: O O
82M O O
w/ O O
h/o O O
HTN, O O
CRI, O O
DM2 O O
but O O
no O O
known O O
CAD O O
p/w O O
syncope, O O
new O O
RBBB O O
and O O
inferior O O
STEMI. O O
Intervention B-CAD O
on I-CAD O
acute I-CAD O
lesion I-CAD O
today I-CAD O
and O O
possible O O
may O O
get O O
re-eval O O
for O O
left-sided O O
circulation O O
with O O
either O O
staged O O
PCI O O
v. O O
CABG. O O
Ischemia: O O
ASA/plavix, O B-MEDICATION
heparin, O O
integrilin. O O
Lipitor. B-MEDICATION B-MEDICATION
CE O O
until O O
peak O O
A1c/lipids, O O
BB O O
if O O
room. O O
Staged O O
PCI O O
vs. O O
CABG O O
Pump: O O
Pending O O
TTE O O
Has O O
not O O
tolerated O O
ACEI O O
before. O O
Can O O
consider O O
ARB O O
if O O
BP O O
room. O O
If O O
difficulty O O
w/ O O
hyperkalemia O O
could O O
consider O O
small O O
standing O O
doses O O
of O O
kayexolate. O O
Currently O O
appears O O
euvolimic O O
Rhythm: O O
Sinus O O
w/ O O
old O O
LAHB, O O
new O O
1st O O
degree O O
AVB O O
and O O
new O O
RBBB. O O
Given O O
right-sided O O
lesion O O
at O O
risk O O
for O O
complete O O
HB. O O
Observe O O
for O O
now. O O
Hold O O
BB O O
Per O O
AHA O O
guidelines O O
class O O
I O O
transcutaneous O O
if O O
develops O O
CHB. O O
Holding O O
BB O O
for O O
now. O O
Daily O O
EKGs. O O
Tele. O O
Renal: O O
NAC, O O
gentle O O
fluids O O
(bicarb) O O
DM2: O O
f/u O O
A1c. O O
RISS O O
FEN: O O
cardiac/diabetic O O
PPx: O O
heparin O O
for O O
now, O O
ppx O O
when O O
sheath O O
out O O
Dispo: O O
pending O O
Code: O O
FULL O O
_______________________________________________________________________ O O
Name O O
Larry O O
Q. O O
Oates O O
MD O O
PhD O O
Pager O O
34071 O O
PGY-2 O O

Record O O
date: O O
2096-04-15 O O
CARDIOLOGY O O
PRIMGHAR O O
CARE O O
CENTER O O
Reason O O
for O O
visit: O O
Elective O O
cardiac O O
catheterization O O
prior O O
to O O
CABG O O
Interval O O
History: O O
Cardiology O O
admission O O
note O O
for O O
Dr. O O
Ickes O O
This O O
is O O
an O O
82 O O
year O O
old O O
male O O
with O O
CAD, B-CAD O
DM, B-DIABETES O
HTN, B-HYPERTENSION O
hyperlipidemia, B-HYPERLIPIDEMIA O
and O O
CRI O O
who O O
presents O O
for O O
elective O O
cardiac O O
catheterization O O
for O O
reevaluation O O
of O O
an B-CAD O
RCA I-CAD O
stent, I-CAD O
which I-CAD O
was I-CAD O
placed I-CAD O
in I-CAD O
12/95 I-CAD O
in I-CAD O
the I-CAD O
setting I-CAD O
of I-CAD O
an I-CAD O
STEMI. I-CAD O
This O O
catheterization O O
is O O
in O O
preparation O O
for O O
planned O O
CABG O O
by O O
Dr. O O
Xaysana O O
on O O
4/23/96. O O
Mr. O O
Jarvis's O O
cardiac O O
history O O
began O O
in O O
12/95, O O
when O O
he O O
was O O
shoveling O O
snow. O O
At O O
that O O
time, O O
he O O
developed O O
dizziness, O O
diaphoresis O O
and O O
nausea. O O
He O O
went O O
inside O O
and O O
had O O
an O O
episode O O
of O O
syncope O O
which O O
lasted O O
approximately O O
5 O O
minutes. O O
His O O
initial O O
EKG O O
showed O O
1 O O
mm O O
STE O O
in O O
II, O O
III O O
and O O
aVF O O
and O O
1 O O
mm O O
STE O O
in O B-CAD
V5 O O
and O O
V6. O O
An O O
EKG O O
seven O O
minutes O O
later O O
showed O O
an O O
increase O O
in O O
STE O O
in O O
the O O
inferior O O
leads O O
and O O
STE O O
in O O
V3 O O
to O O
V6 O O
with O O
a O O
max O O
of O O
4 O O
mm O O
in O O
V3. O O
He O O
never O O
developed O O
chest O O
pain. O O
An B-CAD O
emergent I-CAD O
cardiac I-CAD O
catheterization I-CAD O
at I-CAD O
that I-CAD O
time I-CAD O
showed I-CAD O
a I-CAD O
left I-CAD O
main I-CAD O
with I-CAD O
minor I-CAD O
distal I-CAD O
disease. I-CAD O
The O O
LAD O O
had O O
a O O
proximal O O
80% O O
stenosis. O O
The O O
LCx O O
had O O
mid O O
40% O O
diffuse O O
disease. O O
The O O
1st O O
OM O O
had O O
a O O
tandem O O
lesion O O
of O O
90%. O O
The O O
RCA O O
was O O
large O O
and O O
dominant O O
and O O
had O O
a O O
proximal O O
ulcerated O O
90% B-CAD O
stenosis I-CAD O
with O O
haziness. O O
Given O O
these O O
findings, O O
a O O
2.5 O O
X O O
15mm O O
BMS O O
was O O
placed O O
into O O
the O O
proximal O O
RCA O O
with O O
and O O
excellent O O
result. O O
His O O
peak O O
CK O O
was O O
305 O O
during O O
that O O
admission. O O
An O O
echo O O
performed O O
at O O
that O O
time O O
was O O
a O O
technically O O
difficult O O
study, O O
which O O
showed O O
diffuse O O
inferior O O
hypokinesis. O O
He O O
was O O
discharged O O
home O O
in O O
12/95 O O
in O O
stable O O
condition O O
and O O
follow-up O O
with O O
Dr. O O
Xaysana O O
in O O
his O O
office O O
to O O
discuss O O
possible O O
CABG. O O
It O O
was O O
decided O O
that O O
the O O
patient O O
should O O
have O O
a O O
repeat O O
cardiac O O
catheterization O O
prior O O
to O O
the O O
CABG O O
to O O
determine O O
whether O O
RCA O O
restenosis O O
is O O
present. O O
He O O
is O O
then O O
scheduled O O
to O O
have O O
CABG O O
with O O
Dr. O O
Xaysana O O
on O O
4/23/96. O O
The O O
patient O O
has O O
been O O
feeling O O
well O O
at O O
home O O
from O O
a O O
cardiac O O
standpoint. O O
He O O
denies O O
any O O
chest O O
pain, O O
dyspnea, O O
dizziness, O O
pedal O O
edema, O O
orthopnea, O O
PND, O O
or O O
syncope. O O
He O O
does O O
report O O
some O O
bilateral O O
thigh O O
claudication, O O
noting O O
that O O
he O O
can O O
walk O O
about O O
0.5 O O
miles O O
before O O
he O O
has O O
to O O
stop O O
secondary O O
to O O
leg O O
pain. O O
He O O
denies O O
any O O
calf O O
pain. O O
Past O O
medical O O
history: O O
1. O O
CAD O B-MEDICATION
2. O O
DM O O
3. O O
HTN O O
4. O O
Hyperlipidemia O B-MEDICATION
5. O O
Gout. O O
6. O O
Chronic O O
renal O O
insufficiency O O
Medications O O
Atenolol B-MEDICATION B-MEDICATION
25mg O O
po O O
daily O O
Cozaar B-MEDICATION B-MEDICATION
25mg O O
po O O
bid O O
Ecotrin B-MEDICATION B-MEDICATION
325mg O O
po O O
daily O O
Lipitor B-MEDICATION B-MEDICATION
80mg O O
po O O
daily O O
Nitroglycerin B-MEDICATION B-MEDICATION
0.4mg O O
sl O O
every O O
5 O O
minutes O O
PRN O O
chest O O
pain O O
Plavix B-MEDICATION B-MEDICATION
75mg O O
po O O
daily O O
Prandin O O
0.5 O O
mg O O
BID O O
Citalopram O B-MEDICATION
40mg O O
daily O O
MVI O O
daily O O
Changes O O
to O O
Allergies O O
CAPTOPRIL O B-MEDICATION
- O O
reaction: O O
cough O O
[reviewed] O O
Family O O
history: O O
His B-FAMILY_HIST O
mother I-FAMILY_HIST O
died I-FAMILY_HIST O
at I-FAMILY_HIST O
the I-FAMILY_HIST O
age I-FAMILY_HIST O
of I-FAMILY_HIST O
56 I-FAMILY_HIST O
from I-FAMILY_HIST O
a I-FAMILY_HIST O
MI. I-FAMILY_HIST O
His O O
father O O
died O O
from O O
unknown O O
causes O O
in O O
his O O
80s. O O
His O O
sister O O
committed O O
suicide. O O
His O O
son O O
had O O
a O O
MI O O
at O O
the O O
age O O
of O O
55- O O
he O O
had O O
2 O O
stents O O
placed. O O
Social O O
history: O O
Remote B-SMOKER O
tobacco I-SMOKER O
history-he I-SMOKER O
has I-SMOKER O
a I-SMOKER O
15-20 I-SMOKER O
pack I-SMOKER O
year I-SMOKER O
history, I-SMOKER O
quitting I-SMOKER O
about I-SMOKER O
40 I-SMOKER O
years I-SMOKER O
ago. I-SMOKER O
He O O
drinks O O
about O O
1-2 O O
glasses O O
of O O
wine O O
per O O
week. O O
He O O
denies O O
any O O
illicit O O
drug O O
use. O O
He O O
is O O
married O O
with O O
2 O O
children. O O
He O O
is O O
a O O
Primary O O
Production O O
Manager O O
and O O
has O O
been O O
doing O O
so O O
for O O
the O O
past O O
40-50 O O
years. O O
Review O O
of O O
systems: O O
GEN: O O
No O O
fevers, O O
chills, O O
night O O
sweats O O
HEENT: O O
No O O
hearing O O
or O O
vision O O
changes O O
PULM: O O
No O O
cough, O O
wheezing, O O
or O O
hemoptysis O O
CARDIAC: O O
See O O
HPI O O
GI: O O
No O O
nausea, O O
vomiting, O O
abdominal O O
pain, O O
diarrhea, O O
melena, O O
or O O
BRB O O
per O O
rectum O O
GU: O O
No O O
dysuria O O
or O O
hematuria O O
MS: O O
Occasional O O
gout O O
pain O O
in O O
his O O
bilateral O O
feet O O
with O O
no O O
other O O
arthritis O O
or O O
arthralgias O O
NEURO:No O O
dizziness, O O
syncope, O O
headaches, O O
or O O
seizures O O
Physical O O
examination: O O
-BMI: O O
22.8 O O
Normal, O O
low O O
risk O O
-Pulse: O O
60 O O
regular O O
-resp. O O
rate: O O
16 O O
unlabored O O
-height: O O
69 O O
in. O O
-weight: O O
154 O O
lbs. O O
-General: O O
Elderly O O
male, O O
lying O O
in O O
bed O O
in O O
NAD O O
-HEENT: O O
Sclera O O
anicteric O O
-Neck: O O
No O O
JVD. O O
Carotid O O
volume O O
and O O
upstroke O O
nl, O O
no O O
bruit O O
or O O
transmitted O O
murmur. O O
-Chest: O O
Clear O O
to O O
auscultation O O
bilaterally. O O
-Cardiac: O O
RRR. O O
S1 O O
and O O
S2 O O
normal. O O
No O O
S3, O O
S4, O O
murmur, O O
gallop, O O
or O O
rub. O O
-Abdomen: O O
Soft, O O
nontender. O O
No O O
hepatomegaly O O
or O O
splenomegaly. O O
No O O
bruit. O O
-Extremities: O O
No O O
edema. O O
2+ O O
femorals O O
with O O
no O O
bruits O O
bilaterally. O O
1+ O O
DP/PT O O
bilaterally. O O
-Neuro: O O
A O O
&amp;O O O
X O O
3. O O
MAE. O O
-BP: O O
right O O
130/67 O O
left-146/40 O O
Selected O O
recent O O
labs: O O
Metabolic O O
Date O O
NA O O
K O O
CL O O
CO2 O O
BUN O O
CRE O O
GLU O O
04/10/96 O O
143 O O
109 O O
26.7 O O
04/15/96 O O
4.7 O O
47 O O
2.72 O O
134 O O
Liver O O
and O O
Pancreatic O O
Enzymes O O
Date O O
ALT/SGPT O O
AST/SGOT O O
12/13/95 O O
11 O O
33 O O
Lipid/Thyroid O O
Date O O
CHOL O O
TRIG O O
HDL O O
LDL O O
12/12/95 O O
141 O O
111 O O
49 O O
70 O O
Hematology O O
Date O O
HCT O O
WBC O O
PLT O O
04/10/96 O O
37.0 O O
7.3 O O
255 O O
Coagulation O O
Date O O
PT O O
PT-INR O O
PTT O O
04/10/96 O O
12.8 O O
1.1 O O
30.0 O O
Immunology O O
Date O O
HGBA1C O O
02/08/96 O O
5.40 O O
other O O
Date O O
HGB O O
04/10/96 O O
12.6 O O
Assessment O O
and O O
plan: O O
This O O
is O O
an O O
82 O O
year O O
old O O
male O O
with O O
CAD, O O
HTN, O O
hyperlipidemia, O O
DM, O O
and O O
CRI O O
who O O
is O O
s/p O O
BMS O O
to O O
the O O
RCA O O
with O O
residual O O
3-vessel O O
disease O O
who O O
presents O O
for O O
elective O O
cardiac O O
catheterization O O
for O O
evaluation O O
of O O
the O O
RCA O O
stent O O
prior O O
to O O
planned O O
CABG O O
next O O
week. O O
-Proceed O O
with O O
cardiac O O
catheterization O O
today O O
- O O
He O O
will O O
be O O
premedicated O O
with O O
Mucomyst O O
and O O
Bicarb. O O
given O O
his O O
renal O O
function. O O
-Continue O O
ASA O B-MEDICATION
and O O
statin O O
-Will O O
need O O
to O O
stop O O
Plavix O B-MEDICATION
given O O
upcoming O O
surgery O O
next O O
week. O O
-BP O O
borderline O O
high O O
today- O O
will O O
monitor O O
during O O
the O O
procedure, O O
adjusting O O
his O O
medications O O
as O O
needed. O O
Further O O
recommendations O O
per O O
Dr. O O
Ickes O O
Jenna O O
H. O O
Whittaker, O O
PA O O
Signed O O
electronically O O
by O O
Jenna O O
H. O O
Whittaker, O O
PA O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2091-07-28 O O
Intern O O
Transfer O O
Note O O
Mitchell, O O
Katie O O
MR# O O
6146161 O O
Date O O
of O O
Admission: O O
July O O
24, O O
2091 O O
Date O O
of O O
Transfer: O O
Jul O O
28, O O
2091 O O
Pulm: O O
Geoffrey O O
Lucas O O
PCP: O O
Evelyn O O
Conway O O
(Raymond) O O
Cards: O O
Janssen O O
ID/CC: O O
SOB O O
HPI: O O
Ms. O O
Mitchell O O
is O O
a O O
75 O O
yo O O
woman O O
w/ O O
a O O
PMH O O
notable O O
for O O
COPD O O
w/ O O
FEV1/FVC=63%, O O
HOCM O O
s/p O O
MVR O O
and O O
septal O O
myomectomy O O
in O O
2085 O O
who O O
presents O O
with O O
increasing O O
SOB O O
and O O
DOE O O
for O O
the O O
past O O
4 O O
days. O O
Of O O
note, O O
her O O
and O O
her O O
son O O
note O O
increasing O O
DOE O O
for O O
the O O
past O O
4 O O
months O O
and O O
she O O
was O O
scheduled O O
for O O
outpatient O O
TTE O O
today. O O
She O O
also O O
reports O O
DOE O O
and O O
productive O O
cough O O
with O O
green- O O
yellow O O
sputum O O
that O O
has O O
been O O
blood O O
tinged O O
ever O O
since O O
her O O
EGD O O
on O O
7/10/91. O O
She O O
also O O
notes O O
recent O O
URI O O
symptoms O O
especially O O
runny O O
nose O O
as O O
well O O
as O O
diarrhea O O
the O O
day O O
PTA O O
with O O
6 O O
loose O O
BMs. O O
On O O
the O O
day O O
prior O O
to O O
admission, O O
she O O
had O O
drenching O O
sweats O O
but O O
didn't O O
take O O
her O O
temperature. O O
She O O
has O O
also O O
had O O
decreased O O
po O O
intake O O
(though O O
improved O O
w/ O O
treatment O O
for O O
her O O
trigeminal O O
neuralgia) O O
but O O
denies O O
F/C/CP/abd O O
pain/dysuria. O O
Her O O
symptoms O O
acutely O O
worsened O O
today O O
such O O
that O O
she O O
was O O
in O O
acute O O
respiratory O O
distress O O
and O O
EMS O O
was O O
called.. O O
EMS O O
was O O
called O O
and O O
the O O
patient O O
was O O
noted O O
to O O
initially O O
be O O
speaking O O
in O O
full O O
sentences O O
but O O
became O O
more O O
acutely O O
SOB O O
in O O
the O O
ambulance. O O
In O O
the O O
ED, O O
she O O
was O O
afebrile O O
but O O
tachycardic O O
to O O
120 O O
and O O
hypertensive O O
at O O
180/80. O O
She O O
initially O O
required O O
bipap O O
with O O
O2 O O
sats O O
of O O
93%. O O
She O O
was O O
given O O
prednisone, O O
Levaquin O O
and O O
nebulizers O O
with O O
mild O O
improvement O O
in O O
her O O
symptoms. O O
Of O O
note, O O
she O O
was O O
also O O
noted O O
to O O
have O O
mild O O
ST O O
changes O O
on O O
her O O
EKG O O
while O O
she O O
was O O
tachycardic O O
to O O
the O O
120s. O O
She O O
received O O
ASA, B-MEDICATION B-MEDICATION
Lopressor B-MEDICATION B-MEDICATION
and O O
Ativan O O
and O O
cardiac O O
enzymes O O
showed O O
an O O
elevated O O
CK O O
and O O
CK-MB O O
but O O
negative O O
troponin O O
at O O
0.03. O O
Her O O
EKG O O
improved O O
with O O
rate O O
control O O
w/ O O
IV B-MEDICATION O
Lopressor. I-MEDICATION B-MEDICATION
She O O
was O O
also O O
given O O
30mg O O
IV O O
Lasix O O
given O O
some O O
mild O O
LE O O
edema O O
to O O
which O O
she O O
put O O
out O O
200cc O O
urine. O O
She O O
is O O
now O O
admitted O O
to O O
the O O
floor O O
for O O
further O O
management O O
of O O
her O O
SOB. O O
ROS: O O
No O O
F/C, O O
+ O O
NS. O O
Improving O O
appetite. O O
No O O
CP/Palpitations/Orthopnea/PND/Claudication, O O
+ O O
LE O O
edema O O
for O O
the O O
past O O
1-2 O O
months. O O
No O O
N/V/D/hematochezia/melena. O O
No O O
delta O O
MS/LOC. O O
No O O
slurring O O
of O O
speech, O O
unilateral O O
weakness. O O
No O O
dysuria. O O
Hospital O O
Course: O O
Patient O O
had O O
TTE O O
performed O O
on O O
7/24/91 O O
which O O
showed O O
increase O O
trans-mitral O O
valve O O
gradient. O O
Given O O
patient's O O
history O O
of O O
MVR, O O
TEE O O
was O O
recommended. O O
On O O
the O O
night O O
of O O
7/24/91, O O
patient O O
(who O O
was O O
known O O
to O O
sundown) O O
tried O O
to O O
attack O O
her O O
roommate O O
and O O
fell O O
on O O
the O O
floor O O
hitting O O
her O O
head. O O
No O O
change O O
in O O
MS. O O
In O O
the O O
setting O O
of O O
being O O
on O O
coumadin, O O
patient O O
had O O
a O O
stat O O
CT O O
of O O
the O O
head O O
done O O
which O O
was O O
negative O O
for O O
bleeds. O O
On O O
7/25/91, O O
patient O O
went O O
down O O
for O O
a O O
TEE O O
but O O
desated O O
to O O
80s O O
and O O
the O O
procedure O O
was O O
aborted. O O
Dr. O O
Janssen O O
then O O
decided O O
to O O
perform O O
cardiac O O
cath O O
on O O
the O O
patient O O
Saturday O O
7/28/91. O O
On O O
7/26/91, O O
decision O O
was O O
made O O
to O O
put O O
her O O
on O O
BIPAP O O
for O O
the O O
night, O O
and O O
the O O
patient O O
did O O
well O O
and O O
felt O O
rested O O
the O O
next O O
morning. O O
On O O
7/27/91, O O
because O O
patient O O
looked O O
so O O
well, O O
she O O
was O O
not O O
put O O
on O O
BIPAP O O
but O O
rather O O
only O O
on O O
O2NC O O
for O O
the O O
night. O O
This O O
AM, O O
patient's O O
respiratory O O
status O O
declined O O
satting O O
in O O
the O O
low O O
90s O O
while O O
on O O
O2 O O
6LNC. O O
ABG O O
was O O
performed O O
which O O
showed O O
7.48/52/50. O O
After O O
speaking O O
to O O
cardiology, O O
decision O O
was O O
made O O
to O O
transfer O O
the O O
patient O O
to O O
the O O
CCU O O
for O O
intubation O O
prior O O
to O O
cardiac O O
cath O O
this O O
PM. O O
A O O
TEE O O
will O O
be O O
performed O O
while O O
patient O O
is O O
intubated. O O
Patient O O
is O O
currently O O
NPO O O
ready O O
for O O
cath O O
this O O
PM. O O
PMH: O O
1. O O
COPD- O O
PFTs O O
on O O
7/17/91 O O
w/ O O
FEV1=32%, O O
FEV1/FVC=63% O O
2. O O
MVR- O O
St. O O
Jude's O O
valve, O O
2085 O O
3. O O
HOCM- O O
s/p O O
myomectomy O O
in O O
2085, O O
TTE O O
in O O
2090 O O
showed O O
EF=75%, O O
no O O
segmental O O
wall O O
motion O O
abnormalities, O O
dilated O O
LA, O O
mild O O
AI; O O
cardiac O O
cath O O
in O O
5/85 O O
w/ O O
only O O
mild O O
plaques O O
4. O O
L O O
CEA- O O
10/89 O O
5. O O
GI O O
bleed- O O
secondary O O
to O O
angiodysplasia, O O
EGD/colonoscopy O O
on O O
7/10/91 O O
showed O O
hiatal O O
hernia O O
and O O
diverticulosis O O
respectively O O
6. O O
Trigeminal O O
neuralgia O O
Medications O O
on O O
Admission: O O
Foradil O O
inhaler O O
Metoprolol B-MEDICATION B-MEDICATION
50mg O O
bid O O
Flovent O O
110mcg O O
4 O O
puffs O O
bid O O
Nexium O O
40mg O O
qd O O
Verapamil B-MEDICATION B-MEDICATION
SR I-MEDICATION O
120mg O O
qd O O
MVI O O
Atrovent O O
inhaler O O
Coumadin O O
2.5mg O O
qd O O
Serevent O O
1 O O
puff O O
bid O O
Fosamax O O
70mg O O
qweek O O
Lescol B-MEDICATION O
20mg O O
qd O O
Zyrtec O O
10mg O O
qd O O
prn O O
Tums O O
qd O O
Albuterol O O
inhaler O O
Tegretol O O
XR O O
400mg O O
qd O O
Iron O O
325mg O O
qd O O
Metamucil O O
1 O O
tsp O O
qd O O
Enemas O O
prn O O
Baclofen O O
5mg O O
tid O O
Ultram O O
50mg O O
prn O O
Tylenol O O
prn O O
Neurontin O O
600mg O O
tid O O
Zithromax O O
prior O O
to O O
dental O O
work O O
Medication O O
on O O
Transfer O O
Heparin O O
1000U/hr O O
IV O O
in O O
premixed O O
continuous O O
Laxis O O
20mg O O
IV O O
bid O O
Prednisone O O
40mg O O
po O O
qam O O
Carbamazepin O O
200mg O O
po O O
bid O O
ASA O B-MEDICATION
325mg O O
po O O
qd O O
Atrovent O O
0.5mg O O
neb O O
qid O O
Levofloxacin O O
500mg O O
po O O
qd O O
Iron O O
325mg O O
po O O
qd O O
Baclofen O O
5mg O O
po O O
tid O O
Fosamax O O
70mg O O
po O O
qweek O O
Lescol O O
20mg O O
po O O
qd O O
Nexium O O
40mg O O
po O O
qd O O
Verapamil B-MEDICATION B-MEDICATION
sr I-MEDICATION O
120mg O O
po O O
qd O O
MVI O O
1tab O O
po O O
qd O O
Serevent O O
1puff O O
inh O O
bid O O
Lopressor O B-MEDICATION
50mg O O
po O O
bid O O
Flovent O O
110mcg O O
inh O O
bid O O
Colace O O
100mg O O
po O O
tid O O
Allergies: O O
Amoxicillin, O O
penicillin, O O
Compazine, O O
Bactrim, O O
Sudafed, O O
and O O
Percodan. O O
SH: O O
Lives O O
alone, O O
son O O
lives O O
in O O
NM, O O
come O O
up O O
to O O
help O O
out O O
Tob: B-SMOKER O
50 I-SMOKER O
pack I-SMOKER O
year I-SMOKER O
history, I-SMOKER O
quit I-SMOKER O
EtOH: O O
Denies O O
Illicits: O O
Denies O O
FH: O O
Not O O
elicited O O
Exam: O O
VS: O O
T=97.8 O O
HR=83 O O
BP=106/58 O O
RR=24 O O
SaO2= O O
98% O O
6L O O
General: O O
in O O
mild O O
respiratory O O
distress O O
HEENT: O O
NC/AT, O O
PERRL, O O
anicteric O O
sclera. O O
EOMI. O O
OP O O
w/ O O
MMM, O O
no O O
erythema O O
or O O
injection. O O
Skin: O O
No O O
rashes O O
Neck: O O
Supple, O O
full O O
ROM, O O
JVP O O
flat O O
(difficult O O
to O O
assess) O O
Chest: O O
Diffuse O O
insp O O
and O O
exp O O
wheeze O O
CVS: O O
Tachy O O
nl O O
S1 O O
S2, O O
distorted O O
by O O
pulmonary O O
sounds O O
Abd: O O
+BS, O O
soft, O O
ND/NT O O
GU: O O
Deferred O O
Extr: O O
1+ O O
pitting O O
edema, O O
warm O O
extremities O O
Neuro: O O
Alert O O
and O O
oriented O O
x O O
3 O O
DATA: O O
Chemistry: O O
Plasma O O
Sodium O O
140 O O
135-145 O O
mmol/L O O
Plasma O O
Potassium O O
3.4 O O
3.4-4.8 O O
mmol/L O O
Plasma O O
Chloride O O
95 O O
L O O
100-108 O O
mmol/L O O
Plasma O O
Carbon O O
Dioxide O O
34.5 O O
H O O
23.0-31.9 O O
mmol/L O O
Calcium O O
9.1 O O
8.5-10.5 O O
mg/dl O O
Phosphorus O O
2.0 O O
L O O
2.6-4.5 O O
mg/dl O O
Magnesium O O
1.4 O O
1.4-2.0 O O
meq/L O O
Plasma O O
Urea O O
Nitrogen O O
29 O O
H O O
8-25 O O
mg/dl O O
Plasma O O
Creatinine O O
0.9 O O
0.6-1.5 O O
mg/dl O O
ABG: O O
ART O O
FIO2 O O
5LNC O O
FIO2/L O O
Result O O
Text: O O
.30 O O
ART O O
TEMP O O
OUT O O
37.0 O O
deg O O
C O O
Arterial O O
pH O O
7.48 O O
H O O
7.35-7.45 O O
Arterial O O
PCO2 O O
52 O O
H O O
35-42 O O
mm/Hg O O
Arterial O O
PO2 O O
50 O O
L O O
80-100 O O
mm/Hg O O
Ionic O O
Calcium O O
1.21 O O
1.14-1.30 O O
mmol/L O O
Heme: O O
WBC O O
9.9 O O
4.5-11.0 O O
th/cmm O O
HCT O O
36.0 O O
36.0-46.0 O O
% O O
HGB O O
12.1 O O
12.0-16.0 O O
gm/dl O O
RBC O O
4.19 O O
4.00-5.20 O O
mil/cmm O O
PLT O O
232 O O
150-350 O O
th/cumm O O
MCV O O
86 O O
80-100 O O
fl O O
MCH O O
29.0 O O
26.0-34.0 O O
pg/rbc O O
MCHC O O
33.7 O O
31.0-37.0 O O
g/dl O O
RDW O O
26.1 O O
H O O
11.5-14.5 O O
% O O
PT O O
14.2 O O
H O O
11.1-13.1 O O
sec O O
PT-INR O O
1.3 O O
Result O O
Text: O O
PT-INR O O
values O O
are O O
valid O O
only O O
for O O
WARFARIN O O
ANTI-COAG O O
THERAPY. O O
APTT O O
57.3 O O
H O O
22.1-35.1 O O
sec O O
CT O O
angiogram- O O
Negative O O
for O O
PE O O
on O O
preliminary O O
read O O
CXR: O O
Small O O
bilateral O O
pleural O O
effusions O O
EKG: O O
Sinus O O
tachycardia O O
at O O
112bpm, O O
LAE, O O
1mm O O
ST O O
depressions O O
V4-V6 O O
(similar O O
when O O
compared O O
to O O
previous O O
EKG O O
w/ O O
tachycardia O O
to O O
120) O O
TTE: O O
Compared O O
to O O
the O O
report O O
of O O
09/09/2090, O O
the O O
transmitral O O
gradients O O
have O O
increased, O O
the O O
degree O O
of O O
MR O O
and O O
AI O O
has O O
increased, O O
and O O
the O O
RV O O
systolic O O
pressure O O
has O O
increased O O
significantly. O O
LV O O
size O O
and O O
function O O
remain O O
normal. O O
If O O
clinically O O
indicated, O O
a O O
transesophageal O O
echo O O
is O O
suggested O O
to O O
better O O
evaluate O O
the O O
prosthetic O O
valve. O O
CTHead: O O
1. O O
NO O O
ACUTE O O
INTRACRANIAL O O
HEMORRHAGE O O
OR O O
FRACTURE. O O
2. O O
NON-SPECIFIC O O
PERIVENTRICULAR O O
AND O O
SUBCORTICAL O O
WHITE O O
MATTER O O
HYPOATTENUATING O O
AREAS O O
ARE O O
LIKELY O O
DUE O O
TO O O
CHRONIC O O
MICROANGIOPATHIC O O
CHANGES. O O
___________________________________________ O O
Impression: O O
Ms. O O
Mitchell O O
is O O
a O O
75 O O
yo O O
woman O O
w/ O O
multiple O O
medical O O
problems O O
including O O
HOCM, O O
s/p O O
MVR O O
and O O
myomectomy O O
as O O
well O O
as O O
COPD O O
who O O
presents O O
with O O
increasing O O
SOB O O
and O O
DOE O O
for O O
the O O
past O O
four O O
days. O O
Of O O
note, O O
the O O
patient O O
notes O O
increasing O O
DOE O O
for O O
the O O
past O O
4 O O
months O O
but O O
with O O
acute O O
decompensation O O
today. O O
Her O O
progressive O O
DOE O O
may O O
be O O
related O O
to O O
CHF, O O
especially O O
in O O
the O O
setting O O
of O O
ischemic O O
changes O O
seen O O
on O O
EKG O O
however, O O
her O O
acute O O
decompensation O O
may O O
be O O
related O O
to O O
COPD O O
exacerbation O O
in O O
the O O
setting O O
of O O
a O O
viral O O
illness. O O
Plan: O O
SOB- O O
Unclear O O
etiology O O
currently O O
by O O
may O O
likely O O
be O O
multifactorial O O
--Treat O O
COPD O O
w/ O O
Atrovent O O
nebs, O O
prednisone, O O
O2, O O
Levaquin O O
--Patient O O
did O O
not O O
tolerate O O
tachycardiac O O
so O O
Albuterol O O
was O O
DC'ed O O
--Follow O O
urine O O
output O O
secondary O O
to O O
IV O O
Lasix O O
--Daily O O
weights, O O
strict O O
Is O O
and O O
Os O O
--Keep O O
O2 O O
sats O O
88-90% O O
EKG O O
changes- O O
Pt O O
w/o O O
known O O
history B-CAD O
of I-CAD O
CAD I-CAD O
however O O
w/ O O
and O O
ST O O
depressions O O
on O O
EKG O O
that O O
appear O O
rate O O
related O O
--IV O O
Lopressor O B-MEDICATION
to O O
decrease O O
rate O O
--ASA O O
--Cardiac O O
monitor O O
--Cardiac O O
cath O O
per O O
Dr. O O
Janssen O O
with O O
TEE O O
MVR- O O
On O O
Coumadin O O
--Follow O O
INR O O
Trigeminal O O
neuralgia- O O
Improving O O
w/ O O
pain O O
control O O
and O O
Tegretol O O
--Continue O O
current O O
management O O
FEN- O O
--Encourage O O
Pos O O
--Replete O O
lytes O O
as O O
needed O O
6. O O
Prophylaxis- O O
Nexium, O O
Coumadin O O
_________________________________ O O
Henry O O
Norton, O O
MD O O
Pager O O
#45074 O O

Record O O
date: O O
2091-10-27 O O
Patient: O O
Munoz, O O
Katie O O
MRN: O O
6146161 O O
Date O O
of O O
Admission: O O
10/26/91 O O
Intern: O O
Betty O O
Kaleena-Kern O O
Attending: O O
Youssef O O
Easton O O
PCP: O O
Evelyn O O
Conway O O
Cardiologist: O O
Quinton O O
Janssen O O
Internal O O
Medicine O O
Intern O O
Admission O O
Note O O
Chief O O
Complaint: O O
Increasing O O
SOB O O
and O O
fatigue O O
History O O
of O O
Present O O
Illness: O O
75 O O
yo O O
woman O O
with O O
CHF, O O
HOCM O O
s/p O O
MVR O O
x O O
2 O O
and O O
myomectomy, O O
and O O
COPD O O
with O O
3-4 O O
day O O
history O O
of O O
increasing O O
fatigue O O
and O O
shortness O O
of O O
breath. O O
3 O O
days O O
PTA, O O
the O O
patients O O
VNA O O
nurse O O
noticed O O
that O O
the O O
patient O O
was O O
more O O
SOB. O O
The O O
patient O O
herself O O
notes O O
that O O
she O O
has O O
been O O
feeling O O
much O O
more O O
tired O O
over O O
the O O
past O O
few O O
days O O
and O O
has O O
had O O
gradually O O
worsening O O
shortness O O
of O O
breath O O
both O O
at O O
rest O O
and O O
with O O
exertion. O O
She O O
denies O O
any O O
chest O O
pain O O
or O O
discomfort. O O
She O O
has O O
had O O
no O O
lower O O
extremity O O
edema. O O
Her O O
son O O
weighs O O
her O O
everyday O O
and O O
has O O
noticed O O
no O O
change O O
in O O
weight. O O
She O O
has O O
no O O
orthopnea O O
or O O
PND. O O
She O O
has O O
had O O
a O O
slight O O
cough O O
for O O
the O O
past O O
few O O
weeks. O O
3 O O
weeks O O
ago, O O
her O O
cough O O
was O O
productive O O
of O O
scant O O
greenish O O
sputum O O
and O O
she O O
was O O
given O O
a O O
course O O
of O O
azithromycin O O
which O O
she O O
completed. O O
Recently, O O
her O O
cough O O
has O O
been O O
productive O O
of O O
scant O O
mucus. O O
She O O
denies O O
any O O
fevers, O O
chills, O O
nausea, O O
vomiting, O O
diarrhea, O O
or O O
dysuria. O O
She O O
has O O
had O O
frequency O O
due O O
to O O
her O O
lasix. O O
This O O
morning, O O
Ms. O O
Mitchell O O
awoke O O
feeling O O
quite O O
SOB. O O
She O O
was O O
given O O
3 O O
back O O
to O O
back O O
combivent O O
treatments O O
at O O
home O O
with O O
minimal O O
improvement O O
in O O
her O O
symptoms. O O
EMS O O
was O O
called O O
and O O
she O O
was O O
brought O O
to O O
the O O
PHH O O
ED. O O
Past O O
Medical O O
History: O O
CHF O O
HOCM O O
s/p O O
MVR O O
#1 O O
with O O
St. O O
Jude's O O
valve O O
and O O
myomectomy O O
6/2085 O O
S/p O O
MVR O O
#2 O O
with O O
porcine O O
valve O O
after O O
malfunction O O
of O O
St O O
Jude's O O
valve O O
2/2 O O
thrombosis O O
Cerebrovascular O O
Disease O O
s/p O O
CEA O O
(10/89) O O
COPD O O
- O O
PFTs O O
on O O
7/17/91 O O
w/ O O
FEV1=32%, O O
FEV1/FVC=63% O O
H/o O O
angiodyplasia, O O
gastritis, O O
gastrointestinal O O
bleed O O
Diverticulosis O O
Trigeminal O O
Neuralgia O O
Arthritis O O
Medications O O
on O O
admission: O O
EC B-MEDICATION O
ASA B-MEDICATION B-MEDICATION
81mg O O
qd O O
Verapamil B-MEDICATION B-MEDICATION
120mg O O
qd O O
Coumadin O O
6mg/7.5mg O O
alternating O O
Tegretol O O
XR O O
200mg O O
bid/tid O O
alternating O O
Baclofen O O
5mg O O
tid O O
MVI O O
with O O
no O O
K O O
Nexium O O
40mg O O
qd O O
Calcium O O
Carbonate O O
1000mg O O
qd O O
Clonazepam O O
0.5mg O O
qam, O O
0.25mg O O
qpm O O
Lasix O O
80mg O O
qd O O
KCL O O
20meq O O
qd O O
Ultram O O
prn O O
(for O O
trigeminal O O
neuralgia) O O
Fosamax O O
70mg O O
q O O
Sunday O O
Combivent O O
2-3 O O
puffs O O
q6h O O
Albuterol O O
MDI O O
prn O O
Colace O O
100mg O O
tid O O
Fiber O O
capsule O O
qd O O
Zyrtec O O
10mg O O
qd O O
Nasacort O O
Aq O O
bid O O
Allergies: O O
Heparin O O
(HIT O O
Ab O O
positive), O O
PCN O O
(angioedema), O O
Amoxicillin O O
(itch), O O
Bactrim O O
(itch), O O
Erythromycin O O
(itch), O O
Percocet O O
(rash, O O
SOB), O O
Compazine O O
(itch), O O
Erythromycin O O
(diarrhea) O O
Family O O
History: O O
Mother B-FAMILY_HIST O
died I-FAMILY_HIST O
of I-FAMILY_HIST O
MI I-FAMILY_HIST O
at I-FAMILY_HIST O
age I-FAMILY_HIST O
59. I-FAMILY_HIST O
Father O O
died O O
of O O
cancer. O O
No O O
other O O
family O O
h/o O O
CAD, O O
HTN, O O
or O O
DM. O O
Pt O O
has O O
two O O
older O O
sisters O O
who O O
are O O
alive O O
and O O
well. O O
Social O O
History: O O
After O O
her O O
admission O O
for O O
MVR O O
in O O
8/2091, O O
Ms. O O
Mitchell O O
spent O O
several O O
weeks O O
at O O
NMH O O
for O O
rehab. O O
She O O
has O O
been O O
living O O
at O O
home O O
since O O
the O O
end O O
of O O
September. O O
She O O
receives O O
VNA O O
services O O
at O O
home, O O
in O O
addition O O
her O O
son O O
lives O O
with O O
her O O
and O O
helps O O
to O O
take O O
care O O
of O O
her. O O
She O O
is O O
widowed. O O
50 B-SMOKER O
pack I-SMOKER O
year I-SMOKER O
h/o I-SMOKER O
tobacco. I-SMOKER O
No O O
alcohol O O
or O O
illicit O O
drug O O
use. O O
Review O O
of O O
Systems: O O
As O O
per O O
HPI O O
Physical O O
Examination O O
Vital O O
Signs O O
(ED): O O
T O O
97.2 O O
Tm O O
99.1 O O
HR O O
82 O O
RR O O
22 O O
BP O O
133/57 O O
SaO2 O O
88% O O
RA O O
Vital O O
Signs O O
(floor): O O
T O O
97.1 O O
HR O O
72 O O
RR O O
40 O O
BP O O
122/57 O O
SaO2 O O
91% O O
3L O O
General O O
Appearance: O O
Thin, O O
somewhat O O
anxious, O O
elderly O O
woman, O O
in O O
no O O
acute O O
distress O O
HEENT: O O
normocephalic, O O
PERRL, O O
anicteric O O
sclerae, O O
moist O O
mucous O O
membranes, O O
no O O
cervical, O O
posterior O O
auricular, O O
or O O
supraclavicular O O
adenopathy, O O
oropharynx O O
clear O O
Neck: O O
supple O O
Lungs: O O
crackles O O
at O O
bilateral O O
lung O O
bases, O O
no O O
wheezes O O
Cardiovascular: O O
regular O O
rate O O
and O O
rhythm, O O
2/6 O O
HSM O O
heard O O
best O O
at O O
apex, O O
no O O
rubs O O
or O O
gallops, O O
no O O
heaves, O O
no O O
carotid O O
bruits, O O
JVP O O
= O O
8 O O
Abdomen: O O
normal O O
bowel O O
sounds, O O
non O O
tender, O O
non O O
distended, O O
soft, O O
no O O
guarding O O
or O O
rebound O O
Musculoskeletal: O O
normal O O
bulk O O
and O O
tone O O
Extremities: O O
no O O
peripheral O O
edema, O O
clubbing O O
or O O
cyanosis, O O
1+ O O
DP O O
pulses O O
bilaterally, O O
brisk O O
capillary O O
refill O O
Neuro: O O
alert O O
and O O
oriented O O
x3, O O
CN O O
II-XII O O
grossly O O
intact, O O
5-/5 O O
strength O O
in O O
all O O
extremities O O
Labs: O O
Na O O
133, O O
K O O
4.4, O O
Cl O O
99, O O
CO2 O O
28.1, O O
BUN O O
17, O O
Cr O O
1.0, O O
Glu O O
181 O O
Carbamazepime O O
7.5 O O
WBC O O
20.2, O O
Hct O O
35.5, O O
Hgb O O
11.7, O O
Plt O O
386 O O
CKMB/Trop O O
I O O
negative O O
x O O
1 O O
PT O O
18.3 O O
PTT O O
25.7 O O
UA O O
negative O O
EKG: O O
Irregular, O O
inverted O O
p O O
waves O O
in O O
II, O O
III, O O
aVF O O
(unchanged O O
from O O
prior O O
EKG), O O
no O O
ST O O
elevations O O
or O O
depression, O O
no O O
TWI, O O
poor O O
R O O
wave O O
progression O O
compared O O
to O O
old O O
EKG O O
Last O O
ECHO O O
8/07/91: O O
LA O O
dilation, O O
symmetric O O
LVH, O O
small O O
hyperkinetic O O
LV, O O
EF O O
75% O O
Last O O
Cardiac O O
Cath O O
7/28/91: O O
Right O O
dominant, O O
clean O O
coronaries O O
Radiology: O O
CXR O O
(portable) O O
- O O
small O O
right O O
pleural O O
effusion, O O
Kerley O O
B O O
lines, O O
c/w O O
CHF O O
CXR O O
(PA O O
and O O
lateral) O O
- O O
no O O
infiltrates O O
Impression/Plan: O O
75 O O
yo O O
woman O O
with O O
CHF, O O
s/p O O
MVR O O
x2, O O
COPD O O
with O O
3 O O
day O O
history O O
of O O
increased O O
SOB O O
with O O
likely O O
CHF O O
exacerbation. O O
Cardiac: O O
CHF O O
Pump: O O
Patient O O
with O O
known O O
small, O O
hypertrophic O O
LV O O
with O O
75% O O
EF; O O
Pt O O
somewhat O O
volume O O
overloaded O O
by O O
exam: O O
+JVD, O O
bilateral O O
crackles, O O
however O O
no O O
LE O O
edema; O O
continue O O
diuresis O O
with O O
IV O O
lasix, O O
daily O O
weights, O O
strict O O
I/O O O
Rhythm: O O
NSR, O O
pt O O
has O O
pacer O O
Ischemia O O
- O O
Cardiac O O
enzymes O O
negative O O
x O O
1, O O
ROMI, O O
cardiac O O
monitor O O
COPD: O O
No O O
wheezes O O
on O O
exam O O
Continue O O
home O O
regimen: O O
combivent, O O
advair O O
ID: O O
Pt O O
afebrile, O O
however O O
with O O
elevated O O
wbc, O O
no O O
diff O O
yet O O
UA O O
negative, O O
no O O
infiltrates O O
on O O
CXR, O O
abdominal O O
exam O O
benign, O O
blood O O
cultures O O
pending, O O
will O O
get O O
cbc O O
with O O
diff O O
and O O
follow O O
exam O O
FEN O O
Continue O O
KCL O O
20meq O O
qd, O O
replete O O
lytes O O
as O O
necessary O O
Hyponatremia O O
most O O
likely O O
secondary O O
to O O
volume O O
overload O O
from O O
CHF O O
Neuro/ O O
Psych O O
Continue O O
ativan O O
for O O
anxiety O O
Pt O O
has O O
h/o O O
sundowning: O O
fall O O
precautions, O O
side O O
rails, O O
OOB O O
with O O
assist O O
only O O
Pain O O
Continue O O
Tegretol O O
for O O
Trigeminal O O
neuralgia, O O
carbamazepime O O
level O O
within O O
normal O O
limits O O
Heme O O
Continue O O
coumadin, O O
will O O
check O O
INR O O
Endo O O
Continue O O
Calcium O O
and O O
Fosamax O O
for O O
osteoporosis O O
Prophylaxis O O
DVT O O
- O O
already O O
on O O
coumadin O O
GI O O
- O O
nexium O O
Bowel O O
regimen: O O
Colace, O O
Miralax O O
prn O O
Consult O O
PT/OT O O
________________________________ O O
Betty O O
Kaleena-Kern, O O
MD O O
(Internal O O
Medicine) O O
6-6804 O O

Record O O
date: O O
2092-03-05 O O
Internal O O
Medicine O O
Intern O O
Admit O O
Note O O
Name: O O
Katie O O
Mitchell O O
MR#: O O
6146161 O O
PCP: O O
Evelyn O O
Conway O O
Admitting O O
MD: O O
Michael O O
Doss O O
Date O O
of O O
admission: O O
3/05/92 O O
ID/CC: O O
75 O O
yo O O
woman O O
hx O O
HOCM, O O
s/p O O
recent O O
myomectomy, O O
AS, O O
s/p O O
carotid O O
endarectomy O O
p/w O O
syncopal O O
episode O O
History O O
taken O O
from: O O
patient, O O
notes O O
(please O O
see O O
Camille O O
Dodd O O
admission O O
note O O
in O O
12/91) O O
HPI: O O
Ms. O O
Mitchell O O
is O O
a O O
75 O O
yo O O
woman O O
with O O
CHF, O O
HOCM O O
s/p O O
MVR O O
X O O
2, O O
COPD O O
and O O
multiple O O
other O O
medical O O
problems O O
who O O
was O O
admitted O O
following O O
brief O O
episode O O
of O O
syncope. O O
Per O O
pt O O
and O O
her O O
son, O O
for O O
the O O
past O O
few O O
wks O O
pt O O
has O O
been O O
feeling O O
tired, O O
with O O
some O O
minimal O O
weight O O
gain O O
and O O
ankle O O
swelling. O O
Approximately O O
7-10 O O
days O O
prior O O
to O O
admission, O O
pt O O
given O O
azithromycin O O
for O O
increased O O
cough O O
and O O
COPD. O O
In O O
addition, O O
8 O O
days O O
prior O O
to O O
admission, O O
pt's O O
regular O O
lasix O O
dose O O
was O O
increased O O
from O O
80 O O
to O O
120 O O
mg O O
for O O
four O O
days, O O
then O O
reduced O O
back O O
to O O
80 O O
mg. O O
On O O
the O O
night O O
prior O O
to O O
admission, O O
pt O O
was O O
in O O
the O O
kitchen, O O
leaning O O
on O O
the O O
counter O O
top, O O
feeling O O
hot O O
and O O
tired O O
when O O
as O O
she O O
was O O
turning O O
to O O
walk O O
back O O
to O O
bed, O O
she O O
began O O
to O O
fall O O
back. O O
Her O O
son, O O
who O O
was O O
in O O
the O O
room, O O
was O O
able O O
to O O
catch O O
her O O
before O O
she O O
actually O O
fell. O O
He O O
reports O O
that O O
she O O
seemed O O
awake O O
but O O
was O O
not O O
responding. O O
There O O
was O O
no O O
sz O O
like O O
activity, O O
no O O
bowel O O
or O O
urinary O O
incontinence. O O
Pt O O
was O O
out O O
for O O
approx O O
30-45 O O
seconds O O
when O O
she O O
came O O
to. O O
She O O
does O O
not O O
remember O O
going O O
down. O O
She O O
denies O O
any O O
auras O O
before O O
going O O
down, O O
no O O
chest O O
pain, O O
no O O
palpitations, O O
no O O
increased O O
SOB. O O
No O O
recent O O
fevers, O O
abdom O O
pain O O
or O O
diarrhea. O O
Her O O
son O O
called O O
EMT O O
and O O
she O O
was O O
brought O O
in O O
to O O
PHH. O O
ED O O
Course: O O
initial O O
vitals O O
140/66 O O
78 O O
18 O O
98.0 O O
. O O
She O O
received O O
an O O
aspirin B-MEDICATION B-MEDICATION
along O O
with O O
many O O
of O O
her O O
home O O
meds, O O
CXR O O
c/w O O
pulmonary O O
congestion. O O
She O O
was O O
eventually O O
transferred O O
to O O
floor O O
in O O
stable O O
condition. O O
PMH: O O
CHF O O
HOCM O O
s/p O O
MVR O O
#1 O O
with O O
St. O O
Jude's O O
valve O O
and O O
myomectomy O O
6/2085 O O
S/p O O
MVR O O
#2 O O
(8/91) O O
with O O
porcine O O
valve O O
after O O
malfunction O O
of O O
St O O
Jude's O O
valve O O
2/2 O O
thrombosis O O
Cerebrovascular O O
Disease O O
s/p O O
L O O
CEA O O
(10/89) O O
COPD O O
- O O
PFTs O O
on O O
7/17/91 O O
w/ O O
FEV1=32%, O O
FEV1/FVC=63% O O
H/o O O
angiodyplasia, O O
gastritis, O O
gastrointestinal O O
bleed O O
Diverticulosis O O
Trigeminal O O
Neuralgia O O
Arthritis O O
+HIT O O
2091 O O
Retinal O O
artery O O
vein O O
occlusion O O
s/p O O
repair O O
Right O O
sided O O
pacemaker O O
8/91 O O
CV: O O
-Echo O O
11/91: O O
bioprosthetic O O
prosthetic O O
valve O O
in O O
the O O
mitral O O
position. O O
The O O
valve O O
appears O O
well-seated. O O
The O O
left O O
atrium O O
is O O
dilated. O O
There O O
is O O
restricted O O
aortic O O
leaflet O O
opening O O
c/w O O
valvular O O
aortic O O
stenosis. O O
The O O
peak O O
trans O O
AV O O
gradient O O
is O O
46 O O
mmHg. O O
The O O
mean O O
trans O O
AV O O
gradient O O
is O O
23 O O
mmHg. O O
The O O
aortic O O
valve O O
area O O
is O O
0.8 O O
sqcm., O O
calculated O O
by O O
the O O
continuity O O
equation. O O
(LVOT O O
dimension=1.8 O O
cm.) O O
(LVOT O O
velocity=1.06 O O
m/s.) O O
The O O
peak O O
velocity O O
was O O
obtained O O
from O O
the O O
apical O O
5 O O
chamber O O
view. O O
There O O
is O O
evidence O O
of O O
mild O O
aortic O O
insufficiency. O O
The O O
left O O
ventricular O O
cavity O O
size O O
is O O
small. O O
The O O
left O O
ventricular O O
systolic O O
function O O
is O O
within O O
normal O O
limits. O O
There O O
is O O
symmetric O O
left O O
ventricular O O
hypertrophy. O O
There O O
are O O
no O O
obvious O O
segmental O O
wall O O
motion O O
abnormalities. O O
The O O
estimated O O
ejection O O
fraction O O
is O O
55 O O
%. O O
-Cath O O
08/91: O O
nml O O
vessels O O
All: O O
Heparin O O
(HIT O O
Ab O O
positive), O O
PCN O O
(angioedema), O O
Amoxicillin O O
(itch), O O
Bactrim O O
(itch), O O
Erythromycin O O
(itch), O O
Percocet O O
(rash, O O
SOB), O O
Compazine O O
(itch), O O
Erythromycin O O
(diarrhea) O O
Meds O O
(at O O
home): O O
Lasix O O
80 O O
mg O O
qd O O
KCL O O
10 O O
meq O O
2 O O
daily O O
Nexium O O
40 O O
mg O O
qd O O
Verapamil B-MEDICATION B-MEDICATION
SR I-MEDICATION O
120 O O
mg O O
qd O O
Lescol O O
40 O O
mg O O
qd O O
Tegretol O O
200 O O
mg O O
2 O O
daily O O
plus O O
one O O
every O O
other O O
day O O
Baclofen O O
5 O O
mg O O
tid O O
Ultram O O
50 O O
mg O O
tid O O
prn O O
Paroxetine O O
HCL O O
10 O O
mg O O
qd O O
Clonazepam O O
0.5 O O
mg O O
MVI O O
TUMS O O
Colace O O
Fiber O O
laxative O O
Combivent O O
inhaler O O
Duoneb O O
2.5-0.5/3 O O
ml O O
Advair O O
250/50 O O
1 O O
puff O O
bid O O
Fosamax O O
70 O O
mg O O
qweek O O
Ambien O O
5 O O
mg O O
qhs O O
prn O O
Tylenol O O
prn O O
Zyrtec O O
10 O O
mg O O
prn O O
Social: O O
Widowed O O
and O O
her O O
son O O
has O O
been O O
living O O
with O O
her O O
since O O
July. O O
50 B-SMOKER O
pack I-SMOKER O
year I-SMOKER O
h/o I-SMOKER O
tobacco. I-SMOKER O
Quit I-SMOKER O
7-8 I-SMOKER O
yrs I-SMOKER O
ago I-SMOKER O
No O O
alcohol O O
or O O
illicit O O
drug O O
use. O O
Family O O
Hx: O O
Mother B-FAMILY_HIST O
died I-FAMILY_HIST O
of I-FAMILY_HIST O
MI I-FAMILY_HIST O
at I-FAMILY_HIST O
age I-FAMILY_HIST O
59. I-FAMILY_HIST O
Father O O
died O O
of O O
cancer O O
(unknown O O
primary). O O
Pt O O
with O O
older O O
sister O O
who O O
has O O
heart O O
problems O O
Exam: O O
Vitals: O O
108/46 O O
97.6 O O
62 O O
24 O O
96% O O
on O O
2L O O
Gen: O O
pt O O
resting O O
in O O
bed O O
in O O
NAD O O
HEENT: O O
EOM O O
intact, O O
mucous O O
membranes O O
moist, O O
neck O O
supple O O
Chest: O O
bi-basilar O O
crackles O O
R&gt;L O O
(slightly) O O
approx O O
1/3 O O
to O O
way O O
up O O
Cor: O O
RRR, O O
2/6 O O
blowing O O
crescendo-decrescendo O O
murmur O O
at O O
USB O O
to O O
carotids, O O
carotid O O
bruits, O O
JVP O O
approx O O
7-8 O O
Back: O O
no O O
tenderness O O
Abd: O O
positive O O
BS, O O
soft, O O
NT/ND O O
Extr: O O
warm, O O
no O O
edema O O
____________________________________________ O O
Labs: O O
Creatine O O
Kinase O O
Isoenz O O
NEGATIVE O O
(NEG) O O
Troponin-I O O
NEGATIVE O O
(NEG) O O
Troponin-T O O
0.02 O O
(0.00-0.09) O O
ng/ml O O
Creatine O O
Kinase O O
Isoenz O O
NEGATIVE O O
(NEG) O O
Troponin-I O O
NEGATIVE O O
(NEG) O O
Sodium O O
(Stat O O
Lab) O O
133 O O
L O O
(135-145) O O
mmol/L O O
Potassium O O
(Stat O O
Lab) O O
3.6 O O
(3.4-4.8) O O
mmol/L O O
Chloride O O
(Stat O O
Lab) O O
96 O O
L O O
(100-108) O O
mmol/L O O
CO2 O O
(Stat O O
Lab) O O
27.6 O O
(23.0-31.9) O O
mmol/L O O
BUN O O
(Stat O O
Lab) O O
17 O O
(8-25) O O
mg/dl O O
Creatinine O O
(Stat O O
Lab) O O
0.9 O O
(0.6-1.5) O O
mg/dl O O
Glucose O O
(Stat O O
Lab) O O
105 O O
(70-110) O O
mg/dl O O
Calcium O O
8.9 O O
(8.5-10.5) O O
mg/dl O O
Phosphorus O O
3.6 O O
(2.6-4.5) O O
mg/dl O O
Magnesium O O
1.7 O O
(1.4-2.0) O O
meq/L O O
UA-SED-RBC O O
5-10 O O
(0-2) O O
/hpf O O
UA-SED-WBC O O
20-50 O O
(0-2) O O
/hpf O O
UA-SED-Bacteria O O
Few O O
(NEG) O O
/hpf O O
Hyaline O O
Cast O O
0-2 O O
(0-5) O O
/lpf O O
Squamous O O
Cells O O
Few O O
(NEG) O O
/hpf O O
UA-Specific O O
Gravity O O
1.010 O O
(1.001-1.035) O O
UA-pH O O
5.5 O O
(5.0-9.0) O O
UA-WBC O O
Screen O O
(NEG) O O
1+SAMPLE O O
SENT O O
TO O O
HEME O O
LAB O O
FOR O O
ADDITIONAL O O
TESTING O O
UA-Nitrite O O
NEGATIVE O O
(NEG) O O
UA-Albumin O O
NEGATIVE O O
(NEG) O O
UA-Glucose O O
NEGATIVE O O
(NEG) O O
UA-Ketones O O
Trace O O
(NEG) O O
UA-Occult O O
Blood O O
(NEG) O O
TRACE O O
LYSED O O
WBC O O
5.3 O O
(4.5-11.0) O O
th/cmm O O
HCT O O
30.8 O O
L O O
(36.0-46.0) O O
% O O
HGB O O
11.1 O O
L O O
(12.0-16.0) O O
gm/dl O O
RBC O O
3.32 O O
L O O
(4.00-5.20) O O
mil/cmm O O
PLT O O
382 O O
H O O
(150-350) O O
th/cumm O O
MCV O O
93 O O
(80-100) O O
fl O O
MCH O O
33.6 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
36.2 O O
(31.0-37.0) O O
g/dl O O
RDW O O
18.1 O O
H O O
(11.5-14.5) O O
% O O
DIFFERENTIAL O O
REQUEST O O
RECEIVED O O
Diff O O
Method O O
Auto O O
Poly O O
61 O O
(40-70) O O
% O O
Lymphs O O
22 O O
(22-44) O O
% O O
Monos O O
6 O O
(4-11) O O
% O O
EOS O O
10 O O
H O O
(0-8) O O
% O O
Basos O O
1 O O
(0-3) O O
% O O
Absolute O O
Neuts O O
3.30 O O
(1.8-7.7) O O
th/cmm O O
Absolute O O
Lymphs O O
1.12 O O
(1.0-4.8) O O
th/cmm O O
Absolute O O
Monos O O
0.30 O O
(0.2-0.4) O O
th/cmm O O
Absolute O O
EOS O O
0.53 O O
H O O
(0.1-0.3) O O
th/cmm O O
Absolute O O
Basos O O
0.04 O O
(0.0-0.3) O O
th/cmm O O
Aniso O O
2+ O O
(NORMAL) O O
Hypo O O
None O O
(NORMAL) O O
Macrocytes O O
None O O
Microcytes O O
None O O
Urine O O
cx: O O
pending O O
Radiology: O O
CXR: O O
No O O
acute O O
pulmonary O O
consolidations. O O
Pulmonary O O
vascular O O
congestion. O O
EKG: O O
? O O
sinus, O O
abnormal O O
P-waves O O
morphology O O
Impr/Plan: O O
75 O O
yo O O
woman O O
with O O
MVR, O O
HOCM, O O
severe O O
AS O O
who O O
p/w O O
following O O
episode O O
of O O
syncope. O O
1. O O
Syncope: O O
hx O O
worrisome O O
for O O
cardiac O O
etiology O O
given O O
suddenness O O
of O O
the O O
episode O O
w/o O O
much O O
warning. O O
Likely O O
etiologies O O
could O O
be O O
some O O
decreased O O
pre-load O O
in O O
setting O O
of O O
recent O O
increased O O
diuresis, O O
perhaps O O
decreased O O
po O O
intake O O
in O O
a O O
woman O O
dependent O O
on O O
preload O O
2/2 O O
her O O
valvular O O
disease. O O
In O O
addion, O O
pt O O
could O O
have O O
had O O
an O O
arrythmia O O
which O O
would O O
necessitate O O
interrogating O O
her O O
pacer. O O
Seizure O O
activity O O
is O O
not O O
part O O
of O O
the O O
hx O O
but O O
the O O
pt O O
does O O
have O O
carotid O O
disease O O
which O O
might O O
have O O
been O O
playing O O
a O O
role O O
as O O
well. O O
--will O O
check O O
echo O O
in O O
a.m. O O
to O O
assess O O
valvular O O
disease, O O
LV O O
function, O O
could O O
consider O O
stress O O
test O O
--will O O
consult O O
EP O O
to O O
assess O O
pacer O O
function O O
--pt O O
has O O
already O O
ruled O O
out O O
for O O
MI O O
but O O
will O O
keep O O
her O O
on O O
monitor O O
at O O
least O O
overnight O O
--will O O
need O O
to O O
pay O O
close O O
attention O O
to O O
volume O O
status O O
as O O
pt O O
is O O
very O O
preload O O
dependent O O
--will O O
re-check O O
carotid O O
studies O O
--will O O
re-start B-MEDICATION O
ASA B-MEDICATION O
(it O O
was O O
recently O O
stopped) O O
given O O
carotid O O
and O O
vascular O O
disease O O
2. O O
CHF: O O
pt O O
carries O O
diagnosis O O
of O O
CHF O O
and O O
CXR O O
c/w O O
some O O
pulmonary O O
congestion. O O
On O O
exam, O O
pt O O
with O O
crackles O O
bilaterally O O
also O O
c/w O O
pulm O O
edema. O O
--will O O
cont O O
outpt O O
lasix O O
but O O
need O O
to O O
be O O
very O O
careful O O
given O O
pt's O O
tenous O O
volume O O
status O O
3. O O
COPD: O O
cont O O
outpt O O
regimen O O
4. O O
FEN: O O
normal O O
diet, O O
replete O O
lytes O O
as O O
needed O O
5. O O
proph: O O
boots, O O
TEDS O O
since O O
pt O O
HIT O O
positive, O O
nexium O O
Kevin O O
Henry, O O
MD O O
Pager O O
49057 O O

Record O O
date: O O
2094-04-14 O O
CARDIOLOGY O O
PORT O O
HURON O O
HOSPITAL O O
Reason O O
for O O
visit: O O
77 O O
year O O
old O O
woman O O
with O O
mitral O O
stenosis, O O
S/P O O
redoMVR O O
for O O
thrombosed O O
St. O O
Jude O O
valve, O O
now O O
with O O
porcine O O
MVR, O O
AS, O O
COPD, O O
S/P O O
R O O
total O O
hip O O
replacement. O O
Interval O O
History: O O
Mrs. O O
Mitchell O O
has O O
hypertrophic O O
cardiomyopathy, O O
mitral O O
stenosis, O O
aortic O O
stenosis, O O
hypertension B-HYPERTENSION O
and O O
COPD. O O
She O O
had O O
a O O
mitral O O
valve O O
replacement O O
with O O
the O O
St. O O
Jude's O O
valve O O
and O O
septal O O
myomectomy O O
in O O
2085. O O
Because O O
of O O
thrombosis O O
of O O
the O O
valve O O
with O O
recurrent O O
heart O O
failure, O O
she O O
had O O
a O O
redo O O
mitral O O
valve O O
replacement O O
complicated O O
by O O
sinus O O
arrest O O
and O O
AV O O
nodal O O
block O O
requiring O O
a O O
permanent O O
pacemaker. O O
She O O
also O O
had O O
several O O
episodes O O
of O O
syncope, O O
once O O
after O O
taking O O
an O O
additional O O
dose O O
of O O
Lasix O O
and O O
another O O
in O O
the O O
setting O O
of O O
over O O
diuresis. O O
Repeat O O
echo O O
showed O O
that O O
her O O
AS O O
was O O
not O O
critical O O
and O O
she O O
had O O
significant O O
LV O O
outflow O O
tract O O
obstruction. O O
Other O O
medical O O
problems O O
include O O
severe O O
COPD, O O
trigeminal O O
neuralgia, O O
ruled O O
out O O
for O O
temporal O O
arteritis O O
by O O
several O O
biopsies, O O
R O O
hip O O
osteonecrosis, O O
and O O
bone O O
spur O O
of O O
the O O
right O O
shoulder. O O
Mrs. O O
Mitchell O O
is O O
S/P O O
total O O
hip O O
replacement O O
surgery, O O
and O O
had O O
her O O
rehab O O
atNorth O O
Mountain O O
Hospital. O O
She O O
had O O
intercurrent O O
admissions O O
for O O
overdiuresis O O
and O O
for O O
flash O O
pulmonary O O
edema O O
with O O
over- O O
and O O
under-diuresis, O O
respectively. O O
She O O
currently O O
takes O O
Bumex O O
6 O O
mg O O
po O O
bid, O O
and O O
with O O
this, O O
her O O
weight O O
has O O
been O O
140-145 O O
pounds, O O
which O O
is O O
her O O
target O O
weight. O O
Her O O
BUN O O
and O O
Cr O O
are O O
in O O
the O O
25-40/1.3-1.7 O O
range. O O
Since O O
her O O
last O O
visit, O O
she O O
has O O
done O O
well O O
at O O
home. O O
Her O O
breathing O O
at O O
home O O
is O O
intermittently O O
difficult, O O
especially O O
if O O
she O O
rushes. O O
However, O O
oximetry O O
shows O O
that O O
she O O
is O O
in O O
the O O
mid O O
90's O O
at O O
rest, O O
and O O
that O O
she O O
drops O O
down O O
to O O
high O O
80's O O
to O O
90 O O
with O O
exertion. O O
She O O
has O O
had O O
GI O O
evaluation O O
for O O
anemia O O
in O O
the O O
past, O O
only O O
revealing O O
diverticulosis; O O
her O O
Hct O O
was O O
28 O O
recently, O O
and O O
Dr. O O
Conway O O
arranged O O
for O O
her O O
to O O
udnergo O O
transfusion O O
of O O
one O O
unit O O
of O O
PRBC. O O
She O O
feels O O
more O O
energetic O O
after O O
this. O O
She O O
takes O O
Fe O O
sulfate, O O
but O O
has O O
some O O
constipation O O
from O O
this. O O
She O O
may O O
require O O
ENT O O
surgery O O
for O O
vocal O O
cord O O
growth O O
by O O
Dr. O O
Cherry. O O
This O O
is O O
being O O
considered O O
in O O
consultation O O
with O O
her O O
LMD O O
Dr. O O
Evelyn O O
Conway, O O
and O O
her O O
pulmonologist O O
Dr. O O
Geoffrey O O
Lucas. O O
Medications O O
(Confirmed): O O
Advair O O
500/50mcg O O
spray O O
inh O O
bid O O
Ambien O O
5 O O
mg O O
po O O
qhs O O
Bumex O O
4 O O
mg O O
po O O
bid O O
Colace O O
100 O O
mg O O
po O O
tid O O
Fosamax O O
70mg O O
po O O
qwk O O
Lescol O O
40mg O O
po O O
qhs O O
metoprolol B-MEDICATION B-MEDICATION
100 O O
mg O O
po O O
tid O O
MiraLax O O
17 O O
g O O
2 O O
po O O
qhs O O
Nexium O O
40mg O O
po O O
qd O O
Paxil O O
10mg O O
po O O
qd O O
Plavix B-MEDICATION B-MEDICATION
75mg O O
po O O
qd O O
Spiriva O O
18mcg/capsule O O
inh O O
qd O O
verapamil B-MEDICATION B-MEDICATION
hydrochloride, I-MEDICATION O
SR I-MEDICATION O
(extended O O
release) O O
120mg O O
SR O O
po O O
qd O O
Zyrtec O O
10mg O O
po O O
qd O O
Allergies: O O
Penicillin O O
allergy O O
angioedema O O
Allergic O O
drug O O
reaction O O
percodan, O O
bactrim, O O
pseudophed, O O
leading O O
to O O
angioedema O O
Heparin O O
induced O O
thrombocytopenia O O
HIT O O
Family O O
history: O O
negative O O
for O O
CAD O O
Social B-SMOKER O
history: O O
son O O
Bobby O O
(retired O O
Secondary O O
School O O
Teacher) O O
now O O
lives O O
with O O
her O O
sister O O
lives O O
on O O
Chipley O O
(near O O
Eagle O O
Pass) O O
god-daughter O O
Bethany O O
lives O O
nearby O O
Review O O
of O O
systems: O O
all O O
systems O O
reviewed. O O
except O O
as O O
noted O O
above, O O
noncontributory. O O
Physical O O
examination: O O
-BMI: O O
27.1 O O
Overweight, O O
moderate O O
risk O O
-Pulse: O O
60 O O
-resp. O O
rate: O O
12 O O
-height: O O
61 O O
in. O O
-weight: O O
143 O O
lbs. O O
-General O O
appearance: O O
No O O
acute O O
distress. O O
-Skin: O O
No O O
rashes, O O
anicteric. O O
-Heent: O O
EOM O O
full, O O
PERRL O O
-Neck: O O
Carotids O O
2+ O O
with O O
bruits O O
greater O O
on O O
right O O
than O O
left. O O
JVP O O
approximately O O
5 O O
cm. O O
-Nodes: O O
No O O
cervical, O O
axillary O O
or O O
groin O O
adenopathy O O
appreciated. O O
-Breasts: O O
No O O
masses, O O
dimpling O O
or O O
retractions. O O
-Chest: O O
Clear O O
to O O
auscultation O O
and O O
percussion!!! O O
No O O
crackles. O O
No O O
use O O
of O O
accessory O O
muscles. O O
-Cardiac: O O
Left O O
ventricular O O
impulse O O
discrete O O
and O O
nondisplaced. O O
Regular O O
rate O O
and O O
rhythm, O O
normal O O
S1 O O
and O O
S2, O O
with O O
no O O
S3 O O
or O O
S4. O O
There O O
were O O
no O O
clicks O O
or O O
rubs. O O
There O O
was O O
a O O
3/6 O O
systolic O O
murmur O O
at O O
the O O
base, O O
and O O
a O O
2/6 O O
systolic O O
murmur O O
at O O
the O O
apex. O O
-Abdomen: O O
Normal O O
bowel O O
sounds, O O
soft O O
and O O
nontender, O O
with O O
no O O
hepatosplenomegaly O O
or O O
masses O O
appreciated. O O
-Extremities: O O
No O O
cyanosis, O O
clubbing O O
or O O
edema. O O
2+ O O
femoral O O
pulses O O
without O O
bruits. O O
2+ O O
pedal O O
pulses. O O
-Musc O O
skel: O O
No O O
bony O O
deformities. O O
-Neuro: O O
A&O O O
x3, O O
CN O O
2-12 O O
grossly O O
intact. O O
Reflexes O O
2+ O O
and O O
symmetric O O
x O O
4 O O
extremities. O O
Toes O O
B O O
downgoing. O O
-BP: O O
128/70 O O
EKG: O O
AV O O
sequential O O
pacing O O
Compared O O
with O O
prior O O
tracings, O O
no O O
significant O O
change. O O
Other O O
Data: O O
Name: O O
Mitchell, O O
Katie O O
E. O O
Unit O O
#: O O
6146161 O O
Date: O O
3/13/94 O O
12:41pm O O
Location: O O
82 O O
MD: O O
Geoffrey O O
D. O O
Lucas, O O
M.D. O O
Age: O O
77 O O
Sex: O O
F O O
Height O O
(in): O O
61 O O
Weight O O
(lb): O O
146 O O
Hemoglobin O O
(g/dl): O O
10.1 O O
Hb O O
Date: O O
03/02/2094 O O
Eval O O
Legend: O O
N=Normal O O
A=Abnormal O O
m=Mild O O
M=Moderate O O
S=Severe O O
SPIROMETRY: O O
Pre O O
Bronchodilator O O
Meas. O O
Pred. O O
%Pred O O
CI-Range/Eval O O
--------------------------------------------------------- O O
FEV1 O O
(L) O O
0.86 O O
1.76 O O
49 O O
1.2-2.32 O O
Am O O
FVC O O
(L) O O
1.89 O O
2.36 O O
80 O O
1.68-3.04 O O
N O O
FEV1/FVC O O
(%) O O
46 O O
76 O O
--- O O
67- O O
FEF O O
25-75 O O
(L/s) O O
0.25 O O
1.53 O O
16 O O
0.17-2.89 O O
PEFR O O
(L/s) O O
2.97 O O
4.93 O O
60 O O
2.08-7.78 O O
FIVC O O
(L) O O
1.5 O O
2.36 O O
--- O O
1.68-3.04 O O
FEF50/FIF50 O O
(%) O O
0.1 O O
--- O O
--- O O
- O O
LUNG O O
VOLUMES: O O
Meas. O O
Pred. O O
%Pred O O
CI-Range/Eval O O
--------------------------------------------------------- O O
TLC O O
(L) O O
4.89 O O
4.54 O O
108 O O
3.46-5.62 O O
N O O
FRC O O
(L) O O
3.49 O O
2.64 O O
132 O O
1.58-3.7 O O
N O O
ERV O O
(L) O O
0.49 O O
0.46 O O
107 O O
- O O
RV O O
(L) O O
3 O O
2.18 O O
138 O O
1.41-2.95 O O
Am O O
RV/TLC O O
(L) O O
61 O O
46 O O
--- O O
37-55 O O
VC O O
(L) O O
1.89 O O
2.36 O O
80 O O
1.68-3.04 O O
DIFFUSION: O O
Meas. O O
Pred. O O
%Pred O O
CI-Range/Eval O O
--------------------------------------------------------- O O
DLCO O O
[Hb] O O
(mL/min/mmHg) O O
3.61 O O
18.51 O O
20 O O
11.86-25.16 O O
AM O O
DLCO O O
(mL/min/mmHg) O O
3.05 O O
18.51 O O
16 O O
11.86-25.16 O O
Hb O O
(g/dl) O O
10.1 O O
13.4 O O
--- O O
12-16 O O
VA O O
[BTPS] O O
(L) O O
3.12 O O
4.61 O O
--- O O
4.53-4.69 O O
DL/VA O O
(mL/min/mmHg/L) O O
1.16 O O
3.81 O O
30 O O
2.49-5.13 O O
AM O O
PLETHYSMOGRAPHY: O O
Meas. O O
Pred. O O
%Pred O O
CI-Range/Eval O O
--------------------------------------------------------- O O
Raw O O
(cmH2O/L/s) O O
6.2 O O
2.8 O O
221 O O
- O O
sGaw O O
(L/s/cmH2O) O O
0.04 O O
0.12 O O
33 O O
- O O
OXIMETRY: O O
O2 O O
Sat O O
(%) O O
------------------------------- O O
Normal O O
95-98 O O
Resting O O
(Room O O
O2) O O
88.0 O O
Resting O O
(Elev O O
O2) O O
93.0 O O
INTERPRETATION: O O
FEV1 O O
and O O
FEV1/FVC O O
are O O
reduced, O O
FVC O O
is O O
normal. O O
TLC O O
is O O
normal. O O
FRC O O
is O O
normal. O O
RV O O
is O O
increased. O O
RV/TLC O O
ratio O O
is O O
increased. O O
Resistance O O
is O O
increased; O O
specific O O
conductance O O
is O O
decreased. O O
Single O O
breath O O
diffusion O O
capacity O O
is O O
severely O O
reduced, O O
although O O
there O O
was O O
only O O
one O O
adequate O O
maneuver O O
performed O O
and O O
thus O O
reproducibility O O
cannot O O
be O O
assured. O O
DL/VA O O
is O O
reduced. O O
These O O
data O O
demonstrate O O
a O O
mild O O
obstructive O O
ventilatory O O
deficit. O O
The O O
spirometry O O
obtained O O
today O O
are O O
similar O O
to O O
those O O
from O O
12/14/2092. O O
Resting O O
room O O
air O O
oxygen O O
saturation O O
is O O
below O O
normal O O
limits, O O
and O O
there O O
is O O
significant O O
arterial O O
oxygen O O
desaturation O O
with O O
exertion. O O
Kevondrick O O
K. O O
Naranjo, O O
M.D. O O
/ O O
Charles O O
Yzaguirre, O O
M.D. O O
* O O
end O O
of O O
report O O
* O O
Assessment O O
and O O
plan: O O
77 O O
year O O
old O O
woman O O
S/P O O
redo-MVR, O O
AS, O O
CHF, O O
COPD, O O
S/P O O
R O O
hip O O
replacement. O O
Problems: O O
Congestive O O
heart O O
failure O O
- O O
Her O O
LV O O
outflow O O
tract O O
obstruction O O
and O O
hypertrophic O O
cardiomyopathy O O
is O O
well O O
compensated O O
with O O
metoprolol O B-MEDICATION
and O O
verapamil O B-MEDICATION
SR. O O
She O O
cannot O O
tolerate O O
ACE O O
inhibitors O O
because O O
of O O
her O O
severe O O
aortic O O
stenosis. O O
Continue O O
diuresis O O
with O O
bumex O O
6 O O
mg O O
po O O
bid. O O
Good O O
BUN O O
and O O
Cr, O O
weight O O
close O O
to O O
target, O O
overall O O
euvolemic. O O
Chronic O O
obstructive O O
lung O O
disease O O
- O O
Followed O O
by O O
Dr. O O
Lucas. O O
PFT's O O
stable. O O
Changes O O
to O O
Medications O O
this O O
visit O O
Niferex O O
150 O O
1 O O
po O O
qd O O
Take O O
one O O
pill O O
a O O
day O O
QTY:90 O O
Refills:4 O O
Start: O O
04/14/2094 O O
Zyrtec O O
10mg O O
po O O
qd O O
Start: O O
04/29/2092 O O
Advair O O
500/50mcg O O
spray O O
inh O O
bid O O
Start: O O
04/29/2092 O O
Spiriva O O
18mcg/capsule O O
inh O O
qd O O
use O O
only O O
in O O
HandiHaler O O
device O O
QTY:90 O O
capsules O O
Refills:3 O O
Start: O O
11/11/2092 O O
verapamil O B-MEDICATION
hydrochloride, O O
SR O O
(extended O O
release) O O
120mg O O
SR O O
po O O
qd O O
Start: O O
04/29/2092 O O
metoprolol O B-MEDICATION
100 O O
mg O O
po O O
tid O O
Start: O O
04/29/2092 O O
Lescol O O
40mg O O
po O O
qhs O O
Start: O O
04/29/2092 O O
Plavix O B-MEDICATION
75mg O O
po O O
qd O O
Start: O O
04/29/2092 O O
Nexium O O
40mg O O
po O O
qd O O
Start: O O
04/29/2092 O O
Colace O O
100 O O
mg O O
po O O
tid O O
Start: O O
04/14/2093 O O
Bumex O O
6 O O
mg O O
po O O
bid O O
Start: O O
11/13/2092 O O
MiraLax O O
17 O O
g O O
2 O O
po O O
qhs O O
for O O
constipation O O
Start: O O
04/14/2093 O O
Fosamax O O
70mg O O
po O O
qwk O O
Start: O O
04/29/2092 O O
Ambien O O
5 O O
mg O O
po O O
qhs O O
Start: O O
04/14/2093 O O
Paxil O O
10mg O O
po O O
qd O O
Start: O O
04/29/2092 O O
Signed O O
electronically O O
by O O
Quinton O O
G O O
Janssen O O
MD O O
on O O
Apr O O
14, O O
2094 O O

Record B-SMOKER O
date: O O
2074-10-20 O O
NAME: O O
Fonsea, O O
Lydia O O
MRN: O O
7090253 O O
The O O
patient O O
is O O
a O O
58-year-old O O
white O O
female, O O
who O O
presents O O
in O O
follow O O
up O O
of O O
type B-DIABETES O
2 I-DIABETES O
diabetes I-DIABETES O
mellitus. I-DIABETES O
REVIEW O O
OF O O
SYSTEMS: O O
Review O O
of O O
systems O O
is O O
positive O O
for O O
mild O O
nocturia O O
and O O
negative O O
for O O
chest O O
pain, O O
dyspnea, O O
bleeding, O O
heat O O
or O O
cold O O
intolerance. O O
HOME O O
BLOOD O O
GLUCOSE O O
MONITORING: O O
Semi-compliant. O O
DIET: O O
Semi-compliant O O
with O O
low-salt O O
ADA. O O
ACTIVITY O O
LEVEL: O O
METS O O
2. O O
PHYSICAL O O
EXAMINATION: O O
Vital O O
signs: O O
Blood O O
pressure O O
114/68. O O
Weight O O
198 O O
pounds. O O
Heart O O
rate O O
68. O O
Respiratory O O
rate O O
18. O O
General O O
appearance: O O
Overweight. O O
HEENT: O O
No O O
retinal O O
bleeding. O O
Neck: O O
No O O
JVD, O O
no O O
bruits, O O
no O O
masses. O O
Heart: O O
Heart O O
sounds O O
normal. O O
Lungs: O O
Clear. O O
Extremities: O O
No O O
peripheral O O
edema. O O
ASSESSMENT O O
AND O O
PLAN: O O
(1) O O
Type O O
2 O O
diabetes O O
mellitus. O O
I O O
suspect O O
the O O
control O O
is O O
not O O
adequate. O O
The O O
last O O
hemoglobin B-DIABETES O
A1C I-DIABETES O
was I-DIABETES O
7.9% I-DIABETES O
on I-DIABETES O
04/29/73. I-DIABETES O
Plan: O O
Repeat O O
hemoglobin O O
A1C. O O
Diet O O
and O O
increase O O
activity O O
level. O O
She O O
most O O
likely O O
is O O
going O O
to O O
need O O
a O O
second O O
nighttime O O
injection. O O
(2) O O
Depression. O O
Plan: O O
Continue O O
the O O
same O O
medications. O O
(3) O O
Mild O O
diabetic O O
nephropathy. O O
Plan: O O
Check O O
urine O O
microalbumin. O O
Blood O O
pressure O O
is O O
excellent O O
today. O O
(4) O O
Health O O
maintenance. O O
The O O
patient O O
will O O
need O O
a O O
lipid O O
profile O O
and O O
flu O O
vaccine. O O
The O O
patient O O
will O O
follow O O
up O O
in O O
one O O
month. O O
Austin O O
Jaeger, O O
M.D. O O
AJ/yeung/updegraff O O

Record O O
date: O O
2076-11-20 O O
JMH O O
Internal O O
Medicine O O
Intern O O
Admit O O
Note O O
Patient O O
name: O O
Linda O O
Fonseca O O
MR# O O
7090253 O O
Location: O O
Rm O O
4103 O O
Admitting O O
MD: O O
PCP: O O
Dr. O O
Austin O O
Jaeger O O
(Dr. O O
Lenard O O
Wyatt O O
covering) O O
Wards O O
CODE: O O
Full O O
Date O O
of O O
admission: O O
11/19/2076 O O
CC/RFA: O O
abdominal O O
pain O O
HPI O O
60 O O
year O O
old O O
woman O O
with O O
diabetes B-DIABETES O
and O O
depression O O
presents O O
with O O
abdominal O O
pain. O O
She O O
has O O
had O O
constipation O O
and O O
gas O O
beginning O O
approximately O O
6 O O
weeks O O
ago O O
and O O
for O O
the O O
last O O
two O O
weeks O O
has O O
had O O
watery O O
diarrhea, O O
cramping O O
and O O
gas. O O
She O O
vomited O O
once O O
yesterday, O O
producing O O
a O O
yellow O O
non-bloody O O
discharge. O O
She O O
complains O O
that O O
her O O
abdomen O O
is O O
increasingly O O
distended. O O
She O O
notices O O
no O O
particular O O
association O O
between O O
eating O O
and O O
abdominal O O
complaints, O O
and O O
has O O
not O O
had O O
any O O
relief O O
with O O
Tums, O O
the O O
only O O
medication O O
that O O
she O O
has O O
tried. O O
She O O
denies O O
fever, O O
chills, O O
thin O O
stools, O O
hematochezia, O O
melena, O O
sick O O
contacts, O O
travel O O
or O O
change O O
in O O
diet O O
or O O
medication. O O
She O O
has O O
had O O
no O O
shortness O O
of O O
breath, O O
chest O O
pain O O
or O O
palpitations. O O
She O O
has O O
had O O
no O O
recent O O
change O O
in O O
her O O
weight, O O
no O O
pruritus O O
and O O
has O O
not O O
had O O
any O O
increased O O
bruising O O
or O O
bleeding. O O
ED O O
Course O O
Given O O
zofran O O
4 O O
mg O O
IV O O
x O O
2, O O
MSO4 O O
2 O O
mg O O
IV O O
x O O
3, O O
Abdominal O O
CT, O O
then O O
sent O O
to O O
floor. O O
PMH O O
Breast O O
cancer O O
Depression O O
& O O
anxiety O O
MEDICATIONS O O
ON O O
ADMISSION O O
Buspar O O
10 O O
mg O O
PO O O
TID O O
Clonazepam O O
1 O O
mg O O
PO O O
BID O O
Effexor O O
75 O O
mg O O
5ID O O
Humulin B-MEDICATION B-MEDICATION
n I-MEDICATION O
18 O O
QPM O O
Humulin O B-MEDICATION
n O O
50 O O
QAM O O
Humulin B-MEDICATION O
r I-MEDICATION O
20 O O
QAM O O
Lescol O O
20 O O
mg O O
PO O O
QHS O O
Metformin B-MEDICATION B-MEDICATION
500 O O
mg O O
PO O O
BID O O
Tamoxifen O O
20 O O
mg O O
PO O O
QAM O O
ALLERGIES/ADVERSE O O
DRUG O O
RXN: O O
sulfa O O
drugs O O
cause O O
rash, O O
tricyclic O O
antidepressants O O
cause O O
cough O O
SOCIAL O O
HISTORY O O
Tob: B-SMOKER O
50 B-SMOKER O
pack I-SMOKER O
year, I-SMOKER O
current I-SMOKER O
smoker I-SMOKER O
@ I-SMOKER O
1 I-SMOKER O
pack/day I-SMOKER O
EtOH: O O
none. O O
IVDU: O O
none. O O
FAMILY O O
HISTORY O O
Father O O
died O O
of O O
lymphoma O O
at O O
age O O
78, O O
uncle O O
died O O
of O O
leukemia O O
at O O
age O O
78 O O
ROS O O
Generalized O O
weakness O O
No O O
change O O
in O O
appetite, O O
no O O
sore O O
throat, O O
no O O
cough, O O
no O O
dysphagia, O O
no O O
heartburn. O O
No O O
change O O
in O O
sensorium, O O
no O O
toxic O O
ingestions. O O
Other O O
systems O O
negative O O
in O O
detail. O O
PHYSICAL O O
EXAM O O
VS: O O
T O O
99.2 O O
HR O O
92 O O
BP B-HYPERTENSION O
144/72 I-HYPERTENSION O
RR O O
18 O O
SO2 O O
93% O O
RA O O
Gen: O O
Lying O O
in O O
bed, O O
NAD O O
HEENT: O O
PERRLA/EOMI, O O
MMM O O
Neck: O O
fleshy, O O
supple, O O
no O O
carotid O O
bruit, O O
JV O O
flat O O
Lungs: O O
CTA O O
bilaterally O O
without O O
rales O O
or O O
rhonchi O O
Heart: O O
RRR, O O
no O O
murmur O O
rubs O O
or O O
gallops O O
Abd: O O
Obese, O O
non-protuberant, O O
BS+, O O
no O O
shifting O O
dullness, O O
increased O O
tympany, O O
slight O O
tenderness O O
to O O
palpation O O
in O O
LLQ, O O
no O O
rebound O O
tenderness, O O
no O O
tenderness O O
to O O
percussion, O O
soft, O O
no O O
masses O O
Extr: O O
1+ O O
DP O O
pulses, O O
no O O
cords, O O
clubbing O O
or O O
edema O O
Neuro: O O
A O O
+ O O
Ox3; O O
MS O O
normal; O O
CNs O O
II-XII O O
intact; O O
Babinski O O
sign O O
absent O O
Skin: O O
No O O
rashes O O
or O O
open O O
wounds O O
Guaiac O O
negative O O
stool O O
x O O
2 O O
LABS O O
Sodium O O
(Stat O O
Lab) O O
138 O O
(135-145) O O
mmol/L O O
Potassium O O
(Stat O O
Lab) O O
4.1 O O
(3.4-4.8) O O
mmol/L O O
Chloride O O
(Stat O O
Lab) O O
105 O O
(100-108) O O
mmol/L O O
CO2 O O
(Stat O O
Lab) O O
23.5 O O
(23.0-31.9) O O
mmol/L O O
BUN O O
(Stat O O
Lab) O O
17 O O
(8-25) O O
mg/dl O O
Creatinine O O
(Stat O O
Lab) O O
1.0 O O
(0.6-1.5) O O
mg/dl O O
Glucose O O
(Stat O O
Lab) O O
261 O O
H O O
(70-110) O O
mg/dl O O
Calcium O O
8.6 O O
(8.5-10.5) O O
mg/dl O O
Phosphorus O O
2.2 O O
L O O
(2.6-4.5) O O
mg/dl O O
Magnesium O O
1.3 O O
L O O
(1.4-2.0) O O
meq/L O O
Total O O
Protein O O
7.6 O O
(6.0-8.3) O O
g/dl O O
Albumin O O
3.6 O O
(3.3-5.0) O O
g/dl O O
Globulin O O
4.0 O O
(2.6-4.1) O O
g/dl O O
Direct O O
Bilirubin O O
0.1 O O
(0-0.4) O O
mg/dl O O
Total O O
Bilirubin O O
0.3 O O
(0-1.0) O O
mg/dl O O
Alkaline O O
Phosphatase O O
67 O O
(30-100) O O
U/L O O
Transaminase-SGPT O O
27 O O
(7-30) O O
U/L O O
Lipase O O
3.7 O O
(1.3-6.0) O O
U/dl O O
Transaminase-SGOT O O
33 O O
H O O
(9-32) O O
U/L O O
WBC O O
8.2 O O
(4.5-11.0) O O
th/cmm O O
HCT O O
42.6 O O
(36.0-46.0) O O
% O O
HGB O O
15.2 O O
(12.0-16.0) O O
gm/dl O O
RBC O O
4.34 O O
(4.00-5.20) O O
mil/cmm O O
PLT O O
190 O O
(150-350) O O
th/cumm O O
MCV O O
98 O O
(80-100) O O
fl O O
MCH O O
35.1 O O
H O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
35.7 O O
(31.0-37.0) O O
g/dl O O
RDW O O
13.6 O O
(11.5-14.5) O O
% O O
PT O O
12.8 O O
(11.1-13.1) O O
sec O O
PT-INR O O
1.1 O O
APTT O O
24.8 O O
(22.1-35.1) O O
sec O O
Diff O O
Method O O
Auto O O
Poly O O
76 O O
H O O
(40-70) O O
% O O
Lymphs O O
19 O O
L O O
(22-44) O O
% O O
Monos O O
5 O O
(4-11) O O
% O O
EOS O O
0 O O
(0-8) O O
% O O
Basos O O
0 O O
(0-3) O O
% O O
MICRO: O O
BCX O O
sent; O O
stool O O
sent O O
for O O
fecal O O
leukocytes, O O
C. O O
diff, O O
O&P O O
Colonoscopy: O O
08/20/2073 O O
- O O
normal O O
colon. O O
Abd/Pelvic O O
CT: O O
Air O O
within O O
the O O
gastroepiploic O O
and O O
portal O O
vessels O O
as O O
described, O O
without O O
specific O O
bowel O O
pathology. O O
Heterogeneously O O
enhancing O O
masses O O
within O O
the O O
pelvis O O
as O O
described, O O
likely O O
representing O O
exophytic O O
uterine O O
fibroids. O O
Recommend O O
ultrasound O O
of O O
the O O
pelvis O O
for O O
confirmation. O O
Possible O O
small O O
gallstone O O
within O O
the O O
gallbladder O O
without O O
CT O O
evidence O O
for O O
cholecystitis. O O
Fatty O O
liver. O O
CXR: O O
NO O O
EVIDENCE O O
OF O O
PNEUMONIA O O
OR O O
CHF. O O
KUB: O O
NO O O
EVIDENCE O O
OF O O
OBSTRUCTION O O
OR O O
PERFORATION. O O
EKG: O O
NSR O O
at O O
90 O O
bpm, O O
diffusely O O
flattened O O
T O O
waves, O O
no O O
ST O O
abnormalities O O
ASSESSMENT O O
AND O O
PLAN O O
60 O O
year O O
old O O
woman O O
presents O O
with O O
a O O
history O O
of O O
watery O O
diarrhea, O O
gas O O
and O O
diffuse O O
abdominal O O
pain O O
for O O
the O O
past O O
two O O
weeks O O
that O O
has O O
increased O O
in O O
intensity O O
in O O
the O O
last O O
3 O O
days. O O
For O O
the O O
month O O
prior O O
to O O
the O O
onset O O
of O O
diarrhea O O
she O O
reports O O
that O O
she O O
had O O
been O O
constipated. O O
No O O
fevers O O
or O O
chills; O O
patient O O
is O O
afebrile O O
and O O
the O O
WBC O O
is O O
not O O
elevated. O O
Her O O
abdominal O O
exam O O
is O O
remarkable O O
for O O
obesity, O O
tympany O O
and O O
mild O O
LLQ O O
tenderness. O O
Finding O O
of O O
air O O
in O O
the O O
gastroepiploic O O
and O O
portal O O
vessels O O
with O O
no O O
associated O O
intraabdominal O O
pathology O O
is O O
of O O
uncertain O O
significance. O O
Fibroids, O O
which O O
have O O
been O O
previously O O
diagnosed, O O
are O O
seen. O O
Normal O O
colonoscopy O O
08/20/2076. O O
1) O O
GI: O O
Constipation O O
for O O
a O O
month O O
followed O O
by O O
diarrhea O O
for O O
two O O
weeks. O O
This O O
history O O
is O O
suggestive O O
of O O
overflow O O
diarrhea. O O
Patient O O
denies O O
recent O O
narcotic O O
usage O O
and O O
no O O
obstructing O O
lesions O O
are O O
seen O O
on O O
CT O O
scan. O O
May O O
also O O
be O O
infection, O O
malabsorption, O O
osmotic, O O
inflammatory, O O
secretory O O
or O O
a O O
motility O O
defect. O O
No O O
evidence O O
is O O
seen O O
for O O
ischemia, O O
inflammation O O
or O O
infection. O O
Bowel O O
dysmotility O O
resulting O O
from O O
DM O O
may O O
play O O
a O O
role O O
in O O
a O O
motility O O
disorder. O O
- O O
Diet: O O
clears O O
now, O O
NPO O O
after O O
midnight O O
- O O
Stool O O
for O O
fecal O O
leukocytes, O O
O&P, O O
C. O O
diff O O
- O O
Bowel O O
regimen: O O
colace, O O
senokot, O O
miralax O O
- O O
Reglan O O
PRN O O
nausea O O
- O O
Follow O O
clinical O O
exam O O
- O O
Follow O O
WBC, O O
T, O O
lactate O O
for O O
signs O O
of O O
acute O O
sepsis O O
or O O
ischemia O O
- O O
Appreciate O O
GI O O
input O O
(Dr. O O
Utterback) O O
- O O
Apprecate O O
surgery O O
input O O
(Dr. O O
Espinosa) O O
- O O
Ranitidine O O
prophylaxis, O O
zofran O O
PRN O O
nausea O O
2) O O
Gyn: O O
Patient O O
is O O
s/p O O
breast O O
cancer O O
and O O
has O O
fibroids. O O
No O O
evidence O O
of O O
abdominal O O
mass O O
other O O
than O O
fibroids. O O
- O O
Continue O O
on O O
tamoxifen O O
20 O O
mg O O
PO O O
QAM O O
3) O O
Psychiatric: O O
Depression O O
& O O
anxiety O O
- O O
Buspar O O
- O O
clonazepam O O
- O O
effexor O O
4) O O
DM2: O O
Continue O O
home O O
meds O O
(metformin O O
+ O O
insulin), O O
hold O O
when O O
on O O
diet O O
without O O
substantial O O
calories O O
(clears, O O
NPO) O O
5) O O
Prophylaxis: O O
patient O O
is O O
ambulatory; O O
ranitidine; O O
commode O O
by O O
bedside. O O
Vernon O O
Ewing, O O
JMH O O
Internal O O
Medicine O O
intern O O
Pager O O
#71151 O O

Record O O
date: O O
2078-03-11 O O
EDVISIT^30921467^FONSECA, O O
LINDA^03/11/78^ULLOA, O O
CHRISTOPHER O O
I O O
have O O
interviewed O O
and O O
examined O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation, O O
and O O
concur O O
except O O
as O O
noted. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
is O O
a O O
61-year-old O O
female O O
who O O
presents O O
complaining O O
of O O
chest O O
pain O O
and O O
lightheadedness O O
for O O
the O O
past O O
4 O O
days. O O
The O O
patient O O
has O O
a O O
medical O O
history O O
remarkable O O
for O O
breast O O
cancer, O O
status O O
post O O
mastectomy O O
and O O
node O O
dissection, O O
which O O
have O O
given O O
her O O
chronic O O
left O O
axillary O O
pain. O O
The O O
patient O O
states O O
that O O
this O O
chest O O
pain O O
that O O
she O O
felt O O
is O O
distinct O O
and O O
is O O
nonexertional. O O
It O O
is O O
associated O O
with O O
increased O O
fatigue O O
and O O
shortness O O
of O O
breath O O
associated O O
with O O
it. O O
Today, O O
states O O
that O O
the O O
dyspnea O O
resolved O O
after O O
being O O
given O O
oxygen O O
in O O
the O O
ambulance O O
en O O
route O O
and O O
called O O
her O O
primary O O
care O O
physician O O
who O O
told O O
her O O
to O O
come O O
to O O
the O O
Emergency O O
Department. O O
PAST O O
MEDICAL O O
HISTORY: O O
Remarkable O O
for O O
diabetes B-DIABETES O
and O O
hypercholesterolemia. B-HYPERLIPIDEMIA O
OTHER O O
MEDICAL O O
HISTORY, O O
SURGICAL O O
HISTORY, O O
SOCIAL O O
HISTORY, O O
FAMILY O O
HISTORY, O O
REVIEW O O
OF O O
SYSTEMS, O O
MEDICATIONS, O O
AND O O
ALLERGIES: O O
As O O
noted. O O
The O O
patient O O
is O O
an B-SMOKER O
active I-SMOKER O
smoker. I-SMOKER O
PHYSICAL O O
EXAMINATION: O O
In O O
the O O
Emergency O O
Department, O O
the O O
patient O O
is O O
awake O O
and O O
alert, O O
nontoxic O O
appearing, O O
afebrile, O O
with O O
stable O O
vital O O
signs. O O
HEENT: O O
Atraumatic, O O
normocephalic. O O
Oropharynx O O
clear, O O
moist O O
mucous O O
membranes. O O
Neck: O O
Supple, O O
without O O
meningismus O O
or O O
midline O O
tenderness. O O
Respirations O O
clear O O
with O O
no O O
rhonchi, O O
rales, O O
or O O
wheezes. O O
Cardiovascular: O O
Regular O O
rate O O
without O O
murmurs, O O
rubs, O O
or O O
gallops. O O
Abdomen: O O
Soft, O O
nontender, O O
without O O
rebound O O
or O O
guarding. O O
Skin O O
is O O
warm, O O
well O O
perfused O O
without O O
petechiae O O
or O O
lesions. O O
There O O
is O O
no O O
edema, O O
no O O
calf O O
or O O
thigh O O
tenderness, O O
no O O
CVA O O
tenderness. O O
Neurologically, O O
she O O
is O O
alert O O
and O O
oriented O O
x3, O O
normal O O
mood O O
and O O
affect. O O
No O O
cranial O O
nerve O O
abnormalities. O O
No O O
sensory O O
or O O
motor O O
deficits. O O
LABORATORY O O
DATA: O O
The O O
patient O O
had O O
an O O
unremarkable O O
CBC O O
and O O
chemistry O O
panel O O
with O O
flat O O
enzymes O O
and O O
normal O O
coags. O O
EKG O O
was O O
sinus O O
with O O
no O O
ectopy, O O
interpreted O O
as O O
normal, O O
chest O O
x-ray, O O
which O O
showed O O
postoperative O O
changes O O
but O O
no O O
infiltrate O O
or O O
edema O O
in O O
this O O
patient O O
with O O
nonvertiginous O O
lightheadedness O O
and O O
chest O O
discomfort O O
in O O
the O O
context O O
of O O
shortness O O
of O O
breath O O
and O O
generalized O O
malaise. O O
PLAN: O O
Plan O O
is O O
for O O
admission, O O
serial O O
enzymes, O O
and O O
risk O O
stratification. O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O
DISPOSITION: O O
The O O
patient O O
is O O
admitted. O O
______________________________ O O
ULLOA, O O
CHRISTOPHER O O
D: O O
03/13/78 O O
T: O O
03/13/78 O O
Dictated O O
By: O O
ULLOA, O O
CHRISTOPHER O O
eScription O O
document:7-3872310 O O
CB O O

Record O O
date: O O
2081-06-24 O O
Dunn O O
County O O
Associates O O
Internal O O
Medicine O O
Admission O O
Note O O
Patient: O O
Fonseca, O O
Linda O O
DCA O O
MRN: O O
7090253 O O
Date O O
of O O
Admission O O
to O O
Internal O O
Medicine: O O
06/24/81 O O
Attending: O O
Dr O O
A O O
Jaeger O O
PCP: O O
same O O
Code O O
Status: O O
Full O O
code O O
CC: O O
abdominal O O
pain O O
Source: O O
electronic O O
records, O O
patient O O
HPI: O O
Mr O O
Fonseca O O
is O O
a O O
64 O O
yo O O
F O O
h/o O O
breast O O
cancer, O O
insulin-requiring B-DIABETES O
DM2, B-DIABETES O
lupus, O O
anxiety O O
who O O
is O O
p/w O O
10 O O
days O O
of O O
diarrhea, O O
N/V O O
and O O
anorexia. O O
Pt O O
had O O
originally O O
presented O O
to O O
the O O
DCA O O
ED O O
on O O
06/15/81 O O
with O O
2 O O
days O O
of O O
profuse O O
watery O O
diarrhea; O O
treated O O
with O O
IVF O O
and O O
discharged. O O
No O O
fevers O O
or O O
chills O O
at O O
that O O
time. O O
Reports O O
that O O
she O O
felt O O
better, O O
and O O
experienced O O
complete O O
resolution O O
of O O
her O O
diarrhea. O O
Over O O
the O O
next O O
week, O O
pt O O
had O O
anorexia, O O
and O O
was O O
able O O
to O O
tolerate O O
soups O O
and O O
clears. O O
2 O O
days O O
prior O O
to O O
this O O
current O O
admission, O O
pt O O
had O O
recurrence O O
of O O
her O O
watery O O
profuse O O
diarrhea. O O
She O O
endorses O O
increased O O
frequency O O
(almost O O
q1h O O
diarrhea) O O
that O O
does O O
not O O
seem O O
correlated O O
with O O
food O O
intake. O O
Wakes O O
her O O
at O O
night. O O
Recently O O
has O O
been O O
associated O O
with O O
worsening O O
epigastric O O
and O O
LUQ O O
tenderness. O O
On O O
the O O
day O O
of O O
admission, O O
pt O O
had O O
3 O O
episodes O O
of O O
non-bloody, O O
non-bilious O O
emesis. O O
She O O
denies O O
dysentery, O O
BRBPR, O O
or O O
melena. O O
Denies O O
ingestion O O
of O O
raw O O
or O O
undercooked O O
foods. O O
Pt O O
presented O O
to O O
the O O
DCA O O
ED O O
again, O O
vitals O O
97, O O
85, O O
109/57, O O
99%ra. O O
Given O O
1L O O
NS, O O
D51/2 O O
NS O O
at O O
125cc/hr, O O
levofloxacin O O
250 O O
mg O O
PO O O
x1 O O
for O O
white O O
blood O O
cells O O
in O O
urine, O O
and O O
zofran. O O
Admitted O O
to O O
Internal O O
Medicine O O
for O O
further O O
management. O O
Review O O
of O O
Systems: O O
(+) O O
fatigue, O O
now O O
x O O
1 O O
year O O
Denies O O
visual O O
disturbance, O O
headaches O O
Denies O O
dysphagia, O O
odynophagia, O O
or O O
oral O O
ulcers O O
Denies O O
chest O O
discomfort, O O
palpitations, O O
shortness O O
of O O
breath, O O
DOE. O O
(+) O O
abd O O
pain, O O
N/V, O O
diarrhea O O
as O O
above. O O
Denies O O
melena/hematochezia. O O
Denies O O
dysuria, O O
urethral O O
discharge O O
or O O
increased O O
urinary O O
frequency O O
Denies O O
rashes, O O
photosensitivity O O
(+) O O
intermittent O O
chronic O O
joint O O
tenderness O O
(hand, O O
fingers, O O
wrists, O O
back) O O
Past O O
Medical/Surgical O O
History: O O
Lupus; O O
(+) O O
ANA, O O
dsdna, O O
smith; O O
f/b O O
Dr O O
Merritt O O
Breast O O
ca O O
s/p O O
bilateral O O
mastectomies O O
w/positive O O
nodes; O O
f/b O O
Dr O O
Land O O
Depression O O
and O O
anxiety O O
DM2; O O
insulin-requiring, O O
well O O
controlled O O
A1c B-DIABETES O
6.9% I-DIABETES O
(2/81), I-DIABETES O
malb O O
11 O O
(2/81) O O
Hyperlipidemia B-HYPERLIPIDEMIA B-MEDICATION
h/o O O
back O O
pain O O
h/o O O
ear O O
infection O O
s/p O O
Augmentin O O
Home O O
medications O O
(confirmed O O
with O O
patient): O O
Asa B-MEDICATION B-MEDICATION
81 O O
MG O O
PO O O
QD O O
Clonazepam O O
1MG O O
PO O O
BID O O
PRN O O
Effexor O O
(VENLAFAXINE O O
HCL) O O
150MG O O
(75MG O O
TABLET O O
) O O
PO O O
BID O O
Humulin B-MEDICATION O
N I-MEDICATION O
40 I-MEDICATION O
qAM I-MEDICATION O
/ I-MEDICATION O
22 I-MEDICATION O
qPM I-MEDICATION O
Humulin B-MEDICATION O
R I-MEDICATION O
(INSULIN I-MEDICATION O
REGULAR I-MEDICATION O
HUMAN) I-MEDICATION O
Variable I-MEDICATION O
(100 I-MEDICATION O
U/ML I-MEDICATION O
VIAL I-MEDICATION O
ML) I-MEDICATION O
SC I-MEDICATION O
Hydroxychloroquine O O
200 O O
MG O O
PO O O
QD O O
Letrozole O O
2.5 O O
MG O O
PO O O
QD O O
Prilosec O O
20 O O
MG O O
PO O O
BID O O
Simvastatin B-MEDICATION B-MEDICATION
40 O O
MG O O
PO O O
QHS O O
Topamax O B-MEDICATION
100 O O
MG O O
qAM O O
/ O O
50 O O
MG O O
aPM O O
Allergies: O O
Tricyclic O O
Antidepressants O O
- O O
cough, O O
Sulfa O O
- O O
Rash, O O
EZETIMIBE O O
- O O
lethargy, O O
GI O O
Intolerance O O
Family O O
History O O
(from O O
PCP O O
note O O
and O O
patient): O O
Mom: O O
stroke, O O
CAD, O O
leukemia, O O
ms O O
Dad: O O
breast O O
cancer, O O
CAD, O O
DM, O O
stroke, O O
leukemia, O O
ms O O
Siblings: O O
thyroid O O
cancer O O
Social O O
History: O O
Lives O O
with O O
mother O O
and O O
cousin O O
in O O
house O O
in O O
3 O O
family O O
house. O O
No O O
pets, O O
or O O
recent O O
travel. O O
Not O O
married. O O
Tobacco: O O
active B-SMOKER O
smoker, I-SMOKER O
&#189; O O
to O O
2 O O
ppd O O
&gt;50yrs. O O
Not O O
interested O O
in O O
quitting O O
at O O
this O O
time. O O
Does O O
not O O
want O O
a O O
nicotine O O
patch. O O
Etoh: O O
denies O O
Illicits: O O
denies O O
Physical O O
examinations: O O
Gen: O O
pleasant, O O
smiling, O O
coomfortable O O
Vitals: O O
97, O O
81, O O
128/56, O O
97%ra O O
HEENT: O O
anicteric, O O
MMdry O O
Cor: O O
regular, O O
no O O
murmurs O O
or O O
rubs O O
Lungs: O O
CTAB O O
w/mild O O
rhonci O O
in O O
lower O O
fields, O O
no O O
wheezing O O
or O O
crackles O O
Abd: O O
soft, O O
mildly O O
distended, O O
mild O O
epigastric/LUQ O O
pain, O O
no O O
HSM, O O
hypoactive O O
BS O O
Ext: O O
stable O O
joint O O
tenderness O O
over O O
wrists, O O
fingers, O O
knees, O O
ankles. O O
Joints O O
do O O
not O O
exhibit O O
erythema, O O
warmth O O
or O O
ballotable O O
fluid. O O
Labs: O O
Na O O
141, O O
K O O
3.7, O O
Cl O O
105, O O
CO2 O O
22.5 O O
BUN O O
17, O O
Cr O O
1.13, O O
glu O O
205 O O
Ca O O
9.3, O O
alb O O
4.1, O O
glob O O
3.8, O O
amy O O
90, O O
lipase O O
103 O O
ALT O O
24, O O
AST O O
24, O O
AP O O
115, O O
TB O O
0.3, O O
DB O O
0.1 O O
INR O O
1.0 O O
TSH O O
1.28, O O
FT4 O O
1.0 O O
UA: O O
clear, O O
trace O O
ketone, O O
&gt;1.030, O O
gluc O O
neg, O O
1+ O O
prot, O O
Hcasts O O
neg, O O
1+ O O
WBC O O
WBC O O
15.1, O O
HCT O O
43.6, O O
PLT O O
211 O O
P O O
74%, O O
L O O
11%, O O
M O O
4%, O O
Bands O O
10% O O
CXR- O O
no O O
acute O O
process, O O
clear O O
lungs O O
ECG- O O
NSR O O
80, O O
nl O O
axis, O O
nRWP, O O
no O O
concerning O O
STTW O O
changes O O
Assessment: O O
64 O O
yo O O
F O O
h/o O O
breast O O
cancer, O O
insulin-requiring O O
DM2, O O
lupus, O O
anxiety O O
who O O
is O O
p/w O O
10 O O
days O O
of O O
recurrent O O
diarrhea, O O
N/V, O O
bandemia O O
and O O
anorexia O O
consistent O O
with O O
infectious O O
etiology. O O
Interestingly, O O
pt O O
also O O
has O O
an O O
elevated O O
lipase, O O
alk O O
phos O O
and O O
some O O
mild O O
epigastric O O
tenderness O O
that O O
suggest O O
a O O
mild O O
pancreatitis. O O
Distended O O
abdomen O O
c/f O O
third-spaced O O
fluid. O O
Plan: O O
Diarrhea O O
&#183; O O
Follow-up O O
stool O O
cultures O O
&#183; O O
Support O O
with O O
IV O O
fluids O O
&#183; O O
Consider O O
CT O O
scan O O
if O O
w/u O O
is O O
negative O O
Pancreatitis O O
&#183; O O
Bowel O O
rest, O O
NPO O O
&#183; O O
Aggressive O O
IVF O O
w/D5NS O O
x O O
2 O O
liters O O
&#183; O O
Pain O O
control O O
with O O
morphine O O
prn O O
(but O O
discomfort O O
is O O
very O O
mild) O O
&#183; O O
Check O O
RUQ O O
US O O
to O O
assess O O
for O O
gallbladder/pancreatic O O
pathology O O
DM2 O O
&#183; O O
&#189; O O
dose O O
insulin O O
while O O
NPO O O
&#183; O O
RISS O O
&#183; O O
Consider O O
adding O O
very O O
low O O
dose O O
ACE O O
I O O
after O O
diarrhea O O
resolves O O
UTI: O O
no O O
sx O O
or O O
indication O O
for O O
abx. O O
Will O O
hold O O
on O O
abx, O O
and O O
check O O
urine O O
culture O O
SLE: O O
will O O
cont O O
plaquenil. O O
Appears O O
to O O
be O O
clinically O O
mild, O O
no O O
evidence O O
of O O
flare. O O
?etiology O O
of O O
chronic O O
fatigue O O
Depression/anxiety, O O
breast O O
ca: O O
cont O O
home O O
medications O O
PPX. O O
Lovenox, O O
PPI O O
(reflux) O O
FEN. O O
NPO. O O
D5NS O O
150 O O
cc/h O O
x O O
2 O O
liters O O
CODE: O O
Full O O
code O O
Case O O
discussed O O
with O O
Dr O O
Ritter, O O
coverage O O
for O O
Dr O O
A O O
Jaeger, O O
Medicine O O
Attending. O O
_________________________ O O
Virginia O O
N O O
Volk, O O
MD, O O
PhD O O
PGY-3 O O
Internal O O
Medicine, O O
DCA O O
Pager O O
48249 O O

Record O O
date: O O
2082-04-07 O O
SDU O O
JAR O O
Admission O O
Note O O
Patient: O O
Fonseca, O O
Linda O O
DCA O O
MRN: O O
7090253 O O
Date O O
of O O
Admission: O O
04/07/82 O O
Attending: O O
Asia O O
Doty O O
PCP: O O
Austin O O
Jaeger O O
(Whitehouse) O O
Code O O
Status: O O
Full O O
code O O
CC: O O
chest B-CAD O
pain I-CAD O
HPI: O O
This O O
is O O
a O O
65 O O
yo O O
female O O
with O O
T2DM, B-DIABETES O
HL, B-HYPERLIPIDEMIA O
active B-SMOKER O
smoking, B-SMOKER O
breast O O
cancer O O
s/p O O
BL O O
mastectomy O O
and O O
chemoradiation, O O
and O O
a O O
question O O
of O O
a O O
lupus-like O O
disorder O O
who O O
presents O O
with O O
chest O O
pain. O O
She O O
was O O
seated O O
at O O
breakfast O O
this O O
AM O O
when O O
she O O
developed O O
sudden O O
onset O O
ripping O O
chest O O
pain O O
which O O
radiated O O
&#8220;like O O
a O O
knife&#8221; O O
to O O
her O O
upper O O
back. O O
It O O
was O O
associated O O
with O O
nausea O O
but O O
no O O
vomiting O O
or O O
diaphoresis O O
or O O
shortness O O
of O O
breath. O O
It O O
did O O
radiate O O
down O O
both O O
arms, O O
but O O
she O O
her O O
arm O O
pains O O
are O O
now O O
new. O O
It O O
was O O
not O O
relieved O O
by O O
any O O
positioning, O O
or O O
largely O O
affected O O
by O O
taking O O
deep O O
breaths. O O
It O O
tapered O O
off O O
over O O
about O O
20 O O
minutes. O O
She O O
felt O O
fatigued O O
and O O
layed O O
down, O O
when O O
it O O
occurred O O
again O O
several O O
hours O O
later, O O
again O O
lasting O O
for O O
about O O
20 O O
minutes. O O
She O O
then O O
presented O O
to O O
DCA-ED O O
for O O
evaluation. O O
She O O
had O O
a O O
negative O O
adenosine O O
MIBI O O
at O O
JMH O O
in O O
2078. O O
She O O
has O O
had O O
a O O
difficult O O
time O O
recently, O O
she O O
is O O
under O O
evaluation O O
for O O
a O O
lupus-like O O
syndrome O O
(she O O
has O O
noted O O
positivity O O
for O O
ANA, O O
anti-smith, O O
anti-dsDNA). O O
She O O
has O O
had O O
progressive O O
joint O O
and O O
muscle O O
pain O O
of O O
all O O
of O O
her O O
major O O
joints O O
(ankes, O O
knees, O O
hips, O O
wrists, O O
elbows, O O
shoulders, O O
neck, O O
lumbar O O
back) O O
and O O
the O O
muscles O O
of O O
her O O
arms O O
and O O
legs. O O
She O O
endorses O O
progressive O O
mental O O
&#8220;cloudiness&#8221;, O O
frequently O O
dropping O O
items O O
like O O
cutlery O O
and O O
cups, O O
and O O
increasing O O
tremor O O
in O O
her O O
hands. O O
DCA O O
ED O O
Course: O O
Initial O O
EKG O O
NSR O O
without O O
ischemic O O
changes O O
Initial O O
biomarkers O O
strongly O O
positive O O
with O O
CKMB O O
33 O O
and O O
Troponin O O
0.36. O O
CXR O O
unremarkable. O O
She O O
was O O
treated B-CAD O
for I-CAD O
NSTEMI I-CAD O
with O O
ASA B-MEDICATION B-MEDICATION
325 O O
mg O O
X O O
1, O O
heparin O O
gtt, O O
IV O O
lopressor. B-MEDICATION B-MEDICATION
She O O
had O O
a O O
brief O O
episode O O
of O O
CP O O
which O O
was O O
relieved O O
by O O
SL O O
NTG B-MEDICATION O
and O O
morphine. O O
She O O
was O O
sent O O
to O O
SDU O O
for O O
further O O
evaluation O O
and O O
treatment. O O
ROS O O
(positive O O
findings O O
denoted) O O
Constitutional: O O
fatigue O O
Head/Eyes: O O
occ O O
dizziness O O
ENT/Neck: O O
URI O O
sx O O
two O O
weeks O O
ago, O O
chronic O O
neck O O
pain O O
Chest/Respiratory: O O
See O O
HPI O O
GI/Abdominal: O O
denies O O
Cardiovascular: O O
See O O
HPI O O
Musculoskel/Extr/Back: O O
See O O
HPI O O
Neuro: O O
See O O
HPI O O
MEDICAL O O
HISTORY O O
Hx O O
of O O
pancreatitis O O
Question O O
of O O
SLE; O O
(+) O O
ANA, O O
dsdna, O O
smith; O O
Breast O O
ca O O
- O O
s/p O O
bilateral O O
mastectomies O O
w/positive O O
nodes O O
- O O
s/p O O
chemoradiation O O
on O O
femara O O
Depression O O
and O O
anxiety O O
T2DM; O O
insulin-requiring B-MEDICATION O
Hyperlipidemia B-HYPERLIPIDEMIA B-MEDICATION
h/o O O
back O O
pain O O
h/o O O
ear O O
infection O O
s/p O O
Augmentin O O
FAMILY O O
HISTORY O O
Mom: O O
stroke, O O
CAD/CABG O O
Dad: O O
CAD/CABG, O O
DM, O O
lymphoma O O
SOCIAL O O
HISTORY O O
Lives O O
with O O
90 O O
yo O O
mother O O
and O O
cousin. O O
Etoh O O
- O O
denies O O
Tobacco O O
&#8211; O O
&#189; O O
PPD, O O
down O O
from O O
&gt; O O
2 O O
ppd. O O
Drugs O O
- O O
denies O O
ALLERGIES: O O
Tricyclic O O
Antidepressants O O
- O O
cough, O O
Sulfa O O
- O O
Rash, O O
EZETIMIBE O O
- O O
lethargy, O O
GI O O
Intolerance O O
MEDICATIONS O O
ON O O
ADMISSION O O
1. O O
Asa B-MEDICATION B-MEDICATION
(Acetylsalicylic O O
Acid) O O
81 O O
MG O O
PO O O
QD O O
2. O O
Clonazepam O O
PO O O
as O O
directed O O
prn O O
PAML O O
medication O O
information: O O
unit O O
strength: O O
1MG O O
form: O O
TABLET O O
take: O O
1 O O
Tablet(s) O O
Take O O
one O O
half O O
tab O O
twice O O
a O O
day O O
and O O
half O O
tab O O
upto O O
twice O O
a O O
day. O O
if O O
needed O O
for O O
anxiety. O O
#QJ1829196 O O
3. O O
Cyclobenzaprine O O
Hcl O O
5 O O
MG O O
PO O O
as O O
directed O O
1 O O
hs O O
for O O
5 O O
nights, O O
the O O
1 O O
tid O O
thereafter O O
4. O O
Humulin B-MEDICATION B-MEDICATION
N O O
(Insulin B-MEDICATION O
Nph I-MEDICATION O
Human) I-MEDICATION O
Variable O O
SC O O
40 O O
UNITS O O
QAM O O
x O O
HOURS O O
22 O O
UNITS O O
QPM O O
x O O
HOURS O O
5. O O
Insulin O O
Regular O O
Human O O
(Humulin B-MEDICATION O
R) I-MEDICATION O
Variable O O
SC O O
20 O O
UNITS O O
QAM O O
x O O
HOURS O O
16 O O
UNITS O O
QPM O O
x O O
HOURS O O
6. O O
Letrozole O O
2.5 O O
MG O O
PO O O
QD O O
7. O O
Omeprazole O O
Otc O O
(Prilosec O O
Otc) O O
20 O O
MG O O
PO O O
Q12H O O
8. O O
Simvastatin B-MEDICATION B-MEDICATION
40 O O
MG O O
PO O O
QHS O O
9. O O
Topiramate O O
(Topamax) O O
50 O O
MG O O
PO O O
TID O O
Take O O
two O O
tabs O O
in O O
AM O O
and O O
two O O
tabs O O
at O O
night. O O
10. O O
Effexor O O
(Venlafaxine O O
Hcl) O O
150MG O O
PO O O
BID O O
Take O O
two O O
tabs O O
twice O O
a O O
day. O O
PHYSICAL O O
EXAM O O
VITALS: O O
T-98 O O
BP-134/60R O O
125/55L O O
P-55 O O
SAO2 O O
100 O O
% O O
on O O
RA O O
GEN&#8217;L: O O
awake, O O
alert O O
pleasant, O O
in O O
no O O
distress O O
HEENT: O O
JVD O O
not O O
elevated, O O
no O O
carotid O O
bruits O O
Heart: O O
bradycardic, O O
regular, O O
no O O
murmurs O O
(no O O
diastolic O O
murmur O O
at O O
RUSB O O
while O O
leaning O O
forward). O O
Endorses O O
tenderness O O
to O O
pressure O O
on O O
sternum O O
(different O O
from O O
CP O O
earlier O O
today) O O
LUNG: O O
CTAB O O
no O O
wheezes. O O
s/p O O
BL O O
mastectomy O O
ABD: O O
obese, B-OBESE O
soft, O O
nontender, O O
+BS O O
EXT: O O
warm O O
without O O
edema, O O
2+ O O
DP O O
pulses O O
bilaterally O O
NEURO: O O
A&amp;OX3, O O
CN O O
unremarkable, O O
no O O
dysmetria, O O
no O O
obvious O O
tremor O O
on O O
examination O O
&#183; O O
Chemistries: O O
Plasma O O
Sodium O O
135 O O
(135-145) O O
mmol/L O O
Plasma O O
Potassium O O
4.3 O O
(3.4-4.8) O O
mmol/L O O
Plasma O O
Chloride O O
100 O O
(100-108) O O
mmol/L O O
Plasma O O
Carbon O O
Dioxide O O
24.0 O O
(23.0-31.9) O O
mmol/L O O
Plasma O O
Anion O O
GAP O O
11 O O
(3-15) O O
mmol/L O O
Calcium O O
10.0 O O
(8.5-10.5) O O
mg/dl O O
Plasma O O
Urea O O
Nitrogen O O
16 O O
(8-25) O O
mg/dl O O
Plasma O O
Creatinine O O
1.01 O O
(0.60-1.50) O O
mg/dl O O
eGFR O O
58 O O
mL/min/1.73m2 O O
Plasma O O
Glucose O O
345 O O
H O O
(70-110) O O
mg/dl O O
&#183; O O
Cardiac: O O
Creatine O O
Kinase O O
Isoenzymes O O
32.8 O O
H O O
(0.0-6.9) O O
ng/ml O O
CPK O O
Isoenzymes O O
Index O O
7.7 O O
H O O
(0.0-3.5) O O
% O O
Troponin-T O O
0.36 O O
H O O
(&lt;0.03) O O
ng/ml O O
Creatine O O
Kinase O O
428 O O
H O O
(40-150) O O
U/L O O
&#183; O O
Hematology: O O
WBC O O
9.0 O O
(4.5-11.0) O O
th/cmm O O
HCT O O
44.9 O O
(36.0-46.0) O O
% O O
HGB O O
15.1 O O
(12.0-16.0) O O
gm/dl O O
RBC O O
4.62 O O
(4.00-5.20) O O
mil/cmm O O
PLT O O
202 O O
(150-400) O O
th/cumm O O
MCV O O
97 O O
(80-100) O O
fl O O
Poly O O
77 O O
H O O
(40-70) O O
% O O
Lymphs O O
19 O O
L O O
(22-44) O O
% O O
Monos O O
4 O O
(4-11) O O
% O O
EOS O O
0 O O
(0-8) O O
% O O
Basos O O
0 O O
(0-3) O O
% O O
&#183; O O
Coags: O O
Superstat O O
PT O O
12.9 O O
(10.8-13.4) O O
sec O O
Superstat O O
PT-INR O O
1.1 O O
Superstat O O
APTT O O
25.5 O O
(21.0-33.0) O O
sec O O
&#183; O O
Imaging: O O
CXR O O
&#8211; O O
no O O
acute O O
processes O O
&#183; O O
EKG: O O
(admit O O
to O O
SDU) O O
ASSESSMENT O O
&amp; O O
PLAN O O
This O O
is O O
a O O
65 O O
yo O O
female O O
with O O
T2DM, O O
HL, O O
active O O
smoking, O O
breast O O
cancer O O
s/p O O
BL O O
mastectomy O O
and O O
chemoradiation, O O
and O O
a O O
question O O
of O O
a O O
lupus-like O O
disorder O O
who O O
presents O O
with O O
chest O O
pain, O O
+ O O
troponins, O O
unremarkable O O
EKG. O O
Cardiac O O
RF O O
= O O
age, O O
DM, O O
HL, O O
active O O
smoking. O O
TIMI O O
score O O
= O O
3 O O
(age, O O
asa O O
use, O O
+ O O
biomarkers). O O
DDx O O
= O O
ACS O O
(high O O
risk O O
NSTEMI), O O
aortic O O
dissection O O
(concerning O O
elements O O
of O O
hx), O O
PE O O
(given O O
cancer O O
hx, O O
on O O
SERM), O O
or O O
perimyocarditis O O
(question O O
associated O O
with O O
lupus-like O O
condition). O O
The O O
lack O O
of O O
hypoxia O O
or O O
tachycardia O O
argue O O
against O O
PE. O O
Given O O
her O O
risk O O
factors, O O
after O O
exoneration O O
of O O
her O O
aorta O O
by O O
CT O O
scan, O O
she O O
should O O
undergo O O
cardiac O O
catheterization O O
to O O
assess O O
for O O
epicardial O O
disease. O O
She O O
is O O
currently O O
CP O O
free. O O
1. O O
Chest O O
pain O O
- O O
CTA O O
chest O O
to O O
rule O O
out O O
aortic O O
dissection O O
now O O
- O O
If O O
CTA O O
negative, O O
heparinize, O O
begin O O
integrilin O O
drip O O
(given O O
TIMI O O
of O O
3), O O
continue O O
ASA, O B-MEDICATION
statin, O O
SL O O
nitrate O O
prn, O O
likely O O
coronary O O
catheterization O O
in O O
AM. O O
Cycle O O
serial O O
cardiac O O
enzymes O O
and O O
EKGs. O O
- O O
If O O
positive, O O
transfer O O
to O O
unit O O
for O O
invasive O O
hemodynamic O O
monitoring, O O
aggressive O O
dP/dT O O
control, O O
and O O
CV O O
surgical O O
consult O O
- O O
TTE O O
in O O
AM O O
- O O
Check O O
amylase, O O
lipase O O
- O O
Risk O O
stratify O O
with O O
HbA1c O O
and O O
FLP O O
in O O
AM O O
- O O
Smoking O O
cessation O O
consult O O
2. O O
Lupus-like O O
condition O O
- O O
Alert O O
rheumatology O O
team O O
to O O
admission O O
in O O
AM O O
3. O O
DM O O
- O O
Check O O
HbA1c O O
- O O
BID O O
NPH O O
and O O
AC+HS O O
RISS O O
4. O O
Renal O O
- O O
renal O O
prophylaxis O O
give O O
planned O O
dye O O
loads O O
&#8211; O O
mucormyst O O
1200 O O
BID O O
+ O O
IV O O
bicarbonate O O
5. O O
Psych O O
- O O
continue O O
home O O
regimen O O
&#8211; O O
klonopin, O O
effexor, O O
topamax O O
Code O O
status O O
&#8211; O O
Full O O
code O O
__________________________________ O O
Eli O O
S O O
Lindsay, O O
MD O O
PhD O O
PGY-2 O O
Pager O O
#46656 O O

Record B-SMOKER O
date: O O
2068-03-31 O O
Eudowood O O
Services O O
Physician O O
Group O O
807 O O
Williams O O
Ct O O
MOODY, O O
JOHNNY O O
Hyderabad, O O
WI O O
62297 O O
76324418 O O
547-598-7353 O O
03/31/2068 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
58-year-old O O
white O O
male O O
comes O O
to O O
the O O
office O O
for O O
followup O O
regarding O O
his O O
recent O O
chest O O
pain. O O
Chest O O
pain. O O
The O O
patient O O
was O O
in O O
his O O
usual O O
state O O
of O O
compensated O O
health, O O
but O O
approximately O O
one O O
month O O
ago O O
after O O
clearing O O
significance O O
note O O
from O O
his O O
driveway, O O
the O O
patient O O
started O O
to O O
note O O
some O O
anterior O O
chest O O
discomfort. O O
He O O
has O O
a O O
long B-CAD O
history I-CAD O
of I-CAD O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
and O O
this O O
includes O O
angioplasty B-CAD O
and I-CAD O
coronary B-CAD O
artery I-CAD O
bypass I-CAD O
grafting I-CAD O
in I-CAD O
2065. I-CAD O
The O O
pain O O
did O O
not O O
radiate O O
up O O
to O O
his O O
neck O O
or O O
arm, O O
but O O
when O O
the O O
pain O O
persisted O O
even O O
after O O
returning O O
from O O
Blountstown, O O
he O O
went O O
to O O
Roper O O
Hospital O O
North O O
two O O
days O O
ago O O
because O O
of O O
his O O
chest O O
discomfort O O
to O O
see O O
his O O
cardiologist. O O
He O O
was O O
admitted O O
to O O
the O O
hospital, O O
had O O
a O O
cardiac O O
catheterization, O O
which O O
according O O
to O O
the O O
patient O O
did O O
not O O
show O O
any O O
specific O O
lesion. O O
The O O
doctors O O
felt O O
that O O
he O O
did O O
not O O
have O O
a O O
myocardial O O
infarction, O O
but O O
that O O
in O O
fact O O
his O O
abnormality O O
was O O
due O O
to O O
a O O
chest O O
wall/muscular O O
type O O
syndrome. O O
He O O
was O O
discharged O O
on O O
anti-inflammatory O O
medicine O O
and O O
the O O
patient O O
had O O
noted O O
that O O
when O O
he O O
took O O
the O O
aspirin B-MEDICATION B-MEDICATION
over O O
the O O
past O O
month, O O
his O O
discomfort O O
was O O
improved. O O
The O O
patient O O
states O O
that O O
he O O
had O O
the O O
chest O O
x-rays O O
at O O
the O O
hospital O O
and O O
in O O
fact O O
also O O
had O O
a O O
CT O O
scan, O O
which O O
did O O
not O O
show O O
any O O
pulmonary O O
embolism. O O
It O O
also O O
did O O
not O O
show O O
any O O
dissecting O O
aneurysm O O
according O O
to O O
the O O
patient. O O
Left O O
renal O O
lesion. O O
As O O
part O O
of O O
his O O
routine O O
workup, O O
the O O
patient O O
did O O
have O O
a O O
CT O O
scan O O
and O O
this O O
identified O O
some O O
left O O
kidney O O
mass O O
possibly O O
on O O
this O O
scan. O O
The O O
patient O O
denies O O
specifically O O
any O O
flank O O
pain O O
or O O
any O O
bleeding O O
and O O
he O O
has O O
no O O
recent O O
weight O O
loss. O O
I O O
spoke O O
to O O
the O O
patient O O
at O O
length O O
about O O
this O O
matter O O
and O O
he O O
will O O
consult O O
with O O
Dr. O O
Jung, O O
the O O
urologist O O
at O O
Roper O O
Hospital O O
North. O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2. I-DIABETES O
The O O
patient O O
remains O O
on O O
his O O
usual O O
medicines O O
and O O
according O O
to O O
him, O O
his O O
hemoglobin O O
A1c O O
and O O
blood O O
sugars O O
have O O
remained O O
fairly O O
satisfactory. O O
Obstructive O O
sleep O O
apnea. O O
The O O
patient O O
does O O
not O O
use O O
his O O
mask O O
and O O
I O O
cautioned O O
him O O
to O O
get O O
back O O
using O O
that, O O
as O O
this O O
may O O
have O O
an O O
effect O O
on O O
his O O
coronary O O
artery O B-CAD
disease. O O
Abnormal O O
liver O O
function O O
tests, O O
has O O
been O O
present O O
for O O
many O O
years O O
and O O
previously O O
was O O
thought O O
to O O
be O O
due O O
to O O
a O O
fatty O O
liver. O O
Elevated B-HYPERTENSION O
blood I-HYPERTENSION O
pressure. I-HYPERTENSION O
The O O
patient O O
was O O
noted O O
in O O
the O O
hospital O O
to O O
have O O
elevated O O
blood O O
pressures O O
despite O O
his O O
medicine O O
and O O
he O O
was O O
asked O O
to O O
increase O O
his O O
Norvasc B-MEDICATION B-MEDICATION
from O O
5 O O
mg O O
to O O
10 O O
mg O O
per O O
day. O O
Gastroesophageal O O
reflux. O O
The O O
patient O O
feels O O
well O O
on O O
Zantac. O O
REVIEW O O
OF O O
SYSTEMS: O O
Reveals O O
no O O
specific O O
headaches. O O
He O O
denies O O
any O O
trouble O O
with O O
his O O
ears, O O
nose O O
or O O
throat. O O
He O O
has O O
no O O
chronic O O
cough O O
or O O
coughing O O
blood. O O
He O O
denies O O
any O O
nausea, O O
vomiting, O O
black O O
or O O
bloody O O
stool. O O
He O O
has O O
no O O
burning O O
on O O
urination. O O
PHYSICAL O O
EXAMINATION: O O
Revealed O O
a O O
pleasant O O
white O O
male O O
in O O
no O O
acute O O
distress. O O
His O O
blood O O
pressure O O
was O O
130/90, O O
pulse O O
was O O
60 O O
and O O
weight O O
207 O O
pounds. O O
Head, O O
ears, O O
eyes, O O
nose O O
and O O
throat O O
were O O
normal. O O
The O O
neck O O
showed O O
no O O
thyroid O O
nodes O O
or O O
tenderness. O O
The O O
chest O O
did O O
show O O
a O O
healed O O
coronary O O
artery O O
bypass O O
graft O O
scar, O O
but O O
he O O
did O O
have O O
chest O O
wall O O
discomfort O O
to O O
palpation O O
in O O
the O O
costochondral O O
area O O
on O O
the O O
left. O O
The O O
lungs O O
were O O
clear O O
to O O
percussion O O
and O O
auscultation. O O
Heart O O
showed O O
a O O
regular O O
sinus O O
rhythm. O O
Abdomen O O
is O O
soft. O O
No O O
liver O O
or O O
spleen O O
was O O
felt. O O
Extremities O O
showed O O
no O O
cyanosis, O O
clubbing O O
or O O
edema. O O
Neurologically, O O
the O O
patient O O
was O O
alert. O O
The O O
patient O O
was O O
also O O
sent O O
to O O
the O O
office O O
for O O
evaluation O O
because O O
of O O
his O O
kidney O O
function O O
and O O
the O O
use O O
of O O
the O O
scan O O
during O O
the O O
CT O O
scanning O O
and O O
use O O
of O O
the O O
diet. O O
The O O
patient O O
was O O
therefore O O
ordered O O
to O O
have O O
routine O O
laboratory O O
test O O
including O O
complete O O
blood O O
count, O O
CBC, O O
chem O O
profile, O O
lipid O O
profile, O O
urinalysis O O
and O O
I O O
did O O
a O O
hemoglobin O O
A1c O O
because O O
of O O
his O O
history O O
of O O
diabetes. O O
1. O O
Chest O O
pain, O O
probably O O
due O O
to O O
chest O O
wall O O
rather O O
than O O
coronary O O
artery O O
disease O O
according O O
to O O
the O O
patient's O O
history. O O
2. O O
New O O
discovery O O
of O O
left O O
renal O O
mass O O
to O O
consult O O
with O O
Urology, O O
Dr. O O
Jung. O O
3. O O
Renal O O
function O O
to O O
be O O
rechecked O O
secondary O O
to O O
his O O
CT O O
scanning O O
and O O
history O O
of O O
diabetes O O
with O O
Glucophage, O B-MEDICATION
which O O
he O O
has O O
restarted. O O
4. O O
Status O O
post O O
coronary O O
artery O O
bypass O O
graft. O O
5. O O
Abnormal O O
LFTs O O
by O O
history. O O
6. O O
Diabetes O O
mellitus. O O
7. O O
Obstructive O O
sleep O O
apnea. O O
Will O O
follow O O
up O O
with O O
the O O
patient O O
by O O
phone O O
tomorrow O O
regarding O O
his O O
lab O O
tests O O
and O O
also O O
he O O
will O O
consult O O
with O O
Dr. O O
Jung O O
and O O
has O O
a O O
followup O O
appointment O O
with O O
me O O
for O O
comprehensive O O
exam O O
in O O
one O O
to O O
two O O
months. O O
______________________________ O O
Todd O O
Brandt, O O
M.D. O O
eScription O O
document:0-0901410 O O
CSSten O O
Tel O O
DD: O O
03/31/68 O O
DT: O O
03/31/68 O O
DV: O O
03/31/68 O O

Record O O
date: O O
2068-12-12 O O
Eudowood O O
Services O O
Physician O O
Group O O
128 O O
Williams O O
Ct O O
M O O
OSCAR, O O
JOHNNY O O
Hyderabad, O O
WI O O
62297 O O
76324418 O O
547-598-7353 O O
12/12/2068 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
59-year-old O O
white O O
male O O
who O O
comes O O
to O O
the O O
office O O
for O O
reevaluation O O
regarding O O
his O O
diabetes. B-DIABETES O
He O O
also O O
has O O
high B-HYPERTENSION O
blood I-HYPERTENSION O
pressure I-HYPERTENSION O
and O O
coronary B-CAD O
artery I-CAD O
disease. I-CAD O
Diabetes. O O
The O O
patient O O
is O O
trying O O
to O O
adhere O O
to O O
his O O
diet. O O
He O O
stays O O
on O O
his O O
usual O O
medicines, O O
which O O
include O O
Glucophage B-MEDICATION B-MEDICATION
and O O
glyburide. B-MEDICATION B-MEDICATION
He O O
takes O O
an O O
aspirin B-MEDICATION B-MEDICATION
regularly O O
and O O
he O O
is O O
on O O
his O O
blood O O
pressure O O
medicines. O O
He B-SMOKER O
does B-SMOKER O
not I-SMOKER O
smoke. I-SMOKER O
He O O
follows O O
closely O O
his O O
foot O O
regimen O O
and O O
had O O
not O O
noticed O O
any O O
difficulty. O O
He O O
sees O O
a O O
foot O O
doctor. O O
He O O
has O O
not O O
seen O O
an O O
eye O O
doctor O O
recently. O O
He O O
has O O
not O O
been O O
to O O
the O O
Jay O O
Hospital O O
for O O
his O O
routine O O
followup O O
and O O
says O O
he O O
will O O
start O O
setting O O
up O O
appointments O O
with O O
the O O
diabetes O O
group O O
out O O
in O O
Littleton, O O
Wisconsin O O
where O O
he O O
lives. O O
The O O
patient O O
specifically O O
denies O O
any O O
increased O O
thirst O O
or O O
urination. O O
His O O
blood O O
sugars O O
taken O O
at O O
home O O
are O O
approximately O O
140-160 O O
on O O
a O O
fasting O O
basis. O O
He O O
has O O
not O O
had O O
any O O
episodes O O
of O O
hypoglycemia. O O
Coronary O O
artery O O
disease. O O
The O O
patient O O
is O O
also O O
followed O O
by O O
Dr. O O
Garza. O O
He O O
does O O
stay O O
on O O
his O O
Plavix B-MEDICATION B-MEDICATION
and O O
aspirin O B-MEDICATION
and O O
also O O
is O O
on O O
other O O
medicines O O
including O O
atenolol, B-MEDICATION B-MEDICATION
hydrochlorothiazide, B-MEDICATION B-MEDICATION
Norvasc, B-MEDICATION B-MEDICATION
Vasotec B-MEDICATION O
and O O
he O O
has O O
not O O
needed O O
any O O
nitroglycerin. O B-MEDICATION
He O O
still O O
does O O
complain O O
of O O
some O O
nonspecific O O
chest O O
type O O
discomfort O O
for O O
which O O
he O O
was O O
evaluated O O
by O O
Dr. O O
Garza O O
last O O
spring. O O
He O O
had O O
a O O
cardiac O O
catheterization. O O
Elevated B-HYPERLIPIDEMIA O
cholesterol. I-HYPERLIPIDEMIA O
The O O
patient O O
does O O
take O O
the O O
Lipitor. B-MEDICATION B-MEDICATION
He O O
does O O
not O O
have O O
any O O
muscle O O
aches. O O
Slightly O O
elevated O O
liver O O
function O O
tests. O O
He O O
had O O
a O O
history O O
of O O
fatty O O
liver. O O
Obstructive O O
sleep O O
apnea. O O
The O O
patient O O
refuses O O
to O O
take O O
CPAP. O O
REVIEW O O
OF O O
SYSTEMS: O O
Reveals O O
no O O
headaches, O O
no O O
difficulty O O
with O O
the O O
ears, O O
nose O O
or O O
throat. O O
No O O
neck O O
pain, O O
no O O
chronic O O
cough O O
or O O
sputum O O
production O O
and O O
no O O
chest O O
pains O O
or O O
palpitations. O O
No O O
nausea, O O
vomiting, O O
black O O
or O O
bloody O O
stools. O O
No O O
burning O O
on O O
urination. O O
His O O
weight O O
has O O
been O O
fairly O O
stable. O O
PHYSICAL O O
EXAMINATION: O O
Showed O O
a O O
pleasant O O
white O O
male O O
in O O
no O O
acute O O
distress. O O
Blood O O
pressure O O
taken O O
by O O
me O O
132/76, O O
pulse O O
72 O O
and O O
weight O O
206 O O
pounds. O O
Skin O O
was O O
moist O O
and O O
warm O O
without O O
any O O
specific O O
lesions. O O
Head, O O
ears, O O
eyes, O O
nose O O
and O O
throat O O
were O O
normal. O O
Neck O O
showed O O
no O O
thyroid O O
nodes O O
or O O
tenderness. O O
No O O
bruits O O
were O O
heard. O O
Lungs O O
were O O
clear O O
to O O
percussion O O
and O O
auscultation. O O
Heart O O
showed O O
a O O
regular O O
sinus O O
rhythm. O O
S1, O O
S2 O O
were O O
normal. O O
Abdomen O O
was O O
soft, O O
no O O
liver O O
or O O
spleen O O
was O O
felt. O O
Chest O O
wall O O
without O O
any O O
pain O O
secondary O O
to O O
his B-CAD O
prior I-CAD O
coronary I-CAD O
artery I-CAD O
bypass I-CAD O
graft I-CAD O
surgery. I-CAD O
Extremities O O
showed O O
pulses O O
to O O
be O O
satisfactory. O O
His O O
feet O O
were O O
warm. O O
There O O
was O O
no O O
sign O O
of O O
infection. O O
Neurologic, O O
well O O
oriented. O O
Light O O
touch O O
was O O
found O O
easily O O
in O O
his O O
feet. O O
IMPRESSION: O O
Overall, O O
the O O
patient O O
is O O
satisfied O O
with O O
his O O
health. O O
He O O
has O O
followup O O
appointment O O
with O O
the O O
cardiologist O O
and O O
needs O O
to O O
follow O O
up O O
with O O
the O O
eye O O
doctor O O
as O O
well. O O
He O O
will O O
set O O
up O O
a O O
diabetes O O
follow O O
up O O
at O O
the O O
Rappahannock O O
Medical O O
Clinic. O O
DISCHARGE O O
DIAGNOSES: O O
1. O O
Diabetes O O
mellitus, O O
on O O
oral O O
hypoglycemic O O
medicines, O O
will O O
recheck O O
his O O
hemoglobin O O
A1c, O O
recheck O O
his O O
urine O O
and O O
urine O O
for O O
protein. O O
The O O
patient O O
does O O
take O O
his O O
enalapril B-MEDICATION O
regularly O O
as O O
well. O O
2.Coronary O O
artery O O
disease O O
on O O
multiple O O
medicines O O
without O O
any O O
severe O O
angina. O O
He O O
is O O
followed O O
by O O
Dr. O O
Garza. O O
His O O
weight O O
has O O
been O O
fairly O O
stable. O O
He O O
has O O
not O O
needed O O
to O O
use O O
his O O
nitroglycerin. O B-MEDICATION
3.Obstructive O O
sleep O O
apnea. O O
The O O
patient O O
refuses O O
to O O
take O O
the O O
therapy. O O
Elevated O O
cholesterol, O O
on O O
Lipitor. O O
Essential O O
hypertension O O
on O O
medicine. O O
Left O O
kidney O O
mass. O O
Dr. O O
Jefferson O O
did O O
not O O
feel O O
this O O
was O O
any O O
real O O
finding. O O
Follow O O
up O O
will O O
be O O
in O O
four O O
to O O
six O O
months O O
in O O
my O O
office O O
for O O
a O O
comprehensive O O
exam. O O
Routine O O
laboratory O O
test O O
including O O
CBC, O O
hemoglobin O O
A1c, O O
comprehensive O O
metabolic O O
profile, O O
lipid O O
panel, O O
urinalysis, O O
TSH, O O
urine O O
microalbumin O O
and O O
PSA O O
were O O
ordered O O
today. O O
______________________________ O O
Todd O O
Brandt, O O
M.D. O O
eScription O O
document:4-4822140 O O
CSSten O O
Tel O O
DD: O O
12/12/68 O O
DT: O O
12/12/68 O O
DV: O O
12/12/68 O O

Record O O
date: O O
2070-08-15 O O
Reason O O
for O O
Visit O O
Routine O O
follow-up O O
exam O O
diabetes B-DIABETES O
mellitus/coronary I-DIABETES O
artery B-CAD O
diseaseProblems I-CAD O
Coronary O O
artery O O
disease-Dr O O
GarzaRHN O O
: O O
Has O O
had O O
cardiac O O
cath O O
at O O
RH O O
-Dr O O
Gil O O
-Had B-CAD O
bypass B-CAD O
graft I-CAD O
5/65 I-CAD O
Dr O O
Gil O O
RHNThe O O
patient O O
is O O
feeling O O
much O O
better O O
and O O
without O O
any O O
significant O O
chest O O
pain-he O O
is O O
on O O
his O O
usual O O
protocol O O
of O O
medicines O O
but O O
also O O
is O O
active O O
in O O
exercising O O
and O O
has O O
lost O O
a O O
little O O
weightDiabetes O O
mellitus O O
type O O
2-Dr O O
Willis O O
: O O
Eye O O
appt-JHThe O O
patient O O
has O O
finally O O
seen O O
the O O
consultant O O
near O O
his O O
home-Dr O O
Willis-she O O
recently O O
switched B-MEDICATION O
from I-MEDICATION O
glyburide B-MEDICATION B-MEDICATION
to B-MEDICATION O
glipizide-the I-MEDICATION B-MEDICATION
patient O O
has O O
been O O
noting O O
any O O
improvement O O
in O O
his O O
daily O O
blood O O
sugars O O
which O O
are O O
between O O
100-150. O O
No O O
increased O O
thirst O O
or O O
urination O O
and O O
no O O
hypoglycemic O O
episodes. O O
He O O
has O O
been O O
followed O O
by O O
his O O
eye O O
doctor,Dr O O
Kincaid O O
but O O
needs O O
to O O
set O O
up O O
a O O
followup O O
appointment O O
he O O
does O O
not O O
have O O
any O O
tingling O O
or O O
difficulty O O
in O O
his O O
feet.-Hgb B-DIABETES O
A1c I-DIABETES O
and I-DIABETES O
--better I-DIABETES O
=8.1Essential I-DIABETES O
hypertension B-HYPERTENSION O
The O O
patient O O
is O O
on O O
his O O
medicines O O
with O O
good O O
controlobstructive O O
sleep O O
apnea-refuses O O
CPAP O O
: O O
refuses O O
CpapNo O O
daytime O O
somnolence O O
and O O
refuses O O
CPAPElevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
On O O
LipitorHCT=38 B-MEDICATION B-MEDICATION
rpt O O
1/69 O O
: O O
Iron, O O
B12, O O
folate O O
acid, O O
SPEP-ok O O
2069 O O
patient O O
did O O
not O O
go O O
to O O
hematologyThe O O
patient O O
will O O
get O O
repeat O O
testing O O
todayCreat=1.4-rpt O O
6/60 O O
The O O
patient O O
will O O
get O O
repeat O O
testing O O
todayGerd?-pt O O
requests O O
eval-to O O
Dr O O
Stevenson O O
: O O
The O O
patient O O
called O O
on O O
the O O
telephone O O
and O O
has O O
some O O
symptoms O O
which O O
she O O
believes O O
may O O
be O O
acid O O
reflux O O
and O O
not O O
angina-he O O
will O O
consult O O
with O O
Dr. O O
Stevenson-no O O
black O O
or O O
bloody O O
stoolsThe O O
patient O O
has O O
seen O O
the O O
gastroenterologist,Dr O O
Truong O O
who O O
feels O O
that O O
he O O
needs O O
both O O
the O O
upper O O
and O O
lower O O
endoscopy O O
and O O
the O O
patient O O
needs O O
to O O
schedule O O
I O O
told O O
the O O
patient O O
not O O
to O O
take O O
Prilosec O O
due O O
to O O
the O O
Plavix B-MEDICATION B-MEDICATION
potential O O
problem O O
and O O
he O O
will O O
stay O O
with O O
his O O
Zantac O O
which O O
seems O O
to O O
be O O
workingAllergies O O
Vicodan O O
- O O
ItchingMedications O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
Acid) O O
325MG O O
TABLET O O
Take O O
1 O O
Tablet(s) O O
PO O O
QD O O
#100 O O
Tablet(s)Atenolol B-MEDICATION O
50 O O
MG O O
(50MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s)Ativan O O
(LORAZEPAM) O O
1 O O
MG O O
(1MG O O
TABLET O O
Take O O
1) O O
PO O O
BID, O O
May O O
be O O
sedating/may O O
be O O
addicting O O
#180 O O
Tablet(s)Clopidogrel B-MEDICATION O
75 O O
MG O O
(75MG O O
TABLET O O
Take O O
1) O O
PO O O
QD, O O
Dr O O
Garza O O
#90 O O
Tablet(s)Flomax O O
(TAMSULOSIN) O O
0.4 O O
MG O O
(0.4MG O O
CAP.SR O O
24H O O
Take O O
1) O O
PO O O
QD, O O
take O O
after O O
meals O O
#90 O O
CAP.SRFolic O O
Acid O O
1 O O
MG O O
(1MG O O
TABLET O O
Take O O
1) O O
PO O O
BID O O
x O O
90 O O
days O O
#180 O O
Tablet(s)Glipizide O O
10 O O
MG O O
(10 O O
MG O O
TABLET O O
Take O O
1) O O
PO O O
BID, O O
Dr O O
Willis O O
#180 O O
Tablet(s)Glucophage B-MEDICATION O
(METFORMIN) B-MEDICATION O
1000 O O
MG O O
(500MG O O
TABLET O O
Take O O
2) O O
PO O O
BID O O
#360 O O
Tablet(s)Hydrochlorothiazide B-MEDICATION O
25 O O
MG O O
(25MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s)Lipitor O O
(ATORVASTATIN) O O
20 O O
MG O O
(20MG O O
TABLET O O
Take O O
1) O O
PO O O
QHS O O
#90 O O
Tablet(s)Multivitamins O O
1 O O
TAB O O
PO O O
QD O O
#90 O O
tablet(s)Norvasc B-MEDICATION O
(AMLODIPINE) O O
10MG O O
TABLET O O
PO O O
QD, O O
Dr O O
Garza O O
#90 O O
Tablet(s)Ntg O O
1/150 O O
(NITROGLYCERIN B-MEDICATION O
1/150 O O
(0.4 O O
Mg)) O O
1 O O
TAB O O
SL O O
as O O
directed O O
#30 O O
tablet(s)One O O
Touch O O
PO O O
Vasotec B-MEDICATION O
(ENALAPRIL O O
Maleate) O O
20 O O
MG O O
(20MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s)Zantac O O
(RANITIDINE O O
Hcl) O O
150 O O
MG O O
(150MG O O
TABLET O O
Take O O
1) O O
PO O O
BID, O O
prn O O
#180 O O
Tablet(s)Habits O O
Tobacco: O O
no O O
smokingReview O O
of O O
Systems O O
Few O O
pound O O
decrease O O
in O O
weight O O
on O O
diet. O O
No O O
chronic O O
pain. O O
No O O
headaches, O O
visual O O
disturbances, O O
hearing O O
problems. O O
No O O
CP O O
or O O
palpitations. O O
No O O
dyspnea, O O
cough,or O O
wheezing. O O
No O O
abdominal O O
pain, O O
nausea, O O
vomiting, O O
constipation, O O
diarrhea, O O
BRBPR, O O
or O O
melena. O O
No O O
dysuria O O
or O O
difficulty O O
with O O
urination. O O
. O O
No O O
joint O O
pain O O
or O O
swelling. O O
No O O
skin O O
changes O O
or O O
rash. O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
130/70PULSE O O
70WEIGHT O O
207 O O
lbExam O O
Physical O O
Exam O O
General O O
Appearance O O
well-appearing, O O
NAD. O O
Skin O O
No O O
rashes O O
or O O
suspicious O O
lesions. O O
HEENT O O
PERRLA. O O
EOMI. O O
Sclerae O O
non-icteric. O O
TMs O O
are O O
clear O O
bilaterally. O O
OP O O
is O O
clear O O
without O O
erythema O O
or O O
exudate. O O
Neck O O
is O O
supple. O O
No O O
LAD. O O
No O O
thyromegaly. O O
Nodes/Lymphatic O O
No O O
nodes O O
Chest O O
CHEST:A&amp;P-normal O O
bilaterally O O
with O O
good O O
air O O
movement. O O
No O O
local O O
rales O O
or O O
wheezing O O
Cor/Cardiac O O
regular O O
rate, O O
normal O O
S1, O O
S2. O O
No O O
rubs, O O
gallops, O O
or O O
murmurs. O O
Abdomen O O
soft, O O
nontender, O O
nondistended, O O
+bowel O O
sounds, O O
no O O
HSM O O
Extremity O O
warm, O O
no O O
C/C/E. O O
Bilateral O O
knees O O
without O O
effusion.Pulses O O
-good O O
Sensation-satisfactory O O
fo O O
light O O
touch O O
Neurological O O
A+Ox3. O O
CN O O
II-XII O O
intact. O O
Grossly O O
non-focal.Assessment O O
and O O
Plan O O
Overall O O
the O O
patient O O
is O O
quite O O
satisfied O O
with O O
his O O
health O O
Gastroesophageal O O
reflux-stay O O
on O O
present O O
regimen O O
and O O
set O O
up O O
the O O
upper O O
and O O
lower O O
endoscopy O O
electively O O
with O O
Dr. O O
Truong O O
Mild O O
anemia O O
- O O
repeat O O
testing-hematocrit O O
stable O O
at O O
39 O O
and O O
hemoglobin O O
is O O
normal O O
Mild O O
elevated O O
creatinine-repeat O O
testing O O
and O O
check O O
a O O
urine O O
and O O
microalbumin-microalbumin O O
is O O
present O O
Diabetes O O
appears O O
to O O
be O O
in O O
better O O
control O O
according O O
to O O
his O O
daily O O
blood O O
sugar O O
measurements O O
on O O
his O O
new O O
regimen-he O O
will O O
set O O
up O O
an O O
appointment O O
with O O
the O O
eye O O
doctor-2 O O
set O O
up O O
eye O O
appointment O O
and O O
hemoglobin O O
A1c O O
is O O
better O O
at O O
8.1 O O
Cardiovascularly O O
without O O
angina O O
and O O
satisfactorily O O
exercising O O
Followup O O
in O O
4-6 O O
months O O
or O O
sooner O O
if O O
any O O
problems O O
Routine O O
laboratory O O
tests O O
ordered O O
including O O
CBC O O
and O O
lipid O O
and O O
hemoglobin O O
A1c O O
Health O O
Monitoring O O
HbA1c B-DIABETES O
08/15/2070: I-DIABETES O
8.1Home I-DIABETES O
glucose O O
monitoring O O
12/12/2068: O O
ultratestHypoglycemia O O
Assessment/Counseling O O
06/28/2069: O O
doneM-alb/creat O O
ratio O O
08/15/2070: O O
61.3 O O
Units O O
= O O
mg O O
Alb/g O O
CreMicroalbumin O O
08/15/2070: O O
7.9Ophthal O O
Exam O O
08/15/2070 O O
Done O O
elsewherePodiatry O O
exam O O
12/12/2068: O O
M.D. O O
in O O
LittletonColonoscopy O O
06/28/2069: O O
to O O
doHct O O
(Hematocrit) O O
08/15/2070: O O
38.8Hgb O O
(Hemoglobin) O O
08/15/2070: O O
13.7PSA O O
05/08/2070: O O
0.8Rectal O O
exam O O
05/08/2070 O O
No O O
masses O O
or O O
Hidden O O
blood/ O O
Prostate O O
-not O O
hard O O
or O O
tenderStool O O
Guaiac O O
10/04/2069: O O
negUA-Protein O O
08/15/2070: O O
NEGComplete O O
Physical O O
Exam O O
05/08/2070: O O
doneVitamin O O
D O O
(25 O O
OH) O O
08/15/2070: O O
52 O O
-- O O
REFERENCE O O
VALUE O O
-- O O
25-HYDROXY O O
D O O
TOTAL O O
(D2+D3) O O
Optimum O O
levels O O
in O O
the O O
normal O O
population O O
are O O
25-80 O O
TEST O O
PERFORMED O O
BY O O
BARRY O O
COUNTY O O
EXTENDED O O
CARE O O
FACILITY O O
COLLEGE O O
STATION, O O
WI O O
34674TSH O O
08/15/2070: O O
2.82GFR O O
(estimated) O O
08/15/2070: O O
49 O O
(Abnormal O O
if O O
MCV O O
08/15/2070: O O
83.0Platelets O O
08/15/2070: O O
169Smoking B-SMOKER O
status I-SMOKER O
05/08/2070 I-SMOKER O
Quit B-SMOKER O
tobacco I-SMOKER O
&gt;= I-SMOKER O
1 I-SMOKER O
year I-SMOKER O
ago I-SMOKER O
Quit O O
age O O
28 O O
Influenza O O
Vaccine O O
12/12/2068 O O
pt O O
denies O O
allergies/SEPneumovax O O
03/31/2068 O O
DoneZostavax O O
05/08/2070: O O
to O O
think O O
aboutCholesterol O O
08/15/2070: O O
113Cholesterol-HDL O O
08/15/2070: O O
33Cholesterol-LDL O O
08/15/2070: O O
47Triglycerides O O
08/15/2070: O O
163Orders O O
Laboratory O O
tests-as O O
ordered O O
Follow-Up O O
Appointment- O O
___months O O
Consultation- O O

Record O O
date: O O
2070-09-24 O O
Reason O O
for O O
Visit O O
Routine O O
follow-up O O
exam O O
recent O O
hospitalization O O
for O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
at O O
Roper O O
Hospital O O
NorthProblems O O
NON B-CAD O
ST I-CAD O
elev I-CAD O
MI I-CAD O
9/70 I-CAD O
Dr O O
Gil O O
: O O
Card B-CAD O
cath-oblique I-CAD O
marg I-CAD O
block-stent(coated) B-CAD O
placedThe I-CAD O
patient O O
noted O O
the O O
onset B-CAD O
of I-CAD O
increased I-CAD O
chest B-CAD O
pain I-CAD O
and O O
was O O
admitted O O
to O O
Roper O O
Hospital O O
North O O
on O O
September O O
13, O O
2070-P. O O
type O O
of O O
chest B-CAD O
pain I-CAD O
was I-CAD O
substernal I-CAD O
and I-CAD O
burning I-CAD O
with I-CAD O
radiation I-CAD O
to I-CAD O
his I-CAD O
left I-CAD O
arm I-CAD O
especially O O
on O O
exertion O O
and O O
was O O
relieved O O
with O O
nitroglycerin. B-CAD O
See O O
comprehensive O O
discharge O O
note. O O
The O O
patient O O
has O O
had O O
significant O O
cardiovascular O O
disease O O
and O O
is O O
followed O O
by O O
Dr. O O
Gil-he O O
was O O
on O O
multiple O O
drugs O O
including O O
beta B-MEDICATION O
blocker, I-MEDICATION O
Vasotec, B-MEDICATION O
Norvasc B-MEDICATION B-MEDICATION
and O O
Plavix. B-MEDICATION B-MEDICATION
He O O
does O O
not O O
take O O
Prilosec O O
The O O
patient O O
had O O
negative O O
troponin O O
studies O O
but O O
his O O
stress B-CAD O
test I-CAD O
did I-CAD O
show I-CAD O
anginal I-CAD O
type I-CAD O
symptoms I-CAD O
with O O
very O O
low O O
exercise. O O
He O O
had O O
a O O
cardiac O O
catheterization O O
done O O
which O O
showed O O
obstruction O O
of O O
the O O
oblique O O
marginal O O
and O O
a O O
stent O O
was O O
placed/ O O
Since O O
the O O
hospitalization O O
the O O
patient O O
has O O
been O O
ambulatory O O
and O O
feeling O O
well. O O
He O O
had O O
increase O O
in O O
his O O
Lipitor B-MEDICATION B-MEDICATION
from O O
20 O O
mg O O
to O O
80 O O
mg O O
but O O
otherwise O O
is O O
on O O
the O O
same O O
medical O O
protocol O O
and O O
I O O
reviewed O O
this O O
at O O
length O O
with O O
the O O
patientCoronary O O
artery O O
disease-Dr O O
GarzaRHN O O
: O O
Has O O
had O O
cardiac O O
cath O O
at O O
RH O O
-Dr O O
Gil O O
-Had B-CAD O
bypass I-CAD O
graft I-CAD O
5/65 I-CAD O
Dr O O
Gil O O
RNHHe O O
has O O
a O O
long O O
history O O
of O O
cardiac O O
disease O O
with O O
stenting O O
in O O
the O O
pastDiabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2-Dr I-DIABETES O
Willis O O
: O O
Eye O O
appt-JHThe O O
patient O O
is O O
followed O O
by O O
Dr. O O
Willis O O
and O O
he O O
does O O
check O O
his O O
blood O O
sugars O O
at O O
home O O
which O O
have O O
been O O
improved O O
at O O
approximately O O
150 O O
and O O
he O O
has O O
recently O O
been O O
started O O
on O O
a O O
combination O O
of O O
Glucophage B-MEDICATION B-MEDICATION
and O O
glipizide. B-MEDICATION B-MEDICATION
He O O
has O O
no O O
increased O O
thirst O O
or O O
urinationEssential B-HYPERTENSION O
hypertension B-HYPERTENSION O
Blood O O
pressure O O
has O O
been O O
under O O
satisfactory O O
control O O
on O O
his O O
present O O
regimenobstructive O O
sleep O O
apnea-refuses O O
CPAP O O
: O O
refuses O O
CpapHe O O
has O O
refused O O
to O O
use O O
his O O
CPAPElevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Now O O
on O O
elevated O O
Lipitor-LDL O B-MEDICATION
is O O
52HCT=38 O O
rpt O O
1/69 O O
: O O
Iron, O O
B12, O O
folate O O
acid, O O
SPEP-ok O O
2069 O O
patient O O
did O O
not O O
go O O
to O O
hematologyWe'll O O
repeat O O
studies O O
Hematocrit O O
is O O
37.5Creat=1.4-rpt O O
6/70-to O O
Renal O O
8/70 O O
We'll O O
repeat O O
studies O O
today O O
but O O
according O O
to O O
the O O
patient O O
has O O
creatinine O O
was O O
improved O O
in O O
the O O
hospital O O
Repeat O O
creatinine O O
1.19 O O
Elevated O O
microalbumin-to O O
renal O O
specialistAllergies O O
Vicodan O O
- O O
ItchingMedications O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
Acid) O O
325MG O O
TABLET O O
Take O O
1 O O
Tablet(s) O O
PO O O
QD O O
#100 O O
Tablet(s)Atenolol B-MEDICATION O
50 O O
MG O O
(50MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s)Ativan O O
(LORAZEPAM) O O
1 O O
MG O O
(1MG O O
TABLET O O
Take O O
1) O O
PO O O
BID, O O
May O O
be O O
sedating/may O O
be O O
addicting O O
#180 O O
Tablet(s)Clopidogrel O O
75 O O
MG O O
(75MG O O
TABLET O O
Take O O
1) O O
PO O O
QD, O O
Dr O O
Garza O O
#90 O O
Tablet(s)Flomax O O
(TAMSULOSIN) O O
0.4 O O
MG O O
(0.4MG O O
CAP.SR O O
24H O O
Take O O
1) O O
PO O O
QD, O O
take O O
after O O
meals O O
#90 O O
CAP.SRFolic O O
Acid O O
1 O O
MG O O
(1MG O O
TABLET O O
Take O O
1) O O
PO O O
BID O O
x O O
90 O O
days O O
#180 O O
Tablet(s)Glipizide O O
10 O O
MG O O
(10 O O
MG O O
TABLET O O
Take O O
1) O O
PO O O
BID, O O
Dr O O
Willis O O
#180 O O
Tablet(s)Glucophage O O
(METFORMIN) O O
1000 O O
MG O O
(500MG O O
TABLET O O
Take O O
2) O O
PO O O
BID O O
#360 O O
Tablet(s)Hydrochlorothiazide B-MEDICATION O
25 O O
MG O O
(25MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s)Lipitor O O
(ATORVASTATIN) O O
80 O O
MG O O
(80 O O
MG O O
TABLET O O
Take O O
1) O O
PO O O
QHS, O O
Dr O O
Gil-increased O O
September O O
2070 O O
#90 O O
Tablet(s)Multivitamins O O
1 O O
TAB O O
PO O O
QD O O
#90 O O
tablet(s)Norvasc O O
(AMLODIPINE) O O
10MG O O
TABLET O O
PO O O
QD, O O
Dr O O
Garza O O
#90 O O
Tablet(s)Ntg O O
1/150 O O
(NITROGLYCERIN B-MEDICATION O
1/150 O O
(0.4 O O
Mg)) O O
1 O O
TAB O O
SL O O
as O O
directed O O
#30 O O
tablet(s)One O O
Touch O O
PO O O
Vasotec O O
(ENALAPRIL O O
Maleate) O O
20 O O
MG O O
(20MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s)Zantac O O
(RANITIDINE O O
Hcl) O O
150 O O
MG O O
(150MG O O
TABLET O O
Take O O
1) O O
PO O O
BID, O O
prn O O
#180 O O
Tablet(s)Habits O O
Tobacco: B-SMOKER O
no I-SMOKER O
smokingReview I-SMOKER O
of O O
Systems O O
No O O
change O O
in O O
wt. O O
No O O
chronic O O
pain. O O
No O O
headaches, O O
visual O O
disturbances, O O
hearing O O
problems. O O
No O O
CP O O
or O O
palpitations. O O
No O O
dyspnea, O O
cough,or O O
wheezing. O O
No O O
abdominal O O
pain, O O
nausea, O O
vomiting, O O
constipation, O O
diarrhea, O O
BRBPR, O O
or O O
melena. O O
No O O
dysuria O O
or O O
difficulty O O
with O O
urination. O O
. O O
No O O
joint O O
pain O O
or O O
swelling. O O
No O O
skin O O
changes O O
or O O
rash. O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
134/70PULSE O O
60WEIGHT O O
208 O O
lbExam O O
Physical O O
Exam O O
General O O
Appearance O O
well-appearing, O O
NAD. O O
Status O O
post O O
cardiac O O
surgery O O
scars O O
in O O
the O O
past O O
Skin O O
No O O
rashes O O
or O O
suspicious O O
lesions. O O
HEENT O O
PERRLA. O O
EOMI. O O
Sclerae O O
non-icteric. O O
TMs O O
are O O
clear O O
bilaterally. O O
OP O O
is O O
clear O O
without O O
erythema O O
or O O
exudate. O O
Neck O O
is O O
supple. O O
No O O
LAD. O O
No O O
thyromegaly. O O
Nodes/Lymphatic O O
No O O
nodes O O
in O O
cervical O O
or O O
supraclavicular O O
area O O
Chest O O
CHEST:A&amp;P-normal O O
bilaterally O O
with O O
good O O
air O O
movement. O O
No O O
local O O
rales O O
or O O
wheezing O O
Cor/Cardiac O O
regular O O
rate, O O
normal O O
S1, O O
S2. O O
No O O
rubs, O O
gallops, O O
or O O
murmurs. O O
Abdomen O O
soft, O O
nontender, O O
nondistended, O O
+bowel O O
sounds, O O
no O O
HSM O O
Extremity O O
warm, O O
no O O
C/C/E. O O
Bilateral O O
knees O O
without O O
effusion.Pulses O O
-good O O
Sensation-satisfactory O O
fo O O
light O O
touch O O
Neurological O O
A+Ox3. O O
CN O O
II-XII O O
intact. O O
Grossly O O
non-focal.Assessment O O
and O O
Plan O O
Overall O O
the O O
patient O O
is O O
quite O O
satisfied O O
Chest O O
pain O O
has O O
not O O
recurred O O
and O O
no O O
need O O
for O O
nitroglycerin O O
Coronary O O
artery O O
disease-I O O
had O O
a O O
long O O
talk O O
with O O
the O O
patient O O
and O O
he O O
understands O O
the O O
need O O
to O O
try O O
to O O
follow O O
his O O
diet O O
and O O
also O O
keep O O
his O O
blood O O
sugar O O
under O O
better O O
control O O
Diabetes O O
we'll O O
recheck O O
his O O
hemoglobin O O
A1c-8.3 O O
and O O
will O O
consult O O
with O O
his O O
diabetes O O
specialist O O
Creatinine O O
elevation O O
will O O
repeat-1.19 O O
Mild O O
anemia O O
Will O O
repeat-37.5 O O
Greater O O
than O O
50% O O
of O O
this O O
30 O O
minute O O
visit O O
was O O
spent O O
in O O
patient O O
counseling O O
regarding O O
the O O
above O O
problems O O
Overall O O
the O O
patient O O
is O O
feeling O O
better O O
after O O
his O O
hospitalization O O
He O O
will O O
check O O
with O O
the O O
renal O O
specialist O O
and O O
diabetes O O
specialist O O
Repeat O O
appointment O O
in O O
my O O
office O O
in O O
a O O
few O O
months O O
or O O
sooner O O
if O O
any O O
problems O O
Orders O O
Laboratory O O
tests-as O O
ordered O O
Follow-Up O O
Appointment- O O
___months O O
Consultation- O O

Record B-SMOKER O
date: O O
2076-03-05 O O
Shelby O O
Dental O O
Care O O
Center O O
4040 O O
Oldham O O
Lane O O
PRESTON, O O
FRANCES O O
Cozad, O O
OK O O
53952 O O
05850080 O O
(060) O O
107-3378 O O
03/05/2076 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
51-year-old O O
woman O O
who O O
comes O O
to O O
SDCC O O
to O O
initiate O O
longitudinal O O
care O O
and O O
for O O
follow O O
up O O
of O O
medical O O
problems. O O
PROBLEMS: O O
Hypertension. B-HYPERTENSION O
She O O
has O O
a O O
long O O
history O O
of O O
hypertension. O O
She O O
has O O
not O O
seen O O
a O O
doctor O O
in O O
a O O
year. O O
She O O
is O O
currently O O
taking: O O
1. O O
Amlodipine B-MEDICATION B-MEDICATION
10 O O
mg O O
p.o. O O
daily. O O
2. O O
Lisinopril B-MEDICATION B-MEDICATION
20 O O
mg O O
daily. O O
3. O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
mg O O
p.o. O O
daily. O O
MEDICATIONS: O O
As O O
noted O O
above. O O
ALLERGIES: O O
No O O
known O O
allergies O O
to O O
any O O
medications. O O
SOCIAL O O
HISTORY: O O
She O O
moved O O
here O O
one O O
year O O
ago O O
from O O
Big O O
Pine O O
Key. O O
Has O O
not O O
had O O
medical O O
care O O
here. O O
REVIEW O O
OF O O
SYMPTOMS: O O
Notable O O
for O O
chest O O
pain, O O
episodic O O
left-sided O O
anterior, O O
for O O
many O O
months. O O
No O O
significant O O
weight O O
change, O O
febrile O O
signs O O
or O O
symptoms, O O
headache, O O
blurred O O
vision, O O
tinnitus, O O
cough, O O
shortness O O
of O O
breath, O O
nausea, O O
abdominal O O
pain, O O
nightsweats, O O
diarrhea, O O
dysuria, O O
polyuria, O O
skin O O
rash, O O
bruising, O O
joint O O
pain, O O
or O O
focal O O
weakness. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
in O O
no O O
acute O O
distress. O O
Blood O O
pressure O O
by O O
nurse O O
160/90, B-HYPERTENSION O
by I-HYPERTENSION O
me I-HYPERTENSION O
150/100, I-HYPERTENSION O
weight O O
222 O O
pounds, O O
height O O
63.5 O O
inches, O O
BMI B-OBESE O
38.8. I-OBESE O
Skin O O
exam: O O
No O O
rash. O O
Head O O
and O O
neck: O O
Normal. O O
Chest: O O
Clear O O
to O O
percussion O O
and O O
auscultation. O O
There O O
is O O
focal O O
tenderness O O
over O O
two O O
left-sided O O
mid O O
costochondral O O
junctions O O
which O O
reproduced O O
chief O O
complaint. O O
Cardiovascular O O
exam: O O
No O O
extra O O
sounds O O
or O O
murmurs. O O
Abdominal O O
exam: O O
No O O
masses, O O
tenderness, O O
or O O
organomegaly. O O
Musculoskeletal O O
exam: O O
Full O O
range O O
or O O
motion O O
without O O
tenderness O O
all O O
joints O O
in O O
both O O
upper O O
extremities O O
and O O
lower O O
extremities, O O
no O O
pedal O O
edema. O O
ASSESSMENT O O
AND O O
PLAN: O O
1. O O
Hypertension. O O
Currently, O O
she O O
is O O
not O O
in O O
good O O
control O O
despite O O
three O O
medications. O O
She O O
reports O O
taking O O
medications O O
today, O O
but O O
about O O
an O O
hour O O
ago. O O
Will O O
make O O
no O O
changes O O
today, O O
but O O
follow O O
up O O
in O O
one O O
week. O O
She O O
uses O O
alot O O
of O O
salt O O
which O O
I O O
adviced O O
her O O
not O O
to O O
do O O
2. O O
Costochondritis. O O
No O O
intervention O O
necessary. O O
3. O O
Obesity. B-OBESE O
This O O
will O O
be O O
the O O
subject O O
of O O
future O O
discussions. O O
4. O O
Adult O O
health O O
maintenance. O O
The O O
patient O O
will O O
return O O
for O O
fasting O O
lipids O O
and O O
other O O
blood O O
work. O O
I O O
will O O
see O O
her O O
in O O
one O O
week O O
for O O
a O O
comprehensive O O
exam. O O
______________________________ O O
Louis O O
P O O
Barron, O O
M.D., O O
M.Sc. O O
eScription O O
document:9-6873721 O O
MEeScription O O
DD: O O
03/05/76 O O
DT: O O
03/06/76 O O
DV: O O
03/05/76 O O

Record B-SMOKER O
date: O O
2076-03-29 O O
Shelby O O
Dental O O
Care O O
Center O O
1048 O O
Oldham O O
Lane O O
PRESTON, O O
FRANCES O O
Cozad, O O
OK O O
53952 O O
05850080 O O
(060) O O
107-3378 O O
03/29/2076 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
51-year-old O O
woman O O
who O O
comes O O
in O O
for O O
followup O O
after O O
a O O
recent O O
2-hour O O
glucose O O
tolerance O O
test O O
and O O
other O O
medical O O
problems. O O
PROBLEMS: O O
1. O O
Diabetes B-DIABETES O
mellitus. I-DIABETES O
Her O O
2-hours O O
value O O
was O O
286. O O
No O O
significant O O
polyuria O O
or O O
polydipsia. O O
2. O O
Hyperlipidemia. B-HYPERLIPIDEMIA O
She O O
has O O
not O O
begun O O
on O O
Zocor. O B-MEDICATION
No O O
muscle O O
aches. O O
3. O O
Hypertension. B-HYPERTENSION O
No O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
dizziness. O O
MEDICATIONS: O O
1. O O
Aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
p.o. O O
daily. O O
2. O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
mg O O
p.o. O O
daily. O O
3. O O
Lisinopril B-MEDICATION B-MEDICATION
10 O O
mg O O
p.o. O O
daily. O O
4. O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
mg O O
daily. O O
5. O O
Simvastatin B-MEDICATION B-MEDICATION
20 O O
mg O O
nightly. O O
REVIEW O O
OF O O
SYMPTOMS: O O
No O O
significant O O
weight O O
change, O O
febrile O O
signs O O
or O O
symptoms, O O
headache, O O
blurred O O
vision, O O
tinnitus, O O
cough, O O
shortness O O
of O O
breath, O O
nausea, O O
abdominal O O
pain, O O
nightsweats, O O
diarrhea, O O
dysuria, O O
polyuria, O O
skin O O
rash, O O
bruising, O O
joint O O
pain, O O
or O O
focal O O
weakness. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
in O O
no O O
acute O O
distress. O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
138/92, I-HYPERTENSION O
weight O O
217 O O
pounds, O O
heart O O
rate O O
72 O O
and O O
regular, O O
BMI B-OBESE O
37.9. I-OBESE O
Chest: O O
Clear O O
to O O
percussion O O
and O O
auscultation. O O
Extremities: O O
No O O
edema. O O
ASSESSMENT O O
AND O O
PLAN: O O
1. O O
Diabetes O O
mellitus. O O
The O O
patient O O
will O O
return O O
to O O
spend O O
time O O
with O O
a O O
diabetic O O
educator, O O
Brizeida O O
Xuan. O O
Referred O O
for O O
nutrition O O
and O O
ophthalmology O O
evaluation. O O
A1c O O
and O O
urine O O
for O O
microalbuminuria O O
ordered. O O
Metformin B-MEDICATION B-MEDICATION
extended I-MEDICATION O
release I-MEDICATION O
500 I-MEDICATION O
mg I-MEDICATION O
p.o. I-MEDICATION O
daily I-MEDICATION O
will I-MEDICATION O
be I-MEDICATION O
initiated. I-MEDICATION O
2. O O
Hyperlipidemia. O O
On O O
treatment. O O
3. O O
Hypertension. O O
Will O O
increase O O
lisinopril O B-MEDICATION
to O O
20 O O
mg O O
p.o. O O
daily. O O
4. O O
Obesity. B-OBESE O
She O O
has O O
lost O O
several O O
pounds O O
about O O
which O O
I O O
congratulated O O
her. O O
Encouraged O O
her O O
to O O
do O O
more O O
and O O
again O O
drew O O
attention O O
to O O
the O O
relationship O O
between O O
this O O
problem O O
and O O
her O O
other O O
medical O O
problems. O O
______________________________ O O
Louis O O
P O O
Barron, O O
M.D., O O
M.Sc. O O
eScription O O
document:0-3309412 O O
MEeScription O O
DD: O O
03/29/76 O O
DT: O O
03/30/76 O O
DV: O O
03/29/76 O O

Record B-SMOKER O
date: O O
2076-04-16 O O
Shelby O O
Dental O O
Care O O
Center O O
1888 O O
Oldham O O
Lane O O
PRESTON, O O
FRANCES O O
Cozad, O O
OK O O
53952 O O
05850080 O O
(060) O O
107-3378 O O
04/16/2076 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
51-year-old O O
woman O O
who O O
returns O O
after O O
recent O O
acute B-CAD O
coronary I-CAD O
syndrome I-CAD O
experience O O
and O O
for O O
follow O O
up O O
of O O
other O O
medical O O
problems. O O
PROBLEMS: O O
1. O O
Acute B-CAD O
coronary I-CAD O
syndrome. I-CAD O
She O O
was O O
in O O
New O O
York O O
and O O
experienced O O
chest B-CAD O
pain. I-CAD O
She O O
was O O
seen O O
at O O
Conway O O
Hospital O O
where O O
she O O
underwent O O
placement B-CAD O
of I-CAD O
two B-CAD O
stents I-CAD O
in I-CAD O
the I-CAD O
right I-CAD O
coronary I-CAD O
artery. I-CAD O
EKG O O
changes O O
suggest B-CAD O
IMI. I-CAD O
She O O
was O O
told O O
that O O
she O O
would O O
need O O
further O O
intervention, O O
but O O
comes O O
with O O
no O O
paperwork. O O
She O O
has O O
had O O
no O O
further O O
chest O O
pain. O O
2. O O
Diabetes B-DIABETES O
mellitus. I-DIABETES O
A1c B-DIABETES O
one I-DIABETES O
month I-DIABETES O
ago I-DIABETES O
was I-DIABETES O
6.7. I-DIABETES O
3. O O
Hyperlipidemia. B-HYPERLIPIDEMIA O
Please O O
see O O
prior O O
notes O O
for O O
full O O
lipid O O
analysis, O O
but O O
LDL B-HYPERLIPIDEMIA O
was I-HYPERLIPIDEMIA O
221. I-HYPERLIPIDEMIA O
She O O
has O O
been O O
on O O
Zocor. B-MEDICATION O
4. O O
Mitral O O
valve O O
disease. O O
Prior O O
to O O
recent O O
coronary O O
event, O O
she O O
underwent O O
an O O
echocardiogram O O
which O O
demonstrated O O
a O O
mildly O O
thickened O O
and O O
calcific O O
aortic O O
valve O O
with O O
a O O
slight O O
gradient. O O
There O O
is O O
calcification O O
of O O
the O O
posterior O O
mitral O O
annulus O O
and O O
leaflet O O
as O O
well O O
as O O
the O O
subvalvular O O
apparatus O O
with O O
an O O
echo O O
dense O O
mobile O O
structure O O
and O O
trigger O O
aspect O O
suggesting O O
a O O
partially O O
disrupted O O
chordae. O O
MEDICATIONS: O O
1. O O
Aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
p.o. O O
daily. O O
2. O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
p.o. O O
daily. O O
3. O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
mg O O
daily. O O
4. O O
Zocor O B-MEDICATION
20 O O
mg O O
p.o. O O
nightly O O
though O O
given O O
a O O
prescription O O
for O O
Lipitor B-MEDICATION B-MEDICATION
80 O O
mg O O
nightly O O
in O O
New O O
York. O O
5. O O
Lisinopril B-MEDICATION B-MEDICATION
20 O O
mg O O
p.o. O O
daily. O O
6. O O
Metformin B-MEDICATION B-MEDICATION
500 O O
mg O O
daily. O O
7. O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
mg O O
daily. O O
8. O O
Nitroglycerin B-MEDICATION B-MEDICATION
0.4 O O
mg O O
p.r.n. O O
REVIEW O O
OF O O
SYMPTOMS: O O
No O O
significant O O
weight O O
change, O O
febrile O O
signs O O
or O O
symptoms, O O
headache, O O
blurred O O
vision, O O
tinnitus, O O
cough, O O
shortness O O
of O O
breath, O O
nausea, O O
abdominal O O
pain, O O
nightsweats, O O
diarrhea, O O
dysuria, O O
polyuria, O O
skin O O
rash, O O
bruising, O O
joint O O
pain, O O
or O O
focal O O
weakness. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
in O O
no O O
acute O O
distress. O O
Blood O O
pressure O O
120/88, O O
weight O O
213 O O
pounds, O O
and O O
temperature O O
97.8. O O
Chest O O
clear O O
to O O
percussion O O
and O O
auscultation. O O
Cardiac O O
exam; O O
no O O
extra O O
sounds. O O
Rather O O
coarse O O
near O O
holosystolic O O
murmur. O O
No O O
apprecialble O O
2nd O O
or O O
third O O
compenents. O O
No O O
pedal O O
edema. O O
EKG O O
today: O O
Heart O O
rate O O
was O O
54 O O
and O O
regular O O
with O O
normal O O
intervals. O O
She O O
has O O
a O O
Q-wave O O
in O O
III O O
and O O
F O O
and O O
slight O O
reversal O O
of O O
R-wave O O
progression O O
in O O
right O O
precordium. O O
These O O
are O O
distinct O O
change O O
from O O
EKG O O
done O O
one O O
month O O
ago. O O
ASSESSMENT O O
AND O O
PLAN: O O
1. O O
Status O O
post O O
IMI. O O
Not O O
on O O
beta-blocker O O
and O O
I O O
will O O
not O O
initiate O O
given O O
sinus O O
bradycardia. O O
I O O
have O O
arranged O O
for O O
her O O
to O O
be O O
seen O O
in O O
Cardiology O O
to O O
determine O O
best O O
next O O
steps. O O
I O O
tried O O
to O O
contact O O
the O O
cardiologist O O
who O O
took O O
care O O
of O O
her O O
in O O
Conway O O
Hospital O O
whose O O
phone O O
number O O
is O O
674-449-3338. O O
2. O O
Diabetes O O
mellitus. O O
Good O O
control. O O
3. O O
Hyperlipidemia. O O
Will O O
initiate O O
therapy O O
with O O
Lipitor O B-MEDICATION
80 O O
mg O O
p.o. O O
nightly O O
for O O
this O O
and O O
problem O O
1 O O
above. O O
Prior O O
authorization O O
form O O
completed. O O
4. O O
Mitral O O
valve O O
disease. O O
______________________________ O O
Louis O O
P O O
Barron, O O
M.D., O O
M.Sc. O O
eScription O O
document:0-0320324 O O
MEeScription O O
DD: O O
04/16/76 O O
DT: O O
04/16/76 O O
DV: O O
04/16/76 O O

Record O O
date: O O
2076-04-19 O O
PRESTON, O O
FRANCES O O
05850080 O O
04/19/2076 O O
Louis O O
Barron, O O
M.D. O O
Shelby O O
Dental O O
Care O O
Center O O
5601 O O
Edwards O O
Street O O
Cozad, O O
OK O O
53952 O O
Dear O O
Dr. O O
Barron: O O
Thank O O
you O O
very O O
much O O
for O O
your O O
kind O O
referral O O
of O O
Frances O O
Preston O O
to O O
the O O
Cardiovascular O O
Division O O
of O O
Weston O O
General O O
Hospital. O O
I O O
saw O O
her O O
in O O
consultation O O
this O O
afternoon O O
for O O
her O O
diagnosis O O
of O O
a B-CAD O
recent I-CAD O
myocardial I-CAD O
infarction. I-CAD O
Please O O
allow O O
me O O
to O O
summarize O O
her O O
history O O
for O O
our O O
records. O O
Frances O O
is O O
a O O
very O O
pleasant O O
51-year-old O O
Danish O O
woman O O
who O O
has O O
cardiac O O
risk O O
factors O O
including O O
hypertension, B-HYPERTENSION B-HYPERTENSION
hyperlipidemia, B-HYPERLIPIDEMIA O
and O O
recently O O
diagnosed O O
glucose O O
intolerance. O O
It O O
appears O O
that O O
she O O
had O O
been O O
having O O
a O O
several-month B-CAD O
history I-CAD O
of I-CAD O
anginal-type I-CAD O
symptoms, I-CAD O
although O O
a O O
stress O O
test O O
obtained O O
in O O
March O O
showed O O
no O O
significant O O
ischemia. O O
On O O
04/09/2076 O O
she O O
was O O
in O O
New O O
York O O
helping O O
a O O
family O O
member O O
with O O
start O O
up O O
of O O
a O O
restaurant, O O
when O O
she O O
woke O O
up O O
in O O
the O O
morning O O
with O O
a O O
sudden O O
onset O O
of O O
chest O O
discomfort O O
and O O
lightheadedness, O O
and O O
according O O
to O O
her O O
daughter O O
suffered O O
a O O
cardiac O O
arrest. O O
She O O
was O O
taken O O
emergently O O
to O O
Cabrini O O
Medical O O
Center O O
where O O
she O O
was O O
found O O
to O O
have O O
an O O
inferior O O
wall O O
myocardial O O
infarction O O
and O O
underwent O O
coronary B-CAD O
stenting. I-CAD O
I O O
do O O
not O O
have O O
records O O
from O O
this O O
admission O O
that O O
she O O
does O O
have O O
her O O
stent O O
cards O O
that O O
indicate O O
that O O
she O O
received O O
a O O
3.5 O O
x O O
23 O O
and O O
3.5 O O
x O O
13 O O
Cypher O O
drug-eluting O O
stents O O
to O O
the O O
right O O
coronary O O
artery. O O
Per O O
her O O
daughter's O O
report, O O
she O O
had O O
a O O
significant O O
lesion O O
in O O
another O O
blood O O
vessel, O O
which O O
was O O
felt O O
to O O
require O O
percutaneous O O
coronary O O
intervention. O O
Unfortunately, O O
we O O
do O O
not O O
have O O
details O O
of O O
the O O
remainder O O
of O O
her O O
coronary O O
anatomy. O O
Since O O
her O O
myocardial O O
infarction, O O
she O O
actually O O
has O O
felt O O
quite O O
well. O O
She O O
no O O
longer O O
has O O
the O O
angina O O
that O O
she O O
had O O
prior O O
to O O
her O O
MI. O O
Her O O
major O O
complaints O O
are O O
that O O
she O O
occasionally O O
feels O O
lightheaded O O
and O O
somewhat O O
fatigued O O
but O O
overall O O
feels O O
well. O O
She O O
is O O
able O O
to O O
walk O O
normal O O
distances O O
without O O
cardiac O O
symptoms. O O
Her O O
past O O
medical O O
history O O
is O O
notable O O
for O O
hypertension, O O
hyperlipidemia, O O
and O O
glucose O O
intolerance. O O
Her O O
present O O
medications O O
include O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
a O O
day, O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
a O O
day, O O
metformin B-MEDICATION B-MEDICATION
500 O O
mg O O
a O O
day, O O
simvastatin B-MEDICATION B-MEDICATION
40 O O
mg O O
a O O
day, O O
nitroglycerin B-MEDICATION B-MEDICATION
p.r.n., O O
amlodipine B-MEDICATION B-MEDICATION
10 O O
mg O O
a O O
day, O O
hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
mg O O
a O O
day, O O
and O O
lisinopril B-MEDICATION B-MEDICATION
20 O O
mg O O
a O O
day. O O
She O O
has O O
no O O
known O O
drug O O
allergies. O O
Social O O
History: O O
She O O
is O O
married O O
and O O
has O O
three O O
children. O O
She O O
is O O
presently O O
accompanied O O
by O O
her O O
daughter O O
Landis O O
who O O
handles O O
the O O
majority O O
of O O
her O O
health O O
care. O O
Landis O O
can O O
be O O
reached O O
on O O
a O O
cell O O
phone O O
at O O
944-351-0904. O O
She B-SMOKER O
has I-SMOKER O
never B-SMOKER O
used I-SMOKER O
tobacco. I-SMOKER O
Family O O
history O O
is O O
notable O O
for O O
several O O
aunts O O
with O O
myocardial O O
infarctions O O
and O O
a O O
sister O O
whose O O
has O O
had O O
a O O
prior O O
stroke. O O
There O O
was O O
a O O
significant O O
history O O
of O O
glucose O O
intolerance O O
in O O
the O O
family. O O
Review O O
of O O
Systems: O O
Cardiac: O O
No O O
chest O O
pain, O O
PND, O O
orthopnea, O O
dyspnea, O O
or O O
lower O O
extremity O O
edema. O O
Musculoskeletal: O O
No O O
myalgias O O
or O O
arthralgias O O
on O O
lipid-lowering O O
therapy. O O
All O O
others O O
are O O
negative. O O
On O O
physical O O
examination, O O
she O O
is O O
an O O
overweight O O
yet O O
well-appearing O O
female O O
in O O
no O O
apparent O O
distress. O O
Her O O
blood O O
pressure O O
is O O
131/86 O O
and O O
her O O
heart O O
rate O O
is O O
61 O O
beats O O
per O O
minute. O O
Her O O
weight O O
is O O
213 O O
pounds. O O
Her O O
neck O O
shows O O
2+ O O
carotid O O
upstrokes. O O
There O O
is O O
a O O
hint O O
of O O
a O O
bruit O O
in O O
the O O
left O O
carotid. O O
The O O
carotid O O
upstrokes O O
are O O
full. O O
Her O O
lungs O O
are O O
clear O O
to O O
auscultation. O O
The O O
heart O O
is O O
normal O O
to O O
palpation, O O
no O O
thrills O O
are O O
palpated O O
and O O
the O O
PMI O O
is O O
nondisplaced. O O
The O O
heart O O
is O O
regular O O
in O O
rate O O
and O O
rhythm O O
and O O
a O O
2/6 O O
systolic O O
ejection O O
murmur O O
is O O
heard O O
best O O
in O O
the O O
right O O
upper O O
sternal O O
border O O
throughout O O
the O O
precordium. O O
The O O
abdomen O O
is O O
obese, B-OBESE O
soft, O O
nontender O O
with O O
normal O O
bowel O O
sounds. O O
Her O O
extremities O O
show O O
no O O
edema. O O
Her O O
EKG O O
in O O
the O O
office O O
today O O
shows O O
normal O O
sinus O O
rhythm O O
at O O
a O O
rate O O
of O O
61 O O
with O O
a O O
normal O O
axis O O
and O O
intervals. O O
She O O
has O O
Q O O
waves O O
and O O
T-wave O O
inversions O O
in O O
leads O O
III O O
and O O
F O O
consistent O O
with O O
her O O
recent O O
myocardial O O
infarction. O O
I O O
do O O
not O O
have O O
a O O
recent O O
lipid O O
profile O O
on O O
file. O O
On O O
04/16/2076, O O
she O O
underwent O O
an O O
echocardiogram. O O
She O O
has O O
normal O O
left O O
ventricular O O
function O O
with O O
a O O
mild O O
intracavitary O O
gradient O O
of O O
9 O O
mmHg. O O
She O O
has O O
mild O O
aortic O O
sclerosis O O
with O O
a O O
velocity O O
across O O
the O O
aortic O O
valve O O
of O O
2.2 O O
m/sec. O O
There O O
are O O
no O O
significant O O
wall O O
motion O O
abnormalities. O O
She O O
has O O
only O O
mild O O
mitral O O
regurgitation. O O
In O O
summary, O O
well O O
we O O
do O O
not O O
have O O
records, O O
it O O
is O O
fairly O O
clear O O
that O O
Mrs. O O
Preston O O
has O O
had O O
an O O
inferior O O
wall O O
myocardial O O
infarction O O
treated O O
with O O
coronary O O
stenting. O O
She O O
did O O
receive O O
drug-eluting O O
stents. O O
The O O
good O O
news O O
is O O
that O O
appears O O
that O O
her O O
left O O
ventricular O O
function O O
is O O
very O O
well O O
preserved O O
suggesting O O
that O O
she O O
did O O
not O O
have O O
a O O
large O O
myocardial O O
infarction. O O
What O O
is O O
less O O
clear, O O
however, O O
is O O
the O O
status O O
of O O
her O O
other O O
coronaries, O O
there O O
is O O
some O O
suggestion O O
that O O
she O O
may O O
have O O
significant B-CAD O
coronary I-CAD O
artery I-CAD O
disease I-CAD O
at O O
this O O
time. O O
From O O
a O O
clinical O O
standpoint, O O
I O O
certainly O O
do O O
not O O
think O O
that O O
she O O
requires O O
a O O
cardiac O O
catheterization O O
at O O
this O O
time. O O
She O O
is O O
fairly O O
asymptomatic, O O
and O O
is O O
doing O O
well O O
from O O
the O O
cardiovascular O O
standpoint. O O
I O O
think O O
what O O
would O O
be O O
more O O
helpful O O
in O O
guiding O O
recommendation O O
is O O
whether O O
she O O
has O O
significant O O
underlying O O
ischemia O O
at O O
this O O
point. O O
To O O
this O O
end, O O
I O O
have O O
arranged O O
for O O
her O O
to O O
undergo O O
an O O
adenosine O O
PET O O
scan O O
to O O
assess O O
for O O
residual O O
ischemia. O O
We O O
will O O
guide O O
our O O
recommendations O O
regarding O O
cardiac O O
catheterization O O
based O O
on O O
the O O
results O O
of O O
the O O
study. O O
In O O
terms O O
of O O
her O O
lipids, O O
it O O
appears O O
that O O
she O O
has O O
been O O
switched O O
to O O
Lipitor. B-MEDICATION B-MEDICATION
The O O
goal O O
for O O
her O O
LDL O O
should O O
be O O
in O O
the O O
70s O O
and O O
her O O
HDLs O O
ideally O O
be O O
in O O
the O O
40s. O O
In O O
terms O O
of O O
antithrombotic O O
therapy, O O
she O O
did O O
receive O O
drug-eluting O O
stents. O O
Therefore, O O
she O O
should O O
certainly O O
remain O O
on O O
aspirin O B-MEDICATION
for O O
the O O
remainder O O
of O O
her O O
life O O
and O O
Plavix O B-MEDICATION
for O O
an O O
absolute O O
minimum O O
of O O
one O O
year. O O
After O O
a O O
year, O O
it O O
would O O
likely O O
be O O
acceptable O O
for O O
her O O
to O O
stop O O
her O O
Plavix O O
for O O
brief O O
periods O O
of O O
time O O
should O O
it O O
be O O
necessary O O
for O O
other O O
medical O O
procedures. O O
However, O O
up O O
until O O
that O O
time O O
her O O
Plavix O O
should O O
not O O
be O O
discontinued O O
without O O
a O O
discussion O O
with O O
myself. O O
She O O
is O O
on O O
a O O
very O O
good O O
medical O O
regimen, O O
although O O
I O O
think O O
she O O
would O O
benefit O O
from O O
a O O
beta-blocker. O O
The O O
hydrochlorothiazide B-MEDICATION O
appears I-MEDICATION O
to I-MEDICATION O
be I-MEDICATION O
a I-MEDICATION O
new I-MEDICATION O
medication I-MEDICATION O
for I-MEDICATION O
her, I-MEDICATION O
and I-MEDICATION O
therefore I-MEDICATION O
I I-MEDICATION O
went I-MEDICATION O
ahead I-MEDICATION O
and I-MEDICATION O
discontinued I-MEDICATION O
this I-MEDICATION O
and O O
started B-MEDICATION O
her I-MEDICATION O
on I-MEDICATION O
extended-release I-MEDICATION O
metoprolol B-MEDICATION B-MEDICATION
at O O
25 O O
mg O O
a O O
day. O O
This O O
can O O
certainly O O
be O O
cut O O
uptitrated O O
for O O
better O O
blood O O
pressure O O
control. O O
I O O
will O O
call O O
her O O
daughter O O
Landis O O
with O O
the O O
results O O
of O O
her O O
PET O O
scan O O
and O O
further O O
recommendations, O O
and O O
we O O
will O O
go O O
ahead O O
and O O
make O O
plans O O
for O O
her O O
to O O
see O O
me O O
again O O
in O O
six O O
months. O O
Thank O O
you O O
for O O
allowing O O
me O O
to O O
participate O O
in O O
her O O
care. O O
If O O
you O O
have O O
any O O
further O O
questions O O
regarding O O
her O O
management, O O
do O O
not O O
hesitate O O
to O O
contact O O
me. O O
______________________________ O O
Corrie O O
Q O O
Newland, O O
MD O O
eScription O O
document:3-6567539 O O
IFFocus O O
DD: O O
04/19/76 O O
DT: O O
04/20/76 O O
DV: O O
04/19/76 O O

Record B-SMOKER O
date: O O
2076-12-15 O O
PRESTON, O O
FRANCES O O
05850080 O O
12/15/2076 O O
Louis O O
Barron, O O
M.D. O O
Shelby O O
Dental O O
Care O O
Center O O
9842 O O
Edwards O O
Street O O
Cozad, O O
OK O O
53952 O O
Dear O O
Dr. O O
Barron: O O
I O O
would O O
like O O
to O O
give O O
you O O
followup O O
on O O
our O O
mutual O O
patient O O
Frances O O
Preston. O O
As O O
you O O
know, O O
I O O
referred O O
her O O
to O O
the O O
cardiac O O
catheterization O O
laboratory O O
because O O
of O O
progressive B-CAD O
worsening I-CAD O
angina I-CAD O
and O O
a B-CAD O
stress I-CAD O
test I-CAD O
suggesting I-CAD O
anterior I-CAD O
ischemia. I-CAD O
We O O
performed O O
a O O
catheterization B-CAD O
on I-CAD O
12/14/2076. I-CAD O
We I-CAD O
utilized I-CAD O
the I-CAD O
right I-CAD O
radial I-CAD O
artery I-CAD O
for I-CAD O
access. I-CAD O
We I-CAD O
found I-CAD O
that I-CAD O
she I-CAD O
developed I-CAD O
a I-CAD O
significant I-CAD O
in-stent I-CAD O
restenosis I-CAD O
lesion I-CAD O
within I-CAD O
the I-CAD O
previously I-CAD O
placed I-CAD O
Cypher I-CAD O
drug-eluting I-CAD O
stent. I-CAD O
This O O
is O O
undoubtedly O O
the O O
cause O O
of O O
her O O
symptoms. O O
We O O
were O O
able O O
to O O
treat O O
this O O
lesion O O
with O O
balloon B-CAD O
angioplasty I-CAD O
and I-CAD O
ultimately I-CAD O
stented B-CAD O
with I-CAD O
a I-CAD O
3.5 I-CAD O
x I-CAD O
24 I-CAD O
Taxus I-CAD O
drug-eluting I-CAD O
stent. I-CAD O
The O O
stent O O
was O O
postdilated O O
with O O
a O O
4 O O
mm O O
noncompliant O O
balloon O O
to O O
high O O
pressure. O O
The O O
final O O
angiographic O O
result O O
was O O
excellent. O O
The O O
following O O
morning O O
she O O
was O O
doing O O
quite O O
well O O
and O O
we O O
discharged O O
her O O
later O O
in O O
the O O
day. O O
She O O
will O O
remain O O
on O O
her O O
usual O O
medications O O
and O O
I O O
have O O
stressed O O
the O O
importance O O
of O O
remaining O O
on O O
aspirin B-MEDICATION B-MEDICATION
once O O
a O O
day O O
for O O
the O O
remainder O O
of O O
her O O
life O O
and O O
Plavix B-MEDICATION B-MEDICATION
for O O
a O O
minimum O O
of O O
a O O
year O O
after O O
this O O
procedure, O O
though O O
I O O
will O O
likely O O
favor O O
indefinite O O
therapy. O O
I O O
plan O O
on O O
seeing O O
her O O
again O O
on O O
01/24/2077 O O
in O O
followup. O O
If O O
you O O
have O O
any O O
further O O
questions O O
regarding O O
her O O
care, O O
please O O
do O O
not O O
hesitate O O
to O O
contact O O
me. O O
Sincerely, O O
______________________________ O O
Corrie O O
Q O O
Newland, O O
MD O O
eScription O O
document:0-3743412 O O
IFFocus O O
DD: O O
12/15/76 O O
DT: O O
12/15/76 O O
DV: O O
12/15/76 O O

Record B-SMOKER O
date: O O
2094-05-20 O O
ZELDA O O
UPHAM O O
SMC O O
Unit O O
No: O O
MOLLY O O
STARK O O
HOSPITAL O O
ADULT O O
MEDICINE O O
Date: O O
May O O
20, O O
2094 O O
70-year-old O O
female, O O
first O O
visit O O
to O O
MSH O O
AMED. O O
MEDICATIONS: O O
Ibuprofen O O
800 O O
mg O O
1 O O
p.o. O O
b.i.d., O O
has O O
taken O O
for O O
years. O O
Self-d/c'd O O
meclizine, O O
unclear O O
status O O
on O O
H2 O O
blocker. O O
ALLERGIES: O O
Percocet, O O
codeine, O O
sulfa. O O
PMH: O O
Includes O O
fibromyalgia O O
with O O
chronic O O
pain, O O
osteoarthritis, O O
recurrent O O
vertigo, O O
cervical O O
spondylosis, O O
lumbar O O
spondylosis, O O
carpal O O
tunnel O O
syndrome, O O
myofascial O O
pain, O O
dizziness, O O
syncope, O O
chest O O
pain O O
of O O
unclear O O
etiology, O O
sinusitis, O O
DJD. O O
Status O O
post O O
laminectomy O O
2062. O O
S: O O
70-year-old O O
female O O
accompanied O O
by O O
daughter, O O
Qazi, O O
here O O
to O O
initiate O O
primary O O
care O O
closer O O
to O O
home. O O
Previously O O
followed O O
by O O
Dr. O O
Faust, O O
but O O
daughter O O
needs O O
closer O O
PCP. O O
In O O
addition, O O
patient O O
followed O O
in O O
arthritis O O
clinic O O
by O O
Dr. O O
Solomon O O
and O O
has O O
received O O
injections O O
per O O
patient O O
report O O
from O O
severe O O
muscle O O
spasms O O
of O O
both O O
arms. O O
Also O O
seen O O
by O O
pain O O
clinic. O O
Main O O
issue O O
is O O
continued O O
lower O O
back O O
pain O O
and O O
primary O O
care. O O
Of O O
concern O O
is O O
patient O O
reveals O O
an O O
unclear O O
history O O
of O O
chest O O
pain O O
which O O
was O O
thought O O
to O O
be O O
arthritis, O O
but O O
is O O
accompanied O O
by O O
episodes O O
of O O
syncope, O O
witnessed O O
in O O
a O O
grocery O O
store. O O
Patient O O
has O O
not O O
had O O
to O O
her O O
knowledge O O
a O O
cardiac O O
workup O O
for O O
this. O O
Also O O
had O O
some O O
vascular O O
studies O O
done O O
at O O
that O O
time O O
and O O
was O O
told O O
they O O
were O O
normal. O O
The O O
patient O O
is O O
unclear O O
on O O
status O O
of O O
recent O O
pelvic O O
exam. O O
GYN O O
- O O
G7, O O
P7, O O
still O O
with O O
uterus O O
but O O
not O O
sexually O O
active. O O
Denies O O
any O O
change O O
in O O
bowels. O O
Denies O O
any O O
change O O
in O O
appetite. O O
The O O
patient O O
has O O
been O O
complaining O O
of O O
animals O O
crawling O O
across O O
her O O
chest. O O
States O O
she O O
used O O
a O O
cream O O
for O O
1 O O
week O O
with O O
resolution O O
but O O
now O O
feels O O
the O O
animals O O
are O O
back, O O
and O O
she O O
has O O
been O O
using O O
a O O
pesticide O O
agent O O
which O O
sounds O O
like O O
a O O
Kwell O O
agent O O
to O O
resolve O O
these. O O
Recent O O
testing O O
- O O
L-spine O O
films O O
confirm O O
grade O O
2 O O
anterospondylolisthesis O O
L4-L5 O O
with O O
disc O O
space O O
changes O O
at O O
L1-L2. O O
Negative O O
allergy O O
testing. O O
1/1 O O
immune O O
globulin O O
testing O O
significant O O
for O O
an O O
IgG O O
of O O
15/40 O O
and O O
positive O O
ANA O O
at O O
1:40 O O
and O O
1:60. O O
MRI O O
of O O
spine O O
12/93 O O
shows O O
degenerative O O
changes O O
of O O
lumbar O O
spine. O O
No O O
evidence O O
of O O
disc O O
herniation O O
or O O
canal O O
stenosis. O O
11/92 O O
- O O
Paranasal O O
sinus O O
films O O
show O O
no O O
evidence O O
of O O
sinusitis. O O
Mammo O O
3/94 O O
WNL. O O
Carotid O O
ultrasound O O
done O O
12/93 O O
shows O O
minimal O O
disease O O
of O O
right O O
and O O
left O O
carotid O O
bifurcations. O O
TCDs O O
12/93 O O
suggest O O
a O O
stenosis O O
of O O
the O O
left O O
vertebral O O
artery O O
with O O
an O O
RVA O O
WNL. O O
Velocity O O
suggests O O
a O O
mild O O
stenosis. O O
EKG O O
12/93 O O
shows O O
sinus O O
brad O O
with O O
an O O
LAE. O O
No O O
other O O
significant O O
changes. O O
Nonspecific O O
ST O O
changes. O O
O: O O
HEENT O O
- O O
Unremarkable. O O
Skin O O
- O O
No O O
obvious O O
sign O O
of O O
rash O O
or O O
infection O O
where O O
she O O
states O O
the O O
animals O O
are O O
present. O O
CV O O
- O O
BP B-HYPERTENSION O
is I-HYPERTENSION O
170/88. B-HYPERTENSION O
RR O O
at O O
60. O O
No O O
murmurs, O O
gallops, O O
rubs O O
present. O O
Lungs O O
- O O
Clear O O
to O O
P&A. O O
B12 O O
was O O
331. O O
Attempted O O
Pap O O
smear. O O
External O O
genitalia O O
unremarkable. O O
Vaginal O O
introitus O O
is O O
very O O
small. O O
Patient O O
got O O
very O O
cold O O
and O O
clammy O O
and O O
nervous O O
throughout O O
the O O
tried O O
Pap O O
smear; O O
so O O
Pap O O
smear O O
attempt O O
was O O
terminated O O
at O O
that O O
time. O O
Consent O O
was O O
obtained O O
to O O
conduct O O
Pap O O
smear. O O
Lungs O O
- O O
Clear O O
to O O
P&A. O O
A/P: O O
(1) O O
Dizziness O O
of O O
unclear O O
etiology. O O
Neuro O O
consult O O
had O O
been O O
done O O
when O O
the O O
patient O O
was O O
hospitalized, O O
and O O
meclizine O O
has O O
not O O
been O O
of O O
any O O
benefit. O O
Will O O
refer O O
patient O O
to O O
Vascular O O
to O O
ascertain O O
whether O O
the O O
TCD O O
findings O O
are O O
related. O O
(2) O O
Report O O
of O O
syncope. O O
Will O O
obtain O O
stress O O
test. O O
(3) O O
Chronic O O
NSAID O O
usage. O O
Add O O
ranitidine O O
HCL O O
150 O O
mg O O
to O O
1 O O
p.o. O O
q.h.s. O O
to O O
regime. O O
Patient O O
will O O
follow O O
up O O
with O O
Dr. O O
Helen O O
Whitehead O O
as O O
her O O
new O O
PCP. O O
Frieda O O
Nadeau, O O
RN, O O
ANP O O
FN/warren/forbes O O

Record B-SMOKER O
date: O O
2094-09-28 O O
CHOL B-HYPERLIPIDEMIA O
210 I-HYPERLIPIDEMIA O
(T) I-HYPERLIPIDEMIA O
244 I-HYPERLIPIDEMIA O
(H) I-HYPERLIPIDEMIA O
243 I-HYPERLIPIDEMIA O
(H) I-HYPERLIPIDEMIA O
256 I-HYPERLIPIDEMIA O
(H) I-HYPERLIPIDEMIA O
TRIG O O
50 O O
HDL O O
62 O O
LDL B-HYPERLIPIDEMIA O
138 I-HYPERLIPIDEMIA O
F/u: O O
CAD, B-CAD O
LBP O O
Saw O O
Dr O O
Mora O O
of O O
Cardiology, O O
who O O
she O O
says O O
kept O O
her O O
on O O
ASA B-MEDICATION B-MEDICATION
and O O
SL B-MEDICATION O
NTG. I-MEDICATION O
Says O O
told O O
to O O
attend O O
cardiac O O
rehab O O
2 O O
x O O
week, O O
but O O
that O O
a O O
nurse O O
later O O
told O O
her O O
she O O
didn't O O
need O O
it. O O
Appt O O
with O O
him O O
pending O O
10/28/94. O O
Saw O O
nutritionist. O O
Still O O
gets O O
exertional B-CAD O
CP I-CAD O
in I-CAD O
same O O
pattern. O O
C/o O O
severe, O O
chronic O O
low O O
back O O
for O O
10 O O
years. O O
Followed O O
by O O
Dr. O O
Solomon O O
for O O
3 O O
years. O O
DJD O O
on O O
MRI O O
12/93 O O
and O O
told O O
of O O
sciatica. O O
Uses O O
ibuprofen O O
800 O O
po O O
tid. O O
Not O O
sure O O
about O O
cox O O
2 O O
inhibitor O O
use O O
in O O
the O O
past O O
and O O
Ultram O O
made O O
too O O
groggy.Became O O
tearful O O
when O O
discussing O O
this O O
issue, O O
statingthat O O
paincanbe O O
excruciating. O O
Notes O O
anxiety O O
due O O
to O O
terrorist O O
attacks O O
and O O
is O O
not O O
sleeping O O
well. O O
Lives O O
alone. O O
Asks O O
for O O
some O O
Valium. O O
PE: O O
WD/WN O O
in O O
NAD O O
BLOOD O O
PRESSURE O O
140/70 O O
TEMPERATURE O O
PULSE O O
64 O O
RESPIRATORY O O
RATE O O
O2 O O
SAT O O
HEIGHT O O
WEIGHT O O
151 O O
lb O O
lungs O O
clear O O
back O O
no O O
CVAT O O
or O O
ST O O
cor O O
RRR O O
S1S2, O O
no O O
murmur O O
extrem O O
no O O
LE O O
edema O O
A/P: O O
1)CAD- O O
will O O
look O O
for O O
correspondence O O
from O O
Dr. O O
Mora O O
re: O O
his O O
thoughts. O O
Consider O O
adding O O
low O O
dose O O
beta O O
blocker, O O
since O O
BP O O
is O O
a O O
little. O O
Needs O O
mor O O
aggressive O O
lowereing O O
of O O
lipid. O O
At O O
next O O
visit, O O
repeat O O
lipid, O O
and O O
consider O O
lipitor. O B-MEDICATION
2)Back O O
pain- O O
suspect O O
there O O
is O O
some O O
somatization, O O
but O O
patient O O
is O O
far O O
from O O
being O O
able O O
to O O
accept O O
this. O O
For O O
now, O O
refilled O O
Ibupfofen O O
and O O
follow O O
how O O
often O O
she O O
refills. O O
Note O O
in O O
record O O
of O O
patient O O
requesting O O
Vicodan, O O
which O O
was O O
given O O
to O O
her O O
before O O
by O O
Dr. O O
Solomon. O O
Would O O
avoid O O
if O O
possible. O O
3)Anxiety- O O
Valium O O
5 O O
mg O O
#15 O O
mg, O O
prn. O O
Offer O O
counseling O O
at O O
next O O
visit O O
if O O
persists. O O
4)HMC- O O
will O O
ofer O O
colonoscopy O O
at O O
next O O
visit. O O
RTC O O
6 O O
weeks O O
RTC O O
6 O O
weeks O O
--------------Vital O O
Signs---------- O O

Record B-SMOKER O
date: O O
2095-05-10 O O
NAME: O O
Upham, O O
Zelda O O
MRN: O O
9656797 O O
Patient O O
is O O
here O O
for O O
a O O
follow-up. O O
Patient O O
has O O
returned O O
from O O
her O O
trip O O
to O O
Hong O O
Kong. O O
Says O O
that O O
it O O
was O O
a O O
bit O O
stifling, O O
because O O
she O O
cannot O O
drive O O
and O O
was O O
dependent O O
on O O
other O O
people O O
for O O
transportation. O O
Still O O
has O O
severe O O
right O O
shoulder O O
pain. O O
Still O O
also O O
complaining B-CAD O
of I-CAD O
left I-CAD O
jaw I-CAD O
pain, I-CAD O
that O O
is O O
worse O O
when O O
she O O
has O O
to O O
open O O
her O O
mouth O O
very O O
widely. O O
Reviewed O O
x-rays, O O
which O O
were O O
negative O O
for O O
fracture O O
of O O
frontal O O
facial O O
bones, O O
and O O
did O O
not O O
reveal O O
obvious O O
abnormality O O
in O O
the O O
TMJ O O
area. O O
Has O O
yet O O
to O O
receive O O
an O O
appointment O O
from O O
Dr. O O
Vann O O
for O O
this O O
shoulder O O
pain. O O
Patient O O
was O O
afraid O O
to O O
try O O
the O O
Vioxx, O O
because O O
she O O
was O O
told O O
by O O
the O O
pharmacist O O
that O O
she O O
could O O
not O O
take O O
it O O
with O O
ibuprofen. O O
I O O
explained O O
to O O
her O O
that O O
she O O
should O O
take O O
the O O
Vioxx O O
in O O
place O O
of O O
the O O
ibuprofen O O
and O O
she O O
understands. O O
Is O O
not O O
willing O O
to O O
try O O
Flexeril. O O
Patient O O
spent O O
approximately O O
20 O O
minutes O O
describing O O
her O O
dissatisfaction O O
and O O
difficult O O
interactions O O
with O O
her O O
children. O O
Has O O
not O O
asked O O
for O O
more O O
Valium. O O
Has O O
never O O
been O O
interested O O
in O O
counseling O O
prior O O
to O O
today. O O
Did O O
not O O
become O O
tearful O O
like O O
she O O
has O O
in O O
the O O
past. O O
Asked O O
for O O
refill O O
of O O
sublingual B-MEDICATION O
nitroglycerin. I-MEDICATION B-MEDICATION
Prescription O O
apparently O O
was O O
given O O
to O O
her O O
last O O
spring. O O
Complains O O
also O O
of O O
upper B-CAD O
chest I-CAD O
wall I-CAD O
tenderness. I-CAD O
No O O
clear O O
to O O
me O O
what O O
causes O O
her O O
to O O
take O O
the O O
sublingual O O
nitroglycerine, O O
but O O
says O O
when O O
she O O
takes O O
it, O O
it O O
relieves O O
her O O
symptoms. O O
I O O
have O O
asked O O
her O O
if O O
this O O
pain O O
is O O
ever O O
exertional, O O
or O O
is O O
the O O
same O O
pain O O
that O O
is O O
reproducible O O
when O O
she O O
touches O O
her O O
chest. O O
The O O
patient O O
seems O O
to O O
label O O
her O O
chest O O
wall O O
pain O O
as O O
the O O
same O O
as O O
pain O O
that O O
she O O
gets O O
with O O
exertion. O O
PROBLEMS: O O
As O O
per O O
LMR. O O
MEDICATIONS: O O
As O O
per O O
LMR. O O
ALLERGIES: O O
As O O
per O O
LMR. O O
PHYSICAL O O
EXAMINATION: O O
WD/WN O O
female O O
in O O
NAD. O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
150/80. I-HYPERTENSION O
Pulse O O
80 O O
and O O
regular. O O
Weight O O
152 O O
pounds. O O
Lungs: O O
Clear O O
bilateral O O
breath O O
sounds. O O
COR: O O
RRR. O O
S1 O O
and O O
S2 O O
without O O
murmurs O O
noted. O O
Extremities: O O
No O O
lower O O
extremity O O
edema. O O
Soreness O O
over O O
posterior O O
right O O
upper O O
trapezius. O O
Full O O
range O O
of O O
motion O O
of O O
shoulders. O O
No O O
tenderness O O
over O O
AC O O
joints. O O
Chest B-CAD O
wall I-CAD O
tenderness I-CAD O
over I-CAD O
superior I-CAD O
aspect I-CAD O
of I-CAD O
sternum I-CAD O
and I-CAD O
its I-CAD O
border I-CAD O
on I-CAD O
left. I-CAD O
No O O
masses O O
or O O
deformity O O
noted. O O
ASSESSMENT O O
AND O O
PLAN: O O
(1) O O
Chest O O
pain: O O
Certainly O O
overdue O O
for O O
a O O
follow-up O O
with O O
her O O
cardiologist, O O
Dr. O O
Hunter O O
Mccarthy. O O
Referral O O
done. O O
Also O O
referred O O
sublingual O O
nitroglycerin. O O
(2) O O
Elevated B-HYPERTENSION O
blood I-HYPERTENSION O
pressure. I-HYPERTENSION O
Better O O
than O O
last O O
visit, O O
but O O
remains O O
slightly O O
elevated. O O
At O O
last O O
visit, O O
patient O O
was O O
reluctant O O
to O O
start O O
a O O
beta O O
blocker. O O
Think O O
she O O
may O O
need O O
this O O
at O O
future O O
visit. O O
Will O O
also O O
refer O O
back O O
to O O
her O O
cardiologist. O O
(3) O O
Elevated B-HYPERLIPIDEMIA O
lipids, I-HYPERLIPIDEMIA O
last O O
checked O O
last O O
year. O O
Several O O
medications O O
that O O
patient O O
appears O O
to O O
be O O
sensitive O O
to O O
side O O
effects. O O
At O O
next O O
visit, O O
will O O
give O O
lab O O
slip O O
to O O
repeat O O
fasting O O
profile. O O
Positive O O
checkup. O O
Would O O
probably O O
benefit O O
from O O
lipid O O
lowering. O O
(4) O O
Leg O O
cramps. O O
Toward O O
end O O
of O O
visit, O O
patient O O
also O O
complained O O
of O O
more O O
than O O
25 O O
years O O
of O O
leg O O
cramps. O O
Unable O O
to O O
take O O
quinine O O
because O O
of O O
allergic O O
reaction. O O
Patient O O
already O O
takes O O
Valium O O
p.r.n. O O
and O O
I O O
am O O
reluctant O O
to O O
start O O
any O O
other O O
anxiolytics. O O
Will O O
check O O
electrolytes O O
and O O
calcium O O
at O O
next O O
visit. O O
(5) O O
History O O
of O O
sciatica. O O
Patient O O
states O O
in O O
past O O
that O O
she O O
has O O
received O O
steroid O O
injection O O
for O O
her O O
lower O O
back O O
pain, O O
which O O
resolved. O O
Will O O
simply O O
follow O O
with O O
Vioxx, O O
which O O
will O O
hopefully O O
help O O
other O O
pains O O
that O O
patient O O
is O O
experiencing. O O
Also O O
continue O O
with O O
her O O
rheumatologist, O O
Dr. O O
Solomon, O O
who O O
has O O
followed O O
her O O
chronic O O
fibromyalgia O O
and O O
chronic O O
low O O
back O O
pain. O O
Return O O
to O O
clinic O O
with O O
me O O
in O O
six O O
to O O
eight O O
weeks. O O
ADDENDUM: O O
Patient's O O
referral O O
was O O
receiving O O
by O O
Dr. O O
Vann's O O
office O O
and O O
they O O
tell O O
me O O
she O O
should O O
be O O
able O O
to O O
get O O
an O O
appointment O O
for O O
6/95. O O
Helen O O
Whitehead, O O
M.D. O O
HW/warren/stark O O

Record B-SMOKER O
date: O O
2095-12-07 O O
NAME: O O
Upham, O O
Zelda O O
MRN: O O
0308696 O O
The O O
patient O O
is O O
here O O
for O O
a O O
scheduled O O
visit, O O
status B-CAD O
post I-CAD O
hospitalization I-CAD O
for I-CAD O
emergent I-CAD O
bypass I-CAD O
surgery. I-CAD O
She O O
is O O
late O O
for O O
the O O
visit. O O
She O O
is O O
accompanied O O
by O O
her O O
daughter, O O
Qazi. O O
The O O
patient O O
denies O O
chest O O
pain O O
and O O
has O O
done O O
quite O O
well, O O
based O O
on O O
reports O O
from O O
her O O
rehab O O
stay O O
at O O
the O O
Miller O O
County O O
Hospital. O O
Currently O O
complaining O O
of O O
left-sided O O
chest O O
wall O O
pain. O O
No O O
exertional O O
chest O O
pain O O
and O O
no O O
shortness O O
of O O
breath. O O
Has O O
an O O
appointment O O
pending O O
with O O
her O O
cardiologist O O
tomorrow. O O
Also O O
has O O
an O O
appointment O O
pending O O
with O O
surgeon O O
Dr. O O
Weeks O O
for O O
12/13/95. O O
Has O O
been O O
compliant O O
with O O
medications. O O
The O O
patient's O O
daughter O O
is O O
concerned O O
that O O
the O O
patient O O
is O O
not O O
eating O O
enough. O O
Has O O
lost O O
significant O O
weight O O
since O O
hospitalization. O O
Patient O O
did O O
agree O O
that O O
she O O
has O O
been O O
watching O O
what O O
she O O
eats O O
because O O
she O O
did O O
not O O
want O O
to O O
gain O O
much O O
weight. O O
Explained O O
to O O
her O O
the O O
importance O O
of O O
proper O O
nutrition O O
and O O
getting O O
back O O
her O O
strength. O O
Asked O O
if O O
she O O
can O O
use O O
an O O
OTC O O
pain O O
patch O O
called O O
Salonpas. O O
Says O O
that O O
the O O
chest O O
wall O O
tenderness O O
is O O
very O O
different O O
from O O
any O O
exertional O O
chest O O
pain O O
that O O
she O O
may O O
have O O
had O O
in O O
the O O
past. O O
Would O O
like O O
some O O
relief O O
for O O
this. O O
Uses O O
it O O
on O O
her O O
knees O O
and O O
finds O O
it O O
helpful O O
for O O
the O O
arthritic O O
knee O O
pain. O O
Emotionally, O O
the O O
patient O O
did O O
admit O O
to O O
feeling O O
depressed O O
and O O
did O O
become O O
tearful O O
during O O
the O O
visit. O O
PROBLEMS: O O
See O O
extensive O O
LMR O O
list. O O
MEDICATIONS: O O
See O O
LMR O O
list. O O
ALLERGIES: O O
Sulfa, O O
Percocet O O
and O O
quinine. O O
PHYSICAL O O
EXAMINATION: O O
Well-appearing O O
female. O O
Vital O O
signs: O O
WNL, O O
as O O
per O O
flow O O
sheet. O O
Lungs: O O
Clear O O
with O O
rales. O O
COR: O O
RRR, O O
S1 O O
and O O
S2 O O
without O O
murmurs O O
noted. O O
ASSESSMENT: O O
(1) O O
CAD: B-CAD O
The O O
patient O O
is O O
also O O
on O O
a O O
cholesterol-lowering O O
agent, O O
but O O
will O O
update O O
list O O
at O O
next O O
visit. O O
Keep O O
appointment O O
with O O
cardiologist. O O
(2) O O
Chest O O
wall O O
tenderness O O
status O O
post O O
CABG: O O
Tried O O
to O O
encourage O O
patient O O
that O O
there O O
will O O
be O O
some O O
persistent O O
discomfort O O
in O O
her O O
wound O O
for O O
several O O
months. O O
Told O O
her O O
to O O
hold O O
off O O
on O O
using O O
the O O
OTC O O
pain O O
patch O O
until O O
I O O
can O O
verify O O
the O O
ingredients. O O
(3) O O
Depressed O O
mood O O
status O O
post O O
surgery: O O
Refuses O O
referral O O
to O O
Mental O O
Health. O O
Not O O
suicidal. O O
Encouraged O O
patient O O
to O O
eat O O
more O O
regularly. O O
(4) O O
Return O O
to O O
clinic O O
for O O
follow-up O O
in O O
two O O
weeks. O O
This O O
visit O O
lasted O O
for O O
35 O O
minutes, O O
half O O
of O O
which O O
was O O
spent O O
trying O O
to O O
counsel O O
the O O
patient O O
to O O
obtain O O
proper O O
nutrition O O
and O O
to O O
go O O
to O O
Mental O O
Health. O O
I O O
was O O
unsuccessful O O
in O O
convincing O O
her O O
to O O
attend O O
a O O
Mental O O
Health O O
session. O O
Helen O O
Whitehead, O O
M.D. O O
HW/warren/stark O O

Record B-SMOKER O
date: O O
2097-08-18 O O
MSH O O
Adult O O
Medicine O O
Office O O
Visit O O
PCP O O
Dr O O
Whitehead O O
73 O O
yr O O
old O O
woman O O
with O O
HTN, B-HYPERTENSION O
SP B-CAD O
CABG, I-CAD O
fibromyalgia O O
comes O O
in O O
for O O
follow O O
up O O
of O O
renal O O
MRA O O
done O O
for O O
evaluation O O
of O O
renal O O
insufficiency O O
and O O
associated O O
high O O
K. O O
She O O
was O O
hospitalized O O
in O O
7/97 O O
for O O
a O O
fairly O O
acute O O
deterioration O O
of O O
renal O O
function O O
and O O
hyperkalemia. O O
At O O
that O O
time O O
she O O
was O O
told O O
to O O
DC B-MEDICATION O
Lisinopril B-MEDICATION B-MEDICATION
and O O
Vioxx. O O
Her O O
renal O O
function O O
seemed O O
to O O
improve O O
with O O
that O O
intervention O O
though O O
in O O
early O O
August O O
her O O
K+ O O
rose O O
a O O
bit. O O
The O O
VNA O O
has O O
been O O
seeing O O
her O O
at O O
home. O O
According O O
to O O
the O O
patient O O
her O O
BP O O
has O O
been O O
'normal'. O O
She O O
and O O
her O O
daughter O O
come O O
in O O
now O O
to O O
review O O
results O O
of O O
the O O
recent O O
renal O O
MRA. O O
They O O
are O O
seeing O O
me O O
because O O
there O O
were O O
no O O
appts O O
available O O
for O O
her O O
with O O
her O O
PCP. O O
She O O
denies O O
any O O
chest O O
pain, O O
shortness O O
of O O
breath. O O
Appetite O O
is O O
good. O O
She O O
has O O
been O O
trying O O
to O O
avoid O O
foods O O
high O O
in O O
potassium O O
but O O
she O O
is O O
not O O
sure O O
about O O
K+ O O
content O O
of O O
many O O
foods. O O
She O O
has O O
been O O
taking O O
Lisinopril O B-MEDICATION
at O O
the O O
same O O
dose O O
since O O
her O O
CBG B-CAD O
in I-CAD O
2095 I-CAD O
and O O
has O O
been O O
taking O O
NSAIDs O O
for O O
fibromyalgia O O
for O O
several O O
years. O O
Medications O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
650MG O O
TABLET O O
EC O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Mvi O O
(MULTIVITAMINS) O O
1 O O
CAPSULE O O
PO O O
QD O O
Ntg B-MEDICATION O
1/150 O O
(NITROGLYCERIN B-MEDICATION O
1/150 O O
(0.4 O O
MG)) O O
1 O O
TAB O O
SL O O
Q5 O O
MIN O O
X O O
3 O O
Meclizine O O
HCL O O
25MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
TID O O
Neurontin O O
(GABAPENTIN) O O
300MG O O
CAPSULE O O
take O O
1 O O
Capsule(s) O O
PO O O
QHS O O
x O O
30 O O
days O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QHS O O
Atenolol B-MEDICATION B-MEDICATION
25MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
, O O
use O O
pill O O
cutter O O
Effexor O O
(VENLAFAXINE O O
HCL) O O
50MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Problems O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
: O O
Sesta B-CAD O
mibi I-CAD O
EST I-CAD O
7/18/94 I-CAD O
positive I-CAD O
for I-CAD O
inferoseptal I-CAD O
and I-CAD O
mild I-CAD O
septal I-CAD O
ishemia. I-CAD O
SP O O
CABG O O
X O O
5 O O
2095 O O
Low O O
back O O
pain O O
: O O
MRI, O O
LS O O
spine O O
12/05/93;DJD, O O
no O O
spinal O O
stenosis, O O
o O O
disc O O
herniation. O O
Sciatica O O
: O O
Dr. O O
Solomon O O
follows. O O
Syncope O O
: O O
etiology O O
not O O
clear; O O
? O O
fainting. O O
Anxiety O O
Fibromyalgia O O
: O O
Dr. O O
Solomon O O
Pain O O
in O O
joint O O
: O O
Mild O O
degenerative O O
changes O O
at O O
the O O
rightacromioclavicular O O
joint. O O
granuloma O O
: O O
RUL, O O
stable O O
Acute O O
renal O O
failure O O
: O O
off O O
vioxx O O
and O O
ACE O O
resolved, O O
7/97 O O
Procedures O O
Cardiac O O
bypass O O
graft O O
surgery: O O
CORONARY O O
ARTERY O O
BYPASS O O
GRAFT O O
TIMES O O
FIVE O O
(LEFT O O
INTERNAL O O
MAMMARY O O
ARTERY O O
TO O O
LEFT O O
ANTERIOR O O
DESCENDING, O O
REVERSED O O
SAPHENOUS O O
VEIN O O
TO O O
POSTERIOR O O
LEFT O O
VENTRICLE O O
AND O O
POSTERIOR O O
DESCENDING O O
ARTERY, O O
REVERSED O O
SAPHENOUS O O
VEIN O O
TO O O
DIAGONAL O O
AND O O
RAMUS O O
INTERMEDIUS). O O
Allergies O O
PERCOCET O O
- O O
abdominal O O
discomfort, O O
Codeine O O
- O O
GI O O
upset, O O
Sulfa O O
- O O
Rash, O O
Quinine O O
Sulfate O O
- O O
Unknown O O
Oxycodone O O
10 O O
Mg/acetaminophen O O
650 O O
Mg O O
- O O
Unknown O O
QUININE O O
- O O
LOC O O
after O O
dizzyness, O O
ROFECOXIB O O
- O O
RI, O O
LISINOPRIL O B-MEDICATION
- O O
Renal O O
Toxicity O O
PE: O O
BP O O
140/80 O O
R O O
and O O
L O O
arms O O
sitting O O
P O O
60 O O
reg O O
No O O
JVD. O O
Chest O O
is O O
clear O O
COR: O O
RRR, O O
no O O
m, O O
rub. O O
No O O
edema. O O
Results O O
Radiology O O
Exam O O
Number: O O
5998283 O O
Report O O
Status: O O
Final O O
Type: O O
MRA O O
3D O O
Date/Time: O O
08/06/2097 O O
10:00 O O
AM O O
Associated O O
Reports: O O
9899518: O O
MRA O O
Renal O O
+ O O
& O O
- O O
------------------------------------------------------------------------------ O O
HISTORY: O O
RENAL O O
ARTERY O O
STENOSIS, O O
ACUTE O O
RENAL O O
FAILURE O O
DIAGNOSIS: O O
EPPS O O
REPORT O O
EXAMINATION: O O
MRA O O
RENAL O O
ARTERIES O O
PROCEDURE: O O
MRA O O
of O O
the O O
aorta O O
and O O
renal O O
arteries O O
was O O
obtained O O
according O O
to O O
standard O O
department O O
protocol. O O
3D O O
images O O
were O O
obtained O O
and O O
interpreted. O O
FINDINGS: O O
The O O
celiac, O O
SMA O O
and O O
IMA O O
are O O
patent. O O
There O O
are O O
bilateral O O
single O O
renal O O
arteries. O O
There O O
is O O
a O O
moderate O O
length O O
moderate O O
stenosis O O
of O O
the O O
right O O
renal O O
artery, O O
and O O
the O O
left O O
renal O O
artery O O
is O O
widely O O
patent. O O
The O O
solid O O
abdominal O O
viscera, O O
as O O
visualized, O O
are O O
unremarkable. O O
There O O
is O O
a O O
prominent O O
left O O
gonadal O O
vein. O O
IMPRESSION O O
MODERATE O O
STENOSIS O O
OF O O
THE O O
RIGHT O O
RENAL O O
ARTERY O O
Type: O O
Ultr., O O
Kidney O O
Date/Time: O O
07/23/2097 O O
12:41 O O
PM O O
HISTORY: O O
SOB O O
AND O O
DIZZINESS O O
ASSESS O O
HYDRONEPHROSIS O O
REPORT O O
History: O O
Question O O
hydronephrosis. O O
Images O O
from O O
an O O
ultrasound O O
study O O
of O O
the O O
kidneys O O
and O O
the O O
bladder O O
were O O
acquired. O O
There O O
are O O
no O O
prior O O
studies O O
for O O
comparison. O O
Both O O
kidneys O O
are O O
normal O O
in O O
size O O
and O O
lie. O O
The O O
right O O
kidney O O
measures O O
9.8 O O
and O O
the O O
left O O
kidney O O
measures O O
9.7 O O
cm O O
in O O
sagittal O O
dimension. O O
No O O
hydronephrosis O O
or O O
dominant O O
solid O O
masses O O
are O O
seen. O O
Notice O O
made O O
of O O
a O O
right O O
extrarenal O O
pelvis. O O
The O O
bladder O O
is O O
moderately O O
distended O O
without O O
intraluminal O O
lesions. O O
IMPRESSION O O
No O O
hydronephrosis. O O
08/04/2097 O O
08/02/2097 O O
07/31/2097 O O
07/24/2097 O O
NA O O
138 O O
140 O O
K O O
5.2(H) O O
5.6(H) O O
5.2(H) O O
4.5 O O
CL O O
105 O O
108 O O
CO2 O O
20.5(L) O O
23.7 O O
BUN O O
42(H) O O
47(H) O O
58(H) O O
38(H) O O
CRE O O
1.5 O O
1.7(H) O O
2.3(H) O O
1.3 O O
GLU O O
95 O O
75 O O
187(H) O O
07/23/2097 O O
07/23/2097 O O
07/22/2097 O O
07/22/2097 O O
07/18/2097 O O
NA O O
140 O O
142 O O
136 O O
141 O O
K O O
4.8 O O
4.7 O O
3.8 O O
6.5(HT) O O
5.3(H) O O
CL O O
107 O O
104 O O
106 O O
105 O O
CO2 O O
26.6 O O
25.7 O O
24.6 O O
24.8 O O
BUN O O
57(H) O O
74(H) O O
67(H) O O
54(H) O O
CRE O O
1.7(H) O O
2.4(H) O O
3.1(H) O O
2.3(H) O O
GLU O O
75 O O
83 O O
02/11/2097 O O
01/25/2097 O O
11/12/2096 O O
11/11/2096 O O
02/23/2096 O O
NA O O
137 O O
143 O O
137 O O
142 O O
K O O
5.0(H) O O
3.8 O O
4.2 O O
4.8 O O
CL O O
104 O O
106 O O
105 O O
104 O O
CO2 O O
24.9 O O
24.5 O O
25.7 O O
28 O O
BUN O O
40(H) O O
37(H) O O
26(H) O O
29(H) O O
26(H) O O
CRE O O
1.4 O O
1.6(H) O O
1.3 O O
1.5 O O
0.9 O O
GLU O O
124(H) O O
101 O O
127(H) O O
87 O O
02/08/2096 O O
11/28/2095 O O
11/18/2095 O O
11/14/2095 O O
10/30/2095 O O
NA O O
136 O O
142 O O
142 O O
141 O O
137 O O
K O O
4.9(H) O O
4.5 O O
4.9 O O
4.8 O O
4.2 O O
CL O O
100 O O
108 O O
107 O O
109 O O
97(L) O O
CO2 O O
22.1(L) O O
23 O O
25 O O
23 O O
32(H) O O
BUN O O
46(H) O O
33(H) O O
25(H) O O
21 O O
18 O O
CRE O O
1.6(H) O O
1.2 O O
1.0 O O
0.9 O O
1.0 O O
GLU O O
87 O O
96 O O
98 O O
90 O O
94 O O
07/23/2097 O O
UA-COLOR O O
Yellow O O
UA-TURB O O
Clear O O
UA-GLUC O O
NEGATIVE O O
UA-BILI O O
NEGATIVE O O
UA-KET O O
NEGATIVE O O
UA-SPGR O O
1.018 O O
UA-BLD O O
NEGATIVE O O
UA-PH O O
5.5 O O
UA-ALB O O
NEGATIVE O O
UA-UROBI O O
NEGATIVE O O
UA-NIT O O
NEGATIVE O O
UA-WBC O O
1+ O O
HCAST O O
0-2 O O
UAS-RBC O O
0-2 O O
UAS-WBC O O
3-5 O O
UAS-BACT O O
NEGATIVE O O
UAS-SQHI O O
NEGATIVE O O
According O O
to O O
discharge O O
summary O O
of O O
hospitalization O O
in O O
7/97, O O
urine O O
was O O
negative O O
for O O
eosinophils. O O
A: O O
73 O O
yr O O
old O O
with O O
HTN O O
has O O
had O O
deterioration O O
of O O
renal O O
function O O
since O O
2095 O O
when O O
she O O
began O O
taking O O
ACEi O O
concomitantly O O
with O O
NSAID. O O
The O O
cause O O
for O O
more O O
acute O O
deterioration O O
of O O
renal O O
function O O
in O O
7/2097 O O
and O O
again O O
in O O
early O O
August O O
is O O
unclear. O O
She O O
has O O
not O O
been O O
taking O O
any O O
NSAID O O
including O O
OTC O O
forms. O O
I O O
don't O O
think O O
the O O
moderate O O
renal O O
artery O O
stenosis O O
is O O
a O O
significant O O
contributor O O
to O O
renal O O
dysfunction O O
and O O
her O O
BP O O
is O O
reasonable O O
off O O
the O O
ACEi. O O
P: O O
Her O O
daughter O O
had O O
many O O
questions O O
about O O
what O O
this O O
type O O
of O O
'blockage' O O
means O O
and O O
about O O
prognosis. O O
I O O
attempted O O
to O O
explain O O
the O O
differences O O
between O O
renal O O
perfusion, O O
renal O O
function, O O
and O O
to O O
advise O O
her O O
about O O
the O O
role/impact O O
of O O
ACEi O O
for O O
BP O O
and O O
her O O
heart O O
(her O O
daughter O O
is O O
worried O O
that O O
her O O
heart O O
will O O
suffer O O
if O O
she O O
doesn't O O
take O O
the O O
ACEi). O O
I O O
told O O
her O O
that O O
it O O
is O O
unsafe O O
for O O
her O O
to O O
take O O
any O O
NSAID. O O
I O O
suggested O O
that O O
a O O
renal O O
specialist O O
would O O
be O O
helpful O O
in O O
determining O O
the O O
role O O
of O O
renal O O
artery O O
disease O O
in O O
her O O
renal O O
dysfunction. O O
Provided O O
her O O
with O O
detailed O O
lists O O
of O O
low O O
and O O
high O O
K+ O O
foods. O O
Check O O
lytes, O O
renal O O
function, O O
Phos, O O
Ca O O
and O O
Alb O O
today. O O
Will O O
discuss O O
Nephrology O O
consultation O O
with O O
Dr O O
Whitehead. O O
She O O
has O O
an O O
appt O O
with O O
Dr O O
Whitehead O O
on O O
8/27. O O
Length O O
of O O
visit O O
was O O
45 O O
minutes. O O
_____________________________________________ O O
Carole O O
B. O O
Holland, O O
M.D. O O

Record O O
date: O O
2063-12-31 O O
UHER,OLGA O O
258-16-49-2 O O
12/31/63 O O
CARDIOLOGY O O
OFFICE O O
NOTE O O
NOTE O O
Ms. O O
Uher O O
returns O O
after O O
a O O
4 O O
year O O
hiatus. O O
She O O
is O O
now O O
52 O O
and O O
has O O
long-standing O O
insulin B-DIABETES O
dependant I-DIABETES O
diabetes B-DIABETES O
with O O
a O O
h/o O O
retinopathy O O
OS, O O
possible O O
peripheral O O
neuropathy O O
but O O
not O O
known O O
nephropathy. O O
She O O
had O O
a O O
maximal O O
negative O O
exercise O O
test O O
in O O
2059 O O
and O O
has O O
felt O O
generally O O
well O O
since O O
that O O
time. O O
Over O O
the O O
past O O
year O O
she O O
has O O
not O O
been O O
as O O
careful O O
as O O
previously O O
with O O
her O O
diet O O
and O O
has O O
not O O
been O O
checking O O
her O O
sugars O O
regularly. O O
A B-HYPERLIPIDEMIA O
random I-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
w/i I-HYPERLIPIDEMIA O
the I-HYPERLIPIDEMIA O
past I-HYPERLIPIDEMIA O
year I-HYPERLIPIDEMIA O
was I-HYPERLIPIDEMIA O
over I-HYPERLIPIDEMIA O
300. I-HYPERLIPIDEMIA O
She O O
has O O
intermittently O O
had O O
sharp, O O
brief O O
discomforts O O
of O O
the O O
anterior O O
chest O O
lasting O O
only O O
seconds O O
and O O
not O O
accompanied O O
by O O
dyspnea, O O
diaphoresis O O
or O O
light-headedness. O O
There O O
has O O
not O O
been O O
any O O
reduction O O
in O O
her O O
physical O O
capacity, O O
in O O
fact, O O
she O O
feels O O
stronger O O
than O O
a O O
year O O
ago O O
and O O
is O O
working O O
full-time. O O
There O O
has O O
been O O
no O O
orthopnea, O O
PND O O
or O O
peripheral O O
edema. O O
She O O
is O O
interested O O
in O O
increasing O O
her O O
physical O O
activity O O
program. O O
Cardiac O O
risk O O
factors O O
include O O
remote B-SMOKER O
smoking, I-SMOKER O
stopped I-SMOKER O
by I-SMOKER O
age I-SMOKER O
20, I-SMOKER O
hypercholesterolemia B-HYPERLIPIDEMIA O
and O O
family B-FAMILY_HIST O
history I-FAMILY_HIST O
in I-FAMILY_HIST O
that I-FAMILY_HIST O
her I-FAMILY_HIST O
father I-FAMILY_HIST O
developed I-FAMILY_HIST O
coronary I-FAMILY_HIST O
disease I-FAMILY_HIST O
possibly I-FAMILY_HIST O
in I-FAMILY_HIST O
his I-FAMILY_HIST O
50's. I-FAMILY_HIST O
She O O
is O O
perimenopausal O O
and O O
has O O
discussed O O
later O O
estrogen O O
usage O O
with O O
her O O
gynecologist O O
Dr. O O
Bradley O O
Brandt. O O
Her O O
only O O
medication O O
is O O
lente B-MEDICATION O
insulin I-MEDICATION O
taken O O
twice O O
per O O
day. O O
EXAM O O
She O O
is O O
comfortable O O
at O O
rest. O O
BP O O
110/76, O O
HR O O
80 O O
and O O
reg. O O
No O O
JVD. O O
Carotids O O
full O O
w/o O O
bruits. O O
Chest O O
clr. O O
Cardiac O O
exam O O
shows O O
normal O O
heart O O
sounds O O
w/o O O
gallop O O
or O O
murmur. O O
Abd. O O
soft O O
w/o O O
organomegaly. O O
No O O
peripheral O O
edema. O O
Resting O O
EKG O O
shows O O
sinus O O
rhythm O O
with O O
normal O O
intervals O O
and O O
axis O O
and O O
is O O
a O O
normal O O
tracing. O O
For O O
further O O
evaluation O O
of O O
her O O
chest O O
discomforts O O
and O O
to O O
help O O
gauge O O
her O O
exercise O O
program O O
an O O
exercise O O
treadmill O O
test O O
was O O
performed O O
using O O
the O O
standard O O
bruce O O
protocol. O O
She O O
exercised O O
for O O
9 O O
minutes, O O
8 O O
seconds O O
and O O
stopped O O
because O O
of O O
knee O O
discomfort O O
but O O
not O O
because O O
of O O
chest O O
pain O O
or O O
inordinate O O
dyspnea. O O
Peak O O
heart O O
rate O O
was O O
143 O O
(85% O O
maximal O O
predicted) O O
with O O
an O O
appropriate O O
rise O O
in O O
systolic O O
pressure. O O
There O O
were O O
no O O
diagnostic O O
changes O O
of O O
ischemia O O
at O O
this O O
good O O
work O O
load. O O
Compared O O
to O O
the O O
test O O
of O O
9/15/59 O O
she O O
exercised O O
1 O O
minute, O O
4 O O
seconds O O
longer. O O
IMPRESSION O O
1. O O
No O O
evidence O O
of O O
clinical O O
coronary O O
disease O O
at O O
this O O
time. O O
She O O
has O O
major O O
risk O O
factors O O
of O O
insulin O O
dependant O O
diabetes, O O
hypercholesterolemia, O B-HYPERTENSION
family O O
h/o O O
coronary O O
disease O O
and O O
a O O
perimenopausal O O
state. O O
She O O
will O O
be O O
seeing O O
Dr. O O
David O O
Yun O O
as O O
her O O
primary O O
care O O
provider, O O
and O O
would O O
urge O O
that O O
a O O
fasting O O
lipid O O
profile O O
be O O
obtained O O
and O O
that O O
dietary/pharmacologic O O
therapy O O
be O O
PAGE O O
2 O O
UHER,OLGA O O
12/31/63 O O
instituted O O
to O O
achieve O O
an O O
LDL O O
cholesterol O O
&lt;130. O O
From O O
a O O
cardiac O O
standpoint, O O
post-menopausal O O
estrogen O O
therapy O O
would O O
be O O
desired. O O
Low O O
dose O O
aspirin O B-MEDICATION
therapy O O
could O O
also O O
be O O
considered. O O
I O O
would O O
be O O
happy O O
to O O
see O O
Ms. O O
Uher O O
for O O
additional O O
cardiac O O
evaluation O O
as O O
needed O O
in O O
the O O
future. O O
REFERRING O O
MD O O
cc: O O
David O O
Yun, O O
M.D. O O
Ivan O O
M. O O
Ing, O O
M.D. O O
DD: O O
12/31/63 O O
DT: O O
01/01/64 O O
DV: O O
12/31/63 O O
******** O O
Approved O O
but O O
not O O
reviewed O O
by O O
Attending O O
Provider O O
******** O O

Record B-SMOKER O
date: O O
2064-04-20 O O
OFFICE O O
NOTE O O
Uher, O O
Olga O O
258-16-49-2 O O
04/20/64 O O
She O O
returns O O
to O O
clinic O O
for O O
follow O O
up. O O
Unfortunately O O
she O O
missed O O
her O O
entire O O
appointment O O
and O O
did O O
not O O
bring O O
her O O
blood O O
glucose O O
log O O
with O O
her. O O
She O O
reports O O
that O O
at O O
4 O O
a.m. O O
last O O
Thursday O O
she O O
woke O O
up O O
and O O
felt O O
disoriented O O
with O O
sweats. O O
She O O
checked O O
her O O
blood O O
glucose, O O
it O O
was O O
50, O O
and O O
she O O
treated O O
herself O O
by O O
eating. O O
This O O
led O O
to O O
resolution O O
of O O
her O O
symptoms, O O
although O O
she O O
said O O
that O O
she O O
overshoots. O O
She O O
has O O
developed O O
a O O
foot O O
infection, O O
has O O
been O O
seen O O
by O O
a O O
podiatrist O O
and O O
started O O
on O O
antibiotics. O O
She O O
has O O
also O O
been O O
taking O O
a O O
thyroid O O
hormone O O
but O O
she O O
still O O
feels O O
that O O
it O O
is O O
making O O
her O O
tired. O O
She O O
just O O
in O O
general O O
has O O
not O O
been O O
feeling O O
as O O
well O O
as O O
she O O
had O O
been O O
previously. O O
Past O O
Medical O O
History: O O
1. O O
IDDM. B-DIABETES O
Medications: O O
See O O
previous O O
notes. O O
Allergies: O O
Same. O O
Physical O O
Examination: O O
Not O O
performed. O O
The O O
patient O O
had O O
a O O
special O O
orthopedic O O
shoe O O
on, O O
her O O
foot O O
was O O
wrapped. O O
Impression: O O
Patient O O
with O O
IDDM O O
with O O
usual O O
blood O O
glucoses O O
in O O
the O O
200's O O
and O O
an O O
elevated O O
A1C. O O
Discussed O O
the O O
need O O
for O O
consistent O O
meals O O
and O O
exercise O O
and O O
need O O
for O O
more O O
control. O O
Will O O
increase O O
day O O
time O O
insulin B-MEDICATION O
to O O
17 O O
units O O
of O O
Lente B-MEDICATION O
and O O
evening O O
will O O
stay O O
at O O
10. O O
She O O
will O O
follow O O
up O O
in O O
one O O
month. O O
Will O O
check O O
a O O
TSH O O
today. O O
Phyllis O O
Jacobson, O O
M.D. O O
/lott O O
DD: O O
04/20/64 O O
DT: O O
04/22/64 O O
DV: O O
04/20/64 O O
******** O O
Approved O O
but O O
not O O
reviewed O O
by O O
Attending O O
Provider O O
******** O O

Record O O
date: O O
2070-11-04 O O
Neurology O O
EW O O
Resident O O
Consult O O
ID/CC: O O
59 O O
RHF O O
decreasing O O
visual O O
acuity O O
HPI: O O
Ms O O
Uher O O
was O O
doing O O
well O O
until O O
8/70 O O
when O O
she O O
she O O
was O O
noted O O
to O O
have O O
several O O
'staring O O
spells.' O O
At O O
the O O
same O O
time O O
she O O
had O O
increased O O
gait O O
instability O O
leading O O
to O O
admission O O
to O O
SLMC. O O
A O O
head O O
MRI O O
was O O
reportedly O O
normal. O O
She O O
improved O O
and O O
was O O
discharged O O
without O O
treatment O O
or O O
diagnosis. O O
At O O
that O O
time O O
she O O
also O O
noticed O O
subtle O O
decline O O
in O O
visual O O
acuity O O
and O O
eye O O
exam O O
confirmed O O
this. O O
She O O
was O O
told O O
that O O
this O O
was O O
caused O O
by O O
her O O
diabetes. B-DIABETES O
Her O O
vision O O
continued O O
to O O
worsen O O
and O O
she O O
was O O
treated O O
with O O
laser O O
OS. O O
Over O O
the O O
past O O
month O O
her O O
balance O O
has O O
worsened O O
nad O O
her O O
vision O O
has O O
continued O O
to O O
deteriorate. O O
She O O
reports O O
severe O O
HA O O
in O O
8/70 O O
but O O
none O O
recently. O O
She O O
was O O
seen O O
by O O
ophtalmology O O
at O O
SGAH O O
and O O
noted O O
to O O
have O O
optic O O
disc O O
swelling, O O
cotton O O
wool O O
spots O O
and O O
hemorrhages. O O
She O O
was O O
sent O O
to O O
CCH O O
EW O O
for O O
evaluation. O O
ROS:She O O
c/o O O
painful O O
dysesthesia O O
and O O
weakness O O
BLE O O
(lonstanding). O O
She O O
denies O O
HA, O O
tinnitus, O O
vertigo, O O
numbness, O O
fever, O O
chills, O O
cough, O O
nausea, O O
vomiting, O O
chest O O
pain, O O
palpitations, O O
shortness O O
of O O
breath, O O
heartburn, O O
constipation, O O
diarrhea, O O
dysuria, O O
incontinence, O O
or O O
rash. O O
PMH: O O
ear O O
infection O O
spring O O
2069 O O
requiring O O
IV O O
abx O O
(?mastoiditis) O O
type B-DIABETES O
1 I-DIABETES O
DM I-DIABETES O
x I-DIABETES O
38 I-DIABETES O
year I-DIABETES O
{retinopathy, O O
nephropathy, O O
neuropathy O O
arthritis, O O
tendonitis, O O
capsulitis O O
hypothyroidism O O
hypercholesterolemia B-HYPERLIPIDEMIA O
MED: O O
Insulin B-MEDICATION B-MEDICATION
NPH I-MEDICATION B-MEDICATION
12U O O
qam O O
and O O
9U O O
qpm O O
Insulin B-MEDICATION O
Reg I-MEDICATION O
SS O O
levothyroxine O O
200 O O
mcg O O
qd O O
Epogen O O
3x/wk O O
ALL: O O
NKDA O O
SH: O O
Retired, O O
lives O O
alone O O
in O O
Cape O O
Cod, O O
denies B-SMOKER O
tobacco I-SMOKER O
and O O
alcohol O O
FH: O O
type O O
1 O O
DM O O
VS: O O
T O O
98.8 O O
HR O O
86 O O
BP B-HYPERTENSION O
157/94 I-HYPERTENSION O
RR O O
16 O O
PE: O O
Genl O O
WD O O
WN O O
WF O O
mildly O O
agitated O O
NAD O O
HEENT O O
AT/NC, O O
MMM O O
no O O
lesions O O
Neck O O
Supple, O O
no O O
thyromegaly, O O
no O O
LAN, O O
no O O
bruits O O
Chest O O
CTA O O
B O O
CVS O O
RRR O O
no O O
MGR O O
ABD O O
ND, O O
+BS, O O
NT, O O
no O O
masses, O O
no O O
hepatosplenomegaly O O
EXT O O
b/l O O
olecranon O O
nodules, O O
swollen O O
fingers, O O
no O O
edema, O O
distal O O
pulses O O
full, O O
no O O
rashes O O
or O O
petechiae O O
Rectal O O
deferred O O
Neuro O O
MS: O O
disorganized O O
thought O O
(s/p O O
ativan), O O
speech O O
fluent, O O
flat O O
affect O O
CN: O O
I--not O O
tested; O O
II,III--pupils O O
pharmacologically O O
dilated O O
right O O
sluggishly O O
reactive O O
and O O
left O O
non-reactive, O O
VFF O O
by O O
confrontation, O O
b/l O O
optic O O
disc O O
swelling O O
with O O
small O O
hemorrhages O O
and O O
cotton O O
wool O O
spots; O O
III,IV,VI--EOMI, O O
no O O
ptosis; O O
V--sensation O O
intact O O
to O O
LT/PP, O O
masseters O O
strong O O
symmetrically; O O
VII--face O O
symmetric O O
without O O
weakness; O O
VIII--hears O O
finger O O
rub; O O
IX,X--voice O O
normal, O O
palate O O
elevates O O
symmetrically; O O
XI--SCM/trapezii O O
5/5; O O
XII--tongue O O
protrudes O O
midline, O O
no O O
atrophy O O
or O O
fasciculations O O
Motor: O O
normal O O
bulk O O
and O O
tone, O O
no O O
tremor, O O
rigidity O O
or O O
bradykinesia, O O
no O O
pronator O O
drift.strength: O O
Sh O O
abd O O

Record B-SMOKER O
date: O O
2071-06-26 O O
Long O O
Prairie O O
Memorial O O
Hospital O O
94 O O
Aspen O O
Court O O
Uher, O O
Olga O O
Chilton, O O
IN O O
26297 O O
25816492 O O
(606) O O
846-1043 O O
06/26/71 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
has O O
a O O
new O O
apartment. O O
She O O
is O O
actually O O
in O O
the O O
process O O
of O O
moving. O O
She O O
recognizes O O
that O O
she O O
is O O
improving, O O
and O O
is O O
very O O
excited O O
about O O
the O O
fact O O
that, O O
during O O
the O O
course O O
of O O
the O O
week, O O
she O O
went O O
out O O
to O O
Sel O O
de O O
la O O
Terre, O O
and O O
also O O
went O O
through O O
a O O
movie O O
with O O
her O O
friend. O O
Her O O
sugars O O
are O O
still O O
not O O
well O O
controlled. O O
She O O
has O O
been O O
liberalizing O O
her O O
diet, O O
which O O
I O O
thought O O
was O O
appropriate. O O
I O O
did O O
increase O O
her O O
morning O O
insulin B-MEDICATION O
to O O
20 O O
units O O
of O O
30/70, O O
and O O
suggested O O
that O O
she O O
change O O
from O O
five O O
units O O
of O O
NPH B-MEDICATION O
at O O
bedtime O O
to O O
8 O O
units O O
of O O
30-70, O O
taken O O
with O O
her O O
supper, O O
to O O
try O O
to O O
give O O
her O O
a O O
little O O
better O O
coverage O O
for O O
her O O
evening O O
meal. O O
I O O
wrote O O
a O O
note O O
to O O
the O O
nurse O O
to O O
actuate O O
this O O
change. O O
They O O
actually O O
called O O
me O O
later O O
in O O
the O O
evening, O O
on O O
page, O O
and O O
I O O
discussed O O
this O O
with O O
them, O O
at O O
length, O O
at O O
that O O
time, O O
including O O
the O O
rationale O O
for O O
this O O
change. O O
She O O
is O O
not O O
having O O
any O O
exertional O O
or O O
other O O
chest O O
pain. O O
No O O
orthopnea, O O
PND O O
or O O
peripheral O O
edema. O O
PHYSICAL O O
EXAMINATION: O O
Blood O O
pressure O O
is O O
135/80. O O
Heart O O
rate O O
68 O O
and O O
regular. O O
Respirations O O
14. O O
Venous O O
pressure O O
3. O O
Clear O O
chest. O O
S4, O O
no O O
S3. O O
No O O
retrosternal O O
dullness O O
or O O
rub. O O
She O O
has O O
only O O
a O O
trace O O
of O O
ankle O O
edema. O O
IMPRESSION O O
AND O O
PLAN: O O
Her O O
verbal O O
skills O O
have O O
improved. O O
She O O
got O O
very O O
nervous O O
when O O
I O O
tried O O
to O O
test O O
her O O
cognitive O O
skills, O O
and O O
was O O
able O O
to O O
give O O
me O O
the O O
days O O
of O O
the O O
week O O
forward, O O
but O O
not O O
backwards. O O
I O O
did O O
not O O
push O O
her O O
beyond O O
that. O O
I O O
did O O
tell O O
her O O
that O O
we O O
would O O
need O O
to O O
check O O
her O O
TSH O O
in O O
a O O
couple O O
weeks' O O
time, O O
to O O
see O O
if O O
last O O
increment O O
had O O
returned O O
her O O
to O O
a O O
euthyroid O O
state. O O
______________________________ O O
Sean O O
Ugalde, O O
M.D. O O
eScription O O
document:7-829452 O O
STeScription O O
DD: O O
06/27/71 O O
DT: O O
06/27/71 O O
DV: O O
06/26/71 O O

Record B-SMOKER O
date: O O
2073-10-16 O O
EDVISIT^25816492^Uher, O O
Olga^10/16/73^BALL, O O
MILDRED O O
The O O
patient O O
was O O
seen O O
in O O
conjunction O O
with O O
resident O O
Dr. O O
Sharp. O O
The O O
resident's O O
note O O
reviewed. O O
The O O
patient O O
was O O
seen O O
and O O
examined O O
by O O
me. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Briefly, O O
this O O
is O O
a O O
62-year-old O O
woman O O
who O O
has O O
had O O
decrease O O
in O O
mental O O
status O O
and O O
activity O O
since O O
3 O O
days O O
ago. O O
She O O
has O O
had O O
some O O
fevers O O
off O O
and O O
on. O O
Temperature O O
ranging O O
between O O
100 O O
and O O
101.3. O O
Her O O
blood O O
sugar O O
has O O
been O O
300-500. O O
She O O
reports O O
a O O
decrease O O
in O O
energy. O O
She O O
has O O
end-stage O O
renal O O
disease O O
on O O
hemodialysis O O
Sunday, O O
Tuesday, O O
and O O
Thursday. O O
She O O
had O O
her O O
dialysis O O
today O O
but O O
has O O
much O O
less O O
energy O O
than O O
usual. O O
She O O
has O O
a O O
cough, O O
no O O
nausea, O O
vomiting, O O
or O O
diarrhea, O O
has O O
constipation, O O
takes O O
lactulose, O O
and O O
has O O
a O O
normal O O
bowel O O
movement. O O
Last O O
BM O O
was O O
Thursday O O
evening. O O
This O O
is O O
a O O
normal O O
spacing O O
of O O
her O O
usual O O
bowel O O
movements. O O
According O O
to O O
her O O
visiting O O
nurse, O O
the O O
urine O O
looks O O
dark. O O
Blood O O
pressure O O
is O O
running O O
in O O
the O O
low O O
100 O O
in O O
the O O
last O O
month. O O
Change O O
in O O
mental O O
status O O
for O O
5 O O
days O O
means O O
that O O
she O O
is O O
not O O
as O O
talkative O O
as O O
usually O O
is. O O
PAST O O
MEDICAL O O
HISTORY, O O
SOCIAL O O
HISTORY, O O
AND O O
REVIEW O O
OF O O
SYSTEMS: O O
Reviewed, O O
confirmed, O O
and O O
notable O O
for O O
history O O
of O O
high B-HYPERLIPIDEMIA O
cholesterol, I-HYPERLIPIDEMIA O
arthritis, O O
insulin-dependent B-DIABETES O
diabetes, B-DIABETES O
retinopathy, O O
renal O O
failure, O O
foot O O
ulcers, O O
and O O
hypothyroidism. O O
SOCIAL O O
HISTORY: O O
She O O
was O O
in O O
an O O
acute O O
care O O
facility O O
as O O
a O O
nurse O O
coming O O
regularly. O O
The O O
patient O O
arrives O O
to O O
the O O
hospital O O
with O O
a O O
DNR/DNH O O
order, O O
which O O
near O O
the O O
end O O
of O O
her O O
visit O O
once O O
the O O
family O O
arrived, O O
we O O
got O O
the O O
information O O
that O O
this O O
order O O
has O O
been O O
and O O
rescinded O O
by O O
the O O
family O O
in O O
the O O
past. O O
This O O
is O O
noted O O
nowhere O O
in O O
her O O
chart. O O
REVIEW O O
OF O O
SYSTEMS: O O
Negative O O
except O O
as O O
noted O O
above. O O
MEDICATIONS: O O
The O O
patient O O
takes O O
methylphenidate, O O
Ambien, O O
Prilosec, O O
Ultram, O O
verapamil, B-MEDICATION B-MEDICATION
PhosLo, O O
Coumadin, O O
Renax, O O
Colace, O O
and O O
olanzapine. O O
ALLERGIES: O O
She O O
is O O
allergic O O
to O O
NSAIDs. O O
PHYSICAL O O
EXAMINATION: O O
She O O
has O O
a O O
fever O O
of O O
100.3, O O
pulse O O
of O O
95, O O
respirations O O
24, O O
blood O O
pressure O O
85/53, O O
and O O
saturating O O
90% O O
on O O
room O O
air O O
and O O
100% O O
on O O
3 O O
liters. O O
She O O
has O O
facial O O
asymmetry O O
which O O
nurse O O
believes O O
is O O
baseline. O O
Neck O O
is O O
supple O O
and O O
nontender. O O
She O O
has O O
no O O
elevated O O
JVP. O O
Respirations O O
are O O
bilateral O O
basilar O O
crackles O O
with O O
full O O
inspiration O O
effort. O O
Cardiovascular O O
exam O O
is O O
regular O O
rate O O
and O O
rhythm, O O
tachycardic. O O
Abdomen O O
exam O O
is O O
soft, O O
nontender, O O
no O O
distention, O O
and O O
no O O
organomegaly. O O
Skin O O
is O O
warm, O O
dry, O O
and O O
intact. O O
No O O
lesions O O
or O O
rashes. O O
She O O
does O O
have O O
contractures O O
on O O
both O O
lower O O
extremities. O O
Neurologically, O O
she O O
is O O
not O O
oriented O O
at O O
all O O
and O O
cranial O O
nerves O O
II O O
through O O
XII O O
are O O
grossly O O
intact. O O
There O O
is O O
no O O
motor O O
or O O
sensory O O
deficits. O O
LABORATORY O O
DATA: O O
Reveal O O
white O O
count O O
of O O
6.8 O O
and O O
hematocrit O O
of O O
28.8. O O
Chemistry O O
shows O O
sodium O O
146, O O
potassium O O
4.4, O O
chloride O O
105, O O
bicarbonate O O
29, O O
BUN O O
36, O O
creatinine O O
3.5, O O
glucose O O
263, O O
CK O O
281, O O
CK-MB O O
7.5, O O
and O O
troponin O O
142. O O
Platelets O O
is O O
17.6. O O
PNI O O
37.7 O O
and O O
INR O O
1.4. O O
EKG, O O
what O O
is O O
concerning O O
is O O
she O O
has O O
ST O O
elevations O O
approximately O O
2 O O
mm O O
in O O
leads O O
II, O O
III, O O
and O O
F, O O
and O O
V3 O O
through O O
V5. O O
There O O
is O O
no O O
R-wave O O
progression. O O
Chest O O
x-ray O O
showed O O
mild O O
pulmonary O O
edema. O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O
PRIMARY O O
DIAGNOSIS: O O
Fever. O O
SECONDARY O O
DIAGNOSIS: O O
Possible O O
sepsis. O O
DISPOSITION: O O
She O O
is O O
admitted O O
to O O
the O O
hospital O O
having O O
received O O
ceftriaxone, O O
vancomycin, O O
and O O
levofloxacin O O
in O O
the O O
Emergency O O
Department O O
empirically. O O
She O O
is O O
admitted O O
to O O
the O O
ward O O
in O O
stable O O
condition. O O
______________________________ O O
BALL, O O
MILDRED O O
M.D. O O
D: O O
10/17/73 O O
T: O O
10/17/73 O O
Dictated O O
By: O O
BALL, O O
MILDRED O O
eScription O O
document:8-2575360 O O
BFFocus O O

Record O O
date: O O
2070-10-08 O O
October O O
8, O O
2070 O O
Thomas O O
You, O O
M.D. O O
743 O O
Gilson O O
Road O O
Vernon, O O
ME O O
27525 O O
RE: O O
Jaquante O O
Xuereb O O
SRI: O O
134-43-51 O O
Dear O O
Dr. O O
You: O O
Thank O O
you O O
for O O
asking O O
me O O
to O O
consult O O
in O O
the O O
care O O
of O O
this O O
complex O O
patient. O O
Mr. O O
Xuereb O O
is O O
a O O
55-year-old O O
white O O
male O O
who O O
presents O O
with O O
an O O
ischemic O O
right O O
foot. O O
He O O
has O O
a O O
longstanding O O
history O O
of O O
lower O O
extremity O O
occlusive O O
disease O O
and O O
has O O
worked O O
as O O
a O O
high O O
school O O
principle. O O
He O O
has O O
undergone O O
previous O O
right O O
SFA O O
angioplasty O O
in O O
2059, O O
previous O O
left O O
SFA O O
angioplasty O O
and O O
stent O O
placement O O
in O O
2062, O O
previous O O
right O O
fem-pop O O
above-knee O O
bypass O O
grafting O O
in O O
February O O
2070, O O
previous O O
left O O
leg O O
fem-pop O O
bypass O O
grafting O O
with O O
saphenous O O
vein O O
in O O
April O O
2070 O O
and O O
a O O
redo O O
right O O
fem O O
below-knee O O
popliteal O O
bypass O O
graft O O
with O O
a O O
bifid O O
saphenous O O
vein O O
performed O O
in O O
September O O
2070. O O
After O O
this O O
last O O
procedure, O O
the O O
patient O O
at O O
the O O
time O O
of O O
follow-up O O
office O O
visit O O
was O O
noted O O
to O O
have O O
a O O
nonfunctioning O O
graft O O
with O O
an O O
ischemic O O
right O O
lower O O
extremity. O O
He O O
denies O O
any O O
history O O
of O O
trauma. O O
He O O
is O O
a O O
former B-SMOKER O
smoker. I-SMOKER O
He O O
denies O O
any O O
history O O
of O O
hypercoagulable O O
states O O
or O O
history O O
of O O
significant O O
coronary O O
disease. O O
He O O
does O O
have O O
longstanding O O
non-insulin B-DIABETES O
dependent I-DIABETES O
diabetes B-DIABETES O
mellitus I-DIABETES O
as O O
well O O
as O O
hypertension B-HYPERTENSION B-HYPERTENSION
and O O
COPD. O O
Past O O
surgical O O
history O O
is O O
as O O
above. O O
Medications O O
include O O
Glucophage, B-MEDICATION B-MEDICATION
Lopid, B-MEDICATION B-MEDICATION
Prilosec, O O
Norvasc, B-MEDICATION B-MEDICATION
hydrochlorothiazide, B-MEDICATION O
Lipitor, B-MEDICATION B-MEDICATION
Effexor, O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
q.d., O O
aspirin, B-MEDICATION B-MEDICATION
albuterol, O O
Serevent, O O
Nasacort O O
and O O
Pulmicort. O O
No O O
known O O
drug O O
allergies. O O
Review O O
of O O
systems O O
is O O
positive O O
for O O
diabetes, O O
asthma O O
and O O
hypertension. O O
All O O
other O O
review O O
of O O
systems O O
is O O
negative O O
as O O
per O O
H&P O O
sheet. O O
Habits, O O
he O O
is O O
a O O
former O O
tobacco O O
smoker. O O
He O O
denies O O
alcohol O O
use. O O
Family O O
history O O
is O O
positive O O
for O O
MI, O O
stroke O O
and O O
cancer. O O
On O O
physical O O
exam, O O
the O O
patient O O
is O O
a O O
well-developed O O
and O O
well-nourished O O
male O O
in O O
moderate O O
discomfort. O O
Respiratory O O
rate O O
is O O
12-14. O O
Pulse O O
is O O
60-70 O O
and O O
regular. O O
Weight O O
is O O
172 O O
pounds. O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
170/90 B-HYPERTENSION B-MEDICATION
in I-HYPERTENSION O
the I-HYPERTENSION O
right I-HYPERTENSION O
arm, I-HYPERTENSION O
150/90 I-HYPERTENSION O
in I-HYPERTENSION O
the I-HYPERTENSION O
left. I-HYPERTENSION O
No O O
jugular O O
venous O O
distention. O O
Normal O O
respiratory O O
effort. O O
Lungs O O
are O O
clear O O
to O O
auscultation. O O
Heart, O O
regular O O
rate O O
and O O
rhythm. O O
No O O
murmur O O
or O O
bruit. O O
He O O
has O O
no O O
palpable O O
abdominal O O
aortic O O
aneurysm. O O
He O O
has O O
normal O O
carotid, O O
brachial, O O
radial O O
and O O
femoral O O
pulses O O
bilaterally. O O
Absent O O
pedal O O
pulses O O
on O O
the O O
right O O
with O O
Doppler O O
signals, O O
which O O
are O O
monophasic. O O
On O O
the O O
left O O
side, O O
he O O
has O O
adequately O O
perfused O O
foot O O
with O O
normal O O
capillary O O
refill O O
and O O
Doppler O O
signals. O O
He O O
has O O
moderate O O
edema O O
in O O
the O O
right O O
lower O O
extremity. O O
No O O
varicosities. O O
He O O
does O O
have O O
dependent O O
rubor, O O
cyanosis O O
of O O
the O O
right O O
forefoot O O
and O O
purplish O O
discoloration O O
of O O
the O O
tips O O
of O O
the O O
right O O
second O O
to O O
fifth O O
toes. O O
The O O
right O O
great O O
toe O O
is O O
blanched. O O
He O O
has O O
no O O
abdominal O O
masses, O O
tenderness O O
or O O
hepatosplenomegaly. O O
He O O
has O O
grossly O O
intact O O
musculoskeletal O O
tone O O
and O O
strength O O
with O O
no O O
dermatitis, O O
ulcers O O
or O O
sores. O O
He O O
is O O
alert O O
and O O
oriented O O
to O O
person, O O
place O O
and O O
time O O
with O O
slightly O O
depressed O O
affect. O O
Assessment O O
and O O
Plan: O O
1. O O
Ischemic O O
right O O
lower O O
extremity O O
consistent O O
with O O
thrombosed O O
bypass O O
graft. O O
We O O
will O O
plan O O
to O O
admit O O
the O O
patient O O
for O O
treatment O O
with O O
intravenous O O
heparin O O
and O O
plan O O
to O O
schedule O O
him O O
for O O
an O O
urgent O O
arteriogram O O
within O O
the O O
next O O
24 O O
hours. O O
We O O
will O O
attempt O O
to O O
identify O O
any O O
possible O O
way O O
to O O
re-establish O O
flow O O
with O O
either O O
thrombolysis O O
and/or O O
angioplasty O O
and O O
stenting. O O
If O O
this O O
is O O
unsuccessful, O O
he O O
will O O
ultimately O O
require O O
redo O O
fem-pop O O
bypass O O
graft. O O
2. O O
Tobacco O O
abuse: O O
The O O
patient O O
needs O O
to O O
continue O O
to O O
remain O O
abstinent O O
from O O
smoking. O O
3. O O
Hypertension: O O
Moderately O O
controlled O O
on O O
current O O
medications. O O
His O O
previous O O
angiogram O O
did O O
not O O
reveal O O
any O O
evidence O O
of O O
any O O
hemodynamically O O
significant O O
renal O O
artery O O
stenosis. O O
We O O
will O O
adjust O O
him O O
as O O
appropriate O O
from O O
a O O
medical O O
standpoint. O O
4. O O
Non-insulin O O
dependent O O
diabetes O O
mellitus. O O
The O O
patient's O O
blood O O
sugars O O
are O O
currently O O
under O O
good O O
control O O
on O O
Glucophage, O O
which O O
we O O
will O O
need O O
to O O
hold O O
post O O
arteriogram. O O
I O O
will O O
keep O O
you O O
informed O O
as O O
to O O
the O O
status O O
of O O
this O O
very O O
nice O O
patient. O O
Thank O O
you O O
for O O
allowing O O
me O O
to O O
participate O O
in O O
his O O
management. O O
If O O
I O O
can O O
be O O
of O O
any O O
further O O
assistance O O
and O O
management O O
of O O
this O O
or O O
any O O
of O O
your O O
patients O O
with O O
cerebrovascular, O O
aortic, O O
renovascular O O
or O O
low O O
peripheral O O
vascular O O
disease, O O
particularly O O
those O O
in O O
need O O
of O O
a O O
minimally O O
invasive O O
vascular O O
procedure, O O
please O O
feel O O
free O O
to O O
contact O O
me O O
directly. O O
Sincerely, O O
Shane O O
R. O O
Herring, O O
M.D. O O
cc: O O
Dirk O O
O. O O
Reece, O O
M.D., O O
PCP, O O
Pune, O O
ME O O
SRH/valdovinos O O
19-35905660.doc O O

Record B-SMOKER O
date: O O
2070-12-03 O O
December O O
3, O O
2070 O O
Thomas O O
You, O O
M.D. O O
239 O O
Gilson O O
Road O O
Vernon, O O
ME O O
27525 O O
RE: O O
Jaquante O O
Xuereb O O
SRI: O O
134-43-51 O O
Dear O O
Dr. O O
You: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
our O O
mutual O O
patient, O O
Mr. O O
Jaquante O O
Xuereb, O O
in O O
follow O O
up O O
evaluation O O
in O O
our O O
vascular O O
surgery O O
clinic O O
here O O
at O O
the O O
Santa O O
Rosa O O
Infirmary O O
today. O O
As O O
you O O
remember, O O
he O O
recently O O
underwent O O
a O O
revision O O
of O O
his O O
lower O O
extremity O O
bypass O O
graft O O
with O O
thrombectomy O O
of O O
the O O
fem-pop O O
bypass O O
graft O O
and O O
subsequent O O
jump O O
graft O O
to O O
the O O
below-knee O O
popliteal O O
artery. O O
He O O
returns O O
today O O
for O O
follow O O
up O O
evaluation. O O
He O O
has O O
a O O
warm, O O
well-perfused O O
foot O O
with O O
a O O
palpable O O
dorsalis O O
pedis O O
pulse. O O
Unfortunately, O O
over O O
the O O
last O O
ten O O
days O O
he O O
has O O
developed O O
increased O O
erythema O O
and O O
tenderness O O
on O O
the O O
medial O O
aspect O O
of O O
his O O
left O O
knee O O
with O O
superficial O O
skin O O
breakdown O O
consistent O O
with O O
either O O
a O O
staph O O
or O O
a O O
strep O O
cellulitis. O O
He O O
had O O
been O O
on O O
a O O
course O O
of O O
p.o. O O
antibiotics O O
over O O
a O O
week O O
ago O O
for O O
treatment O O
of O O
strep O O
throat O O
as O O
well. O O
The O O
patient O O
has O O
been O O
increased O O
his O O
activity O O
and O O
prior O O
to O O
this O O
time O O
had O O
been O O
extremely O O
active O O
with O O
no O O
erythema, O O
tenderness O O
or O O
drainage O O
from O O
his O O
leg. O O
My O O
concern O O
is O O
that O O
he O O
has O O
increased O O
warmth O O
with O O
blanching O O
and O O
erythema O O
on O O
the O O
medial O O
aspect O O
of O O
his O O
knee O O
consistent O O
with O O
a O O
superficial O O
cellulitis O O
and O O
I O O
believe O O
that O O
he O O
would O O
benefit O O
from O O
hospital O O
admission O O
with O O
a O O
course O O
of O O
IV O O
antibiotics, O O
bedrest O O
and O O
elevate. O O
We O O
will O O
tentatively O O
plan O O
to O O
admit O O
him O O
for O O
localized O O
wound O O
care O O
measures, O O
treatment O O
with O O
IV O O
Nafcillin O O
on O O
a O O
q.4 O O
hour O O
basis. O O
In O O
addition, O O
he O O
has O O
intact O O
femoral O O
pulses O O
on O O
the O O
left O O
side. O O
He O O
does O O
report O O
when O O
he O O
was O O
ambulating O O
he O O
was O O
having O O
increased O O
difficulty O O
with O O
claudication O O
in O O
the O O
distal O O
left O O
lower O O
extremity O O
and O O
calf O O
region. O O
Most O O
recent O O
vascular O O
lab O O
studies O O
dated O O
November O O
29, O O
2070 O O
reveal O O
an O O
ABI O O
of O O
0.96 O O
on O O
the O O
right, O O
0.56 O O
on O O
the O O
left. O O
I O O
will O O
keep O O
you O O
informed O O
as O O
to O O
the O O
status O O
of O O
Mr. O O
Xuereb. O O
My O O
concern O O
is O O
that O O
if O O
he O O
does O O
infect O O
this O O
PTFE O O
graft O O
we O O
do O O
not O O
have O O
any O O
suitable O O
autogenous O O
conduit O O
to O O
perform O O
an O O
additional O O
reconstruction O O
and O O
he O O
would O O
stand O O
a O O
very O O
high O O
chance O O
of O O
losing O O
his O O
limb O O
at O O
the O O
knee O O
level. O O
If O O
I O O
can O O
be O O
of O O
any O O
further O O
assistance O O
in O O
the O O
management O O
of O O
this O O
or O O
any O O
of O O
your O O
other O O
patients O O
with O O
vascular O O
disease, O O
particularly O O
those O O
in O O
need O O
of O O
a O O
minimally O O
invasive O O
vascular O O
procedure, O O
please O O
feel O O
free O O
to O O
contact O O
me O O
directly. O O
Sincerely, O O
Shane O O
R. O O
Herring, O O
M.D. O O
cc: O O
Dirk O O
O. O O
Reece, O O
M.D., O O
9 O O
Church O O
Street, O O
Pune, O O
ME O O
99597 O O
SH/truitt O O
89-05167655.doc O O

Record B-SMOKER O
date: O O
2071-04-14 O O
Patient O O
Name: O O
XUEREB, O O
JAQUANTE; O O
MRN: O O
1344351 O O
Dictated O O
on: O O
04/27/2071 O O
by O O
LILLIAN O O
STEELE, O O
N.P., O O
PH.D. O O
Mr. O O
Xuereb O O
returns O O
to O O
clinic O O
for O O
evaluation O O
and O O
management O O
of O O
recurrent O O
ulcerations O O
on O O
the O O
hypertrophic O O
scar O O
tissue O O
along O O
the O O
medial O O
aspect O O
of O O
the O O
right O O
lower O O
extremity. O O
Today, O O
on O O
physical O O
examination, O O
the O O
wound O O
bed O O
measured O O
1 O O
cm O O
x O O
0.7 O O
cm. O O
The O O
wound O O
bed O O
was O O
covered O O
with O O
yellow O O
biofilm, O O
which O O
was O O
debrided. O O
The O O
underlying O O
wound O O
bed O O
contained O O
moist O O
red O O
tissue O O
with O O
a O O
few O O
drops O O
of O O
bloody O O
drainage. O O
The O O
margin O O
was O O
clear. O O
IMPRESSION: O O
There O O
has O O
been O O
epithelialization O O
of O O
the O O
wound O O
along O O
the O O
medial O O
aspect O O
of O O
the O O
right O O
knee. O O
There O O
has O O
been O O
no O O
further O O
disruption O O
of O O
the O O
epithelium O O
overlying O O
the O O
hypertrophic O O
scar O O
tissue. O O
PLAN: O O
We O O
will O O
continue O O
with O O
dressing O O
changes O O
every O O
two O O
to O O
three O O
days O O
per O O
the O O
following O O
protocol: O O
spray O O
the O O
wound O O
with O O
AllClenz O O
wound O O
cleanser O O
followed O O
by O O
irrigation O O
with O O
normal O O
saline O O
30 O O
cc O O
x O O
3; O O
apply O O
skin O O
protectant O O
to O O
the O O
periwound O O
margin, O O
Panafil O O
paste O O
1/8' O O
thick O O
to O O
the O O
wound O O
bed, O O
gauze O O
dampened O O
with O O
normal O O
saline O O
(cut-to-fit), O O
covered O O
with O O
DuoDerm O O
secured O O
with O O
Medipore O O
tape. O O
Mr. O O
Xuereb O O
will O O
return O O
to O O
clinic O O
in O O
two O O
weeks. O O
__________________________ O O
Lillian O O
Steele, O O
N.P., O O
Ph.D. O O
DD:04/27/2071 O O
DT:04/28/2071 O O
FJ:801734 O O
:77 O O

Record O O
date: O O
2073-12-03 O O
CCU O O
JAR O O
ADMIT O O
NOTE O O
Name: O O
Xuereb, O O
Jaquante O O
D O O
MRN: O O
1344351 O O
Date O O
of O O
Admission: O O
12/03/73 O O
Admitting O O
Physician: O O
Dr. O O
Burke O O
Code O O
Status: O O
Full O O
Source O O
of O O
Hx: O O
Chart, O O
patient O O
ID/CC: O O
Chest O O
pressure, O O
pulmonary O O
edema. O O
HPI: O O
58 O O
year O O
old O O
man O O
with O O
PMH O O
HTN B-HYPERTENSION O
, O O
Hypercholesterolemia, B-HYPERLIPIDEMIA O
smoking. O O
And O O
PVD. O O
S/P O O
LE O O
bypass O O
was O O
admitted O O
to O O
Vascular O O
service O O
with O O
1-2 O O
day O O
history O O
of O O
RLE O O
pain, O O
discoloration. O O
Found O O
to O O
have O O
occluded O O
fem-pop O O
bypass. O O
Underwent O O
unsuccesfull O O
attmp O O
by O O
IR O O
to O O
open O O
vessel O O
and O O
was O O
awainting O O
sheath O O
pull O O
on O O
the O O
vascular O O
floor O O
when O O
he O O
developed O O
shortness O O
of O O
breath O O
and O O
b/l O O
chest O O
pressure O O
in O O
the O O
setting O O
of O O
FFP O O
transfusion. O O
Did O O
have O O
a O O
troponin O O
0.6 O O
and O O
some O O
anterior O O
ST O O
changes. O O
He O O
was O O
diruesed O O
and O O
placed O O
on O O
CPAP O O
when O O
he O O
began O O
to O O
increasing O O
respiratory O O
effort O O
and O O
evidence O O
of O O
tiring. O O
He O O
was O O
then O O
intubated O O
and O O
transferred O O
to O O
the O O
CCU. O O
On O O
arrival O O
in O O
the O O
CCU O O
pt O O
became O O
hypotensive O O
with O O
MAPS O O
in O O
the O O
40's. O O
He O O
was O O
startered O O
on O O
peripheral O O
dopamine O O
with O O
good O O
respone. O O
No O O
EKG O O
chages O O
associated O O
with O O
these O O
symptoms. O O
. O O
PMH/Old O O
Data O O
PVD O O
Hyperlipidemia O O
HTN O O
Smoking O O
Allergies/Adverse O O
Reactions O O
NKDA O O
PAST O O
MEDICAL O O
HISTORY: O O
Significant O O
for O O
diabetes, B-DIABETES O
hypertension, O O
high O O
cholesterol O O
and O O
depression. O O
PAST O O
SURGICAL O O
HISTORY: O O
Significant O O
for O O
bilateral O O
knee O O
arthroscopies O O
and O O
multiple O O
bypass O O
grafts O O
and O O
revascularizations O O
of O O
his O O
lower O O
extremities. O O
MEDICATIONS: O O
Include O O
Glucophage, B-MEDICATION B-MEDICATION
Actos, B-MEDICATION B-MEDICATION
gemfibrozil, B-MEDICATION B-MEDICATION
Lipitor, B-MEDICATION B-MEDICATION
lisinopril, B-MEDICATION B-MEDICATION
Norvasc, B-MEDICATION B-MEDICATION
hydrochlorothiazide, B-MEDICATION B-MEDICATION
Effexor, O O
warfarin, O O
and O O
aspirin. B-MEDICATION B-MEDICATION
ALLERGIES: O O
He O O
has O O
no O O
known O O
drug O O
allergies. O O
SOCIAL O O
HISTORY: O O
He B-SMOKER O
is I-SMOKER O
an I-SMOKER O
ex-smoker. B-SMOKER O
He I-SMOKER O
quit I-SMOKER O
two I-SMOKER O
years I-SMOKER O
prior I-SMOKER O
to I-SMOKER O
this I-SMOKER O
admission. I-SMOKER O
He O O
was O O
a O O
social O O
drinker O O
and O O
is O O
a O O
school O O
administrator. O O
PE O O
VS: O O
T O O
afebrile O O
, O O
MAPS O O
40-80 O O
, O O
HR O O
50's-60's O O
, O O
O2 O O
Sat O O
97 O O
% O O
on O O
100%fiO2 O O
PC. O O
Gen: O O
Intubated O O
and O O
sedated. O O
HEENT: O O
JVP O O
8-10cm O O
Lungs: O O
CTAB O O
- O O
ant O O
Cor: O O
RRR, O O
no O O
m/r/g O O
Abd: O O
Abdomen O O
soft, O O
NT O O
Extr: O O
Warm, O O
PPP O O
. O O
Left O O
arterial O O
sheath. O O
Pulses: O O
pulse O O
with O O
Doppler O O
on O O
L O O
, O O
none O O
on O O
R. O O
Labs O O
Plasma O O
Sodium O O
137 O O
(135-145) O O
mmol/L O O
Plasma O O
Potassium O O
4.0 O O
(3.4-4.8) O O
mmol/L O O
Plasma O O
Chloride O O
99 O O
L O O
(100-108) O O
mmol/L O O
Plasma O O
Carbon O O
Dioxide O O
26.0 O O
(23.0-31.9) O O
mmol/L O O
Calcium O O
8.6 O O
(8.5-10.5) O O
mg/dl O O
Phosphorus O O
5.5 O O
H O O
(2.6-4.5) O O
mg/dl O O
Magnesium O O
1.7 O O
(1.4-2.0) O O
meq/L O O
Plasma O O
Urea O O
Nitrogen O O
11 O O
(8-25) O O
mg/dl O O
Plasma O O
Creatinine O O
1.0 O O
(0.6-1.5) O O
mg/dl O O
Plasma O O
Glucose O O
405 O O
H O O
(70-110) O O
mg/dl O O
Creatine O O
Kinase O O
Isoenzymes O O
3.7 O O
(0.0-6.9) O O
ng/ml O O
CPK O O
Isoenzymes O O
Index O O
(0.0-3.5) O O
Troponin-T O O
0.65 O O
H O O
(0.00-0.09) O O
ng/ml O O
Creatine O O
Kinase O O
94 O O
(60-400) O O
U/L O O
FIO2/Flow O O
UNSPEC. O O
FIO2/L O O
Temp O O
37.0 O O
deg O O
C O O
Unspecified O O
pH O O
7.29 O O
L O O
(7.32-7.45) O O
Unspecified O O
PCO2 O O
53 O O
H O O
(35-50) O O
mm/Hg O O
Unspecified O O
PO2 O O
204 O O
H O O
(40-90) O O
mm/Hg O O
Potassium O O
4.2 O O
(3.5-5.0) O O
mmol/L O O
Glucose O O
439 O O
H O O
(70-110) O O
mg/dL O O
WBC O O
13.5 O O
H O O
(4.5-11.0) O O
th/cmm O O
HCT O O
37.3 O O
L O O
(41.0-53.0) O O
% O O
HGB O O
12.8 O O
L O O
(13.5-17.5) O O
gm/dl O O
RBC O O
4.29 O O
L O O
(4.50-5.90) O O
mil/cmm O O
PLT O O
324 O O
(150-350) O O
th/cumm O O
MCV O O
87 O O
(80-100) O O
fl O O
MCH O O
29.9 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
34.3 O O
(31.0-37.0) O O
g/dl O O
RDW O O
14.3 O O
(11.5-14.5) O O
% O O
PT O O
20.7 O O
H O O
(11.3-13.3) O O
sec O O
PT-INR O O
2.9 O O
APTT O O
27.7 O O
(22.1-34.0) O O
sec O O
Studies O O
EKG-NSR, O O
dynamic O O
t-wave O O
changes O O
anterior, O O
~1mm O O
ST O O
elevation O O
worse O O
than O O
prior O O
v4-v5 O O
CXR: O O
Vascular O O
congestion. O O
Impression O O
and O O
Plan: O O
58 O O
year O O
old O O
man O O
with O O
PVD, O O
likely B-CAD O
CAD I-CAD O
but I-CAD O
no I-CAD O
available I-CAD O
ischemic I-CAD O
work-up. I-CAD O
Resp O O
decompensation O O
likely O O
secondary O O
to O O
pulmonary O O
edema O O
in O O
the O O
setting O O
of O O
volume O O
load. O O
There O O
is O O
some O O
question O O
as O O
to O O
what O O
to O O
do O O
about O O
EKG O O
changes O O
and O O
mild O O
troponin O O
elevations. O O
No O O
definite O O
ST O O
elevations, O O
but O O
elevation O O
in O O
troponin O O
does O O
seem O O
to O O
be O O
too O O
soon O O
to O O
be O O
directly O O
attributable O O
to O O
flash O O
pulmonary O O
edema O O
and O O
resultant O O
demand. O O
Follow O O
enzymes, O O
heparinize O O
both O O
for O O
?ischemia O O
and O O
for O O
PVD O O
with O O
sheath O O
in O O
place. O O
As O O
not O O
lilely O O
ACS, O O
not O O
emergent O O
indication O O
for O O
cath, O O
but O O
he O O
was O O
scheduled O O
for O O
elective O O
cath O O
12/08 O O
and O O
likely O O
would O O
benefit O O
from O O
expedited O O
diagnosis. O O
Pump O O
- O O
intubated, O O
diruesis O O
as O O
allowed O O
by O O
pressure O O
(JVP O O
up, O O
some O O
edema O O
of O O
CXR). O O
Started O O
on O O
peripheral O O
dopa, O O
but O O
this O O
is O O
at O O
least O O
partially O O
related O O
to O O
sedation. O O
Rhythm O O
- O O
Bradycardia, O O
no O O
acute O O
issues O O
Iscenmia O O
- O O
Demand B-CAD O
ischemia I-CAD O
vs I-CAD O
NSTEMI. I-CAD O
Follow O O
markers. O O
Likely O O
to O O
cath O O
today O O
where O O
it O O
is O O
propble O O
he O O
will O O
have O O
3vd O O
and O O
require O O
CT O O
surg O O
consult. O O
Have O O
request O O
FMC O O
records. O O
Heme O O
- O O
FFP O O
+ O O
lasix O O
prior O O
to O O
cath. O O
Heparin, O O
Resp O O
- O O
Wean O O
vent O O
post O O
cath/OP O O
Prophy O O
- O O
Heparin/nexium/peridex O O
while O O
vented. O O
Code: O O
Full O O
______________ O O
S. O O
Stanley O O
Oberg, O O
MD, O O
PhD O O
Medicine O O
PGY-2 O O
Pager O O
86807 O O

Record O O
date: O O
2073-12-05 O O
CCU O O
JAR O O
TRANSFER O O
NOTE O O
Name: O O
Xuereb, O O
Jaquante O O
D O O
MRN: O O
1344351 O O
Date O O
of O O
Admission: O O
12/03/73 O O
Date O O
of O O
Transfer: O O
12/05/73 O O
Admitting O O
Physician: O O
Dr. O O
Burke O O
Code O O
Status: O O
Full O O
Source O O
of O O
Hx: O O
Chart, O O
patient O O
ID/CC: O O
Chest O O
pressure, O O
pulmonary O O
edema. O O
HPI: O O
58 O O
year O O
old O O
man O O
with O O
PMH O O
significant O O
for O O
HTN B-HYPERTENSION O
, O O
Hypercholesterolemia, B-HYPERLIPIDEMIA B-MEDICATION
smoking B-SMOKER O
and O O
PVD. O O
S/P O O
LE O O
bypass. O O
Admitted O O
to O O
Vascular O O
service O O
with O O
1-2 O O
day O O
history O O
of O O
RLE O O
pain, O O
discoloration. O O
Found O O
to O O
have O O
occluded O O
fem-pop O O
bypass. O O
Underwent O O
unsuccesfull O O
attmp O O
by O O
IR O O
to O O
open O O
vessel O O
and O O
was O O
awaiting O O
sheath O O
pull O O
on O O
the O O
vascular O O
floor O O
when O O
he O O
developed O O
shortness O O
of O O
breath O O
and O O
b/l O O
chest O O
pressure O O
in O O
the O O
setting O O
of O O
FFP O O
transfusion. O O
Did O O
have O O
a O O
troponin O O
bump O O
to O O
0.6 O O
and O O
some O O
anterior O O
ST O O
changes. O O
He O O
was O O
diuresed O O
and O O
placed O O
on O O
CPAP O O
when O O
he O O
began O O
to O O
have O O
increasing O O
respiratory O O
effort O O
and O O
evidence O O
of O O
tiring. O O
He O O
was O O
then O O
intubated O O
and O O
transferred O O
to O O
the O O
CCU. O O
On O O
arrival O O
in O O
the O O
CCU, O O
pt O O
became O O
hypotensive O O
with O O
MAPS O O
in O O
the O O
40's. O O
He O O
was O O
startered O O
on O O
peripheral O O
dopamine O O
with O O
good O O
respone. O O
No O O
EKG O O
chages O O
associated O O
with O O
these O O
symptoms. O O
PMH/Old O O
Data O O
PVD O O
Hyperlipidemia O O
HTN O O
Smoking O O
B O O
knee O O
arthroscopies O O
and O O
multiple O O
bypass O O
grafts O O
and O O
revascularizations O O
of O O
his O O
LE O O
Allergies/Adverse O O
Reactions O O
NKDA O O
Social O O
Hx: O O
Ex-smoker, B-SMOKER O
quit I-SMOKER B-MEDICATION
2 I-SMOKER O
yrs I-SMOKER O
PTA I-SMOKER O
school O O
administrator O O
Home O O
Meds: O O
Glucophage, B-MEDICATION B-MEDICATION
Actos, B-MEDICATION B-MEDICATION
Gemfibrozil, B-MEDICATION O
Lipitor, B-MEDICATION B-MEDICATION
Lisinopril, B-MEDICATION B-MEDICATION
Norvasc, B-MEDICATION B-MEDICATION
HCTZ, B-MEDICATION O
Effexor, O O
Coumadin, O O
ASA. B-MEDICATION B-MEDICATION
Please O O
see O O
admission O O
H&P O O
for O O
initial O O
exam O O
and O O
today's O O
progress O O
note O O
for O O
current O O
exam. O O
Labs/Studies O O
Admission O O
EKG-NSR, O O
dynamic O O
t-wave O O
changes O O
anterior, O O
~1mm B-CAD O
ST I-CAD O
elevation I-CAD O
worse I-CAD O
than I-CAD O
prior I-CAD O
Admission O O
CXR: O O
Vascular O O
congestion. O O
12/05/73: O O
Chem7 O O
WNL, O O
Cr O O
1.0, O O
Glu O B-MEDICATION
200-265, O O
Mag O O
1.8 O O
Peak B-CAD O
Trop I-CAD O
0.65 I-CAD O
(trending I-CAD O
down) I-CAD O
WBC O O
8.8 O O
16.2, O O
Hct O O
33.2, O O
Plt O O
283 O O
INR O O
2.7, O O
PTT O O
61.5 O O
CCU O O
Course/Plan: O O
Ischemia: O O
Patient O O
was O O
taken O O
to O O
cath B-CAD O
lab I-CAD O
on I-CAD O
12/03/73 I-CAD O
and I-CAD O
found I-CAD O
to I-CAD O
have I-CAD O
3-V B-CAD O
CAD I-CAD O
(70% I-CAD O
prox I-CAD O
LAD, I-CAD O
60% I-CAD O
LCx, I-CAD O
occluded I-CAD O
RCA). I-CAD O
He O O
was O O
transferred O O
to O O
the O O
CCU O O
(intubated) O O
but O O
with O O
diuresis O O
he O O
was O O
weaned O O
and O O
extubated O O
on O O
12/04/73. O O
He O O
continued O O
to O O
be O O
medically O O
managed O O
with O O
ASA/Plavix B-MEDICATION B-MEDICATION
(on O O
hold O O
now O O
for O O
anticipated O O
surgery), O O
Statin O B-MEDICATION
(lipitor O O
80 O O
mg O O
po O O
qhs), O O
BB O O
(lopressor O O
50 O O
mg O O
po O O
q6h), O O
and O O
ACE-I O O
(captopril O O
6.25 O O
mg O O
po O O
tid O O
started O O
on O O
12/05/73). O O
He O O
is O O
awaiting O O
CABG O B-MEDICATION
but O O
does O O
not O O
have O O
good O O
conduits O O
as O O
expected O O
given O O
his O O
extensive O O
PVD. O O
Plastic O O
surgery O O
is O O
evaluating O O
patient O O
for O O
potential O O
grafts. O O
CNI O O
pending O O
pre-op. O O
Pump: O O
Patient O O
was O O
quickly O O
weaned O O
off O O
all O O
pressors. O O
TTE O O
was O O
obtained O O
on O O
12/05/73. O O
EF O O
was O O
38%, O O
mild O O
MR, O O
LA O O
dilatation, O O
LV O O
is O O
dilated O O
and O O
fxn O O
is O O
moderately O O
impaired O O
(inf/post/lat O O
dysfunction). O O
There O O
were O O
echodensities O O
noted O O
in O O
the O O
LV O O
apex O O
which O O
may O O
be O O
trabeculations, O O
however, O O
thrombus O O
cannot O O
be O O
excluded. O O
He O O
has O O
received O O
prn O O
doses O O
of O O
lasix O O
(responds O O
to O O
80 O O
IV) O O
and O O
we O O
are O O
continuing O O
his O O
BB O O
and O O
ACE-I. O O
Goal O O
TBB O O
is O O
~-1.0 O O
L. O O
Rhythm: O O
Stable, O O
continuing O O
BB, O O
Telemetry. O O
Resp: O O
Stable, O O
s/p O O
extubation. O O
On O O
NC O O
with O O
sats O O
&gt; O O
95%. O O
Continue O O
diuresis O O
and O O
f/u O O
CXRs. O O
PVD/LE: O O
Unsuccessful O O
attempt O O
at O O
percutaneous O O
revascularization O O
of O O
his O O
RLE. O O
Limb O O
is O O
currently O O
not O O
threatened O O
and O O
he O O
has O O
dopplerable O O
pulses. O O
No O O
plans O O
now O O
for O O
interventions O O
in O O
LE. O O
ID/WBC: O O
WBC O O
elevated O O
on O O
12/05/73 O O
but O O
no O O
fevers. O O
May O O
be O O
due O O
to O O
steroids O O
(was O O
receiving O O
Dex O O
while O O
cort-stim O O
was O O
in O O
process). O O
This O O
was O O
discontinued. O O
Cultures O O
all O O
show O O
no O O
growth O O
to O O
date. O O
Continue O O
to O O
trend O O
WBCs. O O
Proph: O O
Heparin O O
gtt, O O
Nexium. O O
FULL O O
CODE O O
John O O
Yeatts, O O
MD O O
CCU O O
JAR, O O
Pager O O
09171 O O

Record B-SMOKER O
date: O O
2068-02-04 O O
ASSOCIATED O O
ARTHRITIS O O
SPECIALISTS O O
CENTER O O
Quijano, O O
Baylee O O
2-03-68 O O
Identification: O O
Patient O O
is O O
a O O
53-year O O
old O O
markedly O O
obese B-OBESE O
female O O
complaining O O
of O O
bilateral O O
weight O O
knee O O
pain. O O
She O O
denies O O
any O O
morning O O
stiffness, O O
any O O
jelling O O
phenomena. O O
She O O
has O O
had O O
no O O
trauma O O
or O O
effusions O O
in O O
the O O
knee. O O
She O O
had O O
noted O O
on O O
x-ray O O
many O O
years O O
ago O O
that O O
she O O
had O O
had O O
a O O
chipped O O
bone O O
in O O
the O O
right O O
knee O O
and O O
some O O
mild O O
osteoarthritis O O
but O O
it O O
has O O
bothered O O
her O O
only O O
intermittently O O
until O O
this O O
year. O O
Last O O
year O O
she O O
did O O
go O O
to O O
Briggs O O
Stratton O O
and O O
dropped O O
to O O
270 O O
lb. O O
at O O
which O O
point O O
her O O
knees O O
felt O O
better, O O
but O O
currently O O
she O O
is O O
back O O
up O O
to O O
over O O
300 O O
lb. O O
and O O
at O O
her O O
height O O
of O O
5 O O
ft. O O
1 O O
in., O O
she O O
is O O
in O O
pain. O O
She O O
has O O
not O O
visited O O
a O O
physician. O O
She O O
has O O
no O O
internist O O
who O O
currently O O
checks O O
on O O
her O O
general O O
medical O O
health, O O
but O O
she O O
does O O
report O O
that O O
the O O
occasional O O
Advil O O
she O O
takes O O
does O O
produce O O
some O O
dyspepsia. O O
She O O
has O O
no O O
history O O
of O O
gout, O O
no O O
history O O
of O O
psoriasis, O O
no O O
history O O
of O O
pseudogout O O
or O O
any O O
rash, O O
alopecia, O O
headaches, O O
shoulder O O
or O O
hip O O
discomfort. O O
She O O
does O O
not O O
complain O O
of O O
back O O
pain O O
but O O
does O O
have O O
difficult O O
walking O O
50 O O
yards O O
because O O
of O O
the O O
knee O O
pain. O O
Allergies: O O
None. O O
Medications: O O
Occasional O O
Advil. O O
Past O O
Surgical O O
History: O O
Cholecystectomy O O
2064. O O
Two O O
c-sections. O O
Past O O
Medical O O
History: O O
Negative O O
for O O
hypertension, O O
diabetes, O O
cancer, O O
stroke, O O
tuberculosis, O O
hepatitis, O O
asthma, O O
heart O O
disease. O O
Family O O
History: O O
Mother O O
is O O
alive O O
and O O
well O O
with O O
no O O
medical O O
problems. O O
Father O O
is O O
alive O O
and O O
well O O
with O O
no O O
medical O O
problems. O O
She O O
has O O
12 O O
siblings. O O
One O O
sibling O O
died O O
of O O
pneumonia O O
at O O
a O O
young O O
age. O O
Another O O
sibling O O
has O O
asthma. O O
Physical O O
Examination; O O
She O O
is O O
a O O
markedly O O
obese O O
female, O O
no O O
apparent O O
distress. O O
She O O
is O O
5 O O
ft. O O
1 O O
in. O O
and O O
weighs O O
304 O O
lb. O O
Examination O O
of O O
joints: O O
No O O
evidence O O
of O O
active O O
synovitis O O
or O O
pain O O
in O O
her O O
DIPs, O O
PIPs, O O
MCPs, O O
wrists, O O
elbows, O O
shoulders. O O
Bilateral O O
hips O O
are O O
limited O O
in O O
internal O O
external O O
rotation O O
but O O
not O O
because O O
of O O
pain-- O O
due O O
to O O
obesity, O O
bilateral O O
knees O O
have O O
crepitus, O O
but O O
no O O
warmth O O
or O O
swelling. O O
There O O
is O O
some O O
pain O O
at O O
extremes O O
of O O
flexion O O
on O O
the O O
left O O
of O O
110 O O
degrees. O O
Ankles O O
and O O
toes O O
within O O
normal O O
limits. O O
Please O O
note O O
above O O
in O O
the O O
clinical O O
history O O
that O O
she O O
does O O
not O O
complain O O
of O O
back O O
pain O O
but O O
does O O
have O O
difficult O O
walking O O
50 O O
yards O O
because O O
of O O
the O O
knee O O
pain. O O
The O O
blood O O
pressure O O
could O O
not O O
be O O
taken O O
secondary O O
to O O
the O O
fact O O
that O O
the O O
large O O
blood O O
pressure O O
cuff O O
did O O
not O O
fit O O
around O O
her O O
right O O
arm. O O
Impression: O O
1. O O
Probable O O
bilateral O O
osteoarthritis. O O
I O O
will O O
obtain O O
plain O O
films O O
and O O
have O O
prescribed O O
Disalcid O O
3 O O
gm. O O
a O O
day O O
p.r.n. O O
GI O O
and O O
renal O O
side O O
effects O O
explained. O O
2-03-68 O O
2. O O
We O O
discussed O O
seriously O O
the O O
need O O
for O O
weight O O
loss. O O
She O O
will O O
be O O
referred O O
to O O
the O O
nutritionist O O
to O O
get O O
on O O
a O O
weight O O
loss O O
program. O O
She O O
will O O
seriously O O
entertain O O
a O O
weight O O
loss O O
program. O O
Patient O O
will O O
return O O
in O O
a O O
few O O
months O O
unless O O
she O O
has O O
any O O
further O O
problems. O O
3. O O
I O O
have O O
referred O O
her O O
to O O
an O O
Internal O O
Medicine O O
doctor O O
for O O
health O O
maintenance O O
since O O
she O O
does O O
not O O
have O O
one O O
as O O
yet. O O
_________________________ O O
Ada O O
R. O O
Kruger, O O
M.D. O O
FK:SK:3696 O O
DD:2-03-68 O O
DT:2-05-68 O O
DV:2-03-68 O O

Record B-SMOKER O
date: O O
2074-01-22 O O
AASC O O
EMERGENCY O O
DEPT O O
VISIT O O
QUIJANO,BAYLEE O O
853-62-51-4 O O
VISIT O O
DATE: O O
01/22/74 O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
very O O
pleasant O O
50 O O
year O O
old O O
woman O O
with O O
a O O
history O O
of O O
hypertension, B-HYPERTENSION O
on O O
atenolol, B-MEDICATION B-MEDICATION
hydrochlorothiazide, B-MEDICATION O
triamterene O O
who O O
presents O O
to O O
the O O
Emergency O O
Department O O
complaining O O
of O O
subjective O O
fevers, O O
myalgias O O
and O O
cough. O O
REVIEW O O
OF O O
SYSTEMS: O O
Negative O O
for O O
headache, O O
neck O O
pain, O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
dyspnea O O
on O O
exertion, O O
abdominal O O
pain, O O
fevers O O
or O O
chills. O O
PHYSICAL O O
EXAMINATION: O O
Afebrile. O O
Vital O O
signs O O
are O O
normal. O O
Normocephalic, O O
atraumatic. O O
Neck: O O
Supple. O O
JVD O O
to O O
approximately O O
7 O O
cm. O O
Chest O O
has O O
bibasilar O O
faint O O
crackles O O
that O O
do O O
not O O
clear O O
with O O
cough. O O
Abdomen O O
is O O
soft, O O
obese. B-OBESE O
Heart: O O
Regular O O
rate O O
and O O
rhythm. O O
Extremities: O O
1+ O O
non-pitting O O
edema O O
versus O O
obesity. B-OBESE O
LABORATORY O O
EVALUATION: O O
Chest O O
x-ray O O
with O O
bilateral O O
inferior O O
lobe O O
infiltrates O O
with O O
cephalization O O
consistent O O
with O O
mild O O
to O O
moderate O O
CHF, O O
no O O
effusions. O O
EKG O O
with O O
LVH, O O
no O O
ST O O
elevations, O O
T O O
wave O O
inversions O O
or O O
evidence O O
of O O
acute O O
ischemia. O O
ASSESSMENT/PLAN: O O
New O O
onset O O
CHF, O O
setting O O
in O O
a O O
probable O O
URI. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
I O O
will O O
admit O O
to O O
Medical O O
Service O O
for O O
workup O O
of O O
CHF, O O
rule O O
out O O
MI, O O
echocardiogram. O O
The O O
patient O O
is O O
admitted O O
in O O
good O O
condition. O O
___________________________________ O O
ZW011/0863 O O
DAVID O O
ZHU, O O
M.D. O O
DZ0 O O
D:01/22/74 O O
T:01/22/74 O O
Dictated O O
by: O O
DAVID O O
ZHU, O O
M.D. O O
DZ0 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2075-01-15 O O
AASC O O
EMERGENCY O O
DEPT O O
VISIT O O
QUIJANO,BAYLEE O O
853-62-51-4 O O
VISIT O O
DATE: O O
01/15/75 O O
The O O
patient O O
was O O
worked O O
up O O
in O O
the O O
emergency O O
department O O
by O O
myself O O
and O O
the O O
resident, O O
and O O
I O O
concur O O
with O O
her O O
work O O
up O O
and O O
evaluation O O
in O O
the O O
emergency O O
department. O O
PRESENTING O O
COMPLAINT: O O
Chest O O
pain, O O
shortness O O
of O O
breath, O O
productive O O
cough. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
patient O O
is O O
a O O
60-year-old O O
female O O
that O O
presents O O
to O O
the O O
emergency O O
department O O
at O O
Associated O O
Arthritis O O
with O O
complaints O O
of O O
chest O O
pain, O O
shortness O O
of O O
breath O O
and O O
a O O
cough O O
productive O O
of O O
white O O
sputum. O O
The O O
patient O O
denies O O
fever O O
or O O
chills. O O
She O O
denies O O
any O O
other O O
acute O O
complaints. O O
PAST O O
MEDICAL O O
HISTORY: O O
Morbid O O
obesity, B-OBESE O
congestive O O
heart O O
failure, O O
hypertension, B-HYPERTENSION O
rheumatoid O O
arthritis. O O
MEDICATIONS: O O
Zestril, B-MEDICATION B-MEDICATION
a O O
water O O
pill O O
most O O
likely O O
Lasix, O O
Motrin O O
and O O
Tylenol. O O
ALLERGIES: O O
No O O
known O O
allergies. O O
PHYSICAL O O
EXAMINATION: O O
VITAL O O
SIGNS: O O
Temperature O O
99, O O
pulse O O
85, O O
respiratory O O
rate O O
16, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
214/117. B-HYPERTENSION O
Oxygen O O
saturation O O
92% O O
on O O
two O O
liters. O O
HEENT: O O
Normocephalic, O O
atraumatic. O O
Pupils O O
equal, O O
round, O O
reactive. O O
Positive O O
AV O O
nicking. O O
NECK: O O
Positive O O
for O O
jugular O O
venous O O
distension. O O
CHEST: O O
Rales O O
audible O O
bilaterally. O O
HEART: O O
Normal O O
S1/S2. O O
No O O
S3/S4. O O
No O O
murmur. O O
ABDOMEN: O O
Soft, O O
nontender. O O
EXTREMITIES: O O
Positive O O
for O O
2-3+ O O
pitting O O
edema. O O
NEURO: O O
She O O
was O O
awake, O O
alert, O O
and O O
able O O
to O O
follow O O
commands. O O
LABORATORY O O
EVALUATION: O O
CK O O
84. O O
White O O
count O O
10, O O
hemoglobin O O
12, O O
hematocrit O O
42, O O
platelet O O
count O O
329. O O
Urinalysis O O
noted O O
1+ O O
blood O O
in O O
her O O
urine, O O
however, O O
overall, O O
her O O
urinalysis O O
was O O
negative. O O
Chest O O
x-ray O O
which O O
noted O O
cardiomegaly O O
with O O
findings O O
consistent O O
with O O
congestive O O
heart O O
failure. O O
EKG O O
noted O O
no O O
acute O O
changes. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
was O O
given O O
40 O O
mg O O
of O O
Lasix O O
IV O O
initially. O O
For O O
her O O
chest O O
pain, O O
she O O
was O O
given O O
sublingual O O
nitroglycerin. B-MEDICATION O
She O O
was O O
also O O
given O O
one O O
aspirin. B-MEDICATION B-MEDICATION
She O O
had O O
a O O
nitroglycerin O O
patch O O
placed O O
in O O
the O O
emergency O O
department. O O
FINAL O O
DIAGNOSIS: O O
1. O O
Congestive O O
failure. O O
2. O O
Chest O O
pain, O O
no O O
evidence O O
of O O
an O O
acute O O
myocardial O O
infarction. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
will O O
be O O
admitted O O
to O O
the O O
medicine O O
service O O
for O O
further O O
work O O
up O O
and O O
evaluation. O O
The O O
patient O O
is O O
in O O
stable O O
condition. O O
___________________________________ O O
CY313/62627 O O
O. O O
DE O O
OTIS, O O
M.D. O O
DO36 O O
D:01/18/75 O O
T:01/18/75 O O
Dictated O O
by: O O
O. O O
DE O O
OTIS, O O
M.D. O O
DO36 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2076-07-20 O O
Patient O O
Name: O O
QUIJANO,BAYLEE O O
[ O O
MRN: O O
85362514MARY O O
] O O
Date O O
of O O
Visit: O O
07/20/2076Chief O O
Complaint O O
Ms. O O
Quijano O O
is O O
a O O
61 O O
yo O O
morbidly O O
obese B-OBESE O
woman O O
with O O
CAD, B-CAD O
OA, O O
and O O
CHF O O
who O O
is O O
in O O
for O O
follow-up O O
of O O
these O O
problems. O O
History O O
of O O
Present O O
Illness O O
She O O
is O O
working O O
every O O
day O O
and O O
feels O O
much O O
better O O
than O O
she O O
did O O
last O O
year. O O
She O O
has O O
had O O
multiple O O
admissions O O
in O O
the O O
past O O
for O O
CHF O O
and O O
for O O
ischemia. B-CAD O
Recent O O
echo O O
shows O O
septal O O
and O O
apical O O
hypokinesis. O O
She O O
has O O
had O O
no O O
chest O O
pain. O O
She O O
does O O
not O O
complain O O
of O O
SOB. O O
She O O
does O O
cough, O O
but O O
this O O
is O O
because O O
of O O
the O O
air O O
conditioning O O
and O O
postnasal O O
drip, O O
she O O
believes. O O
She O O
also O O
complains O O
of O O
severe O O
knee O O
pain, O O
with O O
the O O
right O O
worse O O
than O O
the O O
left. O O
She O O
can O O
walk O O
a O O
little, O O
but O O
standing O O
is O O
very O O
painful. O O
In O O
addition, O O
she O O
complains O O
of O O
some O O
food O O
intolerance. O O
She O O
has O O
a O O
hard O O
time O O
eating O O
breakfast O O
because O O
she O O
gets O O
abdominal O O
cramps. O O
After O O
eating O O
orange O O
juice, O O
she O O
gets O O
terrible O O
cramping O O
and O O
has O O
to O O
run O O
to O O
the O O
bathroom O O
to O O
have O O
a O O
bowel O O
movement. O O
She O O
has O O
changed O O
her O O
milk O O
to O O
lactaid, O O
which O O
she O O
says O O
helps. O O
Certain O O
types O O
of O O
salad O O
dressing O O
also O O
cause O O
this O O
reaction. O O
Problems O O
MORBID O O
OBESITY O O
KNEE O O
OA O O
ANSERINE O O
BURSITIS, O O
BILAT O O
S/P O O
2 O O
C-SECTIONS O O
HTN B-HYPERTENSION O
CAD O O
CHF O O
ASTHMA O O
Medications O O
VENTOLIN O O
2PUFFS O O
INH O O
QID O O
AZMACORT O O
4PUFFS O O
INH O O
BID O O
ECASA B-MEDICATION B-MEDICATION
1 O O
PO O O
QD O O
ATROVENT O O
2PUFFS O O
INH O O
QID O O
TNG B-MEDICATION O
0.4 O O
MG O O
SL O O
SEREVENT O O
2PUFFS O O
INH O O
BID O O
FLOVENT O O
220MCG O O
INH O O
BID O O
COZAAR B-MEDICATION B-MEDICATION
100MG O O
PO O O
QD O O
LOPRESSOR B-MEDICATION B-MEDICATION
25MG O O
PO O O
TID O O
LASIX O O
60MG O O
PO O O
BID O O
ZANTAC O O
150MG O O
PO O O
BID O O
NORVASC B-MEDICATION B-MEDICATION
10MG O O
PO O O
QD O O
ISOSORBIDE B-MEDICATION B-MEDICATION
DINITRATE I-MEDICATION O
20MG O O
1 O O
Tablet(s) O O
PO O O
TID O O
Allergies O O
LISINOPRIL O B-MEDICATION
COUGH O O
Social O O
History O O
Employment: O O
Works O O
in O O
commercial O O
diving. O O
Marital/Relationship: O O
She O O
is O O
married. O O
Her O O
husband O O
is O O
retired. O O
She O O
has O O
3 O O
children, O O
and O O
3 O O
grandchildren, O O
and O O
2 O O
great O O
grand O O
children! O O
Recently O O
went O O
down O O
to O O
Mississippi O O
to O O
celebrate O O
her O O
father's O O
81st O O
birthday. O O
They O O
drove O O
down O O
in O O
a O O
van O O
because O O
she O O
is O O
afraid O O
of O O
flying. O O
Family O O
History O O
Father: O O
Alive, O O
and O O
very O O
healthy. O O
Mother: O O
Mother O O
died O O
at O O
age O O
80 O O
in O O
Apr, O O
2075, O O
of O O
MI. O O
Siblings: O O
She O O
has O O
12 O O
siblings--she O O
is O O
the O O
oldest. O O
None O O
of O O
them O O
have O O
weight O O
problem. O O
Her O O
two O O
daughters O O
have O O
obesity. O O
Her O O
grandson O O
is O O
also O O
overweight O O
at O O
12 O O
years O O
old. O O
Habits O O
Tobacco: B-SMOKER O
Never. I-SMOKER O
EtOH: O O
None O O
Drugs: O O
None O O
Seatbelts: O O
Yes O O
Domestic O O
violence: O O
None O O
Sleep: O O
She O O
tends O O
to O O
sleep O O
a O O
little O O
less O O
than O O
before. O O
She O O
is O O
tired O O
during O O
the O O
day. O O
No O O
daytime O O
somnolence. O O
She O O
wakes O O
herself O O
up O O
with O O
snoring. O O
Exercise: O O
None. O O
Emotional O O
history: O O
No O O
depression. O O
Diet: O O
She O O
is O O
not O O
really O O
on O O
a O O
regimen. O O
She O O
admits O O
to O O
lots O O
of O O
snacking. O O
Review O O
of O O
Systems O O
No O O
headaches, O O
lightheadedness, O O
vision O O
changes. O O
No O O
chest O O
pain, O O
SOB, O O
DOE, O O
palpitations. O O
No O O
abdominal O O
pain, O O
nausea, O O
vomiting, O O
constipation, O O
diarrhea. O O
No O O
change O O
in O O
bowel O O
habits, O O
BPBPR, O O
melena. O O
No O O
dysuria, O O
dypareunia. O O
No O O
numbness, O O
tingling, O O
weakness, O O
myalgias. O O
No O O
fever, O O
chills, O O
change O O
in O O
appetite, O O
weight O O
loss. O O
Remainder O O
of O O
systems O O
reviewed O O
and O O
negative. O O
Vital O O
Signs O O
Blood B-HYPERTENSION O
Pressure: I-HYPERTENSION O
178/80 B-HYPERTENSION O
Pulse: O O
88 O O
Height: O O
62 O O
Inches O O
Weight: O O
332 O O
Pounds O O
Physical O O
Exam O O
General O O
Appearance: O O
Morbidly O O
obese, O O
very O O
pleasant O O
woman O O
in O O
no O O
acute O O
distress. O O
HEENT: O O
Normocephalic, O O
atraumatic. O O
PERRLA, O O
EOMI. O O
Neck: O O
No O O
thyromegaly. O O
No O O
JVD, O O
carotid O O
bruits, O O
lymphadenopathy. O O
Neck O O
is O O
supple O O
with O O
full O O
ROM. O O
Chest: O O
Clear O O
to O O
P O O
and O O
A. O O
No O O
wheezes, O O
rales, O O
rhonchi. O O
Cardiac: O O
Normal O O
S1, O O
S2, O O
no O O
murmurs, O O
rubs, O O
or O O
gallops. O O
Breasts: O O
Symmetric, O O
no O O
masses, O O
tenderness O O
or O O
nipple O O
discharge. O O
Abdomen: O O
Normal O O
bowel O O
sounds, O O
no O O
HSM O O
or O O
tenderness. O O
Extremities: O O
Crepitance O O
in O O
both O O
knees. O O
4+ O O
pretibial O O
edema. O O
Assessment O O
1. O O
Hypertension: O O
Increased O O
lasix O O
to O O
80 O O
mg O O
po O O
bid. O O
Increased O O
lopressor O B-MEDICATION
to O O
50 O O
mg O O
po O O
bid O O
(she O O
hadn't O O
been O O
taking O O
this). O O
RTC O O
one O O
month O O
to O O
see O O
me O O
for O O
f/u. O O
2. O O
Hypercholesterolemia: B-HYPERLIPIDEMIA O
For O O
some O O
reason, O O
she O O
had O O
stopped B-MEDICATION O
taking I-MEDICATION O
her I-MEDICATION O
zocor. I-MEDICATION O
I O O
restarted B-MEDICATION O
her I-MEDICATION O
on I-MEDICATION O
lipitor I-MEDICATION B-MEDICATION
20 O O
mg O O
po O O
qd, O O
given O O
her O O
very B-HYPERLIPIDEMIA O
high I-HYPERLIPIDEMIA O
dLDL B-HYPERLIPIDEMIA O
on I-HYPERLIPIDEMIA O
5/26/76--171. I-HYPERLIPIDEMIA O
Checked O O
AST O O
today. O O
She O O
will O O
come O O
in O O
tomorrow O O
for O O
fasting O O
cholesterol O O
levels. O O
3. O O
Obesity: O O
She O O
is O O
making O O
no O O
progress O O
in O O
this O O
area, O O
and O O
in O O
fact O O
is O O
getting O O
worse. O O
Her O O
daughter O O
had O O
the O O
gastric O O
bypass O O
operation O O
and O O
has O O
lost O O
100 O O
lbs. O O
She O O
is O O
receptive O O
to O O
the O O
idea O O
of O O
going O O
for O O
a O O
consultation. O O
She O O
had O O
gone O O
to O O
Weight O O
Clinic O O
before O O
for O O
the O O
liquid O O
diet, O O
but O O
she O O
could O O
no O O
longer O O
afford O O
to O O
go. O O
Plan: O O
Referral O O
to O O
Dr. O O
Bobby O O
Davison. O O
Checked O O
TSH O O
4. O O
Polyuria, O O
polydypsia: O O
She O O
has O O
had O O
one O O
random O O
BS O O
of O O
170, O O
and O O
another O O
of O O
136. O O
We O O
will O O
have O O
her O O
come O O
back O O
for O O
a O O
FBS O O
tomorrow. O O
Also O O
checked O O
Cre, O O
K. O O
______________________________ O O
Xanthopoulos, O O
Kelly O O
Willie, O O
M.D. O O

Record B-SMOKER O
date: O O
2077-02-05 O O
AASC O O
EMERGENCY O O
DEPT O O
VISIT O O
QUIJANO,BAYLEE O O
853-62-51-4 O O
Ms. O O
Quijano O O
is O O
a O O
62-year-old O O
female O O
who O O
was O O
seen O O
by O O
the O O
resident O O
and O O
seen O O
and O O
examined O O
by O O
me. O O
PRESENTING O O
COMPLAINT: O O
Nausea, O O
vomiting O O
and O O
diarrhea. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
Patient O O
is O O
a O O
62-year-old O O
female O O
with O O
history O O
of O O
asthma O O
and O O
CHF O O
with O O
coronary B-CAD O
artery I-CAD O
disease, I-CAD O
presents O O
now O O
with O O
multiple O O
episodes O O
of O O
vomiting O O
and O O
diarrhea O O
and O O
'feeling O O
sick'. O O
Has O O
no O O
history O O
of O O
fevers. O O
Mildly O O
tachycardic O O
with O O
a O O
pulse O O
rate O O
of O O
100. O O
REVIEW O O
OF O O
SYSTEMS: O O
Stated O O
that O O
recently O O
was O O
feeling O O
sick. O O
Had O O
a O O
chest O O
x-ray O O
recently O O
and O O
was O O
negative. O O
Treated O O
with O O
Amoxicillin, O O
but O O
still O O
continued O O
to O O
have O O
some O O
mild O O
cough O O
and O O
wheezes. O O
That O O
brought O O
her O O
to O O
the O O
Emergency O O
Department, O O
but O O
no O O
complaints O O
of O O
any O O
new O O
shortness O O
of O O
breath, O O
but O O
has O O
this O O
persistent O O
cough O O
that O O
has O O
not O O
gone O O
away O O
despite O O
being O O
treated O O
with O O
antibiotics. O O
Denies O O
fever O O
or O O
chills. O O
Denies O O
shortness O O
of O O
breath. O O
Denies O O
dyspnea O O
on O O
exertion. O O
Denies O O
PND. O O
Review O O
of O O
systems O O
otherwise O O
unremarkable. O O
PAST O O
MEDICAL O O
HISTORY: O O
History O O
of O O
hypertension, B-HYPERTENSION O
CHF, O O
asthma, O O
status O O
post O O
cholecystectomy. O O
History O O
of O O
coronary O O
artery O O
disease. O O
Status O O
post O O
C-section O O
times O O
two. O O
MEDICATIONS: O O
On O O
multiple O O
medicines O O
including O O
Ventolin, O O
Lasix, O O
Lopressor B-MEDICATION B-MEDICATION
and O O
Zantac O O
as O O
well O O
as O O
Lipitor. B-MEDICATION B-MEDICATION
PHYSICAL O O
EXAMINATION: O O
HEENT: O O
Normal. O O
NECK: O O
Supple. O O
LUNGS: O O
Some O O
mild O O
wheezes O O
bilaterally. O O
No O O
rales O O
however. O O
No O O
respiratory O O
distress. O O
Some O O
course O O
rhonchi O O
heard O O
throughout O O
lung O O
fields. O O
CARDIAC O O
EXAM: O O
Regular O O
rate O O
and O O
rhythm. O O
No O O
murmurs. O O
ABDOMEN: O O
Soft, O O
nontender O O
without O O
any O O
masses. O O
MUSCULOSKELETAL: O O
Shows O O
trace O O
edema O O
greatest O O
in O O
the O O
lower O O
extremities, O O
but O O
good O O
pulses, O O
normal. O O
Capillary O O
refill O O
and O O
neurological O O
is O O
intact. O O
LABORATORY O O
EVALUATION: O O
Full O O
laboratory O O
studies O O
were O O
done O O
including O O
chest O O
x-ray. O O
EKG O O
showed O O
sinus O O
rhythm O O
with O O
T-wave O O
inversion O O
in O O
A, O O
V O O
and O O
L. O O
This O O
is O O
not O O
new O O
based O O
on O O
old O O
cardiograms. O O
Chest O O
x-ray O O
shows O O
some O O
cardiomegaly O O
and O O
a O O
fluffy O O
chest O O
x-ray O O
indicating O O
CHF. O O
Electrolytes, O O
BUN O O
and O O
creatinine O O
normal. O O
Hematocrit O O
of O O
45 O O
and O O
a O O
normal O O
white O O
count. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
Initially O O
systolic O O
blood O O
pressure O O
was O O
over B-HYPERTENSION O
200 I-HYPERTENSION O
and I-HYPERTENSION O
diastolic I-HYPERTENSION O
over I-HYPERTENSION O
91 I-HYPERTENSION O
and O O
patient O O
also O O
received O O
some O O
Diltiazem B-MEDICATION O
for O O
blood O O
pressure O O
control. O O
Assessment: O O
This O O
is O O
a O O
62-year-old O O
woman O O
who O O
has O O
vomiting, O O
diarrhea, O O
and O O
'feeling O O
sick' O O
and O O
she O O
has O O
a O O
chronic O O
cough O O
despite O O
recent O O
treatment O O
with O O
antibiotics, O O
but O O
no O O
shortness O O
of O O
breath, O O
now O O
found O O
to O O
be O O
in O O
CHF O O
on O O
chest O O
x-ray. O O
Patient O O
has O O
been O O
diuresed. O O
PCP O O
is O O
aware. O O
She O O
is O O
going O O
to O O
be O O
admitted. O O
CONSULTATIONS O O
(including O O
PCP): O O
Primary O O
care O O
physician. O O
FINAL O O
DIAGNOSIS: O O
Cough O O
with O O
congestive O O
heart O O
failure. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
was O O
admitted O O
to O O
the O O
hospital O O
in O O
stable O O
condition. O O
___________________________________ O O
UZ272/3146 O O
FRANK O O
ISON, O O
M.D. O O
FI65 O O
D:02/05/77 O O
T:02/05/77 O O
Dictated O O
by: O O
FRANK O O
ISON, O O
M.D. O O
FI65 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2083-05-18 O O
May O O
18, O O
2083 O O
Yesenia O O
Olive, O O
M.D. O O
26 O O
Jeremy O O
Place O O
Antioch, O O
KY O O
71287 O O
RE: O O
Gerald, O O
Marion O O
MRN: O O
48967301 O O
DOV: O O
05/18/83 O O
Dear O O
Dr. O O
Olive, O O
Thanks O O
for O O
asking O O
me O O
to O O
see O O
Marion O O
Gerald O O
who O O
I O O
saw O O
on O O
May O O
18. O O
She O O
is O O
referred O O
for O O
either O O
fibromyalgia O O
or O O
polymyalgia. O O
The O O
patient O O
states O O
she O O
is O O
currently O O
60 O O
but O O
was O O
in O O
her O O
usual O O
state O O
of O O
good O O
health O O
until O O
2065 O O
when O O
she O O
developed O O
diffuse O O
chest O O
wall O O
pain O O
and O O
tingling. O O
This O O
continued O O
to O O
bother O O
her O O
and O O
she O O
eventually O O
was O O
treated O O
with O O
steroids. O O
I O O
am O O
not O O
sure O O
she O O
had O O
a O O
diagnosis O O
of O O
PMR O O
or O O
fibromyalgia. O O
She O O
then O O
was O O
switched O O
to O O
ibuprofen O O
which O O
did O O
not O O
work O O
particularly O O
well. O O
Over O O
this O O
time, O O
she O O
would O O
have O O
intermittent O O
episodes O O
with O O
nocturnal O O
discomfort O O
and O O
most O O
recently O O
has O O
increasing O O
pain O O
in O O
her O O
palms, O O
back, O O
neck, O O
low O O
back, O O
legs, O O
and O O
into O O
her O O
arms. O O
She O O
was O O
seen O O
by O O
Dr. O O
Zink O O
at O O
Barr O O
Clinic, O O
and O O
no O O
blood O O
studies O O
were O O
obtained, O O
but O O
she O O
states O O
she O O
had O O
'25 O O
shots' O O
of O O
steroids. O O
She O O
denies O O
any O O
hot O O
or O O
swollen O O
joints. O O
She O O
has O O
had O O
occasional O O
arm O O
swelling O O
but O O
this O O
has O O
resolved. O O
Extensive O O
ROS O O
reveals O O
no O O
photosensitivity O O
but O O
she O O
does O O
have O O
some O O
oral O O
ulcers O O
and O O
Raynaud's. O O
She O O
has O O
urgency O O
regarding O O
her O O
bladder O O
and O O
has O O
been O O
evaluated O O
but O O
not O O
particularly O O
well. O O
She O O
has O O
continued O O
to O O
be O O
concerned O O
about O O
that. O O
She O O
has O O
had O O
fevers O O
or O O
chills O O
but O O
no O O
temperature O O
elevation. O O
She O O
has O O
intermittent O O
abdominal O O
pain O O
but O O
has O O
had O O
a O O
colonoscopy O O
two O O
years O O
ago O O
and O O
was O O
evaluated O O
for O O
this. O O
She O O
has O O
morning O O
stiffness O O
of O O
about O O
an O O
hour O O
and O O
nocturnal O O
pain O O
through O O
the O O
night. O O
Family O O
history O O
is O O
otherwise O O
remarkable O O
for O O
diabetes B-DIABETES O
in O O
her O O
father. O O
Mother O O
is O O
85. O O
Two O O
sons O O
alive O O
and O O
well. O O
Two O O
siblings O O
alive O O
and O O
well O O
except O O
for O O
hypertension B-HYPERTENSION O
and O O
hypercholesterolemia. B-HYPERLIPIDEMIA O
Past O O
medical O O
history O O
is O O
pertinent O O
for O O
above. O O
She O O
has O O
had O O
a O O
partial O O
hysterectomy, O O
cholecystectomy, O O
and O O
fracture O O
of O O
her O O
wrist. O O
Medications O O
include O O
for O O
hypertension, O O
diabetes, O O
and O O
hypercholesterolemia, O O
the O O
following: O O
metformin B-MEDICATION B-MEDICATION
500 O O
b.i.d., O O
verapamil B-MEDICATION B-MEDICATION
240 O O
b.i.d., O O
Avapro B-MEDICATION B-MEDICATION
150 O O
q.d., O O
Pravachol B-MEDICATION B-MEDICATION
20 O O
mg O O
q.d., O O
Bumex O O
20 O O
q.d., O O
cyclobenzaprine O O
10 O O
q.d., O O
Prilosec O O
20 O O
q.d., O O
and O O
Allegra. O O
No B-SMOKER O
smoking I-SMOKER O
or O O
drinking O O
history. O O
No O O
allergies. O O
No O O
other O O
medical O O
problems. O O
Social O O
history O O
is O O
pertinent O O
in O O
that O O
she O O
lives O O
in O O
Elizabethtown. O O
She O O
works O O
as O O
a O O
midwife O O
and O O
director O O
of O O
Iowa O O
Birth O O
Clinic. O O
Her O O
husband O O
is O O
a O O
Broadcast O O
Technician. O O
They O O
have O O
traveled O O
quite O O
a O O
bit O O
because O O
of O O
this. O O
Yesenia O O
Olive, O O
M.D. O O
RE: O O
Gerald, O O
Marion O O
MRN: O O
48967301 O O
Page O O
2 O O
Physical O O
reveals O O
a O O
very O O
pleasant O O
woman O O
in O O
no O O
distress. O O
Weight O O
152. O O
BP O O
120/80. O O
She O O
had O O
a O O
respiratory O O
rate O O
of O O
16. O O
She O O
had O O
full O O
range O O
of O O
motion O O
of O O
all O O
of O O
her O O
joints O O
with O O
tenderness O O
in O O
epicondyles, O O
greater O O
trochanters, O O
and O O
cervical O O
and O O
lumbar O O
area. O O
Otherwise, O O
no O O
active O O
synovitis O O
or O O
skin O O
lesions. O O
No O O
oral O O
ulcerations. O O
Good O O
salivary O O
pool. O O
No O O
lymphadenopathy, O O
thyromegaly, O O
or O O
axillary O O
adenopathy. O O
Chest: O O
clear O O
to O O
A&P. O O
No O O
carotid O O
bruits. O O
Vascular O O
exam: O O
normal. O O
Cardiac O O
exam: O O
quiet O O
precordium O O
without O O
murmur O O
or O O
gallop. O O
Abdominal O O
exam: O O
nontender O O
without O O
hepatosplenomegaly. O O
Extremities: O O
without O O
edema. O O
I O O
suspect O O
she O O
has O O
fibromyalgia. O O
I O O
do O O
not O O
really O O
know O O
the O O
place O O
of O O
steroids O O
in O O
this O O
setting. O O
I O O
will O O
obtain O O
chemistry O O
profile O O
including O O
CPK, O O
LFTs, O O
TSH, O O
CBC, O O
ESR, O O
as O O
well O O
as O O
a O O
urine, O O
ANA, O O
CRP, O O
and O O
RF. O O
I O O
will O O
see O O
her O O
back O O
in O O
four O O
to O O
six O O
weeks. O O
She O O
will O O
get O O
old O O
records O O
for O O
me O O
to O O
review. O O
We O O
will O O
talk O O
about O O
what O O
therapeutic O O
interventions O O
we O O
may O O
take O O
at O O
that O O
time, O O
but O O
I O O
really O O
need O O
to O O
have O O
more O O
information O O
because O O
at O O
this O O
point O O
her O O
symptoms O O
are O O
rather O O
benign. O O
I O O
will O O
be O O
in O O
touch O O
with O O
her O O
regarding O O
these O O
results O O
as O O
they O O
come O O
in. O O
Sincerely O O
yours, O O
_______________________________ O O
Miguel O O
H. O O
Ames, O O
M.D. O O
cc: O O
Gerald O O
Yan, O O
M.D., O O
PROMPTCARE O O
DD: O O
05/18/83 O O
DT: O O
05/21/83 O O
DV: O O
05/18/83 O O
/maldonado O O

Record B-SMOKER O
date: O O
2083-06-29 O O
Fairview O O
Lakes O O
Regional O O
Medical O O
Center O O
64 O O
Tara O O
Boulevard O O
ASB O O
II, O O
9st O O
Xloor O O
GERALD, O O
MARION O O
Cedar O O
Hill O O
Lakes, O O
KY O O
99249 O O
48967301 O O
(290) O O
680-0790 O O
06/29/83 O O
Xochil O O
Higgins, O O
M.D. O O
091 O O
Keith O O
Street O O
Antioch, O O
KY O O
71287 O O
Dear O O
Dr. O O
Higgins, O O
Marion O O
Gerald O O
will O O
be O O
seeing O O
you O O
sometime O O
in O O
September O O
for O O
primary O O
care. O O
I O O
was O O
seeing O O
her O O
for O O
various O O
rheumatologic O O
issues. O O
She O O
comes O O
in O O
today O O
with O O
ongoing O O
pain O O
in O O
the O O
left O O
side O O
of O O
her O O
face. O O
Actually, O O
upon O O
exam, O O
she O O
clearly O O
simply O O
has O O
left O O
TMJ. O O
She O O
has O O
been O O
told O O
this O O
by O O
ENT O O
and O O
I O O
reinforced O O
to O O
her O O
that O O
that O O
is O O
what O O
she O O
has O O
and O O
she O O
will O O
go O O
ahead O O
with O O
a O O
dental O O
visit O O
that O O
she O O
had O O
planned. O O
However, O O
she O O
has O O
other O O
medical O O
problems O O
which O O
I O O
will O O
deal O O
with O O
until O O
she O O
sees O O
you. O O
At O O
her O O
last O O
visit, O O
there O O
was O O
a O O
question O O
of O O
PMR O O
and O O
she O O
had O O
'25 O O
shots' O O
of O O
steroids O O
but O O
I O O
have O O
not O O
given O O
her O O
steroids O O
and O O
she O O
has O O
done O O
reasonably O O
well. O O
However, O O
she O O
does O O
have O O
a O O
history O O
of O O
a O O
recent O O
mild O O
anemia O O
but O O
has O O
diabetes, B-DIABETES O
hypertension B-HYPERTENSION B-HYPERTENSION
and O O
hypercholesterolemia B-HYPERLIPIDEMIA B-MEDICATION
and O O
medications O O
include O O
metformin, B-MEDICATION B-MEDICATION
verapamil B-MEDICATION B-MEDICATION
250 O O
b.i.d., O O
Avapro B-MEDICATION B-MEDICATION
150 O O
q.d., O O
Pravachol B-MEDICATION B-MEDICATION
20 O O
q.d., O O
Bumex, O O
Bentyl, O O
Prilosec O O
and O O
Allegra. O O
Physical O O
examination O O
today O O
reveals O O
left O O
TMJ O O
pain O O
which O O
reproduces O O
her O O
pain. O O
She O O
had O O
had O O
no O O
lymphadenopathy O O
or O O
thyromegaly. O O
HEENT O O
was O O
otherwise O O
unremarkable. O O
I O O
obtained O O
blood O O
studies O O
which O O
revealed O O
a O O
blood O O
sugar O O
of O O
208, O O
abnormal O O
LFTs O O
with O O
an O O
AST O O
of O O
62 O O
and O O
ALT O O
of O O
58, O O
normal O O
ferritin O O
B12 O O
and O O
folic O O
acid, O O
TSH O O
of O O
8.8 O O
with O O
thyroid O O
antibodies O O
pending, O O
urine O O
microalbumin/creatinine O O
of O O
14.5 O O
and O O
a O O
CBC O O
which O O
had O O
anemia O O
with O O
a O O
hematocrit O O
of O O
32.9. O O
A1c O O
pending. O O
A O O
protein O O
electrophoresis O O
is O O
pending O O
and O O
urinalysis O O
did O O
not O O
reveal O O
proteinuria O O
or O O
sediment. O O
HBsAG O O
and O O
HCV O O
are O O
pending O O
as O O
well. O O
I O O
will O O
be O O
in O O
touch O O
with O O
her O O
regarding O O
these O O
results. O O
I O O
was O O
wondering O O
if O O
you O O
could O O
see O O
her O O
sooner O O
than O O
September O O
because O O
of O O
these O O
abnormalities O O
outlined. O O
Thanks O O
for O O
letting O O
me O O
participate O O
in O O
her O O
care. O O
Sincerely O O
yours, O O
Dictated O O
By: O O
Miguel O O
Ames O O
______________________________ O O
Miguel O O
Ames, O O
M.D. O O
eScription O O
document:6-0391514 O O
ZB O O
DD: O O
06/30/83 O O
DT: O O
07/01/83 O O
DV: O O
06/30/83 O O

Record O O
date: O O
2083-10-01 O O
Westwing O O
Place O O
Nursing O O
Home O O
356 O O
Chablis O O
Court O O
GERALD, O O
MARION O O
Doha, O O
KY O O
63216 O O
48967301 O O
(638) O O
074-1457 O O
10/01/83 O O
(449) O O
515-0294 O O
REASON O O
FOR O O
VISIT: O O
Follow O O
up O O
cholesterol O O
and O O
new O O
problem O O
of O O
chest O O
pain. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Ms. O O
Gerald O O
is O O
a O O
61-year-old O O
patient O O
with O O
history O O
of O O
diabetes, B-DIABETES O
hypertension, B-HYPERTENSION O
elevated B-HYPERLIPIDEMIA O
lipids, I-HYPERLIPIDEMIA O
hypothyroidism O O
and O O
I O O
now O O
have O O
available O O
old O O
records O O
from O O
previous O O
doctor, O O
Yesenia O O
Olive. O O
The O O
following O O
issues O O
addressed: O O
1. O O
Diabetes: O O
She O O
is O O
currently O O
feeling O O
well O O
and O O
denies O O
any O O
symptoms O O
of O O
polyuria O O
and O O
polydipsia. O O
Maintained O O
on O O
Glucophage B-MEDICATION B-MEDICATION
1000 O O
mg O O
b.i.d. O O
Blood O O
sugar O O
testing O O
at O O
home O O
once O O
or O O
twice O O
a O O
day O O
is O O
around O O
120. O O
We O O
will O O
be O O
obtaining O O
glycohemoglobin O O
level O O
today. O O
Has O O
ophthalmological O O
exam O O
scheduled. O O
2. O O
Elevated B-HYPERLIPIDEMIA O
cholesterol: I-HYPERLIPIDEMIA O
With O O
her O O
diabetes, O O
her O O
target O O
LDL O O
will O O
be O O
less O O
than O O
a O O
100. O O
She O O
is O O
maintained O O
on O O
Pravachol B-MEDICATION B-MEDICATION
40 O O
mg O O
a O O
day O O
and O O
LDL B-HYPERLIPIDEMIA O
from I-HYPERLIPIDEMIA O
09/15/83 I-HYPERLIPIDEMIA O
was I-HYPERLIPIDEMIA O
154 I-HYPERLIPIDEMIA O
with O O
a O O
total B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
of I-HYPERLIPIDEMIA O
256. I-HYPERLIPIDEMIA O
We O O
will O O
initiate O O
Zetia B-MEDICATION O
to O O
add O O
to O O
the O O
Pravachol. B-MEDICATION B-MEDICATION
3. O O
Hypothyroidism: O O
Maintained O O
on O O
Levoxyl O O
and O O
TSH O O
level O O
is O O
acceptable O O
at O O
3.93 O O
with O O
a O O
T4 O O
of O O
8.5. O O
4. O O
Hypertension: O O
Maintained O O
on O O
Avapro B-MEDICATION B-MEDICATION
and I-MEDICATION O
verapamil B-MEDICATION B-MEDICATION
and O O
blood O O
pressure O O
is O O
currently O O
acceptable. O O
5. O O
Question O O
of O O
rheumatological O O
disease, O O
elevated O O
sedimentation O O
rate, O O
diagnosis O O
of O O
polymyalgia O O
rheumatica O O
has O O
been O O
considered O O
in O O
the O O
past. O O
No O O
new O O
symptoms O O
of O O
muscle O O
aches, O O
but O O
now O O
report O O
a O O
history O O
of O O
recent O O
chest O O
pain. O O
6. O O
Exercise-induced O O
chest O O
pain. O O
The O O
patient O O
has O O
noted O O
over O O
the O O
past O O
month O O
that O O
she O O
gets O O
a O O
pressure O O
sensation O O
in O O
her O O
mid O O
chest O O
when O O
she O O
is O O
walking O O
after O O
about O O
20 O O
minutes O O
of O O
exertion. O O
This O O
subsides O O
when O O
she O O
stops O O
and O O
rests O O
for O O
a O O
while. O O
This O O
has O O
been O O
reproduced O O
for O O
the O O
last O O
three O O
times O O
she O O
has O O
taken O O
a O O
walk O O
with O O
her O O
husband. O O
Review O O
of O O
records O O
from O O
Dr. O O
Olive O O
show O O
that O O
she O O
had O O
thallium O O
stress O O
test O O
12/26/79 O O
achieving O O
85% O O
of O O
maximum O O
predicted O O
heart O O
rate O O
with O O
a O O
workload O O
of O O
10.1 O O
minutes. O O
EKG O O
showed O O
1 O O
mm O O
ST O O
depression O O
in O O
leads O O
II O O
and O O
V4 O O
through O O
6. O O
The O O
thallium O O
scan O O
showed O O
slight O O
apical O O
ischemia O O
and O O
mild O O
ischemia O O
in O O
the O O
anterior O O
walls O O
suggesting O O
minimal O O
ischemia O O
in O O
the O O
left O O
anterior O O
descending O O
artery O O
distribution. O O
She O O
does O O
not O O
recall O O
having O O
symptoms O O
at O O
that O O
time. O O
Denies O O
palpitations, O O
sweats O O
or O O
shortness O O
of O O
breath O O
with O O
chest B-CAD O
discomfort. I-CAD O
There I-CAD O
are I-CAD O
some I-CAD O
radiation I-CAD O
into I-CAD O
both I-CAD O
shoulders I-CAD O
and I-CAD O
neck. I-CAD O
Multiple O O
cardiac O O
risk O O
factors O O
include O O
elevated O O
lipids, O O
diabetes, O O
hypertension O O
and O O
postmenopausal. O O
CURRENT O O
MEDICATIONS: O O
Levoxyl O O
50 O O
mcg O O
q.d., O O
Pravachol O B-MEDICATION
40 O O
mg O O
h.s., O O
Prilosec O O
20 O O
mg O O
q.d., O O
Flexeril O O
10 O O
mg O O
q.d., O O
Bumex O O
2 O O
mg O O
q.d., O O
Avapro O B-MEDICATION
150 O O
mg O O
q.d., O O
Verapamil O B-MEDICATION
of O O
240 O O
mg O O
b.i.d. O O
and O O
Glucophage O B-MEDICATION
500 O O
mg O O
two O O
tabs O O
b.i.d. O O
DRUG O O
ALLERGIES: O O
None. O O
SOCIAL B-SMOKER O
HISTORY: O O
director/midwife O O
for O O
Iowa O O
Clinic O O
in O O
Temescal O O
Valley. O O
REVIEW O O
OF O O
SYSTEMS: O O
Denies O O
abdominal O O
pain, O O
change O O
in O O
bowel O O
habits, O O
fevers, O O
sweats O O
chills, O O
weight O O
loss; O O
otherwise, O O
as O O
above. O O
PHYSICAL O O
EXAMINATION: O O
She O O
appears O O
in O O
no O O
distress. O O
Temperature O O
of O O
97.8 O O
degrees, O O
BP O O
130/70 O O
and O O
pulse O O
is O O
70. O O
Pupils O O
are O O
equal, O O
round O O
and O O
reactive. O O
Conjunctivae O O
clear. O O
Sclerae O O
anicteric. O O
Oropharynx O O
benign. O O
Neck O O
is O O
supple. O O
No O O
neck O O
vein O O
distention. O O
Thyroid O O
is O O
not O O
palpable. O O
Chest O O
is O O
clear O O
to O O
percussion O O
and O O
auscultation. O O
Heart: O O
Regular O O
rhythm, O O
S1, O O
S2 O O
and O O
no O O
murmur, O O
rub, O O
thrill O O
or O O
gallop. O O
Abdomen: O O
Soft, O O
nontender, O O
active O O
bowel O O
sounds O O
and O O
no O O
organomegaly. O O
Extremities: O O
No O O
clubbing, O O
cyanosis O O
or O O
edema. O O
Neurophysiologic: O O
EKG O O
shows O O
normal O O
sinus O O
rhythm. O O
No O O
abnormal O O
complex. O O
IMPRESSION O O
AND O O
PLAN: O O
1. O O
Diabetes. O O
We O O
will O O
check O O
her O O
glycohemoglobin O O
and O O
assure O O
she O O
has O O
had O O
an O O
ophthalmologic O O
follow O O
up. O O
Maintain O O
Glucophage. O O
2. O O
Elevated O O
cholesterol. O O
Add O O
Zetia O O
10 O O
mg O O
q.d. O O
3. O O
Chest O O
pain. O O
Symptoms B-CAD O
certainly I-CAD O
suggest I-CAD O
ischemia. I-CAD O
I O O
have O O
contacted O O
Dr. O O
Ng O O
in O O
Cardiology O O
and O O
he O O
is O O
arranging O O
for O O
an O O
ETT O O
MIBI O O
and O O
a O O
cardiology O O
consult. O O
I O O
prescribed B-MEDICATION O
nitroglycerin I-MEDICATION B-MEDICATION
1/150 O O
to O O
use O O
sublingual O O
q.5minutes. O O
x O O
3 O O
for O O
chest O O
discomfort O O
and O O
she O O
will O O
limit O O
exercise O O
until O O
ETT O O
is O O
accomplished. O O
Suspect O O
she O O
might O O
need O O
catheterization O O
and O O
hesitant O O
to O O
add O O
beta-blocker O O
because O O
of O O
high-dose O O
verapamil O O
and O O
risk O O
of O O
inducing O O
heart O O
block. O O
4. O O
Hypothyroidism: O O
Adequate O O
replacement O O
dose O O
on O O
current O O
Levoxyl. O O
The O O
patient O O
will O O
see O O
me O O
back O O
in O O
four O O
weeks' O O
time O O
and O O
cardiac O O
workup O O
to O O
be O O
arranged O O
for O O
early O O
next O O
week. O O
______________________________ O O
E O O
Xochil O O
Higgins, O O
M.D. O O
Dictated O O
By: O O
E O O
Xochil O O
Higgins O O
eScription O O
document:8-7850722 O O
EMSSten O O
Tel O O
DD: O O
10/02/83 O O
DT: O O
10/02/83 O O
DV: O O
10/02/83 O O

Record B-SMOKER O
date: O O
2083-11-01 O O
Westwing O O
Place O O
Nursing O O
Home O O
144 O O
Chablis O O
Court O O
GERALD, O O
MARION O O
Doha, O O
KY O O
63216 O O
48967301 O O
(638) O O
074-1457 O O
11/01/83 O O
(449) O O
515-0294 O O
REASON O O
FOR O O
VISIT: O O
Follow O O
up O O
coronary B-CAD O
disease I-CAD O
and O O
diabetes. B-DIABETES O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
1. O O
The O O
patient O O
underwent O O
an O O
angioplasty B-CAD O
on I-CAD O
10/07/83 I-CAD O
and O O
comes O O
in O O
today O O
having O O
just O O
had O O
a O O
stress O O
test. O O
Stress O O
test O O
showed O O
that O O
she O O
was O O
able O O
to O O
do O O
a O O
standard O O
Bruce O O
protocol O O
for O O
7 O O
minutes O O
34 O O
seconds O O
achieving O O
maximal O O
heart O O
rate O O
of O O
116, O O
peak O O
blood O O
pressure O O
122/60, O O
stopped O O
for O O
fatigue. O O
Immediately O O
after O O
exercise, O O
she O O
did O O
have O O
some O O
substernal O O
chest O O
pain, O O
resolved O O
3 O O
minutes O O
into O O
recovery. O O
There O O
were O O
no O O
EKG O O
changes. O O
The O O
patient O O
reports O O
that O O
she O O
has O O
been O O
walking O O
and O O
has O O
resumed O O
her O O
normal O O
pre-hospitalization O O
exercise O O
level O O
and O O
does O O
not O O
have O O
any O O
chest O O
discomfort O O
with O O
walk, O O
which O O
had O O
precipitated O O
the O O
hospitalization O O
initially. O O
She O O
is O O
looking O O
into O O
cardiac O O
rehab O O
program O O
but O O
is O O
not O O
sure O O
that O O
she O O
needs O O
to O O
do O O
this. O O
She O O
feels O O
very O O
comfortable O O
with O O
her O O
current O O
exercise O O
regimen. O O
She O O
has O O
been O O
careful O O
with O O
her O O
eating O O
and O O
feels O O
she O O
is O O
living O O
a O O
healthy O O
lifestyle. O O
She O O
has O O
returned O O
to O O
work. O O
She O O
has O O
follow O O
up O O
scheduled O O
with O O
Dr. O O
Schaefer O O
in O O
two O O
days' O O
time. O O
2. O O
Diabetes: O O
At O O
last O O
visit, O O
I O O
had O O
added B-MEDICATION O
glyburide B-MEDICATION B-MEDICATION
5 O O
mg O O
to O O
her O O
Glucophage B-MEDICATION B-MEDICATION
2000 O O
mg O O
a O O
day. O O
She O O
monitors O O
blood O O
sugars O O
but O O
only O O
in O O
the O O
morning. O O
Evening O O
blood O O
sugars O O
are O O
mostly O O
in O O
90s O O
to O O
low O O
100s. O O
However, O O
at O O
times O O
during O O
the O O
day, O O
she O O
feels O O
hypoglycemically O O
sweating O O
and O O
abdominal O O
discomfort. O O
She O O
has O O
never O O
actually O O
checked O O
her O O
blood O O
sugar O O
during O O
these O O
episodes O O
as O O
they O O
tend O O
to O O
occur O O
at O O
work. O O
She O O
has O O
not O O
had O O
any O O
fainting O O
or O O
dizziness. O O
3. O O
Elevated B-HYPERLIPIDEMIA O
cholesterol, I-HYPERLIPIDEMIA O
is O O
tolerating O O
Zetia. B-MEDICATION O
4. O O
Hypertension. B-HYPERTENSION O
At O O
last O O
visit, O O
we O O
decreased O O
her O O
Avapro B-MEDICATION B-MEDICATION
dose O O
because O O
her O O
blood O O
pressure O O
was O O
quite O O
low O O
at O O
100/64, O O
and O O
currently, O O
she O O
feels O O
somewhat O O
less O O
fatigued. O O
CURRENT O O
MEDICATIONS: O O
Glyburide O B-MEDICATION
5 O O
mg O O
q.d., O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
q.d., O O
atenolol B-MEDICATION B-MEDICATION
50 O O
mg O O
q.d., O O
Zetia O O
10 O O
mg O O
q.d., O O
levoxyl O O
50 O O
mcg O O
q.d., O O
Prilosec O O
20 O O
mg O O
q.d., O O
Flexeril O O
10 O O
mg O O
q.d., O O
Bumex O O
2 O O
mg O O
q.d., O O
Pravachol B-MEDICATION B-MEDICATION
20 O O
mg O O
two O O
tablets O O
q.h.s., O O
Avapro O B-MEDICATION
75 O O
mg O O
q.d., O O
Glucophage O B-MEDICATION
500 O O
mg O O
two O O
tablets O O
b.i.d., O O
and O O
enteric-coated B-MEDICATION O
aspirin. B-MEDICATION B-MEDICATION
DRUG O O
ALLERGIES: O O
None. O O
REVIEW O O
OF O O
SYSTEMS: O O
She O O
denies O O
chest O O
pain, O O
palpitation, O O
shortness O O
of O O
breath, O O
abdominal O O
pain, O O
or O O
joint O O
pain. O O
PHYSICAL O O
EXAMINATION: O O
She O O
appears O O
in O O
excellent O O
health O O
and O O
in O O
good O O
spirits. O O
Weight O O
is O O
145, O O
blood O O
pressure O O
120/68, O O
and O O
pulse O O
is O O
70 O O
and O O
regular. O O
Conjunctivae O O
are O O
clear. O O
Sclerae O O
are O O
anicteric. O O
Neck O O
is O O
supple. O O
No O O
neck O O
vein O O
distention. O O
Chest O O
is O O
clear O O
to O O
percussion O O
and O O
auscultation. O O
Heart: O O
Regular O O
rhythm. O O
S1 O O
and O O
S2. O O
No O O
murmur, O O
rub, O O
thrill, O O
or O O
gallop. O O
Extremities O O
are O O
without O O
clubbing, O O
cyanosis, O O
or O O
edema. O O
IMPRESSION O O
AND O O
PLAN: O O
1. O O
Coronary O O
disease, O O
doing O O
well, O O
status O O
post O O
recent O O
angioplasty O O
with O O
stenting. B-CAD O
Maintaining O O
current O O
medications O O
of O O
Dr. O O
Schaefer. O O
At O O
this O O
point, O O
I O O
am O O
not O O
sure O O
that O O
she O O
actually O O
does O O
need O O
cardiac O O
rehab, O O
and O O
we O O
will O O
defer O O
that O O
decision O O
to O O
him. O O
2. O O
Diabetes, O O
seems O O
as O O
though O O
her O O
control O O
is O O
impressive, O O
perhaps O O
with O O
recent O O
change O O
in O O
her O O
diet. O O
We O O
will O O
discontinue O O
the O O
glyburide O O
and O O
follow O O
up O O
in O O
4 O O
weeks. O O
3. O O
Elevated O O
cholesterol. O O
We O O
will O O
check O O
on O O
lipid O O
status O O
in O O
four O O
weeks' O O
time. O O
On O O
current O O
medications O O
with O O
target O O
of O O
LDL O O
less O O
than O O
100. O O
4. O O
Hypertension. O O
Blood O O
pressure O O
acceptable O O
on O O
current O O
medical O O
regimen. O O
______________________________ O O
E O O
Xochil O O
Higgins, O O
M.D. O O
Dictated O O
By: O O
E O O
Xochil O O
Higgins O O
eScription O O
document:4-4587137 O O
EMSSten O O
Tel O O
DD: O O
11/01/83 O O
DT: O O
11/01/83 O O
DV: O O
11/01/83 O O

Record B-SMOKER O
date: O O
2084-01-10 O O
Chief O O
Complaint O O
f/u O O
DM, B-DIABETES O
CAD B-CAD O
History O O
of O O
Present O O
Illness O O
Marion O O
reports O O
feeling O O
quite O O
well. O O
Saw O O
Dr. O O
Schaefer O O
in O O
mid O O
December O O
c/o O O
dizziness O O
- O O
he O O
lowered O O
doses O O
of O O
Bumex O O
and O O
Avapro, B-MEDICATION B-MEDICATION
finding O O
her O O
hypotensive. O O
She O O
has O O
actually O O
continued O O
to O O
take O O
Bumex O O
QD, O O
because O O
she O O
feels O O
her O O
hands O O
get O O
swollen O O
when O O
she O O
doesn't O O
take O O
it. O O
However, O O
she O O
is O O
no O O
longer O O
feeling O O
dizzy. O O
Denies O O
chest O O
pain. O O
Physically O O
active: O O
25' O O
treadmill O O
daily, O O
10'yoga, O O
10' O O
aerobics. O O
Was O O
dancing O O
New O O
Year's O O
Eve. O O
Has O O
some O O
slight O O
pain O O
L O O
knee. O O
Monitors O O
blood O O
sugars O O
in O O
am O O
- O O
120-130 O O
range. O O
Has O O
decreased O O
glyburide B-MEDICATION B-MEDICATION
to O O
2.5 O O
mg O O
qd. O O
Watching O O
diet. O O
Denies O O
poly O O
sx O O
or O O
hypoglycemia. O O
Problems O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
S/P O O
hysterectomy O O
Polymyalgia O O
rheumatica O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
Anemia O O
Temperomandibular O O
joint O O
disease O O
Hypothyroidism O O
Hypertension B-HYPERTENSION O
Hyperlipidemia B-HYPERLIPIDEMIA O
Gastroesophageal O O
reflux O O
disease O O
Fibromyalgia O O
Abnormal O O
liver O O
function O O
tests O O
S/P O O
cholecystectomy O O
Trigger O O
finger O O
Medications O O
Bumex O O
(BUMETANIDE) O O
1MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Allegra O O
(FEXOFENADINE O O
Hcl) O O
60MG, O O
1 O O
Capsule(s) O O
PO O O
BID O O
Nitroglycerin B-MEDICATION B-MEDICATION
1/150 O O
(0.4 O O
Mg) O O
1 O O
TAB O O
SL O O
Glucophage B-MEDICATION B-MEDICATION
(METFORMIN) O O
500MG, O O
2 O O
Tablet(s) O O
PO O O
BID O O
Avapro O B-MEDICATION
(IRBESARTAN) O O
75MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Flexeril O O
(CYCLOBENZAPRINE O O
Hcl) O O
10MG, O O
1 O O
Tablet(s) O O
PO O O
qd O O
Prilosec O O
(OMEPRAZOLE) O O
20MG, O O
1 O O
Capsule(s) O O
PO O O
QD O O
Levoxyl O O
(LEVOTHYROXINE O O
Sodium) O O
50MCG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Zetia B-MEDICATION O
(EZETIMIBE) O O
10MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
ATENOLOL B-MEDICATION B-MEDICATION
50MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
x O O
90 O O
day(s) O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
PO O O
QD O O
x O O
90 O O
day(s) O O
GLYBURIDE O O
2.5MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
40MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Ecotrin B-MEDICATION B-MEDICATION
(ASPIRIN O O
Enteric O O
Coated) O O
81MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Allergies O O
NKDA O O
Review O O
of O O
Systems O O
No O O
h/a, O O
dizziness, O O
CP, O O
SOB, O O
palpitations, O O
n/v, O O
abd O O
pain, O O
change O O
in O O
bowels, O O
LE O O
edema. O O
S/P: O O
Continues O O
working. O O
Would O O
like O O
to O O
take O O
a O O
dance O O
class O O
if O O
Dr. O O
Schaefer O O
agrees. O O
Physical O O
Exam O O
Delightful O O
woman, O O
appears O O
nad O O
Wt O O
141 O O
BP O O
100/62 O O
P O O
80 O O
C O O
and O O
S O O
clear O O
No O O
nvd O O
Chest O O
clear O O
P O O
and O O
A O O
Cor O O
no O O
m,r,t,g O O
Abd O O
soft, O O
nt O O
active O O
bs O O
no O O
masses, O O
organomegaly O O
Ext O O
no O O
c,c,e O O
Imp: O O
1. O O
CAD O O
- O O
No O O
symptoms, O O
quite O O
active. O O
Remains O O
slt O O
hypotensive O O
- O O
rec O O
taking O O
Bumex O O
.5 O O
mg O O
qd O O
since O O
can't O O
tolerate O O
no O O
diuretic O O
for O O
a O O
day. O O
2. O O
DM O O
- O O
doing O O
well O O
by O O
home O O
monitoring O O
3. O O
Hyperlipidemia O O
- O O
will O O
check O O
FLP O O
in O O
4 O O
wks, O O
on O O
Zetia O O
4. O O
Polypharmacy O O
- O O
reviewed O O
meds O O
w O O
her O O
and O O
she O O
is O O
reluctant O O
to O O
cut O O
back. O O
I O O
suggested O O
we O O
might O O
stop O O
Flexeril O O
but O O
she O O
is O O
afraid O O
her O O
joint O O
pains O O
would O O
flare. O O
f/u O O
3 O O
mos, O O
sooner O O
as O O
needed. O O

Record O O
date: O O
2082-10-30 O O
COLIN O O
RAMEY O O
CHH O O
Unit O O
No: O O
433-88-47 O O
MISSOURI O O
PACIFIC O O
HOSPITAL O O
ADULT O O
MEDICINE O O
Date: O O
October O O
30, O O
2082 O O
78-year-old O O
male O O
who O O
comes O O
in O O
for O O
follow-up O O
of O O
his O O
high O O
blood O O
pressure. O O
He O O
denies O O
having O O
any O O
chest O O
pain, O O
any O O
shortness O O
of O O
breath, O O
or O O
any O O
difficulty O O
sleeping O O
at O O
night. O O
His O O
brother-in-law O O
lives O O
with O O
him. O O
He O O
reports O O
no O O
change O O
in O O
Mr. O O
Ramey O O
at O O
all O O
and O O
no O O
concerns. O O
PAST O O
MEDICAL O O
HISTORY: O O
(1) O O
Mental O O
retardation. O O
(2) O O
Hypertension. B-HYPERTENSION O
(3) O O
A O O
history O O
of O O
anemia. O O
(4) O O
BPH. O O
(5) O O
History O O
of O O
peptic O O
ulcer O O
disease O O
diagnosed O O
by O O
upper O O
endoscopy O O
in O O
2069. O O
MEDICATIONS: O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
mg O O
q.d. O O
and O O
atenolol B-MEDICATION B-MEDICATION
25 O O
mg O O
q.d. O O
ALLERGIES O O
TO O O
MEDICATION: O O
None. O O
SOCIAL O O
HISTORY: O O
He B-SMOKER O
doesn't I-SMOKER O
smoke. I-SMOKER O
PHYSICAL O O
EXAM: O O
Weight O O
147, O O
unchanged. O O
Blood O O
pressure O O
140/70. O O
Pulse O O
72. O O
Lungs O O
clear. O O
No O O
crackles O O
or O O
wheezing. O O
Cardiac O O
- O O
Regular O O
rate O O
and O O
rhythm. O O
S1, O O
S2. O O
His O O
abdomen O O
is O O
soft, O O
nontender. O O
Extremities O O
- O O
trace O O
edema O O
at O O
the O O
ankles. O O
ASSESSMENT O O
AND O O
PLAN: O O
(1) O O
Hypertension, O O
which O O
appears O O
to O O
be O O
stable. O O
Continue O O
present O O
regimen. O O
Will O O
check O O
a O O
potassium, O O
BUN O O
and O O
creatinine. O O
(2) O O
History O O
of O O
normocytic O O
anemia. O O
His O O
last O O
hematocrit O O
in O O
2080 O O
was O O
at O O
38, O O
normal O O
MCV. O O
At O O
his O O
next O O
visit O O
he O O
will O O
need O O
a O O
recheck O O
of O O
this O O
as O O
well O O
as O O
of O O
B12 O O
level. O O
(3) O O
History O O
of O O
borderline O O
sugars, O O
although O O
his O O
glucose O O
today O O
is O O
105. O O
(4) O O
Routine O O
health O O
maintenance. O O
Flu O O
vaccine O O
given O O
to O O
his O O
left O O
deltoid O O
IM. O O
He O O
will O O
need O O
Hemoccult O O
cards O O
at O O
his O O
next O O
visit. O O
Follow O O
up O O
in O O
6 O O
months O O
or O O
sooner O O
as O O
needed. O O
Xavier O O
Combs, O O
M.D. O O
XC/olivas/finn O O

Record O O
date: O O
2083-01-30 O O
COLIN O O
RAMEY O O
CHH O O
Unit O O
No: O O
433-88-47 O O
MISSOURI O O
PACIFIC O O
HOSPITAL O O
ADULT O O
MEDICINE O O
Date: O O
January O O
30, O O
2083 O O
78-year-old O O
male O O
for O O
follow-up O O
of O O
blood O O
pressure. O O
He O O
continues O O
to O O
live O O
at O O
the O O
home O O
of O O
his O O
sister-in-law's O O
brother O O
who O O
reports O O
complaints O O
of O O
knee O O
discomfort O O
that O O
do O O
affect O O
his O O
ability O O
to O O
walk. O O
He O O
is O O
not O O
using O O
his O O
cane. O O
Regarding O O
his O O
inguinal O O
hernia, O O
Mr. O O
Ramey O O
reports O O
that O O
it O O
is O O
only O O
slightly O O
bothersome O O
infrequently. O O
No O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
or O O
abdominal O O
discomfort. O O
He O O
may O O
have O O
at O O
time O O
some O O
difficulty O O
starting O O
to O O
urinate O O
but O O
does O O
not O O
have O O
nocturia O O
on O O
a O O
regular O O
basis. O O
PAST O O
MEDICAL O O
HISTORY: O O
(1) O O
Mental O O
retardation. O O
(2) O O
Hypertension. B-HYPERTENSION O
(3) O O
Anemia. O O
(4) O O
BPH. O O
(5) O O
History O O
of O O
peptic O O
ulcer O O
disease O O
diagnosed O O
by O O
upper O O
endoscopy O O
in O O
2069. O O
MEDICATIONS: O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
q.d., O O
atenolol B-MEDICATION B-MEDICATION
25 O O
q.d. O O
ALLERGIES O O
TO O O
MEDICATIONS: O O
None. O O
SOCIAL O O
HISTORY: O O
Not B-SMOKER O
smoking. I-SMOKER O
PHYSICAL O O
EXAM: O O
Weight O O
is O O
145, O O
down O O
2 O O
lb. O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
today I-HYPERTENSION O
is I-HYPERTENSION O
148/70. B-HYPERTENSION O
Pulse O O
is O O
76. O O
Lungs O O
are O O
clear. O O
Cardiac O O
- O O
Regular O O
rate O O
and O O
rhythm, O O
S1, O O
S2. O O
Abdomen O O
- O O
Soft, O O
nontender. O O
Inguinal O O
examination O O
reveals O O
a O O
left O O
inguinal O O
hernia O O
reducible, O O
nontender O O
today. O O
Rectal O O
- O O
Prostate O O
symmetrically O O
enlarged O O
1+ O O
but O O
no O O
specific O O
nodules O O
or O O
masses. O O
Extremities O O
- O O
Knees O O
- O O
There O O
is O O
some O O
tenderness O O
in O O
the O O
medial O O
joint O O
line O O
bilaterally, O O
but O O
no O O
evidence O O
of O O
any O O
effusion O O
or O O
erythema. O O
No O O
ankle O O
edema. O O
ASSESSMENT O O
AND O O
PLAN: O O
(1) O O
Hypertension, O O
stable. O O
Continue O O
present O O
regimen. O O
Will O O
check O O
a O O
potassium O O
level. O O
(2) O O
History O O
of O O
anemia. O O
Will O O
recheck O O
CBC O O
as O O
well O O
as O O
a O O
B12 O O
level O O
as O O
his O O
MCV O O
was O O
slightly O O
up O O
at O O
97. O O
TSH O O
done O O
in O O
November O O
was O O
normal. O O
(3) O O
Osteoarthritis. O O
Advised O O
use O O
of O O
Tylenol O O
2 O O
tablets O O
Extra-Strength O O
q6 O O
hours O O
as O O
needed. O O
Will O O
get O O
Sissonville O O
VNA O O
to O O
come O O
and O O
see O O
him O O
regarding O O
physical O O
therapy O O
evaluation. O O
He O O
will O O
otherwise O O
follow O O
up O O
in O O
6 O O
months. O O
Xavier O O
Combs, O O
M.D. O O
XC/olivas/quijano O O

Record B-SMOKER O
date: O O
2083-10-14 O O
79 O O
YO O O
male O O
for O O
f/u O O
of O O
blood O O
pressure. O O
Patient O O
is O O
now O O
living O O
in O O
Newton O O
House O O
in O O
Blacksburg O O
with O O
Wllie O O
Falk O O
as O O
his O O
coordinator(856 O O
241 O O
8283). O O
Mr. O O
ramey O O
enjoys O O
living O O
there O O
and O O
enjoys O O
the O O
meals. O O
his O O
only O O
complaint O O
is O O
of O O
left O O
inguinal O O
discomfort O O
which O O
is O O
worse O O
at O O
night. O O
doesn't O O
lift O O
objects O O
but O O
still O O
it O O
is O O
bothersome. O O
--------------Problems---------- O O
Mental O O
retardation O O
Hypertension B-HYPERTENSION O
Anemia O O
Benign O O
prostatic O O
hypertrophy O O
H/O O O
peptic O O
ulcer O O
disease O O
DX. O O
BY O O
UPPER O O
ENDOSCOPY O O
IN O O
2069. O O
--------------Medications---------- O O
ATENOLOL B-MEDICATION B-MEDICATION
25MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
--------------Allergies---------- O O
HCTZ O O
(HYDROCHLOROTHIAZIDE) O O
HYPONATREMIA O O
--------------Vital O O
Signs---------- O O
bp B-HYPERTENSION O
160/80 I-HYPERTENSION O
pulse O O
60 O O
lungs: O O
clear O O
cor:RRRs1s2 O O
abd: O O
soft O O
and O O
nontender O O
left O O
ingunal O O
region O O
there O O
is O O
a O O
bulge O O
about O O
5 O O
cm. O O
ext: O O
no O O
edema O O
a/p O O
probably O O
inguinal O O
hernia O O
that O O
is O O
symptomatic. O O
will O O
therefore O O
refer O O
to O O
dr. O O
nunley O O
from O O
surgery O O
for O O
eval. O O
discussed O O
this O O
with O O
his O O
coordinator. O O
htn: O O
add B-MEDICATION O
lisinopril B-MEDICATION B-MEDICATION
5 O O
mg O O
qd O O
and O O
recheck O O
in O O
three O O
months. O O
--------------Health O O
Maint---------- O O
Influenza O O
Vaccine O O
10/14/2083 O O
GIVEN O O
IM O O
TO O O
LEFT O O
DELTOID O O
Rectal O O
exam O O
01/29/2083 O O
Pneumovax O O
01/29/2083 O O
Done O O
UA-Protein O O
02/28/80 O O
1+ O O
HBA1C O O
10/31/2082 O O
6.00 O O
_______________________________________ O O
Xavier O O
U. O O
Combs, O O
M.D. O O

Record B-SMOKER O
date: O O
2084-05-05 O O
82 O O
yo O O
male O O
for O O
bp O O
follow O O
up. O O
no O O
complaints. O O
underwent O O
successful O O
turp O O
last O O
month. O O
ros: O O
neg O O
for O O
chest O O
pain, O O
cough O O
or O O
shortness O O
of O O
breath. O O
he O O
does O O
have O O
mild O O
swelling O O
of O O
ankles. O O
PROBLEMS O O
Mental O O
retardation O O
Hypertension B-HYPERTENSION O
Anemia O O
H/O O O
peptic O O
ulcer O O
disease O O
DX. O O
BY O O
UPPER O O
ENDOSCOPY O O
IN O O
2069. O O
Benign O O
prostatic O O
hypertrophy O O
s/p O O
turp O O
4/84 O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
ett O O
12/83: O O
The O O
ECG O O
response O O
to O O
pharmacological O O
stress O O
was O O
nondiagnostic O O
for O O
ischemia. O O
The O O
myocardial O O
perfusion O O
scans O O
show O O
a O O
moderate O O
size, O O
severe, O O
fixed O O
inferior O O
and O O
inferolateral O O
defect O O
indicative B-CAD O
of I-CAD O
prior B-CAD O
infarct I-CAD O
with O O
little O O
if O O
any O O
residual O O
ischemia. O O
MEDICATIONS O O
VIOXX O O
(ROFECOXIB) O O
25MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
PROSCAR O O
(FINASTERIDE) O O
5MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
20MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
ALLERGIES O O
HCTZ O O
(HYDROCHLOROTHIAZIDE) O O
HYPONATREMIA O O
exam: O O
weight O O
146 O O
140/60 B-HYPERTENSION O
76 O O
lungs;clear O O
cor:RRRs1s2 O O
with O O
no O O
gallops O O
ext; O O
trace O O
ankle O O
edema O O
a/p: O O
htn: O O
stable. O O
check O O
lytes. O O
cad O O
with O O
mild O O
ankle O O
edema. O O
will O O
send O O
for O O
cardiac O O
echo O O
to O O
assess O O
ef. O O
consider O O
adding O O
lasix. O O
will O O
follow. O O
otherwise O O
no O O
angina O O
or O O
failure. O O
follow O O
up O O
in O O
four O O
months. O O
____________________________ O O
Xavier O O
U. O O
Combs, O O
M.D. O O

Record O O
date: O O
2085-06-16 O O
83 O O
yo O O
male O O
for O O
f/u O O
of O O
heart O O
disease O O
and O O
bp. O O
he O O
states O O
he O O
is O O
fine O O
and O O
denies O O
any O O
chest O O
pressure, O O
dyspnea O O
or O O
abd O O
pain. O O
denies O O
any O O
bleeding O O
from O O
stools. O O
Problems O O
Mental O O
retardation O O
Hypertension B-HYPERTENSION O
Anemia O O
Benign O O
prostatic O O
hypertrophy O O
: O O
s/p O O
turp O O
4/84 O O
H/O O O
peptic O O
ulcer O O
disease O O
: O O
DX. O O
BY O O
UPPER O O
ENDOSCOPY O O
IN O O
2069. O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
: O O
ett O O
12/83: O O
The O O
ECG O O
response O O
to O O
pharmacological O O
stress O O
was O O
nondiagnostic O O
for O O
ischemia. O O
The O O
myocardial O O
perfusion O O
scans O O
show O O
a O O
moderate O O
size, O O
severe, O O
fixed O O
inferior O O
and O O
inferolateral O O
defect O O
indicative B-CAD O
of I-CAD O
prior B-CAD O
infarct I-CAD O
with O O
little O O
if O O
any O O
residual O O
ischemia. O O
Sick O O
sinus O O
syndrome O O
Medications O O
Ecasa B-MEDICATION B-MEDICATION
(ASPIRIN O O
Enteric O O
Coated) O O
81MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Lasix O O
(FUROSEMIDE) O O
20MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Imdur B-CAD B-MEDICATION
(ISOSORBIDE O O
MONONIT.(SR)) O O
30MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Zocor B-MEDICATION B-MEDICATION
(SIMVASTATIN) O O
20MG, O O
1 O O
Tablet(s) O O
PO O O
QHS O O
LISINOPRIL B-MEDICATION B-MEDICATION
30MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Nexium O O
(ESOMEPRAZOLE) O O
40MG, O O
1 O O
Capsule(s) O O
PO O O
QD O O
Percocet O O
(OXYCODONE O O
Apap) O O
325-5, O O
1 O O
Tablet(s) O O
PO O O
Q8H O O
: O O
one O O
half O O
tab O O
to O O
one O O
tab O O
po O O
q8 O O
hours O O
as O O
needed O O
for O O
pain O O
Lopressor B-MEDICATION B-MEDICATION
(METOPROLOL O O
Tartrate) O O
50MG, O O
1 O O
Tablet(s) O O
PO O O
BID O O
Allergies O O
Hctz O O
(HYDROCHLOROTHIAZIDE) O O
- O O
HYPONATREMIA O O
weight:145(up O O
five O O
lbs) O O
bp:110/50 O O
pulse64 O O
appears O O
well O O
cor:RRRs1s2 O O
lungs: O O
clear O O
abd: O O
soft O O
and O O
nontender O O
ext: O O
trace O O
edema O O
a/p: O O
cad: O O
no O O
angina O O
or O O
failure O O
but O O
perhaps O O
slightly O O
fluid O O
overload O O
with O O
edema, O O
trace O O
in O O
ankles O O
and O O
weight O O
up. O O
will O O
increase O O
lasix O O
to O O
20 O O
mg O O
po O O
bid. O O
check O O
lytes. O O
continue O O
all O O
other O O
meds,. O O
h/o O O
pud: O O
cont O O
with O O
nexium. O O
check O O
cbc. O O
anemia; O O
due O O
to O O
gi O O
bleed. O O
recheck. O O
htn: O O
stable. O O
bph: O O
stable. O O
nocturia O O
x2 O O
f/u O O
three O O
months. O O
Health O O
maintenance O O
Influenza O O
Vaccine O O
11/04/2084 O O
Cholesterol O O
09/01/2084 O O
155 O O
DESIRABLE: O O
less O O
then O O
200 O O
Rectal O O
exam O O
01/29/2083 O O
Pneumovax O O
01/29/2083 O O
Smoking B-SMOKER O
status I-SMOKER O
01/20/2085 I-SMOKER O
Never B-SMOKER O
a I-SMOKER O
smoker I-SMOKER O
UA-Protein O O
09/23/2084 O O
1+ O O
HBA1C O O
10/31/2082 O O
6.00 O O
Triglycerides O O
09/01/2084 O O
77 O O
Cholesterol-LDL O O
09/01/2084 O O
95 O O
DESIRABLE: O O
less O O
then O O
130 O O
Hct O O
(Hematocrit) O O
01/20/2085 O O
36.3 O O
Cholesterol-HDL O O
09/01/2084 O O
45 O O
Hgb O O
(Hemoglobin) O O
01/20/2085 O O
11.5 O O
_____________________________________________ O O
Xavier O O
U. O O
Combs, O O
M.D. O O

Record B-SMOKER O
date: O O
2092-08-30 O O
NAME: O O
Yager, O O
Becky O O
MRN: O O
0887181 O O
Becka O O
returns O O
for O O
follow-up O O
of O O
painful O O
neuropathy. O O
She O O
showed O O
me O O
a O O
foot O O
ulcer O O
that O O
she O O
has O O
had O O
since O O
early O O
August. O O
In O O
fact, O O
this O O
was O O
debrided O O
on O O
August O O
9 O O
by O O
Dr. O O
Noyes O O
and O O
was O O
found O O
to O O
contain O O
Staph O O
aureus O O
sensitive O O
to O O
oxacillin O O
and O O
Bactrim. O O
She O O
was O O
treated O O
with O O
Augmentin O O
for O O
2 O O
weeks O O
with O O
little O O
improvement. O O
She O O
has O O
not O O
had O O
any O O
fever. O O
She O O
continues O O
on O O
her O O
chronic O O
pain O O
medications O O
and O O
Percocet. O O
On O O
exam, O O
the O O
second O O
toe O O
on O O
the O O
right O O
foot O O
is O O
severely O O
swollen O O
and O O
red. O O
There O O
is O O
an O O
ulcer O O
which O O
looks O O
quite O O
deep O O
on O O
the O O
medial O O
aspect O O
of O O
the O O
toe. O O
I O O
had O O
Dr. O O
Drew O O
take O O
a O O
look O O
at O O
her O O
foot O O
who O O
agreed O O
that O O
she O O
should O O
be O O
seen O O
in O O
the O O
emergency O O
room. O O
IMPRESSION: O O
Cellulitis/right O O
toe O O
ulcer O O
- O O
Persistent O O
infection O O
and O O
unresponsiveness O O
to O O
2-week O O
course O O
of O O
Augmentin O O
raise O O
concern O O
of O O
underlying O O
osteomyelitis. O O
Rebecca O O
was O O
referred O O
into O O
the O O
emergency O O
room O O
for O O
further O O
evaluation. O O
She O O
also O O
was O O
given O O
a O O
new O O
prescription O O
for O O
her O O
Percocet O O
#100. O O
I O O
will O O
see O O
her O O
in O O
follow-up O O
in O O
1 O O
month. O O
Rowena O O
Xanders, O O
M.D. O O
RX/mcbride/richardson O O
cc: O O
Georgia O O
Xing, O O
M.D. O O

Record B-SMOKER O
date: O O
2092-12-27 O O
NAME: O O
Yager, O O
Rebecca O O
MRN: O O
0887181 O O
FOLLOW-UP O O
VISIT O O
Patient O O
returns O O
for O O
follow-up O O
of O O
painful O O
neuropathy. O O
Since O O
last O O
seen, O O
her O O
Dilantin O O
level O O
came O O
back O O
at O O
18.8. O O
She O O
feels O O
her O O
pain O O
has O O
been O O
under O O
relatively O O
good O O
control. O O
She O O
has O O
had O O
a O O
few O O
falls O O
since O O
she O O
was O O
last O O
seen O O
all O O
due O O
to O O
losing O O
her O O
balance O O
or O O
tripping. O O
No O O
lightheadedness O O
or O O
vertigo O O
preceding O O
her O O
falls. O O
She O O
is O O
trying O O
to O O
be O O
more O O
careful O O
to O O
avoid O O
future O O
falls O O
by O O
watching O O
closely O O
where O O
she O O
is O O
walking. O O
She O O
has O O
no O O
active O O
infection O O
at O O
present. O O
She O O
is O O
scheduled O O
for O O
follow-up O O
EMG O O
nerve O O
conduction O O
studies O O
in O O
January. O O
ON O O
EXAM: O O
She O O
is O O
her O O
usual O O
pleasant O O
self. O O
Examination O O
of O O
the O O
feet O O
shows O O
hammertoes, O O
numerous O O
bunions, O O
some O O
reddened O O
calluses O O
but O O
no O O
ulcers O O
or O O
open O O
lesions. O O
There O O
is O O
vibratory O O
loss O O
to O O
the O O
ankles O O
and O O
absent O O
ankle O O
jerks O O
bilaterally. O O
IMPRESSION: O O
Painful O O
neuropathy O O
with O O
10-year O O
history O O
of O O
progressive O O
symptoms. O O
Numerous O O
previous O O
work-ups O O
for O O
reversible O O
causes O O
of O O
neuropathy O O
have O O
been O O
negative. O O
I O O
would O O
like O O
to O O
have O O
her O O
be O O
evaluated O O
by O O
Dr. O O
Phyllis O O
Brewer O O
of O O
Internal O O
Medicine O O
to O O
see O O
if O O
she O O
has O O
any O O
other O O
ideas O O
as O O
to O O
any O O
additional O O
work-up O O
or O O
treatment. O O
Of O O
note, O O
previously O O
had O O
a O O
DENA O O
panel O O
for O O
sensory O O
neuropathy O O
which O O
was O O
negative. O O
Rebecca O O
was O O
given O O
a O O
new O O
prescription O O
for O O
Percocet O O
#100. O O
I O O
will O O
see O O
her O O
in O O
follow-up O O
in O O
two O O
months. O O
Rowena O O
Xanders, O O
M. O O
D. O O
RX/mcbride/xiang O O

Record B-SMOKER O
date: O O
2094-04-03 O O
NAME: O O
Yager, O O
Becky O O
MRN: O O
0887181 O O
Becky O O
returns O O
for O O
follow-up O O
of O O
painful O O
neuropathy. O O
A O O
lot O O
has O O
happened O O
since O O
she O O
was O O
seen. O O
She O O
was O O
terminated O O
at O O
her O O
job O O
working O O
as O O
a O O
Credit O O
Manager O O
in O O
December O O
2093. O O
She O O
therefore O O
has O O
been O O
having O O
financial O O
problems. O O
She O O
does O O
not O O
have O O
enough O O
money O O
to O O
buy O O
her O O
medications. O O
She O O
has O O
a O O
history O O
of O O
hypertension B-HYPERTENSION O
and O O
hypercholesterolemia. B-HYPERLIPIDEMIA O
She O O
has O O
not O O
taken O O
these O O
medications O O
for O O
months. O O
She O O
states O O
she O O
has O O
been O O
taking O O
her O O
nortriptyline, O O
dilantin O O
and O O
Percocet O O
as O O
previously O O
prescribed. O O
When O O
I O O
called O O
her O O
from O O
the O O
waiting O O
room O O
today, O O
she O O
walked O O
towards O O
me, O O
she O O
veered, O O
and O O
I O O
caught O O
her O O
before O O
she O O
fell. O O
We O O
then O O
got O O
the O O
wheelchair O O
and O O
wheeled O O
her O O
into O O
the O O
room O O
and O O
history O O
was O O
taken. O O
She O O
reports O O
being O O
off O O
balance O O
for O O
about O O
the O O
past O O
month. O O
She O O
has O O
been O O
feeling O O
more O O
unsteady O O
on O O
her O O
feet. O O
She O O
states O O
she O O
has O O
not O O
actually O O
fallen O O
but O O
has O O
come O O
close O O
to O O
falling. O O
She O O
denies O O
any O O
true O O
vertigo, O O
ringing O O
in O O
her O O
ears, O O
headaches, O O
change O O
in O O
mentation, O O
numbness, O O
weakness O O
or O O
change O O
in O O
gait. O O
On O O
review O O
of O O
other O O
systems, O O
she O O
reports O O
a O O
20 O O
lb. O O
weight O O
gain O O
over O O
the O O
past O O
few O O
months O O
which O O
she O O
attributes O O
to O O
not O O
working O O
and O O
being O O
at O O
home O O
and O O
eating O O
more O O
than O O
usual. O O
She O O
also O O
notes O O
that O O
she O O
has O O
begun O O
urinating O O
at O O
night O O
which O O
she O O
previously O O
did O O
not O O
do. O O
She O O
complains O O
of O O
excessive O O
dry O O
mouth. O O
She O O
reports O O
being O O
more O O
thirsty O O
than O O
usual. O O
PHYSICAL O O
EXAM: O O
On O O
exam, O O
she O O
was O O
her O O
usual O O
pleasant O O
self. O O
She O O
is O O
alert O O
and O O
oriented O O
X O O
3. O O
Speech O O
fluent O O
without O O
aphasia. O O
BP B-HYPERTENSION O
sitting I-HYPERTENSION O
145/70. I-HYPERTENSION O
Pulse O O
80. O O
Standing O O
BP O O
unchanged O O
at O O
145/70. O O
Pulse O O
80. O O
Cranial O O
nerve O O
exam O O
notable O O
for O O
prominent O O
bilateral O O
nystagmus. O O
Otherwise O O
intact. O O
On O O
motor O O
exam, O O
no O O
tremor O O
or O O
involuntary O O
movements. O O
No O O
drift. O O
Good O O
power O O
throughout. O O
Fine O O
finger O O
movements O O
intact. O O
Vibratory O O
loss O O
to O O
the O O
ankles. O O
Babinski O O
flexor O O
bilaterally. O O
When O O
she O O
got O O
up O O
to O O
stand O O
at O O
the O O
end O O
of O O
the O O
evaluation O O
to O O
leave O O
and O O
telling O O
me O O
she O O
was O O
fine, O O
she O O
veered O O
to O O
the O O
right O O
and O O
I O O
again O O
caught O O
her. O O
IMPRESSION: O O
Imbalance O O
with O O
history O O
of O O
recently O O
running O O
out O O
of O O
many O O
of O O
her O O
medications O O
though O O
taking O O
her O O
chronic O O
pain O O
medications O O
as O O
previously O O
prescribed. O O
Also O O
notable O O
in O O
the O O
history O O
is O O
new O O
nocturia, O O
increased O O
thirst O O
and O O
dry O O
mouth. O O
Her O O
exam O O
is O O
notable O O
for O O
prominent O O
end-gaze O O
nystagmus. O O
Therefore O O
I O O
suspect O O
toxic O O
metabolic O O
cause. O O
As O O
she O O
will O O
need O O
STAT O O
lytes, O O
blood O O
sugar, O O
dilantin O O
level O O
and O O
tox O O
screen O O
as O O
well O O
as O O
cardiac O O
evaluation, O O
the O O
patient O O
was O O
referred O O
to O O
PROMPTCARE O O
ER. O O
I O O
will O O
be O O
in O O
touch O O
with O O
the O O
physicians O O
after O O
they O O
see O O
her. O O
Rowena O O
Xanders, O O
M.D. O O
RX/mcbride/tucker O O
cc: O O
Georgia O O
Xing, O O
M.D. O O

Record O O
date: O O
2096-04-11 O O
Internal O O
Medicine O O
Intern O O
Admission O O
Note O O
Patient O O
Name: O O
REBECCA O O
YAGER O O
MR#: O O
0887181 O O
Date O O
of O O
Admission: O O
4/11/96 O O
Attending: O O
Dr. O O
Georgia O O
Xing O O
Intern: O O
Branden O O
Ocasio O O
ID/CC: O O
There's O O
a O O
herd O O
of O O
elephants O O
on O O
my O O
chest. O O
HPI: O O
69 O O
yo O O
F O O
with O O
PMH O O
of O O
DM, B-DIABETES O
HTN, B-HYPERTENSION O
s/p B-CAD O
MI B-CAD O
one I-CAD O
year I-CAD O
ago, I-CAD O
now O O
presents O O
with O O
substernal B-CAD O
chest I-CAD O
pain I-CAD O
and I-CAD O
increased I-CAD O
shortness I-CAD O
of I-CAD O
breath I-CAD O
x I-CAD O
2 I-CAD O
days. I-CAD O
Patient O O
was O O
in O O
her O O
usual O O
state O O
of O O
health O O
until O O
3 O O
days O O
prior O O
to O O
admission, O O
when O O
she O O
began O O
experiencing O O
unremitting O O
substernal O O
chest O O
pain, O O
nonradiating. O O
This O O
pain O O
was O O
constant, O O
24 O O
hours/day O O
, O O
and O O
felt O O
like O O
a O O
herd O O
of O O
elephants O O
on O O
my O O
chest. O O
This O O
was O O
accompanied O O
by O O
an O O
increased O O
shortness O O
of O O
breath, O O
especially O O
with O O
exertion, O O
which O O
the O O
patient O O
had O O
not O O
experienced O O
before. O O
The O O
chest O O
pain O O
and O O
shortness O O
of O O
breath O O
would O O
wake O O
her O O
up O O
at O O
night, O O
accompanied O O
by O O
drenching O O
sweats O O
and O O
a O O
dizziness, O O
I O O
felt O O
like O O
I O O
was O O
about O O
to O O
faint. O O
Patient O O
sleeps O O
with O O
two O O
pillows O O
at O O
baseline. O O
The O O
pain O O
eventually O O
grew O O
to O O
be O O
so O O
severe O O
that O O
the O O
patient O O
called O O
EMS. O O
Upon O O
their O O
arrival O O
at O O
her O O
house O O
she O O
was O O
given O O
2 O O
doses O O
of O O
SL B-MEDICATION O
nitro B-MEDICATION O
which O O
improved O O
her O O
pain. O O
In O O
the O O
TPG O O
ED O O
her O O
vital O O
signs O O
were O O
Temp O O
AF, O O
HR O O
70, O O
BP B-HYPERTENSION O
154/79, B-HYPERTENSION O
RR O O
20, O O
satting O O
99% O O
RA. O O
EKG O O
showed O O
a O O
new O O
Twave O O
inversion O O
in O O
V3, O O
otherwise O O
at O O
her O O
baseline O O
normal O O
EKG. O O
IV O O
heparin O O
was O O
started O O
for O O
possible O O
MI O O
given O O
her O O
symptoms O O
and O O
history. O O
D-dimer O O
was O O
elevated O O
at O O
782. O O
Based O O
on O O
these O O
findings O O
and O O
her O O
shortness O O
of O O
breath, O O
PE-CT O O
was O O
obtained, O O
which O O
was O O
negative O O
for O O
PE. O O
However, O O
it O O
did O O
show O O
multiple O O
new O O
mediastinal O O
lymph O O
nodes O O
up O O
to O O
9mm O O
in O O
size, O O
as O O
well O O
as O O
a O O
6mm O O
nodule O O
in O O
the O O
LLL. O O
The O O
patient O O
was O O
given O O
ASA, B-MEDICATION B-MEDICATION
MSO4, O O
nitro, O O
and O O
made O O
chest O O
pain O O
free O O
in O O
the O O
ED. O O
She O O
was O O
admitted O O
for O O
continued O O
rule O O
out O O
for O O
MI O O
and O O
workup O O
of O O
her O O
pulmonary O O
findings. O O
ROS: O O
No O O
fevers/chills. O O
Does O O
report O O
cough, O O
cold O O
sores O O
x O O
1 O O
week. O O
The O O
patient O O
did O O
report O O
having O O
slight O O
lower O O
quadrant O O
abdominal O O
pain, O O
with O O
some O O
nausea O O
but O O
no O O
vomiting, O O
No O O
hematochezia/melena. O O
No O O
increased O O
frequency, O O
no O O
dysuria. O O
No O O
delta O O
MS/LOC. O O
Past O O
Medical O O
History: O O
CAD-s/p B-CAD O
MI, O O
although O O
unclear O O
when O O
this O O
occurred. O O
ETT O O
2092: O O
nondiagnostic O O
for O O
ischemia. O O
No O O
evidence O O
of O O
scar O O
or O O
ischemia. O O
Nonspecific O O
apical O O
thinning. O O
Hx O O
TB-patient O O
says O O
she O O
was O O
diagnosed O O
at O O
age O O
19, O O
received O O
drug O O
therapy O O
and O O
spent O O
time O O
in O O
a O O
sanatorium. O O
Says O O
PPD O O
is O O
always O O
positive, O O
needs O O
CXR O O
to O O
diagnose. O O
hypertension O O
elevated B-HYPERLIPIDEMIA O
cholesterol-trigs I-HYPERLIPIDEMIA O
600s, O O
total B-HYPERLIPIDEMIA O
chol I-HYPERLIPIDEMIA O
280s I-HYPERLIPIDEMIA O
anxiety-treated O O
with O O
SSRIs, O O
Klonopin O O
in O O
the O O
past. O O
chronic O O
pain--Pt O O
had O O
hx O O
of O O
back O O
surg O O
in O O
the O O
2080's O O
for O O
spinal O O
stenosis. O O
Recent O O
MRI O O
showed O O
severe O O
lumbar O O
stenosis. O O
peripheral O O
neuropathy-absent O O
reflexes O O
at O O
baseline, O O
neuropathic O O
pain. O O
Bladder O O
cancer O O
status O O
post O O
resection O O
in O O
2089. O O
Status O O
post O O
hysterectomy O O
in O O
2065. O O
R O O
adrenal O O
mass--dx O O
on O O
ab O O
CT O O
2094 O O
L O O
adnexal O O
cystic O O
lesion O O
Colon O O
polyps O O
s/p O O
scope O O
with O O
resection O O
Diverticulosis O O
Medications: O O
Mvi O O
(MULTIVITAMINS) O O
1 O O
CAPSULE O O
PO O O
QD O O
Calcium O O
ACETATE O O
( O O
1 O O
TABLET=667 O O
MG) O O
667 O O
MG O O
PO O O
TID O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
81MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
, O O
Take O O
as O O
directed O O
Dilantin O O
(PHENYTOIN) O O
400 O O
MG O O
(100MG O O
CAPSULE O O
take O O
4) O O
PO O O
QD O O
Zestril B-MEDICATION B-MEDICATION
(LISINOPRIL) B-MEDICATION O
40MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Pravachol B-MEDICATION B-MEDICATION
(PRAVASTATIN) B-MEDICATION O
40MG O O
TABLET O O
take O O
1 O O
PO O O
QHS O O
Hctz B-MEDICATION O
(HYDROCHLOROTHIAZIDE) B-MEDICATION O
25MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Zanaflex O O
(TIZANIDINE) O O
4 O O
MG O O
(4MG O O
TABLET O O
take O O
1) O O
PO O O
HS O O
Motrin O O
(IBUPROFEN) O O
800MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
TID O O
PRN O O
pain O O
Neurontin O O
(GABAPENTIN) O O
800MG O O
TABLET O O
take O O
1 O O
PO O O
TID O O
Metformin B-MEDICATION B-MEDICATION
500MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
MSO4 O O
SR O O
60 O O
mg O O
TID O O
Allergies: O O
NKDA O O
Family O O
History: O O
patient O O
is O O
an O O
orphan. O O
Social O O
History: O O
Work: O O
Retired O O
manager O O
Marital O O
status: O O
divorced O O
Children: O O
4 O O
Habits: O O
No O O
IVDU. O O
No O O
Etoh. O O
Quit B-SMOKER O
smoking I-SMOKER O
2080, I-SMOKER O
had O O
smoked O O
2-4 O O
packs O O
a O O
day O O
up O O
to O O
that O O
time. O O
Physical O O
Exam: O O
VS: O O
T= O O
97 O O
HR= O O
70 O O
BP=150/75 B-HYPERTENSION O
RR= O O
24 O O
O2sat=99 O O
on O O
2L O O
General: O O
NAD O O
HEENT: O O
NCAT, O O
PERRL, O O
clear O O
OP O O
Neck: O O
JVP O O
= O O
5 O O
cm O O
Chest: O O
clear O O
to O O
auscultation O O
bilaterally. O O
No O O
wheezes/crackles. O O
CVS: O O
RRR O O
nl O O
s1 O O
s2. O O
no O O
m/r/g O O
Abdomen: O O
+BS, O O
soft, O O
minimally O O
tender O O
in O O
lower O O
quadrants, O O
no O O
organomegaly, O O
guaiac O O
negative. O O
Ext: O O
no O O
LE O O
edema, O O
no O O
pain, O O
2+ O O
pulses O O
bilaterally. O O
Neuro: O O
A&O O O
x O O
3; O O
NF. O O
CN O O
2-12 O O
intact, O O
motor O O
5/5 O O
throughout, O O
reflexes O O
not O O
elicited. O O
Babinskis O O
not O O
elicited. O O
Sensory O O
exam O O
notable O O
for O O
decreased O O
pinprick, O O
soft O O
touch O O
sense O O
in O O
stocking/glove O O
distribution. O O
Labs: O O
Sodium O O
141 O O
135-145 O O
mmol/L O O
04/11/96 O O
13:23 O O
Potassium O O
3.5 O O
3.4-4.8 O O
mmol/L O O
04/11/96 O O
13:23 O O
3.0(L) O O
11/03/93 O O
18:26 O O
Chloride O O
104 O O
100-108 O O
mmol/L O O
04/11/96 O O
13:23 O O
98(L) O O
11/03/95 O O
22:29 O O
Carbon O O
Dioxide O O
27.7 O O
23.0-31.9 O O
mmol/L O O
04/11/96 O O
13:23 O O
31.0(H) O O
04/01/93 O O
08:25 O O
BUN O O
24 O O
8-25 O O
mg/dl O O
04/11/96 O O
13:23 O O
Creatinine O O
0.8 O O
0.6-1.5 O O
mg/dl O O
04/11/96 O O
13:23 O O
0.5(L) O O
10/04/87 O O
14:01 O O
Glucose O O
156H O O
70-110 O O
mg/dl O O
04/11/96 O O
13:23 O O
156(H) O O
04/11/96 O O
13:23 O O
General O O
Chemistries O O
Calcium O O
9.8 O O
8.5-10.5 O O
mg/dl O O
04/11/96 O O
14:08 O O
8.4(L) O O
04/01/93 O O
08:25 O O
Phosphorus O O
3.0 O O
2.6-4.5 O O
mg/dl O O
04/11/96 O O
14:08 O O
2.3(L) O O
04/03/94 O O
13:35 O O
Magnesium O O
1.6 O O
1.4-2.0 O O
meq/L O O
04/11/96 O O
14:08 O O
1.3(L) O O
06/16/88 O O
13:15 O O
CK-MB O O
NEGATIVE O O
NEG O O
04/11/96 O O
12:57 O O
8.4(H) O O
04/01/93 O O
01:58 O O
Troponin-I O O
NEGATIVE O O
NEG O O
04/11/96 O O
12:57 O O
Cholesterol B-HYPERLIPIDEMIA O
282 I-HYPERLIPIDEMIA O
mg/dl I-HYPERLIPIDEMIA O
02/13/96 I-HYPERLIPIDEMIA O
18:00 I-HYPERLIPIDEMIA O
263(H) I-HYPERLIPIDEMIA O
03/17/91 I-HYPERLIPIDEMIA O
15:19 I-HYPERLIPIDEMIA O
Triglycerides O O
681H O O
40-150 O O
mg/dl O O
02/13/96 O O
18:00 O O
681(H) O O
02/13/96 O O
18:00 O O
HDL O O
Cholesterol O O
52 O O
35-100 O O
mg/dl O O
02/13/96 O O
18:00 O O
LDL O O
Cholesterol O O
-- O O
mg/dl O O
02/13/96 O O
18:00 O O
151(H) O O
03/17/91 O O
15:19 O O
Chol/HDL O O
Ratio O O
5.4 O O
02/13/96 O O
18:00 O O
WBC O O
14.4H O O
4.5-11.0 O O
th/cmm O O
04/11/96 O O
12:41 O O
14.4(H) O O
04/11/96 O O
12:41 O O
RBC O O
4.50 O O
4.00-5.20 O O
mil/cm O O
04/11/96 O O
12:41 O O
3.80(L) O O
04/01/93 O O
07:40 O O
Hgb O O
13.6 O O
12.0-16.0 O O
gm/dl O O
04/11/96 O O
12:41 O O
11.5(L) O O
04/01/93 O O
07:40 O O
HCT O O
38.4 O O
36.0-46.0 O O
% O O
04/11/96 O O
12:41 O O
35.9(L) O O
10/06/94 O O
12:10 O O
MCV O O
85 O O
80-100 O O
fl O O
04/11/96 O O
12:41 O O
85(L) O O
07/28/88 O O
23:03 O O
MCH O O
30.1 O O
26.0-34.0 O O
pg/rbc O O
04/11/96 O O
12:41 O O
MCHC O O
35.3 O O
31.0-37.0 O O
g/dl O O
04/11/96 O O
12:41 O O
PLT O O
440H O O
150-350 O O
th/cumm O O
04/11/96 O O
12:41 O O
440(H) O O
04/11/96 O O
12:41 O O
RDW O O
14.1 O O
11.5-14.5 O O
% O O
04/11/96 O O
12:41 O O
16.1(H) O O
10/06/94 O O
12:10 O O
Blood O O
Differential O O
% O O
Differential O O
... O O
RECEIVED O O
04/11/96 O O
12:36 O O
Diff O O
Method O O
Auto O O
04/11/96 O O
12:41 O O
Neutrophils O O
79H O O
40-70 O O
% O O
04/11/96 O O
12:41 O O
79(H) O O
04/11/96 O O
12:41 O O
Lymphs O O
15L O O
22-44 O O
% O O
04/11/96 O O
12:41 O O
15(L) O O
04/11/96 O O
12:41 O O
Monos O O
2L O O
4-11 O O
% O O
04/11/96 O O
12:41 O O
2(L) O O
04/11/96 O O
12:41 O O
Eos O O
3 O O
0-8 O O
% O O
04/11/96 O O
12:41 O O
Basos O O
1 O O
0-3 O O
% O O
04/11/96 O O
12:41 O O
Blood O O
Diff O O
- O O
Absolute O O
Neutrophil O O
11.44H O O
1.8-7.7 O O
th/cmm O O
04/11/96 O O
12:41 O O
11.44(H) O O
04/11/96 O O
12:41 O O
Lymph# O O
2.07 O O
1.0-4.8 O O
th/cmm O O
04/11/96 O O
12:41 O O
Mono# O O
0.33 O O
0.2-0.4 O O
th/cmm O O
04/11/96 O O
12:41 O O
Eos# O O
0.45H O O
0.1-0.3 O O
th/cmm O O
04/11/96 O O
12:41 O O
0.45(H) O O
04/11/96 O O
12:41 O O
Baso# O O
0.08 O O
0.0-0.3 O O
th/cmm O O
04/11/96 O O
12:41 O O
Anisocytosis O O
None O O
NORMAL O O
04/11/96 O O
12:41 O O
Hypochromia O O
None O O
NORMAL O O
04/11/96 O O
12:41 O O
Macrocytes O O
None O O
04/11/96 O O
12:41 O O
Microcytes O O
None O O
04/11/96 O O
12:41 O O
PT O O
12.6 O O
11.3-13.3 O O
sec O O
04/11/96 O O
12:54 O O
PTT O O
20.2L O O
22.1-35.1 O O
sec O O
04/11/96 O O
12:54 O O
20.2(L) O O
04/11/96 O O
12:54 O O
D-Dimer O O
(ng/mL) O O
783H O O
&lt;500 O O
ng/ml O O
04/11/96 O O
13:28 O O
783(H) O O
04/11/96 O O
13:28 O O
GLUC O O
- O O
UA O O
NEGATIVE O O
NEG O O
04/11/96 O O
17:17 O O
Bilirubin O O
NEGATIVE O O
NEG O O
11/03/93 O O
17:16 O O
Ketones O O
1+ O O
NEG O O
04/11/96 O O
17:17 O O
Specific O O
Gravity O O
1.015 O O
1.001-1.035 O O
04/11/96 O O
17:17 O O
Blood O O
- O O
UA O O
NEGATIVE O O
NEG O O
04/11/96 O O
17:17 O O
pH O O
5.0 O O
5.0-9.0 O O
04/11/96 O O
17:17 O O
Protein O O
- O O
UA O O
NEGATIVE O O
NEG O O
04/11/96 O O
17:17 O O
Urobilinogen O O
NEGATIVE O O
NEG O O
11/03/93 O O
17:16 O O
Nitrites O O
NEGATIVE O O
NEG O O
04/11/96 O O
17:17 O O
WBC O O
Screen O O
NEGATIVE O O
NEG O O
04/11/96 O O
17:17 O O
Phenytoin O O
- O O
TDM O O
PEND O O
5.0-20.0 O O
mcg/ml O O
04/11/96 O O
15:30 O O
4.0(L) O O
09/27/95 O O
18:17 O O
RADIOLOGY O O
Chest O O
CT: O O
4/11/96 O O
No O O
gross O O
filling O O
defect O O
is O O
noted O O
in O O
the O O
pulmonary O O
arteries O O
to O O
suggest O O
pulmonary O O
embolism. O O
There O O
are O O
several O O
mediastinal O O
lymph O O
nodes O O
measuring O O
slightly O O
less O O
than O O
1 O O
cm O O
in O O
size. O O
However, O O
in O O
the O O
region O O
of O O
the O O
AP O O
window O O
there O O
are O O
numerous O O
AP O O
window O O
lymph O O
nodes O O
measuring O O
approximately O O
9 O O
mm O O
in O O
short O O
axis. O O
These O O
could O O
be O O
reactive O O
or O O
neoplastic. O O
There O O
is O O
a O O
less O O
than O O
1 O O
cm O O
left O O
hilar O O
node. O O
In O O
the O O
posterior O O
left O O
lower O O
lobe O O
there O O
is O O
a O O
6 O O
mm O O
parenchymal O O
nodule. O O
This O O
is O O
best O O
demonstrated O O
on O O
image O O
65. O O
This O O
could O O
possibly O O
represent O O
a O O
malignancy. O O
Alternatively O O
this O O
could O O
represent O O
an O O
intraparenchymal O O
lymph O O
node. O O
This O O
does O O
not O O
appear O O
to O O
touch O O
the O O
pleural O O
surface O O
and O O
rounded O O
atelectasis O O
would O O
seem O O
less O O
likely. O O
Some O O
scarring O O
and O O
volume O O
loss O O
is O O
noted O O
in O O
the O O
medial O O
right O O
lung O O
base. O O
There O O
is O O
no O O
pneumothorax. O O
No O O
significant O O
pleural O O
fluid O O
is O O
noted. O O
There O O
is O O
no O O
pericardial O O
fluid. O O
IMPRESSION: O O
No O O
pulmonary O O
embolism O O
or O O
DVT. O O
There O O
are O O
multiple O O
mediastinal O O
lymph O O
nodes O O
as O O
well O O
as O O
a O O
6 O O
mm O O
nodule O O
in O O
the O O
left O O
lower O O
lobe. O O
Neoplasm O O
cannot O O
be O O
excluded. O O
A O O
follow-up O O
chest O O
CT O O
may O O
be O O
further O O
value. O O
These O O
findings O O
were O O
discussed O O
with O O
Dr. O O
Hendricks O O
at O O
the O O
time O O
of O O
dictation. O O
EKG: O O
NSR, O O
compared O O
to O O
prior O O
there O O
is O O
new O O
flipped O O
T O O
wave O O
in O O
III, O O
however O O
no O O
ST/T O O
wave O O
abnormalities, O O
no O O
evidence O O
of O O
infarction. O O
A/P: O O
Pt O O
is O O
a O O
69 O O
yo O O
F O O
with O O
PMH O O
notable O O
for O O
DM, O O
HTN, O O
peripheral O O
neuropathy O O
and O O
s/p O O
MI O O
with O O
multiple O O
admissions O O
for O O
rule O O
out, O O
who O O
presents O O
with O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
nightsweats, O O
dizziness, O O
and O O
new O O
mediastinal O O
lymphadenopathy O O
with O O
a O O
lung O O
nodule O O
not O O
noted O O
on O O
prior O O
chest O O
X-rays. O O
This O O
constellation O O
of O O
symptoms O O
may O O
be O O
viewed O O
in O O
several O O
different O O
ways: O O
from O O
a O O
cardiac O O
standpoint, O O
as O O
presentation O O
of O O
unstable B-CAD O
angina, I-CAD O
given O O
her O O
hx O O
of O O
MI O O
and O O
cardiac O O
risk O O
factors; O O
from O O
an O O
oncological O O
standpoint, O O
as O O
a O O
pheochromocytoma O O
or O O
carcinoid O O
syndrome, O O
given O O
the O O
sympathomimetic O O
nature O O
of O O
her O O
symptoms O O
such O O
as O O
dizziness, O O
abd O O
pain/nausea, O O
chest O O
pain O O
and O O
dyspnea, O O
and O O
the O O
findings O O
in O O
Ab O O
CT O O
and O O
Chest O O
CT, O O
or O O
a O O
primary O O
lung O O
cancer O O
given O O
her O O
history O O
of O O
smoking; O O
from O O
an O O
infectious O O
disease O O
standpoint, O O
as O O
possible O O
reactivation O O
tuberculosis, O O
given O O
that O O
she O O
has O O
a O O
history O O
of O O
TB O O
infection O O
and O O
treatment. O O
I O O
believe O O
the O O
priority O O
of O O
the O O
differential O O
should O O
be O O
granted O O
to O O
the O O
oncologic O O
and O O
infectious O O
etiologies, O O
given O O
that O O
she O O
appears O O
to O O
be O O
ruling O O
out O O
for O O
an O O
MI, O O
has O O
little O O
to O O
no O O
ischemic O O
changes O O
on O O
EKG, O O
and O O
is O O
chest O O
pain O O
free O O
with O O
continued O O
exacerbation O O
of O O
her O O
shortness O O
of O O
breath O O
and O O
sweating. O O
Workup O O
should O O
proceed O O
in O O
the O O
direction O O
of O O
ruling O O
out O O
TB, O O
and O O
establishing O O
the O O
nature O O
of O O
the O O
pulmonary O O
nodule O O
and O O
mediastinal O O
lymphadenopathy. O O
CV: O O
--Rate: O O
well O O
controlled O O
without O O
medication. O O
--Rhythm: O O
normal O O
sinus O O
--Pump: O O
On O O
ACEI, O O
HCTZ O O
for O O
HTN. O O
--ischemia: O O
on O O
ASA/statin. O O
Rule O O
out O O
for O O
MI O O
with O O
CMs O O
x O O
3. O O
Will O O
obtain O O
stress O O
test O O
in O O
AM. O O
PULM: O O
--plant O O
PPD O O
--send O O
sputum O O
cultures, O O
consider O O
adding O O
AFB. O O
--send O O
ANCA O O
--follow O O
up O O
CT O O
for O O
nodule O O
--nebs/O2 O O
therapy O O
to O O
support O O
breathing O O
ENDO: O O
--urine O O
metanephrines O O
for O O
pheo O O
--5HIAA O O
metabolites O O
for O O
carcinoid O O
--TSH O O
--AB-CT O O
for O O
evolution O O
of O O
adenoma O O
--holding B-MEDICATION O
metformin, I-MEDICATION B-MEDICATION
will O O
control O O
with O O
SSIR. O O
Prophy O O
--Nexium O O
--holding O O
on O O
fragmin O O
for O O
now-low O O
threshold O O
to O O
resume O O
for O O
DVT O O
prophy O O
given O O
possible O O
oncologic O O
diagnosis. O O

Record O O
date: O O
2095-02-06 O O
PATIENT O O
NAME: O O
MEYER, O O
OSCAR; O O
MRN: O O
2771447 O O
Dictated O O
on: O O
02/06/2095 O O
by O O
VICTOR O O
M. O O
ZUBIA, O O
M.D. O O
Oncology O O
CONSULTATION O O
NOTE: O O
DATE O O
OF O O
CONSULTATION: O O
DIAGNOSIS: O O
T2b, O O
NX, O O
M0 O O
Gleason O O
4+3=7 O O
adenocarcinoma O O
of O O
the O O
prostate. O O
HISTORY: O O
Mr. O O
Meyar O O
is O O
a O O
delightful O O
patient O O
referred O O
to O O
me O O
by O O
Dr. O O
Osiel O O
Mckee. O O
His O O
PSA O O
in O O
2093 O O
was O O
3.8, O O
early O O
this O O
year O O
6.3, O O
and O O
on O O
repeat O O
7.1. O O
Abnormality O O
was O O
noted O O
on O O
digital O O
rectal O O
exam. O O
He O O
has O O
very O O
little O O
in O O
the O O
way O O
of O O
voiding O O
symptoms O O
with O O
a O O
good O O
stream, O O
no O O
dribbling, O O
nor O O
any O O
frequency. O O
He O O
does O O
still O O
have O O
his O O
erections, O O
though O O
they O O
are O O
not O O
as O O
good O O
as O O
they O O
used O O
to O O
be. O O
The O O
erections O O
are O O
still O O
an O O
important O O
issue O O
with O O
him. O O
Dr. O O
Mckee O O
performed O O
a O O
transrectal O O
ultrasound O O
that O O
showed O O
a O O
13 O O
cc O O
prostate. O O
He O O
took O O
12 O O
biopsy O O
cores O O
and O O
all O O
12 O O
demonstrated O O
prostate O O
cancer. O O
In O O
4 O O
it O O
was O O
Gleason O O
6 O O
and O O
in O O
the O O
remainder O O
Gleason O O
7. O O
Many O O
cores O O
had O O
a O O
predominant O O
Gleason O O
4 O O
pattern. O O
Many O O
of O O
the O O
cores O O
were O O
heavily O O
involved O O
with O O
40% O O
involvement O O
or O O
more. O O
Mr. O O
Mercado O O
has O O
a O O
CT O O
scan O O
and O O
a O O
pelvic O O
MRI O O
scheduled O O
for O O
next O O
week. O O
PAST O O
MEDICAL O O
HISTORY: O O
1. O O
Diabetes. B-DIABETES O
2. O O
Nephrolithiasis O O
status O O
post O O
lithotripsy. O O
3. O O
Tonsillectomy. O O
4. O O
Right O O
inguinal O O
hernia O O
repair. O O
5. O O
Inflammatory O O
bowel O O
disease. O O
CURRENT O O
MEDICATIONS: O O
Glipizide, B-MEDICATION B-MEDICATION
metformin, B-MEDICATION B-MEDICATION
and O O
Avandia. B-MEDICATION O
DRUG O O
ALLERGIES: O O
None O O
known. O O
SOCIAL O O
HISTORY: O O
His O O
father O O
was O O
diagnosed O O
with O O
prostate O O
cancer O O
in O O
his O O
late O O
70s, O O
but O O
he O O
did O O
not O O
die O O
from O O
his O O
disease. O O
SOCIAL O O
HISTORY: O O
He O O
works O O
as O O
a O O
Web O O
Developer O O
in O O
Audiovox. O O
He O O
is O O
married O O
and O O
came O O
with O O
his O O
wife O O
to O O
the O O
appointment O O
today. O O
He O O
has O O
no O O
children. O O
He O O
is O O
a O O
former B-SMOKER O
smoker I-SMOKER O
and O O
occasional O O
drinker. O O
PHYSICAL O O
EXAM: O O
No O O
anemia, O O
jaundice, O O
cyanosis, O O
or O O
clubbing O O
No O O
gynecomastia O O
Respiration O O
comfortable O O
No O O
neurologic O O
abnormalities O O
in O O
the O O
arms O O
or O O
legs O O
No O O
skeletal O O
deformity O O
or O O
tenderness O O
Head, O O
eyes, O O
ears, O O
and O O
nose O O
normal O O
Abdomen O O
soft O O
with O O
no O O
hepatomegaly, O O
splenomegaly, O O
nor O O
any O O
additional O O
masses. O O
No O O
hernias. O O
Normal O O
penis, O O
scrotum, O O
and O O
testes. O O
Rectum: O O
no O O
mural O O
lesion. O O
Stool O O
guaiac O O
negative O O
Prostate O O
is O O
small. O O
The O O
entire O O
right O O
side O O
of O O
his O O
gland O O
is O O
taken O O
up O O
with O O
tumor. O O
IMPRESSION O O
AND O O
PLAN: O O
Mr. O O
Meyer O O
is O O
a O O
young O O
man O O
with O O
a O O
significant O O
and O O
quite O O
bulky O O
prostate O O
cancer. O O
I O O
certainly O O
do O O
not O O
think O O
active O O
surveillance O O
is O O
an O O
option O O
for O O
him, O O
which O O
is O O
a O O
shame, O O
as O O
that O O
was O O
his O O
preference. O O
Left O O
untreated, O O
I O O
think O O
he O O
will O O
be O O
in O O
deep O O
trouble O O
at O O
some O O
stage O O
over O O
the O O
next O O
few O O
years. O O
His O O
second O O
choice O O
for O O
treatment O O
is O O
prostate O O
brachytherapy O O
but O O
again O O
I O O
believe O O
his O O
disease O O
is O O
too O O
extensive O O
for O O
this O O
and O O
brachytherapy O O
would O O
represent O O
significant O O
under O O
treatment. O O
On O O
balance, O O
my O O
preference O O
for O O
him O O
is O O
either O O
to O O
have O O
a O O
radical O O
prostatectomy, O O
perhaps O O
followed O O
by O O
postoperative O O
radiation O O
or O O
alternatively, O O
if O O
he O O
wishes O O
to O O
avoid O O
surgery O O
and O O
he O O
does, O O
for O O
him O O
to O O
have O O
high-dose O O
external O O
radiation O O
in O O
conjunction O O
with O O
neoadjuvant O O
and O O
concomitant O O
androgen O O
deprivation. O O
While O O
I O O
think O O
he O O
will O O
recover O O
good O O
voiding O O
function O O
after O O
either O O
of O O
these O O
treatment O O
combinations O O
his O O
sex O O
life O O
is O O
under O O
threat O O
and O O
he O O
is O O
aware O O
of O O
this. O O
We O O
will O O
defer O O
the O O
final O O
decision O O
next O O
week O O
until O O
he O O
has O O
had O O
his O O
scans. O O
Obviously, O O
should O O
they O O
show O O
extensive O O
extracapsular O O
disease O O
then O O
surgery O O
will O O
be O O
off O O
the O O
table, O O
if O O
they O O
show O O
nodal O O
disease O O
the O O
same O O
is O O
true O O
and O O
we O O
will O O
be O O
thinking O O
in O O
terms O O
of O O
long-term O O
androgen O O
deprivation. O O
Hopefully O O
neither O O
of O O
these O O
scenarios O O
will O O
occur. O O
Victor O O
M. O O
Zubia, O O
M.D. O O
cc: O O
Osiel O O
U. O O
Mckee, O O
M.D. O O
Urology, O O
Shelby O O
Community O O
Hospital O O
Oscar O O
Nagel, O O
M.D. O O
1502 O O
Maple O O
Street O O
rm O O
929 O O
Kalaheo, O O
AL O O
VZ/78916 O O
HT/148-8151 O O
D: O O
02/06/2095 O O
T: O O
02/07/2095 O O

Record B-SMOKER O
date: O O
2095-08-06 O O
Oncology O O
COMPLETION O O
NOTE O O
Patient: O O
Oscar O O
Meyer O O
#277-14-47 O O
RADIATION O O
ONCOLOGIST: O O
VICTOR O O
M. O O
ZUBIA, O O
MD O O
DATES O O
OF O O
RADIATION: O O
5/27/95 O O
- O O
7/24/95 O O
(58 O O
elapsed O O
days) O O
DIAGNOSIS: O O
Prostate O O
adenocarcinoma O O
T2B O O
Nx, O O
Gleason O O
4+3 O O
= O O
7, O O
PSA O O
7.1 O O
CONCISE O O
HISTORY: O O
Mr. O O
Meyer O O
is O O
a O O
63 O O
year O O
old O O
man O O
who O O
was O O
found O O
to O O
have O O
an O O
elevated O O
PSA O O
of O O
7.1 O O
on O O
screening O O
exam. O O
An O O
abnormality O O
was O O
also O O
noted O O
on O O
DRE O O
at O O
that O O
time. O O
Prostate O O
biopsy O O
was O O
performed, O O
and O O
all O O
12 O O
cores O O
were O O
positive O O
for O O
disease, O O
including O O
8 O O
cores O O
with O O
Gleason O O
7 O O
disease. O O
Prostatic O O
MRI O O
showed O O
no O O
evidence O O
of O O
extracapsular O O
extension. O O
CT O O
of O O
the O O
abdomen O O
and O O
bone O O
scan O O
revealed O O
no O O
evidence O O
of O O
metastatic O O
disease. O O
He O O
was O O
treated O O
with O O
definitive O O
radiation O O
to O O
the O O
prostate O O
and O O
seminal O O
vesicles O O
by O O
IMRT, O O
with O O
concomitant O O
Zoladex O O
treatment. O O
SPECIAL O O
TECHNICAL O O
CONSIDERATIONS: O O
The O O
patient O O
underwent O O
CT-based O O
imaging O O
to O O
define O O
the O O
target O O
volume O O
and O O
the O O
normal O O
tissue O O
structures O O
and O O
3D O O
treatment O O
planning O O
was O O
performed O O
for O O
treatment O O
with O O
IMRT. O O
Daily O O
localization O O
of O O
the O O
prostate O O
was O O
done O O
using O O
the O O
BAT O O
ultrasound. O O
SUMMARY O O
OF O O
RADIATION O O
AND O O
TREATMENT O O
ADMINISTERED: O O
The O O
treatment O O
site O O
was O O
the O O
prostate O O
gland O O
plus O O
the O O
caudal O O
seminal O O
vesicles O O
followed O O
by O O
a O O
boost O O
to O O
the O O
prostate O O
alone. O O
The O O
patient O O
underwent O O
external O O
beam O O
radiotherapy O O
to O O
the O O
prostate O O
and O O
caudal O O
seminal O O
vesicles O O
to O O
a O O
dose O O
of O O
45 O O
Gy O O
given O O
as O O
25 O O
fractions O O
of O O
1.8 O O
Gy/day. O O
He O O
then O O
underwent O O
a O O
boost O O
to O O
the O O
prostate O O
only O O
of O O
34. O O
Gy O O
given O O
in O O
17 O O
fractions O O
of O O
2 O O
Gy/day O O
for O O
a O O
total O O
dose O O
of O O
79 O O
Gy. O O
CLINICAL O O
COURSE: O O
The O O
patient O O
developed O O
mild O O
nocturia O O
and O O
more O O
frequent O O
bowel O O
movements, O O
for O O
which O O
he O O
took O O
Flomax O O
and O O
Metamucil. O O
Mr. O O
Meyer O O
has O O
tolerated O O
his O O
androgen O O
deprivation O O
therapy O O
well. O O
FOLLOW-UP: O O
Mr. O O
Meyer O O
will O O
follow O O
up O O
with O O
us O O
in O O
3 O O
months O O
with O O
a O O
PSA O O
in O O
advance. O O
Ulysses O O
Imler, O O
MD O O
(Resident) O O
Victor O O
Zubia, O O
MD O O
(Attending) O O
cc: O O

Record O O
date: O O
2095-12-02 O O
SECTIONS O O
OF O O
THIS O O
NOTE O O
WERE O O
CREATED O O
WITH O O
A O O
'COPY O O
AND O O
PASTE' O O
ACTION. O O
THESE O O
SECTIONS O O
MAY O O
NOT O O
HAVE O O
COPIED O O
COMPLETELY. O O
PLEASE O O
USE O O
CAUTION O O
WHEN O O
RENDERING O O
CLINICAL O O
JUDGMENT O O
BASED O O
ON O O
THE O O
INFORMATION O O
IN O O
THIS O O
NOTE. O O
SDU O O
JAR O O
Admission O O
Note O O
Patient: O O
Meyer, O O
Oscar O O
MRN: O O
2771447 O O
Admission O O
Date: O O
12/2/2095 O O
JAR: O O
Dr. O O
Patricia O O
Whittaker O O
Attending: O O
Dr. O O
Jolley O O
Source: O O
Patient, O O
records O O
ID/CC: O O
64yoM O O
with O O
type B-DIABETES O
II I-DIABETES O
DM B-DIABETES O
and O O
HL B-HYPERLIPIDEMIA O
p/w O O
exertional B-CAD O
SSCP, I-CAD O
found O O
to O O
have O O
lateral O O
precordial/apical O O
STDs O O
HPI: O O
Oscar O O
Meyer O O
is O O
a O O
64yoM O O
with O O
type O O
II O O
DM O O
and O O
HL O O
who O O
has O O
been O O
having O O
exertional, O O
non-radiating, B-CAD O
SSCP I-CAD O
with O O
activities O O
such O O
as O O
shoveling O O
snow O O
and O O
taking O O
out O O
the O O
trash O O
over O O
the O O
past O O
several O O
months, O O
increasing O O
in O O
frequency. O O
He O O
endorses O O
6 O O
episodes O O
over O O
the O O
last O O
week, O O
the O O
most O O
recent O O
yesterday O O
morning O O
when O O
he O O
was O O
shoveling. O O
The O O
pain O O
always O O
resolves O O
after O O
4-5 O O
min O O
of O O
rest O O
and O O
deep O O
breathing. O O
He O O
denies O O
n/v, O O
palps, O O
LH, O O
and O O
SOB O O
but O O
does O O
have O O
diaphoresis O O
at O O
times. O O
He O O
presented O O
to O O
the O O
SCH O O
ED O O
for O O
evaluation O O
today. O O
OSH O O
course: O O
The O O
patient O O
was O O
hypertensive O O
(max B-HYPERTENSION O
BP B-HYPERTENSION O
200/89); I-HYPERTENSION O
he O O
received O O
Lopressor B-MEDICATION B-MEDICATION
5 O O
mg O O
IV O O
x O O
2, O O
resulting O O
in O O
BP B-HYPERTENSION O
170/90; I-HYPERTENSION B-MEDICATION
an O O
additional O O
5-mg O O
dose O O
resulted O O
in O O
BP B-HYPERTENSION O
160/87 I-HYPERTENSION O
(later, O O
146/79 O O
just O O
prior O O
to O O
transfer). O O
EKG O O
showed O O
small O O
0.5-1 O O
mm O O
STDs O O
in O O
V4-6. O O
Initial O O
TnI O O
was O O
1.00 O O
(CK/MB O O
wnl). O O
He O O
received O O
ASA B-MEDICATION B-MEDICATION
325, O O
Nitropaste B-MEDICATION B-MEDICATION
1/2&#8221; O O
(despite O O
the O O
fact O O
that O O
he O O
takes O O
Viagra O O
at O O
home), O O
A O O
heparin O O
gtt O O
was O O
started O O
(with O O
bolus), O O
and O O
the O O
patient O O
was O O
transferred O O
to O O
WPH O O
in O O
anticipation O O
of O O
cardiac O O
cath. O O
Past O O
Medical/Surgical O O
History O O
Diabetes O O
mellitus O O
type O O
2: O O
gets O O
yearly O O
eye O O
checks O O
and O O
was O O
recently O O
told O O
he O O
needs O O
laser O O
surgery. O O
HbA1c B-DIABETES O
11.0 I-DIABETES O
at I-DIABETES O
SCH I-DIABETES O
today. I-DIABETES O
HL: O O
Not O O
on O O
meds O O
Actinic O O
keratosis O O
: O O
, O O
right O O
hand O O
Squamous O O
cell O O
carcinoma O O
in O O
situ O O
: O O
and O O
, O O
dorsum, O O
left O O
hand, O O
CE&amp;D O O
Hypertrophic O O
callus O O
: O O
, O O
right O O
fifth O O
metatarsal, O O
painful,pared O O
Prostate O O
CA: O O
dx O O
July O O
2095, O O
primary O O
treatment O O
radiation O O
therapy O O
42 O O
fragments. O O
Anxiety: O O
occasional O O
panic O O
attacks O O
H/o O O
positive O O
: O O
2064, O O
s/p O O
INH O O
x O O
3-6 O O
mo O O
at O O
that O O
time O O
H/o O O
Barrett&#8217;s O O
esophagus O O
and O O
GERD O O
Home O O
meds: O O
1. O O
Alprazolam O O
(Xanax) O O
0.25 O O
MG O O
as O O
directed O O
prn O O
anxiety O O
2. O O
Glipizide B-MEDICATION B-MEDICATION
5 O O
MG O O
3. O O
Metformin B-MEDICATION B-MEDICATION
500 O O
MG O O
4. O O
Pimecrolimus O O
(Elidel) O O
1% O O
TOP O O
5. O O
Sildenafil O O
(Viagra) O O
50 O O
MG O O
prn O O
(last O O
dose O O
11/29 O O
p.m.) O O
6. O O
Zolpidem O O
Tartrate O O
(Ambien) O O
5-10 O O
mg O O
QHS O O
7. O O
Maalox O O
prn O O
heartburn O O
Allergies/adverse O O
drug O O
reactions: O O
NKDA O O
FH: O O
Father O O
had O O
a O O
stroke O O
at O O
80 O O
and O O
died O O
of O O
?another O O
stroke O O
at O O
age O O
83. O O
Mother O O
died O O
of O O
colon O O
CA O O
at O O
76. O O
Twin O O
sister O O
A&amp;W. O O
SH: O O
Lives O O
with O O
wife; O O
no O O
children. O O
Works O O
in O O
programming O O
at O O
Audiovox. O O
Formerly O O
at O O
BrightPoint. O O
Cigs: B-SMOKER O
1 I-SMOKER O
ppd I-SMOKER O
x I-SMOKER O
20 I-SMOKER O
yr; I-SMOKER O
quit B-SMOKER O
at I-SMOKER O
age I-SMOKER O
38. I-SMOKER O
EtOH: O O
About O O
1 O O
beer/wk. O O
Illicits: O O
Denies O O
ROS O O
Negative O O
except O O
as O O
per O O
HPI. O O
Denies O O
BRBPR/melena, O O
dysuria/hematuria, O O
HA. O O
Exam: O O
VS: O O
Temp O O
97.8F O O
TA O O
HR O O
66 O O
(SR) O O
BP B-HYPERTENSION O
175/98 I-HYPERTENSION O
RR O O
18 O O
O2sat O O
98% O O
2L O O
NC O O
Gen: O O
Pleasant O O
man, O O
lying O O
in O O
bed O O
in O O
NAD. O O
HEENT: O O
NCAT. O O
Oral O O
MMs O O
moist, O O
w/o O O
lesions. O O
OP O O
clear, O O
w/o O O
exudate. O O
Neck: O O
No O O
JVD. O O
Carotid O O
upstrokes O O
2+ O O
w/o O O
bruits. O O
CV: O O
no O O
MRG. O O
Lungs: O O
CTAB. O O
Abd: O O
Soft, O O
NTND, O O
+BS. O O
Ext: O O
WWP; O O
no O O
edema. O O
DPs/PTs O O
2+ O O
bilaterally. O O
Neuro: O O
AOx3; O O
normal O O
affect O O
and O O
tone. O O
Grossly O O
nonfocal. O O
Data: O O
Plasma O O
Sodium O O
141 O O
(135-145) O O
Plasma O O
Potassium O O
2.8 O O
L O O
(3.4-4.8) O O
Plasma O O
Chloride O O
104 O O
(100-108) O O
Plasma O O
Carbon O O
Dioxide O O
25.6 O O
(23.0-31.9) O O
Calcium O O
9.0 O O
(8.5-10.5) O O
mg/dl O O
Phosphorus O O
3.9 O O
(2.6-4.5) O O
mg/dl O O
Magnesium O O
1.6 O O
(1.4-2.0) O O
meq/L O O
Plasma O O
Urea O O
Nitrogen O O
16 O O
(8-25) O O
mg/dl O O
Plasma O O
Creatinine O O
1.1 O O
(0.6-1.5) O O
mg/dl O O
Plasma O O
Glucose O O
308 O O
H O O
(70-110) O O
mg/dl O O
TOTAL O O
PROTEIN, O O
SERUM O O
6.7 O O
(6.4-8.3) O O
G/DL O O
ALBUMIN O O
4.1 O O
(3.4-4.8) O O
G/DL O O
AST/SGOT O O
21 O O
(6-40) O O
U/L O O
PHOS O O
74 O O
(27-110) O O
U/L O O
/SGPT O O
26 O O
(10-40) O O
U/L O O
TOTAL O O
BILIRUBIN O O
0.3 O O
(0.3-1.2) O O
MG/DL O O
FASTING O O
(LIPIP) O O
NONFASTING O O
* O O
CHOLESTEROL, O O
SERUM O O
220 O O
H O O
(140-200) O O
MG/DL O O
TRIGLYCERIDE O O
247 O O
H O O
(&lt; O O
150) O O
MG/DL O O
CHOLESTEROL O O
37 O O
L O O
(&gt;40) O O
MG/DL O O
CHOLESTEROL O O
134 O O
H O O
(&lt;130) O O
MG/DL O O
1st O O
set O O
biomarkers O O
(SCH): O O
CK O O
156, O O
MB O O
3.8, O O
TnI O O
1&#224;0.93 O O
(Tns O O
&lt; O O
3 O O
hr O O
apart) O O
2nd O O
set O O
biomarkers O O
(WPH): O O
Creatine O O
Kinase O O
Isoenzymes O O
5.4 O O
(0.0-6.9) O O
ng/ml O O
Isoenzymes O O
Index O O
5.4 O O
H O O
(0.0-3.5) O O
% O O
Troponin-T O O
0.38 O O
H O O
(0.00-0.09) O O
ng/ml O O
Creatine O O
Kinase O O
100 O O
(60-400) O O
U/L O O
U/A O O
(SCH): O O
glucose O O
present, O O
but O O
otherwise O O
neg O O
WBC O O
8.6 O O
(4.5-11.0) O O
Hct O O
37.0 O O
L O O
(41.0-53.0) O O
% O O
HGB O O
12.9 O O
L O O
(13.5-17.5) O O
gm/dl O O
Plt O O
350 O O
(150-350) O O
MCV O O
86 O O
(80-100) O O
fl O O
RDW O O
12.6 O O
(11.5-14.5) O O
% O O
PT O O
13.2 O O
(10.3-13.2) O O
sec O O
PT-INR O O
1.2 O O
APTT O O
56.0 O O
H O O
(22.1-34.0) O O
sec O O
EKG O O
(floor O O
arrival): O O
NSR O O
at O O
69 O O
bpm. O O
QT~440 O O
ms; O O
QTc~470 O O
ms. O O
0.5-1 O O
mm O O
STDs O O
in O O
V4-6 O O
and O O
TWF O O
in O O
aVF. O O
CXR O O
(SCH): O O
No O O
acute O O
cardiopulmonary O O
abnormality. O O
Assessment: O O
64yoM O O
with O O
multiple O O
cardiac O O
risk O O
factors O O
p/w O O
NSTEMI. B-CAD O
Ischemia: O O
Plan O O
for O O
cath O O
in O O
a.m. O O
ASA, O B-MEDICATION
Lipitor, O B-MEDICATION
Lopressor, O B-MEDICATION
captopril, B-MEDICATION B-MEDICATION
heparin O O
gtt; O O
tolerate O O
up O O
ACEI/B-blocker O O
as O O
tolerated. O O
Note O O
that O O
patient O O
takes O O
Viagra O O
and O O
therefore O O
should O O
ideally O O
not O O
have O O
nitrates O O
for O O
CP, O O
although O O
he O O
did O O
tolerate O O
Nitropaste O O
at O O
SCH; O O
note O O
that O O
last O O
dose O O
of O O
Viagra O O
was O O
Thursday, O O
11/29. O O
Serial O O
EKGs O O
and O O
telemetry. O O
Will O O
defer O O
initiation O O
of O O
Integrilin O O
until O O
cath O O
lab, O O
as O O
there O O
is O O
no O O
clear O O
benefit O O
to O O
starting O O
now. O O
Need O O
to O O
check O O
fasting O O
lipids. O O
Prolonged O O
QTc: O O
Etiology O O
unclear, O O
and O O
no O O
prior O O
EKGs O O
for O O
comparison. O O
Will O O
replete O O
lytes O O
for O O
goal O O
Mg=2, O O
K=4. O O
Pump: O O
No O O
ssx O O
of O O
CHF. O O
Will O O
obtain O O
post-cath O O
TTE O O
to O O
assess O O
for O O
WMAs. O O
DM: O O
Holding O O
orals O O
while O O
in O O
house. O O
IVF O O
with O O
D5 O O
while O O
npo; O O
cover O O
FSBGs O O
with O O
RISS. O O
Will O O
give O O
Mucomyst O O
and O O
IVF O O
for O O
nephroprotection O O
with O O
cath. O O
Ppx: O O
Heparin. O O
Patricia O O
Whittaker, O O
M.D. O O
PGY-2, O O
Internal O O
Medicine O O
#63765 O O

Record O O
date: O O
2096-03-16 O O
CARDIOLOGY O O
WESTBROOK O O
PLAINS O O
HOSPITAL O O
Reason O O
for O O
visit: O O
s/p O O
cath O O
Interval O O
History: O O
Per O O
HPI O O
J. O O
Jordan O O
Duran: O O
64 O O
y.o. O O
male O O
with O O
known O O
CAD. B-CAD O
He O O
has O O
multiple O O
risk O O
factors O O
and O O
a O O
cardiac O O
history O O
dating O O
back O O
to O O
December O O
2095. O O
At O O
that O O
time O O
he O O
was O O
experiencing O O
exertional O O
chest O O
pressure O O
while O O
shoveling. O O
He O O
initially O O
attributed O O
his O O
symptoms O O
to O O
GERD; O O
however O O
the O O
chest O O
pressure O O
began O O
to O O
occur O O
post O O
prandially O O
and O O
nocturnally. O O
He O O
was O O
admitted O O
at O O
SCH O O
where O O
his O O
ECG O O
revealed O O
non-specific O O
ST O O
T O O
wave O O
abnormalities O O
and O O
he O O
had O O
negative O O
enzymes. O O
He O O
was O O
then O O
transferred O O
to O O
WPH O O
where O O
cardiac B-CAD O
catheterization I-CAD O
revealed I-CAD O
a I-CAD O
90% I-CAD O
LAD I-CAD O
lesion, I-CAD O
a I-CAD O
70% I-CAD O
OM1 I-CAD O
lesion, I-CAD O
a I-CAD O
70% I-CAD O
3rd I-CAD O
OM I-CAD O
and I-CAD O
an I-CAD O
85% I-CAD O
RCA. I-CAD O
His O O
ejection O O
fraction O O
at O O
that O O
time O O
was O O
40%. O O
He O O
was O O
referred O O
for O O
surgery. O O
He O O
underwent O O
a O O
successful O O
CABG B-CAD O
x I-CAD O
5 I-CAD O
with I-CAD O
a I-CAD O
LIMA I-CAD O
to I-CAD O
the I-CAD O
LAD, I-CAD O
a O O
sequential O O
SVG O O
to O O
the O O
Acute O O
Marginal O O
and O O
PDA, O O
and O O
a O O
sequential O O
SVG O O
to O O
the O O
1rst O O
Diagonal O O
and O O
OM1. O O
He O O
now O O
presents O O
with O O
recurrent O O
chest O O
burning. O O
He O O
states O O
that O O
it O O
is O O
similar O O
in O O
nature O O
to O O
his O O
symptoms O O
prior O O
to O O
CABG. O O
His O O
chest O O
burning O O
is O O
exertional O O
and O O
is O O
relieved O O
with O O
rest. O O
He O O
denies O O
dyspnea, O O
nausea, O O
vomiting, O O
dizziness O O
and O O
diaphoresis. O O
During O O
a O O
follow O O
up O O
appointment O O
at O O
SCH, O O
he O O
was O O
referred O O
for O O
a O O
stress O O
test. O O
Per O O
Bruce O O
Protocol O O
he O O
exercised O O
6 O O
minutes O O
and O O
0 O O
seconds. O O
He O O
states O O
that O O
his O O
chest O O
burning O O
symptoms O O
returned O O
and O O
were O O
lessened O O
with O O
SL O O
TNG, B-MEDICATION O
though O O
not O O
completely O O
resolved. O O
MIBI O O
images O O
reveal O O
severe O O
large O O
perfusion O O
defect O O
extending O O
from O O
the O O
septum O O
to O O
apex O O
with O O
reversibility. O O
There O O
is O O
also O O
a O O
fixed O O
basal O O
infero-lateral O O
territory O O
consistent O O
with O O
infarct. O O
His O O
ejection O O
fraction O O
is O O
46%. O O
He O O
was O O
admitted O O
for O O
cardiac B-CAD O
catheterization I-CAD O
done I-CAD O
today I-CAD O
with I-CAD O
full I-CAD O
report I-CAD O
pending. I-CAD O
Reportedly I-CAD O
RCA I-CAD O
diffuse, I-CAD O
SVG-PDA I-CAD O
patent, I-CAD O
SVg-Dx1-OM I-CAD O
patentw/ I-CAD O
mod. I-CAD O
ostial I-CAD O
stenosis, I-CAD O
LIMA-LAD I-CAD O
100%, I-CAD O
LM I-CAD O
mild, I-CAD O
LAD I-CAD O
severe I-CAD O
w/ I-CAD O
distal I-CAD O
100%, I-CAD O
LCx I-CAD O
OM I-CAD O
100%. I-CAD O
Plan I-CAD O
is I-CAD O
for I-CAD O
med I-CAD O
management. I-CAD O
On O O
admit O O
to O O
Internal O O
Medicine, O O
pt. O O
is O O
hemodynamically O O
stable, O O
groin O O
site O O
sealed, O O
stable O O
and O O
no O O
complaints. O O
Past O O
medical O O
history: O O
CAD- O O
as O O
described, O O
NIDDM, B-DIABETES O
GERD, O O
Hyperlipidemia, B-HYPERLIPIDEMIA B-MEDICATION
Nephrolithiasis, O O
Prostate O O
Cancer, O O
Anxiety, O O
Barrett's O O
Esophagus. O O
PSH:Right O O
Inguinal O O
hernia O O
repair, O O
tonsillectomy, O O
lithotripsy. O O
allergies: O O
Ambien O O
- O O
MS O O
changes,sleepwalking O O
meds O O
at O O
home: O O
ASA B-MEDICATION B-MEDICATION
325 O O
mg O O
po O O
qd O O
lisinopril B-MEDICATION B-MEDICATION
7.5 O O
mg O O
po O O
qd O O
atenolol B-MEDICATION B-MEDICATION
25 O O
mg O O
po O O
qd O O
- O O
pt. O O
never O O
increased O O
to O O
bid O O
from O O
last O O
visit O O
Glipizide B-MEDICATION B-MEDICATION
5 O O
mg O O
po O O
bid O O
Metformin B-MEDICATION B-MEDICATION
500 O O
mg O O
po O O
2 O O
in O O
am O O
1 O O
in O O
pm O O
- O O
pt. O O
admits O O
to O O
noncompliance O O
w/ O O
this O O
Prilosec O O
20 O O
mg O O
po O O
qd-inconsistantly O O
Lipitor B-MEDICATION B-MEDICATION
80 O O
mg O O
po O O
qd O O
Viagra O O
50 O O
mg O O
po O O
prn-none O O
in O O
last O O
month O O
Family O O
history: O O
F O O
deceased O O
with O O
CVA O O
at O O
83; O O
M O O
deceased O O
with O O
colon O O
CA O O
at O O
76; O O
1 O O
B O O
at O O
63, O O
1 O O
S O O
at O O
62 O O
and O O
1 O O
twin O O
S O O
without O O
CAD. O O
Social O O
history: O O
Married, O O
no O O
children, O O
works O O
as O O
a O O
web O O
programmer O O
at O O
Audiovox. O O
Tobacco: B-SMOKER O
Quit I-SMOKER O
at I-SMOKER O
38 I-SMOKER O
y/o; O O
ETOH: O O
1-2 O O
beers/week; O O
Caffeine: O O
2 O O
cups/day; O O
Exercise: O O
bikes O O
and O O
walks O O
2-3 O O
times O O
a O O
week; O O
Recreational O O
Drugs: O O
Viagra O O
- O O
none O O
in O O
one O O
month. O O
Review O O
of O O
systems: O O
see O O
interval O O
history O O
Physical O O
examination: O O
-temp: O O
afebrile O O
-Pulse: O O
70 O O
-resp. O O
rate: O O
16 O O
-height: O O
64 O O
in. O O
-weight: O O
150 O O
lbs. O O
-General: O O
No O O
acute O O
distress. O O
-Skin: O O
No O O
rashes, O O
anicteric. O O
-HEENT: O O
Unremarkable O O
-Chest: O O
Lung O O
sounds O O
clear O O
bilaterally. O O
-Cardiac: O O
Left O O
ventricular O O
impulse O O
discrete O O
and O O
nondisplaced. O O
Regular O O
rate O O
and O O
rhythm, O O
normal O O
S1 O O
and O O
S2, O O
with O O
no O O
S3 O O
or O O
S4. O O
There O O
were O O
no O O
clicks O O
or O O
rubs. O O
1/6 O O
SM O O
apex. O O
-Abdomen: O O
Soft, O O
non-tender O O
with O O
active O O
BS. O O
No O O
masses O O
or O O
bruits. O O
-Extremities: O O
Femorals O O
2+ O O
bilaterally O O
without O O
bruits O O
baseline. O O
groin O O
site O O
stable, O O
no O O
hematoma, O O
DP's O O
1+ O O
baseline, O O
no O O
edema, O O
feet O O
cool. O O
-Neuro: O O
Grossly O O
non-focal. O O
-BP: B-HYPERTENSION O
140/76 I-HYPERTENSION O
-BMI: O O
-Neck: O O
Carotids O O
2+ O O
without O O
bruits. O O
JVP O O
no O O
jugular O O
venous O O
distention. O O
Selected O O
recent O O
labs: O O
Metabolic O O
Date O O
K O O
BUN O O
CRE O O
GLU O O
03/11/96 O O
4.6 O O
18 O O
0.9 O O
12/06/95 O O
195 O O
Lipid/Thyroid O O
Date O O
CHOL O O
TRIG O O
HDL O O
LDL O O
02/13/96 O O
120 O O
90 O O
30 O O
72 O O
Hematology O O
Date O O
HCT O O
RBC O O
WBC O O
PLT O O
03/11/96 O O
43.1 O O
5.16 O O
9.4 O O
311 O O
Coagulation O O
Date O O
PT O O
PT-INR O O
PTT O O
03/11/96 O O
14.2 O O
1.1 O O
28.1 O O
24 O O
hr O O
Urine O O
Date O O
CRE O O
03/11/96 O O
0.9 O O
Impression: O O
64 O O
y.o. O O
male O O
w/ O O
Known O O
CAD O O
and O O
recurrent O O
CP O O
and O O
positive O O
stress O O
test O O
as O O
above. O O
Now O O
stable O O
s/p O O
cath O O
as O O
above-awaiting O O
full O O
report. O O
Plan O O
med O O
managnement. O O
BB O O
increased O O
today O O
since O O
pt. O O
never O O
increased O O
as O O
OP-cont. O O
to O O
monitor O O
labile O O
b/p. O O
On O O
statin, O O
ASA, O O
ACE O O
I, O O
prn B-MEDICATION O
sl I-MEDICATION O
NTG. I-MEDICATION O
Lipids, O O
LFTs O O
in O O
am. O O
CBC, O O
lytes, O O
BUN, O O
Cr O O
in O O
am. O O
Monitor O O
groin O O
site O O
per O O
protocol. O O
Consider O O
endo. O O
consult O O
for O O
poor O O
glycemic O O
control. O O
pt. O O
admits O O
to O O
poor O O
adherence O O
to O O
DM O O
med O O
regime O O
and O O
after O O
long O O
discussion O O
re: O O
importance O O
of O O
med O O
adherence O O
is O O
willing O O
to O O
be O O
consistant O O
with O O
rec. O O
meds O O
at O O
this O O
point. O O
Off O O
metformin B-MEDICATION O
for I-MEDICATION O
48 I-MEDICATION O
hours I-MEDICATION O
per I-MEDICATION O
cath I-MEDICATION O
protocol. I-MEDICATION O
Cont. O O
Glipizide. O O
Monitor O O
FS. O O
Sliding O O
scale O O
regular O O
insulin O O
while O O
off O O
metformin. O O
Diet O O
consult O O
ordered. O O
Further O O
recs. O O
per O O
Dr. O O
Oxendine. O O
Freida O O
P. O O
Lloyd O O
pager O O
#82454 O O
Signed O O
electronically O O
by O O
Freida O O
P. O O
Lloyd O O
Document O O
Status: O O
Final O O

Record B-SMOKER O
date: O O
2078-10-13 O O
CDH O O
EMERGENCY O O
DEPT O O
VISIT O O
YARBROUGH,IRENE O O
810-86-43-7 O O
VISIT O O
DATE: O O
10/13/78 O O
PRESENTING O O
COMPLAINT O O
and O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
54-year-old O O
female O O
seen O O
by O O
Dr. O O
Paulson O O
and O O
also O O
by O O
the O O
Oncology O O
service. O O
Briefly, O O
this O O
is O O
a O O
54-year-old O O
female O O
with O O
a O O
known O O
mass O O
in O O
her O O
vagina, O O
who O O
presents O O
now O O
with O O
vaginal O O
bleeding. O O
The O O
patient O O
was O O
seen O O
earlier O O
yesterday O O
by O O
the O O
Oncology O O
service, O O
and O O
is O O
scheduled O O
to O O
have O O
surgery O O
for O O
the O O
mass O O
to O O
be O O
removed, O O
but O O
she O O
developed O O
significant O O
vaginal O O
bleeding O O
and O O
presented O O
to O O
the O O
Emergency O O
Department O O
today. O O
She O O
is O O
otherwise O O
healthy. O O
Her O O
first O O
time O O
seen O O
in O O
the O O
Emergency O O
Department O O
or O O
seen O O
by O O
Oncology O O
was O O
two O O
weeks O O
ago O O
for O O
increased O O
bleeding. O O
She O O
was O O
diagnosed O O
at O O
the O O
time O O
with O O
a O O
necrotic O O
fibroid, O O
and O O
was O O
confirmed O O
by O O
studies O O
to O O
have O O
a O O
large O O
fibroid O O
at O O
that O O
time. O O
She O O
now O O
presents O O
with O O
increasing O O
weakness O O
and O O
light-headedness O O
and O O
more O O
bleeding. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
In O O
the O O
Emergency O O
Department, O O
an O O
IV O O
was O O
started, O O
and O O
laboratory O O
studies O O
sent, O O
including O O
CBC, O O
electrolytes, O O
PT/PTT, O O
and O O
she O O
was O O
also O O
typed O O
and O O
crossed O O
and O O
a O O
urinalysis O O
sent. O O
A O O
chest O O
x-ray O O
and O O
EKG O O
were O O
sent. O O
The O O
patient O O
was O O
made O O
n.p.o. O O
She O O
is O O
a O O
preoperative O O
patient. O O
Her O O
initial O O
hematocrit O O
here O O
was O O
23. O O
A O O
full O O
note O O
was O O
written O O
by O O
the O O
Oncology O O
service, O O
and O O
she O O
is O O
currently O O
admitted O O
to O O
that O O
service. O O
FINAL O O
DIAGNOSIS: O O
Vaginal O O
bleeding O O
with O O
necrotic O O
leiomyoma. O O
DISPOSITION O O
(including O O
condition O O
on O O
discharge): O O
As O O
above. O O
The O O
patient's O O
condition O O
on O O
admission O O
is O O
stable. O O
___________________________________ O O
CQ774/2253 O O
TRISTAN O O
O. O O
XAVIER, O O
M.D. O O
TX12 O O
D:10/13/78 O O
T:10/13/78 O O
Dictated O O
by: O O
TRISTAN O O
O. O O
XAVIER, O O
M.D. O O
TX12 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2078-11-10 O O
November O O
10, O O
2078 O O
Tanae O O
Shirley, O O
M.D. O O
Obstetrics O O
Callaway O O
District O O
Hospital O O
97 O O
Jared O O
Circle O O
Falmouth O O
AL O O
98623 O O
RE:IRENE O O
YARBROUGH O O
CDH#810 O O
86 O O
43 O O
7 O O
Dear O O
Dr. O O
Shirley: O O
Thank O O
you O O
for O O
referring O O
Irene O O
Yarbrough O O
for O O
evaluation O O
of O O
her O O
atrial O O
fibrillation. O O
Mrs. O O
Yarbrough O O
is O O
55 O O
years O O
old. O O
Over O O
the O O
past O O
year O O
she O O
had O O
had O O
menorrhagia O O
and O O
underwent O O
endometrial O O
biopsy O O
in O O
September O O
of O O
2078 O O
followed O O
by O O
total O O
abdominal O O
hysterectomy O O
in O O
early O O
October O O
of O O
2078. O O
Her O O
post-operative O O
course O O
was O O
complicated O O
by O O
a O O
pelvic O O
abscess O O
for O O
which O O
she O O
was O O
rehospitalized O O
in O O
late O O
October O O
and O O
during O O
that O O
hospitalization O O
had O O
an O O
episode O O
of O O
atrial O O
fibrillation O O
which O O
reverted O O
spontaneously O O
to O O
sinus O O
rhythm. O O
The O O
episode O O
was O O
accompanied O O
by O O
some O O
substernal O O
chest O O
heaviness O O
but O O
no O O
other O O
symptoms O O
and O O
she O O
was O O
not O O
aware O O
of O O
any O O
palpitations. O O
She O O
was O O
placed O O
on O O
verapamil B-MEDICATION B-MEDICATION
240 O O
mg O O
daily O O
and O O
has O O
not O O
had O O
any O O
symptomatic O O
recurrences. O O
Her O O
abdominal O O
incision O O
is O O
open O O
but O O
healing O O
and O O
she O O
has O O
been O O
recovering O O
well. O O
She O O
has O O
no O O
prior O O
cardiac O O
history. O O
She O O
specifically O O
denies O O
any O O
exertional O O
chest O O
pain, O O
palpitations, O O
or O O
transient O O
neurologic O O
symptoms. O O
She O O
can O O
climb O O
a O O
flight O O
of O O
stairs O O
at O O
her O O
own O O
pace O O
but O O
is O O
mildly O O
dyspneic O O
at O O
the O O
top O O
of O O
the O O
stairs. O O
She O O
feels O O
that O O
her O O
exertional O O
capacity O O
has O O
increased O O
somewhat O O
over O O
the O O
past B-SMOKER O
year I-SMOKER O
and I-SMOKER O
a I-SMOKER O
half I-SMOKER O
since I-SMOKER O
she I-SMOKER O
stopped B-SMOKER O
smoking. I-SMOKER O
She O O
does O O
not O O
have O O
a O O
known O O
history O O
of O O
hypertension, O B-HYPERTENSION
however O O
VNA O O
has O O
been O O
documenting O O
blood B-HYPERTENSION O
pressures I-HYPERTENSION O
in I-HYPERTENSION O
the I-HYPERTENSION O
range I-HYPERTENSION O
of I-HYPERTENSION O
130 B-HYPERTENSION O
to I-HYPERTENSION O
190 B-HYPERTENSION O
mm I-HYPERTENSION O
Hg I-HYPERTENSION O
systolic I-HYPERTENSION O
with I-HYPERTENSION O
diastolic I-HYPERTENSION O
pressures I-HYPERTENSION O
ranging I-HYPERTENSION O
from I-HYPERTENSION O
72 I-HYPERTENSION O
to I-HYPERTENSION O
110 I-HYPERTENSION O
mm I-HYPERTENSION O
Hg I-HYPERTENSION O
despite O O
therapy O O
with O O
verapamil. O B-MEDICATION
There O O
is O O
no O O
prior O O
history O O
of O O
syncope. O O
Page O O
Two O O
RE:IRENE O O
YARBROUGH O O
CDH#810 O O
86 O O
43 O O
7 O O
November O O
10, O O
2078 O O
Her O O
current O O
medications O O
are O O
verapamil O B-MEDICATION
240 O O
mg O O
daily O O
as O O
above O O
and O O
Premarin. O O
She O O
has O O
GI O O
intolerance O O
to O O
several O O
analgesic O O
medications. O O
She O O
previously O O
smoked O O
two O O
packs O O
per O O
day O O
but O O
quit O O
a O O
year O O
and O O
a O O
half O O
ago O O
of O O
her O O
own O O
volition O O
without O O
any O O
particular O O
change O O
in O O
her O O
health O O
precipitating O O
this. O O
She O O
rarely O O
drinks O O
ethanol. O O
She O O
has O O
not O O
had O O
any O O
prior O O
surgeries. O O
Family O O
history O O
is O O
negative O O
for O O
premature O O
coronary O O
artery O O
disease. O O
Review O O
of O O
systems O O
is O O
negative O O
for O O
thyroid O O
disease O O
and O O
a O O
TSH O O
was O O
normal O O
during O O
her O O
last O O
admission. O O
Physical O O
examination O O
reveals O O
a O O
healthy-appearing O O
obese B-OBESE O
woman O O
sitting O O
comfortably O O
with O O
a O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
of I-HYPERTENSION O
140/90, B-HYPERTENSION B-MEDICATION
heart O O
rate O O
73 O O
and O O
regular. O O
HEENT O O
is O O
externally O O
unremarkable. O O
There O O
is O O
no O O
lid O O
lag O O
and O O
no O O
thyromegaly. O O
Carotids O O
are O O
palpable O O
bilaterally. O O
Lungs O O
are O O
clear O O
to O O
auscultation. O O
Cardiac O O
exam O O
reveals O O
somewhat O O
distant O O
heart O O
tones O O
and O O
I O O
am O O
not O O
able O O
to O O
palpate O O
the O O
apical O O
impulse. O O
There O O
is O O
a O O
soft O O
systolic O O
murmur O O
at O O
the O O
left O O
sternal O O
border. O O
Abdomen O O
is O O
soft O O
and O O
nontender. O O
There O O
is O O
a O O
healing O O
surgical O O
incision O O
in O O
the O O
lower O O
abdomen. O O
Extremities O O
are O O
without O O
edema. O O
Dorsalis O O
pedis O O
pulses O O
are O O
easily O O
palpable. O O
The O O
12-lead O O
electrocardiogram O O
shows O O
sinus O O
rhythm O O
at O O
73 O O
bpm O O
with O O
a O O
PR O O
interval O O
of O O
.18, O O
QRS O O
.08. O O
There O O
are O O
low O O
amplitude O O
T O O
waves O O
in O O
the O O
lateral O O
precordium O O
and O O
inverted O O
T O O
waves O O
in O O
I O O
and O O
aVL O O
with O O
slightly O O
leftward O O
axis. O O
An O O
echocardiogram O O
performed O O
during O O
her O O
last O O
hospitalization O O
was O O
normal, O O
although O O
with O O
some O O
mild O O
evidence O O
of O O
ventricular O O
hypertrophy. O O
My O O
impression O O
is O O
that O O
Ms. O O
Yarbrough O O
has O O
had O O
one O O
episode O O
of O O
atrial O O
fibrillation O O
in O O
the O O
perioperative O O
period. O O
She O O
probably O O
has O O
mild B-HYPERTENSION O
labile I-HYPERTENSION O
hypertension I-HYPERTENSION O
which O O
has O O
not O O
been O O
previously O O
treated. O O
This O O
would O O
explain O O
her O O
electrocardiographic O O
changes O O
and O O
the O O
echocardiogram O O
as O O
well O O
as O O
the O O
possible O O
predisposition O O
to O O
atrial O O
fibrillation. O O
I O O
took O O
the O O
liberty O O
of O O
switching B-MEDICATION O
her I-MEDICATION O
from I-MEDICATION O
verapamil I-MEDICATION B-MEDICATION
240 I-MEDICATION O
mg I-MEDICATION O
daily I-MEDICATION O
to I-MEDICATION O
atenolol B-MEDICATION B-MEDICATION
50 I-MEDICATION O
mg I-MEDICATION O
daily. I-MEDICATION O
Once O O
her O O
incision O O
is O O
further O O
healed O O
we O O
will O O
arrange O O
for O O
her O O
to O O
have O O
an O O
exercise O O
tolerance O O
test O O
to O O
get O O
some O O
reassurance O O
regarding O O
the O O
possible O O
co-existence O O
of O O
coronary O O
artery O O
disease O O
in O O
view O O
of O O
her O O
mild O O
electrocardiographic O O
abnormalities O O
in O O
atrial O O
fibrillation. O O
Page O O
Three O O
RE:IRENE O O
YARBROUGH O O
CDH#810 O O
86 O O
43 O O
7 O O
November O O
10, O O
2078 O O
will O O
see O O
her O O
again O O
in O O
six O O
weeks O O
at O O
which O O
time O O
she O O
will O O
have O O
the O O
exercise O O
tolerance O O
test. O O
We O O
cautioned O O
her O O
to O O
take O O
her O O
pulse O O
on O O
a O O
daily O O
basis O O
and O O
report O O
to O O
us O O
if O O
it O O
becomes O O
irregular O O
and O O
rapid. O O
We B-MEDICATION O
also I-MEDICATION O
gave I-MEDICATION O
her I-MEDICATION O
a I-MEDICATION O
prescription I-MEDICATION O
for I-MEDICATION O
nitroglycerin B-MEDICATION O
0.4 O O
mg O O
and O O
instructions O O
on O O
how O O
to O O
take O O
this O O
medication O O
in O O
the O O
event O O
of O O
a O O
recurrence O O
of O O
the O O
substernal O O
chest O O
discomfort O O
which O O
accompanied O O
her O O
transient O O
atrial O O
fibrillation. O O
Thank O O
you O O
very O O
much O O
for O O
allowing O O
me O O
to O O
participate O O
in O O
her O O
care. O O
Sincerely, O O
Paul O O
N. O O
Shelton, O O
M.D. O O
/xing O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2079-03-10 O O
CDH O O
EMERGENCY O O
DEPT O O
VISIT O O
YARBROUGH,IRENE O O
810-86-43-7 O O
VISIT O O
DATE: O O
03/10/79 O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
patient O O
was O O
seen O O
with O O
Dr. O O
Nettles, O O
Emergency O O
Medicine O O
resident. O O
The O O
Chief O O
Complaint, O O
History O O
of O O
Present O O
Illness, O O
Past O O
Medical O O
History, O O
Medications, O O
Allergies, O O
Social O O
History, O O
Family O O
History O O
and O O
Review O O
of O O
Systems O O
are O O
as O O
noted O O
by O O
Dr. O O
Nettles O O
on O O
the O O
record O O
and O O
were O O
reviewed O O
with O O
him O O
and O O
with O O
the O O
patient. O O
Briefly, O O
this O O
is O O
a O O
55 O O
year O O
old O O
woman O O
who O O
presented O O
with O O
chest O O
pain O O
which O O
was O O
epigastric O O
and O O
substernal O O
in O O
nature, O O
essentially O O
sharp O O
and O O
non-radiating O O
that O O
had O O
come O O
on O O
at O O
rest. O O
She O O
has O O
several O O
cardiac O O
risk O O
factors O O
including O O
hypertension, B-HYPERTENSION O
obesity B-OBESE O
and O O
hormone O O
replacement O O
but O O
had O O
no O O
specific O O
cardiac O O
history. O O
Her O O
symptoms O O
did O O
not O O
resolve O O
with O O
Mylanta. O O
PHYSICAL O O
EXAMINATION: O O
As O O
noted O O
by O O
Dr. O O
Nettles O O
and O O
is O O
most O O
noteworthy O O
for O O
normal O O
heart O O
sounds, O O
although O O
she O O
does O O
have O O
a O O
II/VI O O
systolic O O
ejection O O
murmur O O
at O O
the O O
apex O O
(the O O
upper O O
right O O
sternal O O
border). O O
LABORATORY O O
EVALUATION: O O
An O O
electrocardiogram O O
does O O
not O O
show O O
acute O O
changes O O
but O O
does O O
have O O
T O O
wave O O
inversions O O
in O O
V1 O O
to O O
V3. O O
These O O
were O O
previously O O
noted O O
in O O
10/78. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
required O O
nitroglycerine B-MEDICATION O
and O O
nitroglycerine, O O
IV O O
nitroglycerine O O
and O O
IV O O
heparin O O
with O O
some O O
morphine O O
to O O
relieve O O
her O O
pain. O O
She O O
also O O
received O O
Lopressor B-MEDICATION B-MEDICATION
25 O O
mg O O
IV O O
and O O
was O O
given O O
some O O
GI O O
meds. O O
She O O
eventually O O
became O O
pain-free, O O
although O O
she O O
does O O
admit O O
to O O
a O O
residual O O
mild O O
discomfort O O
in O O
her O O
chest. O O
There O O
are O O
no O O
electrocardiographic O O
changes. O O
IMPRESSION: O O
I O O
concur O O
with O O
Dr. O O
Nettles O O
that O O
this O O
patient O O
has O O
chest O O
pain O O
suspicious O O
for O O
unstable B-CAD O
angina. I-CAD O
She O O
has O O
responded O O
well O O
to O O
aggressive O O
treatment O O
of O O
this O O
and O O
she O O
will O O
be O O
admitted O O
for O O
further O O
evaluation. O O
FINAL O O
DIAGNOSIS: O O
Chest O O
pain. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Admission. O O
Condition O O
satisfactory. O O
___________________________________ O O
MR190/0660 O O
ANTHONY O O
G. O O
PETTY, O O
M.D. O O
AP06 O O
D:03/10/79 O O
T:03/10/79 O O
Dictated O O
by: O O
ANTHONY O O
G. O O
PETTY, O O
M.D. O O
AP06 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2090-07-12 O O
NIGHTFLOAT O O
ADMIT B-DIABETES O
NOTE O O
----------------------------------- O O
Name: O O
Yarbrough, O O
Irene O O
H O O
MRN: O O
81086437 O O
Date O O
of O O
admission: O O
7/12/90 O O
PCP: O O
Intern: O O
Gaines O O
Attending: O O
Silva O O
----------------------------------- O O
Chief O O
complaint: O O
Abdominal O O
pain O O
x O O
4 O O
days. O O
HPI: O O
Patient O O
is O O
a O O
66 O O
year-old O O
female O O
w/ O O
h/o O O
CAD, B-CAD O
hyperlipidemia, B-HYPERLIPIDEMIA O
NIDDM, B-DIABETES O
and O O
chronic O O
pancreatitis O O
who O O
presents O O
with O O
four O O
days O O
of O O
epigastric O O
pain. O O
Pt O O
has O O
had O O
four O O
days O O
constant O O
epigastric O O
pain, O O
5-6/10 O O
intermittently O O
increasing O O
to O O
8/10, O O
characterized O O
as O O
'just O O
pain,' O O
with O O
occasional O O
radiation O O
to O O
the O O
back, O O
and O O
which O O
is O O
made O O
worse O O
by O O
PO O O
intake. O O
Pt O O
notes O O
this O O
pain O O
is O O
very O O
similar O O
to O O
past O O
episodes O O
of O O
pancreatitis. O O
Pt O O
also O O
c/o O O
nausea O O
but O O
denies O O
vomiting, O O
fever, O O
chills, O O
diarrhea, O O
constipation, O O
blood O O
per O O
rectum. O O
ED O O
course: O O
Vitals: O O
T O O
96.3F, O O
P O O
90, O O
RR O O
20, O O
BP B-HYPERTENSION O
149/87, I-HYPERTENSION O
SpO2 O O
96% O O
on O O
RA. O O
Given O O
morphine O O
4mg O O
IV O O
x1, O O
GI O O
cocktail, O O
zofran O O
1 O O
mg O O
IV O O
x1, O O
Dilaudid O O
1mg O O
IV O O
x1, O O
and O O
1L O O
NS. O O
ROS: O O
Constitutional: O O
no O O
fever O O
or O O
chills. O O
No O O
night O O
sweats. O O
No O O
weight O O
loss O O
or O O
gain. O O
No O O
fatigue O O
or O O
general O O
aches. O O
Eyes: O O
no O O
blurred O O
vision, O O
double O O
vision O O
or O O
photophobia. O O
ENT: O O
no O O
hearing O O
loss, O O
no O O
ear O O
pain O O
or O O
discharge. O O
No O O
sore O O
throat. O O
No O O
sinus O O
symptoms O O
or O O
nasal O O
symptoms. O O
Neck: O O
no O O
swelling O O
or O O
swollen O O
lymph O O
nodes. O O
Respiratory: O O
no O O
chest O O
pain, O O
no O O
cough, O O
sputum O O
or O O
hemoptysis, O O
no O O
wheezing. O O
Cardiovascular: O O
No O O
chest O O
pain. O O
No O O
PND O O
or O O
orthopnea. O O
Pt O O
c/o O O
baseline O O
SOB. O O
Gastrointestinal: O O
Per O O
HPI. O O
Genitourinary: O O
No O O
dysuria, O O
frequency O O
or O O
urgency. O O
No O O
urethral O O
or O O
vaginal O O
discharge. O O
No O O
vaginal O O
bleeding. O O
Musculoskeletal: O O
No O O
joint O O
pain O O
or O O
swelling. O O
Skin: O O
no O O
rashes, O O
hives O O
or O O
worrisome O O
skin O O
lesions. O O
Neurological: O O
No O O
seizures, O O
no O O
migraines, O O
no O O
sensory O O
or O O
motor O O
symptoms. O O
Psychiatric: O O
no O O
depression, O O
anxiety O O
or O O
altered O O
mental O O
status. O O
Hematological: O O
no O O
bleeding O O
or O O
bruising, O O
no O O
pallor O O
or O O
shortness O O
of O O
breath, O O
no O O
recurrent O O
infections. O O
All O O
other O O
systems O O
reviewed O O
and O O
were O O
negative O O
for O O
any O O
further O O
symptoms. O O
Past O O
medical O O
history: O O
Paroxysmal O O
a-fib O O
on O O
Coumadin O O
HTN B-HYPERTENSION O
Hyperlipidemia B-HYPERLIPIDEMIA O
CAD O O
s/p B-CAD O
MI, I-CAD O
recent O O
MIBI O O
cardiac O O
SPECT O O
w/o O O
flow-limiting O O
CAD O O
NIDDM O O
(unknown O O
last O O
Hgb O O
A1c) O O
Recurrent O O
pancreatitis O O
(last O O
episode O O
10/89) O O
Obesity B-OBESE O
s/p O O
cholecystectomy O O
for O O
symptomatic O O
cholelithiasis O O
s/p O O
R O O
TKA O O
in O O
2083, O O
L O O
TKA O O
in O O
4/88 O O
recent O O
EGD O O
w/ O O
findings O O
of O O
submucosal O O
lesion O O
in O O
prepyloric O O
area O O
which O O
on O O
EUS O O
appears O O
to O O
be O O
a O O
gastric O O
fold O O
without O O
intramural O O
lesion O O
(per O O
report) O O
Pre-admission O O
medication O O
list: O O
1. O O
Spironolactone O O
(Aldactone) O O
25 O O
MG O O
PO O O
QD O O
2. O O
Amitriptyline O O
Hcl O O
10 O O
MG O O
PO O O
QHS O O
3. O O
Warfarin O O
Sodium O O
(Coumadin) O O
2 O O
MG O O
PO O O
QPM O O
OR O O
AS O O
DIRECTED O O
every O O
day O O
except O O
Saturday, O O
on O O
Saturday O O
take O O
1mg O O
qhs O O
4. O O
Gabapentin O O
300 O O
MG O O
PO O O
TID O O
5. O O
Atorvastatin B-MEDICATION B-MEDICATION
(Lipitor) B-MEDICATION O
20 O O
MG O O
PO O O
QD O O
6. O O
Metformin B-MEDICATION B-MEDICATION
500 O O
MG O O
PO O O
QD O O
7. O O
Nadolol B-MEDICATION O
40 O O
MG O O
PO O O
QD O O
8. O O
Omeprazole O O
(Prilosec) O O
40 O O
MG O O
PO O O
qd O O
9. O O
Verapamil B-MEDICATION O
Sustained O O
Release O O
(Verapamil O O
S.R.) O O
180 O O
MG O O
PO O O
QD O O
Allergies: O O
Latex O O
(facial O O
swelling, O O
itching), O O
erythromycins O O
(prolonged O O
QT O O
interval) O O
Family O O
history: O O
Unremarkable O O
Social O O
history: O O
Smoking: B-SMOKER O
2ppd I-SMOKER O
x I-SMOKER O
54 I-SMOKER O
yrs I-SMOKER O
Alcohol: O O
Rare O O
Illicits: O O
None O O
Contact: O O
Debra O O
Jaquez O O
(daughter): O O
901-063-0839 O O
----------------------------------- O O
PHYSICAL O O
EXAM: O O
T O O
96.0F O O
HR O O
65 O O
BP O O
116/67 O O
RR O O
18 O O
SpO2 O O
97% O O
on O O
RA O O
GENERAL: O O
Obese. B-OBESE O
No O O
apparent O O
distress O O
/ O O
pain, O O
following O O
all O O
commands. O O
HEAD: O O
Atraumatic. O O
Sclerae O O
anicteric O O
with O O
normal O O
conjunctiva O O
and O O
lid, O O
moist O O
mucous O O
membranes, O O
oropharynx O O
without O O
ulcerations O O
or O O
other O O
lesions. O O
NECK: O O
No O O
thyromegaly O O
or O O
lymphadenopathy. O O
Neck O O
supple. O O
CHEST: O O
Clear O O
to O O
auscultation O O
bilaterally. O O
No O O
accessory O O
muscle O O
use. O O
CV: O O
Irregular O O
rhythm O O
without O O
murmurs, O O
rubs, O O
or O O
gallops. O O
Distal O O
pulses O O
present O O
and O O
normal O O
bilaterally. O O
ABDOMEN: O O
Soft, O O
non-tender, O O
non-distended. O O
Normal O O
bowel O O
sounds. O O
No O O
masses O O
or O O
organomegaly. O O
EXTREMITIES: O O
No O O
lower O O
extremity O O
edema. O O
Warm O O
&amp; O O
well-perfused. O O
No O O
clubbing O O
or O O
cyanosis. O O
SKIN: O O
No O O
rashes, O O
hematomas, O O
or O O
pigment O O
changes. O O
NEUROLOGICAL: O O
Alert, O O
attentive, O O
oriented O O
x O O
3. O O
Pupils O O
constricted O O
but O O
reactive O O
bilaterally. O O
Cranial O O
nerves O O
II-XII O O
intact. O O
Moving O O
all O O
extremities O O
to O O
command. O O
Sensation O O
intact O O
to O O
light O O
touch O O
sensation O O
throughout. O O
----------------------------------- O O
LAB O O
STUDIES: O O
NA O O
136 O O
K O O
3.8 O O
CL O O
99 O O
CO2 O O
24 O O
BUN O O
12 O O
CRE O O
1.10 O O
EGFR O O
50(T) O O
GLU O O
128(*) O O
ANION O O
13 O O
CA O O
9.4 O O
TBILI O O
0.6 O O
TP O O
7.6 O O
ALB O O
4.0 O O
GLOB O O
3.6 O O
LIPS O O
80(*) O O
ALT/SGPT O O
20 O O
AST/SGOT O O
21 O O
ALKP O O
120 O O
TBILI O O
0.6 O O
WBC O O
12.79(*) O O
RBC O O
5.72 O O
HGB O O
15.5 O O
HCT O O
47.4 O O
MCV O O
82.8 O O
MCH O O
27.1 O O
MCHC O O
32.7 O O
PLT O O
341 O O
RDW O O
13.8 O O
%POLY-A O O
63.1 O O
%LYMPH-A O O
30.1 O O
%MONO-A O O
4.7 O O
%EOS-A O O
1.8 O O
%BASO-A O O
0.2 O O
ANEUT-A O O
8.08(*) O O
ALYMP-A O O
3.85 O O
AMONO-A O O
0.60 O O
AEOS-A O O
0.23 O O
ABASO-A O O
0.03 O O
DIAGNOSTIC O O
STUDIES: O O
EKG: O O
A-fib, O O
T-wave O O
flattening O O
in O O
I, O O
II, O O
III, O O
no O O
ST-segment O O
changes. O O
----------------------------------- O O
ASSESSMENT: O O
66 O O
yo O O
woman O O
h/o O O
chronic O O
pancreatitis, O O
CAD, O O
hyperlipidemia O O
here O O
with O O
likely O O
acute O O
on O O
chronic O O
pancreatitis. O O
PLAN: O O
GI O O
- O O
Pancreatitis. O O
Pt's O O
abd O O
pain O O
c/w O O
previous O O
episodes O O
of O O
pancreatitis, O O
lipase O O
moderately O O
elevated O O
(never O O
has O O
been O O
extremely O O
elevated), O O
leukocytosis. O O
Ddx O O
includes O O
cardiac O O
chest O O
pain, O O
hepatitis, O O
PNA, O O
AAA, O O
aortic O O
dissection, O O
colitis, O O
enteritis, O O
peptic O O
ulcer O O
dz. O O
Pt's O O
EKG O O
not O O
concerning O O
for O O
MI, O O
liver O O
enzymes O O
are O O
WNL, O O
has O O
no O O
respiratory O O
sx, O O
has O O
no O O
diarrhea, O O
and O O
is O O
hemodynamically O O
stable. O O
Pancreatitis O O
is O O
therefore O O
most O O
likely. O O
-- O O
NPO O O
-- O O
Hydrate O O
with O O
NS. O O
Rec'd O O
1L O O
NS O O
in O O
the O O
ED, O O
does O O
not O O
appear O O
volume-down. O O
Will O O
give O O
another O O
1L O O
bolus, O O
fluids O O
at O O
125/h O O
-- O O
Etiology O O
for O O
pancreatits O O
unclear. O O
Contact O O
her O O
gastroenterologist, O O
Dr. O O
Bert O O
Lord, O O
to O O
notify O O
of O O
this O O
admission O O
and O O
to O O
get O O
previous O O
records O O
-- O O
manage O O
pain O O
w/ O O
Dilaudid O O
- O O
1mg O O
IV O O
effective O O
in O O
ED. O O
CV. O O
Pt O O
w/ O O
h/o O O
HTN, O O
CAD, O O
paroxysmal O O
a-fib. O O
-- O O
continue O O
warfarin O O
2mg O O
qhs O O
except O O
Saturday, O O
1mg O O
qhs O O
on O O
Saturday O O
-- O O
check O O
INR O O
to O O
ensure O O
pt O O
therapeutic O O
on O O
warfarin O O
-- O O
continue O O
nadolol O O
-- O O
continue O O
spironolactone O O
-- O O
hold O O
verapamil O O
sustained O O
release, O O
start O O
verapamil O B-MEDICATION
60 O O
mg O O
q8h O O
b/c O O
BP O O
a O O
bit O O
low O O
-- O O
substitute O O
for O O
Lipitor O B-MEDICATION
20mg O O
qhs O O
per O O
hospital O O
formulary O O
Renal. O O
Pt's O O
creatinine O O
has O O
been O O
trending O O
up O O
over O O
the O O
last O O
year, O O
? O O
possible O O
chronic O O
renal O O
failure. O O
Also O O
possibilty O O
of O O
mild O O
ARF O O
in O O
setting O O
of O O
dehydration. O O
-- O O
check O O
UA O O
-- O O
f/u O O
as O O
outpt O O
Endocrine. O O
Pt O O
w/ O O
DM O O
on O O
metformin. O O
-- O O
send O O
Hgb O O
A1c O O
-- O O
cover O O
with O O
SSI O O
while O O
inpt O O
Neuro. O O
-- O O
continue O O
gabapentin O O
Psych. O O
-- O O
continue O O
amitriptyline O O
10 O O
mg O O
qhs O O
FEN. O O
-- O O
NPO O O
-- O O
hydrate O O
as O O
above O O
DVT O O
prophylaxis. O O
-- O O
dalteparin O O
5000u O O
SQ O O
qday O O
CODE O O
STATUS: O O
FULL O O
________________________________________ O O
Giovanni O O
Huang, O O
MD, O O
PGY-1 O O
(pager O O
76567) O O

Record O O
date: O O
2070-04-23 O O
Stephens O O
Memorial O O
Hospital O O
Anesthesiology O O
Preanesthetic O O
Assessment O O
Traci O O
Y. O O
Mills, O O
M.D. O O
Associate O O
Medical O O
Director O O
April O O
23, O O
2070 O O
Medical O O
Record O O
Number: O O
0189233 O O
Victor O O
Lujan O O
Procedure: O O
The O O
patient O O
is O O
a O O
51 O O
year O O
old O O
male O O
scheduled O O
for O O
AV O O
fistula O O
left O O
forearm. O O
Surgery O O
is O O
scheduled O O
on O O
4/30/70. O O
Chief O O
Complaint O O
& O O
Present O O
Illness: O O
chronic O O
renal O O
failure O O
secondary O O
to O O
diabetes-4/19 B-DIABETES O
creatinine O O
2.9, O O
BUN O O
69, O O
potassium O O
3.5. O O
Patient O O
has O O
been O O
troubled O O
recently O O
by O O
increasing O O
fatigue O O
and O O
shortness O O
of O O
breath-no O O
PND, O O
but O O
has O O
peripheral O O
edema. O O
Past O O
Surgical O O
History: O O
Prior O O
surgery O O
includes: O O
right O O
shoulder O O
arthroscopy-? O O
General O O
anesthesia O O
without O O
any O O
known O O
problems; O O
bilateral O O
carpal O O
tunnel O O
release-local; O O
surgery O O
OS O O
for O O
bleeding-local O O
[no O O
old O O
record O O
available O O
but O O
requested] O O
Family O O
History: O O
There O O
is O O
no O O
family O O
history O O
of O O
adverse O O
reactions O O
to O O
general O O
anesthesia. O O
Medications: O O
Epogen, O O
bupropion O O
100 O O
mg, O O
Zaroxylin O O
1.25 O O
mg, O O
Demodex O O
100 O O
mg, O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
mg, O O
Neurontin O O
200 O O
mg O O
b.i.d., O O
ranitidine O O
150 O O
mg, O O
insulin B-MEDICATION B-MEDICATION
NPH I-MEDICATION B-MEDICATION
20 O O
units O O
in O O
the O O
a.m. O O
17 O O
units O O
in O O
the O O
p.m. O O
plus O O
humalog B-MEDICATION B-MEDICATION
on O O
a O O
sliding O O
scale O O
Allergies: O O
iodine O O
causes O O
convulsions O O
Social O O
History: O O
Smoking: B-SMOKER O
none I-SMOKER O
Alcohol O O
use: O O
none O O
Substance O O
Abuse: O O
none O O
Allergen O O
Exposure O O
within O O
3 O O
Months(blood O O
products/pregnancy): O O
none O O
Review O O
of O O
Systems: O O
HEENT: O O
status O O
post O O
recent O O
surgery O O
OS O O
Cardiovascular: O O
hypertension; B-HYPERTENSION O
peripheral O O
vascular O O
disease; O O
syncopal O O
episode O O
secondary O O
to O O
antihypertensive O O
medication O O
[Zestril]; O O
atypical O O
chest O O
pain O O
prompted O O
stress O O
test O O
3/69: O O
Mets O O
equal O O
11, O O
negative O O
for O O
ischemia, O O
myocardial O O
scan O O
is O O
normal. O O
Echo O O
3/66: O O
EF O O
68 O O
percent, O O
RV O O
and O O
LV O O
okay, O O
trace O O
MR, O O
TI, O O
PI. O O
Carotid O O
ultrasounds O O
3/70-normal. O O
Respiratory: O O
patient O O
has O O
noted O O
onset O O
4/21 O O
of O O
cough O O
and O O
chest O O
congestion O O
Renal: O O
present O O
problem O O
Hepatobiliary: O O
negative O O
Neurological: O O
peripheral O O
neuropathy O O
from O O
knees O O
down O O
to O O
feet O O
bilaterally O O
plus O O
edema; O O
bilateral O O
carpal O O
tunnel O O
Gastrointestinal: O O
positive O O
reflux O O
Hematological: O O
anemia-hematocrit O O
31.7, O O
WBC O O
11.5,platelets O O
549,000 O O
4/23/70 O O
Endocrine/metabolic: O O
diabetes O O
for O O
the O O
past O O
37 O O
years-always O O
on O O
insulin-blood O O
sugar O O
141 O O
this O O
a.m.[120-&gt; O O
200] O O
Musculoskeletal/Skin: O O
weakness O O
of O O
hands O O
Psychiatric: O O
depression-no O O
suicide O O
Obstetrical: O O
negative O O
Vital O O
Signs: O O
BP: B-HYPERTENSION O
167/75 I-HYPERTENSION O
mm I-HYPERTENSION O
Hg I-HYPERTENSION O
P: O O
97 O O
bpm O O
Resp: O O
16 O O
rpm O O
SaO2: O O
95% O O
Temp: O O
98.6 O O
degrees O O
F O O
Ht: O O
67 O O
inches O O
Wt: O O
186.4 O O
pounds O O
Exam: O O
HEEN&T: O O
good O O
range O O
of O O
motion, O O
no O O
bruits O O
Airway: O O
Mallampatti O O
Class O O
II O O
Teeth: O O
none O O
Lungs: O O
end O O
expiratory O O
squeaks O O
and O O
wheezes O O
left O O
lung O O
fields O O
Heart: O O
regular O O
rhythm, O O
no O O
murmurs O O
Assessment: O O
ASA O O
Physical O O
Status O O
III-patients O O
will O O
see O O
Dr. O O
Elliott's O O
nurse O O
today O O
for O O
treatment O O
for O O
bronchitis O O
-please O O
check O O
chest O O
film. O O
Please O O
check O O
old O O
anesthesia O O
record O O
for O O
any O O
problems. O O
Plan: O O
Proposed O O
Anesthetic: O O
MAC/general O O
anesthesia O O
Monitors: O O
standard O O
Pain O O
Management: O O
PO O O
Autologous O O
blood: O O
none O O
Premedication: O O
none O O
Usual O O
Medications: O O
in O O
a.m. O O
of O O
surgery O O
Medications O O
to O O
be O O
held O O
on O O
day O O
of O O
surgery: O O
no O O
regular O O
insulin O O
Diabetic O O
medications: O O
NPH O B-MEDICATION
10 O O
units-no O O
regular O O
NSAIDS: O O
none O O
Aspirin: O B-MEDICATION
none O O
NPO: O O
after O O
midnight O O
Ancillary O O
Studies: O O
EKG-normal O O
sinus O O
rhythm, O O
LAE. O O
Chest O O
film O O
pending O O
________________________________________ O O
Traci O O
Mills, O O
M.D. O O

Record B-SMOKER O
date: O O
2073-03-25 O O
THE O O
SPECIALTY O O
HOSPITAL O O
OF O O
AUSTIN O O
CLINIC O O
NOTE O O
Victor O O
Lujan O O
SMH#: O O
018-92-33 O O
March O O
25, O O
2073 O O
DIAGNOSIS: O O
Bilateral O O
hand O O
numbness O O
and O O
pain, O O
recurrent O O
carpal O O
tunnel O O
syndrome. O O
SUBJECTIVE: O O
The O O
patient O O
is O O
a O O
54-year-old O O
right-hand O O
dominant O O
male O O
with O O
multiple O O
medical O O
problems O O
including O O
diabetes B-DIABETES O
mellitus I-DIABETES O
and O O
renal O O
failure O O
requiring O O
hemodialysis, O O
who O O
was O O
has O O
had O O
bilateral O O
hand O O
numbness O O
for O O
several O O
years, O O
but O O
getting O O
worse O O
within O O
the O O
last O O
year O O
or O O
so. O O
The O O
patient O O
states O O
that O O
he O O
has O O
had O O
past O O
carpal O O
tunnel O O
release O O
and O O
trigger O O
finger O O
release O O
of O O
the O O
bilateral O O
hand O O
and O O
the O O
symptoms O O
that O O
he O O
is O O
feeling O O
now O O
is O O
somewhat O O
similar O O
2-10 O O
years O O
ago O O
appearance O O
of O O
symptoms. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension, B-HYPERTENSION O
diabetes O O
mellitus, O O
and O O
chronic O O
renal O O
failure. O O
PAST O O
SURGICAL O O
HISTORY: O O
Bilateral O O
eye O O
surgeries, O O
right O O
shoulder O O
surgeries, O O
and O O
bilateral O O
carpal O O
tunnel O O
surgery O O
as O O
mentioned O O
above. O O
CURRENT O O
MEDICATIONS: O O
Multiple O O
antibiotics O O
including O O
isoniazid, O B-MEDICATION
doxycycline, O O
insulin, B-MEDICATION O
Cardura, O O
Glucophage, B-MEDICATION B-MEDICATION
Elavil, O O
and O O
Biaxin. O O
Please O O
note O O
that O O
the O O
patient O O
is O O
hepatitis O O
C O O
positive O O
and O O
hepatitis O O
B O O
positive. O O
PHYSICAL O O
EXAMINATION: O O
On O O
today O O
s O O
examination, O O
the O O
patient O O
was O O
noted O O
to O O
have O O
a O O
fairly O O
long O O
carpal O O
tunnel O O
scar O O
on O O
bilateral O O
hands O O
extending O O
all O O
the O O
way O O
to O O
the O O
volar O O
wrist O O
level. O O
Long O O
finger O O
and O O
right O O
index O O
finger O O
scar O O
at O O
the O O
base O O
at O O
the O O
MP O O
joint O O
level O O
is O O
noted, O O
the O O
fourth O O
trigger O O
release, O O
which O O
was O O
performed O O
in O O
2062 O O
as O O
well. O O
The O O
patient O O
has O O
rather O O
stiff O O
fingers O O
overall O O
with O O
inability O O
to O O
fully O O
flex O O
the O O
fingers O O
all O O
the O O
way O O
to O O
the O O
thumb O O
space. O O
There O O
is O O
no O O
locking O O
or O O
triggering, O O
but O O
fairly O O
extensive O O
stiffness O O
involving O O
the O O
flexor O O
tendon O O
was O O
noted. O O
Durkan O O
s O O
test O O
was O O
positive O O
and O O
Phalen O O
s O O
test O O
was O O
positive O O
as O O
well. O O
However, O O
abductor O O
pollicis O O
brevis O O
function O O
is O O
intact. O O
Other O O
examination O O
demonstrated O O
some O O
noticeable O O
decrease O O
in O O
size O O
of O O
the O O
muscle O O
with O O
some O O
prominence O O
of O O
the O O
vasculature O O
on O O
the O O
radial O O
side O O
of O O
the O O
left O O
hand, O O
but O O
otherwise O O
normal O O
examination. O O
IMPRESSION: O O
As O O
above. O O
PLAN: O O
My O O
recommendation O O
is O O
that O O
patient O O
undergo O O
very O O
vigorous O O
assessment O O
for O O
the O O
median O O
nerve O O
function. O O
In O O
addition O O
to O O
this, O O
I O O
would O O
like O O
to O O
actually O O
consider O O
providing O O
him O O
with O O
the O O
stretching O O
exercises O O
and O O
flexion O O
exercises O O
as O O
well O O
as O O
passive O O
range O O
of O O
motion O O
of O O
the O O
fingers. O O
It O O
may O O
be O O
a O O
little O O
to O O
early O O
to O O
consider O O
this O O
option O O
until O O
he O O
returns O O
with O O
the O O
result O O
of O O
EMG O O
nerve O O
conduction O O
study. O O
Vance-Ernest O O
Yamasaki, O O
M.D. O O
Orthopaedics O O
VEY/kiser O O
59-56557099.doc O O
cc: O O
Harold O O
Elliott, O O
M.D. O O

Record O O
date: O O
2073-04-27 O O
SDU O O
Admission O O
Note O O
Tuesday, O O
Apr O O
27, O O
2073 O O
Lujan, O O
Victor O O
SMH O O
0189233 O O
54yM O O
SDU O O
Admission: O O
04/27/73 O O
PCP: O O
Elliott O O
Cards: O O
Alston O O
Chief O O
complaint O O
Chest O O
pain O O
History O O
of O O
present O O
illness O O
54 O O
year O O
old O O
man O O
with O O
DM1 B-DIABETES O
for I-DIABETES O
&gt;40 I-DIABETES O
years, I-DIABETES O
ESRD O O
on O O
HD, O O
CAD, B-CAD O
s/p B-CAD O
PCI B-CAD O
at I-CAD O
VHOC I-CAD O
and I-CAD O
Sipher B-CAD O
stent I-CAD O
to I-CAD O
LAD I-CAD O
(100% I-CAD O
lesion) I-CAD O
on I-CAD O
4/10. I-CAD O
Discharged O O
on O O
heart O O
failure O O
regimen. O O
Developed O O
chest O O
pain O O
last O O
night, O O
pleuritic, O O
different O O
than O O
previous O O
CP. O O
No O O
ECG O O
changes O O
noted O O
in O O
EW, O O
went O O
to O O
Alina O O
Medical O O
where O O
symptoms O O
changed O O
abruptly O O
to O O
8/10 B-CAD O
SSC I-CAD O
pressure I-CAD O
that O O
was O O
similar O O
to O O
pain O O
experienced O O
at O O
VHOC O O
admission.ECG O O
showed O O
biphasic O O
TWI O O
in O O
anterior O O
precordium O O
V1-V3, O O
and O O
saddle-shaped O O
T O O
waves, O O
ST O O
elevations O O
in O O
II/III/aVF. O O
Troponin O O
mildly O O
elevated O O
at O O
0.2. O O
Patient O O
moved O O
to O O
cath O O
lab O O
for O O
urgent O O
re-look. O O
In O O
the O O
cath O O
lab, O O
found O O
a O O
widely O O
patent O O
LAD O O
stent O O
with O O
post-stend O O
40% O O
eccentric O O
plaque. O O
D1 O O
ostial O O
pinch O O
from O O
stent. O O
RCA O O
and O O
LCx O O
patent. O O
No O O
intervention. O O
Transferred O O
to O O
SDU. O O
Currently O O
without O O
chest O O
pain, O O
pressure O O
or O O
discomfort. O O
Past O O
medical O O
history O O
DM1 O O
on O O
insulin, B-MEDICATION O
retinopathy, O O
neuropathy, O O
nephropathy O O
CAD, O O
s/p B-CAD O
MI, B-CAD O
EF O O
40% O O
Hyperhomocystinemia O O
HTN B-HYPERTENSION O
ESRD O O
on O O
HD O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Hypothyroidism O O
Asthma O O
GERD O O
PPD+ O O
on O O
rifampin? O O
Depression O O
Urethral O O
stricture O O
Home O O
medications O O
(from O O
4/09/73 O O
PCP O O
note) O O
lisinopril B-MEDICATION B-MEDICATION
20 O O
mg O O
po O O
qhs O O
QTY:30 O O
Refills:6 O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
mg O O
po O O
qhs O O
QTY:90 O O
Refills:3 O O
phenergan O O
expectorant O O
with O O
codeine O O
1 O O
TSP O O
EVERY O O
4 O O
HRS O O
PRN O O
COUGH O O
QTY:8 O O
oz O O
Refills:0 O O
Nephrocaps O O
1 O O
tab O O
po O O
QD O O
QTY:90 O O
Refills:1 O O
year O O
Nexium O O
40 O O
mg O O
po O O
bid O O
QTY:60 O O
Refills:5 O O
prednisone O O
10mg O O
2 O O
tabs O O
po O O
bid O O
20 O O
mg O O
twice O O
a O O
day O O
for O O
5 O O
days O O
QTY:20 O O
Refills:0 O O
Humulin B-MEDICATION O
n I-MEDICATION O
17 O O
u O O
at O O
8 O O
am O O
16 O O
at O O
7pm O O
Humulin B-MEDICATION O
r I-MEDICATION O
BID O O
per O O
sliding O O
scale O O
Neurontin O O
300 O O
mg O O
BID O O
ketoconazole O O
2% O O
cream/shampo O O
as O O
directed O O
Lac O O
hydrin O O
12% O O
use O O
as O O
directed O O
Pulmicort O O
1 O O
puff O O
po O O
bid O O
bupropion O O
100 O O
mg O O
2 O O
tabs O O
po O O
BID O O
am/pm O O
epoetin O O
alfa O O
VIA O O
DIALYSIS O O
albuterol O O
2 O O
puffs O O
with O O
spacer O O
q4-6h O O
prn O O
Synthroid O O
50 O O
mcg O O
po O O
qd O O
quinine O O
sulfate O O
200 O O
mg O O
1 O O
tab O O
po O O
qd O O
per O O
dialysis O O
folic O O
acid O O
1 O O
mg O O
2 O O
tabs O O
po O O
bid O O
rifampin O O
300mg O O
po O O
2 O O
tabs O O
qd O O
Medications O O
on O O
transfer O O
RISS O O
qid O O
NPH O B-MEDICATION
17/16 O O
Colace O O
ASA B-MEDICATION B-MEDICATION
325 O O
Esomeprazole O O
40 O O
Norvasc O B-MEDICATION
40 O O
Gabapentin O O
300 O O
bid O O
Ketoconazole O O
topical O O
Nephrocaps O O
1 O O
qd O O
Buproprion O O
200 O O
bid O O
Atorvastatin B-MEDICATION B-MEDICATION
40 O O
qd O O
Levoxyl O O
50 O O
qd O O
Folate O O
2 O O
bid O O
Rifampin O O
600 O O
qd O O
Clopidogrel B-MEDICATION B-MEDICATION
75 O O
qd O O
Allergies O O
or O O
adverse O O
reactions O O
IV O O
contrast, O O
INH, O O
metformin O B-MEDICATION
Social O O
history O O
Lives O O
with O O
friend O O
in O O
Zebulon, O O
has O O
not O O
worked O O
for O O
many O O
years O O
Family O O
History O O
Non-contributory O O
Risks O O
Tobacco: B-SMOKER O
none I-SMOKER O
for I-SMOKER O
years I-SMOKER O
EtOH: O O
none O O
IVDU: O O
none O O
Vital O O
Signs O O
T O O
97.4 O O
HR O O
78 O O
sinus O O
BP O O
135/80 O O
MAP O O
SAT O O
99%, O O
2 O O
litres O O
RR O O
18 O O
UOP O O
NR O O
Physical O O
exam O O
Pale O O
male O O
in O O
no O O
distress, O O
conversant, O O
appears O O
tired O O
Anicteric, O O
supple O O
neck, O O
no O O
LAD O O
or O O
JVD O O
Heart O O
is O O
RRR, O O
no O O
murmurs, O O
rubs O O
or O O
gallops O O
Lungs O O
clear O O
anteriorly O O
Belly O O
soft, O O
NT, O O
ND, O O
BS+, O O
no O O
palpable O O
AAA O O
or O O
bruit O O
Left O O
groin O O
arterial O O
access O O
sheath, O O
no O O
hematoma O O
Right O O
groing, O O
no O O
hematoma, O O
+ecchymosis, O O
no O O
bruit O O
Decreased O O
sensation O O
in O O
both O O
LE, O O
DPs O O
1+ O O
bilaterally, O O
toes O O
cool O O
and O O
pale O O
Data O O
Test O O
Name O O
SMH O O
SMH O O
VHOC O O
04/27/73 O O
04/27/73 O O
04/21/73 O O
11:26 O O
04:12 O O
17:52 O O
WBC O O
7.6 O O
10.8 O O
9.54(#) O O
%NEUT O O
44 O O
44 O O
%LYMPH O O
40 O O
37 O O
%MONO O O
7 O O
13(H) O O
%EOS O O
8 O O
6 O O
%BASO O O
1 O O
0 O O
HCT O O
37.6(L) O O
36.3(L) O O
42.3 O O
MCV O O
86 O O
84 O O
85.5 O O
PLT O O
318 O O
369(H) O O
380(#) O O
ANISO O O
None O O
1+ O O
HYPO O O
None O O
None O O
MACRO O O
None O O
None O O
MICRO O O
None O O
1+ O O
04/27/73 O O
04/27/73 O O
04/21/73 O O
13:10 O O
03:55 O O
17:52 O O
NA O O
140 O O
143 O O
135(*) O O
K O O
5.1(H) O O
4.9(H) O O
5.3(*#T) O O
CL O O
100 O O
103 O O
97(*) O O
CO2 O O
27.8 O O
29.6 O O
24 O O
BUN O O
32(H) O O
32(H) O O
42(*) O O
CRE O O
4.4(H) O O
4.5(H) O O
5.2(*) O O
GLU O O
144(H) O O
113(H) O O
197(*#) O O
ANION O O
14 O O
04/27/73 O O
04/27/73 O O
04/21/73 O O
13:10 O O
03:56 O O
17:52 O O
CA O O
8.7 O O
9.0 O O
8.8 O O
PHOS O O
5.3(H) O O
3.9 O O
MG O O
1.4 O O
1.5 O O
TP O O
7.1 O O
8.4(*) O O
ALB O O
3.6 O O
4.6(#T) O O
GLOB O O
3.5 O O
3.8 O O
Test O O
Name O O
SMH O O
VHOC O O
04/27/73 O O
04/21/73 O O
13:10 O O
17:52 O O
ALT/SGPT O O
29 O O
26 O O
AST/SGOT O O
36 O O
36(*) O O
ALKP O O
70 O O
72 O O
TBILI O O
0.3 O O
0.7 O O
DBILI O O
0.1 O O
04/27/73 O O
04/27/73 O O
13:10 O O
03:56 O O
CK O O
197 O O
277 O O
CK-MB O O
5.0 O O
6.5 O O
CKMBRI O O
see O O
detail O O
2.3 O O
TROP-T O O
0.16(H) O O
0.20(H) O O
Test O O
Name O O
SMH O O
SMH O O
SMH O O
VHOC O O
04/27/73 O O
04/27/73 O O
04/27/73 O O
04/21/73 O O
15:37 O O
11:26 O O
04:12 O O
17:52 O O
PT O O
11.9 O O
11.7 O O
13.5 O O
PT-INR O O
0.9(T) O O
1.0 O O
PTT O O
43.5(H) O O
25.5 O O
23.6 O O
29.8 O O
Chest O O
x-ray O O
Chest, O O
1 O O
view O O
27-Apr-2073 O O
04:46 O O
FINDINGS: O O
Comparison O O
is O O
made O O
to O O
prior O O
study O O
on O O
4/12/73. O O
The O O
lung O O
volume O O
is O O
low. O O
The O O
lungs O O
are O O
clear. O O
There O O
is O O
no O O
pleural O O
effusion O O
or O O
pneumothorax. O O
The O O
heart O O
size O O
and O O
mediastinum O O
is O O
within O O
normal O O
limits O O
given O O
lung O O
volume. O O
There O O
is O O
no O O
evidence O O
for O O
a O O
displaced O O
fractures. O O
IMPRESSION: O O
Unremarkable O O
chest O O
radiograph. O O
Other O O
imaging O O
Ribs,unil,&gt;2vws O O
27-Apr-2073 O O
07:29 O O
Technique: O O
Rib O O
detail O O
radiographs. O O
Comparison O O
is O O
made O O
a O O
prior O O
study O O
performed O O
9/19/71. O O
Findings: O O
There O O
are O O
old O O
healed O O
fractures O O
of O O
the O O
anterior O O
lateral O O
aspect O O
of O O
the O O
left O O
5th O O
and O O
6th O O
ribs. O O
No O O
acute O O
fractures O O
are O O
identified. O O
There O O
is O O
patchy O O
opacification O O
within O O
the O O
left O O
lower O O
lobe O O
likely O O
represents O O
atelectasis. O O
IMPRESSION: O O
1. O O
No O O
acute O O
rib O O
fractures. O O
2. O O
Old O O
left O O
healed O O
5th O O
and O O
6th O O
rib O O
fractures. O O
3. O O
Left O O
lower O O
lobe O O
patchy O O
atelectasis. O O
VHOC O O
Arterial O O
Pressure O O
Tests O O
12-Apr-2073 O O
***** O O
Segmental O O
Leg O O
Pressure O O
Measurements O O
***** O O
RIGHT O O
LEFT O O
Arm O O
BP O O
183 O O
Pressure O O
(mmHg) O O
Index O O
Pressure(mmHg) O O
Index O O
Upper O O
Thigh O O
255 O O
mmHg O O
1.39 O O
255 O O
mmHg O O
1.39 O O
Lower O O
Thigh O O
255 O O
mmHg O O
1.39 O O
255 O O
mmHg O O
1.39 O O
Calf O O
255 O O
mmHg O O
1.39 O O
255 O O
mmHg O O
1.39 O O
Ankle: O O
Dorsalis O O
Pedis O O
255 O O
mmHg O O
1.39 O O
255 O O
mmHg O O
1.39 O O
Ankle: O O
Posterior O O
Tibial O O
255 O O
mmHg O O
1.39 O O
255 O O
mmHg O O
1.39 O O
**** O O
Leg O O
Pulse O O
Volume O O
Recording O O
**** O O
CUFF O O
LOCATION O O
RIGHT O O
LEFT O O
Upper O O
Thigh O O
Normal O O
Normal O O
Lower O O
Thigh O O
Normal O O
Normal O O
Upper O O
Calf O O
Normal O O
Normal O O
Ankle O O
Normal O O
Normal O O
Metatarsal O O
Normal O O
Normal O O
CONCLUSIONS O O
Due O O
to O O
the O O
presence O O
of O O
vascular O O
calcification O O
artifact, O O
segmental O O
pressure O O
measurements O O
could O O
not O O
be O O
obtained. O O
The O O
pulse O O
volume O O
recordings, O O
however, O O
were O O
normal. O O
ECG O O
Current- O O
NSR O O
at O O
70 O O
bpm, O O
Aaxis O O
+45 O O
degrees, O O
+RAD, O O
PR O O
200 O O
msecs, O O
QRS O O
80 O O
msecs, O O
QTc O O
~400 O O
msecs, O O
TWI O O
I/L, O O
bipahasic O O
TW O O
V2-V5, O O
convex O O
ST O O
elevation O O
V2 O O
and O O
V3. O O
The O O
latter O O
findings O O
are O O
different O O
than O O
previous O O
ECGs O O
Echocardiogram O O
VHOC O O
ECHO O O
13-Apr-2073 O O
Dimensions O O
Normal O O
adult O O
values O O
Aortic O O
Root: O O
3.3 O O
cm O O
&lt;2.2 O O
cm/m2 O O
Left O O
Atrium: O O
3.9 O O
cm O O
&lt;2.1 O O
cm/m2 O O
I.V. O O
Septum O O
Thickness: O O
16 O O
mm. O O
9-11 O O
mm. O O
L.V. O O
Post.Wall O O
Thickness: O O
15 O O
mm. O O
9-11 O O
mm. O O
Left O O
Ventricle O O
DD: O O
5.2 O O
cm. O O
DS: O O
3.4 O O
cm. O O
EF: O O
42 O O
% O O
55-70% O O
Conclusion: O O
1. O O
Normal O O
left O O
ventricular O O
size O O
with O O
moderate O O
concentric O O
left O O
ventricular O O
hypertrophy. O O
Overall O O
systolic O O
function O O
is O O
mildly O O
reduced O O
with O O
an O O
estimated O O
ejection O O
fraction O O
of O O
42%. O O
There O O
is O O
severe O O
anterior O O
and O O
anteroseptal O O
hypokinesis, O O
extending O O
from O O
base O O
to O O
apex. O O
No O O
left O O
ventricular O O
thombus O O
is O O
detected. O O
2. O O
Normal O O
right O O
ventricular O O
size O O
and O O
systolic O O
function. O O
3. O O
Borderline O O
left O O
atrial O O
enlargement. O O
Normal O O
right O O
atrial O O
size. O O
4. O O
The O O
aortic O O
valve O O
is O O
trileaflet O O
with O O
normal O O
leaflet O O
excursion. O O
No O O
significant O O
aortic O O
stenosis O O
or O O
insufficiency O O
is O O
detected. O O
5. O O
The O O
aortic O O
root O O
appears O O
normal O O
in O O
size. O O
6. O O
The O O
mitral O O
valve O O
appears O O
morphologically O O
normal, O O
without O O
prolapse. O O
There O O
is O O
trace O O
mitral O O
regurgitation. O O
7. O O
Normal O O
tricuspid O O
valve, O O
without O O
detected O O
regurgitation. O O
Right O O
ventricular O O
systolic O O
pressure O O
could O O
not O O
be O O
estimated O O
due O O
to O O
insufficient O O
tricuspid O O
regurgitation. O O
8. O O
There O O
is O O
no O O
significant O O
pulmonic O O
insufficiency. O O
9. O O
No O O
significant O O
pericardial O O
effusion. O O
The O O
inferior O O
vena O O
cava O O
appears O O
normal. O O
Coronary O O
angiography O O
As O O
above O O
Carotids O O
VHOC O O
Carotid O O
Ultrasound O O
Tests O O
12-Apr-2073 O O
Report# O O
89-06402Z O O
Final O O
RIGHT O O
Carotid O O
Artery O O
Plaque O O
Surface O O
CA++ O O
Velocity O O
% O O
Stenosis O O
CCA O O
Prox O O
no O O
plaque O O
smooth O O
85 O O
0 O O
CCA O O
Dist O O
no O O
plaque O O
smooth O O
73 O O
0 O O
ICA O O
Prox O O
no O O
plaque O O
smooth O O
78 O O
0 O O
ICA O O
Mid O O
no O O
plaque O O
smooth O O
96 O O
0 O O
ICA O O
Dist O O
no O O
plaque O O
smooth O O
73 O O
0 O O
ECA O O
no O O
plaque O O
smooth O O
116 O O
&lt;50 O O
LEFT O O
Carotid O O
Artery O O
Plaque O O
Surface O O
CA++ O O
Velocity O O
% O O
Stenosis O O
CCA O O
Prox O O
no O O
plaque O O
smooth O O
79 O O
0 O O
CCA O O
Dist O O
no O O
plaque O O
smooth O O
70 O O
0 O O
ICA O O
Prox O O
no O O
plaque O O
smooth O O
73 O O
0 O O
ICA O O
Mid O O
no O O
plaque O O
smooth O O
66 O O
0 O O
ICA O O
Dist O O
no O O
plaque O O
smooth O O
73 O O
0 O O
ECA O O
no O O
plaque O O
smooth O O
95 O O
&lt;50 O O
VERTEBRAL O O
FLOW O O
Right O O
Antegrade O O
Left O O
Antegrade O O
No O O
evidence O O
of O O
hemodynamically O O
significant O O
disease O O
in O O
either O O
the O O
right O O
or O O
the O O
left O O
internal O O
or O O
external O O
carotid O O
arteries. O O
Assesment/Plan O O
54 O O
year O O
old O O
with O O
high O O
risk O O
cardiac O O
risk O O
factors, O O
s/p O O
recent O O
PCI O O
of O O
LAD O O
with O O
recurrent B-CAD O
CP, I-CAD O
and O O
a O O
cath O O
showing O O
a O O
blocked O O
small O O
diagonals O O
that O O
cannot O O
be O O
opened. O O
Plan O O
for O O
maximal O O
medical O O
management. O O
In O O
addition, O O
he O O
has O O
many O O
other O O
medical O O
problems, O O
including O O
continuing O O
therapy O O
for O O
a O O
+PPD, O O
Ischemia O O
- O O
clopidogrel, B-MEDICATION O
ASA O B-MEDICATION
- O O
Atorvastatin O B-MEDICATION
- O O
Add B-MEDICATION O
isordil B-MEDICATION O
when O O
BP O O
allows O O
- O O
Would O O
benefit O O
from O O
ACE-I, B-MEDICATION O
follow O O
BP O O
and O O
add O O
as O O
tolerated O O
HTN O O
- O O
norvasc O B-MEDICATION
- O O
ACE-I O O
- O O
Question O O
h/o O O
problems O O
with O O
BBs O O
given O O
asthma, O O
check O O
with O O
Dr. O O
Elliott, O O
but O O
would O O
also O O
be O O
a O O
good O O
drug O O
to O O
use O O
ESRD/HD O O
- O O
call O O
HD O O
fellow O O
for O O
dialysis O O
next O O
week O O
- O O
nephrocaps O O
- O O
watch O O
K, O O
PO4 O O
- O O
nephrocaps O O
DM O O
- O O
continue O O
home O O
NPH O O
dose O O
- O O
RISS O O
- O O
CV/DM O O
diet O O
- O O
Gabapentin O O
for O O
neuropathy O O
PPD O O
- O O
continue O O
rifampin O O
Prophylaxis O O
- O O
fragmin O O
2500 O O
qd O O
- O O
esomeprazole O O
20 O O
qd O O
- O O
OOB O O
as O O
soon O O
as O O
possible O O
Harold O O
Younkin, O O
MD O O
Medicine O O
Junior O O
Resident O O
Pager O O
43548 O O

Record O O
date: O O
2073-09-22 O O
SMH O O
Junior O O
Neurology O O
Consult O O
Note O O
9/22/73 O O
ID/CC: O O
55 O O
yo O O
male O O
presents O O
from O O
rehab O O
facility O O
with O O
shaking O O
activity. O O
HPI: O O
He O O
has O O
a O O
h/o O O
frozen O O
shoulder O O
and O O
is O O
s/p O O
left O O
shoulder O O
arthroscopy, O O
capsular O O
release, O O
09/03/2073. O O
He O O
was O O
discharged O O
on O O
OxyContin O O
20 O O
mg O O
p.o. O O
b.i.d. O O
x4 O O
days, O O
oxycodone O O
5-10 O O
mg O O
p.o. O O
q.3h. O O
p.r.n. O O
pain. O O
He O O
returned O O
to O O
the O O
SMH O O
ED O O
on O O
Mon O O
9/17 O O
with O O
shaking O O
activity O O
that O O
was O O
episodic O O
but O O
not O O
rhythmic. O O
He O O
was O O
given O O
Narcan O O
and O O
the O O
shaking O O
subsided. O O
He O O
was O O
sent O O
back O O
to O O
rehab O O
off O O
opiates. O O
He O O
returns O O
today O O
from O O
the O O
rehab O O
facility O O
with O O
recurrence O O
of O O
shaking O O
activity O O
He O O
was O O
given O O
Ativan O O
1mg O O
at O O
rehab O O
today. O O
In O O
the O O
ED O O
he O O
was O O
given O O
Ativan O O
2mg, O O
Haldol O O
5mg, O O
Narcan O O
0.4 O O
mg O O
(after O O
which O O
he O O
was O O
more O O
awake) O O
and O O
Lopressor B-MEDICATION B-MEDICATION
5 O O
mg O O
iv O O
PMH: O O
1. O O
diabetes B-DIABETES O
retinopathy, O O
neuropathy,nephropathy, O O
2. O O
coronary B-CAD O
artery I-CAD O
disease, I-CAD O
3. O O
hyperhomocysteinemia, O O
4. O O
hypertension B-HYPERTENSION O
5. O O
end-stage O O
renal O O
disease O O
on O O
hemodialysis, O O
6. O O
hyperlipidemia, B-HYPERLIPIDEMIA O
7. O O
hypothyroidism, O O
8. O O
asthma, O O
9. O O
gastroesophageal O O
reflux O O
disease O O
10. O O
positive O O
PPD O O
on O O
rifampin. O O
Medications: O O
Lisinopril, B-MEDICATION B-MEDICATION
Norvasc, B-MEDICATION B-MEDICATION
Nephrocaps, O O
Nexium, O O
Humulin, B-MEDICATION O
Neurontin, O O
ketoconazole, O O
Lac-Hydrin, O O
Pulmicort, O O
Bupropion, O O
Epogen, O O
albuterol O O
inhaler, O O
Synthroid, O O
quinine, O O
folate, O O
rifampin. O O
Allergies: O O
Potassium O O
Iod O O
(OBSOLETE) O O
- O O
Unknown O O
: O O
Allergy O O
entered O O
as O O
IODINE O O
SOLN O O
Iv O O
Contrast O O
- O O
Unknown O O
METFORMIN O B-MEDICATION
- O O
diarrhea, O O
ISONIAZID O B-MEDICATION
- O O
Hepatitis, O O
: O O
LFTs O O
returned O O
to O O
normal O O
after O O
INH O O
d/c'd. O O
FH: O O
Not O O
obtained O O
SH: B-SMOKER O
Not O O
obtained O O
ROS: O O
Not O O
obtained O O
ED: O O
Vitals O O
1538: O O
T: O O
p70 O O
BP B-HYPERTENSION O
190/80 I-HYPERTENSION O
up I-HYPERTENSION O
to I-HYPERTENSION O
265/108 B-HYPERTENSION O
rr O O
22 O O
O2 O O
General: O O
eyes O O
fixed O O
shut, O O
NAD O O
HEENT: O O
Anicteric, O O
MMM O O
without O O
lesions, O O
Neck: O O
Supple O O
CV: O O
Reg O O
rhythm, O O
normal O O
s1s2, O O
no O O
m/r/g, O O
no O O
carotid O O
bruits, O O
2+ O O
radial O O
pulses O O
Resp: O O
CTAB O O
and O O
and O O
lat O O
no O O
wheeze O O
Abd: O O
Soft/NT/ND O O
Ext: O O
No O O
C/C/E O O
MS: O O
Responds O O
by O O
grunting O O
'Ouch' O O
to O O
sternal O O
rub, O O
does O O
not O O
follow O O
simple O O
commands, O O
does O O
not O O
answer O O
y/n O O
questions, O O
mute, O O
CN: O O
I O O
- O O
not O O
tested; O O
II,III O O
- O O
pupils O O
round O O
reactive O O
to O O
light O O
bilaterally O O
4-&gt;3mm, O O
VFF O O
by O O
confrontation,; O O
III,IV,VI O O
- O O
no O O
gaze O O
preference, O O
no O O
nystagmus; O O
V-unable O O
to O O
assess O O
VII O O
- O O
no O O
facial O O
asymmetries, O O
y, O O
VIII O O
- O O
hears O O
finger O O
rub O O
2 O O
feet O O
away O O
B; O O
IX,X O O
- O O
voice O O
normal, O O
palate O O
elevates O O
symmetrically, O O
gag O O
intact; O O
XI O O
- O O
SCM/Trapezii O O
5/5 O O
B; O O
XII O O
- O O
tongue O O
protrudes O O
midline. O O
Motor: O O
normal O O
bulk O O
and O O
tone. O O
His O O
arms O O
and O O
legs O O
occasionally O O
flail O O
about O O
in O O
the O O
bed O O
in O O
a O O
nonrhythmic O O
fashion.When O O
he O O
is O O
agitated O O
by O O
being O O
examined O O
the O O
adventitious O O
movements O O
are O O
more O O
pronounced. O O
Occasionally O O
he O O
is O O
coaxed O O
into O O
relaxing O O
his O O
legs O O
and O O
they O O
shake O O
minimally O O
to O O
none O O
Strength: O O
He O O
has O O
good O O
antigravity O O
strength O O
in O O
all O O
ext O O
Reflexes: O O
Jaw O O
Jerk: O O
Crossed O O
hip O O
adduction: O O
none O O
unable O O
to O O
assess O O
patellar O O
reflexes O O
secondary O O
to O O
patient O O
moving O O
in O O
bed. O O
Sensory: O O
withdraws O O
purposefully O O
in O O
all O O
ext O O
Coord: O O
unable O O
to O O
assess O O
Gait: O O
unable O O
to O O
assess O O
Labs: O O
SMH O O
BLOOD O O
22-Sep-2073 O O
00:48 O O
Accession# O O
4981N91964 O O
Sodium O O
(Stat O O
Lab) O O
142 O O
(135-145) O O
mmol/L O O
Potassium O O
(Stat O O
Lab) O O
5.0 O O
H O O
(3.4-4.8) O O
mmol/L O O
Chloride O O
(Stat O O
Lab) O O
110 O O
H O O
(100-108) O O
mmol/L O O
CO2 O O
(Stat O O
Lab) O O
25.1 O O
(23.0-31.9) O O
mmol/L O O
BUN O O
(Stat O O
Lab) O O
18 O O
(8-25) O O
mg/dl O O
Creatinine O O
(Stat O O
Lab) O O
4.2 O O
H O O
(0.6-1.5) O O
mg/dl O O
Glucose O O
(Stat O O
Lab) O O
302 O O
H O O
(70-110) O O
mg/dl O O
Chemistry O O
Detail O O
for O O
LUJAN, O O
VICTOR O O
SMH O O
RANDOM O O
22-Sep-2073 O O
00:02 O O
Accession# O O
0389R30883 O O
Urine O O
Phencyclidine O O
NEGATIVE O O
Urine O O
Barbiturates O O
NEGATIVE O O
Urine O O
Cannabinoids O O
NEGATIVE O O
Urine O O
Amphetamines O O
NEGATIVE O O
Urine O O
Benzodiazepines O O
NEGATIVE O O
Urine O O
Opiates O O
POSITIVE O O
This O O
assay O O
is O O
very O O
sensitive O O
to O O
morphine O O
and O O
codeine. O O
The O O
assay O O
is O O
less O O
sensitive O O
to O O
oxycodone. O O
Large O O
quantities O O
of O O
oxymorphone O O
and/or O O
meperidine O O
can O O
also O O
cause O O
positive O O
results. O O
Urine O O
Cocaine O O
Metabolites O O
NEGATIVE O O
SMH O O
ED O O
LAB O O
21-Sep-2073 O O
16:33 O O
Accession# O O
0646L21612 O O
Creatine O O
Kinase O O
Isoenzymes O O
NEGATIVE O O
(NEG) O O
Troponin-I O O
NEGATIVE O O
(NEG) O O
SMH O O
BLOOD O O
21-Sep-2073 O O
16:10 O O
Accession# O O
1993W67007 O O
Calcium O O
9.6 O O
(8.5-10.5) O O
mg/dl O O
Phosphorus O O
2.4 O O
L O O
(2.6-4.5) O O
mg/dl O O
Magnesium O O
1.5 O O
(1.4-2.0) O O
meq/L O O
Total O O
Protein O O
7.4 O O
(6.0-8.3) O O
g/dl O O
Albumin O O
3.6 O O
(3.3-5.0) O O
g/dl O O
Globulin O O
3.8 O O
(2.6-4.1) O O
g/dl O O
Direct O O
Bilirubin O O
0.2 O O
(0-0.4) O O
mg/dl O O
Total O O
Bilirubin O O
0.4 O O
(0.0-1.0) O O
mg/dl O O
Alkaline O O
Phosphatase O O
69 O O
(45-115) O O
U/L O O
Transaminase-SGPT O O
12 O O
(10-55) O O
U/L O O
Amylase O O
42 O O
(3-100) O O
units/L O O
Lipase O O
2.2 O O
(1.3-6.0) O O
U/dl O O
Transaminase-SGOT O O
23 O O
(10-40) O O
U/L O O
SMH O O
CSF O O
22-Sep-2073 O O
03:31 O O
Accession# O O
4996A57897 O O
CSF O O
Sugar O O
PEND O O
(50-75) O O
mg/dl O O
CSF O O
TP O O
PEND O O
(5-55) O O
mg/dl O O
Studies: O O
CT O O
I O O
-: O O
NO O O
SIGNIFICANT O O
INTERVAL O O
CHANGE O O
FROM O O
THE O O
PRIOR O O
STUDY. O O
NO O O
ACUTE O O
INTRACRANIAL O O
FINDINGS. O O
CXR: O O
Cardiomegaly O O
with O O
interstitial O O
pulmonary O O
edema. O O
The O O
findings O O
are O O
more O O
prominent O O
then O O
the O O
prior O O
study O O
from O O
4/27/73 O O
x-ray. O O
EKG: O O
NSR O O
72 O O
with O O
TWF O O
in O O
I O O
and O O
TWI O O
in O O
L O O
unchanged O O
from O O
9/18 O O
Impression: O O
55 O O
yo O O
male O O
with O O
multiple O O
medical O O
problems O O
presents O O
from O O
rehab O O
facility O O
with O O
recurrence O O
of O O
shaking O O
activity. O O
His O O
current O O
exam O O
is O O
c/w O O
encephalopathy O O
with O O
no O O
focal O O
neurological O O
deficits. O O
The O O
patient O O
has O O
multiple O O
reasons O O
to O O
be O O
encephalopathic O O
including O O
renal O O
insufficiency, O O
opiate O O
withdrawal O O
or O O
hypertensive O O
encephalopathy. O O
He O O
does O O
not O O
appear O O
to O O
be O O
having O O
seizures O O
because O O
his O O
movements O O
are O O
not O O
rhythmic O O
and O O
are O O
altered O O
during O O
interactions O O
with O O
examiners. O O
Recommendations: O O
- O O
check O O
UA, O O
NH3 O O
- O O
lower O O
systolic O O
blood O O
pressure O O
to O O
below O O
200, O O
e.g. O O
with O O
Labetalol. O O
- O O
Give O O
2g O O
MgSO4 O O
(given O O
renal O O
insuff), O O
follow O O
Mg O O
bid O O
and O O
dose O O
Mg O O
bid O O
to O O
keep O O
level O O
at O O
high O O
end O O
of O O
normal. O O
- O O
Check O O
EEG O O
to O O
assess O O
for O O
epileptiform O O
activity O O
- O O
Check O O
MRI/A O O
to O O
assess O O
for O O
posterior O O
leukoencephalopathy O O
This O O
case O O
was O O
discussed O O
with O O
the O O
ED O O
neurology O O
senior O O
resident O O
Dr O O
Benjamin O O
Iles O O
Thank O O
you O O
for O O
this O O
interesting O O
consult. O O
___________________________ O O
Sean O O
Quinto, O O
M.D O O
Resident O O
in O O
Neurology O O
Pgr O O
47878 O O

Record B-SMOKER O
date: O O
2074-09-21 O O
MICHAEL O O
NOLAND O O
FWH O O
Unit O O
No: O O
233-87-20 O O
MINERAL O O
SPRINGS O O
CLINIC O O
ADULT O O
MEDICINE O O
Date: O O
September O O
21, O O
2074 O O
46-year-old O O
male O O
presenting O O
for O O
follow O O
up O O
of O O
his O O
blood O O
pressure. O O
Since O O
his O O
last O O
visit O O
a O O
month O O
ago, O O
he O O
has O O
been O O
exercising, O O
going O O
out O O
for O O
walks O O
every O O
other O O
day, O O
compliant O O
with O O
medications. O O
No O O
new O O
complaints O O
for O O
today. O O
PAST O O
MEDICAL O O
HISTORY: O O
(1) O O
Obesity. B-OBESE O
(2) O O
Hypertension. B-HYPERTENSION O
(3) O O
History O O
of O O
glucose O O
intolerance. O O
(4) O O
Mild B-HYPERLIPIDEMIA O
hyperlipidemia. I-HYPERLIPIDEMIA O
MEDICATIONS: O O
Lisinopril B-MEDICATION B-MEDICATION
40 O O
mg O O
q.d., O O
Procardia B-MEDICATION O
XL I-MEDICATION O
90 O O
mg O O
q.d. O O
PHYSICAL O O
EXAMINATION: O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
today I-HYPERTENSION O
initially I-HYPERTENSION O
190/108. B-HYPERTENSION O
Subsequently, I-HYPERTENSION O
170/110. I-HYPERTENSION O
Rest O O
of O O
exam O O
was O O
deferred O O
as O O
he O O
had O O
an O O
exam O O
a O O
month O O
ago. O O
ASSESSMENT O O
& O O
PLAN: O O
(1) O O
Hypertension. O B-HYPERTENSION
Outpatient O O
readings O O
support O O
today's O O
reading O O
as O O
the O O
patient O O
as O O
an O O
automatic O O
blood O O
pressure O O
machine. O O
Will O O
add B-MEDICATION O
hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
mg O O
q.d. O O
and O O
come O O
back O O
in O O
4 O O
days. O O
A O O
recent O O
urinalysis O O
showed O O
1+ O O
protein. O O
He O O
will O O
come O O
back O O
to O O
check O O
an O O
early O O
AM O O
urinalysis O O
to O O
reassess O O
for O O
presence O O
of O O
protein. O O
Follow O O
up O O
at O O
next O O
visit. O O
(2) O O
History O O
of O O
glucose O O
intolerance. O O
However, O O
he O O
had O O
a O O
normal O O
fasting O O
sugar O O
of O O
104 O O
and O O
a O O
hemoglobin O O
A1C O O
of O O
6.20. O O
Mean O O
glucose O O
of O O
121. O O
(3) O O
History O O
of O O
mild O O
hyperlipidemia. O O
However, O O
cholesterol O O
now O O
of O O
186, O O
HDL O O
46, O O
LDL B-HYPERLIPIDEMIA O
105. I-HYPERLIPIDEMIA O
Cardiac O O
risk O O
ratio O O
4.0. O O
Continue O O
with O O
weight O O
loss. O O
Quince O O
Ezell, O O
M.D. O O
QE/mcclain/newsom O O

Record B-SMOKER O
date: O O
2076-09-28 O O
Nutrition O O
Clinic O O
Initial O O
Assessment O O
9/28/76 O O
Problems: O O
HTN, B-HYPERTENSION O
type B-DIABETES O
2 I-DIABETES O
DM, I-DIABETES O
class O O
III O O
obesity B-OBESE O
Wt: O O
278# O O
Ht: O O
5'6' O O
BMI: B-OBESE O
44.5 I-OBESE O
Weight O O
History: O O
long O O
Hx O O
obesity O O
highest O O
bw O O
285# O O
Activity O O
Level: O O
ADL's O O
just O O
began O O
walking O O
per O O
report O O
q O O
other O O
d O O
Maintenance O O
Calorie O O
Needs: O O
2,400kcals/d O O
wt. O O
loss O O
kcals: O O
1,900kcals/d O O
Diet O O
History: O O
Calories O O
- O O
% O O
Protein O O
- O O
% O O
Fat O O
- O O
% O O
CHO O O
- O O
% O O
Sat O O
Fat O O
- O O
mg O O
Chol- O O
mg O O
Na O O
- O O
Labs: O O
HbAIC B-DIABETES O
8.10% I-DIABETES O
8/76 I-DIABETES O
SMBG O O
qd O O
120-140mg O O
Assessment: O O
48 O O
yo O O
class O O
III O O
obese O O
m. O O
w/ O O
HTN, O O
type O O
2 O O
DM O O
interested O O
in O O
improving O O
bp O O
and O O
wt. O O
Notes O O
w/ O O
past O O
diets O O
difficult O O
to O O
be O O
on O O
b/c O O
some O O
high O O
in O O
Na O O
(atkins O O
he O O
tried) O O
and O O
others O O
not O O
good O O
for O O
DM. O O
Requests O O
2,000kcal O O
diet O O
which O O
will O O
comply O O
w/ O O
his O O
med O O
needs. O O
Also O O
on O O
the O O
road O O
often O O
for O O
work O O
and O O
eats O O
most O O
lunches O O
out. O O
Recall O O
reveals, O O
he O O
is O O
careful O O
w/ O O
label O O
reading O O
yet O O
some O O
inconsistencies O O
in O O
cho O O
intake O O
and O O
high O O
fat O O
, O O
high O O
Na O O
choices O O
when O O
eating O O
out O O
which O O
is O O
qd. O O
Reviewed O O
all O O
basics O O
today O O
including O O
meal O O
plan O O
w/ O O
consistent O O
CHO O O
intake, O O
fiber, O O
and O O
lean O O
pro O O
@ O O
each O O
meal O O
Treatment O O
Plan: O O
5 O O
small O O
meals/d O O
consistent O O
CHO O O
intake O O
@ O O
each O O
meal O O
lean O O
pro O O
w/ O O
each O O
meal O O
increase O O
fiber O O
goal O O
20-35g/d O O
label O O
reading O O
&lt;250 O O
mg O O
Na O O
&lt;2,400mg/d O O
Na O O
goal O O
portion O O
control O O
sat O O
fat O O
&lt;7% O O
kcals O O
healthful O O
eating O O
out O O
guidelines O O
regular O O
exercise O O
Recommended O O
Additional O O
visits: O O
prn O O
Educational O O
materials O O
provided: O O
handouts, O O
written O O
guidelines O O
Pt O O
Response: O O
Receptive O O
RTC: O O
5wks O O
w/ O O
food O O
record O O
Sampson, O O
MS,RD,LDN O O

Record O O
date: O O
2078-06-18 O O
NEUROLOGY O O
JUNIOR O O
ADMIT/CONSULT B-DIABETES O
NOTE O O
CC O O
slurred O O
speech, O O
L O O
hand O O
tingling O O
HPI O O
50 O O
yo O O
RHM O O
presents O O
after O O
episode O O
of O O
L O O
hand O O
tingling O O
and O O
slurred O O
speech. O O
He O O
was O O
in O O
his O O
usual O O
state O O
of O O
health O O
when O O
he O O
woke O O
up O O
at O O
8 O O
am. O O
At O O
around O O
10 O O
am O O
he O O
told O O
his O O
son O O
that O O
he O O
was O O
not O O
feeling O O
well O O
and O O
went O O
to O O
bed. O O
He O O
reports O O
that O O
his O O
speech O O
was O O
normal O O
at O O
that O O
time. O O
At O O
11:30 O O
his O O
wife O O
called O O
him O O
and O O
his O O
speech O O
was O O
slurred. O O
He O O
was O O
able O O
to O O
say O O
real O O
words O O
but O O
they O O
were O O
slurred O O
and O O
almost O O
unintelligible. O O
He O O
also O O
had O O
L O O
hand O O
tingling. O O
The O O
slurred O O
speech O O
and O O
tingling O O
resolved O O
at O O
12:15 O O
pm. O O
He O O
denies O O
weakness, O O
diplopia, O O
difficulty O O
swallowing, O O
headache, O O
vertigo, O O
chest O O
pain, O O
palpitations. O O
One O O
week O O
ago, O O
while O O
he O O
was O O
on O O
vacation O O
in O O
Chincoteague, O O
he O O
had O O
a O O
transient O O
episode O O
of O O
slurred O O
speech. O O
He O O
reports O O
that O O
as O O
he O O
was O O
walking O O
to O O
the O O
bathroom, O O
he O O
suddenly O O
felt O O
lightheaded O O
and O O
fell. O O
He O O
had O O
slurred O O
speech O O
and O O
difficulty O O
standing O O
up O O
but O O
no O O
focal O O
weakness. O O
The O O
episode O O
lasted O O
minutes. O O
PMH O O
HTN B-HYPERTENSION O
hypercholesterolemia B-HYPERLIPIDEMIA O
DM O O
sleep O O
apnea O O
s/p O O
cholecystectomy O O
TTE O O
11/77 O O
- O O
mildly O O
dilated O O
LA, O O
mod O O
LVH, O O
EF O O
66% O O
MEDS O O
ASA B-MEDICATION B-MEDICATION
325 O O
Zestril B-MEDICATION B-MEDICATION
40 O O
HCTZ B-MEDICATION B-MEDICATION
25 O O
Atenolol B-MEDICATION B-MEDICATION
100 O O
Hytrin O B-MEDICATION
2 O O
bid O O
glucophage B-MEDICATION B-MEDICATION
1000 O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
Atrovent O O
ALL O O
nkda O O
FAM O O
HX O O
Parents O O
with O O
hypertension, O B-HYPERTENSION
father O O
with O O
strokes O O
SOCIAL O O
HX O O
Married. O O
No B-SMOKER O
smoking. I-SMOKER O
PE O O
VITALS O O
P70 O O
BP150/80 B-HYPERTENSION O
O2 O O
sat O O
98% O O
2L O O
GENERAL O O
NAD O O
HEENT O O
MMM O O
NECK O O
no O O
bruits O O
CHEST O O
CTAB O O
CV O O
RRR O O
no O O
mrg O O
ABDO O O
soft O O
ND O O
NT O O
EXT O O
no O O
edema O O
NEURO O O
MS: O O
Alert, O O
oriented. O O
Speech O O
fluent O O
without O O
paraphasic O O
errors. O O
Can O O
name, O O
repeat O O
and O O
follow O O
commands. O O
CN: O O
Pupils O O
equal, O O
round, O O
reactive O O
to O O
light O O
Visual O O
fields O O
full O O
to O O
double O O
simultaneous O O
quadrantic O O
visual O O
confrontation. O O
EOMI O O
s O O
nystagmus O O
Facial O O
sensation O O
in O O
V1-V3 O O
intact O O
bilaterally O O
to O O
light O O
touch O O
and O O
pin. O O
Face O O
movement O O
symmetrical. O O
Hearing O O
intact O O
to O O
fingerrub O O
No O O
dysphonia. O O
Palate O O
elevates O O
symmetrically. O O
Tongue O O
and O O
palate O O
midline, O O
no O O
fasciculations. O O
Shoulder O O
shrug O O
equal O O
bilaterally O O
5/5. O O
Motor: O O
normal O O
bulk O O
and O O
tone, O O
no O O
tremor, O O
no O O
drift, O O
leads O O
with O O
L O O
arm O O
on O O
orbiting O O
Del O O
Bic O O
Tri O O
WE O O
WF O O
FE O O
FF O O
IO O O
HF O O
HE O O
KF O O
KE O O
DF O O
PF O O
L O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
R O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
Coord: O O
normal O O
finger O O
to O O
nose, O O
heel O O
to O O
shin O O
Sens: O O
normal O O
light O O
touch, O O
pinprick, O O
vibration O O
Reflexes: O O
2+ O O
c O O
downgoing O O
toes O O
LABS O O
NA O O
135 O O
K O O
3.1(L) O O
CL O O
99(L) O O
CO2 O O
27.5 O O
BUN O O
27(H) O O
CRE O O
1.4 O O
GLU O O
368(H) O O
WBC O O
11.5(H) O O
HCT O O
42.2 O O
MCV O O
84 O O
PLT O O
226 O O
PT O O
12.9 O O
PTT O O
21.8(L) O O
STUDIES O O
Head O O
CT/CTA O O
prelim O O
read O O
negative O O
MRI O O
prelim O O
read O O
- O O
L O O
insular O O
infarct O O
A/P O O
50 O O
yo O O
RHM O O
with O O
45 O O
minute O O
episode O O
of O O
dysarthria O O
and O O
L O O
hand O O
tingling, O O
now O O
asymptomatic O O
with O O
normal O O
neurologic O O
exam. O O
1) O O
Neuro O O
- O O
admit O O
to O O
RDA O O
neurology O O
- O O
continue O O
ASA O B-MEDICATION
- O O
TTE, O O
Holter O O
- O O
continue O O
HCTZ, O O
atenolol, O B-MEDICATION
Norvasc O B-MEDICATION
2) O O
Renal O O
- O O
has O O
Cr O O
1.4, O O
was O O
on O O
glucophage, O O
received O O
contrast O O
--&gt; O O
will O O
need O O
IVF O O
3) O O
DM O O
- O O
SSI, O O
hold O O
glucophage O O
4) O O
Pulm O O
- O O
prn O O
nebs O O
5) O O
Proph O O
- O O
nexium, O O
fragmin O O
Davine O O
Malone, O O
MD O O
5-4328 O O
Pioneer O O
Neurology O O
Resident O O

Record O O
date: O O
2081-09-15 O O
CARDIOLOGY O O
FORT O O
WASHINGTON O O
HOSPITAL O O
Reason O O
for O O
visit: O O
consulted O O
by O O
Dr O O
Dunham O O
for O O
continuity O O
of O O
care O O
s/p O O
cabg B-CAD O
Interval O O
History: O O
This O O
53 O O
yo O O
male O O
was O O
referred O O
with O O
DM B-DIABETES O
and O O
CAD B-CAD O
who O O
today O O
underwent O O
CABG O O
and O O
CEA O O
with O O
Dr O O
Dunham. O O
Specifically O O
he O O
had: O O
CABG B-CAD B-MEDICATION
x I-CAD O
3; I-CAD O
LIMA: O O
Pedicle O O
(IMA) O O
to O O
LAD-Mid O O
Saphenous O O
Vein: O O
Ascending O O
Aorta O O
to O O
Diagonal-2nd O O
Saphenous O O
Vein: O O
Ascending O O
Aorta O O
to O O
Diagonal-3rd; O O
Coronary O O
Endarterectomy. O O
He O O
was O O
in O O
his O O
USOH O O
until O O
several O O
months O O
ago O O
when O O
he O O
first O O
noticed O O
lower O O
extremity O O
edema O O
and O O
activity O O
intolerance. O O
Symptoms O O
waxed O O
and O O
waned, O O
but O O
eventually O O
progressed O O
so O O
he O O
was O O
experiencing O O
daily O O
SOB O O
and O O
fatigue O O
with O O
usual O O
daily O O
activities O O
such O O
as O O
walking O O
or O O
working O O
around O O
his O O
home, O O
and O O
worsening O O
LE O O
edema O O
up O O
to O O
his O O
knees. O O
He O O
sought O O
evaluation O O
from O O
his O O
PCP O O
3 O O
weeks O O
ago O O
was O O
and O O
found O O
to O O
have O O
severe O O
cardiomyopathy O O
with O O
LVEF O O
of O O
25% O O
on O O
stress-MIBI. O O
There O O
was O O
global O O
hypokinesis. O O
Perfusion O O
images O O
suggest O O
a O O
small O O
distal O O
anteroapical O O
scar O O
and O O
moderately O O
dilated O O
LV O O
(both O O
new O O
since O O
2076). O O
There O O
was O O
no O O
definite O O
evidence O O
of O O
ischemia, O O
although O O
it O O
is O O
noted O O
the O O
patient O O
was O O
unable O O
to O O
achieve O O
85% O O
MPHR O O
due O O
to O O
poor O O
activity O O
tolerance. O O
He O O
was O O
started O O
on O O
Coreg, B-MEDICATION O
as O O
well O O
as O O
Lasix O O
which O O
has O O
been O O
uptitrated O O
from O O
20 O O
to O O
60mg O O
qd, O O
with O O
subsequent O O
12-14 O O
lbs O O
weight O O
loss. O O
His O O
lower O O
extremity O O
edema O O
is O O
markedly O O
improved, O O
and O O
activity O O
tolerance O O
is O O
moderately O O
improved. O O
He O O
can O O
perform O O
basic O O
ADLs O O
such O O
as O O
dressing O O
and O O
bathing O O
without O O
difficulty. O O
Walking, O O
especially O O
inclines, O O
climbing O O
stairs, O O
and O O
carrying O O
parcels O O
will O O
cause O O
SOB. O O
He O O
still O O
feels O O
fatigued O O
throughout O O
the O O
day. O O
He O O
has O O
no O O
orthopnea, O O
PND, O O
abdominal O O
distension, O O
early O O
satiety, O O
abdominal O O
pain O O
or O O
anorexia. O O
He O O
reports O O
BPs B-HYPERTENSION O
are I-HYPERTENSION O
much I-HYPERTENSION O
improved I-HYPERTENSION O
with I-HYPERTENSION O
the I-HYPERTENSION O
addition I-HYPERTENSION O
of I-HYPERTENSION O
Coreg, I-HYPERTENSION O
even I-HYPERTENSION O
as I-HYPERTENSION O
they I-HYPERTENSION O
are I-HYPERTENSION O
running I-HYPERTENSION O
130-150s/80-100. I-HYPERTENSION O
Past O O
medical O O
history: O O
1. O O
DCM, O O
diagnosed O O
7/81. O O
2. O O
HTN, B-HYPERTENSION O
long O O
standing, O O
poorly O O
controlled. O O
3. O O
DM, O O
onset O O
~2074. O O
became O O
insulin B-MEDICATION O
dependent O O
several O O
months O O
ago. O O
a. O O
Retinopathy O O
and O O
cotton O O
wool O O
spot. O O
b. O O
No O O
peripheral O O
neuropathy. O O
4. O O
Renal O O
insufficiency, O O
creatinine O O
1.6. O O
5. O O
S/P O O
CVA, O O
L O O
putamen, O O
? O O
cocaine O O
related. O O
6. O O
History O O
of O O
cocaine O O
abuse, O O
last O O
reported O O
use O O
2078. O O
7. O O
Obesity. B-OBESE O
8. O O
Sleep O O
apnea, O O
untreated. O O
9. O O
Hyperlipidemia. B-HYPERLIPIDEMIA O
On O O
low O O
dose O O
statin. B-MEDICATION O
Family O O
history: O O
Father O O
had O O
HTN, O O
stroke O O
age O O
45. O O
Mother O O
had O O
HTN. O O
No O O
known O O
coronary O O
artery O O
disease, O O
arrhythmias, O O
SCD, O O
heart O O
failure, O O
cardiomyopathy O O
in O O
immediate O O
family O O
members. O O
Social O O
history: O O
He O O
is O O
married, O O
with O O
3 O O
young O O
adult O O
children O O
who O O
are O O
A+W. O O
He O O
was O O
formerly O O
self-employed O O
as O O
a O O
CPA O O
and O O
would O O
often O O
travel O O
worldwide. O O
He O O
stopped O O
doing O O
so O O
after O O
2075 O O
so O O
has O O
no O O
recent O O
travel O O
out O O
of O O
the O O
country. O O
He O O
is O O
now O O
employed O O
by O O
Applied O O
Industrial O O
Technologies O O
as O O
an O O
accountant. O O
Habits: O O
Denies B-SMOKER O
any I-SMOKER O
history I-SMOKER O
of I-SMOKER O
tobacco I-SMOKER O
use. I-SMOKER O
Although O O
he O O
denied O O
illicit O O
drug O O
use, O O
his O O
chart O O
review O O
revealed O O
above O O
noted O O
history O O
of O O
cocaine O O
abuse. O O
He O O
subsequently O O
admitted O O
to O O
prior O O
use, O O
i.e. O O
at O O
parties O O
while O O
traveling. O O
He O O
denies O O
related O O
excessive O O
ETOH O O
use, O O
use O O
of O O
other O O
illicit O O
drugs, O O
or O O
high O O
risk O O
sexual O O
behaviors. O O
He O O
admits O O
to O O
3 O O
drinks O O
per O O
week O O
currently. O O
Review O O
of O O
systems: O O
As O O
detailed O O
in O O
HPI. O O
He O O
has O O
never O O
had O O
chest O O
pain O O
or O O
pressure, O O
palpitations, O O
irregular O O
heartbeat, O O
presyncope, O O
or O O
syncope. O O
He O O
denies O O
having O O
had O O
fever, O O
chills, O O
or O O
acute O O
viral O O
illness O O
preceding O O
onset O O
of O O
symptoms, O O
recent O O
travel O O
out O O
of O O
the O O
country O O
or O O
history O O
of O O
tick O O
bites, O O
hepatitis, O O
or O O
TB. O O
He O O
has O O
no O O
known O O
thyroid O O
problems. O O
Remaining O O
ROS O O
noncontributory. O O
Physical O O
examination: O O
-General: O O
Obese B-OBESE O
WM, O O
somewhat O O
anxious O O
appearing O O
in O O
NAD. O O
Intubated/sedated O O
-Skin: O O
No O O
rashes, O O
nonicteric. O O
-HEENT: O O
NC. O O
No O O
scleral O O
icterus. O O
MMM. O O
-Neck: O O
Short O O
neck. O O
Carotids O O
+2 O O
bilaterally, O O
no O O
bruits. O O
JVP O O
assessment O O
difficult O O
due O O
to O O
body O O
habitus, O O
~ O O
8-9cm O O
H20. O O
-Chest: O O
Clear O O
to O O
percussion O O
and O O
ausculation. O O
median O O
sternotomy O O
bandaged. O O
-Cardiac: O O
RRR; O O
no O O
rub O O
-Abdomen: O O
Obese, O O
soft, O O
NTND, O O
no O O
fluid O O
wave. O O
Unable O O
to O O
appreciate O O
liver O O
edge. O O
No O O
palpable O O
masses. O O
-Extremities: O O
Somewhat O O
cool O O
distal O O
to O O
lower O O
shins, O O
with O O
trace O O
pretibial O O
edema O O
bilaterally. O O
Good O O
femoral O O
pulses, O O
no O O
bruit. O O
PT O O
pulses O O
intact. O O
-Neuro: O O
sedated O O
Assessment O O
and O O
plan: O O
53 O O
yom O O
with O O
DM O O
and O O
CAD O O
now O O
immediatey O O
s/p O O
CABG. O O
At O O
this O O
point O O
routing O O
CABG O O
post-op O O
care; O O
will O O
follow O O
with O O
you. O O
As O O
he O O
weans O O
off O O
support O O
would O O
resume O O
his O O
usual O O
regimen O O
of O O
meds. O O
Sherrill O O
Gaines, O O
MD O O
pager O O
#36466 O O
Signed O O
electronically O O
by O O
Sherrill O O
Gaines, O O
MD O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2084-01-21 O O
ORLANDO O O
REGIONAL O O
Xavier, O O
Fred O O
65856594 O O
1-21-84 O O
Mr. O O
Xavier O O
is O O
a O O
71-year-old O O
male O O
coming O O
in O O
for O O
the O O
first O O
time O O
for O O
evaluation O O
and O O
follow O O
up O O
for O O
health O O
maintenance. O O
He O O
comes O O
in O O
without O O
major O O
complaints. O O
He O O
is O O
a O O
gentleman O O
from O O
Eritrea O O
who O O
is O O
now O O
retired. O O
He O O
is O O
a O O
very O O
active O O
person. O O
He O O
is O O
able O O
to O O
walk O O
2-3 O O
kilometers O O
without O O
any O O
dyspnea O O
on O O
exertion, O O
no O O
chest O O
pain, O O
no O O
shortness O O
of O O
breath. O O
He O O
sleeps O O
well. O O
There O O
is O O
no O O
nocturia. O O
There O O
is O O
no O O
orthopnea O O
or O O
PND. O O
There O O
is O O
currently O O
no O O
claudication. O O
He O O
does O O
say O O
that O O
he O O
has O O
a O O
history O O
of O O
a O O
left O O
femoral/popliteal O O
bypass O O
done O O
in O O
January O O
of O O
2083, O O
one O O
month O O
after O O
arriving O O
from O O
Eritrea. O O
This O O
was O O
due O O
to O O
chronic O O
left O O
lower O O
extremity O O
claudication. O O
Since O O
then O O
he O O
has O O
had O O
no O O
symptoms O O
of O O
claudication O O
on O O
both O O
legs. O O
He O O
does O O
say O O
that O O
intermittently O O
over O O
the O O
past O O
3-4 O O
months O O
he O O
has O O
had O O
right O O
knee O O
pain O O
mostly O O
after O O
sitting O O
down O O
for O O
a O O
long O O
time. O O
No O O
predominance O O
of O O
the O O
AM O O
right O O
knee O O
pain. O O
No O O
erythema, O O
no O O
edema. O O
No O O
fevers. O O
He O O
has O O
no O O
other O O
joint O O
involvement. O O
He O O
tells O O
me O O
that O O
he O O
has O O
been O O
told O O
that O O
he O O
has O O
low-grade O O
diabetes B-DIABETES O
that O O
is O O
being O O
treated O O
with O O
diet, O O
although O O
on O O
his O O
presentation O O
to O O
the O O
hospital O O
last O O
year O O
he O O
was O O
found O O
not O O
be O O
be O O
diabetic. O O
His O O
past O O
medical O O
history, O O
as O O
mentioned: O O
1. O O
Status O O
post O O
a O O
left O O
fempop. O O
2. O O
Status O O
post O O
right O O
cataract O O
surgery. O O
3. O O
History B-DIABETES O
of I-DIABETES O
diabetes. I-DIABETES O
Diet O O
control O O
in O O
Eritrea. O O
Medications: O O
only O O
multivitamins. O O
Smoking: B-SMOKER O
1 O O
pack/day O O
x O O
40 O O
years. O O
He O O
stopped O O
one O O
year O O
ago O O
and O O
now B-SMOKER O
smokes I-SMOKER O
intermittently I-SMOKER O
2-3 I-SMOKER O
cigarettes/day. I-SMOKER O
He O O
has O O
never O O
had O O
an O O
alcohol O O
abuse O O
problem. O O
He O O
is O O
not O O
a O O
drug O O
consumer. O O
Physical O O
exam: O O
He O O
has O O
an O O
appearance O O
that O O
is O O
appropriate O O
to O O
his O O
age. O O
He O O
is O O
a O O
very O O
pleasant O O
man O O
in O O
no O O
acute O O
distress. O O
His O O
heart O O
rate O O
is O O
78. O O
His O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
160/80. I-HYPERTENSION O
Respiratory O O
rate O O
16. O O
His O O
eyes O O
have O O
bilateral O O
arcus, O O
no O O
clear-cut O O
central O O
cataract O O
on O O
the O O
right, O O
but O O
on O O
the O O
left O O
there O O
is O O
some O O
opacity. O O
No O O
funduscopic O O
examination O O
was O O
done. O O
HEENT O O
is O O
unremarkable. O O
Neck O O
exam O O
is O O
supple, O O
nontender. O O
He O O
has O O
no O O
bruits. O O
Normal O O
thyroid O O
gland. O O
He O O
has O O
no O O
JVD. O O
His O O
cardiac O O
exam O O
is O O
regular O O
rate O O
and O O
rhythm, O O
no O O
murmurs, O O
no O O
gallops, O O
no O O
rubs, O O
normal O O
S1 O O
and O O
S2. O O
His O O
lung O O
exam O O
is O O
clear O O
to O O
auscultation O O
bilaterally. O O
Abdominal O O
exam O O
is O O
flat, O O
supple, O O
nontender, O O
no O O
organomegaly, O O
normal O O
bowel O O
sounds. O O
Extremities: O O
He O O
has O O
very O O
faint O O
trace O O
left O O
ankle O O
edema O O
where O O
he O O
has O O
status O O
post O O
fifth O O
digit O O
amputation O O
in O O
the O O
past O O
in O O
Eritrea. O O
There O O
is O O
no O O
evidence O O
of O O
hypoperfusion. O O
There O O
is O O
normal O O
color O O
and O O
normal O O
temperature O O
to O O
the O O
skin. O O
There O O
is O O
crepitance O O
upon O O
passive O O
motion O O
of O O
the O O
right O O
knee O O
with O O
no O O
erythema, O O
no O O
edema. O O
His O O
vital O O
extremities O O
are O O
normal. O O
His O O
pulse O O
is O O
1+ O O
on O O
the O O
right O O
posterior O O
tibialis O O
and O O
nonpalpable O O
on O O
the O O
left. O O
His O O
popliteals O O
on O O
the O O
right O O
and O O
the O O
left O O
are O O
normal. O O
ORLANDO O O
REGIONAL O O
Xavier, O O
Fred O O
65856594 O O
Page O O
2 O O
1-21-84 O O
Assessment O O
and O O
Plan: O O
1. O O
Mild B-HYPERTENSION O
systolic I-HYPERTENSION O
hypertension. I-HYPERTENSION O
At O O
this O O
time O O
I O O
will O O
observe O O
and O O
follow O O
this O O
blood O O
pressure. O O
I O O
will O O
get O O
a O O
cholesterol O O
level, O O
a O O
renal O O
and O O
a O O
CBC. O O
2. O O
History O O
of O O
diet-controlled O O
diabetes. O O
I O O
will O O
obtain O O
glycemia O O
today. O O
He O O
is O O
8 O O
hours O O
fasting. O O
3. O O
Right O O
knee O O
pain. O O
This O O
is O O
likely O O
due O O
secondary O O
to O O
osteoarthritis. O O
I O O
am O O
recommending O O
Tylenol O O
for O O
pain. O O
4. O O
Peripheral O O
vascular O O
disease. O O
I O O
am O O
recommending B-MEDICATION O
1 I-MEDICATION O
aspirin B-MEDICATION B-MEDICATION
q.d. O O
for O O
his O O
PVD O O
as O O
well O O
as O O
lowering O O
cardiac O O
risk. O O
_________________________ O O
Yadiel O O
Fisher, O O
M.D. O O
TF:WM:8839 O O
DD:1-21-84 O O
DT:1-22-84 O O
DV:1-21-84 O O
******** O O
Approved O O
but O O
not O O
reviewed O O
by O O
Attending O O
Provider O O
******** O O

Record O O
date: O O
2086-12-30 O O
ORLANDO O O
REGIONAL O O
NICHOLAS-XAVIER, O O
FRED O O
65856594 O O
1-3-87 O O
Mr. O O
Xavier O O
is O O
a O O
73 O O
year O O
old O O
diabetic B-DIABETES O
who O O
was O O
followed O O
this O O
evening O O
by O O
a O O
telephone O O
conversation. O O
ALLERGIES: O O
Patient O O
has O O
no O O
known O O
drug O O
allergies. O O
CURRENT O O
MEDICATIONS: O O
insulin B-MEDICATION O
15 O O
units O O
q.a.m. O O
Patient O O
is O O
being O O
followed O O
at O O
home O O
and O O
also O O
in O O
the O O
Surgical O O
Clinic O O
here. O O
HPI: O O
Was O O
seen O O
in O O
walk-in O O
clinic O O
on O O
12-27-86 O O
with O O
a O O
chief O O
complaint O O
of O O
a O O
sore O O
left O O
fourth O O
toe. O O
Blood O O
sugar O O
at O O
that O O
time O O
was O O
noted O O
to O O
be O O
348 B-DIABETES O
and O O
he O O
denied O O
being O O
on O O
any O O
medication O O
for O O
some O O
time. O O
Patient O O
was O O
referred O O
to O O
Surgical O O
Clinic O O
and O O
is O O
being O O
followed O O
there. O O
Patient O O
was O O
also O O
placed O O
on O O
insulin O O
15mg O O
q.a.m. O O
and O O
diabetic O O
teaching O O
was O O
begun O O
on O O
Thursday, O O
December O O
30th. O O
I O O
am O O
calling O O
the O O
patient O O
this O O
evening. O O
His O O
granddaughter O O
stated O O
that O O
his O O
blood O O
sugars O O
had O O
been O O
running O O
in O O
the O O
a.m. O O
between O O
107 O O
to O O
as O O
high O O
as O O
216. B-DIABETES O
At O O
noon B-DIABETES O
time I-DIABETES O
they I-DIABETES O
have I-DIABETES O
been I-DIABETES O
running I-DIABETES O
in I-DIABETES O
the I-DIABETES O
322 B-DIABETES O
to I-DIABETES O
384 I-DIABETES O
range I-DIABETES O
and I-DIABETES O
in I-DIABETES O
the I-DIABETES O
evening I-DIABETES O
from I-DIABETES O
the I-DIABETES O
141 B-DIABETES O
to I-DIABETES O
250 I-DIABETES O
range. I-DIABETES O
At O O
this O O
time O O
tonight O O
it O O
was O O
decided O O
to O O
change O O
his O O
insulin O O
to O O
Humulin B-MEDICATION O
70/30, I-MEDICATION O
20 O O
units O O
SC O O
q.a.m. O O
Instructions O O
were O O
given O O
to O O
his O O
granddaughter O O
and O O
patient O O
will O O
be O O
followed O O
via O O
telephone O O
on O O
Thursday O O
evening O O
of O O
this O O
week. O O
Patient O O
will O O
also O O
attend O O
the O O
diabetic O O
support O O
group O O
to O O
be O O
held O O
on O O
Thursday, O O
January O O
6th. O O
His O O
granddaughter O O
was O O
instructed O O
that O O
if O O
there O O
were O O
any O O
problems O O
she O O
was O O
to O O
call O O
the O O
emergency O O
number O O
or O O
the O O
Clinic O O
at O O
once. O O
________________________________ O O
Ximena O O
Utter, O O
R.N.C. O O
JB:PH:2186 O O
DD:1-3-87 O O
DT:1-05-87 O O
DV:1-3-87 O O

Record O O
date: O O
2089-10-02 O O
ORLH O O
79 O O
Kessler O O
Farm O O
Drive O O
Nicholas-Xavier, O O
Fred O O
White O O
Hall, O O
MN O O
76715 O O
65856594 O O
(959) O O
149-6104 O O
10/02/89 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Mr. O O
Nicholas O O
Xavier O O
is O O
a O O
76-year-old O O
male O O
who O O
presented O O
to O O
Orlando O O
Regional O O
this O O
evening O O
for O O
diabetes B-DIABETES O
followup. O O
He O O
denies O O
any O O
known O O
drug O O
allergies O O
and O O
at O O
present, O O
he O O
is O O
taking O O
Feratab O O
300 O O
mg O O
t.i.d., O O
Motrin O O
600 O O
mg O O
q.8h. O O
p.r.n., O O
Benadryl O O
50 O O
mg O O
q.h.s. O O
p.r.n., O O
Zestril B-MEDICATION B-MEDICATION
5 O O
mg O O
q.d., O O
glyburide B-MEDICATION B-MEDICATION
2.5 O O
mg O O
q.d., O O
and O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
q.o.d. O O
The O O
patient O O
has O O
been O O
followed O O
fairly O O
frequently O O
in O O
the O O
clinic O O
recently O O
for O O
diabetic O O
foot O O
ulcers O O
on O O
his O O
right O O
foot, O O
between O O
his O O
4th O O
and O O
5th O O
toe. O O
This O O
evening, O O
he O O
presents O O
with O O
worsening O O
ulcers O O
in O O
that O O
area O O
and O O
also O O
a O O
new O O
ulcer O O
between O O
his O O
3rd O O
and O O
4th O O
toes. O O
It O O
has O O
not O O
improved O O
with O O
good O O
skin O O
care O O
and O O
application O O
of O O
bacitracin; O O
in O O
fact, O O
it O O
has O O
worsened. O O
REVIEW O O
OF O O
SYSTEMS: O O
He O O
denies O O
any O O
bleeding O O
with O O
brushing O O
of O O
his O O
teeth. O O
He O O
denies O O
any O O
palpitations O O
or O O
chest O O
pain. O O
He O O
denies O O
any O O
shortness O O
of O O
breath O O
or O O
cough. O O
He O O
denies O O
any O O
nausea, O O
vomiting, O O
diarrhea, O O
or O O
constipation. O O
He O O
states O O
that O O
his O O
bowel O O
movements O O
have O O
become O O
darkened O O
secondary O O
to O O
his O O
iron O O
intake. O O
He O O
denies O O
any O O
symptoms O O
of O O
frequency O O
or O O
nocturia, O O
no O O
burning, O O
itching, O O
or O O
pain O O
with O O
urination. O O
He O O
states O O
that O O
he O O
has O O
occasional O O
elbow O O
pain, O O
which O O
is O O
relieved O O
with O O
Motrin. O O
PHYSICAL O O
EXAMINATION: O O
His O O
temperature O O
is O O
97.8 O O
degrees, O O
his O O
pulse O O
is O O
88, O O
his O O
blood O O
pressure O O
is O O
135/65, O O
weight O O
is O O
141 O O
pounds, O O
and O O
his O O
random B-DIABETES O
blood I-DIABETES O
sugar I-DIABETES O
is I-DIABETES O
159. I-DIABETES O
He O O
states O O
that O O
he O O
did O O
not O O
take O O
his O O
medication O O
today. O O
His O O
heart O O
has O O
a O O
regular O O
rate O O
and O O
rhythm O O
at O O
88. O O
Lungs O O
are O O
clear O O
to O O
auscultation O O
bilaterally. O O
There O O
are O O
bruises O O
noted O O
on O O
his O O
right O O
hand O O
and O O
left O O
upper O O
arm, O O
but O O
he O O
states O O
that O O
both O O
of O O
these O O
were O O
related O O
to O O
trauma. O O
Examination O O
of O O
his O O
feet O O
revealed O O
his O O
toes O O
to O O
be O O
more O O
reddened O O
and O O
somewhat O O
shiny, O O
shinier O O
than O O
previous O O
visits. O O
They O O
were O O
cool O O
to O O
touch. O O
On O O
his O O
right O O
foot, O O
there O O
was O O
a O O
new O O
dime-sized O O
blister O O
on O O
the O O
4th O O
toe, O O
and O O
the O O
toe O O
that O O
bordered O O
his O O
3rd O O
toe, O O
and O O
on O O
the O O
other O O
side. O O
There O O
was O O
an O O
increase O O
in O O
the O O
size O O
on O O
the O O
toe O O
ulcer O O
and O O
also O O
on O O
the O O
ulcer O O
on O O
his O O
5th O O
toe. O O
Scant O O
amount O O
of O O
drainage O O
was O O
noted O O
from O O
the O O
toe O O
areas. O O
Mr. O O
Nicholas O O
Xavier O O
is O O
vigilant O O
with O O
his O O
foot O O
care O O
and O O
has O O
been O O
so. O O
This O O
is O O
definite O O
worsening O O
of O O
his O O
symptoms. O O
Posterior O O
tibial O O
pulses O O
are O O
present. O O
ASSESSMENT O O
1. O O
Noninsulin-dependent B-DIABETES O
diabetes I-DIABETES O
mellitus. I-DIABETES O
2. O O
Diabetic O O
foot O O
ulcers O O
on O O
4th O O
toe, O O
both O O
sides, O O
and O O
5th O O
toe. O O
PLAN: O O
Arterial O O
vascular O O
studies O O
with O O
Doppler O O
imaging O O
to O O
be O O
done. O O
Referral O O
to O O
surgical O O
clinic O O
for O O
evaluation O O
of O O
his O O
ulcers. O O
He O O
was O O
given O O
a O O
prescription O O
for O O
Xeroform O O
gauze O O
to O O
be O O
used O O
twice O O
daily O O
and O O
dressing O O
changes O O
were O O
explained O O
to O O
him. O O
He O O
was O O
instructed O O
to O O
return O O
to O O
clinic O O
in O O
one O O
month O O
for O O
followup. O O
______________________________ O O
Ximena O O
Utter, O O
NP O O
CC: O O
eScription O O
document:0-927126 O O
PQ O O
Focus O O
DD: O O
10/02/89 O O
DT: O O
10/03/89 O O
DV: O O
10/02/89 O O

Record O O
date: O O
2091-03-30 O O
ORLH O O
58 O O
Kessler O O
Farm O O
Drive O O
NICHOLAS-XAVIER, O O
FRED O O
White O O
Hall, O O
MN O O
76715 O O
65856594 O O
(959) O O
149-6104 O O
03/30/91 O O
CHIEF O O
COMPLAINT: O O
Mr. O O
Nicholas O O
Xavier O O
is O O
a O O
73-year-old O O
man O O
who O O
returns O O
to O O
the O O
Orlando O O
Regional O O
today O O
for O O
a O O
quick O O
follow O O
up O O
on O O
his O O
left O O
foot O O
ulceration. O O
CURRENT O O
MEDICATIONS: O O
Glucovance B-MEDICATION B-MEDICATION
5/500 O O
mg O O
b.i.d. O O
and O O
Actos B-MEDICATION O
30 O O
mg O O
q.d. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
ulceration O O
has O O
not O O
significantly O O
changed, O O
but O O
there O O
are O O
no O O
new O O
signs O O
of O O
infection. O O
He O O
has O O
been O O
taking O O
Keflex O O
500 O O
mg O O
t.i.d. O O
for O O
the O O
last O O
seven O O
days. O O
He O O
denies O O
fever O O
and O O
his O O
blood O O
glucose O O
levels O O
have O O
started O O
to O O
improve O O
a O O
little O O
bit. O O
His O O
fingerstick O O
blood B-DIABETES O
sugar I-DIABETES O
today I-DIABETES O
is I-DIABETES O
145. I-DIABETES O
He O O
has O O
an O O
appointment O O
in O O
Vascular O O
Surgery O O
in O O
two O O
days. O O
I O O
have O O
asked O O
him O O
that O O
it O O
is O O
extremely O O
important O O
for O O
him O O
to O O
keep O O
that O O
appointment O O
for O O
the O O
evaluation O O
of O O
this O O
ulceration O O
and O O
his O O
vascular O O
status. O O
I O O
have O O
also O O
reviewed O O
with O O
him O O
that O O
he O O
may O O
need O O
to O O
be O O
hospitalized O O
if O O
a O O
vascular O O
procedure O O
is O O
recommended. O O
Unfortunately, O O
he O O
does O O
not O O
have O O
an O O
appointment O O
with O O
Podiatry O O
until O O
the O O
end O O
of O O
this O O
month. O O
ASSESSMENT O O
AND O O
PLAN: O O
He O O
will O O
be O O
seen O O
by O O
me O O
again O O
in O O
a O O
few O O
days O O
after O O
he O O
is O O
seen O O
in O O
Vascular O O
Surgery. O O
In O O
the O O
meantime, O O
he O O
will O O
continue O O
with O O
all O O
his O O
medications. O O
I O O
have O O
given O O
him O O
a O O
prescription O O
for O O
Zocor B-MEDICATION O
20 O O
mg O O
q.d. O O
since O O
the O O
pharmacy O O
could O O
not O O
give O O
him O O
Lipitor O B-MEDICATION
that O O
I O O
had O O
prescribed. O O
______________________________ O O
Billy O O
Vanpelt, O O
M.D. O O
eScription O O
document:3-9348364 O O
DD: O O
03/30/91 O O
DT: O O
03/31/91 O O
DV: O O
03/30/91 O O

Record O O
date: O O
2091-05-08 O O
May O O
08, O O
2091 O O
Billy O O
Vanpelt, O O
M.D. O O
Orlando O O
Regional O O
Lucerne O O
Hospital O O
60 O O
Kessler O O
Farm O O
Drive O O
White O O
Hall, O O
MN O O
76715 O O
RE:Nicholas-Xaviar, O O
FredMR O O
#65856594 O O
Dear O O
Dr. O O
Vanpelt, O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
Mr. O O
Nicholas-Xavier O O
in O O
follow O O
up O O
after O O
his O O
recent O O
coronary B-CAD O
artery I-CAD O
bypass I-CAD O
graft I-CAD O
surgery. I-CAD O
I O O
followed O O
him O O
in O O
the O O
hospital O O
when O O
he O O
was O O
admitted O O
in O O
Apr O O
for O O
a O O
left O O
foot O O
ulcer. O O
As O O
you O O
know, O O
he O O
is O O
a O O
77 O O
year-old O O
man O O
from O O
Eritrea O O
with O O
a O O
history O O
of O O
diabetes, B-DIABETES O
hypertension B-HYPERTENSION B-HYPERTENSION
and O O
hyperlipidemia, B-HYPERLIPIDEMIA O
as O O
well O O
as O O
peripheral O O
vascular O O
disease O O
who O O
has O O
had O O
bilateral O O
lower O O
extremity O O
bypasses O O
in O O
the O O
past. O O
He O O
was O O
admitted O O
in O O
Apr O O
of O O
2091 O O
with O O
a O O
nonhealing O O
left O O
lower O O
extremity O O
ulcer O O
for O O
lower O O
extremity O O
redo O O
bypass O O
surgery. O O
His O O
preoperative O O
evaluation O O
included O O
a O O
Dobutamine O O
echocardiogram, O O
which O O
revealed O O
a O O
small O O
area O O
of O O
Dobutamine O O
induced O O
hypokinesis O O
in O O
the O O
inferior O O
wall. O O
Since O O
this O O
was O O
a O O
small O O
area, O O
it O O
was O O
felt O O
he O O
could O O
proceed O O
with O O
surgery O O
with O O
moderate O O
risk O O
on O O
a B-MEDICATION O
beta-blocker. B-MEDICATION O
He O O
underwent O O
left O O
lower O O
extremity O O
peripheral O O
bypass O O
surgery O O
and O O
did O O
well O O
postoperative O O
with O O
no O O
symptoms O O
of O O
chest O O
pain O O
and O O
no O O
change O O
in O O
his O O
EKG. O O
However O O
postoperative O O
enzymes O O
revealed O O
peak O O
CK O O
of O O
455 O O
with O O
an O O
MB O O
fraction O O
of O O
35 O O
and O O
a O O
troponin O O
of O O
19.5. O O
As O O
a O O
result O O
of O O
his O O
large O O
troponin O O
leak, O O
he O O
underwent O O
cardiac B-CAD O
catheterization I-CAD O
on I-CAD O
Apr I-CAD O
15, I-CAD O
2091 I-CAD O
which I-CAD O
revealed I-CAD O
an I-CAD O
80% I-CAD O
left I-CAD O
main I-CAD O
stenosis, I-CAD O
100% I-CAD O
totally I-CAD O
occluded I-CAD O
left I-CAD O
anterior I-CAD O
descending I-CAD O
coronary I-CAD O
artery, I-CAD O
100% I-CAD O
proximal I-CAD O
first I-CAD O
diagonal I-CAD O
and I-CAD O
a I-CAD O
60-70% I-CAD O
lesion I-CAD O
at I-CAD O
the I-CAD O
ostium I-CAD O
of I-CAD O
the I-CAD O
posterior I-CAD O
descending I-CAD O
coronary I-CAD O
artery I-CAD O
with I-CAD O
about I-CAD O
a I-CAD O
50% I-CAD O
lesion I-CAD O
in I-CAD O
the I-CAD O
distal I-CAD O
PDA. I-CAD O
Postoperative O O
echocardiogram O O
on O O
Apr O O
13, O O
2091 O O
revealed O O
an O O
ejection O O
fraction O O
of O O
45% O O
with O O
_________ O O
apical O O
hypokinesis O O
and O O
mild O O
mitral O O
insufficiency. O O
Due O O
to O O
his O O
severe B-CAD O
left I-CAD O
main I-CAD O
stenosis, I-CAD O
he I-CAD O
underwent I-CAD O
coronary I-CAD O
artery I-CAD O
bypass I-CAD O
grafting I-CAD O
on I-CAD O
Apr I-CAD O
20, I-CAD O
2091. I-CAD O
He I-CAD O
had I-CAD O
LIMA I-CAD O
to I-CAD O
his I-CAD O
left I-CAD O
anterior I-CAD O
descending I-CAD O
artery I-CAD O
and I-CAD O
a I-CAD O
vein I-CAD O
graft I-CAD O
to I-CAD O
his I-CAD O
obtuse I-CAD O
marginal I-CAD O
artery. I-CAD O
He O O
did O O
not O O
have O O
a O O
graft O O
to O O
his O O
posterior O O
descending O O
artery O O
since O O
he O O
had O O
a O O
limit O O
to O O
the O O
number O O
of O O
conduits O O
secondary O O
Nicholas-Xaviar, O O
Fred O O
MR O O
#65856594 O O
May O O
08, O O
2091 O O
Page O O
Two O O
to O O
his O O
multiple O O
peripheral O O
vascular O O
surgeries. O O
Postoperatively O O
he O O
did O O
quite O O
well O O
and O O
was O O
discharged O O
to O O
rehabilitation O O
on O O
April O O
27, O O
2091. O O
His O O
medications O O
on O O
discharge O O
were O O
aspirin B-MEDICATION B-MEDICATION
325mg, O O
Zocor B-MEDICATION B-MEDICATION
20mg, O O
Subcutaneous O O
Heparin O O
5000 O O
units O O
b.i.d., O O
Metformin B-MEDICATION B-MEDICATION
500mg, O O
Glipizide B-MEDICATION B-MEDICATION
10 O O
in O O
the O O
morning O O
and O O
5 O O
in O O
the O O
evening, O O
Captopril B-MEDICATION B-MEDICATION
12.5 O O
t.i.d. O O
and O O
Lopressor B-MEDICATION B-MEDICATION
25mg O O
q.i.d. O O
Since O O
that O O
time, O O
he O O
has O O
done O O
quite O O
well. O O
He O O
has O O
been O O
progressing O O
at O O
rehabilitation O O
to O O
the O O
point O O
that O O
he O O
is O O
now O O
walking O O
ten O O
minutes O O
three O O
times O O
per O O
day O O
and O O
is O O
working O O
on O O
walking O O
up O O
stairs O O
since O O
he O O
lives O O
on O O
the O O
second O O
floor O O
of O O
his O O
house. O O
He O O
denies O O
any O O
chest O O
pain O O
with O O
walking. O O
He O O
has O O
no O O
shortness O O
of O O
breath O O
or O O
dyspnea O O
on O O
exertion. O O
He O O
has O O
been O O
sleeping O O
on O O
two O O
pillows O O
for O O
a O O
long O O
time O O
and O O
this O O
is O O
unchanged. O O
He O O
denies O O
paroxysmal O O
nocturnal O O
dyspnea O O
or O O
claudication O O
symptoms O O
with O O
walking O O
at O O
this O O
time. O O
He O O
does O O
complain O O
of O O
some O O
pain O O
in O O
his O O
left O O
shin O O
just O O
below O O
his O O
knee, O O
particularly O O
with O O
palpation. O O
He O O
has O O
plans O O
to O O
be O O
discharged O O
from O O
rehabilitation O O
in O O
a O O
few O O
days. O O
On O O
physical O O
examination, O O
his O O
blood O O
pressure O O
is O O
135/80 O O
with O O
a O O
heart O O
rate O O
of O O
60. O O
His O O
jugular O O
venous O O
pressure O O
is O O
flat, O O
and O O
he O O
has O O
good O O
carotid O O
upstrokes O O
without O O
carotid O O
bruits. O O
His O O
lungs O O
are O O
clear O O
to O O
auscultation O O
and O O
percussion O O
bilaterally. O O
His O O
heart O O
has O O
a O O
slight O O
laterally O O
displaced O O
PMI O O
with O O
a O O
regular O O
rate O O
and O O
rhythm, O O
normal O O
S1, O O
and O O
S2 O O
and O O
no O O
audible O O
murmur O O
or O O
gallop. O O
His O O
chest O O
incision O O
as O O
well O O
as O O
his O O
lower O O
extremity O O
and O O
arm O O
incisions O O
is O O
healing O O
well. O O
He O O
has O O
a O O
small O O
scrape O O
on O O
the O O
inner O O
aspect O O
of O O
his O O
left O O
leg, O O
which O O
is O O
also O O
healing O O
well. O O
There O O
is O O
some O O
red O O
discoloration O O
below O O
this O O
lesion O O
that O O
is O O
not O O
warm O O
and O O
does O O
not O O
appear O O
to O O
be O O
cellulitic. O O
His O O
feet O O
are O O
warm. O O
His O O
EKG O O
in O O
my O O
office O O
reveals O O
normal O O
sinus O O
rhythm O O
at O O
60 O O
with O O
T O O
wave O O
inversions O O
in O O
V1 O O
through O O
V5, O O
1 O O
and O O
L. O O
They O O
are O O
particularly O O
deep O O
in O O
V2 O O
and O O
V3 O O
but O O
are O O
unchanged O O
from O O
his O O
discharge O O
EKG O O
from O O
the O O
hospital. O O
In O O
summary, O O
Mr. O O
Nicholas-Xaviar O O
is O O
a O O
77 O O
year-old O O
gentleman O O
with O O
diabetes, O O
hypertension, O B-HYPERTENSION
hyperlipidemia, O B-HYPERTENSION
coronary B-CAD B-CAD
artery I-CAD I-CAD
disease I-CAD O
and O O
peripheral O O
vascular O O
disease O O
who O O
is O O
two O O
weeks O O
status B-CAD O
post I-CAD O
coronary I-CAD O
artery I-CAD O
bypass I-CAD O
grafting I-CAD O
and O O
three O O
weeks O O
left O O
lower O O
extremity O O
bypass O O
who O O
is O O
doing O O
quite O O
well O O
in O O
his O O
recovery. O O
He O O
will O O
continue O O
with O O
rehabilitation O O
and O O
increase O O
his O O
exercise O O
capacity O O
over O O
time. O O
I O O
have O O
reassured O O
him O O
and O O
his O O
granddaughter O O
that O O
he O O
is O O
doing O O
very O O
well O O
and O O
that O O
it O O
will O O
take O O
up O O
to O O
two O O
months O O
until O O
he O O
feels O O
back O O
to O O
his O O
baseline. O O
I O O
have O O
recommended O O
to O O
him O O
and O O
to O O
his O O
rehabilitation O O
facility O O
that O O
he O O
increase O O
his O O
Zocor O B-MEDICATION
from O O
20-40mg O O
q.h.s. O O
I O O
have O O
also O O
changed O O
him O O
to O O
once O O
daily O O
cardiac O O
regimen O O
so O O
I O O
have O O
changed O O
his O O
Nicholas-Xaviar, O O
Fred O O
MR O O
#65856594 O O
May O O
08, O O
2091 O O
Page O O
Three O O
Captopril O B-MEDICATION
to O O
Lisinopril B-MEDICATION B-MEDICATION
20mg O O
q.d. O O
and O O
his O O
Lopressor O B-MEDICATION
to O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
100mg O O
p.o. O O
q.d.. O O
He O O
will O O
follow O O
up O O
with O O
me O O
in O O
three O O
months O O
time O O
or O O
sooner O O
if O O
he O O
develops O O
any O O
new O O
symptoms O O
of O O
chest O O
pain, O O
shortness O O
of O O
breath O O
or O O
any O O
new O O
cardiac O O
concerns. O O
He O O
was O O
seen, O O
examined O O
and O O
discussed O O
with O O
Dr. O O
Steve O O
Franks. O O
Thank O O
you O O
for O O
allowing O O
me O O
to O O
participate O O
in O O
his O O
care. O O
Sincerely, O O
Olivia O O
Spence, O O
M.D.DD: O O
05/08/91DT: O O
05/12/91DV: O O
05/08/91 O O
/piper O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2091-08-02 O O
Chief O O
Complaint O O
AAA O O
History O O
of O O
Present O O
Illness O O
The O O
patient O O
is O O
a O O
66 O O
y.o. O O
male O O
with O O
AAA O O
who O O
is O O
scheduled O O
for O O
endovascular O O
repair O O
of O O
AAA O O
on O O
August O O
06, O O
2091 O O
with O O
Dr. O O
Carter O O
Horne. O O
Pt. O O
was O O
having O O
problems O O
with O O
tingling O O
in O O
right O O
foot O O
and O O
ankle. O O
He O O
went O O
to O O
his O O
PCP O O
who O O
as O O
part O O
of O O
the O O
workup O O
did O O
and O O
ultrasound O O
and O O
pt. O O
AAA O O
was O O
discovered. O O
Pt. O O
had O O
no O O
symptoms O O
then, O O
and O O
has O O
no O O
symptoms O O
now, O O
related O O
to O O
this O O
aneurysm. O O
CRF O O
include O O
h/o O O
hyperchoseterolemia, B-HYPERLIPIDEMIA O
HTN, B-HYPERTENSION O
smoking, B-SMOKER O
male O O
gender. O O
The O O
aorta O O
gram O O
showed O O
an O O
infrarenal O O
AAA O O
which O O
measures O O
5.7 O O
cm O O
at O O
the O O
maximum O O
dimension. O O
Past O O
Medical O O
History O O
1) O O
HTN O O
2) O O
Hypercholesterolemia B-HYPERLIPIDEMIA B-MEDICATION
3) O O
h/o O O
ETOH O O
abuse O O
remote O O
past, O O
30 O O
years O O
ago O O
4) O O
PVD O O
Past O O
Surgical O O
History O O
1) O O
Left O O
CEA, O O
1/2091 O O
(done O O
at O O
Vanderbilt O O
University O O
Hospital) O O
2) O O
Left O O
cataract O O
removal O O
3) O O
Bleeding O O
Ulcer, O O
repaired O O
by O O
surgery, O O
2061 O O
Denies O O
any O O
difficulties O O
with O O
anesthesia. O O
Medications O O
LIPITOR B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20MG O O
PO O O
QD O O
Start O O
Date: O O
ASA B-MEDICATION B-MEDICATION
ENTERIC O O
COATED O O
(ASPIRIN O O
ENTERIC O O
COATED) O O
325MG O O
PO O O
QD O O
Start O O
Date: O O
Stopped O O
taking O O
on O O
7/29/91 O O
ATENOLOL B-MEDICATION B-MEDICATION
50MG O O
PO O O
QD O O
Start O O
Date: O O
VALIUM O O
(DIAZEPAM) O O
5MG O O
PO O O
PRN O O
ANXIETY, O O
USUALLY O O
QD O O
Start O O
Date: O O
SECOND O O
BP O O
MEDICATION, O O
PT. O O
DOES O O
NOT O O
KNOW O O
NAME O O
? O O
Start O O
Date: O O
Allergies O O
NKDA O O
Family O O
History O O
Father: O O
deceased, O O
DM O O
There O O
is O O
no O O
family O O
history O O
of O O
adverse O O
reactions O O
to O O
general O O
anesthesia. O O
Social O O
History O O
Smoking: B-SMOKER O
1- I-SMOKER O
2 I-SMOKER O
ppd I-SMOKER O
X I-SMOKER O
40, I-SMOKER O
recently I-SMOKER O
cut I-SMOKER O
back I-SMOKER O
from I-SMOKER O
3 I-SMOKER O
ppd I-SMOKER O
Alcohol: O O
None, O O
h/o O O
ETOH O O
abuses O O
Substance O O
Abuse: O O
no O O
history O O
of O O
substance O O
abuse O O
Exercise: O O
no O O
exercise O O
routine O O
Occupation: O O
Retired, O O
Air O O
Pilot O O
for O O
S3 O O
Graphics O O
Marital O O
Status: O O
married O O
Review O O
of O O
Systems O O
General: O O
no O O
history O O
of O O
fatigue, O O
weight O O
change, O O
loss O O
of O O
appetite, O O
or O O
weakness. O O
HEENT: O O
S/P O O
LEFT O O
CATARACT O O
REMOVAL; O O
no O O
history O O
of O O
head O O
injury, O O
glaucoma, O O
tinnitus, O O
vertigo, O O
motion O O
sickness, O O
sinus O O
infection, O O
hearing O O
loss. O O
Cardiovascular: O O
HTN, O O
HYPERCHOLESTEROLEMIA; B-HYPERLIPIDEMIA O
no O O
history O O
of O O
hypertension, O O
hypercholesterolemia, O O
murmur, O O
rheumatic O O
fever, O O
MI, O O
angina, O O
syncope, O O
palpitations, O O
edema, O O
dyspnea. O O
Respiratory: O O
no O O
history O O
of O O
asthma, O O
COPD, O O
TB, O O
URI, O O
sleep O O
apnea, O O
SOB. O O
GI: O O
H/O O O
BLEEDING O O
ULCER; O O
DENIES O O
REFLUX; O O
no O O
history O O
of O O
GERD, O O
bleeding, O O
change O O
in O O
bowel O O
habits. O O
Hepatobiliary: O O
no O O
history O O
of O O
jaudice, O O
hepatits, O O
colic. O O
GU: O O
no O O
history O O
of O O
CRF, O O
hematuria, O O
obstruction, O O
colic-stones, O O
UTI. O O
Musculoskeletal: O O
no O O
history O O
of O O
arthritis, O O
joint O O
pain, O O
limitation O O
of O O
ROM. O O
Neuro: O O
TINGLING O O
IN O O
LEFT O O
ANKLE O O
? O O
RELATED O O
TO O O
PVD O O
OR O O
AAA; O O
no O O
history O O
of O O
seizures, O O
stroke, O O
TIAs, O O
migraine, O O
radiculopathy. O O
Peripheral O O
Vascular: O O
H/O O O
PVD; O O
no O O
history O O
of O O
claudication, O O
DVT, O O
varicosities, O O
cramps, O O
ulcers. O O
Endocrine: O O
no O O
history O O
of O O
endocrinopathy O O
or O O
diabetes O O
mellitus. O O
Heme/Onc: O O
no O O
history O O
of O O
bruising, O O
bleeding, O O
anemia, O O
lymphadenopathy, O O
chemotherapy O O
or O O
radiation O O
therapy. O O
Psych: O O
ANXIETY, O O
TAKES O O
MEDICATION; O O
no O O
history O O
of O O
anxiety, O O
panic O O
attacks, O O
depression, O O
or O O
psychosis. O O
Skin: O O
no O O
history O O
of O O
rash, O O
abnormal O O
pigmentation, O O
pruritis. O O
Physical O O
Exam O O
SaO2: O O
98 O O
Resp: O O
18 O O
Temp: O O
97.2 O O
Ht:74.0'' O O
Wt: O O
216.8 O O
BP: B-HYPERTENSION O
213/83 I-HYPERTENSION O
AP: O O
62 O O
General: O O
well O O
developed, O O
well O O
nourished O O
elderly O O
gentleman O O
, O O
slightly O O
anxious O O
HEENT: O O
well O O
healed O O
incision O O
on O O
left O O
lateral O O
neck O O
in O O
the O O
area O O
of O O
the O O
carotid; O O
normocephalic, O O
PERRL, O O
EOMs O O
normal, O O
no O O
icterus, O O
thyroid O O
not O O
palpable, O O
neck O O
veins O O
flat, O O
no O O
bruits, O O
good O O
range O O
of O O
motion. O O
Airway: O O
Mallampatti O O
Class O O
I O O
Teeth: O O
in O O
good O O
repair. O O
Chest: O O
clear O O
to O O
auscultation. O O
Heart: O O
regular O O
rhythm, O O
normal O O
rate, O O
no O O
murmurs, O O
rubs O O
or O O
gallops, O O
S1=S2. O O
Breast: O O
no O O
palpable O O
masses, O O
discharge, O O
nipple O O
retraction. O O
Abdomen: O O
well O O
healed O O
midline O O
abdominal O O
incision O O
with O O
slight O O
bulging O O
around O O
middle O O
of O O
incision; O O
easily O O
palpable, O O
pulsitile O O
mass O O
midline O O
superior O O
to O O
umbilicus; O O
soft, O O
non-tender, O O
no O O
distended, O O
normal O O
bowel O O
sounds, O O
no O O
organomegaly. O O
GU/Rectal: O O
no O O
CVA O O
tenderness, O O
no O O
hernias. O O
Lymphatics: O O
no O O
lymphadenopathy. O O
Peripheral O O
Vascular: O O
carotids- O O
2+ O O
bil, O O
no O O
bruits O O
radials- O O
2+ O O
bil O O
femoral- O O
2+ O O
bil O O
ant O O
tibial- O O
1 O O
bil O O
dorsalis O O
pedis- O O
1 O O
bil O O
Neuro: O O
cranial O O
nerves-II O O
thru O O
XII O O
intact O O
sensory-no O O
deficit O O
motor-normal O O
strength O O
reflexes-normal O O
Musculoskeletal: O O
normal O O
range O O
of O O
motion. O O
Skin: O O
no O O
ulcers O O
or O O
obvious O O
rashes. O O
Assessment O O
ASA O O
Physical O O
Status: O O
III O O
66 O O
y.o O O
male O O
with O O
AAA O O
scheduled O O
for O O
endovascular O O
repair O O
on O O
8/06/91. O O
His O O
CRF O O
include O O
HTN, O O
elevated B-HYPERLIPIDEMIA O
cholesterol, I-HYPERLIPIDEMIA O
smoking, O O
male O O
gender. O O
He O O
denies O O
S O O
& O O
S O O
of O O
cardiac O O
ischemia, O O
no O O
h/o O O
MI. O O
BP O O
(systolic) O O
elevated O O
initially O O
and O O
pt. O O
states O O
it O O
is O O
usually O O
runs O O
140 O O
- O O
150. O O
To O O
have O O
epidural O O
with O O
sedation O O
though O O
pt. O O
would O O
prefer O O
to O O
be O O
'just O O
groggy' O O
rather O O
than O O
asleep. O O
Plan O O
Anesthesia: O O
regional O O
anesthesia O O
Monitors: O O
arterial O O
line O O
Autologous O O
Blood: O O
none O O
Pain O O
Management: O O
IVPCA O O
Premedication: O O
none O O
Medications: O O
atenolol B-MEDICATION B-MEDICATION
and O O
other O O
BP O O
medication O O
Medications O O
to O O
be O O
held: O O
none O O
Aspirin: B-MEDICATION B-MEDICATION
discontinue O O
1 O O
week O O
prior O O
to O O
surgery O O
NSAIDS: O O
discontinue O O
3 O O
days O O
prior O O
to O O
surgery O O
Fasting: O O
NPO O O
after O O
midnight O O
Attending O O
Surgeon O O
Reassessment O O
Note O O
I O O
have O O
reviewed O O
the O O
above O O
history O O
and O O
physical O O
exam O O
and O O
agree O O
with O O
the O O
findings. O O
Additional O O
comments: O O
signed: O O
_________________________________________________ O O
Attending O O
Anesthesiologist O O
Reassessment O O
Note O O
I O O
have O O
reviewed O O
the O O
above O O
history O O
and O O
physical O O
exam O O
and O O
agree O O
with O O
the O O
findings. O O
Additional O O
comments: O O
signed: O O
________________________________________________ O O
______________________________ O O
Araujo, O O
Ursula O O
X,NP O O

Record O O
date: O O
2094-03-19 O O
GSH O O
Internal O O
Medicine O O
Admit O O
Note O O
Patient's O O
name: O O
Faulkner, O O
Yandel O O
MRN: O O
507-55-61 O O
Date O O
of O O
Admission: O O
3/18/94 O O
ATTG: O O
Yazzie O O
CONTACT: O O
Carlos O O
Faulkner O O
(son) O O
441-626-7981; O O
278-032-7163 O O
ID/CC: O O
69 O O
yo O O
M O O
with O O
complicated O O
medical O O
history O O
presents O O
from O O
rehab O O
with O O
likely O O
aspiration O O
event. O O
Most O O
of O O
the O O
data O O
herein O O
is O O
from O O
the O O
medical O O
record. O O
HPI: O O
Patient O O
is O O
a O O
66 O O
yo O O
M O O
with O O
a O O
complicated O O
medical O O
history. O O
Recent O O
medical O O
events O O
summarized O O
below: O O
1/22/94: O O
presented O O
to O O
Vanderbilt O O
University O O
Hospital O O
on O O
1/22/94, O O
notable O O
for O O
the O O
following: O O
- O O
hyperosmolar O O
nonketotic O O
hyperglycemia O O
(BS&gt;1400) B-DIABETES O
- O O
LLE O O
was O O
noted O O
to O O
be O O
cool O O
and O O
ischemic, O O
CPKs O O
&gt; O O
1300 O O
1/24/94: O O
transferred O O
to O O
DCGH O O
for O O
revascularization. O O
Hospital O O
course O O
notable O O
for O O
the O O
following: O O
- O O
ruled O O
in O O
for O O
MI B-CAD O
with O O
peak O O
Tn=0.96 O O
- O O
LLE O O
thrombectomy O O
- O O
Right O O
to O O
left O O
femoral O O
PTFE O O
graft O O
- O O
Discovery O O
of O O
possible O O
embolization O O
from O O
the O O
left O O
endograft O O
limb O O
- O O
Development O O
of O O
postoperative O O
compartment O O
syndrome, O O
requiring O O
fasciotomies O O
of O O
all O O
4 O O
compartments O O
- O O
HIT O O
positivity O O
- O O
DM B-DIABETES O
management O O
by O O
Dr. O O
Phelps O O
- O O
Extubation O O
postoperatively, O O
with O O
reintubation O O
POD O O
#3 O O
2/2 O O
inability O O
to O O
protect O O
airway O O
- O O
Aspiration O O
events, O O
PNA O O
- O O
Sepsis, O O
requiring O O
pressors O O
MRSA O O
- O O
Septic O O
emboli O O
in O O
L O O
lung O O
- O O
Pneumonia O O
Pseudomonas, O O
Klebsiella O O
- O O
Difficult O O
vent O O
weaning O O
- O O
Tracheostomy O O
placement, O O
eventual O O
decanulation O O
- O O
Failure O O
of O O
multiple O O
swallowing O O
trials O O
- O O
G-tube O O
placement O O
- O O
Renal O O
failure, O O
improved O O
when O O
decreased O O
diuresis O O
- O O
Conjunctivitis, O O
bacterial O O
endophthalmitis O O
- O O
Wound O O
Care O O
for O O
chronic O O
LLE O O
wounds O O
- O O
Likely O O
graft O O
infection O O
with O O
the O O
decision O O
to O O
treat O O
with O O
Rifampin O O
and O O
Bactrim O O
for O O
2 O O
months O O
3/15/94: O O
transferred O O
to O O
KH O O
- O O
multiple O O
episodes O O
of O O
TF O O
emesis, O O
cough, O O
gagging, O O
O2 O O
sat O O
80% O O
RA O O
rx'd O O
with O O
sxn, O O
O2, O O
Zofran O O
- O O
3/18/94 O O
patient O O
developed O O
severe O O
hypoxia O O
O2 O O
sat O O
70% O O
RA. O O
ABG O O
on O O
50% O O
TM: O O
46/43/7.47, O O
oximetry O O
90% O O
3/18/94: O O
DCGH O O
ED O O
- O O
SaO2=90% O O
on O O
100% O O
NRB, O O
rx'd O O
with O O
vanco, O O
clinda, O O
NS, O O
combivent O O
ROS: O O
+cougn, O O
no O O
CP/SOB, O O
no O O
abdominal O O
pain, O O
no O O
nausea, O O
no O O
fever/chills O O
PMHx: O O
(as O O
above, O O
also) O O
1. O O
Hypertension. B-HYPERTENSION O
2. O O
Hyperlipidemia. B-HYPERLIPIDEMIA O
3. O O
Peripheral O O
vascular O O
disease O O
4. O O
Cataracts. O O
5. O O
Status O O
post O O
cerebrovascular O O
accident O O
6. O O
peptic O O
ulcer O O
disease O O
status O O
post O O
a O O
bleeding O O
duodenal O O
ulcer O O
7. O O
status O O
post O O
left O O
carotid O O
endarterectomy O O
in O O
January O O
2091. O O
8. O O
DM O O
9. O O
PVD O O
10. O O
chronic O O
LLE O O
wounds O O
11. O O
renal O O
failure O O
Medications O O
on O O
Transfer: O O
NPH B-MEDICATION B-MEDICATION
12 O O
U O O
Q12H O O
Tube O O
Feeds O O
osmolite O O
@ O O
95 O O
(stopped) O O
Nystatin O O
S/spit O O
Atrovent/Albuterol O O
Nebs O O
Asa B-MEDICATION B-MEDICATION
81 O O
Lopressor B-MEDICATION B-MEDICATION
50 O O
Q6H O O
Erythromycin O O
Ophthalmologic O O
Ointment O O
DS O O
Q12H O O
Lasix O O
40 O O
BID O O
Colace O O
100 O O
TID O O
Zaroxyln O O
5 O O
QD O O
Coumadin O O
Regland O O
10 O O
BID O O
Protonix O O
40 O O
QD O O
Epo O O
10,000 O O
U O O
TIW O O
Rifampin O O
600 O O
QD O O
Bactrim O O
DS O O
BID O O
Zofran O O
Silvidine O O
Bacitracin O O
Allergies: O O
heparin O O
HIT O O
FHx: O O
noncontributory O O
SHx: O O
Patient O O
lives O O
in O O
Old O O
River. O O
He B-SMOKER O
has I-SMOKER O
a I-SMOKER O
100 I-SMOKER O
pack-year I-SMOKER O
smoking I-SMOKER O
hx. I-SMOKER O
He O O
quit O O
drinking O O
EtOH O O
30 O O
years O O
ago. O O
Physical O O
Exam: O O
VS: O O
BP=90/50; O O
HR=94; O O
RR=20; O O
SaO2=90-94% O O
4L; O O
T=98 O O
General: O O
uncomfortable, O O
chronically O O
ill-appearing, O O
speech O O
breathy O O
HEENT: O O
NC/AT, O O
PERRL, O O
EOMI, O O
sclera O O
anicteric, O O
MM O O
dry, O O
tongue O O
cracked O O
Neck: O O
plethoric, O O
JVP O O
@ O O
8 O O
cm, O O
trach O O
site O O
well-healed O O
Chest: O O
coarse O O
rhonchi O O
throughout, O O
scattered O O
wheezes O O
Cor: O O
faint O O
HS, O O
regular O O
S1/S2, O O
no O O
murmurs O O
Abdomen: O O
soft, O O
NT/ND, O O
no O O
masses O O
Ext: O O
bilateral O O
clubbing; O O
LLE O O
with O O
multiple O O
shallow O O
ulcers, O O
toes O O
black O O
Neuro: O O
sleepy, O O
arouses O O
easily O O
to O O
voice, O O
follows O O
commands O O
Labs: O O
DCGH O O
BLOOD O O
18-Mar-2094 O O
15:59 O O
Accession# O O
9027U41613 O O
Sodium O O
(Stat O O
Lab) O O
137 O O
135-145 O O
mmol/L O O
Potassium O O
(Stat O O
Lab) O O
4.3 O O
3.4-4.8 O O
mmol/L O O
Chloride O O
(Stat O O
Lab) O O
98 O O
L O O
100-108 O O
mmol/L O O
CO2 O O
(Stat O O
Lab) O O
31.8 O O
H O O
24.0-30.0 O O
mmol/L O O
BUN O O
(Stat O O
Lab) O O
82 O O
H O O
8-25 O O
mg/dl O O
Creatinine O O
(Stat O O
Lab) O O
3.8 O O
H O O
0.6-1.5 O O
mg/dl O O
Glucose B-DIABETES O
(Stat I-DIABETES O
Lab) I-DIABETES O
128 I-DIABETES O
H I-DIABETES O
70-110 I-DIABETES O
mg/dl I-DIABETES O
DCGH O O
BLOOD O O
18-Mar-2094 O O
15:57 O O
Accession# O O
8663L14453 O O
Calcium O O
8.6 O O
8.5-10.5 O O
mg/dl O O
Phosphorus O O
5.3 O O
H O O
2.6-4.5 O O
mg/dl O O
Magnesium O O
1.9 O O
1.4-2.0 O O
meq/L O O
Total O O
Protein O O
7.3 O O
6.0-8.0 O O
g/dl O O
Albumin O O
2.1 O O
L O O
3.1-4.3 O O
g/dl O O
Globulin O O
5.2 O O
H O O
2.6-4.1 O O
g/dl O O
Direct O O
Bilirubin O O
0.5 O O
H O O
0-0.4 O O
mg/dl O O
Total O O
Bilirubin O O
0.7 O O
0-1.0 O O
mg/dl O O
Alkaline O O
Phosphatase O O
96 O O
45-115 O O
U/L O O
Transaminase-SGPT O O
12 O O
10-55 O O
U/L O O
Amylase O O
74 O O
3-100 O O
units/L O O
Lipase O O
0.7 O O
L O O
1.3-6.0 O O
U/dl O O
Transaminase-SGOT O O
21 O O
10-40 O O
U/L O O
DCGH O O
BLOOD O O
18-Mar-2094 O O
15:50 O O
Accession# O O
7428Y74680 O O
WBC O O
18.6 O O
H O O
4.5-11.0 O O
th/cmm O O
HCT O O
29.8 O O
L O O
41.0-53.0 O O
% O O
HGB O O
9.8 O O
L O O
13.5-17.5 O O
gm/dl O O
RBC O O
3.54 O O
L O O
4.50-5.90 O O
mil/cmm O O
PLT O O
413 O O
H O O
150-350 O O
th/cumm O O
MCV O O
84 O O
80-100 O O
fl O O
MCH O O
27.8 O O
26.0-34.0 O O
pg/rbc O O
MCHC O O
33.0 O O
31.0-37.0 O O
g/dl O O
RDW O O
15.5 O O
H O O
11.5-14.5 O O
% O O
Superstat O O
PT O O
18.3 O O
H O O
11.1-13.1 O O
sec O O
Superstat O O
PT-INR O O
2.2 O O
Result O O
Text: O O
PT-INR O O
values O O
are O O
valid O O
only O O
for O O
WARFARIN O O
ANTI-COAG O O
THERAPY. O O
Superstat O O
APTT O O
39.0 O O
H O O
22.1-35.1 O O
sec O O
DIFFERENTIAL O O
REQUEST O O
RECEIVED O O
Diff O O
Method O O
Auto O O
Poly O O
91 O O
H O O
40-70 O O
% O O
Lymphs O O
7 O O
L O O
22-44 O O
% O O
Monos O O
2 O O
L O O
4-11 O O
% O O
EOS O O
0 O O
0-8 O O
% O O
Basos O O
0 O O
0-3 O O
% O O
Absolute O O
Neuts O O
16.82 O O
H O O
1.8-7.7 O O
th/cmm O O
Absolute O O
Lymphs O O
1.33 O O
1.0-4.8 O O
th/cmm O O
Absolute O O
Monos O O
0.38 O O
0.2-0.4 O O
th/cmm O O
Absolute O O
EOS O O
0.00 O O
L O O
0.1-0.3 O O
th/cmm O O
Absolute O O
Basos O O
0.03 O O
0.0-0.3 O O
th/cmm O O
Aniso O O
None O O
NORMAL O O
Hypo O O
1+ O O
NORMAL O O
Macrocytes O O
None O O
Microcytes O O
None O O
DCGH O O
BLOOD O O
18-Mar-2094 O O
15:40 O O
Accession# O O
7741J60844 O O
Calcium O O
8.5 O O
8.5-10.5 O O
mg/dl O O
Phosphorus O O
4.2 O O
2.6-4.5 O O
mg/dl O O
Magnesium O O
1.6 O O
1.4-2.0 O O
meq/L O O
Total O O
Protein O O
7.6 O O
6.0-8.0 O O
g/dl O O
Albumin O O
4.2 O O
3.1-4.3 O O
g/dl O O
Globulin O O
3.4 O O
2.6-4.1 O O
g/dl O O
Direct O O
Bilirubin O O
0.1 O O
0-0.4 O O
mg/dl O O
Total O O
Bilirubin O O
0.1 O O
0-1.0 O O
mg/dl O O
Alkaline O O
Phosphatase O O
269 O O
H O O
45-115 O O
U/L O O
Transaminase-SGPT O O
12 O O
10-55 O O
U/L O O
Transaminase-SGOT O O
30 O O
10-40 O O
U/L O O
Carbamazepine,Chem O O
14.1 O O
H O O
4.0-12.0 O O
mcg/ml O O
DCGH O O
ED O O
LAB O O
18-Mar-2094 O O
16:06 O O
Accession# O O
7607Z82720 O O
Creatine O O
Kinase O O
Isoenzy O O
NEGATIVE O O
NEG O O
Troponin-I O O
NEGATIVE O O
NEG O O
Microbiology O O
(prior O O
admission): O O
DCGH O O
SPUTUM O O
13-Mar-2094 O O
10:31 O O
Accession O O
1540R27019 O O
Gram O O
Stain O O
- O O
Final O O
Reported: O O
16-Mar-94 O O
16:35 O O
Abundant O O
POLYS, O O
Very O O
Rare O O
GRAM O O
POSITIVE O O
COCCI O O
in O O
CLUSTERS O O
Respiratory O O
Culture O O
- O O
Final O O
Reported: O O
16-Mar-94 O O
16:35 O O
Few O O
KLEBSIELLA O O
PNEUMONIAE O O
Few O O
PSEUDOMONAS O O
AERUGINOSA O O
Very O O
Rare O O
STAPHYLOCOCCUS O O
AUREUS O O
NORMAL O O
FLORA O O
ABSENT O O
DCGH O O
BLOOD O O
CULTURE O O
08-Mar-2094 O O
21:13 O O
Accession O O
2503U88389 O O
Blood O O
Culture O O
- O O
Final O O
Reported: O O
15-Mar-94 O O
17:09 O O
Anaerobic O O
bottle: O O
STAPHYLOCOCCUS O O
AUREUS O O
Antibiotic O O
Interpretation O O
---------------------------------------------- O O
Clindamycin O O
Susceptible O O
Erythromycin O O
Resistant O O
Gentamicin O O
Susceptible O O
Levofloxacin O O
Resistant O O
Oxacillin O O
Resistant O O
Penicillin O O
G O O
Resistant O O
Rifampin O O
Resistant O O
Tetracycline O O
Susceptible O O
Trimethoprim/Sulfamethoxazole O O
Susceptible O O
Vancomycin O O
Susceptible O O
DCGH O O
SPUTUM O O
16-Feb-2094 O O
12:19 O O
Accession O O
8388H26401 O O
Respiratory O O
Culture O O
- O O
Final O O
Reported: O O
19-Feb-94 O O
15:42 O O
Moderate O O
KLEBSIELLA O O
PNEUMONIAE O O
RAPID O O
METHOD O O
Antibiotic O O
Interpretation O O
---------------------------------------------- O O
Amikacin O O
Susceptible O O
Ampicillin O O
Resistant O O
Aztreonam O O
Resistant O O
Cefazolin O O
Resistant O O
Cefepime O O
Resistant O O
Cefpodoxime O O
Resistant O O
Ceftriaxone O O
Resistant O O
Gentamicin O O
Resistant O O
Levofloxacin O O
Resistant O O
Meropenem O O
Susceptible O O
Piperacillin O O
Resistant O O
Trimethoprim/Sulfamethoxazole O O
Resistant O O
Moderate O O
PSEUDOMONAS O O
AERUGINOSA O O
DISK O O
METHOD O O
Antibiotic O O
Interpretation O O
------------------------------ O O
Amikacin O O
Susceptible O O
Aztreonam O O
Susceptible O O
Cefepime O O
Susceptible O O
Ciprofloxacin O O
Resistant O O
Gentamicin O O
Resistant O O
Imipenem O O
Resistant O O
Levofloxacin O O
Resistant O O
Piperacillin O O
Susceptible O O
Ticarcillin O O
Susceptible O O
Tobramycin O O
Resistant O O
Few O O
STAPHYLOCOCCUS O O
AUREUS O O
NORMAL O O
FLORA O O
PRESENT O O
Radiology: O O
DCGH O O
Chest, O O
1 O O
view O O
18-Mar-2094 O O
15:59 O O
Accession# O O
3624881 O O
Final O O
Findings O O
suspicious O O
for O O
early O O
right O O
lower O O
lobe O O
pneumonia. O O
Possibly O O
related O O
to O O
aspiration. O O
Clinical O O
correlation O O
and O O
possibly O O
further O O
imaging O O
as O O
described O O
is O O
advised. O O
EKG: O O
sinus, O O
long O O
QT, O O
TWI O O
in O O
V1, O O
TW O O
flattening O O
V2 O O
(old) O O
Assessment/Plan: O O
69 O O
yo O O
M O O
with O O
recent O O
extended O O
hospitalization O O
for O O
HONC, O O
ischemic O O
LLE, O O
recurrent O O
aspiration, O O
presents O O
with O O
aspiration O O
event O O
at O O
rehab. O O
Aspiration O O
PNA: O O
- O O
rx O O
for O O
aspiration O O
PNA: O O
Vanco O O
(MRSA), O O
Clinda O O
(anaerobes), O O
Amikacin O O
(Pseudomonas O O
and O O
Klebsiella, O O
based O O
on O O
prior O O
resistance O O
patterns) O O
- O O
ID O O
consult O O
in O O
AM O O
(need O O
ID O O
approval O O
for O O
Amikacin) O O
- O O
Supplemental O O
O2 O O
- O O
Nebs O O
prn O O
- O O
Chest O O
PT O O
- O O
Incentive O O
spirometry O O
- O O
NPO/NPGT O O
(except O O
meds) O O
for O O
now O O
FEN: O O
- O O
gentle O O
hydration, O O
D5 O O
NS O O
- O O
hold O O
diuretics O O
at O O
present O O
- O O
hold O O
TFs O O
at O O
present O O
- O O
speech/swallow O O
consult O O
Vascular: O O
- O O
consult O O
Madison O O
County's O O
service O O
- O O
wound O O
care O O
with O O
silvadine/bacitracin O O
- O O
wound O O
care O O
consult O O
- O O
continue O O
Rifampin/Bactrim O O
for O O
?graft O O
infxn O O
- O O
coumadin O O
for O O
goal O O
INR=2-3 O O
DM: O O
- O O
management O O
per O O
Dr. O O
Phelps O O
- O O
QID O O
FS O O
- O O
Insulin B-MEDICATION O
SS I-MEDICATION O
coverage I-MEDICATION O
Renal O O
Failure: O O
Baseline O O
BUN/Cre O O
= O O
52/2.1; O O
now O O
82/3.8 O O
- O O
hx O O
embolic O O
events O O
concerning O O
for O O
?cholesterol O O
emboli, O O
?septic O O
emboli O O
send O O
urine O O
eos, O O
complement O O
- O O
check O O
urine O O
sediment O O
- O O
urine O O
lytes, O O
urine O O
urea, O O
urine O O
osms O O
- O O
hold O O
diuretics O O
for O O
?prerenal O O
component O O
to O O
renal O O
failure O O
- O O
consider O O
evaluation O O
for O O
renal O O
artery O O
stenosis O O
Anemia: O O
Patient's O O
baseline O O
Hct O O
on O O
d/c= O O
29; O O
remains O O
at O O
baseline O O
- O O
recheck O O
Fe O O
studies O O
- O O
guaiac O O
stools O O
Ophtho: O O
continue O O
erythromycin O O
ophtho O O
ointment O O
Gen O O
Care: O O
- O O
PT/OT O O
- O O
Access: O O
R O O
PICC O O
line O O
(read O O
on O O
CXR O O
as O O
subclavian O O
- O O
too O O
far?) O O
- O O
Proph: O O
Nexium, O O
coumadin O O
- O O
Precautions: O O
MRSA, O O
aspiration O O
Ursula O O
Isabella-Venegas, O O
MD O O
#25112 O O

Record O O
date: O O
2094-10-29 O O
MICU O O
Intern O O
Admission O O
Note O O
Faulkner, O O
Yandel O O
MR#5075561 O O
Date O O
of O O
Admission: O O
October O O
28, O O
2094 O O
PCP: O O
Lord, O O
Dana O O
ID/CC: O O
GI O O
Bleed O O
HPI: O O
69 O O
yo O O
man O O
w/ O O
h/o O O
AAA, O O
PVD, O O
CAD, B-CAD O
AF O O
w/ O O
tracheostomy O O
and O O
G-tube O O
in O O
place, O O
on O O
coumadin O O
for O O
PVD, O O
HIT O O
+, O O
and O O
DVT O O
w/ O O
INR O O
yesterday O O
of O O
5.3. O O
Noticed O O
black O O
stools O O
x O O
1 O O
day, O O
and O O
blood O O
suctioned O O
form O O
G-tube. O O
Came O O
to O O
ED O O
and O O
while O O
in O O
ED O O
waiting O O
for O O
a O O
room O O
had O O
an O O
episode O O
of O O
near O O
syncope. O O
In O O
ED O O
97.6, O O
Pulse O O
82, O O
BP O O
110/62 O O
RR O O
20. O O
In O O
ED O O
received O O
4 O O
units O O
FFP, O O
2 O O
uPRBCs, O O
and O O
Zantac. O O
GI O O
saw O O
him O O
then O O
and O O
EGD O O
showed O O
large O O
clot O O
in O O
fundus O O
of O O
stomach, O O
but O O
unable O O
to O O
find O O
source O O
of O O
active O O
bleeding. O O
Duodenum O O
was O O
visualized O O
up O O
to O O
the O O
3rd O O
portion O O
was O O
normal. O O
Shortly O O
after O O
transfer O O
to O O
floor O O
he O O
was O O
noted O O
to O O
have O O
hematemesis, O O
then O O
became O O
pulseless O O
and O O
went O O
into O O
Vfib O O
arrest. O O
Pt O O
trached O O
and O O
was O O
bagged. O O
After O O
cardioversion O O
x O O
2, O O
he O O
reverted O O
to O O
sinus O O
rhythm O O
which O O
again O O
returned O O
to O O
asystole. O O
After O O
1 O O
mg O O
of O O
epinephrine O O
he O O
regained O O
pulse O O
and O O
rhythm O O
was O O
sinus O O
tachycardia. O O
Triple O O
lumen O O
placed O O
in O O
R O O
groin O O
and O O
Cordis O O
in O O
L O O
groin. O O
EKG O O
w/ O O
ST O O
depressions O O
in O O
lateral O O
leads. O O
Repeat O O
EGD O O
in O O
MICU O O
showed O O
ulcer O O
2 O O
cm O O
from O O
GE O O
junction O O
w/ O O
protrusion O O
and O O
question O O
of O O
visible O O
vessel. O O
Angioectasia O O
/ O O
active O O
oozing. O O
Both O O
tx'd O O
c/ O O
bipolar O O
resulting O O
in O O
good O O
hemostasis. O O
PMH: O O
1. O O
Atrial O O
fibrillation O O
2. O O
PVD O O
- O O
emergent O O
thrmobectomy, O O
femoral-femoral O O
bypass O O
in O O
1/92PG O O
3. O O
AAA O O
repair O O
in O O
2091 O O
- O O
endovascular O O
repair O O
of O O
his O O
abdominal O O
aortic O O
and O O
bilateral O O
iliac O O
artery O O
aneurysms O O
with O O
an O O
aortoiliac O O
bifurcated O O
modular O O
endograft, O O
bilateral O O
femoral O O
artery O O
repair. O O
4. O O
CAD O O
5. O O
Typ B-DIABETES O
II I-DIABETES O
diabetes I-DIABETES O
6. O O
HTN B-HYPERTENSION O
7. O O
CVA O O
s/p O O
L O O
CEA O O
in O O
January O O
2091 O O
8. O O
PUD O O
9. O O
septic O O
PE O O
10. O O
multiple O O
aspiration O O
pneumonias O O
11. O O
tracheostomy O O
12. O O
G-tube O O
13. O O
HIT O O
+ O O
Medications: O O
1. O O
ASA B-MEDICATION B-MEDICATION
325 O O
mg O O
QD O O
2. O O
Coumadin O O
3. O O
Amlodipine B-MEDICATION B-MEDICATION
10 O O
mg O O
QD O O
4. O O
FeSo4 O O
325 O O
mg O O
QD O O
5. O O
KCL O O
20 O O
meq O O
QD O O
6. O O
Lopressor B-MEDICATION B-MEDICATION
150 O O
mg O O
BID O O
7. O O
rifampin O O
8. O O
doxycycline O O
100 O O
mg O O
BID O O
9. O O
protonix O O
40 O O
mg O O
TID O O
10. O O
reglan O O
5 O O
mg O O
AID O O
Allergies: O O
NKDA O O
SH: O O
Tob: B-SMOKER O
Negative I-SMOKER O
EtOH: O O
Negative O O
Illicits: O O
Negative O O
FH: O O
Exam: O O
VS: O O
T=98.1 O O
HR=100 O O
BP=138/50 O O
RR=14 O O
100% O O
fiO2 O O
997 O O
8/5 O O
SaO2 O O
100% O O
General: O O
Pt O O
confused O O
w/ O O
poor O O
memory. O O
lying O O
comfortably O O
in O O
bed O O
in O O
NAD; O O
HEENT: O O
NC/AT, O O
PERRL, O O
anicteric. O O
EOMI. O O
OP O O
MMM O O
w/,no O O
erythema O O
or O O
injection. O O
Skin: O O
No O O
rashes. O O
Neck: O O
Supple, O O
full O O
ROM, O O
JVP=flat O O
, O O
2+ O O
carotids O O
w/o O O
bruits, O O
no O O
thyromegaly O O
or O O
nodules, O O
no O O
nodes O O
Chest: O O
Coarse O O
BS O O
anteriorly. O O
CVS: O O
distant O O
heart O O
sounds O O
Nl O O
rate O O
nl O O
S1 O O
S2, O O
no O O
m/r/g O O
Abd: O O
soft, O O
NT, O O
ND O O
BS O O
+ O O
no O O
HSM O O
GU: O O
melenic O O
stool O O
Extr: O O
no O O
c/c/e O O
2+ O O
DP's O O
bilaterally O O
Neuro: O O
Oriented O O
to O O
name O O
and O O
place. O O
Motor O O
5/5 O O
UE O O
and O O
LE. O O
DTR's O O
2+ O O
and O O
symmetric O O
in O O
bilat O O
LE O O
and O O
UE. O O
Toes O O
down O O
bilaterally. O O
DATA: O O
Chemistry O O
Detail O O
for O O
FAULKNER, O O
YANDEL O O
B O O
DCGH O O
BLOOD O O
28-Oct-2094 O O
13:45 O O
Accession# O O
8175S66443 O O
Test O O
Description O O
Result O O
Flags O O
Ref. O O
Range O O
Ref. O O
Units O O
Sodium O O
(Stat O O
Lab) O O
139 O O
135-145 O O
mmol/L O O
Potassium O O
(Stat O O
Lab) O O
4.8 O O
3.4-4.8 O O
mmol/L O O
Chloride O O
(Stat O O
Lab) O O
108 O O
100-108 O O
mmol/L O O
CO2 O O
(Stat O O
Lab) O O
21.6 O O
L O O
23.0-31.9 O O
mmol/L O O
BUN O O
(Stat O O
Lab) O O
105 O O
H O O
8-25 O O
mg/dl O O
Creatinine O O
(Stat O O
Lab) O O
1.9 O O
H O O
0.6-1.5 O O
mg/dl O O
Glucose O O
(Stat O O
Lab) O O
154 O O
H O O
70-110 O O
mg/dl O O
Calcium O O
9.0 O O
8.5-10.5 O O
mg/dl O O
Phosphorus O O
3.6 O O
2.6-4.5 O O
mg/dl O O
Magnesium O O
2.0 O O
1.4-2.0 O O
meq/L O O
Total O O
Protein O O
6.6 O O
6.0-8.3 O O
g/dl O O
Albumin O O
3.4 O O
3.3-5.0 O O
g/dl O O
Globulin O O
3.2 O O
2.6-4.1 O O
g/dl O O
Direct O O
Bilirubin O O
0.1 O O
0-0.4 O O
mg/dl O O
Total O O
Bilirubin O O
0.3 O O
0-1.0 O O
mg/dl O O
Alkaline O O
Phosphatase O O
75 O O
45-115 O O
U/L O O
Transaminase-SGPT O O
32 O O
10-55 O O
U/L O O
Amylase O O
56 O O
3-100 O O
units/L O O
Lipase O O
1.5 O O
1.3-6.0 O O
U/dl O O
Transaminase-SGOT O O
25 O O
10-40 O O
U/L O O
FIO2/Flow O O
UNSPEC. O O
FIO2/L O O
Temp O O
37.0 O O
deg O O
C O O
Unspecified O O
pH O O
7.33 O O
7.32-7.45 O O
Unspecified O O
PCO2 O O
27 O O
L O O
35-50 O O
mm/Hg O O
Unspecified O O
PO2 O O
284 O O
H O O
40-90 O O
mm/Hg O O
Sodium O O
139 O O
135-145 O O
mmol/L O O
Potassium O O
3.1 O O
L O O
3.5-5.0 O O
mmol/L O O
Ionic O O
Calcium O O
1.18 O O
1.14-1.30 O O
mmol/L O O
Glucose O O
268 O O
H O O
70-110 O O
mg/dL O O
WBC O O
9.9 O O
4.5-11.0 O O
th/cmm O O
HCT O O
22.2 O O
L O O
41.0-53.0 O O
% O O
HGB O O
7.7 O O
L O O
13.5-17.5 O O
gm/dl O O
RBC O O
2.50 O O
L O O
4.50-5.90 O O
mil/cmm O O
PLT O O
233 O O
150-350 O O
th/cumm O O
MCV O O
89 O O
80-100 O O
fl O O
MCH O O
30.8 O O
26.0-34.0 O O
pg/rbc O O
MCHC O O
34.8 O O
31.0-37.0 O O
g/dl O O
RDW O O
16.1 O O
H O O
11.5-14.5 O O
% O O
PT O O
35.9 O O
H O O
11.1-13.1 O O
sec O O
PT-INR O O
8.5 O O
Result O O
Text: O O
PT-INR O O
values O O
are O O
valid O O
only O O
for O O
WARFARIN O O
ANTI-COAG O O
THERAPY. O O
APTT O O
43.8 O O
H O O
22.1-35.1 O O
sec O O
DIFFERENTIAL O O
REQUEST O O
RECEIVED O O
Diff O O
Method O O
Auto O O
Poly O O
69 O O
40-70 O O
% O O
Lymphs O O
23 O O
22-44 O O
% O O
Monos O O
7 O O
4-11 O O
% O O
EOS O O
1 O O
0-8 O O
% O O
Basos O O
0 O O
0-3 O O
% O O
Absolute O O
Neuts O O
6.89 O O
1.8-7.7 O O
th/cmm O O
Absolute O O
Lymphs O O
2.29 O O
1.0-4.8 O O
th/cmm O O
Absolute O O
Monos O O
0.66 O O
H O O
0.2-0.4 O O
th/cmm O O
Absolute O O
EOS O O
0.08 O O
L O O
0.1-0.3 O O
th/cmm O O
Absolute O O
Basos O O
0.02 O O
0.0-0.3 O O
th/cmm O O
Aniso O O
1+ O O
NORMAL O O
Hypo O O
None O O
NORMAL O O
Macrocytes O O
None O O
Microcytes O O
None O O
HCT O O
SINCE O O
ADMISSION: O O
10/29/94 O O
10/28/94 O O
10/28/94 O O
10/28/94 O O
10/19/94 O O
04:29 O O
23:28 O O
22:37 O O
13:43 O O
16:25 O O
WBC O O
15.4(H) O O
17.1(H) O O
9.9 O O
6.7 O O
RBC O O
2.65(L) O O
2.32(L) O O
2.50(L) O O
3.57(L) O O
HGB O O
8.1(L) O O
7.1(L) O O
7.4(LT) O O
7.7(L) O O
10.8(L) O O
HCT O O
23.0(L) O O
20.6(L) O O
22.2(L) O O
31.4(L) O O
MCV O O
87 O O
89 O O
89 O O
88 O O
MCH O O
30.7 O O
30.8 O O
30.8 O O
30.1 O O
MCHC O O
35.4 O O
34.7 O O
34.8 O O
34.3 O O
PLT O O
144(L) O O
157 O O
233 O O
199 O O
RDW O O
16.2(H) O O
15.9(H) O O
16.1(H) O O
15.0(H) O O
MICRO: O O
CXR: O O
Clear O O
lungs. O O
CTA O O
8/11/94: O O
The O O
patient O O
is O O
status O O
post O O
infrarenal O O
abdominal O O
aortic O O
endograft O O
placement. O O
No O O
endoleak O O
is O O
identified. O O
The O O
left O O
limb O O
of O O
the O O
graft O O
is O O
occluded O O
throughout O O
its O O
entire O O
extent. O O
There O O
is O O
mural O O
thrombus O O
identified O O
in O O
the O O
proximal O O
aspect O O
of O O
the O O
graft O O
circumferentially. O O
The O O
left O O
limb O O
is O O
again O O
noted O O
to O O
extend O O
into O O
the O O
left O O
external O O
iliac O O
artery. O O
The O O
distal O O
right O O
limb O O
terminates O O
in O O
the O O
right O O
common O O
iliac O O
artery. O O
There O O
is O O
a O O
normally O O
patent O O
right O O
to O O
left O O
femoral O O
femoral O O
bypass O O
graft. O O
The O O
aneurysm O O
sac, O O
previously O O
measuring O O
55 O O
x O O
51 O O
mm, O O
now O O
measures O O
53 O O
x O O
50 O O
mm. O O
ECHO O O
2/94: O O
EF O O
&gt; O O
50% O O
Trace O O
to O O
mild O O
mitral O O
regurgitation. O O
There O O
are O O
thin O O
mobile O O
echoes O O
associated O O
with O O
the O O
aortic O O
valve O O
leaflets O O
most O O
c/w O O
Lambl's O O
excresence. O O
There O O
is O O
no O O
evidence O O
of O O
aortic O O
insufficiency O O
by O O
color O O
or O O
spectral O O
Doppler. O O
There O O
are O O
atheroma O O
in O O
the O O
aorta O O
but O O
no O O
protruding O O
or O O
mobile O O
components.The O O
left O O
ventricular O O
cavity O O
size O O
is O O
normal. O O
The O O
left O O
ventricular O O
systolic O O
function O O
is O O
within O O
normal O O
limits.There O O
is O O
a O O
very O O
small O O
circumferential O O
pericardial O O
effusion. O O
There O O
is O O
evidence O O
of O O
a O O
large O O
pleural O O
effusion. O O
EGD O O
1/94: O O
- O O
Savary-Miller O O
Grade O O
III O O
reflux O O
esophagitis. O O
EKG: O O
Sinus O O
rhythm O O
w/ O O
1st O O
degree O O
AV O O
block. O O
Q O O
in O O
I, O O
AVL, O O
and O O
II, O O
II, O O
AVF. O O
T O O
wave O O
inversion O O
in O O
V2-V6. O O
___________________________________________ O O
Impression: O O
70 O O
yo O O
man O O
with O O
history O O
of O O
CAD, O O
AAA O O
repair, O O
vasculopath, O O
presents O O
with O O
GI O O
bleed O O
most O O
likely O O
secondary O O
to O O
gastric O O
ulcer, O O
EKG O O
changes O O
with O O
fast O O
rhythm, O O
bump O O
in O O
cardiac O O
enzymes. O O
Plan: O O
GI O O
Bleed O O
- O O
NPO O O
- O O
Repeat O O
EGD O O
48 O O
hrs O O
- O O
Follow O O
HCT O O
q O O
6h O O
and O O
transfuse O O
for O O
HCT&lt;30 O O
- O O
Acid O O
suppression O O
w/ O O
IV O O
zantac O O
- O O
Received O O
FFP/Vit O O
K O O
to O O
reverse O O
coumadin O O
- O O
will O O
check O O
H. O O
pylori O O
serologies O O
PVD O O
- O O
Will O O
have O O
to O O
monitor O O
extremities O O
w/ O O
acute O O
reversal O O
of O O
anticoagulation O O
- O O
Will O O
need O O
to O O
restart O O
anticoagulation O O
once O O
stable O O
from O O
GI O O
perspective O O
CV O O
Ischemia O O
- O O
Patient O O
w/ O O
EKG O O
changes O O
in O O
setting O O
of O O
arrest. O O
Trend O O
CKs O O
- O O
Holdng B-MEDICATION O
ASA I-MEDICATION O
- O O
follow O O
EKG's O O
- O O
unable B-MEDICATION O
to I-MEDICATION O
give I-MEDICATION O
beta-blockade I-MEDICATION O
at I-MEDICATION O
the I-MEDICATION O
moment I-MEDICATION O
due I-MEDICATION O
to I-MEDICATION O
low I-MEDICATION O
BP I-MEDICATION O
- O O
history O O
of O O
elevated O O
troponins O O
due O O
to O O
CKD O O
Pump O O
BP O O
borderline O O
with O O
low O O
HCT, O O
required O O
Levo O O
to O O
keep O O
pressures O O
up O O
for O O
sedation O O
Pulm O O
- O O
may O O
have O O
aspirated O O
in O O
setting O O
of O O
arrest, O O
CXR O O
clear O O
though O O
- O O
will O O
hold O O
Abx O O
at O O
this O O
time. O O
If O O
WBC O O
rises O O
or O O
spikes O O
w/ O O
begin O O
antibiotics O O
- O O
required O O
vent O O
support O O
briefly O O
with O O
sedation O O
Access O O
- O O
will O O
need O O
to O O
change O O
femoral O O
lines O O
to O O
IJ O O
since O O
placed O O
emergently O O
during O O
code O O
CKD: O O
Acute O O
renal O O
insult O O
on O O
top O O
of O O
CKD. O O
Creatinine O O
responded O O
to O O
volume O O
(PRBCs O O
and O O
fluid). O O
ID: O O
is O O
supposed O O
to O O
be O O
on O O
chronic O O
suppressive O O
doxycycline O O
for O O
history O O
of O O
MRSA, O O
but O O
at O O
the O O
moment O O
no O O
meds O O
PO, O O
so O O
will O O
hold O O
Prophylaxis: O O
Head O O
of O O
bed O O
should O O
be O O
30 O O
degrees, O O
pneumoboots, O O
Zantac. O O
_________________________________ O O
Rachel O O
Quade, O O
MD O O
Pager O O
#29447 O O

Record O O
date: O O
2096-06-02 O O
He O O
comes O O
in O O
for O O
f/u O O
- O O
is O O
feeling O O
great, O O
but O O
has O O
gained O O
a O O
few O O
lbs O O
is O O
now O O
up O O
to O O
210. O O
not O O
checking O O
sugars. O O
bp O O
has O O
been O O
ok O O
at O O
home. O O
Problems O O
S/P O O
abdominal O O
aortic O O
aneurysm O O
: O O
repair O O
in O O
2091 O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
Deep O O
venous O O
thrombosis O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Anemia O O
s/p O O
trach O O
s/p O O
gtube O O
Peripheral O O
vascular O O
disease O O
: O O
s/p O O
fem-fem O O
hit O O
antibody O O
: O O
cannot O O
have O O
heparin O O
Renal O O
insufficiency O O
S/P O O
pneumonia O O
H/O O O
sepsis O O
Medications O O
Asa B-MEDICATION B-MEDICATION
ENTERIC O O
COATED O O
(ASPIRIN B-MEDICATION O
ENTERIC O O
COATED) O O
325 O O
MG O O
PO O O
QD O O
Doxycycline O O
HYCLATE O O
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
GTUBE O O
BID O O
Amlodipine B-MEDICATION B-MEDICATION
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
GTUBE O O
QD O O
Atenolol B-MEDICATION B-MEDICATION
50 O O
MG O O
PO O O
qhs O O
, O O
take O O
1/2 O O
tab/day O O
, O O
if O O
heart O O
rate&gt;50, O O
can O O
increase O O
to O O
one O O
tablet/day O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
MG O O
(25MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Nexium O O
(ESOMEPRAZOLE) O O
40MG O O
CAPSULE O O
EC O O
take O O
1 O O
Capsule(s) O O
PO O O
bid O O
Flonase O O
(FLUTICASONE O O
NASAL O O
SPRAY) O O
1-2 O O
SPRAY O O
NAS O O
QD O O
Allergies O O
Heparin O O
- O O
HIT O O
antibody O O
positive, O O
LISINOPRIL O B-MEDICATION
- O O
Renal O O
Toxicity O O
ROS: O O
denies O O
cp, O O
sob, O O
gi/gu O O
sx, O O
no O O
significant O O
weight O O
changes, O O
remainder O O
of O O
review O O
of O O
systems O O
is O O
negative O O
in O O
detail. O O
PE O O
: O O
nad O O
bp O O
114/54 O O
hr O O
60 O O
reg O O
perrla,eomi,anicteric O O
lungs O O
cta O O
heart:RRR O O
ext:no O O
c/c/e, O O
warm, O O
well O O
perfused O O
a/p: O O
weight O O
gain O O
is O O
concerning O O
to O O
me O O
as O O
he O O
has O O
h/o O O
increased O O
blood O O
sugars: O O
advised O O
him O O
to O O
try O O
to O O
lose O O
10 O O
lbs, O O
we'll O O
check O O
his O O
hga1c O O
and O O
fasting O O
sugar O O
again O O
as O O
well. O O
I'm O O
concerned O O
that O O
he O O
will O O
end O O
up O O
need O O
ing O O
medication O O
for O O
this O O
if O O
he O O
continues O O
to O O
gain O O
weight. O O
his O O
lipids O O
were O O
up O O
last O O
check, O O
but O O
his O O
daughter O O
recollects O O
that O O
he O O
ate O O
a O O
full O O
breakfast O O
prior O O
to O O
that O O
lab O O
draw.. O O
will O O
repeat O O
fasting. O O
htn: B-HYPERTENSION O
in O O
good O O
control O O
cad: B-CAD O
pt O O
to O O
see O O
cardiology O O
next O O
wednesday. O O
I O O
advised O O
him O O
he O O
would O O
probably O O
need O O
a O O
statin O O
if O O
LDL O O
isn't O O
in O O
the O O
60's O O
fasting O O
again. O O
f/u O O
in O O
3 O O
mos O O

Record O O
date: O O
2086-05-25 O O
FCH O O
EMERGENCY O O
DEPT O O
VISIT O O
TANNER,YUL O O
M. O O
099-04-65-0 O O
VISIT O O
DATE: O O
05/25/86 O O
I O O
saw O O
this O O
patient O O
May O O
25 O O
with O O
the O O
SAR O O
and O O
the O O
attending O O
from O O
the O O
Short-stay O O
Unit. O O
PRESENTING O O
COMPLAINT: O O
Polyuria, O O
fatigue. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
50 O O
year O O
old O O
man O O
was O O
referred O O
in O O
by O O
Dr. O O
Locke O O
covering O O
for O O
Dr. O O
Tirado O O
for O O
polyuria O O
and O O
fatigue. O O
His O O
last B-DIABETES O
recorded I-DIABETES O
fasting B-DIABETES O
blood I-DIABETES O
sugar I-DIABETES O
was I-DIABETES O
185. I-DIABETES O
He O O
has O O
come O O
week O O
from O O
a O O
trip O O
for O O
one O O
week O O
and O O
he O O
did O O
follow O O
his O O
diet, O O
but O O
had O O
continued O O
increasing O O
polyuria, O O
polydipsia, O O
blurring O O
of O O
vision O O
and O O
weakness. O O
PAST O O
MEDICAL O O
HISTORY: O O
Renal O O
insufficiency O O
and O O
'incipient O O
type O O
II O O
diabetes' O O
for O O
which O O
he O O
had O O
been O O
following O O
a O O
strict O O
diet. O O
PHYSICAL O O
EXAMINATION: O O
Unremarkable O O
except O O
for O O
a O O
chronic O O
strabismus. O O
LABORATORY O O
EVALUATION: O O
Laboratory O O
studies O O
included O O
a O O
blood B-DIABETES O
glucose I-DIABETES O
of I-DIABETES O
709, I-DIABETES O
an O O
anion O O
gap O O
of O O
23 O O
and O O
elevated O O
beta O O
hydroxybutyrate. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
He O O
was O O
begun O O
on O O
intravenous O O
fluids O O
and O O
intravenous O O
insulin, B-MEDICATION O
and O O
arrangements O O
were O O
made O O
to O O
go O O
to O O
a O O
step-down B-MEDICATION O
unit I-MEDICATION O
on I-MEDICATION O
an I-MEDICATION O
insulin I-MEDICATION O
drip. I-MEDICATION O
FINAL O O
DIAGNOSIS: O O
New B-DIABETES O
onset I-DIABETES O
diabetes. I-DIABETES O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Admitted O O
to O O
hospital, O O
condition O O
satisfactory. O O
___________________________________ O O
HU019/45662 O O
MAX O O
URIARTE, O O
M.D. O O
MU11 O O
D:05/25/86 O O
T:05/25/86 O O
Dictated O O
by: O O
MAX O O
URIARTE, O O
M.D. O O
MU11 O O

Record O O
date: O O
2086-08-28 O O
OFFICE O O
NOTE O O
Floyd O O
County O O
Hospital O O
05 O O
Greeley O O
Street O O
Palm O O
Springs, O O
CO O O
19496 O O
Tanner, O O
Yul O O
MR O O
#099-04-65-0 O O
08/28/86 O O
I O O
saw O O
Mr. O O
Tanner O O
today O O
for O O
a O O
routine O O
follow-up O O
visit. O O
I O O
last O O
saw O O
him O O
in O O
November O O
of O O
2085. O O
In O O
May O O
he O O
presented O O
to O O
the O O
emergency O O
room O O
with O O
dehydration O O
and O O
hyperglycemia. O O
Diagnosis B-DIABETES O
of I-DIABETES O
non-insulin B-DIABETES O
dependent I-DIABETES O
diabetes B-DIABETES O
mellitus I-DIABETES O
was O O
made. O O
He O O
is O O
now O O
on O O
Glyburide B-MEDICATION B-MEDICATION
and O O
metformin. B-MEDICATION B-MEDICATION
His O O
renal O O
function O O
at O O
that O O
time O O
was O O
normal O O
with O O
a O O
BUN O O
of O O
15 O O
and O O
creatinine O O
of O O
0.90. O O
His O O
potassium O O
at O O
that O O
time O O
was O O
4.6. O O
Otherwise, O O
he O O
is O O
doing O O
pretty O O
well. O O
He O O
has O O
lost O O
about O O
40 O O
lb. O O
He O O
has O O
seen O O
a O O
nutritionist O O
regarding O O
dietary O O
counseling. O O
Today O O
his O O
weight O O
is O O
258 O O
lb. O O
Blood O O
pressure O O
120/80. O O
Heart O O
rate O O
100. O O
Current O O
medications O O
lisinopril B-MEDICATION B-MEDICATION
40 O O
mg O O
p.o. O O
q.d., O O
hydrochlorothiazide B-MEDICATION B-MEDICATION
12.5 O O
q.d., O O
Glyburide O B-MEDICATION
5 O O
mg O O
p.o. O O
q.d., O O
metformin O B-MEDICATION
500 O O
mg O O
t.i.d., O O
diltiazem B-MEDICATION O
180 O O
p.o. O O
q.d. O O
Urinalysis O O
shows O O
3+ O O
blood, O O
4+ O O
protein. O O
IMPRESSION: O O
#1) O O
Thin O O
based O O
membrane O O
disease O O
with O O
persistent O O
hematuria O O
and O O
proteinuria. O O
#2) O O
History O O
of O O
renal O O
________. O O
#3) O O
Type B-DIABETES O
2 I-DIABETES O
diabetes. I-DIABETES O
PLAN: O O
Continue O O
current O O
medications. O O
Continue O O
high O O
water O O
intake. O O
Encourage O O
weight O O
loss O O
and O O
compliance O O
with O O
his O O
diet. O O
I O O
spent O O
some O O
time O O
talking O O
to O O
him O O
about O O
the O O
importance O O
of O O
weight O O
loss O O
and O O
controlling O O
his O O
diabetes O O
given O O
his O O
underlying O O
kidney O O
disease. O O
Follow-up O O
visit O O
in O O
nine O O
months. O O
Edward O O
Yim, O O
M.D. O O
/pina O O
cc: O O
Harry O O
Truong, O O
M.D. O O
Floyd O O
County O O
Hospital O O
17 O O
Greeley O O
Street O O
Palm O O
Springs, O O
CO O O
19496 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2088-03-26 O O
Mr. O O
Tanner O O
RTC O O
to O O
discuss O O
diabetes, B-DIABETES O
BP, O O
weight, O O
lipids. O O
HPI: O O
He O O
has O O
been O O
overweight O O
for O O
some O O
time, O O
and O O
was O O
found O O
to O O
have O O
DM B-DIABETES O
II I-DIABETES O
about O O
two O O
years O O
ago. O O
I O O
had O O
treated O O
him O O
with: O O
GLYBURIDE B-MEDICATION B-MEDICATION
5MG O O
PO O O
BID O O
METFORMIN B-MEDICATION B-MEDICATION
500MG O O
PO O O
TID O O
LISINOPRIL B-MEDICATION B-MEDICATION
40MG O O
PO O O
QD O O
DILTIAZEM B-MEDICATION O
CD O O
180MG O O
PO O O
QD O O
HCTZ B-MEDICATION O
12.5MG O O
PO O O
QD O O
however O O
he O O
enrolled O O
in O O
a O O
study, O O
and O O
when O O
it O O
was O O
over O O
he O O
was O O
put O O
on: O O
DILTIAZEM O O
CD O O
180 O O
MG O O
PO O O
QD O O
HYZAAR B-MEDICATION O
(25 O O
MG/100 O O
MG) O O
(HCTZ O O
25MG O O
LOSART... O O
1 O O
TAB O O
PO O O
QD O O
When O O
I O O
found O O
his O O
A1c B-DIABETES O
to I-DIABETES O
be I-DIABETES O
8.7%, I-DIABETES O
I O O
added O O
back O O
5 O O
mg O O
QD O O
of O O
glyburide B-MEDICATION B-MEDICATION
which O O
he O O
has O O
been O O
taking O O
for O O
&lt; O O
1 O O
month. O O
He O O
feels O O
well. O O
He O O
says O O
he's O O
lost O O
10 O O
lbs. O O
since O O
his O O
last O O
visit O O
(262 O O
lbs. O O
on O O
2/26 O O
- O O
263 O O
lbs. O O
today) O O
but O O
he's O O
interested O O
in O O
a O O
weight O O
loss O O
program. O O
MEDICATIONS O O
DILTIAZEM O O
CD O O
180 O O
MG O O
PO O O
QD O O
HYZAAR O O
(25 O O
MG/100 O O
MG) O O
(HCTZ O O
25MG O O
LOSART... O O
1 O O
TAB O O
PO O O
QD O O
GLYBURIDE O B-MEDICATION
5 O O
MG O O
PO O O
QD O O
ALLERGIES O O
NKDA O O
NONE O O
SH: O O
single, O O
Ground O O
Transit O O
Operators O O
Supervisor O O
at O O
HASBRO. O O
Habits: B-SMOKER O
no I-SMOKER O
cigarettes, I-SMOKER O
drugs O O
or O O
alcohol; O O
ROS: O O
denies O O
weight O O
change, O O
fever, O O
chills, O O
fatigue, O O
blurry O O
vision, O O
chest O O
pains, O O
palpitations, O O
dyspnea, O O
cough, O O
abdominal O O
pain, O O
nausea, O O
vomiting, O O
change O O
in O O
bowel/bladder O O
habits, O O
joint O O
pain, O O
dizziness, O O
exanthem, O O
edema. O O
No O O
concerns O O
about O O
pain, O O
functional O O
status O O
or O O
nutritional O O
status. O O
PE O O
notable O O
for: O O
Well O O
nourished O O
well O O
appearing O O
obese B-OBESE O
WM; O O
VITAL O O
SIGNS O O
BLOOD B-HYPERTENSION O
PRESSURE I-HYPERTENSION O
152/84 I-HYPERTENSION O
PULSE O O
68 O O
WEIGHT O O
263 O O
HEENT: O O
sclera O O
clear O O
white O O
OU, O O
EOMI, O O
ear O O
canals O O
and O O
TMs O O
wnl O O
AU; O O
oropharynx O O
without O O
lesions. O O
LN: O O
No O O
palpable O O
neck O O
or O O
SC O O
LN; O O
Cardiac: O O
RRR, O O
rate O O
68 O O
, O O
no O O
extra O O
sounds O O
Resp.: O O
good O O
air O O
movement, O O
no O O
accessory O O
muscle O O
use, O O
no O O
adventitious O O
sounds O O
Plan: O O
1. O O
by O O
his O O
account O O
DM O O
control O O
is O O
still O O
poor, O O
which O O
is O O
not O O
surprising O O
since O O
he O O
previously O O
required O O
10 O O
mg O O
of O O
glyburide O O
and O O
1500 O O
mg O O
of O O
metformin O B-MEDICATION
per O O
day. O O
For O O
now O O
I O O
will O O
increase O O
glyburide O O
to O O
5 O O
mg O O
BID. O O
2. O O
also O O
poor O O
BP O O
control O O
for O O
a O O
diabetic. O O
Increasing O O
Diltiazem B-MEDICATION O
to O O
240 O O
mg O O
QD. O O
It's O O
unfortunate O O
that O O
he O O
was O O
taken O O
off O O
lisinopril. B-MEDICATION B-MEDICATION
3. O O
MALB O O
has O O
improved O O
but O O
is O O
still O O
high; O O
reports O O
suggest O O
Diltiazem O O
might O O
help O O
with O O
this. O O
4. O O
discussed O O
necessity O O
for O O
weight O O
loss O O
for O O
DM, O O
BP, O O
lipids. O O
5. O O
RTC O O
1 O O
month. O O

Record O O
date: O O
2092-12-20 O O
TANNER, O O
YUL O O
09904650 O O
12/20/2092 O O
Harry O O
Truong, O O
M.D. O O
Internal O O
Medicine O O
at O O
Blain O O
Hospital O O
3648 O O
Burgess O O
St O O
Fernley, O O
CO O O
22653 O O
Dear O O
Dr. O O
Truong: O O
We O O
had O O
the O O
pleasure O O
of O O
caring O O
for O O
your O O
patient, O O
Mr. O O
Yul O O
Tanner, O O
during O O
his O O
admission O O
to O O
the O O
Floyd O O
County O O
Hospital O O
from O O
12/19/2092 O O
through O O
12/20/2092 O O
for O O
diagnostic O O
catheterization. O O
As O O
you O O
recall, O O
he O O
is O O
a O O
57-year-old O O
man O O
with O O
a O O
history O O
of O O
diabetes, B-DIABETES O
hypertension, B-HYPERTENSION O
dyslipidemia, B-HYPERLIPIDEMIA O
and O O
obesity, B-OBESE O
who O O
initially O O
presented O O
with O O
chest O O
discomfort O O
on O O
12/09/2092. O O
Mr. O O
Tanner O O
ruled O O
out O O
for O O
myocardial O O
infarction O O
at O O
that O O
time O O
and O O
underwent O O
stress B-CAD O
testing, I-CAD O
which I-CAD O
was I-CAD O
positive. I-CAD O
He O O
returns O O
today O O
for O O
diagnostic O O
catheterization. O O
Cardiac O O
catheterization O O
revealed O O
noncritical O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
with O O
an O O
approximately O O
50% B-CAD O
ostial I-CAD O
right I-CAD O
coronary I-CAD O
artery I-CAD O
lesion I-CAD O
in I-CAD O
a I-CAD O
left I-CAD O
dominant I-CAD O
system. I-CAD O
The O O
right O O
femoral O O
arteriotomy O O
site O O
was O O
manually O O
compressed O O
without O O
complication. O O
Mr. O O
Tanner O O
was O O
admitted O O
to O O
the O O
Cardiovascular O O
Unit O O
overnight O O
for O O
observation. O O
Overnight O O
he O O
did O O
well, O O
specifically, O O
he O O
denied O O
any O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
groin, O O
or O O
flank O O
pain. O O
He O O
remained O O
hemodynamically O O
stable, O O
and O O
was O O
ambulating, O O
eating, O O
and O O
voiding O O
without O O
difficulty. O O
On O O
examination, O O
his O O
cardiac O O
exam O O
revealed O O
a O O
regular O O
rate O O
and O O
rhythm O O
with O O
normal O O
S1 O O
and O O
S2. O O
Lungs O O
were O O
clear O O
to O O
auscultation O O
throughout O O
all O O
lung O O
fields. O O
His O O
groin O O
was O O
soft O O
and O O
mildly O O
tender O O
with O O
no O O
hematoma O O
and O O
no O O
bruit O O
noted. O O
His O O
lower O O
extremities O O
were O O
warm O O
and O O
well O O
perfused O O
with O O
intact O O
distal O O
pulses. O O
His O O
morning O O
labs O O
were O O
significant O O
for O O
sodium O O
of O O
142, O O
potassium O O
of O O
4.1, O O
BUN O O
of O O
18, O O
creatinine O O
of O O
1. O O
A O O
CBC O O
revealed O O
a O O
white O O
blood O O
cell O O
count O O
of O O
4.74, O O
hematocrit O O
of O O
31.6, O O
and O O
platelets O O
of O O
304,000. O O
A O O
fasting O O
lipid O O
panel O O
revealed O O
total O O
cholesterol O O
of O O
107, O O
triglycerides O O
of O O
130, O O
HDL O O
of O O
30, O O
and O O
LDL O O
of O O
51. O O
We O O
are O O
planning O O
on O O
discharging O O
Mr. O O
Tanner O O
on O O
the O O
following O O
medications, O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
daily, O O
Lipitor B-MEDICATION B-MEDICATION
10 O O
mg O O
daily, O O
diltiazem B-MEDICATION B-MEDICATION
extended O O
release O O
360 O O
mg O O
daily, O O
Levoxyl O O
250 O O
mcg O O
daily, O O
lisinopril B-MEDICATION B-MEDICATION
40 O O
mg O O
daily, O O
NPH B-MEDICATION O
insulin I-MEDICATION O
80 O O
units O O
subcutaneous O O
daily, O O
Avandia B-MEDICATION B-MEDICATION
4 O O
mg O O
daily, O O
and O O
metformin B-MEDICATION B-MEDICATION
850 O O
mg O O
twice O O
daily O O
to O O
start O O
on O O
12/21/2092. O O
We O O
have O O
asked O O
that O O
he O O
follow O O
up O O
with O O
you O O
in O O
the O O
next O O
one O O
to O O
two O O
weeks, O O
and O O
to O O
call O O
with O O
any O O
questions O O
or O O
concerns O O
before O O
then. O O
Thank O O
you O O
for O O
allowing O O
us O O
to O O
share O O
in O O
the O O
care O O
of O O
your O O
patient, O O
Mr. O O
Yul O O
Tanner. O O
If O O
you O O
have O O
any O O
questions, O O
please O O
do O O
not O O
hesitate O O
to O O
contact O O
us O O
regarding O O
his O O
ongoing O O
management. O O
Sincerely, O O
Rebecca O O
Eason, O O
MD O O
Dictated O O
by: O O
Regan O O
Montgomery, O O
PA-C O O
eScription O O
document:3-2644464 O O
IFFocus O O
DD: O O
12/20/92 O O
DT: O O
12/20/92 O O
DV: O O
12/20/92 O O

Record O O
date: O O
2090-04-04 O O
Problems O O
HTN B-HYPERTENSION O
History O O
of O O
Present O O
Illness O O
Lovely O O
59 O O
year O O
old O O
woman O O
with O O
a O O
history O O
of O O
hypertension B-HYPERTENSION O
to O O
establish O O
primary O O
care. O O
She O O
is O O
feeling O O
generally O O
well, O O
though O O
feels O O
that O O
her O O
bp O O
med O O
(hyzaar) B-MEDICATION O
makes O O
her O O
feel O O
weak O O
and O O
lightheaded. O O
Would O O
like O O
to O O
change O O
meds. O O
Otherwise, O O
she O O
has O O
no O O
complaints. O O
Past O O
Medical O O
History O O
See O O
above O O
Medications O O
DYAZIDE B-MEDICATION O
(TRIAMTERENE O O
37.5 O O
MG/HCTZ O O
25 O O
MG) O O
1CAPSULE O O
PO O O
QD O O
Start O O
Date: O O
4/04/90 O O
Allergies O O
PCN O O
BENZATHINE O O
(PENICILLIN O O
G O O
BENZATHINE O O
L... O O
Dizziness O O
Family O O
History O O
No O O
significant O O
family O O
history. O O
Social O O
History O O
She O O
is O O
the O O
mother O O
of O O
Tania O O
Foust O O
and O O
mother-in-law O O
of O O
Willie O O
Spencer, O O
classmates O O
of O O
mine O O
from O O
UC O O
Davis. O O
She O O
is O O
retired O O
as O O
a O O
health O O
policy O O
consultant. O O
Emigrated O O
from O O
Hungary O O
in O O
the O O
2060's. O O
No B-SMOKER O
tob, I-SMOKER O
rare O O
etoh. O O
No O O
dv, O O
walks O O
for O O
exercise. O O
Review O O
of O O
Systems O O
neg O O
Vital O O
Signs O O
Blood O O
Pressure: O O
122/70 O O
Left O O
Arm O O
Weight: O O
126 O O
Pounds O O
Physical O O
Exam O O
General O O
Appearance O O
Well O O
appearing O O
in O O
NAD O O
Skin O O
Skin O O
is O O
without O O
appreciable O O
lesions O O
HEENT O O
EOMI. O O
PERRLA. O O
OP O O
benign. O O
Neck O O
Supple O O
with O O
no O O
lympadenopathy O O
or O O
thyromegaly. O O
Carotids O O
are O O
2+ O O
and O O
equal O O
without O O
bruits. O O
Nodes/Lymphatic O O
No O O
axillary O O
or O O
supraclavicular O O
lan. O O
Breast O O
Breast O O
exam O O
is O O
without O O
masses, O O
dimpling, O O
retraction. O O
No O O
nipple O O
d/c O O
noted. O O
Chest O O
Lungs O O
are O O
clear O O
to O O
ascultation O O
Cor/Cardiac O O
Regular O O
rate O O
and O O
rhythm O O
without O O
m/r/g. O O
Normal O O
S1 O O
and O O
S2 O O
Abdomen O O
Soft, O O
nt/nd O O
s O O
hsm. O O
No O O
guarding O O
or O O
rebound O O
tenderness. O O
Extremity O O
Without O O
c/c/e O O
Neurological O O
Intact O O
Disposition O O
and O O
Plans O O
Imp: O O
Healthy O O
woman. O O
She O O
states O O
that O O
her O O
pap/mammo O O
are O O
up O O
to O O
date O O
as O O
of O O
11/89 O O
at O O
the O O
Nye O O
Regional O O
Medical O O
Center. O O
Feels O O
well O O
except O O
would O O
like O O
to O O
change O O
her O O
bp O O
med. O O
At O O
this O O
time, O O
will B-MEDICATION O
have I-MEDICATION O
a I-MEDICATION O
trial I-MEDICATION O
of I-MEDICATION O
dyazide. I-MEDICATION O
I O O
have O O
asked O O
her O O
to O O
come O O
for O O
bp O O
check O O
in O O
2-3 O O
weeks. O O
Also, O O
1. O O
Cholesterol O O
today. O O
2. O O
Encouraged O O
colonoscopy. O O
______________________________ O O
Bethany O O
Kristin O O
Downs, O O
M.D. O O

Record O O
date: O O
2094-03-06 O O
Patient O O
Name: O O
FOUST,FAY O O
[ O O
50294530(LHCC) O O
] O O
Date O O
of O O
Visit: O O
03/06/2094 O O
Problems O O
HTN B-HYPERTENSION O
History O O
of O O
Present O O
Illness O O
Doing O O
well. O O
Working O O
hard O O
on O O
diet O O
and O O
exercise O O
to O O
control O O
her O O
htn B-HYPERTENSION O
and O O
mild O O
hyperglycemia. O O
She O O
is O O
paying O O
$98./month O O
for O O
hyzaar B-MEDICATION O
and O O
would O O
like O O
to O O
try O O
something O O
else. O O
No O O
cp/sob/abdominal O O
pain. O O
Past O O
Medical O O
History O O
See O O
problem O O
list O O
Medications O O
AZITHROMYCIN O O
250MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
x O O
5 O O
days, O O
2 O O
tablets O O
po O O
today O O
and O O
1 O O
eachday O O
thereafter O O
Nifedipine B-MEDICATION B-MEDICATION
(EXTENDED O O
Release) O O
60 O O
MG O O
(60MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Allergies O O
Penicillin O O
G O O
Benzathine O O
Long O O
Acting O O
- O O
Dizziness, O O
Fleet's O O
Phosphosoda O O
- O O
Did O O
not O O
tolerate, O O
Family O O
History O O
No O O
significant O O
family O O
history. O O
Social O O
History O O
She O O
is O O
the O O
mother O O
of O O
Tania O O
Foust O O
and O O
mother-in-law O O
of O O
Willie O O
Spencer, O O
classmates O O
of O O
mine O O
from O O
UC O O
Davis. O O
She O O
is O O
retired O O
as O O
a O O
health O O
policy O O
consultant. O O
Emigrated O O
from O O
Hungary O O
in O O
the O O
2060's. O O
No B-SMOKER O
tob, I-SMOKER O
rare O O
etoh. O O
No O O
dv, O O
walks O O
for O O
exercise. O O
Review O O
of O O
Systems O O
cough, O O
ST, O O
sore O O
in O O
her O O
mouth. O O
Otherwise O O
as O O
above O O
and O O
negative. O O
Vital O O
Signs O O
BLOOD B-HYPERTENSION O
PRESSURE I-HYPERTENSION O
148/76 I-HYPERTENSION O
PULSE O O
68 O O
WEIGHT O O
120 O O
lb O O
Physical O O
Exam O O
General O O
Appearance O O
Well O O
appearing O O
in O O
NAD O O
Skin O O
Skin O O
is O O
without O O
appreciable O O
lesions O O
HEENT O O
EOMI. O O
PERRLA. O O
OP O O
benign, O O
notable O O
for O O
a O O
couple O O
of O O
cold O O
sores. O O
Neck O O
Supple O O
with O O
no O O
lympadenopathy O O
or O O
thyromegaly. O O
Carotids O O
are O O
2+ O O
and O O
equal O O
without O O
bruits. O O
Nodes/Lymphatic O O
No O O
axillary O O
or O O
supraclavicular O O
lan. O O
Breast O O
Breast O O
exam O O
is O O
without O O
masses, O O
dimpling, O O
retraction. O O
No O O
nipple O O
d/c O O
noted. O O
Chest O O
Lungs O O
are O O
clear O O
to O O
ascultation O O
Cor/Cardiac O O
Regular O O
rate O O
and O O
rhythm O O
without O O
m/r/g. O O
Normal O O
S1 O O
and O O
S2 O O
Abdomen O O
Soft, O O
nt/nd O O
s O O
hsm. O O
No O O
guarding O O
or O O
rebound O O
tenderness. O O
Extremity O O
Without O O
c/c/e O O
Neurological O O
Intact O O
Disposition O O
and O O
Plans O O
1. O O
HTN O O
- O O
bp O O
adequately O O
controlled. O O
Check O O
labs. O O
Continue O O
Hyzaar O O
until O O
it's O O
gone. O O
Then O O
we O O
will O O
try O O
nifedipine O O
60 O O
mg O O
to O O
be O O
more O O
cost O O
effective. O O
She O O
will O O
come O O
in O O
for O O
a O O
bp O O
check. O O
Has O O
not O O
tolerated O O
lisinopril B-MEDICATION B-MEDICATION
or O O
atenolol B-MEDICATION B-MEDICATION
in O O
the O O
past. O O
2. O O
Sugar O O
and O O
trigs O O
- O O
Recheck O O
today. O O
She O O
has O O
been O O
working O O
on O O
her O O
nutrition O O
as O O
well. O O
Check O O
A1C. O O
3. O O
HM O O
is O O
up O O
to O O
date. O O
Follow O O
up O O
with O O
me O O
in O O
6 O O
months O O
or O O
as O O
needed. O O
Due O O
for O O
mammo O O
in O O
3/94 O O
and O O
we O O
will O O
schedule. O O
______________________________ O O
Bethany O O
Kristin O O
Downs, O O
M.D. O O

Record O O
date: O O
2095-01-31 O O
EDVISIT^50294530^FOUST, O O
FAY^01/31/95^SULLIVAN, O O
MILTON O O
The O O
patient, O O
Foust, O O
was O O
seen O O
in O O
the O O
Emergency O O
Department O O
on O O
01/31/2095. O O
The O O
patient O O
was O O
seen O O
by O O
Dr. O O
Ferrer. O O
I O O
have O O
discussed O O
the O O
management O O
with O O
him. O O
I O O
have O O
also O O
seen O O
the O O
patient O O
personally O O
and O O
reviewed O O
the O O
ED O O
record. O O
This O O
is O O
an O O
addendum O O
to O O
the O O
record. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
is O O
a O O
64-year-old O O
woman O O
who O O
said O O
this O O
morning O O
she O O
went O O
to O O
the O O
bathroom, O O
was O O
sitting O O
on O O
the O O
commode, O O
felt O O
chest O O
tightness, O O
and O O
then O O
had O O
a O O
syncopal O O
episode. O O
She O O
has O O
never O O
had O O
this O O
chest O O
tightness O O
before. O O
She O O
is O O
unsure O O
whether O O
she O O
hit O O
her O O
head. O O
No O O
shortness O O
of O O
breath O O
and O O
no O O
exertional O O
symptoms O O
in O O
the O O
past. O O
REVIEW O O
OF O O
SYSTEMS: O O
As O O
indicated O O
and O O
otherwise O O
negative. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension. B-HYPERTENSION O
SOCIAL O O
HISTORY: O O
She O O
is O O
a O O
nonsmoker. B-SMOKER O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
well O O
appearing O O
in O O
no O O
acute O O
distress. O O
She O O
has O O
no O O
chest O O
pain O O
or O O
discomfort O O
within O O
the O O
chest O O
in O O
the O O
Emergency O O
Department O O
Initial B-HYPERTENSION O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
systolic I-HYPERTENSION O
218 I-HYPERTENSION O
was I-HYPERTENSION O
reduced I-HYPERTENSION O
to I-HYPERTENSION O
190 I-HYPERTENSION O
range I-HYPERTENSION O
with O O
beta O O
blockade O O
with O O
initial O O
pulse O O
of O O
62. O O
She O O
is O O
normocephalic O O
and O O
atraumatic. O O
Neck O O
has O O
no O O
midline O O
tenderness. O O
She O O
has O O
full O O
range O O
of O O
motion O O
without O O
pain. O O
Chest O O
is O O
bilaterally O O
equal O O
and O O
clear. O O
Heart O O
is O O
regular. O O
Abdomen O O
is O O
soft O O
and O O
nontender. O O
Extremities O O
are O O
nontender. O O
LABORATORY O O
DATA: O O
Hematocrit O O
of O O
40.2. O O
Initial O O
CK O O
and O O
troponin O O
were O O
negative. O O
EKG O O
shows O O
lateral O O
ST O O
depression, O O
most O O
prominent O O
in O O
lead O O
V4 O O
through O O
V6. O O
There O O
is O O
no O O
old O O
available O O
for O O
comparison O O
at O O
this O O
time. O O
She O O
also O O
has O O
T-wave O O
flattening O O
in O O
I O O
and O O
aVL. O O
On O O
repeated O O
questioning, O O
the O O
patient O O
has O O
no O O
symptoms. O O
ASSESSMENT O O
AND O O
PLAN: O O
This O O
is O O
a O O
woman O O
who O O
had O O
a O O
syncopal O O
episode. O O
She O O
had O O
chest O O
tightness O O
prior O O
and O O
has O O
an O O
abnormal O O
EKG. O O
After O O
clearance O O
of O O
the O O
head O O
CT, O O
which O O
shows O O
no O O
bleed, O O
the O O
patient O O
received O O
aspirin. B-MEDICATION B-MEDICATION
I O O
have O O
discussed O O
admission O O
with O O
Dr. O O
Melton O O
who O O
is O O
admitting O O
for O O
the O O
Cardiology O O
team O O
and O O
the O O
patient O O
has O O
been O O
accepted. O O
DISPOSITION: O O
The O O
patient O O
is O O
admitted. O O
CONDITION: O O
Stable. O O
______________________________ O O
SULLIVAN, O O
MILTON O O
M.D. O O
D: O O
01/31/95 O O
T: O O
01/31/95 O O
Dictated O O
By: O O
SULLIVAN, O O
MILTON O O
eScription O O
document:9-8829102 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2095-12-14 O O
EDVISIT^50294530^FOUST, O O
FAY^12/14/95^FISHER, O O
CARRIE O O
The O O
patient O O
was O O
seen O O
in O O
conjunction O O
with O O
Dr. O O
Dickerson. O O
I O O
confirm O O
that O O
I O O
have O O
interviewed O O
and O O
examined O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation O O
on O O
the O O
patient's O O
chart, O O
discussed O O
the O O
evaluation, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient. O O
CHIEF O O
COMPLAINT: O O
Chest B-CAD O
tightness. I-CAD O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Briefly, O O
a O O
65-year-old O O
female O O
with O O
hypertension B-HYPERTENSION B-HYPERTENSION
and O O
atypical B-CAD O
chest I-CAD O
pain I-CAD O
who O O
comes O O
in O O
with O O
bilateral O O
chest O O
tightness O O
since O O
11:00 O O
a.m. O O
and O O
stated O O
that O O
she O O
feels O O
very O O
lousy O O
after O O
taking O O
her O O
meds O O
and O O
daily O O
has O O
been O O
getting O O
chest O O
tightness O O
since O O
her O O
discharge O O
recently O O
in O O
which O O
she O O
was O O
admitted O O
for O O
weakness O O
and O O
hypertensive O O
urgency. O O
The O O
patient O O
stated O O
that O O
she O O
feels O O
like O O
a O O
'dead O O
mouse.' O O
She O O
admits O O
to O O
some O O
headache, O O
dizziness O O
and O O
continued O O
chest O O
discomfort O O
despite O O
medications. O O
She O O
had O O
a O O
negative O O
MIBI O O
and O O
neurological O O
workup O O
and O O
has O O
had O O
significant O O
adjustment O O
for O O
hypertensive O O
medications. O O
Initial O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
239/99 I-HYPERTENSION O
upon O O
arrival. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension B-HYPERTENSION B-HYPERTENSION
and O O
reflux. O O
SOCIAL O O
HISTORY: O O
She O O
lives O O
with O O
family. O O
No B-SMOKER O
tobacco, I-SMOKER O
drugs O O
or O O
alcohol. O O
REVIEW O O
OF O O
SYSTEMS: O O
As O O
documented O O
per O O
written O O
chart. O O
MEDICATIONS: O O
As O O
per O O
medication O O
list. O O
ALLERGIES: O O
Penicillin. O O
PHYSICAL O O
EXAMINATION: O O
Afebrile. O O
Vital O O
signs O O
stable O O
except O O
for O O
high O O
blood O O
pressure. O O
Awake O O
and O O
alert O O
female, O O
in O O
some O O
obvious O O
mild O O
discomfort. O O
HEENT: O O
Atraumatic O O
and O O
normocephalic. O O
Neck: O O
Soft O O
and O O
supple. O O
Lungs: O O
Clear. O O
Abdomen O O
is O O
soft, O O
nontender, O O
and O O
nondistended. O O
Skin: O O
Intact, O O
warm, O O
and O O
dry. O O
Neurologic: O O
Alert, O O
oriented, O O
and O O
moving O O
extremities O O
x4. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
IV O O
placed. O O
Labs O O
sent. O O
EKG O O
is O O
done. O O
The O O
patient O O
concerned O O
for O O
hypertensive O O
urgency O O
given O O
the O O
chest O O
pressure O O
and O O
dizziness. O O
We O O
will O O
give O O
____ O O
10 O O
mg O O
IV O O
given O O
the O O
significantly O O
elevated O O
systolic O O
despite O O
compliance O O
with O O
her O O
hypertensive O O
medication O O
regime O O
to O O
include O O
lisinopril, B-MEDICATION B-MEDICATION
Toprol-XL, B-MEDICATION B-MEDICATION
hydrochlorothiazide, B-MEDICATION B-MEDICATION
nifedipine, B-MEDICATION B-MEDICATION
and O O
apparently O O
had O O
a O O
hard O O
time O O
with O O
blood O O
pressure O O
control O O
in O O
hospital O O
as O O
well. O O
I O O
spoke O O
with O O
PCP O O
coverage. O O
Given O O
the O O
patient's O O
symptoms O O
and O O
degree O O
of O O
change O O
of O O
medications, O O
we O O
would O O
admit O O
for O O
further O O
titration O O
of O O
hypertensive O O
medications O O
in O O
addition, O O
with O O
cycle O O
enzymes. O O
The O O
patient O O
understands O O
and O O
agrees O O
with O O
plan. O O
PRIMARY O O
DIAGNOSIS: O O
Hypertensive O O
urgency. O O
DISPOSITION: O O
Admit O O
to O O
____. O O
______________________________ O O
FISHER, O O
CARRIE O O
M.D. O O
D: O O
12/15/95 O O
T: O O
12/15/95 O O
Dictated O O
By: O O
FISHER, O O
CARRIE O O
eScription O O
document:5-4132381 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2096-03-18 O O
FOUST, O O
FAY O O
50294530 O O
03/18/2096 O O
Bethany O O
Downs, O O
MD O O
Linden O O
Internal O O
Medicine O O
Associates O O
08 O O
Kent O O
Lane, O O
A1-49 O O
Union O O
City, O O
MO O O
43733 O O
1. O O
Hungary O O
native O O
and O O
retired O O
health O O
policy O O
consultant. O O
Daughter O O
and O O
son-in-law O O
were O O
medical O O
school O O
classmates O O
of O O
Dr. O O
Downs. O O
2. O O
Alpha O O
thalassemia O O
trait. O O
12/95 O O
hematocrit O O
34.7, O O
MCV O O
66.1, O O
RDW O O
14.4, O O
and O O
11/95 O O
FE O O
74, O O
TIBC O O
325, O O
ferritin O O
128, O O
B12 O O
422. O O
3. O O
12/95 O O
EGD O O
and O O
biopsies O O
for O O
chest O O
discomfort, O O
gastritis. O O
No O O
metaplasia. O O
H. O O
pylori O O
negative. O O
4. O O
11/95 O O
MRI: O O
Probable O O
cholelithiasis. O O
5. O O
Never B-SMOKER O
smoked. I-SMOKER O
No O O
ethanol O O
usage. O O
6. O O
No O O
family O O
history O O
of O O
coronary O O
artery O O
disease. O O
7. O O
Hypertension, B-HYPERTENSION O
with O O
vigorous O O
left O O
ventricular O O
systolic O O
function O O
and O O
a O O
rigid O O
vasculature, O O
with O O
severe O O
chest O O
and O O
back O O
discomfort O O
with O O
elevated O O
pressures. O O
A. O O
Long O O
use O O
of O O
losartan/hydrochlorothiazide B-MEDICATION O
and O O
during O O
01/95 O O
admission O O
for O O
post O O
narcotic O O
lightheadedness, O O
blood O O
pressure O O
noted O O
to O O
be O O
significantly O O
elevated. O O
B. O O
11/95 O O
complaints O O
of O O
chest O O
tightness O O
and O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
above I-HYPERTENSION O
230 I-HYPERTENSION O
mmHg I-HYPERTENSION O
systolic. I-HYPERTENSION O
Chest O O
discomfort O O
improved O O
with O O
lower O O
blood O O
pressure. O O
C. O O
11/95 O O
investigations O O
for O O
hypertension: B-HYPERTENSION O
BUN O O
below O O
10, O O
creatinine O O
0.6, O O
potassium O O
3.6, O O
calcium O O
9.1, O O
TSH O O
2.17. O O
Cortisol O O
level O O
16. O O
Urine O O
for O O
metanephrine O O
and O O
catecholamines O O
unremarkable. O O
Right O O
kidney O O
reportedly O O
9.3 O O
and O O
left O O
10.2 O O
on O O
ultrasound, O O
left O O
renal O O
artery O O
velocity O O
2.7 O O
meters/second, O O
suggestive O O
of O O
50 O O
to O O
75% O O
stenosis, O O
but O O
MRA O O
only O O
mild O O
left O O
renal O O
artery O O
ostial O O
stenosis. O O
D. O O
01/96, O O
for O O
ongoing O O
poor O O
blood O O
pressure O O
control, O O
lisinopril B-MEDICATION B-MEDICATION
increased, O O
atenolol B-MEDICATION B-MEDICATION
added, O O
hydralazine O O
utilized O O
p.r.n., O O
and O O
ultimately O O
carvedilol B-MEDICATION O
suggested, O O
in O O
place O O
of O O
atenolol, O B-MEDICATION
at O O
low O O
initial O O
dose. O O
E. O O
02/96, O O
admitted O O
with O O
chest O O
pain O O
and O O
yet O O
poorly-controlled O O
hypertension, B-HYPERTENSION O
much O O
improved O O
with O O
progressive O O
increase O O
in O O
carvedilol O O
and O O
with O O
addition O O
of O O
amlodipine. B-MEDICATION B-MEDICATION
03/96, O O
BUN O O
14, O O
creatinine O O
0.7, O O
potassium O O
4.0. O O
Under O O
item O O
9 O O
add O O
a O O
sentence: O O
The O O
patient O O
feels O O
that O O
p.m. O O
lisinopril O B-MEDICATION
can O O
be O O
associated O O
with O O
slight O O
leg O O
swelling O O
but O O
encouraged O O
to O O
continue O O
the O O
medication. O O
Then O O
we O O
will O O
add O O
an O O
item O O
11C O O
that O O
will O O
say: O O
02/96, O O
CTA: O O
Normal O O
left O O
main, O O
30% O O
to O O
40% O O
plaques O O
in O O
proximal O O
LAD, O O
20% O O
to O O
30% O O
LCX O O
proximal O O
plaques, O O
mid O O
RCA O O
30% O O
to O O
50% O O
plaques, O O
distal O O
vessels O O
visualized O O
well. O O
8. O O
Minimal O O
carotid O O
disease O O
on O O
CTA O O
and O O
mild O O
abdominal O O
aortic O O
atherosclerosis O O
on O O
MR O O
( O O
MR O O
of O O
chest O O
not O O
performed) O O
in O O
12/95. O O
9. O O
Type B-DIABETES O
2 I-DIABETES O
diabetes. I-DIABETES O
11/95, B-DIABETES O
A1c B-DIABETES O
7.8%. I-DIABETES O
In O O
01/95, O O
metformin B-MEDICATION B-MEDICATION
suggested, O O
but O O
never O O
utilized. O O
01/96 O O
suggested O O
again. O O
10. O O
Dyslipidemia. B-HYPERLIPIDEMIA O
11/95 B-HYPERLIPIDEMIA O
TC I-HYPERLIPIDEMIA O
199, I-HYPERLIPIDEMIA O
HDL I-HYPERLIPIDEMIA O
42, I-HYPERLIPIDEMIA O
LDL B-HYPERLIPIDEMIA O
122, I-HYPERLIPIDEMIA O
TG O O
171, O O
and O O
simvastatin B-MEDICATION B-MEDICATION
20 O O
initiated O O
with O O
increase O O
in O O
01/96 O O
to O O
40 O O
mg O O
daily O O
for O O
better O O
treatment O O
of O O
microvasculature. O O
11. O O
Last O O
cardiac/structural O O
functional O O
studies O O
for O O
chest O O
discomfort O O
that O O
was O O
present O O
in O O
01/95, O O
but O O
that O O
became O O
worse O O
in O O
11/95, O O
associated O O
with O O
elevations O O
in O O
blood O O
pressure O O
and O O
improved O O
with O O
carotid O O
sinus O O
massage O O
during O O
exam O O
on O O
01/96. O O
A. O O
01/95 O O
and O O
11/95 O O
EDD O O
4.3. O O
ESD O O
2.6. O O
Wall O O
thickness O O
1.4. O O
EF O O
70%. O O
LA O O
4. O O
RA O O
3.9. O O
RV O O
EDD O O
2.3. O O
Early O O
relaxation O O
abnormality. O O
Minimal O O
aortic O O
valve O O
sclerosis. O O
B. O O
11/95 O O
6 O O
minutes O O
21 O O
seconds O O
standard O O
Bruce, O O
heart O O
rate O O
112. O O
Then O O
received O O
adenosine, O O
and O O
there O O
were O O
no O O
new O O
ST O O
segment O O
changes O O
atop O O
baseline O O
inferolateral O O
ST O O
segment O O
depressions. O O
No O O
wall O O
motion O O
abnormalities. O O
EF O O
70%. O O
Dear O O
Bethany: O O
I O O
saw O O
your O O
patient, O O
Fay O O
Foust, O O
in O O
my O O
office O O
today. O O
Mrs. O O
Foust O O
is O O
a O O
65-year-old O O
woman O O
who O O
is O O
feeling O O
significantly O O
improved, O O
but O O
who O O
complains O O
of O O
dizziness O O
after O O
she O O
takes O O
her O O
medications. O O
Her O O
history O O
of O O
severe O O
hypertension, O O
without O O
definite O O
secondary O O
causes, O O
only O O
a O O
mild O O
left O O
renal O O
artery O O
stenosis, O O
a O O
recent O O
admission O O
for O O
chest O O
discomfort O O
and O O
hypertension, O O
with O O
a O O
CTA O O
that O O
disclosed O O
only O O
modest O O
plaques O O
in O O
her O O
3 O O
major O O
coronary O O
arteries, O O
treated O O
dyslipidemia, B-HYPERLIPIDEMIA O
type B-DIABETES O
II I-DIABETES O
diabetes, I-DIABETES O
and O O
vigorous O O
left O O
ventricular O O
systolic O O
function O O
and O O
significant O O
left O O
ventricular O O
hypertrophy, O O
is O O
detailed O O
above. O O
Ms. O O
Foust O O
feels O O
that O O
her O O
life O O
has O O
been O O
brought O O
back O O
to O O
her. O O
She O O
takes O O
her O O
amlodipine, B-MEDICATION B-MEDICATION
lisinopril, B-MEDICATION B-MEDICATION
and O O
carvedilol O O
at O O
8:30 O O
a.m. O O
Thirty O O
minutes O O
later, O O
she O O
states O O
that O O
she O O
feels O O
lightheaded O O
and O O
her O O
blood O O
pressure O O
can O O
be O O
in O O
the O O
100/70 O O
mmHg O O
range O O
to O O
120/80 O O
mmHg O O
range. O O
She O O
believes O O
that O O
her O O
heart O O
rate O O
is O O
approximately O O
60 O O
beats O O
per O O
minute O O
at O O
those O O
times. O O
After O O
1-2 O O
hours, O O
she O O
starts O O
to O O
feel O O
improved. O O
At O O
8:30 O O
p.m., O O
when O O
she O O
takes O O
only O O
her O O
carvedilol O O
and O O
amlodipine, O O
again, O O
she O O
has O O
similar O O
symptoms. O O
When O O
she O O
has O O
the O O
symptoms, O O
she O O
sometimes O O
also O O
notices O O
a O O
discomfort O O
in O O
her O O
low O O
back. O O
She O O
has O O
not O O
had O O
dyspnea O O
and O O
she O O
has O O
only O O
rare O O
episodes O O
of O O
mild O O
chest O O
heaviness. O O
She O O
has O O
not O O
had O O
palpitations. O O
She O O
has O O
not O O
had O O
actual O O
lower O O
extremity O O
swelling, O O
though O O
she O O
feels O O
that O O
after O O
her O O
metformin, O B-MEDICATION
her O O
legs O O
can O O
feel O O
heavy. O O
She O O
is O O
not O O
having O O
an O O
alteration O O
in O O
gastrointestinal O O
or O O
genitourinary O O
habits. O O
She O O
has O O
not O O
had O O
musculoskeletal O O
achiness, O O
aside O O
from O O
the O O
low O O
back O O
discomfort O O
described. O O
She O O
has O O
not O O
had O O
any O O
peripheral O O
numbness. O O
The O O
rest O O
of O O
the O O
review O O
of O O
systems O O
is O O
unremarkable. O O
The O O
present O O
medications O O
are O O
ASA B-MEDICATION B-MEDICATION
81 O O
mg O O
a.m., O O
lisinopril O B-MEDICATION
40 O O
mg O O
a.m., O O
amlodipine O B-MEDICATION
one-half O O
of O O
a O O
10 O O
mg O O
tablet O O
a.m., O O
carvedilol O O
25 O O
mg O O
a.m. O O
and O O
25 O O
mg O O
evening, O O
simvastatin O B-MEDICATION
40 O O
mg O O
before O O
bedtime, O O
and O O
metformin O B-MEDICATION
500 O O
mg O O
before O O
dinner. O O
On O O
examination, O O
the O O
weight O O
is O O
110 O O
pounds, O O
decreased O O
3 O O
pounds O O
compared O O
to O O
01/96. O O
The O O
blood O O
pressure O O
was O O
initially O O
136/60 O O
mmHg O O
with O O
a O O
heart O O
rate O O
of O O
60 O O
beats O O
per O O
minute, O O
respiratory O O
rate O O
12, O O
and O O
she O O
was O O
complaining O O
of O O
low O O
back O O
discomfort, O O
and O O
she O O
was O O
very O O
slightly O O
lightheaded. O O
Later, O O
the O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
was I-HYPERTENSION O
160/70 B-HYPERTENSION O
mmHg I-HYPERTENSION O
and I-HYPERTENSION O
she O O
stated O O
that O O
her O O
blood O O
pressure O O
has O O
not O O
been O O
so O O
high O O
for O O
the O O
last O O
several O O
weeks. O O
She O O
was O O
still O O
complaining O O
of O O
slightly O O
dizziness O O
and O O
low O O
back O O
discomfort. O O
The O O
skin O O
is O O
warm O O
and O O
dry O O
and O O
she O O
looks O O
quite O O
calm. O O
She O O
is O O
fully O O
alert. O O
The O O
neck O O
veins O O
are O O
not O O
elevated. O O
The O O
carotid O O
upstrokes O O
are O O
brisk O O
and O O
the O O
volumes O O
are O O
normal. O O
There O O
are O O
no O O
carotid O O
bruits O O
though O O
there O O
was O O
a O O
transmitted O O
murmur. O O
The O O
lungs O O
are O O
clear. O O
The O O
PMI O O
is O O
not O O
displaced. O O
There O O
is O O
a O O
normal-sounding O O
S1 O O
and O O
a O O
physiologically O O
split O O
S2, O O
with O O
a O O
soft, O O
2/6 O O
early-peaking O O
systolic O O
murmur O O
across O O
the O O
aortic O O
valve O O
that O O
decreases O O
with O O
Valsalva. O O
The O O
abdomen O O
is O O
benign. O O
There O O
is O O
no O O
renal O O
artery O O
bruit. O O
The O O
distal O O
pulses O O
remain O O
excellent O O
and O O
there O O
is O O
no O O
pedal O O
edema. O O
There O O
is O O
no O O
tenderness O O
of O O
her O O
skin. O O
The O O
resting O O
electrocardiogram O O
shows O O
a O O
sinus O O
bradycardia O O
at O O
a O O
rate O O
of O O
56 O O
beats O O
per O O
minute, O O
intervals O O
of O O
0.20/0.08/0.40, O O
45-degree O O
axis, O O
very O O
slight O O
inferolateral O O
ST O O
segment O O
flattening. O O
Impression: O O
Mrs. O O
Foust O O
is O O
feeling O O
much-improved. O O
The O O
dizziness O O
and O O
low O O
back O O
discomfort O O
that O O
she O O
describes O O
could O O
possibly O O
be O O
associated O O
with O O
a O O
drop O O
in O O
blood O O
pressure O O
to O O
170 O O
mmHg, O O
with O O
mild O O
hypoperfusion O O
of O O
her O O
spinal O O
arteries, O O
as O O
well O O
as O O
her O O
head. O O
However, O O
today O O
she O O
had O O
dizziness O O
even O O
with O O
a O O
blood O O
pressure O O
of O O
160 O O
mmHg. O O
Though O O
we O O
could O O
be O O
tempted O O
to O O
juggle O O
with O O
her O O
regimen O O
and O O
reduce O O
her O O
amlodipine O O
slightly, O O
or O O
change O O
the O O
times O O
when O O
she O O
takes O O
the O O
medications, O O
I O O
think O O
that O O
we O O
are O O
facing O O
some O O
difficulties O O
only O O
related O O
to O O
the O O
poor O O
autoregulation O O
of O O
her O O
cerebral O O
and O O
peripheral O O
vessels. O O
I O O
think O O
that O O
we O O
should O O
continue O O
her O O
on O O
her O O
present O O
regimen. O O
Gradually, O O
we O O
would O O
expect O O
her O O
symptoms, O O
related O O
to O O
changes O O
in O O
blood O O
pressure, O O
to O O
improve O O
as O O
her O O
vessel O O
elasticity O O
improves. O O
I O O
think O O
that O O
we O O
can O O
be O O
satisfied O O
that O O
she O O
is O O
not O O
becoming O O
too O O
bradycardic. O O
We O O
are O O
pleased O O
with O O
the O O
present O O
regimen. O O
We O O
have O O
never O O
been O O
absolutely O O
certain O O
that O O
there O O
has O O
been O O
no O O
tiny O O
penetrating O O
aortic O O
ulcer O O
for O O
her O O
discomforts O O
or O O
so O O
dramatic, O O
but O O
the O O
treatment O O
would O O
be O O
precisely O O
as O O
it O O
is O O
now. O O
We O O
were O O
not O O
surprised O O
by O O
her O O
CTA O O
and O O
her O O
treatment, O O
naturally, O O
remains O O
unchanged. O O
I O O
think O O
that O O
we O O
want O O
her O O
to O O
continue O O
her O O
metformin, O O
and O O
we O O
may O O
have O O
to O O
consider O O
increasing O O
it O O
to O O
at O O
least O O
twice O O
daily, O O
depending O O
on O O
followup O O
A1c O O
values. O O
Thank O O
you O O
for O O
allowing O O
me O O
to O O
assist O O
in O O
Mrs. O O
Foust's O O
care. O O
I O O
know O O
that O O
you O O
will O O
continue O O
to O O
follow O O
her O O
closely. O O
I O O
told O O
her O O
that O O
I O O
would O O
see O O
her O O
again O O
in O O
nine O O
months. O O
Sincerely, O O
______________________________ O O
Stephen O O
C O O
Rice, O O
M.D. O O
eScription O O
document:8-1475473 O O
DD: O O
03/18/96 O O
DT: O O
03/19/96 O O
DV: O O
03/18/96 O O

Record O O
date: O O
2092-09-05 O O
Internal O O
Medicine O O
INTERN O O
ADMISSION B-DIABETES O
NOTE O O
Name: O O
Crawford, O O
Patrick O O
MR O O
#: O O
9021555 O O
Date O O
of O O
admission: O O
9/5/92 O O
Intern: O O
Shawn O O
Ott O O
Attending: O O
Yarger, O O
Kathryn O O
CC: O O
Syncope O O
HPI: O O
82 O O
yo O O
man O O
w/ O O
PMH O O
significant O O
for O O
DM O O
(diet O O
control O O
only) O O
and O O
HTN, B-HYPERTENSION O
who O O
has O O
been O O
in O O
his O O
usual O O
state O O
of O O
health O O
until O O
the O O
day O O
of O O
admission, O O
when O O
he O O
went O O
to O O
the O O
grocery O O
store O O
to O O
shop O O
with O O
his O O
sisters O O
and O O
lost O O
consciousness O O
and O O
fell O O
on O O
the O O
ground. O O
He O O
said O O
he O O
has O O
been O O
perfectly O O
fine, O O
in O O
his O O
usual O O
self, O O
when O O
he O O
went O O
to O O
the O O
grocery O O
store, O O
although O O
the O O
days O O
have O O
been O O
humid. O O
He O O
has O O
AC O O
at O O
home. O O
However, O O
about O O
5-10 O O
minutes O O
before O O
he O O
fell, O O
he O O
felt O O
hot O O
and O O
sweaty O O
, O O
but O O
didn't O O
think O O
too O O
much O O
of O O
it. O O
After O O
finishing O O
shopping O O
in O O
the O O
store, O O
he O O
went O O
out O O
to O O
the O O
car O O
to O O
open O O
the O O
trunk, O O
and O O
while O O
he O O
was O O
trying O O
to O O
put O O
the O O
key O O
in O O
the O O
keyhole, O O
he O O
lost O O
consciousness O O
and O O
fell O O
to O O
the O O
ground. O O
According O O
to O O
the O O
witnesses O O
at O O
the O O
scene O O
(his O O
sisters), O O
he O O
lost O O
consciousness O O
for O O
about O O
1-2 O O
minutes, O O
and O O
he O O
quickly O O
came O O
back O O
to O O
himself O O
but O O
did O O
not O O
remember O O
what O O
had O O
happened O O
to O O
him. O O
No O O
head O O
trauma. O O
Other O O
than O O
feeling O O
hot O O
and O O
sweaty, O O
he O O
denied O O
any O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
palpitations, O O
vision O O
changes, O O
focal O O
limb O O
weakness, O O
slurring O O
of O O
speech, O O
and O O
bowel O O
or O O
bladder O O
incontinence. O O
No O O
prior O O
event O O
similar O O
to O O
this, O O
although O O
w/ O O
h/o O O
vertigo O O
dx O O
in O O
2090. O O
He O O
said O O
he O O
has O O
been O O
drinking O O
his O O
usual O O
amount O O
of O O
fluid O O
(but O O
not O O
more O O
than O O
usual) O O
and O O
did O O
not O O
notice O O
any O O
lightheadedness O O
or O O
dizziness O O
at O O
home. O O
At O O
the O O
ED, O O
his O O
vitals O O
were O O
stable, O O
with O O
T97.4, O O
HR O O
66, O O
BP O O
126/61, O O
R O O
16, O O
and O O
100% O O
on O O
RA. O O
He O O
felt O O
completely O O
back O O
to O O
his O O
normal O O
himself, O O
but O O
complained O O
of O O
L O O
ankle O O
pain O O
when O O
he O O
walked. O O
ROS: O O
Per O O
HPI. O O
No O O
F/C/NS. O O
No O O
PND/LE O O
edema/Claudication. O O
No O O
headache, O O
runny O O
nose, O O
cough. O O
No O O
exposures/ingestions/recent O O
travel. O O
PMH: O O
1. O O
DM B-DIABETES O
type I-DIABETES O
2: I-DIABETES O
diagnosed O O
in O O
2080. O O
Was O O
on O O
oral O O
hypoglycemic O O
agent O O
x O O
6months O O
when O O
first O O
diagnosed, O O
but O O
ever O O
since O O
has O O
been O O
managed O O
by O O
diet O O
and O O
exercise O O
only. O O
Last O O
HgbA1c, O O
per O O
pt, O O
was O O
in O O
5-6. O O
2. O O
Hypertension B-HYPERTENSION B-HYPERTENSION
3. O O
Hypercholesterolemia B-HYPERLIPIDEMIA O
4. O O
Lung O O
cancer, O O
s/p O O
L O O
lobectomy O O
(middle O O
and O O
lower O O
lobes) O O
in O O
2072 O O
5. O O
Vertigo: O O
dx O O
in O O
2090. O O
No O O
more O O
episode. O O
6. O O
BPH O O
7. O O
OA, O O
s/p O O
R O O
total O O
hip O O
replacement O O
8. O O
Gout: O O
always O O
involving O O
L O O
big O O
toe, O O
but O O
very O O
rare O O
flares O O
9. O O
Glaucoma O O
OU O O
10. O O
Cataracts O O
OU, O O
s/p O O
cataract O O
surgery O O
Medications O O
at O O
home: O O
ASA B-MEDICATION B-MEDICATION
325mg O O
po O O
qod O O
Lisinopril B-MEDICATION B-MEDICATION
10mg O O
po O O
qhs O O
HCTZ B-MEDICATION O
25mg O O
po O O
qd O O
Simvastatin B-MEDICATION B-MEDICATION
10mg O O
po O O
qd O O
Prazosin O O
8mg O O
po O O
bid O O
Zantac O O
150mg O O
po O O
qd O O
Allopurinol O O
100mg O O
po O O
qd O O
MVI O O
Artificial O O
tears O O
OU O O
Resistene O O
eye O O
drops O O
OU O O
ALL: O O
Latex, O O
alphagan O O
SH: O O
Lives O O
in O O
Owensboro O O
by O O
himself, O O
but O O
two O O
of O O
his O O
sisters O O
live O O
in O O
the O O
same O O
building. O O
Divorced O O
for O O
several O O
years. O O
Has O O
3 O O
children, O O
in O O
all O O
different O O
states. O O
Retried O O
graphic O O
designer O O
at O O
BJ's. O O
Tob: B-SMOKER B-MEDICATION
quit I-SMOKER O
20 I-SMOKER O
years I-SMOKER O
ago, I-SMOKER O
but O O
used O O
to O O
smoke O O
3PPD O O
x O O
30 O O
yrs. O O
Etoh: O O
used O O
to O O
be O O
a O O
heavy O O
beer O O
drinker, O O
but O O
now O O
glass O O
of O O
wine O O
a O O
day O O
Illicit O O
drugs: O O
none O O
FH: O O
Positive O O
DM. O O
Physical O O
Exam: O O
V: O O
T O O
97.4, O O
HR O O
77, O O
BP O O
139/63, O O
O2 O O
sat O O
97% O O
on O O
RA. O O
Gen: O O
Very O O
pleasant, O O
appears O O
comfortable O O
in O O
bed, O O
in O O
NAD, O O
talking O O
in O O
full O O
sentences. O O
No O O
increased O O
use O O
of O O
accessory O O
mm. O O
HEENT: O O
Surgical O O
pupils O O
bilaterally. O O
EOMI, O O
sclera O O
anicteric. O O
OP O O
clear. O O
Neck: O O
Supple, O O
no O O
carotid O O
bruits. O O
2cm O O
lipoma O O
below O O
L O O
mandible. O O
Nodes: O O
No O O
cervical O O
or O O
subclavicular O O
LAD. O O
Cor: O O
RRR O O
S1, O O
S2 O O
nl. O O
2/6 O O
crescendo-decrescendo O O
SEM, O O
best O O
heard O O
at O O
apex. O O
JVP O O
5cm. O O
Chest: O O
CTAB. O O
Abdomen: O O
+BS O O
soft, O O
NT, O O
ND. O O
Guaiac O O
negative. O O
Ext: O O
R O O
ankle: O O
swellings, O O
warm, O O
effusion. O O
Tender O O
w/ O O
movement. O O
Limited O O
ROM. O O
Neuro: O O
Alert O O
and O O
oriented O O
x3. O O
CN O O
2-12 O O
intact. O O
Motor O O
strength O O
5/5 O O
bilaterally O O
in O O
all O O
extremities, O O
except O O
in O O
L O O
dorsi O O
and O O
plantarflexion O O
limited O O
2/2 O O
pain O O
on O O
L O O
ankle. O O
Sensation O O
intact O O
to O O
light O O
touch. O O
No O O
tremors. O O
Gait O O
difficult O O
to O O
test O O
because O O
of O O
the O O
tenderness O O
on O O
pressure O O
of O O
L O O
foot. O O
Labs O O
and O O
Studies: O O
CBC: O O
WBC O O
9.6 O O
(4.5-11.0) O O
th/cmm O O
HCT O O
44.1 O O
(41.0-53.0) O O
% O O
HGB O O
15.4 O O
(13.5-17.5) O O
gm/dl O O
RBC O O
4.77 O O
(4.50-5.90) O O
mil/cmm O O
PLT O O
184 O O
(150-350) O O
th/cumm O O
MCV O O
93 O O
(80-100) O O
fl O O
MCH O O
32.2 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
34.9 O O
(31.0-37.0) O O
g/dl O O
RDW O O
13.0 O O
(11.5-14.5) O O
% O O
Poly O O
85 O O
H O O
(40-70) O O
% O O
Lymphs O O
10 O O
L O O
(22-44) O O
% O O
Monos O O
4 O O
(4-11) O O
% O O
EOS O O
1 O O
(0-8) O O
% O O
Basos O O
0 O O
(0-3) O O
% O O
Chemistry O O
Sodium O O
(Stat O O
Lab) O O
136 O O
(135-145) O O
mmol/L O O
Potassium O O
(Stat O O
Lab) O O
3.6 O O
(3.4-4.8) O O
mmol/L O O
Chloride O O
(Stat O O
Lab) O O
107 O O
(100-108) O O
mmol/L O O
CO2 O O
(Stat O O
Lab) O O
24.9 O O
(23.0-31.9) O O
mmol/L O O
BUN O O
(Stat O O
Lab) O O
21 O O
(8-25) O O
mg/dl O O
Creatinine O O
(Stat O O
Lab) O O
1.5 O O
(0.6-1.5) O O
mg/dl O O
Glucose B-DIABETES O
(Stat I-DIABETES O
Lab) I-DIABETES O
139 I-DIABETES O
H I-DIABETES O
(70-110) I-DIABETES O
mg/dl I-DIABETES O
Calcium O O
9.6 O O
(8.5-10.5) O O
mg/dl O O
Phosphorus O O
2.3 O O
L O O
(2.6-4.5) O O
mg/dl O O
Magnesium O O
1.5 O O
(1.4-2.0) O O
meq/L O O
Creatine O O
Kinase O O
Isoenzymes O O
NEGATIVE O O
(NEG) O O
Troponin-I O O
NEGATIVE O O
(NEG) O O
Creatine O O
Kinase O O
Isoenzymes O O
4.1 O O
(0.0-6.9) O O
ng/ml O O
Troponin-T O O
0.01 O O
(0.00-0.09) O O
ng/ml O O
Creatine O O
Kinase O O
72 O O
(60-400) O O
U/L O O
UA: O O
UA-Specific O O
Gravity O O
1.015 O O
(1.001-1.035) O O
UA-pH O O
7.5 O O
(5.0-9.0) O O
UA-WBC O O
Screen O O
NEGATIVE O O
(NEG) O O
UA-Nitrite O O
NEGATIVE O O
(NEG) O O
UA-Albumin O O
NEGATIVE O O
(NEG) O O
UA-Glucose O O
NEGATIVE O O
(NEG) O O
UA-Ketones O O
1+ O O
(NEG) O O
UA-Occult O O
Blood O O
NEGATIVE O O
(NEG) O O
CXR: O O
Clear. O O
CT O O
Head: O O
No O O
evidence O O
of O O
acute O O
intracranial O O
process. O O
TTE O O
(2090): O O
Mild-mod O O
MR, O O
EF O O
61%, O O
no O O
wall O O
motion O O
abnormality. O O
A/P: O O
82 O O
yo O O
man O O
w/ O O
PMH O O
significant O O
for O O
well-controlled O O
DM, O O
HTN, O O
and O O
lung O O
ca O O
s/p O O
lobectomy, O O
who O O
presents O O
with O O
one O O
episode O O
of O O
syncope. O O
1. O O
Syncope: O O
Most O O
likely O O
etiology O O
of O O
his O O
syncopal O O
episode O O
is O O
vasovagal/ O O
neurocardiogenic, O O
considering O O
the O O
presence O O
of O O
prodromal O O
symptoms O O
(sweating, O O
feeling O O
warm) O O
5 O O
minutes O O
before O O
the O O
event. O O
It O O
is O O
possible O O
that O O
the O O
patient O O
has O O
been O O
dehydrated, O O
considering O O
the O O
last O O
couple O O
days O O
have O O
been O O
very O O
humid, O O
and O O
he O O
hasn't O O
changed O O
his O O
fluid O O
intake. O O
However, O O
the O O
sudden O O
onset O O
of O O
his O O
syncope O O
and O O
LOC O O
for O O
1-2 O O
minutes O O
concerning O O
for O O
cardiogenic O O
causes O O
as O O
well: O O
including O O
sinus O O
brady O O
and O O
other O O
arrhythmic O O
events. O O
Ischemic O O
event O O
is O O
less O O
likely O O
in O O
this O O
man. O O
EKG O O
showed O O
no O O
significant O O
changes O O
compared O O
to O O
the O O
previous O O
one, O O
and O O
he O O
has O O
known O O
MR O O
evidenced O O
on O O
his O O
TTE O O
in O O
2090. O O
Other O O
possible O O
causes O O
include: O O
Neurologic: O O
unlikely O O
with O O
no O O
focal O O
neuro O O
symptoms O O
both O O
witnessed O O
at O O
the O O
time O O
and O O
currently. O O
However, O O
the O O
possibilities O O
include O O
basilar O O
insufficiency. O O
Others: O O
Finger B-DIABETES O
stick I-DIABETES O
glucose I-DIABETES O
on I-DIABETES O
the I-DIABETES O
field I-DIABETES O
130, I-DIABETES O
and O O
Hct O O
36.8 O O
(baseline) O O
ruling O O
out O O
hypoglycemia O O
and O O
anemia O O
as O O
an O O
etiology. O O
Plan: O O
1) O O
Continue O O
hydration O O
overnight. O O
2) O O
Tele O O
monitor O O
to O O
detect O O
any O O
abnormal O O
heart O O
rhythm. O O
3) O O
Continue O O
to O O
rule O O
out O O
with O O
enzymes O O
to O O
rule O O
out O O
ischemia. O O
4) O O
TTE O O
to O O
assess O O
any O O
focal O O
site O O
for O O
arrhythmogenic O O
events. O O
5) O O
TCD O O
and O O
carotid O O
duplex O O
ultrasound O O
to O O
rule O O
out O O
basilar O O
insufficieny, O O
although O O
he O O
displays O O
no O O
signs O O
of O O
it O O
on O O
physical O O
exam. O O
2. O O
DM: B-DIABETES O
Pt I-DIABETES O
diagnosed I-DIABETES O
with I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
DM I-DIABETES O
approximately O O
12 O O
years O O
ago. O O
Seems O O
to O O
be O O
in O O
a O O
good O O
control, O O
with O O
only O O
diet O O
and O O
exercise O O
modification. O O
Per O O
pt, O O
the O O
last O O
HgbA1c O O
was O O
in O O
5-6 O O
range. O O
1) O O
Diabetic O O
diet, O O
RSSI. O O
2) O O
Q6h O O
finger O O
stick O O
check. O O
3) O O
Check O O
HgbA1c O O
in O O
AM. O O
3. O O
L O O
ankle O O
swelling: O O
Most O O
likely O O
from O O
sprain O O
while O O
falling O O
down O O
during O O
the O O
syncope. O O
Tender O O
to O O
palpation O O
and O O
with O O
joint O O
movement. O O
No O O
signs O O
of O O
infection. O O
Good O O
peripheral O O
pulses O O
and O O
intact O O
sensations. O O
1) O O
L O O
ankle O O
plain O O
films O O
to O O
rule O O
out O O
fracture. O O
2) O O
PT O O
consult. O O
4. O O
FEN: O O
Electrolytes O O
all O O
within O O
normal O O
range, O O
except O O
slightly O O
low O O
Mg O O
(1.5). O O
Eating O O
PO. O O
On O O
IVF O O
for O O
hydration. O O
1) O O
Replete O O
Mg. O O
2) O O
K O O
now O O
3.6. O O
If O O
low O O
in O O
AM, O O
replete O O
for O O
the O O
goal O O
of O O
4. O O
3) O O
Diabetic O O
diet O O
for O O
nutrition. O O
5. O O
Prophylaxis: O O
Ranitidine, O O
heparin. O O
8. O O
Dispo: O O
PT O O
consult. O O
Anticipate O O
home O O
discharge. O O
______________________________________________________________________ O O
Name O O
Shawn O O
Ott O O
Pager O O
56770 O O
PGY-1 O O

Record O O
date: O O
2092-10-11 O O
Internal O O
Medicine O O
- O O
MSIII O O
Admission O O
Note O O
Pt: O O
Crawford, O O
Patrick O O
(Mary O O
3562Z) O O
MR#: O O
902-15-55 O O
Date O O
of O O
Admission: O O
10/10/92 O O
Attending: O O
Yancey, O O
Ursula O O
PCP: O O
Estep, O O
Willa O O
Code O O
status: O O
Full O O
CC: O O
Generalized O O
weakness O O
+ O O
diaphoresis O O
HPI: O O
Pt O O
is O O
an O O
82 O O
yo O O
man O O
with O O
a O O
history O O
of O O
diet-controlled B-DIABETES O
DM2, B-DIABETES O
HTN, B-HYPERTENSION O
and O O
a O O
syncopal O O
episode O O
1mo O O
ago O O
who O O
presents O O
with O O
an O O
episode O O
of O O
profuse O O
diaphoresis O O
and O O
generalized O O
weakness O O
while O O
cooking O O
in O O
his O O
home O O
at O O
10am O O
this O O
morning. O O
He O O
had O O
recently O O
returned O O
home O O
from O O
grocery O O
shopping, O O
carrying O O
6 O O
bags O O
of O O
groceries O O
up O O
1 O O
flight O O
to O O
his O O
apartment, O O
and O O
was O O
moving O O
about O O
his O O
kitchen O O
cooking O O
when O O
he O O
felt O O
suddenly O O
drenched O O
in O O
sweat. O O
He O O
immediately O O
felt O O
lightheaded, O O
disoriented, O O
nauseous, O O
generally O O
weak, O O
and O O
as O O
though O O
he O O
was O O
about O O
to O O
faint. O O
He O O
was O O
able O O
to O O
walk O O
a O O
few O O
steps, O O
sit O O
down, O O
and O O
rest O O
for O O
15-20min O O
before O O
he O O
realized O O
his O O
symptoms O O
weren't O O
resolving, O O
called O O
his O O
sister, O O
and O O
put O O
his O O
head O O
on O O
the O O
table O O
and O O
felt O O
he O O
could O O
not O O
really O O
move O O
because O O
he O O
was O O
so O O
weak. O O
He O O
denied O O
any O O
CP, O O
SOB, O O
palpitations, O O
flushes, O O
fever/chills, O O
HA, O O
visual O O
changes, O O
vomiting, O O
and O O
focal O O
weakness O O
associated O O
with O O
the O O
episode. O O
He O O
felt O O
he O O
had O O
been O O
drinking O O
adequate O O
fluids, O O
had O O
no O O
recent O O
infections/cough/rhinorrhea, O O
had O O
no O O
weight O O
loss, O O
and O O
no O O
exposures. O O
When O O
his O O
sister O O
arrived O O
he O O
told O O
her O O
to O O
call O O
911, O O
and O O
soon O O
he O O
was O O
brought O O
to O O
the O O
SOH O O
ED. O O
One O O
month O O
PTA, O O
Mr. O O
Crawford O O
had O O
been O O
in O O
his O O
usual O O
state O O
of O O
health O O
when O O
he O O
had O O
his O O
first O O
ever O O
feeling O O
of O O
lightheadedness O O
and O O
diaphoresis O O
while O O
grocery O O
shopping. O O
Five O O
minutes O O
later O O
while O O
getting O O
into O O
his O O
car, O O
he O O
had O O
increasing O O
lightheadedness O O
and O O
lost O O
consciousness, O O
falling O O
to O O
the O O
ground O O
with O O
no O O
head O O
trauma. O O
As O O
with O O
today's O O
episode, O O
he O O
denied O O
prior O O
CP, O O
SOB, O O
palpitations O O
and O O
other O O
symptoms O O
previously O O
listed. O O
According O O
to O O
his O O
sisters O O
who O O
were O O
present O O
at O O
the O O
time, O O
he O O
regained O O
consciousness O O
2 O O
minutes O O
later, O O
and O O
he O O
recalls O O
knowing O O
exactly O O
where O O
he O O
was O O
but O O
not O O
what O O
had O O
happened O O
to O O
him. O O
He O O
did O O
not O O
lose O O
continence O O
of O O
bladder O O
or O O
bowel. O O
He O O
was O O
brought O O
to O O
the O O
ED, O O
where O O
his O O
vitals O O
were O O
stable O O
with O O
a O O
BP O O
of O O
126/61 O O
and O O
HR O O
66, O O
and O O
was O O
admitted O O
for O O
observation O O
and O O
workup. O O
Head O O
CT O O
was O O
negative O O
for O O
an O O
acute O O
process, O O
CXR O O
was O O
clear, O O
EKG O O
showed O O
some O O
LA O O
enlargement O O
and O O
mild O O
ST O O
/ O O
Twave O O
changes O O
consistent O O
with O O
an O O
EKG O O
of O O
2yrs O O
ago, O O
negative O O
cardiac O O
enzymes, O O
and O O
a O O
cardiac O O
echo O O
showing O O
mild O O
MR, O O
an O O
elongated O O
LA, O O
and O O
an O O
EF O O
of O O
68%. O O
At O O
the O O
time O O
of O O
discharge O O
he O O
was O O
instructed O O
to O O
stop O O
taking O O
Prazosin O O
for O O
his O O
BPH O O
and O O
instead O O
take O O
Flomax. O O
In O O
the O O
past O O
month, O O
Mr. O O
Crawford O O
has O O
had O O
no O O
repeat O O
syncopal O O
episodes, O O
but O O
many O O
episodes O O
of O O
diaphoresis O O
with O O
very O O
mild O O
lightheadedness. O O
He O O
reports O O
that O O
at O O
least O O
every O O
few O O
days O O
he O O
either O O
has O O
a O O
brief O O
diaphoresis O O
episode O O
during O O
his O O
daily O O
activities, O O
or O O
sometimes O O
a O O
profuse O O
diaphoresis O O
that O O
can O O
occur O O
while O O
lying O O
in O O
bed O O
and O O
causing O O
him O O
to O O
change O O
his O O
clothes O O
and O O
bedsheets. O O
He O O
has O O
had O O
no O O
other O O
symptoms. O O
Of O O
note, O O
this O O
morning O O
he O O
had O O
run O O
out O O
of O O
Flomax O O
due O O
to O O
an O O
insurance O O
issue, O O
and O O
resumed O O
taking O O
4mg O O
of O O
leftover O O
Prazosin O O
for O O
his O O
BPH O O
around O O
6am. O O
He O O
disliked O O
the O O
Flomax O O
because O O
it O O
seemed O O
to O O
cause O O
polyuria O O
and O O
generally O O
made O O
him O O
feel O O
'off' O O
in O O
an O O
unidentifiable O O
way. O O
Currently O O
the O O
pt O O
feels O O
slightly O O
lightheaded/'woozy', O O
sometimes O O
worse O O
with O O
positional O O
changes, O O
and O O
still O O
generally O O
weak, O O
with O O
no O O
other O O
symptoms. O O
PMH: O O
- O O
DM2: O O
diagnosed O O
2080, O O
initially O O
took O O
an O O
oral O O
hypoglycemic O O
agent O O
for O O
6mo, O O
but O O
since O O
has O O
been O O
managed O O
by O O
diet O O
and O O
exercise O O
only. O O
HbA1c O O
checked O O
q3mo; O O
most O O
recent O O
was O O
around O O
5.0 O O
per O O
pt. O O
- O O
Hypertension B-HYPERTENSION B-HYPERTENSION
- O O
Hypercholesterolemia B-HYPERLIPIDEMIA B-HYPERTENSION
- O O
TIA O O
workup O O
8/2090 O O
after O O
p/w O O
sensation O O
of O O
burning O O
tongue, O O
metallic O O
taste, O O
some O O
diminished O O
hearing O O
on O O
L, O O
had O O
negative O O
head O O
CT O O
at O O
OSH O O
per O O
pt O O
- O O
Vertigo: O O
dx O O
in O O
10/2090, O O
described O O
as O O
dizziness/room O O
spinning. O O
No O O
subsequent O O
episodes. O O
Negative O O
CTA O O
of O O
the O O
head/neck O O
at O O
SOH. O O
- O O
BPH O O
- O O
Lung O O
cancer, O O
s/p O O
L O O
lobectomy O O
(middle O O
and O O
lower O O
lobes) O O
in O O
2072, O O
did O O
not O O
require O O
chemotherapy O O
or O O
radiation O O
- O O
OA, O O
s/p O O
R O O
total O O
hip O O
replacement O O
- O O
Gout: O O
involves O O
L O O
big O O
toe, O O
but O O
with O O
rare O O
flares O O
- O O
Glaucoma O O
OU O O
- O O
Cataracts O O
OU, O O
s/p O O
cataract O O
surgery O O
- O O
Double O O
hernia O O
repair O O
6/85 O O
- O O
S/p O O
shrapnel O O
injury O O
to O O
L O O
side O O
of O O
body O O
during O O
war, O O
reports O O
retained O O
shrapnel O O
near O O
C-spine, O O
L O O
arm, O O
scalp. O O
Has O O
no O O
permanent O O
injury, O O
but O O
did O O
limp O O
for O O
awhile O O
after O O
being O O
injured O O
which O O
has O O
resolved. O O
- O O
Herpes O O
zoster O O
flare O O
15yrs O O
ago O O
- O O
Mastoiditis O O
as O O
child O O
Meds O O
at O O
Home: O O
Prazosin O O
4mg O O
po O O
bid O O
Lisinopril B-MEDICATION B-MEDICATION
10mg O O
po O O
qhs O O
HCTZ B-MEDICATION O
25mg O O
po O O
qd O O
ASA B-MEDICATION B-MEDICATION
325mg O O
po O O
qod O O
Simvastatin B-MEDICATION B-MEDICATION
10mg O O
po O O
qd O O
Zantac O B-MEDICATION
150mg O O
po O O
qd O O
Allopurinol O O
100mg O O
po O O
qd O O
Artificial O O
tears O O
OU O O
several O O
drops O O
5id O O
Trusopt O O
eye O O
drops O O
OS O O
1drop O O
tid O O
Resistene O O
eye O O
drops O O
OD O O
2x/d O O
12h O O
apart O O
Glucosamine O B-MEDICATION
MVI O O
All: O O
Latex O O
rash O O
on O O
extremities, O O
Alphagan O O
SOB O O
SH: O O
Pt O O
lives O O
alone O O
in O O
an O O
apartment O O
complex; O O
his O O
sister O O
lives O O
in O O
the O O
same O O
complex. O O
Former O O
army O O
corporal O O
s/p O O
non-debilitating O O
shrapnel O O
injury. O O
Worked O O
in O O
design O O
until O O
retiring O O
age O O
62. O O
Active O O
/ O O
walks O O
frequently, O O
gardens, O O
does O O
crafts. O O
Has O O
3 O O
grown O O
children. O O
Tob: B-SMOKER B-MEDICATION
90pack-yr B-SMOKER O
history, I-SMOKER O
quit B-SMOKER O
20yrs I-SMOKER O
ago I-SMOKER O
EtOH: O O
glass O O
of O O
wine O O
per O O
day; O O
former O O
heavy O O
beer O O
drinker O O
Illicits: O O
none O O
FH: O O
Mother: O O
died O O
age O O
90 O O
of O O
Alzheimer's O O
Father: O O
died O O
age O O
66 O O
of O O
brain O O
malignancy O O
Brother: O O
died O O
in O O
his O O
early O O
50s O O
of O O
brain O O
malignancy O O
Sister: O O
living O O
age O O
76, O O
recent O O
diagnosis O O
of O O
NHL O O
Other O O
Sister: O O
OA O O
Mother, O O
Father, O O
Brother, O O
Sister: O O
DM2 O O
No O O
cardiac O O
history. O O
ROS: O O
As O O
in O O
HPI. O O
Additionally: O O
- O O
General: O O
no O O
weight O O
loss/gain, O O
no O O
fatigue, O O
no O O
fevers, O O
no O O
chills, O O
no O O
change O O
in O O
appetite O O
- O O
Respiratory: O O
no O O
cough, O O
no O O
SOB, O O
no O O
DOE, O O
no O O
hemoptysis, O O
no O O
wheezing O O
- O O
HEENT: O O
no O O
neck O O
swelling, O O
no O O
neck O O
stiffness, O O
no O O
hoarseness O O
- O O
Cardiac: O O
no O O
chest O O
pain/pressure, O O
no O O
palpitations, O O
no O O
orthopnea, O O
no O O
PND O O
- O O
Gastrointestinal: O O
no O O
vomiting, O O
no O O
diarrhea, O O
no O O
constipation, O O
no O O
bleeding O O
- O O
Neurologic: O O
no O O
seizures, O O
no O O
headache, O O
no O O
numbness/tingling; O O
has O O
intermittent O O
carpal O O
tunnel-like O O
pain O O
in O O
L O O
wrist O O
- O O
Lymph O O
nodes: O O
no O O
enlarged O O
lymph O O
nodes O O
- O O
Musculoskeletal: O O
No O O
back O O
pain, O O
no O O
neck O O
pain, O O
no O O
leg O O
pain, O O
no O O
arm O O
pain O O
- O O
Urologic: O O
No O O
hematuria, O O
no O O
dysuria, O O
no O O
nocturia O O
- O O
Hematologic: O O
No O O
bruising, O O
no O O
bleeding O O
- O O
Exposures: O O
No O O
sick O O
contacts, O O
no O O
recent O O
travel O O
Exam: O O
Gen: O O
Pt O O
is O O
pleasant, O O
cooperative, O O
and O O
very O O
informed O O
re: O O
his O O
health O O
history. O O
NAD, O O
lying O O
in O O
bed. O O
VS: O O
T O O
97.5 O O
RR O O
18 O O
O2 O O
98 O O
2L O O
Supine O O
HR O O
76, O O
BP O O
136/56 O O
Standing O O
HR O O
84, O O
BP O O
138/58 O O
HEENT: O O
NC/AT, O O
PER O O
but O O
minimally O O
reactive O O
to O O
light, O O
nonicteric. O O
EOMI. O O
No O O
temporal O O
tenderness. O O
MMM, O O
w/o O O
exudates. O O
Upper O O
and O O
lower O O
dentures. O O
Arcus O O
senilis O O
b/l. O O
Neck: O O
supple, O O
NT, O O
full O O
ROM, O O
2+ O O
carotids O O
w/o O O
bruits, O O
no O O
LAD, O O
JVP O O
5cm, O O
palpable O O
subcutaneous O O
mass O O
1x1cm O O
near O O
C7 O O
c/w O O
shrapnel; O O
spongy, O O
freely O O
movable O O
subcutaneous O O
mass O O
1x2cm O O
in O O
anterior O O
L O O
neck, O O
per O O
pt O O
has O O
been O O
seen O O
by O O
PCP O O
over O O
many O O
yrs O O
and O O
is O O
unconcerning O O
Lungs: O O
CTAB; O O
no O O
crackles, O O
no O O
wheezes. O O
Diminished O O
breath O O
sounds O O
L O O
lung O O
lower O O
2/3, O O
c/w O O
lobectomies. O O
Cor: O O
RRR; O O
normal O O
S1S2, O O
2/6 O O
SEM O O
at O O
LUSB O O
Abd: O O
soft, O O
non-tender, O O
non-distended; O O
+BS; O O
no O O
organomegaly O O
G/R: O O
deferred O O
due O O
to O O
ED O O
exam O O
Extr: O O
no O O
c/c/e; O O
2+ O O
dorsalis O O
pulses O O
b/l O O
Neuro: O O
AOx3, O O
MS O O
nl, O O
CN O O
II O O
through O O
XII O O
intact, O O
motor O O
and O O
sensory O O
nonfocal O O
with O O
5/5 O O
strength O O
intact O O
b/l O O
throughout; O O
DTR's O O
1+ O O
and O O
symmetric. O O
JPS O O
nl, O O
F O O
to O O
N O O
nl, O O
Romberg O O
neg. O O
Gait O O
slow, O O
mildly O O
unsteady. O O
Labs: O O
132 O O
99 O O
18 O O
152 O O
7.7 O O
169 O O
3.7 O O
26.8 O O
1.2 O O
41.3 O O
89P O O
/ O O
9L O O
/ O O
2M O O
Ca O O
9.5 O O
/ O O
Mg O O
1.5 O O
/ O O
P O O
1.8 O O
TP O O
7.1 O O
/ O O
Alb O O
4.3 O O
/ O O
Glob O O
2.8 O O
DB O O
0.3 O O
/ O O
TB O O
0.7 O O
/ O O
Alk O O
Phos O O
83 O O
/ O O
SGPT O O
22 O O
/ O O
SGOT O O
24 O O
CK-Iso O O
Neg O O
/ O O
Troponin-I O O
Neg O O
U/A: O O
SG O O
1.015 O O
Neg O O
WBC O O
Screen, O O
Occult O O
Blood, O O
Nitrites, O O
Albumin, O O
Glucose O O
pH O O
8.0 O O
1+ O O
Ketones O O
EKG: O O
NSR; O O
Q O O
in O O
V1, O O
V2 O O
c/w O O
prior O O
EKGs O O
Rads: O O
See O O
HPI. O O
Also: O O
10/10/92 O O
CXR O O
Normal O O
11/02/90 O O
Head/Neck O O
CTA O O
No O O
evidence O O
of O O
any O O
acute O O
intracranial O O
infarction. O O
Nonspecific O O
periventricular O O
white O O
matter O O
hypodensities, O O
which O O
may O O
represent O O
small O O
vessel O O
ischemic O O
changes. O O
Mild O O
atherosclerotic O O
changes O O
without O O
any O O
hemodynamically O O
significant O O
stenoses O O
of O O
the O O
head O O
and O O
neck O O
vessels. O O
Intact O O
vertebrobasilar O O
system. O O
_____________________________________________________________________________________ O O
Impression: O O
Pt O O
is O O
an O O
82 O O
yo O O
man O O
with O O
a O O
h/o O O
DM2, O O
HTN, O O
and O O
a O O
syncopal O O
episode O O
1mo O O
ago O O
p/w O O
diaphoresis O O
and O O
generalized O O
weakness O O
15min O O
after O O
moderate O O
activity. O O
Episode O O
occurred O O
in O O
setting O O
of O O
frequent O O
diaphoresis O O
episodes O O
in O O
the O O
past O O
1mo, O O
and O O
with O O
medication O O
change O O
from O O
Flomax O O
to O O
Prazosin O O
this O O
morning O O
4hrs O O
prior O O
to O O
current O O
episode. O O
No O O
LOC, O O
CP, O O
SOB, O O
or O O
seizure-like O O
activity. O O
No O O
focal O O
deficits O O
and O O
non-orthostatic O O
on O O
exam O O
with O O
strength O O
intact. O O
Stable O O
Hct. O O
Likely O O
etiologies O O
include: O O
1. O O
Arrhythmia, O O
including O O
sick O O
sinus. O O
EKGs O O
demonstrate O O
mild O O
LA O O
enlargement, O O
old O O
V1/V2 O O
Q O O
waves. O O
Could O O
predispose O O
to O O
atrial O O
fib O O
or O O
conduction O O
abnormalities. O O
Sick O O
sinus O O
not O O
seen O O
on O O
EKG, O O
but O O
common O O
cause O O
of O O
pre-syncope. O O
2. O O
Vertebrobasilar/Carotid O O
stenosis. O O
Basilar O O
territory O O
could O O
lead O O
to O O
dizziness; O O
would O O
expect O O
more O O
focal O O
findings O O
if O O
carotid O O
etiology, O O
unless O O
bilateral O O
blockage. O O
3. O O
Prazosin-induced O O
hypotension. O O
In O O
light O O
of O O
very O O
recent O O
change O O
back O O
to O O
Prazosin, O O
which O O
has O O
more O O
vascular/peripheral O O
alpha-1 O O
antagonism O O
than O O
does O O
the O O
more O O
prostate-specific O O
Flomax, O O
could O O
result O O
in O O
cerebral O O
hypoperfusion. O O
4. O O
Neurocardiogenic/Carotid O O
hypersensitivity. O O
Plan: O O
Pre-syncope: O O
- O O
ROMI O O
with O O
2nd O O
and O O
3rd O O
set O O
of O O
cardiac O O
markers O O
- O O
Telemetry O O
- O O
24 O O
hr O O
Holter O O
monitor O O
- O O
Carotid O O
Doppler O O
and O O
Posterior O O
Transcranial O O
Doppler O O
- O O
Check O O
lytes, O O
CBC O O
+ O O
diff O O
in O O
a.m. O O
- O O
IVF: O O
NS O O
500cc O O
at O O
75cc/hr O O
- O O
Continue O O
Lisinopril, B-MEDICATION B-MEDICATION
HCTZ O O
but O O
discontinue O O
Prazosin O O
as O O
inpatient O O
- O O
ASA O B-MEDICATION
qod O O
as O O
at O O
home, O O
consider O O
qd O O
DM2: O O
- O O
Check O O
glucose O O
in O O
a.m. O O
- O O
No O O
insulin O O
requirement; O O
order O O
diabetic O O
diet O O
OA: O O
- O O
Motrin O O
400mg O O
bid; O O
check O O
BUN/Cr O O
and O O
U/A O O
for O O
evidence O O
of O O
AIN O O
or O O
ATN O O
Gout: O O
- O O
Continue O O
Allopurinol O O
Optho: O O
- O O
Continue O O
home O O
regimen O O
of O O
Truopt, O O
Artificial O O
tears, O O
etc. O O
_______________________________ O O
Leon O O
Xayachack O O
Pager O O
#76680 O O
I O O
have O O
seen O O
and O O
examined O O
the O O
patient O O
wtih O O
Leon O O
and O O
agree O O
with O O
his O O
assessment. O O

Record O O
date: O O
2094-04-16 O O
Internal O O
Medicine O O
Admission O O
Note O O
Name: O O
Crawford, O O
Patrick O O
MR#: O O
9021555 O O
Date O O
of O O
Admission: O O
04.15.94 O O
PCP: O O
Ehlers, O O
Willa O O
Attending: O O
Ward O O
Admitting O O
Resident: O O
Kimberly O O
Ring O O
CC: O O
83 O O
y/o O O
man O O
w/ O O
known O O
CAD B-CAD O
presenting O O
with O O
near O O
syncope O O
HPI: O O
83 O O
y/o O O
man O O
w/ O O
CAD, B-CAD O
(no O O
stents), O O
followed O O
by O O
Dr. O O
Youmans, O O
presents O O
after O O
an O O
episode O O
of O O
diaphoresis O O
and O O
upchucking O O
after O O
helping O O
his O O
sister O O
clean O O
out O O
the O O
water O O
in O O
her O O
basement O O
(this O O
happened O O
Saturday O O
am). O O
Of O O
note, O O
he O O
had O O
one O O
episode O O
of O O
diarrhea O O
that O O
morning. O O
He O O
denied O O
any O O
fevers O O
or O O
chills, O O
or O O
nausea O O
or O O
vomiting O O
prior O O
to O O
this O O
episode. O O
When O O
he O O
started O O
vigorously O O
removing O O
the O O
water O O
from O O
the O O
floor, O O
he O O
began O O
feeling O O
lightheaded O O
and O O
nauseated, O O
and O O
was O O
told O O
he O O
was O O
diaphoretic. O O
He O O
sat O O
down O O
on O O
the O O
stairs O O
with O O
assistance O O
from O O
the O O
plumber, O O
and O O
upchucked. O O
After O O
vomiting O O
he O O
still O O
felt O O
dizzy O O
and O O
lightheaded. O O
Ems O O
was O O
called, O O
and O O
upon O O
arrival O O
at O O
the O O
ED, O O
he O O
had O O
another O O
episode O O
of O O
diarrhea. O O
At O O
no O O
point O O
did O O
he O O
have O O
chest O O
pain. O O
He O O
did O O
not O O
lose O O
consciousness. O O
This O O
felt O O
somewhat O O
similar O O
to O O
an O O
episode O O
of O O
near O O
syncope O O
he O O
had O O
in O O
2092. O O
In O O
general, O O
he O O
is O O
limited O O
in O O
his O O
activity O O
by O O
his O O
osteoarthritis. O O
However, O O
he O O
walks O O
up O O
stairs O O
regularly O O
and O O
gardens O O
without O O
chest O O
pain. O O
The O O
only O O
new O O
medicine O O
change O O
is O O
an O O
increase O O
in O O
his O O
norvasc. B-MEDICATION B-MEDICATION
He O O
has O O
not O O
been O O
experiencing O O
any O O
palpitations, O O
or O O
shortness O O
of O O
breath. O O
He O O
denies O O
any O O
headache, O O
visual O O
changes, O O
dysuria, O O
abdominal O O
pain, O O
sore O O
throat. O O
He O O
has O O
heard O O
that O O
there O O
is O O
a O O
bug O O
going O O
around, O O
but O O
denies O O
sick O O
contacts. O O
ED O O
Course: O O
Upon O O
presentation O O
to O O
ED, O O
HR O O
50, O O
BP B-HYPERTENSION O
141/62, I-HYPERTENSION O
18, O O
99% O O
RA, O O
afebrile. O O
Given O O
aspirin, B-MEDICATION B-MEDICATION
home O O
meds, O O
beta B-MEDICATION O
blocker I-MEDICATION O
held I-MEDICATION O
for O O
bradycardia. O O
Decided O O
to O O
admit O O
despite O O
negative O O
troponins O O
and O O
no O O
EKG O O
changes O O
because O O
symptoms O O
of O O
dizziness O O
when O O
walking O O
persisted. O O
ROS: O O
Negative O O
in O O
detail; O O
positives O O
noted O O
in O O
HPI. O O
Medical O O
History: O O
1. O O
CAD: B-CAD O
Adenosine O O
mibi O O
showed O O
reversible, O O
moderate, O O
anteroseptal O O
defect. O O
Cath B-CAD O
10/92 I-CAD O
with I-CAD O
mild I-CAD O
to I-CAD O
moderate I-CAD O
LAD I-CAD O
(focal I-CAD O
50% I-CAD O
stenosis I-CAD O
in I-CAD O
proximal I-CAD O
third; I-CAD O
focal I-CAD O
50% I-CAD O
stenosis I-CAD O
of I-CAD O
mid I-CAD O
third I-CAD O
at I-CAD O
ostia I-CAD O
of I-CAD O
second I-CAD O
diaganol I-CAD O
artery) I-CAD O
and I-CAD O
RCA I-CAD O
(proximal I-CAD O
RCA I-CAD O
w/ I-CAD O
50% I-CAD O
stenosis I-CAD O
in I-CAD O
distal I-CAD O
third) I-CAD O
disease; I-CAD O
interrogation I-CAD O
with I-CAD O
pressure I-CAD O
wire I-CAD O
of I-CAD O
LAD I-CAD O
lesion I-CAD O
revealed I-CAD O
non-hemodynamically I-CAD O
signficiant I-CAD O
lesion. I-CAD O
Discharged O O
from O O
SDU O O
on O O
med O O
management O O
(beta B-MEDICATION O
blocker, I-MEDICATION O
asa, B-MEDICATION B-MEDICATION
ace, B-MEDICATION O
and O O
statin), B-MEDICATION O
with O O
f/u O O
w/ O O
Dr. O O
Youmans O O
(who O O
has O O
followed O O
since). O O
2. O O
Syncope: O O
Admitted O O
twice O O
2092, O O
first O O
attributed O O
to O O
alpha O O
blocker O O
and O O
dehydration, O O
second O O
time O O
ruled O O
out, O O
but O O
had O O
positive O O
adenosine O O
mibi O O
(see O O
above) O O
. O O
- O O
3. O O
DM2: B-DIABETES O
diagnosed O O
2080, O O
initially O O
took O O
an O O
oral O O
hypoglycemic O O
agent O O
for O O
6mo, O O
but O O
since O O
has O O
been O O
managed O O
by O O
diet O O
and O O
exercise O O
only. O O
HbA1c O O
checked O O
q3mo; O O
most O O
recent O O
was O O
around O O
5.0 O O
per O O
pt. O O
4. O O
Hypertension B-HYPERTENSION O
5. O O
Hypercholesterolemia B-HYPERLIPIDEMIA O
6. O O
TIA O O
workup O O
8/2090 O O
after O O
p/w O O
sensation O O
of O O
burning O O
tongue, O O
metallic O O
taste, O O
some O O
diminished O O
hearing O O
on O O
L, O O
had O O
negative O O
head O O
CT O O
at O O
OSH O O
per O O
pt O O
7. O O
Vertigo: O O
dx O O
in O O
10/2090, O O
described O O
as O O
dizziness/room O O
spinning. O O
No O O
subsequent O O
episodes. O O
Negative O O
CTA O O
of O O
the O O
head/neck O O
at O O
SOH. O O
8. O O
BPH O O
9. O O
Lung O O
cancer, O O
s/p O O
L O O
lobectomy O O
(middle O O
and O O
lower O O
lobes) O O
in O O
2072, O O
did O O
not O O
require O O
chemotherapy O O
or O O
radiation O O
10. O O
OA, O O
s/p O O
R O O
total O O
hip O O
replacement O O
(2086) O O
11. O O
Gout: O O
involves O O
L O O
big O O
toe, O O
but O O
with O O
rare O O
flares O O
12. O O
Glaucoma O O
OU O O
13. O O
Cataracts O O
OU, O O
s/p O O
cataract O O
surgery O O
14. O O
Double O O
hernia O O
repair O O
6/85 O O
15. O O
S/p O O
shrapnel O O
injury O O
to O O
L O O
side O O
of O O
body O O
during O O
the O O
war, O O
reports O O
retained O O
shrapnel O O
near O O
C-spine, O O
L O O
arm, O O
scalp. O O
Has O O
no O O
permanent O O
injury, O O
but O O
did O O
limp O O
for O O
awhile O O
after O O
being O O
injured O O
which O O
has O O
resolved. O O
16. O O
Herpes O O
zoster O O
flare O O
15yrs O O
ago O O
17. O O
Mastoiditis O O
as O O
child O O
Medications O O
on O O
Admission O O
(confirmed O O
with O O
Patient): O O
Celebrex O O
200 O O
HCTZ B-MEDICATION O
25 O O
Allopurinol O O
100 O O
Ranitidine O O
150 O O
ASA B-MEDICATION B-MEDICATION
325 O O
MVI O O
Simvastatin B-MEDICATION B-MEDICATION
10 O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
50 O O
bid O O
Lisinopril B-MEDICATION B-MEDICATION
40 O O
Glucosamine O O
Artifical O O
tears O O
Cyclogyl O O
to O O
left O O
eye O O
Lotemax O O
to O O
left O O
eye O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
Acular O O
Left O O
eye O O
Family O O
History: O O
Not O O
obtained. O O
Social O O
History: O O
Pt O O
lives O O
alone O O
in O O
an O O
apartment O O
complex; O O
his O O
sister O O
lives O O
in O O
the O O
same O O
complex. O O
Former O O
army O O
corporal O O
s/p O O
non-debilitating O O
shrapnel O O
injury. O O
Worked O O
in O O
design O O
until O O
retiring O O
age O O
62. O O
Active O O
/ O O
walks O O
frequently, O O
gardens, O O
does O O
crafts. O O
Has O O
3 O O
grown O O
children. O O
Tob: B-SMOKER O
90pack-yr I-SMOKER O
history, I-SMOKER O
quit B-SMOKER O
20yrs I-SMOKER O
ago I-SMOKER O
EtOH: O O
glass O O
of O O
wine O O
per O O
day; O O
former O O
heavy O O
beer O O
drinker O O
Illicits: O O
none O O
Allergies: O O
Latex O O
and O O
beestings O O
Physical O O
Exam: O O
T O O
98.5 O O
68 O O
159/70 B-HYPERTENSION O
99 O O
RA O O
General: O O
well-nourished O O
man; O O
NAD O O
HEENT: O O
NCAT, O O
EOMI, O O
MMM. O O
Neck: O O
supple, O O
no O O
LAD, O O
no O O
JVD; O O
lipoma O O
under O O
left O O
chin O O
Chest: O O
CTAB; O O
Cor: O O
RRR, O O
3/6 O O
systolic O O
murmur O O
heard O O
best O O
at O O
left O O
sternal O O
boarder, O O
2+ O O
distal O O
pulses O O
bilaterally. O O
No O O
carotid O O
bruits O O
Abdomen: O O
+BS, O O
soft, O O
NTND, O O
no O O
organomegaly O O
Neuro: O O
A+Ox3; O O
Normal O O
muscle O O
bulk, O O
tone, O O
and O O
strength. O O
Sensation O O
grossly O O
intact., O O
reflexes O O
trace O O
bilaterally O O
in O O
LE O O
Skin: O O
No O O
lesions O O
or O O
rash O O
Extremities; O O
Warm. O O
No O O
edema, O O
cyanosis, O O
or O O
clubing O O
Labs O O
and O O
Studies: O O
Lab O O
Results O O
for: O O
CRAWFORD, O O
PATRICK O O
P O O
Test O O
Name O O
SOH O O
04/14/94 O O
17:53 O O
NA O O
139 O O
K O O
3.8 O O
CL O O
104 O O
CO2 O O
23.2 O O
BUN O O
27(H) O O
CRE O O
1.2 O O
GLU O O
128(H) O O
Lab O O
Results O O
for: O O
CRAWFORD, O O
PATRICK O O
P O O
Test O O
Name O O
SOH O O
04/14/94 O O
18:26 O O
CA O O
8.9 O O
PHOS O O
1.5(L) O O
MG O O
1.2(L) O O
TBILI O O
0.6 O O
DBILI O O
0.2 O O
TP O O
6.8 O O
ALB O O
4.1 O O
GLOB O O
2.7 O O
Lab O O
Results O O
for: O O
CRAWFORD, O O
PATRICK O O
P O O
Test O O
Name O O
SOH O O
04/14/94 O O
18:26 O O
ALT/SGPT O O
17 O O
AST/SGOT O O
24 O O
ALKP O O
101 O O
TBILI O O
0.6 O O
DBILI O O
0.2 O O
Lab O O
Results O O
for: O O
CRAWFORD, O O
PATRICK O O
P O O
Test O O
Name O O
SOH O O
SOH O O
SOH O O
SOH O O
04/15/94 O O
04/15/94 O O
04/14/94 O O
04/14/94 O O
09:21 O O
00:38 O O
18:27 O O
18:26 O O
NT-BNP O O
340(T) O O
CK-MB O O
Negative O O
Negative O O
Negative O O
TROP-I O O
Negative O O
Negative O O
Negative O O
Lab O O
Results O O
for: O O
CRAWFORD, O O
PATRICK O O
P O O
Test O O
Name O O
SOH O O
04/14/94 O O
18:26 O O
WBC O O
13.5(H) O O
RBC O O
4.91 O O
HGB O O
16.3 O O
HCT O O
45.1 O O
MCV O O
92 O O
MCH O O
33.2 O O
MCHC O O
36.2 O O
PLT O O
195 O O
RDW O O
13.1 O O
DIFFR O O
Received O O
METHOD O O
see O O
detail O O
%NEUT O O
88(H) O O
%LYMPH O O
7(L) O O
%MONO O O
4 O O
%EOS O O
1 O O
%BASO O O
0 O O
ANEUT O O
11.84(H) O O
ALYMP O O
0.90(L) O O
AMONS O O
0.54(H) O O
AEOSN O O
0.17 O O
ABASOP O O
0.04 O O
ANISO O O
None O O
HYPO O O
None O O
MACRO O O
None O O
MICRO O O
None O O
Lab O O
Results O O
for: O O
CRAWFORD, O O
PATRICK O O
P O O
Test O O
Name O O
SOH O O
04/14/94 O O
18:26 O O
PT O O
12.7(T) O O
PT-INR O O
1.1(T) O O
PTT O O
24.9(T) O O
Lab O O
Results O O
for: O O
CRAWFORD, O O
PATRICK O O
P O O
Test O O
Name O O
SOH O O
SOH O O
04/14/94 O O
04/14/94 O O
18:30 O O
18:28 O O
UA-GLUC O O
Negative O O
CREDIT(T) O O
UA-KET O O
1+ O O
CREDIT(T) O O
UA-SPGR O O
1.010 O O
CREDIT(T) O O
UA-BLD O O
Negative O O
CREDIT(T) O O
UA-PH O O
7.0 O O
CREDIT(T) O O
UA-PROT O O
2+ O O
CREDIT(T) O O
UA-NIT O O
Negative O O
CREDIT(T) O O
UA-WBC O O
Negative O O
CREDIT(T) O O
HCAST O O
0-2 O O
UAS-RBC O O
3-5 O O
UAS-WBC O O
0-2 O O
UAS-BACT O O
Negative O O
UAS-SQHI O O
Negative O O
ECG: O O
On O O
floor, O O
NSR O O
w/ O O
poor O O
R O O
wave O O
progression O O
(Q O O
waves O O
in O O
V1 O O
an O O
dV2, O O
TWI O O
III), O O
in O O
ED, O O
EKG O O
w/ O O
frequent O O
PACs O O
Chest O O
xray: O O
Clear O O
Assessment O O
& O O
Plan O O
83 O O
y/o O O
man O O
with O O
known O O
CAD, O O
diabetes, B-DIABETES O
hypertension, B-HYPERTENSION B-HYPERTENSION
hyperlipidemia B-HYPERLIPIDEMIA B-HYPERTENSION
who O O
presents O O
with O O
near O O
syncope, O O
as O O
well O O
as O O
vomiting. O O
Certainly O O
in O O
someone O O
with O O
known O O
CAD, O O
cardiogenic O O
near-syncope O O
is O O
most O O
concerning, O O
namely, O O
MI, O O
with O O
atypical O O
features. O O
However, O O
his O O
EKG O O
is O O
unchanged, O O
his O O
troponins O O
are O O
negative, O O
and O O
he O O
never O O
had O O
chest O O
pain. O O
Perhaps O O
his O O
light-headedness O O
is O O
secondary O O
to O O
bradycardia, O O
as O O
his O O
heart O O
rate O O
has O O
been O O
in O O
the O O
50s O O
and O O
60s. O O
However, O O
I O O
think O O
the O O
most O O
likely O O
explanation O O
is O O
that O O
he O O
has O O
a O O
bit O O
of O O
gastroenteritis, O O
was O O
dehydrated, O O
and O O
had O O
a O O
vasovagal O O
response O O
in O O
the O O
setting O O
of O O
exertion. O O
It O O
is O O
worth O O
checking O O
orthostatics O O
given O O
his O O
rigorous O O
blood O O
pressure O O
regimen. O O
There O O
is O O
nothing O O
to O O
suggest O O
seizure O O
or O O
other O O
neurologic O O
etiologies O O
given O O
his O O
story. O O
Syncope: O O
Stable, O O
no O O
longer O O
feeling O O
dizzy O O
or O O
nauseated O O
Admit O O
to O O
telemetry O O
and O O
monitor O O
overnight O O
Has O O
completed O O
MI O O
r/o O O
Continue O O
ASA, B-MEDICATION B-MEDICATION
beta O O
blocker, O O
(w/ O O
hold O O
parameters), O O
statin, O O
ACE B-MEDICATION O
Has O O
close O O
follow O O
up O O
w/ O O
Dr. O O
Youmans O O
(next O O
week), O O
and O O
likely O O
does O O
not O O
need O O
repeat O O
stress O O
test O O
while O O
in O O
house O O
CAD: O O
As O O
above, O O
will O O
d/c O O
on O O
50 O O
PO O O
Toprol O O
BID O O
per O O
Dr. O O
Youmans O O
recommendations O O
Diabetes: O O
Diet O O
controlled O O
at O O
home O O
RISS O O
while O O
in O O
house O O
with O O
BID O O
fingersticks O O
to O O
assess O O
glucose O O
control O O
Elevated O O
WBC: O O
Likely O O
2/2 O O
gastroenteritis. O O
Afebrile. O O
Hemodynamically O O
stable. O O
U/A O O
and O O
chest O O
xray O O
negative O O
Will O O
send O O
blood O O
cultures O O
and O O
stool O O
cultures O O
if O O
he O O
stools O O
Fen/Renal O O
Replete O O
Mg O O
Proph: O O
Lovenox, O O
nexium O O
__________________________ O O
Kimberly O O
Ring, O O
PGY O O
1, O O
59907 O O

Record O O
date: O O
2096-11-20 O O
CARDIOLOGY O O
SOUTH O O
OAKS O O
HOSPITAL O O
Interval O O
History: O O
Mr. O O
Crawford O O
returns O O
to O O
the O O
clinic O O
for O O
routine O O
scheduled O O
follow-up. O O
His O O
cardiovascular O O
issues O O
include O O
prior O O
syncope, O O
nonobstructive O O
coronary B-CAD O
disease, I-CAD O
and O O
hypertension. B-HYPERTENSION B-HYPERTENSION
In O O
the O O
interval, O O
since O O
our O O
last O O
visit, O O
he O O
has O O
done O O
well O O
from O O
a O O
CV O O
perspective. O O
He O O
has O O
had O O
no O O
episodes O O
of O O
chest O O
pain, O O
pressure, O O
tightness, O O
orthopnea, O O
PND, O O
progressive O O
lower O O
extremity O O
swelling, O O
or O O
claudication. O O
He O O
did O O
unfortunately O O
have O O
an O O
episode O O
of O O
diverticulosis O O
requiring O O
hospitalization O O
at O O
Oakcrest O O
Nursing O O
Home. O O
He O O
did O O
not O O
require O O
transfusion. O O
The O O
bleeding O O
sounds O O
as O O
though O O
it O O
was O O
self-limiting O O
and O O
has O O
not O O
recurred. O O
Otherwise, O O
his O O
health O O
is O O
unchanged. O O
He O O
remains O O
fairly O O
limited O O
due O O
to O O
his O O
osteoarthritis O O
but O O
continues O O
to O O
perform O O
all O O
ADLs O O
successfully. O O
Changes O O
to O O
Allergies O O
BRIMONIDINE O O
TARTRATE O O
- O O
reaction: O O
Unknown O O
[reviewed] O O
Latex O O
- O O
reaction: O O
Rash O O
[reviewed] O O
no O O
known O O
allergies: O O
He O O
has O O
no O O
current O O
allergies O O
- O O
reaction: O O
Unknown O O
[reviewed] O O
Physical O O
examination: O O
-Pulse: O O
50, O O
which O O
is O O
strong O O
and O O
regular O O
-resp. O O
rate: O O
12. O O
He O O
is O O
saturating O O
100% O O
at O O
room O O
air O O
-Extremities: O O
There O O
is O O
trace O O
dependent O O
1+ O O
lower O O
extremity O O
swelling, O O
which O O
is O O
stable. O O
-Abdomen: O O
Soft O O
and O O
nontender. O O
-Cardiac: O O
Regular O O
with O O
nondisplaced O O
PMI, O O
1-2/6 O O
systolic O O
ejection O O
murmur O O
heard O O
best O O
at O O
the O O
base O O
with O O
the O O
crisp O O
S2. O O
-Chest: O O
His O O
lungs O O
are O O
clear. O O
-Neck: O O
Jugular O O
venous O O
pressure O O
is O O
7 O O
cm O O
of O O
water O O
with O O
normal O O
AV O O
contour. O O
He O O
has O O
2+ O O
carotids O O
with O O
brisk O O
upstrokes. O O
-Heent: O O
Normocephalic. O O
-General: O O
He O O
is O O
alert O O
and O O
appropriate O O
in O O
no O O
apparent O O
distress O O
-BP: O O
138/72 O O
in O O
the O O
right O O
arm O O
seated O O
EKG: O O
Sinus O O
bradycardia O O
at O O
50. O O
Delayed O O
R-wave O O
progression. O O
Leftward O O
axis. O O
Nonspecific O O
ST-T O O
wave O O
abnormalities. O O
Selected O O
recent O O
labs: O O
Impression: O O
1.) O O
Nonobstructive B-CAD O
CAD I-CAD O
2.) O O
Neurocardiogenic O O
syncope O O
3.) O O
Hypertension B-HYPERTENSION O
Assessment O O
and O O
plan: O O
Overall O O
he O O
is O O
doing O O
well O O
his O O
cardiovascular O O
issues O O
are O O
stable. O O
His O O
blood O O
pressure O O
slightly O O
above O O
goal O O
but O O
given O O
his O O
past O O
syncopal O O
tendencies O O
with O O
aggressive O O
lowering O O
will O O
hold O O
off O O
on O O
any O O
med O O
changes O O
for O O
now. O O
I O O
will O O
see O O
him O O
back O O
in O O
six O O
months, O O
sooner O O
if O O
new O O
issues O O
arise. O O
Medication O O
List O O
(confirmed) O O
CONFIRMED O O
- O O
allopurinol O O
100 O O
mg O O
PO O O
daily O O
- O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
PO O O
daily O O
- O O
folate O O
1 O O
mg O O
PO O O
daily O O
- O O
hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
mg O O
PO O O
daily O O
- O O
lisinopril B-MEDICATION B-MEDICATION
40 O O
mg O O
PO O O
daily O O
- O O
medication O O
list O O
reviewed O O
in O O
CAS O O
- O O
multivitamins O O
- O O
ranitidine O O
HCl O O
150 O O
mg O O
PO O O
daily O O
PRN O O
- O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
50 O O
mg O O
PO O O
BID O O
- O O
Zocor B-MEDICATION O
10 O O
mg O O
PO O O
daily O O
------------------------------------------------------------ O O
REMOVED B-MEDICATION O
- I-MEDICATION O
Toprol I-MEDICATION O
XL I-MEDICATION O
75 I-MEDICATION O
mg I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
Xavier O O
Youmans, O O
MD O O
pager O O
#24791 O O
Signed O O
electronically O O
by O O
Xavier O O
Youmans, O O
MD O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2097-05-21 O O
CARDIOLOGY O O
SOUTH O O
OAKS O O
HOSPITAL O O
Reason O O
for O O
visit: O O
Routine O O
scheduled O O
followup. O O
Interval O O
History: O O
Mr. O O
Crawford O O
returns O O
to O O
the O O
clinic O O
for O O
routine O O
scheduled O O
follow-up. O O
His O O
cardiovascular O O
issues O O
include O O
prior O O
syncope, O O
nonobstructive B-CAD O
coronary B-CAD O
disease, I-CAD O
and O O
hypertension. B-HYPERTENSION O
In O O
the O O
interval, O O
since O O
our O O
last O O
visit, O O
he O O
continues O O
to O O
do O O
well O O
from O O
a O O
CV O O
perspective. O O
He O O
has O O
had O O
free O O
of O O
chest O O
pain, O O
pressure, O O
tightness, O O
orthopnea, O O
PND, O O
progressive O O
lower O O
extremity O O
swelling, O O
or O O
claudication. O O
He O O
has O O
had O O
no O O
recurrent O O
symptomatic O O
diverticulosis. O O
He O O
remains O O
fairly O O
limited O O
due O O
to O O
his O O
osteoarthritis O O
but O O
continues O O
to O O
perform O O
all O O
ADLs O O
successfully. O O
He O O
is O O
unfortunately O O
not O O
able O O
to O O
do O O
any O O
gardening O O
this O O
year O O
due O O
to O O
progressive O O
joint O O
pain O O
and O O
stiffness. O O
He O O
was O O
recently O O
seen O O
by O O
Dr. O O
Powers O O
(nephrology) O O
after O O
a O O
recent O O
mild O O
bump O O
in O O
his O O
creatinine. O O
His O O
renal O O
workup O O
is O O
ongoing. O O
Physical O O
examination: O O
-Pulse: O O
55, O O
which O O
is O O
strong O O
and O O
regular O O
-resp. O O
rate: O O
12. O O
He O O
is O O
saturating O O
100% O O
at O O
room O O
air O O
-General: O O
He O O
is O O
alert O O
and O O
appropriate O O
in O O
no O O
apparent O O
distress O O
-Heent: O O
Normocephalic. O O
-Neck: O O
Jugular O O
venous O O
pressure O O
is O O
7 O O
cm O O
of O O
water O O
with O O
normal O O
AV O O
contour. O O
He O O
has O O
2+ O O
carotids O O
with O O
brisk O O
upstrokes. O O
-Chest: O O
His O O
lungs O O
are O O
clear. O O
-Cardiac: O O
Regular O O
with O O
nondisplaced O O
PMI, O O
1-2/6 O O
systolic O O
ejection O O
murmur O O
heard O O
best O O
at O O
the O O
base O O
with O O
the O O
crisp O O
S2. O O
-Abdomen: O O
Soft O O
and O O
nontender. O O
-Extremities: O O
There O O
is O O
trace O O
dependent O O
1+ O O
lower O O
extremity O O
swelling, O O
which O O
is O O
stable. O O
-BP: O O
122/74 O O
in O O
the O O
right O O
arm O O
seated O O
EKG: O O
Sinus O O
bradycardia O O
at O O
55. O O
Normal O O
intervals. O O
Leftward O O
axis O O
(-30). O O
Normal O O
repolarization O O
pattern. O O
Impression: O O
1.) O O
Nonobstructive B-CAD O
CAD I-CAD O
2.) O O
Neurocardiogenic O O
syncope O O
3.) O O
Hypertension B-HYPERTENSION O
4.) O O
Aortic O O
sclerosis O O
Assessment O O
and O O
plan: O O
Overall O O
he O O
is O O
doing O O
well O O
his O O
cardiovascular O O
issues O O
are O O
stable. O O
No O O
changes O O
in O O
his O O
cardiovascular O O
regimen O O
today. O O
I O O
will O O
see O O
him O O
back O O
in O O
six O O
months, O O
sooner O O
if O O
new O O
issues O O
arise. O O
Medication O O
List O O
(confirmed) O O
CONFIRMED O O
- O O
allopurinol O O
100 O O
mg O O
PO O O
daily O O
- O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
PO O O
daily O O
- O O
folate O O
1 O O
mg O O
PO O O
daily O O
- O O
hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
mg O O
PO O O
daily O O
- O O
lisinopril B-MEDICATION B-MEDICATION
40 O O
mg O O
PO O O
daily O O
- O O
medication O O
list O O
reviewed O O
in O O
CAS O O
- O O
multivitamins O O
- O O
ranitidine O O
HCl O O
150 O O
mg O O
PO O O
daily O O
PRN O O
- O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
50 O O
mg O O
PO O O
BID O O
- O O
Zocor B-MEDICATION O
10 O O
mg O O
PO O O
daily O O
Xavier O O
K. O O
Youmans, O O
MD O O
pager O O
#24791 O O
Signed O O
electronically O O
by O O
Xavier O O
K. O O
Youmans, O O
MD O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2078-11-22 O O
PONTIAC O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
Sherman, O O
Andrew O O
History O O
of O O
Present O O
Illness: O O
The O O
patient O O
returns O O
one O O
week O O
after O O
being O O
seen O O
here O O
initially O O
in O O
Internal O O
Medicine O O
clinic. O O
On O O
the O O
last O O
visit O O
he O O
was O O
having O O
chest O O
pain O O
and O O
was O O
therefore O O
sent O O
to O O
the O O
Emergency O O
Room O O
for O O
a O O
further O O
evaluation. O O
At O O
that O O
time O O
he O O
had O O
EKGs O O
which O O
did O O
not O O
demonstrate O O
any O O
ischemia O O
during O O
his O O
chest O O
pain O O
and O O
a O O
chest O O
x-ray O O
which O O
was O O
unremarkable. O O
The O O
Emergency O O
Room O O
physicians O O
contacted O O
his O O
doctors O O
at O O
Humbert O O
Hospital O O
and O O
obtained O O
a O O
history O O
that O O
the O O
patient O O
had O O
a O O
cardiomyopathy O O
in O O
the O O
past O O
with O O
a O O
decreased O O
LV O O
function. O O
However O O
repeat O O
echo O O
within O O
the O O
past O O
months O O
demonstrated O O
good O O
LV O O
function O O
and O O
they O O
were O O
in O O
the O O
process O O
of O O
performing O O
further O O
cardiac O O
testing O O
when O O
the O O
patient O O
left O O
the O O
Humbert O O
Hospital O O
against O O
medical O O
advice. O O
After O O
being O O
evaluated O O
in O O
the O O
Emergency O O
Room O O
at O O
Pontiac O O
State, O O
he O O
now O O
returns O O
to O O
be O O
tied O O
in O O
with O O
the O O
Internal O O
Medicine O O
clinic. O O
Medications: O O
His O O
medications O O
since O O
his O O
Emergency O O
Room O O
visit O O
include O O
Carafate O O
1 O O
gm. O O
PO O O
q.i.d., O O
Prinivil B-MEDICATION O
10 O O
mg. O O
PO O O
q.d., O O
Tenormin B-MEDICATION O
50 O O
mg. O O
PO O O
q.d., O O
Motrin O O
600 O O
mg. O O
t.i.d. O O
p.r.n. O O
and O O
Nitrostat B-MEDICATION O
tablets O O
p.r.n. O O
His O O
insulin B-MEDICATION O
dosing O O
consists O O
of O O
40 O O
units O O
of O O
NPH B-MEDICATION O
q.a.m. O O
and O O
18 O O
units O O
q.p.m. O O
and O O
regular B-MEDICATION O
insulin I-MEDICATION O
20 O O
units O O
q.a.m. O O
On O O
return O O
to O O
my O O
office O O
today, O O
he O O
states O O
that O O
the O O
frequency O O
of O O
his O O
chest O O
pain O O
is O O
much O O
diminished O O
but O O
that O O
he O O
has O O
gained O O
some O O
weight O O
since O O
discontinuing O O
his O O
Lasix O O
per O O
order O O
of O O
the O O
Emergency O O
Room O O
physicians. O O
Physical O O
Exam: O O
On O O
exam, O O
his B-HYPERTENSION O
blood I-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
160/100 B-HYPERTENSION O
with O O
a O O
heart O O
rate O O
of O O
76. O O
He O O
is O O
not O O
in O O
any O O
acute O O
distress. O O
His O O
chest O O
is O O
clear O O
to O O
auscultation. O O
His O O
cardiac O O
exam O O
demonstrates O O
S4 O O
gallop O O
and O O
distant O O
heart O O
sounds. O O
His O O
abdominal O O
exam O O
is O O
benign O O
except O O
for O O
massive B-OBESE O
obesity. I-OBESE O
His O O
rectal O O
exam O O
is O O
guaiac O O
negative. O O
His O O
extremities O O
exam O O
demonstrates O O
1+ O O
pitting O O
edema O O
to O O
the O O
shins O O
and O O
his O O
neurologic O O
exam O O
is O O
unremarkable. O O
Assessment O O
and O O
Plan: O O
1. O O
Cardiac. O O
The O O
patient O O
will O O
be O O
scheduled O O
for O O
an O O
ETT O O
thallium O O
study O O
to O O
rule O O
out O O
ischemia. O O
2. O O
Hypertension. B-HYPERTENSION O
His O O
Prinivil O O
will O O
be O O
increased O O
to O O
20 O O
mg. O O
q.d. O O
3. O O
Diabetes. B-DIABETES O
His O O
sugars O O
have O O
been O O
running O O
130 B-DIABETES O
to I-DIABETES O
160 I-DIABETES O
by O O
fingerstick O O
checks O O
at O O
home O O
and O O
he O O
will O O
continue O O
his O O
present O O
regimen. O O
4. O O
The O O
patient O O
will O O
be O O
referred O O
to O O
ophthalmology O O
for O O
the O O
evaluation O O
of O O
his O O
eyes O O
given O O
his O O
history O O
of O O
hypertension B-HYPERTENSION O
and O O
diabetes. B-DIABETES O
5. O O
General. O O
The O O
patient O O
will O O
see O O
me O O
shortly O O
after O O
completion O O
of O O
an O O
ETT O O
thallium O O
study O O
for O O
further O O
discussion O O
of O O
his O O
cardiac O O
status. O O
_________________________ O O
Michael O O
Holman, O O
M.D. O O
rin:KZ:9636:DD:11-24-78:DT:11-25-78:DV:11-22-78 O O

Record O O
date: O O
2079-07-21 O O
PONTIAC O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
Sherman, O O
Andrew O O
7-21-79 O O
History O O
of O O
Present O O
Illness: O O
Mr. O O
Sherman O O
is O O
a O O
patient O O
well O O
known O O
to O O
me. O O
I O O
have O O
seen O O
him O O
on O O
multiple O O
occasions O O
for O O
his O O
coronary B-CAD O
artery I-CAD O
disease, I-CAD O
hypertension, B-HYPERTENSION B-HYPERTENSION
and O O
diabetes. B-DIABETES O
The O O
patient O O
has O O
had O O
a O O
positive B-CAD O
exercise I-CAD O
tolerance I-CAD O
test I-CAD O
recently I-CAD O
and O O
was O O
seen O O
by O O
Cardiology O O
who O O
felt O O
that O O
he O O
should O O
undergo O O
cardiac O O
catheterization. O O
However, O O
patient O O
was O O
overweight O O
and O O
the O O
decision O O
was O O
made O O
for O O
him O O
to O O
reduce O O
his O O
weight O O
by O O
approximately O O
50 O O
lb. O O
at O O
which O O
time O O
he O O
would O O
be O O
suitable O O
for O O
cardiac O O
catheterization O O
on O O
the O O
Pontiac O O
equipment. O O
Patient O O
was O O
seen O O
last O O
night O O
in O O
the O O
Pontiac O O
Emergency O O
Room O O
with O O
a O O
several O O
day O O
history O O
of O O
back O O
pain O O
which O O
began O O
in O O
the O O
middle O O
of O O
his O O
back O O
and O O
has O O
subsequently O O
become O O
right O O
flank O O
pain O O
which O O
is O O
persistent O O
and O O
colicky O O
in O O
nature. O O
On O O
exam O O
in O O
the O O
Emergency O O
Room O O
he O O
was O O
noted O O
to O O
be O O
afebrile. O O
His O O
exam O O
was O O
notable O O
for O O
CVA O O
tenderness O O
and O O
an O O
exam O O
highly O O
suspicious O O
of O O
renal O O
colic. O O
His O O
EKG O O
was O O
unremarkable O O
and O O
his O O
laboratory O O
exam O O
was O O
unremarkable O O
as O O
well. O O
His O O
urinalysis O O
did O O
not O O
demonstrate O O
any O O
red O O
blood O O
cells, O O
however, O O
did O O
have O O
3+ O O
uric O O
acid O O
crystals O O
with O O
a O O
normal O O
uric O O
acid O O
blood O O
level. O O
An O O
abdominal O O
ultrasound O O
was O O
ordered O O
which O O
was O O
unremarkable O O
except O O
for O O
the O O
presence O O
of O O
his O O
slight O O
abnormality O O
in O O
the O O
right O O
pole O O
of O O
a O O
kidney. O O
IVP O O
was O O
recommended O O
by O O
the O O
radiologist O O
for O O
follow-up. O O
He O O
was O O
given O O
Toradol O O
in O O
the O O
Emergency O O
Room O O
with O O
minimal O O
improvement O O
and O O
sent O O
home O O
with O O
some O O
Motrin O O
with O O
the O O
follow-up O O
to O O
be O O
by O O
me O O
in O O
Internal O O
Medicine O O
Clinic. O O
I O O
was O O
called O O
by O O
the O O
patient O O
this O O
morning O O
complaining O O
of O O
worsening O O
pain O O
in O O
his O O
right O O
flank. O O
On O O
it, O O
patient O O
states O O
he O O
is O O
unable O O
to O O
get O O
out O O
of O O
bed O O
and O O
was O O
brought O O
to O O
the O O
Pontiac O O
State O O
Hospital O O
to O O
my O O
Internal O O
Medicine O O
Clinic. O O
On O O
exam O O
he O O
was O O
afebrile O O
and O O
his O O
exam O O
was O O
notable O O
for O O
a O O
right O O
CVA O O
tenderness O O
with O O
pain O O
radiating O O
around O O
to O O
his O O
abdomen O O
and O O
exacerbated O O
by O O
pushing O O
on O O
his O O
abdomen. O O
Patient O O
has O O
good O O
bowel O O
sounds O O
throughout O O
and O O
there O O
are O O
no O O
peritoneal O O
signs. O O
Assessment O O
and O O
Plan: O O
While O O
I O O
am O O
concerned O O
about O O
his O O
possible O O
renal O O
pathology O O
I O O
believe O O
that O O
there O O
is O O
a O O
significant O O
chance O O
that O O
this O O
may O O
be O O
musculoskeletal O O
in O O
nature, O O
however, O O
due O O
to O O
his O O
other O O
medical O O
problems O O
I O O
feel O O
that O O
an O O
intravenous O O
pyelogram O O
is O O
definitely O O
indicated O O
and O O
he O O
will O O
undergo O O
this O O
study O O
this O O
afternoon. O O
I O O
have O O
also O O
sent O O
off O O
a O O
repeat O O
CBC O O
with O O
differential, O O
a O O
repeat O O
urinalysis O O
and O O
amylase O O
and O O
lipase O O
levels O O
to O O
rule O O
out O O
pancreatitis. O O
Of O O
note, O O
patient O O
does O O
have O O
a O O
history O O
of O O
peptic O O
ulcer O O
disease, O O
however, O O
he O O
was O O
guaiac O O
negative O O
in O O
the O O
Emergency O O
Room O O
and O O
reports O O
no O O
episodes O O
of O O
hematemesis, O O
hematochezia, O O
or O O
melena. O O
He O O
is O O
also O O
status O O
post O O
cholecystectomy. O O
I O O
will O O
review O O
his O O
IVP O O
later O O
today O O
and O O
make O O
further O O
therapeutic O O
interventions O O
at O O
that O O
time. O O
_________________________ O O
Michael O O
Holman, O O
M.D. O O
AE:JP:5824:DD:7-21-79:DT:7-24-79 O O
DV:7-21-79 O O

Record O O
date: O O
2093-05-23 O O
Internal O O
Medicine O O
ADMISSION B-DIABETES O
NOTE O O
Patient O O
Name: O O
SHERMAN, O O
ANDREW O O
Medical O O
Record O O
#: O O
149-05-69 O O
Date O O
of O O
Admission: O O
04/01/2091 O O
Attending: O O
Younce O O
PCP: O O
Sacred O O
Heart O O
Cardiologist: O O
None O O
ID/CC: O O
60yoM O O
w/ O O
PMH O O
CAD, B-CAD O
2vCABG, B-CAD O
s/p O O
AICD O O
placement, O O
CHF, O O
DM, O O
CVA O O
p/w O O
syncopal O O
event. O O
HPI: O O
Mr. O O
Sherman O O
is O O
a O O
60yoM O O
with O O
MMP O O
who O O
was O O
traveling O O
in O O
his O O
wheelchair O O
when O O
he O O
states O O
that O O
he O O
lost O O
consciousness O O
and O O
fell O O
out O O
of O O
his O O
wheelchair. O O
Prior O O
to O O
this O O
event, O O
he O O
states O O
that O O
he O O
had O O
been O O
experiencing O O
shortness O O
of O O
breathe O O
and O O
constant O O
substernal O O
chest O O
pressure O O
9/10 O O
x O O
1 O O
hour. O O
He O O
states O O
that O O
at O O
baseline O O
he O O
experiences O O
substernal O O
chest O O
pressure O O
6-7/10 O O
through O O
each O O
and O O
every O O
day. O O
There O O
is O O
nothing O O
in O O
particular O O
that O O
brings O O
on O O
his O O
pain O O
or O O
relieves O O
it. O O
He O O
states O O
that O O
he O O
sleeps O O
on O O
one O O
pillow O O
at O O
night O O
and O O
is O O
short O O
of O O
breathe O O
when O O
flat. O O
He O O
at O O
baseline O O
has O O
swelling O O
in O O
his O O
legs O O
and O O
states O O
that O O
it O O
is O O
not O O
worse. O O
He O O
also O O
states O O
that O O
he O O
has O O
gained O O
35 O O
pounds O O
in O O
the O O
past O O
2 O O
weeks. O O
Mr. O O
Sherman O O
notes O O
that O O
he O O
lost O O
continence O O
during O O
his O O
fall O O
today O O
but O O
states O O
that O O
he O O
frequently O O
has O O
loss O O
of O O
bladder O O
and O O
bowel O O
incontinence. O O
He O O
denied O O
any O O
N/V O O
today. O O
Of O O
note, O O
Mr. O O
Sherman O O
was O O
discharged O O
yesterday O O
from O O
the O O
Sacred O O
Heart O O
Hospital O O
where O O
he O O
was O O
discharged O O
from O O
after O O
a O O
2 O O
week O O
stay. O O
He O O
was O O
admitted O O
there O O
after O O
a O O
syncopal O O
event O O
with O O
head O O
trauma O O
ensuing O O
as O O
well O O
as O O
suicidal O O
ideation. O O
He O O
denies O O
any O O
SI O O
at O O
this O O
time. O O
He O O
states O O
that O O
he O O
syncopizes O O
fairly O O
frequently, O O
approximately O O
&gt; O O
1x O O
per O O
week. O O
He O O
does O O
not O O
recall O O
his O O
AICD O O
having O O
fired O O
in O O
the O O
past O O
3 O O
years. O O
ED O O
Course: O O
ASA, B-MEDICATION B-MEDICATION
RISS, O O
head O O
CT; O O
seem O O
by O O
plastics O O
regarding O O
facial O O
fractures O O
PMH: O O
1. O O
CAD O O
- O O
proximal B-CAD O
LAD I-CAD O
stent I-CAD O
placed I-CAD O
in I-CAD O
2091, I-CAD O
then O O
AICD O O
at O O
OSH O O
(reasons O O
not O O
specified). O O
He O O
subsequently O O
underwent O O
2V-CABG B-CAD O
on I-CAD O
3/15/91 I-CAD O
with I-CAD O
LIMA I-CAD O
LAD I-CAD O
and I-CAD O
LSVG I-CAD O
DIAG. I-CAD O
-Adenosine-MIBI O O
at O O
Bristol O O
in O O
6/92 O O
2. O O
CHF O O
- O O
EF O O
20% O O
by O O
TTE O O
3/20/91 O O
3. O O
HTN B-HYPERTENSION O
4. O O
T2DM B-DIABETES O
5. O O
Embolic O O
stroke O O
(March O O
2088) O O
with O O
residual O O
R O O
sided O O
weakness/uncooridiation O O
and O O
resolved O O
dysarthria. O O
6. O O
Depression O O
with O O
h/o O O
suicidal O O
ideation/attempts(x2) O O
in O O
past O O
7. O O
PTSD O O
8. O O
OA O O
9. O O
OSA O O
10. O O
h/o O O
Dengue O O
fever O O
11. O O
s/p O O
open O O
cholecystectomy O O
12. O O
s/p O O
head O O
wound O O
from O O
schrapnel O O
during O O
Venezuela O O
Conflict O O
ALLERGIES O O
/ O O
REACTIONS: O O
Procardia O O
(rash, O O
angioedema) O O
MEDICATIONS: O O
ASA O B-MEDICATION
325 O O
Digoxin O O
0.125mg O O
QD O O
Lisinopril B-MEDICATION B-MEDICATION
20mg O O
QD O O
Celexa O O
20mg O O
QD O O
Zocor B-MEDICATION B-MEDICATION
40mg O O
QD O O
Lasix O O
40mg O O
QAM O O
Atrovent O O
inhaler, O O
2 O O
puffs O O
QID O O
Atenolol B-MEDICATION B-MEDICATION
50mg O O
QD O O
Rabeprazole O O
20mg O O
QD O O
KCl O O
8meq O O
QAM O O
Metformin B-MEDICATION B-MEDICATION
1000mg O O
BID O O
Colace O O
100mg O O
BID O O
TNG B-MEDICATION O
SL I-MEDICATION O
prn O O
SH: O O
Married O O
and O O
lives O O
with O O
his O O
wife. O O
Appears O O
to O O
be O O
homeless O O
right O O
now O O
and O O
between O O
shelters O O
due O O
to O O
anger O O
management O O
issues. O O
Formerly O O
in O O
the O O
marines. O O
Had O O
lived O O
in O O
Poland. O O
Never B-SMOKER O
smoked. I-SMOKER O
Past O O
alcohol O O
abuse O O
history O O
but O O
sober O O
after O O
detoxing O O
many O O
years O O
ago. O O
FH: O O
CAD O O
ROS: O O
As O O
per O O
HPI. O O
Otherwise O O
negative O O
in O O
detail. O O
P.E.: O O
Vitals: O O
96.4 O O
95 O O
137/92 O O
20 O O
99% O O
GEN: O O
NAD O O
HEENT: O O
eomi O O
NECK: O O
cannot O O
assess O O
JVP O O
PULM: O O
clear O O
COR: O O
regular, O O
distant O O
ABD: O O
benign O O
EXT: O O
1+ O O
edema O O
b/l O O
NEURO: O O
right O O
upper/lower O O
4/5 O O
cn O O
2-12 O O
intact. O O
Light O O
touch O O
in O O
tact. O O
No O O
clonus. O O
LABS: O O
Chemistry O O
Lytes/Renal/Glucose O O
Sodium O O
134L O O
135-145 O O
mmol/L O O
05/22/93 O O
23:49 O O
134(L) O O
05/22/93 O O
23:49 O O
Potassium O O
3.6 O O
3.4-4.8 O O
mmol/L O O
05/22/93 O O
23:49 O O
4.9(H) O O
05/22/93 O O
17:58 O O
Chloride O O
95L O O
100-108 O O
mmol/L O O
05/22/93 O O
23:49 O O
95(L) O O
05/22/93 O O
23:49 O O
Carbon O O
Dioxide O O
30.3 O O
23.0-31.9 O O
mmol/L O O
05/22/93 O O
23:49 O O
36.5(H) O O
04/09/91 O O
06:47 O O
BUN O O
34H O O
8-25 O O
mg/dl O O
05/22/93 O O
23:49 O O
34(H) O O
05/22/93 O O
23:49 O O
Creatinine O O
1.7H O O
0.6-1.5 O O
mg/dl O O
05/22/93 O O
23:49 O O
1.7(H) O O
05/22/93 O O
23:49 O O
Glucose O O
424H O O
70-110 O O
mg/dl O O
05/22/93 O O
23:49 O O
424(H) O O
05/22/93 O O
23:49 O O
General O O
Chemistries O O
Calcium O O
10.0 O O
8.5-10.5 O O
mg/dl O O
05/22/93 O O
04:02 O O
8.3(L) O O
03/04/87 O O
11:42 O O
Phosphorus O O
3.2 O O
2.6-4.5 O O
mg/dl O O
05/22/93 O O
04:02 O O
2.3(L) O O
03/05/87 O O
18:18 O O
Magnesium O O
1.4 O O
1.4-2.0 O O
meq/L O O
05/22/93 O O
04:02 O O
1.3(L) O O
10/16/91 O O
06:03 O O
Uric O O
acid O O
4.2 O O
3.6-8.5 O O
mg/dl O O
03/03/87 O O
17:45 O O
Cardiac O O
Tests O O
CK O O
221 O O
60-400 O O
U/L O O
05/22/93 O O
04:02 O O
30(L) O O
04/03/91 O O
06:31 O O
CK-MB O O
NEGATIVE O O
NEG O O
05/22/93 O O
13:13 O O
CK-MB O O
Index O O
2.6 O O
0.0-3.5 O O
% O O
05/22/93 O O
04:31 O O
LDH O O
194 O O
110-210 O O
U/L O O
05/14/88 O O
16:08 O O
248(H) O O
03/03/87 O O
17:45 O O
Troponin-I O O
NEGATIVE O O
NEG O O
05/22/93 O O
13:13 O O
Troponin-T O O
0.05 O O
0.00-0.09 O O
ng/ml O O
05/23/93 O O
00:17 O O
Hematology O O
Complete O O
Blood O O
Count O O
WBC O O
8.4 O O
4.5-11.0 O O
th/cmm O O
05/22/93 O O
23:09 O O
13.6(H) O O
05/22/93 O O
03:43 O O
RBC O O
4.38L O O
4.50-5.90 O O
mil/cm O O
05/22/93 O O
23:09 O O
4.38(L) O O
05/22/93 O O
23:09 O O
Hgb O O
11.9L O O
13.5-17.5 O O
gm/dl O O
05/22/93 O O
23:09 O O
11.9(L) O O
05/22/93 O O
23:09 O O
HCT O O
35.0L O O
41.0-53.0 O O
% O O
05/22/93 O O
23:09 O O
35.0(L) O O
05/22/93 O O
23:09 O O
MCV O O
80 O O
80-100 O O
fl O O
05/22/93 O O
23:09 O O
MCH O O
27.3 O O
26.0-34.0 O O
pg/rbc O O
05/22/93 O O
23:09 O O
MCHC O O
34.1 O O
31.0-37.0 O O
g/dl O O
05/22/93 O O
23:09 O O
PLT O O
211 O O
150-350 O O
th/cumm O O
05/22/93 O O
23:09 O O
RDW O O
16.2H O O
11.5-14.5 O O
% O O
05/22/93 O O
23:09 O O
16.2(H) O O
05/22/93 O O
23:09 O O
Blood O O
Differential O O
% O O
Differential O O
... O O
RECEIVED O O
05/22/93 O O
22:58 O O
Diff O O
Method O O
Auto O O
05/22/93 O O
23:09 O O
Neutrophils O O
73H O O
40-70 O O
% O O
05/22/93 O O
23:09 O O
73(H) O O
05/22/93 O O
23:09 O O
Lymphs O O
18L O O
22-44 O O
% O O
05/22/93 O O
23:09 O O
18(L) O O
05/22/93 O O
23:09 O O
Monos O O
6 O O
4-11 O O
% O O
05/22/93 O O
23:09 O O
Eos O O
2 O O
0-8 O O
% O O
05/22/93 O O
23:09 O O
Basos O O
1 O O
0-3 O O
% O O
05/22/93 O O
23:09 O O
Blood O O
Diff O O
- O O
Absolute O O
Neutrophil O O
6.21 O O
1.8-7.7 O O
th/cmm O O
05/22/93 O O
23:09 O O
10.80(H) O O
05/22/93 O O
03:43 O O
Lymph# O O
1.48 O O
1.0-4.8 O O
th/cmm O O
05/22/93 O O
23:09 O O
Mono# O O
0.49H O O
0.2-0.4 O O
th/cmm O O
05/22/93 O O
23:09 O O
0.49(H) O O
05/22/93 O O
23:09 O O
Eos# O O
0.20 O O
0.1-0.3 O O
th/cmm O O
05/22/93 O O
23:09 O O
0.05(L) O O
04/01/91 O O
21:28 O O
Baso# O O
0.04 O O
0.0-0.3 O O
th/cmm O O
05/22/93 O O
23:09 O O
Anisocytosis O O
1+ O O
NORMAL O O
05/22/93 O O
23:09 O O
Hypochromia O O
2+ O O
NORMAL O O
05/22/93 O O
23:09 O O
Macrocytes O O
None O O
05/22/93 O O
23:09 O O
Microcytes O O
1+ O O
05/22/93 O O
23:09 O O
Coagulation O O
Routine O O
Coagulation O O
PT O O
13.4H O O
11.3-13.3 O O
sec O O
05/22/93 O O
03:56 O O
13.4(H) O O
05/22/93 O O
03:56 O O
PTT O O
22.7 O O
22.1-35.1 O O
sec O O
05/22/93 O O
03:56 O O
20.9(L) O O
03/03/87 O O
16:50 O O
Urinalysis O O
Urinalysis O O
Color O O
Yellow O O
YELLOW O O
05/22/93 O O
04:52 O O
Turbidity O O
Clear O O
CLEAR O O
05/22/93 O O
04:52 O O
GLUC O O
- O O
UA O O
NEGATIVE O O
NEG O O
05/22/93 O O
04:52 O O
Bilirubin O O
NEGATIVE O O
NEG O O
05/22/93 O O
04:52 O O
Ketones O O
NEGATIVE O O
NEG O O
05/22/93 O O
04:52 O O
Specific O O
Gravity O O
1.021 O O
1.001-1.035 O O
05/22/93 O O
04:52 O O
Blood O O
- O O
UA O O
2+ O O
NEG O O
05/22/93 O O
04:52 O O
pH O O
5.5 O O
5.0-9.0 O O
05/22/93 O O
04:52 O O
Protein O O
- O O
UA O O
3+ O O
NEG O O
05/22/93 O O
04:52 O O
Urobilinogen O O
NEGATIVE O O
NEG O O
05/22/93 O O
04:52 O O
Nitrites O O
NEGATIVE O O
NEG O O
05/22/93 O O
04:52 O O
WBC O O
Screen O O
NEGATIVE O O
NEG O O
05/22/93 O O
04:52 O O
Hyaline O O
Cast O O
0-2 O O
0-5 O O
/lpf O O
05/22/93 O O
05:16 O O
RBC O O
- O O
UA O O
3-5 O O
0-2 O O
/hpf O O
05/22/93 O O
05:16 O O
WBC O O
- O O
UA O O
0-2 O O
0-2 O O
/hpf O O
05/22/93 O O
05:16 O O
Bacteria O O
NEGATIVE O O
NEG O O
/hpf O O
05/22/93 O O
05:16 O O
Squamous O O
Cells O O
NEGATIVE O O
NEG O O
/hpf O O
05/22/93 O O
05:16 O O
Toxicology O O
Toxicology O O
Additional O O
Info O O
Ethanol O O
(Tox O O
... O O
see O O
detail O O
05/22/93 O O
04:03 O O
ATS O O
(Tox O O
Panel) O O
see O O
detail O O
05/22/93 O O
04:06 O O
Urine O O
Toxicology O O
Amphetamine(s... O O
NEGATIVE O O
05/22/93 O O
05:28 O O
Barbiturates,... O O
NEGATIVE O O
05/22/93 O O
05:28 O O
Benzodiazepin... O O
NEGATIVE O O
05/22/93 O O
05:28 O O
Cocaine, O O
urine O O
NEGATIVE O O
05/22/93 O O
05:28 O O
Opiates, O O
urin... O O
NEGATIVE O O
05/22/93 O O
05:28 O O
Phencyclidine... O O
NEGATIVE O O
05/22/93 O O
05:28 O O
THC/Cannabino... O O
NEGATIVE O O
05/22/93 O O
05:28 O O
EKG: O O
septal O O
Q O O
wave. O O
NSR. O O
CXR: O O
no O O
pulmonary O O
edema. O O
Head O O
CT: O O
1. O O
There O O
is O O
a O O
region O O
of O O
low O O
attenuation O O
in O O
the O O
left O O
occipital O O
lobe O O
which O O
may O O
represent O O
a O O
subacute O O
infarct. O O
MRI O O
of O O
the O O
brain O O
with O O
DWI O O
would O O
be O O
helpful O O
for O O
further O O
characterization. O O
2. O O
Right O O
maxillary O O
sinus O O
and O O
nondisplaced O O
right O O
orbital O O
floor O O
fractures, O O
as O O
described O O
above. O O
3. O O
Mild O O
atrophy O O
and O O
nonspecific O O
white-matter O O
change O O
likely O O
related O O
to O O
microangiopathic-small O O
vessel O O
ischemic O O
change. O O
4. O O
Old O O
left O O
thalamic O O
infarct. O O
A/P: O O
57 O O
yoM O O
w/ O O
MMP O O
presenting O O
with O O
syncope O O
and O O
facial O O
fracture. O O
Appears O O
to O O
have O O
recurrent O O
syncope O O
of O O
unclear O O
etiology. O O
Cardiac O O
etiology O O
would O O
be O O
of O O
greatest O O
concern O O
given O O
hx O O
of O O
CAD O O
and O O
chest O O
pain, O O
though O O
certainly O O
cerebrovascular O O
disease O O
is O O
present O O
given O O
CVA O O
history. O O
Plan: O O
1. O O
Neuro: O O
hx O O
of O O
CVA O O
on O O
ASA O O
-MRI/MRA O O
to O O
r/o O O
vertebrobasilar O O
disease O O
2. O O
PULM: O O
CPAP O O
at O O
night O O
for O O
OSA O O
3. O O
COR: O O
ROMI, O O
interrogate O O
pacer, O O
holter O O
monitor, O O
ASA, O B-MEDICATION
ACE, B-MEDICATION O
BB, B-MEDICATION O
Zocor O B-MEDICATION
4.ENDO: O O
RISS O O
5.RENAL: O O
gentle O O
IVF O O
for O O
elevated O O
creatinine O O
likely O O
pre-renal O O
etiology O O
6.DISPO: O O
SS O O
consult. O O
Obtain O O
MR O O
to O O
see O O
what O O
w/u O O
has O O
been O O
done O O
for O O
patient O O
at O O
SHH O O
for O O
syncope. O O
Xavier O O
Holmes O O
MD O O
82764 O O

Record O O
date: O O
2088-01-06 O O
CC: O O
f/up O O
of O O
HTN B-HYPERTENSION O
and O O
DM B-DIABETES O
management O O
HPI: O O
59 O O
yo O O
female O O
who O O
presents O O
back O O
to O O
clinic O O
with O O
her O O
daughter O O
reporting O O
that O O
she O O
needs O O
medical O O
clearance O O
for O O
eye O O
surgery O O
and O O
cardiac O O
testing O O
had O O
been O O
ordered O O
at O O
HDC O O
but O O
she O O
was O O
unable O O
to O O
go. O O
Denies O O
any O O
CP. O O
DOE O O
at O O
baseline. O O
Brings O O
in O O
her O O
machine O O
log O O
showing O O
FS's B-DIABETES O
in I-DIABETES O
AM I-DIABETES O
101-238 B-DIABETES O
with I-DIABETES O
most I-DIABETES O
values I-DIABETES O
in I-DIABETES O
100's. I-DIABETES O
FS's I-DIABETES O
in I-DIABETES O
PM I-DIABETES O
92-235. B-DIABETES O
Reports O O
no O O
symptoms O O
of O O
hyperglycemia O O
except O O
fatigue. O O
Ongoing O O
numbness O O
and O O
tingling O O
in O O
her O O
LE's. O O
11/25 B-DIABETES O
A1C B-DIABETES O
9.1, I-DIABETES O
TChol O O
232. O O
Has O O
been O O
started O O
on O O
Lipitor B-MEDICATION B-MEDICATION
10 O O
mg O O
po O O
qd O O
and O O
Vit O O
D O O
50,000 O O
1 O O
cap O O
weekly O O
by O O
Dr. O O
Yap O O
at O O
MS. O O
Glyburide B-MEDICATION B-MEDICATION
increased O O
to O O
BID. O O
Reports O O
injecting O O
insulin B-MEDICATION O
daily O O
as O O
directed. O O
No O O
prior O O
auth O O
yet O O
for O O
her O O
Cozaar B-MEDICATION O
which O O
she O O
is O O
now O O
out O O
of. O O
================ O O
Problems O O
================ O O
Menopause O O
at O O
age O O
52 O O
H/O O O
R O O
sided O O
sciatica O O
H/O O O
pneumonia O O
1/2082 O O
S/P O O
vocal O O
cord O O
cyst O O
removal O O
S/P O O
cholecystectomy O O
S/P O O
C O O
section O O
x O O
2 O O
Diabetes B-DIABETES O
since O O
'67 O O
Severe O O
nonproliferative O O
diabetic O O
retinopathy O O
with O O
severe O O
macular O O
edema O O
H/O O O
pyelonephritis O O
================ O O
Medications O O
================ O O
ATENOLOL B-MEDICATION B-MEDICATION
100 O O
MG O O
(100MG O O
TABLET O O
take O O
1 O O
) O O
PO O O
QD O O
COZAAR B-MEDICATION B-MEDICATION
(LOSARTAN) O O
100MG O O
TABLET O O
take O O
1 O O
PO O O
QD O O
DARVOCET O O
N O O
100 O O
(PROPOXYPHENE O O
NAP/ACETAMIN... O O
1 O O
TAB O O
PO O O
BID O O
PRN O O
pain O O
ECASA B-MEDICATION B-MEDICATION
(ASPIRIN O O
ENTERIC O O
COATED) O O
81MG O O
TABLET O O
EC O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
GLYBURIDE B-MEDICATION B-MEDICATION
5 O O
MG O O
(5MG O O
TABLET O O
take O O
1 O O
) O O
PO O O
BID O O
IBUPROFEN O O
600 O O
MG O O
(600MG O O
TABLET O O
take O O
1 O O
) O O
PO O O
BID O O
PRN O O
LANTUS B-MEDICATION B-MEDICATION
(INSULIN O O
GLARGINE) O O
84 O O
UNITS O O
SC O O
QAM O O
LASIX O O
(FUROSEMIDE) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1 O O
) O O
PO O O
QD O O
LIPITOR B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1 O O
) O O
PO O O
QD O O
NORTRIPTYLINE O B-MEDICATION
(NORTRIPTYLINE O O
HCL) O O
25 O O
MG O O
(25MG O O
CAPSULE O O
take O O
1 O O
) O O
PO O O
QHS O O
PAXIL O O
(PAROXETINE) O O
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
PROTONIX O O
(PANTOPRAZOLE) O O
40 O O
MG O O
PO O O
QD O O
TYLENOL O O
#2 O O
(ACETAMINOPHEN O O
W/CODEINE O O
15MG) O O
1 O O
TAB O O
PO O O
BID O O
================ O O
Allergies O O
================ O O
NKA: O O
PEx: O O
VS: O O
Wt O O
183, O O
BP B-HYPERTENSION O
145/84, I-HYPERTENSION O
P O O
64 O O
regular, O O
T O O
98.8 O O
WDWN O O
older O O
female O O
in O O
NAD. O O
HEENT: O O
anicteric O O
sclerae O O
Neck: O O
supple, O O
no O O
JVD. O O
Lungs: O O
CTA. O O
CV: O O
RRR, O O
s1s2, O O
nl, O O
II/VI O O
SEM O O
at O O
LSB O O
Abd: O O
soft, O O
NT O O
Ext: O O
no O O
c/c/1+ O O
bil O O
edema. O O
No O O
foot O O
ulcerations. O O
EKG: O O
NSR O O
at O O
63, O O
0.16/0.12/0.47, O O
+RBBB O O
A/P: O O
1. O O
HTN. O O
Mildly O O
elevated O O
in O O
setting O O
of O O
not O O
having O O
Cozaar. O B-MEDICATION
Prior O O
auth O O
requested, O O
will B-MEDICATION O
use I-MEDICATION O
Norvasc B-MEDICATION B-MEDICATION
2.5 O O
mg O O
po O O
qd O O
in O O
addition O O
to O O
Lasix O O
and O O
Atenolol B-MEDICATION B-MEDICATION
until O O
Cozaar O B-MEDICATION
approved, O O
samples O O
given O O
to O O
patient. O O
Dietary O O
and O O
exercise O O
rec's O O
reviewed. O O
2. O O
DM, B-DIABETES O
stable, O O
Glyburide O B-MEDICATION
increased O O
at O O
MS. O O
Dietary O O
rec's O O
reviewed. O O
3. O O
r/o O O
CAD, O O
patient O O
unable O O
to O O
run O O
given O O
chronic O O
joint O O
pains O O
and O O
diabetic O O
neuropathy, O O
will O O
schedule O O
for O O
pharmacologic O O
stress O O
MIBI O O
for O O
presurgical O O
cardiac O O
clearance. O O
Will O O
follow. O O
f/up O O
appt O O
given. O O
4. O O
Diabetic O O
neuropathy, O O
worsening, O O
f/up O O
at O O
Montefiore O O
Springs. O O
Singh, O O
M.D. O O

Record O O
date: O O
2089-12-07 O O
ENT O O
72 O O
Chablis O O
Court O O
UPSHUR, O O
IRENE O O
Argentine, O O
NV O O
57431 O O
78197017 O O
-------- O O
12/07/2089 O O
Steven O O
Short, O O
M.D. O O
Evans O O
Memorial O O
Hospital O O
745 O O
Morgan O O
Street O O
Sag O O
Harbor, O O
NV O O
62945 O O
Dear O O
Dr. O O
Short: O O
I O O
did O O
see O O
Irene O O
Upshur O O
for O O
a O O
followup O O
today. O O
As O O
you O O
know, O O
I O O
did O O
see O O
her O O
back O O
in O O
September O O
where O O
she O O
was O O
diagnosed O O
with O O
possible O O
right-sided O O
eustachian O O
tube O O
dysfunction. O O
Her O O
blood O O
sugars O O
have O O
been O O
under O O
reasonably O O
good O O
control, O O
88 O O
and O O
then O O
300. B-DIABETES O
She O O
reports O O
that O O
her O O
hearing O O
has O O
continued O O
to O O
fluctuate. O O
When O O
questioned, O O
she O O
reports O O
that O O
she O O
only O O
used O O
the O O
nose O O
spray O O
twice O O
since O O
I O O
did O O
prescribe O O
it. O O
On O O
examination O O
today, O O
she O O
otherwise O O
appears O O
well. O O
Ears O O
are O O
unremarkable. O O
Her O O
eardrums O O
are O O
intact. O O
She O O
has O O
no O O
tympanosclerosis O O
or O O
cholesteatoma. O O
Her O O
gait O O
is O O
normal. O O
There O O
is O O
no O O
nystagmus. O O
An O O
audiogram O O
done O O
today O O
does O O
show O O
a O O
sloping O O
high O O
frequency O O
sensorineural O O
hearing O O
loss, O O
which O O
is O O
symmetric. O O
Her O O
discrimination O O
scores O O
are O O
100% O O
in O O
the O O
right O O
ear O O
and O O
100% O O
in O O
the O O
left O O
ear. O O
Assessment: O O
Mild O O
ear O O
fullness O O
with O O
dysequilibrium O O
and O O
blockage. O O
Plan: O O
She O O
does O O
take O O
multiple O O
medications. O O
It O O
continues O O
to O O
be O O
very O O
unclear O O
to O O
me O O
what O O
her O O
underlying O O
causality O O
is. O O
I O O
would O O
like O O
her O O
to O O
use O O
the O O
nasal O O
spray O O
more O O
consistently. O O
If O O
she O O
does O O
fail O O
this O O
and O O
this O O
is O O
not O O
eustachian O O
tube O O
dysfunction, O O
I O O
would O O
consider O O
her O O
to O O
have O O
endolymphatic O O
hydrops. O O
This O O
would O O
respond O O
hopefully O O
to O O
a O O
diuretic O O
and O O
potassium O O
supplementation. O O
However, O O
she O O
has O O
taken O O
multiple O O
medications O O
currently O O
for O O
both O O
blood O O
pressure O O
including O O
atenolol, B-MEDICATION B-MEDICATION
Cozaar, B-MEDICATION B-MEDICATION
Lasix, O O
and O O
verapamil. B-MEDICATION B-MEDICATION
I O O
would O O
need O O
to O O
clear O O
to O O
switch O O
herself O O
??____?? O O
therapy, O O
I O O
would O O
like O O
to O O
see O O
her O O
back O O
after O O
consistent O O
trial O O
of O O
the O O
corticosteroid O O
spray O O
topically. O O
Sincerely, O O
______________________________ O O
Edward O O
T O O
Sheehan, O O
M.D. O O
eScription O O
document:2-3083608 O O
CSSten O O
Tel O O
DD: O O
01/21/90 O O
DT: O O
01/21/90 O O
DV: O O
12/07/89 O O

Record O O
date: O O
2090-01-03 O O
CC: O O
f/up O O
of O O
HTN B-HYPERTENSION O
&amp; O O
DM B-DIABETES O
management O O
HPI: O O
61 O O
yo O O
female O O
who O O
presents O O
back O O
to O O
clinic O O
having O O
an O O
upcoming O O
eye O O
appt O O
again O O
at O O
Harmon O O
Doctors O O
Clinic O O
1/12/90. O O
Most B-DIABETES O
recent I-DIABETES O
A1C I-DIABETES O
8.5 I-DIABETES O
6/15/89, I-DIABETES O
being O O
followed O O
at O O
MS. O O
Denies O O
any O O
symptoms O O
of O O
hyperglycemia O O
or O O
hypoglycemia. O O
Denies O O
any O O
CP, O O
increased O O
SOB O O
beyond O O
her O O
baseline, O O
or O O
headaches. O O
Has O O
had O O
intermittent O O
exacerbations O O
of O O
her O O
chronic O O
back, O O
shoulder, O O
and O O
knees O O
pains. O O
Problems O O
Menopause O O
at O O
age O O
52 O O
H/O O O
R O O
sided O O
sciatica O O
H/O O O
pneumonia O O
1/2082 O O
S/P O O
vocal O O
cord O O
cyst O O
removal O O
S/P O O
cholecystectomy O O
S/P O O
C O O
section O O
x O O
2 O O
Diabetes B-DIABETES O
since I-DIABETES O
'67 I-DIABETES O
Severe O O
nonproliferative O O
diabetic O O
retinopathy O O
with O O
severe O O
macular O O
edema O O
H/O O O
pyelonephritis O O
1/16/88 O O
cardiac O O
MIBI O O
with O O
summed O O
stress O O
score O O
of O O
0 O O
but O O
evidence O O
of O O
extensive O O
calcified O O
coronary O O
plaque O O
burden O O
with O O
coronary O O
calcium O O
score O O
of O O
715 O O
Hypertension B-HYPERTENSION O
Depression O O
7/23/88 O O
R O O
shoulder O O
arthroscopy O O
4/20/89 O O
lumbar O O
CT O O
: O O
No O O
stenosis O O
or O O
disc O O
herniation, O O
mild O O
deg O O
changes O O
of O O
the O O
lower O O
lumbar O O
spine O O
as O O
described O O
with O O
a O O
possible O O
tiny O O
lateral O O
disc O O
protrusion O O
on O O
the O O
L O O
at O O
L3-L4. O O
Medications O O
Atenolol B-MEDICATION B-MEDICATION
100 O O
MG O O
(100MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Cozaar B-MEDICATION B-MEDICATION
(LOSARTAN) O O
100MG O O
TABLET O O
take O O
1 O O
PO O O
QD O O
Darvocet O O
N O O
100 O O
(PROPOXYPHENE O O
NAP/ACETAMIN... O O
1 O O
TAB O O
PO O O
BID O O
PRN O O
pain O O
Ecasa B-MEDICATION B-MEDICATION
(ASPIRIN O O
ENTERIC O O
COATED) O O
81MG O O
TABLET O O
EC O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Glucophage B-MEDICATION B-MEDICATION
(METFORMIN) B-MEDICATION O
1000MG O O
TABLET O O
PO O O
BID O O
Lantus B-MEDICATION B-MEDICATION
(INSULIN O O
GLARGINE) O O
84 O O
UNITS O O
SC O O
QAM O O
Lasix O O
(FUROSEMIDE) O O
60 O O
MG O O
(20MG O O
TABLET O O
take O O
3) O O
PO O O
QD O O
, O O
3 O O
tablets O O
daily O O
- O O
3 O O
tabletas O O
diarias O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Neurontin O O
(GABAPENTIN) O O
400 O O
MG O O
(400MG O O
CAPSULE O O
take O O
1) O O
PO O O
QHS O O
Paxil O O
(PAROXETINE) O O
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Prilosec O O
OTC O O
(OMEPRAZOLE O O
OTC) O O
20 O O
MG O O
(20MG O O
TABLET O O
DR O O
take O O
1) O O
PO O O
QD O O
Verapamil B-MEDICATION B-MEDICATION
SUSTAINED O O
RELEASE O O
120 O O
MG O O
(120MG O O
TABLET O O
SA O O
take O O
1) O O
PO O O
QD O O
Allergies O O
NKA O O
PEx: O O
VS: O O
Wt O O
196, O O
BP O O
130/71, O O
p O O
62 O O
WDWN O O
older O O
female O O
in O O
NAD. O O
HEENT: O O
anicteric O O
sclerae O O
Neck: O O
supple, O O
no O O
JVD. O O
Lungs: O O
CTA. O O
CV: O O
RRR, O O
s1s2, O O
nl, O O
II/VI O O
SEM O O
at O O
LSB O O
Abd: O O
soft, O O
NT O O
Ext: O O
no O O
c/c/bil O O
trace O O
edema. O O
No O O
foot O O
ulcerations. O O
A/P: O O
1. O O
HTN. O O
Stable, O O
no O O
change O O
in O O
regimen. O O
Dietary O O
and O O
exercise O O
rec's O O
reviewed. O O
2. O O
DM. B-DIABETES O
A1C B-DIABETES O
today I-DIABETES O
7.9 I-DIABETES O
(improved O O
from O O
8.5 O O
in O O
6/2089), O O
No O O
change O O
in O O
regimen, O O
being O O
followed O O
at O O
MS. O O
Dietary O O
and O O
exercise O O
rec's O O
reviewed. O O
Home O O
FS O O
monitoring O O
as O O
directed. O O
3. O O
Scheduled O O
for O O
f/up O O
of O O
diabetic O O
retinopathy O O
1/12/90 O O
at O O
HDC. O O
Singh, O O
M.D. O O

Record O O
date: O O
2090-11-21 O O
CC: O O
recent O O
hospitalization O O
and O O
f/up O O
of O O
DM B-DIABETES O
and O O
HTN B-HYPERTENSION O
management O O
HPI: O O
62 O O
yo O O
female O O
who O O
presents O O
back O O
to O O
clinic O O
after O O
recent O O
hospitalization O O
11/13-11/16 O O
with O O
atypical O O
chest O O
pain. O O
She O O
underwent O O
evaluation O O
with O O
MR B-CAD O
stress I-CAD O
test I-CAD O
which I-CAD O
revealed I-CAD O
inferior I-CAD O
ischemia. I-CAD O
Underwent B-CAD O
cath I-CAD O
and I-CAD O
RCA B-CAD B-CAD
stent I-CAD O
placement. I-CAD O
Since O O
then, O O
pt O O
reports O O
some O O
mild O O
SOB O O
and O O
CP O O
only O O
once O O
shortly O O
1 O O
day O O
after O O
discharge. O O
No O O
headaches. O O
Denies O O
any O O
symptoms O O
of O O
hyperglycemia O O
or O O
hypoglycemia. O O
Problems O O
Menopause O O
at O O
age O O
52 O O
H/O O O
R O O
sided O O
sciatica O O
H/O O O
pneumonia O O
1/2082 O O
S/P O O
vocal O O
cord O O
cyst O O
removal O O
S/P O O
cholecystectomy O O
S/P O O
C O O
section O O
x O O
2 O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type O O
2 O O
: O O
onset O O
2067 O O
Severe O O
nonproliferative O O
diabetic O O
retinopathy O O
with O O
severe O O
macular O O
edema O O
H/O O O
pyelonephritis O O
1/16/88 O O
cardiac O O
MIBI O O
with O O
summed O O
stress O O
score O O
of O O
0 O O
but O O
evidence O O
of O O
extensive O O
calcified O O
coronary O O
plaque O O
burden O O
with O O
coronary O O
calcium O O
score O O
of O O
715 O O
Hypertension B-HYPERTENSION B-HYPERTENSION
Depression O O
7/23/88 O O
R O O
shoulder O O
arthroscopy O O
4/20/89 O O
lumbar O O
CT O O
: O O
No O O
stenosis O O
or O O
disc O O
herniation, O O
mild O O
deg O O
changes O O
of O O
the O O
lower O O
lumbar O O
spine O O
as O O
described O O
with O O
a O O
possible O O
tiny O O
lateral O O
disc O O
protrusion O O
on O O
the O O
L O O
at O O
L3-L4. O O
CAD O O
s/p O O
RCA O O
stent O O
placement O O
11/2090 O O
Medications O O
Amitriptyline O O
HCL O O
25 O O
MG O O
(25MG O O
TABLET O O
Take O O
1) O O
PO O O
QHS O O
PRN O O
neuropathic O O
pain O O
, O O
for O O
pain O O
- O O
para O O
el O O
dolor O O
#30 O O
Tablet(s) O O
Cozaar B-MEDICATION B-MEDICATION
(LOSARTAN) O O
100MG O O
TABLET O O
Take O O
1 O O
PO O O
QD O O
#30 O O
Tablet(s) O O
Darvocet O O
N O O
100 O O
(PROPOXYPHENE O O
NAP/ACETAMIN... O O
1 O O
TAB O O
PO O O
BID O O
PRN O O
pain O O
- O O
dolor O O
#60 O O
Tablet(s) O O
Ecasa B-MEDICATION B-MEDICATION
(ASPIRIN O O
ENTERIC O O
COATED) O O
325 O O
MG O O
(325MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#30 O O
Tablet(s) O O
Ergocalciferol O O
50000 O O
UNITS O O
(50000 O O
UNIT O O
CAPSULE O O
Take O O
1) O O
PO O O
QWEEK O O
#1 O O
Month(s) O O
Supply O O
Lantus B-MEDICATION B-MEDICATION
(INSULIN O O
GLARGINE) O O
88 O O
UNITS O O
SC O O
QAM O O
#1 O O
Month(s) O O
Supply O O
Lasix O O
(FUROSEMIDE) O O
20 O O
MG O O
(20MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#1 O O
Month(s) O O
Supply O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
80 O O
MG O O
(80MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#30 O O
Tablet(s) O O
Lisinopril B-MEDICATION B-MEDICATION
5 O O
MG O O
(5MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
x O O
30 O O
days O O
#30 O O
Tablet(s) O O
Neurontin O O
(GABAPENTIN) O O
300 O O
MG O O
(300MG O O
CAPSULE O O
Take O O
1) O O
PO O O
BID O O
#60 O O
Tablet(s) O O
Niaspan B-MEDICATION B-MEDICATION
(NICOTINIC O O
ACID O O
SUSTAINED O O
RELEASE) O O
1000 O O
MG O O
(1000MG O O
TABLET O O
SA O O
Take O O
1) O O
PO O O
QHS O O
#90 O O
Tablet(s) O O
Nifedipine B-MEDICATION B-MEDICATION
(EXTENDED O O
RELEASE) O O
60 O O
MG O O
(60MG O O
TABLET O O
Take O O
1) O O
PO O O
QPM O O
x O O
30 O O
days O O
#30 O O
Tablet(s) O O
Paxil O O
(PAROXETINE) O O
20MG O O
TABLET O O
Take O O
1 O O
Tablet(s) O O
PO O O
QD O O
#30 O O
Tablet(s) O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#30 O O
Tablet(s) O O
Prilosec O O
(OMEPRAZOLE) O O
20 O O
MG O O
(20MG O O
CAPSULE O O
DR O O
Take O O
1) O O
PO O O
QD O O
, O O
before O O
eating O O
#30 O O
Capsule(s) O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
(METOPROLOL O O
SUCCINATE O O
EXTENDED O O
RELEASE) O O
200 O O
MG O O
(200MG O O
TAB.SR O O
24H O O
Take O O
1) O O
PO O O
QD O O
#30 O O
TAB.SR O O
Allergies O O
NKA O O
PEx: O O
Vital O O
Signs: O O
BP O O
117/56, O O
P O O
67, O O
Wt O O
184.6 O O
lbs O O
WDWN O O
older O O
female O O
in O O
NAD. O O
HEENT: O O
anicteric O O
sclerae O O
Neck: O O
supple, O O
no O O
JVD. O O
Lungs: O O
CTA. O O
CV: O O
RRR, O O
s1s2, O O
nl, O O
II/VI O O
SEM O O
at O O
LSB O O
Abd: O O
soft, O O
NT O O
Ext: O O
no O O
c/c/bil O O
1+ O O
edema. O O
A/P: O O
1. O O
HTN/CHF. O O
BP O O
improved O O
with O O
newer O O
medical O O
regimen O O
since O O
discharge, O O
scheduled O O
for O O
Cards O O
f/up O O
12/91, O O
now O O
on O O
Plavix. O B-MEDICATION
Dietary O O
and O O
exercise O O
rec's O O
reviewed. O O
Counseling O O
given O O
regarding O O
recent B-CAD O
RCA I-CAD O
stent I-CAD O
placement. I-CAD O
2. O O
DM, O O
stable, O O
recent B-DIABETES O
A1C B-DIABETES O
9.1 I-DIABETES O
on I-DIABETES O
11/14/90, I-DIABETES O
increased O O
Lantus O B-MEDICATION
to O O
88 O O
units O O
as O O
directed O O
and O O
dietary O O
rec's O O
reviewed. O O
Following. O O
3. O O
Scheduled O O
for O O
renal O O
evaluation O O
12/14/90. O O
Singh, O O
M.D. O O

Record O O
date: O O
2091-03-13 O O
CC: O O
f/up O O
of O O
DM, B-DIABETES O
HTN, B-HYPERTENSION O
and O O
anemia O O
management O O
HPI: O O
62 O O
yo O O
female O O
who O O
presents O O
back O O
to O O
clinic O O
after O O
recent O O
visit O O
with O O
Dr. O O
Robbie-Reid O O
and O O
referred O O
for O O
GI O O
endoscopy O O
for O O
anemia. O O
3/5 O O
Hct O O
32.1, O O
Hgb O O
10.6. O O
Dry O O
wt O O
reportedly O O
184-186 O O
lbs. O O
1/11 O O
Echo O O
with O O
no O O
RWMA's, O O
LV O O
nl, O O
EF O O
60-65%. O O
Denies O O
any O O
SOB O O
or O O
DOE O O
beyond O O
her O O
baseline. O O
No O O
CP. O O
Seen O O
by O O
Renal O O
and O O
started O O
on O O
Tekturna O O
(Aliskiren) O O
which O O
she O O
has O O
but O O
has O O
not O O
started. O O
Ran O O
out O O
of O O
Cozaar B-MEDICATION B-MEDICATION
which O O
she O O
has O O
not O O
had O O
approved. O O
Off O O
Aldomet O O
also. O O
No O O
headaches. O O
Denies O O
any O O
symptoms O O
of O O
hyperglycemia O O
or O O
hypoglycemia. O O
Mood O O
decreased O O
at O O
times O O
given O O
her O O
family O O
problems O O
with O O
her O O
husband. O O
Problems O O
Menopause O O
at O O
age O O
52 O O
H/O O O
R O O
sided O O
sciatica O O
H/O O O
pneumonia O O
1/2082 O O
S/P O O
vocal O O
cord O O
cyst O O
removal O O
S/P O O
cholecystectomy O O
S/P O O
C O O
section O O
x O O
2 O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type O O
2 O O
: O O
onset O O
2067 O O
Severe O O
nonproliferative O O
diabetic O O
retinopathy O O
with O O
severe O O
macular O O
edema O O
H/O O O
pyelonephritis O O
1/16/88 O O
cardiac O O
MIBI O O
with O O
summed O O
stress O O
score O O
of O O
0 O O
but O O
evidence O O
of O O
extensive O O
calcified O O
coronary O O
plaque O O
burden O O
with O O
coronary O O
calcium O O
score O O
of O O
715 O O
Hypertension B-HYPERTENSION O
Depression O O
7/23/88 O O
R O O
shoulder O O
arthroscopy O O
4/20/89 O O
lumbar O O
CT O O
: O O
No O O
stenosis O O
or O O
disc O O
herniation, O O
mild O O
deg O O
changes O O
of O O
the O O
lower O O
lumbar O O
spine O O
as O O
described O O
with O O
a O O
possible O O
tiny O O
lateral O O
disc O O
protrusion O O
on O O
the O O
L O O
at O O
L3-L4. O O
CAD B-CAD O
s/p B-CAD O
RCA B-CAD B-CAD
stent I-CAD O
placement I-CAD O
11/2090 I-CAD O
Medications O O
Aliskiren O O
150 O O
MG O O
PO O O
QD O O
Amitriptyline O O
HCL O O
25 O O
MG O O
(25MG O O
TABLET O O
Take O O
1) O O
PO O O
QHS O O
PRN O O
neuropathic O O
pain O O
, O O
for O O
pain O O
- O O
para O O
el O O
dolor O O
#30 O O
Tablet(s) O O
Cozaar O B-MEDICATION
(LOSARTAN) O O
100MG O O
TABLET O O
Take O O
1 O O
PO O O
QD O O
#30 O O
Tablet(s), O O
ran O O
out O O
Darvocet O O
N O O
100 O O
(PROPOXYPHENE O O
NAP/ACETAMIN... O O
1 O O
TAB O O
PO O O
BID O O
PRN O O
pain O O
- O O
dolor O O
#60 O O
Tablet(s) O O
Ecasa B-MEDICATION B-MEDICATION
(ASPIRIN O O
ENTERIC O O
COATED) O O
325 O O
MG O O
(325MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#30 O O
Tablet(s) O O
Ergocalciferol O O
50000 O O
UNITS O O
(50000 O O
UNIT O O
CAPSULE O O
Take O O
1) O O
PO O O
QWEEK O O
#1 O O
Month(s) O O
Supply O O
Lantus B-MEDICATION B-MEDICATION
(INSULIN O O
GLARGINE) O B-MEDICATION
88 O O
UNITS O O
SC O O
QAM O O
#1 O O
Month(s) O O
Supply O O
Lasix O O
(FUROSEMIDE) O O
80 O O
MG O O
(40MG O O
TABLET O O
Take O O
2) O O
PO O O
QD O O
#1 O O
Month(s) O O
Supply O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
80 O O
MG O O
(80MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#30 O O
Tablet(s) O O
Neurontin O O
(GABAPENTIN) O O
300 O O
MG O O
(300MG O O
CAPSULE O O
Take O O
1) O O
PO O O
BID O O
#60 O O
Tablet(s) O O
Niaspan B-MEDICATION B-MEDICATION
(NICOTINIC O O
ACID O O
SUSTAINED O O
RELEASE) O O
1000 O O
MG O O
(1000MG O O
TABLET O O
SA O O
Take O O
1) O O
PO O O
QHS O O
#90 O O
Tablet(s) O O
Nifedipine B-MEDICATION B-MEDICATION
(EXTENDED O O
RELEASE) O O
90 O O
MG O O
(90MG O O
TABLET O O
Take O O
1) O O
PO O O
QPM O O
x O O
30 O O
days O O
#30 O O
Tablet(s) O O
Paxil O O
(PAROXETINE) O O
20MG O O
TABLET O O
Take O O
1 O O
Tablet(s) O O
PO O O
QD O O
#30 O O
Tablet(s) O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#30 O O
Tablet(s) O O
Prilosec O O
(OMEPRAZOLE) O O
20 O O
MG O O
(20MG O O
CAPSULE O O
DR O O
Take O O
1) O O
PO O O
QD O O
, O O
before O O
eating O O
#30 O O
Capsule(s) O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
(METOPROLOL O O
SUCCINATE O O
EXTENDED O O
RELEASE) O O
200 O O
MG O O
(200MG O O
TAB.SR O O
24H O O
Take O O
1) O O
PO O O
QD O O
#30 O O
TAB.SR O O
Allergies O O
NKA O O
PEx: O O
Vital O O
Signs: O O
BP B-HYPERTENSION O
144/61, I-HYPERTENSION O
P O O
66, O O
Wt O O
193 O O
lbs O O
WDWN O O
older O O
female O O
in O O
NAD. O O
HEENT: O O
anicteric O O
sclerae O O
Neck: O O
supple, O O
no O O
JVD. O O
Lungs: O O
CTA. O O
CV: O O
RRR, O O
s1s2, O O
nl, O O
II/VI O O
SEM O O
at O O
LSB O O
Abd: O O
soft, O O
NT O O
Ext: O O
no O O
c/c/bil O O
1+ O O
edema. O O
A/P: O O
1. O O
HTN/CHF. O O
BP O O
elevated O O
in O O
setting O O
of O O
not O O
having O O
started O O
her O O
new O O
medication O O
Aliskiren, O O
ongoing O O
f/up O O
as O O
scheduled. O O
Ongoing O O
telemonitoring O O
service. O O
Dietary O O
and O O
exercise O O
rec's O O
reviewed. O O
2. O O
DM, O O
still O O
not O O
controlled O O
but O O
stable, O O
A1C B-DIABETES O
8.8, I-DIABETES O
Lantus O B-MEDICATION
88 O O
units O O
as O O
directed O O
and O O
dietary O O
rec's O O
reviewed, O O
follow, O O
seen O O
by O O
HDC O O
ophthalomology O O
on O O
1/19/91. O O
3. O O
Anemia, O O
scheduled O O
for O O
GI O O
endoscopy, O O
following. O O
4. O O
Depression, O O
stable, O O
counseling O O
given. O O
Singh, O O
M.D. O O

Record O O
date: O O
2095-05-05 O O
May O O
03, O O
2095 O O
Carlos O O
Pacheco, O O
M.D. O O
New O O
Milford O O
Hospital O O
Department O O
of O O
Medicine O O
RE: O O
Emery, O O
Donn O O
NMH#: O O
059-57-26 O O
Dear O O
Dr. O O
Pacheco: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
your O O
patient, O O
Donn O O
Emery, O O
in O O
the O O
Internal O O
Medicine O O
recently. O O
Thank O O
you O O
for O O
your O O
kind O O
referral. O O
I O O
will O O
summarize O O
his O O
history O O
and O O
physical O O
examination O O
for O O
my O O
own O O
records. O O
Mr. O O
Emery O O
is O O
a O O
86-year-old O O
right-handed O O
gentleman O O
who O O
is O O
referred O O
with O O
complaint O O
and O O
electrophysiologic O O
findings O O
consistent O O
with O O
a O O
generalized O O
sensory O O
motor O O
polyneuropathy. O O
His O O
symptoms O O
began O O
a O O
number O O
of O O
years O O
ago O O
when O O
he O O
noticed O O
bilateral O O
loss O O
of O O
sensation O O
at O O
the O O
tips O O
of O O
his O O
fingers O O
in O O
the O O
hands. O O
This O O
had O O
extended O O
over O O
several O O
months O O
to O O
include O O
his O O
feet O O
as O O
well. O O
Over O O
many O O
months O O
to O O
years O O
he O O
has O O
noticed O O
a O O
weakness O O
of O O
his O O
grip O O
bilaterally, O O
which O O
over O O
the O O
more O O
recent O O
period O O
of O O
time O O
encompassing O O
the O O
last O O
year O O
has O O
been O O
worse O O
on O O
the O O
left. O O
At O O
one O O
time O O
that O O
grip O O
weakness O O
was O O
ascribed O O
to O O
possible O O
carpal O O
tunnel O O
syndrome O O
and O O
he O O
underwent O O
a O O
right O O
carpal O O
tunnel O O
release O O
on O O
the O O
right O O
approximately O O
four O O
years O O
ago. O O
Three O O
weeks O O
ago O O
he O O
underwent O O
a O O
left O O
carpal O O
tunnel O O
release O O
for O O
these O O
same O O
symptoms. O O
He O O
has O O
had O O
no O O
falls, O O
but O O
does O O
note O O
some O O
unsteadiness O O
on O O
his O O
feet. O O
He O O
has O O
had O O
no O O
sensations O O
of O O
tingling O O
or O O
loss O O
of O O
sensory O O
stimulus O O
around O O
his O O
face. O O
He O O
has O O
had O O
no O O
diplopia, O O
dysarthria, O O
dysphagia, O O
or O O
bowel O O
or O O
bladder O O
complaints O O
that O O
might O O
be O O
related O O
to O O
neurologic O O
problems. O O
He O O
has O O
occasional O O
shortness O O
of O O
breath O O
on O O
exertion. O O
Otherwise, O O
the O O
remainder O O
of O O
his O O
medical O O
and O O
neurologic O O
review O O
of O O
systems O O
is O O
unremarkable. O O
Past O O
medical O O
history O O
is O O
significant O O
for O O
a O O
past O O
episode O O
of O O
urethral O O
stones, O O
history O O
of O O
lymphoma O O
of O O
unclear O O
type O O
by O O
the O O
medical O O
record O O
but O O
would O O
appear O O
to O O
be O O
non-Hodgkins. O O
He O O
is O O
undergoing O O
extensive O O
surveillance O O
on O O
a O O
yearly O O
basis O O
for O O
recurrence. O O
He O O
has O O
a O O
history O O
of O O
prostate O O
hypertrophy, O O
hypertension, B-HYPERTENSION B-HYPERTENSION
and O O
longstanding O O
history O O
of O O
noninsulin-dependent B-DIABETES O
diabetes B-DIABETES O
since O O
the O O
age O O
of O O
50. O O
His O O
glucose O O
control O O
by O O
his O O
history O O
has O O
been O O
very O O
good. O O
He O O
has O O
lumbar O O
back O O
pain, O O
a O O
history O O
of O O
a O O
heart O O
murmur. O O
Current O O
medications O O
include O O
aspirin, B-MEDICATION B-MEDICATION
Cozaar, B-MEDICATION B-MEDICATION
clopamide, O O
Triamterene, O O
Tenormin, B-MEDICATION O
and O O
Glucophage. B-MEDICATION B-MEDICATION
He O O
has O O
no O O
known O O
drug O O
allergies. O O
He O O
does B-SMOKER O
not I-SMOKER O
smoke, I-SMOKER O
uses O O
alcohol O O
socially, O O
lives O O
in O O
Juneau O O
South, O O
has O O
no O O
obvious O O
toxin O O
exposure O O
to O O
heavy O O
metals. O O
His O O
family O O
history O O
is O O
negative O O
for O O
obvious O O
neuromuscular O O
disease. O O
He O O
had O O
a O O
brother O O
who O O
died O O
in O O
his O O
50s O O
of O O
some O O
sort O O
of O O
brain O O
infection. O O
He O O
has O O
several O O
children, O O
all O O
in O O
good O O
health. O O
On O O
my O O
examination O O
today, O O
he O O
is O O
alert O O
and O O
well O O
appearing, O O
with O O
good O O
concentration, O O
memory, O O
and O O
language O O
function. O O
No O O
carotid O O
bruits O O
could O O
be O O
appreciated. O O
The O O
peripheral O O
vascular O O
examination O O
revealed O O
weak O O
pulses O O
in O O
all O O
four O O
limbs. O O
He O O
had O O
full O O
extraocular O O
motility, O O
with O O
normal O O
visual O O
fields O O
bilaterally. O O
Funduscopy O O
was O O
normal O O
bilaterally. O O
Pupillary O O
reflexes O O
were O O
intact O O
to O O
both O O
light O O
and O O
near O O
stimulation. O O
The O O
muscles O O
of O O
facial O O
expression, O O
mastication, O O
and O O
the O O
lower O O
bulbar O O
musculature O O
were O O
intact O O
bilaterally. O O
Facial O O
sensation O O
was O O
intact O O
bilaterally O O
to O O
light O O
touch. O O
On O O
motor O O
examination, O O
occasional O O
fasciculations O O
were O O
seen O O
throughout. O O
There O O
was O O
clear O O
wasting O O
of O O
the O O
intrinsic O O
muscles O O
of O O
the O O
hands O O
bilaterally, O O
and O O
trace O O
weakness O O
at O O
IV+/V O O
by O O
MRC O O
criteria O O
in O O
a O O
symmetric O O
distribution O O
of O O
the O O
hands O O
bilaterally. O O
Otherwise, O O
muscles O O
of O O
the O O
proximal O O
shoulder O O
girdle, O O
forearm, O O
and O O
upper O O
arm O O
were O O
V/V O O
bilaterally. O O
In O O
the O O
lower O O
extremities, O O
again, O O
distal O O
muscle O O
wasting O O
was O O
noted, O O
although O O
power O O
in O O
all O O
muscle O O
groups O O
was O O
full. O O
Sensation O O
testing O O
revealed O O
a O O
moderate-to-severe O O
deficit O O
in O O
vibratory O O
and O O
joint O O
position O O
sense O O
distally O O
in O O
the O O
lower O O
extremities. O O
Temperature, O O
pinprick O O
and O O
light O O
touch O O
sensation O O
appeared O O
to O O
be O O
intact. O O
There O O
was O O
no O O
dysmetria O O
on O O
finger-nose-finger O O
testing, O O
and O O
gait O O
was O O
not O O
ataxic. O O
Romberg O O
was O O
slightly O O
positive O O
with O O
sway O O
but O O
no O O
fall. O O
Deep O O
tendon O O
reflexes O O
were O O
hyporeflexic O O
throughout. O O
Specifically O O
I+ O O
reflexes O O
were O O
elicited O O
in O O
the O O
patellar O O
tendons O O
in O O
a O O
symmetric O O
distribution, O O
trace O O
ankle O O
jerks O O
were O O
elicited, O O
and O O
I+ O O
reflexes O O
were O O
elicited O O
in O O
the O O
biceps, O O
triceps, O O
and O O
brachioradialis. O O
There O O
was O O
no O O
jaw O O
jerk. O O
Toes O O
were O O
downgoing O O
bilaterally. O O
Mr. O O
Emery O O
has O O
already O O
undergone O O
EMG O O
nerve O O
conduction O O
study O O
recently O O
at O O
this O O
institution. O O
Those O O
results O O
were O O
available O O
for O O
me O O
today. O O
They O O
are O O
consistent O O
with O O
a O O
generalized O O
axonal O O
sensory O O
motor O O
polyneuropathy, O O
which O O
is O O
moderate O O
in O O
distal O O
extremities. O O
Both O O
active O O
and O O
chronic O O
denervation O O
changes O O
are O O
seen O O
on O O
the O O
EMG. O O
There O O
is O O
no O O
evidence O O
for O O
demyelinating O O
phenotype, O O
and O O
nerve O O
conduction O O
does O O
reveal O O
a O O
conduction O O
block O O
at O O
common O O
sites O O
of O O
compression O O
of O O
the O O
median O O
nerve O O
in O O
the O O
wrist, O O
consistent O O
with O O
carpal O O
tunnel O O
syndrome. O O
Given O O
the O O
apparent O O
chronic O O
nature O O
of O O
Mr. O O
Emery's O O
complaints, O O
an O O
axonal O O
sensory O O
motor O O
neuropathy O O
most O O
likely O O
idiopathic O O
in O O
origin, O O
or O O
more O O
probably O O
related O O
to O O
the O O
diabetes O O
is O O
the O O
likely O O
diagnosis. O O
With O O
respect O O
to O O
the O O
weakness O O
in O O
the O O
hands, O O
which O O
appears O O
to O O
encompass O O
more O O
muscle O O
groups O O
than O O
would O O
be O O
accounted O O
for O O
by O O
a O O
median O O
nerve O O
compression O O
at O O
the O O
wrist, O O
this O O
is O O
likely O O
the O O
consequence O O
of O O
this O O
longstanding O O
axonal O O
degeneration. O O
There O O
is O O
no O O
abnormality O O
on O O
the O O
history, O O
examination, O O
or O O
current O O
electrophysiology O O
that O O
would O O
lead O O
me O O
to O O
suspect O O
this O O
is O O
anything O O
more O O
unusual. O O
In O O
addition O O
to O O
the O O
diabetes, O O
of O O
course O O
the O O
primary O O
concern O O
would O O
be O O
lymphoma-related O O
neuropathy, O O
either O O
related O O
to O O
direct O O
lymphomatous O O
invasion O O
of O O
the O O
perineurium, O O
or O O
more O O
often O O
as O O
a O O
perineoplastic O O
phenomenon. O O
The O O
very O O
chronic O O
nature O O
of O O
his O O
symptoms O O
would O O
argue O O
against O O
this O O
as O O
a O O
likely O O
etiology, O O
and O O
he O O
is, O O
of O O
course, O O
undergoing O O
extensive O O
surveillance O O
for O O
such O O
a O O
recurrence. O O
I O O
would O O
not O O
think O O
that O O
his O O
current O O
symptomatology O O
would O O
be O O
any O O
cause O O
for O O
greater O O
concern O O
regarding O O
new O O
recurrence O O
of O O
his O O
illness. O O
Unfortunately, O O
as O O
you O O
know, O O
we O O
are O O
not O O
able O O
to O O
offer O O
anything O O
in O O
the O O
way O O
of O O
therapy O O
for O O
this O O
at O O
this O O
time. O O
We O O
can O O
certainly O O
treat O O
any O O
positive O O
symptoms O O
of O O
painful O O
dysesthesias O O
fairly O O
effectively O O
with O O
antineuropathic O O
pain O O
medications O O
such O O
as O O
Amitriptyline, O O
Gabapentin, O O
or O O
sodium O O
channel O O
agents O O
such O O
as O O
phenytoin O O
or O O
_____. O O
However, O O
this O O
is O O
not O O
a O O
prominent O O
complaint O O
of O O
Mr. O O
Emery's O O
and O O
this O O
is O O
not O O
likely O O
to O O
be O O
helpful O O
for O O
him. O O
Nevertheless, O O
there O O
may O O
be O O
other O O
therapies O O
in O O
the O O
near O O
future O O
that O O
might O O
be O O
available O O
for O O
this O O
type O O
of O O
problem. O O
I O O
will O O
be O O
happy O O
to O O
continue O O
to O O
see O O
Mr. O O
Emery O O
on O O
a O O
roughly O O
yearly O O
basis, O O
so O O
that O O
he O O
can O O
keep O O
in O O
touch O O
and O O
be O O
made O O
aware O O
of O O
any O O
therapy O O
that O O
might O O
be O O
helpful O O
and O O
available O O
for O O
him O O
in O O
the O O
future. O O
If O O
you O O
have O O
any O O
questions O O
please O O
do O O
not O O
hesitate O O
to O O
call O O
me. O O
Once O O
again, O O
thank O O
you O O
for O O
your O O
kind O O
referral. O O
Sincerely, O O
Igor O O
Velazquez, O O
M.D., O O
Ph.D. O O
DD:05/05/2095 O O
DT:05/05/2095 O O
WK:65255 O O
:4653 O O

Record O O
date: O O
2096-12-29 O O
NMH O O
GU O O
Donn O O
Emery O O
NMH#: O O
059-57-26 O O
December O O
29, O O
2096 O O
INTERVAL O O
HISTORY: O O
He O O
has O O
been O O
troubled O O
by O O
increasing O O
shortness O O
of O O
breath, O O
which O O
Dr. O O
Pina, O O
the O O
physician O O
covering O O
for O O
Dr. O O
Park, O O
thought O O
might O O
be O O
related O O
to O O
asbestosis. O O
He O O
is O O
to O O
see O O
her O O
next O O
on O O
January O O
15, O O
2097. O O
REVIEW O O
OF O O
SYSTEMS: O O
General: O O
Complaint O O
of O O
mild O O
fatigue. O O
No O O
fevers, O O
chills, O O
or O O
change O O
in O O
appetite. O O
HEENT: O O
No O O
blurred O O
vision, O O
oral O O
ulcers, O O
lesions, O O
thrush, O O
neck O O
swelling, O O
neck O O
stiffness, O O
hoarseness. O O
Pulmonary: O O
No O O
cough, O O
SOB, O O
DOE, O O
hemoptysis, O O
wheezing. O O
Cardiac: O O
No O O
chest O O
pain, O O
palpitations. O O
Gastrointestinal: O O
No O O
nausea, O O
vomiting, O O
diarrhea, O O
constipation, O O
or O O
abdominal O O
pain. O O
Urologic: O O
No O O
dysuria, O O
hematuria. O O
Lymph O O
Nodes: O O
No O O
enlarged O O
lymph O O
nodes. O O
Musculoskeletal: O O
No O O
back O O
pain, O O
neck O O
pain, O O
leg O O
pain, O O
or O O
arm O O
pain. O O
Hematologic: O O
No O O
bruising, O O
bleeding O O
or O O
clotting. O O
Neurologic: O O
The O O
neuropathy O O
has O O
become O O
much O O
worse, O O
the O O
left O O
hand O O
worse O O
than O O
the O O
right. O O
He O O
said O O
that O O
Dr. O O
Pina O O
thought O O
that O O
was O O
likely O O
secondary O O
to O O
his O O
diabetes B-DIABETES O
and O O
made O O
some O O
changes O O
in O O
his O O
medications. O O
He O O
has O O
had O O
some O O
moderately O O
severe O O
back O O
pain. O O
REVIEW O O
OF O O
STUDIES: O O
Blood O O
studies O O
on O O
November O O
14, O O
2096 O O
were O O
satisfactory O O
except O O
for O O
a O O
BUN O O
of O O
41 O O
with O O
a O O
creatinine O O
of O O
1.3. O O
I O O
assume O O
that O O
that O O
will O O
be O O
part O O
of O O
the O O
checking O O
up, O O
which O O
Dr. O O
Pina O O
will O O
be O O
doing. O O
A O O
chest O O
CT O O
scan O O
on O O
December O O
22, O O
2096 O O
showed O O
no O O
change O O
in O O
the O O
small O O
mediastinal O O
nodes, O O
but O O
I O O
will O O
plan, O O
just O O
to O O
be O O
sure, O O
to O O
do O O
a O O
chest O O
CT O O
scan O O
and O O
an O O
abdominal O O
CT O O
scan O O
in O O
six O O
months. O O
If O O
those O O
studies O O
are O O
stable O O
and O O
satisfactory, O O
I O O
discussed O O
with O O
Mr. O O
Emery O O
the O O
fact O O
that O O
I O O
may O O
not O O
do O O
scans O O
subsequently O O
given O O
the O O
absence O O
of O O
activity O O
of O O
lymphoma, O O
the O O
importance O O
of O O
his O O
other O O
medical O O
conditions, O O
and O O
his O O
advancing O O
age. O O
PHYSICAL O O
EXAMINATION: O O
Weight: O O
175 O O
lb. O O
with O O
shoes. O O
Blood O O
Pressure: O O
I O O
did O O
not O O
record O O
a O O
blood O O
pressure, O O
as O O
it B-HYPERTENSION O
was I-HYPERTENSION O
above I-HYPERTENSION O
160 B-HYPERTENSION O
and O O
because O O
of O O
difficulties O O
getting O O
an O O
accurate O O
reading O O
with O O
a O O
digital O O
machine. O O
He O O
is O O
to O O
have O O
this O O
checked O O
by O O
Dr. O O
Pina. O O
Skin: O O
Normal. O O
Lymph O O
Nodes: O O
There O O
was O O
no O O
cervical, O O
axillary, O O
or O O
inguinal O O
lymphadenopathy. O O
There O O
is O O
an O O
abnormality O O
in O O
the O O
medial O O
left O O
supraclavicular O O
fossa O O
unchanged O O
from O O
several O O
previous O O
examinations. O O
Lungs: O O
Clear. O O
Heart: O O
Normal. O O
Abdomen: O O
No O O
masses O O
or O O
tenderness. O O
Extremities: O O
No O O
evidence O O
of O O
DVT. O O
No O O
edema. O O
Rectal O O
Exam: O O
On O O
rectal O O
exam, O O
the O O
prostate O O
was O O
small, O O
without O O
abnormalities. O O
IMPRESSION: O O
He O O
is O O
having O O
considerable O O
difficulties, O O
which O O
relate O O
both O O
to O O
physical O O
issues O O
described O O
above O O
and O O
the O O
fact O O
that O O
he O O
is O O
living O O
alone. O O
His O O
wife O O
is O O
in O O
a O O
care O O
facility, O O
which O O
cares O O
for O O
individuals O O
with O O
Alzheimer O O
s O O
disease O O
and O O
this O O
also O O
has O O
taken O O
its O O
toll O O
on O O
him O O
overall. O O
I O O
will O O
see O O
him O O
next O O
in O O
six O O
months. O O
Connor O O
Quincy, O O
MD O O
cc: O O
Patrick O O
Park, O O
MD O O
Dr. O O
Pina O O
CQ/earley O O
65-77827705.doc O O
Note: O O
The O O
duration O O
of O O
this O O
visit O O
was O O
25 O O
minutes O O
with O O
the O O
majority O O
of O O
the O O
time O O
spent O O
in O O
counseling O O
the O O
patient, O O
including O O
a O O
discussion O O
of O O
the O O
current O O
status O O
of O O
his O O
condition. O O

Record O O
date: O O
2098-11-04 O O
NAME: O O
Emmery, O O
Donn O O
S. O O
MRN: O O
0595726 O O
Patient O O
presents O O
today O O
for O O
nail O O
care. O O
It O O
is O O
an O O
initial O O
visit O O
for O O
him O O
with O O
me. O O
He O O
had O O
seen O O
Dr. O O
Noah O O
Velazquez O O
back O O
in O O
July O O
of O O
this O O
year. O O
PAST O O
MEDICAL O O
HISTORY: O O
Multiple O O
and O O
complex, O O
consistent O O
of O O
hypertension, B-HYPERTENSION O
diabetes, B-DIABETES O
macular O O
degeneration, O O
aortic O O
stenosis, O O
lymphoma, O O
anemia, O O
polyneuropathy, O O
positive O O
ANA O O
nuclear O O
bodies, O O
pulmonary O O
fibrosis, O O
asbestosis, O O
history O O
of O O
SOB, O O
GERD. O O
MEDICATIONS: O O
Multiple O O
meds O O
per O O
the O O
LMR. O O
ALLERGIES: O O
Sulfa O O
medications O O
- O O
urticaria. O O
PAST O O
SURGICAL O O
HISTORY: O O
Tonsillectomy, O O
removal O O
of O O
nephrolithiasis, O O
TURP, O O
electrocardiograms, O O
carpal O O
tunnel O O
syndrome. O O
PEDAL O O
EXAM: O O
Pulses O O
are O O
diminished O O
bilaterally, O O
absent O O
digital O O
hair O O
growth, O O
cool O O
atrophic O O
skin. O O
Sensorium O O
appears O O
intact. O O
Orthopedically O O
speaking, O O
he O O
has O O
a O O
severe O O
pes O O
planus O O
deformity O O
bilaterally O O
with O O
forefoot O O
abductus O O
and O O
collapse O O
of O O
the O O
medial O O
column, O O
left O O
greater O O
than O O
right. O O
Dermatologically O O
speaking, O O
there O O
are O O
no O O
callosities. O O
His O O
nails O O
are O O
grossly O O
dystrophic O O
and O O
elongated. O O
They O O
were O O
all O O
trimmed. O O
There O O
were O O
no O O
signs O O
of O O
infection. O O
Web O O
spaces O O
were O O
clean, O O
dry O O
and O O
intact. O O
ASSESSMENT: O O
Patient O O
with O O
peripheral O O
vascular O O
disease. O O
I O O
recommended O O
regular O O
nail O O
care O O
approximately O O
every O O
2-3 O O
months. O O
I O O
answered O O
all O O
of O O
his O O
questions. O O
He O O
was O O
reappointed O O
as O O
stated. O O
Noah O O
X. O O
Nagle, O O
DPM O O
NXN/wynn/draper O O

Record O O
date: O O
2098-12-10 O O
059-57-26 O O
Emery, O O
Donn O O
December O O
10, O O
2098 O O
Endocrine/Diabetes B-DIABETES O
Present O O
Illness: O O
Asked O O
to O O
see O O
this O O
89 O O
year O O
old O O
patient O O
of O O
Drs. O O
Pina O O
and O O
Keefe, O O
admitted O O
with O O
an O O
acute O O
exacerbation O O
of O O
congestive O O
heart O O
failure O O
in O O
the O O
context O O
of O O
severe O O
aortic O O
stenosis O O
and O O
less O O
attention O O
to O O
diet O O
at O O
the O O
time O O
of O O
his O O
wife's O O
death O O
last O O
week. O O
He O O
is O O
approaching O O
probable O O
AVR O O
and O O
? O O
CABG. O O
He O O
has O O
had O O
diabetes B-DIABETES O
since O O
age O O
50. O O
He O O
was O O
treated O O
with O O
diet O O
initially, O O
then O O
chlorpropamide B-MEDICATION O
(100 O O
mg O O
bid O O
at O O
the O O
time O O
of O O
admission) O O
to O O
which O O
metformin B-MEDICATION B-MEDICATION
(1000 O O
mg O O
bid O O
at O O
the O O
time O O
of O O
admission) O O
was O O
added. O O
His O O
recent B-DIABETES O
A1c B-DIABETES O
was I-DIABETES O
6.5 I-DIABETES O
%. I-DIABETES O
He O O
denies O O
hypoglycemia O O
and O O
does O O
not O O
have O O
hyponatremia. O O
His O O
creatinine O O
is O O
1.5. O O
He O O
has O O
never O O
used O O
insulin O O
until O O
this O O
admission, O O
when O O
his O O
oral B-MEDICATION O
agents I-MEDICATION O
were I-MEDICATION O
stopped I-MEDICATION O
and I-MEDICATION O
Lantus B-MEDICATION O
begun. I-MEDICATION O
Retinopathy: O O
Reports O O
that O O
he O O
does O O
have O O
retinopathy, O O
but O O
lost O O
vision O O
OD O O
to O O
macular O O
degeneration. O O
He O O
is O O
followed O O
by O O
Dr. O O
Valentine O O
and O O
Dr. O O
Wilkes, O O
and O O
reports O O
that O O
he O O
has O O
had O O
laser O O
treatment O O
by O O
Dr. O O
Valentine. O O
Nephropathy: O O
BUN/Cr O O
42/1.5 O O
Neuropathy: O O
Decreased O O
sensation O O
in O O
feet O O
and O O
hands. O O
Notes O O
that O O
he O O
has O O
had O O
flat O O
feet O O
all O O
of O O
his O O
life O O
and O O
does O O
not O O
recall O O
any O O
acute O O
painful O O
episode O O
in O O
L O O
foot. O O
Cardiac: O O
above O O
Vascular: O O
No O O
claudication O O
Pre-op O O
evaluation O O
has O O
included O O
colonoscopy O O
and O O
EGD O O
because O O
of O O
guaiac O O
positive O O
stool. O O
An O O
incidental O O
bladder O O
mass O O
is O O
suspected O O
on O O
the O O
basis O O
of O O
pelvic O O
CT O O
and O O
? O O
cystoscopy O O
is O O
also O O
planned. O O
Past O O
Medical O O
History: O O
Surgery: O O
Lymphoma O O
- O O
treated O O
with O O
surgery O O
and O O
radiation O O
therapy O O
in O O
2077 O O
or O O
so O O
TURP O O
Tonsillectomy O O
Medical: O O
Hypertension B-HYPERTENSION O
Anemia O O
Asbestosis O O
Pulmonary O O
nodule O O
Pulmonary O O
fibrosis O O
GERD O O
Nephrolithiasis O O
Depression O O
Allergies: O O
?? O O
Sulfa O O
- O O
he O O
thinks O O
that O O
he O O
has O O
had O O
sulfa O O
since O O
the O O
time O O
he O O
was O O
labeled O O
with O O
an O O
allergy O O
to O O
it O O
but O O
cannot O O
recall O O
details. O O
Family O O
History: O O
MGF O O
had O O
diabetes. O O
Social O O
History: O O
His O O
wife O O
died O O
last O O
week O O
of O O
Alzheimer's O O
Disease, O O
several O O
months O O
following O O
a O O
fall. O O
He O O
is O O
a O O
Financial O O
Senior O O
Manager. O O
After O O
the O O
successful O O
treatment O O
of O O
his O O
lymphoma O O
at O O
about O O
age O O
68, O O
he O O
went O O
back O O
to O O
school O O
to O O
study O O
sociology. O O
Review O O
of O O
Systems: O O
above O O
Review O O
of O O
systems O O
is O O
otherwise O O
negative. O O
Physical O O
Exam: O O
Delightful O O
elderly O O
man O O
in O O
no O O
distress. O O
BP: B-HYPERTENSION O
148/59 I-HYPERTENSION O
P: O O
64, O O
regular O O
Wt: O O
165 O O
by O O
history, O O
down O O
from O O
maximum O O
of O O
235 O O
Ht: O O
5' O O
10 O O
by O O
his O O
estimate, O O
down O O
from O O
6' O O
1.5 O O
HEENT: O O
Anicteric. O O
Fundi: O O
Not O O
examined O O
Carotids: O O
2+,= O O
with O O
softly O O
transmitted O O
murmur O O
Chest: O O
cleat\retinopathy O O
Heart: O O
Normal O O
S1; O O
single O O
S2.. O O
No O O
gallops. O O
3/6 O O
systolic O O
ejection O O
murmur O O
Abdomen: O O
No O O
hepatosplenomegaly. O O
No O O
masses. O O
No O O
tenderness. O O
No O O
palpable O O
AAA. O O
Extremities: O O
1+ O O
ankle O O
edema. O O
Pop O O
1-2+ O O
R, O O
1+ O O
L. O O
No O O
pedal O O
pulses. O O
R O O
foot O O
has O O
small O O
plantar O O
arch, O O
but O O
L O O
has O O
no O O
arch O O
and O O
bony O O
prominence O O
in O O
the O O
location O O
of O O
plantar O O
arch; O O
there O O
is O O
also O O
some O O
deformity O O
of O O
the O O
L O O
ankle. O O
Neurological: O O
AJ O O
absent. O O
Impressions O O
and O O
Plan: O O
89 O O
year O O
old O O
man O O
with O O
aortic O O
stenosis, O O
coronary B-CAD O
artery I-CAD O
disease, I-CAD O
congestive O O
heart O O
failure O O
and O O
longstanding O O
type B-DIABETES O
2 I-DIABETES O
diabetes. I-DIABETES O
His O O
average O O
control O O
has O O
apparently O O
been O O
good O O
on O O
the O O
combination O O
of O O
chlorpropamide O O
and O O
metformin, O O
although O O
we O O
cannot O O
be O O
sure O O
of O O
that O O
in O O
view O O
of O O
his O O
anemia O O
and O O
the O O
fact O O
that O O
he O O
was O O
not O O
testing O O
his O O
glucose O O
at O O
home. O O
Metformin O O
is O O
relatively O O
contraindicated O O
since O O
his O O
GRF O O
is O O
certainly O O
diminished O O
with O O
creatinine O O
1.5 O O
at O O
age O O
89. O O
Lantus O B-MEDICATION
does O O
not O O
appear O O
to O O
be O O
the O O
right O O
insulin O O
for O O
him. O O
Would O O
D/C B-MEDICATION O
it I-MEDICATION O
in I-MEDICATION O
favor I-MEDICATION O
of I-MEDICATION O
NPH B-MEDICATION O
15 O O
U O O
in O O
AM O O
(watch O O
carefully O O
today O O
since O O
there O O
is O O
persistent O O
Lantus O O
effect). O O
Check O O
QID O O
BS O O
but O O
cover O O
with O O
scale O O
only O O
before O O
breakfast O O
and O O
supper. O O
I O O
have O O
not O O
addressed O O
the O O
issue O O
of O O
long O O
term O O
insulin O O
use O O
with O O
him, O O
although O O
it O O
would O O
be O O
my O O
first O O
choice. O O
Even O O
at O O
his O O
age, O O
I O O
suspect O O
that O O
he O O
would O O
have O O
no O O
difficulty O O
mastering O O
it O O
given O O
his O O
relatively O O
youthful O O
mind. O O
Other O O
alternatives O O
would O O
be O O
sulfonylureas O O
(if O O
forced O O
to O O
use O O
one, O O
would O O
choose O O
glimepiride) O O
and O O
glitinides, O O
for O O
example O O
repaglinide. O O
Thanks. O O
Will O O
follow. O O
Daniel O O
M. O O
Arce, O O
M.D., O O
Ph.D. O O

Record O O
date: O O
2098-12-23 O O
Vascular O O
Surgery O O
Consult- O O
Kinder O O
DATE: O O
12/23/2098 O O
ATTENDING: O O
Quiring O O
PT: O O
Emery, O O
Donn O O
MR#: O O
0595726 O O
Presentation: O O
Bilateral O O
lower O O
extremity O O
ulceration O O
HPI: O O
This O O
is O O
a O O
89yo O O
female O O
s/p B-CAD O
CABG, B-CAD O
AVR O O
8 O O
days O O
ago O O
who O O
presents O O
with O O
bilateral O O
ulceration O O
for O O
the O O
past O O
six O O
month. O O
He O O
also O O
c/o O O
bilateral O O
intermittent O O
claudication O O
of O O
calf O O
and O O
thighs O O
with O O
claudication O O
distance O O
of O O
one O O
block. O O
He O O
denies O O
any O O
trauma O O
or O O
ulceration. O O
Risk O O
Factors O O
1. O O
Hypertension B-HYPERTENSION O
2. O O
Hypercholesterolemia B-HYPERLIPIDEMIA O
3. O O
Ex-heavy B-SMOKER O
smoker I-SMOKER O
4. O O
NIDDM B-DIABETES O
5. O O
CAD B-CAD O
PMHx: O O
1. O O
As O O
above O O
2. O O
GERD O O
3. O O
TURP O O
4. O O
Nephrolithiasis O O
5. O O
Macular O O
degeneration O O
6. O O
Pulmonary O O
fibrosis O O
7. O O
Pulmonary O O
nodule O O
8. O O
Depression O O
9. O O
Polyneuropathy O O
Medications: O O
1. O O
Aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
qd O O
2. O O
Atenolol B-MEDICATION B-MEDICATION
50 O O
mg O O
bid O O
3. O O
Chlropropamiden B-MEDICATION B-MEDICATION
100 O O
mg O O
bid O O
4. O O
Cozaar B-MEDICATION B-MEDICATION
50 O O
mg O O
bid O O
5. O O
Metformin B-MEDICATION B-MEDICATION
1000 O O
mg O O
bid O O
6. O O
Hytrin O O
30 O O
mg O O
qd O O
7. O O
Lasix O O
20 O O
mg O O
qd O O
8. O O
Mevacor B-MEDICATION B-MEDICATION
10 O O
mg O O
qhs O O
9. O O
Loratadine O B-MEDICATION
10 O O
mg O O
qd O O
10. O O
Glucosamine O B-MEDICATION
11. O O
Mulitvitamins O O
12. O O
Soma/Ultram O O
prn O O
Allergies: O O
Sulfa(causes O O
rash) O O
Social O O
History: O O
Recently O O
widowed, O O
lives O O
with O O
daughter, O O
former B-SMOKER O
heavy I-SMOKER O
tobacco I-SMOKER O
use/no I-SMOKER O
ETOH, O O
formerly O O
worked O O
as O O
a O O
Finance O O
manager, O O
with O O
frequent O O
exposure O O
to O O
occupational O O
hazards, O O
including O O
asbestos O O
VS: O O
T=99.2, O O
PR=82, O O
BP=110/54, O O
RR=19, O O
96% O O
(RA) O O
PE: O O
HEENT: O O
NC/AT, O O
PERRL, O O
nonicteric. O O
Neck: O O
supple, O O
NT, O O
full O O
ROM, O O
2+ O O
carotids O O
w/o O O
bruits, O O
no O O
LAD. O O
JVP O O
7cm O O
Lungs: O O
CTAB; O O
no O O
crackles, O O
no O O
wheezes O O
Cardio: O O
RRR; O O
normal O O
S1, O O
S2, O O
no O O
murmurs O O
or O O
crackes O O
Abd: O O
Soft, O O
non-tender O O
PV: O O
Ext: O O
Pulses: O O
Brachial O O
Radial O O
Femoral O O
Popliteal O O
PT O O
DP O O
Right: O O
2+ O O
2+ O O
2+ O O
1+ O O
0 O O
0 O O
Left: O O
2+ O O
2+ O O
2+ O O
1+ O O
0 O O
0 O O
Bilateral O O
heel O O
ulcerations O O
approx O O
5x4 O O
on O O
right O O
and O O
4x4 O O
on O O
left O O
covered O O
with O O
eschar. O O
Bilateral O O
+3 O O
edema O O
extending O O
to O O
mid O O
calf. O O
Chronic O O
ischemic O O
changes O O
LENIs: O O
DOPPLER O O
SIGNAL O O
PULSES O O
DP O O
PT O O
AbdAorta O O
Femoral O O
Auscultation O O
POP O O
DP O O
PT O O
Left: O O
weak O O
weak O O
1 O O
0 O O
0 O O
0 O O
Right: O O
weak O O
weak O O
1 O O
0 O O
0 O O
0 O O
BP O O
RArm: O O
80/50LArm: O O
81/49 O O
LOCATION O O
Right O O
Left O O
RRatio O O
LRatio O O
RPVR O O
LPVR O O
THIGH O O
70 O O
60 O O
0.86 O O
0.74 O O
CALF O O
60 O O
55 O O
0.74 O O
0.68 O O
ANKLE O O
50 O O
30 O O
0.62 O O
0.37 O O
BP O O
P O O
Exercise: O O
MWT O O
minutes O O
seconds O O
RATE: O O
MPH O O
Grade: O O
10% O O
SYMPTOMS: O O
deferred- O O
ulcers O O
FINDINGS O O
Ankle-brachial O O
indices, O O
segmental O O
systolic O O
pressures, O O
and O O
pulse O O
volume O O
recordings O O
are O O
obtained O O
at O O
rest. O O
RIGHT: O O
ABI O O
is O O
.62. O O
Waveforms O O
and O O
pressures O O
demonstrate O O
SFA, O O
popliteal, O O
and/or O O
tibial O O
vessel O O
disease. O O
Perfusion O O
is O O
poor O O
to O O
the O O
digit O O
level. O O
LEFT: O O
ABI O O
is O O
.37. O O
Waveforms O O
and O O
pressures O O
demonstrate O O
iliac, O O
SFA, O O
popliteal, O O
and/or O O
tibial O O
vessel O O
disease. O O
Perfusion O O
is O O
poor O O
to O O
the O O
ankle, O O
TM, O O
and O O
digit O O
levels. O O
Of O O
note, O O
multiple O O
attempts O O
were O O
made O O
to O O
obtain O O
toe O O
pressures, O O
however, O O
this O O
proved O O
to O O
be O O
technically O O
impossible O O
due O O
to O O
patient's O O
constant O O
twitching. O O
IMPRESSIONS: O O
1. O O
RIGHT O O
SFA, O O
POPLITEAL O O
AND/OR O O
TIBIAL O O
VESSEL O O
DISEASE, O O
WITH O O
MODERATE O O
ABI O O
REDUCTION, O O
AND O O
POOR O O
DIGITAL O O
PERFUSION O O
2. O O
LEFT O O
ILIAC, O O
SFA, O O
POPLITEAL O O
AND/OR O O
TIBIAL O O
VESSEL O O
DISEASE, O O
WITH O O
SEVERE O O
ABI O O
REDUCTION, O O
AND O O
POOR O O
PERFUSION O O
TO O O
THE O O
ANKLE, O O
TM, O O
AND O O
TOE O O
LEVELS O O
3. O O
TECHNICALLY O O
UNABLE O O
TO O O
OBTAIN O O
TOE O O
PRESSURES O O
A/P: O O
This O O
is O O
a O O
85yo O O
male O O
s/p O O
AVR, O O
CABG O O
with O O
chronic O O
pressure O O
ulcerations O O
at O O
his O O
soles O O
bilaterally O O
secondary O O
to O O
proximal O O
disease. O O
Recommend O O
foot O O
elevation O O
when O O
at O O
rest, O O
heel O O
protection, O O
specially-fitted O O
shoes. O O
Will O O
D/W O O
Dr. O O
Quiring O O
for O O
endovascular O O
intervention. O O
________________ O O
Vicki O O
Oneil, O O
M.D O O
Vascular O O
Junior O O
#90148 O O

Record O O
date: O O
2076-07-01 O O
EW O O
Neurology O O
Resident O O
Consult O O
Note O O
Patient O O
Name: O O
Yusuf, O O
Russell O O
MRN: O O
1423602 O O
Date: O O
7/01/76 O O
Consult O O
question: O O
evaluate O O
for O O
stroke/TIA O O
HPI: O O
61 O O
RHM O O
was O O
sitting O O
on O O
the O O
couch O O
watching O O
TV. O O
At O O
6p O O
he O O
decided O O
to O O
walk O O
to O O
the O O
store. O O
When O O
he O O
got O O
outside, O O
he O O
had O O
dizziness O O
(lightheadedness, O O
not O O
spinning), O O
and O O
staggering O O
gait. O O
He O O
went O O
home O O
and O O
sat O O
back O O
down. O O
When O O
he O O
got O O
up O O
again, O O
he O O
was O O
again O O
unsteady O O
and O O
lightheaded. O O
When O O
he O O
shuts O O
his O O
eyes, O O
he O O
says O O
he O O
has O O
'spinning' O O
sensation. O O
He O O
took O O
meclizine O O
which O O
did O O
not O O
help. O O
He O O
has O O
meclizine O O
b/c O O
he O O
has O O
had O O
peripheral O O
vertigo O O
in O O
the O O
past. O O
He O O
says O O
that O O
the O O
dizziness O O
he O O
had O O
today O O
was O O
different O O
from O O
that. O O
He O O
had O O
nausea O O
but O O
no O O
vomiting. O O
He O O
also O O
had O O
ringing O O
in O O
his O O
ears O O
and O O
'blurry' O O
vision O O
and O O
a O O
'tingling' O O
in O O
the O O
back O O
of O O
his O O
head O O
with O O
face O O
flushing O O
during O O
this O O
episode. O O
2d O O
ago, O O
he O O
was O O
watching O O
TV O O
and O O
noted O O
blurry O O
vision. O O
He O O
closed O O
his O O
R O O
eye, O O
and O O
the O O
vision O O
was O O
clear O O
in O O
his O O
L O O
eye. O O
He O O
closed O O
his O O
L O O
eye, O O
and O O
the O O
vision O O
out O O
of O O
his O O
R O O
eye O O
was O O
blurry. O O
ROS: O O
Signif O O
for O O
2-3 O O
mos O O
of O O
hallucinations O O
upon O O
waking O O
up O O
from O O
sleep. O O
He O O
had O O
some O O
chest O O
pain O O
the O O
past O O
few O O
mos O O
and O O
was O O
diagnosed O O
with O O
musculoskeletal O O
pain. O O
He O O
used O O
to O O
have O O
some O O
episodes O O
of O O
L O O
leg O O
giving O O
out O O
6-7 O O
yrs O O
ago, O O
had O O
unremarkable O O
emg O O
and O O
muscle O O
bx O O
at O O
Wolfe O O
Clinic, O O
stopped O O
falling O O
3-4 O O
yrs O O
ago O O
and O O
developed O O
bilateral O O
leg O O
pains O O
now O O
tx'd O O
with O O
amitrypiline. O O
Otherwise O O
negative O O
in O O
detail O O
including O O
headache, O O
change O O
in O O
weight, O O
energy, O O
appetite, O O
palpitations, O O
SOB, O O
DOE, O O
F/N/V/D/cough/chills, O O
rash, O O
BRBPR, O O
melena, O O
abdominal O O
pain, O O
change O O
in O O
bowel O O
or O O
bladder O O
habits O O
(i.e O O
incontinence). O O
No O O
change O O
in O O
vision, O O
hearing, O O
vertigo, O O
weakness, O O
numbness, O O
difficulty O O
speaking O O
or O O
with O O
language, O O
swallowing, O O
eating. O O
PMH: O O
Htn B-HYPERTENSION O
DM B-DIABETES O
High B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Leg O O
pain O O
as O O
above O O
Anxiety/depression O O
MED: O O
ASA B-MEDICATION B-MEDICATION
325 O O
Meclizine O O
25 O O
prn O O
Protonix O O
40 O O
Toprol B-MEDICATION B-MEDICATION
50 O O
Klonopin O B-MEDICATION
6 O O
mg O O
qd O O
(being O O
weaned O O
down) O O
Amitryptiline O O
75 O O
qhs O O
Prozac O O
20 O O
(being O O
weaned O O
down) O O
Effexor O O
75 O O
(being O O
titrated O O
up) O O
ALL: O O
codeine O O
and O O
percocet O O
SH: O O
on O O
disability O O
d/t O O
anx/depression. O O
Tobacco B-SMOKER O
ppd, I-SMOKER O
remote O O
heavy O O
ETOH, O O
none O O
now, O O
denies O O
drugs O O
FH: O O
no O O
stroke. O O
Dtr O O
had O O
vertebral O O
dissection O O
this O O
past O O
year O O
VS: O O
T O O
98.2 O O
HR O O
99 O O
BP B-HYPERTENSION O
158/89 I-HYPERTENSION O
RR O O
18 O O
Sat O O
95% O O
on O O
RA O O
PE:Genl O O
WD O O
WN O O
WM O O
NAD O O
HEENT O O
AT/NC, O O
MMM O O
no O O
lesions O O
Neck O O
Supple, O O
no O O
LAN, O O
no O O
bruits O O
Chest O O
CTA O O
B O O
CVS O O
RRR O O
w/o O O
MGR O O
ABD O O
soft, O O
NTND, O O
+ O O
BS O O
EXT O O
no O O
C/C/E, O O
distal O O
pulses O O
full, O O
no O O
rashes O O
or O O
petechiae O O
Neuro O O
MS: O O
AA&Ox3, O O
appropriately O O
interactive, O O
normal O O
affect O O
Attention: O O
intact O O
for O O
interview O O
Speech: O O
fluent O O
w/o O O
paraphasic O O
error O O
Memory: O O
not O O
tested O O
Calculations: O O
not O O
tested O O
No O O
finger O O
agnosia O O
L/R O O
confusion: O O
No O O
L/R O O
confusion O O
Praxis: O O
not O O
tested O O
Spatial: O O
not O O
tested O O
No O O
obvious O O
perseveration. O O
CN: O O
I--not O O
tested; O O
II,III--PERRLA, O O
VFF O O
by O O
confrontation, O O
optic O O
discs O O
sharp; O O
III,IV,VI-EOMI O O
w/o O O
nystagmus, O O
no O O
ptosis; O O
V--sensation O O
intact O O
to O O
LT/PP, O O
masseters O O
strong O O
symmetrically; O O
VII--face O O
symmetric O O
without O O
weakness; O O
VIII--hears O O
finger O O
rub O O
bilaterally; O O
IX,X--voice O O
normal, O O
palate O O
elevates O O
symmetrically; O O
XI--SCM/trapezii O O
5/5; O O
XII--tongue O O
protrudes O O
midline O O
Motor: O O
normal O O
bulk O O
and O O
tone, O O
no O O
tremor, O O
rigidity O O
or O O
bradykinesia, O O
no O O
pronator O O
drift. O O
Arm O O
rolling:symmetric. O O
Strength: O O

Record O O
date: O O
2078-07-01 O O
CARDIOLOGY O O
OAKLAND O O
ASSOCIATES O O
CENTER O O
Interval O O
History: O O
This O O
63 O O
y/o O O
male O O
patient O O
with O O
a O O
h/o O O
HTN, B-HYPERTENSION O
HLP, B-HYPERLIPIDEMIA O
non-revascularized B-CAD O
4-vessel I-CAD O
CAD, B-CAD O
preserved O O
LV O O
systolic O O
function, O O
PAD O O
with O O
past O O
PTA O O
and O O
stenting O O
to O O
the O O
R O O
EIA O O
and O O
distal O O
L O O
SFA, O O
tobacco O O
abuse, O O
type B-DIABETES O
2 I-DIABETES O
DM, I-DIABETES O
peripheral O O
neuropathy, O O
L O O
ulnar O O
nerve O O
compression, O O
ulcerative O O
colitis, O O
GERD, O O
depressive O O
disorder, O O
anxiety O O
disorder, O O
and O O
gouty O O
arthritis O O
presents O O
to O O
the O O
OAC O O
Cath O O
Lab O O
this O O
morning O O
for O O
a O O
scheduled O O
elective O O
peripheral O O
arterial O O
catheterization O O
procedure. O O
The O O
patient O O
was O O
last O O
seen O O
in O O
outpatient O O
vascular O O
medicine O O
follow-up O O
by O O
Dr. O O
Levi O O
Barton O O
at O O
the O O
OAC O O
04/09/2078, O O
at O O
which O O
time O O
he O O
reported O O
recurrent O O
and O O
persistent O O
BLE O O
claudication O O
symptoms, O O
RLE O O
&gt; O O
LLE, O O
with O O
pain O O
in O O
his O O
buttocks, O O
thighs, O O
and O O
calves O O
with O O
ambulation. O O
He O O
reports O O
that O O
these O O
symptoms, O O
coupled O O
with O O
his O O
peripheral O O
neuropathy O O
symptoms, O O
have O O
become O O
quite O O
debilitating O O
and O O
lifestyle-limiting. O O
The O O
patient O O
denies O O
any O O
chronic O O
or O O
poorly-healing O O
ulcers O O
or O O
sores O O
on O O
his O O
feet O O
or O O
lower O O
extremities. O O
Given O O
his O O
history O O
and O O
symptomatic O O
complaints, O O
Dr. O O
Barton O O
recommended O O
that O O
the O O
patient O O
be O O
scheduled O O
to O O
undergo O O
an O O
elective O O
peripheral O O
arteriogram O O
to O O
re-assess O O
his O O
PAD O O
and, O O
if O O
indicated O O
and O O
feasible, O O
to O O
pursue O O
percutaneous O O
revascularization. O O
The O O
patient O O
had O O
previously O O
undergone O O
a O O
peripheral O O
angiogram O O
at O O
the O O
OAC O O
on O O
11/21/2077, O O
performed O O
by O O
Dr. O O
Barton, O O
which O O
culminated O O
in O O
PTA O O
and O O
stenting O O
to O O
the O O
R O O
EIA O O
and O O
the O O
distal O O
L O O
SFA, O O
the O O
former O O
with O O
a O O
balloon-expandable O O
biliary O O
stent O O
and O O
the O O
latter O O
with O O
a O O
self-expanding O O
biliary O O
stent. O O
Follow-up O O
lower O O
extremity O O
non-invasive O O
studies O O
performed O O
at O O
the O O
OAC O O
in O O
01/2078 O O
revealed O O
a O O
depressed O O
resting O O
ABI O O
of O O
0.70 O O
in O O
the O O
RLE, O O
which O O
dropped O O
to O O
0.24 O O
following O O
exercise O O
(as O O
well O O
as O O
a O O
resting O O
ABI O O
of O O
1.00 O O
in O O
the O O
LLE O O
which O O
decreased O O
to O O
0.50 O O
post-exercise). O O
The O O
patient O O
has O O
not O O
been O O
treated O O
with O O
Pletal O O
in O O
the O O
past. O O
An O O
important O O
side O O
note O O
is O O
the O O
fact O O
that O O
the O O
patient's O O
diagnostic B-CAD O
LHC I-CAD O
procedure I-CAD O
at I-CAD O
the I-CAD O
OAC I-CAD O
in I-CAD O
10/2077 I-CAD O
revealed I-CAD O
significant I-CAD O
4-vessel I-CAD O
CAD, I-CAD O
which O O
for O O
some O O
reason O O
was O O
treated O O
medically O O
rather O O
than O O
surgically O O
or O O
percutaneously. O O
The O O
patient O O
has O O
expressed O O
a O O
desire O O
to O O
have O O
his O O
coronary O O
arteries O O
re-assessed O O
by O O
angiography O O
during O O
today's O O
peripheral O O
catheterization O O
procedure, O O
not O O
particularly O O
because O O
of O O
any O O
recurrent O O
CP O O
but O O
mostly O O
out O O
of O O
concern O O
that O O
his O O
CAD O O
may O O
have O O
worsened O O
and O O
because O O
he O O
may O O
undergo O O
surgery O O
for O O
his O O
L O O
ulnar O O
nerve O O
compression O O
in O O
the O O
relatively O O
near O O
future. O O
Past O O
medical O O
history: O O
1. O O
Hypertension B-HYPERTENSION O
(managed O O
with O O
chronic O O
beta-blocker B-MEDICATION O
and O O
ACE-inhibitor B-MEDICATION O
medications). O O
2. O O
Hyperlipidemia B-HYPERLIPIDEMIA O
(managed O O
with O O
a O O
chronic O O
'statin' B-MEDICATION O
medication). O O
3. O O
Coronary B-CAD O
Artery I-CAD O
Disease I-CAD O
(4-vessel B-CAD O
disease I-CAD O
noted I-CAD O
during I-CAD O
the I-CAD O
10/2077 I-CAD O
LHC I-CAD O
procedure, I-CAD O
with O O
no O O
past O O
percutaneous O O
or O O
surgical O O
revascularization O O
procedures). O O
4. O O
Preserved O O
Left O O
Ventricular O O
Systolic O O
Function O O
(EF O O
estimated O O
at O O
65% O O
by O O
LV-gram O O
during O O
the O O
LHC O O
at O O
the O O
OAC O O
in O O
10/2077). O O
5. O O
Peripheral O O
Artery O O
Disease O O
(involving O O
the O O
BLEs, O O
with O O
PTA O O
and O O
stenting O O
to O O
both O O
the O O
distal O O
L O O
SFA O O
and O O
the O O
R O O
EIA O O
at O O
the O O
OAC O O
in O O
11/2077). O O
6. O O
Type B-DIABETES O
2 I-DIABETES O
Diabetes I-DIABETES O
Mellitus I-DIABETES O
(HgbA1c B-DIABETES O
8.2% I-DIABETES O
on I-DIABETES O
06/27/2078; I-DIABETES O
treated O O
with O O
OHAs). O O
7. O O
Peripheral O O
Neuropathy O O
(per O O
the O O
patient; O O
being O O
treated O O
with O O
Neurontin). O O
8. O O
Left O O
Ulnar O O
Nerve O O
Compression O O
(seen O O
by O O
Dr. O O
Ryan O O
and O O
considering O O
surgical O O
treatment). O O
9. O O
Ulcerative O O
Colitis O O
(treated O O
effectively O O
with O O
Prednisone O O
during O O
exacerbations). O O
10. O O
Gastro-Esophageal O O
Reflux O O
Disease O O
(treated O O
with O O
a O O
chronic O O
PPI O O
medication). O O
11. O O
Gouty O O
Arthritis O O
(infrequent O O
exacerbations; O O
no O O
chronic O O
uricosuric O O
pharmacotherapy). O O
12. O O
Depressive O O
Disorder O O
(treated O O
with O O
chronic O O
pharmacotherapy). O O
13. O O
Anxiety O O
Disorder O O
(treated O O
with O O
benzodiazepine O O
pharmacotherapy). O O
14. O O
Tobacco O O
Abuse O O
(35 O O
pack-year O O
history, O O
with O O
cessation O O
5 O O
months O O
ago). O O
Past O O
Surgical O O
History: O O
1. O O
S/p O O
Tonsillectomy O O
and O O
Adenoidectomy. O O
2. O O
S/p O O
Resection O O
of O O
Peri-Rectal O O
Abscess. O O
3. O O
S/p O O
Laparoscopic O O
Cholecystectomy. O O
4. O O
S/p O O
Bilateral O O
Cataract O O
Surgeries. O O
Medications O O
Prior O O
to O O
Admission: O O
1. O O
Aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
p.o. O O
daily O O
(most O O
recent O O
dose O O
taken O O
this O O
morning). O O
2. O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
p.o. O O
daily O O
(most O O
recent O O
dose O O
taken O O
this O O
morning). O O
3. O O
Toprol-XL B-MEDICATION B-MEDICATION
25 O O
mg O O
p.o. O O
daily. O O
4. O O
Lisinopril B-MEDICATION B-MEDICATION
2.5 O O
mg O O
p.o. O O
daily. O O
5. O O
Zocor B-MEDICATION B-MEDICATION
20 O O
mg O O
p.o. O O
daily. O O
6. O O
Nitroglycerin B-MEDICATION B-MEDICATION
0.4 O O
mg O O
sub-lingual O O
q.5 O O
mins. O O
x O O
3 O O
p.r.n. O O
chest O O
pain. O O
7. O O
Metformin B-MEDICATION B-MEDICATION
1,000 O O
mg O O
p.o. O O
b.i.d. O O
with O O
meals O O
(most O O
recent O O
dose O O
on O O
06/30/2078). O O
8. O O
Glipizide B-MEDICATION B-MEDICATION
1.25 O O
mg O O
p.o. O O
a.c. O O
q.a.m. O O
9. O O
Protonix O O
40 O O
mg O O
p.o. O O
daily. O O
10. O O
Effexor-XR O O
225 O O
mg O O
p.o. O O
daily. O O
11. O O
Neurontin O O
300 O O
mg O O
p.o. O O
b.i.d. O O
12. O O
Ibuprofen O O
800 O O
mg O O
p.o. O O
daily O O
p.r.n. O O
pain. O O
13. O O
Chantix O O
1 O O
mg O O
p.o. O O
b.i.d. O O
14. O O
Vitamin-B12 O O
1,000 O O
mcg O O
(1 O O
mg) O O
p.o. O O
b.i.d. O O
15. O O
Hytrin O O
1 O O
mg O O
p.o. O O
q.a.m. O O
and O O
2 O O
mg O O
p.o. O O
q.p.m. O O
Allergies: O O
Drug O O
allergy O O
PERCOCET O O
causes O O
pruritis. O O
Drug O O
reaction O O
CODEINE O O
causes O O
GI O O
upset. O O
No O O
known O O
contrast O O
allergy O O
Family O O
history: O O
Positive O O
for O O
CAD O O
(paternal O O
uncle O O
had O O
MI, O O
but O O
not O O
premature-onset). O O
Positive O O
for O O
DM O O
(father). O O
Negative O O
for O O
any O O
known O O
family O O
h/o O O
CVD O O
or O O
PVD. O O
Social O O
history: O O
The O O
patient O O
is O O
married O O
and O O
lives O O
in O O
Wilkes-Barre, O O
PA O O
with O O
his O O
wife. O O
They O O
have O O
3 O O
grown O O
adult O O
children O O
and O O
10 O O
grandchildren. O O
He O O
is O O
currently O O
on O O
permanent O O
disability, O O
but O O
previously O O
worked O O
as O O
a O O
landscaper. O O
The O O
patient O O
reports O O
smoking O O
cessation O O
approximately O O
5 O O
months O O
ago, O O
which O O
he O O
attributes O O
to O O
the O O
effects O O
of O O
Chantix, O O
and O O
reports O O
a O O
past O O
h/o O O
smoking O O
approximately O O
1 O O
pack O O
of O O
cigarettes O O
per O O
day O O
for O O
roughly O O
35 O O
years O O
(with O O
past O O
cigarette O O
quit O O
attempts O O
and O O
change O O
to O O
cigars O O
for O O
a O O
period O O
of O O
time). O O
He O O
denies O O
any O O
recent O O
or O O
regular O O
EtOH O O
intake, O O
having O O
quit O O
several O O
yeas O O
ago, O O
but O O
reports O O
a O O
past O O
h/o O O
excessive O O
EtOH O O
intake. O O
He O O
denies O O
any O O
illicit O O
drug O O
use. O O
The O O
patient O O
also O O
denies O O
any O O
regular O O
or O O
structured O O
aerobic O O
exercise. O O
Review O O
of O O
systems: O O
Positive O O
for O O
BLE O O
claudication, O O
plantar O O
foot O O
pain O O
bilaterally O O
at O O
rest, O O
LUE O O
pain O O
(related O O
to O O
ulnar O O
nerve O O
compression), O O
depression, O O
and O O
anxiety. O O
Negative O O
for O O
recent O O
constitutional O O
symptoms, O O
seizures, O O
syncope, O O
HAs, O O
CP O O
at O O
rest O O
or O O
with O O
exertion, O O
palpitations, O O
SOB O O
at O O
rest, O O
orthopnea, O O
PND, O O
significant O O
or O O
activity-limiting O O
DOE, O O
pyrosis, O O
dyspepsia, O O
N/V, O O
hematemesis, O O
abdominal O O
pain, O O
melena, O O
recent O O
BRBPR, O O
dysuria, O O
polyuria, O O
or O O
nocturia. O O
Physical O O
examination: O O
-BMI: O O
25.1 O O
Overweight, O O
moderate O O
risk O O
-Pulse: O O
83, O O
regular O O
-resp. O O
rate: O O
16, O O
O2 O O
Sat O O
96% O O
(on O O
RA) O O
-height: O O
67 O O
in. O O
-weight: O O
160 O O
lbs. O O
-General: O O
Alert, O O
conversant, O O
appropriate O O
adult O O
male O O
in O O
NAD. O O
-Skin: O O
Warm O O
and O O
dry, O O
anicteric, O O
with O O
no O O
visible O O
rashes. O O
-HEENT: O O
Anicteric O O
and O O
non-injected O O
sclerae O O
OU, O O
moist O O
oral O O
mucous O O
membranes, O O
and O O
a O O
clear O O
and O O
benign-appearing O O
posterior O O
oropharynx. O O
-Neck: O O
JVP O O
normal O O
at O O
5 O O
- O O
6 O O
cm O O
of O O
H20, O O
with O O
no O O
evidence O O
of O O
JVD. O O
Carotid O O
pulses O O
2+ O O
and O O
with O O
normal O O
upstrokes O O
bilaterally. O O
No O O
appreciable O O
carotid O O
or O O
subclavian O O
bruits O O
on O O
auscultation O O
bilaterally. O O
-Chest: O O
Lungs O O
CTA O O
bilaterally, O O
with O O
no O O
appreciable O O
W/R/R. O O
No O O
increased O O
work O O
of O O
breathing O O
or O O
accessory O O
muscle O O
use. O O
-Cardiac: O O
Heart O O
RRR, O O
with O O
a O O
normal O O
S1 O O
and O O
S2, O O
a O O
non-radiating O O
I/VI O O
systolic O O
murmur O O
along O O
the O O
LSB O O
(LUSB O O
and O O
LLSB), O O
and O O
no O O
appreciable O O
diastolic O O
murmurs, O O
S3 O O
or O O
S4 O O
gallops, O O
rubs, O O
or O O
clicks. O O
-Abdomen: O O
Soft, O O
NT, O O
ND, O O
with O O
NABS, O O
no O O
palpable O O
HSM, O O
no O O
palpable O O
AA O O
widening O O
or O O
pulsatile O O
masses, O O
and O O
no O O
appreciable O O
abdominal O O
bruit O O
on O O
deep O O
auscultation O O
(though O O
an O O
epigastric O O
bruit O O
has O O
been O O
appreciated O O
by O O
others O O
in O O
the O O
past). O O
-Extremities: O O
Femoral O O
pulses O O
2+ O O
bilaterally, O O
with O O
bilateral O O
bruits O O
on O O
auscultation. O O
No O O
peripheral O O
C/C/E. O O
Radial O O
pulses O O
2+ O O
in O O
the O O
BUEs. O O
DP O O
pulses O O
non-palpable O O
in O O
the O O
BLEs O O
(but O O
obtainable O O
by O O
Doppler O O
U/S O O
in O O
the O O
BLEs O O
[RLE O O
&gt; O O
LLE]. O O
PT O O
pulses O O
non-palpable O O
in O O
the O O
BLEs O O
(but O O
obtainable O O
by O O
Doppler O O
U/S O O
in O O
the O O
BLEs O O
[RLE O O
&gt; O O
LLE]). O O
No O O
peripheral O O
ulcerations, O O
skin O O
breakdown, O O
livedo O O
reticularis, O O
signs O O
of O O
recent O O
trauma O O
or O O
infection, O O
or O O
stigmata O O
of O O
athero-embolic O O
disease O O
in O O
the O O
distal O O
BLEs. O O
Distal O O
BLEs O O
warm O O
to O O
palpation, O O
without O O
distal O O
rubor. O O
-BP: O O
114/68 O O
(R) O O
111/67 O O
(L) O O
EKG: O O
(06/27/2078, O O
09:06, O O
at O O
the O O
Perham O O
Memorial O O
Hospital): O O
NSR O O
@ O O
71 O O
bpm. O O
Relative O O
low O O
amplitude/voltage O O
in O O
II O O
and O O
aVF. O O
LAD. O O
Normal O O
P-R O O
intervals O O
(0.136). O O
Normal O O
QRS O O
intervals O O
(0.082). O O
Normal O O
Q-T O O
intervals O O
for O O
HR O O
(0.392, O O
0.425 O O
corrected). O O
No O O
AVBs. O O
No O O
BBBs. O O
No O O
LAHB. O O
No O O
IVCD. O O
Early O O
to O O
normal O O
transition O O
in O O
the O O
precordial O O
leads O O
(between O O
V2 O O
- O O
V3). O O
No O O
LVH O O
by O O
voltage O O
criteria. O O
No O O
LAE. O O
Upright O O
T-waves O O
in O O
V1. O O
T-wave O O
flattening O O
in O O
aVF O O
and O O
V1. O O
T-wave O O
inversions O O
in O O
III O O
and O O
aVR. O O
No O O
diagnostic O O
S-T O O
segment O O
elevations O O
or O O
depressions. O O
Small, O O
pathologic O O
Q-waves O O
in O O
I, O O
aVL, O O
and O O
V6. O O
No O O
pathologic O O
Q-waves. O O
(02/12/2078, O O
14:38, O O
at O O
the O O
OAC): O O
NSR O O
@ O O
82 O O
bpm. O O
Relative O O
low O O
amplitude/voltage O O
in O O
II, O O
aVF, O O
V1, O O
and O O
V6. O O
LAD. O O
Normal O O
P-R O O
intervals O O
(0.138). O O
Normal O O
QRS O O
intervals O O
(0.082). O O
Normal O O
Q-T O O
intervals O O
for O O
HR O O
(0.348, O O
0.406 O O
corrected). O O
No O O
AVBs. O O
Narrow-complex O O
RSR' O O
pattern O O
to O O
the O O
QRS O O
complexes O O
in O O
aVR O O
and O O
V1. O O
No O O
BBBs. O O
No O O
LAHB. O O
No O O
IVCD. O O
Early O O
transition O O
in O O
the O O
precordial O O
leads O O
(between O O
V1 O O
- O O
V2). O O
No O O
LVH O O
by O O
voltage O O
criteria. O O
No O O
LAE. O O
T-wave O O
flattening O O
in O O
III. O O
Relative O O
T-wave O O
flattening O O
in O O
aVL. O O
T-wave O O
inversions O O
in O O
aVR O O
and O O
V1. O O
No O O
diagnostic O O
S-T O O
segment O O
elevations O O
or O O
depressions. O O
Small, O O
non-pathologic O O
Q-waves O O
in O O
I O O
and O O
aVL. O O
No O O
pathologic O O
Q-waves. O O
Other O O
Data: O O
LABS O O
(06/27/2078, O O
11:02, O O
at O O
the O O
Perham O O
Memorial O O
Hospital): O O
Na O O
139, O O
K O O
4.6, O O
Cl O O
103, O O
CO2 O O
30, O O
AG O O
6.0, O O
BUN O O
15, O O
Creat O O
1.4, O O
GFR O O
54*, O O
Ca O O
9.6 O O
ALT O O
25, O O
AST O O
24, O O
Alk O O
Phos O O
90, O O
TB O O
0.3, O O
Album O O
4.1, O O
TP O O
6.5 O O
TC O O
161, O O
LDL O O
88*, O O
HDL O O
52, O O
Trig O O
107, O O
TC/HDL O O
3.1, O O
LDL/HDL O O
1.7 O O
WBC O O
8,900, O O
RBC O O
3.80*, O O
Hgb O O
11.6*, O O
Hct O O
35.1*, O O
MCV O O
93, O O
Plat O O
162,000 O O
HgbA1c O O
8.2*, O O
Gluc O O
117 O O
Left B-CAD O
Heart I-CAD O
Catheterization I-CAD O
(10/12/2077, I-CAD O
at I-CAD O
the I-CAD O
OAC): I-CAD O
Operators: I-CAD O
Dr. I-CAD O
Yahir I-CAD O
Woods, I-CAD O
Dr. I-CAD O
Donna I-CAD O
Yeh. I-CAD O
Access: I-CAD O
R I-CAD O
CFA I-CAD O
(retrograde). I-CAD O
Dominance: I-CAD O
Right I-CAD O
(RCA). I-CAD O
Coronary I-CAD O
Angiography: I-CAD O
Focal B-CAD O
50% I-CAD O
LMCA I-CAD O
stenosis, I-CAD O
focal I-CAD O
total I-CAD O
occlusion I-CAD O
of I-CAD O
the I-CAD O
mid-LAD, I-CAD O
focal I-CAD O
60% I-CAD O
stenosis I-CAD O
of I-CAD O
the I-CAD O
mid-LCx, I-CAD O
focal I-CAD O
60% I-CAD O
stenosis I-CAD O
of I-CAD O
the I-CAD O
OM2 I-CAD O
branch I-CAD O
of I-CAD O
the I-CAD O
LCx, I-CAD O
serial I-CAD O
40 I-CAD O
- I-CAD O
50% I-CAD O
stenoses I-CAD O
within I-CAD O
the I-CAD O
RCA. I-CAD O
Left I-CAD O
Ventriculogram: I-CAD O
Overall I-CAD O
normal I-CAD O
LV I-CAD O
systolic I-CAD O
function, I-CAD O
with I-CAD O
an I-CAD O
estimated I-CAD O
EF I-CAD O
of I-CAD O
65%. I-CAD O
Left I-CAD O
Ventricular I-CAD O
Pressures: I-CAD O
LVSP I-CAD O
elevated I-CAD O
(147 I-CAD O
mmHg), I-CAD O
LVEDP I-CAD O
elevated I-CAD O
(16 I-CAD O
mmHg). I-CAD O
Percutaneous I-CAD O
Intervention: I-CAD O
None I-CAD O
performed. I-CAD O
Contrast I-CAD O
Volume: I-CAD O
85 I-CAD O
cc I-CAD O
of I-CAD O
Isovue I-CAD O
iodinated I-CAD O
contrast I-CAD O
media. I-CAD O
Fluoroscopy I-CAD O
Time: I-CAD O
6:00 I-CAD O
minutes. I-CAD O
Vascular I-CAD O
Closure I-CAD O
Device: I-CAD O
6-French I-CAD O
St. I-CAD O
Jude I-CAD O
AngioSeal I-CAD O
device I-CAD O
to I-CAD O
the I-CAD O
R I-CAD O
CFA. I-CAD O
Peripheral O O
Arteriogram O O
(11/21/2077, O O
at O O
the O O
OAC): O O
Operators: O O
Dr. O O
Levi O O
Barton, O O
Dr. O O
Vernon O O
Vue. O O
Access: O O
R O O
CFA O O
(retrograde). O O
Renal O O
Angiography: O O
20 O O
- O O
30% O O
stenosis O O
within O O
the O O
proximal O O
R O O
RA, O O
grossly O O
patent O O
L O O
RA. O O
RLE O O
Angiography: O O
Mild O O
luminal O O
irregularities O O
within O O
the O O
R O O
CIA, O O
40 O O
- O O
60% O O
proximal O O
R O O
IIA O O
stenosis, O O
diffuse O O
70 O O
- O O
90% O O
mid-R O O
IIA O O
stenosis, O O
60% O O
R O O
EIA O O
stenosis, O O
mild O O
luminal O O
irregularities O O
within O O
the O O
R O O
CFA O O
and O O
R O O
PFA, O O
mild O O
20 O O
- O O
40% O O
serial O O
stenoses O O
within O O
the O O
R O O
SFA, O O
mild O O
luminal O O
irregularities O O
within O O
the O O
R O O
popliteal O O
artery, O O
total O O
occlusion O O
of O O
the O O
proximal O O
R O O
ATA, O O
40 O O
- O O
50% O O
stenosis O O
of O O
the O O
proximal O O
R O O
peroneal O O
artery, O O
total O O
occlusion O O
of O O
the O O
proximal O O
R O O
PTA. O O
LLE O O
Angiography: O O
Mild O O
luminal O O
irregularities O O
within O O
the O O
L O O
CIA, O O
diffuse O O
40 O O
60% O O
stenosis O O
mid-L O O
IIA O O
stenosis, O O
mild O O
luminal O O
irregularities O O
within O O
the O O
L O O
EIA O O
and O O
L O O
CFA, O O
40 O O
- O O
60% O O
ostial O O
L O O
PFA O O
stenosis, O O
20 O O
- O O
30% O O
proximal O O
L O O
SFA O O
stenosis, O O
serial O O
50 O O
- O O
80% O O
stenoses O O
within O O
the O O
L O O
SFA, O O
mild O O
luminal O O
irregularities O O
within O O
the O O
L O O
popliteal O O
artery, O O
50 O O
- O O
70% O O
stenosis O O
of O O
the O O
distal O O
L O O
TPT, O O
total O O
occlusion O O
of O O
the O O
proximal O O
L O O
ATA, O O
mild O O
luminal O O
irregularities O O
within O O
the O O
L O O
peroneal O O
artery, O O
total O O
occlusion O O
of O O
the O O
proximal O O
L O O
PTA. O O
Percutaneous O O
Intervention: O O
PTA O O
and O O
stenting O O
to O O
the O O
distal O O
L O O
SFA O O
(using O O
5.0 O O
mm O O
balloon O O
catheters O O
and O O
a O O
6.0 O O
x O O
60 O O
mm O O
Abbott O O
Xpert O O
self-expanding O O
biliary O O
stent), O O
PTA O O
and O O
stenting O O
to O O
the O O
R O O
EIA O O
(using O O
a O O
5.0 O O
mm O O
balloon O O
catheter O O
and O O
a O O
6.0 O O
x O O
24 O O
mm O O
Cordis O O
Palmaz O O
Blue O O
balloon-expandable O O
biliary O O
stent). O O
Angiographic O O
Results: O O
Contrast O O
Volume: O O
200 O O
cc O O
of O O
Isovue O O
iodinated O O
contrast O O
media. O O
Fluoroscopy O O
Time: O O
26.3 O O
minutes. O O
Vascular O O
Closure O O
Device: O O
None O O
used. O O
Lower O O
Extremity O O
Non-Invasive O O
Studies O O
(01/15/2078, O O
at O O
the O O
OAC): O O
Study O O
included O O
PVRs, O O
segmental O O
pressures, O O
ABIs, O O
and O O
Duplex O O
U/S. O O
Depressed O O
resting O O
ABI O O
in O O
the O O
RLE O O
(0.70). O O
Overall O O
normal O O
resting O O
ABI O O
in O O
the O O
LLE O O
(1.00). O O
Significant O O
decrease O O
in O O
the O O
post-exercise O O
ABI O O
in O O
the O O
RLE O O
(0.24). O O
Mild-to-moderate O O
decrease O O
in O O
the O O
post-exercise O O
ABI O O
in O O
the O O
LLE O O
(0.50). O O
Duplex O O
U/S O O
of O O
the O O
previously-stented O O
distal O O
L O O
SFA O O
revealed O O
mild-to-moderately O O
elevated O O
blood O O
flow O O
velocities O O
in O O
the O O
proximal O O
portion O O
of O O
the O O
stent O O
(PSV O O
178 O O
cm/sec), O O
with O O
normal O O
velocities O O
at O O
the O O
distal O O
end O O
of O O
the O O
stent O O
(PSV O O
73 O O
cm/sec). O O
Duplex O O
U/S O O
also O O
revealed O O
revealed O O
significantly O O
elevated O O
blood O O
flow O O
velocities O O
in O O
the O O
proximal O O
L O O
PFA O O
(PSV O O
306 O O
cm/sec), O O
as O O
well O O
as O O
moderately O O
elevated O O
velocities O O
in O O
the O O
proximal-to-mid O O
L O O
SFA O O
(PSV O O
191 O O
cm/sec). O O
Findings O O
consistent O O
with O O
hemodynamically O O
significant O O
PAD O O
of O O
the O O
BLEs. O O
Assessment O O
and O O
plan: O O
ASSESSMENT: O O
63 O O
y/o O O
male O O
patient O O
with O O
a O O
h/o O O
HTN, O O
HLP, O O
non-revascularized O O
4-vessel O O
CAD, O O
preserved O O
LV O O
systolic O O
function, O O
PAD O O
with O O
past O O
PTA O O
and O O
stenting O O
to O O
the O O
R O O
EIA O O
and O O
distal O O
L O O
SFA, O O
tobacco O O
abuse, O O
type O O
2 O O
DM, O O
peripheral O O
neuropathy, O O
L O O
ulnar O O
nerve O O
compression, O O
ulcerative O O
colitis, O O
GERD, O O
depressive O O
disorder, O O
anxiety O O
disorder, O O
and O O
gouty O O
arthritis O O
who O O
presents O O
to O O
the O O
OAC O O
Cath O O
Lab O O
today O O
for O O
the O O
purpose O O
of O O
undergoing O O
a O O
scheduled O O
elective O O
peripheral O O
arterial O O
catheterization O O
procedure O O
because O O
of O O
recurrent O O
BLE O O
claudication O O
symptoms O O
(RLE O O
&gt; O O
LLE). O O
In O O
addition, O O
a O O
diagnostic O O
coronary O O
angiogram O O
will O O
most O O
likely O O
be O O
performed O O
as O O
well, O O
particularly O O
because O O
of O O
the O O
patient's O O
known O O
unrevascularized O O
multi-vessel O O
CAD O O
and O O
the O O
likelihood O O
that O O
he O O
may O O
undergo O O
surgery O O
in O O
the O O
relatively O O
near O O
future O O
for O O
his O O
L O O
ulnar O O
nerve O O
compression. O O
The O O
patient O O
is O O
presently O O
asymptomatic O O
at O O
rest, O O
hemodynamically O O
stable, O O
in O O
sinus O O
rhythm, O O
well-oxygenated O O
on O O
room O O
air, O O
in O O
no O O
distress, O O
and O O
ready O O
to O O
proceed O O
with O O
his O O
scheduled O O
elective O O
catheterization O O
procedure O O
today. O O
PLAN: O O
1. O O
Proceed O O
with O O
the O O
planned O O
catheterization O O
procedure O O
this O O
morning, O O
which O O
will O O
include O O
coronary O O
angiography O O
and O O
BLE O O
peripheral O O
angiography O O
(+/- O O
possible O O
percutaneous O O
revascularization). O O
2. O O
Informed O O
written O O
consent O O
obtained O O
from O O
the O O
patient O O
(by O O
one O O
of O O
the O O
peripheral O O
vascular O O
interventional O O
fellow) O O
pre-procedure O O
this O O
morning. O O
3. O O
No O O
pre-medication O O
for O O
renal O O
and/or O O
allergy O O
prophylaxis O O
appears O O
clinically O O
warranted O O
prior O O
to O O
angiography. O O
4. O O
Admit O O
the O O
patient O O
to O O
the O O
OAC O O
on O O
the O O
inpatient O O
service O O
of O O
Dr. O O
Barton O O
post-procedure. O O
5. O O
Continue O O
the O O
patient O O
on O O
his O O
same O O
prior O O
regimen O O
and O O
doses O O
of O O
ECASA, B-MEDICATION B-MEDICATION
Plavix, B-MEDICATION B-MEDICATION
Toprol-XL, O B-MEDICATION
Lisinopril, B-MEDICATION B-MEDICATION
and O O
Zocor. O B-MEDICATION
6. O O
Continue O O
holding O O
the O O
patient's O O
prior O O
Metformin O B-MEDICATION
for O O
48 O O
hours O O
following O O
contrast O O
administration O O
during O O
angiography O O
today. O O
7. O O
Monitor O O
the O O
patient's O O
FSBG O O
values O O
and O O
covering O O
with O O
sliding O O
scale O O
regular O O
insulin O O
as O O
needed O O
for O O
episodes O O
of O O
hyperglycemia. O O
8. O O
Continue O O
the O O
patient O O
on O O
Glipizide, B-MEDICATION B-MEDICATION
a O O
PPI O O
(Prilosec O O
in O O
place O O
of O O
his O O
usual O O
Protonix O O
while O O
at O O
the O O
OAC O O
[formulary O O
limitations]), O O
Neurontin, O O
Effexor, O O
Chantix, O O
Hytrin, O O
and O O
Vitamin-B12. O O
9. O O
Lab O O
testing O O
tomorrow O O
morning O O
should O O
include O O
the O O
following: O O
CBC, O O
Chem-7, O O
Mg, O O
CPKs, O O
HS-CRP, O O
Lipoprotein(a), O O
and O O
Homocysteine. O O
10. O O
Discharge O O
timing O O
will O O
depend O O
upon O O
today's O O
procedural O O
findings O O
and O O
events, O O
the O O
patient's O O
peri- O O
and O O
post-catheterization O O
course, O O
and O O
the O O
potential O O
need O O
for O O
further O O
monitoring, O O
testing, O O
or O O
treatment O O
in O O
the O O
inpatient O O
setting. O O
11. O O
Following O O
his O O
hospital O O
discharge, O O
the O O
patient O O
should O O
see O O
Dr. O O
Barton O O
in O O
outpatient O O
vascular O O
medicine O O
follow-up O O
in O O
approximately O O
4 O O
- O O
6 O O
weeks, O O
with O O
follow-up O O
lower O O
extremity O O
non-invasive O O
studies O O
(particularly O O
resting O O
and O O
post-exercise O O
ABIs) O O
at O O
that O O
time. O O
12. O O
Will O O
re-address O O
with O O
Dr. O O
Barton O O
the O O
need O O
to O O
consider O O
the O O
patient's O O
need O O
for O O
coronary O O
arterial O O
revascularization, O O
either O O
percutaneously O O
or O O
surgically, O O
given O O
the O O
severity O O
and O O
multi-vessel O O
involvement. O O
13. O O
Further O O
plans O O
and O O
recommendations O O
as O O
per O O
Dr. O O
Barton. O O
Isaac O O
W. O O
Paredes, O O
M.A., O O
M.H.S., O O
M.P.H., O O
PA-C O O
Physician O O
Assistant O O
- O O
Certified O O
Cardiology O O
Division O O
Oakland O O
Associates O O
Center O O
Pager O O
No. O O
(416) O O
943-8331, O O
55053 O O
Office O O
No. O O
(104) O O
376-0356 O O
Fax O O
No. O O
(385) O O
031-7905 O O
E-Mail: O O
iparedes@oachosp.org O O
Cc: O O
Roger O O
Fagan, O O
M.D. O O
(primary O O
care O O
physician, O O
Denver O O
City, O O
PA) O O
Edwin O O
Erb, O O
M.D. O O
(primary O O
gastroenterologist, O O
Sallisaw, O O
PA) O O
Levi O O
Barton, O O
M.D. O O
(OAC O O
Cardiology, O O
Chicago, O O
PA) O O
Erica O O
Jain, O O
M.D. O O
(OAC O O
Neurology, O O
Chicago, O O
PA) O O
Richard O O
Ryan, O O
M.D. O O
(OAC O O
Orthopaedic O O
Surgery, O O
Chicago, O O
PA) O O
Isaac O O
W. O O
Paredes, O O
PA O O
Signed O O
electronically O O
by O O
Isaac O O
W. O O
Paredes, O O
PA O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2078-11-08 O O
CARDIOLOGY O O
OAKLAND O O
ASSOCIATES O O
CENTER O O
Reason O O
for O O
visit: O O
A O O
63 O O
yr O O
old O O
man O O
with O O
CAD B-CAD O
and O O
extensive O O
PAD O O
history O O
s/p O O
multiple O O
peripheral O O
PCI's O O
admitted O O
after O O
elective O O
cardiac O O
&amp;amp; O O
peripheral O O
angiography O O
and O O
LSFA O O
cryoplasty/PTA/stents. O O
Interval O O
History: O O
Patient O O
is O O
a O O
63-year-old O O
with O O
long-standing O O
right-greater-than-left O O
claudication O O
The O O
Fall O O
of O O
77, O O
he O O
could O O
only O O
walk O O
about O O
25 O O
feet O O
before O O
experiencing O O
pain. O O
Exercise O O
ABI's O O
revealed O O
R O O
ABI O O
drop O O
from O O
0.65 O O
to O O
0.16 O O
and O O
L O O
ABI O O
drop O O
from O O
0.74 O O
to O O
0.24. O O
An O O
MRA O O
revealed O O
non-obstructive O O
plaque O O
in O O
the O O
common O O
iliacs, O O
50% O O
left O O
external O O
iliac O O
and O O
question O O
of O O
disease O O
in O O
right O O
internal O O
iliac; O O
40 O O
to O O
60% O O
common O O
femoral O O
and O O
40 O O
to O O
50% O O
stenosis O O
more O O
distally O O
with O O
60 O O
to O O
70% O O
serial O O
left O O
SFA O O
stenoses. O O
He O O
had O O
a O O
totally O O
occluded O O
anterior O O
tibialis O O
bilaterally O O
with O O
60 O O
to O O
80% O O
trifurcation O O
area O O
disease O O
and O O
high O O
grade O O
posterior O O
tibial O O
on O O
the O O
right O O
and O O
occluded O O
posterior O O
tibial O O
on O O
the O O
left. O O
10/77 O O
he O O
was O O
admitted O O
with O O
angina B-CAD O
and O O
ruled O O
out O O
for O O
an O O
MI. O O
A B-CAD O
cardiac I-CAD O
catheterization I-CAD O
revealed I-CAD O
50% I-CAD O
focal I-CAD O
LM I-CAD O
lesion, I-CAD O
mid I-CAD O
100% I-CAD O
LAD I-CAD O
lesion, I-CAD O
60 I-CAD O
mid I-CAD O
LCX, I-CAD O
50-70 I-CAD O
OM2, I-CAD O
40-50 I-CAD O
dominant I-CAD O
RCA I-CAD O
distal I-CAD O
lesion I-CAD O
with I-CAD O
an I-CAD O
EF I-CAD O
of I-CAD O
65%. I-CAD O
He O O
has O O
been O O
treated O O
medically O O
without O O
any O O
further O O
angina. O O
. O O
11/77 O O
peripheral O O
angiography O O
revealed O O
40-60% O O
LIIA O O
lesion, O O
50-80 O O
LSFA O O
stenosis, O O
40-60 O O
L O O
profunda O O
lesion, O O
totally O O
occluded O O
L O O
AT O O
&amp;amp; O O
L O O
PT, O O
R O O
EIA O O
60% O O
lesion, O O
RIIA O O
40-60 O O
proximal O O
&amp;amp; O O
70-90 O O
mid O O
disease, O O
totally O O
occluded O O
R O O
AT O O
&amp;amp; O O
R O O
PT, O O
70-80 O O
R O O
peroneal. O O
The O O
LSAF O O
was O O
treated O O
with O O
PTA/Xpert O O
6 O O
x O O
60 O O
stent, O O
the O O
R O O
EIA O O
lesion O O
was O O
treated O O
with O O
Palmaz O O
Blue O O
6 O O
x O O
24 O O
stent. O O
6/78 O O
he O O
was O O
taken O O
for O O
peripheral O O
angiography O O
which O O
revealed O O
30% O O
REIA O O
ISR, O O
mod-sev O O
bil O O
IIA O O
disease, O O
R O O
SFA O O
70-75, O O
TO O O
AT/PT O O
and O O
50-60 O O
peroneal. O O
The O O
proximal O O
R O O
SFA O O
was O O
treated O O
with O O
PTA, O O
mid O O
was O O
tx O O
with O O
DCA/PTA O O
Since O O
then O O
he O O
has O O
experienced O O
exertional O O
and O O
rest B-CAD O
CP I-CAD O
occasionally O O
requiring O O
SL B-MEDICATION O
TNG I-MEDICATION O
with O O
relief. O O
In O O
addition, O O
he O O
has O O
experienced O O
SOB O O
with O O
stair O O
climbing O O
but O O
denies O O
SOB O O
with O O
chest O O
pain. O O
He O O
also O O
has O O
been O O
experiencing O O
claudication O O
with O O
left O O
leg O O
worse O O
than O O
right O O
which O O
has O O
been O O
preventing O O
him O O
from O O
performing O O
exercise. O O
A B-CAD O
ETT B-CAD O
MIBI I-CAD O
was I-CAD O
done I-CAD O
10/31/78 I-CAD O
where I-CAD O
he I-CAD O
exercised I-CAD O
for I-CAD O
3 I-CAD O
minutes I-CAD O
53 I-CAD O
seconds. I-CAD O
He I-CAD O
complained I-CAD O
of I-CAD O
b/l I-CAD O
leg I-CAD O
claudication I-CAD O
and I-CAD O
chest I-CAD O
pain I-CAD O
and I-CAD O
actually I-CAD O
fell I-CAD O
on I-CAD O
the I-CAD O
treadmill I-CAD O
because I-CAD O
' I-CAD O
his I-CAD O
legs I-CAD O
gave I-CAD O
out'. I-CAD O
Imaging I-CAD O
revealed I-CAD O
anterior, I-CAD O
apical I-CAD O
and I-CAD O
septal I-CAD O
ischemia I-CAD O
as I-CAD O
well I-CAD O
as I-CAD O
an I-CAD O
EF I-CAD O
of I-CAD O
49% I-CAD O
and I-CAD O
anterior I-CAD O
and I-CAD O
septal I-CAD O
HK. I-CAD O
Dr O O
Barton O O
put O O
him O O
on O O
trial O O
of O O
Nitrodur, B-MEDICATION O
however, O O
he O O
developed O O
lightheadedness O O
and O O
it O O
was O O
stopped. O O
He O O
was O O
referred O O
for O O
cardiac O O
and O O
peripheral O O
angiography. O O
Preliminary O O
Cardiac O O
Cath B-CAD O
reports I-CAD O
reveals I-CAD O
TO I-CAD O
LAD I-CAD O
with I-CAD O
distal I-CAD O
LAD I-CAD O
filling I-CAD O
from I-CAD O
RCA I-CAD O
collaterals I-CAD O
(unchanged I-CAD O
from I-CAD O
previous I-CAD O
cath). I-CAD O
Peripheral O O
angiography O O
was O O
performed O O
and O O
cryoplasty O O
was O O
performed O O
to O O
the O O
LSFA O O
for O O
ISR O O
as O O
well O O
as O O
Precise O O
6x30 O O
stent O O
to O O
LSFA O O
and O O
Cypher O O
2.5x30 O O
stent O O
to O O
the O O
tibeo-peroneal O O
trunk. O O
He O O
arrived O O
on O O
Cardio. O O
divis. O O
in O O
NAD. O O
Past O O
medical O O
history: O O
1. O O
HTN. B-HYPERTENSION O
2. O O
Hyperlipidemia B-HYPERLIPIDEMIA O
. O O
3. O O
CAD O O
as O O
above O O
4. O O
PAD O O
as O O
above O O
5. O O
Type B-DIABETES O
2 I-DIABETES O
DM I-DIABETES O
(HgbA1c B-DIABETES O
7.5 I-DIABETES O
last I-DIABETES O
week) I-DIABETES O
6. O O
Peripheral O O
Neuropathy- O O
much O O
better O O
since O O
beginning O O
Neurontin. O O
7. O O
Ulcerative O O
Colitis O O
- O O
last O O
flare O O
April O O
treated O O
with O O
prednisone O O
8. O O
GERD O O
9. O O
Gout. O O
10. O O
Depression. O O
11. O O
Incontinence O O
- O O
successfully O O
treated O O
with O O
Terazosin O O
PSH: O O
Tonsils O O
Cataract O O
b/l O O
Cholecystectomy O O
s/p O O
L O O
ulnar O O
nerve O O
transposition O O
7/78 O O
for O O
chronic O O
ulnar O O
compression O O
Allergies: O O
Percocet- O O
itchy O O
Codeine- O O
unknown O O
No O O
IV O O
constrast O O
allergy O O
Meds O O
at O O
Home O O
(from O O
patient O O
memory) O O
Metformin B-MEDICATION B-MEDICATION
1000 O O
mg O O
po O O
bid O O
Neurontin O O
300 O O
mg O O
po O O
bid O O
Terazosin O O
1 O O
mg O O
po O O
daily O O
Lisinopril B-MEDICATION B-MEDICATION
2.5 O O
mg O O
po O O
dialy O O
toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
25 O O
mg O O
po O O
bid O O
Effexor O O
75 O O
mg O O
po O O
tid O O
Clonazepam O O
1 O O
mg O O
po O O
bid O O
Simvastatin B-MEDICATION B-MEDICATION
20 O O
mg O O
po O O
dialy O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
po O O
dialy O O
ASA B-MEDICATION B-MEDICATION
325 O O
mg O O
po O O
daily O O
Glipizide B-MEDICATION B-MEDICATION
1.25 O O
mg O O
po O O
daily O O
Protonix O O
40 O O
mg O O
po O O
bid O O
SL O O
TNG O O
Chantix O O
1mg O O
BID O O
Allergies: O O
Drug O O
reaction: O O
CODEINE O O
causes O O
GI O O
upset. O O
percocet O O
causes O O
itching O O
Family O O
history: O O
Positive O O
for O O
CAD O O
(paternal O O
uncle O O
had O O
MI, O O
but O O
not O O
premature-onset). O O
Positive O O
for O O
DM O O
(father). O O
Negative O O
for O O
any O O
known O O
family O O
h/o O O
CVD O O
or O O
PVD. O O
Mother O O
lived O O
to O O
80's O O
Social O O
history: O O
Retired O O
landscape O O
architect. O O
Tob O O
- O O
1ppd/48 O O
for O O
years, O O
none O O
x O O
5 O O
mths, O O
restarted O O
4/78 O O
now O O
d/ced O O
on O O
Chantix O O
Quit O O
heavy O O
ETOH O O
use O O
approximately O O
11 O O
years O O
ago, O O
Drugs O O
- O O
none O O
Married, O O
3 O O
children, O O
lives O O
in O O
Wilkes-Barre O O
No O O
exercise O O
b/c O O
of O O
claudication O O
Review O O
of O O
systems: O O
denies O O
CVA/TIA/ulcers O O
- O O
reports O O
occasional O O
blood O O
in O O
stool O O
with O O
colitis O O
flare O O
Physical O O
examination: O O
-temp: O O
-Pulse: O O
62 O O
-resp. O O
rate: O O
14 O O
-weight: O O
163 O O
lbs. O O
-General: O O
No O O
acute O O
distress. O O
-Skin: O O
No O O
rashes, O O
anicteric. O O
-Heent: O O
Unremarkable O O
-Neck: O O
Carotids O O
2+ O O
without O O
bruits. O O
-Chest: O O
Clear O O
anteriorly O O
-Cardiac: O O
S1 O O
and O O
S2 O O
, O O
no O O
murmur/rub/gallop O O
-Abdomen: O O
Normal O O
bowel O O
sounds, O O
soft O O
and O O
nontender, O O
with O O
no O O
hepatosplenomegaly O O
or O O
masses O O
appreciated. O O
-Extremities: O O
Right O O
femoral O O
sheath O O
D&amp;I, O O
D?P?PT O O
1+/1+ O O
- O O
left O O
femoral O O
1+, O O
+ O O
bruit, O O
DP/PT O O
1+/1+ O O
-Neuro: O O
A&amp;O O O
x3 O O
-BP: O O
124/61 O O
EKG: O O
Selected O O
recent O O
labs: O O
glucose B-DIABETES O
233, I-DIABETES O
BUN O O
19, O O
creat O O
1.1, O O
NA O O
137, O O
K O O
4.9, O O
WBC O O
6.7, O O
HCT O O
37.3, O O
plt O O
169, O O
INR O O
1.0, O O
PT O O
10, O O
PTT O O
29 O O
Assessment O O
and O O
plan: O O
Assessment: O O
A O O
63 O O
yr O O
old O O
man O O
admitted O O
after O O
elective O O
angiography O O
and O O
LSFA O O
cryoplasty/stents O O
Plan: O O
Admit O O
to O O
Cardiology O O
Sheaths O O
out O O
today O O
Hold O O
Glucophage O B-MEDICATION
for O O
48 O O
hours O O
post O O
dye O O
exposure O O
s/s B-MEDICATION O
regular B-MEDICATION O
insulin I-MEDICATION O
if O O
needed O O
Fasting O O
lipids O O
in O O
AM O O
LFT's, O O
HBa1c O O
Smoking O O
Cessation O O
consult O O
Probable O O
D/C O O
in O O
AM O O
- O O
Further O O
plans O O
per O O
Attending O O
Yvette O O
Ferraro, O O
RN, O O
NP O O
Signed O O
electronically O O
by O O
Yvette O O
Ferraro, O O
RN, O O
NP O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2079-06-22 O O
CARDIOLOGY O O
OAKLAND O O
ASSOCIATES O O
CENTER O O
Reason O O
for O O
visit: O O
s/p O O
Left O O
SFA O O
intervention O O
Interval O O
History: O O
Mr O O
. O O
Yusuf O O
is O O
a O O
64 O O
y.o. O O
male O O
who O O
presented O O
to O O
Dr O O
Barton's O O
office O O
on O O
6/18/79 O O
with O O
left O O
foot O O
pain O O
with O O
claudication O O
at O O
approximately O O
20 O O
feet, O O
L&gt;R, O O
and O O
constant O O
left O O
great O O
toe O O
pain. O O
He O O
has O O
intermittent O O
b/l O O
buttock. O O
Found O O
it O O
difficult O O
to O O
walk O O
from O O
the O O
entrance O O
to O O
the O O
Cath B-CAD O
lab O O
today. O O
He O O
describes O O
upon O O
awakening O O
with O O
paresthesias O O
which O O
resolves O O
with O O
ambulation. O O
He O O
does O O
not O O
exercise B-CAD O
but O O
is O O
active O O
during O O
the O O
day. O O
He O O
also O O
c/o O O
chest O O
discomfort O O
starting O O
last O O
week O O
with O O
palpitations O O
associated O O
with O O
lightheaded. O O
He O O
was O O
resting O O
at O O
the O O
time. O O
He O O
took O O
sl B-MEDICATION O
TNG I-MEDICATION O
without O O
any O O
improvement. O O
This O O
has O O
occured O O
2-3 O O
times. O O
He O O
denies O O
sob, O O
n/v, O O
diaphoresis, O O
syncope. O O
CTA O O
RUN O O
on O O
6/03/79 O O
showed O O
multilevel O O
disease O O
involving O O
both O O
SFAs. O O
Right O O
focal O O
area O O
of O O
mild O O
to O O
moderate O O
ISR. O O
Left O O
severe O O
focal O O
stenosis O O
of O O
the O O
SFA O O
proximal O O
to O O
the O O
proximal O O
stent O O
and O O
severe O O
focal O O
in-stent O O
stenosis O O
within O O
the O O
distal O O
stent. O O
One O O
vessel O O
runoff O O
bilaterally O O
via O O
the O O
peroneal O O
arteries. O O
AVF O O
in O O
the O O
right O O
groin. O O
An O O
Adenosine B-CAD O
MIBI I-CAD O
was I-CAD O
performed I-CAD O
on I-CAD O
6/03/79. I-CAD O
Exercised I-CAD O
with I-CAD O
arm I-CAD O
exercises I-CAD O
for I-CAD O
4' I-CAD O
0', I-CAD O
reaching I-CAD O
62% I-CAD O
of I-CAD O
MPHR. I-CAD O
EKG I-CAD O
negative I-CAD O
for I-CAD O
ischemia. I-CAD O
Images B-CAD O
show I-CAD O
small I-CAD O
territory I-CAD O
of I-CAD O
mild I-CAD O
septal I-CAD O
ischemia, I-CAD O
EF I-CAD O
46%. I-CAD O
Compared I-CAD O
to I-CAD O
10/78 I-CAD O
(done I-CAD O
w/ I-CAD O
exercise I-CAD O
as I-CAD O
opposed I-CAD O
to I-CAD O
adenosine) I-CAD O
the I-CAD O
anterior I-CAD O
and I-CAD O
apical I-CAD O
ischemia I-CAD O
is I-CAD O
no I-CAD O
longer I-CAD O
evident I-CAD O
and I-CAD O
the I-CAD O
EF I-CAD O
is I-CAD O
similar I-CAD O
49%. I-CAD O
Today O O
he O O
underwent O O
coronary O O
angiography O O
which O O
revealed O O
no O O
change O O
from O O
prior O O
cath. O O
Peripheral O O
angiogram O O
noted O O
aorta O O
and O O
renal O O
arteries O O
were O O
patent. O O
Left O O
and O O
right O O
common O O
and O O
external O O
iliac O O
arteries O O
patent. O O
Stent O O
at O O
the O O
origin O O
of O O
the O O
right O O
ext O O
iliac O O
had O O
a O O
30% O O
diffuse O O
narrowing. O O
Bilateral O O
internal O O
iliac O O
arteries O O
have O O
moderately O O
severe O O
stenoses O O
in O O
the O O
distal O O
aspect O O
of O O
main O O
branches. O O
The O O
left O O
SFA O O
has O O
two O O
areas O O
of O O
tapered O O
stenosis O O
up O O
to O O
70% O O
one O O
is O O
proximal O O
and O O
the O O
other O O
is O O
midvessel; O O
main O O
popliteal O O
is O O
patent, O O
but O O
focal O O
75% O O
stenosis O O
present O O
at O O
distal O O
portion O O
prior O O
to O O
trifurcation. O O
Anterior O O
and O O
posterial O O
tibial O O
vessels O O
occluded O O
and O O
reconstitute O O
at O O
the O O
ankle O O
by O O
collaterals O O
from O O
the O O
peroneal. O O
The O O
peroneal O O
has O O
calcified O O
60% O O
diffuse O O
disease O O
in O O
the O O
proximal O O
segment. O O
He O O
therefore O O
underwent O O
PTA O O
of O O
the O O
proximal O O
SFA, O O
PTA O O
and O O
stent O O
to O O
the O O
mid O O
SFA, O O
DCA O O
and O O
PTA O O
of O O
distal O O
popliteal O O
lesion, O O
fox O O
hollow O O
and O O
PTA O O
of O O
proximal O O
peroneal O O
stenosis. O O
He O O
is O O
presently O O
being O O
admitted O O
to O O
Cardiology O O
post O O
intervention. O O
Past O O
medical O O
history: O O
1. O O
Coronary B-CAD B-CAD
artery I-CAD I-CAD
disease. I-CAD O
Cath B-CAD O
11/78 I-CAD O
showed I-CAD O
3 I-CAD O
vessel I-CAD O
CAD B-CAD B-CAD
with I-CAD O
involvement I-CAD O
of I-CAD O
distal I-CAD O
coronary I-CAD O
circulation. I-CAD O
All I-CAD O
vessels I-CAD O
narrow I-CAD O
in I-CAD O
caliber. I-CAD O
LM I-CAD O
distal I-CAD O
30%, I-CAD O
LAD I-CAD O
diffuse I-CAD O
proximal I-CAD O
plaque I-CAD O
and I-CAD O
occluded I-CAD O
after I-CAD O
large I-CAD O
diagonal. I-CAD O
Faint I-CAD O
collaterals I-CAD O
supply I-CAD O
distal I-CAD O
LAD I-CAD O
and I-CAD O
septals,. I-CAD O
Diagonal I-CAD O
patent, I-CAD O
Lcx I-CAD O
50% I-CAD O
ostial I-CAD O
stenosis I-CAD O
then I-CAD O
50-60% I-CAD O
irregular I-CAD O
stenosis I-CAD O
in I-CAD O
proximal I-CAD O
aspect I-CAD O
of I-CAD O
AV I-CAD O
groove I-CAD O
artery I-CAD O
after I-CAD O
OM1 I-CAD O
take I-CAD O
off. I-CAD O
OM1 I-CAD O
patent. I-CAD O
Diffuse I-CAD O
plaquing I-CAD O
in I-CAD O
Lcx I-CAD O
and I-CAD O
Om. I-CAD O
RCA I-CAD O
diffuse I-CAD O
plaquing I-CAD O
in I-CAD O
dominant I-CAD O
vessel, I-CAD O
narrow I-CAD O
up I-CAD O
to I-CAD O
35%. I-CAD O
EF O O
65% O O
with O O
mild O O
apical O O
HK. O O
2. O O
PVD: O O
Stent O O
to O O
right O O
external O O
iliac, O O
30% O O
narrowing. O O
PTA O O
to O O
SFA, O O
stent O O
to O O
mid O O
SFA, O O
directional O O
arthrectomy O O
and O O
PTA O O
of O O
distal O O
popliteal O O
lesion, O O
fox O O
hollow O O
PTA O O
or O O
proximal O O
peroneal O O
stenosis. O O
Angiogram O O
11/78: O O
Peripheral O O
artery O O
disease. O O
Aroto O O
iliac O O
vessels O O
patent. O O
Left O O
Common O O
iliac O O
40% O O
plaque O O
distally. O O
Left O O
internal O O
iliac O O
patetn, O O
left O O
external O O
iliac O O
patent, O O
left O O
CFA O O
calcified O O
plaque O O
w/ O O
40% O O
stenosis. O O
Left O O
SFA O O
40% O O
focal O O
proximal, O O
then O O
50-60% O O
mid O O
and O O
70% O O
stenosis O O
proximal O O
to O O
and O O
into O O
prior. O O
Adductor O O
canal O O
stent, O O
70% O O
at O O
egress O O
of O O
stent. O O
Left O O
popliteal O O
patent. O O
Peroneal O O
patent O O
but O O
AT O O
and O O
PT O O
occluded. O O
TPT O O
70% O O
tapered. O O
Right O O
common O O
and O O
external O O
iliacs O O
patent, O O
internal O O
iliac O O
distal O O
stenosis O O
of O O
60-70% O O
at O O
complex O O
trifurcation. O O
Right O O
CFA O O
narrowed O O
50% O O
by O O
plaque. O O
Right O O
SFA O O
and O O
popliteal O O
diffuse O O
plaque O O
deposition, O O
patent. O O
Cryoplasty O O
balloon O O
angioplastyof O O
left O O
distal O O
(within O O
and O O
above O O
prior O O
stent) O O
and O O
mid O O
SFA. O O
Stent O O
7 O O
x O O
30 O O
mm O O
Precise O O
in O O
distal O O
SFA O O
overlapping O O
w/ O O
proximal O O
aspect O O
of O O
prior O O
stent, O O
7 O O
x O O
20 O O
mm O O
Exceed O O
in O O
mid O O
SFA O O
in O O
site O O
of O O
Cryoplasty O O
where O O
there O O
remained O O
a O O
narrowing O O
and O O
dissection. O O
Post O O
dilation O O
of O O
both O O
sites O O
with O O
balloon. O O
PTA O O
and O O
stent O O
2.5 O O
x O O
28 O O
Cypher O O
in O O
TP O O
trunk. O O
Widely O O
patent O O
to O O
ankle. O O
Patent O O
renal O O
arteries O O
3. O O
Hypertension. B-HYPERTENSION O
4. O O
Hyperlipidemia. B-HYPERLIPIDEMIA O
5. O O
Type B-DIABETES O
2 I-DIABETES O
diabetes. I-DIABETES O
6. O O
Left O O
ulnar O O
transposition O O
and O O
left O O
ulnar O O
nerve O O
compression, O O
with O O
prior O O
surgery O O
on O O
07/26/2078. O O
7. O O
Ulcerative O O
colitis O O
diagnosed O O
30 O O
years O O
ago, O O
on O O
medication O O
for O O
a O O
short O O
time. O O
Episode O O
10-15 O O
years O O
ago O O
controlled O O
with O O
meds. O O
In O O
the O O
last O O
2 O O
years O O
he O O
has O O
had O O
increased O O
problems O O
and O O
has O O
been O O
hospitalized. O O
He O O
has O O
never O O
had O O
surgery. O O
His O O
last O O
colonosocpy O O
was O O
3 O O
months O O
ago. O O
8. O O
GERD. O O
9. O O
Gout O O
10.Depression- O O
never O O
hospitalized. O O
See O O
Psychiatrist. O O
Past O O
Surgical O O
History: O O
1. O O
Tonsillectomy O O
2. O O
Cataract O O
b/l O O
3. O O
Cholecystectomy O O
Medications O O
(Confirmed): O O
aspirin B-MEDICATION B-MEDICATION
325 O O
1 O O
tab O O
daily O O
clonazepam O O
1 O O
mg O O
BID O O
Colazal O O
750 O O
mg O O
po O O
tid O O
Effexor O O
XR O O
300 O O
mg O O
qd O O
gabapentin O O
300 O O
mcg O O
bid O O
Indocin O O
25mg O O
po O O
tid O O
lisinopril B-MEDICATION B-MEDICATION
2.5 O O
mg O O
daily O O
metformin B-MEDICATION B-MEDICATION
hydrochloride O B-MEDICATION
1000 O O
mcg O O
BID O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
daily O O
Protonix O O
40mg O O
po O O
bid O O
simvastatin B-MEDICATION B-MEDICATION
20 O O
mg O O
daily O O
terazosin O O
1 O O
mcg O O
BID O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
25 O O
mg O O
po O O
qd O O
Family O O
history: O O
Positive O O
for O O
CAD O O
(paternal O O
uncle O O
had O O
MI, O O
but O O
not O O
premature O O
onset) O O
Positive O O
for O O
DM- O O
dad O O
Social O O
history: O O
Retired O O
landscape O O
architect. O O
Smoked B-SMOKER O
1 I-SMOKER O
ppd I-SMOKER O
x I-SMOKER O
over I-SMOKER O
35 I-SMOKER O
years, I-SMOKER O
Now I-SMOKER O
smoking I-SMOKER O
10 I-SMOKER O
cigarettes I-SMOKER O
a I-SMOKER O
day. I-SMOKER O
Quit I-SMOKER O
twice I-SMOKER O
in I-SMOKER O
the I-SMOKER O
past I-SMOKER O
2 I-SMOKER O
years I-SMOKER O
for I-SMOKER O
5 I-SMOKER O
months I-SMOKER O
each I-SMOKER O
time I-SMOKER O
but I-SMOKER O
started I-SMOKER O
again I-SMOKER O
after I-SMOKER O
being I-SMOKER O
hospilatized I-SMOKER O
for I-SMOKER O
UC. I-SMOKER O
ETOH: O O
denies O O
Exercise: O O
nothing O O
formal. O O
Lives O O
in O O
Wilkes-Barre, O O
Has O O
three O O
children. O O
Married. O O
Review O O
of O O
systems: O O
Denies O O
headaches, O O
visual O O
changes, O O
no O O
copd, O O
asthma, O O
CV O O
as O O
above. O O
Denies O O
ulcer, O O
has O O
BRBPR O O
b/c O O
of O O
UC O O
on O O
occasion. O O
Denies O O
melena, O O
no O O
kidney, O O
prostate, O O
bladder O O
problems, O O
no O O
stroke, O O
no O O
clotting O O
disorder. O O
Physical O O
examination: O O
-BMI: O O
25.1 O O
Overweight, O O
moderate O O
risk O O
-Pulse: O O
55 O O
-height: O O
67 O O
in. O O
-weight: O O
160 O O
lbs. O O
-Neck: O O
Carotid O O
upstrokes O O
are O O
normal O O
with O O
no O O
bruits O O
appreciated. O O
No O O
JVD O O
-Chest: O O
Clear O O
to O O
auscultation O O
-Cardiac: O O
Bradycardic O O
rate, O O
Normal O O
S1 O O
and O O
S2, O O
I/VI O O
systolic O O
murmur. O O
-Abdomen: O O
Soft, O O
nontender. O O
-Extremities: O O
Bilateral O O
femoral O O
artery O O
bruits, O O
right O O
has O O
systolic O O
and O O
diastolic O O
component O O
and O O
may O O
be O O
c/w O O
AVF, O O
the O O
left O O
fem O O
has O O
a O O
systolic O O
bruit. O O
Left O O
foot O O
with O O
trace O O
DP O O
and O O
1+ O O
PT, O O
warm O O
to O O
touch, O O
decreased O O
mobility O O
with O O
downward O O
deflection O O
of O O
toes. O O
Right O O
pulse O O
1+ O O
DP/PT. O O
There O O
is O O
no O O
pedal O O
edema. O O
Mild O O
tenderness O O
to O O
palpation O O
over O O
left O O
DIP O O
joint. O O
-BP: O O
140/65 O O
EKG: O O
Sinus O O
Bradycardia O O
55 O O
.15/.02/.44, O O
normal O O
EKG O O
Selected O O
recent O O
labs: O O
Metabolic O O
Date O O
BUN O O
CRE O O
06/03/79 O O
20 O O
1.43 O O
Impression: O O
64 O O
y.o. O O
male O O
with O O
CAD, O O
PVD O O
who O O
present O O
now O O
with O O
left O O
leg/foot O O
discomfort O O
and O O
chest O O
discomfort. O O
Found O O
to O O
have O O
same O O
coronary O O
anatomy O O
earlier O O
today O O
on O O
angiography. O O
Peripheral O O
angiography O O
noted O O
above O O
stenosis O O
for O O
which O O
he O O
underwent O O
noted O O
interventions. O O
Plan O O
will O O
be O O
for O O
ASA B-MEDICATION O
and O O
plavix B-MEDICATION B-MEDICATION
x O O
3 O O
months O O
or O O
more O O
with O O
plan O O
for O O
discharge O O
in O O
the O O
morning. O O
He O O
should O O
follow O O
up O O
with O O
Kathy O O
Flaherty O O
PA O O
in O O
6-8 O O
weeks O O
with O O
exercise O O
ABI's O O
and O O
duplex O O
SFA O O
and O O
proximal O O
trifurction/distal O O
popliteal. O O
He O O
continues O O
to O O
have O O
tenderness O O
to O O
palpation O O
over O O
left O O
DIP O O
joint O O
which O O
may O O
be O O
consistent O O
with O O
reperfusion O O
issues. O O
It O O
does O O
not O O
appear O O
to O O
be O O
c/w O O
gout, O O
will O O
check O O
uric O O
acid O O
for O O
completeness. O O
Verna O O
P. O O
Kahn, O O
NP O O
Signed O O
electronically O O
by O O
Verna O O
P. O O
Kahn, O O
NP O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2084-05-12 O O
(958) O O
291-8310 O O
GEORGIA O O
REGIONAL O O
HOSPITAL O O
May O O
12, O O
2084 O O
Brit O O
Eastman, O O
M.D. O O
3793 O O
Rhode O O
Island O O
Avenue O O
East O O
Stroudsburg, O O
GA O O
13756 O O
RE: O O
Lara, O O
Uriah O O
MRN: O O
62115644 O O
Dear O O
Dr. O O
Eastman: O O
Thank O O
you O O
very O O
much O O
for O O
referring O O
Uriah O O
Lara O O
to O O
the O O
Georgia O O
Regional. O O
He's O O
a O O
51 O O
year O O
old O O
male O O
who O O
approximately O O
2 O O
weeks O O
ago O O
developed O O
a O O
pain O O
and O O
stiffness O O
in O O
his O O
neck O O
that O O
limits O O
his O O
range O O
of O O
motion. O O
Approximately O O
5 O O
days O O
ago O O
he O O
developed O O
acute, O O
severe O O
and O O
boring O O
pain O O
at O O
the O O
right O O
trapezius O O
and O O
medial O O
scapular O O
that O O
limits O O
his O O
ability O O
to O O
sleep O O
and O O
function. O O
Toradol, O O
anti-inflammatory O O
muscle O O
relaxants O O
and O O
Percocet O O
were O O
of O O
minimal O O
help. O O
He O O
had O O
no O O
other O O
constitutional O O
symptoms; O O
fevers, O O
rashes. O O
He O O
had O O
noticed O O
some O O
numbness O O
and O O
tingling O O
down O O
the O O
right O O
5th O O
finger O O
and O O
the O O
pain O O
would O O
often O O
travel O O
down O O
the O O
outer O O
part O O
of O O
the O O
triceps O O
region O O
to O O
the O O
elbow O O
and O O
down O O
to O O
the O O
right O O
5th O O
finger. O O
He O O
notes O O
certain O O
positions O O
will O O
alleviate O O
the O O
pain. O O
He O O
then O O
presented O O
to O O
a O O
chiropractor O O
on O O
Saturday O O
who O O
manipulated O O
his O O
back, O O
obtained O O
x-rays O O
which O O
showed O O
no O O
abnormality. O O
Sunday, O O
he O O
received O O
another O O
manipulation O O
and O O
on O O
Sunday O O
night O O
he O O
was O O
abdominal O O
to O O
sleep O O
through O O
the O O
night. O O
This O O
morning O O
he O O
states O O
he O O
had O O
no O O
pain O O
in O O
his O O
neck, O O
however, O O
in O O
mid-morning O O
he O O
did O O
have O O
recurrent O O
pain. O O
He O O
presents O O
today O O
for O O
management O O
treatment O O
of O O
his O O
disorder. O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
MEDICATIONS: O O
Flurazepam O B-MEDICATION
20mg. O O
at O O
night. O O
PAST O O
SURGICAL O O
HISTORY: O O
History O O
is O O
significant O O
for O O
repair O O
of O O
a O O
right O O
femoral O O
compound O O
fracture O O
approximately O O
2 O O
years O O
ago O O
and O O
breast O O
reduction O O
surgery. O O
PAST O O
MEDICAL O O
HISTORY: O O
Significant O O
for O O
pulmonary O O
embolism O O
after O O
his O O
orthopedic O O
surgery. O O
SOCIAL O O
HISTORY: O O
The O O
patient O O
works O O
as O O
a O O
pilot O O
for O O
Frontier O O
Airlines. O O
He O O
is O O
married O O
and O O
has O O
3 O O
children O O
who O O
are O O
healthy. O O
He O O
smokes B-SMOKER O
a I-SMOKER O
pipe. I-SMOKER O
FAMILY O O
HISTORY: O O
He O O
has O O
one O O
sister O O
who O O
has O O
had O O
a O O
radiculopathy. O O
Mother O O
is O O
alive O O
and O O
well O O
at O O
86. O O
Father O O
died O O
of O O
an O O
MI. O O
Brit O O
Eastman, O O
M.D. O O
May O O
12, O O
2084 O O
Page O O
2 O O
PHYSICAL O O
EXAMINATION: O O
On O O
examination, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
140/90. I-HYPERTENSION O
HEENT O O
examination O O
was O O
otherwise O O
normal. O O
Posture O O
is O O
somewhat O O
stooped. O O
Examination O O
of O O
the O O
joints O O
reveal O O
deformity O O
and O O
swelling O O
of O O
the O O
right O O
3rd O O
PIP. O O
Has O O
normal O O
DIPs, O O
PIPs, O O
MCPs, O O
wrists, O O
elbows O O
and O O
shoulders. O O
Normal O O
hips, O O
knees, O O
ankles O O
and O O
toes. O O
In O O
the O O
effected O O
arm, O O
he O O
has O O
normal O O
elbow, O O
normal O O
triceps O O
and O O
biceps O O
reflexes. O O
Normal O O
brachioradialis O O
reflexes. O O
He O O
has O O
normal O O
sensation O O
in O O
his O O
hand. O O
He O O
has O O
weakness O O
of O O
the O O
right O O
hand O O
intrinsic O O
muscles O O
and O O
palpation O O
in O O
the O O
medial O O
muscle O O
has O O
felt O O
an O O
improvement O O
in O O
the O O
pain. O O
IMPRESSION: O O
Mr. O O
Lara, O O
I O O
believe, O O
has O O
an O O
acute O O
radiculopathy O O
of O O
the O O
a-cervical O O
nerve. O O
I O O
informed O O
him O O
that O O
this O O
will O O
get O O
better O O
and O O
that O O
it O O
was O O
probably O O
brought O O
on O O
by O O
his O O
antecedent O O
muscle O O
spasm. O O
PLAN: O O
We O O
prescribed O O
a O O
neck O O
collar, O O
Indocin O O
50 O O
TID, O O
Flexeril O O
10 O O
TID O O
and O O
I O O
gave O O
him O O
additional O O
Percocet. O O
I O O
also O O
prescribed O O
a O O
course O O
of O O
physical O O
therapy O O
with O O
ultrasound O O
and O O
massage. O O
He O O
will O O
call O O
me O O
in O O
one O O
week O O
and O O
return O O
in O O
roughly O O
2 O O
weeks. O O
Sincerely O O
yours, O O
Olivia O O
Levin, O O
M.D. O O
KQ:BU:1592 O O
DD:5-12-84 O O
DT:5-13-84 O O
******** O O
Approved O O
but O O
not O O
reviewed O O
by O O
Attending O O
Provider O O
******** O O

Record O O
date: O O
2084-12-16 O O
FOREST O O
HOSPITAL O O
PHYSICIAN O O
GROUP O O
Vincent O O
Y. O O
Keyes, O O
M.D. O O
315 O O
Westchester O O
Dr O O
Lara, O O
Uriah O O
Avra O O
Valley, O O
GA O O
12442 O O
62115644 O O
(708) O O
670-7983 O O
12-16-84 O O
HPI: O O
Uriah O O
called O O
requesting O O
to O O
be O O
seen O O
urgently. O O
He O O
has O O
not O O
been O O
feeling O O
well. O O
He O O
has O O
not O O
slept O O
for O O
several O O
days. O O
He O O
has O O
had O O
a O O
flutter O O
sensation O O
in O O
his O O
chest O O
occasionally. O O
He O O
has O O
been O O
short O O
of O O
breath O O
with O O
some O O
exertion. O O
He O O
has O O
had O O
no O O
chest O O
discomfort. O O
He O O
has O O
had O O
tingling O O
sensations. O O
He O O
also O O
feels O O
not O O
himself O O
when O O
he O O
lays O O
down. O O
When O O
he O O
sits O O
up, O O
he O O
feels O O
better. O O
He O O
says O O
his O O
head O O
feels O O
full O O
and O O
dizzy. O O
He O O
does O O
not O O
feel O O
the O O
room O O
spin O O
around O O
or O O
feel O O
himself O O
spin O O
around. O O
He O O
has O O
been O O
flying O O
every O O
other O O
day. O O
He O O
has O O
had O O
no O O
chest O O
pain O O
or O O
edema. O O
His O O
ankle O O
also O O
is O O
still O O
quite O O
a O O
problem O O
and O O
bothersome O O
and O O
he O O
is O O
having O O
some O O
hip O O
discomfort O O
related O O
to O O
favoring O O
the O O
right O O
ankle. O O
PHYSICAL O O
EXAMINATION: O O
Weight O O
is O O
197. O O
Pulse O O
68 O O
and O O
regular. O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
140/90 I-HYPERTENSION O
supine, O O
138/88 O O
sitting, O O
138/88 O O
standing. O O
The O O
pulse O O
remains O O
68. O O
The O O
head, O O
eyes, O O
ears, O O
nose, O O
and O O
throat O O
are O O
normal, O O
fundi O O
normal, O O
ears O O
normal. O O
The O O
neck O O
is O O
supple; O O
there O O
is O O
no O O
adenopathy. O O
The O O
lungs O O
are O O
clear. O O
Heart: O O
regular. O O
Abdomen: O O
soft. O O
Extremities: O O
no O O
edema. O O
EKG O O
done O O
today O O
reveals O O
normal O O
sinus O O
rhythm; O O
Q, O O
III, O O
and O O
AVF O O
which O O
is O O
unchanged. O O
This O O
cardiogram O O
is O O
unchanged O O
from O O
July O O
2084. O O
Holter O O
monitor O O
will O O
be O O
done O O
as O O
well O O
as O O
blood O O
screening O O
today. O O
IMPRESSION: O O
Palpitation O O
and O O
light-headedness, O O
question O O
dysrhythmia, O O
question O O
inner O O
ear O O
dysfunction O O
from O O
frequent O O
flying. O O
MEDICATIONS: O O
Antivert O O
12.5 O O
t.i.d. O O
PLAN: O O
1. O O
Holter O O
monitor. O O
2. O O
Blood O O
screening O O
including O O
electrolytes. O O
3. O O
Depending O O
on O O
lipids B-HYPERLIPIDEMIA O
today I-HYPERLIPIDEMIA O
(was B-HYPERLIPIDEMIA O
327), B-HYPERLIPIDEMIA O
we O O
will O O
start B-MEDICATION O
atorvastatin B-MEDICATION B-MEDICATION
20 O O
mg O O
once O O
daily. O O
Prescription O O
is O O
given O O
to O O
him O O
today O O
with O O
instructions O O
to O O
take O O
1 O O
at O O
evening O O
meal O O
and O O
to O O
have O O
blood O O
tested O O
again O O
in O O
6 O O
weeks. O O
A O O
lab O O
request O O
is O O
given O O
to O O
patient. O O
He O O
is O O
told O O
to O O
hold O O
off O O
taking O O
the O O
medication O O
until O O
he O O
hears O O
from O O
me O O
about O O
his O O
blood O O
test. O O
4. O O
Further O O
workup O O
based O O
on O O
lab O O
testing O O
and O O
Holter O O
monitor O O
and O O
how O O
patient O O
feels O O
in O O
the O O
next O O
week. O O
______________________________ O O
Vincent O O
Y. O O
Keyes, O O
M.D. O O
BI:YD:0043 O O
DD:12-16-84 O O
DT:12-16-84 O O
DV:12-16-84 O O
******** O O
Approved O O
but O O
not O O
reviewed O O
by O O
Attending O O
Provider O O
******** O O

Record O O
date: O O
2092-03-21 O O
EDVISIT^62115644^Lara, O O
Uriah^03/21/92^MELENDEZ, O O
LEAH O O
Resident's O O
history, O O
physical O O
examination, O O
and O O
evaluation O O
reviewed O O
by O O
me O O
and O O
I O O
concur. O O
In O O
addition, O O
I O O
personally O O
interviewed O O
and O O
examined O O
this O O
patient. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
is O O
a O O
59-year-old O O
male O O
with O O
history O O
of O O
elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
who O O
presents O O
for O O
evaluation O O
of O O
intermittent O O
neck O O
pain O O
and O O
arm O O
discomfort O O
over O O
the O O
course O O
of O O
the O O
last O O
several O O
weeks O O
and O O
now O O
with O O
substernal O O
chest O O
pain O O
radiating O O
to O O
the O O
neck O O
since O O
6 O O
hours O O
prior O O
to O O
admission. O O
The O O
patient O O
does O O
not O O
have O O
any O O
documented O O
history O O
of O O
CAD. O O
He O O
has O O
noted O O
over O O
the O O
last O O
several O O
weeks O O
episodes O O
of O O
exertional O O
right-sided O O
neck O O
aching O O
and O O
arm O O
discomfort O O
with O O
arm O O
numbness, O O
which O O
seems O O
to O O
occur O O
with O O
exertion O O
and O O
resolve O O
with O O
rest. O O
He O O
has O O
no O O
noted O O
over O O
the O O
last O O
week, O O
but O O
on O O
exertion, O O
he O O
has O O
had O O
episodes O O
of O O
bilateral O O
neck O O
aching O O
discomfort O O
with O O
radiating O O
achy O O
into O O
both O O
of O O
the O O
arms. O O
His O O
symptoms O O
generally O O
resolve O O
with O O
rest. O O
Today, O O
approximately O O
6 O O
hours O O
prior O O
to O O
presentation, O O
he O O
was O O
driving O O
when O O
he O O
had O O
the O O
onset O O
of O O
bilateral O O
neck O O
and O O
arm O O
aching O O
pain O O
with O O
substernal O O
chest O O
discomfort, O O
shortness O O
of O O
breath, O O
a O O
sensation O O
of O O
palpitations O O
and O O
mild O O
sweatiness. O O
He O O
had O O
no O O
nausea O O
and O O
no O O
vomiting. O O
His O O
symptoms O O
persisted O O
over O O
the O O
course O O
of O O
last O O
several O O
hours, O O
and O O
he O O
presented O O
to O O
the O O
Emergency O O
Department O O
for O O
evaluation. O O
He O O
denies O O
any O O
prior O O
history O O
of O O
chest O O
pain O O
in O O
the O O
past. O O
PAST O O
MEDICAL O O
HISTORY: O O
Positive O O
only O O
for O O
elevated O O
cholesterol O O
and O O
questionable O O
history O O
of O O
PE O O
in O O
the O O
past. O O
He O O
did B-SMOKER O
smoke I-SMOKER O
in I-SMOKER O
the I-SMOKER O
past I-SMOKER O
and O O
drinks O O
occasionally. O O
He O O
lives O O
with O O
his O O
significant O O
other. O O
FAMILY B-FAMILY_HIST O
HISTORY: I-FAMILY_HIST O
Reviewed I-FAMILY_HIST O
and I-FAMILY_HIST O
is I-FAMILY_HIST O
positive I-FAMILY_HIST O
for I-FAMILY_HIST O
early I-FAMILY_HIST O
CAD I-FAMILY_HIST O
in I-FAMILY_HIST O
his I-FAMILY_HIST O
father. I-FAMILY_HIST O
REVIEW O O
OF O O
SYSTEMS: O O
Other O O
systems O O
are O O
reviewed O O
and O O
otherwise O O
negative O O
except O O
per O O
the O O
HPI. O O
MEDICATIONS: O O
Only O O
Lipitor. B-MEDICATION B-MEDICATION
ALLERGIES: O O
No O O
medical O O
allergies. O O
PHYSICAL O O
EXAMINATION: O O
Temperature O O
is O O
95.2, O O
pulse O O
96, O O
respirations O O
18, O O
blood O O
pressure O O
121/65, O O
and O O
the O O
O2 O O
saturation O O
is O O
94%. O O
The O O
patient O O
is O O
awake, O O
alert, O O
middle O O
age O O
male O O
who O O
appears O O
mildly O O
uncomfortable O O
but O O
in O O
no O O
respiratory O O
distress, O O
reclining O O
on O O
the O O
stretcher. O O
Head O O
examination O O
is O O
normocephalic, O O
atraumatic. O O
His O O
pupils O O
are O O
equal O O
and O O
reactive O O
to O O
light. O O
His O O
sclerae O O
are O O
anicteric. O O
His O O
conjunctivae O O
are O O
pink O O
and O O
moist. O O
He O O
has O O
moist O O
mucous O O
membranes O O
with O O
no O O
erythema. O O
His O O
neck O O
is O O
supple O O
and O O
nontender. O O
The O O
trachea O O
is O O
midline. O O
There O O
is O O
no O O
adenopathy. O O
There O O
is O O
no O O
JVD. O O
He O O
has O O
full O O
range O O
of O O
motion. O O
There O O
is O O
no O O
subcutaneous O O
emphysema. O O
His O O
lungs O O
reveal O O
mild O O
tachypnea. O O
There O O
is O O
no O O
chest O O
wall O O
tenderness. O O
There O O
is O O
no O O
accessory O O
muscle O O
use. O O
He O O
has O O
bibasilar O O
crackles O O
in O O
both O O
lower O O
lung O O
fields. O O
There O O
is O O
no O O
wheezing O O
and O O
equal O O
breath O O
sounds. O O
His O O
cardiac O O
examination O O
is O O
tachycardic O O
and O O
regular O O
at O O
about O O
100 O O
with O O
a O O
4/6 O O
systolic O O
murmur O O
heard O O
prominently O O
at O O
the O O
apex O O
as O O
well O O
as O O
at O O
the O O
right O O
second O O
intercostal O O
space. O O
There O O
is O O
no O O
rub. O O
His O O
pulses O O
are O O
normal. O O
His O O
abdomen O O
is O O
minimally O O
obese O O
but O O
nondistended, O O
soft, O O
nontender, O O
no O O
guarding, O O
no O O
peritoneal O O
signs. O O
There O O
is O O
no O O
organomegaly O O
and O O
no O O
pulsatile O O
masses. O O
His O O
skin O O
is O O
intact, O O
warm, O O
somewhat O O
moist O O
but O O
not O O
diaphoretic. O O
There O O
are O O
no O O
rashes. O O
Extremities O O
reveal O O
no O O
cyanosis, O O
clubbing, O O
or O O
edema. O O
Calves O O
are O O
soft O O
and O O
nontender O O
with O O
no O O
palpable O O
cords, O O
full O O
range O O
of O O
motion O O
with O O
normal O O
strength O O
and O O
tone. O O
He O O
is O O
oriented O O
x3. O O
Cranial O O
nerves O O
are O O
intact. O O
There O O
is O O
no O O
motor O O
or O O
sensory O O
deficit. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
The O O
patient O O
had O O
IV O O
access O O
initiated. O O
He O O
was O O
placed O O
on O O
a O O
cardiac O O
monitor. O O
EKG O O
was O O
performed. O O
He O O
received O O
1 O O
time O O
sublingual B-MEDICATION O
nitroglycerin B-MEDICATION O
with O O
a O O
drop O O
in O O
his O O
blood O O
pressure O O
to O O
systolic O O
in O O
the O O
high O O
70s. O O
A O O
second O O
IV O O
was O O
placed. O O
Right-sided O O
EKG O O
leads O O
were O O
performed, O O
and O O
the O O
patient O O
received O O
IV O O
fluid O O
bolus. O O
He O O
had O O
already O O
received O O
aspirin. B-MEDICATION B-MEDICATION
His O O
white O O
blood O O
cell O O
count O O
is O O
8.4, O O
hematocrit O O
41, O O
and O O
platelets O O
175,000. O O
His O O
electrolytes O O
are O O
within O O
normal O O
limits. O O
His O O
BUN O O
is O O
18, O O
creatinine O O
0.9, O O
and O O
glucose O O
124. O O
His O O
CK O O
was O O
93. O O
His O O
troponin O O
was O O
less O O
than O O
assay. O O
His O O
initial O O
EKG O O
showed O O
normal O O
sinus O O
rhythm O O
in O O
the O O
80s O O
with O O
a O O
normal O O
axis, O O
normal O O
intervals. O O
His O O
pseudonormalization O O
noted O O
only O O
in O O
lead O O
III. O O
He O O
has O O
approximately O O
1.5 O O
mm O O
ST O O
depression O O
with O O
normal O O
ST O O
segments O O
in O O
the O O
anteroseptal O O
leads O O
with O O
somewhat O O
hyperacute O O
appearing O O
T O O
waves. O O
Right-sided O O
leads O O
show O O
some O O
mild, O O
less O O
than O O
1-mm, O O
ST O O
upward O O
sloping O O
in O O
V2 O O
through O O
V5. O O
He O O
had O O
a O O
chest O O
x-ray O O
performed O O
that O O
showed O O
a O O
normal O O
mediastinum O O
and O O
some O O
mild O O
fluffy O O
alveolar O O
infiltrates O O
in O O
the O O
bases O O
but O O
no O O
obvious O O
consolidation O O
and O O
no O O
significant O O
cephalization. O O
He O O
had O O
blood O O
pressures O O
checked O O
in O O
both O O
arms O O
once O O
his O O
blood O O
pressure O O
improved O O
after O O
an O O
IV O O
fluid O O
bolus O O
and O O
was O O
noted O O
to O O
have O O
a O O
persistent O O
20 O O
point O O
difference O O
in O O
systolic O O
blood O O
pressures O O
of O O
136/65 O O
on O O
the O O
right O O
and O O
111/65 O O
on O O
the O O
left. O O
When O O
the O O
patient O O
was O O
questioned O O
about O O
this, O O
he O O
states O O
that O O
he O O
has O O
had O O
that O O
noted O O
in O O
his O O
doctor's O O
office O O
in O O
the O O
past. O O
He O O
underwent O O
CT O O
scanning O O
of O O
the O O
chest, O O
which O O
ruled O O
out O O
aortic O O
dissection O O
after O O
discussion O O
with O O
the O O
attending O O
radiologist. O O
As O O
his O O
blood O O
pressure O O
stabilized, O O
he O O
received O O
IV B-MEDICATION O
Lopressor I-MEDICATION B-MEDICATION
and O O
became O O
pain O O
free. O O
He O O
did O O
not O O
require O O
any O O
further O O
nitroglycerin. O B-MEDICATION
Repeat O O
EKG O O
was O O
performed O O
showing O O
resolution O O
of O O
the O O
0.5 O O
mm O O
ST O O
depression O O
in O O
the O O
anterior O O
leads. O O
Given O O
the O O
patient's O O
cardiac O O
risk O O
factor O O
and O O
his O O
history, O O
which O O
is O O
fairly O O
worrisome O O
for O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O
with O O
a O O
diagnosis O O
of O O
chest O O
pain, O O
rule O O
out O O
new-onset O O
angina. O O
He O O
does O O
remain O O
pain O O
free O O
now O O
and O O
has O O
maintained O O
a O O
stable O O
blood O O
pressure O O
after O O
IV O O
fluid O O
bolus. O O
See O O
the O O
note O O
for O O
full O O
details. O O
Critical O O
care O O
time O O
was O O
45 O O
minutes. O O
______________________________ O O
MELENDEZ, O O
LEAH O O
M.D. O O
D: O O
03/22/92 O O
T: O O
03/22/92 O O
Dictated O O
By: O O
MELENDEZ, O O
LEAH O O
eScription O O
document:3-2120502 O O
BFFocus O O

Record O O
date: O O
2093-01-10 O O
CARDIOLOGY O O
ADMISSION O O
NOTE O O
Uriah O O
LARA O O
FH O O
621-15-64-4 O O
Date O O
of O O
admission O O
01/10/93 O O
PMD: O O
Kenneth O O
Bruce, O O
MD, O O
92 O O
Grand O O
Avenue O O
#704F, O O
East O O
Stroudsburg O O
97162 O O
Ref: O O
Collin O O
L. O O
Cardenas, O O
MD, O O
FH O O
Cardiology O O
This O O
60-yr-old O O
man O O
is O O
admitted O O
w/dizziness O O
and O O
CP. O O
Hx B-CAD O
of I-CAD O
CAD I-CAD O
S/P B-CAD O
stenting I-CAD O
in I-CAD O
7/92, I-CAD O
now O O
has O O
several O O
wks O O
of O O
positional O O
dizziness O O
and O O
CD. O O
Reports O O
over O O
past O O
wks O O
on O O
reaching O O
the O O
top O O
of O O
1 O O
flight O O
of O O
stairs O O
he O O
feels O O
lightheaded O O
and O O
SOB, O O
some O O
episodes O O
accompanied O O
by O O
chest O O
tightness O O
w/radiation O O
to O O
R O O
axilla. O O
Not O O
exactly O O
but O O
somewhat O O
reminiscent O O
of O O
previous O O
CD O O
w/radiation O O
to O O
R O O
scapula. O O
Also O O
had O O
dizziness O O
when O O
rising O O
from O O
squatting O O
to O O
standing, O O
at O O
times O O
quite O O
profound. O O
Has O O
not O O
had O O
LOC O O
w/episodes. O O
Also O O
denies O O
PND, O O
orthopnea, O O
leg O O
edema, O O
fevers, O O
chills, O O
ill O O
contacts, O O
or O O
travel O O
hx. O O
He O O
saw O O
Dr. O O
Cardenas O O
in O O
the O O
office O O
several O O
days O O
ago, O O
was O O
scheduled O O
for O O
ETT O O
and O O
event O O
monitor, O O
but O O
due O O
to O O
persistent O O
symptoms O O
came O O
to O O
FH O O
ER O O
for O O
eval. O O
PMH: O O
CAD O B-MEDICATION
S/P B-CAD O
LAD I-CAD O
DES I-CAD O
placement I-CAD O
7/92, I-CAD O
HTN, B-HYPERTENSION O
dyslipidemia, B-HYPERLIPIDEMIA O
MVA, O O
mild O O
MR. O O
Outpt O O
meds: O O
aspirin B-MEDICATION B-MEDICATION
325 O O
qd, O O
Plavix B-MEDICATION B-MEDICATION
75 O O
qd, O O
Lipitor B-MEDICATION B-MEDICATION
40 O O
qd, O O
Lopid B-MEDICATION B-MEDICATION
600 O O
bid, O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
12.5 O O
qd, O O
folate, O O
trazedone. O O
Intolerance O O
to O O
high O O
dose O O
beta O O
blockers O O
(orthostatic O O
symptoms O O
and O O
fatigue). O O
Former B-SMOKER O
tobacco I-SMOKER O
use, I-SMOKER O
occasional O O
alcohol. O O
Denies O O
IVDU. O O
Recently O O
married. O O
Family O O
hx O O
pos O O
for O O
CAD. O O
ROS: O O
10-system O O
review O O
negative. O O
PE: O O
Afebrile, O O
P O O
80, O O
BP B-HYPERTENSION O
150/90, I-HYPERTENSION O
R O O
18, O O
O2 O O
sat O O
76%. O O
Somewhat O O
disillusioned O O
appearing O O
man O O
lying O O
in O O
bed O O
NAD. O O
HEENT O O
PERLA O O
EOMI, O O
neck O O
supple, O O
JVP O O
&lt;10, O O
no O O
lymphadenopathy O O
or O O
thyromegaly, O O
lungs O O
clear. O O
CV O O
RRR O O
S1 O O
S2, O O
soft O O
MR O O
murmur. O O
Extremities O O
warm O O
w/o O O
edema. O O
Abdomen O O
pos O O
BS O O
soft O O
NT O O
ND. O O
Pulses O O
intact O O
distally. O O
Labs: O O
BUN O O
18, O O
crea O O
1.1, O O
crit O O
40, O O
CK O O
and O O
troponin O O
neg O O
x O O
2. O O
ECG: O O
NSR, O O
normal O O
intervals O O
and O O
axis, O O
no O O
acute O O
ST O O
T-wave O O
abnormalities. O O
ETT B-CAD O
MIBI I-CAD O
today: I-CAD O
5 I-CAD O
minutes, I-CAD O
no I-CAD O
evidence I-CAD O
of I-CAD O
ECG I-CAD O
changes I-CAD O
albeit I-CAD O
at I-CAD O
a I-CAD O
very I-CAD O
low I-CAD O
work I-CAD O
load. I-CAD O
Nuclear I-CAD O
images I-CAD O
(preliminary) I-CAD O
reveal I-CAD O
evidence I-CAD O
of I-CAD O
mild I-CAD O
ischemia I-CAD O
in I-CAD O
the I-CAD O
anterior I-CAD O
territory. I-CAD O
A&P: O O
60-yr-old O O
man O O
w/known O O
CAD O O
S/P B-CAD O
LAD I-CAD O
stenting I-CAD O
presents O O
w/recurrent O O
CP O O
and O O
episodes O O
of O O
lightheadedness. O O
Plan O O
to O O
continue O O
current O O
meds, O O
and O O
in O O
light O O
of O O
hx O O
and O O
mildly O O
positive O O
ETT O O
at O O
low O O
workload O O
will O O
pursue O O
cardiac O O
cath, O O
obtain O O
transthoracic O O
echo. O O
_____________ O O
Steven O O
Huerta, O O
MD O O
DS: O O
01/10/93 O O
DD: O O
01/10/93 O O
DT: O O
01/12/93 O O

Record O O
date: O O
2094-09-07 O O
Forest O O
Hospital O O
/ O O
Mary O O
2827 O O
Hutchinson O O
Street O O
Cardiology, O O
Suite O O
780 O O
LARA, O O
URIAH O O
Pleasant O O
Valley, O O
GA O O
59835 O O
62115644 O O
(466) O O
428-4414 O O
09/07/2094 O O
Kenneth O O
Bruce, O O
M.D. O O
23 O O
Essex O O
Street O O
East O O
Stroudsburg, O O
GA O O
97162 O O
Dear O O
Kenneth: O O
Mr. O O
Lara O O
returned O O
today O O
after O O
a O O
1-year O O
hiatus O O
because O O
of O O
coronary B-CAD O
disease, I-CAD O
status B-CAD O
post I-CAD O
percutaneous I-CAD O
intervention. I-CAD O
He O O
states O O
that O O
his O O
general O O
health O O
has O O
been O O
stable O O
over O O
the O O
past O O
year O O
but O O
over O O
the O O
past O O
several O O
months O O
he O O
has O O
noted, O O
particularly O O
in O O
the O O
hot O O
weather, O O
a O O
sense O O
of O O
dyspnea O O
after O O
walking O O
about O O
170 O O
feet O O
to O O
his O O
mailbox, O O
or O O
across O O
a O O
large O O
parking O O
lot, O O
such O O
as O O
Grand O O
Union. O O
At O O
the O O
end O O
of O O
activity O O
he O O
tends O O
to O O
note O O
a O O
sense O O
of O O
regular O O
fluttering O O
in O O
his O O
chest O O
that O O
persists O O
for O O
a O O
minute O O
or O O
two, O O
and O O
he O O
has O O
also O O
noted O O
the O O
latter O O
almost O O
every O O
night O O
when O O
first O O
lying O O
in O O
bed. O O
He O O
has O O
not O O
had O O
any O O
recurrent O O
orthostatic O O
symptoms O O
since O O
his O O
Toprol B-MEDICATION B-MEDICATION
dose O O
was O O
reduced O O
last O O
year. O O
He O O
has O O
not O O
had O O
any O O
exertionally O O
related O O
chest O O
discomfort O O
or O O
symptoms O O
similar O O
to O O
those O O
prior O O
to O O
his O O
percutaneous O O
interventions. O O
MEDICATIONS: O O
1. O O
Aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
daily. O O
2. O O
Clopidogrel B-MEDICATION B-MEDICATION
75 O O
mg O O
daily. O O
3. O O
Atorvastatin B-MEDICATION B-MEDICATION
40 O O
mg O O
daily. O O
4. O O
Lopid B-MEDICATION B-MEDICATION
600 O O
mg O O
b.i.d. O O
5. O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
12.5 O O
mg O O
daily. O O
6. O O
Xanax, O O
Benadryl O O
at O O
bedtime, O O
multivitamin. O O
INTOLERANCE O O
TO O O
MEDICATIONS: O O
1. O O
Higher-dose O O
beta O O
blocker O O
- O O
orthostasis. O O
2. O O
Lisinopril O B-MEDICATION
- O O
questionable O O
contribution O O
to O O
orthostasis. O O
On O O
examination, O O
he O O
is O O
comfortable O O
at O O
rest. O O
The O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
170/100 I-HYPERTENSION O
checked O O
twice, O O
supine, O O
standing B-HYPERTENSION O
it I-HYPERTENSION O
is I-HYPERTENSION O
160/96, I-HYPERTENSION O
heart O O
rate O O
82 O O
and O O
regular, O O
weight O O
204 O O
pounds, O O
oxygen O O
saturation O O
98%. O O
The O O
jugular O O
venous O O
pressure O O
is O O
5. O O
The O O
carotid O O
upstrokes O O
are O O
symmetric O O
and O O
not O O
delayed. O O
The O O
chest O O
is O O
clear. O O
Cardiac O O
exam O O
shows O O
a O O
grade O O
II/VI O O
holosystolic O O
murmur O O
localized O O
to O O
the O O
apex. O O
The O O
abdominal O O
exam O O
shows O O
no O O
organomegaly, O O
pulsatile O O
masses O O
or O O
bruits. O O
There O O
is O O
no O O
peripheral O O
pitting O O
edema. O O
The O O
electrocardiogram O O
shows O O
sinus O O
rhythm O O
with O O
left O O
atrial O O
abnormality O O
and O O
no O O
new O O
ST-T O O
wave O O
abnormalities O O
compared O O
to O O
October O O
30, O O
2093. O O
In O O
summary, O O
Mr. O O
Lara O O
has: O O
1. O O
History O O
of O O
CAD, B-CAD O
status B-CAD O
placement I-CAD O
of I-CAD O
a I-CAD O
drug-eluting I-CAD O
stent B-CAD O
in I-CAD O
the I-CAD O
LAD, I-CAD O
7/92, O O
without O O
recurrent O O
angina O O
or O O
signs O O
of O O
left O O
ventricular O O
dysfunction. O O
Repeat O O
cardiac O O
catheterization, O O
12/92, O O
because O O
of O O
chest O O
discomfort O O
showed O O
no O O
evidence O O
of O O
restenosis. O O
2. O O
Hypertension, B-HYPERTENSION O
not O O
controlled. O O
His O O
elevated O O
blood O O
pressure O O
may O O
well O O
be O O
contributing O O
to O O
his O O
sense O O
of O O
exertional O O
dyspnea. O O
We O O
spoke O O
about O O
the O O
options. O O
As O O
he O O
had O O
developed O O
orthostatic O O
symptoms O O
previously O O
on O O
higher-dose O O
beta O O
blocker O O
and O O
possibly O O
lisinopril, B-MEDICATION B-MEDICATION
will O O
use O O
smaller O O
doses O O
of O O
alternate O O
agents O O
in O O
an O O
attempt O O
to O O
lower O O
his O O
pressure. O O
He O O
will O O
add B-MEDICATION O
hydrochlorothiazide I-MEDICATION B-MEDICATION
25 O O
mg O O
daily O O
plus B-MEDICATION O
amlodipine I-MEDICATION B-MEDICATION
2.5 O O
mg O O
daily O O
starting O O
today O O
and O O
already O O
has O O
a O O
follow O O
up O O
appointment O O
with O O
you O O
next O O
week. O O
To O O
investigate O O
potential O O
contributions O O
to O O
the O O
elevated O O
pressure O O
and O O
sense O O
of O O
tachycardia, O O
blood O O
studies O O
today O O
will O O
include O O
electrolytes, O O
plasma O O
metanephrine O O
level O O
and O O
TSH. O O
A O O
Holter O O
monitor O O
will O O
also O O
be O O
placed O O
in O O
an O O
attempt O O
to O O
determine O O
what O O
he O O
is O O
experiencing O O
with O O
the O O
sense O O
of O O
'fluttering' O O
which O O
occurs O O
at O O
least O O
nightly. O O
Once O O
his O O
blood O O
pressure O O
is O O
controlled, O O
an O O
exercise O O
test O O
will O O
follow. O O
[Addendum: O O
Holter O O
shows O O
single O O
VPBs/bigeminy O O
at O O
time O O
of O O
his O O
symptoms. O O
Blood O O
studies O O
show O O
normal O O
plasma O O
metanephrines. O O
He O O
reports O O
feeling O O
better O O
with O O
systolic O O
BP O O
in O O
the O O
120's O O
on O O
September O O
18, O O
no O O
further O O
palpitations. O O
He O O
will O O
continue O O
to O O
monitor O O
BP O O
and O O
will O O
call O O
in O O
to O O
schedule O O
ETT] O O
3. O O
Dyslipidemia, B-HYPERLIPIDEMIA O
on O O
combined O O
statin O O
plus O O
gemfibrozil B-MEDICATION O
therapy. O O
When O O
it O O
is O O
time O O
to O O
renew O O
his O O
Lopid, O O
it O O
would O O
be O O
reasonable O O
to O O
switch B-MEDICATION O
to I-MEDICATION O
TriCor I-MEDICATION O
to O O
reduce O O
the O O
potential O O
interaction O O
with O O
statins O O
with O O
respect O O
to O O
myopathy. O O
A O O
serum O O
CK O O
will O O
be O O
included O O
in O O
today's O O
blood O O
studies. O O
4. O O
Mild O O
mitral O O
regurgitation. O O
It O O
was O O
a O O
pleasure O O
to O O
see O O
Mr. O O
Lara O O
today O O
and O O
I O O
will O O
report O O
back O O
to O O
you O O
following O O
his O O
Holter. O O
With O O
kind O O
regards, O O
sincerely O O
yours, O O
______________________________ O O
Collin O O
L O O
Cardenas, O O
MD O O
eScription O O
document:1-3282447 O O
MEeScription O O
CC: O O
Copy O O
to O O
File O O
DD: O O
09/07/94 O O
DT: O O
09/10/94 O O
DV: O O
09/07/94 O O

Record O O
date: O O
2170-02-17 O O
Reason O O
for O O
Visit: O O
chemotherapy O O
Diagnosis/Treatment O O
Summary: O O
10/16/69 O O
EGD O O
@ O O
Griffin O O
Hospital: O O
long O O
partially-obstructing O O
distal O O
esophageal O O
well O O
differentiated O O
invasive O O
adenoCa, O O
from O O
34-39 O O
cm O O
from O O
Barrett's. O O
Rare O O
mucin O O
production. O O
10/17/69 O O
CT O O
chest/abd: O O
prominent O O
thickening O O
distal O O
esophagus. O O
10/21/69 O O
CT O O
chest: O O
LLL O O
8 O O
mm O O
nodule, O O
R-sided O O
pleural O O
thickening. O O
10/21/69 O O
Upper O O
EUS: O O
large O O
esophageal O O
mass O O
extending O O
35-40 O O
cm, O O
9 O O
mm O O
thickness, O O
partially O O
obstructing, O O
suggest O O
invasion O O
muscularis O O
propria. O O
Porta O O
hepatis O O
LAD O O
2 O O
LN, O O
largest O O
12 O O
mm. O O
10/22/69 O O
FNA O O
LN O O
(porta O O
hepatis); O O
no O O
malignancy O O
12/01/69 O O
esophagectomy O O
-&gt; O O
pT2N1 O O
(three O O
positive O O
nodes) O O
2/08/2170 O O
-&gt; O O
adjuvant O O
chemotherapy O O
with O O
5FU/LCV O O
Interval O O
History: O O
Received O O
week O O
1 O O
adjuvant O O
chemo O O
last O O
week. O O
He O O
is O O
able O O
to O O
maintain O O
weight. O O
He O O
has O O
had O O
some O O
vomiting O O
associated O O
with O O
food O O
getting O O
stuck. O O
He O O
is O O
due O O
for O O
a O O
dilation O O
on O O
2/09. O O
He O O
had O O
diarrhea O O
X O O
2 O O
last O O
night, O O
did O O
not O O
need O O
anything O O
to O O
resolve O O
it. O O
He O O
had O O
mild O O
mouth O O
sores O O
on O O
his O O
bottom O O
lip, O O
and O O
tongue. O O
Presents O O
today O O
for O O
chemotherapy O O
PMH/PSH: O O
GERD O O
past O O
20 O O
yrs O O
HTN B-HYPERTENSION O
DM B-DIABETES O
type I-DIABETES O
II I-DIABETES O
Partially O O
blocked O O
L O O
carotid O O
Hypercholesterolemia B-HYPERLIPIDEMIA O
Chronic O O
bronchitis O O
AAA O O
repair O O
x2 O O
2165, O O
2167 O O
Cardiac B-CAD O
stent I-CAD O
2164 I-CAD O
Medications O O
were O O
reviewed O O
today: O O
Aspirin B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
325 O O
MG O O
(325MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Caltrate O O
600 O O
+ O O
D O O
1 O O
TAB O O
PO O O
BID O O
Centrum O O
SILVER O O
(MULTIVITAMINS) O O
1 O O
TAB O O
PO O O
QD O O
Isosorbide B-MEDICATION B-MEDICATION
30 O O
MG O O
1/2 O O
TAB O O
PO O O
bid O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Lisinopril B-MEDICATION B-MEDICATION
40 O O
MG O O
(40MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Metoprolol B-MEDICATION B-MEDICATION
50 O O
MG O O
PO O O
QD O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Prilosec O O
(OMEPRAZOLE) O O
40 O O
MG O O
(40MG O O
CAPSULE O O
DR O O
take O O
1) O O
PO O O
QD O O
Tricor B-MEDICATION O
(FENOFIBRATE O O
(TRICOR)) O O
145 O O
MG O O
(145MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Vitamin O O
C O O
(ASCORBIC O O
ACID) O O
500 O O
MG O O
PO O O
qd O O
Vitamin O O
E O O
(TOCOPHEROL-DL-ALPHA) O O
400 O O
UNITS O O
PO O O
QD O O
Glyburide B-MEDICATION B-MEDICATION
2.5 O O
mg O O
qd O O
Allergies: O O
Adhesive O O
tape-rash O O
SH/FH: O O
Marital O O
status: O O
lives O O
w/ O O
wife O O
Children: O O
3 O O
grown O O
healthy O O
adult O O
children O O
Job: O O
retired O O
2158 O O
Producer O O
for O O
National O O
Radio O O
and O O
Access O O
America O O
Smoking B-SMOKER O
hx: I-SMOKER O
1/2-1ppd I-SMOKER O
x I-SMOKER O
30 I-SMOKER O
yrs, I-SMOKER O
quit I-SMOKER O
2153 I-SMOKER O
ETOH: O O
rare O O
social O O
Illicit O O
drugs: O O
no O O
Environmental O O
exposure: O O
battery O O
chemicals O O
such O O
as O O
zinc O O
chloride, O O
manganese O O
dioxide, O O
carbon, O O
and O O
chemicals O O
for O O
dye O O
production O O
Exercise: O O
generally O O
walks O O
several O O
times O O
a O O
week O O
and O O
plays O O
golf O O
once O O
a O O
week. O O
Able O O
to O O
climb O O
1-2 O O
flt O O
stairs O O
without O O
sob. O O
Mother: O O
died O O
age O O
65 O O
MI O O
Father: O O
died O O
age O O
89 O O
'multip O O
organ O O
failure' O O
Siblings: O O
older O O
brother O O
and O O
younger O O
sister O O
no O O
ca O O
Review O O
of O O
Systems: O O
General: O O
stable O O
weight O O
after O O
losing O O
weight O O
postoperatively, O O
fatigue O O
stable, O O
no O O
fevers, O O
no O O
chills, O O
no O O
change O O
in O O
appetite O O
Respiratory: O O
chronic O O
intermit O O
cough, O O
no O O
SOB, O O
no O O
DOE, O O
no O O
hemoptysis, O O
no O O
wheezing O O
HEENT: O O
No O O
neck O O
swelling, O O
no O O
neck O O
stiffness, O O
slight O O
hoarseness, O O
significant O O
hearing O O
loss, O O
primarily O O
on O O
the O O
left. O O
Cardiac: O O
No O O
chest O O
pain, O O
no O O
palpitations, O O
no O O
arrythmias, O O
no O O
valve O O
disease O O
Gastrointestinal: O O
No O O
nausea, O O
no O O
vomiting, O O
no O O
diarrhea, O O
no O O
constipation, O O
no O O
bleeding, O O
eating O O
by O O
mouth O O
with O O
dysphagia O O
Neurologic: O O
No O O
seizures, O O
occas O O
headache, O O
no O O
weakness, O O
no O O
numbness/ O O
tingling O O
Lymph O O
nodes: O O
No O O
enlarged O O
lymph O O
nodes O O
Musculoskeletal: O O
chronic O O
intermit O O
back O O
pain, O O
no O O
neck O O
pain, O O
no O O
leg O O
pain, O O
no O O
arm O O
pain O O
Urologic: O O
No O O
hematuria, O O
no O O
dysuria, O O
or O O
no O O
obstruction O O
Endocrine: O O
No O O
adrenal, O O
no O O
thyroid O O
or O O
no O O
parathyroid O O
disease O O
Hematologic: O O
No O O
bruising, O O
no O O
clotting, O O
no O O
bleeding O O
Toxicities: O O
0 O O
1 O O
2 O O
3 O O
4 O O
Shortness O O
of O O
Breath O O
Nausea O O
Vomiting O O
x O O
Diarrhea O O
Renal O O
Toxicity O O
Dysphagia O O
/ O O
Esophagitis O O
x O O
Rash O O
Neutropenic O O
Fever O O
Non-Neutropenic O O
Infection O O
Sensory O O
Neuropathy O O
Motor O O
Neuropathy O O
PE O O
/ O O
DVT O O
Physical O O
Examination: O O
Vital O O
Signs O O
BP O O
106/52, O O
P O O
56, O O
RR O O
16, O O
Temp O O
97.8 O O
F, O O
Ht O O
64.75 O O
in, O O
Wt O O
147.5 O O
lb O O
PAIN O O
LEVEL O O
(0-10) O O
0 O O
FATIGUE O O
(0-10) O O
0 O O
PS=1 O O
Neck: O O
no O O
nodes O O
palpable O O
HEENT:grade O O
1 O O
mucositis O O
lower O O
lip; O O
EOMI; O O
PERRL; O O
anicteric O O
Skin: O O
no O O
rash O O
Ext: O O
without O O
edema, O O
clubbing, O O
cyanosis O O
Cor: O O
S1 O O
S2, O O
no O O
mrg O O
Chest: O O
clear O O
lungs O O
without O O
wheezing O O
or O O
crackles, O O
no O O
dullness O O
to O O
percussion; O O
incisions O O
have O O
healed O O
well O O
Abdomen: O O
soft, O O
NT O O
no O O
HSM; O O
G-tube O O
site O O
is O O
clean O O
Nodes: O O
no O O
cervical O O
supraclavicular O O
axillary O O
or O O
inguinal O O
adenopathy O O
Neuro: O O
grossly O O
non-focal O O
Data O O
(laboratory O O
and O O
radiographs) O O
pathology O O
report O O
does O O
above O O
showed O O
a O O
T2N1 O O
cancer O O
with O O
three O O
positive O O
nodes O O
CBC O O
and O O
chemistries O O
were O O
reviewed O O
Assessment O O
and O O
Plan: O O
- O O
locally O O
advanced O O
esophageal O O
cancer O O
status O O
post O O
esophagectomy O O
with O O
negative O O
margins O O
- O O
he O O
has O O
node O O
positive O O
disease, O O
and O O
therefore O O
we O O
recommended O O
adjuvant O O
chemotherapy O O
and O O
radiation. O O
- O O
Week O O
2 O O
5FU/ O O
leukovorin O O
today O O
- O O
dilation O O
2/19 O O
with O O
Dr. O O
Everson. O O
- O O
all O O
questions O O
were O O
answered. O O
_____________________________________________ O O
Pauline O O
Victoria O O
Xenos,NP O O

Record O O
date: O O
2170-03-02 O O
Reason O O
for O O
Visit: O O
Week O O
4 O O
adjuvant O O
chemotherapy O O
with O O
5-FU/LCV O O
Diagnosis/Treatment O O
Summary: O O
10/16/69 O O
EGD O O
@ O O
Griffin O O
Hospital: O O
long O O
partially-obstructing O O
distal O O
esophageal O O
well O O
differentiated O O
invasive O O
adenoCa, O O
from O O
34-39 O O
cm O O
from O O
Barrett's. O O
Rare O O
mucin O O
production. O O
10/17/69 O O
CT O O
chest/abd: O O
prominent O O
thickening O O
distal O O
esophagus. O O
10/21/69 O O
CT O O
chest: O O
LLL O O
8 O O
mm O O
nodule, O O
R-sided O O
pleural O O
thickening. O O
10/21/69 O O
Upper O O
EUS: O O
large O O
esophageal O O
mass O O
extending O O
35-40 O O
cm, O O
9 O O
mm O O
thickness, O O
partially O O
obstructing, O O
suggest O O
invasion O O
muscularis O O
propria. O O
Porta O O
hepatis O O
LAD O O
2 O O
LN, O O
largest O O
12 O O
mm. O O
10/22/69 O O
FNA O O
LN O O
(porta O O
hepatis); O O
no O O
malignancy O O
12/01/69 O O
esophagectomy O O
-&gt; O O
pT2N1 O O
(three O O
positive O O
nodes) O O
2/08/2170 O O
-&gt; O O
adjuvant O O
chemotherapy O O
with O O
5FU/LCV O O
Interval O O
History: O O
One O O
episode O O
of O O
diarrhea; O O
took O O
imodium O O
with O O
effect. O O
Episode O O
of O O
meat O O
getting O O
stuck O O
over O O
the O O
w/e O O
due O O
to O O
eating O O
too O O
fast/not O O
chewing O O
well. O O
To O O
have O O
another O O
dilation O O
this O O
week. O O
To O O
meet O O
with O O
radiation O O
today. O O
Denies O O
numbness/tingling. O O
No O O
fevers. O O
Minimal O O
fatigue. O O
Lisinopril B-MEDICATION B-MEDICATION
was O O
reduced O O
to O O
20mg O O
last O O
week O O
secondary O O
to O O
hypotension. O O
PMH/PSH: O O
GERD O O
past O O
20 O O
yrs O O
HTN B-HYPERTENSION O
DM B-DIABETES O
type I-DIABETES O
II I-DIABETES O
Partially O O
blocked O O
L O O
carotid O O
Hypercholesterolemia B-HYPERLIPIDEMIA O
Chronic O O
bronchitis O O
AAA O O
repair O O
x2 O O
2165, O O
2167 O O
Cardiac B-CAD O
stent I-CAD O
2164 I-CAD O
Medications O O
were O O
reviewed O O
today: O O
Aspirin B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
325 O O
MG O O
(325MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Ativan O B-MEDICATION
(LORAZEPAM) O O
1MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
Q4H O O
PRN O O
nausea O O
Caltrate O O
600 O O
+ O O
D O O
(CALCIUM O O
CARBONATE O O
1500 O O
MG O O
(600 O O
MG O O
ELEM O O
CA)/ O O
VIT O O
D O O
200 O O
IU) O O
1 O O
TAB O O
PO O O
BID O O
Centrum O O
SILVER O O
(MULTIVITAMINS) O O
1 O O
TAB O O
PO O O
QD O O
Glyburide B-MEDICATION B-MEDICATION
2.5 O O
MG O O
(2.5MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Isosorbide B-MEDICATION B-MEDICATION
30 O O
MG O O
1/2 O O
TAB O O
PO O O
bid O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Lisinopril O B-MEDICATION
20MG O O
TABLET O O
PO O O
QD O O
Metoprolol B-MEDICATION B-MEDICATION
SUCCINATE O O
EXTENDED O O
RELEASE O O
50 O O
MG O O
(50MG O O
TAB.SR O O
24H O O
take O O
1) O O
PO O O
QD O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Prilosec O O
(OMEPRAZOLE) O O
40 O O
MG O O
(40MG O O
CAPSULE O O
DR O O
take O O
1) O O
PO O O
QD O O
Reglan O O
5 O O
MG/5 O O
ML O O
SYRUP O O
(METOCLOPRAMIDE O O
5 O O
MG/5 O O
ML O O
SYRUP) O O
10 O O
MG O O
(5MG/5ML O O
SOLUTION O O
take O O
10 O O
ML) O O
PO O O
QID O O
(AC O O
+ O O
HS) O O
PRN O O
nausea O O
, O O
10ML=2tsp O O
Tricor B-MEDICATION O
(FENOFIBRATE O O
(TRICOR)) O O
145 O O
MG O O
(145MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Vitamin O O
C O O
(ASCORBIC O O
ACID) O O
500 O O
MG O O
PO O O
qd O O
Vitamin O O
E O O
(TOCOPHEROL-DL-ALPHA) O O
400 O O
UNITS O O
(400 O O
UNIT O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Zoloft O O
(SERTRALINE) O O
50 O O
MG O O
(50MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Allergies: O O
Adhesive O O
tape-rash O O
SH/FH: O O
Marital O O
status: O O
lives O O
w/ O O
wife O O
Children: O O
3 O O
grown O O
healthy O O
adult O O
children O O
Job: O O
retired O O
2158 O O
Producer O O
for O O
National O O
Radio O O
and O O
Access O O
Americas O O
Smoking B-SMOKER O
hx: I-SMOKER O
1/2-1ppd I-SMOKER O
x I-SMOKER O
30 I-SMOKER O
yrs, I-SMOKER O
quit B-SMOKER O
2153 I-SMOKER O
ETOH: O O
rare O O
social O O
Illicit O O
drugs: O O
no O O
Environmental O O
exposure: O O
battery O O
chemicals O O
such O O
as O O
zinc O O
chloride, O O
manganese O O
dioxide, O O
carbon, O O
and O O
chemicals O O
for O O
dye O O
production O O
Exercise: O O
generally O O
walks O O
several O O
times O O
a O O
week O O
and O O
plays O O
golf O O
once O O
a O O
week. O O
Able O O
to O O
climb O O
1-2 O O
flt O O
stairs O O
without O O
sob. O O
Mother: O O
died O O
age O O
65 O O
MI O O
Father: O O
died O O
age O O
89 O O
'multip O O
organ O O
failure' O O
Siblings: O O
older O O
brother O O
and O O
younger O O
sister O O
no O O
ca O O
Review O O
of O O
Systems: O O
General: O O
No O O
fevers, O O
no O O
chills, O O
no O O
change O O
in O O
appetite O O
Respiratory: O O
chronic O O
intermit O O
cough, O O
no O O
SOB, O O
no O O
DOE, O O
no O O
hemoptysis, O O
no O O
wheezing O O
HEENT: O O
No O O
neck O O
swelling, O O
no O O
neck O O
stiffness, O O
slight O O
hoarseness, O O
significant O O
hearing O O
loss, O O
primarily O O
on O O
the O O
left. O O
Cardiac: O O
No O O
chest O O
pain, O O
no O O
palpitations, O O
no O O
arrythmias, O O
no O O
valve O O
disease O O
Gastrointestinal: O O
No O O
nausea, O O
no O O
vomiting, O O
no O O
diarrhea, O O
no O O
constipation, O O
no O O
bleeding, O O
eating O O
by O O
mouth O O
with O O
intermittent O O
dysphagia O O
Neurologic: O O
No O O
seizures, O O
occas O O
headache, O O
no O O
weakness, O O
no O O
numbness/ O O
tingling O O
Lymph O O
nodes: O O
No O O
enlarged O O
lymph O O
nodes O O
Musculoskeletal: O O
chronic O O
intermit O O
back O O
pain, O O
no O O
neck O O
pain, O O
no O O
leg O O
pain, O O
no O O
arm O O
pain O O
Urologic: O O
No O O
hematuria, O O
no O O
dysuria, O O
or O O
no O O
obstruction O O
Endocrine: O O
No O O
adrenal, O O
no O O
thyroid O O
or O O
no O O
parathyroid O O
disease O O
Hematologic: O O
No O O
bruising, O O
no O O
clotting, O O
no O O
bleeding O O
Toxicities: O O
0 O O
1 O O
2 O O
3 O O
4 O O
Shortness O O
of O O
Breath O O
Nausea O O
Vomiting O O
Diarrhea O O
Renal O O
Toxicity O O
Dysphagia O O
/ O O
Esophagitis O O
x O O
Rash O O
Neutropenic O O
Fever O O
Non-Neutropenic O O
Infection O O
Sensory O O
Neuropathy O O
Motor O O
Neuropathy O O
PE O O
/ O O
DVT O O
Physical O O
Examination: O O
Vital O O
Signs O O
BP O O
88/52, O O
P O O
68, O O
RR O O
18, O O
Temp O O
97.8 O O
F, O O
Ht O O
64.75 O O
in, O O
Wt O O
147.25 O O
lb O O
HT. O O
64.75 O O
in O O
PULSE O O
SITTING O O
68 O O
PAIN O O
LEVEL O O
(0-10) O O
0 O O
FATIGUE O O
(0-10) O O
2 O O
PS=1 O O
Neck: O O
no O O
nodes O O
palpable O O
HEENT:no O O
mucositis; O O
EOMI; O O
PERRL; O O
anicteric O O
Skin: O O
no O O
rash O O
Ext: O O
without O O
edema, O O
clubbing, O O
cyanosis O O
Cor: O O
S1 O O
S2, O O
no O O
mrg O O
Chest: O O
clear O O
lungs O O
without O O
wheezing O O
or O O
crackles, O O
no O O
dullness O O
to O O
percussion; O O
incisions O O
have O O
healed O O
well O O
Abdomen: O O
soft, O O
NT O O
no O O
HSM; O O
G-tube O O
site O O
is O O
clean O O
Nodes: O O
no O O
cervical O O
supraclavicular O O
axillary O O
or O O
inguinal O O
adenopathy O O
Neuro: O O
grossly O O
non-focal O O
Data O O
(laboratory O O
and O O
radiographs) O O
CBC O O
and O O
chemistries O O
were O O
reviewed. O O
Assessment O O
and O O
Plan: O O
- O O
74 O O
yr O O
old O O
gentleman O O
with O O
locally O O
advanced O O
esophageal O O
cancer O O
status O O
post O O
esophagectomy O O
with O O
negative O O
margins. O O
He O O
has O O
node O O
positive O O
disease, O O
and O O
therefore O O
we O O
initiated O O
adjuvant O O
chemotherapy O O
with O O
5-FU/LCV. O O
- O O
Labs O O
adequate O O
for O O
Week O O
4 O O
5FU/ O O
leukovorin O O
today. O O
- O O
To O O
meet O O
with O O
radiation O O
today. O O
- O O
Will O O
decrease O O
lisinopril O B-MEDICATION
to O O
10mg O O
daily, O O
and O O
will O O
contact O O
pt's O O
cardiologist, O O
Dr. O O
Scott O O
Ocasio O O
regarding O O
hypotension. O O
- O O
Instructed O O
to O O
call O O
with O O
temp O O
100.5, O O
and O O
with O O
any O O
questions O O
or O O
concerns. O O
- O O
All O O
questions O O
answered O O
and O O
support O O
and O O
encouragement O O
provided. O O
- O O
RTC O O
in O O
1 O O
week O O
for O O
Week O O
5 O O
5-FU/LCV. O O
__________________________________________ O O
Paula O O
Xin, O O
NP O O

Record O O
date: O O
2171-09-20 O O
09/20/2171 O O
Dr. O O
Charles O O
Calhoun O O
479 O O
Clairmoor O O
Drive O O
Athina, O O
GA O O
39341 O O
RE: O O
HEATH, O O
QUINTEN O O
M O O
MRN: O O
8059475 O O
DOB: O O
08/02/2095 O O
Dear O O
Dr. O O
Calhoun; O O
We O O
had O O
the O O
pleasure O O
of O O
seeing O O
your O O
patient O O
Quinten O O
Heath O O
today O O
in O O
Internal O O
Medicine O O
in O O
followup O O
for O O
osteoporosis O O
and O O
hypogonadism. O O
As O O
you O O
know O O
Mr. O O
Heat O O
is O O
a O O
pleasant O O
76-year-old O O
man O O
with O O
a O O
history O O
of O O
esophageal O O
cancer O O
status O O
post O O
surgery O O
in O O
2169, O O
chemotherapy O O
and O O
radiation O O
who O O
had O O
back O O
pain O O
prompting O O
imaging O O
that O O
revealed O O
several O O
vertebral O O
compression O O
fractures O O
and O O
his O O
BMD O O
was O O
consistent O O
with O O
osteoporosis O O
with O O
a O O
T O O
score O O
of O O
minus O O
4.2 O O
in O O
the O O
lumbar O O
spine O O
and O O
minus O O
2.3 O O
in O O
the O O
femoral O O
neck. O O
We. O O
started O O
zoledronic O O
acid O O
IV O O
in O O
05/2171 O O
that O O
he O O
tolerated O O
fine. O O
In O O
addition, O O
we O O
discovered O O
primary O O
hypogonadism O O
with O O
testosterone O O
levels O O
around O O
45 O O
mg/dL O O
and O O
elevated O O
FSH O O
and O O
LH O O
levels. O O
We O O
started O O
AndroGel O O
therapy O O
for O O
testosterone O O
replacement O O
and O O
appeared O O
that O O
he O O
is O O
taking O O
every O O
day. O O
He O O
does O O
not O O
really O O
feel O O
any O O
better O O
or O O
stronger O O
with O O
this O O
medication. O O
PAST O O
MEDICAL O O
HISTORY: O O
1. O O
Osteoporosis. O O
2. O O
Hypogonadism. O O
3. O O
History O O
of O O
esophageal O O
cancer O O
status O O
post O O
esophagectomy O O
in O O
2169, O O
adjuvant O O
chemotherapy O O
and O O
radiation O O
therapy. O O
4. O O
Gastroesophageal O O
reflux O O
disease. O O
5. O O
Hypertension. B-HYPERTENSION O
6. B-DIABETES O
Diabetes I-DIABETES O
type I-DIABETES O
2. I-DIABETES O
7. O O
Carotid O O
artery O O
disease, O O
left. O O
8. O O
Hypercholesterolemia. B-HYPERLIPIDEMIA O
9. O O
Status O O
post O O
AAA O O
repair O O
in O O
2165. O O
10. O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
with I-CAD O
status I-CAD O
post I-CAD O
stent. I-CAD O
REVIEW O O
OF O O
SYSTEMS: O O
He O O
is O O
anxious O O
because O O
he O O
has O O
some O O
swallowing O O
problems O O
and O O
fears O O
that O O
his O O
esophageal O O
disease O O
is O O
acting O O
up O O
and O O
he O O
is O O
anticipating O O
a O O
CAT O O
scan O O
in O O
a O O
few O O
days. O O
MEDICATIONS: O O
Tricor, B-MEDICATION O
metoprolol, B-MEDICATION B-MEDICATION
Prilosec, O O
Lipitor, B-MEDICATION B-MEDICATION
aspirin, B-MEDICATION B-MEDICATION
Plavix, B-MEDICATION B-MEDICATION
Isordil, B-CAD O
Zoloft, O O
vitamin O O
C, O O
Centrum O O
Caltrate O O
plus O O
D O O
600 O O
mg O O
twice O O
a O O
day, O O
zoledronic O O
acid O O
4 O O
mg O O
IV O O
once O O
a O O
year O O
and O O
AndroGel O O
5 O O
grams O O
once O O
a O O
day. O O
ALLERGIES: O O
Tape. O O
SOCIAL B-SMOKER O
HISTORY: O O
He O O
is O O
married O O
and O O
has O O
3 O O
children. O O
Vital O O
signs: O O
Blood O O
pressure O O
118/48, O O
pulse O O
68, O O
weight O O
136 O O
pounds. O O
Height O O
5 O O
feet O O
4 O O
inches. O O
LABORATORY O O
EVALUATION: O O
His O O
testosterone O O
level O O
on O O
AndroGel O O
is O O
normal O O
at O O
292 O O
mg/dL O O
(normal O O
195-1138) O O
on O O
09/13/2171. O O
His O O
hematocrit O O
is O O
39. O O
It O O
was O O
37 O O
in O O
02/2171.. O O
Platelets O O
are O O
179,000. O O
White O O
count O O
4.8. O O
In O O
summary, O O
Mr. O O
Heath O O
is O O
a O O
76-year-old O O
man O O
with O O
osteoporosis O O
and O O
compression O O
fractures O O
probably O O
secondary O O
to O O
hypogonadism O O
and O O
therapy O O
for O O
esophageal O O
cancer. O O
The O O
cause O O
of O O
hypogonadism O O
is O O
probably O O
the O O
chemotherapy. O O
I O O
asked O O
him O O
again O O
to O O
see O O
a O O
urologist O O
to O O
rule O O
out O O
other O O
causes O O
of O O
primary O O
hypogonadism. O O
He O O
will O O
continue O O
the O O
current O O
treatment O O
with O O
calcium, O O
vitamin O O
D, O O
testosterone O O
and O O
antiresorptive O O
therapy O O
of O O
his O O
yearly O O
zoledronic O O
acid. O O
We O O
will O O
repeat O O
a O O
BMD O O
in O O
2 O O
years O O
from O O
now. O O
Please O O
let O O
me O O
know O O
if O O
you O O
have O O
any O O
questions. O O
Yours O O
sincerely, O O
___________________________ O O
Vincent O O
Voorhees, O O
M.D. O O
cc: O O
Quinten O O
Heath, O O
976 O O
Clinton O O
Street, O O
Gardnerville O O
Ranchos, O O
GA O O
79269 O O
Dr. O O
Quebedeaux O O
Dr. O O
Hendricks O O
DD: O O
09/20/2171 O O
TD: O O
09/21/2171 O O
16:37:30 O O
TR: O O
8190465 O O
BackJob O O
ID: O O
326372 O O
VoiceJob O O
ID: O O
91587262 O O

Record O O
date: O O
2173-02-04 O O
RADIATION O O
ONCOLOGY O O
FOLLOW-UP O O
NOTE O O
HEATH, O O
QUINTEN O O
M. O O
805-94-75 O O
REFERRING O O
PHYSICIAN: O O
Fred O O
Quebedeaux, O O
M.D. O O
DATE O O
OF O O
VISIT: O O
2/4/2173 O O
REASON O O
FOR O O
VISIT: O O
Reassessment O O
of O O
progress, O O
s/p O O
postoperative O O
adjuvant O O
radiation O O
therapy O O
in O O
combination O O
with O O
concurrent O O
chemotherapy O O
for O O
esophageal O O
adenocarcinoma, O O
T2N1 O O
stage O O
IIB, O O
s/p O O
left O O
thoracoabdominal O O
esophagectomy O O
(12/01/69) O O
with O O
pathologic O O
tumor O O
stage O O
T2N1M0 O O
(3/23 O O
involved O O
lymph O O
nodes). O O
POSTOPERATIVE O O
RADIATION O O
THERAPY: O O
For O O
the O O
presence O O
of O O
metastatic O O
disease O O
in O O
regional O O
lymph O O
nodes, O O
he O O
was O O
judged O O
a O O
candidate O O
for O O
postoperative O O
adjuvant O O
chemo-radiation O O
therapy. O O
He O O
was O O
treated O O
with O O
a O O
total O O
dose O O
of O O
45 O O
Gy O O
in O O
25 O O
fractions O O
to O O
the O O
tumor O O
bed O O
region O O
using O O
IMRT, O O
planned O O
with O O
4D O O
CT O O
simulation. O O
This O O
treatment O O
was O O
administered O O
in O O
combination O O
with O O
chemotherapy O O
between O O
March O O
29, O O
2170, O O
and O O
Apr O O
30, O O
2170. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Mr. O O
Quinten O O
Heath O O
is O O
a O O
77 O O
year-old O O
gentleman O O
with O O
a O O
history B-SMOKER O
of I-SMOKER O
smoking, I-SMOKER O
chronic O O
GERD, O O
HTN, B-HYPERTENSION O
CAD B-CAD O
s/p I-CAD O
PCI, I-CAD O
partially O O
blocked O O
L O O
carotid O O
artery O O
and O O
AAA O O
repair O O
x O O
2. O O
He O O
was O O
in O O
his O O
USOH O O
until O O
8/69 O O
when O O
he O O
began O O
to O O
have O O
difficulty O O
swallowing. O O
While O O
eating O O
a O O
hamburger O O
he O O
felt O O
it O O
lodge O O
in O O
his O O
chest O O
with O O
accompanying O O
retrosternal O O
discomfort O O
and O O
increased O O
salivation. O O
He O O
has O O
had O O
about O O
a O O
dozen O O
similar O O
episodes O O
since O O
then, O O
which O O
have O O
generally O O
resolved O O
within O O
10-15 O O
minutes O O
without O O
regurgitation. O O
In O O
9/69 O O
his O O
PCP O O
prescribed O O
a O O
PPI, O O
which O O
helped O O
somewhat, O O
but O O
he O O
continued O O
to O O
have O O
dysphagia. O O
On O O
10/16/69 O O
EGD O O
at O O
Griffin O O
Hospital O O
demonstrated O O
a O O
partially-obstructing O O
distal O O
esophageal O O
mass O O
34-39 O O
cm O O
from O O
the O O
incisors, O O
associated O O
with O O
Barrett&#8217;s O O
esophagus, O O
with O O
pathology O O
significant O O
for O O
well O O
differentiated O O
invasive O O
adenocarcinoma. O O
On O O
10/17/69 O O
CT O O
of O O
the O O
chest O O
and O O
abdomen O O
showed O O
prominent O O
thickening O O
of O O
the O O
distal O O
esophagus. O O
On O O
10/21/69 O O
repeat O O
CT O O
of O O
the O O
chest O O
showed O O
an O O
8 O O
mm O O
LLL O O
nodule O O
and O O
R-sided O O
pleural O O
thickening. O O
Upper O O
EUS O O
showed O O
a O O
partially O O
obstructing O O
esophageal O O
mass O O
extending O O
from O O
35-40 O O
cm O O
with O O
9 O O
mm O O
thickness, O O
suggestive O O
of O O
invasion O O
to O O
the O O
muscularis O O
propria, O O
one O O
suspicious O O
mediastinal O O
LN, O O
and O O
porta O O
hepatis O O
adenopathy. O O
On O O
10/22 O O
FNA O O
of O O
a O O
porta O O
hepatis O O
LN O O
was O O
negative. O O
He O O
underwent O O
a O O
left O O
thoracoabdominal O O
esophagectomy O O
on O O
12/1/69. O O
Pathology O O
showed O O
an O O
ulcerated O O
tumor O O
measuring O O
4.0x3.5x0.8 O O
cm, O O
invading O O
into O O
muscularis O O
propria O O
(pT2) O O
and O O
metastasis O O
to O O
3 O O
of O O
27 O O
LN O O
(N1). O O
INTERVAL O O
HISTORY/REVIEW O O
OF O O
SYSTEMS: O O
He O O
has O O
been O O
doing O O
well O O
without O O
significant O O
GI O O
or O O
respiratory O O
symptoms. O O
He O O
has O O
maintained O O
steady O O
energy O O
and O O
appetite. O O
He O O
has O O
had O O
mild O O
dysphagia O O
for O O
solid O O
and O O
meat. O O
Otherwise, O O
he O O
has O O
been O O
doing O O
well. O O
He O O
denies O O
significant O O
respiratory O O
symptoms. O O
No O O
focal O O
or O O
generalized O O
neurological O O
symptoms. O O
The O O
remainder O O
of O O
review O O
of O O
systems O O
was O O
unremarkable. O O
PAST O O
MEDICAL O O
HISTORY: O O
GERD O O
x O O
20 O O
years O O
HTN O O
Hypercholesterolemia B-HYPERLIPIDEMIA B-MEDICATION
DM B-DIABETES O
type I-DIABETES B-CAD
II I-DIABETES O
CAD O B-CAD
s/p O O
stent O O
2164 O O
Partially O O
blocked O O
L O O
carotid O O
AAA O O
repair O O
2165, O O
2167 O O
Chronic O O
bronchitis O O
CURRENT O O
MEDICATIONS: O O
Aspirin B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
325 O O
MG O O
(325MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
Caltrate O O
600 O O
+ O O
D O O
(CALCIUM O O
CARBONATE O O
1500 O O
MG O O
(600 O O
MG O O
ELEM O O
CA)/ O O
VIT O O
D O O
200 O O
IU) O O
1 O O
TAB O O
PO O O
BID O O
Centrum O O
SILVER O O
(MULTIVITAMINS) O O
1 O O
TAB O O
PO O O
QD O O
Isosorbide B-CAD B-MEDICATION
30 O O
MG O O
1/2 O O
TAB O O
PO O O
bid O O
Metformin B-MEDICATION B-MEDICATION
250 O O
MG O O
(500MG O O
TABLET O O
Take O O
0.5) O O
PO O O
QD O O
Metoprolol B-MEDICATION B-MEDICATION
SUCCINATE O O
EXTENDED O O
RELEASE O O
50 O O
MG O O
(50MG O O
TAB.SR O O
24H O O
Take O O
1) O O
PO O O
QD O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
Prilosec O O
(OMEPRAZOLE) O O
20 O O
MG O O
(20 O O
MG O O
CAPSULE O O
DR O O
Take O O
1) O O
PO O O
QD O O
Reclast O O
(ZOLEDRONIC O O
ACID O O
) O O
4 O O
MG O O
(4MG/5ML O O
VIAL O O
Take O O
5 O O
ML) O O
IV O O
once O O
a O O
year O O
, O O
given O O
6/25/72 O O
Simvastatin B-MEDICATION B-MEDICATION
20 O O
MG O O
(20 O O
MG O O
TABLET O O
Take O O
1) O O
PO O O
QPM O O
Tricor B-MEDICATION O
(FENOFIBRATE O O
(TRICOR)) O O
134 O O
MG O O
(134MG O O
CAPSULE O O
Take O O
1) O O
PO O O
QD O O
Vitamin O O
C O O
(ASCORBIC O O
ACID) O O
500 O O
MG O O
PO O O
qd O O
Zoloft O O
(SERTRALINE) O O
50 O O
MG O O
(50MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#30 O O
Tablet(s) O O
ALLERGIES: O O
Adhesive O O
tape O O
(rash) O O
SOCIAL O O
HISTORY: O O
Lives O O
with O O
wife O O
in O O
Gardnerville O O
Ranchos, O O
GA. O O
3 O O
healthy O O
adult O O
children. O O
Retired O O
2158 O O
as O O
a O O
Producer O O
for O O
National O O
Radi O O
and O O
Access O O
Amer.. O O
Quit B-SMOKER O
smoking I-SMOKER O
2153, I-SMOKER O
prior I-SMOKER O
&#189;-1 I-SMOKER O
ppd I-SMOKER O
x I-SMOKER O
30 I-SMOKER O
years. I-SMOKER O
Rare O O
social O O
alcohol. O O
FAMILY O O
HISTORY: O O
Mother, O O
MI, O O
died O O
age O O
65. O O
Father, O O
died O O
age O O
89. O O
Brother O O
and O O
sister, O O
no O O
cancer. O O
PHYSICAL O O
EXAMINATION: O O
General: O O
pleasant O O
elderly O O
gentleman, O O
NAD O O
ECOG O O
PS: O O
1 O O
Vital O O
Signs: O O
BP O O
118/78, O O
P O O
72, O O
RR O O
16, O O
Temp O O
97.3 O O
F, O O
Ht O O
64.75 O O
in, O O
Wt O O
137.5 O O
lb O O
O2 O O
SAT O O
97 O O
BMI O O
23.1 O O
PAIN O O
LEVEL O O
(0-10) O O
0 O O
HEENT: O O
PERRL, O O
EOMI, O O
MMM, O O
OP O O
clear O O
Neck: O O
supple, O O
no O O
JVD. O O
Nodes: O O
no O O
cervical O O
or O O
supraclavicular O O
LAD O O
Chest: O O
Clear O O
without O O
wheezes O O
or O O
rales. O O
Heart: O O
RRR, O O
no O O
m/r/g O O
Abdomen: O O
soft, O O
NT/ND, O O
no O O
HSM, O O
NABS, O O
well-healed O O
scar O O
from O O
AAA O O
repair O O
Ext: O O
no O O
edema O O
or O O
tenderness. O O
Skin: O O
Unremarkable. O O
Neuro: O O
AOx3, O O
nonfocal O O
RADIOGRAPHS: O O
Restaging O O
CT O O
of O O
chest, O O
abdomen O O
and O O
pelvis O O
obtained O O
on O O
1/28/2173 O O
showed O O
no O O
demonstrable O O
recurrence O O
or O O
metastatic O O
disease. O O
IMPRESSION O O
AND O O
PLAN: O O
This O O
77 O O
year-old O O
man O O
with O O
adenocarcinoma O O
of O O
the O O
distal O O
esophagus, O O
s/p O O
left O O
thoracoabdominal O O
esophagectomy O O
(12/01/69) O O
with O O
pathologic O O
tumor O O
stage O O
T2N1M0 O O
and O O
postoperative O O
adjuvant O O
chemo-radiation O O
therapy O O
has O O
been O O
doing O O
well O O
with O O
no O O
demonstrable O O
recurrence O O
or O O
metastatic O O
disease. O O
He O O
has O O
minimum O O
symptoms O O
of O O
dysphagia O O
with O O
meats. O O
An O O
arrangement O O
has O O
been O O
made O O
for O O
him O O
to O O
be O O
seen O O
at O O
the O O
clinic O O
in O O
6 O O
months O O
with O O
restaging O O
CT O O
of O O
chest, O O
abdomen O O
and O O
pelvis. O O
. O O
_____________________ O O
Benjamin O O
H. O O
Hendricks, O O
M.D. O O
Fernando O O
Quebedeaux, O O
M.D. O O
Vincent O O
Everson, O O
M.D. O O
Larry O O
Quezada, O O
M.D. O O
Charles O O
Chaney, O O
M.D. O O
100 O O
Clairmoor O O
Drive O O
Athina, O O
GA O O
39341 O O

Record O O
date: O O
2077-10-31 O O
CCU O O
Admit O O
Note O O
Xayavong, O O
Brandon O O
MR# O O
7826250 O O
Date O O
of O O
Admission: O O
10/30/77 O O
Attending: O O
Dr. O O
Umphrey O O
ID/CC: O O
56yoM O O
with O O
anterior B-CAD O
STEMI, I-CAD O
s/p O O
lysis, O O
cath O O
showing O O
large O O
LAD O O
plaque O O
HPI: O O
Mr O O
Xayavong O O
is O O
a O O
56yoM O O
with O O
cardiac O O
risk O O
factors O O
of O O
DM, B-DIABETES O
tobacco, B-SMOKER O
HTN B-HYPERTENSION O
who O O
presents O O
from O O
OSH O O
with O O
chest O O
pain O O
beginning O O
at O O
10:30 O O
the O O
morning O O
of O O
admission. O O
He O O
says O O
he O O
doesn't O O
remember O O
what O O
he O O
was O O
doing O O
at O O
the O O
time, O O
but O O
was O O
not O O
engaged O O
in O O
strenuous O O
activity. O O
Describes O O
diaphoresis O O
, O O
then O O
7/10 O O
pain O O
from O O
left O O
shoulder O O
into O O
left O O
arm O O
and O O
chest. O O
He O O
took O O
advil O O
without O O
effect. O O
He O O
presented O O
to O O
Carver O O
Hospital, O O
where O O
he O O
was O O
found O O
to O O
have O O
STE O O
V2-5, O O
Troponin O O
I O O
0.05, O O
CK O O
248, O O
MB O O
2.8. O O
He O O
was O O
started O O
on O O
full-dose O O
integrilin, O O
half-dose O O
reteplase, O O
and O O
heparin O O
gtt, O O
transferred O O
to O O
GNC O O
for O O
emergent O O
cath. O O
LHC O O
showed O O
diffuse O O
thrombotic O O
LAD O O
disease, O O
no O O
interventions. O O
IABP O O
placed, O O
sent O O
to O O
CCU O O
for O O
further O O
monitoring O O
and O O
management. O O
ROS: O O
As O O
above, O O
otherwise O O
negative O O
in O O
detail. O O
PMH: O O
DM2 B-DIABETES O
x I-DIABETES O
8-9 I-DIABETES O
years, I-DIABETES O
non-insulin I-DIABETES O
dependent I-DIABETES O
Tobacco B-SMOKER O
use I-SMOKER O
HTN O O
Toe O O
infection O O
Medications: O O
Glipizide B-MEDICATION B-MEDICATION
5 O O
BID O O
Avandia B-MEDICATION B-MEDICATION
2mg O O
QD O O
Lisinopril B-MEDICATION B-MEDICATION
5mg O O
QD O O
Allergies: O O
NKDA O O
SH: O O
Patient O O
lives O O
in O O
Lake O O
Pocotopaug O O
with O O
wife. O O
Justice O O
of O O
the O O
peace. O O
2ppd O O
x O O
40y, O O
denies O O
etoh. O O
FH: O O
No O O
early O O
heart O O
disease O O
Exam: O O
VS: O O
T= O O
98 O O
HR= O O
70s O O
BP= O O
130/70 O O
RR= O O
14 O O
SaO2= O O
99% O O
2L O O
General: O O
NAD O O
HEENT: O O
NC/AT, O O
PERRL, O O
anicteric. O O
EOMI. O O
OP O O
w/ O O
MMM, O O
no O O
erythema O O
or O O
injection. O O
Skin: O O
No O O
rashes O O
Neck: O O
Supple, O O
full O O
ROM, O O
JVP O O
flat, O O
2+ O O
carotids O O
w/o O O
bruits, O O
no O O
thyromegaly O O
or O O
nodules, O O
no O O
nodes O O
Chest: O O
CTA&P O O
bilaterally O O
CVS: O O
RRR O O
nl O O
S1 O O
S2, O O
IABP O O
in O O
place O O
Abd: O O
nl O O
BS, O O
soft, O O
non-tender, O O
no O O
HSM O O
Extr: O O
no O O
c/c/e O O
2+ O O
DP's O O
bilaterally, O O
no O O
hematoma, O O
no O O
bruit O O
Neuro: O O
AAOX3, O O
MS O O
nl, O O
CN O O
II O O
through O O
XII O O
intact, O O
Motor O O
5/5 O O
UE O O
and O O
LE, O O
Sensory O O
intact. O O
DTR's O O
2+ O O
and O O
symmetric O O
in O O
bilat O O
LE O O
and O O
UE. O O
Toes O O
down O O
bilaterally. O O
DATA: O O
Chemistry: O O
Plasma O O
Sodium O O
137 O O
(135-145) O O
mmol/L O O
Plasma O O
Potassium O O
4.4 O O
(3.4-4.8) O O
mmol/L O O
Plasma O O
Chloride O O
105 O O
(100-108) O O
mmol/L O O
Plasma O O
Carbon O O
Dioxide O O
20.1 O O
L O O
(23.0-31.9) O O
mmol/L O O
Calcium O O
8.5 O O
(8.5-10.5) O O
mg/dl O O
Phosphorus O O
2.9 O O
(2.6-4.5) O O
mg/dl O O
Magnesium O O
1.4 O O
(1.4-2.0) O O
meq/L O O
Plasma O O
Urea O O
Nitrogen O O
19 O O
(8-25) O O
mg/dl O O
Plasma O O
Creatinine O O
1.0 O O
(0.6-1.5) O O
mg/dl O O
Plasma O O
Glucose O O
245 O O
H O O
(70-110) O O
mg/dl O O
Total O O
Protein O O
6.3 O O
(6.0-8.3) O O
g/dl O O
Albumin O O
3.9 O O
(3.3-5.0) O O
g/dl O O
Globulin O O
2.4 O O
L O O
(2.6-4.1) O O
g/dl O O
Direct O O
Bilirubin O O
0.1 O O
(0-0.4) O O
mg/dl O O
Total O O
Bilirubin O O
0.4 O O
(0.0-1.0) O O
mg/dl O O
Triglycerides O O
231 O O
H O O
(40-150) O O
mg/dl O O
Cholesterol O O
135 O O
mg/dl O O
High O O
Density O O
Lipoprotein O O
21 O O
L O O
(35-100) O O
mg/dl O O
Low O O
Density O O
Lipoprotein O O
68 O O
mg/dl O O
Cardiac O O
Risk O O
Ratio O O
6.4 O O
Alkaline O O
Phosphatase O O
72 O O
(45-115) O O
U/L O O
Transaminase-SGPT O O
38 O O
(10-55) O O
U/L O O
Creatine O O
Kinase O O
Isoenzymes O O
PEND O O
(0.0-6.9) O O
ng/ml O O
CPK O O
Isoenzymes O O
Index O O
PEND O O
(0.0-3.5) O O
% O O
Troponin-T O O
PEND O O
(0.00-0.09) O O
ng/ml O O
Transaminase-SGOT O O
213 O O
H O O
(10-40) O O
U/L O O
Creatine O O
Kinase O O
PEND O O
(60-400) O O
U/L O O
Heme: O O
WBC O O
12.7 O O
H O O
(4.5-11.0) O O
th/cmm O O
HCT O O
38.7 O O
L O O
(41.0-53.0) O O
% O O
HGB O O
13.6 O O
(13.5-17.5) O O
gm/dl O O
RBC O O
4.34 O O
L O O
(4.50-5.90) O O
mil/cmm O O
PLT O O
218 O O
(150-350) O O
th/cumm O O
MCV O O
89 O O
(80-100) O O
fl O O
MCH O O
31.3 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
35.1 O O
(31.0-37.0) O O
g/dl O O
RDW O O
13.3 O O
(11.5-14.5) O O
% O O
PT O O
14.9 O O
H O O
(11.3-13.3) O O
sec O O
PT-INR O O
1.4 O O
APTT O O
51.0 O O
H O O
(22.1-35.1) O O
sec O O
DIFFERENTIAL O O
REQUEST O O
RECEIVED O O
Diff O O
Method O O
Auto O O
Poly O O
84 O O
H O O
(40-70) O O
% O O
Lymphs O O
12 O O
L O O
(22-44) O O
% O O
Monos O O
3 O O
L O O
(4-11) O O
% O O
EOS O O
1 O O
(0-8) O O
% O O
Basos O O
0 O O
(0-3) O O
% O O
Urinalysis: O O
Pending O O
CXR: O O
pending O O
EKG: O O
NSR O O
@ O O
79, O O
1mm O O
STE O O
V2-V4, O O
Qs O O
V1-3 O O
Prelim O O
echo: O O
Anteroseptal O O
and O O
lateral O O
hypokinesis, O O
EF O O
30-40%, O O
no O O
significant O O
valvular O O
lesions. O O
___________________________________________ O O
Impression: O O
56yoM O O
with O O
anterior O O
STEMI, O O
s/p O O
half-dose O O
lytics, O O
s/p O O
cath O O
showing O O
thrombotic O O
prox O O
LAD O O
not O O
intervened O O
on. O O
Now O O
on O O
IABP, O O
chest-pain O O
free. O O
Plan: O O
1. O O
Ischemia O O
Will O O
likely O O
go O O
back O O
for O O
repeat O O
cath O O
on O O
Monday, O O
possible O O
LAD O O
intervention O O
IABP O O
1:1 O O
for O O
now, O O
with O O
ancef O O
prophylaxis O O
Keep O O
on O O
integrilin, O O
heparin O O
with O O
close O O
PTT O O
monitoring O O
ASA B-MEDICATION O
Holding O O
on O O
BB O O
given O O
decreased O O
EF, O O
some O O
sinus O O
pauses O O
Holding O O
on O O
statin O O
for O O
now, O O
given O O
transaminitis O O
Trending O O
markers O O
2. O O
Rhythm O O
D/c O O
lidocaine, O O
holding O O
BB O O
Transcutaneous O O
pacing O O
pads O O
3. O O
Pump O O
EF O O
30-40%, O O
will O O
likely O O
re-echo O O
later O O
Appears O O
euvolemic O O
4. O O
DM O O
Holding O O
oral O O
hypoglycemics O O
RISS O O
5. O O
Prophylaxis O O
Heparin, O O
Nexium O O
6. O O
Dispo O O
Full O O
Code O O
_________________________________ O O
Charles O O
Amaya, O O
MD O O
Pager O O
#36784 O O

Record O O
date: O O
2082-06-13 O O
SDU O O
ADMISSION B-DIABETES O
NOTE O O
PATIENT: O O
XAYAVONG, O O
BRANDON O O
MRN: O O
7826250 O O
ADMIT O O
DATE: O O
6/13/2082 O O
PCP: O O
DR. O O
ERNEST O O
EDGE O O
ATTENDING O O
PHYSICIAN: O O
DR. O O
ASHLEI O O
TYSON O O
OUTPATIENT O O
CARDIOLOGIST: O O
DR. O O
BRIAN O O
MOSS O O
(772-261-4350) O O
CHIEF O O
COMPLAINT: O O
fatigue, O O
lightheadedness O O
HISTORY O O
OF O O
THE O O
PRESENT O O
ILLNESS O O
Mr. O O
Xayavong O O
is O O
a O O
61M O O
h/o O O
CAD B-CAD B-CAD
(anterior B-CAD O
STEMI I-CAD O
2077, I-CAD O
stents B-CAD O
x2 I-CAD O
to I-CAD O
LAD, I-CAD O
4 I-CAD O
stents I-CAD O
since I-CAD O
then, I-CAD O
last I-CAD O
2080), I-CAD O
DM, O O
CHF O O
unknown O O
EF, O O
HTN, B-HYPERTENSION O
who O O
p/w O O
~3 O O
days O O
of O O
nonspecific O O
symptoms O O
of O O
fatigue, O O
nausea, O O
and O O
poor O O
sleep. O O
He O O
receives O O
most O O
of O O
his O O
care O O
at O O
Duluth O O
Clinic-Hermantown O O
(Dr. O O
Moss). O O
Two O O
weeks O O
ago, O O
he O O
had O O
BiV/ICD O O
placement, O O
as O O
well O O
as O O
left O O
heart O O
catheterization O O
that O O
showed, O O
per O O
verbal O O
report, O O
&#8220;multivessel O O
disease O O
difficult O O
for O O
CABG.&#8221; O O
He O O
says O O
he O O
also O O
had O O
a O O
chemical O O
stress O O
study O O
but O O
is O O
unsure O O
of O O
the O O
results. O O
He O O
reports O O
that O O
he O O
was O O
then O O
referred O O
to O O
GNC O O
for O O
high-risk O O
CABG O O
(Dr. O O
U. O O
Wyatt) O O
and O O
potential O O
heart O O
transplant O O
evaluation O O
(Dr. O O
A. O O
Tyson). O O
He O O
feels O O
that O O
since O O
the O O
BiV/ICD O O
placement O O
he O O
has O O
been O O
feeling O O
more O O
tired, O O
specifically O O
in O O
the O O
past O O
3 O O
days, O O
wherein O O
he O O
reports O O
fatigue, O O
nausea, O O
poor O O
sleep, O O
exertional O O
lightheadedness. O O
He O O
has O O
not O O
had O O
chest O O
pain O O
(he O O
did O O
have O O
chest O O
pain O O
with O O
prior O O
two O O
MIs), O O
palpitations, O O
vomiting, O O
diarrhea. O O
He O O
does O O
have O O
some O O
orthopnea, O O
but O O
no O O
PND O O
and O O
LE O O
swelling O O
intermittently, O O
but O O
not O O
at O O
present. O O
To O O
his O O
knowledge, O O
he O O
has O O
never O O
had O O
a O O
tachyarrhythmia. O O
However, O O
he O O
does O O
note O O
that O O
he O O
was O O
started O O
on O O
digoxin O O
a O O
few O O
weeks O O
ago, O O
tried O O
it O O
for O O
1 O O
week, O O
then O O
had O O
fatigue, O O
nausea, O O
GI O O
upset, O O
and O O
that O O
the O O
medication O O
was O O
then O O
discontinued. O O
On O O
arrival, O O
he O O
had O O
HR O O
135, O O
BP O O
106/73 O O
with O O
some O O
drops O O
to O O
low O O
of O O
80/50. O O
Felt O O
to O O
be O O
VT O O
versus O O
Afib O O
with O O
aberrancy. O O
EP O O
was O O
consulted, O O
interrogated O O
his O O
device, O O
and O O
confirmed O O
that O O
he O O
was O O
in O O
Afib O O
(and O O
that O O
it O O
had O O
never O O
fired O O
or O O
detected O O
VT/VF). O O
He O O
was O O
given O O
amio O O
load O O
300 O O
and O O
drip O O
at O O
1mg/min, O O
with O O
some O O
HR O O
response O O
to O O
100-120s. O O
For O O
hyperkalemia O O
to O O
5.1, O O
he O O
was O O
given O O
calcium O O
gluconate, O O
insulin, O O
D50, O O
bicard; O O
and O O
his O O
Mg O O
was O O
repleted. O O
Given O O
his O O
persistent O O
symptoms, O O
per O O
EP O O
recs, O O
he O O
was O O
started O O
on O O
heparin O O
drip O O
with O O
5000 O O
units O O
bolus. O O
(He O O
is O O
not O O
on O O
Coumadin O O
at O O
baseline; O O
he O O
takes O O
toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
12.5mg O O
only.) O O
CXR O O
by O O
report O O
was O O
clear. O O
With O O
admiodarone, O O
BPs O O
dropped O O
to O O
75; O O
upon O O
discontinuation, O O
BPs O O
back O O
up O O
to O O
80s, O O
then O O
90s. O O
Of O O
note, O O
he O O
says O O
his O O
baseline O O
HR O O
is O O
80s O O
and O O
SBP O O
is O O
90s. O O
REVIEW O O
OF O O
SYSTEMS O O
Negative O O
in O O
detail O O
except O O
as O O
noted O O
otherwise O O
above. O O
PAST O O
MEDICAL/SURGICAL O O
HISTORY: O O
CAD, O O
h/o O O
STEMI O O
2077, O O
8 O O
stents O O
including O O
LAD O O
at O O
least O O
x2, O O
BiV/ICD O O
placement O O
2 O O
weeks O O
ago, O O
last O O
cath O O
Duluth O O
2 O O
weeks O O
with O O
&#8220;multivessel O O
disease O O
not O O
amenable O O
to O O
CABG&#8221; O O
BiV/ICD O O
(DDD, O O
St. O O
Jude O O
Promote O O
RF, O O
5/13/81) O O
CHF O O
DM O O
HTN O O
Former B-SMOKER O
tobacco I-SMOKER O
RECENT O O
DIAGNOSTIC O O
STUDIES O O
TTE, O O
11/04/2077: O O
LA O O
dil, O O
LV: O O
WMA O O
anterior, O O
septal, O O
apical, O O
no O O
thrombus, O O
delayed O O
relaxation, O O
EF O O
35%, O O
RV O O
nl O O
Interventional O O
LHC, O O
10/2077: O O
Successful O O
stenting O O
of O O
the O O
proximal O O
LAD O O
with O O
a O O
3.5 O O
x O O
15 O O
and O O
3.0 O O
x O O
15 O O
mm O O
Vision O O
stents. O O
LHC, O O
10/2077: O O
Dominance: O O
Right O O
Left O O
Main: O O
normal. O O
LAD: O O
diffuse, O O
irregular, O O
and O O
thrombotic O O
90 O O
% O O
stenosis O O
in O O
its O O
proximal O O
third. O O
D1: O O
focal O O
90 O O
% O O
stenosis O O
in O O
its O O
ostium O O
Ramus: O O
focal O O
95 O O
% O O
stenosis O O
in O O
its O O
ostium. O O
Both O O
the O O
1st O O
Diagonal O O
and O O
Ramus O O
side O O
branches O O
arise O O
from O O
the O O
thrombotic O O
Proximal O O
LAD O O
segment. O O
Cx/RCA: O O
minimal O O
irregularities O O
FAMILY O O
HISTORY: O O
Heart O O
disease O O
on O O
both O O
mother&#8217;s O O
and O O
father&#8217;s O O
side, O O
but O O
no O O
early O O
CAD O O
in O O
1st O O
degree O O
relatives. O O
HTN O O
and O O
HL O O
on O O
both O O
sides. O O
SOCIAL O O
HISTORY: O O
Retired O O
purchasing O O
agent. O O
Quit B-SMOKER O
smoking I-SMOKER O
a I-SMOKER O
few I-SMOKER O
years I-SMOKER O
ago, I-SMOKER O
had I-SMOKER O
smoked I-SMOKER O
1-2ppd I-SMOKER O
since I-SMOKER O
youth. I-SMOKER O
No O O
EtOH, O O
illicits. O O
ALLERGIES/ADVERSE O O
REACTIONS: O O
history O O
of O O
?digoxin O O
toxicity O O
as O O
above O O
MEDICATIONS O O
ON O O
ADMISSION: O O
1. O O
Acetylsalicylic B-MEDICATION B-MEDICATION
Acid I-MEDICATION O
(Aspirin) B-MEDICATION O
325 O O
MG O O
PO O O
QAM O O
2. O O
Esomeprazole O O
(Nexium) O O
40 O O
MG O O
PO O O
QD O O
3. O O
Glipizide B-MEDICATION B-MEDICATION
10 O O
MG O O
PO O O
BID O O
4. O O
Metformin B-MEDICATION B-MEDICATION
500 O O
MG O O
PO O O
BID O O
5. O O
Omega-3-Fatty O O
Acids O O
(Fish O O
Oil O O
Capsule) O O
1200 O O
MG O O
PO O O
QD O O
6. O O
Furosemide O O
(Lasix) O O
20 O O
MG O O
PO O O
QOD O O
7. O O
Nicotinic O O
Acid O O
Extended O O
Release O O
(Niacin O O
Extended O O
Release) O O
500 O O
MG O O
PO O O
QD O O
8. O O
Metoprolol B-MEDICATION B-MEDICATION
Succinate O O
Extended O O
Release O O
(Toprol O O
Xl) O O
12.5 O O
MG O O
PO O O
QPM O O
9. O O
Lisinopril B-MEDICATION B-MEDICATION
10 O O
MG O O
PO O O
QPM O O
10. O O
Simvastatin B-MEDICATION B-MEDICATION
20 O O
MG O O
PO O O
QAM O O
PHYSICAL O O
EXAMINATION O O
VITALS: O O
T O O
96.8 O O
/ O O
HF O O
133 O O
/ O O
BP O O
112/65 O O
/ O O
RR O O
18 O O
/ O O
O2 O O
96% O O
RA O O
General O O
&#8211; O O
NAD, O O
male, O O
pleasant O O
HEENT O O
&#8211; O O
NC/AT, O O
PERRL, O O
EOMI, O O
sclerae O O
anicteric, O O
OP O O
pink/moist O O
without O O
erythema, O O
exudates, O O
or O O
lesions O O
Neck O O
&#8211; O O
No O O
LAD, O O
JVP O O
flat; O O
carotid O O
pulses O O
2+ O O
bilaterally O O
Pulmonary O O
&#8211; O O
no O O
rhonchi, O O
wheezes, O O
+bibasilar O O
few O O
crackles O O
Cardiac O O
&#8211; O O
tachycardic O O
to O O
~100; O O
nl O O
S1/S2; O O
no O O
m/r/g; O O
2+pulses O O
in O O
the O O
extremities O O
bilaterally O O
Abdomen O O
&#8211; O O
soft, O O
NT/ND, O O
no O O
rebound/guarding, O O
+BS, O O
no O O
HSM/masses O O
Extremity O O
&#8211; O O
WWP, O O
no O O
c/c/e O O
Neurology O O
&#8211; O O
CN O O
II-XII O O
grossly O O
intact, O O
good O O
strength/sensation O O
bilaterally O O
Skin O O
&#8211; O O
no O O
concerning O O
lesions O O
Mental O O
status O O
&#8211; O O
alert O O
and O O
oriented O O
x O O
3 O O
LABORATORIES O O
06/13/82 O O
12:03 O O
NA O O
139 O O
K O O
5.1(H) O O
CL O O
101 O O
CO2 O O
24.6 O O
BUN O O
28(H) O O
CRE O O
1.31 O O
EGFR O O
59(T) O O
GLU O O
220(H) O O
CA O O
9.4 O O
PHOS O O
3.0 O O
MG O O
1.3(L) O O
06/13/82 O O
12:07 O O
CK-MB O O
Negative O O
TROP-I O O
Negative O O
WBC O O
8.2 O O
HCT O O
40.0(L) O O
PLT O O
227 O O
%NEUT O O
72(H) O O
%LYMPH O O
20(L) O O
PT O O
14.2(H) O O
PT-INR O O
1.2 O O
PTT O O
23.8 O O
RADIOLOGICAL O O
STUDIES O O
CXR O O
6/6: O O
clear O O
lungs O O
EKG: O O
AFib O O
with O O
aberrancy O O
at O O
98bpm, O O
LBBB O O
morphology, O O
LAD, O O
TWI O O
V5/V6, O O
I/aVL O O
ASSESSMENT O O
AND O O
PLAN O O
Mr. O O
Xayavong O O
is O O
a O O
61M O O
h/o O O
CAD O B-CAD
(anterior O O
STEMI O O
2077, O O
stents O O
x2 O O
to O O
LAD, O O
4 O O
stents O O
since O O
then, O O
last O O
2080), O O
DM, O O
CHF O O
unknown O O
EF, O O
HTN, O O
who O O
p/w O O
a O O
couple O O
days O O
of O O
nonspecific O O
symptoms O O
of O O
fatigue, O O
nausea, O O
and O O
poor O O
sleep. O O
He O O
presented O O
with O O
atrial O O
fibrillation O O
with O O
RVR, O O
with O O
moderate O O
response O O
to O O
IV O O
amiodarone O O
load O O
and O O
bolus O O
but O O
hypotension. O O
He O O
has O O
known O O
multivessel O O
disease O O
felt O O
by O O
report O O
to O O
be O O
a O O
high-risk O O
CABG O O
candidate, O O
and O O
is O O
doubly O O
referred O O
for O O
heart O O
transplant O O
evaluation. O O
CV/RHYTHM: O O
Afib/RVR, O O
with O O
generalized O O
nonspecific O O
symptoms O O
- O O
Not O O
ideally O O
controlled O O
on O O
amiodarone O O
given O O
hypotension, O O
but O O
can O O
tolerate O O
SBP O O
90s O O
given O O
this O O
is O O
his O O
baseline O O
and O O
no O O
evidence O O
of O O
hypoperfusion O O
- O O
Trial O O
digoxin O O
low-dose O O
versus O O
cautiously O O
titrating O O
diltiazem O O
or O O
metoprolol O B-MEDICATION
- O O
Bolus O O
NS O O
as O O
needed O O
for O O
low O O
BPs O O
- O O
High O O
risk O O
for O O
clot O O
given O O
likely O O
prolonged O O
Afib, O O
however, O O
CHADS O O
is O O
2 O O
or O O
3 O O
(HTN, O O
DM, O O
?CHF) O O
- O O
Heparinize, O O
hold O O
on O O
Coumadin O O
bridge O O
in O O
case O O
of O O
possible O O
procedures O O
- O O
Tele, O O
replete O O
lytes O O
CV/ISCHEMIA: O O
Known O O
multivessel O O
disease, O O
difficult O O
to O O
CABG O O
per O O
OSH O O
cardiologist O O
- O O
ASA, B-MEDICATION B-MEDICATION
hold O O
BB/ACEI O O
given O O
hypotention, O O
statin, O O
niacin, O O
check O O
lipids O O
- O O
Given O O
no O O
clear O O
cause O O
for O O
Afib O O
and O O
comorbid O O
with O O
DM, O O
trend O O
cardiac O O
markers O O
- O O
Ongoing O O
outpatient O O
eval O O
for O O
CABG O O
CV/PUMP: O O
Unknown O O
EF, O O
mild O O
crackles O O
on O O
exam, O O
taking O O
lasix O O
QOD O O
at O O
home. O O
Relatively O O
euvolemic. O O
- O O
Continue O O
lasix O O
QOD O O
regimen O O
- O O
Check O O
TTE O O
for O O
new O O
WMA, O O
worsening O O
cardiomyopathy O O
- O O
Will O O
discuss O O
plan O O
with O O
Heart O O
Failure O O
service O O
DM: O O
Hold O O
glipizide, O B-MEDICATION
metofrmin O B-MEDICATION
while O O
in O O
house. O O
RISS O O
+ O O
FSBG O O
AC/HS O O
FEN: O O
cardiac O O
PROPHYLAXIS O O
GI: O O
home O O
PPI O O
DVT: O O
on O O
heparin O O
BOWEL: O O
prn O O
regimen O O
CODE: O O
Full O O
code O O
__________________________________ O O
Armani O O
Iler, O O
MD, O O
MSc O O
GNC O O
Department O O
of O O
Medicine O O
Pager O O
#41393 O O

Record O O
date: O O
2082-10-22 O O
CARDIOLOGY O O
GRIFFIN O O
NURSING O O
CENTER O O
Reason O O
for O O
visit: O O
Interval O O
History: O O
Mr. O O
Xayavong O O
is O O
a O O
61-year-old O O
gentleman O O
with O O
history O O
of O O
CAD, B-CAD B-CAD
anterior B-CAD O
STEMI I-CAD O
2077, I-CAD O
stents B-CAD O
x I-CAD O
2 I-CAD O
to I-CAD O
LAD, I-CAD O
four I-CAD O
stents I-CAD O
since I-CAD O
then, I-CAD O
last I-CAD O
2080, I-CAD O
diabetes, B-DIABETES O
CHF, O O
unknown O O
EF O O
with O O
EF O O
of O O
25%, O O
and O O
hypertension B-HYPERTENSION B-HYPERTENSION
currently O O
under O O
pre O O
cardiac O O
transplant O O
evaluation. O O
In O O
5/82 O O
he O O
had O O
BiV O O
ICD O O
placement O O
as O O
well O O
as O O
left O O
heart O O
catheterization, O O
which O O
showed O O
multivessel O O
disease O O
higher O O
risk O O
for O O
CABG. O O
He O O
was O O
hospitalised O O
in O O
6/82 O O
after O O
he O O
presented O O
with O O
~3 O O
days O O
of O O
nonspecific O O
symptoms O O
of O O
fatigue, O O
nausea, O O
and O O
poor O O
sleep. O O
He O O
was O O
in O O
Afib O O
at O O
that O O
point O O
of O O
time O O
and O O
had O O
elevated O O
NT- O O
proBNP. O O
His O O
medications O O
were O O
adjusted. O O
He O O
was O O
discharged O O
from O O
the O O
hospital O O
class O O
III O O
stage O O
C O O
to O O
D O O
He O O
denies O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
PND, O O
orthopnea, O O
palpitations, O O
or O O
syncope. O O
No O O
ICD O O
discharges O O
reported. O O
He O O
denies O O
any O O
lightheadedness O O
or O O
dizziness O O
He O O
does O O
note O O
a O O
queasy O O
sensation O O
in O O
the O O
stomach O O
on O O
and O O
off. O O
Past O O
medical O O
history: O O
CAD, O O
history O O
of O O
STEMI O O
in O O
2077, O O
eight O O
stents O O
including O O
LAD, O O
at O O
least O O
x O O
2, O O
BiV O O
ICD O O
placement O O
, O O
last O O
cath O O
at O O
OCH O O
showed O O
multivessel O O
disease, O O
BiV O O
ICD, O O
DDD O O
St. O O
Jude, O O
05/13/2081, O O
CHF, O O
diabetes, O O
hypertension, O B-HYPERTENSION
former B-SMOKER O
smoker. I-SMOKER O
Changes O O
to O O
Allergies O O
NKA: O O
No O O
Known O O
Allergies O O
- O O
reaction: O O
[reviewed] O O
Family O O
history: O O
Significant O O
for O O
heart O O
disease O O
in O O
both O O
mother's O O
and O O
father's O O
side, O O
but O O
no O O
early O O
CAD O O
in O O
the O O
first-degree O O
relatives, O O
hypertension O B-HYPERTENSION
and O O
hyperlipidemia O O
in O O
both O O
sides. O O
Social O O
history: O O
He O O
is O O
a O O
retired O O
purchasing O O
agent, O O
quit B-SMOKER O
smoking I-SMOKER O
a I-SMOKER O
few I-SMOKER O
years I-SMOKER O
ago, I-SMOKER O
had I-SMOKER O
smoked I-SMOKER O
one I-SMOKER O
pack I-SMOKER O
per I-SMOKER O
day. I-SMOKER O
He O O
has O O
used O O
no O O
alcohol O O
or O O
illicit O O
drug O O
use, O O
a O O
very O O
supportive O O
family. O O
Review O O
of O O
systems: O O
Negative, O O
otherwise O O
as O O
stated O O
above O O
Physical O O
examination: O O
-BMI: O O
-Pulse: O O
66 O O
-weight: O O
221 O O
lbs. O O
-Neuro: O O
Grossly O O
intact. O O
-Extremities: O O
No O O
edema, O O
1+ O O
pulses O O
bilaterally. O O
-Abdomen: O O
Soft O O
without O O
hepatosplenomegaly, O O
bruits O O
-Cardiac: O O
Apical O O
impulse O O
laterally O O
displaced, O O
RRR, O O
S1/S2, O O
2+ O O
MR O O
murmur, O O
1+ O O
TR O O
ateral O O
PMI. O O
-Chest: O O
Clear O O
to O O
auscultation. O O
-Neck: O O
JVP O O
is O O
approximately O O
8 O O
cm. O O
His O O
neck O O
is O O
supple O O
without O O
thyromegaly. O O
Carotids O O
are O O
brisk O O
without O O
bruits. O O
-Heent: O O
Normocephalic. O O
Atraumatic. O O
Clear O O
oral O O
cavity. O O
Midline O O
thyroid. O O
-Skin: O O
No O O
rashes, O O
anicteric O O
-General: O O
He O O
is O O
a O O
well-appearing O O
gentleman O O
in O O
no O O
acute O O
distress. O O
-BP: O O
82/50 O O
EKG: O O
V-paced O O
rhythm O O
@66bpm, O O
Left O O
axis O O
Deviation, O O
QTc-517. O O
Selected O O
recent O O
labs: O O
Pending O O
Impression: O O
61 O O
year O O
old O O
man O O
with O O
Stage O O
C O O
New O O
York O O
Heart O O
Association O O
class O O
III O O
heart O O
failure. O O
Patient O O
is O O
scheduled O O
for O O
a O O
right O O
heart O O
cath O O
in O O
11/82. O O
His O O
NTproBNP O O
is O O
high, O O
but O O
since O O
he O O
is O O
medically O O
optimized O O
we O O
cannot O O
further O O
titrate O O
his O O
therapies. O O
Medication O O
List O O
CONFIRMED O O
- O O
ACETYLSALICYLIC B-MEDICATION B-MEDICATION
ACID I-MEDICATION O
(ASPIRIN) B-MEDICATION O
81 O O
PO O O
QAM O O
- O O
Aldactone O O
12.5 O O
MG O O
PO O O
daily O O
- O O
esomeprazole O O
40 O O
MG O O
PO O O
daily O O
- O O
Fish O O
oil O O
000mg O O
1200mg O O
po O O
- O O
glipizide B-MEDICATION B-MEDICATION
20 O O
MG O O
PO O O
BID O O
BEFORE O O
BREAKFAST O O
AND O O
BEFORE O O
SUPPER O O
- O O
Lasix O O
40 O O
MG O O
PO O O
daily O O
- O O
lisinopril B-MEDICATION B-MEDICATION
5mg O O
po O O
daily O O
- O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
12.5 O O
MG O O
PO O O
daily O O
- O O
warfarin O O
5 O O
MG O O
PO O O
QPM O O
------------------------------------------------------------ O O
REMOVED O O
- O O
Omega3 O O
1200 O O
MG O O
PO O O
BID O O
Crystal O O
Perez, O O
MD O O
Quintin O O
D. O O
Quesada, O O
MD O O
pager O O
#15657 O O
Signed O O
electronically O O
by O O
Crystal O O
Perez, O O
MD; O O
Quintin O O
D. O O
Quesada, O O
MD O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2083-07-21 O O
CCU O O
Admission O O
Note O O
PATIENT: O O
Brandon O O
Xayavong O O
MRN: O O
7826250 O O
DATE: O O
7/21/83 O O
TIME: O O
4:00pm O O
PCP: O O
Ernest O O
Edge, O O
MD O O
ATTENDING O O
PHYSICIAN: O O
Ashlei O O
Tyson, O O
MD O O
CONTACT O O
INFO: O O
Elisha O O
(wife) O O
- O O
968-774-6381 O O
REASON O O
FOR O O
ADMISSION B-DIABETES O
Tailored O O
therapy O O
HISTORY O O
OF O O
THE O O
PRESENT O O
ILLNESS O O
Mr. O O
Xayavong O O
is O O
a O O
62 O O
year O O
old O O
man O O
with O O
a O O
history O O
of O O
CAD B-CAD O
(s/p B-CAD O
STEMI B-CAD O
and I-CAD O
multiple I-CAD O
stents), I-CAD O
CHF O O
(s/p O O
BiV O O
ICD, O O
class O O
D O O
and O O
stage O O
III), O O
DM, O O
and O O
CRI O O
who O O
was O O
admitted O O
for O O
tailored O O
therapy O O
after O O
a O O
routine O O
RHC O O
demonstrated O O
elevated O O
filling O O
pressures. O O
Mr. O O
Xayavong O O
has O O
a O O
primary O O
cardiologist O O
(Dr. O O
Marshall) O O
in O O
Gloucester O O
and O O
has O O
received O O
much O O
medical O O
care O O
at O O
Oregon O O
City O O
Hospital. O O
He O O
has O O
been O O
followed O O
by O O
Dr. O O
Ashlei O O
Tyson O O
for O O
the O O
possibility O O
of O O
cardiac O O
transplantation O O
and O O
has O O
intermittently O O
been O O
admitted O O
to O O
GNC. O O
He O O
was O O
admitted O O
to O O
GNC O O
from O O
6/13/82 O O
to O O
6/19/82 O O
after O O
being O O
found O O
to O O
be O O
in O O
atrial O O
fibrillation O O
with O O
hypotension, O O
fatigue, O O
and O O
nausea; O O
this O O
was O O
2 O O
weeks O O
after O O
the O O
placement O O
of O O
his O O
BiV O O
ICD. O O
He O O
converted O O
to O O
sinus O O
rhythm O O
after O O
amiodarone O O
was O O
administered, O O
but O O
developed O O
a O O
marked O O
transaminitis. O O
Due O O
to O O
elevated O O
filling O O
pressures O O
(PCWP O O
23), O O
he O O
required O O
IV O O
Lasix O O
for O O
diuresis. O O
He O O
was O O
felt O O
to O O
be O O
a O O
poor O O
candidate O O
for O O
CABG O O
given O O
the O O
degree O O
of O O
heart O O
failure, O O
so O O
transplantation O O
was O O
instead O O
pursued. O O
He O O
was O O
also O O
admitted O O
to O O
GNC O O
from O O
11/10/82 O O
through O O
11/13/82 O O
after O O
again O O
being O O
found O O
with O O
elevated O O
filling O O
pressures O O
after O O
complaining O O
of O O
fatigue O O
(PCWP O O
37); O O
he O O
received O O
a O O
PA O O
line O O
and O O
required O O
a O O
Lasix O O
drip O O
and O O
IV O O
nitroprusside. O O
At O O
the O O
time O O
of O O
discharge, O O
his O O
reported O O
dry O O
weight O O
was O O
206 O O
lbs. O O
He O O
came O O
for O O
a O O
scheduled O O
right-sided O O
heart O O
catheterization O O
today O O
as O O
he O O
has O O
had O O
increasing O O
complaint O O
of O O
fatigue. O O
He O O
reports O O
that O O
he O O
has O O
been O O
feeling O O
&#8220;lousy,&#8221; O O
that O O
his O O
appetite O O
has O O
been O O
&#8220;crummy,&#8221; O O
and O O
that O O
he O O
is O O
&#8220;feeling O O
real O O
tired.&#8221; O O
He O O
feels O O
that O O
these O O
symptoms O O
have O O
been O O
relatively O O
severe O O
but O O
unchanged O O
for O O
the O O
past O O
2 O O
years. O O
He O O
denies O O
overt O O
shortness O O
of O O
breath, O O
but O O
essentially O O
fatigues O O
very O O
easily O O
with O O
physical O O
exertion, O O
and O O
has O O
been O O
requiring O O
multiple O O
naps O O
a O O
day. O O
He O O
states O O
that O O
he O O
has O O
been O O
careful O O
with O O
his O O
diet O O
(both O O
fluid O O
and O O
salt O O
intake) O O
without O O
any O O
changes, O O
and O O
that O O
he O O
has O O
been O O
entirely O O
compliant O O
with O O
his O O
medications. O O
Of O O
note, O O
his O O
cardiologist O O
attempted O O
to O O
change O O
him O O
from O O
Toprol B-MEDICATION B-MEDICATION
XL O O
to O O
Coreg B-MEDICATION O
several O O
months O O
ago, O O
and O O
that O O
seems O O
to O O
have O O
made O O
him O O
feel O O
worse. O O
He O O
continues O O
to O O
urinate O O
to O O
his O O
home O O
Lasix O O
dosing. O O
He O O
denies O O
any O O
sensation O O
of O O
chest O O
pain O O
or O O
chest O O
pressure, O O
and O O
denies O O
chest O O
palpitations O O
or O O
sensation O O
of O O
fluttering; O O
he O O
states O O
clearly O O
that O O
he O O
could O O
tell O O
when O O
his O O
heart O O
was O O
in O O
an O O
abnormal O O
rhythm O O
in O O
6/72. O O
He O O
says O O
that O O
his O O
pacemaker O O
was O O
&#8220;checked&#8221; O O
last O O
week O O
and O O
that O O
he O O
was O O
told O O
he O O
didn&#8217;t O O
have O O
any O O
&#8220;episodes.&#8221; O O
He O O
believes O O
that O O
he O O
has O O
been O O
putting O O
on O O
weight O O
recently, O O
and O O
reports O O
that O O
his O O
baseline O O
weight O O
is O O
~225 O O
lbs. O O
He O O
denies O O
recent O O
fevers O O
or O O
chills. O O
He O O
has O O
no O O
complaint O O
of O O
leg O O
swelling. O O
PAST O O
MEDICAL/SURGICAL O O
HISTORY O O
CAD O B-CAD
STEMI O O
2077 O O
s/p O O
2 O O
stents O O
to O O
the O O
LAD O O
(done O O
at O O
GNC) O O
Reports B-CAD O
2 I-CAD O
other I-CAD O
MI&#8217;s I-CAD O
(2079 I-CAD O
and I-CAD O
2080, I-CAD O
treated I-CAD O
at I-CAD O
OCH) I-CAD O
Reportedly B-CAD O
s/p I-CAD O
~8 I-CAD O
stents I-CAD O
in I-CAD O
total I-CAD O
after I-CAD O
various I-CAD O
interventions I-CAD O
Per O O
report, O O
multi-vessel O O
disease O O
&#8220;difficult O O
for O O
CABG&#8221; O O
5/82 O O
CHF O O
BiV O O
ICD O O
placement O O
DDD O O
5/13/2082 O O
Class O O
D, O O
Stage O O
III O O
Diabetes B-DIABETES O
Chronic O O
Renal O O
Insufficiency O O
h/o O O
Latent O O
Tuberculosis O O
s/p O O
Toe O O
Amputation O O
x2 O O
Last O O
one O O
was O O
taken O O
off O O
several O O
months O O
ago O O
secondary O O
to O O
infection O O
s/p O O
Fused O O
L O O
Ankle O O
RECENT O O
DIAGNOSTIC O O
STUDIES O O
Cardiac O O
Catheterization O O
(10/30/77) O O
Dominance: O O
Right O O
Left O O
Main: O O
The O O
left O O
main O O
coronary O O
artery O O
is O O
of O O
moderate O O
length, O O
intermediate O O
sized O O
vessel. O O
It O O
bifurcates O O
into O O
the O O
LAD O O
and O O
LCX O O
coronary O O
arteries. O O
Left O O
main O O
coronary O O
artery O O
is O O
normal. O O
LAD: B-CAD O
The I-CAD O
Proximal B-CAD O
LAD I-CAD O
has I-CAD O
a I-CAD O
diffuse, I-CAD O
irregular, I-CAD O
and I-CAD O
thrombotic I-CAD O
90 I-CAD O
% I-CAD O
stenosis I-CAD O
in I-CAD O
its I-CAD O
proximal I-CAD O
third. I-CAD O
D1 I-CAD O
has I-CAD O
a I-CAD O
focal I-CAD O
90 I-CAD O
% I-CAD O
stenosis I-CAD O
in I-CAD O
its I-CAD O
ostium. I-CAD O
The I-CAD O
Ramus I-CAD O
has I-CAD O
a I-CAD O
focal I-CAD O
95 I-CAD O
% I-CAD O
stenosis I-CAD O
in I-CAD O
its I-CAD O
ostium. I-CAD O
Both I-CAD O
the I-CAD O
D1 I-CAD O
and I-CAD O
Ramus I-CAD O
side I-CAD O
branches I-CAD O
arise I-CAD O
from I-CAD O
the I-CAD O
thrombotic I-CAD O
proximal I-CAD O
LAD I-CAD O
segment. I-CAD O
Left O O
Circumflex: O O
The O O
left O O
circumflex O O
coronary O O
artery O O
is O O
moderate O O
sized O O
vessel, O O
which O O
gives O O
origin O O
to O O
two O O
obtuse O O
marginal O O
arteries. O O
The O O
artery O O
contains O O
only O O
minimal O O
irregularities. O O
RCA: O O
The O O
right O O
coronary O O
artery O O
is O O
a O O
large O O
vessel. O O
The O O
artery O O
contains O O
only O O
minimal O O
irregularities. O O
TTE O O
(6/15/82) O O
Moderate O O
MR O O
with O O
e/o O O
elevated O O
LA O O
pressure. O O
Dilated O O
LV O O
with O O
severe O O
diffuse O O
hypokinesis O O
(with O O
some O O
preservation O O
of O O
mid-septal, O O
inferior, O O
and O O
lateral O O
segments). O O
EF O O
19%. O O
Moderate O O
TR. O O
RVSP O O
64 O O
mmHg. O O
Dilated O O
RV O O
with O O
diffuse O O
hypokinesis. O O
Thallium O O
Myocardial O O
Imaging O O
(6/17/82) O O
The O O
myocardial O O
scans O O
show O O
apical O O
and O O
distal O O
inferior O O
infarction. O O
The O O
remainder O O
of O O
the O O
myocardium O O
is O O
viable. O O
Distal B-CAD O
anterior I-CAD O
ischemia I-CAD O
was I-CAD O
present I-CAD O
at I-CAD O
rest. I-CAD O
RHC O O
(11/10/82) O O
RA O O
9, O O
RV O O
68/7, O O
PA O O
70/38, O O
PCWP O O
37, O O
CO O O
4.9 O O
RHC O O
(6/9/83) O O
RA O O
10, O O
RV O O
55/15, O O
PA O O
52/23, O O
PCWP O O
23, O O
CO O O
5.8 O O
(Thermo), O O
CI O O
2.62 O O
RHC O O
(7/21/83) O O
Baseline: O O
RA O O
8, O O
RV O O
68/8, O O
PA O O
68/33 O O
(44), O O
PCWP O O
27 O O
(prominent O O
V O O
waves O O
to O O
43) O O
CO O O
4.7, O O
CI O O
2.07 O O
s/p O O
Nitro O B-MEDICATION
100mcg O O
IV: O O
PA O O
53/20 O O
(34), O O
PCWP O O
16 O O
MEDICATIONS O O
ON O O
ADMISSION O O
1. O O
Acetylsalicylic B-MEDICATION B-MEDICATION
Acid I-MEDICATION O
(Aspirin) B-MEDICATION O
81 O O
MG O O
PO O O
QD O O
2. O O
Calcium O O
Citrate O O
630 O O
MG O O
PO O O
BID O O
3. O O
Carvedilol B-MEDICATION O
3.125 O O
MG O O
PO O O
QD O O
4. O O
Cholecalciferol O O
(Vitamin O O
D3) O O
1000 O O
UNITS O O
PO O O
QD O O
5. O O
Diazepam O O
(Valium) O O
5 O O
MG O O
PO O O
prn O O
6. O O
Esomeprazole O O
(Nexium) O O
40 O O
MG O O
PO O O
QD O O
7. O O
Furosemide O O
(Lasix) O O
40 O O
MG O O
PO O O
QD O O
8. O O
Glipizide B-MEDICATION B-MEDICATION
20 O O
MG O O
PO O O
BID O O
9. O O
Insulin B-MEDICATION O
Glargine O O
(Lantus) B-MEDICATION O
24 O O
UNITS O O
SC O O
QHS O O
10. O O
Lisinopril B-MEDICATION B-MEDICATION
5 O O
MG O O
PO O O
QD O O
11. O O
Omega-3-Fatty O O
Acids O O
(Fish O O
Oil O O
Capsule) O O
1200 O O
MG O O
PO O O
QD O O
12. O O
Spironolactone O O
(Aldactone) O O
12.5 O O
MG O O
PO O O
QD O O
13. O O
Warfarin O O
Sodium O O
Alternate O O
PO O O
QPM O O
5mg O O
Mon, O O
Wed, O O
Fri, O O
Sat O O
2.5mg O O
Tue, O O
Thu, O O
Sun O O
ALLERGIES/ADVERSE O O
REACTIONS O O
Digoxin O O
&#8211; O O
General O O
Intolerance O O
FAMILY O O
HISTORY O O
Multiple O O
siblings O O
have O O
diabetes, O O
and O O
2 O O
passed O O
away O O
from O O
complications O O
in O O
their O O
50's. O O
His O O
father O O
died O O
at O O
65 O O
from O O
Alzheimer&#8217;s O O
disease, O O
and O O
his O O
mother O O
at O O
50 O O
from O O
an O O
unspecified O O
cancer. O O
No O O
other O O
known O O
family O O
members O O
with O O
heart O O
disease. O O
SOCIAL O O
HISTORY O O
Presently O O
lives O O
in O O
Lake O O
Pocotopaug O O
with O O
wife O O
and O O
son O O
Brandon. O O
Used O O
to O O
be O O
goods O O
purchaser O O
for O O
34 O O
years. O O
He B-SMOKER O
has I-SMOKER O
a I-SMOKER O
~60 I-SMOKER O
pack-year I-SMOKER O
smoking I-SMOKER O
history, I-SMOKER O
but I-SMOKER O
has I-SMOKER O
since B-SMOKER O
quit. I-SMOKER O
Last O O
drink O O
of O O
EtOH O O
was O O
1.5 O O
years O O
ago. O O
PHYSICAL O O
EXAMINATION O O
Vitals O O
&#8211; O O
T O O
97.7, O O
HR O O
75, O O
BP O O
108/72, O O
RR O O
99% O O
RA O O
PA O O
74/34 O O
(49), O O
CVP O O
9, O O
MvO2 O O
73 O O
General O O
&#8211; O O
Pleasant O O
man O O
in O O
no O O
distress, O O
resting O O
comfortably O O
in O O
bed. O O
Skin O O
&#8211; O O
No O O
rashes. O O
HEENT O O
&#8211; O O
Pupils O O
equal O O
and O O
reactive. O O
Benign O O
oropharynx. O O
Neck O O
&#8211; O O
Supple. O O
R O O
PA O O
catheter O O
in O O
place. O O
Pulmonary O O
&#8211; O O
Decreased O O
air O O
movement. O O
Mild O O
crackles O O
at O O
the O O
R O O
base. O O
Cardiac O O
&#8211; O O
Distant. O O
S1 O O
+ O O
S2. O O
Abdomen O O
&#8211; O O
Soft, O O
non-tender, O O
and O O
non-distended. O O
Active O O
bowel O O
sounds. O O
Extremity O O
&#8211; O O
Warm. O O
1st O O
and O O
2nd O O
toe O O
amputated. O O
No O O
other O O
skin O O
breakdown O O
between O O
the O O
digits. O O
Mental O O
status O O
&#8211; O O
Alert. O O
Neurology O O
&#8211; O O
No O O
gross O O
neurological O O
deficits. O O
LABORATORIES O O
CBC O O
WBC O O
7.2, O O
Hct O O
38.6, O O
Plt O O
210 O O
Chemistries O O
Na O O
137, O O
K O O
4.2, O O
Cl O O
99, O O
CO2 O O
28.8, O O
BUN O O
29, O O
Cr O O
1.24 O O
(EGFR&gt;60), O O
Glu O O
102, O O
AG O O
9 O O
Ca O O
10.0, O O
Phos O O
2.9, O O
Mg O O
1.5 O O
Blood O O
Gas O O
MvO2 O O
73 O O
Coagulation O O
PT O O
16.6, O O
INR O O
1.4, O O
PTT O O
30.9 O O
MICROBIOLOGY O O
N/A O O
RADIOLOGICAL O O
STUDIES O O
CXR O O
(7/21/83) O O
No O O
evidence O O
for O O
pneumothorax. O O
Clear O O
lungs. O O
EKG O O
Atrial-sensed, O O
ventricularly-paced O O
rhythm. O O
No O O
changes O O
compared O O
to O O
4/2083. O O
ASSESSMENT O O
AND O O
PLAN O O
62 O O
yo O O
M O O
with O O
a O O
history O O
of O O
CAD O O
(s/p O O
STEMI O O
and O O
multiple O O
stents), O O
CHF O O
(s/p O O
BiV O O
ICD, O O
class O O
D O O
and O O
stage O O
III), O O
DM, O O
and O O
CRI O O
who O O
was O O
admitted O O
for O O
tailored O O
therapy O O
after O O
a O O
routine O O
RHC O O
demonstrated O O
elevated O O
filling O O
pressures. O O
CV O O
Pump O O
Class O O
III, O O
Stage O O
D O O
heart O O
failure O O
without O O
a O O
clear O O
precipitant O O
leading O O
to O O
recent O O
progressive O O
decline; O O
has O O
been O O
compliant O O
with O O
medications O O
and O O
diet, O O
no O O
evidence O O
of O O
recent O O
arrhythmia, O O
and O O
no O O
signs O O
of O O
active O O
infection. O O
Has O O
been O O
failing O O
current O O
medical O O
regimen, O O
and O O
is O O
presently O O
listed O O
for O O
heart O O
transplantation. O O
Last O O
TTE O O
with O O
an O O
EF O O
of O O
19%. O O
[] O O
Restart O O
Coumadin O O
at O O
home O O
doses O O
(alternating O O
between O O
5mg O O
and O O
2.5mg) O O
[] O O
Repeat O O
TTE O O
Preload: O O
Wedge O O
pressures O O
elevated O O
(27 O O
mmHg), O O
and O O
will O O
require O O
more O O
aggressive O O
diuresis. O O
Goal O O
of O O
PCWP O O
&lt; O O
20. O O
[] O O
Bumex O O
1mg O O
IV O O
x1 O O
- O O
Further O O
boluses O O
if O O
not O O
responsive O O
Afterload: O O
Calculated O O
SVR O O
is O O
~1300. O O
MAPs O O
do O O
not O O
have O O
a O O
lot O O
of O O
room O O
for O O
further O O
afterload O O
reduction. O O
[] O O
Change O O
from O O
lisinopril B-MEDICATION B-MEDICATION
5mg I-MEDICATION O
qD I-MEDICATION O
to I-MEDICATION O
captopril B-MEDICATION B-MEDICATION
12.5mg I-MEDICATION O
TID I-MEDICATION O
- O O
Titrate O O
as O O
BP O O
allows O O
[] O O
Continue O O
Coreg B-MEDICATION O
3.125mg I-MEDICATION O
qD I-MEDICATION O
and O O
Spironolactone O O
12.5mg O O
qD O O
Inotropy: O O
Based O O
on O O
RHC, O O
CO O O
4.7, O O
CI O O
2.07, O O
and O O
MvO3 O O
is O O
73. O O
No O O
present O O
indication O O
for O O
inotropic O O
agents. O O
CV O O
Ischemia O O
No O O
acute O O
clinical O O
changes O O
and O O
completely O O
asymptomatic O O
presently. O O
EKG O O
with O O
V-paced O O
pattern O O
not O O
meeting O O
criteria O O
for O O
acute O O
ST O O
segment O O
changes. O O
Continue O O
with O O
medical O O
management. O O
Will O O
check O O
fasting O O
lipids; O O
does O O
not O O
appear O O
to O O
have O O
been O O
on O O
statin O O
previously, O O
so O O
will O O
start O O
simvastatin B-MEDICATION B-MEDICATION
and O O
await O O
lipid O O
results. O O
[] O O
ASA B-MEDICATION B-MEDICATION
81 O O
qD O O
[] O O
Fish O O
Oil O O
[] O O
Start B-MEDICATION O
simvastatin I-MEDICATION B-MEDICATION
40mg I-MEDICATION O
PO O O
qD O O
CV O O
Rhythm O O
Trial-sensed, O O
ventricularly-paced O O
rhythm O O
which O O
is O O
sinus O O
in O O
origin. O O
No O O
evidence O O
of O O
tachyarrhythmias O O
clinically, O O
and O O
per O O
his O O
report, O O
recent O O
interrogation O O
of O O
his O O
device O O
also O O
did O O
not O O
reveal O O
arrhythmias. O O
[] O O
Monitor O O
on O O
telemetry O O
Diabetes B-DIABETES O
Mellitus I-DIABETES O
Will O O
recheck O O
A1c. O O
On O O
an O O
unusual O O
dose O O
of O O
BID O O
Glipizide O B-MEDICATION
and O O
long-acting B-MEDICATION O
insulin, I-MEDICATION O
but O O
independently O O
verified O O
with O O
both O O
the O O
patient O O
and O O
his O O
wife. O O
[] O O
Lantus O B-MEDICATION
24U O O
qPM O O
[] O O
Glipizide O B-MEDICATION
20mg O O
BID O O
[] O O
ISS O O
and O O
FSBS O O
qAC O O
and O O
qHS O O
[] O O
f/u O O
A1c O O
Chronic O O
Renal O O
Insufficieny O O
Recent O O
baseline O O
appears O O
to O O
be O O
~1.3-1.5; O O
admitted O O
with O O
Cr O O
of O O
1.24. O O
No O O
active O O
issues. O O
[] O O
Follow O O
Cr O O
FEN O O
[] O O
Low O O
Cholesterol, O O
Low O O
Saturated O O
Fat, O O
No O O
Added O O
Salt, O O
Fluid O O
Restriction O O
of O O
2000cc O O
PROPHYLAXIS O O
GI: O O
Omeprazole O O
DVT: O O
Fragmin O O
BOWEL: O O
None O O
LINES/TUBES O O
R O O
PA O O
line O O
at O O
50cm. O O
CODE: O O
Presumed O O
FULL. O O
__________________________________ O O
Carl O O
Ison, O O
MD O O
Internal O O
Medicine, O O
PGY-2 O O
Pager O O
#24779 O O

Record O O
date: O O
2084-01-08 O O
Neurology O O
Resident O O
ED O O
Consult O O
Note O O
Patient O O
Name: O O
XAYAVONG,BRANDON O O
H O O
MRN: O O
7826250(GNC) O O
ID/CC/Reason O O
for O O
consult: O O
? O O
Acute O O
stroke O O
HPI: O O
63 O O
year O O
old O O
RH O O
man O O
with O O
history O O
of O O
CAD B-CAD O
s/p B-CAD O
STEMI B-CAD O
2077 I-CAD O
s/p I-CAD O
8 I-CAD O
stents I-CAD O
including I-CAD O
LAD, I-CAD O
systolic O O
CHF O O
Class O O
Ia O O
with O O
EF O O
20% O O
s/p O O
BiV O O
ICD O O
placement, O O
diabetes, B-DIABETES O
on O O
Coumadin O O
and O O
ASA, B-MEDICATION O
presenting O O
with O O
history O O
of O O
right O O
arm/leg O O
weakness O O
since O O
this O O
morning. O O
He O O
was O O
alone O O
at O O
home O O
this O O
morning O O
(family O O
was O O
out), O O
and O O
he O O
noted O O
a O O
change O O
from O O
normal O O
at O O
9:00am. O O
He O O
had O O
difficulty O O
using O O
his O O
right O O
arm O O
and O O
when O O
he O O
went O O
to O O
walk O O
he O O
felt O O
unsteady O O
and O O
had O O
to O O
sit O O
down. O O
He O O
was O O
also O O
lightheaded O O
at O O
that O O
time. O O
He O O
had O O
no O O
focal O O
weakness O O
of O O
his O O
face. O O
He O O
also O O
denies O O
any O O
tingling/numbness O O
anywhere O O
in O O
the O O
body, O O
or O O
any O O
changes O O
in O O
speech, O O
language, O O
or O O
comprehension. O O
He O O
did O O
not O O
call O O
his O O
family O O
and O O
instead O O
ignored O O
his O O
symptoms. O O
His O O
wife O O
called O O
him O O
around O O
noon O O
to O O
check O O
in, O O
at O O
which O O
point O O
he O O
told O O
her O O
about O O
his O O
right-sided O O
weakness. O O
She O O
then O O
insisted O O
that O O
they O O
come O O
in O O
to O O
the O O
ED O O
for O O
evaluation; O O
they O O
called O O
EMS, O O
and O O
he O O
was O O
transported O O
by O O
ambulance O O
to O O
the O O
ED. O O
He O O
denies O O
any O O
headache, O O
neck O O
pain, O O
chest O O
pain, O O
or O O
shortness O O
of O O
breath. O O
His O O
LVAD O O
was O O
last O O
flushed O O
2 O O
days O O
ago O O
by O O
his O O
wife; O O
she O O
flushes O O
it O O
every O O
Thursday. O O
In O O
the O O
ED, O O
BP O O
114/82, O O
HR O O
69, O O
and O O
he O O
is O O
99% O O
on O O
room O O
air. O O
ROS: O O
Negative O O
for: O O
diplopia, O O
dysarthria, O O
vertigo/lightheadiness; O O
dysphagia, O O
numbness/tingling, O O
weakness, O O
bowel O O
or O O
bladder O O
incontinence, O O
HA, O O
aphasia, O O
loss O O
of O O
balance, O O
seizure, O O
LOC. O O
Also O O
negative O O
for O O
fever/chills/night O O
sweats, O O
CP, O O
SOB, O O
palpitations, O O
abd O O
pain, O O
N/V/D/C, O O
URI O O
sx, O O
wt O O
changes, O O
cough, O O
UTI O O
sx, O O
back O O
pain, O O
neck O O
pain. O O
Past O O
Medical O O
History: O O
CAD O O
s/p O O
STEMI O O
in O O
2077 O O
s/p O O
8 O O
stents O O
including O O
LAD O O
Systolic O O
CHF O O
Class O O
Ia O O
with O O
EF O O
20% O O
s/p O O
BiV O O
ICD O O
placement O O
DDD O O
St. O O
Jude O O
(05/13/2081) O O
Diabetes B-DIABETES O
on O O
glypizide B-MEDICATION B-MEDICATION
HLP B-HYPERLIPIDEMIA O
HTN B-HYPERTENSION O
Medications O O
at O O
home O O
(confirmed O O
w/pt): O O
ASA O B-MEDICATION
81 O O
mg O O
daily O O
Coumadin O O
as O O
prescribed O O
daily O O
Coreg B-MEDICATION O
12.5 O O
mg O O
bid O O
Dipyridamole O O
75 O O
mg O O
tid O O
Doxycycline O O
100 O O
mg O O
bid O O
Esomesoprazole O O
40 O O
mg O O
bid O O
Glipizide B-MEDICATION B-MEDICATION
XL O O
10 O O
mg O O
daily O O
Simvastatin B-MEDICATION B-MEDICATION
40 O O
mg O O
daily O O
Lexapro O O
10 O O
mg O O
daily O O
Polymyxin O O
drops O O
Vitamin O O
D O O
Allergies: O O
DIGOXIN O O
- O O
General O O
Intolerance O O
SH: O O
The O O
patient O O
lives O O
with O O
his O O
wife. O O
He O O
is O O
retired O O
purchasing O O
agent. O O
He B-SMOKER O
quit B-SMOKER O
smoking I-SMOKER O
5 I-SMOKER O
years I-SMOKER O
ago; I-SMOKER O
used I-SMOKER O
to I-SMOKER O
smoke I-SMOKER O
1 I-SMOKER O
PPD I-SMOKER O
x I-SMOKER O
40 I-SMOKER O
years. I-SMOKER O
No O O
alcohol O O
or O O
drug O O
use. O O
FH: O O
Heart O O
disease O O
in O O
both O O
mother's O O
and O O
father's O O
side, O O
but O O
no O O
early O O
CAD O O
in O O
the O O
first-degree O O
relatives, O O
hypertension O O
and O O
hyperlipidemia O O
in O O
both O O
sides. O O
No O O
history O O
of O O
stroke, O O
brain O O
tumor, O O
seizure. O O
PHYSICAL O O
EXAM: O O
VITALS: O O
T O O
97.8 O O
F; O O
BP O O
114/82, O O
HR O O
69, O O
RR O O
18, O O
99% O O
on O O
room O O
air O O
GEN: O O
NAD. O O
Interactive. O O
Well O O
developed. O O
Skin: O O
No O O
rashes O O
or O O
bruising. O O
HEENT: O O
Normocephalic O O
and O O
atraumatic O O
head; O O
pink O O
conjunctiva, O O
no O O
evidence O O
of O O
icterus, O O
teeth O O
in O O
good O O
condition, O O
moist O O
mucous O O
membranes, O O
clear O O
oropharynx. O O
Neck: O O
Supple. O O
No O O
LAD. O O
No O O
masses O O
or O O
goiter. O O
Trachea O O
midline. O O
Lungs: O O
CTA O O
bilaterally O O
with O O
good O O
flow. O O
CV: O O
RRR O O
S1/S2. O O
No O O
MGR. O O
Carotids O O
2+. O O
No O O
JVD. O O
Extr: O O
missing O O
left O O
great O O
toe; O O
Warm O O
and O O
well O O
perfused, O O
no O O
evidence O O
of O O
clubbing, O O
cyanosis, O O
edema O O
Neuro: O O
NIH O O
Stroke O O
Scale O O
Item O O
SCORE O O
(possible O O
range) O O
1a- O O
LOC O O
alert O O
0 O O
(0-3) O O
1b- O O
Question O O
0 O O
(0-2) O O
1c- O O
Commands O O
0 O O
(0-2) O O
2- O O
Horizontal O O
gaze O O
0 O O
(0-2) O O
3- O O
Visual O O
Field O O
0 O O
(0-3) O O
4- O O
Facial O O
Palsy O O
0 O O
(0-3) O O
5- O O
Motor O O
L O O
arm O O
0 O O
(0-4) O O
5- O O
Motor O O
R O O
arm O O
0 O O
(0-4) O O
6- O O
Motor O O
L O O
leg O O
0 O O
(0-4) O O
6- O O
Motor O O
R O O
leg O O
0 O O
(0-4) O O
7- O O
Ataxia O O
0 O O
(0-2) O O
8- O O
Sensory O O
0 O O
(0-2) O O
9- O O
Language O O
0 O O
(0-3) O O
10- O O
Dysarthria O O
0 O O
(0-2) O O
11- O O
Extinction O O
0 O O
(0-2) O O
Total O O
Score O O
0 O O
Date/Time O O
1/8/2084, O O
2:15 O O
PM O O
MENTAL O O
STATUS: O O
Gen: O O
Alert, O O
appropriately O O
interactive, O O
normal O O
affect. O O
Orientation: O O
Full O O
(Name, O O
Place O O
and O O
Time/Date). O O
Attention: O O
Can O O
do O O
days O O
of O O
the O O
week O O
going O O
backwards O O
correctly O O
Speech/Lang: O O
Fluent O O
w/o O O
paraphasic O O
errors; O O
Follows O O
1-part O O
and O O
2-part O O
commands O O
without O O
L/R O O
confusion. O O
Repetition, O O
naming O O
intact. O O
Calculations: O O
Intact O O
(9 O O
quarters O O
= O O
$2.25). O O
CN: O O
I: O O
Not O O
tested. O O
II: O O
VFFC. O O
PERRL O O
4 O O
mm O O
&#224; O O
2 O O
mm. O O
No O O
RAPD. O O
III,IV,VI O O
EOMI O O
w/o O O
nystagmus O O
or O O
saccadic O O
breakdown. O O
No O O
diplopia. O O
No O O
ptosis. O O
V: O O
Sensation O O
intact O O
to O O
LT O O
bilaterally. O O
VII: O O
There O O
was O O
no O O
facial O O
asymmetry, O O
with O O
a O O
normal O O
forehead O O
wrinkle, O O
blink, O O
smile, O O
and O O
cheek O O
puff. O O
VIII: O O
Hears O O
finger O O
rub O O
equally O O
and O O
bilaterally. O O
IX,X: O O
Voice O O
normal. O O
Palate O O
elevates O O
symmetrically. O O
There O O
was O O
no O O
dysarthria. O O
XI: O O
The O O
shoulder O O
shrugs O O
and O O
head O O
turns O O
were O O
normal. O O
XII: O O
Tongue O O
protrudes O O
midline. O O
MOTOR: O O
The O O
bulk O O
and O O
tone O O
were O O
normal. O O
There O O
was O O
no O O
cogwheel O O
rigidity, O O
bradykinesia, O O
fasciculations, O O
myoclonus O O
or O O
tremor. O O
+ O O
Right O O
pronator O O
drift. O O
Orbiting O O
of O O
LUE O O
around O O
RUE. O O
Finger O O
tapping O O
with O O
decreased O O
speed O O
and O O
amplitude O O
on O O
the O O
right. O O
The O O
strength O O
was O O
4/5 O O
in O O
the O O
RUE O O
proximally O O
and O O
distally, O O
with O O
IP O O
4/5, O O
but O O
distally O O
5/5 O O
in O O
plantar O O
and O O
dorsiflexion. O O
On O O
the O O
left, O O
strength O O
was O O
5/5 O O
throughout O O
including: O O
shoulder O O
abduction, O O
flexion O O
and O O
extension O O
at O O
the O O
elbows, O O
fingers, O O
hips, O O
knees, O O
as O O
well O O
as O O
ankle O O
dorsiflexion O O
and O O
plantarflexion. O O
SENSATION: O O
Diffusely O O
intact O O
to O O
light O O
touch, O O
temperature O O
throughout. O O
No O O
evidence O O
of O O
extinction O O
or O O
neglect. O O
Decreased O O
vibratory O O
sensation O O
in O O
his O O
lower O O
extremities O O
in O O
stocking O O
pattern, O O
without O O
involvement O O
of O O
upper O O
extremities. O O
REFLEXES: O O
The O O
deep O O
tendon O O
reflexes O O
were O O
normal O O
and O O
symmetric O O
at O O
the O O
triceps, O O
biceps, O O
brachioradialis, O O
quadriceps O O
and O O
gastrocnemius/soleus. O O
Babinski O O
sign O O
absent O O
bilaterally. O O
CEREBELLAR: O O
The O O
finger-to-nose, O O
heel-to-shin O O
were O O
normal O O
without O O
dysmetria. O O
There O O
was O O
no O O
truncal O O
ataxia. O O
GAIT/STANCE: O O
The O O
stance O O
and O O
stride O O
were O O
normal, O O
as O O
was O O
the O O
ability O O
to O O
tandem, O O
toe, O O
and O O
heel-walk. O O
The O O
Romberg O O
test O O
was O O
negative. O O
Labs/Studies: O O
01/08/2084 O O
NA O O
140, O O
K O O
4.0, O O
CL O O
106, O O
CO2 O O
27.1, O O
BUN O O
20, O O
CRE O O
1.04, O O
EGFR O O
&gt;60, O O
GLU O O
172 O O
(H) O O
01/08/2084 O O
ANION O O
7 O O
01/08/2084 O O
CA O O
8.9, O O
PHOS O O
2.1 O O
(L), O O
MG O O
1.4, O O
TBILI O O
0.5, O O
DBILI O O
0.2, O O
TP O O
6.1, O O
ALB O O
3.7, O O
GLOB O O
2.4 O O
01/08/2084 O O
ALT/SGPT O O
12, O O
AST/SGOT O O
20, O O
ALKP O O
87, O O
TBILI O O
0.5, O O
DBILI O O
0.2 O O
01/08/2084 O O
NT-BNP O O
4419 O O
(H) O O
01/08/2084 O O
TROP-I O O
Negative O O
01/08/2084 O O
WBC O O
5.2, O O
RBC O O
3.39 O O
(L), O O
HGB O O
10.4 O O
(L), O O
HCT O O
30.8 O O
(L), O O
MCV O O
91, O O
MCH O O
30.6, O O
MCHC O O
33.6, O O
PLT O O
162 O O
01/08/2084 O O
RDW O O
16.5 O O
(H) O O
01/08/2084 O O
METHOD O O
Auto, O O
%NEUT O O
72 O O
(H), O O
%LYMPH O O
19 O O
(L), O O
%MONO O O
5, O O
%EOS O O
3, O O
%BASO O O
1 O O
01/08/2084 O O
ANEUT O O
3.78, O O
ALYMP O O
0.93 O O
(L), O O
AMONS O O
0.25, O O
AEOSN O O
0.15, O O
ABASOP O O
0.05 O O
01/08/2084 O O
ANISO O O
1+ O O
(H), O O
HYPO O O
None, O O
MACRO O O
None, O O
MICRO O O
None O O
01/08/2084 O O
PT O O
18.8 O O
(H), O O
PT-INR O O
1.7, O O
PTT O O
28.0 O O
01/08/2084 O O
BB O O
Sp O O
EXP: O O
01/11/2084 O O
23:59 O O
Head O O
CT/CTA O O
Head O O
and O O
Neck O O
(Today): O O
No O O
evidence O O
for O O
intracranial O O
hemorrhage, O O
masses O O
or O O
large O O
territorial O O
infarction. O O
Left O O
M1 O O
segment O O
filling O O
defect O O
likely O O
represent O O
a O O
thrombus O O
which O O
is O O
partially O O
occlusive O O
given O O
the O O
opacification O O
of O O
the O O
distal O O
MCA O O
branches. O O
This O O
finding O O
correlates O O
with O O
patient's O O
given O O
symptoms. O O
EKG O O
(Today): O O
CXR O O
(Today): O O
Large O O
heart O O
Assessment O O
: O O
63 O O
year O O
old O O
RH O O
man O O
with O O
history O O
of O O
CAD O O
s/p O O
STEMI O O
2077 O O
s/p O O
8 O O
stents O O
including O O
LAD, O O
systolic O O
CHF O O
Class O O
Ia O O
with O O
EF O O
20% O O
s/p O O
BiV O O
ICD O O
placement, O O
diabetes, O O
on O O
Coumadin O O
and O O
ASA, O O
presenting O O
with O O
history O O
of O O
right O O
arm/leg O O
weakness O O
since O O
this O O
morning. O O
There O O
have O O
been O O
no O O
other O O
neurological O O
symptoms, O O
and O O
no O O
general O O
symptoms O O
other O O
than O O
some O O
lightheadedness. O O
Exam O O
is O O
notable O O
for O O
decreased O O
strength O O
in O O
the O O
right O O
upper O O
extremity O O
and O O
proximal O O
lower O O
extremity, O O
without O O
facial O O
involvement. O O
He O O
has O O
pronator O O
drift O O
on O O
the O O
right, O O
with O O
decreased O O
speed O O
and O O
amplitude O O
of O O
fine O O
finger O O
movements O O
on O O
the O O
right, O O
and O O
orbiting O O
of O O
the O O
LUE O O
around O O
the O O
RUE. O O
He O O
has O O
no O O
sensory O O
findings, O O
and O O
no O O
dysarthria O O
or O O
aphasia. O O
NIHSS O O
was O O
zero. O O
CT O O
Brain O O
shows O O
loss O O
of O O
gray-white O O
differentiation O O
in O O
Left O O
MCA O O
territory, O O
with O O
Left O O
M1 O O
clot. O O
There O O
is O O
reconstitution O O
of O O
flow O O
in O O
his O O
distal O O
MCA O O
distribution. O O
The O O
most O O
likely O O
mechanism O O
is O O
cardioembolic O O
related O O
to O O
his O O
LVAD. O O
He O O
will O O
be O O
admitted O O
to O O
the O O
Cardiac O O
surgery O O
service O O
for O O
optimal O O
LVAD O O
management O O
with O O
the O O
Stroke O O
consult O O
service O O
following. O O
Plan: O O
- O O
Would O O
agree O O
with O O
admitting O O
to O O
the O O
Cardiac O O
surgery O O
service O O
for O O
optimal O O
LVAD O O
management O O
- O O
Stroke O O
consult O O
service O O
to O O
follow O O
(pager O O
90395) O O
- O O
Head O O
and O O
neck O O
imaging O O
complete; O O
f/u O O
final O O
read O O
- O O
Repeat O O
Head O O
CT O O
tomorrow O O
AM O O
or O O
if O O
there O O
is O O
any O O
change O O
in O O
neurological O O
exam O O
- O O
Neuro O O
checks O O
q4 O O
hours O O
- O O
LVAD O O
needs O O
to O O
be O O
evaluated O O
if O O
possible O O
for O O
thrombus; O O
will O O
consult O O
patient's O O
private O O
cardiologist O O
- O O
Check O O
baseline O O
TCDs; O O
will O O
further O O
decide O O
whether O O
he O O
needs O O
daily O O
TCD O O
monitoring O O
- O O
To O O
improve O O
perfusion, O O
maximize O O
his O O
SBP O O
as O O
possible O O
per O O
cardiac O O
function; O O
patient O O
does O O
not O O
appear O O
to O O
be O O
perfusion-dependent O O
at O O
this O O
time O O
- O O
Continue O O
therapeutic O O
anticoagulation O O
for O O
stroke O O
prevention, O O
currently O O
suspecting O O
small O O
stroke O O
- O O
Continuous O O
telemetry O O
and O O
pulse O O
oximetry O O
- O O
ROMI O O
with O O
serial O O
CE O O
q O O
8h O O
x3, O O
and O O
serial O O
EKGs. O O
- O O
Keep O O
K&gt;4, O O
Mg&gt;2 O O
- O O
Risk O O
factor O O
assessment: O O
ESR, O O
CRP, O O
HBA1c O O
- O O
Check O O
blood O O
cultures O O
- O O
Check O O
chromogenic O O
Factor O O
X O O
level O O
- O O
PT/OT O O
evaluation O O
- O O
Hold O O
Glypizide O O
XL: O O
use O O
RISS O O
for O O
sugar O O
control O O
with O O
target O O
blood O O
glucose&lt;130 O O
Thank O O
you O O
for O O
this O O
consult. O O
Please O O
page O O
90395 O O
with O O
any O O
questions O O
or O O
concerns. O O
___________________________________ O O
Carol O O
Upton O O
M.D. O O
(PGY-2) O O
Winchendon O O
Neurology O O
Resident O O
Pager O O
25539/69926 O O
Discussed O O
with O O
senior O O
resident, O O
Dr. O O
Skylar O O
Watson O O

Record B-SMOKER O
date: O O
2155-05-17 O O
17 O O
May O O
2155 O O
Brandon O O
Ponce, O O
MD O O
974 O O
Parkhurst O O
Drive O O
Peculiar, O O
NE O O
54583 O O
Re: O O
Jarome O O
DEJESUS O O
ECI O O
280-44-07-1 O O
Dear O O
Dr. O O
Ponce: O O
I O O
had O O
the O O
pleasure O O
of O O
caring O O
for O O
Mr. O O
Dejesus O O
during O O
his O O
ECI O O
admission O O
05/16-07/14. O O
He O O
is O O
a O O
72-year-old O O
man O O
with O O
CAD B-CAD O
S/P O O
diagnostic O O
cath O O
one O O
week O O
ago O O
at O O
SCMHC, O O
found O O
to O O
have O O
a O O
moderately B-CAD O
tight I-CAD O
lesion I-CAD O
in I-CAD O
the I-CAD O
LAD I-CAD O
without O O
significant O O
disease O O
in O O
the O O
left O O
circumflex O O
or O O
RCA. O O
Because O O
of O O
the O O
recent O O
onset O O
of O O
angina B-CAD O
and O O
a O O
stress B-CAD O
test I-CAD O
showing I-CAD O
anterior I-CAD O
ischemia, I-CAD O
he O O
was O O
brought O O
to O O
ECI, O O
where O O
Dr. O O
Yoseph O O
Flint O O
stented O O
the O O
LAD O O
lesion O O
with O O
a O O
3.5mm O O
by O O
32mm O O
Taxus O O
drug-eluting O O
stent, O O
with O O
zero O O
percent O O
residual. O O
The O O
right O O
femoral O O
arteriotomy O O
was O O
closed O O
with O O
an O O
Angioseal, O O
and O O
there O O
were O O
no O O
complications. O O
He O O
spent O O
an O O
uneventful O O
evening O O
without O O
complaints, O O
ambulating O O
without O O
difficulty. O O
His O O
left O O
groin O O
was O O
soft O O
without O O
hematoma O O
or O O
bruit, O O
and O O
extremities O O
were O O
warm O O
and O O
well O O
perfused. O O
Morning O O
labs O O
included O O
a O O
BUN O O
of O O
17, O O
creatinine O O
0.9, O O
hematocrit O O
37, O O
platelets O O
236,000, O O
and O O
flat O O
cardiac O O
enzymes. O O
He O O
was O O
discharged O O
home O O
on O O
Plavix, B-MEDICATION B-MEDICATION
75mg O O
po O O
qd O O
for O O
a O O
minimum O O
of O O
six O O
months; O O
enteric-coated O O
aspirin, B-MEDICATION B-MEDICATION
325mg O O
po O O
qd; O O
digoxin, O O
0.25mg O O
po O O
qd; O O
glyburide, B-MEDICATION B-MEDICATION
5mg O O
po O O
bid; O O
metoprolol, B-MEDICATION B-MEDICATION
50mg O O
po O O
bid; O O
Lipitor, B-MEDICATION B-MEDICATION
20mg O O
po O O
qd; O O
Tikosyn, O O
500mcg O O
po O O
bid; O O
Glucophage, B-MEDICATION B-MEDICATION
to O O
be O O
resumed O O
at O O
500mg O O
po O O
bid O O
in O O
two O O
days; O O
and O O
Coumadin, O O
to O O
be O O
resumed O O
tonight. O O
He O O
has O O
PT/INR O O
check O O
arranged O O
in O O
several O O
days. O O
He O O
will O O
follow O O
up O O
with O O
you O O
in O O
the O O
next O O
two O O
weeks, O O
and O O
will O O
see O O
his O O
PMD, O O
Dr. O O
Paige, O O
in O O
the O O
near O O
future. O O
Thank O O
you O O
for O O
allowing O O
us O O
to O O
participate O O
in O O
his O O
care. O O
Please O O
call O O
if O O
you O O
have O O
questions. O O
Sincerely, O O
Barbara O O
A. O O
Rhoades, O O
MD O O
BAR/pham O O
cc: O O
Robert-Joseph O O
Paige, O O
MD, O O
558 O O
Paxton O O
Terrace, O O
Peculiar, O O
NE O O
54583 O O

Record B-SMOKER O
date: O O
2157-07-17 O O
DEJESUS, O O
JAROME O O
28044071 O O
07/17/2157 O O
Yoseph O O
Berg, O O
M.D. O O
Broome O O
Developmental O O
Center O O
84 O O
Parkhurst O O
Drive O O
Peculiar, O O
NE O O
54583 O O
Dear O O
Dr. O O
Berg: O O
We O O
had O O
the O O
pleasure O O
of O O
caring O O
for O O
your O O
patient, O O
Jarome O O
Dejesus, O O
during O O
his O O
admission O O
to O O
the O O
Erie O O
County O O
Infirmary O O
from O O
07/16/2157 O O
to O O
07/17/2157 O O
for O O
evaluation O O
and O O
treatment O O
of O O
his O O
anginal B-CAD O
symptoms. I-CAD O
As O O
you O O
know, O O
Mr. O O
Dejesus O O
is O O
a O O
very O O
pleasant O O
74-year-old O O
gentleman O O
with O O
paroxysmal O O
atrial O O
fibrillation O O
who O O
is O O
on O O
Coumadin. O O
He O O
has O O
a O O
history O O
of O O
insulin-dependent B-DIABETES O
diabetes I-DIABETES O
mellitus, I-DIABETES O
hypertension B-HYPERTENSION B-HYPERTENSION
and O O
dyslipidemia. B-HYPERLIPIDEMIA O
He O O
has O O
known O O
coronary B-CAD B-CAD
artery I-CAD I-CAD
disease I-CAD O
and O O
underwent O O
stenting O O
of O O
his O O
left O O
anterior O O
descending O O
artery O O
in O O
05/2155, O O
at O O
which O O
time O O
he O O
had O O
a O O
Taxus O O
drug-eluting O O
stent O O
placed. O O
He O O
returns O O
now O O
with O O
increasing O O
dyspnea O O
on O O
exertion O O
and O O
had O O
an O O
elective O O
cardiac O O
catheterization O O
performed O O
at O O
the O O
Southwest O O
Colorado O O
Medical O O
on O O
07/13/2157 O O
that O O
showed O O
focal O O
90% O O
instent O O
restenosis O O
in O O
the O O
left O O
anterior O O
descending O O
artery O O
with O O
no O O
other O O
focally O O
occlusive O O
disease. O O
He O O
was O O
transferred O O
to O O
the O O
Erie O O
County O O
Infirmary O O
and O O
on O O
the O O
afternoon O O
of O O
07/16/2157, O O
Dr. O O
Yoseph O O
Flint O O
was O O
able O O
to O O
dilate O O
and O O
stent O O
the O O
lesion O O
in O O
the O O
left O O
anterior O O
descending O O
artery O O
with O O
placement O O
of O O
a O O
3.5 O O
x O O
28 O O
mm O O
Cypher O O
drug-eluting O O
stent. O O
The O O
procedure O O
was O O
complicated O O
by O O
brief O O
transient O O
no O O
re-flow O O
that O O
resolved O O
immediately O O
to O O
intracoronary O O
nitroglycerin. B-MEDICATION B-MEDICATION
The O O
left O O
femoral O O
arteriotomy O O
was O O
closed O O
using O O
an O O
Angio-Seal O O
device. O O
Mr. O O
Dejesus O O
has O O
spent O O
an O O
uneventful O O
evening O O
on O O
our O O
Cardiovascular O O
Service. O O
He O O
has O O
had O O
no O O
complaints O O
of O O
chest O O
pain O O
or O O
shortness O O
of O O
breath. O O
He O O
is O O
ambulating, O O
eating, O O
and O O
voiding O O
without O O
difficulty. O O
His O O
heart O O
rate O O
has O O
been O O
in O O
the O O
70s, O O
blood O O
pressure O O
in O O
the O O
110s/60. O O
He O O
is O O
in O O
atrial O O
fibrillation. O O
His O O
cardiac O O
exam O O
was O O
irregular O O
with O O
no O O
appreciable O O
murmur. O O
His O O
lungs O O
were O O
clear O O
to O O
auscultation O O
bilaterally. O O
His O O
left O O
groin O O
is O O
moderately O O
ecchymotic O O
but O O
soft. O O
There O O
is O O
no O O
hematoma O O
or O O
bruit. O O
Extremities O O
are O O
warm O O
and O O
well O O
perfused. O O
His O O
morning O O
labs O O
revealed O O
a O O
sodium O O
of O O
138, O O
potassium O O
of O O
4.9, O O
BUN O O
of O O
21, O O
creatinine O O
of O O
1.2. O O
His O O
total O O
CK O O
is O O
58 O O
with O O
a O O
CK-MB O O
of O O
0.4. O O
His O O
hematocrit O O
is O O
stable O O
at O O
38, O O
white O O
count O O
of O O
9, O O
platelets O O
of O O
300,000. O O
His O O
fasting O O
lipid O O
panel O O
showed O O
a O O
total O O
cholesterol O O
123 O O
with O O
an O O
HDL O O
of O O
25, O O
LDL O O
of O O
49, O O
and O O
triglycerides O O
of O O
244. O O
We O O
are O O
discharging O O
him O O
home O O
on O O
the O O
following O O
medications: O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
p.o. O O
daily, O O
which O O
must O O
be O O
continued O O
for O O
a O O
minimum O O
of O O
the O O
next O O
three O O
months, O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
p.o. O O
daily O O
is O O
to O O
be O O
backed O O
off O O
to O O
81 O O
mg O O
after O O
a O O
few O O
months. O O
He O O
will O O
resume O O
his O O
Coumadin O O
at O O
5 O O
mg O O
daily, O O
and O O
have O O
this O O
checked O O
with O O
his O O
primary O O
care O O
physician, O O
Dr. O O
Paige. O O
He O O
will O O
be O O
on O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
mg O O
p.o. O O
daily, O O
digoxin O O
0.25 O O
mg O O
p.o. O O
daily, O O
Tikosyn O O
500 O O
mcg O O
p.o. O O
b.i.d., O O
glyburide B-MEDICATION B-MEDICATION
5 O O
mg O O
p.o. O O
daily, O O
Avandia B-MEDICATION O
4 O O
mg O O
p.o. O O
daily, O O
Diovan B-MEDICATION O
80 O O
mg O O
p.o. O O
daily, O O
NPH B-MEDICATION B-MEDICATION
insulin I-MEDICATION O
16 O O
units O O
each O O
evening O O
and O O
sublingual B-MEDICATION O
nitroglycerin I-MEDICATION B-MEDICATION
to O O
be O O
used O O
as O O
needed O O
for O O
chest O O
pain. O O
We O O
have O O
asked O O
him O O
to O O
arrange O O
a O O
followup O O
appointment O O
with O O
you O O
within O O
the O O
next O O
couple O O
of O O
weeks O O
and O O
to O O
see O O
Robert-Joseph O O
Paige O O
in O O
the O O
near O O
future O O
also. O O
Thank O O
you O O
very O O
much O O
for O O
allowing O O
us O O
to O O
participate O O
in O O
the O O
care O O
of O O
this O O
pleasant O O
gentleman, O O
and O O
please O O
do O O
not O O
hesitate O O
to O O
contact O O
us O O
with O O
any O O
issues O O
regarding O O
his O O
ongoing O O
management. O O
With O O
warmest O O
regards. O O
Sincerely, O O
______________________________ O O
Irving O O
R. O O
Ramirez, O O
M.D. O O
ATTENDING O O
______________________________ O O
Dictated O O
by: O O
Henry O O
Phelps, O O
PA O O
eScription O O
document:8-0687422 O O
DFFocus O O
CC: O O
Robert-Joseph O O
Paige O O
M.D. O O
Koenen O O
Collins O O
County O O
Clinic O O
886 O O
Paxton O O
Terrace O O
Peculiar, O O
NE O O
19649 O O
DD: O O
07/17/57 O O
DT: O O
07/17/57 O O
DV: O O
07/17/57 O O

Record O O
date: O O
2161-06-03 O O
DEJESUS, O O
JAROME O O
28044071 O O
06/03/2161 O O
Isaiah O O
Y. O O
Dill, O O
M.D. O O
Southwest O O
Colorado O O
Medical O O
Health O O
Center O O
607 O O
Batchelder O O
Street O O
Suite O O
975 O O
Robstown, O O
NE O O
29768 O O
Dear O O
Dr. O O
Dill: O O
DOB: O O
10/11/2082 O O
Thank O O
you O O
for O O
referring O O
Mr. O O
Dejesus O O
to O O
the O O
Erie O O
County O O
Arrhythmia O O
Service O O
for O O
consideration O O
of O O
catheter O O
ablation O O
of O O
atrial O O
fibrillation. O O
As O O
you O O
know O O
him O O
well, O O
I O O
will O O
summarize O O
his O O
history O O
briefly O O
for O O
our O O
records. O O
Mr. O O
Dejesus O O
is O O
a O O
78-year-old O O
gentleman O O
with O O
an O O
extensive O O
cardiac O O
history O O
that O O
includes O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
status B-CAD O
post I-CAD O
multiple I-CAD O
percutaneous B-CAD O
coronary I-CAD O
interventions I-CAD O
and I-CAD O
stents I-CAD O
to I-CAD O
the I-CAD O
LAD I-CAD O
as I-CAD O
well I-CAD O
as I-CAD O
RCA I-CAD O
territories, I-CAD O
a O O
cardiomyopathy B-CAD O
with I-CAD O
an I-CAD O
ejection I-CAD O
fraction I-CAD O
of I-CAD O
approximately I-CAD O
35-40%, I-CAD O
and O O
atrial O O
fibrillation. O O
In O O
addition, O O
he O O
has O O
multiple O O
cardiac O O
risk O O
factors O O
including O O
diabetes, B-DIABETES O
hypertension, B-HYPERTENSION B-HYPERTENSION
dyslipidemia, B-HYPERLIPIDEMIA O
and O O
obstructive O O
sleep O O
apnea. O O
In O O
addition O O
to O O
disease O O
in O O
his O O
coronary O O
vascular O O
bed, O O
he O O
has O O
a O O
history O O
of O O
carotid O O
disease O O
status O O
post O O
left O O
CEA. O O
He O O
came O O
to O O
your O O
attention O O
early O O
this O O
year O O
with O O
symptoms O O
of O O
exertional O O
dyspnea. O O
On O O
further O O
questioning, O O
he O O
reports O O
feeling O O
quite O O
symptomatic O O
when O O
ambulating O O
relatively O O
short O O
distances O O
around O O
his O O
home O O
or O O
up O O
and O O
down O O
the O O
driveway. O O
He O O
can O O
walk O O
no O O
further O O
than O O
approximately O O
50-100 O O
feet O O
before O O
developing O O
significant O O
shortness O O
of O O
breath O O
and O O
fatigue. O O
He O O
was O O
recently O O
diagnosed O O
as O O
having O O
paroxysmal O O
atrial O O
fibrillation O O
that O O
has O O
transitioned O O
to O O
persistent. O O
He O O
has O O
undergone O O
multiple O O
cardioversions O O
most O O
recently O O
in O O
03/19/2161, O O
but O O
was O O
unsuccessful. O O
Prior O O
to O O
that, O O
cardioversion O O
in O O
February O O
resulted O O
in O O
a O O
brief O O
period O O
of O O
restoration O O
of O O
sinus O O
rhythm O O
during O O
which O O
time O O
he O O
felt O O
symptomatically O O
improved. O O
He O O
also O O
describes O O
occasional O O
fleeting O O
episodes O O
of O O
sharp O O
left-sided O O
chest O O
discomfort. O O
Cardiac B-CAD O
catheterization I-CAD O
on I-CAD O
01/18/2161 I-CAD O
revealed I-CAD O
a I-CAD O
30% I-CAD O
LAD I-CAD O
in-stent I-CAD O
restenosis, I-CAD O
90% B-CAD O
septal I-CAD O
lesion, I-CAD O
and I-CAD O
65% I-CAD O
-70% I-CAD O
PDA I-CAD O
lesion I-CAD O
that O O
was B-CAD O
stented. I-CAD O
A O O
Ventriculogram O O
at O O
that O O
time O O
revealed O O
an O O
EF O O
of O O
35-40%. O O
Other O O
than O O
significant O O
exertional O O
shortness O O
of O O
breath, O O
he O O
feels O O
relatively O O
well. O O
He O O
has O O
occasional O O
symptoms O O
of O O
orthostatic O O
lightheadedness O O
but O O
no O O
history O O
of O O
syncope. O O
He O O
denies O O
any O O
PND, O O
orthopnea, O O
or O O
lower O O
extremity O O
swelling. O O
He O O
has O O
no O O
history O O
of O O
heart O O
failure O O
hospitalizations. O O
His O O
weight O O
has O O
been O O
stable. O O
On O O
review O O
of O O
systems, O O
he O O
denies O O
any O O
fevers, O O
chills, O O
or O O
night O O
sweats. O O
His O O
weight O O
has O O
remained O O
stable. O O
He O O
denies O O
any O O
new O O
onset O O
cough, O O
wheezing, O O
or O O
hemoptysis. O O
Past O O
Medical O O
History: O O
1. O O
CAD O B-CAD
status O O
post O O
LAD B-CAD O
PCI/stenting I-CAD O
in I-CAD B-CAD
2155. I-CAD O
He O O
developed O O
in-stent B-CAD B-CAD
restenosis I-CAD O
in I-CAD B-CAD
07/2157, I-CAD O
during I-CAD O
which I-CAD O
time I-CAD O
he I-CAD O
received I-CAD O
a I-CAD O
second I-CAD O
drug-eluting I-CAD B-CAD
stent I-CAD I-CAD
to I-CAD I-CAD
the I-CAD I-CAD
LAD I-CAD O
lesion. I-CAD B-CAD
He O O
developed O O
recurrent O O
chest O O
discomfort O O
in O B-CAD
12/2159, O O
and O O
he O O
underwent O O
cardiac B-CAD O
catheterization I-CAD O
during I-CAD O
which I-CAD O
time I-CAD O
he I-CAD O
was I-CAD O
found I-CAD O
to I-CAD O
have I-CAD O
an I-CAD O
80% I-CAD O
mid I-CAD O
LAD I-CAD O
lesion I-CAD O
distal I-CAD O
to I-CAD O
his I-CAD O
prior I-CAD O
stents I-CAD O
as I-CAD O
well I-CAD O
as I-CAD O
a I-CAD O
30% I-CAD O
proximal I-CAD O
RCA I-CAD B-CAD
mid I-CAD O
PDA I-CAD O
stenosis. I-CAD O
He O O
underwent O O
a O O
drug-eluting B-CAD O
stent I-CAD B-CAD
to I-CAD O
the I-CAD O
mid I-CAD O
LAD I-CAD O
lesion. I-CAD O
A O O
followup B-CAD O
catheterization I-CAD O
in I-CAD O
01/2161 I-CAD O
revealed I-CAD O
a I-CAD O
30% I-CAD O
LAD I-CAD O
stenosis, I-CAD B-CAD
90% I-CAD O
large I-CAD O
septal I-CAD O
branch I-CAD O
lesion, I-CAD O
and I-CAD O
a I-CAD O
65-70% I-CAD O
proximal I-CAD O
PDA I-CAD O
stenosis. I-CAD O
Ventriculogram O O
revealed O O
an O O
EF O O
of O O
35-40%. O O
He O O
underwent O O
stenting B-CAD O
to I-CAD O
the I-CAD O
PDA I-CAD O
lesion I-CAD O
on I-CAD O
03/06/2161. I-CAD O
An O O
exercise O O
Myoview O O
performed O O
in O O
01/2160 O O
revealed O O
no O O
evidence O O
of O O
inducible O O
ischemia. O O
2. O O
Hypertension. B-HYPERTENSION B-HYPERTENSION
3. O O
Dyslipidemia. B-HYPERLIPIDEMIA O
4. O O
Diabetes. B-DIABETES O
5. O O
Obstructive O O
sleep O O
apnea. O O
6. O O
COPD, O O
prescribed O O
home O O
oxygen, O O
though O O
he O O
is O O
not O O
taking O O
this. O O
7. O O
Carotid O O
disease, O O
status O O
post O O
left O O
CEA O O
after O O
presenting O O
with O O
an O O
ipsilateral O O
episode O O
of O O
amaurosis O O
fugax. O O
8.? O O
History O O
of O O
BLANK O O
AAA O O
by O O
ultrasound O O
in O O
07/2159. O O
9. O O
Atrial O O
fibrillation. O O
10. O O
Obesity. B-OBESE O
He O O
has O O
no O O
known O O
drug O O
allergies. O O
His O O
current O O
medications O O
include O O
amiodarone O O
200 O O
mg O O
BLANK, O O
but O O
this O O
has O O
been O O
discontinued O O
since O O
April, O O
metoprolol B-MEDICATION B-MEDICATION
50 O O
mg O O
b.i.d., O O
digoxin O O
0.25 O O
mg O O
daily, O O
Zocor B-MEDICATION B-MEDICATION
20 O O
mg O O
daily, O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
daily, O O
TriCor B-MEDICATION O
145 O O
mg O O
daily, O O
Lasix O O
20 O O
mg O O
daily, O O
BLANK O O
5 O O
mg O O
nightly, O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
daily, O O
Lantus B-MEDICATION B-MEDICATION
insulin B-MEDICATION B-MEDICATION
62 O O
units O O
daily, O O
Humalog B-MEDICATION B-MEDICATION
insulin, O B-MEDICATION
and O O
Protonix O O
40 O O
mg O O
daily. O O
His O O
social O O
history O O
is O O
notable O O
for O O
remote B-SMOKER O
history I-SMOKER O
of I-SMOKER O
tobacco I-SMOKER O
dependence. I-SMOKER O
He O O
was O O
formally O O
employed O O
in O O
buidling O O
construction. O O
He O O
has O O
multiple O O
environmental O O
exposures O O
including O O
insulation O O
as O O
well O O
as O O
spray O O
paint O O
and O O
without O O
respiratory O O
protection. O O
He O O
does B-SMOKER O
not I-SMOKER O
currently I-SMOKER O
smoke I-SMOKER O
or O O
drink O O
alcohol. O O
His O O
family O O
history O O
is O O
negative O O
for O O
early O O
onset O O
CAD, O O
sudden O O
cardiac O O
death, O O
or O O
cardiomyopathy. O O
His O O
father O O
lived O O
until O O
the O O
age O O
of O O
88. O O
His O O
mother O O
died O O
of O O
a O O
stroke O O
at O O
the O O
age O O
of O O
80. O O
He O O
has O O
a O O
single O O
sister O O
who O O
is O O
86 O O
years O O
of O O
age O O
and O O
has O O
no O O
history O O
of O O
heart O O
troubles. O O
Physical O O
Examination: O O
His O O
blood O O
pressure O O
is O O
115/60 O O
BLANK O O
of O O
66 O O
beats O O
per O O
minute. O O
In O O
general, O O
he O O
is O O
overweight O O
elderly O O
man O O
in O O
no O O
distress. O O
Sitting O O
upright O O
his O O
jugular O O
venous O O
pressure O O
is O O
below O O
the O O
clavicles. O O
Carotid O O
upstrokes O O
are O O
brisk O O
bilaterally. O O
Lungs O O
are O O
notable O O
for O O
a O O
few O O
crackles O O
at O O
the O O
bases, O O
but O O
otherwise O O
clear. O O
There O O
is O O
no O O
wheezing. O O
Cardiac O O
exam O O
reveals O O
an O O
irregular O O
rate O O
with O O
a O O
variable O O
S1 O O
and O O
S2. O O
There O O
is O O
no O O
audible O O
murmur, O O
rub O O
or O O
gallop. O O
Abdomen O O
is O O
obese, B-OBESE O
soft, O O
and O O
nontender. O O
Lower O O
extremities O O
are O O
warm O O
and O O
well O O
perfused. O O
There O O
is O O
trace O O
pitting O O
edema O O
at O O
the O O
ankles. O O
Recent O O
blood O O
work O O
reveals O O
an O O
INR O O
of O O
2.2 O O
on O O
05/28/2161. O O
EKG O O
today O O
reveals O O
atrial O O
fibrillation O O
at O O
a O O
rate O O
of O O
approximately O O
66 O O
beats O O
per O O
minute. O O
There O O
are O O
some O O
nonspecific O O
T-wave O O
abnormalities, O O
but O O
otherwise O O
no O O
evidence O O
of O O
prior O O
infarct O O
or O O
ST O O
changes. O O
There O O
is O O
some O O
low O O
voltage O O
in O O
the O O
limb O O
leads, O O
though O O
I O O
suspect O O
this O O
is O O
related O O
to O O
his O O
habitus. O O
Overall, O O
Mr. O O
Dejesus O O
is O O
a O O
pleasant O O
78-year-old O O
man O O
with O O
a O O
complex O O
prior O O
medical O O
history O O
who O O
appears O O
to O O
have O O
persistent O O
atrial O O
fibrillation O O
with O O
a O O
principal O O
functional O O
limitation O O
of O O
exertional O O
shortness O O
of O O
breath. O O
He O O
appears O O
to O O
be O O
functional O O
class O O
III. O O
He O O
does O O
not O O
have O O
any O O
frank O O
evidence O O
of O O
volume O O
overload O O
on O O
exam O O
today, O O
though O O
his O O
ventricular O O
function O O
and O O
is O O
not O O
entirely O O
normal. O O
Moreover, O O
he O O
has O O
multiple O O
comorbidities O O
which O O
may O O
exacerbate O O
his O O
exertional O O
dyspnea O O
including O O
COPD O O
and O O
coronary O O
artery O O
disease. O O
We O O
discussed O O
atrial O O
fibrillation O O
with O O
Mr. O O
Dejesus O O
and O O
his O O
family O O
today. O O
We O O
explained O O
that O O
the O O
brief O O
period O O
of O O
normal O O
sinus O O
rhythm O O
associated O O
with O O
symptomatic O O
improvement O O
may O O
be O O
a O O
reason O O
to O O
proceed O O
with O O
catheter O O
ablation. O O
However, O O
given O O
his O O
comorbidities O O
and O O
the O O
presence O O
of O O
persistent O O
arrhythmia O O
we O O
warned O O
that O O
a O O
single O O
catheter O O
ablation O O
procedure O O
may O O
not O O
be O O
entirely O O
successful O O
and O O
that O O
waiting O O
period O O
of O O
approximately O O
3-4 O O
month O O
post-ablation O O
may O O
be O O
required O O
to O O
adjudicate O O
success. O O
Given O O
the O O
length O O
of O O
the O O
procedure O O
as O O
well O O
as O O
his O O
comorbidities, O O
we O O
feel O O
reasonable O O
to O O
consult O O
with O O
our O O
anesthesia O O
colleagues O O
for O O
possible O O
consideration O O
of O O
performing O O
the O O
procedure O O
under O O
general O O
anesthesia O O
versus O O
with O O
MAC O O
and O O
had O O
procedural O O
sedation. O O
We O O
will O O
leave O O
this O O
decision O O
to O O
them. O O
Moreover, O O
prior O O
to O O
the O O
ablation, O O
we O O
will O O
request O O
a O O
transesophageal O O
echocardiogram O O
to O O
rule O O
out O O
left O O
atrial O O
clot O O
prior O O
to O O
ablation. O O
Thank O O
you O O
very O O
much O O
for O O
referring O O
Mr. O O
Dejesus O O
to O O
our O O
care. O O
We O O
will O O
be O O
in O O
touch O O
following O O
the O O
procedure. O O
As O O
always, O O
feel O O
free O O
to O O
call O O
with O O
any O O
questions. O O
Sincerely, O O
______________________________ O O
Oscar O O
U O O
Rice, O O
M.D. O O
eScription O O
document:0-16320445 O O
HFFocus O O
CC: O O
Robert-Joseph O O
Paige O O
M.D. O O
Koenen O O
Collins O O
County O O
Clinic O O
266 O O
Paxton O O
Terrace O O
Peculiar, O O
NE, O O
54583 O O
Fax: O O
Email: O O
DD: O O
06/03/61 O O
DT: O O
06/04/61 O O
DV: O O
06/03/61 O O

Record B-SMOKER O
date: O O
2088-06-28 O O
Reason O O
for O O
Visit O O
Comprehensive O O
physical O O
exam O O
and O O
ongoing O O
management O O
of O O
multiple O O
medical O O
problems. O O
Problems O O
Congestive O O
heart O O
failure O O
He O O
had O O
admission O O
to O O
MCH O O
9/87 O O
with O O
CHF. O O
He O O
was O O
started O O
on O O
Carvedilol B-MEDICATION O
and O O
Spironolactone O O
during O O
that O O
visit. O O
He O O
was O O
aggressively O O
diuresed O O
with O O
marked O O
improvement O O
in O O
his O O
symptoms. O O
Beta O O
blocker O O
was O O
reduced O O
during O O
that O O
admission O O
as O O
well. O O
Most O O
recent O O
echo O O
from O O
5/02/88 O O
showed O O
severely O O
depressed O O
LV O O
systolic O O
function, O O
EF O O
30%, O O
global O O
hypokinesis O O
with O O
antero-apical O O
akinesis. O O
Moderate O O
LV O O
margin. O O
Mild O O
concentric O O
LVH O O
and O O
mild O O
L O O
atrial O O
enlargement O O
(41 O O
mm.). O O
Dilated O O
aortic O O
loop. O O
Normal O O
RV O O
size O O
and O O
function. O O
Mild O O
aortic O O
insufficiency O O
and O O
trace O O
MR. O O
He O O
is O O
now O O
doing O O
exceedingly O O
well O O
on O O
his O O
current O O
regimen O O
and O O
denies O O
any O O
symptoms O O
of O O
SOB, O O
orthopnea O O
or O O
pedal O O
edema. O O
He O O
continues O O
to O O
be O O
followed O O
regularly O O
by O O
regularly O O
by O O
Dr. O O
Cook O O
for O O
his O O
ischemic B-CAD O
cardiomyopathy/CHF. I-CAD O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
After O O
his O O
admission O O
for O O
CHF, O O
he O O
underwent O O
dolbutamine B-CAD O
stress B-CAD O
test I-CAD O
on I-CAD O
9/30/87, I-CAD O
which I-CAD O
revealed I-CAD O
a I-CAD O
small I-CAD O
area I-CAD O
of I-CAD O
ischemia I-CAD O
in I-CAD O
mid-anterior I-CAD O
and I-CAD O
a I-CAD O
moderate I-CAD O
to I-CAD O
large-sized I-CAD O
area I-CAD O
of I-CAD O
ischemia I-CAD O
inferiorly I-CAD O
and I-CAD O
there I-CAD O
was I-CAD O
moderate I-CAD O
LV I-CAD O
dilatation I-CAD O
following I-CAD O
stress. I-CAD O
Based O O
on O O
this, O O
he O O
was O O
admitted O O
to O O
MCH O O
and O O
underwent O O
cardiac O O
catheterization. O O
10/87 B-CAD O
he I-CAD O
underwent I-CAD O
stenting B-CAD O
X4 I-CAD O
of I-CAD O
L I-CAD O
circumflex I-CAD O
coronary I-CAD O
artery I-CAD O
and I-CAD O
third I-CAD O
obtuse I-CAD O
marginal I-CAD O
branch. I-CAD O
Notably, O O
his O O
cath O O
also O O
revealed O O
a O O
dominant O O
RCA O B-CAD
which O O
was O O
occluded O O
proximately O O
and O O
was O O
collateralized O O
from O O
the O O
LAD, O O
which O O
was O O
supplied O O
by O O
the O O
L O O
internal O O
mammary O O
artery. O O
The O O
L O O
main O O
had O O
no O O
significant O O
lesions. O O
The O O
LAD O O
had O O
a O O
50% O O
lesion O O
just O O
before O O
the O O
first O O
diagonal O O
and O O
the O O
mid-LAD B-CAD O
was I-CAD O
occluded. I-CAD O
He O O
had O O
successful O O
stenting O O
with O O
very O O
good O O
angiographic O O
results O O
and O O
he O O
received O O
adjuvant O O
intravenous O O
[ O O
] O O
therapy. O O
He O O
was O O
discharged O O
the O O
following O O
day O O
without O O
complications. O O
Although O O
his O O
current O O
activity O O
level O O
is O O
somewhat O O
limited O O
by O O
his O O
DJD O O
(see O O
below), O O
he O O
is O O
exercising O O
regularly O O
in O O
the O O
pool O O
and O O
he O O
currently O O
denies O O
any O O
symptoms O O
of O O
angina. O O
pacemaker O O
S/P O O
DDD O O
pacemaker O O
for O O
sick O O
sinus O O
syndrome O O
7/83 O O
and O O
doing O O
well. O O
Continues O O
follow-up O O
with O O
Dr. O O
Whitlock/Cook. O O
S/P O O
CARDIAC B-CAD O
ARREST I-CAD O
12/76. O O
10/76 B-CAD O
DEVELOPED I-CAD O
EXERTIONAL I-CAD O
ANGINA, B-CAD O
POSITIVE O O
ETT. O O
CATH O O
AT O O
NEDH O O
REVEALED O O
THREE-VESSEL O O
CAD. O O
AWAITING O O
CABG B-CAD O
WHEN O O
12/76 B-CAD O
SUFFERED I-CAD O
CARDIAC I-CAD O
ARREST. I-CAD O
FOUND O O
TO O O
BE O O
IN O O
VT, O O
HAD O O
RECURRENT O O
VT. O O
TRANSFERRED O O
TO O O
MCH O O
AND O O
UNDERWENT B-CAD O
CABG I-CAD O
AND I-CAD O
AICD I-CAD O
2/77. O O
[04-Nov-2078] O O
He O O
is O O
doing O O
well O O
S/P O O
ICD O O
implantation O O
in O O
2/77 O O
with O O
revisions O O
in O O
7/80 O O
and O O
in O O
2084. O O
hypertension B-HYPERTENSION B-HYPERTENSION
BP O O
is O O
slightly O O
high O O
today, O O
but O O
we O O
will O O
recheck O O
at O O
next O O
visit. O O
If O O
it O O
remains O O
elevated, O O
would O O
consider O O
increasing B-MEDICATION O
Carvedilol I-MEDICATION B-MEDICATION
diabetes B-DIABETES B-MEDICATION
mellitus I-DIABETES B-MEDICATION
He O O
continues O O
on O O
Glyburide B-MEDICATION B-MEDICATION
and O O
although O O
he O O
checks O O
fasting O O
sugars O O
infrequently, O O
they O O
are O O
typically O O
in O O
the O O
120's O O
and O O
he O O
denies O O
any O O
symptoms O O
of O O
hypoglycemia. O O
He O O
has O O
not O O
seen O O
a O O
podiatrist O O
regularly O O
and O O
I O O
have O O
encouraged O O
him O O
to O O
begin O O
this O O
process. O O
Will O O
check O O
FBS, O O
HBA1C O O
and O O
urine O O
for O O
microalbumin O O
today. O O
hypercholesterolemia B-HYPERLIPIDEMIA B-MEDICATION
He O O
has O O
had O O
virtual O O
normalization O O
of O O
his O O
lipid O O
profile O O
with O O
Lipitor. B-MEDICATION B-MEDICATION
We O O
will O O
check O O
fasting O O
lipids O O
and O O
LFT's O O
today. O O
nephropathy O O
S/P O O
renal O O
biopsy O O
10/79 O O
for O O
severe O O
proteinuria O O
which O O
was O O
consistent O O
with O O
diabetic O O
nephropathy. O O
As O O
noted O O
above, O O
a O O
24-hour O O
urine O O
recently O O
revealed O O
6gm O O
of O O
protein. O O
He O O
is O O
on O O
new O O
maximal O O
doses O O
of O O
ACEI's. O O
[02-Jun-2087] O O
Recheck O O
BUN O O
and O O
creatinine O O
today. O O
peripheral O O
vascular O O
disease O O
He O O
has O O
bilateral O O
femoral O O
bruits O O
and O O
diminished O O
peripheral O O
pulses, O O
but O O
because O O
of O O
his O O
limited O O
walking O O
ability, O O
currently O O
has O O
no O O
symptoms O O
of O O
claudication. O O
RECTAL O O
FISTULA O O
SINCE O O
LAST O O
VISIT O O
HE O O
WAS O O
SEEN O O
BY O O
DR. O O
JENSON O O
AND O O
UNDERWENT O O
A O O
FLEXIBLE. O O
SIG. O O
HE O O
HAD O O
A O O
SINUS O O
OPENING O O
IN O O
THE O O
LEFT O O
POSTERIOR O O
PERIANAL O O
AREA. O O
HE O O
FELT O O
THAT O O
TO O O
FULLY O O
EVALUATE O O
THIS O O
TO O O
SEE O O
WHETHER O O
IT O O
WAS O O
AN O O
ANAL O O
FISTULA O O
OR O O
A O O
PILONIDAL O O
CYST O O
THAT O O
EXAM O O
UNDER O O
ANESTHESIA O O
WITH O O
UNROOFING O O
OF O O
THE O O
LESION O O
WAS O O
INDICATED. O O
PT O O
SO O O
FAR O O
HAS O O
DECLINED O O
THIS, O O
BUT O O
WILL O O
LET O O
DR. O O
JENSON O O
KNOW O O
IF O O
HE O O
RECONSIDERS. O O
CURRENTLY O O
HE O O
IS O O
WILLING O O
TO O O
LIVE O O
WITH O O
HIS O O
SYMPTOMS. O O
OSTEOARTHRITIS O O
He O O
has O O
had O O
recent O O
significant O O
worsening O O
in O O
his O O
L O O
knee O O
pain. O O
It O O
has O O
now O O
gotten O O
to O O
the O O
point O O
where O O
it O O
limits O O
his O O
ability O O
to O O
walk, O O
so O O
that O O
he O O
can O O
only O O
'limp O O
less O O
than O O
a O O
block' O O
and O O
has O O
difficulty O O
with O O
stairs. O O
Given O O
that O O
he O O
has O O
done O O
well O O
from O O
a O O
cardiac O O
standpoint O O
since O O
his O O
admissions O O
in O O
the O O
spring, O O
he O O
is O O
interested O O
in O O
pursuing O O
a O O
L O O
TKR O O
replacement O O
if O O
Cardiology O O
feels O O
it O O
would O O
be O O
feasible. O O
Will O O
refer O O
him O O
to O O
Dr. O O
Robles O O
for O O
initial O O
evaluation. O O
Carotid O O
stenosis O O
According O O
to O O
Dr. O O
Cook's O O
records, O O
a O O
carotid O O
artery O O
duplex O O
scan O O
from O O
5/06 O O
showed O O
60 O O
to O O
80% O O
stenosis O O
of O O
the O O
RICA, O O
but O O
I O O
do O O
not O O
find O O
those O O
records O O
of O O
PCIS. O O
Apparently O O
he O O
is O O
scheduled O O
for O O
a O O
repeat O O
study O O
before O O
he O O
follows O O
up O O
with O O
Dr. O O
Cook. O O
He O O
is O O
S/P O O
R O O
cerebellar O O
CVA O O
back O O
in O O
'80 O O
and O O
has O O
had O O
stable O O
minor O O
neurologic O O
deficits O O
since O O
that O O
time O O
and O O
currently O O
denies O O
any O O
new O O
neurologic O O
symptoms. O O
Review O O
of O O
Systems O O
Small O O
lesion O O
on O O
his O O
R O O
ear. O O
Recent O O
R O O
groin O O
infection O O
which O O
required O O
treatment O O
with O O
antiobiotics O O
by O O
Dr. O O
Valentine O O
in O O
5/06. O O
Nocturia O O
X1. O O
Denies O O
symptoms O O
of O O
hypoglycemia. O O
No O O
neurologic O O
symptoms. O O
Denies O O
palpitations, O O
SOB, O O
chest O O
pain, O O
lightheadedness O O
or O O
syncope. O O
Denies O O
peripheral O O
edema. O O
No O O
abdominal O O
pain O O
or O O
change O O
in O O
his O O
bowels. O O
He O O
does O O
have O O
chronic O O
rectal O O
fistula O O
and O O
continues O O
to O O
have O O
intermittent O O
hematochezia O O
and O O
discharge, O O
but O O
he O O
is O O
able O O
to O O
self-treat O O
this O O
and O O
declines O O
surgery. O O
No O O
melena. O O
Vital O O
Signs O O
Weight: O O
188 O O
Pounds O O
Blood B-HYPERTENSION O
Pressure: I-HYPERTENSION O
140/60 I-HYPERTENSION O
Pulse: O O
64 O O
Regular O O
Physical O O
Exam O O
General O O
Appearance O O
Well O O
appearing. O O
Skin O O
Extensive O O
sun O O
damage, O O
with O O
several O O
actinic-appearing O O
lesions O O
over O O
scalp, O O
forehead O O
and O O
pinna. O O
There O O
is O O
also O O
one O O
small O O
pustule O O
on O O
his O O
R O O
pinna. O O
HEENT O O
Oropharynx O O
edentulous. O O
No O O
lesions. O O
Neck O O
Neck O O
is O O
supple, O O
without O O
thyromegaly. O O
Chest O O
Lungs O O
are O O
clear O O
to O O
A&P. O O
Cor O O
RRR. O O
Normal O O
S1/S2. O O
No O O
JVD. O O
Carotids O O
2+ O O
bilaterally, O O
with O O
very O O
soft O O
bruits. O O
I/VI O O
HSM O O
at O O
the O O
apex, O O
without O O
change. O O
No O O
S3 O O
appreciated. O O
Abdomen O O
ICD O O
in O O
place. O O
No O O
abdominal O O
masses. O O
Nontender. O O
No O O
bruits. O O
Rectal O O
Exam O O
Fistula O O
present, O O
without O O
evidence O O
of O O
erythema O O
or O O
drainage. O O
No O O
rectal O O
masses. O O
Prostate O O
diffusely O O
enlarged, O O
without O O
discrete O O
nodules. O O
Stool O O
is O O
brown, O O
but O O
trace O O
guaiac-positive. O O
Genito-Urinary O O
Testes O O
without O O
masses. O O
No O O
inguinal O O
hernias. O O
No O O
evidence O O
of O O
recent O O
R O O
groin O O
infection. O O
Extremity O O
No O O
C/C/E. O O
Diminished O O
peripheral O O
pulses. O O
Disposition O O
and O O
Plans O O
(1) O O
Follow O O
up O O
in O O
spring O O
of O O
'88, O O
recheck O O
BP. O O
? O O
increase O O
Carvedilol. O O
(2) O O
Guaiac-positive O O
stool. O O
Recent O O
negative O O
sig. O O
Will O O
obtain O O
barium O O
enema. O O
(3) O O
Warm O O
compresses O O
and O O
Bacitracin O O
to O O
pustule O O
on O O
R O O
ear. O O
If O O
worsening, O O
pt. O O
to O O
call. O O
Referral O O
to O O
Dr. O O
Thomas/Dermatology O O
for O O
a O O
full O O
skin O O
evaluation. O O
(4) O O
Referral O O
to O O
Dr. O O
Robles O O
for O O
? O O
left O O
TKR. O O
(5) O O
Referral O O
to O O
Podiatry. O O
(6) O O
Ongoing O O
follow-up O O
with O O
Cardiology. O O
(7) O O
Needs O O
pneumovax O O
and O O
flu O O
vaccine O O
in O O
the O O
winter. O O
cc: O O
Keith O O
Cook, O O
M.D./Cardiology, O O
EUD1 O O
K. O O
Alex O O
Whitlock, O O
M.D./Cardiology, O O
NOU042 O O
Vincent O O
Thomas, O O
M.D./Dermatology, O O
AUX745 O O
Owen O O
Robles, O O
M.D./Orthopedics, O O
KMZ928 O O

Record O O
date: O O
2089-06-27 O O
OFFICE O O
NOTE O O
George, O O
Rickey O O
MR O O
#113-14-14 O O
06/27/2089 O O
COMPREHENSIVE O O
EXAM. O O
PERSONAL O O
DATA O O
AND O O
OVERALL O O
HEALTH: O O
Now O O
63, O O
despite O O
his O O
multiple O O
medical O O
problems, O O
he O O
continues O O
to O O
spend O O
spring O O
in O O
West O O
Virginia O O
and O O
remain O O
reasonably O O
active. O O
Wife O O
very O O
helpful O O
in O O
cooking O O
appropriate O O
meals O O
and O O
helping O O
with O O
day O O
to O O
day O O
issues. O O
ONGOING O O
MANAGEMENT/MULTIPLE O O
MEDICAL O O
PROBLEMS: O O
1. O O
Health O O
maintenance. O O
Eye O O
exam. O O
Continue O O
to O O
recommend O O
annual O O
exams O O
with O O
Dr. O O
Ortiz. O O
Influenza O O
vaccine O O
advised, O O
Winter O O
89. O O
PSA O O
sent. O O
2. O O
Preventative O O
counseling. O O
Continues O O
to O O
swim O O
in O O
a O O
pool, O O
no O O
alcohol, O O
no B-SMOKER O
cigarettes. I-SMOKER O
Advised O O
regular O O
skin O O
checks. O O
Avoidance O O
of O O
sun. O O
Rectal O O
exam O O
neg. O O
Smoking B-SMOKER O
status: I-SMOKER O
none I-SMOKER O
smoker. O O
Stool O O
guaiac O O
test: O O
home O O
with O O
stool O O
guaiac O O
cards. O O
PROBLEMS: O O
1. O O
CAD. B-CAD O
He O O
continues O O
to O O
do O O
quite O O
well O O
with O O
no O O
evidence O O
of O O
current O O
symptoms O O
of O O
angina. O O
He O O
is O O
s/p B-CAD O
CABG I-CAD O
and I-CAD O
most I-CAD O
recently I-CAD O
s/p I-CAD O
stent I-CAD O
distal I-CAD O
LCX I-CAD O
10/87. I-CAD O
2. O O
CHF. O O
He O O
has O O
severe O O
ischemic B-CAD O
cardiomyopathy I-CAD O
with O O
chronic O O
CHF. O O
His O O
most O O
recent O O
echocardiogram O O
4/88, O O
showed O O
a O O
severe O O
depressed O O
LV O O
systolic O O
function O O
with O O
estimated O O
EF O O
of O O
30% O O
with O O
global O O
hypokinesis O O
and O O
antero-apical O O
akinesis O O
with O O
moderate O O
LV O O
enlargement O O
and O O
mild O O
concentric O O
LVH O O
with O O
left O O
atrial O O
enlargement, O O
dilated O O
aortic O O
root, O O
mild O O
AI O O
and O O
trace O O
MR. O O
despite O O
this, O O
since O O
getting O O
on O O
a O O
stable O O
dose O O
of O O
Lasix O O
and O O
Carvedilol, B-MEDICATION O
which O O
was O O
added O O
during O O
his O O
hospitalization O O
for O O
CHF O O
in O O
10/87, O O
he O O
has O O
done O O
well O O
and O O
currently O O
denies O O
symptoms O O
of O O
orthopnea, O O
PND O O
or O O
edema. O O
3. O O
S/P O O
AICD. O O
He O O
is O O
s/p O O
recent O O
admission O O
to O O
MCH, O O
6/17 O O
through O O
6/19/89 O O
for O O
replacement O O
of O O
his O O
cardiac O O
defibrillator. O O
He O O
did O O
well O O
without O O
complication O O
and O O
he O O
continues O O
to O O
follow O O
up O O
Dr. O O
Cook O O
on O O
a O O
regular O O
basis. O O
He O O
has O O
had O O
no O O
VT, O O
VF, O O
which O O
has O O
been O O
symptomatic O O
or O O
which O O
has O O
caused O O
triggering O O
of O O
his O O
AICD. O O
4. O O
S/P O O
DDD O O
pacemaker O O
for O O
sick O O
sinus O O
syndrome, O O
7/83. O O
Continues O O
to O O
do O O
well, O O
again, O O
with O O
close O O
monitoring O O
by O O
Dr. O O
Cook. O O
5. O O
Hypertension. B-HYPERTENSION B-HYPERTENSION
Blood O O
pressure O O
is O O
excellent O O
on O O
current O O
regimen O O
and O O
will O O
continue O O
same. O O
George, O O
Rickey O O
MR O O
#113-14-14 O O
-2- O O
June O O
27, O O
2089 O O
6. O O
Diabetes B-DIABETES O
mellitus. I-DIABETES O
He O O
continues O O
on O O
oral O O
agents, O O
watching O O
his O O
diet O O
and O O
exercising O O
as O O
much O O
as O O
he O O
is O O
able. O O
He O O
does O O
not O O
monitor O O
sugars O O
often O O
but O O
he O O
reports O O
when O O
he O O
does O O
have O O
them O O
done, O O
sugars O O
are O O
typically O O
fasting O O
100-150 O O
and O O
no O O
symptoms O O
of O O
hypoglycemia. O O
Will O O
check O O
HBA1C O O
and O O
urine O O
for O O
micro O O
albumin O O
today. O O
7. O O
Cerebral O O
vascular O O
disease. O O
He O O
is O O
s/p O O
cerebellar O O
CVA, O O
7/80 O O
with O O
mild O O
residual O O
dysarthria O O
and O O
right O O
sided O O
weakness O O
but O O
has O O
had O O
no O O
new O O
neurologic O O
events. O O
His O O
most O O
recent O O
carotid O O
artery O O
duplex O O
study O O
was O O
from O O
5/88, O O
showed O O
a O O
60-80% O O
stenosis O O
of O O
the O O
RICA O O
but O O
I O O
don't O O
actually O O
hear O O
a O O
bruit O O
on O O
his O O
exam O O
today. O O
He O O
continues O O
on O O
Coumadin O O
anticoagulation. O O
8. O O
Hypercholesterolemia. B-HYPERLIPIDEMIA O
His O O
most O O
recent O O
lipid O O
profile O O
is O O
quite O O
improved O O
with O O
Lipitor B-MEDICATION B-MEDICATION
with O O
a O O
total O O
cholesterol O O
down O O
to O O
136, O O
triglycerides O O
313, O O
HDL O O
25, O O
LDL O O
48 O O
on O O
6/11/89. O O
Unfortunately, O O
since O O
his O O
HDL O O
remains O O
low, O O
which O O
is O O
suboptimal, O O
but O O
he O O
has O O
not O O
tolerated O O
Niacin O O
in O O
the O O
past. O O
9. O O
Peripheral O O
vascular O O
disease. O O
He O O
continues O O
to O O
have O O
bilateral O O
femoral O O
bruits O O
and O O
diminished O O
peripheral O O
pulses O O
but O O
because O O
of O O
his O O
limited O O
walking O O
ability, O O
he O O
currently O O
has O O
no O O
symptoms O O
of O O
claudication. O O
10. O O
Osteoarthritis. O O
He O O
is O O
s/p O O
left O O
TKR O O
by O O
Dr. O O
Robles O O
last O O
year O O
and O O
is O O
now O O
doing O O
quite O O
well. O O
Notably, O O
he O O
would O O
require O O
antibiotic O O
prophylaxis O O
for O O
procedures. O O
REVIEW O O
OF O O
SYSTEMS: O O
He O O
denies O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
abdominal O O
pain. O O
He O O
continues O O
to O O
have O O
a O O
rectal O O
fistula. O O
Last O O
year, O O
had O O
a O O
negative O O
Barium O O
enema O O
study O O
and O O
several O O
years O O
ago O O
a O O
sigmoidoscopy O O
because O O
of O O
guaiac O O
positive O O
stool O O
but O O
this O O
is O O
presumably O O
secondary O O
to O O
the O O
rectal O O
fistula, O O
which O O
intermittently O O
bleeds. O O
He O O
has O O
had O O
no O O
recent O O
edema O O
in O O
his O O
legs. O O
His O O
left O O
knee O O
is O O
doing O O
quite O O
well O O
and O O
he O O
is O O
working O O
to O O
strengthen O O
the O O
thigh O O
muscles. O O
He O O
has O O
nocturia O O
one O O
time O O
per O O
night. O O
He O O
has O O
stable O O
impotence, O O
some O O
decreased O O
interest O O
as O O
well O O
as O O
some O O
decreased O O
ability O O
to O O
have O O
erections, O O
though O O
he O O
can O O
still O O
have O O
a O O
partial O O
erection. O O
Generalized O O
decreased O O
energy O O
level. O O
PHYSICAL O O
EXAM: O O
Blood O O
pressure: O O
136/60, O O
pulse: O O
60 O O
and O O
regular. O O
Weight: O O
181. O O
General: O O
amazingly O O
well O O
appearing. O O
Skin: O O
no O O
suspicious O O
lesions. O O
HEENT: O O
oropharynx O O
edentulous, O O
no O O
lesions. O O
Lungs: O O
clear O O
to O O
A&P. O O
COR: O O
carotids O O
2+, O O
no O O
bruits O O
appreciated O O
by O O
my O O
exam. O O
JVP O O
flat. O O
Thyroid: O O
no O O
thyromegaly. O O
Nodes: O O
no O O
adenopathy. O O
COR: O O
s/p O O
median O O
sternotomy O O
scar. O O
Pacer O O
left O O
upper O O
chest O O
wall. O O
AICD O O
with O O
fresh O O
Steri O O
strips O O
in O O
place. O O
No O O
evidence O O
George, O O
Rickey O O
MR O O
#113-14-14 O O
-3- O O
June O O
27, O O
2089 O O
of O O
erythema. O O
Left O O
upper O O
abdomen. O O
S1, O O
S2, O O
2/6, O O
HSM, O O
apex O O
no O O
S3, O O
or O O
diastolic O O
murmur O O
appreciated. O O
Abdomen: O O
positive O O
bowel O O
sounds, O O
soft O O
non O O
tender, O O
no O O
HSM O O
or O O
masses. O O
Rectal: O O
mildly O O
diffusely O O
enlarged O O
prostate O O
without O O
nodules, O O
no O O
rectal O O
masses. O O
Stool O O
brown, O O
guaiac O O
negative. O O
Extremities: O O
scar O O
over O O
the O O
left O O
knee, O O
no O O
peripheral O O
edema. O O
DISPOSITION: O O
Follow O O
up O O
with O O
Opal O O
Fierro. O O
Flu O O
shot O O
in O O
the O O
winter, O O
sooner O O
PRN. O O
Opal O O
Fierro, O O
M.D. O O
Dictated/Not O O
Read O O
OF/valle O O

Record O O
date: O O
2090-07-07 O O
OFFICE O O
NOTE O O
George, O O
Rickey O O
MR#: O O
1131414 O O
July O O
7, O O
2090 O O
Reason O O
for O O
visit: O O
Comprehensive O O
annual O O
exam/ongoing O O
management O O
of O O
multiple O O
chronic O O
medical O O
problems. O O
Health O O
maintenance. O O
Complete O O
physical O O
examination O O
7/7/90. O O
Eye O O
exam: O O
continues O O
to O O
follow O O
up O O
annually O O
with O O
Dr. O O
Ortiz. O O
Influenza O O
vaccine O O
scheduled O O
winter O O
90. O O
PSA O O
deferred O O
given O O
age, O O
cardiac O O
issues. O O
Podiatry O O
exam: O O
routine. O O
Rectal: O O
neg. O O
Sigmoidoscopy O O
10/87, O O
divertic's, O O
Dr. O O
Ramsey. O O
Smoking B-SMOKER O
status: I-SMOKER O
90 I-SMOKER O
pack/year, I-SMOKER O
approximately I-SMOKER O
100 I-SMOKER O
pack/year I-SMOKER O
smoking I-SMOKER O
history. I-SMOKER O
Quit. I-SMOKER O
Stool O O
guaiac: O O
home O O
with O O
stool O O
guaiac O O
cards. O O
Other O O
problems: O O
1. O O
CAD. B-CAD O
Status O O
post O O
CABG B-CAD O
1/77. I-CAD O
PTCA I-CAD O
stent I-CAD O
distal I-CAD O
LCX I-CAD O
10/87. I-CAD O
No O O
recent O O
symptoms O O
of O O
angina O O
though O O
he O O
apparently O O
was O O
started O O
on O O
Imdur B-CAD O
during O O
a O O
hospitalization O O
in O O
West O O
Virginia O O
this O O
spring. O O
2. O O
Status O O
post O O
VF O O
arrest. O O
Status O O
post O O
AICD. O O
Continues O O
to O O
follow O O
up O O
with O O
Dr. O O
Cook O O
on O O
a O O
regular O O
basis. O O
AICD O O
has O O
not O O
triggered. O O
3. O O
Status O O
post O O
DDD O O
pacer O O
for O O
sic O O
sinus O O
syndrome. O O
He O O
has O O
frequent O O
ectopics O O
versus O O
? O O
AF O O
by O O
exam O O
today. O O
Will O O
check O O
EKG O O
and O O
rhythm O O
strip. O O
4. O O
CHF/CMCAD. O O
He O O
had O O
an O O
episode O O
of O O
shortness O O
of O O
breath O O
leading O O
to O O
hospitalization O O
this O O
spring O O
down O O
in O O
West O O
Virginia. O O
Unfortunately, O O
I O O
do O O
not O O
have O O
records O O
but O O
there O O
was O O
some O O
question O O
of O O
whether O O
this O O
was O O
related O O
to O O
asthma, O O
allergies O O
or O O
CHF. O O
He O O
has O O
had O O
two O O
pillow O O
orthopnea O O
and O O
worsening O O
edema O O
than O O
in O O
the O O
past. O O
He O O
has O O
also O O
noted O O
some O O
more O O
exertional O O
dyspnea. O O
He O O
denies O O
cough, O O
wheeze, O O
hemoptysis. O O
? O O
PND. O O
Most O O
recent O O
echo O O
4/88, O O
severely O O
depressed O O
LV O O
with O O
EF O O
about O O
30%. O O
Mild O O
concentric O O
LVH. O O
Dilated O O
aortic O O
route. O O
Mild O O
AI. O O
Trace O O
MR. O O
He O O
is O O
currently O O
on O O
a O O
regimen O O
of O O
Imdur, O O
Lasix, O O
Carvedilol, B-MEDICATION O
Zestril B-MEDICATION B-MEDICATION
and O O
Digoxin. O O
Will O O
plan O O
increase O O
Lasix O O
to O O
80 O O
q.d. O O
Check O O
chest O O
x-ray, O O
PFTs O O
and O O
reassess. O O
George, O O
Rickey O O
MR#: O O
1131414 O O
July O O
7, O O
2090 O O
Page O O
2 O O
5. O O
Diabetes B-DIABETES O
mellitus. I-DIABETES O
Continues O O
on O O
oral O O
agents O O
and O O
has O O
been O O
quite O O
good O O
with O O
his O O
diet. O O
Weight O O
is O O
actually O O
down O O
10 O O
pounds O O
which O O
he O O
attributes O O
to O O
excellent O O
attention O O
to O O
diet. O O
Will O O
recheck O O
FBS, O O
HB O O
A1c O O
today. O O
He O O
continues O O
to O O
receive O O
routine O O
dental O O
and O O
podiatry O O
care. O O
6. O O
Status O O
post O O
cerebellar O O
CVA. O O
Mild O O
residual O O
dysarthria O O
and O O
right O O
sided O O
weakness. O O
No O O
new O O
neurologic O O
events. O O
Most O O
recent O O
carotid O O
study O O
5/88, O O
60-80% O O
stenosis O O
right O O
internal O O
carotid. O O
He O O
continues O O
on O O
Coumadin. O O
7. O O
Hyperlipidemia. B-HYPERLIPIDEMIA O
Continues O O
on O O
Lipitor B-MEDICATION B-MEDICATION
with O O
improved O O
lipid O O
profile O O
though O O
HDL O O
remains O O
low. O O
He O O
has O O
not O O
tolerated O O
Niacin B-MEDICATION O
in O O
the O O
past. O O
Will O O
recheck O O
fasting O O
lipids O O
today. O O
8. O O
Peripheral O O
vascular O O
disease. O O
Continues O O
to O O
have O O
bilateral O O
femoral O O
bruits O O
but O O
no O O
complaints O O
of O O
claudication. O O
9. O O
Osteoarthritis/left O O
knee O O
pain. O O
He O O
is O O
status O O
post O O
left O O
TKR O O
by O O
Dr. O O
Robles O O
last O O
year. O O
Unfortunately O O
had O O
a O O
knee O O
injury O O
down O O
in O O
West O O
Virginia O O
this O O
spring O O
and O O
has O O
quite O O
a O O
bit O O
of O O
problem O O
with O O
swelling O O
and O O
pain. O O
He O O
was O O
seen O O
by O O
Dr. O O
Robles O O
who O O
treated O O
him O O
briefly O O
with O O
Vioxx O O
but O O
this O O
caused O O
significant O O
worsening O O
lower O O
extremity O O
edema O O
and O O
decreased O O
urine O O
output O O
requiring O O
its O O
discontinuation. O O
He O O
is O O
now O O
carefully O O
using O O
ibuprofen O O
and O O
has O O
follow O O
up O O
scheduled O O
with O O
Dr. O O
Robles. O O
10. O O
Nephropathy. O O
Status O O
post O O
renal O O
biopsy O O
10/79 O O
for O O
severe O O
proteinuria. O O
Biopsy O O
consistent O O
with O O
diabetic O O
nephropathy. O O
Continues O O
on O O
ACE O O
inhibitor. O O
Will O O
recheck O O
BUN, O O
creatinine O O
today. O O
Review O O
of O O
systems: O O
As O O
per O O
HPI, O O
no O O
abdominal O O
pain, O O
nausea, O O
vomiting, O O
melena, O O
hematochezia, O O
hematuria. O O
Otherwise O O
as O O
noted O O
above. O O
Physical O O
examination: O O
Weight O O
175 O O
(down O O
from O O
181 O O
6/89). O O
Pulse O O
64, O O
? O O
frequent O O
ectopic O O
beats O O
versus O O
irregularly O O
irregular O O
rhythm. O O
Blood O O
pressure O O
130/70. O O
General: O O
thin, O O
but O O
well O O
appearing. O O
Skin: O O
no O O
suspicious O O
lesions. O O
HEENT: O O
oropharynx O O
edentulous, O O
no O O
lesions. O O
Lungs: O O
clear O O
to O O
A&P. O O
Cor.: O O
Carotids O O
2+, O O
no O O
bruits O O
appreciated O O
on O O
my O O
exam. O O
No O O
thyromegaly. O O
Nodes: O O
no O O
adenopathy. O O
Cor.: O O
status O O
post O O
median O O
sternotomy. O O
Pacer O O
left O O
George, O O
Rickey O O
MR#: O O
1131414 O O
July O O
7, O O
2090 O O
Page O O
3 O O
upper O O
chest O O
wall, O O
AICD O O
left O O
upper O O
abdomen. O O
Distant O O
heart O O
sounds, O O
S1, O O
S2, O O
II/VI O O
HSM O O
apex, O O
no O O
S3 O O
or O O
diastolic O O
murmur O O
appreciated. O O
Femoral O O
pulses O O
2+ O O
with O O
soft O O
bruits O O
bilaterally. O O
Distal O O
pulses O O
not O O
palpable. O O
Abdomen: O O
positive O O
bowel O O
sounds, O O
soft, O O
nontender, O O
no O O
HSM O O
or O O
mass. O O
Rectal: O O
mildly O O
diffuse O O
prostate O O
without O O
nodules, O O
no O O
rectal O O
masses. O O
Stool O O
brown O O
guaiac O O
negative. O O
Extremities: O O
knee O O
brace, O O
left O O
knee. O O
1+ O O
edema O O
bilaterally. O O
Disposition: O O
Follow O O
up O O
with O O
Opal O O
Fierro O O
after O O
PFTs. O O
Opal O O
Fierro, O O
M.D. O O
Dictated/Not O O
Read O O
/harris O O
cc: O O
Keith O O
Cook, O O
M.D. O O
Massillon O O
Community O O
Hospital O O
7 O O
Monterey O O
Avenue O O
Mexico O O
CT O O
51299 O O

Record B-SMOKER O
date: O O
2092-06-10 O O
OFFICE O O
NOTE O O
George, O O
Rickey O O
MRN: O O
1131414 O O
06/10/92 O O
REASON O O
FOR O O
VISIT: O O
Scheduled O O
follow O O
up O O
of O O
multiple O O
medical O O
problems. O O
PROBLEMS: O O
1. O O
Status O O
post O O
removal O O
of O O
infected O O
AICD O O
and O O
pacer. O O
Admitted O O
to O O
Massillon O O
Community O O
12/91 O O
with O O
infection O O
of O O
his O O
AICD O O
and O O
permanent O O
pacer. O O
He O O
was O O
managed O O
by O O
multiple O O
services O O
including O O
EP, O O
Cardiology, O O
and O O
ID. O O
His O O
OR O O
cultures O O
grew O O
candida O O
and O O
he O O
was O O
treated O O
with O O
a O O
prolonged O O
course O O
of O O
fluconazole. O O
Although O O
he O O
had O O
runs O O
of O O
NSVT, O O
he O O
was O O
managed O O
effectively O O
with O O
carvedilol. B-MEDICATION O
Notably O O
his O O
digoxin O O
was O O
stopped O O
because O O
of O O
bradycardia O O
during O O
the O O
hospitalization. O O
He O O
never O O
had O O
any O O
sustained O O
VT O O
or O O
VF. O O
He O O
was O O
subsequently O O
discharged O O
home O O
with O O
a O O
Life O O
vest O O
defibrillator. O O
He O O
has O O
done O O
well O O
with O O
no O O
recurrent O O
evidence O O
of O O
infection. O O
He O O
currently O O
has O O
no O O
AICD O O
or O O
pacemaker O O
but O O
saw O O
Dr. O O
Cook O O
yesterday O O
and O O
apparently O O
he O O
is O O
being O O
evaluated O O
for O O
new O O
hardware O O
for O O
his O O
arrhythmia O O
issues. O O
He O O
has O O
a O O
history O O
of O O
both O O
VF O O
arrest O O
and O O
sick O O
sinus O O
syndrome. O O
Currently O O
his O O
heart O O
rate O O
is O O
slightly O O
irregular O O
but O O
a O O
reasonable O O
rate O O
and O O
he O O
will O O
continue O O
on O O
his O O
current O O
regimen O O
as O O
prescribed O O
by O O
Dr. O O
Cook O O
with O O
close O O
follow O O
up. O O
2. O O
CHF. O O
Immediately O O
after O O
his O O
discharge O O
from O O
CCGH O O
after O O
his O O
hospitalization, O O
he O O
went O O
directly O O
to O O
West O O
Virginia O O
where O O
his O O
wife O O
was O O
able O O
to O O
care O O
for O O
him. O O
He O O
had O O
one O O
episode O O
of O O
CHF, O O
which O O
was O O
managed O O
as O O
an O O
outpatient, O O
and O O
he O O
is O O
now O O
on O O
slightly O O
doses O O
of O O
Lasix O O
than O O
previously. O O
At O O
the O O
present O O
time, O O
he O O
has O O
no O O
active O O
symptoms O O
of O O
CHF, O O
he O O
continues O O
to O O
sleep O O
on O O
two O O
large O O
pillows O O
at O O
night O O
without O O
symptoms O O
of O O
orthopnea O O
and O O
has O O
minimal O O
to O O
no O O
peripheral O O
edema. O O
He O O
does O O
continue O O
on O O
an O O
ACE O O
inhibitor O O
and O O
potassium O O
along O O
with O O
his O O
Lasix. O O
3. O O
Coronary B-CAD O
artery I-CAD O
disease. I-CAD O
Despite O O
all O O
of O O
his O O
active O O
issues, O O
he O O
has O O
no O O
current O O
symptoms O O
of O O
angina O O
and O O
has O O
tolerated O O
his O O
multiple O O
recent O O
procedures O O
well. O O
4. O O
Status O O
post O O
infected O O
(staph) O O
left O O
knee O O
arthroplasty. O O
His O O
left O O
TKR O O
also O O
required O O
removal O O
due O O
to O O
infection O O
and O O
he O O
had O O
replacement O O
of O O
new O O
hardware O O
by O O
Dr. O O
Judd O O
10/91. O O
He O O
has O O
had O O
no O O
recurrent O O
infection, O O
but O O
his O O
rehabilitation O O
has O O
been O O
more O O
limited O O
because O O
of O O
his O O
other O O
medical O O
issues. O O
He O O
does O O
report O O
that O O
he O O
was O O
swimming O O
in O O
the O O
pool O O
and O O
doing O O
things O O
on O O
his O O
own O O
while O O
down O O
in O O
West O O
Virginia, O O
but O O
we O O
will O O
make O O
a O O
formal O O
rehab O O
referral O O
now O O
that O O
he O O
is O O
back O O
in O O
the O O
Mexico O O
area. O O
5. O O
Diabetes B-DIABETES O
mellitus. I-DIABETES O
Throughout O O
his O O
numerous O O
medical O O
problems O O
over O O
the O O
past O O
six O O
to O O
twelve O O
months, O O
he O O
has O O
had O O
a O O
significant O O
weight O O
loss O O
and O O
not O O
surprisingly, O O
his O O
diabetes B-DIABETES O
regimen O O
has O O
been O O
gradually O O
decreased. O O
He O O
is O O
now O O
on O O
Glyburide B-MEDICATION B-MEDICATION
5 O O
mg O O
b.i.d. O O
and O O
he O O
reports O O
that O O
his O O
fasting O O
sugars O O
which O O
he O O
is O O
checking O O
about O O
three O O
times O O
a O O
week O O
are O O
running O O
quite O O
good O O
in O O
the O O
100 O O
to O O
120 O O
range. O O
He O O
has O O
no O O
complaints O O
of O O
hypoglycemia O O
or O O
blood O O
sugars O O
greater O O
than O O
200. O O
We O O
will O O
check O O
his O O
HbA1c O O
today O O
and O O
continue O O
his O O
current O O
regimen. O O
George, O O
Rickey O O
MRN: O O
1131414 O O
06/10/92 O O
Page O O
2 O O
6. O O
Hyperlipidemia. B-HYPERLIPIDEMIA O
He O O
continues O O
on O O
Lipitor. B-MEDICATION B-MEDICATION
We'll O O
recheck O O
his O O
fasting O O
lipids, O O
LFTs O O
and O O
CPK. O O
7. O O
Diabetic O O
nephropathy. O O
He O O
remains O O
on O O
ACE O O
inhibitor O O
and O O
will O O
check O O
renal O O
function O O
today O O
to O O
re-establish O O
baseline. O O
8. O O
Status O O
post O O
CVA. O O
Known O O
moderate O O
right O O
carotid O O
stenosis. O O
Minimal O O
residual O O
dysarthria O O
and O O
right-sided O O
weakness. O O
Has O O
had O O
no O O
recent O O
neurologic O O
symptoms O O
and O O
remains O O
on O O
Coumadin. O O
PHYSICAL O O
EXAM: O O
Blood O O
pressure O O
by O O
palpation O O
130. O O
Was O O
unable O O
to O O
get O O
sufficient O O
blood O O
pressure O O
by O O
cuff. O O
Pulse O O
60, O O
mostly O O
irregular. O O
General, O O
thin, O O
but O O
no O O
distress. O O
Lungs, O O
clear O O
to O O
auscultation O O
and O O
percussion. O O
Cor, O O
distant O O
heart O O
sounds. O O
No O O
S3 O O
appreciated. O O
Old O O
pacer/AICD O O
site. O O
No O O
evidence O O
of O O
erythema O O
or O O
fluctuance. O O
Extremities, O O
trace O O
edema O O
bilaterally. O O
DISPOSITION: O O
Close O O
ongoing O O
follow O O
up. O O
ADDENDUM: O O
In O O
reviewing O O
patient's O O
medical O O
records O O
after O O
he O O
left O O
today, O O
I O O
found O O
mention O O
of O O
both O O
hematuria O O
and O O
guaiac O O
positive O O
stool O O
during O O
his O O
recent O O
hospitalizations. O O
At O O
this O O
time, O O
he O O
was O O
quite O O
debilitated O O
and O O
I O O
do O O
not O O
think O O
it O O
would O O
be O O
a O O
good O O
time O O
for O O
colonoscopy. O O
He O O
did O O
deny O O
abdominal O O
symptoms O O
as O O
part O O
of O O
my O O
review O O
of O O
systems O O
today. O O
At O O
this O O
point, O O
my O O
plan O O
will O O
be O O
to O O
send O O
him O O
some O O
stool O O
guaiac O O
cards O O
which O O
he O O
can O O
do O O
at O O
home O O
and O O
send O O
in O O
to O O
me O O
by O O
mail. O O
I O O
have O O
also O O
sent O O
off O O
a O O
CBC O O
today. O O
I O O
will O O
plan O O
to O O
repeat O O
urinalysis O O
at O O
his O O
next O O
visit. O O
If O O
he O O
has O O
persistent O O
hematuria O O
or O O
guaiac O O
positive O O
stool, O O
then O O
we O O
will O O
need O O
to O O
discuss O O
more O O
aggressive O O
work-up, O O
but O O
given O O
his O O
overall O O
health O O
condition, O O
I O O
do O O
not O O
feel O O
the O O
need O O
to O O
be O O
aggressive O O
at O O
this O O
time O O
and O O
would O O
like O O
to O O
see O O
him O O
get O O
some O O
strength O O
back O O
first. O O
____________________________________ O O
Opal O O
C. O O
Fierro, O O
M.D. O O
Dictated/Not O O
read O O
kurtz O O
cc: O O
Keith O O
Cook, O O
M.D. O O
Massillon O O
Community O O
Hospital O O
22 O O
Monterey O O
Avenue, O O
Cardiology O O
Service O O
Mexico, O O
CT O O
33383-9795 O O

Record O O
date: O O
2092-10-05 O O
OFFICE O O
NOTE O O
Rickey O O
George O O
MR#1131414 O O
October O O
05, O O
2092 O O
Reason O O
for O O
visit: O O
scheduled O O
follow O O
up O O
status O O
post O O
MCH O O
hospitalization. O O
PROBLEMS: O O
PVD: O O
since O O
last O O
visit O O
he O O
was O O
admitted O O
to O O
MCH O O
with O O
gangrene O O
in O O
his O O
left O O
second O O
toe. O O
Admitted O O
MCH O O
8/29 O O
through O O
9/9/92. O O
Treated O O
by O O
Dr. O O
Randall. O O
Underwent O O
extensive O O
revascularization O O
including O O
right O O
common O O
and O O
external O O
artery O O
transluminal O O
balloon O O
angioplasty O O
and O O
stenting, O O
bilateral O O
common O O
and O O
profunda O O
femoral O O
artery O O
endarterectomies, O O
right O O
and O O
left O O
femoral O O
to O O
femoral O O
bypass O O
graft, O O
left O O
femoral O O
to O O
above O O
knee O O
popliteal O O
bypass O O
graft. O O
With O O
this O O
surgery, O O
only O O
his O O
left O O
second O O
toe O O
remained O O
gangrenous O O
and O O
he O O
was O O
able O O
to O O
avoid O O
BKA. O O
He O O
will O O
likely O O
either O O
auto-amputate O O
or O O
will O O
require O O
amputation O O
of O O
his O O
left O O
second O O
toe O O
which O O
remains O O
gangrenous O O
but O O
he O O
has O O
reasonable O O
perfusion O O
to O O
the O O
remainder O O
of O O
his O O
left O O
foot O O
and O O
has O O
follow O O
up O O
scheduled O O
next O O
week O O
with O O
Dr. O O
Randall. O O
Renal O O
insufficiency: O O
during O O
his O O
hospitalization O O
he O O
bumped O O
his O O
creatinine O O
quite O O
a O O
bit O O
but O O
this O O
appeared O O
to O O
be O O
due O O
to O O
acute O O
interstitial O O
nephritis O O
caused O O
by O O
Unasyn O O
(positive O O
urine O O
EO's), O O
reached O O
a O O
high O O
of O O
3.9 O O
on O O
9/02 O O
but O O
was O O
down O O
to O O
1.4 O O
which O O
is O O
baseline O O
at O O
the O O
time O O
of O O
hospital O O
discharge O O
9/9. O O
Will O O
recheck O O
renal O O
function O O
today. O O
Diabetes B-DIABETES O
mellitus: I-DIABETES O
his O O
appetite O O
has O O
been O O
poor O O
and O O
he O O
had O O
blood O O
sugars, O O
which O O
were O O
low O O
on O O
oral O O
agents, O O
and O O
these O O
have O O
been O O
discontinued. O O
His O O
blood O O
sugars O O
are O O
now O O
in O O
the O O
normal O O
range O O
on O O
no O O
oral O O
agents O O
or O O
insulin. O O
Will O O
need O O
to O O
monitor O O
closely O O
through O O
rehab. O O
CHF: O O
he O O
had O O
been O O
on O O
80 O O
b.i.d. O O
of O O
Lasix O O
prior O O
to O O
his O O
hospitalization. O O
At O O
the O O
time O O
of O O
hospital O O
discharge O O
his O O
dose O O
was O O
down O O
to O O
40 O O
b.i.d. O O
and O O
not O O
surprisingly O O
he O O
developed O O
quite O O
a O O
bit O O
of O O
recurrent O O
peripheral O O
edema. O O
He O O
called O O
the O O
office O O
and O O
I O O
increased O O
his O O
Lasix O O
back O O
up O O
to O O
60 O O
b.i.d. O O
but O O
he O O
still O O
has O O
significant O O
edema. O O
Will O O
go O O
back O O
to O O
80 O O
b.i.d. O O
with O O
close O O
monitoring. O O
Hypertension: B-HYPERTENSION O
with O O
diuresis O O
and O O
weight O O
loss, O O
his O O
BP O O
is O O
running O O
low. O O
Will O O
hold O O
lisinopril B-MEDICATION B-MEDICATION
for O O
now. O O
Close O O
VNA O O
follow O O
up. O O
COPD: O O
doing O O
well O O
despite O O
recent O O
surgery. O O
Continues O O
to O O
use O O
Combivent O O
inhaler O O
p.r.n. O O
Anemia: O O
Crit O O
was O O
in O O
the O O
20's O O
during O O
his O O
hospitalization O O
in O O
the O O
setting O O
of O O
acute O O
renal O O
failure O O
and O O
surgery O O
with O O
blood O O
loss. O O
His O O
Crit O O
at O O
the O O
time O O
of O O
discharge O O
was O O
approximately O O
28.7 O O
and O O
he O O
was O O
being O O
started O O
on O O
Epogen. O O
Unfortunately O O
because O O
of O O
insurance O O
issues, O O
he O O
has O O
not O O
actually O O
been O O
able O O
to O O
yet O O
obtain O O
it O O
but O O
the O O
plan O O
is O O
for O O
him O O
to O O
get O O
2,000 O O
units O O
3 O O
times O O
a O O
Rickey O O
George O O
MR#1131414 O O
October O O
05, O O
2092 O O
Page O O
2 O O
week. O O
For O O
now, O O
he O O
is O O
on O O
vitamins O O
and O O
iron O O
supplements O O
as O O
his O O
bowels O O
tolerate. O O
Given O O
his O O
history B-CAD O
of I-CAD O
CAD, I-CAD O
goal O O
is O O
to O O
keep O O
his O O
hematocrit O O
between O O
30-32. O O
Coronary B-CAD O
artery I-CAD O
disease: I-CAD O
despite O O
his O O
recent O O
surgical O O
stress O O
and O O
anemia, O O
he O O
has O O
had O O
no O O
anginal O O
symptoms. O O
Review O O
of O O
systems: O O
constipation O O
related O O
to O O
the O O
iron. O O
Generally O O
weak. O O
Home O O
services O O
now O O
include O O
VNA, O O
home O O
health O O
aide, O O
PTOT, O O
walking O O
with O O
a O O
walker, O O
biggest O O
issue O O
is O O
mostly O O
depression O O
in O O
the O O
setting O O
of O O
his O O
failing O O
health. O O
Social B-SMOKER O
history: O O
wife O O
very O O
involved O O
with O O
his O O
care. O O
Physical O O
exam: O O
BP O O
98/60. O O
Pulse O O
64. O O
Lungs O O
clear O O
to O O
A O O
& O O
P. O O
Cor: O O
SEMACIAN O O
gallop. O O
No O O
rub. O O
Abdomen: O O
mildly O O
distended, O O
nontender. O O
Multiple O O
well O O
healed O O
surgical O O
scars. O O
Extremities: O O
incisions O O
in O O
the O O
groin. O O
No O O
erythema. O O
Right O O
groin O O
several O O
cm O O
question O O
cystic O O
structure O O
beneath O O
the O O
incision. O O
Soft, O O
nontender, O O
non-erythematous. O O
2-3+ O O
edema O O
in O O
the O O
extremities O O
bilaterally. O O
Dry O O
gangrene O O
left O O
second O O
toe. O O
Disposition: O O
1. O O
Increase O O
Lasix O O
to O O
80 O O
b.i.d. O O
phone O O
follow O O
up O O
within O O
several O O
days. O O
2. O O
Temporarily O O
hold O O
lisinopril O B-MEDICATION
given O O
low O O
BP. O O
3. O O
Continue O O
Percocet O O
for O O
toe O O
pain. O O
4. O O
Follow O O
up O O
with O O
Dr. O O
Randall O O
who O O
needs O O
to O O
assess O O
the O O
cystic O O
mass O O
in O O
his O O
right O O
groin. O O
5. O O
Will O O
continue O O
to O O
work O O
with O O
insurance O O
to O O
try O O
to O O
obtain O O
Epogen. O O
In O O
the O O
meantime, O O
will O O
transfuse O O
if O O
Crit O O
drops O O
below O O
28. O O
6. O O
Add O O
Lexapro O O
10mg O O
1 O O
p.o. O O
q.d. O O
Addendum: O O
long O O
discussion O O
with O O
the O O
patient O O
and O O
his O O
wife O O
(his O O
healthcare O O
proxy) O O
today O O
about O O
end O O
of O O
life O O
issues. O O
Specifically O O
he O O
states O O
he O O
would O O
never O O
consider O O
any O O
amputation O O
other O O
than O O
his O O
single O O
toe O O
at O O
this O O
point. O O
He O O
would O O
specifically O O
'rather O O
die' O O
than O O
undergo O O
a O O
BKA. O O
He O O
also O O
states O O
he O O
wishes O O
to O O
be O O
DNR O O
and O O
would O O
not O O
consider O O
intubation O O
even O O
under O O
the O O
circumstances O O
of O O
acute O O
CHF O O
or O O
pneumonia. O O
Opal O O
Fierro, O O
M.D. O O
Dictated/Not O O
Read O O
/howell O O
Rickey O O
George O O
MR#1131414 O O
October O O
05, O O
2092 O O
Page O O
3 O O
cc. O O
Oscar O O
Randall, O O
M.D. O O
cc. O O
Keith O O
Caldwell, O O
M.D. O O

Record O O
date: O O
2134-11-09 O O
CCU O O
Resident O O
Transfer O O
Note O O
Patient O O
Name: O O
George O O
Quinn O O
MR# O O
7924118 O O
Date O O
of O O
admission: O O
November O O
09, O O
2134 O O
PCP: O O
Michael O O
Quakenbush O O
Fellow: O O
Unknown O O
Ivory O O
Attending: O O
Inglis O O
Code O O
Status: O O
FULL O O
Contact: O O
Wife, O O
Tammy O O
Quinn O O
746-313-1881 O O
Please O O
see O O
admit O O
note O O
for O O
details O O
of O O
patients O O
presentation. O O
Briefly, O O
Pt O O
is O O
a O O
59 O O
yo O O
man O O
with O O
the O O
following O O
CV O O
risk O O
factors: O O
smoker, B-SMOKER O
HTN B-HYPERTENSION O
who O O
presents O O
with O O
L O O
sided O O
chest O O
pain O O
and O O
found O O
to O O
have O O
inf O O
STEMI B-CAD O
no I-CAD O
w I-CAD O
s/p I-CAD O
baremetal I-CAD O
stent I-CAD O
x I-CAD O
3 I-CAD O
placement O O
awaiting O O
repeat O O
catherization O O
for O O
L O O
Circ O O
PCI. O O
CCU O O
course O O
by O O
problem: O O
Cardiac O O
Ischemia O O
Pt O O
presented O O
with O O
L O O
sided O O
Chest O O
pain, O O
EKG O O
showed O O
2-3 O O
mm O O
STE O O
in O O
I, O O
aVL O O
and O O
STD O O
in O O
V4-6. O O
Cardiac O O
catherization O O
showed O O
tight O O
LCx O O
lesion O O
(no O O
intervention), O O
distal O O
RCA O O
thrombotic O O
lesion O O
with O O
2 O O
distal O O
PLV O O
that O O
were O O
ballooned O O
and O O
3 O O
bare O O
metal O O
stents: O O
1 O O
in O O
distal O O
RCA O O
distal O O
(vision O O
3.5 O O
x15) O O
and O O
prox O O
and O O
distal O O
PLV O O
(minivision). O O
Post O O
cath O O
he O O
was O O
chest O O
pain O O
free O O
with O O
resolution O O
of O O
his O O
STE. O O
At O O
cath, O O
he O O
was O O
loaded O O
with O O
plavix B-MEDICATION B-MEDICATION
at O O
cath O O
and O O
received O O
integrillin. O O
Post O O
procedure O O
he O O
was O O
B O O
blocked O O
with O O
lopressor B-MEDICATION B-MEDICATION
(HR O O
in O O
50 O O
s), O O
given O O
ASA, B-MEDICATION B-MEDICATION
plavix, O B-MEDICATION
and O O
lipitor B-MEDICATION B-MEDICATION
80, O O
and O O
started B-MEDICATION O
on I-MEDICATION O
captopril. B-MEDICATION B-MEDICATION
Presently, O O
plan O O
(per O O
cardiology) O O
is O O
for O O
repeat O O
cath O O
for O O
PCI O O
of O O
L O O
circ. O O
LDL O O
was O O
84, O O
on O O
80 O O
mg O O
QD O O
lipitor. O B-MEDICATION
Pt B-SMOKER O
expressed I-SMOKER O
desire I-SMOKER O
to I-SMOKER O
quit I-SMOKER O
smoking I-SMOKER O
smoking I-SMOKER O
cessation I-SMOKER O
consult I-SMOKER O
pending. I-SMOKER O
Cardiac O O
Pump O O
Echo O O
done O O
on O O
11/08 O O
showed O O
an O O
EF O O
of O O
54% O O
with O O
no O O
RV O O
or O O
LV O O
dysfunction, O O
no O O
WMA O O
and O O
no O O
valvular O O
abnormalities. O O
Pt O O
did O O
not O O
demonstrate O O
evidence O O
of O O
volume O O
overload. O O
he O O
was O O
hemodynamically O O
stable. O O
Cardiac O O
Rhythym O O
Pt O O
had O O
junctional O O
rhythym O O
precatherization O O
with O O
no O O
further O O
episodes. O O
Currently O O
sinus O O
bradycardia O O
well O O
tolerated. O O
Medications O O
on O O
admission: O O
Motrin O O
800 O O
tid O O
Lisinopril B-MEDICATION B-MEDICATION
20 O O
qd O O
Vit O O
B12 O O
injections O O
Medications O O
on O O
Transfer: O O
Lipitor B-MEDICATION B-MEDICATION
80 O O
mg O O
QD O O
ASA O B-MEDICATION
325 O O
mg O O
QD O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
QD O O
Lovenox O O
30 O O
mg O O
BID O O
Lopressor B-MEDICATION B-MEDICATION
12.5 O O
TID O O
Captopril B-MEDICATION B-MEDICATION
6.25 O O
TID O O
Colace O O
Senna O O
Nexium O O
Allergies: O O
NKDA O O
Exam: O O
Hemodynamically O O
stable, O O
please O O
see O O
today O O
s O O
progress O O
note O O
for O O
exam. O O
_________________________________ O O
Eric O O
Donovan, O O
MD O O
PhD O O
PGY O O
2 O O
Pager O O
#36472 O O

Record O O
date: O O
2135-02-23 O O
**The O O
source O O
of O O
this O O
note O O
is O O
the O O
Perdue O O
Emergency O O
Dept. O O
Information O O
System. O O
All O O
updates O O
should O O
originate O O
in O O
EDIS.** O O
Perdue O O
Medical O O
Center O O
Emergency O O
Department O O
Record O O
- O O
Observation O O
Unit O O
EDIS O O
Note O O
Status: O O
Signed O O
Patient: O O
QUINN O O
SR, O O
GEORGE O O
MRN: O O
7924118 O O
DOB: O O
6/12/2075 O O
Sex: O O
M O O
Registration O O
Date/Time: O O
2/23/2135 O O
1:50:00 O O
PM O O
ED O O
OBS O O
Note O O
Admission O O
Note O O
Chief O O
Complaint O O
CP, O O
R/O O O
MI B-CAD O
HPI O O
59 O O
y.o. O O
male O O
followed O O
by O O
PMC O O
Cardiologist O O
Jan O O
Ivory, O O
is O O
3 O O
months O O
s/p O O
stents, B-CAD O
p/w O O
c/c O O
dull, O O
aching O O
chest O O
pain O O
which O O
is O O
NOT O O
exertional. O O
He O O
took O O
NTG B-MEDICATION O
and O O
this O O
&gt; O O
no O O
change. O O
He O O
is O O
certain O O
were O O
assocaited O O
with O O
post-meals. O O
He O O
is O O
certai O O
that O O
his O O
sx O O
are O O
now O O
differnt O O
than O O
those O O
he O O
recalls O O
prior O O
to O O
his O O
acute B-CAD O
intervention/ I-CAD O
stents. I-CAD O
Currently O O
no O O
SOB. O O
Some O O
relief O O
with O O
antacids. O O
PFSHx/ROS O O
CAD B-CAD O
, O O
stents. O O
Hx O O
DVT. O O
HTN B-HYPERTENSION O
, O O
elev B-HYPERLIPIDEMIA O
lipids. I-HYPERLIPIDEMIA O
Former B-SMOKER O
smoker, I-SMOKER B-MEDICATION
quit I-SMOKER B-MEDICATION
11/34 I-SMOKER O
. O O
Meds O O
ASA, B-MEDICATION B-MEDICATION
Metoprolol, B-MEDICATION B-MEDICATION
Lisinopril B-MEDICATION B-MEDICATION
, O O
Atorvastatin B-MEDICATION B-MEDICATION
Allergy O O
NKA O O
ROS O O
Constitutional O O
See O O
HPI. O O
Chest/Respiratory O O
See O O
HPI. O O
Cardiovascular O O
See O O
HPI. O O
GI/Abdominal O O
See O O
HPI. O O
ROS O O
and O O
PFSHx O O
as O O
noted O O
above O O
and O O
in O O
the O O
ED O O
record O O
for O O
this O O
encounter. O O
All O O
other O O
systems O O
otherwise O O
negative. O O
PE O O
Constitutional O O
Patient O O
is O O
awake. O O
Patient O O
is O O
alert. O O
Patient O O
is O O
oriented O O
x3. O O
Neck O O
Carotid O O
bruits O O
are O O
absent. O O
Chest/Respiratory O O
Thorax O O
is O O
non-tender. O O
The O O
lungs O O
are O O
clear O O
to O O
auscultation O O
bilaterally. O O
Cardiovascular O O
Heart O O
is O O
regular O O
rate O O
and O O
rhythm. O O
GI/Abdomen O O
Obese B-OBESE O
abdomen, O O
Musculoskeletal O O
Trace O O
non-pitting O O
edema. O O
Skin O O
Evidence O O
of O O
changes O O
c/w O O
chronic O O
venous O O
insufficiency. O O
Neurologic O O
Patient O O
is O O
alert O O
and O O
oriented O O
x O O
3. O O
Psychiatric O O
Patient O O
is O O
non O O
delusional. O O
Consults O O
Consults O O
On O O
site O O
= O O
Dr.Ivory, O O
Cardiology O O
Testing O O
Results O O
X-ray O O
Interpretation O O
No O O
acute O O
process O O
. O O
Medical O O
Decision O O
Making/Plan O O
59 O O
y.o. O O
w/ O O
known O O
CAD, O O
current O O
hx O O
suggest O O
UGI O O
in O O
etiology O O
. O O
ETT O O
is O O
planned O O
and O O
pending O O
. O O
Will O O
dispo O O
on O O
an O O
H2 O O
or O O
PPI O O
if O O
Stress O O
Test O O
WNL O O
This O O
note O O
has O O
been O O
electronically O O
signed O O
by O O
MARGIE O O
ECHOLS, O O
NP O O
3/1/2135 O O
8:00:12 O O
AM O O
Clinical O O
staff O O
documenting O O
in O O
the O O
ED O O
note O O
include: O O
Other O O
Providers O O
MARGIE O O
ECHOLS, O O
NP O O
Attending O O
Note O O
Attending O O
MD O O
Notes O O
Pt O O
has O O
hx O O
of O O
CAD O O
s/p O O
stenting B-CAD O
in I-CAD O
Nov I-CAD O
'34. I-CAD O
Presents O O
with O O
chest O O
ache. O O
EKG O O
no O O
acute O O
change O O
2 O O
sets O O
of O O
markers O O
neg O O
will O O
be O O
admitted O O
to O O
the O O
EDOU O O
for O O
ETT. O O
for O O
I O O
have O O
examined O O
the O O
patient O O
and O O
discussed O O
with O O
the O O
Nurse O O
Practitioner O O
the O O
patient's O O
care O O
and O O
agree O O
with O O
the O O
plan. O O
This O O
note O O
has O O
been O O
electronically O O
signed O O
by O O
Henry O O
X. O O
Shelton, O O
MD O O
2/23/2135 O O
3:35:26 O O
PM O O
Clinical O O
staff O O
documenting O O
in O O
the O O
ED O O
note O O
include: O O
Attending/Nurse O O
Practitioners(s) O O
Henry O O
X. O O
Shelton, O O
MD O O

Record O O
date: O O
2135-12-15 O O
CARDIOLOGY O O
PERDUE O O
MEDICAL O O
CENTER O O
Reason O O
for O O
visit: O O
Follow O O
up O O
visit O O
visit O O
Interval O O
History: O O
60 O O
year O O
old O O
man O O
with O O
Coronary B-CAD O
artery I-CAD B-CAD
disease I-CAD O
who O O
presented O O
in O O
November O O
2134 O O
with O O
substernal O O
chest O O
pressure O O
and O O
evidence O O
of O O
inferior O O
ST-segment O O
elevation. O O
Known O O
risk O O
factors O O
at O O
that O O
time O O
(in O O
addition O O
to O O
his O O
age O O
and O O
gender) O O
were O O
Hypertension B-HYPERTENSION B-HYPERTENSION
and O O
tobacco B-SMOKER O
smoking. I-SMOKER O
Details O O
of O O
that O O
presentation O O
as O O
per O O
my O O
12/16/34 O O
office O O
note. O O
Emergent B-CAD O
catheterization I-CAD O
showed I-CAD O
three I-CAD O
areas I-CAD O
of I-CAD O
severe I-CAD O
stenosis I-CAD O
in I-CAD O
the I-CAD O
RCA I-CAD O
territory, I-CAD O
one I-CAD O
in I-CAD O
the I-CAD O
ditsal I-CAD O
RCA I-CAD O
and I-CAD O
two I-CAD O
in I-CAD O
the I-CAD O
PLV. I-CAD O
The B-CAD O
PLV I-CAD O
lesions I-CAD O
each I-CAD O
received I-CAD O
2.5 I-CAD O
x15mm I-CAD O
Minivision I-CAD O
(bare I-CAD O
metal I-CAD O
stents) I-CAD O
and I-CAD O
the I-CAD O
distal I-CAD O
RCA I-CAD B-CAD
lesion I-CAD O
received I-CAD O
a I-CAD O
3.5 I-CAD O
x15mm I-CAD O
Vision I-CAD O
(bare I-CAD O
metal I-CAD O
stent). I-CAD B-CAD
A O O
non-dominant O O
Left O O
Circumflex O O
had O O
a O O
70% O O
stenosis O O
that O O
was O O
not O O
intervened O O
upon. O O
There O O
was O O
non-obstructive O O
disease O O
in O O
the O O
LAD. O O
A O O
transthoracic O O
echo O O
showed O O
an O O
LV O O
EF O O
of O O
54% O O
and O O
no O O
wall O O
motion O O
abnormalities. O O
Left O O
atrium O O
was O O
slightly O O
dilated O O
to O O
39mm. O O
RV O O
function O O
was O O
normal. O O
He O O
recovered O O
well O O
and O O
was O O
discharged O O
on O O
an O O
appropriate O O
medical O O
program O O
(see O O
below). O O
He O O
had O O
an O O
outpatient O O
ETT-MIBI B-CAD O
to O O
further O O
evaluate O O
the O O
significance O O
of O O
the O O
residual O O
LCx O O
disease. O O
He O O
had O O
this O O
on O O
12/07/34 O O
and O O
he O O
exercised O O
for O O
6 O O
minutes, O O
7 O O
METS O O
and O O
achieved O O
a O O
heart O O
rate O O
70% O O
of O O
predicted. O O
He O O
did O O
not O O
experience O O
chest O O
pain, O O
had O O
an O O
appropriate O O
increase O O
in O O
systolic O O
blood O O
pressure O O
and O O
the O O
study O O
was O O
terminated O O
due O O
to O O
leg O O
fatigue. O O
The O O
images O O
showed O O
inferior O O
and O O
apical O O
thinning O O
without O O
ischemia. O O
LV O O
EF O O
63%. O O
He O O
had O O
a O O
recurrent O O
episode O O
of O O
chest O O
pain O O
(somewhat O O
different O O
than O O
his O O
MI O O
as O O
it O O
was O O
not O O
pressure O O
like) O O
and O O
presented O O
to O O
the O O
ED O O
in O O
March. O O
His O O
ECG O O
was O O
stable O O
and O O
biomarkers O O
were O O
negative O O
and O O
he O O
had O O
a O O
repeat O O
ETT-MIBI O O
in O O
which O O
he O O
exercised O O
for O O
7 O O
mins O O
10 O O
sec, O O
achieving O O
9 O O
METS, O O
80% O O
MPHR, O O
peak O O
double O O
product O O
19K. O O
A O O
different O O
type O O
of O O
chest O O
pain O O
occurrred O O
during O O
the O O
study O O
and O O
was O O
not O O
study-limiting. O O
The O O
ECG O O
was O O
negative O O
for O O
ischemia O O
and O O
the O O
perfusion O O
images O O
were O O
normal, O O
without O O
evidence O O
of O O
ischemia O O
or O O
infarction. O O
LV O O
EF O O
68%. O O
He O O
has O O
overall O O
done O O
well O O
since O O
the O O
time O O
of O O
his O O
STEMI. B-CAD O
He O O
completed O O
part O O
of O O
the O O
program O O
at O O
cardiac O O
rehab. O O
He B-SMOKER O
quit B-SMOKER O
cigarette I-SMOKER O
smoking I-SMOKER O
at I-SMOKER O
the I-SMOKER O
time I-SMOKER O
of I-SMOKER O
the I-SMOKER O
MI, I-SMOKER O
and O O
has O O
remained O O
abstinent O O
since O O
then. O O
He O O
resumed O O
normal O O
activities O O
without O O
limiting O O
symptoms O O
in O O
terms O O
of O O
chest O O
pain O O
or O O
shortness O O
of O O
breath. O O
His O O
overall O O
activity O O
is O O
at O O
times O O
limited O O
due O O
to O O
ankylosing O O
spondylitis O O
and O O
associated O O
pain. O O
Three O O
days O O
ago O O
he O O
reports O O
the O O
onset O O
of O O
chest O O
pain. O O
This O O
occurs O O
in O O
his O O
left O O
chest O O
and O O
lasts O O
hours O O
at O O
a O O
time. O O
Not O O
related O O
to O O
exertion O O
and O O
he O O
has O O
not O O
tried O O
SL O O
TNG. O O
He O O
states O O
that O O
he O O
has O O
been O O
carrying O O
heavy O O
holiday O O
packages O O
and O O
did O O
some O O
light O O
outdoor O O
work, O O
and O O
wonders O O
if O O
the O O
pain O O
may O O
have O O
been O O
caused O O
by O O
those O O
activities O O
(i.e. O O
muscolskeletal O O
in O O
nature). O O
He O O
has O O
2 O O
flights O O
of O O
stairs O O
at O O
home O O
and O O
is O O
able O O
to O O
climb O O
them O O
with O O
minimal O O
shortness O O
of O O
breath, O O
which O O
has O O
not O O
changed O O
since O O
the O O
onset O O
of O O
the O O
CP. O O
He O O
is O O
unsure O O
how O O
the O O
character O O
relates O O
to O O
that O O
of O O
his O O
previous O O
MI, O O
and O O
he O O
thinks O O
it O O
is O O
similar O O
to O O
the O O
discomfort O O
he O O
had O O
in O O
March O O
that O O
prompted O O
his O O
ED O O
visit O O
and O O
negative O O
stress O O
test. O O
He O O
denies O O
lightheadedness O O
or O O
syncope. O O
No O O
orthopnea O O
or O O
lower O O
extremity O O
swelling. O O
He O O
continues O O
to O O
be O O
compliant O O
with O O
his O O
medical O O
regimen. O O
He O O
had O O
a O O
past O O
sleep O O
study O O
which O O
indicates O O
the O O
presence O O
of O O
sleep O O
disordered O O
breathing O O
and O O
he O O
states O O
he O O
is O O
in O O
the O O
process O O
of O O
acquiring O O
home O O
CPAP O O
therapy. O O
He O O
does O O
report O O
weight O O
gain O O
since O O
stopping O O
cigarettes. O O
Past O O
medical O O
history: O O
1) O O
CAD B-CAD O
status O O
post O O
inferior O O
STEMI O O
11/34 O O
with O O
3 O O
bare O O
metal O O
stents O O
to O O
RCA O O
territory O O
(1 O O
in O O
distal O O
RCA O O
and O O
two O O
in O O
the O O
PLV). O O
Known O O
residual O O
LCx O O
70% O O
lesion O O
in O O
a O O
small, O O
non-dominant O O
vessel O O
2) O O
Hypertension O B-HYPERTENSION
3) O O
Hyperlipideimia B-HYPERLIPIDEMIA B-HYPERTENSION
4) O O
Former B-SMOKER O
smoker I-SMOKER O
- I-SMOKER O
quit I-SMOKER O
at I-SMOKER O
the I-SMOKER O
time I-SMOKER O
of I-SMOKER O
his I-SMOKER O
MI I-SMOKER O
5) O O
Ankylosing O O
spondylitis O O
6) O O
Thrombophlebitis O O
of O O
the O O
left O O
leg, O O
report O O
of O O
DVT O O
in O O
other O O
notes O O
Changes O O
to O O
Allergies O O
NKA: O O
No O O
Known O O
Allergies O O
- O O
reaction: O O
[reviewed] O O
Medications O O
(Confirmed): O O
ASA B-MEDICATION B-MEDICATION
Lipitor B-MEDICATION B-MEDICATION
20mg O O
po O O
daily O O
lisinopril B-MEDICATION B-MEDICATION
10 O O
mg O O
po O O
daily O O
Niaspan B-MEDICATION B-MEDICATION
Plavix B-MEDICATION B-MEDICATION
75mg O O
po O O
daily O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
25 O O
mg O O
PO O O
daily O O
Physical O O
examination: O O
-Pulse: O O
50 O O
regular O O
-weight: O O
268 O O
lbs. O O
-General: O O
Looks O O
well, O O
overweight, O O
pleasant O O
-HEENT: O O
Jugular O O
venous O O
pressure O O
7cm, O O
carotids O O
2+ O O
bilaterally O O
without O O
bruits O O
-Chest: O O
CTAB O O
-Cardiac: O O
Point O O
of O O
maximal O O
impulse O O
is O O
midclavicular; O O
Distant, O O
regular, O O
S1 O O
and O O
S2, O O
no O O
murmurs O O
or O O
rubs O O
-Abdomen: O O
Soft, O O
obese, B-OBESE O
non-tender O O
-Extremities: O O
No O O
lower O O
extremity O O
edema, O O
2+ O O
posterior O O
tibial O O
pulses O O
bilaterally O O
-BP: O O
130/75 O O
both O O
arms O O
EKG: O O
Baseline O O
artifact, O O
Sinus O O
bradycardia O O
at O O
50 O O
bpm, O O
clockwise O O
rotation, O O
minor O O
nonspecific O O
T O O
wave O O
changes; O O
compared O O
to O O
16-June-2135, O O
the O O
heart O O
rate O O
is O O
slightly O O
decreased, O O
otherwise O O
no O O
important O O
change. O O
Assessment O O
and O O
plan: O O
60 O O
year O O
old O O
man O O
with O O
CAD O O
status O O
post O O
inferior O O
STEMI O O
11/34 O O
treated O O
with O O
3 O O
bare O O
metal O O
stents O O
to O O
the O O
RCA O O
territory, O O
Hypertension, O B-HYPERTENSION
Hyperlipidemia, B-HYPERLIPIDEMIA B-HYPERTENSION
and O O
Ankylosing O O
spondylitis O O
who O O
is O O
overall O O
doing O O
well O O
with O O
secondary O O
prevention O O
efforts O O
for O O
his O O
coronary O O
disease, O O
although O O
he O O
does O O
report O O
a O O
chest O O
pain O O
syndrome O O
for O O
the O O
past O O
several O O
days. O O
1) O O
Coronary O B-CAD
artery O I-CAD
disease: O O
Bare O O
metal O O
stents O O
only O O
are O O
in O O
place O O
in O O
the O O
RCA O O
territory, O O
and O O
he O O
has O O
now O O
completed O O
over O O
a O O
12 O O
month O O
course O O
of O O
Plavix O B-MEDICATION
therapy. O O
Given O O
that O O
the O O
main O O
treatment O O
plan O O
at O O
this O O
time O O
for O O
his O O
ankylosing O O
spondylitis O O
is O O
NSAIDs O O
(i.e. O O
Motrin), O O
he O O
will O O
stop B-MEDICATION O
Plavix I-MEDICATION B-MEDICATION
to O O
help O O
minimize O O
the O O
bleeding O O
risk O O
and O O
since O O
there O O
is O O
no O O
absolute O O
indication O O
for O O
him O O
to O O
continue O O
it O O
at O O
this O O
point. O O
He O O
will O O
continue O O
the O O
medical O O
regimen O O
of O O
ASA O B-MEDICATION
81mg O O
daily, O O
Lipitor O B-MEDICATION
20mg O O
daily, O O
Toprol O B-MEDICATION
XL O B-MEDICATION
25mg O O
daily O O
and O O
Lisinopril B-MEDICATION B-MEDICATION
10mg O O
daily. O O
His O O
heart O O
rate O O
and O O
blood O O
pressure O O
are O O
well O O
controlled. O O
The O O
chest O O
pain O O
syndrome O O
that O O
he O O
has O O
been O O
having O O
for O O
the O O
past O O
several O O
days O O
is O O
reassuring O O
in O O
the O O
sense O O
that O O
it O O
is O O
not O O
exertion O O
related O O
and O O
it O O
seems O O
similar O O
to O O
March O O
when O O
he O O
had O O
an O O
ETT-MIBI O O
without O O
ischemia O B-MEDICATION
on O O
perfusion O O
images. O O
He O O
does O O
have O O
a O O
known B-CAD O
70% I-CAD O
stenosis I-CAD O
in I-CAD O
a I-CAD O
non-dominant I-CAD O
LCx, I-CAD O
but O O
two O O
imaging O O
studies O O
have O O
not O O
shown O O
ischemia O O
in O O
that O O
territory. O O
His O O
ECG O O
today O O
is O O
unchanged O O
from O O
priors. O O
However, O O
given O O
his O O
history O O
we O O
will O O
be O O
vigilant O O
for O O
any O O
change O O
or O O
persistence O O
in O O
symptoms. O O
I O O
will O O
call O O
the O O
patient O O
in O O
several O O
days O O
time, O O
and O O
if O O
he O O
continues O O
to O O
have O O
symptoms O O
he O O
can O O
have O O
a O O
repeat O O
ETT. O O
2) O O
Secondary O O
prevention: O O
Most O O
recent O O
Lipid O O
panel O O
in O O
10/35 O O
on O O
Lipitor O B-MEDICATION
20mg O O
daily O O
shows O O
TC O O
126, O O
LDL O O
62, O O
HDL O O
25 O O
and O O
TGs O O
195. O O
His O O
LDL O O
has O O
been O O
well O O
controlled O O
however O O
his O O
HDL O O
has O O
been O O
very O O
low O O
on O O
several O O
readings. O O
Given O O
this, O O
along O O
with O O
an O O
elevated O O
TG O O
value, O O
we O O
will O O
start B-MEDICATION O
Niaspan. I-MEDICATION O
He O O
can O O
start O O
with O O
500 O O
mg O O
qhs O O
for O O
the O O
first O O
2-3 O O
weeks O O
to O O
help O O
get O O
through O O
the O O
common O O
adverse O O
effects O O
(i.e. O O
flushing). O O
He O O
should O O
take O O
the O O
medication O O
with O O
a O O
glass O O
of O O
cold O O
water O O
and O O
may O O
take O O
his O O
daily O O
aspirin O B-MEDICATION
30 O O
minutes O O
before O O
to O O
help O O
minimize O O
side O O
effects. O O
After O O
a O O
few O O
weeks, O O
he O O
can O O
increase O O
to O O
the O O
maintenance O O
dose O O
of O O
1000 O O
mg O O
qhs. O O
He B-SMOKER O
has I-SMOKER O
quit I-SMOKER O
smoking I-SMOKER O
completely I-SMOKER O
since O O
the O O
time O O
of O O
the O O
MI O O
and O O
plans O O
to O O
continue O O
this O O
forward. O O
He O O
was O O
encouraged O O
to O O
increase O O
his O O
physical O O
activity O O
level. O O
3) O O
Hypertension: O B-HYPERTENSION
Reasonably O O
well O O
controlled O O
on O O
Toprol O B-MEDICATION
XL O O
25mg O O
daily O O
and O O
Lisinopril O B-MEDICATION
10mg O O
daily. O O
He O O
will O O
be O O
starting O O
CPAP O O
for O O
sleep O O
apnea O O
soon O O
which O O
may O O
have O O
a O O
favorable O O
effect O O
on O O
his O O
blood O O
pressure. O O
Changes O O
to O O
Medications O O
this O O
visit O O
Niaspan O B-MEDICATION
500mg O O
SR O O
po O O
at O O
bedtime O O
2 O O
tablets O O
each O O
night O O
QTY:90 O O
Refills:2 O O
Start: O O
12/15/2135 O O
Plavix O B-MEDICATION
75mg O O
po O O
daily O O
Start: O O
12/16/2134 O O
End: O O
12/19/2135 O O
- O O
Inactivated O O
ASA O B-MEDICATION
81mg O O
po O O
daily O O
Start: O O
12/16/2134 O O
Disposition: O O
Return O O
in O O
4-6 O O
months O O
or O O
PRN O O
Jan O O
Ivory, O O
MD O O
cc: O O
ADDENDUM: O O
I O O
spoke O O
with O O
the O O
patient O O
on O O
12/21 O O
and O O
his O O
chest O O
discomfort O O
symptoms O O
have O O
resolved O O
and O O
he O O
is O O
feeling O O
well O O
in O O
his O O
usual O O
activities. O O
So, O O
no O O
further O O
testing O O
at O O
this O O
point. O O
He O O
will O O
call O O
me O O
if O O
symptoms O O
recur. O O
Signed O O
electronically O O
by O O
Jan O O
Ivory, O O
MD O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2136-09-09 O O
CARDIOLOGY O O
PERDUE O O
MEDICAL O O
CENTER O O
Reason O O
for O O
visit: O O
Cardiology O O
Admit O O
Note O O
Interval O O
History: O O
Primary O O
cardiologist: O O
Jan O O
Ivory O O
(Kevin O O
Mcdaniel) O O
61 O O
y/o O O
M O O
with O O
h/o B-CAD O
CAD B-CAD O
admitted O O
for O O
CP. B-CAD O
Cardiovascular O O
history O O
notable O O
for: O O
- O O
Nov B-CAD O
34 I-CAD O
- I-CAD O
acute B-CAD O
IMI; I-CAD O
cath B-CAD O
(11/08/34) I-CAD O
LM, I-CAD O
LAD I-CAD O
and I-CAD O
large I-CAD O
Ramus I-CAD O
with I-CAD O
minimal I-CAD O
disease, I-CAD O
LCx I-CAD O
with I-CAD O
tandem I-CAD O
70% I-CAD O
and I-CAD O
50% I-CAD O
stenosis I-CAD O
in I-CAD O
non-dominant I-CAD O
vessel, I-CAD O
distal I-CAD O
RCA I-CAD O
with I-CAD O
90% B-CAD O
stenosis I-CAD O
and I-CAD O
mid I-CAD O
and I-CAD O
distal I-CAD O
PLV I-CAD O
with I-CAD O
tandem I-CAD O
80% I-CAD O
lesions; I-CAD O
Rx: I-CAD O
Vision I-CAD O
2.5 I-CAD O
x I-CAD O
15 I-CAD O
to I-CAD O
distal I-CAD O
RCA, I-CAD O
Minivision B-CAD O
x I-CAD O
2 I-CAD O
(2.5 I-CAD O
x I-CAD O
15 I-CAD O
each) I-CAD O
to I-CAD O
mid I-CAD O
and I-CAD O
distal I-CAD O
PLV I-CAD O
- O O
echo O O
(11/08/34) O O
EF O O
54%, O O
overall O O
unremarkable O O
- O O
last O O
ETT-MIBI O O
(2/23/35) O O
7:10, O O
9 O O
METs, O O
80% O O
mphr, O O
pkdp O O
19k, O O
developed O O
chest O O
pain O O
(different O O
from O O
presenting) O O
at O O
7 O O
mins, O O
ECG O O
negative O O
to O O
HR O O
attained, O O
images O O
without O O
ischemia O O
or O O
infarction, O O
EF O O
68% O O
He O O
has O O
done O O
quite B-SMOKER O
well O O
from O O
a O O
cardiac O O
perspective O O
since O O
the O O
MI. O O
He O O
has O O
occasional O O
fleeting O O
chest O O
pain O O
but O O
never O O
sustained O O
and O O
nothing O O
in O O
the O O
past O O
1-2 O O
months. O O
He O O
awoke O O
this O O
AM O O
with O O
dull O O
left O O
chest O O
pain O O
which O O
has O O
persisted O O
throughout O O
the O O
day. O O
Pain O O
was O O
6/10 O O
at O O
worst, O O
unchanged O O
with O O
exertion O O
and O O
similar O O
in O O
quality O O
(albeit O O
less O O
intense) O O
to O O
pain O O
during O O
STEMI. B-CAD O
No O O
associated O O
SOB, O O
nausea, O O
diaphoresis O O
or O O
radiation. O O
Given O O
the O O
CP O O
persistance, O O
he O O
presented O O
to O O
the O O
ER. O O
Initial O O
ECGs O O
showed O O
sinus O O
brady O O
with O O
a O O
relatively O O
normal O O
tracing; O O
no O O
acute O O
ischemic O O
changes O O
and O O
no O O
significant O O
change O O
from O O
prior. O O
After O O
a O O
combination O O
of O O
4 O O
SL B-CAD O
nitro, I-CAD O
IV I-CAD O
nitro, I-CAD O
IV I-CAD O
heparin I-CAD O
and I-CAD O
morphine I-CAD O
(2mg I-CAD O
IV I-CAD O
x I-CAD O
2), I-CAD O
the I-CAD O
CP I-CAD O
eventually I-CAD O
subsided. I-CAD O
Currently, O O
he O O
is O O
CP O O
free O O
and O O
resting O O
comfortably. O O
At O O
baseline, O O
he O O
doesn't O O
exercise O O
formally O O
but O O
he O O
has O O
3 O O
flights O O
of O O
stairs O O
at O O
home O O
and O O
he's O O
able O O
to O O
climb O O
them O O
without O O
exertional O O
symptoms. O O
Also, O O
he O O
was O O
previously O O
on O O
therapy O O
for O O
GERD O O
but O O
stopped O O
taking O O
prilosec O O
several O O
months O O
ago. O O
Past O O
medical O O
history: O O
- O O
CAD O B-MEDICATION
- O O
as O O
above O O
- O O
HTN B-HYPERTENSION O
- O O
hyperlipidemia B-HYPERLIPIDEMIA B-MEDICATION
- O O
DM2 B-DIABETES O
- O O
no O O
known O O
microvascular O O
disease; O O
last B-DIABETES O
A1c B-DIABETES O
7.3 I-DIABETES O
(June I-DIABETES O
36) I-DIABETES O
- O O
Ankylosing O O
spondylitis O O
- O O
h/o O O
thrombophlebitis O O
(vs O O
DVT) O O
of O O
left O O
leg O O
- O O
hemorrhoids O O
s/p O O
banding O O
Home O O
meds: O O
ASA B-MEDICATION B-MEDICATION
81, O O
lipitor B-MEDICATION B-MEDICATION
20, O O
metformin B-MEDICATION B-MEDICATION
500, O O
zestril B-MEDICATION B-MEDICATION
10, O O
toprol B-MEDICATION B-MEDICATION
25 O O
Changes O O
to O O
Allergies O O
NKA: O O
No O O
Known O O
Allergies O O
- O O
reaction: O O
[reviewed] O O
Social O O
history: O O
Lives O O
with O O
wife O O
in O O
Avra O O
Valley, O O
KS. O O
Retired O O
social O O
policy O O
program O O
officer O O
Tob B-SMOKER O
- I-SMOKER O
former I-SMOKER O
1ppd, I-SMOKER O
quit I-SMOKER O
at I-SMOKER O
time I-SMOKER O
of I-SMOKER O
STEMI I-SMOKER O
in I-SMOKER O
2134 I-SMOKER O
EtOH O O
- O O
rare O O
Drugs O O
- O O
none O O
Review O O
of O O
systems: O O
otherwise O O
negative O O
in O O
detail O O
Physical O O
examination: O O
-Pulse: O O
50s O O
regular O O
-General: O O
NAD O O
-Neck: O O
JVP&lt;6cm, O O
carotids O O
2+, O O
no O O
bruits O O
-Chest: O O
CTA O O
B O O
-Cardiac: O O
distant, O O
RRR, O O
no O O
M/R/G O O
-Abdomen: O O
soft, O O
NT, O O
pos O O
BS O O
-Extremities: O O
femorals O O
1+, O O
no O O
bruits; O O
LLE O O
with O O
2+ O O
edema O O
and O O
chronic O O
stasis O O
changes; O O
DPs/PTs O O
2+ O O
bilaterally O O
-BP: O O
125/70 O O
right O O
arm O O
EKG: O O
sinus O O
brady O O
(51), O O
minor O O
NSSTTWA, O O
no O O
significant O O
change O O
from O O
4/05/36 O O
Selected O O
recent O O
labs: O O
Date O O
NA O O
K O O
CL O O
CO2 O O
BUN O O
CRE O O
GLU O O
CA O O
PHOS O O
MG O O
09/09/36 O O
138 O O
3.9 O O
103 O O
25.1 O O
15 O O
1.04 O O
112 O O
9.7 O O
3.4 O O
2.0 O O
Date O O
CK-MB O O
TROP-I O O
09/09/36 O O
NEGATIVE O O
NEGATIVE O O
Date O O
ALB O O
TP O O
ALKP O O
DBILI O O
TBILI O O
ALT/SGPT O O
AST/SGOT O O
AMY O O
LIPS O O
09/09/36 O O
4.2 O O
8.1 O O
84 O O
0.1 O O
0.5 O O
27 O O
25 O O
85 O O
42 O O
Date O O
HCT O O
WBC O O
PLT O O
09/09/36 O O
45.4 O O
14.2 O O
395 O O
Date O O
PT O O
PT-INR O O
PTT O O
09/09/36 O O
12.0 O O
1.0 O O
29.2 O O
Date O O
MCV O O
%LYMPH O O
%NEUT O O
09/09/36 O O
87 O O
31 O O
57 O O
Other O O
Data: O O
PA/lat O O
CXR O O
- O O
LLL O O
opacity O O
Assessment O O
and O O
plan: O O
61 O O
y/o O O
M O O
with O O
h/o O O
CAD O O
p/w O O
CP. O O
Some O O
features O O
are O O
concerning O O
for O O
angina O O
(similar O O
to O O
prior O O
symptoms, O O
some O O
improvement O O
with O O
nitro...), O O
whereas O O
other O O
aspects O O
are O O
less O O
concerning O O
(prolonged O O
CP O O
without O O
ECG O O
changes O O
or O O
biomarker O O
leak). O O
Overall, O O
doubt O O
ACS. O O
In O O
terms O O
of O O
subtle O O
LLL O O
opacity O O
on O O
CXR, O O
doubt O O
PNA O O
given O O
lack O O
of O O
cough, O O
sputum O O
or O O
fever...He O O
has O O
mild O O
leukocytosis O O
(normal O O
differential) O O
of O O
unclear O O
etiology. O O
Plan: O O
- O O
cycle O O
troponins O O
- O O
continue O O
IV O O
heparin O O
overnight O O
- O O
if O O
biomarkers O O
negative O O
and O O
no O O
recurrent O O
CP, O O
would O O
favor O O
ETT-MIBI O O
in O O
AM O O
for O O
further O O
risk O O
stratification O O
- O O
continue O O
home O O
meds O O
- O O
hold B-MEDICATION O
metformin, I-MEDICATION B-MEDICATION
in I-MEDICATION O
case I-MEDICATION O
cath I-MEDICATION O
required I-MEDICATION O
- O O
repeat O O
CBC O O
with O O
diff O O
in O O
AM, O O
check O O
U/A O O
FULL O O
CODE O O
Brennen O O
May, O O
MD O O
Signed O O
electronically O O
by O O
Brennen O O
May, O O
MD O O
Document O O
Status: O O
Final O O

Record B-SMOKER O
date: O O
2069-05-05 O O
OFFICE O O
NOTE O O
Chandler, O O
Jessica O O
MRN O O
#748-80-38-0 O O
May O O
05, O O
2069 O O
Ms. O O
Chandler O O
returns O O
today O O
for O O
a O O
follow-up O O
status O O
post O O
her O O
coronary B-CAD O
artery I-CAD O
bypass I-CAD O
surgery I-CAD O
on I-CAD O
4/1/69. I-CAD O
Since O O
the O O
surgery O O
she O O
has O O
done O O
quite O O
well. O O
She O O
was O O
in O O
Sibley O O
Care O O
Center O O
from O O
4/08 O O
to O O
4/22/69 O O
and O O
had O O
undergone O O
physical O O
therapy, O O
occupational O O
therapy O O
and O O
also O O
education O O
on O O
dietary O O
modification. O O
During O O
her O O
hospital O O
course O O
she O O
had O O
a O O
repeat O O
echocardiogram O O
which O O
revealed O O
a O O
left O O
ventricular O O
ejection O O
fraction O O
of O O
50% O O
and O O
hypokinesis O O
of O O
the O O
septal O O
wall O O
with O O
mild O O
to O O
moderate O O
pulmonary O O
artery O O
hypertension. O O
She O O
was O O
started O O
on O O
lisinopril B-MEDICATION B-MEDICATION
to O O
help O O
prevent O O
diabetic O O
nephropathy. O O
She O O
also O O
received O O
two O O
units O O
of O O
packed O O
red O O
blood O O
cells O O
at O O
her O O
stay O O
at O O
Sibley O O
Care O O
as O O
it O O
was O O
noted O O
that O O
her O O
hematocrit O O
was O O
only O O
24. O O
She O O
was O O
also O O
briefly O O
treated O O
with O O
Epogen O O
and O O
it O O
was O O
felt O O
that O O
her O O
renal O O
dysfunction O O
may O O
have O O
been O O
the O O
cause O O
of O O
her O O
low O O
hematocrit. O O
Her O O
renal O O
function O O
has O O
improved O O
considerably O O
since O O
stopping O O
diuretics. O O
Since O O
going O O
home O O
from O O
Sibley O O
Care, O O
she O O
is O O
starting O O
to O O
walk O O
more O O
with O O
assistance O O
from O O
a O O
physical O O
therapist O O
around O O
the O O
house. O O
She O O
is O O
not O O
experiencing O O
any O O
exertional O O
chest O O
pressure, O O
pain O O
or O O
shortness O O
of O O
breath. O O
She O O
also O O
mentions O O
she O O
is O O
currently O O
going O O
to O O
a O O
Diabetes B-DIABETES O
Support O O
Group O O
tomorrow O O
and O O
plans O O
to O O
get O O
some O O
psychotherapy O O
through O O
Northern O O
Illinois O O
Medical O O
Center O O
later O O
next O O
month. O O
Medications: O O
Her O O
current O O
medications O O
are O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg. O O
p.o. O O
q.d., O O
lisinopril, O B-MEDICATION
increased O O
to O O
20 O O
p.o. O O
daily O O
today, O O
Coumadin O O
5 O O
p.o. O O
q.d., O O
Kayexalate O O
15 O O
p.o. O O
q. O O
day, O O
albuterol O O
metered O O
dose O O
inhaler O O
4 O O
puffs O O
q.i.d., O O
Azmacort O O
4 O O
puffs O O
b.i.d., O O
Lasix O O
40 O O
p.o. O O
q. O O
day, O O
Nephrocaps O O
one O O
tablet O O
p.o. O O
q. O O
day, O O
NPH B-MEDICATION B-MEDICATION
Insulin I-MEDICATION B-MEDICATION
75 O O
units O O
q. O O
a.m. O O
and O O
60 O O
units O O
subcu O O
q. O O
p.m., O O
Prilosec O O
20 O O
p.o. O O
q.d., O O
Paxil O O
30 O O
mg. O O
p.o. O O
q. O O
day O O
and O O
CPAP O O
8 O O
centimeters O O
water O O
plus O O
2 O O
liters O O
O2 O O
q. O O
h.s. O O
Physical O O
Examination: O O
On O O
physical O O
examination O O
her O O
weight O O
is O O
326 O O
pounds. O O
Her B-HYPERTENSION O
blood I-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
150/110, B-HYPERTENSION O
on O O
repeat O O
per O O
M.D. O O
150/100, O O
pulse O O
is O O
80. O O
Her O O
skin O O
is O O
without O O
any O O
rashes O O
or O O
ecchymoses, O O
or O O
suspicious O O
nevi O O
present. O O
Heart O O
regular O O
rhythm, O O
distant O O
heart O O
sounds O O
with O O
positive O O
S1 O O
and O O
S2. O O
Her O O
lungs O O
are O O
clear, O O
there O O
is O O
no O O
sternal O O
instability O O
and O O
the O O
sternal O O
wound O O
is O O
well O O
healed. O O
Her O O
extremities O O
are O O
without O O
any O O
edema. O O
Her O O
O2 O O
sat O O
on O O
room O O
air O O
is O O
98%. O O
Diagnosis: O O
1) O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
status O O
post O O
bypass O O
surgery O O
4/1/69. O O
2) O O
Chronic O O
renal O O
insufficiency.Chandler, O O
Jessica O O
MRN O O
#748-80-38-0 O O
May O O
05, O O
2069 O O
Page O O
2 O O
3) O O
Diabetes B-DIABETES O
mellitus. I-DIABETES O
4) O O
Anemia O O
of O O
chronic O O
disease. O O
5) O O
Obstructive O O
sleep O O
apnea. O O
6) O O
Intermittent O O
problems O O
with O O
hyperkalemia. O O
7) O O
Hypertension. B-HYPERTENSION B-HYPERTENSION
8) O O
Morbid B-OBESE O
obesity. B-OBESE O
Plan: O O
1) O O
Coronary O O
artery O O
disease O O
status O O
post O O
CABG. B-CAD O
She O O
is O O
clinically O O
doing O O
quite O O
well O O
without O O
any O O
signs O O
of O O
congestive O O
heart O O
failure O O
or O O
angina. O O
Her O O
ejection O O
fraction O O
significantly O O
improved O O
postoperatively. O O
I O O
am O O
concerned O O
about O O
a O O
relatively O O
high O O
blood O O
pressure O O
and O O
the O O
visiting O O
nurses O O
have O O
reported O O
that O O
it O O
has O O
been O O
going O O
up O O
into O O
the O O
180s B-HYPERTENSION O
systolic I-HYPERTENSION O
with I-HYPERTENSION O
ambulation. I-HYPERTENSION O
I O O
will O O
increase O O
her O O
lisinopril O B-MEDICATION
from O O
10 O O
to O O
20 O O
mg. O O
with O O
a O O
careful O O
watch O O
of O O
her O O
potassium. O O
2) O O
Chronic O O
renal O O
insufficiency. O O
Again O O
we'll O O
check O O
regular O O
labs O O
once O O
to O O
twice O O
weekly O O
monitoring O O
renal O O
function. O O
3) O O
Diabetes O O
mellitus. O O
Stable. O O
Her O O
blood O O
pressure O O
have O O
been O O
under O O
fairly O O
good O O
control. O O
She O O
has O O
also O O
lost O O
a O O
significant O O
amount O O
of O O
weight O O
over O O
20 O O
pounds. O O
Her O O
current O O
weight O O
is O O
326 O O
pounds. O O
We'll O O
check O O
hemoglobin O O
A1 O O
with O O
next O O
blood O O
draw. O O
4) O O
Anemia O O
of O O
chronic O O
disease. O O
We'll O O
also O O
recheck O O
her O O
blood O O
count O O
and O O
follow-up. O O
5) O O
Obstructive O O
sleep O O
apnea. O O
The O O
patient O O
is O O
using O O
her O O
CPAP O O
machine O O
at O O
night O O
time O O
and O O
I've O O
encouraged O O
her O O
to O O
do O O
so. O O
6) O O
Hyperkalemia. O O
She O O
will O O
continue O O
with O O
the O O
Kayexalate O O
as O O
prescribed O O
and O O
also O O
we'll O O
continue O O
to O O
monitor O O
her O O
potassium O O
regularly O O
over O O
the O O
next O O
several O O
months O O
until O O
they O O
normalize. O O
7) O O
Morbid O O
obesity. O O
She O O
is O O
making O O
good O O
progress O O
with O O
her O O
weight O O
loss. O O
She O O
is O O
going O O
to O O
continue O O
on O O
an O O
out-patient O O
program O O
once O O
weekly O O
and O O
she O O
is O O
also O O
going O O
to O O
be O O
going O O
for O O
some O O
mental O O
health O O
counseling O O
as O O
well O O
which O O
will O O
hopefully O O
continue O O
her O O
on O O
a O O
successful O O
weight O O
loss O O
plan.Chandler, O O
Jessica O O
MRN O O
#748-80-38-0 O O
May O O
05, O O
2069 O O
Page O O
3 O O
She O O
will O O
follow-up O O
with O O
me O O
in O O
one O O
month's O O
time. O O
Ruby O O
Ayala, O O
M.D. O O
DD: O O
05/09/69 O O
DT: O O
05/11/69 O O
DV: O O
05/05/69 O O
/denny O O
cc: O O
Noah O O
Kimball, O O
M.D. O O
Cardiac O O
Surgery O O
- O O
FSH O O
William O O
Wesley, O O
M.D. O O
Cardiology O O
Division O O
- O O
FSH O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2070-01-08 O O
FSH O O
EMERGENCY O O
DEPT O O
VISIT O O
CHANDLER,JESSICA O O
748-80-38-0 O O
VISIT O O
DATE: O O
01/08/70 O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
was O O
seen O O
and O O
evaluated O O
by O O
Dr. O O
Wooten. O O
Please O O
see O O
Dr. O O
Wooten's O O
note. O O
The O O
patient O O
is O O
a O O
41 O O
year O O
old O O
morbidly B-OBESE O
obese B-OBESE O
diabetic B-DIABETES O
female O O
with O O
two O O
days O O
of O O
shortness O O
of O O
breath O O
and O O
cough, O O
productive O O
of O O
some O O
whitish O O
sputum. O O
She O O
has O O
had O O
no O O
chest O O
pain, O O
no O O
nausea, O O
no O O
vomiting. O O
Minimal O O
diaphoresis. O O
She O O
has O O
had O O
a O O
fever. O O
No O O
urinary O O
symptoms. O O
She O O
does O O
have O O
chronic O O
renal O O
insufficiency, O O
COPD, O O
CHF O O
and O O
diabetes. B-DIABETES O
PAST O O
MEDICAL O O
HISTORY: O O
As O O
above O O
plus O O
status B-CAD O
post I-CAD O
coronary I-CAD O
artery I-CAD O
bypass I-CAD O
grafting. I-CAD O
MEDICATIONS: O O
Lasix, O O
Prilosec, O O
Cozaar, B-MEDICATION B-MEDICATION
aspirin, B-MEDICATION B-MEDICATION
Paxil, O O
Flovent, O O
albuterol O O
and O O
Nephrocaps. O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
SOCIAL O O
HISTORY: O O
A B-SMOKER O
non-smoker. I-SMOKER O
PHYSICAL O O
EXAMINATION: O O
An O O
obese O O
female, O O
mild O O
acute O O
distress. O O
Temperature O O
101 O O
degrees. O O
Heart O O
has O O
a O O
regular O O
rate O O
and O O
rhythm. O O
Lungs: O O
Diffuse O O
rhonchi O O
throughout O O
with O O
bibasilar O O
rales. O O
The O O
abdomen O O
is O O
obese, O O
soft. O O
Neurologic O O
exam O O
is O O
non-focal. O O
LABORATORY O O
EVALUATION: O O
Chest O O
x-ray O O
shows O O
a O O
poor O O
inspiratory O O
effort, O O
no O O
obvious O O
infiltrate, O O
perhaps O O
some O O
hazy O O
infiltrates. O O
EKG O O
is O O
unchanged. O O
Labs: O O
Unable O O
to O O
obtain O O
at O O
this O O
time. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
was O O
seen O O
and O O
evaluated. O O
Chest O O
x-ray O O
was O O
obtained. O O
The O O
patient O O
has O O
an O O
IV O O
established O O
but O O
were O O
unable O O
to O O
draw O O
labs. O O
Under O O
my O O
direct O O
supervision O O
and O O
with O O
some O O
attempts O O
by O O
me, O O
multiple O O
attempts O O
are O O
made O O
at O O
the O O
infraclavicular O O
and O O
supraclavicular O O
left O O
and O O
right O O
subclavian O O
vein O O
without O O
success. O O
The O O
groins O O
bilateral O O
have O O
damp, O O
moist O O
exudate O O
and O O
the O O
neck O O
anatomy O O
is O O
difficult O O
to O O
assess. O O
We O O
are O O
unable O O
to O O
establish O O
a O O
line. O O
She O O
has O O
a O O
chest O O
x-ray O O
for O O
rule O O
out O O
of O O
pneumothorax O O
or O O
hemothorax O O
and O O
she O O
will O O
need O O
an O O
arterial O O
stick O O
for O O
blood O O
draws. O O
IMPRESSION: O O
Hypoxia, O O
possible O O
pneumonia O O
and O O
a O O
facial O O
abscess. O O
PLAN: O O
Admission. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Condition O O
on O O
admission O O
is O O
stable. O O
___________________________________ O O
RJ446/0820 O O
RONNIE O O
HUFFMAN, O O
M.D. O O
RH31 O O
D:01/08/70 O O
T:01/09/70 O O
Dictated O O
by: O O
RONNIE O O
HUFFMAN, O O
M.D. O O
RH31 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2070-07-28 O O
OFFICE O O
NOTE O O
FRANKFORT O O
INTERNAL O O
MEDICINE O O
28 O O
Bailey O O
Street O O
2nd O O
Floor O O
North O O
Webster, O O
SD O O
48493 O O
Chandler, O O
Jessica O O
MRN: O O
748-80-38-0 O O
07/28/70 O O
Jessica O O
returns O O
today O O
for O O
follow-up O O
after O O
her O O
admission O O
for O O
acute O O
shortness O O
of O O
breath O O
and O O
congestive O O
heart O O
failure. O O
I O O
had O O
added O O
Zaroxolyn O O
on O O
to O O
her O O
regimen O O
which O O
she O O
is O O
tolerating O O
well. O O
However, O O
her O O
recent O O
laboratory O O
studies O O
show O O
that O O
she O O
has O O
a O O
significant O O
increase O O
in O O
her O O
BUN O O
and O O
creatinine. O O
Her O O
BUN O O
is O O
in O O
the O O
80's, O O
and O O
her O O
creatinine O O
is O O
about O O
3.4. O O
She O O
states O O
her O O
breathing O O
has O O
been O O
excellent, O O
however. O O
She O O
is O O
not O O
experiencing O O
as O O
much O O
dyspnea O O
on O O
exertion. O O
She O O
is O O
sleeping O O
through O O
the O O
night, O O
and O O
she O O
is O O
no O O
longer O O
having O O
any O O
kind O O
of O O
dry O O
cough. O O
Medications: O O
Her O O
current O O
medicines O O
are O O
Nephrocaps O O
1 O O
tablet O O
p.o. O O
q.day, O O
Paxil O O
20 O O
p.o. O O
q.day, O O
Cozaar B-MEDICATION B-MEDICATION
50 O O
p.o. O O
q.day, O O
Prilosec O O
20 O O
mg O O
p.o. O O
q. O O
day, O O
Atenolol B-MEDICATION B-MEDICATION
50 O O
p.o. O O
q.day, O O
Lasix O O
120 O O
p.o. O O
b.i.d., O O
Zaroxolyn O O
2.5 O O
p.o. O O
q.day, O O
Albuterol O O
nebulizers O O
p.r.n., O O
nph B-MEDICATION O
40 I-MEDICATION O
units I-MEDICATION O
in I-MEDICATION O
the I-MEDICATION O
morning I-MEDICATION O
and I-MEDICATION O
40 I-MEDICATION O
units I-MEDICATION O
at I-MEDICATION O
night I-MEDICATION O
time I-MEDICATION O
and O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
p.o. O O
q.day. O O
Allergies: O O
Cephalexin O O
causes O O
questionable O O
rash. O O
Physical O O
Examination: O O
Today O O
she O O
is O O
a O O
pleasant O O
black O O
female O O
in O O
no O O
acute O O
distress. O O
Her O O
weight O O
is O O
330 O O
pounds. O O
This O O
is O O
down O O
over O O
20 O O
pounds O O
over O O
the O O
past O O
month. O O
Her O O
blood O O
pressure O O
is O O
122/80. O O
Her O O
pulse O O
is O O
80. O O
Her O O
lungs O O
are O O
clear. O O
Her O O
heart O O
reveals O O
distant O O
heart O O
sounds O O
but O O
regular O O
in O O
rhythm O O
and O O
rate. O O
Her O O
extremities O O
are O O
notable O O
for O O
the O O
absence O O
of O O
lower O O
extremity O O
edema. O O
Her O O
abdomen O O
is O O
also O O
noted O O
to O O
be O O
significantly O O
less O O
edematous O O
than O O
it O O
has O O
been O O
in O O
the O O
past. O O
Inspection O O
of O O
her O O
left O O
lower O O
extremity O O
reveals O O
that O O
she O O
continues O O
to O O
have O O
an O O
ulcer O O
over O O
the O O
lateral O O
aspect O O
of O O
the O O
foot O O
on O O
the O O
plantar O O
surface O O
that O O
measures O O
2 O O
x O O
3 O O
cm. O O
There O O
is O O
beefy O O
red O O
granulation O O
tissue O O
surrounding O O
this. O O
Diagnosis: O O
1. O O
Congestive O O
heart O O
failure. O O
2. O O
Coronary B-CAD O
artery I-CAD O
disease, I-CAD O
status B-CAD O
post I-CAD O
CABG. B-CAD O
3. O O
Morbid B-OBESE O
obesity. I-OBESE O
4. O O
Adult B-DIABETES O
onset I-DIABETES O
diabetes B-DIABETES O
mellitus. I-DIABETES O
5. O O
Chronic O O
renal O O
insufficiency. O O
6. O O
Foot O O
ulcer. O O
7. O O
Depression. O O
8. O O
Health O O
maintenance. O O
Chandler, O O
Jessica O O
MRN: O O
748-80-38-0 O O
07/28/70 O O
Page O O
Two O O
Plan: O O
1. O O
Congestive O O
heart O O
failure. O O
She O O
is O O
doing O O
much O O
better O O
on O O
higher O O
doses O O
of O O
diuretics O O
with O O
a O O
weight O O
loss O O
of O O
over O O
20 O O
pounds O O
since O O
her O O
last O O
visit O O
here O O
about O O
a O O
month O O
ago. O O
At O O
this O O
point O O
in O O
time, O O
however, O O
I O O
think O O
that O O
we O O
need O O
to O O
cut O O
back O O
on O O
her O O
Zaroxolyn O O
given O O
the O O
elevation O O
in O O
her O O
BUN O O
and O O
creatinine, O O
and O O
I've O O
asked O O
her O O
to O O
hold O O
her O O
Zaroxolyn O O
dosage O O
and O O
continue O O
on O O
a O O
relatively O O
low-fat O O
and O O
low-sodium O O
diet O O
and O O
to O O
have O O
a O O
scale O O
and O O
obtain O O
daily O O
weights, O O
and O O
she O O
will O O
follow-up O O
with O O
me O O
in O O
the O O
office O O
in O O
two O O
weeks O O
and O O
per O O
telephone O O
conversation O O
in O O
four O O
days. O O
Should O O
she O O
have O O
an O O
increase O O
in O O
her O O
weight O O
by O O
more O O
than O O
five O O
pounds, O O
she O O
will O O
contact O O
me. O O
2. O O
Coronary O O
artery O B-CAD
disease, O O
status O O
post O O
CABG. O O
Stable O O
without O O
any O O
symptoms O O
of O O
exertional O O
chest O O
pain. O O
Continue O O
current O O
medication. O O
3. O O
Morbid O O
obesity. O O
She O O
decided O O
not O O
to O O
go O O
to O O
the O O
Frankfort O O
State O O
Hospital O O
weight O O
loss O O
program. O O
I O O
strongly O O
wanted O O
her O O
to O O
go O O
on O O
a O O
liquid O O
protein O O
diet O O
plan, O O
but O O
she O O
states O O
it's O O
inconvenient O O
for O O
her O O
to O O
come O O
to O O
the O O
Hospital O O
at O O
night O O
time O O
for O O
the O O
meetings. O O
She O O
is O O
planning O O
to O O
try O O
and O O
enroll O O
in O O
a O O
program O O
at O O
Sibley O O
Care. O O
I O O
told O O
her O O
I O O
would O O
help O O
her O O
out O O
in O O
any O O
way O O
possible, O O
but O O
strongly O O
reinforced O O
to O O
her O O
the O O
need O O
for O O
her O O
to O O
take O O
off O O
weight. O O
4. O O
Adult-onset B-DIABETES O
diabetes I-DIABETES O
mellitus. I-DIABETES O
Stable. O O
Continue O O
current O O
regimen. O O
5. O O
Chronic O O
renal O O
insufficiency. O O
The O O
plan O O
as O O
above O O
is O O
to O O
stop O O
Zaroxolyn O O
and O O
repeat O O
electrolytes O O
in O O
five O O
days. O O
6. O O
Diabetic O O
foot O O
ulcer. O O
I O O
also O O
gave O O
her O O
a O O
duoderm O O
dressing O O
to O O
try, O O
and O O
she O O
is O O
going O O
to O O
continue O O
to O O
follow-up O O
with O O
her O O
podiatrist, O O
and O O
I O O
will O O
speak O O
with O O
her O O
visiting O O
nurse O O
about O O
appropriate O O
treatment. O O
Ruby O O
C. O O
Ayala, O O
M.D. O O
DD: O O
07/28/70 O O
DT: O O
07/31/70 O O
DV: O O
07/28/70 O O
/naranjo O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2073-05-03 O O
Reason O O
for O O
Visit O O
Issues O O
Today: O O
1) O O
CAD: B-CAD O
Doing O O
well, O O
no O O
chest O O
pain O O
or O O
dyspnea O O
with O O
exercise, O O
going O O
to O O
card O O
rehab O O
2x/wk O O
and O O
County O O
Sports O O
Club O O
other O O
days. O O
To O O
see O O
Dr. O O
Ishmael O O
in O O
6/73. O O
Still O O
on O O
plavix. B-MEDICATION B-MEDICATION
2) O O
BPH: O O
Saw O O
Dr. O O
Maddox O O
w/in O O
last O O
2 O O
wks, O O
PSA O O
3.2 O O
(had O O
been O O
&gt;6 O O
in O O
2064). O O
Flomax O O
was O O
making O O
him O O
sick O O
with O O
dry O O
heaves O O
when O O
took O O
in O O
am, O O
better O O
now O O
he's O O
taking O O
qhs. O O
3) O O
HTN/past B-SMOKER O
tobacco/elev I-SMOKER O
chol: B-HYPERLIPIDEMIA O
no O O
changes O O
in O O
meds. O O
SHx: O O
he O O
and O O
sisters O O
moved O O
from O O
house O O
of O O
31 O O
yrs O O
to O O
new O O
apartment O O
complex O O
in O O
Lima O O
with O O
pool; O O
likes O O
it. O O
Problems O O
Hyperlipidemia B-HYPERLIPIDEMIA B-HYPERTENSION
Past B-SMOKER O
smoking I-SMOKER O
: I-SMOKER O
1-2 I-SMOKER O
ppd I-SMOKER O
x I-SMOKER O
40 I-SMOKER O
yrs I-SMOKER O
HTN O O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
CAD O O
: O O
S/P B-CAD O
MI,PTCA/Stent I-CAD O
RCA, I-CAD O
LAD I-CAD O
50%,LCX I-CAD O
50% I-CAD O
Elevated O O
PSA O O
: O O
(-) O O
bx O O
CVA O O
: O O
(lacunar) O O
-(L) O O
BG O O
2/73 O O
BPH O O
Medications O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
5MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Ecasa B-MEDICATION B-MEDICATION
(ASPIRIN O O
Enteric O O
Coated) O O
325MG, O O
PO O O
QD O O
Flomax O O
(TAMSULOSIN) O O
0.4MG, O O
1 O O
Capsule(s) O O
PO O O
QHS O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
PO O O
QD O O
Allergies O O
Penicillins O O
- O O
Unknown O O
Review O O
of O O
Systems O O
+ O O
occasional O O
bruising O O
on O O
plavix O B-MEDICATION
and O O
aspirin. O B-MEDICATION
+ O O
nocturia O O
x1, O O
stable. O O
Denies O O
fever, O O
chills, O O
night O O
sweats, O O
or O O
weight O O
loss. O O
No O O
nausea, O O
vomiting, O O
active O O
heartburn, O O
or O O
dysphagia. O O
No O O
diarrhea, O O
constipation, O O
blood O O
per O O
rectum O O
or O O
melena. O O
No O O
urinary O O
frequency O O
or O O
dysuria. O O
No O O
joint O O
or O O
muscle O O
pains O O
or O O
swelling. O O
No O O
visual O O
or O O
hearing O O
loss. O O
Physical O O
Exam O O
General: O O
well O O
appearing O O
male, O O
no O O
distress. O O
HEENT: O O
pupils O O
equal, O O
reative O O
to O O
light, O O
occular O O
movements O O
full. O O
oropharynx O O
clear O O
without O O
erythema. O O
no O O
sinus O O
tenderness. O O
tympanic O O
membranes O O
obsured O O
by O O
cerumen, O O
L&gt;R. O O
Neck: O O
supple O O
without O O
lymphadenopathy O O
or O O
thyromegaly. O O
No O O
bruits O O
heard. O O
CV: O O
regular O O
rate O O
and O O
rhythm, O O
normal O O
heart O O
sounds, O O
no O O
murmurs O O
or O O
rubs O O
heard. O O
jugular O O
venous O O
pressure O O
normal. O O
Pulm: O O
clear O O
to O O
auscultation O O
posteriorly, O O
without O O
wheezes, O O
ronchi, O O
or O O
rales. O O
Abd: O O
soft O O
and O O
non-tender O O
without O O
distension O O
or O O
rebound. O O
normoactive O O
bowel O O
sounds, O O
no O O
organomegaly. O O
Back: O O
without O O
spinal O O
or O O
costovertebral O O
angle O O
tenderness. O O
Extremities: O O
warm O O
and O O
well O O
perfused O O
with O O
2/2 O O
DP O O
pulses. O O
no O O
edema. O O
+ O O
clubbing O O
(chronic) O O
of O O
fingers. O O
Skin: O O
without O O
suspicious O O
moles. O O
Prostate: O O
deferred O O
as O O
done O O
by O O
urologist O O
2 O O
wks O O
ago. O O
Laboratory O O
Data O O
2/15/73: O O
chol O O
123, O O
ldl O O
69, O O
hdl O O
36, O O
tg O O
89, O O
sgot O O
20, O O
ck O O
71 O O
1/17/73: B-DIABETES O
hgb B-DIABETES O
A1c I-DIABETES O
6.80, I-DIABETES O
mean O O
glucose O O
141 O O
Assessment O O
and O O
Plan O O
1. O O
CAD: O O
excellent O O
control O O
of O O
sx O O
on O O
current O O
regimen. O O
May O O
be O O
able O O
to O O
stop O O
Plavix O O
at O O
next O O
visit O O
with O O
Dr. O O
Ishmael. O O
2. O O
Chol: O O
recheck O O
fasting O O
lipids O O
in O O
9/73. O O
Cont O O
lipitor B-MEDICATION B-MEDICATION
3. O O
BPH: O O
stable O O
on O O
flomax O O
0.4 O O
qhs. O O
4. O O
elevated O O
A1c O O
in O O
2/73: O O
recheck O O
today. O O
5. O O
ceruminosis: O O
left O O
ear O O
irrigated O O
by O O
RN. O O
6. O O
f/u O O
9/73. O O

Record O O
date: O O
2074-02-06 O O
Follow O O
Up O O
- O O
post O O
hospitalization O O
visit O O
He O O
was O O
admitted O O
2/01-2/03/74 B-CAD O
for I-CAD O
NSTEMI. B-CAD O
On O O
1/31 O O
he O O
had O O
symptoms O O
similar O O
to O O
those O O
he O O
experienced O O
prior O O
to O O
his O O
MI O O
in O O
2073: O O
pain O O
in O O
back O O
of O O
left O O
neck, O O
left O O
shoulder, O O
and O O
left O O
arm. O O
As O O
a O O
result O O
he O O
did O O
not O O
exercise O O
that O O
day. O O
The O O
symptoms O O
improved O O
spontaneously. O O
On O O
2/01 O O
he O O
did O O
his O O
normal O O
exercise O O
routine, O O
running O O
on O O
the O O
treadmill O O
for O O
40 O O
minutes; O O
he O O
felt O O
fine. O O
Later O O
that O O
day, O O
he O O
had O O
recurrence O O
of O O
the O O
symptoms O O
so O O
he O O
called O O
Dr. O O
Ishmael's O O
answering O O
service. O O
Dr. O O
Patterson O O
was O O
covering O O
and O O
recommended O O
he O O
go O O
to O O
ED. O O
He O O
is O O
very O O
impressed O O
that O O
Dr. O O
Patterson O O
saw O O
him O O
that O O
evening O O
in O O
the O O
ED. O O
There O O
EKG O O
showed O O
no O O
changes O O
but O O
troponin-I O O
and O O
CK O O
screen O O
were O O
positive. O O
He O O
was O O
admitted O O
to O O
cardiology O O
service O O
and O O
managed O O
with O O
integrullin O O
and O O
heparin. O O
When O O
second O O
set O O
of O O
enzymes O O
was O O
positive O O
on O O
2/02 O O
he O O
went O O
to O O
cath O O
lab, O O
where O O
old O O
RCA O O
stent O O
was O O
'pristine,' O O
LAD O O
showed O O
stable O O
50% O O
lesion, O O
but O O
distal O O
LCx O O
showed O O
90% O O
lesion. O O
He O O
had O O
PTCA O O
and O O
stenting O O
with O O
medicated O O
stent, O O
producing O O
excellent O O
result. O O
He O O
was O O
discharged O O
on O O
2/03 O O
on O O
plavix. B-MEDICATION B-MEDICATION
Today, O O
he O O
says O O
he O O
has O O
had O O
no O O
recurrence O O
of O O
symptoms. O O
He O O
is O O
feeling O O
great. O O
He O O
is O O
concerned O O
that O O
he O O
had O O
the O O
MI O O
despite O O
taking O O
all O O
his O O
medications O O
as O O
prescribed O O
and O O
feeling O O
so O O
well O O
with O O
exercise. O O
He O O
wonders O O
whether O O
he O O
needs O O
to O O
re-start O O
cardiac O O
rehab. O O
He O O
is O O
avoiding O O
exercise O O
until O O
he O O
sees O O
Dr. O O
Ishmael O O
next O O
week. O O
He O O
has O O
had O O
no O O
groin O O
hematoma O O
or O O
other O O
complications. O O
Problems O O
Hyperlipidemia B-HYPERLIPIDEMIA B-MEDICATION
Past B-SMOKER O
smoking I-SMOKER O
: I-SMOKER O
1-2 I-SMOKER O
ppd I-SMOKER O
x I-SMOKER O
40 I-SMOKER O
yrs I-SMOKER O
HTN B-HYPERTENSION O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
CAD B-CAD O
: O O
S/P O O
MI,PTCA/Stent B-CAD O
RCA, O B-CAD
LAD O O
50%,LCX O O
50% O O
Elevated O O
PSA O O
: O O
(-) O O
bx O O
CVA O O
: O O
(lacunar) O O
-(L) O O
BG O O
2/73 O O
BPH O O
Allergies O O
Penicillins O O
- O O
Unknown O O
Ativan O O
(LORAZEPAM) O O
- O O
Mental O O
Status O O
Change O O
: O O
agitation O O
Medications O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
5MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Ecasa B-MEDICATION B-MEDICATION
(ASPIRIN O O
Enteric O O
Coated) O O
325MG, O O
PO O O
QD O O
Ntg B-MEDICATION O
1/150 O O
(NITROGLYCERIN B-MEDICATION O
1/150 O O
(0.4 O O
Mg)) O O
1 O O
TAB O O
SL O O
x1 O O
PRN O O
chest O O
pain O O
: O O
use O O
one O O
tablet O O
every O O
5 O O
minutes O O
upto O O
3x; O O
if O O
pain O O
continues, O O
call O O
doctor. O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
qd O O
ROS O O
BPH O O
stable, O O
off O O
flomax O O
x O O
1 O O
year. O O
Nocturia O O
1-2x/nt. O O
Denies O O
fever, O O
chills, O O
night O O
sweats, O O
or O O
weight O O
loss. O O
No O O
exertional O O
chest O O
pain O O
or O O
dyspnea. O O
No O O
nausea, O O
vomiting, O O
active O O
heartburn, O O
or O O
dysphagia. O O
No O O
diarrhea, O O
constipation, O O
blood O O
per O O
rectum O O
or O O
melena. O O
No O O
joint O O
or O O
muscle O O
pains O O
or O O
swelling. O O
Physical O O
Exam O O
bp O O
130/76, O O
p O O
60, O O
wt O O
142 O O
lbs O O
General: O O
well O O
appearing, O O
no O O
distress O O
Neck: O O
supple, O O
no O O
LAD, O O
no O O
thyromegaly O O
CV: O O
rrr, O O
no O O
m/r/g, O O
jvp O O
normal O O
Pulm: O O
cta/p, O O
no O O
w/r/r O O
Abd: O O
soft, O O
nt/nd, O O
+bs, O O
no O O
hsm O O
Back: O O
no O O
cvat, O O
no O O
spinal O O
tenderness O O
Exts: O O
no O O
edema, O O
warm, O O
PT/DPs O O
2/2 O O
bilaterally O O
Skin: O O
no O O
rash O O
or O O
suspicious O O
moles O O
G/U: O O
R O O
groin O O
without O O
hematoma O O
or O O
bruit; O O
mild O O
ecchymosis O O
infero-lateral O O
R O O
hip. O O
Data O O
2/01: O O
CK O O
299 O O
-&gt; O O
398 O O
-&gt; O O
167; O O
CPK O O
Index O O
20.6 O O
-&gt; O O
31.8 O O
-&gt; O O
6.3; O O
Trop-T O O
0.76 O O
-&gt; O O
0.85. O O
2/02: O O
A1c O O
6.50. O O
2/02: O O
chol O O
140, O O
LDL O O
84, O O
HDL O O
38, O O
TG O O
88 O O
A/P O O
1. O O
CAD: O O
s/p O O
NSTEMI O O
2/01: O O
no O O
symptoms O O
currently O O
s/p O O
stent O O
LCx. O O
May O O
need O O
increase O O
in O O
atenolol B-MEDICATION B-MEDICATION
to O O
bid O O
to O O
avoid O O
plaque O O
rupture O O
in O O
future; O O
now O O
on O O
plavix O B-MEDICATION
(gave O O
him O O
some O O
samples O O
b/c O O
of O O
cost), O O
will O O
continue O O
x O O
6 O O
months; O O
he O O
will O O
avoid O O
exercising O O
for O O
now O O
and O O
discuss O O
cardiac O O
rehab O O
with O O
Dr. O O
Ishmael. O O
2. O O
Lipids: O O
good O O
control O O
on O O
lipitor B-MEDICATION B-MEDICATION
10 O O
mg O O
qd. O O
3. O O
HTN: O O
good O O
control O O
on O O
lisinopril B-MEDICATION B-MEDICATION
5 O O
mg O O
qd, O O
atenolol O B-MEDICATION
100 O O
mg O O
qd. O O
4. O O
BPH: O O
stable O O
symptoms O O
off O O
flomax. O O
F/u O O
3 O O
months. O O
_____________________________________________ O O
Peter O O
H O O
Uddin, O O
M.D. O O

Record O O
date: O O
2074-12-25 O O
Episodic O O
Visit O O
He O O
has O O
had O O
a O O
cold O O
for O O
5 O O
days O O
and O O
wanted O O
to O O
get O O
checked. O O
He O O
says O O
it O O
started O O
Saturday O O
with O O
a O O
tickle O O
in O O
his O O
throat; O O
he O O
went O O
to O O
the O O
race O O
track O O
on O O
Sunday O O
and O O
felt O O
the O O
same; O O
on O O
Tuesday O O
he O O
had O O
dry O O
cough, O O
occasionally O O
bringing O O
up O O
clear O O
sputum. O O
He O O
had O O
no O O
fevers O O
but O O
perhaps O O
some O O
mild O O
sweats. O O
He O O
notes O O
mild O O
sinus O O
congestion O O
and O O
post-nasal O O
drip. O O
No O O
known O O
sick O O
contacts. O O
He O O
got O O
a O O
flu O O
shot O O
at O O
the O O
TFMC O O
in O O
11/74 O O
and O O
pneumovax O O
at O O
last O O
appt O O
in O O
11/74. O O
He O O
is O O
feeling O O
mostly O O
better, O O
and O O
was O O
able O O
to O O
work O O
out O O
on O O
the O O
treadmill O O
for O O
1.5 O O
miles O O
without O O
difficulty. O O
He O O
has O O
had O O
no O O
chest O O
pain O O
or O O
dyspnea. O O
He O O
is O O
using O O
Robitussin O O
DM, O O
but O O
askes O O
if O O
there O O
is O O
anything O O
better O O
for O O
him O O
to O O
use. O O
Problems O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Past B-SMOKER O
smoking I-SMOKER O
: I-SMOKER O
1-2 I-SMOKER O
ppd I-SMOKER O
x I-SMOKER O
40 I-SMOKER O
yrs I-SMOKER O
HTN B-HYPERTENSION O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
CAD B-CAD O
: O O
S/P B-CAD O
MI,PTCA/Stent B-CAD O
RCA, I-CAD B-CAD
LAD I-CAD O
50%,LCX I-CAD O
50% I-CAD O
Elevated O O
PSA O O
: O O
(-) O O
bx O O
CVA O O
: O O
(lacunar) O O
-(L) O O
BG O O
2/73 O O
BPH O O
Allergies O O
Penicillins O O
- O O
Unknown O O
LORAZEPAM O B-MEDICATION
- O O
Mental O O
Status O O
Change O O
Medications O O
Lisinopril B-MEDICATION B-MEDICATION
5MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Atenolol B-MEDICATION B-MEDICATION
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Ecasa B-MEDICATION B-MEDICATION
(ASPIRIN O O
ENTERIC O O
COATED) O O
325MG O O
TABLET O O
EC O O
PO O O
QD O O
Ntg B-MEDICATION O
1/150 O O
(NITROGLYCERIN B-MEDICATION O
1/150 O O
(0.4 O O
MG)) O O
1 O O
TAB O O
SL O O
x1 O O
PRN O O
chest O O
pain O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
PO O O
QD O O
Folate O O
(FOLIC O O
ACID) O O
1MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Spectazole O O
(ECONAZOLE O O
NITRATE O O
1%) O O
APPLY O O
CREAM O O
TOP O O
QD O O
PRN O O
fungal O O
rash O O
Zocor B-MEDICATION B-MEDICATION
(SIMVASTATIN) O O
40MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QHS O O
Physical O O
Exam O O
bp O O
120/76, O O
p O O
72, O O
temp O O
97.5, O O
wt O O
145 O O
lbs O O
General: O O
well O O
appearing, O O
in O O
no O O
distress O O
HEENT: O O
PERRL, O O
EOMI, O O
no O O
scleral O O
icterus; O O
OP-clear, O O
with O O
no O O
exudate; O O
TMs O O
wnl; O O
no O O
sinus O O
tenderness. O O
Neck: O O
supple, O O
no O O
LAD, O O
no O O
thyromegaly O O
CV: O O
RRR, O O
no O O
m/r/g, O O
JVP O O
normal O O
Pulm: O O
CTA/p, O O
no O O
w/r/r O O
Abd: O O
soft, O O
NT/ND, O O
+bs, O O
no O O
HSM O O
Exts: O O
no O O
edema, O O
warm, O O
PT/DP O O
pulses O O
2+/2+ O O
bilaterally O O
A/P O O
1. O O
URI: O O
likely O O
viral, O O
already O O
improving. O O
I O O
have O O
told O O
him O O
not O O
to O O
use O O
sudafed O O
containing O O
products O O
because O O
of O O
his O O
cad B-CAD O
and O O
htn; B-HYPERTENSION O
he O O
will O O
try O O
nasonex O O
NAS O O
to O O
clear O O
his O O
sinuses; O O
robitussin O O
AC O O
given O O
for O O
prn O O
qhs O O
use. O O
2. O O
cad: O O
stable. O O
he O O
reports O O
his O O
cardiologist O O
plans O O
to O O
stop O O
plavix O O
after O O
one O O
year O O
course. O O
_____________________________________________ O O
Peter O O
H O O
Uddin, O O
M.D. O O

Record O O
date: O O
2077-02-09 O O
BRENNAN O O
CONVALESCENT O O
HOME O O
Reason O O
For O O
Visit O O
Cough. O O
History O O
Of O O
Present O O
Illness O O
68 O O
year-old O O
male O O
presents O O
with O O
complaint O O
of O O
cough O O
productive O O
of O O
white-to-clear O O
sputum O O
for O O
two O O
days. O O
He O O
feels O O
minimal O O
chest O O
tightness, O O
with O O
no O O
shortness O O
of O O
breath. O O
No O O
dyspnea O O
on O O
exertion O O
or O O
PND. O O
He O O
denies O O
wheeze. O O
He O O
is O O
able O O
to O O
tolerate O O
exercise O O
on O O
treadmill O O
without O O
chest O O
pain. O O
He O O
denies O O
fever O O
or O O
chills. O O
Presently, O O
self-treating O O
with O O
Robitussin O O
DM O O
and O O
Halls O O
cough O O
drops. O O
Has O O
clear O O
rhinorrhea. O O
No O O
ear O O
pain, O O
no O O
throat O O
pain. O O
No O O
sinus O O
pain O O
or O O
pressure. O O
Past O O
Medical O O
History O O
CAD, B-CAD O
status B-CAD O
post I-CAD O
stent B-CAD O
x2. I-CAD O
MI. B-CAD O
Hypertension. B-HYPERTENSION B-HYPERTENSION
Hyperlipidemia. B-HYPERLIPIDEMIA O
CVA. O O
BPH. O O
Elevated O O
PSA. O O
Tobacco B-SMOKER O
use I-SMOKER O
in I-SMOKER O
the I-SMOKER O
past. I-SMOKER O
Physical O O
Exam O O
Temperature: O O
97.9 O O
degrees O O
Pulse: O O
64 O O
Blood B-HYPERTENSION O
Pressure: I-HYPERTENSION O
140/70 I-HYPERTENSION O
General: O O
Well-developed O O
white O O
male O O
in O O
no O O
acute O O
distress O O
HEENT: O O
TMs O O
and O O
oropharynx O O
unremarkable. O O
Oropharynx O O
is O O
clear O O
without O O
exudate O O
or O O
tonsillar O O
hypertrophy. O O
No O O
posterior O O
pharynx O O
exudate. O O
Sinuses O O
are O O
nontender O O
Chest: O O
Lungs O O
are O O
clear O O
to O O
auscultation O O
bilaterally O O
Cardiac: O O
Regular O O
rate O O
and O O
rhythm. O O
No O O
murmur, O O
rub, O O
or O O
gallop O O
Extremities: O O
No O O
peripheral O O
edema O O
Assessment O O
And O O
Plan O O
1. O O
Cough, O O
likely O O
viral. O O
Robitussin O O
DM O O
as O O
directed O O
for O O
daytime O O
use, O O
may O O
use O O
Robitussin O O
A-C O O
at O O
HS O O
PRN,(patient O O
has O O
own). O O
Reassurance O O
re: O O
findings O O
on O O
exam. O O
2. O O
Hypertension. O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
again I-HYPERTENSION O
today I-HYPERTENSION O
140/70. I-HYPERTENSION O
Continue O O
to O O
monitor O O
for O O
indication O O
of O O
increase O O
in O O
Lisinopril B-MEDICATION B-MEDICATION
per O O
Dr. O O
Uddin. O O
The O O
patient O O
has O O
followup O O
with O O
Cardiology O O
on O O
02/17/2077. O O
____________________________________ O O
Yazmin O O
Doss, O O
NP O O

Record O O
date: O O
2073-08-02 O O
MAMARONECK O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
Orta, O O
Phil O O
55931516 O O
8-02-73 O O
HPI: O O
Mr. O O
Orta O O
is O O
a O O
50-year-old O O
African-American O O
man O O
who O O
has O O
been O O
treated O O
for O O
the O O
five O O
past O O
years O O
by O O
LBH O O
at O O
Edgefield. O O
He O O
was O O
seen O O
in O O
MHC O O
clinic O O
prior O O
to O O
that. O O
His O O
LBH O O
physician O O
was O O
Dr. O O
Jaeger O O
and O O
his O O
phone O O
number O O
is O O
872-9985. O O
Patient O O
was O O
last O O
seen O O
one O O
year O O
ago O O
due O O
to O O
the O O
fact O O
that O O
he O O
lost O O
his O O
job O O
and O O
his O O
insurance O O
with O O
LBH O O
and O O
states O O
that O O
he O O
has O O
not O O
seen O O
a O O
physician O O
in O O
the O O
past O O
year. O O
His O O
medical O O
problems O O
include: O O
1. O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
with O O
angioplasty B-CAD O
in I-CAD O
2063. I-CAD O
It O O
is O O
unclear O O
which O O
vessels O O
were O O
plastied. O O
2. O O
Hypercholesterolemia B-HYPERLIPIDEMIA O
treated O O
in O O
the O O
past O O
with O O
gemfibrozil B-MEDICATION O
and O O
niacin B-MEDICATION O
for O O
coexistent O O
hypertriglyceridemia. O O
However, O O
he O O
has O O
not O O
taken O O
any O O
niacin O B-MEDICATION
or O O
gemfibrozil O O
for O O
the O O
past O O
year O O
as O O
well. O O
3. O O
Anxiety. O O
4. O O
Condyloma O O
last O O
fall. O O
Medications: O O
1) O O
enteric O O
coated O O
aspirin B-MEDICATION B-MEDICATION
325mg O O
q.d.; O O
2) O O
lorazepam O B-MEDICATION
1mg O O
PO O O
q.h.s. O O
prescribed O O
by O O
Dr. O O
Guadalupe O O
Thacker O O
at O O
LBH. O O
Patient O O
also O O
had O O
nitroglycerin B-MEDICATION B-MEDICATION
tablets O O
at O O
home. O O
Patient O O
used B-MEDICATION O
to I-MEDICATION O
use I-MEDICATION O
diltiazem B-MEDICATION O
30mg O O
PO O O
t.i.d.; O O
however, O O
that O O
was O O
stopped O O
a O O
year O O
ago O O
when O O
he O O
lost O O
his O O
insurance. O O
He O O
does O O
not O O
have O O
any O O
history O O
of O O
hypertension O O
in O O
the O O
past. O O
Social B-SMOKER O
history: O O
He O O
is O O
currently O O
not O O
working. O O
He O O
has O O
been O O
unemployed O O
for O O
a O O
month O O
and O O
a O O
half. O O
He O O
used O O
to O O
be O O
a O O
social O O
worker O O
which O O
did O O
not O O
involve O O
any O O
heavy O O
lifting. O O
He O O
did O O
community O O
services O O
managment. O O
He O O
lives O O
with O O
his O O
mother O O
and O O
his O O
sister O O
and O O
has O O
never O O
been O O
married. O O
Review O O
of O O
systems: O O
Patient O O
states O O
that O O
he O O
has O O
very O O
infrequent O O
episodes O O
of O O
chest O O
pains O O
over O O
the O O
last O O
10 O O
years. O O
However, O O
he O O
does O O
say O O
that O O
his O O
last O O
chest O O
pain O O
was O O
approximately O O
a O O
week O O
and O O
a O O
half O O
ago. O O
When O O
asked O O
where O O
the O O
pain O O
was O O
he O O
put O O
his O O
hand O O
over O O
this O O
mid-epigastrium O O
and O O
stated O O
that O O
the O O
pain O O
was O O
very O O
similar O O
to O O
the O O
pain O O
he O O
used O O
to O O
have O O
prior O O
to O O
his O O
angioplasty. O O
He O O
took O O
two O O
sublingual O O
nitroglycerins B-MEDICATION O
and O O
the O O
pain O O
was O O
relieved O O
within O O
a O O
few O O
minutes O O
of O O
the O O
second O O
nitroglycerin O B-MEDICATION
tablet. O O
At O O
the O O
time O O
he O O
was O O
just O O
sitting O O
on O O
his O O
couch O O
watching O O
television. O O
He O O
has O O
no O O
history O O
of O O
exertional O O
angina O O
over O O
the O O
last O O
several O O
years. O O
However, O O
this O O
complaint O O
of O O
chest O O
pain O O
at O O
rest O O
is O O
very O O
worrisome O O
for O O
unstable O O
angina. O O
He O O
currently O O
does O O
not O O
complain O O
of O O
any O O
shortness O O
of O O
breath, O O
dyspnea O O
on O O
exertion, O O
palpitation, O O
or O O
pre-syncope. O O
On O O
physical O O
examination O O
Mr. O O
Orta O O
is O O
a O O
middle-aged O O
black O O
male O O
in O O
no O O
apparent O O
distress. O O
Temperature O O
was O O
afebrile. O O
Heart O O
rate O O
was O O
68 O O
and O O
regular. O O
Blood O O
pressure O O
was O O
126/92 O O
in O O
the O O
right O O
arm O O
in O O
a O O
sitting O O
position. O O
HEENT O O
was O O
within O O
normal O O
limits. O O
Lungs O O
were O O
clear O O
bilaterally. O O
Heart O O
exam O O
was O O
regular O O
rate O O
and O O
rhythm O O
with O O
no O O
murmurs, O O
rubs, O O
or O O
gallops. O O
Abdomen O O
was O O
benign. O O
Extremities O O
were O O
without O O
edema O O
or O O
lesions. O O
MHC O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
Orta, O O
Phil O O
Page O O
2 O O
55931516 O O
8-02-73 O O
Assessment O O
and O O
Plan: O O
1. O O
Cardiovascular. O O
Patient O O
clearly O O
has O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
given O O
his O O
past O O
history O O
of O O
angioplasty O O
and O O
his O O
recent O O
complaint O O
of O O
chest O O
pain O O
at O O
rest O O
is O O
worrisome O O
for O O
unstable O O
angina. O O
Given O O
that O O
he O O
is O O
on O O
no O O
current O O
cardiac O O
medication O O
except O O
for O O
aspirin, O B-MEDICATION
I O O
will O O
decide O O
to O O
initiate B-MEDICATION O
therapy I-MEDICATION O
with I-MEDICATION O
diltiazem I-MEDICATION O
CD O O
120mg O O
PO O O
q.d. O O
in O O
an O O
attempt O O
to O O
control O O
his O O
blood O O
pressure O O
and O O
heart O O
rate. O O
I O O
also O O
encouraged O O
him O O
to O O
continue O O
his O O
aspirin O B-MEDICATION
daily O O
and O O
gave O O
him O O
a O O
fresh O O
bottle O O
of O O
nitroglycerin O B-MEDICATION
tablets O O
for O O
use O O
with O O
any O O
chest O O
pain O O
in O O
the O O
near O O
future. O O
The O O
plan O O
will O O
be O O
to O O
get O O
the O O
patient O O
on O O
stable O O
dose O O
of O O
diltiazem O O
and O O
maximize O O
the O O
dose O O
for O O
his O O
heart O O
and O O
blood O O
pressure O O
control. O O
After O O
he O O
has O O
been O O
on O O
a O O
stable O O
dose O O
for O O
several O O
days, O O
we O O
will O O
perform O O
an O O
outpatient O O
stress O O
test O O
to O O
evaluate O O
whether O O
the O O
patient O O
has O O
any O O
evidence O O
of O O
ischemia O O
at O O
this O O
time. O O
If O O
he O O
does, O O
we O O
will O O
recommend O O
a O O
cardiac O O
catheterization O O
to O O
treat O O
any O O
potential O O
lesions O O
which O O
may O O
be O O
causing O O
syms O O
of O O
rest O O
angina. O O
The O O
case O O
was O O
discussed O O
with O O
any O O
cardiacs O O
that O O
are O O
on O O
call. O O
2. O O
Given O O
the O O
patient's O O
history O O
of O O
coronary O O
artery O O
disease O O
I O O
sent O O
an O O
SMA-20 O O
level O O
off O O
to O O
assess O O
for O O
hypercholesterolemia B-HYPERLIPIDEMIA O
which O O
he O O
does O O
have O O
with O O
a O O
cholesterol B-HYPERLIPIDEMIA O
of I-HYPERLIPIDEMIA O
291 I-HYPERLIPIDEMIA O
and O O
hypertriglyceridemia O O
which O O
he O O
also O O
has O O
at O O
a O O
level O O
of O O
336. O O
He O O
has O O
been O O
taking O O
gemfibrozil O O
and O O
niacin O O
in O O
the O O
past; O O
however, O O
he O O
has O O
not O O
been O O
taking O O
it O O
for O O
the O O
last O O
year. O O
I O O
instructed O O
him O O
to O O
decrease O O
the O O
amount O O
of O O
cholesterol O O
and O O
fats O O
in O O
his O O
diet O O
and O O
explained O O
which O O
food O O
contain O O
those O O
products. O O
I O O
will O O
also O O
initiate O O
treatment O O
with O O
a O O
HMG O O
CoA O O
inhibitor O O
which O O
should O O
decrease O O
both O O
his O O
cholesterol O O
as O O
well O O
as O O
the O O
triglycerides. O O
We O O
will O O
start B-MEDICATION O
him I-MEDICATION O
off I-MEDICATION O
on I-MEDICATION O
simvastatin B-MEDICATION B-MEDICATION
20mg O O
PO O O
q.d. O O
later O O
this O O
week. O O
3. O O
Daily O O
anxiety. O O
Will O O
continue O O
the O O
patient's O O
Ativan O O
in O O
an O O
attempt O O
to O O
control O O
his O O
daily O O
anxiety O O
which O O
he O O
says O O
is O O
well O O
controlled O O
without O O
Ativan. O O
4. O O
History O O
of O O
condyloma O O
in O O
his O O
genital O O
area O O
from O O
last O O
year. O O
Patient O O
states O O
that O O
he O O
currently O O
has O O
several O O
lesions O O
which O O
we O O
will O O
examine O O
on O O
his O O
next O O
visit. O O
If O O
he O O
does, O O
we O O
will O O
refer O O
him O O
to O O
dermatology O O
for O O
liquid O O
nitrogen O O
treatment O O
to O O
remove O O
the O O
lesions. O O
MHC O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
Orta, O O
Phil O O
Page O O
3 O O
55931516 O O
8-02-73 O O
5. O O
Patient O O
is O O
now O O
applying O O
for O O
free O O
care O O
at O O
Mamaroneck O B-MEDICATION
Health O O
Center O O
status O O
post O O
losing O O
his O O
job O O
and O O
LBH O O
insurance O O
last O O
year. O O
The O O
patient's O O
home O O
phone O O
number O O
is O O
534-3442. O O
_________________________ O O
Oscar O O
Allen, O O
M.D. O O
LF:XS:4181 O O
DD:8-06-73 O O
DT:8-07-73 O O
DV:8-02-73 O O

Record O O
date: O O
2080-07-19 O O
MHC O O
EMERGENCY O O
DEPT O O
VISIT O O
ORTA,PHIL O O
F. O O
559-31-51-6 O O
VISIT O O
DATE: O O
07/19/80 O O
The O O
patient O O
was O O
interviewed O O
and O O
examined O O
by O O
myself, O O
Dr. O O
Palmer, O O
and O O
the O O
resident. O O
Please O O
see O O
note O O
for O O
full O O
details. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
57 O O
year O O
old O O
gentleman O O
with O O
history O O
of O O
hypertension, B-HYPERTENSION B-HYPERTENSION
high B-HYPERLIPIDEMIA O
cholesterol, I-HYPERLIPIDEMIA O
and O O
angina B-CAD O
in O O
the O O
past, O O
comes O O
in O O
today O O
with O O
increasing O O
use O O
of O O
nitroglycerins B-CAD B-MEDICATION
and O O
chest O O
pain, O O
light O O
headedness O O
and O O
diaphoresis O O
after O O
exerting O O
himself O O
this O O
afternoon. O O
He O O
took O O
two O O
of O O
the O O
sublingual O O
nitros O B-MEDICATION
with O O
gradual O O
improvement O O
and O O
gradually O O
became O O
chest O O
pain O O
free. O O
EMS O O
gave O O
him O O
aspirin. B-MEDICATION B-MEDICATION
Of O O
note, O O
he O O
has O O
had O O
two O O
episodes O O
of O O
chest O O
pain O O
over O O
the O O
last O O
few O O
day. O O
REVIEW O O
OF O O
SYSTEMS: O O
Negative O O
for O O
shortness O O
of O O
breath O O
or O O
chest O O
pain O O
currently. O O
PAST O O
MEDICAL O O
HISTORY: O O
Myocardial B-CAD O
infarction I-CAD O
in I-CAD O
2063, I-CAD O
and O O
apparently B-CAD O
had I-CAD O
PTCA B-CAD O
and I-CAD O
cath. I-CAD O
Status O O
post O O
back O O
surgery. O O
MEDICATIONS: O O
Zocor, B-MEDICATION B-MEDICATION
Lisinopril, B-MEDICATION B-MEDICATION
aspirin O B-MEDICATION
and O O
Zoloft. O O
ALLERGIES: O O
Sulfa. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
Past B-SMOKER O
tobacco. I-SMOKER O
Family O O
history O O
is O O
positive O O
for O O
coronary B-CAD O
artery I-CAD O
disease. I-CAD O
PHYSICAL O O
EXAMINATION: O O
Alert O O
and O O
awake O O
gentleman, O O
no O O
apparent O O
distress, O O
obese. B-OBESE O
Temperature O O
97, O O
pulse O O
81, O O
respiratory O O
rate O O
18, O O
blood O O
pressure O O
112/56, O O
02 O O
sat O O
100% O O
on O O
room O O
air. O O
Physical O O
examination O O
continued, O O
clear O O
lungs. O O
Heart O O
is O O
regular O O
rate O O
and O O
rhythm. O O
Soft O O
abdomen, O O
although O O
obese. O O
Neuro O O
is O O
alert O O
and O O
oriented O O
X3. O O
No O O
obvious O O
cranial, O O
motor O O
or O O
sensory O O
deficits. O O
LABORATORY O O
EVALUATION: O O
CK O O
in O O
the O O
625, O O
MB O O
fraction O O
11.2, O O
and O O
troponin O O
0.02, O O
this O O
could O O
be O O
on O O
the O O
rise. O O
His O O
electrocardiogram O O
was O O
85, O O
with O O
Q O O
waves O O
in O O
3 O O
and O O
F, O O
and O O
T O O
wave O O
inversions O O
in O O
2 O O
and O O
F, O O
as O O
well O O
as O O
flattening O O
in O O
V4 O O
through O O
V6. O O
Chest O O
x-ray O O
showed O O
no O O
congestive O O
heart O O
failure O O
but O O
an O O
elevated O O
right O O
hemidiaphragm. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
In O O
the O O
emergency O O
room O O
he O O
is O O
treated O O
with O O
a O O
full O O
dose O O
of O O
aspirin O B-MEDICATION
even O O
though O O
he O O
was O O
chest O O
pain O O
free O O
on O O
arrival. O O
FINAL O O
DIAGNOSIS: O O
Unstable B-CAD O
angina. I-CAD O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
He O O
is O O
admitted O O
to O O
the O O
hospital O O
in O O
stable O O
condition. O O
___________________________________ O O
EO166/60228 O O
RUTH O O
R. O O
PALMER, O O
M.D. O O
RP11 O O
D:07/19/80 O O
T:07/20/80 O O
Dictated O O
by: O O
RUTH O O
R. O O
PALMER, O O
M.D. O O
RP11 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2081-04-21 O O
58 O O
yo O O
male O O
here O O
for O O
f/u O O
of O O
his O O
various O O
medical O O
issues: O O
1)CV: O O
admitted O O
2/81 O O
w/atypical O O
CP O O
(similar O O
admission O O
in O O
recent O O
past). O O
Ruled O O
out. O O
MIBI O O
w/small O O
fixed O O
defect O O
ant/lat O O
wall. O O
EF O O
61% O O
w/out O O
WMA. O O
Statin B-MEDICATION O
changed I-MEDICATION O
to I-MEDICATION O
Zetia B-MEDICATION O
for O O
elevated O O
CK O O
(2412). O O
Last O O
lipid O O
panel O O
3/17 O O
chol O O
184, O O
trig O O
281, O O
HDL O O
31, O O
LDL O O
97, O O
VLDL O O
56. O O
Also O O
continues O O
on O O
Plavix B-MEDICATION B-MEDICATION
and O O
ASA B-MEDICATION B-MEDICATION
(for O O
prior O O
stroke), O O
lisinopril. B-MEDICATION B-MEDICATION
Will O O
recheck O O
CK O O
and O O
lipid O O
panel. O O
2) O O
Neuro: O O
CT O O
2080 O O
old O O
infarct O O
R O O
caudate O O
region. O O
MRI O O
confirmed O O
R O O
caudate O O
lesion, O O
other O O
small O O
vessel O O
dz O O
(small O O
foci O O
infarcts O O
basal O O
ganglia, O O
few O O
foci O O
increased O O
signal O O
intestity O O
subcortical O O
white O O
matter.) O O
Neuro O O
testing O O
recently O O
showed O O
mild O O
deficits O O
in O O
attention, O O
processing; O O
intellectual O O
capacity O O
superior O O
range. O O
Per O O
Dr. O O
Sims O O
(stroke O O
clinic), O O
lesions O O
on O O
imaging O O
could O O
explain O O
memory O O
problems O O
and O O
slurred O O
speech. O O
Pt O O
continuing O O
on O O
ASA O O
and O O
Plavix. O O
Also O O
Zetia O O
as O O
above. O O
3) O O
Depresion: O O
Pt O O
continues O O
on O O
100 O O
Zoloft O O
(had O O
incr O O
to O O
200 O O
per O O
pt O O
request O O
but O O
made O O
him O O
'feel O O
funny'). O O
Pt O O
referred O O
to O O
psych, O O
upcoming O O
appt. O O
Ambien O O
QHS. O O
3) O O
LFT's: O O
Isoloated O O
Elevated O O
AST O O
(3/18 O O
193, O O
3/17 O O
62). O O
Will O O
check O O
hep O O
C. O O
and O O
recheck O O
LFT's. O O
4) O O
Pilonidal O O
cyst: O O
see O O
separate O O
note O O
dated O O
today. O O
5) O O
Health O O
maintenance: O O
Lipids: O O
see O O
above. O O
Sigmoidoscopy O O
1/20 O O
normal O O
6) O O
HTN: B-HYPERTENSION O
stable. O O
Continue O O
lisinopril O B-MEDICATION
_____________________________________________ O O
Quiana O O
Lou O O
Qu, O O
M.D. O O

Record O O
date: O O
2082-08-19 O O
EDVISIT^55931516^Orta, O O
Phil^08/19/82^IP, O O
INDIGO O O
JOHN O O
The O O
patient O O
was O O
interviewed O O
and O O
examined O O
by O O
the O O
resident. O O
He O O
was O O
also O O
interviewed O O
and O O
examined O O
by O O
me. O O
Resident's O O
note O O
reviewed O O
by O O
me. O O
The O O
patient's O O
medical O O
management O O
was O O
discussed O O
with O O
the O O
resident. O O
CHIEF O O
COMPLAINT: O O
Chest O O
pain. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
59-year-old O O
male O O
who O O
presents O O
to O O
Mamaroneck O O
Health O O
Emergency O O
Department O O
on O O
08/19/2082. O O
He O O
has O O
history B-CAD O
of I-CAD O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
and O O
status O O
post O O
cardiac O O
catheterization O O
in O O
2062, O O
now O O
presents O O
with O O
dyspnea O O
on O O
exertion O O
worsening O O
during O O
throughout O O
this O O
week. O O
No O O
PND, O O
no O O
pedal O O
edema, O O
no O O
fevers O O
or O O
chills, O O
no O O
nausea O O
or O O
vomiting, O O
no O O
chest O O
pain, O O
no O O
dysuria, O O
no O O
dyspnea O O
at O O
rest, O O
and O O
no O O
pleuritic O O
chest O O
pain. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension B-HYPERTENSION B-HYPERTENSION
and O O
coronary O O
disease; O O
has O O
had O O
a O O
negative O O
stress O O
test O O
in O O
2080. O O
SOCIAL O O
HISTORY: O O
Past B-SMOKER O
tobacco I-SMOKER O
use, I-SMOKER O
occasional O O
ETOH, O O
no O O
IV O O
drug O O
abuse. O O
He O O
is O O
unemployed O O
and O O
lives O O
alone. O O
SURGICAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
Noncontributory. O O
REVIEW O O
OF O O
SYSTEMS, O O
MEDICATIONS, O O
AND O O
ALLERGIES: O O
As O O
noted O O
in O O
the O O
patient's O O
chart. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
awake O O
and O O
alert, O O
in O O
no O O
acute O O
distress. O O
Temperature O O
97, O O
pulse O O
63, O O
respiratory O O
rate O O
20, O O
blood O O
pressure O O
134/64, O O
and O O
O2 O O
sat O O
98% O O
on O O
room O O
air. O O
HEENT: O O
Atraumatic. O O
ENT, O O
normal O O
inspection. O O
Pharynx O O
is O O
normal. O O
Neck O O
is O O
supple O O
and O O
nontender. O O
Respiratory O O
exam: O O
Chest O O
wall O O
is O O
nontender, O O
normal O O
breath O O
sounds O O
bilaterally. O O
Cardiac O O
exam: O O
Regular O O
rate O O
and O O
rhythm, O O
no O O
murmur, O O
normal O O
pulses O O
throughout. O O
Abdomen O O
is O O
soft O O
and O O
nontender. O O
Skin O O
is O O
warm, O O
dry, O O
and O O
intact. O O
No O O
lesions O O
or O O
rashes. O O
Extremities O O
are O O
nontender. O O
No O O
clubbing, O O
cyanosis, O O
or O O
edema. O O
Neurologic O O
exam: O O
Cranial O O
nerves O O
II-XII O O
intact O O
bilaterally. O O
No O O
motor O O
or O O
sensory O O
deficits. O O
The O O
patient O O
has O O
a O O
foot O O
drop O O
on O O
the O O
left. O O
LABORATORY O O
DATA: O O
Significant O O
for O O
white O O
count O O
of O O
6.3, O O
hematocrit O O
39.9, O O
sodium O O
136, O O
potassium O O
4.9, O O
chloride O O
102, O O
bicarbonate O O
26, O O
BUN O O
17, O O
creatinine O O
1.1, O O
and O O
glucose O O
is O O
73. O O
First O O
troponin O O
is O O
less O O
than O O
assay. O O
The O O
patient O O
has O O
a O O
CK O O
of O O
1028; O O
has O O
persistent O O
elevated O O
high O O
CKs. O O
UA O O
is O O
negative. O O
Urine O O
tox O O
negative. O O
EKG O O
shows O O
first-degree O O
AV O O
block, O O
sinus O O
rhythm, O O
otherwise O O
no O O
acute O O
ST-T O O
wave O O
changes. O O
Chest O O
x-ray O O
is O O
negative. O O
PRIMARY O O
DIAGNOSIS: O O
Dyspnea O O
on O O
exertion, O O
concern O O
for O O
this O O
being O O
a O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
history. I-CAD O
DISPOSITION: O O
The O O
patient O O
is O O
being O O
admitted O O
to O O
ED O O
Observation O O
for O O
rule O O
out O O
MI O O
by O O
enzymes O O
and O O
for O O
exercise O O
stress O O
test. O O
I O O
reviewed O O
and O O
confirmed O O
the O O
findings O O
with O O
Dr. O O
Irizarry O O
who O O
is O O
the O O
resident O O
taking O O
care O O
of O O
the O O
patient O O
with O O
me. O O
______________________________ O O
IP, O O
INDIGO O O
JOHN O O
M.D. O O
D: O O
08/19/82 O O
T: O O
08/19/82 O O
Dictated O O
By: O O
IP, O O
INDIGO O O
JOHN O O
eScription O O
document:2-6098361 O O
BFFocus O O

Record O O
date: O O
2065-06-28 O O
Chief O O
Complaint O O
The O O
patient O O
presents O O
for O O
ongoing O O
care O O
of O O
her O O
diabetes B-DIABETES O
and O O
leg O O
pain. O O
History O O
of O O
Present O O
Illness O O
Ms O O
Barrera O O
is O O
an O O
85 O O
yo O O
woman O O
accompanied O O
by O O
her O O
daughter, O O
Uhura. O O
She O O
has O O
a O O
h/o O O
DM, B-DIABETES O
HTN, B-HYPERTENSION O
GERD, O O
LBP O O
and O O
CAD. B-CAD O
She O O
was O O
formerly O O
followed O O
by O O
Dr. O O
Laura O O
Link O O
and O O
is O O
transferring O O
her O O
care. O O
She O O
has O O
not O O
had O O
any O O
CP O O
or O O
SOB O O
-- O O
her B-CAD O
ETT I-CAD O
MIBI I-CAD O
in I-CAD O
2062 I-CAD O
revealed I-CAD O
mild B-CAD O
ischemia I-CAD O
in I-CAD O
the I-CAD O
inferior I-CAD O
wall I-CAD O
and I-CAD O
EF I-CAD O
of I-CAD O
63%. I-CAD O
She O O
has O O
had O O
not O O
diabetic O O
complications. O O
Her O O
last O O
A1C O O
was O O
5.9 O O
in O O
February. O O
She O O
reports O O
significant O O
R&gt;L O O
LE O O
pain O O
that O O
limits O O
her O O
mobilitiy. O O
This O O
has O O
been O O
ongoing O O
for O O
some O O
time O O
but O O
is O O
getting O O
worse. O O
No O O
pain O O
at O O
rest; O O
only O O
with O O
walking. O O
She O O
rarely O O
takes O O
anything O O
for O O
the O O
pain. O O
She O O
wonders O O
if O O
she O O
needs O O
to O O
monitor O O
her O O
glucose. O O
PMH O O
as O O
above. O O
Habits: O O
no O O
exercise. O O
No B-SMOKER O
tobacco I-SMOKER O
or O O
EtOH O O
FH O O
non O O
contributory O O
SH: O O
lives O O
alone O O
in O O
an O O
apartment O O
in O O
a O O
senior O O
home. O O
Daughter O O
involved O O
in O O
her O O
care. O O
Medications O O
ECASA B-MEDICATION B-MEDICATION
325MG O O
PO O O
QD O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG O O
PO O O
QD O O
GLYBURIDE B-MEDICATION B-MEDICATION
2.5MG O O
PO O O
QD O O
HCTZ B-MEDICATION B-MEDICATION
50MG O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
20MG O O
PO O O
QD O O
ZOCOR B-MEDICATION B-MEDICATION
20MG O O
PO O O
QHS O O
KCL O O
IMMEDIATE O O
REL. O O
10MEQ O O
2 O O
Capsule(s) O O
PO O O
QD O O
NORVASC B-MEDICATION B-MEDICATION
(AMLODIPINE) O O
5MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
OSCAL+D O O
(CALCIUM O O
CARBONATE O O
+ O O
VIT O O
D(1TABLE... O O
PO O O
BID O O
TYLENOL O O
(ACETAMINOPHEN) O O
500MG O O
1 O O
Capsule(s) O O
PO O O
Q4H O O
Physical O O
Exam O O
WDWN O O
F, O O
NAD O O
153# O O
R O O
160/70 B-HYPERTENSION O
L154/70 B-HYPERTENSION O
P64 O O
R12 O O
Chest: O O
CTA/P O O
Cor: O O
RRR, O O
S1, O O
S2, O O
No O O
MRG O O
Abd: O O
Soft, O O
NT. O O
+BS. O O
No O O
HSM O O
Ext: O O
No O O
C/C/E; O O
no O O
focal O O
tenderness; O O
B/L O O
lateral O O
thigh O O
pain O O
with O O
internal O O
rotation O O
of O O
hips. O O
Assessment O O
1. O O
DM O O
- O O
well-controlled. O O
check O O
A1C. O O
On O O
ace-i. O O
up O O
to O O
date O O
with O O
optho O O
and O O
podiatry; O O
no O O
indication O O
for O O
home O O
BS O O
monitoring O O
at O O
this O O
time. O O
2. O O
HTN O O
- O O
will O O
increase O O
lisinopril O B-MEDICATION
from O O
10 O O
to O O
20 O O
mg O O
qd; O O
check O O
lytes O O
3. O O
Hip O O
pain O O
- O O
likely O O
OA. O O
will O O
obtain O O
hip O O
films O O
and O O
prescribe O O
tylenol O O
500mg O O
q6hrs O O
prn. O O
4. O O
constipation O O
- O O
using O O
senekot O O
and O O
metamucil O O
with O O
good O O
results. O O
5. O O
Lipids O O
- O O
LDL O O
59, O O
HDL O O
37 O O
in O O
February. O O
Continue O O
zocor. B-MEDICATION O
6. O O
HCM-UTD. O O
The O O
patient O O
will O O
f/u O O
with O O
me O O
in O O
12-16 O O
weeks, O O
or O O
sooner O O
prn. O O
______________________________ O O
Xenakis, O O
Tracy O O
T., O O
M.D. O O

Record B-SMOKER O
date: O O
2066-02-12 O O
Patient O O
Name: O O
BARRERA,MARY O O
[ O O
MRN: O O
45167459SLO O O
] O O
Date O O
of O O
Visit: O O
02/12/2066 O O
Chief O O
Complaint O O
The O O
patient O O
presents O O
for O O
care O O
of O O
pain O O
in O O
her O O
legs. O O
History O O
of O O
Present O O
Illness O O
86F O O
reports O O
worsening O O
b/l O O
leg O O
pain. O O
Pain O O
only O O
occurs O O
when O O
she O O
walks. O O
No O O
trauma. O O
No O O
pain O O
at O O
rest. O O
Pain O O
is O O
in O O
both O O
legs O O
and O O
can't O O
be O O
localized O O
to O O
any O O
specific O O
part O O
of O O
her O O
leg. O O
No O O
pain O O
when O O
lying O O
down. O O
She O O
takes O O
tylenol O O
bid O O
which O O
helps O O
somewhat, O O
but O O
is O O
now O O
less O O
effective O O
than O O
previously. O O
No O O
problems O O
with O O
medications. O O
No O O
CP O O
or O O
new O O
numbness O O
or O O
weakness. O O
No O O
problems O O
with O O
GERD. O O
No O O
new O O
muscle O O
pain. O O
No O O
symptoms O O
of O O
hypo- O O
or O O
hyperglycemia. O O
Pt O O
recently O O
had O O
brain O O
MRI O O
ordered O O
by O O
ophtho O O
for O O
? O O
R O O
hemianonymous O O
hemianopsia. O O
MRI O O
revealed O O
multiple O O
lacunes. O O
Medications O O
ECASA B-MEDICATION B-MEDICATION
325MG O O
PO O O
QD O O
ZOCOR B-MEDICATION O
20MG O O
PO O O
QHS O O
TYLENOL O O
(ACETAMINOPHEN) O O
500MG O O
1 O O
Capsule(s) O O
PO O O
Q4H O O
OSCAL+D O O
(CALCIUM O O
CARBONATE O O
+ O O
VIT O O
D(1TABLE... O O
500MG O O
PO O O
BID O O
KCL O O
SLOW O O
REL. O O
10MEQ O O
2 O O
Tablet(s) O O
PO O O
QD O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG O O
PO O O
QD O O
GLYBURIDE B-DIABETES B-MEDICATION
2.5MG O O
PO O O
QD O O
HCTZ B-MEDICATION O
50MG O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
40MG O O
PO O O
QD O O
NORVASC B-MEDICATION B-MEDICATION
(AMLODIPINE) O O
10MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
Physical O O
Exam O O
WDWN O O
elderly O O
F, O O
NAD O O
175/70 B-HYPERTENSION O
P64 O O
R12 O O
153# O O
Chest: O O
CTA/P O O
Cor: O O
RRR, O O
S1, O O
S2, O O
No O O
MRG O O
Abd: O O
Soft, O O
NT. O O
+BS. O O
No O O
HSM O O
Ext: O O
No O O
C/C/E; O O
FROM; O O
SLR O O
negative O O
bilaterally; O O
no O O
focal O O
tenderness; O O
no O O
knee O O
or O O
hip O O
pain. O O
Assessment O O
1. O O
AODM B-DIABETES O
- O O
last O O
A1C=5.3; O O
will O O
recheck O O
today, O O
but O O
d/c B-MEDICATION O
glyburide B-MEDICATION O
2. O O
HTN B-HYPERTENSION O
- O O
increase O O
lisinopril O B-MEDICATION
to O O
40 O O
mg O O
and O O
norvasc O B-MEDICATION
to O O
10; O O
check O O
chem O O
3. O O
OA O O
- O O
vioxx O O
12.5 O O
qd O O
with O O
tylenol O O
bid O O
prn. O O
4. O O
Multiple O O
lacunes O O
- O O
control O O
htn O O
5. O O
CAD, B-CAD O
PVD O O
and O O
hiatal O O
hernia O O
- O O
stable O O
The O O
patient O O
will O O
f/u O O
with O O
me O O
in O O
3 O O
mos, O O
or O O
sooner O O
prn. O O
______________________________ O O
Tracy O O
T. O O
Xenakis, O O
M.D. O O

Record B-SMOKER O
date: O O
2068-04-06 O O
Patient O O
Name: O O
BARRERA,MARY O O
U O O
[ O O
45167459(SLO) O O
] O O
Date O O
of O O
Visit: O O
04/06/2068 O O
Chief O O
Complaint O O
The O O
patient O O
presents O O
for O O
care O O
of O O
recent O O
fall, O O
HTN, B-HYPERTENSION O
DM B-DIABETES O
and O O
hyperlipidemia. B-HYPERLIPIDEMIA O
History O O
of O O
Present O O
Illness O O
88F O O
with O O
CAD, B-CAD O
DM, O O
HTN, O O
hyperlipidemia O O
and O O
LE O O
pain. O O
Not O O
seen O O
in O O
~10 O O
mos. O O
Feels O O
generally O O
well O O
until O O
fall O O
6d O O
ago. O O
Pt O O
unclear O O
as O O
to O O
reasons O O
of O O
fall O O
but O O
confident O O
that O O
she O O
didn't O O
blackout O O
or O O
feel O O
faint. O O
Pt O O
thinks O O
she O O
may O O
have O O
slipped. O O
was O O
not O O
using O O
walker O O
at O O
home. O O
was O O
able O O
to O O
get O O
up O O
immediately O O
afterwards O O
and O O
felt O O
fine O O
until O O
soreness O O
set O O
in O O
the O O
next O O
AM. O O
She O O
now O O
reports O O
improving O O
bruise O O
on O O
her O O
head, O O
LBP O O
and O O
L O O
toe O O
pain. O O
Pt O O
lives O O
in O O
assisted O O
living O O
facility O O
where O O
meals O O
are O O
prepared O O
for O O
her, O O
etc. O O
Pt O O
does O O
c/o O O
R O O
sided O O
hip O O
and O O
leg O O
pain O O
that O O
worsens O O
when O O
she O O
walks. O O
No O O
LE O O
swelling. O O
No O O
numbness O O
or O O
weakness. O O
Reports O O
taking O O
all O O
the O O
meds O O
she's O O
been O O
prescribed O O
but O O
doesn't O O
know O O
names. O O
Medications O O
ATENOLOL B-MEDICATION B-MEDICATION
100 O O
MG O O
PO O O
QD O O
HCTZ B-MEDICATION B-MEDICATION
50 O O
MG O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
40 O O
MG O O
PO O O
QD O O
ZOCOR B-MEDICATION B-MEDICATION
20 O O
MG O O
PO O O
QHS O O
Norvasc B-MEDICATION B-MEDICATION
(AMLODIPINE) O O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Oscal+d O O
(CALCIUM O O
Carbonate O O
+ O O
Vit O O
D(1TABLE... O O
500 O O
MG O O
PO O O
BID O O
Tylenol O O
(ACETAMINOPHEN) O O
500MG O O
CAPSULE O O
take O O
1 O O
Capsule(s) O O
PO O O
Q4H O O
PRN O O
knee O O
pain O O
Kcl O O
Slow O O
Rel. O O
10MEQ O O
TABLET O O
CR O O
take O O
2 O O
Tablet(s) O O
PO O O
QD O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
Acid) O O
81MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Physical O O
Exam O O
WDWN O O
frail O O
F, O O
NAD O O
157# O O
114/64 O O
P72 O O
R12 O O
HEENT: O O
NC. O O
1 O O
cm O O
hematoma O O
on O O
occiput; O O
slightly O O
tender. O O
Chest: O O
CTA/P O O
Back: O O
no O O
focal O O
tenderness; O O
SLR O O
slightly O O
positive O O
on O O
R O O
Cor: O O
RRR, O O
S1, O O
S2, O O
No O O
MRG O O
Abd: O O
Soft, O O
NT. O O
+BS. O O
No O O
HSM O O
Ext: O O
No O O
C/C/E; O O
reflexes O O
trace O O
or O O
absent O O
bilaterally O O
Romberg O O
positive O O
Assessment O O
1. O O
s/p O O
fall O O
- O O
likely O O
due O O
to O O
mechanical O O
fall, O O
possibly O O
due O O
to O O
deconditioning, O O
weakness O O
and O O
poor O O
balance. O O
will O O
ask O O
PT O O
to O O
do O O
home O O
safety O O
eval O O
and O O
make O O
recommendations O O
2. O O
R O O
hip/leg O O
pain O O
- O O
likely O O
sciatica O O
and/or O O
hip O O
OA. O O
check O O
L/S O O
films O O
to O O
r/o O O
compression O O
fx O O
and O O
hip O O
films; O O
refer O O
for O O
home O O
PT O O
3. O O
DM O O
- O O
check O O
A1C O O
and O O
chem O O
panel O O
4. O O
HTN O O
- O O
check O O
chem O O
panel O O
5. O O
Lipids O O
- O O
check O O
lipids O O
6. O O
Med O O
adherence O O
- O O
pt O O
to O O
bring O O
in O O
meds O O
to O O
all O O
visits. O O
The O O
patient O O
will O O
f/u O O
with O O
me O O
in O O
6-8 O O
weeks, O O
or O O
sooner O O
prn. O O
______________________________ O O
Tracy O O
T. O O
Xenakis, O O
M.D. O O

Record O O
date: O O
2089-04-13 O O
April O O
13, O O
2089 O O
Quadarius O O
Kirk, O O
M.D. O O
Carrizoza O O
Health O O
Center O O
531 O O
Westfield O O
St O O
Clifton O O
Forge, O O
WI O O
11674 O O
RE: O O
Parrish, O O
Christopher O O
SFC#: O O
553-15-48 O O
Dear O O
Dr. O O
Kirk: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
your O O
patient, O O
Christopher O O
Parrish, O O
in O O
follow O O
up O O
today. O O
He O O
is O O
a O O
71-year-old, O O
right-handed O O
man O O
who O O
was O O
admitted O O
to O O
the O O
Sutton O O
Family O O
Care O O
on O O
December O O
29, O O
2088 O O
with O O
left O O
arm O O
weakness, O O
ataxia O O
and O O
dysarthria. O O
The O O
impression O O
at O O
that O O
time O O
was O O
for O O
lacunar O O
stroke. O O
An O O
MRI O O
showed O O
a O O
larger O O
area O O
of O O
infarct O O
in O O
the O O
right O O
corona O O
radiata. O O
The O O
patient O O
had O O
worsening O O
weakness O O
on O O
the O O
night O O
of O O
admission, O O
despite O O
being O O
heparinized. O O
The O O
following O O
day, O O
he O O
had O O
a O O
flaccid O O
hemiparesis O O
of O O
the O O
left O O
side. O O
Further O O
workup O O
included O O
a O O
magnetic O O
resonance O O
angiogram O O
that O O
showed O O
irregularity O O
of O O
the O O
proximal O O
middle O O
cerebral O O
arteries O O
bilaterally. O O
There O O
was O O
no O O
critical O O
carotid O O
stenosis. O O
He O O
had O O
an O O
embolic O O
workup O O
which O O
consisted O O
of O O
an O O
echocardiogram O O
showing O O
a O O
preserved O O
ejection O O
fraction, O O
dilated O O
left O O
atrium, O O
very O O
mild O O
inferior O O
hypokinesis, O O
and O O
no O O
patent O O
foramen O O
ovale. O O
He O O
had O O
a O O
Holter O O
monitor O O
which O O
did O O
not O O
reveal O O
any O O
dysrhythmias. O O
His O O
cholesterol O O
level O O
was O O
152 O O
with O O
an O O
HDL O O
of O O
23. O O
It O O
was O O
felt O O
that O O
his O O
stroke O O
was O O
most O O
likely O O
due O O
to O O
atherosclerosis O O
of O O
the O O
middle O O
cerebral O O
artery, O O
involving O O
either O O
one O O
or O O
possibly O O
several O O
lenticulostriate O O
arteries. O O
He O O
did O O
not O O
have O O
any O O
evidence O O
of O O
a O O
flow O O
limiting O O
MCA O O
stenosis. O O
He O O
had O O
been O O
on O O
aspirin B-MEDICATION B-MEDICATION
prior, O O
Plavix B-MEDICATION B-MEDICATION
was O O
added O O
to O O
his O O
regimen. O O
Since O O
his O O
discharge O O
from O O
the O O
hospital, O O
he O O
has O O
been O O
in O O
rehabilitation O O
for O O
the O O
last O O
two O O
months. O O
He O O
has O O
had O O
no O O
further O O
episodes O O
of O O
weakness, O O
numbness, O O
tingling, O O
ataxia, O O
dysarthria, O O
or O O
dysphagia. O O
He O O
has O O
no O O
symptoms O O
of O O
aphasia. O O
He O O
has O O
been O O
left O O
with O O
some O O
dysarthria O O
from O O
his O O
initial O O
event, O O
which O O
he O O
feels O O
has O O
improved. O O
I O O
would O O
agree O O
with O O
him. O O
He O O
also O O
has O O
regained O O
some O O
strength O O
in O O
the O O
left O O
leg, O O
and O O
is O O
currently O O
working O O
on O O
using O O
a O O
walker O O
with O O
assistance. O O
Unfortunately, O O
he O O
has O O
not O O
regained O O
any O O
use O O
of O O
the O O
left O O
arm. O O
He O O
has O O
not O O
had O O
any O O
problems O O
with O O
spasms. O O
His O O
past O O
medical O O
history O O
is O O
significant O O
for O O
hypertension B-HYPERTENSION B-HYPERTENSION
and O O
type B-DIABETES O
II I-DIABETES O
diabetes I-DIABETES O
mellitus. I-DIABETES O
He O O
had O O
an O O
inferior B-CAD O
myocardial I-CAD O
infarction I-CAD O
in I-CAD O
2060. I-CAD O
He O O
had O O
a O O
quadruple B-CAD O
bypass I-CAD O
in I-CAD O
2083. I-CAD O
His O O
last O O
stress B-CAD O
test I-CAD O
in I-CAD O
2087 I-CAD O
showed I-CAD O
moderate I-CAD O
inferolateral I-CAD O
ischemia I-CAD O
in O O
the O O
region O O
of O O
a O O
prior B-CAD O
myocardial I-CAD O
infarct. I-CAD O
He O O
has O O
pulmonary O O
disease O O
due O O
to O O
asbestosis. O O
He O O
has O O
chronic O O
renal O O
failure O O
and O O
neuropathy O O
secondary O O
to O O
his O O
diabetes. O O
He O O
has O O
also O O
had O O
laser O O
surgery O O
for O O
diabetic O O
retinopathy. O O
His O O
medications O O
currently O O
include O O
clonidine O O
.1 O O
mg. O O
p.o. O O
b.i.d., O O
Plavix O B-MEDICATION
75 O O
mg. O O
p.o. O O
q.d., O O
aspirin O B-MEDICATION
325 O O
mg. O O
p.o. O O
q.d., O O
Neurontin O O
300 O O
mg. O O
p.o. O O
q.h.s., O O
Gemfibrozil B-MEDICATION O
600 O O
mg. O O
p.o. O O
b.i.d., O O
Isordil B-MEDICATION O
and O O
Lasix. O O
He O O
had O O
been B-MEDICATION O
on I-MEDICATION O
Captopril I-MEDICATION B-MEDICATION
earlier, I-MEDICATION O
but O O
he O O
has O O
since O O
been O O
taken O O
off O O
that O O
medicine. O O
He O O
was O O
managed O O
with O O
insulin B-MEDICATION O
during O O
his O O
prior O O
admission. O O
I O O
assume O O
he O O
is O O
still O O
on O O
this O O
medicine, O O
although O O
he O O
did O O
not O O
specifically O O
state O O
so. O O
He O O
has O O
an O O
allergy O O
to O O
sulfa O O
drugs. O O
The O O
patient O O
lives O O
with O O
a O O
friend O O
who O O
works O O
at O O
Marble O O
Slab O O
Creamery. O O
The O O
patient O O
quit B-SMOKER O
smoking I-SMOKER O
15 I-SMOKER O
years I-SMOKER O
ago I-SMOKER O
and O O
only O O
rarely O O
drinks O O
alcohol O O
on O O
social O O
occasions. O O
There O O
is O O
a O O
history O O
of O O
coronary O O
artery O O
disease O O
in O O
his O O
father O O
and O O
at O O
least O O
one O O
of O O
his O O
brothers, O O
but O O
no O O
family O O
history O O
of O O
stroke. O O
On O O
examination, O O
he O O
was O O
a O O
pleasant O O
gentleman O O
in O O
no O O
apparent O O
distress. O O
His O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
was I-HYPERTENSION O
150/90. B-HYPERTENSION O
His O O
language O O
was O O
intact. O O
His O O
speech O O
was O O
somewhat O O
dysarthric, O O
although O O
this O O
was O O
improved O O
from O O
his O O
admission. O O
He O O
was O O
alert O O
and O O
oriented. O O
His O O
conversation O O
was O O
appropriate. O O
The O O
visual O O
fields O O
were O O
full. O O
The O O
pupils O O
were O O
equal O O
and O O
reactive O O
at O O
4 O O
mm. O O
Facial O O
sensation O O
was O O
normal. O O
There O O
was O O
an O O
upper O O
motor O O
neuron O O
left O O
facial O O
droop. O O
The O O
tongue O O
and O O
palate O O
were O O
midline. O O
The O O
patient O O
had O O
0/5 O O
flaccid O O
hemiplegia O O
of O O
the O O
left O O
arm. O O
There O O
was O O
atrophy O O
of O O
the O O
left O O
biceps. O O
There O O
was O O
full O O
range O O
of O O
motion O O
of O O
the O O
joints. O O
The O O
patient O O
had O O
2/5 O O
left O O
iliopsoas, O O
4+/5 O O
hip O O
extensors, O O
3/5 O O
left O O
quadriceps, O O
3/5 O O
left O O
ankle O O
dorsiflexors, O O
and O O
3/5 O O
ankle O O
plantar O O
flexors. O O
The O O
tone O O
in O O
the O O
lower O O
extremities O O
was O O
not O O
increased. O O
His O O
right O O
side O O
was O O
5/5. O O
He O O
had O O
hyperreflexia O O
of O O
the O O
left O O
side O O
and O O
an O O
equivocal O O
toe. O O
His O O
right O O
toe O O
was O O
downgoing. O O
Sensation O O
was O O
intact O O
to O O
light O O
touch O O
and O O
pinprick. O O
I O O
could O O
not O O
find O O
any O O
evidence O O
to O O
pinprick O O
of O O
his O O
neuropathy. O O
Vibration O O
sense O O
was O O
very O O
mildly O O
reduced O O
at O O
the O O
toes. O O
He O O
was O O
in O O
a O O
wheelchair, O O
and O O
his O O
gait O O
was O O
not O O
assessed. O O
Mr. O O
Parrish's O O
recovery O O
is O O
progressing. O O
He O O
has O O
regained O O
some O O
strength O O
in O O
his O O
left O O
leg O O
and O O
his O O
goal O O
is O O
to O O
be O O
able O O
to O O
walk O O
on O O
his O O
own O O
with O O
either O O
a O O
cane O O
or O O
walker. O O
I O O
hope O O
that O O
this O O
will O O
be O O
the O O
case. O O
Unfortunately, O O
his O O
left O O
arm O O
has O O
remained O O
flaccid O O
and O O
he O O
has O O
no O O
movement. O O
I O O
told O O
him O O
that O O
his O O
left O O
arm O O
will O O
most O O
likely O O
remain O O
with O O
severe O O
weakness. O O
His O O
stroke O O
was O O
most O O
likely O O
related O O
to O O
atheroma O O
of O O
the O O
middle O O
cerebral O O
artery O O
and O O
lenticulostriate O O
arteries. O O
I O O
would O O
encourage O O
his O O
blood O O
pressure O O
to O O
be O O
controlled, O O
as O O
has O O
been O O
done, O O
and O O
to O O
continue O O
an O O
anticholesterol O O
agent. O O
I O O
believe O O
he O O
has O O
been O O
on O O
Gemfibrozil O O
for O O
a O O
while. O O
The O O
literature O O
suggests O O
benefit O O
for O O
the O O
statin O O
drugs O O
in O O
primary O O
prevention O O
of O O
stroke O O
in O O
patients O O
with O O
elevated O O
cholesterol. O O
I O O
do O O
not O O
think O O
that O O
gemfibrozil B-MEDICATION O
has O O
been O O
studied O O
in O O
the O O
same O O
way. O O
However, O O
since O O
he O O
has O O
been O O
on O O
this O O
medicine O O
so O O
long, O O
it O O
may O O
be O O
worthwhile O O
to O O
continue O O
using O O
it O O
if O O
it O O
is O O
controlling O O
his O O
total O O
cholesterol O O
well. O O
He O O
should O O
continue O O
on O O
an O O
aspirin O B-MEDICATION
a O O
day. O O
He O O
states O O
that O O
he O O
is O O
having O O
difficulty O O
obtaining O O
Plavix O O
due O O
to O O
the O O
cost. O O
I O O
recommended O O
to O O
him O O
that, O O
in O O
the O O
experience O O
of O O
the O O
Stroke O O
Service O O
at O O
Sutton O O
Family O O
Care, O O
patients O O
in O O
his O O
situation O O
do O O
benefit O O
from O O
being O O
on O O
Plavix O O
for O O
a O O
period O O
of O O
time O O
after O O
a O O
stroke O O
of O O
this O O
type. O O
We O O
recommended O O
to O O
him O O
that O O
he O O
continue O O
on O O
Plavix O O
for O O
another O O
six O O
months O O
because O O
of O O
this. O O
This O O
should O O
give O O
adequate O O
time O O
for O O
any O O
ulcerated O O
or O O
unstable O O
plaque O O
in O O
his O O
middle O O
cerebral O O
artery O O
to O O
heal. O O
After O O
six O O
months, O O
if O O
he O O
has O O
had O O
no O O
further O O
clinical O O
events, O O
it O O
would O O
be O O
reasonable O O
to O O
assume O O
that O O
his O O
atheroma O O
is O O
stable O O
and O O
that O O
he O O
could O O
be O O
adequately O O
treated O O
with O O
aspirin. O O
I O O
will O O
see O O
him O O
again O O
in O O
clinic O O
in O O
approximately O O
six O O
months. O O
I O O
will O O
arrange O O
for O O
carotid O O
noninvasives O O
and O O
anterior O O
transcranial O O
Dopplers O O
to O O
evaluate O O
his O O
carotid O O
and O O
middle O O
cerebral O O
artery O O
in O O
approximately O O
one O O
year's O O
time. O O
The O O
patient O O
was O O
seen O O
and O O
examined O O
by O O
Dr. O O
Laith O O
Greene O O
of O O
the O O
Sutton O O
Family O O
Care O O
Stroke O O
Service, O O
who O O
was O O
present O O
for O O
all O O
relevant O O
portions O O
of O O
the O O
history O O
and O O
physical O O
examination. O O
Sincerely, O O
Johnathan O O
Kiefer, O O
M. O O
D. O O
DD:04/13/89 O O
DT:04/14/89 O O
AL:0138:855 O O

Record O O
date: O O
2089-09-20 O O
Personal O O
Data O O
and O O
Overall O O
Health O O
Mr. O O
Parrish O O
is O O
72 O O
y.o. O O
Unfortunatley O O
had O O
a O O
stroke O O
leaving O O
him O O
with O O
L-hemiplegia O O
in O O
2088. O O
He O O
is O O
living O O
independently O O
with O O
the O O
help O O
of O O
a O O
home O O
health O O
aide O O
and O O
friends. O O
Has O O
seen O O
Dr. O O
Ashley O O
of O O
Cardiology, O O
Dr. O O
Scott O O
or O O
Opthalmology, O O
Dr. O O
Insley O O
of O O
Endocrinology, O O
Dr. O O
Lane O O
of O O
Neurology O O
and O O
Dr. O O
Johnathan O O
Kiefer O O
of O O
Neurology. O O
Reason O O
for O O
Visit O O
Established O O
patient. O O
Annual O O
PE. O O
Problems O O
hypertension B-HYPERTENSION O
Pt. O O
has O O
hypertension. O B-HYPERTENSION
He O O
is O O
currently O O
managed O O
on O O
Beta-blocker, O O
ACE O O
inhibitor, O O
calcium O O
channel O O
blocker, O O
and O O
diuretic. O O
BP B-HYPERTENSION O
today I-HYPERTENSION O
is I-HYPERTENSION O
150/90. B-HYPERTENSION O
Will O O
plan O O
to O O
titrate O O
BP O O
meds. O O
Low-salt O O
diet. O O
diabetes B-DIABETES O
mellitus I-DIABETES O
Pt. O O
has O O
Type B-DIABETES O
II I-DIABETES O
diabetes. I-DIABETES O
Is O O
now O O
insulin B-MEDICATION O
dependent. O O
He O O
has O O
retinopathy, O O
neuropathy, O O
and O O
nephropathy. O O
He O O
sees O O
Dr. O O
Scott O O
of O O
Opthamology, O O
and O O
Dr. O O
Insley O O
of O O
Endocrinology O O
Currently O O
taking O O
two O O
insulin O O
shots O O
QD. O O
He O O
denies O O
hypoglycenia. O O
He O O
is O O
following O O
an O O
AODM B-DIABETES O
diet. O O
He O O
has O O
a O O
hemoglobin B-DIABETES O
A1C I-DIABETES O
of I-DIABETES O
7.8. I-DIABETES O
A: O O
Diabetes B-DIABETES O
with O O
neuropathy, O O
retinopathy, O O
and O O
nephropathy. O O
P: O O
Quanify O O
microalbumin. O O
Continue O O
Neurontin O O
for O O
diabetic O O
neuropathy. O O
FU O O
with O O
Dr. O O
Shah O O
for O O
retina O O
checks. O O
Pulmonary O O
problem O O
Pt. O O
has O O
a O O
h/o O O
asbestos O O
exposure O O
and O O
a O O
h/o B-SMOKER O
tobacco I-SMOKER O
abuse. I-SMOKER O
PFTs O O
have O O
revealed O O
mild O O
to O O
moderate O O
obstructive O O
defect O O
and O O
restrictive O O
defect O O
consistent O O
with O O
these O O
risk O O
factors. O O
He O O
is O O
currently O O
not O O
SOB O O
with O O
his O O
activities. O O
Will O O
FU O O
with O O
pulmonary O O
PRN. O O
Neuropathy O O
Patient O O
has O O
neuropathy O O
secondary O O
to O O
diabetes O O
mellitus O O
that O O
is O O
being O O
treated O O
with O O
Neurontin. O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
Pt. O O
had O O
an O O
MI B-CAD O
in I-CAD O
2060. I-CAD O
Had O O
four-vessel B-CAD O
bypass I-CAD O
with I-CAD O
Dr. I-CAD O
London I-CAD O
Rhoades I-CAD O
7/83. I-CAD O
His O O
ifsf O O
for O O
hypokensis O O
with O O
mild O O
MR O O
and O O
dilated O O
LA O O
with O O
EF O O
of O O
69%. O O
There O O
is O O
discreet O O
upper O O
septal O O
hypertrophy O O
w/o O O
evidence O O
of O O
outflow O O
obstruction. O O
A: O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
with O O
multiple O O
risk O O
factors O O
and O O
preserved O O
ejection O O
function O O
following O O
CABG. B-CAD O
Currently O O
w/o O O
evidence O O
of O O
cardiac O O
insufficiency. O O
P: O O
Modify O O
risk O O
factors O O
of O O
diabetes, O O
hypertension, O B-HYPERTENSION
and O O
hyperlipidemia. B-HYPERLIPIDEMIA O
He O O
will O O
take O O
aspirin O B-MEDICATION
as O O
an O O
anti-platelet. O O
He O O
will O O
FU O O
with O O
Dr. O O
Ashley. O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Has O O
elevated O O
lipids. O O
Will B-MEDICATION O
treat I-MEDICATION O
with I-MEDICATION O
Lipitor. B-MEDICATION B-MEDICATION
Follow O O
LFTs. O O
Low-cholesterol O O
diet. O O
PERIPHERAL O O
VASCULAR O O
DISEASE O O
Prior O O
to O O
his O O
stroke, O O
pt. O O
had O O
evidence O O
of O O
claudication O O
after O O
walking O O
400 O O
to O O
500 O O
feet. O O
Currently O O
w/o O O
claudication O O
at O O
rest O O
or O O
evidence O O
of O O
vascular O O
insufficiency. O O
Pedal O O
pulses O O
are O O
or O O
not O O
palpable. O O
A: O O
Peripheral O O
vascular O O
disease. O O
P: O O
Modify O O
secondary O O
risk O O
factors. O O
Further O O
intervention O O
is O O
warranted. O O
Stroke O O
Pt. O O
had O O
R O O
lacunar O O
stroke O O
12/29/88 O O
with O O
symptoms O O
of O O
gait O O
unsteadiness, O O
speech O O
slurring, O O
and O O
face O O
drooping. O O
Seen O O
by O O
the O O
Stroke O O
Service O O
and O O
has O O
been O O
through O O
a O O
rehab O O
hospital. O O
He O O
has O O
L O O
leg O O
&gt; O O
L O O
arm O O
and O O
L O O
face O O
hemiplegia. O O
He O O
is O O
currently O O
ambulatory O O
with O O
assitance O O
device O O
at O O
home. O O
He O O
has O O
a O O
homemaker O O
3X/week O O
and O O
devoted O O
friends O O
and O O
family. O O
He O O
is O O
frustrated O O
by O O
his O O
disease, O O
but O O
he O O
is O O
adjusting O O
slowly. O O
A: O O
S/P O O
R-lucunar O O
stroke. O O
P: O O
Modify O O
secondary O O
risk O O
factors, O O
continue O O
anti-platelet O O
agent, O O
and O O
FU O O
with O O
Dr. O O
Kiefer O O
of O O
Neurology O O
Clinic. O O
Pt. O O
encouraged O O
to O O
do O O
home O O
PT O O
exercises. O O
Health O O
maintenance O O
Discussed O O
seat O O
belt O O
use, O O
low-salt/low-cholesterol O O
diet, O O
AODM O O
diet, O O
stool O O
cards, O O
flexsig, O O
annual O O
eye O O
exams. O O
Procedures O O
influenza O O
vaccine O O
11/3/2087 O O
PNEUMOVAX O O
GIVEN O O
RIGHT O O
SHOULDER. O O
S/P O O
CORONARY B-CAD O
ARTERY I-CAD O
BYPASS I-CAD O
GRAFT I-CAD O
6/30/2083 O O
S/P O O
TETANUS O O
TOXOID O O
12/31/2080 O O
S/P O O
TONSILLECTOMY O O
Allergies O O
SULFA O O
Rash O O
Family O O
History O O
FATHER O O
DIED O O
OF O O
A O O
HEART O O
ATTACK. O O
MOTHER O O
WITH O O
HIGH O O
BP. O O
ONE O O
BROTHER O O
WITH O O
CAD, O O
S/P O O
CABG. O O
ONE O O
SISTER O O
DIED O O
OF O O
LUNG O O
AND O O
THROAT O O
CANCER. O O
SISTER O O
HAS O O
LUPUS. O O
Social O O
History O O
He O O
is O O
a O O
former O O
Banking O O
Manager. O O
He O O
is O O
widowed. O O
Has O O
two O O
daughters O O
and O O
one O O
son, O O
has O O
grandchildren. O O
He O O
lives O O
alone O O
but O O
has O O
a O O
companion. O O
Has B-SMOKER O
a I-SMOKER O
aremote I-SMOKER O
30 I-SMOKER O
pk.-yr. I-SMOKER O
h/o I-SMOKER O
smoking. I-SMOKER O
Minimal O O
alcohol. O O
Review O O
of O O
Systems O O
Thirteen O O
systems O O
reviewed. O O
Positive O O
findings O O
listed O O
above. O O
He O O
has O O
had O O
a O O
h/o O O
bladder O O
infections. O O
He O O
has O O
dentures. O O
He O O
wears O O
glasses. O O
He O O
has O O
lost O O
approximately O O
30 O O
lbs. O O
in O O
the O O
past O O
year O O
secondary O O
to O O
stroke. O O
He O O
has O O
some O O
nocturia O O
(2-3X O O
per O O
night). O O
No O O
SOB, O O
no O O
chest O O
wall O O
pain. O O
No O O
hypoglycemia. O O
He O O
also O O
has O O
painful O O
neuropathy O O
below O O
his O O
knees. O O
Otherwise O O
unremarkable O O
in O O
detail. O O
Vital O O
Signs O O
Blood B-HYPERTENSION O
Pressure: I-HYPERTENSION O
150/90 I-HYPERTENSION O
Weight: O O
195 O O
Pounds O O
Height: O O
69.5 O O
Inches O O
Pulse: O O
72 O O
Respiratory O O
Rate: O O
16 O O
Physical O O
Exam O O
General O O
Appearance O O
PLEASANT O O
GENTLEMAN O O
OF O O
GERMAN O O
EXTRACTION, O O
SITTING O O
IN O O
A O O
WHEECHAIR. O O
Skin O O
Multiple O O
seborrheic O O
keratoses O O
and O O
cherry O O
angiomas O O
w/o O O
suspicious O O
lesions. O O
HEENT O O
PERRLA. O O
EOMI. O O
TM O O
normal. O O
OP O O
normal. O O
There O O
is O O
AV O O
nicking O O
with O O
sharp O O
discs O O
and O O
there O O
is O O
a O O
L-facial O O
droop. O O
Neck O O
No O O
thyromegaly. O O
Carotids O O
w/o O O
bruits. O O
Nodes/Lymphatic O O
No O O
adenopathy. O O
Chest O O
LUNGS O O
CLEAR O O
TO O O
ASCULTATION. O O
Cor/Cardiac O O
STERNOTOMY O O
SCAR. O O
RRR, O O
S1 O O
S2, O O
SOFT O O
I-II/VI O O
SEM O O
AT O O
THE O O
LSB. O O
Abdomen O O
BS O O
PRESENT, O O
NT O O
ND. O O
NO O O
HERNIAS O O
PRESENT. O O
NO O O
MASSES O O
PRESENT. O O
Rectal O O
Exam O O
PROSTATE O O
FIRM O O
AND O O
SLIGHTLY O O
ENLARGED O O
W/O O O
NODULES. O O
NO O O
MASSES. O O
STOOL O O
BROWN O O
AND O O
HEME O O
NEG. O O
Genito-Urinary O O
NO O O
TESTICULAR O O
LESIONS. O O
Extremity O O
No O O
edema. O O
Vascular O O
- O O
unable O O
to O O
palpate O O
distal O O
pulses. O O
Femoral O O
are O O
2+. O O
Carotid O O
are O O
2+. O O
Neurological O O
CN O O
II-XII O O
testes O O
and O O
intact. O O
Decreased O O
CN O O
VII O O
on O O
the O O
L. O O
Motor O O
exam O O
reveals O O
L-upper O O
extremity O O
flacid O O
paralysis. O O
There O O
is O O
atrophy O O
of O O
the O O
L O O
biceps. O O
The O O
patient O O
had O O
no O O
evidence O O
of O O
contractures. O O
L-lower O O
extremity O O
with O O
II/V O O
L O O
iliosoas, O O
4+5 O O
hip O O
extensors, O O
3/5 O O
L O O
quadraceps, O O
3/5 O O
L-ankle O O
dorsoflexion, O O
and O O
3/5 O O
ankle O O
plantar O O
flexion. O O
There O O
is O O
no O O
increased O O
tone O O
or O O
rigidity O O
on O O
the O O
L O O
side. O O
DTRs O O
reveal O O
3+ O O
reflex O O
at O O
the O O
L O O
patellar O O
ankle O O
jerk O O
w/o O O
clonus. O O
R O O
toe O O
is O O
downgoing. O O
Sensation O O
intact O O
to O O
light O O
touch O O
and O O
pinprick. O O
Reduced O O
vibration O O
sense O O
in O O
ankle O O
and O O
toes. O O
Gait O O
not O O
assessed O O
as O O
he O O
is O O
in O O
a O O
wheel O O
chair. O O
Vascular O O
carotids O O
and O O
femoral O O
pulses O O
are O O
2+. O O
DP O O
and O O
anti-tib O O
are O O
not O O
appreciated. O O
Medications O O
captopril B-MEDICATION B-MEDICATION
50MG O O
PO O O
TID O O
ECOTRIN B-MEDICATION O
(ASPIRIN O O
ENTERIC O O
COATED) O O
325MG O O
PO O O
QD O O
insulin O O
isophane O B-MEDICATION
(nph) O O
14units O O
SC O O
QPM O O
INSULIN B-MEDICATION O
N O O
28units O O
QAM O O
ISORDIL B-MEDICATION B-MEDICATION
PO O O
TID O O
Lipitor O B-MEDICATION
10MG O O
PO O O
QD O O
Lopressor B-MEDICATION B-MEDICATION
50MG I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
MAXAIR O O
INHALER O O
INH O O
NEURONTIN O O
(GABAPENTIN) O O
300MG O O
PO O O
BID O O
NORVASC B-MEDICATION B-MEDICATION
(AMLODIPINE) O O
BID O O
PO O O
NPH B-MEDICATION O
REGULAR I-MEDICATION O
14units O O
QAM O O
REGULAR B-MEDICATION O
INSULIN I-MEDICATION B-MEDICATION
10U O O
INJ O O
QAM O O
Disposition O O
and O O
Plans O O
I O O
will O O
ask O O
him O O
to O O
FU O O
Dr. O O
Kiefer O O
of O O
Neurology, O O
Dr. O O
Ashley O O
of O O
Cardiology, O O
Dr. O O
Insley O O
of O O
Endocrinology O O
He O O
will O O
follow O O
an O O
AMOD O O
diet, O O
low-salt/low-cholesterol O O
diet, O O
flexsig., O O
stool O O
cards. O O
FU O O
with O O
me O O
in O O
three O O
month's O O
time O O
or O O
sooner O O
as O O
needed. O O
He O O
will O O
FU O O
with O O
Dr. O O
Scott O O
of O O
Opthalmology. O O
cc: O O
Drs. O O
Ashley/Cardiology O O
- O O
CCR O O
412 O O
Snyder/Opthalmology O O
- O O
Insley/Endocrinology O O
- O O
End O O
6 O O
Lane/Neurology O O
- O O
NEU O O
265 O O
J. O O
Kiefer/NeuroSurgery O O

Record O O
date: O O
2093-12-29 O O
Christopher O O
presents O O
with O O
his O O
significant O O
other, O O
Emily, O O
for O O
review O O
of O O
peripheral O O
vascular O O
disease, O O
hypertension, B-HYPERTENSION O
renal O O
insufficiency, O O
diabetes B-DIABETES O
mellitus, I-DIABETES O
hyperlipidemia, B-HYPERLIPIDEMIA O
rib O O
pain, O O
and O O
gout. O O
They O O
going O O
back O O
to O O
New O O
Jersey. O O
Bronchitis: O O
he O O
has O O
developed O O
cough O O
w/ O O
yellow O O
phlegm O O
w/o O O
fever O O
or O O
chills O O
or O O
rigors. O O
he O O
has O O
more O O
coughing O O
at O O
night. O O
he O O
is O O
SOB O O
w/ O O
transfers. O O
He O O
has O O
rhonchi O O
in O O
right O O
lower O O
lobe. O O
a/p O O
bronchitis O O
vs O O
pna O O
in O O
former B-SMOKER O
smoker I-SMOKER O
w/ O O
COPD. O O
will O O
obtain O O
CXR. O O
rx O O
w/ O O
levoflox O O
and O O
rob O O
AC O O
(sugar O O
free) O O
Diabetes B-DIABETES O
mellitus: I-DIABETES O
His O O
blood O O
sugar O O
has O O
been O O
well O O
controlled. O O
He O O
states O O
that O O
his O O
glucose O O
is O O
usually O O
between O O
100 O O
and O O
at O O
most O O
150. O O
He O O
does O O
have O O
microalbuminuria O O
and O O
renal O O
insufficiency O O
and O O
neuropathy. O O
He O O
does O O
have O O
peripheral O O
vascular O O
disease O O
and O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
as O O
well O O
as O O
diabetes O O
mellitus. O O
We O O
will O O
need O O
to O O
check O O
hemoglobin O O
A1c O O
to O O
determine O O
the O O
level O O
of O O
control. O O
Last B-DIABETES O
hemoglobin I-DIABETES O
A1c I-DIABETES O
was I-DIABETES O
June I-DIABETES O
2093, I-DIABETES O
and I-DIABETES O
it I-DIABETES O
was I-DIABETES O
6.8. B-DIABETES O
Continue O O
current O O
management O O
of O O
diabetes O O
mellitus O O
with O O
insulin. B-MEDICATION O
Continue O O
to O O
treat O O
and O O
monitor O O
blood O O
pressure. O O
Patient O O
is O O
intolerant O O
of O O
ACE O O
inhibitor O O
due O O
to O O
renal O O
dysfunction. O O
Renal O O
dysfunction: O O
He O O
has O O
seen O O
Dr. O O
Krause O O
from O O
Renal O O
associates. O O
He O O
does O O
have O O
bilateral O O
renal O O
artery O O
stenosis. O O
He O O
has O O
also O O
seen O O
Dr. O O
Locklear O O
for O O
consideration O O
of O O
intervention O O
for O O
renal O O
artery O O
stenosis. O O
Patient O O
cannot O O
tolerate O O
an O O
ACE O O
inhibitor. O O
Will O O
plan O O
to O O
monitor O O
blood O O
pressure O O
and O O
avoid O O
hyper O O
and O O
hypotension. O O
He O O
will O O
have O O
imaging O O
today. O O
Chronic O O
obstructive O O
pulmonary O O
disease: O O
The O O
patient O O
has O O
obstructive O O
lung O O
disease. O O
Is O O
currently O O
not O O
short O O
of O O
breath O O
at O O
rest. O O
Only O O
short O O
of O O
breath O O
with O O
activity. O O
Currently O O
using O O
Advair, O O
and O O
Combivent. O O
He O O
also O O
uses O O
Atrovent O O
or O O
albuterol O O
nebulizers O O
as O O
needed. O O
Lungs O O
are O O
without O O
wheezes O O
today. O O
There O O
are O O
fine O O
expiratory O O
rhonchi. O O
Assessment O O
is O O
chronic O O
obstructive O O
pulmonary O O
disease. O O
Plan O O
will O O
be O O
to O O
continue O O
current O O
management. O O
Coronary B-CAD O
artery I-CAD O
disease: I-CAD O
Has O O
no O O
signs O O
or O O
symptoms O O
of O O
cardiac O O
insufficiency O O
or O O
chest O O
wall O O
pain. O O
Continue O O
to O O
treat O O
with O O
nitrates O O
and O O
modify O O
secondary O O
risk O O
factors. O O
Hypertension: B-HYPERTENSION O
Blood O O
pressure O O
today O O
is O O
128/72 O O
with O O
a O O
pulse O O
of O O
76. O O
Will O O
continue O O
current O O
management. O O
Gout: O O
The O O
patient O O
had O O
an O O
episode O O
of O O
gout O O
on O O
his O O
right O O
wrist O O
2 O O
weeks O O
ago O O
while O O
in O O
New O O
Jersey. O O
Currently O O
taking O O
colchicine O O
with O O
resolution O O
of O O
symptoms. O O
Neuropathy: O O
He O O
has O O
neuropathy O O
of O O
the O O
lower O O
extremities O O
in O O
a O O
stocking-glove O O
distribution. O O
Currently O O
taking O O
Neurontin. O O
CVA: O O
He O O
is O O
status O O
post O O
stroke O O
with O O
left O O
hemiplegia. O O
He O O
is O O
wheelchair O O
mobile. O O
Currently O O
without O O
new O O
signs O O
or O O
symptoms O O
of O O
neurologic O O
deficits. O O
Will O O
plan O O
to O O
continue O O
to O O
modify O O
secondary O O
risk O O
factors. O O
Shortness O O
of O O
breath: O O
Patient O O
states O O
he O O
has O O
some O O
exertional O O
shortness O O
of O O
breath. O O
He O O
is O O
not O O
short O O
of O O
breath O O
at O O
rest. O O
There O O
is O O
no O O
PND, O O
or O O
orthopnea. O O
There O O
is O O
no O O
edema. O O
Examination O O
of O O
the O O
lungs O O
do O O
not O O
revealing O O
any O O
rales. O O
Assessment O O
is O O
shortness O O
of O O
breath O O
which O O
is O O
likely O O
related O O
bronchitis. O O
He O O
has O O
multiple O O
reasons O O
(chronic O O
obstructive O O
pulmonary O O
disease O O
and O O
coronary O O
artery O O
disease) O O
and O O
deconditioning O O
and O O
that O O
can O O
account O O
for O O
his O O
baseline O O
shortness O O
of O O
breath. O O
Health O O
care O O
maintenance: O O
The O O
patient O O
received O O
a O O
flu O O
shot O O
this O O
year. O O
FAMILY O O
HISTORY: O O
No O O
changes O O
relevant O O
to O O
current O O
exam. O O
SOCIAL O O
HISTORY: O O
Is B-SMOKER O
not I-SMOKER O
smoking. I-SMOKER O
Not O O
drinking O O
alcohol. O O
He O O
lives O O
in O O
New O O
Jersey O O
and O O
is O O
living O O
at O O
times O O
in O O
the O O
Clifton O O
Forge O O
area. O O
REVIEW O O
OF O O
SYSTEMS: O O
Thirteen O O
systems O O
reviewed. O O
Positive O O
findings O O
listed O O
above. O O
In O O
addition, O O
he O O
has O O
resolving O O
left O O
anterior O O
chest O O
wall O O
pain O O
where O O
he O O
fell O O
from O O
his O O
wheelchair O O
last O O
week. O O
This O O
was O O
a O O
mechanical O O
fall. O O
Reflexes O O
intact. O O
There O O
is O O
no O O
melena. O O
No O O
hematochezia. O O
No O O
hematuria. O O
No O O
hypoglycemia, O O
fevers, O O
or O O
chills. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
presents O O
in O O
a O O
wheelchair. O O
Blood O O
pressure O O
noted O O
above. O O
Respiratory O O
rate O O
is O O
18 O O
and O O
unlabored. O O
T O O
95. O O
There O O
are O O
no O O
accessory O O
muscle O O
use. O O
Skin O O
without O O
rashes. O O
ENT: O O
Anicteric. O O
Extraocular O O
movements O O
are O O
intact. O O
Tympanic O O
membrane O O
and O O
OP O O
are O O
normal. O O
Neck O O
is O O
supple. O O
There O O
is O O
no O O
thyromegaly. O O
Carotids O O
are O O
2+. O O
Cardiac: O O
Distant O O
heart O O
sounds; O O
regular O O
rate O O
and O O
rhythm; O O
S1 O O
and O O
S2; O O
there O O
is O O
no O O
S4. O O
Lungs O O
have O O
faint O O
expiratory O O
rhonchi O O
in O O
rt O O
lower O O
lobe; O O
no O O
rales. O O
Abdomen O O
is O O
benign; O O
BS O O
present. O O
NT O O
ND; O O
no O O
HSM. O O
Right O O
extremity O O
without O O
edema. O O
Neurologic: O O
He O O
has O O
a O O
dense O O
left O O
hemiplegia. O O
ASSESSMENT O O
AND O O
PLAN: O O
Will O O
continue O O
management O O
of O O
multiple O O
complex O O
medical O O
issues O O
as O O
noted O O
above. O O
will O O
check O O
cxray O O
for O O
pneumonia. O O
levofloxacin O O
500mg O O
qd O O
for O O
7 O O
days. O O
He O O
will O O
follow O O
up O O
with O O
Dr. O O
Paul O O
Krause O O
for O O
following O O
his O O
renal O O
function. O O
Will O O
discuss O O
possible O O
management O O
of O O
renal O O
artery O O
stenosis O O
with O O
Dr. O O
Locklear O O
and O O
Dr. O O
Krause. O O
Given O O
overall O O
comorbidities, O O
would O O
be O O
hesitant O O
to O O
pursue O O
any O O
invasive O O
procedure O O
or O O
surgery O O
that O O
does O O
not O O
have O O
a O O
good O O
chance O O
for O O
success. O O
______________________________ O O
Carter O O
K. O O
Li, O O
M.D. O O

Record O O
date: O O
2094-05-24 O O
Internal O O
Medicine O O
Intern O O
Admit O O
Note O O
Patient O O
Name: O O
Parrish, O O
Christopher O O
MR# O O
5531548 O O
Date O O
of O O
Admission: O O
5/24/94 O O
Attending: O O
Dr. O O
Li O O
PCP: O O
Dr. O O
Li O O
CC/ID: O O
foot O O
redness O O
/ O O
swelling O O
HPI: O O
The O O
patient O O
is O O
a O O
77 O O
year O O
old O O
male O O
with O O
a O O
past O O
medical O O
history O O
significant O O
for O O
diabetes, B-DIABETES O
peripheral O O
vascular O O
disease O O
and O O
stroke O O
who O O
was O O
in O O
his O O
usual O O
state O O
of O O
health O O
until O O
two O O
weeks O O
prior O O
to O O
admission O O
when O O
he O O
developed O O
a O O
blister O O
on O O
his O O
left O O
foot O O
where O O
his O O
shoe O O
meets O O
his O O
brace. O O
The O O
patient O O
reportedly O O
noticed O O
a O O
blister O O
under O O
the O O
toes O O
of O O
his O O
left O O
foot O O
and O O
so O O
he O O
presented O O
to O O
his O O
primary O O
care O O
physician's O O
office O O
who O O
determined O O
that O O
the O O
patient O O
had O O
developed O O
a O O
foot O O
ulcer. O O
During O O
the O O
course O O
of O O
the O O
last O O
two O O
weeks, O O
the O O
foot O O
became O O
red O O
and O O
swollen. O O
The O O
patient O O
however O O
denied O O
having O O
any O O
fevers O O
or O O
chills. O O
Notably, O O
the O O
patient O O
developed O O
staph O O
septicemia O O
from O O
an O O
infected O O
ulcer O O
in O O
2091. O O
In O O
the O O
ER, O O
the O O
patient O O
received O O
iv O O
unasyn O O
and O O
was O O
then O O
admitted O O
to O O
the O O
medical O O
service. O O
PMH: O O
Hypertension B-HYPERTENSION O
Peripheral O O
vascular O O
disease O O
Stroke O O
in O O
2088 O O
- O O
has O O
left O O
sided O O
paralysis, O O
but O O
mobile O O
in O O
a O O
wheelchair O O
Left O O
sided O O
foot O O
contracture O O
CAD B-CAD O
s/p B-CAD O
4v I-CAD O
CABG B-CAD B-MEDICATION
CHF O O
- O O
ischemic B-CAD O
cardiomyopathy, I-CAD O
EF O O
18% O O
Chronic O O
renal O O
failure O O
- O O
baseline O O
Cr O O
1.8 O O
- O O
2.5 O O
Asbesosis O B-MEDICATION
Impotence O O
Peripheral O O
Neuropathy O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Hyperlipidemia B-HYPERLIPIDEMIA B-MEDICATION
Foot O O
ulcers O O
Medications: O O
NPH B-MEDICATION O
21 O O
U O O
qam O O
/ O O
11 O O
U O O
qpm O O
ASA-EC B-MEDICATION B-MEDICATION
325 O O
mg O O
po O O
qd O O
Neurontin O O
600 O O
mg O O
po O O
bid O O
prn O O
pain O O
Hydralazine O O
25 O O
mg O O
po O O
tid O O
Nexium O O
20 O O
mg O O
po O O
qd O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
100 O O
mg O O
po O O
qd O O
Albuterol O O
neb O O
prn O O
Zoloft O O
100 O O
mg O O
po O O
qd O O
Combivent O O
2 O O
puff O O
qid O O
Imdur B-CAD B-MEDICATION
30 O O
mg O O
po O O
qd O O
Lasix O O
60 O O
/ O O
40 O O
mg O O
po O O
qam/qpm O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
mg O O
po O O
qhs O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
po O O
qd O O
Advair O O
100/50 O O
bid O O
Allergies: O O
Sulfa O O
- O O
rash O O
SH: O O
Patient O O
lives O O
in O O
Flint O O
with O O
his O O
friend O O
Epstein. O O
He O O
has O O
3 O O
children. O O
He O O
used O O
to O O
work O O
in O O
banking. O O
Tob: B-SMOKER B-MEDICATION
Denies I-SMOKER O
EtOH: O O
Denies O O
Illicits: O O
Denies O O
FH: O O
Cardiac O O
disease O O
in O O
family. O O
Exam: O O
VS: O O
T=97.4 O O
HR=76 O O
BP=134/68 O O
RR=20 O O
SaO2=100% O O
on O O
RA O O
General: O O
no O O
acute O O
distress, O O
calm, O O
resting O O
in O O
bed. O O
HEENT: O O
pupils O O
equal O O
and O O
reactive O O
to O O
light, O O
anicteric O O
sclera, O O
extraocular O O
movements O O
intact. O O
Neck: O O
supple, O O
no O O
jugular O O
venous O O
distention. O O
Chest: O O
clear O O
to O O
auscultation O O
bilaterally. O O
CVS: O O
regular O O
rate O O
& O O
rhythm, O O
II/VI O O
systolic O O
murmur. O O
Abd: O O
soft, O O
non-distended, O O
non-tender O O
to O O
palpation, O O
normoactive O O
bowel O O
sounds. O O
Extr: O O
ulcer O O
over O O
plantar O O
aspect O O
of O O
left O O
foot O O
close O O
to O O
5th O O
toe O O
(2x2 O O
cm) O O
erythema O O
over O O
left O O
foot O O
extending O O
from O O
plantar O O
surface O O
to O O
top O O
surface O O
no O O
fluctulance, O O
no O O
drainage, O O
outlined O O
with O O
marker O O
Neuro: O O
CN O O
II O O
through O O
XII O O
intact, O O
unable O O
to O O
move O O
left O O
arm O O
or O O
foot, O O
markedly O O
decreased O O
sensation O O
in O O
stocking-glove O O
distribution O O
DATA O O
Test O O
Description O O
Result O O
Ref. O O
Range/Units O O
Date/Time O O
Last O O
Abnormal O O
Chemistry O O
Lytes/Renal/Glucose O O
Sodium O O
142 O O
135-145 O O
mmol/L O O
05/24/94 O O
15:02 O O
146(H) O O
05/24/93 O O
Potassium O O
4.6 O O
3.4-4.8 O O
mmol/L O O
05/24/94 O O
15:02 O O
5.7(H) O O
12/08/91 O O
Chloride O O
109H O O
100-108 O O
mmol/L O O
05/24/94 O O
15:02 O O
109(H) O O
05/24/94 O O
Carbon O O
Dioxide O O
28.0 O O
23.0-31.9 O O
mmol/L O O
05/24/94 O O
15:02 O O
22.2(L) O O
12/15/93 O O
BUN O O
67H O O
8-25 O O
mg/dl O O
05/24/94 O O
15:02 O O
67(H) O O
05/24/94 O O
Creatinine O O
2.6H O O
0.6-1.5 O O
mg/dl O O
05/24/94 O O
15:02 O O
2.6(H) O O
05/24/94 O O
Glucose O O
124H O O
70-110 O O
mg/dl O O
05/24/94 O O
15:02 O O
124(H) O O
05/24/94 O O
General O O
Chemistries O O
Calcium O O
8.6 O O
8.5-10.5 O O
mg/dl O O
05/24/94 O O
15:51 O O
8.2(L) O O
05/16/94 O O
Phosphorus O O
4.2 O O
2.6-4.5 O O
mg/dl O O
05/24/94 O O
15:51 O O
4.7(H) O O
10/18/93 O O
Magnesium O O
2.0 O O
1.4-2.0 O O
meq/L O O
05/24/94 O O
15:51 O O
2.1(H) O O
12/29/88 O O
Cardiac O O
Tests O O
CRP, O O
High O O
Sen... O O
PEND O O
mg/L O O
05/24/94 O O
14:54 O O
Hematology O O
WBC O O
7.6 O O
4.5-11.0 O O
th/cmm O O
05/24/94 O O
15:31 O O
14.6(H) O O
12/11/91 O O
RBC O O
4.57 O O
4.50-5.90 O O
mil/cm O O
05/24/94 O O
15:31 O O
4.38(L) O O
12/15/93 O O
Hgb O O
12.7L O O
13.5-17.5 O O
gm/dl O O
05/24/94 O O
15:31 O O
12.7(L) O O
05/24/94 O O
HCT O O
38.7L O O
41.0-53.0 O O
% O O
05/24/94 O O
15:31 O O
38.7(L) O O
05/24/94 O O
MCV O O
85 O O
80-100 O O
fl O O
05/24/94 O O
15:31 O O
85(L) O O
06/01/83 O O
MCH O O
27.8 O O
26.0-34.0 O O
pg/rbc O O
05/24/94 O O
15:31 O O
27.6(L) O O
05/16/94 O O
MCHC O O
32.8 O O
31.0-37.0 O O
g/dl O O
05/24/94 O O
15:31 O O
PLT O O
183 O O
150-350 O O
th/cumm O O
05/24/94 O O
15:31 O O
387(H) O O
01/17/91 O O
RDW O O
16.3H O O
11.5-14.5 O O
% O O
05/24/94 O O
15:31 O O
16.3(H) O O
05/24/94 O O
Blood O O
Differential O O
% O O
Neutrophils O O
75H O O
40-70 O O
% O O
05/24/94 O O
15:31 O O
75(H) O O
05/24/94 O O
Lymphs O O
18L O O
22-44 O O
% O O
05/24/94 O O
15:31 O O
18(L) O O
05/24/94 O O
Monos O O
4 O O
4-11 O O
% O O
05/24/94 O O
15:31 O O
2(L) O O
12/11/91 O O
Eos O O
2 O O
0-8 O O
% O O
05/24/94 O O
15:31 O O
Basos O O
1 O O
0-3 O O
% O O
05/24/94 O O
15:31 O O
Other O O
Hematology O O
ESR O O
24H O O
0-17 O O
mm/hr O O
05/24/94 O O
16:49 O O
24(H) O O
05/24/94 O O
Urinalysis O O
GLUC O O
- O O
UA O O
NEGATIVE O O
NEG O O
05/24/94 O O
13:08 O O
Ketones O O
NEGATIVE O O
NEG O O
05/24/94 O O
13:08 O O
Specific O O
Gravity O O
1.010 O O
1.001-1.035 O O
05/24/94 O O
13:08 O O
Blood O O
- O O
UA O O
NEGATIVE O O
NEG O O
05/24/94 O O
13:08 O O
pH O O
5.0 O O
5.0-9.0 O O
05/24/94 O O
13:08 O O
Protein O O
- O O
UA O O
NEGATIVE O O
NEG O O
05/24/94 O O
13:08 O O
Nitrites O O
NEGATIVE O O
NEG O O
05/24/94 O O
13:08 O O
WBC O O
Screen O O
NEGATIVE O O
NEG O O
05/24/94 O O
13:08 O O
Impression: O O
77 O O
year O O
old O O
male O O
with O O
diabetes, O O
s/p O O
CVA O O
& O O
peripheral O O
neuropathy O O
presents O O
with O O
left O O
lower O O
extremity O O
ulcer, O O
swelling O O
and O O
erythema. O O
Non-healing O O
left O O
plantar O O
foot O O
ulcer O O
/ O O
lower O O
extremity O O
swelling O O
/ O O
erythema O O
DDx: O O
Cellulitis O O
/ O O
Fascitis O O
/ O O
DVT O O
Most O O
likely O O
cellulitis O O
given O O
erythema, O O
skin O O
induration, O O
swelling O O
Will O O
initiate O O
empiric O O
antibiotic O O
therapy O O
with O O
unasyn O O
3 O O
gm O O
iv O O
q O O
6 O O
hr O O
(need O O
to O O
cover O O
for O O
beta-hemolytic O O
streptococci, O O
staphylococcus O O
aureus, O O
aerobic O O
gram O O
negative O O
bacilli, O O
and O O
anaerobes O O
given O O
history O O
diabetes) O O
Will O O
keep O O
leg O O
elevated O O
Will O O
obtain O O
serial O O
WBC O O
to O O
evaluate O O
for O O
signs O O
of O O
systemic O O
infection O O
Will O O
follow O O
serial O O
examinations O O
after O O
marking O O
area O O
of O O
erythema O O
Will O O
obtain O O
wound O O
care O O
consult O O
Will O O
obtain O O
vascular O O
surgery O O
consult O O
to O O
Dr. O O
Locklear O O
to O O
determine O O
whether O O
the O O
patient O O
would O O
benefit O O
from O O
debridement O O
Cardiac O O
(Hypertension O O
/ O O
PVD O O
/ O O
CHF) O O
Appears O O
euvolemic O O
at O O
the O O
moment O O
Will O O
continue O O
ASA O B-MEDICATION
/ O O
hydralazine O O
/ O O
toprol B-MEDICATION B-MEDICATION
xl O O
/ O O
lasix O O
/ O O
lipitor B-MEDICATION B-MEDICATION
/ O O
plavix B-MEDICATION B-MEDICATION
Will B-MEDICATION O
use I-MEDICATION O
isordil B-MEDICATION B-MEDICATION
10 I-MEDICATION O
mg I-MEDICATION O
po I-MEDICATION O
tid I-MEDICATION O
while I-MEDICATION O
inpatient I-MEDICATION O
Chronic O O
renal O O
failure O O
Cr O O
nearly O O
at O O
baseline O O
Will O O
monitor O O
serially O O
while O O
inpatient O O
Will O O
initiate O O
low O O
salt O O
/ O O
low O O
potassium O O
diet O O
Prophylaxis O O
DVT O O
prophylaxis: O O
will O O
initiate O O
heparin O O
sc O O
GI O O
prophylaxis: O O
will O O
initiate O O
nexium O O
& O O
colace O O
& O O
senna O O
Dispo O O
The O O
patient O O
will O O
likely O O
return O O
home O O
after O O
stabilization O O
of O O
his O O
acute O O
medical O O
illness O O
Full O O
Code O O
_________________________________ O O
Quantarius O O
G. O O
Jameson, O O
MD O O
Pager O O
#00311 O O

Record O O
date: O O
2069-11-18 O O
Mr O O
Gallegos O O
comes O O
into O O
clinic O O
to O O
follow-up O O
on O O
his O O
multiple O O
medical O O
problems: O O
EtOH O O
: O O
last O O
drink O O
4/27/63 O O
Hepatitis O O
C O O
Htn B-HYPERTENSION O
H/O O O
hepatitis O O
B O O
: O O
15 O O
years O O
ago O O
after O O
episode O O
of O O
jaundice O O
with O O
HCV O O
two O O
years O O
ago O O
H/O O O
drug O O
abuse O O
: O O
IV O O
drug O O
user O O
stopped O O
heroin O O
2 O O
years O O
ago-methadone O O
95 O O
mg O O
per O O
day. O O
fracture O O
: O O
thumb O O
age O O
47 O O
Hernia O O
repair O O
: O O
bilateral O O
inguinal O O
hernia O O
repair O O
Obesity B-OBESE O
abnormal O O
SPEP O O
: O O
could O O
be O O
from O O
Hep O O
C O O
but O O
needs O O
fol O O
esp O O
in O O
light O O
of O O
periph O O
neuropathy O O
- O O
repeat O O
in O O
4 O O
mos O O
(1/67) O O
Type B-DIABETES O
2 I-DIABETES O
diabetes/insulin I-DIABETES O
He O O
is O O
accompanied O O
by O O
his O O
wife. O O
He O O
states O O
that O O
he O O
stopped O O
using O O
insulin. O O
He O O
stopped O O
for O O
the O O
past O O
month. O O
His O O
blood O O
sugars O O
run O O
low O O
of O O
95 O O
to O O
a O O
high O O
of O O
160 O O
fasting, O O
after O O
meals O O
120 O O
to O O
180. O O
He O O
has O O
not O O
had O O
an O O
eye O O
exam O O
as O O
of O O
yet. O O
His B-DIABETES O
hemoglobin I-DIABETES O
A1c I-DIABETES O
was I-DIABETES O
13% I-DIABETES O
in I-DIABETES O
June. I-DIABETES O
His O O
urine O O
is O O
negative O O
for O O
protein. O O
He O O
also O O
continues O O
in O O
his O O
methadone O O
maintenance O O
program O O
on O O
95 O O
mg O O
per O O
day. O O
He O O
is O O
substance O O
free. O O
He O O
has O O
a O O
history O O
of O O
hepatitis O O
C. O O
No O O
abdominal O O
pain, O O
nausea O O
or O O
vomiting. O O
No O O
change O O
in O O
bowel O O
movements. O O
He O O
did O O
not O O
have O O
his O O
ultrasound. O O
He B-SMOKER O
smokes B-SMOKER O
one I-SMOKER O
pack I-SMOKER O
of I-SMOKER O
cigarettes I-SMOKER O
per I-SMOKER O
day. I-SMOKER O
He O O
notes O O
that O O
over O O
the O O
past O O
month, O O
specifically O O
over O O
the O O
past O O
two O O
weeks O O
he O O
has O O
had O O
dyspnea O O
on O O
exertion O O
and O O
chest B-CAD O
pain I-CAD O
with O O
exertion. O O
He O O
notes O O
that O O
the O O
chest O O
pain O O
is O O
substernal. O O
It O O
stops O O
with O O
rest. O O
He O O
feels O O
slightly O O
weak O O
when O O
the O O
chest O O
pain O O
occurs. O O
He O O
denies O O
any O O
palpitations O O
or O O
presyncope. O O
He O O
has O O
no O O
other O O
complaints. O O
Exam: O O
Vital O O
Signs O O
BP O O
126/78, O O
Wt O O
212 O O
lb O O
Recheck O O
blood O O
pressure O O
140/90. O O
Heart O O
rate O O
regular O O
72. O O
Normal O O
S1 O O
and O O
S2. O O
No O O
murmurs O O
rubs O O
gallops. O O
Lungs O O
clear O O
bilaterally. O O
Lower O O
extremities O O
no O O
edema. O O
Weight O O
stable. O O
ECG: O O
Flip O O
T O O
waves O O
in O O
2, O O
3, O O
aVF, O O
no O O
ST O O
elevation O O
or O O
depression. O O
Assessment O O
and O O
plan: O O
1. O O
Question O O
unstable B-CAD O
angina: I-CAD O
Patient O O
not O O
presently O O
with O O
chest O O
pain O O
in O O
the O O
office O O
however O O
his O O
history O O
is O O
concerning. O O
His O O
ECG O O
is O O
abnormal. O O
I O O
have O O
reviewed O O
this O O
with O O
Dr. O O
Fenton O O
who O O
agrees. O O
I O O
have O O
made O O
the O O
recommendation O O
to O O
patient O O
to O O
go O O
to O O
the O O
emergency O O
unit O O
for O O
cardiac O O
evaluation, O O
stressed O O
to O O
him O O
that O O
type O O
2 O O
diabetes O O
sometimes O O
masks O O
chest O O
pain. O O
He O O
is O O
a B-FAMILY_HIST O
strong I-FAMILY_HIST O
positive I-FAMILY_HIST O
family I-FAMILY_HIST O
history I-FAMILY_HIST O
of I-FAMILY_HIST O
CAD, I-FAMILY_HIST O
father I-FAMILY_HIST O
died I-FAMILY_HIST O
age I-FAMILY_HIST O
49. I-FAMILY_HIST O
Brother I-FAMILY_HIST O
may I-FAMILY_HIST O
have I-FAMILY_HIST O
CAD. I-FAMILY_HIST O
Patient O O
did O O
not O O
agree O O
with O O
my O O
recommendation O O
at O O
first O O
however O O
after O O
speaking O O
to O O
brother O O
and O O
wife O O
again, O O
he O O
agreed O O
to O O
go O O
to O O
emergency O O
unit O O
for O O
evaluation O O
tonight. O O
He O O
was O O
sent O O
via O O
ALS O O
ambulance O O
in O O
stable O O
condition. O O
2. O O
Type O O
2 O O
diabetes: O O
Patient O O
has O O
stopped O O
insulin. O O
Blood O O
sugar O O
is O O
slightly O O
on O O
the O O
high O O
side. O O
Have O O
recheck O O
hemoglobin O O
A1c. O O
was O O
13% O O
in O O
June. O O
No O O
proteinuria. O O
Will O O
readdress O O
after O O
hospitalization. O O
He O O
needs O O
ophthalmology O O
exam. O O
3. O O
Hypertension: O O
Recheck O O
post O O
hospitalization. O O
Patient O O
has O O
not O O
been O O
taking O O
Lopressor O B-MEDICATION
as O O
prescribed. O O
4. O O
Hepatitis O O
C: O O
Have O O
checked O O
LFTs/amylase. O O
Reordered O O
abdominal O O
ultrasound. O O
Patient O O
to O O
return O O
to O O
clinic O O
in O O
one O O
to O O
two O O
weeks. O O

Record B-SMOKER O
date: O O
2069-11-25 O O
Mr O O
Gallegos O O
is O O
here O O
in O O
clinic O O
for O O
follow-up O O
of O O
his O O
recent O O
hospitalization O O
for O O
chest B-CAD O
pain. I-CAD O
He O O
was O O
seen O O
in O O
clinic O O
on O O
11/18 O O
and O O
sent O O
to O O
emergency O O
unit O O
due O O
to O O
unstable B-CAD O
angina I-CAD O
and O O
ECG O O
changes. O O
He O O
had O O
a O O
cardiac O O
catheterization O O
which O O
showed O O
inferior O O
lateral O O
reversible O O
defect. O O
He O O
had O O
two B-CAD O
stents I-CAD O
to I-CAD O
the I-CAD O
RCA. I-CAD O
He O O
had O O
a O O
right O O
groin O O
stick. O O
He O O
has O O
a O O
right O O
groin O O
pressure O O
dressing O O
and O O
the O O
area O O
is O O
slightly O O
tender. O O
He O O
has O O
no O O
lower O O
extremity O O
symptoms. O O
His O O
medications O O
were O O
changed B-MEDICATION O
to I-MEDICATION O
Plavix, B-MEDICATION B-MEDICATION
Toprol-XL, B-MEDICATION B-MEDICATION
lisinopril, B-MEDICATION B-MEDICATION
aspirin, B-MEDICATION B-MEDICATION
simvastatin. B-MEDICATION B-MEDICATION
Patient O O
is O O
now O O
currently O O
off O O
his O O
diabetes B-DIABETES O
medications O O
including O O
insulin. O O
His B-DIABETES O
recent I-DIABETES O
hemoglobin I-DIABETES O
A1c I-DIABETES O
was I-DIABETES O
6% I-DIABETES O
down I-DIABETES O
from I-DIABETES O
16%. I-DIABETES O
He O O
continues O O
to O O
follow O O
a O O
diabetic O O
diet. O O
His O O
blood O O
sugars O O
are O O
less O O
than O O
150. O O
He O O
has O O
no O O
other O O
complaints. O O
His O O
medical O O
record O O
was O O
reviewed O O
in O O
detail. O O
Exam: O O
Vital O O
Signs O O
BP O O
123/70, O O
Wt O O
213 O O
lb O O
Heart O O
rate O O
regular O O
62. O O
Lungs O O
clear O O
bilaterally. O O
Right O O
groin: O O
Small O O
hematoma O O
measuring O O
1 O O
cm. O O
Slightly O O
tender. O O
The O O
site O O
is O O
intact O O
and O O
not O O
infected. O O
There O O
is O O
surrounding O O
ecchymosis. O O
Good O O
pulses O O
in O O
the O O
right O O
leg O O
including O O
DP O O
and O O
PT. O O
Foot O O
is O O
warm. O O
Dressing O O
was O O
removed O O
and O O
replaced O O
with O O
Tegaderm. O O
Assessment O O
and O O
plan: O O
1. O O
CAD: B-CAD O
Patient O O
with O O
recent O O
urgent O O
admission O O
for O O
reversible O O
defects, O O
two O O
stents O O
to O O
the O O
RCA O O
placed. O O
Patient O O
now O O
on O O
Plavix, O B-MEDICATION
aspirin, O B-MEDICATION
higher O O
dose O O
of O O
statin, O B-MEDICATION
lisinopril O B-MEDICATION
and O O
Toprol O B-MEDICATION
xl. O O
He O O
is O O
tolerating O O
the O O
medications. O O
Will O O
check O O
fasting O O
labs O O
to O O
ascertain O O
that O O
LDL O O
is O O
below O O
70 O O
and O O
liver O O
function O O
is O O
stable. O O
Patient O O
was O O
urged O O
to O O
report O O
any O O
chest O O
discomfort O O
immediately O O
or O O
weakness, O O
palpitations, O O
bleeding. O O
Has O O
follow O O
up O O
with O O
cardiology. O O
2. O O
Type B-DIABETES O
2 I-DIABETES O
diabetes: I-DIABETES O
Continue O O
diet O O
only. O O
Patient O O
will O O
contact O O
the O O
practice O O
if O O
blood O O
sugar O O
goes O O
over O O
200. O O
Excellent O O
reduction O O
of O O
hemoglobin O O
A1c O O
to O O
6%. O O
Eye O O
exam O O
arranged. O O
3. O O
Hepatitis O O
C: O O
Have O O
checked O O
CBC, O O
platelets O O
on O O
Plavix O B-MEDICATION
and O O
aspirin. O B-MEDICATION
LFTs O O
on O O
higher O O
dose O O
of O O
simvastatin. O B-MEDICATION
Ultrasound O O
scheduled O O
for O O
next O O
month. O O
Follow-up O O
with O O
PCP O O
as O O
planned. O O

Record O O
date: O O
2070-03-11 O O
Reason O O
for O O
Visit O O
Followup O O
History O O
of O O
Present O O
Illness O O
S/p B-CAD O
Cath I-CAD O
with I-CAD O
stents, B-CAD O
no O O
pain O O
since O O
per O O
pt, O O
but O O
wife O O
says O O
he O O
does O O
have O O
pain O O
sometimes O O
which O O
is O O
relieved O O
by O O
resting. O O
He O O
denies O O
any O O
significant O O
pain O O
and O O
denies O O
any O O
associated O O
sx. O O
He O O
attributes O O
the O O
sensation O O
to O O
anxiety. O O
He O O
has O O
a O O
stress O O
test O O
next O O
week. O O
Dicsused O O
potential O O
hazards O O
of O O
ignoring O O
pain, O O
which O O
could O O
be O O
a O O
sign O O
of O O
blockage O O
in O O
one O O
of O O
the O O
stents. O O
Trying O O
hard O O
to O O
change O O
lifestyle O O
though O O
wife O O
reports O O
little O O
physical O O
activity. O O
Diet O O
not O O
as O O
good O O
as O O
it O O
was O O
prior. O O
Pt O O
reports O O
increased O O
feelings O O
depression O O
recently. O O
Continues O O
meds, O O
continues O O
with O O
psych. O O
- O O
Dr O O
Godwin O O
@ O O
Whitney O O
St; O O
counselling O O
w/ O O
Vaughn. O O
Sober O O
x O O
5 O O
years. O O
DM: B-DIABETES O
HbA1c O O
11/18/2069 O O
6.00 O O
Home O O
glucose O O
monitoring O O
Hypoglycemia O O
Assessment/Counseling O O
M-alb/creat O O
ratio O O
07/14/2069 O O
4.1 O O
Microalbumin O O
07/14/2069 O O
0.6 O O
Nutrition O O
Referral O O
Ophthal O O
Exam O O
12/17/2069 O O
Appointment O O
scheduled O O
Podiatry O O
exam O O
HTN B-HYPERTENSION O
- O O
Tols O O
meds O O
wellHepC O O
- O O
stable O O
labs. O O
Abd O O
u/s O O
notable O O
for O O
enlarged O O
spleen O O
in O O
April O O
-- O O
repeat O O
ordered O O
last O O
visit O O
but O O
not O O
yet O O
scheduled. O O
Plt O O
count O O
slightly O O
low. O O
Discussed O O
with O O
pt, O O
q6 O O
month O O
checks O O
necessary. O O
Labs O O
Tuesday O O
U/s O O
Stable O O
persistant O O
LE O O
edema O O
better O O
with O O
the O O
Lasix. O O
Continued O O
pain O O
L O O
shoulder, O O
still O O
wrosening O O
for O O
about O O
a O O
year. O O
Has O O
ortho O O
appt O O
- O O
has O O
missed O O
prior O O
apps O O
because O O
he O O
is O O
afraid. O O
narcotic O O
refills O O
planned. O O
Agree O O
to O O
methadone O O
this O O
time O O
in O O
light O O
of O O
Percocet O O
shortage O O
and O O
possible O O
preferability O O
of O O
methadone O O
rx. O O
Addictions: O O
Has O O
fol O O
at O O
HMI O O
where O O
he O O
gets O O
his O O
methadone O O
(90mg) O O
Review O O
of O O
Systems O O
HEENT O O
no O O
sore O O
throat, O O
dysphagia, O O
odynophagia, O O
trouble O O
hearing O O
or O O
seeing, O O
rhinitis, O O
or O O
sinus O O
painCV O O
no O O
palpitations, O O
orthopnea, O O
PND, O O
claudication O O
sx.RESP O O
negative O O
for O O
SOB, O O
wheeze, O O
coughGI O O
negative O O
for O O
abd O O
pain, O O
diarrhea, O O
heartburn, O O
dyspepsia, O O
anorexiaMUSCULOSKEL O O
as O O
aboveSKIN O O
negativeNEURO O O
negative O O
for O O
numbness, O O
tingling, O O
weakness, O O
fallsPSYCH O O
+ O O
depression O O
and O O
anxietyALLERGIC O O
negative O O
Problems O O
EtOH O O
: O O
last O O
drink O O
4/27/63Hepatitis O O
C O O
Htn O O
H/O O O
hepatitis O O
B O O
: O O
15 O O
years O O
ago O O
after O O
episode O O
of O O
jaundice O O
with O O
HCV O O
two O O
years O O
agoH/O O O
drug O O
abuse O O
: O O
IV O O
drug O O
user O O
stopped O O
heroin O O
2 O O
years O O
ago-methadone O O
maintenence O O
95 O O
mg O O
qdfracture O O
: O O
thumb O O
age O O
47Hernia O O
repair O O
: O O
bilateral O O
inguinal O O
hernia O O
repair O O
Obesity B-OBESE O
abnormal O O
SPEP O O
: O O
could O O
be O O
from O O
Hep O O
C O O
but O O
needs O O
fol O O
esp O O
in O O
light O O
of O O
periph O O
neuropathy O O
- O O
repeat O O
in O O
4 O O
mos O O
(1/67)Coronary B-CAD O
artery I-CAD O
disease I-CAD O
: O O
2 B-CAD O
stents I-CAD O
rcaDiabetes I-CAD O
mellitus O O
type O O
2 O O
: O O
insulinMedications B-MEDICATION B-MEDICATION
Aspirin B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
Acid) O O
325 O O
MG O O
(325MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
, O O
per O O
cards O O
enteric O O
coatedLISINOPRIL B-MEDICATION O
5 O O
MG O O
(5MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
, O O
per O O
cards O O
#30 O O
Tablet(s)Lopressor B-MEDICATION O
(METOPROLOL B-MEDICATION O
Tartrate) O O
50 O O
MG O O
(50MG O O
TABLET O O
Take O O
1) O O
PO O O
BID O O
#60 O O
Tablet(s)Neurontin O O
(GABAPENTIN) O O
600 O O
MG O O
(300MG O O
CAPSULE O O
Take O O
2) O O
PO O O
QID O O
x O O
30 O O
days O O
#1 O O
Month(s) O O
SupplyPlavix B-MEDICATION O
(CLOPIDOGREL) B-MEDICATION O
75 O O
MG O O
(75MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
, O O
per O O
cards O O
#30 O O
Tablet(s)Risperdal O O
(RISPERIDONE) O O
2 O O
MG O O
(2MG O O
TABLET O O
Take O O
1) O O
PO O O
QHS O O
, O O
via O O
psychSIMVASTATIN B-MEDICATION O
40 O O
MG O O
(40MG O O
TABLET O O
Take O O
1) O O
PO O O
QHS O O
x O O
30 O O
days O O
#30 O O
Tablet(s)Allergies O O
Sulfa O O
- O O
Rash, O O
Codeine O O
- O O
Rash, O O
Family O O
History O O
See O O
LMR O O
Social O O
History O O
NonSmokerHealth O O
Maintenance O O
Cholesterol-HDL O O
12/27/2068 O O
25 O O
Cholesterol-LDL O O
12/27/2068 O O
71 O O
DESIRABLE: O O
Cholesterol O O
12/17/2069 O O
Appointment O O
scheduled O O
Complete O O
Physical O O
Exam O O
06/11/2067 O O
GFR O O
(estimated) O O
11/21/2069 O O
&gt;60 O O
Abnormal O O
if O O
HbA1c O O
11/18/2069 O O
6.00 O O
HBsAB O O
04/04/2063 O O
NEG O O
HBsAG O O
04/04/2063 O O
NEG O O
Hct O O
(Hematocrit) O O
11/21/2069 O O
38.4 O O
Hep O O
A O O
Vaccine O O
11/13/2063 O O
Hep O O
B O O
Vaccine O O
11/13/2063 O O
Hgb O O
(Hemoglobin) O O
11/21/2069 O O
13.3 O O
Influenza O O
Vaccine O O
09/30/2069 O O
M-alb/creat O O
ratio O O
07/14/2069 O O
4.1 O O
Microalbumin O O
07/14/2069 O O
0.6 O O
Ophthal O O
Exam O O
12/17/2069 O O
Appointment O O
scheduled O O
PPD O O
09/20/2066 O O
Negative O O
0mm O O
induration O O
Smoking O O
status O O
05/08/2068 B-SMOKER O
Current I-SMOKER O
smoker I-SMOKER O
Td O O
Booster O O
01/07/2062 O O
Triglycerides O O
12/27/2068 O O
181 O O
TSH O O
12/27/2068 O O
1.67 O O
UA-Protein O O
11/18/2069 O O
NEGATIVE O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
128/68 O O
WEIGHT O O
210 O O
lbAGE O O
56y0.5mPhysical O O
Exam O O
Stable O O
fatigued O O
appearance O O
NAD O O
Good O O
eye O O
contact, O O
still O O
slightly O O
pressured.HEENT: O O
EOMI, O O
PERRL. O O
O/p O O
clear O O
no O O
erythema, O O
no O O
exudate. O O
Dentures. O O
Tonsils O O
not O O
enlarged.Neck O O
supple O O
FROM, O O
no O O
cervical O O
LAD. O O
Thyroid O O
nontender, O O
nonpalpable.TMs O O
clear O O
bilat O O
without O O
effusion O O
or O O
erythema. O O
CV: O O
RRR O O
nl O O
s1s2 O O
no O O
MRG. O O
LUNGS: O O
CTA O O
bilat O O
with O O
good O O
air O O
movement, O O
no O O
wheeze, O O
rhonchi, O O
crackles. O O
Normal O O
PMIGI: O O
Abd O O
soft O O
+ O O
BS O O
nontender, O O
obese, O O
no O O
masses, O O
no O O
HSMSKIN: O O
Mild O O
pretibial O O
discoloration O O
without O O
woody O O
induration. O O
no O O
bruising. O O
Trace O O
peripheral O O
edema. O O
Plan O O
1. O O
Counselling O O
as O O
above: O O
calcium, O O
diet O O
and O O
exercise, O O
seatbelts2. O O
DM: O O
Doing O O
much O O
better, O O
repeat O O
labs O O
Tuesday. O O
3. O O
Cirrhosis, O O
Hep O O
C, O O
labs O O
due. O O
Repeat O O
u/s. O O
4. O O
Shoudler O O
pain O O
- O O
ortho O O
appt. O O
coming O O
up, O O
refill O O
rx. O O
5. O O
Depression O O
up O O
and O O
down, O O
more O O
or O O
less O O
stable, O O
fol O O
mental O O
health O O
- O O
stable O O
Creat O O
now O O
off O O
lithium. O O
6. O O
HTN O O
- O O
a O O
bit O O
high O O
today. O O
repeat O O
1 O O
month O O
7. O O
Clean O O
and O O
sober. O O
On O O
methadone. O O
8. O O
Considering O O
Smoking O O
Cessation. O O
Rx O O
patch O O
with O O
instructions. O O
9. O O
CP O O
as O O
above. O O
20 O O
min O O
discussion O O
of O O
importance O O
reporting O O
sx O O
accurately, O O
possible O O
risks O O
ignoring O O
CP. O O
ETT O O
next O O
week O O
- O O
pt O O
confirms O O
that O O
he O O
will O O
go O O
for O O
this O O
without O O
fail. O O
ECG O O
requested O O
today O O
but O O
pt O O
did O O
not O O
take O O
lab O O
slip O O
with O O
him O O
to O O
have O O
it O O
done. O O
TOtal O O
visit: O O
50 O O
min O O
Counelling O O
on O O
topics O O
listed O O
above O O
(DM, O O
need O O
for O O
Hep O O
C O O
labs O O
q6 O O
mo, O O
HTN/low O O
salt O O
diet, O O
Smoking O O
cessation, O O
and O O
CP) O O
40 O O
min. O O

Record O O
date: O O
2070-10-13 O O
Internal O O
Medicine O O
Team O O
2 O O
Intern O O
Admission O O
Note O O
PATIENT: O O
Gallegos, O O
Stephen O O
MRN: O O
5605330 O O
DATE: O O
10/13/2070 O O
1:13 O O
AM O O
ATTENDING: O O
Albright O O
PCP: B-CAD O
Julie O O
Morrow O O
HCP: O O
Oconnor O O
(wife) O O
988-128-8518 O O
Code O O
status: O O
Full O O
(discussed O O
with O O
patient) O O
CHIEF O O
COMPLAINT: O O
Chest B-CAD O
Pain I-CAD O
HISTORY O O
OF O O
THE O O
PRESENT O O
ILLNESS: O O
56 O O
yo O O
M O O
h/o O O
CAD B-CAD O
s/p B-CAD O
BMS B-CAD O
x2 I-CAD O
to I-CAD O
RCA, I-CAD O
HTN, B-HYPERTENSION O
HLD, B-HYPERLIPIDEMIA O
diet-controlled B-DIABETES O
DM, B-DIABETES O
smoking, B-SMOKER O
who O O
developed O O
sudden O O
onset O O
of O O
chest B-CAD O
discomfort, I-CAD O
SOB, I-CAD O
and O O
overall O O
feeling O O
unwell O O
tonight O O
at O O
approximately O O
7:30pm O O
while O O
watching O O
television. O O
He O O
said O O
the O O
chest O O
discomfort O O
was O O
moderate, O O
substernal O O
and O O
L O O
chest, O O
nonradiating, O O
relieved O O
by O O
a O O
single O O
dose O O
of O O
NTG. B-MEDICATION O
He O O
asked O O
his O O
wife O O
to O O
call O O
EMS, O O
by O O
the O O
time O O
they O O
arrived O O
he O O
was O O
CP O O
free O O
but O O
decided O O
to O O
come O O
to O O
the O O
ER O O
given O O
his O O
cardiac O O
history. O O
On O O
arrival O O
to O O
the O O
floor O O
he O O
continued O O
to O O
be O O
CP O O
free. O O
Of O O
note, O O
1d O O
PTA O O
he O O
called O O
his O O
PCP O O
clinic O O
and O O
c/o O O
CP. O O
He O O
stated O O
when O O
walking O O
from O O
the O O
H O O
J O O
Heinz O O
Company O O
he O O
had O O
progressive O O
SOB O O
with O O
mild O O
L O O
CP O O
that O O
was O O
similar O O
to, O O
but O O
much O O
milder O O
than O O
this O O
current O O
episode. O O
It O O
was O O
relieved O O
by O O
rest O O
and O O
worsened O O
with O O
exertion. O O
ER O O
Course: O O
He O O
remained O O
CP O O
free O O
with O O
stable O O
VS. O O
The O O
first O O
set O O
of O O
cardiac O O
markers O O
CK O O
1738, O O
CKMB O O
26.3, O O
Index O O
1.5, O O
Trop O O
0.03. O O
He O O
received O O
ASA. B-MEDICATION O
REVIEW O O
OF O O
SYSTEMS O O
He O O
had O O
no O O
HA, O O
visual O O
changes, O O
light-headedness, O O
SOB, O O
abd O O
pain, O O
n/v/d/c, O O
LE O O
edema. O O
Past O O
Medical O O
History O O
1. O O
CAD O B-MEDICATION
&#8211; O O
non-dx O O
treadmill O O
stress O O
(exercise O O
8 O O
mets) O O
3/70; O O
cath B-CAD O
11/69 O O
BMS O O
of O O
RCA O O
x2; O O
treadmill B-CAD O
mibi I-CAD O
11/69 I-CAD O
inferior I-CAD O
reversible I-CAD O
ischemia I-CAD O
2. O O
HTN O O
3. O O
HLD O O
&#8211; O O
6/70 O O
lipids O O
LDL O O
45, O O
HDL O O
35, O O
TG O O
123 O O
4. O O
DM2 O O
&#8211; O O
A1c B-DIABETES O
6.7 I-DIABETES O
in I-DIABETES O
6/70 I-DIABETES O
5. O O
CVA O O
in O O
2064 O O
w/residual O O
L O O
facial O O
droop O O
(no O O
other O O
sx) O O
6. O O
Hepatitis O O
B O O
&#8211; O O
2063: O O
HBV O O
CAB O O
pos, O O
SAB O O
neg, O O
SAG O O
neg; O O
HBV O O
Vaccine O O
most O O
recent O O
7/70 O O
7. O O
Hepatitis O O
C O O
&#8211; O O
failed O O
IFN O O
tx O O
in O O
the O O
past; O O
HCV O O
VL&gt;700k O O
6/70; O O
AFP O O
17.5 O O
6/70 O O
(up O O
from O O
15.1 O O
in O O
3/70, O O
15.6 O O
12/68) O O
8. O O
Alcohol O O
Abuse O O
&#8211; O O
last O O
drink O O
7 O O
yrs O O
ago, O O
goes O O
to O O
AA/NA O O
9. O O
IVDA O O
&#8211; O O
on O O
methadone O O
~10 O O
yrs O O
MEDICATIONS O O
ON O O
ADMISSION O O
(source O O
of O O
information) O O
1. O O
ASA O B-MEDICATION
81mg O O
PO O O
daily O O
2. O O
Plavix B-MEDICATION B-MEDICATION
75mg O O
PO O O
daily O O
3. O O
Propanolol B-MEDICATION O
80mg O O
PO O O
BID O O
4. O O
Lisinopril B-MEDICATION B-MEDICATION
5mg O O
PO O O
daily O O
5. O O
Simvastatin B-MEDICATION B-MEDICATION
40mg O O
PO O O
qPM O O
6. O O
NTG O O
0.4 O O
SL O O
prn O O
7. O O
Gabapentin O B-MEDICATION
800mg O O
PO O O
BID O O
8. O O
Risperdal O O
1mg O O
PO O O
BID O O
9. O O
Methadone O O
93mg O O
daily O O
&#224; O O
Physicians O O
Hospital, O O
46 O O
Champagne O O
Drive, O O
Freeport, O O
WY O O
94152 O O
587-033-5624 O O
ALLERGIES/ADVERSE O O
REACTIONS O O
NKDA O O
FAMILY O O
HISTORY O O
Father B-FAMILY_HIST O
died I-FAMILY_HIST O
of I-FAMILY_HIST O
MI I-FAMILY_HIST O
age I-FAMILY_HIST O
49 I-FAMILY_HIST O
Mother O O
alive O O
in O O
her O O
80s, O O
has O O
gallstones O O
5 O O
Brothers, O O
2 O O
Sisters O O
all O O
healthy O O
SOCIAL O O
HISTORY O O
Lives O O
in O O
Manti O O
with O O
wife O O
and O O
dog, O O
not O O
working O O
(wife O O
works O O
as O O
Forestry O O
Technologist), O O
smokes O O
10 O O
cigarettes/day O O
(wants O O
to O O
quit), O O
no O O
etoh O O
x7yrs, O O
no O O
IVDA O O
in O O
~10yrs O O
(previously O O
heroin) O O
now O O
on O O
methadone O O
maintenance O O
PHYSICAL O O
EXAMINATION O O
VITALS: O O
97.2, O O
52, O O
134/79, O O
22 O O
100% O O
RA O O
General O O
&#8211; O O
middle-aged O O
man O O
laying O O
in O O
bed O O
Skin O O
&#8211; O O
tan O O
in O O
sun-exposed O O
areas, O O
scattered O O
angiomata O O
bilat O O
LE O O
HEENT O O
&#8211; O O
PEERL, O O
no O O
scleral O O
icterus, O O
OP O O
clear, O O
MMM O O
Lymph O O
nodes O O
&#8211; O O
no O O
palpable O O
LAD O O
Pulmonary O O
&#8211; O O
CTAB, O O
no O O
wheezes O O
or O O
rhonchi O O
Cardiac O O
&#8211; O O
brady, O O
reg O O
rhythm, O O
nl O O
s1 O O
s2, O O
no O O
murmurs O O
Abdomen O O
&#8211; O O
obese, O O
soft, O O
nontender, O O
no O O
HSM, O O
no O O
caput O O
Extremity O O
&#8211; O O
bilt O O
hemosiderin O O
changes O O
LABORATORIES O O
Na O O
137, O O
K O O
4.1, O O
Cl O O
99, O O
CO2 O O
29.5, O O
BUN O O
14, O O
Cr O O
0.96, O O
Glu O O
87, O O
AG O O
9, O O
Ca O O
9.4, O O
Mg O O
1.8, O O
Phos O O
3.8 O O
WBC O O
6.4, O O
Hct O O
44.3, O O
Plt O O
137 O O
INR O O
1.3, O O
PTT O O
26.6 O O
CK O O
1738, O O
CKMB O O
26.3, O O
Index O O
1.5, O O
Trop O O
0.03 O O
MICROBIOLOGY O O
None O O
RADIOLOGICAL O O
STUDIES O O
CXR O O
&#8211; O O
image O O
not O O
yet O O
available O O
ECG O O
Sinus O O
bradycardia O O
@52bpm, O O
TWI O O
in O O
III, O O
flat O O
in O O
AVF, O O
biphasic O O
in O O
V2-V6 O O
previous O O
ECG O O
showed O O
only O O
TWI O O
in O O
III O O
ASSESSMENT O O
AND O O
PLAN O O
56 O O
yo O O
M O O
h/o O O
CAD O O
s/p O O
BMS O O
x2 O O
to O O
RCA, O O
HTN, O O
HLD, O O
diet-controlled O O
DM, O O
smoking, O O
p/w O O
chest O O
pain O O
at O O
rest O O
#) O O
Chest O O
Pain: O O
Certain O O
aspects O O
of O O
the O O
history O O
(similar O O
to O O
previous O O
e/o O O
angina, O O
sudden O O
onset, O O
relief O O
with O O
NTG) O O
are O O
concerning O O
for O O
cardiac O O
cause. O O
The O O
subtle O O
but O O
real O O
changes O O
in O O
the O O
ECG O O
and O O
the O O
non-zero O O
troponin O O
are O O
also O O
concerning. O O
Other O O
etiologies O O
include O O
anxiety O O
(pt O O
described O O
a O O
sense O O
of O O
doom), O O
pulmonary O O
causes O O
(less O O
likely O O
given O O
nl O O
exam O O
and O O
lack O O
of O O
hypoxia), O O
musculoskeletal O O
(pt O O
denies O O
trauma), O O
PE O O
(pt O O
is O O
not O O
tachycardic O O
or O O
hypoxemic). O O
-Telemetry O O
-f/u O O
repeat O O
troponin, O O
CK-MB O O
-If O O
positive O O
will O O
start O O
heparin O O
gtt O O
-If O O
negative O O
will O O
continue O O
to O O
cycle O O
enzymes O O
-Treadmill O O
stress O O
w/imaging O O
in O O
AM O O
-Continue O O
ASA O B-MEDICATION
325mg, O O
Plavix O B-MEDICATION
-f/u O O
LFTs O O
given O O
CK O O
elevation O O
but O O
continue O O
home O O
statin O O
(no O O
increase O O
in O O
dose O O
given O O
c/f O O
statin O O
myopathy) O O
#) O O
Thrombocytopenia: O O
appears O O
to O O
be O O
longstanding O O
and O O
stable O O
by O O
labs. O O
The O O
most O O
likely O O
etiology O O
is O O
HCV O O
given O O
the O O
strong O O
association O O
of O O
HCV O O
with O O
thrombocytopenia O O
and O O
his O O
longstanding O O
disease. O O
Other O O
possibilities O O
include O O
Plavix O O
effect O O
(although O O
thrombocytopenia O O
predates O O
starting O O
plavix), O O
alcohol O O
(although O O
pt O O
claims O O
abstinence), O O
or O O
ITP. O O
Hypoproductive O O
etiologies O O
are O O
less O O
likely O O
given O O
nl O O
WBC O O
and O O
Hct. O O
-f/u O O
smear O O
-monitor O O
CBC O O
#) O O
HTN: O O
Well O O
controlled O O
on O O
arrival O O
-Continue O O
Lisinopril O B-MEDICATION
5mg O O
PO O O
daily, O O
Propanolol O O
80mg O O
PO O O
BID O O
(given O O
bradycardia O O
may O O
need O O
to O O
decrease O O
dose O O
although O O
currently O O
tolerating O O
well) O O
#) O O
HLD: O O
Given O O
CK O O
elevation O O
will O O
defer O O
acutely O O
increasing O O
statin O O
dose O O
-6/70 O O
lipids O O
LDL O O
45, O O
HDL O O
35, O O
TG O O
123 O O
-Simvastatin O O
40mg O O
PO O O
qPM O O
#) O O
DM: O O
most O O
recent O O
A1c O O
6.7 O O
-FSBG O O
AC+HS O O
-RISS O O
AC O O
#) O O
HBV: O O
given O O
h/o O O
HBVcAB O O
pos O O
with O O
HBVsAg O O
neg O O
and O O
HBVsAb O O
neg O O
likely O O
either O O
chronic O O
seropositive O O
occult O O
HBV O O
with O O
extremely O O
low-level O O
viremia O O
not O O
triggering O O
surface O O
antibody O O
response, O O
or O O
resolved O O
acute O O
HBV O O
having O O
lost O O
high O O
antibody O O
titers O O
over O O
time. O O
-s/p O O
HBV O O
vaccine O O
x4 O O
doses, O O
most O O
recently O O
7/70 O O
-f/u O O
repeat O O
HBVsAb O O
repeat O O
to O O
assess O O
response O O
to O O
vaccine O O
-f/u O O
HBV O O
DNA O O
to O O
eval O O
for O O
occult O O
chronic O O
infection O O
#) O O
HCV: O O
s/p O O
PEG O O
IFN O O
and O O
Ribavirin O O
3/65-9/65 O O
with O O
inadequate O O
tx O O
response O O
-Up O O
to O O
date O O
on O O
HCC O O
screening O O
(AFP O O
and O O
ultrasound O O
within O O
last O O
year) O O
#) O O
Addiction: O O
abstinent O O
from O O
etoh O O
and O O
IVD O O
&gt;5yrs O O
-Urine O O
tox O O
-Encouraged O O
pt O O
to O O
continue O O
to O O
attend O O
AA/NA O O
meetings O O
-Nicotine O O
patch, O O
consult O O
tobacco O O
cessation O O
-Will O O
call O O
methadone O O
clinic O O
in O O
AM: O O
Physicians O O
Hospital, O O
65 O O
Champagne O O
Drive, O O
Freeport, O O
WY O O
94152 O O
587-033-5624 O O
-Verify O O
methadone O O
dose O O
and O O
let O O
them O O
know O O
pt O O
in O O
hospital O O
-Continue O O
methadone O O
while O O
in O O
house O O
#) O O
Bipolar: O O
continue O O
risperdal O O
and O O
neurontin O O
-f/u O O
with O O
PCP O O
vs. O O
psych O O
to O O
check O O
doses O O
(chart O O
lists O O
risperdal O O
as O O
1mg O O
PO O O
BID O O
vs. O O
2mg O O
PO O O
QHS) O O
and O O
Neurontin O O
as O O
800mg O O
PO O O
BID O O
vs. O O
600mg O O
PO O O
QID) O O
#) O O
F/E/N: O O
NPO O O
for O O
stress; O O
D5 O O
&#189; O O
NS O O
while O O
NPO; O O
replete O O
lytes O O
prn O O
K&gt;4, O O
Mg&gt;2 O O
#) O O
Ppx: O O
DVT-ASA/Plavix, O O
hold O O
fragmin O O
given O O
pending O O
heparin O O
gtt O O
decision O O
; O O
GI-not O O
indicated O O
; O O
Bowel-colace/senna/dulculax O O
#) O O
Dispo: O O
likely O O
home O O
pending O O
cardiac O O
w/u O O
#) O O
CODE: O O
FULL O O
(discussed O O
with O O
patient) O O
__________________________________ O O
Stephen O O
Olguin, O O
MD O O
Pager O O
#25204 O O

Record O O
date: O O
2093-07-13 O O
CCU O O
JAR O O
Admission O O
Note O O
Name: O O
Urban, O O
Russell O O
MRN: O O
4722064 O O
Date O O
of O O
Admission: O O
7/09/93 O O
PCP: O O
Georgia O O
Cards: O O
ward O O
ID: O O
50 O O
y/o O O
man O O
transferred O O
to O O
CCU O O
for O O
wide O O
complex O O
tachyarrhythmia O O
HPI: O O
50 O O
y/o O O
man O O
with O O
no O O
PMH O O
and O O
cardiac O O
risk O O
factors O O
of O O
smoking B-SMOKER O
and O O
family B-FAMILY_HIST O
history I-FAMILY_HIST O
(father I-FAMILY_HIST O
died I-FAMILY_HIST O
of I-FAMILY_HIST O
MI I-FAMILY_HIST O
at I-FAMILY_HIST O
age I-FAMILY_HIST O
41) I-FAMILY_HIST O
who O O
presented O O
to O O
the O O
ED O O
with O O
chest B-CAD O
pain. I-CAD O
He O O
had O O
an O O
ETT O O
per O O
patient O O
report O O
in O O
Georgia O O
which O O
was O O
neg O O
for O O
ischemia O O
4 O O
years O O
ago. O O
He O O
claims O O
excellent O O
exercise O O
tolerance O O
can O O
run O O
at O O
least O O
3 O O
miles O O
without O O
SOB O O
or O O
CP O O
but O O
does O O
not O O
exercise O O
regularly. O O
At O O
concert O O
on O O
day O O
of O O
admission, O O
he O O
was O O
sitting O O
at O O
rest O O
when O O
he O O
had O O
sudden O O
onset O O
of O O
crushing B-CAD O
sub-sternal I-CAD O
chest I-CAD O
pain, I-CAD O
8/10, I-CAD O
no I-CAD O
radiation, I-CAD O
associated I-CAD O
with I-CAD O
mild I-CAD O
SOB I-CAD O
and I-CAD O
marked I-CAD O
diaphoresis. I-CAD O
Pt O O
reported O O
some O O
associated O O
back O O
pain O O
with O O
onset, O O
like O O
'I O O
was O O
being O O
crushed O O
like O O
a O O
sandwich.' O O
Was O O
not O O
eating O O
at O O
time, O O
not O O
like O O
heartburn, O O
no O O
fevers, O O
chills, O O
cough, O O
or O O
chest O O
trauma. O O
EMT O O
was O O
called-2 O O
SL O O
ntg O O
relieved O O
pain, O O
was O O
given O O
ASA. B-MEDICATION O
On O O
arrival O O
to O O
the O O
ED, O O
he O O
was O O
chest O O
pain O O
free. O O
His O O
HR O O
was O O
52-60 O O
in O O
normal O O
sinus O O
rhythm. O O
On O O
hindsight, O O
EKG O O
showed O O
sinus O O
bradycardia O O
with O O
1mm O O
STE O O
in O O
III, O O
mm O O
aVF, O O
1mm O O
STD O O
in O O
I, O O
? O O
aVL O O
with O O
biphasic O O
T O O
in O O
I, O O
TWI O O
in O O
aVL. O O
He O O
received O O
ASA O O
and O O
SLTNG O O
Cardiac O O
RF O O
include O O
tobacco O O
(1/2 O O
ppd O O
x O O
30 O O
yrs) O O
and O O
early O O
family O O
hx O O
(Dad O O
died O O
of O O
MI, O O
first O O
MI O O
at O O
41). O O
No O O
known O O
HTN, O O
DM, O O
or O O
hyperlipidemia. O O
Course O O
on O O
floor: O O
Seen O O
for O O
initial O O
H&P O O
when O O
patient O O
came O O
to O O
CCU5. O O
During O O
exam, O O
patient O O
became O O
acutely O O
diaphoretic, O O
appeared O O
uncomfortable, O O
still O O
complaining O O
of O O
CP O O
with O O
some O O
mild O O
back O O
pain. O O
BP: O O
L O O
arm O O
105/66, O O
R O O
arm O O
90/63. O O
(2 O O
rpt O O
BPs O O
were O O
equal O O
on O O
both O O
arms O O
within O O
5 O O
mm O O
Hg) O O
HR O O
bradycardia O O
in O O
high O O
40s, O O
sat O O
98% O O
2L. O O
Tele O O
demonstrated O O
sinus O O
brady, O O
then O O
several O O
runs O O
of O O
40-50bt O O
wide O O
QRS O O
tachyarrythmia O O
which O O
spontaneously O O
resolved O O
back O O
to O O
sinus O O
bradycardia. O O
Pt O O
was O O
symptomatic O O
during O O
these O O
episodes O O
and O O
appeared O O
acutely O O
SOB, O O
diaphoretic. O O
Nursing O O
supervisor O O
and O O
medical O O
senior O O
stat O O
paged, O O
12 O O
ld O O
EKG O O
repeated, O O
pt O O
was O O
given O O
2 O O
mg O O
IV O O
magnesium O O
and O O
100mg O O
of O O
lidocaine, O O
started O O
on O O
nonbreather. O O
Heparin O O
was O O
ordered O O
and O O
pt O O
was O O
transferred O O
to O O
the O O
CCU. O O
On O O
arrival O O
to O O
CCU, O O
pt O O
was O O
lethargic O O
and O O
diaphoretic. O O
He O O
denied O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
nausea. O O
SDU O O
Course: O O
For O O
ventricular O O
ectopy O O
(likely O O
AIVR O O
in O O
setting O O
of O O
ischemia), O O
pt O O
was O O
transitioned O O
to O O
Amiodarone. O O
This O O
was O O
tapered O O
off O O
and O O
he O O
had O O
no O O
further O O
ectopy. O O
Echo O O
was O O
performed O O
7/10: O O
(normal) O O
(completed O O
only O O
if O O
abn.) O O
MITRAL O O
VALVE O O
NORM O O
SEGMENT O O
BASE O O
MID O O
APEX O O
LEFT O O
ATRIUM O O
NORM O O
LA O O
37 O O
AV. O O
A0. O O
LVOT O O
NORM O O
AO O O
29 O O
anterior O O
LEFT O O
VENT. O O
ABN O O
LVIDd O O
50 O O
ant.sep. O O
TV. O O
RA. O O
VC. O O
NORM O O
LVIDs O O
44 O O
mid.sep. O O
PV. O O
INF. O O
PA. O O
NORM O O
PWT O O
10 O O
inf.sep. O O
RIGHT O O
VENT. O O
ABN O O
IVS O O
11 O O
inferior O O
IAS. O O
IVS. O O
NORM O O
inf.pos. O O
COMPLEX O O
CHD O O
EF O O
28 O O
% O O
( O O
&gt;50 O O
%) O O
pos.lat. O O
CORONARIES O O
lateral O O
PERICARDIUM O O
NORM O O
MITRAL O O
VALVE O O
There O O
is O O
no O O
evidence O O
of O O
mitral O O
valve O O
prolapse. O O
There O O
is O O
trace O O
mitral O O
regurgitation O O
by O O
color O O
and O O
spectral O O
Doppler. O O
LEFT O O
ATRIUM O O
There O O
is O O
no O O
evidence O O
of O O
left O O
atrial O O
dilatation. O O
AORTIC O O
VALVE, O O
AORTA, O O
LVOT O O
There O O
is O O
no O O
evidence O O
of O O
valvular O O
aortic O O
stenosis. O O
The O O
aortic O O
valve O O
is O O
tricuspid. O O
There O O
is O O
no O O
evidence O O
of O O
aortic O O
insufficiency O O
by O O
color O O
or O O
spectral O O
Doppler. O O
LEFT O O
VENTRICLE O O
The O O
left O O
ventricular O O
cavity O O
size O O
is O O
normal. O O
The O O
left O O
ventricular O O
systolic O O
function O O
is O O
impaired. O O
The O O
left O O
ventricle O O
is O O
diffusely O O
hypokinetic O O
with O O
regional O O
variation. O O
The O O
Inferior O O
wall O O
is O O
akinetic. O O
The O O
estimated O O
ejection O O
fraction O O
is O O
28 O O
%. O O
TRICUSPID O O
VALVE O O
- O O
IVC, O O
SVC O O
There O O
is O O
color O O
and O O
spectral O O
Doppler O O
evidence O O
of O O
trace O O
tricuspid O O
insufficiency. O O
RIGHT O O
VENTRICLE O O
The O O
right O O
ventricle O O
is O O
not O O
dilated. O O
The O O
right O O
ventricle O O
is O O
diffusely O O
hypokinetic. O O
PERICARDIAL O O
DISEASE O O
AND O O
EXTRACARDIAC O O
MASSES O O
There O O
is O O
no O O
evidence O O
of O O
pericardial O O
effusion. O O
Pt O O
was O O
taken O O
to O O
the O O
cath B-CAD O
lab I-CAD O
7/11 I-CAD O
where I-CAD O
his I-CAD O
RHC I-CAD O
showed I-CAD O
RA I-CAD O
9, I-CAD O
PA I-CAD O
25/15/20, I-CAD O
PCWP I-CAD O
13, I-CAD O
CO I-CAD O
6.4. I-CAD O
Mild I-CAD O
LAD I-CAD O
disease, I-CAD O
30% I-CAD O
circumflex I-CAD O
stenosis, I-CAD O
RCA I-CAD O
100% I-CAD O
occlusion, I-CAD O
stented B-CAD O
x3 I-CAD O
with I-CAD O
dissection I-CAD O
of I-CAD O
RCA I-CAD O
during I-CAD O
procedure. I-CAD O
He O O
also O O
had O O
transient O O
reocclusion O O
during O O
procedure. O O
TIMI O O
II O O
flow O O
after O O
IC O O
adenosine. O O
IABP O O
and O O
temp O O
wire O O
(for O O
profound O O
bradycardia) O O
were O O
placed O O
during O O
procedure. O O
V-gram O O
showed O O
basal O O
inferior O O
AK O O
and O O
anterolateral O O
HK, O O
EF O O
approximately O O
40%. O O
His O O
peak O O
CK O O
were O O
1491. O O
Because O O
his O O
initial O O
echo O O
showed O O
low O O
EF O O
out O O
of O O
proportion O O
to O O
his O O
ischemic O O
event, O O
other O O
causes O O
of O O
low O O
EF O O
were O O
investigated. O O
His O O
serum O O
Fe O O
was O O
slightly O O
low, O O
TSH O O
was O O
normal, O O
SPEP O O
had O O
several O O
low O O
Igs O O
but O O
no O O
evidence O O
of O O
myeloma. O O
Lipid O O
profile O O
showed O O
Cholesterol O O
210, O O
Trig O O
59, O O
HDL O O
45, O O
LDL B-HYPERLIPIDEMIA O
153. B-HYPERLIPIDEMIA O
HgbA1c O O
was O O
6.3. O O
Because O O
of O O
reocclusion O O
during O O
cath, O O
hypercoag O O
workup O O
was O O
sent O O
and O O
was O O
negative O O
(including O O
lupus O O
anticoagulant, O O
hypercoag O O
panel, O O
HIT). O O
He O O
continued O O
to O O
have O O
some O O
chest O O
pain O O
post-cath O O
with O O
mild O O
increase O O
of O O
CK O O
likely O O
d/t O O
distal O O
embolization. O O
He O O
has O O
now O O
been O O
persistently O O
pain-free. O O
His O O
IABP O O
was O O
d/ced O O
7/12. O O
He O O
was O O
continued O O
on O O
ASA, O B-MEDICATION
Plavix, B-MEDICATION B-MEDICATION
Lipitor B-MEDICATION B-MEDICATION
and O O
Bblocker, B-MEDICATION B-MEDICATION
Captopril B-MEDICATION B-MEDICATION
were O O
added O O
and O O
can O O
be O O
titrated O O
up. O O
PMH: O O
None O O
per O O
patient. O O
FamHx: O O
Father O O
as O O
above. O O
Mother O O
no O O
signific O O
hx. O O
SocHx: O O
Married, O O
originally O O
from O O
Nicaragua, O O
lives O O
in O O
Citrus O O
Ridge O O
now. O O
Works O O
as O O
professional. O O
HRB: O O
Tob: O O
ppd O O
x O O
30 O O
yrs. O O
EtOH: O O
Scarce. O O
Drugs: O O
None O O
Medications/Doses: O O
None O O
Medications O O
at O O
Transfer: O O
Lipitor O B-MEDICATION
20 O O
mg O O
po O O
qd O O
ASA O B-MEDICATION
325 O O
mg O O
po O O
qd O O
Plavix O B-MEDICATION
75 O O
mg O O
po O O
qd O O
Fragmin O O
5000 O O
U O O
sc O O
qd O O
Captopril O B-MEDICATION
25 O O
mg O O
po O O
TID O O
Lopressor B-MEDICATION B-MEDICATION
75 O O
mg O O
po O O
TID O O
Nicotine O O
patch O O
14 O O
mcg/d O O
q O O
24 O O
hrs O O
Allergies: O O
NKDA O O
Review O O
of O O
Systems O O
(negative O O
unless O O
checked): O O
General: O O
Fatigue( O O
), O O
fevers O O
( O O
), O O
appetite O O
( O O
), O O
weight O O
loss/gain O O
( O O
), O O
heat/cold O O
intolerance O O
( O O
), O O
diaphoresis O O
( O O
), O O
chills O O
( O O
), O O
sweats O O
( O O
), O O
travel O O
( O O
), O O
sick O O
contacts O O
( O O
) O O
HEENT: O O
acute O O
visual O O
changes O O
( O O
), O O
acute O O
hearing O O
changes O O
( O O
), O O
dizziness O O
( O O
), O O
HA O O
( O O
), O O
trauma O O
( O O
), O O
sore O O
throat O O
( O O
) O O
rhinorrhea O O
( O O
), O O
facial O O
pain O O
( O O
) O O
Respiratory: O O
SOB( O O
), O O
cough O O
( O O
), O O
hemoptysis O O
( O O
), O O
wheezing O O
( O O
), O O
sputum O O
( O O
) O O
CV: O O
CP O O
x O O
), O O
vomiting O O
( O O
), O O
pain O O
( O O
), O O
diarrhea O O
( O O
), O O
constipation O O
( O O
), O O
melena/BRBPR O O
( O O
), O O
hematemesis O O
( O O
), O O
diff O O
swallow O O
( O O
) O O
GU: O O
dysuria O O
( O O
), O O
urgency O O
( O O
), O O
frequency O O
( O O
), O O
hematuria O O
( O O
), O O
discharge O O
( O O
) O O
, O O
STD O O
( O O
), O O
burning O O
( O O
), O O
discharge O O
( O O
) O O
Musculoskeltal/neuro: O O
weakness O O
( O O
), O O
pain O O
( O O
), O O
tremor O O
( O O
), O O
sensation O O
( O O
), O O
skin O O
rashes O O
( O O
) O O
Please O O
see O O
today's O O
note O O
for O O
exam O O
and O O
data. O O
Imp: O O
50 O O
y/o O O
man O O
with O O
CRFs O O
smoking O O
and O O
family O O
history O O
s/p O O
RCA O O
stent O O
x3, O O
s/p O O
IABP O O
now O O
titrating O O
up O O
meds. O O
Plan O O
1. O O
Ischemia O O
- O O
ASA, O B-MEDICATION
Plavix, O B-MEDICATION
B-Blocker, O O
Captopril, O B-MEDICATION
titrate O O
up O O
as O O
tolerated. O O
2. O O
Pump O O
- O O
EF O O
improved O O
on O O
LV O O
gram O O
at O O
cath. O O
Diurese O O
prn, O O
plan O O
echo O O
in O O
2-3 O O
months O O
to O O
assess O O
recovery. O O
If O O
persistent O O
low O O
EF, O O
may O O
need O O
further O O
w/u O O
for O O
additional O O
causes O O
of O O
cardiomyopathy. O O
3. O O
Rhythm O O
- O O
no O O
ectopy, O O
now O O
off O O
Amiodarone. O O
Replete O O
K, O O
Mg. O O
4. O O
Prophylaxis: O O
Fragmin, O O
Nexium O O
Louise O O
Eisenberg, O O
MD O O
pgr O O
76699 O O

Record O O
date: O O
2093-08-19 O O
August O O
19, O O
2093 O O
John O O
Ussery, O O
M.D. O O
Worthington O O
- O O
Internal O O
Medicine O O
80 O O
Shattuck O O
Street, O O
IM O O
270 O O
Citrus O O
Ridge, O O
MT O O
43782 O O
Re: O O
Russell O O
Urban O O
WRH# O O
4722064 O O
Dear O O
Dr. O O
Ussery: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
Mr. O O
Russell O O
Urban O O
in O O
Cardiology O O
Clinic O O
today. O O
As O O
you O O
know, O O
Mr. O O
Urban O O
is O O
a O O
very O O
pleasant O O
50-year-old O O
gentleman O O
who O O
on O O
July O O
09, O O
2093, O O
while O O
sitting O O
at O O
a O O
concert O O
in O O
Central O O
Park O O
had O O
the O O
sudden O O
onset O O
of O O
feeling O O
unwell O O
, O O
epigastric O O
discomfort, O O
and O O
profound O O
diaphoresis. O O
He O O
came O O
to O O
the O O
Worthington O O
Regional O O
Hospital O O
Emergency O O
Room O O
at O O
that O O
time. O O
By O O
the O O
time O O
he O O
arrived, O O
his O O
symptoms O O
had O O
abated. O O
He O O
had O O
an O O
unremarkable O O
electrocardiogram O O
initially O O
and O O
negative O O
cardiac O O
markers, O O
and O O
was O O
admitted O O
to O O
the O O
medicine O O
service O O
to O O
rule-out O O
a O O
myocardial B-CAD O
infarction. I-CAD O
That O O
evening, O O
he O O
had O O
recurrent O O
symptoms O O
and O O
was O O
noted O O
to O O
have O O
sustained O O
wide O O
complex O O
tachycardia, O O
which O O
appears O O
to O O
be O O
ventricular O O
tachycardia. O O
He O O
was O O
transferred O O
to O O
the O O
Cardiac O O
Care O O
Unit O O
for O O
further O O
management. O O
The O O
next O O
morning, O O
he O O
underwent O O
cardiac O O
ultrasound, O O
which O O
revealed O O
an O O
ejection O O
fraction O O
of O O
28% O O
and O O
a O O
diffusely O O
hypokinetic O O
left O O
ventricle O O
with O O
an O O
akinetic O O
inferior O O
wall. O O
Additionally O O
his O O
next O O
set O O
of O O
cardiac B-CAD O
markers I-CAD O
returned I-CAD O
positive. I-CAD O
He O O
therefore O O
went O O
cardiac B-CAD O
catheterization I-CAD O
revealing I-CAD O
a I-CAD O
total B-CAD O
occlusion I-CAD O
of I-CAD O
his I-CAD O
right I-CAD O
coronary I-CAD O
artery I-CAD O
and I-CAD O
minimal I-CAD O
non-obstructive I-CAD O
disease I-CAD O
of I-CAD O
the I-CAD O
left I-CAD O
system. I-CAD O
This O O
artery B-CAD O
was I-CAD O
stented I-CAD O
with I-CAD O
total I-CAD O
of I-CAD O
three I-CAD O
stents B-CAD O
(two I-CAD O
Express I-CAD O
stents I-CAD O
2.5 I-CAD B-CAD
x I-CAD O
24 I-CAD O
mm I-CAD O
and I-CAD O
one I-CAD O
Pixel I-CAD O
stent I-CAD O
2.5 I-CAD O
x I-CAD O
28 I-CAD O
mm), I-CAD O
encompassing I-CAD O
the I-CAD O
entire I-CAD O
length I-CAD O
of I-CAD O
the I-CAD O
right I-CAD O
coronary I-CAD O
artery. I-CAD O
A O O
left O O
ventriculogram O O
was O O
performed O O
and O O
demonstrated O O
an O O
ejection O O
fraction O O
of O O
30% O O
with O O
a O O
diffusely O O
hypokinetic O O
ventricle O O
and O O
and O O
akinetic O O
inferior O O
wall. O O
He O O
ruled O O
in O O
for O O
myocardial O O
infarction O O
with O O
a O O
peak O O
CK O O
of O O
1490 O O
and O O
a O O
peak O O
troponin O O
of O O
2.0. O O
A O O
follow-up O O
echocardiogram O O
was O O
performed O O
on O O
July O O
15, O O
2093. O O
This O O
study O O
showed O O
his O O
ejection O O
fraction O O
had O O
improved O O
to O O
36%; O O
the O O
left O O
ventricle O O
was O O
diffusely O O
hypokinetic O O
and O O
the O O
inferior O O
wall O O
appeared O O
severely O O
hypokinetic. O O
His O O
reduced O O
ejection O O
fraction O O
was O O
out O O
of O O
proportion O O
to O O
his O O
degree O O
of O O
coronary B-CAD O
disease. I-CAD O
Because O O
of O O
this, O O
a O O
series O O
of O O
laboratory O O
tests O O
were O O
performed O O
which O O
revealed O O
normal O O
iron O O
studies, O O
normal O O
thyroid O O
function, O O
and O O
a O O
normal O O
serum O O
protein O O
electrophoresis O O
pattern. O O
He O O
was O O
discharged O O
in O O
stable O O
condition O O
to O O
follow O O
up O O
with O O
me O O
as O O
an O O
outpatient. O O
Since O O
his O O
myocardial O O
infarction, O O
Mr. O O
Urban O O
has O O
been O O
feeling O O
quite O O
well. O O
He O O
has O O
returned O O
to O O
work O O
in O O
the O O
factory O O
where O O
his O O
employed O O
as O O
a O O
manufacturing O O
manager. O O
He O O
has O O
had O O
no O O
symptoms O O
of O O
angina, O O
dyspnea, O O
nausea, O O
or O O
diaphoresis. O O
He O O
has O O
felt O O
very O O
well. O O
He O O
continues O O
to O O
take O O
his O O
medications O O
without O O
difficulty, O O
and O O
denies O O
any O O
symptomatology O O
whatsoever. O O
His O O
past O O
medical O O
history O O
prior O O
to O O
this O O
hospitalization O O
is O O
largely O O
unremarkable O O
because O O
he O O
had O O
not O O
sought O O
medical O O
care. O O
Of O O
note, O O
he O O
reports O O
to O O
me O O
that O O
about O O
8 O O
or O O
9 O O
years O O
ago O O
while O O
living O O
in O O
Georgia, O O
he O O
presented O O
to O O
an O O
emergency O O
room O O
with O O
some O O
chest O O
discomfort. O O
He O O
was O O
evaluated O O
and O O
released. O O
He O O
never O O
had O O
any O O
further O O
testing. O O
He O O
did O O
not O O
have O O
a O O
stress O O
test, O O
cardiac O O
ultrasound O O
or O O
catheterization. O O
Prior O O
to O O
his O O
admission, O O
he O O
did O O
not O O
have O O
any O O
known O O
hypertension B-HYPERTENSION O
or O O
hyperlipidemia, B-HYPERLIPIDEMIA O
but O O
has O O
been O O
diagnosed O O
with O O
these O O
conditions O O
while O O
in O O
the O O
hospital. O O
His O O
medications O O
include O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
daily, O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
daily, O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
mg O O
daily, O O
lisinopril B-MEDICATION B-MEDICATION
10 O O
mg O O
daily, O O
and O O
carvedilol B-MEDICATION O
6.25 O O
mg O O
twice O O
each O O
day. O O
He O O
has O O
no O O
known O O
drug O O
allergies. O O
Ms. O O
Urban O O
is O O
originally O O
from O O
Nicaragua O O
but O O
after O O
working O O
for O O
Imports, O O
Inc, O O
he O O
moved O O
to O O
Georgia O O
where O O
he O O
lived O O
for O O
24 O O
years O O
working O O
as O O
a O O
Registered O O
Nurse O O
and O O
in O O
various O O
other O O
positions. O O
He O O
immigrated O O
to O O
America O O
about O O
a O O
year O O
or O O
so O O
ago. O O
He O O
has O O
been O O
working O O
in O O
Borders. O O
He O O
currently O O
lives O O
in O O
Toledo, O O
Montana, O O
with O O
his O O
wife. O O
He O O
has O O
no O O
children. O O
He O O
smoked B-SMOKER O
1 I-SMOKER O
to I-SMOKER O
1-1/2 I-SMOKER O
packs I-SMOKER O
per I-SMOKER O
day I-SMOKER O
for I-SMOKER O
about I-SMOKER O
30 I-SMOKER O
years, I-SMOKER O
but I-SMOKER O
has I-SMOKER O
not B-SMOKER O
smoked I-SMOKER O
since I-SMOKER O
his I-SMOKER O
hospitalization. I-SMOKER O
He O O
drinks O O
only O O
socially O O
and O O
denies O O
illicit O O
drug O O
use. O O
He O O
has O O
a B-FAMILY_HIST O
family I-FAMILY_HIST O
history I-FAMILY_HIST O
of I-FAMILY_HIST O
coronary I-FAMILY_HIST O
artery I-FAMILY_HIST O
disease I-FAMILY_HIST O
in O O
that O O
his B-FAMILY_HIST O
father I-FAMILY_HIST O
had I-FAMILY_HIST O
3 I-FAMILY_HIST O
myocardial I-FAMILY_HIST O
infarctions I-FAMILY_HIST O
and I-FAMILY_HIST O
died B-FAMILY_HIST O
at I-FAMILY_HIST O
a I-FAMILY_HIST O
young I-FAMILY_HIST O
age I-FAMILY_HIST O
of I-FAMILY_HIST O
heart I-FAMILY_HIST O
disease. I-FAMILY_HIST O
On O O
physical O O
exam, O O
his O O
blood O O
pressure O O
was O O
130/82 O O
mmHg O O
in O O
his O O
right O O
arm O O
and O O
126/80 O O
mmHg O O
in O O
his O O
left O O
arm. O O
His O O
heart O O
rate O O
is O O
60 O O
and O O
regular. O O
In O O
general, O O
he O O
is O O
in O O
no O O
apparent O O
distress. O O
His O O
jugular O O
venous O O
pressure O O
is O O
6 O O
cm O O
of O O
water. O O
His O O
chest O O
is O O
clear O O
to O O
auscultation O O
without O O
rales, O O
wheezes, O O
or O O
rhonchi. O O
His O O
heart O O
is O O
regular O O
in O O
rhythm O O
and O O
rate O O
with O O
a O O
normal O O
S1 O O
and O O
S2. O O
He O O
has O O
no O O
murmurs, O O
rubs, O O
or O O
gallops. O O
His O O
abdomen O O
is O O
benign. O O
His O O
extremities O O
are O O
warm O O
and O O
well O O
perfused O O
and O O
without O O
clubbing, O O
cyanosis, O O
or O O
edema. O O
On O O
vascular O O
exam O O
his O O
carotid O O
pulses O O
are O O
2+, O O
brisk O O
and O O
without O O
bruits. O O
His O O
femoral O O
pulses O O
are O O
2+, O O
brisk O O
and O O
without O O
bruits. O O
His O O
right O O
femoral O O
artery O O
was O O
entered O O
for O O
cardiac O O
catheterization. O O
The O O
site O O
looks O O
clean O O
and O O
intact O O
with O O
no O O
hematoma O O
and O O
no O O
bruit O O
and O O
a O O
strong O O
pulse. O O
His O O
distal O O
pulses O O
are O O
2+ O O
and O O
symmetric O O
throughout. O O
His O O
lipid O O
panel O O
from O O
his O O
hospitalization O O
reveals O O
total B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
of I-HYPERLIPIDEMIA O
210 B-HYPERLIPIDEMIA O
mg/dl, I-HYPERLIPIDEMIA O
LDL B-HYPERLIPIDEMIA O
of I-HYPERLIPIDEMIA O
153 B-HYPERLIPIDEMIA O
mg/dl, I-HYPERLIPIDEMIA O
and O O
HDL O O
of O O
45mg/dl. O O
His O O
electrocardiogram O O
revealed O O
normal O O
sinus O O
rhythm. O O
He O O
has O O
T O O
wave O O
inversions O O
in O O
III O O
and O O
aVF, O O
and O O
he O O
has O O
a O O
greater O O
than O O
15 O O
degree O O
disparity O O
between O O
his O O
R O O
and O O
T O O
wave O O
axis. O O
Mr. O O
Urban O O
underwent O O
a O O
exercise O O
treadmill O O
test O O
with O O
sestamibi O O
imaging O O
yesterday. O O
He O O
exercised O O
for O O
10 O O
minutes O O
43 O O
seconds O O
achieving O O
a O O
maximum O O
workload O O
of O O
12 O O
METS, O O
and O O
a O O
peak O O
double O O
product O O
of O O
21,600. O O
His O O
electrocardiogram O O
was O O
negative O O
for O O
ischemia. O O
His O O
nuclear O O
images O O
revealed O O
a O O
mild O O
reduction O O
in O O
tracer O O
activity O O
in O O
the O O
inferior O O
wall O O
which O O
persisted O O
after O O
reinjection O O
consistent O O
with O O
his O O
inferior O O
myocardial O O
infarction. O O
There O O
was O O
no O O
evidence O O
of O O
ischemia O O
elsewhere. O O
His O O
left O O
ventricular O O
ejection O O
fraction O O
was O O
measured O O
at O O
51%. O O
In O O
short, O O
Mr. O O
Urban O O
is O O
a O O
51-year-old O O
who O O
had O O
an O O
inferior O O
myocardial O O
infarction, O O
but O O
interestingly O O
during O O
his O O
hospitalization O O
had O O
systolic O O
dysfunction O O
well O O
out O O
of O O
proportion O O
to O O
his O O
coronary O O
disease. O O
Also, O O
his O O
systolic O O
function O O
has O O
improved O O
over O O
time. O O
I O O
think O O
there O O
are O O
two O O
processes O O
going O O
on. O O
One O O
is O O
coronary O O
artery O O
disease. O O
Clearly O O
this O O
has O O
manifested O O
itself O O
as O O
an O O
inferior O O
myocardial O O
infarction O O
due O O
to O O
an O O
occluded O O
right O O
coronary O O
artery, O O
which O O
was O O
treated O O
during O O
his O O
hospitalization O O
with O O
stenting. O O
The O O
other O O
issue O O
is O O
his O O
transient O O
systolic O O
dysfunction O O
that O O
is O O
out O O
of O O
proportion O O
to O O
his O O
coronary O O
artery O O
disease. O O
Given O O
the O O
rapid O O
improvement O O
in O O
his O O
ejection O O
fraction, O O
I O O
can O O
only O O
speculate O O
as O O
to O O
the O O
etiology O O
of O O
this. O O
He O O
does O O
not O O
appear O O
to O O
have O O
a O O
persistent O O
cardiomyopathy, O O
but O O
a O O
transient O O
one. O O
I O O
suspect O O
that O O
this O O
is O O
myocarditis. O O
Unfortunatley, O O
I O O
have O O
no O O
way O O
of O O
proving O O
this O O
for O O
certain O O
but O O
clinically O O
it O O
seems O O
to O O
fit. O O
It O O
is O O
possible O O
that O O
whatever O O
led O O
to O O
his O O
myocarditis O O
also O O
triggered O O
his O O
acute O O
coronary O O
syndrome. O O
From O O
the O O
aspect O O
of O O
his O O
coronary O O
artery O O
disease, O O
he O O
will O O
continue O O
on O O
aspirin O B-MEDICATION
for O O
life. O O
He O O
received O O
quite O O
a O O
substantial O O
amount O O
of O O
stenting O O
to O O
his O O
right O O
coronary O O
artery, O O
and O O
I O O
would O O
opt O O
to O O
continue O O
his O O
Plavix O B-MEDICATION
for O O
at O O
least O O
12 O O
months. O O
For O O
his O O
hyperlipidemia, O O
I O O
agree O O
with O O
Lipitor, O B-MEDICATION
and O O
we O O
will O O
recheck O O
his O O
lipid O O
profile O O
to O O
see O O
if O O
the O O
dose O O
of O O
Lipitor O B-MEDICATION
is O O
adequate. O O
His O O
LDL O O
goal O O
will O O
be O O
less O O
than O O
100. O O
He O O
is O O
well O O
beta-blocked O O
on O O
his O O
carvedilol, O O
and O O
we O O
will O O
continue O O
with O O
the O O
current O O
dose O O
of O O
6.25 O O
mg O O
twice O O
daily. O O
His O O
blood O O
pressure O O
allows O O
us O O
to O O
increase O O
his O O
lisinopril O B-MEDICATION
from O O
10 O O
to O O
15 O O
mg O O
daily. O O
I O O
will O O
see O O
Mr. O O
Urban O O
again O O
in O O
three O O
months O O
for O O
followup. O O
I O O
will O O
repeat O O
his O O
echocardiogram O O
in O O
six O O
months' O O
time O O
to O O
see O O
where O O
his O O
ejection O O
fraction O O
has O O
settled O O
out. O O
Thank O O
you O O
for O O
allowing O O
me O O
to O O
participate O O
in O O
the O O
care O O
of O O
this O O
very O O
interesting O O
and O O
pleasant O O
gentleman. O O
The O O
patient O O
was O O
seen O O
and O O
examined, O O
and O O
the O O
case O O
was O O
discussed O O
with O O
Dr. O O
Orville O O
Ness. O O
Sincerely, O O
Jimmy O O
Orozco, O O
M.D. O O
JO/0564 O O
FI: O O
400908 O O
DD: O O
08/19/93 O O
DT: O O
08/20/93 O O

Record O O
date: O O
2094-05-11 O O
Patient O O
Name: O O
Urban, O O
Russell O O
Patient O O
ID: O O
472-20-64 O O
Provider O O
Name: O O
Orozco, O O
Jimmy O O
Date O O
of O O
Visit: O O
05/11/2094 O O
Visit O O
Type: O O
Return O O
Visit O O
John O O
Ussery, O O
M.D. O O
Worthington O O
Internal O O
Medicine O O
28 O O
Shattuck O O
Street, O O
IM O O
270 O O
Citrus O O
Ridge, O O
MT O O
43782 O O
Dear O O
Dr. O O
Ussery: O O
I O O
saw O O
Mr. O O
Urban O O
in O O
follow-up O O
in O O
the O O
office O O
today. O O
Since O O
his O O
last O O
visit O O
in O O
November, O O
he O O
has O O
been O O
feeling O O
well. O O
He O O
has O O
had O O
no O O
angina, O B-MEDICATION
no O O
exertional O O
dyspnea, O O
no O O
shortness O O
of O O
breath, O O
no O O
orthopnea, O O
no O O
paroxysmal O O
nocturnal O O
dyspnea, O O
no O O
palpitations, O O
and O O
no O O
other O O
symptoms O O
of O O
note. O O
Since O O
his O O
last O O
visit O O
with O O
me, O O
he O O
has O O
participated O O
in O O
and O O
completed O O
outpatient O O
cardiac O O
rehabilitation. O O
He O O
found O O
this O O
program O O
to O O
be O O
very O O
helpful; O O
he O O
sis O O
very O O
well O O
with O O
the O O
program. O O
He O O
is O O
currently O O
exercising O O
on O O
a O O
regular O O
basis O O
and O O
has O O
no O O
chest O O
discomfort O O
of O O
dyspnea O O
with O O
exercise. O O
He O O
has O O
stopped B-SMOKER O
smoking. I-SMOKER O
There O O
have O O
been O O
no O O
difficulties O O
with O O
his O O
medications. O O
On O O
03/16/2094, O O
he O O
had O O
a O O
follow-up O O
echocardiogram O O
done; O O
this O O
study O O
shows O O
an O O
LV O O
ejection O O
fraction O O
of O O
37% O O
with O O
septal O O
hypokinesis O O
and O O
inferoposterior O O
akinesis; O O
there O O
is O O
trace O O
mitral O O
regurgitation; O O
and O O
aortic O O
sclerosis, O O
but O O
no O O
stenosis. O O
Notably, O O
he O O
has O O
a O O
right O O
ventricular O O
systolic O O
pressure O O
estimated O O
to O O
be O O
46 O O
mmHg O O
with O O
a O O
right O O
ventricle O O
that O O
is O O
mildly O O
dilated O O
and O O
mildly-to-moderately O O
hypokinetic. O O
He O O
has O O
been O O
feeling O O
quite O O
well O O
and O O
has O O
no O O
other O O
symptoms. O O
His O O
review O O
of O O
systems O O
is O O
as O O
above O O
and O O
is O O
otherwise O O
negative O O
in O O
detail. O O
Medications: O O
Aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
daily O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
daily O O
Lipitor B-MEDICATION B-MEDICATION
40 O O
mg O O
daily O O
lisinopril B-MEDICATION B-MEDICATION
10 O O
mg O O
daily O O
Coreg B-MEDICATION O
6.25 O O
mg O O
daily. O O
Physical O O
examination: O O
He O O
appears O O
quite O O
well O O
and O O
is O O
in O O
no O O
apparent O O
distress. O O
His O O
blood O O
pressure O O
is O O
112/60 O O
mmHg O O
and O O
his O O
pulse O O
rate O O
is O O
50 O O
beats O O
per O O
minutes O O
and O O
regular. O O
His O O
JVP O O
is O O
7 O O
cm O O
of O O
water O O
with O O
no O O
Kussmaul's O O
sign. O O
His O O
chest O O
is O O
clear O O
to O O
auscultation O O
bilaterally. O O
His O O
heart O O
is O O
regular O O
in O O
rhythm O O
and O O
rate O O
with O O
a O O
normal O O
S1 O O
and O O
S2. O O
He O O
has O O
no O O
S3 O O
or O O
S4 O O
gallop O O
and O O
no O O
audible O O
murmurs. O O
His O O
abdomen O O
is O O
soft. O O
It O O
is O O
neither O O
tender O O
nor O O
distended. O O
He O O
has O O
normal O O
bowel O O
sounds. O O
His O O
extremities O O
are O O
warm O O
and O O
well O O
perfused. O O
He O O
has O O
no O O
edema. O O
Impression: O O
This O O
is O O
a O O
50 O O
year-old O O
man O O
with O O
coronary B-CAD O
disease I-CAD O
who O O
suffered O O
an B-CAD O
inferoposterior B-CAD O
myocardial I-CAD O
infarction I-CAD O
in I-CAD O
July I-CAD O
2093. I-CAD O
Additionally, O O
he O O
was O O
also O O
found O O
to O O
have O O
cardiomyopathy B-CAD O
with O O
an O O
LV O O
ejection O O
fraction O O
of O O
37 O O
percent. O O
He O O
is O O
currently O O
asymptomatic O O
from O O
his O O
coronary O O
disease O O
and O O
his O O
LV O O
dysfunction. O O
Notably, O O
his O O
last O O
echocardiogram O O
shows O O
that O O
he O O
has O O
increased O O
RV O O
systolic O O
pressure O O
and O O
some O O
early O O
right O O
ventricular O O
dysfunction. O O
The O O
etiology O O
of O O
this O O
right O O
ventricular O O
dysfunction O O
is O O
not O O
clear. O O
There O O
is O O
likely O O
a O O
component O O
of O O
left O O
heart O O
failure. O O
In O O
addition, O O
he O O
may O O
have O O
right O O
heart O O
failure O O
out-of-proportion O O
to O O
left O O
heart O O
failure: O O
he O O
has O O
a O O
longstanding O O
smoking O O
history O O
and O O
may O O
have O O
a O O
degree O O
of O O
COPD O O
and, O O
lastly, O O
he O O
may O O
have O O
obstructive O O
sleep O O
apnea. O O
He O O
reports O O
to O O
me O O
that O O
he O O
does O O
snore O O
at O O
night, O O
and O O
his O O
first O O
wife O O
in O O
Georgia O O
had O O
told O O
him O O
for O O
many O O
years O O
that O O
during O O
the O O
night O O
he O O
had O O
periods O O
were O O
he O O
would O O
stop O O
breathing. O O
This O O
raises O O
obstructive O O
sleep O O
apnea O O
as O O
a O O
consideration. O O
Recommendations: O O
Initially, O O
I O O
am O O
going O O
to O O
start O O
him O O
on O O
Lasix O O
20 O O
mg O O
daily O O
to O O
lower O O
his O O
preload O O
to O O
help O O
with O O
any O O
component O O
of O O
LV O O
failure O O
that O O
is O O
leading O O
to O O
this. O O
The O O
rest O O
of O O
his O O
regimen O O
is O O
quite O O
good, O O
and O O
I O O
intend O O
to O O
continue O O
them. O O
To O O
help O O
to O O
see O O
if O O
there O O
is O O
any O O
component O O
of O O
cor O O
pulmonale O O
that O O
may O O
be O O
contributing O O
to O O
this, O O
I O O
am O O
going O O
to O O
obtain O O
first O O
a O O
chest O O
x-ray, O O
secondly O O
a O O
pulmonary O O
function O O
testing, O O
and O O
lastly O O
a O O
sleep O O
study. O O
If O O
indeed O O
we O O
find O O
components O O
of O O
obstructive O O
lung O O
disease O O
or O O
obstructive O O
sleep O O
apnea, O O
we O O
will O O
have O O
him O O
see O O
a O O
pulmonologist O O
and O O
treat O O
these O O
accordingly. O O
I O O
will O O
see O O
him O O
again O O
in O O
six O O
months' O O
time. O O
Thank O O
you O O
for O O
allowing O O
me O O
to O O
participate O O
in O O
the O O
care O O
of O O
this O O
pleasant O O
gentleman. O O
Regards, O O
__________________________ O O
Jimmy O O
J. O O
Orozco O O
M.D. O O
Internal O O
Medicine O O
Worthington O O
Regional O O
Hospital O O

Record O O
date: O O
2095-09-19 O O
Chief O O
Complaint O O
Cardiac O O
Access O O
Admission O O
Note O O
Russell O O
P O O
Urban O O
472 O O
20 O O
64 O O
9/19/95 O O
Mr O O
Urban O O
is O O
admitted O O
s/p B-CAD O
PTCA/stent I-CAD O
x I-CAD O
2 I-CAD O
(Cyphers) I-CAD O
to I-CAD O
his I-CAD O
LCX I-CAD O
today I-CAD O
History O O
of O O
Present O O
Illness O O
This O O
52 O O
yo O O
gentleman O O
has O O
known O O
CAD B-CAD O
dating O O
back O O
to O O
an O O
MI B-CAD O
in I-CAD O
7/93. I-CAD O
He O O
underwent B-CAD O
RCA I-CAD B-CAD
stenting I-CAD O
at O O
that O O
time, O O
jailing O O
the O O
RV O O
marginal O O
with O O
sluggish O O
flow O O
afterward. O O
Post O O
MI O O
ECHO O O
showed O O
EF O O
of O O
36% O O
w/diffuse O O
HK. O O
He O O
underwent O O
f/u O O
ETT O O
w/imaging O O
in O O
8/93 O O
which O O
showed O O
a O O
small O O
fixed O O
inferior O O
defect O O
with O O
considerable O O
residual O O
viable O O
myocardium O O
and O O
no O O
evidence O O
of O O
ischemia. O O
EF O O
at O O
that O O
time O O
was O O
51%. O O
He O O
has O O
done O O
reasonably O O
well O O
since O O
then. O O
In O O
late O O
spring, O O
Mr O O
Urban O O
noted O O
some O O
chest B-CAD O
tightness I-CAD O
and O O
SOB O O
similar O O
in O O
quality O O
to O O
his O O
prior O O
angina, B-CAD O
but O O
markedly O O
less O O
severe, O O
which O O
occurred O O
with O O
exertion. O O
He O O
had O O
a O O
repeat O O
ETT B-CAD O
7/31/95. I-CAD O
EKG B-CAD O
was I-CAD O
positive I-CAD O
for I-CAD O
ischemia. I-CAD O
Imaging O O
showed O O
a O O
defect O O
that O O
was O O
c/w O O
ischemia. O O
His O O
meds O O
were O O
adjsuted, O O
but O O
his O O
symptoms O O
have O O
persisted. O O
Today B-CAD O
he I-CAD O
presented I-CAD O
for I-CAD O
elective I-CAD O
cath I-CAD O
+/- I-CAD O
via I-CAD O
SDA. I-CAD O
Cath B-CAD O
showed I-CAD O
his I-CAD O
RCA I-CAD O
to I-CAD O
be I-CAD O
totally I-CAD O
occluded, I-CAD O
with I-CAD O
2 I-CAD O
LCX I-CAD O
lesions. I-CAD O
His B-CAD O
LCX I-CAD O
was I-CAD O
stented I-CAD O
with I-CAD O
2 I-CAD O
cyphers I-CAD O
(3.5 I-CAD O
x13 I-CAD O
and I-CAD O
3 I-CAD O
x I-CAD O
23) I-CAD O
with I-CAD O
good I-CAD O
results. I-CAD O
He O O
was O O
put O O
on O O
reopro O O
and O O
transferred O O
to O O
Cardiology O O
where O O
he O O
arrived O O
pain O O
free O O
and O O
in O O
no O O
distress. O O
Past O O
Medical O O
History O O
CAD O O
s/p O O
IMI, O O
RCA O B-CAD
stent O O
x O O
2 O O
2093 O O
Cardiomyopathy O O
CHF O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Hypertension B-HYPERTENSION O
OSA O O
Allergies O O
NKDA O O
Social O O
History O O
Married, O O
lives O O
with O O
wife O O
Works O O
in O O
Borders O O
Habits O O
ETOH: O O
occasional O O
social O O
Smoking: B-SMOKER O
45 B-SMOKER O
pkyr I-SMOKER O
hx, I-SMOKER O
none I-SMOKER O
for I-SMOKER O
2 I-SMOKER O
yrs I-SMOKER O
Caffeine: O O
2-3 O O
cups O O
in O O
am O O
daily O O
Diet: O O
low O O
fat, O O
low O O
chol, O O
NAS O O
Exercise: O O
was O O
walking O O
regularly O O
until O O
symptoms O O
recurred O O
Family O O
History O O
Father B-FAMILY_HIST O
with I-FAMILY_HIST O
MI I-FAMILY_HIST O
x3 I-FAMILY_HIST O
at I-FAMILY_HIST O
early I-FAMILY_HIST O
age I-FAMILY_HIST O
Medications O O
At O O
Home: O O
ASA B-MEDICATION B-MEDICATION
81 O O
mg O O
QD O O
Lisinopril B-MEDICATION B-MEDICATION
10 O O
mg O O
QD O O
Coreg B-MEDICATION O
6.25 O O
mg O O
BID O O
Lasix O O
20 O O
mg O O
QD O O
Lipitor B-MEDICATION B-MEDICATION
80 O O
mg O O
qPM O O
Klonipin O O
1 O O
mg O O
qPM O O
Physical O O
Exam O O
Height: O O
73 O O
Weight: O O
182 O O
VS: O O
90-110/60's, O O
50-60 O O
Monitor: O O
SR O O
Gen: O O
well O O
appearing O O
caucasian O O
male O O
in O O
NAD O O
Neuro: O O
alert, O O
oriented O O
x O O
3, O O
speech O O
clear O O
and O O
articulate. O O
CN O O
II-XII O O
intact. O O
Strength O O
5/5 O O
BUE- O O
lower O O
extremities O O
not O O
tested O O
d/t O O
activity O O
limitations O O
Neck: O O
supple, O O
thyroid O O
midline O O
without O O
nodularity. O O
JVP O O
flat, O O
no O O
HJR. O O
Carotid O O
pulses O O
2+, O O
no O O
bruits. O O
No O O
appreciable O O
adenopathy O O
Cardiac: O O
regular O O
S1, O O
S2, O O
no O O
S3/S4, O O
no O O
m/r/g. O O
PMI O O
not O O
displaced O O
Resp: O O
clear O O
anteriorly O O
Abd: O O
soft, O O
non-tender/non-distended. O O
No O O
HSM/masses/bruits. O O
Bowel O O
sounds O O
in O O
all O O
quads O O
Ext: O O
right O O
femoral O O
sheath O O
in O O
place. O O
No O O
hematoma/ooze/bruit. O O
Pulses O O
2+ O O
DP/PT, O O
no O O
c/c/e. O O
Review O O
of O O
Systems O O
Negative O O
in O O
detail O O
except O O
as O O
noted O O
above O O
Lab O O
Test O O
Labs: O O
EKG: O O
Disposition O O
and O O
Plans O O
Impression: O O
52 O O
yo O O
w/+ O O
FH, O O
prior O O
MI, O O
s/p O O
RCA O O
stents, O O
now O O
w/recurrent B-CAD O
angina I-CAD O
and O O
+ O O
ETT O O
Plan: O O
1. O O
Cardiac: O O
HR, O O
BP O O
well O O
controlled. O O
Lipids O O
were O O
somewhat O O
elevated O O
in O O
recent O O
past- O O
lipitor O B-MEDICATION
inc O O
to O O
80 O O
mg O O
QD- O O
will O O
repeat O O
in O O
am O O
with O O
LFT's O O
and O O
add B-MEDICATION O
zetia B-MEDICATION O
tonite O O
for O O
better O O
risk O O
modification. O O
Increase O O
ASA O B-MEDICATION
to O O
325 O O
mg O O
QD O O
and O O
add B-MEDICATION O
plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
QD O O
indefinitely. O O
He O O
is O O
at O O
high O O
risk O O
of O O
progressive O O
disease O O
given O O
his O O
early O O
RCA O O
ISR. O O
Continue O O
reopro O O
as O O
ordered. O O
Remove O O
sheaths O O
once O O
PTT O O
normalizes. O O
Ambulate O O
once O O
activity O O
restrictions O O
lifted. O O
Continue O O
heart O O
healthy O O
diet, O O
exercise, O O
meds O O
as O O
ordered. O O
Weigh O O
daily, O O
strict O O
I&O O O
given O O
hx O O
CHF O O
after O O
his O O
MI. O O
LP(a) O O
was O O
24 O O
last O O
draw- O O
Dr O O
Orozco O O
will O O
consider O O
adding O O
niaspan O B-MEDICATION
after O O
evaluating O O
effect O O
of O O
zetia/lipitor O O
in O O
clinic. O O
Further O O
plans O O
per O O
Dr O O
Ness/Dr O O
Orozco O O
Rose O O
Kang, O O
MS, O O
NP-C O O
b O O
28961 O O

Record B-SMOKER O
date: O O
2096-05-09 O O
CARDIOLOGY O O
WORTHINGTON O O
REGIONAL O O
HOSPITAL O O
Reason O O
for O O
visit: O O
Follow-up O O
Interval O O
History: O O
Mr. O O
Urban O O
is O O
doing O O
well O O
today. O O
Since O O
his O O
last O O
visit O O
with O O
me O O
he O O
continues O O
to O O
feel O O
well O O
without O O
chest O O
pain, O O
shortness O O
of O O
breath O O
or O O
other O O
symptoms. O O
He O O
remains O O
very O O
physically O O
active O O
and O O
has O O
no O O
symptoms O O
with O O
sctivity. O O
Medications O O
(Confirmed): O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
po O O
qd O O
atorvastatin B-MEDICATION B-MEDICATION
80 O O
mg O O
po O O
qd O O
Coreg B-MEDICATION B-MEDICATION
6.25mg O O
PO O O
BID O O
CPAP O O
Klonopin O O
1.0mg O O
po O O
QPM O O
Lasix O O
20 O O
mg O O
po O O
qd O O
lisinopril B-MEDICATION B-MEDICATION
10 O O
mg O O
po O O
qd O O
Zetia B-MEDICATION O
10mg O O
po O O
qd O O
Allergies: O O
No O O
known O O
drug O O
allergy O O
Physical O O
examination: O O
-Pulse: O O
58 O O
beats O O
per O O
minute O O
and O O
regular O O
-General: O O
He O O
is O O
well O O
appearing O O
and O O
in O O
no O O
apparent O O
distress. O O
-Neck: O O
His O O
JVP O O
is O O
4 O O
cm. O O
No O O
carotid O O
bruits O O
-Chest: O O
Clear O O
to O O
auscultation O O
bilaterally. O O
-Cardiac: O O
Regular O O
in O O
rhythm, O O
but O O
bradycardic. O O
Normal O O
S1 O O
and O O
S2. O O
He O O
has O O
no O O
S3 O O
or O O
S4. O O
He O O
has O O
no O O
audible O O
murmurs. O O
-Abdomen: O O
Soft. O O
It O O
is O O
neither O O
tender O O
nor O O
distended. O O
-Extremities: O O
Warm O O
and O O
well O O
perfused. O O
No O O
edema. O O
-BP: O O
120/72 O O
mmHg. O O
EKG: O O
Sinus O O
bradycardia. O O
Otherwise O O
normal O O
Assessment O O
and O O
plan: O O
Overall, O O
Mr. O O
Urban O O
is O O
doing O O
very O O
well. O O
He O O
continues O O
to O O
be O O
very O O
active O O
with O O
no O O
symptoms O O
of O O
angina O O
or O O
congestive O O
heart O O
failure. O O
Currently, O O
his O O
lipids O O
are O O
under O O
excellent O O
control O O
as O O
is O O
his O O
blood O O
pressure. O O
Ongoing O O
secondary O O
prevention O O
and O O
risk O O
factor O O
modification O O
will O O
continue O O
to O O
be O O
paramount O O
in O O
Mr. O O
Urban's O O
care. O O
I O O
have O O
discussed O O
these O O
issues O O
with O O
him O O
in O O
detail. O O
I O O
would O O
like O O
to O O
obtain O O
another O O
echocardiogram O O
to O O
re-assess O O
his O O
ejection O O
fraction O O
which O O
has O O
been O O
low O O
in O O
the O O
past. O O
Also, O O
I O O
would O O
like O O
to O O
see O O
if O O
he O O
has O O
had O O
further O O
development O O
of O O
pulmonary O O
hypertension. O O
He O O
will O O
continue O O
his O O
current O O
medications O O
and O O
return O O
to O O
see O O
me O O
in O O
six O O
months' O O
time O O
or O O
sooner O O
if O O
need O O
be. O O
Changes O O
to O O
Medications O O
this O O
visit O O
lisinopril O B-MEDICATION
10 O O
mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
08/24/2093 O O
Coreg O O
6.25mg O O
PO O O
BID O O
QTY:180 O O
Refills:2 O O
Start: O O
08/24/2093 O O
atorvastatin O B-MEDICATION
80 O O
mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
08/24/2093 O O
Zetia O O
10mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Lasix O O
20 O O
mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
06/06/2094 O O
aspirin O B-MEDICATION
325 O O
mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
08/24/2093 O O
Klonopin O O
1.0mg O O
po O O
QPM O O
QTY:30 O O
Refills:3 O O
Start: O O
05/01/2095 O O
CPAP O O
Nocturnal. O O
Signed O O
electronically O O
by O O
Jimmy O O
Orozco O O
MD O O
on O O
May O O
09, O O
2096 O O

Record O O
date: O O
2083-07-26 O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
SAN O O
FERNANDO O O
HOSPITAL O O
Reason O O
for O O
visit O O
Annual O O
Examination O O
Problem O O
List O O
(reviewed) O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
MAJOR O O
Hypertension B-HYPERTENSION O
MAJOR O O
Myocardial B-CAD O
infarction I-CAD O
MAJOR O O
STATUS O O
POST O O
Pleural O O
effusion O O
MAJOR O O
Weight O O
loss O O
MAJOR O O
Health O O
maintenance O O
MAJOR O O
Pulmonary O O
embolism O O
MAJOR O O
Torticollis O O
Blindness O O
Congestive O O
heart O O
failure O O
Chronic O O
renal O O
insufficiency O O
Ventricular O O
tachyarrhythmia O O
Major O O
Problems O O
Diabetes O O
mellitus O O
Hypertension O O
10/29/81 O O
= O O
cont O O
in O O
good O O
range, O O
120/80. O O
P: O O
Check O O
lyts, O O
CR O O
today O O
on O O
diuretic. O O
Myocardial B-CAD O
infarction I-CAD O
STATUS I-CAD O
POST I-CAD O
Other O O
Problems O O
Chronic O O
renal O O
insufficiency O O
Ventricular O O
tachyarrhythmia O O
AICD. O O
Dr. O O
Lacy O O
from O O
CCH O O
7/26/83 O O
Active O O
Medications O O
nph B-MEDICATION O
insulin I-MEDICATION O
8u O O
hs O O
dose O O
will O O
change--started O O
10/21 O O
QTY:1 O O
bottle O O
Refills:3 O O
Insulin O O
syringes O O
ultra O O
fine O O
insulin O O
syringe O O
100 O O
U---1 O O
box--of O O
100 O O
refills O O
3 O O
Ecotrin B-MEDICATION B-MEDICATION
325mg O O
PO O O
QD O O
Prinivil B-MEDICATION O
20mg O O
po O O
qd O O
Norvasc B-MEDICATION B-MEDICATION
5mg O O
po O O
qd O O
Lipitor B-MEDICATION B-MEDICATION
10mg O O
po O O
qd O O
vitamin O O
e O O
multivitamins O O
Glucotrol B-MEDICATION B-MEDICATION
xl O O
2.5mg O O
po O O
qd O O
2 O O
tabs O O
am O O
1 O O
tab O O
pm O O
metoprolol B-MEDICATION B-MEDICATION
50 O O
mg O O
po O O
1/2 O O
tid O O
Lasix O O
20 O O
mg O O
po O O
qd O O
isosorbide B-MEDICATION B-MEDICATION
dinitrate I-MEDICATION O
10 O O
mg O O
po O O
1 O O
tid O O
digoxin O O
0.125 O O
mg O O
po O O
qd O O
folic O O
acid O O
1 O O
mg O O
po O O
qd O O
One O O
touch O O
strips O O
use O O
bid O O
#100 O O
REFILL O O
#12 O O
Change O O
in O O
therapies O O
and O O
Renewals O O
nph O B-MEDICATION
insulin O O
8u O O
hs O O
QTY:1 O O
bottle O O
Refills:3 O O
Start: O O
10/5/2081 O O
dose O O
will O O
change--started O O
10/21 O O
Insulin O O
syringes O O
Family O O
history O O
mother O O
died O O
of O O
unclear O O
reasons O O
in O O
80's O O
and O O
father O O
in O O
80's O O
of O O
Alz. O O
Social B-SMOKER O
history O O
Lives O O
with O O
sister, O O
not O O
married. O O
Walks O O
2-3 O O
miles/day. O O
Retired O O
baker O O
Review O O
of O O
systems O O
No O O
SOB, O O
Gi O O
or O O
GU O O
issues. O O
Upset O O
about O O
Left O O
abdominal O O
mass O O
(old O O
AICD). O O
Physical O O
examination O O
Pulse O O
70 O O
and O O
regular O O
Blood O O
pressure O O
120/70 O O
Respiratory O O
rate O O
16 O O
Weight O O
160 O O
General O O
appearance O O
Well O O
developed, O O
well O O
nourished, O O
no O O
acute O O
distress. O O
Chest O O
CTA O O
B O O
w/o O O
c/w/r. O O
No O O
dullness O O
to O O
precussion, O O
no O O
egophony. O O
Cor O O
Reg O O
rate, O O
no O O
murmur O O
Abdomen O O
NT/ND, O O
no O O
HSM. O O
Normal O O
active O O
bowel O O
sounds. O O
Extrem O O
No O O
clubbing, O O
cyanosis; O O
mild O O
edema O O
Rectal O O
exam O O
guaiac O O
negative, O O
nl O O
tone. O O
Prostate O O
without O O
nodules O O
and O O
large O O
size. O O
Genitalia O O
descended O O
testes O O
bilaterally, O O
no O O
masses. O O
Assessment O O
and O O
plan O O
Hypertension. O B-HYPERTENSION
Good O O
control O O
on O O
current O O
medication O O
Type O O
2 O O
diabetes O O
mellitus. O O
I O O
urged O O
to O O
have O O
an O O
annual O O
eye O O
examination O O
for O O
his O O
fasting O O
blood O O
sugar. O O
His O O
fingerstick O O
today O O
is O O
quite O O
good. O O
We O O
will O O
check O O
a O O
hemoglobin O O
A1c. O O
AICD O O
checked. O O
Reviewed O O
lipids.. O O
BPH/PSA O O
Disposition O O
RTC O O
3 O O
months O O
Signed O O
electronically O O
by O O
Gary O O
O O O
Xa O O
MD O O
on O O
Aug O O
5, O O
2083 O O

Record B-SMOKER O
date: O O
2084-07-30 O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
SAN O O
FERNANDO O O
HOSPITAL O O
Reason O O
for O O
visit O O
tc O O
to O O
review O O
blood O O
sugars O O
and O O
insulin B-MEDICATION O
titration O O
History O O
of O O
present O O
illness O O
S O O
pt O O
says O O
he O O
started O O
Lantus B-MEDICATION B-MEDICATION
10 O O
units O O
at O O
bedtime O O
on O O
7/21/84 O O
and O O
his O O
blood O O
sugars O O
have O O
been O O
am O O
fastings O O
a O O
range O O
of O O
114-213 O O
and O O
pm O O
180-270. O O
Changes O O
to O O
Medications O O
this O O
visitLantus O O
16 O O
units O O
sc O O
qhs O O
- O O
change. O O
(QTY:3-month O O
supply O O
Refills:3) O O
do O O
not O O
mix O O
with O O
other O O
insulins O O
in O O
same O O
syringe O O
Assessment O O
and O O
plan O O
P O O
I O O
will O O
increase O O
his O O
Lantus O O
to O O
16 O O
units O O
at O O
HS O O
according O O
to O O
insulin O O
titration O O
algorithm O O
and O O
will O O
call O O
him O O
in O O
1 O O
week O O
to O O
further O O
review O O
blood O O
sugars O O
and O O
titrate O O
his O O
insulin O O
dose. O O
Disposition O O
Ximena O O
M. O O
Gillespie, O O
RN O O
Signed O O
electronically O O
by O O
Ximena O O
M. O O
Gillespie, O O
RN O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2085-11-25 O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
SAN O O
FERNANDO O O
HOSPITAL O O
Reason O O
for O O
visit O O
Change O O
in O O
MS/O2 O O
sats O O
low O O
History O O
of O O
present O O
illness O O
Failing O O
at O O
home. O O
Anorexia. O O
Lethargy. O O
Erratic O O
diabetic B-DIABETES O
care. O O
Sister O O
primary O O
care O O
taker. O O
VNA O O
noted O O
today's O O
changes. O O
Problem O O
List O O
(reviewed) O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
MAJOR O O
Hypertension B-HYPERTENSION B-HYPERTENSION
MAJOR O O
Myocardial B-CAD O
infarction I-CAD O
MAJOR I-CAD O
STATUS I-CAD O
POST I-CAD O
Pleural O O
effusion O O
MAJOR O O
Weight O O
loss O O
MAJOR O O
Health O O
maintenance O O
MAJOR O O
Pulmonary O O
embolism O O
MAJOR O O
Adenoma O O
MAJOR O O
Torticollis O O
Blindness O O
Congestive O O
heart O O
failure O O
Chronic O O
renal O O
insufficiency O O
Ventricular O O
tachyarrhythmia O O
Hoarseness O O
Stroke O O
Alcohol O O
abuse O O
Patient O O
fall O O
Atrial O O
fibrillation O O
Peripheral O O
vascular O O
disease O O
Major O O
Problems O O
Diabetes O O
mellitus O O
His O O
current O O
blood O O
sugar O O
readings O O
are O O
fasting O O
95-131 O O
but O O
2 O O
hrs O O
after O O
meals O O
in O O
the O O
afternoon O O
and O O
evening O O
have O O
ranges O O
from O O
159-276. O O
he O O
says O O
his O O
diet O O
has O O
been O O
reasonable O O
with O O
a O O
few O O
exceptions O O
when O O
he O O
has O O
cheated O O
and O O
his O O
blood O O
sugar O O
did O O
reflect O O
what O O
he O O
ate. O O
I O O
believe O O
it`s O O
time O O
to O O
change O O
him O O
to O O
Lantus B-MEDICATION O
for O O
better O O
coverage. O O
P O O
I O O
will O O
change O O
his O O
NPH B-MEDICATION O
to O O
Lantus O O
10units O O
at O O
bedtime O O
he O O
will O O
continue O O
testing O O
at O O
least O O
twice O O
a O O
day O O
and O O
he O O
says O O
he O O
is O O
going O O
to O O
test O O
at O O
least O O
4x`s O O
a O O
day O O
for O O
a O O
while. O O
he O O
is O O
still O O
on O O
glucotrol B-MEDICATION B-MEDICATION
which O O
we O O
may O O
need O O
to O O
discontinue O O
as O O
not O O
to O O
increase O O
his O O
hypoglcemic O O
episodes. O O
I O O
will O O
mail O O
him O O
scripts O O
to O O
fill O O
at O O
his O O
request O O
and O O
call O O
him O O
to O O
review O O
blood O O
sugars O O
and O O
need O O
for O O
titration O O
in O O
about O O
2 O O
weeks O O
to O O
give O O
him O O
enough O O
time O O
to O O
be O O
on O O
the O O
insulin O O
for O O
at O O
least O O
1 O O
week. O O
7/15/84 O O
Home O O
BS O O
quite O O
good! O O
Low O O
100s O O
9/12/84.....In O O
general, O O
he O O
has O O
been O O
failing O O
at O O
home, O O
unable O O
to O O
care O O
for O O
himself, O O
and O O
requiring O O
increasing O O
VNA. O O
Hypertension O O
10/29/81 O O
= O O
cont O O
in O O
good O O
range, O O
120/80. O O
P: O O
Check O O
lyts, O O
CR O O
today O O
on O O
diuretic. O O
Myocardial O O
infarction, O O
STATUS O O
POST O O
2071 O O
cardiac O O
arrest O O
s/p B-CAD O
CABG I-CAD O
and I-CAD O
AICD I-CAD O
implantation I-CAD O
Pleural O O
effusion O O
Weight O O
loss O O
Weight O O
now O O
increased O O
170. O O
Feels O O
better. O O
F/U O O
2-3 O O
weeks. O O
8/16/81 O O
Wt O O
167. O O
Feels O O
well. O O
9/12/84 O O
135 O O
1/22/85 O O
138 O O
2/6/85. O O
CCT, O O
Abd O O
CT, O O
lab O O
work, O O
EGD O O
(h O O
pylori), O O
colonoscopy. O O
Doubt O O
depression. O O
CHF, O O
T2DM. O O
check O O
TSH, O O
cortisol. O O
2/06/85 O O
PET O O
scans O O
neck, O O
chest, O O
abdomen O O
unremarkable O O
but O O
for O O
slight O O
uptake O O
in O O
spleen. O O
Has O O
now O O
gained O O
16lbs O O
in O O
less O O
than O O
a O O
month O O
4/04/85 O O
Cancelled O O
two O O
attempts O O
for O O
EGD/colonoscopy O O
85 O O
Health O O
maintenance O O
Flu, O O
pneumonia O O
vaccine O O
10/81. O O
Cancelled O O
two O O
attempts O O
for O O
EGD/colonoscopy O O
85 O O
Pulmonary O O
embolism O O
Adenoma O O
2080 O O
Dr. O O
Wm O O
Moses O O
colonoscopist. O O
6/04/84 O O
Due O O
for O O
repeat O O
and O O
scheduled O O
9/12/84 O O
Cancelled O O
two O O
attempts O O
for O O
EGD/colonoscopy O O
85 O O
Other O O
Problems O O
Torticollis O O
Blindness O O
Congestive O O
heart O O
failure O O
EF O O
&lt;20% O O
5/81 O O
Chronic O O
renal O O
insufficiency O O
Dr. O O
Omar O O
Needham O O
Ventricular O O
tachyarrhythmia O O
AICD. O O
Dr. O O
Lewis O O
from O O
CCH O O
7/26/83 O O
Hoarseness O O
Refer O O
for O O
laryngoscopy O O
to O O
Dr. O O
Underwood O O
7/7/85 O O
Stroke O O
lacunes O O
caudate O O
and O O
corona O O
radiata O O
(old) O O
head O O
CT O O
7/5/85 O O
Alcohol O O
abuse O O
Four O O
whiskies O O
per O O
night O O
per O O
sister O O
Wendy; O O
he O O
says O O
no O O
more O O
than O O
two. O O
Patient O O
fall O O
Atrial O O
fibrillation O O
Peripheral O O
vascular O O
disease O O
Active O O
Medications O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
po O O
qd O O
Celexa O O
20mg O O
po O O
qd O O
cyanocobalamin O O
1 O O
mg O O
po O O
qd O O
folic O O
acid O O
1 O O
mg O O
po O O
qd O O
free O O
text O O
medication O O
#1 O O
qid O O
one O O
touch O O
ultra O O
test O O
strips O O
free O O
text O O
medication O O
#2 O O
qid O O
one O O
touch O O
ultra O O
lancets O O
glyburide B-MEDICATION B-MEDICATION
5mg O O
po O O
qd O O
take O O
with O O
breakfast O O
or O O
first O O
meal O O
Insulin O O
syringes O O
isosorbide B-MEDICATION B-MEDICATION
dinitrate I-MEDICATION O
10 O O
mg O O
po O O
1 O O
tid O O
Lasix O O
40 O O
mg O O
po O O
qd O O
Lipitor B-MEDICATION B-MEDICATION
20mg O O
po O O
qd O O
Megace O O
40mg O O
po O O
qid O O
metoprolol B-MEDICATION B-MEDICATION
50mg O O
po O O
bid O O
multivitamins O O
nph O B-MEDICATION
insulin O O
5 O O
units O O
sc O O
q O O
AM O O
take O O
30-60 O O
minutes O O
before O O
a O O
meal O O
or O O
at O O
bedtime O O
Onetouch O O
strips O O
Plavix B-MEDICATION B-MEDICATION
75mg O O
po O O
qd O O
Prinivil B-MEDICATION O
20mg O O
po O O
qd O O
Family O O
history O O
mother O O
died O O
of O O
unclear O O
reasons O O
in O O
80's O O
and O O
father O O
in O O
80's O O
of O O
Alz. O O
Social O O
history O O
Lives O O
with O O
sister, O O
not O O
married. O O
Walks O O
2-3 O O
miles/day. O O
Retired O O
Baker O O
Habits/Risk O O
Screening O O
Smoking B-SMOKER O
status: I-SMOKER O
former B-SMOKER O
smoker I-SMOKER O
Alcohol O O
use O O
status: O O
abuse O O
Heavy O O
drinker. O O
Whiskey. O O
Activity O O
level: O O
sedentary O O
Procedures O O
and O O
Immunizations O O
Influenza O O
vaccine O O
(Medicare O O
Flu O O
Shot O O
Program O O
Card)10/81ye423zc6/82; O O
2085 O O
deltoid O O
10/81 O O
Pneumovax O O
5519v O O
aug/82 O O
r O O
deltoid O O
10/81 O O
Coronary O O
artery O O
bypass O O
graft O O
X4. O O
Review O O
of O O
systems O O
Cannot O O
report O O
Physical O O
examination O O
Blood O O
pressure O O
120/60 O O
Pulse O O
70 O O
reg O O
Respiratory O O
rate O O
16 O O
Office O O
o2 O O
saturation O O
100% O O
2L O O
General O O
appearance O O
cachectic, O O
disheveled. O O
knows O O
me, O O
SFH O O
not O O
month O O
Skin O O
No O O
rashes, O O
anicteric. O O
mult O O
seb O O
kers. O O
back O O
cyst O O
Neck O O
JVP O O
flat O O
Chest O O
Crackles O O
bilaterally O O
Cor O O
heart O O
rate O O
reg. O O
no O O
murmurs O O
Abdomen O O
NT/ND, O O
no O O
HSM. O O
Normal O O
active O O
bowel O O
sounds. O O
Selected O O
recent O O
labs O O
11/25/85 O O
NT-proBNP O O
PEND, O O
11/25/85 O O
Plasma O O
Glucose O O
172 O O
H, O O
11/25/85 O O
Plasma O O
Creatinine O O
1.6 O O
H, O O
11/25/85 O O
Albumin O O
2.9 O O
L, O O
11/25/85 O O
Troponin-I O O
NEGATIVE, O O
11/25/85 O O
Creatine O O
Kinase O O
Isoenzymes O O
NEGATIVE, O O
11/25/85 O O
Tox O O
Panel O O
2 O O
(ATS) O O
, O O
11/25/85 O O
HCT O O
40.2 O O
L, O O
11/25/85 O O
WBC O O
14.2 O O
H, O O
09/17/85 O O
Thyroid O O
Stimulating O O
Hormone O O
0.64 O O
ECG O O
decreased O O
ST O O
seg O O
in O O
V2-V5; O O
AF/Af O O
CXR O O
pna O O
vs O O
pulm O O
edema O O
Assessment O O
and O O
plan O O
Does O O
he O O
have O O
a O O
pneumonia? O O
If O O
so O O
is O O
it O O
an O O
aspiration? O O
Is O O
he O O
ischemic O O
with O O
CHF O O
(ECG O O
changes)? O O
ACS? O O
Let's O O
rule O O
out O O
for O O
infarction. O O
Alert O O
William O O
Lewis O O
(cards). O O
Start O O
levoflox O O
250 O O
QD. O O
Full O O
code. O O
Disposition O O
Admit O O
Signed O O
electronically O O
by O O
Xa, O O
Gary O O
O O O
on O O
Nov O O
25, O O
2085 O O

Record O O
date: O O
2065-07-29 O O
GREEN O O
EMERGENCY O O
DEPT O O
VISIT O O
WAGNER,LONNIE O O
097-87-37-2 O O
VISIT O O
DATE: O O
07/29/65 O O
The O O
patient O O
was O O
interviewed O O
and O O
examined O O
by O O
me O O
and O O
Dr. O O
Chase. O O
Please O O
see O O
the O O
note O O
for O O
full O O
details. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
patient O O
is O O
a O O
very O O
pleasant O O
gentleman O O
accompanied O O
by O O
his O O
wife O O
who O O
gives O O
most O O
of O O
the O O
history O O
complaining O O
of O O
bleeding O O
in O O
the O O
right O O
groin. O O
He O O
is O O
status O O
post O O
catheterization O O
and O O
stent O O
approximately O O
two O O
weeks. O O
He O O
was O O
recently O O
discharged O O
from O O
rehabilitation O O
and O O
at O O
home O O
his O O
wife O O
found O O
the O O
right O O
groin O O
to O O
be O O
soaked O O
in O O
blood. O O
The O O
patient's O O
wife O O
also O O
noticed O O
some O O
swelling O O
at O O
the O O
site. O O
He O O
has O O
had O O
no O O
fevers O O
and O O
no O O
chills. O O
He O O
has O O
recently O O
been O O
diagnosed O O
with O O
myelodysplastic O O
syndrome O O
with O O
white O O
counts O O
in O O
the O O
30's. O O
REVIEW O O
OF O O
SYSTEMS: O O
Review O O
of O O
systems O O
is O O
notable O O
for O O
bleeding O O
only. O O
He O O
denies O O
any O O
abdominal O O
pain. O O
He O O
denies O O
any O O
fever O O
or O O
chills. O O
No O O
neurologic O O
complaints. O O
No O O
distal O O
neurovascular O O
complaints O O
either. O O
PAST O O
MEDICAL O O
HISTORY: O O
The O O
patient's O O
past O O
medical O O
history O O
is O O
notable O O
for O O
diabetes, B-DIABETES O
hypertension B-HYPERTENSION O
as O O
well O O
as O O
cerebrovascular O O
accident, O O
gastrointestinal O O
bleed O O
and O O
myelodysplasia. O O
Surgeries O O
and O O
procedures O O
are O O
as O O
above. O O
MEDICATIONS: O O
The O O
patient's O O
medications O O
include O O
Plavix B-MEDICATION B-MEDICATION
and O O
aspirin. B-MEDICATION B-MEDICATION
ALLERGIES: O O
The O O
patient O O
has O O
no O O
allergies. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
No B-SMOKER O
current I-SMOKER O
tobacco I-SMOKER O
or O O
ethyl O O
alcohol. O O
He O O
lives O O
at O O
home O O
with O O
his O O
wife. O O
He O O
has O O
VNA O O
services O O
although O O
they O O
are O O
not O O
coming O O
tomorrow. O O
PHYSICAL O O
EXAMINATION: O O
I O O
agree O O
with O O
the O O
physical O O
examination O O
as O O
documented. O O
GENERAL: O O
The O O
patient O O
is O O
an O O
awake, O O
alert, O O
pleasant O O
male O O
in O O
no O O
apparent O O
distress. O O
VITAL O O
SIGNS: O O
Temperature O O
96, O O
pulse O O
56, O O
respiratory O O
rate O O
20, O O
blood O O
pressure O O
97/49, O O
oxygen O O
saturation O O
96%. O O
EXTREMITIES: O O
The O O
right O O
groin O O
shows O O
a O O
slightly O O
tender O O
area O O
with O O
a O O
little O O
bit O O
of O O
ooze O O
but O O
dried O O
blood. O O
No O O
active O O
bleeding O O
right O O
now. O O
Distally O O
he O O
has O O
popliteal O O
pulses. O O
He O O
has O O
bilateral O O
dopplerable O O
dorsalis O O
pedis O O
and O O
posterior O O
tibial O O
pulses. O O
He O O
has O O
full O O
range O O
of O O
motion O O
and O O
denies O O
any O O
numbness. O O
LABORATORY O O
EVALUATION: O O
Basic O O
laboratory O O
studies O O
here O O
show O O
a O O
hematocrit O O
of O O
28 O O
and O O
a O O
white O O
count O O
of O O
43. O O
His O O
white O O
count O O
is O O
up O O
from O O
a O O
baseline O O
of O O
about O O
33. O O
His O O
baseline O O
hematocrit O O
is O O
30. O O
His O O
platelets O O
are O O
291. O O
His O O
right O O
groin O O
ultrasound O O
is O O
negative O O
for O O
pseudoaneurysm O O
or O O
AV O O
fistula. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
is O O
being O O
sent O O
home. O O
We O O
are O O
arranging O O
VNA O O
to O O
follow O O
up O O
tomorrow. O O
CONSULTATIONS O O
(including O O
PCP): O O
The O O
patient's O O
primary O O
care O O
physician O O
was O O
called O O
for O O
coverage O O
for O O
Dr. O O
Duong. O O
FINAL O O
DIAGNOSIS: O O
Bleeding O O
right O O
groin O O
after O O
catheterization, O O
resolved. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
was O O
discharged O O
in O O
stable O O
condition. O O
___________________________________ O O
NU604/29497 O O
AMANDA O O
A. O O
VAUGHT, O O
M.D. O O
AV55 O O
D:07/29/65 O O
T:07/29/65 O O
Dictated O O
by: O O
AMANDA O O
A. O O
VAUGHT, O O
M.D. O O
AV55 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2065-09-29 O O
September O O
29, O O
2065 O O
Cecilia O O
Delong, O O
M.D. O O
Green O O
Oaks O O
Hospital O O
72 O O
John O O
Street O O
San O O
Luis O O
Obispo, O O
MD O O
53925 O O
RE: O O
Wagner, O O
Lonnie O O
MR O O
#097-87-37-2 O O
Dear O O
Cecilia; O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
Lonnie O O
in O O
the O O
Clinic O O
today. O O
As O O
you O O
know, O O
he O O
is O O
a O O
72-year-old O O
gentleman O O
recently O O
diagnosed O O
with O O
myelodysplastic/myeloproliferative O O
syndrome. O O
He O O
has O O
required O O
blood O O
cell O O
transfusions O O
for O O
this. O O
He O O
is O O
currently O O
receiving O O
Hydrea O O
for O O
this. O O
He O O
also O O
has O O
coronary B-CAD O
disease, I-CAD O
for O O
which O O
he O O
had O O
stents B-CAD O
placed I-CAD O
in I-CAD O
his I-CAD O
LAD I-CAD O
and I-CAD O
OM I-CAD O
in I-CAD O
07/65. I-CAD O
This O O
has O O
been O O
stable. O O
He O O
also O O
had O O
some O O
congestive O O
heart O O
failure, O O
for O O
which O O
he O O
has O O
no O O
further O O
symptoms O O
at O O
this O O
time. O O
His O O
weight O O
is O O
only O O
up O O
1-2 O O
pounds O O
but O O
has O O
remained O O
stable O O
with O O
an O O
increased O O
appetite. O O
Medications: O O
Include O O
atenolol B-MEDICATION B-MEDICATION
25 O O
mg O O
p.o. O O
q.d., O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
q.d., O O
vitamin O O
B12 O O
injections O O
q. O O
monthly, O O
metformin B-MEDICATION B-MEDICATION
850 O O
mg O O
t.i.d., O O
lisinopril B-MEDICATION B-MEDICATION
10 O O
mg O O
p.o. O O
q.d., O O
Lasix O O
40 O O
mg O O
p.o. O O
q.d. O O
Physical O O
Examination: O O
Blood O O
pressure: O O
102/60. O O
Heart O O
rate: O O
60 O O
beats/min. O O
Neck O O
examination O O
reveals O O
no O O
jugular O O
venous O O
distention O O
Chest O O
examination O O
is O O
clear O O
to O O
auscultation O O
bilaterally. O O
Cardiac O O
examination O O
reveals O O
normal O O
S1, O O
physiologically O O
split O O
S2, O O
no O O
evidence O O
of O O
a O O
murmurs, O O
rubs O O
or O O
gallops O O
at O O
this O O
time. O O
He O O
has O O
no O O
peripheral O O
edema O O
or O O
clubbing. O O
EKG: O O
Normal O O
sinus O O
rhythm, O O
nonspecific O O
ST O O
or O O
T O O
wave O O
abnormalities. O O
Compared O O
to O O
his O O
prior O O
EKG, O O
T O O
wave O O
changes O O
in O O
the O O
anterior O O
leads O O
are O O
improved. O O
Wagner, O O
Lonnie O O
MR O O
#097-87-37-2 O O
-2- O O
September O O
29, O O
2065 O O
Impression: O O
Mr. O O
Wagner O O
is O O
doing O O
very O O
well O O
from O O
an O O
ischemic O O
and O O
heart O O
failure O O
perspective. O O
He O O
remains O O
on O O
a O O
good O O
regimen O O
of O O
afterload O O
reduction O O
and O O
anti-ischemic O O
agents. O O
At O O
this O O
time, O O
I O O
do O O
not O O
recommend O O
any O O
changes O O
in O O
his O O
cardiac O O
medications. O O
The O O
patient O O
was O O
seen O O
in O O
consultation O O
with O O
Dr. O O
Jacqueline O O
Lam. O O
Sincerely, O O
David O O
F. O O
Irick, O O
M.D. O O
\tolbert O O
cc: O O
Tristan O O
Hanson, O O
M.D. O O
Leake O O
County O O
Memorial O O
Hospital O O
50 O O
Indian O O
Rock O O
Road O O
San O O
Luis O O
Obispo, O O
MD O O
53925 O O
Larry O O
, O O
M.D. O O
Leake O O
County O O
Memorial O O
Hospital O O
65 O O
Indian O O
Rock O O
Road O O
San O O
Luis O O
Obispo, O O
MD O O
53925 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2065-10-12 O O
GOH O O
EMERGENCY O O
DEPT O O
VISIT O O
WAGNER,LONNIE O O
097-87-37-2 O O
This O O
patient O O
was O O
seen O O
with O O
the O O
resident. O O
The O O
past O O
medical O O
history, O O
social O O
history, O O
family O O
history, O O
review O O
of O O
systems, O O
medications O O
and O O
allergies O O
were O O
reviewed O O
and O O
confirmed. O O
I O O
interviewed O O
and O O
examined O O
the O O
patient O O
myself. O O
PRESENTING O O
COMPLAINT: O O
This O O
is O O
a O O
72-year-old O O
male O O
who O O
presents O O
with O O
weakness. O O
REVIEW O O
OF O O
SYSTEMS: O O
His O O
review O O
of O O
systems O O
is O O
essentially O O
negative O O
other O O
than O O
some O O
difficulty O O
with O O
ambulation O O
secondary O O
to O O
weakness. O O
He O O
has O O
had O O
no O O
fever, O O
chills, O O
cough O O
or O O
dysuria. O O
No O O
diarrhea. O O
No O O
blood O O
per O O
rectum. O O
He O O
just O O
complains O O
of O O
loss O O
of O O
strength O O
globally. O O
No O O
visual O O
changes. O O
No O O
headache. O O
No O O
other O O
complaints. O O
PAST O O
MEDICAL O O
HISTORY: O O
He O O
has O O
a O O
history O O
of O O
myelodysplastic O O
syndrome, O O
history O O
of O O
CVA, O O
diabetes, B-DIABETES O
hypertension, B-HYPERTENSION B-HYPERTENSION
hypercholesterolemia, B-HYPERLIPIDEMIA B-HYPERTENSION
low O O
EF, O O
and O O
CAD. B-CAD O
He O O
had O O
a O O
history O O
of O O
anemia O O
with O O
apparently O O
an B-CAD O
MI I-CAD O
in O O
the O O
setting O O
of O O
the O O
anemia. O O
MEDICATIONS: O O
He O O
takes O O
aspirin, B-MEDICATION B-MEDICATION
metformin, B-MEDICATION B-MEDICATION
lisinopril, B-MEDICATION B-MEDICATION
Plavix, B-MEDICATION B-MEDICATION
Lasix, O O
Colace, O O
Nexium, O O
hydroxyurea. O O
ALLERGIES: O O
He O O
has O O
no O O
allergies. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
He B-SMOKER O
is I-SMOKER O
a I-SMOKER O
former B-SMOKER O
smoker. I-SMOKER O
He O O
lives O O
with O O
his O O
family. O O
He O O
has O O
a O O
family O O
history O O
of O O
CAD. O O
PHYSICAL O O
EXAMINATION: O O
VITAL O O
SIGNS: O O
He O O
is O O
afebrile. O O
Heart O O
rate O O
71, O O
blood O O
pressure O O
90/40, O O
respiratory O O
rate O O
16, O O
oxygen O O
saturation O O
99% O O
on O O
room O O
air. O O
GENERAL: O O
He O O
is O O
awake, O O
alert, O O
oriented, O O
in O O
no O O
acute O O
distress. O O
HEENT: O O
Normocephalic, O O
atraumatic. O O
Pupils O O
are O O
equal, O O
round, O O
and O O
reactive O O
to O O
light. O O
Extraocular O O
movements O O
are O O
full. O O
Oropharynx O O
is O O
clear. O O
Mucous O O
membranes O O
are O O
moist. O O
He O O
is O O
slightly O O
pale. O O
NECK: O O
Supple. O O
There O O
is O O
7 O O
cm O O
JVP. O O
CHEST: O O
With O O
crackles O O
at O O
the O O
left O O
base, O O
otherwise O O
clear. O O
CARDIOVASCULAR: O O
Regular O O
rate O O
and O O
rhythm O O
with O O
no O O
murmur, O O
rub O O
or O O
gallop. O O
ABDOMEN: O O
Soft O O
and O O
nontender. O O
SKIN: O O
Warm O O
and O O
dry. O O
EXTREMITIES: O O
Without O O
clubbing, O O
cyanosis O O
or O O
edema. O O
NEUROLOGIC: O O
Alert O O
and O O
oriented. O O
Cranial O O
nerves O O
II-XII O O
are O O
intact. O O
There O O
are O O
no O O
motor O O
or O O
sensory O O
deficits. O O
Gait O O
is O O
slightly O O
unsteady. O O
No O O
dysmetria. O O
No O O
pronator O O
drift. O O
Reflexes O O
are O O
normal. O O
LABORATORY O O
EVALUATION: O O
His O O
white O O
count O O
is O O
105.7, O O
increased O O
from O O
45 O O
on O O
the O O
12th O O
of O O
September O O
and O O
50 O O
on O O
August O O
1. O O
His O O
hematocrit O O
is O O
21, O O
which O O
is O O
decreased O O
from O O
26.6 O O
on O O
August O O
1 O O
and O O
24 O O
on O O
9/12. O O
BUN O O
is O O
45 O O
and O O
creatinine O O
is O O
2.3, O O
up O O
from O O
31 O O
and O O
1.1. O O
CK O O
is O O
16, O O
troponin O O
is O O
0.02, O O
and O O
INR O O
is O O
1.3. O O
Electrocardiogram O O
is O O
normal O O
sinus O O
rhythm O O
without O O
any O O
change O O
from O O
previous O O
EKG. O O
Chest O O
x-ray O O
is O O
unremarkable O O
for O O
infiltrate O O
or O O
effusion. O O
FINAL O O
DIAGNOSIS: O O
Symptomatic O O
worsening O O
of O O
myelodysplastic O O
syndrome O O
on O O
hydroxyurea. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
He O O
is O O
admitted O O
for O O
possible O O
transfusion O O
and O O
Hematology/Oncology O O
consultation. O O
He O O
is O O
stable O O
at O O
the O O
time O O
of O O
his O O
admission. O O
___________________________________ O O
GF977/84271 O O
LARRY O O
INOUE, O O
M.D. O O
LI12 O O
D:10/12/65 O O
T:10/13/65 O O
Dictated O O
by: O O
LARRY O O
INOUE, O O
M.D. O O
LI12 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2065-11-03 O O
GREEN O O
EMERGENCY O O
DEPT O O
VISIT O O
WAGNER,LONNIE O O
097-87-37-2 O O
VISIT O O
DATE: O O
11/03/65 O O
The O O
resident's O O
history, O O
physical O O
examination O O
and O O
evaluation O O
were O O
reviewed O O
by O O
me O O
and O O
I O O
concur. O O
In O O
addition, O O
I O O
personally O O
interviewed O O
and O O
examined O O
this O O
patient O O
and O O
spoke O O
with O O
his O O
wife O O
who O O
presents O O
with O O
him. O O
Please O O
see O O
the O O
resident's O O
note O O
for O O
the O O
remainder O O
of O O
the O O
details O O
of O O
the O O
patient's O O
history. O O
Please O O
see O O
the O O
note O O
for O O
further O O
details. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
is O O
a O O
72-year-old O O
male O O
with O O
a O O
history O O
of O O
myeloproliferative O O
disorder O O
who O O
is O O
followed O O
by O O
hematology/oncology O O
after O O
diagnosis O O
in O O
July O O
of O O
2065. O O
He O O
now O O
presents O O
with O O
several O O
episodes O O
of O O
bleeding. O O
He O O
has O O
been O O
having O O
epistaxis O O
for O O
approximately O O
one O O
month. O O
He O O
had O O
one O O
episode O O
of O O
hematemesis O O
this O O
morning O O
with O O
red O O
blood O O
with O O
clots. O O
He O O
has O O
also O O
noted O O
some O O
red O O
blood O O
around O O
his O O
stool O O
when O O
he O O
moves O O
his O O
bowels O O
over O O
the O O
last O O
two O O
days. O O
His O O
bowel O O
movements O O
have O O
not O O
been O O
black O O
but O O
there O O
has O O
been O O
red O O
blood O O
that O O
fills O O
the O O
toilet O O
water. O O
He O O
denies O O
any O O
light-headedness O O
although O O
his O O
wife O O
states O O
that O O
he O O
has O O
been O O
complaining O O
of O O
feeling O O
dizzy O O
at O O
home. O O
He O O
denies O O
any O O
headache O O
or O O
visual O O
change, O O
denies O O
any O O
shortness O O
of O O
breath O O
or O O
chest O O
pain. O O
PHYSICAL O O
EXAMINATION: O O
VITAL O O
SIGNS: O O
Temperature O O
96.6, O O
pulse O O
91, O O
respirations O O
18, O O
blood O O
pressure O O
120/58. O O
The O O
O2 O O
saturation O O
is O O
96%. O O
GENERAL: O O
The O O
patient O O
is O O
tired O O
by O O
awake, O O
middle-aged O O
male, O O
reclining O O
on O O
his O O
right O O
side. O O
HEENT: O O
Normocephalic O O
and O O
atraumatic. O O
His O O
pupils O O
are O O
equal O O
at O O
approximately O O
2 O O
mm. O O
His O O
sclera O O
are O O
anicteric. O O
His O O
conjunctiva O O
are O O
very O O
pale. O O
He O O
is O O
edentulous O O
with O O
moist O O
mucous O O
membranes. O O
He O O
has O O
petechiae O O
of O O
the O O
pallet O O
and O O
the O O
buccal O O
mucosa. O O
NECK: O O
Supple, O O
nontender O O
with O O
no O O
meningismus. O O
LUNGS: O O
Clear O O
except O O
for O O
crackles O O
at O O
the O O
bases O O
bilaterally O O
with O O
fairly O O
good O O
air O O
movement. O O
CARDIAC: O O
Regular, O O
rate O O
and O O
rhythm, O O
somewhat O O
distant. O O
ABDOMEN: O O
Nondistended, O O
soft O O
and O O
nontender O O
with O O
no O O
guarding O O
and O O
no O O
peritoneal O O
signs. O O
RECTAL: O O
Examination O O
performed O O
by O O
the O O
resident O O
showed O O
heme O O
positive O O
stool. O O
SKIN: O O
Intact, O O
warm, O O
somewhat O O
pale O O
and O O
dry. O O
EXTREMITIES: O O
Trace O O
ankle O O
edema. O O
His O O
calves O O
are O O
soft O O
and O O
nontender. O O
He O O
has O O
full O O
range O O
of O O
motion. O O
LABORATORY O O
EVALUATION: O O
His O O
white O O
blood O O
cell O O
count O O
is O O
156,000. O O
Hematocrit O O
is O O
27.5, O O
platelets O O
25,000. O O
His O O
differential O O
shows O O
4% O O
blasts. O O
His O O
electrolytes O O
are O O
within O O
normal O O
limits. O O
BUN O O
is O O
36, O O
creatinine O O
1.5 O O
and O O
glucose O O
96. O O
His O O
transaminases O O
are O O
flat, O O
amylase O O
is O O
52 O O
and O O
lipase O O
is O O
31. O O
His O O
INR O O
is O O
1.3. O O
The O O
patient O O
had O O
an O O
electrocardiogram O O
performed O O
showing O O
a O O
normal O O
sinus O O
rhythm O O
with O O
nonspecific O O
ST O O
changes. O O
Chest O O
x-ray O O
showed O O
minimal O O
vascular O O
engorgement O O
but O O
no O O
edema O O
and O O
no O O
infiltrate. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
had O O
IV O O
access O O
initiated. O O
Laboratory O O
studies O O
were O O
sent. O O
FINAL O O
DIAGNOSES: O O
Gastrointestinal O O
bleeding, O O
anemia O O
and O O
thrombocytopenia O O
secondary O O
to O O
myeloproliferative O O
disorder. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
was O O
seen O O
in O O
the O O
emergency O O
department O O
by O O
Dr. O O
Hanson O O
from O O
oncology. O O
The O O
patient O O
is O O
known O O
to O O
be O O
transfusion O O
dependent. O O
She O O
has O O
most O O
recently O O
been O O
transfused O O
packed O O
red O O
blood O O
cells O O
but O O
has O O
not O O
required O O
a O O
platelet O O
transfusion O O
for O O
several O O
weeks. O O
He O O
is O O
being O O
admitted O O
to O O
the O O
oncology O O
service. O O
The O O
patient O O
remains O O
hemodynamically O O
stable O O
here, O O
awaiting O O
transfusion O O
and O O
admission. O O
The O O
patient O O
is O O
currently O O
in O O
stable O O
condition. O O
___________________________________ O O
DV105/64892 O O
KATHERN O O
OLMSTEAD, O O
M.D. O O
KO19 O O
D:11/03/65 O O
T:11/03/65 O O
Dictated O O
by: O O
KATHERN O O
OLMSTEAD, O O
M.D. O O
KO19 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2096-07-15 O O
Results01/31/2096 O O
GLU-POC O O
159 O O
(*)10/03/2095 O O
GLU-POC O O
11211/05/2095 O O
HGBA1C B-DIABETES O
7.8 I-DIABETES O
(*) I-DIABETES O
Spanish O O
30 O O
Dan O O
Chan O O
OSWALDO O O
AUSTIN, O O
HENRY O O
Angels O O
City, O O
NH O O
31731 O O
64415974 O O
(729) O O
481-3539 O O
07/15/96 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Mr. O O
Austin O O
is O O
a O O
78 O O
year O O
old O O
Ecuadorian O O
gentleman O O
with O O
known O O
Diabetes B-DIABETES O
and O O
history O O
of O O
cerebellar O O
CVA O O
but O O
no O O
HO O O
CAD B-CAD O
who O O
returned O O
from O O
Ecuador O O
2 O O
days O O
ago. O O
He O O
left O O
Angels O O
City O O
after O O
I O O
saw O O
him O O
in O O
January O O
when O O
he O O
was O O
free O O
of O O
angina. O O
While O O
taking O O
an O O
afternoon O O
walk O O
in O O
Quito O O
during O O
early O O
June O O
he O O
experienced O O
fairly O O
severe B-CAD O
mid-sternal I-CAD O
pain I-CAD O
without O O
diaphoresis; O O
pain O O
radiated O O
to O O
the O O
left O O
upper O O
arm O O
and O O
patient O O
discribed O O
it O O
as O O
'sharp O O
burning O O
pressure'. O O
He O O
went O O
back O O
home O O
and O O
rest O O
releived O O
the O O
pain O O
he O O
estimates O O
within O O
15 O O
minutes. O O
There O O
days O O
later O O
pain O O
reccurred, O O
again O O
it O O
lasted O O
about O O
15 O O
minutes O O
but O O
this O O
time O O
he O O
went O O
to O O
ED. O O
An O O
EKG O O
was O O
'normal' O O
and O O
he O O
was O O
discharged O O
on O O
NG. B-MEDICATION O
Approximately O O
one O O
week O O
later O O
he O O
experienced O O
another O O
episode O O
of O O
CP O O
similar O O
to O O
the O O
previous O O
ones, O O
he O O
was O O
taken O O
to O O
another O O
hospital O O
and O O
he O O
was O O
hospitalized. O O
On O O
July O O
1st O O
he O O
was O O
catheterized B-CAD O
and I-CAD O
found I-CAD O
to I-CAD O
have I-CAD O
'diffuse B-CAD O
CAD' I-CAD O
involving I-CAD O
several I-CAD O
vessels. I-CAD O
Stent O O
placement O O
was O O
not O O
attempted. O O
His O O
LV O O
EF O O
was O O
55% O O
and O O
he O O
was O O
transferred O O
to O O
a O O
medical O O
ward. O O
A O O
day O O
later, O O
on O O
July O O
3rd, O O
he O O
was O O
readmitted O O
to O O
the O O
ICU O O
because O O
of O O
CP; O O
he O O
was O O
stabilized O O
and O O
eventually O O
discharged O O
on O O
July O O
5 O O
on O O
the O O
following O O
medication: O O
ASA B-MEDICATION B-MEDICATION
81 O O
mg O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
po O O
qd O O
Bisoprolol B-MEDICATION B-MEDICATION
5mg O O
po O O
qd O O
Isosorbide B-MEDICATION B-MEDICATION
20 O O
mg O O
one O O
po O O
in O O
am O O
1/2 O O
po O O
in O O
pm O O
Ranitidine O O
300 O O
mg O O
po O O
qd O O
Lipitor B-MEDICATION B-MEDICATION
40 O O
mg O O
po O O
qd O O
A O O
sleeping O O
medication O O
3 O O
mg O O
?Lexotan O O
one O O
po O O
hs O O
Metformin B-MEDICATION B-MEDICATION
1000 O O
mg O O
po O O
bid O O
Mr. O O
Austin O O
has O O
been O O
pain O O
free O O
since O O
his O O
discharge O O
until O O
today O O
when O O
he O O
was O O
readying O O
himself O O
to O O
come O O
to O O
the O O
hospital. O O
He O O
then O O
experienced O O
a O O
brief O O
episode O O
of O O
pain O O
in O O
mid O O
sternum O O
without O O
radiation O O
to O O
the O O
left O O
shoulder O O
which O O
had O O
been O O
present O O
during O O
previous O O
episodes. O O
It O O
is O O
worth O O
noting O O
that O O
ETT B-CAD O
here I-CAD O
in I-CAD O
2091 I-CAD O
was I-CAD O
suggestive I-CAD O
of I-CAD O
CAD I-CAD O
but O O
stress O O
echocardiogram O O
was O O
was O O
read O O
as O O
not O O
suggestive O O
of O O
ischemia: O O
Testing O O
performed: O O
STRESS O O
ECHO, O O
DOPPLER, O O
COLOR O O
DOPPLER O O
M-Mode: O O
2D O O
Quality: O O
Conclusion: O O
1. O O
Patient O O
exercised O O
6 O O
min O O
20 O O
sec O O
on O O
a O O
standard O O
Bruce O O
treadmill O O
protocol, O O
reaching O O
stage O O
3, O O
and O O
stopped O O
secondary O O
to O O
fatigue. O O
No O O
chest O O
pain O O
was O O
reported. O O
Maximal O O
heart O O
rate O O
attained O O
was O O
123 O O
bpm O O
(84% O O
of O O
maximum O O
HR O O
predicted O O
for O O
age), O O
and O O
BP O O
at O O
peak O O
exercise O O
was O O
154/68. O O
The O O
maximum O O
rate-pressure O O
product O O
was O O
18,942.2. O O
See O O
exercise O O
report O O
for O O
full O O
ECG O O
details. O O
Baseline O O
resting O O
ECG O O
is O O
normal O O
sinus O O
rhythm. O O
There O O
were O O
1 O O
mm O O
horizontal/upsloping O O
ST O O
depressions O O
in O O
leads O O
V3-6 O O
and O O
lead O O
II O O
at O O
peak O O
exercise.3. O O
Baseline O O
resting O O
echocardiogram O O
reveals: O O
Normal O O
left O O
ventricular O O
size O O
and O O
systolic O O
function. O O
Estimated O O
resting O O
ejection O O
fraction O O
is O O
60%. O O
No O O
resting O O
segmental O O
wall O O
motion O O
abnormalities. O O
Trace O O
mitral O O
regurgitation.4. O O
Echocardiographic O O
images O O
obtained O O
immediately O O
following O O
peak O O
exercise O O
reveal: O O
Normal O O
increase O O
in O O
overall O O
systolic O O
function, O O
with O O
an O O
estimated O O
ejection O O
fraction O O
of O O
&gt;80%. O O
All O O
segments O O
augment O O
normally, O O
without O O
inducible O O
wall O O
motion O O
abnormalities.SUMMARY: O O
No O O
echocardiogrphic O O
evidence O O
of O O
infarct O O
or O O
inducible O O
ischemia, O O
atslightly O O
less O O
than O O
target O O
heart O O
rate O O
(which O O
decreases O O
the O O
sensitivity O O
of O O
thisexam).ATTENDING O O
STAFF: O O
WINSTON,LATASHA O O
V.,M.D.,PH.D. O O
Mr. O O
Austin O O
has O O
Type O O
II O O
diabetes O O
on O O
oral O O
hypoglycemics O O
and O O
h/o O O
CVA O O
in O O
2090 O O
which O O
resulted O O
in O O
right O O
hemiparesis O O
(now O O
fully O O
resolved) O O
who O O
was O O
last O O
seen O O
in O O
January. O O
At O O
that O O
time O O
he O O
denied O O
any O O
symptoms O O
suggestive O O
of O O
angina. O O
Glycemic O O
control O O
ahs O O
been O O
variable. O O
Last O O
HGBA1C O O
in O O
11/85 O O
was O O
7.8. O O
Lately O O
there O O
has O O
been O O
an O O
increase O O
in O O
fating O O
levels. O O
Today O O
BG O O
162. O O
Last O O
week O O
112 O O
at O O
home. O O
He O O
is O O
no O O
longer O O
exercising. O O
Has O O
nocturia O O
X2 O O
but O O
without O O
dysuria. O O
Denies O O
polyuria, O O
polydipsia, O O
nause, O O
chills O O
and O O
fever. O O
Appetite O O
normal. O O
He O O
has O O
residual O O
right O O
shoulder O O
pain O O
after O O
a O O
fall O O
in O O
Dec O O
2094 O O
which O O
was O O
significantly O O
improved O O
by O O
steroid O O
injections. O O
Episode O O
of O O
bilateral O O
low-pitched O O
ringing O O
in O O
his O O
ears O O
has O O
abated. O O
Uses O O
two O O
pillows. O O
No O O
PND, O O
orthopnea O O
and O O
leg O O
edema. O O
Denies O O
vision O O
changes. O O
. O O
Denies O O
episodes O O
of O O
light-headedness O O
or O O
vertigo. O O
PMHx: O O
H/O O O
diabetes O O
mellitus O O
type O O
2 O O
: O O
h/o O O
poorly O O
controlled O O
diabetes, O O
which O O
improved O O
and O O
then O O
deteriorated. O O
Cataracts. O O
He O O
was O O
seen O O
by O O
Ophthalmology O O
and O O
was O O
told O O
insurance O O
does O O
not O O
cover O O
cataract O O
surgery O O
which O O
he O O
needs. O O
Vital O O
Signs O O
BP O O
125/65, O O
P O O
64, O O
Temp O O
95.7 O O
F, O O
Wt O O
144 O O
lb O O
GEN: O O
well-appearing, O O
thin O O
elderly O O
gentleman O O
HEENT: O O
Hazing O O
of O O
left O O
lens, O O
no O O
arcus O O
senilis. O O
PERRLA O O
CARD: O O
nl O O
S1, O O
S2. O O
No O O
m/r/g. O O
JVP O O
&lt;5cm. O O
RESP: O O
CTAB O O
Abdomen: O O
soft, O O
normal O O
BS, O O
No O O
hepatomegaly, O O
no O O
masses. O O
EXT: O O
WWP. O O
Pedal O O
pulses O O
2+ O O
bilaterally. O O
No O O
evidence O O
of O O
foot O O
ulcers O O
or O O
calluses O O
, O O
multiple O O
varicose O O
veins. O O
ASSESSMENT O O
AND O O
PLAN: O O
A O O
78-year-old O O
gentleman O O
with O O
a O O
history O O
of O O
adult-onset O O
diabetes O O
and O O
CVA O O
who O O
has O O
new O O
onset O O
of O O
exertional B-CAD O
angina I-CAD O
who O O
was O O
catheterized O O
in O O
Quito O O
2 O O
weeks O O
ago. O O
Findings: O O
difuse, O O
severe O O
multi O O
vessel O O
disease O O
weith O O
well O O
preserved O O
LVF. O O
LAD: B-CAD O
Critical B-CAD O
stenosis I-CAD O
95% I-CAD O
at I-CAD O
origen I-CAD O
and I-CAD O
bad I-CAD O
distal I-CAD O
bed I-CAD O
LCX I-CAD O
obstructed I-CAD O
disttally I-CAD O
Good I-CAD O
marginal I-CAD O
obtuse I-CAD O
branch I-CAD O
with I-CAD O
90% I-CAD O
stenosis I-CAD O
med-proximal I-CAD O
RCA I-CAD O
Normal I-CAD O
origen I-CAD O
difuse I-CAD O
disease I-CAD O
75-80% I-CAD O
stenosis. I-CAD O
Plan: O O
Consult O O
Cardiology O O
ASAP O O
meanwhile O O
check O O
BP, O O
Lipids, O O
CBC, O O
TSH, O O
MA O O
and O O
alt O O
ast. O O
Nitroglycerine O O
prescription O O
renewed. O O
Continue O O
present O O
regimen. O O
Patient O O
instructed O O
to O O
call O O
and O O
come O O
to O O
ED O O
if O O
he O O
experiences O O
CP. O O
However O O
he O O
lives O O
in O O
Chardon O O
and O O
driving O O
in O O
can O O
take O O
some O O
time. O O
______________________________ O O
Harry O O
Bernard-Moyer, O O
M.D. O O
Health O O
Maintenance O O
Cholesterol-HDL O O
05/24/2095 O O
44 O O
Cholesterol-LDL B-HYPERLIPIDEMIA O
05/24/2095 I-HYPERLIPIDEMIA O
101 I-HYPERLIPIDEMIA O
Cholesterol O O
05/24/2095 O O
167 O O
GFR O O
(estimated) O O
05/24/2095 O O
67 O O
(Abnormal O O
if O O
&lt;60 O O
mL/min/1.73m2If O O
patient O O
is O O
black, O O
multiply O O
by O O
1.21) O O
HbA1c B-DIABETES O
05/24/2095 I-DIABETES O
9.2 I-DIABETES O
Hct O O
(Hematocrit) O O
05/24/2095 O O
39.3 O O
Hgb O O
(Hemoglobin) O O
05/24/2095 O O
13.8 O O
Influenza O O
Vaccine O O
10/03/2095 O O
Manufaturer O O
- O O
SanDisk O O
M-alb/creat O O
ratio O O
05/24/2095 O O
3.7 O O
Units O O
= O O
mg O O
Alb/g O O
Cre O O
Microalbumin O O
05/24/2095 O O
0.5 O O
Pneumovax O O
10/03/2095 O O
expiration O O
10/4/96 O O
PSA O O
05/24/2095 O O
0.9 O O
Triglycerides O O
05/24/2095 O O
111 O O
TSH O O
08/15/2095 O O
2.240 O O
UA-Protein O O
05/29/2091 O O
NEG O O
Immunization O O
Influenza O O
Vaccine O O
10/03/2095 O O
Pneumovax O O
10/03/2095 O O

Record O O
date: O O
2096-08-02 O O
Graydon O O
Harold O O
Jean, O O
MD O O
Nevada O O
Hospital O O
Internal O O
Medicine O O
01 O O
Dan O O
Chan O O
Angels O O
City, O O
NH O O
31731 O O
Dear O O
Gray: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
your O O
patient O O
Mr. O O
Henry O O
Oswaldo O O
in O O
clinic O O
today. O O
As O O
you O O
know, O O
he O O
is O O
a O O
78-year-old O O
gentleman O O
with O O
diabetes B-DIABETES O
who O O
was O O
hospitalized O O
at O O
06/28/2096 O O
in O O
Quito O O
with O O
any O O
acute B-CAD O
coronary I-CAD O
syndrome I-CAD O
with O O
anterior B-CAD O
myocardial I-CAD O
infarction. I-CAD O
I O O
am O O
seeing O O
him O O
on O O
your O O
request O O
to O O
evaluate O O
him O O
for O O
possible O O
coronary O O
artery O O
bypass O O
surgery. O O
I O O
have O O
reviewed O O
his O O
records O O
and O O
I O O
have O O
summarized O O
the O O
findings. O O
The O O
patient O O
denies O O
having O O
had O O
symptoms O O
of O O
angina O O
until O O
his O O
recent O O
visit O O
to O O
Quiti. O O
At O O
that O O
time O O
in O O
June O O
he O O
had O O
several O O
days O O
of O O
very O O
sharp O O
chest O O
tightness O O
and O O
diaphoresis O O
that O O
were O O
prolonged. O O
He O O
then O O
presented O O
to O O
the O O
Merlin O O
Clinic O O
in O O
Quuto. O O
He O O
was O O
found O O
to O O
have O O
an O O
anterior O O
myocardial O O
infarction O O
and O O
underwent B-CAD O
catheterization B-CAD O
there I-CAD O
that I-CAD O
showed I-CAD O
a I-CAD O
critical I-CAD O
stenosis I-CAD O
of I-CAD O
the I-CAD O
LAD I-CAD O
( I-CAD O
sequential I-CAD O
lesions I-CAD O
95 I-CAD O
and I-CAD O
99%), I-CAD O
first I-CAD O
OM(90%) I-CAD O
and I-CAD O
his I-CAD O
right I-CAD O
( I-CAD O
dominant I-CAD O
vessel I-CAD O
with I-CAD O
an I-CAD O
80% I-CAD O
proximal I-CAD O
and I-CAD O
then I-CAD O
90% I-CAD O
distal). I-CAD O
An O O
LV O O
gram O O
showed O O
an O O
EF O O
of O O
55% O O
with O O
just O O
mild O O
mitral O O
regurgitation. O O
An O O
echo O O
performed O O
here O O
at O O
the O O
Wyandot O O
was O O
consistent. O O
Since O O
he O O
has O O
returned O O
to O O
America O O
several O O
weeks O O
ago, O O
he O O
has O O
only O O
had O O
one O O
episode O O
of O O
his O O
chest O O
discomfort, O O
which O O
occurred O O
when O O
he O O
was O O
getting O O
rushed O O
to O O
come O O
to O O
the O O
clinic. O O
Since O O
then, O O
he O O
has O O
had O O
no O O
further O O
episodes. O O
ROS: O O
Denies O O
PND, O O
orthopnea, O O
symptoms O O
of O O
TIA, O O
stroke, O O
lightheaded, O O
or O O
syncope. O O
He O O
does O O
get O O
some O O
pain O O
in O O
his O O
right O O
leg O O
with O O
exertion. O O
PMH: O O
Diabetes, O O
hypertension, B-HYPERTENSION B-HYPERTENSION
hypercholesterolemia, B-HYPERLIPIDEMIA O
stroke O O
(numbness O O
in O O
his O O
right O O
hand O O
and O O
leg, O O
but O O
that O O
had O O
predominantly O O
resolved). O O
Meds: O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
a O O
day, O O
clopidogrel B-MEDICATION B-MEDICATION
75 O O
mg O O
a O O
day, O O
bisoprolol B-MEDICATION B-MEDICATION
5 O O
mg O O
once O O
a O O
day, O O
ranitidine O O
300 O O
mg O O
a O O
day, O O
atorvastatin B-MEDICATION B-MEDICATION
40 O O
mg O O
a O O
day, O O
metformin B-MEDICATION B-MEDICATION
1000 O O
mg O O
b.i.d., O O
and O O
Imdur B-MEDICATION B-MEDICATION
20 O O
mg O O
in O O
the O O
morning O O
and O O
10 O O
in O O
the O O
evening. O O
This O O
is O O
an O O
Equadorian O O
formulation. O O
SHx: O O
He B-SMOKER O
does I-SMOKER O
not I-SMOKER O
drink, I-SMOKER O
nor I-SMOKER O
smoke. I-SMOKER O
FHx: O O
Cancer O O
of O O
the O O
prostate O O
and O O
a O O
mother O O
who O O
died O O
of O O
cancer O O
at O O
60. O O
Brother O O
who O O
is O O
diabetic O O
and O O
the O O
other O O
who O O
had O O
cancer O O
of O O
the O O
prostate. O O
On O O
exam, O O
he O O
looks O O
well. O O
His O O
heart O O
rate O O
is O O
in O O
the O O
64. O O
His O O
blood O O
pressure O O
was O O
115/70. O O
His O O
carotids O O
were O O
2+ O O
with O O
normal O O
upstrokes O O
and O O
no O O
bruits. O O
His O O
jugular O O
venous O O
pressures O O
were O O
not O O
elevated. O O
His O O
chest O O
was O O
clear O O
to O O
auscultation. O O
His O O
cardiac O O
exam O O
revealed O O
a O O
2/6 O O
holosystolic O O
murmur O O
at O O
the O O
apex. O O
His O O
abdomen O O
was O O
soft. O O
Extremities O O
were O O
warm O O
and O O
well O O
perfused O O
with O O
good O O
femoral O O
and O O
distal O O
pulses. O O
Neurological O O
exam O O
is O O
grossly O O
normal O O
without O O
focal O O
deficit. O O
In O O
summary, O O
Mr. O O
Oswaldo O O
is O O
a O O
very O O
nice O O
Spanish O O
speaking O O
78-year-old O O
gentleman O O
with O O
diabetes O O
and O O
a O O
significant O O
3-vessel O O
disease. O O
He O O
is O O
likely O O
best O O
suited O O
for O O
CABG O O
and O O
I O O
spent O O
a O O
significant O O
amount O O
of O O
time O O
explaining O O
why O O
stenting O O
his O O
situation O O
would O O
be O O
less O O
satisfactory. O O
I O O
will O O
obtain O O
a O O
screening O O
duplex O O
ultrasound O O
of O O
his O O
carotids O O
to O O
assess O O
this O O
risk O O
prior O O
to O O
proceeding. O O
With O O
warm O O
regards, O O
Sincerely O O
yours, O O

Record B-SMOKER O
date: O O
2096-10-04 O O
Graydon O O
Harold O O
Jean, O O
MD O O
Nevada O O
Hospital O O
Internal O O
Medicine O O
72 O O
Dan O O
Chan O O
Angels O O
City, O O
NH O O
31731 O O
Dear O O
Dr. O O
Jean: O O
Your O O
patient O O
Henry O O
Oswaldo O O
was O O
seen O O
today O O
by O O
myself O O
at O O
the O O
Atmore O O
Community O O
Hospital O O
today O O
following O O
coronary B-CAD O
artery I-CAD O
bypass I-CAD O
on I-CAD O
August I-CAD O
15, I-CAD O
2096 I-CAD O
. I-CAD O
He O O
has O O
had O O
a O O
relatively O O
unremarkable O O
recovery O O
with O O
out O O
complication. O O
Today, O O
Mr. O O
Oswaldo O O
looks O O
and O O
feels O O
well, O O
and O O
complains O O
of O O
no O O
issues. O O
On O O
examination, O O
the O O
lungs O O
are O O
clear, O O
cardiac O O
rate O O
and O O
rhythm O O
are O O
normal. O O
The O O
incision O O
is O O
healing O O
very O O
nicely. O O
Chest O O
radiograph O O
reveals O O
normal O O
findings. O O
EKG O O
shows O O
no O O
acute O O
changes O O
and O O
is O O
basically O O
normal. O O
His O O
rate O O
is O O
mildly O O
elevated O O
today O O
despite O O
being O O
on O O
a B-MEDICATION O
beta B-MEDICATION O
blocker. I-MEDICATION O
Patient O O
education O O
was O O
completed O O
with O O
respect O O
to: O O
medication O O
review, O O
weight O O
restriction/lifting/activities, O O
cardiac O O
rehabilitation. O O
Overall, O O
I O O
am O O
quite O O
pleased O O
with O O
progress. O O
He O O
has O O
increased O O
activity O O
and O O
should O O
plan O O
to O O
enroll O O
in O O
cardiac O O
rehabilitation O O
in O O
a O O
few O O
weeks. O O
He O O
seems O O
to O O
be O O
making O O
an O O
excellent O O
recovery O O
from O O
surgery. O O
Thank O O
you O O
for O O
the O O
privilege O O
of O O
participating O O
in O O
the O O
care O O
of O O
this O O
very O O
nice O O
gentleman. O O
I O O
am O O
confident O O
the O O
surgery O O
will O O
afford O O
significant O O
and O O
lasting O O
benefit O O
and O O
relief O O
from O O
symptoms O O
of O O
angina O O
. O O
I O O
would O O
consider O O
increasing O O
his O O
Toprol B-MEDICATION B-MEDICATION
dose, O O
but O O
will O O
leave O O
this O O
to O O
your O O
discretion O O
if O O
his O O
rate O O
remains O O
elevated O O
in O O
follow-up. O O
I O O
am O O
releasing O O
him O O
to O O
your O O
care. O O
We O O
would O O
be O O
happy O O
to O O
see O O
him O O
at O O
any O O
time O O
in O O
the O O
future, O O
if O O
you O O
should O O
so O O
desire. O O
With O O
warm O O
regards, O O
Sincerely O O
yours, O O

Record B-SMOKER O
date: O O
2096-11-18 O O
Spanish O O
71 O O
Dan O O
Chan O O
OSWALDO O O
AUSTIN, O O
HENRY O O
Angels O O
City, O O
NH O O
31731 O O
64415974 O O
(729) O O
481-3539 O O
11/18/96 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Mr. O O
Austin O O
is O O
a O O
78 O O
year O O
old O O
Ecuadorian O O
gentleman O O
with O O
known O O
Diabetes B-DIABETES O
and O O
history O O
of O O
cerebellar O O
CVA O O
who O O
returns O O
to O O
the O O
practice O O
three O O
months O O
after O O
undergoing O O
CABG B-CAD B-MEDICATION
for I-CAD O
multiple I-CAD O
vessel I-CAD O
disease. I-CAD O
His O O
recovery O O
was O O
been O O
uneventful, O O
he O O
has O O
had O O
no O O
further O O
angin O B-MEDICATION
and O O
inspite O O
rather O O
severe O O
anemia O O
he O O
has O O
noted O O
marked O O
improvement O O
in O O
exercise O O
tolerance. O O
Appetite O O
is O O
better. O O
No O O
PND O O
orthopnea O O
or O O
ankle O O
edema. O O
There O O
is O O
mild O O
chest O O
soreness O O
on O O
the O O
right O O
side. O O
There O O
was O O
aignificant O O
decline O O
in O O
Hct O O
in O O
spite O O
of O O
the O O
fact O O
that O O
he O O
received O O
2 O O
transfusions O O
in O O
the O O
hospital O O
and O O
he O O
is O O
on O O
iron. O O
Mr. O O
Oswaldo O O
has O O
appointmernt O O
with O O
Dr. O O
Jean O O
in O O
the O O
near O O
future. O O
Mr. O O
Oswaldo O O
has O O
Type O O
II O O
diabetes O O
well O O
controlled O O
on O O
oral O O
hypoglycemics O O
HGBHA1C O O
on O O
8/17 O O
= O O
6.4. O O
h/o O O
CVA O O
in O O
2090 O O
which O O
resulted O O
in O O
right O O
hemiparesis O O
(now O O
fully O O
resolved) O O
. O O
Medications O O
Aspirin B-MEDICATION B-MEDICATION
ENTERIC O O
COATED O O
325 O O
MG O O
PO O O
QD O O
Ferrous O O
SULFATE O O
325 O O
MG O O
(325(65)MG O O
TABLET O O
Take O O
1) O O
PO O O
as O O
directed O O
, O O
Un O O
dia O O
si O O
y O O
un O O
dia O O
no O O
#30 O O
Tablet(s) O O
Metformin B-MEDICATION B-MEDICATION
1000 O O
MG O O
(1000MG O O
TABLET O O
Take O O
1) O O
PO O O
BID O O
#180 O O
Tablet(s) O O
Metoprolol B-MEDICATION B-MEDICATION
SUCCINATE O O
EXTENDED O O
RELEASE O O
100 O O
MG O O
(100MG O O
TAB.SR O O
24H O O
Take O O
1) O O
PO O O
QD O O
#30 O O
TAB.SR O O
Nitroglycerin B-MEDICATION B-MEDICATION
1/200 O O
(0.3 O O
MG) O O
1 O O
TAB O O
(0.3MG O O
TAB O O
SUBL O O
) O O
SL O O
Q2H O O
PRN O O
#30 O O
Tablet(s) O O
Zocor B-MEDICATION B-MEDICATION
(SIMVASTATIN) O O
40 O O
MG O O
(40MG O O
TABLET O O
Take O O
1) O O
PO O O
QPM O O
#30 O O
Tablet(s) O O
Vital O O
Signs O O
BP O O
121/63, O O
P O O
80, O O
Wt O O
137 O O
lb O O
GEN: O O
well-appearing O O
but O O
pale O O
and O O
thin O O
elderly O O
gentleman. O O
Fragile O O
but O O
not O O
in O O
pain O O
HEENT: O O
PERRLA O O
CARD: O O
Healed O O
CABG O O
scar. O O
Tender O O
to O O
pressure O O
nl O O
S1, O O
S2. O O
No O O
m/r/g. O O
Lungs O O
clear O O
to O O
auscultation. O O
EXT: O O
WWP. O O
Healed O O
incisions O O
on O O
medialaspect O O
of O O
RLE O O
where O O
veins O O
were O O
harvested. O O
THere O O
is O O
an O O
echymoses O O
about O O
2 O O
cm O O
in O O
diameter O O
on O O
the O O
shaft O O
of O O
the O O
pennis. O O
No O O
other O O
bleeding, O O
possibly O O
result O O
of O O
trauma O O
when O O
pulling O O
up O O
his O O
pants. O O
Pedal O O
pulses O O
2+ O O
bilaterally. O O
No O O
evidence O O
of O O
foot O O
ulcers O O
or O O
calluses O O
, O O
multiple O O
varicose O O
veins. O O
Hommans O O
negative O O
ASSESSMENT O O
AND O O
PLAN: O O
A O O
78-year-old O O
gentleman O O
with O O
a O O
history O O
of O O
adult-onset O O
diabetes O O
and O O
CVA O O
post O O
CABG. O O
Remarkable O O
recovery O O
; O O
weight O O
has O O
not O O
increased O O
but O O
anemia O O
has O O
improved. O O
Prior O O
to O O
surgery O O
he O O
had O O
mild O O
anemia O O
which O O
was O O
macrocytic. O O
Will O O
check O O
Fe, O O
B12, O O
FA O O
,CBC O O
and O O
HGBA1C O O
before O O
next O O
visit O O
in O O
1 O O
month. O O
Encouraged O O
gentle O O
ambulation. O O
He O O
will O O
see O O
Dr.Jean O O
in O O
3 O O
weeks. O O
Encouraged O O
to O O
call O O
if O O
any O O
new O O
symptoms O O
or O O
echymosis O O
and O O
told O O
him O O
to O O
eat O O
what O O
he O O
likes O O
for O O
time O O
being O O
except O O
sugar O O
and O O
sweets. O O
Return O O
in O O
one O O
month O O
or O O
prn O O
______________________________ O O
Harry O O
Bernard-Moyer, O O
M.D. O O

Record B-SMOKER O
date: O O
2125-07-24 O O
Routine O O
F/U O O
================ O O
Vital O O
signs O O
================ O O
Blood O O
Pressure: O O
130/80 O O
[Left O O
Arm, O O
Sitting] O O
Weight: O O
216 O O
[Pounds] O O
================ O O
Medications O O
================ O O
GLUCOPHAGE B-MEDICATION B-MEDICATION
(METFORMIN) O O
Variable O O
PO O O
ZESTRIL B-MEDICATION B-MEDICATION
(LISINOPRIL) O O
10MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
NPH B-MEDICATION O
HUMULIN I-MEDICATION B-MEDICATION
INSULIN I-MEDICATION O
(INSULIN O O
NPH O O
HUMAN) O O
Variable O O
SC O O
TOPROL B-MEDICATION B-MEDICATION
XL I-MEDICATION O
(METOPROLOL O O
(SUST. O O
REL.)) O O
200MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
ISOSORBIDE B-MEDICATION B-MEDICATION
MONONIT.(SR) I-MEDICATION O
30MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
ASA B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
325MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
LIPITOR B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10MG O O
1 O O
Tablet(s) O O
PO O O
QHS O O
Issues: O O
CAD...Now B-CAD O
s/p B-CAD O
CABG. I-CAD O
Sx O O
preop O O
were O O
DOE, O O
now O O
no O O
longer O O
dyspnic O O
even O O
going O O
up O O
2 O O
flight O O
stairs. O O
doing O O
cardiac O O
rehab. O O
tolerating O O
well, O O
early O O
in O O
course, O O
doing O O
almost O O
2miles/45 O O
min O O
already. O O
Tachcardia O O
on O O
ToprolXL, O B-MEDICATION
still O O
80-90 O O
at O O
rest, O O
105 O O
with O O
exertion O O
by O O
design. O O
Advised O O
that O O
pulse O O
may O O
fall O O
as O O
conditioning O O
improves. O O
Wt O O
decreased O O
6# O O
since O O
last O O
visit. O O
DM B-DIABETES O
Notes O O
BGs O O
180 O O
post O O
rehab O O
at O O
11am, O O
160s O O
at O O
HS, O O
FBG~~120 O O
or O O
less. O O
On O O
metformin O B-MEDICATION
500/500/1000, O O
NPH O B-MEDICATION
30q11am/28qHS. O O
Discussed O O
rational O O
and O O
controll. O O
A1C B-DIABETES O
8.1, I-DIABETES O
above O O
7.0 O O
goal. O O
Recc O O
checking O O
bg O O
at O O
4pm O O
as O O
well, O O
change O O
am O O
NPH O O
to O O
7-8 O O
am O O
to O O
cover O O
lunch O O
and O O
dinner, O O
and O O
would O O
increase O O
2U O O
q O O
1-2days, O O
watching O O
tid-qid O O
BGs O O
and O O
adjusting O O
HS O O
dose O O
downward O O
if O O
FBGs O O
&lt;100. O O
Goal O O
is O O
no O O
BGs O O
&lt;80, O O
most O O
&lt;140. O O
Reduce O O
frequ O O
of O O
increases O O
as O O
levels O O
approach O O
goals. O O
Lipids O O
well O O
controlled O O
ldl=97 O O
Claudication O O
seems O O
to O O
be O O
improving O O
with O O
exercise O O
training. O O
Advised O O
to O O
continue. O O
Consideration O O
for O O
bypass O O
only O O
if O O
limiting O O
long-term O O
progress. O O
HTN B-HYPERTENSION O
well O O
controlled. O O
15 O O
of O O
25 O O
minute O O
visit O O
counseling. O O
RTC O O
3 O O
Months, O O
call O O
if O O
? O O
concerning O O
DM O O
control. O O
Note O O
printed O O
for O O
pt. O O
______________________________ O O
Fontenot, O O
Leon, O O
M.D. O O

Record O O
date: O O
2126-01-04 O O
This O O
is O O
an O O
urgent O O
care O O
visit O O
for O O
Mr. O O
Valdivia.he O O
is O O
c/o O O
URI O O
like O O
sx O O
with O O
nasal O O
congestion, O O
non O O
productive O O
couch O O
and O O
sore O O
throat O O
for O O
several O O
days. O O
he O O
is O O
also O O
c/o O O
pressure O O
in O O
his O O
sinuses O O
and O O
congestion O O
in O O
his O O
eyes O O
with O O
excessive O O
tearing. O O
He O O
has O O
also O O
been O O
c/o O O
progreesive O O
SOB, O O
he O O
is O O
diabetic B-DIABETES O
with O O
CAD B-CAD O
s/p B-CAD O
CABG I-CAD O
and O O
states O O
that O O
after O O
his O O
cardiac O O
rehab O O
finished O O
about O O
two O O
months O O
ago O O
he O O
sarted O O
c/o O O
progressively O O
worsening O O
SOB O O
and O O
he O O
is O O
now O O
back O O
to O O
the O O
level O O
he O O
was O O
at O O
before O O
his O O
surgery O O
with O O
SOB O O
developing O O
after O O
walking O O
for O O
50 O O
yards. O O
he O O
has O O
been O O
compliant O O
with O O
his O O
medications O O
and O O
contacted O O
his O O
cardiologist O O
regarding O O
these O O
sx O O
and O O
was O O
told O O
he O O
should O O
be O O
seen O O
today O O
by O O
the O O
cardiologist O O
covering O O
for O O
his O O
regular O O
cardiologist O O
who O O
is O O
away, O O
but O O
he O O
refused O O
and O O
opted O O
to O O
wait O O
till O O
his O O
cardiologist O O
comes O O
back O O
next O O
week. O O
he O O
denies O O
any O O
chest O O
pain, O O
but O O
admits O O
to O O
bipedal O O
swelling O O
frequently. O O
ROS: O O
negative O O
in O O
detail O O
except O O
as O O
above. O O
PROBLEMS O O
Retinopathy O O
s/p O O
treatment, O O
Dr. O O
Lau, O O
HWS O O
Hypertension B-HYPERTENSION O
Obesity B-OBESE O
Hyperlipidemia B-HYPERLIPIDEMIA O
Peripheral O O
vascular O O
disease O O
claudication O O
Insomnia O O
since O O
service. O O
NTI O O
helped O O
a O O
little O O
in O O
past, O O
not O O
after O O
a O O
while. O O
Impotence O O
w/u O O
neg O O
5/23-treated O O
with O O
viagra O O
with O O
good O O
result O O
H/O O O
Low O O
back O O
pain O O
treated O O
with O O
PT O O
in O O
the O O
past; O O
c/o O O
10/24-treated O O
with O O
nortryptiline O B-MEDICATION
PTSD O O
Glaucoma O B-MEDICATION
Dr. O O
Massey, O O
HWS O O
Tachycardia O O
(sinus) O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
s/p I-CAD O
CABG I-CAD O
5/25 O O
PAST O O
Medical O O
History O O
Tinea O O
corporis O O
resolved O O
18Axillary O O
intertrigo O O
4/19h/o O O
Substance O O
abuse, O O
distantR O O
leg O O
Fx O O
x2Pneumonia O O
in O O
serviceEtOH O O
sober O O
2114greater O O
then O O
Social B-SMOKER O
history O O
Lives O O
alone, O O
seperated O O
from O O
wife O O
19, O O
still O O
work O O
together O O
at O O
CNET O O
(manager), O O
along O O
with O O
son. O O
24 O O
Working O O
less. O O
Dating O O
monogamously O O
Laura O O
23greater O O
then O O
. O O
No O O
pets. O O
Grew O O
up O O
Brownstown, O O
BS O O
math O O
Brown O O
U., O O
near O O
MA O O
math. O O
Served O O
in O O
Air O O
Force O O
in O O
Canada, O O
pilot. O O
Family O O
history O O
(+)(-)prostate/colonCa/CADPGP O O
d O O
80s O O
?cause, O O
MGF O O
d90 O O
age, O O
MGM O O
d73 O O
CVAM O O
d O O
73 O O
stomach O O
Ca, O O
OA, O O
obeseF O O
d O O
84 O O
multi-infarct O O
dementiaS O O
b66 O O
DMS O O
b74 O O
DMSon O O
b93D O O
b94 O O
GC O O
due22D O O
Fran O O
b03 O O
Abn O O
pap24 O O
Nephropathy O O
3/25 O O
UTPro/Cre O O
2340/2.3 O O
Diabetes O B-MEDICATION
mellitus O O
Type O O
2 O O
MEDICATIONS O O
GLUCOPHAGE B-MEDICATION B-MEDICATION
(METFORMIN) O O
Variable O O
PO O O
ZESTRIL B-MEDICATION B-MEDICATION
(LISINOPRIL) O O
10MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
ASA B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
325MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
LIPITOR B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20MG O O
1 O O
Tablet(s) O O
PO O O
QHS O O
TOPROL B-MEDICATION B-MEDICATION
XL I-MEDICATION O
(METOPROLOL O O
(SUST. O O
REL.)) O O
200MG O O
1.5 O O
Tablet(s) O O
PO O O
QD O O
FUROSEMIDE O O
20MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
NPH B-MEDICATION B-MEDICATION
HUMULIN I-MEDICATION B-MEDICATION
INSULIN B-DIABETES O
(INSULIN O O
NPH O O
HUMAN) O O
Variable O O
SC O O
insulin B-MEDICATION O
syringes O O
USE O O
AS O O
disp O O
#100 O O
order O O
number O O
38/48 O O
ALLERGY O O
NKDA O O
PE: O O
in O O
no O O
acute O O
distress. O O
VITAL O O
SIGNS O O
BLOOD B-HYPERTENSION O
PRESSURE I-HYPERTENSION O
150/90 B-HYPERTENSION O
repeat O O
BP O O
150/90 O O
TEMPERATURE O O
97.8 O O
Perrla O O
eomi, O O
throat: O O
erythematous O O
with O O
lots O O
of O O
secretions O O
but O O
no O O
pus O O
or O O
whitish O O
lesions. O O
sig O O
nasal O O
congestion O O
moderate O O
sinus O O
pressure O O
on O O
percussion O O
no O O
pain. O O
lungs: O O
minimal O O
bibasilar O O
crackles. O O
CVS: O O
s1s2 O O
rrr. O O
abdomen: O O
obese O O
soft O O
NT O O
good O O
BS. O O
ext: O O
minimal O O
pitting O O
edema. O O
neuro: O O
non O O
focal O O
A/P: O O
1) O O
URI O O
like O O
sx O O
with O O
pharyngitis O O
and O O
some O O
sinus O O
pressure. O O
will O O
get O O
throat O O
cx O O
to O O
r/o O O
strep O O
throat. O O
will O O
also O O
give O O
a O O
course O O
of O O
zithromax O O
500 O O
x1 O O
then O O
250 O O
qd O O
for O O
4 O O
days. O O
pt O O
to O O
call O O
in O O
AM O O
to O O
get O O
results O O
of O O
throat O O
cx. O O
will O O
give O O
cepacol O O
OTC O O
for O O
sore O O
throat O O
relief O O
and O O
afrin O O
spray O O
for O O
nasal O O
congetsion. O O
2) O O
SOB/CVS O O
symptoms O O
I O O
advised O O
the O O
patient O O
that O O
he O O
needs O O
to O O
go O O
to O O
the O O
EW O O
now O O
to O O
be O O
evaluated O O
for O O
his O O
cardiac O O
symptoms O O
and O O
explained O O
to O O
him O O
that O O
his O O
diabetes, O O
his O O
Hx O O
of O O
CAD/CABG O O
and O O
the O O
recurrence O O
of O O
his O O
sx O O
puts O O
him O O
at O O
a O O
significant O O
high O O
risk O O
. O O
I O O
offered O O
to O O
send O O
him O O
by O O
ambulance O O
from O O
here, O O
he O O
did O O
not O O
want O O
to O O
go O O
to O O
EW, O O
did O O
not O O
want O O
an O O
ECG O O
stating O O
that O O
he O O
will O O
see O O
his O O
cardiologist O O
next O O
week. O O
he O O
clearly O O
understands O O
the O O
risks O O
and O O
benefits O O
including O O
the O O
risk O O
of O O
death O O
if O O
he O O
does O O
not O O
go O O
to O O
EW O O
today. O O
3) O O
increased O O
BP, O O
he O O
said O O
he O O
is O O
compliant O O
with O O
his O O
meds,he O O
agreed O O
to O O
come O O
back O O
in O O
Am O O
for O O
recheck. O O

Record O O
date: O O
2129-01-09 O O
Team O O
2 O O
Intern O O
Admit O O
Note O O
Patient: O O
Valdivia, O O
Elijah O O
EVC O O
Unit O O
Number: O O
845 O O
52 O O
82 O O
Date O O
of O O
Admission: O O
9 O O
January O O
2129 O O
Attending O O
Physician: O O
Quentin O O
Lemus, O O
MD O O
Room: O O
Internal O O
Medicine O O
1718 O O
Code O O
Status: O O
Full O O
PCP: O O
Leon O O
Fontenot, O O
MD O O
of O O
Elkhorn O O
Valley O O
Source: O O
Patient O O
Chief O O
Complaint: O O
Weakness, O O
Weight O O
Loss O O
History O O
of O O
The O O
Present O O
Illness: O O
58 O O
year-old O O
man O O
with O O
a O O
history B-CAD O
of I-CAD O
CAD I-CAD O
s/p I-CAD O
CABG, I-CAD O
CHF, O O
DM, B-DIABETES O
HL, B-HYPERLIPIDEMIA O
HTN, B-HYPERTENSION O
and O O
OSA O O
who O O
presents O O
with O O
a O O
complaint O O
of O O
weakness O O
and O O
weight O O
loss O O
in O O
the O O
setting O O
of O O
increased O O
diuretic O O
use. O O
Patient O O
has O O
a O O
history O O
dietary O O
indiscretion O O
and O O
difficult O O
to O O
control O O
volume O O
overload. O O
He O O
called O O
into O O
his O O
cardiologist's O O
office O O
Queenie O O
Yeargan O O
on O O
01/03/29, O O
who O O
was O O
being O O
covered O O
by O O
Dr. O O
Haynes O O
to O O
report O O
increasing O O
lower O O
extremity O O
edema O O
and O O
worsening O O
shortness O O
of O O
breath. O O
He O O
was O O
prescribed O O
5 O O
mg O O
of O O
Zaroxolyn O O
daily O O
and O O
had O O
a O O
14 O O
lb O O
weight O O
loss O O
over O O
the O O
next O O
three O O
days. O O
The O O
patient O O
developed O O
weakness O O
and O O
continued O O
to O O
feel O O
weak O O
and O O
lose O O
weight O O
despite O O
discontinuing O O
Zaroxolyn O O
on O O
01/05/29 O O
under O O
the O O
advise O O
of O O
Dr. O O
Haynes. O O
The O O
patient O O
did O O
continue O O
to O O
take O O
the O O
rest O O
of O O
his O O
medications. O O
He O O
reported O O
to O O
the O O
ED O O
for O O
lab O O
draw O O
after O O
reporting O O
his O O
symptoms O O
to O O
Dr. O O
Quentin O O
Lemus. O O
In O O
the O O
ED O O
the O O
patient O O
had O O
vitals O O
of O O
98.5 O O
80 O O
107/62 O O
18 O O
97% O O
on O O
RA. O O
The O O
patient O O
was O O
given O O
1L O O
of O O
NS, O O
500 O O
mg O O
levofloxacin, O O
30 O O
U O O
of O O
NPH/10 B-MEDICATION B-MEDICATION
U O O
of O O
Regular, O O
100 O O
mg O O
of O O
Lipitor, B-MEDICATION B-MEDICATION
and O O
200 O O
mg O O
of O O
Zoloft. O O
The O O
patient O O
noted O O
a O O
decreased O O
amount O O
of O O
concentrated O O
foul O O
smelling O O
urine, O O
worsening O O
SOB, O O
and O O
dry O O
cough. O O
The O O
pt O O
denied O O
lightheadedness, O O
syncope, O O
chest O O
pain, O O
F/C, O O
N/V, O O
abdominal O O
pain, O O
diarrhea. O O
Past O O
Medical/Surgical O O
History: O O
CAD O O
s/p O O
MI B-CAD O
& O O
CABG O O
(5/25: B-CAD O
LIMA I-CAD O
to I-CAD O
LAD, I-CAD O
SVG I-CAD O
to I-CAD O
PDA, I-CAD O
Radial I-CAD O
Artery I-CAD O
to I-CAD O
OM1); I-CAD O
last O O
catheterization O O
1/2126 O O
patent O O
grafts, O O
last O O
stress O O
12/2127 O O
adenosine O O
MIBI, O O
equivocal O O
inferolateral O O
ischemia O O
and O O
small O O
posterobasal O O
scar, O O
last O O
ECHO O O
2/2128 O O
Mild O O
MR, O O
LA O O
dilatation, O O
EF O O
62 O O
%, O O
trace O O
TR, O O
RVSP O O
25 O O
mmHg O O
CHF(diastolic O O
dysfunction) O O
DM O O
II O O
-complicated O O
by O O
retinopathy O O
s/p O O
laser O O
treatment, O O
nephropathy O O
OSA O O
-on O O
BiPAP(15/10 O O
cm) O O
HTN O O
Obesity-BMI B-OBESE O
39 I-OBESE O
being O O
evaluated O O
by O O
the O O
weight O O
center O O
for O O
possible O O
gastric O O
banding O O
HL O O
PVD O O
PSTD-Pilot O O
(Air O O
Force O O
2090-2092) O O
Plantar O O
Fasciitis O O
Allergies: O O
Lisinopril O B-MEDICATION
cough O O
Medications: O O
Metformin B-MEDICATION B-MEDICATION
1000 O O
mg O O
BID O O
Cartia O O
XT O O
240 O O
mg O O
QD O O
Lipitor O B-MEDICATION
100 O O
mg O O
QD O O
Lasix O O
80 O O
mg O O
BID O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
100 O O
QD O O
Humulin B-MEDICATION B-MEDICATION
NPH I-MEDICATION B-MEDICATION
60 O O
mg O O
BID O O
ASA B-MEDICATION B-MEDICATION
325 O O
mg O O
QD O O
Zoloft O O
100 O O
mg O O
QD O O
Altace B-MEDICATION O
10 O O
mg O O
QD O O
Social O O
History: O O
Occupation O O
- O O
Retired O O
communications O O
manager O O
Tobacco B-SMOKER O
- I-SMOKER O
30 I-SMOKER O
pack-year I-SMOKER O
history, I-SMOKER O
quit I-SMOKER O
18 I-SMOKER O
years I-SMOKER O
ago I-SMOKER O
Alcohol/Illicit/IV O O
Drugs O O
- O O
History O O
of O O
cocaine O O
and O O
EtOH O O
abuse O O
clean O O
x O O
14 O O
yrs O O
Lives O O
at O O
home O O
with O O
son O O
Family O O
History: O O
Non-Contributory O O
Review O O
of O O
Systems: O O
As O O
per O O
HPI, O O
otherwise O O
negative O O
in O O
detail. O O
Physical O O
Examination: O O
T O O
96.7 O O
HR O O
91 O O
BP B-HYPERTENSION O
148/77 I-HYPERTENSION O
RR O O
22 O O
SaO2 O O
97% O O
on O O
RA O O
General O O
- O O
well O O
appearing, O O
well O O
nourished O O
patient O O
in O O
NAD, O O
appropriate O O
HEENT O O
- O O
normocephalic, O O
atraumatic, O O
PERRLA, O O
anicteric, O O
dry O O
mucous O O
membranes, O O
no O O
JVP~10 O O
cm O O
H2O O O
Pulmonary O O
- O O
CTAB, O O
good O O
air O O
movement O O
bilaterally, O O
no O O
crackles O O
Cardiac O O
- O O
distant, O O
regular O O
rate O O
and O O
rhythm, O O
S1 O O
and O O
S2 O O
normal, O O
no O O
murmurs O O
Abdomen O O
- O O
obese, B-OBESE O
non-tender, O O
mildly O O
distended, O O
active O O
bowel O O
sounds O O
Extremity O O
- O O
no O O
cyanosis, O O
clubbing, O O
2+ O O
edema, O O
2+ O O
and O O
equal O O
distal O O
pulses O O
Neurology O O
- O O
AAOx3 O O
Skin O O
- O O
no O O
worrisome O O
rashes O O
or O O
lesions O O
Data: O O
Chemistries: O O
Na O O
133 O O
K O O
3.8 O O
Cl O O
104 O O
HCO3 O O
24 O O
BUN O O
87 O O
Cr O O
2.1 O O
2.4 O O
2.2 O O
(baseline~1.4), O O
Glucose O O
310 O O
Ca O O
8.8 O O
Phos O O
4.7 O O
Mg O O
1.7 O O
ALT O O
16AST O O
19AlkP O O
86 O O
Tbili O O
0.4 O O
Dbili O O
0.1 O O
Albumin O O
3.3 O O
CK O O
165 O O
186 O O
CK-MB O O
-- O O
4.5 O O
RI O O
-- O O
-- O O
Trop O O
T O O
0.02 O O
&lt;0.01 O O
Blood O O
Counts: O O
WBC O O
8.7 O O
HCT O O
38.8 O O
Plts O O
179 O O
MCV O O
79, O O
RDW O O
14.8 O O
12.9/--/23.3 O O
Microbiology: O O
U/A: O O
2+ O O
Glucose, O O
(-) O O
Ketones. O O
2+ O O
albumin, O O
1+ O O
blood, O O
nitrite O O
(-), O O
1+ O O
WBC, O O
0-2 O O
casts, O O
moderate O O
bacteria, O O
moderate O O
squamous O O
cells, O O
5-10 O O
WBCs, O O
20-50 O O
WBCs O O
Radiology: O O
CXR: O O
s/p O O
CABG, O O
low O O
lung O O
volumes, O O
no O O
pulmonary O O
edema O O
Cardiogram: O O
NSR O O
@ O O
85 O O
BPM, O O
primary O O
AV O O
delay O O
(PR O O
interval O O
260 O O
ms), O O
LAD, O O
RBBB, O O
TWI O O
in O O
leads O O
V1-V2 O O
Assessment: O O
58 O O
year-old O O
man O O
with O O
a O O
history O O
of O O
CAD O O
CHF, O O
and O O
OSA O O
who O O
presents O O
with O O
weakness, O O
weight O O
loss, O O
SOB, O O
and O O
ARF O O
in O O
the O O
setting O O
of O O
increased O O
diuretic O O
use. O O
Plan: O O
1. O O
ARF: O O
-responding O O
to O O
slow O O
hydration, O O
will O O
aim O O
for O O
euvolemia O O
and O O
hold O O
diuresis O O
and O O
ACE-I. O O
Gentle O O
IVF O O
at O O
this O O
time O O
given O O
tenuous O O
balance O O
between O O
being O O
dry O O
and O O
volume O O
overloaded, O O
will O O
reassess O O
volume O O
status O O
in O O
the O O
AM O O
along O O
with O O
AM O O
lytes O O
-hold O O
lasix, O O
ACE-I O O
-Urine O O
lytes O O
obtained O O
in O O
the O O
ED O O
difficult O O
to O O
interpret O O
in O O
the O O
setting O O
of O O
diuretic O O
use O O
-check O O
Urine O O
Eos O O
(per O O
attg) O O
-Renal O O
U/S O O
(per O O
attg) O O
-treat O O
UTI O O
(levoflox O O
x O O
10 O O
D), O O
f/u O O
UCx O O
2. O O
HTN O O
-continue O O
lopressor, O B-MEDICATION
hold B-MEDICATION O
Cartia I-MEDICATION O
XT I-MEDICATION O
and I-MEDICATION O
Altace I-MEDICATION O
3. O O
SOB: O O
Expected O O
improvement O O
in O O
symptoms O O
with O O
diuresis O O
but O O
patient O O
actually O O
reports O O
worsening O O
of O O
SOB. O O
Last O O
ECHO O O
demonstrated O O
normal O O
RSVP O O
but O O
concern O O
now O O
for O O
progressive O O
primary O O
pulmonary O O
process O O
contributing O O
to O O
R O O
heart O O
failure O O
not O O
L O O
sided O O
dysfunction. O O
-repeat O O
ECHO O O
in O O
the O O
AM O O
4. O O
DM O O
-holding O O
metformin O B-MEDICATION
in O O
the O O
setting O O
of O O
ARF O O
-half O O
home O O
NPH O O
dose O O
with O O
SSI O O
5. O O
CAD O B-MEDICATION
-hold O O
lipitor O B-MEDICATION
given O O
renal O O
failure, O O
-continue O O
ASA, O B-MEDICATION
toprol, O B-MEDICATION
6. O O
Dispo O O
-Return O O
to O O
home O O
___________________________ O O
Quincey O O
Harmon, O O
MD O O
Intern O O
in O O
Internal O O
Medicine O O
Pager O O
32591 O O

Record B-SMOKER O
date: O O
2129-05-10 O O
Booked O O
for O O
CPE, O O
but O O
current O O
symptoms O O
took O O
precedence. O O
Pt O O
presents O O
very O O
discouraged O O
over O O
escalating O O
Lasix O O
doses O O
and O O
persistant O O
problems O O
with O O
reccurent O O
edema O O
and O O
cough, O O
each O O
time O O
relieved O O
by O O
increasing O O
diuretics, O O
so O O
ACEI B-MEDICATION O
cough O O
seems O O
unlikely. O O
Avoiding O O
all O O
salt O O
in O O
diet O O
with O O
good O O
compliance. O O
Did O O
see O O
sleep O O
lab O O
tech, O O
tried O O
new O O
settings O O
and O O
mask O O
on O O
new O O
machine, O O
but O O
still O O
tolerates O O
poorly. O O
When O O
discussed O O
in O O
some O O
detail, O O
notes O O
feelings O O
of O O
suffocation O O
with O O
wearing O O
mask O O
for O O
any O O
period O O
of O O
time. O O
Also O O
notes O O
sense O O
of O O
being O O
tied O O
down O O
frrom O O
mask O O
very O O
difficult O O
to O O
tolerate. O O
Without O O
exploring O O
details O O
greatly, O O
we O O
discussed O O
potential O O
role O O
of O O
PTSD O O
in O O
precipitating O O
symptoms O O
related O O
to O O
mask O O
use, O O
and O O
potentially O O
the O O
effect O O
of O O
nocturnal O O
hypoxia O O
and O O
RV O O
strain O O
on O O
accumulation O O
of O O
fluid. O O
Improving O O
tolerance O O
of O O
CPAP O O
seems O O
very O O
key. O O
Pt O O
has O O
started O O
atkins O O
dt O O
with O O
good O O
success O O
(6# O O
in O O
first O O
week), O O
and O O
improving O O
BGs O O
are O O
requiring O O
reduction O O
in O O
insulin, B-MEDICATION O
which O O
is O O
great. O O
so O O
it O O
seems O O
that O O
addressing O O
OSA O O
is O O
the O O
key O O
to O O
improving O O
overall O O
status O O
now. O O
We O O
discussed O O
some O O
options...Including O O
potential O O
for O O
tracheostomy O O
to O O
fix O O
this O O
without O O
having O O
to O O
address O O
mask, O O
but O O
agreed O O
to O O
try O O
to O O
initiate O O
trial O O
of O O
CBT O O
to O O
see O O
if O O
we O O
can O O
improve O O
mask O O
talerance O O
with O O
symptom O O
reduction. O O
He O O
remains O O
quite O O
clear O O
that O O
he O O
has O O
no O O
interest O O
in O O
furhter O O
'exploring' O O
the O O
PTSD O O
history, O O
and O O
I O O
reassured O O
him O O
that O O
CBT O O
does O O
not O O
require O O
doing O O
this. O O
OSA: O O
Likely O O
has O O
near O O
optimal O O
mask O O
set O O
up O O
now...We'll O O
explore O O
potential O O
for O O
CBT O O
with O O
sleep O O
center O O
or O O
perhaps O O
cardiac O O
rehab O O
source. O O
Hopefully O O
this O O
would O O
address O O
fluid O O
imbalance O O
to O O
a O O
greater O O
extent O O
as O O
well. O O
DM: B-DIABETES O
improving O O
with O O
wt O O
loss O O
and O O
diet. O O
Agree O O
with O O
insulin O O
taper O O
as O O
sugars O O
drop. O O
UAMLB O O
high O O
but O O
&lt; O O
1 O O
year O O
ago, O O
recheck O O
in O O
future. O O
Creatinine O O
stable O O
2 O O
months O O
ago, O O
recheck O O
renal O O
panel O O
with O O
labs. O O
Optho O O
and O O
podiatry O O
current. O O
Lipids: O O
last O O
LDL O O
was O O
an O O
outlier..Has O O
slip O O
fro O O
repeat O O
FLP. O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
: O O
s/p B-CAD O
CABG I-CAD O
5/25, I-CAD O
satable O O
on O O
ASA/Statin/ACEI/BB B-MEDICATION B-MEDICATION
Hypertension B-HYPERTENSION O
Vital O O
Signs O O
BP O O
118/70, O O
Wt O O
235 O O
lb O O
well O O
controlled. O O
Peripheral O O
vascular O O
disease O O
: O O
claudication O O
limited O O
Sx O O
with O O
limited O O
exercise O O
tolerance. O O
Obesity B-OBESE O
: O O
adtkins O O
dt O O
as O O
above. O O
Glaucoma O O
: O O
Dr. O O
Russo, O O
HWS, O O
gets O O
regular O O
f/u. O O
Insomnia O O
: O O
since O O
service. O O
NTI O O
helped O O
a O O
little O O
in O O
past, O O
not O O
after O O
a O O
while. O O
CBT O O
might O O
help O O
if O O
successful. O O
Reviewed O O
HM, O O
mostly O O
up O O
to O O
date, O O
should O O
get O O
Td O O
update O O
at O O
some O O
point O O
or O O
if O O
wound, O O
counseled. O O
Most O O
of O O
40 O O
minute O O
visit O O
counseling O O
on O O
CBT, O O
PTSD, O O
sleep O O
apnea, O O
and O O
concern O O
about O O
failing O O
regimen. O O
Emailed O O
Barbara O O
Fierro, O O
Sleep O O
center, O O
Dr. O O
Yeargin, O O
and O O
Dr. O O
Ingham O O
of O O
Rehab O O
to O O
help O O
identify O O
best O O
CBT O O
practitioner O O
for O O
this. O O
_____________________________________________ O O
Leon O O
Virgil O O
Fontenot, O O
M.D. O O

Record O O
date: O O
2130-08-09 O O
CARDIOLOGY O O
ELKHORN O O
VALLEY O O
CLINIC O O
Reason O O
for O O
visit: O O
A O O
59 O O
yr O O
old O O
IDDM B-DIABETES O
man O O
s/p B-CAD O
CABG I-CAD O
in I-CAD O
25 I-CAD O
with O O
IDDM O O
and O O
CHF O O
admitted O O
after O O
elective B-CAD O
cardiac I-CAD O
cath I-CAD O
which I-CAD O
revealed I-CAD O
new I-CAD O
RCA I-CAD O
occlusion I-CAD O
for O O
post O O
hydration/Mucomyst/bicarb. O O
Interval O O
History: O O
Cardiac O O
history O O
began O O
in O O
2125 O O
with O O
inappropriate O O
sinus O O
tachycardia. O O
A O O
cardiac O O
echo O O
revealed O O
EF O O
of O O
64% O O
with O O
no O O
valvular O O
disease O O
and O O
normal O O
wall O O
motion. O O
An O O
Aden B-CAD O
MIBI I-CAD O
4/25 I-CAD O
revealed I-CAD O
inferior I-CAD O
and I-CAD O
PL I-CAD O
ischemia I-CAD O
and I-CAD O
he I-CAD O
was I-CAD O
taken I-CAD O
to I-CAD O
the I-CAD O
cath I-CAD O
lab. I-CAD O
The I-CAD O
cath B-CAD O
revealed I-CAD O
mild I-CAD O
pulmonary I-CAD O
hypertension, I-CAD B-HYPERTENSION
PCW I-CAD O
of I-CAD O
14, I-CAD O
co-dominance I-CAD O
with I-CAD O
65% I-CAD O
PDA, I-CAD O
moderate I-CAD O
LCX I-CAD O
disease I-CAD O
and I-CAD O
severe I-CAD O
proximal I-CAD O
LAD I-CAD O
lesion. I-CAD O
HE B-CAD O
subsequently I-CAD O
underwent I-CAD O
CABG B-CAD O
with I-CAD O
LIMA I-CAD O
to I-CAD O
LAD, I-CAD O
radial I-CAD O
artery I-CAD O
to I-CAD O
LCX I-CAD O
and I-CAD O
VG I-CAD O
to I-CAD O
PDA. I-CAD O
1/26 O O
he O O
noted O O
progressive O O
DOE O O
with O O
upper O O
chest O O
discomfort O O
and O O
was O O
brought O O
to O O
the O O
cath O O
lab. O O
His O O
PA O O
pressure O O
was O O
45/20 O O
with O O
a O O
PCW O O
of O O
20, O O
all O O
grafts O O
were O O
open O O
and O O
his O O
BB B-MEDICATION O
and O O
lasix O O
were O O
increased. O O
An O O
Aden B-CAD O
MIBI I-CAD O
12/27 I-CAD O
showed I-CAD O
an I-CAD O
EF I-CAD O
of I-CAD O
60% I-CAD O
w I-CAD O
small I-CAD O
PB I-CAD O
scar I-CAD O
& I-CAD O
inferior-lateral I-CAD O
ischemia. I-CAD O
Echo O O
2/28 O O
revealed O O
new O O
LA O O
enlargement O O
with O O
EF O O
of O O
62%. O O
He O O
was O O
admitted O O
1/29 O O
with O O
HF O O
exacerbation/acute O O
renal O O
failure O O
in O O
the O O
setting O O
of O O
rapid O O
out-patient O O
diureses O O
with O O
zaroxolyn. O O
(BUN O O
74, O O
creat O O
2.2) O O
Diuretics B-MEDICATION O
as O O
well O O
as O O
Glucophage O B-MEDICATION
and O O
ACE O O
I O O
were O O
held O O
and O O
he O O
was O O
discharged O O
with O O
a O O
creat O O
of O O
1.2. O O
An O O
echo O O
revealed O O
new O O
mild O O
MR O O
and O O
RF O O
of O O
59%. O O
Over O O
the O O
last O O
few O O
months O O
he O O
has O O
noted O O
episodes O O
of O O
sudden O O
lightheadedness/dizziness, O O
floaters. O O
He O O
would O O
take O O
his O O
BP O O
with O O
a O O
home O O
machine O O
and O O
it O O
could O O
be O O
as O O
low O O
as O O
77/47. O O
In O O
addition, O O
he O O
has O O
noted O O
progressive O O
DOE O O
as O O
well O O
an O O
now O O
rest O O
angina O O
that O O
is O O
requiring O O
a B-MEDICATION O
SL I-MEDICATION O
TNG I-MEDICATION O
for O O
relief. O O
He O O
has O O
3 O O
flights O O
of O O
stairs O O
to O O
climb O O
to O O
his O O
apartment O O
and O O
uses O O
1 O O
SL O O
TNG O O
prophylactically. O O
An O O
exercise O O
adenosine B-CAD O
MIBI I-CAD O
was I-CAD O
done I-CAD O
6/14 I-CAD O
which I-CAD O
revealed I-CAD O
an I-CAD O
EF I-CAD O
of I-CAD O
75% I-CAD O
with I-CAD O
mild I-CAD O
anterior I-CAD O
and I-CAD O
IPL I-CAD O
ischemia. I-CAD O
He O O
was O O
admitted O O
for O O
a O O
cardiac O O
cath O O
6/20, O O
however O O
due O O
to O O
a O O
creatinine O O
of O O
2.4 O O
only O O
a O O
right O O
heart O O
cath O O
was O O
done. O O
It O O
revealed O O
RAP O O
of O O
7, O O
RVP O O
of O O
36/17, O O
PAP O O
of O O
35/17, O O
PCW O O
of O O
17 O O
and O O
CO O O
5.9. O O
Given O O
his O O
episodes O O
of O O
sudden O O
hypotension O O
as O O
well O O
as O O
increasing O O
creatinine, O O
Diltiazem O O
as O O
well O O
as O O
Ramipril O B-MEDICATION
and O O
Aldactone O O
have O O
been O O
held. O O
He O O
reports O O
no O O
further O O
episodes O O
of O O
hypotension O O
since O O
stopping O O
these O O
meds. O O
He O O
is O O
being O O
followed O O
by O O
Dr O O
You O O
in O O
renal O O
service. O O
Of O O
note, O O
he O O
continues O O
to O O
use O O
the O O
oxygen O O
at O O
night.(2 O O
liters O O
NP) O O
Cardiac B-CAD O
cath I-CAD O
today I-CAD O
revealed I-CAD O
normal I-CAD O
LM, I-CAD O
TO I-CAD O
mid I-CAD O
LAD I-CAD O
with I-CAD O
LIMA I-CAD O
to I-CAD O
LAD I-CAD O
filling I-CAD O
distal I-CAD O
LAD, I-CAD O
mild I-CAD O
LCX I-CAD O
disease, I-CAD O
RCA I-CAD O
is I-CAD O
totally I-CAD O
occluded I-CAD O
with I-CAD O
distal I-CAD O
vessel I-CAD O
filling I-CAD O
via I-CAD O
VG I-CAD O
to I-CAD O
RPDA, I-CAD O
VG I-CAD O
to I-CAD O
RCA I-CAD O
small I-CAD O
vessel I-CAD O
but I-CAD O
patent, I-CAD O
LIMA I-CAD O
to I-CAD O
LAD I-CAD O
patent. I-CAD O
Althought I-CAD O
the I-CAD O
RA I-CAD O
graft I-CAD O
to I-CAD O
the I-CAD O
PDA I-CAD O
and I-CAD O
VG I-CAD O
to I-CAD O
LCX I-CAD O
are I-CAD O
patent I-CAD O
- I-CAD O
they I-CAD O
are I-CAD O
small I-CAD O
and I-CAD O
atretic. I-CAD O
Past O O
medical O O
history: O O
CAD B-CAD O
IDDM O O
x O O
10 O O
yrs O O
retinopathy O O
s/p O O
laser O O
HTN B-HYPERTENSION O
CRI O O
OSA O O
- O O
can't O O
tolerate O O
CPAP O O
LBP O O
bilateral O O
claudication O O
if O O
he O O
walks O O
fast O O
reactive O O
airway O O
disease O O
PTSD O O
Recovering O O
alcoholic O O
- O O
sober O O
x O O
16 O O
years O O
remote O O
ulcer O O
- O O
in O O
his O O
20's O O
CHF O O
- O O
dry O O
wt O O
215 O O
PSHx: O O
CABG O B-MEDICATION
25 O O
with O O
LIMA O O
to O O
LAD, O O
radial O O
artery O O
to O O
RPDA, O O
VG O O
to O O
LCX O O
Medications O O
(Confirmed): O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
QD O O
Atrovent O O
18 O O
mcg/spray O O
inh O O
tid O O
Flonase O O
1 O O
spray O O
BID O O
furosemide O O
80 O O
mg O O
qam O O
isosorbide B-MEDICATION B-MEDICATION
mononitrate I-MEDICATION O
30 O O
mg O O
qd O O
Lipitor B-MEDICATION B-MEDICATION
80 O O
mg O O
QHS O O
Nephrocaps O O
1 O O
tab O O
qd O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
100 O O
mg O O
qd O O
u100 O O
NPH B-MEDICATION B-MEDICATION
insulin I-MEDICATION B-MEDICATION
Zetia B-MEDICATION O
10 O O
mg O O
qd O O
Allergies: O O
Drug O O
reaction O O
lisinopril O B-MEDICATION
causes O O
cough O O
Family O O
history: O O
father O O
mild O O
MI O O
age O O
59 O O
Social O O
history: O O
divorced, O O
quit B-SMOKER O
smoking I-SMOKER O
in I-SMOKER O
08, I-SMOKER O
sober O O
x O O
10 O O
yrs, O O
retired O O
communications O O
manager O O
Review O O
of O O
systems: O O
denies O O
ortho/PND/thyroid O O
disease/melena/recent O O
ulcer O O
Physical O O
examination: O O
-BMI: O O
-Pulse: O O
85 O O
-resp. O O
rate: O O
16 O O
-height: O O
67 O O
in. O O
-weight: O O
220 O O
-General: O O
No O O
acute O O
distress. O O
-Skin: O O
No O O
rashes, O O
anicteric. O O
-Heent: O O
Unremarkable O O
-Neck: O O
JVP O O
flat O O
but O O
difficult O O
to O O
see. O O
- O O
carotids O O
2+, O O
bilateral O O
bruits O O
R&gt;L O O
-Chest: O O
Lungs O O
clear O O
anteriorly O O
-Cardiac: O O
He O O
has O O
a O O
normal O O
S1 O O
and O O
S2, O O
and O O
a O O
soft O O
systolic O O
ejection O O
murmur O O
at O O
the O O
left O O
lower O O
sternal O O
border O O
and O O
apex O O
-Abdomen: O O
Normal O O
bowel O O
sounds, O O
soft O O
and O O
nontender, O O
with O O
no O O
hepatosplenomegaly O O
or O O
masses O O
appreciated. O O
-Extremities: O O
right O O
groin O O
D&I, O O
no O O
hematoma O O
or O O
bruit O O
DP/PT O O
1+/1+, O O
left O O
groin O O
2+, O O
no O O
bruit O O
DP/PT O O
1+/1+ O O
-Neuro: O O
A&O O O
x3, O O
CN O O
2-12 O O
grossly O O
intact. O O
-BP: O O
139/85 O O
EKG: O O
75 O O
RBBB O O
- O O
first O O
degree O O
AVB O O
w O O
PR O O
.22 O O
Selected O O
recent O O
labs: O O
Metabolic O O
Date O O
K O O
CL O O
CO2 O O
BUN O O
CRE O O
GLU O O
CA O O
08/09/30 O O
4.8 O O
46 O O
1.6 O O
08/08/30 O O
100 O O
30.9 O O
263 O O
9.2 O O
Liver O O
and O O
Pancreatic O O
Enzymes O O
Date O O
ALB O O
TP O O
ALKP O O
TBILI O O
ALT/SGPT O O
AST/SGOT O O
07/05/30 O O
4.1 O O
05/30/30 O O
7.4 O O
93 O O
0.4 O O
22 O O
26 O O
Hematology O O
Date O O
HCT O O
RBC O O
WBC O O
PLT O O
08/01/30 O O
33.1 O O
4.14 O O
11.0 O O
221 O O
Coagulation O O
Date O O
PT O O
PT-INR O O
PTT O O
HCYS/PBH O O
08/01/30 O O
12.0 O O
1.0 O O
01/09/29 O O
23.3 O O
07/31/27 O O
10.9 O O
Immunology O O
Date B-DIABETES O
HGBA1C B-DIABETES O
04/11/30 I-DIABETES O
11.40 I-DIABETES O
other O O
Date O O
CORT O O
RENIN O O
07/25/30 O O
37.0 O O
8.9 O O
Other O O
Data: O O
PFT's O O
7/26 O O
VC O O
66%, O O
FEV1/VC O O
109% O O
Assessment O O
and O O
plan: O O
77 O O
yo O O
diabetic O O
male O O
admitted O O
after O O
cardiac O O
catheterization O O
for O O
post O O
hydration O O
Plan: O O
Admit O O
to O O
Internal O O
Medicine O O
Bedrest O O
for O O
6 O O
hours O O
Resume O O
Lasix O O
tonight O O
- O O
patient O O
has O O
not O O
voided O O
all O O
day, O O
just O O
completing O O
Bicarb O O
drip O O
Fasting O O
lipids, O O
Lipo O O
a, O O
BNP O O
in O O
AM O O
Continue O O
to O O
hold O O
Ramipril, O O
Aldactone O O
and O O
Diltiazem O O
Complete O O
Bicarb O O
drip O O
and O O
total O O
of O O
4 O O
doses O O
of O O
Mucomyst O O
Follow O O
Renal O O
function O O
CNIS O O
to O O
evaluate O O
carotid O O
bruits O O
Continue O O
NPH O O
BID O O
- O O
s/s O O
regular O O
insulin O O
as O O
needed O O
- O O
especially O O
given O O
bicarb O O
qtt O O
in O O
D5W O O
Nutrition O O
consult O O
for O O
HBA1c O O
11.4, O O
obesity B-OBESE O
Per O O
Attending O O
- O O
medical O O
management O O
for O O
now O O
- O O
RCA O O
lesion O O
is O O
long, O O
would O O
be O O
challenging O O
and O O
require O O
significant O O
dye O O
- O O
will O O
increase O O
Imdur O O
to O O
60 O O
qd O O
Will O O
need O O
ABX O O
prophylaxis O O
for O O
MR O O
at O O
discharge O O
Andreea O O
Marquez O O
RN, O O
MN O O
1-3051 O O
Changes O O
to O O
Medications O O
this O O
visit O O
Nephrocaps O O
1 O O
tab O O
qd O O
u100 O O
NPH O O
insulin O O
Start: O O
08/09/2130 O O
Flonase O O
1 O O
spray O O
BID O O
nasally O O
Atrovent O O
18 O O
mcg/spray O O
inh O O
tid O O
Start: O O
08/09/2130 O O
isosorbide O B-MEDICATION
mononitrate O O
30 O O
mg O O
qd O O
Toprol O B-MEDICATION
XL O O
100 O O
mg O O
qd O O
Lipitor O B-MEDICATION
80 O O
mg O O
QHS O O
Zetia O O
10 O O
mg O O
qd O O
furosemide O O
80 O O
mg O O
qam O O
in O O
the O O
and O O
80 O O
mg O O
in O O
the O O
qpm O O
Start: O O
07/13/2130 O O
aspirin O B-MEDICATION
325 O O
mg O O
QD O O
Signed O O
electronically O O
by O O
Andreea O O
Marquez O O
RN, O O
NP O O
on O O
Aug O O
10, O O
2130 O O

Record B-SMOKER O
date: O O
2096-08-06 O O
BHC O O
EMERGENCY O O
DEPT O O
VISIT O O
MARVINYANDELL,GRACE O O
904-68-07-1 O O
VISIT O O
DATE: O O
08/06/96 O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
patient O O
is O O
a O O
68 O O
year O O
old O O
woman O O
who O O
is O O
being O O
seen O O
by O O
Dr. O O
Dodd O O
who O O
had O O
what O O
was O O
a O O
syncopal O O
episode O O
on O O
the O O
premises. O O
A O O
code O O
was O O
called O O
when O O
bystanders O O
and O O
medics O O
reported O O
she O O
was O O
on O O
the O O
floor, O O
diaphoretic O O
and O O
clammy. O O
The O O
patient O O
drank O O
something O O
and O O
then O O
proceeded O O
to O O
be O O
taken O O
to O O
the O O
Emergency O O
Department. O O
The O O
patient O O
had O O
a O O
cystoscopy O O
planned O O
for O O
today. O O
She O O
took O O
her O O
medication O O
for O O
her O O
diabetes B-DIABETES O
and O O
presented O O
here O O
with O O
weakness, O O
nausea, O O
diaphoresis O O
and O O
felt O O
like O O
she O O
may O O
have O O
passed O O
out. O O
Her O O
other O O
complaint O O
was O O
mild O O
back O O
pain O O
from O O
passing O O
out. O O
No O O
epigastric O O
pain O O
or O O
tenderness O O
and O O
no O O
chest O O
pain. O O
The O O
patient O O
never O O
had O O
any O O
chest O O
pain O O
prior O O
to O O
her O O
event. O O
She O O
is O O
followed O O
by O O
the O O
United O O
Medical O O
Center O O
East O O
and O O
their O O
input O O
is O O
pending O O
at O O
this O O
point. O O
PAST O O
MEDICAL O O
HISTORY: O O
The O O
patient O O
has O O
a O O
past O O
medical O O
history O O
significant O O
for O O
diabetes, O O
hypertension, B-HYPERTENSION O
hypothyroidism O O
and O O
migraines. O O
MEDICATIONS: O O
The O O
patient's O O
current O O
medications O O
include O O
Plavix, B-MEDICATION B-MEDICATION
Calan B-MEDICATION O
slow O O
release O O
and O O
Glucophage. B-MEDICATION B-MEDICATION
ALLERGIES: O O
The O O
patient O O
is O O
allergic O O
to O O
intravenous O O
pyelogram O O
dye, O O
Percocet, O O
penicillin, O O
cephalosporin O O
and O O
lisinopril. O B-MEDICATION
PHYSICAL O O
EXAMINATION: O O
HEENT: O O
Examination O O
is O O
normal. O O
LUNGS: O O
Clear O O
bilaterally. O O
CARDIAC: O O
Regular O O
rate O O
and O O
rhythm O O
with O O
no O O
murmurs. O O
ABDOMEN: O O
Soft O O
and O O
nontender. O O
EXTREMITIES: O O
Normal. O O
GENERAL: O O
The O O
patient O O
looks O O
well O O
and O O
has O O
no O O
complaints O O
here. O O
LABORATORY O O
EVALUATION: O O
Finger O O
stick O O
in O O
the O O
Emergency O O
Department O O
was O O
160. O O
Electrocardiogram O O
shows O O
some O O
PR O O
depressions O O
in O O
multiple O O
leads. O O
No O O
significant O O
ST O O
elevations. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
Impression O O
is O O
this O O
patient O O
is O O
a O O
68 O O
year O O
old O O
female O O
with O O
planned O O
cystoscopy O O
today O O
who O O
passed O O
out O O
on O O
the O O
premises. O O
A O O
code O O
was O O
called O O
overhead. O O
Bystanders O O
reported O O
that O O
the O O
patient O O
was O O
diaphoretic. O O
They O O
gave O O
her O O
something O O
to O O
drink. O O
Her O O
blood O O
sugar O O
here O O
was O O
within O O
normal O O
limits. O O
The O O
patient O O
has O O
no O O
complaints O O
of O O
chest O O
pain O O
or O O
shortness O O
of O O
breath. O O
She O O
looks O O
well O O
but O O
does O O
have O O
PR O O
depressions O O
on O O
electrocardiogram O O
but O O
has O O
no O O
rubs O O
or O O
gallops O O
on O O
her O O
electrocardiogram. O O
The O O
patient O O
was O O
made O O
NPO O O
because O O
of O O
her O O
cystoscopy O O
procedure. O O
FINAL O O
DIAGNOSES: O O
1. O O
Syncopal O O
episode O O
versus O O
presyncope O O
from O O
the O O
taking O O
of O O
her O O
diabetes O O
medicine O O
this O O
morning. O O
2. O O
PR O O
depression O O
on O O
electrocardiogram O O
which O O
appears O O
to O O
be O O
new. O O
No O O
old O O
electrocardiogram O O
to O O
compare. O O
We O O
need O O
to O O
address O O
the O O
PR O O
depressions. O O
This O O
is O O
possibly O O
pericarditis O O
but O O
it O O
is O O
unlikely. O O
I O O
would O O
think O O
that O O
this O O
more O O
likely O O
ischemia O O
than O O
pericarditis. O O
3. O O
Cardiac O O
ischemia. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
will O O
need O O
admission O O
and O O
a O O
formal O O
rule O O
out. O O
She O O
may O O
even O O
need O O
an O O
echocardiogram O O
inpatient. O O
A O O
full O O
work O O
up O O
is O O
pending. O O
The O O
patient's O O
full O O
disposition O O
is O O
pending O O
and O O
she O O
was O O
signed O O
out O O
to O O
Dr. O O
Aleta O O
Nunley O O
at O O
15:00. O O
___________________________________ O O
TR682/13484 O O
GEORGE O O
DUNHAM, O O
M.D. O O
GD74 O O
D:08/06/96 O O
T:08/06/96 O O
Dictated O O
by: O O
GEORGE O O
DUNHAM, O O
M.D. O O
GD74 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2102-08-28 O O
Gibson O O
Internal O O
Medicine O O
Intern O O
Admission O O
Note O O
PATIENT: O O
Grace O O
Marvin O O
Yandell O O
MRN: O O
8099832 O O
ADMIT B-DIABETES O
DATE: O O
8/27/02 O O
PCP: O O
unknown O O
CC: O O
tx O O
from O O
Mount O O
San O O
Rafael O O
Hospital O O
HPI: O O
80F O O
with O O
multiple O O
medical O O
problems O O
including O O
breast O O
ca O O
s/p O O
R. O O
breast O O
lumpectomy, O O
chemotherapy O O
and O O
radiation O O
treatment O O
30 O O
years O O
ago, O O
recurrent O O
syncope, O O
and O O
seizure O O
disorder O O
who O O
was O O
admitted O O
to O O
San O O
Rafael O O
Mount O O
Hospital O O
following O O
a O O
syncopal O O
event O O
at O O
her O O
neurologist O O
s O O
office O O
on O O
7/30/02. O O
At O O
that O O
time, O O
she O O
c/o O O
dizziness, O O
nausea, O O
and O O
her O O
bp O O
reportedly O O
decreased O O
to O O
60/40. O O
As O O
per O O
pt O O
s O O
family, O O
she O O
initially O O
refused O O
to O O
go O O
to O O
the O O
ED O O
but O O
in O O
the O O
car O O
on O O
the O O
way O O
home O O
became O O
increasingly O O
confused, O O
dizzy, O O
and O O
nauseas O O
and O O
was O O
brought O O
to O O
Rafael O O
Mount O O
ED. O O
Five O O
weeks O O
ago O O
prior O O
to O O
her O O
hospital O O
admission O O
- O O
pt O O
s O O
family O O
reports O O
that O O
during O O
a O O
vacation O O
pt O O
had O O
one O O
episode O O
of O O
seizure O O
like O O
activity O O
for O O
which O O
she O O
was O O
seen O O
in O O
Massachusetts O O
and O O
declared O O
stable O O
and O O
released O O
and O O
a O O
second O O
unwitnessed O O
collapse O O
in O O
alaska O O
where O O
she O O
was O O
brought O O
to O O
a O O
hospital O O
in O O
Anchorage O O
and O O
treated O O
for O O
dehydration. O O
Upon O O
return O O
from O O
vacation, O O
and O O
daughter O O
recalls O O
that O O
she O O
had O O
cough O O
and O O
cold O O
sxs O O
at O O
the O O
time, O O
c/o O O
increasing O O
weakness, O O
backpain, O O
and O O
fevers. O O
During O O
the O O
same O O
time, O O
the O O
patient O O
reports O O
that O O
she O O
was O O
being O O
weaned O O
off O O
her O O
seizure O O
medications O O
and O O
other O O
medications O O
that O O
might O O
adversely O O
affect O O
her O O
LFTs O O
secondary O O
to O O
LFT O O
elevation O O
on O O
laboratory O O
exams. O O
At O O
present, O O
pt. O O
c/o O O
severe(10/10) O O
upper O O
back O O
pain O O
and O O
mid-sternal B-CAD O
CP I-CAD O
(8/10) I-CAD O
that O O
seems O O
fixed O O
to O O
her O O
back O O
pain O O
improved O O
with O O
pain O O
medications O O
and O O
worse O O
with O O
movement. O O
She O O
reports O O
that O O
she O O
is O O
short O O
of O O
breath O O
all O O
the O O
time O O
and O O
has O O
been O O
coughing O O
a O O
thick O O
mucous. O O
Hospital O O
Course: O O
MRSA O O
Bacteremia: O O
Blood O O
cultures O O
at O O
San O O
Rafael O O
Hospital O O
grew O O
S. O O
aureus O O
and O O
pt. O O
was O O
started O O
on O O
IV O O
vancomycin. O O
The O O
bacteremic O O
source O O
remains O O
unclear. O O
TTE O O
on O O
8/01/02 O O
showed O O
an O O
EF O O
of O O
60-65%, O O
no O O
evidence O O
of O O
endocarditis O O
reported. O O
A O O
TEE O O
on O O
8/7/02 O O
visualezed O O
all O O
the O O
valves O O
and O O
no O O
vegetations O O
were O O
seen. O O
Her O O
R. O O
knee O O
was O O
tapped O O
on O O
8/8/02 O O
and O O
cultures O O
were O O
negative. O O
A O O
bone O O
scan O O
on O O
7/7/02 O O
showed O O
a O O
metastatic O O
lesion O O
on O O
MRI O O
in O O
the O O
lower O O
thoracic O O
region O O
and O O
focal O O
increased O O
uptake O O
in O O
the O O
lateral O O
tibial O O
plateau O O
o O O
f O O
R. O O
knee. O O
Back O O
pain: O O
Pt. O O
c/o O O
moderately O O
severe O O
back O O
pain O O
throughout O O
hospital O O
stay O O
at O O
MSRH. O O
Thoracic O O
spine O O
xrays O O
on O O
7/31/02 O O
showed O O
osteopenia O O
with O O
no O O
acute O O
fracture O O
or O O
subluxation. O O
An O O
MRI O O
of O O
thoracic O O
spin O O
(8/02/02) O O
showed O O
a O O
marrow O O
replacing O O
process O O
in O O
the O O
L. O O
T10 O O
pedicle O O
and O O
another O O
smaller O O
lesion O O
at O O
the O O
L. O O
inferior O O
aspect O O
of O O
T11. O O
The O O
lesion O O
was O O
suspicious O O
for O O
metastatic O O
disease. O O
No O O
epidural O O
extension O O
was O O
noted. O O
There O O
was O O
a O O
patent O O
spinal O O
canal O O
and O O
lack O O
of O O
impingement O O
on O O
the O O
thoracic O O
cord. O O
Pt. O O
received O O
dilaudid O O
1-3 O O
mg O O
q4hours O O
prn O O
back O O
pain. O O
As O O
per O O
psych O O
notes, O O
she O O
did O O
not O O
wish O O
to O O
change O O
medications O O
to O O
methadone O O
or O O
fentanyl. O O
A O O
CT O O
guided O O
bx O O
of O O
the O O
thoracic O O
spine O O
took O O
place O O
on O O
8/15/02 O O
and O O
was O O
non-diagnostic. O O
A O O
neurosurgery O O
consult O O
reported O O
that O O
an O O
open O O
bx O O
might O O
destabilize O O
her O O
given O O
the O O
locationo O O
f O O
the O O
pedicle O O
and O O
recommended O O
that O O
the O O
biopsy O O
be O O
done O O
at O O
GCH. O O
A O O
repeat O O
MRI O O
was O O
done O O
on O O
8/20/02 O O
due O O
to O O
increasing O O
c/o O O
back O O
pain O O
and O O
showed O O
a O O
50% O O
compression O O
fx O O
of O O
T4, O O
persitent O O
abnl O O
marrow O O
signal O O
in O O
L. O O
pedicle O O
of O O
T11, O O
and O O
overall O O
heterogenous O O
marrow O O
signal O O
pattern O O
throughout O O
the O O
visualized O O
vertebral O O
bodies. O O
Immunoelectrophoresis O O
was O O
ordered O O
to O O
r/o O O
myeloma. O O
Right O O
Breast O O
Mass: O O
A O O
firm O O
R. O O
breast O O
mass O O
was O O
noted O O
at O O
the O O
7 O O
o/clock O O
position O O
of O O
R. O O
breast O O
at O O
site O O
of O O
lumpectomy O O
scar O O
and O O
the O O
thickening O O
was O O
thought O O
to O O
be O O
2/2 O O
to O O
previous O O
sx O O
by O O
surgeous O O
at O O
OSH. O O
A O O
mammogram O O
on O O
8/5/02 O O
showed O O
innumerable O O
benign O O
appearing O O
calcifications O O
in O O
both O O
breasts. O O
The O O
R. O O
Breast O O
was O O
significantly O O
smaller O O
and O O
a O O
heterogeneously O O
dense O O
parenchymal O O
pattern O O
was O O
identified. O O
An O O
u/s O O
of O O
R. O O
breast O O
showed O O
no O O
discrete O O
mass. O O
A O O
biopsy O O
was O O
delayed O O
2/2 O O
to O O
bacteremia. O O
Renal O O
failure: O O
Pt. O O
developed O O
renal O O
failure O O
while O O
on O O
vancomycin O O
with O O
an O O
increase O O
of O O
cr O O
from O O
1.1 O O
to O O
2.4. O O
Her O O
vancomycin O O
level O O
was O O
noted O O
to O O
be O O
&gt;60 O O
on O O
8/13/02 O O
and O O
vanco O O
was O O
discontinued. O O
Repeat O O
blood O O
cultures O O
were O O
negative O O
for O O
S. O O
aureus. O O
Anemia: O O
On O O
admission O O
to O O
Rafael O O
Hospital, O O
Hb/Hct: O O
11.6/35.5. O O
She O O
was O O
started O O
on O O
procrit O O
by O O
hematology. O O
She O O
was O O
transfused O O
on O O
unit O O
of O O
PRBCs O O
in O O
the O O
hospital. O O
TIA: O O
Pt. O O
has O O
a O O
hx O O
of O O
TIAs O O
with O O
one O O
episode O O
while O O
hospitalized O O
significant O O
for O O
difficulty O O
with O O
speech O O
and O O
R. O O
hand O O
tingling. O O
An O O
MRI O O
that O O
day O O
showed O O
new O O
increased O O
signal O O
w/in O O
the O O
ventricles O O
and O O
subarachnoid O O
space O O
noted O O
diffusely. O O
This O O
finding O O
was O O
likely O O
due O O
to O O
prior O O
IV O O
contrast O O
administration O O
of O O
gadolinium, O O
though O O
an O O
underlying O O
hemorrhage O O
or O O
infection O O
could O O
not O O
be O O
excluded. O O
A O O
brain O O
MRI O O
on O O
8/18/02 O O
showed O O
resolution O O
of O O
abnl O O
signal O O
w/in O O
the O O
ventricles, O O
decrease O O
in O O
high O O
signal O O
in O O
the O O
subarachnoid O O
space, O O
likely O O
representing O O
resolution O O
of O O
sequelae O O
from O O
prior O O
IV O O
gadolinium. O O
No O O
findings O O
of O O
meningitis O O
but O O
persisting O O
increased O O
signal O O
w/in O O
the O O
L. O O
lope, O O
which O O
may O O
represent O O
vitreal O O
hemorrhage. O O
HTN: B-HYPERTENSION O
Pt. O O
required O O
adjustments O O
in O O
her O O
meciations O O
during O O
her O O
hospital O O
stay O O
to O O
control O O
hypertension. O O
MEDICAL O O
HISTORY O O
Recurrent O O
syncope: O O
2086-2100, O O
3-4 O O
events O O
per O O
year, O O
last O O
event O O
prior O O
to O O
hospitalization O O
Seizure O O
disorder: O O
first O O
sz O O
in O O
2090s O O
with O O
unresponsive, O O
staring, O O
mouth O O
movements; O O
often O O
occurred O O
in O O
clusters O O
once O O
a O O
year, O O
last O O
sz O O
prior O O
to O O
admission. O O
COPD, O O
asthma O O
Frequent O O
UTIs O O
Elevated O O
LFTs O O
thought O O
to O O
be O O
2/2 O O
to O O
anti-epileptics O O
CAD B-CAD O
HTN O O
(since O O
adolescence) O O
DM B-DIABETES O
adult I-DIABETES O
onset I-DIABETES O
Hypercholesterolemia B-HYPERLIPIDEMIA O
Breast O O
Ca. O O
s/p O O
R. O O
breast O O
lumpectomy O O
and O O
node O O
removal, O O
chemotherapy, O O
radiation O O
in O O
2070s O O
GERD O O
TIAs O O
Osteoporosis O O
Chronic O O
lymphedema O O
and O O
frequent O O
cellulites O O
of O O
RUE O O
s/p O O
node O O
removal O O
for O O
breast O O
ca. O O
MRSA O O
bacteremia O O
CA O O
stenosis O O
dx O O
2090s, O O
no O O
surgeries O O
Hypothyroidism O O
FAMILY O O
HISTORY O O
non-contributory O O
SOCIAL B-SMOKER O
HISTORY O O
Widowed O O
for O O
&gt;30years, O O
lives O O
with O O
sister O O
and O O
daughter O O
who O O
provide O O
support O O
and O O
care. O O
ALLERGIES: O O
PCN O O
(rash, O O
swelling), O O
shellfish O O
(swelling), O O
cephalosporins O O
(swelling), O O
hydromorphone O O
(vomiting), O O
iodine O O
(unknown), O O
percocet O O
(nausea), O O
sulfa O O
(unknown), O O
aspirin O B-MEDICATION
(liver O O
problems), O O
codeine O O
(nausea) O O
MEDICATIONS O O
ON O O
TRANSFER O O
Diovan B-MEDICATION O
320 O O
mg O O
PO O O
qday O O
Dilaudid O O
1-3 O O
mg O O
IV O O
q4hours O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
mg O O
PO O O
qday O O
Vitamin O O
B6 O O
50 O O
mg O O
PO O O
qday O O
Clonidine O O
TTS-3 O O
one O O
weekly O O
Zocor B-MEDICATION B-MEDICATION
20 O O
mg O O
PO O O
qday O O
Niferex O O
150 O O
mg O O
PO O O
bid O O
Lasix O O
20 O O
mg O O
pO O O
qday O O
Zestril B-MEDICATION B-MEDICATION
20 O O
mg O O
PO O O
bid O O
Nexium O O
40 O O
mg O O
PO O O
qday O O
Reglan O O
10 O O
mg O O
IV O O
q4hours O O
prn O O
n/v O O
Labetalol B-MEDICATION B-MEDICATION
100 O O
mg O O
PO O O
bid O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
qday O O
Melatonin O O
1 O O
mg O O
PO O O
qhs O O
and O O
prn O O
Heparin O O
500 O O
units O O
SC O O
tid O O
Procrit O O
40,000 O O
units O O
qWednesday O O
Senokot O O
one O O
tab O O
pO O O
qday O O
Levothyroxine O O
? O O
0.5mg O O
PO O O
bid O O
NTG B-MEDICATION O
one O O
inch O O
q6hours, O O
hold O O
if O O
bp&lt;100 O O
RISS B-MEDICATION O
Kytril O O
100 O O
mcg O O
q8hrs O O
prn O O
Erythromycin O O
250 O O
mg O O
PO O O
bid O O
Vitamin O O
B12 O O
1000 O O
mcg O O
qam O O
Folic O O
acid O O
1 O O
mg O O
pO O O
qday O O
Albuterol O O
2 O O
puffs O O
qid O O
and O O
prn O O
Vancomycin O O
500 O O
mg O O
IV O O
qday O O
PHYSICAL O O
EXAM O O
VITALS: O O
T O O
99 O O
HR O O
96 O O
BP B-HYPERTENSION O
196/89 I-HYPERTENSION O
(in I-HYPERTENSION O
pain) I-HYPERTENSION O
improved I-HYPERTENSION O
to I-HYPERTENSION O
156/67 I-HYPERTENSION O
O2 O O
sats: O O
100% O O
on O O
2LNC, O O
96% O O
RA O O
HEENT: O O
pinpoint O O
pupils, O O
anicteric O O
sclera, O O
noninfected O O
conjunctiva, O O
no O O
cervical O O
LAD O O
CV:S1,S2, O O
rrr, O O
II/VI O O
murmur O O
loudest O O
at O O
aortic O O
area O O
Pulm: O O
CTA O O
b/l O O
Breast O O
exam: O O
R O O
breast O O
significantly O O
smaller O O
than O O
L. O O
breast, O O
no O O
axillary O O
LAD O O
either O O
axilla, O O
R. O O
breast O O
with O O
thickening O O
at O O
scar O O
at O O
7 O O
o O O
clock, O O
small O O
&lt;1cm O O
round O O
mobile O O
mass O O
palpated O O
between O O
scar O O
and O O
nipple, O O
non-tender, O O
no O O
discharge O O
from O O
nipple O O
L. O O
breast O O
non O O
tender, O O
no O O
palpable O O
masses, O O
no O O
discharge O O
from O O
nipples O O
Abd: O O
soft, O O
tender O O
to O O
palpation O O
with O O
pain O O
felt O O
at O O
site O O
of O O
touch O O
and O O
in O O
back, O O
no O O
guarding, O O
no O O
rebound, O O
no O O
HSM, O O
+BS O O
Ext: O O
WWP O O
Neuro: O O
CN O O
II-XII O O
intact, O O
UE O O
strength O O
4/5 O O
equal O O
b/l O O
at O O
extensors O O
and O O
flexors O O
apparently O O
limited O O
by O O
pain, O O
LE O O
strength O O
4/5 O O
at O O
extensors/flexors O O
b/l O O
also O O
limited O O
by O O
pain; O O
sensation O O
grossly O O
intact O O
at O O
LE, O O
negative O O
babinski O O
b/l O O
LABS O O
PENDING O O
ASSESSMENT O O
& O O
PLAN O O
80F O O
with O O
multiple O O
medical O O
problems O O
including O O
breast O O
ca O O
s/p O O
R. O O
breast O O
lumpectomy, O O
chemotherapy O O
and O O
radiation O O
treatment O O
30 O O
years O O
ago, O O
recurrent O O
syncope, O O
and O O
seizure O O
disorder O O
who O O
was O O
admitted O O
to O O
San O O
Rafael O O
Hospital O O
following O O
a O O
syncopal O O
event O O
on O O
7/30/02. O O
Found O O
to O O
have O O
a O O
MRSA O O
bacteremia O O
with O O
an O O
unidentified O O
source, O O
lesions O O
at O O
T10/T11 O O
on O O
spinal O O
MRI, O O
and O O
continued O O
c/o O O
back O O
pain O O
and O O
nausea. O O
Back O O
pain: O O
MRI O O
of O O
T O O
spine O O
with O O
abnl O O
and O O
prior O O
percutaneous O O
bx O O
non-diagnostic. O O
Differential O O
dx O O
includes O O
metastatic O O
disease O O
vs. O O
infection. O O
Neurosurgery O O
consulted O O
at O O
San O O
Rafael O O
who O O
felt O O
it O O
to O O
be O O
a O O
high O O
risk O O
procedure O O
and O O
tx O O
here O O
for O O
further O O
mngmt. O O
MRI O O
read O O
at O O
MSRH O O
indicated O O
that O O
lesion O O
was O O
more O O
consistent O O
with O O
malignancy O O
than O O
infection. O O
-re-read O O
of O O
OSH O O
studies O O
by O O
radiologists O O
at O O
GCH O O
-IR O O
guided O O
bone O O
bx O O
as O O
per O O
IR O O
-neurosurgery O O
if O O
IR O O
unable O O
to O O
biopsy O O
-dilaudid O O
1-3 O O
mg O O
IV O O
q4hours, O O
reglan O O
and O O
zofran O O
prn O O
nausea O O
-consider O O
pain O O
consult O O
2. O O
ID: O O
Staph O O
bacteremia O O
at O O
OSH, O O
TTE O O
and O O
TEE O O
showed O O
no O O
vegetations O O
indicating O O
that O O
endocarditis O O
is O O
not O O
the O O
source, O O
R. O O
knee O O
aspiration O O
also O O
negative. O O
Pt. O O
has O O
now O O
completed O O
4 O O
weeks O O
antibiotics O O
with O O
renal O O
failure O O
during O O
course O O
of O O
vancomycin. O O
d/c O O
vancomycin O O
con O O
to O O
monitor O O
fever O O
curve O O
if O O
osteomyelitis O O
found O O
on O O
bx, O O
will O O
need O O
further O O
course O O
of O O
antibiotics O O
blood O O
cx O O
x2 O O
now, O O
and O O
reculture O O
if O O
febrile O O
ongoing O O
nausea O O
and O O
vomiting: O O
consider O O
non O O
contrast O O
head O O
CT O O
to O O
r/o O O
septic O O
emboli, O O
pt O O
has O O
had O O
multiple O O
MRIs O O
at O O
OSH O O
held O O
erythromycin O O
250 O O
mg O O
PO O O
bid, O O
pt O O
reportedly O O
takes O O
it O O
as O O
prophylaxis O O
for O O
R. O O
arm O O
cellulites, O O
consider O O
restarting O O
heart O O
murmur O O
heard O O
on O O
PE, O O
not O O
documented O O
in O O
prior O O
notes; O O
consider O O
re-echoing O O
pt O O
here O O
Breast O O
mass: O O
As O O
per O O
San O O
Rafael, O O
mass O O
on O O
R. O O
breast O O
is O O
likely O O
due O O
to O O
thickening O O
s/p O O
lumpectomy O O
thirty O O
years O O
ago. O O
A O O
mammogram O O
on O O
8/5/02 O O
showed O O
innumerable O O
benign O O
appearing O O
calcifications O O
in O O
both O O
breasts. O O
The O O
R. O O
Breast O O
was O O
significantly O O
smaller O O
and O O
a O O
heterogeneously O O
dense O O
parenchymal O O
pattern O O
was O O
identified. O O
An O O
u/s O O
of O O
R. O O
breast O O
showed O O
no O O
discrete O O
mass. O O
A O O
biopsy O O
was O O
delayed O O
2/2 O O
to O O
bacteremia. O O
-consider O O
biopsy O O
of O O
R. O O
breast O O
mass O O
now O O
that O O
bacteremia O O
resolved O O
Renal: O O
s/p O O
acute O O
renal O O
failure O O
while O O
on O O
vancomycin, O O
recheck O O
creatinine O O
and O O
hold O O
vanco O O
for O O
now O O
-f/u O O
creatinine O O
HTN: O O
At O O
San O O
Rafael, O O
bp O O
medications O O
adjusted. O O
Restarted O O
on O O
same O O
medications O O
here. O O
-cont O O
to O O
monitor O O
-adjust O O
as O O
needed O O
FEN: O O
soft O O
mechanical O O
diet O O
PROPHYLAXIS O O
GI: O O
none, O O
consider O O
nexium O O
DVT: O O
heparin O O
5000 O O
units O O
sc O O
tid O O
BOWEL: O O
senna O O
CODE: O O
Full O O
__________________________________ O O
Ximena O O
Espinoza, O O
MD O O
Pager O O
#60806 O O

Record B-SMOKER O
date: O O
2102-12-01 O O
ID: O O
The O O
patient O O
is O O
a O O
74 O O
yr O O
old O O
woman O O
with O O
multiple O O
medical O O
problems, O O
who O O
comes O O
in O O
after O O
recent O O
5 O O
month O O
hospitalization O O
for O O
followup O O
and O O
to O O
review O O
recent O O
course O O
of O O
events. O O
HPI: O O
I O O
had O O
last O O
seen O O
her O O
in O O
5/02 O O
at O O
which O O
time O O
her O O
DM B-DIABETES O
was O O
being O O
treated O O
with O O
Lantus B-MEDICATION B-MEDICATION
10 O O
units, O O
and O O
Glucotrol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
10 O O
mg O O
bid. O O
Her O O
Lipitor B-MEDICATION B-MEDICATION
had I-MEDICATION O
been I-MEDICATION O
held I-MEDICATION O
as I-MEDICATION O
had I-MEDICATION O
her I-MEDICATION O
Actos B-MEDICATION O
due O O
to O O
elevated O O
LFT's, O O
and O O
her O O
Depakote O O
had O O
been O O
discontinued O O
by O O
her O O
neurologist. O O
Her O O
LFT's O O
had O O
come O O
down O O
from O O
her O O
hospitalization O O
in O O
March O O
but O O
were O O
still O O
elevated O O
at O O
AST O O
87 O O
and O O
ALT O O
124. O O
Liver O O
biopsy O O
was O O
being O O
considered O O
by O O
Dr. O O
Yamasaki, O O
her O O
gastroenterologist. O O
She O O
also O O
had O O
been O O
recently O O
hospitalized O O
at O O
San O O
Rafael O O
for O O
syncope O O
with O O
history O O
of O O
partial O O
seizure O O
disorder O O
vs O O
TIA O O
with O O
history O O
of O O
transient O O
episodes O O
of O O
right O O
arm O O
numbness O O
and O O
weakness O O
dating O O
to O O
2098 O O
but O O
with O O
no O O
seizures O O
in O O
3 O O
yrs. O O
In O O
July O O
O2 O O
she O O
had O O
several O O
episodes O O
of O O
syncope, O O
one O O
of O O
which O O
occured O O
in O O
her O O
neurologist's O O
office. O O
She O O
was O O
apparently O O
hypotensive O O
and O O
initially O O
refused O O
to O O
go O O
to O O
the O O
ED, O O
but O O
later O O
her O O
family O O
brought O O
her O O
to O O
the O O
ED O O
at O O
San O O
Rafael. O O
She O O
was O O
found O O
to O O
be O O
bacteremic O O
with O O
MRSA O O
and O O
was O O
treated O O
with O O
IV O O
vancomycin. O O
Endovascular O O
sources O O
were O O
found O O
to O O
be O O
negative O O
as O O
source, O O
as O O
was O O
a O O
knee O O
tap, O O
and O O
no O O
source O O
was O O
ever O O
identified. O O
She O O
was O O
transferred O O
to O O
GCH O O
in O O
August. O O
She O O
had O O
severe O O
back O O
pain O O
and O O
two O O
bone O O
biopsies O O
were O O
negative O O
for O O
osteomyelitis O O
in O O
the O O
spine. O O
She O O
was O O
also O O
found O O
to O O
have O O
a O O
50% O O
compression O O
fracture O O
of O O
T4 O O
and O O
this O O
was O O
treated O O
at O O
GCH O O
with O O
a O O
T4 O O
vertebroplasty O O
in O O
September O O
10. O O
She O O
also O O
was O O
worked O O
up O O
for O O
mets O O
to O O
spine O O
but O O
only O O
benign O O
hemangiomas O O
were O O
found. O O
She O O
was O O
discharged O O
to O O
rehab O O
in O O
mid O O
September. O O
She O O
required O O
at O O
least O O
two O O
more O O
admissions O O
from O O
rehab O O
to O O
San O O
Rafael O O
over O O
the O O
next O O
two O O
months. O O
She O O
apparently O O
had O O
severe O O
gastroparesis O O
and O O
was O O
unable O O
to O O
eat, O O
requiring O O
portacath O O
for O O
TPN O O
around O O
October O O
10. O O
She O O
had O O
then O O
gone O O
back O O
to O O
rehab O O
again O O
but O O
was O O
readmitted O O
with O O
DVT O O
of O O
the O O
left O O
Subclavian O O
vein O O
around O O
the O O
site O O
of O O
the O O
Portacath. O O
She O O
was O O
started O O
on O O
Coumadin O O
and O O
was O O
back O O
in O O
rehab O O
for O O
another O O
few O O
weeks. O O
The O O
arm O O
swelling O O
quickly O O
resolved. O O
There O O
was O O
also O O
reportedly O O
a O O
TIA O O
which O O
occured O O
after O O
an O O
MRI O O
scan O O
with O O
right O O
facial O O
droop O O
and O O
slurred O O
speech O O
at O O
SRH. O O
She O O
was O O
finally O O
discharged O O
to O O
home O O
on O O
November O O
21st. O O
MEDS: O O
Coumadin O O
7.5 O O
mg O O
qd, O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
mg O O
qd, O O
Isordil B-MEDICATION B-MEDICATION
20 O O
mg O O
tid, O O
Neurontin O O
300 O O
mg O O
po O O
bid, O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
po O O
qd, O O
Prilosec O O
20 O O
mg O O
qd, O O
Folic O O
aid O O
1 O O
mg O O
qd, O O
Synthroid O O
50 O O
mcg O O
qd, O O
Labetolol B-MEDICATION B-MEDICATION
200 O O
mg O O
bid, O O
Glipizide B-MEDICATION B-MEDICATION
2.5 O O
mg O O
po O O
qd, O O
Albuterol O O
inhaler O O
prn, O O
erytab O O
250 O O
bid, O O
Ultram O O
50 O O
mg O O
q O O
6hrs O O
prn, O O
MVI, O O
Vitamin O O
B12 O O
1000. O O
Rhinocort O O
Aqua, O O
Nitrostat B-MEDICATION O
prn, O O
Was O O
d'cd O O
from O O
Reglan, O O
taking O O
Donperdon? O O
PE: O O
WDWN O O
BF O O
NAD O O
Wt O O
135 B-HYPERLIPIDEMIA O
lbs O O
BP O O
100/64 O O
Heent: O O
throat O O
clear, O O
EOMI. O O
Perrl. O O
Neck: O O
supple O O
without O O
adenopathy O O
or O O
thyromegaly. O O
Cor: O O
RRR, O O
no O O
m's. O O
Lungs; O O
clear. O O
Abdomen; O O
soft, O O
nontender O O
no O O
HSM. O O
Extr; O O
no O O
edema. O O
A/P: O O
74 O O
yr O O
old O O
woman O O
with O O
multiple O O
medical O O
problems, O O
s/p O O
5 O O
month O O
hospitalization. O O
1) O O
Diabetes. O O
Throughout O O
her O O
hospitalization O O
she O O
lost O O
a O O
lot O O
of O O
weight O O
down O O
from O O
160's O O
to O O
170's O O
last O O
spring O O
to O O
current O O
level O O
of O O
135 O O
lbs. O O
Insulin O O
was O O
stopped O O
and O O
just O O
recently O O
Glipizide O O
2.5 O O
mg O O
added O O
on. O O
Recent O O
Hg O O
A1C O O
obtained O O
after O O
this O O
visit O O
on O O
12/04/02 O O
was O O
6.0. O O
Bun O O
/Cr O O
was O O
11/0.9. O O
glucose O O
196. O O
Cholesterol B-HYPERLIPIDEMIA O
225/68/135. I-HYPERLIPIDEMIA O
LFT's O O
were O O
not O O
done O O
and O O
need O O
to O O
be O O
done, O O
will O O
be O O
ordered O O
next O O
lab O O
draw. O O
If O O
normalized O O
then O O
will O O
add O O
back O O
Lipitor. O B-MEDICATION
History O O
of O O
gastroparesis, O O
on O O
new O O
med O O
has O O
replaced O O
Reglan, O O
doing O O
better. O O
2) O O
Hypertension. B-HYPERTENSION O
Doing O O
well O O
on O O
Norvasc O B-MEDICATION
10, O O
Labetolol O B-MEDICATION
200 O O
bid O O
and O O
Isordil O O
20 O O
tid. O O
3) O O
S/p O O
recent O O
upper O O
extremity O O
DVT, O O
on O O
coumadin. O O
Per O O
Dr. O O
Herbert O O
Paris's O O
note O O
of O O
12/02, O O
she O O
needs O O
3 O O
months O O
of O O
anticoag, O O
and O O
then O O
1mg/day O O
until O O
the O O
portacath O O
discontinued. O O
With O O
history O O
2 O O
prior O O
DVT's O O
will O O
need O O
to O O
discuss O O
whether O O
she O O
should O O
be O O
on O O
long O O
term O O
therapy. O O
She O O
is O O
now O O
getting O O
FS O O
INR's O O
thru O O
the O O
VNA, O O
but O O
will O O
be O O
transitioned O O
to O O
Internal O O
Medicine, O O
with O O
access O O
thru O O
the O O
portacath, O O
or O O
continued O O
FS's. O O
INR O O
has O O
been O O
in O O
good O O
range O O
with O O
7.5 O O
mg O O
coumadin. O O
4) O O
S/P O O
compression O O
fracture O O
of O O
T4, O O
s/p O O
vertebroplasty O O
with O O
successful O O
resolution O O
of O O
the O O
pain. O O
Has O O
other O O
compression O O
fractures O O
but O O
not O O
interested O O
in O O
further O O
procedures O O
at O O
this O O
time. O O
5) O O
History O O
of O O
hypothyroidism. O O
Had O O
recent O O
labs O O
at O O
SRH O O
on O O
12/04/02 O O
with O O
TSH O O
of O O
1.3 O O
and O O
Free O O
T4 O O
of O O
0.9. O O
6) O O
History O O
of O O
anemia, O O
requiring O O
Procrit O O
and O O
? O O
transfusions O O
during O O
her O O
hospitalizations, O O
with O O
normal O O
hct O O
of O O
41.1 O O
on O O
12/04/02. O O
7) O O
Neuro; O O
History O O
of O O
partial O O
seizures, O O
TIA's. O O
Followed O O
by O O
Dr. O O
Gary O O
Keyes. O O
History O O
of O O
silent O O
cerebellar O O
brain O O
infarction O O
on O O
MRI. O O
History O O
of O O
moderate O O
intracranial O O
carotid O O
stenosis, O O
with O O
recent O O
? O O
TIA O O
left O O
hemisphere, O O
? O O
repeat O O
carotid O O
noninvasives O O
per O O
Dr. O O
Keyes O O
vs O O
CT O O
angiogram. O O
On O O
Plavix O O
and O O
coumadin. O O
Per O O
Dr. O O
Keyes O O
coumadin O O
alone O O
would O O
be O O
enough O O
for O O
stroke O O
prophylaxis, O O
and O O
he O O
would O O
defer O O
to O O
Dr. O O
Barry O O
as O O
to O O
whether O O
to O O
continue O O
Plavix. O O
8) O O
History O O
of O O
elevated O O
LFT's. O O
May O O
have O O
been O O
medication O O
related, O O
due O O
to O O
Lipitor, O B-MEDICATION
Actos, O O
Depakote. O O
Now O O
off O O
all O O
meds, O O
need O O
redo O O
as O O
above, O O
and O O
consideration O O
if O O
normal O O
of O O
retrial O O
of O O
statin. O O

Record O O
date: O O
2103-07-29 O O
Internal O O
Medicine O O
Admission O O
Note O O
PATIENT: O O
Grace O O
Marvin O O
Yandell O O
MRN: O O
8099832 O O
ADMIT O O
DATE: O O
7/28/03 O O
ATTENDING: O O
WINTERS O O
PCP: O O
Dr. O O
Patricia O O
Mcfarland O O
(MEDIQUIK) O O
127-319-4834 O O
CONTACT: O O
Daughter: O O
Penelope O O
Yandell O O
761-259-5716 O O
Code O O
status: O O
Full O O
Source: O O
CC: O O
Syncope O O
HPI: O O
Ms. O O
Yandell O O
is O O
a O O
delightful O O
81 O O
year O O
old O O
female O O
with O O
an O O
extensive O O
PMH O O
including O O
HTN, B-HYPERTENSION O
Sz O O
d/o O O
vs O O
TIAs, O O
dyslipidemia, B-HYPERLIPIDEMIA O
breast O O
cancer, O O
and O O
DVTs O O
who O O
presents O O
following O O
a O O
syncopal O O
episode O O
on O O
the O O
day O O
of O O
admission. O O
Per O O
a O O
note O O
from O O
her O O
neurologist, O O
Dr. O O
Gary O O
Keyes, O O
Ms. O O
Yandell O O
has O O
a O O
history O O
of O O
transient O O
neurologic O O
events, O O
consisting O O
of O O
right O O
hand O O
numbness O O
and O O
weakness, O O
in O O
2098 O O
and O O
2099. O O
She O O
had O O
an O O
extensive O O
workup O O
in O O
which O O
it O O
was O O
unclear O O
whether O O
these O O
represented O O
a O O
transient O O
ischemic O O
attack O O
or O O
partial O O
seizures. O O
She O O
was O O
started O O
on O O
Depakote O O
for O O
this. O O
Between O O
March O O
and O O
April O O
of O O
2102 O O
her O O
Depakote O O
was O O
weaned O O
because O O
of O O
a O O
lack O O
of O O
interval O O
seizures. O O
EEG O O
in O O
January O O
2102 O O
showed O O
no O O
evidence O O
of O O
epileptiform O O
activity. O O
In O O
July O O
2102 O O
she O O
had O O
several O O
episodes O O
of O O
loss O O
of O O
consciousness O O
which O O
ultimately O O
were O O
diagnosed O O
as O O
syncope. O O
Dr. O O
Keyes O O
witnessed O O
one O O
of O O
these O O
events O O
in O O
his O O
office O O
in O O
7/02 O O
and O O
it O O
was O O
associated O O
with O O
hypotension. O O
Ms. O O
Yandell O O
s O O
family O O
describes O O
her O O
syncopal O O
events O O
differently, O O
stating O O
that O O
she O O
will O O
stare O O
into O O
space O O
for O O
5-8 O O
minutes, O O
during O O
which O O
time O O
she O O
is O O
unresponsive. O O
When O O
she O O
wakes O O
up, O O
she O O
is O O
confused O O
and O O
sleepy O O
for O O
~ O O
20 O O
minutes O O
and O O
will O O
often O O
have O O
nausea O O
and O O
vomiting. O O
These O O
episodes O O
are O O
associated O O
with O O
jaw-clenching, O O
but O O
no O O
tonic-clonic O O
movements. O O
Ms. O O
Yandell O O
does O O
state O O
that O O
she O O
feels O O
dizzy O O
and O O
lightheaded O O
before O O
these O O
events, O O
and O O
reports O O
that O O
her O O
family O O
says O O
she O O
looks O O
pale O O
and O O
clammy. O O
She O O
does O O
not O O
recall O O
the O O
events O O
herself. O O
The O O
family O O
does O O
not O O
report O O
loss O O
of O O
bowel O O
or O O
bladder O O
incontinence, O O
although O O
the O O
patient O O
did O O
apparently O O
lose O O
continence O O
of O O
bowel O O
shortly O O
after O O
being O O
admitted O O
(unclear O O
circumstances O O
surrounding O O
this). O O
The O O
family O O
reports O O
that O O
EMS O O
checked O O
her O O
blood O O
sugar O O
on O O
the O O
scene O O
it O O
was O O
normal. O O
In O O
the O O
emergency O O
department, O O
Ms. O O
Yandell O O
s O O
was O O
afebrile, O O
82 O O
158/70 B-HYPERTENSION O
18 O O
95% O O
on O O
2L. O O
She O O
received O O
zofran O O
for O O
nausea, O O
ASA, B-MEDICATION O
and O O
IVF, O O
and O O
was O O
transferred O O
up O O
to O O
the O O
floor O O
for O O
further O O
management. O O
The O O
patient O O
denies O O
that O O
the O O
episodes O O
occur O O
after O O
she O O
rises O O
from O O
a O O
sitting O O
position. O O
Do O O
not O O
occur O O
when O O
bearing O O
down, O O
or O O
when O O
she O O
is O O
exerting O O
herself. O O
The O O
episodes O O
are O O
not O O
sudden O O
she O O
appears O O
to O O
have O O
some O O
warning O O
before O O
one O O
occurs. O O
She O O
denies O O
fevers/chills. O O
No O O
chest O O
pain, O O
palpitations. O O
Some O O
shortness O O
of O O
breath O O
when O O
walking, O O
which O O
sounds O O
like O O
it O O
is O O
unchanged. O O
Has O O
had O O
a O O
cough O O
for O O
a O O
few O O
months O O
and O O
it O O
is O O
occasionally O O
productive O O
of O O
?color O O
mucus. O O
She O O
takes O O
antihypertensive O O
medications, O O
but O O
takes O O
them O O
as O O
directed O O
and O O
by O O
report O O
does O O
not O O
group O O
them O O
together. O O
PAST O O
MEDICAL O O
HISTORY: O O
1. O O
Hypertension O O
2. O O
History O O
of O O
supraventricular O O
tachycardia O O
3. O O
Dyslipidemia O O
4. O O
Chronic O O
dyspnea O O
5. O O
Inappropriate O O
sinus O O
tachycardia O O
6. O O
Seizure O O
disorder O O
7. O O
TIA/stroke, O O
09/13/98, O O
on O O
Plavix B-MEDICATION O
subsequently O O
8. O O
Migraine O O
headaches O O
9. O O
Type B-DIABETES O
II I-DIABETES O
diabetes I-DIABETES O
mellitus I-DIABETES O
since O O
2084 O O
10. O O
Multiple O O
syncopal O O
episodes O O
11. O O
History O O
of O O
hysterectomy O O
12. O O
History O O
of O O
cervical O O
spine O O
surgery O O
in O O
2065 O O
13. O O
Bilateral O O
cataract O O
surgeries O O
14. O O
Breast O O
cancer O O
in O O
the O O
early O O
70's O O
with O O
positive O O
lymph O O
nodes, O O
treated O O
with O O
radiation O O
therapy O O
15. O O
History O O
of O O
esophageal O O
stricture O O
requiring O O
dilatation O O
in O O
November O O
2095 O O
16. O O
Pancreatitis O O
in O O
2096, O O
admitted O O
to O O
San O O
Rafael O O
17. O O
Abnormal O O
pulmonary O O
function O O
studies O O
with O O
moderate O O
restriction O O
and O O
normal O O
DLCO O O
in O O
2092 O O
18. O O
Esophageal O O
diverticulum O O
on O O
barium O O
swallow O O
19. O O
History O O
of O O
cellulitis/DVT O O
of O O
the O O
right O O
arm O O
in O O
8/92 O O
20. O O
Carotid O O
stenosis O O
left O O
50% O O
21. O O
Two O O
admissions O O
to O O
San O O
Rafael O O
February O O
and O O
March, O O
2102 O O
for O O
syncopal O O
episodes. O O
22. O O
DVT O O
10/02, O O
left O O
upper O O
extremity O O
- O O
prior O O
right O O
upper O O
extremity O O
(post O O
compression O O
fracture O O
of O O
T4) O O
23. O O
Increased O O
LFTs, O O
Lipitor O B-MEDICATION
was O O
stopped O O
24. O O
Slip O O
and O O
fall O O
fracturing O O
T4 O O
with O O
vertebroplasty O O
7/02 O O
ALLERGIES: O O
Penicillins O O
cause O O
rash O O
Cephalosporins O O
cause O O
rash O O
Percocet O O
causes O O
unknown O O
reaction O O
Codeine O O
- O O
vomiting O O
Acetaminophen O O
- O O
Unknown: O O
Allergy O O
entered O O
as O O
TYLENOL O O
IV O O
Contrast O O
causes O O
unknown O O
reaction O O
Lisinopril O B-MEDICATION
causes O O
edema, O O
?anaphylaxis, O O
Sulfa O O
causes O O
rash O O
MEDICATIONS O O
ON O O
ADMISSION: O O
Albuterol O O
inhaler O O
Coumadin O O
7.5 O O
MG O O
(5 O O
MG O O
TABLET O O
take O O
1.5) O O
PO O O
QPM O O
Ery-tab O O
(ERYTHROMYCIN) O O
250 O O
MG O O
(250 O O
MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
, O O
Take O O
with O O
food. O O
Glipizide B-MEDICATION B-MEDICATION
2.5 O O
MG O O
(2.5 O O
MG O O
TAB O O
OSM O O
24 O O
take O O
1) O O
PO O O
Q O O
Nitrostat B-MEDICATION O
1/150 O O
(NITROGLYCERIN O O
1/150 O O
(0.4 O O
MG)) O O
1 O O
TAB O O
(0.4MG O O
TAB O O
SUBL O O
) O O
SL O O
prn O O
Norvasc B-MEDICATION B-MEDICATION
(AMLODIPINE) O O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Plavix O B-MEDICATION
75 O O
MG O O
(75 O O
MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Synthroid O O
50 O O
MCG O O
TABLET O O
PO O O
QD O O
, O O
No O O
Substitutes O O
Ultram O O
(TRAMADOL) O O
50 O O
MG O O
(50MG O O
TABLET O O
take O O
1) O O
PO O O
Q6H O O
PRN O O
Motillium O O
10 O O
mg O O
Q6hours O O
Labetalol B-MEDICATION B-MEDICATION
200 O O
mg O O
BID O O
FAMILY O O
HISTORY: O O
Notable B-FAMILY_HIST O
for I-FAMILY_HIST O
brother, I-FAMILY_HIST O
sister, I-FAMILY_HIST O
and I-FAMILY_HIST O
children I-FAMILY_HIST O
with I-FAMILY_HIST O
CAD, I-FAMILY_HIST O
HTN; O O
Mother O O
with O O
history O O
of O O
cancer; O O
Sisters O O
and O O
brothers O O
with O O
DM; O O
Sister O O
and O O
brother-in-law O O
with O O
TB. O O
SOCIAL O O
HISTORY: O O
Lives O O
with O O
daughter O O
and O O
other O O
family O O
members. O O
Denies B-SMOKER O
tobacco/EtOH. I-SMOKER O
No O O
illicits. O O
PHYSICAL O O
EXAM: O O
VITALS: O O
Afebrile O O
86 O O
161/69 B-HYPERTENSION O
20 O O
100% O O
on O O
RA O O
Orthostatics: O O
Recumbent O O
125/70 O O
82 O O
Seated O O
128/70 O O
88 O O
Standing O O
125/75 O O
102 O O
GEN O O
L O O
NAD, O O
Non-toxic O O
appearing, O O
AO O O
x O O
3 O O
HEENT O O
MMM, O O
no O O
scleral O O
icterus, O O
no O O
pale O O
conjunctiva O O
NECK O O
supple, O O
no O O
thyromegaly, O O
no O O
LAD. O O
JVP&lt;5 O O
cm, O O
no O O
carotid O O
bruits O O
appreciated O O
Heart: O O
RRR, O O
normal O O
S1, O O
S2 O O
; O O
II/VI O O
systolic O O
murmur O O
LUNG: O O
CTA O O
bilaterally O O
with O O
no O O
c/r/w; O O
no O O
increased O O
work O O
of O O
breathing O O
ABD: O O
Soft, O O
non-tender, O O
non-distended, O O
NABS. O O
No O O
HSM. O O
No O O
masses, O O
rebound. O O
EXT: O O
wwp, O O
no O O
edema O O
NEURO: O O
AO O O
x O O
3; O O
alert; O O
CN O O
II-XII O O
grossly O O
intact; O O
surgical O O
pupils O O
s/p O O
cataract O O
surgery. O O
Motor: O O
5/5 O O
B O O
UE/LE; O O
sensation O O
grossly O O
intact O O
to O O
light O O
touch O O
RAM O O
intact; O O
no O O
pronator O O
drift O O
RESULTS: O O
Chemistry O O
Lytes/Renal/Glucose O O
Sodium O O
140 O O
135-145 O O
mmol/L O O
07/29/03 O O
05:57 O O
134(L) O O
09/14/02 O O
23:06 O O
Potassium O O
3.9 O O
3.4-4.8 O O
mmol/L O O
07/29/03 O O
05:57 O O
5.2(H) O O
09/14/02 O O
23:06 O O
Chloride O O
107 O O
100-108 O O
mmol/L O O
07/29/03 O O
05:57 O O
95(L) O O
09/14/02 O O
23:06 O O
Carbon O O
Dioxide O O
23.1 O O
23.0-31.9 O O
mmol/L O O
07/29/03 O O
05:57 O O
32.8(H) O O
09/15/02 O O
06:20 O O
BUN O O
21 O O
8-25 O O
mg/dl O O
07/29/03 O O
05:57 O O
26(H) O O
07/28/03 O O
17:39 O O
Creatinine O O
1.1 O O
0.6-1.5 O O
mg/dl O O
07/29/03 O O
05:57 O O
1.6(H) O O
09/07/02 O O
16:34 O O
Glucose O O
132H O O
70-110 O O
mg/dl O O
07/29/03 O O
05:57 O O
132(H) O O
07/29/03 O O
05:57 O O
General O O
Chemistries O O
Calcium O O
8.6 O O
8.5-10.5 O O
mg/dl O O
07/29/03 O O
05:57 O O
7.7(L) O O
09/13/02 O O
17:01 O O
Phosphorus O O
2.6 O O
2.6-4.5 O O
mg/dl O O
07/28/03 O O
17:57 O O
1.6(L) O O
09/13/02 O O
17:01 O O
Magnesium O O
1.5 O O
1.4-2.0 O O
meq/L O O
07/28/03 O O
17:57 O O
Bilirubin O O
(To... O O
0.1 O O
0.0-1.0 O O
mg/dl O O
07/28/03 O O
20:05 O O
Bilirubin O O
(Di... O O
0.1 O O
0-0.4 O O
mg/dl O O
07/28/03 O O
20:05 O O
Total O O
Protein O O
7.2 O O
6.0-8.3 O O
g/dl O O
07/28/03 O O
20:05 O O
5.7(L) O O
09/13/02 O O
17:01 O O
Albumin O O
3.7 O O
3.3-5.0 O O
g/dl O O
07/28/03 O O
20:05 O O
2.0(L) O O
09/13/02 O O
17:01 O O
Globulin O O
3.5 O O
2.6-4.1 O O
g/dl O O
07/28/03 O O
20:05 O O
4.8(H) O O
09/02/02 O O
11:35 O O
Lactic O O
acid O O
(... O O
0.5 O O
0.5-2.2 O O
mmol/L O O
07/28/03 O O
18:14 O O
Amylase O O
63 O O
3-100 O O
units/L O O
07/28/03 O O
20:05 O O
Lipase O O
2.2 O O
1.3-6.0 O O
U/dl O O
07/28/03 O O
20:05 O O
0.9(L) O O
09/13/02 O O
17:01 O O
Liver O O
Function O O
Tests O O
ALT O O
(SGPT) O O
(U/L) O O
7 O O
7-30 O O
U/L O O
07/28/03 O O
20:05 O O
AST O O
(SGOT) O O
16 O O
9-32 O O
U/L O O
07/28/03 O O
20:05 O O
38(H) O O
09/13/02 O O
17:01 O O
Alk O O
Phos O O
159H O O
30-100 O O
U/L O O
07/28/03 O O
20:05 O O
159(H) O O
07/28/03 O O
20:05 O O
Bilirubin O O
(To... O O
0.1 O O
0.0-1.0 O O
mg/dl O O
07/28/03 O O
20:05 O O
Bilirubin O O
(Di... O O
0.1 O O
0-0.4 O O
mg/dl O O
07/28/03 O O
20:05 O O
Cardiac O O
Tests O O
CK O O
100 O O
40-150 O O
U/L O O
07/29/03 O O
05:57 O O
34(L) O O
08/31/02 O O
08:03 O O
CK-MB O O
4.0 O O
0.0-6.9 O O
ng/ml O O
07/29/03 O O
05:56 O O
CK-MB O O
Index O O
see O O
detail O O
07/29/03 O O
05:59 O O
Troponin-I O O
NEGATIVE O O
NEG O O
07/28/03 O O
17:55 O O
Troponin-T O O
&lt;0.01 O O
0.00-0.09 O O
ng/ml O O
07/29/03 O O
05:56 O O
Neg O O
x O O
2 O O
TSH O O
PEND O O
0.40-5.00 O O
uU/ml O O
07/29/03 O O
05:22 O O
Urine O O
Chemistries O O
Random O O
Sodium, O O
urine O O
27 O O
NOTDEF O O
mmol/L O O
09/04/02 O O
20:59 O O
UN, O O
urine O O
370 O O
NOTDEF O O
mg% O O
09/04/02 O O
21:03 O O
Creatinine, O O
u... O O
2.66 O O
mg/ml O O
09/04/02 O O
22:04 O O
Osmolality, O O
u... O O
408 O O
NOTDEF O O
mosm/kg O O
09/04/02 O O
21:02 O O
Hematology O O
Complete O O
Blood O O
Count O O
WBC O O
4.2L O O
4.5-11.0 O O
th/cmm O O
07/29/03 O O
06:04 O O
4.2(L) O O
07/29/03 O O
06:04 O O
RBC O O
4.28 O O
4.00-5.20 O O
mil/cm O O
07/29/03 O O
06:04 O O
3.99(L) O O
08/29/02 O O
10:40 O O
Hgb O O
11.1L O O
12.0-16.0 O O
gm/dl O O
07/29/03 O O
06:04 O O
11.1(L) O O
07/29/03 O O
06:04 O O
HCT O O
33.2L O O
36.0-46.0 O O
% O O
07/29/03 O O
06:04 O O
33.2(L) O O
07/29/03 O O
06:04 O O
MCV O O
78L O O
80-100 O O
fl O O
07/29/03 O O
06:04 O O
78(L) O O
07/29/03 O O
06:04 O O
MCH O O
25.9L O O
26.0-34.0 O O
pg/rbc O O
07/29/03 O O
06:04 O O
25.9(L) O O
07/29/03 O O
06:04 O O
MCHC O O
33.4 O O
31.0-37.0 O O
g/dl O O
07/29/03 O O
06:04 O O
PLT O O
164 O O
150-350 O O
th/cumm O O
07/29/03 O O
06:04 O O
361(H) O O
09/07/02 O O
16:29 O O
RDW O O
14.8H O O
11.5-14.5 O O
% O O
07/29/03 O O
06:04 O O
14.8(H) O O
07/29/03 O O
06:04 O O
Blood O O
Differential O O
% O O
Differential O O
... O O
RECEIVED O O
07/28/03 O O
17:30 O O
Diff O O
Method O O
Auto O O
07/28/03 O O
17:45 O O
Neutrophils O O
50 O O
40-70 O O
% O O
07/28/03 O O
17:45 O O
Lymphs O O
38 O O
22-44 O O
% O O
07/28/03 O O
17:45 O O
Monos O O
6 O O
4-11 O O
% O O
07/28/03 O O
17:45 O O
Eos O O
5 O O
0-8 O O
% O O
07/28/03 O O
17:45 O O
Basos O O
1 O O
0-3 O O
% O O
07/28/03 O O
17:45 O O
Blood O O
Diff O O
- O O
Absolute O O
Neutrophil O O
2.06 O O
1.8-7.7 O O
th/cmm O O
07/28/03 O O
17:45 O O
Lymph# O O
1.55 O O
1.0-4.8 O O
th/cmm O O
07/28/03 O O
17:45 O O
Mono# O O
0.26 O O
0.2-0.4 O O
th/cmm O O
07/28/03 O O
17:45 O O
Eos# O O
0.22 O O
0.1-0.3 O O
th/cmm O O
07/28/03 O O
17:45 O O
Baso# O O
0.02 O O
0.0-0.3 O O
th/cmm O O
07/28/03 O O
17:45 O O
Smear O O
Morphology O O
Anisocytosis O O
None O O
None O O
07/28/03 O O
17:45 O O
Hypochromia O O
None O O
None O O
07/28/03 O O
17:45 O O
Macrocytes O O
None O O
None O O
07/28/03 O O
17:45 O O
Microcytes O O
1+H O O
None O O
07/28/03 O O
17:45 O O
1+(H) O O
07/28/03 O O
17:45 O O
Coagulation O O
Routine O O
Coagulation O O
PT O O
28.7H O O
10.3-13.2 O O
sec O O
07/28/03 O O
17:48 O O
28.7(H) O O
07/28/03 O O
17:48 O O
PT-INR O O
3.0 O O
07/28/03 O O
17:48 O O
PTT O O
30.4 O O
22.1-34.0 O O
sec O O
07/28/03 O O
17:48 O O
37.4(H) O O
09/06/02 O O
14:18 O O
EKG: O O
Sinus O O
at O O
86. O O
Appears O O
as O O
though O O
there O O
is O O
diffuse O O
ST O O
segment O O
elevation, O O
although O O
when O O
compared O O
to O O
EKG O O
from O O
&gt;11/02, O O
this O O
appears O O
unchanged. O O
CXR O O
7/28: O O
NAD O O
Chest O O
CT O O
4/03: O O
IMPRESSION: O O
Appearance O O
of O O
chest O O
may O O
be O O
at O O
baseline O O
following O O
right O O
mastectomy O O
with O O
radiation O O
therapy O O
effect O O
in O O
right O O
lung O O
apex. O O
Prior O O
histoplasmosis O O
infection O O
could O O
account O O
for O O
all O O
of O O
tiny O O
lung O O
nodules O O
seen. O O
MRI O O
9/02 O O
Findings: O O
Diffusion O O
weighted O O
images O O
show O O
no O O
evidence O O
of O O
acute O O
ischemia. O O
There O O
is O O
susceptibility O O
artifact O O
in O O
the O O
region O O
of O O
the O O
right O O
posterior O O
temporal O O
bone O O
which O O
may O O
be O O
related O O
to O O
prior O O
burr O O
hole O O
or O O
craniotomy. O O
There O O
are O O
chronic O O
appearing, O O
small O O
right O O
cerebellar O O
infarcts. O O
There O O
are O O
scattered O O
periventricular O O
FLAIR O O
and O O
T2 O O
hyperintense O O
white O O
matter O O
foci O O
that O O
are O O
most O O
consistent O O
with O O
small O O
vessel O O
ischemic O O
change. O O
There O O
is O O
FLAIR O O
hyperintensity O O
in O O
this O O
sulci O O
of O O
the O O
bilateral O O
posterior O O
frontal, O O
bilateral O O
parietal O O
and O O
left O O
occipital O O
lobes. O O
No O O
abnormal O O
enhancement O O
is O O
seen. O O
The O O
brain O O
parenchyma, O O
ventricles O O
and O O
sulci O O
are O O
otherwise O O
unremarkable. O O
The O O
major O O
intracranial O O
flow O O
voids O O
are O O
normal. O O
There O O
is O O
a O O
retention O O
cyst O O
in O O
the O O
left O O
maxillary O O
sinus. O O
There O O
is O O
partial O O
opacification O O
of O O
the O O
right O O
mastoid O O
air O O
cells. O O
There O O
are O O
bilateral O O
lens O O
implants. O O
The O O
bones, O O
soft O O
tissues O O
and O O
orbits O O
are O O
otherwise O O
unremarkable. O O
MRA: O O
There O O
is O O
signal O O
dropout O O
in O O
the O O
P2 O O
segment O O
of O O
the O O
right O O
posterior O O
cerbral O O
artery. O O
There O O
is O O
diffuse O O
irregularity O O
of O O
the O O
proximal O O
left O O
posterior O O
cerebral O O
artery. O O
There O O
is O O
moderate O O
stenosis O O
of O O
the O O
left O O
paraclinoid O O
internal O O
carotid O O
artery. O O
The O O
distal O O
right O O
vertebral O O
artery O O
is O O
not O O
well O O
visualized. O O
There O O
is O O
otherwise O O
normal O O
flow O O
related O O
enhancement O O
in O O
the O O
major O O
vessels O O
of O O
the O O
circle O O
of O O
Willis. O O
Impression: O O
Flair O O
hyperintensity O O
in O O
the O O
bilateral O O
sulci O O
with O O
a O O
posterior O O
predominance O O
as O O
described. O O
This O O
could O O
represent O O
hemorrhage, O O
high O O
protein O O
content, O O
high O O
oxygenation O O
or O O
recent O O
previous O O
gadolinium O O
injection. O O
Signal O O
dropout O O
in O O
the O O
right O O
posterior O O
cerebral O O
artery, O O
consistent O O
with O O
severe O O
stenosis O O
with O O
clot O O
not O O
excluded. O O
Diffuse O O
irregularity O O
of O O
the O O
left O O
posterior O O
cerebral O O
artery. O O
These O O
findings O O
could O O
be O O
secondary O O
to O O
atheromatous O O
disease O O
in O O
an O O
older O O
patient O O
but O O
vasculitis O O
is O O
another O O
possibility. O O
Moderate O O
stenosis O O
of O O
the O O
left O O
paraclinoid O O
internal O O
carotid O O
artery. O O
No O O
acute O O
ischemia O O
or O O
mass O O
lesion O O
identified. O O
Chronic O O
right O O
cerebellar O O
infarction. O O
Small O O
vessel O O
ischemic O O
changes. O O
Carotid O O
US O O
3/02 O O
IMPRESSIONS: O O
1. O O
RIGHT O O
PROXIMAL O O
CCA O O
STENOSIS. O O
2. O O
MINIMAL O O
DISEASE O O
OF O O
THE O O
RIGHT O O
CAROTID O O
ARTERY O O
BIFURCATION. O O
3. O O
MINIMAL O O
DISEASE O O
OF O O
THE O O
LEFT O O
CAROTID O O
ARTERY O O
BIFURCATION. O O
4. O O
BILATERAL O O
ANTEGRADE O O
VERTEBRAL O O
ARTERY O O
FLOW. O O
Echo O O
01 O O
1. O O
Normal O O
cavity O O
sizes, O O
wall O O
thicknesses O O
and O O
global O O
and O O
regional O O
right O O
ventricular O O
and O O
left O O
ventricular O O
systolic O O
function. O O
Left O O
ventricular O O
ejection O O
fraction O O
is O O
in O O
the O O
range O O
of O O
60%. O O
There O O
is O O
no O O
flattening O O
of O O
the O O
interventricular O O
septum, O O
asymmetric O O
septal O O
hypertrophy O O
or O O
evident O O
right O O
ventricular O O
hypertrophy O O
to O O
suggest O O
any O O
appreciable O O
elevation O O
of O O
pulmonary O O
arterial O O
pressure. O O
There O O
is O O
a O O
reduced O O
mitral O O
valve O O
diastolic O O
Doppler O O
E/A O O
ratio, O O
which O O
may O O
represent O O
a O O
reduced O O
rate O O
of O O
left O O
ventricular O O
relaxation. O O
2. O O
There O O
is O O
fibrosis O O
of O O
the O O
mitral O O
annulus O O
(very O O
mild) O O
and O O
of O O
the O O
interannular O O
fibrosa O O
between O O
the O O
anterior O O
mitral O O
leaflet O O
and O O
the O O
posterior O O
aortic O O
root. O O
There O O
are O O
also O O
some O O
echodensities O O
within O O
the O O
very O O
proximal O O
aorta O O
which O O
may O O
represent O O
atherosclerotic O O
change. O O
3. O O
The O O
aortic O O
valve O O
is O O
trileaflet. O O
Cannot O O
fully O O
exclude O O
the O O
possibility O O
of O O
some O O
thickening O O
of O O
the O O
bases O O
of O O
the O O
aortic O O
valve, O O
but, O O
alternatively, O O
the O O
increased O O
echogenicity O O
seen O O
within O O
the O O
proximal O O
aorta O O
may O O
represent O O
atherosclerotic O O
change O O
of O O
the O O
aorta. O O
There O O
is O O
no O O
evident O O
aortic O O
stenosis O O
or O O
aortic O O
insufficiency. O O
Very O O
mild O O
mitral O O
annular O O
fibrosis. O O
Otherwise, O O
the O O
mitral O O
valve O O
appears O O
structurally O O
normal. O O
Normal O O
appearing O O
tricuspid O O
and O O
pulmonary O O
leaflets. O O
There O O
are O O
signals O O
of O O
trace O O
mitral O O
regurgitation O O
and O O
trace O O
tricuspid O O
regurgitation. O O
Flow O O
velocity O O
could O O
not O O
be O O
optimally O O
assessed O O
in O O
the O O
tricuspid O O
regurgitant O O
jet O O
to O O
permit O O
accurate O O
estimation O O
of O O
pulmonary O O
artery O O
systolic O O
pressure. O O
4. O O
There O O
is O O
no O O
evident O O
pericardial O O
effusion. O O
ASSESSMENT O O
& O O
PLAN: O O
1) O O
Syncope O O
: O O
Unclear O O
etiology. O O
History O O
from O O
family O O
sounds O O
much O O
more O O
like O O
seizure. O O
Episode O O
in O O
neurologist O O
s O O
office O O
sounds O O
much O O
more O O
like O O
orthostatic O O
or O O
vasovagal O O
syncope. O O
Doubt O O
arrhythmia O O
given O O
prodrome. O O
Doubt O O
mechanical O O
etiology O O
given O O
not O O
related O O
to O O
exertion. O O
Continue O O
MI O O
rule-out O O
Repeat O O
echo O O
Continue O O
telemetry O O
EEG O O
F/u O O
TSH O O
F/U O O
UA O O
/ O O
Ucx O O
F/U O O
guiac O O
F/U O O
neuro O O
recs O O
2) O O
Hx O O
of O O
clot- O O
continue O O
coumadin O O
3) O O
DM O O
continue O O
outpatient O O
regimen, O O
but O O
hold O O
for O O
procedures O O
4) O O
HTN O O
continue O O
outpatient O O
regimen, O O
but O O
hold O O
for O O
low O O
BP O O
5) O O
Hypothyroid O O
continue O O
synthroid O O
6) O O
Hx O O
TIA O O
continue O O
plavix O O
__________________________________ O O
Noah O O
X. O O
Rush, O O
M.D., O O
Pager O O
#02428 O O

Record O O
date: O O
2104-09-23 O O
Patient: O O
MARVINYANDELL,GRACE O O
[ O O
90468071(BHC) O O
] O O
FDate O O
of O O
Visit: O O
09/23/2104 O O
Dear O O
Dr. O O
Mcfarland: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
Mrs. O O
Marvinyandell O O
at O O
the O O
Cardiac O O
Laboratory O O
in O O
follow-up O O
of O O
her O O
exertional O O
dyspnea. O O
As O O
you O O
know, O O
she O O
is O O
a O O
pleasant O O
82 O O
yo O O
woman O O
with O O
h/o O O
asthma, O O
recurrent O O
DVT O O
on O O
coumadin, O O
breast O O
cancer O O
s/p O O
lumpectomy O O
+ O O
chemo O O
and O O
radiation O O
therapy O O
30 O O
years O O
ago O O
with O O
resultant O O
mild O O
radiation O O
fibrosis O O
- O O
now O O
with O O
recurrence O O
in O O
the O O
contralateral O O
breast, O O
DM, B-DIABETES O
HTN, B-HYPERTENSION O
HLP, B-HYPERLIPIDEMIA O
anemia O O
and O O
hypothyroidism O O
who O O
is O O
being O O
evaluated O O
at O O
the O O
CL O O
for O O
exertional O O
dyspnea O O
since O O
2102 O O
when O O
she O O
fell O O
and O O
suffered O O
a O O
compression O O
fracture. O O
Her O O
other O O
respirtory-related O O
symtpoms O O
include O O
orthopnea O O
and O O
intermittent O O
wheezing O O
with O O
seasonal O O
allergies. O O
She O O
has O O
no O O
chest O O
pain, O O
PND O O
or O O
LE O O
edema. O O
Her O O
work-up O O
to O O
date O O
has O O
revealed O O
a O O
mixed O O
restrictive O O
and O O
(mild) O O
obstructive O O
ventilatory O O
deficit O O
which O O
was O O
attributed O O
to O O
kyphosis O O
and O O
radiation O O
fibrosis O O
+ O O
asthma O O
respectively. O O
She O O
has O O
had O O
a O O
negative O O
cardiac O O
stress O O
test. O O
PMH O O
as O O
above O O
Meds: O O
synthroid, O O
labetalol, B-MEDICATION B-MEDICATION
norvasc, B-MEDICATION B-MEDICATION
glipizide, B-MEDICATION B-MEDICATION
coumadin, O O
erythropoetin, O O
pravastatin, B-MEDICATION B-MEDICATION
ultram, O O
albuterol, O O
pentasa O O
Allergies: O O
PCN, O O
cephalosporins, O O
vancomysin, O O
shellfish O O
SH: O O
no B-SMOKER O
tobacco I-SMOKER O
ever. I-SMOKER O
She O O
is O O
a O O
professional O O
tool O O
maker. O O
She O O
has O O
a O O
dog O O
FH: O O
asthma, O O
CAD, O O
DM, O O
HTN O O
ROS: O O
as O O
per O O
HPI, O O
otherwise O O
negative O O
in O O
detail O O
EXAM: O O
HR O O
88, O O
BP O O
135/60, O O
98% O O
RA, O O
Wt O O
146lb O O
OP O O
clear O O
Lungs O O
CTAB O O
Heart O O
RRR O O
Abdomen O O
soft O O
NTND O O
1+ O O
LE O O
edema, O O
no O O
clubbing O O
Marvinyandell,Grace O O
Date: O O
09/23/04 O O
Broadwater O O
Health O O
Center O O
Pulmonary O O
Function O O
Laboratory O O
14 O O
A O O
Street O O
Watseka, O O
Arkansas O O
19842 O O
Phone: O O
(091)920-5569 O O
Fax: O O
(251)628-xxxx O O
Medical O O
Director: O O
Yvonne O O
X. O O
Olmstead, O O
M.D. O O
Name: O O
MARVINYANDELL,GRACE O O
MRN: O O
90468071 O O
Date O O
of O O
Birth: O O
05/24/22 O O
Date O O
of O O
Test O O
09/23/04 O O
Gender: O O
Female O O
Location: O O
Chest O O
Lab O O
Height: O O
65 O O
in O O
Referring O O
Physician: O O
Weller,Mark O O
Weight: O O
145 O O
lb O O
Attending O O
Physician: O O
KNOX,KEITH O O
D O O
Race: O O
Black O O
Technician: O O
MT572 O O
Resp.Diagnosis: O O
786.09 O O
Study O O
Status: O O
Final O O
SPIROMETRY O O
(BTPS) O O
Predicted O O
Pre-BD O O
Post-BD O O
Percent O O
Range O O
Change O O
Mean O O
95% O O
CI O O
Actual O O
%Pred O O
Actual O O
%PredFVC O O
(Lts) O O
2.33 O O
1.65 O O
1.38 O O
59 O O
1.38 O O
59 O O
0FEV1 O O
(Lts) O O
1.67 O O
1.11 O O
1.02 O O
61 O O
1.08 O O
65 O O
6FEV6 O O
(Lts) O O
1.97 O O
1.25 O O
1.38 O O
70 O O
1.38 O O
70 O O
0FEV1/FVC O O
(%) O O
73 O O
64 O O
74 O O
101 O O
78 O O
107 O O
5FEV1/FEV6 O O
(%) O O
78 O O
69 O O
74 O O
95 O O
78 O O
100 O O
5FEF25_75 O O
(L/s) O O
1.23 O O
0.09 O O
0.71 O O
58 O O
0.94 O O
76 O O
32PEFR O O
(L/s) O O
3.88 O O
1.81 O O
4.95 O O
128 O O
4.62 O O
119 O O
-7FET O O
(Secs) O O
6.67 O O
7.64 O O
15 O O
PHYSICIAN O O
INTERPRETATIONFEV1 O O
and O O
FVC O O
are O O
reduced, O O
FEV1/FVC O O
is O O
normal. O O
There O O
was O O
not O O
a O O
significantresponse O O
to O O
inhaled O O
bronchodilator. O O
The O O
reduced O O
FVC O O
is O O
consistent O O
with O O
arestrictive O O
deficit. O O
Suggest O O
lung O O
volumes O O
if O O
clinically O O
indicated. O O
Since6/03/04, O O
the O O
FEV1 O O
and O O
FVC O O
have O O
not O O
changed. O O
IMPRESSION O O
AND O O
RECOMMENDATIONS: O O
DOE O O
is O O
likely O O
multifactorial. O O
It O O
may O O
be O O
beneficial O O
to O O
separate O O
cardiac O O
from O O
pulmonary O O
limitatio O O
from O O
deconditioning O O
and O O
I O O
recommended O O
a O O
cardio-pulmonary O O
exercise O O
test O O
to O O
the O O
patient, O O
to O O
which O O
she O O
agreed. O O
In O O
addition, O O
as O O
previously O O
discussed, O O
she O O
would O O
benefit O O
from O O
pulmonary O O
rehab. O O
Finally, O O
I O O
am O O
not O O
sure O O
how O O
much O O
asthma O O
is O O
contributing O O
to O O
the O O
picture. O O
There O O
was O O
no O O
response O O
to O O
brnonchodialtor O O
today O O
and O O
the O O
patient O O
does O O
not O O
feel O O
any O O
help O O
from O O
it O O
either. O O
I O O
told O O
her O O
that O O
she O O
does O O
not O O
need O O
to O O
use O O
albuterol O O
if O O
it O O
doesn't O O
help O O
her. O O
I've O O
requested O O
RAST O O
allergy O O
testing O O
to O O
further O O
investigate O O
the O O
possiblity O O
of O O
allergic O O
asthma. O O
We O O
will O O
not O O
do O O
the O O
methacholine O O
challange O O
testing O O
due O O
to O O
patient's O O
already O O
deacreased O O
FEV1 O O
(due O O
to O O
restriction) O O
as O O
it O O
might O O
be O O
dangerous O O
to O O
precipitate O O
bronchoconstriciton O O
in O O
the O O
setting O O
of O O
an O O
already O O
limited O O
reserve. O O
Seen O O
and O O
d/w O O
Dr. O O
Weller O O
____________________________________ O O
Xavier O O
U. O O
Mahoney, O O
M.D. O O

Record O O
date: O O
2064-08-03 O O
Brady O O
Rural O O
for O O
Dr. O O
Fallon O O
66 O O
y.o. O O
man, O O
new O O
to O O
the O O
Brady O O
Rural O O
Health O O
Clinic, O O
here O O
today O O
for O O
sore O O
throat, O O
earache O O
x O O
2 O O
days. O O
PMH: O O
1. O O
Hypercholesterolemia. B-HYPERLIPIDEMIA O
2. O O
Hiatal O O
hernia, O O
which O O
was O O
diagnosed O O
at O O
least O O
10 O O
years O O
ago. O O
3. O O
Ulcers O O
diagnosed O O
about O O
4-5 O O
years O O
ago. O O
4. O O
Arthritis. O O
5. O O
CAD, B-CAD O
s/p B-CAD O
imi I-CAD O
x I-CAD O
2, I-CAD O
'61 O O
Brady, O O
cardiologist O O
Dr. O O
Yingling O O
ett O O
mibi O O
9/2062: O O
prior O O
posterobasal O O
infarction O O
without O O
evidence O O
of O O
ischemia O O
MEDICATIONS O O
ON O O
ADMISSION: O O
1. O O
Lopressor B-MEDICATION B-MEDICATION
12.5 O O
BID. O O
2. O O
Aspirin B-MEDICATION B-MEDICATION
325 O O
QD. O O
3. O O
Folic O O
acid O O
1 O O
mg. O O
QD. O O
4. O O
Lopid B-MEDICATION B-MEDICATION
600 O O
mg. O O
QD. O O
5. O O
Lipitor B-MEDICATION B-MEDICATION
40 O O
mg. O O
QD. O O
6. O O
Protonix O O
QD. O O
ALLERGIES: O O
Penicillin O O
causes O O
swelling. O O
Erythromycin O O
causes O O
hives, O O
and O O
IV O O
dye O O
causes O O
convulsions. O O
SH: O O
ex-tob, B-SMOKER O
quit I-SMOKER O
'61, I-SMOKER O
no O O
etoh, O O
disabled O O
Immigration O O
Officer O O
(disability O O
is O O
cad) O O
ROS: O O
achey O O
joints O O
today O O
only, O O
no O O
fever O O
or O O
chills O O
Family O O
Hx: O O
brother O O
with O O
cancer O O
(lung), O O
smoker O O
Exam: O O
BP O O
116/70, O O
T O O
98.7 O O
well O O
appearing, O O
TM's O O
clear, O O
anicteric O O
sclera, O O
OP O O
clear, O O
neck O O
supple O O
CV: O O
rrr, O O
no O O
m/r/g O O
Chest: O O
cta O O
bilat, O O
spine O O
nt O O
Ext: O O
no O O
leg O O
edema, O O
no O O
splinter O O
hemorrrhage O O
Data: O O
lft's O O
5/2064 O O
wnl O O
A/P O O
1. O O
Pharyngitis: O O
no O O
sign O O
of O O
strep O O
infection, O O
no O O
ulcers. O O
Possible O O
allergies, O O
no O O
sign O O
of O O
bronchitis. O O
recommend O O
Cepacol O O
throat O O
lozenges O O
prn O O
pain, O O
tums O O
at O O
bedtime O O
in O O
case O O
acid O O
reflux, O O
to O O
EW O O
if O O
chest O O
pressure, O O
chest O O
pain O O
or O O
n/v/abd O O
pains. O O
2. O O
Cough: O O
clear O O
exam, O O
recommend O O
conservative O O
treatment O O
with O O
fluids, O O
Possible O O
allergies. O O
Use O O
A/C, O O
call O O
if O O
fever, O O
productive O O
phlegm. O O
3. O O
CAD: O O
stable O O
by O O
history. O O
f/u O O
with O O
Dr. O O
Fallon O O
for O O
new O O
PCP O O
visit O O
Oct O O
'64 O O
(previously O O
followed O O
at O O
Internal O O
Medicine O O
in O O
Brady O O
Rural). O O
4. O O
hyperlipidemia: O O
stable, O O
lft's O O
reassuring. O O
Pt O O
to O O
stop O O
med O O
and O O
call O O
office O O
if O O
muscle O O
aches O O
persist O O
for O O
several O O
days O O
or O O
if O O
intolerant O O
to O O
meds. O O
LFT's O O
at O O
that O O
time. O O
_____________________________________________ O O
Bryan O O
Y. O O
Hill, O O
M.D. O O

Record B-SMOKER O
date: O O
2065-06-20 O O
Prents O O
for O O
followup O O
of O O
medical O O
problems: O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
: O O
stable O O
disease, O O
medical O O
management. O O
Deneis O O
chest O O
pain. O O
Walking O O
at O O
least O O
3 O O
miles O O
a O O
day O O
without O O
difficulty. O O
Hyperlipidemia B-HYPERLIPIDEMIA O
: O O
on O O
lipitor B-MEDICATION B-MEDICATION
and O O
working O O
on O O
wt O O
loss/diet/exercise O O
to O O
bring O O
down O O
TGs. O O
Borderline O O
diabetes O O
mellitus O O
: O O
last O O
Hba1c O O
HbA1c O O
6.4. O O
No O O
hypoglycemic O O
episdoes O O
Impotence O O
: O O
Viagra O O
prn O O
asking O O
for O O
sample O O
pack O O
today O O
Claudication O O
: O O
symptoms O O
of O O
le O O
pain O O
on O O
ambulation, O O
minimally O O
symptomatic. O O
Tells O O
me O O
today O O
that O O
sxs O O
resolved O O
Pancreatitis O O
: O O
+ O O
FH O O
pancreatic O O
ca. O O
chronic, O O
noted O O
on O O
CT O O
abd O O
for O O
eval O O
of O O
kidney O O
stones O O
- O O
no O O
stones O O
noted. O O
Presented O O
with O O
R O O
flank O O
pain O O
- O O
sxs O O
resolved O O
with O O
toradol, O O
inc O O
fluids. O O
Amylase O O
117/lipase O O
4.7. O O
Since O O
our O O
last O O
visit, O O
he O O
saw O O
GI O O
- O O
going O O
for O O
scope O O
to O O
eval O O
pancreas O O
and O O
do O O
biopsies? O O
NO O O
other O O
complaints. O O
Thinks O O
he O O
mgiht O O
have O O
passed O O
a O O
small O O
kidney O O
stone O O
a O O
few O O
weeks O O
ago. O O
Now O O
no O O
urinary O O
sxs. O O
NO O O
fevers. O O
ROS O O
o/w O O
negaitve. O O
Medications O O
Metoprolol B-MEDICATION B-MEDICATION
TARTRATE I-MEDICATION O
50MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
, O O
?dose O O
37.5? O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
325MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
, O O
Take O O
as O O
directed O O
Folic O O
ACID O O
1MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Viagra O O
(SILDENAFIL) O O
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
x1 O O
PRN O O
prn O O
, O O
do O O
not O O
combine O O
with O O
nitroglycerin O B-MEDICATION
Protonix O O
(PANTOPRAZOLE) O O
40MG O O
TABLET O O
EC O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
, O O
Take O O
as O O
directed O O
Toradol O O
(KETOROLAC O O
TROMETHAMINE) O O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
Q8H O O
PRN O O
prn O O
pain O O
, O O
TAke O O
with O O
food O O
Lopid B-MEDICATION O
(GEMFIBROZIL) O O
600MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
Allergies O O
Penicillins O O
- O O
Angiodema, O O
Hives, O O
Erythromycins O O
- O O
Hives, O O
Iv O O
Contrast O O
- O O
convulsions, O O
Hypotension O O
Vital O O
signs O O
BP O O
132/70, O O
Wt O O
179 O O
lb O O
Gen O O
NAD. O O
A&Ox4 O O
Affect O O
nl O O
NEck O O
supple O O
Lungs O O
CTAb O O
Cardiac O O
RRR. O O
Abd O O
soft, O O
nt, O O
nd, O O
nl O O
bs. O O
No O O
hsm O O
noted O O
Ext O O
no O O
edema O O
A/P: O O
Coronary O O
artery O O
disease O O
: O O
stable, O O
asympt, O O
no O O
changes O O
Hyperlipidemia O O
: O O
controleld O O
on O O
lipitor, O B-MEDICATION
cont O O
efforts O O
with O O
diet/exercise O O
Borderline O O
diabetes O O
mellitus O O
: O O
controlled O O
with O O
diet/exercise O O
- O O
continue O O
Impotence O O
:Viagra O O
prn O O
- O O
gave O O
sample O O
pack O O
and O O
directions O O
today O O
Pancreatitis O O
: O O
plan O O
for O O
scope O O
to O O
eval O O
pancreas O O
with O O
GI O O
noted O O
? O O
Kidney O O
stone O O
: O O
counseled O O
inc O O
po O O
fluids O O
to O O
dec O O
risk O O
of O O
recurrent O O
stones. O O
f/u O O
3 O O
mos O O

Record O O
date: O O
2066-01-13 O O
Patient O O
is O O
a O O
67 O O
yo O O
M O O
who O O
presents O O
for O O
yearly O O
physical O O
exam O O
and O O
followup O O
of O O
medical O O
problems: O O
Issues O O
addressed O O
today: O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
: I-CAD O
asympt, O O
followed O O
by O O
Dr. O O
Arval O O
Yingling. O O
Walking O O
without O O
diff. O O
Denies O O
chest O O
pain, O O
sob, O O
nausea. O O
Hyperlipidemia B-HYPERLIPIDEMIA O
: O O
on O O
lipitor20 B-MEDICATION B-MEDICATION
mg O O
and O O
lopid B-MEDICATION B-MEDICATION
600 O O
bid. O O
TGs O O
high O O
last O O
check O O
- O O
working O O
on O O
diet/exercise. O O
He O O
is O O
fasting O O
today O O
for O O
blood O O
draw O O
and O O
sgpt/cpk O O
chck O O
glucose O O
intolerance O O
: O O
has O O
been O O
controlled O O
on O O
diet/exercise. O O
Experiencing O O
some O O
increase O O
in O O
urination, O O
gained O O
a O O
few O O
lbs O O
over O O
holidays. O O
Impotence O O
: O O
viagra O O
prn O O
Complaints O O
today O O
include: O O
above. O O
Full O O
ros O O
obtained O O
and O O
o/w O O
negative. O O
Current O O
medications:Medications O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
325MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
, O O
Take O O
as O O
directed O O
Viagra O O
(SILDENAFIL) O O
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
x1 O O
PRN O O
prn O O
, O O
do O O
not O O
combine O O
with O O
nitroglycerin O B-MEDICATION
Metoprolol B-MEDICATION B-MEDICATION
TARTRATE I-MEDICATION O
50MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
Lopid B-MEDICATION O
(GEMFIBROZIL) O O
600MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
, O O
Take O O
as O O
directed O O
Arthrotec O O
(DICLOFENAC/MISOPROSTOL) O O
75 O O
MG O O
SL O O
BID O O
Protonix O O
(PANTOPRAZOLE) O O
40MG O O
TABLET O O
EC O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Folic O O
ACID O O
1MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Allergies O O
Penicillins O O
- O O
Angiodema, O O
Hives, O O
Erythromycins O O
- O O
Hives, O O
Iv O O
Contrast O O
- O O
convulsions, O O
Hypotension O O
Social O O
History: O O
Single, O O
divorced. O O
3 O O
children, O O
4 O O
grandchildren. O O
Retired, O O
used O O
to O O
do O O
immigration O O
policing. O O
Lives O O
in O O
Havre O O
De O O
Grace O O
with O O
his O O
brother. O O
Dating O O
current O O
girlfriend O O
x O O
3 O O
years O O
now, O O
sexually O O
active. O O
Walks O O
avidly. O O
Daughter O O
keeps O O
him O O
busy O O
doing O O
odd O O
jobs. O O
Quit B-SMOKER O
smoking I-SMOKER O
2061. I-SMOKER O
Smoked I-SMOKER O
1 I-SMOKER O
ppd I-SMOKER O
x I-SMOKER O
30 I-SMOKER O
years. I-SMOKER O
Occ O O
etoh. O O
NO O O
illicit O O
drugs. O O
Occ O O
wears O O
his O O
seatbelts. O O
Exercises O O
regularly. O O
Family O O
History: O O
Mother O O
died O O
of O O
cancer O O
- O O
pancreatic O O
cancer. O O
Father O O
died O O
at O O
age O O
29 O O
of O O
alcohol O O
related O O
problems. O O
Brother O O
(half) O O
died O O
at O O
age O O
51 O O
of O O
pancreatic O O
cancer. O O
Other O O
brother O O
has O O
lung O O
cancer O O
- O O
smoker. O O
Sister O O
has O O
hyperlipdemia. O O
Negative O O
for O O
early O O
CAD, O O
stroke, O O
HTN, O O
DM, O O
bleeding/clotting O O
disorders, O O
breast O O
cancer, O O
colon O O
cancer, O O
skin O O
cancer. O O
FH O O
otherwise O O
negative. O O
PE: O O
Vitals: O O
bp O O
110/70 O O
Wt O O
183 O O
lbs O O
Ht O O
65 O O
inches O O
Gen: O O
NAD. O O
A&Ox4. O O
Affect: O O
normal O O
HEENT: O O
PERRLA. O O
EOMs O O
intact. O O
Oropharynx O O
clear O O
Neck: O O
supple, O O
no O O
adenopathy, O O
no O O
thyromegaly O O
or O O
thyroid O O
nodules. O O
NO O O
carotid O O
bruits O O
Lungs: O O
CTAB. O O
No O O
crackles O O
or O O
wheezes O O
Cardiac: O O
RRR. O O
No O O
m/g/r O O
Abdomen: O O
soft, O O
ND, O O
NT, O O
nl O O
BS. O O
No O O
masses O O
or O O
hsm O O
Ext: O O
no O O
edema. O O
Pulses O O
1+ O O
bilaterally. O O
Feet O O
warm. O O
Monofilament O O
normal. O O
Back: O O
no O O
flank O O
tenderness, O O
no O O
spinal O O
tenderness O O
Rectal: O O
Heme O O
negative. O O
Prostate O O
mildly O O
enlarged O O
- O O
golf O O
ball O O
size, O O
no O O
nodules. O O
Skin: O O
no O O
unusual O O
rashes O O
or O O
lesions O O
noted. O O
Neuro O O
DTRs O O
2+ O O
bilat, O O
strength O O
5/5 O O
bilat, O O
gait O O
nl O O
A/P: O O
Coronary O O
artery O O
disease O O
: O O
asymptomatic, O O
cont O O
medical O O
management. O O
Hyperlipidemia O O
: O O
on O O
lipitor20 O B-MEDICATION
mg O O
and O O
lopid O B-MEDICATION
600 O O
bid. O O
Will O O
plan O O
recheck O O
f. O O
lipids, O O
sgpt, O O
cpk O O
today O O
and O O
adjust O O
meds O O
as O O
needed O O
glucose O O
intolerance O O
: O O
counseled O O
diet/exercise. O O
Check O O
glucose O O
today O O
Health O O
Maintenance O O
Prostate O O
exam O O
01/13/2066 O O
smooth, O O
mildly O O
enlarged O O
- O O
golf O O
ball O O
size O O
Stool O O
Guaiac O O
01/13/2066 O O
Done O O
- O O
negative O O
Influenza O O
Vaccine O O
01/13/2066 O O
Cholesterol O O
01/13/2066 O O
Done/scheduled O O
Rectal O O
exam O O
01/11/2065 O O
prostate O O
smooth, O O
mildly O O
enlarged O O
- O O
golf O O
ball O O
size O O
M-alb/creat O O
ratio O O
10/11/2064 O O
8.0 O O
Pneumovax O O
01/11/2064 O O
Done O O
Smoking O O
status O O
01/13/2066 O O
Past O O
smoker O O
UA-Protein O O
04/08/2065 O O
:N O O
Colonoscopy O O
01/04/2062 O O
polyps O O
removed O O
per O O
patient O O
- O O
repeat O O
in O O
5 O O
years O O
Ophthal O O
Exam O O
01/13/2066 O O
Done/scheduled O O
PSA O O
10/17/2064 O O
1.6, O O
fPSA O O
0.39 O O
Urine O O
Culture O O
03/22/2065 O O
see O O
report O O
in O O
Results O O
Td O O
Booster O O
12/04/2064 O O
injured O O
finger O O
Triglycerides O O
04/08/2065 O O
279 O O
TSH O O
09/23/2065 O O
1.65 O O
Cholesterol-LDL O O
04/08/2065 O O
86 O O
DESIRABLE: O O
&lt;130 O O
Microalbumin O O
10/11/2064 O O
0.9 O O
Hct O O
(Hematocrit) O O
09/20/2065 O O
41.0 O O
Hypoglycemia O O
Assessment/Counseling O O
01/11/2065 O O
Complete O O
Physical O O
Exam O O
01/13/2066 O O
Cholesterol-HDL O O
04/08/2065 O O
35 O O
Hgb O O
(Hemoglobin) O O
09/20/2065 O O
14.6 O O
HbA1c O O
09/20/2065 O O
6.50 O O
Flu O O
vaccine O O
given O O
today O O
PE O O
1 O O
year O O
f/u O O
March-April O O

Record B-SMOKER O
date: O O
2070-01-23 O O
71 O O
year-old O O
gentleman O O
presents O O
today O O
for O O
follow-up O O
of O O
several O O
medical O O
issues. O O
Physically, O O
feeling O O
well. O O
Concerned O O
because O O
of O O
a O O
change O O
in O O
previously O O
noted O O
pulmonary O O
nodule. O O
He O O
has O O
a O O
pet O O
CT O O
scan O O
pending O O
for O O
March. O O
He O O
reports O O
No O O
recent O O
flank O O
or O O
back O O
discomfort. O O
He O O
reports O O
no O O
dysuria. O O
Reports O O
that O O
his O O
morning O O
sugars O O
range O O
between O O
110 O O
and O O
148 O O
based O O
upon O O
meals. O O
He O O
reports O O
no O O
polyuria O O
or O O
polydipsia.Review O O
of O O
systems O O
is O O
otherwise O O
negative. O O
Past O O
Medical O O
History:Coronary B-CAD O
artery I-CAD O
disease I-CAD O
: O O
inf B-CAD O
MI I-CAD O
11/2061. I-CAD O
Cath B-CAD O
- I-CAD O
3v I-CAD O
disease I-CAD O
with I-CAD O
50% I-CAD O
LAD, I-CAD O
40% I-CAD O
diag, I-CAD O
100% I-CAD O
distal I-CAD O
cx, I-CAD O
100% I-CAD O
prox I-CAD O
RCA I-CAD O
- O O
collat O O
from O O
L. O O
Medical O O
management O O
since O O
well-collateralized. O O
Dr. O O
Arval O O
Yingling10/64: O O
doing O O
well O O
on O O
current O O
meds, O O
no O O
chest O O
pains. O O
Walks O O
5 O O
miles O O
without O O
difficulty.6/66: O O
asympt, O O
K4.0, O O
Cr O O
1.1, O O
u/a O O
neg O O
prot7/67 O O
116/82Hyperlipidemia B-HYPERLIPIDEMIA O
: O O
on O O
lipitor20 B-MEDICATION B-MEDICATION
mg O O
and O O
lopid B-MEDICATION B-MEDICATION
600 O O
bid. O O
Prior O O
HDL O O
19.8/67 O O
TC O O
170, O O
TG O O
162, O O
H40, O O
L98, O O
ratio O O
4.3diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
: O O
progression O O
to O O
diabetes O O
7/67- B-DIABETES O
HbA1c B-DIABETES O
8.10 I-DIABETES O
- O O
start O O
metformin. B-MEDICATION B-MEDICATION
Followed O O
by O O
diabetes O O
center.Impotence O O
: O O
10/64: O O
testosterone O O
level O O
nl. O O
+ O O
success O O
with O O
Viagra O O
100 O O
mg O O
prn, O O
not O O
on O O
nitrates. O O
Gave O O
samples O O
of O O
Levitra O O
10 O O
mg O O
to O O
use O O
prn. O O
#6.1/65: O O
Viagra O O
prn O O
- O O
gave O O
sample O O
pack O O
and O O
Rx O O
todayClaudication O O
: O O
3/65: O O
symptoms O O
of O O
le O O
pain O O
on O O
ambulation, O O
minimally O O
symptomatic. O O
Medical O O
managment, O O
no O O
studies O O
unless O O
progresses.H/O O O
Pancreatitis O O
: O O
3/65: O O
+ O O
FH O O
pancreatic O O
ca. O O
chronic, O O
noted O O
on O O
CT O O
abd O O
for O O
eval O O
of O O
kidney O O
stones O O
- O O
no O O
stones O O
noted. O O
Presented O O
with O O
R O O
flank O O
pain O O
- O O
sxs O O
resolved O O
with O O
toradol, O O
inc O O
fluids. O O
Amylase O O
117/lipase O O
4.7. O O
4/65: O O
counseled. O O
To O O
stop O O
all O O
etoh O O
- O O
drinks O O
6 O O
vodkas O O
on O O
Fri. O O
Referral O O
submitted O O
to O O
GI6/65: O O
saw O O
GI O O
- O O
going O O
for O O
scope O O
to O O
eval O O
pancreas O O
- O O
normal O O
appearance O O
of O O
pancreas, O O
no O O
evid O O
of O O
chronic O O
pancreatitis O O
or O O
mass? O O
Kidney O O
stone O O
: O O
3/65: O O
R O O
abd/flank O O
pain O O
with O O
nausea. O O
u/a O O
+ O O
blood, O O
cx O O
negative. O O
Better O O
with O O
toradol, O O
inc O O
po O O
fluids. O O
CT O O
renal O O
negative O O
for O O
stonesH/O O O
Rib O O
fracture O O
: O O
2/2066Dyspepsia O O
Chronic O O
obstructive O O
pulmonary O O
disease O O
: O O
and O O
interstital O O
fibrosis O O
on O O
CXR O O
8/67. O O
Sxs O O
- O O
increasing O O
sob, O O
cough. O O
Gave O O
albuterol O O
inhaler O O
to O O
use O O
prn O O
and O O
referred O O
to O O
pulm O O
8/67Macular O O
degeneration O O
Asbestosis O O
Positive O O
PPD O O
: O O
Patient O O
has O O
declined O O
treatmentPulmonary O O
nodule O O
: O O
On O O
CT O O
scan, O O
June O O
2068. O O
Repeat O O
January O O
2069 O O
AllergiesPenicillins O O
- O O
see O O
comment, O O
: O O
Angiodema, O O
Hives. O O
anaphylaxis, O O
angioedemaErythromycins O O
- O O
Hives O O
: O O
Iv O O
Contrast O O
- O O
convulsions, O O
HypotensionGLYBURIDE B-MEDICATION O
- O O
irritability, O O
sweating, O O
Codeine O O
- O O
nausea, O O
Health O O
MaintCholesterol-HDL O O
12/05/2069 O O
29 O O
Cholesterol-LDL O O
12/05/2069 O O
34 O O
DESIRABLE: O O
&lt;130 O O
Colonoscopy O O
05/13/2067 O O
see O O
report O O
in O O
Results O O
Influenza O O
Vaccine O O
10/02/2069 O O
M-alb/creat O O
ratio O O
03/13/2069 O O
11.4 O O
Microalbumin O O
03/13/2069 O O
0.9 O O
Ophthal O O
Exam O O
09/23/2070 O O
PSA O O
05/25/2069 O O
1.54 O O
Td O O
Booster O O
12/04/2064 O O
injured O O
finger O O
MedicationsAlbuterol O O
inhaler O O
1-2 O O
PUFFS O O
PO O O
QID O O
PRN O O
prn O O
cough/sob O O
#1 O O
Inhaler(s)Asa B-MEDICATION O
(ACETYLSALICYLIC O O
ACID) O O
325MG O O
TABLET O O
Take O O
1 O O
Tablet(s) O O
PO O O
QD O O
, O O
Take O O
as O O
directed O O
Colace O O
(DOCUSATE O O
SODIUM) O O
100 O O
MG O O
(100MG O O
TABLET O O
Take O O
1) O O
PO O O
TID O O
#40 O O
Tablet(s)Flomax O O
(TAMSULOSIN) O O
0.4 O O
MG O O
(0.4MG O O
CAP.SR O O
24H O O
Take O O
1) O O
PO O O
QD O O
x O O
14 O O
days O O
#14 O O
CAP.SRFolic O O
ACID O O
1MG O O
TABLET O O
Take O O
1 O O
Tablet(s) O O
PO O O
QD O O
#90 O O
Tablet(s)Glipizide B-MEDICATION O
2.5 O O
MG O O
(5MG O O
TABLET O O
Take O O
0.5) O O
PO O O
QD O O
, O O
this O O
replaces O O
metformin O B-MEDICATION
while O O
creatinine O O
is O O
elevated O O
#30 O O
Tablet(s)Halflytely O O
AND O O
BISACODYL O O
TABLETS O O
(BISACODYL-PEG O O
ELECTROLYTE O O
SOLUTION) O O
COMBO. O O
PKG O O
5MGX2-210G O O
COMBO. O O
PKG O O
PO O O
as O O
directed O O
, O O
Please O O
follow O O
the O O
instructions O O
provided O O
in O O
your O O
packet O O
from O O
GI O O
Associates O O
#1 O O
UnitLipitor O B-MEDICATION
(ATORVASTATIN) B-MEDICATION O
80 O O
MG O O
(80MG O O
TABLET O O
Take O O
1) O O
PO O O
QHS O O
, O O
Take O O
as O O
directed O O
#90 O O
Tablet(s)Metformin B-MEDICATION O
850 O O
MG O O
PO O O
BID O O
#180 O O
Tablet(s)Naproxen O O
500 O O
MG O O
(500MG O O
TABLET O O
Take O O
1) O O
PO O O
BID O O
PRN O O
, O O
take O O
with O O
food O O
#30 O O
Tablet(s)Niaspan B-MEDICATION O
(NICOTINIC O O
ACID O O
EXTENDED O O
RELEASE) O O
1000 O O
MG O O
(1000MG O O
TABLET O O
SA O O
Take O O
1) O O
PO O O
QHS O O
#30 O O
Tablet(s)Percocet O O
5 O O
MG/325 O O
MG O O
(OXYCODONE O O
5 O O
MG/ACETAMINOPHEN O O
325 O O
MG) O O
1 O O
TAB O O
(5MG-325MG O O
TABLET O O
) O O
PO O O
Q4-6H O O
#40 O O
Tablet(s)Prilosec O O
OTC O O
(OMEPRAZOLE O O
OTC) O O
20 O O
MG O O
(20MG O O
TABLET O O
DR O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s)Pyridium O O
(PHENAZOPYRIDINE O O
HCL) O O
200 O O
MG O O
(200MG O O
TABLET O O
Take O O
1) O O
PO O O
TID O O
#9 O O
Tablet(s)Toprol B-MEDICATION O
XL I-MEDICATION O
(METOPROLOL B-MEDICATION O
SUCCINATE O O
EXTENDED O O
RELEASE) O O
200 O O
MG O O
(200MG O O
TAB.SR O O
24H O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s)Trazodone O O
50MG O O
TABLET O O
PO O O
HS O O
PRN O O
prn O O
insomnia O O
, O O
Take O O
as O O
directed O O
#30 O O
Tablet(s) O O
Physical O O
exam: O O
In O O
no O O
acute O O
distress. O O
Blood O O
pressure O O
is O O
126/78. O O
Pulse O O
is O O
70 O O
and O O
regular. O O
Respiratory O O
rate O O
is O O
15. O O
HEENT: O O
Pupils O O
equal O O
round O O
reactive O O
to O O
light. O O
Oropharynx O O
is O O
moist O O
without O O
erythema O O
or O O
exudate. O O
Neck: O O
Supple O O
without O O
JVD. O O
Lungs: O O
Clear O O
to O O
auscultation O O
bilaterally O O
without O O
wheezes, O O
rhonchi O O
or O O
rhales. O O
Cardiac O O
exam: O O
Regular O O
rate O O
and O O
rhythm, O O
Normal O O
S1 O O
and O O
S2 O O
without O O
murmurs, O O
rubs O O
or O O
gallops. O O
Abdomen: O O
Soft, O O
nondistended, O O
nontender. O O
Positive O O
bowel O O
sounds. O O
Extremities: O O
Without O O
clubbing, O O
cyanosis O O
or O O
edema. O O
Distal O O
pulses O O
2+ O O
palpable. O O
Assessment O O
and O O
plan:1. O O
coronary O O
artery O O
disease: O O
Blood O O
pressure O O
and O O
target. O O
Continuing O O
current O O
antihypertensive O O
regimen. O O
Cholesterol O O
most O O
recently O O
checked O O
was O O
a O O
target O O
as O O
well. O O
Continuing O O
current O O
dose O O
Lipitor.2. O B-MEDICATION
Diabetes: O O
Current O O
on O O
routine O O
screening. O O
Checking O O
hemoglobin O O
A1c O O
and O O
electrolytes O O
today.3. O O
Pulmonary O O
nodule: O O
Reviewed O O
significance O O
of O O
findings O O
with O O
patient. O O
Plan O O
at O O
present O O
is O O
to O O
arrange O O
follow O O
the O O
based O O
upon O O
results O O
of O O
PET O O
CT.4. O O
Sclerotic O O
lesion: O O
Noted O O
on O O
abdominal O O
CT, O O
a O O
questionable O O
sclerotic O O
lesion O O
was O O
noted O O
to O O
the O O
left O O
femur. O O
Checking O O
plain O O
films O O
of O O
the O O
femur O O
to O O
better O O
characterize O O
this O O
finding O O
today.5. O O
Health O O
care O O
maintenance: O O
Otherwise O O
current. O O
I'll O O
see O O
the O O
patient O O
in O O
follow O O
up O O
in O O
four O O
months O O
or O O
sooner O O
as O O
is O O
indicated O O

Record O O
date: O O
2092-10-29 O O
Team O O
3 O O
Intern O O
Admit O O
Note O O
Name: O O
Walton, O O
Levi O O
MR#: O O
2554172 O O
Date: O O
10/29/92 O O
PCP: O O
Paul O O
Eggleston O O
Cardiology: O O
Youmans O O
CC: O O
emesis, O O
light-headedness O O
HPI: O O
85 O O
y/o O O
with O O
CAD B-CAD O
and O O
active B-CAD O
ischemia I-CAD O
on I-CAD O
6/87 I-CAD O
stress I-CAD O
test I-CAD O
(medically O O
managed) O O
who O O
was O O
feeling O O
well O O
until O O
last O O
night. O O
During O O
the O O
day O O
yesterday, O O
he O O
went O O
on O O
his O O
daily O O
walk O O
with O O
his O O
wife O O
and O O
felt O O
fine. O O
In O O
the O O
evening O O
around O O
8:30 O O
pm, O O
he O O
experienced O O
dull, B-CAD O
8/10 I-CAD O
pain I-CAD O
under I-CAD O
both I-CAD O
arm I-CAD O
pits I-CAD O
which I-CAD O
resolved I-CAD O
within O O
20 O O
minutes O O
after O O
taking O O
3 O O
SL B-MEDICATION O
TNG I-MEDICATION O
5 O O
mins O O
apart. O O
He O O
denies O O
SOB, O O
N/V, O O
radiation O O
or O O
diaphoresis O O
associated O O
with O O
this O O
arm O O
pain. O O
He O O
states O O
that O O
he O O
gets O O
similar O O
bilateral O O
underarm O O
pain O O
about O O
twice O O
per O O
week O O
which O O
is O O
usually O O
relieved O O
by O O
a O O
single O O
SL O O
TNG O O
within O O
10-15 O O
mins. O O
The O O
arm O O
pain O O
is O O
not O O
exertional. O O
After O O
the O O
arm O O
pain O O
relieved O O
last O O
night, O O
the O O
pt O O
took O O
3 O O
Aleve O O
tabs O O
which O O
his O O
daughter O O
bought O O
for O O
him O O
for O O
arthritis O O
pain. O O
A O O
couple O O
of O O
hours O O
later, O O
he O O
became O O
nauseated O O
and O O
had O O
a O O
single O O
episode O O
of O O
dark O O
brown O O
emesis. O O
After O O
vomiting, O O
he O O
felt O O
light-headed O O
while O O
walking O O
around O O
the O O
house. O O
He O O
had O O
a O O
bowel O O
movement O O
this O O
AM O O
which O O
he O O
states O O
was O O
darker O O
than O O
usual, O O
almost O O
black O O
looking. O O
He O O
denies O O
BRBPR, O O
abdominal O O
pain, O O
CP, O O
SOB, O O
palpitations, O O
headache, O O
fever O O
or O O
chills. O O
In O O
the O O
setting O O
of O O
significant O O
fatigue O O
and O O
light-headedness, O O
the O O
pt O O
presented O O
to O O
the O O
ED O O
this O O
morning. O O
Admission O O
vitals: O O
97.2, O O
120/78, O O
HR O O
80's, O O
RR12, O O
sats O O
97% O O
RA. O O
He O O
was O O
noted O O
to O O
be O O
in O O
A O O
fib. O O
Hct O O
was O O
22 O O
(down O O
from O O
38 O O
last O O
week). O O
NG O O
lavage O O
was O O
not O O
performed O O
in O O
the O O
ED. O O
However, O O
he O O
did O O
have O O
another O O
episode O O
of O O
bilateral O O
arm O O
pain O O
which O O
was O O
relieved O O
by O O
SL O O
TNG O O
x O O
3. O O
HR O O
at O O
the O O
time O O
of O O
arm O O
pain O O
was O O
in O O
the O O
80's O O
and O O
ECG O O
showed O O
A O O
fib O O
with O O
possible O O
TWI O O
in O O
I,L O O
and O O
V6 O O
but O O
relatively O O
unchanged O O
from O O
admission O O
ECG O O
without O O
pain. O O
He O O
subsequently O O
received O O
lopressor B-MEDICATION B-MEDICATION
2.5 O O
IV/12.5 O O
PO, O O
isordil B-MEDICATION B-MEDICATION
10 O O
PO O O
and O O
zantac O O
50 O O
IV. O O
PMHx: O O
1. O O
CAD O O
a. O O
S/p B-CAD O
anterior I-CAD O
MI I-CAD O
2082 I-CAD O
- O O
pt O O
does O O
not O O
recall O O
having O O
chest O O
pain O O
associated O O
with O O
MI O O
b. O O
Cath B-CAD O
2082 I-CAD O
- I-CAD O
3 I-CAD O
vessel I-CAD O
CAD, I-CAD O
PTCA B-CAD O
to O O
mid-LAD O O
lesion, O O
90% O O
RCA, O O
occluded O O
OM2 O O
c. O O
ETT-mibi B-CAD O
6/87 I-CAD O
- I-CAD O
75% I-CAD O
MPHR, I-CAD O
8 I-CAD O
METS. I-CAD O
0.5-1 I-CAD O
mm I-CAD O
ST I-CAD O
depressions I-CAD O
in I-CAD O
inferior I-CAD O
and I-CAD O
percordial I-CAD O
(V4, I-CAD O
V5) I-CAD O
leads; I-CAD O
imaging I-CAD O
showed I-CAD O
inferior I-CAD O
and I-CAD O
posterior I-CAD O
ischemia I-CAD O
d. O O
ECHO O O
3/87 O O
- O O
EF O O
67%, O O
LA O O
37mm, O O
no O O
WMA O O
2. O O
BPH O O
3. O O
OA/DJD O O
bilateral O O
shoulders O O
4. O O
colonoscopy O O
2087 O O
- O O
hemorrhoids, O O
diverticulosis, O O
single O O
tubular O O
adenoma O O
excised; O O
no O O
endoscopy O O
since O O
then O O
5. O O
DM B-DIABETES O
II I-DIABETES O
- I-DIABETES O
diet O O
controlled; O O
last B-DIABETES O
A1c I-DIABETES O
6.6 I-DIABETES O
(10/92) I-DIABETES O
6. O O
hyperlipidemia B-HYPERLIPIDEMIA O
- O O
chol O O
111, O O
LDL O O
55 O O
HDL O O
33, O O
tri O O
115 O O
(10/92 O O
on O O
treatment) O O
Meds: O O
1. O O
atenolol B-MEDICATION B-MEDICATION
100 O O
QD O O
2. O O
isordil O B-MEDICATION
30 O O
QID O O
3. O O
ASA B-MEDICATION B-MEDICATION
81 O O
QD O O
4. O O
lisinopril B-MEDICATION B-MEDICATION
20 O O
QD O O
5. O O
SL O O
TNG O O
prn O O
6. O O
MVI O O
7. O O
lipitor B-MEDICATION B-MEDICATION
10 O O
QD O O
Allergies: O O
NKDA O O
SHx: O O
lives O O
with O O
wife; O O
walks O O
around O O
the O O
mall O O
daily O O
Tobacco B-SMOKER O
- I-SMOKER O
quit I-SMOKER O
&gt;35 I-SMOKER O
years I-SMOKER O
ago I-SMOKER O
EtOH O O
- O O
2 O O
mixed O O
drinks O O
(vodka) O O
per O O
night; O O
denies O O
anything O O
more O O
Drugs O O
- O O
none O O
PE: O O
vitals O O
95.0 O O
115/58 O O
87 O O
18 O O
98% O O
RA O O
General: O O
no O O
acute O O
distress O O
HEENT: O O
sclera O O
anicteric; O O
EOMI, O O
PERRLA, O O
OP O O
without O O
masses O O
or O O
infiltrate O O
NECK: O O
JVP O O
flat; O O
carotid O O
pulses O O
brisk O O
and O O
symmetric; O O
no O O
carotid O O
bruits; O O
no O O
thyromegaly; O O
no O O
cervical O O
or O O
supraclav. O O
LAD O O
LUNGS: O O
CTA O O
B O O
CARDIAC: O O
irreg O O
irreg, O O
nl O O
s1s2, O O
no O O
M/R/G O O
ABD: O O
soft, O O
NT/ND, O O
pos. O O
BS, O O
no O O
HSM O O
RECTAL: O O
guaiac O O
positive, O O
normal O O
tone O O
(per O O
ED O O
resident) O O
EXT: O O
no O O
axillary O O
or O O
inguinal O O
LAD; O O
no O O
c/c/e O O
MSK: O O
significantly O O
limited O O
and O O
painful O O
ROM O O
at O O
both O O
shoulders O O
NEURO: O O
A&O O O
x O O
3; O O
CN O O
II-XII O O
intact; O O
otherwise O O
non-focal O O
Labs: O O
Sodium O O
(Stat O O
Lab) O O
134 O O
L O O
(135-145) O O
mmol/L O O
Potassium O O
(Stat O O
Lab) O O
3.9 O O
(3.4-4.8) O O
mmol/L O O
Chloride O O
(Stat O O
Lab) O O
102 O O
(100-108) O O
mmol/L O O
CO2 O O
(Stat O O
Lab) O O
22.5 O O
L O O
(23.0-31.9) O O
mmol/L O O
BUN O O
(Stat O O
Lab) O O
67 O O
H O O
(8-25) O O
mg/dl O O
Creatinine O O
(Stat O O
Lab) O O
1.4 O O
(0.6-1.5) O O
mg/dl O O
Glucose O O
(Stat O O
Lab) O O
291 O O
H O O
(70-110) O O
mg/dl O O
Calcium O O
9.2 O O
(8.5-10.5) O O
mg/dl O O
Phosphorus O O
3.9 O O
(2.6-4.5) O O
mg/dl O O
Magnesium O O
1.6 O O
(1.4-2.0) O O
meq/L O O
Total O O
Protein O O
6.5 O O
(6.0-8.3) O O
g/dl O O
Albumin O O
3.5 O O
(3.3-5.0) O O
g/dl O O
Globulin O O
3.0 O O
(2.6-4.1) O O
g/dl O O
Direct O O
Bilirubin O O
0.1 O O
(0-0.4) O O
mg/dl O O
Total O O
Bilirubin O O
0.3 O O
(0-1.0) O O
mg/dl O O
Alkaline O O
Phosphatase O O
67 O O
(45-115) O O
U/L O O
Transaminase-SGPT O O
16 O O
(10-55) O O
U/L O O
Amylase O O
16 O O
(3-100) O O
units/L O O
Lipase O O
2.5 O O
(1.3-6.0) O O
U/dl O O
Transaminase-SGOT O O
28 O O
(10-40) O O
U/L O O
Creatine O O
Kinase O O
Isoenz O O
BORDERLINE O O
(NEG) O O
Troponin-I O O
NEGATIVE O O
(NEG) O O
Creatine O O
Kinase O O
Isoenz O O
13.2 O O
H O O
(0.0-6.9) O O
ng/ml O O
CPK O O
Isoenzymes O O
Index O O
12.8 O O
H O O
(0.0-3.5) O O
% O O
Troponin-T O O
0.06 O O
(0.00-0.09) O O
ng/ml O O
Creatine O O
Kinase O O
103 O O
(60-400) O O
U/L O O
Admission: O O
WBC O O
18.4 O O
H O O
(4.5-11.0) O O
th/cmm O O
HCT O O
22.2 O O
L O O
(41.0-53.0) O O
% O O
HGB O O
7.4 O O
L O O
(13.5-17.5) O O
gm/dl O O
RBC O O
2.25 O O
L O O
(4.50-5.90) O O
mil/cmm O O
PLT O O
243 O O
(150-350) O O
th/cumm O O
MCV O O
99 O O
(80-100) O O
fl O O
MCH O O
33.0 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
33.4 O O
(31.0-37.0) O O
g/dl O O
RDW O O
15.6 O O
H O O
(11.5-14.5) O O
% O O
Superstat O O
PT O O
14.0 O O
H O O
(11.1-13.1) O O
sec O O
Superstat O O
APTT O O
25.3 O O
(22.1-35.1) O O
sec O O
UA-Specific O O
Gravity O O
&lt;1.005 O O
(1.001-1.035) O O
UA-pH O O
5.0 O O
(5.0-9.0) O O
UA-WBC O O
Screen O O
NEGATIVE O O
(NEG) O O
UA-Nitrite O O
NEGATIVE O O
(NEG) O O
UA-Albumin O O
NEGATIVE O O
(NEG) O O
UA-Glucose O O
Trace O O
(NEG) O O
UA-Ketones O O
NEGATIVE O O
(NEG) O O
UA-Occult O O
Blood O O
NEGATIVE O O
(NEG) O O
WBC O O
17.2 O O
H O O
(4.5-11.0) O O
th/cmm O O
HCT O O
24.7 O O
L O O
(41.0-53.0) O O
% O O
HGB O O
8.6 O O
L O O
(13.5-17.5) O O
gm/dl O O
RBC O O
2.65 O O
L O O
(4.50-5.90) O O
mil/cmm O O
PLT O O
210 O O
(150-350) O O
th/cumm O O
MCV O O
93 O O
(80-100) O O
fl O O
MCH O O
32.5 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
35.0 O O
(31.0-37.0) O O
g/dl O O
RDW O O
16.8 O O
H O O
(11.5-14.5) O O
% O O
Studies: O O
EKG O O
AF O O
(92) O O
LAD O O
TWI O O
I,L,V6 O O
CXR O O
IMPRESSION: O O
There O O
are O O
linear O O
opacities O O
at O O
both O O
bases O O
consistent O O
with O O
subsegmental O O
atelectasis. O O
Bilateral O O
calcified O O
pleural O O
plaques O O
are O O
consistent O O
with O O
asbestos O O
exposure. O O
There O O
is O O
no O O
pneumothorax. O O
No O O
pleural O O
effusions O O
are O O
visualized. O O
There O O
is O O
extensive O O
change O O
including O O
both O O
shoulders. O O
Assessment: O O
85 O O
y/o O O
with O O
medically O O
management O O
multivessel O O
CAD O O
who O O
presents O O
with O O
light-headedness, O O
fatigue O O
and O O
anemia. O O
Likely O O
coffee O O
gound O O
emesis, O O
melana O O
and O O
increased O O
BUN O O
concerning O O
for O O
UGIB. O O
Given O O
history O O
of O O
alcohol O O
consumption O O
(suspect O O
that O O
consumption O O
may O O
be O O
slightly O O
more O O
than O O
given O O
by O O
history) O O
and O O
NSAID O O
use, O O
gastritis O O
is O O
a O O
possibility. O O
No O O
clear O O
reason O O
for O O
other O O
sources O O
of O O
UGIB. O O
Pt O O
also O O
found O O
to O O
be O O
in O O
Afib O O
of O O
unknown O O
duration. O O
Unclear O O
if O O
Afib O O
was O O
prompted O O
by O O
anemia O O
due O O
to O O
UGIB. O O
Plan: O O
1. O O
UGIB O O
a. O O
Active O O
blood O O
back O O
sample, O O
IV O O
access O O
b. O O
Hct O O
increased O O
from O O
22.2 O O
to O O
24.7 O O
after O O
2u O O
pRBCs. O O
Given O O
CAD O O
history, O O
will O O
transfuse O O
one O O
more O O
unit O O
c. O O
GI O O
consult O O
for O O
possible O O
EGD O O
(pt O O
likely O O
also O O
needs O O
colonoscopy O O
given O O
h/o O O
tubular O O
adenoma) O O
d. O O
IV O O
zantac O O
e. O O
Hold O O
aspirin O B-MEDICATION
for O O
now O O
2. O O
CV O O
a. O O
Ischemia O O
- O O
TVI O O
on O O
admission O O
on O O
ECG O O
from O O
ED. O O
Will O O
cycle O O
cardiac O O
enzymes. O O
Hold O O
aspirin O B-MEDICATION
for O O
now O O
given O O
GIB. O O
Continue O O
beta O O
blocker O O
both O O
for O O
ischemia O O
protection O O
and O O
AF O O
rate O O
control; O O
will O O
hold O O
other O O
anti-hypertensives O O
for O O
now O O
b. O O
Rhythm O O
- O O
unclear O O
duration O O
of O O
Afib O O
so O O
immediate O O
cardioversion O O
not O O
an O O
option O O
(avoid O O
TEE O O
in O O
the O O
setting O O
of O O
UGIB); O O
lopressor O B-MEDICATION
for O O
rate O O
control; O O
no O O
anticoagulation O O
for O O
now; O O
central O O
telmetry O O
c. O O
Pump O O
- O O
no O O
active O O
issues O O
3. O O
increased O O
WBC O O
a. O O
unclear O O
etiology O O
? O O
reactive O O
b. O O
Afebrile, O O
no O O
signs O O
of O O
infection; O O
will O O
follow O O
4. O O
diabetes O O
a. O O
SSI O O
John O O
Kirk, O O
MD O O
Intern O O
in O O
Medicine O O
Pager O O
92915 O O

Record O O
date: O O
2093-10-29 O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
MISSOULA B-CAD O
CLINIC O O
CENTER O O
Reason O O
for O O
visit O O
86 O O
year O O
old O O
man O O
h/o O O
type B-DIABETES O
2 I-DIABETES O
DM, I-DIABETES O
CAD B-CAD O
s/p O O
peptic O O
ulcer O O
bleed O O
and O O
MI B-CAD O
11/92. I-CAD O
History O O
of O O
present O O
illness O O
Doing O O
well- O O
no O O
complains O O
of O O
dyspnea O O
unless O O
he O O
is O O
'doing O O
a O O
lot.' O O
Able O O
to O O
walk O O
up O O
stairs O O
without O O
symptoms. O O
Weight O O
is O O
up O O
to O O
129 O O
at O O
home, O O
no O O
orthopnea, O O
PND, O O
ankle O O
swelling. O O
He O O
wakes O O
up O O
at O O
night O O
several O O
times O O
with O O
nocturia O O
or O O
restlessness. O O
Major O O
Problems O O
Coronary O O
artery O O
disease O O
s/p O O
anterior O O
MI O O
2082, O O
LAD B-CAD O
PTCA B-CAD O
2082. I-CAD O
Cath B-CAD O
90% I-CAD O
RCA, I-CAD O
occluded I-CAD O
OM2 I-CAD O
2082. I-CAD O
Echo O O
2087 O O
EF O O
=67%, O O
no O O
WMA O O
(previously O O
had O O
apical O O
dyskinesis). O O
R/I'd O O
for O O
NSTEMI O O
(TnT O O
1.35) O O
in O O
setting O O
of O O
4 O O
U O O
GI O O
Bleed O O
(11/92), O O
complicated O O
by O O
CHF. O O
Diabetes O O
mellitus O O
Dx O O
7/88, O O
on O O
low O O
dose O O
glucophage B-MEDICATION B-MEDICATION
with I-MEDICATION O
excellent I-MEDICATION O
control- I-MEDICATION O
d/c'd I-MEDICATION O
10/91 I-MEDICATION O
when O O
HbA1C O O
all O O
wnl. O O
Urine O O
alb O O
slightly O O
high O O
at O O
36 O O
(10/92). O O
After O O
MI, O O
HbA1C B-DIABETES O
inc I-DIABETES O
to I-DIABETES O
7.9% I-DIABETES O
(12/92), I-DIABETES O
now O O
down O O
to O O
6.8%. O O
Lately O O
he O O
has O O
not O O
been O O
adherent O O
to O O
diet O O
(ice O O
cream, O O
cake, O O
etc). O O
Other O O
Problems O O
Myocardial O O
infarction O O
(anterior O O
wall) O O
- O O
Inactivated O O
see O O
CAD O O
Patient O O
fall O O
- O O
Inactivated O O
Active O O
Medications O O
atenolol B-MEDICATION B-MEDICATION
100mg O O
po O O
qd O O
aspirin B-MEDICATION B-MEDICATION
81mg O O
po O O
qd O O
furosemide O O
20 O O
mg O O
po O O
2-3 O O
tabs O O
daily O O
lisinopril B-MEDICATION B-MEDICATION
2.5 O O
mg O O
po O O
qd O O
nitroglycerin B-MEDICATION B-MEDICATION
0.3mg O O
AS O O
DIRECTED O O
multivitamins O O
Lipitor B-MEDICATION B-MEDICATION
10mg O O
po O O
qd O O
lidocaine O B-MEDICATION
5% O O
ointment O O
apply O O
to O O
rectum O O
4x O O
daily O O
prn O O
Family O O
history O O
No O O
cancer, O O
one O O
sister O O
living O O
age O O
84, O O
2 O O
other O O
sisters O O
in O O
late O O
80's- O O
one O O
in O O
Oklahoma, O O
one O O
in O O
New O O
Hamp.. O O
. O O
Social O O
history O O
Married, O O
4 O O
daughters O O
from O O
previous O O
marriage. O O
3 O O
sons O O
each O O
killed O O
in O O
separate O O
MVA. O O
Former B-SMOKER O
smoker I-SMOKER O
quit I-SMOKER O
20 I-SMOKER O
years I-SMOKER O
ago, I-SMOKER O
(+) O O
EtOH. O O
11 O O
grandchildren, O O
8 O O
GGC O O
Review O O
of O O
systems O O
As O O
above, O O
no O O
abdominal O O
pain, O O
no O O
N/V. O O
No O O
complaints O O
of O O
constipation O O
or O O
rectal O O
pain. O O
No O O
BRBPR. O O
Urination O O
as O O
above. O O
Physical O O
examination O O
Pulse O O
64 O O
Blood O O
pressure O O
130/68 O O
Weight O O
129 O O
Neck O O
carotids O O
1+, O O
JVP O O
6 O O
cm, O O
no O O
nodes, O O
thyroid O O
non O O
palpable O O
Chest O O
CTA, O O
except O O
few O O
crackles O O
L O O
&gt; O O
R O O
Cor O O
RRR, O O
normal O O
s1, O O
split O O
s2, O O
no O O
murmur O O
Abdomen O O
soft O O
NT O O
Extrem O O
1+ O O
edema, O O
radial O O
pulses O O
2+, O O
popliteal/DP O O
1+, O O
DJD O O
at O O
base O O
of O O
1st O O
MC O O
right O O
Assessment O O
and O O
plan O O
1. O O
CAD: O O
s/p O O
MI, O O
CHF O O
seems O O
well O O
controlled O O
at O O
this O O
time. O O
Class O O
II. O O
Continue O O
furosemide O O
at O O
40 O O
mg O O
po O O
qd. O O
Call O O
with O O
increased O O
weight. O O
Continue O O
BB, O O
statin, O O
ACEI O O
and O O
ASA. O B-MEDICATION
Last O O
LDL O O
55 O O
(10/92)- O O
check O O
again O O
today. O O
2. O O
PUD: O O
s/p O O
Rx O O
for O O
H. O O
pylori, O O
completed O O
4 O O
weeks O O
of O O
PPI. O O
Resolved O O
3. O O
DM: O O
HbA1C B-DIABETES O
6.8%, I-DIABETES O
no O O
meds- O O
check O O
today. O O
Needs O O
to O O
adhere O O
to O O
diet. O O
4. O O
HCM: O O
Fluvax O O
when O O
available, O O
did O O
not O O
want O O
c-scope. O O
Selected O O
recent O O
labs O O
CMP/Chol/CBC/HbA1C O O
Disposition O O
RTC O O
3 O O
months O O
Signed O O
electronically O O
by O O
Eggleston, O O
William O O
on O O
Jan O O
31, O O
2094 O O

Record O O
date: O O
2096-03-16 O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
MISSOULA B-CAD O
CLINIC O O
CENTER O O
Reason O O
for O O
visit O O
88 O O
year O O
old O O
man O O
h/o O O
type B-DIABETES O
2 I-DIABETES O
DM, B-DIABETES O
CAD B-CAD O
here O O
for O O
follow O O
up O O
History O O
of O O
present O O
illness O O
He O O
missed O O
his O O
last O O
appointment, O O
but O O
today O O
he O O
states O O
that O O
he O O
has O O
been O O
feeling O O
fine. O O
He O O
reports O O
no O O
chest O O
pain, O O
no O O
dyspnea, O O
no O O
palpitations, O O
no O O
orthopnea, O O
no O O
PND. O O
He O O
is O O
ambulating O O
around O O
the O O
house O O
without O O
a O O
problem. O O
He O O
has O O
some O O
occasional O O
leg O O
pains, O O
but O O
he O O
now O O
takes O O
acetaminophen O O
instead O O
of O O
nitroglycerin. B-MEDICATION B-MEDICATION
He O O
reports O O
no O O
recent O O
ankle O O
swelling, O O
because O O
he O O
states O O
that O O
he O O
elevates O O
his O O
legs. O O
He O O
cares O O
for O O
his O O
wife- O O
doing O O
chores O O
around O O
the O O
house, O O
such O O
as O O
washing O O
dishes O O
or O O
making O O
the O O
bed. O O
The O O
only O O
thing O O
he O O
reports O O
being O O
unable O O
to O O
do O O
is O O
lifting O O
arms O O
over O O
his O O
head O O
(old O O
problem). O O
Major O O
Problems O O
Coronary O O
artery O O
disease O O
s/p B-CAD O
anterior I-CAD O
MI I-CAD O
2082, I-CAD O
LAD B-CAD O
PTCA B-CAD O
2082. I-CAD O
Cath B-CAD O
90% B-CAD O
RCA, I-CAD O
occluded I-CAD O
OM2 I-CAD O
2082. I-CAD O
Echo O O
2087 O O
EF O O
=67%, O O
no O O
WMA O O
(previously O O
had O O
apical O O
dyskinesis). O O
R/I'd O O
for O O
NSTEMI O O
(TnT O O
1.35) O O
in O O
setting O O
of O O
4 O O
U O O
GI O O
Bleed O O
(11/92), O O
complicated O O
by O O
CHF. O O
Last O O
LDL O O
59 O O
on O O
lovastatin. B-MEDICATION B-MEDICATION
Osteoarthritis O O
Severe O O
DJD O O
of O O
bilat O O
shoulder O O
-limited O O
abduction O O
80 O O
degrees. O O
No O O
significant O O
symptoms. O O
Seen O O
by O O
Dr. O O
Etheridge O O
in O O
past. O O
Diabetes O O
mellitus O O
Dx O O
7/88, O O
on O O
low B-MEDICATION O
dose I-MEDICATION O
glucophage B-MEDICATION B-MEDICATION
with I-MEDICATION O
excellent I-MEDICATION O
control- I-MEDICATION O
d/c'd I-MEDICATION O
10/91 O O
when O O
HbA1C O O
all O O
wnl. O O
Urine O O
alb O O
slightly O O
high O O
at O O
71 O O
(8/94). O O
HbA1C B-DIABETES O
up I-DIABETES O
to I-DIABETES O
8.0%- I-DIABETES O
started O O
on O O
glyburide. B-DIABETES B-MEDICATION
Last I-DIABETES O
check I-DIABETES O
6.7% I-DIABETES O
Active O O
Medications O O
aspirin B-MEDICATION B-MEDICATION
81mg O O
po O O
qd O O
atenolol B-MEDICATION B-MEDICATION
100mg O O
po O O
qd O O
furosemide O O
20 O O
mg O O
po O O
2-3 O O
tabs O O
daily O O
glyburide O B-MEDICATION
1.25mg O O
po O O
qd O O
take O O
with O O
breakfast O O
or O O
first O O
meal O O
lisinopril B-MEDICATION B-MEDICATION
2.5 O O
mg O O
po O O
qd O O
lovastatin O B-MEDICATION
20mg O O
po O O
qpm O O
take O O
with O O
food O O
multivitamins O O
nitroglycerin O B-MEDICATION
0.3mg O O
AS O O
DIRECTED O O
Social O O
history O O
Married, O O
4 O O
daughters O O
from O O
previous O O
marriage. O O
3 O O
sons O O
each O O
killed O O
in O O
separate O O
MVA. O O
Former B-SMOKER O
smoker I-SMOKER B-MEDICATION
quit B-SMOKER O
20 I-SMOKER O
years I-SMOKER O
ago, I-SMOKER O
(+) O O
EtOH. O O
11 O O
grandchildren, O O
9 O O
GGC O O
Procedures O O
and O O
Immunizations O O
Influenza O O
vaccine O O
Received O O
11/95 O O
MLL O O
Review O O
of O O
systems O O
As O O
above, O O
no O O
abdominal O O
pain, O O
no O O
urinary O O
complaints. O O
No O O
complaints O O
of O O
constipation O O
or O O
rectal O O
pain. O O
No O O
BRBPR. O O
Nocturia O O
x O O
1-2. O O
Rest O O
negative O O
in O O
detail. O O
Physical O O
Exam O O
Blood O O
pressure O O
124/70 O O
Pulse O O
68 O O
irregular O O
Weight O O
136 O O
General O O
appearance O O
Elderly O O
man O O
appears O O
well O O
Neck O O
carotids O O
1+, O O
JVP O O
8 O O
cm, O O
no O O
nodes, O O
thyroid O O
non O O
palpable O O
Chest O O
CTA O O
except O O
right O O
greater O O
than O O
left O O
basilar O O
crackles O O
Cor O O
RRR, O O
normal O O
s1, O O
wide O O
split O O
s2, O O
no O O
murmur O O
Abdomen O O
soft O O
NT O O
no O O
masses O O
Extrem O O
No O O
edema, O O
radial O O
pulses O O
2+, O O
popliteal/DP O O
1+, O O
DJD O O
at O O
base O O
of O O
1st O O
MC O O
right O O
Selected O O
recent O O
labs O O
EKG- O O
AF O O
at O O
68, O O
new O O
RBBB, O O
LAH. O O
CMP/CBC/HbA1C O O
Urine O O
for O O
albumin O O
Assessment O O
and O O
plan O O
1. O O
AF: O O
recurrence O O
of O O
his O O
AF, O O
but O O
no O O
significant O O
CHF O O
and O O
no O O
symptoms O O
to O O
suggest O O
active O O
ischemia. O O
He O O
is O O
already O O
rate O O
controlled O O
on O O
beta O O
blocker. O O
Decision O O
to O O
anti-coagulate O O
is O O
not O O
easy. O O
On O O
one O O
hand, O O
he O O
is O O
a O O
very O O
functional O O
man. O O
On O O
the O O
other O O
hand, O O
he O O
is O O
88, O O
walks O O
with O O
a O O
cane O O
for O O
balance, O O
and O O
is O O
not O O
very O O
fond O O
of O O
frequent O O
doctors O O
visits. O O
Discussed O O
EKG O O
findings O O
and O O
anticoagulation O O
with O O
Dr. O O
Youmans, O O
his O O
cardiologist. O O
Dr. O O
Youmans O O
will O O
see O O
patient O O
next O O
week. O O
2. O O
CAD/CHF: O O
Stable- O O
Continue O O
ASA/BB/ACEI/statin. O B-MEDICATION
BP O O
OK. O O
3. O O
DM: O O
HbA1C O O
normal O O
on O O
low O O
dose O O
glyburide. O B-MEDICATION
(+) O O
microalb- O O
on O O
ACEI- O O
check O O
again O O
today. O O
4. O O
PUD: O O
no O O
recent O O
bleeding. O O
No O O
symptoms. O O
5. O O
HCM: O O
Flushot O O
11/95. O O
Declines O O
c-scope O O
(last O O
2087). O O
Disposition O O
RTC O O
3 O O
months O O
-William O O
Eggleston, O O
MD O O
pager O O
#40547 O O
Signed O O
electronically O O
by O O
William O O
Eggleston, O O
MD O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2096-06-22 O O
Eggleston, O O
William O O
Internal O O
Medicine O O
Associates, O O
Suite O O
Z O O
Internal O O
Medicine, O O
9th O O
Zloor O O
, O O
Noom O O
964 O O
Pine O O
Bluff, O O
WA, O O
63879-1383 O O
RE: O O
LEVI O O
WALTON O O
6/22/2096 O O
Admission O O
Note O O
Mr. O O
Walton O O
is O O
an O O
88 O O
year O O
old O O
man O O
h/o O O
AF, O O
CAD, B-CAD O
DM, B-DIABETES O
who O O
is O O
admitted O O
with O O
dizziness O O
and O O
back O O
pain O O
after O O
a O O
fall. O O
He O O
was O O
seen O O
one O O
week O O
ago O O
in O O
clinic, O O
and O O
appeared O O
medically O O
stable. O O
Gait O O
was O O
normal. O O
He O O
had O O
a O O
return O O
of O O
AF O O
in O O
March, O O
but O O
rate O O
was O O
controlled O O
and O O
there O O
was O O
no O O
CHF. O O
Evaluation O O
with O O
Dr. O O
Youmans O O
was O O
planned O O
this O O
week O O
for O O
? O O
start O O
anticoagulation. O O
On O O
Friday, O O
June O O
19, O O
he O O
fell O O
backwards O O
in O O
the O O
kitchen O O
while O O
at O O
the O O
sink. O O
He O O
reports O O
no O O
headache, O O
dizziness, O O
chest O O
pain, O O
dyspnea, O O
palpitations, O O
or O O
pain O O
before O O
the O O
fall. O O
He O O
struck O O
his O O
head O O
and O O
back. O O
No O O
LOC. O O
On O O
Wednesday O O
June O O
21, O O
his O O
family O O
called O O
to O O
report O O
he O O
was O O
unsteady O O
and O O
feeling O O
dizzy. O O
He O O
was O O
referred O O
to O O
the O O
MCC O O
ER. O O
Of O O
note, O O
he O O
had O O
his B-CAD O
usual B-CAD O
chest I-CAD O
pain, I-CAD O
relieved I-CAD O
with I-CAD O
one I-CAD O
SL I-CAD O
TNG I-CAD O
several O O
times O O
a O O
week. O O
He O O
did O O
take O O
one O O
SL O O
TNG O O
shortly O O
before O O
his O O
fall. O O
In O O
ER, O O
he O O
was O O
diagnosed O O
with O O
UTI O O
and O O
admitted O O
for O O
treatment O O
and O O
gait O O
evaluation. O O
PMHX: O O
1. O O
Atrial O O
fibrillation: O O
Developed O O
AF O O
during O O
11/92 O O
GI O O
bleed/MI. B-CAD O
Then O O
spontaneously O O
cardioverted. O O
Return O O
of O O
AF O O
3/96- O O
no O O
symptoms. O O
2. O O
Coronary O O
artery O O
disease: O O
s/p B-CAD O
anterior I-CAD O
MI I-CAD O
2082, I-CAD O
LAD B-CAD O
PTCA I-CAD O
2082. I-CAD O
Cath B-CAD O
90% I-CAD O
RCA, I-CAD O
occluded I-CAD O
OM2 I-CAD O
2082. I-CAD O
Echo O O
2087 O O
EF O O
=67%, O O
no O O
WMA O O
(previously O O
had O O
apical O O
dyskinesis). O O
R/I'd O O
for O O
NSTEMI O O
(TnT O O
1.35) O O
in O O
setting O O
of O O
4 O O
U O O
GI O O
Bleed O O
(11/92), O O
complicated O O
by O O
CHF. O O
Last O O
LDL O O
59 O O
on O O
lovastatin. B-MEDICATION B-MEDICATION
3. O O
Diabetes O O
mellitus: O O
Dx O O
7/88, O O
on O O
low O O
dose O O
glucophage B-MEDICATION B-MEDICATION
with I-MEDICATION O
excellent I-MEDICATION O
control- I-MEDICATION O
d/c'd I-MEDICATION O
10/91 I-MEDICATION O
when O O
HbA1C O O
all O O
wnl. O O
Urine O O
alb O O
slightly O O
high O O
at O O
71-77 O O
(3/96). O O
HbA1C B-DIABETES O
up I-DIABETES O
to I-DIABETES O
8.0%- I-DIABETES O
started O O
on O O
glyburide. B-MEDICATION B-MEDICATION
Last B-DIABETES O
check I-DIABETES O
6.5% I-DIABETES O
4. O O
Benign O O
prostatic O O
hypertrophy: O O
s/p O O
TURP O O
2086 O O
5. O O
Peptic O O
ulcer: O O
Admitted O O
with O O
GI O O
Bleed- O O
Hct O O
to O O
22, O O
EGD- O O
two O O
gastric O O
and O O
one O O
duodenal O O
ulcer O O
(11/92). O O
H. O O
pylori O O
(+) O O
- O O
treated O O
with O O
2 O O
week O O
course O O
of O O
AOC O O
and O O
one O O
month O O
PPI. O O
Medications: O O
lisinopril B-MEDICATION B-MEDICATION
2.5 O O
mg O O
po O O
qd, O O
atenolol B-MEDICATION B-MEDICATION
100mg O O
po O O
qd, O O
lovastatin O B-MEDICATION
20mg O O
po O O
qpm, O O
aspirin B-MEDICATION B-MEDICATION
81mg O O
po O O
qd, O O
nitroglycerin B-MEDICATION B-MEDICATION
0.3mg O O
PRN O O
glyburide O B-MEDICATION
1.25mg O O
po O O
qd, O O
omeprazole O O
20 O O
mg O O
po O O
bid O O
Allergies: O O
No O O
known O O
drug O O
allergy O O
Family O O
history: O O
No O O
cancer, O O
he O O
has O O
2 O O
sisters O O
in O O
their O O
80's. O O
Twin O O
brother O O
died O O
of O O
CAD O O
in O O
his O O
70's. O O
Social O O
history: O O
Married, O O
4 O O
daughters O O
from O O
previous O O
marriage. O O
3 O O
sons O O
each O O
killed O O
in O O
separate O O
MVA. O O
Former B-SMOKER O
smoker I-SMOKER O
quit B-SMOKER O
20 I-SMOKER O
years I-SMOKER O
ago, I-SMOKER O
(+) O O
EtOH- O O
1-2 O O
per O O
night. O O
11 O O
grandchildren, O O
9 O O
GGC O O
Review O O
of O O
systems: O O
As O O
above, O O
no O O
abdominal O O
pain, O O
no O O
urinary O O
complaints. O O
No O O
complaints O O
of O O
constipation O O
or O O
rectal O O
pain. O O
No O O
BRBPR. O O
Nocturia O O
x O O
1-2. O O
No O O
dysuria, O O
no O O
hematuria, O O
no O O
incontinence. O O
Rest O O
negative O O
in O O
detail. O O
Physical O O
Exam: O O
Elderly O O
man O O
appears O O
well O O
Blood O O
pressure: O O
130/70's O O
Pulse: O O
82 O O
irregular O O
Respiratory O O
rate: O O
12-16 O O
Weight: O O
136 O O
HEENT: O O
EOMI, O O
sclera O O
NI, O O
O/P O O
normal O O
Neck: O O
carotids O O
1+, O O
JVP O O
6 O O
cm, O O
no O O
nodes, O O
thyroid O O
non O O
palpable O O
Chest: O O
CTA O O
Cor: O O
Irregular, O O
normal O O
s1, O O
wide O O
split O O
s2, O O
no O O
murmur O O
Abdomen: O O
soft O O
NT O O
no O O
masses O O
Extrem: O O
No O O
edema, O O
radial O O
pulses O O
2+, O O
popliteal/DP O O
1+. O O
Limited O O
shoulder O O
abduction O O
to O O
80 O O
degrees. O O
Neuro: O O
CN O O
intact, O O
motor O O
= O O
bilateral, O O
reflexes O O
1+ O O
upper O O
and O O
lower O O
extremity. O O
Finger O O
to O O
nose O O
limited O O
by O O
shoulder O O
limits. O O
Labs: O O
Chem O O
7 O O
normal, O O
WBC O O
12.3, O O
Hct O O
36.7, O O
normal O O
LFTs, O O
TnT O O
negative O O
x O O
3, O O
TSH O O
normal. O O
EKG: O O
Af, O O
LAD, O O
RBBB, O O
old O O
inferior O O
MI, O O
No O O
ST O O
depressions O O
or O O
TWI O O
(no O O
change O O
from O O
3/96 O O
EKG) O O
Head O O
CT O O
with O O
right O O
caudate O O
nucleus O O
lacune O O
MRI/MRA: O O
small O O
chronic O O
infarct O O
in O O
the O O
right O O
caudate O O
with O O
porencephalic O O
changes. O O
Apparent O O
moderate O O
stenosis O O
at O O
the O O
origin O O
of O O
the O O
right O O
vertebral O O
artery O O
Chest O O
CT: O O
No O O
acute O O
displaced O O
fracture O O
or O O
dislocation. O O
Multiple O O
large O O
mediastinal O O
lymph O O
nodes, O O
largest O O
in O O
right O O
paratracheal O O
region. O O
Findings O O
may O O
be O O
reactive. O O
Follow O O
up O O
is O O
recommended O O
if O O
clinically O O
indicated. O O
Pleural O O
calcifications O O
with O O
associated O O
nodules, O O
also O O
seen O O
on O O
prior O O
examination. O O
Findings O O
likely O O
represent O O
asbestos O O
exposure. O O
Echo: O O
moderate O O
MR, O O
EF O O
46%, O O
inferoapical O O
HK/AK, O O
Elevated O O
RVSP O O
88 O O
A/P: O O
88 O O
year O O
old O O
man O O
s/p O O
mechanical O O
fall, O O
perhaps O O
some O O
orthostasis O O
due O O
to O O
NTG O O
or O O
postprandial O O
state. O O
He O O
looks O O
baseline. O O
Testing O O
has O O
revealed O O
a O O
number O O
of O O
abnormalities O O
but O O
do O O
not O O
think O O
this O O
is O O
directly O O
related O O
to O O
presentation. O O
1. O O
s/p O O
fall: O O
evaluate O O
with O O
PT, O O
check O O
orthostatics O O
after O O
meal. O O
Back O O
pain O O
likely O O
muscular- O O
no O O
fracture- O O
treat O O
with O O
low O O
dose O O
oxycodone O O
2. O O
UTI: O O
on O O
levofloxacin, O O
await O O
culture O O
3. O O
CAD/CHF: O O
appears O O
euvolemic, O O
ruled O O
out O O
for O O
MI. O O
Resume O O
outpatient O O
lasix O O
and O O
ACEI O O
if O O
BP O O
allows. O O
Echo O O
shows O O
Inferoapical O O
HK, O O
and O O
high O O
RV O O
pressures- O O
? O O
volume O O
overload, O O
? O O
pulmonary O O
disease. O O
Will O O
ask O O
Dr. O O
Youmans O O
to O O
advise O O
on O O
management. O O
4. O O
Chronic O O
lacunar O O
stroke: O O
already O O
on O O
ASA/statin. O B-MEDICATION
5. O O
Mediastinal O O
adenopathy: O O
no O O
work O O
up O O
in O O
hospital. O O
6. O O
DM: O O
May O O
continue O O
oral O O
agents, O O
check O O
FS O O
glucose. O O
He O O
would O O
like O O
to O O
go O O
home O O
ASAP- O O
he O O
is O O
not O O
interested O O
in O O
many O O
tests, O O
and O O
goal O O
will O O
be O O
to O O
d/c O O
home O O
with O O
services. O O
William O O
Eggleston, O O
MD O O
pager O O
#40547 O O
Signed O O
electronically O O
by O O
William O O
Eggleston, O O
MD O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2096-12-18 O O
MCC O O
Gastroenterology O O
Pedro O O
Quesnel, O O
MD O O
Gastroenterology O O
Tlake O O
1 O O
08 O O
Doncaster O O
Drive O O
Pine O O
Bluff, O O
Washington O O
63879-1383 O O
Tel O O
(Patient O O
Care): O O
945 O O
669-1044 O O
Fax: O O
778 O O
210-2105 O O
GI O O
Fellow O O
Consult O O
Note O O
Date: O O
12/18/2096 O O
Time: O O
11:00AM O O
Patient: O O
Walton, O O
Levi O O
MR#: O O
2554172 O O
GI O O
Attending: O O
Navarrete, O O
Pamela O O
DOA: O O
12/18/2096 O O
REASON O O
FOR O O
CONSULT: O O
HCT O O
drop, O O
guaiac O O
+ O O
HPI: O O
89M O O
admitted O O
on O O
12/18 O O
with O O
hypotension O O
and O O
HCT O O
drop. O O
The O O
patient O O
was O O
admitted O O
on O O
Dec O O
13th O O
and O O
seen O O
by O O
Dr. O O
Esposito O O
from O O
GI. O O
Per O O
her O O
note, O O
he O O
was O O
admitted O O
with O O
'complaints O O
of O O
vomiting O O
up O O
food O O
and O O
constant O O
chest O O
pain O O
for O O
3-4 O O
days. O O
He O O
reports O O
that O O
he O O
has O O
had O O
some O O
troubles O O
with O O
food O O
for O O
the O O
past O O
few O O
months O O
but O O
can't O O
define O O
precisely O O
what O O
the O O
troubles O O
were. O O
It O O
seems O O
that O O
he O O
intermittently O O
vomited O O
or O O
regurgitated O O
both O O
liquids O O
and O O
solids O O
and O O
had O O
a O O
sensation O O
of O O
something O O
getting O O
stuck O O
in O O
his O O
chest. O O
Over O O
the O O
last O O
3-4 O O
days O O
everything O O
he O O
ate O O
or O O
drank, O O
including O O
water, O O
would O O
come O O
up. O O
He O O
denies O O
nausea. O O
There O O
is O O
no O O
abdominal O O
pain O O
but O O
he O O
describes O O
a O O
constant O O
pain O O
across O O
his O O
chest O O
at O O
the O O
level O O
of O O
his O O
nipples O O
for O O
the O O
past O O
3-4 O O
days. O O
His O O
pain O O
is O O
currently O O
controlled. O O
He O O
denies O O
pain O O
on O O
swallowing. O O
He O O
does O O
report O O
some O O
weight O O
loss O O
but O O
is O O
unable O O
to O O
identify O O
how O O
much. O O
He O O
denies O O
any O O
new O O
neurologic O O
deficits O O
or O O
headaches. O O
A O O
barium O O
swallow O O
was O O
obtained O O
which O O
showed O O
a O O
fixed O O
narrowing O O
in O O
the O O
distal O O
esophagus. O O
He O O
has O O
a O O
hx O O
of O O
gastric O O
and O O
duodenal O O
ulcers O O
on O O
endoscopy O O
from O O
2092 O O
in O O
the O O
setting O O
of O O
NSAID O O
use. O O
He O O
had O O
a O O
normal O O
colonoscopy O O
in O O
2087.' O O
During O O
that O O
admission. O O
He O O
underwent O O
upper O O
endoscopy O O
that O O
showed O O
severe O O
esophagitis. O O
Two O O
gastric O O
ulcers O O
with O O
clean O O
bases O O
in O O
the O O
prepyloric O O
area O O
which O O
were O O
biopsied. O O
The O O
duodenum O O
was O O
normal. O O
He O O
was O O
discharged O O
on O O
December O O
15th O O
with O O
HCT O O
31.3. O O
The O O
patient O O
now O O
returns O O
with O O
HCT O O
drop O O
to O O
19 O O
and O O
hypotension. O O
He O O
reports O O
continued O O
difficulty O O
swallowing O O
and O O
some O O
nausea, O O
vomiting. O O
'Everything O O
comes O O
up.' O O
He O O
says O O
this O O
has O O
been O O
persistent O O
since O O
his O O
discharge. O O
He O O
also O O
reports O O
continued O O
black O O
stools O O
since O O
discharge O O
as O O
well. O O
No O O
clear O O
BRBPR. O O
His O O
wife O O
notes O O
one O O
episode O O
of O O
hematemesis O O
yesterday. O O
No O O
lightheadedness, O O
dizziness, O O
DOE, O O
SOB. O O
In O O
the O O
ED, O O
hypotensive O O
to O O
60's O O
/ O O
70's O O
SBP, O O
HCT O O
19, O O
his O O
ABD O O
CT O O
was O O
negative. O O
INR O O
pending. O O
He O O
was O O
started O O
on O O
pressors O O
(levophed O O
and O O
vasopressin) O O
and O O
transferred O O
to O O
the O O
MICU O O
for O O
ongoing O O
care. O O
Currently O O
the O O
patient O O
has O O
no O O
abdominal O O
pain, O O
nausea, O O
vomiting, O O
diarrhea, O O
melena, O O
or O O
BRBPR. O O
__________________________________________________________________ O O
General: O O
Denies O O
weight O O
loss, O O
fatigue, O O
fevers, O O
change O O
in O O
appetite, O O
sweats, O O
chills O O
HEENT: O O
Denies O O
headaches, O O
no O O
vision O O
complaints O O
or O O
changes, O O
no O O
nasal O O
discharge O O
or O O
epistaxis, O O
no O O
sore O O
throat, O O
no O O
neck O O
swelling O O
or O O
stiffness O O
Cardiac: O O
Denies O O
chest O O
pain, O O
palpitations, O O
arrhythmias, O O
valve O O
disease, O O
hypertension O O
Respiratory: O O
Denies O O
cough, O O
SOB, O O
DOE, O O
hemoptysis, O O
wheezing, O O
hoarseness O O
Gastrointestinal: O O
Denies O O
nausea, O O
vomiting, O O
constipation, O O
diarrhea. O O
No O O
melena O O
or O O
abdominal O O
pain O O
Neurologic: O O
Denies O O
seizures, O O
weakness, O O
numbness/tingling. O O
Musculoskeletal: O O
Denies O O
back O O
pain, O O
neck O O
pain, O O
leg O O
pain, O O
arm O O
pain O O
Hematologic: O O
as O O
per O O
HPI O O
PMHx: O O
Asbestosis O O
Atrial O O
fibrillation, O O
chronic, O O
no O O
anticoag O O
given O O
fall O O
risk O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Osteoarthritis O O
Benign O O
prostatic O O
hypertrophy O O
Cerebrovascular O O
accident O O
MEDICATIONS: O O
Home O O
Meds: O O
lisinopril B-MEDICATION B-MEDICATION
2.5 O O
mg O O
po O O
daily O O
atenolol B-MEDICATION B-MEDICATION
100mg O O
po O O
daily O O
lovastatin B-MEDICATION B-MEDICATION
20mg O O
po O O
qpm O O
take O O
with O O
food O O
omeprazole O O
20 O O
mg O O
po O O
daily O O
Lasix O O
20 O O
mg O O
po O O
daily O O
1-2 O O
tabs O O
daily O O
aspirin B-MEDICATION B-MEDICATION
81mg O O
po O O
daily O O
Current O O
Medications: O O
Vanco O O
Flagyl O O
Meropenem O O
Albuterol O O
Atrovent O O
Vasopressin O O
norepinephrine O B-MEDICATION
Insulin B-MEDICATION O
Nexium O O
IV O O
ALLERGIES: O O
NKDA O O
FAMILY O O
HISTORY: O O
No O O
cancer, O O
he O O
has O O
2 O O
sisters O O
in O O
their O O
80's. O O
Twin O O
brother O O
died O O
of O O
CAD O O
in O O
his O O
70's. O O
SOCIAL O O
HISTORY: O O
Married, O O
lives O O
w/ O O
his O O
wife O O
independently O O
though O O
less O O
active O O
recently. O O
Tobacco: O O
smoked B-SMOKER O
from I-SMOKER O
age I-SMOKER O
7 I-SMOKER O
to I-SMOKER O
15, I-SMOKER O
has I-SMOKER O
not I-SMOKER O
smoked I-SMOKER O
since I-SMOKER O
15. I-SMOKER O
EtOH: O O
Drinks O O
1-2 O O
black O O
Russians O O
per O O
day, O O
previously O O
slightly O O
more O O
(vodka) O O
PHYSICAL O O
EXAM: O O
T O O
P O O
75 O O
BP O O
98/56 O O
(on O O
pressors) O O
RR O O
16 O O
O2 O O
sat O O
99% O O
on O O
2L O O
Gen: O O
NAD O O
HEENT: O O
conjunctiva O O
pale, O O
no O O
appreciable O O
scleral O O
icterus, O O
PERRLA O O
NECK: O O
supple, O O
no O O
LAD O O
Resp: O O
CTAB O O
CV: O O
RRR. O O
no O O
r/g/m O O
ABD: O O
soft, O O
NT/ND, O O
no O O
HSM, O O
no O O
fluid O O
wave O O
appreciated, O O
no O O
masses, O O
NABS O O
Skin: O O
no O O
apparent O O
jaundice O O
EXT: O O
no O O
c/c/e O O
Rectal: O O
guaiac O O
+ O O
LABS:Date/Time O O
NA O O
K O O
CL O O
CO2 O O
12/18/2096 O O
136 O O
4.2 O O
97 O O
(L) O O
16.9 O O
(L) O O
Date/Time O O
BUN O O
CRE O O
GLU O O
12/18/2096 O O
64 O O
(H) O O
1.7 O O
(H) O O
245 O O
(H) O O
Date/Time O O
LACT O O
AMY O O
LIPS O O
12/18/2096 O O
9.3 O O
(H) O O
12/18/2096 O O
19 O O
24 O O
Date/Time O O
ALT/SGPT O O
AST/SGOT O O
ALKP O O
TBILI O O
12/18/2096 O O
18 O O
63 O O
(H) O O
67 O O
0.6 O O
Date/Time O O
DBILI O O
12/18/2096 O O
0.4 O O
Date/Time O O
WBC O O
HCT O O
MCV O O
PLT O O
12/18/2096 O O
14.3 O O
(H) O O
19.5 O O
(L) O O
108 O O
(H) O O
247 O O
12/15/2096 O O
9.0 O O
31.3 O O
(L) O O
104 O O
(H) O O
196 O O
STUDIES: O O
Dec O O
13th O O
EGD O O
Impression: O O
- O O
LA O O
Grade O O
D O O
esophagitis. O O
It O O
could O O
represent O O
reflux O O
esophagitis, O O
Barrett's O O
esophagitis O O
or O O
underlying O O
malignancy. O O
Biopsied. O O
- O O
Two O O
gastric O O
ulcers O O
with O O
clean O O
bases O O
in O O
the O O
prepyloric O O
area O O
which O O
were O O
biopsied. O O
- O O
Normal O O
examined O O
duodenum. O O
IMPRESSION: O O
89M O O
with O O
PMH O O
gastric O O
ulcers O O
and O O
severe O O
esophagitis O O
who O O
returns O O
with O O
HCT O O
drop. O O
In O O
the O O
setting O O
of O O
guaiac O O
positive O O
stool, O O
he O O
may O O
have O O
bleeding O O
from O O
his O O
gastric O O
ulcers O O
or O O
from O O
the O O
severe O O
esophagitis O O
that O O
was O O
seen O O
endoscopically O O
last O O
week. O O
He O O
may O O
have O O
a O O
visible O O
vessel O O
at O O
the O O
ulcer O O
site. O O
Alternatively, O O
he O O
may O O
have O O
a O O
Mallory-Weiss O O
Tear O O
from O O
the O O
wretching O O
due O O
to O O
persistent O O
nausea O O
and O O
vomiting. O O
RECOMMENDATIONS: O O
1. O O
Please O O
make O O
Patient O O
NPO O O
2. O O
Please O O
ensure O O
two O O
large O O
bore O O
IV's O O
are O O
in O O
place O O
3. O O
Active O O
Type O O
and O O
Cross O O
4. O O
HCT O O
checks O O
TID O O
5. O O
IV O O
PPI O O
6. O O
Plan O O
EGD O O
today O O
once O O
resuscitated7. O O
7. O O
Please O O
check O O
INR O O
and O O
reverse O O
if O O
needed. O O
With O O
an O O
elevated O O
lactate, O O
he O O
may O O
be O O
septic. O O
Thank O O
you O O
for O O
allowing O O
us O O
to O O
participate O O
in O O
this O O
patient's O O
care. O O
Please O O
page O O
with O O
any O O
additional O O
questions. O O
Attending O O
to O O
Staff. O O
____________________________ O O
Pedro O O
Quesnel, O O
MD O O
GI O O
Fellow O O
MCC O O
Gastroenterology O O
Pager O O
04401 O O

Record O O
date: O O
2070-01-05 O O
January O O
5, O O
2070 O O
Matthew O O
Wyatt, O O
M.D. O O
Notre O O
Dame O O
Nursing O O
Home O O
4379 O O
New O O
Street O O
Hyannis, O O
NV O O
21113 O O
Re: O O
William O O
Potts O O
MR# O O
109-16-75-8 O O
Dear O O
Matt: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
Mr. O O
Potts O O
in O O
follow O O
up O O
today. O O
As O O
you O O
know, O O
he O O
recently O O
had O O
a O O
complicated O O
hospital O O
course. O O
He O O
underwent O O
cardiac B-CAD O
catheterization, I-CAD O
which I-CAD O
revealed I-CAD O
serial I-CAD O
stenoses I-CAD O
of I-CAD O
the I-CAD O
LAD I-CAD O
including I-CAD O
70% I-CAD O
and I-CAD O
90% I-CAD O
stenoses. I-CAD O
The O O
first O O
marginal O O
branch O O
had O O
a O O
60% O O
ostial O O
stenosis. O O
The O O
right O O
coronary O B-CAD
artery O I-CAD
had O O
60 O O
and O O
80% O O
stenoses, O O
respectively. O O
The O O
PDA O O
had O O
a O O
70% O O
narrowing. O O
Given O O
his O O
very O O
significant O O
wish O O
not O O
to O O
have O O
bypass O O
surgery, O O
it O O
was O O
decided O O
to O O
proceed O O
with O O
angioplasty B-CAD O
of I-CAD O
the I-CAD O
right I-CAD O
coronary I-CAD O
artery I-CAD O
as I-CAD O
well I-CAD O
as I-CAD O
the I-CAD O
obtuse I-CAD O
marginal. I-CAD O
It O O
was O O
felt O O
that O O
the O O
LAD O O
was O O
a O O
small O O
vessel, O O
and O O
not O O
worth O O
going O O
after O O
at O O
this O O
time. O O
The O O
RCA B-CAD O
was I-CAD O
successfully I-CAD O
stented, B-CAD O
but O O
was O O
complicated O O
by O O
occlusion O O
of O O
the O O
posterior O O
left O O
ventricular O O
branch. O O
By O O
the O O
end O O
of O O
the O O
procedure, O O
flow O O
had O O
been O O
restored O O
to O O
some O O
degree O O
to O O
the O O
posterior O O
left O O
ventricular O O
branch, O O
but O O
Mr. O O
Potts O O
rule B-CAD O
in I-CAD O
for I-CAD O
a I-CAD O
small I-CAD O
subendocardial I-CAD O
myocardial I-CAD O
infarction. I-CAD O
Due O O
to O O
the O O
closure O O
of O O
the O O
left O O
posterior O O
ventricular O O
branch, O O
the O O
obtuse O O
marginal O O
branch O O
was O O
not O O
dilated. O O
Mr. O O
Potts O O
underwent O O
two O O
exercise O O
tests O O
post O O
procedure. O O
The O O
second O O
exercise O O
test O O
was O O
performed O O
with O O
MIBI O O
imaging. O O
He O O
exercised O O
for O O
nine O O
minutes O O
on O O
a O O
submaximal O O
Bruce O O
protocol, O O
and O O
experienced O O
chest B-CAD O
pain. I-CAD O
He O O
had O O
a O O
maximal O O
blood O O
pressure O O
of O O
148/72 O O
and O O
a O O
heart O O
rate O O
of O O
121. O O
MIBI B-CAD O
images I-CAD O
revealed I-CAD O
a I-CAD O
small I-CAD O
nontransmural I-CAD O
myocardial I-CAD O
infarction I-CAD O
of I-CAD O
the I-CAD O
basal I-CAD O
1/3 I-CAD O
of I-CAD O
the I-CAD O
inferior I-CAD O
wall. I-CAD O
There B-CAD O
was I-CAD O
moderate I-CAD O
to I-CAD O
severe I-CAD O
ischemia I-CAD O
of I-CAD O
the I-CAD O
inferolateral I-CAD O
territory I-CAD O
in I-CAD O
the I-CAD O
territory I-CAD O
of I-CAD O
the I-CAD O
RCA. I-CAD O
Given O O
these O O
findings, O O
it O O
was O O
highly O O
recommended O O
that O O
Mr. O O
Potts O O
undergo O O
bypass O O
surgery. O O
Mr. O O
Potts O O
was O O
discharged O O
on O O
aspirin, B-MEDICATION B-MEDICATION
Ticlid B-MEDICATION O
250 O O
mg O O
b.i.d., O O
Atorvastatin B-MEDICATION B-MEDICATION
20 O O
mg O O
q.h.s., O O
Atenolol B-MEDICATION B-MEDICATION
50 O O
mg O O
b.i.d., O O
Imdur B-MEDICATION B-MEDICATION
60 O O
mg O O
q.d. O O
He O O
also O O
takes O O
vitamin O O
E O O
and O O
a O O
multivitamin. O O
Of O O
note O O
is O O
that O O
Mr. O O
Potts O O
has O O
been O O
under O O
quite O O
a O O
bit O O
of O O
stress O O
recently. O O
His O O
89-year-old O O
mother O O
has O O
been O O
at O O
Whitehead O O
recovering O O
William O O
Potts O O
MR# O O
109-16-75-8 O O
-2- O O
January O O
5, O O
2070 O O
from O O
a O O
hip O O
fracture. O O
He O O
is O O
having O O
difficulty O O
arranging O O
the O O
appropriate O O
insurance O O
to O O
cover O O
her O O
medications. O O
Mr. O O
Potts O O
has O O
been O O
experiencing O O
chest O O
pain O O
since O O
discharge. O O
This O O
occurs O O
with O O
increased O O
activity, O O
and O O
is O O
relief O O
with O O
either O O
rest O O
and/or O O
1 O O
nitroglycerin. B-MEDICATION O
He O O
has O O
decreased O O
his O O
work O O
level O O
considerably, O O
and O O
is O O
relatively O O
sedentary. O O
On O O
physical O O
exam, O O
he O O
was O O
well O O
appearing O O
and O O
in O O
no O O
distress. O O
He O O
had O O
a O O
blood O O
pressure O O
of O O
112/70, O O
with O O
a O O
heart O O
rate O O
of O O
60. O O
His O O
weight O O
was O O
203 O O
pounds. O O
Chest O O
was O O
clear O O
to O O
auscultation O O
and O O
percussion. O O
Cardiac O O
exam O O
revealed O O
a O O
flat O O
JVP O O
of O O
30 O O
degrees, O O
a O O
nondisplaced O O
PMI O O
with O O
a O O
normal O O
S1 O O
and O O
S2, O O
without O O
murmurs, O O
rubs, O O
or O O
gallops. O O
Carotids O O
are O O
2+ O O
bilaterally O O
without O O
bruits. O O
His O O
abdomen O O
is O O
soft, O O
nontender. O O
There O O
is O O
no O O
organomegaly, O O
and O O
no O O
hepatojugular O O
reflux. O O
Extremities O O
are O O
without O O
edema. O O
Electrocardiogram O O
reveals O O
a O O
normal O O
sinus O O
rhythm O O
with O O
a O O
rate O O
of O O
61. O O
Intervals O O
are O O
.16/.08/.42, O O
with O O
an O O
axis O O
of O O
-10 O O
degrees. O O
There O O
are O O
flipped O O
T-waves O O
in O O
III O O
and O O
AVF. O O
I O O
did O O
not O O
have O O
an O O
old O O
electrocardiogram O O
here O O
for O O
comparison. O O
Therefore, O O
Mr. O O
Potts O O
returns O O
today O O
still O O
experiencing O O
angina B-CAD O
with O O
mild O O
exertion. O O
He O O
has O O
agreed O O
to O O
undergo O O
coronary O O
artery O O
bypass O O
surgery. O O
He O O
has O O
found O O
out O O
that O O
if O O
he O O
is O O
cleared O O
to O O
go O O
back O O
to O O
work O O
by O O
his O O
physicians, O O
that O O
the O O
Screen O O
Actor's O O
Guild O O
will O O
make O O
a O O
good O O
case O O
for O O
this. O O
There O O
has O O
been O O
precedent O O
for O O
those O O
who O O
have O O
had O O
bypass O O
surgery O O
to O O
return O O
to O O
work O O
as O O
an O O
actor. O O
Given O O
Mr. O O
Potts's O O
current O O
feeling, O O
I O O
will O O
make O O
an O O
appointment O O
with O O
Dr. O O
Earl O O
Jacob O O
as O O
soon O O
as O O
possible O O
for O O
him O O
to O O
be O O
seen O O
prior O O
to O O
scheduling O O
bypass O O
surgery. O O
It O O
is O O
somewhat O O
worrisome O O
that O O
Mr. O O
Potts O O
will O O
be O O
caring O O
for O O
his O O
89- O O
year-old O O
mother O O
at O O
home, O O
along O O
with O O
his O O
wife. O O
His O O
mother O O
currently O O
uses O O
a O O
walker, O O
and O O
I O O
have O O
warned O O
Mr. O O
Potts O O
that O O
he O O
really O O
cannot O O
exert O O
himself O O
to O O
any O O
great O O
degree O O
in O O
terms O O
of O O
helping O O
his O O
mother O O
in O O
the O O
house. O O
He O O
understands O O
this, O O
and O O
if O O
his O O
chest O O
pain O O
should O O
become O O
more O O
frequent, O O
intense, O O
or O O
prolonged, O O
he O O
will O O
immediately O O
call O O
me. O O
If O O
Mr. O O
Potts O O
is O O
not O O
scheduled O O
for O O
surgery, O O
I O O
will O O
see O O
him O O
in O O
two O O
weeks O O
at O O
NDNH. O O
With O O
best O O
regards. O O
Sincerely, O O
Olivia O O
Xing, O O
M.D. O O
Monmouth O O
Medical O O
Center O O
81 O O
Clergy O O
Street O O
Casper, O O
NV O O
33182William O O
Potts O O
MR# O O
109-16-75-8 O O
-3- O O
January O O
5, O O
2070 O O
DD: O O
01/05/70 O O
DT: O O
01/06/70 O O
DV: O O
01/05/70 O O
cc: O O
Earl O O
Jacob, O O
M.D. O O
Cardiac O O
Surgery O O
Laurel O O
Regional O O
Hospital O O
96 O O
Clergy O O
Street O O
Casper, O O
NV O O
33182 O O
******** O O
Approved O O
but O O
not O O
reviewed O O
by O O
Attending O O
Provider O O
******** O O

Record B-SMOKER O
date: O O
2073-09-28 O O
59 O O
y/o O O
male O O
for O O
f/u: O O
1) O O
BP O O
- O O
No O O
CP, O O
SOB, O O
pedal O O
edema O O
2) O O
low O O
HDL O O
- O O
walking O O
daily O O
3) O O
ED O O
- O O
Viagra O O
working O O
well O O
at O O
50 O O
mg O O
4) O O
hi O O
LDL O O
- O O
continues O O
Lipitor B-MEDICATION B-MEDICATION
w/o O O
muscle O O
pain O O
O/E O O
Looks O O
well. O O
BLOOD O O
PRESSURE O O
120/70 O O
wt O O
218 O O
HR O O
68 O O
reg O O
chest O O
- O O
CTA O O
ext O O
- O O
no O O
edema O O
A/P O O
1) O O
BP O O
- O O
good O O
control O O
2) O O
low O O
HDL O O
- O O
much O O
time O O
spent O O
discussing O O
lifestyle O O
treatment. O O
Has O O
increased O O
exercise O O
to O O
walking O O
but O O
wght O O
unchanged O O
&gt; O O
will O O
increase O O
exercise O O
3) O O
ED O O
- O O
no O O
change O O
4) O O
hi O O
LDL O O
- O O
good O O
control. O O
No O O
change O O

Record B-SMOKER O
date: O O
2074-08-02 O O
Notre O O
Dame O O
Nursing O O
Home O O
1992 O O
Madera O O
Circle O O
Potts, O O
William O O
Hyannis, O O
NV O O
21113 O O
10916758 O O
(391) O O
643-6925 O O
08/02/74 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Mr. O O
Potts O O
is O O
a O O
60 O O
year O O
old O O
male O O
who O O
comes O O
for O O
follow O O
up O O
of O O
hypertension, B-HYPERTENSION B-HYPERTENSION
hyperlipidemia B-HYPERLIPIDEMIA O
and O O
other O O
medical O O
problems. O O
1. O O
Hypertension. O B-HYPERTENSION
Continues O O
on O O
medications O O
without O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
or O O
pedal O O
edema. O O
2. O O
Hyperlipidemia. O O
Continues O O
on O O
medication. O O
No O O
myalgias.. O O
3. O O
Erectile O O
disorder. O O
He O O
has O O
run O O
out O O
of O O
Viagra, O O
which O O
continues O O
to O O
work O O
well O O
at O O
50 O O
mg O O
dose. O O
Would O O
like O O
more. O O
4. O O
Low O O
HDL. O O
He O O
has O O
not O O
been O O
taking O O
Lopid O B-MEDICATION
for O O
the O O
past O O
2 O O
months O O
because O O
his O O
prescription O O
ran O O
out O O
and O O
has O O
had O O
difficulty O O
getting O O
in O O
here O O
to O O
have O O
it O O
renewed. O O
5. O O
Anxiety. O O
He O O
has O O
not O O
had O O
any O O
further O O
unpredictable O O
attacks O O
of O O
anxiety. O O
He O O
did O O
recently O O
use O O
some O O
lorazepam O B-MEDICATION
when O O
he O O
had O O
to O O
fly, O O
but O O
not O O
at O O
any O O
other O O
times. O O
6. O O
Seasonal O O
allergies. O O
Episodic O O
rhinitis O O
and O O
pruritus. O O
Needs O O
more O O
Claritan O O
MEDICATIONS: O O
Viagra, O O
lorazepam O B-MEDICATION
0.5 O O
mg O O
t.i.d. O O
p.r.n., O O
atenolol B-MEDICATION B-MEDICATION
50 O O
mg O O
q.d., O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
mg O O
q.d., O O
aspirin B-MEDICATION B-MEDICATION
q.d., O O
diltiazem B-MEDICATION O
extended O O
release O O
180 O O
mg O O
q.d., O O
and O O
Claritin-D O O
24-Hour O O
1 O O
p.o. O O
q.d. O O
p.r.n. O O
REVIEW O O
OF O O
SYSTEMS: O O
As O O
above O O
and O O
no O O
nausea, O O
vomiting, O O
dysuria, O O
or O O
leg O O
pain. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
appears O O
well. O O
Blood O O
pressure O O
126/76, O O
weight O O
224 O O
pounds, O O
heart O O
rate O O
72 O O
and O O
regular. O O
Chest: O O
Clear O O
to O O
percussion O O
and O O
auscultation. O O
Cardiovascular O O
exam: O O
Notable O O
for O O
1/6 O O
holosystolic O O
murmur O O
at O O
the O O
lower O O
left O O
sternal O O
border O O
to O O
the O O
apex. O O
Abdominal O O
exam: O O
No O O
masses, O O
tenderness, O O
or O O
organomegaly. O O
Extremities: O O
No O O
edema. O O
ASSESSMENT O O
AND O O
PLAN: O O
1. O O
Hypertension. O B-HYPERTENSION
Good O O
control, O O
no O O
change O O
in O O
therapy. O O
2. O O
Hyperlipidemia. O O
He O O
did O O
not O O
return O O
for O O
fasting O O
lipid O O
analysis. O O
Will O O
continue O O
medication O O
at O O
present O O
level O O
and O O
again O O
ask O O
him O O
to O O
return O O
for O O
fasting O O
exam. O O
3. O O
Erectile O O
disorder. O O
Viagra O O
refilled. O O
4. O O
Low O O
HDL. O O
I O O
will O O
try B-MEDICATION O
Niaspan I-MEDICATION O
sustained O O
release O O
1500 O O
mg O O
p.o. O O
q.d. O O
I O O
discussed O O
flushing O O
sensation. O O
I O O
asked O O
him O O
to O O
take O O
it O O
at O O
bedtime. O O
If O O
the O O
flushing O O
sensation O O
gets O O
to O O
be O O
a O O
problem, O O
I O O
encouraged O O
him O O
to O O
take O O
it O O
in O O
the O O
morning O O
about O O
half O O
an O O
hour O O
after O O
he O O
takes O O
his O O
aspirin. O B-MEDICATION
5. O O
Anxiety. O O
Improved. O O
6. O O
Seasonal O O
allergies. O O
Renewed O O
Claritin O O
prescription. O O
In O O
addition O O
to O O
above O O
prescriptions, O O
renewed O O
all O O
other O O
chronic O O
prescriptions O O
as O O
well. O O
______________________________ O O
Matthew O O
H. O O
Wyatt, O O
M.D. O O
eScription O O
document:8-959314 O O
AFFocus O O
DD: O O
08/02/74 O O
DT: O O
08/03/74 O O
DV: O O
08/02/74 O O

Record O O
date: O O
2077-03-31 O O
Notre O O
Dame O O
Nursing O O
Home O O
1410 O O
Madera O O
Circle O O
POTTS, O O
WILLIAM O O
Hyannis, O O
NV O O
21113 O O
10916758 O O
(391) O O
643-6925 O O
03/31/2077 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Mr. O O
Potts O O
is O O
a O O
60-year-old O O
male O O
who O O
comes O O
for O O
annual O O
review O O
and O O
follow O O
up O O
of O O
medical O O
problems. O O
1. O O
Hypertension. B-HYPERTENSION O
No O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
or O O
pedal O O
edema. O O
2. O O
Hypercholesterolemia. B-HYPERLIPIDEMIA O
Recent O O
fasting O O
lipid O O
analysis O O
shows O O
total O O
cholesterol O O
of O O
118, O O
triglycerides O O
of O O
121, O O
LDL O O
61, O O
HDL O O
33. O O
3. O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
status B-CAD O
post I-CAD O
CABG I-CAD O
2070. I-CAD O
He O O
has O O
a O O
stable O O
pattern O O
of O O
dyspnea O O
with O O
exercise. O O
No O O
significant O O
chest O O
pain. O O
4. O O
Prostate O O
CA. O O
He O O
has O O
begun O O
prostatic O O
brachytherapy O O
four O O
months O O
ago. O O
5. O O
Depression. O O
He O O
needs O O
to O O
arrange O O
follow O O
up O O
with O O
our O O
counseling O O
department. O O
6. O O
Benign O O
prostatic O O
hypertrophy O O
and O O
bladdre O O
outlet O O
obstruction. O O
He O O
is O O
going O O
to O O
undergo O O
further O O
evaluation. O O
He O O
has O O
responded O O
well O O
to O O
medical O O
therapy. O O
MEDICATIONS: O O
Aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
daily, O O
atenolol B-MEDICATION B-MEDICATION
50 O O
mg O O
daily, O O
diltiazem B-MEDICATION B-MEDICATION
180 O O
mg O O
daily, O O
fluoxetine O O
20 O O
mg O O
daily, O O
folic O O
acid O O
1 O O
mg O O
daily, O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
mg O O
daily, O O
Naprosyn O O
500 O O
mg O O
b.i.d. O O
p.r.n., O O
terazosin O O
5 O O
mg O O
b.i.d., O O
nitroglycerin B-MEDICATION O
p.r.n. O O
ALLERGIES: O O
Sulfa O O
medications. O O
HABITS: O O
He B-SMOKER O
denies I-SMOKER O
tobacco I-SMOKER O
or O O
drug O O
use O O
and O O
drinks O O
rarely. O O
FAMILY O O
HISTORY: O O
Unchanged. O O
SOCIAL O O
HISTORY: O O
Unchanged. O O
REVIEW O O
OF O O
SYMPTOMS: O O
Notable O O
for O O
slightly O O
worsening O O
back O O
pain, O O
which O O
he O O
has O O
had O O
for O O
all O O
his O O
life O O
since O O
trauma O O
as O O
a O O
youth. O O
The O O
pain O O
is O O
most O O
noticeable O O
after O O
standing O O
for O O
a O O
long O O
period O O
of O O
time. O O
No O O
nocturnal O O
back O O
pain. O O
No O O
significant O O
weight O O
change, O O
febrile O O
signs O O
or O O
symptoms, O O
headache, O O
blurred O O
vision, O O
tinnitus, O O
chest O O
pain, O O
cough, O O
shortness O O
of O O
breath, O O
nausea, O O
abdominal O O
pain, O O
nightsweats, O O
diarrhea, O O
dysuria, O O
skin O O
rash, O O
bruising, O O
joint O O
pain, O O
or O O
focal O O
weakness. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
in O O
no O O
acute O O
distress. O O
Blood O O
pressure O O
108/60, O O
weight O O
224 O O
pounds, O O
height O O
69 O O
inches. O O
BMI B-OBESE O
33.1. I-OBESE O
Skin O O
exam: O O
No O O
rash. O O
Head O O
and O O
neck O O
normal. O O
Chest: O O
Clear O O
to O O
percussion O O
and O O
auscultation. O O
Cardiovascular O O
exam: O O
S4. O O
No O O
extra O O
sounds O O
or O O
murmurs. O O
Pedal O O
pulses O O
1+ O O
bilaterally. O O
Abdominal O O
exam: O O
No O O
masses, O O
tenderness, O O
or O O
organomegaly. O O
Stool O O
guaiac O O
negative. O O
GU O O
exam: O O
Both O O
testes O O
are O O
without O O
masses O O
or O O
tenderness. O O
Prostate O O
not O O
significantly O O
palpable. O O
Lymph O O
exam: O O
No O O
axillary O O
or O O
cervical O O
lymphadenopathy. O O
Musculoskeletal O O
exam O O
grossly O O
intact. O O
Bilateral O O
pes O O
planus. O O
Neuro O O
exam O O
grossly O O
intact. O O
ASSESSMENT O O
AND O O
PLAN: O O
1. O O
Hypertension. O O
Stable. O O
2. O O
Hypercholesterolemia. O O
Adequate O O
LDL O O
treatment. O O
3. O O
Coronary O O
artery O O
disease. O O
Symptomatically O O
stable O O
though O O
I O O
wish O O
he O O
had O O
better O O
exercise O O
tolerance. O O
Will O O
follow. O O
4. O O
Prostate O O
CA. O O
Under O O
treatment. O O
5. O O
Depression. O O
I O O
encouraged O O
him O O
to O O
follow O O
up O O
with O O
our O O
counseling O O
department. O O
6. O O
Prostatic O O
hypertrophy O O
and O O
outlet O O
obstruction. O O
He O O
has O O
follow O O
up O O
arranged O O
with O O
Dr. O O
Uren. O O
7. O O
Low O O
HDL. O O
I O O
will O O
initiate B-MEDICATION O
treatment I-MEDICATION O
with I-MEDICATION O
Tricor. B-MEDICATION O
Previous O O
trials O O
with O O
niacin O O
failed. O O
8. O O
Pes O O
planus. O O
Not O O
symptomatically O O
a O O
problem. O O
9. O O
Low O O
back O O
pain. O O
The O O
pattern O O
has O O
been O O
stable. O O
Will O O
not O O
further O O
intervene. O O
10. O O
Obesity. B-OBESE O
I O O
discussed O O
with O O
him O O
the O O
need O O
to O O
reduce O O
weight O O
but O O
it O O
has O O
been O O
stable O O
for O O
some O O
time. O O
11. O O
Adult O O
health O O
maintenance. O O
Tetanus O O
up-to-date. O O
He O O
has O O
had O O
endoscopy. O O
Guaiac O O
cards O O
given. O O
Screening O O
blood O O
work O O
up-to-date. O O
______________________________ O O
Matthew O O
H O O
Wyatt, O O
M.D. O O
eScription O O
document:2-4489673 O O
EMS O O
DD: O O
03/31/77 O O
DT: O O
03/31/77 O O
DV: O O
03/31/77 O O

Record B-SMOKER O
date: O O
2080-03-09 O O
Notre O O
Dame O O
Nursing O O
Home O O
6250 O O
Madera O O
Circle O O
POTTS, O O
WILLIAM O O
Hyannis, O O
NV O O
21113 O O
10916758 O O
(391) O O
643-6925 O O
03/09/2080 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Mr. O O
Potts O O
is O O
a O O
65-year-old O O
male O O
who O O
comes O O
in O O
for O O
followup O O
of O O
chronic O O
kidney O O
disease O O
and O O
other O O
medical O O
problems. O O
1. O O
Chronic O O
kidney O O
disease. O O
Creatinine O O
stable O O
at O O
1.42. O O
He O O
is O O
on O O
no O O
ACE O O
inhibitor. O O
2. O O
Borderline B-DIABETES O
diabetes I-DIABETES O
mellitus. I-DIABETES O
He O O
is O O
not O O
currently O O
treated. O O
However, O O
A1c B-DIABETES O
recently I-DIABETES O
6.6. I-DIABETES O
3. O O
Low O O
HDL. O O
Recent O O
fasting O O
lipid O O
analysis O O
showed O O
total O O
cholesterol O O
121, O O
triglycerides O O
74, O O
LDL O O
85, O O
and O O
HDL O O
21. O O
4. O O
History O O
of O O
prostate O O
cancer. O O
PSA O O
less O O
than O O
assay. O O
MEDICATIONS: O O
Albuterol O O
q.i.d. O O
p.r.n., O O
atenolol B-MEDICATION B-MEDICATION
50 O O
mg O O
p.o. O O
daily, O O
diltiazem B-MEDICATION O
180 O O
mg O O
p.o. O O
daily, O O
Flomax O O
0.8 O O
mg O O
daily, O O
Flonase O O
2 O O
sprays O O
b.i.d., O O
folic O O
acid O O
2 O O
mg O O
b.i.d., O O
Lipitor B-MEDICATION B-MEDICATION
40 O O
mg O O
p.o. O O
daily, O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
p.o. O O
daily, O O
and O O
TriCor B-MEDICATION O
200 O O
mg O O
p.o. O O
daily. O O
REVIEW O O
OF O O
SYMPTOMS: O O
No O O
significant O O
weight O O
change, O O
febrile O O
signs O O
or O O
symptoms, O O
headache, O O
blurred O O
vision, O O
tinnitus, O O
chest O O
pain, O O
cough, O O
shortness O O
of O O
breath, O O
nausea, O O
abdominal O O
pain, O O
nightsweats, O O
diarrhea, O O
dysuria, O O
polyuria, O O
skin O O
rash, O O
bruising, O O
joint O O
pain, O O
or O O
focal O O
weakness. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
in O O
no O O
acute O O
distress. O O
Blood O O
pressure O O
100/60, O O
weight O O
226 O O
pounds, O O
heart O O
rate O O
68 O O
and O O
regular. O O
Chest: O O
Clear O O
to O O
percussion O O
and O O
auscultation. O O
Extremities: O O
No O O
edema. O O
ASSESSMENT O O
AND O O
PLAN: O O
1. O O
Chronic O O
kidney O O
disease. O O
This O O
remains O O
stable. O O
However, O O
he O O
should O O
be O O
on O O
an O O
ACE O O
inhibitor. O O
I O O
will O O
initiate B-MEDICATION O
lisinopril B-MEDICATION B-MEDICATION
10 O O
mg O O
p.o. O O
daily, O O
substituted O O
for O O
diltiazem. O O
2. O O
Borderline O O
glucose O O
tolerance. O O
The O O
patient O O
will O O
return O O
for O O
2 O O
hour O O
glucose O O
tolerance O O
test. O O
3. O O
Low O O
HDL. O O
Remains O O
quite O O
low O O
in O O
the O O
setting O O
of O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
despite O O
treatment. O O
We O O
will O O
continue O O
TriCor. O O
4. O O
History O O
of O O
prostate O O
cancer. O O
No O O
evidence O O
of O O
recurrence. O O
5. O O
Hypertension. B-HYPERTENSION O
Good O O
control. O O
Substitute O O
lisinopril O B-MEDICATION
for O O
diltiazem O O
as O O
noted O O
above. O O
______________________________ O O
Matthew O O
H O O
Wyatt, O O
M.D., O O
M.Sc. O O
eScription O O
document:6-0114243 O O
CSSten O O
Tel O O
DD: O O
03/09/80 O O
DT: O O
03/09/80 O O
DV: O O
03/09/80 O O

Record O O
date: O O
2078-05-31 O O
VASCULAR O O
SURGERY O O
H&P O O
Ulysses O O
Richard O O
8913196 O O
May O O
31, O O
2078 O O
Service: O O
Mosley O O
Attending: O O
Snyder O O
Fellow: O O
Allison O O
Senior: O O
Fulton O O
Junior: O O
Benitez O O
Mr O O
Richard O O
is O O
an O O
85 O O
year O O
old O O
gentleman O O
with O O
a O O
long-standing O O
history O O
of O O
peripheral O O
vascular O O
disease O O
who O O
presents O O
with O O
progressive O O
rest O O
pain O O
and O O
ischemic O O
ulceration O O
of O O
his O O
right O O
foot. O O
He O O
underwent O O
angiography, O O
but O O
no O O
lesions O O
amenable O O
to O O
percutaneous O O
intervention O O
were O O
identified. O O
He O O
presents O O
now O O
in O O
anticipation O O
of O O
a O O
distal O O
bypass O O
procedure. O O
PMH: O O
CAD B-CAD O
HTN B-HYPERTENSION O
CRI O O
(Cr O O
1.8 O O
at O O
baseline) O O
DM B-DIABETES O
PVD O O
s/p O O
left O O
fem-pop O O
(failed) O O
and O O
redo O O
left O O
fem-pop-peroneal O O
CAS O O
s/p O O
endarterectomy O O
CHF O O
Atrial O O
Fibrillation O O
Nephrolithiasis O O
Spinal O O
Stenosis O O
Meds: O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
Glyburide B-MEDICATION B-MEDICATION
10 O O
BID O O
Labetalol B-MEDICATION B-MEDICATION
200 O O
BID O O
Lisinopril B-MEDICATION B-MEDICATION
10 O O
BID O O
ASA B-MEDICATION B-MEDICATION
325 O O
Plavix B-MEDICATION B-MEDICATION
75 O O
Doxazosin O O
4 O O
Aciphex O O
20 O O
BID O O
Zocor B-MEDICATION B-MEDICATION
20 O O
NitroDur B-MEDICATION B-MEDICATION
0.2mg/hr O O
Ativan O O
0.5 O O
PRN O O
Lasix O O
40 O O
PRN O O
Vicodin O O
PRN O O
Tylenol O O
PRN O O
Zantac O O
PRN O O
Coumadin O O
Allergies: O O
ASA O O
SH: O O
never B-SMOKER O
smoked, I-SMOKER O
widower O O
PE: O O
Afebrile O O
75SR O O
132/52 O O
94% O O
RA O O
NAD O O
Chest O O
CTAB O O
Heart O O
Irreg, O O
II/VI O O
SEM O O
Abd O O
soft O O
RLE O O
with O O
ischemic, O O
but O O
clean O O
ulceration. O O
LLE O O
warm O O
without O O
lesions O O
Vasc: O O
Car O O
Rad O O
Fem O O
Pop O O
DP O O
PT O O
R O O
2+ O O
2+ O O
1+ O O
- O O
- O O
- O O
L O O
2+ O O
2+ O O
2+ O O
1+ O O
D O O
1+ O O
EKG O O
Afeb O O
PVR O O
pulsatile O O
on O O
L, O O
flat O O
on O O
R O O
CXR O O
No O O
acute O O
processes O O
Impression: O O
RLE O O
limb O O
ischemia O O
Plan: O O
OR O O
in O O
AM O O
for O O
Fem-distal O O
bypass O O
IV O O
Heparin O O
overnight O O
Consent O O
obtained O O
Richard O O
Benitez, O O
MD, O O
MPH O O
Resident O O
in O O
Surgery O O

Record B-SMOKER O
date: O O
2078-07-26 O O
Plastic O O
Surgery O O
Consult O O
Note O O
Patient: O O
Richard, O O
Ulysses O O
MRN#: O O
8913196 O O
Date O O
of O O
Consult: O O
7/26/78 O O
Chief O O
Complaint: O O
Open O O
surgical O O
wound O O
right O O
leg O O
HPI: O O
85 O O
yo O O
WM O O
w/ O O
multiple O O
medical O O
problems O O
presents O O
s/p O O
right O O
common O O
femoral O O
to O O
anterior O O
tibial O O
bypass O O
with O O
failure O O
of O O
his O O
right O O
lower O O
leg O O
surgical O O
wound O O
to O O
close. O O
He O O
has O O
peripheral O O
vascular O O
disease O O
with O O
a O O
prior O O
left O O
femoral-tibial O O
bypass O O
graft. O O
He O O
initially O O
presented O O
to O O
the O O
vascular O O
surgery O O
clinic O O
with O O
an O O
ischemic O O
ulceration O O
in O O
the O O
right O O
foot. O O
There O O
were O O
no O O
lesions O O
amenable O O
to O O
percutaneous O O
intervention O O
and O O
he O O
underwent O O
right O O
common O O
femoral O O
artery O O
to O O
distal O O
anterior O O
tibial O O
artery O O
in O O
situ O O
saphenous O O
vein O O
bypass O O
graft O O
on O O
6/01/78. O O
He O O
was O O
discharged O O
to O O
an O O
acute O O
rehabilitation O O
facility O O
on O O
6/07 O O
where O O
he O O
reports O O
initially O O
doing O O
well. O O
The O O
patient O O
was O O
readmitted O O
in O O
early O O
June O O
because O O
of O O
fevers. O O
No O O
source O O
of O O
the O O
fevers O O
were O O
determined O O
but O O
he O O
was O O
started O O
on O O
an O O
empiric O O
regimen O O
of O O
antibiotics. O O
During O O
that O O
admission, O O
every O O
other O O
staple O O
in O O
his O O
wound O O
was O O
removed. O O
The O O
patient O O
came O O
back O O
to O O
clinic O O
where O O
all O O
of O O
his O O
sutures O O
were O O
removed. O O
The O O
surgical O O
site O O
over O O
the O O
lower O O
leg O O
never O O
completely O O
healed O O
and O O
the O O
open O O
area O O
was O O
treated O O
with O O
daily O O
dressing O O
changes. O O
He O O
was O O
seen O O
in O O
clinic O O
for O O
follow-up O O
today O O
where O O
his O O
wound O O
was O O
again O O
noted O O
to O O
be O O
open O O
in O O
proximity O O
to O O
the O O
graft. O O
Plastic O O
surgery O O
is O O
consulted O O
regarding O O
closure O O
options. O O
PMH/PSH: O O
1. O O
CAD B-CAD B-MEDICATION
2. O O
HTN B-HYPERTENSION O
3. O O
CRI O O
(Cr O O
1.8 O O
at O O
baseline) O O
4. O O
DM B-DIABETES O
5. O O
PVD O O
s/p O O
left O O
fem-pop O O
(failed), O O
redo O O
left O O
fem-pop-peroneal, O O
right O O
fem-AT O O
CAS, O O
s/p O O
endarterectomy O O
6. O O
CHF O O
7. O O
Atrial O O
Fibrillation O O
8. O O
Nephrolithiasis O O
9. O O
Spinal O O
Stenosis O O
Allergies: O O
ASA O B-MEDICATION
(GI O O
intolerance) O O
Meds: O O
1. O O
Aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
p.o. O O
every O O
day. O O
2. O O
Albuterol O O
nebulizer O O
2.5 O O
mg O O
nebulized O O
q4 O O
hours O O
prn O O
wheeze. O O
3. O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
mg O O
p.o. O O
bid. O O
4. O O
Colace O O
100 O O
mg O O
p.o. O O
bid. O O
5. O O
Doxazosin O O
2 O O
mg O O
p.o. O O
qhs. O O
6. O O
Lexapro O O
10 O O
mg O O
p.o. O O
every O O
day. O O
7. O O
Nexium O O
40 O O
mg O O
p.o. O O
every O O
day. O O
8. O O
Glyburide B-MEDICATION B-MEDICATION
5 O O
mg O O
p.o. O O
bid O O
before O O
breakfast O O
and O O
before O O
supper. O O
9. O O
Vicodin O O
1 O O
tab O O
p.o. O O
q4 O O
hours O O
prn O O
pain. O O
10. B-MEDICATION O
Sliding I-MEDICATION O
scale I-MEDICATION O
insulin. I-MEDICATION B-MEDICATION
11. O O
Atrovent O O
0.5 O O
mg O O
nebs O O
qid O O
prn O O
wheeze. O O
12. O O
Ativan O O
0.5 O O
to O O
1 O O
mg O O
p.o. O O
bid O O
prn O O
anxiety. O O
13. O O
Lopressor B-MEDICATION B-MEDICATION
12.5 O O
mg O O
p.o. O O
bid. O O
14. O O
Multivitamin O O
1 O O
tab O O
p.o. O O
every O O
day. O O
15. O O
Nitro-Dur B-MEDICATION O
patch O O
0.2 O O
mg O O
per O O
hour O O
transdermal O O
every O O
day. O O
16. O O
SENNA O O
2 O O
tabs O O
p.o. O O
bid. O O
17. O O
Silvadene O O
one O O
application O O
topically O O
bid O O
to O O
wound. O O
18. O O
Zocor B-MEDICATION O
20 O O
mg O O
every O O
day. O O
19. O O
Coumadin O O
5 O O
mg O O
p.o. O O
qpm. O O
Vitals: O O
T: O O
96.9, O O
HR: O O
75, O O
BP: B-HYPERTENSION O
179/78, I-HYPERTENSION O
RR: O O
18, O O
O2 O O
sat: O O
96% O O
RA O O
Physical O O
Examination: O O
General: O O
Alert, O O
oriented, O O
NAD, O O
good O O
historian O O
Lower O O
extremities: O O
Multiple O O
well-healed O O
incisions. O O
On O O
the O O
right O O
lower O O
extremity, O O
there O O
is O O
an O O
incision O O
from O O
the O O
groin O O
to O O
the O O
foot. O O
It O O
is O O
well-healed O O
with O O
the O O
exception O O
of O O
a O O
5 O O
x O O
2 O O
cm O O
area O O
over O O
the O O
lower O O
third O O
of O O
the O O
leg O O
just O O
medial O O
to O O
the O O
tibia. O O
The O O
graft O O
is O O
palpable O O
just O O
lateral O O
to O O
the O O
area. O O
The O O
base O O
of O O
the O O
wound O O
appears O O
to O O
have O O
granulation O O
tissue. O O
No O O
odor. O O
There O O
is O O
minimal O O
erythema O O
and O O
tenderness O O
around O O
the O O
site. O O
Distal O O
pulses O O
palpable. O O
Foot O O
warm O O
and O O
well-perfused O O
but O O
with O O
no O O
sensation O O
below O O
the O O
ankle. O O
There O O
are O O
other O O
venous O O
stasis O O
ulcers O O
in O O
various O O
stages O O
of O O
healing. O O
The O O
great O O
toe O O
has O O
an O O
ulcer O O
with O O
overlying O O
eschar. O O
Relevant O O
Laboratory O O
Values: O O
Pending O O
Assessment: O O
85 O O
yo O O
WM O O
w/ O O
multiple O O
medical O O
comorbidities O O
presents O O
with O O
need O O
for O O
wound O O
coverage O O
of O O
a O O
right O O
saphenous O O
vein O O
bypass O O
graft. O O
This O O
may O O
be O O
amenable O O
to O O
local O O
flap O O
coverage. O O
Recommendations: O O
-Tentative O O
plan O O
wound O O
debridement/possible O O
flap O O
closure O O
this O O
week O O
-Will O O
discuss O O
with O O
Dr. O O
Ring O O
(covering O O
for O O
Dr. O O
Velasco) O O
and O O
plan O O
to O O
assist O O
with O O
closure. O O
-Preoperative O O
labs O O
and O O
studies O O
pending. O O
-Continue O O
daily O O
dressing O O
changes O O
for O O
now. O O
The O O
patient O O
was O O
discussed O O
with O O
Dr. O O
Uriah O O
Wills. O O
James O O
Kopp, O O
M.D. O O
PH O O
Surgery, O O
Pager O O
#: O O
79920 O O

Record O O
date: O O
2078-09-06 O O
Vascular O O
Surgery O O
H&P O O
Date O O
09/06/78 O O
Name: O O
Richard, O O
Ulysses O O
Medical O O
Record: O O
8913196 O O
Attending: O O
Snyder O O
History O O
of O O
Present O O
Illness: O O
Mr O O
Ulysses O O
is O O
an O O
85 O O
yom O O
with O O
h/p O O
PVD O O
s/p O O
multiple O O
bilateral O O
lower O O
extremity O O
revascularizations O O
and O O
a O O
non-healing O O
wound O O
on O O
the O O
RLE. O O
Most O O
recently, O O
he O O
had O O
undergone O O
Rle O O
necrotic O O
ulcer O O
debridement O O
(07/78),R O O
CFA O O
to O O
distal O O
anterior O O
tibial O O
BPG O O
on O O
05/78. O O
The O O
wound O O
was O O
overlying O O
the O O
BPG. O O
He O O
was O O
made O O
NWB O O
on O O
R, O O
with O O
VAC O O
dressing O O
applied O O
to O O
the O O
wound O O
to O O
be O O
changed O O
twice O O
weekly. O O
He O O
has O O
been O O
followed O O
in O O
clinic. O O
Though O O
he O O
was O O
noted O O
to O O
have O O
good O O
granulation O O
tissue O O
during O O
his O O
hospitalization O O
one O O
month O O
ago, O O
recently O O
his O O
wound O O
has O O
been O O
concerning O O
for O O
non-healing. O O
In O O
clinic, O O
his O O
RLE O O
is O O
ischemic, O O
and O O
there O O
is O O
a O O
concern O O
for O O
wound O O
infection. O O
The O O
patient O O
reports O O
that O O
the O O
proximal O O
aspect O O
of O O
his O O
wound O O
had O O
pregressive O O
breakdown O O
over O O
the O O
past O O
2-3 O O
weeks, O O
with O O
associated O O
increase O O
in O O
pain, O O
especially O O
with O O
VAC O O
changes. O O
He O O
says O O
that O O
he O O
could O O
no O O
longer O O
feel O O
a O O
palpable O O
graft O O
pulse O O
as O O
he O O
could O O
just O O
after O O
the O O
surgery. O O
His O O
foot O O
became O O
increasingly O O
discolored, O O
and O O
his O O
toe O O
became O O
necrotic O O
after O O
some O O
minor O O
trauma O O
without O O
response O O
to O O
silvadene. O O
No O O
fevers, O O
chills, O O
nausea, O O
vomiting. O O
Past O O
Medical O O
History: O O
CAD, B-CAD O
Htn, B-HYPERTENSION O
CRI O O
(Cr O O
1.8 O O
at O O
baseline), O O
DM, B-DIABETES O
PVD, O O
Carotid O O
Stenosis O O
s/p O O
R O O
CEA O O
3/73, O O
CHF, O O
AF, O O
Nephrolithiasis, O O
Spinal O O
Stenosis O O
Past O O
Surgical O O
History: O O
RLE O O
wound O O
debridement O O
2078 O O
R O O
CFA O O
to O O
distal O O
anterior O O
tibial O O
in-situ O O
saphenous O O
BPG O O
2078 O O
L O O
fem/pop/peroneal O O
BPG O O
redo O O
2074 O O
L O O
fem/pop O O
BPG O O
2073 O O
R O O
CEA O O
Allergies: O O
ASA B-MEDICATION B-MEDICATION
GI O O
intolerance O O
Medications: O O
Lasix O O
40 O O
po O O
qd O O
Ipatropium O B-MEDICATION
inh O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
bid O O
KCL O O
20 O O
QD O O
Zocor B-MEDICATION B-MEDICATION
20 O O
mg O O
po O O
qhs O O
Fentanyl O O
patch O O
Doxazosin O O
2mg O O
po O O
qhs O O
Nitroglycerine B-MEDICATION B-MEDICATION
patch O O
0.2mg/h O O
Lopressor B-MEDICATION B-MEDICATION
12.5 O O
po O O
bid O O
Nexium O O
40 O O
mg O O
po O O
qd O O
Lexapro O O
10 O O
mg O O
po O O
qd O O
ASA O B-MEDICATION
325 O O
mg O O
po O O
qd O O
Glyburide B-MEDICATION B-MEDICATION
5mg O O
po O O
qd O O
Percocet O O
prn O O
Ativan O O
0.5 O O
mg O O
po O O
bid O O
prn O O
Social O O
history: O O
Denies B-SMOKER O
tobacco I-SMOKER O
use I-SMOKER O
in I-SMOKER O
past I-SMOKER O
or I-SMOKER O
currently. I-SMOKER O
Alcohol O O
1 O O
glass O O
wine O O
every O O
few O O
weeks. O O
Physical O O
Exam: O O
T= O O
97.9 O O
P=101 O O
BP= O O
131/70 O O
RR= O O
16 O O
96% O O
RA O O
CV: O O
reg O O
Pulm: O O
clear O O
Pulses: O O
Femoral O O
L: O O
1+ O O
R: O O
1+ O O
Pop O O
L: O O
1+ O O
R: O O
1+ O O
DP: O O
L: O O
np O O
R: O O
np O O
PT O O
L: O O
np O O
R: O O
np O O
RLE O O
cool O O
~15cm O O
below O O
knee, O O
wound O O
of O O
medial O O
leg, O O
with O O
erythema O O
and O O
breakdown O O
healed O O
medial O O
saphenous O O
harvest O O
wound O O
foot O O
dusky, O O
poor O O
cap O O
refill, O O
necrotic O O
1st O O
toe O O
LLE O O
warm, O O
healed O O
medial O O
saphenous O O
harvest O O
wound, O O
OK O O
cap O O
refill O O
Recent O O
studies: O O
Labs: O O
Pending O O
CXR: O O
pending O O
Impression/Plan: O O
Ischemic O O
RLE O O
Admit O O
to O O
Vascular O O
Service, O O
Dr. O O
Matthew O O
Snyder O O
attending O O
Send O O
wound O O
culture, O O
start O O
vancomycin O O
empirically O O
Plan O O
for O O
R O O
BKA O O
on O O
09/08 O O
This O O
has O O
been O O
discussed O O
with O O
Dr. O O
Jackson O O
Roth, O O
Vascular O O
Surgery O O
Fellow O O
_________________________________________ O O
Julia O O
Jorgenson, O O
MD, O O
Vascular O O
surgery O O
, O O
Junior O O
Resident O O
Pager O O
04873 O O

Record O O
date: O O
2094-08-11 O O
CARDIOLOGY O O
COQUILLE O O
VALLEY O O
HOSPITAL O O
Reason O O
for O O
visit: O O
Evaluation O O
for O O
cardiac O O
catheterization O O
with O O
Dr. O O
Irvin O O
Vitale. O O
Interval O O
History: O O
Multiple O O
risk O O
factors O O
for O O
CAD B-CAD O
including O O
DM, B-DIABETES O
HTN, B-HYPERTENSION O
CRI. O O
Now O O
with O O
complaints O O
of O O
exertional O O
dyspnea O O
and O O
fatigue. O O
Progressed O O
and O O
she O O
was O O
evaluated O O
by O O
Bonnie O O
Eaves. O O
8/25 O O
Bruce O O
protocol O O
was O O
postive O O
at O O
9 O O
minutes, O O
64% O O
PMHR. O O
Complaints O O
of O O
dyspnea. O O
EKG O O
with O O
borderline O O
changes. O O
Nuclear O O
images O O
with O O
moderate O O
sized O O
defect O O
of O O
anteroapical O O
zone O O
with O O
partial O O
reperfusion. O O
Some O O
scar. O O
Mild O O
LV O O
dysfunction O O
with O O
EF O O
45-50% O O
and O O
apical O O
dyskinesis. O O
Arranged O O
for O O
elective O O
cardiac O O
catheterization O O
with O O
Dr O O
Vitale. O O
Past O O
medical O O
history: O O
CVA O O
of O O
left O O
PCA O O
territory O O
2093. O O
No O O
residual. O O
Rx O O
with O O
ASA, B-MEDICATION B-MEDICATION
folate, O O
niaspan O O
IDDM B-DIABETES O
diagnosed O O
30 O O
yrs O O
ago O O
CRI O O
with O O
creat O O
baseline O O
3.7 O O
(followed O O
by O O
Orlando O O
Ernst) O O
and O O
recent O O
eval O O
by O O
Dr O O
Ratliff O O
for O O
transplant. O O
+proteinuria O O
with O O
nephrotic O O
syndrome. O O
Donor O O
kidney O O
lined O O
up. O O
HTN O O
High B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Diabetic O O
retinopathy O O
Anemia O O
Medications: O O
Toprol B-MEDICATION B-MEDICATION
25 O O
QD O O
Diovan B-MEDICATION O
160 O O
QD O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
QD O O
Lasix O O
80 O O
QD O O
Plavix B-MEDICATION B-MEDICATION
75 O O
QD O O
ASA O B-MEDICATION
81 O O
QD O O
MVI O O
Insulin B-MEDICATION O
pump I-MEDICATION O
Vytorin O O
QD O O
Family O O
history: O O
Mom O O
A&W O O
in O O
her O O
60's O O
with O O
HTN. O O
Dad O O
A&W. O O
Social O O
history: O O
Works O O
as O O
Patternmaker O O
at O O
IMN. O O
volunteer O O
firefighter. O O
Single O O
and O O
lives O O
with O O
her O O
parents. O O
Never B-SMOKER O
smoked. I-SMOKER O
No O O
ETOH. O O
Review O O
of O O
systems: O O
no O O
peripheral O O
edema O O
currently O O
(but O O
had O O
it O O
in O O
the O O
past). O O
No O O
fever, O O
chills, O O
sweating. O O
Problems O O
with O O
gastroparesis O O
and O O
is O O
planning O O
to O O
have O O
a O O
gastric O O
pacemaker O O
inserted O O
(has O O
been O O
having O O
delayed O O
spikes O O
in O O
insulin). O O
Physical O O
examination: O O
-BP: B-HYPERTENSION O
150/100 I-HYPERTENSION O
L O O
154-90 O O
R O O
-Pulse: O O
70 O O
-resp. O O
rate: O O
16 O O
-weight: O O
153 O O
-BMI: O O
-General O O
appearance: O O
No O O
acute O O
distress. O O
-Skin: O O
No O O
rashes, O O
anicteric. O O
-Heent: O O
Unremarkable O O
-Neck: O O
Carotids O O
2+ O O
without O O
bruits. O O
JVP O O
no O O
jugular O O
venous O O
distention O O
-Chest: O O
Clear O O
to O O
auscultation O O
and O O
percussion. O O
-Cardiac: O O
Left O O
ventricular O O
impulse O O
discrete O O
and O O
nondisplaced. O O
Regular O O
rate O O
and O O
rhythm, O O
normal O O
S1 O O
and O O
S2, O O
with O O
no O O
S3 O O
or O O
S4. O O
There O O
were O O
no O O
murmurs, O O
clicks O O
or O O
rubs. O O
-Abdomen: O O
Normal O O
bowel O O
sounds, O O
soft O O
and O O
nontender, O O
with O O
no O O
hepatosplenomegaly O O
or O O
masses O O
appreciated. O O
-Extremities: O O
No O O
cyanosis, O O
clubbing O O
or O O
edema. O O
2+ O O
femoral O O
pulses O O
without O O
bruits. O O
2+ O O
pedal O O
pulses. O O
-Neuro: O O
A&O O O
x3, O O
CN O O
2-12 O O
grossly O O
intact. O O
Reflexes O O
2+ O O
and O O
symmetric O O
x O O
4 O O
extremities. O O
Toes O O
B O O
downgoing. O O
EKG: O O
Selected O O
recent O O
labs: O O
8/4/94: O O
WBC O O
7.1, O O
Crit O O
35.2, O O
Plts O O
274. O O
INR O O
0.9. O O
Na O O
139, O O
K O O
4.3, O O
Creat O O
3.4. O O
AST/ALT O O
39-30. O O
Assessment O O
and O O
plan: O O
40 O O
y.o. O O
with O O
multiple O O
risk O O
factors O O
for O O
CAD. O O
HTN, O O
high B-HYPERLIPIDEMIA O
chol, I-HYPERLIPIDEMIA O
IDDM. O O
Now O O
with O O
progressive B-CAD O
angina I-CAD O
and O O
a O O
positive O O
ETT. O O
Plan O O
for O O
cath. O O
She O O
will O O
probably O O
end O O
up O O
on O O
dialysis O O
given O O
severe O O
renal O O
failure. O O
Pretreated O O
with O O
musomyst. O O
Give O O
bicarb O O
in O O
holding O O
room. O O
Impression: O O
Further O O
plan O O
per O O
Dr O O
Vitale O O
and O O
Dr O O
Rollins. O O
Follow O O
up O O
with O O
Dr O O
Bonnie O O
Eaves. O O
Frances O O
Travis O O
Potts O O
NP O O
23119 O O
Signed O O
electronically O O
by O O
Frances O O
T O O
Potts O O
NP O O
on O O
Aug O O
11, O O
2094 O O

Record O O
date: O O
2094-12-26 O O
CARDIOLOGY O O
COQUILLE O O
VALLEY O O
HOSPITAL O O
Reason O O
for O O
visit: O O
NSTEMI B-CAD O
Interval O O
History: O O
Multiple O O
risk O O
factors O O
for O O
CAD B-CAD B-CAD
including O O
DM, B-DIABETES O
HTN, B-HYPERTENSION O
CRI. O O
Developed O O
complaints O O
of O O
exertional O O
dyspnea O O
and O O
fatigue O O
during O O
the O O
spring O O
of O O
2094. O O
Progressed O O
and O O
she O O
was O O
evaluated O O
by O O
Bonnie O O
Eaves. O O
Bruce B-CAD O
protocol I-CAD O
was I-CAD O
postive I-CAD O
at I-CAD O
9 I-CAD O
minutes, I-CAD O
64% I-CAD O
PMHR. I-CAD O
Complaints I-CAD O
of I-CAD O
dyspnea. I-CAD O
EKG I-CAD O
with I-CAD O
borderline I-CAD O
changes. I-CAD O
Nuclear I-CAD O
images I-CAD O
with I-CAD O
moderate I-CAD O
sized I-CAD O
defect I-CAD O
of I-CAD O
anteroapical I-CAD O
zone I-CAD O
with I-CAD O
partial I-CAD O
reperfusion. I-CAD O
Some I-CAD O
scar. I-CAD O
Mild I-CAD O
LV I-CAD O
dysfunction I-CAD O
with I-CAD O
EF I-CAD O
45-50% I-CAD O
and I-CAD O
apical I-CAD O
dyskinesis. I-CAD O
8/2094 B-CAD O
Admitted I-CAD O
to I-CAD O
CVH I-CAD O
for I-CAD O
elective I-CAD O
cath. I-CAD O
Cath I-CAD O
with I-CAD O
Dr I-CAD O
Vitale I-CAD O
found I-CAD O
nl I-CAD O
LM. I-CAD O
99% B-CAD O
subtotal I-CAD O
LAD I-CAD O
with I-CAD O
TIMI I-CAD O
I I-CAD O
flow. I-CAD O
Circ I-CAD O
was I-CAD O
patent. I-CAD O
RCA I-CAD O
with I-CAD O
proximal I-CAD O
30% I-CAD O
lesions I-CAD O
and I-CAD O
mid I-CAD O
80% I-CAD O
lesion. I-CAD O
Nl O O
LV O O
gram. O O
Treated B-CAD O
with I-CAD O
PTCA I-CAD O
and I-CAD O
stent B-CAD O
to I-CAD O
mid I-CAD O
LAD I-CAD O
with I-CAD O
mini-vision I-CAD O
non-drug-eluding I-CAD O
stent I-CAD O
(2.5 I-CAD O
X I-CAD O
18 I-CAD O
mm). I-CAD O
Excellent I-CAD O
results. I-CAD O
Distal I-CAD O
LAD I-CAD O
with I-CAD O
residual I-CAD O
diffuse I-CAD O
30-40% I-CAD O
lesion. I-CAD O
Plan I-CAD O
to I-CAD O
return I-CAD O
for I-CAD O
staged I-CAD O
intervention I-CAD O
to I-CAD O
RCA. I-CAD O
9/29/2094 B-CAD O
she I-CAD O
was I-CAD O
readmitted I-CAD O
for I-CAD O
elective I-CAD O
RCA I-CAD O
PCI. I-CAD O
A I-CAD O
relook I-CAD O
at I-CAD O
her I-CAD O
LAD I-CAD O
stent I-CAD O
found I-CAD O
&gt;90% I-CAD O
restenosis I-CAD O
to I-CAD O
proximal I-CAD O
edge I-CAD O
of I-CAD O
LAD I-CAD O
stent. I-CAD O
Treated B-CAD O
with I-CAD O
2.75 I-CAD O
X I-CAD O
12 I-CAD O
mm I-CAD O
TAXUS B-CAD O
stent. I-CAD O
Tolerated I-CAD O
procedure I-CAD O
well. I-CAD O
Discharged I-CAD O
the I-CAD O
following I-CAD O
day I-CAD O
with I-CAD O
creat I-CAD O
3.3. I-CAD O
Plan I-CAD O
was I-CAD O
to I-CAD O
again I-CAD O
return I-CAD O
for I-CAD O
RCA I-CAD O
PCI. I-CAD O
10/94 B-CAD O
Cath: I-CAD O
patent I-CAD O
LAD I-CAD O
stents. I-CAD O
Mid I-CAD O
RCA I-CAD O
lesion I-CAD O
treated I-CAD O
with I-CAD O
2.5 I-CAD O
X I-CAD O
13 I-CAD O
mm I-CAD O
cypher I-CAD O
stent. I-CAD O
Discharge O O
delayed O O
for O O
neurologic O O
changes O O
(LOC O O
and O O
unresponsive) O O
but O O
EEG, O O
CNIS, O O
CT, O O
all O O
without O O
new O O
infarct O O
(old O O
PCA O O
CVA). O O
12/25 O O
Developed O O
SOB O O
and O O
arrived O O
in O O
EW O O
at O O
SMM O O
with O O
chest O O
pain. O O
EKG O O
without O O
changes. O O
Trop O O
+/- O O
but O O
continued O O
to O O
have O O
chest O O
pain. O O
Given O O
previous O O
stents, O O
she O O
was O O
transferred O O
urgently O O
to O O
CVH O O
for O O
cath. O O
Past O O
medical O O
history: O O
CVA O O
of O O
left O O
PCA O O
territory O O
2093. O O
No O O
residual. O O
Rx O O
with O O
ASA, B-MEDICATION O
folate, O O
niaspan B-MEDICATION O
Complete O O
neurologic O O
evaluation O O
in O O
LOC O O
in O O
10/94 O O
and O O
previously O O
in O O
2093 O O
IDDM B-DIABETES O
diagnosed O O
30 O O
yrs O O
ago O O
on O O
insulin B-MEDICATION O
pump I-MEDICATION O
CRI O O
with O O
creat O O
baseline O O
3.7 O O
(followed O O
by O O
Orlando O O
Ernst) O O
and O O
recent O O
eval O O
by O O
Dr O O
Ratliff O O
for O O
transplant. O O
+proteinuria O O
with O O
nephrotic O O
syndrome. O O
Donor O O
kidney O O
(sister)lined O O
up. O O
No O O
date O O
for O O
transplant O O
made...needs O O
to O O
complete O O
Plavix B-MEDICATION B-MEDICATION
course O O
first. O O
HTN O O
High B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Diabetic O O
retinopathy O O
Anemia O O
Medications O O
(Confirmed): O O
Colace O O
100 O O
mg O O
po O O
qd O O
Diovan B-MEDICATION O
160mg O O
po O O
qd O O
Epogen O O
10000u O O
sc O O
sundays O O
erythromycin O O
333mg O O
po O O
TID O O
folic O O
acid O O
1 O O
mg O O
po O O
qd O O
Insulin B-MEDICATION O
pump I-MEDICATION O
iron O O
supplement O O
325mg O O
po O O
am O O
isosorbide B-MEDICATION B-MEDICATION
dinitrate I-MEDICATION O
Lasix O O
80 O O
mg O O
po O O
qd O O
multivitamins O O
1 O O
tab O O
po O O
qd O O
Niaspan B-MEDICATION O
1000mg O O
SR O O
po O O
qhs O O
Norvasc B-MEDICATION B-MEDICATION
5mg O O
po O O
q O O
pm O O
Phoslo O O
and O O
vitamin O O
B O O
1 O O
Plavix O B-MEDICATION
75mg O O
po O O
qd O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
25 I-MEDICATION O
mg I-MEDICATION O
po I-MEDICATION O
qd I-MEDICATION O
Vytorin B-MEDICATION O
10mg/80mg I-MEDICATION O
po I-MEDICATION O
qhs I-MEDICATION O
Allergies: O O
No O O
known O O
drug O O
allergy O O
Family O O
history: O O
Mom O O
A&W O O
in O O
her O O
60's O O
with O O
HTN. O O
Dad O O
A&W. O O
Sister O O
is O O
planning O O
to O O
be O O
donor O O
kidney. O O
Other O O
sister O O
is O O
back-up O O
donor. O O
Social O O
history: O O
Works O O
as O O
Patternmaker O O
at O O
IMN. O O
volunteer O O
firefighter. O O
Single O O
and O O
lives O O
with O O
her O O
parents. O O
Never B-SMOKER O
smoked. I-SMOKER O
No O O
ETOH. O O
Review O O
of O O
systems: O O
no O O
peripheral O O
edema O O
currently O O
(but O O
had O O
it O O
in O O
the O O
past). O O
No O O
fever, O O
chills, O O
sweating. O O
Problems O O
with O O
gastroparesis O O
and O O
is O O
planning O O
to O O
have O O
a O O
gastric O O
pacemaker O O
inserted O O
(has O O
been O O
having O O
delayed O O
spikes O O
in O O
insulin). O O
Physical O O
examination: O O
-BP: O O
110/50 O O
-Pulse: O O
70 O O
-resp. O O
rate: O O
16 O O
-weight: O O
153 O O
-General O O
appearance: O O
No O O
acute O O
distress. O O
-Skin: O O
No O O
rashes, O O
anicteric. O O
-Heent: O O
Unremarkable O O
-Neck: O O
Carotids O O
2+ O O
without O O
bruits. O O
JVP O O
no O O
jugular O O
venous O O
distention O O
-Chest: O O
Clear O O
to O O
auscultation O O
and O O
percussion. O O
-Cardiac: O O
Left O O
ventricular O O
impulse O O
discrete O O
and O O
nondisplaced. O O
Regular O O
rate O O
and O O
rhythm, O O
normal O O
S1 O O
and O O
S2, O O
with O O
no O O
S3 O O
or O O
S4. O O
There O O
were O O
no O O
murmurs, O O
clicks O O
or O O
rubs. O O
-Abdomen: O O
Normal O O
bowel O O
sounds, O O
soft O O
and O O
nontender, O O
with O O
no O O
hepatosplenomegaly O O
or O O
masses O O
appreciated. O O
-Extremities: O O
No O O
cyanosis, O O
clubbing O O
or O O
edema. O O
2+ O O
femoral O O
pulses O O
without O O
bruits. O O
2+ O O
pedal O O
pulses. O O
-Neuro: O O
A&O O O
x3, O O
CN O O
2-12 O O
grossly O O
intact. O O
Reflexes O O
2+ O O
and O O
symmetric O O
x O O
4 O O
extremities. O O
Toes O O
B O O
downgoing. O O
Selected O O
recent O O
labs: O O
K O O
4.4, O O
Creat O O
4.2. O O
WBC O O
7.5, O O
Creat O O
35.8, O O
Plts O O
401. O O
INR O O
0.9 O O
Assessment O O
and O O
plan: O O
40 O O
y.o. O O
with O O
multiple O O
risk O O
factors O O
for O O
CAD. O O
HTN, O O
high B-HYPERLIPIDEMIA O
chol, I-HYPERLIPIDEMIA O
IDDM. O O
Previous O O
LAD O O
stent O O
with O O
restenosis. O O
Then O O
second O O
LAD O O
stent O O
and O O
finally O O
RCA O O
stent. O O
Now O O
with O O
admit O O
for O O
NSTEMI. O O
Transferred O O
for O O
urgent O O
cath. O O
Plan O O
for O O
eventual O O
renal O O
transplant O O
at O O
CVH O O
(had O O
been O O
waiting O O
for O O
Plavix O O
to O O
be O O
completed). O O
Pre-treated O O
with O O
mucomyst. O O
Given O O
her O O
previous O O
restenosis, O O
and O O
the O O
fact O O
that O O
further O O
Plavix O O
courses O O
are O O
postponing O O
her O O
renal O O
transplant....she O O
would O O
be O O
best O O
served O O
with O O
CABG O O
if O O
she O O
has O O
restenosis. O O
Further O O
plan O O
per O O
Dr O O
Rollins O O
Follow O O
up O O
with O O
Dr O O
Eaves O O
Frances O O
Travis O O
Potts O O
NP O O
Changes O O
to O O
Medications O O
this O O
visit O O
Diovan O O
160mg O O
po O O
qd O O
Start: O O
09/28/2094 O O
Lasix O O
80 O O
mg O O
po O O
qd O O
Start: O O
09/28/2094 O O
Toprol O B-MEDICATION
XL O O
25 O O
mg O O
po O O
qd O O
Start: O O
09/28/2094 O O
just O O
increased O O
to O O
50 O O
Norvasc O B-MEDICATION
5mg O O
po O O
q O O
pm O O
Start: O O
09/28/2094 O O
Plavix O B-MEDICATION
75mg O O
po O O
qd O O
Start: O O
09/28/2094 O O
Niaspan O O
1000mg O O
SR O O
po O O
qhs O O
Start: O O
09/28/2094 O O
Vytorin O O
10mg/80mg O O
po O O
qhs O O
Start: O O
09/28/2094 O O
folic O O
acid O O
1 O O
mg O O
po O O
qd O O
Start: O O
09/28/2094 O O
Epogen O O
10000u O O
sc O O
sundays O O
Start: O O
09/28/2094 O O
multivitamins O O
1 O O
tab O O
po O O
qd O O
Start: O O
09/28/2094 O O
iron O O
supplement O O
325mg O O
po O O
am O O
Start: O O
09/28/2094 O O
Colace O O
100 O O
mg O O
po O O
qd O O
Start: O O
09/28/2094 O O
isosorbide O O
dinitrate O O
Start: O O
09/28/2094 O O
erythromycin O O
333mg O O
po O O
TID O O
Start: O O
09/28/2094 O O
for O O
gastroparesis O O
Phoslo O O
and O O
vitamin O O
B O O
1 O O
Start: O O
09/28/2094 O O
Insulin O O
pump O O
Signed O O
electronically O O
by O O
Frances O O
T O O
Potts O O
NP O O
on O O
Dec O O
26, O O
2094 O O

Record O O
date: O O
2095-07-16 O O
Transplant O O
Surgery O O
Admit O O
Note O O
Surgical O O
Attending: O O
Dr. O O
John O O
Escamilla O O
Fellow: O O
Dr. O O
Robert O O
Ivy O O
Senior O O
Resident: O O
Dr. O O
Zachary O O
Terrell O O
Intern: O O
Dr. O O
Victor O O
L. O O
Bonilla O O
MRN: O O
0658969 O O
Pt O O
Name: O O
Fagan, O O
Joanne O O
Date O O
of O O
admission: O O
7/16/95 O O
RFA: O O
Living-related O O
renal O O
transplant O O
(from O O
sister) O O
HPI: O O
The O O
patient O O
is O O
a O O
41 O O
year O O
old O O
woman O O
with O O
ESRD O O
2/2 O O
DM B-DIABETES O
nephropathy O O
here O O
for O O
living-related O O
renal O O
transplant O O
this O O
morning. O O
She O O
continues O O
to O O
make O O
urine O O
and O O
her O O
disease O O
has O O
not O O
been O O
complicated O O
by O O
UTI O O
or O O
voiding O O
dysfunction. O O
Her O O
past O O
medical O O
history O O
is O O
significant O O
for O O
CV O O
disease O O
she O O
has O O
had O O
3 B-CAD O
cardiac I-CAD O
stents I-CAD O
placed O O
since O O
2094 O O
and O O
suffered O O
an O O
ischemic O O
stroke O O
in O O
2089 O O
for O O
which O O
she O O
takes O O
Plavix. B-MEDICATION B-MEDICATION
This O O
morning, O O
she O O
denies O O
fever, O O
chills, O O
N/V/D, O O
SOB, O O
dyspnea, O O
burning O O
on O O
urination, O O
or O O
any O O
other O O
symptoms. O O
PAST O O
MEDICAL/SURGICAL O O
HISTORY: O O
IDDM B-DIABETES O
diagnosed O O
30 O O
yrs O O
ago O O
CAD: B-CAD B-CAD
8/94 O O
stent O O
to O O
mid O O
LAD, O O
9/94 O O
restenosis O O
of O O
LAD O O
taxus O O
sten O O
to O O
LADt, O B-CAD
RCA O I-CAD
stent O O
10/94 O O
12/94: O O
dyspnea O O
40% O O
in-stent O O
restenosis O O
of O O
LAD. O O
RCA O B-CAD
stent O O
patent. O O
with O O
Cypher O O
stents O O
(2) O O
to O O
RCA O O
(prox O O
and O O
distal). O O
Recent O O
TTE: O O
EF O O
77% O O
Recent O O
stress O O
test: O O
8 O O
mets, O O
mild O O
anterior O O
ischemia O O
CVA O O
of O O
left O O
PCA O O
territory O O
2093. O O
No O O
residual. O O
Rx O O
with O O
ASA, B-MEDICATION B-MEDICATION
folate, O O
niaspan O B-MEDICATION
CKD O O
HTN B-HYPERTENSION O
High B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Diabetic O O
retinopathy O O
Anemia O O
MEDICATIONS: O O
Lasix O O
80 O O
mg O O
qday O O
Toprol B-MEDICATION B-MEDICATION
25 O O
mg O O
qam O O
Vytorin B-MEDICATION O
5/40 O O
mg O O
qpm O O
Niaspan B-MEDICATION B-MEDICATION
1000 O O
mg O O
qpm O O
Folic O O
Acid O O
1 O O
mg O O
qdayEpogen O O
10,000 O O
U O O
q O O
Sunday O O
Vitamin O O
B12 O O
500 O O
mg O O
qam O O
Vitamin O O
B6 O O
100 O O
mg O O
qam O O
Colace O O
prn O O
Isosorbide B-MEDICATION B-MEDICATION
30 O O
mg O O
qam O O
Insulin B-MEDICATION O
pump I-MEDICATION O
at I-MEDICATION O
1U/hr I-MEDICATION O
( I-MEDICATION O
= I-MEDICATION O
NPH I-MEDICATION B-MEDICATION
12 I-MEDICATION O
U I-MEDICATION O
qam I-MEDICATION O
as O O
per O O
Dr. O O
Valenti) O O
Sodium O O
bicarbonate O O
650 O O
mg O O
tid O O
Diovan B-MEDICATION O
160 O O
mg O O
qd O O
(held) O O
Norvasc B-MEDICATION B-MEDICATION
5 O O
mg O O
qd O O
(held) O O
Plavix O B-MEDICATION
75 O O
mg O O
qd O O
(held) O O
ASA O B-MEDICATION
325 O O
mg O O
qd O O
(held) O O
ALLERGIES: O O
NKDA/NKA O O
SOCIAL O O
HISTORY: O O
seamstress, O O
lives O O
with O O
parents O O
(single). O O
Tobacco: B-SMOKER O
negative I-SMOKER O
EtOH: O O
negative O O
Other O O
drugs: O O
FAMILY O O
HISTORY: O O
Father: O O
HTN O O
Mother: O O
HTN, O O
hyperlipidemia O O
Maternal O O
grandmother: O O
CVA O O
in O O
her O O
60's, O O
CAD, O O
HTN O O
- O O
deceased O O
at O O
age O O
70 O O
Siblings: O O
all O O
alive O O
and O O
well- O O
no O O
DM, O O
CAD, O O
CVA O O
ROS: O O
As O O
per O O
HPI. O O
PHYSICAL O O
EXAM: O O
Gen: O O
appears O O
well, O O
in O O
NAD O O
VS: O O
pending O O
HEENT: O O
NCAT, O O
PERRLA, O O
OC/OP O O
clear, O O
sclerae O O
anicteric O O
Pulm: O O
CTAB O O
Cardiac: O O
RRR, O O
no O O
M/R/G O O
Abd: O O
soft, O O
NT/ND, O O
BS+ O O
Ext: O O
WWP, O O
no O O
LE O O
edema. O O
2+ O O
DP/PT O O
pulses O O
LABS: O O
U/A: O O
negative O O
Serologies: O O
CMV O O
NEG O O
HBsAb O O
POS O O
HBsAg O O
NEG O O
HBcAb O O
HCV O O
NEG O O
EBV O O
VZV O O
HIV O O
NEG O O
IMAGING: O O
CXR: O O
clear O O
A/P: O O
41 O O
year O O
old O O
woman O O
with O O
diabetic O O
nephropathy-induced O O
ESRD O O
here O O
this O O
morning O O
for O O
living-related O O
renal O O
transplant O O
from O O
sister. O O
Cellcept O O
in O O
the O O
AM, O O
no O O
thymoglobulin O O
to O O
the O O
OR O O
today O O
Victor O O
L. O O
Bonilla, O O
MD, O O
PhD O O
Pager O O
76006 O O

Record O O
date: O O
2096-05-28 O O
CARDIOLOGY O O
COQUILLE O O
VALLEY O O
HOSPITAL O O
Reason O O
for O O
visit: O O
42 O O
y.o. O O
s/p O O
cath O O
with O O
no O O
progression O O
of O O
CAD B-CAD O
Interval O O
History: O O
Please O O
refer O O
to O O
detailed O O
Cardiology O O
admit O O
note, O O
reviewed O O
and O O
agreed O O
with, O O
briefly O O
here: O O
--08/11/2094 O O
Vision O O
stent O O
to O O
LAD. O O
--09/29/2094 O O
elective O O
relook, O O
LAD O O
ISR--&gt; O O
Taxus O O
stent O O
2.75 O O
x O O
12 O O
mm. O O
--10/06/2094 O O
Cypher O O
stent O O
2.5 O O
x O O
13 O O
mm O O
to O O
the O O
mid O O
right O O
coronary O O
artery. O B-CAD
--12/25/2094 O O
RCA O B-CAD
with O O
Cypher O O
stent O O
3 O O
x O O
13 O O
mm O O
and O O
Cypher O O
stent O O
2.5 O O
x O O
18 O O
mm. O O
--7/2095 O O
Renal O O
transplant O O
at O O
CVH. O O
Donor O O
is O O
sister O O
(live O O
donor O O
transplant). O O
--2/5/96 O O
RCA O O
with O O
two O O
stents O O
(DES) O O
placed O O
at O O
OSH. O O
--3/2096 O O
ETT O O
to O O
6+ O O
minutes O O
(61% O O
MPHR). O O
EF O O
70%. O O
Small O O
anteroapical O O
defect O O
with O O
partial O O
reperfusion O O
(small). O O
Septal O O
DK. O O
Had O O
done O O
well O O
until O O
the O O
past O O
few O O
weeks. O O
Complaints O O
of O O
SOB O O
and O O
fatigue. O O
5/27 O O
Admitted O O
to O O
Ripley O O
Clinic O O
with O O
SOB. O O
Ruled O O
out. O O
Had O O
episode O O
of O O
LOC O O
(has O O
done O O
in O O
past O O
at O O
CVH). O O
Head O O
CT O O
negative. O O
She O O
has O O
been O O
listed O O
for O O
pancreatic O O
transplant O O
Cath O O
today O O
revealing: O O
Coronary O O
angiography: O O
Mild O O
to O O
moderate O O
stenosis O O
of O O
LAD. O O
Severe O O
ostial O O
right O O
PDA O O
disease. O O
Patent O O
stents O O
in O O
the O O
LAD O O
and O O
RCA. O O
Left O O
ventriculography: O O
preserved O O
systolic O O
function O O
with O O
no O O
MR. O O
No O O
hemodynamically O O
significant O O
gradient O O
across O O
the O O
aortic O O
valve O O
with O O
catheter O O
pull-back. O O
Past O O
medical O O
history: O O
CAD O O
as O O
above O O
with O O
multiple B-CAD O
PCIs I-CAD O
CVA O O
in O O
2093 O O
without O O
residual. O O
Neuro O O
events O O
(neg O O
TIA O O
or O O
CVA O O
or O O
Sz) O O
post O O
cath. O O
IDDM B-DIABETES O
on O O
insulin B-MEDICATION O
pump I-MEDICATION O
times O O
4yrs, O O
pt O O
states O O
glucose O O
has O O
not O O
been O O
&lt;200 O O
over O O
the O O
past O O
Renal O O
transplant O O
HTN B-HYPERTENSION O
High B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Diabetic O O
retinopathy O O
Anemia O O
Medications O O
(Confirmed): O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
PO O O
QD O O
Cellcept O O
1000mg O O
po O O
QD O O
Colace O O
100mg O O
po O O
BID O O
folic O O
acid O O
1 O O
mg O O
PO O O
QD O O
Imdur B-MEDICATION B-MEDICATION
30 O O
mg O O
PO O O
QD O O
insulin O B-MEDICATION
isosorbide B-MEDICATION B-MEDICATION
dinitrate I-MEDICATION O
30 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
Lasix O O
20 O O
mg O O
po O O
daily O O
lisinopril B-MEDICATION B-MEDICATION
5 O O
mg O O
po O O
daily O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
PO O O
QD O O
Prilosec O O
20mg O O
po O O
daily O O
Prograf O O
2 O O
mg O O
2 O O
mg O O
oral O O
twice O O
a O O
day O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
50 O O
mg O O
PO O O
QD O O
Vytorin B-MEDICATION O
5/40 O O
mg O O
PO O O
QD O O
Family O O
history: O O
Mom O O
A&W O O
in O O
her O O
60's O O
with O O
HTN. O O
Dad O O
A&W. O O
Other O O
sister O O
is O O
back-up O O
donor. O O
Social B-SMOKER O
history: O O
The O O
patient O O
is O O
single O O
and O O
lives O O
with O O
her O O
parents. O O
She O O
has O O
two O O
sisters O O
who O O
live O O
nearby. O O
She O O
is O O
a O O
Patternmaker O O
at O O
the O O
Ion O O
Media O O
Networks O O
in O O
Erwin. O O
Review O O
of O O
systems: O O
Neuro O O
symptoms O O
follow O O
cath O O
in O O
past O O
(at O O
least O O
twice). O O
Unresponsive O O
and O O
unable O O
to O O
speak. O O
Neuro O O
evaluation O O
and O O
CT O O
both O O
times. O O
EEGs O O
negative. O O
Glucose O O
was O O
normal. O O
Physical O O
examination: O O
-Pulse: O O
64 O O
-resp. O O
rate: O O
16 O O
-weight: O O
153 O O
-General: O O
Comfortable O O
appearing O O
white O O
female O O
in O O
no O O
acute O O
distress O O
-Skin: O O
No O O
rashes, O O
anicteric. O O
-HEENT: O O
Unremarkable O O
-Neck: O O
Supple. O O
No O O
thyromegaly. O O
Carotids O O
2+ O O
with O O
possible O O
soft O O
bruit O O
bilaterally O O
-Chest: O O
Clear O O
-Cardiac: O O
No O O
JVD. O O
PMI O O
not O O
displaced. O O
2/6 O O
SEM O O
at O O
base/RSB. O O
No O O
rub. O O
-Abdomen: O O
Bowel O O
sounds O O
present. O O
No O O
hepatosplenomegaly. O O
No O O
masses O O
or O O
tenderness O O
-Extremities: O O
left O O
groin O O
no O O
ooze, O O
no O O
hematoma, O O
+2 O O
dp O O
and O O
pt, O O
right O O
groin O O
attempted O O
canulization, O O
no O O
ooze, O O
no O O
hematoma O O
-Neuro: O O
A&O O O
x3, O O
CN O O
2-12 O O
grossly O O
intact. O O
-BP: O O
170/64 O O
Selected O O
recent O O
labs: O O
WBC O O
12.6, O O
Crit O O
36.9, O O
Plts O O
216. O O
INR O O
1.1. O O
Na O O
134, O O
K O O
4.5,BUN O O
21. O O
Creat O O
1.2. O O
Assessment O O
and O O
plan: O O
The O O
patient O O
is O O
a O O
41-year-old O O
white O O
female O O
with O O
a O O
history O O
of O O
insulin-dependent B-DIABETES O
diabetes I-DIABETES O
mellitus I-DIABETES O
with O O
renal O O
transplant O O
in O O
2095. O O
Previous O O
PCIs O O
to O O
RCA O O
and O O
LAD O O
with O O
several O O
DES. O O
Now B-CAD O
with I-CAD O
recurrent B-CAD O
angina. I-CAD O
Cath O O
today O O
with O O
no O O
progression O O
of O O
disease O O
-continue O O
current O O
medications O O
-IVF O O
overnight O O
-patient O O
to O O
adjust O O
insulin O O
pump O O
as O O
indicated O O
-plan O O
for O O
d/c O O
in O O
am O O
-further O O
plans O O
per O O
Dr O O
Rollins O O
Francisca O O
Kline O O
NP O O
Changes O O
to O O
Medications O O
this O O
visit O O
insulin O O
pump O O
Patient O O
adjusts O O
her O O
insulin O O
pump O O
independently O O
lisinopril O B-MEDICATION
10 O O
mg O O
po O O
daily O O
Start: O O
05/28/2096 O O
Cellcept O O
1000mg O O
po O O
bid O O
Start: O O
05/28/2096 O O
Vytorin O O
10/80 O O
PO O O
QD O O
Francisca O O
Kline, O O
RN O O
Transcribed O O
by: O O
Francisca O O
Kline O O
Signed O O
electronically O O
by O O
Francisca O O
Kline, O O
RN O O
Document O O
Status: O O
Final O O

Record B-SMOKER O
date: O O
2098-10-11 O O
CARDIOLOGY O O
COQUILLE O O
VALLEY O O
HOSPITAL O O
Reason O O
for O O
visit: O O
45 O O
y O O
o O O
seamstress O O
with O O
h/o B-CAD O
CAD, B-CAD O
renal O O
transplant, O O
CVA, O O
here O O
for O O
cardiology O O
FU O O
after O O
having O O
been O O
inactivated O O
from O O
pancreas O O
transplant O O
list. O O
Interval O O
History: O O
Ms. O O
Fagan O O
notes O O
that O O
she O O
is O O
doing O O
very O O
well. O O
She O O
does O O
not O O
have O O
any O O
chest O O
pain O O
and O O
only O O
rare O O
dyspnea. O O
She O O
has O O
not O O
had O O
any O O
dizziness O O
and O O
lightheadedness. O O
She O O
had O O
previously O O
been O O
on O O
the O O
CVH O O
pancreas O O
transplant O O
list O O
and O O
had O O
full O O
cardiac O O
workup O O
including O O
recent O O
dobutamine O O
echo O O
which O O
revealed O O
normal O O
LV O O
function O O
and O O
no O O
ischemia. O O
However, O O
there O O
was O O
concern O O
about O O
her O O
extensive O O
visceral O O
and O O
iliac O O
vascular O O
calcification O O
by O O
CT O O
which O O
rendered O O
her O O
high O O
surgical O O
risk. O O
She O O
is O O
understandably O O
upset O O
about O O
this O O
reclassification O O
and O O
is O O
here O O
today O O
for O O
an O O
overview O O
of O O
her O O
cardiac O O
status. O O
Past O O
medical O O
history: O O
IDDM B-DIABETES O
for O O
many O O
years O O
for O O
which O O
she O O
is O O
on O O
an O O
insulin B-MEDICATION O
pump. I-MEDICATION O
She O O
now O O
also O O
has O O
a O O
continuous O O
glucometer O O
as O O
she O O
has O O
had O O
a O O
h/o O O
recurrent O O
hypoglycemic O O
episodes O O
CAD O O
- O O
s/p B-CAD O
PCI I-CAD O
LAD I-CAD O
8/94 I-CAD O
with O O
subsequent O O
DES B-CAD O
to I-CAD O
mid I-CAD O
RCA I-CAD O
and O O
restent B-CAD O
proximal I-CAD O
edge I-CAD O
of I-CAD O
LAD I-CAD O
stent I-CAD O
9/94. I-CAD O
12/94 O O
RCA O O
stenting. B-CAD O
Repeat O O
RCA O B-CAD
stenting O O
2/96. O O
70% O O
OMB2 O O
detected. O O
Subsequent O O
cath O O
no O O
change. O O
No O O
ischemia O O
by O O
9/98 O O
dobutamine O O
Echo O O
Small O O
anteroapical O O
defect O O
with O O
partial O O
reperfusion O O
by O O
8/97 O O
nuclear, O O
unchanged O O
LVEF O O
75% O O
h/o O O
CHF O O
s/p O O
renal O O
transplant O O
with O O
Cr O O
1.1-1.2 O O
Hypercholesterolemia B-HYPERLIPIDEMIA O
h/o O O
L O O
temporal-occipital O O
CVA O O
2093 O O
with O O
subsequent O O
agraphia O O
and O O
inability O O
to O O
read O O
which O O
has O O
resolved. O O
Diabetic O O
retinopathy O O
s/p O O
R O O
wrist O O
fx O O
2/96 O O
s/p O O
L O O
foot O O
fx O O
with O O
surgery O O
5/97 O O
for O O
nonhealing O O
and O O
wound O O
infection O O
Changes O O
to O O
Allergies O O
reglan O O
- O O
reaction: O O
GI O O
Intolerance O O
[reviewed] O O
Family O O
history: O O
Mother O O
with O O
HTN, O O
cancerdiabetes. O O
Father O O
afib. O O
Grandmother O O
CVA. O O
Social O O
history: O O
The O O
patient O O
is O O
single O O
and O O
lives O O
with O O
her O O
parents. O O
She O O
is O O
a O O
Patternmaker O O
at O O
the O O
Ion O O
Media O O
Networks O O
in O O
Erwin. O O
Review O O
of O O
systems: O O
No O O
fever, O O
chills O O
or O O
sweats. O O
No O O
nausea O O
vomiting O O
or O O
diarrhea. O O
No O O
cough O O
or O O
respiratory O O
sxs. O O
No O O
abdominal O O
pain. O O
No O O
headaches O O
or O O
neurologic O O
sxs. O O
Remainder O O
of O O
ros O O
negative O O
except O O
as O O
described O O
in O O
HPI. O O
Physical O O
examination: O O
-BMI: O O
24.2 O O
Normal, O O
low O O
risk O O
-Pulse: O O
73 O O
-resp. O O
rate: O O
12 O O
-height: O O
66.25 O O
in. O O
-weight: O O
151 O O
lbs. O O
-General: O O
Well-appearing O O
middle O O
aged O O
white O O
female O O
in O O
no O O
apparent O O
distress. O O
Skin O O
is O O
warm O O
and O O
dry. O O
HEENT O O
examination O O
is O O
within O O
normal O O
limits. O O
Neck O O
is O O
without O O
jugular O O
venous O O
distention. O O
Carotids O O
are O O
2 O O
bilaterally O O
without O O
bruits. O O
There O O
is O O
no O O
lymphadenopathy. O O
Lungs O O
are O O
clear O O
without O O
wheezes O O
or O O
rhonchi. O O
Cardiac O O
exam O O
reveals O O
a O O
nondisplaced O O
PMI O O
S1-S2 O O
regular O O
rhythm O O
with O O
no O O
murmur, O O
rub O O
or O O
gallop. O O
Abdomen O O
is O O
soft O O
and O O
nontender O O
with O O
positive O O
bowel O O
sounds. O O
Extremities O O
are O O
without O O
peripheral O O
edema. O O
Distal O O
pulses O O
are O O
2 O O
bilaterally. O O
There O O
is O O
no O O
clubbing O O
or O O
cyanosis. O O
Neuro O O
exam O O
is O O
grossly O O
nonfocal. O O
NS O O
-BP: O O
106 O O
66 O O
(l) O O
EKG: O O
NSR O O
at O O
73. O O
LVH O O
by O O
voltage. O O
Septal O O
infarct O O
- O O
age O O
indeterminate. O O
No O O
change O O
compared O O
with O O
7/11/98. O O
Selected O O
recent O O
labs: O O
Lipid/Thyroid O O
Date O O

Record O O
date: O O
2097-06-09 O O
Renal O O
Consult O O
Note O O
Quinton O O
Delong,M.D. O O
CC/ID: O O
Asked O O
to O O
assit O O
in O O
the O O
mangement O O
of O O
Lori O O
Stevens O O
with O O
hypertension, B-HYPERTENSION O
nausea O O
and O O
vomiting. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
She O O
is O O
a O O
62 O O
year O O
old O O
lady O O
with O O
ESRD O O
who O O
has O O
been O O
admitted O O
in O O
the O O
past O O
with O O
nausea, O O
vomiting O O
and O O
severe O O
hypertension. O O
She O O
was O O
treated O O
with O O
BP O O
medications. O O
She O O
has O O
had O O
a O O
CT O O
scan O O
and O O
is O O
seen O O
in O O
dialysis. O O
She O O
is O O
stable O O
on O O
dialysis O O
currently. O O
PAST O O
MEDICAL O O
HISTORY: O O
1. O O
Diabetes B-DIABETES O
Mellitus I-DIABETES O
x O O
many O O
years. O O
2. O O
History O O
of O O
hypertension O O
x O O
many O O
years. O O
3. O O
History O O
of O O
GI O O
bleeding. O O
4. O O
ESRD O O
secondary O O
to O O
DM O O
on O O
HD O O
x O O
years. O O
On O O
HD O O
Mon/Wed/Fri. O O
5. O O
CAD B-CAD O
s/p B-CAD O
NSTEMI. I-CAD O
6. O O
Meningitis O O
in O O
the O O
past. O O
( O O
Viral) O O
MEDICATIONS O O
Unavailable O O
SOCIAL B-SMOKER O
HISTORY: O O
Lives O O
in O O
Nursing O O
Home. O O
PHYSICAL O O
EXAMINATION: O O
BP: B-HYPERTENSION O
159/70 B-HYPERTENSION O
P: O O
72 O O
R: O O
16 O O
T=97 O O
SKIN: O O
No O O
rash O O
HEENT: O O
Anicteric O O
NECK: O O
Supple. O O
JVP= O O
6 O O
cm O O
CHEST: O O
Left O O
base O O
crackles&gt; O O
right O O
COR: O O
S1 O O
S2 O O
ABD: O O
Benign. O O
No O O
HSM O O
EXT: O O
No O O
edema O O
Labs: O O
Plasma O O
Sodium O O
136 O O
(135-145) O O
mmol/LPlasma O O
Potassium O O
3.9 O O
(3.4-4.8) O O
mmol/LPlasma O O
Chloride O O
91 O O
L O O
(100-108) O O
mmol/LPlasma O O
Carbon O O
Dioxide O O
29.1 O O
(23.0-31.9) O O
mmol/LPlasma O O
Anion O O
GAP O O
16 O O
H O O
(3-15) O O
mmol/LCalcium O O
10.0 O O
(8.5-10.5) O O
mg/dlPhosphorus O O
4.6 O O
H O O
(2.6-4.5) O O
mg/dlMagnesium O O
2.0 O O
(1.4-2.0) O O
meq/LPlasma O O
Urea O O
Nitrogen O O
50 O O
H O O
(8-25) O O
mg/dlPlasma O O
Creatinine O O
3.93 O O
H O O
(0.60-1.50) O O
mg/dleGFR O O
12 O O
mL/min/1.73m2Plasma O O
Glucose O O
132 O O
H O O
(70-110) O O
mg/dlTotal O O
Protein O O
8.0 O O
(6.0-8.3) O O
g/dlAlbumin O O
3.6 O O
(3.3-5.0) O O
g/dlGlobulin O O
4.4 O O
H O O
(2.6-4.1) O O
g/dlDirect O O
Bilirubin O O
0.2 O O
(0-0.4) O O
mg/dlTotal O O
Bilirubin O O
0.4 O O
(0.0-1.0) O O
mg/dlAlkaline O O
Phosphatase O O
345 O O
H O O
(30-100) O O
U/LTransaminase-SGPT O O
9 O O
(7-30) O O
U/LAmylase O O
54 O O
(3-100) O O
units/LTransaminase-SGOT O O
19 O O
(9-32) O O
U/LLipase O O
18 O O
(13-60) O O
U/L O O
WBC O O
15.9 O O
H O O
(4.5-11.0) O O
th/cmmHCT O O
39.0 O O
(36.0-46.0) O O
%HGB O O
12.4 O O
(12.0-16.0) O O
gm/dlRBC O O
4.39 O O
(4.00-5.20) O O
mil/cmmPLT O O
558 O O
H O O
(150-400) O O
th/cummMCV O O
89 O O
(80-100) O O
flMCH O O
28.2 O O
(26.0-34.0) O O
pg/rbcMCHC O O
31.9 O O
(31.0-37.0) O O
g/dlRDW O O
20.9 O O
H O O
(11.5-14.5) O O
%Poly O O
82 O O
H O O
(40-70) O O
%Lymphs O O
8 O O
L O O
(22-44) O O
%Monos O O
4 O O
(4-11) O O
%EOS O O
6 O O
(0-8) O O
%Basos O O
0 O O
(0-3) O O
%Absolute O O
Neuts O O
13.18 O O
H O O
(1.8-7.7) O O
th/cmmAbsolute O O
Lymphs O O
1.20 O O
(1.0-4.8) O O
th/cmmAbsolute O O
Monos O O
0.58 O O
(0.2-1.2) O O
th/mm3Absolute O O
EOS O O
0.88 O O
H O O
(0.1-0.3) O O
th/cmmAbsolute O O
Basos O O
0.02 O O
(0.0-0.3) O O
th/cmmAniso O O
2+ O O
H O O
(None)Hypo O O
3+ O O
H O O
(None)Macrocytes O O
None O O
(None)Microcytes O O
1+ O O
H O O
(None) O O
IMPRESSION: O O
Ms. O O
Stevens O O
is O O
a O O
64 O O
year O O
old O O
lady O O
with O O
ESRD O O
admitted O O
with O O
hypertension O O
and O O
nausea O O
as O O
well O O
as O O
vomiting. O O
She O O
was O O
quite O O
hypertensive B-HYPERTENSION O
and O O
I O O
would O O
wonder O O
about O O
the O O
effect O O
of O O
BP. O O
She O O
also O O
looks O O
fluid O O
overloaded. O O
PLAN: O O
HD O O
x O O
3 O O
1/4 O O
hours, O O
2 O O
K, O O
2.5 O O
Ca O O
Negative O O
3 O O
liters O O
Needs O O
Medication O O
clarification O O
and O O
good O O
BP O O
control. O O
Quinton O O
Delong,M.D. O O

Record O O
date: O O
2097-12-01 O O
RENAL O O
CONSULT O O
NOTE O O
AUTHOR/FELLOW O O
&#8211; O O
Morrison O O
ATTENDING O O
&#8211; O O
Ingle O O
Consult O O
indication O O
&#8211; O O
Pt O O
with O O
ESRD, O O
consulted O O
for O O
HD O O
needs O O
HPI O O
&#8211; O O
64 O O
yo O O
F O O
with O O
ho O O
ESRD O O
due O O
to O O
DM B-DIABETES O
on O O
HD O O
TTS, O O
Type B-DIABETES O
2 I-DIABETES O
DM, I-DIABETES O
CVA, O O
prior O O
GI O O
bleeds O O
-&gt; O O
admitted O O
for O O
probable O O
PNA O O
and O O
colitis O O
-&gt; O O
consulted O O
for O O
HD O O
needs. O O
Recently O O
admitted O O
8/27-8/30/97 O O
for O O
HTN B-HYPERTENSION O
urgency, O O
N/V, O O
and O O
CT O O
findings O O
of O O
asc O O
colon O O
thickening O O
suggestive O O
of O O
colitis. O O
BP O O
controlled O O
with O O
IV O O
and O O
oral O O
medications O O
and O O
UF O O
on O O
HD. O O
Was O O
seen O O
by O O
GI O O
consult O O
who O O
felt O O
that O O
CT O O
findings O O
were O O
an O O
artifact O O
in O O
context O O
of O O
volume O O
overload. O O
Cdif O O
toxin O O
x O O
1 O O
negative, O O
was O O
also O O
given O O
ivermectin O O
for O O
positive O O
stronyloides O O
serology. O O
Was O O
d/c&#8217;ed O O
on O O
vanc O O
x O O
2 O O
weeks O O
with O O
HD O O
for O O
sacral O O
decub O O
ulcer. O O
Admitted O O
from O O
NGH O O
with O O
N/V, O O
abd O O
pain. O O
In O O
ER, O O
had O O
BP B-HYPERTENSION O
204/99, I-HYPERTENSION O
nl O O
HR, O O
RR, O O
and O O
was O O
afebrile. O O
Had O O
CT O O
a/p O O
with O O
contrast O O
showing O O
resolution O O
of O O
asc O O
colon O O
thickening, O O
now O O
with O O
sigmoid/rectal O O
thickening O O
concerning O O
for O O
infectious O O
colitis, O O
also O O
with O O
LLL O O
opacity O O
possible O O
pna; O O
cdif O O
x O O
1 O O
negative. O O
Per O O
ER O O
notes, O O
had O O
bloody O O
BM O O
overnight. O O
Received O O
vanc O O
1 O O
g, O O
cefepime O O
1 O O
g, O O
and O O
flagyl O O
500 O O
mg. O O
Pt O O
currently O O
endorses O O
abd O O
pain O O
localized O O
to O O
LLQ; O O
denies O O
melena, O O
hematochezia. O O
Has O O
had O O
N/V O O
x O O
1 O O
day, O O
no O O
hematemsis. O O
Denies O O
fevers, O O
dyspnea, O O
cough, O O
chest O O
pain, O O
rash. O O
Makes O O
small O O
amt O O
of O O
urine, O O
no O O
dysuria. O O
All O O
other O O
ROS O O
evaluated O O
and O O
found O O
to O O
be O O
negative. O O
PMH O O
&#8211; O O
1. O O
ESRD O O
since O O
2096 O O
- O O
etiology O O
presumed O O
DM O O
- O O
access O O
= O O
L O O
brachiocephalic O O
AVF O O
2. O O
Chronic O O
decubitus O O
ulcers O O
3. O O
Type B-DIABETES O
II I-DIABETES O
DM I-DIABETES O
4. O O
Prior O O
GI O O
bleeding O O
- O O
no O O
prior O O
endoscopy O O
report O O
from O O
MH O O
5. O O
CVA O O
12/96, O O
previous O O
PEG O O
tube O O
now O O
removed O O
6. O O
Cataracts O O
7. O O
Hypertension B-HYPERTENSION O
(intermittently O O
difficult O O
to O O
control) O O
8. O O
Past O O
TTE O O
7/97 O O
Mild O O
AI, O O
TR, O O
PI, O O
LVSF O O
68, O O
R O O
PA O O
dilation, O O
RV O O
no O O
diln/hypokinesis O O
Medications: O O
(taken O O
from O O
NGH O O
list) O O
phoslo O O
1 O O
tab O O
po O O
tidac O O
labetaolol B-MEDICATION O
200 O O
tid, O O
am O O
dose O O
held O O
HD O O
days O O
lisinopril B-MEDICATION B-MEDICATION
30 O O
qday O O
renocaps O O
1 O O
tab O O
po O O
qday O O
MOM O O
maalox O O
oxycodone O O
compazine O O
supp O O
tyl O O
prn O O
albuterol O O
ipratropium O O
cholestyramine O O
powder O O
omeprazole O O
40 O O
qday O O
70/30 B-MEDICATION O
4 O O
am O O
3 O O
pm O O
acetaminophen O O
prn O O
ALL O O
&#8211; O O
nkda O O
FH/SH B-SMOKER O
&#8211; O O
lives O O
in O O
nursing O O
facility O O
reports O O
that O O
dtr O O
lives O O
nearby O O
PEX O O
&#8211; O O
187/57 B-HYPERTENSION O
89 O O
at O O
start O O
of O O
HD O O
gen O O
pleasant, O O
able O O
to O O
answer O O
questions O O
appropriately O O
jvp O O
JVP O O
~14 O O
cm O O
at O O
45 O O
degrees O O
pulm O O
cta O O
b, O O
no O O
wrr O O
cv O O
rrr, O O
systolic O O
murmur O O
heard O O
throughout O O
precordium O O
gi O O
+ O O
bs, O O
+ O O
distn, O O
TTP O O
in O O
LLQ O O
only, O O
no O O
reb/rig/guarding O O
extrem O O
no O O
edema, O O
LUE O O
AVF O O
with O O
good O O
thrill/bruit O O
LABS O O
&#8211; O O
cbc O O
11.4, O O
hb O O
13.5, O O
plt O O
285 O O
na O O
137, O O
k O O
5.4, O O
cl O O
89, O O
bicarb O O
26.2, O O
bun O O
61, O O
cr O O
4.99, O O
gluc O O
196, O O
ca O O
10.5, O O
mg O O
1.9, O O
phos O O
4.1 O O
vit O O
d O O
20 O O
8/27/97 O O
alb O O
4.2 O O
fe O O
50, O O
tibc O O
204, O O
ferritin O O
878 O O
8/27 O O
inr O O
1.1 O O
pth O O
115 O O
8/27 O O
CT O O
A/P O O
WITH O O
IV O O
CONTRAST O O
12/1 O O
Patchy O O
LLL O O
consolidation, O O
B O O
effusions O O
(pleural) O O
CM O O
Periportal O O
edema, O O
tr O O
ascites O O
Atrophic O O
pancreas, O O
stable O O
low O O
attenuation O O
lesion O O
at O O
head O O
Stable O O
nonobstructing O O
R O O
lower O O
pole O O
renal O O
calculi O O
measuring O O
approximately O O
3 O O
to O O
4 O O
mm O O
Uterine O O
fibroids O O
Nonspecific O O
thickening O O
of O O
bladder O O
wall O O
Vascular O O
calcification O O
G O O
tube O O
removal O O
with O O
thickening O O
at O O
site O O
Resolution O O
of O O
asc O O
colon O O
thickening, O O
new O O
mild O O
to O O
moderate O O
diffuse O O
sigmoid O O
colon O O
and O O
rectal O O
thickening, O O
no O O
obstruction O O
Diffuse O O
soft O O
tissue O O
edema O O
CXR O O
LLL O O
opacity, O O
small O O
R O O
effn, O O
int O O
edema O O
IMPRESSION O O
- O O
1. O O
ESRD O O
- O O
HD O O
today O O
3 O O
hrs O O
(12/97 O O
was O O
undergoing O O
2.5 O O
hr O O
HD O O
runs, O O
but O O
9/97 O O
was O O
undergoing O O
3 O O
hr O O
runs; O O
will O O
measure O O
URR O O
and O O
Kt/V), O O
2K/2.5Ca, O O
3L O O
UF, O O
no O O
EPO, O O
zemplar O O
1 O O
mcg. O O
No O O
heparin O O
with O O
HD O O
given O O
possible O O
GI O O
bleed. O O
2. O O
ACCESS O O
&#8211; O O
During O O
8/97 O O
admission, O O
was O O
to O O
undergo O O
fistulogram O O
but O O
per O O
notes O O
from O O
last O O
9/97 O O
admission O O
AVF O O
was O O
functioning O O
well. O O
Good O O
thrill/bruit O O
on O O
exam. O O
Place O O
sign O O
over O O
bed O O
indicating O O
no O O
BP's/IV's/blood O O
draws O O
from O O
LUE. O O
3. O O
ANEMIA O O
&#8211; O O
Hb O O
currently O O
high, O O
but O O
per O O
ER O O
notes O O
had O O
bloody O O
stool O O
overnight O O
(per O O
signout O O
from O O
current O O
ER O O
nurse O O
and O O
resident, O O
no O O
recurrence O O
of O O
hematochezia), O O
has O O
not O O
had O O
sufficient O O
time O O
to O O
equilibrate. O O
Will O O
hold O O
EPO O O
for O O
now, O O
would O O
consider O O
serial O O
CBC's. O O
Consider O O
GI O O
consult O O
given O O
hematochezia, O O
sigmoid O O
c/rectal O O
thickening O O
on O O
CT; O O
distribution O O
of O O
colon O O
involvement O O
not O O
in O O
watershed O O
area, O O
but O O
given O O
extensive O O
atherosclerotic O O
disease, O O
ischemic O O
colitis O O
possible O O
in O O
addition O O
to O O
infectious O O
etiologies. O O
4. O O
MINERALS O O
&#8211; O O
Phos O O
at O O
goal, O O
on O O
phoslo O O
1 O O
tab O O
po O O
tidac. O O
PTH O O
below O O
goal, O O
will O O
give O O
low O O
dose O O
zemplar O O
1 O O
mcg O O
IV. O O
VIt O O
25oh O O
D O O
low O O
8/27/97, O O
may O O
have O O
already O O
received O O
course O O
of O O
ergo, O O
will O O
repeat O O
levels O O
and O O
if O O
&lt; O O
30, O O
will O O
need O O
addtl O O
course O O
ergocalciferol. O O
5. O O
VOLUME/HTN O O
&#8211; O O
Pt O O
with O O
elevated O O
BP, O O
volume O O
up O O
on O O
exam; O O
CT O O
study O O
also O O
demonstrates O O
pleural O O
effusions, O O
mild O O
ascites, O O
and O O
diffuse O O
soft O O
tissue O O
edema. O O
Pre-HD O O
wt O O
not O O
obtained, O O
will O O
aim O O
for O O
3L O O
UF O O
(EDW O O
48 O O
kg). O O
6. O O
NUTRITION O O
&#8211; O O
1.5L O O
fluid O O
restrict, O O
2g O O
K O O
restrict, O O
continue O O
nephrocaps. O O
Continue O O
labetalol O B-MEDICATION
and O O
lisinopril. O B-MEDICATION
7. O O
HEMATOCHEZIA O O
- O O
See O O
#3. O O
8. O O
LUNG O O
OPACITY O O
- O O
Received O O
vanc O O
and O O
cefepime O O
for O O
possible O O
pna O O
in O O
ER O O
prior O O
to O O
arrival O O
on O O
HD. O O
Vanc O O
not O O
given O O
on O O
HD. O O
Would O O
give O O
addtl O O
dose O O
of O O
cefepime O O
1 O O
g O O
today O O
after O O
HD. O O
Blood O O
cx's O O
x O O
2 O O
drawn O O
on O O
HD. O O
Pt O O
to O O
be O O
discussed O O
with O O
Dr. O O
Ingle. O O
Thelma O O
Morrison, O O
renal O O
fellow, O O
pager O O
96794 O O
Renal O O
Staff O O
Addendum O O
Patient O O
seen O O
and O O
examined O O
on O O
dialysis. O O
Discussed O O
with O O
Renal O O
Fellow. O O
Agree O O
with O O
details O O
per O O
her O O
note. O O
Admitted O O
with O O
nausea O O
vomiting O O
abdominal O O
pain O O
and O O
accelerated O O
hypertension. O O
Initial O O
evaluation O O
notable O O
for O O
pulmonary O O
infiltrate O O
and O O
colonic O O
thickening O O
with O O
mildly O O
elevated O O
WBC O O
cnt. O O
On O O
exam O O
Afebrile O O
with O O
BP O O
initially O O
180 O O
decreasing O O
to O O
110 O O
on O O
dialysis. O O
Chest O O
exam O O
notable O O
for O O
crackles O O
with O O
O2 O O
sat O O
97%. O O
Is O O
not O O
in O O
overt O O
CHF O O
although O O
appears O O
volume O O
overloaded O O
with O O
peripheral O O
edema. O O
Abdominal O O
exam O O
benign O O
despite O O
CT O O
findings. O O
Labs O O
showing O O
hyperkalemia. O O
Dialysis: O O
3 O O
hrs O O
2K O O
bath O O
Ultrafiltration: O O
2L O O
Anemia O O
management: O O
Epogen O O
on O O
hold O O
due O O
t O O
dialysis O O
CVD: O O
optimize O O
dry O O
wt O O
and O O
anti-hypertensives O O
ID: O O
broadly O O
covered O O
with O O
Vancomycin O O
and O O
Cefeopime; O O
r/o O O
C O O
diff O O
John O O
Ingle O O
MD. O O

Record O O
date: O O
2098-02-12 O O
RENAL O O
CONSULT O O
NOTE O O
ATTENDING O O
&#8211; O O
Dr. O O
John O O
Ingle O O
DOA O O
&#8211; O O
02/12/98 O O
Consult O O
indication O O
- O O
Pt O O
with O O
ESRD, O O
consulted O O
for O O
HD O O
needs O O
from O O
ED O O
department O O
HPI O O
- O O
64 O O
yo O O
F O O
with O O
ho O O
ESRD O O
due O O
to O O
DM B-DIABETES O
on O O
HD O O
TTS, O O
Type B-DIABETES O
2 I-DIABETES O
DM, I-DIABETES O
CVA, O O
prior O O
GI O O
bleeds O O
-&gt; O O
admitted O O
with O O
nausea O O
and O O
vomiting O O
and O O
abdo O O
distention. O O
Very O O
difficult O O
history O O
in O O
ED O O
as O O
limited O O
English O O
and O O
orevious O O
dysphasia O O
from O O
CVA. O O
Recently O O
admitted O O
12/1-12/10/97 O O
for O O
N/V/abd O O
pain. O O
CT O O
abdomen O O
demonstrated O O
thickened O O
sigmoid O O
colon/rectum. O O
Underwent O O
colonoscopy O O
demonstrating O O
polyp O O
-&gt; O O
high O O
grade O O
dysplasia/adenoca O O
on O O
path. O O
CT O O
pancreas O O
protocol O O
demonstrated O O
low O O
density O O
foci O O
in O O
the O O
head O O
and O O
uncinate O O
process O O
unchanged O O
since O O
1/96. O O
Had O O
blood O O
cx O O
positive O O
for O O
stenotrophomonas O O
(cefepime O O
resistant), O O
e O O
faecium, O O
and O O
achromobacter, O O
briefly O O
received O O
cefepime, O O
surveillance O O
cx&#8217;s O O
negative, O O
and O O
abx O O
were O O
d/c&#8217;ed. O O
PMH O O
- O O
1. O O
ESRD O O
since O O
2096 O O
- O O
etiology O O
presumed O O
DM O O
- O O
access O O
= O O
L O O
brachiocephalic O O
AVF O O
2. O O
Chronic O O
decubitus O O
ulcers O O
3. O O
Type B-DIABETES O
II I-DIABETES O
DM I-DIABETES O
4. O O
Prior O O
GI O O
bleeding O O
- O O
no O O
prior O O
endoscopy O O
report O O
from O O
MH O O
5. O O
CVA O O
12/96, O O
previous O O
PEG O O
tube O O
now O O
removed O O
6. O O
Cataracts O O
7. B-HYPERTENSION O
Hypertension I-HYPERTENSION O
8. O O
Past O O
TTE O O
7/97 O O
Mild O O
AI, O O
TR, O O
PI, O O
LVSF O O
68, O O
R O O
PA O O
dilation, O O
RV O O
no O O
diln/hypokinesis O O
9. O O
Stage O O
I-II O O
colon O O
cancer O O
Medications O O
(from O O
last O O
discharge): O O
Heparin O O
5000 O O
UNITS O O
SC O O
TIDAlbuterol O O
Nebulizer O O
2.5 O O
MG O O
NEB O O
Q6H O O
prnCalcium O O
Acetate O O
( O O
1 O O
Gelcap=667 O O
Mg) O O
667 O O
MG O O
PO O O
TIDCholestyramine O O
Resin O O
Dried O O
4 O O
GM O O
PO O O
BIDLisinopril B-MEDICATION O
40 O O
MG O O
PO O O
QDNephrocaps O O
1 O O
CAPSULE O O
PO O O
QDOmeprazole O O
40 O O
MG O O
PO O O
BIDOndansetron O O
Hcl O O
(Non O O
Chemo) O O
(Zofran O O
(Non O O
Chemo) O O
) O O
4 O O
MG O O
IV O O
Q8H O O
prnAcetaminophen O O
(Tylenol O O
) O O
650 O O
MG O O
PO O O
Q6H O O
prnInsulin B-MEDICATION O
Regular I-MEDICATION O
Inj O O
SC O O
AC O O
(Sliding O O
Scale)Labetalol B-MEDICATION O
Hcl O O
300 O O
MG O O
PO O O
TIDAcetylsalicylic O O
Acid O O
(Aspirin B-MEDICATION O
) O O
81 O O
MG O O
PO O O
QDInsulin B-MEDICATION O
Glargine I-MEDICATION O
(Lantus B-MEDICATION O
) I-MEDICATION O
5 O O
UNITS O O
SC O O
QHSAmlodipine B-MEDICATION O
10 O O
MG O O
PO O O
QPMHydralazine O O
Hcl O O
10 O O
MG O O
PO O O
QID O O
prn O O
Allergies: O O
NKDA O O
FH/SH B-SMOKER O
- O O
Lives O O
in O O
nursing O O
facility O O
No O O
alcohol, O O
no O O
illicitr O O
Daughter O O
lives O O
nearby O O
EXAM: O O
BP B-HYPERTENSION O
193/69 B-HYPERTENSION O
HR O O
62 O O
T O O
98F O O
Hands: O O
no O O
clubbing O O
H+N: O O
no O O
elevated O O
JVP, O O
erythema O O
and O O
injection O O
elft O O
eye? O O
conjunctivitis, O O
no O O
nodes O O
CVS: O O
normal O O
S1 O O
and O O
S2, O O
no O O
added.murmurs/rubs O O
heard O O
Chest: O O
dull O O
right O O
abse, O O
creps O O
bibasally O O
Abdo: O O
SNT, O O
distended, O O
BS O O
present O O
Legs: O O
no O O
odema, O O
Calves O O
soft O O
LABS: O O
Results02/12/2098 O O
NA O O
139, O O
K O O
6.2 O O
(H), O O
CL O O
94 O O
(L), O O
CO2 O O
29.2, O O
BUN O O
37 O O
(H), O O
CRE O O
3.47 O O
(H)02/12/2098 O O
NA O O
135, O O
K O O
6.6 O O
(H), O O
CL O O
93 O O
(L), O O
CO2 O O
26.1, O O
BUN O O
38 O O
(H), O O
CRE O O
3.56 O O
(H)02/12/2098 O O
CA O O
10.102/12/2098 O O
CA O O
9.9, O O
ALB O O
4.2, O O
LIPS O O
2202/12/2098 O O
aPO2 O O
96, O O
aPCO2 O O
52 O O
(H), O O
aPH O O
7.40, O O
K-PL O O
5.2 O O
(H)02/12/2098 O O
ALT/SGPT O O
32 O O
(H), O O
AST/SGOT O O
87 O O
(H), O O
ALKP O O
233 O O
(H), O O
TBILI O O
0.502/12/2098 O O
WBC O O
9.6, O O
HGB O O
13.7, O O
PLT O O
29702/12/2098 O O
PT-INR O O
1.2 O O
A/PLAN: O O
Nausea+Vomiting O O
Concerning O O
in O O
light O O
of O O
history O O
of O O
colon O O
ca, O O
but O O
did O O
not O O
appear O O
to O O
have O O
large O O
intraluminal O O
lesion O O
from O O
what O O
I O O
can O O
see. O O
Note O O
plan O O
for O O
CT O O
tonight O O
per O O
ED O O
management O O
ESKD O O
K O O
from O O
ABG O O
was O O
5.2 O O
No O O
immediate O O
need O O
to O O
dialyse O O
tonight O O
Will O O
schedule O O
for O O
HD O O
first O O
shift O O
tomorrow O O
Treat O O
K O O
medically O O
overnight O O
as O O
needed; O O
please O O
limit O O
IV O O
fluids O O
Anaemia O O
Hb O O
above O O
target, O O
hold O O
EPO O O
for O O
now O O
Bone O O
Please O O
check O O
phosphate O O
and O O
iPTH O O
Will O O
dose O O
adjust O O
binders O O
and O O
Vit O O
based O O
on O O
results O O
HTN B-HYPERTENSION O
Need O O
to O O
assess O O
complaince O O
with O O
meds O O
Consider O O
prn O O
iv O O
labetalol O B-MEDICATION
as O O
needed O O
for O O
severe O O
HTN O O
Perhaps O O
add O O
nitrate O O
if O O
needed O O
for O O
longer-term O O
management O O
Pleural O O
effusions O O
Consider O O
tapping O O
if O O
not O O
done O O
recently O O
in O O
light O O
of O O
malignancy O O
in O O
history O O
Calvin O O
Stanley O O
Tripp O O
Renal O O
Fellow O O
#94122 O O
Renal O O
Staff O O
Addendum O O
Patient O O
seen O O
and O O
examined O O
on O O
dialysis. O O
Case O O
discussed O O
with O O
Fellow. O O
Note O O
appreciated. O O
- O O
presents O O
with O O
nausea O O
and O O
vomiting O O
- O O
abd O O
CT O O
shows: O O
increasing O O
size O O
colonic O O
neoplasm O O
right O O
sided O O
colitis O O
markedly O O
distended O O
bladder O O
- O O
BP O O
poorly O O
controlled O O
- O O
Hyperkalemia O O
- O O
Hypoglycemia O O
REC O O
1. O O
Dialysis O O
3hrs O O
2K O O
2.5Ca O O
2. O O
UF O O
2L O O
3. O O
AVG O O
access O O
4. O O
Epogen O O
and O O
Zemplar O O
pre O O
outpatient O O
regimen O O
5. O O
Straight O O
cath O O
bladder O O
and O O
send O O
off O O
urine O O
culture: O O
Retention O O
of O O
urine O O
and O O
UTI O O
might O O
explain O O
her O O
prsentation O O
6. O O
Surgical O O
f/u O O
re O O
colon O O
neoplasm: O O
she O O
is O O
a O O
high O O
risk O O
surgical O O
candidate O O
7. O O
D10W O O
IV O O
while O O
NPO; O O
RISS O O
8. O O
Resume O O
po O O
BP O O
meds. O O
(no O O
hold O O
on O O
dialysis O O
days) O O
John O O
Ingle O O
MD. O O

Record B-SMOKER O
date: O O
2098-11-02 O O
MERCED O O
MEDICAL O O
CENTER O O
ATTENDING O O
ADMISSION B-DIABETES O
NOTE O O
PATIENT: O O
Stevens, O O
Lori O O
MRN: O O
8593546 O O
ADMIT O O
DATE: O O
11/2/2098 O O
TIME: O O
6 O O
pm O O
PCP: O O
Dr. O O
Iyan O O
Winston O O
CONTACT: O O
Daughter, O O
Sally, O O
at O O
011-053-5691 O O
Code O O
status: O O
DNR/DNI O O
Source: O O
Patient, O O
patient O O
record O O
CC: O O
hypotension O O
HPI: O O
65 O O
y/o O O
F O O
with O O
colon O O
cancer O O
(known, O O
surgery/GI O O
refuse O O
to O O
proceduralize), O O
ESRD O O
on O O
HD O O
(M/W/F), O O
CVA O O
c/b O O
severe O O
residual O O
speech/cognitive O O
deficits, O O
HTN, B-HYPERTENSION O
recurrent O O
GIB O O
who O O
presents O O
with O O
hypotension. O O
She O O
was O O
en O O
route O O
to O O
her O O
normal O O
dialysis O O
session, O O
and O O
EMT O O
took O O
BP O O
that O O
was O O
80s/40s, O O
brought O O
to O O
LCH O O
ED O O
for O O
evaluation. O O
Notably O O
recently O O
admitted O O
to O O
Santa O O
Rosa O O
on O O
9/10/2098 O O
for O O
hematemesis/hematochezia, O O
but O O
no O O
intervention O O
done. O O
No O O
report O O
of O O
recent O O
GI O O
bleeding. O O
In O O
ED, O O
initial O O
BP O O
in O O
80s/30s, O O
got O O
1.5 O O
liters O O
of O O
IV O O
fluid, O O
came O O
up O O
to O O
90s/50s. O O
Also O O
was O O
on O O
4-5 O O
liters O O
of O O
oxygen O O
with O O
sat O O
95%. O O
Blood O O
and O O
urine O O
cultures O O
sent, O O
Vancomycin O O
and O O
Cefepime O O
given. O O
Daughter O O
was O O
contacted, O O
who O O
states O O
patient O O
is O O
definitely O O
DNR/DNI O O
and O O
no O O
invasive O O
interventions O O
are O O
to O O
be O O
done O O
(including O O
central O O
lines, O O
surgery, O O
etc.) O O
Bedside O O
ultrasounds O O
revealed O O
known O O
pleural O O
effusions, O O
pericardial O O
effusion O O
without O O
signs O O
of O O
tamponade, O O
and O O
hypoechoic O O
material O O
in O O
bladder O O
suspicious O O
for O O
abscess/infection. O O
CT O O
abdomen O O
done, O O
was O O
notable O O
for O O
bladder O O
wall O O
thickening O O
potentially O O
c/w O O
cystitis, O O
a O O
new O O
moderate O O
sized O O
pericardial O O
effusion, O O
and O O
rectal O O
wall O O
thickening O O
c/w O O
proctitis. O O
After O O
CT, O O
Foley O O
placed O O
with O O
reported O O
return O O
of O O
400-500 O O
cc O O
of O O
frank O O
pus. O O
Labs O O
notable O O
for O O
K O O
5.0, O O
BUN/Cr O O
39/4.02, O O
WBC O O
count O O
7.7. O O
Patient O O
seen O O
in O O
ED O O
&#8211; O O
BP O O
80s/40s, O O
but O O
arousable O O
and O O
able O O
to O O
answer O O
simple O O
questions. O O
Denies O O
any O O
complaints, O O
including O O
pain, O O
dyspnea, O O
nausea, O O
with O O
one-word O O
answers. O O
When O O
daughter O O
subsequently O O
arrives, O O
she O O
confirms O O
desire O O
for O O
no O O
invasive O O
procedures, O O
lines, O O
surgeries, O O
or O O
ICU O O
level O O
care. O O
She O O
does O O
add O O
that O O
patient O O
was O O
at O O
Levi O O
Hospital O O
two O O
weeks O O
ago, O O
treated O O
for O O
&#8220;lung O O
infection.&#8221; O O
Uncertain O O
of O O
specifics. O O
ROS O O
15-point O O
ROS O O
as O O
above; O O
limited O O
by O O
mental O O
status. O O
MEDICAL O O
HISTORY O O
1 O O
&#8211; O O
Recurrent O O
GIB O O
&#8211; O O
s/p O O
EGD/colo O O
showing O O
multiple O O
duodenal/colonic O O
polyps O O
(12/2097) O O
, O O
here O O
with O O
GI O O
bleed O O
in O O
September, O O
no O O
workup O O
pursued O O
as O O
thought O O
to O O
be O O
major O O
cardiac O O
risk. O O
2 O O
&#8211; O O
Colon O O
Ca O O
- O O
Pt O O
seen O O
by O O
surgery O O
and O O
is O O
not O O
a O O
surgical O O
candidate O O
2/2 O O
multiple O O
medical O O
comorbidities. O O
3 O O
&#8211; O O
ESRD O O
since O O
2096 O O
(HD: O O
M/W/F) O O
-Access O O
L O O
brachiocephalic O O
AVF O O
-Presumed O O
2/2 O O
longstanding O O
DM O O
4 O O
&#8211; O O
DM2 B-DIABETES O
&#8211; O O
On O O
SSI O O
2/2 O O
frequent O O
hypoglycemia O O
episodes O O
on O O
long O O
acting O O
insulin B-MEDICATION O
5 O O
&#8211; O O
Chronic O O
decubitus O O
ulcers O O
presumed O O
2/2 O O
immobility O O
6 O O
&#8211; O O
HTN O O
7 O O
&#8211; O O
CVA O O
(12/2096) O O
&#8211; O O
c/b O O
significant O O
residual O O
speech/cognitive O O
deficits O O
8 O O
&#8211; O O
Gastroparesis O O
&#8211; O O
presumed O O
2/2 O O
longstanding O O
DM. O O
s/p O O
gastric O O
emptying O O
study O O
2/2098 O O
9 O O
- O O
Cataracts O O
10 O O
&#8211; O O
history B-CAD O
of I-CAD O
NSTEMI I-CAD O
per O O
some O O
prior O O
notes O O
MEDICATIONS O O
ON O O
ADMISSION: O O
from O O
discharge O O
med O O
list O O
in O O
September; O O
have O O
requested O O
current O O
med O O
list O O
from O O
NGH. O O
Amlodipine B-MEDICATION B-MEDICATION
10 O O
MG O O
PO O O
QPM O O
Cholestyramine O O
Resin O O
Dried O O
4 O O
GM O O
PO O O
BID O O
(last O O
dose: O O
09/14/98 O O
09:00 O O
am) O O
Hydralazine O O
Hcl O O
50 O O
MG O O
PO O O
Q6H O O
(last O O
dose: O O
09/14/98 O O
12:40 O O
am) O O
Irbesartan B-MEDICATION B-MEDICATION
(Avapro) B-MEDICATION O
150 O O
MG O O
PO O O
QD O O
Labetalol B-MEDICATION B-MEDICATION
Hcl O O
300 O O
MG O O
PO O O
TID O O
(last O O
dose: O O
09/13/98 O O
08:20 O O
pm) O O
Simvastatin B-MEDICATION B-MEDICATION
40 O O
MG O O
PO O O
QPM O O
(last O O
dose: O O
09/13/98 O O
08:00 O O
pm) O O
Albuterol O O
Nebulizer O O
Solution O O
2.5 O O
MG O O
NEB O O
Q6H O O
prn O O
Calcium O O
Acetate O O
( O O
1 O O
Gelcap=667 O O
Mg) O O
667 O O
MG O O
PO O O
TID O O
(last O O
dose: O O
09/14/98 O O
12:30 O O
pm) O O
Docusate O O
Sodium O O
(Colace O O
) O O
100 O O
MG O O
PO O O
TID O O
(last O O
dose: O O
09/14/98 O O
12:30 O O
pm) O O
Omeprazole O O
40 O O
MG O O
PO O O
QD O O
(last O O
dose: O O
09/14/98 O O
09:00 O O
am) O O
Polyethylene O O
Glycol O O
(Miralax) O O
17 O O
GM O O
PO O O
QD O O
prn O O
Sennosides O O
(Senna O O
Tablets) O O
2 O O
TAB O O
PO O O
BID O O
prn O O
Sevelamer O O
(Renagel) O O
400 O O
MG O O
PO O O
AC O O
(last O O
dose: O O
09/14/98 O O
12:30 O O
pm) O O
Divalproex O O
Sodium O O
(Depakote) O O
250 O O
MG O O
PO O O
QHS O O
Insulin B-MEDICATION O
Regular I-MEDICATION O
Inj O O
SC O O
AC O O
(Sliding O O
Scale) O O
If O O
BS O O
&lt;= O O
200 O O
give O O
0 O O
Units O O
For O O
BS O O
from O O
201 O O
to O O
250 O O
give O O
4 O O
Units O O
For O O
BS O O
from O O
251 O O
to O O
300 O O
give O O
6 O O
Units O O
For O O
BS O O
from O O
301 O O
to O O
350 O O
give O O
8 O O
Units O O
For O O
BS O O
from O O
351 O O
to O O
400 O O
give O O
10 O O
Units O O
For O O
BS O O
=&gt; O O
401 O O
give O O
12 O O
Units O O
and O O
call O O
responding O O
clinician O O
Donepezil O O
Hcl O O
(Aricept) O O
5 O O
MG O O
PO O O
QHS O O
Erythromycin O O
Ethylsuccinate O O
200 O O
Mg/5 O O
Ml O O
200 O O
MG O O
PO O O
AC O O
Nephrocaps O O
1 O O
CAPSULE O O
PO O O
QD O O
Acetylsalicylic B-MEDICATION O
Acid I-MEDICATION O
81 O O
MG O O
PO O O
QD O O
ALLERGIES: O O
NKDA O O
FAMILY O O
HISTORY O O
(from O O
past O O
notes): O O
Mother O O
with O O
breast O O
cancer, O O
father O O
with O O
lung O O
cancer. O O
No O O
FH O O
of O O
DM. O O
No O O
FH O O
of O O
intrinsic O O
renal O O
disease. O O
SOCIAL O O
HISTORY O O
Lives O O
in O O
Wheatland O O
Manor, O O
has O O
one O O
daughter. O O
Per O O
prior O O
notes, O O
no O O
tobacco, O O
alcohol, O O
illicits. O O
Daughter&#8217;s O O
contact O O
info: O O
Sally, O O
home O O
011-053-5691, O O
cell O O
544-761-0912 O O
Wheatland O O
Manor: O O
154-734-1487, O O
x557 O O
(4th O O
floor) O O
PHYSICAL O O
EXAM O O
VITALS: O O
T: O O
97.4 O O
HR: O O
60s O O
BP: O O
80-90/30s-40s O O
RR: O O
O2Sat: O O
95%, O O
currently O O
on O O
4.5 O O
liters O O
GEN&#8217;L: O O
somnolent O O
but O O
arousable, O O
alert O O
to O O
hospital, O O
but O O
not O O
month O O
and O O
year, O O
knows O O
daughter&#8217;s O O
name O O
SKIN O O
: O O
no O O
rashes O O
noted O O
HEENT O O
: O O
essentially O O
normocephalic, O O
atraumatic, O O
no O O
facial O O
droop O O
noted O O
NECK: O O
supple O O
HEART O O
: O O
regular, O O
difficult O O
to O O
localize O O
systolic O O
murmur O O
heard O O
LUNG O O
: O O
Decreased O O
breath O O
sounds O O
globally, O O
but O O
no O O
discrete O O
crackles/wheezes O O
heard O O
ABD: O O
hypoactive O O
bowel O O
sounds; O O
is O O
diffusely O O
tender. O O
Fluid O O
wave O O
does O O
appear O O
to O O
be O O
present. O O
RECTAL: O O
not O O
performed O O
at O O
this O O
time. O O
EXT: O O
does O O
not O O
appear O O
to O O
be O O
able O O
to O O
move O O
lower O O
extremities O O
significantly O O
on O O
own. O O
NEURO: O O
as O O
above; O O
LABORATORY O O
STUDIES O O
of O O
note: O O
Hct O O
33, O O
platelets O O
481, O O
WBC O O
7.7 O O
with O O
unremarkable O O
diff O O
Na O O
136, O O
K O O
5.0, O O
bicarb O O
31, O O
BUN/Cr O O
39/4.02 O O
Lactate O O
1.2 O O
UA O O
with O O
over O O
100 O O
WBCs. O O
MICROBIOLOGY O O
Blood O O
and O O
urine O O
cultures O O
pending O O
RADIOLOGY O O
Abdominal O O
CT O O
IMPRESSION: O O
1. O O
New O O
moderate-sized O O
pericardial O O
effusion O O
with O O
pericardial O O
enhancement O O
which O O
may O O
be O O
due O O
to O O
pericarditis O O
or O O
pericardial O O
metastatic O O
disease. O O
2. O O
Rectal O O
wall O O
thickening O O
with O O
fecal O O
impaction, O O
consistent O O
with O O
proctitis, O O
possibly O O
due O O
to O O
venous O O
stasis. O O
3. O O
Thickened O O
urinary O O
bladder O O
wall O O
with O O
irregularity O O
and O O
enhancement O O
consistent O O
with O O
cystitis. O O
4. O O
Slight O O
increase O O
in O O
moderate O O
ascites O O
since O O
4/2/98. O O
5. O O
Distended O O
urinary O O
bladder O O
with O O
unchanged O O
bladder O O
wall O O
thickening. O O
Also O O
noted O O
are O O
moderate O O
bilateral O O
pleural O O
effusions. O O
CXR: O O
IMPRESSION: O O
Pulmonary O O
edema O O
with O O
large O O
left O O
effusion O O
small O O
right O O
effusion. O O
TTE: O O
MITRAL O O
VALVE O O
There O O
is O O
calcification O O
of O O
the O O
posterior O O
mitral O O
annulus. O O
There O O
is O O
no O O
evidence O O
of O O
mitral O O
valve O O
prolapse. O O
There O O
is O O
trace O O
mitral O O
regurgitation O O
by O O
color O O
and O O
spectral O O
Doppler. O O
There O O
is O O
a O O
calcified O O
papillary O O
muscle O O
tip. O O
LEFT O O
ATRIUM O O
The O O
left O O
atrium O O
is O O
elongated. O O
The O O
antero-posterior O O
left O O
atrial O O
dimension O O
is O O
38 O O
mm O O
(normal O O
range: O O
up O O
to O O
38 O O
mm). O O
The O O
medial-lateral O O
left O O
atrial O O
dimension O O
is O O
42 O O
mm O O
(normal O O
range: O O
up O O
to O O
49 O O
mm). O O
The O O
superior-inferior O O
left O O
atrial O O
dimension O O
is O O
56 O O
mm O O
(normal O O
range: O O
up O O
to O O
53 O O
mm). O O
AORTIC O O
VALVE, O O
AORTA, O O
LVOT O O
Multiple O O
aortic O O
leaflets O O
are O O
thickened O O
but O O
there O O
is O O
no O O
stenosis. O O
The O O
aortic O O
valve O O
is O O
tricuspid. O O
There O O
is O O
evidence O O
of O O
mild O O
aortic O O
insufficiency O O
by O O
color O O
and O O
spectral O O
Doppler. O O
The O O
aortic O O
diameter O O
at O O
the O O
sinuses O O
of O O
Valsalva O O
is O O
29 O O
mm O O
(normal: O O
less O O
than O O
40mm). O O
The O O
ascending O O
aorta O O
diameter O O
above O O
the O O
sinotubular O O
junction O O
is O O
28 O O
mm O O
(normal: O O
less O O
than O O
or O O
equal O O
to O O
36mm). O O
LEFT O O
VENTRICLE O O
The O O
left O O
ventricular O O
cavity O O
size O O
is O O
normal. O O
The O O
left O O
ventricular O O
systolic O O
function O O
is O O
within O O
normal O O
limits. O O
There O O
is O O
symmetric O O
left O O
ventricular O O
hypertrophy. O O
There O O
are O O
no O O
obvious O O
segmental O O
wall O O
motion O O
abnormalities. O O
The O O
estimated O O
ejection O O
fraction O O
is O O
66 O O
%. O O
LVEF O O
was O O
measured O O
by O O
the O O
single O O
dimension O O
method. O O
TRICUSPID O O
VALVE O O
- O O
IVC, O O
SVC O O
There O O
is O O
color O O
and O O
spectral O O
Doppler O O
evidence O O
of O O
mild O O
tricuspid O O
insufficiency. O O
The O O
inferior O O
vena O O
cava O O
is O O
dilated. O O
There O O
is O O
no O O
phasic O O
collapse O O
of O O
the O O
IVC O O
noted. O O
PULMONARY O O
VALVE, O O
INFUND., O O
P.A. O O
There O O
is O O
evidence O O
of O O
mild O O
pulmonary O O
insufficiency O O
by O O
color O O
and O O
spectral O O
Doppler. O O
The O O
RV O O
systolic O O
pressure O O
was O O
estimated O O
from O O
the O O
regurgitant O O
tricuspid O O
velocity O O
(assuming O O
an O O
RA O O
pressure O O
of O O
10mmHg). O O
The O O
estimated O O
RV O O
systolic O O
pressure O O
is O O
41 O O
mmHg. O O
RIGHT O O
VENTRICLE O O
The O O
right O O
ventricle O O
is O O
not O O
dilated. O O
There O O
is O O
right O O
ventricular O O
hypertrophy. O O
The O O
right O O
ventricular O O
systolic O O
function O O
is O O
within O O
normal O O
limits. O O
INTERATRIAL O O
SEPTUM, O O
INTERVENTRICULAR O O
SEPTUM O O
There O O
is O O
no O O
evidence O O
of O O
a O O
patent O O
foramen O O
ovale O O
by O O
Doppler. O O
PERICARDIAL O O
DISEASE O O
AND O O
EXTRACARDIAC O O
MASSES O O
There O O
is O O
a O O
small O O
circumferential O O
pericardial O O
effusion. O O
There O O
is O O
no O O
echocardiographic O O
evidence O O
of O O
tamponade. O O
There O O
are O O
intrapericardial O O
fibrinous O O
strands. O O
There O O
is O O
evidence O O
of O O
a O O
large O O
pleural O O
effusion. O O
There O O
is O O
ascites. O O
CONCLUSIONS O O
Compared O O
to O O
the O O
study O O
of O O
3/18/98, O O
a O O
small O O
circumferential O O
pericardial O O
effusion O O
is O O
now O O
noted, O O
and O O
the O O
measured O O
RVSP O O
has O O
decreased O O
(55 O O
mm O O
Hg O O
previously). O O
LVH O O
and O O
RVH O O
have O O
appeared. O O
EKG: O O
EKG O O
reviewed O O
&#8211; O O
notable O O
for O O
low O O
voltages, O O
normal O O
intervals, O O
no O O
significant O O
ST O O
changes O O
compared O O
to O O
prior O O
ASSESSMENT O O
&amp; O O
PLAN O O
65F O O
with O O
colon O O
cancer O O
(but O O
not O O
candidate O O
for O O
intervention), O O
CVA O O
with O O
residual O O
speech/cognitive O O
deficits, O O
recurrent O O
GI O O
bleeds, O O
HTN, O O
p/w O O
hypotension. O O
Suspect O O
likely O O
UTI O O
as O O
source O O
given O O
frank O O
pyuria. O O
Can&#8217;t O O
rule O O
out O O
SBP O O
in O O
setting O O
of O O
ascites O O
and O O
abdominal O O
pain, O O
but O O
seems O O
less O O
likely. O O
Does O O
have O O
bilateral O O
pleural O O
effusions, O O
but O O
these O O
are O O
chronic O O
and O O
without O O
other O O
signs O O
of O O
empyema, O O
and O O
small O O
pericardial O O
effusion O O
with O O
no O O
signs O O
of O O
tamponade. O O
Goals O O
of O O
care O O
are O O
decidedly O O
conservative. O O
Shock, O O
likely O O
2/2 O O
urosepsis: O O
Foley O O
placed, O O
purulent O O
material O O
returned. O O
Culture O O
pending. O O
Got O O
Vanc O O
1 O O
gm O O
in O O
ED O O
at O O
approximately O O
noon, O O
2 O O
gm O O
cefepime O O
at O O
noon. O O
-continue O O
cefepime O O
1 O O
gm O O
daily O O
-vanc O O
1 O O
gm O O
with O O
HD O O
-consider O O
diagnostic O O
paracentesis O O
tonight O O
(daughter O O
said O O
this O O
procedure O O
seems O O
reasonable), O O
but O O
would O O
be O O
of O O
limited O O
value O O
given O O
diagnostic O O
only O O
and O O
more O O
likely O O
source O O
of O O
UTI O O
-with O O
finding O O
of O O
proctitis O O
on O O
CT, O O
will O O
add O O
IV O O
flagyl O O
Hypoxia, O O
bilateral O O
pleural O O
effusions: O O
on O O
4-5 O O
L, O O
suspect O O
fluid O O
overload O O
as O O
culprit O O
-could O O
consider O O
therapeutic O O
thoracentesis O O
if O O
this O O
would O O
allow O O
more O O
aggressive O O
fluid O O
resuscitation, O O
but O O
should O O
discuss O O
with O O
daughter O O
first O O
ESRD: O O
renal O O
following, O O
will O O
consider O O
HD O O
tomorrow, O O
pending O O
labs/hemodynamics O O
h/o O O
GI O O
bleeds: O O
hct O O
seems O O
stable O O
without O O
evidence O O
for O O
bleed O O
as O O
cause O O
of O O
shock, O O
but O O
follow O O
Hct O O
in O O
AM O O
DM: O O
SSI O O
HTN: O O
holding O O
anti-hypertensives O O
Goals O O
of O O
care: O O
as O O
above, O O
no O O
surgeries/invasive O O
interventions/ICU O O
level O O
care O O
Med O O
recon: O O
PAML O O
created O O
from O O
last O O
discharge O O
med O O
list; O O
have O O
requested O O
current O O
med O O
list O O
from O O
NGH, O O
not O O
yet O O
received O O
by O O
fax O O
FEN: O O
-boluses O O
tonight O O
as O O
needed O O
-follow O O
lytes O O
-NPO O O
for O O
now O O
given O O
mental O O
status, O O
active O O
resuscitation O O
PPX: O O
-GI: O O
continue O O
omeprazole O O
if O O
awake O O
enough O O
to O O
take O O
POs O O
-DVT: O O
subq O O
heparin O O
-BOWEL: O O
docusate/senna O O
Code O O
Status: O O
DNR/DNI O O
(Discussed O O
with O O
patient&#8217;s O O
daughter/HCP.) O O
__________________________________ O O
Quenton O O
Stark, O O
MD O O
MMC/Team O O
4 O O
Pager O O
#00138 O O

Record B-SMOKER O
date: O O
2061-10-13 O O
October O O
13, O O
2061 O O
Philip O O
Stanley, O O
M.D. O O
Internal O O
Medicine O O
Donnellson O O
Community O O
Clinic O O
RE: O O
Shilpa O O
Pickett O O
MR O O
#129-53-47-3 O O
Dear O O
Philip: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
Shilpa O O
Pickett O O
in O O
Cardiovascular O O
Clinic O O
today. O O
Since O O
her O O
discharge O O
from O O
the O O
hospital O O
in O O
September, O O
she O O
has O O
noticed O O
that O O
she O O
is O O
fatigue O O
with O O
exertion O O
but O O
has O O
had O O
no O O
chest O O
pressure O O
and O O
no O O
exertional O O
diaphoresis, O O
nausea, O O
or O O
jaw O O
pain. O O
She O O
does O O
note O O
occasional O O
lightheadedness O O
throughout O O
the O O
day, O O
this O O
is O O
not O O
related O O
to O O
position O O
or O O
going O O
from O O
sitting O O
to O O
standing O O
position. O O
As O O
you O O
are O O
aware, O O
her O O
MIBI O O
test O O
showed O O
very O O
small O O
amount O O
of O O
ischemia O O
almost O O
undetectable O O
in O O
amount. O O
Her O O
medical O O
regimen O O
includes O O
Lasix O O
40 O O
mg O O
po O O
q.d., O O
Lisinopril B-MEDICATION B-MEDICATION
20 O O
mg O O
po O O
q.d., O O
125 O O
mg O O
of O O
hydrochlorothiazide B-MEDICATION B-MEDICATION
b.i.d. O O
Of O O
note, O O
she O O
was O O
taking O O
an O O
additional O O
Lisinopril O B-MEDICATION
at O O
20 O O
mg O O
po O O
b.i.d. O O
Labetalol B-MEDICATION B-MEDICATION
200 O O
mg O O
b.i.d., O O
Isordil B-MEDICATION B-MEDICATION
40 O O
t.i.d., O O
Prilosec O O
20 O O
mg O O
po O O
q.d., O O
Cisapride O B-MEDICATION
10 O O
mg O O
po O O
q.d., O O
simvastatin B-MEDICATION B-MEDICATION
10 O O
mg O O
po O O
q.d., O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
po O O
q.d. O O
On O O
physical O O
exam, O O
her O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
140/90 I-HYPERTENSION O
right I-HYPERTENSION O
and I-HYPERTENSION O
left I-HYPERTENSION O
arm I-HYPERTENSION O
seated, I-HYPERTENSION O
heart O O
rate O O
is O O
77 O O
and O O
irregular, O O
respiratory O O
rate O O
is O O
12. O O
There O O
is O O
no O O
increase O O
in O O
jugular O O
venous O O
pressure. O O
Carotids O O
are O O
free O O
of O O
bruits. O O
Lungs O O
are O O
clear O O
to O O
auscultation O O
throughout. O O
Cardiac O O
exam O O
is O O
notable O O
for O O
distant O O
heart O O
sounds O O
with O O
no O O
S3, O O
S4. O O
Abdomen O O
is O O
soft O O
and O O
nontender. O O
The O O
extremities O O
are O O
free O O
of O O
edema. O O
Electrocardiogram O O
is O O
normal O O
sinus O O
rhythm O O
with O O
left O O
bundle O O
branch O O
block O O
unchanged O O
from O O
prior O O
electrocardiograms. O O
In O O
summary, O O
Shilpa O O
Pickett O O
certainly O O
has O O
cardiovascular O O
risk O O
factors O O
of O O
sedentary O O
lifestyle, O O
diabetes, B-DIABETES O
high B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
and O O
increase O O
in O O
weight. O O
We O O
will O O
be O O
rechecking O O
her O O
lipid O O
profile O O
today. O O
She O O
reports O O
to O O
me O O
that O O
she O O
has O O
absolutely O O
no O O
appetite O O
for O O
the O O
foods O O
she O O
usually O O
eats O O
and O O
has O O
occasionally O O
had O O
trouble O O
eating. O O
She O O
notes O O
no O O
dysphoria O O
and O O
no O O
other O O
signs O O
or O O
symptoms O O
of O O
depression. O O
She O O
has O O
had O O
no O O
change O O
in O O
her O O
hair O O
or O O
skin. O O
For O O
the O O
Pickett, O O
Shilpa O O
MR O O
#129-53-47-3 O O
-2- O O
October O O
13, O O
2061 O O
moment, O O
I O O
will O O
be O O
reviewing O O
her O O
SMA O O
20 O O
for O O
evidence O O
of O O
liver O O
dysfunction O O
but O O
would O O
strongly O O
consider O O
both O O
depression O O
and O O
hyperthyroidism O O
for O O
further O O
workup O O
of O O
this O O
loss O O
of O O
appetite. O O
It O O
is O O
certainly O O
a O O
pleasure O O
for O O
me O O
to O O
participate O O
in O O
Shilpa O O
Pickett' O O
care. O O
Let O O
me O O
know O O
if O O
there O O
are O O
any O O
questions O O
or O O
issues O O
I O O
can O O
be O O
of O O
help O O
with. O O
Sincerely, O O
Leona O O
Xiques, O O
M.D. O O
Second O O
Alabama O O
Hospital O O
78 O O
Parkhurst O O
Drive O O
Ladysmith, O O
TN O O
47657 O O
DD: O O
10/13/61 O O
DT: O O
10/14/61 O O
DV: O O
10/13/61 O O
/maynard O O
******** O O
Approved O O
but O O
not O O
reviewed O O
by O O
Attending O O
Provider O O
******** O O

Record B-SMOKER O
date: O O
2062-07-29 O O
DONELLSON O O
EMERGENCY O O
DEPT O O
VISIT O O
PICKETT,SHILPA O O
129-53-47-3 O O
VISIT O O
DATE: O O
07/29/62 O O
PRESENTING O O
COMPLAINT: O O
Syncope. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
Seventy-year-old O O
female O O
with O O
diabetes, B-DIABETES O
hypertension, B-HYPERTENSION B-HYPERTENSION
coronary B-CAD O
artery I-CAD O
disease I-CAD O
complaining O O
about O O
syncopal O O
episode O O
today. O O
The O O
patient O O
states O O
that O O
over O O
the O O
last O O
couple O O
of O O
weeks O O
she O O
has O O
had O O
increased O O
chest O O
palpitations O O
and O O
two O O
weeks O O
ago O O
was O O
given O O
an O O
event O O
monitor O O
which O O
he O O
has O O
intermittently O O
worn O O
saying O O
it O O
is O O
difficult O O
to O O
wear O O
during O O
the O O
heat O O
wave. O O
This O O
a.m. O O
the O O
patient O O
had O O
a O O
syncopal O O
episode O O
while O O
watching O O
a O O
disagreement O O
between O O
her O O
two O O
grandchildren. O O
The O O
patient O O
states O O
had O O
no O O
chest O O
pain, O O
dizziness, O O
nausea, O O
or O O
vomiting. O O
The O O
patient O O
fell O O
to O O
the O O
floor O O
and O O
awoke, O O
denies O O
incontinence O O
or O O
tongue O O
biting. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension, B-HYPERTENSION B-HYPERTENSION
diabetes, O O
coronary B-CAD O
artery I-CAD O
disease, I-CAD O
CVA. O O
MEDICATIONS: O O
Aspirin, B-MEDICATION B-MEDICATION
Lasix, O O
Lopressor, B-MEDICATION B-MEDICATION
Isordil, B-MEDICATION O
insulin, B-MEDICATION O
lisinopril, B-MEDICATION B-MEDICATION
Colace, O O
nitroglycerin B-MEDICATION B-MEDICATION
sublingual, O O
Cisapride, O O
Prilosec. O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
PHYSICAL O O
EXAMINATION: O O
Well O O
developed, O O
well O O
nourished O O
female O O
with O O
a O O
Glasgow O O
Coma O O
Scale O O
of O O
15. O O
HEENT O O
normocephalic, O O
atraumatic. O O
Neck O O
supple O O
without O O
spinal O O
tenderness. O O
Heart O O
regular O O
rate O O
and O O
rhythm, O O
positive O O
2/6 O O
systolic O O
ejection O O
murmur. O O
Chest O O
is O O
clear. O O
Abdomen O O
is O O
soft, O O
nontender, O O
positive O O
bowel O O
sounds. O O
Extremities O O
without O O
clubbing, O O
cyanosis O O
or O O
edema. O O
Neuro O O
alert O O
and O O
oriented O O
times O O
three, O O
good O O
motor O O
strength O O
throughout, O O
sensory O O
intact, O O
no O O
focality. O O
FINAL O O
DIAGNOSIS: O O
Syncopal O O
episode O O
most O O
likely O O
cardiac O O
in O O
origin. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Will O O
admit O O
to O O
monitor O O
and O O
rule O O
out O O
for O O
MI. O O
The O O
patient O O
was O O
admitted O O
in O O
stable O O
condition. O O
___________________________________ O O
IE615/5791 O O
LINDA O O
ANDREWS, O O
M.D. O O
LA06 O O
D:07/29/62 O O
T:07/30/62 O O
Dictated O O
by: O O
LINDA O O
ANDREWS, O O
M.D. O O
LA06 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2063-03-20 O O
EASLEY O O
BAPTIST O O
HOSPITAL O O
Pickett, O O
Silpa O O
12953473 O O
03-20-63 O O
CHIEF O O
COMPLAINT: O O
Ms. O O
Pickett O O
comes O O
to O O
the O O
Easley O O
Baptist O O
Hospital O O
with O O
numerous O O
complaints. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
She O O
states O O
that O O
she O O
has O O
not O O
been O O
feeling O O
well O O
since O O
her O O
upper O O
respiratory O O
tract O O
infection. O O
She O O
had O O
the O O
flu O O
in O O
January O O
and O O
then O O
developed O O
another O O
upper O O
respiratory O O
tract O O
infection O O
a O O
couple O O
of O O
weeks O O
ago. O O
She O O
states O O
that O O
this O O
has O O
severely O O
debilitated O O
her. O O
She O O
is O O
complaining O O
of O O
occasional O O
nonproductive O O
cough, O O
post O O
nasal O O
drip, O O
and O O
occasional O O
dull O O
headache. O O
However, O O
her O O
main O O
concern O O
is O O
her O O
stomach O O
and O O
her O O
back. O O
Ms. O O
Pickett O O
continues O O
to O O
have O O
postprandial O O
nausea O O
and O O
discomfort O O
in O O
her O O
epigastrium, O O
particularly O O
after O O
eating. O O
This O O
is O O
different O O
than O O
her O O
reflux O O
disease, O O
which O O
she O O
feels O O
is O O
under O O
fairly O O
good O O
control, O O
with O O
the O O
Prilosec-Propulsid O O
combination. O O
She O O
is O O
describing O O
some O O
anorexia, O O
although O O
she O O
has O O
not O O
lost O O
any O O
weight. O O
She O O
has O O
not O O
had O O
any O O
alterations O O
in O O
her O O
bowel O O
movements. O O
She O O
has O O
not O O
been O O
constipated O O
or O O
had O O
diarrhea. O O
She O O
wonders O O
whether O O
this O O
could O O
be O O
in O O
gallbladder. O O
In O O
addition, O O
she O O
is O O
continuing O O
to O O
have O O
some O O
back O O
pain O O
with O O
radiation O O
down O O
her O O
left O O
leg O O
in O O
the O O
L5/S1 O O
distribution. O O
She O O
had O O
one O O
epidural O O
steroid O O
injection O O
but O O
was O O
due O O
to O O
go O O
back. O O
Given O O
her O O
upper O O
respiratory O O
tract O O
infection, O O
this O O
was O O
postponed. O O
She O O
is O O
not O O
having O O
any O O
heart O O
symptoms O O
or O O
shortness O O
of O O
breath. O O
Her O O
sugars O O
have O O
been O O
under O O
good O O
control, O O
ranging O O
between O O
111 O O
and O O
143. O O
Her O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
152/70 B-HYPERTENSION O
today, O O
with O O
a O O
pulse O O
of O O
70. O O
She O O
is O O
saturating O O
well. O O
PHYSICAL O O
EXAMINATION: O O
On O O
physical O O
exam, O O
lungs O O
were O O
clear O O
to O O
auscultation. O O
There O O
was O O
no O O
JVD. O O
Heart: O O
regular O O
rate O O
and O O
rhythm O O
with O O
positive O O
S4, O O
? O O
S3 O O
with O O
no O O
significant O O
murmur. O O
Abdomen O O
was O O
soft, O O
nondistended, O O
with O O
some O O
mild O O
tenderness O O
without O O
rebound O O
or O O
guarding O O
over O O
the O O
right O O
upper O O
quadrant. O O
Abdomen O O
was O O
somewhat O O
bloated O O
per O O
patient O O
and O O
diffusely O O
tender. O O
Extremities O O
revealed O O
some O O
mild O O
pedal O O
edema O O
left O O
greater O O
than O O
right. O O
ASSESSMENT O O
AND O O
PLAN: O O
A O O
seventy-one-year-old O O
woman O O
with O O
multiple O O
medical O O
issues, O O
including O O
coronary B-CAD O
artery I-CAD O
disease, I-CAD O
CHF, O O
diabetes, B-DIABETES O
hypertension, B-HYPERTENSION O
and O O
cerebrovascular O O
disease. O O
She O O
came O O
in O O
today O O
for O O
discussion O O
of O O
her O O
ongoing O O
lumbar O O
radiculopathic O O
pain O O
as O O
well O O
as O O
her O O
abdominal O O
complaint. O O
With O O
regard O O
to O O
her O O
back O O
pain, O O
she O O
wanted O O
a O O
prescription O O
for O O
Tylenol O O
with O O
codeine, O O
which O O
has O O
helped O O
in O O
the O O
past. O O
I O O
gave O O
her O O
a O O
prescription. O O
I O O
warned O O
her O O
about O O
the O O
possible O O
side O O
effects O O
of O O
constipation. O O
She O O
should O O
contact O O
the O O
pain O O
clinic O O
as O O
soon O O
as O O
she O O
feels O O
able, O O
for O O
a O O
repeat O O
epidural O O
steroid O O
injection. O O
With O O
regard O O
to O O
her O O
abdominal O O
complaints, O O
the O O
bubbling O O
in O O
her O O
chest, O O
postprandial O O
nausea O O
and O O
anorexia O O
could O O
certainly O O
be O O
due O O
to O O
gallbladder O O
disease. O O
Unclear O O
contribution O O
from O O
her O O
reflux. O O
Dr. O O
Mario O O
Robison O O
recommended O O
elective O O
cholecystectomy. O O
Given O O
the O O
fact O O
that O O
Ms. O O
Pickett O O
is O O
being O O
more O O
and O O
more O O
bothered O O
by O O
these O O
symptoms, O O
it O O
may O O
be O O
reasonable O O
to O O
EASLEY O O
BAPTIST O O
HOSPITAL O O
Pickett, O O
Silpa O O
12953473 O O
03-20-63 O O
page O O
2 O O
consider O O
her O O
for O O
the O O
surgery. O O
I O O
have O O
asked O O
her O O
to O O
call O O
Dr. O O
Xiques O O
and O O
make O O
an O O
appointment O O
to O O
discuss O O
her O O
cardiovascular O O
risk O O
so O O
that O O
she O O
can O O
make O O
an O O
informed O O
decision O O
about O O
the O O
surgery. O O
She O O
is O O
otherwise O O
up O O
to O O
date O O
with O O
her O O
issues O O
and O O
doing O O
relatively O O
well O O
from O O
a O O
cardiovascular O O
and O O
diabetic O O
perspective. O O
She O O
would O O
probably O O
do O O
better O O
with O O
lower O O
blood O O
pressure. O O
We O O
could O O
consider O O
increasing O O
her O O
Imdur. O O
I O O
plan O O
to O O
follow O O
up O O
with O O
her O O
in O O
a O O
few O O
weeks O O
time. O O
_________________________ O O
Una O O
Romano, O O
M.D. O O
LL:OB:6245 O O
DD:03-20-63 O O
DT:03-20-63 O O
DV:03-20-63 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2064-10-05 O O
DONELLSON O O
EMERGENCY O O
DEPT O O
VISIT O O
PICKETT,SHILPA O O
129-53-47-3 O O
VISIT O O
DATE: O O
10/05/64 O O
Please O O
see O O
the O O
resident's O O
handwritten O O
note O O
for O O
additional O O
complete O O
details. O O
I O O
also O O
saw O O
the O O
patient O O
to O O
supervise O O
the O O
resident's O O
care. O O
PRESENTING O O
COMPLAINT: O O
Chest B-CAD O
pain. I-CAD O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
A O O
73-year-old O O
woman O O
with O O
known O O
coronary B-CAD O
disease I-CAD O
with O O
cardiac O O
catheterization O O
and O O
three-vessel O O
disease O O
in O O
2062, O O
and O O
a O O
positive O O
exercise O O
tolerance O O
test O O
in O O
2063. O O
She O O
was O O
with O O
relatively O O
stable O O
symptoms O O
until O O
early O O
this O O
morning O O
when O O
she O O
had O O
increase B-CAD O
in I-CAD O
chest I-CAD O
tightness I-CAD O
and I-CAD O
dyspnea I-CAD O
on I-CAD O
exertion. I-CAD O
She O O
has O O
actually O O
been O O
stuttering O O
on O O
and O O
off O O
for O O
18-24 O O
hours, O O
and O O
she O O
came O O
to O O
the O O
emergency O O
department O O
in O O
the O O
earl O O
morning O O
hours O O
for O O
evaluation O O
of O O
this O O
problem. O O
She O O
is O O
presently O O
pain O O
free O O
after O O
having O O
received O O
nitrates O O
in O O
the O O
emergency O O
department. O O
SOCIAL B-SMOKER O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
Noted O O
on O O
handwritten O O
emergency O O
department O O
record. O O
PHYSICAL O O
EXAMINATION: O O
GENERAL: O O
Patient O O
is O O
presently O O
comfortable O O
in O O
no O O
respiratory O O
distress. O O
HEART: O O
No O O
murmurs O O
or O O
gallops. O O
Pulses O O
are O O
equal O O
and O O
symmetric. O O
LUNGS: O O
Clear O O
to O O
auscultation O O
bilaterally. O O
LABORATORY O O
EVALUATION: O O
Electrocardiogram O O
shows O O
left O O
bundle O O
branch O O
pattern O O
which O O
is O O
old. O O
Her O O
cardiac O O
markers O O
are O O
positive O O
for O O
troponin O O
I O O
of O O
0.32. O O
FINAL O O
DIAGNOSIS: O O
Acute O O
coronary O O
insufficiency. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Patient O O
is O O
presently O O
comfortable O O
and O O
will O O
be O O
admitted O O
to O O
cardiology O O
service. O O
___________________________________ O O
LR676/41602 O O
ADAM O O
OLDHAM, O O
M.D. O O
AO66 O O
D:10/05/64 O O
T:10/05/64 O O
Dictated O O
by: O O
ADAM O O
OLDHAM, O O
M.D. O O
AO66 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2069-06-27 O O
EDVISIT^12953473^PICKETT, O O
SHILPA^06/27/69^RICO, O O
WILLARD O O
The O O
patient O O
was O O
seen O O
with O O
Dr. O O
Mueller. O O
I O O
confirmed O O
her O O
history O O
and O O
physical. O O
I O O
also O O
interviewed O O
and O O
examined O O
the O O
patient. O O
Please O O
see O O
her O O
note O O
for O O
more O O
details. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
is O O
a O O
77-year-old O O
female O O
with O O
a O O
several-week O O
history O O
of O O
nausea, O O
vomiting, O O
abdominal O O
pain, O O
which O O
has O O
worsened O O
over O O
the O O
past O O
3 O O
days, O O
per O O
the O O
patient O O
and O O
her O O
son. O O
These O O
episodes O O
are O O
'gassy O O
feeling' O O
in O O
the O O
epigastrium O O
associated O O
with O O
nausea O O
and O O
vomiting O O
and O O
lightheadedness. O O
No O O
chest O O
pain, O O
no O O
shortness O O
of O O
breath. O O
Of O O
note, O O
the O O
patient O O
has O O
a O O
history O O
of O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
with O O
atypical O O
symptoms. O O
She O O
has O O
also O O
had O O
a O O
history O O
of O O
pancreatitis. O O
PHYSICAL O O
EXAMINATION: O O
She O O
is O O
awake O O
and O O
alert, O O
in O O
no O O
distress O O
at O O
this O O
time. O O
Afebrile O O
with O O
a O O
pulse O O
of O O
62, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
140/60, I-HYPERTENSION O
and O O
O2 O O
sat O O
100% O O
on O O
room O O
air. O O
Neck O O
is O O
supple O O
with O O
no O O
signs O O
of O O
meningismus. O O
Head O O
is O O
atraumatic. O O
Moist O O
mucous O O
membranes. O O
Lungs O O
are O O
clear O O
to O O
auscultation O O
bilaterally. O O
Heart O O
has O O
regular O O
rate O O
and O O
rhythm. O O
Abdomen O O
is O O
soft O O
with O O
mild O O
epigastric O O
tenderness O O
to O O
palpation. O O
No O O
guarding O O
or O O
rebound O O
on O O
my O O
exam. O O
Extremities O O
are O O
warm O O
and O O
well O O
perfused. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
The O O
patient's O O
IV O O
access O O
was O O
established. O O
Labs O O
were O O
drawn O O
revealing O O
white O O
count O O
of O O
8, O O
hematocrit O O
of O O
39. O O
BUN O O
and O O
creatinine O O
of O O
36 O O
and O O
1.5, O O
which O O
is O O
normal O O
for O O
the O O
patient. O O
LFTs O O
are O O
normal. O O
Lipase O O
is O O
slightly O O
elevated O O
at O O
67. O O
Troponin O O
less O O
than O O
assay. O O
Urinalysis O O
25-30 O O
white O O
cells. O O
The O O
patient's O O
EKG O O
was O O
left O O
bundle-branch O O
block, O O
which O O
is O O
unchanged. O O
KUB O O
shows O O
no O O
air O O
fluid O O
levels. O O
This O O
patient O O
has O O
a O O
possible O O
mild O O
pancreatitis O O
as O O
well O O
as O O
a O O
mild O O
urinary O O
tract O O
infection. O O
In O O
addition, O O
she O O
has O O
multiple O O
cardiac O O
risk O O
factors O O
and O O
an O O
EKG, O O
which O O
will O O
not O O
allow O O
for O O
conventional O O
cardiac O O
stress O O
testing. O O
She O O
will O O
be O O
admitted O O
the O O
hospital O O
for O O
enzymatic O O
rule O O
out O O
MI O O
with O O
a O O
possible O O
necessity O O
to O O
have O O
a O O
stress O O
MIBI O O
as O O
well O O
as O O
to O O
give O O
IV O O
antibiotics O O
for O O
urinary O O
tract O O
infection O O
and O O
hydration O O
and O O
serial O O
exams O O
for O O
her O O
probable O O
pancreatitis. O O
The O O
patient O O
was O O
admitted O O
to O O
the O O
floor O O
in O O
stable O O
condition. O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O
______________________________ O O
RICO, O O
WILLARD O O
MD O O
D: O O
06/28/69 O O
T: O O
06/28/69 O O
Dictated O O
By: O O
RICO, O O
WILLARD O O
eScription O O
document:3-4025432 O O
BF O O

Record O O
date: O O
2074-09-03 O O
HSP O O
Cardiovascular O O
Division O O
CVD O O
MR8 O O
99 O O
Fitzpatrick O O
Circle O O
SERGIO-STEVEN, O O
FRANCESCA O O
Adrian, O O
TN O O
13467 O O
80780896 O O
(433) O O
758-3431 O O
09/03/74 O O
REFERRING O O
PHYSICIAN: O O
Armando O O
Newton, O O
M.D. O O
Mrs. O O
Francesca O O
Sergio-Steven O O
is O O
a O O
72-year-old O O
Hispanic O O
female O O
who O O
presents O O
with O O
a O O
new-onset B-CAD O
acute I-CAD O
MI. B-CAD O
She O O
has O O
no O O
known O O
prior O O
manifestations O O
of O O
coronary B-CAD O
disease, I-CAD O
but O O
has O O
a O O
long O O
history O O
of O O
insulin-dependent B-DIABETES O
diabetes B-DIABETES O
mellitus I-DIABETES O
and O O
hypertension. B-HYPERTENSION B-HYPERTENSION
She O O
had O O
been O O
in O O
her O O
usual O O
state O O
of O O
health O O
until O O
about O O
2 O O
weeks O O
ago, O O
when O O
she O O
began O O
to O O
have O O
episodes O O
of O O
chest O O
discomfort. O O
She O O
has O O
only O O
had O O
two O O
such O O
episodes O O
until O O
the O O
morning O O
of O O
admission, O O
when O O
she O O
developed O O
severe O O
episode O O
of O O
chest O O
pain O O
at O O
rest O O
associated O O
with O O
shortness O O
of O O
breath. O O
She O O
presented O O
to O O
the O O
emergency O O
room O O
here O O
where O O
she O O
was O O
found O O
to O O
have O O
new-onset O O
ST-segment O O
elevation O O
in O O
the O O
inferior O O
leads O O
with O O
a O O
coving O O
morphology O O
involving O O
the O O
lateral O O
leads O O
as O O
well. O O
There O O
was O O
also O O
poor O O
R-wave O O
progression O O
V1 O O
through O O
V3. O O
She O O
was O O
taken O O
urgently O O
to O O
the O O
cardiac O O
catheterization O O
laboratory, O O
where O O
she O O
was O O
found O O
to O O
have O O
a O O
markedly O O
elevated O O
wedge O O
pressure O O
at O O
30 O O
mmHg O O
with O O
a O O
normal O O
cardiac O O
index O O
and O O
blood O O
pressure. O O
She O O
had O O
mid O O
inferior O O
wall O O
and O O
lateral O O
wall O O
akinesis O O
initially O O
with O O
3+ O O
mitral O O
regurgitation. O O
There O O
was O O
severe O O
diffuse O O
coronary O O
disease O O
with O O
diffuse O O
LAD O O
disease O O
and O O
total O O
occlusion O O
of O O
the O O
proximal O O
circumflex. O O
The O O
right O O
coronary O O
artery O O
was O O
small O O
with O O
a O O
70% O O
proximal O O
stenosis. O O
The O O
occluded O O
circumflex O O
was O O
crossed O O
with O O
a O O
wire O O
and O O
was O O
stented B-CAD O
with O O
a O O
Cypher O O
drug-eluting O O
stent. O O
She O O
had O O
an O O
excellent O O
result O O
with O O
the O O
wedge O O
also O O
decreasing O O
to O O
20 O O
mmHg. O O
She O O
had O O
an O O
estimated O O
70% O O
ejection O O
fraction O O
despite O O
the O O
inferior O O
and O O
lateral O O
akinesis. O O
Cardiac O O
index O O
was O O
2.5 O O
with O O
SVR O O
of O O
1739. O O
She O O
was O O
then O O
brought O O
to O O
the O O
coronary O O
care O O
unit O O
for O O
further O O
evaluation. O O
Her O O
past O O
medical O O
history O O
is O O
notable O O
for O O
hypertension O O
for O O
which O O
she O O
takes O O
lisinopril B-MEDICATION B-MEDICATION
40 O O
mg O O
q.d. O O
and O O
atenolol B-MEDICATION B-MEDICATION
50 O O
mg O O
q.d. O O
She O O
also O O
has O O
insulin-dependent O O
diabetes O O
mellitus O O
and O O
takes O O
insulin. O O
Past O O
medical O O
history O O
is O O
also O O
notable O O
for O O
a O O
hysterectomy. O O
Social O O
history O O
is O O
notable O O
for O O
no B-SMOKER O
cigarette I-SMOKER O
or O O
alcohol O O
use. O O
She O O
is O O
from O O
Paraguay O O
and O O
has O O
recently O O
arrived O O
in O O
this O O
country. O O
Review O O
of O O
systems O O
show O O
no O O
fever, O O
chills, O O
nausea, O O
or O O
vomiting. O O
On O O
exam, O O
she O O
is O O
comfortable O O
with O O
a O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
initially I-HYPERTENSION O
160/80 B-HYPERTENSION O
with O O
a O O
heart O O
rate O O
of O O
70 O O
and O O
regular. O O
Followup O O
pressure O O
125/80 O O
with O O
a O O
heart O O
rate O O
of O O
72 O O
beats O O
per O O
minute. O O
Head O O
and O O
neck O O
were O O
unremarkable. O O
Chest O O
is O O
clear. O O
Cardiac O O
exam O O
shows O O
no O O
jugular O O
venous O O
distention O O
at O O
30 O O
degrees. O O
PMI O O
is O O
normal. O O
S1 O O
and O O
S2 O O
were O O
normal O O
with O O
a O O
physiological O O
split. O O
There O O
is O O
an O O
S4 O O
and O O
a O O
1/6 O O
systolic O O
ejection O O
murmur O O
as O O
well O O
as O O
a O O
1 O O
to O O
2/6 O O
holosystolic O O
murmur O O
and O O
mitral O O
regurgitation O O
at O O
the O O
left O O
lower O O
sternal O O
border. O O
There O O
is O O
no O O
S3. O O
Abdominal O O
exam O O
was O O
unremarkable O O
without O O
organomegaly. O O
Bowel O O
sounds O O
are O O
normal. O O
Extremities O O
showed O O
no O O
edema O O
or O O
cyanosis. O O
Calf O O
site O O
is O O
clean O O
without O O
bruits. O O
Distal O O
pulse O O
is O O
decreased O O
but O O
palpable. O O
Her B-CAD O
resting I-CAD O
12-lead I-CAD O
electrocardiogram I-CAD O
shows I-CAD O
evidence I-CAD O
of I-CAD O
her I-CAD O
evolving I-CAD O
inferolateral I-CAD O
MI. I-CAD O
Other O O
lab O O
values O O
included O O
creatinine O O
1.0 O O
with O O
normal O O
electrolytes, O O
hematocrit O O
is O O
44.4%, O O
white O O
blood O O
cell O O
count O O
3.8 O O
with O O
platelets O O
322,000. O O
Liver O O
function O O
tests O O
are O O
normal. O O
A O O
portable O O
chest O O
x-ray O O
shows O O
pulmonary O O
edema. O O
Mrs. O O
Sergio-Steven O O
clearly O O
has O O
evidence O O
of O O
an O O
inferoposterior O O
MI O O
initially O O
with O O
a O O
very O O
high O O
filling O O
pressure O O
and O O
pulmonary O O
edema O O
and O O
mitral O O
regurgitation. O O
She O O
has O O
had O O
her O O
circumflex, O O
which O O
is O O
a O O
very O O
large O O
vessel, O O
well O O
treated O O
now O O
with O O
a O O
drug-eluting O O
stent, O O
and O O
her O O
wedge O O
has O O
come O O
down, O O
and O O
her O O
mitral O O
regurgitation O O
is O O
substantially O O
improved. O O
At O O
this O O
point, O O
we O O
will O O
bring O O
her O O
to O O
the O O
coronary O O
care O O
unit O O
for O O
careful O O
management O O
with O O
aspirin, B-MEDICATION B-MEDICATION
Plavix, B-MEDICATION B-MEDICATION
heparin, O O
continue O O
the O O
Integrilin, O O
as O O
well O O
as O O
Lasix O O
and O O
nitrates. B-MEDICATION O
We O O
will O O
plan O O
to O O
initiate O O
afterload O O
reduction O O
as O O
soon O O
as O O
tolerated, O O
and O O
also O O
plan O O
beta-blockade O O
to O O
limit O O
her O O
myocardial O O
oxygen O O
demands. O O
She O O
certainly O O
has O O
co-existent O O
quite O O
substantial B-CAD O
coronary I-CAD O
disease I-CAD O
including O O
primarily O O
the O O
right O O
coronary O O
artery O O
degree O O
and O O
to O O
some O O
degree O O
the O O
LAD. O O
At O O
this O O
point, O O
if O O
she O O
were O O
to O O
have O O
developed O O
recurrent O O
ischemia, O O
we O O
would O O
proceed O O
to O O
consideration O O
of O O
bypass O O
surgery. O O
______________________________ O O
Yakov O O
Ferris, O O
MD O O
Dictated O O
By: O O
Yakov O O
Ferris O O
eScription O O
document:5-4672574 O O
BFFocus O O
DD: O O
09/03/74 O O
DT: O O
09/03/74 O O
DV: O O
09/03/74 O O

Record B-SMOKER O
date: O O
2074-12-09 O O
Francesca O O
is O O
a O O
72 O O
y/o O O
woman O O
here O O
for O O
f/u O O
abnormal O O
lab O O
tests O O
done O O
11/21. O O
Feels O O
ok. O O
Problems O O
DM B-DIABETES O
HTN B-HYPERTENSION O
Hysterectomy O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
: O O
CABG-9/74 B-CAD B-MEDICATION
Medications O O
Colace O O
(DOCUSATE O O
SODIUM) O O
100 O O
MG O O
(100MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
Nystatin B-MEDICATION O
SUSPENSION O O
(MOUTHWASH) O O
5 O O
ML O O
SWISH O O
& O O
SPIT O O
QID O O
Lisinopril B-MEDICATION B-MEDICATION
40 O O
MG O O
PO O O
QD O O
Lantus B-MEDICATION B-MEDICATION
(INSULIN O O
GLARGINE) O B-MEDICATION
30 O O
UNITS O O
SC O O
QHS O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Protonix O O
(PANTOPRAZOLE) O O
40 O O
MG O O
(40MG O O
TABLET O O
DR O O
take O O
1) O O
PO O O
QD O O
Amiodarone O O
400 O O
MG O O
(200MG O O
TABLET O O
take O O
2) O O
PO O O
BID O O
Furosemide O O
80 O O
MG O O
(80MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
Ntg B-MEDICATION O
1/150 O O
(NITROGLYCERIN B-MEDICATION O
1/150 O O
(0.4 O O
MG)) O O
1 O O
TAB O O
SL O O
x1 O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Mg O O
OXIDE O O
(MAGNESIUM O O
OXIDE O O
) O O
800 O O
MG O O
(400MG O O
TABLET O O
take O O
2) O O
PO O O
BID O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
(METOPROLOL B-MEDICATION O
SUCCINATE O O
EXTENDED O O
RELEASE) O O
100MG O O
TAB.SR O O
24H O O
PO O O
QD O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
81MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Allergies O O
NKA O O
Takes O O
meds. O O
Home O O
glu80-300. O O
The O O
more O O
she O O
eats O O
the O O
lower O O
her O O
blood O O
sugar. O O
Endocrine: O O
No O O
polydipsia, O O
polyuria, O O
polyphagia, O O
weight O O
change, O O
sweats,heat O O
intolerance. O O
Cor- O O
No O O
chest O O
pain. O O
No O O
SOB. O O
No O O
palpitations. O O
No O O
lighthead. O O
No O O
PND. O O
No O O
orthopnea. O O
No O O
claudication. O O
No O O
edema. O O
Pulm- O O
No O O
cough. O O
No O O
wheeze. O O
No O O
SOB. O O
GI- O O
No O O
nausea. O O
No O O
vomitting. O O
No O O
dyspepsia. O O
No O O
reflux. O O
No O O
abdo O O
pain. O O
No O O
diarrhea. O O
No O O
constipation. O O
No O O
melena. O O
No O O
BRBPR. O O
GU- O O
no O O
hematuria; O O
no O O
dysuria; O O
no O O
frequency; O O
no O O
urgency; O O
no O O
incontinence. O O
no O O
vaginal O O
dc O O
or O O
itch. O O
No O O
dyspareunia. O O
No O O
abnormal O O
bleeding. O O
Constitutional: O O
No O O
weight O O
loss. O O
No O O
fevers. O O
NO O O
chills. O O
NO O O
night O O
sweats. O O
No O O
fatigue. O O
NO O O
pain. O O
Going O O
to O O
Paraguay O O
12/13 O O
for O O
3 O O
months. O O
Vital O O
Signs O O
BP O O
126/78, O O
P O O
68, O O
Wt O O
133 O O
lb O O
WD,WN,NAD. O O
M&T- O O
lips O O
and O O
gums O O
unremarkable. O O
Good O O
dentition. O O
Moist; O O
no O O
erythema; O O
no O O
exudate; O O
no O O
lesions O O
Neck- O O
supple. O O
No O O
JVD. O O
No O O
bruit. O O
No O O
LAN. O O
No O O
thyromegaly O O
Pulm- O O
NO O O
accessory O O
muscle O O
use. O O
Percussion- O O
normal. O O
Palpation-normal. O O
Auscultation-clear. O O
Cor- O O
reg O O
rhyhm. O O
S1S2 O O
normal. O O
No O O
gallop. O O
No O O
rub. O O
NO O O
murmer. O O
Abdo- O O
normal O O
BS;soft O O
with O O
no O O
HSM. O O
No O O
mass. O O
No O O
tenderness O O
Ext- O O
skin O O
intact. O O
DP-trace. O O
NO O O
edema. O O
Monofilament O O
intact. O O
ASS: O O
DM.CAD. B-CAD O
AbnormalCMP. O O
P- O O
Repeat O O
CMP. O O
Information O O
given O O
for O O
her O O
MD O O
in O O
DR. O O
f/u O O
when O O
she O O
returns O O
in O O
3-4 O O
months. O O

Record B-SMOKER O
date: O O
2075-07-03 O O
EDVISIT^80780896^SERGIO-STEVEN, O O
FRANCESCA^07/03/75^VARNER, O O
FALLON O O
The O O
patient O O
was O O
seen O O
in O O
conjunction O O
with O O
the O O
resident, O O
Dr. O O
Vue. O O
Resident's O O
note O O
was O O
reviewed. O O
The O O
patient O O
was O O
seen O O
and O O
examined O O
by O O
me. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Briefly, O O
this O O
is O O
a O O
73-year-old O O
woman O O
with O O
extensive O O
cardiac O O
history O O
of O O
hypertension B-HYPERTENSION B-HYPERTENSION
and O O
coronary B-CAD O
artery I-CAD O
disease, I-CAD O
IMI B-CAD O
with I-CAD O
any I-CAD O
EF I-CAD O
40%, I-CAD O
history I-CAD O
of I-CAD O
V-TACH, I-CAD O
high B-HYPERLIPIDEMIA O
cholesterol, I-HYPERLIPIDEMIA O
insulin-dependent B-DIABETES O
diabetes, I-DIABETES O
and O O
status O O
post O O
AICD O O
cardiac O O
catheterization O O
and O O
in O O
the O O
past. O O
The O O
patient O O
was O O
in O O
the O O
Emergency O O
Department O O
today O O
visiting O O
a O O
family O O
member. O O
She O O
was O O
completely O O
asymptomatic, O O
but O O
had O O
her O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
taken I-HYPERTENSION O
which I-HYPERTENSION O
showed I-HYPERTENSION O
a I-HYPERTENSION O
pressure I-HYPERTENSION O
of I-HYPERTENSION O
190/98. I-HYPERTENSION O
The O O
patient O O
states O O
that O O
she O O
usually O O
takes O O
9 O O
cardiac O O
and O O
antihypertensive O O
medicines O O
but O O
the O O
prescriptions O O
has O O
run O O
out O O
and O O
so O O
for O O
the O O
past O O
week O O
or O O
so, O O
she O O
has O O
been O O
taking O O
only O O
4 O O
of O O
the O O
9. O O
She O O
is O O
unable O O
to O O
say O O
exactly O O
which O O
ones. O O
She O O
denies O O
any O O
headache, O O
visual O O
changes, O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
palpitations, O O
dizziness, O O
or O O
lightheadedness. O O
Her O O
husband O O
is O O
the O O
one O O
in O O
the O O
Emergency O O
Department O O
today O O
and O O
that O O
is O O
causing O O
her O O
some O O
stress. O O
Denies O O
any O O
rash, O O
joint O O
pain, O O
back O O
pain, O O
polyuria, O O
or O O
polydipsia. O O
Please O O
see O O
the O O
resident's O O
note O O
for O O
details O O
of O O
the O O
patient's O O
past O O
medical O O
history, O O
surgical O O
history, O O
family O O
history, O O
review O O
of O O
systems, O O
and O O
physical O O
exam. O O
PHYSICAL O O
EXAMINATION: O O
She O O
is O O
awake, O O
alert, O O
in O O
no O O
distress O O
with O O
no O O
complaints. O O
Has B-HYPERTENSION O
a I-HYPERTENSION O
repeat I-HYPERTENSION O
blood I-HYPERTENSION O
pressure I-HYPERTENSION O
of I-HYPERTENSION O
190/95 I-HYPERTENSION O
and O O
saturating O O
99% O O
on O O
room O O
air O O
with O O
a O O
pulse O O
of O O
70. O O
Exam O O
is O O
remarkable O O
for O O
a O O
systolic O O
ejection O O
murmur O O
at O O
the O O
right O O
upper O O
sternal O O
border O O
of O O
3/6. O O
No O O
JVD, O O
with O O
good O O
and O O
equal O O
pulses. O O
Abdomen O O
is O O
soft O O
and O O
nontender. O O
She O O
has O O
no O O
papilledema O O
and O O
fundal O O
exam O O
is O O
clear. O O
Neurologically, O O
she O O
is O O
oriented O O
x3 O O
with O O
normal O O
mood O O
and O O
affect. O O
IMAGING O O
STUDIES: O O
EKG O O
shows O O
first-degree O O
AV O O
block O O
with O O
an O O
old O O
LAD. O O
This O O
is O O
considered O O
normal O O
for O O
this O O
patient O O
and O O
is O O
unchanged O O
from O O
before. O O
Urinary O O
dip O O
is O O
negative. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
The O O
patient's O O
usual O O
pharmacy O O
is O O
contacted. O O
Correct O O
doses O O
of O O
her O O
medications O O
are O O
obtained O O
and O O
refills O O
for O O
2 O O
weeks O O
were O O
given. O O
She O O
is O O
told O O
to O O
follow O O
up O O
with O O
her O O
primary O O
care O O
physician O O
within O O
2 O O
weeks. O O
She O O
says O O
she O O
will O O
be O O
able O O
to O O
do O O
that O O
and O O
remains O O
asymptomatic O O
throughout O O
her O O
Emergency O O
Department O O
stay. O O
At O O
one O O
point O O
during O O
her O O
stay, O O
her O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
went I-HYPERTENSION O
up I-HYPERTENSION O
to I-HYPERTENSION O
as I-HYPERTENSION O
high I-HYPERTENSION O
as I-HYPERTENSION O
209/98, I-HYPERTENSION O
however, O O
on O O
my O O
last O O
recheck, O O
just O O
prior O O
to O O
the O O
patient O O
leaving, O O
the B-HYPERTENSION O
pressure I-HYPERTENSION O
was I-HYPERTENSION O
185/90. I-HYPERTENSION O
The O O
patient's O O
primary O O
care O O
physician O O
was O O
contacted O O
about O O
this O O
and O O
agrees O O
to O O
follow O O
up O O
with O O
the O O
patient O O
within O O
3 O O
days. O O
DISPOSITION: O O
The O O
patient O O
is O O
discharged O O
home O O
in O O
satisfactory O O
condition. O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O
PRIMARY O O
DIAGNOSIS: O O
Hypertension. B-HYPERTENSION O
______________________________ O O
VARNER, O O
FALLON O O
M.D. O O
D: O O
07/03/75 O O
T: O O
07/03/75 O O
Dictated O O
By: O O
VARNER, O O
FALLON O O
eScription O O
document:1-0201766 O O
BF O O

Record B-SMOKER O
date: O O
2076-06-22 O O
Reason O O
for O O
Visit O O
Francesca O O
is O O
a O O
74 O O
y/o O O
woman O O
here O O
for O O
evaluation O O
of O O
HTN,cardiac B-HYPERTENSION O
and O O
DM B-DIABETES O
treatment. O O
Problems O O
DM O O
HTN O O
Hysterectomy O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
: O O
CABG-9/74 B-CAD O
Medications O O
Ntg B-MEDICATION O
1/150 O O
(NITROGLYCERIN B-MEDICATION O
1/150 O O
(0.4 O O
Mg)) O O
1 O O
TAB O O
SL O O
x1 O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
Acid) O O
81MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Humulin B-MEDICATION B-MEDICATION
N O O
UNITS O O
SC O O
QAM O O
and O O
before O O
bed O O
, O O
20 O O
units O O
AM, O O
30 O O
units O O
HS O O
FUROSEMIDE O O
80 O O
MG O O
(80MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
CAPTOPRIL B-MEDICATION B-MEDICATION
25MG O O
TABLET O O
PO O O
TID O O
x O O
30 O O
days O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
x O O
14 O O
days O O
Toprol B-MEDICATION B-MEDICATION
Xl O O
(METOPROLOL B-MEDICATION O
Succinate O O
Extended O O
Release) O O
100MG O O
TAB.SR O O
24H O O
PO O O
QD O O
x O O
14 O O
days O O
Allergies O O
NKA O O
Narrative O O
History O O
Takes O O
meds. O O
No O O
SEs. O O
Nocturia O O
x O O
1 O O
; O O
polys-0 O O
; O O
Eyes- O O
no O O
complaints. O O
Last O O
exam O O
-none. O O
Feet- O O
no O O
pain, O O
numbness, O O
burning. O O
Cor- O O
No O O
chest O O
pain. O O
No O O
SOB. O O
No O O
palpitations. O O
When O O
gets O O
up O O
from O O
bed, O O
has O O
lighthead. O O
No O O
PND. O O
No O O
orthopnea. O O
No O O
claudication. O O
No O O
edema. O O
GI- O O
No O O
nausea. O O
No O O
vomitting. O O
No O O
dyspepsia. O O
No O O
reflux. O O
No O O
abdo O O
pain. O O
No O O
diarrhea. O O
No O O
constipation. O O
No O O
melena. O O
No O O
BRBPR. O O
Neuro- O O
No O O
headache. O O
No O O
vision O O
change. O O
NO O O
hearing O O
change. O O
No O O
numbness. O O
No O O
tingling. O O
No O O
loss O O
of O O
strength. O O
No O O
seizures. O O
No O O
loss O O
of O O
balance. O O
ETOH/drugs- O O
no O O
Cigs- O O
no O O
Diet-no O O
Exercise-no O O
Home O O
glu- O O
machine O O
not O O
working O O
well. O O
Hypoglycemia-no O O
Other O O
complaints-no O O
Sleep- O O
ok. O O
Not O O
depressed. O O
Vital O O
Signs O O
BLOOD B-HYPERTENSION O
PRESSURE I-HYPERTENSION O
146/84 I-HYPERTENSION O
PULSE O O
80 O O
WEIGHT O O
143.5 O O
lb O O
Exam O O
NAD,WD,WN O O
Eyes- O O
conj O O
& O O
sclera O O
not O O
injected O O
EOMI,PERLA O O
M&T- O O
lips O O
and O O
gums O O
unremarkable. O O
Moist O O
no O O
erythema; O O
no O O
exudate; O O
no O O
lesions O O
Neck- O O
supple. O O
No O O
JVD. O O
No O O
bruit. O O
No O O
LAN. O O
No O O
thyromegaly O O
Cor- O O
reg O O
rhyhm. O O
S1S2 O O
normal. O O
No O O
gallop. O O
No O O
rub. O O
NO O O
murmer. O O
Pulm- O O
NO O O
accessory O O
muscle O O
use. O O
Percussion- O O
normal. O O
Palpation-normal. O O
Auscultation-clear. O O
Abdo- O O
normal O O
BS;soft O O
with O O
no O O
HSM. O O
No O O
mass. O O
No O O
tenderness O O
Ext/ O O
feet: O O
no O O
edema; O O
DP O O
Pulses O O
absent. O O
Skin O O
intact. O O
Monofilament O O
absent. O O
Results O O
05/26/2076 O O
NA O O
142, O O
K O O
3.6 O O
(#), O O
CL O O
100, O O
CO2 O O
34 O O
(*), O O
BUN O O
13, O O
CRE O O
1.3, O O
EGFR O O
43 O O
[1], O O
GLU O O
93 O O
(#) O O
[1] O O
RESULT O O
COMMENT: O O
(Abnormal O O
if O O
Assessment O O
DM- O O
poor O O
control O O
Asymp O O
CAD B-CAD O
HTN- O O
elevted O O
today O O
but O O
has O O
been O O
fine. O O
Disposition O O
and O O
Plans O O
Cont O O
meds O O
but O O
increase O O
PM O O
insulin O O
to O O
30 O O
units. O O
RTC O O
3 O O
month O O
or O O
PRN. O O
______________________________ O O
Armando O O
Brian O O
Nettles, O O
M.D. O O

Record O O
date: O O
2077-03-31 O O
EDVISIT^80780896^SERGIO O O
STEVEN, O O
FRANCESCA^03/31/77^DELACRUZ, O O
ARMANDO O O
I O O
evaluated O O
this O O
patient O O
independently O O
and O O
concur O O
with O O
findings O O
as O O
noted O O
on O O
the O O
medical O O
record, O O
supervised O O
the O O
care O O
as O O
provided O O
by O O
the O O
residents O O
in O O
the O O
Emergency O O
Department. O O
CHIEF O O
COMPLAINT: O O
In O O
brief, O O
this O O
is O O
a O O
74-year-old O O
female O O
with O O
complaint O O
of O O
worsening O O
renal O O
function. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
patient O O
is O O
a O O
74-year-old O O
female O O
with O O
a O O
history O O
of O O
hypertension, B-HYPERTENSION B-HYPERTENSION
diabetes B-DIABETES O
of I-DIABETES O
type I-DIABETES O
2, I-DIABETES O
and O O
diabetic O O
neuropathy, O O
followed O O
by O O
her O O
primary O O
care O O
physician, O O
Dr. O O
Nettles O O
and O O
has O O
had O O
worsening O O
a O O
diabetic O O
control O O
and O O
poor O O
p.o. O O
intake. O O
The O O
patient O O
has O O
had O O
switched O O
recently O O
captopril B-MEDICATION B-MEDICATION
dosing O O
and O O
also O O
insulin B-MEDICATION O
dosing O O
per O O
Dr. O O
Nettles. O O
She O O
has O O
been O O
eating O O
and O O
drinking O O
well O O
and O O
has O O
no O O
specific O O
complaints O O
of O O
fever, O O
chills, O O
nausea, O O
vomiting, O O
diarrhea, O O
or O O
additional O O
symptoms. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension, B-HYPERTENSION O
diabetes, O O
hypercholesterolemia, B-HYPERLIPIDEMIA B-MEDICATION
and O O
diabetic O O
neuropathy. O O
SOCIAL O O
HISTORY: O O
Negative B-SMOKER O
for I-SMOKER O
drugs, I-SMOKER O
alcohol, I-SMOKER O
or I-SMOKER O
tobacco. I-SMOKER O
FAMILY O O
HISTORY: O O
Noncontributory. O O
PAST O O
SURGICAL O O
HISTORY: O O
CABG B-CAD O
in I-CAD O
09/2074 I-CAD O
and O O
pacemaker O O
placement. O O
REVIEW O O
OF O O
SYSTEMS: O O
Significant O O
for O O
complaint O O
of O O
worsening O O
renal O O
function O O
but O O
no O O
additional O O
symptoms. O O
All O O
other O O
systems O O
are O O
reviewed O O
and O O
are O O
negative O O
as O O
noted O O
on O O
the O O
medical O O
record. O O
MEDICATIONS: O O
Numerous. O O
Please O O
see O O
the O O
medical O O
record. O O
ALLERGIES: O O
None. O O
PHYSICAL O O
EXAMINATION: O O
Awake, O O
alert, O O
and O O
oriented O O
female O O
in O O
no O O
apparent O O
distress. O O
Vital O O
signs O O
are O O
as O O
noted O O
in O O
the O O
medical O O
record. O O
I O O
examined O O
this O O
patient, O O
and O O
agree O O
with O O
physical O O
exam O O
findings O O
as O O
noted O O
on O O
the O O
medical O O
record. O O
Please O O
refer O O
to O O
the O O
chart. O O
ASSESSMENT O O
AND O O
MEDICAL O O
DECISION O O
MAKING: O O
This O O
is O O
a O O
74-year-old O O
female O O
with O O
worsening O O
prerenal O O
azotemia; O O
probably O O
dehydration, O O
and O O
worsening O O
renal O O
function O O
and O O
noted O O
to O O
have O O
BUN O O
in O O
the O O
50 O O
and O O
creatinine O O
of O O
2.4. O O
PLAN: O O
We O O
discussed O O
this O O
case O O
with O O
her O O
physician, O O
Dr. O O
Nettles O O
who O O
suggest O O
Benson O O
admission, O O
discuss O O
this O O
with O O
Benson. O O
They O O
will O O
agree O O
to O O
accept O O
the O O
patient O O
for O O
IV O O
hydration O O
and O O
following O O
the O O
renal O O
function. O O
PRIMARY O O
DIAGNOSIS: O O
Dehydration. O O
SECONDARY O O
DIAGNOSIS: O O
Acute O O
renal O O
insufficiency. O O
THIRD O O
DIAGNOSIS: O O
Diabetes B-DIABETES O
mellitus. I-DIABETES O
______________________________ O O
DELACRUZ, O O
ARMANDO O O
M.D. O O
D: O O
03/31/77 O O
T: O O
03/31/77 O O
Dictated O O
By: O O
DELACRUZ, O O
ARMANDO O O
eScription O O
document:6-0689198 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2082-06-29 O O
Narrative O O
History O O
The O O
patient O O
is O O
here O O
today O O
for O O
the O O
following O O
issues: O O
1. O O
Patient O O
is O O
scheduled O O
for O O
gastric O O
bypass O O
surgery O O
July O O
22nd. O O
She O O
is O O
leaving O O
for O O
vacation. O O
She O O
wants O O
to O O
make O O
sure O O
she O O
is O O
cleared O O
for O O
her O O
surgery O O
2. O O
Patient O O
completed O O
Vit. O O
D O O
supplementation O O
and O O
her O O
new O O
VIT O O
D O O
level O O
is O O
49 O O
(up O O
from O O
9). O O
3. O O
Patient O O
complaining O O
of O O
persistent O O
chest O O
pain O O
- O O
she O O
saw O O
Dr. O O
Uzzell O O
who O O
feels O O
she O O
is O O
cleared O O
for O O
surgery O O
from O O
a O O
cardiac O O
perspective. O O
4. O O
Patient O O
has O O
persistednt O O
recurrent O O
LE O O
edema. O O
5. O O
She O O
complaining O O
of O O
occasional O O
shortness O O
of O O
breath O O
and O O
has O O
a O O
pulmonary O O
appointment O O
in O O
July O O
prior O O
to O O
her O O
surgery. O O
6. O O
Patient O O
saw O O
Dr. O O
Newkirk O O
who O O
is O O
still O O
awaiting O O
some O O
bloodwork O O
but O O
feels O O
she O O
is O O
cleared O O
for O O
surgery. O O
Her O O
hct O O
most O O
recently O O
was O O
35.6 O O
7. O O
OSA O O
- O O
feels O O
she O O
does O O
awake O O
in O O
the O O
middle O O
of O O
the O O
night O O
with O O
sob. O O
8. O O
Patient O O
gets O O
an O O
occasional O O
leg O O
cramp O O
on O O
the O O
right O O
- O O
question O O
related O O
to O O
LBP. O O
K+ O O
normal O O
on O O
June O O
23rd. O O
Will O O
follow O O
up O O
after O O
surgery. O O
No O O
weakness O O
or O O
numbness. O O
Problems O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
S/P O O
Abortion O O
SPONTANEOUS O O
4/80 O O
Chlamydia O O
CERVICITIS-TREATED O O
H/O O O
Abnormal O O
pap O O
test O O
Positive O O
PPD O O
NEG O O
CXR O O
PARONYCHIAL O O
INFECTION O O
LEFT O O
HAND O O
78 O O
Ectopic O O
pregnancy O O
74 O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
Anemia O O
Shortness O O
of O O
breath O O
Hypertension B-HYPERTENSION O
Gastroesophageal O O
reflux O O
disease O O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Hyperthyroidism O O
Obesity B-OBESE O
Review O O
of O O
Systems O O
Unless O O
mentioned O O
in O O
the O O
history O O
above O O
the O O
following O O
ROS O O
were O O
asked O O
and O O
are O O
negative: O O
Constitutional,Respiratory, O O
Cardiac, O O
GI O O
(above), O O
Heme O O
(above), O O
Endocrine, O O
GYN, O O
Musculoskeletal, O O
Psych, O O
and O O
Neuro. O O
Medications O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
ASA B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
ACID) O O
325MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
LIPITOR B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
INSULIN B-MEDICATION B-MEDICATION
70/30 O O
(HUMAN) O O
SEE O O
BELOW O O
SC O O
5ID O O
IMDUR B-MEDICATION O
(ISOSORBIDE I-MEDICATION O
MONONIT.(SR)) I-MEDICATION O
30MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
NEXIUM O O
(ESOMEPRAZOLE) O O
40MG O O
1 O O
Capsule(s) O O
PO O O
BID O O
KLONOPIN O O
(CLONAZEPAM) O O
0.5MG O O
1 O O
Tablet(s) O O
PO O O
TID O O
ZESTRIL B-MEDICATION B-MEDICATION
(LISINOPRIL) B-MEDICATION O
5MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
ZANTAC O O
(RANITIDINE O O
HCL) O O
300MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
VITAMIN O O
D O O
(ERGOCALCIFEROL) O O
50000 O O
U O O
IM O O
q72 O O
HOURS O O
36 O O
day(s) O O
MECLIZINE O O
HCL O O
25MG O O
1 O O
Tablet(s) O O
PO O O
TID O O
7 O O
day(s) O O
Allergies O O
NKDA O O
Physical O O
Exam O O
120/80 O O
GENERAL: O O
obese B-OBESE O
female I-OBESE O
EXT: O O
No O O
edema O O
LABS O O
reviewed. O O
Assessment O O
and O O
Plan O O
1. O O
Gastric O O
Bypass O O
- O O
Will O O
proceed O O
to O O
preop O O
evaluation O O
and O O
hopeful O O
surgery O O
on O O
July O O
22nd. O O
Dr. O O
Rivers O O
will O O
be O O
consulted O O
to O O
assist O O
with O O
sugar O O
management. O O
2. O O
Vit O O
D O O
deficiency O O
- O O
Corrected O O
with O O
Vit O O
D O O
supplementation. O O
3. O O
LE O O
edema O O
will O O
likely O O
improve O O
with O O
weight O O
loss. O O
Follow O O
up O O
after O O
surgery. O O
4. O O
CAD B-CAD O
- O O
followed O O
by O O
Dr. O O
Uzzell O O
5. O O
shortness O O
of O O
breath O O
- O O
Likely O O
mostly O O
secondary O O
to O O
deconditioning O O
and O O
weight O O
but O O
will O O
be O O
evaluated O O
by O O
pulmonary. O O
6. O O
OSA O O
- O O
sees O O
pulmonary O O
in O O
July. O O
appointment O O
time O O
35 O O
minutes O O
- O O
Discussed O O
with O O
patient O O
at O O
lenght O O
surgery O O
and O O
what O O
to O O
expect O O
after. O O
She O O
seems O O
motivated O O
to O O
lose O O
weight. O O

Record B-SMOKER O
date: O O
2083-03-08 O O
Narrative O O
History O O
The O O
patient O O
is O O
here O O
today O O
for O O
the O O
following O O
issues: O O
1. O O
Patient's O O
father O O
recently O O
died O O
- O O
massive O O
MI. O O
Klonipin O O
has O O
been O O
helping O O
patient O O
at O O
night. O O
She O O
tried O O
it O O
during O O
the O O
day O O
but O O
too O O
sleepy. O O
2. O O
She O O
has O O
had O O
persistent O O
chest O O
pain O O
and O O
sob O O
since O O
Father's O O
dealth. O O
She O O
tried O O
SLNTG B-MEDICATION O
without O O
improvement. O O
HAs O O
have O O
also O O
returned. O O
Pain O O
not O O
worse O O
with O O
exertion. O O
3. O O
Patient O O
asking O O
about O O
IUD O O
removal. O O
4. O O
Patient O O
has O O
lost O O
90 O O
pounds O O
so O O
far. O O
Appetite O O
is O O
down O O
and O O
smaller O O
portions. O O
5. O O
Diabetes B-DIABETES O
- O O
Dr. O O
Rivers O O
started B-MEDICATION O
glucophage B-MEDICATION B-MEDICATION
825 O O
BID O O
but O O
she O O
doesn't O O
take O O
it O O
all O O
the O O
time. O O
6. O O
She O O
admits O O
to O O
not O O
taking O O
her O O
lipitor B-MEDICATION B-MEDICATION
- O O
worrries O O
it O O
had O O
some O O
effect O O
on O O
her O O
vision. O O
Problems O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
S/P O O
Abortion O O
: O O
SPONTANEOUS O O
4/80 O O
Chlamydia O O
: O O
CERVICITIS-TREATED O O
H/O O O
Abnormal O O
pap O O
test O O
: O O
'76 O O
S/P O O
COLPOSCOPY O O
IN O O
PAST; O O
RECENT O O
PAP O O
NORMAL O O
Positive O O
PPD O O
: O O
NEG O O
CXR O O
PARONYCHIAL O O
INFECTION O O
: O O
LEFT O O
HAND O O
78 O O
Ectopic O O
pregnancy O O
: O O
74 O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
Anemia O O
Shortness O O
of O O
breath O O
Hypertension B-HYPERTENSION O
Gastroesophageal O O
reflux O O
disease O O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Hyperthyroidism O O
Obesity B-OBESE O
Medications O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
Acid) O O
325MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Klonopin O O
(CLONAZEPAM) O O
0.5MG, O O
1 O O
Tablet(s) O O
PO O O
TID O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Imdur B-MEDICATION B-MEDICATION
(ISOSORBIDE I-MEDICATION O
MONONIT.(SR)) I-MEDICATION O
30MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Nexium O O
(ESOMEPRAZOLE) O O
40MG, O O
1 O O
Capsule(s) O O
PO O O
QD O O
Allergies O O
NKDA O O
Review O O
of O O
Systems O O
Unless O O
mentioned O O
in O O
the O O
history O O
above O O
the O O
following O O
ROS O O
were O O
asked O O
and O O
are O O
negative: O O
Constitutional, O O
Respiratory, O O
Cardiac, O O
GI, O O
Endocrine, O O
GYN, O O
Musculoskeletal, O O
Psych O O
- O O
no O O
SI. O O
Vital O O
signs O O
BP O O
120/75, O O
Wt O O
228 O O
lb O O
Physical O O
Exam O O
108/70 O O
GENERAL: O O
Healthy O O
appearing O O
overweight O O
female O O
NECK: O O
No O O
thyromegaly, O O
no O O
nodes O O
CHEST O O
Clear O O
lungs, O O
NL O O
frame O O
COR: O O
RRR, O O
NL O O
S1S2, O O
no O O
murmur, O O
rubs, O O
or O O
gallops. O O
BIMAN O O
c O O
no O O
adnexal O O
masses, O O
no O O
CMT O O
EXT: O O
No O O
edema O O
NEURO: O O
NL O O
MS, O O
NL O O
gait O O
Labs O O
reviewed O O
EKG O O
done O O
and O O
unchanged O O
from O O
8/82 O O
Assessment O O
and O O
Plan O O
1. O O
Chest O O
pain, O O
Headaches O O
and O O
shortness O O
of O O
breath O O
- O O
No O O
evidence O O
of O O
USA. O O
All O O
likely O O
secondary O O
to O O
anxiety O O
and O O
grief O O
over O O
father's O O
death. O O
Patient O O
reassured. O O
Will O O
continue O O
cardiac O O
medications. O O
Return O O
to O O
cardiac O O
rehab O O
on O O
Thursday. O O
Will O O
add O O
.5mg O O
klonipin O O
during O O
the O O
day O O
as O O
needed. O O
Continue O O
1mg O O
klonipin O O
at O O
night. O O
Patient O O
declines O O
psychotherapy. O O
Also, O O
will O O
restart O O
nexium O O
as O O
some O O
of O O
chest O O
pain O O
may O O
be O O
recurrence O O
of O O
reflux. O O
2. O O
DM B-DIABETES O
- O O
Encouraged O O
patient O O
to O O
take O O
glucophage O B-MEDICATION
as O O
prescribed. O O
She O O
is O O
worried O O
she O O
will O O
always O O
have O O
DM. O O
Discussed O O
with O O
patient O O
importance O O
of O O
controlling O O
BSs O O
now O O
and O O
losing O O
remaining O O
weight. O O
She O O
will O O
continue O O
to O O
monitor O O
home O O
FSBS. O O
3. O O
Obesity O O
- O O
Impressive O O
90 O O
pound O O
weight O O
loss. O O
Patient O O
very O O
encourage. O O
Continue O O
with O O
smaller O O
meals. O O
4. O O
Hyperlipidemia B-HYPERLIPIDEMIA O
- O O
Patient O O
will O O
restart O O
lipitor. O B-MEDICATION
Follow O O
up O O
fasting O O
cholesterol O O
and O O
SGOT. O O
5. O O
CAD B-CAD O
- O O
Continue O O
Imdur, O O
aspirin B-MEDICATION B-MEDICATION
and O O
lipitor. O B-MEDICATION
Cardiac O O
rehab. O O
Follow O O
up O O
if O O
new O O
chest O O
pain. O O
6. O O
IUD O O
- O O
Discussed O O
briefly. O O
Stressed O O
importance O O
of O O
no O O
pregnancies O O
with O O
CAD. O O
She O O
wants O O
to O O
rediscuss O O
at O O
end O O
of O O
year. O O
7. O O
History O O
of O O
hyperthyroidism O O
- O O
Recheck. O O

Record O O
date: O O
2085-10-30 O O
Narrative O O
History O O
The O O
patient O O
is O O
here O O
today O O
for O O
the O O
following O O
issues: O O
1. O O
Patient O O
is O O
pregnant. O O
No O O
bleeding O O
or O O
cramping. O O
Followed O O
by O O
Dr. O O
Kilgore. O O
She O O
did O O
not O O
intend O O
to O O
get O O
pregnant O O
again O O
but O O
would O O
like O O
to O O
keep O O
this O O
pregnancy. O O
2. O O
Labs O O
in O O
past O O
indicated O O
hyperthyroidism. O O
This O O
is O O
being O O
followed O O
by O O
endocrine. O O
No O O
palpitations. O O
3. O O
DM B-DIABETES O
- O O
Has O O
not O O
been O O
taking O O
insulin B-MEDICATION O
since O O
birth O O
of O O
son. O O
HgA1C B-DIABETES O
&gt;10. I-DIABETES O
She O O
will O O
be O O
seen O O
by O O
Endocrine O O
today. O O
4. O O
Followed O O
by O O
Dr. O O
Uzzell O O
for O O
CAD. B-CAD O
No O O
chest O O
pain. O O
On O O
atenolol, B-MEDICATION B-MEDICATION
aspirin B-MEDICATION B-MEDICATION
and O O
imdur. B-MEDICATION B-MEDICATION
Problems O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
S/P O O
Abortion O O
: O O
SPONTANEOUS O O
4/80 O O
Chlamydia O O
: O O
CERVICITIS-TREATED O O
H/O O O
Abnormal O O
pap O O
test O O
: O O
'76 O O
S/P O O
COLPOSCOPY O O
IN O O
PAST; O O
RECENT O O
PAP O O
NORMAL O O
Positive O O
PPD O O
: O O
NEG O O
CXR O O
PARONYCHIAL O O
INFECTION O O
: O O
LEFT O O
HAND O O
78 O O
Ectopic O O
pregnancy O O
: O O
74 O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
Anemia O O
Shortness O O
of O O
breath O O
Hypertension B-HYPERTENSION O
Gastroesophageal O O
reflux O O
disease O O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Hyperthyroidism O O
Obesity B-OBESE O
Review O O
of O O
Systems O O
Unless O O
mentioned O O
in O O
the O O
history O O
above O O
the O O
following O O
ROS O O
were O O
asked O O
and O O
are O O
negative: O O
Constitutional, O O
Respiratory, O O
Cardiac, O O
GI, O O
Endocrine, O O
Musculoskeletal. O O
Medications O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
Acid) O O
325MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Natalcare O O
Plus O O
1TAB O O
PO O O
qd O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Imdur B-MEDICATION B-MEDICATION
(ISOSORBIDE I-MEDICATION O
MONONIT.(SR)) I-MEDICATION O
30MG O O
TABLET O O
CR O O
24HR O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Allergies O O
NKA O O
Social B-SMOKER O
History O O
NP O O
in O O
Laplace O O
- O O
waiting O O
for O O
researcher O O
job. O O
Son O O
born O O
in O O
2085 O O
name O O
Uri, O O
older O O
child O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
122/70 O O
WEIGHT O O
220 O O
lb O O
AGE O O
32y5.7m O O
Physical O O
Exam O O
GENERAL: O O
Healthy O O
appearing O O
Labs O O
reviewed. O O
Assessment O O
and O O
Plan O O
1. O O
Pregnancy O O
- O O
Counseled O O
patient- O O
especially O O
on O O
need O O
to O O
control O O
sugars. O O
Limited O O
weight O O
gain. O O
She O O
will O O
discuss O O
with O O
ob O O
and O O
cardiology O O
when O O
to O O
stop O O
aspirin. O B-MEDICATION
She O O
will O O
likely O O
be O O
induced O O
early. O O
2. O O
Hyperthyroidism O O
- O O
Denies O O
symptoms- O O
repeat O O
today O O
Follow O O
up O O
with O O
Dr. O O
Kirkpatrick. O O
3. O O
DM O O
- O O
Followed O O
by O O
diabetes O O
clinic. O O
HgA1C&gt; B-DIABETES O
10 I-DIABETES O
. O O
Will O O
need O O
to O O
restart O O
insulin O O
- O O
counseled. O O
4. O O
CAD O O
- O O
On O O
atenolol, O B-MEDICATION
asa, B-MEDICATION B-MEDICATION
imdur. O O
Followed O O
by O O
Dr. O O
Uzzell. O O
25 O O
minutes O O
spent O O
with O O
the O O
patient O O
- O O
the O O
majority O O
counseling O O
on O O
above. O O

Record B-SMOKER O
date: O O
2087-09-15 O O
CARDIOLOGY O O
SAINT O O
VINCENT O O
HOSPITAL O O
Interval O O
History: O O
Since O O
last O O
seen, O O
Ursula O O
notes O O
that O O
her O O
weight O O
continues O O
to O O
rise, O O
and O O
with O O
this, O O
her O O
angina B-CAD O
is O O
clearly O O
worse. O O
She O O
has O O
stable O O
symptoms, O O
nothing O O
to O O
suggest O O
an O O
ACS, O O
but O O
she's O O
dyspneic O O
with O O
exertion O O
and O O
takes O O
nitro B-MEDICATION B-MEDICATION
occasionally. O O
Medications: O O
Atenolol B-MEDICATION B-MEDICATION
100 O O
mg O O
qd, O O
Aspirin B-MEDICATION B-MEDICATION
81 O O
mg. O O
qd, O O
Imdur B-MEDICATION B-MEDICATION
30 O O
mg., O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
mg O O
qd, O O
glucophage B-MEDICATION B-MEDICATION
Physical O O
examination: O O
Reveals O O
her O O
to O O
be O O
obese B-OBESE O
weighing O O
231 O O
lbs. O O
Her O O
BP O O
is O O
120/ O O
palp O O
in O O
her O O
left O O
arm O O
and O O
her O O
heart O O
rate O O
is O O
80. O O
Her O O
lungs O O
are O O
clear O O
throughout. O O
Her O O
apical O O
impulse O O
is O O
non-displaced O O
with O O
a O O
regular O O
rate O O
and O O
rhythm, O O
a O O
normal O O
S1 O O
and O O
S2, O O
but O O
no O O
S3 O O
or O O
S4. O O
There O O
is O O
a O O
grade O O
1 O O
MR O O
murmur O O
noted. O O
There O O
is O O
no O O
jugular O O
venous O O
distention O O
and O O
carotid O O
pulses O O
are O O
2+ O O
bilaterally O O
with O O
soft O O
bilateral O O
bruits. O O
Her O O
abdomen O O
is O O
morbidly O O
obese. O O
Her O O
extremities O O
are O O
notable O O
for O O
trace O O
lower O O
extremity O O
edema. O O
EKG: O O
NSR O O
with O O
an O O
old O O
IPMI. O O
She O O
also O O
has O O
non O O
specific O O
STT O O
wave O O
abnormalities. O O
When O O
compared O O
to O O
a O O
previous O O
tracing O O
there O O
is O O
no O O
change. O O
Impression: O O
1.CAD, B-CAD O
s/p O O
cath O O
and O O
stenting: O O
her O O
angina O O
is O O
clearly O O
related O O
to O O
her O O
weight O O
going O O
up O O
again; O O
I O O
worry O O
about O O
this, O O
and O O
wonder O O
if O O
she O O
should O O
have O O
another O O
weight O O
loss O O
surgery. O O
For O O
the O O
meantime, O O
I O O
will O O
increase O O
Imdur O O
to O O
60 O O
mg O O
qd, O O
and O O
consider O O
an O O
increase O O
in O O
atenolol. O B-MEDICATION
Umberto O O
M. O O
Uzzell, O O
MD O O
pager O O
#12472 O O
Signed O O
electronically O O
by O O
Umberto O O
M. O O
Uzzell, O O
MD O O
Document O O
Status: O O
Final O O

Record B-SMOKER O
date: O O
2089-04-05 O O
CARDIOLOGY O O
SAINT O O
VINCENT O O
HOSPITAL O O
Interval O O
History: O O
Ursula O O
is O O
seen O O
in O O
the O O
Cardiology O O
office O O
for O O
a O O
followup O O
visit. O O
Since O O
last O O
seen, O O
she O O
notes O O
a O O
number O O
of O O
somewhat O O
concerning O O
symptoms. O O
First O O
of O O
all, O O
she O O
is O O
noting O O
some O O
mid O O
sternal O O
chest O O
discomfort O O
with O O
exertion. O O
She O O
associates O O
this O O
with O O
back O O
pain O O
related O O
to O O
a O O
remote O O
back O O
injury, O O
but O O
nonetheless O O
with O O
exertions O O
she O O
develops O O
some O O
degree O O
of O O
mid O O
sternal O O
chest O O
discomfort, O O
non O O
radiating, O O
associated O O
may O O
be O O
with O O
some O O
shortness O O
of O O
breath. O O
She O O
has O O
not O O
used O O
any O O
nitroglycerin O O
for O O
it. O O
It O O
gets O O
better O O
when O O
she O O
rests. O O
She O O
denies O O
palpitations, O O
PND, O O
or O O
orthopnea. O O
Her O O
sugars O O
are O O
out O O
of O O
control. O O
Her O O
weight O O
is O O
down, O O
nonetheless. O O
Physical O O
examination: O O
-Pulse: O O
80 O O
-BP: O O
130/85 O O
-weight: O O
206 O O
lbs. O O
-General: O O
Overweight. O O
Well O O
appearing. O O
-Skin: O O
No O O
rashes. O O
Anicteric. O O
-Heent: O O
Unremarkable. O O
-Neck: O O
JVP O O
less O O
than O O
5, O O
possible O O
venous O O
hums O O
bilaterally. O O
Carotids O O
without O O
bruits. O O
-Chest: O O
Clear O O
to O O
auscultation O O
and O O
percussion. O O
-Cardiac: O O
Apical O O
impulse O O
nondisplaced O O
and O O
discrete. O O
Regular O O
rate O O
and O O
rhythm. O O
Normal O O
S1 O O
and O O
split O O
S2. O O
Soft O O
S4 O O
gallop. O O
-Abdomen: O O
Obese, B-OBESE O
soft, O O
nontender, O O
and O O
nondistended O O
without O O
hepatosplenomegaly, O O
bruits, O O
dilated O O
aorta. O O
-Extremities: O O
No O O
clubbing, O O
cyanosis, O O
or O O
edema. O O
Procedures: O O
Electrocardiogram O O
normal O O
sinus O O
rhythm O O
IVCD, O O
old B-CAD O
IMI. I-CAD O
In O O
addition, O O
she O O
has O O
nonspecific O O
ST O O
and O O
T-wave O O
changes. O O
Compared O O
there O O
is O O
no O O
important O O
change. O O
Impression: O O
1. O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
status B-CAD O
post I-CAD O
multiple B-CAD O
PCIs. I-CAD O
Ursula O O
has O O
the O O
return O O
of O O
chest O O
symptoms O O
which O O
are O O
suggestive O O
for O O
angina. B-CAD O
I O O
will O O
refer O O
her O O
for O O
an O O
exercise O O
tolerance O O
test O O
to O O
better O O
evaluate O O
this. O O
I O O
will O O
continue O O
on O O
the O O
current O O
medication O O
program. O O
2. O O
Hypertension. B-HYPERTENSION O
Her O O
blood O O
pressure O O
is O O
a O O
bit O O
elevated. O O
Given O O
her O O
diabetes, B-DIABETES O
I O O
think O O
it O O
is O O
prudent O O
to O O
add B-MEDICATION O
an I-MEDICATION O
ACE I-MEDICATION O
inhibitor. I-MEDICATION O
Accordingly, I-MEDICATION O
lisinopril B-MEDICATION B-MEDICATION
2.5 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
was I-MEDICATION O
added I-MEDICATION O
to I-MEDICATION O
her I-MEDICATION O
program. I-MEDICATION O
3. O O
Lipids O O
will O O
be O O
checked. O O
I O O
strongly O O
suspect O O
that O O
her O O
LDL O O
is O O
not O O
well O O
suppressed. O O
Our O O
goal O O
LDL O O
in O O
this O O
case O O
is O O
less O O
than O O
70 O O
mg/dL. O O
Umberto O O
Uzzell, O O
MD O O
Signed O O
electronically O O
by O O
Umberto O O
Uzzell, O O
MD O O
Document O O
Status: O O
Final O O

Record B-SMOKER O
date: I-SMOKER O
2067-09-05 I-SMOKER O
Internal O O
Medicine O O
Vance, O O
Jennifer O O
54266003 O O
9-5-67 O O
CHIEF O O
COMPLAINT: O O
Ms. O O
Vance O O
is O O
a O O
45 O O
year O O
old O O
woman O O
with O O
diabetes, B-DIABETES O
porphyria O O
and O O
coronary B-CAD O
artery I-CAD O
disease, I-CAD O
who O O
came O O
in O O
today O O
for O O
annual O O
visit. O O
HPI: O O
1. O O
Pain O O
in O O
right O O
hand. O O
The O O
patient O O
has O O
a O O
Dupuytren's O O
contraction O O
in O O
the O O
right O O
hand. O O
She O O
did O O
have O O
one O O
in O O
the O O
left O O
hand O O
for O O
which O O
she O O
had O O
surgery O O
in O O
June, O O
2064. O O
The O O
surgery O O
was O O
performed O O
by O O
Dr. O O
Peter O O
Vandenberg. O O
At O O
that O O
time, O O
she O O
also O O
had O O
an O O
ulnar O O
nerve O O
decompression. O O
She O O
had O O
trigger O O
fingers O O
in O O
the O O
left O O
index O O
and O O
ring O O
finger O O
as O O
well, O O
which O O
were O O
repaired. O O
She O O
is O O
a O O
Transport O O
Operations O O
Supervisor O O
that O O
uses O O
her O O
hands O O
extensively O O
and O O
is O O
very O O
concerned O O
about O O
the O O
pain O O
in O O
her O O
right O O
hand. O O
2. O O
Diabetes B-DIABETES O
mellitus. I-DIABETES O
She O O
only O O
rarely O O
checks O O
her O O
blood O O
sugars. O O
They O O
tend O O
to O O
run O O
about O O
160. O O
She O O
has O O
had O O
diabetes O O
for O O
28 O O
years. O O
She O O
takes O O
NPH B-MEDICATION B-MEDICATION
insulin B-MEDICATION O
25 O O
units O O
sub O O
q O O
q.a.m. O O
and O O
CGI B-MEDICATION O
10 O O
units O O
sub O O
q O O
q.a.m. O O
She O O
is O O
not O O
on O O
an O O
evening O O
dose. O O
Her O O
last O O
ophthalmology O O
visit O O
was O O
in O O
6/66. O O
She O O
denies O O
any O O
problems O O
with O O
peripheral O O
neuropathy. O O
3. O O
Coronary B-CAD O
artery I-CAD O
disease. I-CAD O
She O O
is O O
status O O
post O O
single B-CAD O
vessel I-CAD O
CABG B-CAD O
in I-CAD O
9/61 I-CAD O
for I-CAD O
isolated I-CAD O
lesion. I-CAD O
Since O O
then O O
she O O
has O O
had O O
no O O
angina. O O
She O O
has O O
been O O
on O O
no O O
medications O O
for O O
coronary O O
artery O O
disease O O
since O O
2063. O O
4. O O
Left O O
breast O O
lesion. O O
She O O
was O O
found O O
to O O
have O O
a O O
breast O O
mass O O
in O O
12/66 O O
and O O
underwent O O
wire O O
localization O O
and O O
biopsy. O O
At O O
that O O
time, O O
she O O
had O O
micro O O
calcifications O O
on O O
her O O
mammogram O O
at O O
that O O
time. O O
The O O
past O O
report O O
revealed O O
atypical O O
ductal O O
hyperplasia O O
only. O O
CURRENT O O
MEDICATIONS: O O
NPH O O
insulin O O
25 O O
units O O
sub O O
q O O
q.a.m., O O
CGI O O
10 O O
units O O
sub O O
q O O
q.a.m., O O
Tylenol O O
p.r.n., O O
aspirin B-MEDICATION B-MEDICATION
85 O O
mg O O
PO O O
q.d. O O
PHYSICAL O O
EXAM: O O
Blood O O
pressure O O
114/50. O O
Weight O O
111.5 O O
lbs. O O
General O O
appearance: O O
healthy O O
appearing O O
middle O O
aged O O
woman O O
in O O
no O O
acute O O
distress. O O
HEENT: O O
no O O
retinopathy O O
was O O
noted O O
on O O
my O O
exam. O O
Neck: O O
no O O
thyromegaly. O O
Chest O O
is O O
clear O O
to O O
P&A. O O
She O O
has O O
sternotomy O O
scars O O
present. O O
Cardiac: O O
normal O O
S1, O O
S2. O O
Breasts: O O
right O O
breast O O
is O O
normal, O O
left O O
breast O O
reveals O O
surgical O O
incisional O O
scars O O
at O O
12:00 O O
and O O
3:00 O O
O'clock. O O
She O O
does O O
have O O
a O O
firm O O
mass O O
below O O
the O O
incisional O O
scar O O
at O O
3:00 O O
P.M. O O
Abdomen: O O
midline O O
scar O O
in O O
the O O
lower O O
abdomen O O
is O O
evident O O
from O O
her O O
C O O
section. O O
No O O
hepatosplenomegaly. O O
Extremities: O O
no O O
edema. O O
Pelvic O O
exam: O O
external O O
genitalia O O
are O O
normal. O O
Vagina, O O
cervix, O O
fundus, O O
adnexae O O
all O O
normal. O O
IMPRESSION: O O
1. O O
Painful O O
right O O
hand. O O
The O O
patient O O
was O O
referred O O
back O O
to O O
Dr. O O
Peter O O
Vandenberg O O
for O O
evaluation O O
for O O
surgery. O O
2. O O
Diabetes O O
mellitus. O O
I O O
asked O O
the O O
patient O O
to O O
keep O O
track O O
of O O
her O O
blood O O
sugars O O
for O O
then O O
next O O
month O O
and O O
to O O
return O O
to O O
see O O
me. O O
I O O
also O O
checked O O
a O O
BUN O O
and O O
creatinine O O
as O O
well O O
as O O
a O O
urine O O
micro O O
albumen. O O
We O O
checked O O
her O O
annual O O
cholesterol. O O
Her O O
previous O O
cholesterol O O
was O O
done O O
5/66 O O
and O O
was O O
203. O O
She O O
was O O
referred O O
to O O
Dr. O O
Nava O O
for O O
a O O
good O O
retinal O O
exam. O O
INDIANOLA O O
VALLEY O O
CENTER O O
Vance, O O
Jennifer O O
Page O O
2 O O
54266003 O O
9-5-67 O O
3. O O
Status O O
post O O
CABG. O O
I O O
started B-MEDICATION O
her I-MEDICATION O
on I-MEDICATION O
atenolol B-MEDICATION B-MEDICATION
25 O O
mg O O
PO O O
q.d. O O
given O O
that O O
she O O
does O O
have O O
coronary O O
artery O O
disease, O O
and O O
there O O
is O O
a O O
question O O
as O O
to O O
whether B-CAD O
or I-CAD O
not I-CAD O
she I-CAD O
had I-CAD O
an I-CAD O
MI B-CAD O
in I-CAD O
2061, I-CAD O
which O O
she O O
will O O
return O O
in O O
one O O
month O O
for O O
blood O O
pressure O O
check O O
and O O
also O O
to O O
review O O
her O O
blood O O
sugars. O O
_________________________ O O
Vester O O
Light, O O
M.D. O O
WV:AV:8176 O O
DD:9-5-67 O O
DT:9-6-67 O O
DV:9-5-67 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2069-07-18 O O
July O O
18, O O
2069 O O
Vester O O
Light, O O
M.D. O O
Internal O O
Medicine O O
Barton O O
Memorial O O
Hospital O O
RE: O O
Jennifer O O
Vance O O
MR O O
#542-66-00-3 O O
Dear O O
Vester: O O
Mrs. O O
Vance O O
presents O O
to O O
the O O
office O O
today O O
for O O
general O O
cardiac O O
evaluation. O O
As O O
her O O
history O O
is O O
well O O
known O O
to O O
you, O O
I O O
will O O
repeat O O
it O O
briefly O O
for O O
our O O
records. O O
Mrs. O O
Vance O O
is O O
a O O
47-year-old O O
woman O O
with O O
a O O
history O O
of O O
variegata O O
porphyria, O O
insulin B-DIABETES O
dependent I-DIABETES O
diabetes I-DIABETES O
and O O
significant O O
coronary B-CAD B-CAD
artery I-CAD I-CAD
disease. I-CAD O
In O O
2061, O O
after O O
a O O
four O O
to O O
five O O
day O O
history O O
of O O
retrosternal O O
chest O O
discomfort, O O
she O O
was O O
admitted O O
to O O
the O O
Barton O O
Memorial O O
Hospital O O
where O O
coronary O B-CAD
angiography O O
revealed O O
a O O
95% O O
proximal O O
left O O
anterior O O
descending O O
artery O O
stenosis. O O
She B-CAD O
underwent I-CAD O
balloon I-CAD O
angioplasty B-CAD O
of I-CAD O
her I-CAD O
LAD I-CAD O
times I-CAD O
two I-CAD O
with I-CAD O
inadequate I-CAD O
results. I-CAD O
She I-CAD O
therefore I-CAD O
was I-CAD O
taken I-CAD O
electively I-CAD O
for I-CAD O
coronary B-CAD O
artery I-CAD O
bypass I-CAD O
graft I-CAD O
surgery I-CAD O
with I-CAD O
placement I-CAD O
of I-CAD O
a I-CAD O
left I-CAD O
internal I-CAD O
mammary I-CAD O
artery I-CAD O
to I-CAD O
her I-CAD O
LAD. I-CAD O
She O O
subsequently O O
continued O O
to O O
have O O
chest O O
discomfort O O
and O O
underwent O O
repeat O O
cardiac O O
catheterization O O
in O O
May O O
of O O
2063 O O
at O O
which O O
time O O
coronary O O
angiography O O
revealed O O
a O O
60% O O
stenosis O O
in O O
the O O
proximal O O
left O O
anterior O O
descending O O
artery O O
and O O
a O O
50% O O
stenosis O O
in O O
the O O
mid O O
right O O
coronary O O
artery. O O
The O O
catheterization O O
report O O
does O O
not O O
indicate O O
the O O
status O O
of O O
her O O
left O O
internal O O
mammary O O
artery O O
graft. O O
Since O O
then, O O
she O O
has O O
continued O O
to O O
have O O
episodes O O
of O O
intermittent O O
abdominal O O
discomfort. O O
She O O
recently O O
has O O
undergone O O
an O O
extensive O O
evaluation O O
by O O
the O O
gastroenterology O O
service O O
for O O
her O O
abdominal O O
pain O O
without O O
specific O O
pathology O O
being O O
discovered. O O
Trials O O
of O O
H2 O O
blockers O O
and O O
proton O O
pump O O
inhibitors O O
have O O
been O O
ineffective. O O
In O O
November O O
of O O
2068, O O
she O O
underwent O O
a O O
Bruce O O
protocol O O
stress O O
test O O
exercising O O
for O O
eight O O
minutes O O
to O O
a O O
peak O O
heart O O
rate O O
of O O
131, O O
peak O O
blood O O
pressure O O
of O O
188/82 O O
stopping O O
because O O
of O O
fatigue. O O
She O O
had O O
no O O
ischemic O O
changes O O
on O O
electrocardiogram. O O
Over O O
the O O
past O O
two O O
weeks O O
however, O O
she O O
has O O
noticed O O
that O O
her O O
chronic O O
abdominal O O
pain O O
syndrome O O
(which O O
she O O
often O O
describes O O
as O O
feeling O O
like O O
indigestion) O O
now O O
includes O O
radiation O O
to O O
her O O
left O O
shoulder. O O
The O O
pain O O
is O O
not O O
exacerbated O O
by O O
position, O O
time O O
of O O
day O O
or O O
any O O
particular O O
activity. O O
The O O
pain O O
does O O
not O O
awaken O O
her O O
from O O
sleep O O
nor O O
does O O
it O O
occur O O
at O O
rest. O O
Of O O
note, O O
her O O
lipid O O
profile O O
from O O
October O O
2068 O O
indicates O O
a O O
cholesterol O O
of O O
229, O O
triglyceride O O
of O O
68, O O
HDL O O
51, O O
LDL B-HYPERLIPIDEMIA O
of I-HYPERLIPIDEMIA O
164. B-HYPERLIPIDEMIA O
Vance, O O
Jennifer O O
MR O O
#542-66-00-3 O O
-2- O O
July O O
18, O O
2069 O O
Past O O
medical O O
history O O
is O O
notable O O
for O O
variegata O O
porphyria, O O
insulin B-DIABETES O
dependent I-DIABETES O
diabetes, I-DIABETES O
right O O
hand O O
carpal O O
tunnel O O
syndrome, O O
Dupuytren's O O
contracture O O
and O O
tendinitis O O
and O O
hypertension. B-HYPERTENSION B-HYPERTENSION
Medications O O
at O O
Present: O O
Enteric O O
coated O O
aspirin B-MEDICATION B-MEDICATION
one O O
tab O O
po O O
q.d., O O
NPH B-MEDICATION O
insulin I-MEDICATION O
25 O O
units O O
sub O O
q O O
qAM, O O
CZI B-MEDICATION O
10 O O
units O O
sub O O
q O O
qAM. O O
Allergies: O O
None. O O
Cigarettes B-SMOKER O
- I-SMOKER O
none. B-SMOKER O
Ethanol O O
- O O
social. O O
Family O O
history O O
is O O
notable O O
for O O
her O O
father O O
dying O O
from O O
carcinoma, O O
mother O O
dying O O
of O O
colon O O
cancer, O O
question B-FAMILY_HIST O
coronary I-FAMILY_HIST O
disease, I-FAMILY_HIST O
one I-FAMILY_HIST O
brother B-FAMILY_HIST O
having I-FAMILY_HIST O
a I-FAMILY_HIST O
myocardial I-FAMILY_HIST O
infarction I-FAMILY_HIST O
at I-FAMILY_HIST O
age I-FAMILY_HIST O
25, I-FAMILY_HIST O
another O O
brother O O
dying O O
from O O
melanoma O O
age O O
36. O O
The O O
rest O O
of O O
her O O
siblings O O
and O O
children O O
have O O
not O O
heart O O
disease. O O
Physical O O
exam O O
reveals O O
a O O
delightful O O
woman O O
in O O
no O O
acute O O
distress. O O
Blood O O
pressure O O
right O O
arm O O
sitting O O
110/64, O O
heart O O
rate O O
85 O O
and O O
regular, O O
respirations O O
12 O O
and O O
unlabored, O O
weight O O
104 O O
pounds. O O
The O O
neck O O
is O O
supple. O O
JVP O O
flat. O O
Carotids O O
are O O
2+ O O
with O O
bilateral O O
soft O O
right O O
greater O O
than O O
left O O
bruits. O O
Chest O O
is O O
clear. O O
Cardiac O O
exam O O
shows O O
a O O
normal O O
S1, O O
physiologically O O
split O O
S2 O O
and O O
a O O
I/VI O O
systolic O O
ejection O O
murmur O O
radiating O O
from O O
the O O
apex O O
to O O
the O O
base, O O
no O O
significant O O
diastolic O O
murmur. O O
The O O
abdomen O O
is O O
benign. O O
Extremities O O
reveal O O
no O O
appreciable O O
edema. O O
Peripheral O O
pulses O O
are O O
intact. O O
Electrocardiogram O O
shows O O
sinus O O
rhythm O O
at O O
a O O
rate O O
of O O
85. O O
PR O O
interval O O
of O O
.12, O O
QRS O O
.06, O O
QT O O
.36, O O
axis O O
85 O O
degrees. O O
There O O
are O O
minor O O
nonspecific O O
ST-T O O
wave O O
changes. O O
Impression: O O
Mrs. O O
Vance O O
is O O
a O O
47-year-old O O
woman O O
with O O
a O O
history O O
of O O
variegata O O
porphyria, O O
insulin O O
dependent O O
diabetes, O O
hypertension O B-HYPERTENSION
and O O
dyslipidemia B-HYPERLIPIDEMIA O
with O O
known O O
coronary O O
artery O O
disease. O O
She O O
has O O
had O O
a O O
retrosternal O O
chest O O
pain O O
syndrome O O
for O O
the O O
past O O
several O O
years O O
and O O
her O O
most O O
recent O O
stress O O
test O O
approximately O O
one O O
year O O
ago O O
did O O
not O O
show O O
significant O O
provokable O O
ischemia. O O
Nonetheless, O O
I O O
am O O
concerned O O
that O O
her O O
clinical O O
presentation O O
may O O
still O O
represent O O
recurrent O O
ischemia. O O
I O O
therefore O O
have O O
scheduled O O
her O O
for O O
an O O
exercise O O
MIBI O O
stress O O
test O O
and O O
I O O
will O O
obtain O O
both O O
an O O
echocardiogram O O
and O O
carotid O O
noninvasive O O
studies. O O
In O O
light O O
of O O
her O O
significant O O
dyslipidemia O O
and O O
insulin O O
dependent O O
diabetes, O O
I O O
strongly O O
recommend O O
beginning O O
aggressive O O
antilipemic O O
pharmacologic O O
therapy. O O
Unless O O
her O O
variegata O O
porphyria O O
precludes O O
the O O
use O O
of O O
atorvastatin, O B-MEDICATION
I O O
would O O
begin O O
this O O
at O O
10 O O
mg O O
po O O
q.d. O O
I O O
would O O
target O O
her O O
LDL O O
cholesterol O O
to O O
less O O
than O O
90. O O
In O O
addition, O O
I O O
have O O
started O O
her O O
on O O
atenolol O B-MEDICATION
at O O
25 O O
mg O O
po O O
q.d. O O
and O O
I O O
would O O
consider O O
beginning O O
an O O
ACE O O
inhibitor O O
again O O
if O O
her O O
porphyria O O
does O O
not O O
Vance, O O
Jennifer O O
MR O O
#542-66-00-3 O O
-3- O O
July O O
18, O O
2069 O O
preclude O O
this. O O
She O O
understands O O
that O O
if O O
she O O
has O O
evidence O O
for O O
significant O O
provokable O O
ischemia O O
that O O
I O O
would O O
strongly O O
encourage O O
her O O
to O O
undergo O O
repeat O O
coronary O O
angiography. O O
Thank O O
you O O
very O O
much O O
for O O
allowing O O
me O O
to O O
assist O O
in O O
her O O
care. O O
Sincerely O O
yours, O O
Timothy O O
Quarterman, O O
M.D. O O
DD: O O
07/18/69 O O
DT: O O
07/28/ O O
DV: O O
07/18/69 O O
/riggs O O
cc: O O
John O O
Koontz, O O
M.D. O O
Kearney O O
Urology O O
Center O O
49 O O
Buswell O O
St O O
Minerva, O O
TN O O
41694 O O
cc: O O
Vincent O O
Veal, O O
M.D. O O
Gastroenterology O O
Division O O
- O O
BMH O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2070-06-10 O O
June O O
11, O O
2070 O O
Wanda O O
Koontz, O O
M.D. O O
Internal O O
Medicine O O
Barton O O
Memorial O O
Hospital O O
12 O O
Batchelder O O
Street O O
Minerva, O O
TN O O
41694 O O
Re: O O
Jennifer O O
Vance O O
MR# O O
542-66-00-3 O O
Dear O O
Wanda: O O
Mrs. O O
Vance O O
returns O O
for O O
routine O O
follow O O
up. O O
At O O
the O O
present O O
time, O O
she O O
continues O O
to O O
complain O O
of O O
exertional B-CAD O
angina, B-CAD O
and O O
states O O
that O O
she O O
is O O
willing O O
to O O
consider O O
undergoing O O
cardiac O O
catheterization. O O
As O O
you O O
know, O O
I O O
had O O
suggested O O
this O O
to O O
her O O
last O O
November. O O
She O O
continues O O
now O O
on O O
a O O
regimen O O
of O O
Atenolol B-MEDICATION B-MEDICATION
25 O O
mg O O
p.o. O O
q.d., O O
Paxil O O
20 O O
mg O O
p.o. O O
q.d., O O
Humalog B-MEDICATION B-MEDICATION
10 O O
units O O
sub.q. O O
q.a.m., O O
NPH B-MEDICATION O
25 O O
units O O
sub.q. O O
q.a.m., O O
sliding B-MEDICATION O
scale I-MEDICATION O
CZI I-MEDICATION O
throughout O O
the O O
day, O O
isosorbide B-MEDICATION B-MEDICATION
mononitrate I-MEDICATION O
60 I-MEDICATION O
mg I-MEDICATION O
p.o. I-MEDICATION O
q.d., I-MEDICATION O
Pravastatin O B-MEDICATION
20 O O
mg O O
p.o. O O
q.d., O O
Flonase, O O
Neurontin O O
300 O O
mg O O
p.o. O O
b.i.d., O O
and O O
Celexa. O O
Physical O O
exam O O
reveals O O
a O O
thin O O
woman O O
in O O
no O O
acute O O
distress. O O
Blood O O
pressure O O
right O O
arm O O
sitting O O
92/60, O O
heart O O
rate O O
75 O O
and O O
regular. O O
Respirations O O
12 O O
and O O
unlabored. O O
Weight O O
109 O O
pounds. O O
This O O
is O O
one O O
pound O O
above O O
her O O
weight O O
of O O
six O O
months O O
ago. O O
The O O
neck O O
is O O
supple. O O
JVP O O
is O O
flat. O O
Carotids O O
with O O
continuing O O
right O O
greater O O
than O O
left O O
bruits. O O
Chest O O
is O O
clear. O O
Cardiac O O
exam O O
reveals O O
a O O
normal, O O
physiologically O O
split O O
S2, O O
and O O
a O O
soft O O
systolic O O
ejection O O
murmur O O
radiating O O
from O O
the O O
apex O O
to O O
the O O
base. O O
No O O
significant O O
diastolic O O
murmur. O O
The O O
abdomen O O
is O O
benign. O O
Extremities O O
are O O
without O O
edema. O O
The O O
pulses O O
are O O
intact. O O
Electrocardiogram O O
shows O O
a O O
sinus O O
rhythm O O
at O O
a O O
rate O O
of O O
75, O O
PR O O
interval O O
.12, O O
QRS O O
.08, O O
QT O O
.34, O O
axis O O
75 O O
degrees. O O
There O O
are O O
lateral O O
ST O O
and O O
T O O
wave O O
changes O O
compatible O O
with O O
strain O O
or O O
ischemia. O O
Compared O O
to O O
her O O
last O O
electrocardiogram, O O
there O O
has O O
been O O
no O O
significant O O
change. O O
Impression: O O
Ms. O O
Vance O O
is O O
a O O
48-year-old O O
woman O O
with O O
a O O
history O O
of O O
variegata O O
porphyria, O O
insulin B-DIABETES O
dependent I-DIABETES O
diabetes, B-DIABETES O
and O O
significant O O
Jennifer O O
Vance O O
MR# O O
542-66-00-3 O O
June O O
10, O O
2070 O O
-2- O O
coronary B-CAD O
artery I-CAD O
disease. I-CAD O
She B-CAD O
is I-CAD O
status I-CAD O
post I-CAD O
intramammary I-CAD O
artery I-CAD O
graft B-CAD O
to I-CAD O
her I-CAD O
LAD, I-CAD O
after I-CAD O
developing I-CAD O
restenosis I-CAD O
at I-CAD O
the I-CAD O
site I-CAD O
of I-CAD O
a I-CAD O
balloon I-CAD O
LAD I-CAD O
angioplasty. B-CAD O
The O O
results O O
of O O
the O O
catheterization O O
will O O
determine O O
subsequent O O
therapeutic O O
recommendations. O O
She O O
will O O
have O O
her O O
insulin O O
dose O O
on O O
the O O
morning O O
of O O
her O O
scheduled O O
catheterization. O O
Thank O O
you O O
very O O
much O O
for O O
allowing O O
me O O
to O O
assist O O
in O O
her O O
care. O O
Sincerely O O
yours, O O
Timothy O O
E. O O
Quarterman, O O
M.D. O O
/quintal O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2071-01-12 O O
Problems O O
IDDM B-DIABETES O
COR B-CAD O
ART I-CAD O
DIS I-CAD O
MI B-CAD O
PORPHYRIA O O
PAST B-SMOKER O
SMOKER I-SMOKER O
QUIT I-SMOKER O
2061; I-SMOKER O
1/2 I-SMOKER O
PPD I-SMOKER O
X I-SMOKER O
15 I-SMOKER O
YEARS I-SMOKER O
S/P O O
SURGERY O O
LEFT O O
HAND, O O
REPAIR O O
DUPYTRENS O O
CONTRACTURE O O
History O O
of O O
Present O O
Illness O O
Jennifer O O
comes O O
in O O
doing O O
well. O O
She O O
has O O
had O O
little O O
chest O O
pain O O
and O O
has O O
required O O
few O O
nitros. O B-MEDICATION
No O O
chest O O
pain O O
at O O
rest O O
or O O
shortness O O
of O O
breath. O O
She O O
continues O O
to O O
have O O
significant O O
discomfort O O
from O O
her O O
DM O O
neuropathy. O O
She O O
has O O
been O O
taking O O
neurontin O O
and O O
has O O
noticed O O
an O O
improvement O O
in O O
this, O O
but O O
the O O
pain O O
does O O
continue O O
to O O
be O O
problematic. O O
She O O
saw O O
Pearline O O
Rush O O
in O O
neurology O O
who O O
felt O O
that O O
she O O
was O O
not O O
likely O O
to O O
be O O
having O O
seizures, O O
but O O
planned O O
an O O
EEG O O
and O O
MRI O O
to O O
r/o O O
any O O
structural O O
disease. O O
Seen O O
in O O
GYN O O
for O O
embx O O
which O O
was O O
negative O O
for O O
hyperplasia. O O
Has O O
not O O
had O O
her O O
period O O
for O O
3 O O
months. O O
Seen O O
in O O
ED O O
with O O
a O O
tick O O
bite. O O
No O O
rashes O O
or O O
joint O O
symptoms. O O
Past O O
Medical O O
History O O
See O O
problem O O
list O O
Medications O O
TYLENOL O O
PO O O
PRN O O
ASPIRIN B-MEDICATION B-MEDICATION
81MG O O
PO O O
QD O O
* O O
HUMULOG B-MEDICATION O
Variable O O
qid O O
CELEXA O O
(CITALOPRAM) O O
40MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
SYNALAR O O
0.025% O O
CREAM O O
(FLUOCINOLONE O O
0.025%... O O
TOP O O
BID O O
FLONASE O O
(FLUTICASONE O O
NASAL O O
SPRAY) O O
2SPRAY O O
INH O O
each O O
nostril O O
qd O O
IMDUR B-MEDICATION O
(ISOSORBIDE I-MEDICATION O
MONONIT.(SR)) I-MEDICATION O
60MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
NPH B-MEDICATION B-MEDICATION
INSULIN I-MEDICATION B-MEDICATION
25UNITS/3units O O
SC O O
QAM/qpm O O
LOPRESSOR B-MEDICATION B-MEDICATION
25MG O O
PO O O
QD O O
TNG B-MEDICATION O
0.4 I-MEDICATION O
MG I-MEDICATION O
(NITROGLYCERIN I-MEDICATION O
1/150 I-MEDICATION O
(0.4 I-MEDICATION O
MG)) I-MEDICATION O
1TAB O O
SL O O
Q5 O O
MIN O O
X O O
3 O O
NEURONTIN O O
(GABAPENTIN) O O
300MG O O
2 O O
Capsule(s) O O
PO O O
TID O O
PRAVACHOL B-MEDICATION B-MEDICATION
(PRAVASTATIN) I-MEDICATION O
40MG O O
1 O O
Tablet(s) O O
PO O O
QHS O O
PLAVIX B-MEDICATION B-MEDICATION
(CLOPIDOGREL) I-MEDICATION O
75MG O O
PO O O
QD O O
NEXIUM O O
(ESOMEPRAZOLE) O O
20MG O O
PO O O
QD O O
Allergies O O
TEGRETOL O O
(CARBAMAZEPINE) O O
porphyria O O
ELAVIL O O
(AMITRIPTYLINE O O
HCL) O O
porphyria O O
Morphine O O
Rash O O
VARIEGATE O O
PORPHYRIA O O
CHECK O O
LONGMONT O O
FOR O O
LIST O O
OF O O
DRUGS; O O
INCLUDES O O
SULFA,BARBITUATES, O O
MEPROBAMATE, O O
VALPROATE, O O
GRISEOFULVIN, O O
ERGOTS, O O
STEROIDS O O
Family O O
History O O
Mother, O O
sister, O O
brother, O O
nephew O O
DM O O
Mother O O
Porphyria O O
Sister O O
Porphyria O O
Social O O
History O O
Formerly O O
worked O O
as O O
an O O
Transport O O
Operations O O
Supervisor. O O
Married O O
with O O
1 O O
son. O O
No O O
tob. O O
No O O
etoh. O O
Review O O
of O O
Systems O O
No O O
sob/worsening O O
cp O O
Vital O O
Signs O O
Blood O O
Pressure: O O
128/68 O O
Weight: O O
107 O O
Pounds O O
Physical O O
Exam O O
Disposition O O
and O O
Plans O O
1. O O
CAD B-CAD O
- O O
Follow O O
closely. O O
Continue O O
current O O
regimen. O O
2. O O
DM O O
- O O
poor O O
control. O O
Very O O
brittle. O O
Recently O O
seen O O
by O O
Dr. O O
Nelson. O O
3. O O
Cholesterol O O
- O O
last O O
LDL O O
&lt;100. O O
Pravachol B-MEDICATION B-MEDICATION
increased O O
to O O
40mg. O O
4. O O
Menorrhagia O O
- O O
currently O O
not O O
an O O
issue. O O
5. O O
DM O O
neuropathy O O
- O O
will O O
increase O O
neurontin O O
to O O
600 O O
mg O O
tid. O O
6. O O
HM O O
up O O
to O O
date O O
Return O O
to O O
Clinic O O
in O O
4 O O
months. O O
cc: O O
John O O
Koontz, O O
MD; O O
Timothy O O
Quarterman, O O
MD O O
______________________________ O O
Wanda O O
Andrea O O
Koontz, O O
M.D. O O

Record B-SMOKER O
date: O O
2073-05-10 O O
LUH O O
Cardiovascular O O
Division O O
CVD O O
ER8 O O
92 O O
Batchelder O O
Street O O
VANCE, O O
JENNIFER O O
Minerva, O O
TN O O
41694 O O
54266003 O O
(727) O O
859-7945 O O
05/10/73 O O
Wanda O O
A. O O
Koontz, O O
M.D. O O
Internal O O
Medicine O O
Associates O O
Barton O O
Memorial O O
Hospital O O
70 O O
Batchelder O O
Street O O
Minerva, O O
TN O O
41694 O O
Dear O O
Wanda: O O
Mr. O O
Vance O O
returns O O
for O O
followup. O O
Since O O
last O O
seen, O O
she O O
apparently O O
was O O
recently O O
seen O O
in O O
the O O
walk-in O O
clinic O O
in O O
your O O
office O O
complaining O O
of O O
profound O O
fatigue O O
and O O
depression. O O
She O O
wonders O O
if O O
she O O
was O O
having O O
a O O
flare O O
of O O
her O O
porphyria. O O
Apparently, O O
her O O
examination O O
at O O
that O O
time O O
was O O
relatively O O
benign, O O
and O O
no O O
specific O O
new O O
findings O O
were O O
noted. O O
After O O
talking O O
with O O
Dr. O O
Vogt O O
at O O
that O O
office O O
visit, O O
she O O
felt O O
modestly O O
improved, O O
and O O
over O O
the O O
past O O
few O O
weeks O O
feels O O
that O O
her O O
energy O O
level O O
has O O
returned O O
to O O
its O O
baseline. O O
Lab O O
studies O O
obtained O O
at O O
that O O
time O O
revealed O O
creatinine O O
0.9, O O
glucose O O
elevated O O
at O O
236, O O
hematocrit O O
of O O
43, O O
with O O
a O O
white O O
count O O
10. O O
As O O
no O O
specific O O
pathology O O
was O O
noted, O O
she O O
was O O
sent O O
home O O
without O O
any O O
change O O
in O O
her O O
medical O O
regimen. O O
Currently, O O
she O O
continues O O
on O O
Lantus B-MEDICATION B-MEDICATION
insulin I-MEDICATION B-MEDICATION
20 O O
units O O
subcutaneous. O O
q.p.m., O O
Celexa O O
40 O O
mg O O
p.o. O O
q.d., O O
enteric-coated O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
p.o. O O
q.d., O O
Flonase O O
1-2 O O
puffs O O
p.o. O O
q.d., O O
isosorbide B-MEDICATION B-MEDICATION
mononitrate I-MEDICATION O
60 O O
mg O O
p.o. O O
q.d., O O
Neurontin O O
600 O O
mg O O
p.o. O O
t.i.d., O O
nitroglycerin B-MEDICATION B-MEDICATION
p.r.n. O O
which O O
she O O
has O O
not O O
had O O
to O O
take, O O
lisinopril B-MEDICATION B-MEDICATION
10 O O
mg O O
p.o. O O
q.d., O O
furosemide O O
20 O O
mg O O
p.o. O O
q.d., O O
and O O
p.r.n. O O
Motrin. O O
Physical O O
exam O O
reveals O O
a O O
thin O O
woman O O
in O O
no O O
acute O O
distress. O O
Blood O O
pressure O O
right O O
arm O O
sitting O O
105/78, O O
heart O O
rate O O
70 O O
and O O
regular, O O
respirations O O
14 O O
and O O
unlabored, O O
and O O
weight O O
is O O
pending. O O
The O O
neck O O
is O O
supple. O O
JVP O O
is O O
flat. O O
Carotids O O
are O O
2+ O O
with O O
very O O
soft O O
bilateral O O
referred O O
murmurs. O O
Chest O O
is O O
clear. O O
Cardiac O O
exam O O
shows O O
normal O O
S1, O O
physiologically O O
split O O
S2 O O
with O O
1/6 O O
systolic O O
ejection O O
murmur O O
radiating O O
from O O
the O O
apex O O
to O O
the O O
base, O O
and O O
a O O
1-2/6 O O
holosystolic O O
murmur O O
radiating O O
from O O
the O O
apex O O
to O O
the O O
axilla. O O
No O O
significant O O
diastolic O O
murmur O O
or O O
rub. O O
The O O
abdomen O O
is O O
benign. O O
Extremities O O
reveal O O
trace O O
bipedal O O
edema. O O
Peripheral O O
pulses O O
are O O
diminished O O
but O O
detectable. O O
Electrocardiogram O O
is O O
pending. O O
Impression: O O
Ms. O O
Vance O O
remains O O
relatively O O
stable O O
from O O
a O O
cardiovascular O O
perspective. O O
However, O O
as O O
you O O
know, O O
her O O
last O O
echocardiogram O O
did O O
show O O
evidence O O
of O O
at O O
least O O
moderate O O
mitral O O
regurgitation O O
with O O
significantly O O
reduced O O
left O O
ventricular O O
systolic O O
function. O O
She O O
has O O
made O O
it O O
quite O O
clear O O
that O O
under O O
no O O
circumstances O O
would O O
she O O
consider O O
repeat O O
cardiac O O
surgery O O
to O O
treat O O
her O O
valvular O O
heart O O
disease. O O
Nonetheless, O O
I O O
think O O
it O O
would O O
be O O
helpful O O
for O O
her O O
to O O
undergo O O
repeat O O
echocardiogram O O
to O O
help O O
gauge O O
the O O
current O O
status O O
of O O
her O O
left O O
ventricle O O
and O O
degree O O
of O O
regurgitation, O O
which O O
may O O
allow O O
for O O
additional O O
modifications O O
to O O
her O O
therapeutic O O
regimen. O O
Beyond O O
this, O O
her O O
condition O O
is O O
actually O O
relatively O O
stable O O
from O O
a O O
cardiovascular O O
standpoint. O O
I O O
have O O
not O O
further O O
altered O O
her O O
medical O O
regimen. O O
Thank O O
you O O
very O O
much O O
for O O
allowing O O
me O O
to O O
assist O O
in O O
her O O
care. O O
Sincerely O O
yours, O O
______________________________ O O
Timothy O O
Quarterman, O O
M.D. O O
Dictated O O
By: O O
Timothy O O
Quarterman O O
eScription O O
document:6-0437424 O O
GFFocus O O
CC: O O
John O O
Koontz O O
MD O O
489 O O
MONICA O O
STREET O O
MINERVA, O O
TN O O
41694 O O
DD: O O
05/10/73 O O
DT: O O
05/11/73 O O
DV: O O
05/10/73 O O

Record O O
date: O O
2091-07-02 O O
CARDIOLOGY O O
BEAUREGARD O O
MEMORIAL O O
HOSPITAL O O
Nathan O O
J O O
Fernandes O O
M.D. O O
College O O
Station, O O
NC O O
22169 O O
Dear O O
Dr. O O
Fernandes: O O
Dr. O O
Nunes O O
and O O
I O O
had O O
the O O
pleasure O O
to O O
see O O
your O O
patient, O O
Mr. O O
Christian O O
Mullen, O O
this O O
morning O O
in O O
the O O
office O O
for O O
a O O
routine O O
vascular O O
followup. O O
It O O
has O O
been O O
nearly O O
18 O O
months O O
since O O
his O O
last O O
visit O O
here O O
and O O
in O O
the O O
interim O O
time, O O
has O O
been O O
having O O
discomfort O O
involving O O
both O O
of O O
his O O
hips, O O
thighs, O O
and O O
calves. O O
As O O
you O O
well O O
know, O O
Mr. O O
Mullen O O
is O O
a O O
delightful O O
69-year-old O O
gentleman O O
with O O
history O O
of O O
hypertension, B-HYPERTENSION B-HYPERTENSION
hyperlipidemia, B-HYPERLIPIDEMIA B-HYPERTENSION
coronary B-CAD B-CAD
artery I-CAD O
disease, I-CAD O
type B-DIABETES O
2 I-DIABETES O
diabetes B-DIABETES O
mellitus, I-DIABETES O
and O O
peripheral O O
arterial O O
disease O O
who O O
previously O O
underwent O O
left O O
common O O
femoral O O
and O O
left O O
popliteal O O
artery O O
revascularization O O
November O O
2088 O O
followed O O
by O O
right O O
external, O O
right O O
internal, O O
and O O
right O O
common O O
femoral O O
artery O O
revascularization O O
in O O
February O O
2089. O O
Despite O O
the O O
technical O O
success O O
of O O
both O O
procedures, O O
he O O
continued O O
to O O
have O O
bilateral O O
hip O O
claudication O O
symptoms. O O
When O O
we O O
had O O
last O O
evaluated O O
him O O
in O O
November O O
2089, O O
we O O
had O O
considered O O
moving O O
forward O O
with O O
CT O O
angiography O O
to O O
assess O O
the O O
patency O O
of O O
his O O
aorto-iliac O O
anatomy. O O
At O O
the O O
time, O O
he O O
favored O O
moving O O
on O O
a O O
conservative O O
course O O
with O O
improved O O
walking O O
regimen O O
and O O
weight O O
loss. O O
Unfortunately, O O
despite O O
these O O
measures, O O
he O O
feels O O
quite O O
disabled O O
and O O
limited O O
by O O
his O O
claudication O O
symptoms. O O
Symptoms O O
are O O
noticeable O O
between O O
20 O O
and O O
50 O O
yards O O
distance O O
occurring O O
in O O
the O O
hip O O
area O O
as O O
well O O
as O O
extending O O
down O O
in O O
to O O
his O O
thigh O O
and O O
occasionally O O
the O O
calves. O O
Symptoms O O
resolve O O
with O O
sitting O O
and O O
resting O O
for O O
approximately O O
2.5 O O
minutes. O O
He O O
notes O O
that O O
symptoms O O
will O O
improve O O
with O O
standing O O
still O O
however O O
sitting O O
symptoms O O
resolve O O
much O O
quicker. O O
He O O
does O O
not O O
necessarily O O
notice O O
any O O
change O O
with O O
inclines O O
or O O
going O O
up O O
stairs; O O
in O O
fact, O O
he O O
is O O
actually O O
able O O
to O O
climb O O
18 O O
stairs O O
to O O
his O O
office O O
without O O
limitation. O O
From O O
the O O
cardiac O O
perspective, O O
Mr. O O
Mullen O O
has O O
been O O
free O O
of O O
any O O
symptoms O O
of O O
exertional O O
chest O O
tightness, O O
pressure, O O
or O O
shortness O O
of O O
breath. O O
We O O
understand O O
that O O
you O O
are O O
following O O
him O O
in O O
closely O O
in O O
this O O
regard O O
and O O
now O O
requesting O O
up O O
coming O O
chemical O O
stress O O
test O O
given O O
that O O
has O O
been O O
nearly O O
10 O O
years O O
from O O
his O O
coronary B-CAD O
artery I-CAD O
bypass I-CAD O
surgery. I-CAD O
Past O O
medical O O
history: O O
Hypertension. B-HYPERTENSION O
Hyperlipidemia. B-HYPERLIPIDEMIA O
CAD. B-CAD O
PAD. O O
Prior B-SMOKER O
tobacco I-SMOKER O
use. I-SMOKER O
Obesity. B-OBESE O
Type B-DIABETES O
2 I-DIABETES O
diabetes I-DIABETES O
mellitus. I-DIABETES O
Depressive O O
disorder. O O
Cervical O O
spine O O
disease. O O
Congenital O O
hypospadias. O O
Prostatitis. O O
Hemorrhoids. O O
Colonic O O
polyps. O O
Chronic O O
normocytic O O
anemia. O O
Medications O O
(Confirmed): O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
qd O O
Atacand B-MEDICATION B-MEDICATION
15 O O
mg O O
qd O O
doxepin O O
glyburide B-MEDICATION B-MEDICATION
Lipitor B-MEDICATION B-MEDICATION
80 O O
mg O O
qd O O
Lopid B-MEDICATION B-MEDICATION
600 O O
mg O O
BID O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
50 O O
mg O O
qd O O
Wellbutrin O O
Physical O O
examination: O O
-Pulse: O O
66 O O
and O O
regular O O
-General: O O
Mr. O O
Mullen O O
is O O
well O O
appearing O O
in O O
no O O
apparent O O
distress O O
-Heent: O O
Benign O O
-Neck: O O
Carotids O O
are O O
2+ O O
without O O
bruits O O
-Chest: O O
Lungs O O
are O O
clear O O
to O O
auscultation O O
bilaterally O O
without O O
any O O
wheezes, O O
rhonchi, O O
or O O
rubs O O
-Cardiac: O O
Discloses O O
regular O O
rhythm O O
with O O
a O O
rate O O
of O O
approximately O O
66 O O
beats O O
per O O
minute. O O
S1 O O
and O O
S2. O O
There O O
is O O
no O O
murmur, O O
rub, O O
or O O
gallop O O
-Abdomen: O O
Obese, B-OBESE O
nontender, O O
and O O
nondistended. O O
There O O
are O O
no O O
masses O O
or O O
bruits O O
appreciated O O
-Extremities: O O
Reveals O O
1+ O O
right O O
femoral O O
pulse O O
with O O
audible O O
bruits. O O
Trace O O
to O O
1+ O O
left O O
femoral O O
pulse O O
with O O
audible O O
bruit. O O
Distal O O
pulses O O
are O O
1+ O O
without O O
any O O
evidence O O
of O O
edema, O O
skin O O
breakdown, O O
or O O
ulceration O O
-BP: B-HYPERTENSION O
145/80 I-HYPERTENSION O
on I-HYPERTENSION O
the I-HYPERTENSION O
right I-HYPERTENSION O
Other O O
Data: O O
Three-vessel B-CAD O
coronary I-CAD O
artery I-CAD B-CAD
bypass I-CAD I-CAD
surgery I-CAD O
2082. O O
Status O O
post O O
C6-C7 O O
disk O O
surgery O O
2079. O O
Hypospadias O O
repair O O
in O O
childhood. O O
Assessment O O
and O O
plan: O O
Mr. O O
Christian O O
Mullen O O
is O O
a O O
delightful O O
69-year-old O O
gentleman O O
with O O
history O O
of O O
coronary O O
artery O O
disease, O O
hypertension, O B-HYPERTENSION
hyperlipidemia, O O
type O O
2 O O
diabetes O O
mellitus, O O
peripheral O O
arterial O O
disease O O
with O O
prior O O
bilateral O O
aortoiliac O O
revascularization O O
here O O
for O O
a O O
vascular O O
followup O O
with O O
symptoms O O
of O O
bilateral O O
hip, O O
buttock, O O
thigh, O O
and O O
claudication. O O
Mr. O O
Mullen's O O
symptoms O O
at O O
present O O
are O O
suggestive O O
of O O
vascular O O
claudication O O
and O O
in O O
the O O
sense O O
that O O
they O O
are O O
exertionally O O
related. O O
Interestingly, O O
he O O
has O O
had O O
these O O
symptoms O O
dating O O
back O O
to O O
immediately O O
following O O
his O O
revascularization O O
procedures O O
in O O
2088 O O
and O O
2089. O O
On O O
examination O O
today, O O
his O O
femoral O O
pulses O O
are O O
certainly O O
not O O
robust O O
and O O
may O O
suggest O O
the O O
presence O O
of O O
restenosis. O O
We O O
discussed O O
with O O
Mr. O O
Mullen O O
the O O
potential O O
of O O
going O O
forward O O
with O O
lower O O
extremity O O
noninvasive O O
studies; O O
however, O O
these O O
revealed O O
supra-normal O O
ABIs O O
in O O
the O O
past O O
secondary O O
to O O
his O O
diabetes. O O
Likewise, O O
we O O
discussed O O
the O O
possibility O O
of O O
moving O O
forward O O
with O O
a O O
non-invasive O O
imaging O O
study O O
i.e. O O
CT O O
angiogram; O O
however, O O
this O O
would O O
not O O
provide O O
the O O
option O O
of O O
therapeutic O O
intervention O O
if O O
indeed O O
narrowings O O
were O O
noted. O O
Accordingly, O O
Mr. O O
Mullen O O
is O O
in O O
favor O O
of O O
proceeding O O
forward O O
with O O
diagnostic O O
peripheral O O
angiography O O
plus/minus O O
therapeutic O O
intervention O O
if O O
restenosis O O
of O O
his O O
aortoiliac O O
segments O O
are O O
noted. O O
It O O
is O O
indeed O O
possible O O
that O O
there O O
is O O
a O O
contributing O O
factor O O
of O O
spinal O O
stenosis O O
in O O
that O O
Mr. O O
Mullen's O O
symptoms O O
are O O
relieved O O
more O O
quickly O O
in O O
the O O
sitting O O
position. O O
Likewise, O O
he O O
has O O
noted O O
improvement O O
upon O O
leaning O O
forward O O
and O O
against O O
a O O
tree. O O
We O O
understand O O
that O O
Mr. O O
Mullen O O
is O O
being O O
considered O O
for O O
an O O
upcoming O O
chemical O O
stress O O
test O O
to O O
assess O O
the O O
patency O O
for O O
any O O
silent O O
coronary O O
ischemia. O O
He O O
is O O
quite O O
reticent O O
to O O
go O O
forward O O
with O O
the O O
chemical O O
stress O O
test O O
though O O
we O O
did O O
broach O O
the O O
subject O O
of O O
performing O O
coronary O O
catheterization O O
at O O
the O O
time O O
of O O
his O O
peripheral O O
angiogram O O
given O O
that O O
we O O
are O O
actually O O
going O O
to O O
be O O
in O O
there. O O
He O O
has O O
actually O O
requested O O
this O O
as O O
opposed O O
to O O
going O O
forward O O
with O O
the O O
chemical O O
stress O O
test. O O
With O O
your O O
permission, O O
we O O
will O O
perform O O
both O O
coronary O O
catheterization O O
to O O
assess O O
the O O
patency O O
of O O
his O O
grafts O O
in O O
addition O O
to O O
his O O
peripheral O O
angiogram O O
plus/minus O O
therapeutic O O
intervention O O
of O O
his O O
lower O O
extremities. O O
Paramount O O
to O O
his O O
ongoing O O
cardiovascular O O
fitness, O O
we O O
certainly O O
recommend O O
blood O O
pressure O O
of O O
130/80 O O
or O O
below O O
and O O
LDL O O
cholesterol O O
70 O O
or O O
below O O
and O O
ongoing O O
exercise O O
and O O
weight O O
loss. O O
We O O
will O O
plan O O
to O O
schedule O O
his O O
procedure O O
in O O
the O O
upcoming O O
weeks O O
and O O
he O O
is O O
to O O
notify O O
us O O
if O O
symptoms O O
are O O
progressed O O
in O O
the O O
interim O O
time. O O
Changes O O
to O O
Medications O O
this O O
visit O O
glyburide O B-MEDICATION
Toprol O B-MEDICATION
XL O O
50 O O
mg O O
qd O O
Atacand O B-MEDICATION
15 O O
mg O O
qd O O
Lipitor O B-MEDICATION
80 O O
mg O O
qd O O
Lopid O B-MEDICATION
600 O O
mg O O
BID O O
aspirin O B-MEDICATION
325 O O
mg O O
qd O O
Wellbutrin O O
doxepin O O
Thank O O
you O O
for O O
allowing O O
us O O
to O O
participate O O
in O O
his O O
care. O O
If O O
you O O
indeed O O
have O O
any O O
questions O O
regarding O O
his O O
visit O O
here O O
today O O
or O O
upcoming O O
procedure, O O
please O O
do O O
not O O
hesitate O O
to O O
contact O O
us. O O
Sincerely, O O
Sharon O O
Oglesby O O
PA O O
I O O
saw O O
this O O
patient O O
and O O
personally O O
obtained O O
the O O
history O O
of O O
present O O
illness. O O
I O O
also O O
reviewed O O
and O O
confirmed O O
the O O
PMH, O O
medications, O O
social O O
and O O
family O O
history, O O
and O O
detailed O O
ROS. O O
I O O
personally O O
performed O O
a O O
comprehensive O O
cardiovascular O O
examination, O O
including O O
assessment O O
of O O
VS; O O
auscultation O O
of O O
carotid O O
arteries, O O
lungs, O O
heart, O O
and O O
abdomen; O O
palpation O O
of O O
carotid O O
arteries, O O
evaluation O O
of O O
jugular O O
venous O O
pressure, O O
palpation O O
of O O
abdominal O O
aorta O O
and O O
lower O O
extremity O O
pulses O O
and O O
perfusion, O O
and O O
neurologic O O
examination O O
for O O
focal O O
deficits. O O
I O O
interpreted O O
the O O
EKG O O
and O O
other O O
pertinent O O
laboratory O O
data. O O
I O O
discussed O O
findings O O
with O O
the O O
patient O O
and O O
personally O O
developed O O
the O O
management O O
strategy O O
and O O
plans. O O
My O O
findings O O
and O O
plans O O
are O O
elaborated O O
on O O
the O O
note O O
above, O O
with O O
which O O
I O O
concur. O O
Guy O O
Nunes O O
M.D. O O
Guyton O O
Nunes, O O
MD O O
pager O O
#53530 O O
Signed O O
electronically O O
by O O
Sharon O O
Oglesby, O O
PA; O O
Guyton O O
Nunes, O O
MD O O
pager O O
#53530 O O
Document O O
Status: O O
Final O O

Record B-SMOKER O
date: O O
2093-04-13 O O
CARDIOLOGY O O
BEAUREGARD O O
MEMORIAL O O
HOSPITAL O O
Steven O O
N O O
Cooper O O
M.D. O O
8 O O
Riverview O O
Avenue, O O
Suite O O
185 O O
, O O
College O O
Station, O O
NC O O
22169 O O
Dear O O
Dr. O O
Cooper: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
your O O
patient, O O
Christian O O
Mullen O O
today O O
in O O
the O O
office O O
in O O
followup O O
for O O
his O O
peripheral O O
artery O O
disease, O O
as O O
well O O
as O O
his O O
coronary B-CAD O
disease. I-CAD O
I O O
permanently O O
follow O O
him O O
for O O
PAD, O O
as O O
I O O
know O O
he O O
follows O O
with O O
Dr. O O
Fernandes O O
for O O
his O O
coronary O O
disease. O O
Regarding O O
his O O
peripheral O O
disease, O O
he O O
is O O
status O O
post O O
left O O
common O O
femoral O O
endarterectomy, O O
performed O O
at O O
my O O
request O O
by O O
Dr. O O
Fredrick O O
Xa O O
couple O O
of O O
years O O
ago. O O
This O O
alleviated O O
some O O
of O O
his O O
left O O
leg O O
claudication, O O
though O O
he O O
still O O
has O O
some O O
residual O O
symptoms O O
in O O
that O O
left O O
calf. O O
The O O
right O O
calf O O
is O O
what O O
bothers O O
him O O
more, O O
with O O
symptoms O O
that O O
are O O
earlier O O
in O O
onset. O O
They O O
occurred O O
about O O
100 O O
yards O O
of O O
walking O O
on O O
the O O
flat. O O
While O O
Chris O O
is O O
affected O O
by O O
this, O O
it O O
does O O
not O O
preclude O O
him O O
from O O
doing O O
his O O
usual O O
activities O O
of O O
daily O O
living. O O
He O O
also O O
continues O O
to O O
travel O O
(on O O
his O O
way O O
to O O
Bogalusa O O
with O O
Brad O O
Fair, O O
his O O
partner, O O
next O O
week), O O
and O O
also O O
continues O O
to O O
work O O
actively. O O
The O O
biggest O O
problem O O
with O O
his O O
claudication O O
is O O
that O O
it O O
prevents O O
him O O
from O O
being O O
physically O O
active O O
enough O O
to O O
lose O O
enough O O
weight. O O
As O O
he O O
says, O O
he O O
put O O
on O O
about O O
80 O O
pounds O O
after O O
his O O
coronary B-CAD O
bypass I-CAD O
graft I-CAD O
in I-CAD O
2082, I-CAD O
and O O
he O O
has O O
had O O
trouble O O
losing O O
the O O
weight. O O
He O O
is O O
considering O O
weight O O
reduction O O
surgery, O O
but O O
has O O
not O O
made O O
a O O
decision O O
about O O
this O O
yet. O O
He O O
is O O
struggling O O
with O O
the O O
decision. O O
I O O
would O O
support O O
him O O
either O O
way O O
in O O
this O O
regard, O O
encouraging O O
him O O
to O O
lose O O
weight O O
however O O
he O O
can O O
do O O
so. O O
In O O
terms O O
of O O
his O O
lower O O
extremities, O O
his O O
exam O O
demonstrates O O
diminished O O
pulses O O
(absent O O
to O O
palpation) O O
in O O
both O O
ankles, O O
but O O
they O O
are O O
audible O O
by O O
Doppler. O O
Both O O
feet O O
are O O
well O O
perfused, O O
with O O
good O O
capillary O O
refill. O O
He O O
has O O
no O O
ulcers O O
or O O
gangrene. O O
From O O
a O O
cardiac O O
standpoint, O O
Chris O O
is O O
doing O O
well. O O
He O O
denies O O
significant O O
dyspnea O O
or O O
chest O O
discomfort, O O
although O O
he O O
is O O
limited O O
in O O
terms O O
of O O
walking O O
because O O
of O O
his O O
legs. O O
It O O
has O O
been O O
11 O O
years O O
since O O
his O O
bypass B-CAD O
operation, I-CAD O
and O O
I O O
think O O
it O O
would O O
be O O
reasonable O O
to O O
do O O
a O O
stress O O
test O O
on O O
him O O
to O O
make O O
certain O O
that O O
there O O
is O O
no O O
evidence O O
of O O
silent O O
ischemia. O O
While O O
this O O
might O O
be O O
controversial, O O
as O O
to O O
whether O O
to O O
do O O
a O O
stress O O
test O O
or O O
not, O O
my O O
own O O
gut O O
feeling O O
is O O
that O O
it O O
is O O
probably O O
the O O
right O O
time O O
in O O
this O O
patient O O
with O O
significant O O
risk O O
factors O O
and O O
limitations O O
on O O
the O O
basis O O
of O O
his O O
lower O O
extremity O O
disease. O O
He O O
requests O O
specifically O O
we O O
do O O
this O O
study O O
here, O O
so O O
I O O
will O O
take O O
the O O
liberty O O
of O O
ordering O O
an O O
adenosine O O
MIBI, O O
and O O
certainly O O
will O O
forward O O
you O O
the O O
results. O O
Otherwise, O O
Chris O O
is O O
doing O O
great. O O
We O O
will O O
continue O O
to O O
work O O
on O O
risk O O
factor O O
modification O O
and O O
I O O
will O O
see O O
him O O
again O O
in O O
six O O
months. O O
We O O
will O O
also O O
order O O
an O O
exercise O O
ABI O O
and O O
duplex O O
of O O
his O O
lower O O
extremities O O
to O O
assess O O
where O O
we O O
stand O O
at O O
the O O
present O O
time. O O
If O O
his O O
symptoms O O
progress O O
to O O
the O O
point O O
where O O
they O O
are O O
more O O
disabling, O O
then O O
we O O
would O O
consider O O
further O O
evaluation. O O
Otherwise, O O
as O O
long O O
as O O
his O O
symptoms O O
remain O O
stable O O
and O O
his O O
lifestyle O O
is O O
not O O
terribly O O
limited, O O
we O O
will O O
continue O O
the O O
same. O O
Other O O
Data: O O
I O O
saw O O
him O O
today O O
with O O
Vernon O O
Galvan, O O
one O O
of O O
my O O
cardiovascular O O
fellows, O O
who O O
have O O
written O O
a O O
detailed O O
note. O O
We O O
will O O
send O O
this O O
along O O
to O O
you O O
as O O
well. O O
Thanks O O
again. O O
Best O O
personal O O
regards, O O
Guyton O O
Nunes O O
MD O O
cc: O O
Nathan O O
Fernandes O O
M.D.; O O
Vernon O O
X O O
Galvan O O
M.D.; O O
V O O
Signed O O
electronically O O
by O O
Guyton O O
Nunes, O O
MD O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2093-12-27 O O
CARDIOLOGY O O
BEAUREGARD O O
MEMORIAL O O
HOSPITAL O O
Reason O O
for O O
visit: O O
73 O O
yo O O
male O O
admitted O O
via O O
CCL O O
s/p O O
PTA O O
to O O
right O O
profunda O O
and O O
CFA O O
and O O
stenting O O
to O O
right O O
CIA O O
and O O
right O O
EIA O O
Interval O O
History: O O
Mr. O O
Mullen O O
is O O
a O O
73 O O
yo O O
male O O
with O O
an O O
extensive O O
history O O
of O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
(bypass B-CAD O
surgery I-CAD O
in I-CAD O
2082) I-CAD O
peripheral O O
arterial O O
disease, O O
hypertension, B-HYPERTENSION B-HYPERTENSION
hyperlipidemia, B-HYPERLIPIDEMIA O
diabetes, B-DIABETES O
and O O
obesity, B-OBESE O
His O O
PVD O O
includes: O O
Left O O
Common O O
femoral O O
and O O
left O O
popliteal O O
artery O O
revascularization O O
in O O
11/88 O O
. O O
He O O
received O O
stent O O
Medtronic O O
Bridge O O
Assurant O O
to O O
Left O O
CIA. O O
He O O
then O O
had O O
right O O
external, O O
right O O
internal, O O
and O O
right O O
common O O
femoral O O
artery O O
revascularization O O
in O O
2/89. O O
Right O O
CFA O O
received O O
15 O O
mm O O
Express O O
stent O O
Patient O O
now O O
with O O
claudication O O
in O O
his O O
right O O
calf O O
after O O
ambulating O O
only O O
50 O O
yards O O
or O O
so. O O
Six O O
months O O
ago O O
he O O
was O O
able O O
to O O
ambulate O O
for O O
over O O
a O O
100 O O
yards O O
without O O
significant O O
claudication O O
symptoms. O O
He O O
does O O
not O O
describe O O
any O O
rest O O
pain O O
or O O
ulceration O O
in O O
his O O
right O O
leg. O O
He O O
does O O
get O O
some O O
claudication O O
in O O
his O O
left O O
leg, O O
although O O
this O O
is O O
fairly O O
minor O O
compared O O
to O O
the O O
right O O
leg. O O
He O O
denies O O
chest O O
pain/angina O O
nor O O
any O O
significant O O
shortness O O
of O O
breath, O O
orthopnea, O O
paroxysmal O O
nocturnal O O
dyspnea, O O
LEE, O O
palpitations O O
or O O
presyncopal O O
or O O
syncopal O O
symptoms. O O
12/23 O O
- O O
LE O O
CTA O O
showing: O O
Patent O O
distal O O
aortoiliac O O
system; O O
Extensive, O O
severe O O
atherosclerotic O O
calcification O O
of O O
aorta, O O
pelvic O O
and O O
lower O O
extremity O O
arteries; O O
On O O
the O O
right: O O
Patent O O
arterial O O
tree; O O
On O O
the O O
left: O O
Patent O O
arterial O O
tree; O O
No O O
evidence O O
of O O
thrombosis O O
of O O
pelvic O O
veins, O O
femoral O O
or O O
popliteal O O
veins O O
bilaterally. O O
Patient O O
is O O
admitted O O
now O O
for O O
angiogram O O
12/27/93 O O
SDA O O
to O O
CCL O O
with O O
preliminary O O
results O O
showing: O O
All O O
vessels O O
very O O
heavily O O
calcified.1) O O
Abd. O O
Aorta O O
calcified O O
with O O
plaque, O O
but O O
non-obstructive O O
2) O O
Lt O O
renal O O
has O O
approx O O
50% O O
stenosis O O
3) O O
Lt O O
common O O
iliac O O
has O O
35-50% O O
stenosis, O O
non-flow O O
limiting O O
4) O O
Rt O O
side: O O
Common O O
iliac O O
- O O
70% O O
eccentric O O
calcified O O
plaque O O
prox O O
vessel; O O
ulcerated O O
plaque O O
distal O O
vessel. O O
Internal O O
iliac O O
- O O
65-70% O O
stenosis O O
mid O O
vessel O O
External O O
iliac O O
- O O
serial O O
50% O O
stenoses O O
, O O
eccentric O O
and O O
calcified O O
COmmon O O
femoral O O
and O O
profunda- O O
both O O
severely O O
narrowed O O
with O O
heavily O O
calcified O O
plaque, O O
extending O O
into O O
prox O O
Profunda O O
and O O
prox O O
SFA. O O
SFA O O
- O O
serial O O
stenoses O O
(prox O O
90%, O O
focal O O
mid-90%, O O
and O O
distal O O
diffuse O O
calcific/exophytic/coral O O
reef O O
stenosis O O
in O O
adductor O O
canal O O
(75%). O O
Pop O O
- O O
patent O O
Infrapop- O O
trifurcation O O
patent. O O
AT O O
arises O O
at O O
knee O O
joint O O
and O O
is O O
patent O O
to O O
ankle. O O
TPT O O
patent, O O
but O O
PT O O
is O O
threadlike O O
and O O
small O O
caliber. O O
does O O
not O O
go O O
to O O
ankle; O O
Peroneal O O
patent O O
at O O
least O O
half O O
way O O
down O O
to O O
ankle O O
Patient O O
underwent O O
successful O O
balloon O O
inflation O O
and O O
revasc O O
of O O
Rt O O
leg O O
with O O
PTA O O
alone, O O
up O O
to O O
6mm O O
balloons. O O
Successful O O
balloon O O
inflation O O
iand O O
revasc O O
of O O
Rt O O
profunda O O
and O O
Common O O
Femoral O O
artery O O
with O O
PTA O O
and O O
kissing O O
balloon O O
into O O
profunda. O O
Successful O O
revasc O O
of O O
Rt O O
External O O
iliac O O
and O O
Rt O O
Common O O
Iliac O O
with O O
PTA/stents. O O
Past O O
medical O O
history: O O
CAD B-CAD O
-- O O
2082 O O
CABG B-CAD O
x I-CAD O
3 I-CAD O
-- O O
10/9/91 O O
LIMA O O
to O O
LAD O O
patent; O O
mod O O
LAD O O
stenosis O O
beyond O O
graft; O O
SVT O O
to O O
OM O O
patent; O O
SVG O O
to O O
RCA O O
occl O O
@ O O
origin O O
-- O O
10/91 B-CAD O
rota-stenting I-CAD O
of I-CAD O
mid I-CAD O
RCA I-CAD O
99% I-CAD O
--&gt; I-CAD O
0% I-CAD O
Hypertension. B-HYPERTENSION B-HYPERTENSION
Hyperlipidemia. B-HYPERLIPIDEMIA O
PAD O O
-- O O
11/88 O O
left O O
common O O
femoral O O
and O O
left O O
popliteal O O
artery O O
revasc; O O
stent O O
Medtronic O O
bridge O O
Assurant O O
ot O O
left O O
common O O
iliac O O
art O O
-- O O
2/89 O O
right O O
external O O
and O O
internal O O
and O O
right O O
common O O
femoral O O
artery O O
revasc; O O
stent O O
to O O
right O O
common O O
femoral O O
art O O
Obesity. B-OBESE O
Type B-DIABETES O
2 I-DIABETES O
diabetes I-DIABETES O
mellitus I-DIABETES O
(2/2089 B-DIABETES O
HgbA1c I-DIABETES O
-- I-DIABETES O
6.50) I-DIABETES O
Depressive O O
disorder, O O
none O O
x O O
20 O O
years, O O
no O O
hospitalization O O
or O O
harm O O
to O O
self O O
Cervical O O
spine O O
disease O O
s/p O O
C6-C7 O O
disk O O
surgery O O
2079 O O
Congenital O O
hypospadias. O O
Prostatitis- O O
since O O
age O O
30, O O
takes O O
antibiotic O O
daily. O O
Hemorrhoids. O O
Colonic O O
polyps. O O
Chronic O O
normocytic O O
anemia. O O
Beginning O O
of O O
cataracts O O
Medications: O O
EcASA B-MEDICATION B-MEDICATION
325 O O
mg O O
daily O O
NPH B-MEDICATION B-MEDICATION
68 O O
u O O
qpm O O
about O O
9pm O O
Atacand B-MEDICATION O
16 O O
mg O O
daily O O
Glyburide B-MEDICATION B-MEDICATION
3 O O
mg O O
bid O O
Metroprolol B-MEDICATION B-MEDICATION
25 O O
mg O O
tid O O
(patient O O
takes O O
75 O O
mg O O
daily) O O
Norvasc B-MEDICATION B-MEDICATION
5 O O
mg O O
daily O O
Januvia B-MEDICATION O
100 O O
mg O O
daily O O
Bactrim O O
SS O O
1 O O
tab O O
daily O O
Crestor B-MEDICATION O
20 O O
mg O O
daily O O
Pristiq O O
50 O O
mg O O
daily O O
Mirtazapine O B-MEDICATION
7.5 O O
mg O O
qhs O O
Social O O
history: O O
Married, O O
glazier, O O
3 O O
grown O O
adult O O
children O O
Tob: B-SMOKER O
quit I-SMOKER B-MEDICATION
2071 I-SMOKER O
smoked I-SMOKER O
3 I-SMOKER O
packs I-SMOKER O
of I-SMOKER O
cigarettes I-SMOKER O
per I-SMOKER O
day I-SMOKER O
for I-SMOKER O
approximately I-SMOKER O
30 I-SMOKER O
years I-SMOKER O
Exercise: O O
Negative O O
for O O
any O O
regular O O
exercise O O
b/c O O
of O O
claudication O O
ETOH: O O
1 O O
beer O O
a O O
week O O
Negative O O
for O O
illicit O O
drug O O
use. O O
Review O O
of O O
systems: O O
+ O O
claudication O O
as O O
above O O
denies O O
headache, O O
seizures, O O
stroke, O O
syncope, O O
visual O O
changes, O O
asthma, O O
COPD, O O
recent O O
fever, O O
recent O O
URI, O O
PUD, O O
GERD, O O
Hematemesis, O O
BRBPR, O O
weight O O
changes, O O
LEE, O O
blood O O
clots O O
Physical O O
examination: O O
-BMI: B-OBESE O
38.9 I-OBESE O
Obese, B-OBESE O
high O O
risk O O
-Pulse: O O
65 O O
-resp. O O
rate: O O
16 O O
-height: O O
72 O O
in. O O
-weight: O O
286 O O
lbs. O O
-General: O O
well O O
appearing O O
male, O O
No O O
acute O O
distress. O O
-Neck: O O
Carotids O O
2+ O O
without O O
bruits. O O
JVP O O
not O O
appreciated O O
-Chest: O O
Clear O O
ant/lat O O
-Cardiac: O O
distant O O
HS, O O
RRR, O O
normal O O
S1S2, O O
no O O
M/R/G O O
-Abdomen: O O
Round, O O
NT, O O
+ O O
BS O O
no O O
masses O O
appreciated O O
-Extremities: O O
no O O
C/C/E O O
left O O
groin O O
- O O
art O O
sheaths O O
inplace, O O
no O O
obvious O O
hematoma O O
or O O
ooze, O O
dop O O
DP, O O
dop O O
PT O O
feet O O
warm O O
-Neuro: O O
Alert O O
and O O
oriented O O
times O O
3. O O
speech O O
clear. O O
strengths O O
equal O O
through O O
out, O O
grossly O O
non O O
focal O O
-BP: O O
132/56 O O
Assessment O O
and O O
plan: O O
73 O O
yo O O
male O O
with O O
H/O O O
cardiovascular O O
disease O O
now O O
with O O
right O O
LE O O
claudication O O
admitted O O
now O O
s/p O O
PTA O O
to O O
Rt O O
profunda O O
and O O
Common O O
Femoral O O
artery O O
with O O
PTA O O
and O O
kissing O O
balloon O O
into O O
profunda. O O
and O O
stenting O O
to O O
Rt O O
External O O
iliac O O
and O O
Rt O O
Common O O
Iliac. O O
- O O
sheath O O
removal O O
tonight O O
- O O
cont O O
ASA O B-MEDICATION
and O O
Plavix B-MEDICATION B-MEDICATION
- O O
cont O O
present O O
medications O O
presently O O
BP O O
and O O
HR O O
well O O
controlled O O
- O O
check O O
fasting O O
lipids O O
and O O
LFTs O O
DM B-DIABETES O
- O O
cont O O
NPH, O O
Glyburide, O B-MEDICATION
and O O
Januvia O O
- O O
follow O O
FS O O
BS O O
- O O
SS O O
Insulin B-MEDICATION O
PRN O O
- O O
Hga1c O O
as O O
out O O
patient O O
Depression O O
- O O
cont O O
Mirtazepine O B-MEDICATION
and O O
Pristiq O O
further O O
plans O O
per O O
Nunes O O
Frances O O
Teresa O O
Quevedo, O O
NP O O
Transcribed O O
by: O O
Frances O O
Teresa O O
Quevedo O O
Signed O O
electronically O O
by O O
Frances O O
Teresa O O
Quevedo, O O
NP O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2094-12-27 O O
CARDIOLOGY O O
BEAUREGARD O O
MEMORIAL O O
HOSPITAL O O
RE: O O
Follow-up O O
of O O
coronary B-CAD O
and I-CAD O
peripheral I-CAD O
arterial I-CAD O
disease. I-CAD O
Dear O O
Dr. O O
Cooper: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
Christian O O
Mullen O O
in O O
the O O
office O O
today O O
with O O
Dr. O O
Nunes. O O
As O O
you O O
know O O
he O O
has O O
an O O
extensive O O
coronary B-CAD O
and I-CAD O
peripheral I-CAD O
arterial I-CAD O
disease I-CAD O
history. I-CAD O
He O O
last O O
underwent O O
intervention O O
on O O
his O O
right O O
leg O O
vessels O O
in O O
December O O
2093. O O
He O O
underwent O O
PTA/Stenting O O
of O O
the O O
right O O
external O O
and O O
common O O
iliac O O
arteries O O
and O O
PTA O O
of O O
the O O
right O O
common O O
femoral/Profunda O O
arteries. O O
As O O
you O O
know, O O
he O O
previously O O
has O O
had O O
patch O O
endarterectomy O O
of O O
his O O
left O O
common O O
femoral O O
and O O
common O O
iliac O O
and O O
popliteal O O
stenting O O
on O O
the O O
left. O O
He O O
previously O O
has O O
undergone O O
CABG B-CAD O
in I-CAD O
2082 I-CAD O
with O O
repeat O O
angio O O
in O O
2091 O O
showing O O
patent O O
IMA O O
to O O
LAD O O
graft, O O
patent O O
SVG-OM1 O O
graft, O O
and O O
occluded O O
grafts O O
to O O
OM2 O O
and O O
RCA. O O
He B-CAD O
underwent I-CAD O
rotastenting I-CAD O
of I-CAD O
his I-CAD O
native I-CAD O
RCA I-CAD O
with I-CAD O
a I-CAD O
BMS I-CAD O
at I-CAD O
that I-CAD O
time. I-CAD O
Additionally, O O
he O O
has O O
asymptomatic O O
moderate O O
RICA O O
stenosis O O
with O O
mild O O
LICA O O
stenosis. O O
He O O
returns O O
today O O
for O O
review. O O
He O O
remains O O
in O O
reasonable O O
health. O O
He O O
is O O
still O O
struggling O O
to O O
lose O O
weight O O
and O O
is O O
interested O O
in O O
bariatric O O
surgery. O O
He O O
has O O
limiting O O
bilateral O O
claudication O O
worse O O
since O O
his O O
last O O
visit, O O
on O O
each O O
side. O O
He O O
also O O
has O O
dyspnea O O
on O O
exertion O O
but O O
does O O
not O O
describe O O
angina. O O
However, O O
it O O
is O O
now O O
3 O O
years O O
since O O
his O O
last O O
nulcear O O
perfusion O O
study. O O
He O O
does O O
not O O
report O O
any O O
neurovascular O O
symptoms. O O
Past O O
medical O O
history: O O
CAD B-CAD O
-- O O
2082 O O
CABG B-CAD B-MEDICATION
x I-CAD O
3 I-CAD O
-- O O
10/9/91 O O
LIMA O O
to O O
LAD O O
patent; O O
mod O O
LAD O O
stenosis O O
beyond O O
graft; O O
SVT O O
to O O
OM O O
patent; O O
SVG O O
to O O
RCA O O
occl O O
@ O O
origin O O
-- O O
10/91 O O
rota-stenting O O
of O O
mid O O
RCA O B-CAD
99% O O
--&gt; O O
0% O O
Hypertension. B-HYPERTENSION B-HYPERTENSION
Hyperlipidemia. B-HYPERLIPIDEMIA O
PAD O O
-- O O
11/88 O O
left O O
common O O
femoral O O
and O O
left O O
popliteal O O
artery O O
revasc; O O
stent O O
Medtronic O O
bridge O O
Assurant O O
ot O O
left O O
common O O
iliac O O
art O O
-- O O
2/89 O O
right O O
external O O
and O O
internal O O
and O O
right O O
common O O
femoral O O
artery O O
revasc; O O
stent O O
to O O
right O O
common O O
femoral O O
art O O
Obesity. B-OBESE O
Type B-DIABETES O
2 I-DIABETES O
diabetes I-DIABETES O
mellitus I-DIABETES O
(2/2089 B-DIABETES O
HgbA1c I-DIABETES O
-- I-DIABETES O
6.50) I-DIABETES O
Depressive O O
disorder, O O
none O O
x O O
20 O O
years, O O
no O O
hospitalization O O
or O O
harm O O
to O O
self O O
Cervical O O
spine O O
disease O O
s/p O O
C6-C7 O O
disk O O
surgery O O
2079 O O
Congenital O O
hypospadias. O O
Prostatitis- O O
since O O
age O O
30, O O
takes O O
antibiotic O O
daily. O O
Hemorrhoids. O O
Colonic O O
polyps. O O
Chronic O O
normocytic O O
anemia. O O
Beginning O O
of O O
cataracts O O
Medications: O O
EcASA B-MEDICATION B-MEDICATION
325 O O
mg O O
daily O O
NPH B-MEDICATION O
68 O O
u O O
qpm O O
about O O
9pm O O
Atacand B-MEDICATION O
16 O O
mg O O
daily O O
Glyburide B-MEDICATION B-MEDICATION
3 O O
mg O O
bid O O
Metroprolol B-MEDICATION B-MEDICATION
25 O O
mg O O
tid O O
(patient O O
takes O O
75 O O
mg O O
daily) O O
Norvasc B-MEDICATION B-MEDICATION
5 O O
mg O O
daily O O
Januvia B-MEDICATION O
100 O O
mg O O
daily O O
Bactrim O O
SS O O
1 O O
tab O O
daily O O
Crestor B-MEDICATION B-MEDICATION
20 O O
mg O O
daily O O
Pristiq O O
50 O O
mg O O
daily O O
Mirtazapine O B-MEDICATION
7.5 O O
mg O O
qhs O O
Changes O O
to O O
Allergies O O
Fentanyl O O
- O O
reaction: O O
see O O
comment O O
(nausea O O
and O O
vomiting O O
during O O
11/23/2088 O O
catheterization) O O
[reviewed] O O
NKA: O O
No O O
Known O O
Allergies O O
- O O
reaction: O O
see O O
comment O O
(No O O
known O O
allergies O O
to O O
shellfish, O O
iodine, O O
or O O
contrast O O
media) O O
[reviewed] O O
Penicillins O O
- O O
reaction: O O
Rash O O
[reviewed] O O
Family O O
history: O O
Positive O O
for O O
CVD O O
and O O
DM. O O
Social O O
history: O O
Married, O O
glazier, O O
3 O O
grown O O
adult O O
children O O
Tob: B-SMOKER O
quit I-SMOKER O
2071 I-SMOKER O
smoked I-SMOKER O
3 I-SMOKER O
packs I-SMOKER O
of I-SMOKER O
cigarettes I-SMOKER O
per I-SMOKER O
day I-SMOKER O
for I-SMOKER O
approximately I-SMOKER O
30 I-SMOKER O
years I-SMOKER O
Exercise: O O
Negative O O
for O O
any O O
regular O O
exercise O O
b/c O O
of O O
claudication O O
ETOH: O O
1 O O
beer O O
a O O
week O O
Negative O O
for O O
illicit O O
drug O O
use. O O
Physical O O
examination: O O
-Pulse: O O
77 O O
-General: O O
No O O
acute O O
distress. O O
-Skin: O O
No O O
rashes, O O
anicteric. O O
-Heent: O O
Unremarkable O O
-Neck: O O
Carotids O O
2+ O O
without O O
bruits. O O
JVP O O
no O O
jugular O O
venous O O
distention. O O
-Chest: O O
Clear O O
to O O
auscultation O O
and O O
percussion. O O
-Cardiac: O O
Left O O
ventricular O O
impulse O O
discrete O O
and O O
nondisplaced. O O
Regular O O
rate O O
and O O
rhythm, O O
normal O O
S1 O O
and O O
S2, O O
with O O
no O O
S3 O O
or O O
S4. O O
There O O
were O O
no O O
murmurs, O O
clicks O O
or O O
rubs. O O
-Abdomen: O O
Normal O O
bowel O O
sounds, O O
soft O O
and O O
nontender, O O
with O O
no O O
hepatosplenomegaly O O
or O O
masses O O
appreciated. O O
-Extremities: O O
No O O
cyanosis, O O
clubbing O O
or O O
edema. O O
2+ O O
femoral O O
pulses O O
with O O
bruits. O O
Doppler O O
+ O O
right O O
DP/ O O
PT O O
biphasic O O
signal, O O
doppler O O
(+) O O
left O O
DP/PT O O
monophasic O O
signal O O
-BP: O O
130/60 O O
Bilaterally O O
EKG: O O
NSR O O
(73), O O
normal O O
axis, O O
IVCD, O O
no O O
acute O O
ischemic O O
changes. O O
Impression: O O
Mr O O
Mullen O O
is O O
a O O
74 O O
year O O
old O O
gentleman O O
with O O
extensive O O
PAD O O
andCAD O O
now O O
limited O O
again O O
with O O
recurrent O O
intermittent O O
claudication. O O
He O O
is O O
now O O
also O O
3 O O
years O O
since O O
his O O
last O O
perfusion O O
study O O
for O O
coronary O O
ischemia. O O
Finally, O O
he O O
warrants O O
repeat O O
duplex O O
of O O
his O O
carotids. O O
Assessment O O
and O O
plan: O O
1. O O
CAD- O O
will O O
continue O O
current O O
medication O O
regimen O O
and O O
arrange O O
Nuclear O O
Adenosine O O
MIBI O O
stress O O
test. O O
2. O O
PAD- O O
worsening O O
claudication, O O
will O O
review O O
angiographic O O
images O O
and O O
plan O O
for O O
repeat O O
catheterization O O
to O O
re-intervene. O O
3. O O
Carotid O O
disease; O O
currently O O
asymptomatic, O O
will O O
repeat O O
CANIs. O O
Medication O O
List O O
CONFIRMED O O
- O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
daily O O
- O O
Bactrim O O
1 O O
mg O O
daily O O
- O O
bupropion O O
150 O O
mg O O
daily O O
- O O
candesartan B-MEDICATION B-MEDICATION
16 O O
mg O O
daily O O
- O O
Colace O O
100 O O
mg O O
BID O O
- O O
Colace O O
BID O O
100 O O
- O O
Crestor O O
dose O O
unknown O O
- O O
doxepin O O
- O O
gemfibrozil B-MEDICATION O
600 O O
mg O O
BID O O
- O O
glyburide B-MEDICATION B-MEDICATION
2.5 O O
mg O O
daily O O
- O O
insulin B-MEDICATION O
- O O
Lipitor B-MEDICATION B-MEDICATION
80 O O
mg O O
daily O O
- O O
metoprolol B-MEDICATION B-MEDICATION
tartrate O O
75 O O
mg O O
daily O O
- O O
sitagliptin B-MEDICATION B-MEDICATION
dose O O
unknown O O
UNCONFIRMED O O
- O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
50 O O
mg O O
daily O O
------------------------------------------------------------ O O
REMOVED O O
- B-MEDICATION O
Avandia B-MEDICATION O
8 I-MEDICATION O
mg I-MEDICATION O
daily I-MEDICATION O
- O O
clopidogrel B-MEDICATION O
bisulfate I-MEDICATION O
75 I-MEDICATION O
mg I-MEDICATION O
daily I-MEDICATION O
Thanks O O
for O O
allowing O O
us O O
to O O
participate O O
in O O
his O O
care. O O
Best O O
personal O O
regards, O O
Nicholas O O
B O O
Fuchs O O
MD O O
I O O
saw O O
this O O
patient O O
and O O
confirmed O O
the O O
history O O
of O O
present O O
illness, O O
PMH, O O
medications, O O
and O O
ROS. O O
I O O
also O O
confirmed O O
the O O
cardiovascular O O
examination O O
and O O
interpreted O O
the O O
pertinent O O
laboratory O O
data. O O
I O O
discussed O O
findings O O
with O O
the O O
patient O O
and O O
developed O O
the O O
management O O
strategy. O O
My O O
findings O O
and O O
plans O O
are O O
elaborated O O
on O O
the O O
note O O
above. O O
Issues:1) O O
12 O O
years O O
out O O
from O O
CABG. O O
He O O
is O O
experiencing O O
increasing O O
DOE, O O
which O O
is O O
likely O O
due O O
to O O
his O O
weight O O
and O O
other O O
factors. O O
but O O
I O O
am O O
concerned O O
that O O
we O O
make O O
certain O O
his O O
myocardial O O
perfusion O O
is O O
OK. O O
Will O O
order O O
Stress O O
MIBI.2) O O
PAD- O O
claudicating O O
L&gt;R O O
leg...calf. O O
Rutherford O O
2. O O
Disabling. O O
Has O O
signif O O
disease O O
previously O O
treated. O O
Will O O
review O O
films O O
and O O
consider O O
repeat O O
CTA O O
to O O
decide O O
whether O O
he O O
warrants O O
relook O O
and O O
repeat O O
intervention. O O
He O O
is O O
s/p O O
CFA/Profunda O O
endarterectomy.3) O O
Weight O O
- O O
will O O
provide O O
him O O
names O O
of O O
Bariatric O O
surgeons O O
here O O
at O O
BMH.4) O O
Carotids O O
- O O
asymptomatic. O O
repeating O O
CNI's O O
Guyton O O
Nunes, O O
MD O O
pager O O
#53530 O O
Signed O O
electronically O O
by O O
Nicholas O O
B. O O
Fuchs, O O
MD; O O
Guyton O O
Nunes, O O
MD O O
pager O O
#53530 O O
Document O O
Status: O O
Final O O

Record O O
date: O O
2078-08-20 O O
New O O
office O O
visit O O
Referring O O
Physician: O O
Dr. O O
Ebert O O
BMC O O
PCP: O O
Dr.Bryan O O
Edmondson O O
BMC O O
CHIEF O O
PAIN O O
COMPLAINT: O O
'I O O
have O O
pain O O
in O O
the O O
back O O
radiating O O
down O O
my O O
legs.' O O
PAIN O O
HISTORY: O O
The O O
patient's O O
pain O O
started O O
spontaneously O O
about O O
two O O
years O O
ago. O O
It O O
is O O
located O O
in O O
the O O
lower O O
back, O O
radiating O O
to O O
the O O
back O O
of O O
the O O
legs, O O
to O O
the O O
level O O
of O O
the O O
knees. O O
The O O
pain O O
is O O
brought O O
on O O
by O O
walking O O
and O O
made O O
better O O
by O O
stopping O O
or O O
sitting O O
down. O O
Bending O O
over O O
forward O O
also O O
helps O O
the O O
pain. O O
There O O
is O O
no O O
numbness O O
or O O
weakness O O
associated O O
with O O
the O O
pain. O O
The O O
pain O O
is O O
better O O
at O O
night O O
than O O
during O O
the O O
day. O O
The O O
patient O O
has O O
separate O O
pain O O
complaint, O O
which O O
is O O
burning O O
pain O O
in O O
her O O
feet, O O
is O O
worse O O
at O O
night O O
than O O
during O O
the O O
day. O O
Patient O O
denies O O
bowel O O
or O O
bladder O O
changes. O O
The O O
patient O O
has O O
tried O O
Celebrex, O O
Vioxx O O
and O O
Motrin O O
but O O
has O O
not O O
found O O
any O O
relief O O
for O O
her O O
pain. O O
She O O
currently O O
does O O
not O O
take O O
any O O
pain O O
medications. O O
She O O
denies O O
a O O
history O O
of O O
heartburn, O O
gastric O O
or O O
duodenal O O
ulcers O O
or O O
GI O O
bleeds. O O
She O O
has O O
trouble O O
falling O O
asleep O O
and O O
staying O O
asleep O O
because O O
of O O
the O O
burning O O
pain O O
in O O
her O O
feet. O O
She O O
is O O
being O O
referred O O
to O O
us O O
by O O
Dr. O O
Ebert O O
from O O
Neurosurgery O O
after O O
an O O
MRI O O
scan O O
showed O O
spinal O O
stenosis O O
at O O
L5-S1 O O
and O O
at O O
L4-5 O O
as O O
well O O
as O O
spondylolithiasis O O
between O O
L4 O O
and O O
L5. O O
She O O
had O O
been O O
reluctant O O
to O O
undergo O O
surgery O O
and O O
was O O
therefore O O
referred O O
to O O
see O O
if O O
epidural O O
steroid O O
injections O O
could O O
help. O O
PAST O O
MEDICAL O O
HISTORY: O O
Diabetes, B-DIABETES O
hypertension, B-HYPERTENSION B-HYPERTENSION
coronary B-CAD O
artery I-CAD O
disease I-CAD O
with O O
myocardial B-CAD O
infarction I-CAD O
four I-CAD O
years I-CAD O
ago. I-CAD O
PAST O O
SURGICAL O O
HISTORY: O O
Coronary B-CAD O
stent B-CAD O
placement I-CAD O
times I-CAD O
two I-CAD O
in I-CAD O
December I-CAD O
2074. I-CAD O
CURRENT O O
MEDICATIONS: O O
Metformin B-MEDICATION B-MEDICATION
500 O O
mg O O
q. O O
day, O O
Monopril B-MEDICATION B-MEDICATION
40 O O
mg O O
q. O O
day, O O
baby O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
q. O O
day, O O
HCTZ B-MEDICATION O
12.5 O O
mg O O
q. O O
day, O O
Norvasc B-MEDICATION B-MEDICATION
5 O O
mg O O
q. O O
day O O
and O O
Pravachol B-MEDICATION B-MEDICATION
20 O O
mg O O
q. O O
day. O O
Social O O
History: O O
She B-SMOKER O
does B-SMOKER O
not I-SMOKER O
smoke, I-SMOKER O
does O O
smoke, O O
does O O
not O O
drink O O
and O O
does O O
not O O
use O O
drugs. O O
She O O
came O O
from O O
Bermuda O O
four O O
years O O
ago. O O
She O O
is O O
married O O
and O O
retired. O O
Allergies: O O
NKDA O O
Review O O
of O O
systems: O O
Constitutional: O O
Denies O O
fever, O O
recent O O
weight O O
change, O O
fatigue, O O
or O O
anxiety. O O
Neurological: O O
Denies O O
confusion, O O
double O O
vision, O O
light-headedness. O O
HEENT: O O
No O O
symptoms. O O
Respiratory: O O
Non-smoker. B-SMOKER O
No O O
dyspnea, O O
bronchospasm, O O
cough, O O
COPD. O O
Cardiac: O O
No, O O
palpitations, O O
syncope. O O
Gastrointestinal: O O
Denies O O
N O O
& O O
V, O O
heartburn, O O
constipation, O O
diarrhea, O O
bleeding. O O
Renal: O O
No O O
history O O
of O O
renal O O
problems. O O
No O O
dysuria, O O
urgency O O
or O O
frequency. O O
Skin: O O
No O O
recent O O
changes. O O
Musculoskeletal: O O
Denies O O
muscle O O
pain, O O
positive O O
for O O
leg O O
cramps O O
cramps, O O
arthritis. O O
Hematologic: O O
Pt O O
denies O O
spontaneous O O
nose O O
bleeds O O
or O O
easy O O
bruising. O O
Physical O O
examination: O O
Vital O O
signs O O
BP B-HYPERTENSION O
145/60 I-HYPERTENSION O
,P O O
56 O O
,VAS O O
SCORE O O
8/10 O O
HEENT: O O
Normal. O O
Lungs: O O
CTA O O
(B) O O
Heart: O O
RRR, O O
S1, O O
S2, O O
no O O
murmurs O O
Abdomen: O O
Soft, O O
non-tender, O O
bowel O O
sounds O O
present O O
Extremities: O O
No O O
cyanosis, O O
clubbing O O
or O O
edema. O O
Targeted O O
examination O O
showed O O
an O O
age O O
appropriate O O
woman O O
in O O
no O O
apparent O O
distress. O O
Mental O O
Status: O O
She O O
was O O
fully O O
awake O O
and O O
alert. O O
Her O O
mood O O
was O O
appropriate. O O
There O O
was O O
mild O O
sensory O O
loss O O
in O O
a O O
stocking O O
distribution O O
over O O
the O O
lets O O
as O O
well O O
as O O
in O O
a O O
glove O O
distribution O O
over O O
the O O
hands. O O
There O O
was O O
no O O
frank O O
allodynia O O
of O O
the O O
feet. O O
Patellar O O
and O O
ankle O O
reflexes O O
were O O
retained. O O
Toe O O
response O O
was O O
flexor. O O
The O O
patient O O
could O O
walk, O O
including O O
heel O O
and O O
toe O O
walk. O O
There O O
was O O
no O O
pain O O
on O O
straight O O
leg O O
raising. O O
There O O
was O O
no O O
local O O
tenderness O O
over O O
the O O
back, O O
however, O O
a O O
moderate O O
degree O O
of O O
muscle O O
spasm O O
over O O
the O O
lower O O
back. O O
IMPRESSION: O O
1. O O
Spinal O O
stenosis. O O
2. O O
Diabetic O O
neuropathy. O O
PLAN: O O
1. O O
Start O O
Neurontin O O
with O O
a O O
target O O
dose O O
of O O
300 O O
mg O O
t.i.d. O O
for O O
now. O O
If O O
tolerated, O O
we O O
will O O
increase O O
to O O
600 O O
mg O O
t.i.d. O O
2. O O
One O O
week O O
after O O
Neurontin, O O
start O O
Zanaflex O O
2 O O
mg O O
p.o. O O
q.h.s. O O
to O O
be O O
titrate O O
up O O
to O O
4 O O
mg O O
after O O
one O O
week. O O
3. O O
Lumbar O O
epidural O O
steroid O O
injection O O
at O O
L4-5 O O
or O O
L5-S1. O O
If O O
treatment O O
with O O
injections O O
is O O
unsuccessful, O O
we O O
will O O
ask O O
the O O
patient O O
to O O
be O O
reevaluate O O
by O O
Neurosurgery. O O
Ila O O
Easter, O O
M.D. O O

Record B-SMOKER O
date: O O
2079-04-22 O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
BROADLAWNS O O
MEDICAL O O
CENTER O O
Reason B-HYPERTENSION O
for I-HYPERTENSION O
visit I-HYPERTENSION O
elevated I-HYPERTENSION O
B/P I-HYPERTENSION O
History O O
of O O
present O O
illness O O
Seen O O
in O O
ER O O
for O O
HTN.yesterday B-HYPERTENSION O
224/105 O O
Per O O
dau O O
TX O O
w/ O O
IV B-MEDICATION O
lopressor I-MEDICATION B-MEDICATION
x O O
4 O O
doses, O O
betalol B-MEDICATION O
& O O
NTG B-MEDICATION O
Today B-HYPERTENSION O
B/P I-HYPERTENSION O
210/90 B-HYPERTENSION O
this I-HYPERTENSION O
AM I-HYPERTENSION O
Meds O O
not O O
changed. O O
No O O
ha, O O
no O O
chest O O
pain, O O
no O O
SOB, O O
no O O
blurred O O
vision. O O
Change O O
in O O
therapies O O
and O O
Renewals O O
Norvasc B-MEDICATION B-MEDICATION
5mg O O
po O O
qd O O
QTY:30 O O
Refills:3 O O
Start: O O
3/12/2075 O O
Assessment O O
and O O
plan O O
HTN O O
Discussed O O
w/ O O
Dr O O
Edmondson O O
by O O
phone. O O
Will O O
add O O
Norvasc O B-MEDICATION
5 O O
mg O O
qd O O
Advised O O
family. O O
Called O O
to O O
pharm O O
Disposition O O
Appt O O
w/ O O
Dr O O
Edmondson O O
4/28/79 O O
Addendum O O
I O O
was O O
present O O
during O O
key O O
portions O O
of O O
the O O
evaluation O O
of O O
the O O
patient O O
and O O
agree O O
with O O
Noreen O O
Dotson's O O
findings O O
and O O
plan O O
as O O
written. O O
Bryan O O
Edmondson O O
Signed O O
electronically O O
by O O
Noreen O O
O O O
Dotson O O
RN O O
on O O
Apr O O
22, O O
2079 O O
Bryan O O
Edmondson O O
MD O O
on O O
Aug O O
20, O O
2079 O O

Record B-SMOKER O
date: O O
2080-01-26 O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
BROADLAWNS O O
MEDICAL O O
CENTER O O
History O O
of O O
present O O
illness O O
This O O
is O O
an O O
81-year-old O O
black O O
female O O
with O O
hypertension, B-HYPERTENSION B-HYPERTENSION
type B-DIABETES O
2 I-DIABETES O
diabetes I-DIABETES O
mellitus, I-DIABETES O
coronary B-CAD B-CAD
artery I-CAD I-CAD
disease, I-CAD O
and O O
paroxysmal O O
atrial O O
fibrillation O O
who O O
is O O
here O O
for O O
followup. O O
The O O
patient O O
feels O O
generally O O
well. O O
Her O O
only O O
complaint O O
is O O
difficulty O O
sleeping. O O
She O O
wakes O O
up O O
at O O
night. O O
She O O
does O O
not O O
sleep O O
soundly. O O
She O O
denies O O
any O O
orthopnea O O
or O O
PND. O O
No O O
chest O O
pain. O O
No O O
back O O
pain. O O
She O O
had O O
a O O
history O O
of O O
low O O
back O O
pain O O
secondary O O
to O O
spinal O O
stenosis; O O
however, O O
her O O
pain O O
has O O
not O O
been O O
a O O
problem O O
lately. O O
She O O
denies O O
any O O
palpitations, O O
lightheadedness, O O
or O O
shortness O O
of O O
breath. O O
Change O O
in O O
therapies O O
and O O
Renewals O O
Norvasc B-MEDICATION B-MEDICATION
5 O O
mg O O
1 O O
tab O O
qd O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
1 O O
tab O O
qd O O
Glucophage B-MEDICATION B-MEDICATION
500 O O
mg O O
bid O O
hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
mg O O
QD O O
ibuprofen O O
800 O O
mg O O
tid O O
Isordil B-MEDICATION B-MEDICATION
40 O O
mg O O
tid O O
fosinopril B-MEDICATION O
40 O O
mg O O
QD O O
metoprolol B-MEDICATION B-MEDICATION
50 O O
mg O O
BID O O
Pravachol B-MEDICATION B-MEDICATION
20 O O
mg O O
QD O O
Physical O O
examination O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
170/80 I-HYPERTENSION O
Weight O O
179 O O
pounds O O
General O O
appearance O O
Overweight O O
in O O
no O O
acute O O
distress O O
Skin O O
Clear O O
Heent O O
Eyes, O O
nonicteric O O
Nodes O O
Normal O O
Chest O O
Lungs O O
are O O
clear O O
Cor O O
Regular O O
rhythm. O O
S1 O O
and O O
S2 O O
are O O
normal. O O
No O O
murmur, O O
S3, O O
or O O
S4 O O
Abdomen O O
Soft O O
and O O
nontender. O O
No O O
masses O O
Extrem O O
No O O
edema O O
Assessment O O
and O O
plan O O
Coronary O O
artery O O
disease. O O
Stable. O O
Continue O O
present O O
medications. O O
Hypertension. B-HYPERTENSION O
Systolic O O
a O O
little O O
high O O
today. O O
We O O
will O O
not O O
change O O
her O O
medicine O O
right O O
now. O O
Her O O
blood O O
pressure O O
has O O
been O O
satisfactory O O
in O O
the O O
past. O O
Degenerative O O
arthritis O O
with O O
low O O
back O O
pain. O O
Stable O O
and O O
asymptomatic. O O
Continue O O
ibuprofen O O
PRN. O O
Paroxysmal O O
atrial O O
fibrillation. O O
Asymptomatic. O O
Pulse O O
is O O
regular O O
today. O O
No O O
change O O
in O O
treatment. O O
Diabetes. B-DIABETES O
Continue O O
Glucophage. O O
Check O O
hemoglobin O O
A1c. O O
Insomnia. O O
Trial O O
of O O
trazodone O O
50 O O
mg O O
QHS O O
PRN. O O
Disposition O O
Return O O
in O O
three O O
months. O O
Note O O
transcribed O O
by O O
outside O O
service O O
Transcription O O
errors O O
may O O
be O O
present. O O
Signed O O
electronically O O
by O O
Edmondson, O O
Bryan O O
on O O
Feb O O
2, O O
2080 O O

Record O O
date: O O
2082-06-23 O O
CARDIOLOGY O O
BROADLAWNS O O
MEDICAL O O
CENTER O O
Reason O O
for O O
visit: O O
Mrs O O
Vanmeter O O
presents O O
for O O
routine O O
follow O O
up O O
of O O
her O O
CAD, B-CAD O
HTN B-HYPERTENSION O
and O O
hyperlipidemia B-HYPERLIPIDEMIA B-MEDICATION
Interval O O
History: O O
She O O
presents O O
stating O O
that O O
she O O
is O O
getting O O
along O O
reasonably O O
well. O O
Her O O
main O O
problem O O
is O O
burning O O
in O O
her O O
legs O O
and O O
feet, O O
also O O
present O O
in O O
her O O
hands. O O
She O O
also O O
reports O O
an O O
increased O O
frequency O O
of O O
her O O
chest O O
tightness, O O
occuring O O
mainly O O
at O O
night, O O
sometimes O O
before O O
going O O
to O O
sleep, O O
sometimes O O
durign O O
the O O
night. O O
This O O
is O O
responsive O O
to O O
1 O O
SL B-MEDICATION O
TNG I-MEDICATION O
typically, O O
although O O
sometimes O O
is O O
goes O O
away O O
without O O
intervention. O O
She O O
denies O O
SOB, O O
PND, O O
orthopnea, O O
presycope O O
or O O
syncope. O O
She O O
has O O
intermittant O O
mild O O
LE O O
edema. O O
She O O
occasionally O O
has O O
palpitations, O O
lasting O O
~ O O
5 O O
minutes, O O
resolving O O
spontaneously. O O
She O O
cannot O O
relate O O
them O O
to O O
any O O
time O O
of O O
day O O
or O O
activity, O O
and O O
they O O
are O O
not O O
associated O O
w/ O O
lightheadedness O O
or O O
CP. O O
Recently O O
she O O
called O O
me O O
w/ O O
complaints O O
of O O
increased O O
LE O O
edema. O O
This O O
is O O
minor O O
on O O
exam. O O
Her O O
echo O O
showed O O
preserved O O
LV O O
function O O
and O O
no O O
significnat O O
valvular O O
disease. O O
Past O O
medical O O
history: O O
CAD O O
s/p O O
IMI B-CAD O
in I-CAD O
2074, I-CAD O
s/p O O
stent B-CAD O
placement I-CAD O
x2 I-CAD O
in I-CAD O
2074. I-CAD O
HTN O O
PAF O O
Type B-DIABETES O
2 I-DIABETES O
DM I-DIABETES O
Sciatica O O
Hyperlipidemia B-HYPERLIPIDEMIA B-MEDICATION
GERD O O
Glaucoma O O
Multinodular O O
goiter O O
Medications O O
(Confirmed): O O
acetaminophen O O
and O O
codeine O O
(tylenol O O
with O O
codeine O O
#3) O O
tablets O O
Alphagan O O
P O O
0.15% O O
x O O
1 O O
drop O O
ou O O
bid O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
QD O O
fosinopril B-MEDICATION O
Glucophage B-MEDICATION B-MEDICATION
500 O O
mg O O
bid O O
Isordil B-MEDICATION B-MEDICATION
40 O O
mg O O
tid O O
Removed B-MEDICATION O
- I-MEDICATION O
lisinopril B-MEDICATION B-MEDICATION
40 O O
mg O O
qd O O
Lopressor B-MEDICATION B-MEDICATION
25 O O
mg O O
1/2 O O
bid O O
nitroglycerin B-MEDICATION B-MEDICATION
Norvasc B-MEDICATION B-MEDICATION
5 O O
mg O O
1/2 O O
qd O O
Pravachol B-MEDICATION B-MEDICATION
20 O O
mg O O
qd O O
Trusopt O O
1 O O
drop O O
od O O
daily O O
Tylenol O O
325mg O O
x O O
2 O O
tabs O O
po O O
q4-6h O O
PRN O O
pain O O
Allergies: O O
No O O
known O O
drug O O
allergy O O
Family O O
history: O O
Mother O O
died O O
in O O
her O O
early O O
60s O O
of O O
'heart O O
problems', O O
not O O
otherwise O O
specified. O O
Father O O
in O O
mid O O
50s O O
with O O
'kidney O O
problems'. O O
Social O O
history: O O
She O O
is O O
married, O O
retired, O O
comes O O
originally O O
from O O
Bermuda. O O
Has O O
several O O
children/grandchildren O O
who O O
help O O
with O O
her O O
medical O O
issues. O O
She B-SMOKER O
does I-SMOKER O
not I-SMOKER O
smoke I-SMOKER O
or I-SMOKER O
drink I-SMOKER O
alcohol. I-SMOKER O
Review O O
of O O
systems: O O
Otherwise O O
negative O O
in O O
detail. O O
Physical O O
examination: O O
-BMI: B-OBESE O
32.6 I-OBESE O
Obese, B-OBESE O
high O O
risk O O
-Pulse: O O
57 O O
-resp. O O
rate: O O
18 O O
-height: O O
61 O O
in. O O
-weight: O O
172 O O
lbs. O O
-General O O
appearance: O O
No O O
acute O O
distress. O O
-Skin: O O
No O O
rashes, O O
anicteric. O O
-HEENT: O O
Unremarkable O O
-Neck: O O
Carotids O O
2+ O O
without O O
bruits. O O
JVP O O
no O O
jugular O O
venous O O
distention O O
-Chest: O O
Clear O O
to O O
auscultation O O
and O O
percussion. O O
-Cardiac: O O
Left O O
ventricular O O
impulse O O
discrete O O
and O O
nondisplaced. O O
Regular O O
rate O O
and O O
rhythm, O O
normal O O
S1 O O
and O O
S2, O O
with O O
no O O
S3 O O
or O O
S4. O O
There O O
were O O
no O O
murmurs, O O
clicks O O
or O O
rubs. O O
-Abdomen: O O
Normal O O
bowel O O
sounds, O O
soft O O
and O O
nontender, O O
with O O
no O O
hepatosplenomegaly O O
or O O
masses O O
appreciated. O O
-Extremities: O O
No O O
cyanosis, O O
clubbing O O
or O O
edema. O O
2+ O O
pedal O O
pulses. O O
Mild O O
fullness O O
over O O
the O O
dorsum O O
of O O
the O O
left O O
foot. O O
LLE O O
varicosities. O O
-BP: O O
130/65 O O
EKG: O O
SB. O O
52. O O
Old B-CAD O
Inf I-CAD O
apical I-CAD O
MI. I-CAD O
No O O
change O O
from O O
the O O
prior. O O
Selected O O
recent O O
labs: O O
Metabolic O O
Date O O
NA O O
K O O
CL O O
CO2 O O
BUN O O
CRE O O
GLU O O
CA O O
PHOS O O
MG O O
05/18/82 O O
142 O O
4.1 O O
105 O O
26.1 O O
27 O O
1.3 O O
107 O O
9.4 O O
11/14/79 O O
3.4 O O
04/21/79 O O
1.7 O O
Date O O
URIC O O
05/18/82 O O
6.8 O O
11/14/79 O O
04/21/79 O O
Lipid/Thyroid O O
Date O O
CHOL O O
TRIG O O
HDL O O
LDL O O
TSH O O
T3 O O
T4 O O
10/08/81 O O
133 O O
66 O O
53 O O
67 O O
01/14/81 O O
0.54 O O
05/23/78 O O
109 O O
10.1 O O
Hematology O O
Date O O
HCT O O
WBC O O
PLT O O
12/22/80 O O
32.9 O O
6.4 O O
323 O O
Immunology O O
Date B-DIABETES O
HGBA1C B-DIABETES O
05/18/82 I-DIABETES O
6.70 I-DIABETES O
Assessment O O
and O O
plan: O O
Mrs. O O
Vanmeter O O
presents O O
today O O
stating O O
that O O
she O O
continues O O
to O O
have O O
some O O
mild O O
nighttime O O
chest O O
discomfort, O O
responsive O O
to O O
SL O O
TNG. O O
Her O O
last O O
stress O O
test O O
was O O
in O O
January O O
2082 O O
and O O
was O O
without O O
ischemia O O
with O O
a O O
posterobasal O O
scar O O
(Adeno O O
MIBI). O O
A O O
recent O O
echo O O
in O O
June O O
2081 O O
done O O
to O O
evaluate O O
increased O O
LE O O
edema O O
was O O
normal. O O
Problems: O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
- O O
She O O
reports O O
an O O
increased O O
frequency O O
of O O
her O O
nighttime O O
CP O O
and O O
takes O O
SL O O
TNG O O
when O O
with O O
good O O
relief. O O
Takes O O
it O O
about O O
once/month. O O
These O O
episodes O O
only O O
occur O O
at O O
night O O
when O O
she O O
is O O
in O O
bed. O O
Her O O
echo O O
showed O O
preserved O O
LV O O
function O O
and O O
no O O
significnat O O
valvular O O
disease. O O
A O O
repeat O O
adenosine O O
MIBI O O
was O O
negative O O
for O O
recurrent O O
ischemia O O
with O O
an O O
inferobasal O O
scar O O
and O O
LVEF O O
54%. O O
I O O
advised O O
her O O
to O O
take O O
an O O
H2 O O
blocker O O
before O O
bedtime O O
and O O
if O O
symptoms O O
don't O O
improve, O O
seek O O
a O O
workup O O
with O O
her O O
PCP. O O
Hyperlipidemia O O
- O O
Her O O
last O O
lipid O O
profile O O
showed O O
that O O
her O O
LDL O O
was O O
in O O
range O O
at O O
67, O O
and O O
her O O
TG O O
were O O
normal! O O
I O O
advised O O
her O O
about O O
the O O
metabolic O O
syndrome O O
and O O
the O O
importance O O
of O O
careful O O
diabetic O O
control O O
as O O
well O O
as O O
regular O O
exercise. O O
Continue O O
her O O
present O O
dose O O
of O O
statin. O O
HTN O O
- O O
Her O O
BP O O
is O O
well-controlled O O
today. O O
Continue O O
her O O
current O O
regimen. O O
Changes O O
to O O
Medications O O
this O O
visit O O
Glucophage O B-MEDICATION
500 O O
mg O O
bid O O
half O O
a O O
tab O O
lisinopril O B-MEDICATION
40 O O
mg O O
qd O O
End: O O
6/23/2082 O O
- O O
Inactivated O O
fosinopril O O
40 O O
mg O O
QD O O
QTY:90 O O
Refills:1 O O
year O O
Start: O O
11/21/2072 O O
Norvasc O B-MEDICATION
5 O O
mg O O
1/2 O O
qd O O
half O O
a O O
tab O O
nitroglycerin O B-MEDICATION
0.4 O O
mg O O
sl O O
PRN O O
QTY:100 O O
Refills:3 O O
Start: O O
08/20/2078 O O
Isordil O B-MEDICATION
40 O O
mg O O
tid O O
Lopressor O B-MEDICATION
25 O O
mg O O
1/2 O O
bid O O
half O O
a O O
tab O O
aspirin O B-MEDICATION
81 O O
mg O O
QD O O
acetaminophen O O
and O O
codeine O O
(tylenol O O
with O O
codeine O O
#3) O O
tablets O O
1-2 O O
tabs O O
po O O
q O O
4-6 O O
hours O O
PRN O O
pain O O
QTY:100 O O
Refills:1 O O
Start: O O
04/14/2081 O O
Pravachol O B-MEDICATION
20 O O
mg O O
qd O O
Trusopt O O
1 O O
drop O O
od O O
daily O O
Alphagan O O
P O O
0.15% O O
x O O
1 O O
drop O O
ou O O
bid O O
Tylenol O O
325mg O O
x O O
2 O O
tabs O O
po O O
q4-6h O O
PRN O O
pain O O
Disposition: O O
6 O O
months O O
with O O
me O O
Barbara O O
T. O O
Sandoval, O O
MD O O
pager O O
#19360 O O
cc: O O
Dr. O O
Bryan O O
Edmondson O O
Document O O
Status: O O
Preliminary O O

Record O O
date: O O
2066-11-14 O O
Chief O O
Complaint O O
Dyspnea O O
and O O
exertional O O
chest O O
discomfort O O
History O O
of O O
Present O O
Illness O O
Patient O O
is O O
a O O
59-year-old O O
Chadian O O
gentleman O O
with O O
multiple O O
medical O O
problems O O
including O O
DM B-DIABETES O
and O O
HTN B-HYPERTENSION O
and O O
ESRF, O O
recently O O
started O O
on O O
hemodialysis O O
who O O
is O O
admitted O O
for O O
right O O
and O O
left O O
heart O O
cath O O
prior O O
to O O
MVR/CABG/MAZE. B-CAD O
Pt O O
presented O O
1 O O
year O O
ago O O
with O O
complaints O O
of O O
increased O O
abd O O
girth, O O
lower O O
ext O O
edema, O O
and O O
worsening O O
DOE. O O
Cardiac O O
ultrasound O O
at O O
that O O
time O O
revealed O O
severe O O
mitral O O
regurgitation O O
secondary O O
to O O
diffuse O O
ventricular O O
dilation O O
and O O
papillary O O
muscle O O
displacement O O
with O O
ejection O O
fraction O O
36%. O O
He O O
denied O O
CP, O O
PND O O
and O O
orthopnea O O
at O O
the O O
time O O
and O O
adenoMibi O O
showed O O
inferior O O
thinning O O
which O O
might O O
be O O
consistent B-CAD O
with I-CAD O
a I-CAD O
prior B-CAD O
(silent) I-CAD O
IMI I-CAD O
without O O
evidence O O
of O O
ongoing O O
ischemia. O O
He O O
refused O O
further O O
work-up O O
or O O
intervention O O
until O O
recently. O O
He O O
presents O O
now O O
for O O
cath O O
and O O
surgery. O O
Review O O
of O O
Systems O O
As O O
in O O
HPI, O O
additionally; O O
- O O
General: O O
no O O
weight O O
loss/gain O O
- O O
ID: O O
no O O
fever O O
chills O O
- O O
Derm: O O
no O O
rash O O
pruritus O O
- O O
Gastrointestinal: O O
no O O
nausea O O
dysphagia O O
vomiting O O
dyspesia O O
- O O
Respiratory:no O O
dysnpnea O O
wheezing O O
- O O
Neuorologic: O O
no O O
weakness O O
numbness/tingling O O
seizures O O
syncope O O
- O O
Hematologic: O O
no O O
excessive O O
bruising, O O
bleeding O O
- O O
MSK O O
no O O
joint O O
pain O O
swelling O O
Problems O O
Neuropathy O O
Nephropathy O O
: O O
cr. O O
2.6. O O
3.3 O O
gm O O
proteinuria O O
Hemodialysis O O
for O O
the O O
past O O
2 O O
months. O O
Mature O O
L O O
fistula. O O
problems O O
with O O
fistula O O
last O O
week O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Hypertension B-HYPERTENSION O
Previously O O
reasonably O O
controlled O O
on O O
meds. O O
Greatly O O
Improved O O
after O O
start O O
of O O
dialysis O O
Obesity B-OBESE O
Diabetes B-DIABETES O
mellitus I-DIABETES O
: I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Noncompliance O O
: O O
poor O O
compliance O O
repeated O O
noncompliance, O O
frequently, O O
but O O
not O O
always, O O
due O O
to O O
financial O O
constraints O O
and O O
language O O
barrier O O
Basal O O
cell O O
carcinoma O O
: O O
carcinoma O O
of O O
skin O O
left O O
cheek O O
Lower O O
extremity O O
ulcer O O
: O O
DIABETIC O O
FOOT O O
ULCER. O O
L O O
Foot O O
Abscess O O
: O O
Rt O O
shin O O
2062 O O
Back: O O
11/64. O O
S/P O O
I&D O O
Mitral O O
valve O O
insufficiency O O
: O O
severe, O O
with O O
cardiomyopathy O O
and O O
EF O O
36% O O
Colonic O O
polyps O O
: O O
tubulovillious O O
adenoma O O
11/65. O O
Needs O O
repeat O O
scope O O
11/66 O O
Social B-SMOKER O
History O O
Married O O
with O O
2 O O
daughters. O O
Lives O O
in O O
De O O
Soto O O
and O O
assists O O
in O O
care O O
of O O
his O O
grandchildren. O O
He O O
has O O
been O O
unable O O
to O O
work O O
due O O
to O O
his O O
chronic O O
medical O O
conditions O O
and O O
is O O
exceptionally O O
limited O O
financially. O O
He O O
worked O O
(his O O
wife O O
works) O O
in O O
visual O O
art. O O
Medications O O
Aspirin B-MEDICATION B-MEDICATION
Buffered O O
325MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Toprol B-MEDICATION B-MEDICATION
Xl O O
(METOPROLOL O O
Succinate O O
Extended O O
Release) O O
100 O O
MG O O
(100MG O O
TAB.SR O O
24H O O
take O O
1) O O
PO O O
QD O O
Ferrous O O
Sulfate O O
325 O O
MG O O
(325(65)MG O O
TABLET O O
take O O
1) O O
PO O O
TID O O
Aranesp O O
(DARBEPOETIN O O
Alfa) O O
60MCG/.3ML O O
DISP O O
SYRIN O O
ML O O
SC O O
QWeek O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
80 O O
MG O O
(80MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Zetia B-MEDICATION O
(EZETIMIBE) O O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Norvasc B-MEDICATION B-MEDICATION
(AMLODIPINE) O O
15 O O
MG O O
PO O O
QD O O
Ca O O
Acetate O O
(CALCIUM O O
Acetate O O
( O O
1 O O
Tablet=667 O O
Mg)) O O
1334 O O
MG O O
(667MG O O
TABLET O O
take O O
2) O O
PO O O
TID O O
x O O
30 O O
days, O O
take O O
with O O
meals; O O
if O O
snack O O
inbetween O O
meals O O
take O O
one O O
extra O O
pill O O
LISINOPRIL B-MEDICATION B-MEDICATION
10MG O O
TABLET O O
PO O O
QD O O
, O O
Evening O O
Qpm O O
Insulin B-MEDICATION O
70/30 I-MEDICATION O
(HUMAN) I-MEDICATION O
Variable I-MEDICATION O
(70-30 I-MEDICATION O
U/ML I-MEDICATION O
VIAL I-MEDICATION O
) I-MEDICATION O
SC I-MEDICATION O
Physical O O
Exam O O
General:mildly O O
obese B-OBESE O
adult O O
male, O O
dishevelled O O
Integument: O O
Warm O O
and O O
dry O O
HEENT:Moist O O
mucous O O
membranes, O O
edentulous O O
Neck: O O
Supple, O O
no O O
thryomegaly, O O
carotids O O
Chest: O O
Lungs O O
clear O O
to O O
auscultation O O
and O O
percussion O O
Cardiac:apical O O
impulse, O O
Normal O O
S1, O O
S2 O O
III O O
HSM O O
murmer, O O
S3 O O
gallop O O
Abdomen: O O
soft, O O
nondistended, O O
normal O O
bowel O O
sounds O O
Ext: O O
External O O
Labs O O
Lab O O
Results O O
For: O O
Ogrady,Ulysses O O
Test O O
IMC O O
11/08/2066 O O
13:37 O O
WBC O O
12.5(H) O O
RBC O O
4.36(L) O O
HGB O O
12.7(L) O O
HCT O O
38.2(L) O O
MCV O O
88 O O
MCH O O
29.1 O O
MCHC O O
33.2 O O
PLT O O
329 O O
RDW O O
15.6(H) O O
PT O O
13.8(H) O O
PT-INR O O
1.2(T) O O
PTT O O
NA O O
137 O O
K O O
4.8 O O
CL O O
98(L) O O
CO2 O O
26.6 O O
BUN O O
42(H) O O
CRE O O
5.6(H) O O
GLU O O
130(H) O O
Nov O O
08 O O
LEFT O O
FOREARM O O
RADIOCEPHALIC O O
AV O O
FISTULA O O
WITH O O
MARKED O O
STENOSIS O O
WITHIN O O
THE O O
VENOUS O O
OUTFLOW O O
JUST O O
BEYOND O O
THE O O
AV O O
ANASTOMOSIS O O
SUCCESSFULLY O O
TREATED O O
WITH O O
ANGIOPLASTY. O O
CXR O O
8/18/66 O O
REPORT: O O
No O O
prior: O O
Findings: O O
The O O
lungs O O
are O O
clear O O
however O O
there O O
is O O
some O O
cephalization O O
of O O
blood O O
flow. O O
The O O
cardiac O O
shadow O O
is O O
at O O
the O O
upper O O
limits O O
of O O
normal. O O
The O O
bony O O
thorax O O
demonstrates O O
degenerative O O
changes. O O
Impression: O O
Cephalization O O
of O O
blood O O
flow O O
and O O
cardiomegaly O O
Assessment O O
58-year-old O O
Chadian O O
gentleman O O
with O O
multiple O O
medical O O
problems O O
including O O
DM, O O
HTN O O
and O O
ESRF O O
on O O
dialysis. O O
In O O
addition O O
he O O
has O O
ischemic B-CAD O
cardiomyopathy I-CAD O
complicated O O
by O O
severe O O
mitral O O
regurgitation. O O
He O O
has O O
been O O
reluctant O O
to O O
consider O O
surgery O O
in O O
the O O
past O O
but O O
in O O
the O O
face O O
of O O
worsening O O
symptoms O O
has O O
now O O
agreed O O
to O O
proceed. O O
Plan O O
1. O O
Admit O O
for O O
right O O
and O O
left O O
heart O O
cath O O
with O O
cors. O O
2. O O
Pt O O
schedulled O O
for O O
dialysis O O
on O O
Friday O O
please O O
notify O O
Dr O O
Mcdaniel O O
of O O
his O O
arrival. O O
3. O O
CABG/MVR/MAZE B-CAD O
schedulled I-CAD O
for I-CAD O
Thursday I-CAD O

Record B-SMOKER O
date: O O
2067-08-02 O O
60 O O
year O O
old O O
gentleman O O
presents O O
for O O
follow-up O O
of O O
right O O
lower O O
extremity O O
foot O O
ulcer. O O
It O O
would O O
appear O O
that O O
two O O
weeks O O
prior, O O
the O O
patient O O
sustained O O
a O O
burn O O
to O O
the O O
right O O
lower O O
extremity O O
while O O
walking O O
on O O
a O O
hot O O
sandy O O
beach. O O
He O O
has O O
been O O
followed O O
regularly O O
by O O
a O O
podiatrist O O
Dr. O O
Sanchez, O O
who O O
has O O
attempted O O
debridement O O
of O O
lesion. O O
He O O
also O O
asked O O
that O O
the O O
patient O O
receive O O
vancomycin O O
at O O
the O O
time O O
of O O
his O O
dialysis. O O
In O O
the O O
setting O O
of O O
four O O
compliance O O
and O O
poor O O
wound O O
healing, O O
the O O
patient O O
was O O
admitted O O
for O O
48 O O
hours O O
to O O
the O O
Northport O O
Veterans O O
Hospital. O O
Records O O
are O O
not O O
immediately O O
available O O
but O O
it O O
would O O
appear O O
that O O
he O O
received O O
intravenous O O
antibiotics O O
at O O
that O O
time. O O
He O O
was O O
discharged O O
without O O
clear O O
follow-up. O O
The O O
patient O O
presents O O
to O O
my O O
office O O
with O O
his O O
foot O O
unwrapped O O
and O O
undressed. O O
He O O
has O O
been O O
ambulating O O
on O O
the O O
wound. O O
He O O
reports O O
that O O
it O O
appears O O
less O O
red O O
and O O
has O O
less O O
drainage O O
than O O
at O O
his O O
initial O O
presentation. O O
He O O
reports O O
no O O
pain. O O
Having O O
spoken O O
with O O
his O O
podiatrist, O O
it O O
would O O
appear O O
that O O
the O O
patient O O
has O O
been O O
noncompliant O O
with O O
leg O O
elevation O O
and O O
dressing O O
overall. O O
Review O O
of O O
systems O O
is O O
otherwise O O
negative. O O
Past O O
Medical O O
History: O O
Neuropathy O O
Nephropathy O O
: O O
cr. O O
2.6. O O
3.3 O O
gm O O
proteinuria. O O
Currently O O
on O O
hemodialysis O O
Hyperlipidemia B-HYPERLIPIDEMIA B-HYPERTENSION
Hypertension B-HYPERTENSION B-HYPERTENSION
Obesity B-OBESE O
Diabetes B-DIABETES O
mellitus I-DIABETES O
: I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Noncompliance O O
: O O
poor O O
compliance O O
Basal O O
cell O O
carcinoma O O
: O O
carcinoma O O
of O O
skin O O
left O O
cheek O O
Lower O O
extremity O O
ulcer O O
: O O
DIABETIC O O
FOOT O O
ULCER. O O
L O O
Foot O O
Abscess O O
: O O
Rt O O
shin O O
2062Back: O O
11/64. O O
S/P O O
I&D O O
Mitral O O
valve O O
insufficiency O O
: O O
severe, O O
with O O
cardiomyopathy O O
and O O
EF O O
36% O O
Colonic O O
polyps O O
: O O
tubulovillious O O
adenoma O O
11/65. O O
Needs O O
repeat O O
scope O O
11/66 O O
FH O O
Uncoded O O
Information: O O
Comments: O O
Noncontributory O O
Allergies O O
NKA O O
Medications O O
Aspirin B-MEDICATION B-MEDICATION
BUFFERED O O
325MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Nephrocaps O O
1 O O
CAPSULE O O
PO O O
QD O O
x O O
90 O O
days O O
Ca O O
ACETATE O O
(CALCIUM O O
ACETATE O O
( O O
1 O O
TABLET=667 O O
MG)) O O
1334 O O
MG O O
(667MG O O
TABLET O O
take O O
2) O O
PO O O
TID O O
x O O
30 O O
days, O O
take O O
with O O
meals; O O
if O O
snack O O
inbetween O O
meals O O
take O O
one O O
extra O O
pill O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
80 O O
MG O O
(80MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Zetia B-MEDICATION O
(EZETIMIBE) O O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
(METOPROLOL O O
SUCCINATE O O
EXTENDED O O
RELEASE) O O
100 O O
MG O O
(100MG O O
TAB.SR O O
24H O O
take O O
1) O O
PO O O
QD O O
Lisinopril B-MEDICATION B-MEDICATION
40 O O
MG O O
(40MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
, O O
Evening O O
Qpm O O
Insulin B-MEDICATION O
70/30 I-MEDICATION O
(HUMAN) I-MEDICATION O
Variable I-MEDICATION O
(70-30 I-MEDICATION O
U/ML I-MEDICATION O
VIAL I-MEDICATION O
) I-MEDICATION O
SC I-MEDICATION O
, I-MEDICATION O
45 I-MEDICATION O
am, I-MEDICATION O
Pm I-MEDICATION O
Physical O O
exam: O O
In O O
no O O
acute O O
distress. O O
Blood O O
pressure O O
is O O
100/58. O O
Weight O O
is O O
236. O O
Pulse O O
is O O
70 O O
and O O
regular.HEENT: O O
Pupils O O
equal O O
round O O
reactive O O
to O O
light. O O
Extraocular O O
motions O O
intact. O O
Oropharynx O O
moist O O
without O O
erythema O O
or O O
exudate. O O
Neck: O O
Supple O O
without O O
JVD, O O
lymphadenopathy, O O
or O O
thyromegaly. O O
Chest: O O
Clear O O
to O O
auscultation O O
bilaterally O O
without O O
wheezes O O
or O O
rhonchi O O
or O O
rhales. O O
Cardiac: O O
Regular O O
rate O O
and O O
rhythm, O O
normal O O
S1 O O
and O O
S2 O O
without O O
murmurs O O
rubs O O
or O O
gallops. O O
Extremities: O O
Right O O
lower O O
extremity O O
with O O
a O O
1.6 O O
cm O O
x O O
1.6 O O
cm O O
black O O
eschar O O
to O O
be O O
great O O
toe. O O
Lesion O O
is O O
soft. O O
It O O
is O O
unclear O O
if O O
there O O
is O O
significant O O
tracking O O
beneath O O
the O O
surface. O O
A O O
3 O O
cm O O
x O O
2 O O
cm O O
flat O O
based O O
ulcer O O
with O O
surrounding O O
callus O O
formation O O
is O O
noted O O
to O O
be O O
ball O O
of O O
the O O
right O O
foot O O
with O O
some O O
granulation O O
and O O
no O O
drainage. O O
A O O
collar O O
is O O
noted. O O
No O O
surrounding O O
erythema O O
is O O
appreciated. O O
Dorsalis O O
pedis O O
and O O
posterior O O
tibial O O
pulses O O
are O O
palpable O O
but O O
clearly O O
diminished. O O
Assessment O O
and O O
plan: O O
This O O
is O O
a O O
60 O O
year O O
old O O
gentleman O O
with O O
multiple O O
medical O O
issues O O
including O O
end-stage O O
renal O O
disease O O
my O O
for O O
regurgitation, O O
congestive O O
heart O O
failure, O O
severe O O
peripheral O O
neuropathy, O O
diabetes. B-DIABETES O
Present O O
in O O
with O O
two O O
large O O
altars O O
to O O
the O O
right O O
lower O O
extremity. O O
He O O
is O O
status O O
post O O
hospitalization O O
and O O
some O O
debridement O O
and O O
appears O O
to O O
have O O
had O O
little O O
overall O O
improvement O O
in O O
clinical O O
status. O O
I O O
will O O
proceed O O
with O O
an O O
aggressive O O
outpatient O O
treatment O O
plan O O
however O O
I O O
suspect O O
that O O
he O O
will O O
need O O
inpatient O O
admission O O
once O O
again O O
if O O
significant O O
improvement O O
is O O
not O O
rapidly O O
obtained. O O
A O O
referral O O
has O O
been O O
made O O
to O O
the O O
Island O O
Medical O O
Center O O
wound O O
clinic O O
for O O
this O O
Tuesday. O O
Visiting O O
nurse O O
has O O
been O O
arranged O O
for O O
his O O
home O O
for O O
wound O O
care O O
in O O
the O O
interim. O O
He O O
is O O
advised O O
to O O
avoid O O
all O O
weight-bearing O O
and O O
to O O
keep O O
his O O
foot O O
dressed O O
at O O
all O O
times. O O
I O O
have O O
explained O O
to O O
the O O
patient O O
that O O
he O O
is O O
at O O
risk O O
of O O
amputation O O
of O O
at O O
least O O
his O O
right O O
great O O
toe O O
should O O
his O O
healing O O
not O O
improve. O O
With O O
regards O O
to O O
his O O
other O O
medical O O
issues, O O
he O O
continues O O
on O O
dialysis. O O
I O O
have O O
asked O O
for O O
a O O
hemoglobin O O
A1c O O
and O O
fasting O O
cholesterol O O
to O O
be O O
drawn O O
at O O
the O O
time O O
of O O
his O O
dialysis O O
tomorrow. O O
I'll O O
see O O
the O O
patient O O
on O O
Tuesday. O O
His O O
blood O O
pressure O O
is O O
appropriately O O
controlled O O
and O O
he O O
is O O
no O O
stigmata O O
of O O
congestive O O
heart O O
failure O O
At O O
today's O O
visit, O O
the O O
patient's O O
wound O O
was O O
dressed O O
and O O
cleaned O O
the O O
our O O
nursing O O
staff O O

Record O O
date: O O
2069-04-16 O O
Patient O O
Name: O O
OGRADY,ULYSSES O O
[ O O
0937884(IMC) O O
] O O
Date O O
of O O
Visit: O O
04/16/2069 O O
Renal O O
Staff O O
Patient O O
seen O O
and O O
examined O O
on O O
dialysis. O O
Agree O O
with O O
details O O
per O O
Fellow O O
Note. O O
62 O O
year O O
old O O
man O O
referred O O
to O O
ED O O
after O O
missing O O
dialysis O O
yesterday O O
and O O
noted O O
to O O
be O O
mentally O O
confused. O O
On O O
presentation O O
he O O
was O O
hyperkalemic O O
to O O
7.4. O O
He O O
has O O
been O O
evaluated O O
in O O
ED O O
setting O O
with O O
negative O O
head O O
CT O O
and O O
LP. O O
Family O O
reports O O
h/o O O
poor O O
compliance O O
and O O
self O O
care O O
deficit. O O
PMH/PSH:ESRD, O O
presumed O O
from O O
HTN/DM, B-DIABETES O
TTS, O O
LUE O O
AVF; O O
initiated O O
dialysis O O
in O O
2067; O O
has O O
left O O
arm O O
AVF; O O
HD O O
at O O
Eureka O O
Springs O O
Hospital O O
- O O
Dr O O
Allan O O
Jester O O
is O O
attending O O
NephrologistHyperlipidemia B-HYPERLIPIDEMIA O
Hypertension B-HYPERTENSION O
Obesity B-OBESE O
Diabetes B-DIABETES O
mellitus I-DIABETES O
: I-DIABETES O
type I-DIABETES O
2, I-DIABETES O
with O O
tripothyNoncompliance O O
Basal O O
cell O O
carcinoma O O
: O O
carcinoma O O
of O O
skin O O
left O O
cheekLower O O
extremity O O
ulcer O O
: O O
DIABETIC O O
FOOT O O
ULCER. O O
L O O
FootAbscess O O
: O O
Rt O O
shin O O
2062Back: O O
11/64. O O
S/P O O
I&amp;DMitral O O
valve O O
insufficiency O O
: O O
severe, O O
with O O
cardiomyopathy O O
and O O
EF O O
36%Colonic O O
polyps O O
: O O
tubulovillious O O
adenoma O O
11/65. O O
Needs O O
repeat O O
scope O O
11/66 O O
Medications O O
Insulin B-MEDICATION O
variable I-MEDICATION O
dosing I-MEDICATION O
Reportedly O O
not O O
taking O O
other O O
meds O O
SOCIAL B-SMOKER O
Lives O O
in O O
De O O
Soto O O
with O O
Wife O O
and O O
Daughter O O
ROS O O
As O O
detailed. O O
He O O
also O O
has O O
been O O
c/o O O
dizziness O O
and O O
weakness O O
after O O
dialysis, O O
which O O
was O O
the O O
main O O
reason O O
he O O
refused O O
to O O
go O O
for O O
HD O O
yesterday. O O
No O O
additional O O
hx O O
is O O
available, O O
no O O
known O O
sick O O
contact O O
per O O
wife. O O
When O O
he O O
was O O
in O O
ED, O O
he O O
was O O
noted O O
to O O
have O O
LGF O O
100.4, O O
hypertensive O O
and O O
tachycardic. O O
He O O
is O O
waiting O O
for O O
head O O
CT O O
and O O
possible O O
LP. O O
EXAM O O
T O O
100.4, O O
P O O
110, O O
BP B-HYPERTENSION O
150/80, I-HYPERTENSION O
R O O
26, O O
SO2 O O
94%(4L) O O
NAD, O O
limited O O
cooperation O O
with O O
exam, O O
A+O O O
x2 O O
CV: O O
tachy/reg, O O
no O O
rubs O O
CHEST: O O
CTA O O
ant O O
ABD: O O
soft, O O
NT/ND/NABS O O
EXT: O O
1+ O O
edema O O
Neuro: O O
nonfocal-limited O O
exam O O
DATAEKG O O
is O O
not O O
available O O
for O O
review, O O
but O O
no O O
acute O O
ischemic O O
changes O O
and O O
no O O
widened O O
QRS/peaked O O
T O O
wave O O
per O O
ED. O O
PCXR: O O
poor O O
penetration, O O
but O O
no O O
acute O O
process O O
Head O O
CT O O
IMPRESSION: O O
1. O O
No O O
hemorrhage, O O
mass O O
lesion, O O
or O O
evidence O O
of O O
acute O O
territorial O O
infarction. O O
2. O O
Extensive O O
nonspecific O O
periventricular, O O
deep, O O
and O O
subcortical O O
white O O
matter O O
changes O O
are O O
likely O O
sequela O O
from O O
chronic O O
microangiopathic O O
disease. O O
3. O O
Old O O
lacunar O O
infarctions O O
in O O
the O O
left O O
caudate O O
head O O
and O O
right O O
caudate-anterior O O
corona O O
radiata. O O
Evaluation O O
for O O
acute O O
ischemia O O
is O O
limited O O
in O O
the O O
areas O O
of O O
extensive O O
white O O
matter O O
disease. O O
Brain O O
MRI O O
with O O
diffusion-weighted O O
imaging O O
is O O
more O O
sensitive O O
in O O
assessing O O
for O O
acute O O
ischemia O O
and O O
should O O
be O O
obtained O O
as O O
clinically O O
indicated. O O
UA-SED-RBC O O
20-50 O O
(0-2) O O
/hpfUA-SED-WBC O O
5-10 O O
(0-2) O O
/hpfUA-SED-Bacteria O O
Many O O
(NEG) O O
/hpf O O
WBC O O
20.7 O O
H O O
(4.5-11.0) O O
th/cmmHCT O O
33.6 O O
L O O
(41.0-53.0) O O
%HGB O O
11.3 O O
L O O
(13.5-17.5) O O
gm/dlRBC O O
3.77 O O
L O O
(4.50-5.90) O O
mil/cmmPLT O O
239 O O
(150-400) O O
th/cumm O O
Plasma O O
Sodium O O
133 O O
L O O
(135-145) O O
mmol/LPlasma O O
Potassium O O
7.4 O O
H O O
(3.4-4.8) O O
mmol/L O O
Plasma O O
Chloride O O
94 O O
L O O
(100-108) O O
mmol/LPlasma O O
Carbon O O
Dioxide O O
18.1 O O
L O O
(23.0-31.9) O O
mmol/LPlasma O O
Anion O O
GAP O O
21 O O
H O O
(3-15) O O
mmol/LCalcium O O
9.6 O O
(8.5-10.5) O O
mg/dlPhosphorus O O
7.3 O O
H O O
(2.6-4.5) O O
mg/dlMagnesium O O
2.2 O O
H O O
(1.4-2.0) O O
meq/LPlasma O O
Urea O O
Nitrogen O O
68 O O
H O O
(8-25) O O
mg/dlPlasma O O
Creatinine O O
9.18 O O
H O O
(0.60-1.50) O O
mg/dlAlbumin O O
4.6 O O
(3.3-5.0) O O
g/dlDirect O O
Bilirubin O O
0.5 O O
H O O
(0-0.4) O O
mg/dlTotal O O
Bilirubin O O
1.1 O O
H O O
(0.0-1.0) O O
mg/dlA+P O O
1. O O
ESRD, O O
with O O
hyperkalemia O O
2. O O
AMS, O O
found O O
down O O
s/p O O
LP O O
with O O
results O O
pending O O
and O O
extensive O O
CNS O O
white O O
matter O O
changes O O
3. O O
Medical O O
noncompliance O O
4. O O
Leukocytosis O O
with O O
infected O O
leg O O
ulcer O O
and O O
? O O
cellulitis O O
5. O O
Pyuria O O
- O O
Dialysis O O
3 O O
hrs O O
1K, O O
2.5Ca O O
- O O
UF O O
2L O O
- O O
AVF O O
access O O
- O O
Hold O O
Epogen O O
today O O
- O O
F/U O O
LP O O
results O O
- O O
Blood O O
Cultures O O
on O O
dialysis; O O
wound O O
culture, O O
urine O O
culture O O
- O O
Vancomycin O O
1g O O
post O O
dialysis; O O
Levofloxacin O O
500mg O O
qod O O
- O O
cycle O O
cardiac O O
enzymes O O
- O O
Review O O
outpatient O O
medication O O
regimen O O
____________________________________ O O
Kenneth O O
DUSTIN O O
Mcdaniel, O O
M.D. O O

Record O O
date: O O
2069-10-07 O O
IMC O O
Odem O O
IM O O
Attending O O
Medicine O O
Consult O O
NotePt: O O
Ulysses O O
OgradyIMC O O
0937884Date: O O
10/07/69 O O
Time: O O
12:15pmPCP: O O
Paul O O
Jaramillo, O O
MD O O
Pager O O
52666 O O
HPI: O O
Asked O O
to O O
see O O
patient O O
by O O
surgical O O
team O O
in O O
consultation O O
for O O
is O O
multiple O O
medical O O
issues. O O
I O O
have O O
served O O
as O O
his O O
PCP O O
for O O
eight O O
years. O O
Pt O O
seen O O
and O O
examined. O O
Case O O
discussed O O
in O O
detail O O
. O O
This O O
is O O
a O O
62 O O
y/o O O
male O O
with O O
multiple O O
medical O O
issues O O
last O O
admitted O O
in O O
September O O
for O O
increased O O
falls, O O
found O O
to O O
have O O
a O O
small O O
stroke O O
in O O
addition O O
to O O
his O O
likely O O
vascular O O
dementia. O O
Readmitted O O
last O O
week O O
in O O
the O O
setting O O
of O O
Purulent O O
L O O
foot O O
ulcer/ O O
S/P O O
debridement O O
and O O
later O O
TMA. O O
He O O
has O O
a O O
long O O
history O O
well O O
documented O O
in O O
the O O
electronic O O
medical O O
record O O
which O O
is O O
notable O O
for O O
poor O O
compliance O O
with O O
medication O O
and O O
follow-up. O O
At O O
baseline, O O
patient O O
has O O
declined O O
further O O
cardiology O O
workup O O
for O O
his O O
severe O O
mitral O O
regurgitation O O
and O O
cardiomyopathy, O O
has O O
declined O O
treatment O O
for O O
his O O
hyperlipidemia B-HYPERLIPIDEMIA O
and O O
takes O O
his O O
blood O O
pressure O O
medications O O
with O O
less O O
than O O
25% O O
compliance. O O
At O O
the O O
time O O
of O O
his O O
last O O
admission, O O
he O O
was O O
actually O O
admitted O O
to O O
a O O
nursing O O
home O O
with O O
plans O O
for O O
long O O
term O O
placement. O O
The O O
patient's O O
wound O O
has O O
currently O O
not O O
been O O
closed. O O
He O O
has O O
a O O
vac O O
dressing O O
in O O
place. O O
He O O
has O O
been O O
attending O O
dialysis O O
per O O
schedule O O
of O O
nephrology. O O
Current O O
hospital O O
course O O
has O O
been O O
complicated O O
by O O
increased O O
agitation O O
and O O
last O O
evening, O O
self O O
limited O O
substernal O O
chest O O
pain O O
and O O
dyspnea. O O
This O O
resolved O O
spontaneously. O O
He O O
has O O
also O O
been O O
intermittently O O
refusing O O
his O O
medications O O
and O O
has O O
been O O
attempting O O
to O O
ambulate. O O
This O O
AM. O O
the O O
patient O O
actually O O
denies O O
ever O O
experiencing O O
chest O O
pain. O O
He O O
also O O
only O O
recalls O O
his O O
foot O O
pain O O
with O O
repeated O O
prompting. O O
He O O
denies O O
any O O
pain, O O
dyspnea O O
ROS O O
otherwise O O
negative., O O
Past O O
Medical O O
History: O O
Neuropathy O O
Nephropathy O O
: O O
cr. O O
2.6. O O
3.3 O O
gm O O
proteinuria. O O
Currently O O
on O O
hemodialysisHyperlipidemia B-HYPERLIPIDEMIA O
Hypertension B-HYPERTENSION O
Obesity B-OBESE O
Diabetes B-DIABETES O
mellitus I-DIABETES O
: I-DIABETES O
type I-DIABETES O
2Noncompliance I-DIABETES O
: O O
poor O O
complianceBasal O O
cell O O
carcinoma O O
: O O
carcinoma O O
of O O
skin O O
left O O
cheekLower O O
extremity O O
ulcer O O
: O O
DIABETIC O O
FOOT O O
ULCER. O O
L O O
FootAbscess O O
: O O
Rt O O
shin O O
2062 O O
Back: O O
11/64. O O
S/P O O
I&amp;DMitral B-DIABETES O
valve O O
insufficiency O O
: O O
severe, O O
with O O
cardiomyopathy O O
and O O
EF O O
36%Colonic O O
polyps O O
: O O
tubulovillious O O
adenoma O O
11/65. O O
CAD: B-CAD O
cath B-CAD O
in I-CAD O
2066 I-CAD O
showed I-CAD O
occluded B-CAD O
mid I-CAD O
LAD I-CAD O
with I-CAD O
collaterals. I-CAD O
Stress B-CAD O
test I-CAD O
showed I-CAD O
mid-distal I-CAD O
anterior I-CAD O
wall I-CAD O
and I-CAD O
apical I-CAD O
ischemia. I-CAD O
- I-CAD O
Cardiomyopathy I-CAD O
with I-CAD O
EF=36%, I-CAD O
severe O O
mitral O O
regurg O O
not O O
on O O
any O O
SBE O O
ppx O O
Medications: O O
As O O
prescribed:Olanzapine O O
5mg O O
BID O O
SQ O O
Hepatin O O
Toprol B-MEDICATION B-MEDICATION
XL, I-MEDICATION O
50mg O O
Lisinopril B-MEDICATION B-MEDICATION
40mg O O
po O O
qd O O
Vancomycin: O O
dosed O O
at O O
dialysis O O
RISS O O
Oxycodone O O
prn O O
Simvastatin B-MEDICATION B-MEDICATION
Levofloxacin O O
Fluoxetine O O
Nephocaps O O
Calcium O O
acetate. O O
Allergies: O O
NKDA O O
Social O O
History/FH O O
per O O
Surgical O O
notes. O O
Pt B-SMOKER O
is I-SMOKER O
a I-SMOKER O
nonsmoker. B-SMOKER O
No O O
ETOH O O
or O O
Drug O O
use O O
hx. O O
Formerly O O
lived O O
with O O
daughter. O O
Emigrated O O
to O O
tajikistan O O
many O O
years O O
prior O O
but O O
still O O
primarily O O
speaks O O
Chad. O O
Examination: O O
Modestly O O
confused O O
but O O
not O O
agitated. O O
Does O O
recognize O O
PCP. O O
Does O O
not O O
know O O
date O O
or O O
time. O O
Does O O
not O O
clearly O O
know O O
why O O
he O O
is O O
hospitalized. O O
VITALS: O O
99.0 O O
hr O O
80-101 O O
R O O
BP B-HYPERTENSION O
150/76 B-HYPERTENSION O
.GEN&#8217;L O O
NAD, O O
AO O O
X O O
2 O O
(&#8220;Superior O O
Memorial O O
Hospital)HEENT O O
MMM, O O
no O O
scleral O O
icterus, O O
no O O
pale O O
conjunctiva. O O
No O O
roth O O
spots. O O
NECK O O
supple, O O
no O O
thyromegaly, O O
no O O
LAD, O O
no O O
carotid O O
bruits. O O
+ O O
10cm O O
JVOP O O
Heart: O O
RRR, O O
no O O
m/r/gLUNG: O O
Bibasilar O O
crackles. O O
No O O
wheezeABD: O O
Soft, O O
non-tender, O O
obese, O O
NABS. O O
No O O
HSM. O O
No O O
masses, O O
no O O
rebound. O O
EXT: O O
RLE O O
in O O
Vac O O
dressing. O O
Wound O O
open O O
without O O
surrounding O O
erythema.NEURO: O O
AO O O
x O O
3; O O
alert; O O
CN O O
II-XII O O
grossly O O
intact; O O
Motor: O O
5/5 O O
B O O
UE/LE; O O
sensation O O
dinished O O
to O O
light O O
tough, O O
proprioception. O O
Full O O
neurologic O O
eval O O
per O O
neurology O O
assessment O O
Data: O O
Date/Time O O
NA O O
K O O
CL O O
CO2 O O
10/07/2069 O O
136 O O
4.4 O O
100 O O
24.5 O O
10/07/2069 O O
138 O O
4.7 O O
100 O O
26.4 O O
10/06/2069 O O
136 O O
4.7 O O
99 O O
(L) O O
26.6 O O
10/06/2069 O O
136 O O
4.2 O O
98 O O
(L) O O
Date/Time O O
BUN O O
CRE O O
EGFR O O
GLU O O
10/07/2069 O O
35 O O
(H) O O
6.64 O O
(H) O O
9 O O
[1] O O
124 O O
(H) O O
10/07/2069 O O
35 O O
(H) O O
6.38 O O
(H) O O
9 O O
[2] O O
106 O O
10/06/2069 O O
34 O O
(H) O O
6.33 O O
(H) O O
10 O O
[3] O O
141 O O
(H) O O
Date/Time O O
ANION O O
10/07/2069 O O
12 O O
10/07/2069 O O
12 O O
10/06/2069 O O
10 O O
Date/Time O O
CA O O
PHOS O O
MG O O
ALB O O
10/07/2069 O O
8.5 O O
5.0 O O
(H) O O
2.0 O O
3.0 O O
(L) O O
10/07/2069 O O
8.5 O O
4.8 O O
(H) O O
2.0 O O
10/06/2069 O O
8.7 O O
10/06/2069 O O
8.4 O O
(L) O O
4.0 O O
2.0 O O
3.4 O O
Date/Time O O
25 O O
OH-VITD O O
10/02/2069 O O
23 O O
(L)[13] O O
Date/Time O O
CK O O
CK-MB O O
CKMBRI O O
TROP-T O O
10/07/2069 O O
25 O O
(L) O O
2.7 O O
SEE O O
DETAIL[14] O O
0.07 O O
10/06/2069 O O
32 O O
(L) O O
2.8 O O
SEE O O
DETAIL[15] O O
0.08 O O
Date/Time O O
FE O O
TIBC O O
FER O O
10/02/2069 O O
23 O O
(L) O O
156 O O
(L) O O
501 O O
(H) O O
Date/Time O O
PTH O O
10/02/2069 O O
66 O O
(H) O O
Date/Time O O
WBC O O
RBC O O
HGB O O
HCT O O
10/07/2069 O O
13.9 O O
(H) O O
3.42 O O
(L) O O
9.7 O O
(L) O O
29.4 O O
(L) O O
10/07/2069 O O
16.4 O O
(H) O O
3.34 O O
(L) O O
9.6 O O
(L) O O
29.2 O O
(L) O O
10/06/2069 O O
14.6 O O
(H) O O
3.58 O O
(L) O O
10.0 O O
(L) O O
31.2 O O
(L) O O
Date/Time O O
MCV O O
MCH O O
MCHC O O
PLT O O
10/07/2069 O O
86 O O
28.2 O O
32.9 O O
372 O O
10/07/2069 O O
88 O O
28.8 O O
32.9 O O
372 O O
10/06/2069 O O
87 O O
28.0 O O
32.1 O O
Date/Time O O
RETIC O O
10/02/2069 O O
1.6 O O
Date/Time O O
PT O O
PT-INR O O
PTT O O
10/07/2069 O O
17.6 O O
(H) O O
1.6 O O
30.6 O O
10/01/2069 O O
17.3 O O
(H) O O
1.6 O O
29.2 O O
[21] O O
Date/Time O O
HBV-SAB O O
HBV-SAG O O
HCVAB O O
10/02/2069 O O
EQUIVOCAL O O
Non-Reactive O O
Non-Reactive O O
Date/Time O O
VANC O O
TR-VANC O O
10/07/2069 O O
13.2 O O
[22] O O
10/04/2069 O O
38.6 O O
[23] O O
Specimen O O
Type: O O
BLOOD O O
CULTURE O O
Few O O
POLYS, O O
Few O O
MONONUCLEAR O O
CELLS, O O
Abundant O O
GRAM O O
NEGATIVE O O
RODS, O O
Rare O O
LARGE O O
GRAM O O
POSITIVE O O
RODS O O
Wound O O
Culture O O
- O O
Final O O
Reported: O O
06-Oct-69 O O
14:55 O O
Specimen O O
received O O
from O O
OR O O
Abundant O O
KLEBSIELLA O O
PNEUMONIAE O O
RAPID O O
MIC O O
METHOD O O
Antibiotic O O
Interpretation O O
---------------------------------------------- O O
Amikacin O O
Susceptible O O
Ampicillin O O
Resistant O O
Aztreonam O O
Susceptible O O
Cefazolin O O
Susceptible O O
Cefepime O O
Susceptible O O
Ceftriaxone O O
Susceptible O O
Ciprofloxacin O O
Susceptible O O
Gentamicin O O
Susceptible O O
Levofloxacin O O
Susceptible O O
Piperacillin O O
Resistant O O
Trimethoprim/Sulfamethoxazole O O
Susceptible O O
Abundant O O
PSEUDOMONAS O O
AERUGINOSA O O
DISK O O
METHOD O O
Antibiotic O O
Interpretation O O
---------------------------------------- O O
Aztreonam O O
Susceptible O O
Cefepime O O
Susceptible O O
Gentamicin O O
Susceptible O O
Levofloxacin O O
Susceptible O O
Piperacillin/Tazobactam O O
Susceptible O O
Ticarcillin O O
Susceptible O O
Tobramycin O O
Susceptible O O
Abundant O O
MORGANELLA O O
MORGANII O O
SUBSPECIES O O
MORGANII O O
RAPID O O
MIC O O
METHOD O O
Antibiotic O O
Interpretation O O
---------------------------------------------- O O
Amikacin O O
Susceptible O O
Ampicillin O O
Resistant O O
Aztreonam O O
Susceptible O O
Cefazolin O O
Resistant O O
Cefepime O O
Susceptible O O
Ceftriaxone O O
Susceptible O O
Ciprofloxacin O O
Susceptible O O
Gentamicin O O
Susceptible O O
Levofloxacin O O
Susceptible O O
Piperacillin O O
Susceptible O O
Trimethoprim/Sulfamethoxazole O O
Susceptible O O
Anaerobic O O
Culture O O
- O O
Preliminary O O
Reported: O O
06-Oct-69 O O
11:48 O O
Specimen O O
received O O
from O O
OR O O
NO O O
ANAEROBES O O
ISOLATED O O
SO O O
FAR O O
EKG: O O
NSR O O
@ O O
90, O O
incomplete O O
RBBB, O O
L O O
anterior O O
fascicular O O
block; O O
QTC O O
495 O O
ms. O O
Assessment/Plan O O
In O O
summary,62 O O
y/o O O
male O O
with O O
multiple O O
medical O O
issues O O
as O O
outlined O O
in O O
this O O
and O O
many O O
other O O
notes. O O
Presenting O O
with O O
necrotic O O
foot O O
infection, O O
polymicrobial. O O
S/P O O
Rt O O
TMA. O O
Mildly O O
delerious O O
and O O
certainly O O
off O O
from O O
a O O
baseline O O
that O O
was O O
tenuous O O
to O O
start. O O
By O O
issue: O O
1) O O
CAD: O O
The O O
patient O O
does O O
have O O
CAD, O O
MR O O
and O O
cardiomyopathy O O
that O O
are O O
really O O
not O O
amenable O O
to O O
intervention, O O
given O O
patient O O
noncompliance. O O
The O O
best O O
goal O O
at O O
present O O
is O O
going O O
to O O
be O O
continued O O
medical O O
management. O O
If O O
BP O O
allows, O O
could O O
increase O O
toprol O B-MEDICATION
XL, O O
although O O
I O O
suspect O O
that O O
this O O
will O O
not O O
be O O
an O O
option. O O
In O O
addition, O O
would O O
aim O O
to O O
keep O O
even O O
at O O
dialysis. O O
Certainly, O O
cycle O O
CKs O O
and O O
troponin O O
and O O
follow O O
sx. O O
I O O
will O O
defer O O
to O O
Dr. O O
Shah, O O
but O O
I O O
don't O O
see O O
clear O O
benefit O O
for O O
cardiac O O
cath, O O
especially O O
as O O
we O O
are O O
not O O
going O O
to O O
proceed O O
to O O
valve O O
repair O O
at O O
this O O
juncture. O O
If O O
he O O
were O O
to O O
become O O
more O O
compliant, O O
this O O
might O O
be O O
another O O
consideration O O
and O O
as O O
he O O
is O O
now O O
a O O
CT O O
resident, O O
perhaps O O
this O O
will O O
be O O
a O O
future O O
consideration. O O
2) O O
Delirium: O O
He O O
does O O
have O O
a O O
very O O
tenuous O O
baseline O O
and O O
has O O
significant O O
vascular O O
dementia O O
to O O
start. O O
He O O
is O O
off O O
of O O
this O O
baseline, O O
likely O O
reflecting O O
sundowning, O O
medications O O
and O O
underlying O O
metabolic O O
processes. O O
Please O O
d/c O O
medications O O
that O O
might O O
be O O
contributing O O
to O O
sx. O O
Fluoxetine O O
can O O
be O O
held O O
for O O
now O O
as O O
it O O
was O O
only O O
started O O
3 O O
weeks O O
prior. O O
Might O O
hold O O
ranitidine O O
as O O
well. O O
Haldol O O
is O O
d/cd O O
in O O
the O O
setting O O
of O O
his O O
prolonged O O
QTc. O O
Currently O O
on O O
olanzapine. O O
Would O O
continue O O
to O O
follow O O
QTc O O
closely O O
and O O
would O O
d/c O O
this O O
med O O
as O O
well O O
is O O
still O O
prolonged. O O
Please O O
send O O
urine O O
culture O O
and O O
surveillance O O
blood O O
cultures. O O
3) O O
Infection: O O
Appreciate O O
excellent O O
surgical O O
management O O
of O O
patient's O O
wound. O O
Levofloxacin O O
has O O
been O O
d/cd O O
2nd O O
to O O
concerns O O
for O O
altered O O
mental O O
status. O O
All O O
bacteria O O
are O O
sensitive O O
to O O
aztreonam O O
so O O
perhaps O O
this O O
would O O
be O O
a O O
reasonable O O
alternative. O O
Would O O
seek O O
ID O O
input O O
to O O
the O O
end. O O
Wound O O
care O O
per O O
vascular O O
with O O
plans O O
for O O
D/C O O
when O O
stable O O
and O O
return O O
for O O
closure O O
in O O
the O O
future. O O
4) O O
ESRD: O O
Patient O O
HAD O O
dialysis O O
today O O
. O O
Recs O O
per O O
nephrology O O
3) O O
DM: O O
HgA1c O O
was O O
at O O
target. O O
Please O O
cover O O
as O O
needed O O
with O O
RISS O O
for O O
now. O O
5) O O
Competency: O O
certainly O O
not O O
able O O
to O O
make O O
informed O O
decisions O O
at O O
this O O
time. O O
Please O O
confirm O O
that O O
his O O
daughter O O
is O O
his O O
HCP. O O
Would O O
try O O
to O O
use O O
a O O
Chadian O O
interpreter O O
and O O
not O O
daughters O O
if O O
at O O
all O O
possible. O O
Thanks, O O
____________________________________Paul O O
Anthony O O
Jaramillo, O O
M.D.Pager O O
52666.Sheila O O
Strong O O
to O O
cover O O
for O O
Thursday O O
and O O
Friday O O

Record O O
date: O O
2069-03-26 O O
Problems O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Taking O O
meds O O
below, O O
HbA1C O O
not O O
incontrol O O
at O O
last O O
measure. O O
Hypertension B-HYPERTENSION O
On O O
meds O O
below, O O
feels O O
tired. O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
No O O
chest O O
pain. O O
Had O O
both O O
exercise O O
stress O O
test O O
and O O
dobutamine O O
echo O O
showing O O
borderline O O
inferior O O
thinning. O O
Seeing O O
Dr. O O
Ily O O
Light. O O
Had O O
episode O O
of O O
A O O
flutter O O
last O O
month O O
in O O
setting O O
of O O
chest O O
pain O O
and O O
snow O O
shovelling. O O
Easily O O
converted O O
in O O
hospital. O O
Now O O
on O O
Coumadin O O
for O O
another O O
2 O O
wks. O O
Atrial O O
flutter O O
: O O
Converted O O
to O O
NSR O O
See O O
above. O O
Hyperlipidemia B-HYPERLIPIDEMIA O
: O O
Syndrome O O
X O O
Low O O
HDL, O O
high O O
triglycerides, O O
abd O O
obesity, B-OBESE O
Type B-DIABETES O
2 I-DIABETES O
DM. I-DIABETES O
Now O O
starting O O
to O O
exercise O O
regularly O O
and O O
diet. O O
Medications O O
ALLOPURINOL O O
300MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
x O O
90 O O
day(s) O O
Potassium O O
Citrate O O
1020 O O
MG O O
PO O O
TID O O
PRN O O
kidney O O
stones O O
: O O
Takes O O
usually O O
for O O
4 O O
days O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC I-MEDICATION O
Acid) I-MEDICATION O
81MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Viagra O O
(SILDENAFIL) O O
100MG, O O
1 O O
Tablet(s) O O
PO O O
x1 O O
Zestril B-MEDICATION B-MEDICATION
(LISINOPRIL) I-MEDICATION O
20MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
x O O
90 O O
day(s) O O
Micronase B-MEDICATION O
(GLYBURIDE) I-MEDICATION O
5MG, O O
1.5 O O
Tablet(s) O O
PO O O
BID O O
x O O
30 O O
day(s) O O
Glucophage B-MEDICATION B-MEDICATION
(METFORMIN) B-MEDICATION O
1000MG, O O
1 O O
Tablet(s) O O
PO O O
BID O O
x O O
90 O O
day(s) O O
ATENOLOL B-MEDICATION B-MEDICATION
50MG, O O
1.5 O O
Tablet(s) O O
PO O O
QD O O
x O O
90 O O
day(s) O O
Coumadin O O
(WARFARIN O O
Sodium) O O
5MG, O O
1.5 O O
Tablet(s) O O
PO O O
QPM O O
x O O
30 O O
day(s) O O
Lopid B-MEDICATION O
(GEMFIBROZIL) I-MEDICATION O
600MG, O O
1 O O
Tablet(s) O O
PO O O
BID O O
x O O
30 O O
day(s) O O
Narrative O O
History O O
Here O O
for O O
monitoring O O
of O O
above. O O
Got O O
event O O
monitor O O
from O O
Ilya O O
Light O O
for O O
occ O O
palps. O O
Past O O
Medical O O
History O O
L O O
Bell's O O
2064 O O
saw O O
Dr. O O
Quint, O O
L O O
eye O O
still O O
tears. O O
Umbilical O O
hernia. O O
Saw O O
Dr. O O
Umstead, O O
said O O
to O O
just O O
watch O O
it. O O
Records O O
received O O
from O O
Dr. O O
Alcala O O
via O O
Dr. O O
Adams. O O
2064 O O
value O O
for O O
HbA1C B-DIABETES O
was I-DIABETES O
9.1, I-DIABETES O
BP B-HYPERTENSION O
10/31/64 I-HYPERTENSION O
was I-HYPERTENSION O
190/105. I-HYPERTENSION O
EKG O O
WNL. O O
Records O O
from O O
Dr. O O
Quint O O
and O O
Dr. O O
Faust O O
re O O
Bell's O O
and O O
stones. O O
On O O
Urocit O O
and O O
allopurinol. O O
Health O O
Maintenance O O
Cholesterol O O
02/23/2069 O O
182 O O
DESIRABLE: O O
&lt;200 O O
Rectal O O
exam O O
03/22/2068 O O
Prostate O O
normal O O
size O O
and O O
consistency. O O
No O O
masses O O
or O O
tenderness. O O
M-alb/creat O O
ratio O O
03/25/2068 O O
120.5 O O
PERFORMED O O
AT O O
HOLLY O O
MANOR O O
NURSING O O
HOME O O
(NOTE)Reference O O
Range: O O
&lt;30.0 O O
mg/g O O
creatinine O O
EKG O O
03/02/2069 O O
RBBB, O O
otherwise O O
normal O O
UA-Protein O O
04/16/2066 O O
NEGATIVE O O
Ophthal O O
Exam O O
07/03/2067 O O
Done O O
elsewhere O O
HBA1C B-DIABETES O
03/23/2068 I-DIABETES O
10.30 I-DIABETES O
Microalbumin O O
03/25/2068 O O
20.0 O O
PERFORMED O O
AT O O
HOLLY O O
MANOR O O
NURSING O O
HOME O O
(NOTE)Reference O O
Range: O O
Random O O
urine O O
&lt;2.0 O O
mg/dL O O
24 O O
hr O O
urine O O
&lt;300 O O
mg/24 O O
hr O O
Allergies O O
Penicillins O O
- O O
Rash O O
: O O
2061. O O
Social O O
History O O
Married. O O
Lives O O
with O O
wife. O O
Sexually O O
active, O O
usually O O
needs O O
Viagra. O O
Communications O O
senior O O
manager, O O
marketing, O O
worked O O
for O O
Brinker O O
International, O O
now O O
Facebook. O O
Then O O
Twitter. O O
Now O O
about O O
to O O
start O O
job O O
as O O
securities O O
investment O O
dealer. O O
Review O O
of O O
Systems O O
General O O
- O O
Neg O O
Eyes O O
- O O
see O O
above O O
Ears O O
- O O
ext O O
ear O O
infs O O
from O O
swimming, O O
wears O O
wax O O
earplugs O O
Mouth O O
- O O
Neg O O
Heart O O
and O O
Lungs O O
- O O
Had O O
chest O O
pain, O O
stress O O
test O O
done O O
at O O
Delnor, O O
2067, O O
neg. O O
Occ O O
feels O O
skipped O O
beat. O O
Adm O O
in O O
Feb O O
2069 O O
for O O
A O O
flutter, O O
see O O
above. O O
GI O O
- O O
Neg O O
GU O O
- O O
impotence, O O
needs O O
Viagra. O O
Musc-skel O O
- O O
elbows O O
bother O O
him O O
at O O
times, O O
after O O
lifting. O O
Skin O O
- O O
legs O O
stasis O O
dermatitis, O O
has O O
cream O O
that O O
helps. O O
Steroid. O O
Neuro O O
- O O
Bell's O O
in O O
past. O O
Emotional O O
- O O
Neg O O
Endocrine O O
- O O
DM O O
Hematologic O O
- O O
Neg O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
130/70 O O
PULSE O O
80 O O
TEMPERATURE O O
97.8 O O
WEIGHT O O
263 O O
lb O O
Physical O O
Exam O O
Skin O O
- O O
stasis O O
dermatitis O O
changes, O O
tr O O
edema O O
both O O
lower O O
legs. O O
Neck O O
- O O
no O O
adenopathy, O O
thy O O
normal, O O
carotids O O
2+ O O
without O O
bruit. O O
JVP O O
&lt; O O
5 O O
cm. O O
Lungs O O
- O O
clear O O
to O O
P&A. O O
Heart O O
- O O
S1S2 O O
normal, O O
no O O
murmur, O O
rub, O O
gallop. O O
Abd O O
- O O
BS O O
normal. O O
No O O
LSKK, O O
masses, O O
hernias, O O
tenderness, O O
aneurysm. O O
Feet O O
- O O
no O O
sores. O O
Assessment O O
DM O O
- O O
not O O
well O O
controlled O O
in O O
past. O O
CAD O O
- O O
stable. O O
Atr O O
flutter O O
- O O
resolved. O O
PVCs. O O
Hchol. O O
Counseling O O
On O O
DM O O
care, O O
importance O O
of O O
controlling O O
blood O O
sugar, O O
wt O O
reduction, O O
need O O
for O O
regular O O
follow-up O O
to O O
work O O
on O O
controlling O O
above. O O
Plan O O
Ret O O
1 O O
mo. O O
PT/INR, O O
lipids, O O
AST, O O
HbA1C. O O
Continue O O
above O O
meds. O O

Record O O
date: O O
2070-02-14 O O
Patient O O
Name: O O
VERA,XANDER O O
N O O
[ O O
2152363(BMH) O O
] O O
Problems O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
On O O
meds O O
below. O O
Missed O O
earlier O O
appointment. O O
Last O O
fasting O O
sugar O O
was O O
140. O O
Hypertension B-HYPERTENSION O
On O O
meds O O
below, O O
no O O
side O O
effects. O O
Kidney O O
stone O O
: O O
Uric O O
acid O O
No O O
episodes O O
of O O
colic. O O
Has O O
small O O
stones O O
on O O
CT O O
one O O
year O O
ago. O O
Atrial O O
flutter O O
: O O
Converted O O
to O O
NSR O O
No O O
symptomatic O O
palpitations. O O
No O O
chest O O
pains. O O
Off O O
Coumadin. O O
Hyperlipidemia B-HYPERLIPIDEMIA O
: O O
Syndrome O O
X O O
Taking O O
statin O O
and O O
fibrate, O O
no O O
myalgias, O O
weakness, O O
abdominal O O
pain O O
or O O
anorexia. O O
Medications O O
Zestril B-MEDICATION B-MEDICATION
(LISINOPRIL) I-MEDICATION O
20MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
x O O
90 O O
day(s) O O
ALLOPURINOL O O
300MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
x O O
90 O O
day(s) O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC I-MEDICATION O
Acid) I-MEDICATION O
81MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Glucophage B-MEDICATION B-MEDICATION
(METFORMIN) I-MEDICATION O
1000MG, O O
1 O O
Tablet(s) O O
PO O O
BID O O
x O O
90 O O
day(s) O O
ATENOLOL B-MEDICATION B-MEDICATION
50MG, O O
1.5 O O
Tablet(s) O O
PO O O
QD O O
x O O
90 O O
day(s) O O
Lopid B-MEDICATION B-MEDICATION
(GEMFIBROZIL) I-MEDICATION O
600MG, O O
1 O O
Tablet(s) O O
PO O O
BID O O
x O O
90 O O
day(s) O O
GLYBURIDE B-MEDICATION B-MEDICATION
5MG, O O
2 O O
Tablet(s) O O
PO O O
BID O O
x O O
90 O O
day(s) O O
OMEPRAZOLE O O
20MG, O O
1 O O
Capsule(s) O O
PO O O
QD O O
x O O
90 O O
day(s) O O
Urocit-k O O
(POTASSIUM O O
Citrate) O O
10MEQ, O O
1 O O
Tablet(s) O O
PO O O
TID O O
x O O
30 O O
day(s) O O
PRN O O
kidney O O
stone O O
Pravachol B-MEDICATION B-MEDICATION
(PRAVASTATIN) I-MEDICATION O
20MG, O O
1 O O
Tablet(s) O O
PO O O
QHS O O
x O O
90 O O
day(s) O O
Valisone O O
0.1% O O
(BETAMETHASONE O O
Valerate O O
0.1%) O O
LOTION O O
TOP O O
BID O O
x O O
90 O O
day(s) O O
Avandia B-MEDICATION B-MEDICATION
(ROSIGLITAZONE) I-MEDICATION O
4MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
x O O
90 O O
day(s) O O
Tng O O
0.4 O O
Mg O O
(NITROGLYCERIN B-MEDICATION O
1/150 O O
(0.4 O O
Mg)) O O
1 O O
TAB O O
SL O O
x1 O O
x O O
90 O O
day(s) O O
PRN O O
chest O O
pain O O
Narrative O O
History O O
Has O O
seen O O
urologist O O
for O O
erectile O O
dysfunction O O
since O O
last O O
visit. O O
Is O O
taking O O
injections O O
for O O
impotence O O
now. O O
Past O O
Medical O O
History O O
L O O
Bell's O O
2064 O O
saw O O
Dr. O O
Quint, O O
L O O
eye O O
still O O
tears. O O
Umbilical O O
hernia. O O
Saw O O
Dr. O O
Umstead, O O
said O O
to O O
just O O
watch O O
it. O O
On O O
Urocit O O
K O O
and O O
allopurinol. O O
Takes O O
former O O
only O O
when O O
he O O
is O O
having O O
a O O
stone O O
passage O O
problem, O O
because O O
it O O
upsets O O
his O O
stomach. O O
CAD B-CAD O
found O O
in O O
May. O O
DM O O
recently O O
diagnosed. O O
Longstanding O O
Hchol O O
on O O
two O O
drugs O O
now. O O
HT, O O
good O O
control. O O
GERD, O O
controlled O O
on O O
omeprazole. O O
Stasis O O
dermatitis, O O
ankles. O O
T. O O
pedis O O
with O O
nail O O
involvement. O O
Health O O
Maintenance O O
EKG O O
03/02/2069 O O
RBBB, O O
otherwise O O
normal O O
Ophthal O O
Exam O O
04/16/2069 O O
No O O
diabetic O O
complications O O
Done O O
elsewhere O O
Colonoscopy O O
06/20/2068 O O
Normal O O
Cholesterol O O
07/17/2069 O O
164 O O
M-alb/creat O O
ratio O O
03/25/2068 O O
120.5 O O
PERFORMED O O
AT O O
HOLLY O O
MANOR O O
NURSING O O
HOME O O
(NOTE)Reference O O
Range: O O
&lt;30.0 O O
mg/g O O
creatinine O O
UA-Protein O O
04/16/2066 O O
NEGATIVE O O
HBA1C B-DIABETES O
07/18/2069 I-DIABETES O
9.50 I-DIABETES O
Triglycerides O O
07/17/2069 O O
142 O O
Cholesterol-LDL B-HYPERLIPIDEMIA O
07/17/2069 I-HYPERLIPIDEMIA O
104 I-HYPERLIPIDEMIA O
Microalbumin O O
03/25/2068 O O
20.0 O O
PERFORMED O O
AT O O
HOLLY O O
MANOR O O
NURSING O O
HOME O O
(NOTE)Reference O O
Range: O O
Random O O
urine O O
&lt;2.0 O O
mg/dL O O
24 O O
hr O O
urine O O
&lt;300 O O
mg/24 O O
hr O O
Hct O O
(Hematocrit) O O
02/22/2069 O O
40.2 O O
Cholesterol-HDL O O
07/17/2069 O O
32 O O
Hgb O O
(Hemoglobin) O O
02/22/2069 O O
13.8 O O
Rectal O O
exam O O
03/22/2068 O O
Prostate O O
normal O O
size O O
and O O
consistency. O O
No O O
masses O O
or O O
tenderness. O O
Review O O
of O O
Systems O O
General O O
-obese, B-OBESE O
has O O
not O O
been O O
able O O
to O O
lose O O
weight. O O
Heart O O
and O O
Lungs O O
-see O O
above. O O
GI O O
-heartburn, O O
improved O O
with O O
omeprazole. O O
GU O O
-erectile O O
dysfunction, O O
history O O
of O O
kidney O O
stones, O O
none O O
recently. O O
Skin O O
-feet O O
much O O
improved, O O
seen O O
podiatrist. O O
Neuro O O
- O O
Neg O O
Endocrine O O
- O O
AODM O O
Habits O O
Tob B-SMOKER O
- I-SMOKER O
Alc O O
- O O
Exercise O O
- O O
Vital O O
Signs O O
BLOOD B-HYPERTENSION O
PRESSURE I-HYPERTENSION O
140/80 B-HYPERTENSION O
TEMPERATURE O O
97.5 O O
F O O
PULSE O O
66 O O
Physical O O
Exam O O
Lungs O O
- O O
clear O O
to O O
P&A. O O
Heart O O
- O O
S1S2 O O
normal, O O
no O O
murmur, O O
rub, O O
gallop. O O
Abd O O
- O O
BS O O
normal. O O
No O O
LSKK, O O
masses, O O
hernias, O O
tenderness, O O
aneurysm. O O
Rectal O O
- O O
pros O O
1+, O O
normal O O
consistency, O O
no O O
masses O O
or O O
Feet O O
- O O
no O O
edema O O
or O O
sores. O O
Position, O O
light O O
touch O O
intact. O O
Assessment O O
DM, O O
fair O O
control. O O
Hchol. O O
HT. O O
GERD. O O
Erectile O O
dysfunction. O O
Kidney O O
stone. O O
A O O
flutter, O O
no O O
symptomatic O O
recurrences O O
since O O
August. O O
Plan O O
Fasting O O
lipids, O O
CK, O O
AST, O O
HbA1C, O O
chem O O
8, O O
Ret O O
3 O O
mos. O O
Continue O O
above O O
meds. O O
All O O
meds O O
renewed. O O
______________________________ O O
Xavier O O
Tristan O O
Huerta, O O
M.D. O O

Record O O
date: O O
2071-01-30 O O
CARDIOLOGY O O
BETHESDA O O
MEMORIAL O O
HOSPITAL O O
Xavier O O
T O O
Huerta O O
M.D. O O
BMH O O
Health O O
Associates O O
583 O O
Appaloosa O O
Place O O
CHESTERTOWN, O O
NY O O
91987 O O
Dear O O
Dr. O O
Huerta: O O
Reason O O
for O O
visit: O O
Today, O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
Irving O O
Vera O O
in O O
Cardiology O O
clinic. O O
He O O
is O O
a O O
former O O
patient O O
of O O
Dr. O O
Ilya O O
Light. O O
He O O
is O O
a O O
59-year-old O O
man O O
with O O
diabetes B-DIABETES O
type I-DIABETES O
2, I-DIABETES O
hypertension, B-HYPERTENSION B-HYPERTENSION
hypercholesterolemia, B-HYPERLIPIDEMIA B-HYPERTENSION
and O O
mild B-CAD O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
who O O
had O O
a O O
brief O O
episode O O
of O O
atrial O O
flutter O O
in O O
2069. O O
He O O
presented O O
in O O
2069 O O
with O O
chest O O
pain O O
and O O
rapid O O
heart O O
rate O O
following O O
snow O O
shoveling. O O
He O O
was O O
found O O
to O O
be O O
in O O
atrial O O
flutter O O
with O O
a O O
rapid O O
ventricular O O
response. O O
He O O
was O O
cardioverted O O
two O O
days O O
later O O
and O O
has O O
remained O O
in O O
sinus O O
rhythm O O
since O O
then. O O
Echocardiogram O O
performed O O
on O O
02/22/2069 O O
showed O O
normal O O
ejection O O
fraction O O
of O O
72%, O O
borderline O O
left O O
atrium O O
at O O
43 O O
mm, O O
and O O
no O O
significant O O
valvular O O
abnormalities. O O
Stress O O
test O O
performed O O
on O O
03/16/2069 O O
showed O O
5 O O
minutes O O
of O O
exercise, O O
7 O O
METS, O O
and O O
a O O
peak O O
double O O
product O O
of O O
22, O O
000. O O
He O O
had O O
no O O
EKG O O
changes, O O
and O O
a O O
small B-CAD O
mild I-CAD O
posterobasilar I-CAD O
defect I-CAD O
suggestive I-CAD O
of I-CAD O
a I-CAD O
very I-CAD O
limited I-CAD O
area I-CAD O
of I-CAD O
mild I-CAD O
ischemia. I-CAD O
The O O
patient O O
has O O
been O O
managed O O
medically O O
since O O
then. O O
He O O
has O O
used O O
an O O
event O O
monitor O O
and O O
since O O
then O O
has O O
not O O
had O O
any O O
subsequent O O
episodes O O
of O O
atrial O O
flutter O O
or O O
fibrillation. O O
The O O
patient O O
has O O
been O O
doing O O
well O O
over O O
the O O
past O O
several O O
months. O O
Currently, O O
he O O
exercises O O
once O O
or O O
twice O O
a O O
week O O
by O O
swimming O O
30 O O
minutes O O
in O O
a O O
pool. O O
A O O
few O O
months O O
ago, O O
he O O
was O O
exercising O O
almost O O
everyday. O O
His O O
weight O O
has O O
been O O
up O O
and O O
down. O O
He O O
does O O
not O O
complain O O
of O O
any O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
or O O
other O O
symptoms. O O
Occasionally O O
in O O
the O O
morning O O
when O O
he O O
takes O O
his O O
pulse, O O
he O O
notices O O
a O O
skipped O O
beat. O O
I O O
have O O
reassured O O
him O O
that O O
this O O
is O O
not O O
a O O
cause O O
for O O
concern. O O
Past O O
medical O O
history: O O
Diabetes, O O
hypertension, O O
hypercholesterolemia, O B-MEDICATION
atrial O O
flutter O O
as O O
above, O O
coronary O O
artery O O
disease O O
as O O
above, O O
Bell's O O
palsy O O
with O O
residual O O
left O O
eye O O
tearing, O O
kidney O O
stones, O O
and O O
glaucoma. O O
Current O O
Medications: O O
lisinopril B-MEDICATION B-MEDICATION
20 O O
mg O O
QD O O
Glucophage B-MEDICATION B-MEDICATION
1 O O
g O O
BID O O
glyburide B-MEDICATION B-MEDICATION
10 O O
mg O O
BID O O
atenolol B-MEDICATION B-MEDICATION
50 O O
mg O O
QAM; O O
Dir: O O
and O O
25 O O
mg O O
QPM O O
Lopid B-MEDICATION B-MEDICATION
600 O O
mg O O
BID O O
allopurinol O O
300 O O
mg O O
QD O O
omeprazole O O
20 O O
mg O O
QD O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
QD O O
Pravachol B-MEDICATION B-MEDICATION
80 O O
mg O O
QD O O
Avandia B-MEDICATION B-MEDICATION
8 O O
mg O O
QD O O
Allergies: O O
Penicillin O O
allergy O O
Penicillin O O
and O O
erythromycin, O O
causing O O
rash. O O
Family O O
history: O O
Not O O
significant O O
for O O
coronary O O
artery O O
disease. O O
Social O O
history: O O
Former B-SMOKER O
tobacco I-SMOKER O
user, I-SMOKER O
works O O
part O O
time O O
in O O
securities. O O
Review O O
of O O
systems: O O
As O O
above, O O
otherwise O O
negative. O O
Physical O O
examination: O O
-Pulse: O O
60 O O
-General: O O
Obese B-OBESE O
talkative O O
man O O
in O O
no O O
distress O O
-Chest: O O
Lungs O O
are O O
clear O O
bilaterally O O
-Cardiac: O O
JVP O O
is O O
7 O O
cm O O
with O O
normal O O
waveform. O O
PMI O O
is O O
discrete O O
and O O
nondisplaced. O O
Regular O O
rate O O
and O O
rhythm O O
with O O
normal O O
S1 O O
and O O
S2. O O
Soft O O
2/6 O O
holosystolic O O
murmur O O
heard O O
at O O
the O O
lower O O
left O O
sternal O O
border O O
-Abdomen: O O
Obese O O
and O O
tender O O
-Extremities: O O
Have O O
trace O O
edema O O
with O O
chronic O O
venous O O
stasis O O
changes O O
Selected O O
recent O O
labs: O O
On O O
06/18/2070, O O
total O O
cholesterol O O
168, O O
triglycerides O O
104, O O
HDL O O
38, O O
and O O
LDL B-HYPERLIPIDEMIA O
109. I-HYPERLIPIDEMIA O
His O O
Pravachol O B-MEDICATION
dose O O
has O O
been O O
increased O O
since O O
this O O
time. O O
Assessment O O
and O O
plan: O O
This O O
is O O
a O O
59-year-old O O
man O O
with O O
metabolic O O
syndrome, O O
diabetes O O
type O O
2, O O
hyperlipidemia, O B-HYPERTENSION
hypertension, O B-HYPERTENSION
obesity, O O
and O O
mild O O
coronary O O
artery O O
disease O O
that O O
has O O
been O O
medically O O
managed. O O
He O O
is O O
doing O O
well. O O
He O O
had O O
an O O
episode O O
of O O
atrial O O
flutter O O
for O O
two O O
days O O
in O O
2069 O O
but O O
has O O
not O O
had O O
any O O
repeat O O
episodes. O O
He O O
is O O
currently O O
not O O
anticoagulated. O O
Given O O
new O O
recommendations, O O
his O O
target O O
LDL O O
should O O
be O O
less O O
than O O
70. O O
He O O
is O O
due O O
for O O
a O O
fasting O O
lipid O O
profile O O
in O O
one O O
week. O O
If O O
his O O
LDL O O
is O O
not O O
below O O
70, O O
then O O
he O O
should O O
either O O
be O O
switched O O
to O O
Lipitor O B-MEDICATION
80 O O
mg O O
day O O
or O O
Zetia O O
should O O
be O O
added O O
to O O
his O O
present O O
regimen. O O
He O O
is O O
slightly O O
hypertensive O O
today O O
with O O
a O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
of I-HYPERTENSION O
140/75. I-HYPERTENSION O
The O O
patient O O
will O O
check O O
his O O
blood O O
pressure O O
at O O
home O O
since O O
he O O
is O O
somewhat O O
anxious O O
male. O O
In O O
the O O
office O O
today, O O
if O O
his O O
blood O O
pressure O O
remains O O
elevated, O O
then O O
I O O
will O O
increase O O
his O O
lisinopril O B-MEDICATION
to O O
30 O O
mg O O
a O O
day. O O
Otherwise, O O
he O O
is O O
doing O O
very O O
well O O
without O O
any O O
cardiac O O
symptoms. O O
Changes O O
to O O
Medications O O
this O O
visit O O
lisinopril O B-MEDICATION
20 O O
mg O O
QD O O
Glucophage O B-MEDICATION
1 O O
g O O
BID O O
glyburide O B-MEDICATION
10 O O
mg O O
BID O O
atenolol O B-MEDICATION
50 O O
mg O O
QAM O O
and O O
25 O O
mg O O
QPM O O
Lopid O B-MEDICATION
600 O O
mg O O
BID O O
allopurinol O O
300 O O
mg O O
QD O O
omeprazole O O
20 O O
mg O O
QD O O
aspirin O B-MEDICATION
81 O O
mg O O
QD O O
Pravachol O B-MEDICATION
80 O O
mg O O
QD O O
Avandia O B-MEDICATION
8 O O
mg O O
QD O O
Thank O O
you O O
for O O
allowing O O
me O O
to O O
participate O O
in O O
the O O
care O O
of O O
this O O
patient. O O
If O O
you O O
have O O
any O O
questions, O O
please O O
feel O O
free O O
to O O
contact O O
me. O O
Steven O O
Vega O O
MD O O
Signed O O
electronically O O
by O O
Steven O O
Vega O O
MD O O
on O O
Feb O O
3, O O
2071 O O

Record O O
date: O O
2072-11-16 O O
Internal O O
Medicine O O
JAR O O
ADMIT O O
NOTE O O
Name: O O
Xander O O
Vera O O
MR O O
#: O O
2152363 O O
Date O O
of O O
admission: O O
11/16/2072 O O
Attending: O O
Hodges O O
Cards O O
Fellow: O O
Steven O O
Vega O O
PCP: O O
Dr. O O
Xavier O O
Huerta O O
Code: O O
FULL O O
CC: O O
SOB, O O
LE O O
edema O O
HPI: O O
60M O O
with O O
obesity, B-OBESE O
DM2, B-DIABETES O
HTN, B-HYPERTENSION O
hyperlipidemia, B-HYPERLIPIDEMIA O
and O O
stress B-CAD O
test I-CAD O
in I-CAD O
2069 I-CAD O
with I-CAD O
mild I-CAD O
posterobasal I-CAD O
reversible I-CAD O
defect I-CAD O
managed O O
medically O O
sent O O
to O O
ED O O
by O O
PCP O O
for O O
LE O O
edema O O
and O O
SOB. O O
The O O
patient O O
reports O O
several O O
days O O
of O O
increasing O O
LLE O O
swelling O O
and O O
erythema. O O
He O O
presented O O
to O O
his O O
PCP O O
with O O
a O O
chief O O
complaint O O
of O O
SOB, O O
although O O
he O O
currently O O
denies O O
that. O O
He O O
has O O
also O O
apparently O O
had O O
intermittent B-CAD O
left-sided I-CAD O
chest B-CAD O
pressure I-CAD O
x O O
1 O O
day, O O
which O O
he O O
also O O
denies. O O
+fevers O O
at O O
home O O
to O O
101. O O
No O O
cough. O O
No O O
nausea/vomiting/diarrhea. O O
No O O
abdominal O O
pain. O O
No O O
urinary O O
symptoms. O O
In O O
ED: O O
Febrile O O
to O O
103. O O
HR O O
in O O
90s. O O
BP B-HYPERTENSION O
91-175/46-81, I-HYPERTENSION O
R20s, O O
95-100% O O
RA. O O
EKG O O
with O O
baseline O O
RBBB. O O
Tn+ O O
at O O
0.44. O O
LENIs O O
negative O O
for O O
DVT. O O
CT O O
PE O O
negative O O
for O O
PE/DVT. O O
Started O O
on O O
IV O O
heparin. O O
Vanco O O
and O O
levo. O O
Mucomyst O O
x1 O O
dose. O O
ASA O B-MEDICATION
325. O O
Lopressor B-MEDICATION B-MEDICATION
25po. O O
NSx O O
1L. O O
PMH: O O
CAD B-CAD B-MEDICATION
--3/69 B-CAD O
ETT I-CAD O
mibi I-CAD O
METS I-CAD O
7, I-CAD O
ECG I-CAD O
non-dx I-CAD O
due I-CAD O
to I-CAD O
submax I-CAD O
HR, I-CAD O
small, I-CAD O
mild I-CAD O
posterobasal I-CAD O
defect I-CAD O
which I-CAD O
improves I-CAD O
at I-CAD O
rest I-CAD O
suggestive I-CAD O
for I-CAD O
a I-CAD O
very I-CAD O
limited I-CAD O
area I-CAD O
of I-CAD O
mild I-CAD O
ischemia I-CAD O
--2/69 O O
TTE O O
EF O O
72%, O O
no O O
WMA, O O
no O O
valvular O O
abnormalities, O O
RVSP O O
27 O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2: I-DIABETES O
7/72 O O
HbA1c O O
6.10, O O
+microalbuminuria, O O
mild O O
retinopathy O O
Hypertension B-HYPERTENSION O
Hyperlipidemia: O O
8/72 O O
chol O O
169, O O
Tgl O O
67, O O
hdl O O
37, O O
ldl B-HYPERLIPIDEMIA O
119 I-HYPERLIPIDEMIA O
Obesity O O
OSA- O O
recently O O
started O O
on O O
home O O
CPAP O O
at O O
12cmH20 O O
H/o O O
atrial O O
flutter O O
sp O O
DCCV O O
2069, O O
no O O
anticoagulation O O
RBBB O O
Rectal O O
bleeding: O O
felt O O
to O O
be O O
due O O
to O O
hemorrhoids O O
Anemia: O O
colonoscopy O O
2068 O O
wnl; O O
6/72 O O
Fe O O
47, O O
TIBC O O
464, O O
10%sat, O O
ferritin O O
38, O O
b12 O O
nl; O O
7/72 O O
bilis O O
and O O
SPEP O O
normal; O O
8/72 O O
epo O O
elevated O O
Nephrolithiasis: O O
uric O O
acid O O
Glaucoma O O
Bells O O
palsy O O
Stasis O O
dermatitis O O
Tinea O O
pedis O O
Medications O O
on O O
admission O O
(confirmed O O
with O O
patient): O O
Allopurinol O O
300MG O O
PO O O
QD O O
Asa B-MEDICATION B-MEDICATION
81MG O O
PO O O
QD O O
Atenolol B-MEDICATION B-MEDICATION
75MG O O
PO O O
QD O O
Avandia B-MEDICATION B-MEDICATION
(ROSIGLITAZONE) I-MEDICATION O
8MG O O
TABLET O O
PO O O
QD O O
Clobetasol O O
PROPIONATE O O
0.05% O O
0.05% O O
CREAM(GM) O O
TOP O O
BID O O
Glucophage B-MEDICATION B-MEDICATION
(METFORMIN) B-MEDICATION O
1000MG O O
PO O O
BID O O
Glyburide B-MEDICATION B-MEDICATION
10MG O O
TABLET O O
PO O O
BID O O
Lopid B-MEDICATION O
(GEMFIBROZIL) I-MEDICATION O
600MG O O
TABLET O O
PO O O
BID O O
Multivitamin O O
W/IRON O O
1 O O
TAB O O
PO O O
QD O O
Omeprazole O O
20MG O O
CAPSULE O O
CR O O
PO O O
QD O O
Vytorin B-MEDICATION O
(80 I-MEDICATION O
simvastatin/10 B-MEDICATION B-MEDICATION
zetia) I-MEDICATION O
PO O O
QD O O
Tng O O
0.4 O O
MG O O
(NITROGLYCERIN B-MEDICATION O
1/150 O O
(0.4 O O
MG)) O O
1 O O
TAB O O
SL O O
x1 O O
PRN O O
chest O O
pain O O
Urocit-k O O
(POTASSIUM O O
CITRATE) O O
10MEQ O O
TABLET O O
CR O O
PO O O
TID O O
PRN O O
kidney O O
stone O O
Valisone O O
0.1% O O
(BETAMETHASONE O O
VALERATE O O
0.1%) O O
LOTION O O
TOP O O
BID O O
Vitamin O O
B12 O O
(CYANOCOBALAMIN) O O
1000 O O
MCG O O
PO O O
QD O O
Zestril B-MEDICATION B-MEDICATION
(LISINOPRIL) I-MEDICATION O
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
ALL: O O
penicillins, O O
erythromycins, O O
tape O O
rash O O
SH: O O
Married O O
with O O
5 O O
adult O O
children. O O
Works O O
in O O
communications. O O
Denies B-SMOKER O
tobacco/etoh/illicits. I-SMOKER O
FH: O O
Father O O
with O O
HTN, O O
arrhythmia. O O
Mother O O
with O O
DM, O O
CAD. O O
Sister O O
and O O
daugther O O
w/ITP. O O
Physical O O
Exam: O O
V: O O
T O O
99.2, O O
P72, O O
R18, O O
112/54, O O
98% O O
4L O O
Gen: O O
lying O O
with O O
eyes O O
closed O O
HEENT: O O
PERRL, O O
EOMI, O O
OP O O
clear, O O
thick O O
neck O O
Neck: O O
Supple, O O
no O O
thyromegaly, O O
no O O
carotid O O
bruits, O O
JVP O O
8cm O O
Nodes: O O
No O O
cervical O O
or O O
supraclavicular O O
LAN O O
Cor: O O
RRR, O O
nl O O
S1, O O
S2. O O
No O O
m/r/g. O O
Distant O O
heart O O
sounds O O
Chest: O O
CTAB O O
Abdomen: O O
S/NT/ND, O O
+BS. O O
No O O
HSM O O
Ext: O O
marked O O
LLE O O
erythema O O
with O O
warmth, O O
2+ O O
pitting O O
edema; O O
2+ O O
pedal O O
pulses O O
bilat; O O
chronic O O
venous O O
stasis O O
Neuro: O O
AAOx3, O O
CNII-XII O O
intact, O O
muscle O O
strength/sensation O O
intact O O
Labs O O
and O O
Studies: O O
Na O O
137, O O
K O O
3.7, O O
Cl O O
107, O O
CO2 O O
23.8, O O
BUN O O
27, O O
Cr O O
1.5 O O
(baseline O O
1.3-1.4), O O
glu O O
85 O O
WBC O O
15.2 O O
w/ O O
96%polys, O O
Hct O O
30.6 O O
(baseline O O
33), O O
MCV O O
82, O O
RDW O O
15.8, O O
Plt O O
229 O O
CK-MB, O O
Tn-I O O
POSITIVE O O
at O O
kiosk O O
#1 O O
CK O O
347, O O
CK-MB O O
11.5, O O
CKMBRI O O
3.3, O O
Tn-T O O
0.44 O O
#2 O O
CK O O
663, O O
CK-MB O O
15.7, O O
CKMBRI O O
2.4, O O
Tn-T O O
1.07 O O
INR O O
1.4, O O
PTT O O
32.9 O O
CXR: O O
2 O O
views, O O
no O O
pneumonia O O
or O O
CHF O O
LENIs: O O
no O O
DVT O O
bilaterally O O
PECT: O O
negative O O
for O O
PE/DVT O O
UA: O O
SG O O
&gt;1.030, O O
2+blood, O O
3+protein, O O
nit O O
neg, O O
0-5 O O
RBC, O O
3-5 O O
WBC, O O
few O O
bact O O
Blood O O
cultures: O O
gram O O
+cocci O O
in O O
pairs O O
and O O
chains O O
2/2 O O
bottles O O
EKG: O O
NSR O O
at O O
74bpm, O O
baseline O O
RBBB, O O
no O O
ischemic O O
changes O O
A/P: O O
60 O O
yo O O
man O O
with O O
metabolic O O
syndrome O O
presents O O
with O O
LLE O O
edema O O
and O O
SOB O O
with O O
+troponin. O O
Initially O O
concerning O O
for O O
PE O O
but O O
ruled O O
out O O
with O O
LENIs/CT O O
scan. O O
He O O
does O O
have O O
a O O
severe O O
LLE O O
cellulitis O O
now O O
with O O
bacteremia O O
likely O O
due O O
to O O
strep. O O
His O O
cardiac O O
enzymes O O
continue O O
to O O
increase O O
suggesting O O
ongoing O O
myocardial O O
damage O O
either O O
from O O
silent O O
cardiac O O
ischemia O O
or O O
demand O O
from O O
fever/tachycardia. O O
Could O O
also O O
consider O O
endomyocarditis O O
secondary O O
to O O
bactermia. O O
ISCHEMIA O O
-cont O O
ASA, O O
BB, O O
heparin, O O
statin O O
-plan O O
for O O
cardiac O O
cath O O
to O O
r/o O O
flow-limiting O O
CAD, O O
although O O
likely O O
delayed O O
due O O
to O O
bactermia O O
-check O O
TTE O O
r/o O O
endocarditis O O
-cont O O
to O O
cycle O O
cardiac O O
enzymes O O
-follow O O
EKGs O O
BACTEREMIA O O
-Likely O O
seeded O O
blood O O
stream O O
from O O
cellulitis O O
due O O
to O O
strep, O O
must O O
also O O
consider O O
enterococcus O O
-Minimal O O
response O O
to O O
vanco O O
overnight O O
-gentamicin O O
x O O
1 O O
dose O O
to O O
cover O O
anaerobes/GN O O
-consider O O
VRE, O O
?source O O
-surveillance O O
cultures O O
-TTE O O
as O O
above O O
DM O O
-hold O O
oral O O
hypoglycemics O O
for O O
now O O
-RISS O O
coverage O O
RENAL O O
INSUFFICIENCY O O
-creatinine O O
mildly O O
above O O
baseline O O
-high O O
risk O O
for O O
contrast O O
nephropathy O O
given O O
DM O O
and O O
underlying O O
renal O O
insufficiency O O
-continue O O
mucomyst O O
and O O
bicarb, O O
especially O O
with O O
upcoming O O
cath O O
-follow O O
renal O O
function O O
NUTRITION O O
-cardiac, O O
diabetic O O
diet O O
PPX O O
-nexium, O O
anticoagulation O O
FULL O O
CODE O O
___________________________________________________________ O O
Edan O O
I. O O
Frederick, O O
MD O O
Pager O O
00212 O O
PGY-2 O O
Medicine O O

Record O O
date: O O
2073-02-07 O O
Internal O O
Medicine O O
JAR O O
Admit O O
Note O O
Pt: O O
Xander O O
Vera O O
MR#: O O
2152363 O O
Date O O
of O O
Admission: O O
2/7/73 O O
Attending: O O
Alton O O
Uher O O
PCP: O O
Richard O O
Huerta O O
Contact: O O
Molly O O
Vera O O
(Wife) O O
371-514-1494 O O
Code: O O
Full O O
Code O O
CC/RFA: O O
Pt O O
is O O
a O O
61-year-old O O
man O O
w/ O O
CAD, B-CAD O
DM, B-DIABETES O
HTN B-HYPERTENSION O
hypercholesterolemia B-HYPERLIPIDEMIA B-MEDICATION
and O O
recurrent O O
atrial O O
flutter O O
admitted O O
for O O
atrial O O
flutter O O
ablation. O O
HPI: O O
Pt O O
s O O
cardiac O O
hx O O
begins O O
in O O
2069 O O
when O O
he O O
presented O O
with O O
chest O O
pain O O
and O O
palpitations O O
while O O
shoveling O O
snow O O
and O O
was O O
found O O
to O O
be O O
in O O
atrial O O
flutter. O O
Pt O O
was O O
subsequently O O
cardioverted O O
to O O
NSR. O O
Pt O O
did O O
well O O
post O O
cardioversion. O O
He O O
was O O
suffered O O
NSTEMI B-CAD O
in I-CAD O
11/72 I-CAD O
in O O
the O O
setting O O
of O O
bactermia O O
and O O
Streptococcal O O
cellulitis. O O
Coronary O O
angiography O O
showed O O
diffuse O O
non-critical O O
disease; O O
decision O O
was O O
made O O
to O O
manage O O
CAD O O
medically. O O
Pt O O
was O O
found O O
to O O
be O O
in O O
atrial O O
flutter O O
on O O
follow O O
up O O
visit O O
with O O
cardiology. O O
He O O
was O O
referred O O
to O O
Dr. O O
Uher O O
in O O
appx O O
two O O
weeks O O
prior O O
to O O
admission, O O
who O O
recommended O O
radiofrequency O O
ablation O O
of O O
atrial O O
flutter. O O
Pt O O
underwent O O
radiofrequency O O
ablation O O
of O O
atrial O O
flutter O O
on O O
2/7/73. O O
The O O
procedure O O
was O O
was O O
successful O O
and O O
the O O
patient O O
was O O
transferred O O
to O O
the O O
floor O O
in O O
normal O O
sinus O O
rhythm. O O
He O O
has O O
no O O
complaints O O
and O O
specifically O O
reports O O
no O O
CP/SOB/palpitations. O O
PMH: O O
Coronary B-CAD B-CAD
artery I-CAD I-CAD
disease I-CAD O
Diabetes B-DIABETES O
Hypertension B-HYPERTENSION B-HYPERTENSION
Hypercholesterolemia B-HYPERLIPIDEMIA B-HYPERTENSION
Atrial O O
flutter. O O
Hx O O
Bell O O
s O O
palsy: O O
residual O O
left O O
eye O O
tearing O O
thought O O
to O O
be O O
due O O
to O O
aberrant O O
reinnervation O O
Kidney O O
stones O O
Glaucoma O O
Mild O O
renal O O
failure O O
Cardiac O O
Hx/Risk O O
Factors: O O
Echocardiogram O O
(11/72): O O
EF O O
71%; O O
left O O
ventricular O O
function O O
normal O O
with O O
symmetric O O
hypertrophy; O O
minimal O O
valvular O O
disease O O
Stress O O
Test O O
(3/69): O O
normal O O
exercise O O
capacity O O
(METS O O
achieved O O
= O O
7.); O O
ECG O O
response O O
to O O
stress O O
was O O
nondiagnostic O O
for O O
ischemia; O O
myocardial B-CAD O
perfusion I-CAD O
scan I-CAD O
show I-CAD O
a I-CAD O
small, I-CAD O
mild I-CAD O
posterobasal I-CAD O
defect I-CAD O
which I-CAD O
improves I-CAD O
at I-CAD O
rest I-CAD O
suggestive I-CAD O
for I-CAD O
a I-CAD O
very I-CAD O
limited I-CAD O
area I-CAD O
of I-CAD O
mild I-CAD O
ischemia I-CAD O
Cardiac B-CAD O
Catheterization I-CAD O
(11/72): I-CAD O
Diffuse I-CAD O
mild I-CAD O
to I-CAD O
moderate I-CAD O
CAD: I-CAD O
LMCA I-CAD O
- I-CAD O
20% I-CAD O
plaque; I-CAD O
LAD I-CAD O
- I-CAD O
diffuse I-CAD O
plaque; I-CAD O
LCx I-CAD O
- I-CAD O
Diffuse I-CAD O
plque I-CAD O
in I-CAD O
a I-CAD O
small I-CAD O
AV I-CAD O
groove I-CAD O
artery; I-CAD O
RCA I-CAD O
- I-CAD O
patent I-CAD O
proximally; I-CAD O
calcified; I-CAD O
Occluded I-CAD O
right I-CAD O
after I-CAD O
take I-CAD O
off I-CAD O
of I-CAD O
PDA, I-CAD O
distal I-CAD O
branches I-CAD O
fill I-CAD O
by I-CAD O
collats I-CAD O
from I-CAD O
L I-CAD O
Meds O O
on O O
Admission: O O
1. O O
Atenolol B-MEDICATION B-MEDICATION
PO O O
50 O O
MG O O
BID O O
2. O O
Lisinopril B-MEDICATION B-MEDICATION
PO O O
20 O O
MG O O
QD O O
3. O O
Metformin B-MEDICATION B-MEDICATION
PO O O
1000 O O
MG O O
BID O O
4. O O
Glimepiride B-MEDICATION B-MEDICATION
PO O O
1 O O
MG O O
QD O O
5. O O
Rosiglitazone B-MEDICATION O
(Avandia) I-MEDICATION O
PO O O
8 O O
MG O O
QD O O
6. O O
Gemfibrozil B-MEDICATION B-MEDICATION
(Lopid I-MEDICATION O
) I-MEDICATION O
PO O O
600 O O
MG O O
BID O O
7. O O
Ezetimibe B-MEDICATION B-MEDICATION
And I-MEDICATION O
Simvastatin B-MEDICATION B-MEDICATION
(Vytorin) B-MEDICATION O
po O O
10mg/80mg O O
qhs O O
8. O O
Allopurinol O O
300 O O
mg O O
QD O O
9. O O
Furosemide O O
PO O O
20 O O
MG O O
QOD O O
10. O O
Omeprazole O O
PO O O
20 O O
MG O O
QD O O
11. O O
Acetylsalicylic B-MEDICATION B-MEDICATION
Acid I-MEDICATION O
(Aspirin) I-MEDICATION O
PO O O
81 O O
MG O O
QD O O
12. O O
Cyanocobalamin O O
(Vitamin O O
B12 O O
) O O
PO O O
1000 O O
MCG O O
QD O O
13. O O
Coumadin O O
(Warfarin O O
Sodium) O O
PO O O
QPM O O
14. O O
Ferrous O O
Sulfate O O
PO O O
325 O O
MG O O
QD O O
All: O O
Clindamycin O O
rash O O
Azithromycin O O
rash O O
Erythromycin O O
rash O O
SHx: O O
Pt O O
lives O O
with O O
his O O
wife O O
in O O
Guatemala O O
City. O O
He O O
has O O
five O O
children. O O
Former O O
communications O O
manager; O O
currently O O
works O O
part O O
time O O
in O O
securities O O
Tob: B-SMOKER O
minimal I-SMOKER O
past I-SMOKER O
use I-SMOKER O
EtOH: O O
1 O O
drink/wk O O
Illicits: O O
none O O
FHx: O O
Mother: O O
CAD O O
s/p O O
CABG O O
ROS: O O
Ten O O
point O O
review O O
of O O
systems O O
negative O O
except O O
as O O
noted O O
in O O
HPI. O O
Exam: O O
Pt O O
is O O
a O O
well O O
appearing O O
middle-aged O O
man O O
lying O O
comfortably O O
in O O
bed O O
VS: O O
T- O O
97, O O
HR- O O
95, O O
BP- B-HYPERTENSION O
141/63, I-HYPERTENSION O
RR- O O
18 O O
HEENT: O O
MMM, O O
w/o O O
exudates. O O
Neck: O O
supple, O O
NT, O O
full O O
ROM O O
Chest: O O
CTAB; O O
no O O
crackles, O O
no O O
wheezes O O
CV: O O
RRR; O O
normal O O
S1S2, O O
no O O
m/r/g O O
appreciated; O O
JVP O O
7cm; O O
2+ O O
carotids O O
without O O
bruit; O O
2+ O O
radial O O
and O O
DP O O
pulses; O O
R O O
groin O O
dressing O O
w/ O O
small O O
amount O O
of O O
blood, O O
pulse O O
2+, O O
no O O
obvious O O
hematoma O O
Abd: O O
bruising O O
across O O
lower O O
abdomen, O O
NABS; O O
soft, O O
non-tender, O O
distended; O O
no O O
organomegaly O O
Nodes: O O
no O O
cervical O O
LAD O O
Extr: O O
1+ O O
bilateral O O
lower O O
extremity O O
edema O O
to O O
knees O O
with O O
chronic O O
erythematous O O
skin O O
changes, O O
non O O
tender O O
Neuro: O O
AOx3, O O
MS O O
nl, O O
CN O O
II O O
through O O
XII O O
intact, O O
motor O O
and O O
sensory O O
nonfocal O O
EKG: O O
NSR, O O
RBBB O O
________________________________________________________________________________ O O
I/P: O O
61M O O
w/ O O
CAD, O O
DM, O O
HTN, O O
hyperlipidemia B-HYPERLIPIDEMIA O
and O O
atrial O O
flutter O O
s/p O O
flutter O O
ablation O O
Atrial O O
flutter: O O
NSR O O
s/p O O
ablation O O
Groin O O
check O O
every O O
four O O
hours; O O
monitor O O
for O O
signs O O
of O O
tamponade; O O
anticoagulation O O
with O O
Heparin/Coumadin O O
bridge O O
Ischemia O O
Continue O O
ASA, O B-MEDICATION
Atenolol O B-MEDICATION
HTN O O
Continue O O
Lisinopril O B-MEDICATION
DM O O
Continue O O
Metformin, O B-MEDICATION
Avandia, O B-MEDICATION
Glimepiride O O
Hyperlipidemia O O
Continue O O
Gemfibrozil O O
Nutrition: O O
Cardiac O O
Diet O O
Therapists: O O
None O O
Access: O O
Peripheral O O
IV O O
fluids: O O
None O O
Telemetry: O O
Continuous O O
Prophylaxis: O O
Heparin O O
/Coumadin, O O
Nexium O O
Code O O
status: O O
Full O O
Code O O
_______________________________ O O
Andrew O O
Kendrick, O O
M.D. O O
(pager O O
99225) O O

Record O O
date: O O
2088-06-26 O O
Personal O O
Data O O
and O O
Overall O O
Health O O
66 O O
year O O
old O O
white O O
female O O
scheduled O O
for O O
surgery O O
on O O
July O O
1st. O O
Chief O O
Complaint O O
The O O
patient O O
is O O
scheduled O O
for O O
bone-muscle O O
graft O O
from O O
the O O
fibula O O
to O O
the O O
right O O
arm. O O
History O O
of O O
Present O O
Illness O O
The O O
patient O O
complains O O
of O O
a O O
nonunion O O
fx O O
of O O
the O O
right O O
arm O O
in O O
January O O
2087. O O
Past O O
Surgical O O
History O O
Prior O O
surgery O O
includes: O O
10 O O
procedurews O O
on O O
the O O
right O O
arm, O O
colectomy, O O
brain O O
tumor. O O
General O O
anesthesia O O
for O O
all O O
procedures O O
without O O
problems. O O
Family O O
History O O
There O O
in O O
no O O
family O O
history O O
of O O
adverse O O
reactions O O
to O O
general O O
anesthesia. O O
Past O O
Medical O O
History O O
Current O O
medical O O
problems O O
include: O O
diabetes B-DIABETES O
mellitus, I-DIABETES O
pituitary O O
adenoma, O O
CAD, B-CAD O
meningitis, O O
fibromyalgia, O O
severe O O
fatty O O
liver; O O
see O O
attached O O
problem O O
list. O O
Social O O
History O O
Smoking: B-SMOKER O
stopped I-SMOKER O
15 I-SMOKER O
years I-SMOKER O
ago. I-SMOKER O
Alcohol O O
use: O O
no O O
history O O
of O O
excessive O O
use O O
Substance O O
abuse: O O
none O O
Review O O
of O O
Systems O O
Medications: O O
Prilosec O O
Vasotec B-MEDICATION O
Serzone O O
Diflucan O O
Lipitor B-MEDICATION B-MEDICATION
Reglan O O
Bactrim O O
Synthroid O O
Permpro O O
Prednisone O O
2.5 O O
mg O O
QD O O
Valium O O
Lancet O O
Humulin B-MEDICATION B-MEDICATION
NPH I-MEDICATION O
20 O O
units O O
BID O O
Allergies: O O
none O O
Cardiovascular: O O
no O O
history O O
of O O
hypertension, O B-HYPERTENSION
no O O
MI; O O
hx O O
of O O
well O O
controlled O O
angina, O O
uses B-MEDICATION O
NTG B-MEDICATION O
rarely, I-MEDICATION O
very O O
little O O
exercise, O O
no O O
ankle O O
edema, O O
syncope. O O
Respiratory: O O
no O O
history O O
of O O
asthma O O
or O O
chronic O O
lung O O
disease; O O
denies O O
unusual O O
shortness O O
of O O
breath; O O
recent O O
productive O O
cough O O
following O O
URI, O O
started O O
on O O
Levaquin. O O
Neurological: O O
hx O O
of O O
pituitary O O
adenoma O O
with O O
hypophysectomy O O
in O O
2081, O O
no O O
stroke O O
Gastrointestinal: O O
no O O
history O O
of O O
PUD; O O
denies O O
reflux O O
but O O
is O O
on O O
Prilosec O O
Hepatobiliary: O O
history O O
of O O
liver O O
disease O O
with O O
fatty O O
liver, O O
LFTs O O
are O O
normal O O
at O O
this O O
time O O
except O O
for O O
hypoalbuminemia; O O
denies O O
jaundice O O
or O O
hepatitis O O
Renal/Genitourinary: O O
no O O
history O O
of O O
renal O O
failure; O O
denies O O
hematuria, O O
dysuria, O O
obstructive O O
uropathy O O
Musculoskeletal: O O
see O O
PI O O
Endocrine/metabolic: O O
history O O
of O O
diabetes O O
since O O
hypophysectomy O O
in O O
2081, O O
BS O O
~ O O
100-150; O O
endocrinopathy O O
with O O
pan O O
hypopit, O O
T4 O O
is O O
low. O O
Heme/Onc: O O
no O O
history O O
of O O
bleeding, O O
blood O O
diseases; O O
no O O
history O O
of O O
malignancy, O O
chemotherapy, O O
or O O
radiation O O
therapy O O
Psychiatric: O O
no O O
significant O O
psychiatric O O
problems O O
Exam O O
Ht: O O
68' O O
Wt: O O
224# O O
BP: O O
106/58 O O
P: O O
88 O O
SaO2: O O
98% O O
HEEN&T: O O
good O O
range O O
of O O
motion, O O
no O O
masses, O O
neck O O
veins O O
flat, O O
no O O
bruits O O
Airway: O O
Mallampatti O O
Class O O
I O O
or O O
II O O
Teeth: O O
dentures O O
Lungs: O O
coarse O O
rhonchi O O
bilaterally O O
Heart: O O
regular O O
rhythm, O O
no O O
murmurs, O O
S1=S2, O O
no O O
gallop O O
Abdomen: O O
not O O
examined O O
Extremities: O O
not O O
examined O O
Assessment O O
ASA O O
Physical O O
Status: O O
III O O
Well O O
prepared O O
for O O
surgery; O O
subacute O O
respiratory O O
infection O O
is O O
being O O
treated O O
with O O
Levaquin. O O
Consider O O
delaying O O
surgery O O
if O O
not O O
improved O O
by O O
time O O
of O O
surgery. O O
Plan O O
Proposed O O
Anesthetic: O O
general O O
anesthesia O O
Monitors: O O
standard O O
Pain O O
Management: O O
IVPCA O O
Autologous O O
blood: O O
none O O
Premedication: O O
none O O
Usual O O
Medications: O O
take O O
on O O
day O O
of O O
surgery O O
Medications O O
to O O
be O O
held O O
on O O
day O O
of O O
surgery: O O
none O O
Diabetic O O
medications: O O
10 O O
units O O
NPH O O
on O O
am O O
of O O
surgery O O
NSAIDS: O O
avoid O O
for O O
3 O O
days O O
before O O
surgery O O
Aspirin: O B-MEDICATION
avoid O O
for O O
7 O O
days O O
before O O
surgery O O
NPO: O O
after O O
midnight O O
Consider O O
steroid O O
supplement. O O
Consider O O
insulin O O
infusion. O O
External O O
Labs O O
She O O
has O O
had O O
a O O
stress O O
test. O O
I O O
will O O
try O O
to O O
get O O
results O O
from O O
PCP. O O
Attending O O
Anesthesiologist O O
Reassessment O O
Note O O
I O O
have O O
reviewed O O
this O O
preanesthetic O O
assessment O O
and O O
concur O O
with O O
the O O
assessment O O
and O O
recommended O O
plan O O
with O O
the O O
following O O
exceptions: O O
______________________________ O O
Hunt, O O
Xavier O O
I., O O
MD O O

Record O O
date: O O
2090-10-07 O O
NAME: O O
Olivo, O O
Kimberly O O
MRN: O O
3299811 O O
INITIAL O O
VISIT O O
This O O
is O O
a O O
69-year-old O O
white O O
female O O
coming O O
for O O
her O O
fu O O
visit. O O
The O O
patient O O
has O O
a O O
history O O
of O O
type B-DIABETES O
II I-DIABETES O
diabetes I-DIABETES O
mellitus I-DIABETES O
and O O
pituitary O O
adenoma O O
and O O
recently O O
was O O
hospitalized O O
at O O
American O O
Legion O O
Hospital O O
with O O
general O O
malaise O O
syndrome O O
and O O
back/chest O O
pain. O O
Initially O O
the O O
patient O O
was O O
seen O O
at O O
Neligh O O
Clinic O O
and O O
cardiac O O
ischemia O O
was O O
ruled O O
out. O O
She O O
was O O
found O O
to O O
have O O
a O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
of I-HYPERTENSION O
250 I-HYPERTENSION O
systolic I-HYPERTENSION O
at O O
Neligh O O
Clinic O O
associated O O
with O O
persistent O O
headaches. O O
She O O
was O O
transferred O O
to O O
American O O
Legion O O
Hospital O O
after O O
being O O
found O O
collapsed O O
on O O
the O O
floor O O
of O O
the O O
hospital O O
bathroom. O O
She O O
was O O
transferred O O
to O O
the O O
Intensive O O
Care O O
Unit O O
at O O
Neligh O O
Clinic O O
and O O
treated O O
for O O
tonic-clonic O O
convulsions O O
with O O
diazepam O O
and O O
lorazepam. O O
She O O
also O O
suffered O O
a O O
urinary O O
tract O O
infection O O
in O O
hospital, O O
treated O O
with O O
Cipro. O O
She O O
was O O
transferred O O
to O O
the O O
American O O
Legion O O
Hospital O O
on O O
October O O
02, O O
2089, O O
at O O
which O O
time O O
she O O
was O O
awake O O
but O O
unable O O
to O O
give O O
a O O
history. O O
On O O
admission O O
to O O
American O O
Legion O O
Hospital O O
she O O
had O O
a O O
blood O O
pressure O O
of O O
127/70, O O
pulse O O
was O O
80, O O
and O O
temperature O O
was O O
99.3. O O
She O O
had O O
a O O
myxedematous O O
face O O
and O O
was O O
obese. B-OBESE O
She O O
was O O
cardiovascularly O O
stable. O O
Neurologically, O O
she O O
was O O
able O O
to O O
move O O
all O O
four O O
extremities O O
with O O
good O O
strength O O
and O O
symmetrical O O
reflexes. O O
Cranial O O
nerves O O
intact. O O
Initially, O O
the O O
impression O O
was O O
that O O
patient O O
suffered O O
seizure O O
secondary O O
to O O
elevated O O
blood O O
pressure. O O
Most O O
likely, O O
she O O
suffered O O
hypertensive O O
encephalopathy. O O
Patient O O
underwent O O
neurologic O O
evaluation O O
including O O
MRA O O
of O O
the O O
brain, O O
lumbar O O
puncture, O O
both O O
of O O
which O O
were O O
negative. O O
Electroencephalogram O O
was O O
performed O O
and O O
showed O O
no O O
epileptiform O O
foci O O
and O O
diffuse O O
temporal O O
slowing O O
bilaterally. O O
The O O
patient's O O
alertness O O
and O O
responsiveness O O
increased O O
gradually O O
during O O
the O O
hospital O O
stay. O O
She O O
had O O
an O O
episode O O
of O O
chest O O
pain O O
which O O
was O O
associated O O
with O O
some O O
ST O O
flattening O O
in O O
the O O
lateral O O
leads. O O
Acute O O
cardiac O O
event O O
was O O
ruled O O
out. O O
The O O
patient O O
underwent O O
a O O
course O O
of O O
physical O O
therapy O O
and O O
then, O O
finally, O O
was O O
transferred O O
to O O
a O O
rehabilitation O O
facility. O O
A O O
specific O O
cause O O
of O O
the O O
patient's O O
seizure O O
was O O
not O O
found O O
although O O
it O O
was O O
assumed O O
that O O
this O O
might O O
have O O
been O O
provoked O O
by O O
the O O
hypertensive O O
encephalopathy O O
associated O O
with O O
use O O
of O O
ciprofloxacin O O
for O O
the O O
treatment O O
of O O
the O O
UTI O O
which O O
could O O
have O O
lowered O O
her O O
threshold O O
for O O
seizure O O
activity. O O
Upon O O
discharge, O O
the O O
patient O O
was O O
in O O
stable O O
condition. O O
PAST O O
MEDICAL O O
HISTORY: O O
Remarkable O O
for O O
seizure, O O
type O O
II O O
diabetes O O
mellitus, O O
panhypopituitarism O O
secondary O O
to O O
pituitary O O
surg, O O
hypertension, B-HYPERTENSION B-HYPERTENSION
right O O
arm O O
bone O O
tumor O O
excision O O
associated O O
with O O
right O O
radial O O
neuropathy, O O
and O O
hyperlipidemia. B-HYPERLIPIDEMIA O
MEDICATIONS: O O
See O O
LMR. O O
FAMILY O O
HISTORY: O O
Negative. O O
SOCIAL B-SMOKER O
HISTORY: I-SMOKER O
Denies I-SMOKER O
alcohol I-SMOKER O
intake, I-SMOKER O
smoking. I-SMOKER O
REVIEW O O
OF O O
SYSTEMS: O O
Denies O O
visual O O
or O O
hearing O O
disturbance, O O
headaches, O O
weakness, O O
numbness, O O
seizure O O
activity, O O
chest O O
pain, O O
palpitations, O O
syncope, O O
dyspnea, O O
wheezing, O O
cough, O O
coryza, O O
nausea, O O
vomiting, O O
diarrhea, O O
constipation, O O
abdominal O O
pain. O O
Positive O O
for O O
mild O O
nocturia O O
with O O
no O O
dysuria. O O
No O O
polydipsia. O O
Positive O O
mild O O
paresthesias O O
right O O
upper O O
extremity. O O
Occasional O O
mid-morning O O
reactions. O O
Home O O
blood O O
glucose O O
monitoring O O
b.i.d. O O
with O O
most O O
glucose O O
readings O O
between O O
100 O O
and O O
200. O O
Positive O O
mild O O
tiredness O O
without O O
any O O
hoarseness, O O
heat O O
or O O
cold O O
intolerance. O O
Mild O O
arthralgia. O O
No O O
bleeding, O O
rash, O O
pruritus. O O
Diet: O O
Low O O
salt. O O
Mets O O
2-3. O O
ALLERGIES: O O
Sulfa, O O
codeine, O O
morphine. O O
PHYSICAL O O
EXAM: O O
General O O
appearance: O O
Well-developed, O O
well-nourished. O O
Vital O O
signs: O O
Blood O O
pressure O O
130/80, O O
respiratory O O
rate O O
18, O O
heart O O
rate O O
76, O O
temperature O O
afebrile. O O
HEENT O O
exam: O O
No O O
exophthalmos, O O
no O O
lid O O
lag, O O
equally O O
reactive O O
pupils, O O
difficult O O
to O O
visualize O O
fundi; O O
pharynx O O
clear; O O
ears O O
clear. O O
Neck: O O
No O O
JVD, O O
no O O
bruits, O O
thyroid O O
within O O
normal O O
limits. O O
Chest: O O
Clear, O O
no O O
rales O O
or O O
wheezes. O O
Heart O O
sounds O O
normal. O O
No O O
murmurs. O O
Abdomen: O O
Soft, O O
nontender, O O
no O O
organomegaly. O O
Extremities: O O
No O O
edema. O O
Neuro: O O
Awake O O
and O O
alert O O
although O O
at O O
times O O
forgets O O
details O O
of O O
past O O
history; O O
no O O
focal O O
neurologic O O
signs. O O
A/P: O O
1. O O
Type O O
II O O
diabetes O O
mellitus.good O O
control. O O
Plan O O
- O O
Continue O O
diet. O O
2. O O
Panhypopituitarism O O
secondary O O
to O O
pituitary O O
surgery O O
for O O
pituitary O O
adenoma. O O
Need O O
to O O
obtain O O
record O O
from O O
surgeon O O
for O O
details O O
on O O
what O O
type O O
of O O
tumor O O
this O O
was. O O
Patient O O
on O O
replacement O O
therapy O O
with O O
levothyroxine O O
and O O
prednisone. O O
She O O
will O O
continue O O
both O O
with O O
the O O
understanding O O
that O O
should O O
she O O
become O O
sick O O
for O O
whatever O O
reason O O
she O O
needs O O
to O O
double O O
or O O
triple O O
dose O O
her O O
prednisone O O
and O O
contact O O
me. O O
She O O
needs O O
to O O
wear O O
a O O
bracelet O O
for O O
this O O
as O O
well O O
as O O
for O O
her O O
diabetes. O O
3. O O
Seizure O O
disorder, O O
? O O
etiology. O O
She O O
saw O O
the O O
neurologist; O O
she O O
will O O
need O O
to O O
remain O O
on O O
anti-seizure O O
medications. O O
4. O O
Hyperlipidemia: O O
Plan O O
- O O
Check O O
fast O O
lipid O O
profile. O O
Discussed O O
with O O
Dr O O
Xavier;P:: O O
lipitor B-MEDICATION B-MEDICATION
10 O O
mg O O
/d. O O
5 O O
Cryptogenic O O
cirrhosis, O O
LFT O O
ok; O O
discussed O O
with O O
Dr O O
Xavier O O
; O O
no O O
absolute O O
contraindication O O
to O O
lipitor. O B-MEDICATION
6 O O
? O O
CAD O O
x O O
family; O O
no O O
clear O O
documet; O O
P: O O
adenosine O O
MIBI O O
since O O
pt O O
is O O
diabetic O O
and O O
unable O O
to O O
perform O O
exercis O O
eETT. O O
WT O O
loss O O
? O O
etiol; O O
ct O O
abd O O
neg O O
and O O
cxr O O
neg; O O
P: O O
colonoscopy. O O
refuses O O
vaccines O O
To O O
follow O O
up O O
in O O
2 O O
months. O O
Isaac O O
Ng, O O
M.D. O O
IN/rowe/yeater O O

Record O O
date: O O
2091-12-16 O O
Team O O
D O O
Intern O O
Admission O O
Note O O
Patient O O
Name O O
Here: O O
Olivo, O O
Kimberly O O
MR# O O
3299811 O O
Location: O O
Suite O O
53-02Q O O
Date O O
of O O
Admission: O O
December O O
15, O O
2091 O O
PCP: O O
Isaac O O
Ng O O
ID/CC: O O
Change O O
in O O
mental O O
status O O
HPI: O O
70 O O
y/o O O
Female O O
with O O
PMHx O O
significant O O
for O O
Pituitary O O
adenoma O O
s/p O O
resection, O O
cryptogenic O O
cirrhosis, O O
presenting O O
with O O
confusion O O
for O O
the O O
past O O
3 O O
days. O O
Patient O O
confused O O
and O O
unable O O
to O O
give O O
history O O
at O O
time O O
of O O
admission. O O
As O O
per O O
son O O
and O O
daughter, O O
they O O
have O O
noticed O O
increasing O O
confusion O O
and O O
inappropriate O O
behavior O O
over O O
the O O
past O O
3 O O
days. O O
They O O
report O O
that O O
she O O
has O O
woken O O
up O O
in O O
the O O
middle O O
of O O
the O O
night O O
c/o O O
feeling O O
weak O O
and O O
confused. O O
The O O
first O O
two O O
nights, O O
her O O
son O O
treated O O
her O O
initially O O
with O O
increasing O O
lactulose O O
administration O O
when O O
she O O
would O O
wake O O
up O O
at O O
night O O
(although O O
it O O
is O O
unclear O O
whether O O
she O O
had O O
any O O
increase O O
in O O
her O O
stool) O O
and O O
he O O
reports O O
that O O
she O O
would O O
behave O O
better O O
during O O
the O O
day. O O
On O O
the O O
night O O
prior O O
to O O
administration, O O
the O O
patient O O
urinated O O
in O O
her O O
bed O O
at O O
night O O
and O O
called O O
her O O
daughter O O
on O O
the O O
phone O O
in O O
the O O
middle O O
of O O
the O O
night. O O
She O O
also O O
forgot O O
the O O
names O O
of O O
her O O
grandchildren. O O
The O O
son O O
became O O
worried O O
about O O
her O O
behavior, O O
contacted O O
her O O
PCP, O O
and O O
brought O O
her O O
to O O
the O O
ALH O O
ED. O O
The O O
family O O
reports O O
that O O
she O O
experienced O O
similar O O
behavior O O
prior O O
to O O
grand-mal O O
seizures O O
that O O
were O O
a O O
consequence O O
of O O
uncontrolled O O
hypertension B-HYPERTENSION O
about O O
2 O O
yrs O O
ago. O O
She O O
also O O
suffers O O
from O O
chronic O O
UTI's O O
and O O
often O O
becomes O O
confused O O
during O O
times O O
of O O
infection. O O
ED O O
Course: O O
Vitals O O
T O O
98.2, O O
HR O O
64, O O
BP B-HYPERTENSION O
215, I-HYPERTENSION O
115, I-HYPERTENSION O
RR O O
24, O O
Sa02 O O
100% O O
NRB. O O
Blood O O
Pressure: O O
Treated O O
with O O
labetalol B-MEDICATION B-MEDICATION
10 O O
mg O O
IV O O
x O O
1, O O
Hydral O O
10 O O
mg O O
IV O O
x O O
1, O O
decreased O O
to O O
176/74. B-HYPERTENSION O
Hyponatremia: O O
NS O O
x O O
1 O O
L O O
PMH: O O
Pituitary O O
adenoma O O
2080 O O
s/p O O
resection, O O
XRT O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Type I-DIABETES O
II I-DIABETES O
- O O
On O O
Humulin B-MEDICATION B-MEDICATION
15/15 O O
Hypertension B-HYPERTENSION B-HYPERTENSION
- O O
on O O
Avapro, B-MEDICATION B-MEDICATION
allergy O O
to O O
Ace-I O O
Angina B-CAD B-MEDICATION
pectoris I-CAD O
- I-CAD O
negative I-CAD O
stress I-CAD O
Seizure O O
- O O
According O O
to O O
discharge O O
summaries O O
in O O
YPZ, O O
patient O O
had O O
two O O
episodes O O
of O O
general O O
tonic-clonic O O
seizures O O
at O O
OSH O O
prior O O
to O O
transfer O O
to O O
ALH. O O
Extensive O O
neuro O O
work-up O O
at O O
ALH O O
including O O
MRI/MRA, O O
carotid O O
non-invasives, O O
TCVs, O O
EEG, O O
LP O O
revealed O O
no O O
definitive O O
etiology O O
of O O
seizure O O
but O O
thought O O
to O O
be O O
likely O O
related O O
to O O
her O O
uncontrolled O O
hypertension O O
with O O
systolic O O
BP O O
250's, O O
her O O
morbid O O
state O O
in O O
setting O O
of O O
UTI, O O
and O O
lower O O
seizure O O
threshold O O
with O O
ciprofloxacin. O O
Hyperlipidemia B-HYPERLIPIDEMIA O
- O O
was B-MEDICATION O
on I-MEDICATION O
zocor, I-MEDICATION B-MEDICATION
recently B-MEDICATION O
switched I-MEDICATION O
to I-MEDICATION O
zetia, B-MEDICATION O
?myositis O O
Hypothyroid O O
- O O
central, O O
secondary O O
to O O
pituitary O O
XRT O O
Arthritis O O
Cryptogenic O O
cirrhosis O O
- O O
HIV, O O
HBV, O O
HCV O O
negative O O
(4/90), O O
ANA O O
negative, O O
Anti-mitochondrial O O
Ab O O
negative, O O
no O O
evidence O O
of O O
hemachromatosis, O O
alpha-1-antitrypsin O O
deficiency O O
or O O
Wilson's O O
disease O O
on O O
biopsy, O O
findings O O
consistent O O
with O O
NASH. O O
Medications: O O
Avapro O B-MEDICATION
75MG O O
1 O O
QD O O
Cabergoline O O
0.25 O O
QWEEK O O
Humulin O O
15 O O
bid O O
Kcl O O
slow O O
release O O
20MEQ O O
1 O O
QD O O
Lactulose O O
30 O O
TID O O
Levothyroxine O O
sodium O O
100MCG O O
Macrodantin O O
100MG O O
1 O O
QD O O
Nortriptyline O B-MEDICATION
hcl O O
25MG O O
1 O O
HS O O
Prednisone O O
2.5 O O
QD O O
Prempro O O
0.625 O O
QD O O
Serax O O
15MG O O
1 O O
QHS O O
Zoloft O O
75MG O O
QD O O
Allergies: O O
Sulfa O O
drugs O O
Codeine O O
Lisinopril O B-MEDICATION
SH: O O
Lives O O
in O O
Ardmore O O
with O O
son. O O
Husband O O
died O O
3 O O
years O O
ago. O O
Three O O
children. O O
Tob: B-SMOKER O
1 I-SMOKER O
ppd I-SMOKER O
x I-SMOKER O
many I-SMOKER O
years I-SMOKER O
EtOH: O O
Denies O O
Illicits: O O
Denies O O
Exam: O O
VS: O O
General: O O
NAD, O O
extrapyramidal O O
movements, O O
responding O O
to O O
commands. O O
HEENT: O O
NC/AT, O O
Right O O
pupil O O
w/minimal O O
proptosis O O
and O O
unreactive O O
to O O
light, O O
left O O
pupil O O
RRLA, O O
anicteric. O O
EOMI. O O
OP O O
w/ O O
MMM, O O
Skin: O O
No O O
rashes O O
Neck: O O
Supple, O O
full O O
ROM, O O
2+ O O
carotids O O
w/o O O
bruits, O O
no O O
thyromegaly O O
or O O
nodules, O O
no O O
nodes O O
Chest: O O
CTA O O
b/l, O O
coarse O O
upper O O
airway O O
sounds O O
CVS: O O
RRR O O
nl O O
S1 O O
S2, O O
no O O
m/r/g O O
Abd: O O
nl O O
BS, O O
soft, O O
non-tender, O O
no O O
HSM, O O
no O O
fluid O O
wave, O O
no O O
fluid O O
shift O O
Extr: O O
no O O
c/c/e O O
2+ O O
DP's O O
bilaterally O O
Neuro: O O
Oriented O O
to O O
person O O
and O O
place. O O
Somnolent O O
but O O
arousable. O O
Able O O
to O O
follow O O
simple O O
commands. O O
Muscle O O
strength O O
5/5 O O
except O O
RUE O O
where O O
limited O O
by O O
prior O O
surgery. O O
DATA: O O
Sodium O O
(Stat O O
Lab) O O
125 O O
L O O
(135-145) O O
mmol/L O O
Potassium O O
(Stat O O
Lab) O O
3.8 O O
(3.4-4.8) O O
mmol/L O O
Chloride O O
(Stat O O
Lab) O O
98 O O
L O O
(100-108) O O
mmol/L O O
CO2 O O
(Stat O O
Lab) O O
25.8 O O
(23.0-31.9) O O
mmol/L O O
BUN O O
(Stat O O
Lab) O O
7 O O
L O O
(8-25) O O
mg/dl O O
Creatinine O O
(Stat O O
Lab) O O
0.6 O O
(0.6-1.5) O O
mg/dl O O
Glucose O O
(Stat O O
Lab) O O
128 O O
H O O
(70-110) O O
mg/dl O O
Calcium O O
8.8 O O
(8.5-10.5) O O
mg/dl O O
Phosphorus O O
1.9 O O
L O O
(2.6-4.5) O O
mg/dl O O
Magnesium O O
1.5 O O
(1.4-2.0) O O
meq/L O O
Total O O
Protein O O
6.2 O O
(6.0-8.3) O O
g/dl O O
Albumin O O
3.4 O O
(3.3-5.0) O O
g/dl O O
Globulin O O
2.8 O O
(2.6-4.1) O O
g/dl O O
Direct O O
Bilirubin O O
0.2 O O
(0-0.4) O O
mg/dl O O
Total O O
Bilirubin O O
0.5 O O
(0-1.0) O O
mg/dl O O
Alkaline O O
Phosphatase O O
75 O O
(30-100) O O
U/L O O
Transaminase-SGPT O O
12 O O
(7-30) O O
U/L O O
Amylase O O
25 O O
(3-100) O O
units/L O O
Lipase O O
2.7 O O
(1.3-6.0) O O
U/dl O O
Transaminase-SGOT O O
18 O O
(9-32) O O
U/L O O
Creatine O O
Kinase O O
Isoenz O O
NEGATIVE O O
(NEG) O O
Troponin-I O O
NEGATIVE O O
(NEG) O O
Nortriptyline O O
&lt;50 O O
mcg/L O O
Desmethylsertraline O O
PRESENT O O
mcg/L O O
Sertraline O O
&lt;50 O O
mcg/L O O
REF. O O
RANGE: O O
40-160 O O
WBC O O
5.5 O O
(4.5-11.0) O O
th/cmm O O
HCT O O
37.0 O O
(36.0-46.0) O O
% O O
HGB O O
13.3 O O
(12.0-16.0) O O
gm/dl O O
RBC O O
4.21 O O
(4.00-5.20) O O
mil/cmm O O
PLT O O
187 O O
(150-350) O O
th/cumm O O
MCV O O
88 O O
(80-100) O O
fl O O
MCH O O
31.6 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
36.0 O O
(31.0-37.0) O O
g/dl O O
RDW O O
12.4 O O
(11.5-14.5) O O
% O O
Superstat O O
PT O O
12.9 O O
(11.1-13.1) O O
sec O O
Superstat O O
PT-INR O O
1.1 O O
Superstat O O
APTT O O
30.7 O O
(22.1-35.1) O O
sec O O
Poly O O
65 O O
(40-70) O O
% O O
Lymphs O O
28 O O
(22-44) O O
% O O
Monos O O
4 O O
(4-11) O O
% O O
EOS O O
3 O O
(0-8) O O
% O O
Basos O O
0 O O
(0-3) O O
% O O
UA-Specific O O
Gravity O O
1.025 O O
(1.001-1.035) O O
UA-pH O O
7.0 O O
(5.0-9.0) O O
UA-WBC O O
Screen O O
NEGATIVE O O
(NEG) O O
UA-Nitrite O O
NEGATIVE O O
(NEG) O O
UA-Albumin O O
(NEG) O O
2+SAMPLE O O
SENT O O
TO O O
HEME O O
LAB O O
FOR O O
ADDITIONAL O O
TESTING O O
UA-Glucose O O
NEGATIVE O O
(NEG) O O
UA-Ketones O O
NEGATIVE O O
(NEG) O O
UA-Occult O O
Blood O O
NEGATIVE O O
(NEG) O O
CXR: O O
no O O
acute O O
cardiopulmonary O O
process O O
HEAD O O
CT: O O
CT O O
HEAD O O
WITHOUT O O
CONTRAST O O
History: O O
Mental O O
status O O
change. O O
Right O O
sided O O
weakness. O O
Hypertension. O O
Procedure: O O
Contiguous O O
axial O O
images O O
of O O
the O O
head O O
were O O
performed O O
from O O
the O O
skull O O
base O O
to O O
the O O
vertex O O
without O O
intravenous O O
contrast. O O
Bone O O
and O O
soft-tissue O O
windows O O
were O O
reviewed. O O
Comparison: O O
MRI O O
dated O O
7/16/91 O O
Findings: O O
The O O
cerebral O O
parenchyma, O O
posterior O O
fossa, O O
basal O O
cisterns O O
and O O
ventricular O O
system O O
appear O O
normal. O O
There O O
is O O
no O O
evidence O O
of O O
any O O
mass O O
or O O
mass O O
effect. O O
There O O
is O O
no O O
evidence O O
of O O
acute O O
infarction O O
although O O
this O O
would O O
be O O
better O O
assessed O O
by O O
MR O O
with O O
diffusion. O O
There O O
is O O
no O O
evidence O O
of O O
parenchymal O O
or O O
extra-axial O O
hemorrhage. O O
A O O
right O O
frontal O O
mucocele O O
has O O
enlarged O O
since O O
the O O
previous O O
exam. O O
It O O
extends O O
into O O
the O O
right O O
orbit O O
resulting O O
in O O
proptosis. O O
There O O
are O O
bilateral O O
lens O O
implants. O O
IMPRESSION: O O
No O O
acute O O
intracranial O O
hemorrhage. O O
Enlarging O O
right O O
frontal O O
mucocele O O
which O O
causes O O
right O O
proptosis. O O
Pituitary O O
MRI: O O
(7/91) O O
No O O
evidence O O
of O O
recurrent O O
pituitary O O
adenoma. O O
Interval O O
increase O O
in O O
the O O
size O O
of O O
an O O
expansile O O
lesion O O
within O O
the O O
right O O
ethmoid O O
bed, O O
with O O
increased O O
extension O O
into O O
the O O
right O O
orbit. O O
The O O
lesion O O
contacts O O
the O O
right O O
globe. O O
This O O
lesion O O
most O O
likely O O
represents O O
a O O
mucocele. O O
EKG: O O
NSR O O
@ O O
73, O O
normal O O
axis, O O
normal O O
intervals, O O
biphasic O O
t O O
wave O O
v2, O O
no O O
sttw O O
changes. O O
ALH O O
Cardiology O O
25-Oct-2090 O O
13:00 O O
DURATION O O
@ O O
MAX O O
DOSE O O
(min:sec) O O
5:00 O O
HR O O
(REST=&gt;MAX) O O
57 O O
=&gt; O O
76 O O
(50% O O
PREDICTED) O O
BP B-HYPERTENSION O
(INITIAL=&gt;PEAK) I-HYPERTENSION O
146/60 B-HYPERTENSION O
=&gt; I-HYPERTENSION O
146/60 I-HYPERTENSION O
(MINIMUM O O
= O O
114/52) O O
PEAK O O
DOUBLE O O
PRODUCT: O O
11096 O O
ENDPOINT(S): O O
The O O
protocol O O
was O O
completed. O O
Chest O O
pain O O
did O O
not O O
occur. O O
The O O
baseline O O
cardiac O O
rhythm O O
was O O
normal O O
sinus O O
rhythm. O O
The O O
rest O O
electrocardiogram O O
revealed O O
nonspecific O O
ST O O
segment O O
and O O
T-wave O O
abnormalities. O O
Small O O
inferior O O
q's. O O
No O O
ST O O
segment O O
changes O O
were O O
observed O O
during O O
this O O
test. O O
Negative O O
for O O
ischemia. O O
However, O O
the O O
sensitivity O O
of O O
Adenosine-induced O O
ST O O
segment O O
changes O O
for O O
detecting O O
significant O O
CAD O O
is O O
limited. O O
SCAN O O
RESULTS: O O
The O O
left O O
ventricle O O
is O O
normal O O
in O O
size. O O
Regional O O
left O O
ventricular O O
perfusion O O
is O O
normal. O O
The O O
left O O
ventricular O O
ejection O O
fraction O O
was O O
77% O O
on O O
the O O
stress O O
study. O O
Regional O O
wall O O
motion O O
was O O
normal O O
on O O
the O O
stress O O
study. O O
CONCLUSIONS: O O
The O O
ECG O O
response O O
to O O
pharmacological O O
stress O O
was O O
negative O O
for O O
ischemia. O O
The O O
myocardial O O
scans O O
are O O
within O O
normal O O
limits O O
and O O
do O O
not O O
demonstrate O O
evidence O O
of O O
myocardial O O
ischemia O O
or O O
infarction. O O
ALH O O
CARDIAC O O
ULTRASOUND O O
11-May-2087 O O
Serial# O O
732087 O O
Final O O
(normal) O O
(Completed O O
only O O
if O O
abn.) O O
MITRAL O O
VALVE O O
NORM O O
AO O O
29 O O
mm.(24-39mm) O O
SEGMENT O O
BASE O O
MID O O
APEX O O
LEFT O O
ATRIUM O O
NORM O O
AV. O O
AO. O O
LVOT O O
ABN O O
LA O O
38 O O
mm.(25-38mm) O O
anterior O O
LEFT O O
VENT. O O
NORM O O
ant.sep. O O
TV. O O
RA. O O
VC. O O
NORM O O
LVID O O
44 O O
mm.(37-53mm) O O
mid.sep. O O
PV. O O
INF. O O
PA. O O
ABN O O
inf.sep. O O
RIGHT O O
VENT. O O
NORM O O
PWT O O
11 O O
mm.( O O
7-11mm) O O
inferior O O
IAS. O O
IVS. O O
NORM O O
inf.pos. O O
COMPLEX O O
CHD O O
NORM O O
IVS O O
11 O O
mm.( O O
7-11mm) O O
pos.lat. O O
CORONARIES O O
UV O O
lateral O O
PERICARDIUM O O
NORM O O
EF O O
75 O O
% O O
( O O
&gt;50 O O
%) O O
MITRAL O O
VALVE O O
There O O
is O O
trace O O
to O O
mild O O
mitral O O
regurgitation O O
by O O
color O O
and O O
spectral O O
Doppler. O O
LEFT O O
ATRIUM O O
There O O
is O O
no O O
evidence O O
of O O
left O O
atrial O O
dilatation. O O
AORTIC O O
VALVE, O O
AORTA, O O
LVOT O O
Multiple O O
aortic O O
leaflets O O
are O O
thickened O O
but O O
there O O
is O O
no O O
stenosis. O O
There O O
is O O
no O O
evidence O O
of O O
aortic O O
insufficiency O O
by O O
color O O
and O O
spectral O O
Doppler. O O
LEFT O O
VENTRICLE O O
The O O
left O O
ventricular O O
size O O
and O O
systolic O O
function O O
are O O
within O O
normal O O
limits. O O
There O O
are O O
no O O
obvious O O
segmental O O
wall O O
motion O O
abnormalities. O O
The O O
estimated O O
ejection O O
fraction O O
is O O
75%. O O
TRICUSPID O O
VALVE O O
- O O
IVC, O O
SVC O O
There O O
is O O
color O O
and O O
spectral O O
Doppler O O
evidence O O
of O O
mild O O
tricuspid O O
insufficiency. O O
There O O
is O O
a O O
prominent O O
Eustachian O O
valve. O O
PULMONARY O O
VALVE, O O
INFUND., O O
P.A. O O
Color O O
and O O
spectral O O
Doppler O O
study O O
c/w O O
trace O O
pulmonary O O
insufficiency. O O
The O O
RV O O
systolic O O
pressure O O
estimated O O
from O O
the O O
regurgitant O O
tricuspid O O
velocity O O
is O O
53 O O
mmHg O O
(assuming O O
an O O
RA O O
pressure O O
of O O
10mmHg). O O
RIGHT O O
VENTRICLE O O
The O O
right O O
ventricle O O
is O O
not O O
dilated. O O
The O O
right O O
ventricular O O
systolic O O
function O O
is O O
within O O
normal O O
limits. O O
PERICARDIAL O O
DISEASE O O
AND O O
EXTRACARDIAC O O
MASSES O O
Echo O O
free O O
space O O
between O O
visceral O O
& O O
parietal O O
pericardium O O
is O O
c/w O O
pericardial O O
fat. O O
TEST O O
TYPE: O O
CAROTID O O
ULTRASOUND O O
10/2089 O O
FINDINGS O O
No O O
carotid O O
bruits O O
are O O
heard. O O
Blood O O
flow O O
velocity O O
is O O
within O O
normal O O
limits O O
in O O
the O O
common, O O
internal, O O
external O O
carotid, O O
and O O
extracranial O O
vertebral O O
arteries, O O
bilaterally. O O
Ophthalmic O O
artery O O
flow O O
is O O
normal O O
in O O
direction, O O
via O O
the O O
transorbital O O
approach, O O
bilaterally. O O
Ultrasound O O
visualization O O
of O O
the O O
bifurcations O O
is O O
good. O O
There O O
is O O
dense O O
plaque O O
visualized O O
in O O
each O O
bifurcation. O O
Plaque O O
does O O
not O O
alter O O
flow O O
in O O
either O O
vessel. O O
IMPRESSIONS: O O
1. O O
MINIMAL O O
DISEASE O O
OF O O
BOTH O O
CAROTID O O
ARTERY O O
BIFURCATION. O O
LIVER, O O
BIOPSY: O O
(11/2089) O O
NOTE: O O
There O O
is O O
established O O
cirrhosis, O O
confirmed O O
on O O
trichrome O O
stain. O O
There O O
is O O
a O O
mild O O
to O O
moderate O O
mixed O O
portal O O
tract O O
inflammatory O O
infiltrate, O O
composed O O
of O O
lymphocytes, O O
plasma O O
cells, O O
and O O
eosinophils. O O
There O O
is O O
no O O
interface O O
or O O
lobular O O
activity. O O
There O O
is O O
mild O O
macrovesicular O O
steatosis. O O
There O O
are O O
scattered O O
glycogenated O O
nuclei O O
in O O
periportal O O
hepatocytes, O O
consistent O O
with O O
diabetes O O
and/or O O
obesity. B-OBESE O
There O O
is O O
mild O O
periportal O O
edema O O
and O O
copper O O
deposition, O O
consistent O O
with O O
chronic O O
cholestasis. O O
There O O
is O O
no O O
Mallory's O O
hyaline. O O
There O O
is O O
no O O
evidence O O
of O O
hemachromatosis, O O
alpha-1-antitrypsin O O
deficiency O O
or O O
Wilson's O O
disease O O
based O O
on O O
iron, O O
PAS/D, O O
and O O
copper O O
stains, O O
respectively. O O
The O O
inflammatory O O
infiltrate O O
is O O
not O O
ductulocentric, O O
and O O
there O O
is O O
minimal O O
bile O O
duct O O
damage. O O
Immunostains O O
for O O
cytokeratins O O
7 O O
and O O
19 O O
highlight O O
bile O O
ductular O O
reduplication, O O
but O O
there O O
is O O
no O O
ductopenia. O O
The O O
findings O O
of O O
cirrhosis O O
are O O
not O O
specific, O O
but O O
are O O
compatible O O
with O O
end-stage O O
non-alcoholic O O
steatohepatitis O O
(NASH). O O
___________________________________________ O O
ASSESSMENT O O
AND O O
PLAN: O O
70 O O
y/o O O
female O O
with O O
PMHx O O
sig O O
for O O
pituitary O O
adenoma O O
s/p O O
resection, O O
cryptogenic O O
cirrhosis, O O
hypothyroidism, O O
htn, O O
DM, O O
who O O
presents O O
with O O
increasing O O
confusion O O
and O O
depressed O O
mental O O
status. O O
1. O O
Change O O
in O O
mental O O
status O O
1. O O
Hyponatremia O O
- O O
Euvolemic O O
by O O
exam, O O
Serum O O
sodium O O
125, O O
Serum O O
Osm O O
262, O O
Urine O O
sodium O O
126, O O
Urine O O
Osm O O
387. O O
Consistent O O
with O O
SIADH O O
(euvolemic O O
hypotonic O O
hyponatremia, O O
Uosm&gt;100, O O
Una&gt;20). O O
Will O O
place O O
on O O
fluid O O
restriction, O O
follow O O
correction O O
rate O O
slowly. O O
Past O O
Na O O
levels: O O
130 O O
(10/91), O O
135 O O
(6/91), O O
133 O O
(1/91). O O
Other O O
etiologies: O O
diuretics, O O
polydipsia, O O
adrenal O O
insufficiency, O O
hypoaldo, O O
third-spacing O O
less O O
likely. O O
2. O O
Hepatic O O
encephalopathy O O
- O O
known O O
cirrhosis, O O
on O O
home O O
standing O O
lactulose. O O
By O O
exam, O O
no O O
asterixis. O O
Abdomen O O
obese O O
but O O
no O O
obvious O O
fluid O O
collection. O O
Somewhat O O
tender, O O
no O O
peritoneal O O
signs. O O
Will O O
schedule O O
for O O
Abdominal O O
U/S O O
to O O
r/o O O
ascites. O O
Low O O
suspicion O O
for O O
SBP, O O
will O O
hold O O
off O O
prophylaxis O O
antibiotics. O O
3. O O
Hypertensive O O
encephalopthy O O
- O O
history O O
of O O
mental O O
status O O
changes O O
and O O
seizures O O
with O O
elevated O O
blood O O
pressures O O
in O O
the O O
past. O O
Extremely O O
hypertensive O O
upon O O
presentation O O
to O O
the O O
ED. O O
Will O O
continue O O
to O O
titrate O O
up O O
beta-blocker O O
as O O
tolerated, O O
MAP O O
goal O O
reduction O O
of O O
25% O O
obtained, O O
will O O
continue O O
to O O
lower O O
with O O
PO O O
agents. O O
Consider O O
MRI O O
to O O
look O O
for O O
PLE O O
changes. O O
4. O O
Infection O O
- O O
history O O
of O O
chronic O O
UTIs. O O
U/A O O
negative, O O
CXR O O
negative. O O
Will O O
send O O
blood O O
cx O O
and O O
urine O O
cx O O
to O O
complete O O
fever O O
work-up. O O
5. O O
Standard O O
work-up O O
- O O
TSH, O O
RPR, O O
B12, O O
Folate, O O
cortisol O O
2. O O
Diabetes O O
- O O
Finger O O
sticks O O
with O O
sliding O O
scale O O
insulin B-MEDICATION O
coverage O O
QID O O
3. O O
Hypothyroidism O O
- O O
check O O
TSH, O O
T4, O O
T3. O O
Recent O O
adjustment O O
to O O
synthroid O O
dose. O O
4. O O
Prolactinoma O O
- O O
Check O O
prolactin O O
level, O O
have O O
patient O O
bring O O
in O O
home O O
cabergoline O O
for O O
weekly O O
dose. O O
_________________________________ O O
Taquan O O
Q. O O
Cantu, O O
MD O O
Pager O O
#30547 O O

Record O O
date: O O
2097-06-29 O O
AMERICAN O O
LEGION O O
HOSPITAL O O
NEUROCRITICAL O O
RESIDENT O O
ADMIT B-DIABETES O
NOTE O O
Name: O O
Ollivo, O O
Kimberly O O
MRN: O O
3299811 O O
Date: O O
6/29/97 O O
Time O O
of O O
Exam: O O
5:20 O O
p.m. O O
NICU O O
day: O O
1 O O
Critically O O
ill O O
secondary O O
to: O O
R. O O
BG/thalamus O O
hemorrhage O O
with O O
IVH O O
extension, O O
with O O
potential O O
for O O
fatal O O
neurologic O O
deterioration O O
Critical O O
Care O O
Min: O O
35 O O
min O O
History: O O
Ms. O O
Olivo O O
is O O
a O O
75-year-old O O
RHW O O
with O O
DM, O O
HTN B-HYPERTENSION O
and O O
dementia, O O
LSW O O
at O O
11:00 O O
a.m., O O
then O O
found O O
by O O
son O O
at O O
1:45 O O
pm O O
to O O
be O O
less O O
responsive O O
with O O
left-sided O O
weakness. O O
BP B-HYPERTENSION O
was I-HYPERTENSION O
200/96 I-HYPERTENSION O
when O O
EMS O O
arrived. O O
Here O O
her O O
SBP B-HYPERTENSION O
was I-HYPERTENSION O
in I-HYPERTENSION O
the I-HYPERTENSION O
220s I-HYPERTENSION O
with O O
heart O O
rate O O
in O O
the O O
50-60s. O O
Her O O
initial O O
exam O O
revealed O O
somnolence, O O
but O O
able O O
to O O
follow O O
some O O
very O O
simple O O
commands O O
like O O
squeezing O O
hand, O O
nodding O O
head; O O
she O O
had O O
right O O
gaze O O
deviation, O O
left O O
hemianopsia, O O
left O O
facial O O
palsy, O O
left O O
arm O O
and O O
leg O O
plegia, O O
right O O
arm O O
and O O
leg O O
paresis, O O
and O O
dysarthria. O O
She O O
received O O
10 O O
mg O O
of O O
hydralazine O O
for O O
her O O
SBP O O
greater O O
than O O
220. O O
CT O O
revealed O O
a O O
right O O
basal O O
ganglia/thalamic O O
hemorrhage O O
with O O
intraventricular O O
extension O O
including O O
casting O O
of O O
the O O
4th O O
ventricle, O O
7 O O
mm O O
mls O O
to O O
the O O
left, O O
contrast O O
extravasation O O
suggestive O O
of O O
active O O
hemorrhage O O
but O O
no O O
evidence O O
of O O
any O O
vascular O O
abnormality. O O
She O O
was O O
intubated O O
for O O
worsening O O
mental O O
status O O
and O O
had O O
an O O
a-line O O
placed O O
for O O
Bp O O
monitoring O O
and O O
management. O O
At O O
baseline, O O
Ms. O O
Olivo O O
is O O
wheelchair-bound, O O
according O O
to O O
her O O
daughter, O O
due O O
to O O
her O O
neuropathy. O O
She O O
is O O
dependent O O
for O O
all O O
of O O
her O O
ADLs O O
and O O
has O O
a O O
home O O
health O O
aide. O O
PMHx: O O
DM, O O
HTN, O O
dementia, O O
h/o O O
sz O O
d/o O O
not O O
on O O
AED O O
now, O O
Pituitary O O
adenoma, O O
s/p O O
hypophysectomy, O O
hypothyroidism, O O
COPD, O O
dyslipidemia, B-HYPERLIPIDEMIA O
obesity, B-OBESE O
fatty O O
liver, O O
fibromyalgia, O O
arthritis, O O
depression, O O
anxiety, O O
meningitis, O O
Rt O O
humerus O O
fx/osteo/nonunion, O O
Cirrhosis O O
or O O
unclear O O
etiology O O
with O O
hyperammonemia, O O
Neuropathy O O
with O O
paresthesias, O O
presumably O O
due O O
to O O
diabetes O O
Home O O
meds: O O
Mirtazapine O B-MEDICATION
15 O O
mg O O
daily, O O
Namenda O O
10 O O
mg O O
daily, O O
Potassium O O
supplementation O O
20 O O
meq O O
daily, O O
Levothyroxine O O
100 O O
mcg O O
daily, O O
Metoprolol B-MEDICATION B-MEDICATION
(unclear O O
if O O
metoprolol O B-MEDICATION
succinate O O
or O O
tartrate) O O
25 O O
mg O O
daily, O O
Prednisone O O
2.5 O O
mg O O
daily, O O
MVI O O
All: O O
Morphine O O
( O O
Unknown O O
) O O
Codeine O O
( O O
Unknown O O
) O O
ACE O O
Inhibitor O O
( O O
Unknown O O
) O O
LISINOPRIL O B-MEDICATION
(cough O O
) O O
CIPROFLOXACIN O O
HCL O O
(dec O O
effects O O
of O O
sz O O
med O O
) O O
ATORVASTATIN O B-MEDICATION
(abnormal O O
LFT O O
) O O
SH: O O
Lives O O
with O O
her O O
son O O
in O O
Ardmore. O O
Has O O
two O O
sons O O
and O O
a O O
daughter. O O
Daughter, O O
Yolanda, O O
is O O
the O O
HCP O O
(817-638-1328) O O
and O O
primary O O
caregiver. O O
She B-SMOKER O
quit B-SMOKER O
smoking I-SMOKER O
16 I-SMOKER O
years I-SMOKER O
ago. I-SMOKER O
24 O O
hour O O
events: O O
admitted O O
to O O
NICU O O
Flowsheet O O
Data: O O
VS: O O
Tm O O
HR O O
52-70 O O
SR O O
SBP B-HYPERTENSION O
223/90 I-HYPERTENSION O
&#224; O O
148/53 B-HYPERTENSION O
MAP O O
RR O O
19 O O
O2 O O
sat O O
100 O O
% O O
on O O
FiO2 O O
1.0 O O
CVP O O
ICP O O
CPP O O
ICU O O
Titrateable O O
Drips: O O
propofol O O
Vent O O
Settings: O O
AC O O
f12 O O
PEEP O O
5.0 O O
FiO2 O O
1.0 O O
PC O O
12 O O
TBB: O O
since O O
MN O O
EVD O O
output: O O
Maintenance O O
IVF: O O
D5NS O O
Nutrition: O O
npo O O
IVF: O O
D5NS O O
FSBG: O O
Lines: O O
L. O O
Rad O O
art O O
line O O
Significant O O
Medications: O O
propofol O O
, O O
RISS, B-MEDICATION O
peridex, O O
synthroid, O O
lactulose O O
Significant O O
LABS: O O
INR O O
1.1 O O
Plt O O
273 O O
Physical O O
Exam O O
Cardio: O O
S1, O O
S2, O O
reg O O
Pulm: O O
CTAB O O
Abd: O O
soft, O O
hypoactive O O
bowel O O
sounds O O
Skin: O O
erthematous O O
lesions O O
with O O
centers O O
of O O
white O O
rash O O
in O O
skin O O
folds: O O
neck, O O
under O O
breasts O O
Ortho: O O
R. O O
arm O O
fracture O O
(old) O O
Neuro O O
Exam: O O
Off O O
sedation O O
&#8211; O O
no O O
verbal O O
response O O
to O O
noxious O O
stimuli, O O
intermittently O O
extensor O O
postures; O O
minimally O O
reactive O O
small O O
pupils, O O
midline O O
gaze O O
in O O
primary O O
position, O O
able O O
to O O
x-midline, O O
no O O
BTT, O O
+ O O
R. O O
corneal O O
brisk O O
vs. O O
L., O O
grimace O O
to O O
nasal O O
tickle O O
better O O
on O O
the O O
L. O O
than O O
on O O
the O O
R., O O
R. O O
UE O O
slight O O
w/d O O
to O O
deep O O
noxious O O
stim, O O
plegic O O
in O O
LUE., O O
w/d O O
briskly O O
in O O
the O O
L. O O
LE O O
vs. O O
RLE, O O
toes O O
up O O
b/l O O
Imaging/Studies/TCD: O O
Head O O
CT/A O O
(6/29): O O
Prelim O O
read O O
shows O O
a O O
right O O
basal O O
ganglia/thalamic O O
hemorrhage O O
(1.87 O O
cm O O
x O O
4.5 O O
cm O O
in O O
largest O O
dimension) O O
with O O
intraventricular O O
extension O O
including O O
casting O O
of O O
the O O
4th O O
ventricle, O O
and O O
mls O O
of O O
7 O O
mm O O
to O O
the O O
left. O O
CTA O O
showed O O
at O O
least O O
3 O O
spot O O
signs O O
indicating O O
active O O
hemorrhage O O
but O O
no O O
evidence O O
of O O
any O O
vascular O O
abnormality. O O
Assessment: O O
Olivo O O
is O O
a O O
75-year-old O O
right-handed O O
woman O O
with O O
diabetes B-DIABETES O
mellitus, I-DIABETES O
HTN O O
and O O
dementia, O O
and O O
found O O
with O O
a O O
~ O O
11 O O
cc O O
R. O O
BG/thalamic O O
bleed O O
with O O
pan-ventricular O O
extension O O
with O O
casted O O
3rd O O
and O O
4th O O
ventricles, O O
and O O
mild O O
midline O O
shift. O O
The O O
etiology O O
appears O O
to O O
be O O
hypertensive O O
in O O
nature; O O
CTA O O
was O O
negative O O
for O O
a O O
vascular O O
anomaly. O O
A O O
mass O O
lesion O O
cannot O O
be O O
excluded O O
at O O
this O O
time O O
however, O O
and O O
will O O
need O O
an O O
MRI. O O
Her O O
prognosis O O
is O O
somewhat O O
difficult O O
to O O
articulate O O
at O O
this O O
time O O
using O O
the O O
conventional O O
FUNC O O
(8) O O
and O O
ICH O O
(2) O O
scores O O
given O O
her O O
clinical O O
status O O
and O O
medical O O
comorbidities. O O
Plan: O O
Neuro: O O
ICH O O
with O O
IVH, O O
prior O O
h/o O O
sz O O
d/o O O
not O O
AEDs O O
now O O
-Serial O O
neuro O O
exams O O
-repeat O O
I-HCT O O
in O O
6 O O
h O O
(at O O
9:45 O O
p.m.), O O
24 O O
h O O
(6/30/97 O O
at O O
3:45 O O
p.m.), O O
and O O
STAT O O
with O O
exam O O
change O O
-SBP O O
goal O O
&lt; O O
140 O O
mm O O
Hg O O
-A-line O O
-propofol O O
for O O
BP O O
control O O
-HOB O O
&gt; O O
30 O O
degrees O O
-no O O
antiplatelet O O
or O O
anticoagulants O O
-labetalol B-MEDICATION O
prn, O O
nicardipine B-MEDICATION O
prn O O
-no O O
need O O
for O O
AEDs O O
unless O O
declares O O
self O O
with O O
new O O
sz O O
(has O O
been O O
stably O O
off O O
AEDs O O
for O O
prior O O
h/o O O
Sz O O
d/o) O O
-MRI O O
to O O
r/o O O
underlying O O
mass O O
lesion O O
when O O
able O O
-N. O O
Surg O O
c/s O O
appreciated O O
for O O
EVD O O
placement O O
Pulm: O O
-intubated O O
-wean O O
as O O
tolerated O O
-daily O O
CXR O O
while O O
intubated O O
CV: O O
HTN, O O
HL, O O
angina B-CAD O
-BP O O
control O O
as O O
above O O
-Tn O O
x O O
3 O O
-SBP O O
goal O O
&lt; O O
140 O O
mm O O
Hg O O
RENAL: O O
-foley, O O
strict O O
I/O O O
-no O O
hypotonic O O
fluids O O
-D5 O O
NS O O
for O O
now O O
-trend O O
UOP, O O
Cr O O
-renoprotection O O
for O O
iv O O
contrast O O
-replete O O
lytes O O
ID: O O
-follow O O
U/A, O O
temp, O O
WBC O O
-nystatin O O
for O O
crural O O
dermatophytosis O O
GI/Nutrition: O O
Cirrhosis O O
-daily O O
LFTs O O
, O O
NH3 O O
-lactulose O O
at O O
home O O
dose O O
-npo O O
-IV O O
fluids O O
for O O
now O O
Heme: O O
-trend O O
CBC O O
-type O O
and O O
hold O O
-no O O
antiplatelet O O
or O O
anticoagulation O O
for O O
now O O
Endo: O O
DM, O O
hypothyroid O O
-synthroid O O
-Fsg O O
q6h O O
-RISS O O
Skin: O O
-Nystatin O O
-turn O O
and O O
position O O
q2h O O
Ortho: O O
-Old O O
R. O O
arm O O
fx O O
per O O
family O O
-baseline O O
R. O O
elbow O O
XRay O O
pending O O
Prophy: O O
DVT O O
teds O O
&amp; O O
boots, O O
fragmin O O
if O O
repeat O O
CT O O
stable O O
in O O
48 O O
h O O
Sz O O
- O O
GI O O
PPI O O
VAP O O
peridex O O
Restraints O O
- O O
CODE/Dispo: O O
FULL/ICU O O
-continue O O
code O O
status O O
discussion O O
with O O
the O O
family O O
_______________________________ O O
Yuval O O
Xaysana, O O
M.D., O O
Ph.D. O O
Neurology O O
Resident O O

Record O O
date: O O
2079-02-28 O O
DOUGLAS O O
EMERGENCY O O
DEPT O O
VISIT O O
DODD,STEVEN O O
350-93-05-3 O O
VISIT O O
DATE: O O
02/28/79 O O
This O O
patient O O
was O O
evaluated O O
in O O
conjunction O O
with O O
a O O
resident O O
and O O
I O O
confirmed O O
the O O
history O O
and O O
physical O O
findings O O
as O O
documented O O
in O O
the O O
handwritten O O
record. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
patient O O
is O O
a O O
63 O O
year O O
old O O
gentleman O O
with O O
underlying O O
diabetes B-DIABETES O
and O O
congestive O O
failure O O
as O O
well O O
as O O
extensive O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
now O O
presenting O O
with O O
worsening O O
fatigue O O
and O O
shortness O O
of O O
breath O O
over O O
the O O
preceding O O
few O O
days. O O
PHYSICAL O O
EXAMINATION: O O
Physical O O
examination O O
is O O
suggestive O O
of O O
congestive O O
failure. O O
LABORATORY O O
EVALUATION: O O
Electrolytes O O
are O O
normal. O O
Electrocardiogram O O
shows O O
no O O
definite O O
ischemic O O
change. O O
Chest O O
x-ray O O
is O O
a O O
limited O O
study O O
due O O
to O O
body O O
habitus. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
was O O
treated O O
with O O
diuretics O O
and O O
ultimately O O
admitted O O
to O O
the O O
hospital O O
for O O
further O O
care. O O
FINAL O O
DIAGNOSIS: O O
Congestive O O
heart O O
failure. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
was O O
admitted O O
to O O
the O O
hospital O O
in O O
stable O O
condition. O O
___________________________________ O O
TO761/1620 O O
VIRGIL O O
L. O O
IVERY, O O
M.D. O O
VI65 O O
D:02/28/79 O O
T:02/28/79 O O
Dictated O O
by: O O
VIRGIL O O
L. O O
IVERY, O O
M.D. O O
VI65 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2079-09-28 O O
DOUGLAS O O
EMERGENCY O O
DEPT O O
VISIT O O
DODD,STEVEN O O
350-93-05-3 O O
VISIT O O
DATE: O O
09/28/79 O O
The O O
patient O O
was O O
interviewed O O
and O O
examined O O
by O O
me O O
as O O
well O O
as O O
by O O
the O O
resident. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
In O O
brief, O O
this O O
is O O
a O O
64-year-old O O
gentleman O O
with O O
morbid O O
obesity. B-OBESE O
He O O
is O O
on O O
CPAP. O O
He O O
has O O
CHF, O O
hypertension, B-HYPERTENSION B-HYPERTENSION
chronic O O
renal O O
insufficiency, O O
triple O O
bypass, O O
and O O
diabetes. B-DIABETES O
He O O
had O O
three B-CAD O
episodes I-CAD O
of I-CAD O
chest I-CAD O
pain I-CAD O
which I-CAD O
woke I-CAD O
him I-CAD O
up I-CAD O
from I-CAD O
CPAP I-CAD O
last I-CAD O
last I-CAD O
night. I-CAD O
Each I-CAD O
episode I-CAD O
reminded I-CAD O
him I-CAD O
of I-CAD O
his I-CAD O
typical I-CAD O
angina, I-CAD O
but O O
the O O
last O O
time O O
he O O
had O O
it O O
was O O
in O O
May. O O
Those O O
three O O
episodes O O
were O O
resolved O O
with O O
one O O
sublingual B-MEDICATION O
nitroglycerin. B-MEDICATION B-MEDICATION
He O O
woke O O
up O O
today O O
and O O
thought O O
he O O
needed O O
to O O
be O O
evaluated. O O
He O O
is O O
also O O
complaining O O
of O O
low O O
grade O O
temperature. O O
He O O
has O O
recently O O
been O O
receiving O O
VNA O O
services O O
as O O
a O O
result O O
of O O
a O O
left O O
foot O O
ulcer O O
as O O
a O O
result O O
of O O
an O O
oxygen O O
tank O O
burn. O O
His O O
VNA O O
came O O
to O O
visit O O
him O O
today O O
and O O
found O O
that O O
he O O
had O O
some O O
crackles O O
in O O
his O O
lungs O O
with O O
a O O
temperature O O
and O O
was O O
concerned O O
about O O
a O O
pneumonia. O O
Please O O
see O O
the O O
resident's O O
note O O
for O O
details. O O
REVIEW O O
OF O O
SYSTEMS: O O
He O O
denies O O
chest O O
pain O O
now. O O
No O O
shortness O O
of O O
breath O O
now. O O
He O O
states O O
that O O
his O O
foot O O
appears O O
to O O
be O O
getting O O
better. O O
MEDICATIONS: O O
Atenolol, B-MEDICATION B-MEDICATION
aspirin, B-MEDICATION B-MEDICATION
isosorbide, B-MEDICATION B-MEDICATION
Lasix, O O
Glyburide, B-MEDICATION B-MEDICATION
Lipitor, B-MEDICATION B-MEDICATION
and O O
Lorazepam. O B-MEDICATION
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
PHYSICAL O O
EXAMINATION: O O
GENERAL O O
APPEARANCE: O O
The O O
patient O O
is O O
a O O
morbidly O O
obese O O
gentleman. O O
VITAL O O
SIGNS: O O
Temperature O O
100.2, O O
pulse O O
62, O O
respiratory O O
rate O O
18, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
173/74. I-HYPERTENSION O
O2 O O
saturation O O
is O O
99%. O O
LUNGS: O O
He O O
has O O
rales O O
at O O
the O O
right O O
base. O O
Unable O O
to O O
assess O O
JVD. O O
ABDOMEN: O O
He O O
is O O
obese O O
with O O
active O O
bowel O O
sounds. O O
EXTREMITIES: O O
Distal O O
left O O
foot O O
lateral O O
ulcer O O
is O O
dry, O O
necrotic, O O
without O O
surrounding O O
edema O O
or O O
tenderness. O O
LABORATORY O O
EVALUATION: O O
His O O
white O O
count O O
here O O
is O O
14. O O
His O O
BUN O O
and O O
creatinine O O
are O O
25 O O
and O O
2.4, O O
which O O
is O O
his O O
baseline. O O
CK O O
is O O
28, O O
troponin O O
pending. O O
INR O O
is O O
1.2. O O
EKG O O
shows O O
no O O
changes O O
from O O
prior. O O
Chest O O
x-ray O O
shows O O
right O O
pleural O O
effusion O O
with O O
question O O
right O O
paratracheal O O
mass. O O
CONSULTATIONS O O
(including O O
PCP): O O
His O O
care O O
was O O
discussed O O
with O O
the O O
Christus O O
Spohn O O
cardiology. O O
FINAL O O
DIAGNOSIS: O O
Unstable O O
angina O O
pectoris. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
He O O
is O O
going O O
to O O
be O O
treated O O
with O O
antibiotics, O O
aspirin, O B-MEDICATION
Lopressor, B-MEDICATION B-MEDICATION
and O O
admitted O O
to O O
the O O
hospital O O
for O O
a O O
rule O O
out. O O
Condition O O
on O O
admission O O
is O O
stable. O O
He O O
will O O
be O O
presumptively O O
treated O O
for O O
a O O
pneumonia O O
on O O
the O O
right O O
side. O O
___________________________________ O O
QQ632/54034 O O
FREDA O O
F. O O
PELLETIER, O O
M.D. O O
FP00 O O
D:09/28/79 O O
T:09/28/79 O O
Dictated O O
by: O O
FREDA O O
F. O O
PELLETIER, O O
M.D. O O
FP00 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2080-08-08 O O
EDVISIT^35093053^Dodd, O O
Steven^08/08/80^DURHAM, O O
DENA O O
CHRISTENA O O
CHIEF O O
COMPLAINT: O O
Chest O O
pain. O O
I O O
confirm O O
that O O
I O O
have O O
seen O O
and O O
evaluated O O
this O O
patient, O O
reviewed O O
the O O
resident's O O
documentation, O O
discussed O O
the O O
evaluation, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
is O O
a O O
65-year-old O O
gentleman O O
with O O
a O O
history O O
of O O
coronary B-CAD O
artery I-CAD O
disease I-CAD O
who O O
is O O
transferred O O
here O O
from O O
an O O
outlying O O
institution O O
after O O
an O O
episode O O
of O O
left O O
chest O O
radiated O O
to O O
his O O
arm O O
that O O
awoke O O
him O O
from O O
sleep O O
at O O
about O O
11 O O
o'clock. O O
This O O
resolved O O
after O O
some O O
sublingual B-MEDICATION O
nitroglycerin B-MEDICATION O
at O O
the O O
hospital O O
but O O
was O O
associated O O
with O O
some O O
diaphoresis. O O
He O O
cannot O O
tell O O
if O O
it O O
is O O
like O O
his O O
previous O O
coronary O O
pain O O
or O O
not. O O
REVIEW O O
OF O O
SYSTEMS: O O
Negative O O
for O O
nausea, O O
vomiting, O O
diarrhea, O O
abdominal O O
pain, O O
fever, O O
or O O
chills. O O
Otherwise, O O
negative. O O
PAST O O
MEDICAL O O
HISTORY, O O
MEDICATIONS, O O
ALLERGIES, O O
SOCIAL, O O
AND O O
FAMILY O O
HISTORY: O O
As O O
per O O
the O O
chart. O O
PHYSICAL O O
EXAMINATION: O O
Shows O O
a O O
well-developed O O
morbidly O O
obese B-OBESE O
gentleman O O
snoring O O
in O O
the O O
bed O O
in O O
no O O
acute O O
distress. O O
He O O
is O O
asymptomatic O O
when O O
I O O
see O O
him O O
and O O
complaining O O
of O O
being O O
tired. O O
HEENT O O
is O O
normocephalic, O O
atraumatic. O O
Oropharynx O O
is O O
unremarkable. O O
Neck O O
is O O
supple. O O
Chest O O
is O O
clear. O O
Abdomen O O
is O O
morbidly O O
obese, O O
soft, O O
and O O
nontender. O O
Extremities O O
are O O
without O O
cyanosis, O O
clubbing, O O
or O O
edema. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
The O O
patient O O
has O O
an O O
EKG, O O
an O O
abnormal O O
but O O
unchanged O O
in O O
comparison O O
with O O
previously. O O
He O O
had O O
a O O
total O O
troponin O O
here O O
of O O
0.99 O O
equal O O
to O O
the O O
0.1 O O
at O O
the O O
outlying O O
institution. O O
His O O
MB O O
is O O
8 O O
with O O
a O O
CK O O
of O O
242. O O
His O O
creatinine O O
is O O
also O O
4.5. O O
PLAN: O O
Admission O O
to O O
the O O
hospital O O
for O O
further O O
evaluation. O O
DIAGNOSIS: O O
Non-Q-wave, B-CAD O
non-ST-elevation I-CAD O
myocardial I-CAD O
infarction. I-CAD O
DISPOSITION: O O
The O O
patient O O
is O O
admitted O O
for O O
further O O
care. O O
______________________________ O O
DURHAM, O O
DENA O O
CHRISTENA O O
M.D. O O
D: O O
08/08/80 O O
T: O O
08/08/80 O O
Dictated O O
By: O O
DURHAM, O O
DENA O O
CHRISTENA O O
eScription O O
document:5-0405500 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2080-09-20 O O
EDVISIT^35093053^Dodd, O O
Steven^09/20/80^FARMER, O O
F. O O
KELLY O O
TIME O O
OF O O
DICTATION: O O
6:40 O O
a.m. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
patient O O
is O O
a O O
65-year-old O O
male O O
who O O
presents O O
to O O
Douglas O O
Community O O
Hospital O O
Department O O
of O O
Emergency O O
Medicine O O
with O O
complaints O O
of O O
chest B-CAD O
pain. I-CAD O
The O O
chest O O
pain O O
is O O
midsternal O O
pressure O O
type O O
in O O
sensation O O
and O O
not O O
associated O O
with O O
nausea O O
or O O
vomiting. O O
He O O
is O O
awake O O
and O O
alert O O
in O O
the O O
ED O O
and O O
noted O O
to O O
be O O
in O O
mild O O
distress. O O
This O O
patient O O
is O O
a O O
morbidly O O
obese B-OBESE O
male O O
and O O
weighs O O
approximately O O
400 O O
pounds. O O
The O O
resident's O O
note O O
was O O
reviewed. O O
The O O
patient O O
was O O
interviewed. O O
The O O
patient O O
was O O
examined O O
by O O
me. O O
I O O
concur O O
with O O
the O O
workup O O
and O O
evaluation O O
of O O
the O O
patient O O
in O O
the O O
ED. O O
For O O
more O O
detailed O O
note O O
on O O
this O O
patient, O O
please O O
review O O
the O O
resident's O O
note. O O
Please O O
review O O
the O O
resident's O O
note O O
for O O
past O O
medical O O
history, O O
surgical O O
history, O O
review O O
of O O
systems, O O
medications, O O
allergies, O O
family O O
history, O O
and O O
social O O
history. O O
PHYSICAL O O
EXAMINATION: O O
HEENT: O O
Normocephalic, O O
atraumatic. O O
Pupils O O
were O O
equal, O O
round, O O
and O O
reactive. O O
Fundi O O
were O O
benign. O O
Neck O O
was O O
supple. O O
Chest O O
was O O
clear O O
to O O
auscultation O O
and O O
percussion. O O
I O O
noted O O
no O O
rales, O O
wheezes, O O
or O O
rhonchi. O O
Heart O O
noted O O
a O O
normal O O
S1, O O
S2. O O
No O O
S3, O O
S4. O O
No O O
murmur. O O
Abdomen O O
was O O
protruding. O O
It O O
was O O
nontender. O O
I O O
noted O O
no O O
masses O O
or O O
guarding. O O
His O O
extremities O O
were O O
positive O O
for O O
1+ O O
pitting O O
edema. O O
Neurologically, O O
he O O
was O O
awake, O O
alert, O O
and O O
able O O
to O O
follow O O
all O O
commands. O O
Negative O O
Babinski. O O
LABORATORY O O
DATA: O O
He O O
had O O
a O O
white O O
count O O
of O O
7 O O
and O O
hematocrit O O
of O O
34. O O
Normal O O
serum O O
electrolytes O O
except O O
for O O
a O O
creatinine O O
of O O
4.6 O O
with O O
a O O
BUN O O
of O O
57 O O
as O O
well O O
as O O
a O O
glucose O O
of O O
213 O O
and O O
as O O
well O O
as O O
sodium O O
of O O
130. O O
His O O
troponin O O
I O O
was O O
0.69. O O
His O O
CK O O
was O O
140. O O
His O O
CK-MB O O
was O O
6.4. O O
His O O
PT O O
was O O
15, O O
PTT O O
was O O
34, O O
and O O
INR O O
was O O
1.1. O O
Chest O O
x-ray O O
noted O O
increased O O
markings O O
but O O
not O O
consistent O O
with O O
congestive O O
failure. O O
His O O
EKG O O
noted O O
a O O
normal O O
sinus O O
rhythm O O
with O O
a O O
nonspecific O O
interventricular O O
block. O O
DIAGNOSTIC O O
IMPRESSION O O
IN O O
THE O O
EMERGENCY O O
DEPARTMENT: O O
Acute O O
coronary O O
syndrome. O O
The O O
patient O O
had O O
an O O
IV O O
placed. O O
He O O
was O O
given O O
Lopressor, B-MEDICATION B-MEDICATION
heparin, O O
and O O
morphine O O
for O O
his O O
chest O O
pain, O O
and O O
admitted O O
to O O
the O O
Internal O O
Medicine O O
Service O O
for O O
further O O
workup O O
and O O
evaluation O O
of O O
his O O
chest O O
pain. O O
______________________________ O O
FARMER, O O
F. O O
KELLY O O
M.D. O O
D: O O
09/21/80 O O
T: O O
09/21/80 O O
Dictated O O
By: O O
FARMER, O O
F. O O
KELLY O O
eScription O O
document:7-5881990 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2081-03-02 O O
EDVISIT^35093053^Dodd, O O
Steven^03/02/81^CHURCH, O O
XION O O
I O O
interviewed O O
and O O
examined O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation O O
on O O
the O O
patient's O O
chart, O O
and O O
discussed O O
the O O
evaluation, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient. O O
The O O
Medical O O
Intensive O O
Care O O
Unit O O
team, O O
the O O
senior O O
admitting O O
resident, O O
and O O
other O O
members O O
of O O
the O O
medical O O
staff. O O
Please O O
refer O O
to O O
the O O
resident's O O
chart O O
for O O
details. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Briefly, O O
Mr. O O
Dodd O O
is O O
a O O
65-year-old O O
man O O
with O O
congestive O O
heart O O
failure O O
and O O
multiple O O
other O O
medical O O
problems, O O
who O O
was O O
brought O O
in O O
by O O
ambulance O O
in O O
respiratory O O
distress. O O
We O O
found O O
him O O
to O O
be O O
in O O
near O O
respiratory O O
failure. O O
He O O
was O O
treated O O
with O O
bilevel O O
positive O O
airway O O
pressure O O
ventilation O O
as O O
well O O
as O O
morphine, O O
aspirin, B-MEDICATION B-MEDICATION
Lasix, O O
and O O
nitroglycerin. B-MEDICATION O
He O O
had O O
a O O
dramatic O O
improvement. O O
Further O O
details O O
are O O
in O O
the O O
resident's O O
chart. O O
PRIMARY O O
DIAGNOSIS: O O
Congestive O O
heart O O
failure O O
exacerbation O O
with O O
incipient O O
respiratory O O
failure. O O
SECONDARY O O
DIAGNOSIS: O O
Acute O O
on O O
chronic O O
renal O O
insufficiency. O O
THIRD O O
DIAGNOSIS: O O
Urinary O O
tract O O
infection. O O
PLAN: O O
Antibiotic O O
treatment. O O
Continued O O
bilevel O O
positive O O
airway O O
pressure O O
ventilation, O O
admission O O
to O O
the O O
Medical O O
Intensive O O
Care O O
Unit. O O
CRITICAL O O
CARE O O
TIME: O O
35 O O
minutes. O O
CONDITION: O O
Fair. O O
______________________________ O O
CHURCH, O O
XION O O
M.D. O O
D: O O
03/02/81 O O
T: O O
03/02/81 O O
Dictated O O
By: O O
CHURCH, O O
XION O O
eScription O O
document:6-1192641 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2088-03-06 O O
RHINELAND O O
EMERGENCY O O
DEPT O O
VISIT O O
PIERRE,EDEN O O
241-52-56-3 O O
VISIT O O
DATE: O O
03/06/88 O O
The O O
patient O O
was O O
evaluated O O
by O O
me O O
with O O
a O O
resident. O O
The O O
resident's O O
history O O
was O O
reviewed O O
and O O
the O O
patient O O
interviewed O O
and O O
examined. O O
Briefly, O O
history O O
is O O
as O O
follows. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
patient O O
is O O
a O O
72 O O
year-old O O
female O O
complaining O O
of O O
chest B-CAD O
tightness I-CAD O
lasting O O
approximately O O
30 O O
minutes O O
after O O
climbing O O
stairs O O
at O O
home. O O
She O O
reports O O
she O O
has O O
been O O
having O O
increasing O O
bouts O O
of O O
shortness O O
of O O
breath O O
over O O
the O O
preceding O O
week. O O
She O O
denies O O
diaphoresis, O O
palpitations O O
or O O
radiations. O O
REVIEW O O
OF O O
SYSTEMS: O O
There O O
is O O
chest B-CAD O
pain, I-CAD O
as O O
noted O O
above, O O
and O O
shortness O O
of O O
breath, O O
as O O
noted O O
above. O O
All O O
other O O
systems O O
are O O
negative O O
except O O
as O O
noted. O O
PAST O O
MEDICAL O O
HISTORY: O O
Previous O O
myocardial B-CAD O
infarction I-CAD O
and O O
hypothyroidism. O O
MEDICATIONS: O O
See O O
nursing O O
note. O O
ALLERGIES: O O
Morphine O O
sulfate. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
The O O
patient O O
is O O
a O O
past B-SMOKER O
smoker I-SMOKER O
and O O
a O O
nondrinker O O
who O O
lives O O
alone. O O
Family O O
history O O
is O O
noncontributory. O O
PHYSICAL O O
EXAMINATION: O O
GENERAL: O O
Awake, O O
alert O O
and O O
in O O
no O O
acute O O
distress. O O
VITAL O O
SIGNS: O O
Stable O O
and O O
normal. O O
HEENT: O O
Benign. O O
NECK: O O
Supple. O O
LUNGS: O O
Breath O O
sounds O O
showed O O
left O O
lower O O
lobar O O
rales O O
and O O
rhonchi. O O
HEART: O O
Regular O O
rate O O
and O O
rhythm. O O
ABDOMEN: O O
Soft O O
and O O
non-tender. O O
LABORATORY O O
EVALUATION: O O
Electrolytes O O
were O O
normal. O O
Cardiac O O
enzymes O O
were O O
negative. O O
CBC O O
was O O
normal. O O
EKG O O
showed O O
sinus O O
rhythm O O
with O O
nonspecific O O
ST-T O O
wave O O
changes. O O
Chest O O
x-ray O O
showed O O
mild O O
cardiomegaly O O
without O O
other O O
abnormality. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
was O O
treated O O
with O O
aspirin, B-MEDICATION B-MEDICATION
beta B-MEDICATION O
blockers, I-MEDICATION O
and O O
oxygen. O O
Ultimately O O
she O O
was O O
admitted O O
to O O
the O O
hospital O O
for O O
definitive O O
evaluation O O
and O O
further O O
care O O
following O O
consultation O O
with O O
the O O
DHD O O
cardiologist. O O
See O O
resident's O O
note O O
for O O
further O O
details. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Admitted O O
in O O
stable O O
condition. O O
___________________________________ O O
FT188/35814 O O
ORLANDO O O
R. O O
PIERRE, O O
M.D. O O
OP63 O O
D:03/07/88 O O
T:03/07/88 O O
Dictated O O
by: O O
ORLANDO O O
R. O O
PIERRE, O O
M.D. O O
OP63 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2089-03-28 O O
RHINELAND O O
EMERGENCY O O
DEPT O O
VISIT O O
PIERRE,EDEN O O
241-52-56-3 O O
VISIT O O
DATE: O O
03/28/89 O O
The O O
patient O O
was O O
interviewed O O
and O O
examined O O
by O O
myself O O
with O O
the O O
resident O O
on O O
3/28/89. O O
Please O O
see O O
resident's O O
note O O
for O O
full O O
details. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
female O O
with O O
history O O
of O O
coronary B-CAD O
artery I-CAD O
disease, I-CAD O
AICD, O O
and O O
cardiomyopathy B-CAD O
who O O
comes O O
in O O
today O O
with O O
chest B-CAD O
pain, I-CAD O
onset O O
iffy O O
while O O
she O O
is O O
walking, O O
substernal O O
right O O
anterior O O
chest. O O
Went O O
to O O
sleep, O O
had O O
some O O
shortness O O
of O O
breath, O O
no O O
diaphoresis, O O
nausea O O
or O O
dizziness. O O
Similar O O
to O O
this O O
pain O O
in O O
the O O
past O O
was O O
her O O
myocardial B-CAD O
infarction. I-CAD O
She O O
has O O
chronic O O
risk O O
factors O O
of O O
hypercholesterolemia, B-HYPERLIPIDEMIA O
apparent O O
menopausal, O O
echocardiogram B-CAD O
on I-CAD O
9/87, I-CAD O
10 I-CAD O
to I-CAD O
15% I-CAD O
global I-CAD O
hypokinesis. I-CAD O
Catheterization B-CAD O
is I-CAD O
left I-CAD O
main I-CAD O
disease, I-CAD O
50% I-CAD O
ostial I-CAD O
disease. I-CAD O
REVIEW O O
OF O O
SYSTEMS: O O
As O O
in O O
history O O
of O O
present O O
illness O O
but O O
no O O
recent O O
upper O O
respiratory O O
infection O O
symptoms O O
or O O
orthopnea, O O
or O O
exercise O O
intolerance. O O
PAST O O
MEDICAL O O
HISTORY: O O
As O O
above. O O
Surgery O O
procedure: O O
ASAD O O
placement. O O
MEDICATIONS: O O
See O O
nurses O O
notes O O
for O O
details. O O
ALLERGIES: O O
See O O
nurses O O
notes O O
for O O
details. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
No B-SMOKER O
tobacco I-SMOKER O
or O O
ETOH. O O
Lives O O
with O O
family, O O
accompanied O O
by O O
a O O
friend O O
tonight. O O
Family O O
history: O O
Diabetes. O O
PHYSICAL O O
EXAMINATION: O O
Alert O O
and O O
awake, O O
pleasant O O
female O O
in O O
no O O
apparent O O
distress. O O
Agree O O
with O O
resident's O O
documentation O O
including O O
normal O O
pulse, O O
blood O O
pressure O O
120/86, O O
02 O O
sat O O
98%. O O
Clear O O
lungs. O O
Heart O O
is O O
regular O O
rate O O
and O O
rhythm. O O
Abdomen O O
is O O
soft. O O
Neuro: O O
Alert O O
and O O
oriented O O
x3. O O
No O O
obvious O O
cranial, O O
or O O
motor O O
or O O
sensory O O
deficit. O O
LABORATORY O O
EVALUATION: O O
Given O O
her O O
history O O
of O O
coronary O O
artery O O
disease O O
and O O
her O O
symptoms O O
an O O
electrocardiogram O O
was O O
unchanged. O O
Hematocrit O O
is O O
37. O O
BUN O O
and O O
creatinine O O
19 O O
and O O
1. O O
Liver O O
function O O
tests O O
are O O
within O O
normal O O
limits. O O
CK O O
127, O O
troponin O O
.01. O O
Electrocardiogram, O O
rhythm O O
is O O
paced, O O
unchanged O O
from O O
priors. O O
Chest O O
x-ray O O
is O O
mild O O
congestive O O
heart O O
failure O O
compared O O
to O O
prior O O
examinations. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
Aspirin B-MEDICATION B-MEDICATION
was O O
given O O
and O O
she O O
is O O
chest O O
pain O O
free O O
currently. O O
Case O O
was O O
discussed O O
with O O
Guzmans O O
Hospital O O
Cardiology. O O
Will O O
try O O
for O O
an O O
exercise O O
tolerance O O
test O O
later O O
on O O
in O O
the O O
afternoon. O O
Care O O
was O O
discussed O O
with O O
Dr. O O
Rhodes. O O
FINAL O O
DIAGNOSIS: O O
Chest O O
pain, O O
rule O O
out O O
acute O O
coronary O O
syndrome. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Patient O O
currently O O
in O O
stable O O
condition. O O
___________________________________ O O
ZP289/32887 O O
FLORENCE O O
F. O O
CASEY, O O
M.D. O O
FC44 O O
D:03/28/89 O O
T:03/28/89 O O
Dictated O O
by: O O
FLORENCE O O
F. O O
CASEY, O O
M.D. O O
FC44 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2090-07-15 O O
EDVISIT^24152563^Pierre, O O
Eden^07/15/90^MCCARTY, O O
QUINTON O O
Seen O O
with O O
Dr. O O
Feliciano. O O
The O O
past O O
medical O O
history, O O
social O O
history, O O
family O O
history, O O
review O O
of O O
systems, O O
medications, O O
and O O
allergies O O
were O O
reviewed O O
and O O
confirmed. O O
Please O O
see O O
resident's O O
note O O
for O O
further O O
details. O O
I O O
had O O
interviewed O O
and O O
examined O O
the O O
patient O O
myself. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Briefly, O O
this O O
is O O
a O O
75-year-old O O
female O O
with O O
a O O
known O O
history B-CAD O
of I-CAD O
CAD, B-CAD O
status O O
post O O
MI, B-CAD O
EF O O
of O O
10 O O
to O O
15% O O
with O O
an O O
AICD O O
placement. O O
Also, O O
history O O
of O O
CHF O O
and O O
hyperparathyroidism. O O
She O O
presents O O
with O O
complaints O O
of O O
shortness O O
of O O
breath O O
for O O
the O O
past O O
3 O O
hours O O
with O O
some O O
epigastric O O
discomfort. O O
She O O
denies O O
fever, O O
chills, O O
or O O
cough. O O
She O O
has O O
had O O
some O O
abdominal O O
and O O
chest O O
discomfort. O O
She O O
may O O
be O O
from O O
1 O O
year O O
ago O O
showing O O
no O O
reversible O O
ischemia O O
but O O
a O O
previous O O
catheterization O O
showing O O
no O O
disease. O O
SOCIAL O O
HISTORY: O O
She O O
lives O O
with O O
her O O
family. O O
She O O
is O O
a O O
former B-SMOKER O
smoker. I-SMOKER O
REVIEW O O
OF O O
SYSTEMS: O O
Otherwise, O O
negative. O O
MEDICATIONS: O O
She O O
takes O O
albuterol, O O
Lipitor, B-MEDICATION B-MEDICATION
captopril, B-MEDICATION B-MEDICATION
digoxin, O O
Levoxyl, O O
Lasix, O O
and O O
Coumadin. O O
ALLERGIES: O O
Has O O
allergies O O
to O O
morphine. O O
PHYSICAL O O
EXAMINATION: O O
She O O
is O O
afebrile, O O
heart O O
rate111, O O
blood O O
pressure O O
105/7118, O O
and O O
oxygen O O
saturation O O
100% O O
on O O
4 O O
liters. O O
She O O
is O O
awake, O O
alert, O O
and O O
in O O
moderate O O
distress. O O
HEENT: O O
Normocephalic, O O
atraumatic. O O
Pupils: O O
Equal, O O
round O O
and O O
reactive O O
to O O
light. O O
Sclerae O O
are O O
anicteric. O O
Neck O O
is O O
supple O O
and O O
nontender. O O
Chest O O
is O O
with O O
bibasilar O O
crackles. O O
Cardiovascular O O
exam: O O
Irregularly O O
irregular O O
with O O
a O O
2/6 O O
systolic O O
murmur O O
at O O
the O O
left O O
upper O O
sternal O O
border. O O
Abdomen O O
is O O
soft O O
and O O
nontender. O O
Skin O O
is O O
warm O O
and O O
dry. O O
Extremities O O
without O O
clubbing, O O
cyanosis, O O
or O O
edema. O O
Neurological: O O
Alert O O
and O O
oriented. O O
Cranial O O
nerves O O
II O O
through O O
XII O O
are O O
intact. O O
There O O
are O O
no O O
motor O O
or O O
sensory O O
deficits. O O
Initial O O
cardiogram O O
showing O O
numerous O O
PVCs O O
with O O
occasional O O
negative O O
complex O O
is O O
consistent O O
with O O
her O O
previous O O
EKG O O
with O O
the O O
appearance O O
of O O
likely O O
atrial O O
fibrillation. O O
After O O
some O O
diuresis O O
and O O
a O O
beta O O
blockade, O O
she O O
has O O
slowed O O
down O O
to O O
the O O
90s O O
from O O
the O O
130s O O
and O O
appeared O O
to O O
have O O
normal O O
sinus O O
rhythm O O
with O O
frequent O O
PVCs. O O
Her O O
chest O O
film O O
shows O O
some O O
mild O O
CHF, O O
and O O
she O O
was O O
started O O
on O O
heparin. O O
LABORATORY O O
DATA: O O
Sodium O O
134, O O
glucose O O
178. O O
Normal O O
extending O O
chemistries. O O
CK O O
of O O
115 O O
with O O
an O O
MB O O
of O O
2. O O
Digoxin O O
level O O
is O O
0.8. O O
TSH O O
is O O
8.8. O O
Troponin O O
is O O
less O O
than O O
assay. O O
White O O
count O O
is O O
7.5, O O
hematocrit O O
42, O O
and O O
platelets O O
238,000. O O
INR O O
2.1. O O
Heparin O O
was O O
not O O
initiated O O
as O O
she O O
was O O
already O O
anticoagulated, O O
but O O
she O O
did O O
receive O O
diuresis. O O
She O O
is O O
admitted O O
in O O
stable O O
condition. O O
CLINICAL O O
IMPRESSION: O O
Unstable B-CAD O
angina I-CAD O
with O O
frequent O O
PVCs. O O
Her O O
cardiology O O
consultation O O
is O O
pending O O
at O O
this O O
time. O O
______________________________ O O
MCCARTY, O O
QUINTON O O
M.D. O O
D: O O
07/16/90 O O
T: O O
07/16/90 O O
Dictated O O
By: O O
MCCARTY, O O
QUINTON O O
eScription O O
document:1-6926631 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2091-10-14 O O
EDVISIT^24152563^Pierre, O O
Eden^10/14/91^PITTMAN, O O
THOMAS O O
CHIEF O O
COMPLAINT: O O
Shortness O O
of O O
breath. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
67-year-old O O
female O O
with O O
end-stage O O
cardiac O O
disease O O
with O O
ischemic B-CAD O
cardiomyopathy, I-CAD O
who O O
I O O
see O O
together O O
with O O
the O O
resident. O O
The O O
resident's O O
history O O
was O O
reviewed. O O
The O O
patient O O
was O O
interviewed O O
and O O
examined O O
by O O
me. O O
In O O
brief, O O
apparently O O
the O O
EMS O O
was O O
summoned O O
to O O
the O O
scene O O
inadvertently O O
this O O
morning. O O
She O O
is O O
end-stage, O O
she O O
is O O
on O O
hospice O O
and O O
comfort O O
measures O O
only, O O
and O O
she O O
apparently O O
was O O
quite O O
poorly O O
feeling O O
this O O
morning O O
and O O
was O O
transported. O O
Her O O
son O O
has O O
called O O
several O O
times O O
and O O
wants O O
to O O
transport O O
her O O
back O O
in O O
a O O
discussion O O
with O O
her. O O
She O O
is O O
quite O O
weak O O
and O O
understands O O
her O O
circumstances, O O
wishes O O
to O O
be O O
transported O O
back O O
as O O
well. O O
PAST O O
MEDICAL O O
HISTORY, O O
REVIEW O O
OF O O
SYSTEMS, O O
SOCIAL O O
HISTORY, O O
MEDICATIONS, O O
AND O O
ALLERGIES: O O
All O O
per O O
the O O
chart. O O
PHYSICAL O O
EXAMINATION: O O
She O O
is O O
alert. O O
She O O
certainly O O
appears O O
end-stage. O O
She O O
has O O
a O O
JVP O O
at O O
14-16 O O
cm. O O
She O O
has O O
lungs O O
with O O
decreased O O
breath O O
sounds O O
throughout O O
her O O
heart. O O
There O O
is O O
a O O
3/6 O O
holosystolic O O
murmur O O
heard O O
very O O
weakly. O O
Her O O
abdomen O O
is O O
soft O O
and O O
nontender O O
without O O
organomegaly. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
She O O
has O O
electrocardiogram, O O
which O O
is O O
remarkable O O
for O O
sinus O O
rhythm O O
with O O
nonspecific O O
intraventricular O O
conduction O O
delay O O
and O O
ugly O O
appearing. O O
Electrocardiogram O O
is O O
rather O O
wide O O
complexed. O O
She O O
has O O
a O O
first-degree O O
AV O O
block O O
and O O
a O O
leftward O O
axis. O O
The O O
case O O
was O O
discussed O O
with O O
her O O
cardiologist, O O
social O O
worker, O O
case O O
manager, O O
and O O
family O O
and O O
she O O
is O O
discharged O O
home. O O
IMPRESSION: O O
End-stage B-CAD O
ischemic I-CAD O
cardiomyopathy. I-CAD O
DISPOSITION O O
AND O O
PLAN: O O
She O O
is O O
discharged O O
home O O
to O O
continue O O
with O O
hospice O O
and O O
expectant O O
care. O O
______________________________ O O
PITTMAN, O O
THOMAS O O
M.D. O O
D: O O
10/14/91 O O
T: O O
10/14/91 O O
Dictated O O
By: O O
PITTMAN, O O
THOMAS O O
eScription O O
document:1-6434630 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2067-06-18 O O
JELLICO O O
EMERGENCY O O
DEPT O O
VISIT O O
FOY,KEONTE O O
H. O O
732-35-79-0 O O
VISIT O O
DATE: O O
06/18/67 O O
PRESENTING O O
COMPLAINT O O
and O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
patient O O
was O O
evaluated O O
in O O
conjunction O O
with O O
a O O
resident. O O
Briefly, O O
the O O
history O O
is O O
as O O
follows: O O
This O O
patient O O
is O O
a O O
54-year-old O O
black O O
male O O
with O O
a O O
history O O
of O O
insulin-dependent B-DIABETES O
diabetes I-DIABETES O
mellitus, I-DIABETES O
who O O
presents O O
with O O
acute, O O
severe B-CAD O
substernal I-CAD O
chest I-CAD O
pain. I-CAD O
This O O
pain O O
began O O
approximately O O
five O O
hours O O
prior O O
to O O
presentation, O O
but O O
accelerated O O
within O O
the O O
previous O O
one O O
to O O
two O O
hours. O O
It O O
is O O
accompanied O O
by O O
diaphoresis, O O
but O O
not O O
by O O
shortness O O
of O O
breath O O
or O O
nausea. O O
The O O
patient O O
does O O
have O O
a O O
history O O
of O O
prior O O
CVAs, O O
but O O
no O O
history O O
of O O
previously O O
documented O O
cardiac O O
disease. O O
PHYSICAL O O
EXAMINATION: O O
On O O
physical O O
examination, O O
the O O
patient O O
is O O
in O O
acute, O O
severe O O
distress. O O
He O O
is O O
diaphoretic O O
and O O
somewhat O O
pale. O O
The O O
vital O O
signs O O
are O O
as O O
recorded O O
in O O
the O O
Nurses' O O
Notes O O
but O O
are O O
stable O O
initially. O O
The O O
HEENT O O
examination O O
shows O O
the O O
sclerae O O
to O O
be O O
anicteric. O O
The O O
oropharynx O O
is O O
somewhat O O
dry. O O
The O O
neck O O
is O O
supple, O O
without O O
venous O O
distention. O O
The O O
breath O O
sounds O O
are O O
clear O O
bilaterally. O O
The O O
heart O O
shows O O
a O O
regular O O
rate O O
and O O
rhythm O O
with O O
somewhat O O
distant O O
tones, O O
without O O
discrete O O
murmur. O O
The O O
abdomen O O
is O O
slightly O O
obese O O
and O O
soft O O
throughout, O O
without O O
tenderness. O O
The O O
extremities O O
show O O
no O O
discoloration O O
or O O
edema. O O
LABORATORY O O
EVALUATION: O O
The O O
electrocardiogram O O
shows O O
an O O
acute B-CAD O
anterior I-CAD O
myocardial I-CAD O
infarction. I-CAD O
Other O O
laboratory O O
studies O O
are O O
pending O O
at O O
this O O
time. O O
A O O
chest O O
x-ray O O
has O O
been O O
obtained, O O
though O O
it O O
has O O
not O O
been O O
processed O O
at O O
the O O
time O O
of O O
this O O
dictation. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
was O O
treated O O
with O O
aspirin B-MEDICATION B-MEDICATION
and O O
nitroglycerin B-MEDICATION B-MEDICATION
en O O
route. O O
He O O
was O O
started O O
on O O
a O O
nitroglycerin B-MEDICATION O
drip, I-MEDICATION O
which O O
was O O
incrementally O O
increased O O
to O O
80 O O
micrograms O O
per O O
minute. O O
He O O
was O O
given O O
morphine O O
sulfate O O
in O O
2 O O
mg O O
increments O O
to O O
a O O
total O O
of O O
10 O O
mg. O O
He O O
was O O
given O O
5000 O O
units O O
of O O
intravenous O O
heparin. O O
He O O
was O O
given O O
2.5 O O
mg O O
of O O
intravenous B-MEDICATION O
Lopressor. B-MEDICATION B-MEDICATION
The O O
Cardiology O O
Service O O
is O O
here O O
with O O
the O O
patient O O
and O O
he O O
is O O
being O O
taken O O
to O O
the O O
Cardiac O O
Catheterization O O
Laboratory O O
for O O
immediate O O
angioplasty. O O
FINAL O O
DIAGNOSIS: O O
Myocardial O O
infarction. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
As O O
above. O O
Please O O
see O O
the O O
handwritten O O
record O O
for O O
further O O
details. O O
___________________________________ O O
HA304/1577 O O
EDGAR O O
BELTRAN, O O
M.D. O O
EB83 O O
D:06/18/67 O O
T:06/18/67 O O
Dictated O O
by: O O
EDGAR O O
BELTRAN, O O
M.D. O O
EB83 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2067-07-28 O O
JELLICO O O
EMERGENCY O O
DEPT O O
VISIT O O
FOY,KEONTE O O
H. O O
732-35-79-0 O O
VISIT O O
DATE: O O
07/28/67 O O
PRESENTING O O
COMPLAINT: O O
Chest O O
pain. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
was O O
seen O O
in O O
the O O
emergency O O
department O O
with O O
Dr. O O
Holden. O O
History O O
was O O
reviewed O O
with O O
Dr. O O
Holden O O
and O O
patient. O O
Briefly, O O
this O O
is O O
a O O
59 O O
year O O
old O O
gentleman O O
with O O
a O O
past O O
medical O O
history O O
positive O O
for O O
insulin B-DIABETES O
dependent I-DIABETES O
diabetes, I-DIABETES O
CVA, O O
peptic O O
ulcer O O
disease, O O
who O O
presented O O
to O O
the O O
emergency O O
department O O
with O O
acute B-CAD O
substernal I-CAD O
chest I-CAD O
pain I-CAD O
radiating I-CAD O
to I-CAD O
the I-CAD O
left I-CAD O
arm, I-CAD O
positive O O
diaphoresis O O
and O O
shortness O O
of O O
breath, O O
three O O
or O O
four O O
episodes O O
in O O
the O O
last O O
few O O
hours, O O
the O O
last O O
episode O O
lasting O O
20 O O
minutes. O O
REVIEW O O
OF O O
SYSTEMS: O O
As O O
documented O O
by O O
Dr. O O
Holden. O O
PAST O O
MEDICAL O O
HISTORY: O O
As O O
documented O O
by O O
Dr. O O
Holden. O O
MEDICATIONS: O O
As O O
documented O O
by O O
Dr. O O
Holden. O O
ALLERGIES: O O
As O O
documented O O
by O O
Dr. O O
Holden. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
As O O
documented O O
by O O
Dr. O O
Holden. O O
PHYSICAL O O
EXAMINATION: O O
No O O
acute O O
distress. O O
Blood O O
pressure O O
is O O
120/100, O O
pulse O O
100 O O
and O O
regular, O O
respirations O O
16, O O
afebrile, O O
O2 O O
sat O O
on O O
room O O
air O O
97%. O O
Negative O O
HEENT. O O
Patent O O
airway. O O
Neck: O O
Supple, O O
no O O
JVD, O O
nodes O O
or O O
bruits. O O
Lungs: O O
Clear, O O
equal O O
breath O O
sounds. O O
Heart: O O
Regular O O
rate, O O
no O O
murmur. O O
No O O
chest O O
wall O O
tenderness. O O
Abdomen: O O
Soft, O O
positive O O
bowel O O
sounds. O O
Extremities: O O
No O O
deformities. O O
Guaiac O O
negative. O O
Neurologic: O O
Alert, O O
nonfocal. O O
The O O
rest O O
of O O
the O O
examination O O
is O O
unremarkable. O O
LABORATORY O O
EVALUATION: O O
Electrolytes, O O
BUN O O
and O O
creatinine O O
were O O
within O O
normal O O
limits. O O
Glucose O O
of O O
26. O O
CBC O O
negative. O O
CK O O
75, O O
troponin O O
0. O O
EKG O O
shows O O
hyperacute O O
T O O
wave O O
in O O
V1 O O
and O O
V2. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
In O O
the O O
emergency O O
department, O O
the O O
patient O O
was O O
treated O O
with O O
IV O O
Heparin, O O
Nitroglycerin, B-MEDICATION O
aspirin. B-MEDICATION B-MEDICATION
Symptoms O O
improved O O
markedly, O O
and O O
he O O
was O O
transferred O O
to O O
the O O
Cardiac O O
Service O O
for O O
further O O
evaluation O O
and O O
treatment. O O
FINAL O O
DIAGNOSIS: O O
Chest O O
pain, O O
rule O O
out O O
M.I. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Total O O
time O O
was O O
2 O O
hours. O O
Condition O O
on O O
admission O O
stable. O O
___________________________________ O O
MF916/9742 O O
TAYLOR O O
E. O O
INNIS, O O
M.D. O O
TI56 O O
D:07/28/67 O O
T:07/28/67 O O
Dictated O O
by: O O
TAYLOR O O
E. O O
INNIS, O O
M.D. O O
TI56 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2068-12-22 O O
Jellico O O
EMERGENCY O O
DEPT O O
VISIT O O
FOY,KEONTE O O
H. O O
732-35-79-0 O O
VISIT O O
DATE: O O
12/22/68 O O
The O O
patient O O
was O O
seen O O
by O O
me O O
and O O
examined. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
Briefly, O O
the O O
history O O
is O O
as O O
follows: O O
the O O
patient O O
is O O
a O O
60-year-old O O
black O O
male O O
with O O
past O O
medical O O
history O O
significant O O
for O O
insulin B-DIABETES O
dependent I-DIABETES O
diabetes I-DIABETES O
mellitus, I-DIABETES O
coronary B-CAD O
artery I-CAD O
disease, I-CAD O
status O O
post O O
a O O
myocardial B-CAD O
infarction, I-CAD O
status O O
post O O
cerebrovascular O O
accident O O
who O O
now O O
presents O O
for O O
evaluation O O
of O O
syncope. O O
The O O
patient O O
states O O
that O O
this O O
PM O O
he O O
had O O
an O O
episode O O
where O O
he O O
experienced O O
nausea, O O
dizziness O O
and O O
weakness. O O
He O O
also O O
states O O
that O O
he O O
developed O O
left B-CAD O
sided I-CAD O
substernal I-CAD O
chest I-CAD O
pressure I-CAD O
which O O
was O O
non-radiating. O O
He O O
states O O
that O O
he O O
took O O
one O O
sublingual O O
nitroglycerin B-MEDICATION O
with O O
relief O O
of O O
his O O
discomfort. O O
He O O
states O O
that O O
after O O
about O O
10 O O
minutes O O
he O O
had O O
a O O
brief O O
syncopal O O
episode O O
lasting O O
20-30 O O
seconds. O O
He O O
states O O
that O O
it O O
was O O
witnessed O O
by O O
his O O
wife O O
and O O
it O O
was O O
non-observed O O
seizure O O
activity, O O
incontinence, O O
or O O
post O O
ictal O O
confusion. O O
He O O
states O O
that O O
the O O
episode O O
occurred O O
while O O
he O O
was O O
walking O O
to O O
the O O
bathroom. O O
He O O
does O O
remember O O
falling O O
to O O
the O O
floor, O O
but O O
denies O O
any O O
trauma. O O
He O O
specifically O O
denies O O
any O O
headache, O O
neck O O
pain, O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
abdominal O O
pain, O O
or O O
focal O O
numbness O O
or O O
weakness. O O
The O O
patient O O
was O O
found O O
by O O
paramedics O O
awake, O O
alert, O O
oriented O O
x O O
3. O O
An O O
Accu-Chek O O
in O O
the O O
field O O
revealed O O
a O O
blood O O
sugar O O
of O O
30 O O
and O O
the O O
patient O O
was O O
treated O O
with O O
1 O O
amp O O
of O O
D50. O O
He O O
was O O
subsequently O O
transferred O O
to O O
Jellico O O
Community O O
Hospital O O
Emergency O O
Department O O
for O O
further O O
evaluation O O
and O O
management. O O
REVIEW O O
OF O O
SYSTEMS: O O
Review O O
of O O
systems O O
is O O
as O O
noted O O
above. O O
PAST O O
MEDICAL O O
HISTORY: O O
Past O O
medical O O
history O O
is O O
as O O
noted O O
above. O O
MEDICATIONS: O O
Current O O
medications O O
are O O
significant O O
for O O
atenolol, B-MEDICATION B-MEDICATION
Axid, O O
nitroglycerin, O O
Coumadin O O
and O O
insulin. O O
ALLERGIES: O O
He O O
has O O
a O O
known O O
drug O O
allergy O O
to O O
zocor. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
Social O O
history O O
is O O
significant O O
for O O
the O O
patient O O
stop B-SMOKER O
smoking I-SMOKER O
approximately I-SMOKER O
one I-SMOKER O
year I-SMOKER O
ago. I-SMOKER O
He O O
denies O O
alcohol O O
use. O O
PHYSICAL O O
EXAMINATION: O O
GENERAL O O
EXAMINATION: O O
Well-developed, O O
well-nourished, O O
well-appearing O O
male O O
in O O
no O O
acute O O
distress. O O
VITAL O O
SIGNS: O O
Temperature O O
100.3, O O
blood O O
pressure O O
110/65, O O
pulse O O
84, O O
respiratory O O
rate O O
18 O O
and O O
oxygen O O
saturation O O
is O O
96% O O
on O O
room O O
air. O O
HEAD, O O
EYES, O O
EARS, O O
NOSE O O
AND O O
THROAT O O
EXAMINATION: O O
Normocephalic O O
and O O
atraumatic. O O
Mucous O O
membranes O O
are O O
moist O O
without O O
lesions. O O
NECK O O
EXAMINATION: O O
The O O
neck O O
is O O
supple, O O
non-tender O O
with O O
full O O
range O O
of O O
motion O O
and O O
no O O
JVD. O O
LUNGS: O O
Lungs O O
are O O
clear O O
to O O
auscultation. O O
CARDIOVASCULAR O O
EXAMINATION: O O
Heart O O
has O O
a O O
regular O O
rate O O
and O O
rhythm. O O
ABDOMINAL O O
EXAMINATION: O O
Abdomen O O
is O O
soft, O O
non-tender O O
and O O
non-distended. O O
PELVIC O O
EXAMINATION: O O
Pelvis O O
is O O
stable. O O
BACK O O
EXAMINATION: O O
Back O O
has O O
no O O
costovertebral O O
angle O O
tenderness. O O
No O O
midline, O O
thoracic, O O
lumbar, O O
and O O
sacral O O
spine O O
tenderness. O O
EXTREMITIES: O O
Extremities O O
are O O
atraumatic, O O
full O O
range O O
of O O
motion O O
with O O
no O O
clubbing, O O
cyanosis, O O
or O O
edema. O O
No O O
calf O O
tenderness O O
and O O
negative O O
Homan's O O
signs. O O
NEUROLOGIC O O
EXAMINATION: O O
Awake, O O
alert O O
and O O
oriented O O
x O O
3. O O
Speech O O
is O O
clear, O O
fluent O O
and O O
articulate. O O
Cranial O O
nerves O O
II-XII O O
intact. O O
Motor O O
is O O
5/5. O O
Reflexes O O
are O O
2+ O O
with O O
downgoing O O
toes. O O
Cerebella, O O
finger O O
to O O
nose O O
intact. O O
Gait O O
was O O
not O O
tested. O O
LABORATORY O O
EVALUATION: O O
CBC, O O
white O O
blood O O
cell O O
count O O
15, O O
hematocrit O O
44, O O
and O O
platelets O O
346. O O
SMA O O
7 O O
notable O O
for O O
a O O
blood O O
sugar O O
of O O
264, O O
creatine O O
phosphokinase O O
42, O O
cardiac O O
troponin O O
I O O
0.0 O O
and O O
INR O O
of O O
3.6. O O
ELECTROCARDIOGRAM: O O
Electrocardiogram O O
revealed O O
a O O
normal O O
sinus O O
rhythm O O
at O O
a O O
rate O O
of O O
86 O O
with O O
right O O
bundle O O
branch O O
block O O
and O O
nonspecific O O
T O O
wave O O
changes. O O
CHEST O O
X-RAY: O O
Chest O O
x-ray O O
is O O
pending. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
will O O
be O O
admitted O O
to O O
the O O
Medical O O
Service O O
for O O
further O O
evaluation O O
and O O
management. O O
His O O
primary O O
care O O
physician, O O
Dr. O O
Hooper O O
was O O
notified O O
and O O
agreed O O
with O O
the O O
management O O
and O O
plan. O O
CONSULTATIONS O O
(including O O
PCP): O O
His O O
primary O O
care O O
physician, O O
Dr. O O
Hooper. O O
FINAL O O
DIAGNOSIS: O O
1. O O
Syncope, O O
rule O O
out O O
myocardial O O
infarction. O O
2. O O
Hypoglycemia, O O
resolved. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
was O O
admitted O O
to O O
the O O
hospital O O
in O O
satisfactory O O
condition. O O
___________________________________ O O
PD770/9096 O O
KYLE O O
TEAGUE, O O
M.D. O O
KT24 O O
D:12/23/68 O O
T:12/23/68 O O
Dictated O O
by: O O
KYLE O O
TEAGUE, O O
M.D. O O
KT24 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2070-06-15 O O
JELLICO O O
COMMUNITY O O
HOSPITAL O O
Jellico O O
Internal O O
Medicine O O
Associates O O
44 O O
Brigham O O
St O O
Elwood, O O
OH O O
49817 O O
Foy, O O
Keonte O O
73235790 O O
06/15/70 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
pleasant O O
62-year-old O O
African O O
American O O
gentleman O O
returns O O
to O O
my O O
clinic O O
today O O
for O O
follow-up O O
of O O
diabetes, B-DIABETES O
status O O
post O O
MI, B-CAD O
hyperlipidemia, B-HYPERLIPIDEMIA O
and O O
hypertension. B-HYPERTENSION B-HYPERTENSION
1. O O
He O O
brings O O
in O O
his O O
blood O O
sugar O O
values O O
with O O
him O O
today. O O
These O O
are O O
improved O O
since O O
his O O
last O O
visit, O O
and O O
somewhat O O
more O O
believable O O
ranging O O
from O O
128 O O
to O O
195, O O
predominantly O O
higher O O
in O O
the O O
evenings O O
more O O
than O O
the O O
mornings O O
ranging O O
from O O
150 O O
to O O
190. O O
He O O
is O O
currently O O
on O O
a O O
somewhat O O
odd O O
regime O O
of O O
6 O O
units O O
of O O
insulin B-MEDICATION O
regular I-MEDICATION O
twice O O
a O O
day, O O
with O O
a O O
large O O
24 O O
units O O
of O O
insulin O O
at O O
night, O O
and O O
14 O O
units O O
insulin O O
in O O
the O O
morning. O O
He O O
has O O
not O O
had O O
any O O
further O O
hypoglycemic O O
attacks, O O
is O O
having O O
no O O
nocturnal O O
awakening, O O
and O O
seems O O
to O O
be O O
sticking O O
more O O
to O O
the O O
diet. O O
He O O
has O O
however O O
gained O O
some O O
weight, O O
which O O
is O O
a O O
little O O
disconcerting. O O
He O O
does O O
attend O O
a O O
podiatrist O O
and O O
is O O
doing O O
well O O
from O O
that O O
perspective. O O
He O O
is O O
to O O
return O O
to O O
the O O
ophthalmologist O O
for O O
further O O
diabetic O O
screening O O
later O O
on O O
in O O
the O O
year. O O
He O O
missed O O
his O O
last O O
nutrition O O
appointment O O
and O O
is O O
not O O
interested O O
in O O
further O O
follow-up O O
with O O
nutrition O O
at O O
this O O
time. O O
2. O O
Cardiovascular. O O
He O O
is O O
on O O
atorvastatin B-MEDICATION B-MEDICATION
20 O O
mg O O
for O O
hyperglyceridemia, O O
atenolol B-MEDICATION B-MEDICATION
25 O O
mg, O O
and O O
aspirin. B-MEDICATION B-MEDICATION
Further O O
question O O
regarding O O
his O O
stroke O O
back O O
in O O
2061 O O
shows O O
that O O
this O O
presents O O
with O O
confusional O O
episode O O
with O O
unsteadiness, O O
resolving O O
after O O
approximately O O
36 O O
hours, O O
and O O
he O O
was O O
found O O
to O O
have O O
a O O
hole O O
in O O
his O O
heart O O
at O O
that O O
time. O O
He O O
was O O
eventually O O
stopped O O
off O O
Coumadin O O
in O O
2063, O O
but O O
had O O
a O O
recurrent O O
episode O O
at O O
that O O
time O O
and O O
he O O
was O O
put O O
on O O
Coumadin O O
for O O
life O O
at O O
that O O
point. O O
He O O
had O O
an O O
aborted B-CAD O
myocardial I-CAD O
infarction I-CAD O
in I-CAD O
2067. I-CAD O
He O O
has O O
had O O
no O O
chest O O
pain O O
in O O
the O O
interim, O O
has O O
good O O
exercise O O
tolerance O O
with O O
walking, O O
although, O O
he O O
can O O
only O O
run O O
about O O
50 O O
yards O O
before O O
getting O O
very O O
short O O
of O O
breath. O O
He O O
has O O
no O O
orthopnea O O
or O O
PND. O O
He O O
has O O
no O O
chest O O
pain O O
or O O
use O O
of O O
sublingual O O
nitro. O O
3. O O
Health O O
maintenance. O O
We O O
discussed O O
screening O O
colonoscopy O O
versus O O
flexible O O
sigmoidoscopy O O
and O O
the O O
relative O O
benefit O O
of O O
each O O
of O O
those. O O
He O O
has O O
agreed O O
to O O
proceed O O
with O O
colonoscopy, O O
and O O
I O O
have O O
instructed O O
him O O
stop O O
his O O
Coumadin O O
and O O
aspirin O B-MEDICATION
five O O
days O O
before O O
the O O
test O O
and O O
to O O
have O O
an O O
INR O O
checked O O
on O O
the O O
day O O
prior O O
to O O
the O O
test. O O
This O O
will O O
be O O
scheduled O O
by O O
our O O
secretary. O O
He O O
will O O
restart O O
the O O
Coumadin O O
after O O
the O O
colonoscopy O O
at O O
his O O
standard O O
dose O O
and O O
titrate O O
up O O
slowly. O O
CURRENT O O
MEDICATIONS: O O
Include O O
aspirin, O B-MEDICATION
atenolol, O B-MEDICATION
insulin, O O
Coumadin, O O
and O O
Lipitor. O B-MEDICATION
Foy, O O
Keonte O O
73235790 O O
06/15/70 O O
Page O O
2 O O
PHYSICAL O O
EXAMINATION: O O
His O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
148/82. I-HYPERTENSION O
He O O
is O O
tachycardic O O
at O O
98 O O
beats O O
per O O
minute. O O
Examination O O
of O O
his O O
eyes O O
shows O O
persistent O O
left- O O
sided O O
cataract. O O
Examination O O
of O O
the O O
heart O O
and O O
lungs O O
was O O
normal. O O
The O O
abdominal O O
examination O O
is O O
also O O
normal. O O
His O O
injection O O
sites O O
were O O
clean O O
and O O
without O O
erythema. O O
There O O
is O O
no O O
evidence O O
of O O
peripheral O O
neuropathy O O
and O O
his O O
feet O O
appeared O O
well. O O
We O O
spent O O
some O O
time O O
today O O
talking O O
about O O
diabetes O O
education O O
again, O O
including O O
appropriate O O
foods, O O
drinks, O O
and O O
what O O
items O O
to O O
avoid. O O
PLAN: O O
1. O O
Supplied O O
educational O O
materials O O
regarding O O
diabetes O O
management, O O
including O O
calorie O O
counting, O O
weight O O
loss, O O
information O O
about O O
hypoglycemia O O
and O O
hyperglycemia, O O
and O O
diabetic O O
eye O O
care. O O
2. O O
I O O
have O O
increased O O
insulin O O
in O O
the O O
mornings O O
from O O
14 O O
to O O
16 O O
units O O
and O O
left O O
the O O
other O O
doses O O
as O O
is. O O
3. O O
I O O
have O O
increased O O
the O O
atenolol O B-MEDICATION
from O O
25 O O
mg O O
to O O
50 O O
mg O O
for O O
hypertension O O
and O O
cardioprotection O O
with O O
the O O
tachycardia. O O
4. O O
We O O
will O O
check O O
cholesterol, O O
hemoglobin O O
A1c, O O
CBC, O O
and O O
chem-7. O O
5. O O
I O O
have O O
scheduled O O
an O O
elective O O
outpatient O O
colonoscopy O O
as O O
detailed O O
above O O
for O O
colorectal O O
cancer O O
screening. O O
6. O O
Return O O
to O O
see O O
in O O
a O O
week's O O
time, O O
understands. O O
He O O
can O O
discuss O O
any O O
management O O
issues O O
regarding O O
his O O
insulin O O
doses O O
or O O
others O O
anytime. O O
Yale O O
Jordan, O O
M.D. O O
YJ:isenberg:74:585:40;00-10142.doc;DD:06/15/70;DT:06/16/70;DV:06/15/70 O O
========================== O O
Preceptor's O O
Note O O
========================== O O
62 O O
year O O
old O O
man O O
with O O
dm O O
and O O
vascular O O
disease. O O
He O O
is O O
starting O O
to O O
improve O O
his O O
self-care O O
of O O
dm O O
and O O
last B-DIABETES O
a1c B-DIABETES O
was I-DIABETES O
8.2 I-DIABETES O
Blood O O
sugars O O
mostly O O
less O O
than O O
250. O O
Increased O O
am O O
insulin O O
and O O
will O O
increase O O
atenolol O B-MEDICATION
from O O
25---&gt;50 O O
mg O O
for O O
a O O
bp O O
of O O
150/88. B-HYPERTENSION O
______________________________ O O
Cochran, O O
Patricia O O
Hannah, O O
M.D. O O

Record O O
date: O O
2066-07-26 O O
CHIEF O O
COMPLAINT: O O
PER O O
DR O O
VARNEY O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
s/p O O
CABG B-CAD O
2 I-CAD O
weeks I-CAD O
ago; I-CAD O
doing O O
well O O
without O O
Sx O O
CP/SOB; O O
was O O
depressed O O
last O O
week O O
but O O
now O O
feeling O O
much O O
better O O
that O O
she O O
walking O O
outside O O
home O O
and O O
back O O
on O O
Wellbutrin O O
(inadvertantly O O
stopped) O O
Here O O
to O O
have O O
chest O O
skin O O
sutures O O
removed O O
PAST O O
MEDICAL O O
HISTORY: O O
Entered O O
By:frye O O
On:03/13/2066 O O
Endocrine O O
disorders: O O
type B-DIABETES O
II, I-DIABETES O
non-insulin I-DIABETES O
dependent I-DIABETES O
diabetes I-DIABETES O
mellitus. I-DIABETES O
REVIEW O O
OF O O
SYSTEMS: O O
Const: O O
no O O
fever, O O
chills, O O
sweats, O O
weight O O
change, O O
or O O
malaise O O
CV: O O
no O O
chest O O
pain, O O
dyspnea O O
on O O
exertion O O
or O O
palpitations O O
Resp: O O
no O O
SOB, O O
no O O
cough, O O
no O O
wheezing O O
GI: O O
no O O
abdominal O O
pain, O O
no O O
diarrhea, O O
no O O
constipation O O
Musc: O O
no O O
back, O O
shoulder, O O
limb O O
pain, O O
no O O
myalgias O O
Skin: O O
no O O
rashes O O
or O O
pruritis O O
Psych: O O
not O O
depressed O O
or O O
anxious O O
. O O
EXAMINATION: O O
well O O
appearing, O O
in O O
good O O
spirits O O
lungs O O
CTA; O O
no O O
JVD, O O
incision O O
C/D O O
without O O
erythema O O
RRR O O
nl O O
S1S2 O O
no O O
murmur/rub O O
no O O
edema O O
8 O O
sutures O O
removed O O
without O O
complication O O
from O O
along O O
chest O O
incision O O
line O O
IMPRESSION: O O
Con't O O
current O O
meds O O
smok O O
cessation O O
reinforced O O
D/C O O
dig O O
secondary O O
to O O
adverse O O
effects O O
f/u O O
cardiac O O
surg: O O
Dr. O O
Austin O O
MEDICATIONS: O O
ACETAMINOPHEN O O
W/CODEINE O O
30-300MG O O
One O O
PO O O
q4 O O
- O O
PAIN O O
: O O
07/25/2066 O O
- O O
04/17/2067 O O
ACT O O
: O O
emmons O O
Script: O O
Amt: O O
12 O O
Refill: O O
0 O O
Date: O O
07/25/2066 O O
: O O
emmons O O
LIPITOR B-MEDICATION B-MEDICATION
10MG O O
PO O O
qd O O
: O O
05/10/2066 O O
- O O
04/15/2068 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
QS O O
Refill: O O
1 O O
Date: O O
11/20/2067 O O
: O O
rosenberg O O
Glucophage B-MEDICATION B-MEDICATION
500mg O O
one O O
PO O O
bid O O
: O O
04/08/2065 O O
- O O
11/12/2067 O O
ACT O O
: O O
stephens O O
Script: O O
Amt: O O
60 O O
Refill: O O
3 O O
Date: O O
04/24/2067 O O
: O O
stephens O O
ASPIRIN B-MEDICATION B-MEDICATION
325MG O O
PO O O
qd O O
: O O
03/02/2065 O O
- O O
03/30/2074 O O
ACT O O
: O O
rosenberg O O
multivitamin O O
1 O O
po O O
qd O O
: O O
03/02/2065 O O
- O O
03/30/2074 O O
ACT O O
: O O
rosenberg O O
LOPRESSOR B-MEDICATION B-MEDICATION
50MG O O
qd O O
: O O
03/02/2065 O O
- O O
11/12/2067 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
30 O O
Refill: O O
3 O O
Date: O O
10/26/2066 O O
: O O
rosenberg O O
IMMUNIZATIONS: O O
Infl O O
11/25/2065 O O
Pneu O O
11/25/2065 O O
THIS O O
IS O O
A O O
COPY O O
PRODUCED O O
FOR O O
THE O O
LMR. O O
THE O O
ORGINAL O O
IS O O
STORED O O
ON O O
THE O O
BRIGHTPOINT O O
SERVER O O
AT O O
COLUMBIA O O
KINGWOOD O O
MEDICAL O O
CENTER O O
AND O O
IN O O
PRINT O O
IN O O
THE O O
PATIENT'S O O
CKMC O O
PAPER O O
RECORD. O O

Record O O
date: O O
2067-08-07 O O
CHIEF O O
COMPLAINT: O O
F/U O O
DF O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
f/u O O
CABG/CAD/DM B-DIABETES O
feeling O O
very O O
well O O
without O O
intercurrent O O
problems, O O
though O O
discouraged O O
about O O
wt O O
gain O O
and O O
not O O
exercsiing O O
regularly O O
still B-SMOKER O
not I-SMOKER O
smoking I-SMOKER O
after I-SMOKER O
13 I-SMOKER O
months! I-SMOKER O
taking O O
meds O O
without O O
difficulty O O
or O O
adverse O O
effects O O
checking O O
feet O O
daily; O O
no O O
CP, O O
SOB O O
orthop O O
PND O O
PAST O O
MEDICAL O O
HISTORY: O O
Entered O O
By:frye O O
On:03/13/2066 O O
Endocrine O O
disorders: O O
type B-DIABETES O
II, I-DIABETES O
non-insulin I-DIABETES O
dependent I-DIABETES O
diabetes I-DIABETES O
mellitus. I-DIABETES O
REVIEW O O
OF O O
SYSTEMS: O O
Const: O O
no O O
fever, O O
chills, O O
sweats, O O
weight O O
change, O O
or O O
malaise O O
CV: O O
no O O
chest O O
pain, O O
dyspnea O O
on O O
exertion O O
or O O
palpitations O O
Resp: O O
no O O
SOB, O O
no O O
cough, O O
no O O
wheezing O O
GI: O O
no O O
abdominal O O
pain, O O
no O O
diarrhea, O O
no O O
constipation O O
Musc: O O
no O O
back, O O
shoulder, O O
limb O O
pain, O O
no O O
myalgias O O
Skin: O O
no O O
rashes O O
or O O
pruritis O O
Psych: O O
not O O
depressed O O
or O O
anxious O O
. O O
VITAL O O
SIGNS: O O
Date/Time: O O
08/07/2067 O O
04:17 O O
PM O O
- O O
rosenberg O O
Respiration: O O
16 O O
breaths/min O O
Pulse O O
1: O O
80 O O
bpm O O
Blood O O
Pressure O O
1: O O
130 O O
/ O O
80 O O
mmHg O O
Weight: O O
202.00 O O
lbs. O O
EXAMINATION: O O
[Constitution] O O
- O O
well O O
nourished O O
and O O
developed. O O
[Eyes] O O
- O O
conjunctivae O O
clear, O O
pupils O O
equal, O O
no O O
discharge, O O
[ENMT] O O
- O O
Ears O O
- O O
, O O
external O O
ears O O
normal. O O
[ENMT] O O
- O O
Nose O O
no O O
discharge. O O
[ENMT] O O
- O O
Throat O O
- O O
normal O O
color O O
and O O
without O O
tonsillar O O
enlargement. O O
[Neck] O O
- O O
supple O O
no O O
lymphadenopathy O O
or O O
thyromegaly. O O
[CV] O O
- O O
regular O O
rate O O
no O O
murmurs, O O
rubs O O
or O O
gallops, O O
no O O
heave; O O
carotid O O
and O O
pedal O O
pulses O O
normal, O O
no O O
extremities O O
edema. O O
No O O
JVD. O O
well O O
healed O O
stermotomy O O
scar. O O
[Respiratory] O O
- O O
clear, O O
breath O O
sounds O O
bilaterally, O O
no O O
accessory O O
muscle O O
use. O O
[GI] O O
- O O
abdomen O O
soft, O O
no O O
hepatosplenomegaly, O O
no O O
abnormal O O
masses O O
or O O
hernias. O O
[Skin]- O O
no O O
significant O O
rashes O O
or O O
other O O
lesions. O O
[Musc/Skel] O O
- O O
normal O O
tone, O O
no O O
edema O O
[Neuro] O O
- O O
5/5 O O
gross O O
motor O O
strength, O O
grossly O O
normal O O
coordination O O
and O O
gait O O
[Psych] O O
- O O
alert O O
and O O
oriented O O
for O O
age, O O
normal O O
mood O O
and O O
affect O O
IMPRESSION: O O
BP O O
well O O
controlled, O O
we O O
discussed O O
elevated O O
HbA1c B-DIABETES O
fro I-DIABETES O
last I-DIABETES O
visit I-DIABETES O
of I-DIABETES O
8.3 I-DIABETES O
and O O
need O O
for O O
exercise O O
otherwise, O O
Excellent O O
secondary O O
prevention O O
regmen O O
RTC O O
3-4 O O
mo O O
ALLERGIES: O O
No O O
Known O O
Drug O O
Allergies O O
04/17/2067 O O
rosenberg O O
MEDICATIONS: O O
wellbutrin O O
sr O O
150mg O O
2 O O
tabs O O
po O O
qd O O
: O O
06/19/2067 O O
- O O
03/25/2068 O O
ACT O O
: O O
um O O
Script: O O
Amt: O O
60 O O
Refill: O O
3 O O
Date: O O
09/23/2067 O O
: O O
um O O
HYDROCHLOROTHIAZIDE B-MEDICATION O
25MG O O
One O O
PO O O
qd O O
: O O
09/06/2066 O O
- O O
03/25/2068 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
30 O O
Refill: O O
3 O O
Date: O O
11/20/2067 O O
: O O
rosenberg O O
LIPITOR B-MEDICATION B-MEDICATION
10MG O O
PO O O
qd O O
: O O
05/10/2066 O O
- O O
04/15/2068 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
QS O O
Refill: O O
1 O O
Date: O O
11/20/2067 O O
: O O
rosenberg O O
Glucophage B-MEDICATION O
500mg I-MEDICATION O
one O O
PO O O
bid O O
: O O
04/08/2065 O O
- O O
11/12/2067 O O
ACT O O
: O O
stephens O O
Script: O O
Amt: O O
60 O O
Refill: O O
3 O O
Date: O O
04/24/2067 O O
: O O
stephens O O
ASPIRIN B-MEDICATION B-MEDICATION
325MG O O
PO O O
qd O O
: O O
03/02/2065 O O
- O O
03/30/2074 O O
ACT O O
: O O
rosenberg O O
multivitamin O O
1 O O
po O O
qd O O
: O O
03/02/2065 O O
- O O
03/30/2074 O O
ACT O O
: O O
rosenberg O O
LOPRESSOR B-MEDICATION B-MEDICATION
50MG O O
qd O O
: O O
03/02/2065 O O
- O O
11/12/2067 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
30 O O
Refill: O O
3 O O
Date: O O
10/26/2066 O O
: O O
rosenberg O O
Glucophage B-MEDICATION O
850MG I-MEDICATION O
BID I-MEDICATION O
- O O
01/29/2068 O O
ACT O O
: O O
rosenberg O O
IMMUNIZATIONS: O O
Infl O O
11/25/2065 O O
Pneu O O
11/25/2065 O O
PROBLEMS O O
- O O
CARE O O
PLANS: O O
Problem: O O
a. O O
Adult O O
symptom(s) O O
Code: O O
414.00 O O
Coronary B-CAD O
Artery I-CAD O
Disease I-CAD O
Careplan: O O
RTC O O
3 O O
mo O O
secondary O O
prevention O O
counseling O O
reinforced O O
including O O
wt O O
loss, O O
exercise, O O
con't O O
smoking O O
cessation, O O
medication O O
adherence, O O
diet, O O
ASA, O O
MVI O O
Problem: O O
a. O O
Adult O O
symptom(s) O O
Code: O O
250.00 O O
Diabetes O O
Mellitus, O O
Uncomplicated O O
Careplan: O O
Diet: O O
ADA O O
Step O O
II O O
Medications: O O
Glucophage O O
- O O
850MG O O
- O O
BID. O O
will O O
recheck O O
HbA1c O O
next O O
visit O O
Patient O O
Education: O O
1. O O
diabetes O O
teaching O O
2. O O
avoid O O
concentrated O O
sweets O O
3. O O
stress O O
important O O
of O O
meticulous O O
foot O O
care O O
and O O
hygiene O O
4. O O
discuss O O
importance O O
of O O
tight O O
diabetes O O
control, O O
including O O
potential O O
complications O O
of O O
diabetes. O O
Problem: O O
a. O O
Adult O O
symptom(s) O O
Code: O O
272.4 O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Careplan: O O
Patient O O
Education: O O
1. O O
reduce O O
dietary O O
saturated O O
fats O O
to O O
less O O
than O O
10% O O
total O O
calories O O
2. O O
reduce O O
weight O O
3. O O
restrict O O
total O O
fat O O
to O O
&lt; O O
30% O O
of O O
total O O
calories O O
4. O O
limit O O
cholesterol O O
to O O
&lt; O O
300 O O
mg/d O O
5. O O
allow O O
carbohydrates O O
to O O
account O O
for O O
50-60% O O
of O O
calories. O O
Substitute O O
complex O O
carbohydrates O O
for O O
saturated O O
fats, O O
increase O O
intake O O
of O O
soluble O O
fiber. O O
THIS O O
IS O O
A O O
COPY O O
PRODUCED O O
FOR O O
THE O O
LMR. O O
THE O O
ORGINAL O O
IS O O
STORED O O
ON O O
THE O O
BRIGHTPOINT O O
SERVER O O
AT O O
COLUMBIA O O
KINGWOOD O O
MEDICAL O O
CENTER O O
AND O O
IN O O
PRINT O O
IN O O
THE O O
PATIENT'S O O
CKMC O O
PAPER O O
RECORD. O O

Record O O
date: O O
2068-03-25 O O
CHIEF O O
COMPLAINT: O O
F/U O O
BH O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
f/u O O
CABG/CAD/DM/HTN B-DIABETES O
feeling O O
very O O
well O O
without O O
intercurrent O O
problems; O O
encouaged O O
about O O
recent O O
wt O O
loss O O
after O O
joining O O
wt O O
watchers O O
we O O
increased O O
glucophage B-MEDICATION B-MEDICATION
9 O O
mo O O
ago O O
due O O
to O O
HbA1c B-DIABETES O
of I-DIABETES O
8.3; I-DIABETES O
but I-DIABETES O
repeat I-DIABETES O
9.3; I-DIABETES O
thinks O O
diet O O
is O O
much O O
better O O
now O O
still B-SMOKER O
not B-SMOKER O
smoking I-SMOKER O
after I-SMOKER O
2 I-SMOKER O
years! I-SMOKER O
Has O O
stpped O O
Welbutrin O O
and O O
notes O O
no O O
problems O O
with O O
this; O O
feeling O O
well O O
with O O
Sx O O
of O O
depession O O
taking O O
meds O O
without O O
difficulty O O
or O O
adverse O O
effects O O
checking O O
feet O O
daily; O O
no O O
CP, O O
SOB O O
orthop O O
PND O O
PAST O O
MEDICAL O O
HISTORY: O O
Entered O O
By:frye O O
On:03/13/2066 O O
Endocrine O O
disorders: O O
type B-DIABETES O
II, I-DIABETES O
non-insulin I-DIABETES O
dependent I-DIABETES O
diabetes I-DIABETES O
mellitus. I-DIABETES O
REVIEW O O
OF O O
SYSTEMS: O O
Const: O O
no O O
fever, O O
chills, O O
sweats, O O
or O O
malaise O O
CV: O O
no O O
chest O O
pain, O O
dyspnea O O
on O O
exertion O O
or O O
palpitations O O
Resp: O O
no O O
SOB, O O
no O O
cough, O O
no O O
wheezing O O
GI: O O
no O O
abdominal O O
pain, O O
no O O
diarrhea, O O
no O O
constipation O O
Musc: O O
no O O
back, O O
shoulder, O O
limb O O
pain, O O
no O O
myalgias O O
Skin: O O
no O O
rashes O O
or O O
pruritis O O
Psych: O O
not O O
depressed O O
or O O
anxious O O
. O O
VITAL O O
SIGNS: O O
Date/Time: O O
03/25/2068 O O
12:29 O O
PM O O
- O O
rosenberg O O
Respiration: O O
16 O O
breaths/min O O
Pulse O O
1: O O
84 O O
bpm O O
Blood B-HYPERTENSION O
Pressure I-HYPERTENSION O
1: I-HYPERTENSION O
140 I-HYPERTENSION O
/ I-HYPERTENSION O
90 I-HYPERTENSION O
mmHg I-HYPERTENSION O
Weight: O O
197.00 O O
lbs. O O
EXAMINATION: O O
[Constitution] O O
- O O
well O O
nourished O O
and O O
developed. O O
obese B-OBESE O
[Eyes] O O
- O O
conjunctivae O O
clear, O O
pupils O O
equal, O O
no O O
discharge, O O
[ENMT] O O
- O O
Ears O O
- O O
, O O
external O O
ears O O
normal. O O
[ENMT] O O
- O O
Nose O O
no O O
discharge. O O
[ENMT] O O
- O O
Throat O O
- O O
normal O O
color O O
and O O
without O O
tonsillar O O
enlargement. O O
[Neck] O O
- O O
supple O O
no O O
lymphadenopathy O O
or O O
thyromegaly. O O
[CV] O O
- O O
regular O O
rate O O
no O O
murmurs, O O
rubs O O
or O O
gallops, O O
no O O
heave; O O
carotid O O
and O O
pedal O O
pulses O O
normal, O O
no O O
extremities O O
edema. O O
No O O
JVD. O O
well O O
healed O O
stermotomy O O
scar. O O
[Respiratory] O O
- O O
clear, O O
breath O O
sounds O O
bilaterally, O O
no O O
accessory O O
muscle O O
use. O O
[GI] O O
- O O
abdomen O O
soft, O O
no O O
hepatosplenomegaly, O O
no O O
abnormal O O
masses O O
or O O
hernias. O O
[Skin]- O O
no O O
significant O O
rashes O O
or O O
other O O
lesions. O O
[Musc/Skel] O O
- O O
normal O O
tone, O O
no O O
edema O O
[Neuro] O O
- O O
5/5 O O
gross O O
motor O O
strength, O O
grossly O O
normal O O
coordination O O
and O O
gait O O
[Psych] O O
- O O
alert O O
and O O
oriented O O
for O O
age, O O
normal O O
mood O O
and O O
affect O O
IMPRESSION: O O
BP O O
borderline, O O
could O O
use O O
improvement O O
we O O
discussed O O
elevated O O
HbA1c O O
fro O O
last O O
visit O O
and O O
need O O
to O O
improve O O
glycemic O O
control O O
otherwise, O O
Excellent O O
secondary O O
prevention O O
regmen O O
ALLERGIES: O O
No O O
Known O O
Drug O O
Allergies O O
04/17/2067 O O
rosenberg O O
MEDICATIONS: O O
glucovance B-MEDICATION B-MEDICATION
5/500 O O
bid O O
for O O
30 O O
days O O
: O O
03/25/2068 O O
- O O
04/15/2068 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
#60 O O
Refill: O O
3 O O
Date: O O
03/25/2068 O O
: O O
rosenberg O O
LESCOL B-MEDICATION O
XL O O
80MG O O
PO O O
qd O O
: O O
03/25/2068 O O
- O O
04/15/2068 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
30 O O
Refill: O O
3 O O
Date: O O
03/25/2068 O O
: O O
rosenberg O O
ZESTRIL B-MEDICATION O
10MG O O
PO O O
qd O O
: O O
03/25/2068 O O
- O O
03/30/2074 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
30 O O
Refill: O O
3 O O
Date: O O
01/13/2074 O O
: O O
rosenberg O O
Glucophage B-MEDICATION O
850MG I-MEDICATION O
One O O
PO O O
bid O O
: O O
01/29/2068 O O
- O O
04/15/2068 O O
ACT O O
: O O
emmons O O
Script: O O
Amt: O O
60 O O
Refill: O O
5 O O
Date: O O
01/29/2068 O O
: O O
emmons O O
toprol B-MEDICATION B-MEDICATION
xl I-MEDICATION O
50MG O O
one O O
po O O
qd O O
: O O
09/25/2067 O O
- O O
03/30/2074 O O
ACT O O
: O O
um O O
Script: O O
Amt: O O
30 O O
Refill: O O
3 O O
Date: O O
03/11/2074 O O
: O O
um O O
LIPITOR B-MEDICATION B-MEDICATION
10MG O O
PO O O
qd O O
: O O
05/10/2066 O O
- O O
04/15/2068 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
QS O O
Refill: O O
1 O O
Date: O O
11/20/2067 O O
: O O
rosenberg O O
ASPIRIN B-MEDICATION B-MEDICATION
325MG O O
PO O O
qd O O
: O O
03/02/2065 O O
- O O
03/30/2074 O O
ACT O O
: O O
rosenberg O O
multivitamin O O
1 O O
po O O
qd O O
: O O
03/02/2065 O O
- O O
03/30/2074 O O
ACT O O
: O O
rosenberg O O
IMMUNIZATIONS: O O
Infl O O
11/25/2065 O O
Pneu O O
11/25/2065 O O
PROBLEMS O O
- O O
CARE O O
PLANS: O O
Problem: O O
a. O O
Adult O O
symptom(s) O O
Code: O O
414.00 O O
Coronary B-CAD O
Artery I-CAD O
Disease I-CAD O
Careplan: O O
RTC O O
3 O O
mo O O
secondary O O
prevention O O
counseling O O
reinforced O O
including O O
wt O O
loss, O O
exercise, O O
con't O O
smoking O O
cessation, O O
medication O O
adherence, O O
diet, O O
ASA, O O
MVI O O
As O O
far O O
as O O
HTN O O
goes, O O
will O O
change B-MEDICATION O
to I-MEDICATION O
ACE-i I-MEDICATION O
given I-MEDICATION O
benefits I-MEDICATION O
in I-MEDICATION O
prevention I-MEDICATION O
for I-MEDICATION O
both I-MEDICATION O
CAD I-MEDICATION O
and I-MEDICATION O
renal I-MEDICATION O
protection I-MEDICATION O
starting I-MEDICATION O
with I-MEDICATION O
lisinopril I-MEDICATION B-MEDICATION
10 I-MEDICATION O
d I-MEDICATION O
and I-MEDICATION O
work I-MEDICATION O
up I-MEDICATION O
RTC O O
1 O O
mo O O
Problem: O O
a. O O
Adult O O
symptom(s) O O
Code: O O
250.00 O O
Diabetes O O
Mellitus, O O
Uncomplicated O O
Careplan: O O
Diet: O O
ADA O O
Step O O
II O O
Medications: O O
change O O
to O O
glucovane O B-MEDICATION
5/500 O O
BID O O
will O O
recheck O O
HbA1c O O
today O O
Patient O O
Education: O O
1. O O
diabetes O O
teaching O O
2. O O
avoid O O
concentrated O O
sweets O O
3. O O
stress O O
important O O
of O O
meticulous O O
foot O O
care O O
and O O
hygiene O O
4. O O
discuss O O
importance O O
of O O
tight O O
diabetes O O
control, O O
including O O
potential O O
complications O O
of O O
diabetes. O O
Problem: O O
a. O O
Adult O O
symptom(s) O O
Code: O O
272.4 O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Careplan: O O
Patient O O
Education: O O
1. O O
reduce O O
dietary O O
saturated O O
fats O O
to O O
less O O
than O O
10% O O
total O O
calories O O
2. O O
reduce O O
weight O O
3. O O
restrict O O
total O O
fat O O
to O O
&lt; O O
30% O O
of O O
total O O
calories O O
4. O O
limit O O
cholesterol O O
to O O
&lt; O O
300 O O
mg/d O O
5. O O
allow O O
carbohydrates O O
to O O
account O O
for O O
50-60% O O
of O O
calories. O O
Substitute O O
complex O O
carbohydrates O O
for O O
saturated O O
fats, O O
increase O O
intake O O
of O O
soluble O O
fiber. O O
lipitor O B-MEDICATION
as O O
prescribed; O O
might O O
change O O
to O O
lescol O O
check O O
LFTs O O
and O O
lipids O O
today O O
THIS O O
IS O O
A O O
COPY O O
PRODUCED O O
FOR O O
THE O O
LMR. O O
THE O O
ORGINAL O O
IS O O
STORED O O
ON O O
THE O O
BRIGHTPOINT O O
SERVER O O
AT O O
COLUMBIA O O
KINGWOOD O O
MEDICAL O O
CENTER O O
AND O O
IN O O
PRINT O O
IN O O
THE O O
PATIENT'S O O
CKMC O O
PAPER O O
RECORD. O O

Record O O
date: O O
2069-01-13 O O
CHIEF O O
COMPLAINT: O O
F/U O O
BH O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
feeling O O
well O O
except O O
slight O O
cold; O O
getting O O
daily O O
exercise O O
and O O
still B-SMOKER O
not I-SMOKER O
smoking I-SMOKER O
(2 I-SMOKER O
years) I-SMOKER O
f/u O O
type B-DIABETES O
2 I-DIABETES O
DM B-DIABETES O
and O O
CAD B-CAD O
we O O
discussed O O
the O O
elevation O O
in O O
last O O
HbA1c O O
and O O
need O O
to O O
improve O O
control; O O
possible O O
need O O
for O O
insulin O O
future O O
not O O
yet O O
measuriong O O
home O O
glucose: O O
given O O
instructions O O
a O O
prescriptions O O
today O O
to O O
do O O
this O O
No O O
cp/SOB/DOE/Orthop O O
we O O
reviewed O O
meds O O
and O O
above O O
list O O
is O O
correct; O O
adherent; O O
no O O
adverse O O
effects O O
doing O O
dailt O O
foot O O
exams O O
PAST O O
MEDICAL O O
HISTORY: O O
Entered O O
By:frye O O
On:03/13/2066 O O
Endocrine O O
disorders: O O
type O O
II, O O
non-insulin O O
dependent O O
diabetes O O
mellitus. O O
REVIEW O O
OF O O
SYSTEMS: O O
Const: O O
no O O
fever, O O
Const: O O
no O O
weight O O
change, O O
CV: O O
no O O
chest O O
pain, O O
CV: O O
no O O
palpitations, O O
Resp: O O
no O O
shortness O O
of O O
breath, O O
Resp: O O
no O O
cough, O O
Resp: O O
no O O
wheezing, O O
GI: O O
no O O
vomiting, O O
GI: O O
no O O
constipation, O O
GI: O O
no O O
diarrhea, O O
GU: O O
no O O
frequent O O
urination, O O
Neuro: O O
no O O
headaches O O
and O O
Skin: O O
no O O
rash O O
VITAL O O
SIGNS: O O
Date/Time: O O
01/13/2069 O O
10:03 O O
AM O O
- O O
rosenberg O O
Respiration: O O
18 O O
breaths/min O O
Pulse O O
1: O O
78 O O
bpm O O
Blood O O
Pressure O O
1: O O
110 O O
/ O O
70 O O
mmHg O O
Weight: O O
196.00 O O
lbs. O O
EXAMINATION: O O
[Constitution] O O
- O O
well O O
nourished O O
and O O
developed. O O
[Eyes] O O
- O O
conjunctivae O O
clear, O O
pupils O O
equal, O O
no O O
discharge O O
[Neck] O O
- O O
supple O O
no O O
lymphadenopathy O O
or O O
thyromegaly. O O
[CV] O O
- O O
regular O O
rate O O
no O O
murmurs, O O
rubs O O
or O O
gallops, O O
no O O
heave; O O
carotid O O
pulses O O
normal, O O
no O O
extremities O O
edema. O O
[Respiratory] O O
- O O
clear, O O
breath O O
sounds O O
bilaterally, O O
no O O
accessory O O
muscle O O
use. O O
[GI] O O
- O O
abdomen O O
soft, O O
no O O
hepatosplenomegaly, O O
no O O
abnormal O O
masses O O
or O O
hernias. O O
[Skin]- O O
no O O
significant O O
rashes O O
or O O
other O O
lesions. O O
[Musc/Skel] O O
- O O
normal O O
tone, O O
no O O
edema; O O
feet O O
without O O
lesions; O O
decreased O O
VS O O
to O O
ankles O O
bilat O O
[Neuro] O O
- O O
5/5 O O
gross O O
motor O O
strength, O O
grossly O O
normal O O
coordination O O
and O O
gait O O
[Psych] O O
- O O
alert O O
and O O
oriented O O
for O O
age, O O
normal O O
mood O O
and O O
affect O O
IMPRESSION: O O
excellent O O
regimen O O
for O O
DM O O
and O O
CAD O O
but O O
increased O O
HBA1c O O
a O O
concern O O
and O O
we O O
discussed O O
diet/exercise O O
for O O
15 O O
minutes O O
will O O
check O O
HbA1c O O
again O O
today O O
ALLERGIES: O O
No O O
Known O O
Drug O O
Allergies O O
04/17/2067 O O
rosenberg O O
MEDICATIONS: O O
lancets O O
for O O
gluc O O
monitoring O O
BID O O
for O O
3 O O
mo O O
: O O
01/13/2069 O O
- O O
03/30/2074 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
QS O O
Refill: O O
3 O O
Date: O O
01/13/2069 O O
: O O
rosenberg O O
one-touch O O
basic O O
glucose O O
test O O
strips O O
BID O O
for O O
3 O O
mo O O
: O O
01/13/2069 O O
- O O
03/30/2074 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
QS O O
Refill: O O
3 O O
Date: O O
01/13/2069 O O
: O O
rosenberg O O
GLUCOPHAGE B-MEDICATION O
850MG I-MEDICATION O
One O O
PO O O
bid O O
: O O
06/17/2068 O O
- O O
09/22/2069 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
60 O O
Refill: O O
1 O O
Date: O O
06/10/2069 O O
: O O
rosenberg O O
ZESTRIL B-MEDICATION O
10MG O O
PO O O
qd O O
: O O
03/25/2068 O O
- O O
03/30/2074 O O
ACT O O
: O O
rosenberg O O
Script: O O
Amt: O O
30 O O
Refill: O O
3 O O
Date: O O
01/13/2074 O O
: O O
rosenberg O O
toprol B-MEDICATION O
xl I-MEDICATION O
50MG O O
one O O
po O O
qd O O
: O O
09/25/2067 O O
- O O
03/30/2074 O O
ACT O O
: O O
um O O
Script: O O
Amt: O O
30 O O
Refill: O O
3 O O
Date: O O
03/11/2074 O O
: O O
um O O
LIPITOR B-MEDICATION B-MEDICATION
10MG O O
One O O
PO O O
qd O O
: O O
05/10/2066 O O
- O O
10/03/2073 O O
ACT O O
: O O
emmons O O
Script: O O
Amt: O O
90 O O
Refill: O O
1 O O
Date: O O
04/05/2073 O O
: O O
emmons O O
ASPIRIN B-MEDICATION B-MEDICATION
325MG O O
PO O O
qd O O
: O O
03/02/2065 O O
- O O
03/30/2074 O O
ACT O O
: O O
rosenberg O O
multivitamin O O
1 O O
po O O
qd O O
: O O
03/02/2065 O O
- O O
03/30/2074 O O
ACT O O
: O O
rosenberg O O
IMMUNIZATIONS: O O
INF2 O O
11/24/2068 O O
Infl O O
11/25/2065 O O
Pneu O O
11/25/2065 O O
PROBLEMS O O
- O O
CARE O O
PLANS: O O
Problem: O O
a. O O
Adult O O
symptom(s) O O
Code: O O
250.00 O O
Diabetes O O
Mellitus, O O
Uncomplicated O O
Careplan: O O
as O O
above, O O
RTC O O
3 O O
mo O O
THIS O O
IS O O
A O O
COPY O O
PRODUCED O O
FOR O O
THE O O
LMR. O O
THE O O
ORGINAL O O
IS O O
STORED O O
ON O O
THE O O
BRIGHTPOINT O O
SERVER O O
AT O O
COLUMBIA O O
KINGWOOD O O
MEDICAL O O
CENTER O O
AND O O
IN O O
PRINT O O
IN O O
THE O O
PATIENT'S O O
CKMC O O
PAPER O O
RECORD. O O

Record O O
date: O O
2096-02-15 O O
ST O O
VINCENT O O
EMERGENCY O O
DEPT O O
VISIT O O
LAU,HELEN O O
M. O O
544-41-32-1 O O
VISIT O O
DATE: O O
02/15/96 O O
PRESENTING O O
COMPLAINT: O O
Syncope. O O
History O O
and O O
Physical O O
reviewed. O O
Patient O O
examined O O
with O O
the O O
Medicine O O
Resident O O
and O O
medical O O
student. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
Briefly, O O
this O O
is O O
a O O
68 O O
year O O
old O O
female O O
with O O
a O O
history B-CAD O
of I-CAD O
coronary I-CAD O
artery I-CAD O
disease I-CAD O
and O O
syncope O O
in O O
the O O
past O O
who O O
presents O O
with O O
two O O
syncopal O O
episodes O O
today O O
while O O
in O O
the O O
Orthopedic O O
Clinic. O O
The O O
patient O O
was O O
in O O
the O O
Orthopedic O O
Clinic O O
having O O
her O O
trigger O O
finger O O
evaluated O O
and O O
had O O
a O O
digital O O
block O O
done O O
with O O
Lidocaine. O O
As O O
she O O
was O O
walking O O
out O O
of O O
the O O
Clinic, O O
she O O
slumped O O
to O O
the O O
chair, O O
hit O O
her O O
head O O
on O O
the O O
table O O
and O O
was O O
out O O
for O O
a O O
few O O
minutes. O O
Patient O O
felt O O
a O O
pressure B-CAD O
like I-CAD O
sensation I-CAD O
in I-CAD O
the I-CAD O
left I-CAD O
chest I-CAD O
with I-CAD O
radiation I-CAD O
to I-CAD O
the I-CAD O
neck, I-CAD O
some O O
shortness O O
of O O
breath O O
and O O
diaphoresis O O
immediately O O
preceding O O
the O O
event. O O
When O O
patient O O
came O O
to O O
was O O
slightly O O
disoriented O O
and O O
approximately O O
five O O
minutes O O
later O O
felt O O
the O O
same O O
light O O
headedness O O
and O O
again O O
lost O O
consciousness O O
while O O
sitting O O
in O O
the O O
chair. O O
Patient O O
had O O
no O O
fever, O O
chills O O
or O O
recent O O
illness. O O
Past O O
Medical O O
History, O O
Current O O
Medications, O O
Social O O
History, O O
Allergies O O
all O O
per O O
Resident's O O
note. O O
REVIEW O O
OF O O
SYSTEMS: O O
Per O O
HPI, O O
otherwise O O
negative. O O
PHYSICAL O O
EXAMINATION: O O
Patient's O O
temperature O O
was O O
98.2; O O
Pulse O O
62; O O
Blood B-HYPERTENSION O
Pressure I-HYPERTENSION O
163/89; I-HYPERTENSION O
Respirations O O
20; O O
Oxygen O O
saturation O O
97%. O O
General: O O
Well O O
developed O O
elderly O O
female O O
in O O
no O O
apparent O O
distress O O
sitting O O
on O O
the O O
gurney. O O
HEENT: O O
Is O O
unremarkable. O O
Neck: O O
Supple. O O
Chest: O O
Is O O
clear. O O
Heart: O O
Is O O
regular O O
rate O O
and O O
rhythm. O O
Abdomen: O O
Is O O
soft, O O
nontender. O O
Extremities: O O
No O O
clubbing, O O
cyanosis O O
or O O
edema. O O
Neurologic O O
exam: O O
Patient O O
is O O
alert O O
and O O
oriented O O
x O O
three, O O
cranial O O
nerves O O
are O O
intact, O O
motor O O
5/5, O O
sensation O O
intact O O
throughout. O O
LABORATORY O O
EVALUATION: O O
EKG O O
shows O O
normal O O
sinus O O
rhythm O O
with O O
no O O
acute O O
changes. O O
CPK O O
was O O
98, O O
troponin O O
pending. O O
Other O O
labs O O
were O O
unremarkable. O O
FINAL O O
DIAGNOSIS: O O
Syncopal O O
episode O O
with O O
chest O O
pressure. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Patient O O
will O O
be O O
admitted O O
to O O
the O O
Hospital O O
for O O
rule O O
out O O
MI, O O
Short O O
Stay O O
Unit, O O
for O O
further O O
work O O
up O O
and O O
care. O O
Condition O O
on O O
admission O O
stable. O O
___________________________________ O O
XD305/7899 O O
IVAN O O
UHER, O O
M.D. O O
IU67 O O
D:02/15/96 O O
T:02/15/96 O O
Dictated O O
by: O O
IVAN O O
UHER, O O
M.D. O O
IU67 O O
******** O O
Approved O O
but O O
not O O
reviewed O O
by O O
Attending O O
Provider O O
******** O O

Record O O
date: O O
2096-07-19 O O
ST O O
VINCENT O O
EMERGENCY O O
DEPT O O
VISIT O O
LAU,HELEN O O
M. O O
544-41-32-1 O O
VISIT O O
DATE: O O
07/19/96 O O
The O O
patient O O
was O O
seen O O
by O O
me O O
and O O
Dr. O O
Foust O O
07-19-96 O O
at O O
8:30 O O
a.m. O O
PRESENTING O O
COMPLAINT O O
and O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
67-year-old O O
black O O
female O O
complaining O O
of O O
substernal B-CAD O
chest I-CAD O
pain I-CAD O
times O O
one O O
hour O O
while O O
at O O
the O O
Pain O O
Clinic O O
this O O
a.m. O O
The O O
complaints O O
are O O
presently O O
resolved. O O
The O O
patient O O
states O O
she O O
was O O
being O O
seen O O
in O O
the O O
Pain O O
Clinic O O
for O O
back O O
pain, O O
and O O
developed O O
the O O
sudden O O
onset O O
of O O
substernal O O
chest O O
pain O O
associated O O
with O O
shortness O O
of O O
breath, O O
nausea, O O
vomiting, O O
and O O
diaphoresis, O O
as O O
well O O
as O O
syncope. O O
The O O
patient O O
states O O
the O O
pain O O
was O O
a O O
10/10, O O
worse O O
than O O
normal O O
angina, B-CAD O
and O O
also O O
reports O O
one O O
episodes O O
of O O
hematemesis O O
this O O
a.m., O O
with O O
a O O
small O O
amount O O
of O O
red O O
blood O O
in O O
the O O
vomitus. O O
The O O
patient O O
denies O O
abdominal O O
pain, O O
weakness, O O
or O O
any O O
other O O
complaints. O O
PAST O O
MEDICAL O O
HISTORY: O O
Positive O O
for O O
angina. O O
Positive B-CAD O
catheterization I-CAD O
approximately I-CAD O
two I-CAD O
years I-CAD O
ago, I-CAD O
with I-CAD O
30-40% I-CAD O
lesions. I-CAD O
Also, O O
history O O
of O O
insulin-dependent B-DIABETES O
diabetes B-DIABETES O
mellitus I-DIABETES O
and O O
spinal O O
stenosis. O O
CARDIAC O O
RISK O O
FACTORS: O O
Hypertension, B-HYPERTENSION B-HYPERTENSION
increased B-HYPERLIPIDEMIA O
cholesterol, I-HYPERLIPIDEMIA O
diabetes O O
mellitus. O O
MEDICATIONS: O O
Metoprolol, B-MEDICATION B-MEDICATION
lovastatin, B-MEDICATION B-MEDICATION
Macrodantin, O O
Motrin, O O
insulin B-MEDICATION B-MEDICATION
70/30, I-MEDICATION O
nitroglycerin, B-MEDICATION B-MEDICATION
and O O
aspirin. B-MEDICATION B-MEDICATION
PHYSICAL O O
EXAMINATION: O O
This O O
is O O
a O O
well-developed, O O
well-nourished O O
female O O
lying O O
on O O
the O O
stretcher, O O
presently O O
without O O
complaints. O O
The O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
194/88, B-HYPERTENSION O
the O O
pulse O O
90, O O
the O O
respirations O O
16, O O
and O O
the O O
O2 O O
saturation O O
97% O O
on O O
2 O O
liters O O
per O O
nasal O O
cannula. O O
The O O
HEENT O O
examination O O
reveals O O
a O O
normocephalic, O O
atraumatic O O
head. O O
The O O
pupils O O
are O O
equal O O
and O O
reactive, O O
and O O
the O O
extraocular O O
movements O O
are O O
intact. O O
The O O
chest O O
shows O O
positive O O
bibasilar O O
rales O O
and O O
is O O
otherwise O O
clear. O O
The O O
abdomen O O
is O O
obese O O
and O O
soft, O O
with O O
positive O O
bowel O O
sounds. O O
The O O
heart O O
has O O
a O O
regular O O
rate O O
and O O
rhythm. O O
The O O
extremities O O
are O O
without O O
cyanosis, O O
clubbing, O O
or O O
edema. O O
The O O
rectal O O
examination O O
is O O
guaiac-negative. O O
On O O
Neurologic O O
Examination, O O
the O O
patient O O
is O O
alert O O
and O O
oriented O O
times O O
two O O
(could O O
not O O
give O O
the O O
exact O O
date); O O
otherwise, O O
no O O
focality. O O
LABORATORY O O
EVALUATION: O O
The O O
EKG O O
shows O O
a O O
sinus O O
rhythm O O
unchanged O O
from O O
previous O O
EKGs, O O
with O O
a O O
normal O O
interpretation O O
and O O
no O O
signs O O
of O O
acute O O
ischemia. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
is O O
admitted O O
to O O
the O O
hospital O O
for O O
rule O O
out O O
MI. O O
Aspirin O B-MEDICATION
is O O
given. O O
Further O O
work-up O O
as O O
per O O
the O O
inpatient O O
Medicine O O
team. O O
The O O
patient O O
was O O
admitted O O
in O O
stable O O
condition O O
at O O
11:15 O O
a.m. O O
FINAL O O
DIAGNOSIS: O O
Rule O O
out O O
myocardial O O
infarction O O
(MI). O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
As O O
above. O O
The O O
condition O O
on O O
admission O O
is O O
stable. O O
___________________________________ O O
OX540/6976 O O
MARY O O
LUND, O O
M.D. O O
ML82 O O
D:07/19/96 O O
T:07/19/96 O O
Dictated O O
by: O O
MARY O O
LUND, O O
M.D. O O
ML82 O O

Record O O
date: O O
2096-10-17 O O
ST O O
VINCENT O O
EMERGENCY O O
DEPT O O
VISIT O O
LAU,HELEN O O
M. O O
544-41-32-1 O O
VISIT O O
DATE: O O
10/17/96 O O
PRESENTING O O
COMPLAINT O O
and O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
68-year-old O O
female O O
status O O
post O O
CABG B-CAD O
in I-CAD O
September I-CAD O
of I-CAD O
this I-CAD O
past I-CAD O
year. I-CAD O
She O O
comes O O
in O O
with O O
an O O
acute O O
headache O O
this O O
morning, O O
followed O O
by O O
a O O
syncopal O O
event, O O
which O O
lasted O O
approximately O O
five O O
seconds. O O
Currently, O O
she O O
is O O
complaining O O
of O O
intermittent B-CAD O
chest I-CAD O
pain I-CAD O
and O O
a O O
continuing O O
headache O O
across O O
her O O
head O O
and O O
down O O
to O O
her O O
eyes. O O
PAST O O
MEDICAL O O
and O O
SURGICAL O O
HISTORY: O O
The O O
past O O
history O O
is O O
notable O O
for O O
her O O
CABG, O O
as O O
well O O
as O O
for O O
a O O
history O O
of O O
temporal O O
arteritis. O O
MEDICATIONS: O O
She O O
was O O
on O O
prednisone, O O
which O O
was O O
recently O O
stopped. O O
The O O
rest O O
of O O
the O O
PAST O O
MEDICAL O O
HISTORY, O O
MEDICATIONS, O O
and O O
ALLERGIES: O O
As O O
documented O O
in O O
the O O
written O O
chart O O
by O O
the O O
resident O O
physician, O O
and O O
as O O
reviewed O O
by O O
me. O O
PHYSICAL O O
EXAMINATION: O O
On O O
physical O O
examination, O O
she O O
is O O
an O O
elderly O O
black O O
female O O
in O O
no O O
acute O O
distress. O O
She O O
has O O
a O O
temperature O O
of O O
100 O O
degrees O O
F., O O
a O O
pulse O O
of O O
90, O O
and O O
a O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
of I-HYPERTENSION O
150/70. I-HYPERTENSION O
The O O
O2 O O
saturation O O
is O O
97% O O
on O O
room O O
air. O O
The O O
examination O O
is O O
notable O O
for O O
a O O
surgically O O
altered O O
pupil O O
in O O
the O O
right O O
eye, O O
which O O
is O O
non-reactive. O O
The O O
extraocular O O
movements O O
are O O
intact. O O
She O O
has O O
no O O
palpable O O
temporal O O
or O O
skull O O
tenderness. O O
The O O
lungs O O
show O O
rhonchorous O O
breath O O
sounds O O
throughout. O O
The O O
cardiovascular O O
examination O O
shows O O
a O O
midline O O
scar, O O
with O O
a O O
regular O O
rate O O
and O O
rhythm O O
and O O
no O O
murmur. O O
The O O
abdomen O O
is O O
soft O O
and O O
non-tender. O O
The O O
extremities O O
show O O
1+ O O
pitting O O
edema O O
bilaterally. O O
The O O
neurologic O O
examination O O
is O O
grossly O O
intact. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
This O O
is O O
an O O
elderly O O
female O O
status O O
post O O
recent O O
CABG, O O
who O O
had O O
a O O
syncopal O O
episode O O
this O O
morning O O
after O O
complaining O O
of O O
a O O
headache. O O
The O O
plan O O
at O O
this O O
time O O
is O O
to O O
obtain O O
a O O
head O O
CT O O
to O O
rule O O
out O O
an O O
intracerebral O O
process. O O
She O O
has O O
had O O
an O O
EKG, O O
which O O
does O O
show O O
some O O
T-wave O O
changes, O O
different O O
from O O
when O O
she O O
was O O
here O O
for O O
her O O
CABG. O O
She O O
will O O
also O O
have O O
cardiac O O
enzymes O O
sent O O
and O O
will O O
be O O
admitted O O
to O O
the O O
hospital O O
for O O
further O O
monitoring O O
of O O
her O O
syncopal O O
event. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
As O O
above. O O
The O O
patient's O O
condition O O
on O O
admission O O
is O O
stable. O O
___________________________________ O O
HA563/486 O O
FRANCES O O
LOVELL, O O
M.D. O O
FL01 O O
D:10/17/96 O O
T:10/17/96 O O
Dictated O O
by: O O
FRANCES O O
LOVELL, O O
M.D. O O
FL01 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2097-01-30 O O
ST O O
VINCENT O O
EMERGENCY O O
DEPT O O
VISIT O O
LAU,HELEN O O
M. O O
544-41-32-1 O O
VISIT O O
DATE: O O
01/30/97 O O
PRESENTING O O
COMPLAINT: O O
Chest B-CAD O
pain I-CAD O
and O O
shortness O O
of O O
breath. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
is O O
a O O
lady O O
who O O
has O O
a O O
history O O
of O O
a O O
coronary B-CAD O
artery I-CAD O
bypass I-CAD O
graft I-CAD O
in I-CAD O
September I-CAD O
of I-CAD O
2096, I-CAD O
who O O
presents O O
complaining O O
of O O
chest O O
pain. O O
The O O
patient O O
describes O O
it O O
as O O
being O O
sharp O O
and O O
stabbing. O O
It O O
was O O
associated O O
with O O
some O O
diaphoresis. O O
She O O
states O O
that O O
this O O
pain O O
is O O
similar O O
to O O
her O O
angina, B-CAD O
however, O O
it O O
is O O
more O O
frequent O O
and O O
persistent. O O
She O O
has O O
no O O
fever, O O
no O O
chills, O O
no O O
cough, O O
no O O
vomiting, O O
no O O
diarrhea, O O
no O O
abdominal O O
pain, O O
and O O
no O O
urinary O O
symptoms. O O
PAST O O
MEDICAL O O
HISTORY: O O
Past O O
medical O O
history O O
is O O
significant O O
for O O
hypertension, B-HYPERTENSION O
coronary B-CAD O
artery I-CAD O
disease, I-CAD O
insulin B-DIABETES O
dependent I-DIABETES O
diabetes, I-DIABETES O
chronic O O
renal O O
insufficiency, O O
breast O O
cancer, O O
depression, O O
mitral O O
valve O O
replacement, O O
and O O
hypothyroidism. O O
MEDICATIONS: O O
Medications O O
are O O
multiple O O
and O O
are O O
on O O
the O O
chart. O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
The B-SMOKER O
patient I-SMOKER O
never I-SMOKER O
smoked. I-SMOKER O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
was O O
afebrile O O
and O O
vital O O
signs O O
were O O
stable. O O
This O O
is O O
a O O
well-developed, O O
well-nourished O O
female O O
who O O
was O O
alert O O
and O O
oriented O O
times O O
three. O O
Heent O O
examination O O
was O O
normocephalic, O O
atraumatic. O O
Neck O O
was O O
soft O O
and O O
supple O O
with O O
no O O
jugular O O
venous O O
distention. O O
Mouth O O
and O O
throat O O
normal O O
with O O
well O O
hydrated, O O
moist O O
mucosa. O O
Conjunctiva O O
was O O
clear. O O
Sclera O O
were O O
anicteric. O O
Heart O O
had O O
a O O
regular O O
rate O O
and O O
rhythm. O O
Lungs O O
were O O
clear. O O
Abdomen O O
was O O
non-tender O O
and O O
non-distended. O O
The O O
patient O O
had O O
no O O
hepatosplenomegaly. O O
Extremities O O
showed O O
no O O
clubbing, O O
cyanosis O O
or O O
edema. O O
Rectal O O
was O O
heme O O
negative. O O
LABORATORY O O
EVALUATION: O O
EKG O O
showed O O
first O O
degree O O
AV O O
block, O O
no O O
acute O O
ischemic O O
changes. O O
Chest O O
x-ray O O
showed O O
mild O O
pleural O O
effusion. O O
White O O
count O O
was O O
9.7. O O
Hematocrit O O
was O O
28. O O
CPK O O
and O O
troponin O O
were O O
negative. O O
Electrolytes O O
were O O
normal O O
for O O
her. O O
BUN O O
and O O
creatinine O O
were O O
32 O O
and O O
1.2. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
Nursing O O
notes O O
were O O
reviewed. O O
The O O
patient O O
was O O
seen O O
with O O
the O O
resident O O
physician, O O
Dr. O O
Nix, O O
and O O
I O O
agree O O
with O O
his O O
note. O O
Please O O
see O O
chart. O O
FINAL O O
DIAGNOSIS: O O
Unstable B-CAD O
angina. I-CAD O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
will O O
be O O
admitted. O O
Condition O O
at O O
this O O
time O O
is O O
satisfactory. O O
___________________________________ O O
MG040/1987 O O
VIRGIL O O
HARRELL, O O
M.D. O O
VH79 O O
D:02/12/97 O O
T:02/13/97 O O
Dictated O O
by: O O
VIRGIL O O
HARRELL, O O
M.D. O O
VH79 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2089-02-20 O O
Vi O O
K. O O
Xayarath, O O
M.D., O O
Ph.D. O O
Resident, O O
Phoenix O O
Neurology O O
Neurology O O
ED O O
Consult O O
Date: O O
Thursday, O O
February O O
20, O O
2089 O O
21:42 O O
PCP: O O
Rhonda O O
Riddle; O O
(called O O
by O O
Valerie O O
Xian) O O
Patient: O O
Garrison O O
Sexton O O
HDH O O
Record O O
4210443 O O
Chief O O
Complaint: O O
'dizzy, O O
slurred O O
speech' O O
History O O
of O O
Present O O
Illness: O O
65 O O
year O O
old O O
RH O O
gentleman O O
with O O
Hx O O
notable O O
for O O
HTN B-HYPERTENSION O
and O O
CASHD, B-CAD O
was O O
working O O
on O O
taxes O O
and O O
making O O
barbecued O O
chicken O O
this O O
afternoon, O O
when O O
at O O
1am O O
he O O
had O O
the O O
sudden O O
onset O O
of O O
feeling O O
'dizzy, O O
disoriented' O O
and O O
having O O
'slurred O O
speech'. O O
He O O
reports O O
that O O
he O O
'couldn't O O
remember O O
what O O
I O O
was O O
trying O O
to O O
say', O O
and O O
that O O
his O O
words O O
both O O
sounded O O
'like O O
[I] O O
was O O
drunk'. O O
He O O
also O O
stated O O
that O O
at O O
times, O O
when O O
he O O
would O O
try O O
to O O
talk, O O
nothing O O
would O O
come O O
out. O O
He O O
walked O O
downstairs, O O
with O O
difficulty, O O
and O O
his O O
wife O O
noticed O O
that O O
in O O
the O O
hallway O O
he O O
was O O
bumping O O
into O O
items O O
on O O
(falling O O
to) O O
his O O
right. O O
Denies O O
weakness, O O
paresthesias, O O
pain. O O
EMTs O O
report O O
that O O
when O O
asked O O
the O O
President's O O
name, O O
pt O O
responded O O
'Chrysler O O
Dodge'. O O
Brought O O
initially O O
to O O
OSH, O O
symptoms O O
mostly O O
resolved O O
within O O
20 O O
minutes. O O
I- O O
CT O O
at O O
OSH O O
negative. O O
Pt O O
transferred O O
to O O
HDH O O
ED O O
at O O
suggestion O O
of O O
covering O O
PCP. O O
Past O O
Medical O O
Hx: O O
HTN, O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
(s/p O O
angioplasty B-CAD O
and I-CAD O
atherectomy; I-CAD O
s/p O O
CABG B-CAD O
x I-CAD O
5 I-CAD O
in I-CAD O
2081), I-CAD O
diabetes B-DIABETES O
mellitus, I-DIABETES O
prostate O O
ca O O
(s/p O O
radical O O
retropubic O O
prostatectomy O O
4/0, O O
negative O O
nodes O O
and O O
margins), O O
obesity. B-OBESE O
Bladder O O
suspension. O O
Baseline O O
bradycardia O O
(40s O O
average). O O
Allergies: O O
Hydrochlorothiazide, O O
furosemide, O O
gemfibrozil, O O
amoxicillin, O O
hydrocodone, O O
oxycodone O O
Medicines: O O
Isosorbide B-MEDICATION B-MEDICATION
20 O O
qid O O
Cardizem B-MEDICATION O
HCM O O
180 O O
qD O O
Atenolol B-MEDICATION B-MEDICATION
25 O O
qD O O
ECASA B-MEDICATION B-MEDICATION
325 O O
qD O O
Atorvastatin B-MEDICATION B-MEDICATION
10 O O
qD O O
Glucophage B-MEDICATION B-MEDICATION
500 O O
bid O O
Avapro B-MEDICATION B-MEDICATION
150 O O
qD O O
Bumetanide O O
1 O O
qD O O
Claritin O O
1 O O
qD O O
Family O O
History: O O
Mom O O
with O O
stroke O O
in O O
her O O
80s O O
Social O O
History: O O
Married O O
41 O O
years. O O
Pastor O O
(still O O
practicing). O O
No B-SMOKER O
cigarettes. I-SMOKER O
EtOH O O
&lt; O O
1 O O
glass O O
wine/month. O O
Review O O
of O O
Systems: O O
Mild O O
frontal O O
HA, O O
no O O
tinnitus, O O
no O O
CP/SOB/abdom O O
pain. O O
+ O O
diplopia O O
occasionally O O
this O O
AM O O
(horizontal), O O
no O O
dysuria. O O
Examination: O O
Gen: O O
Pleasant O O
65 O O
yo O O
RH O O
gentleman, O O
NAD O O
148/67 B-HYPERTENSION O
P44-48 O O
R16 O O
RRR O O
No O O
carotid/occipital O O
bruits. O O
Neurologic O O
exam O O
MS: O O
Alert, O O
interactive, O O
NAD. O O
Fully O O
oriented. O O
Accurate O O
describes O O
stroke O O
card O O
scene. O O
Speech: O O
Articulate, O O
appropriate. O O
Reading O O
and O O
repetition O O
intact. O O
Naming O O
all O O
items O O
on O O
stroke O O
card O O
('couch'; O O
when O O
asked O O
for O O
alternative, O O
'chair'). O O
Several O O
hesitancies O O
of O O
speech, O O
occasional O O
phonemic O O
paraphasic O O
error O O
(recognized). O O
CN: O O
PERRL O O
4 O O
2 O O
bilaterally, O O
EOMI, O O
VFFtC, O O
facial O O
sensation O O
intact, O O
eyes O O
shut O O
tight, O O
smile O O
symmetric, O O
hearing O O
intact, O O
palate O O
elevates O O
symmetrically, O O
shoulder O O
shrug O O
strong, O O
tongue O O
midline. O O
Motor: O O
5/5 O O
strength O O
UE/LE O O
bilaterally O O
proximally O O
and O O
distally. O O
Normal O O
tone/bulk. O O
No O O
fasciculations O O
noted. O O
No O O
drift. O O
Rapid O O
finger O O
movements O O
slightly O O
slower O O
on O O
R O O
(dominant O O
side) O O
than O O
L. O O
Sensory: O O
Pinprick, O O
temperature, O O
light O O
touch, O O
vibration, O O
proprioception O O
intact. O O
Reflexes: O O
2+ O O
B/T O O
bilaterally. O O
21+ O O
patellar, O O
1+ O O
ankle O O
reflexes. O O
R O O
toe O O
up, O O
L O O
toe O O
down O O
(could O O
not O O
repeat O O
1 O O
hour O O
later). O O
Coordination: O O
F-N-F O O
intact. O O
Rapid O O
alternating O O
movements O O
intact. O O
Gait: O O
Normal. O O
Tandems O O
well. O O
Romberg O O
negative. O O
CXR: O O
pending O O
CT: O O
from O O
OSH, O O
mild O O
cortical O O
atrophy O O
with O O
mild O O
hydrocephalus O O
ex O O
vacuo. O O
Basilar O O
artery O O
is O O
prominent, O O
though O O
not O O
severely O O
hyperdense. O O
Labs: O O
NA O O
142 O O
K O O
4.0 O O
CL O O
102 O O
CO2 O O
26.2 O O
BUN O O
34 O O
CRE O O
1.6 O O
GLU O O
106 O O
CA O O
8.7 O O
PHOS O O
3.3 O O
MG O O
1.6 O O
WBC O O
9.4 O O
HCT O O
37.1(L) O O
HGB O O
13.3(L) O O
PLT O O
152 O O
MCV O O
80 O O
RDW O O
13.0 O O
%NEUT O O
58 O O
%LYMPH O O
32 O O
%MONO O O
6 O O
%EOS O O
3 O O
%BASO O O
1 O O
PT O O
12.8 O O
PTT O O
25.8 O O
Impression: O O
65 O O
year O O
old O O
gentleman O O
with O O
multiple O O
stroke O O
risk O O
factors, O O
onset O O
of O O
dysarthria, O O
aphasia, O O
dizziness, O O
ataxia O O
at O O
13:00 O O
today. O O
Symptoms O O
improving O O
over O O
first O O
30-60 O O
minutes, O O
but O O
residual O O
RUE O O
drift, O O
dysarthria, O O
and O O
(initally) O O
upgoing O O
R O O
toe. O O
Suspicious O O
for O O
L O O
MCA O O
cortical O O
event. O O
L O O
ICA O O
stenosis O O
and/or O O
embolic O O
event O O
+/- O O
fetal O O
left O O
PCA O O
possible O O
concerns O O
(?cortical O O
vs O O
v-b O O
etiology O O
of O O
dizziness). O O
Cannot O O
obtain O O
CTA O O
secondary O O
to O O
elevated O O
creatinine. O O
Plan: O O
1. O O
Admit O O
to O O
RDA O O
2. O O
MRI/MRA. O O
MR O O
Perfusion O O
study O O
if O O
L O O
ICA O O
stenosis O O
or O O
suggestion O O
of O O
intracranial O O
stenosis. O O
3. O O
As O O
event O O
occurred O O
on O O
ASA, O O
provide O O
heparin O O
PTT O O
60-80, O O
continue O O
ASA O O
at O O
decreased O O
dose O O
(81 O O
qD). O O
Watch O O
platelets, O O
as O O
pt O O
starting O O
with O O
platelets O O
= O O
150 O O
4. O O
Hold B-MEDICATION O
antihypertensive, I-MEDICATION O
but O O
continue O O
isosorbide O O
for O O
known O O
cardiac O O
ischemic O O
history. O O
5. O O
Echo, O O
Holter O O
(for O O
known O O
bradycardia; O O
eval O O
for O O
events O O
with O O
HR O O
&lt;&lt;40. O O
6. O O
PT/speech O O
therapy. O O
7. O O
Careful O O
glycemic O O
control O O
(holding B-MEDICATION O
metformin). B-MEDICATION O
Vi O O
K. O O
Xayarath, O O
M.D., O O
Ph.D. O O
Resident, O O
Phoenix O O
Neurology O O

Record O O
date: O O
2092-03-17 O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
HOLDEN O O
DISTRICT O O
HOSPITAL O O
Reason O O
for O O
visit O O
Three O O
months O O
of O O
followup O O
for O O
multiple O O
medical O O
problems. O O
History O O
of O O
present O O
illness O O
Since O O
his O O
last O O
visit, O O
he O O
has O O
started O O
to O O
resume O O
exercising O O
on O O
his O O
treadmill, O O
but O O
has O O
not O O
been O O
watching O O
his O O
weight O O
or O O
diet. O O
Major O O
Problems O O
Hyperlipidemia B-HYPERLIPIDEMIA O
His O O
most O O
recent O O
labs O O
are O O
within O O
reasonable O O
range O O
with O O
an O O
LDL O O
of O O
76 O O
and O O
fasting O O
triglycerides O O
263, O O
which O O
improved O O
from O O
his O O
previous O O
values. O O
He O O
has O O
been O O
intolerant O O
to O O
Lopid B-MEDICATION O
which O O
resulted O O
in O O
pancreatitis. O O
He O O
has O O
not O O
lost O O
any O O
weight, O O
but O O
has O O
begun O O
to O O
exercise. O O
Allergic O O
rhinitis O O
He O O
has O O
chronic O O
postnasal O O
drip O O
and O O
nasal O O
congestion O O
for O O
which O O
he O O
uses O O
Nasonex O O
on O O
a O O
regular O O
basis O O
with O O
some O O
improvement. O O
He O O
has O O
had O O
no O O
sinus O O
pains, O O
headache, O O
or O O
recent O O
sinusitis. O O
Cerebrovascular O O
accident O O
The O O
patient O O
has O O
had O O
no O O
recent O O
neurological O O
symptoms O O
or O O
changes. O O
He O O
had O O
a O O
mild O O
aphasia O O
which O O
has O O
totally O O
resolved. O O
He O O
has O O
had O O
no O O
headaches O O
or O O
any O O
focal O O
symptoms. O O
Gastroesophageal O O
reflux O O
disease O O
The O O
patient O O
continues O O
on O O
his O O
ranitidine O O
at O O
night O O
with O O
improvement O O
in O O
his O O
intermittent O O
epigastric O O
discomfort. O O
Sleep O O
apnea O O
The O O
patient O O
had O O
a O O
sleep O O
study O O
in O O
November O O
2091 O O
due O O
to O O
excessive O O
fatigue O O
and O O
snoring. O O
He O O
was O O
noted O O
to O O
have O O
sleep O O
apnea, O O
and O O
CPAP O O
was O O
prescribed. O O
He O O
has O O
not O O
been O O
using O O
the O O
CPAP O O
since O O
he O O
was O O
recently O O
on O O
vacation, O O
but O O
he O O
plans O O
to O O
start O O
in O O
the O O
near O O
future. O O
During O O
his O O
sleep O O
study, O O
he O O
was O O
not O O
uncomfortable O O
wearing O O
the O O
mask O O
and O O
hopefully, O O
this O O
will O O
help. O O
Prostatic O O
carcinoma O O
The O O
patient O O
is O O
followed O O
regularly O O
by O O
the O O
urologist O O
and O O
last O O
had O O
a O O
visit O O
in O O
January O O
2092 O O
with O O
PSA O O
in O O
a O O
very O O
good O O
range O O
at O O
less O O
than O O
0.2. O O
He O O
has O O
no O O
dysuria, O O
urgency, O O
frequency, O O
or O O
significant O O
nocturia. O O
Carpal O O
tunnel O O
syndrome O O
Currently, O O
he O O
does O O
not O O
complain O O
of O O
any O O
pain O O
or O O
paresthesias O O
in O O
his O O
wrists. O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
The O O
patient O O
has O O
had O O
no O O
angina O O
since O O
his O O
last O O
visit. O O
He O O
exercises O O
on O O
a O O
treadmill O O
five O O
times O O
a O O
week O O
and O O
can O O
walk O O
up O O
to O O
five O O
miles O O
in O O
any O O
given O O
setting. O O
He O O
does O O
not O O
have O O
any O O
palpitations, O O
chest O O
pressure, O O
pain, O O
or O O
significant O O
dyspnea O O
on O O
exertion. O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
The O O
patient O O
checks O O
his O O
blood O O
sugars O O
at O O
home, O O
and O O
they O O
have O O
been O O
in O O
the O O
120 O O
range, O O
although O O
he O O
admits O O
to O O
not O O
losing O O
weight O O
and O O
on O O
his O O
recent O O
trip O O
was O O
not O O
exercising O O
as O O
regularly. O O
He O O
has O O
had O O
no O O
symptoms O O
with O O
hypoglycemia. O O
Hypertension B-HYPERTENSION B-HYPERTENSION
The O O
patient O O
monitors O O
his O O
blood O O
pressure O O
closely O O
at O O
home O O
and O O
finds O O
it O O
to O O
be O O
at O O
around O O
120/70. O O
He O O
has O O
not O O
had O O
any O O
headaches O O
or O O
any O O
other O O
focal O O
symptoms. O O
Atrial O O
fibrillation O O
- O O
Inactivated O O
Bronchitis O O
- O O
Inactivated O O
Allergies O O
Allergic O O
drug O O
reaction O O
Acf O O
inhibitor O O
- O O
cough. O O
Procardia B-MEDICATION O
- O O
leg O O
edema. O O
Lopid O B-MEDICATION
- O O
pancreatitis. O O
Cardura O O
- O O
ankle O O
swelling. O O
Dyazide O O
- O O
elevated O O
bun/creat. O O
Exedrin O O
- O O
rash. O O
Amox O O
- O O
vomiting. O O
Norvasc B-MEDICATION B-MEDICATION
- O O
leg O O
edema. O O
HCTZ O O
- O O
rash O O
per O O
derm. O O
Estynil O O
- O O
rash. O O
Drug O O
allergy O O
ACE O O
inhibitor-cough O O
procardia-leg O O
edema O O
lopid-pancreatitis O O
cardura-ankle O O
swelling O O
dyazide-elevated O O
bun/creat O O
edecrine-rash O O
amox-vomiting O O
norvasc-leg O B-MEDICATION
edema O O
hctz-rash O O
per O O
derm O O
catapres-rash O O
aggrenox O O
- O O
pancreatitis. O O
Active O O
Medications O O
Lipitor B-MEDICATION B-MEDICATION
20mg O O
po O O
qd O O
Glucophage B-MEDICATION B-MEDICATION
500 O O
mg O O
po O O
BID; O O
Dir: O O
take O O
1 O O
tab O O
am O O
and O O
2 O O
tabs O O
pm O O
atenolol B-MEDICATION B-MEDICATION
25mg O O
po O O
bid O O
glyburide B-MEDICATION B-MEDICATION
tablets O O
1.25 O O
po O O
qd O O
Isordil B-MEDICATION B-MEDICATION
20 O O
mg O O
QID O O
Cardizem B-MEDICATION O
cd O O
180 O O
mg O O
PO O O
QD O O
Bumex O O
1 O O
mg O O
2 O O
tabs O O
PO O O
QD O O
Avapro B-MEDICATION B-MEDICATION
150 O O
mg O O
Nitro B-MEDICATION B-MEDICATION
stat I-MEDICATION O
0.3mg O O
SL O O
PRN; O O
Dir: O O
chest O O
pain,max O O
3 O O
pills O O
& O O
call O O
pcp O O
Coumadin O O
5 O O
mg O O
po O O
as O O
directed O O
folic O O
acid O O
1 O O
mg O O
PO O O
4 O O
QD O O
Clarinex O O
5mg O O
po O O
qd O O
Zoloft O O
100 O O
mg O O
po O O
QHS O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
ranitidine O O
hcl O O
300mg O O
po O O
qhs O O
Nasonex O O
50mcg/spray O O
nasal O O
qd; O O
Dir: O O
2 O O
sprays/nostril; O O
start O O
2wks O O
before O O
expected O O
allergy O O
season O O
free O O
text O O
medications O O
lipitor B-MEDICATION B-MEDICATION
10mg O O
po O O
qd; O O
Dir: O O
as O O
directed O O
Continuous O O
positive O O
airway O O
pressure O O
Accucheck O O
advantage O O
glucose O O
test O O
strips O O
Change O O
in O O
therapies O O
and O O
Renewals O O
Lipitor O B-MEDICATION
20mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
2/06/2087 O O
atenolol O B-MEDICATION
25mg O O
po O O
bid O O
QTY:180 O O
Refills:3 O O
Start: O O
3/25/2087 O O
free O O
text O O
medications O O
QTY: O O
Refills: O O
Start: O O
03/17/2092 O O
CPAP O O
as O O
directed O O
Past O O
medical O O
history O O
History O O
of O O
coronary B-CAD O
artery I-CAD O
bypass I-CAD O
surgery I-CAD O
in I-CAD O
August I-CAD O
2081. I-CAD O
History O O
of O O
carpal O O
tunnel O O
surgery O O
bilaterally. O O
History O O
of O O
prostatectomy O O
in O O
June O O
2088 O O
for O O
prostate O O
cancer. O O
Procedures O O
Colonoscopy O O
in O O
June O O
2087. O O
Family O O
history O O
Mother O O
with O O
hypertension. O B-HYPERTENSION
Father O O
with O O
hypertension O B-HYPERTENSION
and O O
Alzheimer's O O
disease. O O
Mother O O
with O O
a O O
stroke O O
and O O
diabetes. O O
Two O O
brothers O O
and O O
a O O
grandfather O O
with O O
colon O O
polyps. O O
A O O
grandfather O O
with O O
colon O O
cancer. O O
A O O
grandmother O O
with O O
breast O O
cancer. O O
Two O O
brothers O O
with O O
hyperlipidemia. O O
No O O
history O O
of O O
prostate O O
cancer. O O
Social O O
history O O
The O O
patient O O
is O O
a O O
retired O O
pastor O O
who O O
lives O O
with O O
his O O
wife. O O
He O O
is O O
active, O O
independent, O O
and O O
cares O O
for O O
his O O
grandchildren O O
on O O
a O O
regular O O
basis. O O
Habits O O
Smoking B-SMOKER O
status: I-SMOKER O
never B-SMOKER O
smoked I-SMOKER O
Alcohol O O
use O O
status: O O
occasional. O O
Drug O O
use O O
status: O O
none O O
Activity O O
level: O O
active O O
Review O O
of O O
systems O O
Constitutional, O O
some O O
mild O O
fatigue O O
and O O
snoring. O O
A O O
recent O O
eye O O
exam O O
in O O
January O O
2092 O O
by O O
report, O O
no O O
retinopathy. O O
Musculoskeletal, O O
no O O
recent O O
joint O O
problems O O
or O O
complaints. O O
Dermatologic, O O
he O O
sees O O
the O O
podiatrist O O
every O O
six O O
weeks O O
for O O
foot O O
care. O O
The O O
remainder O O
of O O
his O O
review O O
of O O
systems O O
is O O
negative O O
in O O
detail O O
except O O
for O O
noted O O
up O O
in O O
his O O
problem O O
list O O
above. O O
Physical O O
examination O O
Pulse O O
56 O O
and O O
regular O O
Blood O O
pressure O O
134/70 O O
132-134/70 O O
Weight O O
186.5 O O
pounds O O
Skin O O
No O O
evidence O O
of O O
skin O O
lesions O O
Heent O O
Full O O
extraocular O O
movements. O O
No O O
nystagmus. O O
Nose, O O
mild O O
erythema. O O
No O O
discharge. O O
Oropharynx, O O
no O O
lesions. O O
Dentition O O
in O O
good O O
repair O O
Neck O O
Thyroid, O O
not O O
enlarged. O O
No O O
fibroid O O
nodules. O O
Carotid O O
upstrokes O O
brisk. O O
No O O
bruits O O
Chest O O
Clear O O
to O O
auscultation O O
and O O
percussion O O
Cor O O
Normal O O
S1 O O
and O O
S2. O O
Regular O O
rhythm. O O
No O O
murmurs, O O
gallops, O O
or O O
rubs O O
Abdomen O O
Obese O O
and O O
nontender O O
Extrem O O
No O O
clubbing, O O
cyanosis, O O
or O O
edema. O O
Distal O O
pulses, O O
dorsalis O O
pedis, O O
and O O
posterior O O
tibial O O
are O O
full O O
and O O
symmetrical O O
Foot O O
exam O O
No O O
evidence O O
of O O
skin O O
lesions O O
Neuro O O
Grossly O O
nonfocal. O O
Speech O O
fluent O O
without O O
paraphasic O O
errors. O O
Memory, O O
excellent O O
and O O
intact. O O
Gait O O
normal O O
Assessment O O
and O O
plan O O
The O O
patient's O O
multiple O O
issues O O
were O O
reviewed O O
in O O
detail O O
and O O
his O O
medications O O
were O O
updated. O O
He O O
remains O O
overweight, O O
and O O
this O O
was O O
discussed O O
with O O
the O O
patient O O
in O O
terms O O
of O O
portion O O
control O O
and O O
continuing O O
his O O
vigorous O O
exercise O O
program. O O
He O O
will O O
try O O
to O O
lose O O
weight. O O
Diabetes. O O
His O O
last O O
hemoglobin O O
A1c O O
was O O
not O O
in O O
adequate O O
control. O O
In O O
the O O
past, O O
we O O
have O O
tried O O
to O O
increase O O
his O O
Glucophage. O B-MEDICATION
He O O
did O O
not O O
tolerate O O
it O O
due O O
to O O
severe O O
GI O O
upset. O O
If O O
his O O
sugars O O
remain O O
high, O O
he O O
will O O
need O O
his O O
regimen O O
adjusted. O O
His O O
eye O O
exam O O
and O O
throat O O
exam O O
are O O
up-to-date O O
and O O
urine O O
for O O
microalbumin O O
was O O
negative. O O
Coronary O O
artery O O
disease. O O
No O O
recent O O
angina. O O
He O O
will O O
continue O O
on O O
his O O
current O O
regimen. O O
Sleep O O
apnea. O O
It O O
was O O
highly O O
recommended O O
that O O
he O O
start O O
his O O
CPAP O O
therapy O O
for O O
overall O O
improvement O O
in O O
his O O
health. O O
Hypertension. O O
Very O O
well O O
controlled, O O
and O O
no O O
side O O
effects O O
to O O
his O O
current O O
medications. O O
Laboratory O O
studies O O
were O O
sent, O O
and O O
he O O
will O O
return O O
for O O
followup O O
in O O
three O O
months O O
or O O
sooner O O
if O O
needed. O O
Addendum O O
Allergies O O
were O O
reviewed. O O
Note O O
transcribed O O
by O O
outside O O
service O O
Transcription O O
errors O O
may O O
be O O
present. O O
Signed O O
electronically O O
by O O
Riddle, O O
Rhonda O O
on O O
Mar O O
31, O O
2092 O O

Record O O
date: O O
2092-09-18 O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
HOLDEN O O
DISTRICT O O
HOSPITAL O O
Reason O O
for O O
visit O O
Followup O O
of O O
multiple O O
issues. O O
History O O
of O O
present O O
illness O O
Since O O
his O O
last O O
visit, O O
the O O
patient O O
has O O
had O O
two O O
episodes O O
of O O
pressure B-CAD O
in I-CAD O
his I-CAD O
chest. I-CAD O
This O O
occurred O O
approximately O O
one O O
week O O
ago O O
in O O
the O O
setting O O
of O O
walking O O
up O O
the O O
stairs O O
and O O
carrying O O
a O O
heavy O O
package. O O
He O O
notes O O
that O O
his O O
pulse O O
went O O
up O O
to O O
101 O O
and O O
he O O
had O O
overall O O
felt O O
'tired O O
in O O
his O O
chest'. O O
He O O
did O O
not O O
take O O
any O O
nitroglycerine, O O
and O O
his O O
symptoms O O
promptly O O
resolved. O O
He O O
has O O
continued O O
to O O
notice O O
episodes O O
of O O
intermittent O O
rapid O O
pulses O O
with O O
pulses O O
up O O
to O O
100. O O
He O O
has O O
had O O
no O O
syncope O O
or O O
near O O
syncope. O O
Generally, O O
he O O
has O O
been O O
walking O O
on O O
the O O
treadmill O O
up O O
to O O
four O O
to O O
six O O
miles O O
a O O
day O O
several O O
times O O
a O O
week. O O
Over O O
the O O
last O O
few O O
weeks, O O
he O O
has O O
felt O O
a O O
little O O
bit O O
more O O
fatigued O O
and O O
now O O
can O O
only O O
walk O O
approximately O O
four O O
miles. O O
He O O
has O O
not O O
had O O
any O O
sustained O O
palpitation, O O
syncope, O O
or O O
near O O
syncope, O O
but O O
has O O
noted O O
a O O
slight O O
decrease O O
in O O
his O O
exercise O O
tolerance. O O
Problem O O
List O O
(reviewed) O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
MAJOR I-CAD O
Hypertension B-HYPERTENSION B-HYPERTENSION
MAJOR O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
MAJOR I-DIABETES O
Carpal O O
tunnel O O
syndrome O O
MAJOR O O
Allergic O O
rhinitis O O
MAJOR O O
Angina B-CAD O
pectoris I-CAD O
MAJOR O O
STATUS O O
POST O O
Prostatic O O
carcinoma O O
MAJOR O O
Cerebrovascular O O
accident O O
MAJOR O O
Sleep O O
apnea O O
MAJOR O O
Gastroesophageal O O
reflux O O
disease O O
MAJOR O O
Hyperlipidemia B-HYPERLIPIDEMIA O
MAJOR O O
Colonic O O
polyp O O
MAJOR O O
Major O O
Problems O O
Coronary O O
artery O O
disease O O
see O O
HPI O O
Hypertension O B-HYPERTENSION
The O O
patient O O
monitors O O
his O O
blood O O
pressure O O
closely O O
at O O
home O O
and O O
finds O O
it O O
to O O
be O O
at O O
around O O
120/70. O O
He O O
has O O
not O O
had O O
any O O
headaches O O
or O O
any O O
other O O
focal O O
symptoms. O O
Diabetes O O
mellitus O O
The O O
patient O O
checks O O
his O O
blood O O
sugars O O
at O O
home, O O
and O O
they O O
have O O
been O O
in O O
the O O
120 O O
range, O O
he O O
has O O
been O O
exercising O O
more O O
regularly. O O
He O O
has O O
had O O
no O O
symptoms O O
of O O
hypoglycemia O O
and O O
generally O O
has O O
been O O
doing O O
well O O
Carpal O O
tunnel O O
syndrome O O
Currently, O O
he O O
does O O
not O O
complain O O
of O O
any O O
pain O O
or O O
paresthesias O O
in O O
his O O
wrists. O O
Allergic O O
rhinitis O O
He O O
has O O
chronic O O
postnasal O O
drip O O
and O O
nasal O O
congestion O O
for O O
which O O
he O O
uses O O
clarinexon O O
a O O
regular O O
basis O O
with O O
some O O
improvement. O O
He O O
has O O
had O O
no O O
sinus O O
pains, O O
headache, O O
or O O
recent O O
sinusitis. O O
Angina O O
pectoris O O
STATUS O O
POST O O
Unstable B-CAD O
angina I-CAD O
1/86 I-CAD O
cath B-CAD O
lad I-CAD O
stenosis. I-CAD O
ETT O O
1/84. O O
ETT B-CAD O
3/2091 I-CAD O
mild I-CAD O
ant./basal I-CAD O
ischemia I-CAD O
Prostatic O O
carcinoma O O
The O O
patient O O
is O O
followed O O
regularly O O
by O O
the O O
urologist O O
and O O
last O O
had O O
a O O
visit O O
in O O
July O O
2092 O O
with O O
PSA O O
in O O
a O O
very O O
good O O
range O O
at O O
less O O
than O O
0.2. O O
He O O
has O O
no O O
dysuria, O O
urgency, O O
frequency, O O
or O O
significant O O
nocturia O O
Cerebrovascular O O
accident O O
The O O
patient O O
has O O
had O O
no O O
recent O O
neurological O O
symptoms O O
or O O
changes. O O
He O O
had O O
a O O
mild O O
aphasia O O
which O O
has O O
totally O O
resolved. O O
He O O
has O O
had O O
no O O
headaches O O
or O O
any O O
focal O O
symptoms. O O
Sleep O O
apnea O O
The O O
patient O O
had O O
a O O
sleep O O
study O O
in O O
November O O
2091 O O
due O O
to O O
excessive O O
fatigue O O
and O O
snoring. O O
He O O
was O O
noted O O
to O O
have O O
sleep O O
apnea, O O
and O O
CPAP O O
was O O
prescribed. O O
He O O
has O O
been O O
using O O
the O O
CPAP O O
.. O O
Gastroesophageal O O
reflux O O
disease O O
The O O
patient O O
continues O O
on O O
his O O
ranitidine O O
at O O
night O O
with O O
improvement O O
in O O
his O O
intermittent O O
epigastric O O
discomfort.No O O
dysphagia, O O
odynophagia O O
Hyperlipidemia O O
taking O O
his O O
medication, O O
and O O
watching O O
his O O
weight O O
Colonic O O
polyp O O
7/11/92 O O
2 O O
polyps O O
excised O O
transverse O O
colon O O
Allergies O O
Drug O O
allergy O O
ACE O O
inhibitor-cough O O
procardia-leg B-MEDICATION O
edema O O
lopid-pancreatitis O B-MEDICATION
cardura-ankle O O
swelling O O
dyazide-elevated O O
bun/creat O O
edecrine-rash O O
amox-vomiting O O
norvasc-leg B-MEDICATION B-MEDICATION
edema O O
hctz-rash O O
per O O
derm O O
catapres-rash O O
aggrenox O O
- O O
pancreatitis. O O
Active O O
Medications O O
Lipitor B-MEDICATION B-MEDICATION
10mg O O
po O O
3 O O
tabs O O
qd O O
dose O O
has O O
been O O
increased O O
to O O
30mg O O
Glucophage B-MEDICATION B-MEDICATION
500 O O
mg O O
po O O
BID O O
take O O
1 O O
tab O O
am O O
and O O
2 O O
tabs O O
pm O O
atenolol B-MEDICATION B-MEDICATION
25mg O O
po O O
bid O O
glyburide B-MEDICATION B-MEDICATION
tablets O O
1.25 O O
po O O
qd O O
Isordil B-MEDICATION B-MEDICATION
20 O O
mg O O
QID O O
Cardizem B-MEDICATION O
cd O O
180 O O
mg O O
PO O O
QD O O
Bumex O O
1 O O
mg O O
2 O O
tabs O O
PO O O
QD O O
Avapro B-MEDICATION B-MEDICATION
150 O O
mg O O
Nitro B-MEDICATION B-MEDICATION
stat I-MEDICATION O
0.3mg O O
SL O O
PRN O O
chest O O
pain,max O O
3 O O
pills O O
& O O
call O O
pcp O O
Coumadin O O
5 O O
mg O O
po O O
as O O
directed O O
folic O O
acid O O
1 O O
mg O O
PO O O
4 O O
QD O O
Clarinex O O
5mg O O
po O O
qd O O
Zoloft O O
100 O O
mg O O
1/2 O O
tab O O
po O O
QHS O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
ranitidine O O
hcl O O
300mg O O
po O O
qhs O O
Nasonex O O
50mcg/spray O O
nasal O O
qd O O
2 O O
sprays/nostril O O
Advair O O
100/50mcg O O
spray O O
inh O O
bid O O
free O O
text O O
medications O O
lipitor O B-MEDICATION
10mg O O
po O O
qd O O
as O O
directed O O
Continuous O O
positive O O
airway O O
pressure O O
use O O
as O O
directed O O
Accucheck O O
advantage O O
glucose O O
test O O
strips O O
use O O
as O O
directed O O
qty:300 O O
rfl:3 O O
Past O O
medical O O
history O O
History O O
of O O
coronary B-CAD O
artery I-CAD O
bypass I-CAD O
surgery I-CAD O
in I-CAD O
August I-CAD O
2081. I-CAD O
History O O
of O O
carpal O O
tunnel O O
surgery O O
bilaterally. O O
History O O
of O O
prostatectomy O O
in O O
June O O
2088 O O
for O O
prostate O O
cancer. O O
Family O O
history O O
Mother O O
with O O
hypertension. O O
Father O O
with O O
hypertension O O
and O O
Alzheimer's O O
disease. O O
Mother O O
with O O
a O O
stroke O O
and O O
diabetes. O O
Two O O
brothers O O
and O O
a O O
grandfather O O
with O O
colon O O
polyps. O O
A O O
grandfather O O
with O O
colon O O
cancer. O O
A O O
grandmother O O
with O O
breast O O
cancer. O O
Two O O
brothers O O
with O O
hyperlipidemia. O O
Brother O O
with O O
prostate O O
cancer. O O
Social O O
history O O
The O O
patient O O
is O O
a O O
retired O O
pastor O O
who O O
lives O O
with O O
his O O
wife. O O
He O O
is O O
active, O O
independent, O O
and O O
cares O O
for O O
his O O
grandchildren O O
on O O
a O O
regular O O
basis. O O
Habits O O
Activity O O
level: O O
active O O
treadmill O O
1-2 O O
hours O O
4-6X O O
per O O
week O O
Smoking B-SMOKER O
status: I-SMOKER O
never B-SMOKER O
smoked I-SMOKER O
Alcohol O O
use O O
status: O O
none/minimal O O
occasional. O O
Drug O O
use O O
status: O O
none O O
Procedures O O
and O O
Immunizations O O
Influenza O O
vaccine O O
STATUS O O
POST O O
[ O O
9/18/2092 O O
] O O
Fluzone O O
Lot O O
#S3124HR O O
Exp. O O
26 O O
Jun O O
92 O O
(l) O O
Deltoid O O
Left O O
deltoid O O
lot O O
STGLX647RM O O
Review O O
of O O
systems O O
The O O
patient O O
has O O
had O O
no O O
fevers, O O
chills, O O
or O O
night O O
sweats. O O
He O O
haschronic O O
bilateral O O
nasal O O
congestion O O
. O O
He O O
has O O
no O O
sputum O O
production. O O
No O O
joint O O
symptoms, O O
GI, O O
GU, O O
or O O
neurological O O
complaints. O O
No O O
skin O O
rashes. O O
Physical O O
examination O O
Blood O O
pressure O O
120/70 O O
Pulse O O
72, O O
irregularly, O O
irregular O O
Weight O O
182lbs O O
General O O
appearance O O
Well O O
developed, O O
well O O
nourished, O O
no O O
acute O O
distress. O O
Heent O O
NC/AT, O O
PERRL, O O
EOMI, O O
O/P O O
clear O O
without O O
erythema O O
or O O
exudates. O O
Neck O O
JVP O O
flat; O O
carotids O O
brisk, O O
2+ O O
bilaterally O O
without O O
bruits, O O
no O O
goiter. O O
Chest O O
Clear O O
to O O
auscultation O O
bilaterally. O O
Cor O O
PMI O O
at O O
5th O O
ICS, O O
MCL. O O
RRR O O
nl O O
s1, O O
s2 O O
without O O
m/r/g. O O
Extrem O O
No O O
clubbing, O O
cyanosis, O O
edema. O O
Full O O
pedal O O
pulses. O O
Neuro O O
Grossly O O
nonfocal. O O
Speech O O
fluent O O
without O O
paraphasic O O
errors. O O
Memory, O O
excellent O O
and O O
intact. O O
Gait O O
normal O O
Foot O O
exam O O
Negative O O
Preventive O O
eye O O
exam O O
5/92 O O
Selected O O
recent O O
labs O O
ECG O O
new O O
atrial O O
fibrillation O O
at O O
rate O O
74. O O
Right O O
bundle O O
branch O O
block, O O
no O O
ischemic O O
changes O O
Assessment O O
and O O
plan O O
The O O
patient's O O
symptoms O O
and O O
exam O O
as O O
well O O
as O O
EKG O O
are O O
consistent O O
with O O
atrial O O
fibrillation. O O
Of O O
note, O O
the O O
patient O O
had O O
a O O
history O O
of O O
paroxysmal O O
atrial O O
fibrillation O O
after O O
his O O
CABG. O O
However, O O
he O O
has O O
not O O
had O O
any O O
significant O O
symptoms O O
since O O
that O O
time. O O
He O O
remains O O
active O O
without O O
any O O
evidence O O
of O O
congestive O O
heart O O
failure O O
on O O
exam. O O
He O O
continues O O
to O O
exercise O O
on O O
a O O
regular O O
basis. O O
Given O O
his O O
slightly O O
elevated O O
pulse O O
rate, O O
his O O
atenolol O B-MEDICATION
will O O
be O O
increased O O
to O O
25 O O
mg O O
PO O O
BID O O
from O O
one O O
per O O
day O O
which O O
is O O
what O O
he O O
is O O
currently O O
taking. O O
His O O
blood O O
pressure O O
is O O
under O O
good O O
control. O O
Given O O
his O O
recent O O
episode O O
of O O
repeat O O
stress O O
test O O
will O O
be O O
sent. O O
If O O
there O O
is O O
any O O
prolonged O O
episode O O
of O O
pain, O O
he O O
will O O
come O O
to O O
the O O
emergency O O
room O O
immediately. O O
He O O
is O O
encouraged O O
to O O
use O O
nitroglycerine O O
sublingually O O
if O O
he O O
has O O
any O O
evidence O O
or O O
any O O
chest O O
pressure. O O
For O O
his O O
diabetes, O O
his O O
labs O O
will O O
be O O
sent. O O
He O O
remains O O
on O O
Coumadin O O
for O O
anticoagulation, O O
and O O
his O O
INR O O
has O O
been O O
therapeutic. O O
He O O
will O O
follow O O
up O O
in O O
three O O
months O O
but O O
sooner O O
pending O O
the O O
above O O
evaluation. O O
If O O
he O O
has O O
any O O
increase O O
in O O
his O O
symptoms, O O
he O O
will O O
be O O
admitted O O
immediately. O O
Note O O
transcribed O O
by O O
outside O O
service O O
Transcription O O
errors O O
may O O
be O O
present. O O
Signed O O
electronically O O
by O O
Riddle, O O
Rhonda O O
on O O
Sep O O
25, O O
2092 O O

Record O O
date: O O
2092-12-31 O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
HOLDEN O O
DISTRICT O O
HOSPITAL O O
Reason O O
for O O
visit O O
Followup O O
of O O
recent O O
MI B-CAD O
and O O
multiple O O
medical O O
problems. O O
History O O
of O O
present O O
illness O O
Since O O
the O O
patient's O O
last O O
visit, O O
he O O
developed O O
a O O
maculopapular O O
rash O O
and O O
his O O
Plavix B-MEDICATION B-MEDICATION
was I-MEDICATION O
discontinued. I-MEDICATION O
Since O O
this O O
is O O
the O O
only O O
new O O
medication, O O
it O O
was O O
presumed O O
that O O
Plavix O B-MEDICATION
was O O
the O O
cause O O
of O O
the O O
new O O
skin O O
rash. O O
He O O
also O O
changed O O
his O O
beta O O
blocker O O
and O O
started B-MEDICATION O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
approximately O O
one O O
week O O
ago. O O
At O O
home, O O
he O O
states O O
his O O
pulse O O
has O O
been O O
under O O
better O O
control, O O
and O O
now, O O
is O O
in O O
the O O
60 O O
range. O O
He O O
denies O O
any O O
palpitations, O O
PND, O O
orthopnea, O O
or O O
shortness O O
of O O
breath. O O
He O O
has O O
had O O
no O O
recurrent O O
angina O O
and O O
has O O
tried O O
this O O
week O O
to O O
slowly O O
start O O
to O O
walk O O
for O O
about O O
15 O O
minutes O O
on O O
his O O
treadmill O O
at O O
a O O
low O O
pace. O O
He O O
has O O
not O O
had O O
any O O
angina O O
or O O
chest O O
pain O O
with O O
this O O
walking O O
routine. O O
He O O
also O O
knows O O
that O O
his O O
sugars O O
at O O
home O O
had O O
been O O
very O O
low O O
at O O
55 O O
and O O
56 O O
in O O
the O O
evening. O O
He O O
has O O
had O O
weight O O
loss O O
and O O
slightly O O
diminished O O
appetite O O
and O O
this O O
may O O
account O O
for O O
his O O
low O O
blood O O
sugars. O O
He O O
is O O
here O O
for O O
a O O
followup. O O
Of O O
note, O O
his O O
Bumex O O
dose O O
was O O
decreased O O
due O O
to O O
an O O
elevated O O
BUN O O
and O O
creatinine. O O
His O O
weight O O
has O O
been O O
stabled, O O
and O O
he O O
feels O O
better O O
on O O
the O O
lower O O
dose O O
of O O
diuretics O O
without O O
symptoms O O
of O O
congestive O O
heart O O
failure. O O
Major O O
Problems O O
Coronary B-CAD O
artery I-CAD O
disease I-CAD O
see O O
HPI O O
Atrial O O
fibrillation O O
Rx O O
with O O
rate O O
control, O O
and O O
coumadin. O O
rate O O
60,s O O
at O O
home. O O
No O O
CHF, O O
neuro O O
Sx O O
Hypertension B-HYPERTENSION B-HYPERTENSION
The O O
patient O O
monitors O O
his O O
blood O O
pressure O O
closely O O
at O O
home O O
and O O
finds O O
it O O
to O O
be O O
at O O
around O O
110/70. O O
He O O
has O O
not O O
had O O
any O O
headaches O O
or O O
any O O
other O O
focal O O
symptoms. O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
See O O
HPI O O
Allergic O O
rhinitis O O
He O O
has O O
chronic O O
postnasal O O
drip O O
and O O
nasal O O
congestion O O
for O O
which O O
he O O
uses O O
clarinex O O
on O O
a O O
regular O O
basis O O
with O O
some O O
improvement. O O
He O O
has O O
had O O
no O O
sinus O O
pains, O O
headache, O O
or O O
recent O O
sinusitis. O O
Angina B-CAD O
pectoris I-CAD O
STATUS I-CAD O
POST I-CAD O
Unstable B-CAD O
angina I-CAD O
1/86 I-CAD O
cath B-CAD O
lad I-CAD O
stenosis. I-CAD O
ETT O O
1/84. O O
ETT B-CAD O
3/2091 I-CAD O
mild I-CAD O
ant./basal I-CAD O
ischemia. I-CAD O
S/P B-CAD O
MI B-CAD O
12/92 I-CAD O
with I-CAD O
cardiac I-CAD O
cath, I-CAD O
stent I-CAD O
RCA. I-CAD O
Cerebrovascular O O
accident O O
The O O
patient O O
has O O
had O O
no O O
recent O O
neurological O O
symptoms O O
or O O
changes. O O
He O O
had O O
a O O
mild O O
aphasia O O
which O O
has O O
totally O O
resolved. O O
He O O
has O O
had O O
no O O
headaches O O
or O O
any O O
focal O O
symptoms. O O
Sleep O O
apnea O O
The O O
patient O O
had O O
a O O
sleep O O
study O O
in O O
November O O
2091 O O
due O O
to O O
excessive O O
fatigue O O
and O O
snoring. O O
He O O
was O O
noted O O
to O O
have O O
sleep O O
apnea, O O
and O O
CPAP O O
was O O
prescribed. O O
He O O
has O O
been O O
using O O
the O O
CPAP O O
.. O O
Gastroesophageal O O
reflux O O
disease O O
The O O
patient O O
continues O O
on O O
his O O
ranitidine O O
at O O
night O O
with O O
improvement O O
in O O
his O O
intermittent O O
epigastric O O
discomfort.No O O
dysphagia, O O
odynophagia O O
Hyperlipidemia B-HYPERLIPIDEMIA O
taking O O
his O O
medication, O O
and O O
watching O O
his O O
weight O O
Allergies O O
Drug O O
allergy O O
ACE O O
inhibitor-cough O O
procardia-leg B-MEDICATION O
edema O O
lopid-pancreatitis O B-MEDICATION
cardura-ankle O O
swelling O O
dyazide-elevated O O
bun/creat O O
edecrine-rash O O
amox-vomiting O O
norvasc-leg B-MEDICATION B-MEDICATION
edema O O
hctz-rash O O
per O O
derm O O
catapres-rash O O
aggrenox O O
- O O
pancreatitis.Plavix-rash O O
Active O O
Medications O O
Accucheck O O
Advantage O O
glucose O O
test O O
strips O O
Advair O O
100/50mcg O O
spray O O
inh O O
bid O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
po O O
qd O O
Avapro B-MEDICATION B-MEDICATION
150 O O
mg O O
Bumex O O
1 O O
mg O O
2 O O
tabs O O
PO O O
bid O O
Cardizem B-MEDICATION O
cd O O
180 O O
mg O O
PO O O
QD O O
Clarinex O O
10mg O O
po O O
qd O O
Continuous O O
positive O O
airway O O
pressure O O
Coumadin O O
5 O O
mg O O
po O O
as O O
directed O O
folic O O
acid O O
1 O O
mg O O
PO O O
4 O O
QD O O
free O O
text O O
medications O O
toprol O B-MEDICATION
xl O O
100mg O O
po O O
qd O O
Glucophage B-MEDICATION B-MEDICATION
500 O O
mg O O
po O O
BID O O
glyburide B-MEDICATION B-MEDICATION
tablets O O
1.25 O O
po O O
qd O O
Isordil B-MEDICATION B-MEDICATION
20 O O
mg O O
QID O O
Lipitor B-MEDICATION B-MEDICATION
80mg O O
po O O
qd O O
Nasonex O O
50mcg/spray O O
nasal O O
qd O O
2 O O
sprays/nostril O O
Nitro B-MEDICATION O
stat I-MEDICATION O
0.3mg O O
SL O O
PRN O O
chest O O
pain,max O O
3 O O
pills O O
&amp; O O
call O O
pcp O O
ranitidine O O
hcl O O
300mg O O
po O O
qhs O O
Toprol O B-MEDICATION
XL O O
50 O O
mg O O
po O O
qd O O
Zoloft O O
100 O O
mg O O
1/2 O O
tab O O
po O O
QHS O O
Change O O
in O O
therapies O O
and O O
Renewals O O
Lipitor O B-MEDICATION
80mg O O
po O O
qd O O
Start: O O
2/06/2087 O O
atenolol B-MEDICATION B-MEDICATION
25mg I-MEDICATION O
po I-MEDICATION O
bid I-MEDICATION O
QTY:180 I-MEDICATION O
Refills:3 I-MEDICATION O
Start: I-MEDICATION O
3/25/2087 I-MEDICATION O
End: I-MEDICATION O
12/31/2092 I-MEDICATION O
- I-MEDICATION O
Inactivated I-MEDICATION O
Clarinex O O
10mg O O
po O O
qd O O
Start: O O
1/24/2090 O O
aspirin O B-MEDICATION
325 O O
mg O O
po O O
qd O O
Start: O O
4/27/2090 O O
Levaquin O O
250 O O
mg O O
po O O
qd O O
x10d O O
QTY:10 O O
Refills:0 O O
Start: O O
12/11/2092 O O
End: O O
12/31/2092 O O
- O O
Inactivated O O
free O O
text O O
medications O O
toprol O B-MEDICATION
xl O O
100mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
12/31/2092 O O
Plavix O B-MEDICATION
75mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
12/15/2092 O O
End: O O
12/31/2092 O O
- O O
Inactivated O O
Habits/Risk O O
Screening O O
Smoking B-SMOKER O
status: I-SMOKER O
never B-SMOKER O
smoked I-SMOKER O
Alcohol O O
use O O
status: O O
none/minimal O O
occasional. O O
Review O O
of O O
systems O O
The O O
patient O O
has O O
had O O
no O O
fevers, O O
chills, O O
or O O
night O O
sweats. O O
No O O
cough. O O
He O O
has O O
chronic O O
nasal O O
congestion O O
. O O
He O O
has O O
no O O
sputum O O
production. O O
No O O
joint O O
symptoms, O O
GI, O O
GU, O O
or O O
neurological O O
complaints. O O
No O O
skin O O
rashes. O O
Physical O O
examination O O
Blood O O
pressure O O
110/60 O O
Pulse O O
94 O O
irregularly, O O
irregular O O
Weight O O
172lbs O O
height O O
60in O O
Office O O
O2 O O
saturation O O
99% O O
General O O
appearance O O
Well O O
developed, O O
well O O
nourished, O O
no O O
acute O O
distress. O O
Heent O O
NC/AT, O O
PERRL, O O
EOMI, O O
O/P O O
clear O O
without O O
erythema O O
or O O
exudates. O O
Neck O O
JVP O O
flat; O O
carotids O O
brisk, O O
2+ O O
bilaterally O O
without O O
bruits, O O
no O O
goiter. O O
Chest O O
Clear O O
to O O
auscultation O O
bilaterally. O O
Cor O O
PMI O O
at O O
5th O O
ICS, O O
MCL. O O
RRR O O
nl O O
s1, O O
s2 O O
without O O
m/r/g. O O
Extrem O O
No O O
clubbing, O O
cyanosis, O O
edema. O O
Full O O
pedal O O
pulses. O O
Musc O O
skel O O
No O O
bony O O
deformities. O O
Neuro O O
Grossly O O
nonfocal. O O
Speech O O
fluent O O
without O O
paraphasic O O
errors. O O
Memory, O O
excellent O O
and O O
intact. O O
Gait O O
normal O O
Preventive O O
eye O O
exam O O
5/92 O O
Assessment O O
and O O
plan O O
The O O
patient's O O
multiple O O
issues O O
were O O
reviewed O O
with O O
the O O
patient O O
in O O
detail. O O
His O O
weight O O
has O O
remained O O
fairly O O
stable O O
on O O
the O O
lower O O
dose O O
of O O
diuretics, O O
and O O
a O O
repeat O O
BUN O O
and O O
creatinine O O
were O O
sent O O
today. O O
He O O
was O O
volume O O
depleted O O
at O O
his O O
last O O
visit. O O
Currently, O O
he O O
has O O
no O O
symptoms O O
of O O
unstable O O
angina O O
and O O
no O O
evidence O O
of O O
congestive O O
heart O O
failure O O
on O O
exam. O O
His O O
blood O O
sugars O O
have O O
been O O
low, O O
and O O
therefore, O O
he O O
will O O
hold B-MEDICATION O
his I-MEDICATION O
glyburide I-MEDICATION B-MEDICATION
for O O
now. O O
His O O
pulse O O
remained O O
somewhat O O
elevated, O O
and O O
he O O
will O O
follow O O
up O O
with O O
his O O
cardiologist O O
relative O O
to O O
the O O
need O O
for O O
cardioversion O O
for O O
an O O
attempt O O
to O O
get O O
him O O
back O O
into O O
normal O O
sinus O O
rhythm. O O
His O O
weight O O
control O O
has O O
been O O
a O O
problem. O O
He O O
will O O
slowly O O
increase O O
his O O
ambulation O O
and O O
will O O
check O O
his O O
pulse O O
and O O
blood O O
pressure O O
at O O
home. O O
He O O
will O O
follow O O
up O O
here O O
in O O
two O O
months O O
or O O
sooner O O
if O O
needed. O O
Note O O
transcribed O O
by O O
outside O O
service O O
Transcription O O
errors O O
may O O
be O O
present. O O
Signed O O
electronically O O
by O O
Riddle, O O
Rhonda O O
on O O
Jan O O
07, O O
2093 O O

Record O O
date: O O
2112-07-28 O O
OFFICE O O
VISIT O O
Dawson, O O
Quinten O O
MR#: O O
4692758 O O
July O O
28, O O
2112 O O
Return O O
visit. O O
Reason O O
for O O
visit: O O
A O O
71-year-old O O
male O O
for O O
comprehensive O O
eval/management O O
of O O
multiple O O
issues. O O
Problems: O O
1. O O
Diabetes: B-DIABETES O
Continues O O
on O O
oral O O
agents O O
since O O
2087. O O
A1C O O
is O O
below O O
7.0 O O
at O O
goal. O O
No O O
hypoglycemia. O O
Fasting O O
sugars O O
less O O
than O O
130 O O
on O O
balance. O O
Has O O
regular O O
follow O O
up. O O
2. O O
Hypertension: B-HYPERTENSION O
Blood O O
pressure O O
well O O
controlled O O
on O O
valsartan. B-MEDICATION O
Cardiac O O
ultrasound O O
2111 O O
with O O
normal O O
ejection O O
fraction, O O
no O O
LVH O O
and O O
normal O O
mitral O O
regurg. O O
Continue O O
current O O
program. O O
3. O O
Coronary B-CAD O
artery I-CAD O
disease: I-CAD O
Patient O O
had O O
mildly B-CAD O
abnormal I-CAD O
stress I-CAD O
test I-CAD O
with I-CAD O
moderate I-CAD O
posterior I-CAD O
ischemia I-CAD O
in I-CAD O
2112. I-CAD O
This O O
was O O
done O O
due O O
to O O
exertional O O
shortness O O
of O O
breath. O O
Those O O
symptoms O O
have O O
essentially O O
resolved. O O
He O O
has O O
never O O
used O O
nitroglycerin. O O
He O O
has O O
gone O O
through O O
the O O
cardiac O O
rehab O O
program. O O
Now O O
put O O
on O O
beta O O
blocker O O
due O O
to O O
patient's O O
preference. O O
No O O
strong O O
indication O O
given. O O
No O O
MI O O
or O O
symptomatic O O
angina. O O
4. O O
Hyperlipidemia: B-HYPERLIPIDEMIA O
Tight O O
control O O
of O O
lipids O O
achieved O O
on O O
Zocor. B-MEDICATION O
LDL O O
less O O
than O O
100. O O
5. O O
Stroke: O O
Status-post O O
stroke O O
2111 O O
with O O
slurred O O
speech O O
and O O
left O O
facial O O
droop. O O
Warfarin O O
recommended O O
for O O
one O O
year O O
at O O
that O O
time O O
for O O
presumed O O
cardiac O O
embolus. O O
Considered O O
discontinuing O O
this O O
visit. O O
6. O O
Anemia: O O
Patient O O
has O O
had O O
a O O
mild O O
hyperproliferative O O
anemia. O O
Has O O
been O O
seen O O
by O O
Dr. O O
Barr. O O
This O O
has O O
remained O O
stable. O O
Bone O O
marrow O O
biopsy O O
nondiagnostic. O O
7. O O
Hypogonadism: O O
Patient O O
has O O
been O O
evaluated O O
by O O
Dr. O O
Dominique O O
Stokes. O O
Placed O O
on O O
AndroGel O O
2111. O O
Testosterone O O
levels O O
have O O
improved. O O
Question O O
if O O
that O O
has O O
improved O O
his O O
fatigue O O
and O O
anemia. O O
Review O O
of O O
systems: O O
He O O
does O O
have O O
sleep O O
apnea O O
on O O
CPAP. O O
Has O O
bilateral O O
hearing O O
loss O O
on O O
audiogram. O O
Has O O
some O O
peripheral O O
edema O O
on O O
occasion. O O
Have O O
recommended O O
support O O
stockings. O O
Urinalysis O O
today O O
showed O O
greater O O
than O O
100 O O
red O O
blood O O
cells O O
and O O
he O O
said O O
this O O
was O O
due O O
to O O
penile O O
trauma O O
from O O
tight O O
shorts. O O
We O O
will O O
repeat O O
this. O O
He O O
did O O
see O O
blood O O
that O O
day. O O
He O O
has O O
never O O
seen O O
it O O
since. O O
He O O
has O O
multiple O O
seborrheic O O
keratoses O O
including O O
on O O
his O O
penis. O O
He O O
will O O
see O O
Field O O
Crest O O
Care O O
Center. O O
Otherwise O O
ROS O O
is O O
negative. O O
Family O O
history: O O
Mother O O
died O O
of O O
cancer O O
in O O
her O O
80's O O
of O O
unknown O O
primary. O O
Father O O
died O O
of O O
stroke O O
in O O
his O O
80's. O O
Physical O O
exam: O O
Weight O O
was O O
197. O O
Baseline O O
190. O O
Max O O
210. O O
Goal O O
185. O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
was I-HYPERTENSION O
140/78. I-HYPERTENSION O
Pulse O O
60. O O
Skin: O O
normal. O O
HEENT: O O
pupils O O
equal O O
and O O
reactive O O
to O O
light. O O
EOMs O O
full. O O
Fundi O O
normal. O O
Mouth O O
clear. O O
Neck: O O
JVP6. O O
Carotids O O
2+ O O
without O O
bruit. O O
Thyroid O O
normal. O O
Nodes: O O
none. O O
Chest: O O
clear O O
lungs. O O
Cardiac: O O
S1 O O
and O O
S2 O O
normal. O O
Grade O O
II/VI O O
Dawson, O O
Quinten O O
MR#: O O
4692758 O O
July O O
28, O O
2112 O O
Page O O
Two O O
systolic O O
murmur O O
with O O
mitral O O
regurg. O O
Abdomen: O O
no O O
mass O O
or O O
organomegaly. O O
Extremities: O O
trace O O
edema. O O
Pulses O O
full. O O
Rectal: O O
mildly O O
enlarged O O
prostate O O
without O O
nodule. O O
Stool O O
guaiac O O
negative. O O
Assessment: O O
Management O O
of O O
all O O
medical O O
problems O O
as O O
above. O O
Lab O O
work O O
updated O O
including O O
PSA. O O
Colorectal O O
screening O O
up O O
to O O
date O O
with O O
colonoscopy O O
2108/Dr. O O
Wilkinson. O O
Disposition: O O
Every O O
four O O
months, O O
12/12, O O
comprehensive O O
8/13. O O
Labs O O
in O O
advance. O O
Gerald O O
Everhart, O O
M.D. O O
Dictated/not O O
read O O
GE/tierney O O

Record O O
date: O O
2114-01-10 O O
OFFICE O O
NOTE O O
Quinten O O
Dawson O O
MR#4692758 O O
January O O
10, O O
2114 O O
Return O O
visit. O O
Reason O O
for O O
visit: O O
73 O O
year O O
old O O
male O O
for O O
evaluation/management O O
multiple O O
issues. O O
Diabetes: B-DIABETES O
he O O
is O O
on O O
maximal O O
dose O O
of O O
glipizide B-MEDICATION B-MEDICATION
and O O
Glucophage B-MEDICATION B-MEDICATION
and O O
A1C B-DIABETES O
has I-DIABETES O
been I-DIABETES O
going I-DIABETES O
up I-DIABETES O
steadily I-DIABETES O
now I-DIABETES O
to I-DIABETES O
8.0. I-DIABETES O
His O O
sugars O O
vary O O
greatly O O
in O O
the O O
morning O O
from O O
100 O O
to O O
174. O O
He O O
hasn't O O
been O O
checking O O
pre O O
dinner. O O
We O O
discussed O O
insulin O O
and O O
he O O
really O O
is O O
quite O O
against O O
it. O O
We O O
will O O
continue O O
discussion O O
open. O O
Asked O O
him O O
to O O
check O O
pre O O
dinner O O
sugars. O O
Coronary B-CAD O
disease: I-CAD O
patient O O
had O O
a O O
mild B-CAD O
posterior I-CAD O
ischemia I-CAD O
in I-CAD O
2112 I-CAD O
on I-CAD O
a I-CAD O
screening I-CAD O
stress I-CAD O
test. I-CAD O
He O O
is O O
actually O O
having O O
some O O
progressive O O
dyspnea O O
on O O
exertion O O
and O O
a O O
sense O O
of O O
chest O O
tightness O O
with O O
one O O
block. O O
He O O
is O O
a O O
bit O O
of O O
a O O
denier. O O
He O O
hasn't O O
tried O O
nitroglycerin, O O
which O O
I O O
have O O
given O O
him. O O
I O O
suggested O O
he O O
do O O
that. O O
He O O
will O O
have O O
a O O
follow O O
up O O
stress O O
test O O
and O O
we O O
will O O
arrange O O
a O O
cardiology O O
consult. O O
UTI: O O
patient O O
had O O
an O O
E O O
coli O O
UTI O O
9/13. O O
He O O
doesn't O O
really O O
have O O
much O O
in O O
terms O O
of O O
other O O
prostate O O
symptoms O O
and O O
no O O
nocturia. O O
He O O
has O O
however, O O
developed O O
urinary O O
urgency O O
again O O
in O O
the O O
last O O
week O O
or O O
two. O O
Will O O
check O O
another O O
culture. O O
May O O
need O O
urology O O
referral. O O
Knee O O
pain: O O
patient O O
with O O
longstanding O O
DJD O O
of O O
the O O
knees. O O
Will O O
have O O
a O O
consult O O
at O O
Christiana O O
Hospital O O
considering O O
replacement. O O
Family O O
history: O O
unchanged. O O
Review O O
of O O
systems: O O
status O O
post O O
an O O
embolic O O
stroke O O
in O O
2111 O O
and O O
took O O
warfarin O O
for O O
2 O O
years O O
and O O
followed O O
by O O
Dr. O O
Dillon. O O
He O O
is O O
still O O
on O O
Celexa O O
for O O
depression. O O
He O O
is O O
having O O
hearing O O
loss O O
with O O
equivocal O O
audiograms. O O
Suggested O O
otology O O
consult O O
at O O
Naples O O
Community O O
Hospital. O O
He O O
has O O
a O O
mild O O
hypoproliferative O O
anemia O O
that O O
is O O
stable. O O
Sleep O O
apnea. O O
All O O
other O O
systems O O
negative. O O
Physical O O
exam: O O
his O O
weight O O
is O O
196 O O
pounds. O O
Most O O
recent O O
195. O O
BP B-HYPERTENSION O
was I-HYPERTENSION O
140/70. I-HYPERTENSION O
Pulse O O
60. O O
Skin O O
normal. O O
Nodes: O O
none. O O
Chest O O
clear O O
lungs. O O
Cardiac: O O
S1, O O
S2 O O
normal. O O
Grade O O
II/VI O O
systolic O O
murmur O O
of O O
mitral O O
regurgitation O O
(confirmed O O
by O O
echo). O O
Abdomen O O
no O O
mass O O
or O O
organomegaly. O O
Extremities: O O
mild O O
venous O O
stasis. O O
Trace O O
edema. O O
DP O O
pulses O O
are O O
1+. O O
Assessment: O O
management O O
of O O
multiple O O
medical O O
problems O O
as O O
above. O O
Lab O O
work O O
up O O
to O O
date. O O
Disposition: O O
every O O
4 O O
months. O O
Comprehensive O O
5/14. O O
Gerald O O
Everhart, O O
M.D. O O
Dictated/Not O O
Read O O
Quinten O O
Dawson O O
MR#4692758 O O
January O O
10, O O
2114 O O
Page O O
2 O O
/talbot O O
cc. O O
Cardiology O O
consult O O

Record O O
date: O O
2114-03-12 O O
CARDIOLOGY O O
SAN O O
ANTONIO O O
HOSPITAL O O
Narrative O O
Note: O O
INITIAL O O
CARDIAC O O
CONSULT O O
Name: O O
Quinten O O
Dawson O O
Date: O O
03/12/14 O O
SAH#: O O
469-27-58 O O
Age: O O
73 O O
Problem O O
List: O O
Diabetes. B-DIABETES O
Hypertension. B-HYPERTENSION O
Hyperlipidemia. B-HYPERLIPIDEMIA O
Sleep O O
apnea. O O
2/1/11 O O
stroke O O
4/4/12 B-CAD O
exercise I-CAD O
sestamibi-SAH: I-CAD O
Small I-CAD O
posterolateral I-CAD O
scar I-CAD O
and I-CAD O
ischemia I-CAD O
2/21/14 I-CAD O
exercise I-CAD O
sestamibi-SAH: I-CAD O
Moderate-severe I-CAD O
anterior I-CAD O
apical I-CAD O
and I-CAD O
inferior I-CAD O
ischemia. I-CAD O
Medications: O O
Glucophage B-MEDICATION B-MEDICATION
850 O O
mg O O
t.i.d., O O
glipizide B-MEDICATION B-MEDICATION
10 O O
mg O O
b.i.d., O O
Cozaar B-MEDICATION B-MEDICATION
50 O O
mg, O O
Zocor B-MEDICATION B-MEDICATION
20 O O
mg, O O
Detrol O O
2 O O
mg, O O
Colace, O O
aspirin B-MEDICATION B-MEDICATION
81, O O
isosorbide B-MEDICATION B-MEDICATION
40 O O
mg O O
q.a.m., O O
multivitamin, O O
glucosamine O B-MEDICATION
and O O
chondroitin O O
b.i.d., O O
Naprosyn O B-MEDICATION
220-2 O O
pills O O
b.i.d., O O
Celexa O O
20 O O
mg. O O
BiPAP O O
Reactions O O
to O O
Medicines: O O
None O O
Chief O O
Complaint: O O
Shortness O O
of O O
breath O O
which O O
is, O O
in O O
fact, O O
chest O O
tightness O O
History O O
of O O
Present O O
Illness: O O
This O O
73 O O
year-old O O
hypertensive O O
hyperlipidemic O B-MEDICATION
diabetic O O
had O O
a O O
previous O O
stroke O O
on O O
2/1/11 O O
and O O
a O O
recent O O
exercise B-CAD O
test I-CAD O
that I-CAD O
showed I-CAD O
extensive I-CAD O
ischemia I-CAD O
as O O
noted O O
above. O O
He O O
has O O
noted O O
shortness O O
or O O
breath O O
for O O
the O O
last O O
three O O
months. O O
In O O
fact O O
the O O
shortness O O
of O O
breath O O
is O O
exertional O O
chest O O
tightness O O
which O O
comes O O
on O O
with O O
exertion O O
and O O
is O O
relieved O O
by O O
rest. O O
He O O
is O O
sent O O
by O O
Dr. O O
Everhart O O
for O O
consideration O O
for O O
coronary O O
angiogram. O O
On O O
1/08/14 O O
his O O
cholesterol O O
was O O
165, O O
triglyceride O O
109, O O
HDL O O
54 O O
and O O
LDL O O
89. O O
He O O
does O O
get O O
some O O
lightheadedness O O
if O O
he O O
has O O
a O O
high O O
sugar. O O
He's O O
had O O
no O O
rapid O O
heart O O
action O O
or O O
sudden O O
dizzy O O
spells. O O
ROS:Const.-Negative O O
Eyes O O
-Negative O O
ENMT: O O
Bilateral O O
hearing O O
loss O O
CV: O O
See O O
above O O
Respiratory: O O
Sleep O O
apnea O O
GI O O
-. O O
Recent O O
constipation O O
GU O O
-Impotence. O O
Urgency O O
and O O
incontinence O O
MS O O
- O O
arthritis O O
of O O
both O O
knees O O
and O O
hands. O O
Considering O O
knee O O
replacement O O
Skin O O
- O O
Negative O O
Neuro O O
-CVA O O
in O O
past. O O
Mild O O
residual O O
left O O
facial O O
drooping O O
and O O
occasional O O
trouble O O
finding O O
words. O O
Psych O O
- O O
Depression O O
well O O
controlled O O
on O O
Celexa O O
Endocrine O O
- O O
Diabetes O O
Heme-No O O
blood O O
problems O O
Allergies O O
- O O
No O O
drug O O
allergies O O
and O O
no O O
allergies O O
to O O
dye O O
Past O O
History: O O
T O O
& O O
A, O O
laparoscopic O O
cholecystectomy. O O
He O O
has O O
no O O
other O O
major O O
illnesses. O O
He B-SMOKER O
does B-SMOKER O
not I-SMOKER O
smoke I-SMOKER O
and O O
drinks O O
about O O
one O O
glass O O
of O O
wine O O
per O O
day. O O
Family O O
History: O O
His O O
father O O
died O O
at O O
83 O O
of O O
a O O
stroke, O O
cancer O O
and O O
diabetes. O O
Mother O O
died O O
at O O
73 O O
of O O
heart O O
disease, O O
diabetes O O
and O O
cancer. O O
Two O O
sisters O O
are O O
living O O
without O O
diabetes. O O
Social O O
History: O O
He O O
a O O
mapping O O
technologist O O
and O O
is O O
actively O O
working. O O
He O O
is O O
divorced O O
and O O
has O O
two O O
children O O
and O O
one O O
grandchild. O O
His O O
significant O O
other O O
works O O
as O O
an O O
optician. O O
She O O
is O O
divorced O O
and O O
has O O
three O O
children O O
and O O
one O O
grandchild. O O
Complete O O
Cardiovascular O O
Exam:. O O
BP O O
100 O O
50/65. O O
His O O
jugular O O
venous O O
pressure O O
is O O
seven O O
and O O
he O O
has O O
no O O
carotid O O
bruits. O O
He O O
has O O
no O O
rales. O O
He O O
has O O
a O O
1/6 O O
aortic O O
ejection O O
murmur, O O
a O O
2/6 O O
MR O O
murmur O O
at O O
the O O
apex O O
with O O
a O O
normal O O
S2 O O
and O O
no O O
S3. O O
He O O
has O O
no O O
enlargement O O
of O O
the O O
liver O O
and O O
no O O
edema. O O
EKG: O O
NSR O O
59, O O
LAE, O O
NSTTWA O O
Assessment: O O
I O O
agree O O
he O O
clearly O O
needs O O
a O O
coronary O O
angiogram O O
as O O
well O O
as O O
a O O
left O O
ventricular O O
angiogram O O
to O O
assess O O
MR. O O
He O O
should O O
also O O
have O O
a O O
left O O
right O O
heart O O
catheter O O
because O O
of O O
the O O
aortic O O
ejection O O
murmur. O O
In O O
the O O
meantime O O
I O O
will O O
ask O O
into O O
double O O
his O O
isosorbide O B-MEDICATION
to O O
40 O O
mg O O
in O O
the O O
morning O O
and O O
again O O
at O O
3 O O
p.m. O O
to O O
give O O
him O O
better O O
protection O O
throughout O O
the O O
day. O O
I O O
will O O
ask O O
him O O
to O O
increase O O
his O O
aspirin O B-MEDICATION
to O O
325 O O
mg O O
a O O
day. O O
I O O
will O O
also O O
add O O
fish O O
oil O O
1000 O O
mg O O
a O O
day O O
which O O
is O O
been O O
shown O O
to O O
reduce O O
the O O
risk O O
of O O
sudden O O
death. O O
Finally O O
we O O
will O O
double O O
his O O
Zocor O O
to O O
40 O O
mg O O
to O O
try O O
to O O
reach O O
the O O
new O O
goal O O
of O O
an O O
LDL O O
of O O
less O O
than O O
70. O O
I O O
explained O O
the O O
rationale O O
for O O
proceeding O O
on O O
with O O
the O O
catheterization O O
and O O
the O O
probability O O
that O O
we O O
will O O
find O O
multivessel O O
disease O O
that O O
will O O
not O O
be O O
suitable O O
for O O
PCI O O
but O O
rather O O
for O O
continued O O
medicine O O
or O O
possible O O
surgery. O O
Of O O
course O O
the O O
catheterization O O
will O O
determine O O
that. O O
He O O
should O O
not O O
consider O O
any O O
total O O
knee O O
operation O O
until O O
the O O
cardiac O O
status O O
is O O
clarified. O O
Quentin O O
T. O O
Edward, O O
Jr., O O
M.D. O O
CC: O O
Mr. O O
Quinten O O
Dawson, O O
653 O O
Wildwood O O
Lane, O O
New O O
Ashford, O O
VA O O
67999 O O
Dr. O O
Xavier O O
Everhart, O O
Internal O O
Medicine, O O
SAH O O
Signed O O
electronically O O
by O O
Quentin O O
T O O
Edward O O
MD O O
on O O
Mar O O
12, O O
2114 O O

Record O O
date: O O
2114-04-07 O O
07 O O
April, O O
2114 O O
RENAL O O
CONSULTATION O O
NOTE O O
Dawson, O O
Quinten O O
W O O
SAH O O
469 O O
27 O O
58 O O
Intro: O O
73 O O
yo O O
male O O
s/p O O
CABG B-CAD O
with O O
progressive O O
acute O O
renal O O
failure. O O
Present O O
Illness O O
and O O
Past O O
Med O O
Hx: O O
1) O O
Renal O O
failure O O
a) O O
Baseline O O
chronic O O
renal O O
failure O O
i) O O
Creat O O
1.2 O O
to O O
1.4 O O
range, O O
1.5 O O
on O O
admission O O
ii) O O
History O O
of O O
DM B-DIABETES O
iii) O O
Preop O O
urine O O
negative O O
for O O
albumin O O
and O O
blood. O O
b) O O
Progressive O O
renal O O
failure O O
i) O O
Gradual O O
rise O O
in O O
creatinine O O
to O O
2.7 O O
ii) O O
Non O O
oliguric, O O
making O O
~ O O
1 O O
liter O O
/day O O
2) O O
CAD B-CAD O
a) O O
Cath B-CAD O
i) B-CAD O
Occluded B-CAD O
RCA, I-CAD O
subtotal I-CAD O
circumflex I-CAD O
and I-CAD O
95% I-CAD O
LAD I-CAD O
and I-CAD O
90% I-CAD O
stenosis I-CAD O
of I-CAD O
first I-CAD O
diagonal I-CAD O
ii) O O
EF O O
preserved O O
at O O
55% O O
b) O O
CABG O O
i) O O
Off O O
pump O O
ii) O O
X O O
4 O O
vessels O O
LIMA O O
iii) O O
Post O O
op O O
CPK O O
to O O
594 O O
and O O
troponin O O
to O O
0.53. O O
3) O O
DM B-DIABETES O
type I-DIABETES O
2 I-DIABETES O
4) O O
Hyperlipidemia B-HYPERLIPIDEMIA O
5) O O
Hypertension B-HYPERTENSION B-HYPERTENSION
6) O O
S/p O O
CVA O O
7/2111 O O
with O O
residual O O
word O O
finding O O
difficulty O O
and O O
mild O O
facial O O
droop. O O
7) O O
Obstructive O O
sleep O O
apnea O O
- O O
uses O O
home O O
CPAP. O O
8) O O
Diverticulosis O O
9) O O
BPH O O
- O O
reports O O
that O O
he O O
was O O
in O O
the O O
process O O
of O O
getting O O
this O O
addressed O O
when O O
he O O
developed O O
symptoms O O
of O O
his O O
CAD. O O
10) O O
Peripheral O O
neuropathy O O
11) O O
Osteoarthritis O O
12) O O
S/p O O
cholecystectomy O O
Meds: O O
Albuterol O O
ASA B-MEDICATION B-MEDICATION
325 O O
Celexa O O
40 O O
Plavix B-MEDICATION B-MEDICATION
75 O O
Nexium O O
20 O O
bid O O
Furosemide O O
40 O O
bid O O
Motrin O O
500 O O
tid O O
Regular B-MEDICATION O
insulinSS I-MEDICATION O
q O O
6 O O
Metoprolol B-MEDICATION B-MEDICATION
12.5 O O
bid O O
KCL O O
20 O O
qd O O
Zocor B-MEDICATION B-MEDICATION
40 O O
qd O O
Allergies: O O
NKDA O O
Soc O O
Hx: O O
Smoking: B-SMOKER O
quit I-SMOKER O
in I-SMOKER O
2066; I-SMOKER O
EtOH: O O
1 O O
glass O O
of O O
wine O O
a O O
day; O O
Divorced. O O
Works O O
in O O
mapping. O O
Fam O O
Hx: O O
NC O O
ROS: O O
Chest O O
pain O O
and O O
shortness O O
of O O
breath O O
with O O
walking O O
to O O
the O O
bathroom O O
relieved O O
by O O
percoset O O
and O O
rest. O O
Denies O O
cough, O O
hemoptysis, O O
chest O O
pain, O O
orthopnea, O O
pnd, O O
rhinitis, O O
nausea, O O
vomiting, O O
hematemasis, O O
melena, O O
hematochezia, O O
ocular O O
problem, O O
sinusitis, O O
dyuria, O O
urgency, O O
hematuria, O O
trouble O O
voiding, O O
skin O O
rash, O O
arthritis O O
. O O
Exam: O O
Uncomfortable O O
appearing O O
BP: O O
128/60 O O
P: O O
80 O O
R: O O
20 O O
96% O O
on O O
2 O O
liters O O
AFEBRILE O O
SKIN: O O
benign O O
HEENT: O O
anicteric, O O
sclera O O
clear O O
NECK: O O
Supple, O O
no O O
adenopathy, O O
no O O
thyromegaly O O
CHEST: O O
few O O
rales O O
COR: O O
distant O O
heart O O
sounds. O O
Without O O
gallup O O
or O O
rub. O O
ABD: O O
positive O O
bowel O O
sounds, O O
mildly O O
distended, O O
minimally O O
tender. O O
EXT: O O
1+ O O
edema O O
Urine O O
- O O
PVR O O
of O O
~225 O O
cc O O
Labs: O O
Na O O
140, O O
K O O
4.6, O O
Cl O O
103, O O
HCO3 O O
28.1, O O
BUN O O
60, O O
Creat O O
2.7 O O
Amylase O O
330 O O
(32) O O
WBC O O
7.1, O O
Hct O O
26.1, O O
Plt O O
91 O O
UA O O
dip O O
with O O
trace O O
protein O O
and O O
negative O O
blood O O
Micro O O
with O O
many O O
hyaline O O
and O O
few O O
granular O O
casts. O O
EKG O O
sinus O O
at O O
77 O O
Non O O
specific O O
STTW O O
changes, O O
minimal O O
change O O
from O O
other O O
post O O
op O O
EKGs. O O
Impression: O O
1) O O
Renal O O
failure O O
a. O O
Chronic O O
component O O
i. O O
Suggestive O O
of O O
early O O
DM O O
nephrop O O
ii. O O
Baseline O O
1.4 O O
b. O O
Acute O O
component O O
i. O O
Prerenal O O
component O O
with O O
pancreatitis O O
ii. O O
No O O
major O O
ATN O O
iii. O O
? O O
obstructive O O
component O O
1. O O
now O O
with O O
increased O O
urine O O
output O O
after O O
Foley O O
catheter. O O
2) O O
Pancreatitis O O
a. O O
Amylase O O
up O O
today O O
3) O O
Chest O O
pain O O
a. O O
With O O
exertion O O
- O O
too O O
bathroom. O O
b. O O
With O O
shortness O O
of O O
breath O O
c. O O
Incisional O O
with O O
movement O O
vs O O
? O O
ischemic O O
Rec/Plan: O O
1) O O
Foley O O
catheter O O
overnight O O
2) O O
Urine O O
for O O
Na O O
and O O
creat. O O
3) O O
Flomax O O
for O O
24 O O
hours O O
prior O O
to O O
removing O O
Foley O O
with O O
voiding O O
trial O O
4) O O
Serial O O
Amylase O O
5) O O
Serial O O
cardiac O O
enzymes O O
6) O O
Lasix O O
prn. O O
- O O
now O O
seems O O
to O O
be O O
diuresing O O
reasonably. O O
7) O O
EKG O O
with O O
recurrent O O
chest O O
symptoms. O O
Uriel O O
Y. O O
Springer O O

Record O O
date: O O
2073-06-13 O O
EDVISIT^98044905^WARE, O O
VINCENT^06/13/73^ZORN, O O
TYLER O O
The O O
patient O O
is O O
a O O
65-year-old O O
gentleman O O
who O O
presents O O
complaining O O
of O O
shortness O O
of O O
breath, O O
weakness, O O
and O O
fatigue. O O
The O O
patient O O
was O O
seen O O
in O O
conjunction O O
with O O
resident O O
physician, O O
Ostrowski. O O
Please O O
see O O
her O O
note O O
for O O
details O O
of O O
the O O
visit. O O
Resident's O O
history O O
was O O
reviewed O O
by O O
me. O O
The O O
patient O O
was O O
interviewed O O
and O O
examined O O
by O O
me. O O
PAST O O
MEDICAL O O
HISTORY: O O
Significant O O
for O O
non-Hodgkin O O
lymphoma, O O
diabetes, B-DIABETES O
and O O
hypercholesterolemia. B-HYPERLIPIDEMIA O
MEDICATIONS: O O
Metformin, B-MEDICATION B-MEDICATION
insulin, B-MEDICATION B-MEDICATION
aspirin, B-MEDICATION B-MEDICATION
and O O
multivitamins. O O
ALLERGIES: O O
The O O
patient O O
has O O
no O O
allergies. O O
FAMILY O O
HISTORY: O O
Negative O O
for O O
chronic O O
diseases. O O
SOCIAL O O
HISTORY: O O
No B-SMOKER O
alcohol, I-SMOKER O
tobacco, B-SMOKER O
or O O
illicit O O
substances. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
followed O O
by O O
his O O
hematology-oncologist O O
for O O
unexplainable O O
anemia. O O
The O O
patient O O
presents O O
complaining O O
of O O
dyspnea. O O
REVIEW O O
OF O O
SYSTEMS: O O
Significant O O
for O O
dyspnea O O
on O O
exertion, O O
weakness, O O
fatigue, O O
fever O O
and O O
shortness O O
of O O
breath, O O
negative O O
for O O
headache, O O
blurred O O
vision, O O
chest O O
pain. O O
Other O O
systems O O
were O O
reviewed O O
and O O
found O O
to O O
be O O
negative, O O
unless O O
noted O O
positive O O
on O O
resident's O O
note. O O
PHYSICAL O O
EXAMINATION: O O
I O O
concur O O
with O O
documented O O
resident's O O
note. O O
Specifically, O O
abdomen O O
was O O
soft O O
and O O
nontender. O O
Rectal O O
Exam: O O
Guaiac O O
negative, O O
normal O O
tone, O O
and O O
no O O
masses. O O
ASSESSMENT O O
AND O O
PLAN: O O
Laboratory O O
studies O O
remarkable O O
for O O
hematocrit O O
of O O
24. O O
EKG O O
is O O
unremarkable. O O
Chest O O
x-ray O O
is O O
negative. O O
The O O
patient's O O
management O O
was O O
discussed O O
with O O
Dr. O O
Walsh, O O
oncology. O O
The O O
patient O O
will O O
be O O
admitted O O
to O O
oncology O O
hematology O O
for O O
workup. O O
______________________________ O O
ZORN, O O
TYLER O O
M.D. O O
D: O O
06/13/73 O O
T: O O
06/13/73 O O
Dictated O O
By: O O
ZORN, O O
TYLER O O
eScription O O
document:2-2004166 O O
IFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2073-09-20 O O
MANAMANA O O
nfectious O O
Disease O O
Consultation O O
Note O O
Patient: O O
Vincent O O
Ware O O
(71417347 O O
2Y) O O
Student: O O
Casey O O
Best, O O
MS-4 O O
ID O O
Fellow: O O
Tina O O
Isaiah-Villagomez O O
MD O O
ID O O
Attending: O O
Alexander O O
Y O O
Xian O O
MD O O
Referring O O
Physician: O O
Webster O O
MD O O
Date O O
of O O
Consult: O O
September O O
20, O O
2073 O O
Reason O O
for O O
consult: O O
cough, O O
nightsweats O O
and O O
weightloss, O O
two O O
days O O
prior O O
to O O
transplant O O
HPI: O O
66 O O
yo O O
M O O
with O O
h/o O O
IDDM, B-DIABETES O
large O O
cell O O
lymphoma O O
in O O
2066, O O
and O O
now O O
with O O
myelodysplastic O O
syndrome. O O
He O O
was O O
treated O O
with O O
CHOP O O
in O O
2066 O O
followed O O
by O O
radiotherapy, O O
completed O O
in O O
Nov O O
2066. O O
He O O
was O O
free O O
of O O
disease O O
since O O
then O O
until O O
May O O
2073. O O
He O O
sought O O
primary O O
care O O
for O O
a O O
URI O O
and O O
was O O
noted O O
to O O
be O O
anemic O O
(HCT O O
31). O O
His O O
counts O O
were O O
followed O O
and O O
when O O
his O O
HCT O O
dropped O O
as O O
low O O
as O O
22 O O
a O O
Bone O O
Marrow O O
was O O
done O O
and O O
showed O O
myelodysplastic O O
syndrome. O O
He O O
was O O
considered O O
for O O
a O O
allogenic O O
stem-cell O O
transplant. O O
His O O
major O O
complaint O O
is O O
a O O
dry O O
cough O O
that O O
he O O
has O O
had O O
since O O
May O O
2073. O O
It O O
is O O
provoked O O
by O O
eating, O O
drinking O O
and O O
lying O O
down. O O
And O O
only O O
occasionally O O
does O O
he O O
produce O O
any O O
sputum. O O
He O O
has O O
been O O
on O O
numerous O O
antibiotics O O
in O O
the O O
past O O
four O O
months O O
for O O
the O O
cough O O
and O O
he O O
also O O
developed O O
a O O
periorbital O O
cellulitis O O
for O O
which O O
he O O
was O O
hospitalized O O
at O O
Educare-Fargo O O
for O O
which O O
he O O
received O O
a O O
3 O O
week O O
course O O
of O O
Ceftriaxone, O O
Nafcillin O O
and O O
flagyl O O
(finished O O
at O O
the O O
end O O
of O O
July). O O
In O O
retrospect, O O
he O O
recognizes O O
sinus O O
pressure/congestion O O
associated O O
with O O
periorbital O O
cellulitis. O O
In O O
August O O
2073 O O
he O O
had O O
a O O
questionable O O
LLL O O
PNA O O
and O O
was O O
treated O O
with O O
cipro. O O
On O O
pre-transplant O O
work-up, O O
CXR O O
revealed O O
increase O O
conspicuity O O
of O O
ill-defined O O
LL O O
zone O O
opacity. O O
CT O O
chest O O
reviewed O O
today O O
revealed O O
mutlifocal O O
pneumonia O O
with O O
associated O O
radiation-related O O
changes. O O
Throughout O O
this O O
time O O
period O O
he O O
has O O
only O O
had O O
a O O
few O O
days O O
of O O
fever O O
for O O
which O O
he O O
was O O
at O O
KCGH O O
and O O
given O O
abx O O
and O O
defervesced. O O
He O O
recalls O O
nightsweats O O
as O O
the O O
fevers O O
broke. O O
He O O
does O O
admit O O
to O O
maybe O O
a O O
10 O O
lb O O
weight O O
loss O O
in O O
the O O
past O O
4 O O
months. O O
He O O
denies O O
SOB O O
(unless O O
he O O
s O O
severely O O
anemic), O O
orthopnea, O O
sore O O
throat, O O
dysphagia, O O
odynophagia, O O
CP, O O
palpitations, O O
angina-like O O
symptoms, O O
acid-reflux, O O
nausea, O O
vomiting, O O
diarrhea, O O
constipation, O O
BRBPR, O O
dysuria, O O
frequency, O O
nocturia, O O
joint O O
or O O
muscle O O
pain. O O
He O O
does O O
have O O
mild O O
peripheral O O
neuropathy O O
in O O
his O O
feet O O
bilaterally. O O
PMH: O O
MDS O O
Peri-Orbital O O
cellulitis, O O
recent O O
Insulin B-DIABETES O
dependent I-DIABETES O
diabetes I-DIABETES O
mellitus I-DIABETES O
Hypercholesterolemia B-HYPERLIPIDEMIA O
Non-hodgkin O O
s O O
lymphoma O O
(2066; O O
tx O O
w/ O O
CHOP O O
and O O
radiation) O O
Pt: O O
RPR O O
neg, O O
CMV O O
neg, O O
HSV O O
pos, O O
TOXO O O
pos, O O
EBV O O
pos, O O
VZV O O
pos, O O
Hep O O
Panel O O
neg, O O
HTLV O O
neg O O
and O O
HIV O O
neg, O O
PPD O O
neg O O
9/20/73 O O
and O O
8/7/73 O O
Donor: O O
RPR O O
neg, O O
CMV O O
neg, O O
Hep O O
Panel O O
neg, O O
HIV O O
neg, O O
HTLV O O
neg, O O
PPD O O
neg O O
(traveled O O
to O O
Saudi O O
Arabia, O O
Cartersville, O O
Newport) O O
Medications O O
on O O
admission: O O
Cipro O O
(last O O
dose O O
9/18/73) O O
Lantus B-MEDICATION B-MEDICATION
and I-MEDICATION O
novolog B-MEDICATION B-MEDICATION
Procrit O O
Zetia, B-MEDICATION O
ASA, B-MEDICATION O
VitB/MVI O O
Inpatient O O
medication: O O
Antimicrobials/immune O O
booster: O O
Acyclovir O O
Bactrim O O
(to O O
d/c O O
day O O
0) O O
Levaquin O O
(to O O
start O O
day O O
1) O O
GCSF O O
(start O O
d+1) O O
Immunosuppressants: O O
Fludarabine, O O
Vusulfan O O
Tacrolimus O O
(start O O
day O O
3) O O
Rapamycin O O
(start O O
day O O
3) O O
Other: O O
zoran, O O
ativan/compazine, O O
mvi/folate, O O
ompeprazole, O O
lantus, B-MEDICATION O
novolog, O B-MEDICATION
metformin, B-MEDICATION B-MEDICATION
Demerol, O O
oxycodone O O
Allergies: O O
NKDA O O
Social O O
History: O O
He O O
is O O
a O O
programmer O O
and O O
works O O
as O O
a O O
Industrial O O
Engineering O O
and O O
Manufacturing O O
Technologist O O
at O O
Activision O O
Blizzard. O O
NO O O
occupational O O
exposures. O O
He O O
is O O
married O O
with O O
three O O
children O O
and O O
4 O O
grandchildren. O O
He B-SMOKER O
does B-SMOKER O
not I-SMOKER O
smoke I-SMOKER O
or O O
drink. O O
He O O
has O O
remote O O
travel O O
hx O O
to O O
the O O
Rockefeller O O
Centre, O O
more O O
recent O O
global O O
travel O O
(Fernley, O O
Cartersville, O O
Iceland), O O
and O O
frequent O O
travel O O
to O O
Muscat O O
area. O O
He O O
recently O O
gave O O
his O O
indoor O O
cat O O
away O O
as O O
he O O
hypothesized O O
that O O
she O O
had O O
something O O
to O O
do O O
with O O
his O O
cough/MDS. O O
He O O
does O O
not O O
recall O O
tick O O
bites O O
and O O
has O O
infrequently O O
visited O O
Storting O O
and O O
Capitol. O O
Family O O
hx: O O
Sister O O
died O O
of O O
metastatic O O
cancer O O
likely O O
lung. O O
Father O O
died O O
of O O
diabetes, O O
Mother O O
died O O
at O O
age O O
90. O O
ROS: O O
negative O O
in O O
detail O O
except O O
as O O
outlined O O
above O O
in O O
HPI O O
Physical O O
Exam: O O
VS: O O
T O O
97.3 O O
Tm O O
98.6 O O
HR O O
88 O O
BP O O
120/70 O O
R O O
20 O O
O2sat O O
98% O O
RA O O
Gen: O O
WDWN O O
male O O
in O O
NAD, O O
AAOx3 O O
doing O O
extremely O O
complex O O
math O O
at O O
presentation O O
HEENT: O O
EOMI, O O
conjunctiva O O
pink, O O
PERRLA, O O
no O O
oropharyngeal O O
erythema, O O
thrush O O
or O O
exudate O O
CV: O O
S1 O O
S2 O O
nl, O O
RRR, O O
no O O
M/R/G O O
Lungs: O O
mild O O
coarse O O
crackles O O
at O O
L O O
base; O O
R O O
clear O O
Abd: O O
soft, O O
NT, O O
ND, O O
no O O
organomegaly O O
Ext: O O
no O O
C/C/E O O
Lines: O O
hickman, O O
L O O
subclavian, O O
no O O
erythema, O O
warmth O O
Relevant O O
Labs: O O
09/20/2073 O O
CRE O O
1.13 O O
09/20/2073 O O
LDH O O
113 O O
09/20/2073 O O
ALT/SGPT O O
15, O O
AST/SGOT O O
13, O O
ALKP O O
65, O O
TBILI O O
0.5, O O
DBILI O O
0.2 O O
09/20/2073 O O
1-3BGLUC O O
PEND O O
09/20/2073 O O
WBC O O
2.25 O O
(*), O O
HGB O O
8.5 O O
(*), O O
HCT O O
24.7 O O
(*), O O
PLT O O
118 O O
(*) O O
09/20/2073 O O
%POLY-M O O
70, O O
%BAND-M O O
1, O O
%LYMPH-M O O
18, O O
%ATYPS O O
0, O O
%MONO-M O O
10 O O
(*), O O
%EOS-M O O
0, O O
%BASO-M O O
1 O O
09/20/2073 O O
GALACT-AG O O
0.14 O O
[1] O O
Microbiology O O
09/19/2073 O O
Microbiology O O
URINE: O O
Total O O
Colony O O
Count O O
100: O O
PROBABLE O O
STAPHYLOCOCCI O O
09/18/2073 O O
NASAL O O
(ASPERGILLUS O O
SCREEN): O O
FUNGUS O O
CULTURE: O O
NO O O
REPORT O O
SO O O
FAR O O
Radiology O O
09/19/2073 O O
CT O O
SCAN O O
CHEST O O
W/O O O
CONTRAST O O
REPORT O O
NOT O O
FINALIZED O O
09/19/2073 O O
Chest O O
PA O O
& O O
Lateral O O
IMPRESSION: O O
Chest O O
PA O O
and O O
lateral O O
views O O
are O O
compared O O
to O O
prior O O
done O O
on O O
9/18/2073. O O
Paramediastinal O O
opacification O O
is O O
changed. O O
Cardiomediastinal O O
silhoutte O O
is O O
stable. O O
Nodular O O
opacity O O
in O O
the O O
left O O
perihilar O O
region O O
appears O O
less O O
apparent. O O
No O O
new O O
consolidations O O
are O O
seen. O O
There O O
is O O
a O O
new O O
left-sided O O
Hickman O O
catheter O O
with O O
its O O
tip O O
in O O
the O O
SVC. O O
No O O
pneumothorax O O
is O O
seen O O
. O O
Impression: O O
66 O O
yo O O
M O O
with O O
h/o O O
IDDM, O O
large O O
cell O O
lymphoma O O
in O O
2066, O O
and O O
now O O
with O O
myelodysplastic O O
syndrome O O
who O O
presents O O
with O O
fourth O O
months O O
of O O
cough O O
of O O
unclear O O
etiology. O O
The O O
differential O O
diagnosis O O
is O O
broad O O
and O O
includes O O
both O O
infectious O O
and O O
non-infectious O O
diagnoses. O O
Our O O
leading O O
diagnosis O O
is O O
either O O
radiation O O
fibrosis O O
or O O
a O O
primary O O
interstitial O O
lung O O
disease, O O
such O O
as O O
COP. O O
However, O O
we O O
also O O
think O O
that O O
several O O
infectious O O
etiologies O O
should O O
be O O
considered. O O
Endemic O O
mycoses O O
(histo, O O
blasto O O
and O O
crypto), O O
cryptococcal O O
pneumonia, O O
nocardiasis, O O
aspergillus, O O
mucormycosis O O
and O O
MAC O O
are O O
some O O
diseases O O
to O O
consider O O
in O O
this O O
patient. O O
While O O
the O O
clinical O O
picture O O
of O O
granulomas O O
on O O
chest O O
CT O O
and O O
cough O O
is O O
consistent O O
with O O
the O O
diagnosis O O
of O O
mycobacterial O O
disease, O O
the O O
patient O O
is O O
very O O
low O O
risk O O
for O O
this O O
infection O O
and O O
his O O
lack O O
of O O
fevers, O O
progressive O O
weight O O
loss O O
and O O
systemic O O
illness O O
argues O O
against O O
this O O
diagnosis. O O
I O O
(AYX) O O
have O O
interviewed O O
and O O
examined O O
Mr. O O
Ware, O O
and O O
confirmed O O
all O O
of O O
the O O
findings O O
documented O O
in O O
this O O
note. O O
My O O
highest O O
suspicion O O
is O O
for O O
an O O
inflammatory O O
process, O O
such O O
as O O
radiation O O
pneumonitis O O
or O O
BOOP/COP. O O
An O O
occult O O
infection O O
is O O
quite O O
possible, O O
such O O
as O O
pulmonary O O
MAC O O
or O O
a O O
mold O O
(the O O
lesion O O
in O O
his O O
left O O
lower O O
lobe O O
is O O
especially O O
suspicious). O O
Clinically O O
he O O
is O O
unchanged O O
over O O
many O O
months, O O
so O O
empiric O O
antibiotics O O
would O O
not O O
be O O
indicated. O O
We O O
recommend O O
the O O
following O O
work-up: O O
-Expectorated O O
sputum O O
for O O
gram O O
stain O O
and O O
culture O O
-Induced O O
sputum O O
for O O
-PCP O O
-Modified O O
AFB O O
smear O O
(looking O O
for O O
Nocardia) O O
-Fungal O O
stain O O
and O O
culture O O
-Urine O O
histo O O
antigen O O
-Serum O O
cryptococcal O O
antigen O O
-Weekly O O
monitoring O O
of O O
galactomannan O O
and O O
D-glucan O O
-Nasopharyngeal O O
swab O O
for O O
respiratory O O
viral O O
panel O O
(RSV, O O
Adenovirus, O O
Influenza O O
A O O
and O O
B, O O
paraflu O O
A O O
and O O
B) O O
and O O
viral O O
culture O O
If O O
the O O
above O O
work-up O O
is O O
unrevealing, O O
please O O
consult O O
pulmonology O O
for O O
a O O
bronchoscopy O O
-- O O
sooner O O
rather O O
than O O
later. O O
It O O
is O O
reasonable O O
to O O
start O O
is O O
levaquin O O
500 O O
mg O O
QD O O
now O O
to O O
treat O O
empirically O O
for O O
typical O O
and O O
atypical O O
pathogens O O
(this O O
medication O O
is O O
scheduled O O
to O O
begin O O
in O O
two O O
days, O O
per O O
protocol). O O
Our O O
recommendations O O
were O O
communicated O O
to O O
Dr. O O
Dalton O O
and O O
Dr. O O
Robin O O
Jeffery O O
of O O
the O O
patient O O
s O O
primary O O
team. O O
Thank O O
you O O
for O O
this O O
consult. O O
Our O O
team O O
will O O
follow O O
with O O
you O O
______________________________________ O O
Tina O O
Isaiah-Villagomez, O O
MD; O O
Fellow O O
Alexander O O
Y. O O
Xian, O O
MD; O O
Attending O O
-- O O
Pager O O
43486 O O
Division O O
of O O
Infectious O O
Diseases O O

Record O O
date: O O
2074-12-21 O O
EDVISIT^98044905^WARE, O O
VINCENT^12/21/74^VILLA, O O
SCOTT O O
CHIEF O O
COMPLAINT: O O
Dyspnea O O
on O O
exertion. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Mr. O O
Ware O O
is O O
a O O
67-year-old O O
man O O
with O O
a O O
history O O
of O O
diabetes B-DIABETES O
and O O
myelodysplastic O O
syndrome, O O
status O O
post O O
stem O O
cell O O
transplant O O
who O O
presents O O
to O O
the O O
Emergency O O
Department O O
with O O
a O O
2 O O
to O O
3 O O
week O O
history O O
of O O
increasing O O
exertional O O
dyspnea. O O
The O O
patient O O
denies O O
chest O O
pain, O O
palpitations, O O
or O O
syncope O O
but O O
does O O
complain O O
of O O
bilateral O O
lower O O
extremity O O
edema O O
times O O
several O O
weeks. O O
The O O
patient O O
has O O
been O O
worked O O
up O O
for O O
the O O
symptoms O O
as O O
an O O
outpatient O O
and O O
placed O O
on O O
Lasix O O
for O O
the O O
past O O
2 O O
weeks O O
and O O
had O O
an O O
echocardiogram O O
today, O O
which O O
was O O
remarkable O O
for O O
atrial O O
fibrillation. O O
The O O
patient O O
was O O
sent O O
to O O
the O O
Emergency O O
Department O O
for O O
further O O
evaluation. O O
Please O O
see O O
the O O
written O O
record O O
for O O
further O O
details. O O
PAST O O
MEDICAL O O
HISTORY: O O
Insulin-dependent B-DIABETES O
diabetes, I-DIABETES O
myelodysplastic O O
syndrome, O O
status O O
post O O
stem O O
cell O O
transplant. O O
PAST O O
SURGICAL O O
HISTORY: O O
Basal O O
cell O O
resection. O O
SOCIAL O O
HISTORY: O O
The O O
patient O O
denies B-SMOKER O
smoking, I-SMOKER O
alcohol, O O
or O O
illicit O O
drug O O
use. O O
MEDICATIONS: O O
Lasix, O O
vitamin O O
D, O O
Lantus, B-MEDICATION O
and O O
acyclovir. O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
PHYSICAL O O
EXAMINATION: O O
I O O
have O O
examined O O
the O O
patient O O
and O O
agree O O
with O O
the O O
physical O O
as O O
documented. O O
Of O O
note, O O
the O O
patient O O
is O O
awake O O
and O O
alert, O O
in O O
no O O
acute O O
distress. O O
Vitals: O O
Temperature O O
is O O
96.9, O O
pulse O O
is O O
100 O O
to O O
128, O O
respiratory O O
rate O O
of O O
18, O O
blood O O
pressure O O
is O O
118/70, O O
and O O
oxygen O O
saturation O O
is O O
96%. O O
Lungs: O O
Clear O O
bilaterally O O
with O O
no O O
rales, O O
rhonchi, O O
or O O
wheezing. O O
Cardiovascular O O
exam: O O
Irregularly O O
irregular O O
rhythm. O O
Normal O O
S1 O O
and O O
S2. O O
No O O
murmurs. O O
Abdomen: O O
Soft O O
with O O
no O O
tenderness, O O
guarding, O O
or O O
rebound. O O
Extremity O O
exam: O O
The O O
patient O O
has O O
bilateral O O
lower O O
extremity O O
2+ O O
pitting O O
edema, O O
left O O
greater O O
than O O
right. O O
No O O
calf O O
tenderness. O O
MEDICAL O O
DECISION O O
MAKING O O
AND O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
Mr. O O
Ware O O
is O O
a O O
67-year-old O O
man O O
with O O
diabetes O O
and O O
a O O
2-week O O
history O O
of O O
increasing O O
dyspnea O O
on O O
exertion. O O
His O O
chest O O
x-ray O O
did O O
not O O
demonstrate O O
pulmonary O O
edema, O O
but O O
was O O
significant O O
for O O
bilateral O O
pleural O O
effusions. O O
The O O
patient's O O
EKG O O
demonstrated O O
a O O
flutter O O
with O O
a O O
ventricular O O
rate O O
of O O
121 O O
with O O
inferolateral O O
T-wave O O
inversions. O O
The O O
patient O O
was O O
given O O
IV O O
and O O
p.o. O O
Cardizem B-MEDICATION O
with O O
control O O
of O O
the O O
ventricular O O
rate. O O
At O O
the O O
time O O
of O O
this O O
dictation, O O
the O O
patient's O O
laboratory O O
data O O
are O O
not O O
available. O O
The O O
plan O O
is O O
to O O
admit O O
the O O
patient O O
to O O
the O O
hospital O O
for O O
further O O
management. O O
PRIMARY O O
DIAGNOSIS: O O
New O O
onset O O
AFib. O O
DISPOSITION: O O
Admission. O O
CONDITION O O
UPON O O
ADMISSION: O O
Good. O O
______________________________ O O
VILLA, O O
SCOTT O O
M.D. O O
D: O O
12/21/74 O O
T: O O
12/21/74 O O
Dictated O O
By: O O
VILLA, O O
SCOTT O O
eScription O O
document:7-5753770 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2075-03-03 O O
ID O O
CONSULT O O
NOTE O O
PATIENT O O
NAME: O O
Vincent O O
Ware O O
MRN: O O
98044905 O O
DATE O O
OF O O
ADMISSION: O O
3/02/75 O O
DATE O O
OF O O
CONSULT: O O
3/03/75 O O
ID O O
ATTENDING: O O
Haney O O
ID O O
FELLOW: O O
Riddle O O
SERVICE O O
ATTENDING: O O
Vann O O
REASON O O
FOR O O
CONSULT: O O
Cough, O O
dyspnea, O O
fevers O O
s/p O O
HSCT O O
off O O
immune O O
suppression O O
HPI: O O
Mr. O O
Ware O O
is O O
a O O
67-year-old O O
man O O
with O O
a O O
history O O
non-Hodgkins's O O
lymphoma O O
(spinal O O
mass, O O
s/p O O
CHOP, O O
radiation, O O
in O O
long O O
term O O
remission) O O
and O O
secondary O O
MDS O O
s/p O O
reduced O O
intensity O O
allo-HSCT O O
12/73. O O
His O O
post-tx O O
course O O
was O O
unremarkable. O O
Peritransplant O O
he O O
devloped O O
a O O
multifocal O O
PNA O O
of O O
unclear O O
etiology. O O
Pretransplant O O
imaging O O
showed O O
peribronchial O O
thickening, O O
and O O
post O O
transplant O O
a O O
tree O O
&amp; O O
bud O O
appearance O O
with O O
more O O
focal O O
areas O O
of O O
consolidation. O O
Per O O
the O O
patient, O O
he O O
had O O
a O O
dry O O
hacking O O
cough O O
with O O
occaisional O O
fevers O O
and O O
night O O
sweats O O
that O O
lasted O O
from O O
April O O
through O O
November O O
of O O
73 O O
and O O
resolved O O
on O O
their O O
own. O O
He O O
had O O
several O O
courses O O
of O O
quinolones O O
(and O O
other O O
abx) O O
during O O
this O O
period O O
without O O
significant O O
relief, O O
but O O
ultimately O O
his O O
symptoms O O
improved O O
on O O
their O O
own. O O
His O O
immune O O
suppression O O
was O O
d/c'd O O
7/74. O O
He O O
deveoloped O O
iron O O
overload O O
(Ferritin O O
1356) O O
and O O
started O O
phlebotomy O O
9/74. O O
Mr. O O
Ware O O
did O O
well O O
from O O
a O O
respiratory O O
standpoint O O
until O O
11/74 O O
when O O
he O O
noticed O O
intermittent O O
fevers O O
approximately O O
every O O
2 O O
weeks. O O
At O O
first O O
they O O
were O O
in O O
the O O
99 O O
range O O
and O O
they O O
would O O
last O O
1-2days O O
and O O
be O O
associated O O
with O O
malaise. O O
He O O
also O O
again O O
experienced O O
symptoms O O
of O O
a O O
dry O O
hacking O O
cough O O
that O O
occurs O O
with O O
change O O
in O O
positioning O O
(not O O
necessarily O O
lying O O
flat). O O
By O O
the O O
end O O
of O O
November, O O
the O O
fevers O O
were O O
a O O
bit O O
higher O O
(100.5). O O
He O O
saw O O
his O O
PCP O O
who O O
thought O O
he O O
might O O
have O O
PNA. O O
He O O
obtained O O
a O O
CXR O O
and O O
gave O O
hime O O
a O O
course O O
ofr O O
azithromycin O O
(5d). O O
His O O
fevers O O
improved. O O
In O O
early O O
December, O O
he O O
began O O
experienceing O O
SOB O O
with O O
exertional O O
dyspnea. O O
He O O
saw O O
his O O
PCP O O
again O O
who O O
rx O O
avelox. O O
He O O
got O O
another O O
CXR O O
which O O
showed O O
some O O
'fluid' O O
and O O
was O O
strated O O
on O O
lasix. O O
He O O
was O O
also O O
referred O O
for O O
echocardiogram, O O
PFTs, O O
and O O
chest O O
CT. O O
On O O
arrival, O O
he O O
was O O
found O O
to O O
be O O
in O O
AFB O O
w/RVR. O O
He O O
was O O
admitted O O
from O O
12/21-01/02. O O
He O O
was O O
rate O O
controlled O O
and O O
had O O
minimal O O
diuresis. O O
Cardiac O O
MRI O O
suggested O O
constrictive O O
pericarditis O O
and O O
possible O O
areas O O
of O O
active O O
pericarditis. O O
Right O O
&amp; O O
left O O
heart O O
cath O O
which O O
showed O O
no O O
evidence O O
of O O
cosntriction O O
hemodynamically. O O
He O O
had O O
1 O O
temperature O O
to O O
101.4, O O
and O O
given O O
his O O
history O O
he O O
was O O
seen O O
by O O
our O O
service. O O
Blood O O
cultures O O
were O O
negative. O O
Induced O O
sputum O O
was O O
negative O O
for O O
AFB O O
x O O
3. O O
He O O
and O O
influenza/rsv/paraflu/adnevorus O O
nasal O O
swabs O O
which O O
were O O
also O O
negative. O O
Sputum O O
cultures O O
grew O O
oral O O
flora. O O
CMV O O
VL, O O
glucan, O O
and O O
galactomannan O O
were O O
also O O
negative. O O
He O O
improved O O
w/regard O O
to O O
SOB O O
but O O
cough O O
persisted. O O
He O O
was O O
seen O O
by O O
Dr. O O
Vann O O
who O O
was O O
concerned O O
for O O
an O O
immunologic O O
process O O
given O O
his O O
bilateral O O
pleural O O
effusions O O
&amp; O O
question O O
of O O
pericarditis. O O
He O O
had O O
a O O
URI O O
syndrome O O
in O O
January O O
that O O
lasted O O
3 O O
weeks O O
then O O
resolved. O O
On O O
February O O
19th, O O
he O O
noticed O O
the O O
onset O O
of O O
low-grade O O
temps O O
(100.0-100.5) O O
with O O
malaise O O
and O O
mild O O
chills. O O
These O O
happened O O
nightly O O
through. O O
He O O
saw O O
his O O
PCP O O
2/23 O O
who O O
rx O O
moxifloxacin. O O
He O O
had O O
no O O
change O O
in O O
his O O
symptoms. O O
He O O
had O O
some O O
mild O O
rhinorrhea O O
and O O
mildly O O
increased O O
SOB. O O
He O O
denies O O
CP, O O
abdominal O O
pain, O O
HA, O O
N/V/D, O O
joint O O
pain, O O
skin O O
rashes, O O
dysuria. O O
His O O
son O O
had O O
a O O
'head O O
cold' O O
prior O O
to O O
the O O
onset O O
of O O
his O O
symptoms. O O
No O O
other O O
sick O O
contacts. O O
He O O
was O O
admitted O O
for O O
further O O
workup. O O
He O O
is O O
up O O
tp O O
date O O
received O O
influenza O O
&amp; O O
pneumococcal O O
vaccines. O O
ROS: O O
as O O
above, O O
otherwise O O
negative O O
PMH: O O
1. O O
Lymphoma, O O
non-Hodgkin's, O O
large O O
B-cell O O
lymphoma O O
status O O
post O O
CHOP O O
in O O
2066 O O
and O O
radiation O O
therapy O O
for O O
a O O
T9 O O
to O O
T12 O O
mass, O O
in O O
remission. O O
2. O O
Secondary O O
MDS, O O
newly O O
diagnosed O O
06/73 O O
s/p O O
unrelated O O
donor O O
nonmyeloablative O O
stem O O
cell O O
transplant O O
12/73 O O
Pt: O O
RPR O O
neg, O O
CMV O O
neg, O O
HSV O O
pos, O O
TOXO O O
pos, O O
EBV O O
pos, O O
VZV O O
pos, O O
Hep O O
Panel O O
neg, O O
HTLV O O
neg O O
and O O
HIV O O
neg, O O
PPD O O
neg O O
9/20/73 O O
and O O
8/7/73 O O
Donor: O O
RPR O O
neg, O O
CMV O O
neg, O O
Hep O O
Panel O O
neg, O O
HIV O O
neg, O O
HTLV O O
neg, O O
PPD O O
neg O O
(traveled O O
to O O
Saudi O O
Arabia, O O
Cartersville, O O
Newport) O O
3. O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2. I-DIABETES O
He O O
is O O
on O O
insulin B-MEDICATION O
at O O
home O O
and O O
his O O
last B-DIABETES O
hemoglobin I-DIABETES O
A1C I-DIABETES O
was I-DIABETES O
around I-DIABETES O
8. I-DIABETES O
4. O O
Hyperlipidemia B-HYPERLIPIDEMIA O
on O O
Zetia. B-MEDICATION O
5. O O
B12 O O
deficiency. O O
7. O O
History O O
of O O
basal O O
cell O O
cancer O O
status O O
post O O
resection. O O
8. O O
Tonsillectomy. O O
9. O O
Orbital O O
Cellulitis O O
(7/73 O O
tx O O
with O O
ceftriaxone/nafcillin/flagyl) O O
Home O O
Medications: O O
Actigall O O
(URSODIOL) O O
300 O O
MG O O
(300MG O O
CAPSULE O O
Take O O
1) O O
PO O O
TID O O
#90 O O
Capsule(s) O O
Aspirin B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC O O
Acid) O O
81 O O
MG O O
(81MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
Folic O O
Acid O O
1MG O O
TABLET O O
Take O O
1 O O
Tablet(s) O O
PO O O
QD O O
, O O
please O O
ship O O
to O O
patients O O
home- O O
they O O
are O O
out O O
of O O
medication O O
#30 O O
Tablet(s) O O
Lantus B-MEDICATION B-MEDICATION
(INSULIN O O
Glargine) O B-MEDICATION
18 O O
UNITS O O
SC O O
QHS O O
Novolog B-MEDICATION B-MEDICATION
(INSULIN O O
Aspart) O B-MEDICATION
6-8 O O
UNITS O O
SC O O
tid O O
Vitamin O O
D O O
1000 O O
U O O
PO O O
QD O O
Acyclovir O O
400mg O O
PO O O
TID O O
Lasix O O
20mg O O
PO O O
daily O O
Current O O
Medications: O O
Acyclovir O O
400mg O O
po O O
TID, O O
ASA, B-MEDICATION B-MEDICATION
Insulin, B-MEDICATION O
Pravaastatin, B-MEDICATION B-MEDICATION
Sotalol, B-MEDICATION O
ASA, O B-MEDICATION
Vitamin O O
D3 O O
Allergies: O O
NKDA O O
FH: O O
Mother O O
lived O O
to O O
90. O O
Dad O O
died O O
of O O
complications O O
of O O
diabetes/heart O O
disease. O O
One O O
sister O O
w/metastatic O O
lung O O
CA. O O
Younger O O
brother O O
with O O
skin O O
CA. O O
No O O
rheumatologic O O
disease O O
that O O
he O O
is O O
aware O O
of. O O
Social O O
History: O O
He O O
is O O
a O O
programmer O O
and O O
works O O
as O O
a O O
Industrial O O
Engineering O O
and O O
Manufacturing O O
Technologist O O
at O O
Activision O O
Blizzard. O O
No O O
occupational O O
exposures. O O
He O O
is O O
married O O
with O O
three O O
children O O
and O O
4 O O
grandchildren. O O
He B-SMOKER O
does I-SMOKER O
not I-SMOKER O
smoke I-SMOKER O
or O O
drink. O O
He O O
has O O
remote O O
travel O O
hx O O
to O O
the O O
Rockefeller O O
Centre, O O
more O O
recent O O
global O O
travel O O
(Fernley, O O
Cartersville, O O
Iceland), O O
and O O
frequent O O
travel O O
to O O
Muscat O O
area. O O
He O O
recently O O
gave O O
away O O
his O O
indoor O O
cat O O
prior O O
to O O
transplant. O O
He O O
does O O
not O O
recall O O
tick O O
bites O O
and O O
has O O
infrequently O O
visited O O
Storting O O
and O O
Acropolis. O O
He O O
works O O
on O O
model O O
planes. O O
He O O
has O O
no O O
TB O O
exposures. O O
PHYSICAL O O
EXAM: O O
VITALS: O O
tmax O O
99.1 O O
bp O O
120/62 O O
hr O O
83 O O
rr O O
20 O O
sat O O
93% O O
RA O O
GEN: O O
NAD O O
HEENT: O O
NC/AT, O O
PERRLA, O O
OP O O
clear O O
without O O
lesions O O
or O O
thrush O O
NECK: O O
supple O O
CHEST: O O
mildly O O
decreased O O
BS O O
bilateral O O
bases O O
CV: O O
RRR, O O
NO O O
M/G/R O O
ABDOMEN: O O
soft, O O
NT/ND, O O
normoactive O O
BS, O O
no O O
HSM O O
EXTREMITIES: O O
no O O
clubbing O O
or O O
cyanosis, O O
trace O O
to O O
1+ O O
bilateral O O
LE O O
edema O O
LYMPH O O
NODES: O O
no O O
cervical, O O
submandibular, O O
axillary, O O
or O O
inguinal O O
adenopathy O O
SKIN: O O
no O O
rashes O O
LABORATORY: O O
Na O O
135 O O
K O O
5.1 O O
CHL O O
103 O O
CO2 O O
26 O O
BUN O O
16 O O
Cr O O
1.03 O O
GLU B-DIABETES O
259 I-DIABETES O
AST O O
35 O O
ALT O O
21 O O
ALk O O
Phos O O
265 O O
TB O O
0.6 O O
WBC O O
9.71 O O
HCT O O
35.6 O O
PLT O O
366 O O
67%P, O O
17%L, O O
6%E O O
ESR O O
61 O O
CMV O O
2/9 O O
negative O O
MICROBIOLOGY: O O
BLOOD O O
3/02, O O
3/03 O O
NGTD O O
URINE O O
3/02 O O
1K O O
probable O O
enterococcus O O
STOOL O O
3/02 O O
culture O O
pending O O
3/03 O O
FlU/Paraflu/RSV O O
pending O O
RADIOLOGY: O O
CXR O O
3/02: O O
Increased O O
moderate O O
effusions O O
since O O
1/29/2075. O O
CHEST O O
CT O O
3/03: O O
Pericardial O O
effusion O O
has O O
resolved O O
without O O
apparent O O
change O O
in O O
bilateral O O
pleural O O
effusions O O
since O O
12/14/2074. O O
Prior O O
granulomatous O O
infection O O
is O O
evident. O O
TTE: O O
The O O
left O O
ventricle O O
is O O
normal O O
in O O
size. O O
Overall O O
left O O
ventricular O O
function O O
is O O
mildly O O
to O O
moderately O O
reduced. O O
The O O
estimated O O
ejection O O
fraction O O
is O O
40-45%. O O
There O O
is O O
global O O
hypokinesis O O
with O O
regional O O
variation. O O
There O O
is O O
septal O O
?bounce? O O
raising O O
the O O
possibility O O
of O O
constrictive O O
physiology. O O
IMPRESSION O O
&amp; O O
RECOMMENDATIONS: O O
67yoM O O
with O O
h/o O O
NHL O O
in O O
remission, O O
secondary O O
MDS O O
s/p O O
non O O
myeloabaltive O O
allo O O
BMT O O
now O O
off O O
all O O
immune O O
suppression O O
since O O
7/74 O O
presenting O O
with O O
fevers, O O
SOB, O O
and O O
malaise. O O
He O O
has O O
not O O
yet O O
had O O
documented O O
fevers O O
in O O
the O O
hospital, O O
but O O
his O O
rhinorrhea O O
after O O
sick O O
contact O O
during O O
this O O
season O O
is O O
suggestive O O
of O O
a O O
viral O O
syndrome. O O
He O O
has O O
chronically O O
mildly O O
elevated O O
LFTs O O
which O O
are O O
stable. O O
He O O
has O O
a O O
new O O
mild O O
eospinophila O O
of O O
unclear O O
etiology. O O
-nasopharyngeal O O
swab O O
AND O O
pertussis O O
IgM/IgG O O
for O O
pertussis O O
given O O
persistent O O
cough O O
and O O
low O O
grade O O
temps O O
-f/u O O
respiratory O O
viral O O
panel O O
-given O O
mild O O
eosinophilia, O O
can O O
check O O
strongyloides O O
antibody O O
and O O
stool O O
for O O
ova O O
and O O
parasites O O
though O O
no O O
clear O O
exposure O O
history, O O
would O O
also O O
check O O
urinary O O
histo O O
Ag O O
and O O
cocciodes O O
IgM/IgG O O
(given O O
old O O
granulomatous O O
disease O O
on O O
chest O O
CT) O O
-would O O
consider O O
AM O O
cortisol O O
to O O
r/o O O
adrenal O O
insufficiency O O
-would O O
repeat O O
hepatitis O O
serologies O O
(HepB O O
sAG, O O
cAB, O O
sAB, O O
HepA O O
AB, O O
HepC O O
Ab) O O
given O O
persistent O O
mildly O O
elevated O O
LFTs O O
-would O O
check O O
toxoplasma O O
DNA O O
given O O
risk O O
of O O
dz O O
post-transplant O O
________________________________ O O
Riley O O
Riddle O O
MD, O O
MPH O O
Infectious O O
Disease O O
Fellow O O
pager O O
65296 O O

Record O O
date: O O
2082-11-22 O O
ZHH O O
EMERGENCY O O
DEPT O O
VISIT O O
FINNEY,INDIANA O O
432-94-73-9 O O
VISIT O O
DATE: O O
11/22/82 O O
PRESENTING O O
COMPLAINT: O O
Chest O O
pain. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
Ms. O O
Finney O O
is O O
a O O
45 O O
year-old O O
woman O O
with O O
type B-DIABETES O
II I-DIABETES O
diabetes I-DIABETES O
who O O
presents O O
with O O
new O O
onset O O
of O O
palpitations O O
and O O
chest O O
tightness. O O
The O O
episodes O O
last O O
10-15 O O
minutes O O
and O O
mainly O O
occur O O
with O O
exertion, O O
relieved O O
by O O
rest. O O
These O O
occurred O O
at O O
rest O O
today O O
and O O
so O O
she O O
came O O
to O O
the O O
hospital. O O
She O O
reports O O
being O O
ill O O
lately O O
with O O
a O O
cough, O O
for O O
a O O
long O O
time. O O
She O O
has O O
no O O
history O O
of O O
coronary O O
artery O O
disease. O O
She O O
has O O
had O O
no O O
fever. O O
PAST O O
MEDICAL O O
HISTORY: O O
She O O
had O O
recent O O
dental O O
work O O
and O O
she O O
was O O
told O O
she O O
has O O
a O O
heart O O
murmur. O O
MEDICATIONS: O O
Oral O O
hypoglycemics. O O
ALLERGIES: O O
No O O
known O O
allergies. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
She B-SMOKER O
does I-SMOKER O
not I-SMOKER O
smoke. I-SMOKER O
PHYSICAL O O
EXAMINATION: O O
VITAL O O
SIGNS: O O
Pulse O O
111, O O
temperature O O
100, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
157/69. I-HYPERTENSION O
GENERAL: O O
Alert, O O
calm O O
and O O
oriented. O O
In O O
no O O
distress. O O
NECK: O O
No O O
adenopathy. O O
Thyroid O O
was O O
not O O
palpable. O O
Oropharynx O O
was O O
normal. O O
CHEST: O O
Clear. O O
CARDIOVASCULAR: O O
Regular O O
rate O O
and O O
rhythm. O O
ABDOMEN: O O
Soft O O
and O O
non-tender. O O
EXTREMITIES: O O
No O O
clubbing, O O
cyanosis O O
or O O
edema. O O
She O O
had O O
no O O
rash. O O
LABORATORY O O
EVALUATION: O O
Electrocardiogram O O
showed O O
mild O O
ST O O
segment O O
change O O
that O O
was O O
non-diagnostic O O
and O O
confirmed O O
the O O
tachycardia. O O
Laboratory O O
evaluation O O
is O O
pending O O
at O O
the O O
time O O
of O O
dictation. O O
Chest O O
x-ray O O
is O O
pending O O
and O O
the O O
results O O
will O O
be O O
appended O O
by O O
my O O
successor. O O
FINAL O O
DIAGNOSIS: O O
Chest O O
pain, O O
exertional O O
type. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Disposition O O
will O O
be O O
appended O O
by O O
my O O
successor. O O
Patient O O
is O O
currently O O
in O O
stable O O
condition. O O
___________________________________ O O
TJ371/9248 O O
YVES O O
BLACKBURN, O O
M.D. O O
HB79 O O
D:11/22/82 O O
T:11/23/82 O O
Dictated O O
by: O O
YVES O O
BLACKBURN, O O
M.D. O O
HB79 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2086-06-29 O O
EDVISIT^43294739^Finney, O O
Indiana^06/29/86^GAY, O O
G. O O
VERNAL O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
patient O O
is O O
a O O
48-year-old O O
female O O
who O O
presents O O
to O O
Zucker O O
Hillside O O
Hospital O O
Department O O
of O O
Emergency O O
Medicine O O
with O O
complaints O O
of O O
chest O O
pain. O O
She O O
was O O
admitted O O
to O O
ED O O
Observation O O
Unit, O O
after O O
having O O
no O O
acute O O
findings O O
on O O
EKG O O
and O O
a O O
normal O O
set O O
of O O
cardiac O O
enzymes. O O
Awake, O O
alert, O O
and O O
in O O
no O O
acute O O
distress. O O
Vital O O
signs O O
in O O
the O O
ED O O
this O O
a.m. O O
were O O
grossly O O
within O O
normal O O
limits. O O
No O O
chest O O
pain O O
this O O
a.m. O O
PHYSICAL O O
EXAMINATION: O O
HEENT: O O
Normocephalic, O O
atraumatic. O O
Pupils O O
equal, O O
round, O O
and O O
reactive. O O
Fundi O O
benign. O O
Neck: O O
Supple. O O
Chest O O
is O O
clear O O
to O O
auscultation O O
and O O
percussion. O O
No O O
rales, O O
wheezes, O O
or O O
rhonchi. O O
Heart O O
notes O O
a O O
normal O O
S1, O O
S2, O O
no O O
S3, O O
S4, O O
no O O
murmur. O O
Abdomen O O
is O O
benign, O O
soft, O O
nontender, O O
no O O
masses, O O
guarding, O O
rebound, O O
or O O
organomegaly. O O
Extremities: O O
Grossly O O
within O O
normal O O
limits. O O
Neurologic: O O
Awake, O O
alert, O O
able O O
to O O
follow O O
commands. O O
Negative O O
Babinski. O O
She O O
had O O
a O O
second O O
set O O
of O O
cardiac O O
enzymes O O
done O O
in O O
the O O
observation O O
portion O O
of O O
the O O
ED, O O
which O O
were O O
negative. O O
PLAN: O O
Do O O
ETT O O
this O O
a.m. O O
If O O
negative, O O
to O O
home O O
to O O
be O O
followed O O
by O O
her O O
PMD, O O
to O O
return O O
to O O
the O O
Emergency O O
Department O O
at O O
Zucker O O
Hillside O O
Hospital O O
if O O
her O O
problems O O
persist O O
or O O
worsen. O O
______________________________ O O
GAY, O O
G. O O
VERNAL O O
M.D. O O
D: O O
06/30/86 O O
T: O O
06/30/86 O O
Dictated O O
By: O O
GAY, O O
G. O O
VERNAL O O
eScription O O
document:3-9073761 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2087-08-15 O O
EDVISIT^43294739^FINNEY, O O
INDIANA^08/15/87^NARANJO, O O
KENNETH O O
The O O
patient O O
was O O
seen O O
and O O
examined O O
in O O
the O O
Emergency O O
Department O O
on O O
08/15/2087. O O
The O O
patient O O
was O O
seen O O
by O O
Dr. O O
Kaminski. O O
I O O
have O O
discussed O O
the O O
management O O
with O O
her. O O
I O O
have O O
also O O
seen O O
the O O
patient O O
personally O O
and O O
reviewed O O
the O O
medical O O
record. O O
This O O
is O O
an O O
addendum O O
to O O
the O O
medical O O
record. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
is O O
a O O
50-year-old O O
female O O
who O O
is O O
sent O O
in O O
by O O
her O O
primary O O
doctor O O
after O O
having O O
had O O
EKG O O
changes O O
today. O O
Her O O
history, O O
which O O
I O O
personally O O
obtained O O
and O O
in O O
review O O
of O O
the O O
record, O O
she O O
has O O
a O O
history O O
of O O
sarcoidosis, O O
recently O O
has O O
had O O
increased O O
cough O O
and O O
some O O
shortness O O
of O O
breath, O O
given O O
albuterol O O
with O O
symptomatic O O
improvement O O
yesterday O O
and O O
returned O O
today O O
with O O
some O O
persistent O O
pain, O O
which O O
she O O
says O O
is O O
generally O O
related O O
to O O
cough. O O
She O O
has O O
had O O
no O O
fevers, O O
chills, O O
or O O
shortness O O
of O O
breath. O O
REVIEW O O
OF O O
SYSTEMS: O O
As O O
indicated O O
and O O
otherwise O O
negative. O O
She O O
is O O
asymptomatic O O
at O O
this O O
time. O O
She O O
has O O
had O O
no O O
recent O O
travel. O O
PAST O O
MEDICAL O O
HISTORY: O O
Diabetes. B-DIABETES O
SOCIAL O O
HISTORY: O O
She O O
is O O
a O O
nonsmoker. B-SMOKER O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
very O O
well O O
appearing, O O
pleasant O O
and O O
in O O
no O O
acute O O
distress. O O
Her O O
vital O O
signs O O
are O O
stable. O O
She O O
is O O
normocephalic, O O
atraumatic. O O
Pharynx O O
and O O
ENT O O
is O O
normal. O O
Neck O O
is O O
supple O O
and O O
nontender. O O
Chest O O
is O O
clear. O O
Heart O O
is O O
regular O O
with O O
normal O O
pulses. O O
Abdomen O O
is O O
soft O O
and O O
nontender O O
without O O
masses O O
that O O
are O O
appreciated. O O
Skin O O
is O O
warm O O
and O O
dry. O O
She O O
has O O
no O O
CVA O O
tenderness, O O
no O O
back O O
tenderness. O O
She O O
is O O
awake, O O
alert, O O
and O O
oriented. O O
Sensory O O
and O O
motor O O
exam O O
are O O
normal. O O
ASSESSMENT O O
AND O O
PLAN: O O
This O O
is O O
a O O
woman O O
who O O
complains O O
of O O
having O O
had O O
some O O
chest O O
discomfort. O O
She O O
has O O
a O O
history O O
of O O
sarcoid O O
and O O
has O O
EKG, O O
which O O
I O O
reviewed, O O
which O O
shows O O
lateral O O
T-wave O O
changes O O
as O O
suggested O O
by O O
her O O
referring O O
doctor. O O
She O O
is O O
pain O O
free. O O
Initial O O
lab O O
results O O
show O O
hematocrit O O
of O O
40, O O
INR O O
of O O
1, O O
and O O
a O O
troponin O O
which O O
was O O
negative. O O
Plan O O
at O O
this O O
time O O
is O O
for O O
hospital O O
admission O O
to O O
rule O O
out O O
MI O O
given O O
her O O
EKG O O
change. O O
She O O
looks O O
clinically O O
stable. O O
______________________________ O O
NARANJO, O O
KENNETH O O
M.D. O O
D: O O
08/15/87 O O
T: O O
08/15/87 O O
Dictated O O
By: O O
NARANJO, O O
KENNETH O O
eScription O O
document:3-7918390 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2089-11-05 O O
EDOBS^43294739^FINNEY, O O
INDIANA^11/04/89^YEAGER, O O
HAROLD O O
I O O
saw O O
this O O
patient O O
with O O
Dr. O O
Sawyer. O O
I O O
confirm O O
that O O
I O O
have O O
interviewed O O
and O O
examined O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation O O
on O O
the O O
patient's O O
chart, O O
and O O
discussed O O
the O O
evaluation, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient. O O
CHIEF O O
COMPLAINT: O O
Heart O O
is O O
racing. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
52-year-old O O
female O O
with O O
history O O
of O O
diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
and O O
sarcoid, O O
who O O
presents O O
with O O
onset O O
one O O
hour O O
prior O O
to O O
admission O O
of O O
left O O
arm O O
pressure O O
and O O
heart O O
racing. O O
The O O
patient O O
denies O O
shortness O O
of O O
breath. O O
She O O
has O O
no O O
nausea, O O
vomiting, O O
and O O
no O O
fevers O O
or O O
chills. O O
She O O
says O O
that O O
she O O
has O O
occasionally O O
had O O
these O O
symptoms O O
in O O
the O O
past, O O
they O O
have O O
already O O
stopped O O
on O O
their O O
own. O O
Tonight, O O
they O O
lasted O O
for O O
approximately O O
30 O O
minutes O O
prior O O
to O O
calling O O
EMS. O O
En O O
route O O
EMS O O
took O O
12-lead O O
ECG O O
showing O O
a O O
rate O O
of O O
150, O O
suspected O O
a O O
flutter O O
and O O
was O O
given O O
20 B-MEDICATION O
mg I-MEDICATION O
diltiazem B-MEDICATION O
by O O
EMS O O
with O O
no O O
response. O O
She O O
describes O O
feeling O O
in O O
her O O
left O O
arm O O
as O O
dull O O
pain, O O
it O O
is O O
3/10, O O
and O O
it O O
has O O
not O O
made O O
better O O
or O O
worse O O
by O O
anything. O O
PAST O O
MEDICAL O O
HISTORY: O O
Please O O
see O O
paper O O
chart. O O
SOCIAL O O
HISTORY: O O
Please O O
see O O
paper O O
chart. O O
REVIEW O O
OF O O
SYSTEMS: O O
Please O O
see O O
paper O O
chart. O O
MEDICATIONS: O O
Please O O
see O O
paper O O
chart. O O
ALLERGIES: O O
Please O O
see O O
paper O O
chart. O O
PAST O O
SURGICAL O O
HISTORY: O O
None. O O
FAMILY O O
HISTORY: O O
Reviewed O O
and O O
noncontributory. O O
PHYSICAL O O
EXAMINATION: O O
A O O
middle-aged O O
African-American O O
woman, O O
awake, O O
alert, O O
and O O
in O O
mild O O
distress. O O
Exam O O
limited O O
by O O
obesity. B-OBESE O
Exam O O
is O O
significant O O
for O O
neck; O O
normal O O
to O O
inspection, O O
supple, O O
nontender, O O
and O O
unable O O
to O O
appreciate O O
JVP. O O
Respiratory: O O
No O O
distress. O O
Chest: O O
Nontender O O
and O O
normal O O
breath O O
sounds. O O
Cardiovascular: O O
Tachycardic O O
at O O
115 O O
and O O
regular O O
and O O
2/6 O O
systolic O O
ejection O O
murmur, O O
no O O
gallop, O O
and O O
no O O
friction O O
rub. O O
Abdomen: O O
Soft, O O
nontender, O O
no O O
organomegaly, O O
and O O
no O O
masses, O O
otherwise, O O
as O O
documented O O
on O O
the O O
paper O O
chart. O O
IMAGING O O
STUDIES: O O
ECG O O
shows O O
a O O
flutter O O
at O O
150 O O
beats O O
per O O
minute O O
in O O
ECG O O
#1. O O
ECG O O
final O O
shows O O
a O O
sinus O O
rhythm O O
at O O
approximately O O
60 O O
beats O O
per O O
minute O O
with O O
no O O
signs O O
of O O
ischemia. O O
IMPRESSION: O O
The O O
patient O O
is O O
a O O
52-year-old O O
female O O
with O O
a O O
history O O
of O O
occasional O O
brief O O
palpitations O O
now O O
with O O
one O O
hour O O
of O O
continuous O O
palpitations O O
and O O
ECG O O
consistent O O
with O O
atrial O O
flutter. O O
She O O
was O O
given O O
20 O O
mg O O
of O O
diltiazem O O
IV O O
by O O
EMS. O O
In O O
the O O
Emergency O O
Department, O O
she O O
was O O
given O O
20 B-MEDICATION O
mg I-MEDICATION O
without I-MEDICATION O
significant I-MEDICATION O
response, I-MEDICATION O
followed I-MEDICATION O
by I-MEDICATION O
40 B-MEDICATION O
mg I-MEDICATION O
ID I-MEDICATION O
and O O
was O O
achieved O O
a O O
good O O
response. O O
As O O
the O O
patient O O
required O O
a O O
significant O O
amount O O
of O O
diltiazem O O
to O O
slow O O
her O O
rate O O
and O O
convert O O
her O O
and O O
she O O
is O O
also O O
feeling O O
somewhat O O
nervous, O O
we O O
will O O
keep O O
her O O
in O O
the O O
Observation O O
Unit O O
overnight. O O
She B-MEDICATION O
should I-MEDICATION O
get I-MEDICATION O
an I-MEDICATION O
oral I-MEDICATION O
dose I-MEDICATION O
of I-MEDICATION O
diltiazem I-MEDICATION O
overnight. I-MEDICATION O
She O O
should O O
get O O
cardiac O O
monitoring O O
in O O
the O O
morning. O O
PLAN: O O
To O O
discuss O O
with O O
KEKELA O O
Cardiology O O
and O O
obtain O O
consultation O O
as O O
to O O
possible O O
discharge O O
on O O
beta-blockers O O
versus O O
calcium O O
channel O O
blockers. O O
If O O
the O O
patient O O
does O O
not O O
have O O
a O O
new O O
symptoms O O
she O O
would O O
be O O
stable O O
for O O
discharge O O
in O O
the O O
morning. O O
PRIMARY O O
DIAGNOSIS: O O
Atrial O O
flutter O O
with O O
rapid O O
ventricular O O
response. O O
SECONDARY O O
DIAGNOSIS: O O
Left O O
arm O O
pain. O O
CRITICAL O O
CARE O O
TIME: O O
35 O O
minutes. O O
______________________________ O O
YEAGER, O O
HAROLD O O
M.D. O O
D: O O
11/05/89 O O
T: O O
11/05/89 O O
Dictated O O
By: O O
YEAGER, O O
HAROLD O O
eScription O O
document:0-6602107 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2090-12-14 O O
EDVISIT^43294739^FINNEY, O O
INDIANA^12/15/90^MARTIN, O O
CONSTANCE O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
53-year-old O O
female O O
with O O
a O O
history O O
of O O
insulin-dependent B-DIABETES O
diabetes, I-DIABETES O
hypertension B-HYPERTENSION O
and O O
atrial O O
fibrillation O O
who O O
comes O O
in O O
to O O
the O O
ER O O
complaining O O
of O O
sensation O O
of O O
a O O
racing O O
heart O O
since O O
5:10 O O
p.m. O O
in O O
the O O
evening. O O
She O O
said O O
it O O
was O O
acute O O
onset O O
and O O
felt O O
like O O
palpitations. O O
She O O
also O O
said O O
it O O
felt O O
like O O
a O O
burning. O O
She O O
had O O
mild O O
shortness O O
of O O
breath O O
and O O
left O O
arm O O
achiness. O O
She O O
had O O
no O O
nausea, O O
no O O
vomiting, O O
no O O
fevers O O
or O O
chills. O O
She O O
had O O
no O O
trauma, O O
no O O
lightheadedness, O O
and O O
no O O
syncope. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension, B-HYPERTENSION O
insulin-dependent O O
diabetes, O O
and O O
atrial O O
fibrillation. O O
PAST O O
SURGICAL O O
HISTORY: O O
Not O O
related. O O
SOCIAL O O
HISTORY: O O
No B-SMOKER O
tobacco I-SMOKER O
or O O
occasional O O
alcohol. O O
FAMILY O O
HISTORY: O O
Reviewed O O
and O O
noncontributory. O O
REVIEW O O
OF O O
SYSTEMS: O O
Palpitations, O O
otherwise O O
negative. O O
MEDICATIONS: O O
Metoprolol, B-MEDICATION B-MEDICATION
the O O
patient O O
missed O O
two O O
doses O O
today, O O
aspirin, B-MEDICATION B-MEDICATION
simvastatin, B-MEDICATION B-MEDICATION
glyburide B-MEDICATION B-MEDICATION
and O O
NovoLog. B-MEDICATION B-MEDICATION
ALLERGIES: O O
Erythromycin O O
and O O
IV O O
dye. O O
PHYSICAL O O
EXAMINATION: O O
Temperature O O
97, O O
heart O O
rate O O
155, O O
respiratory O O
rate O O
18, O O
blood O O
pressure O O
136/52, O O
O2 O O
100% O O
on O O
2 O O
liters. O O
The O O
patient O O
is O O
awake O O
and O O
alert, O O
well O O
developed, O O
well O O
nourished, O O
talking O O
in O O
complete O O
sentences, O O
in O O
no O O
acute O O
distress. O O
ENT: O O
Atraumatic, O O
normal O O
to O O
inspection. O O
Eyes O O
are O O
normal. O O
Neck: O O
Normal O O
to O O
inspection, O O
supple, O O
and O O
nontender. O O
Respiratory: O O
Clear O O
to O O
auscultation O O
bilaterally. O O
Cardiovascular: O O
Regular O O
rate O O
and O O
rhythm. O O
No O O
murmurs, O O
rubs, O O
or O O
gallops. O O
GI: O O
Abdomen O O
is O O
soft O O
and O O
nontender. O O
Skin O O
is O O
intact, O O
warm, O O
and O O
dry. O O
Back O O
is O O
nontender. O O
Musculoskeletal: O O
No O O
lower O O
extremity O O
swelling O O
or O O
edema. O O
Neuropsychiatric: O O
Oriented O O
x3. O O
Mood O O
and O O
affect O O
is O O
normal. O O
Cranial O O
nerves O O
II O O
through O O
XII O O
tested O O
and O O
intact. O O
No O O
motor O O
or O O
sensory O O
deficits. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
Initial O O
EKG O O
showed O O
a O O
rate O O
of O O
about O O
150, O O
unclear. O O
It O O
seemed O O
that O O
there O O
was O O
T O O
waves O O
in O O
V3. O O
There O O
is O O
no O O
evidence O O
of O O
ST O O
elevation O O
MI. O O
We O O
thought O O
this O O
could O O
be O O
an O O
SVT. O O
It O O
was O O
not O O
really O O
consistent O O
with O O
an O O
atrial O O
fibrillation. O O
Our O O
plan O O
was O O
to O O
give O O
adenosine, O O
however, O O
during O O
the O O
IV O O
placement. O O
Prior O O
to O O
giving O O
adenosine, O O
the O O
patient O O
converted O O
to O O
a O O
normal O O
sinus O O
rhythm O O
with O O
mild O O
tachycardia O O
at O O
around O O
100, O O
but O O
it O O
was O O
clear O O
that O O
there O O
was O O
T O O
waves. O O
At O O
this O O
point, O O
we O O
decided O O
to O O
give O O
her O O
baseline O O
metoprolol B-MEDICATION B-MEDICATION
dose I-MEDICATION O
and O O
she O O
missed O O
two O O
doses. O O
LABORATORY O O
DATA: O O
Labs O O
checked O O
include O O
sodium O O
of O O
139, O O
potassium O O
3.7, O O
chloride O O
104, O O
bicarbonate O O
23, O O
BUN O O
14, O O
creatinine O O
0.81, O O
glucose O O
268. O O
ALT O O
19, O O
AST O O
18, O O
CK O O
350, O O
alkaline O O
phosphatase O O
128, O O
total O O
bilirubin O O
0.5, O O
CK-MB O O
5.2, O O
troponin O O
I O O
less O O
than O O
0.04, O O
calcium O O
9.1, O O
and O O
mag O O
1.9. O O
White O O
blood O O
cells O O
10.29, O O
hematocrit O O
42.7, O O
and O O
platelets O O
438, O O
000. O O
INR O O
is O O
1. O O
UA O O
is O O
negative O O
for O O
infection O O
with O O
trace O O
blood O O
present. O O
PLAN: O O
Our O O
plan O O
is O O
to O O
check O O
two O O
more O O
enzymes O O
because O O
the O O
patient O O
had O O
the O O
left O O
arm O O
heaviness O O
during O O
the O O
palpitations. O O
If O O
both O O
of O O
those O O
enzymes O O
are O O
negative, O O
we O O
feel O O
that O O
she O O
is O O
safe O O
to O O
go O O
home O O
from O O
the O O
ED O O
Observation O O
Unit. O O
It O O
is O O
unclear O O
the O O
etiology O O
of O O
her O O
arrhythmia. O O
It O O
did O O
seem O O
to O O
be O O
likely O O
SVT, O O
which O O
broke O O
spontaneously. O O
The O O
patient O O
is O O
to O O
follow O O
up O O
with O O
her O O
primary O O
doctor. O O
DISPOSITION: O O
ED O O
Observation O O
Unit. O O
CONDITION O O
ON O O
DISCHARGE: O O
Satisfactory. O O
I O O
confirm O O
that O O
I O O
have O O
interviewed O O
and O O
examined O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation, O O
the O O
patient's O O
chart, O O
discussed O O
the O O
evaluation, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient. O O
______________________________ O O
MARTIN, O O
CONSTANCE O O
M.D. O O
D: O O
12/15/90 O O
T: O O
12/15/90 O O
Dictated O O
By: O O
MARTIN, O O
CONSTANCE O O
eScription O O
document:8-4109370 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2062-10-30 O O
54 O O
yo O O
male O O
from O O
Kazakhstan O O
here O O
for O O
f/u O O
of O O
GI O O
mucor. O O
Briefly, O O
he O O
was O O
admitted O O
6/20/62 O O
with O O
DKA B-DIABETES O
and O O
MSSA O O
bacteremia. O O
He O O
was O O
found O O
to O O
have O O
perirectal O O
abscess O O
s/p O O
CT-guided O O
drains O O
as O O
well O O
as O O
L O O
hip O O
infected O O
prosthesis O O
and O O
abscess O O
s/p O O
removal O O
and O O
drainage O O
in O O
OR O O
on O O
7/07 O O
and O O
by O O
IR O O
7/22, O O
both O O
sites O O
positive O O
for O O
MSSA. O O
Hospital O O
course O O
c/b O O
GIB O O
and O O
was O O
found O O
to O O
have O O
free O O
air O O
with O O
perforated O O
duodenum O O
s/p O O
ex-lap O O
6/22, O O
gastrectomy O O
with O O
partial O O
large O O
bowel O O
resection, O O
splenectomy O O
and O O
primary O O
anastamosis, O O
with O O
path O O
positive O O
for O O
mucormycosis O O
without O O
clean O O
margins. O O
He O O
also O O
had O O
VRE/klebsiella O O
LUQ O O
abscess O O
s/p O O
IR O O
drainage. O O
He O O
was O O
initially O O
treated O O
with O O
nafcillin O O
and O O
ambisome, O O
but O O
developed O O
maculopapular O O
rash O O
on O O
chest O O
and O O
arms O O
thought O O
to O O
be O O
secondary O O
to O O
nafcillin. O O
So O O
he O O
was O O
switched O O
to O O
vanco/ambisome/linezolid/meropenem/amikacin O O
for O O
LUQ O O
abscess. O O
After O O
6 O O
weeks O O
of O O
high-dose O O
ambisome, O O
he O O
was O O
taken O O
back O O
to O O
OR O O
on O O
7/31 O O
for O O
re-exploration O O
and O O
was O O
found O O
to O O
have O O
some O O
more O O
necrosis O O
around O O
his O O
esophageal-jejunostomy O O
site O O
that O O
surgeons O O
'scooped O O
out' O O
as O O
much O O
as O O
they O O
could, O O
but O O
were O O
not O O
able O O
to O O
get O O
clean O O
margins O O
because O O
of O O
difficult O O
anatomic O O
restrictions. O O
Given O O
the O O
inability O O
to O O
completely O O
en-bloc O O
resect O O
Mr. O O
Ethridge's O O
GI O O
mucor O O
despite O O
a O O
long-trial O O
of O O
Ambisome, O O
he O O
was O O
started O O
on O O
an O O
investigational O O
drug, O O
posaconazole, O O
provided O O
by O O
Emcor O O
on O O
a O O
compassionate O O
use O O
basis. O O
This O O
has O O
had O O
50% O O
success O O
of O O
curing O O
mucor O O
as O O
salvage O O
therapy O O
in O O
small O O
trials. O O
He O O
was O O
started O O
on O O
this O O
drug O O
on O O
8/28/62 O O
and O O
has O O
tolerated O O
it O O
well O O
despite O O
some O O
nausea, O O
diarrhea. O O
He O O
has O O
been O O
at O O
EDUCARE-FARGO O O
reports O O
increase O O
in O O
strength O O
and O O
improved O O
ability O O
to O O
bear O O
weight O O
on O O
his O O
hip. O O
He O O
walks O O
with O O
a O O
walker. O O
He O O
had O O
repeat O O
CT O O
abd/pelvix O O
10/26 O O
which O O
showed O O
no O O
intraabdominal O O
collection O O
and O O
stable O O
L O O
hip O O
collection. O O
He O O
had O O
abd O O
drains O O
removed O O
3 O O
weeks O O
ago O O
but O O
continues O O
to O O
have O O
L O O
hip O O
drain, O O
without O O
much O O
output. O O
He O O
was O O
started O O
on O O
TPN O O
1 O O
week O O
ago O O
due O O
to O O
maltrition, O O
despite O O
po O O
intake. O O
He O O
has O O
been O O
trying O O
to O O
eat, O O
but O O
reports O O
some O O
nausea O O
and O O
diarrhea, O O
especially O O
after O O
he O O
eats O O
and O O
since O O
starting O O
posaconazole. O O
He O O
reports O O
good O O
glycemic O O
control. O O
He O O
denies O O
fevers/abd O O
pain/nightsweats/chills/visual O O
changes/HA/melena/cough/SOB. O O
PMHx: O O
DM B-DIABETES O
GI O O
mucor O O
s/p O O
total O O
gastrectomy, O O
esophagojejunostomy, O O
distal O O
pancreatectomy, O O
transverse O O
colectomy O O
6/62 O O
s/p O O
splenectomy O O
s/p O O
L O O
THR O O
3 O O
years O O
ago O O
L O O
hip O O
MSSA O O
abscess O O
s/p O O
resection O O
of O O
arthroplasty O O
and O O
drainage O O
perirectal O O
abscess O O
VRE/klebsiella O O
LUQ O O
(subdiaphragmatic O O
and O O
esophageal O O
hiatal) O O
abscess O O
CRI O O
HTN B-HYPERTENSION O
anemia O O
neg O O
HIV O O
7/62 O O
Meds: O O
posaconazole O O
200 O O
po O O
QID O O
(liquid) O O
amlodipine B-MEDICATION B-MEDICATION
5 O O
qd O O
metoprolol B-MEDICATION B-MEDICATION
50 O O
tid O O
clonidine O O
0.3 O O
mg O O
qweek O O
niferex O O
epogen O O
30,000U O O
SQ O O
qweek O O
insulin B-MEDICATION O
CZI I-MEDICATION O
All: O O
nafcillin-- O O
rash O O
SH: O O
immigrated O O
to O O
UKRAINE O O
10 O O
years O O
ago, O O
no O O
relatives O O
here, O O
all O O
in O O
Kazakhstan, O O
single, O O
lived O O
in O O
Alva O O
previously O O
Habits: O O
no B-SMOKER O
EtOH/cig/IVDU I-SMOKER O
FHx: O O
NC O O
PE: O O
96.3, O O
60, O O
102/60, O O
16 O O
HEENT: O O
o/p O O
clear, O O
no O O
cervical O O
LAD, O O
neck O O
FROM, O O
mild O O
icterus O O
in O O
sclera O O
Lungs: O O
CTA O O
CV: O O
rr, O O
s1 O O
and O O
s2, O O
no O O
m/r/g O O
Abd: O O
soft, O O
NT/ND, O O
+BS, O O
abd O O
incisions O O
well-healed O O
Ext: O O
L O O
hip O O
drain O O
in O O
place, O O
limited O O
ROM O O
on O O
L O O
hip O O
but O O
improved O O
Skin: O O
no O O
rash O O
EKG: O O
QT O O
363, O O
no O O
acute O O
changes O O
Imp: O O
54 O O
yo O O
male O O
with O O
DM O O
s/p O O
long O O
hospital O O
course O O
for O O
DKA, O O
multiple O O
infections O O
in O O
hip O O
and O O
abd, O O
and O O
GI O O
mucor O O
s/p O O
resection O O
x2, O O
but O O
with O O
residual O O
disease. O O
Currently O O
on O O
posaconazole O O
and O O
tolerating O O
well, O O
but O O
does O O
have O O
significant O O
nausea, O O
somewhat O O
controlled O O
with O O
zofran. O O
Diarrhea O O
can O O
be O O
a O O
component O O
posaconazole O O
side O O
effect, O O
or O O
due O O
to O O
dumping O O
syndrome. O O
Plan: O O
1) O O
continue O O
posaconazole O O
2) O O
need O O
to O O
have O O
ortho O O
f/u O O
to O O
evaluate O O
L O O
hip O O
collection O O
3) O O
RTC O O
in O O
1 O O
month O O
12/04/62 O O
at O O
10am O O
to O O
f/u O O
for O O
posaconazole. O O
Will O O
need O O
EKG O O
again O O
at O O
EDUCARE-FARGO O O
before O O
transfer O O
here. O O
Mr. O O
Ethridge O O
seen O O
and O O
examined O O
with O O
Dr. O O
Roberts. O O
He O O
is O O
very O O
slowly O O
improving O O
in O O
terms O O
of O O
strength, O O
no O O
doubt O O
in O O
part O O
due O O
to O O
nocturnal O O
TPN. O O
Hard O O
to O O
tease O O
out O O
the O O
cause O O
of O O
his O O
nausea, O O
although O O
anatomic O O
reasons O O
are O O
as O O
likely O O
as O O
medication O O
side O O
effects. O O
On O O
balance, O O
if O O
his O O
labs O O
are O O
ok, O O
I'd O O
favor O O
continuing O O
the O O
posaconazole O O
given O O
most O O
recent O O
OR O O
findings. O O
ECG O O
without O O
QTc O O
prolongation. O O
Abdomen O O
is O O
bening. O O
Left O O
hip O O
still O O
sore, O O
but O O
more O O
and O O
more O O
stable. O O
Brandon O O
Gaines, O O
MD O O

Record O O
date: O O
2064-01-08 O O
Internal O O
Medicine O O
- O O
Team O O
3 O O
Intern O O
Admit O O
Note O O
Patient O O
Name: O O
Ethridge, O O
Clayton O O
Medical O O
Record O O
#: O O
8381729 O O
Date O O
of O O
Admission: O O
01/08/64 O O
Attending: O O
Dr. O O
Burton O O
CC/ID: O O
clotted O O
AV O O
fistula O O
/ O O
renal O O
failure O O
HPI: O O
The O O
patient O O
is O O
a O O
55 O O
year O O
old O O
male O O
with O O
a O O
past O O
medical O O
history O O
significant O O
for O O
chronic O O
renal O O
failure O O
(secondary O O
to O O
diabetes B-DIABETES O
& O O
hypertension) B-HYPERTENSION B-HYPERTENSION
and O O
gastrointestinal O O
mucormycosis O O
who O O
underwent O O
an O O
arteriovenous O O
graft O O
placement O O
ten O O
days O O
prior O O
to O O
admission. O O
The O O
patient O O
was O O
doing O O
well O O
until O O
a O O
few O O
days O O
prior O O
to O O
admission O O
when O O
he O O
noticed O O
a O O
swelling O O
in O O
his O O
new O O
graft O O
and O O
a O O
decrease O O
in O O
the O O
degree O O
of O O
its O O
pulse. O O
Then O O
on O O
the O O
morning O O
of O O
admission O O
when O O
he O O
noticed O O
his O O
graft O O
was O O
without O O
a O O
palpable O O
pulse O O
or O O
thrill. O O
The O O
patient O O
then O O
presented O O
to O O
the O O
EDUCARE-PULLMAN O O
ER O O
for O O
evaluation O O
and O O
treatment. O O
In O O
the O O
ER, O O
the O O
patient O O
was O O
found O O
to O O
have O O
an O O
engorged O O
AV O O
graft O O
without O O
dopplerable O O
pulse O O
or O O
bruit. O O
The O O
patient O O
was O O
seen O O
by O O
surgery O O
and O O
an O O
ultrasound O O
of O O
the O O
upper O O
extremity O O
revealed O O
a O O
clotted O O
graft O O
and O O
so O O
the O O
patient O O
was O O
admitted O O
to O O
the O O
medical O O
service O O
for O O
further O O
evaluation O O
and O O
treatment. O O
Of O O
note, O O
the O O
patient O O
denies O O
any O O
pain O O
/ O O
numbness O O
/ O O
coolness O O
in O O
his O O
hand. O O
He O O
further O O
denies O O
any O O
shortness O O
of O O
breath, O O
increased O O
swelling O O
in O O
his O O
legs, O O
or O O
changes O O
in O O
his O O
weight. O O
He O O
does O O
indicate O O
that O O
he O O
has O O
suffered O O
from O O
decreased O O
oral O O
intake O O
lately O O
secondary O O
to O O
feeling O O
tired O O
and O O
having O O
a O O
decreased O O
appetite. O O
PMH: O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Diabetic O O
neuropathy O O
Hypertension B-HYPERTENSION B-HYPERTENSION
Chronic O O
renal O O
disease O O
- O O
secondary O O
to O O
diabetes O O
& O O
hypertension, O B-HYPERTENSION
baseline O O
Cr O O
4 O O
Anemia O O
- O O
baseline O O
hematocrit O O
mid O O
30s O O
Gastrointestinal O O
mucormycosis O O
- O O
s/p O O
GI O O
surgery O O
(see O O
below) O O
PSH: O O
Hip O O
replacement O O
Total O O
gastrectomy, O O
gastroesophagojejunostomy, O O
distal O O
pancreatectomy, O O
transverse O O
colectomy O O
Splenectomy O O
Left O O
total O O
hip O O
replacement O O
Allergies: O O
Nafcillin O O
- O O
rash O O
SH: O O
Patient O O
lives O O
in O O
Kemmerer O O
at O O
the O O
Chestnut O O
Lodge O O
Sanitarium. O O
He O O
is O O
from O O
Kazakhstan O O
originally, O O
has O O
no O O
family O O
nearby O O
and O O
works O O
as O O
a O O
Glazier. O O
Tob: B-SMOKER O
Denies I-SMOKER O
EtOH: O O
Denies O O
Illicits: O O
Denies O O
FH: O O
Non-contributory. O O
Medications: O O
procrit O O
10,000 O O
U O O
qthursday O O
catapres O O
tts-3 O O
qwednesday O O
oscal O O
po O O
tid O O
hydralazine O O
50 O O
mg O O
po O O
tid O O
remeron O O
15 O O
mg O O
po O O
qhs O O
colace O O
100 O O
mg O O
po O O
bid O O
neurontin O O
100 O O
mg O O
po O O
qd O O
folate O O
1 O O
mg O O
po O O
qd O O
norvasc B-MEDICATION B-MEDICATION
10 O O
mg O O
po O O
qd O O
trazadone O O
50 O O
mg O O
po O O
qhs O O
nephrocaps O O
daily O O
bumetanide O O
0.5 O O
mg O O
po O O
qd O O
niferex O O
150 O O
mg O O
po O O
qd O O
calcitrol O O
0.25 O O
mg O O
po O O
qd O O
enulose O O
prn O O
tramadol O O
prn O O
nitroglycerin O O
ointment O O
prn O O
milk O O
of O O
magnesia O O
prn O O
maalox O O
prn O O
zofran O O
prn O O
lopermide O O
prn O O
tylenol O O
prn O O
Exam: O O
VS: O O
T=96.6 O O
HR=62 O O
BP=125/61 O O
RR=18 O O
SaO2=99% O O
on O O
RA O O
General: O O
no O O
acute O O
distress, O O
calm, O O
resting O O
comfortably. O O
HEENT: O O
pupils O O
equal O O
and O O
reactive O O
to O O
light, O O
anicteric O O
sclera, O O
extraocular O O
movements O O
intact. O O
Skin: O O
no O O
rashes. O O
Neck: O O
supple. O O
Chest: O O
clear O O
to O O
auscultation O O
bilaterally. O O
CVS: O O
regular O O
rate O O
& O O
rhythm, O O
III/VI O O
holosystolic O O
murmurs, O O
no O O
rubs. O O
Abd: O O
soft, O O
non-distended, O O
non-tender O O
to O O
palpation, O O
normoactive O O
bowel O O
sounds. O O
Extr: O O
+1 O O
edema, O O
no O O
papable O O
thrill O O
or O O
auscultatable O O
bruit O O
in O O
AV O O
graft. O O
MSK: O O
no O O
joint O O
swelling, O O
no O O
erythema, O O
full O O
range O O
of O O
motion. O O
Neuro: O O
CN O O
II O O
through O O
XII O O
intact, O O
motor O O
strength O O
5/5 O O
UE O O
and O O
LE, O O
sensory O O
intact. O O
DATA O O
Test O O
Description O O
Result O O
Ref. O O
Range/Units O O
Date/Time O O
Last O O
Abnormal O O
Chemistry O O
Lytes/Renal/Glucose O O
Sodium O O
136 O O
135-145 O O
mmol/L O O
01/08/64 O O
13:51 O O
133(L) O O
08/28/62 O O
Potassium O O
4.9H O O
3.4-4.8 O O
mmol/L O O
01/08/64 O O
13:51 O O
4.9(H) O O
01/08/64 O O
Chloride O O
111H O O
100-108 O O
mmol/L O O
01/08/64 O O
13:51 O O
111(H) O O
01/08/64 O O
Carbon O O
Dioxide O O
18.6L O O
23.0-31.9 O O
mmol/L O O
01/08/64 O O
13:51 O O
18.6(L) O O
01/08/64 O O
BUN O O
82H O O
8-25 O O
mg/dl O O
01/08/64 O O
13:51 O O
82(H) O O
01/08/64 O O
Creatinine O O
5.9H O O
0.6-1.5 O O
mg/dl O O
01/08/64 O O
13:51 O O
5.9(H) O O
01/08/64 O O
Glucose B-DIABETES O
133H I-DIABETES O
70-100 O O
mg/dl O O
01/08/64 O O
17:54 O O
133(H) O O
01/08/64 O O
Hematology O O
Complete O O
Blood O O
Count O O
WBC O O
5.1 O O
4.5-11.0 O O
th/cmm O O
01/08/64 O O
13:44 O O
4.3(L) O O
04/29/63 O O
RBC O O
3.12L O O
4.50-5.90 O O
mil/cm O O
01/08/64 O O
13:44 O O
3.12(L) O O
01/08/64 O O
Hgb O O
10.1L O O
13.5-17.5 O O
gm/dl O O
01/08/64 O O
13:44 O O
10.1(L) O O
01/08/64 O O
HCT O O
31.1L O O
41.0-53.0 O O
% O O
01/08/64 O O
13:44 O O
31.1(L) O O
01/08/64 O O
MCV O O
100 O O
80-100 O O
fl O O
01/08/64 O O
13:44 O O
101(H) O O
12/22/63 O O
MCH O O
32.5 O O
26.0-34.0 O O
pg/rbc O O
01/08/64 O O
13:44 O O
MCHC O O
32.6 O O
31.0-37.0 O O
g/dl O O
01/08/64 O O
13:44 O O
30.1(L) O O
07/09/62 O O
PLT O O
179 O O
150-350 O O
th/cumm O O
01/08/64 O O
13:44 O O
370(H) O O
08/27/62 O O
RDW O O
15.0H O O
11.5-14.5 O O
% O O
01/08/64 O O
13:44 O O
15.0(H) O O
01/08/64 O O
Blood O O
Differential O O
% O O
Neutrophils O O
43 O O
40-70 O O
% O O
01/08/64 O O
13:44 O O
77(H) O O
08/27/62 O O
Lymphs O O
46H O O
22-44 O O
% O O
01/08/64 O O
13:44 O O
46(H) O O
01/08/64 O O
Monos O O
5 O O
4-11 O O
% O O
01/08/64 O O
13:44 O O
2(L) O O
08/27/62 O O
Eos O O
5 O O
0-8 O O
% O O
01/08/64 O O
13:44 O O
Basos O O
1 O O
0-3 O O
% O O
01/08/64 O O
13:44 O O
Urinalysis O O
GLUC O O
- O O
UA O O
Trace O O
NEG O O
01/08/64 O O
15:20 O O
Ketones O O
NEGATIVE O O
NEG O O
01/08/64 O O
15:20 O O
Specific O O
Gravity O O
1.015 O O
1.001-1.035 O O
01/08/64 O O
15:20 O O
1.037(H) O O
07/16/59 O O
Blood O O
- O O
UA O O
NEGATIVE O O
NEG O O
01/08/64 O O
15:20 O O
pH O O
5.0 O O
5.0-9.0 O O
01/08/64 O O
15:20 O O
Nitrites O O
NEGATIVE O O
NEG O O
01/08/64 O O
15:20 O O
WBC O O
Screen O O
NEGATIVE O O
NEG O O
01/08/64 O O
15:20 O O
Hyaline O O
Cast O O
None O O
0-5 O O
/lpf O O
01/08/64 O O
16:19 O O
RBC O O
- O O
UA O O
3-5 O O
0-2 O O
/hpf O O
01/08/64 O O
16:19 O O
WBC O O
- O O
UA O O
0-2 O O
0-2 O O
/hpf O O
01/08/64 O O
16:19 O O
Bacteria O O
NEGATIVE O O
NEG O O
/hpf O O
01/08/64 O O
16:19 O O
Squamous O O
Cells O O
NEGATIVE O O
NEG O O
/hpf O O
01/08/64 O O
16:19 O O
Micro: O O
Blood O O
& O O
urine O O
cultures O O
pending O O
UpperExt O O
U/S: O O
Clotted O O
right O O
upper O O
extremity O O
arteriovenous O O
graft. O O
Impression: O O
55 O O
year O O
old O O
male O O
with O O
chronic O O
renal O O
failure, O O
hypertension, O O
diabetes O O
and O O
gastrointestinal O O
mucormycosis O O
who O O
is O O
s/p O O
AV O O
graft O O
placement O O
presents O O
with O O
clotted O O
AV O O
graft O O
& O O
renal O O
failure. O O
AV O O
Graft O O
Patient O O
will O O
undergo O O
IR O O
intervention O O
on O O
01/09 O O
in O O
an O O
attempt O O
to O O
restore O O
flow O O
to O O
the O O
AV O O
graft O O
Will O O
keep O O
patient O O
NPO O O
after O O
midnight O O
Will O O
avoid O O
systemic O O
anticoagulants O O
Will O O
obtain O O
hypercoagulable O O
labs O O
Renal O O
Failure O O
Patient O O
has O O
chronic O O
renal O O
failure, O O
secondary O O
to O O
diabetes O O
and O O
hypertension O O
Will O O
need O O
dialysis O O
soon O O
Will O O
continue O O
nephrocaps, O O
calcitrol, O O
procrit O O
Hypertension O O
Will O O
continue O O
outpatient O O
regimen O O
Anemia O O
Will O O
continue O O
iron O O
supplementation O O
/ O O
procrit O O
weekly O O
injections O O
Prophylaxis O O
DVT O O
prophylaxis: O O
will O O
encourage O O
ambulation O O
GI O O
prophylaxis: O O
will O O
initiate O O
nexium O O
& O O
colace O O
Dispo O O
Patient O O
will O O
likely O O
return O O
to O O
Chestnut O O
Lodge O O
Sanitarium O O
on O O
discharge O O
_________________________________ O O
Uriel O O
Q. O O
Yarbrough, O O
MD O O
Pager O O
#89356 O O

Record O O
date: O O
2064-01-28 O O
Patient O O
Name: O O
Ethridge, O O
Clayton O O
Medical O O
Record O O
#: O O
8381729 O O
Attending: O O
Dr. O O
Burton O O
CC/ID: O O
fever O O
post O O
HD O O
HPI: O O
The O O
patient O O
is O O
a O O
55 O O
year O O
old O O
male O O
with O O
a O O
past O O
medical O O
history O O
significant O O
for O O
chronic O O
renal O O
failure O O
(secondary O O
to O O
diabetes B-DIABETES O
& O O
hypertension) B-HYPERTENSION O
and O O
gastrointestinal O O
mucormycosis O O
who O O
was O O
recently O O
admitted O O
for O O
a O O
clotted O O
AVF, O O
s/p O O
thrombectomy. O O
Unfortunately, O O
graft O O
eventually O O
reclotted O O
and O O
was O O
deemed O O
unsalvageable- O O
the O O
patient O O
was O O
then O O
started O O
on O O
HD O O
via O O
a O O
tunnelled O O
catheter. O O
Was O O
tolerating O O
this O O
well, O O
until O O
day O O
prior O O
to O O
admission O O
noted O O
a O O
fever O O
prior O O
to O O
going O O
to O O
HD. O O
Blood O O
cultures O O
taken O O
yesterday O O
at O O
HD, O O
returned O O
today O O
with O O
GPC O O
in O O
clusters, O O
further O O
speciation O O
to O O
follow. O O
Admitted O O
for O O
fever O O
workup. O O
Pt. O O
currently O O
complains O O
of O O
some O O
generalized O O
fatigue, O O
malaise, O O
nausea. O O
Has O O
a O O
hx O O
of O O
abdominal O O
mucormycosis O O
resulting O O
in O O
chronic O O
abdominal O O
discomfort, O O
which O O
today O O
is O O
at O O
baseline. O O
No O O
CP, O O
SOB. O O
PMH: O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Diabetic O O
neuropathy O O
Hypertension B-HYPERTENSION O
Chronic O O
renal O O
disease O O
- O O
secondary O O
to O O
diabetes O O
& O O
hypertension, O B-HYPERTENSION
baseline O O
Cr O O
4 O O
Anemia O O
- O O
baseline O O
hematocrit O O
mid O O
30s O O
Gastrointestinal O O
mucormycosis O O
- O O
s/p O O
GI O O
surgery O O
(see O O
below) O O
PSH: O O
Hip O O
replacement O O
Total O O
gastrectomy, O O
gastroesophagojejunostomy, O O
distal O O
pancreatectomy, O O
transverse O O
colectomy O O
Splenectomy O O
Left O O
total O O
hip O O
replacement O O
Allergies: O O
Nafcillin O O
- O O
rash O O
SH: O O
Patient O O
lives O O
in O O
Kemmerer O O
at O O
the O O
Chestnut O O
Lodge O O
Sanitarium. O O
He O O
is O O
from O O
Kazakhstan O O
originally, O O
has O O
no O O
family O O
nearby O O
and O O
works O O
as O O
a O O
Glazier. O O
Tob: B-SMOKER B-MEDICATION
Denies I-SMOKER O
EtOH: O O
Denies O O
Illicits: O O
Denies O O
FH: O O
Non-contributory. O O
Medications: O O
1) O O
Tylenol O O
PRN O O
2) O O
Remeron O O
15 O O
mg O O
at O O
bedtime O O
3) O O
Folic O O
acid O O
1 O O
mg O O
PO O O
daily O O
4) O O
Trazodone O O
50 O O
mg O O
at O O
bedtime O O
5) O O
Nephrocaps O O
1 O O
PO O O
daily O O
6) O O
Calcium O O
carbonate O O
with O O
vitamin O O
D O O
250 O O
mg O O
3 O O
x O O
day O O
7) O O
Nexium O O
20 O O
mg O O
PO O O
daily O O
8) O O
Hydralazine O O
50 O O
mg O O
3 O O
x O O
day O O
9) O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
mg O O
PO O O
daily O O
10) O O
Clonidine O O
0.1 O O
mg O O
twice O O
a O O
day O O
11) O O
Regular B-MEDICATION O
insulin I-MEDICATION O
sliding I-MEDICATION O
scale I-MEDICATION O
12) O O
Procrit O O
10K O O
U O O
weekly O O
Exam: O O
VS: O O
T=999.9 O O
HR=69 O O
BP=124/63 O O
RR=18 O O
SaO2=99% O O
on O O
RA O O
General: O O
no O O
acute O O
distress, O O
calm, O O
resting O O
comfortably. O O
HEENT: O O
pupils O O
equal O O
and O O
reactive O O
to O O
light, O O
anicteric O O
sclera, O O
extraocular O O
movements O O
intact. O O
Skin: O O
no O O
rashes. O O
Neck: O O
supple. O O
S O O
subclavian O O
HD O O
catheter O O
CDI O O
Chest: O O
clear O O
to O O
auscultation O O
bilaterally. O O
CVS: O O
regular O O
rate O O
& O O
rhythm, O O
III/VI O O
holosystolic O O
murmurs, O O
no O O
rubs. O O
Abd: O O
soft, O O
non-distended, O O
non-tender O O
to O O
palpation, O O
normoactive O O
bowel O O
sounds. O O
Extr: O O
+1 O O
edema, O O
no O O
papable O O
thrill O O
or O O
auscultatable O O
bruit O O
in O O
AV O O
graft. O O
MSK: O O
no O O
joint O O
swelling, O O
no O O
erythema, O O
full O O
range O O
of O O
motion. O O
Neuro: O O
CN O O
II O O
through O O
XII O O
intact, O O
motor O O
strength O O
5/5 O O
UE O O
and O O
LE, O O
sensory O O
intact. O O
Results O O
Date/Time O O
NA O O
K O O
CL O O
CO2 O O
01/23/2064 O O
135 O O
3.9 O O
101 O O
26.2 O O
Date/Time O O
BUN O O
CRE O O
GLU O O
01/23/2064 O O
17 O O
2.3 O O
(H) O O
01/23/2064 O O
49 O O
(H) O O
5.1 O O
(H) O O
159 B-DIABETES O
(H) O O
Date/Time O O
CA O O
PHOS O O
ALB O O
01/23/2064 O O
6.7 O O
(L) O O
4.1 O O
3.0 O O
(L) O O
Date/Time O O
CCOM O O
01/25/2064 O O
[1] O O
01/23/2064 O O
[2] O O
Date/Time O O
WBC O O
RBC O O
HGB O O
HCT O O
01/28/2064 O O
5.3 O O
2.50 O O
(L) O O
8.2 O O
(L) O O
25.6 O O
(L) O O
01/25/2064 O O
7.0 O O
2.45 O O
(L) O O
8.0 O O
(L) O O
25.4 O O
(L) O O
01/23/2064 O O
4.6 O O
2.37 O O
(L) O O
7.8 O O
(L) O O
24.2 O O
(L) O O
Date/Time O O
MCV O O
MCH O O
MCHC O O
PLT O O
01/28/2064 O O
103 O O
(H) O O
32.9 O O
32.1 O O
315 O O
01/25/2064 O O
104 O O
(H) O O
32.8 O O
31.6 O O
303 O O
01/23/2064 O O
102 O O
(H) O O
32.7 O O
32.1 O O
334 O O
Date/Time O O
RDW O O
01/28/2064 O O
14.1 O O
01/25/2064 O O
14.6 O O
(H) O O
01/23/2064 O O
14.1 O O
Date/Time O O
DIFFR O O
METHOD O O
%NEUT O O
%LYMPH O O
01/28/2064 O O
RECEIVED O O
Auto O O
46 O O
45 O O
(H) O O
Date/Time O O
%MONO O O
%EOS O O
%BASO O O
01/28/2064 O O
6 O O
3 O O
0 O O
Date/Time O O
ANEUT O O
ALYMP O O
AMONS O O
AEOSN O O
01/28/2064 O O
2.48 O O
2.34 O O
0.31 O O
0.14 O O
Date/Time O O
ABASOP O O
01/28/2064 O O
0.01 O O
Date/Time O O
ANISO O O
HYPO O O
MACRO O O
MICRO O O
01/28/2064 O O
None O O
1+ O O
2+ O O
None O O
Date/Time O O
PROTSF O O
PROTCF O O
PROTCA O O
[1] O O
RESULT O O
COMMENT: O O
PREDOMINANT O O
GROWTH O O
OF O O
[2] O O
RESULT O O
COMMENT: O O
Post O O
dialysis O O
Microbiology O O
01/28/2064 O O
21:47 O O
EDUCARE-PULLMAN O O
Microbiology O O
Specimen O O
Type O O
BLOOD O O
CULTURE O O
Accession O O
5856E7910 O O
Specimen: O O
5856E7910 O O
Collected O O
28-Jan-64 O O
21:47 O O
Received O O
28-Jan-64 O O
21:47 O O
Specimen O O
Group: O O
BLOOD/SERUM O O
Specimen O O
Type: O O
BLOOD O O
CULTURE O O
Specimen O O
Comment: O O
PERIPHERAL O O
IV O O
SET O O
2 O O
Blood O O
Culture O O
- O O
Pending O O
01/28/2064 O O
21:46 O O
EDUCARE-PULLMAN O O
Microbiology O O
Specimen O O
Type O O
BLOOD O O
CULTURE O O
Accession O O
6934P2380 O O
Specimen: O O
6934P2380 O O
Collected O O
28-Jan-64 O O
20:00 O O
Received O O
28-Jan-64 O O
21:46 O O
Specimen O O
Group: O O
BLOOD/SERUM O O
Specimen O O
Type: O O
BLOOD O O
CULTURE O O
Specimen O O
Comment: O O
SET O O
1 O O
Blood O O
Culture O O
- O O
Pending O O
01/27/2064 O O
15:01 O O
EDUCARE-PULLMAN O O
Microbiology O O
Specimen O O
Type O O
BLOOD O O
CULTURE O O
Accession O O
6931L53151 O O
Specimen: O O
6931L53151 O O
Collected O O
27-Jan-64 O O
12:30 O O
Received O O
27-Jan-64 O O
15:01 O O
Specimen O O
Group: O O
BLOOD/SERUM O O
Specimen O O
Type: O O
BLOOD O O
CULTURE O O
Specimen O O
Comment: O O
SET O O
2 O O
DIALYSIS O O
Blood O O
Culture O O
- O O
Preliminary O O
Reported: O O
28-Jan-64 O O
17:29 O O
Aerobic O O
bottle: O O
GRAM O O
POSITIVE O O
COCCI O O
IN O O
CLUSTERS O O
Susceptibilities O O
pending O O
RESULT O O
CALLED O O
TO O O
CARE O O
UNIT O O
AND/OR O O
MD O O
ON O O
1/28/64 O O
01/27/2064 O O
14:59 O O
EDUCARE-PULLMAN O O
Microbiology O O
Specimen O O
Type O O
BLOOD O O
CULTURE O O
Accession O O
3194S62727 O O
Specimen: O O
3194S62727 O O
Collected O O
27-Jan-64 O O
12:30 O O
Received O O
27-Jan-64 O O
14:59 O O
Specimen O O
Group: O O
BLOOD/SERUM O O
Specimen O O
Type: O O
BLOOD O O
CULTURE O O
Specimen O O
Comment: O O
SET O O
1 O O
DIALYSIS O O
Blood O O
Culture O O
- O O
Preliminary O O
Reported: O O
28-Jan-64 O O
07:24 O O
NO O O
GROWTH O O
1 O O
DAY O O
Impression: O O
55 O O
year O O
old O O
male O O
with O O
chronic O O
renal O O
failure, O O
hypertension, O O
diabetes O O
and O O
gastrointestinal O O
mucormycosis O O
who O O
is O O
s/p O O
recent O O
tunnelled O O
catheter O O
placement, O O
now O O
presenting O O
with O O
fever O O
post O O
HD, O O
GPC O O
in O O
blood. O O
ID- O O
Likely O O
catheter O O
related O O
infection, O O
will O O
continue O O
vanco O O
for O O
now, O O
await O O
speciation O O
of O O
GPC. O O
Will O O
recx O O
if O O
spikes O O
above O O
101.5. O O
FU O O
urine O O
cx. O O
Vanco/Gent. O O
Ultimately O O
needs O O
line O O
out. O O
ESRD-continue O O
dialysis O O
schedule, O O
will O O
continue O O
nephrocaps, O O
calcitrol, O O
procrit O O
Hypertension O O
Will O O
continue O O
outpatient O O
regime O O
DM- B-DIABETES O
Sliding O O
scale O O
insulin O O
Heme O O
Protein O O
C O O
and O O
S O O
levels O O
decreased O O
on O O
repeat O O
testing. O O
I O O
believe O O
protein O O
C O O
can O O
be O O
influenced O O
by O O
ESRD, O O
but O O
not O O
protein O O
S. O O
This O O
needs O O
to O O
be O O
followed O O
up O O
further. O O
Prophylaxis O O
DVT O O
prophylaxis: O O
Fragmin O O
GI O O
prophylaxis: O O
nexium O O
_____________________________________________ O O
Herbert O O
C. O O
Guerrero, O O
M. O O
D. O O

Record O O
date: O O
2064-07-28 O O
Team O O
2 O O
Internal O O
Medicine O O
Intern O O
Admission O O
Note O O
Name: O O
Ethridge, O O
Clayton O O
MR#: O O
8381729 O O
Admit O O
Date: O O
7/28/64 O O
Attending: O O
Dr. O O
Tomlin O O
Admitting O O
intern: O O
Ursula O O
Quiles, O O
MD O O
Code: O O
Full O O
Source: O O
Medical O O
record, O O
Patient O O
Chief O O
Complaint: O O
fistula O O
clot O O
History O O
of O O
Present O O
Illness: O O
Pt O O
is O O
a O O
59 O O
yo O O
Khazakhstani O O
male, O O
with O O
h/o O O
HTN, B-HYPERTENSION O
DM, B-DIABETES O
mucormycosis, O O
and O O
ESRD O O
on O O
HD O O
presenting O O
with O O
a O O
thrombosed O O
AVF O O
in O O
his O O
left O O
arm, O O
established O O
in O O
April O O
of O O
2064 O O
by O O
Dr. O O
Jordon. O O
The O O
patient O O
has O O
a O O
history O O
of O O
multiple O O
problems O O
with O O
access O O
(clots, O O
stenoses), O O
requiring O O
frequent O O
thrombectomies O O
and O O
revisions. O O
The O O
patient O O
first O O
noticed O O
a O O
problem O O
on O O
July O O
23, O O
and O O
by O O
the O O
24th O O
he O O
said O O
that O O
'the O O
access O O
had O O
collapsed.' O O
On O O
July O O
25, O O
interventional O O
radiology O O
attempted O O
to O O
thrombectomize O O
the O O
clot, O O
with O O
no O O
success, O O
requiring O O
placement O O
of O O
a O O
new O O
tunneled O O
catheter O O
in O O
left O O
IJ O O
to O O
allow O O
dialysis. O O
At O O
present, O O
patient O O
is O O
on O O
the O O
OR O O
waiting O O
list O O
for O O
tomorrow, O O
for O O
thrombectomy/revision. O O
Of O O
note, O O
patient O O
was O O
admitted O O
in O O
April O O
of O O
2064 O O
after O O
a O O
nurse O O
at O O
the O O
McLaren O O
Hospital O O
detected O O
a O O
new O O
cardiac O O
murmur. O O
Pt O O
was O O
found O O
to O O
have O O
a O O
RA O O
thrombus O O
by O O
echo, O O
presumed O O
to O O
be O O
a O O
complication O O
from O O
a O O
prior O O
catheter, O O
started O O
on O O
a O O
heparin O O
gtt O O
and O O
transitioned O O
to O O
coumadin. O O
ROS: O O
No O O
fever/chills, O O
HA, O O
SOB, O O
CP, O O
N/V/D O O
(though O O
states O O
that O O
stomach O O
sometimes O O
'sensitive'). O O
Past O O
Medical O O
History: O O
DM B-DIABETES O
- I-DIABETES O
Type I-DIABETES O
2 I-DIABETES O
HTN O O
ESRD O O
on O O
HD O O
MWF, O O
with O O
h/o O O
multiple O O
problems O O
with O O
access, O O
Cr O O
baseline O O
4 O O
s/p O O
extensive O O
bowel O O
resection O O
for O O
mucormycosis, O O
June O O
2062 O O
(gastrectomy, O O
esophagojejunostomy, O O
splenectomy, O O
distal O O
pancreatectomy, O O
segmental O O
transverse O O
colectomy) O O
s/p O O
L O O
THR O O
s/p O O
resection O O
arthroplasty O O
of O O
left O O
femoral O O
head O O
and O O
acetabulum O O
for O O
fungal O O
infection O O
(mucomycosis O O
above, O O
June O O
2062) O O
R O O
atrial O O
thrombus O O
by O O
echo O O
in O O
4/63 O O
Allergies: O O
Nafcillin- O O
rash O O
Penicillin- O O
rash O O
Medications O O
(upon O O
admission) O O
Remeron O O
(MIRTAZAPINE) O O
15 O O
MG O O
(15MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Nexium O O
(ESOMEPRAZOLE) O O
20 O O
MG O O
(20MG O O
CAPSULE O O
DR O O
take O O
1) O O
PO O O
QD O O
TRAZODONE O O
50 O O
MG O O
(50MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Colace O O
(DOCUSATE O O
Sodium) O O
100 O O
MG O O
(100MG O O
TABLET O O
take O O
1) O O
PO O O
TID O O
Norvasc B-MEDICATION B-MEDICATION
(AMLODIPINE) I-MEDICATION O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Diovan B-MEDICATION O
(VALSARTAN) I-MEDICATION O
80 O O
MG O O
(80MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Insulin B-MEDICATION O
Regular I-MEDICATION O
Human I-MEDICATION O
SC O O
NEPHROCAPS O O
1 O O
CAPSULE O O
PO O O
QD O O
Renagel O O
(SEVELAMER) O O
806 O O
MG O O
(403MG O O
CAPSULE O O
take O O
2) O O
PO O O
TID O O
Folate O O
(FOLIC O O
Acid) O O
1 O O
MG O O
(1MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Calcium O O
Carbonate O O
(500 O O
Mg O O
Elemental O O
Ca++) O O
1250 O O
MG O O
PO O O
AC O O
Warfarin O O
Sodium O O
2.5 O O
MG O O
(2.5MG O O
TABLET O O
take O O
1) O O
PO O O
QPM O O
Social O O
History: O O
Patient O O
is O O
a O O
native O O
of O O
Kazakhstan, O O
who O O
moved O O
to O O
the O O
UKRAINE O O
to O O
study O O
Electrical O O
Mechanics O O
at O O
OpenMarket O O
Inc. O O
He O O
is O O
currently O O
unable O O
to O O
pursue O O
this O O
field, O O
due O O
to O O
his O O
debilitated O O
state, O O
however O O
he O O
would O O
like O O
to O O
try O O
to O O
intern, O O
when O O
he O O
feels O O
up O O
to O O
it. O O
He O O
lives O O
in O O
the O O
McLaren O O
Hospital O O
in O O
Kemmerer O O
(a O O
facility O O
for O O
homeless O O
individuals.) O O
No B-SMOKER O
tobacco, I-SMOKER O
EtOH, O O
illicits. O O
Family O O
History: O O
Non-contributory. O O
Exam: O O
Vitals: O O
BP O O
121/62 O O
HR O O
78 O O
RR O O
16 O O
T O O
97.5 O O
O2 O O
sat O O
100% O O
RA O O
Gen: O O
HEENT: O O
PERL, O O
OP O O
without O O
erythema, O O
exudates; O O
mucous O O
membranes O O
moist; O O
no O O
scleral O O
icterus O O
Pulm: O O
CTA O O
with O O
good O O
air O O
movement O O
bilat.; O O
no O O
c/w/r O O
Cor/Cardiac: O O
RRR O O
nl. O O
S1,S2; O O
no O O
m/g/r, O O
neck O O
veins O O
flat O O
Abdomen: O O
S/NT/ND; O O
+BS O O
throughout; O O
no O O
HSM, O O
palpable/pulsatile O O
masses O O
Extremity: O O
no O O
c/c/e; O O
distal O O
pulses O O
2+ O O
bilat; O O
left O O
LE O O
shorter O O
than O O
right O O
and O O
internally O O
rotated O O
Neurological: O O
CN O O
II-XII O O
grossly O O
intact, O O
strength O O
5/5 O O
all O O
major O O
muscle O O
groups; O O
DTR's O O
2+ O O
bilat. O O
UE/LE, O O
Laboratory O O
Hematology O O
EDUCARE-PULLMAN O O
BLOOD O O
27-Jul-2064 O O
16:10 O O
Accession# O O
8911Z65654 O O
WBC O O
8.0 O O
(4.5-11.0) O O
th/cmm O O
HCT O O
34.7 O O
L O O
(41.0-53.0) O O
% O O
HGB O O
11.0 O O
L O O
(13.5-17.5) O O
gm/dl O O
RBC O O
3.55 O O
L O O
(4.50-5.90) O O
mil/cmm O O
PLT O O
255 O O
(150-350) O O
th/cumm O O
MCV O O
98 O O
(80-100) O O
fl O O
MCH O O
31.1 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
31.8 O O
(31.0-37.0) O O
g/dl O O
RDW O O
15.3 O O
H O O
(11.5-14.5) O O
% O O
Retic O O
2.6 O O
H O O
(0.5-2.5) O O
% O O
Chemistry O O
EDUCARE-PULLMAN O O
BLOOD O O
27-Jul-2064 O O
16:10 O O
Accession# O O
8911Z65654 O O
Plasma O O
Sodium O O
135 O O
(135-145) O O
mmol/L O O
Plasma O O
Potassium O O
5.0 O O
H O O
(3.4-4.8) O O
mmol/L O O
Plasma O O
Chloride O O
100 O O
(100-108) O O
mmol/L O O
Plasma O O
Carbon O O
Dioxide O O
19.4 O O
L O O
(23.0-31.9) O O
mmol/L O O
Calcium O O
7.7 O O
L O O
(8.5-10.5) O O
mg/dl O O
Phosphorus O O
5.3 O O
H O O
(2.6-4.5) O O
mg/dl O O
Plasma O O
Urea O O
Nitrogen O O
74 O O
H O O
(8-25) O O
mg/dl O O
Plasma O O
Creatinine O O
7.7 O O
H O O
(0.6-1.5) O O
mg/dl O O
Plasma O O
Glucose O O
113 O O
H O O
(70-110) O O
mg/dl O O
Albumin O O
3.7 O O
(3.3-5.0) O O
g/dl O O
Parathyroid O O
Hormone O O
187 O O
H O O
(10-60) O O
pg/ml O O
EKG: O O
NSR O O
at O O
75-80, O O
normal O O
axis, O O
normal O O
intervals. O O
No O O
ST O O
changes O O
or O O
TWIs O O
compared O O
to O O
prior O O
in O O
April O O
2064 O O
(J O O
point O O
elevation O O
in O O
V1-V3 O O
in O O
both). O O
Cardiac O O
Studies O O
Echo: O O
4/25/2064 O O
EF O O
65%, O O
LVH, O O
mobile O O
mass O O
(27x22mm) O O
in O O
RA, O O
small O O
pericardial O O
effusion. O O
Radiology O O
CXR O O
July O O
27, O O
2064 O O
IMPRESSION: O O
Dual O O
lumen O O
dialysis O O
catheter O O
from O O
the O O
left O O
jugular O O
region O O
to O O
the O O
right O O
atrium O O
without O O
pneumothorax, O O
hematoma, O O
or O O
pleural O O
effusion. O O
No O O
new O O
or O O
enlarging O O
infiltrates O O
or O O
masses. O O
Slight O O
fullness O O
in O O
the O O
region O O
of O O
the O O
right O O
thyroid O O
gland. O O
Assessment O O
and O O
Plan: O O
59 O O
yo O O
Kazakhstani O O
male, O O
with O O
HTN, O O
DM, O O
and O O
ESRD O O
on O O
HD, O O
and O O
h/o O O
access O O
issues O O
(multiple O O
thromboses, O O
stenoses O O
requiring O O
frequent O O
revisions) O O
and O O
admitted O O
with O O
clotted O O
left O O
AVF O O
for O O
revision/thrombectomy O O
in O O
the O O
OR. O O
1. O O
Access: O O
clotted O O
L O O
AVF, O O
functional O O
left O O
IJ O O
tunneled O O
cath. O O
a. O O
On O O
waiting O O
list O O
with O O
Dr. O O
Jordon O O
for O O
procedure O O
tomorrow O O
i. O O
NPO O O
p O O
MN O O
ii. O O
Hold O O
coumadin O O
b. O O
IV O O
access O O
for O O
R O O
arm. O O
2. O O
ESRD O O
on O O
HD O O
a. O O
Patient O O
for O O
dialysis O O
on O O
Monday, O O
if O O
still O O
inpatient. O O
b. O O
Contine O O
nephrocaps, O O
renagel, O O
CaCarbonate, O O
3. O O
DM: O O
Pt O O
reports O O
well-controlled, O O
rarely O O
c O O
FS&gt;200 O O
a. O O
FS O O
qam, O O
qpm O O
before O O
breakfast O O
and O O
dinner; O O
reg B-MEDICATION O
ins I-MEDICATION O
sliding I-MEDICATION O
scale I-MEDICATION O
b. O O
Diabetic O O
diet O O
4. O O
HTN O O
a. O O
Continue O O
outpatient O O
regimen O O
of O O
norvasc B-MEDICATION O
and O O
diovan B-MEDICATION O
b. O O
Note: O O
these O O
meds O O
are O O
held O O
on O O
dialysis O O
days O O
(MWF) O O
5. O O
h/o O O
R O O
atrial O O
clot O O
a. O O
INR O O
goal O O
1.8-2.5 O O
b. O O
Consider O O
repeat O O
echo, O O
to O O
evaluate O O
clot O O
stabilization O O
and O O
to O O
better O O
plan O O
anticoagulation O O
regimen O O
c. O O
Follow O O
coags O O
6. O O
Elevated O O
K O O
to O O
5.8 O O
5.0 O O
on O O
7/27. O O
a. O O
Check O O
pm O O
labs, O O
assess O O
need O O
for O O
kayexalate. O O
7. O O
Low O O
Hct O O
(lowest O O
since O O
1/64) O O
a. O O
Anemia O O
panel O O
8. O O
Prophylaxis O O
a. O O
Nexium, O O
on O O
coumadin O O
tx O O
(though O O
held O O
tonight) O O
9. O O
Code O O
status: O O
full O O
code O O
Ursula O O
Quiles, O O
MD O O
Team O O
2 O O
intern O O
#50684 O O

Record O O
date: O O
2059-06-19 O O
PROMPTCARE O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
Rutledge, O O
Eva O O
29195561 O O
6-19-59 O O
HPI: O O
This O O
is O O
a O O
regularly O O
scheduled O O
visit O O
for O O
this O O
Eva O O
Ruledge O O
a O O
44-year O O
old O O
woman O O
with O O
a O O
history O O
of O O
hypertension B-HYPERTENSION B-HYPERTENSION
and O O
borderline B-OBESE O
obesity. I-OBESE O
She O O
was O O
last O O
here O O
in O O
February O O
with O O
no O O
complaints, O O
but O O
did O O
have O O
an O O
elevated O O
creatinine O O
for O O
which O O
she O O
was O O
referred O O
to O O
the O O
Internal O O
Medicine O O
for O O
further O O
evaluation. O O
The O O
patient O O
did O O
not, O O
however, O O
present O O
to O O
the O O
Internal O O
Medicine O O
as O O
planned. O O
She O O
states O O
that O O
she O O
has O O
been O O
'too O O
busy.' O O
Her O O
only O O
complaint O O
today O O
is O O
of O O
some O O
right O O
leg O O
pain, O O
which O O
she O O
says O O
is O O
chronic O O
and O O
which O O
is O O
relieved O O
to O O
some O O
extent O O
by O O
acetaminophen. O O
Eva O O
continues O O
to O O
take O O
Procardia B-MEDICATION O
XL I-MEDICATION O
30 O O
mg. O O
PO O O
q.day. O O
A O O
noted O O
in O O
her O O
ambulatory O O
record, O O
the O O
Procardia O O
is O O
prescribed O O
as O O
a O O
b.i.d. O O
drug, O O
however, O O
Eva O O
believes O O
it O O
gives O O
her O O
headaches O O
and O O
refuses O O
to O O
take O O
it O O
other O O
than O O
on O O
an O O
almost O O
p.r.n. O O
basis. O O
Review O O
of O O
systems O O
is O O
essentially O O
normal. O O
Specifically, O O
she O O
denies O O
any O O
headaches, O O
any O O
chest O O
pain, O O
any O O
shortness O O
of O O
breath. O O
She O O
also O O
denies O O
any O O
symptoms O O
or O O
signs O O
referable O O
to O O
her O O
urinary O O
tract. O O
She O O
has O O
no O O
history O O
of O O
dysuria, O O
of O O
frequent O O
urinary O O
tract O O
infection, O O
or O O
of O O
hematuria. O O
Physical O O
Examination: O O
She O O
is O O
robust O O
appearing. O O
Vital O O
signs O O
are O O
significant O O
for O O
a O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
of I-HYPERTENSION O
140/100. B-HYPERTENSION O
HEENT O O
exam O O
is O O
unremarkable. O O
Lungs O O
are O O
clear. O O
Cardiac O O
exam O O
reveals O O
a O O
regular O O
rate O O
and O O
rhythm, O O
a O O
normal O O
S1, O O
S2. O O
No O O
S3 O O
is O O
appreciated. O O
There O O
are O O
no O O
murmurs O O
or O O
rubs. O O
Abdomen O O
is O O
slightly O O
obese, O O
nontender, O O
and O O
with O O
normal O O
bowel O O
sounds. O O
No O O
masses O O
are O O
appreciated. O O
Lower O O
extremities O O
are O O
without O O
edema O O
and O O
joint O O
exam O O
does O O
not O O
suggest O O
effusion O O
or O O
limitation O O
of O O
her O O
range O O
of O O
motion. O O
Indeed, O O
exam O O
of O O
her O O
legs O O
is O O
entirely O O
unremarkable. O O
Laboratory: O O
Will O O
include O O
a O O
repeat O O
creatinine, O O
a O O
urinalysis O O
and O O
urine O O
sediment O O
and O O
a O O
urine O O
creatinine. O O
Assessment O O
and O O
Plan: O O
1. O O
Hypertension: B-HYPERTENSION O
Eva O O
has O O
had O O
persistently O O
elevated O O
blood O O
pressure O O
on O O
her O O
Procardia. O O
I O O
have O O
asked O O
her O O
to O O
stop O O
taking O O
Procardia, O O
which O O
she O O
blames O O
for O O
headaches O O
and O O
to O O
begin O O
taking O O
taking O O
atenolol, B-MEDICATION B-MEDICATION
beginning O O
at O O
50 O O
mg. O O
PO O O
q.day. O O
I O O
will O O
see O O
her O O
in O O
a O O
few O O
days O O
in O O
order O O
to O O
make O O
sure O O
that O O
she O O
is O O
not O O
having O O
any O O
difficulties O O
with O O
this O O
drug O O
and O O
also O O
to O O
check O O
her O O
blood O O
pressure O O
once O O
again. O O
2. O O
Right O O
leg O O
pain: O O
This O O
would O O
appear O O
to O O
be O O
chronic O O
and O O
may O O
well O O
be O O
related O O
to O O
her O O
work, O O
which O O
requires O O
her O O
to O O
scuttle O O
throughout O O
the O O
hospital O O
at O O
fairly O O
high O O
speed O O
(She O O
is O O
a O O
Pulping O O
Control O O
Operator.) O O
I O O
have O O
asked O O
her O O
to O O
continue O O
taking O O
Tylenol O O
and O O
we O O
will O O
re-evaluate O O
her O O
need O O
for O O
more O O
powerful O O
agents, O O
such O O
as O O
nonsteroidals O O
if O O
the O O
need O O
arises. O O
PROMPTCARE O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
Rutledge, O O
Eva O O
Page O O
2 O O
29195561 O O
6-19-59 O O
3. O O
Elevated O O
creatinine: O O
Unfortunately, B-SMOKER O
Eva O O
has O O
not O O
kept O O
her O O
Renal O O
appointment. O O
In O O
order O O
to O O
prevent O O
this O O
from O O
recurring O O
a O O
third O O
time, O O
I O O
have O O
called O O
and O O
made O O
an O O
appointment O O
for O O
her O O
with O O
Dr. O O
Eileen O O
Xayavong. O O
She O O
is O O
to O O
see O O
him O O
on O O
the O O
29th O O
of O O
this O O
month O O
at O O
1:00 O O
p.m. O O
and O O
I O O
have O O
also O O
left O O
a O O
message O O
on O O
his O O
E O O
mail O O
mentioning O O
Eva O O
to O O
him. O O
Hopefully, O O
he O O
can O O
help O O
ultrasound O O
identify O O
the O O
etiology O O
of O O
this O O
elevated O O
creatinine O O
before O O
there O O
is O O
further O O
loss O O
of O O
her O O
kidney O O
function. O O
4. O O
Health O O
Maintenance: O O
The O O
patient O O
was O O
scheduled O O
to O O
have O O
a O O
Pap O O
smear O O
today, O O
but O O
again O O
was O O
'too O O
busy O O
to O O
stay O O
that O O
long.' O O
She O O
is O O
to O O
see O O
me O O
again O O
shortly, O O
and O O
a O O
Pap O O
smear O O
will O O
be O O
done O O
at O O
that O O
time. O O
Her O O
February O O
mammogram O O
was O O
essentially O O
not O O
suggestive O O
of O O
malignancy O O
and O O
will O O
not O O
be O O
repeated O O
until O O
next O O
year. O O
_________________________ O O
Ulysses O O
Quijano, O O
M.D. O O
TD:PX:4740 O O
DD:6-20-59 O O
DT:6-19-59 O O
DV:6-19-59 O O
******** O O
Approved O O
but O O
not O O
reviewed O O
by O O
Attending O O
Provider O O
******** O O

Record O O
date: O O
2066-10-08 O O
Patient O O
Name: O O
RUTLEDGE,EVA O O
[ O O
MRN: O O
37947241ZGJ O O
] O O
Date O O
of O O
Visit: O O
10/08/2066 O O
PROMPTCAREIMA O O
Clinic O O
Note O O
Mrs. O O
Rutledge O O
is O O
a O O
former O O
patient O O
of O O
Dr. O O
Xia's O O
who O O
comes O O
in O O
today O O
to O O
establish O O
a O O
new O O
PCP O O
and O O
for O O
follow-up O O
of O O
her O O
hypertension, B-HYPERTENSION O
diabetes, B-DIABETES O
chronic O O
renal O O
insufficiency O O
(baseline O O
creatinine O O
2.2), O O
and O O
GERD. O O
She O O
is O O
currently O O
on O O
procardia B-MEDICATION O
xl, I-MEDICATION O
losartan, B-MEDICATION B-MEDICATION
and O O
atenolol B-MEDICATION B-MEDICATION
for O O
her O O
hypertension. O O
She O O
takes O O
a O O
baby O O
aspirin B-MEDICATION B-MEDICATION
qd I-MEDICATION O
for O O
cardiac O O
protection. O O
Her O O
diabetes O O
is O O
controlled O O
by O O
diet O O
alone, O O
and O O
her O O
GERD O O
by O O
zantac O O
150 O O
qd O O
or O O
bid O O
prn. O O
Her O O
last O O
HbA1C B-DIABETES O
was I-DIABETES O
6.9, I-DIABETES O
with O O
a O O
malb/cr O O
ratio O O
of O O
222.2 O O
and O O
trace O O
protein O O
on O O
U/A. O O
She O O
has O O
had O O
a O O
prior O O
cardiac O O
work-up O O
for O O
atypical O O
chest O O
pain O O
with O O
a O O
negative O O
ETT/SPECT O O
in O O
2062 O O
and O O
a O O
negative O O
ETT O O
in O O
2064. O O
An O O
echo O O
in O O
2062 O O
showed O O
an O O
EF O O
of O O
65% O O
with O O
no O O
valvular O O
abnormalities. O O
She O O
is O O
currently O O
well O O
with O O
no O O
complaints. O O
She O O
is O O
being O O
followed O O
in O O
opthalmology O O
for O O
possible O O
glaucoma. O O
She O O
does O O
not O O
check O O
her O O
blood O O
sugars O O
at O O
home, O O
although O O
she O O
has O O
a O O
glucometer. O O
When O O
asked O O
if O O
her O O
sugars O O
are O O
ever O O
low, O O
she O O
states O O
that O O
she O O
has O O
the O O
same O O
symptoms O O
with O O
hypoglycemia O O
that O O
she O O
does O O
with O O
hyperglycemia: O O
dizziness O O
and O O
hot O O
flashes. O O
She's O O
not O O
had O O
this O O
recently. O O
She O O
also O O
does O O
not O O
check O O
her O O
BP O O
at O O
home. O O
She O O
denies O O
any O O
numbness O O
or O O
tingling O O
in O O
her O O
fingers, O O
or O O
any O O
chest O O
pain. O O
She O O
did O O
pull O O
a O O
muscle O O
in O O
her O O
shoulder O O
last O O
night O O
and O O
still O O
feels O O
tender O O
in O O
that O O
area. O O
She O O
follows O O
a O O
diabetic O O
diet O O
(avoids O O
sweets), O O
gets O O
no O O
regular O O
exercise, O O
but O O
works O O
in O O
Electrical O O
and O O
Avionics O O
Mechanics O O
so O O
does O O
have O O
physical O O
activity O O
during O O
the O O
day. O O
PSHx: O O
none O O
PGynHx: O O
G7 O O
P4 O O
SAB1 O O
TAB2, O O
still O O
menstruating O O
q O O
month, O O
no O O
hot O O
flashes, O O
heavy O O
periods O O
but O O
no O O
clots; O O
LMP O O
10/01/66 O O
Allergies: O O
NKAD O O
Habits: O O
never B-SMOKER O
smoked, I-SMOKER O
very O O
rare O O
EtOH, O O
no O O
illicit O O
drugs O O
Medications: O O
ASA B-MEDICATION B-MEDICATION
81MG O O
PO O O
QD O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG O O
PO O O
QD O O
(she O O
has O O
run O O
out O O
of O O
this O O
and O O
did O O
not O O
take O O
it O O
today) O O
PROCARDIA B-MEDICATION B-MEDICATION
XL I-MEDICATION O
30MG O O
PO O O
QD O O
RANITIDINE O O
HCL O O
150MG O O
PO O O
QD O O
LOSARTAN B-MEDICATION B-MEDICATION
50MG O O
PO O O
2 O O
qd O O
Physical O O
Exam O O
================ O O
Vital O O
signs O O
================ O O
Blood O O
Pressure: O O
-- O O
136/76 O O
Pulse: O O
-- O O
76 O O
Weight: O O
-- O O
139 O O
[Pounds] O O
General: O O
no O O
acute O O
distress O O
HEENT: O O
PERLA, O O
anicteric, O O
O/P O O
clear O O
Neck: O O
no O O
thyromegaly O O
or O O
LAN; O O
no O O
carotid O O
bruits O O
Chest: O O
lungs O O
are O O
clear O O
to O O
auscultation O O
bilaterally O O
with O O
no O O
crackles O O
Heart: O O
regular O O
rate O O
and O O
rhythm, O O
S1 O O
and O O
S2 O O
normal, O O
no O O
m/g/r O O
Abd: O O
soft, O O
NT/ND. O O
+BS. O O
No O O
HSM O O
or O O
masses O O
Pelvic: O O
Pap O O
done, O O
with O O
normal O O
vaginal O O
mucosa O O
and O O
cervix O O
Ext: O O
no O O
edema, O O
peripheral O O
pulses O O
present O O
and O O
feet O O
without O O
lesions. O O
Assessment: O O
51 O O
yo O O
woman O O
with O O
diabetes, O O
hypertension, O B-HYPERTENSION
CRI O O
from O O
hypertension/diabetic O B-HYPERTENSION
nephropathy O O
likely. O O
Current O O
Plan: O O
1. O O
Diabetes. B-DIABETES O
Checking O O
A1C O O
off O O
medication. O O
Would O O
like O O
to O O
have O O
patient O O
check O O
FS O O
when O O
she's O O
feeling O O
ill O O
or O O
if O O
A1C O O
is O O
elevated. O O
Will O O
refer O O
to O O
NP O O
for O O
review O O
glucometer O O
use, O O
diabetic O O
diet. O O
She O O
has O O
been O O
tried O O
on O O
glucotrol O B-MEDICATION
XL O O
in O O
the O O
past O O
and O O
was O O
hypoglycemia. O O
This O O
is O O
also O O
probably O O
not O O
a O O
good O O
choice O O
due O O
to O O
her O O
renal O O
insufficiency. O O
May O O
try O O
glyburide O O
if O O
A1C O O
elevated. O O
Being O O
followed O O
by O O
opthalmology O O
with O O
upcoming O O
appt. O O
Podiatry O O
referral O O
deferred. O O
Consider O O
repeat O O
referral O O
to O O
nutrition. O O
Lipids O O
very O O
good O O
(LDL O O
82) O O
last O O
check O O
off O O
medication. O O
2. O O
Hypertension. B-HYPERTENSION O
BP O O
borderline O O
elevated O O
today, O O
but O O
off O O
atenolol. O B-MEDICATION
HR O O
also O O
up. O O
Refilled O O
all O O
meds; O O
will O O
ask O O
NP O O
to O O
check O O
her O O
pressure O O
at O O
next O O
visit. O O
Will O O
continue O O
qd O O
ASA O O
for O O
CAD/stroke O O
prevention. O O
3. O O
GERD. O O
Continue O O
zantac O O
bid O O
as O O
needed. O O
Also O O
recommended O O
that O O
patient O O
start O O
using O O
Tums O O
for O O
calcium O O
supplementation O O
and O O
relief O O
of O O
intermittent O O
dyspepsia. O O
She O O
will O O
try O O
this O O
and O O
get O O
back O O
to O O
me O O
about O O
the O O
effect. O O
4. O O
Chronic O O
renal O O
insufficiency. O O
Will O O
get O O
24-hour O O
urine O O
to O O
assess O O
creatinine O O
clearance O O
and O O
urine O O
protein. O O
Checking O O
chem O O
7 O O
today O O
for O O
K O O
and O O
Creatinine. O O
5. O O
Health O O
maintenance. O O
Patient O O
due O O
to O O
dT O O
shot, O O
requested O O
today. O O
Normal O O
mammogram O O
in O O
5/66. O O
Stool O O
guaiac O O
and O O
flex O O
sig O O
can O O
be O O
done O O
at O O
next O O
appt; O O
will O O
follow-up O O
Pap. O O
______________________________ O O
Xena O O
Danielle O O
Elmore, O O
M.D. O O
========================== O O
Preceptor's O O
Note O O
========================== O O
51 O O
yo O O
Puerto O O
Rican O O
woman O O
with O O
dm, B-DIABETES O
htn, B-HYPERTENSION O
cri. O O
Cre O O
last O O
checked O O
2.2. O O
On O O
procadia, B-MEDICATION O
losartan, O B-MEDICATION
atenolol. O B-MEDICATION
Ran O O
out O O
of O O
atenolol. O B-MEDICATION
Does O O
not O O
check O O
blood O O
sugars. O O
No O O
neuropathy. O O
She O O
is O O
active O O
through O O
her O O
job O O
(Electrical O O
and O O
Avionics O O
Mechanics O O
Technician O O
). O O
ETT O O
was O O
negative O O
10/64. O O
136/76 O O
pulse O O
76 O O
Plan: O O
currently, O O
on O O
diet O O
control. O O
Last B-DIABETES O
A1c I-DIABETES O
6.9%. I-DIABETES O
Refilled O O
Meds. O O
Pap O O
done. O O
______________________________ O O
Xen O O
Chris O O
Emmons, O O
M.D. O O

Record O O
date: O O
2069-11-18 O O
HPI O O
54 O O
yo O O
F O O
with O O
h/o O O
CRI, O O
DM B-DIABETES O
on I-DIABETES O
insulin, I-DIABETES O
HTN, B-HYPERTENSION O
obesity, B-OBESE O
GERD, O O
glaucoma, O O
anemia, O O
p/f O O
for O O
f/u. O O
She O O
is O O
generally O O
doing O O
well O O
and O O
has O O
no O O
complaints. O O
She O O
lost O O
her O O
glucometer O O
and O O
hasnt O O
check O O
her O O
BS O O
for O O
2 O O
weeks. O O
Last B-DIABETES O
A1C B-DIABETES O
after I-DIABETES O
starting I-DIABETES O
insulin I-DIABETES O
down I-DIABETES O
to I-DIABETES O
7.5, I-DIABETES O
only O O
on O O
5 O O
glyburide B-MEDICATION O
bc O O
of O O
BS O O
lows. O O
For O O
her O O
CRI, O O
which O O
is O O
multifactorial O O
(DM, O O
HTN O O
and O O
L O O
renal O O
artery O O
stenosis) O O
she O O
sees O O
Dr O O
Uriarte O O
in O O
Internal O O
Medicine, O O
saw O O
him O O
yesterday, O O
Cr O O
stable O O
and O O
PTH O O
up O O
a O O
bit O O
to O O
226. O O
================ O O
Problems O O
================ O O
ESSENTIAL O O
HYPERTENSION B-HYPERTENSION O
MODERATE B-OBESE O
OBESITY I-OBESE O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Chronic O O
renal O O
dysfunction O O
cre O O
cl O O
estimate O O
23 O O
in O O
12/67 O O
Glaucoma O O
Lactose O O
intolerance O O
Atypical O O
chest O O
pain O O
negative O O
ETT O O
4/8/67, O O
negative O O
ETT O O
2064, O O
ETT O O
w/ O O
SPECT O O
2062 O O
Iron-deficiency O O
anemia O O
Gastritis O O
EGD O O
9/67, O O
also O O
GERD O O
symptoms O O
================ O O
Medications O O
================ O O
Asa B-MEDICATION B-MEDICATION
81 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Procardia B-MEDICATION O
XL I-MEDICATION O
60 O O
MG O O
(60MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
, O O
may O O
use O O
adalat O O
instead O O
Ranitidine O O
HCL O O
150 O O
MG O O
PO O O
QD O O
Losartan B-MEDICATION B-MEDICATION
100 O O
MG O O
PO O O
QD O O
Glyburide B-MEDICATION B-MEDICATION
5MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Ferrous O O
GLUCONATE O O
325MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
TID O O
, O O
Take O O
one O O
tablet O O
with O O
every O O
meal O O
for O O
iron O O
deficiency O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
25MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
, O O
Take O O
every O O
day O O
for O O
blood O O
pressure O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
(METOPROLOL O O
SUCCINATE O O
EXTENDED O O
... O O
50MG O O
TABLET O O
CR O O
24HR O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Calcitriol O O
0.25MCG O O
CAPSULE O O
take O O
1 O O
Capsule(s) O O
PO O O
QD O O
Zocor B-MEDICATION B-MEDICATION
(SIMVASTATIN) I-MEDICATION O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Lantus B-MEDICATION B-MEDICATION
(INSULIN I-MEDICATION O
GLARGINE) I-MEDICATION B-MEDICATION
16 O O
UNITS O O
SC O O
QHS O O
, O O
dose O O
increase O O
Timolol O O
XE O O
0.25% O O
1 O O
DROP O O
OU O O
QD O O
, O O
must O O
keep O O
appt O O
Xalatan O O
(LATANOPROST) O O
1 O O
DROP O O
OU O O
QPM O O
, O O
must O O
keep O O
scheduled O O
appt O O
ALLERGIES O O
NKDA O O
PHYSICAL O O
EXAM O O
VS: O O
BP O O
110/60 O O
Cor: O O
RRR, O O
nl O O
S1S2, O O
1/6 O O
sys O O
M, O O
no O O
rubs, O O
gallops O O
Lungs: O O
CTA O O
b/l, O O
no O O
rales, O O
rhonchi O O
or O O
wheezes O O
Abd: O O
Soft, O O
NTND. O O
Normal O O
active O O
bowel O O
sounds. O O
No O O
c/c/e O O
A/P O O
54 O O
yo O O
F O O
with O O
h/o O O
CRI, O O
DM, O O
HTN, O O
obesity, O O
GERD, O O
glaucoma, O O
anemia O O
for O O
f/u. O O
1. O O
DM: O O
Last B-DIABETES O
A1C I-DIABETES O
7.5 I-DIABETES O
from O O
9.3 B-DIABETES O
after I-DIABETES O
starting I-DIABETES O
insulin, I-DIABETES O
still O O
on O O
Lantus O O
16 O O
and O O
now O O
Glyburide O B-MEDICATION
5 O O
qam. O O
She O O
sees O O
Optho O O
2x/yr O O
as O O
she O O
has O O
glaucoma, O O
saw O O
them O O
2mos O O
ago. O O
--Prescribed O O
glucometer O O
--Cont O O
current O O
regimen O O
--check O O
A1C O O
(pt O O
left O O
without O O
getting O O
labs, O O
will O O
get O O
at O O
next O O
visit) O O
--2/69 O O
urine O O
mcalb/cr O O
200 O O
--on B-MEDICATION O
statin I-MEDICATION O
2. O O
CRI: O O
Multifactorial, O O
followed O O
by O O
Dr O O
Uriarte. O O
Last O O
Cr O O
2.8 O O
on O O
5/69. O O
She O O
has O O
2ndary O O
hyperparathyroidism O O
as O O
well, O O
PTH O O
yest O O
226. O O
On O O
Calcitriol. O O
--Cont O O
ARB. B-MEDICATION O
--F/u O O
with O O
Dr O O
Uriarte. O O
3. O O
Anemia, O O
h/o, O O
Fe O O
deficiency, O O
on O O
Fe O O
supp. O O
Last O O
Hct O O
36. O O
4. O O
H/o O O
bowel O O
ischemia O O
but O O
most O O
recent O O
CT O O
wnl O O
so O O
more O O
likely O O
it O O
was O O
an O O
infectious O O
etiology. O O
5. O O
HTN: O O
Cont O O
on O O
ARB, O O
Toprol, B-MEDICATION B-MEDICATION
Procardia, O O
HCTZ. B-MEDICATION O
Today O O
somewhat O O
high, O O
increased O O
Procardia O O
to O O
60 O O
qd. O O
On O O
ASA B-MEDICATION B-MEDICATION
for O O
1ry O O
prevention O O
of O O
CAD. O O
Statin. B-MEDICATION O
6.GERD: O O
Cont O O
Zantac, O O
well O O
controlled O O
sx. O O
7. O O
Galucoma: O O
followed O O
by O O
Optho, O O
cont O O
eye O O
drops O O
8. O O
HM: O O
--lipids O O
8/69much O O
improved O O
with O O
addition O O
of O O
statin O O
TC O O
121, O O
TG O O
309, O O
HDL O O
28, O O
LDL O O
31. O O
Lfts O O
ok. O O
Will O O
check O O
again O O
in O O
Feb O O
--BMD O O
10/68 O O
wnl O O
--colonoscopy O O
2/68 O O
wnl O O
--Mammo O O
will O O
be O O
scheduled O O
for O O
12/69 O O
--PAP O O
overdue, O O
will O O
reschedule O O
a O O
PAP O O
appt O O
______________________________ O O
Quiana O O
Gagnon, O O
M.D. O O
========================== O O
Preceptor's O O
Note O O
========================== O O
I O O
have O O
discussed O O
the O O
evaluation O O
and O O
care O O
of O O
this O O
patient O O
with O O
Dr. O O
Gagnon. O O
______________________________ O O
David O O
R. O O
Quintin, O O
M.D. O O

Record O O
date: O O
2072-03-13 O O
Patient O O
Name: O O
RUTLEDGE,EMMA O O
[ O O
MRN: O O
37947241ZGJ O O
] O O
Date O O
of O O
Visit:3/13/2072 O O
HPI B-SMOKER O
DM, B-DIABETES O
CRI, O O
HTN-, B-HYPERTENSION O
with O O
L5-S1 O O
disc O O
protrusion O O
on O O
MRI O O
, O O
with O O
normal O O
Ct O O
scan O O
hip/leg O O
56 O O
yo O O
F O O
with O O
h/o O O
CRI, O O
DM O O
on O O
insulin, B-MEDICATION O
HTN, O O
obesity, B-OBESE O
GERD, O O
glaucoma, O O
anemia, O O
p/f O O
for O O
f/u. O O
For O O
her O O
CRI, O O
which O O
is O O
multifactorial O O
(DM, O O
HTN O O
and O O
L O O
renal O O
artery O O
stenosis) O O
she O O
sees O O
Dr O O
Uriarte O O
in O O
Internal O O
Medicine, O O
w/ O O
an O O
appt O O
on O O
next O O
week O O
and O O
unchanged O O
Cr O O
4.5 O O
She O O
had O O
an O O
AV O O
fistula O O
placed O O
in O O
anticipation O O
for O O
future O O
dialysis. O O
In O O
March O O
2070, O O
she O O
was O O
admitted O O
for O O
for O O
ischemia O O
colitis O O
and O O
had O O
a O O
colonoscopy O O
revealing O O
this. O O
Underwent O O
surgery O O
for O O
ischemia O O
colitis O O
in O O
April O O
2070 O O
with O O
a O O
right O O
colectomy. O O
She O O
had O O
a O O
mammo O O
in O O
2/13/2071 O O
wnl. O O
Pap O O
9/27/2070 O O
wnl. O O
separated O O
from O O
husband. O O
Has O O
children O O
and O O
granchildren. O O
Needs O O
refills O O
of O O
losartan, B-MEDICATION O
procardia, B-MEDICATION O
and O O
toprol B-MEDICATION B-MEDICATION
XL. I-MEDICATION O
Main O O
issues O O
for O O
her O O
are O O
her O O
leg O O
pain O O
( O O
due O O
to O O
L5-S1 O O
disc O O
protrusion), O O
and O O
HTN O O
which O O
is O O
elevated O O
171/94 B-HYPERTENSION O
( O O
sec O O
to O O
leg O O
pain) O O
Denies O O
trauma, O O
fall. O O
Had O O
PT O O
at O O
home O O
briefly O O
but O O
not O O
at O O
PROMPTCARE. O O
She O O
was O O
supposed O O
to O O
have O O
had O O
an O O
appt O O
with O O
ortho O O
spine O O
clinic O O
per O O
discharge O O
summary, O O
but O O
she O O
said O O
they O O
did O O
not O O
call O O
her. O O
================ O O
Problems O O
================ O O
ESSENTIAL O O
HYPERTENSION B-HYPERTENSION B-HYPERTENSION
MODERATE B-OBESE O
OBESITY I-OBESE O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Chronic O O
renal O O
dysfunction O O
cre O O
cl O O
estimate O O
23 O O
in O O
12/68 O O
Glaucoma O O
Lactose O O
intolerance O O
Atypical O O
chest O O
pain O O
negative O O
ETT O O
4/8/67, O O
negative O O
ETT O O
2064, O O
ETT O O
w/ O O
SPECT O O
2062 O O
Iron-deficiency O O
anemia O O
Gastritis O O
EGD O O
9/67, O O
also O O
GERD O O
symptoms O O
================ O O
Medications O O
================ O O
Asa B-MEDICATION B-MEDICATION
81 O O
MG O O
PO O O
QD O O
Procardia B-MEDICATION O
XL I-MEDICATION O
60 O O
MG O O
(60MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
, O O
may O O
use O O
adalat O O
instead O O
Ranitidine O O
HCL O O
150 O O
MG O O
PO O O
QD O O
Losartan B-MEDICATION B-MEDICATION
100 O O
MG O O
PO O O
QD O O
Glyburide B-MEDICATION B-MEDICATION
5MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Ferrous O O
GLUCONATE O B-MEDICATION
325MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
TID O O
, O O
Take O O
one O O
tablet O O
with O O
every O O
meal O O
for O O
iron O O
deficiency O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
25MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
, O O
Take O O
every O O
day O O
for O O
blood O O
pressure O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
(METOPROLOL I-MEDICATION O
SUCCINATE I-MEDICATION O
EXTENDED I-MEDICATION O
... O O
50MG O O
TABLET O O
CR O O
24HR O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Calcitriol O O
0.25MCG O O
CAPSULE O O
take O O
1 O O
Capsule(s) O O
PO O O
QD O O
Zocor B-MEDICATION B-MEDICATION
(SIMVASTATIN) I-MEDICATION O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Lantus B-MEDICATION B-MEDICATION
(INSULIN I-MEDICATION O
GLARGINE) I-MEDICATION B-MEDICATION
16 O O
UNITS O O
SC O O
QHS O O
, O O
dose O O
increase O O
Timolol O O
XE O O
0.25% O O
1 O O
DROP O O
OU O O
QD O O
, O O
must O O
keep O O
appt O O
Xalatan O O
(LATANOPROST) O O
1 O O
DROP O O
OU O O
QPM O O
, O O
must O O
keep O O
scheduled O O
appt O O
ALLERGIES O O
NKDA O O
PHYSICAL O O
EXAM O O
Vital O O
Signs O O
BP B-HYPERTENSION O
171/94, I-HYPERTENSION O
P O O
90, O O
Wt O O
125 O O
lb O O
FS: O O
84 O O
postprandial O O
HEENT: O O
op O O
clear,supple O O
neck,no O O
thyromegaly O O
HEART O O
RR, O O
S1S2 O O
LUNGS O O
CTA O O
no O O
r/r/w O O
ABD: O O
+Bs, O O
soft, O O
nt,nd O O
LABS O O
HGA1C O O
A/P O O
56 O O
yo O O
F O O
with O O
h/o O O
CRI, O O
DM, O O
HTN, O O
obesity, O O
GERD, O O
glaucoma, O O
anemia O O
for O O
f/u O O
s/p O O
right O O
colectomy O O
for O O
ischemia O O
colitis, O O
sciatica O O
with O O
L5-S1 O O
disc O O
protrusion O O
on O O
MRI O O
3 O O
weeks O O
ago O O
. O O
1. O O
DM: O O
Last O O
A1C B-DIABETES O
7.5 I-DIABETES O
down O O
from O O
9.3 B-DIABETES O
previously O O
after O O
starting O O
insulinTaking O O
novulin B-MEDICATION O
12 O O
units O O
QAM O O
and O O
novulog B-MEDICATION O
4 O O
units O O
q O O
OM. O O
She O O
sees O O
Optho O O
2x/yr O O
as O O
she O O
has O O
glaucoma O O
w/ O O
an O O
appt O O
3/28/2071. O O
missed O O
podiatry O O
again. O O
-check O O
HGA1C; O O
Cr O O
increased O O
to O O
4.5 O O
per O O
renal O O
and O O
has O O
app O O
with O O
renal O O
next O O
week O O
2. O O
CRI: O O
Multifactorial, O O
followed O O
by O O
Dr O O
Uriarte. O O
Last O O
Cr O O
2.5 O O
on O O
4/2070. O O
She O O
has O O
2ndary O O
hyperparathyroidism O O
as O O
well, O O
On O O
Calcitriol. O O
--Cont O O
ARB. B-MEDICATION O
--F/u O O
with O O
Dr O O
Uriarte. O O
- O O
Cr O O
4.5 O O
3. O O
Anemia, O O
h/o, O O
Fe O O
deficiency, O O
on O O
Fe O O
supp. O O
Last O O
Hct O O
33 O O
in O O
4/2070. O O
4. O O
H/o O O
bowel O O
ischemia O O
s/p O O
colectomy O O
f/u O O
with O O
surgery. O O
5. O O
HTN: O O
Cont O O
on O O
ARB, O O
Toprol, B-MEDICATION B-MEDICATION
Procardia. O O
Increase O O
toprol O B-MEDICATION
XL O O
to O O
100 O O
mg O O
poq O O
d. O O
Cont O O
losartan O O
100 O O
mg O O
qd, O O
procardia O O
60 O O
mg O O
poq O O
d. O O
Has B-MEDICATION O
been I-MEDICATION O
off I-MEDICATION O
HCTZ. I-MEDICATION O
Pulse O O
90 O O
and O O
should O O
tolerate O O
inc O O
toprol O B-MEDICATION
to O O
100 O O
6.GERD: O O
Cont O O
Zantac, O O
well O O
controlled O O
sx. O O
7. O O
Glaucoma: O O
followed O O
by O O
Optho, O O
cont O O
eye O O
drops O O
8. O O
HM: O O
--lipids O O
recheck O O
today O O
--BMD O O
10/68 O O
wnl O O
--colonoscopy O O
3/2070 O O
c/w O O
ischemia O O
colitis O O
o/w O O
unremarkable O O
( O O
s/p O O
surgery O O
4/8/2070) O O
--Mammo O O
wnl O O
2/2071. O O
recsched O O
next O O
visit, O O
because O O
she O O
is O O
most O O
concerned O O
with O O
her O O
leg/hip O O
pain O O
from O O
sciatica O O
--PAP O O
utd O O
Breast O O
exam O O
done. O O
SBE O O
counseled. O O
RTC O O
1 O O
month O O
for O O
BP O O
check; O O
f/u O O
HGA1C O O
______________________________ O O
Betty O O
Doris O O
Hanna, O O
MD O O

Record O O
date: O O
2092-09-21 O O
MEDIQUIK O O
Cardiovascular O O
Division O O
CVD O O
TR1 O O
23 O O
Tamworth O O
Place O O
TRENT, O O
SHIRLEY O O
Galena, O O
MN O O
64864 O O
99210914 O O
(176) O O
232-6146 O O
09/21/92 O O
Robert O O
J. O O
Trujillo, O O
M.D. O O
Department O O
of O O
Vascular O O
Surgery O O
Lenox O O
Care O O
Center O O
21 O O
Tamworth O O
Place O O
Galena, O O
MN O O
64864 O O
Dear O O
Dr. O O
Trujillo: O O
Thank O O
you O O
for O O
referring O O
Mrs. O O
Shirley O O
Trent, O O
a O O
68-year-old O O
lady O O
with O O
peripheral O O
artery O O
disease, O O
on O O
whom O O
you O O
plan O O
to O O
do O O
revascularization O O
of O O
the O O
right O O
leg. O O
Her O O
history O O
is O O
well O O
known O O
to O O
you O O
but O O
I O O
will O O
repeat O O
it O O
for O O
our O O
records. O O
She O O
has O O
a O O
long B-SMOKER O
history I-SMOKER O
of I-SMOKER O
cigarette I-SMOKER O
smoking I-SMOKER O
with I-SMOKER O
a I-SMOKER O
3-packet-per-day I-SMOKER O
history I-SMOKER O
for I-SMOKER O
30 I-SMOKER O
years, I-SMOKER O
stopping I-SMOKER O
15 I-SMOKER O
years I-SMOKER O
ago. I-SMOKER O
She O O
has O O
developed O O
claudication, O O
particularly O O
in O O
the O O
right O O
leg, O O
over O O
the O O
last O O
year O O
since O O
her O O
husband O O
died, O O
which O O
has O O
all O O
the O O
typical O O
symptoms O O
and O O
is O O
relieved O O
by O O
rest. O O
This O O
seems O O
predominantly O O
in O O
the O O
right O O
calf O O
but O O
is O O
also O O
in O O
the O O
right O O
thigh O O
as O O
well. O O
She O O
had O O
segmental O O
leg O O
pressures O O
done O O
which O O
shows O O
some O O
mild O O
diminution O O
in O O
the O O
left O O
leg O O
but O O
an O O
ankle-brachial O O
index O O
of O O
0.65 O O
in O O
the O O
right O O
leg. O O
An O O
MR O O
angiogram O O
showed O O
stenosis, O O
although O O
I O O
do O O
not O O
have O O
the O O
full O O
report O O
on O O
this O O
as O O
yet. O O
She O O
has O O
intercurrent O O
problems O O
with O O
insulin-dependent B-DIABETES O
diabetes I-DIABETES O
mellitus, I-DIABETES O
which O O
she O O
has O O
had O O
for O O
10 O O
years. O O
Her O O
other O O
cardiac O O
risk O O
factors O O
apart O O
from O O
cigarette O O
smoking O O
include O O
a O O
family O O
history O O
of O O
myocardial O O
infarction O O
in O O
her O O
father, O O
and O O
it O O
is O O
uncertain O O
what O O
her O O
cholesterol O O
level O O
is. O O
She O O
has O O
no O O
history O O
of O O
hypertension, O O
although O O
I O O
am O O
uncertain O O
whether O O
this O O
has O O
been O O
checked O O
in O O
the O O
past. O O
She O O
has O O
a O O
past O O
history O O
of O O
partial O O
gastrectomy O O
in O O
2059 O O
for O O
a O O
bleeding O O
peptic O O
ulcer O O
and O O
this O O
has O O
led O O
to O O
some O O
difficulty O O
in O O
swallowing O O
tablets O O
and O O
keeping O O
them O O
down. O O
She O O
also O O
has O O
a O O
past O O
history O O
of O O
a O O
right O O
middle O O
lobectomy O O
in O O
2079 O O
for O O
adenocarcinoma O O
that O O
had O O
clear O O
margins O O
and O O
did O O
not O O
require O O
further O O
adjunctive O O
therapy. O O
She O O
also O O
had O O
a O O
cholecystectomy O O
in O O
2079, O O
which O O
was O O
uneventful. O O
Systems O O
review O O
reveal O O
no O O
chest O O
discomfort, O O
dyspnea, O O
ankle O O
edema, O O
palpitations, O O
syncope, O O
cough, O O
sputum, O O
hemoptysis, O O
GI O O
bleeding, O O
weakness O O
down O O
the O O
arms, O O
face, O O
or O O
legs, O O
seizures O O
or O O
visual O O
disturbances, O O
and O O
all O O
other O O
systems O O
are O O
negative. O O
She O O
lives O O
alone, O O
and O O
her O O
current O O
medications O O
include O O
insulin O O
only. O O
She O O
has O O
no O O
allergies. O O
On O O
physical O O
examination, O O
she O O
is O O
alert O O
and O O
orientated O O
without O O
any O O
signs O O
of O O
jaundice, O O
clubbing, O O
or O O
cyanosis. O O
Her O O
heart O O
rate O O
was O O
85 O O
beats O O
per O O
minute O O
with O O
a O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
of I-HYPERTENSION O
160/85 I-HYPERTENSION O
in O O
both O O
arms. O O
The O O
jugular O O
venous O O
pressure O O
was O O
not O O
elevated, O O
and O O
her O O
carotid O O
upstrokes O O
were O O
reduced, O O
but O O
she O O
had O O
no O O
bruits O O
audible. O O
Her O O
apex O O
beat O O
was O O
not O O
palpable, O O
and O O
she O O
had O O
a O O
normal O O
first O O
and O O
second O O
heart O O
sound O O
without O O
added O O
sounds, O O
murmurs, O O
or O O
gallops. O O
Her O O
chest O O
was O O
clear O O
to O O
percussion O O
and O O
auscultation. O O
She O O
had O O
no O O
hepatosplenomegaly O O
and O O
no O O
abdominal O O
masses O O
or O O
pulsations. O O
She O O
had O O
the O O
scars O O
from O O
previous O O
operations O O
present. O O
Her O O
femoral O O
pulses O O
were O O
absent O O
on O O
the O O
right O O
side O O
and O O
reduced O O
on O O
the O O
left O O
side O O
without O O
bruits. O O
She O O
had O O
reduced O O
but O O
palpable O O
dorsalis O O
pedis O O
and O O
posterior O O
tibial O O
pulses O O
on O O
the O O
left O O
leg O O
but O O
no O O
pedal O O
pulses O O
on O O
the O O
right O O
leg. O O
There O O
were O O
no O O
trophic O O
changes O O
in O O
her O O
legs. O O
She O O
had O O
reduced O O
sensation O O
to O O
pinprick O O
in O O
both O O
feet O O
to O O
the O O
mid O O
calf O O
level O O
in O O
a O O
stocking O O
distribution. O O
Her O O
ECG O O
showed O O
sinus O O
rhythm O O
without O O
abnormalities. O O
Assessment: O O
This O O
lady O O
obviously O O
has O O
severe O O
claudication O O
and O O
requires O O
revascularization, O O
but O O
is O O
uncertain O O
whether O O
she O O
has O O
any O O
myocardial O O
ischemia. O O
I O O
therefore O O
think O O
a O O
stress O O
test O O
is O O
required. O O
She O O
also O O
has O O
difficulty O O
in O O
swallowing O O
medications O O
and O O
this O O
will O O
prove O O
a O O
problem O O
for O O
the O O
long-term O O
management O O
of O O
her O O
atherosclerosis, O O
which O O
I O O
would O O
like O O
to O O
further O O
evaluate. O O
Plan: O O
I O O
therefore O O
organized O O
a O O
dobutamine O O
stress O O
test O O
to O O
assess O O
for O O
myocardial O O
ischemia O O
and O O
cardiovascular O O
risk. O O
I O O
have O O
also O O
asked O O
her O O
to O O
start B-MEDICATION O
on I-MEDICATION O
a I-MEDICATION O
small I-MEDICATION O
dose I-MEDICATION O
of I-MEDICATION O
a I-MEDICATION O
beta-blocker B-MEDICATION O
for O O
reducing O O
her O O
perioperative O O
risk O O
as O O
well O O
as O O
treating O O
her O O
blood O O
pressure, O O
which O O
is O O
elevated. O O
I O O
have O O
also O O
asked O O
her O O
to O O
have O O
a O O
fasting O O
blood O O
lipid O O
test O O
today O O
so O O
we O O
can O O
assess O O
her O O
cholesterol O O
level, O O
as O O
it O O
is O O
likely O O
that O O
she O O
would O O
benefit O O
from O O
lipid-lowering O O
therapy. O O
I O O
plan O O
to O O
evaluate O O
all O O
these O O
in O O
approximately O O
a O O
month O O
or O O
so O O
after O O
her O O
operation O O
so O O
that O O
we O O
can O O
manage O O
her O O
in O O
the O O
long O O
term. O O
I O O
will O O
let O O
you O O
know O O
the O O
results O O
of O O
her O O
stress O O
test O O
when O O
they O O
become O O
available. O O
Thank O O
you O O
for O O
allowing O O
me O O
to O O
take O O
part O O
in O O
this O O
lady's O O
care. O O
Yours O O
sincerely, O O
Dictated O O
By: O O
James O O
Patel O O
______________________________ O O
James O O
Patel, O O
MBBS, O O
PHD O O
eScription O O
document:8-6022994 O O
TFFocus O O
CC: O O
Rose O O
Samuel O O
Isaac-Ly O O
M.D. O O
Internal O O
Medicine O O
20 O O
Tamworth O O
Place O O
Galena, O O
MN O O
64864 O O
DD: O O
09/21/92 O O
DT: O O
09/21/92 O O
DV: O O
09/21/92 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2093-06-12 O O
Dutch O O
19 O O
Tamworth O O
Place O O
TRENT, O O
SHIRLEY O O
Galena, O O
MN O O
64864 O O
99210914 O O
(676) O O
312-7662 O O
06/12/93 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Ms. O O
Trent O O
is O O
69, O O
a O O
pleasant O O
lady O O
who O O
is O O
now O O
a O O
widow O O
well O O
known O O
to O O
me O O
for O O
her O O
insulin-dependent B-DIABETES O
diabetes I-DIABETES O
and O O
her O O
poor O O
compliance O O
with O O
treatment. O O
In O O
the O O
past, O O
she O O
also O O
has O O
experienced O O
upper O O
GI O O
bleeding O O
due O O
to O O
a O O
peptic O O
ulcer O O
and O O
has O O
undergone O O
cholecystectomy O O
as O O
well O O
as O O
lobectomy O O
for O O
carcinoma O O
of O O
the O O
lung. O O
CURRENT O O
MEDICATIONS: O O
Humulin B-MEDICATION O
N I-MEDICATION O
25 O O
units O O
in O O
the O O
morning. O O
She O O
is O O
supposed O O
to O O
be O O
using O O
28 O O
units O O
in O O
the O O
morning O O
and O O
8 O O
units O O
in O O
the O O
evening O O
depending O O
on O O
blood O O
sugars. O O
She O O
also O O
has O O
been O O
prescribed O O
an O O
ACE B-MEDICATION O
inhibitor I-MEDICATION O
and O O
a O O
beta B-MEDICATION O
blocker, I-MEDICATION O
which O O
she O O
has O O
neglected O O
to O O
take. O O
Her O O
last O O
visit O O
to O O
the O O
practice O O
was O O
in O O
September O O
of O O
last O O
year. O O
At O O
the O O
time O O
of O O
her O O
last O O
visit, O O
I O O
referred O O
to O O
vascular O O
surgery O O
because O O
of O O
claudication O O
of O O
the O O
right O O
leg. O O
She O O
underwent O O
a O O
femoral O O
public O O
TL O O
bypass O O
in O O
December O O
and O O
did O O
well O O
postoperatively. O O
She O O
was O O
discharged O O
on O O
simvastatin, B-HYPERLIPIDEMIA B-MEDICATION
Plavix, B-MEDICATION B-MEDICATION
as O O
well O O
as O O
atenolol B-MEDICATION B-MEDICATION
and O O
lisinopril. B-MEDICATION B-MEDICATION
She O O
abandoned O O
all O O
tablets O O
on O O
her O O
own O O
and O O
did O O
not O O
come O O
for O O
her O O
followup O O
appointment O O
with O O
us. O O
Today, O O
she O O
tells O O
me O O
that O O
claudication O O
in O O
the O O
right O O
leg O O
has O O
disappeared O O
completely O O
but O O
during O O
the O O
past O O
two O O
months, O O
she O O
has O O
begun O O
noticing O O
pain O O
in O O
the O O
left O O
leg O O
after O O
10-15 O O
minutes O O
of O O
walking O O
which O O
forces O O
her O O
to O O
stop. O O
An O O
arteriogram O O
carried O O
out O O
in O O
September O O
of O O
last O O
year O O
showed O O
mild O O
diffuse O O
disease O O
involving O O
the O O
left O O
common O O
iliac, O O
external O O
iliac, O O
and O O
common O O
femoral O O
arteries. O O
She O O
did O O
not O O
have O O
symptoms O O
on O O
the O O
left O O
side O O
at O O
the O O
time. O O
The O O
patient O O
denies O O
chest O O
pain, O O
palpitation, O O
shortness O O
of O O
breath, O O
orthopnea, O O
and O O
ankle O O
edema. O O
Prior O O
to O O
her O O
bypass O O
surgery O O
on O O
the O O
right O O
leg, O O
she O O
underwent O O
a O O
Persantine O O
MIBI O O
which O O
showed O O
only O O
1 O O
mm O O
ST O O
depressions O O
and O O
was O O
considered O O
not O O
diagnostic. O O
Ms. O O
Trent O O
has O O
experienced O O
some O O
polyuria O O
and O O
mild O O
polydipsia O O
and O O
has O O
two O O
times O O
nocturia. O O
She O O
denies O O
dysuria. O O
The O O
last O O
hemoglobin B-DIABETES O
A1c I-DIABETES O
was I-DIABETES O
8.4 I-DIABETES O
in O O
September O O
of O O
last O O
year. O O
At O O
that O O
time, O O
her O O
serum O O
cholesterol O O
was O O
238, O O
HDL O O
was O O
59, O O
and O O
triglycerides O O
were O O
263. O O
PHYSICAL O O
EXAMINATION: O O
Today, O O
she O O
is O O
pleasant O O
and O O
talkative. O O
Her O O
weight O O
is O O
127-1/2 O O
pounds, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
180/76, I-HYPERTENSION O
and O O
heart O O
rate O O
is O O
96. O O
Oxygen O O
saturation O O
100% O O
on O O
room O O
air. O O
Random O O
fingerstick O O
glucose O O
is O O
202. O O
Extraocular O O
movements O O
are O O
full. O O
The O O
thyroid O O
is O O
not O O
enlarged. O O
The O O
neck O O
veins O O
are O O
flat. O O
The O O
chest O O
is O O
clear O O
to O O
auscultation. O O
The O O
breasts O O
are O O
free O O
of O O
masses. O O
There O O
is O O
no O O
axillary O O
lymphadenopathy. O O
The O O
heart O O
sounds O O
are O O
regular. O O
There O O
are O O
no O O
rubs O O
or O O
gallops. O O
There O O
is O O
a O O
midline O O
abdominal O O
scar O O
which O O
corresponds O O
to O O
an O O
old O O
operation O O
for O O
peptic O O
ulcer. O O
There O O
is O O
also O O
a O O
right O O
upper O O
quadrant O O
cholecystectomy O O
scar O O
which O O
is O O
surrounded O O
by O O
a O O
mass, O O
which O O
has O O
been O O
present O O
in O O
the O O
past O O
that O O
probably O O
represents O O
fibrosis O O
under O O
the O O
scar. O O
No O O
other O O
masses O O
are O O
palpable. O O
The O O
lower O O
extremities O O
are O O
free O O
of O O
edema. O O
I O O
do O O
not O O
palpate O O
the O O
pulse O O
except O O
in O O
the O O
dorsalis O O
pedis O O
area O O
of O O
the O O
right O O
side, O O
but O O
there O O
are O O
no O O
trophic O O
changes O O
and O O
the O O
skin O O
is O O
warm O O
and O O
pink. O O
ASSESSMENT O O
AND O O
PLAN: O O
A O O
69-year-old O O
widow O O
lady O O
with O O
moderately O O
controlled O O
insulin-dependent O O
diabetes O O
and O O
hyperlipidemia. B-HYPERLIPIDEMIA B-HYPERTENSION
She O O
has O O
not O O
been O O
compliant O O
with O O
her O O
medications. O O
She O O
has O O
suffered O O
from O O
peripheral O O
vascular O O
disease O O
and O O
claudication O O
in O O
the O O
past O O
underwent O O
a O O
bypass O O
surgery O O
on O O
the O O
right O O
lower O O
extremity O O
in O O
October O O
of O O
last O O
year. O O
She O O
now O O
has O O
mild O O
symptoms O O
of O O
claudication O O
on O O
the O O
left. O O
She O O
continues O O
to O O
consume O O
three O O
or O O
four O O
beers B-SMOKER O
a O O
day. O O
The O O
relationship O O
to O O
her O O
vascular O O
atherosclerosis O O
is O O
not O O
clear. O O
Liver O O
function O O
in O O
the O O
past O O
has O O
been O O
normal O O
and O O
she O O
does O O
not O O
have O O
significant O O
proteinuria. O O
Today, O O
I O O
have O O
repeated O O
her O O
hemoglobin O O
A1c, O O
comprehensive O O
panel, O O
CBC, O O
and O O
urine O O
analysis. O O
I O O
have O O
spent O O
20 O O
minutes O O
speaking O O
to O O
her O O
and O O
to O O
her O O
daughter O O
concerning O O
the O O
importance O O
of O O
compliance O O
and O O
explaining O O
the O O
rationale O O
for O O
the O O
lisinopril. O B-MEDICATION
I O O
have O O
prescribed O O
Lipitor B-MEDICATION B-MEDICATION
10 O O
mg O O
p.o. O O
q.d., O O
lisinopril O B-MEDICATION
10 O O
mg O O
p.o. O O
q.d., O O
and O O
enteric-coated B-MEDICATION O
aspirin B-MEDICATION B-MEDICATION
81 I-MEDICATION O
mg I-MEDICATION O
p.o. O O
q.d. O O
She O O
is O O
also O O
to O O
take O O
a O O
multivitamin O O
q.d. O O
I O O
will O O
see O O
her O O
again O O
after O O
the O O
above O O
test O O
results O O
to O O
decide O O
whether O O
we O O
need O O
to O O
adjust O O
her O O
medications. O O
I O O
have O O
increased O O
her O O
insulin O O
to O O
28 O O
units O O
every O O
morning. O O
She O O
will O O
come O O
to O O
see O O
the O O
nurse O O
practitioner O O
in O O
three O O
days' O O
time O O
to O O
learn O O
how O O
to O O
use O O
a O O
glucometer O O
and O O
to O O
review O O
diabetes O O
care. O O
An O O
electrocardiogram O O
will O O
be O O
obtained O O
and O O
a O O
consultation O O
will O O
be O O
arranged O O
with O O
vascular O O
surgery O O
concerning O O
the O O
claudication O O
now O O
on O O
the O O
left O O
leg. O O
______________________________ O O
Rose O O
Irvin-Ly, O O
M.D. O O
Dictated O O
By: O O
Rose O O
Irvin-Ly O O
eScription O O
document:0-2524422 O O
EMSSten O O
Tel O O
DD: O O
06/12/93 O O
DT: O O
06/13/93 O O
DV: O O
06/12/93 O O

Record O O
date: O O
2093-11-24 O O
History O O
of O O
Present O O
Illness O O
Asked O O
by O O
Dr. O O
Trujillo O O
to O O
comment O O
on O O
diabetes B-DIABETES O
management O O
for O O
this O O
patient. O O
Hx O O
from O O
chart O O
as O O
pt O O
is O O
dutch O O
speaking O O
only. O O
Mrs. O O
Trent O O
is O O
a O O
pleasant O O
69 O O
y/o O O
woman O O
with O O
type B-DIABETES O
2 I-DIABETES O
DM I-DIABETES O
insulin I-DIABETES O
treated. I-DIABETES O
She O O
has O O
acknowledged O O
difficulty O O
following O O
her O O
regimen, O O
per O O
notes O O
should O O
be O O
taking O O
insulin O O
BID O O
but O O
only O O
takes O O
it O O
in O O
am O O
- O O
prescribed O O
dose O O
NPH B-MEDICATION O
30 I-MEDICATION O
in O O
am O O
and O O
8 O O
at O O
HS. O O
Reports O O
BG B-DIABETES O
at I-DIABETES O
home I-DIABETES O
near I-DIABETES O
150. I-DIABETES O
She O O
is O O
s/p O O
L O O
SFA O O
and O O
doing O O
well O O
from O O
that O O
standopoint, O O
however O O
developed O O
N&V O O
today O O
and O O
required O O
NG O O
tube O O
placement, O O
now O O
better O O
but O O
remaoins O O
NPO. O O
She O O
has O O
been O O
on O O
NPH O O
30 O O
in O O
am O O
and O O
BG's B-DIABETES O
have I-DIABETES O
been I-DIABETES O
126- I-DIABETES O
low I-DIABETES O
200's. I-DIABETES O
Past O O
Medical O O
History O O
Hypertension B-HYPERTENSION O
Hyperlipidemia B-HYPERLIPIDEMIA O
PVD O O
- O O
s/p O O
R O O
fem O O
pop O O
PUD O O
/ O O
GERD O O
kidney O O
stones O O
lung O O
cancer O O
- O O
lobectomy O O
Medications O O
Text O O
Significant O O
meds:zocor; B-MEDICATION O
lisinopril; B-MEDICATION B-MEDICATION
pspcid; O O
lopresor; B-MEDICATION B-MEDICATION
hydralazine; O O
pavix; B-MEDICATION O
reglan O O
currently O O
on O O
D5 O O
1/2NS O O
at O O
100 O O
ml/hr O O
Family O O
History O O
NC O O
Social O O
History O O
Smoking B-SMOKER O
none I-SMOKER O
EtOH O O
1-2 O O
beers O O
daily O O
Other O O
widowed O O
recently O O
Review O O
of O O
Systems O O
NA O O
Physical O O
Exam O O
VS O O
98.4; O O
126/58; O O
94% O O
sat O O
on O O
RA; O O
72 O O
General O O
Appearance O O
Well/ O O
post O O
op O O
HEENT O O
MM O O
moist, O O
sclera O O
anicteric O O
Neck O O
no O O
thyromgally, O O
trachea O O
midline O O
Chest O O
Resp O O
unlabored O O
Cor/Cardiac O O
RRR O O
Edema: O O
none O O
Abdomen O O
Soft O O
Extremity O O
Skin O O
intact, O O
no O O
deformity O O
Musc O O
Skel O O
Nl O O
build, O O
no O O
joint O O
deformity O O
Neurological O O
A/O O O
Sensory O O
exam: O O
diminished O O
to O O
touch O O
Skin O O
Intact O O
No O O
acanthosis O O
nigracans O O
Laboratory O O
Data O O
A1c: O O
pend O O
Creat: O O
0.7 O O
Assessment O O
Type B-DIABETES O
2 I-DIABETES O
DM I-DIABETES O
- O O
uncontrolled O O
in O O
the O O
post O O
operative O O
period O O
requring O O
IV B-MEDICATION O
insulin I-MEDICATION O
for O O
control. O O
Complicated O O
by O O
PVD, O O
neuropathy, O O
retinopathy O O
and O O
nephropathy. O O
Glycemic O O
control O O
in O O
the O O
post O O
operative O O
period O O
is O O
essential O O
to O O
good O O
wound O O
healing O O
and O O
minimizing O O
risk O O
of O O
infections. O O
Our O O
target O O
is O O
to O O
maintain O O
BG O O
under O O
150. O O
Recommendation O O
- O O
While O O
NPO O O
please O O
use O O
1/2 O O
day O O
time O O
NPH O O
but O O
her O O
usual O O
prescribed O O
bed O O
time O O
dose O O
- O O
for O O
now O O
15 O O
nph O O
in O O
am O O
and O O
8 O O
at O O
hs O O
- O O
Once O O
eating O O
can O O
resume O O
usual O O
doses, O O
may O O
need O O
addition O O
of O O
rapid O O
action O O
insulin O O
with O O
meals O O
as O O
well O O
Thank O O
you, O O
please O O
page O O
Internal O O
Medicine O O
42721 O O
with O O
any O O
questions. O O
Wendy O O
Kiefer O O
MD O O

Record O O
date: O O
2094-12-08 O O
Neurology O O
Resident O O
ED O O
Consult O O
Note O O
Patient O O
Name: O O
Trent, O O
Shirley O O
MRN: O O
99210914 O O
Date: O O
12/08/94 O O
PCP: O O
Dr. O O
Rose O O
Irvin-Ly O O
CC: O O
right O O
sided O O
weakness O O
HPI: O O
The O O
patient O O
is O O
a O O
70 O O
year-old O O
right-handed O O
Dutch-speaking O O
female O O
with O O
history O O
of O O
DM, B-DIABETES O
PVD O O
presenting O O
to O O
ED O O
with O O
right-sided O O
weakness O O
which O O
started O O
yesterday O O
morning. O O
The O O
patient's O O
grand-nephew O O
is O O
translating, O O
initially, O O
then O O
joined O O
by O O
Dutch O O
interpreter; O O
history O O
is O O
challenging O O
to O O
obtain. O O
The O O
patient O O
reports O O
that O O
since O O
she O O
awoke O O
in O O
the O O
AM O O
on O O
12/07/94, O O
she O O
noticed O O
that O O
her O O
RUE O O
and O O
RLE O O
was O O
weak O O
and O O
numb. O O
She O O
apparently O O
had O O
come O O
to O O
the O O
ED O O
about O O
2 O O
days O O
ago O O
for O O
RLE O O
numbness O O
and O O
pain O O
which O O
has O O
been O O
worsening O O
over O O
the O O
past O O
1-2 O O
months, O O
but O O
reportedly O O
had O O
good O O
strength O O
on O O
neurological O O
exam, O O
and O O
she O O
was O O
not O O
admitted. O O
She O O
was O O
given O O
a O O
2-day O O
course O O
of O O
Levaquin O O
for O O
UTI. O O
She O O
states O O
that O O
despite O O
the O O
pain O O
in O O
the O O
RLE O O
2 O O
days O O
ago, O O
she O O
was O O
able O O
to O O
move O O
her O O
RLE O O
whereas O O
since O O
yesterday O O
she O O
has O O
not O O
been O O
able O O
to O O
move O O
it O O
as O O
easily O O
or O O
bear O O
weight. O O
She O O
also O O
noted O O
that O O
her O O
RUE O O
was O O
weak, O O
and O O
she O O
was O O
unable O O
to O O
raise O O
it O O
very O O
far O O
off O O
the O O
bed. O O
She O O
was O O
unable O O
to O O
walk O O
independently O O
since O O
yesterday, O O
and O O
required O O
full O O
assistance O O
of O O
her O O
son O O
to O O
walk O O
to O O
the O O
bathroom. O O
She O O
has O O
had O O
no O O
facial O O
weakness. O O
She O O
has O O
never O O
had O O
weakness O O
of O O
this O O
kind O O
in O O
her O O
right O O
arm O O
or O O
leg, O O
but O O
had O O
similar O O
weakness O O
in O O
the O O
left O O
arm O O
and O O
leg O O
in O O
2089 O O
which O O
completely O O
resolved. O O
She O O
states O O
that O O
she O O
has O O
had O O
a O O
mild O O
right-sided O O
headache O O
since O O
yesterday O O
AM. O O
Since O O
this O O
morning, O O
she O O
has O O
had O O
nausea O O
and O O
vomiting O O
as O O
well O O
(did O O
not O O
have O O
this O O
yesterday), O O
and O O
has O O
not O O
had O O
any O O
fevers O O
or O O
chest O O
pain. O O
She O O
has O O
had O O
SOB O O
today. O O
She O O
reports O O
having O O
frequent O O
BLE O O
spasms, O O
usually O O
at O O
night, O O
and O O
her O O
legs O O
become O O
quite O O
restless. O O
ROS: O O
Gen: O O
No O O
fevers/chills/sweats, O O
CP, O O
palpitations, O O
N/V, O O
URI, O O
cough, O O
abd O O
pain, O O
dysuria, O O
melena, O O
BRBPR, O O
rash, O O
travel O O
Neurological: O O
Recent O O
RLE O O
pain O O
as O O
above. O O
No O O
recent O O
new O O
changes O O
in O O
memory, O O
vision, O O
hearing. O O
No O O
vertigo/dizziness, O O
no O O
bowel/bladder O O
incontinence. O O
No O O
swallowing O O
or O O
speech O O
problems. O O
No O O
h/o O O
seizures. O O
Possible O O
TIA O O
in O O
2089 O O
with O O
transient O O
left-sided O O
weakness, O O
CT O O
head O O
normal O O
per O O
PCP O O
note. O O
PAST O O
MEDICAL O O
HISTORY: O O
Diabetes B-DIABETES O
type I-DIABETES O
1 I-DIABETES O
Right O O
middle O O
lobectomy O O
on O O
Jun O O
07, O O
2079 O O
for O O
T1N0M0 O O
papillary O O
adenocarcinoma. O O
Peptic O O
ulcer O O
with O O
bleeding O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Peripheral O O
vascular O O
disease O O
R O O
LE O O
bypass O O
surgery O O
about O O
2 O O
years O O
ago O O
LLE O O
bypass O O
surgery O O
about O O
1 O O
year O O
ago. O O
Left O O
LE O O
claudication O O
Recent O O
pain/numbness O O
in O O
RLE O O
with O O
shooting O O
pain O O
from O O
buttocks O O
to O O
calf' O O
? O O
TIA O O
in O O
2089 O O
MEDICATIONS O O
Insulin B-MEDICATION B-MEDICATION
Lispro I-MEDICATION B-MEDICATION
Insulin B-MEDICATION B-MEDICATION
NPH I-MEDICATION B-MEDICATION
(or I-MEDICATION O
Humulin I-MEDICATION B-MEDICATION
N?) I-MEDICATION O
Atorvastatin B-MEDICATION B-MEDICATION
10 O O
PO O O
QD O O
Lisinopril B-MEDICATION B-MEDICATION
20 O O
PO O O
QD O O
EC B-MEDICATION O
Aspirin B-MEDICATION B-MEDICATION
81 O O
PO O O
QD O O
ALLERGIES: O O
NKDA O O
SOCIAL O O
HISTORY: O O
From O O
Suriname, O O
recently O O
spent O O
time O O
there O O
until O O
5/94. O O
Widowed, O O
lives O O
with O O
son. O O
Per O O
LMR, O O
no B-SMOKER O
smoking, I-SMOKER O
1-2 O O
beers/day. O O
EXAM O O
VS: O O
T O O
97.5 O O
HR O O
106 O O
BP O O
186/72 B-HYPERTENSION O
RR O O
18 O O
Sat O O
90 O O
% O O
on O O
RA O O
PE: O O
General O O
Uncomfortable, O O
vomiting O O
HEENT O O
AT/NC, O O
MMM O O
no O O
lesions O O
Neck O O
Supple, O O
no O O
bruits O O
Chest O O
CTA O O
B O O
CVS O O
Tachycardic, O O
regular O O
ABD O O
soft, O O
NTND, O O
+ O O
BS O O
EXT O O
no O O
C/C/E O O
NEUROLOGICAL O O
MS: O O
General: O O
alert, O O
feeling O O
ill/nauseous O O
Orientation: O O
states O O
January O O
2082 O O
Attention: O O
fair-months O O
of O O
year O O
forward O O
only, O O
skipping O O
one O O
Speech/Lang: O O
fluent O O
w/o O O
paraphasic O O
errors; O O
simple O O
and O O
complex O O
command-following O O
w/o O O
L/R O O
confusion. O O
Repetition, O O
naming O O
intact O O
(via O O
Suriname O O
interpreter) O O
Praxis: O O
Mimics O O
brushing O O
hair O O
with O O
both O O
hands. O O
CN: O O
II,III: O O
VF O O
difficult O O
to O O
test O O
due O O
to O O
pt O O
cooperation, O O
appears O O
to O O
blink O O
to O O
threat O O
on O O
both O O
sides., O O
pupils O O
3 O O
2 O O
mm O O
bilaterally O O
to O O
light, O O
could O O
not O O
visualize O O
optic O O
disc O O
due O O
to O O
pt O O
cooperation. O O
III,IV,V: O O
EOM O O
appear O O
intact, O O
does O O
not O O
maintain O O
upward O O
gaze, O O
no O O
nystagmus O O
noted, O O
no O O
gaze O O
preference O O
V: O O
sensation O O
intact O O
to O O
LT/temp O O
VII: O O
Facial O O
strength O O
intact O O
VIII: O O
hears O O
finger O O
rub O O
bilaterally O O
IX,X: O O
voice O O
normal, O O
palate O O
elevates O O
symmetrically O O
XI: O O
SCM/trapezeii O O
5/5 O O
bilaterally O O
XII: O O
tongue O O
protrudes O O
midline O O
without O O
atrophy O O
or O O
fasciculation O O
Motor: O O
Normal O O
bulk O O
and O O
tone; O O
no O O
tremor, O O
rigidity, O O
or O O
bradykinesia. O O
Unable O O
to O O
cooperate O O
to O O
test O O
drift, O O
but O O
appears O O
to O O
have O O
some O O
difficulty O O
raising O O
right O O
arm. O O
When O O
right O O
arm O O
was O O
passively O O
raised O O
by O O
examiner, O O
pt O O
was O O
able O O
to O O
maintain O O
posture O O
for O O
several O O
seconds O O
without O O
drift O O
or O O
tremor. O O
Moves O O
LUE O O
with O O
ease O O
for O O
overhead O O
movements; O O
difficult O O
to O O
test O O
against O O
resistance O O
due O O
to O O
pt O O
cooperation/understanding O O
of O O
task. O O
Unable O O
to O O
elevate O O
RLE O O
off O O
bed; O O
elevates O O
LLE O O
only O O
slightly O O
off O O
bed. O O
Reflex: O O
Pt O O
holding O O
extremities O O
tensely, O O
unable O O
to O O
relax; O O
appears O O
to O O
have O O
1+ O O
for O O
BUEs, O O
unable O O
to O O
elicit O O
patellar O O
or O O
ankle O O
jerks. O O
Toe O O
appears O O
to O O
be O O
upgoing O O
bilaterally O O
but O O
difficult O O
exam. O O
Sensation: O O
Inconsistent O O
responses O O
for O O
BUE O O
and O O
BLE. O O
Subjectively O O
decreased O O
to O O
LT O O
on O O
the O O
RLE. O O
Coordination: O O
manipulating O O
objects O O
without O O
dysmetria O O
LUE, O O
less O O
movement O O
of O O
the O O
RUE. O O
Gait: O O
unable O O
to O O
test O O
at O O
this O O
time O O
due O O
to O O
pt O O
feeling O O
ill. O O
LAB: O O
12/08/94 O O
12:06 O O
NA O O
136 O O
K O O
3.5(#) O O
CL O O
99 O O
CO2 O O
25 O O
BUN O O
15 O O
CRE O O
1.0 O O
EGFR O O
58(T) O O
GLU B-DIABETES O
313(*) I-DIABETES O
ANION O O
12 O O
CA O O
9.2 O O
TP O O
8.0 O O
ALB O O
4.4 O O
GLOB O O
3.6 O O
ALT/SGPT O O
16 O O
AST/SGOT O O
19 O O
ALKP O O
106 O O
TBILI O O
0.6 O O
CK O O
PEND O O
CK-MB O O
3.1 O O
TROP-I O O
&lt; O O
0.1 O O
WBC O O
12.55(*) O O
HGB O O
10.4(*) O O
HCT O O
35.2(*) O O
MCV O O
69.3(*#T) O O
PLT O O
458(*) O O
RDW O O
16.6(*#) O O
PT O O
13.1 O O
PT-INR O O
1.0 O O
PTT O O
25.3(#) O O
IMAGING: O O
CT O O
head O O
without O O
contrast O O
12/08/94: O O
Prelim: O O
Mulitple O O
regions O O
of O O
hypodensity O O
in O O
the O O
subcortical O O
white O O
matter O O
bilaterally, O O
and O O
in O O
bilateral O O
capsulothalamic O O
regions O O
as O O
well O O
as O O
the O O
left O O
caudate/periventricular O O
region. O O
MRI/MRA O O
head O O
and O O
neck: O O
Not O O
yet O O
completed. O O
Recent O O
MRI O O
of O O
L-spine O O
11/24/94: O O
The O O
vertebral O O
bodies, O O
posterior O O
elements, O O
and O O
alignment O O
are O O
intact. O O
Very O O
prominent O O
facet O O
degeneration O O
is O O
seen O O
on O O
the O O
right O O
at O O
L5-S1, O O
and O O
less O O
prominently O O
elsewhere. O O
There O O
is O O
straightening O O
of O O
the O O
lumbar O O
spine. O O
T12-L1, O O
L1-L2, O O
L2-L3, O O
L3-L4: O O
Normal O O
caliber O O
canal O O
and O O
foramina. O O
L4-L5: O O
Mild O O
broadbased O O
bulge O O
and O O
facet O O
hypertrophy O O
is O O
not O O
associated O O
with O O
significant O O
stenosis. O O
L5-S1: O O
Prominent O O
facet O O
hypertrophy O O
as O O
described O O
with O O
ligamentum O O
hypertrophy O O
and O O
broadbased O O
disk O O
protrusion O O
mildly O O
narrows O O
the O O
central O O
canal O O
and O O
mildly O O
narrows O O
each O O
foramen. O O
There O O
is O O
narrowing O O
of O O
the O O
lateral O O
recesses O O
on O O
each O O
side, O O
and O O
may O O
be O O
impingement O O
of O O
the O O
traversing O O
S1 O O
nerve O O
roots, O O
more O O
prominent O O
on O O
the O O
right, O O
as O O
seen O O
in O O
images O O
17 O O
and O O
18 O O
of O O
the O O
axial O O
sequence. O O
Old O O
CT O O
brain O O
6/16/89: O O
Mildly O O
prominent O O
ventricles O O
and O O
subarachnoid O O
spaces O O
are O O
not O O
uncommon O O
for O O
a O O
patient O O
of O O
this O O
age. O O
There O O
are O O
no O O
regions O O
of O O
hypoattenuation O O
within O O
the O O
brain O O
to O O
suggest O O
a O O
prior O O
infarction. O O
Basal O O
ganglia O O
and O O
basis O O
pontis O O
appear O O
normal O O
without O O
evidence O O
of O O
lacunar O O
infarction. O O
No O O
significant O O
periventricular O O
white O O
matter O O
changes O O
are O O
evident. O O
_______________________________________________________________ O O
IMPRESSION: O O
70 O O
year-old O O
right-handed O O
female O O
with O O
h/o O O
DM, O O
PVD O O
presenting O O
to O O
ED O O
for O O
RUE O O
and O O
RLE O O
numbness O O
and O O
weakness, O O
onset O O
12/07/94 O O
AM. O O
She O O
has O O
had O O
numbness/tingling O O
and O O
shooting O O
pain O O
in O O
the O O
RLE O O
for O O
the O O
past O O
1-2 O O
months O O
likely O O
due O O
to O O
disease O O
in O O
the O O
lumbar O O
spine O O
seen O O
on O O
MRI O O
(L5-S1). O O
She O O
states O O
that O O
the O O
current O O
weakness O O
in O O
the O O
RLE O O
is O O
new, O O
as O O
is O O
the O O
weakness O O
in O O
the O O
RUE. O O
Additionally, O O
she O O
has O O
new O O
nausea/vomiting O O
and O O
SOB O O
since O O
this O O
AM. O O
While O O
in O O
the O O
ED, O O
following O O
her O O
CT O O
scans, O O
she O O
was O O
tachycardic O O
to O O
the O O
150s O O
and O O
hypertensive B-HYPERTENSION O
to I-HYPERTENSION O
the I-HYPERTENSION O
230s I-HYPERTENSION O
systolic. I-HYPERTENSION O
She O O
had O O
persistent O O
nausea O O
and O O
vomiting. O O
Her O O
neurological O O
exam O O
was O O
difficult O O
with O O
inconsistent O O
findings. O O
She O O
appears O O
to O O
have O O
decreased O O
spontaneous O O
movement O O
of O O
the O O
RUE, O O
but O O
when O O
passively O O
moved O O
into O O
shoulder O O
flexion O O
she O O
was O O
able O O
to O O
hold O O
the O O
position O O
against O O
gravity O O
for O O
several O O
seconds. O O
Her O O
RLE O O
symptoms O O
are O O
likely O O
confounded O O
by O O
her O O
lumbar O O
spine O O
disease O O
at O O
L5/S1 O O
as O O
noted O O
above. O O
She O O
is O O
hyperglycemic B-DIABETES O
(serum I-DIABETES O
glucose I-DIABETES O
313), I-DIABETES O
has O O
a O O
mild O O
leukocytosis, O O
is O O
iron O O
deficient, O O
and O O
has O O
new O O
onset O O
today O O
of O O
fairly O O
severe O O
nausea/vomiting O O
and O O
SOB O O
of O O
unclear O O
etiology. O O
She O O
appears O O
to O O
have O O
vasculopathic O O
changes/lacunes O O
in O O
the O O
brain O O
seen O O
as O O
hypodensities O O
on O O
the O O
CT O O
today, O O
all O O
appearing O O
old. O O
She O O
does O O
not O O
have O O
any O O
right O O
facial O O
weakness, O O
no O O
dysarthria, O O
no O O
aphasia, O O
no O O
flaccidity/spasticity, O O
no O O
gaze O O
preference. O O
While O O
stroke O O
can O O
not O O
be O O
ruled O O
out, O O
her O O
exam O O
does O O
not O O
clearly O O
suggest O O
a O O
typical O O
stroke O O
syndrome. O O
Ddx O O
includes O O
seizure, O O
infection O O
or O O
metabolic O O
abnormality O O
causing O O
unmasking O O
of O O
stroke-like O O
symptoms, O O
migraine O O
phenomena O O
superimposed O O
on O O
current O O
medical/metabolic O O
abnormalities. O O
RECOMMENDATIONS: O O
1. O O
MRI/MRA O O
of O O
the O O
head O O
and O O
neck O O
(stroke O O
protocol), O O
as O O
well O O
as O O
MRI O O
of O O
C-spine O O
given O O
UE O O
symptoms O O
2. O O
We O O
currently O O
recommend O O
admission O O
to O O
medicine O O
given O O
multiple O O
medical O O
issues O O
(severe O O
HTN, B-HYPERTENSION O
SOB O O
as O O
yet O O
unexplained, O O
N/V, O O
hyperglycemia). O O
3. O O
BP O O
control: O O
Labetolol B-MEDICATION B-MEDICATION
to O O
maintain O O
BP O O
less O O
than O O
200 O O
systolic; O O
avoid O O
large/rapid O O
shifts O O
to O O
maintain O O
cerebral O O
perfusion O O
pressure. O O
Would O O
allow O O
some O O
degree O O
of O O
hypertension B-HYPERTENSION O
(max O O
200 O O
SBP) O O
until O O
stroke O O
protocol O O
MRI/MRA O O
obtained. O O
4. O O
Glycemic O O
control-need O O
to O O
clarify O O
home O O
insulin O O
regimen O O
5. O O
Resend O O
cardiac O O
markers O O
in O O
setting O O
of O O
tachycardia O O
to O O
150s O O
6. O O
F/u O O
PE O O
protocol O O
CT O O
(done O O
in O O
ED). O O
7. O O
Patient O O
will O O
be O O
followed O O
by O O
the O O
Neurology O O
consult O O
service. O O
This O O
case O O
was O O
discussed O O
with O O
Dr. O O
James O O
Rosado O O
MD, O O
senior O O
Neurology O O
resident. O O
________________________________ O O
Alex O O
Waters, O O
MD O O
Resident O O
in O O
Neurology O O
Pager O O
#45445 O O

Record O O
date: O O
2096-02-22 O O
RE: O O
TRENT, O O
SHIRLEY O O
LCC O O
#99210914 O O
02/22/2096 O O
Xitlalic O O
Pearson, O O
M.D. O O
Martha O O
Washington O O
Hospital O O
617 O O
Comanche O O
Street O O
Milbank, O O
MN O O
49757 O O
Dear O O
Dr. O O
Pearson: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
Mrs. O O
Shirley O O
Trent O O
in O O
follow O O
up O O
this O O
morning. O O
Mrs. O O
Trent O O
is O O
a O O
71 O O
year-old O O
right-handed O O
woman O O
with O O
a O O
history O O
of O O
a O O
left O O
corona O O
radiata O O
stroke O O
in O O
December O O
2094 O O
complicated O O
by O O
a O O
dense O O
right O O
hemiparesis. O O
She O O
presented O O
today O O
with O O
her O O
granddaughter, O O
Ms. O O
Carey O O
Trent. O O
Ms. O O
Trent O O
translated O O
and O O
provided O O
supplemental O O
interval O O
history. O O
Interval O O
History O O
Mrs. O O
Trent O O
moved O O
to O O
the O O
Eddie O O
Bauer O O
Nursing O O
home O O
approximately O O
one O O
month O O
ago. O O
She O O
has O O
continued O O
to O O
have O O
a O O
dense O O
paresis O O
of O O
the O O
right O O
arm O O
and O O
leg, O O
which O O
has O O
confined O O
her O O
to O O
a O O
wheelchair. O O
She O O
has O O
had O O
spasticity, O O
in O O
particular O O
of O O
the O O
right O O
leg, O O
that O O
has O O
been O O
painful O O
at O O
times O O
and O O
has O O
contributed O O
to O O
sleeping O O
difficulties. O O
Baclofen O O
was O O
initiated O O
and O O
titrated O O
to O O
20 O O
mg O O
TID, O O
with O O
some O O
efficacy. O O
According O O
to O O
Carey, O O
another O O
medication O O
may O O
have O O
been O O
used O O
around O O
the O O
turn O O
of O O
the O O
year. O O
Gabapentin O O
was O O
initiated O O
at O O
a O O
dose O O
of O O
100 O O
mg O O
HS O O
on O O
2/10/96. O O
Mrs. O O
Trent O O
related O O
that O O
she O O
has O O
had O O
a O O
depressed O O
mood O O
in O O
recent O O
months. O O
A O O
son O O
with O O
whom O O
she O O
was O O
close O O
died O O
in O O
August O O
of O O
last O O
year O O
from O O
complications O O
following O O
an O O
admission O O
to O O
the O O
hospital O O
with O O
asthma. O O
This O O
was O O
extremely O O
difficult O O
for O O
Mrs. O O
Trent. O O
She O O
has O O
felt O O
'alone,' O O
but O O
has O O
enjoyed O O
visits O O
to O O
the O O
nursing O O
home O O
from O O
Carey O O
and O O
from O O
Carey's O O
aunt, O O
one O O
of O O
Mrs. O O
Trent's O O
daughters. O O
Her O O
other O O
children O O
have O O
not O O
maintained O O
close O O
contact. O O
Mrs. O O
Trent O O
had O O
increased O O
weakness O O
and O O
slurring O O
of O O
her O O
speech O O
in O O
early O O
February, O O
which O O
may O O
have O O
been O O
related O O
to O O
a O O
urinary O O
tract O O
infection O O
or O O
sedating O O
medication O O
used O O
at O O
that O O
time. O O
Aside O O
from O O
that O O
episode, O O
Mrs. O O
Trent O O
reported O O
no O O
episodes O O
of O O
weakness, O O
numbness, O O
clumsiness, O O
visual O O
changes, O O
slurred O O
speech, O O
dizziness, O O
language O O
difficulties, O O
or O O
other O O
neurological O O
symptoms O O
concerning O O
for O O
stroke O O
since O O
her O O
stroke O O
in O O
December O O
2094. O O
Past O O
Medical O O
History O O
type B-DIABETES O
2 I-DIABETES O
diabetes I-DIABETES O
mellitus I-DIABETES O
requiring I-DIABETES O
insulin I-DIABETES O
h/o O O
peptic O O
ulcer O O
disease O O
with O O
GI O O
bleeding O O
hyperlipidemia B-HYPERLIPIDEMIA O
peripheral O O
arterial O O
disease, O O
bypass O O
surgery O O
on O O
the O O
right O O
leg, O O
mild O O
symptoms O O
of O O
claudication O O
on O O
the O O
left O O
left O O
internal O O
carotid O O
artery O O
stenosis O O
Medications O O
(confirmed) O O
Baclofen O O
20 O O
MG O O
(10MG O O
TABLET O O
take O O
2) O O
PO O O
TID O O
Clopidogrel B-MEDICATION O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Gabapentin O B-MEDICATION
100 O O
MG O O
(100MG O O
CAPSULE O O
take O O
1) O O
PO O O
QHS O O
Metoclopramide O B-MEDICATION
HCL O O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
AC O O
Mirtazapine O B-MEDICATION
30 O O
MG O O
(30MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Multivitamin O O
WITH O O
FOLIC O O
ACID O O
(MULTIVITAMINS) O O
1 O O
TAB O O
PO O O
QD O O
x O O
60 O O
days O O
Novolog B-MEDICATION B-MEDICATION
(INSULIN I-MEDICATION O
ASPART) I-MEDICATION B-MEDICATION
SC O O
QAM, O O
QPM O O
and O O
SS O O
Omeprazole O O
20 O O
MG O O
(20MG O O
CAPSULE O O
DR O O
take O O
1) O O
PO O O
QD O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
(METOPROLOL I-MEDICATION O
SUCCINATE I-MEDICATION O
EXTENDED I-MEDICATION O
RELEASE) I-MEDICATION O
100 O O
MG O O
(100MG O O
TAB.SR O O
24H O O
take O O
1) O O
PO O O
QD O O
Allergies O O
NKA O O
Social O O
History O O
Mrs. O O
Trent O O
is O O
originally O O
from O O
Suriname. O O
She O O
is O O
widowed, O O
with O O
six O O
living O O
children. O O
A O O
son O O
died O O
at O O
age O O
42 O O
in O O
August, O O
2095. O O
Mrs. O O
Trent O O
has O O
a O O
remote B-SMOKER O
history I-SMOKER O
of I-SMOKER O
smoking. I-SMOKER O
She O O
does O O
not O O
consume O O
alcohol. O O
She O O
has O O
recently O O
spent O O
much O O
of O O
her O O
time O O
watching O O
television O O
(like O O
soap O O
operas O O
in O O
Dutch) O O
and O O
participating O O
in O O
group O O
activities O O
(such O O
as O O
Bingo) O O
at O O
the O O
home. O O
Review O O
of O O
Systems O O
Negative O O
for O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
visual O O
changes, O O
weakness, O O
numbness, O O
burning O O
pain, O O
paresthesias, O O
difficulties O O
speaking O O
or O O
understanding O O
others, O O
nausea, O O
vomiting, O O
diarrhea, O O
pain O O
or O O
burning O O
on O O
urination. O O
Positive O O
for O O
frequent O O
nighttime O O
awakening. O O
Appetite O O
has O O
been O O
'o.k.' O O
Exam O O
Blood O O
Pressure O O
128/58 O O
Heart O O
Rate O O
76 O O
Neck: O O
no O O
carotid O O
bruits O O
Lungs: O O
CTA O O
bilaterally O O
Heart: O O
regular O O
rate O O
and O O
rhythm, O O
II/VI O O
systolic O O
ejection O O
murmur O O
ABD: O O
soft, O O
nontender, O O
nondistended, O O
bowel O O
sounds O O
present O O
EXT: O O
no O O
edema O O
MS: O O
alert, O O
pleasant, O O
cooperative, O O
good O O
eye O O
contact. O O
Fatigued, O O
mildly O O
depressed O O
looking O O
affect. O O
Oriented O O
to O O
'LCC' O O
in O O
'Galena,' O O
'March O O
2095.' O O
Speech O O
fluent O O
in O O
Dutch. O O
Followed O O
2-step O O
verbal O O
commands O O
with O O
left O O
hand. O O
Recalled O O
recent O O
events O O
from O O
soap O O
opera O O
episodes O O
in O O
detail. O O
CN: O O
pupils O O
4mm, O O
round, O O
LR O O
to O O
2mm. O O
EOMI. O O
Mild O O
right O O
UMN O O
facial O O
weakness. O O
Palate O O
elevation O O
symmetrical O O
and O O
tongue O O
protrusion O O
midline. O O
MOTOR: O O
increased O O
tone O O
with O O
clasp O O
knife O O
phenomenon O O
right O O
arm O O
and O O
leg. O O
Minimal O O
movement O O
of O O
right O O
arm O O
(elbow O O
flexion, O O
index O O
finger O O
extension, O O
finger O O
flexion) O O
and O O
right O O
foot O O
(knee O O
flexion, O O
ankle O O
flexion, O O
toe O O
extension). O O
5/5 O O
strength O O
in O O
proximal O O
and O O
distal O O
muscles O O
of O O
the O O
left O O
arm O O
and O O
leg. O O
SENSORY: O O
reduced O O
sensation O O
to O O
temperature O O
and O O
vibration O O
right O O
arm O O
and O O
leg O O
relative O O
to O O
the O O
left. O O
DTRs: O O
3 O O
in O O
the O O
right O O
biceps, O O
BR, O O
triceps, O O
2 O O
on O O
the O O
left. O O
Trace O O
patellar O O
and O O
ankle O O
reflexes O O
bilaterally. O O
Right O O
plantar O O
response O O
extensor, O O
left O O
flexor. O O
CEREB: O O
no O O
dysmetria O O
left O O
finger O O
nose O O
finger. O O
MRI O O
brain O O
12/10/94: O O
small-to-medium O O
sized O O
stroke O O
in O O
the O O
left O O
corona O O
radiata O O
CTA O O
head O O
and O O
neck O O
12/11/94: O O
dense O O
calcification O O
at O O
the O O
carotid O O
bifurcation, O O
precluding O O
a O O
legitimate O O
interpretation. O O
CNIS O O
12/14/94: O O
demonstrated O O
25 O O
to O O
49% O O
stenosis O O
in O O
the O O
proximal O O
left O O
ICA; O O
velocity O O
of O O
143 O O
in O O
the O O
proximal O O
ICA O O
versus O O
50 O O
in O O
the O O
distal O O
CCA O O
suggests O O
a O O
possible O O
moderate O O
(50-70%) O O
stenosis O O
of O O
the O O
vessel O O
Echocardiogram O O
(transthoracic) O O
12/14/94: O O
estimated O O
EF O O
of O O
55 O O
to O O
60%, O O
no O O
regional O O
wall O O
motion O O
abnormalities, O O
mild O O
left O O
atrial O O
enlargement, O O
and O O
no O O
other O O
significant O O
abnormalities. O O
Impression O O
Mrs. O O
Shirley O O
Trent O O
is O O
a O O
71 O O
year-old O O
right-handed O O
woman O O
who O O
had O O
a O O
stroke O O
in O O
the O O
left O O
corona O O
radiata O O
in O O
December O O
2094. O O
Her O O
stroke O O
risk O O
factors O O
include O O
history O O
of O O
diabetes O O
mellitus, O O
dyslipidemia, B-HYPERLIPIDEMIA O
peripheral O O
arterial O O
disease, O O
and O O
left O O
carotid O O
stenosis O O
with O O
a O O
calcified O O
plaque. O O
She O O
has O O
not O O
had O O
any O O
clinical O O
events O O
suggestive O O
of O O
stroke O O
in O O
the O O
interim O O
between O O
11/94 O O
and O O
now. O O
Mrs. O O
Trent's O O
current O O
neurological O O
and O O
psychiatric O O
problems O O
include O O
spasticity O O
of O O
the O O
right O O
arm O O
and O O
leg O O
and O O
depression. O O
Plan O O
1. O O
We O O
will O O
obtain O O
repeat O O
carotid O O
studies O O
to O O
assess O O
for O O
interval O O
progression O O
of O O
the O O
left O O
carotid O O
stenosis. O O
2. O O
We O O
recommend O O
continued O O
management O O
of O O
vascular O O
risk O O
factors, O O
with O O
(1) O O
target O O
BP O O
120/80 O O
or O O
less, O O
(2) O O
target O O
LDL O O
&lt; O O
100, O O
(3) O O
continued O O
glycemic O O
control. O O
Continue O O
clopidogrel B-MEDICATION O
as O O
an O O
antiplatelet O O
agent. O O
3. O O
Regarding O O
the O O
spasticity, O O
it O O
is O O
reasonable O O
to O O
utilize O O
a O O
higher O O
evening O O
dose O O
of O O
gabapentin O O
and O O
assess O O
the O O
efficacy. O O
Other O O
potential O O
agents O O
to O O
consider O O
for O O
future O O
use O O
include O O
cyclobenzaprine, O O
tizanidine, O O
and O O
trihexyphenidyl. O O
I O O
will O O
continue O O
to O O
follow O O
and O O
would O O
be O O
happy O O
to O O
discuss O O
this O O
management O O
with O O
you O O
at O O
any O O
time. O O
4. O O
I O O
agree O O
with O O
mirtazapine O B-MEDICATION
for O O
antidepressant O O
therapy O O
given O O
Mrs. O O
Trent's O O
poor O O
appetite O O
and O O
impaired O O
sleep. O O
After O O
her O O
gabapentin O O
has O O
been O O
appropriately O O
titrated, O O
one O O
may O O
consider O O
increasing O O
mirtazapine O B-MEDICATION
to O O
45 O O
mg O O
HS. O O
5. O O
Mrs. O O
Trent O O
will O O
be O O
scheduled O O
for O O
follow O O
up O O
in O O
approximately O O
6 O O
months. O O
It O O
is O O
a O O
pleasure O O
to O O
participate O O
in O O
the O O
care O O
of O O
Mrs. O O
Trent O O
with O O
you. O O
Greater O O
than O O
50% O O
of O O
this O O
60 O O
minute O O
follow O O
up O O
visit O O
was O O
spent O O
counseling O O
regarding O O
the O O
above O O
issues. O O
Please O O
do O O
not O O
hesitate O O
to O O
contact O O
me O O
with O O
questions. O O
Sincerely, O O
______________________________ O O
James O O
Rosado, O O
M.D. O O
Neurology O O
Lenox O O
Care O O
Center O O
cc: O O
Ms. O O
Carey O O
Trent O O
45 O O
Hoyts O O
Lane, O O
Qpt. O O
0 O O
Galena, O O
MN O O
64864 O O

Record O O
date: O O
2121-03-31 O O
Kern O O
Medical O O
Center O O
Preadmission O O
Testing O O
Area O O
Department O O
of O O
Internal O O
Medicine O O
Preanesthetic O O
Assessment O O
Tina O O
L. O O
Purcell, O O
M.D. O O
Associate O O
Medical O O
Director O O
March O O
31, O O
2121 O O
Medical O O
Record O O
Number: O O
4698877 O O
Isabella O O
T. O O
Valle O O
Procedure: O O
The O O
patient O O
is O O
a O O
53 O O
year O O
old O O
female O O
scheduled O O
for O O
parathyroidectomy. O O
Surgery O O
is O O
scheduled O O
on O O
4/03/21. O O
Chief O O
Complaint O O
& O O
Present O O
Illness: O O
hyperparathyroidism-parathormone O O
level O O
&gt; O O
900-resulting O O
in O O
spontaneous O O
fractures. O O
Patient O O
had O O
previous O O
semi O O
total O O
parathyroidectomy O O
in O O
2112. O O
Past O O
Surgical O O
History: O O
Prior O O
surgery O O
includes: O O
' O O
09 O O
TAH-BSO;' O O
10 O O
parathyroidectomy;' O O
13 O O
renal O O
transplant O O
recipient; O O
'18 O O
left O O
nephrectomy-easy O O
mask O O
and O O
intubation; O O
ventral O O
hernia O O
repair; O O
AV O O
fistulas O O
x2-general O O
anesthesia O O
without O O
any O O
known O O
problems O O
Family O O
History: O O
There O O
is O O
no O O
family O O
history O O
of O O
adverse O O
reactions O O
to O O
general O O
anesthesia. O O
Medications: O O
Neoral, O O
Lasix O O
40 O O
mg, O O
Norvasc B-MEDICATION B-MEDICATION
5 O O
mg O O
b.i.d., O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
mg O O
b.i.d., O O
Cellcept O O
50 O O
mg O O
q.i.d., O O
Bactrim, O O
Estrotab, O O
prednisone O O
10 O O
mg, O O
Epogen, O O
iron, O O
insulin B-MEDICATION O
NPH B-MEDICATION B-MEDICATION
45 O O
units O O
plus O O
regular B-MEDICATION O
10 O O
units O O
in O O
a.m. O O
Allergies: O O
none O O
Social O O
History: O O
Smoking: B-SMOKER O
none I-SMOKER O
Alcohol O O
use: O O
rare O O
Substance O O
Abuse: O O
none O O
Allergen O O
Exposure O O
within O O
3 O O
Months(blood O O
products/pregnancy): O O
none O O
Review O O
of O O
Systems: O O
HEENT: O O
negative O O
Cardiovascular: O O
hypertension; B-HYPERTENSION O
patient O O
usually O O
walks O O
one O O
mile O O
per O O
day O O
and O O
climbs O O
one O O
flight O O
of O O
stairs O O
without O O
any O O
angina O O
or O O
shortness O O
of O O
breath O O
Respiratory: O O
negative O O
Renal: O O
polycystic O O
renal O O
disease O O
diagnosed O O
15 O O
years O O
ago O O
resulting O O
in O O
renal O O
transplant O O
2/13 O O
and O O
now O O
renal O O
failure O O
with O O
elevated O O
creatinine O O
5.3-no O O
dialysis O O
at O O
present O O
Hepatobiliary: O O
negative O O
Neurological: O O
negative O O
Gastrointestinal: O O
no O O
reflux O O
Hematological: O O
bruises O O
easily, O O
anemia-last O O
hematocrit O O
31 O O
percent O O
but O O
has O O
been O O
as O O
low O O
as O O
19 O O
within O O
the O O
last O O
year O O
Endocrine/metabolic: O O
diabetes B-DIABETES O
treated O O
with O O
insulin-blood B-DIABETES O
sugar I-DIABETES O
190 I-DIABETES O
Musculoskeletal/Skin: O O
recent O O
infection O O
in O O
left O O
foot O O
fourth O O
toe; O O
left O O
hip O O
deterioration O O
causing O O
pain O O
Psychiatric: O O
negative O O
Obstetrical: O O
negative O O
Vital O O
Signs: O O
BP: B-HYPERTENSION O
152/87 I-HYPERTENSION O
mm I-HYPERTENSION O
Hg I-HYPERTENSION O
P: O O
88 O O
bpm O O
Resp: O O
20 O O
rpm O O
SaO2: O O
97% O O
Temp: O O
97.7 O O
degrees O O
F O O
Ht: O O
66 O O
inches O O
Wt: O O
158.8 O O
pounds O O
Exam: O O
HEEN&T: O O
good O O
range O O
of O O
motion, O O
no O O
bruits O O
Airway: O O
Mallampatti O O
Class O O
II O O
Teeth: O O
dentures O O
Lungs: O O
clear O O
to O O
auscultation O O
bilaterally O O
Heart: O O
regular O O
rhythm, O O
no O O
murmurs O O
Assessment: O O
ASA O O
Physical O O
Status O O
III-53 O O
year O O
old O O
female O O
with O O
history O O
of O O
polycystic O O
disease O O
in O O
renal O O
failure O O
status O O
post O O
renal O O
transplant. O O
Patient O O
has O O
elevated O O
parathormone O O
level O O
with O O
resultant O O
spontaneous O O
fractures. O O
EKG O O
today O O
shows O O
normal O O
sinus O O
rhythm O O
with O O
biphasic O O
T-wave O O
in O O
V4 O O
and O O
inverted O O
T-wave O O
in O O
V5, O O
V6. O O
Discussed O O
patient O O
with O O
Dr. O O
Uren-T-wave O O
changes O O
are O O
new O O
since O O
1/21. O O
He O O
will O O
order O O
a O O
preoperative O O
stress O O
test. O O
Plan: O O
Proposed O O
Anesthetic: O O
general O O
endotracheal O O
anesthesia O O
Monitors: O O
standard O O
Pain O O
Management: O O
PCA O O
Autologous O O
blood: O O
none O O
Premedication: O O
STRESS O O
steroids O O
Usual O O
Medications: O O
in O O
a.m. O O
of O O
surgery O O
Medications O O
to O O
be O O
held O O
on O O
day O O
of O O
surgery: O O
Lipitor B-MEDICATION B-MEDICATION
D/C'd I-MEDICATION O
today I-MEDICATION O
Diabetic O O
medications: O O
NPH O O
24 O O
units O O
in O O
a.m.-no O O
regular O O
insulin O O
NSAIDS: O O
D/C'd O O
Aspirin: O B-MEDICATION
none O O
NPO: O O
after O O
midnight O O
Ancillary O O
Studies: O O
EKG-normal O O
sinus O O
rhythm, O O
possible O O
lateral O O
ischemia-official O O
reading O O
pending O O
________________________________________ O O
Tina O O
Purcell, O O
M.D. O O

Record O O
date: O O
2122-04-23 O O
Patient O O
Name: O O
VALLE,ISABELLA O O
[ O O
MRN: O O
4698877KMC O O
] O O
Date O O
of O O
Visit: O O
4/23/2122, O O
10:45 O O
p O O
Neurosurgery O O
H O O
& O O
P: O O
CC/HPI: O O
54 O O
yo O O
F O O
w/ O O
h/o O O
PCKD O O
and O O
HTN B-HYPERTENSION O
presents O O
w/ O O
worst O O
H/A O O
of O O
her O O
life. O O
The O O
patient O O
over-slept O O
this O O
morning O O
because O O
of O O
a O O
severe O O
H/A O O
and O O
'groginess.' O O
She O O
awoke O O
at O O
10 O O
am O O
by O O
her O O
Husband O O
who O O
was O O
calling O O
to O O
check O O
on O O
her O O
(given O O
she O O
usually O O
awakens O O
by O O
6 O O
am). O O
She O O
called O O
911 O O
and O O
was O O
transferred O O
to O O
us O O
for O O
further O O
care. O O
We O O
were O O
consulted O O
at O O
10:40 O O
pm O O
for O O
Head O O
CT O O
showing O O
SAH. O O
She O O
now O O
only O O
c/o O O
mild O O
H/A O O
w/o O O
any O O
vertigo, O O
tinnitus, O O
weakness, O O
nor O O
numbness. O O
PMH: O O
Polycystic O O
kidney O O
disease: O O
- O O
renal O O
failure O O
- O O
s/p O O
renal O O
transplant O O
in O O
'13 O O
- O O
s/p O O
nephrectomy O O
in O O
'18 O O
- O O
now O O
on O O
peritoneal O O
dialysis O O
Secondary O O
Hyperparathyroidism O O
- O O
has O O
had O O
spont O O
fractures O O
- O O
s/p O O
semi O O
total O O
parathyroidectomy O O
in O O
2112 O O
HTN O O
Hypercholesteremia B-HYPERLIPIDEMIA O
IDDM B-DIABETES O
PSH: B-SMOKER O
' O O
09 O O
TAH-BSO O O
' O O
10 O O
parathyroidectomy O O
' O O
18 O O
left O O
nephrectomy O O
AV O O
fistulas O O
x2 O O
Meds: O O
Lasix O O
40 O O
mg O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
mg O O
po O O
qd O O
Lipitor B-MEDICATION B-MEDICATION
40 I-MEDICATION O
mg O O
po O O
qd, O O
prednisone O O
10 O O
mg, O O
Epogen O O
10kU O O
4x/week O O
Insulin B-MEDICATION B-MEDICATION
NPH I-MEDICATION B-MEDICATION
38 O O
units O O
plus O O
regular B-MEDICATION O
8 O O
units O O
in O O
a.m. O O
NKDA O O
SH: O O
non-contributory. O O
FH: O O
Mother O O
died O O
of O O
an O O
aneurysm O O
at O O
KMC O O
PE: O O
Afebrile, O O
BP B-HYPERTENSION O
160/80, I-HYPERTENSION O
P O O
80, O O
R O O
16 O O
Neuro: O O
AA O O
& O O
Ox3, O O
speech O O
clear O O
PRL O O
(L6 O O
to O O
5, O O
R O O
5 O O
to O O
4), O O
FOV O O
full O O
grossly, O O
EOMI, O O
FS, O O
TML, O O
SCM/TPZ O O
5/5 O O
B O O
MAE O O
@ O O
5/5, O O
mild O O
RUE O O
drift O O
No O O
gross O O
sensory O O
deficit O O
DTR: O O
1+ O O
B O O
Bicep/BR/Patella O O
NEG O O
Babinski's O O
No O O
cerebellar O O
signs O O
Head O O
CTA: O O
Fischer O O
grade O O
1 O O
SAH O O
in O O
B O O
sylvian O O
fissures. O O
Small O O
amount O O
of O O
paramesencephalic O O
SAH O O
in O O
the O O
Right. O O
A O O
6 O O
mm O O
L O O
MCA O O
bifurcation O O
aneurysm O O
pointing O O
latero-superiorly O O
is O O
seen. O O
LABS: O O
Normal O O
CBC,lytes, O O
and O O
coags O O
except O O
WBC O O
= O O
12.6, O O
K O O
= O O
5.3, O O
BUN/CR O O
= O O
48 O O
/ O O
9.6, O O
Trop O O
= O O
0.25 O O
A/P: O O
54 O O
yo O O
F O O
w/ O O
PCDK O O
& O O
HTN O O
p/w O O
Hunt O O
Hess O O
grade O O
2, O O
Fischer O O
grade O O
1 O O
SAH O O
from O O
L O O
MCA O O
aneurysm. O O
D/W O O
Drs. O O
Ashley O O
& O O
Dang: O O
- O O
D/W O O
Dr. O O
Uren O O
and O O
Dr. O O
Quenton O O
Vanburen O O
who O O
related O O
that O O
CTA O O
and O O
Angio O O
could O O
both O O
be O O
done O O
for O O
this O O
patient O O
safely. O O
A O O
dialysis O O
RN O O
will O O
be O O
by O O
soon O O
to O O
dialyse O O
the O O
patient. O O
CTA O O
done. O O
- O O
Booked O O
for O O
OR O O
Waitlist O O
in O O
AM O O
- O O
Pre-op O O
labs O O
done O O
- O O
EKG O O
shows O O
no O O
ischemia O O
w/ O O
LVH O O
- O O
Vanc/Gent O O
for O O
open O O
Peritoneal O O
catheter O O
noted O O
on O O
exam O O
______________________________ O O
Michael O O
Tomlinson, O O
M.D. O O

Record O O
date: O O
2122-07-21 O O
Valle, O O
Isabella O O
KMC O O
Neuro O O
EW O O
Consult O O
Date O O
7/21/22 O O
MRN O O
4698877 O O
DOB: O O
7/30/67 O O
CC: O O
Unresponsive O O
this O O
AM, O O
with O O
R O O
sided O O
deficit O O
HPI O O
: O O
54 O O
yo O O
?handedness O O
WF O O
with O O
sig O O
h/o O O
PCKD O O
on O O
peritoneal O O
dialysis, O O
HTN, B-HYPERTENSION O
hypercholesterolemia, B-HYPERLIPIDEMIA O
IDDM, B-DIABETES O
s/p O O
L O O
MCA O O
aneurysmal O O
rupture O O
and O O
repair O O
4/22, O O
who O O
presents O O
this O O
AM O O
found O O
unresponsive O O
by O O
husband O O
(All O O
report O O
given O O
by O O
EMS&lt; O O
cannot O O
contact O O
husband O O
and O O
he O O
is O O
not O O
currently O O
present.) O O
Pt O O
reportedly O O
was O O
last O O
seen O O
in O O
USOH O O
last O O
night O O
about O O
9pm O O
when O O
peritoneal O O
dialysis O O
was O O
started. O O
She O O
was O O
found O O
this O O
AM O O
with O O
her O O
dialysate O O
fluid O O
half O O
run O O
through O O
and O O
it O O
was O O
on O O
the O O
floor, O O
she O O
was O O
unresponsive. O O
Pt O O
intermittenly O O
responds O O
to O O
commands O O
and O O
is O O
not O O
speaking, O O
so O O
ROS O O
is O O
unabl O O
to O O
obtain O O
at O O
this O O
point. O O
ALL: O O
unknown O O
if O O
any O O
allergies O O
Meds: O O
Lipitor, B-MEDICATION B-MEDICATION
Prednisone,Zestril, B-MEDICATION O
Norvasc, B-MEDICATION B-MEDICATION
Calcitol, O O
Phenytoin, O O
Mesnest, O O
Nephrocaps, O O
Phoslo, O O
Insulin B-MEDICATION B-MEDICATION
NPH I-MEDICATION B-MEDICATION
37 I-MEDICATION O
and O O
Reg B-MEDICATION O
7 O O
Med O O
Hx: O O
as O O
above, O O
HTN, O O
hypercholesterolemia, O B-MEDICATION
PCKD, O O
IDDM, O O
s/p O O
L O O
MCA O O
aneurysm O O
4/22 O O
Soc B-SMOKER O
Hx: I-SMOKER O
unknown O O
at O O
this O O
time O O
PE: O O
T O O
96.6 O O
P O O
101 O O
R O O
20 O O
BP B-HYPERTENSION O
167/62 I-HYPERTENSION O
O2=100 O O
RA O O
Gen: O O
WF, O O
appears O O
older O O
than O O
stated O O
age, O O
withdrawing O O
R O O
side, O O
looking O O
to O O
left O O
HEENT: O O
normocephalic,atraumatic O O
Neck: O O
supple, O O
no O O
bruits O O
Lungs: O O
CTAB O O
no O O
w/r/c O O
Heart: O O
RRR O O
S1, O O
S2, O O
no O O
m/r/g O O
Abd: O O
soft, O O
+BSs, O O
slightly O O
firm, O O
peritoneal O O
dialysate O O
access O O
in O O
abdomen, O O
abd O O
bandaged, O O
fluid O O
exuding O O
from O O
abdomen O O
Ext: O O
no O O
c/c/e O O
Neuro: O O
alert, O O
cannot O O
assess O O
if O O
pt O O
is O O
oriented O O
to O O
person, O O
place, O O
time, O O
pt O O
completely O O
aphasic, O O
follows O O
verbal O O
commands, O O
cannot O O
perform O O
rest O O
of O O
MMSE O O
at O O
this O O
time O O
CN: O O
PERRLA, O O
EOMI, O O
eyes O O
deviated O O
to O O
L, O O
not O O
roving, O O
able O O
to O O
track O O
and O O
cross O O
midline, O O
no O O
blink O O
to O O
threat O O
on O O
the O O
L, O O
visual O O
acuity O O
unable O O
to O O
assess, O O
sensation O O
face O O
equal O O
bilaterally, O O
R O O
sided O O
NLF O O
flattening, O O
Motor: O O
no O O
PND O O
on O O
L, O O
cannot O O
lift O O
R O O
arm O O
off O O
bed O O
to O O
command, O O
normal O O
bulk O O
on O O
R, O O
increased O O
tone O O
on O O
R, O O
atrophy O O
of O O
leg O O
and O O
arm O O
on O O
L, O O
no O O
tremors O O
or O O
fasiculations O O
noted O O
Strength O O
unable O O
to O O
assess O O
officially, O O
moving O O
L O O
arm O O
and O O
leg O O
spontaneously, O O
no O O
movement O O
of O O
R O O
upper O O
and O O
lower O O
extremities, O O
only O O
demonstrates O O
flexor O O
withraw O O
to O O
painful O O
stimuli O O
on O O
R O O
side O O
Sensation: O O
unable O O
to O O
assess, O O
pt O O
does O O
not O O
respond O O
to O O
questions O O
re:extinction O O
or O O
sensation O O
but O O
does O O
respond O O
to O O
painful O O
stimuli O O
Cerebellum: O O
unable O O
to O O
assess O O
Gait: O O
unable O O
to O O
assess O O
Reflexes: O O
biceps, O O
triceps, O O
BR O O
R O O
3+, O O
L O O
2+ O O
Patellar, O O
Achilles O O
3+ O O
R, O O
2+ O O
L, O O
toes O O
upgoing O O
on O O
R, O O
downgoing O O
on O O
L O O
Labs: O O
WBC O O
sig O O
for O O
17.5 O O
w/ O O
90%N, O O
chem O O
7 O O
pending O O
Imaging: O O
Pending O O
CXR O O
A/P: O O
54 O O
yo O O
WF O O
with O O
sig O O
medical O O
problems, O O
including O O
L O O
MCA O O
stroke O O
in O O
4/22, O O
now O O
with O O
new O O
R O O
sided O O
deficits O O
?stroke O O
vs. O O
sz O O
-CT O O
no O O
angio O O
for O O
now O O
givenperitoneal O O
dialysis O O
-likely O O
for O O
MRI/A O O
of O O
head O O
and O O
neck O O
with O O
diffusion O O
as O O
per O O
acute O O
stroke O O
protocol O O
-likely O O
CMF O O
admission/ O O
stroke O O
team O O
unless O O
suspicion O O
for O O
sz, O O
infectious O O
cause O O
Thelma O O
Delarosa O O
MD,PhD O O
Neurology O O
Resident O O
Pager O O
04272 O O

Record O O
date: O O
2123-03-02 O O
TEAM O O
2 O O
INTERN O O
ADMISSION O O
NOTE O O
Name: O O
Isabella O O
Valle O O
4698877 O O
Date O O
of O O
Admission: O O
3/01/2123 O O
Attending: O O
Dr. O O
L. O O
Uren O O
HPI: O O
55 O O
y/o O O
female O O
with O O
multiple O O
medical O O
problems O O
presents O O
to O O
ED O O
after O O
husban O O
called O O
EMS O O
for O O
seizure O O
that O O
lasted O O
approximately O O
5 O O
minutes. O O
She O O
has O O
a O O
known O O
seizure O O
disorder O O
secondary O O
to O O
hemmorragic O O
CVA O O
in O O
past. O O
Pt. O O
had O O
recent O O
reduction O O
in O O
Dilantin O O
dose O O
and O O
has O O
documented O O
subtherapuetic O O
levels O O
since O O
this O O
change. O O
Pt. O O
denies O O
any O O
other O O
complaints O O
prior O O
to O O
or O O
after O O
seizure. O O
In O O
the O O
ED O O
waiting O O
area-pt. O O
Suffered O O
another O O
seizure O O
and O O
was O O
transferred O O
to O O
the O O
trauma O O
section O O
of O O
the O O
ER. O O
Patient O O
was O O
given O O
2mg O O
of O O
Ativan O O
with O O
resolution O O
of O O
seizure O O
and O O
then O O
was O O
in O O
an O O
obvious O O
post-ictal O O
state. O O
Foley O O
was O O
placed O O
with O O
drainage O O
of O O
pus O O
and O O
patient O O
given O O
80mg O O
IV O O
gentamycin O O
and O O
1 O O
gram O O
of O O
Vancomycin. O O
Head O O
CT O O
negative O O
for O O
any O O
acute O O
process O O
and O O
abd/pelvic O O
CT O O
performed-results O O
pending. O O
Past O O
Med: O O
#1. O O
Subarachnoid O O
hemorrhage, O O
status O O
post O O
left O O
MCA O O
aneurysm O O
clipped O O
in O O
04/22. O O
#2. O O
Left O O
MCA O O
stroke O O
in O O
07/22. O O
#3. O O
End O O
stage O O
renal O O
disease O O
from O O
polycystic O O
kidney O O
disease O O
status O O
post O O
left O O
nephrectomy, O O
status O O
post O O
renal O O
transplant O O
and O O
hemodialysis. O O
#4. O O
Steroid B-DIABETES O
induced I-DIABETES O
diabetes I-DIABETES O
mellitus. I-DIABETES O
#5. O O
Hypertension. B-HYPERTENSION O
#6. O O
Status O O
post O O
parathyroidectomy. O O
#7. O O
Status O O
post O O
thyroid O O
adenoma O O
resection. O O
#8. O O
History O O
of O O
fungal O O
peritonitis O O
in O O
07/22. O O
#9. O O
Hyperlipidemia. B-HYPERLIPIDEMIA O
#10. O O
Recent O O
line O O
sepsis O O
with O O
Enterococci O O
10/22. O O
#11. O O
Status O O
post O O
TAH/BSO O O
for O O
menorrhagia, O O
and O O
status O O
post O O
ventral O O
hernia O O
repair. O O
#12 O O
HD O O
catheter O O
infection O O
Meds: O O
Lopressor B-MEDICATION B-MEDICATION
25 O O
Bid, O O
Lactobacillus O O
1 O O
packt O O
PO O O
bid, O O
Ranitidine O O
50 O O
IV O O
qd, O O
Colace O O
100 O O
mg O O
PO O O
bid, O O
Aggrenox O O
1 O O
cap O O
PO O O
BID, O O
Dulcolax O O
prn, O O
Celexa O O
40 O O
po O O
qd, O O
CaCO3 O O
1250 O O
po O O
tid, O O
prednisone O O
5 O O
mg O O
po O O
qam, O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
po O O
qd O O
Allergies: O O
NKDA O O
Social O O
History: O O
no B-SMOKER O
tobacco, I-SMOKER O
or O O
etoh, O O
lives O O
with O O
husband O O
who O O
helps O O
her O O
with O O
ADLs O O
as O O
she O O
is O O
hemiparetic O O
Family O O
History: O O
not O O
obtained O O
Physical O O
Exam: O O
T= O O
98.1, O O
RR=20, O O
P=63, O O
BP=124/66, O O
97% O O
2L O O
GEN: O O
NAD O O
HEENT: O O
PERRL, O O
no O O
oral O O
lesions O O
visible O O
LUNGS: O O
clear O O
posteriorly O O
crackles O O
HEART: O O
S1, O O
S2, O O
+systolic O O
murmer O O
heard O O
throughout O O
ABD: O O
BS+, O O
soft, O O
NT O O
EXT: O O
No O O
edema O O
except O O
for O O
RUE O O
NEURO: O O
cannot O O
move O O
right O O
side O O
of O O
body, O O
upgoing O O
toes O O
on O O
right O O
Labs: O O
WBC O O
12.8 O O
H O O
4.5-11.0 O O
th/cmm O O
HCT O O
37.2 O O
36.0-46.0 O O
% O O
HGB O O
11.4 O O
L O O
12.0-16.0 O O
gm/dl O O
RBC O O
3.52 O O
L O O
4.00-5.20 O O
mil/cmm O O
PLT O O
988 O O
H O O
150-350 O O
th/cumm O O
MCV O O
106 O O
H O O
80-100 O O
fl O O
MCH O O
32.3 O O
26.0-34.0 O O
pg/rbc O O
MCHC O O
30.6 O O
L O O
31.0-37.0 O O
g/dl O O
RDW O O
18.7 O O
H O O
11.5-14.5 O O
% O O
PT O O
13.0 O O
11.1-13.1 O O
sec O O
PT-INR O O
1.1 O O
Result O O
Text: O O
PT-INR O O
values O O
are O O
valid O O
only O O
for O O
WARFARIN O O
ANTI-COAG O O
THERAPY. O O
APTT O O
23.8 O O
22.1-35.1 O O
sec O O
DIFFERENTIAL O O
REQUEST O O
RECEIVED O O
Diff O O
Method O O
Auto O O
Poly O O
63 O O
40-70 O O
% O O
Lymphs O O
31 O O
22-44 O O
% O O
Monos O O
4 O O
4-11 O O
% O O
EOS O O
1 O O
0-8 O O
% O O
Basos O O
1 O O
0-3 O O
% O O
Absolute O O
Neuts O O
8.11 O O
H O O
1.8-7.7 O O
th/cmm O O
Absolute O O
Lymphs O O
3.92 O O
1.0-4.8 O O
th/cmm O O
Absolute O O
Monos O O
0.54 O O
H O O
0.2-0.4 O O
th/cmm O O
Absolute O O
EOS O O
0.18 O O
0.1-0.3 O O
th/cmm O O
Absolute O O
Basos O O
0.08 O O
0.0-0.3 O O
th/cmm O O
Aniso O O
2+ O O
NORMAL O O
Hypo O O
3+ O O
NORMAL O O
Macrocytes O O
3+ O O
Microcytes O O
None O O
Sodium O O
(Stat O O
Lab) O O
136 O O
135-145 O O
mmol/L O O
Potassium O O
(Stat O O
Lab) O O
5.9 O O
H O O
3.4-4.8 O O
mmol/L O O
Result O O
Text: O O
SPECIMEN O O
NOT O O
HEMOLYZED O O
Chloride O O
(Stat O O
Lab) O O
97 O O
L O O
100-108 O O
mmol/L O O
CO2 O O
(Stat O O
Lab) O O
34.2 O O
H O O
24.0-30.0 O O
mmol/L O O
BUN O O
(Stat O O
Lab) O O
36 O O
H O O
8-25 O O
mg/dl O O
Creatinine O O
(Stat O O
Lab) O O
4.4 O O
H O O
0.6-1.5 O O
mg/dl O O
Glucose O O
(Stat O O
Lab) O O
100 O O
70-110 O O
mg/dl O O
Calcium O O
7.6 O O
L O O
8.5-10.5 O O
mg/dl O O
Phosphorus O O
2.0 O O
L O O
2.6-4.5 O O
mg/dl O O
Magnesium O O
1.7 O O
1.4-2.0 O O
meq/L O O
Dilantin,Chem O O
2.0 O O
L O O
5.0-20.0 O O
mcg/ml O O
UA-SED-RBC O O
50-100 O O
0-2 O O
/hpf O O
UA-SED-WBC O O
PACKED O O
0-2 O O
/hpf O O
UA-SED-Bacteria O O
Few O O
NEG O O
/hpf O O
Hyaline O O
Cast O O
3-5 O O
0-5 O O
/lpf O O
Squamous O O
Cells O O
Few O O
NEG O O
/hpf O O
Microscopic O O
Sediment O O
Completed O O
EKG: O O
NSR, O O
prolonged O O
QT-no O O
change O O
from O O
prior-non O O
specific O O
ST/T O O
wave O O
abnormalities O O
CT O O
Head-1. O O
No O O
intracranial O O
hemorrhage O O
or O O
CT O O
evidence O O
of O O
acute O O
stroke O O
though O O
MRI O O
diffusion O O
weighted O O
imaging O O
would O O
be O O
more O O
sensitive. O O
2. O O
Stable O O
encephalomalacia O O
and O O
Wallerian O O
degeneration O O
from O O
left O O
MCA O O
stroke. O O
3. O O
Prior O O
left O O
pterional O O
craniotomy O O
and O O
left O O
MCA O O
aneurysm O O
clipping. O O
Assessment/Plan: O O
1. O O
Seizures-likely O O
in O O
setting O O
of O O
subtherapuetic O O
Dilantin O O
dose-will O O
finish O O
one O O
gram O O
load O O
and O O
start O O
PO O O
dilantin O O
in O O
am O O
at O O
300 O O
tid O O
per O O
neurology O O
recommendations O O
and O O
check O O
levels O O
and O O
await O O
levels O O
10-15. O O
Head O O
CT O O
negative O O
for O O
new O O
process O O
and O O
no O O
evidence O O
of O O
other O O
reason O O
for O O
seizure. O O
Patient O O
on O O
Keppra O O
in O O
past-needed O O
now? O O
Will O O
ask O O
neurology O O
2. O O
Pyuria-uncertian O O
if O O
significant O O
due O O
to O O
the O O
patient's O O
likely O O
minimal O O
urine O O
output-sent O O
for O O
culture-will O O
await O O
results-continue O O
broad O O
specrtrum O O
coverage O O
of O O
potential O O
pathogens O O
with O O
Vancomycin O O
(1 O O
gram O O
given O O
in O O
ED) O O
and O O
ceftriaxone. O O
3. O O
High O O
WBC-Abd O O
CT O O
reportedly O O
negative O O
as O O
was O O
CXR-will O O
check O O
final O O
results O O
and O O
patient O O
without O O
symptoms-blood O O
cultures O O
pending-follow O O
temp O O
curve O O
and O O
WBC O O
and O O
continue O O
abx O O
until O O
cultures O O
negative O O
4. O O
Electrolyte O O
abnormalities-patient O O
on O O
hemodialysis-will O O
schedule O O
for O O
am-if O O
not O O
possible O O
will O O
have O O
to O O
treat O O
for O O
hyperkalemia. O O
5. O O
Renal O O
transplant-continue O O
Prednisone O O
6. O O
CVA-Will O O
continue O O
Aggrenox O O
for O O
now O O
7. O O
Other-continue O O
home O O
meds O O
for O O
now O O
except O O
lactobacillus O O
as O O
certain O O
of O O
purpose? O O
Bradley O O
Burch O O
69264 O O
Team O O
2 O O
Intern O O

Record O O
date: O O
2120-01-18 O O
January O O
18, O O
2120 O O
Freeman O O
Faust, O O
M.D. O O
Evergreen O O
Court O O
Hospital O O
97 O O
Factory O O
Street O O
Haleyville, O O
MN O O
78826 O O
RE: O O
Jacob O O
Rodriquez, O O
M.D. O O
MR O O
#863-35-65-5 O O
Dear O O
Dr. O O
Faust: O O
Thank O O
you O O
for O O
kindly O O
referring O O
your O O
patient, O O
Jacob O O
Rodriquez, O O
to O O
the O O
Internal O O
Medicine O O
for O O
evaluation O O
of O O
pulmonary O O
hypertension. B-HYPERTENSION O
Although O O
I'm O O
sure O O
you O O
are O O
familiar O O
with O O
his O O
history, O O
I O O
will O O
review O O
it O O
now O O
for O O
our O O
records. O O
Dr. O O
Rodriquez O O
is O O
a O O
77-year-old O O
retired O O
Electrician O O
at O O
Wells O O
Fargo O O
who O O
by O O
his O O
report O O
has O O
enjoyed O O
excellent O O
health O O
until O O
the O O
past O O
year. O O
He O O
denies O O
any O O
prior O O
history O O
of O O
hypertension, O B-HYPERTENSION
coronary O O
artery O O
disease, O O
chest O O
pains, O O
significant O O
childhood O O
illnesses O O
or O O
malignancy. O O
He O O
describes O O
his O O
usual O O
baseline O O
health O O
as O O
excellent. O O
He O O
is O O
a O O
religious O O
walker, O O
walking O O
multiple O O
times O O
each O O
week O O
as O O
well O O
as O O
a O O
woodwind O O
and O O
singing O O
enthusiast. O O
Dr. O O
Rodriquez O O
states O O
that O O
in O O
approximately O O
April O O
or O O
Mayof O O
the O O
past O O
year O O
he O O
was O O
first O O
diagnosed O O
with O O
hyperglycemia. O O
This O O
was O O
treated O O
with O O
Metformin. B-MEDICATION O
Subsequently O O
Hydrochlorothiazide B-MEDICATION O
and O O
Zestril B-MEDICATION B-MEDICATION
were O O
added O O
apparently O O
for O O
hypertension O O
(although O O
the O O
patient O O
does O O
not O O
believe O O
he O O
has O O
been O O
diagnosed O O
with O O
hypertension). O O
He O O
subsequently O O
developed O O
diarrhea O O
which O O
he O O
felt O O
was O O
related O O
to O O
Glucophage B-MEDICATION B-MEDICATION
which O O
was O O
subsequently O O
reduced O O
in O O
dose. O O
In O O
June O O
of O O
the O O
past O O
year O O
the O O
patient O O
was O O
noted O O
to O O
be O O
anemic O O
which O O
was O O
felt O O
to O O
be O O
related O O
to O O
sulfa O O
in O O
his O O
Hydrochlorothiazide. O O
At O O
that O O
time O O
he O O
also O O
was O O
found O O
to O O
have O O
lower O O
extremity O O
edema O O
which O O
worsened O O
with O O
the O O
discontinuation O O
of O O
the O O
Hydrochlorothiazide. O O
The O O
patient O O
states O O
in O O
September O O
of O O
2119 O O
he O O
traveled O O
to O O
trinidad O O
and O O
tobago. O O
While O O
in O O
trinidad O O
and O O
tobago O O
he O O
had O O
a O O
marked O O
increase O O
in O O
his O O
lower O O
extremity O O
edema O O
to O O
the O O
point O O
that O O
he O O
found O O
it O O
difficult O O
to O O
ambulate. O O
He O O
denied O O
any O O
difficulty O O
with O O
chest O O
pains O O
or O O
shortness O O
of O O
breath. O O
He O O
had O O
no O O
hemoptysis O O
and O O
no O O
focal O O
unilateral O O
leg O O
swelling O O
despite O O
the O O
long O O
period O O
of O O
immobility O O
during O O
the O O
trip. O O
He O O
was O O
seen O O
by O O
a O O
Trinidad O O
physician O O
who O O
prescribed O O
an O O
ethacrynic O O
acid O O
which O O
reduced O O
his O O
lower O O
extremity O O
edema O O
significantly. O O
However, O O
he O O
subsequently O O
developed O O
diarrhea O O
to O O
this O O
medication O O
and O O
it O O
was O O
stopped. O O
Subsequently O O
his O O
lower O O
extremity O O
has O O
once O O
again O O
worsened O O
and O O
has O O
been O O
treated O O
with O O
increasing O O
doses O O
of O O
Lasix O O
and O O
with O O
the O O
recent O O
addition O O
of O O
Zaroxolyn. B-MEDICATION O
At O O
the O O
present O O
time O O
Dr. O O
Rodriquez O O
states O O
that O O
he O O
has O O
no O O
overt O O
shortness O O
of O O
breath. O O
He O O
still O O
able O O
to O O
sing O O
vigorously O O
and O O
to O O
play O O
woodwinds O O
without O O
any O O
Page O O
2 O O
Freeman O O
Faust, O O
M.D. O O
RE: O O
Jacob O O
Rodriquez, O O
M.D. O O
January O O
18, O O
2120 O O
limitation. O O
He O O
does O O
find O O
ambulating O O
difficult O O
due O O
to O O
the O O
swelling O O
in O O
his O O
lower O O
extremities. O O
He O O
has O O
no O O
chest O O
pain, O O
has O O
no O O
cough, O O
no O O
sputum O O
production, O O
no O O
hemoptysis. O O
He O O
has O O
no O O
fevers O O
or O O
chills. O O
He O O
believes O O
his O O
weight O O
is O O
increased O O
by O O
35 O O
pounds O O
in O O
the O O
past O O
several O O
months. O O
He O O
believes O O
this O O
is O O
entirely O O
due O O
to O O
edema O O
accumulation. O O
He O O
denies O O
any O O
difficulties O O
with O O
disrupted O O
sleep O O
although O O
he O O
does O O
note O O
that O O
he's O O
becoming O O
increasingly O O
fatigued O O
during O O
the O O
day O O
and O O
is O O
often O O
napping O O
in O O
the O O
reclining O O
chair O O
which O O
is O O
new O O
for O O
him. O O
He O O
denies O O
any O O
history O O
of O O
snoring. O O
He O O
has O O
noted O O
no O O
new O O
joint O O
complaints O O
although O O
he O O
has O O
had O O
a O O
pruritic O O
eruption O O
on O O
the O O
anterior O O
surface O O
of O O
his O O
right O O
lower O O
extremity O O
as O O
well O O
as O O
on O O
his O O
left O O
arm. O O
This O O
has O O
been O O
present O O
for O O
approximately O O
two O O
or O O
three O O
months. O O
Other O O
than O O
that O O
he O O
believes O O
his O O
bowel O O
and O O
bladder O O
function O O
is O O
normal. O O
Review O O
of O O
systems O O
is O O
otherwise O O
unremarkable. O O
His O O
past O O
medical O O
history O O
is O O
significant O O
for: O O
1. O O
Type B-DIABETES O
II I-DIABETES O
diabetes I-DIABETES O
as O O
above. O O
2. O O
An B-HYPERTENSION O
apparent I-HYPERTENSION O
diagnosis I-HYPERTENSION O
of I-HYPERTENSION O
labile I-HYPERTENSION O
hypertension I-HYPERTENSION B-HYPERTENSION
noted I-HYPERTENSION O
in I-HYPERTENSION O
his I-HYPERTENSION O
chart. I-HYPERTENSION O
3. O O
Anemia O O
thought O O
secondary O O
to O O
Hydrochlorothiazide. O O
4. O O
Past O O
history O O
of O O
right O O
bundle O O
branch O O
block. O O
He O O
has O O
no O O
history O O
of O O
rheumatic O O
fever. O O
Current O O
medications O O
include O O
Atenolol B-MEDICATION B-MEDICATION
25mg O O
daily, O O
folic O O
acid, O O
Glucophage O B-MEDICATION
850mg O O
bid, O O
Lasix O O
120mg O O
daily, O O
Lisinopril B-MEDICATION B-MEDICATION
15mg O O
daily, O O
compression O O
stockings, O O
Metolazone O B-MEDICATION
2.5mg O O
daily O O
was O O
added O O
recently. O O
Drug O O
allergies O O
include O O
possible O O
hemolytic O O
anemia O O
due O O
to O O
Hydrochlorothiazide. O O
Family O O
history O O
is O O
significant O O
for O O
diabetes O O
mellitus. O O
Social O O
history O O
is O O
assuming O O
for O O
the O O
fact O O
that O O
the O O
patient O O
is O O
an O O
immigrant O O
from O O
trinidad O O
and O O
tobago. O O
He O O
has O O
been O O
living O O
in O O
Haleyville O O
since O O
the O O
early O O
2059's. O O
He O O
is O O
a O O
Electrician O O
at O O
Wells O O
Fargo. O O
He O O
has O O
minimal O O
exposure O O
to O O
chemicals O O
in O O
his O O
research O O
towards O O
his O O
bachelor's O O
degree O O
but O O
none O O
since O O
then. O O
He O O
is O O
a O O
non B-SMOKER O
tobacco I-SMOKER O
user. I-SMOKER O
He O O
uses O O
alcohol O O
minimally. O O
He's O O
never O O
had O O
any O O
blood O O
transfusions. O O
He O O
lives O O
with O O
his O O
wife. O O
They O O
have O O
no O O
pets. O O
He O O
does O O
not O O
enjoy O O
any O O
unusual O O
hobbies O O
not O O
noted O O
above. O O
He O O
has O O
been O O
exposed O O
to O O
tuberculosis O O
in O O
the O O
past O O
and O O
has O O
a O O
history O O
of O O
a O O
positive O O
PPD. O O
On O O
physical O O
examination O O
today O O
Dr. O O
Rodriquez O O
weighs O O
193 O O
pounds. O O
Blood O O
pressure O O
is O O
136/90. O O
Pulse O O
83 O O
and O O
regular. O O
Respiratory O O
rate O O
is O O
20. O O
Temperature O O
is O O
96.8. O O
Resting O O
oxygen O O
saturation O O
is O O
98-99% O O
with O O
ambulation O O
in O O
the O O
hallway. O O
This O O
fell O O
to O O
a O O
minimum O O
of O O
97% O O
with O O
an O O
increase O O
in O O
his O O
heart O O
rate O O
to O O
100. O O
HEENT O O
exam O O
is O O
significant O O
for O O
a O O
clear O O
oropharynx. O O
Sclera O O
are O O
white. O O
Conjunctiva O O
are O O
minimally O O
pale. O O
Page O O
3 O O
Freeman O O
Faust, O O
M.D. O O
RE: O O
Jacob O O
Rodriquez, O O
M.D. O O
January O O
18, O O
2120 O O
The O O
thyroid O O
gland O O
is O O
normal. O O
Jugular O O
venous O O
distention O O
to O O
approximately O O
10 O O
cm. O O
was O O
noted. O O
Neck O O
was O O
supple. O O
Examination O O
of O O
the O O
chest O O
revealed O O
diminished O O
breath O O
sounds O O
bilaterally O O
with O O
dullness O O
at O O
both O O
bases. O O
There O O
was O O
no O O
egophony O O
and O O
no O O
wheezes. O O
Otherwise O O
the O O
lungs O O
were O O
clear. O O
Cardiac O O
exam O O
with O O
a O O
regular O O
rate O O
in O O
rhythm, O O
normal O O
S1 O O
and O O
S2, O O
an O O
intermittent O O
S4 O O
was O O
appreciated. O O
No O O
RV O O
heave O O
or O O
lift O O
was O O
appreciated. O O
No O O
pulmonary O O
artery O O
tap O O
was O O
appreciated. O O
The O O
pontic O O
component O O
of O O
S2 O O
was O O
moderately O O
enhanced. O O
No O O
appreciable O O
murmurs O O
were O O
detected. O O
The O O
point O O
of O O
maximum O O
impulse O O
was O O
in O O
the O O
anterior O O
axillary O O
line. O O
Examination O O
of O O
the O O
abdomen O O
revealed O O
a O O
nontender O O
abdomen O O
with O O
a O O
palpable O O
liver O O
edge, O O
three O O
fingerbreadths O O
below O O
the O O
right O O
costal O O
margin. O O
This O O
was O O
nontender O O
and O O
smooth. O O
Minimal O O
splenomegaly O O
was O O
also O O
appreciated O O
as O O
well. O O
Normal O O
bowel O O
sounds O O
were O O
present. O O
Examination O O
of O O
the O O
extremities O O
reveal O O
three O O
plus O O
symmetric O O
edema O O
to O O
the O O
top O O
of O O
the O O
thigh O O
in O O
the O O
lower O O
extremities, O O
one O O
plus O O
edema O O
was O O
also O O
present O O
in O O
both O O
upper O O
extremities. O O
No O O
clubbing O O
was O O
noted. O O
There O O
were O O
no O O
skin O O
changes O O
consistent O O
with O O
collagen O O
vascular O O
disease. O O
Multiple O O
follicular O O
lesions O O
were O O
noted O O
on O O
the O O
anterior O O
aspect O O
of O O
the O O
right O O
thigh O O
as O O
well O O
as O O
on O O
the O O
left O O
arm. O O
Neurological O O
exam O O
was O O
grossly O O
nonfocal. O O
Objective O O
data O O
include O O
a O O
CBC O O
which O O
most O O
recently O O
demonstrated O O
a O O
white O O
count O O
of O O
11.8, O O
hematocrit O O
of O O
32.1, O O
platelet O O
count O O
of O O
250. O O
Differential O O
was O O
not O O
remarkable. O O
LVH O O
is O O
elevated O O
at O O
599, O O
AST O O
is O O
most O O
recently O O
22. O O
A O O
urinalysis O O
on O O
12/07/19 O O
was O O
negative O O
for O O
protein. O O
No O O
reportive O O
cast O O
was O O
made. O O
A O O
CEA O O
was O O
notable O O
for O O
a O O
level O O
of O O
2.4 O O
on O O
1/05/20. O O
An O O
echocardiogram O O
obtained O O
on O O
12/22/19 O O
demonstrated O O
normal O O
LV O O
size O O
with O O
mild O O
concentric O O
LVH O O
and O O
preserved O O
LV O O
function. O O
The O O
right O O
ventricle O O
was O O
mildly O O
dilated O O
and O O
hypertrophied O O
with O O
mild O O
reduction O O
in O O
RV O O
function. O O
There O O
was O O
trace O O
MR O O
with O O
moderate O O
TR. O O
A O O
peak O O
systolic O O
artery O O
pressure O O
of O O
64 O O
plus O O
right O O
atrial O O
pressure O O
was O O
noted. O O
In O O
summary O O
Dr. O O
Rodriquez O O
is O O
a O O
77-year-old O O
gentleman O O
with O O
a O O
clear O O
cut O O
pulmonary O O
hypertension. O O
The O O
etiology O O
of O O
this O O
is O O
not O O
clear O O
at O O
the O O
moment. O O
Differential O O
diagnosis O O
could O O
include O O
chronic O O
thromboembolic O O
disease, O O
occult O O
underlying O O
pulmonary O O
disease O O
(doubt), O O
obstructive O O
sleep O O
apnea, O O
and O O
collagen O O
vascular O O
disease. O O
In O O
addition O O
some O O
patients O O
develop O O
a O O
marked O O
pulmonary O O
artery O O
hypertension O O
in O O
the O O
setting O O
of O O
stiff O O
left O O
ventricle O O
even O O
with O O
preserved O O
left O O
ventricular O O
function O O
although O O
this O O
I O O
think O O
would O O
be O O
a O O
diagnosis O O
of O O
exclusion. O O
The O O
degree O O
of O O
his O O
edema O O
is O O
quite O O
striking O O
and O O
I O O
agree O O
with O O
increasing O O
his O O
diuretic O O
regimen. O O
I'm O O
embarking O O
on O O
a O O
course O O
of O O
evaluation O O
to O O
exclude O O
the O O
most O O
likely O O
causes. O O
In O O
specific O O
he O O
will O O
be O O
having O O
a O O
CT O O
with O O
IV O O
contrast O O
to O O
rule O O
out O O
chronic O O
thromboembolic O O
disease O O
this O O
afternoon. O O
This O O
has O O
already O O
been O O
arranged O O
by O O
Dr. O O
Faust. O O
In O O
addition O O
I'm O O
sending O O
serology O O
including O O
an O O
ANA, O O
an O O
antidouble O O
stranded O O
DNA O O
and O O
an O O
anti O O
SCL70. O O
I've O O
also O O
asked O O
Dr. O O
Rodriquez O O
Page O O
4 O O
Freeman O O
Faust, O O
M.D. O O
RE: O O
Jacob O O
Rodriquez, O O
M.D. O O
January O O
18, O O
2120 O O
to O O
undergo O O
polysonography O O
to O O
exclude O O
obstructive O O
sleep O O
apnea. O O
He O O
will O O
be O O
following O O
up O O
with O O
our O O
pulmonary O O
function O O
lab O O
to O O
have O O
formal O O
pulmonary O O
function O O
testing O O
performed O O
in O O
addition O O
to O O
having O O
an O O
arterial O O
blood O O
gas O O
drawn. O O
If O O
this O O
evaluation O O
should O O
be O O
unrevealing, O O
he O O
may O O
require O O
more O O
invasive O O
diagnostics. O O
I've O O
already O O
consulted O O
formally O O
with O O
Dr. O O
Eddie O O
Roy, O O
the O O
physician O O
with O O
most O O
experience O O
in O O
pulmonary O O
hypertension O O
at O O
this O O
hospital O O
and O O
he O O
would O O
be O O
able O O
to O O
assist O O
us O O
in O O
the O O
further O O
evaluation O O
of O O
Dr. O O
Rodriquez O O
if O O
our O O
workup O O
is O O
nondiagnostic. O O
Dr. O O
Faust, O O
thank O O
you O O
again O O
for O O
referring O O
Dr. O O
Rodriquez O O
for O O
evaluation. O O
I'll O O
plan O O
on O O
seeing O O
him O O
in O O
approximately O O
three O O
to O O
four O O
weeks O O
after O O
his O O
diagnostic O O
tests O O
have O O
been O O
performed. O O
Please O O
do O O
not O O
hesitate O O
to O O
call O O
me O O
with O O
any O O
further O O
questions O O
or O O
concerns. O O
Sincerely, O O
Jose O O
Church, O O
M.D. O O
/ray O O
DD: O O
01/18/20 O O
DT: O O
01/19/:0 O O
DV: O O
01/18/20 O O

Record O O
date: O O
2120-09-08 O O
MARY O O
EMERGENCY O O
DEPT O O
VISIT O O
RODRIQUEZ,JACOB O O
863-35-65-5 O O
VISIT O O
DATE: O O
09/08/20 O O
I O O
saw O O
and O O
examined O O
the O O
patient O O
personally. O O
I O O
also O O
reviewed O O
and O O
confirm O O
the O O
resident's O O
detailed O O
note. O O
Please O O
refer O O
to O O
it. O O
PRESENTING O O
COMPLAINT: O O
Foot O O
ulcer. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
is O O
a O O
78-year-old O O
gentleman O O
who O O
is O O
a O O
diabetic B-DIABETES O
developed O O
left O O
foot O O
ulcer O O
six O O
weeks O O
ago O O
after O O
he O O
had O O
shaving O O
of O O
some O O
calluses O O
by O O
a O O
podiatrist. O O
The O O
wound O O
has O O
not O O
healed O O
and O O
then O O
got O O
infected. O O
He O O
was O O
started O O
on O O
Keflex, O O
then O O
when O O
the O O
initial O O
cultures O O
came O O
back O O
showing O O
resistance O O
to O O
Keflex O O
so O O
he O O
was O O
switched O O
to O O
Cipro, O O
however, O O
his O O
final O O
cultures O O
showed O O
MRSA. O O
He O O
comes O O
in O O
with O O
increasing O O
redness O O
and O O
pain. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension, B-HYPERTENSION B-HYPERTENSION
diabetes, B-DIABETES O
peripheral O O
vascular O O
disease, O O
mitral O O
regurgitation, O O
anemia, O O
sleep O O
apnea O O
and O O
pulmonary O O
hypertension. O O
MEDICATIONS: O O
Documented O O
on O O
the O O
chart. O O
ALLERGIES: O O
Documented O O
on O O
the O O
chart. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
He O O
is O O
a O O
Electrician. O O
He O O
drinks O O
alcohol O O
occasionally, O O
he B-SMOKER O
does B-SMOKER O
not I-SMOKER O
smoke. I-SMOKER O
Family O O
history O O
of O O
kidney O O
stones. O O
PHYSICAL O O
EXAMINATION: O O
VITAL O O
SIGNS: O O
He O O
is O O
afebrile, O O
vital O O
signs O O
are O O
stable. O O
GENERAL: O O
The O O
patient O O
was O O
awake, O O
alert O O
in O O
no O O
distress. O O
He O O
does O O
not O O
look O O
toxic. O O
HEART: O O
He O O
had O O
a O O
small O O
heart O O
murmur. O O
LUNGS: O O
Clear O O
to O O
auscultation. O O
ABDOMEN: O O
Soft O O
and O O
nontender. O O
EXTREMITIES: O O
He O O
had O O
multiple O O
ulcers O O
on O O
his O O
left O O
foot, O O
stage O O
two O O
or O O
three, O O
an O O
ulcer O O
on O O
his O O
heel O O
as O O
well O O
as O O
the O O
distal O O
third O O
and O O
fourth O O
toes. O O
There O O
was O O
some O O
mild O O
surrounding O O
cellulitis. O O
He O O
had O O
3+ O O
pedal O O
edema. O O
The O O
casts O O
were O O
symmetric O O
and O O
nontender. O O
There O O
is O O
no O O
adenopathy. O O
LABORATORY O O
EVALUATION: O O
The O O
patient O O
had O O
a O O
white O O
count O O
of O O
about O O
16, O O
mildly O O
elevated O O
but O O
no O O
bandemia. O O
His O O
BUN O O
and O O
creatinine O O
were O O
50 O O
and O O
1.8. O O
Blood O O
cultures O O
were O O
sent. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
He O O
was O O
given O O
a O O
dose O O
of O O
Vancomycin. O O
Surgery O O
was O O
consulted. O O
The O O
primary O O
came O O
and O O
saw O O
the O O
patient O O
as O O
well O O
and O O
he O O
was O O
admitted O O
to O O
the O O
hospital. O O
FINAL O O
DIAGNOSIS: O O
Diabetic O O
foot O O
ulceration O O
with O O
cellulitis, O O
rule O O
out O O
osteomyelitis. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Condition O O
is O O
stable. O O
___________________________________ O O
TT554/9917 O O
CHRISTOPHER O O
QUIGLEY, O O
M.D. O O
CQ03 O O
D:09/09/20 O O
T:09/09/20 O O
Dictated O O
by: O O
CHRISTOPHER O O
QUIGLEY, O O
M.D. O O
CQ03 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2120-12-15 O O
Chief O O
Complaint O O
This O O
is O O
a O O
visit O O
for O O
this O O
patient O O
with O O
a O O
chief O O
complaint O O
1.diabetes B-DIABETES O
management, O O
difficulty O O
getting O O
in O O
control.Also O O
to O O
monitor O O
for O O
potential O O
complications O O
of O O
treatment O O
and O O
complications O O
of O O
the O O
disease. O O
2. O O
followup O O
of O O
ulcers O O
on O O
feet O O
3. O O
edema O O
4. O O
hypertension B-HYPERTENSION O
5. O O
pulmonary O O
hypertension O O
Problems O O
Venous O O
insufficiency O O
Edema O O
Mitral O O
regurgitation O O
Anemia O O
Hypertension B-HYPERTENSION O
Bundle O O
branch O O
block O O
Pulmonary O O
hypertension O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Sleep O O
apnea O O
Lower O O
extremity O O
ulcer O O
History O O
of O O
Present O O
Illness O O
Diabetes= O O
on O O
oral O O
agents- O O
just O O
glyburide B-MEDICATION B-MEDICATION
one O O
2.5 O O
mg O O
qd O O
Trying O O
to O O
keep O O
diet O O
- O O
reviewed O O
weight:stable O O
Keeps O O
track O O
of O O
sugars- O O
Does O O
not O O
Bring O O
in O O
book O O
to O O
review O O
- O O
but O O
says O O
that O O
sugars B-DIABETES O
are I-DIABETES O
running I-DIABETES O
about I-DIABETES O
200 I-DIABETES O
past I-DIABETES O
two I-DIABETES O
weeks I-DIABETES O
No O O
hypoglycemic O O
episodes O O
no O O
polyuria,polydipsia,no O O
fevers, O O
no O O
weight O O
loss O O
2. O O
followup O O
of O O
ulcers O O
on O O
feet- O O
ws O O
to O O
have O O
started O O
on O O
antibiotics O O
wednesday, O O
but O O
the O O
prescription O O
was O O
not O O
delivered. O O
Three/of O O
four O O
ulcers O O
have O O
healed. O O
Seeing O O
nurse O O
daily O O
for O O
dressing O O
changes. O O
Has O O
heel O O
pad O O
to O O
remove O O
pressure O O
3. O O
edema O O
taking O O
zaroxylyn O O
and O O
lasix O O
better O O
controlled O O
when O O
on O O
both O O
4. O O
hypertension O O
on O O
lisinopril, B-MEDICATION B-MEDICATION
lasix. O O
not O O
on O O
atenolol O B-MEDICATION
? O O
why O O
5. O O
pulmonary O O
hypertension O O
not O O
using O O
his O O
CPAP O O
- O O
did O O
not O O
like O O
it O O
this O O
summer O O
--found O O
it O O
hot. O O
Discussed O O
- O O
advised O O
to O O
try O O
again. O O
Past O O
Medical O O
History O O
Past O O
Medical O O
History O O
- O O
pulm O O
hypertension O O
sleep O O
apnea O O
diabetes O O
mitral O O
regurg O O
anemia, O O
felt O O
secondary O O
to O O
HCTZ O O
RBBB O O
+PPD O O
in O O
college O O
Allergies O O
METFORMIN O B-MEDICATION
Diarrhea O O
EDECRIN O O
(ETHACRYNATE O O
SODIUM) O O
GI O O
upset O O
HCTZ O O
(HYDROCHLOROTHIAZIDE) O O
Hemolytic O O
anemia O O
Preventive O O
Health O O
History O O
says O O
he O O
is O O
up O O
to O O
date. O O
has O O
not O O
had O O
colonoscopy- O O
we O O
are O O
waiting O O
for O O
ulcers O O
to O O
heal, O O
etc. O O
Habits O O
smoking-no B-SMOKER O
drink O O
alcohol-social O O
only O O
drug O O
use O O
no O O
illicit O O
drugs O O
seat O O
belts O O
yes O O
Review O O
of O O
Systems O O
Constitutional: O O
no O O
weight O O
loss, O O
fevers, O O
fatigue,aches O O
Skin:Persistent O O
rash O O
on O O
back, O O
responsive O O
to O O
steroid O O
cream;No O O
change O O
moles O O
HEENT: O O
saw O O
eye O O
doctor O O
- O O
has O O
hemorrhage O O
- O O
to O O
get O O
laser O O
treatment O O
Respir: O O
no O O
cough,sputum; O O
no O O
wheezing O O
Cor: O O
no O O
chest O O
pain, O O
SOB, O O
PND. O O
+edema O O
GI: O O
no O O
heartburn, O O
nausea,vomiting,diarrhea O O
,constip O O
GU: O O
no O O
dysuria,frequency, O O
urgency, O O
hematuria O O
Endo: O O
no O O
sweating, O O
heat O O
intolerance O O
Heme: O O
no O O
bruising, O O
bleeding O O
Vital O O
Signs O O
Blood B-HYPERTENSION O
Pressure: I-HYPERTENSION O
164/86 B-HYPERTENSION O
Weight: O O
185 O O
Pounds O O
Physical O O
Exam O O
WdWN O O
male O O
164/86 O O
185 O O
pounds O O
82 O O
eczema O O
on O O
back O O
with O O
some O O
round O O
1+ O O
palpable O O
femoral O O
pulses O O
bilaterally, O O
nonpalp O O
popliteal O O
arteries. O O
Neuropathic O O
ulcers O O
on O O
heel, O O
left O O
foot O O
: O O
ulcer O O
on O O
heel O O
still O O
open,with O O
some O O
drainage. O O
clean O O
margins O O
edema O O
1+ O O
Neck: O O
supple O O
no O O
nodes; O O
thyroid O O
not O O
enlarged, O O
no O O
nodules. O O
no O O
bruits O O
CHEST: O O
some O O
crackles O O
at O O
bases, O O
R&gt;L; O O
no O O
wheezes, O O
rhonchi O O
COR: O O
reg O O
rhythm, O O
murm, O O
soft,systolic O O
blowing O O
m;,No O O
thrill, O O
gallop, O O
rub O O
ABD: O O
soft, O O
BS O O
nl. O O
no O O
masses O O
No O O
liver/spleen O O
enlarg; O O
no O O
tendrnes O O
Impression O O
Diabetes. B-DIABETES O
on O O
glyburide O O
+ O O
evidence O O
of O O
visual O O
changes(hemorrhage)- O O
followed O O
by O O
ophthal O O
No O O
evid O O
of O O
hypoglycemic O O
episodes O O
by O O
hx. O O
Not O O
adequately O O
controlled O O
on O O
current O O
regimen. O O
2. O O
followup O O
of O O
ulcers O O
on O O
feet- O O
three O O
healed, O O
one O O
still O O
open O O
3. O O
edema O O
pretty O O
good O O
control O O
4. O O
hypertension O O
still O O
not O O
adequately O O
controlled O O
5. O O
pulmonary O O
hypertension O O
Plan O O
Total O O
face-to-face O O
visit O O
time: O O
45 O O
minutes O O
Time O O
spent O O
counselling: O O
38 O O
min O O
Diagnosis O O
explained O O
reviewed O O
potential O O
complications O O
of O O
diabetes O O
reviewed O O
diet O O
reviewed O O
meds O O
- O O
increase O O
glyburide O O
Ophthalmology O O
return O O
in O O
one O O
month O O
2. O O
followup O O
of O O
ulcers O O
on O O
feet O O
3. O O
edema O O
4. O O
hypertension O O
5. O O
pulmonary O O
hypertension O O
Return: O O

Record O O
date: O O
2121-03-28 O O
Chief O O
Complaint O O
This O O
is O O
a O O
visit O O
for O O
this O O
patient O O
with O O
a O O
chief O O
complaint O O
1.diabetes B-DIABETES O
managementAlso O O
to O O
monitor O O
for O O
potential O O
complications O O
of O O
treatment O O
and O O
complications O O
of O O
the O O
disease. O O
2. O O
followup O O
of O O
ulcers O O
on O O
feet O O
3. O O
edema O O
4. B-HYPERTENSION O
hypertension B-HYPERTENSION O
5. O O
pulmonary O O
hypertension O O
Problems O O
Venous O O
insufficiency O O
Edema O O
Mitral O O
regurgitation O O
Anemia O O
Hypertension B-HYPERTENSION O
Bundle O O
branch O O
block O O
Pulmonary O O
hypertension O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Sleep O O
apnea O O
Lower O O
extremity O O
ulcer O O
History O O
of O O
Present O O
Illness O O
Diabetes= O O
on O O
oral O O
agents- O O
just O O
glyburide B-MEDICATION O
5mg I-MEDICATION O
tab I-MEDICATION O
bid I-MEDICATION O
Trying O O
to O O
keep O O
diet O O
- O O
reviewed O O
Says O O
sugars O O
in O O
range O O
- O O
tho O O
again O O
no O O
diary.Tells O O
me O O
that O O
sugars O O
usually O O
in O O
acceptable O O
range, O O
tho O O
once O O
was O O
55. O O
No O O
other O O
hypoglycemic O O
episodes O O
no O O
polyuria,polydipsia,no O O
fevers, O O
no O O
weight O O
loss O O
We O O
talked O O
again O O
about O O
bringing O O
in O O
his O O
log- O O
I O O
suspect O O
he O O
is O O
very O O
out O O
of O O
range O O
but O O
dont O O
know, O O
and O O
his O O
report O O
of O O
sugars O O
of O O
55 O O
make O O
me O O
concerned O O
about O O
increasing O O
meds. O O
Still O O
having O O
problems O O
with O O
ulcers O O
- O O
seeing O O
Dr O O
Ulbrich O O
regularly O O
seeing O O
nurse O O
daily O O
for O O
dressing O O
changes. O O
Has O O
heel O O
pad O O
to O O
remove O O
pressure. O O
Has O O
had O O
shoes O O
checked. O O
Is O O
to O O
see O O
Dr O O
Ulbrich O O
's O O
nurse O O
today O O
for O O
debridement. O O
Is O O
off O O
antibiotics O O
now; O O
was O O
on O O
? O O
a O O
few O O
weeks O O
ago?? O O
3. O O
edema- O O
good O O
control O O
recently O O
taking O O
zaroxylyn O O
and O O
lasix O O
better O O
controlled O O
when O O
on O O
both O O
4. O O
hypertension O O
on O O
lisinopril, B-MEDICATION B-MEDICATION
lasix. O O
not O O
on O O
atenolol O B-MEDICATION
- O O
he O O
stopped O O
it O O
because O O
he O O
did O O
not O O
like O O
it, O O
made O O
him O O
feel O O
sleepy. O O
Need O O
to O O
consider O O
increasing O O
bp O O
meds- O O
will O O
await O O
Creatinine O O
tpday O O
5. O O
pulmonary O O
hypertension O O
not O O
using O O
his O O
CPAP O O
- O O
did O O
not O O
like O O
it O O
Discussed O O
- O O
advised O O
to O O
try O O
again.we O O
reviewed O O
the O O
whole O O
issue O O
of O O
pulm O O
hypertension/ O O
leg O O
swelling O O
etc O O
Past O O
Medical O O
History O O
Past O O
Medical O O
History O O
- O O
pulm O O
hypertension O O
sleep O O
apnea O O
diabetes O O
mitral O O
regurg O O
anemia, O O
felt O O
secondary O O
to O O
HCTZ O O
RBBB O O
+PPD O O
in O O
college O O
Allergies O O
METFORMIN O B-MEDICATION
Diarrhea O O
EDECRIN O O
(ETHACRYNATE O O
SODIUM) O O
GI O O
upset O O
HCTZ O O
(HYDROCHLOROTHIAZIDE) O O
Hemolytic O O
anemia O O
Preventive O O
Health O O
History O O
says O O
he O O
is O O
up O O
to O O
date. O O
has O O
not O O
had O O
colonoscopy- O O
we O O
are O O
waiting O O
for O O
ulcers O O
to O O
heal, O O
etc. O O
Habits O O
smoking-no B-SMOKER O
drink O O
alcohol-social O O
only O O
drug O O
use O O
no O O
illicit O O
drugs O O
seat O O
belts O O
yes O O
Review O O
of O O
Systems O O
Constitutional: O O
no O O
weight O O
loss, O O
fevers, O O
++fatigue, O O
NOaches O O
Skin: O O
rash O O
better O O
(shingles) O O
HEENT:Got O O
laser O O
treatment- O O
stable O O
Respir: O O
no O O
cough,sputum; O O
no O O
wheezing O O
Cor: O O
no O O
chest O O
pain, O O
SOB, O O
PND. O O
+edema,. O O
better O O
than O O
before O O
GI: O O
no O O
heartburn, O O
nausea,vomiting,constip. O O
GU: O O
no O O
dysuria,frequency, O O
urgency, O O
hematuria O O
Endo: O O
no O O
sweating, O O
heat O O
intolerance O O
Heme: O O
no O O
bruising, O O
bleeding O O
Vital O O
Signs O O
Blood O O
Pressure: O O
140/80 O O
Left O O
Arm O O
Weight O O
182 O O
today O O
Physical O O
Exam O O
WdWN O O
male O O
eczema O O
on O O
back O O
1+ O O
palpable O O
femoral O O
pulses O O
bilaterally, O O
nonpalp O O
popliteal O O
arteries. O O
Feet: O O
dressings O O
not O O
changed O O
as O O
he O O
is O O
sseeing O O
Dr O O
Ulbrich O O
shortly O O
after O O
this O O
apt O O
today O O
1+ O O
femoral O O
pulses O O
bilaterallyNothing O O
palp O O
below O O
Neck: O O
supple O O
no O O
nodes; O O
thyroid O O
not O O
enlarged, O O
no O O
nodules. O O
no O O
bruits O O
CHEST: O O
some O O
crackles O O
at O O
bases, O O
R&gt;L; O O
no O O
wheezes, O O
rhonchi O O
Extrem: O O
1+ O O
edema O O
Impression O O
Diabetes. B-DIABETES O
on O O
glyburide O O
+ O O
evidence O O
of O O
visual O O
changes(hemorrhage)- O O
followed O O
by O O
ophthal O O
? O O
hypoglycemic O O
episodes O O
by O O
hx. O O
?? O O
adequately O O
controlled O O
on O O
current O O
regimen. O O
Last O O
A1C O O
very O O
high. O O
If O O
still O O
high, O O
I O O
think O O
he O O
needs O O
much O O
more O O
help O O
getting O O
in O O
control. O O
Since O O
he O O
sees O O
nurse O O
daily, O O
will O O
have O O
to O O
ask O O
for O O
her O O
to O O
check O O
sugars, O O
adjust O O
meds O O
after. O O
2. O O
ulcers O O
3. O O
edema O O
4. O O
hypertension O O
not O O
adequately O O
controlled O O
5. O O
pulmonary O O
hypertension O O
6. O O
Renal O O
insuff- O O
need O O
to O O
better O O
control O O
his O O
sugars O O
and O O
bp O O
7 O O
anemia O O
8. O O
Really O O
overall O O
not O O
doing O O
well. O O
Plan O O
1. O O
Diabetes: O O
will O O
check O O
A1C O O
and O O
sugar. O O
Will O O
contact O O
VNA O O
to O O
begin O O
sugars O O
by O O
VNA O O
so O O
we O O
can O O
try O O
and O O
control O O
better. O O
reviewed O O
meds O O
- O O
reviewed O O
vascular O O
complications O O
reviewed O O
checking O O
sugars O O
and O O
bringing O O
in O O
book O O
2. O O
followup O O
of O O
ulcers O O
on O O
feet O O
to O O
see O O
Dr O O
Ulbrich. O O
3. O O
edema O O
continue O O
current O O
combination O O
of O O
lasix O O
and O O
zaroxy. O O
Check O O
K, O O
creat O O
4. O O
hypertension O O
check O O
renal O O
function O O
- O O
? O O
restart O O
atenolol O B-MEDICATION
or O O
add O O
increase O O
lisinopril O B-MEDICATION
5. O O
pulmonary O O
hypertension O O
encourage O O
cpap O O
6. O O
anemia- O O
check O O
if O O
elig O O
for O O
epo O O
Could O O
start O O
at O O
40000u/week O O
Return: O O
one O O
month O O
Call O O
pt O O
when O O
i O O
have O O
results O O
Note: O O
reviewed O O
old O O
heme O O
values. O O
Tends O O
to O O
run O O
high O O
WBC, O O
low O O
lymphs, O O
high O O
ESR. O O
??? O O
why. O O
May O O
need O O
heme O O
consult. O O

Record O O
date: O O
2078-05-01 O O
HENDRICKS, O O
HANNAH O O
75322175 O O
05/01/2078 O O
Hunter O O
N. O O
Ishikawa, O O
M.D. O O
Surgery O O
03 O O
Greenwood O O
Drive O O
Dyersville, O O
WI O O
69617 O O
Dear O O
Hicks, O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
Hannah O O
Hendricks O O
in O O
Internal O O
Medicine O O
today. O O
She O O
was O O
seen O O
alongside O O
my O O
attending, O O
Dr. O O
Heidi O O
Erik-Roy. O O
As O O
you O O
know, O O
she O O
is O O
a O O
lovely O O
52-year-old O O
female O O
in O O
whom O O
you O O
have O O
found O O
a O O
left O O
lower O O
extremity O O
bypass O O
surgery. O O
She O O
comes O O
in O O
today O O
for O O
perioperative O O
risk O O
assessment. O O
Ms. O O
Hendricks O O
tells O O
me O O
that O O
she O O
has O O
longstanding O O
type B-DIABETES O
1 I-DIABETES O
diabetes, B-DIABETES O
hypertension, B-HYPERTENSION B-HYPERTENSION
hyperlipidemia, B-HYPERLIPIDEMIA O
and O O
peripheral O O
arterial O O
disease. O O
She O O
in O O
fact O O
has O O
undergone O O
lower O O
extremity O O
bypass O O
grafting O O
in O O
both O O
her O O
left O O
and O O
right O O
lower O O
extremities. O O
Specifically, O O
she O O
is O O
status O O
post O O
a O O
right O O
fem-pop O O
bypass O O
in O O
2066 O O
and O O
a O O
left O O
fem-DP O O
bypass O O
also O O
in O O
2066. O O
It O O
appears O O
that O O
her O O
right O O
graft O O
has O O
been O O
functioning O O
well, O O
but O O
her O O
left O O
graft O O
was O O
noted O O
to O O
be O O
occluded O O
many O O
years O O
ago. O O
She O O
comes O O
in O O
now O O
with O O
a O O
nonhealing O O
ulcer O O
and O O
gangrene O O
in O O
her O O
left O O
toe. O O
You O O
have O O
planned O O
a O O
redo O O
bypass O O
for O O
this O O
upcoming O O
Saturday. O O
Ms. O O
Hendricks O O
tells O O
me O O
that O O
she O O
has O O
never O O
had O O
any O O
history O O
of O O
coronary O O
artery O O
disease. O O
She O O
has O O
never O O
had O O
any O O
chest O O
discomfort, O O
shortness O O
of O O
breath, O O
orthopnea, O O
PND, O O
lower O O
extremity O O
edema, O O
palpitations, O O
lightheadedness, O O
or O O
syncope. O O
She O O
does O O
have O O
a O O
strong B-FAMILY_HIST O
family I-FAMILY_HIST O
history I-FAMILY_HIST O
of I-FAMILY_HIST O
coronary B-FAMILY_HIST O
artery I-FAMILY_HIST O
disease I-FAMILY_HIST O
with I-FAMILY_HIST O
a I-FAMILY_HIST O
brother I-FAMILY_HIST O
who I-FAMILY_HIST O
had I-FAMILY_HIST O
several I-FAMILY_HIST O
myocardial I-FAMILY_HIST O
infarctions I-FAMILY_HIST O
and I-FAMILY_HIST O
died I-FAMILY_HIST O
at I-FAMILY_HIST O
the I-FAMILY_HIST O
age I-FAMILY_HIST O
of I-FAMILY_HIST O
48 I-FAMILY_HIST O
of I-FAMILY_HIST O
an I-FAMILY_HIST O
MI. I-FAMILY_HIST O
She O O
has O O
a O O
report O O
of O O
a O O
prior O O
EKG O O
with O O
suggestion B-CAD O
of I-CAD O
an I-CAD O
old I-CAD O
anteroseptal I-CAD O
MI. I-CAD O
She O O
has O O
never O O
had O O
any O O
evaluation O O
for O O
underlying B-CAD O
coronary I-CAD O
artery I-CAD O
disease I-CAD O
nor O O
has O O
she O O
had O O
any O O
symptoms O O
referable O O
to O O
CAD. O O
In O O
terms O O
of O O
her O O
functional O O
capacity, O O
she O O
tells O O
me O O
that O O
up O O
until O O
a O O
year O O
ago, O O
she O O
was O O
doing O O
spinning O O
classes O O
without O O
any O O
chest O O
discomfort O O
or O O
shortness O O
of O O
breath O O
whatsoever. O O
Because O O
of O O
increasing O O
discomfort O O
in O O
her O O
left O O
lower O O
extremity, O O
she O O
had O O
to O O
reduce O O
her O O
exercise O O
and O O
of O O
late O O
has O O
only O O
been O O
able O O
to O O
do O O
weightlifting O O
without O O
aerobic O O
exercise. O O
She O O
is O O
however O O
able O O
to O O
climb O O
stairs O O
in O O
her O O
home O O
without O O
any O O
discomfort O O
in O O
her O O
chest O O
or O O
any O O
shortness O O
of O O
breath. O O
She O O
is O O
unfortunately O O
limited O O
significantly O O
by O O
foot O O
pain. O O
Her O O
past O O
medical O O
history O O
is O O
as O O
noted O O
above O O
including O O
type O O
1 O O
diabetes O O
for O O
which O O
she O O
uses O O
an O O
insulin B-MEDICATION O
pump, I-MEDICATION O
peripheral O O
arterial O O
disease, O O
status O O
post O O
bilateral O O
lower O O
extremity O O
bypass, O O
hypertension, O O
and O O
hyperlipidemia. B-HYPERLIPIDEMIA O
Her O O
current O O
medications O O
include O O
aspirin B-MEDICATION B-MEDICATION
325 O O
mg, O O
which O O
she O O
started O O
a O O
few O O
days O O
ago, O O
Lipitor B-MEDICATION B-MEDICATION
10 O O
mg O O
once O O
daily, O O
Diovan B-MEDICATION O
160 O O
mg O O
twice O O
daily, O O
vitamin O O
C, O O
vitamin O O
B O O
and O O
folic O O
acid O O
supplementation. O O
She O O
has O O
no O O
clear O O
drug O O
allergies, O O
but O O
does O O
get O O
nauseous O O
and O O
vomiting O O
with O O
Percocet. O O
She O O
is O O
a O O
past B-SMOKER O
smoker I-SMOKER O
and I-SMOKER O
had I-SMOKER O
smoked I-SMOKER O
for I-SMOKER O
approximately I-SMOKER O
three I-SMOKER O
years, I-SMOKER O
one I-SMOKER O
pack I-SMOKER O
per I-SMOKER O
day I-SMOKER O
in I-SMOKER O
her I-SMOKER O
early I-SMOKER O
20s. I-SMOKER O
She O O
works O O
as O O
a O O
Senior O O
Manager O O
of O O
Broadcasting O O
at O O
giant O O
food O O
in O O
Albemarle. O O
As O O
I O O
mentioned O O
previously, O O
her O O
family O O
history O O
is O O
notable O O
for O O
a O O
brother B-FAMILY_HIST O
who I-FAMILY_HIST O
died I-FAMILY_HIST O
of I-FAMILY_HIST O
an I-FAMILY_HIST O
MI I-FAMILY_HIST O
in I-FAMILY_HIST O
his I-FAMILY_HIST O
late I-FAMILY_HIST O
40s. I-FAMILY_HIST O
On O O
physical O O
examination, O O
her O O
blood O O
pressure O O
is O O
135/79, O O
heart O O
rate O O
is O O
97 O O
and O O
her O O
weight O O
is O O
137 O O
pounds. O O
In O O
general, O O
she O O
is O O
very O O
well O O
appearing O O
and O O
in O O
no O O
apparent O O
distress O O
at O O
rest. O O
She O O
has O O
a O O
jugular O O
venous O O
pressure O O
of O O
approximately O O
5 O O
cm O O
of O O
water. O O
She O O
has O O
2+ O O
carotids O O
with O O
no O O
audible O O
bruits. O O
Her O O
upper O O
extremities O O
demonstrate O O
2+ O O
brachial O O
and O O
radial O O
pulses O O
bilaterally. O O
Her O O
chest O O
is O O
clear O O
to O O
auscultation O O
bilaterally. O O
Her O O
cardiac O O
exam O O
reveals O O
a O O
regular O O
rate O O
and O O
rhythm, O O
normal O O
S1 O O
and O O
S2, O O
and O O
a O O
soft O O
2/6 O O
systolic O O
ejection O O
murmur O O
best O O
heard O O
at O O
the O O
left O O
sternal O O
border. O O
Her O O
abdomen O O
is O O
benign. O O
She O O
has O O
no O O
abdominal O O
bruits O O
and O O
no O O
significantly O O
palpable O O
aorta. O O
Her O O
lower O O
extremity O O
exam O O
is O O
notable O O
for O O
a O O
hyperemic O O
left O O
foot O O
with O O
a O O
bandage, O O
which O O
is O O
covering O O
what O O
is O O
reportedly O O
a O O
gangrenous O O
toe. O O
Her O O
left O O
lower O O
extremity O O
pulses O O
are O O
1+ O O
in O O
the O O
femoral, O O
absent O O
popliteal O O
and O O
absent O O
distal O O
pulses. O O
In O O
her O O
right O O
lower O O
extremity, O O
she O O
has O O
1+ O O
femoral, O O
with O O
no O O
bruit, O O
2+ O O
popliteal, O O
2+ O O
DP O O
and O O
1+ O O
PT. O O
An O O
EKG O O
done O O
in O O
our O O
clinic O O
today O O
demonstrates O O
a O O
normal O O
sinus O O
rhythm O O
at O O
a O O
rate O O
of O O
97 O O
beats O O
per O O
minute O O
with O O
a O O
left O O
axis O O
deviation. O O
There O O
is O O
left O O
atrial O O
enlargement O O
and O O
Q-waves O O
in O O
V1 O O
through O O
V3 O O
suggestive O O
of O O
an O O
old O O
anteroseptal O O
MI. O O
There O O
are O O
also O O
Q-waves O O
in O O
lead O O
III O O
and O O
aVF, O O
which O O
raises O O
suspicion O O
of O O
an O O
old B-CAD O
inferior I-CAD O
MI. I-CAD O
In O O
summary, O O
Ms. O O
Hendricks O O
is O O
a O O
lovely O O
52-year-old O O
female O O
with O O
longstanding O O
diabetes, O O
hypertension, O O
hyperlipidemia, O O
and O O
peripheral O O
arterial O O
disease O O
who O O
comes O O
in O O
today O O
for O O
perioperative O O
risk O O
assessment O O
in O O
light O O
of O O
an O O
anticipated O O
redo O O
left O O
lower O O
extremity O O
bypass O O
graft. O O
She O O
appears O O
to O O
have O O
an O O
excellent O O
functional O O
capacity O O
up O O
until O O
several O O
months O O
ago. O O
However, O O
I O O
am O O
concerned O O
by O O
her O O
electrocardiogram, O O
which O O
raises O O
the O O
suspicion O O
of O O
underlying O O
coronary O O
artery O O
disease O O
given O O
the O O
findings O O
of O O
a O O
probable B-CAD O
inferior I-CAD O
and I-CAD O
old I-CAD O
anteroseptal I-CAD O
myocardial I-CAD O
infarction. I-CAD O
As O O
such, O O
I O O
think O O
that O O
it O O
would O O
be O O
wise O O
to O O
better O O
delineate O O
her O O
burden O O
of O O
coronary O O
artery O O
disease O O
by O O
way O O
of O O
a O O
stress O O
test O O
prior O O
to O O
her O O
surgery. O O
Given O O
that O O
her O O
functional O O
status O O
has O O
been O O
so O O
good O O
up O O
until O O
recently, O O
I O O
do O O
not O O
think O O
that O O
we O O
need O O
to O O
delay O O
her O O
surgery. O O
However, O O
I O O
would O O
start O O
her O O
on O O
a O O
beta-blocker B-MEDICATION O
and O O
as O O
such, O O
I O O
have O O
given O O
her O O
a O O
prescription O O
for O O
atenolol B-MEDICATION B-MEDICATION
25 O O
mg O O
once O O
daily, O O
which O O
she O O
will O O
start O O
today O O
and O O
continue O O
up O O
to O O
and O O
beyond O O
the O O
perioperative O O
period. O O
During O O
the O O
perioperative O O
period, O O
we O O
would O O
recommend O O
that O O
she O O
has O O
tight O O
control O O
of O O
her O O
blood O O
pressure O O
and O O
heart O O
rate O O
with O O
a O O
goal O O
blood O O
pressure O O
less O O
than O O
120/80 O O
and O O
a O O
goal O O
heart O O
rate O O
less O O
than O O
60. O O
I O O
would O O
also O O
make O O
sure O O
to O O
obtain O O
a O O
postoperative O O
EKG O O
to O O
ensure O O
there O O
has O O
not O O
been O O
any O O
changes. O O
We O O
will O O
try O O
to O O
arrange O O
for O O
an O O
exercise O O
test O O
with O O
arm O O
ergometry O O
and O O
MIBI O O
imaging O O
for O O
tomorrow O O
morning. O O
If O O
we O O
are O O
unable O O
to O O
do O O
arm O O
exercise, O O
we O O
will O O
obtain O O
an O O
adenosine O O
MIBI. O O
I O O
will O O
follow O O
up O O
with O O
the O O
results O O
tomorrow O O
after O O
the O O
study O O
is O O
performed. O O
As O O
I O O
mentioned O O
because O O
her O O
functional O O
capacity O O
is O O
good, O O
I O O
do O O
not O O
anticipate O O
that O O
we O O
will O O
need O O
to O O
make O O
any O O
changes O O
in O O
the O O
surgical O O
scheduling O O
based O O
on O O
the O O
test O O
results. O O
This O O
is O O
more O O
in O O
order O O
to O O
give O O
us O O
a O O
sense O O
of O O
the O O
underlying B-CAD O
burden I-CAD O
of I-CAD O
coronary I-CAD O
artery I-CAD O
disease. I-CAD O
It O O
was O O
a O O
pleasure O O
seeing O O
Ms. O O
Hendricks O O
in O O
clinic O O
today. O O
We O O
are O O
certainly O O
available O O
during O O
the O O
perioperative O O
period O O
if O O
any O O
cardiovascular O O
issues O O
are O O
to O O
arise. O O
Please O O
feel O O
free O O
to O O
contact O O
me O O
with O O
any O O
questions. O O
Sincerely, O O
______________________________ O O
Fatima O O
K O O
Baird, O O
M.D. O O
eScription O O
document:0-1465457 O O
IFFocus O O
CC: O O
Trevon O O
Schmidt O O
M.D. O O
54 O O
Clinton O O
Street O O
Decatur, O O
WI O O
96857 O O
DD: O O
05/01/78 O O
DT: O O
05/02/78 O O
DV: O O
05/01/78 O O

Record O O
date: O O
2078-05-08 O O
ED O O
Surgery O O
Consult O O
Date/Time: O O
5/8/78 O O
4:56PM O O
**************************************************** O O
Name: O O
Hendricks, O O
Hannah O O
MRN# O O
75322175 O O
Resident: O O
Xavier O O
G. O O
England, O O
MD, O O
EdM O O
Attending: O O
Dr. O O
Hunter O O
Ishikawa O O
**************************************************** O O
CC: O O
Bleeding O O
from O O
groin O O
wound O O
HPI: O O
Ms. O O
Hendricks O O
is O O
a O O
52yoF O O
with O O
a O O
history O O
of O O
PVD O O
and O O
non-healing O O
wounds O O
of O O
the O O
LLE O O
s/p O O
redo O O
left O O
femoral-tibial O O
bypass O O
with O O
arm O O
vein O O
on O O
5/3/78 O O
who O O
was O O
discharged O O
to O O
home O O
yesterday O O
and O O
now O O
returns O O
after O O
she O O
noted O O
a O O
gush O O
of O O
blood O O
from O O
her O O
left O O
groin O O
wound O O
while O O
coughing O O
earlier O O
today. O O
She O O
was O O
doing O O
well O O
until O O
this O O
morning O O
when O O
she O O
coughed O O
and O O
immediately O O
noted O O
that O O
her O O
left O O
pant O O
leg O O
was O O
soaked O O
with O O
blood O O
from O O
the O O
left O O
groin O O
down O O
the O O
left O O
leg. O O
When O O
she O O
took O O
off O O
her O O
pants O O
there O O
was O O
no O O
active O O
bleeding O O
from O O
the O O
wound O O
and O O
she O O
denies O O
any O O
light-headedness O O
or O O
dizziness. O O
There O O
has O O
been O O
no O O
further O O
bleeding O O
from O O
the O O
wound O O
and O O
she O O
is O O
otherwise O O
without O O
complaints. O O
PMHx: O O
PVD, O O
HTN, B-HYPERTENSION O
Hypercholesterolemia B-HYPERLIPIDEMIA O
PSHx: O O
Right O O
fem-pop O O
bypass O O
2066, O O
Left O O
fem-dp O O
bypass O O
2066, O O
redo O O
left O O
fem-pt O O
bypass O O
5/3/78. O O
Meds: O O
Tylenol, O O
ASA, B-MEDICATION B-MEDICATION
Vitamin O O
C, O O
Atenolol, B-MEDICATION B-MEDICATION
Lipitor, B-MEDICATION B-MEDICATION
Colace, O O
Folic O O
Acid, O O
Lactulose, O O
Milk O O
of O O
Magnesia, O O
Oxycodone, O O
Valsartan B-MEDICATION O
All: O O
Percocet-&gt;nausea O O
SHx: O O
Denies B-SMOKER O
any I-SMOKER O
recent I-SMOKER O
etoh/ivda/tob I-SMOKER O
PE: O O
98.7 O O
78 O O
134/72 O O
12 O O
100% O O
on O O
RA O O
General: O O
No O O
distress O O
HEENT: O O
NCAT O O
Chest: O O
CTAB O O
Heart: O O
RRR, O O
no O O
mrg O O
Abdomen: O O
soft, O O
NT/NE O O
Extremities: O O
RUE O O
wound O O
healing O O
well O O
without O O
erythema/warmth/tenderness. O O
Left O O
groin O O
wound O O
with O O
small O O
mobile O O
collection O O
at O O
cephalad O O
portion O O
of O O
wound. O O
No O O
obvious O O
bleeding. O O
Pulses: O O
Biphasic O O
dp/pt O O
on O O
LLE O O
Labs: O O
CBC: O O
Pending O O
Imaging: O O
LLE O O
U/S O O
at O O
bedside: O O
3x2 O O
cm O O
simple O O
fluid O O
collection O O
at O O
cephalad O O
portion O O
of O O
groin O O
wound. O O
Assessment/Plan: O O
- O O
52yoF O O
s/p O O
recent O O
redo O O
left O O
fem-tib O O
bypass O O
with O O
right O O
arm O O
vein O O
with O O
single O O
episode O O
of O O
bleeding O O
from O O
left O O
groin O O
wound. O O
This O O
likely O O
represents O O
extrusion O O
of O O
a O O
postoperative O O
hematoma. O O
There O O
is O O
currently O O
no O O
evidence O O
of O O
active O O
bleeding O O
from O O
the O O
wound. O O
A O O
CBC O O
should O O
be O O
obtained O O
in O O
the O O
ED O O
to O O
ensure O O
that O O
her O O
hct O O
is O O
stable O O
and O O
she O O
can O O
then O O
d/c O O
home. O O
She O O
will O O
follow O O
up O O
with O O
Dr. O O
Ishikawa O O
at O O
her O O
scheduled O O
postop O O
visit. O O
Should O O
the O O
bleeding O O
persist O O
or O O
return O O
she O O
should O O
return O O
to O O
the O O
ER O O
or O O
the O O
clinic O O
for O O
a O O
vascular O O
U/S O O
to O O
assess O O
for O O
a O O
pseudoaneurysm O O
or O O
AV O O
fistula. O O
D/W O O
Dr. O O
Casey O O
Iacono O O
(Surgery O O
Fellow), O O
who O O
agrees O O
with O O
assessment O O
and O O
plan. O O
Thanks, O O
Xavier O O
G. O O
England, O O
MD, O O
EdM O O
#15725 O O

Record O O
date: O O
2078-09-17 O O
HENDRICKS, O O
HANNAH O O
75322175 O O
09/17/2078 O O
Trevon O O
Schmidt, O O
M.D. O O
47 O O
Clinton O O
Street, O O
Guite O O
299 O O
Decatur, O O
WI O O
33955 O O
Dear O O
Dr. O O
Schmidt: O O
Your B-SMOKER O
patient, I-SMOKER O
Hannah O O
Hendricks, O O
was O O
in O O
the O O
Surgery O O
Clinic O O
today. O O
As O O
you O O
know, O O
she O O
is O O
a O O
52-year-old O O
woman O O
with O O
a O O
history O O
of O O
peripheral O O
vascular O O
disease. O O
She O O
underwent O O
a O O
redo O O
left O O
femoral O O
to O O
anterior O O
tibial O O
bypass O O
graft O O
using O O
basilic O O
and O O
cephalic O O
vein O O
from O O
her O O
right O O
arm O O
on O O
May O O
3, O O
2078. O O
She O O
has O O
done O O
well O O
since O O
the O O
procedure. O O
She O O
is O O
now O O
comes O O
here O O
complaining O O
of O O
left O O
foot O O
pain. O O
She O O
had O O
an O O
ultrasound O O
in O O
the O O
vascular O O
lab O O
to O O
rule O O
out O O
a O O
DVT, O O
which O O
it O O
did. O O
She O O
explains O O
the O O
discomfort O O
as O O
pain O O
and O O
burning O O
in O O
the O O
bottom O O
of O O
her O O
foot O O
as O O
well O O
as O O
her O O
arch O O
and O O
over O O
the O O
dorsum O O
of O O
the O O
foot. O O
On O O
exam, O O
she O O
is O O
a O O
well O O
appearing O O
female O O
in O O
no O O
acute O O
distress. O O
She O O
is O O
alert O O
and O O
oriented O O
x3. O O
She O O
appears O O
grossly O O
neurologically O O
intact. O O
Her O O
lower O O
extremity O O
exam O O
reveals O O
easily O O
palpable O O
bypass O O
graft O O
pulse O O
in O O
her O O
left O O
leg. O O
Her O O
left O O
foot O O
is O O
warm O O
and O O
well O O
perfused O O
and O O
she O O
has O O
a O O
very O O
small O O
pinhole O O
ulcer O O
over O O
the O O
plantar O O
aspect O O
of O O
her O O
left O O
great O O
toe. O O
This O O
does O O
not O O
appear O O
infected O O
and O O
I O O
cannot O O
probe O O
to O O
bone. O O
It O O
remains O O
superficial. O O
She O O
has O O
no O O
other O O
ischemic O O
skin O O
changes O O
noted. O O
I O O
have O O
discussed O O
with O O
Hannah O O
that O O
her O O
discomfort O O
most O O
likely O O
is O O
due O O
to O O
peripheral O O
neuropathy O O
due O O
to O O
her O O
diabetes. B-DIABETES O
She O O
also O O
experienced O O
this O O
discomfort O O
prior O O
to O O
her O O
surgery. O O
She O O
is O O
enquiring O O
about O O
starting O O
Neurontin. O O
I O O
have O O
said O O
she O O
would O O
be O O
able O O
to O O
try O O
either O O
Neurontin O O
or O O
Lyrica O O
to O O
help O O
with O O
the O O
peripheral O O
neuropathy. O O
She O O
will O O
return O O
next O O
week O O
for O O
her O O
postoperative O O
graft O O
scan O O
to O O
assess O O
her O O
circulation. O O
She O O
knows O O
to O O
contact O O
us O O
sooner O O
if O O
thing O O
worsen. O O
If O O
I O O
can O O
be O O
of O O
further O O
assistance O O
in O O
her O O
care, O O
do O O
not O O
hesitate O O
to O O
contact O O
me. O O
Sincerely, O O
Hunter O O
Shea, O O
MD O O
Dictated O O
by: O O
Quanisha O O
Logan, O O
PA-C O O

Record O O
date: O O
2078-09-26 O O
Date O O
09/26/2078 O O
Surgery O O
ADMISSION O O
NOTE O O
PATIENT: O O
Hendricks, O O
Hannah O O
MRN: O O
75322175 O O
Attending: O O
Shea O O
CC: O O
L O O
foot O O
pain O O
HPI: O O
52 O O
y/o O O
F O O
with O O
Hx O O
of O O
HTN, B-HYPERTENSION O
hyperlipidemia, B-HYPERLIPIDEMIA B-HYPERTENSION
PVD, O O
s/p O O
R O O
fem-pop O O
bypass O O
and O O
L O O
fem-DP O O
bypass, O O
both O O
in O O
2066. O O
She O O
was O O
doing O O
well O O
until O O
April O O
2078, O O
when O O
she O O
presented O O
with O O
a O O
non-healing O O
ulcer O O
and O O
gangrene O O
in O O
her O O
L O O
third O O
toe O O
and O O
subsequently O O
underwent O O
a O O
redo O O
L O O
fem-anterior O O
tibial O O
bypass O O
using O O
R O O
basilic O O
and O O
cephalic O O
veins O O
on O O
5/3/78. O O
On O O
6/11/78 O O
she O O
had O O
graft O O
scanning, O O
which O O
indicated O O
a O O
widely O O
patent O O
left O O
leg O O
graft O O
and O O
ankle-brachial O O
indices O O
at O O
that O O
time O O
were O O
normal O O
bilaterally. O O
However, O O
she O O
presented O O
on O O
9/17/78 O O
c/o O O
L O O
foot O O
pain. O O
On O O
physical O O
exam, O O
she O O
was O O
noted O O
to O O
have O O
a O O
very O O
small O O
pinhole O O
ulcer O O
over O O
the O O
plantar O O
aspect O O
of O O
her O O
left O O
great O O
toe. O O
She O O
now O O
presents O O
with O O
increasing O O
pain, O O
&#8220;32&#8221; O O
on O O
scale O O
0-10 O O
that O O
is O O
constant O O
in O O
nature, O O
with O O
occasional O O
sharp O O
spikes O O
in O O
intensity. O O
She O O
also O O
confirms O O
loss O O
of O O
sensation O O
and O O
motor O O
strength O O
in O O
the O O
L O O
foot, O O
but O O
there O O
is O O
no O O
paresthesia. O O
She O O
denies O O
CP, O O
SOB, O O
N/V, O O
flank O O
pain, O O
or O O
any O O
urinary O O
Sx O O
and O O
has O O
no O O
history O O
of O O
cardiac O O
disease. O O
PMH: O O
- O O
diabetes B-DIABETES O
type I-DIABETES O
1 I-DIABETES O
since I-DIABETES O
age I-DIABETES O
10 I-DIABETES O
- O O
PVD O O
- O O
HTN O O
- O O
hyperlipidemia O O
PSH: O O
- O O
L O O
fem-anterior O O
tibial O O
bypass O O
- O O
5/3/78 O O
- O O
Right O O
fem-pop O O
bypass O O
- O O
2066 O O
- O O
Left O O
fem-DP O O
bypass O O
&#8211; O O
2066 O O
MEDS: O O
- O O
Atenolol B-MEDICATION B-MEDICATION
25mg O O
PO O O
QD O O
- O O
Valsartan B-MEDICATION B-MEDICATION
160mg O O
PO O O
BID O O
- O O
ASA B-MEDICATION B-MEDICATION
325mg O O
PO O O
QD O O
- O O
Oxycodone O O
5-10mg O O
PO O O
Q3H O O
PRN O O
pain O O
- O O
Vitamin O O
C O O
500mg O O
PO O O
BID O O
- O O
Folic O O
Acid O O
1mg O O
PO O O
BID O O
- O O
Colace O O
100mg O O
PO O O
BID O O
- O O
Neurontin O O
300mg O O
PO O O
TID O O
ALL: O O
Percocet O O
- O O
nausea O O
FH: O O
Brother B-FAMILY_HIST O
died I-FAMILY_HIST O
of I-FAMILY_HIST O
heart I-FAMILY_HIST O
attack I-FAMILY_HIST O
at I-FAMILY_HIST O
48, I-FAMILY_HIST O
father I-FAMILY_HIST O
had I-FAMILY_HIST O
MI I-FAMILY_HIST O
x3; I-FAMILY_HIST O
no O O
one O O
else O O
in O O
the O O
family O O
has O O
had O O
either O O
DM O O
type O O
I O O
or O O
PVD O O
SH: O O
Lives O O
in O O
Morehead, O O
WI O O
with O O
her O O
partner. O O
Smoked B-SMOKER O
for I-SMOKER O
3 I-SMOKER O
years I-SMOKER O
in I-SMOKER O
her I-SMOKER O
early I-SMOKER O
20's, I-SMOKER O
but I-SMOKER O
there I-SMOKER O
is I-SMOKER O
no I-SMOKER O
recent I-SMOKER O
EtOH/TOB/IVDU. I-SMOKER O
Works O O
as O O
a O O
Senior O O
Manager O O
of O O
Broadcasting. O O
PHYSICAL O O
EXAMINATION: O O
VITALS O O
97.8 O O
74 O O
136/48 O O
18 O O
95%RA O O
FSglucose O O
74 O O
General O O
&#8211; O O
NAD, O O
well O O
appearing O O
Pulmonary O O
&#8211; O O
clear O O
to O O
auscultation O O
bilaterally, O O
with O O
no O O
crackles O O
or O O
wheezes O O
appreciated O O
Cardiac O O
&#8211; O O
regular O O
rate O O
and O O
rhythm; O O
S1 O O
and O O
S2 O O
normal; O O
no O O
murmurs, O O
rubs O O
or O O
gallops; O O
Abdomen O O
&#8211; O O
soft, O O
non-distended; O O
non-tender O O
without O O
rebound O O
and O O
guarding O O
Extremity O O
&#8211; O O
Warm O O
bilaterally; O O
well-healed O O
bypass O O
incisions O O
bilaterally; O O
L O O
foot O O
erythematous, O O
mildly O O
edematous; O O
no O O
clubbing, O O
cyanosis; O O
ulcer O O
on O O
the O O
L O O
big O O
toe O O
and O O
a O O
small O O
dermal O O
hematoma O O
on O O
the O O
L O O
5th O O
toe; O O
tissue O O
loss O O
of O O
tip O O
of O O
2nd O O
and O O
3rd O O
toes, O O
tip O O
of O O
3rd O O
toe O O
with O O
blackened, O O
necrotic O O
tissue, O O
no O O
drainage O O
Pulses: O O
Fem O O
Pop O O
DP O O
PT O O
R O O
2+ O O
2+ O O
2+ O O
2+ O O
L O O
2+ O O
2+ O O
non-dopplerable O O
non- O O
dopplerable O O
Neurology O O
&#8211; O O
CN O O
II-XII O O
grossly O O
intact, O O
5/5 O O
motor O O
strength O O
and O O
normal O O
sensation O O
bilaterally O O
including O O
L O O
foot O O
Mental O O
status O O
&#8211; O O
alert O O
and O O
oriented O O
x O O
3 O O
-- O O
LABORATORIES: O O
Chem O O
7, O O
CBC, O O
coags, O O
clot O O
ordered O O
UA O O
negative O O
-- O O
EKG: O O
Sinus; O O
rate O O
~75; O O
normal O O
intervals; O O
normal O O
R O O
wave O O
progression; O O
T O O
wave O O
inversion O O
in O O
V1; O O
no O O
ST O O
segment O O
changes; O O
overall O O
comparable O O
to O O
previous O O
EKG O O
-- O O
RADIOLOGICAL O O
STUDIES: O O
CXR O O
09/26/2078: O O
(Prelim) O O
Lung O O
fields O O
clear, O O
no O O
effusions O O
09/26/78 O O
Type: O O
Arterial O O
Ultrasound O O
Tests O O
The O O
following O O
are O O
the O O
velocities O O
in O O
cm/s, O O
proximal O O
to O O
distal: O O
COMMON O O
FEMORAL O O
200 O O
PROXIMAL O O
ANASTOMOSIS O O
307 O O
PROXIMAL O O
GRAFT O O
84 O O
PROXIMAL O O
GRAFT O O
211 O O
PROXIMAL O O
GRAFT O O
318 O O
PROXIMAL-MID O O
94 O O
MID O O
THIGH O O
26 O O
DISTAL O O
THIGH O O
13 O O
PROX O O
TO O O
DISTAL O O
ANASTOMOSIS O O
5 O O
DISTAL O O
ANASTOMOSIS O O
40 O O
Brachial O O
pressure=152 O O
/ O O
Right O O
ankle=141 O O
abi=0.92 O O
/ O O
Left O O
ankle=30 O O
(anterior O O
tibial) O O
abi=0.19 O O
Date: O O
09/17/78 O O
Type: O O
Venous O O
Ultrasound O O
Tests O O
There O O
is O O
no O O
evidence O O
of O O
thrombosis O O
in O O
either O O
the O O
right O O
or O O
left O O
common O O
femoral, O O
superficial O O
femoral O O
and O O
popliteal O O
veins. O O
There O O
is O O
no O O
gross O O
evidence O O
of O O
deep O O
vein O O
thrombosis O O
in O O
the O O
left O O
calf. O O
Date: O O
06/11/78 O O
Type: O O
Arterial O O
Ultrasound O O
Tests O O
right O O
brachial O O
pressure O O
168 O O
mmHg O O
left O O
brachial O O
pressure O O
169 O O
mmhg O O
right O O
dp O O
154 O O
mmhg O O
left O O
dp O O
143 O O
mmHg O O
right O O
pt O O
156 O O
mmHg O O
left O O
pt O O
151 O O
mmHg O O
Patent O O
arterial O O
bypass O O
graft O O
with O O
no O O
evidence O O
of O O
hemodynamically O O
significant O O
stenosis. O O
ASSESSMENT O O
AND O O
PLAN: O O
52 O O
y/o O O
F O O
with O O
Hx O O
of O O
diabetes B-DIABETES O
type I-DIABETES O
I I-DIABETES O
and O O
PVD, O O
s/p O O
several O O
bypasses, O O
presenting O O
with O O
worsening O O
L O O
foot O O
pain O O
of O O
two O O
weeks O O
duration. O O
On O O
physical O O
exam, O O
L O O
foot O O
is O O
exquisitely O O
tender O O
and O O
while O O
it O O
is O O
warm O O
to O O
touch, O O
it O O
is O O
erythematous O O
and O O
there O O
is O O
an O O
ulcer O O
on O O
the O O
plantar O O
surface O O
of O O
the O O
big O O
toe. O O
In O O
addition, O O
ABIs O O
from O O
today O O
show O O
L O O
ankle O O
ABI O O
of O O
0.19. O O
The O O
etiology O O
of O O
her O O
pain O O
is O O
an O O
occlusion O O
of O O
the O O
L O O
fem-anterior O O
tibial O O
bypass O O
vs. O O
diabetic O O
neuropathy, O O
however, O O
she O O
has O O
been O O
taking O O
neurontin O O
without O O
relief O O
and O O
the O O
diabetic O O
neuropathy O O
is O O
less O O
likely. O O
- O O
oxycodone O O
for O O
pain O O
control, O O
continue O O
neurontin O O
- O O
continue O O
home O O
atenolol, B-MEDICATION B-MEDICATION
ASA, O B-MEDICATION
Valsartan O O
- O O
NPO O O
from O O
midnight, O O
pepcid O O
- O O
check O O
chem7, O O
CBC, O O
coags O O
- O O
has O O
an O O
insulin B-MEDICATION O
pump I-MEDICATION O
- O O
angiography O O
vs. O O
angioplasty O O
tomorrow O O
_____________ O O
Hayden O O
Shepherd O O
MANAMANA O O
IV O O
01722 O O
Patient O O
seen O O
and O O
examined. O O
Agree O O
with O O
medical O O
student O O
note O O
above. O O
Briefly, O O
52yF O O
with O O
DM B-DIABETES O
I, I-DIABETES O
HTN, O O
hyperlipidemia O O
s/p O O
bilateral O O
revascularization O O
procedures O O
for O O
PVD O O
presents O O
with O O
complaints O O
of O O
left O O
foot O O
pain O O
limiting O O
walking O O
to O O
several O O
feet O O
as O O
well O O
as O O
with O O
small O O
ulcers O O
on O O
her O O
toes. O O
ABIs O O
are O O
very O O
diminished O O
on O O
the O O
left O O
and O O
graft O O
scan O O
shows O O
elevated O O
velocities O O
at O O
proximal O O
anastomosis. O O
She O O
is O O
admitted O O
in O O
anticipation O O
of O O
angiography O O
in O O
am. O O
N: O O
Cont O O
oxycodone, O O
neurontin O O
CV: O O
Cont O O
home O O
meds O O
Resp: O O
F/u O O
final O O
CXR O O
read O O
GI: O O
Diabetic O O
diet; O O
NPO O O
after O O
MN O O
GU: O O
D5 O O
&#189; O O
NS O O
@ O O
100 O O
after O O
MN; O O
foley O O
to O O
be O O
placed O O
at O O
6AM O O
Heme: O O
SQH O O
ID: O O
No O O
issues O O
Endo: O O
Patient O O
has O O
insulin O O
pump O O
and O O
knows O O
to O O
adjust O O
this O O
when O O
she O O
is O O
NPO O O
Other: O O
Consent O O
for O O
angiogram O O
in O O
chart O O
Discussed O O
with O O
Dr. O O
Weller, O O
vascular O O
chief O O
resident, O O
who O O
agrees O O
with O O
assessment O O
and O O
plan. O O
______________ O O
Kathryn O O
Brewer, O O
MD O O
PGY O O
2 O O
Pg O O
68283 O O

Record O O
date: O O
2079-08-04 O O
EDVISIT^75322175^HENDRICKS, O O
HANNAH^08/04/79^FAULKNER, O O
GABRIAL O O
CHIEF O O
COMPLAINT: O O
Lower O O
extremity O O
cellulitis. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
is O O
a O O
53-year-old O O
diabetic B-DIABETES O
vasculopathic O O
with O O
a O O
history O O
of O O
multiple O O
lower O O
extremity O O
arterial O O
bypass O O
who O O
comes O O
in O O
today O O
with O O
bilateral O O
lower O O
extremity O O
cellulitis, O O
has O O
diagnosed O O
by O O
her O O
PCP. O O
She O O
was O O
recently O O
treated O O
at O O
an O O
outside O O
hospital O O
for O O
bilateral O O
lower O O
extremity O O
cellulitis, O O
had O O
a O O
2-day O O
hospital O O
stay, O O
and O O
was O O
discharged O O
home O O
on O O
Keflex. O O
She O O
felt O O
that O O
she O O
did O O
have O O
some O O
improvement O O
but O O
over O O
the O O
past O O
48 O O
hours O O
has O O
had O O
worsening O O
erythema O O
in O O
lower O O
extremities. O O
She O O
has O O
also O O
been O O
having O O
some O O
emesis, O O
myalgias O O
and O O
fatigue, O O
but O O
has O O
not O O
had O O
any O O
hematemesis, O O
abdominal O O
pain, O O
constipation, O O
diarrhea, O O
or O O
other O O
symptomatology. O O
She O O
has O O
also O O
not O O
noticed O O
any O O
urinary O O
symptoms O O
of O O
frequency. O O
PAST O O
MEDICAL O O
HISTORY: O O
Peripheral O O
vascular O O
disease, O O
hypertension, B-HYPERTENSION O
hyperlipidemia, B-HYPERLIPIDEMIA O
and O O
diabetes. B-DIABETES O
PAST O O
SURGICAL O O
HISTORY: O O
Amputation O O
to O O
the O O
left O O
second, O O
third O O
and O O
fifth O O
toes, O O
bilateral O O
fem-pop O O
bypasses O O
right O O
in O O
2061, O O
left O O
in O O
2066 O O
and O O
anterior O O
tibial O O
bypass O O
graft O O
in O O
05/2078. O O
SOCIAL O O
HISTORY: O O
The O O
patient O O
works O O
as O O
a O O
Senior O O
Manager O O
of O O
Broadcasting O O
and O O
denies B-SMOKER O
tobacco, I-SMOKER O
alcohol, O O
or O O
drugs. O O
PHYSICAL O O
EXAMINATION: O O
Blood O O
pressure O O
146/66, B-HYPERTENSION O
pulse O O
98, O O
respiratory O O
rate O O
20, O O
temperature O O
101.2, O O
and O O
O2 O O
saturation O O
99% O O
on O O
room O O
air. O O
General: O O
This O O
is O O
a O O
well-appearing O O
woman O O
in O O
no O O
apparent O O
distress. O O
Respiratory: O O
Clear O O
to O O
auscultation O O
bilaterally, O O
no O O
rales, O O
rhonchi, O O
or O O
wheezes. O O
Cardiovascular: O O
Regular O O
rate O O
and O O
rhythm, O O
no O O
murmurs, O O
rubs, O O
or O O
gallops. O O
GI: O O
The O O
abdomen O O
is O O
soft. O O
The O O
patient O O
does O O
have O O
insulin B-MEDICATION O
pump I-MEDICATION O
in O O
place, O O
but O O
has O O
no O O
erythema O O
or O O
fluctuance O O
over O O
the O O
pump. O O
Skin O O
is O O
warm, O O
dry, O O
and O O
intact O O
with O O
the O O
exception O O
of O O
the O O
left O O
lower O O
extremity, O O
which O O
is O O
erythematous, O O
warm O O
and O O
slightly O O
swollen O O
compared O O
to O O
the O O
right O O
lower O O
extremity. O O
This O O
erythema O O
stops O O
at O O
the O O
ankle O O
and O O
does O O
not O O
extend O O
up O O
above O O
the O O
knee. O O
The O O
patient O O
also O O
has O O
an O O
open O O
chronic O O
nonhealing O O
wound O O
on O O
the O O
plantar O O
surface O O
of O O
her O O
left O O
foot O O
as O O
well. O O
There O O
is O O
no O O
erythema O O
surrounding O O
this O O
wound O O
Neurologic: O O
Awake, O O
alert, O O
and O O
oriented O O
x3 O O
except O O
for O O
some O O
decreased O O
sensation O O
in O O
her O O
left O O
foot, O O
which O O
is O O
chronic. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
The O O
patient O O
was O O
seen O O
and O O
evaluated O O
by O O
me O O
and O O
the O O
resident. O O
I O O
confirm O O
that O O
I O O
have O O
seen O O
and O O
evaluated O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation O O
on O O
the O O
patient's O O
chart, O O
and O O
discussed O O
the O O
evaluation, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient O O
as O O
well O O
as O O
the O O
resident. O O
The O O
patient O O
had O O
a O O
CBC O O
and O O
metabolic O O
panel. O O
CBC O O
showed O O
white O O
count O O
of O O
14 O O
with O O
shift. O O
LFTs O O
were O O
within O O
normal O O
limits. O O
X-ray O O
of O O
her O O
left O O
foot O O
showed O O
no O O
osteomyelitis O O
seen O O
on O O
x-ray O O
and O O
x-ray O O
of O O
her O O
tib-fib O O
continued O O
to O O
show O O
no O O
osteomyelitis. O O
Given O O
the O O
erythema O O
and O O
swelling, O O
I O O
was O O
concerned O O
about O O
a O O
cellulitis O O
in O O
this O O
vasculopathic O O
who O O
was O O
also O O
diabetic O O
and O O
so O O
we O O
gave O O
her O O
a O O
1 O O
g O O
of O O
vancomycin O O
(especially O O
given O O
the O O
fact O O
that O O
she O O
has O O
failed O O
outpatient O O
therapy O O
with O O
oral O O
antibiotics) O O
and O O
we O O
are O O
admitting O O
her O O
to O O
the O O
Medicine O O
Service O O
for O O
cellulitis. O O
The O O
patient's O O
erythema O O
and O O
swelling O O
does O O
not O O
extend O O
to O O
her O O
foot O O
and O O
would O O
be O O
extremely O O
atypical O O
for O O
a O O
DVT. O O
We O O
also O O
notified O O
the O O
Internal O O
Medicine O O
resident O O
of O O
the O O
patient's O O
admission O O
to O O
Medicine O O
as O O
she O O
is O O
followed O O
closely O O
by O O
Surgery O O
and O O
this O O
notification O O
was O O
made O O
at O O
8:30 O O
p.m. O O
Given O O
the O O
fact O O
that O O
she O O
does O O
not O O
have O O
osteomyelitis O O
at O O
this O O
point O O
we O O
have O O
not O O
discussed O O
the O O
PICC O O
line O O
and O O
given O O
the O O
fact O O
that O O
she O O
does O O
not O O
have O O
any O O
____ O O
abnormalities, O O
I O O
did O O
not O O
believe O O
that O O
she O O
needs O O
pressors O O
or O O
aggressive O O
hydration O O
and O O
we O O
are O O
starting O O
her O O
on O O
maintenance O O
fluids, O O
antibiotics, O O
and O O
admitting O O
her O O
to O O
the O O
hospital. O O
DIAGNOSIS: O O
Left O O
lower O O
extremity O O
cellulitis. O O
CONDITION: O O
Stable. O O
DISPOSITION: O O
Admit O O
to O O
hospital. O O
______________________________ O O
FAULKNER, O O
GABRIAL O O
MD O O
D: O O
08/05/79 O O
T: O O
08/05/79 O O
Dictated O O
By: O O
FAULKNER, O O
GABRIAL O O
eScription O O
document:7-11192535 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2095-03-16 O O
Trinity O O
Regional O O
Medical O O
Center O O
8699 O O
Mill O O
Street O O
MARSH, O O
CARL O O
Albertville, O O
RI O O
87193 O O
39955317 O O
(906) O O
517-8625 O O
03/16/2095 O O
HISTORY B-SMOKER O
OF O O
PRESENT O O
ILLNESS: O O
Mr. O O
Marsh O O
is O O
a O O
73-year-old O O
male O O
who O O
comes O O
for O O
first O O
visit O O
to O O
TRMC O O
to O O
initiate O O
longitudinal O O
care O O
and O O
follow O O
up O O
of O O
multiple O O
medical O O
problems. O O
PROBLEMS: O O
1. O O
Chronic O O
renal O O
failure. O O
He O O
has O O
been O O
on O O
dialysis O O
for O O
the O O
past O O
four O O
years. O O
He O O
is O O
currently O O
dialyzed O O
two O O
times O O
per O O
week. O O
He O O
apparently O O
had O O
been O O
three O O
times O O
per O O
week O O
in O O
the O O
past. O O
2. O O
Hyperlipidemia. B-HYPERLIPIDEMIA O
Fasting O O
lipid O O
analysis O O
one O O
year O O
ago O O
showed O O
total O O
cholesterol O O
225, O O
triglycerides O O
265, O O
LDL B-HYPERLIPIDEMIA O
161, I-HYPERLIPIDEMIA O
and O O
HDL O O
40. O O
He O O
has O O
not O O
been O O
treated. O O
3. O O
Hyperparathyroidism. O O
PTH O O
level O O
one O O
year O O
ago O O
was O O
143. O O
He O O
is O O
on O O
calcium O O
replacement. O O
4. O O
IgG O O
monoclonal O O
gammopathy. O O
This O O
was O O
noted O O
on O O
immunoelectrophoresis. O O
It O O
was O O
at O O
very O O
low O O
levels. O O
MEDICATIONS: O O
Aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
q.d., O O
Nephrocaps O O
one O O
q.d., O O
and O O
PhosLo O O
2001 O O
mg O O
t.i.d. O O
by O O
his O O
report. O O
REVIEW O O
OF O O
SYMPTOMS: O O
He O O
states O O
he O O
was O O
told O O
he O O
was O O
hypertensive O O
at O O
last O O
dialysis. O O
No O O
significant O O
weight O O
change, O O
febrile O O
signs O O
or O O
symptoms, O O
headache, O O
blurred O O
vision, O O
tinnitus, O O
chest O O
pain, O O
cough, O O
shortness O O
of O O
breath, O O
nausea, O O
abdominal O O
pain, O O
nightsweats, O O
diarrhea, O O
skin O O
rash, O O
bruising, O O
joint O O
pain, O O
or O O
focal O O
weakness. O O
ALLERGIES: O O
No O O
known O O
allergies. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
appears O O
well. O O
Blood O O
pressure O O
on O O
multiple O O
measurements O O
range O O
from O O
150-160/78-82, B-HYPERTENSION O
weight O O
144 O O
pounds, O O
and O O
heart O O
rate O O
72 O O
and O O
regular. O O
Chest: O O
Clear O O
to O O
percussion O O
and O O
auscultation. O O
Cardiovascular O O
exam: O O
No O O
extra O O
sounds O O
or O O
murmurs. O O
Abdominal O O
exam: O O
No O O
masses, O O
tenderness, O O
or O O
organomegaly. O O
Extremities: O O
No O O
edema. O O
Skin: O O
No O O
rash. O O
Musculoskeletal O O
exam: O O
Grossly O O
intact. O O
ASSESSMENT/PLAN: O O
1. O O
Chronic O O
renal O O
failure. O O
The O O
patient O O
will O O
continue O O
on O O
dialysis. O O
I O O
have O O
requested O O
screening O O
blood O O
tests. O O
2. O O
Hyperlipidemia. O O
This O O
needs O O
to O O
be O O
treated. O O
I O O
have O O
asked O O
him O O
to O O
return O O
for O O
reestablishment O O
of O O
baseline. O O
3. O O
Hyperparathyroidism. O O
Secondary O O
to O O
chronic O O
renal O O
failure. O O
He O O
is O O
on O O
calcium O O
replacement. O O
4. O O
Low-grade O O
IgG O O
monoclonal O O
gammopathy. O O
Will O O
recheck O O
values O O
and O O
follow. O O
5. O O
Hypertension. B-HYPERTENSION O
A O O
degrees O O
systolic O O
hypertension O O
warrants O O
therapy. O O
He O O
is O O
due O O
for O O
dialysis O O
tomorrow, O O
however. O O
I O O
gave O O
him O O
a O O
prescription O O
for O O
atenolol B-MEDICATION B-MEDICATION
25 O O
mg O O
p.o. O O
q.d. O O
6. O O
Adult O O
health O O
maintenance. O O
I O O
gave O O
him O O
a O O
prescription O O
for O O
aspirin, B-MEDICATION B-MEDICATION
which O O
he O O
should O O
be O O
taking O O
and O O
asked O O
him O O
to O O
return O O
in O O
two O O
weeks O O
for O O
a O O
full O O
annual O O
review. O O
I O O
instructed O O
him O O
to O O
show O O
renal O O
staff O O
the O O
prescriptions O O
tomorrow O O
at O O
dialysis. O O
______________________________ O O
Xavier O O
T O O
Mccoy, O O
M.D. O O
eScription O O
document:4-4113812 O O
EMS O O
DD: O O
03/16/95 O O
DT: O O
03/16/95 O O
DV: O O
03/16/95 O O

Record O O
date: O O
2095-09-19 O O
KEKELA O O
INPATIENT O O
DIALYSIS O O
ADMIT O O
NOTE O O
NAME: O O
Marsh, O O
Carl O O
MRN: O O
99579205 O O
Primary O O
Care O O
MD: O O
Xavier O O
T. O O
Mccoy O O
Outpatient O O
Nephrologist: O O
Keith O O
Tierney O O
Outpatient O O
Dialysis O O
Unit: O O
Sanford O O
Memorial O O
Hospital, O O
S O O
and O O
T O O
Estimated O O
dry O O
weight: O O
61 O O
kg O O
Dialysis O O
access: O O
left O O
AVF O O
Reason O O
for O O
admission: O O
body O O
jerking O O
since O O
last O O
night O O
HPI: O O
74 O O
year O O
old O O
Turkmenistan O O
male O O
with O O
a O O
past O O
medical O O
history O O
of O O
ESRD O O
presumably O O
secondary O O
to O O
HTN B-HYPERTENSION O
presents O O
to O O
the O O
KEKELA O O
ED O O
with O O
complaints O O
of O O
body O O
jerking O O
since O O
last O O
night. O O
The O O
patient O O
was O O
in O O
his O O
otherwise O O
good O O
state O O
of O O
health O O
when O O
he O O
went O O
to O O
his O O
normal O O
dialysis O O
session O O
yesterday. O O
The O O
session O O
was O O
uneventful, O O
and O O
he O O
finished O O
dialysis O O
around O O
7:30 O O
pm. O O
Around O O
9 O O
pm, O O
he O O
started O O
noting O O
un-controlable O O
jerky O O
movements O O
of O O
his O O
jaw, O O
arms, O O
and O O
legs. O O
He O O
was O O
unable O O
to O O
stand O O
by O O
himself, O O
and O O
had O O
difficulty O O
with O O
any O O
motor O O
activity. O O
It O O
was O O
so O O
bad O O
that O O
he O O
was O O
unable O O
to O O
feed O O
himself, O O
and O O
needed O O
help O O
from O O
his O O
wife O O
to O O
do O O
so. O O
The O O
jerking O O
continued O O
throughout O O
the O O
night O O
without O O
getting O O
better, O O
and O O
his O O
daughter O O
called O O
his O O
PCP's O O
office O O
today, O O
at O O
which O O
time O O
he O O
was O O
instructed O O
to O O
proceed O O
to O O
the O O
KEKELA O O
ED. O O
He O O
has O O
had O O
a O O
similar O O
episode O O
like O O
this O O
before O O
in O O
January O O
of O O
2092, O O
when O O
he O O
developed O O
the O O
exact O O
same O O
jerking O O
movements O O
after O O
a O O
long O O
three O O
day O O
weekend O O
when O O
he O O
went O O
without O O
dialysis O O
(see O O
note O O
in O O
LMR O O
by O O
neurology O O
consultant). O O
It O O
was O O
deemed O O
at O O
that O O
time O O
that O O
his O O
myoclonus O O
was O O
due O O
to O O
electrolyte O O
disarray, O O
and O O
he O O
was O O
admitted O O
to O O
EDUCARE-FARGO O O
and O O
received O O
dialysis O O
the O O
same O O
day O O
with O O
complete O O
resolution O O
of O O
symptoms. O O
He O O
has O O
been O O
symptom-free O O
since O O
that O O
time. O O
He O O
reports O O
no O O
other O O
new O O
events. O O
He O O
denies O O
any O O
new O O
medications. O O
Past O O
Medical O O
History: O O
1.) O O
ESRD O O
secondary O O
to O O
hypertension B-HYPERTENSION O
n O O
on O O
HD O O
since O O
November O O
2090 O O
n O O
current O O
access O O
is O O
left O O
radiocephalic O O
fistula O O
placed O O
in O O
April O O
of O O
2091 O O
n O O
currently O O
followed O O
by O O
Dr. O O
Tierney O O
at O O
the O O
Sanford O O
Memorial O O
Hospital O O
2.) O O
HTN O O
3.) O O
IgG O O
monoclonal O O
gammopathy O O
4.) O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Allergies: O O
NKDA O O
Medications: O O
Vitamin O O
D O O
Atenolol B-MEDICATION B-MEDICATION
25 I-MEDICATION O
mg I-MEDICATION O
po I-MEDICATION O
qd I-MEDICATION O
ASA B-MEDICATION O
(he O O
stopped O O
on O O
his O O
own) O O
Nephrocaps O O
1 O O
tab O O
po O O
qd O O
Phos-Lo O O
2001 O O
mg O O
po O O
tid O O
Social B-SMOKER O
History: I-SMOKER O
The O O
patient O O
immigrated O O
from O O
Tonga O O
to O O
Uganda O O
in O O
2061. O O
He O O
lives O O
with O O
his O O
wife O O
in O O
Mount O O
Airy. O O
He O O
lives O O
with O O
his O O
wife O O
in O O
Mount O O
Airy. O O
He O O
has O O
five O O
adult O O
children. O O
Review O O
of O O
Systems: O O
Constitutional: O O
(-) O O
fevers, O O
chills, O O
night O O
sweats. O O
Pulmonary: O O
(-) O O
shortness O O
of O O
breath. O O
Cardiovascular: O O
(-) O O
chest O O
pain, O O
palpitations. O O
Gastrointestinal: O O
(-) O O
N/V, O O
diarrhea, O O
constipation O O
Skin: O O
denies O O
easy O O
bruising O O
Rheumatologic: O O
No O O
arthritis O O
or O O
gout O O
Neurologic: O O
(+) O O
jerking O O
movements O O
PHYSICAL O O
EXAM O O
Temp: O O
98.2 O O
BP: O O
102/61 O O
HR: O O
63 O O
RR:20 O O
Sats: O O
96% O O
on O O
RA O O
Gen: O O
pleasant O O
older O O
gentleman, O O
lying O O
in O O
gurney O O
with O O
obvious O O
myoclonus O O
affecting O O
his O O
speech O O
HEENT: O O
sclerae O O
non-icteric, O O
mucous O O
membranes O O
moist, O O
normal O O
sized O O
tongue O O
Neck: O O
supple, O O
JVP O O
8, O O
2+ O O
carotids O O
Lungs: O O
slightly O O
diminished O O
breath O O
sound O O
on O O
the O O
left, O O
otherwise O O
unremarkable O O
Cor: O O
S1, O O
S2, O O
regular O O
with O O
PVC's, O O
soft O O
systolic O O
murmur O O
at O O
base O O
Abd: O O
soft, O O
NTND, O O
no O O
HSM, O O
no O O
bruits O O
Ext: O O
no O O
edema O O
in O O
LE O O
b/l, O O
1+ O O
pulses O O
distally O O
Skin: O O
+ O O
fat O O
pads O O
in O O
supraclavicular O O
region O O
Access: O O
left O O
AVF O O
with O O
good O O
thrill O O
Neuro: O O
CN O O
3-12 O O
intact O O
myoclonic O O
jerking O O
evident O O
in O O
jaw, O O
arms, O O
and O O
legs, O O
worse O O
with O O
intentional O O
movements O O
strength O O
normal O O
throughout O O
sensation O O
preserved O O
to O O
light O O
touch O O
reflexes O O
1+ O O
in O O
upper O O
extremities, O O
difficult O O
in O O
LE O O
due O O
to O O
myoclonic O O
jerking O O
cerebellar O O
exam O O
normal O O
LABS: O O
GLUCOSE O O
73 O O
(54-118) O O
mg/dL O O
UREA O O
N O O
41 O O
* O O
(9-25) O O
mg/dL O O
CREATININE O O
9.2 O O
* O O
(0.7-1.3) O O
mg/dL O O
SODIUM O O
141 O O
(136-142) O O
mmol/L O O
POTASSIUM O O
5.5 O O
* O O
(3.5-5.0) O O
mmol/L O O
CHLORIDE O O
91 O O
* O O
(98-108) O O
mmol/L O O
TOTAL O O
CO2 O O
37 O O
* O O
(23-32) O O
mmol/L O O
ANION O O
GAP O O
13 O O
(3-15) O O
mmol/L O O
ALT/GPT O O
19 O O
(7-52) O O
U/L O O
AST/GOT O O
24 O O
(9-30) O O
U/L O O
ALK O O
PHOS O O
59 O O
(36-118) O O
U/L O O
AMYLASE O O
176 O O
* O O
(20-70) O O
U/L O O
TOT O O
BILI O O
0.4 O O
(0.2-1.2) O O
mg/dL O O
LIPASE O O
50 O O
(3-60) O O
U/L O O
TOT O O
PROT O O
8.5 O O
* O O
(6.0-8.0) O O
g/dL O O
ALBUMIN O O
4.6 O O
(3.7-5.4) O O
g/dL O O
GLOBULIN O O
3.9 O O
(2.0-4.0) O O
g/dL O O
CALCIUM O O
9.7 O O
(8.8-10.5) O O
mg/dL O O
PHOSPHATE O O
6.1 O O
*# O O
(2.4-5.0) O O
mg/dL O O
MAGNESIUM O O
2.4 O O
(1.8-2.5) O O
mg/dL O O
WBC O O
7.64 O O
(4-10) O O
K/uL O O
RBC O O
4.68 O O
(4.5-6.4) O O
M/uL O O
HGB O O
14.5 O O
(13.5-18.0) O O
g/dL O O
HCT O O
41.8 O O
(40-54) O O
% O O
MCV O O
89.3 O O
(80-95) O O
um3 O O
MCH O O
30.9 O O
(27-32) O O
uug O O
MCHC O O
34.6 O O
(32-36) O O
g/dL O O
RDW O O
14.8 O O
* O O
(10-14.5) O O
PLT O O
232 O O
(150-450) O O
K/uL O O
LYMP O O
% O O
25.7 O O
(18-41) O O
MONO O O
% O O
9.2 O O
* O O
(2.5-8.5) O O
NEUT O O
% O O
61.0 O O
(48-76) O O
EOS O O
% O O
3.9 O O
(0-5) O O
BASO O O
% O O
0.3 O O
(0-1.5) O O
PT O O
14.1 O O
(11.8-14.6) O O
sec O O
PTT O O
27.5 O O
(23.8-36.6) O O
sec O O
PT(INR) O O
1.1 O O
(0.9-1.1) O O
ASSESSMENT: O O
74 O O
year O O
old O O
male O O
who O O
presents O O
with: O O
1.) O O
Myoclonus O O
unclear O O
etiology O O
without O O
obvious O O
precipitants; O O
the O O
last O O
time O O
this O O
happened, O O
it O O
was O O
in O O
the O O
setting O O
of O O
not O O
getting O O
dialyzed O O
after O O
three O O
days. O O
While O O
he O O
did O O
get O O
dialysis O O
yesterday O O
per O O
his O O
normal O O
schedule, O O
it O O
is O O
odd O O
that O O
his O O
potassium O O
today O O
is O O
5.5, O O
suggesting O O
perhaps O O
either O O
dietary O O
indiscretion O O
(which O O
he O O
denies) O O
or, O O
perhaps, O O
inadequate O O
dialysis. O O
In O O
addition, O O
he O O
says O O
that O O
his O O
dialysis O O
center O O
has O O
been O O
taking O O
him O O
off O O
early O O
a O O
few O O
times O O
in O O
the O O
past O O
week, O O
though O O
he O O
notes O O
that O O
he O O
got O O
a O O
full O O
run O O
yesterday O O
(3 O O
hours) O O
2.) O O
chronic O O
HD O O
3.) O O
h/o O O
MGUS O O
shoulder O O
fat O O
pads O O
PLAN: O O
1.) O O
Admit O O
to O O
Renal O O
Medicine O O
service, O O
Dr. O O
Tierney O O
attending O O
2.) O O
Will O O
plan O O
on O O
dialysis O O
tomorrow O O
for O O
two O O
reasons: O O
(1) O O
high O O
potassium, O O
(2) O O
see O O
if O O
this O O
helps O O
with O O
myoclonus O O
3.) O O
Will O O
contact O O
dialysis O O
center O O
tomorrow O O
to O O
see O O
if O O
any O O
problems O O
with O O
his O O
runs, O O
and O O
what O O
his O O
most O O
recent O O
URR O O
or O O
Kt/V O O
was O O
4.) O O
continue O O
Phos-Lo O O
2001 O O
tid O O
with O O
meals O O
5.) O O
Kayexalate O O
30 O O
po O O
tonight O O
for O O
elevated O O
potassium O O
Discussed O O
with O O
Dr. O O
Tierney O O
______________________ O O
Uriah O O
T. O O
Quin, O O
M.D. O O
Renal O O
Fellow O O
#80467 O O

Record O O
date: O O
2096-12-13 O O
Trinity O O
Regional O O
Medical O O
Center O O
1190 O O
Mill O O
Street O O
MARSH, O O
CARL O O
Albertville, O O
RI O O
87193 O O
39955317 O O
(906) O O
517-8625 O O
12/13/2096 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Mr. O O
Marsh O O
is O O
a O O
75-year-old O O
male O O
who O O
comes O O
for O O
comprehensive O O
exam O O
and O O
follow O O
up O O
medical O O
problems. O O
1. O O
Chronic O O
renal O O
failure. O O
He O O
is O O
on O O
chronic O O
dialysis O O
twice O O
a O O
week. O O
2. O O
Hyperlipidemia. B-HYPERLIPIDEMIA O
Fasting O O
lipid O O
analysis O O
18 O O
months O O
ago O O
showed O O
total O O
cholesterol O O
221, O O
triglycerides O O
192, O O
LDL B-HYPERLIPIDEMIA O
136, I-HYPERLIPIDEMIA O
and O O
HDL O O
47. O O
3. O O
Cataracts. O O
He O O
is O O
about O O
to O O
undergo O O
cataract O O
removal. O O
Comes O O
as O O
well O O
today O O
for O O
clearance. O O
MEDICATIONS: O O
Nephrocaps O O
1 O O
p.o. O O
daily, O O
Phoslo O O
670 O O
mg O O
tablets O O
3 O O
p.o. O O
t.i.d., O O
and O O
senna O O
two O O
tablets O O
b.i.d. O O
p.r.n. O O
ALLERGIES: O O
No O O
known O O
allergies O O
to O O
any O O
medications. O O
HABITS: O O
He B-SMOKER O
smokes I-SMOKER O
one I-SMOKER O
pack I-SMOKER O
per I-SMOKER O
week. I-SMOKER O
Denies O O
alcohol O O
or O O
drug O O
use. O O
FAMILY O O
HISTORY: O O
Unchanged. O O
SOCIAL O O
HISTORY: O O
He O O
lives O O
with O O
wife O O
and O O
daughter. O O
He O O
is O O
retired. O O
REVIEW O O
OF O O
SYMPTOMS: O O
No O O
significant O O
weight O O
change, O O
febrile O O
signs O O
or O O
symptoms, O O
headache, O O
blurred O O
vision, O O
tinnitus, O O
chest O O
pain, O O
cough, O O
shortness O O
of O O
breath, O O
nausea, O O
abdominal O O
pain, O O
nightsweats, O O
diarrhea, O O
dysuria, O O
polyuria, O O
skin O O
rash, O O
bruising, O O
joint O O
pain, O O
or O O
focal O O
weakness. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
in O O
no O O
acute O O
distress. O O
Blood O O
pressure O O
125/82, O O
weight O O
138 O O
pounds, O O
and O O
temperature O O
97.3. O O
BMI O O
19.8. O O
Skin O O
exam: O O
No O O
rash. O O
Head O O
and O O
neck O O
exam: O O
Patient O O
has O O
bilateral O O
arcus O O
senilis. O O
He O O
is O O
edentulous. O O
Chest: O O
Clear O O
to O O
percussion O O
and O O
auscultation. O O
Cardiovascular O O
exam: O O
No O O
extra O O
sounds O O
or O O
murmurs. O O
Pedal O O
pulses O O
are O O
trace O O
posterior O O
tibial O O
bilaterally. O O
Abdominal O O
exam: O O
No O O
masses, O O
tenderness, O O
or O O
organomegaly. O O
Stool O O
guaiac O O
negative. O O
GU O O
exam: O O
Both O O
testes O O
descended. O O
Testes O O
were O O
soft. O O
Prostate O O
2+ O O
enlarged O O
without O O
masses O O
or O O
tenderness. O O
Lymph O O
exam: O O
No O O
axillary O O
or O O
cervical O O
lymphadenopathy. O O
Musculoskeletal O O
exam: O O
Grossly O O
intact. O O
Neuro O O
exam: O O
Grossly O O
intact. O O
ASSESSMENT O O
AND O O
PLAN: O O
1. O O
Chronic O O
renal O O
failure. O O
Appears O O
to O O
be O O
stable O O
on O O
routine O O
dialysis. O O
Will O O
check O O
screening O O
blood O O
work. O O
2. O O
Hyperlipidemia. O O
His O O
LDL O O
goal O O
is O O
less O O
than O O
130. O O
He O O
is O O
slightly O O
above O O
that. O O
Encouraged O O
careful O O
attention O O
to O O
nutrition. O O
3. O O
Cataract. O O
EKG O O
and O O
other O O
preop O O
testing O O
were O O
requested. O O
4. O O
Adult O O
health O O
maintenance. O O
Tetanus O O
and O O
Pneumovax O O
given O O
last O O
year. O O
He O O
reports O O
influenza O O
vaccine O O
was O O
given O O
elsewhere. O O
A O O
colonoscopy O O
has O O
not O O
been O O
done O O
according O O
to O O
our O O
records. O O
Colonoscopy O O
requested O O
today. O O
Home O O
guaiac O O
cards O O
given O O
as O O
well. O O
______________________________ O O
Xavier O O
T O O
Mccoy, O O
M.D., O O
M.Sc. O O
eScription O O
document:6-2359741 O O
EMSSten O O
Tel O O
DD: O O
12/14/96 O O
DT: O O
12/15/96 O O
DV: O O
12/13/96 O O

Record O O
date: O O
2098-02-04 O O
Trinity O O
Regional O O
Medical O O
Center O O
1949 O O
Mill O O
Street O O
MARSH, O O
CARL O O
Albertville, O O
RI O O
87193 O O
39955317 O O
(906) O O
517-8625 O O
02/04/2098 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
76-year-old O O
man O O
male O O
who O O
comes O O
in O O
for O O
follow O O
up O O
of O O
chronic O O
kidney O O
disease O O
and O O
other O O
medical O O
problems. O O
PROBLEMS: B-SMOKER O
1. O O
Chronic O O
renal O O
disease. O O
He O O
has O O
dialysis O O
twice O O
per O O
week. O O
He O O
tells O O
me O O
he O O
is O O
on O O
the O O
transplant O O
list. O O
The O O
transplant O O
team O O
would O O
like O O
a O O
positive O O
CVS O O
treated O O
with O O
levofloxacin O O
2. O O
Hyperlipidemia. B-HYPERLIPIDEMIA O
Fasting O O
lipid O O
analysis O O
2 B-HYPERLIPIDEMIA O
weeks I-HYPERLIPIDEMIA O
ago I-HYPERLIPIDEMIA O
showed I-HYPERLIPIDEMIA O
total I-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
255, I-HYPERLIPIDEMIA O
triglycerides O O
203, O O
HDL O O
39, O O
and O O
LDL B-HYPERLIPIDEMIA O
175. I-HYPERLIPIDEMIA O
He O O
had O O
been O O
taking O O
Crestor B-MEDICATION O
but O O
says O O
the O O
bottle O O
emptied O O
and O O
he O O
did O O
not O O
know O O
to O O
refill O O
it. O O
3. O O
Secondary O O
hyperparathyroidism. O O
Recent O O
PTH O O
829, O O
calcium O O
10.1, O O
and O O
phosphorus O O
6.7. O O
4. O O
Superficial O O
back O O
pain. O O
He O O
had O O
an O O
abscess O O
drained O O
overlying O O
the O O
right O O
scapula O O
several O O
months O O
ago. O O
Since O O
then, O O
he O O
has O O
had O O
some O O
mild O O
pain. O O
MEDICATIONS: O O
He O O
did O O
not O O
bring O O
any O O
tonight. O O
As O O
listed: O O
1. O O
Aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
daily. O O
2. O O
Nephrocaps O O
1 O O
daily. O O
3. O O
Phoslo O O
2001 O O
mg O O
t.i.d. O O
REVIEW O O
OF O O
SYMPTOMS: O O
No O O
significant O O
weight O O
change, O O
febrile O O
signs O O
or O O
symptoms, O O
headache, O O
blurred O O
vision, O O
tinnitus, O O
chest O O
pain, O O
cough, O O
shortness O O
of O O
breath, O O
nausea, O O
abdominal O O
pain, O O
nightsweats, O O
diarrhea, O O
dysuria, O O
polyuria, O O
bruising, O O
joint O O
pain, O O
or O O
focal O O
weakness. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
in O O
no O O
acute O O
distress. O O
Chest: O O
Clear O O
to O O
percussion O O
and O O
auscultation. O O
Skin O O
exam: O O
There O O
are O O
two O O
small O O
cavities O O
overlying O O
the O O
right O O
scapula O O
filled O O
with O O
dirt O O
and O O
slight O O
surrounding O O
erythema.. O O
Abdominal O O
exam: O O
No O O
masses, O O
tenderness O O
or O O
organomegaly. O O
Extremities: O O
No O O
edema. O O
ASSESSMENT O O
AND O O
PLAN: O O
1. O O
Chronic O O
kidney O O
disease. O O
On O O
dialysis. O O
2. O O
Hyperlipidemia. O O
I O O
prescribed O O
Zocor. B-MEDICATION O
3. O O
Secondary O O
hyperparathyroidism. O O
I O O
am O O
concerned O O
about O O
bone O O
status. O O
Bone O O
mineral O O
density O O
exam O O
requested. O O
4. O O
Skin O O
changes O O
after O O
abscess O O
drainage. O O
Area O O
was O O
cleaned O O
and O O
covered. O O
The O O
patient O O
has O O
history O O
of O O
elevated O O
total O O
protein O O
and O O
amylase. O O
Will O O
need O O
follow O O
up. O O
______________________________ O O
Xavier O O
T O O
Mccoy, O O
M.D., O O
M.Sc. O O
eScription O O
document:6-6685590 O O
MEeScription O O
DD: O O
02/04/98 O O
DT: O O
02/04/98 O O
DV: O O
02/04/98 O O

Record O O
date: O O
2085-08-21 O O
MIMA O O
5Z O O
36 O O
Santa O O
Fe O O
Road, O O
Suite O O
Z O O
WILKERSON, O O
EDWARD O O
Louisa, O O
MS O O
59817 O O
37199514 O O
(238) O O
757-3898 O O
08/21/85 O O
CHIEF O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
61 O O
year O O
old O O
gentleman O O
here O O
for O O
his O O
first O O
visit O O
to O O
me O O
as O O
his O O
PCP, O O
referred O O
by O O
Dr. O O
Xavier. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS/PAST O O
MEDICAL O O
HISTORY O O
BY O O
PROBLEMS: O O
The O O
patient O O
has O O
no O O
acute O O
complaints O O
today. O O
His O O
medical O O
history O O
includes: O O
1. O O
Hypertension. B-HYPERTENSION O
He O O
is O O
currently O O
on O O
hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
mg O O
q.d. O O
and O O
aspirin B-MEDICATION B-MEDICATION
q.d. O O
2. O O
Hypercholesterolemia. B-HYPERLIPIDEMIA B-MEDICATION
The O O
patient O O
is O O
on O O
30 O O
mg O O
q.h.s. O O
of O O
simvastatin. B-MEDICATION B-MEDICATION
His O O
last O O
lipid O O
panel O O
in O O
April O O
of O O
this O O
year O O
showed O O
total O O
cholesterol O O
of O O
196, O O
triglycerides O O
169, O O
HDL O O
52, O O
and O O
LDL B-HYPERLIPIDEMIA O
of I-HYPERLIPIDEMIA O
110. I-HYPERLIPIDEMIA O
He O O
has O O
no O O
LFTs O O
on O O
file. O O
3. O O
Psychiatry. O O
According O O
to O O
the O O
patient, O O
he O O
carried O O
a O O
diagnosis O O
of O O
major O O
depression O O
with O O
paranoid O O
features. O O
He O O
is O O
being O O
followed O O
by O O
Dr. O O
Uhler, O O
psychiatrist O O
at O O
Marshfield O O
Clinic O O
as O O
well O O
as O O
Betty O O
Villasenor, O O
a O O
therapist O O
at O O
Marshfield O O
Clinic. O O
He O O
is O O
currently O O
on O O
Depakote, O O
Tegretol, O O
Risperdal, O O
and O O
Paxil O O
although O O
he O O
does O O
not O O
know O O
the O O
doses O O
of O O
his O O
medications. O O
He O O
still O O
feels O O
depressed O O
but O O
his O O
paranoid O O
symptoms O O
have O O
subsided. O O
He O O
has O O
no O O
manic O O
or O O
hypermanic O O
episodes. O O
MEDICATIONS: O O
Aspirin B-MEDICATION B-MEDICATION
325 O O
mg O O
q.d., O O
Paxil, O O
Risperdal, O O
Tegretol, O O
Depakote O O
doses O O
unknown, O O
simvastatin O B-MEDICATION
30 O O
mg O O
q.h.s., O O
HCTZ B-MEDICATION O
20 O O
mg O O
q.d. O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
SOCIAL O O
HISTORY: O O
No B-SMOKER O
tobacco, I-SMOKER O
alcohol, O O
or O O
recreational O O
drugs. O O
He O O
quit O O
drinking O O
alcohol O O
16 O O
years O O
ago. O O
He O O
has O O
not O O
been O O
sexually O O
active O O
for O O
16 O O
years O O
and O O
is O O
currently O O
not O O
interested. O O
He O O
lives O O
by O O
himself O O
in O O
Denver O O
Drive, O O
walks O O
about O O
20 O O
minutes O O
per O O
day, O O
and O O
is O O
from O O
Louisa O O
originally. O O
FAMILY O O
HISTORY: O O
Mother O O
and O O
father O O
died O O
of O O
MIs O O
in O O
their O O
70s. O O
There O O
is O O
no O O
history O O
of O O
sudden O O
cardiac O O
death. O O
No O O
cancer, O O
liver, O O
kidney, O O
or O O
thyroid O O
disease O O
in O O
the O O
family. O O
PHYSICAL O O
EXAMINATION: O O
Blood O O
pressure O O
132/84, O O
heart O O
rate O O
84, O O
and O O
weight O O
202 O O
pounds. O O
The O O
remainder O O
of O O
the O O
exam O O
is O O
deferred. O O
ASSESSMENT O O
AND O O
PLAN: O O
1. O O
Hypertension. O O
The O O
patient O O
is O O
well O O
controlled O O
on O O
his O O
current O O
regimen. O O
I O O
will O O
therefore O O
not O O
change O O
anything O O
today. O O
2. O O
Hypercholesterolemia. O O
The O O
patient O O
is O O
at O O
his O O
goal O O
LDL O O
level. O O
I O O
will O O
continue O O
to O O
follow O O
his O O
lipid O O
panel O O
yearly. O O
I O O
will O O
also O O
check O O
LFTs O O
today, O O
given O O
that O O
he O O
had O O
a O O
statin. O O
3. O O
Psychiatry. O O
The O O
patient O O
will O O
follow O O
up O O
with O O
his O O
psychiatrist O O
and O O
therapist. O O
He O O
will O O
let O O
me O O
know O O
his O O
actual O O
medication O O
and O O
medication O O
doses O O
at O O
his O O
earliest O O
convenience. O O
Also, O O
I O O
will O O
recheck O O
an O O
LFT O O
as O O
stated O O
above, O O
given O O
that O O
he O O
is O O
on O O
possibly O O
hepatotoxic O O
psychoactive O O
medications. O O
4. O O
Healthcare O O
maintenance. O O
I O O
have O O
emphasized O O
to O O
the O O
patient O O
the O O
benefits O O
of O O
weight O O
reduction O O
as O O
well O O
as O O
increasing O O
his O O
exercise. O O
He O O
is O O
not O O
interested O O
in O O
any O O
exercise O O
as O O
in O O
walking O O
and O O
I O O
have O O
therefore O O
counseled O O
him O O
to O O
walk O O
longer O O
and O O
faster. O O
He O O
had O O
a O O
negative O O
flexible O O
sigmoidoscopy O O
in O O
November O O
2083 O O
and O O
I O O
will O O
give O O
him O O
stool O O
cards O O
today. O O
His O O
last O O
tetanus O O
was O O
10 O O
years O O
ago O O
and O O
he O O
is O O
not O O
interested O O
in O O
the O O
booster O O
today. O O
His O O
immunizations O O
are O O
otherwise O O
up O O
to O O
date O O
according O O
to O O
him O O
and O O
he O O
will O O
need O O
the O O
remainder O O
of O O
the O O
history O O
and O O
a O O
full O O
physical O O
exam O O
at O O
the O O
next O O
visit O O
in O O
3 O O
months' O O
time. O O
______________________________ O O
Wyatt O O
Yeo, O O
M.D. O O
eScription O O
document:0-726841 O O
CFFocus O O
DD: O O
08/21/85 O O
DT: O O
08/22/85 O O
DV: O O
08/21/85 O O
========================== O O
Preceptor's O O
Note O O
========================== O O
August O O
21st O O
Dr O O
Yeo O O
Mr O O
Wilkerson O O
61 O O
year O O
old O O
man O O
Hx O O
hypertension.Hx B-HYPERTENSION O
elev B-HYPERLIPIDEMIA O
cholesterol, I-HYPERLIPIDEMIA O
on O O
zocor. B-MEDICATION O
Recently O O
underwent O O
a O O
stress O O
test O O
for O O
chest O O
pain, O O
with O O
completely O O
negative O O
dopamine O O
MIBI. O O
PMH O O
also O O
+ O O
depression O O
and O O
paranoia O O
, O O
on O O
rx. O O
BP O O
132/84, O O
p O O
84. O O
\Health O O
maintenance: O O
will O O
be O O
given O O
stool O O
cards, O O
is O O
up O O
to O O
date O O
with O O
others O O
. O O
Declines O O
tetanus. O O
Dr. O O
Yeo O O
and O O
I O O
jointly O O
interviewed O O
and O O
examined O O
this O O
61year O O
old O O
patient O O
who O O
presents O O
with O O
for O O
f/u O O
hypercholesterolemia, B-HYPERLIPIDEMIA O
hypertension, O O
recent O O
stress O O
test. O O
See O O
resident's O O
note O O
for O O
details. O O
PMH/FH/SH O O
significant O O
for O O
depression/paranoia. O O
ROS O O
remarkable O O
for O O
+ O O
depression O O
at O O
this O O
time O O
. O O
On O O
exam, O O
we O O
found O O
bp O O
132/80 O O
pulse O O
80. O O
Rest O O
of O O
exam O O
deferred. O O
See O O
Resident's O O
note O O
for O O
further O O
detail. O O
Impression O O
and O O
Plan O O
reviewed O O
and O O
I O O
agree O O
with O O
the O O
resident's O O
assessment O O
of O O
and O O
diagnosis O O
of O O
dperession, O O
hypertension O O
. O O
We O O
agree O O
on O O
the O O
plan O O
to O O
review O O
test O O
results O O
with O O
patient, O O
stool O O
cards O O
given, O O
tetanus O O
offered O O
and O O
declined. O O
______________________________ O O
Connie O O
Angelina O O
Wills, O O
M.D. O O

Record O O
date: O O
2087-03-11 O O
Telephone O O
call O O
from O O
pt O O
Complaining B-SMOKER O
of O O
brief O O
episodes O O
of O O
feeling O O
faint, O O
sweaty O O
on O O
the O O
back O O
of O O
his O O
neck O O
yesterday O O
and O O
today. O O
Sxs O O
resolve O O
when O O
he O O
sits O O
down O O
and O O
rests O O
a O O
few O O
minutes. O O
No O O
associated O O
sxs O O
headaches, O O
ataxia, O O
vertigo, O O
nausea, O O
palps, O O
CP, O O
SOB, O O
URI O O
sxs, O O
fever, O O
trauma. O O
Checked O O
fingerstick O O
when O O
sxs O O
developed O O
today, O O
125. O O
Drank O O
orange O O
juice, O O
but O O
sxs O O
persisted, O O
resolved O O
after O O
approx O O
1hr. O O
Problems O O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
PSYCH O O
DISORDER: O O
ANXIETY,PARANOIA, O O
DEPRESSION O O
PERSONALITY O O
DISORDER O O
H/O O O
hematuria O O
H/O O O
breast O O
mass O O
Hypertension B-HYPERTENSION O
Borderline O O
diabetes O O
mellitus O O
Overweight O O
Erectile O O
dysfunction O O
Medications O O
Risperdal O O
(RISPERIDONE) O O
3 O O
MG O O
PO O O
QD O O
Tegretol O O
(CARBAMAZEPINE) O O
400 O O
MG O O
PO O O
QD O O
Paxil O O
(PAROXETINE) O O
40MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Depakote O O
(DIVALPROEX O O
Sodium) O O
500MG, O O
2 O O
Tablet(s) O O
PO O O
QD O O
Thorazine O O
(CHLORPROMAZINE O O
Hcl) O O
25MG, O O
1/2 O O
Tablet(s) O O
PO O O
QD O O
ASA B-MEDICATION B-MEDICATION
81 O O
MG O O
PO O O
QD O O
Hctz B-MEDICATION O
(HYDROCHLOROTHIAZIDE) O O
25MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
10MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Folate O O
(FOLIC O O
Acid) O O
1MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
METFORMIN B-MEDICATION B-MEDICATION
500MG, O O
1 O O
Tablet(s) O O
PO O O
BID O O
He O O
declines O O
appt O O
today O O
for O O
eval. O O
Urged O O
to O O
come O O
to O O
ED O O
today O O
for O O
eval O O
if O O
sxs O O
worsen. O O
Otherwise, O O
agrees O O
to O O
urgent O O
care O O
appt O O
tomorrow O O
at O O
2:50pm. O O
_____________________________________________ O O
Patricia O O
Y O O
Whittaker,N.P.,M.S. O O

Record O O
date: O O
2088-03-03 O O
Patient O O
Name: O O
WILKERSON,EDWARD O O
[ O O
MRN: O O
37199514MEDIQUIK O O
] O O
Date O O
of O O
Visit: O O
3/3/2088 O O
MIMA O O
PCP O O
VISIT O O
Health B-SMOKER O
problems I-SMOKER O
discussed: O O
1. O O
DM B-DIABETES O
type I-DIABETES O
2. I-DIABETES O
Fingerstick B-DIABETES O
in I-DIABETES O
the I-DIABETES O
office I-DIABETES O
today I-DIABETES O
130. I-DIABETES O
At O O
home, O O
these O O
have O O
been O O
mostly O O
in O O
the O O
84 O O
-130s, O O
but O O
rarely O O
up O O
to O O
the O O
180-190s. O O
Last O O
HbA1c O O
was O O
5.8. O O
--given O O
outlier O O
hyperglycemia O O
and O O
no O O
hypoglycemia, O O
increase O O
metformin B-MEDICATION B-MEDICATION
to O O
1000 O O
bid O O
from O O
1000 O O
qAM/500 O O
qPM O O
--recheck O O
A1c O O
today O O
--increase O O
lisinopril B-MEDICATION B-MEDICATION
to I-MEDICATION O
20 O O
daily O O
given O O
BP B-HYPERTENSION O
142/66 I-HYPERTENSION O
today O O
2. O O
Lipids. O O
Last B-HYPERLIPIDEMIA O
dLDL B-HYPERLIPIDEMIA O
108. I-HYPERLIPIDEMIA O
Denies O O
any O O
muscle O O
cramps O O
or O O
weakness. O O
--increase O O
atorvastatin B-MEDICATION B-MEDICATION
to O O
40 O O
daily, O O
check O O
transaminases O O
3. O O
Weight. O O
Has O O
lost O O
11 O O
pounds O O
intentionally O O
since O O
September O O
by O O
doing O O
more O O
walking, O O
eating O O
fewer O O
potatoes, O O
red O O
meat, O O
rice. O O
BMI O O
now O O
26. O O
Patient O O
congratulated, O O
encouraged O O
to O O
continue O O
with O O
his O O
current O O
diet O O
and O O
increase O O
exercise O O
as O O
tolerated. O O
Cautioned O O
on O O
caffeine O O
given O O
h/o O O
SVT. O O
4. O O
SVT. O O
To O O
see O O
Dr. O O
Pate O O
from O O
cardiology O O
in O O
2 O O
days O O
to O O
f/u O O
his O O
SVT. O O
No O O
known O O
further O O
episodes O O
since O O
starting O O
verapamil. O O
5. O O
Health O O
maintenance. O O
--due O O
for O O
colonoscopy: O O
referred, O O
given O O
Rx O O
for O O
Golytely O O
PE: O O
Blood O O
Pressure: O O
142/66 O O
[Left O O
Arm, O O
Sitting] O O
Pulse: O O
74 O O
[Regular, O O
Brachial] O O
Weight: O O
191 O O
[Pounds] O O
NAD, O O
does O O
not O O
appear O O
to O O
be O O
responding O O
to O O
internal O O
stimuli O O
JVP O O
7 O O
CTA O O
bilat O O
RRR O O
no O O
mrg, O O
no O O
heave O O
Abd O O
soft, O O
nt/nd, O O
nabs, O O
no O O
mass O O
No O O
foot O O
lesions O O
Trace O O
bilat O O
ankle O O
pitting O O
2+ O O
DP O O
and O O
PTs O O
bilat O O
______________________________ O O
Floyd O O
Bobby O O
Ventura, O O
M.D. O O
========================== O O
Preceptor's O O
Note O O
========================== O O
Pt O O
discussed O O
with O O
Dr. O O
Ventura; O O
I O O
agree O O
with O O
his O O
evaluation O O
and O O
plan. O O
______________________________ O O
Nancy O O
Elizabeth O O
Roman, O O
M.D. O O

Record O O
date: O O
2093-01-17 O O
EDVISIT^37199514^WILKERSON, O O
EDWARD^01/17/93^HODGES, O O
CHAD O O
Please O O
see O O
the O O
written O O
documentation O O
undertaken O O
by O O
Dr. O O
Caldwell, O O
the O O
resident O O
who O O
saw O O
the O O
patient O O
primarily. O O
I O O
have O O
seen O O
and O O
examined O O
the O O
patient O O
personally, O O
reviewed O O
the O O
written O O
documentation O O
and O O
agree O O
with O O
the O O
assessment O O
and O O
plan. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Mr. O O
Wilkerson O O
is O O
a O O
68-year-old O O
gentleman O O
without O O
significant O O
past O O
medical O O
history, O O
who O O
is O O
actually O O
being O O
seen O O
here O O
by O O
his O O
primary O O
care O O
physician O O
who O O
happens O O
to O O
be O O
a O O
resident O O
rotating O O
____ O O
normally O O
sees O O
him O O
in O O
MIMAIMA O O
Clinic. O O
According O O
to O O
Dr. O O
Caldwell, O O
his O O
PCP, O O
he O O
generally O O
does O O
not O O
have O O
very O O
much O O
past O O
medical O O
history, O O
but O O
when O O
he O O
gets O O
infected, O O
he O O
gets O O
confused. O O
He O O
presents O O
today O O
with O O
confusion. O O
His O O
visiting O O
nurse O O
today O O
noticed O O
that O O
he O O
has O O
been O O
having O O
weakness O O
and O O
fatigue O O
over O O
the O O
last O O
few O O
days, O O
but O O
today, O O
he O O
was O O
confused O O
as O O
he O O
has O O
been O O
when O O
he O O
has O O
been O O
ill O O
in O O
the O O
past. O O
PAST O O
MEDICAL O O
HISTORY: O O
Dementia, O O
SVT, O O
hypertension, B-HYPERTENSION O
and O O
diabetes B-DIABETES O
type I-DIABETES O
2. I-DIABETES O
SOCIAL O O
HISTORY: O O
He B-SMOKER O
is I-SMOKER O
a I-SMOKER O
former B-SMOKER O
smoker. I-SMOKER O
PAST O O
SURGICAL O O
HISTORY: O O
Otherwise, O O
negative. O O
REVIEW O O
OF O O
SYSTEMS: O O
Otherwise O O
negative O O
except O O
as O O
previously O O
dictated. O O
MEDICATIONS: O O
Lisinopril, B-MEDICATION B-MEDICATION
hydrochlorothiazide, B-MEDICATION B-MEDICATION
omeprazole, O O
Risperdal, O O
Tegretol, O O
verapamil, B-MEDICATION B-MEDICATION
and O O
Tylenol O O
#3. O O
ALLERGIES: O O
He O O
has O O
no O O
known O O
drug O O
allergies. O O
PHYSICAL O O
EXAMINATION: O O
He O O
is O O
a O O
healthy, O O
well-appearing O O
Caucasian O O
gentleman O O
who O O
nevertheless O O
is O O
disoriented O O
to O O
time. O O
He O O
knows O O
place O O
and O O
name. O O
His O O
heart O O
rate O O
is O O
101, O O
respiratory O O
rate O O
is O O
20, O O
blood O O
pressure O O
is O O
121/92, B-HYPERTENSION O
and O O
oxygen O O
saturation O O
is O O
96% O O
on O O
room O O
air, O O
and O O
his O O
temperature O O
is O O
101.5. O O
He O O
had O O
left O O
lower O O
lobe O O
crackles O O
in O O
his O O
lung O O
exam. O O
The O O
remainder O O
of O O
his O O
physical O O
exam O O
was O O
otherwise O O
normal. O O
Mucus O O
membranes O O
were O O
moist. O O
Abdomen O O
was O O
soft. O O
Extremities O O
had O O
no O O
clubbing, O O
cyanosis, O O
or O O
edema. O O
LABORATORY O O
DATA: O O
The O O
patient O O
had O O
a O O
normal O O
chest O O
x-ray, O O
negative O O
urinalysis. O O
White O O
blood O O
cell O O
count O O
was O O
7.12. O O
He O O
had O O
a O O
creatinine O O
of O O
1.24, O O
up O O
from O O
his O O
baseline O O
and O O
a O O
lactate O O
of O O
3.8. O O
His O O
chest O O
x-ray O O
showed O O
no O O
acute O O
process. O O
IMPRESSION: O O
My O O
impression O O
is O O
that O O
the O O
patient O O
has O O
severe O O
sepsis O O
by O O
virtue O O
of O O
evidence O O
of O O
change O O
in O O
his O O
mental O O
status O O
and O O
his O O
creatinine, O O
he O O
was O O
given O O
a O O
liter O O
of O O
normal O O
saline O O
in O O
the O O
Emergency O O
Department O O
as O O
a O O
bolus. O O
Given O O
that O O
pneumonia O O
and O O
urinary O O
tract O O
infection O O
were O O
highest O O
on O O
the O O
list, O O
we O O
decided O O
to O O
treat O O
him O O
with O O
Rocephin O O
and O O
azithromycin. O O
He O O
will O O
be O O
admitted O O
to O O
the O O
Medical O O
Service. O O
______________________________ O O
HODGES, O O
CHAD O O
M.D. O O
D: O O
01/17/93 O O
T: O O
01/17/93 O O
Dictated O O
By: O O
HODGES, O O
CHAD O O
eScription O O
document:0-50096032 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2093-04-11 O O
MEDIQUIK O O
Neurology O O
Consultation O O
Edward O O
Wilkerson O O
MRN: O O
37199514 O O
Please O O
refer O O
to O O
Student O O
Doctor O O
Nicky O O
Li O O
for O O
HPI, O O
ROS O O
and O O
past O O
medical O O
history. O O
Briefly, B-SMOKER O
68 O O
yr O O
old O O
male O O
w O O
a O O
h/o O O
HTN, B-HYPERTENSION O
HL, B-HYPERLIPIDEMIA O
DMII, B-DIABETES O
peripheral O O
neuropathy, O O
schizoaffective O O
disorder, O O
Borderline O O
Personality O O
Disorder O O
s/p O O
SVT O O
ablation O O
on O O
4/10 O O
who O O
post-operatively O O
has O O
been O O
confused O O
with O O
gait O O
disturbance. O O
Neurology O O
was O O
consulted O O
for O O
an O O
evaluation O O
of O O
gait O O
disturbance O O
and O O
encephalopathy. O O
On O O
exam O O
patient O O
is O O
normotensive O O
and O O
afebrile O O
with O O
cognition O O
remarkable O O
for O O
inattention, O O
disorientation, O O
perseveration O O
and O O
preservation O O
of O O
speech O O
and O O
visual O O
spatial O O
processing. O O
His O O
physical O O
exam O O
is O O
further O O
remarkable O O
for O O
asterixis O O
and O O
bilateral O O
upper O O
extremity O O
tremulousness. O O
His O O
cranial O O
nerves O O
are O O
intact. O O
His O O
has O O
four O O
limb O O
give O O
way O O
weakness O O
without O O
focality. O O
Reflexes O O
are O O
3+ O O
and O O
symmetric O O
in O O
the O O
upper O O
extremities O O
and O O
2+ O O
and O O
symmetric O O
in O O
the O O
lower O O
extremities. O O
Toes O O
are O O
down. O O
Finger O O
to O O
nose O O
is O O
preserved. O O
He O O
is O O
unable O O
to O O
stand O O
without O O
assistance. O O
Differential O O
includes O O
toxic O O
metabolic O O
disturbance O O
(i.e. O O
hyper O O
ammonia O O
in O O
the O O
setting O O
of O O
depakote O O
use O O
vs. O O
drugs O O
of O O
abuse, O O
vs. O O
alcohol O O
withdrawal O O
vs. O O
additional O O
superimposed O O
toxic O O
metabolic O O
disturbance) O O
Recommendations: O O
-please O O
check O O
Liver O O
function O O
panel O O
-check O O
ammonia O O
-Check O O
B12, O O
folate, O O
RPR, O O
TSH O O
-please O O
start O O
multivitamin O O
and O O
thiamine O O
100mg O O
daily O O
-please O O
check O O
carbamazepine O O
and O O
valproic O O
acid O O
levels; O O
please O O
verify O O
carbamazepine O O
dosing O O
as O O
prior O O
records O O
suggest O O
400mg O O
QD O O
and O O
patient O O
is O O
on O O
BID O O
dosing O O
-serum O O
and O O
urine O O
toxicology O O
screen O O
-obtain O O
collateral O O
history O O
regarding O O
possible O O
alcohol O O
abuse O O
and O O
monitor O O
for O O
alcohol O O
withdrawal O O
-would O O
hold O O
amitriptyline O O
given O O
anticholinergic O O
properties O O
-if O O
above O O
workup O O
negative O O
and O O
unrevealing O O
would O O
consider O O
NCHCT O O
but O O
defer O O
imaging O O
at O O
this O O
time O O
Please O O
page O O
73703 O O
with O O
questions O O
Charles O O
Wallace O O
MDp73703 O O

Record O O
date: O O
2072-12-16 O O
MRN: O O
56817864 O O
CAROLYN O O
HUNTINGTON O O
BAILEY O O
HEALTH O O
CENTER O O
468 O O
Kristina O O
Street O O
Xia, O O
Jean O O
North O O
East, O O
AL O O
81699 O O
CHB9278143 O O
(687) O O
396-2722 O O
12-15-72 O O
CHIEF O O
COMPLAINT: O O
Ms. O O
Xia O O
is O O
a O O
53 O O
year O O
old O O
woman O O
who O O
comes O O
in O O
in O O
follow O O
up. O O
She O O
notes O O
that O O
she O O
is O O
still O O
having O O
occasional O O
sweats O O
at O O
night. O O
She O O
is O O
using O O
the O O
clonidine O O
but O O
she O O
can't O O
take O O
it O O
two O O
times O O
a O O
day, O O
it O O
makes O O
her O O
too O O
sleepy, O O
so O O
she O O
takes O O
it O O
about O O
3:30 O O
towards O O
the O O
end O O
of O O
her O O
workday O O
and O O
then O O
again O O
before O O
she O O
goes O O
to O O
bed. O O
She O O
is O O
having O O
some O O
right O O
lower O O
back O O
pain O O
and O O
otherwise O O
is O O
feeling O O
well. O O
REVIEW O O
OF O O
SYSTEMS: O O
Negative O O
except O O
as O O
noted. O O
She O O
is O O
also O O
taking O O
the O O
Cozaar B-MEDICATION B-MEDICATION
which O O
she O O
had O O
been O O
taking O O
before. O O
She O O
was O O
called O O
back O O
in O O
today O O
as O O
a O O
result O O
of O O
labs O O
which O O
were O O
done O O
recently O O
which O O
showed O O
hemoglobin B-DIABETES O
A1C I-DIABETES O
of I-DIABETES O
8.7, I-DIABETES O
an O O
elevated O O
urine O O
microalbuminuria O O
and O O
hypertension B-HYPERTENSION O
which O O
needed O O
follow O O
up. O O
PHYSICAL O O
EXAMINATION: O O
On O O
exam O O
today, O O
she O O
is O O
well O O
developed O O
and O O
well O O
nourished O O
in O O
no O O
acute O O
distress. O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
158/116, I-HYPERTENSION O
pulse O O
80, O O
weight O O
166. O O
Pupils O O
are O O
equal O O
and O O
equally O O
reactive O O
to O O
light. O O
Lids O O
and O O
conjunctiva O O
normal. O O
Retinal O O
fields O O
normal. O O
Disks O O
sharp. O O
Mouth O O
and O O
pharynx O O
without O O
erythema O O
or O O
exudate. O O
No O O
adenopathy O O
or O O
tenderness O O
in O O
the O O
submandibular, O O
cervical, O O
posterior O O
cervical, O O
supraclavicular O O
areas. O O
Heart O O
sounds: O O
S1, O O
S2, O O
with O O
a O O
II/VI O O
systolic O O
murmur O O
heard O O
best O O
at O O
the O O
right O O
sternal O O
border. O O
No O O
rub O O
or O O
gallop. O O
Her O O
chest O O
was O O
clear O O
to O O
auscultation O O
anteriorly O O
and O O
posteriorly O O
with O O
no O O
rales, O O
wheezes O O
or O O
rhonchi. O O
She O O
was O O
clear O O
to O O
percussion. O O
She O O
has O O
normal O O
bowel O O
sounds. O O
Her O O
abdomen O O
was O O
soft O O
and O O
nontender, O O
no O O
mass, O O
organomegaly, O O
and O O
no O O
guarding, O O
no O O
rebound. O O
Her O O
extremities O O
are O O
without O O
edema, O O
cyanosis O O
or O O
clubbing. O O
She O O
has O O
no O O
spine O O
or O O
flank O O
tenderness. O O
Her O O
neck O O
is O O
supple, O O
no O O
bruits. O O
Her O O
skin O O
is O O
essentially O O
quite O O
dry O O
and O O
itchy. O O
She O O
has O O
multiple O O
dark, O O
hyperpigmented, O O
post-inflammatory O O
scarring O O
on O O
her O O
lower O O
extremities. O O
Her O O
mouth O O
and O O
pharynx O O
are O O
without O O
erythema O O
or O O
exudate. O O
IMPRESSION/PLAN: O O
1. O O
Hypertension. B-HYPERTENSION O
Her O O
blood O O
pressure O O
is O O
really O O
not O O
well O O
controlled. O O
I O O
will O O
add B-MEDICATION O
atenolol I-MEDICATION B-MEDICATION
to O O
her O O
regimen O O
50mg O O
PO O O
q.d. O O
She O O
drinks O O
one O O
cup O O
of O O
coffee O O
a O O
day O O
and O O
rarely O O
has O O
alcohol O O
although O O
she O O
notes O O
that O O
she O O
will O O
occasionally O O
have O O
one, O O
a O O
scotch, O O
on O O
Friday O O
or O O
Saturday. O O
She O O
does O O
not O O
do O O
drugs. B-SMOKER O
She O O
will O O
return O O
in O O
three O O
week O O
for O O
follow O O
up O O
of O O
her O O
blood O O
pressure O O
and O O
at O O
that O O
time O O
for O O
a O O
physical O O
exam O O
for O O
which O O
she O O
will O O
be O O
due. O O
2. O O
Diabetes. B-DIABETES O
The O O
patient O O
had O O
been O O
told O O
in O O
the O O
past O O
that O O
she O O
had O O
diabetes B-DIABETES O
but O O
she O O
was O O
told O O
she O O
did O O
not O O
need O O
any O O
sort O O
of O O
treatment O O
for O O
it. O O
Her O O
creatinine O O
was O O
0.8 O O
last O O
month O O
and O O
I O O
explained O O
to O O
her O O
that O O
with O O
her B-DIABETES O
elevated I-DIABETES O
hemoglobin I-DIABETES O
at I-DIABETES O
8.7 I-DIABETES O
she O O
needs O O
treatment. O O
We O O
will B-MEDICATION O
start I-MEDICATION O
her I-MEDICATION O
on I-MEDICATION O
Glucophage I-MEDICATION B-MEDICATION
500mg O O
PO O O
b.i.d. O O
I O O
expect O O
we O O
will O O
need O O
to O O
increase O O
this O O
and O O
if O O
she O O
tolerates O O
this O O
she O O
should O O
increase O O
it O O
to O O
1000mg O O
over O O
the O O
next O O
week. O O
I O O
also O O
explained O O
to O O
her O O
that O O
if O O
she O O
does O O
not O O
eat O O
or O O
she O O
is O O
unable O O
to O O
eat O O
or O O
if O O
she O O
is O O
NPO O O
she O O
needs O O
to O O
stop O O
taking O O
this O O
medication. O O
I O O
suggested O O
she O O
actually O O
take O O
it O O
with O O
food O O
to O O
insure O O
that O O
she O O
only O O
takes O O
when O O
she O O
is O O
eating. O O
I O O
gave O O
her O O
a O O
referral O O
to O O
Ophthalmology O O
and O O
to O O
Podiatry. O O
She O O
also O O
requested O O
a O O
glucometer O O
machine O O
and O O
this O O
was O O
ordered O O
for O O
her O O
along O O
with O O
CAROLYN O O
HUNTINGTON O O
BAILEY O O
HEALTH O O
CENTER O O
592 O O
Kristina O O
Street O O
Xia, O O
Jean O O
North O O
East, O O
AL O O
81699 O O
CHB9278143 O O
(687) O O
396-2722 O O
12-16-72 O O
Page O O
2 O O
lancets, O O
alcohol O O
wipes O O
and O O
test O O
strips O O
and O O
again O O
she O O
will O O
return O O
in O O
two O O
weeks O O
for O O
follow O O
up. O O
______________________________ O O
Yolanda O O
Osburn, O O
M.D. O O
CP:FO:3549 O O
; O O
DD:12-16-72 O O
; O O
DT:12-16-72 O O
; O O
DV:12-16-72 O O

Record O O
date: O O
2076-04-23 O O
Carolyn O O
Huntington O O
Bailey O O
Health O O
Center O O
592 O O
Kristina O O
Street O O
XIA, O O
JEAN O O
North O O
East, O O
AL O O
81699 O O
58269151 O O
(375) O O
512-0897 O O
04/23/76 O O
SUBJECTIVE: B-SMOKER O
The O O
patient O O
comes O O
in O O
today O O
for O O
followup O O
of O O
various O O
problems. O O
She O O
has O O
hypertension. B-HYPERTENSION O
She O O
reports O O
she O O
ran O O
out O O
of O O
medication O O
she O O
received O O
yesterday O O
for O O
refills O O
but O O
has O O
not O O
gotten O O
them O O
yet. O O
She O O
brings O O
in O O
her O O
medication O O
bottles. O O
Apparently, O O
for O O
her O O
blood O O
pressure, O O
she O O
is O O
taking O O
Norvasc B-MEDICATION B-MEDICATION
and O O
Cozaar, B-MEDICATION B-MEDICATION
for O O
her O O
diabetes B-DIABETES O
she O O
is O O
taking O O
Glucotrol B-MEDICATION B-MEDICATION
and O O
Glucophage. B-MEDICATION B-MEDICATION
Regarding O O
her O O
diabetes, O O
she O O
says O O
her O O
fasting O O
sugar O O
are O O
somewhere O O
around O O
90. O O
Her O O
last O O
hemoglobin O O
A1c O O
was O O
in O O
11/2075 O O
and O O
was O O
6.4%. O O
Her O O
hypertension, O O
she O O
has O O
been O O
out O O
of O O
medication O O
for O O
three O O
or O O
four O O
day, O O
but O O
she O O
generally O O
reports O O
is O O
well O O
controlled. O O
She O O
does O O
not O O
know O O
why O O
she O O
was O O
on O O
atenolol, B-MEDICATION B-MEDICATION
but O O
has O O
been O O
taking O O
it. O O
She O O
has O O
no O O
complaints. O O
She O O
does O O
complain O O
of O O
lower O O
back O O
pain. O O
She O O
says O O
she O O
has O O
had O O
this O O
for O O
many O O
many O O
years. O O
She O O
underwent O O
physical O O
therapy O O
last O O
year O O
which O O
was O O
at O O
Schroder O O
Hospital. O O
She O O
says O O
she O O
has O O
no O O
trauma. O O
She O O
has O O
pain O O
across O O
the O O
lower O O
back. O O
She O O
rates O O
it O O
8/10. O O
She O O
has O O
it O O
everyday O O
and O O
radiates O O
down O O
to O O
her O O
right O O
leg. O O
It O O
has O O
been O O
worse O O
recently. O O
She O O
takes O O
Aleve O O
with O O
minimal O O
relief. O O
She O O
says O O
that O O
she O O
wants O O
a O O
speciality O O
referral. O O
REVIEW O O
OF O O
SYSTEMS: O O
She O O
has O O
no O O
chest O O
pain O O
or O O
pressure, O O
palpitations, O O
pedal O O
edema. O O
She O O
has O O
no O O
shortness O O
of O O
breath, O O
cough, O O
or O O
wheezing. O O
She O O
has O O
no O O
urinary O O
frequency O O
or O O
urgency. O O
She O O
has O O
no O O
nausea O O
or O O
vomiting, O O
no O O
diarrhea, O O
heartburn O O
or O O
abdominal O O
pain. O O
Medications O O
Cozaar B-MEDICATION B-MEDICATION
(LOSARTAN) I-MEDICATION O
100 O O
MG O O
PO O O
QD O O
, O O
NEEDS O O
TO O O
MAKE O O
AN O O
APPOINTMENT O O
Glucophage B-MEDICATION B-MEDICATION
(METFORMIN) I-MEDICATION O
1000 O O
MG O O
take O O
bid O O
bid O O
PO O O
BID O O
Norvasc B-MEDICATION B-MEDICATION
(AMLODIPINE) I-MEDICATION O
10 O O
MG O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Glucotrol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
(GLIPIZIDE I-MEDICATION O
XL) I-MEDICATION O
5 O O
MG O O
take O O
qd O O
Tablet(s) O O
PO O O
QD O O
Ultram O O
(TRAMADOL) O O
50 O O
MG O O
(50MG O O
TABLET O O
take O O
1) O O
PO O O
Q6H O O
PRN O O
pain O O
Skelaxin O O
(METAXALONE) O O
800 O O
MG O O
(800MG O O
TABLET O O
take O O
1) O O
PO O O
TID O O
PRN O O
muscle O O
pain O O
Problems O O
Diabetes B-DIABETES O
HX O O
kidney O O
stones O O
Perimenopausal O O
sx O O
Hypertension B-HYPERTENSION O
Allergies O O
Clonidine O O
Hcl O O
- O O
Sleepiness, O O
Codeine O O
- O O
Rash, O O
Vital O O
signs O O
BP B-HYPERTENSION O
174/100, I-HYPERTENSION O
P O O
72, O O
Wt O O
163 O O
lb O O
Gen: O O
Well O O
appearing O O
in O O
NAD O O
ENT-Sclera O O
were O O
white, O O
conjuctiva O O
clear. O O
The O O
oropharynx O O
was O O
pink O O
without O O
exudate. O O
The O O
neck O O
was O O
supple O O
with O O
out O O
adenopathy. O O
LUNG- O O
clear O O
bilaterally, O O
without O O
rhonci, O O
wheeze O O
or O O
rales, O O
Normal O O
excursion O O
was O O
noted. O O
Cor- O O
heart O O
rate O O
was O O
normal, O O
rhythm O O
was O O
regular. O O
No O O
murmurs, O O
gallops O O
or O O
rubs O O
were O O
detected O O
ABD- O O
soft, O O
nontender, O O
with O O
bowel O O
sounds O O
present. O O
No O O
organomegaly O O
was O O
detected. O O
Extremities: O O
no O O
clubbing O O
cyanosis O O
or O O
edema. O O
No O O
swelling O O
or O O
erythema O O
was O O
noted O O
on O O
joint O O
examOn O O
examination, O O
there O O
is O O
pain O O
on O O
palpation O O
of O O
the O O
lower O O
lumbar O O
region O O
including O O
over O O
the O O
sacroiliac O O
area. O O
She O O
has O O
positive O O
straight O O
leg O O
raise O O
on O O
the O O
right. O O
Skin- O O
no O O
abnormal O O
lesions O O
noted. O O
MMP O O
ASSESSMENT: O O
1. O O
Hypertension, O O
poorly O O
controlled O O
at O O
this O O
time. O O
We O O
will O O
have O O
her O O
start O O
the O O
Norvasc O B-MEDICATION
and O O
Cozaar, O B-MEDICATION
have O O
her O O
return O O
in O O
two O O
weeks O O
for O O
followup O O
of O O
blood O O
pressure. O O
2. O O
Diabetes. O O
I O O
will O O
check O O
a O O
hemoglobin O O
A1c. O O
It O O
is O O
due, O O
it O O
has O O
been O O
six O O
months. O O
I O O
will O O
have O O
her O O
continue O O
Glucophage O B-MEDICATION
at O O
this O O
point. O O
3. O O
Lower O O
back O O
pain. O O
I O O
will O O
obtain O O
x-ray O O
of O O
the O O
lower O O
back. O O
We O O
will O O
have O O
her O O
see O O
Orthopedics O O
for O O
evaluation O O
of O O
her O O
back O O
pain. O O
______________________________ O O
Charles O O
Moran, O O
M.D. O O
Dictated O O
By: O O
Charles O O
Moran O O
eScription O O
document:0-0545950 O O
SFFocus O O
DD: O O
04/23/76 O O
DT: O O
04/24/76 O O
DV: O O
04/23/76 O O

Record O O
date: O O
2077-01-22 O O
Carolyn O O
Huntington O O
Bailey O O
Health O O
Center O O
592 O O
Kristina O O
Street O O
XIA, O O
JEAN O O
North O O
East, O O
AL O O
81699 O O
58269151 O O
(375) O O
512-0897 O O
01/22/77 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Ms. O O
Xia O O
is O O
a O O
57-year-old O O
woman O O
who O O
comes O O
in O O
for O O
evaluation O O
of O O
treatment O O
of O O
diabetes B-DIABETES O
and O O
hypertension, B-HYPERTENSION O
reporting O O
that O O
for O O
the O O
last O O
3 O O
days O O
she O O
has O O
had O O
trouble O O
with O O
her O O
vision, O O
her O O
blood O O
pressure O O
has O O
been O O
high. O O
She O O
has O O
been O O
having O O
a O O
lot O O
of O O
headaches. O O
She O O
has O O
had O O
pain O O
in O O
her O O
right O O
thumb O O
that O O
goes O O
to O O
her O O
right O O
lateral O O
side O O
area. O O
She O O
has O O
been O O
having O O
hot O O
flashes O O
but O O
no O O
fevers, O O
sweats O O
or O O
chills. O O
Her O O
sugars O O
have O O
been O O
okay O O
in O O
the O O
99-120 O O
range, O O
the O O
highest O O
was O O
about O O
135-140. O O
She O O
does O O
not O O
really O O
understand O O
why O O
she O O
is O O
feeling O O
so O O
bad O O
with O O
these O O
headaches O O
and O O
other O O
problems. O O
REVIEW O O
OF O O
SYSTEMS: O O
Conducted O O
in O O
detail O O
and O O
was O O
otherwise O O
negative. O O
MEDICATIONS: O O
She O O
has O O
not O O
taken O O
any O O
medications O O
for O O
the O O
last O O
two O O
days. O O
She O O
does O O
have O O
her O O
diabetes O O
medications O O
but O O
no O O
blood O O
pressure O O
medication. O O
She O O
usually O O
takes O O
Cozaar B-MEDICATION B-MEDICATION
100 O O
daily, O O
Glucophage B-MEDICATION B-MEDICATION
1000 O O
b.i.d., O O
Glucotrol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
5 O O
daily, O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
daily, O O
Norvasc B-MEDICATION B-MEDICATION
10 O O
daily. O O
She O O
has O O
not O O
been O O
needing O O
Nexium O O
of O O
late. O O
ALLERGIES: O O
Clonidine O O
caused O O
sleepiness O O
and O O
codeine O O
rash. O O
SOCIAL O O
HISTORY: O O
She B-SMOKER O
does B-SMOKER O
not I-SMOKER O
smoke I-SMOKER O
or O O
use O O
street O O
drugs. O O
She O O
does O O
have O O
a O O
little O O
bit O O
of O O
white O O
wine O O
when O O
she O O
has O O
guests O O
on O O
occasion. O O
PHYSICAL O O
EXAMINATION: O O
On O O
exam, O O
well O O
developed, O O
well O O
nourished, O O
no O O
acute O O
distress. O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
152/120, I-HYPERTENSION O
pulse O O
76, O O
temperature O O
97.2, B-DIABETES O
weight O O
166. O O
Pleasant, O O
articulate O O
in O O
English, O O
she O O
appears O O
comfortable. O O
Pupils O O
equal, O O
equally O O
reactive O O
to O O
light. O O
Retinal O O
fields O O
have O O
sharp O O
disks. O O
Mouth O O
and O O
pharynx O O
without O O
erythema O O
or O O
exudate, O O
no O O
adenopathy O O
or O O
tenderness O O
in O O
the O O
submandibular, O O
cervical, O O
posterior O O
cervical, O O
supraclavicular O O
areas. O O
Thyroid O O
nontender, O O
non-nodular. O O
Neck O O
supple, O O
no O O
spine O O
or O O
flank O O
tenderness. O O
No O O
bruits, O O
no O O
stridor. O O
Heart O O
sounds O O
S1, O O
S2, O O
regular O O
rate O O
and O O
rhythm, O O
no O O
murmur, O O
rub O O
or O O
gallop. O O
Chest O O
is O O
clear O O
to O O
auscultation O O
anteriorly O O
and O O
posteriorly O O
with O O
no O O
rales, O O
wheezes O O
or O O
rhonchi. O O
She O O
is O O
clear O O
to O O
percussion. O O
Normal O O
bowel O O
sounds. O O
Abdomen O O
soft, O O
nontender, O O
no O O
mass, O O
organomegaly, O O
no O O
guarding, O O
no O O
rebound. O O
Extremities O O
are O O
without O O
edema, O O
cyanosis O O
or O O
clubbing, O O
no O O
calf O O
tenderness. O O
Sensation O O
is O O
intact O O
to O O
microfilament O O
testing O O
bilaterally O O
on O O
her O O
feet. O O
Pedal O O
pulses O O
are O O
present. O O
Feet O O
are O O
warm. O O
There O O
is O O
no O O
rash, O O
maceration, O O
or O O
lesion O O
on O O
her O O
feet. O O
LABORATORY O O
DATA: O O
Hemoglobin B-DIABETES O
A1c I-DIABETES O
from I-DIABETES O
October I-DIABETES O
was I-DIABETES O
7.2. I-DIABETES O
LDL B-HYPERLIPIDEMIA O
from I-HYPERLIPIDEMIA O
last I-HYPERLIPIDEMIA O
May I-HYPERLIPIDEMIA O
was I-HYPERLIPIDEMIA O
164. I-HYPERLIPIDEMIA O
IMPRESSION O O
AND O O
PLAN: O O
1. O O
Diabetes. B-DIABETES O
Her O O
diabetes O O
has O O
been O O
near O O
goal. O O
We O O
will O O
recheck O O
glucose, O O
hemoglobin O O
A1c, O O
UA, O O
and O O
microalbuminuria O O
and O O
see O O
how O O
she O O
is O O
doing O O
today. O O
2. O O
Elevated B-HYPERLIPIDEMIA O
cholesterol. I-HYPERLIPIDEMIA O
Her O O
cholesterol O O
was O O
nowhere O O
near O O
our O O
target O O
of O O
100. O O
She O O
is O O
on O O
an O O
increased O O
Lipitor. O B-MEDICATION
We O O
will O O
check O O
cholesterol, O O
see O O
how O O
she O O
is O O
doing O O
at O O
this O O
point, O O
and O O
an O O
OT, O O
PT O O
to O O
make O O
sure O O
she O O
is O O
tolerating O O
the O O
medication. O O
3. O O
Hypertension. B-HYPERTENSION O
All O O
of O O
her O O
symptoms O O
today O O
are O O
most O O
likely O O
due O O
to O O
her O O
hypertension. O O
I O O
explained O O
at O O
great O O
length O O
that O O
the O O
reason O O
for O O
all O O
of O O
her O O
symptoms O O
is O O
the O O
fact O O
she O O
stopped O O
taking O O
her O O
medication. O O
She O O
seemed O O
surprised O O
that O O
it O O
would O O
have O O
such O O
an O O
immediate O O
and O O
strong O O
effect O O
and O O
I O O
explained O O
to O O
her O O
that O O
it O O
does. O O
She O O
has O O
to O O
take O O
her O O
medication O O
every O O
day. O O
I O O
told O O
her O O
she O O
had O O
to O O
leave O O
the O O
Carolyn O O
Huntington O O
right O O
now, O O
go O O
immediately O O
to O O
the O O
drugstore O O
to O O
pick O O
up O O
the O O
medication O O
and O O
she O O
said O O
she O O
would O O
do O O
that. O O
I O O
also O O
asked O O
her O O
to O O
return O O
next O O
week O O
so O O
we O O
can O O
recheck O O
her O O
blood O O
pressure O O
and O O
make O O
sure O O
it O O
is O O
controlled. O O
4. O O
Health O O
maintenance. O O
I O O
will O O
schedule O O
her O O
for O O
a O O
mammogram. O O
5. O O
Colonic O O
adenoma O O
from O O
11/2076. O O
She O O
will O O
need O O
follow-up O O
colonoscopy O O
every O O
three O O
years O O
per O O
GI. O O
hga1c B-DIABETES O
6.9, I-DIABETES O
ldl O O
86, O O
letter O O
to O O
pt O O
______________________________ O O
Yolanda O O
Osburn, O O
M.D. O O
Dictated O O
By: O O
Yolanda O O
Osburn O O
eScription O O
document:9-2062651 O O
EMSSten O O
Tel O O
DD: O O
01/23/77 O O
DT: O O
01/24/77 O O
DV: O O
01/22/77 O O

Record O O
date: O O
2078-06-22 O O
Patient O O
Name: O O
XIA,JEAN O O
[ O O
58269151(PROMPTCARE) O O
] O O
Date O O
of O O
Visit: O O
06/22/2078 O O
Reason B-SMOKER O
for O O
Visit O O
pt O O
was O O
cleaning O O
ear, O O
now O O
has O O
pain O O
mainly O O
in O O
left. O O
worse O O
over O O
past O O
three O O
days. O O
reports O O
now O O
taking O O
atenolol B-MEDICATION B-MEDICATION
(50 O O
mg O O
which O O
she O O
just O O
took O O
half O O
an O O
hour O O
ago) O O
and O O
losartan, B-MEDICATION B-MEDICATION
Reports O O
stopped B-MEDICATION O
amilodipine B-MEDICATION O
and O O
hctz. B-MEDICATION O
she O O
had O O
leg O O
cramps, O O
but O O
is O O
not O O
clear O O
which O O
of O O
these O O
caused O O
that. O O
reports O O
feels O O
bp O O
is O O
high O O
because O O
she O O
forgot O O
to O O
take O O
med. O O
Review O O
of O O
Systems O O
Constitutional: O O
No O O
fever, O O
chills, O O
fatigue, O O
nightsweats, O O
insomnia, O O
change O O
in O O
weight O O
ENT/Mouth: O O
No O O
rhinitis, O O
epistaxis, O O
sinus O O
pain, O O
change O O
in O O
hearing, O O
tinnitus, O O
discharge O O
from O O
ears, O O
oral O O
lesions, O O
problems O O
chewing, O O
dental O O
pain, O O
sore O O
throat O O
Cardiovascular: O O
no O O
chest O O
pain, O O
pressure, O O
palpitation, O O
PND, O O
orthopnea, O O
dyspnea O O
on O O
exertion, O O
pedal O O
edema, O O
nocturia, O O
claudication, O O
Respiratory: O O
no O O
cough, O O
sputum, O O
dyspnea, O O
pleuritic O O
pain, O O
wheeze, O O
loud O O
snoring, O O
hemoptysis O O
Allergies O O
CLONIDINE O O
- O O
Sleepiness, O O
Codeine O O
- O O
Rash, O O
LISINOPRIL O B-MEDICATION
- O O
cough, O O
Ibuprofen O O
- O O
cramps, O O
AMLODIPINE O B-MEDICATION
- O O
cramps, O O
Problems O O
Diabetes B-DIABETES O
HX O O
kidney O O
stones O O
Perimenopausal O O
sx O O
Hypertension B-HYPERTENSION O
Colonic O O
adenoma O O
11/11/76 O O
Medications O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
, O O
please O O
cancel O O
previous O O
script O O
for O O
10 O O
mg O O
of O O
lipitor O B-MEDICATION
thanks O O
you, O O
dr O O
osburn O O
Glucotrol B-MEDICATION B-MEDICATION
Xl I-MEDICATION O
(GLIPIZIDE I-MEDICATION O
Xl) I-MEDICATION O
5 O O
MG O O
take O O
qd O O
Tablet(s) O O
PO O O
QD O O
PIROXICAM O B-MEDICATION
20 O O
MG O O
(20MG O O
CAPSULE O O
take O O
1) O O
PO O O
QD O O
Glucophage B-MEDICATION B-MEDICATION
(METFORMIN) I-MEDICATION O
1000 O O
MG O O
take O O
bid O O
bid O O
PO O O
BID O O
Cozaar B-MEDICATION B-MEDICATION
(LOSARTAN) O O
100 O O
MG O O
PO O O
QD O O
ATENOLOL B-MEDICATION B-MEDICATION
100 I-MEDICATION O
MG I-MEDICATION O
(100MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Cortisporin O O
Otic O O
Suspension O O
4 O O
DROP O O
AS O O
QID O O
Vital O O
Signs O O
BLOOD B-HYPERTENSION O
PRESSURE I-HYPERTENSION O
210/118 I-HYPERTENSION O
PULSE O O
80 O O
TEMPERATURE O O
97.3 O O
F O O
WEIGHT O O
160 O O
lb O O
Physical O O
Exam O O
Gen: O O
Well O O
appearing O O
in O O
NAD, O O
WD, O O
WN O O
ENT-Sclera O O
were O O
white, O O
fundi O O
disc O O
sharp, O O
conjunctiva O O
clear, O O
tympanic O O
membranes O O
normal, O O
ear O O
canal O O
AS O O
somewhat O O
red. O O
The O O
oropharynx O O
was O O
pink O O
without O O
exudate. O O
The O O
neck O O
was O O
supple O O
with O O
out O O
adenopathy. O O
LUNG- O O
clear O O
bilaterally, O O
without O O
rhonci, O O
wheeze O O
or O O
rales, O O
Normal O O
excursion O O
was O O
noted. O O
Cor- O O
heart O O
rate O O
was O O
normal, O O
rhythm O O
was O O
regular. O O
No O O
murmurs, O O
gallops O O
or O O
rubs O O
were O O
detected O O
Extremities: O O
no O O
clubbing O O
cyanosis O O
or O O
edema. O O
Skin- O O
no O O
abnormal O O
lesions O O
noted. O O
Impression O O
Ear- O O
benign O O
exam O O
but O O
symptomatic O O
- O O
try O O
cortisporun O O
otic O O
HTN- B-HYPERTENSION O
very O O
high, O O
no O O
sign O O
of O O
end O O
organ O O
injury O O
at O O
this O O
moment- O O
will O O
increase B-MEDICATION O
atenolol I-MEDICATION B-MEDICATION
to I-MEDICATION O
100, I-MEDICATION O
and O O
have O O
her O O
rtc O O
for O O
recheck. O O
It O O
would O O
be O O
helpful O O
to O O
know O O
whether O O
cramps O O
came O O
from O O
hctz O O
or O O
amilodipine. O O
______________________________ O O
Charles O O
Craig O O
Max O O
Zavaleta, O O
M.D. O O

Record O O
date: O O
2092-05-06 O O
Patient O O
Name: O O
WILHELM, O O
GOLDY; O O
MRN: O O
9543443 O O
Dictated O O
at: O O
05/06/2092 O O
by O O
EDWARD O O
XAYASANE, O O
M.D. O O
CHIEF O O
COMPLAINT: O O
Right O O
leg O O
pain O O
and O O
difficulty O O
walking. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Ms. O O
Wilhelm O O
is O O
a O O
68-year-old O O
right-handed O O
female O O
who O O
has O O
had O O
a O O
three-week O O
history O O
of O O
having O O
right O O
leg O O
pain O O
and O O
difficulty O O
walking. O O
She O O
states O O
that O O
her O O
pain O O
started O O
about O O
three O O
weeks O O
ago O O
when O O
she O O
was O O
bending O O
and O O
picking O O
up O O
a O O
pot. O O
She O O
states O O
she O O
had O O
a O O
pain O O
in O O
her O O
back O O
that O O
radiated O O
around O O
her O O
right O O
side O O
down O O
her O O
groin O O
into O O
her O O
medial O O
leg, O O
not O O
past O O
the O O
knee. O O
She O O
states O O
that O O
it O O
went O O
away O O
at O O
that O O
time. O O
The O O
next O O
day O O
she O O
felt O O
worsened O O
and O O
had O O
difficulty O O
working O O
and O O
saw O O
her O O
physician. O O
An O O
MRI O O
was O O
ordered. O O
Since O O
then, O O
she O O
feels O O
about O O
60-75 O O
percent O O
better. O O
She O O
states O O
that O O
her O O
pain O O
is O O
constant O O
and O O
describes O O
it O O
as O O
a O O
sharp O O
pain. O O
She O O
does O O
state O O
she O O
feels O O
weak O O
and O O
her O O
knee O O
would O O
buckle. O O
She O O
does O O
not O O
have O O
any O O
numbness O O
or O O
tingling. O O
She O O
states O O
she O O
uses O O
a O O
walker O O
to O O
get O O
to O O
her O O
bathroom, O O
however, O O
otherwise O O
stays O O
in O O
the O O
recliner. O O
Her O O
symptoms O O
are O O
increased O O
with O O
lying O O
down O O
and O O
standing O O
and O O
decreased O O
with O O
sitting. O O
Therapeutically, O O
she O O
has O O
not O O
received O O
any O O
physical O O
therapy O O
or O O
occupational O O
therapy. O O
She O O
is O O
currently O O
taking O O
Darvocet, O O
however, O O
less O O
frequently, O O
and O O
Celebrex O O
for O O
arthritis. O O
Diagnostically, O O
she O O
has O O
had O O
an O O
MRI O O
scan O O
in O O
April O O
2092 O O
that O O
showed O O
multi-level O O
spinal O O
stenosis, O O
most O O
prominent O O
at O O
L3/L4, O O
especially O O
on O O
the O O
right O O
side, O O
secondary O O
to O O
facet O O
arthropathy O O
and O O
ligamentum O O
flavum O O
infolding, O O
as O O
well O O
as O O
possibly O O
a O O
mild O O
disk O O
bulge. O O
Her O O
mammogram O O
was O O
done O O
in O O
2091 O O
which O O
was O O
okay. O O
She O O
has O O
not O O
had O O
a O O
bone O O
mineral O O
density O O
at O O
this O O
time. O O
MEDICATIONS: O O
Currently, O O
the O O
medication O O
she O O
is O O
on O O
is O O
Celebrex, O O
Hyzaar B-MEDICATION O
for O O
her O O
blood O O
pressure, O O
and O O
Darvocet O O
for O O
her O O
pain. O O
ALLERGIES: O O
She O O
states O O
that O O
taking O O
Tylenol O O
With O O
Codeine O O
gives O O
her O O
toes O O
a O O
burning O O
sensation, O O
and O O
ibuprofen O O
causes O O
tinnitus. O O
PAST O O
MEDICAL O O
HISTORY: O O
She O O
has O O
got O O
high O O
blood O O
pressure O O
and O O
shoulder O O
arthritis. O O
PAST O O
SURGICAL O O
HISTORY: O O
She O O
had O O
a O O
left O O
breast O O
biopsy O O
which O O
she O O
states O O
was O O
not O O
cancerous. O O
SOCIAL/FUNCTIONAL O O
HISTORY: O O
She O O
is O O
functionally O O
currently O O
not O O
working. O O
She O O
is O O
taking O O
sick O O
time. O O
She O O
has O O
not O O
worked O O
for O O
the O O
past O O
three O O
weeks. O O
She O O
is O O
a O O
Head O O
Nurse O O
and O O
worked O O
at O O
The O O
Library O O
Corporation O O
for O O
the O O
last O O
35 O O
years. O O
She O O
states O O
her O O
job O O
is O O
medium O O
as O O
far O O
as O O
intensity O O
of O O
work. O O
Functionally, O O
her O O
activities O O
of O O
daily O O
living O O
are O O
limited, O O
and O O
she O O
uses O O
an O O
assistive O O
device. O O
SOCIAL O O
HISTORY: O O
She O O
is O O
widowed O O
and O O
she O O
has O O
four O O
healthy O O
children, O O
ages O O
51, O O
50, O O
48, O O
and O O
46. O O
She B-SMOKER O
does I-SMOKER O
not I-SMOKER O
smoke I-SMOKER O
or O O
drink. O O
FAMILY O O
HISTORY: O O
She O O
has O O
aunts O O
with O O
diabetes O O
and O O
brother O O
that O O
had O O
an O O
myocardial O O
infarction O O
at O O
59. O O
REVIEW O O
OF O O
SYSTEMS: O O
On O O
review O O
of O O
systems, O O
no O O
fevers, O O
chills, O O
recent O O
infections, O O
bladder, O O
thyroid O O
problems, O O
rash, O O
shortness O O
of O O
breath, O O
palpations, O O
chest O O
pain, O O
nausea, O O
abdominal O O
pain, O O
diarrhea, O O
or O O
bowel O O
or O O
bladder O O
or O O
sexual O O
problems O O
or O O
urination O O
difficulty. O O
She O O
does O O
have O O
some O O
joint O O
pain O O
and O O
swelling O O
in O O
her O O
shoulders O O
and O O
her O O
feet O O
occasionally. O O
She O O
does O O
not O O
have O O
any O O
numbness O O
or O O
tingling. O O
She O O
does O O
have O O
some O O
trouble O O
walking O O
secondary O O
to O O
the O O
pain. O O
She O O
does O O
not O O
feel O O
fatigued O O
and O O
her O O
appetite O O
is O O
okay O O
and O O
she O O
does O O
not O O
feel O O
anxious O O
or O O
stressed. O O
She O O
does O O
have O O
some O O
mild O O
trouble O O
with O O
sleeping, O O
however, O O
this O O
has O O
improved O O
over O O
the O O
last O O
few O O
days. O O
PHYSICAL O O
EXAMINATION: O O
On O O
physical O O
examination, O O
well-developed, O O
well-nourished, O O
well-groomed, O O
normal O O
mood O O
and O O
affect, O O
but O O
slightly O O
anxious O O
with O O
movement, O O
female O O
in O O
no O O
acute O O
distress O O
at O O
this O O
time. O O
On O O
musculoskeletal O O
examination O O
of O O
lumbar O O
spine, O O
flexion O O
was O O
within O O
normal O O
limits. O O
Extension O O
she O O
had O O
her O O
type O O
of O O
pain O O
at O O
about O O
10-20 O O
degrees. O O
Side-bending O O
was O O
unremarkable. O O
On O O
hip O O
examination O O
she O O
had O O
some O O
decreased O O
internal O O
rotation O O
on O O
the O O
right O O
when O O
compared O O
to O O
the O O
left. O O
Straight O O
leg O O
raise O O
bilaterally O O
was O O
negative, O O
however, O O
supine, O O
slight O O
guarding O O
on O O
the O O
right. O O
Femoral O O
stretch O O
was O O
positive O O
on O O
the O O
right O O
but O O
not O O
on O O
the O O
left. O O
On O O
neurological O O
examination, O O
as O O
far O O
as O O
motor O O
examination, O O
there O O
is O O
some O O
slight O O
decrease, O O
half O O
a O O
grade, O O
quadriceps O O
and O O
hip O O
flexors; O O
however, O O
this O O
was O O
functional; O O
otherwise O O
unremarkable O O
on O O
the O O
right O O
or O O
the O O
left. O O
Her O O
reflexes O O
were O O
2 O O
plus O O
in O O
the O O
achilles. O O
Babinskis O O
were O O
downgoing, O O
1 O O
plus O O
at O O
the O O
patella O O
on O O
the O O
right, O O
and O O
2 O O
plus O O
on O O
the O O
left. O O
Sensory O O
examination O O
slightly O O
decreased O O
at O O
L3 O O
on O O
the O O
right; O O
however, O O
normal O O
throughout; O O
otherwise, O O
gait O O
was O O
antalgic O O
on O O
the O O
right O O
and O O
she O O
did O O
not O O
want O O
to O O
bear O O
weight. O O
IMPRESSION: O O
1. O O
Right O O
L3 O O
acute O O
radiculopathy O O
secondary O O
to O O
herniated O O
disk O O
and O O
facet O O
arthropathy. O O
2. O O
Functional O O
limitations O O
secondary O O
to O O
pain, O O
causing O O
her O O
functional O O
weakness. O O
RECOMMENDATIONS: O O
1. O O
Transforaminal O O
epidural O O
steroid O O
injection O O
at O O
L3 O O
and O O
L4 O O
on O O
the O O
right. O O
2. O O
Physical O O
therapy O O
after O O
her O O
injection. O O
3. O O
Continue O O
her O O
medications O O
of O O
Darvocet O O
and O O
Celebrex. O O
4. O O
Keep O O
her O O
out O O
of O O
work O O
until O O
she O O
is O O
able O O
to O O
receive O O
the O O
injection, O O
as O O
well O O
as O O
continue O O
with O O
her O O
physical O O
therapy O O
to O O
improve O O
her O O
strength, O O
given O O
her O O
acute O O
radiculopathy. O O
The O O
patient O O
was O O
seen O O
and O O
examined O O
with O O
Dr. O O
Xayasane, O O
who O O
agrees O O
with O O
the O O
plan O O
above. O O
_______________________________ O O
Edward O O
Xayasane, O O
M.D. O O
cc: O O
David O O
Utterback, O O
M.D. O O
DD:05/06/2092 O O
DT:05/09/2092 O O
TL:95468 O O
:423 O O

Record O O
date: O O
2097-06-03 O O
Time O O
of O O
visit: O O
6/03/2097, O O
1330 O O
hours O O
Time O O
of O O
note: O O
1630 O O
hours O O
Patient O O
seen O O
and O O
examined O O
with O O
the O O
team. O O
Note O O
of O O
Dr. O O
Ellis O O
reviewed, O O
findings O O
confirmed. O O
Available O O
electronic O O
notes O O
reviewed, O O
X-rays O O
reviewed, O O
labs O O
reviewed. O O
73 O O
y. O O
o. O O
woman O O
who O O
has O O
worked O O
as O O
a O O
nurse O O
at O O
TLC O O
for O O
40 O O
years. O O
Nonsmoker. B-SMOKER O
History O O
of O O
hypertension B-HYPERTENSION O
treated O O
with O O
Hyzaar. B-MEDICATION O
Current O O
illness O O
began O O
5-6 O O
months O O
ago O O
with O O
fatigue, O O
dyspnea O O
on O O
exertion O O
that O O
has O O
progressed O O
to O O
the O O
point O O
that O O
she O O
has O O
to O O
stop O O
to O O
catch O O
her O O
breath O O
after O O
walking O O
up O O
only O O
4-5 O O
steps O O
in O O
a O O
stairwell. O O
She O O
finds O O
it O O
difficult O O
to O O
get O O
started O O
on O O
her O O
work O O
because O O
of O O
fatigue. O O
She O O
has O O
had O O
a O O
cough O O
that O O
initially O O
produced O O
yellowish, O O
'slimy' O O
sputum, O O
but O O
more O O
recently O O
has O O
been O O
dry. O O
She O O
notes O O
occasional O O
wheezing. O O
She O O
also O O
noted O O
muscle O O
and O O
joint O O
pain O O
involving O O
the O O
shoulders O O
and O O
lower O O
extremities O O
over O O
the O O
past O O
5-6 O O
months O O
that O O
she O O
attributed O O
to O O
'arthritis'. O O
No O O
polyuria, O O
but O O
has O O
noted O O
nocturia O O
X2 O O
for O O
the O O
past O O
5-6 O O
months. O O
During O O
the O O
same O O
period O O
of O O
time, O O
has O O
noted O O
very O O
dry O O
mouth. O O
No O O
abdominal O O
pain, O O
but O O
some O O
difficulty O O
with O O
constipation O O
for O O
the O O
past O O
two O O
weeks. O O
Appetite O O
diminished O O
and O O
she O O
lost O O
about O O
30 O O
pounds. O O
She O O
noted O O
a O O
nodule O O
on O O
the O O
extensor O O
surface O O
of O O
the O O
left O O
elbow O O
that O O
her O O
PCP O O
'cut O O
into' O O
recently. O O
She O O
has O O
also O O
noted O O
a O O
nodule O O
on O O
the O O
dorsal O O
surface O O
of O O
the O O
right O O
foot O O
that O O
seems O O
to O O
'get O O
larger'. O O
She O O
experienced O O
substernal O O
chest O O
pain O O
with O O
radiation O O
to O O
the O O
back O O
that O O
lasted O O
several O O
hours, O O
prompting O O
her O O
to O O
come O O
to O O
the O O
ER. O O
No O O
associated O O
diaphoresis, O O
nausea. O O
Pain O O
somewhat O O
better O O
with O O
sitting O O
up. O O
Of O O
note, O O
she O O
has O O
known O O
of O O
having O O
a O O
cardiac O O
murmur O O
for O O
many O O
years. O O
Exam: O O
Pleasant O O
black O O
woman O O
in O O
no O O
distress. O O
BP B-HYPERTENSION O
158/79, I-HYPERTENSION O
Pulse O O
80, O O
regular; O O
O2 O O
sat O O
98% O O
on O O
room O O
air. O O
Afebrile. O O
Skin O O
darkly O O
pigmented O O
nodule O O
left O O
elbow O O
extensor O O
surface, O O
similar O O
nodule O O
right O O
dorsal O O
foot O O
just O O
proximal O O
to O O
4th/5th O O
toe. O O
No O O
other O O
rashes. O O
HEENT: O O
pale O O
conjunctivae, O O
anicteric. O O
No O O
nasal O O
findings, O O
no O O
facial O O
skin O O
findings O O
(specifically, O O
no O O
lupus O O
pernio). O O
Dry O O
mucous O O
membranes. O O
Neck: O O
small, O O
soft, O O
mobile O O
0.5 O O
cm O O
node O O
left O O
anterior O O
cervical O O
chain. O O
Chest: O O
inspiratory O O
crackles O O
at O O
both O O
bases. O O
Cardiac: O O
No O O
JVD. O O
Regular O O
rhythm. O O
III/VI O O
(I O O
do O O
not O O
feel O O
a O O
thrill) O O
harsh O O
nearly O O
holosystolic O O
murmur O O
heard O O
throughout O O
the O O
precordium, O O
but O O
especially O O
prominent O O
at O O
the O O
RUSB O O
with O O
radiation O O
to O O
the O O
clavicles, O O
neck. O O
Also O O
heard O O
at O O
the O O
apex O O
and O O
radiates O O
to O O
the O O
left O O
mid-back O O
(?same O O
murmur). O O
The O O
murmur O O
intensifies O O
when O O
she O O
stands. O O
No O O
gallops. O O
No O O
rub. O O
Abdomen O O
soft O O
and O O
nontender. O O
No O O
spleen O O
tip. O O
Liver O O
edge O O
not O O
palpable. O O
Lymph O O
nodes: O O
fullness O O
below O O
the O O
left O O
axilla, O O
although O O
not O O
confident O O
of O O
discrete O O
nodes. O O
Data: O O
There O O
is O O
considerable O O
testing O O
available O O
to O O
us O O
from O O
her O O
recent O O
visits O O
to O O
the O O
Walk-In O O
Clinic O O
and O O
to O O
Dr. O O
Utter. O O
A O O
CXR O O
from O O
5/2097 O O
shows O O
bilateral O O
hilar O O
adenopathy, O O
mediastinal O O
adenopathy, O O
and O O
interstitial O O
infiltrates. O O
Creatinine O O
1.7 O O
Date/Time O O
CA O O
ALB O O
06/03/2097 O O
12.3 O O
(H) O O
3.4 O O
06/02/2097 O O
12.8 O O
(H) O O
3.5 O O
05/28/2097 O O
11.8 O O
(H) O O
3.5 O O
Date/Time O O
ALT/SGPT O O
AST/SGOT O O
ALKP O O
TBILI O O
06/03/2097 O O
41 O O
(H) O O
41 O O
(H) O O
67 O O
0.7 O O
Date/Time O O
NT-BNP O O
CK O O
CK-MB O O
CKMBRI O O
06/03/2097 O O
135 O O
9.6 O O
(H) O O
06/03/2097 O O
126 O O
8.6 O O
(H) O O
6.8 O O
(H) O O
E O O
06/02/2097 O O
4285 O O
(H)[1] O O
06/02/2097 O O
NEGATIVE O O
Date/Time O O
TROP-I O O
TROP-T O O
06/03/2097 O O
0.12 O O
(H) O O
06/03/2097 O O
0.12 O O
(H) O O
06/02/2097 O O
NEGATIVE O O
06/02/2097 O O
NEGATIVE O O
Date/Time O O
FE O O
TIBC O O
FER O O
05/28/2097 O O
33 O O
237 O O
130 O O
Date/Time O O
WBC O O
RBC O O
HGB O O
HCT O O
06/03/2097 O O
6.4 O O
3.98 O O
(L) O O
10.2 O O
(L) O O
30.4 O O
(L) O O
Date/Time O O
MCV O O
MCH O O
MCHC O O
PLT O O
06/03/2097 O O
76 O O
(L) O O
25.5 O O
(L) O O
33.5 O O
198 O O
Date/Time O O
DIFFR O O
METHOD O O
%NEUT O O
%LYMPH O O
06/03/2097 O O
RECEIVED O O
Auto O O
71 O O
(H) O O
20 O O
(L) O O
Date/Time O O
%MONO O O
%EOS O O
%BASO O O
06/03/2097 O O
6 O O
3 O O
0 O O
Date/Time O O
RETIC O O
06/03/2097 O O
1.7 O O
Serum O O
angiotensin O O
converting O O
enzyme O O
68 O O
(7-46 O O
U/L) O O
LDH O O
354 O O
EKG: O O
ST O O
elevations O O
V1-3. O O
Problems: O O
1. O O
Dyspnea O O
on O O
exertion, O O
progressive. O O
2. O O
Interstitial O O
lung O O
disease. O O
3. O O
Bilateral O O
hilar O O
adenopathy O O
4. O O
Weight O O
loss O O
5. O O
Symptomatic O O
hypercalcemia O O
Nocturia O O
Arthralgias O O
Constipation O O
Fatigue O O
6. O O
Prominent O O
systolic O O
murmur(s?). O O
Changes O O
with O O
maneuvers O O
suggest O O
this O O
may O O
be O O
secondary O O
to O O
hypertrophic O O
obstructive O O
cardiomyopathy. O O
There O O
was O O
evidence O O
to O O
suggest O O
this O O
on O O
an O O
echo O O
from O O
2085, O O
but O O
obviously, O O
need O O
more O O
recent O O
data. O O
7. O O
Minimally O O
elevated O O
troponins. O O
Uncertain O O
significance. O O
8. O O
Anemia, O O
mildly O O
microcytic. O O
9. O O
Elevated O O
LDH. O O
10. O O
Renal O O
insufficiency, O O
likely O O
secondary O O
to O O
uncontrolled O O
hypercalcemia. O O
11. O O
History O O
of O O
hypertension. O O
Discussion: O O
Sarcoidosis, O O
until O O
proven O O
otherwise. O O
She O O
is O O
obviously O O
older O O
than O O
typical O O
presentation O O
of O O
sarcoidosis, O O
but O O
she O O
had O O
previous O O
lymphadenopathy O O
that O O
may O O
have O O
been O O
a O O
first O O
presentation O O
of O O
the O O
illness O O
with O O
spontaneous O O
remission. O O
The O O
lung O O
findings, O O
systemic O O
symptoms, O O
hypercalcemia, O O
anemia, O O
abnormal O O
serum O O
ACE O O
level O O
are O O
all O O
suggestive O O
of O O
this O O
diagnosis. O O
Her O O
hypercalcemia O O
is O O
symptomatic O O
and O O
should O O
be O O
treated O O
with O O
volume O O
repletion. O O
She O O
should O O
not O O
receive O O
diuretics O O
at O O
present. O O
Long O O
term O O
treatment O O
will O O
be O O
dependent O O
on O O
the O O
underlying O O
diagnosis O O
and O O
its O O
treatment. O O
I O O
think O O
she O O
will O O
need O O
corticosteroids O O
for O O
her O O
sarcoidosis O O
and O O
I O O
expect O O
this O O
will O O
improve O O
the O O
hypercalcemia, O O
but O O
we O O
need O O
definitive O O
diagnosis O O
first. O O
The O O
cardiac O O
murmur O O
is O O
impressive, O O
but O O
likely O O
unrelated O O
to O O
the O O
pulmonary O O
disease. O O
We O O
need O O
echocardiogram O O
to O O
better O O
define O O
valvular O O
function. O O
The O O
minimally O O
elevated O O
troponins O O
are O O
not O O
felt O O
to O O
be O O
of O O
clinical O O
significance O O
at O O
this O O
point. O O
Appreciate O O
Cardiology O O
input O O
on O O
this O O
finding. O O
Suggest: O O
1. O O
Stop B-MEDICATION O
HCTZ,avoid I-MEDICATION O
diuretics O O
until O O
fully O O
volume O O
repleted. O O
2. O O
IV O O
normal O O
saline. O O
May O O
need O O
rates O O
in O O
the O O
150-200 O O
range O O
to O O
control O O
her O O
hypercalcemia O O
acutely, O O
but O O
she O O
has O O
had O O
this O O
for O O
some O O
time, O O
so O O
can O O
be O O
conservative O O
with O O
fluids O O
approach. O O
3. O O
Agree O O
with O O
check O O
PTH, O O
vitamin O O
D O O
levels. O O
4. O O
Follow O O
lytes, O O
creatinine, O O
calcium, O O
Hct. O O
5. O O
Agree O O
with O O
check O O
echocardiogram. O O
6. O O
We O O
should O O
ask O O
the O O
Pulmonary O O
Service O O
to O O
see O O
her O O
in O O
consultation. O O
Bronchoscopy O O
with O O
biopsy O O
may O O
be O O
the O O
best O O
way O O
to O O
obtain O O
confirmatory O O
tissue O O
for O O
diagnosis O O
of O O
sarcoidosis. O O
_____________________________________________ O O
Edmond O O
I. O O
Utterback, O O
M.D. O O
Pager O O
#57863 O O
Internal O O
Medicine O O
B O O
Attending O O

Record O O
date: O O
2097-06-29 O O
Internal O O
Medicine O O
B O O
Intern O O
Admission O O
Note O O
PATIENT: O O
GOLDY O O
WILHELM O O
MRN: O O
9543443 O O
ADMIT O O
DATE: O O
June O O
29, O O
2097 O O
ATTENDING: O O
Dr. O O
William O O
Xian O O
PCP: O O
Dr. O O
Casey O O
Frey O O
(new) O O
CONTACT: O O
Leo O O
Wilhelm, O O
son O O
705-690-8475 O O
CODE: O O
Full O O
Source: O O
Patient, O O
family, O O
chart O O
ID/CC: O O
no O O
appetite, O O
acute O O
renal O O
failure O O
HPI: O O
73 O O
yo O O
black O O
woman O O
with O O
h/o O O
HTN B-HYPERTENSION O
and O O
recurrent O O
non-malignant O O
axillary O O
lymphadenopathy, O O
newly O O
diagnosed O O
with O O
HOCM O O
in O O
the O O
setting O O
of O O
fatigue, O O
weight O O
loss O O
and O O
hypercalcemia O O
concerning O O
for O O
sarcoidosis O O
during O O
a O O
work-up O O
at O O
her O O
last O O
admission O O
to O O
MEDIQUIK O O
on O O
6/2-6/20/97. O O
At O O
that O O
time, O O
the O O
patient O O
noted O O
that O O
3-4 O O
mo O O
PTA O O
she O O
had O O
experienced O O
worsening O O
fatigue O O
and O O
dry O O
mouth, O O
as O O
well O O
as O O
poor O O
oral O O
intake O O
with O O
associated O O
30 O O
lb O O
weight O O
loss. O O
In O O
early O O
May, O O
she O O
presented O O
to O O
the O O
walk-in O O
clinic O O
with O O
these O O
complaints O O
and O O
a O O
CXR O O
showed O O
increased O O
interstitial O O
markings O O
and O O
mediastinal O O
lymphadenopathy O O
subsequently O O
confirmed O O
by O O
CT. O O
A O O
PET O O
CT O O
showed O O
FDG O O
avidity O O
in O O
multiple O O
enlarged O O
thoracic O O
and O O
axillary O O
nodes. O O
The O O
patient O O
was O O
seen O O
at O O
the O O
lymphoma O O
center O O
by O O
Dr. O O
Utter, O O
and O O
concern O O
was O O
raised O O
for O O
multiple O O
processes O O
including O O
sarcoid, O O
lupus-like O O
syndromes, O O
Castleman's, O O
and O O
indolent O O
lymphoma. O O
Labs O O
drawn O O
at O O
different O O
times O O
in O O
recent O O
past O O
were O O
notable O O
for O O
a O O
Ca O O
of O O
11.8 O O
with O O
Alb O O
of O O
3.5, O O
a O O
mild O O
tranaminitis O O
in O O
the O O
40s, O O
LDH O O
of O O
354, O O
ACE O O
of O O
68, O O
normal O O
TSH, O O
HCT O O
of O O
30.2, O O
ESR O O
of O O
85, O O
SPEP O O
with O O
diffuse O O
gamma O O
globulin O O
increase, O O
positive O O
ANA O O
at O O
1:2560 O O
with O O
nuclear O O
pore O O
staining O O
(highly O O
specific O O
for O O
biliary O O
cirrhosis), O O
elevated O O
B2MG O O
at O O
17.5, O O
and O O
elevated O O
kappa O O
and O O
lambda O O
free O O
light O O
chains O O
at O O
66 O O
and O O
83.5, O O
respectively O O
and O O
negative O O
HIV. O O
The O O
patient O O
s O O
hypercalcemia O O
was O O
treated O O
with O O
IVF, O O
lasix O O
at O O
times, O O
and O O
a O O
dose O O
of O O
bisphosphonate, O O
which O O
led O O
to O O
a O O
decrease O O
in O O
Ca O O
to O O
10.1. O O
Axillary O O
lymph O O
node O O
biopsy O O
6/08/97 O O
revealed O O
non-specific O O
follicular O O
hyperplasia, O O
though O O
to O O
be O O
consistent O O
with O O
a O O
reactive O O
process. O O
Oncology O O
was O O
consulted, O O
and O O
a O O
lymphoma O O
work-up O O
was O O
pursued; O O
flow O O
cytometry O O
revealed O O
polyclonal O O
CD19+ O O
B O O
cells, O O
CD4+ O O
and O O
CD8+ O O
T O O
cells, O O
with O O
no O O
evidence O O
for O O
a O O
monoclonal O O
B O O
or O O
unusual O O
T O O
cell O O
population. O O
Repeat O O
CT O O
examination O O
of O O
the O O
chest O O
revealed O O
no O O
change O O
in O O
the O O
bilateral O O
axillary, O O
mediastinal, O O
and O O
hilar O O
lymphadenopathy O O
and O O
offered O O
no O O
further O O
clues O O
to O O
diagnostic O O
possibilities. O O
The O O
patient O O
underwent O O
pulmonary O O
function O O
testing, O O
which O O
showed O O
a O O
reduction O O
in O O
the O O
FEV1, O O
FVC, O O
and O O
FEV1/FVC O O
ratio; O O
total O O
lung O O
capacity O O
and O O
subdivisions O O
were O O
normal, O O
resistance O O
and O O
specific O O
conductance O O
were O O
normal, O O
and O O
single O O
breath O O
diffusion O O
capacity O O
was O O
reduced. O O
On O O
7/19/97, O O
a O O
bronchoscopy O O
was O O
attempted, O O
but O O
the O O
patient O O
was O O
unable O O
to O O
tolerate O O
the O O
procedure, O O
and O O
it O O
was O O
not O O
performed. O O
Thoracic O O
surgery O O
was O O
consulted O O
and O O
recommended O O
that O O
the O O
patient O O
be O O
evaluated O O
in O O
the O O
outpatient O O
setting O O
for O O
biopsy O O
under O O
general O O
anesthesia. O O
Fungal O O
antibodies O O
were O O
sent, O O
and O O
a O O
trial O O
of O O
steroids O O
was O O
not O O
attempted O O
during O O
hospitalization. O O
Since O O
discharge, O O
the O O
pt O O
reports O O
that O O
she O O
continues O O
to O O
feel O O
very O O
fatigued, O O
and O O
has O O
not O O
felt O O
like O O
eating. O O
She O O
reports O O
significant O O
acid O O
reflux, O O
saying O O
only O O
water O O
goes O O
down O O
and O O
a O O
lack O O
of O O
appetite O O
with O O
very O O
dry O O
mouth. O O
She O O
notes O O
continued O O
weight O O
loss O O
of O O
15lbs O O
since O O
leaving O O
the O O
hospital, O O
tolerating O O
little O O
more O O
than O O
1-2 O O
cans O O
of O O
Ensure/day O O
per O O
her O O
family. O O
She O O
further O O
denies O O
N/V, O O
diarrhea, O O
fever/chills/dizziness O O
or O O
recent O O
infection. O O
Of O O
note, O O
she O O
has O O
been O O
drinking O O
little, O O
but O O
urinating O O
9-10 O O
times O O
a O O
day, O O
clear O O
urine O O
with O O
large O O
volumes. O O
She O O
has O O
not O O
had O O
a O O
bowel O O
movement O O
for O O
several O O
days. O O
She O O
has O O
continued O O
her O O
medications O O
as O O
instructed O O
at O O
the O O
time O O
of O O
discharge. O O
In O O
addition, O O
her O O
family O O
notes O O
a O O
dramatic O O
change O O
in O O
her O O
mood O O
and O O
activity O O
level O O
since O O
prior O O
to O O
hospitalization. O O
She O O
used O O
to O O
be O O
very O O
active, O O
working O O
nearly O O
every O O
day O O
and O O
keeping O O
up O O
her O O
household. O O
She O O
now O O
spends O O
most O O
of O O
her O O
day O O
in O O
bed O O
sleeping, O O
relying O O
on O O
her O O
children O O
for O O
help O O
and O O
awakening O O
early O O
in O O
the O O
AM O O
unintentionally. O O
She O O
has O O
felt O O
too O O
tired O O
to O O
pursue O O
her O O
usual O O
nightly O O
bingo O O
game. O O
She O O
denies O O
suicidal O O
ideation, O O
saying O O
she O O
has O O
her O O
four O O
grandchildren O O
to O O
liver O O
for. O O
ED O O
COURSE: O O
At O O
the O O
ED, O O
the O O
patient O O
was O O
afebrile, O O
HR O O
59, O O
BP O O
136/61, O O
RR O O
16, O O
O2 O O
Sat O O
95%. O O
She O O
was O O
given O O
IVF O O
and O O
labs O O
were O O
drawn. O O
PMH/PSH: O O
HOCM O O
LAD O O
HTN O O
Uterine O O
prolapse O O
Urge O O
incontinence O O
Rectocele O O
Bladder O O
prolapse O O
MEDICATIONS O O
ON O O
ADMISSION: O O
Multivitamins O O
(Mvi) O O
1 O O
TAB O O
PO O O
QD O O
Acetylsalicylic B-MEDICATION B-MEDICATION
Acid I-MEDICATION O
(Aspirin B-MEDICATION O
) I-MEDICATION O
325 O O
MG O O
PO O O
QD O O
Atorvastatin B-MEDICATION B-MEDICATION
(Lipitor I-MEDICATION O
) I-MEDICATION O
40 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Sennosides O O
(Senna O O
Tablets O O
) O O
2 O O
TAB O O
PO O O
BID O O
prn O O
[constipation] O O
Docusate O O
Sodium O O
(Colace O O
) O O
100 O O
MG O O
PO O O
TID O O
prn O O
[constipation] O O
Metoprolol B-MEDICATION B-MEDICATION
Tartrate I-MEDICATION O
(Lopressor) B-MEDICATION O
100 O O
MG O O
PO O O
Q6H O O
Omeprazole O O
(Prilosec O O
) O O
40 O O
MG O O
PO O O
QD O O
Verapamil B-MEDICATION B-MEDICATION
Hcl I-MEDICATION O
60 O O
MG O O
PO O O
Q8H O O
Nifedipine B-MEDICATION B-MEDICATION
(Sustained O O
Release) O O
30 O O
MG O O
PO O O
QD O O
ALLERGIES: O O
NKDA O O
SH: O O
No B-SMOKER O
EtOH, I-SMOKER O
tob, I-SMOKER B-MEDICATION
drugs. I-SMOKER O
Originally O O
from O O
Tajikistan. O O
4 O O
children, O O
4 O O
grandchildren, O O
all O O
in O O
the O O
area. O O
Widowed O O
for O O
42 O O
years, O O
has O O
worked O O
at O O
MEDIQUIK O O
for O O
40 O O
years O O
as O O
a O O
nurse. O O
FH: O O
DM O O
in O O
children. O O
Exam: O O
VS: O O
T=98.3 O O
HR=73-84 O O
reg O O
BP= B-HYPERTENSION O
127-160/63-74 I-HYPERTENSION O
RR=18-20 O O
SaO2= O O
96% O O
RA O O
General: O O
thin O O
black O O
woman O O
lying O O
in O O
bed O O
HEENT: O O
PERRL, O O
prominent O O
arcus O O
senilus O O
w/ O O
?band O O
keratopathy, O O
dry O O
muc O O
membranes, O O
geographic O O
tongue O O
Skin: O O
atrophic, O O
hypopigmented O O
scars O O
over O O
knees O O
bilaterally O O
Neck: O O
Soft O O
and O O
supple, O O
no O O
appreciable O O
cervical O O
LAD, O O
flat O O
JVP O O
Chest: O O
dry O O
crackles O O
diffusely O O
at O O
bases, O O
otherwise O O
clear O O
Cardiac: O O
regular, O O
IV/VI O O
harsh O O
SEM O O
at O O
RSB, O O
louder O O
with O O
valsalva O O
Abd: O O
soft, O O
nontender O O
Extr: O O
without O O
edema O O
Neuro: O O
A&O O O
x3, O O
CN O O
II-XII O O
intact, O O
motor O O
strength O O
grossly O O
intact O O
throughout, O O
patient O O
able O O
to O O
stand O O
and O O
walk O O
unassisted O O
DTRs O O
within O O
nlm O O
range O O
DATA: O O
06/30/97 O O
06/29/97 O O
06/20/97 O O
05:05 O O
03:51 O O
00:06 O O
NA O O
136 O O
132(L) O O
136 O O
K O O
3.5 O O
3.5 O O
3.4 O O
CL O O
104 O O
104 O O
99(L) O O
CO2 O O
25.3 O O
25.2 O O
23.8 O O
BUN O O
19 O O
30(H) O O
17 O O
CRE O O
1.8(H) O O
2.2(H) O O
1.6(H) O O
GLU O O
93 O O
113(H) O O
TBILI O O
0.5 O O
DBILI O O
0.2 O O
TP O O
8.0 O O
ALB O O
3.4 O O
GLOB O O
4.6(H) O O
AMY O O
90 O O
LIPS O O
4.1 O O
ALT/SGPT O O
55(H) O O
AST/SGOT O O
56(H) O O
ALKP O O
113(H) O O
TBILI O O
0.5 O O
DBILI O O
0.2 O O
CK O O
61 O O
CK-MB O O
5.4 O O
WBC O O
5.8 O O
6.7 O O
5.8 O O
RBC O O
3.84(L) O O
3.64(L) O O
3.73(L) O O
HGB O O
10.4(L) O O
9.7(L) O O
10.0(L) O O
HCT O O
29.9(L) O O
28.0(L) O O
28.5(L) O O
MCV O O
78(L) O O
77(L) O O
76(L) O O
MCH O O
27.0 O O
26.7 O O
26.9 O O
MCHC O O
34.8 O O
34.8 O O
35.2 O O
PLT O O
235 O O
247 O O
247 O O
RDW O O
16.5(H) O O
16.4(H) O O
16.0(H) O O
DIFFR O O
Received O O
Received O O
METHOD O O
see O O
detail O O
see O O
detail O O
%NEUT O O
63 O O
70 O O
%LYMPH O O
24 O O
20(L) O O
%MONO O O
8 O O
6 O O
%EOS O O
4 O O
3 O O
%BASO O O
1 O O
1 O O
ANEUT O O
4.30 O O
4.10 O O
ALYMP O O
1.60 O O
1.16 O O
AMONS O O
0.51(H) O O
0.37 O O
AEOSN O O
0.25 O O
0.15 O O
ABASOP O O
0.04 O O
0.03 O O
ANISO O O
1+(H) O O
None O O
HYPO O O
None O O
None O O
MACRO O O
None O O
None O O
MICRO O O
2+(H) O O
2+(H) O O
P-COM O O
see O O
detail O O
see O O
detail O O
PT O O
12.4(T) O O
PT-INR O O
1.1(T) O O
UA-COLOR O O
Yellow O O
Yellow O O
UA-APP O O
Clear O O
Clear O O
UA-GLUC O O
Negative O O
1+ O O
UA-BILI O O
Negative O O
Negative O O
UA-KET O O
Negative O O
Negative O O
UA-SPGR O O
1.010 O O
1.010(T) O O
UA-BLD O O
1+ O O
1+ O O
UA-PH O O
5.5 O O
6.0 O O
UA-PROT O O
1+ O O
1+ O O
UA-UROBI O O
Trace O O
Negative O O
UA-NIT O O
Negative O O
Negative O O
UA-WBC O O
Negative O O
Negative O O
HCAST O O
0-2 O O
3-5 O O
UAS-RBC O O
0-2 O O
0-2 O O
UAS-WBC O O
3-5 O O
3-5 O O
UAS-BACT O O
Negative O O
Negative O O
UAS-SQHI O O
Negative O O
Few O O
ECG: O O
NSR O O
@ O O
82bpm, O O
LVH O O
unchanged O O
from O O
prior O O
study O O
Impression: O O
73F O O
h/o O O
newly O O
dx O O
HOCM, O O
chronic O O
systemic O O
LAD, O O
fatigue, O O
and O O
weight O O
loss O O
concerning O O
for O O
sarcoid O O
vs. O O
PBC O O
vs. O O
neoplasm, O O
presenting O O
with O O
acute O O
renal O O
failure O O
in O O
setting O O
of O O
little O O
PO O O
intake O O
and O O
likely O O
hypercalcemia. O O
Hypercalcemia O O
(as O O
in O O
vitamin O O
D O O
excess O O
secondary O O
to O O
sarcoid) O O
can O O
cause O O
polyuria O O
via O O
osmotic O O
diuresis, O O
with O O
dehydration, O O
anorexia, O O
constipation, O O
and O O
PUD, O O
fatigue O O
and O O
depression. O O
This O O
would O O
thus O O
represent O O
a O O
unifying O O
diagnosis O O
for O O
this O O
pt O O
s O O
anorexia O O
and O O
acute O O
renal O O
failure, O O
which O O
is O O
most O O
likely O O
prerenal. O O
Plan: O O
ARF: O O
- O O
f/u O O
Ca O O
+ O O
Phos. O O
Expect O O
Ca O O
to O O
be O O
high, O O
Phos O O
to O O
be O O
low. O O
Cont O O
IVF O O
- O O
Cre O O
2.2 O O
1.8 O O
(bl O O
1.2-15) O O
s/p O O
IVF O O
500cc O O
x1, O O
on O O
D5 O O
NS O O
@ O O
100cc/hr, O O
re-evaluate O O
and O O
re-bolus O O
in O O
AM O O
- O O
Maintain O O
good O O
UO, O O
no O O
Foley O O
b/c O O
recording O O
stricts O O
I O O
s O O
+ O O
O O O
s, O O
700cc O O
out O O
of O O
clear O O
urine O O
O/N O O
Fatigue/Weight O O
Loss/LAD/lack O O
of O O
appetite: O O
-prior O O
labs O O
somewhat O O
concerning O O
for O O
PBC, O O
esp O O
with O O
elev O O
AlkP O O
-f/u O O
anti-mitochondrial O O
Ab, O O
TSH, O O
f/u O O
pending O O
labs O O
from O O
prior O O
w/u O O
-consider O O
re-attempting O O
transbronchial O O
biopsy, O O
revisit O O
w/ O O
thoracics O O
Anemia: O O
-Hct O O
stable, O O
slightly O O
microcytic. O O
MVI O O
___________________________________________ O O
Casey O O
Frey, O O
M.D. O O
Pager O O
46311 O O

Record O O
date: O O
2097-12-15 O O
SECTIONS O O
OF O O
THIS O O
NOTE O O
WERE O O
CREATED O O
WITH O O
A O O
'COPY O O
AND O O
PASTE' O O
ACTION. O O
THESE O O
SECTIONS O O
MAY O O
NOT O O
HAVE O O
COPIED O O
COMPLETELY. O O
PLEASE O O
USE O O
CAUTION O O
WHEN O O
RENDERING O O
CLINICAL O O
JUDGMENT O O
BASED O O
ON O O
THE O O
INFORMATION O O
IN O O
THIS O O
NOTE. O O
Internal O O
Medicine O O
B O O
Admission O O
Note O O
PATIENT: O O
Goldy O O
Wilhelm O O
MRN: O O
9543443 O O
ADMIT B-DIABETES O
DATE: O O
12/15/97 O O
ATTENDING: O O
Gregory O O
Thomson O O
PCP: O O
Casey O O
Frey O O
CONTACT: O O
Gracen O O
Logan O O
(HCP, O O
daughter) O O
625-248-3647; O O
Flowers O O
(son) O O
705-690-8475 O O
Code O O
status: O O
Full O O
Source: O O
patient, O O
son, O O
records O O
CC: O O
N/V, O O
poor O O
PO O O
intake O O
HPI: O O
Ms. O O
Wilhelm O O
is O O
a O O
74 O O
year-old O O
woman O O
with O O
a O O
history O O
of O O
HOCM, O O
HTN, B-HYPERTENSION O
DM, B-DIABETES O
and O O
sarcoidosis O O
who O O
underwent O O
a O O
Hartmann&#8217;s O O
procedure O O
with O O
small O O
bowel O O
resection O O
on O O
10/18 O O
after O O
which O O
she O O
was O O
discharged O O
to O O
Harton O O
Center O O
on O O
11/07 O O
and O O
then O O
re-admitted O O
to O O
MEDIQUIK O O
on O O
11/17 O O
with O O
left-sided O O
pleuritic O O
chest O O
pain O O
and O O
a O O
saddle O O
pulmonary O O
embolus O O
as O O
well O O
as O O
large O O
right O O
lower O O
extremity O O
DVT. O O
She O O
had O O
an O O
IVC O O
filter O O
placed O O
and O O
was O O
started O O
on O O
anticoagulation O O
and O O
discharged O O
again O O
to O O
Harton O O
Center O O
on O O
12/1 O O
and O O
now O O
presents O O
with O O
nausea, O O
vomiting, O O
and O O
several O O
days O O
of O O
poor O O
PO O O
intake. O O
This O O
is O O
actually O O
her O O
fifth O O
admission O O
to O O
MEDIQUIK O O
this O O
year O O
&#8211; O O
first O O
in O O
June O O
when O O
she O O
was O O
diagnosed O O
with O O
HOCM O O
and O O
then O O
in O O
July O O
when O O
she O O
was O O
started O O
on O O
empiric O O
steroids O O
for O O
sarcoidosis. O O
She O O
says O O
her O O
appetite O O
has O O
never O O
returned O O
to O O
normal O O
since O O
her O O
surgery O O
(although O O
her O O
July O O
admission O O
note O O
also O O
documented O O
malaise O O
and O O
poor O O
appetite) O O
and O O
that O O
she O O
has O O
had O O
some O O
mild O O
nausea O O
on O O
a O O
daily O O
basis O O
since O O
her O O
surgery. O O
The O O
nausea O O
and O O
her O O
fatigue O O
became O O
worse O O
four O O
or O O
five O O
days O O
prior O O
to O O
admission O O
and O O
since O O
then O O
she O O
has O O
been O O
vomiting O O
many O O
times O O
a O O
day. O O
The O O
nausea O O
is O O
not O O
related O O
to O O
meals O O
and O O
she O O
has O O
not O O
noted O O
any O O
blood O O
in O O
the O O
emesis. O O
She O O
has O O
had O O
poor O O
intake O O
as O O
a O O
result O O
of O O
the O O
nausea O O
and O O
has O O
only O O
had O O
broth O O
over O O
the O O
last O O
few O O
days. O O
She O O
denies O O
fevers, O O
chills, O O
headaches, O O
cough, O O
abdominal O O
pain, O O
or O O
change O O
in O O
the O O
character O O
of O O
her O O
colostomy O O
output. O O
ED O O
COURSE: O O
On O O
arrival O O
to O O
the O O
ED, O O
vitals O O
were O O
as O O
follows: O O
98, O O
164/84, B-HYPERTENSION O
84, O O
24, O O
98%/RA. O O
Her O O
abdomen O O
was O O
non-tender O O
and O O
minimally O O
distended. O O
CT O O
of O O
the O O
abdomen O O
was O O
concerning O O
for O O
a O O
distal O O
small O O
bowel O O
obstruction O O
although O O
no O O
focal O O
transition O O
point O O
was O O
identified. O O
She O O
was O O
seen O O
by O O
surgery O O
and O O
an O O
NGT O O
was O O
placed. O O
She O O
was O O
given O O
2L O O
of O O
IVF O O
and O O
morphine O O
2mg O O
IV O O
x2. O O
ROS O O
As O O
above, O O
otherwise O O
reports O O
baseline O O
blurry O O
vision O O
(has O O
been O O
told O O
of O O
cataracts O O
in O O
the O O
past). O O
Denies O O
SOB, O O
cough, O O
CP, O O
chest O O
pressure, O O
orthopnea, O O
palpitations. O O
Foley O O
catheter O O
in O O
place O O
but O O
denies O O
suprapubic O O
tenderness. O O
MEDICAL O O
HISTORY O O
- O O
PE: O O
saddle O O
embolus O O
11/17, O O
s/p O O
IVC O O
filter, O O
on O O
coumadin O O
- O O
lupus O O
anticoagulant O O
positive O O
- O O
HTN O O
- O O
HOCM: O O
diagnosed O O
6/97 O O
- O O
Sarcoidosis: O O
empirically O O
started O O
on O O
prednisone O O
7/97 O O
in O O
the O O
setting O O
of O O
hypercalcemia O O
- O O
PBC: O O
+AMA, O O
not O O
confirmed O O
on O O
biopsy O O
- O O
Urge O O
incontinence, O O
rectocele, O O
bladder O O
prolapse O O
- O O
H/o O O
PAF O O
- O O
DM O O
SURGICAL O O
HISTORY O O
- O O
10/18/97: O O
Perforated O O
diverticulitis, O O
s/p O O
ex O O
lap, O O
hartmanns O O
procedure, O O
small O O
bowel O O
resection O O
and O O
mobilization O O
of O O
left O O
colon O O
- O O
Multiple O O
LN O O
biopsies O O
FAMILY O O
HISTORY O O
Three O O
children O O
with O O
DM. O O
SOCIAL O O
HISTORY O O
Originally O O
from O O
. O O
Widowed O O
42 O O
years, O O
4 O O
children, O O
4 O O
grandchildren. O O
Works O O
in O O
TLC O O
as O O
a O O
nurse. O O
No B-SMOKER O
tobacco/alcohol/drugs. I-SMOKER O
ALLERGIES: O O
NKDA O O
MEDICATIONS O O
ON O O
ADMISSION: O O
1. O O
Acetaminophen O O
(Tylenol O O
) O O
650 O O
MG O O
PO O O
Q4H O O
prn O O
2. O O
Albuterol O O
Inhaler O O
(Albuterol O O
Mdi O O
) O O
4 O O
PUFF O O
INH O O
Q2H O O
prn O O
bronchospasm O O
3. O O
Albuterol O O
Nebulizer O O
2.5 O O
MG O O
QID O O
4. O O
Aluminum/Magnesium O O
Hydroxide O O
+ O O
Simethicone O O
(Maalox O O
Susp) O O
15-30 O O
ML O O
PO O O
Q6H O O
prn O O
GI O O
Upset/Heartburn O O
5. O O
Amiodarone O O
200 O O
MG O O
QD O O
6. O O
Ascorbic O B-MEDICATION
Acid O O
500 O O
MG O O
BID O O
7. O O
Bisacodyl O O
(Dulcolax O O
) O O
10 O O
MG O O
PO O O
QD O O
prn O O
constipation O O
8. O O
Clopidogrel B-MEDICATION O
(Plavix I-MEDICATION O
) I-MEDICATION O
75 O O
MG O O
QD O O
9. O O
Docusate O O
Sodium O O
(Colace O O
) O O
100 O O
MG O O
BID O O
10. O O
Ferrous O O
Sulfate O O
325 O O
MG O O
QD O O
11. O O
Furosemide O O
(Lasix O O
) O O
20 O O
MG O O
QOD O O
12. O O
Insulin B-MEDICATION O
Regular I-MEDICATION O
Inj I-MEDICATION O
Sliding O O
scale O O
SC O O
If O O
BS O O
&lt;= O O
200 O O
give O O
0 O O
Units O O
For O O
BS O O
from O O
201 O O
to O O
250 O O
give O O
4 O O
Units O O
For O O
BS O O
from O O
251 O O
to O O
300 O O
give O O
6 O O
Units O O
For O O
BS O O
from O O
301 O O
to O O
350 O O
give O O
8 O O
Units O O
For O O
BS O O
from O O
351 O O
to O O
400 O O
give O O
10 O O
Units O O
13. O O
Ipratropium O O
Inhaler O O
4 O O
PUFF O O
INH O O
Q2H O O
prn O O
bronchospasm O O
14. O O
Magnesium O O
Oxide O O
400 O O
MG O O
BID O O
15. O O
Metoprolol B-MEDICATION B-MEDICATION
Tartrate I-MEDICATION O
(Lopressor I-MEDICATION O
) I-MEDICATION O
100 O O
MG O O
Q8H O O
16. O O
Mirtazapine O B-MEDICATION
7.5 O O
MG O O
QHS O O
17. O O
Omeprazole O O
20 O O
MG O O
BID O O
18. O O
Ondansetron O B-MEDICATION
Odt O O
(Chemo O O
N/V) O O
(Zofran O O
Odt O O
(Chemo O O
N/V)) O O
4 O O
MG O O
PO O O
Q8H O O
prn O O
nausea O O
19. O O
Oxycodone O O
5-10 O O
MG O O
PO O O
Q6H O O
prn O O
pain O O
20. O O
Pentoxifylline O O
(Trental) O O
400 O O
MG O O
TID O O
21. O O
Prednisone O O
5 O O
MG O O
QD O O
22. O O
Quetiapine O O
(Seroquel) O O
25 O O
MG O O
PO O O
BID O O
prn O O
agitation O O
23. O O
Sennosides O O
(Senna O O
Tablets) O O
2 O O
TAB O O
PO O O
QHS O O
prn O O
constipation O O
24. O O
Simethicone O O
160 O O
MG O O
TID O O
25. O O
Spironolactone O O
(Aldactone O O
) O O
25 O O
MG O O
QD O O
26. O O
Verapamil B-MEDICATION B-MEDICATION
Hcl I-MEDICATION O
60 O O
MG O O
TID O O
27. O O
Warfarin O O
Sodium O O
(Coumadin O O
) O O
5 O O
MG O O
QPM O O
PHYSICAL O O
EXAM O O
VITALS: O O
99.1, O O
95, O O
132/86, O O
97%/RA O O
GEN&#8217;L O O
pleasant O O
African-American O O
woman, O O
tired O O
but O O
NAD, O O
HEENT O O
dry O O
mucous O O
membranes, O O
NGT O O
in O O
place, O O
OP O O
clear, O O
+conjunctival O O
pallor O O
NECK O O
supple, O O
no O O
LAD, O O
JVP&lt;5 O O
cm, O O
no O O
carotid O O
bruits O O
HEART O O
RRR, O O
normal O O
S1, O O
S2, O O
3/6 O O
SEM O O
louder O O
at O O
base O O
and O O
increases O O
in O O
harshness O O
with O O
valsalva O O
LUNG O O
CTAB, O O
no O O
rhonchi, O O
rales O O
ABD O O
+BS, O O
soft, O O
non-tender, O O
non-distended, O O
midline O O
incisional O O
wound O O
with O O
dry, O O
sterile O O
dressing, O O
colostomy O O
bag O O
in O O
LLQ O O
with O O
brown O O
stool O O
EXT O O
R O O
LE O O
with O O
dry O O
sterile O O
dressing O O
over O O
shin, O O
2+ O O
DP O O
pulse, O O
wwp; O O
L O O
LE O O
with O O
dry O O
sterile O O
dressing O O
from O O
foot O O
to O O
knee, O O
toes O O
warm, O O
no O O
edema O O
NEURO: O O
AO O O
x O O
3; O O
alert; O O
CN O O
II-XII O O
grossly O O
intact; O O
Motor: O O
4/5 O O
B O O
UE/LE; O O
sensation O O
grossly O O
intact O O
to O O
light O O
touch O O
LABS: O O
&#183;Hematology: O O
12/15/97 O O
12/14/97 O O
WBC O O
6.0 O O
7.4 O O
HGB O O
7.6(L) O O
8.6(L) O O
HCT O O
22.7(L) O O
25.6(L) O O
MCV O O
87 O O
87 O O
PLT O O
372(H) O O
416(H) O O
RDW O O
15.2(H) O O
15.3(H) O O
%NEUT O O
68(H) O O
79(H) O O
%LYMPH O O
24 O O
16(L) O O
%MONO O O
7 O O
5 O O
%EOS O O
1 O O
0 O O
%BASO O O
0 O O
0 O O
&#183;Chemistries: O O
12/15/97 O O
12/14/97 O O
NA O O
134(L) O O
133(L) O O
K O O
4.5 O O
5.7(HT) O O
CL O O
100 O O
100 O O
CO2 O O
22.7(L) O O
22.5(L) O O
BUN O O
31(H) O O
32(H) O O
CRE O O
1.8(H) O O
2.1(H) O O
GLU O O
82 O O
139(H) O O
ALB O O
2.7(L) O O
LACT O O
0.6 O O
&#183;LFTs: O O
ALT/SGPT O O
23 O O
AST/SGOT O O
18 O O
ALKP O O
123(H) O O
TBILI O O
0.5 O O
DBILI O O
0.1 O O
&#183;Coags: O O
12/15/97 O O
12/14/97 O O
PT O O
38.7(H) O O
35.7(HT) O O
PT-INR O O
4.3 O O
3.9(T) O O
PTT O O
48.1(HT) O O
RADIOLOGY/STUDIES: O O
CXR O O
(12/14): O O
Lines/tubes: O O
Interval O O
placement O O
of O O
left-sided O O
PICC O O
line O O
the O O
tip O O
of O O
the O O
PICC O O
line O O
does O O
not O O
cross O O
midline O O
there O O
is O O
a O O
nasogastric O O
tube O O
with O O
the O O
tip O O
below O O
the O O
diaphragm O O
Lungs: O O
There O O
is O O
a O O
persistent O O
opacity O O
in O O
the O O
left O O
mid O O
hemithorax O O
Pleura: O O
There O O
is O O
no O O
pleural O O
effusion O O
or O O
pneumothorax. O O
Heart O O
and O O
mediastinum: O O
The O O
heart O O
and O O
the O O
mediastinum O O
are O O
normal. O O
CT O O
Abd O O
(12/14): O O
LOWER O O
THORAX: O O
There O O
been O O
interval O O
resolution O O
of O O
the O O
previously O O
identified O O
bilateral O O
pleural O O
effusions. O O
There O O
is O O
linear O O
atelectasis O O
of O O
the O O
lung O O
bases. O O
HEPATOBILIARY: O O
No O O
focal O O
hepatic O O
lesions. O O
No O O
biliary O O
ductal O O
dilatation. O O
There O O
are O O
stable O O
findings O O
of O O
porcelain O O
gallbladder. O O
SPLEEN: O O
No O O
splenomegaly. O O
PANCREAS: O O
No O O
focal O O
masses O O
or O O
ductal O O
dilatation. O O
ADRENALS: O O
No O O
adrenal O O
nodules. O O
KIDNEYS/URETERS: O O
No O O
hydronephrosis, O O
stones, O O
or O O
solid O O
mass O O
lesions. O O
Two O O
left O O
renal O O
exophytic O O
lesions O O
are O O
identified, O O
stable O O
in O O
size O O
compared O O
with O O
the O O
prior O O
examination O O
and O O
consistent O O
with O O
renal O O
cysts. O O
PELVIC O O
ORGANS/BLADDER: O O
There O O
is O O
a O O
Foley O O
catheter O O
in O O
place. O O
There O O
is O O
a O O
fibroid O O
uterus. O O
PERITONEUM O O
/ O O
RETROPERITONEUM: O O
No O O
free O O
air O O
is O O
seen. O O
There O O
is O O
trace O O
free O O
fluid. O O
LYMPH O O
NODES: O O
No O O
lymphadenopathy. O O
VESSELS: O O
There O O
are O O
scattered O O
vascular O O
calcifications. O O
An O O
IVC O O
filter O O
is O O
in O O
place. O O
GI O O
TRACT: O O
There O O
is O O
diffuse O O
dilation O O
of O O
the O O
proximal O O
and O O
mid O O
small O O
bowel O O
with O O
multiple O O
air O O
fluid O O
levels. O O
There O O
are O O
loops O O
of O O
nondilated O O
distal O O
small O O
bowel O O
and O O
the O O
colon O O
is O O
not O O
dilated. O O
There O O
has O O
been O O
a O O
prior O O
a O O
prior O O
colostomy. O O
There O O
is O O
diverticulosis. O O
BONES O O
AND O O
SOFT O O
TISSUES: O O
Unremarkable. O O
IMPRESSION: O O
Findings O O
concerning O O
for O O
distal O O
small O O
bowel O O
obstruction O O
though O O
no O O
discrete O O
transition O O
point O O
is O O
identified. O O
Alternately, O O
this O O
could O O
reflect O O
ileus. O O
Close O O
clinical O O
follow O O
up O O
advised. O O
EKG: O O
NSR O O
at O O
94bpm, O O
leftward O O
axis, O O
biatrial O O
enlargement, O O
normal O O
PR O O
interval, O O
narrow O O
QRS, O O
LVH, O O
TWIs O O
in O O
I, O O
aVL O O
ASSESSMENT O O
&amp; O O
PLAN O O
Ms. O O
Wilhelm O O
is O O
a O O
74 O O
year-old O O
woman O O
with O O
a O O
history O O
of O O
HOCM, O O
hypertension, B-HYPERTENSION O
sarcoidosis, O O
diabetes, B-DIABETES O
who O O
underwent O O
a O O
Hartmann&#8217;s O O
procedure O O
with O O
small O O
bowel O O
resection O O
on O O
10/18 O O
and O O
was O O
re-admitted O O
on O O
11/17 O O
with O O
a O O
saddle O O
PE O O
and O O
large O O
RLE O O
DVT O O
for O O
which O O
she O O
was O O
managed O O
with O O
IVC O O
filter O O
and O O
anticoagulation O O
who O O
now O O
presents O O
with O O
several O O
days O O
of O O
nausea O O
and O O
vomiting O O
and O O
concern O O
for O O
small O O
bowel O O
obstruction O O
on O O
CT. O O
SBO: O O
Her O O
clinical O O
presentation O O
and O O
CT O O
findings O O
are O O
concerning O O
for O O
small O O
bowel O O
obstruction O O
(although O O
ileus O O
remains O O
a O O
possibility. O O
Lactate O O
was O O
within O O
normal O O
limits O O
so O O
small O O
bowel O O
ischemia O O
unlikely. O O
Also O O
abdominal O O
exam O O
remains O O
benign O O
at O O
this O O
time. O O
Appreciate O O
surgery O O
input O O
NGT O O
to O O
low O O
wall O O
suction O O
NPO O O
except O O
meds O O
for O O
bowel O O
rest O O
Serial O O
abdominal O O
exams O O
Check O O
colostomy O O
output O O
guaiac O O
Acute O O
renal O O
failure: O O
Her O O
creatinine O O
was O O
up O O
from O O
a O O
baseline O O
of O O
1.0 O O
to O O
2.1 O O
on O O
admission. O O
With O O
IVF O O
hydration O O
in O O
the O O
ED O O
it O O
has O O
already O O
started O O
to O O
come O O
down O O
to O O
1.8 O O
so O O
it O O
was O O
likely O O
pre-renal O O
in O O
the O O
setting O O
of O O
poor O O
intake O O
and O O
vomiting. O O
Continue O O
IVF O O
while O O
NPO O O
Will O O
trend O O
Cr O O
and O O
pursue O O
further O O
ARF O O
work-up O O
if O O
not O O
down O O
on O O
AM O O
labs O O
Anemia: O O
Baseline O O
hematocrit O O
in O O
low O O
30s, O O
last O O
32.6 O O
prior O O
to O O
discharge O O
on O O
11/30. O O
She O O
does O O
not O O
appear O O
to O O
have O O
an O O
active O O
source O O
of O O
bleeding O O
and O O
her O O
bilirubin O O
is O O
within O O
normal O O
limits O O
so O O
she O O
is O O
unlikely O O
to O O
be O O
hemolyzing. O O
She O O
likely O O
either O O
has O O
iron-deficiency O O
anemia O O
(although O O
she O O
has O O
been O O
taking O O
iron O O
supplements) O O
or O O
anemia O O
of O O
chronic O O
disease O O
&#8211; O O
or O O
a O O
combination O O
thereof. O O
Her O O
RDW O O
is O O
only O O
mildly O O
elevated O O
which O O
likely O O
indicates O O
inappropriately O O
low O O
hematopoiesis. O O
Transfuse O O
1U O O
PRBCs O O
Check O O
colostomy O O
guaiac O O
Check O O
iron O O
studies, O O
reticulocyte O O
count O O
Elevated O O
INR/hypercoagulability: O O
She O O
is O O
baseline O O
hypercoagulable O O
with O O
lupus O O
anticoagulant O O
and O O
has O O
had O O
the O O
recent O O
large O O
DVT/PE O O
s/p O O
IVC O O
filter O O
placement. O O
She O O
comes O O
in O O
with O O
an O O
elevated O O
INR O O
and O O
is O O
likely O O
supratherapeutic O O
on O O
her O O
coumadin. O O
She O O
does O O
not O O
need O O
to O O
be O O
reversed O O
as O O
she O O
does O O
not O O
seem O O
to O O
be O O
actively O O
bleeding. O O
Hold O O
Coumadin O O
for O O
now O O
Follow O O
up O O
INR, O O
goal O O
2-3 O O
HOCM/HTN: O O
Continue O O
lopressor, B-MEDICATION B-MEDICATION
verapamil B-MEDICATION B-MEDICATION
Sarcoid: O O
Continue O O
Prednisone O O
at O O
5mg O O
daily O O
PAF O O
Continue O O
Amiodarone O O
&#8211; O O
follow-up O O
with O O
PCP O O
regarding O O
indication O O
for O O
Amio O O
F/E/N: O O
NPO O O
PPX: O O
coumadin, O O
PPI, O O
bowel O O
regimen O O
CODE: O O
Full O O
__________________________________ O O
Antoinette O O
S O O
Delaney, O O
MD, O O
Pager O O
#63784 O O

Record O O
date: O O
2098-08-03 O O
Internal O O
Medicine O O
G O O
Intern O O
Admission O O
Note O O
PATIENT: O O
Wilhelm, O O
Goldy O O
MRN: O O
9543443 O O
ADMIT B-DIABETES O
DATE: O O
8/2/98 O O
PCP: O O
Dr. O O
Casey O O
Frey O O
HPI: O O
74F O O
with O O
sarcoidosis, O O
HTN, B-HYPERTENSION O
CHF, O O
HOCM, O O
PE O O
s/p O O
IVC O O
filter O O
now O O
on O O
coumadin, O O
PVD O O
s/p O O
L O O
BKA, O O
and O O
DM O O
who O O
presents O O
from O O
her O O
rehab O O
facility O O
with O O
failure O O
to O O
thrive O O
and O O
increasing O O
lethargy O O
for O O
several O O
weeks. O O
Of O O
note, O O
pt O O
had O O
recent O O
admission O O
to O O
MEDIQUIK O O
(6/29-7/05) O O
at O O
which O O
time O O
she O O
presented O O
with O O
similar O O
complaints O O
of O O
fatigue/lethargy O O
and O O
routine O O
CBC O O
demonstrated O O
an O O
elevated O O
WBC O O
(15) O O
and O O
low O O
Hct O O
(23). O O
She O O
was O O
ultimately O O
found O O
to O O
have O O
an O O
Enterococcus O O
bacteremia O O
and O O
intra-abdominal O O
abscess O O
that O O
grew O O
out O O
E. O O
coli. O O
She O O
underwent O O
IR O O
drainage O O
of O O
the O O
abdominal O O
collection O O
and O O
completed O O
a O O
course O O
of O O
Vanc/CTX. O O
Outpatient O O
f/u O O
abd O O
CT O O
(7/18) O O
showed O O
near O O
complete O O
resolution O O
of O O
the O O
intra-abdominal O O
collection. O O
Since O O
that O O
time, O O
however, O O
pt&#8217;s O O
sons O O
report O O
increasing O O
lethargy O O
at O O
her O O
nursing O O
facility. O O
Patient O O
has O O
no O O
complaints. O O
Specifically, O O
she O O
denies O O
fatigue, O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
dizziness, O O
motor O O
weakness O O
and O O
fevers O O
and O O
chills. O O
However, O O
given O O
concern O O
on O O
the O O
part O O
of O O
her O O
sons, O O
pt O O
was O O
taken O O
to O O
the O O
MEDIQUIK O O
ED. O O
In O O
the O O
MEDIQUIK O O
ED, O O
she O O
was O O
afebrile O O
with O O
HR O O
70, O O
BP B-HYPERTENSION O
150/74, I-HYPERTENSION O
RR O O
24, O O
and O O
Sa02 O O
100% O O
RA. O O
PMH: O O
Hypertension B-HYPERTENSION O
History O O
of O O
Congestive O O
heart O O
failure, O O
HOCM(EF O O
=77%) O O
Pulmonary O O
embolism O O
(11/97) O O
s/p O O
IVC O O
filter O O
now O O
on O O
coumadin O O
Peripheral O O
vascular O O
disease O O
s/p O O
left O O
BKA O O
4/29/98 O O
due O O
to O O
ischemic O O
gangrene O O
of O O
left O O
foot. O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
(HbA1C O O
= O O
6.3mg/dL O O
- O O
1/98) O O
Sarcoidosis O O
Breast O O
mass O O
w/ O O
axillary O O
lymphadenopathy O O
Perforated O O
small O O
bowel O O
diverticulitis O O
s/p O O
sigmoid O O
resection O O
w/Hartmann O O
procedure O O
with O O
diverting O O
colostomy O O
by O O
Dr. O O
Joshi O O
in O O
10/97 O O
(removed O O
9' O O
of O O
jejunum) O O
Heterozygous O O
hemoglobin O O
S O O
- O O
on O O
6/20/2085 O O
Hb O O
electropheresis O O
Meds: O O
1. O O
Artificial O O
Tears O O
1 O O
DROP O O
OD O O
QID O O
2. O O
Bisacodyl O O
(Dulcolax) O O
5 O O
MG O O
PO O O
QD O O
prn O O
constipation O O
3. O O
Calcium O O
Carbonate/Vitd O O
(250mg O O
Ca++/125u O O
Vitd) O O
2 O O
TAB O O
PO O O
BID O O
4. O O
Citalopram O O
(Celexa) O O
40 O O
MG O O
PO O O
QD O O
5. O O
Clonidine O O
0.1 O O
MG O O
PO O O
BID O O
6. O O
Docusate O O
Sodium O O
(Colace O O
) O O
100 O O
MG O O
PO O O
BID O O
7. O O
Hydralazine O O
Hcl O O
100 O O
MG O O
PO O O
QID O O
8. O O
Insulin B-MEDICATION O
Glargine I-MEDICATION O
(Lantus B-MEDICATION O
) I-MEDICATION O
25 I-MEDICATION O
UNITS I-MEDICATION O
SC I-MEDICATION O
QAM I-MEDICATION O
9. O O
Megestrol O O
Acetate O O
Suspension O O
(Megace O O
) O O
400 O O
MG O O
PO O O
QD O O
10. O O
Melatonin O O
3 O O
MG O O
PO O O
QHS O O
11. O O
Metoclopramide O B-MEDICATION
Hcl O O
(Reglan) O O
10 O O
MG O O
PO O O
Q6H O O
12. O O
Multivitamins O O
(Mvi) O O
1 O O
TAB O O
PO O O
QD O O
13. O O
Niferex O O
150 O O
150 O O
MG O O
PO O O
BID O O
14. O O
Omeprazole O O
(Prilosec) O O
20 O O
MG O O
PO O O
QD O O
15. O O
Ondansetron O O
Odt O O
(Zofran O O
Odt) O O
4 O O
MG O O
PO O O
Q8H O O
prn O O
nausea/vomiting O O
16. O O
Pentoxifylline O O
400 O O
MG O O
PO O O
TID O O
17. O O
Polyethylene O O
Glycol O O
(Miralax) O O
17 O O
GM O O
PO O O
QD O O
18. O O
Prednisone O O
10 O O
MG O O
PO O O
QD O O
19. O O
Propoxyphene O O
Nap/Acetaminophen O O
100/650 O O
(Darvocet-N O O
100) O O
1 O O
TAB O O
PO O O
Q4H O O
prn O O
20. O O
Propranolol B-MEDICATION O
Hcl I-MEDICATION O
(Inderal B-MEDICATION O
) I-MEDICATION O
60 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QID I-MEDICATION O
21. O O
Verapamil B-MEDICATION B-MEDICATION
Hcl I-MEDICATION O
120 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
TID I-MEDICATION O
22. O O
Warfarin O O
Sodium O O
(Coumadin O O
) O O
4 O O
MG O O
PO O O
QPM O O
Allergies: O O
Propranolol O O
- O O
SOB O O
Family O O
history: O O
Noncontributory O O
Social O O
History: O O
Pt O O
lives O O
at O O
Ingham O O
Hospital. O O
She B-SMOKER O
denies I-SMOKER O
EtOH, I-SMOKER O
tobacco, I-SMOKER O
and I-SMOKER O
illicit I-SMOKER O
drugs. I-SMOKER O
ROS: O O
As O O
per O O
HPI O O
PE: O O
Vitals: O O
T O O
97.2 O O
HR O O
85 O O
BP B-HYPERTENSION O
192/80 I-HYPERTENSION O
RR O O
18 O O
Sa02 O O
98% O O
RA O O
Gen: O O
Quiet O O
woman, O O
whispering, O O
appears O O
somnolent O O
but O O
NAD O O
HEENT: O O
PERRL, O O
MMM, O O
o/p O O
clear O O
Neck: O O
No O O
bruits, O O
JVP O O
flat O O
Chest: O O
CTAB O O
Card: O O
RRR, O O
nl O O
s1/s2, O O
II/VI O O
crescendo/decrescendo O O
murmur O O
at O O
USBs, O O
harsh O O
SEM O O
at O O
apex O O
Abd: O O
+ O O
BS, O O
NTND, O O
no O O
HSM, O O
rectal O O
exam O O
is O O
guaiac O O
negative O O
Ext: O O
L O O
BKA, O O
R O O
pulses O O
acquired O O
via O O
doppler O O
Neuro: O O
A&amp;Ox3, O O
CNs O O
II-XII O O
intact O O
Labs: O O
140 O O
106 O O
46 O O
----------------------(145 O O
5.7(H) O O
23 O O
1.58 O O
Baseline O O
Cr O O
1.2 O O
Ca O O
9.2 O O
PO4 O O
3.9 O O
Mg O O
2 O O
15.5&gt;25.1&lt;252 O O
(Baseline O O
Hct O O
30) O O
PT O O
40 O O
PTT O O
30.8 O O
INR O O
4.6 O O
U/A: O O
0-2 O O
RBCs, O O
20-50 O O
WBCs, O O
moderate O O
squams O O
EKG: O O
84bpm, O O
sinus, O O
normal O O
axis, O O
ST O O
elevations O O
in O O
V2-V3 O O
(old) O O
Imaging: O O
CXR O O
(8/2/98): O O
1. O O
Increased O O
interstitial O O
markings O O
may O O
represent O O
worsened O O
mild O O
pulmonary O O
edema O O
or O O
interstitial O O
infection. O O
Abd O O
CT O O
(7/18/98): O O
Near O O
complete O O
resolution O O
of O O
previously O O
seen O O
left O O
lower O O
quadrant O O
fluid O O
collection. O O
Stable O O
small O O
cystic O O
lesions O O
in O O
pancreas O O
which O O
likely O O
represent O O
side O O
branch O O
IPMN. O O
Abd O O
CT O O
(6/30/98): O O
New O O
4.8 O O
x O O
4.0 O O
cm O O
thick O O
walled O O
fluid O O
collection O O
in O O
the O O
LLQ O O
which O O
contains O O
a O O
small O O
amount O O
of O O
gas. O O
This O O
would O O
be O O
amenable O O
to O O
percutaneous O O
drainage. O O
Small O O
bilateral O O
pleural O O
effusions, O O
decreased O O
in O O
size. O O
Bilateral O O
benign O O
renal O O
cysts. O O
Gallbladder O O
wall O O
calcifications. O O
A/P: O O
74F O O
with O O
sarcoidosis, O O
HTN, O O
CHF, O O
HOCM, O O
PE O O
s/p O O
IVC O O
filter O O
now O O
on O O
coumadin, O O
PVD O O
s/p O O
L O O
BKA, O O
and O O
DM O O
who O O
presents O O
from O O
her O O
rehab O O
facility O O
with O O
failure O O
to O O
thrive O O
and O O
increasing O O
lethargy O O
for O O
several O O
weeks. O O
1. O O
Failure O O
to O O
thrive O O
/ O O
lethargy: O O
The O O
etiology O O
of O O
this O O
pt&#8217;s O O
lethargy O O
is O O
unclear. O O
It O O
is O O
notable, O O
however, O O
that O O
her O O
presentation O O
on O O
this O O
admission O O
is O O
very O O
similar O O
to O O
her O O
presentation O O
in O O
July O O
at O O
which O O
time O O
she O O
was O O
found O O
to O O
be O O
bacteremic O O
with O O
an O O
additional O O
intra-abdominal O O
bacterial O O
collection. O O
At O O
present, O O
there O O
is O O
no O O
clear O O
source O O
of O O
infection, O O
although O O
her O O
urinalysis O O
is O O
suspicious O O
for O O
a O O
UTI. O O
Elevated O O
WBC O O
in O O
someone O O
on O O
chronic O O
steroids O O
is O O
concerning O O
for O O
infection, O O
but O O
pt O O
is O O
hemodynamically O O
stable O O
and O O
afebrile. O O
In O O
addition O O
to O O
bacteremia, O O
UTI O O
and O O
re-accumulation O O
of O O
an O O
intra-abdominal O O
collection, O O
other O O
possible O O
causes O O
of O O
her O O
lethargy O O
include O O
toxic/metabolic O O
causes O O
(such O O
as O O
uremia), O O
anemia, O O
or O O
depression. O O
- O O
F/u O O
blood, O O
urine, O O
and O O
respiratory O O
cultures O O
- O O
Will O O
hold O O
off O O
on O O
empirically O O
starting O O
abx O O
based O O
on O O
urinalysis O O
(If O O
we O O
were O O
to O O
start O O
abx, O O
would O O
recommend O O
vanc/cefepime O O
given O O
micro O O
history) O O
- O O
Culture O O
if O O
spikes O O
- O O
Consider O O
repeat O O
abd O O
imaging O O
if O O
pt O O
continues O O
to O O
have O O
a O O
leukocytosis O O
and O O
doesn&#8217;t O O
clinically O O
improve O O
2. O O
Anemia O O
&#8211; O O
Source O O
of O O
anemia O O
has O O
been O O
unclear O O
in O O
the O O
past. O O
During O O
last O O
admission, O O
pt O O
was O O
found O O
to O O
be O O
guaiac O O
positive O O
on O O
rectal O O
exam O O
but O O
guaiac O O
negative O O
out O O
of O O
colostomy. O O
GI O O
at O O
that O O
time O O
had O O
deferred O O
colonoscopy. O O
It O O
is O O
possible O O
that O O
her O O
anemia O O
may O O
be O O
responsible O O
for O O
her O O
failure O O
to O O
thrive. O O
- O O
Type O O
and O O
screen O O
- O O
Will O O
transfuse O O
1 O O
unit O O
of O O
pRBCs O O
and O O
monitor O O
for O O
clinical O O
improvement O O
- O O
Check O O
post-transfusion O O
Hct O O
3. O O
HTN O O
&#8211; O O
pt O O
has O O
long-standing B-HYPERTENSION O
refractory I-HYPERTENSION O
hypertension I-HYPERTENSION O
despite O O
numerous O O
anti-hypertensive O O
agents O O
- O O
Per O O
pharmacy O O
recommendations, O O
holding O O
propranolol O O
given O O
h/o O O
SOB O O
- O O
Continue O O
clonidine, O O
verapimil B-MEDICATION B-MEDICATION
and O O
hydral O O
(titrate O O
as O O
needed) O O
4. O O
Elevated O O
INR O O
&#8211; O O
pt O O
has O O
a O O
supratherapeutic O O
INR. O O
Given O O
that O O
pt O O
is O O
near O O
discharge O O
Hct O O
from O O
previous O O
admission, O O
do O O
not O O
feel O O
that O O
she O O
is O O
actively O O
bleeding. O O
As O O
such, O O
do O O
not O O
feel O O
the O O
need O O
to O O
actively O O
reverse O O
her. O O
- O O
Monitor O O
daily O O
INRs O O
- O O
Hold O O
warfarin O O
overnight O O
5. O O
Renal O O
insufficiency O O
&#8211; O O
Cr O O
1.58 O O
today O O
(baseline O O
1.2). O O
Likely O O
secondary O O
to O O
prerenal O O
- O O
Fluid O O
resuscitation O O
- O O
Recheck O O
lytes O O
in O O
AM O O
6. O O
Diabetes O O
- O O
FSG O O
QAC O O
+ O O
HS O O
- O O
Lantus O O
+ O O
RISS O O
7. O O
FEN O O
- O O
Diabetic O O
diet O O
8. O O
PPx O O
&#8211; O O
Pboots, O O
teds O O
on O O
R O O
leg O O
Gerardo O O
Valadez, O O
M.D. O O
Internal O O
Medicine, O O
PGY-1 O O
Pager O O
47234 O O

Record O O
date: O O
2093-01-13 O O
EDVISIT^32612454^Barr, O O
Nicky^01/13/93^IP, O O
CARRIE O O
I O O
saw O O
this O O
patient O O
in O O
conjunction O O
with O O
Dr. O O
Xue. O O
I O O
confirm O O
that O O
I O O
have O O
interviewed O O
and O O
examined O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation O O
on O O
the O O
patient's O O
chart, O O
and O O
discussed O O
the O O
evaluation, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient. O O
CHIEF O O
COMPLAINT: O O
A O O
57-year-old O O
with O O
back O O
pain. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
young O O
woman O O
with O O
a O O
complicated O O
past O O
medical O O
history, O O
presents O O
with O O
a O O
chronic O O
history O O
of O O
low O O
back O O
pain, O O
worse O O
over O O
the O O
last O O
week. O O
She O O
states O O
that O O
3 O O
years O O
ago, O O
she O O
had O O
a O O
motor O O
vehicle O O
accident. O O
Since O O
that O O
time, O O
has O O
had O O
chronic O O
low O O
back O O
pain. O O
She O O
has O O
been O O
able O O
to O O
ambulate O O
at O O
home. O O
Denies O O
any O O
fevers, O O
rashes, O O
history O O
of O O
urinary O O
incontinence, O O
weakness, O O
or O O
numbness. O O
She O O
went O O
to O O
EDUCARE-FARGO O O
earlier O O
this O O
week O O
and O O
was O O
prescribed O O
Percocet, O O
comes O O
here O O
now O O
because O O
the O O
patient's O O
family O O
and O O
the O O
patient O O
would O O
like O O
to O O
change O O
her O O
care O O
to O O
Lansing O O
Dover O O
Clinic. O O
Denies O O
any O O
numbness O O
or O O
weakness. O O
States O O
that O O
she O O
is O O
no O O
longer O O
taking O O
her O O
pills O O
at O O
home. O O
Denies O O
any O O
suicidal O O
or O O
homicidal O O
ideation, O O
has O O
a O O
flat O O
affect. O O
Denies O O
any O O
depression. O O
Her O O
son, O O
however, O O
with O O
whom O O
she O O
lives O O
disagrees O O
and O O
is O O
very O O
concerned O O
that O O
she O O
may O O
be O O
depressed. O O
He O O
is O O
also O O
very O O
concerned O O
that O O
she O O
is O O
not O O
taking O O
her O O
medicines O O
and O O
that O O
she O O
is O O
not O O
caring O O
for O O
herself O O
well O O
at O O
home. O O
PAST O O
MEDICAL O O
HISTORY: O O
Remarkable O O
for O O
hypertension, B-HYPERTENSION O
diabetes, B-DIABETES O
and O O
a O O
prior O O
stroke. O O
PAST O O
SURGICAL O O
HISTORY: O O
She O O
has O O
also O O
had O O
knee O O
surgery. O O
SOCIAL O O
HISTORY, O O
FAMILY O O
HISTORY, O O
AND O O
REVIEW O O
OF O O
SYSTEMS: O O
As O O
per O O
the O O
written O O
note. O O
The O O
patient B-SMOKER O
was I-SMOKER O
counseled I-SMOKER O
regarding I-SMOKER O
smoking B-SMOKER O
cessation. I-SMOKER O
MEDICATIONS: O O
Hydrochlorothiazide B-MEDICATION O
and O O
Coumadin. O O
ALLERGIES: O O
None. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
awake O O
and O O
alert O O
in O O
no O O
acute O O
distress. O O
Vital O O
signs O O
are O O
within O O
normal O O
limits O O
as O O
documented. O O
For O O
full O O
physical O O
exam O O
findings, O O
please O O
see O O
the O O
resident's O O
written O O
note. O O
Specifically, O O
HEENT, O O
neck, O O
respiratory, O O
cardiac, O O
rectal, O O
and O O
abdominal O O
exam O O
are O O
within O O
normal O O
limits O O
as O O
documented. O O
Skin O O
exam O O
is O O
remarkable O O
for O O
erythematous O O
changes O O
in O O
the O O
groin O O
where O O
the O O
patient O O
has O O
significant O O
skin O O
fold O O
due O O
to O O
obesity. O O
Musculoskeletal O O
exam O O
is O O
otherwise O O
unremarkable. O O
Range O O
of O O
motion O O
is O O
full. O O
Strength O O
and O O
tone O O
is O O
normal. O O
The O O
patient O O
does O O
have O O
a O O
positive O O
straight O O
leg O O
raise O O
on O O
the O O
left, O O
reproducing O O
her O O
back O O
pain. O O
Neurologically, O O
the O O
patient O O
has O O
a O O
flat O O
affect O O
but O O
is O O
oriented O O
with O O
intact O O
cranial O O
nerves O O
and O O
no O O
focal O O
neurologic O O
deficit O O
in O O
either O O
motor O O
or O O
sensory O O
distribution. O O
She O O
does, O O
however, O O
walk O O
with O O
a O O
limp, O O
which O O
is O O
chronic O O
for O O
her. O O
LABORATORY O O
DATA: O O
White O O
blood O O
count O O
is O O
slightly O O
elevated O O
at O O
11.3. O O
BUN O O
and O O
creatinine O O
is O O
also O O
significantly O O
elevated O O
at O O
26 O O
and O O
1.1, O O
respectively. O O
Potassium O O
is O O
also O O
quite O O
low O O
at O O
2.9. O O
Urinalysis O O
is O O
positive O O
with O O
35-40 O O
white O O
blood O O
cells, O O
15-20 O O
red O O
blood O O
cells, O O
and O O
2+ O O
bacteria. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
My O O
chief O O
concern O O
for O O
this O O
patient O O
is O O
her O O
inability O O
to O O
care O O
for O O
self O O
at O O
home. O O
It O O
is O O
apparent O O
that O O
her O O
son O O
is O O
interested O O
in O O
helping O O
her O O
and O O
do O O
so, O O
but O O
the O O
patient O O
on O O
physical O O
exam O O
has O O
some O O
obvious O O
lack O O
of O O
hygiene O O
and O O
I O O
am O O
concerned O O
that O O
potentially O O
the O O
patient O O
has O O
either O O
an O O
underlying O O
neurologic O O
or O O
psychiatric O O
issue O O
that O O
is O O
preventing O O
her O O
from O O
thriving O O
at O O
home. O O
Psychiatry O O
initially O O
was O O
consulted. O O
Their O O
impression O O
was O O
that O O
the O O
patient O O
may O O
have O O
neuro O O
behavior O O
problem O O
that O O
needs O O
further O O
outpatient O O
workup, O O
and O O
she O O
was O O
referred O O
to O O
a O O
specific O O
providers O O
within O O
the O O
next O O
2 O O
weeks. O O
The O O
patient O O
was O O
treated O O
with O O
potassium O O
chloride O O
for O O
her O O
hypokalemia. O O
Care O O
coordinator O O
and O O
social O O
services O O
were O O
consulted. O O
The O O
patient O O
will O O
have O O
a O O
home O O
safety O O
evaluation O O
and O O
will O O
be O O
referred O O
for O O
primary O O
care O O
services, O O
was O O
discharged O O
with O O
a O O
cane O O
for O O
ambulation, O O
and O O
will O O
likely O O
also O O
receive O O
VNA O O
Services O O
to O O
help O O
her O O
with O O
medication O O
compliance O O
and O O
other O O
ADLs. O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O
DIAGNOSES: O O
1. O O
Chronic O O
low O O
back O O
pain. O O
2. O O
Hypokalemia. O O
3. O O
Urinary O O
tract O O
infection. O O
4. O O
Failure O O
to O O
thrive. O O
DISPOSITION: O O
Discharged. O O
CONDITION O O
ON O O
DISCHARGE: O O
Satisfactory. O O
______________________________ O O
IP, O O
CARRIE O O
MD O O
D: O O
01/13/93 O O
T: O O
01/13/93 O O
Dictated O O
By: O O
IP, O O
CARRIE O O
eScription O O
document:1-1843613 O O
BFFocus O O

Record O O
date: O O
2093-02-28 O O
Personal O O
Data O O
and O O
Overall O O
Health O O
Mrs. O O
Barr O O
is O O
a O O
57 O O
years O O
old O O
lady O O
with O O
multiple O O
significant O O
medical O O
problems O O
new O O
to O O
KEKELA. O O
Chief O O
Complaint O O
She O O
is O O
here O O
today O O
for O O
a O O
Physical O O
Exam O O
History O O
of O O
Present O O
Illness O O
Patient O O
has O O
HO O O
HTN B-HYPERTENSION O
for O O
years O O
and O O
CVA. O O
She O O
has O O
had O O
4 O O
CVAs O O
in O O
the O O
past. O O
First O O
one O O
in O O
2087, O O
2088, O O
2089 O O
and O O
2090. O O
She O O
was O O
not O O
taking O O
her O O
BP O O
meds O O
those O O
times O O
and O O
she B-SMOKER O
has I-SMOKER O
been I-SMOKER O
smoking B-SMOKER O
1 I-SMOKER O
PPD I-SMOKER O
since I-SMOKER O
then I-SMOKER O
despite O O
being O O
told O O
she O O
had O O
to O O
quit O O
smoking. O O
She O O
was O O
seen O O
at O O
the O O
LDC O O
ED O O
twice O O
in O O
Jan O O
13 O O
and O O
21/05. O O
First O O
visit O O
she O O
was O O
taken O O
by O O
her O O
son O O
after O O
he O O
couldn't O O
take O O
care O O
of O O
her O O
anymore. O O
Not O O
doing O O
anything O O
at O O
home, O O
not O O
caring O O
about O O
anything. O O
Was O O
seen O O
by O O
psych O O
and O O
arranged O O
to O O
have O O
a O O
PCP, O O
spoke O O
about O O
therapy O O
as O O
well. O O
Then O O
1/21/93 O O
seen O O
for O O
chest O O
pain. O O
EKG O O
negative O O
and O O
was O O
D/C O O
home. O O
Had O O
a O O
MIBI O O
done O O
1/23/93 O O
1. O O
Clinical O O
Response: O O
Non-ischemic. O O
2. O O
ECG O O
Response: O O
No O O
ECG O O
changes O O
during O O
infusion. O O
3. O O
Myocardial O O
Perfusion: O O
Normal. O O
4. O O
Global O O
LV O O
Function: O O
Normal. O O
She O O
states O O
she O O
is O O
supposed O O
to O O
be O O
on O O
Coumadin O O
for O O
the O O
strokes O O
and O O
she O O
self O O
D/C O O
it O O
last O O
year. O O
Previous O O
PCP O O
at O O
EDUCARE-FARGO O O
Dr. O O
Nancy O O
Odell. O O
Changing O O
to O O
KEKELA O O
because O O
her O O
son O O
thinks O O
she O O
can O O
get O O
better O O
help O O
here. O O
She O O
looks O O
depressed O O
and O O
I O O
mentioned O O
that O O
to O O
her. O O
She O O
states O O
'I O O
always O O
have O O
looked O O
the O O
same'. O O
After O O
speaking O O
for O O
her O O
for O O
20 O O
minutes O O
she O O
tells O O
me O O
that O O
at O O
age O O
28 O O
she O O
had O O
a O O
miscarriage O O
of O O
her O O
twins. O O
She O O
was O O
jumping O O
rope O O
and O O
after O O
coming O O
back O O
home O O
her O O
husband O O
told O O
her O O
if O O
she O O
was O O
trying O O
to O O
kill O O
the O O
twins. O O
That O O
night O O
she O O
had O O
a O O
miscarriage O O
and O O
one O O
baby O O
was O O
born O O
in O O
the O O
toilet O O
and O O
the O O
otherone O O
was O O
taken O O
by O O
the O O
EMTs. O O
She O O
was O O
4 O O
months O O
pregnant. O O
She O O
had O O
therapy O O
then O O
and O O
meds O O
and O O
felt O O
a O O
little O O
better. O O
Her O O
husband O O
died O O
6 O O
years O O
ago O O
and O O
before O O
he O O
died O O
he O O
reminded O O
her O O
that O O
she O O
had O O
killed O O
his O O
twins. O O
She O O
felt O O
bad O O
and O O
has O O
felt O O
bad O O
since. O O
She O O
cries O O
during O O
interview. O O
She O O
worked O O
for O O
many O O
years O O
for O O
mcilhenny O O
company, O O
Fire O O
Chief O O
and O O
retird O O
last O O
year. O O
She O O
denies O O
being O O
depressed, O O
denies O O
suicidal O O
ideation O O
or O O
plan. O O
States O O
has O O
trouble O O
sleeping O O
and O O
wants O O
AMbien O O
she O O
has O O
taken O O
in O O
the O O
past. O O
Also O O
has O O
taken O O
Zoloft O O
in O O
the O O
past. O O
Not O O
interested O O
on O O
meds O O
now. O O
Past O O
Medical O O
History O O
Hypertension B-HYPERTENSION O
Obesity B-OBESE O
Cerebrovascular O O
accident O O
2087,2088,2089,2090 O O
Past O O
Surgical O O
History O O
Cesarean O O
section O O
x O O
1 O O
Left O O
leg O O
ORIF O O
Allergies O O
NKA O O
Medications O O
HYDROCHLOROTHIAZIDE B-MEDICATION O
25 O O
MG O O
PO O O
QD O O
Metoprolol B-MEDICATION B-MEDICATION
Tartrate I-MEDICATION O
50MG I-MEDICATION O
TABLET I-MEDICATION O
take I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
Family O O
History O O
Negative O O
for O O
breast O O
cancer, O O
colon O O
cancer, O O
prostate O O
cancer, O O
skin O O
cancer, O O
leukemias, O O
CAD, O O
Myocardial O O
infarction, O O
Hypertension, O B-HYPERTENSION
Diabetes O O
Mellitus, O O
Hypercholesterolemia, O B-HYPERTENSION
Asthma. O O
Social O O
History O O
Lives O O
at O O
home O O
with O O
her O O
son O O
and O O
his O O
wife O O
Smoking B-SMOKER O
1 I-SMOKER O
PPD I-SMOKER O
cigarretes I-SMOKER O
ETOH O O
occasional. O O
Denies O O
IVDA. O O
Denies O O
other O O
recreational O O
drugs O O
Sexually O O
active O O
with O O
the O O
same O O
partner O O
for O O
the O O
past O O
1 O O
year. O O
Doesn't O O
use O O
condoms. O O
No O O
history O O
of O O
blood O O
transfussions O O
Retired O O
MC O O
employee O O
- O O
Fire O O
Chief O O
Routine O O
screening O O
questions O O
for O O
abuse O O
asked. O O
Patient O O
stated O O
that O O
abuse O O
is O O
not O O
an O O
issue O O
at O O
the O O
present O O
time. O O
Habits O O
Exercises O O
rarely O O
Uses O O
seat O O
belt O O
most O O
of O O
the O O
time O O
Preventive O O
Health O O
History O O
Last O O
Physical O O
exam O O
1/92 O O
Last O O
mammogram O O
1/92 O O
at O O
EDUCARE-FARGO O O
by O O
her O O
report O O
Last O O
Pap O O
smear O O
1/92 O O
normal O O
at O O
EDUCARE-FARGO O O
by O O
her O O
report O O
COlonoscopy O O
- O O
never O O
Bone O O
density O O
test O O
- O O
never O O
Review O O
of O O
Systems O O
Cardiopulmonary O O
: O O
Occasional O O
chest O O
pain, O O
Denies O O
shortness O O
of O O
breath, O O
PND, O O
orthopnea, O O
leg O O
edema, O O
Palpitations O O
HEENT: O O
doesn't O O
wear O O
glasses, O O
normal O O
hearing O O
Genitourinary: O O
denies O O
dysuria, O O
polyuria, O O
vaginal O O
discharge. O O
Occasional O O
back O O
pain O O
LMP O O
: O O
4/92 O O
General: O O
Denies O O
weight O O
changes, O O
fever, O O
chills, O O
night O O
sweats. O O
Doesn't O O
follow O O
a O O
diet, O O
eats O O
fast O O
foods, O O
regular O O
sodas O O
Endocrino: O O
Denies O O
dizzyness, O O
diaphoresis O O
Gastrointestinal: O O
Denies O O
diarrhea, O O
constipation, O O
abdominal O O
pain, O O
heartburn, O O
nausea, O O
vomiting, O O
no O O
rectal O O
bleeding O O
Skin O O
: O O
no O O
lesions, O O
no O O
hair O O
loss O O
Neurological: O O
no O O
weakness, O O
numbness, O O
tingling O O
after O O
the O O
strokes. O O
Recovered O O
completely O O
Musculoskeletal: O O
left O O
leg O O
pain O O
every O O
day O O
and O O
low O O
back O O
pain. O O
Wants O O
Celebrex. O O
Psychiatric: O O
no O O
anxiety, O O
Denies O O
depression O O
or O O
suicidal O O
thoughts O O
but O O
cries O O
many O O
times O O
when O O
confronted O O
about O O
depression O O
All O O
other O O
systems O O
are O O
negative O O
Vital O O
Signs O O
BLOOD B-HYPERTENSION O
PRESSURE I-HYPERTENSION O
150/90 I-HYPERTENSION O
PULSE O O
76 O O
RESPIRATORY O O
RATE O O
14 O O
TEMPERATURE O O
97 O O
F O O
HEIGHT O O
64 O O
in O O
WEIGHT O O
234 O O
lb O O
BMI B-OBESE O
40.2 I-OBESE O
Physical O O
Exam O O
Alert, O O
obese, B-OBESE O
unkempt, O O
in O O
no O O
respiratory O O
distress, O O
tolerates O O
decubitus O O
Normocephalic, O O
no O O
scalp O O
lesions, O O
wearing O O
a O O
wig. O O
PEERL, O O
EOMI, O O
no O O
jaundice O O
in O O
sclerae, O O
no O O
conjunctival O O
hyperhemia. O O
Bilateral O O
fundoscopy: O O
sharp O O
disks, O O
no O O
papilledema, O O
no O O
AV O O
nicking O O
Bilateral O O
otoscopy: O O
normal, O O
no O O
exudates, O O
normal O O
timpanic O O
membranes. O O
No O O
sinus O O
tenderness O O
on O O
palpation O O
on O O
percussion. O O
Bilateral O O
rhinoscopy: O O
normal O O
Oral O O
mucosa O O
moist, O O
no O O
oral O O
thrush, O O
no O O
lesions, O O
no O O
masses O O
Throat: O O
normal, O O
no O O
exudates O O
or O O
plaques, O O
normal O O
tonsils. O O
Neck: O O
supple, O O
no O O
masses O O
or O O
adenopathies, O O
normal O O
thyroid O O
palpation, O O
no O O
JVD, O O
normal O O
carotid O O
pulses, O O
no O O
carotid O O
bruit. O O
Lungs: O O
N O O
use O O
of O O
accesory O O
muscles, O O
no O O
intercostal O O
retractions, O O
clear O O
anteriorly O O
and O O
posteriroly O O
to O O
auscultation, O O
no O O
rhonchi, O O
crackles O O
or O O
wheezes, O O
normal O O
percussion, O O
no O O
egophony. O O
Heart: O O
regular, O O
rhythmic, O O
S1S2 O O
normal, O O
no O O
S3 O O
or O O
murmurs. O O
Breast O O
examination O O
: O O
Large O O
sized O O
breasts, O O
no O O
masses, O O
no O O
skin O O
lesions, O O
no O O
tenderness, O O
no O O
nipple O O
discharges O O
or O O
axillary O O
adenopathies. O O
Abdomen: O O
lower O O
midline O O
surgical O O
scar, O O
no O O
aortic O O
bruit, O O
soft, O O
diffuse O O
tenderness, O O
no O O
masses O O
or O O
organomegalies, O O
BS(+), O O
no O O
rebound. O O
No O O
inguinal O O
adenopathies O O
or O O
hernias, O O
good O O
femoral O O
pulses. O O
Pelvic O O
exam: O O
athrophic O O
external O O
genitalia, O O
no O O
masses O O
or O O
lesions, O O
normal O O
hair O O
distribution, O O
no O O
cystocele O O
or O O
rectocele. O O
No O O
masses, O O
scaring O O
or O O
tenderness O O
on O O
urethra O O
examination. O O
Stool O O
seen O O
on O O
the O O
rectal O O
area O O
Speculum O O
exam: O O
Normal O O
looking O O
cervix,closed O O
oz, O O
no O O
vaginal O O
discharge O O
or O O
lesions. O O
Pap O O
smear O O
taken, O O
GC O O
and O O
Chlamydia O O
taken. O O
Bimanual O O
exam: O O
no O O
cervical O O
motion O O
tenderness, O O
no O O
masses, O O
no O O
adnexal O O
tenderness O O
or O O
masses, O O
unable O O
to O O
feel O O
uterine O O
size O O
due O O
to O O
obesity O O
Rectal O O
exam: O O
no O O
external O O
hemmorrhoids O O
Digital O O
exam: O O
no O O
lesions, O O
normal O O
sphincter O O
tone, O O
Guaiac O O
stool O O
Negative O O
Ext: O O
1++ O O
edema O O
left O O
leg, O O
ORIF O O
midline O O
large O O
surgical O O
scar O O
seen, O O
good O O
pulses, O O
normal O O
skin, O O
no O O
varicosities O O
Skin: O O
no O O
lesions O O
Neurological: O O
Alert, O O
oriented O O
x O O
3, O O
Speech O O
normal. O O
Cranial O O
nerves O O
Normal, O O
Strenght O O
5/5/ O O
bilateral O O
symmetrical O O
in O O
upper O O
and O O
lower O O
extremities. O O
DTR O O
2++ O O
symmetrical, O O
sensory O O
intact, O O
no O O
pathological O O
reflexes O O
Assessment O O
Physical O O
exam O O
remarkable O O
for O O
: O O
1. O O
HYPERTENSION B-HYPERTENSION O
Explained O O
the O O
pathophysiology O O
of O O
Hypertension O O
and O O
the O O
importance O O
of O O
goog O O
blood O O
pressure O O
control O O
Explained O O
the O O
increased O O
risk O O
of O O
CVA, O O
CAD, O O
eye O O
and O O
renal O O
problems O O
Spoke O O
about O O
the O O
need O O
to O O
quit O O
smoking, O O
loose O O
weight, O O
follow O O
a O O
low O O
fat O O
low O O
carb O O
diet. O O
Patient O O
undesrtood O O
Recommended O O
to O O
follow O O
a O O
low O O
salt O O
diet O O
and O O
exercise O O
regulalry O O
Will O O
check O O
a O O
SMA-7, O O
CBCm O O
TSH O O
and O O
U/A O O
to O O
evaluate O O
renal O O
function O O
Continue O O
taking O O
HCTZ O O
QD O O
30 O O
and O O
6 O O
refills O O
and O O
follow O O
up O O
in O O
6 O O
weeks O O
for O O
BP O O
check. O O
Increase O O
Metroprolol B-MEDICATION B-MEDICATION
to O O
50 O O
mg O O
BID O O
60 O O
and O O
6 O O
refills O O
Increased O O
risk O O
for O O
CAD O O
and O O
needs O O
to O O
modify O O
life O O
style. O O
2. O O
HO O O
CEREBROVASCULAR O O
ACCIDENT O O
She O O
reports O O
4 O O
strokes O O
and O O
no O O
residual O O
neurological O O
deficit. O O
Declines O O
Coumadin. O O
Is O O
on O O
ASA B-MEDICATION O
sometimes O O
Start O O
Plavix O B-MEDICATION
75mg O O
QD O O
30 O O
and O O
6 O O
refills O O
to O O
decrease O O
risk O O
of O O
CVA O O
Again O O
needs O O
to O O
quit O O
smoking O O
ASAP O O
3. O O
OBESITY B-OBESE O
Calculated B-OBESE O
BMI B-OBESE O
40 I-OBESE O
Obesity B-OBESE O
Type I-OBESE O
2 I-OBESE O
Spoke O O
about O O
diet O O
and O O
exercise O O
as O O
the O O
main O O
steps O O
to O O
loose O O
weigth. O O
Explained O O
that O O
Obesity O O
predisposes O O
patients O O
to O O
develop O O
Diabetes O O
Mellitus, O O
Hypertension, O O
CAD, O O
CVA, O O
Strokes, O O
Osteoarthritis O O
specially O O
of O O
the O O
knees, O O
Colon O O
cancer O O
and O O
breast O O
cancer O O
and O O
endometrial O O
cancer O O
in O O
woman O O
Encouraged O O
the O O
patient O O
to O O
increase O O
the O O
exercise O O
to O O
5-7 O O
times O O
per O O
week O O
and O O
35-45 O O
minutes O O
of O O
cardiovascular. O O
Change O O
to O O
diet O O
sodas, O O
and O O
avoid O O
fast O O
foods O O
completely O O
Increase O O
the O O
amount O O
of O O
vegetables O O
and O O
avoid O O
carbohydrates, O O
sugar O O
products O O
and O O
follow O O
a O O
low O O
fat O O
diet O O
Check O O
TSH, O O
Lipid O O
profile O O
and O O
Glucose O O
4. O O
SMOKER B-SMOKER O
Recommendations O O
to O O
quit O O
smoking O O
Spoke O O
about O O
increased O O
risk O O
for O O
lung O O
cancer, O O
bladder O O
cancer, O O
cervical O O
cancer, O O
CAD, O O
CVA O O
on O O
smokers O O
Spoke O O
about O O
Nicotine O O
patch, O O
Nicotine O O
gum, O O
Zyban O O
etc O O
Recommended O O
the O O
patient O O
to O O
use O O
Nicorette O O
gum. O O
Referal O O
to O O
see O O
Georgia O O
Upshaw O O
- O O
smoking O O
cessation O O
counselour. O O
She O O
is O O
not O O
iterested O O
on O O
quitting O O
5. O O
DEPRESSION O O
Spent O O
25 O O
minutes O O
with O O
her O O
talking O O
about O O
depression. O O
She O O
was O O
very O O
quit O O
at O O
the O O
beggining O O
of O O
the O O
visit O O
and O O
denied O O
depression O O
even O O
after O O
finishing O O
her O O
visit. O O
But O O
she O O
cried O O
a O O
lot O O
when O O
telling O O
me O O
about O O
her O O
twins. O O
Explained O O
that O O
is O O
never O O
late O O
to O O
get O O
therapy O O
and O O
feel O O
happier O O
on O O
meds O O
and O O
therapy. O O
She O O
has O O
had O O
4 O O
CVA O O
and O O
still O O
smokes O O
and O O
doesn't O O
care O O
of O O
herself, O O
which O O
is O O
remarkable O O
and O O
seems O O
to O O
me O O
she O O
is O O
passively O O
suicidal O O
by O O
following O O
those O O
behaviours. O O
Spoke O O
about O O
depression O O
and O O
different O O
modalities O O
of O O
therapy O O
Spoke O O
about O O
mental O O
therapy O O
and O O
pharmacological O O
therapy O O
for O O
depression. O O
Recommended O O
her O O
to O O
start O O
medications, O O
she O O
declines O O
I O O
agree O O
to O O
Rx O O
Ambien O O
5 O O
mg O O
QHS O O
PRN O O
30 O O
and O O
6 O O
refills O O
She O O
will O O
call O O
the O O
Psychiatric O O
department O O
at O O
KEKELA O O
to O O
start O O
therapy O O
5. O O
MENOPAUSE O O
Start O O
Calcium O O
500 O O
mg O O
2 O O
tb O O
QD O O
60 O O
and O O
6 O O
refills O O
MVI O O
30 O O
and O O
6 O O
refills O O
Schedule O O
BDT O O
and O O
tehrapy O O
if O O
indicated O O
6. O O
LEFT O O
LEG O O
PAIN O O
after O O
ORIF O O
Tylenol O O
XS O O
TID O O
for O O
now O O
No O O
Celebre O O
on O O
a O O
patient O O
with O O
high O O
risk O O
of O O
CVA O O
and O O
CAD O O
Plan O O
Will O O
send O O
the O O
Pap O O
smear O O
results O O
in O O
2 O O
weeks O O
Will O O
call O O
if O O
GC O O
or O O
Chlamydia O O
positive O O
in O O
48 O O
hours O O
Will O O
check O O
a O O
lipid O O
profile O O
Schedule O O
BDT O O
Schedule O O
mammogram O O
Schedule O O
colonoscopy O O
Three O O
stool O O
cards O O
given O O
to O O
bring O O
soon O O
Counseling O O
Recommendations O O
to O O
exercise O O
2-3 O O
times O O
per O O
week O O
Follow O O
a O O
low O O
fat O O
diet O O

Record O O
date: O O
2093-12-26 O O
Patient O O
Name: O O
BARR,NICKY O O
[ O O
MRN: O O
32612454LDC O O
] O O
Date O O
of O O
Visit: O O
12/26/93 O O
Chief O O
Complaint O O
Mrs O O
Barr O O
is O O
here O O
to O O
follow O O
up O O
on O O
Hypertension, B-HYPERTENSION O
diabetes B-DIABETES O
History O O
of O O
Present O O
Illness O O
Mrs O O
Barr O O
has O O
been O O
doing O O
well. O O
Has O O
a O O
8 O O
weeks O O
grandaughter O O
and O O
is O O
very O O
happy O O
with O O
her. O O
Interesetd B-SMOKER O
on I-SMOKER O
quiting I-SMOKER O
smoking. I-SMOKER O
Can O O
not O O
hold O O
the O O
baby O O
as O O
long O O
as O O
she B-SMOKER O
smokes I-SMOKER O
and O O
she O O
has O O
decided O O
to O O
quit O O
to O O
be O O
able O O
to O O
care O O
or O O
the O O
baby. O O
She O O
is O O
taking O O
all O O
her O O
meds O O
as O O
directed. O O
HbA1C B-DIABETES O
in I-DIABETES O
5/93 I-DIABETES O
7.2 I-DIABETES O
and O O
LDL O O
99 O O
on O O
Lipitor B-MEDICATION B-MEDICATION
20 I-MEDICATION O
mg. I-MEDICATION O
She B-SMOKER O
still I-SMOKER O
smokes I-SMOKER O
1/2 I-SMOKER O
PPD I-SMOKER O
but O O
better O O
than O O
before O O
Declines O O
the O O
FLu O O
shot O O
and O O
Pneumovax O O
Not O O
exercising. O O
Walks O O
daily O O
1-2 O O
blocks O O
for O O
chores. O O
Review O O
of O O
Systems O O
C/P:Denies O O
chest O O
pain, O O
SOB O O
Skin(-) O O
MSK(-) O O
HEENT O O
: O O
Denies O O
cold O O
sx O O
GU(-) O O
General: O O
Denies O O
fever, O O
chills, O O
weigth O O
loss O O
GI O O
:Denies O O
nausea, O O
vomiting, O O
diarrhea O O
Neuro: O O
denies O O
headaches O O
All O O
other O O
systems O O
negative O O
Problems O O
Cerebrovascular O O
accident O O
: O O
x O O
4 O O
Obesity B-OBESE O
: O O
BMI B-OBESE O
40 I-OBESE O
- O O
Type O O
3 O O
Hypertension O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Osteopenia O O
: O O
T O O
score O O
-1.8 O O
L1-4 O O
Allergies O O
NKA O O
Medications O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) B-MEDICATION O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
25 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Metoprolol B-MEDICATION B-MEDICATION
TARTRATE I-MEDICATION O
100 I-MEDICATION O
MG I-MEDICATION O
(100MG I-MEDICATION O
TABLET I-MEDICATION O
take I-MEDICATION O
1) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Multivitamins O O
1 O O
CAPSULE O O
PO O O
QD O O
Ambien O O
(ZOLPIDEM O O
TARTRATE) O O
5 O O
MG O O
PO O O
QHS O O
Fosamax O O
(ALENDRONATE) O O
35MG O O
TABLET O O
PO O O
QSunday O O
AM O O
, O O
Take O O
it O O
with O O
8 O O
Oz O O
of O O
water O O
Lisinopril B-MEDICATION B-MEDICATION
5 I-MEDICATION O
MG I-MEDICATION O
(5MG I-MEDICATION O
TABLET I-MEDICATION O
take I-MEDICATION O
1) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Oscal O O
500 O O
+ O O
D O O
(CALCIUM O O
CARBONATE O O
1250 O O
MG O O
(500MG O O
ELEM O O
CA)/ O O
VIT O O
D O O
200 O O
IU)) O O
2 O O
TAB O O
PO O O
qd O O
Ibuprofen O O
800 O O
MG O O
(800MG O O
TABLET O O
take O O
1) O O
PO O O
TID O O
PRN O O
leg O O
pain O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
20MG I-MEDICATION O
TABLET I-MEDICATION O
PO I-MEDICATION O
QHS I-MEDICATION O
Vital O O
Signs O O
BP B-HYPERTENSION O
136/90, I-HYPERTENSION O
P O O
68, O O
RR O O
14, O O
Wt O O
242 O O
lb O O
Physical O O
Exam O O
Alert, O O
in O O
no O O
distress, O O
obese, B-OBESE O
happy O O
looking, O O
smiling O O
HEENT O O
: O O
PEERL, O O
EOMI, O O
oral O O
mucosa O O
moist, O O
no O O
lesions O O
Neck O O
: O O
supple, O O
no O O
masses O O
or O O
nodes, O O
no O O
JVD. O O
Lungs: O O
clear O O
anteriorly O O
and O O
posteriroly O O
to O O
auscultation, O O
no O O
rhonchi, O O
crackles O O
or O O
wheezes O O
Heart: O O
regular,. O O
S1S2 O O
normal, O O
no O O
S3 O O
or O O
murmurs O O
Abdomen: O O
soft, O O
no O O
tenderness O O
BS(+), O O
no O O
rebound O O
Ext: O O
no O O
edema, O O
normal O O
skin O O
Feet O O
exam: O O
normal O O
ksin,. O O
good O O
DP, O O
good O O
capillary O O
filling O O
Assessment O O
1. O O
HYPERTENSION B-HYPERTENSION O
Poorly O O
controlled O O
today O O
Continue O O
Lisinopril O B-MEDICATION
5 O O
mg O O
QD O O
30 O O
and O O
3 O O
refills O O
Increase O O
Metroprolol B-MEDICATION B-MEDICATION
to O O
50 O O
mg O O
BID O O
from O O
QD O O
and O O
HCTZ B-MEDICATION O
25 O O
mg O O
QD O O
See O O
me O O
in O O
8 O O
weeks O O
to O O
recheck O O
BP O O
Check O O
SMA-7 O O
2. O O
CEREBROVASCULAR O O
ACCIDENT O O
Uncontrolled B-HYPERTENSION O
HTN I-HYPERTENSION O
Smoking B-SMOKER O
- I-SMOKER O
active I-SMOKER O
Elevated B-HYPERLIPIDEMIA O
LDL I-HYPERLIPIDEMIA O
Obese B-OBESE O
Sedentary O O
On O O
statins. O O
Goal O O
LDL O O
&lt;100 O O
Check O O
Lipid O O
profile O O
and O O
LFTs O O
Goal O O
LDL O O
&lt;70 O O
Quit O O
smoking O O
- O O
try O O
Nicorette O O
Gum. O O
Referal O O
to O O
see O O
Georgia O O
Upshaw- O O
smoking O O
cessation O O
counselour O O
Plavix B-MEDICATION B-MEDICATION
75 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
3. O O
DIABETES B-DIABETES O
MELLITUS I-DIABETES O
HbA1C B-DIABETES O
7.2 I-DIABETES O
in I-DIABETES O
5/93 I-DIABETES O
Goal O O
below O O
7 O O
Repeat O O
HbA1C O O
and O O
microalbuminuria O O
Due O O
for O O
eye O O
exam. O O
Declines O O
Flu O O
shot O O
4. O O
OSTEOPENIA O O
Continue O O
Fosamax O O
35 O O
mg O O
Q O O
week, O O
calcium O O
and O O
MVI O O
Plan O O
Follow O O
up O O
in O O
8 O O
weeks O O
_____________________________________________ O O
Victoria O O
Amy-Armstrong, O O
M.D. O O

Record O O
date: O O
2094-09-07 O O
Patient O O
Name: O O
BARR,NICKY O O
[ O O
32612454(LDC) O O
] O O
Date O O
of O O
Visit: O O
09/07/2094 O O
Chief O O
Complaint O O
Mrs O O
Barr O O
is O O
here O O
to O O
follow O O
up O O
on O O
Hypertension, B-HYPERTENSION O
diabetes, B-DIABETES O
cholesterol B-HYPERLIPIDEMIA O
History O O
of O O
Present O O
Illness O O
Mrs O O
Barr O O
has O O
been O O
doing O O
well. O O
Didn't O O
take O O
her O O
blood O O
pressure O O
meds O O
today, O O
forgot O O
Seen O O
yesterday O O
by O O
RN O O
and O O
got O O
glucemeter. O O
Still O O
can O O
not O O
make O O
it O O
work O O
Has O O
been O O
on O O
Metformin B-MEDICATION B-MEDICATION
850 I-MEDICATION O
mg I-MEDICATION O
TID O O
and O O
Avandia B-MEDICATION B-MEDICATION
4 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
Not O O
checking O O
her O O
glucose O O
yet O O
Last B-DIABETES O
HbA1C B-DIABETES O
9.6 I-DIABETES O
on I-DIABETES O
6/28 I-DIABETES O
down I-DIABETES O
from I-DIABETES O
5/11/94 I-DIABETES O
- I-DIABETES O
10.6 I-DIABETES O
She O O
is O O
taking O O
Lipitor B-MEDICATION B-MEDICATION
80 I-MEDICATION O
mg I-MEDICATION O
for O O
few O O
weeks. O O
Last B-HYPERLIPIDEMIA O
LDL B-HYPERLIPIDEMIA O
134 I-HYPERLIPIDEMIA O
on O O
6/28 O O
On O O
Lisinopril B-MEDICATION B-MEDICATION
to I-MEDICATION O
40 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
and O O
Metoprolol B-MEDICATION B-MEDICATION
100 I-MEDICATION O
mg I-MEDICATION O
BID I-MEDICATION O
She B-SMOKER O
still I-SMOKER O
smokes B-SMOKER O
1/2 I-SMOKER O
PPD I-SMOKER O
Review O O
of O O
Systems O O
C/P: O O
Occasional O O
chest O O
pain O O
on O O
and O O
off, O O
No O O
SOB O O
or O O
leg O O
edema O O
Skin(-) O O
MSK(-) O O
HEENT O O
: O O
Denies O O
cold O O
sx O O
General: O O
Denies O O
fever, O O
chills, O O
weigth O O
loss O O
GI O O
:Denies O O
nausea, O O
vomiting, O O
diarrhea O O
Neuro: O O
denies O O
headaches O O
Psych: O O
depressed. O O
All O O
other O O
systems O O
negative O O
Problems O O
Cerebrovascular O O
accident O O
: O O
x O O
4 O O
Obesity B-OBESE O
: I-OBESE O
BMI B-OBESE O
40 I-OBESE O
- O O
Type O O
3 O O
Hypertension O B-HYPERTENSION
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Osteopenia O O
: O O
T O O
score O O
-1.8 O O
L1-4 O O
Allergies O O
NKA O O
Medications O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) I-MEDICATION O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
MG O O
PO O O
QD O O
Multivitamins O O
1 O O
CAPSULE O O
PO O O
QD O O
Fosamax O O
(ALENDRONATE) O O
35MG O O
TABLET O O
PO O O
QSundayAM O O
, O O
Take O O
it O O
with O O
8 O O
Oz O O
of O O
water O O
Oscal O O
500 O O
+ O O
D O O
(CALCIUM O O
CARBONATE O O
1250 O O
MG O O
(500MG O O
ELEM O O
CA)/ O O
VIT O O
D O O
200 O O
IU)) O O
2 O O
TAB O O
PO O O
qd O O
Ambien O O
(ZOLPIDEM O O
TARTRATE) O O
5 O O
MG O O
PO O O
QHS O O
Ibuprofen O O
800 O O
MG O O
(800MG O O
TABLET O O
take O O
1) O O
PO O O
TID O O
PRN O O
leg O O
pain O O
Lisinopril O B-MEDICATION
40 O O
MG O O
(40MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
, O O
dose O O
increased O O
from O O
10 O O
to O O
20 O O
mg O O
QD O O
on O O
5/11/94 O O
and O O
from O O
20 O O
to O O
40 O O
mg O O
today O O
6/1/94 O O
Metoprolol B-MEDICATION B-MEDICATION
TARTRATE I-MEDICATION O
150 O O
MG O O
(100MG O O
TABLET O O
take O O
1.5) O O
PO O O
BID O O
, O O
Change O O
of O O
dose O O
from O O
100 O O
mg O O
BID O O
to O O
150 O O
mg O O
BID O O
Avandia B-MEDICATION B-MEDICATION
(ROSIGLITAZONE) I-MEDICATION O
4 O O
MG O O
(4MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
80MG O O
TABLET O O
PO O O
QHS O O
, O O
dose O O
increased O O
from O O
40 O O
to O O
80 O O
mg O O
today O O
Metformin O B-MEDICATION
850MG O O
TABLET O O
PO O O
TID O O
, O O
dose O O
increased O O
today O O
from O O
500 O O
mg O O
TID O O
to O O
850 O O
mg O O
TID. O O
Thanks O O
Vital O O
Signs O O
BP B-HYPERTENSION O
160/110, I-HYPERTENSION O
P O O
78, O O
RR O O
14, O O
Temp O O
97 O O
F, O O
Wt O O
249 O O
lb O O
Physical O O
Exam O O
Alert, O O
in O O
no O O
distress, O O
obese, B-OBESE O
flat O O
affect O O
HEENT O O
: O O
oral O O
mucosa O O
moist, O O
no O O
lesions. O O
Throat O O
clear O O
Neck O O
: O O
supple, O O
no O O
masses O O
or O O
nodes, O O
no O O
JVD. O O
Lungs: O O
clear O O
anteriorly O O
and O O
posteriroly O O
to O O
auscultation, O O
no O O
rhonchi, O O
crackles O O
or O O
wheezes O O
Heart: O O
regular,. O O
S1S2 O O
normal, O O
no O O
S3 O O
or O O
murmurs O O
Abdomen: O O
soft, O O
no O O
tenderness O O
BS(+), O O
no O O
rebound O O
Ext: O O
no O O
edema, O O
normal O O
skin O O
Feet O O
exam: O O
normal O O
skin,. O O
good O O
DP, O O
good O O
capillary O O
filling O O
Assessment O O
1. O O
HYPERTENSION B-HYPERTENSION B-HYPERTENSION
Poorly O O
controlled O O
today O O
hasn't O O
taken O O
her O O
meds O O
yet O O
Explained O O
the O O
importance O O
of O O
taking O O
BP O O
meds O O
eraly O O
AM O O
Keep O O
same O O
meds O O
and O O
see O O
me O O
in O O
6 O O
weeks O O
Continue O O
Metroprolol B-MEDICATION B-MEDICATION
to O O
150 O O
mg O O
BID O O
Continue O O
HCTZ B-MEDICATION O
25 O O
mg O O
QD O O
Continue O O
Lisinopril O B-MEDICATION
to O O
40 O O
mg O O
QD O O
See O O
me O O
in O O
2 O O
weeks O O
to O O
recheck O O
BP O O
2. O O
CEREBROVASCULAR O O
ACCIDENT O O
Uncontrolled B-HYPERTENSION O
HTN I-HYPERTENSION O
Smoking B-SMOKER O
- I-SMOKER O
active I-SMOKER O
Elevated B-HYPERLIPIDEMIA O
LDL I-HYPERLIPIDEMIA O
Obese B-OBESE O
Sedentary O O
On O O
statins. O O
Goal O O
LDL O O
&lt;100 O O
Goal O O
LDL O O
&lt;70 O O
Plavix O B-MEDICATION
75 O O
mg O O
QD O O
3. O O
DIABETES B-DIABETES O
MELLITUS I-DIABETES O
Start O O
checking O O
glucose O O
QD O O
Continue O O
Avandia O B-MEDICATION
4 O O
mg O O
QD O O
and O O
Metformin O B-MEDICATION
850 O O
mg O O
TID O O
Goal O O
below O O
7 O O
Repeat O O
HbA1C O O
now O O
and O O
glucose O O
Nutritionist O O
referal O O
Due O O
for O O
eye O O
exam. O O
LDL O O
134 O O
on O O
Lipitor O B-MEDICATION
40 O O
Repeat O O
cholesterol O O
and O O
lipir O O
profile O O
today O O
4. O O
OSTEOPENIA O O
Continue O O
Fosamax O O
35 O O
mg O O
Q O O
week, O O
calcium O O
and O O
MVI O O
Plan O O
Follow O O
up O O
in O O
2 O O
weeks O O
_____________________________________________ O O
Victoria O O
Amy-Armstrong, O O
M.D. O O

Record O O
date: O O
2094-10-26 O O
Saint O O
John O O
Valley O O
Health O O
Center O O
157 O O
Peterborough O O
Place O O
KIM O O
JR, O O
DOUGLAS O O
Sulphur, O O
AR O O
26822 O O
20163512 O O
(426) O O
819-5183 O O
10/26/94 O O
CHIEF O O
COMPLAINT: O O
Followup O O
of O O
atrial O O
fibrillation O O
and O O
recent O O
lab O O
results. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
A O O
54 O O
year O O
old O O
male O O
with O O
history O O
of O O
paroxysmal O O
atrial O O
fibrillation, O O
borderline B-DIABETES O
diabetes, I-DIABETES O
and O O
borderline B-HYPERTENSION O
hypertension I-HYPERTENSION B-HYPERTENSION
who O O
presents O O
back O O
to O O
clinic O O
for O O
followup. O O
He O O
reports O O
that O O
he O O
has O O
been O O
feeling O O
generally O O
well. O O
He O O
reports O O
that O O
he O O
feels O O
like O O
he O O
is O O
in O O
sinus O O
today. O O
He O O
denies O O
any O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
palpitations, O O
or O O
edema. O O
I O O
reviewed O O
with O O
him O O
his O O
lab O O
results O O
from O O
10/14/2094, O O
which O O
were O O
remarkable O O
for O O
a O O
total B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
of I-HYPERLIPIDEMIA O
242, I-HYPERLIPIDEMIA O
HDL O O
of O O
33, O O
triglyceride O O
level O O
of O O
549, O O
hemoglobin B-DIABETES O
A1c I-DIABETES O
of I-DIABETES O
9.8, I-DIABETES O
and O O
INR O O
of O O
1.0. O O
The O O
patient O O
denies O O
any O O
symptoms O O
of O O
hyperglycemia O O
or O O
hypoglycemia. O O
MEDICATIONS: O O
None. O O
ALLERGIES: O O
Penicillin. O O
SOCIAL O O
HISTORY: O O
The O O
patient O O
is O O
smoking B-SMOKER O
2 I-SMOKER O
packs I-SMOKER O
per I-SMOKER O
day. I-SMOKER O
PHYSICAL O O
EXAMINATION: O O
Vital O O
signs: O O
Weight O O
193 O O
pounds, O O
blood B-HYPERTENSION O
pressure B-HYPERTENSION O
140/98, I-HYPERTENSION O
pulse O O
92 O O
and O O
regular. O O
Well-developed, O O
well-nourished O O
male O O
in O O
no O O
acute O O
distress. O O
HEENT: O O
Anicteric O O
sclerae, O O
oropharynx O O
clear. O O
Neck: O O
Supple, O O
no O O
JVD. O O
Lungs: O O
Clear O O
to O O
auscultation O O
bilaterally. O O
Cardiovascular O O
exam: O O
Regular O O
rate O O
and O O
rhythm, O O
S1, O O
S2 O O
normal, O O
no O O
murmur. O O
Abdomen: O O
Soft, O O
nontender, O O
nondistended, O O
normal O O
bowel O O
sounds. O O
Extremities: O O
No O O
cyanosis, O O
clubbing, O O
or O O
edema. O O
ASSESSMENT O O
AND O O
PLAN O O
1. O O
Paroxysmal O O
atrial O O
fibrillation. O O
EKG O O
done O O
today O O
showing O O
normal O O
sinus O O
rhythm O O
at O O
96 O O
beats O O
per O O
minute O O
with O O
normal O O
intervals, O O
flat O O
T-waves O O
in O O
leads O O
III, O O
aVF, O O
V5, O O
and O O
V6. O O
No O O
ST O O
changes. O O
Will O O
refer O O
to O O
cardiology O O
regarding O O
whether O O
to O O
anticoagulate O O
him. O O
Will O O
treat O O
today O O
with O O
Ecotrin B-MEDICATION O
325 O O
mg O O
p.o. O O
q.d. O O
2. O O
History O O
of O O
borderline O O
diabetes. O O
Last B-DIABETES O
hemoglobin I-DIABETES O
A1c I-DIABETES O
was I-DIABETES O
9.8. I-DIABETES O
Will O O
treat O O
with O O
Glucophage B-MEDICATION B-MEDICATION
500 O O
mg O O
p.o. O O
q.a.m. O O
Dietary O O
recommendations O O
given. O O
We O O
will O O
schedule O O
for O O
a O O
nursing O O
educator O O
and O O
nutritionist O O
appointment. O O
Home O O
fingerstick O O
monitoring O O
as O O
directed. O O
3. O O
Hypertension. B-HYPERTENSION O
Elevated B-HYPERTENSION O
diastolic I-HYPERTENSION O
blood I-HYPERTENSION O
pressure. I-HYPERTENSION O
Will O O
treat O O
with O O
lisinopril O B-MEDICATION
10 O O
mg O O
p.o. O O
day, O O
#30 O O
tablets O O
dispensed O O
with O O
2 O O
refills. O O
Will O O
follow. O O
4. O O
Smoking O O
cessation O O
counseling O O
given. O O
Will O O
follow. O O
______________________________ O O
QUEST O O
J. O O
QUEENAN, O O
M.D. O O
eScription O O
document:2-320209 O O

Record O O
date: O O
2095-04-03 O O
LEPROSARIUM O O
EMERGENCY O O
DEPT O O
VISIT O O
KIM,DOUGLAS O O
JR O O
201-63-51-2 O O
VISIT O O
DATE: O O
04/03/95 O O
The O O
patient O O
was O O
seen O O
primarily O O
by O O
me. O O
PRESENTING O O
COMPLAINT: O O
Fall, O O
right O O
knee O O
injury. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
Mr. O O
Killian O O
is O O
a O O
very O O
pleasant O O
54-year-old O O
gentleman, O O
with O O
a O O
history B-DIABETES O
of I-DIABETES O
diabetes, B-DIABETES O
who O O
had O O
a O O
fall O O
on O O
December O O
18, O O
2094. O O
At O O
the O O
time, O O
he O O
sustained O O
an O O
injury O O
to O O
his O O
right O O
knee O O
which O O
healed O O
and O O
then O O
began O O
to O O
break O O
down, O O
and O O
he O O
developed O O
a O O
large O O
wound O O
which O O
began O O
draining O O
and O O
had O O
foul O O
odor. O O
The O O
patient O O
had O O
continued O O
difficulty O O
ambulating O O
and O O
presented O O
to O O
the O O
emergency O O
department O O
for O O
evaluation. O O
The O O
patient O O
denies O O
having O O
any O O
hardware O O
in O O
his O O
knee. O O
No O O
history O O
of O O
osteomyelitis. O O
No O O
hardware. O O
No O O
history O O
of O O
peripheral O O
neuropathy. O O
REVIEW O O
OF O O
SYSTEMS: O O
Patient O O
denies O O
any O O
fevers O O
or O O
chills. O O
No O O
nausea O O
or O O
vomiting. O O
No O O
abdominal O O
pain. O O
No O O
chest O O
pain O O
or O O
shortness O O
of O O
breath. O O
Patient O O
is O O
only O O
complaining O O
of O O
difficulty O O
ambulating O O
secondary O O
to O O
the O O
pain. O O
PAST O O
MEDICAL O O
HISTORY: O O
Two O O
patellar O O
tendon O O
repairs O O
at O O
EDUCARE-PULLMAN O O
in O O
2083, O O
repair O O
of O O
a O O
patellar O O
fracture. O O
Recent O O
diagnosis O O
of O O
diabetes, O O
atrial O O
fibrillation. O O
Hypertension, B-HYPERTENSION B-HYPERTENSION
high B-HYPERLIPIDEMIA O
cholesterol, I-HYPERLIPIDEMIA O
and O O
positive O O
PPD. O O
MEDICATIONS: O O
Please O O
see O O
nurses O O
note O O
for O O
list O O
of O O
medications. O O
ALLERGIES: O O
PENICILLIN O O
(rash). O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
The B-SMOKER O
patient I-SMOKER O
is I-SMOKER O
a I-SMOKER O
smoker. I-SMOKER O
He O O
does O O
not O O
drink O O
alcohol. O O
He O O
works O O
in O O
engineering, O O
and O O
lives O O
alone. O O
Family O O
history O O
is O O
noncontributory. O O
PHYSICAL O O
EXAMINATION: O O
GENERAL: O O
Patient O O
is O O
awake, O O
alert, O O
talking O O
in O O
full O O
sentences, O O
in O O
mild O O
distress O O
secondary O O
to O O
pain. O O
VITAL O O
SIGNS: O O
Afebrile, O O
temperature O O
99.3, O O
respiratory O O
rate O O
20, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
161/96, I-HYPERTENSION O
pulse O O
95. O O
HEAD: O O
Atraumatic. O O
NECK: O O
Supple. O O
LUNGS: O O
Clear O O
to O O
auscultation. O O
No O O
wheezes, O O
rales O O
or O O
rhonchi. O O
HEART: O O
Regular O O
rate. O O
No O O
murmurs, O O
gallops O O
or O O
rubs. O O
ABDOMEN: O O
Soft, O O
nontender. O O
SKIN: O O
A O O
large O O
ulcer O O
to O O
the O O
right O O
knee, O O
right O O
over O O
the O O
patella, O O
with O O
significant O O
amount O O
of O O
break-down O O
necrotic O O
tissue O O
and O O
purulent O O
discharge O O
with O O
a O O
foul O O
odor. O O
The O O
depth O O
of O O
the O O
wound O O
is O O
difficult O O
to O O
assess. O O
Intact O O
motor O O
function O O
and O O
sensation. O O
Full O O
flexion O O
and O O
extension O O
of O O
the O O
knee, O O
and O O
evidence O O
of O O
well-healed O O
midline O O
scar O O
above O O
the O O
ulcer. O O
NEURO: O O
Intact O O
with O O
good O O
pulses O O
palpable O O
throughout. O O
LABORATORY O O
EVALUATION: O O
Plain O O
film O O
of O O
the O O
right O O
knee, O O
CT O O
of O O
the O O
right O O
knee, O O
and O O
laboratory O O
values O O
done. O O
Laboratory O O
values O O
demonstrated O O
a O O
white O O
count O O
of O O
14, O O
ESR O O
of O O
13, O O
ESRP O O
of O O
2.1. O O
Rest O O
of O O
the O O
labs O O
were O O
normal O O
except O O
for O O
an O O
elevated O O
glucose O O
to O O
226. O O
Film O O
of O O
the O O
knee O O
shows O O
patellofemoral O O
arthritis O O
with O O
no O O
evidence O O
of O O
osteomyelitis, O O
no O O
hardware O O
seen. O O
CT O O
of O O
the O O
knee O O
showed O O
a O O
superficial O O
ulcer O O
to O O
the O O
depth O O
of O O
the O O
patellar O O
tendon O O
but O O
the O O
patellar O O
tendon O O
itself O O
was O O
intact. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
was O O
initially O O
seen O O
by O O
orthopedic O O
who O O
felt O O
that O O
the O O
ulcer O O
was O O
over O O
the O O
patellar O O
tendon, O O
at O O
the O O
site O O
of O O
prior O O
surgeries, O O
with O O
no O O
effusion O O
or O O
joint O O
pain, O O
and O O
normal O O
range O O
of O O
motion O O
with O O
joint O O
involvement O O
unlikely. O O
We O O
are O O
all O O
very O O
hesitant O O
to O O
tap O O
this O O
knee O O
and O O
it O O
will O O
not O O
be O O
done O O
at O O
this O O
time O O
for O O
fear O O
of O O
introducing O O
infection O O
into O O
the O O
joint. O O
The O O
patient O O
is O O
awaiting O O
consultation O O
by O O
general O O
surgery O O
for O O
probable O O
admission O O
and O O
debridement O O
in O O
the O O
operating O O
room. O O
The O O
plan O O
at O O
this O O
time O O
was O O
to O O
hold O O
off O O
on O O
antibiotics. O O
Blood O O
cultures O O
were O O
sent. O O
The O O
patient O O
is O O
receiving O O
IV O O
fluids. O O
CONSULTATIONS O O
(including O O
PCP): O O
Orthopedics, O O
general O O
surgery. O O
FINAL O O
DIAGNOSIS: O O
Knee O O
ulcer. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
was O O
admitted O O
and O O
transitioned O O
to O O
ED O O
Obs, O O
awaiting O O
evaluation O O
by O O
the O O
surgical O O
service O O
for O O
probable O O
admission. O O
The O O
patient O O
is O O
currently O O
in O O
stable O O
and O O
satisfactory O O
condition, O O
in O O
Obs O O
awaiting O O
surgery O O
evaluation. O O
___________________________________ O O
VN983/2356 O O
SHERRY O O
PERKINS, O O
M.D. O O
SP79 O O
D:04/03/95 O O
T:04/04/95 O O
Dictated O O
by: O O
SHERRY O O
PERKINS, O O
M.D. O O
SP79 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2096-02-13 O O
Saint O O
John O O
Valley O O
Health O O
Center O O
707 O O
Newburgh O O
Street O O
Sulphur, O O
AR. O O
26822 O O
859-168-0145 O O
CC: O O
f/up O O
of O O
RLE O O
ulcerations O O
HPI: O O
55 O O
yo O O
male O O
with O O
f/up O O
for O O
RLE O O
ulcerations O O
reporting O O
a O O
temp O O
this O O
past O O
Wednesday O O
AM O O
to O O
101.2. O O
Started O O
Keflex O O
at O O
home O O
because O O
he O O
had O O
some O O
and O O
took O O
for O O
2 O O
days. O O
Also, O O
reports O O
FS's B-DIABETES O
have I-DIABETES O
been I-DIABETES O
above I-DIABETES O
200. I-DIABETES O
Changing O O
dressings O O
as O O
directed. O O
================ O O
Problems O O
================ O O
Smoking B-SMOKER O
S/P O O
R O O
knee O O
surgery O O
x O O
3 O O
S/P O O
tonsillectomy O O
Hypertension B-HYPERTENSION O
H/O O O
+PPD O O
in O O
'70's, O O
treated O O
for O O
1 O O
yr O O
diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Hypertriglyceridemia B-HYPERLIPIDEMIA O
H/O O O
paroxysmal O O
afib O O
VNA O O
171-311-7974 O O
================ O O
Medications O O
================ O O
ATENOLOL B-MEDICATION B-MEDICATION
50MG O O
1 O O
Tablet(s) O O
PO O O
QAM O O
COUMADIN O O
(WARFARIN O O
SODIUM) O O
5MG O O
1 O O
Tablet(s) O O
PO O O
QPM O O
ECASA B-MEDICATION B-MEDICATION
(ASPIRIN I-MEDICATION O
ENTERIC I-MEDICATION O
COATED) I-MEDICATION O
81MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
GLUCOPHAGE B-MEDICATION B-MEDICATION
(METFORMIN) I-MEDICATION O
850MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
GLYBURIDE B-MEDICATION B-MEDICATION
1.25MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
LISINOPRIL B-MEDICATION B-MEDICATION
20MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
PERCOCET O O
(OXYCODONE+APAP) O O
325-5MG O O
1 O O
Tablet(s) O O
PO O O
BID O O
PRN O O
pain O O
SERAX O O
(OXAZEPAM) O O
15MG O O
1 O O
Tablet(s) O O
PO O O
QHS O O
PRN O O
insomnia O O
================ O O
Allergies O O
================ O O
Penicillins O O
Unknown O O
PEx: O O
VS: O O
Wt O O
196, O O
BP O O
130/86, O O
T O O
99.2, O O
P O O
76 O O
regular O O
WDWN O O
male O O
in O O
NAD. O O
HEENT: O O
anicteric O O
sclerae. O O
Neck: O O
supple, O O
no O O
JVD. O O
Lungs: O O
CTA. O O
CV: O O
Irregularly O O
irregular O O
Abd: O O
soft, O O
NT/ND, O O
nl O O
BS. O O
Ext: O O
slow O O
healing O O
ulcers O O
on O O
RLE O O
with O O
ongoing O O
mild O O
surrounding O O
erythema O O
A/P: O O
1. O O
RLE O O
ulcerations, O O
slow O O
to O O
heal, O O
ongoing O O
dressing O O
changes O O
as O O
directed. O O
Will O O
continue O O
Keflex O O
500 O O
mg O O
QID O O
x O O
1 O O
more O O
week. O O
Percocet O O
5/325 O O
1 O O
tab O O
po O O
qhs-BID O O
PRN O O
pain O O
2. O O
DM, B-DIABETES O
increase O O
Glyburide B-MEDICATION B-MEDICATION
to O O
2.5 O O
mg O O
po O O
qd O O
as O O
directed. O O
Follow O O
home O O
FS O O
as O O
directed. O O
Quijada, O O
M.D. O O

Record O O
date: O O
2098-10-14 O O
Saint O O
John O O
Valley O O
Health O O
Center O O
739 O O
Newburgh O O
Street O O
Sulphur, O O
AR. O O
26822 O O
CC: O O
s/p O O
foreign O O
body O O
removal O O
and O O
HTN/AFIB B-HYPERTENSION O
management O O
HPI: O O
58 O O
yo O O
male O O
who O O
presents O O
back O O
to O O
clinic O O
having O O
undergone O O
paraesophageal O O
hernia O O
repair O O
and O O
PEG O O
placement O O
on O O
8/13/98. O O
9/25 O O
had O O
foreign O O
body O O
removed O O
by O O
dilatation O O
by O O
Dr. O O
Doty O O
secondary O O
to O O
esophageal O O
stricture O O
and O O
placed O O
on O O
mech O O
soft O O
diet. O O
Doing O O
well. O O
Denies O O
any O O
CP, O O
SOB, O O
or O O
abd O O
pain. O O
No O O
fever. O O
10/13 O O
INR O O
2.4. O O
================ O O
Problems O O
================ O O
Smoking B-SMOKER O
S/P O O
R O O
knee O O
surgery O O
x O O
3 O O
S/P O O
tonsillectomy O O
Hypertension B-HYPERTENSION O
H/O O O
+PPD O O
in O O
'70's, O O
treated O O
for O O
1 O O
yr O O
diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
H/O O O
paroxysmal O O
atrial O O
fibrillation O O
427.31 O O
VNA O O
171-311-7974 O O
H/O O O
drug O O
abuse O O
- O O
patient O O
prefers O O
not O O
to O O
use O O
any O O
narcotics O O
Sleep O O
disorder O O
09/23/97 O O
colonoscopy O O
normal O O
Fatty O O
liver O O
Cataracts O O
s/p O O
paraesophageal O O
hernia O O
repair O O
with O O
PEG O O
8/13/98 O O
================ O O
Medications O O
================ O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG O O
TABLET O O
PO O O
QD O O
COLACE O O
(DOCUSATE O O
SODIUM) O O
100 O O
MG O O
(100MG O O
TABLET O O
take O O
1 O O
) O O
PO O O
QD O O
COUMADIN O O
(WARFARIN O O
SODIUM) O O
5 O O
MG O O
(5MG O O
TABLET O O
take O O
1 O O
) O O
PO O O
QPM O O
, O O
none O O
except O O
Wednesdays O O
ECASA B-MEDICATION B-MEDICATION
(ASPIRIN O O
ENTERIC O O
COATED) O O
81MG O O
TABLET O O
EC O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
GLUCOPHAGE B-MEDICATION B-MEDICATION
(METFORMIN) O O
1000MG O O
TABLET O O
take O O
1 O O
PO O O
BID O O
HYDROCHLOROTHIAZIDE B-MEDICATION B-MEDICATION
25 O O
MG O O
(25MG O O
TABLET O O
take O O
1 O O
) O O
PO O O
QD O O
IRON O O
SULFATE O O
(FERROUS O O
SULFATE) O O
325 O O
MG O O
(325(65)MG O O
TABLET O O
take O O
1 O O
) O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
40MG O O
TABLET O O
take O O
1 O O
PO O O
QD O O
PRILOSEC O O
OTC O O
(OMEPRAZOLE O O
OTC) O O
20 O O
MG O O
(20MG O O
TABLET O O
DR O O
take O O
1 O O
) O O
PO O O
QD O O
SIMETHICONE O O
80 O O
MG O O
(80MG O O
TAB O O
CHEW O O
take O O
1 O O
) O O
PO O O
BID O O
PRN O O
TRAZODONE O O
300 O O
MG O O
(100MG O O
TABLET O O
take O O
3 O O
) O O
PO O O
HS O O
ZOCOR B-MEDICATION B-MEDICATION
(SIMVASTATIN) I-MEDICATION O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1 O O
) O O
PO O O
QHS O O
================ O O
Allergies O O
================ O O
Penicillins: O O
Rash O O
PEx: O O
VS: O O
Wt O O
175, O O
BP O O
122/82, O O
P O O
80 O O
regular, O O
T O O
97.9 O O
WDWN O O
older O O
male O O
in O O
NAD. O O
HEENT: O O
anicteric O O
sclerae O O
Neck: O O
supple, O O
no O O
JVD, O O
no O O
LAD. O O
Lungs: O O
CTA. O O
CV: O O
RRR O O
Abd: O O
soft, O O
NT/ND. O O
Ext: O O
no O O
c/c/edema. O O
A/P: O O
1. O O
s/p O O
hernia O O
repair O O
and O O
PEG O O
placement O O
with O O
recent O O
foreign O O
body O O
removal O O
9/25 O O
due O O
to O O
esophageal O O
stricture, O O
doing O O
well. O O
Mech O O
soft O O
diet O O
as O O
per O O
surgery. O O
f/up O O
with O O
Dr. O O
Langley O O
as O O
scheduled. O O
RTC O O
if O O
new O O
or O O
worsening O O
symptoms. O O
2. O O
HTN, O O
stable, O O
no O O
change O O
in O O
regimen. O O
3. O O
paroxysmal O O
AFIB, O O
coumadin O O
therapeutic O O
without O O
changes. O O
10/13 O O
INR O O
2.4. O O
Quijada, O O
M.D. O O

Record O O
date: O O
2099-07-17 O O
KEKELA O O
EMERGENCY O O
DEPT O O
VISIT O O
LEON,MAURICE O O
436-34-21-1 O O
VISIT O O
DATE: O O
07/17/99 O O
Patient B-SMOKER O
seen O O
on O O
7/17/99 O O
by O O
myself O O
and O O
the O O
medical O O
resident O O
at O O
4:30 O O
p.m. O O
PRESENTING O O
COMPLAINT: O O
Chest O O
wall O O
pain. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
44 O O
year O O
old O O
male O O
complaining O O
of O O
chest O O
wall O O
pain, O O
constant, O O
times O O
24 O O
hours. O O
The O O
patient O O
states O O
the O O
pain O O
is O O
worse O O
with O O
respirations O O
and O O
movement. O O
The O O
patient O O
claims O O
similar O O
episode O O
in O O
past, O O
and O O
was O O
told O O
had O O
a O O
'pulled O O
muscle'. O O
REVIEW O O
OF O O
SYSTEMS: O O
Patient O O
denies O O
trauma, O O
denies O O
nausea O O
and O O
vomiting, O O
diaphoresis O O
and O O
shortness O O
of O O
breath. O O
PAST O O
MEDICAL O O
HISTORY: O O
Positive O O
for O O
hypertension B-HYPERTENSION O
and O O
asthma. O O
MEDICATIONS: O O
Procardia, B-MEDICATION O
Albuterol, O O
Accolate. O O
ALLERGIES: O O
None. O O
PHYSICAL O O
EXAMINATION: O O
A O O
well O O
developed, O O
well O O
nourished O O
male O O
lying O O
on O O
stretcher, O O
communicative O O
and O O
in O O
no O O
apparent O O
distress. O O
Temp O O
98.3, O O
heart O O
rate O O
112, O O
blood O O
pressure O O
133/86, O O
pulse O O
ox O O
95% O O
on O O
room O O
air. O O
HEENT O O
- O O
normocephalic, O O
atraumatic. O O
Heart O O
- O O
regular O O
rate O O
and O O
rhythm O O
without O O
murmurs, O O
rubs O O
or O O
gallops. O O
Lungs O O
clear O O
without O O
wheezing. O O
Abdomen O O
soft, O O
non-tender, O O
positive O O
bowel O O
sounds. O O
Extremities O O
without O O
clubbing, O O
cyanosis O O
or O O
edema. O O
Chest O O
wall O O
- O O
positive O O
reproducible O O
pain O O
on O O
palpation O O
which O O
improved O O
when O O
palpation O O
stopped. O O
FINAL O O
DIAGNOSIS: O O
Chest O O
wall O O
pain, O O
probable O O
costochondritis. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Plan O O
- O O
discharge O O
with O O
nonsteroidal O O
anti-inflammatories O O
which O O
patient O O
has O O
taken O O
and O O
tolerated O O
in O O
the O O
past. O O
Discharged O O
in O O
stable O O
condition. O O
___________________________________ O O
HP506/6486 O O
WINIFRED O O
MANNING, O O
M.D. O O
WM26 O O
D:07/17/99 O O
T:07/17/99 O O
Dictated O O
by: O O
WINIFRED O O
MANNING, O O
M.D. O O
WM26 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2099-02-01 O O
KEKELA O O
EMERGENCY O O
DEPT O O
VISIT O O
LEON,MAURICE O O
436-34-21-1 O O
VISIT O O
DATE: O O
02/01/99 O O
Resident O O
history O O
reviewed, O O
patient O O
seen O O
and O O
examined O O
by O O
me. O O
PRESENTING O O
COMPLAINT: O O
Chest O O
pain. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
patient O O
is O O
a O O
45-year-old O O
black O O
male O O
who O O
now O O
presents O O
for O O
evaluation O O
of O O
chest O O
pain. O O
The O O
patient O O
states O O
he O O
has O O
had O O
intermittent O O
left-sided O O
chest O O
pain O O
for O O
the O O
past O O
several O O
weeks. O O
He O O
states O O
he O O
had O O
a O O
more O O
prolonged O O
episode O O
of O O
substernal O O
chest O O
pressure O O
today O O
while O O
driving. O O
He O O
states O O
the O O
pain O O
radiated O O
down O O
his O O
left O O
arm O O
and O O
he O O
did O O
experience O O
a O O
mild O O
amount O O
of O O
associated O O
shortness O O
of O O
breath O O
and O O
diaphoresis. O O
He O O
denies O O
any O O
nausea, O O
vomiting, O O
palpitations, O O
light-headedness O O
or O O
syncope. O O
On O O
arrival O O
he O O
states O O
the O O
pain O O
is O O
approximately O O
7/10 O O
in O O
intensity. O O
He O O
denies O O
any O O
prior O O
history O O
of O O
coronary O O
artery O O
disease, O O
pulmonary O O
embolus O O
or O O
deep O O
venous O O
thrombosis. O O
His O O
cardiac O O
risk O O
factors O O
include O O
history O O
of O O
hypertension B-HYPERTENSION B-HYPERTENSION
and O O
hypercholesterolemia. B-HYPERLIPIDEMIA O
He O O
also O O
denies O O
any O O
chest O O
wall O O
trauma O O
or O O
any O O
recent O O
upper O O
respiratory O O
infection O O
symptoms, O O
cough, O O
fever O O
or O O
chills. O O
REVIEW O O
OF O O
SYSTEMS: O O
Negative O O
except O O
per O O
HPI. O O
PAST O O
MEDICAL O O
HISTORY: O O
Significant O O
for O O
hypertension, O B-HYPERTENSION
asthma O O
and O O
hypercholesterolemia. O O
MEDICATIONS: O O
Tenovate, O O
albuterol O O
MDI, O O
Azmacort O O
MDI, O O
adalat. B-MEDICATION O
ALLERGIES: O O
Bupropron O O
which O O
causes O O
pruritus. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
He O O
is O O
adopted O O
and O O
does O O
not O O
know O O
his O O
family O O
history. O O
The O O
patient O O
is O O
a O O
former B-SMOKER O
smoker I-SMOKER O
who I-SMOKER O
quit I-SMOKER O
approximately I-SMOKER O
one I-SMOKER O
year I-SMOKER O
ago. I-SMOKER O
The O O
patient O O
is O O
a O O
former B-SMOKER O
smoker I-SMOKER O
with I-SMOKER O
an I-SMOKER O
approximately I-SMOKER O
15-pack-year I-SMOKER O
history. I-SMOKER O
He O O
states O O
he O O
quit B-SMOKER O
one I-SMOKER O
year I-SMOKER O
ago. I-SMOKER O
He O O
does O O
admit O O
to O O
heavy O O
drinking, O O
approximately O O
3-4 O O
drinks O O
per O O
day. O O
He O O
has O O
no O O
prior O O
history O O
of O O
illicit O O
drug O O
use O O
and O O
currently O O
lives O O
with O O
his O O
family. O O
PHYSICAL O O
EXAMINATION: O O
GENERAL: O O
This O O
is O O
a O O
well-developed, O O
well-nourished, O O
slightly O O
anxious O O
appearing O O
male O O
who O O
appears O O
in O O
otherwise O O
no O O
acute O O
distress. O O
VITAL O O
SIGNS: O O
Temperature O O
is O O
96.2, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
142/96, B-HYPERTENSION O
pulse O O
108, O O
respiratory O O
rate O O
20, O O
oxygen O O
saturation O O
96% O O
on O O
room O O
air. O O
HEENT: O O
Mucous O O
membranes O O
are O O
moist O O
without O O
lesions. O O
NECK: O O
Supple O O
without O O
jugular O O
venous O O
distention. O O
LUNGS: O O
Clear O O
to O O
auscultation. O O
HEART: O O
Tachycardic, O O
regular O O
rate O O
and O O
rhythm O O
without O O
gallops, O O
murmurs O O
or O O
rubs. O O
ABDOMEN: O O
Soft, O O
nontender, O O
nondistended. O O
EXTREMITIES: O O
No O O
clubbing, O O
cyanosis O O
or O O
edema. O O
No O O
calf O O
tenderness. O O
Negative O O
Homan's O O
sign. O O
NEURO: O O
Awake, O O
alert, O O
oriented O O
x O O
3. O O
Nonfocal. O O
LABORATORY O O
EVALUATION: O O
CBC, O O
white O O
count O O
6.2, O O
hematocrit O O
45, O O
platelets O O
210. O O
SMA-7 O O
notable O O
for O O
a O O
bicarb O O
of O O
19. O O
D-dimer O O
is O O
pending. O O
CPK O O
134, O O
cardiac O O
troponin O O
I O O
0.00, O O
coagulation O O
profile O O
is O O
normal. O O
Electrocardiogram O O
shows O O
normal O O
sinus O O
rhythm O O
at O O
a O O
rate O O
of O O
93 O O
with O O
nonspecific O O
T O O
wave O O
changes. O O
No O O
significant O O
change O O
compared O O
with O O
prior O O
tracing O O
dated O O
May O O
01, O O
2099. O O
Chest O O
x-ray O O
reveals O O
no O O
acute O O
disease. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
was O O
treated O O
with O O
aspirin, B-MEDICATION B-MEDICATION
nitroglycerin B-MEDICATION O
and O O
morphine O O
with O O
relief O O
of O O
his O O
pain O O
and O O
remained O O
hemodynamically O O
stable. O O
CONSULTATIONS O O
(including O O
PCP): O O
The O O
patient's O O
primary O O
care O O
physician, O O
Dr. O O
Greene O O
was O O
notified O O
and O O
agrees O O
with O O
the O O
management O O
plan. O O
FINAL O O
DIAGNOSIS: O O
Atypical O O
chest O O
pain. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
was O O
admitted O O
to O O
emergency O O
department O O
observation O O
under O O
low O O
risk O O
for O O
cardiac O O
ischemia O O
protocol O O
and O O
is O O
currently O O
awaiting O O
evaluation O O
with O O
an O O
exercise O O
stress O O
test O O
as O O
well O O
as O O
results O O
of O O
D-dimer O O
to O O
evaluate O O
for O O
the O O
remote O O
possibility O O
of O O
pulmonary O O
embolism. O O
The O O
patient O O
is O O
currently O O
in O O
stable O O
condition. O O
___________________________________ O O
CL893/2080 O O
MAX O O
RHODES, O O
M.D. O O
MR75 O O
D:02/01/99 O O
T:02/01/99 O O
Dictated O O
by: O O
MAX O O
RHODES, O O
M.D. O O
MR75 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2099-09-27 O O
EDVISIT^43634211^LEON, O O
MAURICE^9/27/2099^HALEY, O O
BEVERLY O O
ADDENDUM: O O
The O O
patient O O
had O O
dizzy O O
spells O O
since O O
12/2099, O O
which O O
resolved O O
after O O
resection O O
of O O
his O O
cervical O O
medullary O O
tumor. O O
He O O
had O O
recurrence O O
3 O O
times O O
this O O
morning O O
of O O
similar O O
episodes. O O
He O O
feels O O
presyncopal O O
and O O
has O O
headache. O O
He O O
denies O O
any O O
nausea, O O
vomiting, O O
fevers, O O
chills O O
or O O
upper O O
respiratory O O
symptoms. O O
He O O
has O O
had O O
some O O
epigastric O O
pain. O O
During O O
all O O
of O O
these O O
episodes, O O
he O O
never O O
lost O O
consciousness, O O
but O O
he O O
does O O
a O O
fall O O
and O O
slump. O O
He O O
feels O O
lightheaded O O
prior O O
to O O
the O O
episode. O O
PAST O O
MEDICAL O O
HISTORY: O O
Remarkable O O
for O O
rheumatoid O O
arthritis, O O
psoriasis, O O
hypertension, B-HYPERTENSION O
cholesterol, B-HYPERLIPIDEMIA O
and O O
asthma. O O
Social O O
history, O O
family O O
history, O O
and O O
review O O
of O O
systems O O
are O O
as O O
per O O
the O O
written O O
note. O O
The O O
patient O O
was O O
counseled O O
regarding O O
smoking B-SMOKER O
cessation. I-SMOKER O
MEDICATIONS: O O
Aspirin, B-MEDICATION B-MEDICATION
Lipitor, B-MEDICATION B-MEDICATION
nifedipine, B-MEDICATION B-MEDICATION
and O O
Neurontin. O O
ALLERGIES: O O
None. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient O O
is O O
awake, O O
alert, O O
in O O
no O O
acute O O
distress. O O
Vital O O
signs O O
are O O
remarkable O O
for O O
temperature O O
of O O
97.3, O O
pulse O O
58, O O
respiratory O O
rate O O
16, O O
blood O O
pressure O O
134/79, O O
and O O
oxygen O O
saturation O O
is O O
96% O O
on O O
room O O
air. O O
For O O
full O O
physical O O
exam O O
findings, O O
please O O
see O O
the O O
resident's O O
written O O
notes. O O
Specifically, O O
HEENT O O
exam O O
is O O
atraumatic O O
and O O
normal O O
to O O
inspection. O O
There O O
is O O
minimal O O
right O O
ptosis O O
on O O
my O O
exam. O O
Neck O O
is O O
normal, O O
supple, O O
with O O
posterior O O
well-healed O O
cervical O O
scar. O O
There O O
is O O
no O O
lymphadenopathy O O
on O O
my O O
exam. O O
Respiratory, O O
cardiac, O O
abdominal, O O
skin, O O
and O O
musculoskeletal O O
exam O O
are O O
within O O
normal O O
limits O O
as O O
documented. O O
Neurologically, O O
the O O
patient O O
is O O
oriented O O
with O O
normal O O
pleasant O O
mood O O
and O O
affect. O O
Speech O O
is O O
fluent. O O
Cranial O O
nerves O O
are O O
remarkable O O
only O O
for O O
intermittent O O
right-sided O O
ptosis. O O
Extraocular O O
movements O O
are O O
otherwise O O
intact, O O
and O O
the O O
patient O O
is O O
moving O O
all O O
4 O O
extremities O O
without O O
any O O
motor O O
or O O
sensory O O
deficit. O O
LABORATORY O O
DATA: O O
CBC O O
and O O
electrolytes O O
are O O
remarkable O O
for O O
BUN O O
and O O
creatinine O O
ratio O O
of O O
22-0.9 O O
respectively. O O
CK O O
and O O
troponin O O
are O O
flat. O O
INR O O
is O O
1. O O
EKG O O
demonstrates O O
sinus O O
rhythm O O
without O O
any O O
significant O O
ST-T O O
wave O O
changes O O
when O O
compared O O
to O O
prior O O
studies. O O
IMAGING O O
STUDIES: O O
Head O O
CT O O
is O O
unremarkable. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
The O O
patient O O
with O O
possible O O
presyncope O O
without O O
EKG O O
changes, O O
nor O O
any O O
evidence O O
for O O
new O O
disease O O
on O O
his O O
head O O
CT, O O
will O O
undergo O O
consultation O O
by O O
Neurology O O
and O O
Neurosurgery, O O
and O O
will O O
be O O
admitted O O
to O O
the O O
ED O O
Observation O O
area O O
for O O
likely O O
MR O O
imaging O O
prior O O
to O O
admission. O O
The O O
patient O O
if O O
not O O
admitted O O
to O O
either O O
of O O
the O O
Neurosurgery O O
or O O
Neurology O O
Services O O
will O O
require O O
admission O O
to O O
the O O
Medicine O O
Service O O
for O O
syncope O O
workup. O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O
DISPOSITION: O O
Admitted O O
to O O
ED O O
Observation O O
Unit. O O
PRIMARY O O
DIAGNOSIS: O O
Near O O
syncope. O O
SECONDARY O O
DIAGNOSIS: O O
Status O O
post O O
cervical O O
medullary O O
tumor O O
resection. O O
______________________________ O O
HALEY, O O
BEVERLY O O
MD O O
D: O O
09/27/99 O O
T: O O
09/27/99 O O
Dictated O O
By: O O
HALEY, O O
BEVERLY O O
eScription O O
document:7-2933615 O O
BFFocus O O

Record O O
date: O O
2099-03-29 O O
Neurology O O
resident O O
consult O O
note O O
Patient O O
Name: O O
Leon O O
MRN: O O
43634211 O O
Date: O O
0021 O O
Consult O O
reason: O O
?abnormal O O
gait O O
HPI: O O
53RHM O O
who O O
going O O
to O O
bed O O
Wednesday O O
was O O
in O O
usoh, O O
but O O
Thursday O O
2:30AM O O
awoke O O
w/ O O
terrible O O
HA, O O
so O O
came O O
to O O
ED; O O
got O O
CT O O
head O O
and O O
LP, O O
both O O
negative O O
for O O
blood. O O
However, O O
BP B-HYPERTENSION O
was I-HYPERTENSION O
reportedly I-HYPERTENSION O
as I-HYPERTENSION O
high I-HYPERTENSION O
as I-HYPERTENSION O
190/106 I-HYPERTENSION O
(and O O
wife O O
says O O
she&#8217;s O O
measured O O
it O O
this O O
high O O
at O O
home O O
at O O
least O O
once O O
in O O
past O O
2 O O
weeks), O O
and O O
blood B-DIABETES O
glucose I-DIABETES O
400s. I-DIABETES O
I O O
see O O
no O O
LMR O O
note O O
about O O
the O O
visit, O O
but O O
am O O
told O O
that O O
he O O
was O O
given O O
some O O
medication O O
for O O
his O O
BP, O O
given B-MEDICATION O
some I-MEDICATION O
insulin B-MEDICATION O
and I-MEDICATION O
a I-MEDICATION O
Rx I-MEDICATION O
for I-MEDICATION O
insulin, I-MEDICATION O
and O O
instructed O O
to O O
see O O
his O O
PCP O O
the O O
next O O
day, O O
and O O
discharged. O O
Friday O O
he O O
did O O
see O O
his O O
PCP, O O
who O O
told O O
him O O
not O O
to O O
take O O
insulin O O
but O O
to O O
take O O
oral O O
DM B-DIABETES O
meds O O
instead, O O
and O O
told O O
him O O
to O O
return O O
to O O
the O O
ED O O
b/c O O
he O O
still O O
had O O
a O O
terrible O O
HA, O O
so O O
he O O
came O O
back O O
to O O
the O O
EDUCARE-PULLMAN O O
ED O O
tonight. O O
He O O
was O O
given O O
caffeine, O O
ibuprofen, O O
Tylenol, O O
and O O
compazine, O O
reported O O
that O O
his O O
HA O O
was O O
gone. O O
However, O O
a O O
staff O O
physician O O
in O O
the O O
ED O O
on O O
exam O O
noted O O
a O O
wide O O
based O O
gait. O O
An O O
MRI O O
was O O
originally O O
ordered, O O
but O O
canceled O O
when O O
it O O
came O O
to O O
notice O O
that O O
he O O
has O O
an O O
implanted O O
device O O
to O O
prevent O O
syncope O O
that O O
precludes O O
MRI. O O
Neurology O O
is O O
now O O
consulted.to O O
comment O O
on O O
his O O
gait O O
and O O
other O O
sx. O O
Patient O O
and O O
his O O
wife O O
tell O O
me O O
that O O
his O O
gait O O
is O O
baseline, O O
and O O
has O O
been O O
as O O
it O O
is O O
for O O
years; O O
they O O
have O O
noticed O O
no O O
change O O
and O O
have O O
no O O
complaints. O O
He O O
is O O
very O O
unpleasant O O
and O O
un-forthcoming O O
about O O
his O O
history, O O
slow O O
to O O
cooperate O O
w/ O O
exam; O O
says O O
he O O
wants O O
to O O
go O O
home, O O
resents O O
being O O
in O O
the O O
ED O O
still O O
now O O
that O O
his O O
HA O O
is O O
gone. O O
VS O O
in O O
ED O O
tonight: O O
BP B-HYPERTENSION O
172/95 I-HYPERTENSION O
max, O O
but O O
mostly O O
150-160s; O O
temp O O
98, O O
hr O O
89, O O
100% O O
RA O O
Blood O O
glucose O O
not O O
measured O O
tonight. O O
ROS: O O
Negative O O
for: O O
changes O O
in O O
vision O O
or O O
hearing, O O
neck O O
pain, O O
tinnitus, O O
vertigo, O O
weakness, O O
numbness, O O
difficulty O O
with O O
comprehension, O O
speaking, O O
language, O O
swallowing, O O
eating, O O
balance O O
or O O
gait. O O
General O O
review O O
of O O
systems O O
negative O O
for: O O
fevers, O O
chills, O O
rashes, O O
change O O
in O O
weight, O O
energy O O
level O O
or O O
appetite, O O
chest O O
pain, O O
palpitations, O O
shortness O O
of O O
breath, O O
cough, O O
abdominal O O
pain, O O
nausea, O O
vomiting, O O
and O O
change O O
in O O
bowel O O
or O O
bladder O O
habits O O
(i.e O O
incontinence). O O
MEDS: O O
metoprolol, B-MEDICATION B-MEDICATION
omeprazole, O O
simvastatin B-MEDICATION B-MEDICATION
(he O O
is O O
unsure O O
whether O O
this O O
is O O
all) O O
ALL: O O
nkda O O
PMH: O O
-HTN; B-HYPERTENSION O
he O O
denies B-DIABETES O
prior I-DIABETES O
dx I-DIABETES O
of I-DIABETES O
DM I-DIABETES O
before I-DIABETES O
yesterday I-DIABETES O
night I-DIABETES O
-recurrent O O
cardiogenic O O
syncope, O O
for O O
which O O
he O O
has O O
had O O
&#8220;Reveal&#8221; O O
device O O
implanted, O O
then O O
explanted O O
b/c O O
of O O
pain, O O
then O O
recurrent O O
sycope O O
and O O
reimplantation O O
of O O
device, O O
after O O
which O O
syncope O O
stopped O O
(see O O
notes O O
in O O
LMR O O
from O O
Dr. O O
Susan O O
Root) O O
SH: O O
denies B-SMOKER O
t/e/d, I-SMOKER O
works O O
as O O
&#8220;Pipefitter&#8221; O O
FH: O O
HTN, O O
DM O O
Neurologic O O
Examination: O O
MS: O O
unpleasant, O O
uncooperative O O
w/ O O
history, O O
angry O O
about O O
being O O
in O O
the O O
ED O O
still O O
AOx3, O O
appropriately O O
interactive O O
and O O
conversational. O O
Normal O O
affect. O O
Speech O O
is O O
fluent O O
with O O
intact O O
comprehension O O
and O O
repetition, O O
no O O
paraphasic O O
errors. O O
Concentration O O
and O O
attention O O
intact. O O
CN: O O
Visual O O
fields O O
full O O
to O O
confrontation; O O
pupils O O
equal O O
and O O
reactive O O
3&gt;2 O O
direct O O
and O O
concensual; O O
no O O
ptosis; O O
Extraocular O O
movements O O
full O O
without O O
nystagmus; O O
facial O O
sensation O O
to O O
LT O O
normal. O O
Hearing O O
intact O O
to O O
finger O O
rub O O
bilaterally; O O
face, O O
tongue O O
and O O
palate O O
are O O
symmetric; O O
SCM O O
and O O
traps O O
5/5. O O
Motor: O O
Normal O O
bulk O O
and O O
tone; O O
no O O
tremor, O O
rigidity, O O
or O O
bradykinesia. O O
No O O
pronator O O
drift. O O
Finger O O
tapping O O
normal. O O
Delt O O
Bi O O
Tri O O
FE O O
IP O O
Quad O O
Hamst O O
TibAnt O O
EHL O O
Gastro O O
C5 O O
C6 O O
C7 O O
C8/T1 O O
L2 O O
L3 O O
L4-S1 O O
L4 O O
L5 O O
S1 O O
R O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
L O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
Sensory: O O
Intact/symmetric O O
LT/PP/T/JPS O O
throughout. O O
Reflexes: O O
absent O O
throughout. O O
Cerebellar: O O
Finger-nose-finger, O O
rapid O O
alternating O O
movements, O O
heel-knee-shin O O
normal O O
and O O
symmetric O O
b/l. O O
Gait: O O
Slightly O O
wide O O
based. O O
Normal O O
arm O O
swing, O O
normal O O
speed. O O
Able O O
to O O
walk O O
on O O
toes O O
and O O
heels. O O
Some O O
difficulty O O
w/ O O
tandem O O
walk. O O
Negative O O
Romberg. O O
A/P: O O
53RHM O O
w/ O O
HTN O O
urgency O O
yesterday, O O
newly B-DIABETES O
diagnosed I-DIABETES O
DM I-DIABETES O
w/ O O
FS B-DIABETES O
in I-DIABETES O
300-400s I-DIABETES O
yesterday, I-DIABETES O
who O O
yesterday O O
presented O O
w/ O O
new O O
HA O O
and O O
negative O O
w/u O O
for O O
SAH, O O
now O O
back O O
again O O
for O O
same O O
HA, O O
which O O
has O O
finally O O
resolved O O
in O O
apparently O O
in O O
concert O O
w/ O O
some O O
improvement O O
in O O
BP O O
(current B-HYPERTENSION O
BP I-HYPERTENSION O
150s) I-HYPERTENSION O
and O O
w/ O O
medications. O O
Neurology O O
was O O
specifically O O
consulted O O
for O O
his O O
gait, O O
which O O
does O O
appear O O
a O O
bit O O
wide-based, O O
but O O
he O O
and O O
wife O O
confirm O O
that O O
this O O
is O O
chronic, O O
and O O
I O O
strongly O O
doubt O O
any O O
relation O O
to O O
his O O
current O O
HA O O
problems. O O
Most O O
obvious O O
medical O O
issues O O
to O O
focus O O
on O O
here O O
are O O
his O O
poorly O O
controlled O O
HTN, O O
which O O
I O O
suspect O O
is O O
the O O
primary O O
cause O O
of O O
his O O
HA, O O
and O O
his O O
uncontrolled O O
DM, O O
of O O
which O O
he O O
obviously O O
does O O
not O O
yet O O
understand O O
the O O
import O O
and O O
does O O
not O O
seem O O
likely O O
to O O
comply O O
with O O
insulin O O
treatment O O
without O O
further O O
education. O O
In O O
any O O
case, O O
I O O
find O O
no O O
acute O O
neurological O O
issues. O O
Recs: O O
-BP O O
management O O
-DM O O
management. O O
Thanks O O
for O O
this O O
interesting O O
consult. O O
Case/plan O O
discussed O O
w/ O O
KEKELA O O
neurology O O
attending O O
by O O
phone, O O
Dr. O O
Ivan O O
Guy. O O
Call O O
w/ O O
questions O O
86383. O O
Keith O O
Gilbert, O O
MD, O O
PhD, O O
Neurology O O
resident O O
PGY3 O O
Addendum: O O
He O O
did O O
not O O
mention O O
this O O
when O O
I O O
questioned O O
him O O
and O O
wife O O
about O O
PMH, O O
but O O
digging O O
through O O
prior O O
LMR O O
notes O O
I O O
find O O
this O O
addition O O
to O O
his O O
PMH: O O
A O O
note O O
from O O
Dr. O O
Robert O O
Irish, O O
neurosurgery, O O
from O O
3/2099 O O
notes O O
that O O
he O O
is O O
s/p O O
&#8220;cervical O O
laminectomy O O
and O O
foramen O O
magnum O O
resection O O
followed O O
by O O
removal O O
of O O
an O O
intramedullary O O
tumor O O
near O O
his O O
foramen O O
magnum. O O
He O O
is O O
doing O O
much O O
better O O
today. O O
He O O
states O O
that O O
his O O
headaches O O
are O O
considerably O O
better, O O
and O O
the O O
left O O
hemibody O O
dysesthesias O O
are O O
much O O
better O O
tolerated O O
since O O
the O O
initiation O O
of O O
Neurontin.&#8221; O O

Record O O
date: O O
2072-11-25 O O
RGH O O
EMERGENCY O O
DEPT O O
VISIT O O
MULLINS,DOLORES O O
U O O
728-41-92-0 O O
VISIT O O
DATE: O O
01/24/73 O O
This B-SMOKER O
patient O O
was O O
seen, O O
interviewed O O
and O O
examined O O
by O O
myself O O
as O O
well O O
as O O
Dr. O O
Hawkins O O
whose O O
note O O
I O O
reviewed O O
and O O
with O O
which O O
I O O
agree. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
is O O
a O O
70-year-old O O
female O O
who O O
presents O O
with O O
inability O O
to O O
control O O
her O O
left O O
arm O O
and O O
left O O
leg. O O
The O O
patient O O
had O O
onset O O
of O O
her O O
symptoms O O
approximately O O
two O O
hours O O
prior O O
to O O
arrival. O O
The O O
patient O O
denies O O
any O O
change O O
in O O
sensation O O
but O O
she O O
definitely O O
did O O
notice O O
weakness O O
with O O
decreased O O
ability O O
to O O
control O O
her O O
left O O
side O O
extremities. O O
The O O
patient O O
states O O
that O O
her O O
left O O
arm O O
control O O
was O O
regained O O
after O O
approximately O O
one O O
or O O
two O O
hours. O O
Her O O
left O O
leg O O
control O O
is O O
better O O
but O O
still O O
is O O
not O O
back O O
to O O
baseline. O O
Review O O
of O O
systems, O O
family O O
history O O
and O O
social O O
history O O
as O O
per O O
the O O
resident's O O
note. O O
PAST O O
MEDICAL O O
HISTORY: O O
Insulin-dependent B-DIABETES O
diabetes I-DIABETES O
mellitus, I-DIABETES O
hypertension. B-HYPERTENSION B-HYPERTENSION
MEDICATIONS: O O
Insulin, O O
Diltiazem, B-MEDICATION O
labetalol. B-MEDICATION B-MEDICATION
ALLERGIES: O O
TETANUS. O O
PHYSICAL O O
EXAMINATION: O O
This O O
is O O
a O O
well-developed, O O
well-nourished O O
female, O O
in O O
mild O O
distress, O O
appears O O
concerned. O O
Temperature O O
is O O
96.9 O O
degrees, O O
pulse O O
65, O O
respiratory O O
rate O O
of O O
18, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
163/104. I-HYPERTENSION O
Repeat B-HYPERTENSION O
blood I-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
174/80. I-HYPERTENSION O
Oxygen O O
saturation O O
is O O
97% O O
on O O
room O O
air. O O
HEENT: O O
Normocephalic, O O
atraumatic. O O
Pupils O O
are O O
equally O O
round O O
and O O
reactive O O
to O O
light O O
and O O
accommodation. O O
Extraocular O O
motions O O
are O O
intact. O O
No O O
nystagmus. O O
NECK: O O
Supple O O
with O O
full O O
range O O
of O O
motion. O O
2+ O O
carotids, O O
no O O
bruits. O O
CARDIAC: O O
Regular O O
rate O O
and O O
rhythm. O O
EXTREMITIES: O O
No O O
clubbing, O O
cyanosis O O
or O O
edema. O O
Extremities O O
are O O
nontender O O
to O O
palpation O O
throughout. O O
NEURO: O O
Alert, O O
oriented O O
x O O
3. O O
Follows O O
commands, O O
appropriate. O O
Cranial O O
nerves O O
II-XII O O
are O O
intact. O O
There O O
is O O
5/5 O O
motor O O
strength O O
in O O
individual O O
motor O O
group O O
testing O O
of O O
the O O
upper O O
extremities O O
and O O
lower O O
extremities O O
bilaterally. O O
The O O
patient O O
is O O
unable O O
to O O
stand O O
without O O
assistance. O O
Comprehension O O
is O O
within O O
normal O O
limits. O O
Further O O
details O O
of O O
the O O
physical O O
examination O O
are O O
as O O
per O O
the O O
resident's O O
note. O O
LABORATORY O O
EVALUATION: O O
Labs O O
are O O
significant O O
for O O
a O O
glucose O O
of O O
162, O O
BUN O O
of O O
20, O O
creatinine O O
1.3, O O
sodium O O
145, O O
potassium O O
4.2, O O
chloride O O
108, O O
bicarb O O
26, O O
calcium O O
9.4. O O
White O O
count O O
is O O
8.1, O O
hematocrit O O
39.0, O O
platelets O O
341. O O
A O O
UA O O
shows O O
no O O
blood, O O
no O O
leucocyte O O
esterase, O O
no O O
ketones. O O
Head O O
CT O O
shows O O
no O O
acute O O
intracranial O O
abnormality O O
and O O
mild O O
involutional O O
changes. O O
EKG O O
shows O O
a O O
sinus O O
rhythm O O
at O O
57 O O
beats O O
per O O
minute O O
with O O
non-specific O O
T O O
wave O O
changes. O O
This O O
is O O
compared O O
to O O
an O O
EKG O O
from O O
2068 O O
and O O
was O O
found O O
to O O
be O O
without O O
significant O O
change. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
was O O
seen O O
and O O
evaluated O O
in O O
the O O
Emergency O O
Department O O
with O O
labs O O
and O O
studies O O
obtained O O
as O O
documented O O
above. O O
The O O
initial O O
concerns O O
were O O
for O O
a O O
focal O O
seizure O O
versus O O
a O O
TIA. O O
The O O
patient O O
was O O
hypertensive B-HYPERTENSION O
on O O
her O O
arrival O O
and, O O
therefore, O O
received O O
labetalol O B-MEDICATION
for O O
improved O O
blood O O
pressure O O
control O O
and O O
the O O
Neurology O O
Service O O
was O O
consulted O O
early O O
in O O
the O O
patient's O O
care. O O
The O O
patient O O
does O O
not O O
have O O
any O O
evidence O O
of O O
focal O O
motor O O
group O O
weakness O O
at O O
this O O
time, O O
nor O O
sensation O O
changes. O O
The O O
patient O O
will O O
require O O
admission O O
to O O
the O O
Neurology O O
Service O O
for O O
further O O
workup O O
of O O
her O O
seizure O O
versus O O
TIA. O O
FINAL O O
DIAGNOSIS: O O
TIA. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
is O O
admitted O O
to O O
the O O
hospital O O
in O O
satisfactory O O
condition. O O
___________________________________ O O
OH527/2519 O O
YULIANNA O O
ELKINS, O O
M.D. O O
YE96 O O
D:01/24/73 O O
T:01/24/73 O O
Dictated O O
by: O O
YULIANNA O O
ELKINS, O O
M.D. O O
YE96 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2079-09-01 O O
Rheumatology O O
Consult O O
Note O O
Name: O O
Mullins, O O
Dolores O O
U O O
MRN: O O
72841920 O O
DOB: O O
06/06/02 O O
Location: O O
78Q-47-4 O O
Consult O O
date: O O
09/01/79 O O
Referring O O
Physician: O O
Gay O O
Langley O O
Source O O
of O O
history: O O
patient O O
interview, O O
medical O O
records O O
Code O O
status: O O
Full O O
Reason O O
for O O
Consult: O O
bilateral O O
LE O O
pain O O
up O O
to O O
knees O O
HPI: O O
77 O O
yo O O
F O O
w/h/o O O
type B-DIABETES O
I I-DIABETES O
DM B-DIABETES O
and O O
HTN. B-HYPERTENSION O
At O O
the O O
beginning O O
of O O
this O O
year, O O
she O O
began O O
to O O
have O O
intermittent O O
burning O O
pain O O
of O O
her O O
feet O O
and O O
sometimes O O
her O O
lower O O
legs/feet. O O
This O O
pain O O
typically O O
occurred O O
on O O
one O O
leg O O
more O O
than O O
the O O
other, O O
without O O
an O O
overall O O
predominance O O
of O O
one O O
side. O O
In O O
the O O
past O O
month, O O
she O O
has O O
had O O
continuous, O O
bilateral O O
burning O O
pain O O
that O O
began O O
in O O
both O O
feet. O O
Several O O
weeks O O
ago, O O
her O O
pain O O
worsened O O
considerably O O
such O O
that O O
she O O
was O O
having O O
difficulty O O
shopping. O O
Around O O
this O O
time, O O
the O O
pain O O
spread O O
up O O
her O O
legs O O
to O O
above O O
her O O
knees. O O
She O O
also O O
noted O O
having O O
difficulty O O
putting O O
on O O
shoes O O
and O O
was O O
told O O
by O O
a O O
friend O O
that O O
her O O
feet O O
were O O
swollen O O
(she O O
is O O
unable O O
to O O
see O O
her O O
feet O O
due O O
to O O
blindness). O O
Her O O
pain O O
continued O O
to O O
worsen O O
until O O
the O O
night O O
prior O O
to O O
admission, O O
when O O
she O O
was O O
in O O
her O O
bathroom O O
and O O
found O O
herself O O
in O O
such O O
pain O O
that O O
she O O
was O O
unable O O
to O O
get O O
up O O
to O O
leave O O
the O O
bathroom. O O
A O O
friend O O
found O O
her O O
after O O
8 O O
hours O O
and O O
EMS O O
was O O
called. O O
In O O
the O O
ED, O O
she O O
was O O
found O O
to O O
have O O
BP B-HYPERTENSION O
elevated I-HYPERTENSION O
to I-HYPERTENSION O
190, I-HYPERTENSION O
Cr O O
elevated O O
to O O
2.8, O O
FSG O O
down O O
to O O
51, O O
and O O
R-sided O O
hydronephrosis. O O
Labetolol/diltiazem B-MEDICATION B-MEDICATION
were O O
given O O
for O O
HTN O O
with O O
good O O
response, O O
IV O O
hydration O O
was O O
given O O
with O O
subsequent O O
decline O O
in O O
Cr, O O
and O O
Foley O O
was O O
placed O O
with O O
resolution O O
of O O
hydronephrosis O O
on O O
subsequent O O
MRI. O O
She O O
has O O
never O O
had O O
burning O O
pain O O
of O O
the O O
kind O O
that O O
she O O
presented O O
with O O
prior O O
to O O
this O O
year. O O
Of O O
note, O O
she O O
has O O
had O O
years O O
of O O
tingling O O
without O O
numbness O O
in O O
her O O
lower O O
extremities O O
bilaterally O O
extending O O
to O O
above O O
her O O
knees. O O
She O O
also O O
notes O O
numbness O O
of O O
the O O
tips O O
of O O
her O O
R O O
2nd-4th O O
digits. O O
ROS O O
positive O O
for O O
subjective O O
decline O O
in O O
urine O O
output O O
and O O
constipation O O
(1 O O
BM/2days). O O
She O O
denies O O
fever/chills/sweats, O O
recent O O
weight O O
loss, O O
fatigue, O O
hypoglycemic O O
episodes, O O
cough/rhinorrhea/sore O O
throat, O O
SOB, O O
orthpnea, O O
CP, O O
palpitations, O O
abdominal O O
pain, O O
diarrhea, O O
dysuria, O O
polyuria/polydipsia. O O
PMH: O O
1) O O
DM B-DIABETES O
type I-DIABETES O
1, I-DIABETES O
since O O
2060, O O
c/b O O
retinopathy, O O
nephropathy O O
2) O O
HTN O O
3) O O
Hypercholesterolemia B-HYPERLIPIDEMIA O
4) O O
L O O
internal O O
capsule O O
CVA O O
11/72 O O
5) O O
L O O
eye O O
legally O O
blind O O
2/2 O O
open O O
angle O O
glaucoma O O
6) O O
thyroid O O
nodule O O
7/78 O O
benign O O
per O O
patient O O
7) O O
CRI O O
per O O
HHMR, O O
Cr O O
1.4 O O
(4/78, O O
1/79) O O
and O O
1.84 O O
on O O
6/29/79 O O
PSH: O O
1) O O
bilateral O O
cataracts O O
2) O O
L O O
eye O O
glaucoma O O
surgery O O
3) O O
L O O
eye O O
pressure O O
shunt O O
4) O O
TAH O O
at O O
age O O
25 O O
Admission O O
Meds: O O
1) O O
Labetalol B-MEDICATION B-MEDICATION
200 O O
mg O O
bid O O
2) O O
HCTZ B-MEDICATION O
25 O O
mg O O
qd O O
3) O O
Lovastatin B-MEDICATION B-MEDICATION
20 O O
mg O O
qd O O
4) O O
Enalapril B-MEDICATION O
20 O O
mg O O
qd O O
5) O O
Diltiazem B-MEDICATION O
120 O O
mg O O
bid O O
6) O O
ASA B-MEDICATION B-MEDICATION
81 O O
mg O O
qd O O
7) O O
Novolin B-MEDICATION B-MEDICATION
10 O O
U O O
qam O O
8) O O
NPH B-MEDICATION O
70 O O
U O O
qam, O O
40 O O
U O O
qpm O O
Inpatient O O
Meds: O O
1) O O
Ferrous O O
sulphate O O
325 O O
po O O
tid O O
2) O O
Enoxaparin O O
30 O O
sc O O
qd O O
3) O O
Simvastatin B-MEDICATION B-MEDICATION
40 O O
po O O
qhs O O
4) O O
Diltiazem O O
SR O O
120 O O
po O O
bid O O
5) O O
Labetolol O B-MEDICATION
200 O O
mg O O
bid O O
6) O O
Novolog B-MEDICATION B-MEDICATION
SS O O
ac, O O
RISS O O
qhs O O
7) O O
NPH O B-MEDICATION
70 O O
U O O
qam, O O
30 O O
U O O
qpm O O
8) O O
Regular B-MEDICATION O
Insulin I-MEDICATION O
10 O O
U O O
qam O O
9) O O
Colchicine O O
0.6 O O
mg O O
qd O O
(2 O O
doses O O
given) O O
10) O O
Lumigan O O
ou O O
1 O O
drop O O
qd O O
11) O O
Prednisolone O O
1% O O
1 O O
drop O O
au O O
bid O O
12) O O
Colace O O
100 O O
mg O O
po O O
bid O O
13) O O
ASA O B-MEDICATION
81 O O
mg O O
po O O
qd O O
14) O O
Oxycodone O O
10 O O
mg O O
po O O
q6h O O
prn O O
Gabapentin O O
100 O O
mg O O
tid O O
5 O O
doses O O
given O O
before O O
being O O
discontinued O O
Allergies: O O
NKDA O O
SH: O O
Never B-SMOKER O
smoked, I-SMOKER O
does O O
not O O
currently O O
drink O O
ETOH, O O
no O O
h/o O O
substance O O
abuse, O O
lives O O
on O O
the O O
2nd O O
floor O O
of O O
an O O
apartment O O
(15 O O
steps) O O
and O O
has O O
neighbors O O
who O O
check O O
in O O
on O O
her. O O
She O O
is O O
widowed O O
with O O
closest O O
family O O
being O O
a O O
cousin O O
in O O
Alaska. O O
She O O
has O O
been O O
able O O
to O O
meet O O
her O O
needs O O
of O O
daily O O
living O O
independently. O O
FH: O O
Mother O O
with O O
fatal O O
MI O O
at O O
65, O O
no O O
family O O
h/o O O
rheumatic O O
disease O O
or O O
cancer. O O
PE: O O
Tm O O
99.5, O O
Tc O O
97.3, O O
HR O O
51 O O
(46-72), O O
BP B-HYPERTENSION O
126/50 I-HYPERTENSION O
(120-154/50-70), B-HYPERTENSION O
RR O O
18 O O
(16-18), O O
O2 O O
sat O O
96% O O
(94-98) O O
RA O O
Gen O O
NAD O O
when O O
immobile, O O
but O O
great O O
pain O O
with O O
minimal O O
movement O O
or O O
contact O O
with O O
lower O O
extremities O O
HEENT O O
2 O O
mm O O
pupils, O O
EOM O O
intact, O O
no O O
scleral O O
icterus, O O
oropharnyx O O
nl, O O
no O O
gouty O O
tophi O O
on O O
pinna O O
Neck O O
Supple, O O
no O O
lymphadenopathy, O O
no O O
JVD O O
CV O O
RRR, O O
nl O O
S1 O O
S2, O O
2/6 O O
SEM O O
best O O
heard O O
in O O
RUSB O O
Chest O O
Late O O
inspiratory O O
crackles O O
at O O
bases O O
bilaterally O O
Abd O O
+BS, O O
soft, O O
NT, O O
ND, O O
liver O O
edge O O
above O O
chostochondral O O
margin, O O
no O O
palpable O O
splenomegaly, O O
no O O
masses O O
Back O O
R O O
CVA O O
and O O
flank O O
tenderness O O
MSK O O
Heberdin O O
and O O
Bouchard O O
s O O
nodes O O
of O O
PIPs/DIPs O O
bilaterally, O O
varus O O
deformity O O
of O O
R O O
2nd-4th O O
DIPs, O O
no O O
joint O O
tenderness O O
or O O
reduced O O
ROM O O
of O O
upper O O
extremities; O O
visible O O
knee O O
effusions O O
bilaterally O O
without O O
erythema O O
or O O
warmth; O O
exquisite O O
tenderness O O
to O O
minimal O O
motion O O
or O O
palpation O O
of O O
knees, O O
tibio-talars, O O
tarsals, O O
and O O
MTPs; O O
no O O
effusions O O
palpable O O
or O O
visible O O
in O O
tibio-talars, O O
tarsals, O O
and O O
MTPs O O
Ext O O
WWP, O O
1+ O O
pedal O O
edema O O
bilaterally O O
Pulses O O
2+ O O
DP O O
bilaterally O O
Skin O O
no O O
rashes, O O
dry O O
skin O O
covering O O
LEs O O
greatest O O
on O O
medial O O
aspect O O
Neuro O O
no O O
focal O O
upper O O
extremity O O
motor O O
deficits, O O
5/5 O O
finger O O
grip O O
Labs: O O
Na O O
139, O O
K O O
4.2, O O
Cl O O
106, O O
CO2 O O
23, O O
BUN O O
61, O O
Cr O O
1.79 O O
(1.69 O O
yesterday), O O
Glu O O
141, O O
Ca O O
8.9, O O
P O O
3.8, O O
Mg O O
2.1 O O
TP O O
6.9, O O
Alb O O
3.0, O O
Glob O O
3.9 O O
ALT O O
14, O O
AST O O
12, O O
ALKP O O
76, O O
TBILI O O
0.4 O O
FE O O
12, O O
TIBC O O
205, O O
B12 O O
303, O O
Folate O O
12.7 O O
HGBA1C O O
6.1 O O
Uric O O
acid O O
11.5 O O
ESR O O
101, O O
CRP O O
141.6 O O
WBC O O
12.51 O O
(N76 O O
L14 O O
M8 O O
E2), O O
Hct O O
28.8, O O
Plt O O
398 O O
Beta-hydroxybutyrate O O
0.41 O O
UA O O
sg O O
1.018, O O
pH O O
5.0, O O
protein O O
2+, O O
6 O O
WBCs/hpf, O O
2+ O O
bacteria, O O
1+ O O
squames, O O
no O O
urine O O
crystals O O
Studies: O O
TTE O O
(8/31/79, O O
no O O
prior O O
studies) O O
Mild O O
concentric O O
LVH, O O
LVEF O O
77%, O O
impaired O O
relaxation O O
c/w O O
diastolic O O
dysfunction, O O
mild O O
left O O
atrial O O
enlargement, O O
nl O O
right O O
atrium O O
and O O
ventricle, O O
mild O O
aortic O O
stenosis, O O
mild O O
mitral O O
regurgitation, O O
estimated O O
PASP O O
48.6, O O
nl O O
aortic O O
root, O O
no O O
pericardial O O
effusions O O
LE O O
Doppler O O
(8/31/79) O O
No O O
evidence O O
of O O
proximal O O
DVTs O O
or O O
calf O O
DVTs O O
bilaterally O O
Abdominal O O
MRI O O
(8/31/79) O O
Tiny O O
cortical O O
right O O
renal O O
hemorrhagic O O
cysts, O O
small O O
hiatal O O
hernia, O O
right O O
extrarenal O O
pelvis O O
without O O
hydronephrosis O O
or O O
obstructing O O
mass O O
lesion O O
Renal O O
U/S O O
(8/30/79) O O
Mild O O
right O O
hydronephrosis O O
with O O
prominent O O
extrarenal O O
pelvis O O
and O O
multiple O O
renal O O
cysts, O O
nl O O
left O O
kidney O O
CXR O O
(8/29/79) O O
No O O
evidence O O
of O O
pulmonary O O
edema, O O
PNX, O O
or O O
pleural O O
effusion; O O
aorta O O
tortuous O O
and O O
partially O O
calcified; O O
degenerative O O
changes O O
of O O
thoracic O O
spine O O
and O O
left O O
shoulder, O O
cardiac O O
silhouette O O
prominent O O
but O O
wnl O O
Microbiology: O O
Blood O O
cultures O O
x2 O O
Negative O O
at O O
2 O O
days O O
Urine O O
cultures O O
x2 O O
5000 O O
colonies O O
mixed, O O
500 O O
colonies O O
probable O O
lactobacilli O O
A/P: O O
77 O O
yo O O
F O O
w/h/o O O
DM O O
and O O
HTN O O
who O O
presented O O
with O O
several O O
weeks O O
of O O
worsening O O
bilateral O O
LE O O
burning O O
pain O O
exacerbated O O
by O O
movement O O
and O O
pressure. O O
She O O
was O O
found O O
to O O
have O O
exquisitely O O
tender O O
joints O O
up O O
to O O
and O O
including O O
her O O
knees O O
with O O
visible O O
synovial O O
effusions O O
of O O
her O O
knees O O
bilaterally. O O
Aspiration O O
of O O
one O O
of O O
her O O
knees O O
revealed O O
needle-shaped O O
negatively O O
birefringent O O
crystals, O O
diagnostic O O
of O O
gout. O O
This O O
is O O
consistent O O
with O O
her O O
elevated O O
uric O O
acid O O
and O O
her O O
elevated O O
markers O O
of O O
inflammation O O
(ESR/CRP). O O
Given O O
that O O
she O O
has O O
a O O
long O O
history O O
of O O
symptoms O O
of O O
LE O O
diabetic O O
neuropathy O O
and O O
that O O
she O O
has O O
some O O
diffuse O O
soft O O
tissue O O
tenderness, O O
she O O
may O O
also O O
have O O
some O O
pain O O
from O O
diabetic O O
neuropathy O O
that O O
may O O
declare O O
itself O O
after O O
her O O
gout O O
is O O
treated. O O
However, O O
her O O
current O O
inability O O
to O O
walk O O
can O O
be O O
clearly O O
attributed O O
to O O
gout. O O
Recs: O O
- O O
Solumedrol O O
40 O O
mg O O
bid O O
IV, O O
prednisone O O
40 O O
mg O O
qd O O
starting O O
tomorrow O O
with O O
12-day O O
outpatient O O
taper O O
(40 O O
mg O O
x O O
3 O O
days, O O
30 O O
mg O O
x O O
3 O O
days, O O
20 O O
mg O O
x O O
3 O O
days, O O
10 O O
mg O O
x O O
3 O O
days) O O
- O O
Colchicine O O
po O O
0.6 O O
mg O O
qd O O
for O O
2 O O
weeks, O O
then O O
0.6 O O
mg O O
qod O O
for O O
2 O O
weeks O O
- O O
Continue O O
to O O
hold O O
HCTZ O O
discuss O O
with O O
PCP O O
need O O
to O O
restart O O
as O O
outpatient O O
as O O
it O O
is O O
a O O
risk O O
factor O O
for O O
hyperuricemia O O
- O O
F/u O O
with O O
rheumatology O O
in O O
4 O O
weeks O O
for O O
initiation O O
of O O
allopurinol O O
(please O O
arrange O O
appointment O O
w/ O O
Dr. O O
Yau) O O
Procedure: O O
R O O
knee O O
aspiration O O
Patient O O
was O O
informed O O
of O O
the O O
risks O O
of O O
bleeding O O
and O O
infection O O
and O O
gave O O
consent. O O
The O O
medial O O
aspect O O
of O O
the O O
right O O
knee O O
was O O
sterilized O O
using O O
iodine O O
swabs O O
x3, O O
sterile O O
gloves O O
used O O
in O O
a O O
one-handed O O
sterile O O
lateral O O
approach. O O
1.5cc O O
of O O
1% O O
lidocaine O O
was O O
injected O O
to O O
raise O O
a O O
wheal O O
inferior O O
to O O
the O O
R O O
patella. O O
A O O
18G O O
needle O O
was O O
inserted O O
into O O
the O O
knee O O
and O O
approximately O O
20cc O O
of O O
opaque, O O
yellow O O
fluid O O
was O O
withdrawn. O O
A O O
slide O O
was O O
prepared O O
and O O
examined O O
under O O
the O O
microscope O O
by O O
myself, O O
Dr. O O
Yau, O O
and O O
Dr. O O
Woodard. O O
Abundant O O
intracellular O O
and O O
extracellular O O
needle-shapped O O
negatively O O
birefringent O O
crystals O O
were O O
observed. O O
Synovial O O
fluid O O
sample O O
was O O
also O O
submitted O O
for O O
culture, O O
Gram O O
stain, O O
cell O O
count, O O
and O O
crystal O O
analysis. O O
__________________________________ O O
Isaac O O
Ito, O O
MS4 O O
x79975 O O
Addendum: O O
Patient O O
seen, O O
records O O
reviewed, O O
case O O
reviewed O O
with O O
medical O O
student. O O
Agree O O
with O O
excellent O O
note O O
above. O O
Patient O O
seen O O
with O O
Dr. O O
Woodard. O O
______________________ O O
Unknown O O
Yau, O O
MD O O
Rheumatology O O
fellow O O

Record O O
date: O O
2080-06-04 O O
EDVISIT^72841920^MULLINS, O O
DOLORES^06/04/80^KROLL, O O
OLIVIA O O
The O O
patient O O
was O O
seen O O
in O O
conjunction O O
with O O
the O O
PA. O O
This O O
is O O
a O O
shared O O
visit. O O
I O O
confirm O O
I O O
have O O
interviewed O O
and O O
examined O O
the O O
patient. O O
CHIEF O O
COMPLAINT: O O
Rule O O
out O O
CVA. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Briefly, O O
this O O
is O O
a O O
70-year-old O O
female O O
with O O
hypertension, B-HYPERTENSION B-HYPERTENSION
hypercholesteremia, B-HYPERLIPIDEMIA O
and O O
diabetes B-DIABETES O
who O O
was O O
found O O
by O O
a O O
neighbor O O
at O O
approximately O O
9:30 O O
this O O
morning, O O
nonverbal O O
with O O
right-sided O O
facial O O
droop. O O
The O O
patient O O
was O O
seated O O
in O O
the O O
chair O O
upon O O
EMS O O
arrival. O O
Per O O
the O O
neighbor O O
who O O
had O O
returned O O
from O O
vacation, O O
went O O
up O O
to O O
check O O
on O O
her O O
and O O
found O O
her O O
this O O
way, O O
nonverbal, O O
seated O O
in O O
a O O
chair, O O
but O O
consciousness. O O
Per O O
EMS, O O
the O O
patient O O
was O O
responding O O
to O O
commands, O O
able O O
to O O
stand, O O
had O O
symmetric O O
handgrips, O O
unknown O O
when O O
she O O
was O O
last O O
seen O O
normal. O O
Per O O
the O O
neighbor, O O
the O O
patient's O O
baseline O O
is O O
alert O O
and O O
oriented. O O
Fingerstick O O
in O O
the O O
field O O
was O O
179. O O
PAST O O
MEDICAL O O
HISTORY: O O
As O O
stated O O
per O O
HPI O O
and O O
written O O
chart. O O
SOCIAL O O
HISTORY: O O
Unknown. B-SMOKER O
FAMILY O O
HISTORY: O O
Unknown. O O
REVIEW O O
OF O O
SYSTEMS: O O
Limited O O
secondary O O
to O O
the O O
patient's O O
medical O O
condition O O
and O O
severity. O O
MEDICATIONS: O O
Per O O
medication O O
list. O O
ALLERGIES: O O
Tetanus O O
per O O
old O O
medical O O
records. O O
PHYSICAL O O
EXAMINATION: O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
216/76, B-HYPERTENSION O
pulse O O
is O O
68, O O
and O O
O2 O O
saturation O O
99%. O O
HEENT: O O
Atraumatic O O
with O O
left O O
pupil O O
defect. O O
Lungs: O O
Equal O O
and O O
bilateral. O O
Cardiovascular: O O
S1 O O
and O O
S2. O O
Abdomen: O O
Soft O O
and O O
nontender. O O
Skin: O O
Intact, O O
warm, O O
and O O
dry. O O
Neurologic: O O
Right-sided O O
facial O O
droop, O O
bilateral O O
hand O O
grip. O O
Normal O O
plantar O O
flexion O O
able O O
to O O
sit O O
up, O O
and O O
following O O
commands. O O
IMAGING O O
STUDIED: O O
EKG O O
normal O O
sinus, O O
no O O
acute O O
ST O O
segment O O
elevation. O O
LABORATORY O O
DATA: O O
Chemistries O O
are O O
remarkable O O
for O O
creatinine O O
of O O
2.8, O O
sodium O O
and O O
chloride O O
pending. O O
Bicarbonate O O
of O O
22. O O
CK O O
256 O O
with O O
a O O
MB O O
of O O
4, O O
troponin O O
negative. O O
No O O
white O O
count, O O
hematocrit O O
of O O
34, O O
and O O
platelets O O
of O O
410,000. O O
INR O O
1.1. O O
UA O O
showed O O
3+ O O
protein, O O
no O O
leukocyte O O
esterase, O O
nitrites. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
Upon O O
the O O
patient's O O
arrival O O
in O O
Emergency O O
Department, O O
Stroke O O
team O O
was O O
paged, O O
underwent O O
a O O
stat O O
head O O
CT, O O
which O O
showed O O
no O O
bleed, O O
but O O
a O O
question O O
of O O
a O O
hypodensity. O O
The O O
patient O O
sent O O
her O O
for O O
an O O
urgent O O
MRI/MRA O O
and O O
will O O
be O O
admitted O O
to O O
the O O
Neurology O O
Service. O O
PRIMARY O O
DIAGNOSIS: O O
CVA. O O
SECONDARY O O
DIAGNOSES: O O
Diabetes B-DIABETES O
and O O
hypertension. O O
DISPOSITION: O O
Plan O O
for O O
admission O O
to O O
Neurology O O
Service. O O
Please O O
see O O
written O O
chart O O
and O O
nurse's O O
note. O O
Old O O
HHMR O O
records O O
reviewed. O O
______________________________ O O
KROLL, O O
OLIVIA O O
M.D. O O
D: O O
06/04/80 O O
T: O O
06/04/80 O O
Dictated O O
By: O O
KROLL, O O
OLIVIA O O
eScription O O
document:7-1892564 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2080-07-19 O O
EDVISIT^72841920^MULLINS, O O
DOLORES^07/19/80^TAVARES, O O
IDRIS O O
I O O
saw O O
this O O
patient O O
with O O
Dr. O O
Xavier O O
Palacios. O O
I O O
confirm O O
that O O
I O O
have O O
interviewed O O
and O O
examined O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation O O
on O O
the O O
patient's O O
chart, O O
and O O
discussed O O
the O O
evaluation, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient. O O
Please O O
see O O
the O O
resident's O O
note O O
for O O
further O O
details. O O
CHIEF O O
COMPLAINT: O O
Fast O O
heart O O
rate. O O
HISTORY B-SMOKER O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
78-year-old O O
female O O
with O O
history O O
of O O
a O O
left O O
MCA O O
stroke, O O
atrial O O
fibrillation, O O
hypertension, B-HYPERTENSION O
diabetes, B-DIABETES O
and O O
renal O O
insufficiency O O
who O O
was O O
transferred O O
from O O
Southwest O O
Montana O O
Radiology O O
for O O
atrial O O
fibrillation O O
with O O
rapid O O
ventricular O O
response. O O
The O O
patient O O
has O O
been O O
in O O
Southwest O O
Montana O O
for O O
the O O
last O O
several O O
weeks. O O
During O O
her O O
rehabilitation O O
stay, O O
the O O
patient O O
was O O
noted O O
to O O
have O O
sinus O O
bradycardia O O
and O O
sinus O O
pauses. O O
The O O
patient's O O
metoprolol B-MEDICATION B-MEDICATION
was O O
stopped. O O
The O O
patient O O
was O O
previously O O
on O O
metoprolol O B-MEDICATION
6.25 O O
mg O O
every O O
6 O O
hours. O O
The O O
patient O O
was O O
noted O O
to O O
have O O
atrial O O
fibrillation O O
with O O
rapid O O
ventricular O O
response O O
on O O
exam O O
this O O
morning. O O
The O O
patient O O
is O O
followed O O
by O O
Dr. O O
Octavia O O
Xue O O
of O O
Heritage O O
Hospital O O
Cardiology. O O
Given O O
the O O
difficulty O O
that O O
Southwest O O
Montana O O
has O O
had O O
____ O O
the O O
patient's O O
atrial O O
fibrillation, O O
the O O
patient O O
was O O
transferred O O
here O O
to O O
Riverton O O
General O O
Hospital O O
for O O
further O O
management O O
and O O
further O O
placement. O O
The O O
patient O O
is O O
asymptomatic. O O
The O O
patient O O
denies O O
any O O
chest O O
pain O O
or O O
shortness O O
of O O
breath. O O
The O O
patient O O
denies O O
any O O
lightheadedness. O O
The O O
patient O O
has O O
no O O
other O O
complaints. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient's O O
vital O O
signs O O
revealed O O
the O O
following: O O
Temperature O O
is O O
96.4, O O
heart O O
rate O O
of O O
79, O O
respiratory O O
rate O O
of O O
18, O O
blood O O
pressure O O
is O O
112/63, O O
and O O
oxygen O O
saturations O O
at O O
100% O O
on O O
room O O
air. O O
The O O
patient's O O
oxygen O O
saturation O O
was O O
interpreted O O
as O O
normal. O O
General: O O
No O O
acute O O
distress, O O
pleasant, O O
and O O
multiple O O
family O O
members O O
at O O
bedside. O O
HEENT: O O
The O O
patient's O O
head O O
was O O
normocephalic. O O
Mucous O O
membranes O O
were O O
dry. O O
Posterior O O
oropharynx O O
was O O
clear. O O
Neck: O O
Supple. O O
No O O
carotid O O
bruits. O O
No O O
JVD. O O
Respiratory: O O
Clear O O
to O O
auscultation O O
bilaterally. O O
No O O
focal O O
rhonchi, O O
rales, O O
or O O
wheezes. O O
Cardiovascular: O O
Irregularly O O
irregular, O O
tachycardic. O O
No O O
gross O O
murmurs, O O
rubs, O O
or O O
gallops O O
were O O
appreciated. O O
GI: O O
Abdomen: O O
Soft. O O
No O O
rebound O O
or O O
guarding. O O
Minimal O O
suprapubic O O
tenderness O O
to O O
palpation. O O
G-tube O O
in O O
place. O O
Rectal O O
exam: O O
Deferred. O O
GU O O
exam: O O
Deferred. O O
Skin: O O
Warm O O
and O O
dry. O O
No O O
rash O O
or O O
lesions O O
were O O
noted. O O
Back: O O
No O O
costovertebral O O
angle O O
tenderness. O O
Extremities: O O
Warm O O
and O O
well O O
perfused. O O
Lower O O
extremity O O
pitting O O
edema O O
rising O O
up O O
to O O
the O O
knees. O O
No O O
palpable O O
cords. O O
Neurologic: O O
The O O
patient O O
was O O
alert O O
and O O
oriented. O O
The O O
patient O O
moved O O
all O O
4 O O
extremities O O
with O O
fair O O
strength. O O
The O O
patient O O
did O O
have O O
a O O
right O O
facial O O
droop. O O
I O O
did O O
not O O
ambulate O O
the O O
patient. O O
INITIAL O O
IMPRESSION O O
AND O O
PLAN: O O
The O O
patient O O
is O O
a O O
78-year-old O O
female O O
with O O
history O O
of O O
atrial O O
fibrillation, O O
and O O
recent O O
left O O
MCA O O
stroke O O
who O O
was O O
transferred O O
from O O
Southwest O O
Montana O O
for O O
management O O
of O O
her O O
atrial O O
fibrillation O O
with O O
rapid O O
ventricular O O
response. O O
The O O
patient O O
is O O
hemodynamically O O
stable O O
at O O
this O O
time. O O
The O O
patient O O
is O O
asymptomatic. O O
The O O
patient O O
will O O
need O O
rate O O
control O O
and O O
will O O
need O O
to O O
be O O
admitted O O
to O O
Heritage O O
Hospital O O
Cardiology. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
Upon O O
arrival O O
to O O
the O O
Emergency O O
Department, O O
the O O
patient O O
had O O
history O O
and O O
physical O O
exam O O
performed. O O
The O O
patient O O
then O O
had O O
12-lead O O
EKG O O
performed. O O
The O O
patient's O O
12-lead O O
EKG O O
was O O
notable O O
for O O
atrial O O
fibrillation O O
with O O
rapid O O
ventricular O O
response. O O
The O O
patient O O
did O O
have O O
some O O
nonspecific O O
ST-T O O
changes O O
when O O
compared O O
to O O
her O O
prior O O
EKG. O O
The O O
patient's O O
laboratory O O
studies O O
so O O
far O O
has O O
been O O
largely O O
unremarkable. O O
The O O
patient's O O
first O O
set O O
of O O
cardiac O O
markers O O
were O O
negative. O O
The O O
patient's O O
complete O O
blood O O
count O O
was O O
notable O O
for O O
an O O
elevated O O
white O O
blood O O
cell O O
count O O
of O O
10.8. O O
The O O
patient's O O
hematocrit O O
of O O
33.2. O O
The O O
patient's O O
platelets O O
were O O
somewhat O O
elevated O O
at O O
560,000. O O
The O O
patient's O O
portable O O
chest O O
x-ray O O
has O O
been O O
ordered O O
and O O
results O O
of O O
the O O
patient's O O
portable O O
chest O O
x-ray O O
are O O
still O O
pending O O
at O O
this O O
time. O O
The O O
case O O
was O O
then O O
discussed O O
with O O
the O O
Heritage O O
Hospital O O
cardiologist O O
on O O
call. O O
The O O
patient O O
____ O O
will O O
be O O
admitted O O
to O O
Heritage O O
Hospital O O
Cardiology O O
and O O
to O O
a O O
monitor O O
bed. O O
I O O
did O O
try O O
to O O
page O O
Dr. O O
Octavia O O
Xue O O
to O O
let O O
her O O
know O O
about O O
the O O
patient's O O
admission O O
to O O
Heritage O O
Hospital O O
Cardiology. O O
The O O
patient O O
and O O
patient's O O
family O O
were O O
in O O
agreement O O
with O O
the O O
plan. O O
The O O
patient O O
was O O
started O O
on O O
metoprolol O B-MEDICATION
down O O
her O O
G-tube. O O
The O O
patient O O
had O O
a O O
good O O
response O O
to O O
the O O
metoprolol. O B-MEDICATION
The O O
patient O O
was O O
given O O
metoprolol O B-MEDICATION
6.25 O O
mg. O O
PRIMARY O O
DIAGNOSES: O O
1. O O
Atrial O O
fibrillation O O
with O O
rapid O O
ventricular O O
response. O O
2. O O
History O O
of O O
a O O
left O O
MCA O O
stroke. O O
DISPOSITION: O O
The O O
patient O O
was O O
admitted O O
to O O
Heritage O O
Hospital O O
Cardiology. O O
CONDITION O O
AT O O
TIME O O
OF O O
DISPOSITION: O O
Stable O O
and O O
satisfactory. O O
______________________________ O O
TAVARES, O O
IDRIS O O
M.D. O O
D: O O
07/19/80 O O
T: O O
07/19/80 O O
Dictated O O
By: O O
TAVARES, O O
IDRIS O O
eScription O O
document:4-5337537 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2085-11-28 O O
CC: O O
Pt O O
presents O O
to O O
walk-in O O
clinic, O O
wants O O
to O O
establish O O
care O O
w/ O O
me. O O
HPI: O O
73 O O
y.o. O O
man, O O
here O O
w/ O O
his O O
son, O O
wants O O
to O O
establish O O
care O O
w/ O O
me. O O
He O O
needs O O
medication O O
refills O O
today. O O
Prior O O
MD O O
was O O
Dr. O O
Valerio O O
on O O
the O O
Weedsport. O O
He O O
has O O
DM, B-DIABETES O
HTN, B-HYPERTENSION O
glaucoma, O O
is O O
legally O O
blind. O O
He O O
feels O O
well O O
today, O O
has O O
no O O
complaints O O
presently. O O
Problems B-SMOKER O
Diabetes B-DIABETES B-MEDICATION
mellitus I-DIABETES O
Hypertension B-HYPERTENSION B-HYPERTENSION
Glaucoma O O
Visual O O
impairment O O
: O O
pt O O
legally O O
blind O O
Medications O O
DIPYRIDAMOLE O O
75MG, O O
2 O O
Tablet(s) O O
PO O O
TID O O
Enalapril B-MEDICATION O
Maleate I-MEDICATION O
20MG, I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Metoprolol B-MEDICATION B-MEDICATION
Tartrate I-MEDICATION O
50MG, I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
TRAZODONE O O
50MG, O O
1 O O
Tablet(s) O O
PO O O
QHS O O
PRN O O
insomnia O O
Insulin B-MEDICATION O
70/30 I-MEDICATION O
Human I-MEDICATION O
30 O O
UNITS O O
SC O O
BID O O
: O O
30U O O
qAM, O O
30U O O
qPM O O
Allergies O O
NKDA O O
PE: O O
156/80 B-HYPERTENSION O
72 O O
Gen: O O
overweight, O O
elderly O O
man, O O
NAD O O
HEENT: O O
PERRL, O O
EOM O O
intact; O O
oral O O
mucosa O O
moist, O O
no O O
lesions O O
Neck: O O
supple, O O
no O O
LAN O O
Lungs: O O
clear O O
to O O
auscultation O O
bilaterally O O
CV: O O
RRR, O O
nl O O
S1, O O
S2, O O
no O O
M/R/G O O
Extrem: O O
no O O
clubbing, O O
cyanosis O O
or O O
edema O O
A/P: O O
73 O O
y.o. O O
man O O
w/ O O
DM, O O
HTN, O O
claucoma, O O
legally O O
blind, O O
here O O
to O O
establish O O
care. O O
Will O O
refill O O
pt's O O
meds; O O
he O O
should O O
make O O
appt O O
w/ O O
me O O
in O O
one O O
month O O
for O O
CPE; O O
he O O
will O O
obtain O O
his O O
medical O O
records O O
prior O O
to O O
next O O
visit. O O

Record O O
date: O O
2086-01-17 O O
Xavier O O
Oshea O O
MGH O O
#581 O O
77 O O
50 O O
1/17/86 O O
Referred O O
for O O
urologic O O
consultation O O
by O O
:Veronica O O
Frey, O O
MD O O
Reason O O
for O O
consultation:Voiding O O
dysfunction O O
Chief O O
Complaint O O
of:Problem O O
urinatingHistory O O
of O O
Present O O
Illness O O
Pt O O
iss/p O O
TURP O O
in O O
2082 O O
in O O
NY. O O
for O O
BPH. O O
He O O
was O O
on O O
Flomax O O
but O O
stopped O O
because O O
he O O
felt O O
it O O
was O O
not O O
helping O O
his O O
nocturia O O
3-4x. O O
He O O
says O O
he O O
had O O
2 O O
prostate O O
bx's O O
in O O
NY O O
that O O
were O O
negative. O O
His O O
PSA O O
in O O
past O O
has O O
been O O
in O O
range O O
of O O
5.2-6.5. O O
He O O
has O O
sent O O
some O O
Urology O O
notes O O
from O O
previous O O
providers O O
but O O
these O O
are O O
not O O
here O O
today.No O O
frequency, O O
hesitancy O O
or O O
urgency O O
or O O
gross O O
hematuria. O O
Past O O
Medical O O
History: O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Hypertension B-HYPERTENSION B-HYPERTENSION
Glaucoma O O
Visual O O
impairment O O
: O O
pt O O
legally O O
blind O O
Past O O
Surgical O O
History: O O
Medications: O O
DIPYRIDAMOLE O O
75MG, O O
2 O O
Tablet(s) O O
PO O O
TID O O
Enalapril B-MEDICATION O
Maleate I-MEDICATION O
20MG, I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Metoprolol B-MEDICATION B-MEDICATION
Tartrate I-MEDICATION O
50MG, I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
TRAZODONE O O
50MG, O O
1 O O
Tablet(s) O O
PO O O
QHS O O
PRN O O
insomnia O O
Insulin B-MEDICATION O
70/30 I-MEDICATION O
Human I-MEDICATION O
30 O O
UNITS O O
SC O O
BID O O
: O O
30U O O
qAM, O O
30U O O
qPM O O
Insulin B-MEDICATION B-MEDICATION
Nph I-MEDICATION B-MEDICATION
Human I-MEDICATION O
30 O O
UNITS O O
SC O O
BID O O
BEFORE O O
BREAKFAST O O
AND O O
BEFORE O O
SUPPER O O
Allergies: O O
NKDA O O
Family O O
History O O
mother O O
died O O
age O O
37 O O
of O O
?PE; O O
father O O
died O O
age O O
52 O O
complication O O
of O O
EtOHism; O O
otherwise O O
non-contributory. O O
Social O O
History O O
language: O O
English O O
living: O O
w/ O O
son O O
and O O
his O O
wife; O O
moved O O
here O O
from O O
NY O O
in O O
12/2084 O O
work: O O
retired O O
tobacco: B-SMOKER O
2 I-SMOKER O
ppd I-SMOKER O
x I-SMOKER O
24 I-SMOKER O
yrs; I-SMOKER O
quit I-SMOKER O
age I-SMOKER O
39 I-SMOKER O
EtOH: O O
remote O O
hx O O
heavy O O
use; O O
quit O O
age O O
39 O O
drug: O O
none O O
sexual: O O
not O O
active O O
No O O
family O O
history O O
of O O
GU O O
diseases O O
or O O
malignancies O O
Married/Single O O
Sexually O O
Active O O
Smoke O O
Alcohol O O
use O O
Review O O
of O O
Systems: O O
ROS: O O
pt O O
denies O O
fever, O O
chills, O O
wt O O
change; O O
denies O O
eye O O
problems, O O
visual O O
change, O O
hearing O O
problems, O O
sinus O O
symptoms, O O
throat O O
soreness; O O
denies O O
chest O O
pain, O O
palpitations; O O
denies O O
sob, O O
wheezing, O O
cough; O O
denies O O
nausea, O O
vomiting, O O
diarrhea, O O
constipation, O O
abdominal O O
pain, O O
BRBPR; O O
denies O O
hesitancy, O O
weak O O
stream,denies O O
cold O O
or O O
heat O O
intolerance, O O
tremor, O O
hair O O
loss; O O
denies O O
polyuria, O O
polydipsia, O O
polyphagia; O O
denies O O
rashes; O O
All O O
other O O
systems O O
reviewed O O
and O O
are O O
unremarkable. O O
Genitourinary O O
Review O O
of O O
Systems O O
No O O
Kidney O O
stones O O
No O O
Urinary O O
tract O O
infections O O
No O O
Strictures O O
No O O
Sexually O O
transmitted O O
diseases O O
Physical O O
Examination: O O
Vital O O
Signs: O O
Well O O
nourished, O O
well-developed O O
Respirations: O O
14 O O
Pulse O O
Regular O O
Complete O O
Genitourinary O O
Examination: O O
Flank: O O
Non O O
tender O O
to O O
palpation O O
or O O
masses O O
Bladder: O O
Non O O
tender O O
Non O O
distended O O
Scrotum: O O
No O O
lesions O O
Intrascrotal: O O
No O O
hydrocele, O O
varicocele O O
or O O
spermatocele O O
Hernia: O O
Non O O
palpable O O
Epididymus: O O
No O O
masses, O O
cyst O O
Testes:Descended O O
bilaterally O O
No O O
masses O O
or O O
tenderness O O
Urethral O O
Meatus: O O
Normal O O
size O O
and O O
location O O
Penis: O O
Foreskin O O
without O O
lesions O O
Prostate: O O
No O O
Nodules, O O
non O O
tender O O
or O O
boggy O O
BPH O O
1+ O O
Seminal O O
Vesicles: O O
Symmetric O O
Sphincter O O
Tone: O O
Normal O O
Hemorrhoids: O O
Absent O O
Rectal O O
Masses: O O
Absent O O
Laboratory O O
Values: O O
X-Ray O O
studies:N/A O O
Post-void O O
residual O O
by O O
bladder O O
scan O O
is O O
cc's O O
An O O
independent O O
review O O
of O O
a O O
urinalysis O O
shows: O O
No O O
WBC's O O
No O O
RBC's O O
No O O
Glucose O O
No O O
Protein O O
No O O
Bilirubin O O
Nitrite O O
Negative O O
: O O
Impression: O O
S/P O O
TURP O O
for O O
BPH O O
with O O
persistent O O
LUTS O O
Plan: O O
Repeat O O
PSA O O
and O O
Free% O O
Recommended O O
to O O
restart O O
Flomax O O
0.4mgqhs O O
(Pt O O
will O O
think O O
about O O
this) O O
Follow O O
Up: O O
prn O O
Signed, O O
Taj O O
E. O O
Landers, O O
MD O O
Urology- O O
Martinsville O O
General O O
Hospital O O
Norfolk O O
University O O
131-631-4189 O O
cc:Dr. O O
Veronica O O
Frey O O

Record O O
date: O O
2088-02-18 O O
Reason O O
for O O
Visit O O
Mr. O O
Oshea O O
is O O
here O O
for O O
f/u O O
of O O
diabetes, B-DIABETES O
other O O
issues. O O
We O O
increased O O
his O O
70/30 B-MEDICATION O
insulin I-MEDICATION O
from O O
30 O O
to O O
35U O O
BID O O
last O O
month. O O
He O O
has O O
been O O
keeping O O
track O O
of O O
sugars O O
at O O
least O O
BID O O
since O O
then. O O
He O O
still O O
has O O
the O O
majority B-DIABETES O
of I-DIABETES O
sugars I-DIABETES O
in I-DIABETES O
the I-DIABETES O
low I-DIABETES O
200 I-DIABETES O
range, I-DIABETES O
some I-DIABETES O
in I-DIABETES O
the I-DIABETES O
300's, I-DIABETES O
a O O
few O O
in O O
the O O
100's. O O
Interestingly, O O
his O O
fasting B-DIABETES O
sugars I-DIABETES O
are O O
for O O
the O O
most O O
part O O
higher O O
than O O
his O O
daytime O O
sugars. O O
He O O
has O O
not O O
been O O
adhering O O
to O O
a O O
good O O
diabetes O O
diet O O
- O O
he O O
enjoys O O
a O O
blueberry O O
muffin O O
from O O
RR O O
Donnelley O O
daily. O O
His O O
daughter-in-law O O
who O O
is O O
also O O
my O O
patient O O
has O O
told O O
me O O
that O O
he O O
eats O O
anything O O
he O O
wants O O
and O O
all O O
the O O
wrong O O
things. O O
I O O
addressed O O
this O O
issue O O
w/ O O
Mr. O O
Oshea. O O
He O O
says O O
he O O
tries, O O
but O O
he O O
enjoys O O
these O O
things O O
and O O
feels O O
he O O
doesn't O O
have O O
much O O
else O O
in O O
life O O
to O O
enjoy. O O
He O O
is O O
worried O O
about O O
his O O
remaining O O
vision. O O
He O O
was O O
told O O
by O O
Dr. O O
Villagomez O O
that O O
the O O
pressure O O
in O O
his O O
L O O
eye O O
was O O
unusually O O
high. O O
She O O
wants O O
to O O
see O O
him O O
back O O
again O O
this O O
month O O
for O O
another O O
exam O O
and O O
wants O O
him O O
to O O
bring O O
his O O
eye O O
drops. O O
He O O
also O O
is O O
having O O
trouble O O
sleeping. O O
He O O
never O O
had O O
a O O
great O O
sleep O O
pattern O O
since O O
he O O
worked O O
as O O
a O O
Senior O O
Manager O O
of O O
Broadcasting O O
and O O
was O O
up O O
at O O
all O O
hours. O O
He O O
has O O
no O O
trouble O O
falling O O
asleep, O O
but O O
wakes O O
up O O
about O O
2 O O
a.m. O O
every O O
morning O O
and O O
can't O O
fall O O
back O O
asleep. O O
He O O
does O O
take O O
naps O O
in O O
the O O
afternoon O O
at O O
times. O O
Problems O O
H/O O O
Cerebrovascular O O
accident O O
: O O
unclear O O
when; O O
pt O O
describes O O
as O O
mild O O
stroke; O O
was O O
started O O
on O O
dipyrimadole O O
at O O
that O O
time O O
by O O
neurologist. O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Hypertension B-HYPERTENSION B-HYPERTENSION
Glaucoma O O
Visual O O
impairment O O
: O O
pt O O
legally O O
blind O O
Retinopathy O O
: O O
s/p O O
multiple O O
laser O O
surg; O O
legally O O
blind O O
Benign O O
prostatic O O
hypertrophy O O
: O O
followed O O
by O O
Dr. O O
Landers O O
Medications O O
Artificial O O
Tears O O
2 O O
DROP O O
OS O O
TID O O
TRAZODONE O O
50MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QHS O O
PRN O O
insomnia O O
Timolol O O
Maleate O O
0.5% O O
2 O O
DROP O O
OU O O
BID O O
Insulin B-MEDICATION B-MEDICATION
70/30 I-MEDICATION O
Human I-MEDICATION O
35 O O
UNITS O O
SC O O
BID O O
DIPYRIDAMOLE O O
75MG O O
TABLET O O
take O O
2 O O
Tablet(s) O O
PO O O
TID O O
Enalapril B-MEDICATION O
Maleate I-MEDICATION O
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
x O O
90 O O
days O O
Metoprolol B-MEDICATION B-MEDICATION
Tartrate I-MEDICATION O
50MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
x O O
90 O O
days O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Ambien O O
(ZOLPIDEM O O
Tartrate) O O
5 O O
MG O O
(5MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
PRN O O
insomnia O O
Proscar O O
(FINASTERIDE) O O
5 O O
MG O O
(5MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Flomax O O
(TAMSULOSIN) O O
0.4 O O
MG O O
(0.4MG O O
CAP.SR O O
24H O O
take O O
1) O O
PO O O
QD O O
Allergies O O
NKA O O
Social O O
History O O
language: O O
English O O
living: O O
w/ O O
son O O
and O O
his O O
wife; O O
pt's O O
wife O O
passed O O
away; O O
moved O O
here O O
from O O
NY O O
in O O
12/2084 O O
work: O O
retired O O
Senior O O
Manager O O
of O O
Broadcasting O O
tobacco: B-SMOKER B-HYPERTENSION
2 I-SMOKER O
ppd I-SMOKER O
x I-SMOKER O
24 I-SMOKER O
yrs; I-SMOKER O
quit I-SMOKER O
age I-SMOKER O
39 I-SMOKER O
EtOH: O O
remote O O
hx O O
heavy O O
use; O O
quit O O
age O O
39 O O
drug: O O
none O O
sexual: O O
not O O
active O O
domestic O O
violence: O O
neg O O
Review O O
of O O
Systems O O
Denies O O
headache, O O
visual O O
change, O O
confusion, O O
focal O O
weakness O O
or O O
paresthesias; O O
denies O O
chest O O
pain, O O
sob, O O
change O O
in O O
exercise O O
tolerance, O O
pedal O O
edema, O O
orthopnea; O O
denies O O
symptoms O O
of O O
hypoglycemia; O O
does O O
have O O
frequent O O
urination, O O
some O O
urinary O O
incontinence O O
despite O O
meds. O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
124/60 O O
PULSE O O
72 O O
WEIGHT O O
238 O O
lb O O
Physical O O
Exam O O
Gen: O O
obese B-OBESE O
man, O O
NAD, O O
appears O O
tired O O
today O O
HEENT: O O
PERRL, O O
EOM O O
intact, O O
oral O O
mucosa O O
moist, O O
no O O
lesions O O
Neck: O O
supple, O O
no O O
LAN, O O
no O O
masses O O
Lungs: O O
clear O O
bilat O O
CV: O O
RRR, O O
nl O O
S1, O O
S2, O O
no O O
M/R/G O O
Extrem: O O
no O O
edema; O O
radial O O
and O O
p.t. O O
pulses O O
2+ O O
bilat O O
Assessment O O
and O O
Plan O O
75 O O
y.o. O O
man O O
w/ O O
DM B-DIABETES O
type I-DIABETES O
2, I-DIABETES O
HTN, B-HYPERTENSION O
hyperlipidemia, B-HYPERLIPIDEMIA O
BPH, O O
legally O O
blind, O O
still O O
w/ O O
elevated O O
blood O O
sugars. O O
1) O O
DM: O O
emphasized O O
to O O
pt O O
the O O
importance O O
of O O
diet O O
in O O
controlling O O
blood O O
sugar; O O
he O O
says O O
he O O
will O O
make O O
an O O
honest O O
attempt O O
to O O
do O O
better; O O
will O O
recheck O O
HbA1c O O
in O O
April; O O
he O O
will O O
continue O O
to O O
monitor O O
blood O O
sugars O O
at O O
home; O O
has O O
appt O O
w/ O O
Dr. O O
Villagomez O O
of O O
MEDIQUIK O O
this O O
month, O O
is O O
up O O
to O O
date O O
w/ O O
podiatry. O O
2) O O
hyperlipidemia: O O
will O O
recheck O O
fasting O O
lipids O O
in O O
April; O O
continue O O
lipitor. B-MEDICATION B-MEDICATION
3) O O
HTN: O O
good O O
control O O
today; O O
continue O O
enalapril, B-MEDICATION O
metoprolol. B-MEDICATION B-MEDICATION
4) O O
BPH: O O
followed O O
by O O
Dr. O O
Landers; O O
has O O
f/u O O
w/ O O
him O O
later O O
this O O
year. O O
5) O O
insomnia: O O
early O O
morning O O
waking O O
difficult O O
to O O
treat O O
w/ O O
a O O
pill; O O
despite O O
my O O
discussion O O
w/ O O
pt O O
regarding O O
this, O O
he O O
would O O
like O O
to O O
try O O
Ambien. O O
Will O O
give O O
some O O
for O O
short O O
term O O
use. O O
RTC O O
in O O
3 O O
mos O O
for O O
f/u, O O
sooner O O
prn. O O

Record O O
date: O O
2088-03-02 O O
Mediquik O O
B O O
- O O
Intern O O
Admission O O
Note O O
Oshea, O O
Xavier O O
MR# O O
581-77-50 O O
Date O O
of O O
Presented O O
to O O
EW: O O
2/27/88 O O
Date O O
Admitted O O
to O O
Internal O O
Medicine: O O
3/01/88 O O
Contact: O O
Daughter-In-Law O O
(Petty): O O
138-378-3051 O O
Attendings: O O
Dr. O O
Queen O O
& O O
Dr. O O
Pineda O O
Source: O O
Patient, O O
pass-off, O O
daughter-in-law O O
CC: O O
falls O O
HPI: O O
Mr. O O
Oshea O O
is O O
a O O
pleasant O O
76-year-old O O
male O O
with O O
a O O
past O O
medical O O
history O O
significant O O
for O O
DM, B-DIABETES O
HTN, B-HYPERTENSION O
h/of O O
CVA, O O
and O O
glaucoma O O
who O O
presents O O
after O O
increasing O O
number O O
of O O
falls O O
at O O
home. O O
Pt O O
lives O O
with O O
daughter-in-law O O
and O O
grandchildren, O O
who O O
were O O
both O O
recently O O
sick O O
and O O
recovering O O
from O O
influenza. O O
The O O
pt O O
began O O
to O O
have O O
a O O
non-productive O O
cough O O
associated O O
with O O
a O O
fever O O
(101o-102o), O O
watery O O
eyes, O O
diaphoresis, O O
and O O
chills O O
early O O
this O O
week O O
after O O
his O O
family O O
was O O
sick. O O
His O O
daughter-in-law O O
states O O
that O O
he O O
has O O
also O O
been O O
increasingly O O
confused O O
during O O
this O O
time O O
period. O O
He O O
has O O
been O O
confusing O O
the O O
time O O
of O O
day O O
(confusing O O
night O O
for O O
daytime O O
and O O
vice O O
versa), O O
increasingly O O
forgetful, O O
and O O
falling O O
more O O
than O O
usual. O O
He O O
has O O
been O O
falling O O
with O O
increasing O O
frequency O O
over O O
the O O
last O O
3 O O
months. O O
On O O
average, O O
he O O
would O O
fall O O
about O O
once O O
a O O
week. O O
On O O
the O O
day O O
prior O O
to O O
admission, O O
the O O
pt O O
walked O O
to O O
Procter O O
Gamble O O
(2 O O
blocks O O
from O O
house) O O
and O O
fell O O
twice. O O
He O O
was O O
helped O O
back O O
up O O
by O O
by-standers. O O
He O O
describes O O
the O O
fall O O
as O O
his O O
legs O O
giving O O
out O O
from O O
under O O
him, O O
and O O
has O O
been O O
shuffling O O
his O O
gait O O
more O O
than O O
usual O O
recently. O O
During O O
each O O
fall O O
he O O
denies O O
LOC, O O
denies O O
CP, O O
denies, O O
SOB, O O
denies O O
incontinence, O O
and O O
denies O O
head O O
trauma. O O
On O O
the O O
day O O
of O O
presentation, O O
the O O
daughter-in-law O O
reports O O
that O O
the O O
pt O O
fell O O
13 O O
times O O
and O O
when O O
she O O
could O O
no O O
longer O O
help O O
him O O
rise O O
called O O
EMS. O O
EW O O
Vital O O
signs: O O
T:98.6o, O O
P:99, O O
BP:174/65, B-HYPERTENSION O
RR:20, O O
SaO2: O O
91% O O
on O O
RA O O
EW: O O
After O O
the O O
pt O O
presented O O
to O O
the O O
EW, O O
he O O
tested O O
positive O O
for O O
influenza O O
A O O
and O O
was O O
treated O O
supportively. O O
He O O
was O O
also O O
noted O O
to O O
have O O
a O O
UTI O O
and O O
given O O
a O O
dose O O
of O O
antibiotics O O
(levofloxacin O O
and O O
vancomycin). O O
ROS: O O
as O O
noted O O
above O O
PMH: O O
1. O O
H/O O O
Cerebrovascular O O
accident: O O
unclear O O
when; O O
pt O O
describes O O
as O O
mild O O
stroke; O O
was O O
started O O
on O O
dipyrimadole O O
at O O
that O O
time O O
by O O
neurologist. O O
2. O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
c/b O O
diabetic O O
retinopathy O O
3. O O
Hypertension B-HYPERTENSION B-HYPERTENSION
4. O O
Glaucoma O O
5. O O
Retinopathy: O O
s/p O O
multiple O O
laser O O
surg; O O
legally O O
blind O O
6. O O
BPH: O O
followed O O
by O O
Dr. O O
Landers O O
MEDICATIONS O O
(From O O
PCP O O
note, O O
reviewed O O
with O O
patient): O O
1. O O
Artificial O O
Tears O O
2 O O
DROP O O
OS O O
TI O O
2. O O
Trazadone O O
50MG O O
PO O O
QHS O O
PRN O O
insomnia O O
3. O O
Timolol O O
Maleate O O
0.5% O O
2 O O
DROP O O
OU O O
BID O O
4. O O
Insulin B-MEDICATION O
70/30 I-MEDICATION O
Human I-MEDICATION O
35 O O
UNITS O O
SC O O
BID O O
5. O O
DIPYRIDAMOLE O O
75MG O O
PO O O
TID O O
6. O O
Enalapril B-MEDICATION O
Maleate I-MEDICATION O
20MG O O
PO O O
BID O O
7. O O
Metoprolol B-MEDICATION B-MEDICATION
Tartrate I-MEDICATION O
50MG O O
PO O O
BID O O
8. O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
10MG O O
PO O O
QD O O
9. O O
Ambien O O
(ZOLPIDEM O O
Tartrate) O O
5 O O
MG O O
PO O O
QHS O O
PRN O O
insomnia O O
10. O O
Proscar O O
(FINASTERIDE) O O
5 O O
MG O O
PO O O
QD O O
11. O O
Flomax O O
(TAMSULOSIN) O O
0.4 O O
MG O O
PO O O
QD O O
Allergies: O O
NKDA O O
SH: O O
Pt O O
has O O
complicated O O
living O O
situation. O O
He O O
has O O
been O O
living O O
with O O
his O O
daughter-in-law O O
(Petty) O O
for O O
the O O
past O O
year. O O
His O O
daughter-in-law O O
seems O O
to O O
be O O
estranged O O
from O O
his O O
son. O O
She O O
cares O O
for O O
him O O
greatly, O O
but O O
is O O
unable O O
to O O
care O O
for O O
him O O
any O O
longer. O O
The O O
pt's O O
daughter O O
in O O
New O O
York O O
has O O
agreed O O
to O O
take O O
care O O
of O O
him. O O
Tob: B-SMOKER O
quit B-SMOKER O
@ I-SMOKER O
age I-SMOKER O
39, I-SMOKER O
48 I-SMOKER O
pack I-SMOKER O
year I-SMOKER O
history I-SMOKER O
(2ppd I-SMOKER O
x I-SMOKER O
24 I-SMOKER O
years) I-SMOKER O
EtOH: O O
quit O O
@ O O
age O O
39, O O
EtOH O O
abuse O O
previously O O
Ivdu: O O
denied O O
FH: O O
Father: O O
Died O O
@ O O
52 O O
from O O
EtOH O O
abuse O O
(unclear O O
exact O O
etiology) O O
Mother: O O
Died O O
@ O O
36 O O
from O O
blood O O
clot O O
in O O
heart O O
Brother: O O
Died O O
of O O
suicide O O
at O O
50 O O
Sisters: O O
Healthy O O
Exam: O O
VS(Floor): O O
T=96 O O
, O O
HR=84, O O
BP=154/78, B-HYPERTENSION O
RR=24, O O
SaO2= O O
93% O O
on O O
RA O O
General: O O
NAD O O
Heent: O O
oral O O
mucosa O O
dry O O
Neck: O O
supple, O O
JVP O O
not O O
elevated O O
Chest: O O
diffuse O O
rhonchi, O O
soft O O
expiratory O O
wheeze O O
CV: O O
RRR, O O
nl O O
S1, O O
S2 O O
Abd: O O
+BS, O O
soft, O O
NTND O O
Extr: O O
trace O O
edema, O O
superficial O O
abrasions O O
over O O
knees O O
bilaterally O O
Neuro: O O
alert, O O
slightly O O
confused, O O
nonfocal O O
MMSE: O O
24/30, O O
pt O O
lost O O
3 O O
points O O
on O O
orientation O O
(not O O
oriented O O
to O O
year/season/day), O O
lost O O
1 O O
point O O
for O O
recall, O O
lost O O
2 O O
points O O
for O O
language O O
Gait: O O
pt O O
uneasy O O
on O O
feet, O O
negative O O
romberg O O
sign O O
DATA: O O
02/28/88 O O
02/28/88 O O
02/27/88 O O
01/17/88 O O
20:24 O O
13:13 O O
22:21 O O
17:58 O O
NA O O
131(L) O O
129(L) O O
140 O O
K O O
3.5 O O
3.3(L) O O
3.8 O O
CL O O
99(L) O O
97(L) O O
99(L) O O
CO2 O O
30.6 O O
27.4 O O
32.3(H) O O
BUN O O
11 O O
10 O O
12 O O
CRE O O
1.0 O O
1.0 O O
1.1 O O
GLU O O
246(H) O O
194(H) O O
210(H) O O
148(H) O O
02/28/88 O O
02/27/88 O O
01/17/88 O O
00:25 O O
23:07 O O
17:58 O O
CA O O
8.7 O O
9.5 O O
PHOS O O
3.0 O O
MG O O
1.8 O O
OSM O O
278(L) O O
02/27/88 O O
22:17 O O
CK-MB O O
Negative O O
TROP-I O O
Negative O O
02/28/88 O O
00:22 O O
UNA O O
63 O O
UCREAT O O
0.93 O O
UOSM O O
440 O O
02/27/88 O O
22:51 O O
WBC O O
5.4 O O
RBC O O
4.74 O O
HGB O O
15.2 O O
HCT O O
42.0 O O
MCV O O
89 O O
MCH O O
32.0 O O
MCHC O O
36.1 O O
PLT O O
242 O O
RDW O O
13.8 O O
DIFFR O O
Received O O
METHOD O O
Auto O O
%NEUT O O
79(H) O O
%LYMPH O O
14(L) O O
%MONO O O
7 O O
%EOS O O
0 O O
%BASO O O
0 O O
02/27/88 O O
22:51 O O
PT O O
13.7(HT) O O
PTT O O
30.0(T) O O
U/A O O
(2/28/88): O O
yellow, O O
cloudy, O O
gluc O O
1+, O O
prot: O O
1+, O O
Urine O O
Nitrite: O O
Positive, O O
UA-BLD: O O
2+, O O
UA-WBC: O O
2+, O O
UAS-WBC: O O
10-20, O O
UAS-Bact: O O
Moderate, O O
UASquamous: O O
Negative O O
Micro: O O
UC: O O
Abundant O O
(&gt;=100,000 O O
CFU/ml) O O
STAPHYLOCOCCUS O O
SPECIES O O
Nasal O O
Swab: O O
POSITIVE O O
for O O
INFLUENZA O O
VIRUS O O
TYPE O O
A O O
ANTIGEN O O
EKG O O
(3/01/88): O O
NSR O O
at O O
84 O O
bpm O O
w/ O O
RBBB, O O
LAHB, O O
q O O
waves O O
in O O
V3-4, O O
no O O
ST O O
segment O O
changes O O
Radiology: O O
CXR O O
(2/27/88): O O
No O O
evidence O O
of O O
acute O O
cardiopulmonary O O
process. O O
CT O O
Brain O O
(2/27/88): O O
1. O O
Atherosclerotic O O
disease, O O
extensive O O
microangiopathic O O
changes O O
and O O
chronic O O
appearing O O
lacunar O O
infarcts, O O
as O O
described. O O
No O O
specific O O
evidence O O
of O O
acute O O
infarction, O O
although O O
DW-MRI O O
is O O
more O O
sensitive O O
for O O
acute O O
ischemia. O O
2. O O
No O O
intracranial O O
hemorrhage. O O
Assessment: O O
76yo O O
M O O
w/ O O
history O O
of O O
DM, O O
HTN, O O
and O O
h/o O O
of O O
CVA O O
presents O O
with O O
AMS O O
and O O
increasing O O
falls O O
in O O
setting O O
of O O
influenza. O O
PLAN: O O
1. O O
Delirium: O O
Pt's O O
waxing O O
and O O
waning O O
mental O O
status O O
likely O O
secondary O O
from O O
his O O
underlying O O
infectious O O
processes O O
- O O
influenza O O
and O O
UTI. O O
a. O O
Correct O O
hyponatremia O O
b. O O
Monitor O O
mental O O
status O O
as O O
infection O O
is O O
treated O O
2. O O
Falls: O O
Pt's O O
recent O O
falls O O
likely O O
have O O
a O O
multifactorial O O
etiology. O O
Pt O O
has O O
many O O
risk O O
factors O O
for O O
falls O O
including O O
visual O O
impairment, O O
mild O O
cognitive O O
impairment O O
(on O O
MMSE), O O
possible O O
diabetic O O
neuropathy, O O
and O O
a. O O
Check O O
orthostatic O O
vital O O
signs O O
b. O O
Check O O
RPR/B12 O O
c. O O
Pt O O
needs O O
PT O O
evaluation, O O
may O O
require O O
walker O O
or O O
other O O
equipment O O
to O O
help O O
him O O
ambulate O O
3. O O
Hypovolemic O O
Hyponatremia: O O
Pt O O
clinically O O
appears O O
hypovolemic. O O
A O O
FeNa O O
of O O
0.5% O O
also O O
suggests O O
a O O
hypovolemic O O
picture. O O
a. O O
Will O O
check O O
Na O O
now, O O
and O O
if O O
sodium O O
continues O O
to O O
improve O O
will O O
continue O O
IVFs O O
4. O O
UTI: O O
Pt O O
has O O
positive O O
U/A O O
and O O
UC O O
for O O
stap O O
(awaiting O O
speciation O O
and O O
sensitivity). O O
Staph O O
is O O
an O O
unusual O O
cause O O
of O O
a O O
UTI. O O
A O O
further O O
investigation O O
of O O
the O O
cause O O
of O O
source O O
of O O
the O O
staph O O
is O O
warranted. O O
Empiric O O
coverage O O
with O O
vancomycin O O
is O O
also O O
necessary O O
given O O
the O O
pt's O O
history O O
of O O
methicillin O O
and O O
levofloxacin O O
resistant O O
CNS. O O
a. O O
F/u O O
UC O O
b. O O
Empiric O O
treatment O O
with O O
Vancomycin O O
1g O O
q12h O O
for O O
7 O O
days O O
(CrCl O O
&gt; O O
60), O O
await O O
c&s O O
for O O
possible O O
alternative O O
agents O O
5. O O
Influenza O O
A O O
a. O O
Continuous O O
oxygen O O
monitoring O O
b. O O
Supportive O O
care O O
6. O O
Code O O
Status: O O
Discussed O O
with O O
patient, O O
who O O
expressed O O
to O O
me O O
he O O
would O O
like O O
to O O
be O O
DNR/DNI O O
7. O O
PPx O O
a. O O
Nexium O O
b. O O
Fragmin O O
_________________________________ O O
David O O
Phillips, O O
MD O O
Pager O O
#93278 O O

Record O O
date: O O
2095-08-21 O O
Bailey O O
EMERGENCY O O
DEPT O O
VISIT O O
DARLING,BETTY O O
785-67-87-3 O O
Resident O O
history O O
reviewed, O O
the O O
patient O O
seen, O O
interviewed, O O
and O O
examined O O
by O O
me. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
Briefly, O O
the O O
history O O
is O O
as O O
follows: O O
The O O
patient O O
is O O
a O O
75-year-old O O
white O O
female O O
with O O
past O O
medical O O
history O O
significant O O
for O O
throat O O
cancer, O O
status O O
post O O
radiation O O
therapy; O O
breast O O
cancer, O O
status O O
post O O
multiple O O
lumpectomies; O O
non-insulin B-DIABETES O
dependent I-DIABETES O
diabetes B-DIABETES O
mellitus, I-DIABETES O
hypothyroidism, O O
hypertension, B-HYPERTENSION B-HYPERTENSION
and O O
peripheral O O
vascular O O
disease O O
with O O
bilateral O O
carotid O O
stenosis O O
- O O
status O O
post O O
right O O
carotid O O
endarterectomy, O O
who O O
was O O
seen O O
earlier O O
today O O
at O O
Faith O O
Hospital O O
after O O
an O O
episode O O
of O O
word O O
finding O O
difficulty O O
associated O O
with O O
acute O O
vision O O
loss O O
in O O
her O O
left O O
eye O O
while O O
riding O O
as O O
a O O
passenger O O
in O O
a O O
car. O O
The O O
event O O
was O O
witnessed O O
and O O
reportedly O O
there O O
was O O
severe O O
word O O
finding O O
difficulty. O O
The O O
patient O O
was O O
transferred O O
to O O
the O O
Bailey O O
Memorial O O
Hospital O O
Emergency O O
Department O O
for O O
further O O
evaluation O O
and O O
management. O O
On O O
arrival, O O
she O O
states O O
her O O
symptoms O O
have O O
largely O O
resolved. O O
Evaluation O O
at O O
the O O
outside O O
facility O O
included O O
a O O
head O O
CT O O
which O O
reportedly O O
revealed O O
no O O
events O O
of O O
acute O O
hemorrhage. O O
Prior O O
to O O
transfer, O O
she O O
was O O
treated O O
with O O
aspirin. B-MEDICATION B-MEDICATION
REVIEW O O
OF O O
SYSTEMS: O O
All O O
systems O O
reviewed O O
are O O
negative O O
except O O
per O O
HPI. O O
PAST O O
MEDICAL O O
HISTORY: O O
As O O
noted O O
above. O O
MEDICATIONS: O O
Klonopin, O B-MEDICATION
Glyburide, B-MEDICATION B-MEDICATION
Coumadin, O O
meclozine, O O
Timoptic O O
ophthalmic O O
drops, O O
Zestril, B-MEDICATION B-MEDICATION
Celebrex, O O
and O O
Synthroid. O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
The O O
patient O O
denies B-SMOKER O
tobacco, I-SMOKER O
alcohol, O O
or O O
any O O
history O O
of O O
illicit O O
drug O O
use. O O
She O O
presently O O
lives O O
alone. O O
Family O O
history O O
is O O
only O O
notable O O
for O O
a O O
sister O O
with O O
breast O O
cancer. O O
PHYSICAL O O
EXAMINATION: O O
Well-developed, O O
well-nourished, O O
well-appearing O O
female O O
who O O
appears O O
in O O
no O O
acute O O
distress. O O
VITAL O O
SIGNS: O O
Temperature O O
96, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
167/84, I-HYPERTENSION O
pulse O O
92, O O
respiratory O O
rate O O
18, O O
O2 O O
saturations O O
100% O O
on O O
room O O
air. O O
HEENT: O O
Normocephalic, O O
atraumatic. O O
Pupils O O
equal, O O
round, O O
and O O
reactive O O
to O O
light. O O
Extraocular O O
muscles O O
intact. O O
Funduscopic O O
exam O O
reveals O O
sharp O O
disks O O
bilaterally. O O
NECK: O O
Supple. O O
LUNGS: O O
Clear O O
to O O
auscultation. O O
HEART: O O
Regular O O
rate O O
and O O
rhythm O O
with O O
a O O
2/6 O O
systolic O O
murmur O O
at O O
the O O
left O O
sternal O O
border. O O
ABDOMEN: O O
Soft, O O
nontender, O O
nondistended. O O
NEURO: O O
Awake, O O
alert, O O
and O O
oriented O O
x O O
3. O O
Speech O O
clear O O
and O O
fluent O O
and O O
well O O
articulated. O O
Motor O O
5/5 O O
and O O
symmetric O O
throughout. O O
Reflexes O O
2+ O O
with O O
downgoing O O
toes. O O
Cerebellar: O O
Finger-to-nose O O
intact. O O
Gait O O
not O O
tested. O O
LABORATORY O O
EVALUATION: O O
SMA-7 O O
notable O O
for O O
glucose O O
of O O
124. O O
CBC: O O
White O O
count O O
8.2, O O
hematocrit O O
36.3, O O
platelets O O
379. O O
Coagulation O O
profile O O
notable O O
for O O
an O O
INR O O
of O O
2.0. O O
Urinalysis O O
benign. O O
EKG: O O
Normal O O
sinus O O
rhythm O O
at O O
a O O
rate O O
of O O
70 O O
with O O
nonspecific O O
T-wave O O
changes. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
She O O
is O O
currently O O
awaiting O O
evaluation O O
with O O
an O O
MRI O O
and O O
MR O O
angiogram O O
of O O
the O O
head O O
and O O
neck. O O
CONSULTATIONS O O
(including O O
PCP): O O
The O O
patient O O
was O O
seen O O
in O O
consultation O O
by O O
Neurology. O O
FINAL O O
DIAGNOSIS: O O
Transient O O
ischemic O O
attack O O
vs. O O
cerebrovascular O O
accident. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
will O O
be O O
admitted O O
to O O
the O O
Neurology O O
Service O O
for O O
further O O
evaluation O O
and O O
management. O O
The O O
patient O O
is O O
currently O O
in O O
stable O O
condition. O O
___________________________________ O O
YA226/51903 O O
OMAR O O
IM, O O
M.D. O O
OI23 O O
D:08/21/95 O O
T:08/21/95 O O
Dictated O O
by: O O
OMAR O O
IM, O O
M.D. O O
OI23 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2095-12-09 O O
Cookson O O
Memorial O O
Home O O
Internal O O
Medicine O O
Room O O
960 O O
87 O O
Wellesley O O
Rd O O
Darling, O O
Betty O O
Seattle, O O
SC O O
84126 O O
78567873 O O
(121) O O
537-3484 O O
12/09/95 O O
CHIEF O O
COMPLAINT: O O
Multiple O O
acute O O
and O O
chronic O O
medical O O
issues, O O
including O O
subacute O O
weight O O
loss. O O
IDENTIFICATION: O O
This O O
is O O
my O O
first O O
medical O O
visit O O
with O O
this O O
75-year-old O O
woman O O
with O O
multiple O O
recent O O
hospitalizations. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
She O O
has O O
a O O
long O O
history O O
of O O
severe O O
cerebrovascular O O
disease, O O
with O O
multiple O O
strokes. O O
She O O
has O O
stenosis O O
in O O
both O O
anterior O O
and O O
posterior O O
circulation. O O
Past O O
right O O
carotid O O
endarterectomy. O O
In O O
August O O
2095, O O
she O O
was O O
admitted O O
to O O
BMH O O
with O O
a O O
right O O
cerebellar O O
stroke, O O
complicated O O
by O O
a O O
brief O O
intubation O O
and O O
pneumonia. O O
She O O
underwent O O
stenting O O
of O O
her O O
right O O
vertebral O O
artery O O
and O O
left O O
common O O
carotid O O
artery. O O
She O O
had O O
subsequent O O
episodes O O
of O O
worsening O O
speech, O O
and O O
was O O
started O O
on O O
Coumadin, O O
with O O
an O O
INR O O
goal O O
of O O
2.5 O O
to O O
3.0. O O
She O O
is O O
followed O O
closely O O
by O O
Neurology O O
and O O
may, O O
at O O
some O O
point, O O
undergo O O
further O O
interventional O O
radiology O O
procedures, O O
to O O
be O O
determined. O O
During O O
her O O
most O O
recent O O
hospitalization O O
she O O
had O O
some O O
confusion O O
which O O
was O O
attributed O O
to O O
low O O
sodium. O O
This O O
was O O
felt O O
to O O
be O O
the O O
result O O
of O O
osmotic O O
diuresis, O O
and O O
possible O O
SIADH. O O
This O O
is O O
being O O
treated O O
with O O
salt O O
tablets, O O
saline O O
boluses O O
in O O
her O O
G-tube, O O
water O O
restriction, O O
and O O
low-dose O O
Lasix. O O
No O O
evidence O O
of O O
adrenal O O
insufficiency. O O
Since O O
leaving O O
the O O
hospital, O O
she O O
has O O
had O O
ongoing O O
weight O O
loss. O O
Baseline O O
weight O O
170 O O
pounds. O O
Weight O O
in O O
early O O
September, O O
167 O O
pounds. O O
Weight O O
October O O
20th, O O
160 O O
pounds. O O
Weight O O
&lt;PHI O O
TYPE='DATE'&gt;November O O
28th&lt;/PHI&gt;, O O
141 O O
pounds. O O
Weight O O
today O O
in O O
clinic O O
146 O O
pounds O O
on O O
our O O
scale. O O
She O O
had O O
a O O
swallowing O O
study O O
on O O
October O O
26, O O
2095, O O
which O O
revealed O O
no O O
aspiration, O O
but O O
very O O
poor O O
bolus O O
formation. O O
The O O
G-tube O O
was O O
placed O O
in O O
August, O O
and O O
has O O
healed O O
well, O O
but O O
has O O
never O O
been O O
used O O
for O O
daily O O
tube O O
feeds O O
on O O
an O O
outpatient O O
basis. O O
Over O O
the O O
past O O
couple O O
of O O
weeks, O O
she O O
has O O
worsening O O
trouble O O
with O O
coughing, O O
choking O O
and O O
sputtering, O O
as O O
she O O
attempts O O
to O O
swallow. O O
Her O O
caloric O O
p.o. O O
intake O O
sounds O O
as O O
if O O
it O O
has O O
been O O
quite O O
minimal, O O
with O O
a O O
couple O O
of O O
ounces O O
of O O
potatoes O O
or O O
pureed O O
foods O O
here O O
and O O
there. O O
She O O
is O O
drinking O O
two O O
or O O
three O O
can O O
of O O
booster O O
Ensure O O
daily, O O
but O O
clearly O O
not O O
meeting O O
her O O
caloric O O
needs. O O
Today's O O
visit O O
was O O
with O O
the O O
patient, O O
and O O
her O O
daughter O O
(phone O O
number O O
507.741.8042). O O
Most O O
recent O O
laboratory O O
studies, O O
done O O
12/7/2095: O O
Sodium O O
137, O O
potassium O O
4.8, O O
chloride O O
95, O O
Bicarb O O
32, O O
BUN O O
22, O O
creatinine O O
1.0, O O
calcium O O
9.9, O O
glucose O O
162. O O
The O O
patient O O
has O O
felt O O
increasingly O O
weak O O
and O O
debilitated, O O
as O O
her O O
weight O O
has O O
decreased. O O
REVIEW O O
OF O O
SYSTEMS: O O
Also O O
remarkable O O
for O O
slight O O
bright O O
red O O
blood O O
per O O
rectum O O
within O O
the O O
last O O
week. O O
The O O
patient's O O
daughter O O
describes O O
that O O
she O O
had O O
a O O
normal O O
colonoscopy O O
in O O
early O O
2095, O O
at O O
the O O
Richwood O O
Area O O
Community O O
Hospital. O O
The O O
patient's O O
daughter O O
will O O
bring O O
me O O
these O O
records O O
at O O
the O O
next O O
visit. O O
PAST O O
MEDICAL O O
HISTORY: O O
1. O O
Cerebrovascular O O
disease, O O
as O O
noted O O
above. O O
2. O O
Throat O O
cancer O O
in O O
early O O
2060s. O O
Status O O
post O O
XRT O O
to O O
the O O
neck O O
(may O O
have O O
predisposed O O
her O O
to O O
the O O
severe O O
carotid O O
and O O
vertebral O O
disease). O O
3. O O
Breast O O
cancer. O O
Details O O
unknown. O O
Will O O
review O O
at O O
next O O
visit. O O
4. O O
Diabetes, B-DIABETES O
type I-DIABETES O
II. I-DIABETES O
On O O
glyburide. B-MEDICATION B-MEDICATION
Further O O
details O O
unknown. O O
5. O O
SIADH. O O
Will O O
review O O
hospital O O
chart O O
in O O
detail. O O
6. O O
Hypertension. B-HYPERTENSION O
Per O O
Neurology, O O
goal O O
blood O O
pressure O O
140 O O
to O O
170. O O
7. O O
Hypothyroidism. O O
Details O O
unknown. O O
Recent O O
TSH O O
normal. O O
8. O O
Glaucoma. O O
9. O O
Anxiety. O O
Being O O
followed O O
by O O
Psychiatry O O
on O O
an O O
active O O
basis. O O
This O O
was O O
apparently O O
a O O
large O O
factor O O
during O O
her O O
recent O O
hospitalizations. O O
10. O O
Possible O O
recent O O
anemia. O O
Has O O
not O O
been O O
evaluated O O
thus O O
far. O O
MEDICATIONS: O O
1. O O
Lisinopril B-MEDICATION B-MEDICATION
40 O O
mg O O
p.o. O O
q.d. O O
2. O O
Synthroid O O
100 O O
mcg O O
p.o. O O
q.d. O O
3. O O
Lasix O O
10 O O
mg O O
p.o. O O
Qa O O
m O O
and O O
Qpm O O
4. O O
Glyburide B-MEDICATION B-MEDICATION
5 O O
mg O O
p.o. O O
b.i.d. O O
5. O O
Colace O O
100 O O
mg O O
p.o. O O
b.i.d. O O
to O O
t.i.d. O O
6. O O
Enteric-coated B-MEDICATION O
baby I-MEDICATION O
aspirin I-MEDICATION B-MEDICATION
81 O O
mg O O
p.o. O O
q.d. O O
7. O O
Sodium O O
chloride O O
1 O O
g O O
p.o. O O
Qa O O
m O O
via O O
G-tube O O
8. O O
Timolol O O
0.5%, O O
one O O
drop O O
to O O
the O O
right O O
eye O O
q.d. O O
9. O O
Prevacid O O
30 O O
mg O O
p.o. O O
q.d. O O
10. O O
Normal O O
saline O O
300 O O
cc O O
via O O
G-tube O O
after O O
breakfast, O O
lunch, O O
and O O
dinner O O
11. O O
Multivitamin O O
p.o. O O
q.d. O O
12. O O
Coumadin, O O
with O O
goal O O
INR O O
2.5 O O
to O O
3.0 O O
(followed O O
by O O
Internal O O
Medicine) O O
13. O O
Xalatan O O
0.005%, O O
one O O
drop O O
each O O
eye O O
q.h.s. O O
14. O O
Dulcolax O O
5 O O
mg O O
p.o. O O
q.d. O O
PRN, O O
constipation O O
15. O O
Risperdal O O
0.125 O O
mg O O
to O O
0.25 O O
mg O O
p.o. O O
q.h.s. O O
PRN O O
16. O O
Ambien O O
5 O O
mg O O
to O O
10 O O
mg O O
p.o. O O
q.h.s. O O
PRN O O
17. O O
Saliva O O
substitute O O
PRN O O
18. O O
Nystatin, O O
swish-and-swallow O O
PRN O O
19. O O
Fleet O O
Enema O O
PRN O O
20. O O
Tylenol O O
650 O O
mg O O
p.o. O O
PRN O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
SOCIAL B-SMOKER O
HISTORY: O O
The O O
patient O O
has O O
four O O
children. O O
Her O O
daughter O O
Fitzpatrick O O
is O O
a O O
Food O O
Service O O
Supervisor. O O
Another O O
daughter O O
is O O
staying O O
with O O
the O O
patient O O
full-time. O O
Visiting O O
nurse O O
is O O
involved. O O
Previous O O
to O O
the O O
last O O
few O O
months, O O
the O O
patient O O
was O O
fairly O O
independent. O O
PHYSICAL O O
EXAMINATION: O O
GENERAL: O O
Cachectic, O O
anxious O O
woman, O O
who O O
is O O
slightly O O
unsteady O O
on O O
her O O
feet, O O
but O O
safe O O
with O O
ambulation O O
if O O
she O O
moves O O
slowly O O
and O O
carefully. O O
Has O O
a O O
cane, O O
but O O
does O O
not O O
always O O
use O O
it. O O
VITAL O O
SIGNS: O O
BP B-HYPERTENSION O
214/108, I-HYPERTENSION O
initially I-HYPERTENSION O
(patient I-HYPERTENSION O
very I-HYPERTENSION O
anxious), I-HYPERTENSION O
and I-HYPERTENSION O
171/74 B-HYPERTENSION O
on I-HYPERTENSION O
repeat. I-HYPERTENSION O
Pulse O O
80. O O
Weight O O
146.5 O O
pounds, O O
fully O O
clothed. O O
ABDOMEN: O O
With O O
good O O
bowel O O
sounds. O O
Soft, O O
nontender O O
and O O
nondistended. O O
No O O
hepatosplenomegaly. O O
No O O
masses. O O
G-tube O O
is O O
flushed O O
with O O
water, O O
and O O
flushes O O
easily. O O
G-tube O O
site O O
itself O O
is O O
well-healed O O
and O O
nontender, O O
with O O
no O O
pussy O O
discharge. O O
LUNGS: O O
Clear O O
to O O
auscultation. O O
HEART: O O
Regular O O
rate O O
and O O
rhythm. O O
No O O
murmurs. O O
ASSESSMENT O O
AND O O
PLAN: O O
1. O O
Weight O O
loss. O O
Probably O O
due O O
to O O
poor O O
caloric O O
intake. O O
This O O
is O O
a O O
significant O O
health O O
concern O O
for O O
her, O O
as O O
she O O
has O O
become O O
progressively O O
cachectic O O
and O O
weak. O O
This O O
is O O
probably O O
attributed O O
to, O O
by O O
some O O
extent, O O
her O O
progressive O O
dysphagia. O O
She O O
is O O
referred O O
urgently O O
to O O
Nutrition, O O
and O O
will O O
see O O
them O O
on O O
Tuesday. O O
I O O
suggested O O
to O O
the O O
daughter O O
and O O
to O O
the O O
nutritionist O O
that O O
we O O
transition O O
her O O
to O O
tube O O
feeds O O
for O O
at O O
least O O
a O O
couple O O
of O O
weeks, O O
to O O
get O O
her O O
muscle O O
mass O O
up, O O
and O O
then O O
reevaluate. O O
She O O
should O O
continue O O
to O O
take O O
p.o. O O
foods O O
as O O
tolerated, O O
but O O
she O O
needs O O
to O O
attempt O O
to O O
meet O O
her O O
caloric O O
intake O O
via O O
the O O
G-tube, O O
since O O
she O O
is O O
clearly O O
not O O
meeting O O
it O O
p.o. O O
Will O O
try O O
Glucerna O O
because O O
of O O
her O O
diabetes O O
history. O O
The O O
patient's O O
daughter O O
and O O
the O O
nutritionist O O
are O O
aware O O
of O O
her O O
issues O O
with O O
vitamin O O
K O O
and O O
Coumadin, O O
and O O
they O O
will O O
discuss O O
this O O
further O O
when O O
she O O
sees O O
Nutrition O O
Clinic O O
in O O
two O O
days. O O
2. O O
Cerebrovascular O O
disease. O O
Followed O O
closely O O
by O O
Neurology. O O
No O O
acute O O
change O O
in O O
neuro O O
status O O
today. O O
Will O O
continue O O
Coumadin. O O
Being O O
followed O O
closely O O
by O O
Internal O O
Medicine O O
for O O
this. O O
Recent O O
INR O O
1.4. O O
Will O O
adjust O O
Coumadin O O
as O O
advised O O
by O O
IM O O
nurse. O O
3. O O
SIADH. O O
I O O
need O O
to O O
review O O
these O O
records O O
more O O
closely, O O
and O O
try O O
to O O
make O O
sure O O
there O O
is O O
no O O
other O O
underlying O O
disorder. O O
In O O
the O O
meantime, O O
her O O
sodiums O O
have O O
been O O
quite O O
good O O
recently. O O
4. O O
Diabetes. O O
Recent O O
hyperglycemia, O O
with O O
sugars O O
in O O
the O O
300 O O
to O O
350 O O
range. O O
Most O O
recently, O O
with O O
sugars O O
in O O
the O O
100 O O
to O O
200 O O
range O O
over O O
the O O
past O O
few O O
days. O O
Continue O O
glyburide O B-MEDICATION
5 O O
mg O O
p.o. O O
b.i.d. O O
Finger-sticks O O
three O O
to O O
four O O
times O O
daily. O O
Further O O
adjustments O O
PRN. O O
Our O O
current O O
goal O O
is O O
simply O O
to O O
maintain O O
her O O
sugars O O
between O O
120 O O
and O O
approximately O O
220 O O
to O O
250. O O
Once O O
her O O
dietary O O
issues O O
are O O
stabilized, O O
we O O
can O O
aim O O
for O O
slightly O O
tighter O O
control. O O
Wish O O
to O O
avoid O O
hypoglycemia, O O
given O O
her O O
troubles O O
with O O
p.o. O O
intake. O O
5. O O
Recent O O
history O O
of O O
bright O O
red O O
blood O O
per O O
rectum. O O
Daughter O O
will O O
bring O O
me O O
her O O
recent O O
colonoscopy O O
report, O O
and O O
we O O
will O O
take O O
it O O
from O O
there. O O
6. O O
Constipation. O O
Continue O O
Colace. O O
Add O O
Dulcolax O O
PRN. O O
Continue O O
Fleet O O
Enema O O
PRN O O
by O O
visiting O O
nurse. O O
If O O
she O O
does O O
have O O
chronic O O
constipation, O O
this O O
may O O
impact O O
her O O
appetite O O
and O O
her O O
ability O O
to O O
eat O O
successfully. O O
7. O O
Hypertension. O O
Currently O O
in O O
reasonable O O
control. O O
Goal O O
BP O O
140 O O
to O O
170, O O
systolic. O O
Initial O O
severe B-HYPERTENSION O
hypertension I-HYPERTENSION O
this O O
visit, O O
attributed O O
to O O
anxiety, O O
which O O
clearly O O
is O O
a O O
major O O
issue O O
for O O
her. O O
Follow-up O O
at O O
next O O
visit. O O
8. O O
Anxiety. O O
Followed O O
by O O
Psychiatry. O O
Extensive O O
reassurance O O
given O O
today O O
to O O
the O O
patient. O O
She O O
is O O
very O O
concerned O O
about O O
her O O
weight O O
loss, O O
as O O
am O O
I. O O
I O O
tried O O
to O O
reassure O O
her O O
that O O
we O O
would O O
take O O
this O O
seriously O O
and O O
address O O
it O O
in O O
a O O
very O O
rapid O O
fashion. O O
Addendum O O
- O O
spoke O O
with O O
psych O O
- O O
they O O
will O O
start O O
paxil O O
5 O O
mg O O
qd O O
watch O O
for O O
worsening O O
SIADH O O
and/or O O
anthicholinergic O O
side O O
effects. O O
9. O O
Multiple O O
other O O
issues. O O
To O O
be O O
addressed O O
at O O
further O O
visits. O O
Given O O
her O O
weight O O
loss O O
and O O
complexity, O O
I O O
will O O
see O O
her O O
on O O
a O O
weekly O O
basis O O
for O O
the O O
next O O
few O O
weeks, O O
or O O
sooner O O
PRN. O O
Daughter O O
has O O
my O O
pager O O
number, O O
and O O
knows O O
how O O
to O O
reach O O
me. O O
______________________________ O O
Julia O O
Yale, O O
M.D. O O
CC: O O
eScription O O
document:0-136282 O O
ST O O
eScription O O
DD: O O
12/09/95 O O
DT: O O
12/09/95 O O
DV: O O
12/09/95 O O

Record O O
date: O O
2097-11-30 O O
Cookson O O
Memorial O O
Home O O
Internal O O
Medicine O O
Room O O
960 O O
50 O O
Wellesley O O
Rd O O
DARLING, O O
BETTY O O
Seattle, O O
SC O O
84126 O O
78567873 O O
(121) O O
537-3484 O O
11/30/97 O O
CHIEF O O
COMPLAINT: O O
Hypertension, B-HYPERTENSION O
proteinuria, O O
status O O
post O O
fall, O O
reevaluate O O
Coumadin. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Urgent O O
care O O
visit O O
for O O
this O O
77-year-old O O
woman O O
with O O
the O O
history O O
of O O
diabetes, B-DIABETES O
multiple O O
strokes, O O
hypertension, B-HYPERTENSION B-HYPERTENSION
hyperlipidemia, B-HYPERLIPIDEMIA O
and O O
multiple O O
other O O
issues. O O
Last O O
week O O
she O O
was O O
at O O
Saint O O
Joseph O O
Memorial O O
Hospital O O
for O O
an O O
eye O O
evaluation. O O
It O O
was O O
a O O
very O O
very O O
windy O O
day. O O
Afterwards O O
she O O
was O O
outside O O
and O O
a O O
huge O O
gust O O
of O O
wind O O
knocked O O
her O O
over. O O
Her O O
daughter O O
Fitzpatrick O O
was O O
with O O
her O O
and O O
Fitzpatrick O O
herself O O
actually O O
had O O
to O O
hold O O
on O O
to O O
something O O
when O O
the O O
wind O O
blew. O O
There O O
is O O
no O O
chest O O
pain O O
or O O
presyncope, O O
and O O
no O O
loss O O
of O O
consciousness O O
either O O
before, O O
during, O O
or O O
after O O
the O O
episode. O O
She O O
struck O O
her O O
left O O
trochanteric O O
area, O O
left O O
deltoid O O
area, O O
and O O
left O O
eyebrow. O O
She O O
was O O
taken O O
to O O
EFH O O
where O O
she O O
had O O
a O O
normal O O
head O O
CT. O O
A O O
single O O
stitch O O
was O O
placed O O
in O O
the O O
laceration O O
along O O
the O O
lateral O O
edge O O
of O O
her O O
left O O
eyebrow. O O
She O O
had O O
films O O
of O O
her O O
wrist O O
and O O
hips O O
both O O
of O O
which O O
were O O
fine. O O
She O O
has O O
bruising O O
in O O
these O O
areas. O O
Other O O
than O O
some O O
pain O O
where O O
the O O
bruising O O
is O O
she O O
feels O O
entirely O O
back O O
to O O
normal. O O
She O O
had O O
marked O O
hypertension B-HYPERTENSION O
up I-HYPERTENSION O
to I-HYPERTENSION O
250. B-HYPERTENSION O
She O O
was O O
treated O O
with O O
hydralazine O O
in O O
the O O
ER, O O
and O O
was O O
noted O O
to O O
have O O
proteinuria O O
with O O
some O O
hematuria. O O
Her O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
at I-HYPERTENSION O
home I-HYPERTENSION O
since I-HYPERTENSION O
then I-HYPERTENSION O
has I-HYPERTENSION O
been I-HYPERTENSION O
180 I-HYPERTENSION O
and I-HYPERTENSION O
210 I-HYPERTENSION O
systolic I-HYPERTENSION O
on O O
her O O
usual O O
40 O O
mg O O
daily O O
of O O
lisinopril. B-MEDICATION B-MEDICATION
She O O
is O O
not O O
on O O
a O O
beta-blocker O O
currently. O O
She O O
has O O
not O O
had O O
any O O
episodes O O
of O O
chest O O
pain. O O
She O O
does O O
feel O O
slightly O O
more O O
woozy O O
than O O
usual. O O
MEDICATIONS: O O
Metformin B-MEDICATION B-MEDICATION
500 O O
mg O O
p.o. O O
b.i.d., O O
Prevacid O O
30 O O
mg O O
p.o. O O
q.d., O O
atorvastatin B-MEDICATION B-MEDICATION
10 O O
mg O O
q.d., O O
sertraline O O
50 O O
mg O O
q.d., O O
warfarin, O O
lisinopril O B-MEDICATION
40 O O
mg O O
q.d., O O
Ambien O O
10 O O
mg O O
q.h.s. O O
p.r.n., O O
levothyroxine O O
100 O O
mg O O
p.o. O O
q.d., O O
aspirin, B-MEDICATION B-MEDICATION
eyedrops, O O
Colace, O O
and O O
Dulcolax. O O
SOCIAL B-SMOKER O
HISTORY: O O
She O O
is O O
looking O O
forward O O
to O O
a O O
good O O
Christmas. O O
She O O
is O O
here O O
today O O
with O O
her O O
daughter O O
Fitzpatrick. O O
PHYSICAL O O
EXAMINATION: O O
Temperature O O
97.2, O O
pulse O O
74, O O
BP B-HYPERTENSION O
208/66, I-HYPERTENSION O
weight O O
148 O O
pounds. O O
GENERAL: O O
Well O O
appearing O O
woman. O O
HEENT: O O
PERRL. O O
Single O O
stitch O O
along O O
the O O
lateral O O
aspect O O
of O O
her O O
left O O
eyebrow O O
is O O
easily O O
removed. O O
No O O
evidence O O
of O O
any O O
infection. O O
Her O O
left O O
deltoid O O
area O O
is O O
fine O O
and O O
she O O
has O O
good O O
range O O
of O O
motion O O
in O O
the O O
shoulder. O O
Her O O
left O O
ribcage O O
is O O
slightly O O
tender O O
but O O
without O O
any O O
bony O O
step-offs. O O
She O O
walks O O
well O O
with O O
no O O
pain O O
in O O
her O O
left O O
hip. O O
There O O
is O O
a O O
hand O O
sized O O
deep O O
purple O O
bruise O O
over O O
the O O
trochanteric O O
bursa. O O
ASSESSMENT O O
AND O O
PLAN: O O
Mechanical O O
fall O O
with O O
laceration O O
and O O
bruising O O
but O O
no O O
more O O
serious O O
complications. O O
Fortunately O O
she O O
did O O
not O O
have O O
intracranial O O
bleeding. O O
I O O
am O O
not O O
sure O O
why O O
her O O
blood O O
pressure O O
is O O
up, O O
whether O O
this O O
is O O
related O O
to O O
the O O
stress O O
of O O
the O O
falls O O
verses O O
independent O O
causes. O O
Given O O
that O O
the O O
high O O
blood O O
pressure O O
has O O
persisted, O O
I O O
will O O
add B-MEDICATION O
atenolol I-MEDICATION B-MEDICATION
12.5 O O
mg O O
p.o. O O
q.d., O O
and O O
discuss O O
via O O
phone O O
or O O
E-mail O O
with O O
her O O
daughter O O
next O O
week O O
to O O
see O O
how O O
well O O
this O O
is O O
working. O O
Goal O O
BP O O
140-160 O O
systolic. O O
Her O O
urine O O
was O O
checked O O
today. O O
Hematuria O O
has O O
resolved. O O
She O O
has O O
2+ O O
proteinuria. O O
I O O
will O O
recheck O O
this O O
in O O
a O O
week O O
or O O
two O O
after O O
we O O
treat O O
her O O
hypertension. O O
We O O
spent O O
over O O
half O O
of O O
today's O O
45-minute O O
visit O O
discussing O O
risks O O
and O O
benefits O O
of O O
Coumadin O O
therapy. O O
Although O O
she O O
is O O
at O O
risk O O
for O O
falls, O O
she O O
feels O O
quite O O
clearly O O
that O O
she O O
prefers O O
to O O
be O O
on O O
the O O
Coumadin O O
due O O
to O O
her O O
fear O O
of O O
having O O
a O O
repeated O O
thrombotic O O
stroke. O O
She O O
feels O O
that O O
she O O
has O O
not O O
had O O
any O O
bleeding O O
complications, O O
and O O
that O O
she O O
really O O
would O O
not O O
like O O
to O O
suffer O O
through O O
another O O
stroke. O O
I O O
explained O O
that O O
there O O
was O O
some O O
risk O O
with O O
falls O O
of O O
intracranial O O
hemorrhage O O
and O O
its O O
consequences. O O
I O O
spoke O O
with O O
Dr. O O
Dewitt O O
last O O
month O O
about O O
her O O
Coumadin, O O
and O O
we O O
both O O
feel O O
that O O
it O O
seems O O
to O O
be O O
working O O
well O O
in O O
terms O O
of O O
stroke O O
prevention, O O
but O O
that O O
she O O
is O O
at O O
increased O O
risk O O
for O O
falls. O O
It O O
seems O O
to O O
me O O
that O O
she O O
is O O
in O O
a O O
gray O O
area O O
with O O
no O O
clear O O
right O O
answer O O
in O O
terms O O
of O O
risk O O
benefit O O
analysis O O
for O O
Coumadin O O
for O O
her. O O
She O O
feels O O
very O O
strongly O O
that O O
she O O
wishes O O
to O O
continue. O O
This O O
was O O
discussed O O
in O O
detail O O
with O O
her O O
and O O
her O O
daughter, O O
and O O
this O O
probably O O
is O O
a O O
reasonable O O
decision. O O
I O O
encouraged O O
her O O
to O O
restart O O
physical O O
therapy O O
to O O
work O O
on O O
her O O
strength O O
and O O
hopefully O O
diminish O O
her O O
risk O O
of O O
a O O
subsequent O O
fall. O O
More O O
than O O
half O O
of O O
today's O O
45-minute O O
visit O O
spent O O
in O O
patient O O
counseling O O
and O O
education. O O
______________________________ O O
Julia O O
Yale, O O
M.D. O O
Dictated O O
By: O O
Julia O O
Yale O O
eScription O O
document:3-5285833 O O
EMSSten O O
Tel O O
DD: O O
11/30/97 O O
DT: O O
11/30/97 O O
DV: O O
11/30/97 O O

Record O O
date: O O
2098-06-13 O O
Betty O O
has O O
been O O
doing O O
'okay' O O
since O O
our O O
last O O
visit; O O
she O O
continues O O
to O O
report O O
a O O
slow O O
decline O O
in O O
swallowing O O
ability. O O
She O O
had O O
a O O
video O O
swallow O O
at O O
SJMH; O O
she O O
and O O
Fitzpatrick O O
were O O
told O O
that O O
the O O
underlying O O
problem O O
was O O
local O O
changes O O
due O O
to O O
her O O
radiation. O O
Her O O
gait O O
has O O
been O O
unchanged, O O
but O O
she O O
still O O
feels O O
it O O
has O O
deteriorated O O
a O O
little O O
over O O
the O O
last O O
year. O O
She O O
is O O
gardening, O O
and O O
trying O O
to O O
stay O O
active; O O
she O O
has O O
had O O
no O O
falls O O
and O O
uses O O
a O O
cane. O O
She O O
recently O O
added O O
amlodipine B-MEDICATION B-MEDICATION
for O O
her O O
hypertension. B-HYPERTENSION O
Echocardiogram: O O
Date: O O
9/02/95: O O
borderline O O
LVH, O O
preserved O O
EF. O O
Posterobasal O O
HK. O O
Not O O
done O O
for O O
PFO. O O
Brain O O
& O O
Vessel O O
Studies: O O
MRI/A: O O
CTA: O O
3/20/98: O O
'severe O O
proximal O O
LICA O O
stenosis', O O
just O O
distal O O
to O O
bifurcation...no O O
comment O O
on O O
comparison. O O
9/29/95: O O
&gt;90% O O
RCCA, O O
unchanged O O
from O O
the O O
exam O O
of O O
9/04/95. O O
&gt;90% O O
LCCA O O
proximal O O
to O O
the O O
stent O O
with O O
elevated O O
flow O O
velocities O O
within O O
the O O
stent. O O
70-75% O O
LICA. O O
The O O
estimation O O
of O O
stenosis O O
in O O
the O O
left O O
internal O O
carotid O O
artery O O
may O O
be O O
low O O
because O O
of O O
tandem O O
stenoses O O
in O O
the O O
left O O
carotid O O
artery. O O
Compared O O
to O O
the O O
study O O
of O O
9/04/95, O O
the O O
LICA O O
lesion O O
is O O
modestly O O
worse. O O
&gt;50% O O
in O O
B O O
ECAs. O O
9/26/95: O O
Lbif O O
stenosis O O
&gt;= O O
50%. O O
Rbif O O
without O O
significant O O
stenosis. O O
RVA O O
dominant. O O
Ultrasound: O O
8/24/95: O O
Low O O
RCCA O O
50-75%, O O
Mid O O
LCCA O O
75-90%, O O
calcified O O
LICA O O
possibly O O
&gt;50% O O
Angiography: O O
8/27/95: O O
proximal O O
RCCA O O
stenosis O O
&gt;80%, O O
ACA O O
cross-filling O O
from O O
L--&gt;R. O O
Right O O
vertebral O O
irregular/stenotic. O O
LCCA, O O
bifurcation, O O
LICA O O
with O O
significant O O
tandem O O
stenoses; O O
at O O
the O O
proximal O O
mid-LCCA, O O
&gt;80%. O O
Functional O O
Cerebrovascular O O
Studies: O O
Diamox O O
SPECT O O
7/14/97: O O
interpreted O O
as O O
normal. O O
Vascular O O
Procedures: O O
Right O O
CEA O O
(years O O
ago) O O
8/31/95: O O
(1) O O
right O O
vertebral O O
origin O O
balloon O O
angioplasty, O O
successful. O O
(2) O O
LCCA O O
stent O O
followed O O
by O O
balloon O O
angioplasty. O O
(3) O O
although O O
wanted O O
to O O
stent O O
LICA, O O
exceeded O O
fluoro O O
time. O O
Lipids: O O
Date: O O
11/96: O O
TC O O
183 O O
TG O O
91 O O
LDL O O
72 O O
HDL O O
82, O O
Lipoprotein(a): O O
, O O
Homocysteine: O O
8.7 O O
Hypercoagulable O O
studies: O O
Date: O O
ESR: O O
Anticardiolipin O O
IgG O O
/ O O
IgM: O O
negative O O
9/05 O O
Blood B-HYPERTENSION O
Pressure: I-HYPERTENSION O
12/15/97-3/5/98: O O
141-194/58-76 B-HYPERTENSION O
(with O O
pulse O O
between O O
56 O O
and O O
70) O O
Diabetes: B-DIABETES O
2/97: O O
HbA1C B-DIABETES O
8.6 I-DIABETES O
Smoking: B-SMOKER O
none I-SMOKER O
Other: O O
s/p O O
XRT O O
for O O
throat O O
cancer O O
~30 O O
years O O
ago O O
Medications O O
COUMADIN O O
(directed O O
by O O
Internal O O
Medicine) O O
ASPIRIN B-MEDICATION B-MEDICATION
81 O O
LISINOPRIL B-MEDICATION B-MEDICATION
40 O O
ATENOLOL B-MEDICATION B-MEDICATION
12.5 O O
(started O O
11/97) O O
ATORVASTATIN B-MEDICATION B-MEDICATION
10 O O
METFORMIN B-MEDICATION B-MEDICATION
500 O O
AM O O
/ O O
1000 O O
PM O O
FUROSEMIDE O O
10 O O
(started O O
12/97) O O
MULTIVITAMIN O O
QD O O
XALATAN O O
1 O O
DROP O O
OU O O
QPM O O
LEVOTHYROXINE O O
100MCG O O
QD O O
AMBIEN O O
prn O O
sleep O O
SERTRALINE O O
50 O O
QD O O
PREVACID O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
in I-HYPERTENSION O
the I-HYPERTENSION O
left I-HYPERTENSION O
arm I-HYPERTENSION O
is I-HYPERTENSION O
174/60. I-HYPERTENSION O
She O O
appears O O
well O O
overall, O O
but O O
slightly O O
anxious. O O
Cognitively, O O
she O O
appears O O
unchanged; O O
her O O
speech O O
is O O
fluent, O O
with O O
intact O O
repetition O O
and O O
comprehension, O O
and O O
her O O
recall O O
of O O
recent O O
events O O
(corroborated O O
by O O
her O O
daughter) O O
is O O
good. O O
Pupils O O
are O O
equal O O
and O O
reactive, O O
EOMI, O O
VFFTC. O O
Face, O O
tongue O O
and O O
palate O O
are O O
symmetric, O O
but O O
she O O
is O O
dysarthric; O O
glottal O O
sounds O O
worst. O O
This O O
sounds O O
slightly O O
worse O O
than O O
our O O
previous O O
visit. O O
Strength O O
is O O
full O O
in O O
all O O
extremities; O O
her O O
mild O O
dysmetria O O
is O O
unchanged. O O
Her O O
walk, O O
always O O
wide-based O O
and O O
slightly O O
unsteady, O O
appears O O
mildly O O
worse O O
than O O
our O O
previous O O
visit, O O
but O O
she O O
is O O
not O O
using O O
a O O
cane, O O
and O O
is O O
able O O
to O O
catch O O
herself O O
after O O
mild O O
stumbles. O O
She O O
is O O
unable O O
to O O
tandem O O
gait. O O
Impression: O O
Betty O O
is O O
a O O
78 O O
year O O
old O O
woman O O
with O O
progressive O O
cerebrovascular O O
disease O O
due O O
to O O
local O O
radiation, O O
plus O O
diabetes, B-DIABETES O
hypertension, O O
hyperlipidemia. B-HYPERLIPIDEMIA O
She O O
is O O
s/p O O
left O O
ICA O O
stents O O
and O O
right O O
VA O O
angioplasty. O O
Her O O
most O O
significant O O
vascular O O
lesion O O
is O O
stenosis O O
proximal O O
to O O
the O O
ICA O O
stent, O O
but O O
there O O
is O O
no O O
hint O O
now O O
of O O
transient O O
or O O
orthostatic O O
symptoms. O O
My O O
continued O O
feeling O O
is O O
that O O
we O O
ought O O
to O O
focus O O
on O O
her O O
controllable O O
risk O O
factors, O O
such O O
as O O
diabetes, O O
hypertension, O O
hyperlipidemia, O O
as O O
you O O
are O O
doing. O O
I O O
understand O O
you O O
have O O
recently O O
been O O
adjusting O O
her O O
antihypertensive O O
regimen. O O
I O O
would O O
recommend O O
a O O
goal O O
systolic O O
blood O O
pressure O O
no O O
lower O O
than O O
120 O O
mmHg. O O
I O O
think O O
a O O
reasonable O O
way O O
to O O
approach O O
this O O
is O O
to O O
use O O
(1) O O
her O O
clinical O O
status, O O
and O O
(2) O O
'functional' O O
imaging, O O
such O O
as O O
Diamox O O
SPECT, O O
to O O
follow O O
her O O
cerebrovascular O O
disease. O O
I O O
think O O
intervention O O
would O O
be O O
warranted O O
if O O
there O O
were O O
a O O
deterioration O O
in O O
one O O
of O O
these O O
parameters. O O
I O O
have O O
not O O
yet O O
heard O O
from O O
Howard O O
Yelverton O O
about O O
his O O
thoughts O O
regarding O O
the O O
recent O O
scan, O O
but O O
I O O
did O O
review O O
the O O
CT O O
scans O O
with O O
neuroradiology. O O
Our O O
impression O O
is O O
that, O O
while O O
the O O
wording O O
of O O
the O O
reports O O
seems O O
to O O
suggest O O
significant O O
progression O O
of O O
the O O
LICA O O
stenosis, O O
it's O O
not O O
significant O O
enough O O
to O O
prompt O O
us O O
to O O
act, O O
in O O
the O O
absence O O
of O O
symptomatic O O
or O O
functional O O
changes. O O
I O O
am O O
ordering O O
a O O
Diamox O O
SPECT O O
scan, O O
since O O
the O O
previous O O
one O O
was O O
in O O
July O O
of O O
last O O
year. O O
This O O
is O O
my O O
last O O
general O O
neurology O O
clinic O O
at O O
BMH; O O
I O O
will O O
be O O
a O O
neuromuscular O O
fellow O O
here O O
next O O
year. O O
While O O
I O O
can O O
be O O
available O O
for O O
questions O O
or O O
concerns, O O
I O O
will O O
be O O
referring O O
Betty's O O
care O O
to O O
one O O
of O O
the O O
more O O
junior O O
residents. O O
________________________ O O
Elvin O O
Cox O O
MD, O O
MBA O O
BMH O O
Neurology O O

Record O O
date: O O
2067-12-06 O O
Chief O O
Complaint O O
1. O O
cough O O
is O O
better. O O
She O O
uses O O
the O O
inhalers O O
regularly. O O
2. O O
Funny O O
taste O O
in O O
the O O
mouth O O
after O O
she O O
does O O
the O O
inhalers O O
in O O
the O O
morning. O O
No O O
sore O O
throat. O O
She O O
does O O
rinse O O
her O O
mouth O O
after O O
the O O
pulmicort. O O
3. O O
No O O
recurrence O O
of O O
the O O
hand O O
numbness. O O
Problems O O
Hypertension B-HYPERTENSION O
Insomnia O O
H/O O O
cerebrovascular O O
accident O O
borderline O O
aodm O O
Basal O O
cell O O
carcinoma O O
Medications O O
Vioxx O O
(ROFECOXIB) O O
25MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Lotrisone O O
Cream O O
(BETAMETHASONE O O
And O O
Clotri... O O
APPLY O O
CREAM O O
TOP O O
BID O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC I-MEDICATION O
Acid) I-MEDICATION O
325MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Allegra O O
(FEXOFENADINE O O
Hcl) O O
60MG, O O
1 O O
Tablet(s) O O
PO O O
BID O O
PRN O O
. O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
10MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG, O O
1 O O
Tablet(s) O O
PO O O
BID O O
: O O
take O O
1/2 O O
in O O
morning O O
and O O
1 O O
in O O
evening O O
Flonase O O
(FLUTICASONE O O
Nasal O O
Spray) O O
1-2 O O
SPRAY O O
NAS O O
QD O O
Celexa O O
(CITALOPRAM) O O
20MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Prilosec O O
(OMEPRAZOLE) O O
20MG, O O
1 O O
Capsule(s) O O
PO O O
QHS O O
Dyazide B-MEDICATION O
(TRIAMTERENE I-MEDICATION O
37.5 I-MEDICATION O
Mg/hctz I-MEDICATION O
25 I-MEDICATION O
Mg) I-MEDICATION O
1 O O
CAPSULE O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
10MG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
Albuterol O O
Inhaler O O
2 O O
PUFF O O
INH O O
Q4-6H O O
PRN O O
.cough O O
: O O
use O O
with O O
chamber O O
Singulair O O
(MONTELUKAST) O O
10MG, O O
1 O O
Tablet(s) O O
PO O O
QHS O O
Pulmicort O O
(BUDESONIDE O O
Oral O O
Inhaler) O O
2 O O
PUFF O O
INH O O
BID O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) I-MEDICATION O
75 O O
MG O O
PO O O
QD O O
Allergies O O
Sulfa O O
- O O
Unknown O O
Penicillins O O
- O O
Unknown O O
Social O O
History O O
Married. O O
Her O O
husband O O
has O O
Alzheimer's. O O
His O O
moods O O
are O O
variable. O O
She O O
has O O
been O O
going O O
to O O
FitSport O O
and O O
exercising O O
better. O O
non-smoker. B-SMOKER O
Six O O
children O O
and O O
six O O
grandchildren. O O
No O O
alcohol O O
in O O
30 O O
years. O O
Prior O O
alcohol O O
dependence. O O
Her O O
daughter, O O
son-in-law O O
and O O
18 O O
month O O
old O O
twins O O
are O O
living O O
in O O
her O O
house. O O
Her O O
Daughter, O O
Uber, O O
in O O
Vietnam O O
may O O
come O O
back O O
for O O
the O O
holidays. O O
Her O O
Daughter, O O
Ingalls, O O
lives O O
in O O
BOURNE-she O O
is O O
a O O
variable O O
cause O O
of O O
stress. O O
She O O
is O O
going O O
to O O
FitSport O O
almost O O
every O O
day. O O
Review O O
of O O
Systems O O
ROS-Sleep O O
has O O
been O O
OK, O O
occ O O
wakening O O
in O O
the O O
middle O O
of O O
the O O
night-she O O
uses O O
amytriptiline O O
at O O
night. O O
energy O O
is O O
better O O
since O O
she O O
is O O
exercising O O
more. O O
Vital O O
Signs O O
BLOOD B-HYPERTENSION O
PRESSURE I-HYPERTENSION O
140/80 B-HYPERTENSION O
Exam O O
HEENT-NC/AT, O O
EOMI, O O
PERRL O O
TM-Clear O O
Pharynx-Clear O O
Chest-clear O O
to O O
P O O
and O O
A O O
Cor-S1S2 O O
normal O O
no O O
murmers, O O
rubs O O
or O O
gallops O O
Abd-soft, O O
nontender, O O
no O O
hepatosplenomegaly O O
Ext-no O O
edema O O
Disposition O O
and O O
Plans O O
1. O O
Cough-we O O
discussed O O
that O O
she O O
will O O
need O O
to O O
stay O O
on O O
the O O
albuterol O O
and O O
the O O
pulmicort O O
in O O
order O O
to O O
prevent O O
the O O
cough O O
from O O
coming O O
back. O O
2. O O
Insomnia O O
which O O
had O O
been O O
such O O
a O O
problem O O
seems O O
better O O
now. O O
Continue O O
the O O
celexa O O
20mg O O
and O O
she O O
is O O
also O O
on O O
amytriptiline O O
(per O O
Dr. O O
Dill). O O
She O O
will O O
double O O
check O O
the O O
dose O O
through O O
him. O O
3. B-HYPERLIPIDEMIA O
Hyperlipidemia-On B-HYPERLIPIDEMIA O
lipitor. B-MEDICATION B-MEDICATION
Check O O
LFTs O O
and O O
CPK O O
along O O
with O O
chol/HDL O O
today. O O
4. O O
HTN-good B-HYPERTENSION O
control O O
on O O
the O O
lisinopril, B-MEDICATION B-MEDICATION
atenolol B-MEDICATION B-MEDICATION
and O O
dyazide. B-MEDICATION O
Check O O
electrolytes O O
today. O O
5. O O
Borderline O O
AODM. O O
Check O O
glucose O O
today. O O
______________________________ O O
Othel O O
Vidal, O O
M.D. O O

Record O O
date: O O
2068-06-01 O O
Chief O O
Complaint O O
1. O O
She O O
increased O O
the O O
lisinopril B-MEDICATION B-MEDICATION
to O O
20mg. O O
she O O
is O O
tolerating O O
it O O
well. O O
No O O
dizziness, O O
no O O
side O O
effects. O O
BP O O
at O O
home O O
is O O
excellent. O O
2. O O
She O O
is O O
interested O O
in O O
starting O O
an O O
antioxidant, O O
her O O
friend O O
used O O
it O O
and O O
felt O O
better. O O
3. O O
Skin O O
lesions: O O
left O O
side O O
of O O
the O O
face, O O
left O O
forearm. O O
Problems O O
Hypertension B-HYPERTENSION O
Insomnia O O
H/O O O
cerebrovascular O O
accident O O
borderline O O
aodm O O
Basal O O
cell O O
carcinoma O O
Medications O O
Vioxx O O
(ROFECOXIB) O O
25MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Lotrisone O O
Cream O O
(BETAMETHASONE O O
And O O
Clotri... O O
APPLY O O
CREAM O O
TOP O O
BID O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC I-MEDICATION O
Acid) I-MEDICATION O
325MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Allegra O O
(FEXOFENADINE O O
Hcl) O O
60MG O O
CAPSULE O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
PRN O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
, O O
take O O
1/2 O O
in O O
morning O O
and O O
1 O O
in O O
evening O O
Flonase O O
(FLUTICASONE O O
Nasal O O
Spray) O O
1-2 O O
SPRAY O O
NAS O O
QD O O
Prilosec O O
(OMEPRAZOLE) O O
20MG O O
CAPSULE O O
CR O O
take O O
1 O O
Capsule(s) O O
PO O O
QHS O O
Dyazide B-MEDICATION O
(TRIAMTERENE I-MEDICATION O
37.5 I-MEDICATION O
Mg/hctz B-MEDICATION O
25 I-MEDICATION O
Mg) I-MEDICATION O
1 O O
CAPSULE O O
PO O O
QD O O
Albuterol O O
Inhaler O O
2 O O
PUFF O O
INH O O
Q4-6H O O
PRN O O
.cough O O
, O O
use O O
with O O
chamber O O
Singulair O O
(MONTELUKAST) O O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QHS O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) I-MEDICATION O
75 O O
MG O O
PO O O
QD O O
Pulmicort O O
(BUDESONIDE O O
Oral O O
Inhaler) O O
4 O O
PUFF O O
INH O O
BID O O
Robitussin O O
Ac O O
(GUAIFENESIN O O
Ac) O O
5 O O
ML O O
TO O O
10 O O
ML O O
PO O O
Q4H O O
PRN O O
.cough O O
, O O
UL5104263 O O
Celexa O O
(CITALOPRAM) O O
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
20MG O O
TABLET O O
take O O
1 O O
PO O O
QD O O
Allergies O O
Sulfa O O
- O O
Unknown O O
Penicillins O O
- O O
Unknown O O
Social O O
History O O
Married. O O
Her O O
husband O O
has O O
Alzheimer's. O O
He O O
has O O
gotten O O
a O O
little O O
more O O
'mellow' O O
non-smoker. B-SMOKER O
Six O O
children O O
and O O
six O O
grandchildren. O O
Her O O
daughter O O
with O O
her O O
2 O O
year O O
old O O
twins, O O
and O O
other O O
daughter, O O
Judd, O O
are O O
living O O
with O O
her. O O
No O O
alcohol O O
in O O
30 O O
years. O O
Prior O O
alcohol O O
dependence. O O
Review O O
of O O
Systems O O
ROS-no O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
no O O
cough. O O
Mood O O
is O O
good. O O
Sleep O O
is O O
good. O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
114/64 O O
Exam O O
Chest-clear O O
to O O
P O O
and O O
A O O
Cor-S1S2 O O
normal O O
no O O
murmers, O O
rubs O O
or O O
gallops O O
Abd-soft, O O
nontender, O O
no O O
hepatosplenomegaly O O
Ext-no O O
edema O O
Skin-raised, O O
erythematous O O
lesion O O
near O O
left O O
angle O O
of O O
the O O
jaw, O O
raised O O
verrucous O O
lestion O O
on O O
left O O
calf. O O
Disposition O O
and O O
Plans O O
1. O O
BP O O
is O O
under O O
excellent O O
control. O O
Continue O O
atenolol, B-MEDICATION B-MEDICATION
dyzide, B-MEDICATION O
lisinopril. O B-MEDICATION
f/u O O
with O O
me O O
in O O
3 O O
months, O O
sooner O O
for O O
any O O
problems. O O
2. O O
Asthma-under O O
good O O
control. O O
3. O O
Skin O O
lesions: O O
she O O
will O O
f/u O O
with O O
Dr. O O
Kim. O O
______________________________ O O
Othel O O
Vidal, O O
M.D. O O

Record O O
date: O O
2068-09-26 O O
Reason B-SMOKER O
for I-SMOKER O
Visit O O
Patient O O
presents O O
for O O
pre-op O O
physical O O
exam. O O
Having O O
left O O
eye O O
cataract O O
surgery O O
Dr. O O
Janes O O
on O O
10/04/68. O O
Feels O O
well. O O
Problems O O
Hypertension B-HYPERTENSION O
Insomnia O O
H/O O O
cerebrovascular O O
accident O O
borderline O O
aodm O O
Basal O O
cell O O
carcinoma O O
Asthma O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Procedures O O
Tonsillectomy O O
Medications O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC I-MEDICATION O
Acid) I-MEDICATION O
325MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Allegra O O
(FEXOFENADINE O O
Hcl) O O
60MG O O
CAPSULE O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
PRN O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
, O O
take O O
1/2 O O
in O O
morning O O
and O O
1 O O
in O O
evening O O
Flonase O O
(FLUTICASONE O O
Nasal O O
Spray) O O
1-2 O O
SPRAY O O
NAS O O
QD O O
Prilosec O O
(OMEPRAZOLE) O O
20MG O O
CAPSULE O O
CR O O
take O O
1 O O
Capsule(s) O O
PO O O
QHS O O
Dyazide B-MEDICATION O
(TRIAMTERENE I-MEDICATION O
37.5 I-MEDICATION O
Mg/hctz I-MEDICATION O
25 I-MEDICATION O
Mg) I-MEDICATION O
1 O O
CAPSULE O O
PO O O
QD O O
Albuterol O O
Inhaler O O
2 O O
PUFF O O
INH O O
Q4-6H O O
PRN O O
.cough O O
, O O
use O O
with O O
chamber O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) I-MEDICATION O
75 O O
MG O O
PO O O
QD O O
Pulmicort O O
(BUDESONIDE O O
Oral O O
Inhaler) O O
4 O O
PUFF O O
INH O O
BID O O
Celexa O O
(CITALOPRAM) O O
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
20MG O O
TABLET O O
take O O
1 O O
PO O O
QD O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Singulair O O
(MONTELUKAST) O O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QHS O O
Allergies O O
Sulfa O O
- O O
Unknown O O
Penicillins O O
- O O
Unknown O O
Assessment O O
and O O
Plan O O
1. O O
Pre-op O O
Physical O O
Exam O O
-EKG O O
-Labs: O O
CBC, O O
PT, O O
PTT O O
-Completed O O
form, O O
see O O
chart O O
-will O O
fax O O
form O O
once O O
have O O
lab O O
results O O
_____________________________________________ O O
Inez O O
Yelverton, O O
NP O O

Record O O
date: O O
2070-04-02 O O
Chief O O
Complaint O O
1. O O
Feels O O
pretty O O
well. O O
She O O
had O O
the O O
MOHS O O
surgery O O
on O O
the O O
left O O
side O O
of O O
her O O
face, O O
it O O
has O O
gotten O O
infected. O O
2. O O
Her O O
husband, O O
Xin, O O
has O O
progressive O O
dementia O O
and O O
that O O
is O O
difficult. O O
Problems O O
Hypertension B-HYPERTENSION O
on O O
atenolol B-MEDICATION B-MEDICATION
and O O
lisinopril B-MEDICATION B-MEDICATION
Insomnia O O
much O O
better O O
recently O O
H/O O O
cerebrovascular O O
accident O O
on O O
aspirin B-MEDICATION B-MEDICATION
and O O
plavix B-MEDICATION B-MEDICATION
Basal O O
cell O O
carcinoma O O
s/p O O
MOHS O O
surgery O O
in O O
3/2070 O O
Asthma O O
well O O
controlled O O
with O O
flovent O O
and O O
singulair. O O
She O O
uses O O
PRN O O
albuterol O O
Hyperlipidemia B-HYPERLIPIDEMIA O
on O O
Lipitor B-MEDICATION B-MEDICATION
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
: O O
Started O O
metformin B-MEDICATION B-MEDICATION
2069 O O
checking O O
blood O O
sugars O O
at O O
home. O O
Medications O O
Asa B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC I-MEDICATION O
Acid) I-MEDICATION O
325MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Flonase O O
(FLUTICASONE O O
Nasal O O
Spray) O O
1-2 O O
SPRAY O O
NAS O O
QD O O
Prilosec O O
(OMEPRAZOLE) O O
20MG O O
CAPSULE O O
CR O O
take O O
1 O O
Capsule(s) O O
PO O O
QHS O O
Albuterol O O
Inhaler O O
2 O O
PUFF O O
INH O O
Q4-6H O O
PRN O O
.cough O O
, O O
use O O
with O O
chamber O O
Flovent O O
(FLUTICASONE O O
Propionate) O O
44MCG O O
AEROSOL O O
take O O
2 O O
Puff(s) O O
INH O O
BID O O
Dyazide B-MEDICATION O
(TRIAMTERENE I-MEDICATION O
37.5 I-MEDICATION O
Mg/hctz I-MEDICATION O
25 I-MEDICATION O
Mg) I-MEDICATION O
1 O O
CAPSULE O O
PO O O
QD O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) I-MEDICATION O
75 O O
MG O O
PO O O
QD O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
10MG I-MEDICATION O
TABLET I-MEDICATION O
take I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Glucophage B-MEDICATION B-MEDICATION
(METFORMIN) I-MEDICATION O
500MG I-MEDICATION O
TABLET I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
ATENOLOL B-MEDICATION B-MEDICATION
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
, O O
take O O
1/2 O O
in O O
morning O O
and O O
1 O O
in O O
evening O O
Celexa O O
(CITALOPRAM) O O
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
20MG O O
TABLET O O
take O O
1 O O
PO O O
QD O O
Singulair O O
(MONTELUKAST) O O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QHS O O
Allegra O O
(FEXOFENADINE O O
Hcl) O O
60MG O O
CAPSULE O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
PRN O O
Allergies O O
Sulfa O O
- O O
Unknown O O
Penicillins O O
- O O
Unknown O O
Social B-SMOKER O
History O O
Marital O O
status: O O
married O O
EtOH: O O
none O O
for O O
many O O
years O O
Occupation: O O
cashier, O O
active O O
in O O
the O O
community O O
Exercise: O O
active O O
liefstyle O O
Review O O
of O O
Systems O O
ROS-no O O
fever, O O
chills, O O
shortness O O
of O O
breath. O O
She O O
has O O
ongoing O O
cough. O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
120/78 O O
Exam O O
Chest-clear O O
to O O
P O O
and O O
A O O
Cor-S1S2 O O
normal O O
no O O
murmers, O O
rubs O O
or O O
gallops O O
Abd-soft, O O
nontender, O O
no O O
hepatosplenomegaly O O
Ext-no O O
edema O O
Disposition O O
and O O
Plans O O
1. O O
Routine O O
health-scheduled O O
mammogram, O O
colonoscopy. O O
2. O O
Type B-DIABETES O
2 I-DIABETES O
DM-she I-DIABETES O
will O O
see O O
Carolyn O O
Delong, O O
nutrition. O O
She O O
will O O
start O O
doing O O
home O O
glucose O O
monitoring. O O
Continue O O
the O O
metformin O O
BID. O O
Check O O
HbA1C O O
today, O O
she O O
will O O
schedule O O
ophtho O O
and O O
podiatry O O
apt O O
for O O
yearly O O
check. O O
3. O O
HTN B-HYPERTENSION O
is O O
under O O
excellent O O
control. O O
4. O O
Depression O O
is O O
controlled O O
with O O
celexa-she O O
is O O
sleeping O O
better. O O
5. O O
Asthma-controlled O O
with O O
singulair, O O
flovent O O
and O O
albuterol. O O
6. O O
Hyperlipidemia-check O O
labs O O
every O O
6 O O
months. O O
______________________________ O O
Othel O O
Vidal, O O
M.D. O O

Record O O
date: O O
2071-11-17 O O
Chief O O
Complaint O O
Urso O O
comes O O
in O O
with O O
several O O
days O O
of: O O
nausea, O O
diarrhea O O
(5-6 O O
times) O O
with O O
'everything O O
going O O
through O O
her'. O O
She O O
has O O
no O O
vomiting. O O
+ O O
abd O O
cramping O O
pain. O O
No O O
blood O O
in O O
the O O
stool. O O
She O O
had O O
low O O
grade O O
fever. O O
In O O
addition, O O
she O O
feels O O
increased O O
chest O O
congestion, O O
cough, O O
productive O O
of O O
white O O
sputum. O O
Her O O
finger O O
sticks O O
at O O
home O O
are O O
running O O
at O O
280. O O
No O O
one O O
at O O
home O O
has O O
been O O
sick. O O
She O O
had O O
dental O O
work O O
done O O
and O O
received O O
antibiotics O O
about O O
a O O
month O O
ago. O O
Problems O O
Hypertension B-HYPERTENSION O
: O O
Well O O
controlled O O
on O O
dyazide, B-MEDICATION O
lisinopril B-MEDICATION B-MEDICATION
and O O
atenolol B-MEDICATION B-MEDICATION
Insomnia O O
H/O O O
cerebrovascular O O
accident O O
Basal O O
cell O O
carcinoma O O
Asthma O O
: O O
on O O
Flovent O O
and O O
Singulair. O O
Good O O
control O O
Hyperlipidemia B-HYPERLIPIDEMIA O
: O O
On O O
lipitor B-MEDICATION B-MEDICATION
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
: O O
On O O
Glucovance B-MEDICATION B-MEDICATION
2.5/500 O O
BID O O
Medications O O
Albuterol O O
Inhaler O O
2 O O
PUFF O O
INH O O
Q4-6H O O
PRN O O
.cough O O
, O O
use O O
with O O
chamber O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
, O O
take O O
1/2 O O
in O O
morning O O
and O O
1 O O
in O O
evening O O
Carmol O O
40 O O
Cream O O
(UREA O O
40%) O O
1 O O
APPLICATION O O
TOP O O
QD O O
, O O
apply O O
to O O
thick O O
skin O O
on O O
feet O O
once O O
a O O
day O O
Celexa O O
(CITALOPRAM) O O
20MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Dyazide B-MEDICATION O
(TRIAMTERENE O O
37.5 O O
Mg/hctz B-MEDICATION O
25 O O
Mg) O O
1 O O
CAPSULE O O
PO O O
QD O O
Flonase O O
(FLUTICASONE O O
Nasal O O
Spray) O O
1-2 O O
SPRAY O O
NAS O O
QD O O
Flovent O O
(FLUTICASONE O O
Propionate) O O
44MCG O O
AEROSOL O O
take O O
2 O O
Puff(s) O O
INH O O
BID O O
Glucovance O B-MEDICATION
(GLYBURIDE/METFORMIN) O O
2.5/500 O O
MG O O
PO O O
BID O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
20MG O O
TABLET O O
take O O
1 O O
PO O O
QD O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
PO O O
QD O O
PREDNISONE O O
10MG O O
TABLET O O
take O O
4 O O
po O O
qd O O
x O O
3 O O
days, O O
2 O O
po O O
qd O O
x O O
3 O O
days, O O
1 O O
po O O
qd O O
x O O
3 O O
days O O
Tablet(s) O O
PO O O
QAM O O
PRN O O
bronchitis O O
Serevent O O
Diskus O O
(SALMETEROL O O
Diskus) O O
1 O O
PUFF O O
INH O O
BID O O
Singulair O O
(MONTELUKAST) O O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QHS O O
Triamcinolone O O
Ointment O O
0.1% O O
OINTMENT O O
TOP O O
bid O O
PRN O O
, O O
apply O O
to O O
rash O O
two O O
to O O
three O O
times O O
per O O
day; O O
avoid O O
face, O O
groin, O O
and O O
underarms O O
Allergies O O
Sulfa O O
- O O
Unknown O O
Penicillins O O
- O O
Unknown O O
Social O O
History O O
Married, O O
her O O
husband O O
has O O
Alzheimers. O O
He O O
has O O
been O O
moved O O
to O O
Portland O O
Sanatorium. O O
Her O O
daughter O O
and O O
3 O O
grandchildren O O
are O O
living O O
with O O
her. O O
Her O O
other O O
daughter O O
has O O
breast O O
cancer O O
and O O
is O O
going O O
through O O
RT O O
treatments. O O
She O O
had O O
7 O O
children, O O
one O O
died. O O
She O O
has O O
6 O O
adult O O
children. O O
EtOH-none O O
Smoking-none B-SMOKER O
Review O O
of O O
Systems O O
ROS-No O O
chest O O
pain, O O
no O O
headache, O O
no O O
photophobia. O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
110/68 O O
PULSE O O
83 O O
TEMPERATURE O O
98.1 O O
F O O
O2 O O
SAT O O
96 O O
Exam O O
HEENT-NC/AT, O O
EOMI, O O
PERRL O O
TM-Clear O O
Pharynx-Clear O O
Chest-clear O O
to O O
P O O
and O O
A-no O O
wheezing O O
on O O
exam O O
today. O O
Cor-S1S2 O O
normal O O
no O O
murmers, O O
rubs O O
or O O
gallops O O
Abd-soft, O O
nontender, O O
no O O
hepatosplenomegaly O O
Disposition O O
and O O
Plans O O
1. O O
Type B-DIABETES O
2 I-DIABETES O
DM. I-DIABETES O
She O O
has O O
elevated O O
blood O O
sugar O O
at O O
home. O O
Will O O
increase O O
glyburide/metformin O B-MEDICATION
to O O
5/500. O O
Check O O
HbA1c O O
today. O O
2. O O
Diarrhea-will O O
check O O
C.diff O O
and O O
stool O O
C O O
and O O
S. O O
Use O O
imodium O O
PRN. O O
3. O O
Cough O O
and O O
congestion. O O
Will O O
check O O
CXR O O
today. O O
Will O O
write O O
for O O
zithromax, O O
hold O O
on O O
starting O O
and O O
call O O
tomorrow O O
with O O
how O O
she O O
is O O
doing. O O
4. O O
Chronic O O
cough O O
and O O
mucus O O
production. O O
Will O O
f/u O O
again O O
in O O
10 O O
days, O O
bring O O
in O O
medication O O
that O O
she O O
is O O
using O O
and O O
discuss O O
further O O
management. O O
______________________________ O O
Othel O O
Vidal, O O
M.D. O O

Record O O
date: O O
2143-04-03 O O
PL O O
Neurology O O
PROMPTCARE/Leprosarium O O
Neurology O O
0446 O O
Sky O O
Meadow O O
Drive, O O
Suite O O
20 O O
LIU, O O
OLGA O O
Tunis, O O
IA O O
49952 O O
94318406 O O
077-765-3083 O O
04/03/2143 O O
DATE O O
OF O O
BIRTH: O O
09/12/81. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
61-year-old O O
ambidextrous O O
female O O
is O O
referred O O
by O O
Dr. O O
Orellana O O
for O O
followup O O
of O O
possible O O
stroke O O
or O O
TIA. O O
The O O
patient O O
is O O
interviewed O O
and O O
available O O
records O O
are O O
reviewed. O O
In O O
February, O O
she O O
developed O O
left O O
leg O O
weakness O O
on O O
arising O O
one O O
morning. O O
There O O
was O O
also O O
some O O
possible O O
ataxia O O
of O O
the O O
left O O
upper O O
extremity O O
with O O
decreased O O
control O O
of O O
both O O
the O O
arm O O
and O O
the O O
leg. O O
This O O
seemed O O
to O O
occur O O
for O O
two O O
days O O
in O O
a O O
row O O
and O O
on O O
one O O
occasion, O O
she O O
fell O O
getting O O
out O O
of O O
bed. O O
The O O
symptoms O O
resolved O O
before O O
she O O
could O O
be O O
evaluated. O O
She O O
attributed O O
the O O
symptoms O O
to O O
not O O
enough O O
air O O
pressure O O
in O O
her O O
air O O
mattress O O
and O O
once O O
this O O
was O O
corrected, O O
she O O
feels O O
that O O
the O O
event O O
has O O
not O O
re-occured. O O
The O O
second O O
event O O
was O O
apparently O O
associated O O
with O O
some O O
left O O
facial O O
weakness O O
as O O
well. O O
She O O
was O O
seen O O
by O O
Neurology O O
on O O
02/10/43 O O
after O O
she O O
was O O
admitted. O O
The O O
history O O
includes O O
also O O
lightheadedness O O
and O O
foggy O O
vision O O
per O O
that O O
report. O O
Initially O O
MRI O O
of O O
the O O
head O O
showed O O
no O O
acute O O
events O O
but O O
did O O
show O O
a O O
change O O
in O O
the O O
right O O
posterior O O
cerebral O O
artery O O
and O O
a O O
lesion O O
in O O
the O O
left O O
temporal O O
lobe. O O
Also, O O
in O O
the O O
record O O
is O O
noted O O
that O O
at O O
the O O
time O O
of O O
the O O
second O O
event, O O
her O O
glucose O O
was O O
very O O
low O O
at O O
around O O
32 O O
and O O
symptoms O O
resolved O O
after O O
treatment O O
with O O
D50. O O
There O O
was O O
also O O
further O O
history O O
that O O
the O O
patient O O
had O O
been O O
seeing O O
a O O
chiropractor O O
for O O
treatment O O
of O O
neck O O
pain O O
in O O
the O O
several O O
months O O
leading O O
up O O
to O O
the O O
event. O O
On O O
examination O O
at O O
the O O
time O O
of O O
admission, O O
there O O
were O O
no O O
clear O O
findings. O O
MRI O O
was O O
said O O
to O O
show O O
periventricular O O
white O O
matter O O
changes. O O
The O O
area O O
of O O
abnormality O O
adjacent O O
to O O
the O O
left O O
lateral O O
ventricle O O
was O O
thought O O
to O O
perhaps O O
represent O O
an O O
old O O
prior O O
small O O
hemorrhage. O O
MRA O O
of O O
the O O
brain O O
showed O O
absence O O
of O O
visualization O O
of O O
the O O
right O O
PCA O O
about O O
1 O O
cm O O
beyond O O
its O O
origin O O
but O O
MRA O O
of O O
the O O
neck O O
showed O O
no O O
significant O O
changes. O O
Subsequent O O
echocardiogram O O
showed O O
mild O O
LVH O O
with O O
no O O
evidence O O
of O O
a O O
shunt. O O
Currently, O O
the O O
patient O O
is O O
asymptomatic O O
and O O
presents O O
for O O
routine O O
followup. O O
It O O
has O O
been O O
unclear O O
what O O
the O O
cause O O
of O O
her O O
symptoms O O
was. O O
Some O O
have O O
attributed O O
the O O
symptoms O O
to O O
hypoglycemia O O
and O O
another O O
formulation O O
was O O
that O O
of O O
a O O
thalamic O O
TIA O O
given O O
the O O
changes O O
in O O
the O O
right O O
PCA O O
on O O
MRA. O O
Another O O
consideration O O
was O O
dissection O O
from O O
manipulation O O
by O O
the O O
chiropractor. O O
There O O
is O O
no O O
clinical O O
history O O
to O O
go O O
with O O
the O O
possible O O
old O O
small O O
hemorrhage. O O
REVIEW O O
OF O O
SYSTEMS: O O
Notable O O
for O O
multifocal O O
muscle O O
aches O O
and O O
a O O
chronic O O
cough. O O
The O O
patient O O
also O O
has O O
some O O
shortness O O
of O O
breath O O
but O O
there O O
is O O
no O O
report O O
of O O
chest O O
pain O O
or O O
fever O O
or O O
chills. O O
There O O
are O O
no O O
medication O O
allergies O O
reported. O O
PAST O O
FAMILY/SOCIAL O O
HISTORY: O O
Past O O
medical O O
history O O
is O O
notable O O
for O O
hypertension, B-HYPERTENSION O
hypercholesterolemia, B-HYPERLIPIDEMIA B-MEDICATION
spinal O O
stenosis, O O
diabetes, B-DIABETES O
depression, O O
neuropathy, O O
anxiety, O O
COPD, O O
arthritis, O O
and O O
sinus O O
symptoms. O O
MEDICATIONS: O O
Lisinopril, B-MEDICATION B-MEDICATION
Lopressor, B-MEDICATION B-MEDICATION
glyburide, B-MEDICATION B-MEDICATION
Naprosyn, O O
Neurontin, O O
Paxil, O O
Lescol, B-MEDICATION O
Advair, O O
trazodone, O O
Glucophage, B-MEDICATION B-MEDICATION
and O O
?___?. O O
Not O O
withstanding O O
the O O
above, O O
the B-SMOKER O
patient I-SMOKER O
continues B-SMOKER O
to I-SMOKER O
smoke. I-SMOKER O
She O O
uses O O
alcohol O O
occasionally. O O
She O O
has O O
a O O
12th O O
grade O O
education. O O
She O O
lives O O
alone O O
and O O
is O O
a O O
widow. O O
PHYSICAL O O
EXAMINATION: O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
148/86, I-HYPERTENSION O
pulse O O
83 O O
and O O
regular, O O
respirations O O
20. O O
The O O
patient O O
is O O
overweight. B-OBESE O
Height B-OBESE O
is I-OBESE O
5 I-OBESE O
foot I-OBESE O
3 I-OBESE O
inches. I-OBESE O
Weight I-OBESE O
is I-OBESE O
217 I-OBESE O
pounds. I-OBESE O
Range O O
of O O
motion O O
of O O
the O O
neck O O
is O O
reduced O O
in O O
all O O
quadrants, O O
though O O
without O O
clear O O
spasm. O O
Poor O O
neck O O
posture O O
is O O
noted. O O
Funduscopic O O
examination O O
is O O
normal O O
with O O
regard O O
to O O
disks O O
and O O
vessels. O O
Cardiovascular O O
testing, O O
carotids O O
are O O
2+ O O
without O O
bruits. O O
Temporal O O
arteries O O
are O O
normal. O O
Musculoskeletal O O
testing, O O
gait O O
and O O
station O O
show O O
a O O
slight O O
slowing O O
of O O
gait O O
that O O
has O O
been O O
present O O
for O O
years. O O
Romberg O O
is O O
negative. O O
Tandem O O
gait O O
is O O
normal. O O
The O O
patient O O
does O O
move O O
slowly O O
in O O
general, O O
this O O
is O O
probably O O
not O O
reflective O O
of O O
true O O
bradykinesia. O O
There O O
is O O
some O O
asymmetry O O
of O O
the O O
shoulders O O
with O O
elevation O O
on O O
the O O
right O O
compared O O
with O O
the O O
left. O O
This O O
affects O O
movements O O
of O O
the O O
arms O O
and O O
range O O
of O O
motion O O
of O O
the O O
arms O O
but O O
it O O
appears O O
to O O
be O O
orthopedic O O
in O O
nature O O
and O O
not O O
neurologic. O O
There O O
is O O
no O O
focal O O
muscle O O
weakness O O
or O O
atrophy O O
noted. O O
NEUROLOGICAL O O
TESTING: O O
Mental O O
status O O
is O O
essentially O O
normal O O
to O O
orientation, O O
memory, O O
attention, O O
language O O
and O O
fund O O
of O O
information. O O
Cranial O O
nerve O O
testing, O O
pupils O O
are O O
3 O O
mm O O
and O O
briskly O O
reactive. O O
Extraocular O O
movements O O
are O O
full. O O
Visual O O
fields O O
are O O
intact. O O
There O O
is O O
no O O
facial O O
sensory O O
loss, O O
but O O
there O O
is O O
a O O
mild O O
facial O O
asymmetry O O
that O O
did O O
not O O
look O O
pathological. O O
Visual O O
fields O O
are O O
intact. O O
Hearing O O
is O O
intact. O O
Oropharynx O O
is O O
normal. O O
Palate O O
elevates O O
well. O O
Tongue O O
is O O
midline. O O
Sensory O O
testing O O
shows O O
absent O O
vibration O O
sensation O O
in O O
the O O
feet O O
bilaterally O O
but O O
sensory O O
testing O O
is O O
otherwise O O
intact. O O
Reflexes O O
are O O
absent O O
in O O
the O O
lower O O
extremities O O
and O O
1+ O O
in O O
the O O
upper O O
extremities. O O
There O O
is O O
possible O O
withdrawal O O
at O O
the O O
left O O
toe O O
but O O
the O O
right O O
toe O O
seems O O
downgoing. O O
Coordination O O
testing O O
today O O
seemed O O
intact. O O
Prior O O
neurologic O O
evaluation O O
from O O
02/10/43 O O
is O O
reviewed. O O
Homocystine O O
level O O
was O O
elevated O O
at O O
14, O O
normal O O
zero O O
to O O
ten. O O
Recommended O O
treatment O O
included O O
folate, O O
pyridoxine, O O
and O O
B12. O O
IMPRESSION: O O
Transient O O
neurologic O O
symptoms, O O
question O O
etiology. O O
Comment. O O
I O O
would O O
agree O O
with O O
prior O O
examiners O O
that O O
the O O
symptoms O O
probably O O
do O O
not O O
relate O O
to O O
the O O
position O O
of O O
the O O
bed O O
or O O
air O O
in O O
the O O
air O O
mattress. O O
I O O
do O O
not O O
think O O
the O O
symptoms O O
are O O
approximate O O
enough O O
to O O
the O O
chiropractic O O
manipulation O O
to O O
be O O
relevant. O O
Symptoms O O
could O O
have O O
related O O
to O O
hypoglycemia O O
or O O
could O O
have O O
been O O
vascular O O
in O O
nature. O O
In O O
this O O
regard, O O
the O O
PCA O O
stenosis O O
or O O
occlusion O O
may O O
be O O
relevant. O O
It O O
is O O
not O O
immediately O O
clear O O
how O O
to O O
fit O O
in O O
the O O
old O O
hemorrhage. O O
PLAN: O O
Although, O O
she O O
should O O
be O O
on O O
some O O
type O O
of O O
antiplatelet O O
agent. O O
She O O
was O O
on O O
aspirin B-MEDICATION B-MEDICATION
at O O
the O O
time O O
of O O
the O O
event O O
and O O
therefore O O
would O O
be O O
considered O O
an O O
aspirin O B-MEDICATION
failure. O O
We O O
therefore O O
suggested O O
Plavix O B-MEDICATION
75 O O
mg O O
daily. O O
We O O
were O O
subsequently O O
called O O
by O O
the O O
pharmacy O O
and O O
informed O O
that O O
she O O
is O O
already O O
on O O
Aggrenox. O O
It O O
probably O O
does O O
not O O
matter O O
which O O
medication O O
she O O
chooses; O O
however, O O
she O O
should O O
be O O
on O O
one O O
or O O
the O O
other O O
and O O
not O O
both. O O
For O O
treatment O O
of O O
the O O
homocysteine O O
level O O
elevation, O O
we O O
have O O
added O O
simply O O
multivitamins O O
two O O
daily. O O
I O O
am O O
not O O
sure O O
how O O
significant O O
this O O
finding O O
is O O
in O O
relation O O
to O O
the O O
above O O
symptoms. O O
She O O
is O O
advised O O
to O O
watch O O
her O O
glucose O O
level O O
and O O
adjust O O
medicines O O
accordingly. O O
We O O
have O O
suggested O O
a O O
followup O O
in O O
Neurology O O
in O O
six O O
months. O O
______________________________ O O
Robert O O
F O O
Titus, O O
MD O O
eScription O O
document:0-9416184 O O
IL O O
DD: O O
04/11/43 O O
DT: O O
04/11/43 O O
DV: O O
04/03/43 O O

Record O O
date: O O
2145-07-25 O O
Olga O O
comes O O
in O O
for O O
4 O O
mo O O
f/u. O O
She O O
c/o O O
worsening O O
L O O
knee O O
pain O O
with O O
swelling. O O
She O O
is O O
due O O
to O O
see O O
Dr. O O
Walter O O
in O O
11/45. O O
She O O
had O O
RTKR O O
done O O
last O O
year. O O
Breathing O O
has O O
been O O
stable. O O
Increased O O
stress O O
taking O O
care O O
of O O
elderly O O
mother O O
who O O
does O O
not O O
live O O
with O O
her. O O
Problems O O
Hypertension B-HYPERTENSION O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Hyperlipidemia B-HYPERLIPIDEMIA O
Chronic O O
obstructive O O
pulmonary O O
disease O O
Smoking B-SMOKER O
Polycythemia O O
Depression O O
Degenerative O O
joint O O
disease O O
Total O O
hip O O
replacement O O
Diverticulosis O O
Obesity B-OBESE O
Transient O O
ischemic O O
attack O O
Allergies O O
NKA O O
Medications O O
Advair O O
Diskus O O
500/50 O O
(FLUTICASONE O O
Propionate/salmeterol O O
500/50) O O
1 O O
PUFF O O
INH O O
BID O O
ALPRAZOLAM O O
0.25 O O
MG O O
(0.25MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
HYDROCHLOROTHIAZIDE B-MEDICATION B-MEDICATION
25 I-MEDICATION O
MG O O
(25MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Lescol B-MEDICATION O
(FLUVASTATIN) O O
40 O O
MG O O
(40MG O O
CAPSULE O O
take O O
1) O O
PO O O
QHS O O
LISINOPRIL B-MEDICATION B-MEDICATION
40 O O
MG O O
(40MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Lopressor B-MEDICATION B-MEDICATION
(METOPROLOL O O
Tartrate) O O
50 O O
MG O O
(50MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
METFORMIN B-MEDICATION B-MEDICATION
1000 O O
MG O O
(1000MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
NAPROXEN O O
500 O O
MG O O
(500MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
PAROXETINE O O
40 O O
MG O O
(40MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
TRAZODONE O O
50 O O
MG O O
(50MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Verapamil B-MEDICATION B-MEDICATION
Sustained O O
Release O O
120 O O
MG O O
(120MG O O
TABLET O O
SA O O
take O O
1) O O
PO O O
QD O O
Social O O
hx O O
- O O
continues B-SMOKER O
to I-SMOKER O
smoke. I-SMOKER O
Married O O
with O O
children. O O
PE: O O
Flowsheets O O
BLOOD B-HYPERTENSION O
PRESSURE I-HYPERTENSION O
140/100 I-HYPERTENSION O
Rpt O O
by O O
me O O
140/94 B-HYPERTENSION O
TEMPERATURE O O
97.0 O O
F O O
PULSE O O
70 O O
RESPIRATORY O O
RATE O O
18 O O
WEIGHT O O
213 O O
lb O O
(stable) O O
Pt O O
appears O O
well, O O
in O O
NAD O O
NEck O O
- O O
no O O
bruits O O
or O O
nodes O O
Chest O O
- O O
clear O O
Cor O O
- O O
RRR, O O
nlS1S2 O O
Ext O O
- O O
no O O
C/C/Ed O O
L O O
knee O O
positive O O
swelling O O
A/P: O O
1. O O
COPD O O
- O O
stable O O
2. O O
HTN B-HYPERTENSION O
- O O
mildly O O
elevated. O O
3. O O
DM B-DIABETES O
- O O
check O O
HgA1C O O
4. O O
Hyperlipidemia O O
- O O
check O O
lipids O O
today. O O
5. O O
RTC O O
4 O O
months O O
CPE/PAP. O O
3 O O
stool O O
cards O O
and O O
tetanus O O
today. O O
6. O O
L O O
knee O O
DJD O O
- O O
suggested O O
seeing O O
Dr. O O
Walter O O
sooner. O O
Janet O O
Orellana O O
MD O O

Record O O
date: O O
2145-12-19 O O
Olga O O
comes O O
in O O
accomapnied O O
by O O
her O O
daughter O O
after O O
undergoing O O
L O O
TKR O O
by O O
Dr. O O
Walter O O
on O O
10/15/45. O O
She O O
was O O
transferred O O
to O O
Leprosarium O O
rehab O O
when O O
after O O
5 O O
days, O O
her O O
INR O O
increased O O
to O O
16 O O
prompting O O
readmission O O
to O O
MEDIQUIK. O O
While O O
there, O O
R O O
leg O O
weakness O O
was O O
noted. O O
MRI O O
LS O O
spine O O
showed O O
DJD O O
and O O
some O O
spinal O O
stenosis. O O
She O O
was O O
transferred O O
to O O
Parsons O O
Hospital O O
on O O
11/05 O O
where O O
she O O
stayed O O
till O O
12/10/45. O O
She O O
has O O
been O O
staying O O
with O O
her O O
daughter O O
since O O
then. O O
She O O
is O O
receiving O O
VNA, O O
PT. O O
She O O
continues O O
to O O
have O O
R O O
quadriceps O O
weakness, O O
cannot O O
lift O O
leg. O O
It O O
is O O
in O O
a O O
brace O O
with O O
knee O O
immobilized. O O
She O O
is O O
unable O O
to O O
walk O O
independently. O O
SHe O O
notes O O
her O O
L O O
lower O O
leg O O
is O O
swollen. O O
SHe O O
is O O
taking O O
percoset O O
for O O
pain O O
in O O
leg. O O
Also O O
has O O
pain O O
in O O
low O O
back. O O
Her O O
breathing O O
has O O
been O O
stable. O O
She O O
has O O
lost O O
more O O
weight. O O
She O O
was O O
on O O
a O O
strict O O
ADA O O
diet O O
while O O
at O O
rehab. O O
Problems O O
Hypertension B-HYPERTENSION O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Hyperlipidemia B-HYPERLIPIDEMIA O
Chronic O O
obstructive O O
pulmonary O O
disease O O
Polycythemia O O
Depression O O
Degenerative O O
joint O O
disease O O
: O O
s/p O O
R O O
TKR O O
11/44 O O
Total O O
hip O O
replacement O O
Diverticulosis O O
Obesity B-OBESE O
Transient O O
ischemic O O
attack O O
Smoking B-SMOKER O
Insomnia O O
Allergies O O
NKA O O
Medications O O
Advair O O
Diskus O O
500/50 O O
(FLUTICASONE O O
Propionate/salmeterol O O
500/50) O O
1 O O
PUFF O O
INH O O
BID O O
ALPRAZOLAM O O
0.25 O O
MG O O
(0.25MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
HYDROCHLOROTHIAZIDE B-MEDICATION O
25 O O
MG O O
(25MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
40 O O
MG O O
(40MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Lopressor B-MEDICATION B-MEDICATION
(METOPROLOL O O
Tartrate) O O
50 O O
MG O O
(50MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
x O O
30 O O
days O O
METFORMIN B-MEDICATION B-MEDICATION
1000 O O
MG O O
(1000MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
NAPROXEN O B-MEDICATION
500 O O
MG O O
(500MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
x O O
30 O O
days O O
OMEPRAZOLE O O
20 O O
MG O O
(20MG O O
CAPSULE O O
DR O O
take O O
1) O O
PO O O
QD O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
SIMVASTATIN B-MEDICATION B-MEDICATION
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
TRAZODONE O O
125 O O
MG O O
(100MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Verapamil B-MEDICATION B-MEDICATION
Sustained O O
Release O O
120 O O
MG O O
(120MG O O
TABLET O O
SA O O
take O O
1) O O
PO O O
QD O O
x O O
30 O O
days O O
PE: O O
Vital O O
Signs O O
WEIGHT O O
196 O O
lb O O
(-15lbs/2.5mos) O O
134/70 O O
P60 O O
T97 O O
Walker O O
in O O
room, O O
unable O O
to O O
get O O
on O O
table O O
Pt O O
alert O O
and O O
oriented, O O
thinner O O
NEck O O
- O O
no O O
nodes O O
or O O
bruits O O
Chest O O
- O O
clear O O
Cor O O
-RRR, O O
nlS1S2 O O
Abd O O
- O O
soft, O O
NT O O
Ext O O
- O O
L O O
knee O O
scar O O
well O O
healed; O O
LLL O O
bigger O O
than O O
right O O
with O O
trace O O
pitting O O
edema, O O
no O O
tenderness O O
over O O
calf, O O
no O O
redness O O
or O O
warmth O O
Neuro O O
- O O
R O O
leg O O
in O O
brace; O O
3/5 O O
strenght, O O
CN's O O
grossly O O
intact O O
A/P: O O
1. O O
R O O
leg O O
weakness O O
- O O
Obtain O O
MRI O O
brain. O O
Refer O O
neurology. O O
EMG O O
was O O
discussed, O O
per O O
PT O O
recommendation. O O
2. O O
Requests O O
back O O
brace O O
- O O
PT O O
to O O
order. O O
3. O O
Pain O O
back O O
- O O
Vicodin O O
5/500mg O O
prn. O O
4. O O
Resume O O
Neurontin. O O
5. O O
HTN B-HYPERTENSION O
- O O
stable. O O
6. O O
DM B-DIABETES O
- O O
check O O
HGA1C. O O
7. O O
Weight O O
loss O O
- O O
follow. O O
8/ O O
f/u O O
3 O O
months. O O
Janet O O
Orellana O O
MD O O

Record O O
date: O O
2146-02-20 O O
Olga O O
comes O O
in O O
for O O
f/u, O O
accomapanied O O
by O O
her O O
daughter. O O
She O O
was O O
admitted O O
to O O
MEDIQUIK O O
in O O
12/45 O O
for O O
inability O O
to O O
walk O O
secondary O O
to O O
R O O
leg O O
weakness; O O
transferred O O
to O O
Parsons O O
Hospital O O
in O O
Vernal O O
on O O
1/7 O O
till1/29. O O
She O O
loved O O
it O O
there. O O
She O O
had O O
EMG O O
while O O
there O O
which O O
revealed O O
R O O
femoral O O
neuropaty, O O
with O O
6 O O
mo O O
rpt O O
test O O
recommended. O O
She O O
wears O O
a O O
brace O O
most O O
of O O
the O O
time, O O
and O O
walks O O
with O O
aid O O
of O O
walker. O O
She O O
was O O
with O O
her O O
daughter O O
initially O O
upon O O
d/c, O O
and O O
now O O
at O O
her O O
own O O
home O O
alone O O
for O O
past O O
10 O O
days. O O
MAnaging O O
okay. O O
Received O O
PT O O
few O O
times O O
a O O
week. O O
VNA O O
d/c'd. O O
Wants O O
to O O
be O O
able O O
to O O
drive O O
again. O O
Has O O
some O O
mobility O O
in O O
R O O
leg, O O
but O O
not O O
much. O O
Notes O O
swelling O O
L O O
dorsum O O
foot. O O
Meds O O
were O O
reviewed O O
today. O O
She O O
ran O O
out O O
of O O
lisinopril B-MEDICATION B-MEDICATION
and O O
cozaar B-MEDICATION B-MEDICATION
(started O O
in O O
rehab) O O
couple O O
wks O O
ago. O O
She O O
does B-MEDICATION O
not I-MEDICATION O
take I-MEDICATION O
HCTZ B-MEDICATION O
daily O O
secondary O O
to O O
urinary O O
frequency. O O
Her O O
metformin B-MEDICATION B-MEDICATION
was I-MEDICATION O
d/c'd, I-MEDICATION O
secondary O O
to O O
low O O
fsbs O O
reads O O
in O O
am O O
in O O
30's. O O
Her O O
zocor B-MEDICATION B-MEDICATION
was I-MEDICATION O
stopped I-MEDICATION O
in I-MEDICATION O
hospital. I-MEDICATION O
She O O
needs O O
refills O O
today. O O
She O O
has B-SMOKER O
remained B-SMOKER O
off I-SMOKER O
cigarettes!! I-SMOKER O
Problems O O
Hypertension B-HYPERTENSION B-HYPERTENSION
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Hyperlipidemia B-HYPERLIPIDEMIA B-HYPERTENSION
Chronic O O
obstructive O O
pulmonary O O
disease O O
Depression O O
Degenerative O O
joint O O
disease O O
: O O
s/p O O
R O O
TKR O O
11/44 O O
Transient O O
ischemic O O
attack O O
Insomnia O O
Allergies O O
NKA O O
Medications O O
Advair O O
Diskus O O
500/50 O O
(FLUTICASONE O O
Propionate/salmeterol O O
500/50) O O
1 O O
PUFF O O
INH O O
BID O O
ALPRAZOLAM O O
0.25 O O
MG O O
(0.25MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
GABAPENTIN O B-MEDICATION
600 O O
MG O O
(600MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
LISINOPRIL B-MEDICATION B-MEDICATION
60 O O
MG O O
(40MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Lopressor B-MEDICATION B-MEDICATION
(METOPROLOL O O
Tartrate) O O
50 O O
MG O O
(50MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
x O O
30 O O
days O O
PAROXETINE O O
40 O O
MG O O
(40MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
x O O
30 O O
days O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
TRAZODONE O O
150 O O
MG O O
(150MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Verapamil B-MEDICATION O
Sustained O O
Release O O
120 O O
MG O O
(120MG O O
TABLET O O
SA O O
take O O
1) O O
PO O O
QD O O
x O O
30 O O
days O O
HCTZ O O
25mg O O
qd O O
PE: O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
130/80 O O
PULSE O O
68 O O
RESPIRATORY O O
RATE O O
17 O O
TEMPERATURE O O
97.0 O O
F O O
Pt O O
in O O
NAD, O O
appears O O
well O O
Neck O O
- O O
no O O
bruits O O
Chest O O
- O O
clear O O
without O O
wheezes O O
Cor O O
-RRR, O O
nlS1S2 O O
Ext O O
- O O
trace O O
edema O O
LL's O O
A/P: O O
1. O O
HTN O O
- O O
stable O O
on O O
metoprolol B-MEDICATION B-MEDICATION
and O O
verapamil B-MEDICATION O
alone. O O
d/c O O
HCTZ. O O
d/c B-MEDICATION O
cozaar. I-MEDICATION B-MEDICATION
2. O O
DM B-DIABETES O
- O O
check O O
HgA1c; O O
off O O
meds. O O
3. O O
Elev B-HYPERLIPIDEMIA O
CHol I-HYPERLIPIDEMIA O
- O O
check O O
lipids O O
today. O O
Resume O O
zocor. O B-MEDICATION
4. O O
Leg O O
edema O O
- O O
use O O
lasix O O
20mg O O
prn. O O
5. O O
R O O
femoral O O
neuropathy O O
- O O
cont O O
PT. O O
6. O O
COPD O O
- O O
stable. O O
6. O O
f/u O O
2 O O
months. O O
J. O O
Orellana O O
MD O O

Record B-SMOKER O
date: O O
2063-09-04 O O
124-23-22-9 O O
She O O
returns O O
for O O
follow-up O O
visit. O O
She O O
has O O
essential O O
hypertension B-HYPERTENSION O
and O O
diabetes B-DIABETES O
and O O
is O O
s/p O O
a O O
small O O
CVA. O O
Medications O O
currently O O
include O O
vasotec B-MEDICATION O
20 I-MEDICATION O
b.i.d., I-MEDICATION O
chlorpropamide B-MEDICATION O
250 I-MEDICATION O
b.i.d. I-MEDICATION O
I O O
once O O
again O O
encouraged O O
her O O
to O O
take O O
aspirin B-MEDICATION B-MEDICATION
which O O
she O O
said O O
gives O O
her O O
a O O
funny O O
feeling O O
in O O
her O O
stomach, O O
but O O
she O O
is O O
now O O
agreeable O O
to O O
taking O O
80 O O
mg O O
q.d. O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
was I-MEDICATION O
stopped I-MEDICATION O
secondary O O
to O O
an O O
episode O O
of O O
hyponatremia. O O
She O O
said O O
she O O
has O O
felt O O
the O O
best O O
over O O
the O O
last O O
three O O
months O O
and O O
reports O O
no O O
cardiovascular O O
or O O
neurological O O
symptoms. O O
Blood O O
pressure O O
130/70. O O
No O O
JVD. O O
Carotid O O
impulses O O
normal. O O
No O O
bruits. O O
Lungs O O
clear. O O
Cardiac O O
exam O O
normal. O O
Unremarkable O O
abdomen. O O
Full O O
pulses O O
throughout O O
with O O
no O O
edema. O O
ECG O O
is O O
within O O
normal O O
limits. O O
I O O
have O O
made O O
no O O
changes O O
to O O
her O O
medical O O
regimen O O
and O O
she O O
will O O
return O O
to O O
see O O
Dr. O O
Isaiah O O
Viola O O
in O O
six O O
months. O O
Otha O O
V. O O
Espinal, O O
M.D. O O
******** O O
Approved O O
but O O
not O O
reviewed O O
by O O
Attending O O
Provider O O
******** O O

Record O O
date: O O
2070-03-22 O O
PROMPTCARE O O
EMERGENCY O O
DEPT O O
VISIT O O
UMALI,DANA O O
YURI O O
124-23-22-9 O O
The O O
patient O O
was O O
seen O O
by O O
me O O
along O O
with O O
Dr. O O
Frank O O
Griffin O O
on O O
03/22/70. O O
The O O
history O O
is O O
documented O O
by O O
Dr. O O
Griffin. O O
It O O
was O O
reviewed O O
by O O
me O O
with O O
the O O
patient O O
found O O
to O O
be O O
accurate O O
and O O
complete. O O
The O O
physical O O
examination O O
was O O
confirmed O O
by O O
my O O
examination. O O
Evaluation O O
and O O
management O O
was O O
also O O
concurred O O
with. O O
PRESENTING O O
COMPLAINT: O O
Right O O
face O O
and O O
arm O O
numbness. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
is O O
a O O
66-year-old O O
woman O O
with O O
a O O
new O O
onset O O
at O O
11 O O
p.m. O O
with O O
right O O
face O O
and O O
right O O
arm O O
numbness, O O
now O O
improving. O O
No O O
speech O O
or O O
motor O O
deficits. O O
No O O
recent O O
illness. O O
REVIEW O O
OF O O
SYSTEMS: O O
No O O
fever, O O
chills, O O
nausea O O
or O O
vomiting. O O
No O O
headache, O O
no O O
neck O O
stiffness. O O
All O O
negative. O O
PAST O O
MEDICAL O O
HISTORY: O O
History O O
of O O
hypertension, B-HYPERTENSION B-HYPERTENSION
diabetes B-DIABETES O
and O O
has O O
a O O
history O O
of O O
hypercholesterolemia. B-HYPERLIPIDEMIA O
She O O
had O O
a O O
cerebrovascular O O
accident O O
with O O
left O O
sided O O
weakness O O
which O O
has O O
resolved O O
in O O
the O O
past. O O
MEDICATIONS: O O
Hydrochlorothiazide, B-MEDICATION B-MEDICATION
Zocor, B-MEDICATION B-MEDICATION
Glyburide, B-MEDICATION B-MEDICATION
Captopril B-MEDICATION B-MEDICATION
and O O
enalapril. B-MEDICATION O
The O O
patient O O
also O O
takes O O
metformin. B-MEDICATION B-MEDICATION
ALLERGIES: O O
None. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
She B-SMOKER O
does B-SMOKER O
not I-SMOKER O
smoke I-SMOKER O
or I-SMOKER O
drink. I-SMOKER O
She O O
lives O O
with O O
her O O
family O O
and O O
her O O
husband. O O
The O O
patient O O
speaks O O
Taiwanese O O
and O O
daughter O O
and O O
son O O
are O O
interpreting. O O
PHYSICAL O O
EXAMINATION: O O
GENERAL: O O
Awake, O O
alert O O
and O O
oriented O O
woman O O
in O O
no O O
apparent O O
distress. O O
She O O
is O O
a O O
very O O
pleasant O O
lady, O O
smiling O O
at O O
times O O
and O O
makes O O
eye O O
contact. O O
VITAL O O
SIGNS: O O
Temperature O O
97.8, O O
pulse O O
84, O O
respirations O O
20, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
166/66. B-HYPERTENSION O
HEENT: O O
Normal. O O
NECK: O O
Normal. O O
LUNGS: O O
Clear O O
of O O
rales, O O
wheezes O O
or O O
rhonchi. O O
CARDIOVASCULAR: O O
Regular, O O
rate O O
and O O
rhythm. O O
ABDOMEN: O O
Nondistended. O O
Bowel O O
sounds O O
are O O
normoactive O O
and O O
nontender. O O
SKIN: O O
Intact, O O
warm O O
and O O
dry O O
with O O
no O O
lesions O O
or O O
rashes. O O
EXTREMITIES: O O
No O O
cyanosis. O O
Normal O O
extremities O O
with O O
no O O
deformities, O O
joint O O
effusions O O
or O O
crepitance O O
noted O O
over O O
her O O
joints. O O
She O O
has O O
a O O
subjective O O
decreased O O
sensation O O
over O O
her O O
right O O
lower O O
forearm. O O
NEUROLOGICAL: O O
Cranial O O
nerves O O
II O O
through O O
XII O O
are O O
intact. O O
She O O
is O O
oriented O O
x3. O O
She O O
has O O
5/5 O O
motor O O
in O O
upper O O
and O O
lower O O
extremities. O O
She O O
has O O
not O O
walked, O O
therefore O O
gait O O
cannot O O
be O O
assessed. O O
She O O
has O O
no O O
dysarthria, O O
no O O
dysmetria O O
and O O
no O O
signs O O
of O O
any O O
focal O O
weakness. O O
LABORATORY O O
EVALUATION: O O
Electrocardiogram O O
revealed O O
a O O
sinus O O
rhythm. O O
CT O O
of O O
the O O
head O O
was O O
negative O O
on O O
initial O O
evaluation. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
As O O
such, O O
neurology O O
was O O
called O O
and O O
they O O
elected O O
to O O
admit O O
her. O O
She O O
was O O
admitted O O
on O O
03/22/70 O O
by O O
Dr. O O
Yang O O
in O O
stable O O
condition. O O
___________________________________ O O
JT365/31932 O O
NORRIS O O
ELDER, O O
M.D. O O
NE00 O O
D:03/22/70 O O
T:03/23/70 O O
Dictated O O
by: O O
NORRIS O O
ELDER, O O
M.D. O O
NE00 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2077-09-20 O O
UMALI, O O
DANA O O
12423229 O O
09/20/2077 O O
HISTORY B-SMOKER O
OF O O
PRESENT O O
ILLNESS: O O
Ms. O O
Umali O O
returns O O
for O O
followup O O
after O O
her O O
angioplasty O O
of O O
a O O
superficial O O
femoral O O
artery O O
occlusive O O
disease, O O
with O O
a O O
more O O
proximal O O
left O O
iliac O O
stent O O
placement O O
of O O
the O O
common O O
iliac. O O
She O O
has O O
a O O
nonhealing O O
left O O
great O O
toe O O
ulceration. O O
She O O
is O O
followed O O
by O O
Dr. O O
Holden, O O
and O O
I O O
performed O O
an O O
endovascular O O
recanalization. O O
PHYSICAL O O
EXAMINATION: O O
Today, O O
she O O
is O O
doing O O
well, O O
after O O
her O O
procedure O O
on O O
09/14/77. O O
IMAGING: O O
Noninvasive O O
vascular O O
lab O O
studies O O
were O O
performed O O
today, O O
showing O O
an O O
ABI O O
on O O
the O O
left O O
of O O
0.67 O O
on O O
the O O
right O O
of O O
0.42. O O
This O O
is O O
a O O
great O O
improvement O O
from O O
the O O
0.24 O O
ABI O O
on O O
the O O
left O O
before O O
the O O
endovascular O O
procedure. O O
ASSESSMENT O O
AND O O
PLAN: O O
Dr. O O
Holden O O
explained O O
to O O
the O O
patient O O
and O O
family O O
about O O
toe O O
amputation O O
recommendations O O
at O O
this O O
time. O O
Otherwise, O O
from O O
a O O
circulatory O O
standpoint, O O
we O O
counseled O O
them O O
that O O
this O O
was O O
the O O
optimal O O
time O O
to O O
perform O O
toe O O
amputation O O
to O O
allow O O
for O O
primary O O
healing. O O
They O O
will O O
follow O O
up O O
with O O
Dr. O O
Holden O O
in O O
2 O O
weeks, O O
once O O
they O O
decide. O O
Vernon O O
Ramses O O
Cruz, O O
M.D. O O

Record B-SMOKER O
date: O O
2077-12-04 O O
EDVISIT^12423229^UMALI, O O
DANA^12/04/77^DUFFY, O O
FELICIA O O
CHIEF O O
COMPLAINT: O O
Foot O O
pain. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Ms. O O
Umali O O
is O O
a O O
73-year-old O O
woman O O
with O O
a O O
history O O
of O O
diabetes, B-DIABETES O
peripheral O O
vascular O O
disease O O
who O O
presents O O
to O O
the O O
Emergency O O
Department O O
complaining O O
of O O
several O O
days O O
of O O
increasing O O
right O O
great O O
toe O O
pain. O O
The O O
patient O O
denies O O
fever, O O
chills, O O
or O O
drainage O O
from O O
the O O
foot. O O
Please O O
see O O
the O O
written O O
record O O
for O O
further O O
details. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension, B-HYPERTENSION O
diabetes, O O
CVA, O O
peripheral O O
vascular O O
disease, O O
and O O
hyperlipidemia. B-HYPERLIPIDEMIA O
PAST O O
SURGICAL O O
HISTORY: O O
Left O O
great O O
toe O O
amputation O O
and O O
left O O
lower O O
extremity O O
arterial O O
revascularization. O O
MEDICATIONS: O O
Please O O
see O O
the O O
LMR. O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
PHYSICAL O O
EXAMINATION: O O
I O O
have O O
examined O O
the O O
patient O O
and O O
agree O O
with O O
the O O
physical O O
as O O
documented. O O
Of O O
note, O O
the O O
patient O O
is O O
awake, O O
alert, O O
and O O
in O O
no O O
distress. O O
Vitals: O O
Heart O O
rate O O
88, O O
respiratory O O
rate O O
20, O O
blood O O
pressure O O
135/63, O O
temperature O O
97, O O
and O O
oxygen O O
saturation O O
98% O O
on O O
room O O
air. O O
Lungs: O O
Clear O O
bilaterally O O
with O O
no O O
rales, O O
rhonchi, O O
or O O
wheezing. O O
Cardiovascular O O
exam: O O
Regular O O
rate O O
and O O
rhythm. O O
Normal O O
S1 O O
and O O
S2. O O
Abdomen: O O
Soft. O O
No O O
tenderness, O O
guarding, O O
or O O
rebound. O O
Extremity O O
exam: O O
The O O
patient's O O
right O O
lower O O
extremity O O
is O O
warm O O
with O O
less O O
than O O
2 O O
second O O
capillary O O
refills. O O
The O O
patient O O
has O O
no O O
palpable O O
or O O
Doppler O O
to O O
dorsalis O O
pedis O O
or O O
posterior O O
tibial O O
pulses. O O
The O O
patient's O O
right O O
great O O
toe O O
is O O
tender, O O
erythematous, O O
and O O
mildly O O
swollen. O O
MEDICAL O O
DECISION O O
MAKING O O
AND O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
Ms. O O
Umali O O
is O O
a O O
73-year-old O O
woman O O
with O O
diabetes, O O
peripheral O O
vascular O O
disease O O
who O O
presents O O
to O O
the O O
Emergency O O
Department O O
with O O
right O O
foot O O
cellulitis. O O
The O O
patient's O O
labs O O
are O O
available O O
on O O
the O O
LMR. O O
Of O O
note, O O
the O O
patient's O O
white O O
count O O
is O O
11.7. O O
The O O
patient O O
was O O
evaluated O O
by O O
the O O
Vascular O O
Surgery O O
Service. O O
The O O
plan O O
is O O
to O O
obtain O O
an O O
x-ray O O
of O O
the O O
foot O O
and O O
admit O O
the O O
patient O O
to O O
the O O
Vascular O O
Surgery O O
Service O O
for O O
further O O
management. O O
PRIMARY O O
DIAGNOSIS: O O
Right O O
foot O O
cellulitis. O O
SECONDARY O O
DIAGNOSIS: O O
Diabetes B-DIABETES O
with O O
poor O O
control. O O
THIRD O O
DIAGNOSIS: O O
Peripheral O O
vascular O O
disease. O O
DISPOSITION: O O
Admission. O O
CONDITION O O
UPON O O
ADMISSION: O O
Good. O O
______________________________ O O
DUFFY, O O
FELICIA O O
M.D. O O
D: O O
12/04/77 O O
T: O O
12/04/77 O O
Dictated O O
By: O O
DUFFY, O O
FELICIA O O
eScription O O
document:6-60827686 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2074-11-11 O O
LEPROSARIUM O O
EMERGENCY O O
DEPT O O
VISIT O O
OLIVIER,OZELL O O
337-67-25-9 O O
VISIT O O
DATE: O O
11/11/74 O O
Resident O O
history O O
reviewed, O O
patient O O
interviewed O O
and O O
examined O O
by O O
me. O O
PRESENTING O O
COMPLAINT: O O
Cough. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
is O O
a O O
67-year-old O O
woman O O
from O O
South O O
Korea O O
who O O
has O O
been O O
in O O
Canada O O
for O O
one O O
year, O O
translated O O
by O O
her O O
son. O O
She O O
has O O
had O O
a O O
cough O O
for O O
three O O
days, O O
which O O
is O O
white, O O
and O O
then O O
turned O O
to O O
yellow O O
productive O O
sputum. O O
She O O
has O O
mild O O
shortness O O
of O O
breath, O O
chronic O O
dyspnea O O
on O O
exertion, O O
and O O
chest O O
pain O O
only O O
with O O
coughing. O O
The O O
patient O O
has O O
no O O
fever, O O
no O O
chills, O O
no O O
nausea, O O
no O O
vomiting. O O
Positive O O
coryza, O O
cough, O O
and O O
sore O O
throat. O O
She O O
has O O
been O O
self-treating O O
with O O
amoxicillin O O
for O O
two O O
days. O O
REVIEW O O
OF O O
SYSTEMS: O O
See O O
HPI. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension, B-HYPERTENSION O
hypothyroidism, O O
obstructive O O
sleep O O
apnea. O O
Surgical O O
history O O
is O O
positive O O
for O O
cholecystectomy. O O
MEDICATIONS: O O
Synthroid, O O
Amoxil, O O
hydrochlorothiazide. B-MEDICATION O
ALLERGIES: O O
Penicillin; O O
she O O
had O O
urticaria. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
Social O O
history O O
is O O
negative B-SMOKER O
for I-SMOKER O
tobacco, I-SMOKER O
ETOH, O O
intravenous O O
drug O O
abuse. O O
She O O
lives O O
with O O
family. O O
Family O O
history O O
is O O
cancer. O O
PHYSICAL O O
EXAMINATION: O O
Vital O O
signs O O
are O O
stable O O
at O O
98, O O
83, O O
17, O O
162/67, B-HYPERTENSION O
and O O
94%. O O
GENERAL: O O
This O O
patient O O
is O O
awake, O O
alert, O O
and O O
oriented, O O
well-nourished, O O
well-developed, O O
in O O
no O O
distress. O O
HEENT: O O
Pupils O O
are O O
equal, O O
round, O O
reactive O O
to O O
light O O
and O O
accommodation. O O
Extraocular O O
muscles O O
are O O
intact. O O
Oropharynx O O
has O O
no O O
enlarged O O
tonsils O O
and O O
no O O
exudate. O O
NECK: O O
Supple. O O
RESPIRATORY: O O
No O O
respiratory O O
distress. O O
She O O
has O O
bi-basilar O O
crackles. O O
CARDIOVASCULAR: O O
Regular O O
rate O O
and O O
rhythm. O O
S1, O O
S2. O O
ABDOMEN: O O
Soft, O O
non-tender. O O
EXTREMITIES: O O
No O O
clubbing, O O
cyanosis, O O
or O O
edema. O O
NEUROPSYCHIATRIC: O O
Alert O O
and O O
oriented O O
x O O
3. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
will O O
be O O
discharged O O
on O O
a O O
Z-pak O O
and O O
is O O
to O O
follow O O
up O O
with O O
the O O
Lakeview O O
Clinic. O O
FINAL O O
DIAGNOSIS: O O
Bronchitis. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
was O O
discharged O O
home O O
in O O
satisfactory O O
condition. O O
___________________________________ O O
OK878/13176 O O
ROXANNE O O
SPEARS, O O
M.D. O O
RS40 O O
D:11/11/74 O O
T:11/12/74 O O
Dictated O O
by: O O
ROXANNE O O
SPEARS, O O
M.D. O O
RS40 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2076-03-23 O O
Lakeview O O
Clinic O O
Note O O
Patient B-SMOKER O
comes O O
in O O
today O O
for O O
follow-up O O
of O O
recent O O
hospitalization O O
for O O
L1 O O
fracture O O
following O O
a O O
fall. O O
She O O
was O O
in O O
her O O
usual O O
state O O
of O O
health O O
until O O
2 O O
months O O
ago O O
when O O
she O O
suffered O O
a O O
mechanical O O
fall O O
while O O
visiting O O
family O O
in O O
South O O
Korea. O O
She O O
sustained O O
an O O
L1 O O
fracture O O
without O O
surgical O O
intervention, O O
and O O
returned O O
to O O
canada O O
where O O
she O O
presented O O
to O O
the O O
ED O O
on O O
3/9/76 O O
wiht O O
back O O
pain, O O
L1 O O
planar O O
fracture O O
with O O
evidence O O
of O O
minimal O O
cord O O
compressionl O O
She O O
was O O
admitted O O
and O O
seen O O
by O O
neurosurgery O O
who O O
felt O O
that O O
there O O
was O O
no O O
acute O O
indication O O
for O O
surgery. O O
Since O O
then, O O
she O O
has O O
had O O
continued O O
pain O O
in O O
her O O
back O O
with O O
occasional O O
burning O O
in O O
her O O
feet O O
but O O
no O O
numbness O O
or O O
tingling. O O
She O O
would O O
like O O
to O O
undergo O O
surgery O O
at O O
this O O
point O O
because O O
her O O
pain O O
is O O
intolerable. O O
She O O
is O O
in O O
contact O O
with O O
a O O
neurosurgeon O O
at O O
this O O
time O O
regarding O O
when O O
to O O
proceed O O
with O O
surgery. O O
She O O
is O O
otherwise O O
doing O O
well. O O
ROS O O
positive O O
for O O
chest O O
tightness O O
with O O
walking O O
one O O
block O O
with O O
some O O
feeling O O
of O O
being O O
'winded.' O O
She O O
does O O
not O O
have O O
this O O
feeling O O
at O O
rest, O O
and O O
states O O
it O O
has O O
been O O
ongoing O O
for O O
the O O
past O O
year. O O
She O O
describes O O
some O O
peripheral O O
edema, O O
as O O
well O O
as O O
PND. O O
Also O O
c/o O O
left O O
eye O O
tearing O O
and O O
R O O
ear O O
itching. O O
no O O
eye O O
pain O O
or O O
change O O
in O O
her O O
vision. O O
Problems O O
Hypertension B-HYPERTENSION O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Cervical O O
polyp O O
endometrial O O
polyp O O
osteoarthritis O O
Sleep O O
apnea O O
Current O O
Medications: O O
DIOVAN B-MEDICATION O
80 I-MEDICATION O
mg I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Nexium O O
(ESOMEPRAZOLE) O O
20 O O
MG O O
PO O O
QD O O
x O O
30 O O
day(s) O O
HYDROCHLOROTHIAZIDE B-MEDICATION B-MEDICATION
25MG, I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Celebrex O O
(CELECOXIB) O O
100MG, O O
1 O O
Capsule(s) O O
PO O O
bid O O
Levothyroxine O O
Sodium O O
125MCG, O O
1 O O
Tablet(s) O O
PO O O
QD O O
x O O
30 O O
day(s) O O
Caltrate O O
And O O
D O O
2 O O
TABS O O
PO O O
qd O O
x O O
30 O O
day(s) O O
Percocet O O
(OXYCODONE+APAP) O O
325-5, O O
1 O O
Tablet(s) O O
PO O O
Q6H O O
x O O
20 O O
day(s) O O
Lopid B-MEDICATION O
(GEMFIBROZIL) I-MEDICATION O
600MG, I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QPM I-MEDICATION O
x I-MEDICATION O
30 I-MEDICATION O
day(s) I-MEDICATION O
Lopressor B-MEDICATION B-MEDICATION
(METOPROLOL I-MEDICATION O
Tartrate) I-MEDICATION O
12.5MG, I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
x I-MEDICATION O
30 I-MEDICATION O
day(s) I-MEDICATION O
fosomax O O
70 O O
PO O O
qwk O O
x O O
30 O O
day(s) O O
Physical O O
Exam O O
VSS: O O
BP144/76 B-HYPERTENSION O
, O O
wt O O
209 O O
lbs O O
HEENT: O O
no O O
mouth O O
lesions O O
Thyroid: O O
no O O
thyromegaly O O
Chest: O O
scant O O
crackles O O
at O O
bilateral O O
bases O O
Heart: O O
regular O O
rate O O
and O O
rhythm, O O
S1 O O
and O O
S2 O O
normal, O O
no O O
gallops, O O
no O O
murmurs O O
Abd: O O
soft, O O
NT/ND O O
Extr: O O
1-2+ O O
ankle O O
edema, O O
brisk O O
capillary O O
refill O O
Recent O O
Relevant O O
Data: O O
random O O
glucose O O
148 O O
Hemoglobin B-DIABETES O
A1c: I-DIABETES O
6.8 I-DIABETES O
CBC, O O
chem O O
7, O O
tash, O O
cholesterol O O
all O O
WNL O O
in O O
march O O
2076. O O
iPTH O O
41, O O
alk O O
phos O O
hi O O
at O O
129, O O
nl O O
LFTs, O O
ESR O O
34 O O
SPEP O O
negative, O O
bone O O
scan O O
with O O
osteopenia, O O
mammogram O O
negative O O
CXR O O
with O O
? O O
of O O
confluence O O
of O O
shadows O O
vs O O
nodule O O
at O O
2nd O O
rib O O
space, O O
favor O O
shadows, O O
ecg O O
with O O
T O O
wave O O
abnormalities O O
and O O
low O O
qrs O O
voltages O O
ETT O O
2074 O O
10 O O
min O O
82% O O
predicted O O
negative O O
for O O
ischmia O O
Echo O O
2074 O O
EF O O
60% O O
Assessment O O
and O O
Current O O
Plan: O O
67 O O
yo O O
F O O
with O O
recent O O
L1 O O
planar O O
fracture O O
and O O
multiple O O
medical O O
problems O O
including O O
HTN B-HYPERTENSION O
and O O
new B-DIABETES O
DM B-DIABETES O
1. O O
Neurosurg O O
for O O
possible O O
surgery O O
later O O
this O O
month, O O
percocet O O
for O O
pain O O
control O O
- O O
will O O
need O O
PFTs O O
pre-op O O
given O O
some O O
c/o O O
DOE O O
2. O O
CV: O O
will O O
also O O
need O O
nuclear O O
study O O
of O O
heart O O
given O O
anginal O O
sx's O O
and O O
new O O
T O O
wave O O
abnormalities O O
on O O
ECG. O O
Cannot O O
do O O
ETT O O
given O O
resting O O
ECG O O
abnormalities, O O
and O O
will O O
need O O
pharmocologic O O
stress O O
given O O
she O O
cannot O O
walk O O
from O O
back O O
pain. O O
- O O
will O O
start O O
her O O
on O O
lasix O O
both O O
for O O
BP O O
and O O
for O O
diuresis O O
as O O
she O O
appears O O
volume O O
overloaded. O O
- O O
will O O
rpt O O
echo O O
if O O
dobutamine O O
MIBI O O
not O O
informative O O
3.optho O O
referral O O
per O O
pt O O
request O O
for O O
eye O O
tearing O O
4.elevated O O
gluc O O
and O O
A1c O O
concerning O O
for O O
new O O
DM. O O
However, O O
given O O
only O O
1 O O
high O O
b.s O O
documented O O
and O O
A1C O O
borderline O O
elevated, O O
I O O
have O O
advised O O
her O O
that O O
we O O
can O O
probably O O
control O O
this O O
with O O
diet, O O
exercise, O O
and O O
wt O O
loss.She O O
will O O
see O O
nutrition O O
to O O
help O O
her O O
avoid O O
high O O
carb O O
foods O O
and O O
to O O
lose O O
wt O O
. O O
If O O
this O O
fails O O
to O O
control O O
her O O
DM O O
we O O
will O O
start O O
her O O
on O O
Metformin. O O
She O O
will O O
need O O
optho O O
eval O O
for O O
this O O
reason O O
as O O
well. O O
5. O O
Pt O O
with O O
strong O O
fhx O O
of O O
uterine O O
ca, O O
wishes O O
to O O
see O O
GYN O O
regarding O O
screening O O
for O O
this. O O
She O O
denies O O
sx's O O
of O O
vaginal O O
bleeding O O
at O O
this O O
pt. O O
6.consider O O
rpt O O
CXR O O
given O O
?of O O
shadow O O
vs O O
nodule. O O
7. O O
will O O
review O O
HM O O
at O O
next O O
visit O O
Patient O O
will O O
return O O
for O O
a O O
follow-up O O
visit O O
in O O
clinic O O
in O O
1 O O
wk O O
for O O
chem O O
7 O O
and O O
1 O O
month O O
to O O
see O O
me O O
re O O
bp O O
and O O
volume O O
status O O
. O O
========================== O O
Preceptor's O O
Note O O
========================== O O
67 O O
yr O O
old O O
woman O O
with O O
recent O O
L1 O O
fracture, O O
with O O
minimal O O
cord O O
compression, O O
has O O
had O O
persistent O O
pain O O
and O O
is O O
in O O
contact O O
with O O
a O O
neurosurgeon O O
for O O
consideration O O
of O O
surgery. O O
Also O O
has O O
had O O
some O O
exertional O O
chest O O
pain O O
in O O
last O O
yr, O O
and O O
has O O
baseline O O
EKG O O
T O O
wave O O
changes, O O
and O O
is O O
unable O O
to O O
do O O
treadmill O O
due O O
to O O
back O O
pain. O O
Will O O
get O O
dobutamine O O
MIBI O O
study. O O
Repeat O O
CXR O O
as O O
above O O
in O O
resident's O O
note. O O

Record O O
date: O O
2079-06-18 O O
Pt O O
is O O
a O O
pleasant O O
obese B-OBESE O
70yo O O
South O O
Korean O O
woman O O
presenting O O
for O O
f/u O O
DM, B-DIABETES O
HTN. B-HYPERTENSION O
She O O
is O O
a O O
poor O O
historian, O O
accompanied O O
by O O
family O O
members O O
who O O
interpret, O O
both O O
in O O
Korean O O
and O O
English. O O
Also O O
spoke O O
w/ O O
daughter O O
by O O
phone O O
during O O
the O O
visit O O
to O O
help O O
clarify O O
med O O
regimen. O O
Problems O O
Hypertension B-HYPERTENSION O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Cervical O O
polyp O O
endometrial O O
polyp O O
osteoarthritis O O
Sleep O O
apnea O O
diastolic O O
heart O O
failure O O
Restrictive O O
pulmonary O O
disease O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
FH O O
Uncoded O O
Information: O O
Comments: O O
Denies O O
family O O
h/o O O
ovarian, O O
endometrial, O O
breast O O
or O O
GI O O
cancer. O O
Reports O O
mother O O
and O O
older O O
sister O O
with O O
endometrial O O
ca. O O
Medications O O
Colace O O
(DOCUSATE O O
SODIUM) O O
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
TID O O
Caltrate O O
and O O
D O O
2 O O
TABS O O
PO O O
qd O O
, O O
keep O O
md O O
appt O O
for O O
11/15/77 O O
Lopressor B-MEDICATION B-MEDICATION
(METOPROLOL I-MEDICATION O
TARTRATE) I-MEDICATION O
12.5MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
Zantac O O
(RANITIDINE O O
HCL) O O
150MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
Estrace O O
(ESTRADIOL) O O
1 O O
GM O O
PV O O
BIW O O
, O O
keep O O
md O O
appt O O
for O O
11/15/77 O O
Neurontin O O
(GABAPENTIN) O O
300 O O
MG O O
(300MG O O
CAPSULE O O
take O O
1) O O
PO O O
TID O O
Loratadine O O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Diazepam O O
5 O O
MG O O
(5MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
x O O
30 O O
days O O
Nexium O O
(ESOMEPRAZOLE) O O
40 O O
MG O O
(40MG O O
CAPSULE O O
DR O O
take O O
1) O O
PO O O
QD O O
x O O
30 O O
days O O
Lasix O O
(FUROSEMIDE) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
x O O
30 O O
days O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
MG O O
(25MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Levothyroxine O O
SODIUM O O
100MCG O O
TABLET O O
PO O O
QD O O
Fosamax O O
(ALENDRONATE) O O
70 O O
MG O O
(70MG O O
TABLET O O
take O O
1) O O
PO O O
QWEEK O O
Diovan B-MEDICATION O
(VALSARTAN) I-MEDICATION O
160 O O
MG O O
(160MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) I-MEDICATION O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Metformin B-MEDICATION B-MEDICATION
500 I-MEDICATION O
MG I-MEDICATION O
(500MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
Percocet O O
(OXYCODONE+APAP) O O
325-5 O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
TID O O
x O O
30 O O
days O O
Zocor B-MEDICATION B-MEDICATION
(SIMVASTATIN) I-MEDICATION O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
, O O
to O O
replace O O
lipitor O B-MEDICATION
Last O O
seen O O
by O O
PCP O O
approx O O
3 O O
wks O O
ago. O O
Pt O O
was O O
having O O
sxs O O
dyastolic O O
dysfunction, O O
asked O O
to O O
take O O
Lasix O O
20mg O O
qd. O O
Bp O O
meds O O
include O O
Diovan B-MEDICATION O
160mg, I-MEDICATION O
HCTZ B-MEDICATION B-MEDICATION
25mg I-MEDICATION O
and O O
Bisoprolol B-MEDICATION B-MEDICATION
5mg I-MEDICATION O
qd, I-MEDICATION O
which I-MEDICATION O
replaced I-MEDICATION O
Lopressor I-MEDICATION B-MEDICATION
at O O
some O O
point. O O
Unclear O O
from O O
pt/family O O
when O O
this O O
was O O
changed. O O
Patient O O
denies O O
CP, O O
increased O O
SOB O O
or O O
edema. O O
Sleeps O O
on O O
2 O O
pillows. O O
Adds O O
salt O O
to O O
food O O
and O O
is O O
sedentary. O O
Has O O
gained O O
an O O
additional O O
#2 O O
since O O
last O O
visit. O O
According O O
to O O
her O O
daughter, O O
she O O
eats O O
sweets O O
every O O
day O O
and O O
complains O O
of O O
feeling O O
dizzy O O
if O O
she O O
does O O
not O O
eat O O
sweets. O O
Also O O
eats O O
mod O O
amts O O
starches. O O
Takes O O
Metformin B-MEDICATION B-MEDICATION
500mg I-MEDICATION O
bid I-MEDICATION O
w/ O O
recent B-DIABETES O
A1c B-DIABETES O
6.7. I-DIABETES O
She O O
uses O O
a O O
glucometer O B-MEDICATION
to O O
test O O
fingersticks, O O
though O O
inconsistently. O O
Family O O
reports O O
typical B-DIABETES O
fasting B-DIABETES O
results I-DIABETES O
110-130, I-DIABETES O
randoms I-DIABETES O
150-170's; I-DIABETES O
no I-DIABETES O
200's. I-DIABETES O
She O O
is O O
a O O
former B-SMOKER O
smoker. I-SMOKER B-MEDICATION
No O O
alcohol O O
or O O
OTC O O
meds. O O
Followed O O
by O O
multiple O O
disciplines O O
including O O
cards, O O
neuro, O O
ortho O O
and O O
pain O O
mgmt. O O
Also O O
has O O
upcoming O O
appt O O
w/ O O
nutrition. O O
Exam: O O
pleasant O O
obese O O
70yo O O
woman O O
NAD O O
Bp B-HYPERTENSION O
144/64 B-HYPERTENSION O
in I-HYPERTENSION O
triage, I-HYPERTENSION O
140/70 I-HYPERTENSION O
rechecked I-HYPERTENSION O
by I-HYPERTENSION O
me I-HYPERTENSION O
HR O O
64reg O O
Wt O O
#220 O O
Random O O
fingerstick O O
137 O O
Neck: O O
obese, O O
supple; O O
no O O
JVD O O
Lungs: O O
clear; O O
no O O
rales, O O
ronchi, O O
wheezes O O
Cor: O O
RRR; O O
no O O
r/m/g O O
Extrems: O O
(+)1 O O
ptiting O O
edema O O
bilat O O
1/3 O O
up O O
legs; O O
pulses O O
intact, O O
no O O
lesions O O
A/P: O O
70yo O O
woman O O
w/ O O
multiple O O
medical O O
problems, O O
overall O O
poor O O
understanding O O
of O O
meds O O
and O O
problems. O O
Pt O O
counselled O O
regarding O O
importance O O
of O O
no O O
sweets O O
or O O
added O O
salt O O
in O O
her O O
diet. O O
She O O
needs O O
to O O
lose O O
wt O O
for O O
both O O
her O O
medical O O
and O O
subjectvie O O
well O O
being. O O
Encouraged O O
to O O
walk O O
as O O
tolerated, O O
elevate O O
feet O O
when O O
seated. O O
Asked O O
to O O
bring O O
all O O
meds O O
plus O O
glucometer O O
to O O
next O O
PCP O O
appt O O
in O O
2 O O
wks O O
for O O
full O O
clarification. O O
Cont O O
current O O
regimen O O
for O O
now O O
until O O
completely O O
sure O O
of O O
her O O
regimen. O O
Asked O O
to O O
check O O
fingersticks O O
when O O
feeling O O
dizzy. O O
If O O
&lt; O O
80, O O
treat O O
w/ O O
4oz O O
orange O O
juice O O
and O O
healthy O O
snack. O O
Sent O O
to O O
lab O O
to O O
check O O
basic O O
panel O O
on O O
Lasix, O O
also O O
for O O
urine O O
malb/creat O O
for O O
hx O O
DM, O O
f/u O O
as O O
needed. O O
RTC O O
to O O
PCP, O O
other O O
appts O O
as O O
scheduled, O O
prn. O O
_____________________________________________ O O
Virginia O O
M O O
Townsend,N.P.,M.S. O O

Record B-SMOKER O
date: O O
2079-10-02 O O
71F O O
w/ O O
multiple O O
medical O O
problems, O O
including O O
dCHF, O O
restrictive O O
lung O O
disease, O O
severe O O
polyarthritis O O
returns O O
to O O
clinic O O
doing O O
significantly O O
better O O
for O O
the O O
most O O
part. O O
Regarding O O
her O O
shortness O O
of O O
breath, O O
she O O
undewent O O
a O O
stress O O
test O O
which O O
was O O
completely O O
wnl. O O
She O O
has O O
also O O
lost O O
some O O
weight O O
(intentional) O O
and O O
states O O
that, O O
although O O
she O O
still O O
gets O O
short O O
of O O
breath O O
with O O
exertion, O O
it O O
is O O
noticeably O O
better. O O
She O O
is O O
being O O
followed O O
by O O
the O O
pulmonary O O
department O O
and O O
is O O
under O O
consideration O O
for O O
a O O
cardiopulmonary O O
exercise O O
test. O O
For O O
her O O
cough, O O
the O O
nexium O O
has O O
helped O O
a O O
lot O O
and O O
she O O
likely O O
has O O
sig O O
reflux O O
despite O O
the O O
negative O O
esophagram. O O
The O O
weight O O
loss O O
is O O
probably O O
helping O O
with O O
the O O
gerd O O
as O O
well. O O
Regarding O O
her O O
arthritis, O O
he O O
L O O
shoulder O O
pain O O
is O O
much O O
improved O O
with O O
PT. O O
Her O O
biggest O O
complaint O O
at O O
the O O
moment, O O
though, O O
is O O
her O O
low O O
back O O
pain. O O
She O O
was O O
seen O O
in O O
pain O O
clinic O O
for O O
two O O
injections. O O
She O O
states O O
that O O
the O O
injections O O
may O O
have O O
helped O O
for O O
1-2 O O
days O O
but O O
then O O
the O O
pain O O
returned. O O
She O O
says O O
this O O
is O O
her O O
most O O
limiting O O
symptom. O O
She O O
is O O
begging O O
for O O
narcotics. O O
Lastly, O O
she O O
has O O
clear O O
stress O O
urinary O O
incontinence, O O
was O O
cleared O O
for O O
a O O
TOT O O
sling O O
but O O
has O O
now O O
decided O O
to O O
push O O
this O O
procedure O O
off O O
until O O
next O O
spring. O O
Problems O O
Hypertension B-HYPERTENSION O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Cervical O O
polyp O O
endometrial O O
polyp O O
osteoarthritis O O
Sleep O O
apnea O O
diastolic O O
heart O O
failure O O
Restrictive O O
pulmonary O O
disease O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Medications O O
Caltrate O O
and O O
D O O
2 O O
TABS O O
PO O O
qd O O
, O O
keep O O
md O O
appt O O
for O O
11/15/77 O O
Zantac O O
(RANITIDINE O O
HCL) O O
150MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
, O O
keep O O
md O O
appt O O
for O O
oct O O
12 O O
Percocet O O
(OXYCODONE+APAP) O O
325-5 O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
TID O O
x O O
30 O O
days O O
Ativan O O
(LORAZEPAM) O O
1 O O
MG O O
(1MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Naproxen O O
375 O O
MG O O
(375MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
x O O
30 O O
days O O
Miralax O O
(POLYETHYLENE O O
GLYCOL O O
) O O
17 O O
GM O O
PO O O
QD O O
x O O
7 O O
days, O O
Each O O
17 O O
GM O O
dose O O
to O O
be O O
dissolved O O
in O O
8 O O
oz O O
of O O
water O O
Estrace O O
(ESTRADIOL) O O
1 O O
GM O O
(0.01% O O
CREAM/APPL O O
) O O
PV O O
BIW O O
Nexium O O
(ESOMEPRAZOLE) O O
40 O O
MG O O
(40MG O O
CAPSULE O O
DR O O
take O O
1) O O
PO O O
bid O O
x O O
30 O O
days O O
Lasix O O
(FUROSEMIDE) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
x O O
30 O O
days O O
Hydrochlorothiazide B-MEDICATION O
25 O O
MG O O
(25MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Levothyroxine O O
SODIUM O O
100MCG O O
TABLET O O
PO O O
QD O O
Colace O O
(DOCUSATE O O
SODIUM) O O
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
TID O O
x O O
30 O O
days, O O
keep O O
md O O
appt O O
oct O O
12 O O
2077 O O
for O O
more O O
refills O O
Loratadine O O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Neurontin O O
(GABAPENTIN) O O
300 O O
MG O O
(300MG O O
CAPSULE O O
take O O
1) O O
PO O O
TID O O
x O O
30 O O
days, O O
generic O O
ok; O O
keep O O
md O O
appt O O
for O O
11/15/77 O O
Fosamax O O
(ALENDRONATE) O O
70 O O
MG O O
(70MG O O
TABLET O O
take O O
1) O O
PO O O
QWEEK O O
Diovan B-MEDICATION O
(VALSARTAN) O O
160 O O
MG O O
(160MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Metformin B-MEDICATION B-MEDICATION
Variable O O
(500MG/5ML O O
SOLUTION O O
take O O
1 O O
ML) O O
PO O O
Calcium O O
+ O O
D O O
(500 O O
ELEM. O O
CA) O O
(CALCIUM O O
CARBONATE O O
1250 O O
MG O O
(500MG O O
ELEM O O
CA)/ O O
VIT O O
D O O
200 O O
IU)) O O
2 O O
TAB O O
(500MG-200 O O
TABLET O O
) O O
PO O O
Q12H O O
x O O
30 O O
days O O
Senna O O
TABLETS O O
(SENNOSIDES) O O
2 O O
TAB O O
(187MG O O
TABLET O O
) O O
PO O O
BID O O
x O O
30 O O
days O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10 O O
MG O O
PO O O
QD O O
Carvedilol B-MEDICATION O
6.25 O O
MG O O
(6.25MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
Oxycodone O O
5 O O
MG O O
(5MG O O
TABLET O O
take O O
1) O O
PO O O
q12h O O
PRN O O
pain O O
Allergies O O
Penicillins O O
- O O
rash, O O
Gadolinium O O
Chelates O O
- O O
Itching, O O
Hives, O O
Bronchospasm O O
or O O
Wheezing O O
: O O
8/03/76 O O
Patient O O
developed O O
a O O
moderate O O
( O O
grade O O
II) O O
reaction O O
to O O
Gadolinuim. O O
Based O O
on O O
this O O
even, O O
recommendations O O
for O O
future O O
studies O O
include O O
pre-treatment O O
with O O
corticosteroids O O
followed O O
by O O
Gadolinium O O
chealtes. O O
PE: O O
BP O O
138/76, O O
P O O
67, O O
Wt O O
199 O O
lb O O
(from O O
214) O O
FINGER O O
BLOOD O O
GLUCOSE O O
104 O O
JVP O O
flat, O O
lungs O O
clear O O
w/ O O
scant O O
crackles O O
rrr O O
s1 O O
s2 O O
abd O O
obese, B-OBESE O
nt/nd/ O O
+BS O O
No O O
edema O O
A/P: O O
71F O O
w/ O O
MMPs O O
including O O
CAD B-CAD O
w/ O O
recent O O
normal O O
MIBI, O O
diastolic O O
CHF, O O
restrictive O O
lung O O
disease, O O
osteoarthritis O O
returns O O
to O O
clinic O O
doing O O
somewhat O O
better O O
than O O
before. O O
1)CV: O O
Pt O O
has O O
diastolic O O
CHF, O O
w/ O O
vol O O
status O O
cont O O
to O O
be O O
improved O O
on O O
exam O O
w/ O O
almost O O
no O O
le O O
edema O O
on O O
lasix O O
(minimal O O
hjr). O O
She O O
still O O
c/o O O
doe O O
but O O
even O O
this O O
is O O
much O O
improved. O O
Etiology O O
is O O
likely O O
multifactorial O O
(restrictive O O
lung, O O
diastolic O O
chf, O O
obesity/OSA/deconditioning). B-OBESE O
Recent O O
echo O O
w/ O O
EF O O
65% O O
and O O
DD. O O
Recent O O
MIBI O O
wnl--no O O
ischemia. O O
BP O O
well O O
controlled O O
and O O
HR O O
60s. O O
Cont O O
to O O
eat O O
salt. O O
-cont O O
diovan B-MEDICATION O
160, O O
hctz B-MEDICATION O
25, O O
lasix O O
20, O O
carvedilol, B-MEDICATION O
plavix B-MEDICATION B-MEDICATION
(per O O
family O O
doc), O O
lipitor. B-MEDICATION B-MEDICATION
-Close O O
monitoring O O
of O O
electrolytes. O O
Re-check O O
today. O O
-low O O
fat, O O
low O O
Na O O
diet O O
-Check O O
lytes, O O
LFTs O O
today. O O
-F/U O O
with O O
cardiology O O
in O O
clinic O O
2)Pulm: O O
Shortness O O
of O O
breath O O
likely O O
multifactorial. O O
Recent O O
PFTs O O
reveal O O
presence O O
of O O
restrictive O O
lung O O
disease O O
with O O
impaired O O
diffusion. O O
However, O O
effort O O
was O O
sub-optimal O O
and O O
patient O O
volume O O
overloaded. O O
Also O O
w/ O O
significant O O
obesity. O O
Pt O O
had O O
recent O O
sleep O O
study O O
confirming O O
OSA. O O
CT O O
chest O O
w/ O O
non-specific O O
findings O O
and O O
an O O
'indeterminate' O O
nodule. O O
-Am O O
not O O
opposed O O
to O O
cardiopulmonary O O
testing O O
per O O
pulmonary, O O
though O O
sxs O O
are O O
slowly O O
improving. O O
-Pt O O
would O O
like O O
to O O
discuss O O
w/ O O
pulm O O
re: O O
CPAP O O
for O O
her O O
OSA. O O
Will O O
hold O O
off O O
setting O O
up O O
cpap O O
titration O O
until O O
then. O O
-Repeat O O
CT O O
chest O O
regarding O O
pulm O O
nodule--likely O O
benign O O
-F/u O O
in O O
pulm O O
dept O O
3)Endocrine: O O
Pt O O
w/ O O
recently O O
diagnosed O O
diabetes B-DIABETES O
w/ O O
hba1c B-DIABETES O
about I-DIABETES O
6.8. I-DIABETES O
FS O O
log O O
reveals O O
good O O
AM O O
glycemic O O
control. O O
Also O O
w/ O O
a O O
hx O O
of O O
hypothyroidism. O O
Feeling O O
cold O O
recently, O O
needs O O
more O O
test O O
strips. O O
-Cont O O
metfromin B-MEDICATION O
to O O
1000/500. O O
-Check O O
Hba1c O O
at O O
next O O
visit. O O
-Cont O O
Home O O
glucometer. O O
Refills O O
given. O O
-Re-check O O
TSH O O
today. O O
-Re-emphasized O O
need O O
for O O
continued O O
weight O O
loss O O
and O O
congratulated O O
patient O O
on O O
recent O O
efforts. O O
4)OB/GYN: O O
Hx O O
of O O
thickened O O
endometrial O O
stripe, O O
but O O
normal O O
endometrial O O
bipsy. O O
Also O O
hx O O
of O O
atrophic O O
vaginitis O O
prescribed O O
topical O O
estrogen O O
cream. O O
Not O O
currently O O
sexually O O
active. O O
Also O O
w/ O O
urinary O O
incontinence, O O
needs O O
a O O
TOT O O
sling O O
but O O
pushing O O
this O O
off O O
for O O
now. O O
-cont O O
topical O O
estradiol O O
-f/u O O
in O O
ob/gyn O O
regarding O O
sling O O
in O O
future. O O
5)GI: O O
Patient O O
c/o O O
sensation O O
of O O
fullness O O
in O O
throat, O O
occasional O O
dysphagia O O
w/ O O
regurgitation O O
now O O
improved O O
on O O
increased O O
dose O O
of O O
nexium. O O
Barium O O
swallow O O
wnl. O O
Has O O
abd O O
scar O O
w/ O O
mild O O
drainage O O
tract. O O
Per O O
surgery, O O
correction O O
only O O
needed O O
for O O
cosmetic O O
purposes. O O
+gallstones O O
on O O
CT. O O
-Cont O O
nexium O O
BID O O
-weight O O
loss O O
6)MSK: O O
Has O O
degenerative O O
disk O O
disease, O O
arthritis O O
s/p O O
lumbar O O
fusion. O O
Also O O
w/ O O
R O O
and O O
L O O
glenohumeral O O
OA, O O
b/l O O
knee O O
OA O O
s/p O O
knee O O
replacements. O O
Recently O O
dxd O O
carpal O O
tunnel O O
b/l O O
s/p O O
tunnel O O
release. O O
Recent O O
lumbar O O
injection O O
w/ O O
only O O
transient O O
pain O O
relief. O O
Requesting O O
oxycodone. O O
-Cont O O
ibuprofen O O
for O O
pain. O O
-Will O O
prescribe O O
oxycodone O O
5mg O O
BID O O
prn O O
pain. O O
Pt O O
informed O O
that O O
I O O
am O O
still O O
hoping O O
that O O
this O O
be O O
temporary. O O
However, O O
may O O
need O O
chronic O O
narcotics O O
if O O
cant O O
get O O
relief O O
from O O
pain O O
clinic. O O
-f/u O O
in O O
pain O O
clinic O O
for O O
repeat O O
injection/eval. O O
-F/u O O
with O O
Dr O O
Ferrara O O
in O O
ortho O O
clinic O O
7)Health: O O
- O O
mammogram O O
on O O
7/16/79 O O
wnl. O O
-Will O O
need O O
repeat O O
colonoscopy O O
in O O
2.5 O O
years O O
2/2 O O
polyp/small O O
adenoma O O
at O O
old O O
colonoscopy. O O
-Desperately O O
needs O O
to O O
cont O O
to O O
lose O O
weight. O O
Nutrition O O
f/u. O O
-RTC O O
to O O
see O O
me O O
in O O
two O O
months. O O
_____________________________________________ O O
Erik O O
D. O O
Raines, O O
M.D. O O

Record O O
date: O O
2080-05-27 O O
71F O O
w/ O O
MMPs O O
returns O O
to O O
clinic O O
for O O
a O O
routine O O
f/u O O
visit. O O
Since O O
I O O
last O O
saw O O
her, O O
she O O
has O O
made O O
some O O
nice O O
strides. O O
Her O O
breathing O O
and O O
ability O O
to O O
exert O O
herself O O
is O O
significantly O O
better O O
w/ O O
BP O O
control, O O
diuretics, O O
control O O
of O O
gerd, O O
and O O
mild O O
weight O O
loss. O O
She O O
had O O
a O O
sling O O
placed O O
for O O
incontinence O O
which O O
has O O
helped. O O
She O O
also O O
has O O
some O O
improved O O
back O O
pain O O
w/ O O
lidoderm O O
patches O O
and O O
prn O O
oxycodone. O O
She O O
had O O
a O O
sleep O O
study O O
recently O O
confirming O O
the O O
presence O O
of O O
sleep O O
apnea. O O
Problems O O
Hypertension B-HYPERTENSION O
Elevated B-HYPERLIPIDEMIA O
cholesterol I-HYPERLIPIDEMIA O
Cervical O O
polyp O O
endometrial O O
polyp O O
osteoarthritis O O
Sleep O O
apnea O O
diastolic O O
heart O O
failure O O
Restrictive O O
pulmonary O O
disease O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Medications O O
Calcium O O
+ O O
D O O
(500 O O
ELEM. O O
CA) O O
(CALCIUM O O
CARBONATE O O
1250 O O
MG O O
(500MG O O
ELEM O O
CA)/ O O
VIT O O
D O O
200 O O
IU)) O O
2 O O
TAB O O
(500MG-200 O O
TABLET O O
) O O
PO O O
Q12H O O
Carvedilol B-MEDICATION O
6.25 O O
MG O O
(6.25MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
Celebrex O O
(CELECOXIB) O O
100 O O
MG O O
(100MG O O
CAPSULE O O
take O O
1) O O
PO O O
BID O O
Diovan B-MEDICATION O
(VALSARTAN) O O
160 O O
MG O O
(160MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Fosamax O O
(ALENDRONATE) O O
70 O O
MG O O
(70MG O O
TABLET O O
take O O
1) O O
PO O O
QWEEK O O
Hydrochlorothiazide B-MEDICATION B-MEDICATION
25 O O
MG O O
(25MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Lasix O O
(FUROSEMIDE) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Levothyroxine O O
SODIUM O O
100MCG O O
TABLET O O
PO O O
QD O O
Lidoderm O O
5% O O
PATCH O O
(LIDOCAINE O O
5% O O
PATCH) O O
1 O O
PATCH O O
(5% O O
ADH. O O
PATCH O O
) O O
TRANSDERMAL O O
QD O O
, O O
Patch O O
should O O
be O O
applied O O
to O O
intact O O
skin O O
only, O O
covering O O
the O O
most O O
painful O O
area(s). O O
Remove O O
release O O
liner O O
and O O
apply O O
up O O
to O O
3 O O
patches O O
at O O
one O O
time, O O
for O O
up O O
to O O
12 O O
hours O O
within O O
a O O
24-hour O O
period. O O
Patches O O
may O O
be O O
cut O O
into O O
smaller O O
sizes O O
with O O
scissors O O
prior O O
to O O
removal O O
of O O
the O O
release O O
liner. O O
Loratadine O O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Metformin B-MEDICATION B-MEDICATION
Variable O O
(500MG/5ML O O
SOLUTION O O
take O O
1 O O
ML) O O
PO O O
Neurontin O O
(GABAPENTIN) O O
300 O O
MG O O
(300MG O O
CAPSULE O O
take O O
1) O O
PO O O
TID O O
x O O
30 O O
days O O
Percocet O O
(OXYCODONE+APAP) O O
325-5 O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
TID O O
x O O
30 O O
days O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Prilosec O O
(OMEPRAZOLE) O O
20 O O
MG O O
(20MG O O
CAPSULE O O
DR O O
take O O
1) O O
PO O O
QD O O
Senna O O
TABLETS O O
(SENNOSIDES) O O
2 O O
TAB O O
(187MG O O
TABLET O O
) O O
PO O O
BID O O
Zantac O O
(RANITIDINE O O
HCL) O O
150MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
, O O
keep O O
md O O
appt O O
for O O
oct O O
12 O O
Zocor B-MEDICATION B-MEDICATION
(SIMVASTATIN) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
, O O
to O O
replace O O
lipitor B-MEDICATION B-MEDICATION
Allergies O O
Penicillins O O
- O O
rash, O O
Gadolinium O O
Chelates O O
- O O
Itching, O O
Hives, O O
Bronchospasm O O
or O O
Wheezing O O
: O O
8/03/76 O O
Patient O O
developed O O
a O O
moderate O O
( O O
grade O O
II) O O
reaction O O
to O O
Gadolinuim. O O
Based O O
on O O
this O O
even, O O
recommendations O O
for O O
future O O
studies O O
include O O
pre-treatment O O
with O O
corticosteroids O O
followed O O
by O O
Gadolinium O O
chealtes. O O
PE: O O
PULSE O O
67 O O
BLOOD O O
PRESSURE O O
124/62 O O
WEIGHT O O
202 O O
lb O O
FINGER O O
BLOOD O O
GLUCOSE O O
103 O O
well O O
appearing, O O
nad, O O
JVP O O
7 O O
lungs O O
clear, O O
rrr O O
s1 O O
s2 O O
soft O O
sys O O
murmur O O
abd O O
soft O O
nt/nd O O
+bs O O
legs O O
w/ O O
essentially O O
no O O
edema O O
A/P: O O
71F O O
w/ O O
MMPs O O
including B-CAD O
CAD B-CAD O
w/ O O
recent O O
normal O O
MIBI, O O
diastolic O O
CHF, O O
restrictive O O
lung O O
disease, O O
osteoarthritis O O
returns O O
to O O
clinic O O
doing O O
better O O
than O O
before. O O
1)CV: O O
Pt O O
has O O
diastolic O O
CHF, O O
w/ O O
vol O O
status O O
cont O O
to O O
be O O
improved O O
on O O
exam O O
w/ O O
almost O O
no O O
le O O
edema O O
on O O
lasix O O
(minimal O O
hjr). O O
She O O
still O O
c/o O O
doe O O
but O O
even O O
this O O
is O O
much O O
improved. O O
Etiology O O
is O O
likely O O
multifactorial O O
(restrictive O O
lung, O O
diastolic O O
chf, O O
obesity/OSA/deconditioning). B-OBESE O
Recent O O
echo O O
w/ O O
EF O O
65% O O
and O O
DD. O O
Recent O O
MIBI O O
wnl--no O O
ischemia. O O
BP O O
well O O
controlled O O
and O O
HR O O
60s. O O
Cont O O
to O O
eat O O
salt. O O
-cont O O
diovan B-MEDICATION O
160, O O
hctz B-MEDICATION O
25, O O
lasix O O
20, O O
carvedilol, O O
plavix B-MEDICATION B-MEDICATION
(per O O
family O O
doc), O O
lipitor. O B-MEDICATION
-Close O O
monitoring O O
of O O
electrolytes. O O
Re-check O O
today. O O
-low O O
fat, O O
low O O
Na O O
diet O O
-Check O O
lytes, O O
LFTs O O
today. O O
-F/U O O
with O O
cardiology O O
in O O
clinic O O
2)Pulm: B-SMOKER O
Shortness O O
of O O
breath O O
likely O O
multifactorial. O O
Recent O O
PFTs O O
reveal O O
presence O O
of O O
restrictive O O
lung O O
disease O O
with O O
impaired O O
diffusion. O O
However, O O
effort O O
was O O
sub-optimal O O
and O O
patient O O
volume O O
overloaded. O O
Also O O
w/ O O
significant O O
obesity. O O
Pt O O
had O O
recent O O
sleep O O
study O O
confirming O O
OSA. O O
CT O O
chest O O
w/ O O
non-specific O O
findings O O
and O O
an O O
'indeterminate' O O
nodule. O O
-Am O O
not O O
opposed O O
to O O
cardiopulmonary O O
testing O O
per O O
pulmonary, O O
though O O
sxs O O
are O O
slowly O O
improving. O O
-Had O O
+ O O
sleep O O
study O O
and O O
have O O
provided O O
Rx O O
for O O
cpap O O
to O O
begin O O
next O O
month. O O
-Repeat O O
CT O O
chest O O
regarding O O
pulm O O
nodule--likely O O
benign O O
-F/u O O
in O O
pulm O O
dept O O
3)Endocrine: O O
Pt O O
w/ O O
recently O O
diagnosed O O
diabetes B-DIABETES O
w/ O O
hba1c B-DIABETES O
about I-DIABETES O
6.8. I-DIABETES O
FS O O
log O O
reveals O O
good O O
AM O O
glycemic O O
control. O O
Also O O
w/ O O
a O O
hx O O
of O O
hypothyroidism. O O
Feeling O O
cold O O
recently, O O
needs O O
more O O
test O O
strips. O O
-Cont O O
metfromin B-MEDICATION O
500 O O
BID. O O
-Check O O
Hba1c. O O
-Cont O O
Home O O
glucometer. O O
Refills O O
given. O O
-Re-check O O
TSH O O
today O O
for O O
complaints O O
of O O
feeling O O
cold. O O
-Re-emphasized O O
need O O
for O O
continued O O
weight O O
loss O O
and O O
congratulated O O
patient O O
on O O
recent O O
efforts. O O
4)OB/GYN: O O
Hx O O
of O O
thickened O O
endometrial O O
stripe, O O
but O O
normal O O
endometrial O O
bipsy. O O
Also O O
hx O O
of O O
atrophic O O
vaginitis O O
prescribed O O
topical O O
estrogen O O
cream. O O
Not O O
currently O O
sexually O O
active. O O
Also O O
w/ O O
urinary O O
incontinence O O
s/p O O
sling O O
w/ O O
improvement. O O
-cont O O
topical O O
estradiol O O
-f/u O O
in O O
ob/gyn O O
clinic O O
5)GI: O O
Patient O O
c/o O O
sensation O O
of O O
fullness O O
in O O
throat, O O
occasional O O
dysphagia O O
w/ O O
regurgitation O O
now O O
improved O O
on O O
increased O O
dose O O
of O O
nexium. O O
Barium O O
swallow O O
wnl. O O
Has O O
abd O O
scar O O
w/ O O
mild O O
drainage O O
tract. O O
Per O O
surgery, O O
correction O O
only O O
needed O O
for O O
cosmetic O O
purposes. O O
+gallstones O O
on O O
CT. O O
-Cont O O
nexium O O
BID O O
-weight O O
loss O O
6)MSK: O O
Has O O
degenerative O O
disk O O
disease, O O
arthritis O O
s/p O O
lumbar O O
fusion. O O
Also O O
w/ O O
R O O
and O O
L O O
glenohumeral O O
OA, O O
b/l O O
knee O O
OA O O
s/p O O
knee O O
replacements. O O
Recently O O
dxd O O
carpal O O
tunnel O O
b/l O O
s/p O O
tunnel O O
release. O O
Recent O O
lumbar O O
injection O O
w/ O O
only O O
transient O O
pain O O
relief. O O
Requesting O O
oxycodone. O O
-Cont O O
ibuprofen O O
for O O
pain O O
and O O
represcribe O O
lidoderm O O
patch O O
which O O
seems O O
to O O
help. O O
-Will O O
cont O O
oxycodone O O
5mg O O
BID O O
prn O O
pain. O O
Pt O O
informed O O
that O O
I O O
am O O
still O O
hoping O O
that O O
this O O
be O O
temporary. O O
However, O O
may O O
need O O
chronic O O
narcotics O O
if O O
cant O O
get O O
relief O O
from O O
pain O O
clinic. O O
-f/u O O
in O O
pain O O
clinic O O
for O O
repeat O O
injection/eval. O O
-F/u O O
with O O
Dr O O
Ferrara O O
in O O
ortho O O
clinic O O
7)Health: O O
- O O
mammogram O O
on O O
7/16/79 O O
wnl. O O
-Will O O
need O O
repeat O O
colonoscopy O O
in O O
2.5 O O
years O O
2/2 O O
polyp/small O O
adenoma O O
at O O
old O O
colonoscopy. O O
-Desperately O O
needs O O
to O O
cont O O
to O O
lose O O
weight. O O
Nutrition O O
f/u. O O
-RTC O O
to O O
see O O
me O O
in O O
three O O
months. O O
_____________________________________________ O O
Erik O O
D O O
Raines, O O
MD O O
========================== O O
Preceptor's O O
Note O O
========================== O O
Discussed O O
with O O
Dr. O O
Raines. O O
71 O O
yo O O
woman O O
with O O
multiple O O
medical O O
problems O O
including O O
DM, O O
HTN, O O
OSA, O O
obesity. O O
We O O
will O O
arrange O O
for O O
CPAP. O O
_____________________________________________ O O
Tannon O O
Jose O O
Olivares, O O
M.D. O O

Record O O
date: O O
2120-10-23 O O
Patient O O
Name: O O
FLAHERTY, O O
XAVIER; O O
MRN: O O
1935081 O O
Dictated O O
on: O O
10/23/2120 O O
by O O
ROSITA O O
KO, O O
M.D. O O
The O O
patient O O
is O O
a O O
72-year-old O O
male, O O
paraplegic, O O
referred O O
for O O
evaluation O O
of O O
recurrent O O
bladder O O
infections. O O
The O O
patient O O
has O O
persistent O O
presence O O
of O O
bacteria O O
in O O
his O O
urine O O
and O O
there O O
is O O
a O O
concern O O
that O O
he O O
might O O
have O O
a O O
persistent O O
source O O
of O O
infection. O O
The O O
patient O O
denies O O
fevers, O O
chills, O O
sweats, O O
decrease O O
in O O
energy, O O
loss O O
of O O
appetite, O O
pain O O
in O O
the O O
lower O O
abdomen O O
or O O
penile O O
discharge. O O
He O O
reports O O
there O O
is O O
some O O
soreness O O
around O O
the O O
meatus, O O
which O O
he O O
attributes O O
to O O
self-catheterizing O O
he O O
is O O
required O O
to O O
do O O
3 O O
times O O
a O O
day. O O
He O O
is O O
well O O
educated O O
in O O
terms O O
of O O
cleaning O O
around O O
the O O
side O O
and O O
the O O
appropriate O O
way O O
to O O
do O O
self-catheterization. O O
PAST O O
MEDICAL O O
HISTORY: O O
Diabetes, B-DIABETES O
hypertension, B-HYPERTENSION O
paraplegia O O
secondary O O
to O O
unclear O O
disk O O
problems O O
in O O
2107, O O
right O O
hip O O
ulcer O O
with O O
trochanteric O O
osteomyelitis O O
in O O
December O O
2118, O O
treated O O
with O O
Unasyn O O
x6 O O
weeks O O
and O O
debridement O O
and O O
surgical O O
flap, O O
sacral O O
decubiti O O
in O O
2119 O O
treated O O
with O O
Unasyn O O
x6 O O
weeks, O O
local O O
debridement O O
healing O O
by O O
secondary O O
intention. O O
No O O
history O O
of O O
kidney O O
stones. O O
SOCIAL: O O
Ex-tobacco B-SMOKER O
use I-SMOKER O
2-3 I-SMOKER O
packs I-SMOKER O
per I-SMOKER O
day, I-SMOKER O
quit I-SMOKER O
25 I-SMOKER O
years. I-SMOKER O
Alcohol O O
prior O O
heavy O O
use, O O
quit O O
25 O O
years. O O
Lives O O
alone. O O
Prior O O
work O O
included O O
Heavy-Duty O O
Equipment O O
Mechanic, O O
Ironworker, O O
as O O
well O O
as O O
Electric O O
Appliance O O
Servicer. O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
MEDICATIONS: O O
Blood O O
pressure O O
medication, O O
name O O
unknown. O O
Metformin. B-MEDICATION O
Note, O O
patient O O
had O O
been O O
on O O
Bactrim O O
prophylaxis O O
over O O
the O O
spring. O O
PHYSICAL O O
EXAMINATION: O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
150/100, I-HYPERTENSION O
heart O O
rate O O
100, O O
temperature O O
97.9. O O
In O O
general, O O
vigorous, O O
well-appearing O O
man O O
in O O
wheelchair. O O
Awake O O
and O O
alert. O O
HEENT, O O
sclerae O O
anicteric. O O
Conjunctivae O O
noninjected. O O
Neck O O
supple. O O
No O O
significant O O
lymphadenopathy. O O
Chest, O O
clear O O
to O O
auscultation O O
bilaterally. O O
Cardiac, O O
regular O O
rate O O
and O O
rhythm. O O
No O O
murmurs. O O
Abdomen O O
benign. O O
Extremities, O O
warm O O
and O O
well O O
perfused. O O
No O O
edema. O O
IMPRESSION: O O
Presence O O
of O O
bacteria O O
in O O
static O O
urine O O
within O O
the O O
bladder O O
is O O
not O O
necessarily O O
diagnostic O O
as O O
infection O O
given O O
patient's O O
lack O O
of O O
symptoms O O
and O O
likely O O
reflects O O
colonization. O O
PLAN: O O
Would O O
not O O
treat O O
patient O O
with O O
antibiotics O O
unless O O
he O O
develops O O
signs O O
or O O
symptoms O O
of O O
infection O O
such O O
as O O
fevers, O O
chills, O O
sweats, O O
elevated O O
white O O
blood O O
cell O O
count, O O
pain O O
in O O
the O O
suprapubic O O
area O O
or O O
decreased O O
energy. O O
_________________________ O O
Rosita O O
Ko, O O
M.D. O O
DD:10/23/2120 O O
DT:10/24/2120 O O
AO:29724 O O
:0269 O O

Record O O
date: O O
2121-05-19 O O
Internal O O
Medicine O O
HOLY O O
CROSS O O
HOSPITAL O O
History O O
of O O
present O O
illness O O
The O O
patient O O
is O O
a O O
72 O O
year O O
old O O
male, O O
with O O
a O O
past O O
medical O O
history O O
of O O
paraplegia O O
(due O O
to O O
spinal O O
ischemia), O O
DMII, B-DIABETES O
HTN, B-HYPERTENSION O
and O O
recurrent O O
UTI's, O O
who O O
came O O
in O O
for O O
a O O
follow O O
up O O
visit. O O
The O O
patient O O
says O O
that O O
he O O
has O O
been O O
feeling O O
well. O O
He O O
continues O O
to O O
exercise O O
frequently. O O
No O O
chest O O
pain, O O
abdominal O O
pain, O O
SOB, O O
or O O
fevers. O O
Allergies O O
No O O
known O O
drug O O
allergy O O
Change O O
in O O
therapies O O
and O O
Renewals O O
Zestril B-MEDICATION B-MEDICATION
30mg O O
PO O O
QD O O
QTY:90 O O
Refills:3 O O
Start: O O
11/22/2118 O O
iron O O
supplement O O
325mg O O
po O O
qd O O
QTY:30 O O
Refills:1 O O
year O O
Start: O O
6/15/2119 O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
po O O
qd O O
QTY:30 O O
Refills:1 O O
yr O O
Start: O O
6/15/2119 O O
Xanax O O
0.25mg O O
po O O
bid O O
QTY:180 O O
Refills:3 O O
Start: O O
6/15/2119 O O
free O O
text O O
medications O O
regranex O O
45 O O
gram O O
QTY:1 O O
Refills:1 O O
yr O O
Start: O O
6/19/2119 O O
Glucophage B-MEDICATION B-MEDICATION
850 O O
mg O O
po O O
bid O O
QTY:180 O O
Refills:3 O O
Start: O O
7/18/2120 O O
take O O
with O O
meals O O
Lipitor B-MEDICATION B-MEDICATION
20mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
4/07/2121 O O
Neurontin O O
300 O O
mg O O
po O O
tid O O
QTY:270 O O
Refills:3 O O
Start: O O
4/07/2121 O O
multivitamins O O
1 O O
tab O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
5/19/2121 O O
atenolol B-MEDICATION B-MEDICATION
25mg O O
po O O
qd O O
Start: O O
5/19/2121 O O
Past O O
medical O O
history O O
Paraplegia- O O
On O O
10/06 O O
the O O
patient O O
had O O
a O O
lumbar O O
laminectomy O O
for O O
sciatica. O O
His O O
sciatical O O
pain O O
improved O O
until O O
5/07 O O
when O O
he O O
developed O O
proximal O O
leg O O
weakness. O O
By O O
7/07 O O
the O O
patient O O
was O O
bound O O
to O O
a O O
wheelchair. O O
Orginally O O
an O O
extensive O O
workup O O
suggested O O
that O O
the O O
patient O O
had O O
an O O
extramedullary O O
tumor O O
from O O
T8-T12. O O
However O O
all O O
biopsies O O
were O O
inconclusive. O O
The O O
patient O O
subsequently O O
received O O
a O O
T10 O O
laminectomy O O
on O O
9/09 O O
that O O
revealed O O
Spinal O O
Vascular O O
Malformation O O
but O O
no O O
tumor. O O
The O O
patient O O
received O O
serial O O
MRI's O O
until O O
12/14 O O
that O O
were O O
able O O
to O O
demonstrate O O
no O O
'recurrent' O O
tumors. O O
DMII-first O O
diagnosed O O
in O O
2113 O O
HTN O O
Recurrent O O
UTI's O O
PSA O O
of O O
6.6 O O
Flap O O
3 O O
Closure O O
Surgery-patient O O
says O O
that O O
he O O
received O O
this O O
surgery O O
to O O
correct O O
damage O O
to O O
his O O
skin O O
caused O O
by O O
his O O
multiple O O
back O O
surgeries O O
2690's O O
received O O
surgery O O
for O O
shrapnel O O
removal O O
Sacral O O
decubitus O O
ulcers O O
Family O O
history O O
Father O O
- O O
was O O
an O O
alcoholic O O
who O O
died O O
in O O
an O O
accident O O
Mom- O O
died O O
at O O
the O O
age O O
of O O
76 O O
with O O
peripheral O O
vascular O O
disease O O
Brother- B-FAMILY_HIST O
died I-FAMILY_HIST O
in I-FAMILY_HIST O
50's I-FAMILY_HIST O
of I-FAMILY_HIST O
CAD, I-FAMILY_HIST O
was I-FAMILY_HIST O
an I-FAMILY_HIST O
alcoholic I-FAMILY_HIST O
Social O O
history O O
The O O
patient O O
lives O O
alone. O O
He O O
never O O
married O O
and O O
has O O
no O O
children. O O
He O O
is O O
a O O
retired O O
Heavy-Duty O O
Equipment O O
Mechanic O O
(15yrs) O O
and O O
Concrete O O
Finisher O O
(25yrs). O O
He O O
is O O
a O O
veteran. O O
The O O
patient O O
quit B-SMOKER O
smoking I-SMOKER O
20 I-SMOKER O
years I-SMOKER O
ago I-SMOKER O
but I-SMOKER O
had I-SMOKER O
smoked I-SMOKER O
1.5ppd*20yrs I-SMOKER O
(30 I-SMOKER O
pack I-SMOKER O
year). I-SMOKER O
Very O O
rarely O O
drinks. O O
Physical O O
examination O O
Pulse O O
92 O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
150/80 B-HYPERTENSION O
Respiratory O O
rate O O
16 O O
General O O
appearance O O
NAD O O
Heent O O
PERRLA, O O
EOMI, O O
no O O
oral O O
erythema O O
or O O
lesions O O
Chest O O
b/l O O
clear O O
to O O
ascultation O O
Cor O O
S1/S2+, O O
RRR, O O
no O O
murmurs O O
Abdomen O O
Nt/nd/ O O
+bs O O
Extrem O O
no O O
edema O O
Assessment O O
and O O
plan O O
The O O
patient O O
is O O
a O O
72 O O
year O O
old O O
male, O O
with O O
a O O
past O O
medical O O
history O O
of O O
paraplegia O O
(due O O
to O O
spinal O O
ischemia), O O
DMII, O O
HTN, O O
and O O
recurrent O O
UTI's, O O
who O O
came O O
in O O
for O O
a O O
follow O O
up O O
visit. O O
1. O O
Diabetes B-DIABETES O
-HemA1C B-DIABETES O
10/20-&gt;7.5. I-DIABETES O
Will O O
recheck O O
-cont O O
metformin B-MEDICATION B-MEDICATION
to O O
850mg O O
bid O O
- O O
Ordered O O
repeat O O
chem O O
7 O O
(creatinine) O O
and O O
LFTs O O
-patient O O
sees O O
an O O
opthamologist O O
yearly O O
-referred O O
patient O O
again O O
to O O
podiatrist O O
-NEXT O O
visit O O
patient O O
will O O
bring O O
cath O O
supplies O O
and O O
WILL O O
check O O
for O O
microalbuniuria O O
- O O
-increased O O
lipitor B-MEDICATION B-MEDICATION
to O O
20 O O
(patient's O O
Chol O O
179 O O
and O O
LDL B-HYPERLIPIDEMIA O
111) I-HYPERLIPIDEMIA O
-&gt; O O
goal O O
LDL O O
70 O O
-patient O O
refused O O
nutrition O O
consult O O
-patient O O
is O O
taking O O
ASA B-MEDICATION B-MEDICATION
-patient O O
is O O
on O O
a O O
MVI O O
2. O O
HTN O O
-started O O
atenolol O B-MEDICATION
25 O O
qd O O
-current O O
regiment O O
is O O
atenolol O B-MEDICATION
25qd O O
and O O
Zestril O B-MEDICATION
to O O
30mg O O
qd O O
3. O O
?CAD O O
-EKG O O
4/21 O O
showed O O
evidence O O
of O O
old B-CAD O
('silent') I-CAD O
inferior I-CAD O
MI I-CAD O
-ordered O O
TTE O O
-WILL O O
consider O O
ETT O O
-will O O
check O O
homocysteine O O
level O O
3. O O
Paraplegia O O
-on O O
neurontin O O
for O O
neuropathic O O
pain O O
control O O
4.Recurent O O
UTI O O
-appreciate O O
ID O O
consult O O
will O O
give O O
prophylaxis O O
for O O
recurrent O O
UTI's. O O
Also, O O
will O O
not O O
treat O O
patient O O
unless O O
he O O
has O O
systemic O O
symptoms O O
of O O
fevers O O
or O O
there O O
is O O
a O O
great O O
increase O O
in O O
the O O
amount O O
of O O
burning O O
he O O
has O O
on O O
urination O O
5. O O
Elevated O O
PSA O O
-appreciate O O
urology O O
consult O O
-they O O
felt O O
that O O
in O O
light O O
of O O
stability O O
of O O
PSA O O
and O O
patient's O O
desire O O
not O O
be O O
biopsied O O
that O O
no O O
intervention O O
should O O
occur O O
at O O
this O O
time. O O
-urology O O
wants O O
to O O
see O O
the O O
patient O O
annually O O
(next O O
visit O O
12/21) O O
6. O O
Anxiety O O
-well O O
controlled, O O
will O O
continue O O
the O O
Zanax O O
7. O O
Health O O
Maintenance O O
-patient O O
has O O
received O O
pneumovac O O
-last O O
colonoscopy O O
was O O
on O O
12/18 O O
-NEEDS O O
flu O O
vaccine O O
in O O
spring O O
Return O O
to O O
clinic O O
in O O
1 O O
month O O
Addendum O O
I O O
was O O
present O O
during O O
key O O
portions O O
of O O
the O O
evaluation O O
of O O
the O O
patient O O
and O O
agree O O
with O O
John O O
Ross's O O
findings O O
and O O
plan O O
as O O
written.Diabetes O O
followup O O
good. O O
Appropriately O O
managed. O O
Rebecca O O
Downs O O
Signed O O
electronically O O
by O O
John O O
Ross O O
MD O O
on O O
May O O
25, O O
2121 O O
Rebecca O O
Downs O O
MD O O
on O O
May O O
29, O O
2121 O O

Record O O
date: O O
2122-09-14 O O
Internal O O
Medicine O O
HOLY O O
CROSS O O
HOSPITAL O O
History O O
of O O
present O O
illness O O
Mr. O O
Flaherty O O
is O O
a O O
74 O O
year O O
old O O
male O O
with O O
a O O
PMH O O
paraplegia O O
(secondary O O
to O O
spinal O O
ischemia), O O
DM, B-DIABETES O
HTN, B-HYPERTENSION O
sacral O O
decibutus O O
ulcer, O O
and O O
recurrent O O
UTI's O O
who O O
came O O
in O O
for O O
a O O
follow O O
up O O
visit. O O
The O O
patient O O
says O O
that O O
he O O
feels O O
well. O O
He O O
says O O
that O O
his O O
fingersticks O O
have O O
averaged O O
about O O
'124' O O
and O O
have O O
ranged O O
80-150. O O
He's O O
says O O
that O O
he's O O
improved O O
his O O
diet. O O
He O O
says O O
that O O
his O O
BP O O
has O O
been O O
checked O O
several O O
times O O
by O O
visiting O O
nurses O O
and O O
each O O
time O O
was O O
SBP O O
of O O
120. O O
He O O
says O O
that O O
his O O
abcess O O
under O O
his O O
left O O
axilla O O
has O O
healed O O
well O O
and O O
is O O
no O O
longer O O
bothering O O
him. O O
He O O
says O O
that O O
his O O
sacral O O
decibutus O O
ulcer O O
has O O
resolved. O O
On O O
review O O
of O O
systems, O O
no O O
chest O O
pain, O O
SOB, O O
abdominal O O
pain, O O
nausea/vomiting, O O
fevers, O O
dysuria, O O
or O O
lightheadnesses. O O
Allergies O O
No O O
known O O
drug O O
allergy O O
Change O O
in O O
therapies O O
and O O
Renewals O O
Zestril B-MEDICATION B-MEDICATION
20mg I-MEDICATION O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
11/22/2118 O O
iron O O
supplement O O
325mg O O
po O O
qd O O
QTY:30 O O
Refills:1 O O
year O O
Start: O O
6/15/2119 O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
po O O
qd O O
QTY:30 O O
Refills:1 O O
yr O O
Start: O O
6/15/2119 O O
Xanax O O
0.25mg O O
po O O
bid O O
QTY:180 O O
Refills:3 O O
Start: O O
6/15/2119 O O
Glucophage B-MEDICATION B-MEDICATION
1000 O O
mg O O
po O O
bid O O
QTY:180 O O
Refills:3 O O
Start: O O
7/18/2120 O O
take O O
with O O
meals O O
Lipitor B-MEDICATION B-MEDICATION
20mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
4/07/2121 O O
Neurontin O O
300 O O
mg O O
po O O
tid O O
QTY:270 O O
Refills:3 O O
Start: O O
4/07/2121 O O
multivitamins O O
1 O O
tab O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
5/19/2121 O O
atenolol B-MEDICATION B-MEDICATION
25mg I-MEDICATION O
po I-MEDICATION O
qd I-MEDICATION O
QTY:90 O O
Refills:6 O O
Start: O O
5/19/2121 O O
Past O O
medical O O
history O O
1. O O
Paraplegia- O O
On O O
10/06 O O
the O O
patient O O
had O O
a O O
lumbar O O
laminectomy O O
for O O
sciatica. O O
His O O
sciatical O O
pain O O
improved O O
until O O
5/07 O O
when O O
he O O
developed O O
proximal O O
leg O O
weakness. O O
By O O
7/07 O O
the O O
patient O O
was O O
bound O O
to O O
a O O
wheelchair. O O
Orginally O O
an O O
extensive O O
workup O O
suggested O O
that O O
the O O
patient O O
had O O
an O O
extramedullary O O
tumor O O
from O O
T8-T12. O O
However O O
all O O
biopsies O O
were O O
inconclusive. O O
The O O
patient O O
subsequently O O
received O O
a O O
T10 O O
laminectomy O O
on O O
9/09 O O
that O O
revealed O O
Spinal O O
Vascular O O
Malformation O O
but O O
no O O
tumor. O O
The O O
patient O O
received O O
serial O O
MRI's O O
until O O
12/14 O O
that O O
were O O
able O O
to O O
demonstrate O O
no O O
'recurrent' O O
tumors. O O
2. O O
DMII-first B-DIABETES O
diagnosed O O
in O O
2113 O O
3. O O
HTN O O
4. O O
Recurrent O O
UTI's O O
5. O O
PSA O O
of O O
6.6 O O
6. O O
Flap O O
3 O O
Closure O O
Surgery-patient O O
says O O
that O O
he O O
received O O
this O O
surgery O O
to O O
correct O O
damage O O
to O O
his O O
skin O O
caused O O
by O O
his O O
multiple O O
back O O
surgeries O O
2070's O O
received O O
surgery O O
for O O
shrapnel O O
removal O O
7. O O
Sacral O O
decubitus O O
ulcers O O
Family O O
history O O
Father O O
- O O
was O O
an O O
alcoholic O O
who O O
died O O
in O O
an O O
accident O O
Mom- O O
died O O
at O O
the O O
age O O
of O O
76 O O
with O O
peripheral O O
vascular O O
disease O O
Brother- B-FAMILY_HIST O
died I-FAMILY_HIST O
in I-FAMILY_HIST O
50's I-FAMILY_HIST O
of I-FAMILY_HIST O
CAD, I-FAMILY_HIST O
was I-FAMILY_HIST O
an I-FAMILY_HIST O
alcoholic I-FAMILY_HIST O
Social O O
history O O
The O O
patient O O
lives O O
alone. O O
He O O
never O O
married O O
and O O
has O O
no O O
children. O O
He O O
is O O
a O O
retired O O
Heavy-Duty O O
Equipment O O
Mechanic O O
(15yrs) O O
and O O
Concrete O O
Finisher O O
(25yrs). O O
He O O
is O O
a O O
veteran. O O
The O O
patient O O
quit B-SMOKER O
smoking I-SMOKER O
20 I-SMOKER O
years I-SMOKER O
ago I-SMOKER O
but I-SMOKER O
had I-SMOKER O
smoked I-SMOKER O
1.5ppd*20yrs I-SMOKER O
(30 I-SMOKER O
pack I-SMOKER O
year). I-SMOKER O
Very O O
rarely O O
drinks. O O
Physical O O
examination O O
Blood O O
pressure O O
135/70 O O
Pulse O O
82 O O
Respiratory O O
rate O O
12 O O
General O O
appearance O O
NAD, O O
pleasant. O O
In O O
a O O
wheelchair O O
Skin O O
Abcess O O
under O O
left O O
axilla O O
has O O
healed O O
well. O O
No O O
erythema O O
or O O
exudate. O O
Heent O O
PERRLA, O O
EOMI, O O
no O O
oral O O
erythema O O
or O O
lesions O O
Chest O O
b/l O O
clear O O
to O O
ascultation O O
Cor O O
S1/S2+, O O
RRR, O O
no O O
murmurs O O
Abdomen O O
Nt/nd/ O O
+bs O O
Rectal O O
exam O O
refused O O
Genitalia O O
refused O O
Extrem O O
no O O
edema O O
Neuro O O
CNII-XII O O
intact, O O
5/5 O O
strength O O
in O O
upper O O
2 O O
extermities, O O
no O O
numbness O O
or O O
tingling, O O
0/5 O O
strength O O
b/l O O
lower O O
extremities O O
Assessment O O
and O O
plan O O
The O O
patient O O
is O O
a O O
74 O O
year O O
old O O
male, O O
with O O
a O O
past O O
medical O O
history O O
of O O
paraplegia O O
(due O O
to O O
spinal O O
ischemia), O O
DMII, O O
HTN, O O
and O O
recurrent O O
UTI's, O O
who O O
came O O
in O O
for O O
a O O
follow O O
up O O
visit. O O
1. O O
Diabetes B-DIABETES O
-spoke O O
with O O
the O O
patient O O
about O O
his O O
diabetes O O
control. O O
He O O
understands O O
that O O
his O O
hemoglobin B-DIABETES O
A1C B-DIABETES O
is I-DIABETES O
8.4. I-DIABETES O
However, O O
he O O
doesnt O O
want O O
to O O
start O O
insulin O O
(inconvenient) O O
and O O
actos O O
(the O O
expense). O O
Our O O
plan O O
is O O
to O O
check O O
another O O
hemoglobin O O
A1C O O
since O O
his O O
diet O O
has O O
improved. O O
Will O O
consider O O
starting O O
low O O
dose O O
glypizide O B-MEDICATION
if O O
hem O O
A1C O O
still O O
grossly O O
elevated O O
-current O O
regiment O O
is O O
metformin B-MEDICATION B-MEDICATION
1000mg O O
bid O O
-HemA1C B-DIABETES O
2/22 I-DIABETES O
was I-DIABETES O
8.5 I-DIABETES O
-patient O O
sees O O
an O O
opthamologist O O
yearly O O
-patient O O
saw O O
a O O
podiatrist O O
in O O
1/22 O O
-patient O O
on O O
lipitor B-MEDICATION B-MEDICATION
20 O O
-&gt; O O
9/21 O O
lipid O O
panel O O
Cholesterol O O
147, O O
LDL O O
67, O O
HDL O O
42 O O
-patient O O
is O O
taking O O
ASA B-MEDICATION B-MEDICATION
-patient O O
is O O
on O O
a O O
MVI O O
2. O O
HTN O O
-spoke O O
with O O
the O O
patient O O
about O O
the O O
fact O O
that O O
his O O
SBP O O
is O O
130-135. O O
He O O
said O O
that O O
he O O
would O O
like O O
to O O
hold O O
off O O
on O O
advancing O O
treatment O O
for O O
now O O
-for O O
now O O
will O O
continue O O
Zestril O B-MEDICATION
20mg O O
qd O O
and O O
atenolol O B-MEDICATION
25mg O O
po O O
qd O O
-current O O
regiment O O
is O O
atenolol B-MEDICATION B-MEDICATION
25qd I-MEDICATION O
and O O
Zestril B-MEDICATION B-MEDICATION
10mg I-MEDICATION O
qd I-MEDICATION O
3. O O
Sacral O O
decibutus O O
ulcer O O
-patient O O
says O O
that O O
the O O
wound O O
has O O
healed O O
4. O O
Paraplegia O O
-on O O
neurontin O O
for O O
neuropathic O O
pain O O
control O O
-WILL O O
CONSIDER O O
increase O O
the O O
dosage O O
5.Recurent O O
UTI O O
-Will O O
not O O
give O O
prophylaxis O O
for O O
recurrent O O
UTI's. O O
Also, O O
will O O
not O O
treat O O
patient O O
unless O O
he O O
has O O
systemic O O
symptoms O O
of O O
fevers O O
or O O
there O O
is O O
a O O
great O O
increase O O
in O O
the O O
amount O O
of O O
burning O O
he O O
has O O
on O O
urination O O
6. O O
Elevated O O
PSA O O
-urology O O
felt O O
that O O
in O O
light O O
of O O
stability O O
of O O
PSA O O
and O O
patient's O O
desire O O
not O O
be O O
biopsied O O
that O O
no O O
intervention O O
should O O
occur O O
at O O
this O O
time. O O
-urology O O
wants O O
to O O
see O O
the O O
patient O O
annually. O O
Spoke O O
with O O
the O O
patient O O
again O O
about O O
this O O
today. O O
He O O
doesnt O O
want O O
to O O
see O O
urology O O
again O O
and O O
doesnt O O
want O O
a O O
rectal O O
exam. O O
7. O O
Anxiety O O
-well O O
controlled, O O
will O O
continue O O
the O O
Zanax O O
8. O O
Health O O
Maintenance O O
-patient O O
has O O
received O O
pneumovac O O
-last O O
colonoscopy O O
was O O
on O O
12/18 O O
-gave O O
the O O
patient O O
a O O
flu O O
vaccine O O
(9/22) O O
(Lot O O
BDIKB454QH O O
and O O
expiration O O
7/3/23) O O
Return O O
to O O
clinic O O
in O O
2 O O
months O O
(spoke O O
to O O
patient O O
about O O
him O O
coming O O
more O O
frequently O O
but O O
he O O
says O O
that O O
it O O
is O O
very O O
difficult O O
to O O
come O O
in O O
so O O
he'll O O
do O O
the O O
best O O
he O O
can) O O
Addendum O O
I O O
was O O
present O O
during O O
key O O
portions O O
of O O
the O O
evaluation O O
of O O
the O O
patient O O
and O O
agree O O
with O O
John O O
Ross's O O
findings O O
and O O
plan O O
as O O
written. O O
Pt. O O
is O O
thin, O O
has O O
gotten O O
maximum O O
benefit O O
from O O
metformin O O
so O O
options O O
include O O
sulfonyurea O O
or O O
insulin. O O
Francis O O
Lawrence O O
Signed O O
electronically O O
by O O
Ross, O O
John O O
on O O
Sep O O
21, O O
2122 O O
Lawrence, O O
Francis O O
X O O
on O O
Sep O O
22, O O
2122 O O

Record O O
date: O O
2126-09-04 O O
Manamana O O
5 O O
Admission O O
Note O O
PATIENT: O O
Flaherty, O O
Xavier O O
MRN: O O
1935081 O O
ADMIT B-DIABETES O
DATE: O O
9/04/26 O O
PCP: O O
Michael O O
Ring O O
MD O O
ATTENDING O O
PHYSICIAN: O O
Manamana O O
5 O O
WARD O O
Source: O O
patient, O O
chart O O
(please O O
note O O
that O O
patient O O
is O O
a O O
poor O O
historian) O O
CHIEF O O
COMPLAINT- O O
s/p O O
2 O O
falls O O
at O O
home O O
fever O O
in O O
the O O
emergency O O
ward O O
HISTORY O O
OF O O
THE O O
PRESENT O O
ILLNESS O O
Mr. O O
Flaherty O O
is O O
a O O
78 O O
yo O O
gentleman O O
with O O
a O O
PMH O O
notable O O
for O O
diabetes B-DIABETES O
mellitus, I-DIABETES O
HTN, B-HYPERTENSION O
paraplegia O O
2/2 O O
spinal O O
vascular O O
malformations O O
now O O
wheelchair O O
bound O O
with O O
a O O
suprapubic O O
catheter, O O
and O O
multiple O O
ulcers O O
who O O
presents O O
after O O
2 O O
falls O O
at O O
home, O O
found O O
by O O
EMS O O
to O O
be O O
living O O
in O O
squalor O O
and O O
found O O
to O O
have O O
a O O
Tmax O O
of O O
104 O O
degrees O O
F O O
in O O
the O O
emergency O O
ward. O O
Patient O O
states O O
that O O
he O O
was O O
in O O
his O O
usual O O
state O O
of O O
health, O O
which O O
includes O O
wheeling O O
himself O O
around O O
his O O
apartment O O
and O O
preparing O O
simple O O
meals O O
such O O
as O O
oatmeal, O O
until O O
the O O
week O O
prior O O
to O O
admission. O O
Mr O O
Flaherty O O
noted O O
that O O
he O O
felt O O
&#8220;lousy&#8221; O O
throughout O O
the O O
week. O O
He O O
is O O
unable O O
to O O
characterize O O
this O O
feeling, O O
stating O O
simply, O O
&#8220;something O O
wasn&#8217;t O O
right.&#8221; O O
Patient O O
states O O
he O O
&#8220;may O O
have O O
felt O O
nauseous&#8221; O O
and O O
&#8220;I O O
might O O
have O O
had O O
a O O
fever.&#8221; O O
However, O O
patient O O
denies O O
vomiting, O O
sick O O
contacts, O O
abdominal O O
pain, O O
change O O
in O O
appetite, O O
recent O O
antibiotic O O
use, O O
SOB, O O
DOE, O O
chest O O
pain/pressure/tightness, O O
suprapubic O O
pain, O O
change O O
in O O
stool O O
caliber/color/frequency, O O
sore O O
throat, O O
change O O
in O O
his O O
chronic O O
cough, O O
sputum O O
production, O O
drainage O O
around O O
his O O
SPC O O
site, O O
hematemesis, O O
pain O O
at O O
his O O
ulcer O O
sites, O O
and O O
increased O O
pus/output O O
from O O
ulcer O O
sites. O O
Of O O
note, O O
patient O O
states, O O
&#8220;If O O
it O O
wasn&#8217;t O O
for O O
the O O
fireman, O O
I O O
wouldn&#8217;t O O
be O O
here. O O
Of O O
note, O O
patient O O
states, O O
&#8220;My O O
house O O
is O O
fine.&#8221; O O
He O O
denies O O
feeling O O
unsafe O O
at O O
home, O O
denies O O
difficulty O O
with O O
bills, O O
denies O O
rodent/vermin/cockroach O O
infestation, O O
denies O O
leaving O O
his O O
stove O O
on. O O
EMS-&gt;ED O O
course: O O
Upon O O
EMS O O
arrival, O O
they O O
found O O
his O O
apartment O O
in O O
disarray O O
and O O
placed O O
a O O
section O O
12 O O
order. O O
VS: O O
BP: O O
140/90, O O
HR O O
117, O O
RR20, O O
T97.1, O O
95% O O
RA, O O
after O O
blood O O
cultures O O
were O O
drawn, O O
the O O
patient O O
was O O
started O O
on O O
unasyn, O O
given O O
a O O
500 O O
cc O O
bolus, O O
and O O
sent O O
to O O
the O O
floor. O O
REVIEW O O
OF O O
SYSTEMS O O
General O O
no O O
weight O O
loss, O O
gain; O O
no O O
chills, O O
night O O
sweats O O
HEENT O O
+rhinorrhea O O
Pulmonary O O
no O O
wheezing, O O
no O O
hemoptysis O O
Cardiac O O
no O O
palpitations O O
Endocrine O O
no O O
polydipsia, O O
polyuria, O O
or O O
polyphagia O O
Extremity O O
&#8211; O O
no O O
lower O O
extremity O O
edema O O
Neurology O O
&#8211; O O
no O O
headache, O O
no O O
photophobia, O O
no O O
changes O O
in O O
strength O O
or O O
sensation O O
PAST O O
MEDICAL O O
HISTORY/PSH O O
1. O O
Paraplegia- O O
2/2 O O
spinal O O
ischemia O O
from O O
surgical O O
complication O O
2. O O
DMII B-DIABETES O
- O O
first O O
diagnosed O O
in O O
2113, O O
last B-DIABETES O
A1C I-DIABETES O
8.4 I-DIABETES O
(8/1/26) O O
3. O O
HTN O O
4. O O
Recurrent O O
UTI's O O
(requires O O
catheterization O O
to O O
urinate) O O
5. O O
PSA O O
of O O
6.6 O O
6. O O
2070's O O
received O O
surgery O O
for O O
shrapnel O O
removal O O
7. O O
Sacral O O
decubitus O O
ulcers O O
MEDICATIONS O O
ON O O
ADMISSION O O
- O O
iron O O
supplement O O
325mg O O
po O O
bid O O
- O O
from O O
325mg O O
po O O
daily O O
- O O
Rx O O
(Qty:180 O O
Rf:3)- O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
po O O
daily- O O
atenolol B-MEDICATION B-MEDICATION
50mg I-MEDICATION O
po I-MEDICATION O
daily I-MEDICATION O
(called O O
to O O
pharm)- O O
Colace O O
100mg O O
1 O O
po O O
daily O O
take O O
one O O
tab O O
tid- O O
Glucophage B-MEDICATION B-MEDICATION
1000 I-MEDICATION O
mg I-MEDICATION O
po I-MEDICATION O
bid I-MEDICATION O
take O O
with O O
meals- O O
Lantus B-MEDICATION B-MEDICATION
SoloStar I-MEDICATION O
Pen I-MEDICATION O
10 I-MEDICATION O
units I-MEDICATION O
sc I-MEDICATION O
at I-MEDICATION O
bedtime- I-MEDICATION O
Lipitor B-MEDICATION B-MEDICATION
20mg I-MEDICATION O
po I-MEDICATION O
daily- I-MEDICATION O
multivitamins O O
1 O O
tab O O
po O O
daily- O O
Neurontin O O
600 O O
mg O O
po O O
tid- O O
Xanax O O
0.25mg O O
po O O
bid O O
prn- O O
Zestril B-MEDICATION B-MEDICATION
40mg I-MEDICATION O
po I-MEDICATION O
daily I-MEDICATION O
ALLERGIES/ADVERSE O O
REACTIONS O O
nkda O O
FAMILY O O
HISTORY O O
Father O O
- O O
was O O
an O O
alcoholic O O
who O O
died O O
in O O
an O O
accident O O
Mom- O O
died O O
at O O
the O O
age O O
of O O
76 O O
with O O
peripheral O O
vascular O O
disease O O
Brother- B-FAMILY_HIST O
died I-FAMILY_HIST O
in I-FAMILY_HIST O
50's I-FAMILY_HIST O
of I-FAMILY_HIST O
CAD, I-FAMILY_HIST O
was I-FAMILY_HIST O
an I-FAMILY_HIST O
alcoholic I-FAMILY_HIST O
SOCIAL O O
HISTORY O O
General O O
&#8211; O O
Pt O O
lives O O
alone O O
in O O
a O O
2 O O
bdr O O
apt. O O
Needs O O
help O O
with O O
shopping, O O
which O O
he O O
gets O O
from O O
his O O
good O O
friend. O O
ADLs: O O
Dress O O
with O O
assistance, O O
eats O O
independently, O O
ambulate O O
with O O
wheel O O
chair, O O
toilet O O
independently, O O
and O O
hygiene O O
is O O
questionable O O
(especially O O
at O O
home). O O
IADLs: O O
shop O O
with O O
friend, O O
housekeep O O
with O O
friend, O O
accounting O O
independently, O O
food O O
prep O O
independently, O O
and O O
transportation O O
with O O
help O O
from O O
friend O O
He O O
never O O
married O O
and O O
has O O
no O O
children. O O
He O O
is O O
a O O
retired O O
Heavy-Duty O O
Equipment O O
Mechanic O O
(15yrs) O O
and O O
Concrete O O
Finisher O O
(25yrs). O O
He O O
is O O
a O O
veteran. O O
Tobacco B-SMOKER O
&#8211; I-SMOKER O
The I-SMOKER O
patient I-SMOKER O
quit B-SMOKER O
smoking I-SMOKER O
23 I-SMOKER O
years I-SMOKER O
ago I-SMOKER O
&#8211; O O
distant O O
30 O O
pack O O
year O O
smoking O O
history O O
Alcohol O O
&#8211; O O
rarely O O
drinks O O
Illicit O O
drugs O O
&#8211; O O
none O O
PHYSICAL O O
EXAMINATION O O
VITALS: O O
T98 O O
HR94 O O
BP134/63 O O
RR12 O O
SaO299 O O
RA O O
General O O
&#8211; O O
obese O O
older O O
gentleman, O O
resting O O
comfortably O O
in O O
bed, O O
mildy O O
malodorous, O O
appropriately O O
conversant, O O
speaking O O
full O O
sentences O O
HEENT- O O
no O O
evidence O O
of O O
head O O
trauma, O O
no O O
pharyngeal O O
erythema/exudates O O
Neck O O
&#8211; O O
supple O O
with O O
no O O
lymphadenopathy O O
Pulmonary O O
&#8211; O O
equal O O
air O O
entry O O
b/l, O O
crackles O O
1/3 O O
the O O
way O O
up O O
b/l, O O
decreased O O
BS O O
LLB O O
Cardiac O O
&#8211; O O
distant O O
HS, O O
S1+S2 O O
nml, O O
RRR, O O
no O O
MRG O O
Abdomen O O
&#8211; O O
soft O O
and O O
obese, O O
SPC O O
in O O
place O O
w/o O O
drainage/fluctuance, O O
+BS, O O
no O O
TTP O O
Back O O
&#8211; O O
lumbar O O
scar O O
noted, O O
no O O
CVAT O O
Extremity O O
&#8211; O O
b/l O O
LE O O
atrophic, O O
no O O
edema, O O
L O O
large O O
area O O
of O O
blanching, O O
confluent O O
erythema O O
from O O
mid-thigh O O
to O O
lateral O O
lower O O
L O O
leg, O O
+warmth, O O
L O O
hip O O
ulcer O O
5 O O
cm O O
diam O O
with O O
induration O O
Rectal O O
&#8211; O O
decreased O O
tone, O O
hard O O
stool O O
in O O
vault, O O
9 O O
o&#8217;clock O O
.5 O O
cm O O
area O O
of O O
increased O O
density O O
(?folliculitis), O O
no O O
fluctuance O O
or O O
pain O O
LABORATORIES O O
NA O O
132(L) O O
K O O
3.5 O O
CL O O
94(L) O O
CO2 O O
26.8 O O
BUN O O
14 O O
CRE O O
0.78 O O
EGFR O O
&gt;60(T) O O
GLU O O
244(H) O O
ANION O O
11 O O
CA O O
9.5 O O
CK-MB O O
Negative O O
TROP-I O O
Negative O O
WBC O O
19.7(H) O O
RBC O O
4.61 O O
HGB O O
13.8 O O
HCT O O
40.7(L) O O
MCV O O
88 O O
MCH O O
29.9 O O
MCHC O O
33.9 O O
PLT O O
319 O O
RDW O O
13.5 O O
UA-COLOR O O
Yellow O O
UA-APP O O
Clear O O
UA-GLUC O O
2+(T) O O
UA-BILI O O
Negative O O
UA-KET O O
3+ O O
UR-SPGR O O
1.020(T) O O
UA-BLD O O
2+ O O
UA-PH O O
6.0 O O
UA-PROT O O
2+ O O
UA-UROBI O O
Negative O O
UA-NIT O O
Negative O O
UA-WBC O O
Negative O O
UAS-RBC O O
None O O
UAS-WBC O O
20-50 O O
UAS-BACT O O
Moderate O O
UAS-AMOR O O
PRESENT O O
RADIOLOGICAL O O
STUDIES O O
CT O O
brain O O
w/o O O
contrast: O O
No O O
evidence O O
of O O
acute O O
intracranial O O
hemorrhage, O O
mass-effect, O O
midline O O
shift O O
or O O
acute O O
territorial O O
infarction. O O
Chronic O O
healed O O
naso-orbito-ethmoid O O
fracture. O O
CXR O O
- O O
Progression O O
of O O
predominantly O O
bibasilar O O
nodular O O
and O O
interstitial O O
opacities, O O
possibly O O
be O O
due O O
to O O
chronic O O
aspiration. O O
Recommend O O
CT. O O
EKG O O
Nsr O O
94 O O
bpm, O O
LAD, O O
no O O
Q O O
waves, O O
no O O
ST-T O O
changes O O
ASSESSMENT O O
AND O O
PLAN O O
78 O O
yo O O
M O O
with O O
DM, O O
HTN, O O
ulcers, O O
indwelling O O
SPC O O
who O O
presents O O
with O O
one O O
week O O
of O O
feeling O O
&#8220;lousy&#8221; O O
and O O
a O O
maximum O O
temperature O O
of O O
104 O O
degrees O O
F. O O
Exam O O
was O O
remarkable O O
for O O
LLE O O
erythema O O
consistent O O
with O O
cellulitis. O O
Labs O O
were O O
notable O O
for O O
a O O
high O O
WBC O O
with O O
a O O
neutrophilic O O
predominance O O
and O O
a O O
clean O O
urinalysis. O O
Given O O
his O O
history O O
of O O
fever, O O
exam, O O
and O O
lab O O
studies, O O
infection O O
is O O
the O O
most O O
likely O O
cause O O
of O O
Mr. O O
Flaherty&#8217;s O O
current O O
presentation. O O
ISSUE O O
#1: O O
Fever O O
and O O
leukocytosis O O
Most O O
likely O O
secondary O O
to O O
cellulitis O O
vs O O
wound O O
infection O O
Blood O O
cultures, O O
urine O O
cultures, O O
wound O O
cultures, O O
and O O
respiratory O O
cultures O O
Panculture O O
if O O
SPIKES O O
f/u O O
microbiology O O
c O O
and O O
s O O
start O O
broad O O
spectrum O O
antibiotics: O O
Vancomycin O O
1 O O
g O O
q12 O O
IV O O
for O O
presumed O O
MRSA O O
and O O
Unasyn O O
3000 O O
mg O O
IV O O
q6 O O
for O O
presumed O O
gram O O
negatives O O
(with O O
minimal O O
anaerobe O O
coverage) O O
if O O
clinically O O
decompensates, O O
will O O
consider O O
Zosyn O O
for O O
pseudomonal O O
coverage O O
and O O
Flagyl O O
for O O
anaerobe O O
coverage O O
ISSUE O O
#2: O O
Diabetes B-DIABETES O
Mellitus I-DIABETES O
continue O O
with O O
home O O
regimen O O
of O O
metformin B-MEDICATION B-MEDICATION
1000 O O
bid O O
and O O
lantus B-MEDICATION B-MEDICATION
14 O O
SC O O
insulin B-MEDICATION O
sliding I-MEDICATION O
scale I-MEDICATION O
for I-MEDICATION O
coverage I-MEDICATION O
FSBG O O
AC+HS O O
Last B-DIABETES O
A1C I-DIABETES O
8.4 I-DIABETES O
8/1/26 I-DIABETES O
ISSUE O O
#3: O O
HTN O O
Continue O O
with O O
home O O
regimen O O
of O O
lisinopril B-MEDICATION B-MEDICATION
40 O O
mg O O
daily, O O
atenolol O B-MEDICATION
50 O O
mg O O
daily O O
Monitor O O
and O O
titrate O O
as O O
needed O O
ISSUE O O
#4: O O
Home O O
safety O O
and O O
cleanliness O O
Will O O
ask O O
for O O
assistance O O
from O O
social O O
work O O
and O O
case O O
management O O
re: O O
potential O O
need O O
of O O
home O O
safety O O
evaluation O O
Assess O O
for O O
competency O O
&#8211; O O
re: O O
safety O O
at O O
home O O
FEN: O O
diabetic O O
diet, O O
replete O O
lytes O O
prn, O O
will O O
bolus O O
1000 O O
cc O O
NS O O
PROPHYLAXIS O O
GI: O O
omeprazole O O
DVT: O O
Fragmin O O
BOWEL: O O
Colace, O O
Senna O O
prn O O
CODE: O O
unknown O O
__________________________________ O O
Kenneth O O
Titus, O O
MD O O
MA O O
PGY-1, O O
Pager O O
#55518 O O

Record O O
date: O O
2081-01-05 O O
Reason O O
for O O
Visit: O O
72 O O
yo O O
M O O
with O O
Stage O O
3B O O
lymphocyte O O
depleted O O
Hodgkin's O O
who O O
presents O O
for O O
cycle O O
3B O O
of O O
ABVD O O
chemotherapy. O O
Oncology O O
History: O O
Mr. O O
Jimenez O O
developed O O
fevers, O O
drenching O O
night O O
sweats, O O
and O O
a O O
15 O O
pound O O
weight O O
loss O O
in O O
September O O
of O O
2080. O O
He O O
was O O
admitted O O
to O O
LCH O O
on O O
10/11/80 O O
at O O
which O O
point O O
a O O
fever O O
workup O O
was O O
negative O O
but O O
CT O O
scans O O
revealed O O
bulky O O
lymphadenopaty O O
in O O
his O O
neck O O
and O O
abdomen O O
as O O
well O O
as O O
splenomegaly. O O
He O O
underwent O O
an O O
excitional O O
biopsy O O
of O O
a O O
R O O
supraclav O O
node O O
which O O
was O O
positive O O
for O O
lymphocyte O O
depleted O O
HD. O O
A O O
gallium O O
scan O O
and O O
a O O
PET O O
scan O O
were O O
negative O O
except O O
for O O
the O O
biopsy O O
site. O O
He O O
was O O
started O O
on O O
ABVD O O
chemotherapy O O
prior O O
to O O
discharge. O O
He O O
has O O
tolerated O O
chemotherapy O O
well, O O
receiving O O
5 O O
days O O
of O O
G-CSF O O
with O O
each O O
half-cycle O O
of O O
chemotherapy. O O
Interval O O
History: O O
Tolerated O O
cycle O O
3A O O
of O O
chemotherapy O O
well. O O
He O O
has O O
had O O
no O O
F/C/N/V/SOB. O O
He O O
has O O
had O O
a O O
mild O O
increase O O
in O O
his O O
level O O
of O O
fatigue. O O
He O O
continues O O
to O O
go O O
to O O
the O O
library O O
daily. O O
He O O
continues O O
to O O
have O O
pain O O
in O O
the O O
R O O
side O O
of O O
his O O
chest O O
as O O
he O O
has O O
had O O
for O O
the O O
past O O
month. O O
PMH: O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Hyperplastic O O
colonic O O
polyp O O
and O O
internal O O
hemorrhoids O O
Lacunar O O
CVA O O
in O O
3/78 O O
for O O
which O O
he O O
is O O
maintained O O
on O O
coumadin O O
50-70% O O
occlusion O O
of O O
R O O
ICA O O
HTN B-HYPERTENSION O
Hypercholesterolemia B-HYPERLIPIDEMIA O
FH/SH: O O
Father O O
had O O
colon O O
Ca O O
age O O
74. O O
Mother O O
died O O
age O O
89. O O
Sister O O
had O O
breast O O
cancer O O
age O O
78. O O
Pt O O
lives O O
alone O O
and O O
has O O
2 O O
daughters O O
who O O
live O O
nearby O O
on O O
the O O
same O O
street. O O
Former O O
Computer O O
and O O
Network O O
Operator. O O
Smoked B-SMOKER O
1 I-SMOKER O
PPD I-SMOKER O
x I-SMOKER O
20 I-SMOKER O
years, I-SMOKER O
but I-SMOKER O
stopped I-SMOKER O
many I-SMOKER O
years I-SMOKER O
ago. I-SMOKER O
Occ O O
EtOH. O O
ROS-Toxicities: O O
General: O O
No O O
weight O O
loss, O O
fatigue, O O
fevers, O O
chills, O O
change O O
in O O
appetite O O
Respiratory: O O
No O O
cough, O O
SOB, O O
DOE, O O
hemoptysis, O O
wheezing O O
HEENT: O O
No O O
neck O O
swelling, O O
neck O O
stiffness, O O
hoarseness O O
Cardiac: O O
No O O
chest O O
pain, O O
palpitations, O O
arrythmias, O O
valve O O
disease O O
Gastrointestinal: O O
No O O
nausea, O O
vomiting, O O
diarrhea, O O
constipation, O O
bleeding O O
Neurologic: O O
No O O
seizures, O O
headache, O O
weakness, O O
numbness/tingling O O
Lymph O O
nodes: O O
No O O
enlarged O O
lymph O O
nodes O O
Musculoskeletal: O O
No O O
back O O
pain, O O
neck O O
pain, O O
leg O O
pain, O O
arm O O
pain O O
Urologic: O O
No O O
hematuria, O O
dysuria, O O
or O O
obstruction O O
Endocrine: O O
No O O
adrenal, O O
thyroid O O
or O O
parathyroid O O
disease O O
Hematologic: O O
No O O
bruising, O O
clotting, O O
bleeding O O
MEDICATIONS O O
GLYBURIDE B-MEDICATION B-MEDICATION
5MG O O
1 O O
Tablet(s) O O
PO O O
BID O O
IRON O O
SULFATE O O
(FERROUS O O
SULFATE) O O
325MG O O
1 O O
Tablet(s) O O
PO O O
TID O O
COUMADIN O O
(WARFARIN O O
SODIUM) O O
7.5MG O O
1 O O
Tablet(s) O O
PO O O
QPM O O
PRINIVIL B-MEDICATION O
(LISINOPRIL) I-MEDICATION O
10MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
FOLATE O O
(FOLIC O O
ACID) O O
1MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
PROCRIT O O
(EPOETIN O O
ALFA) O O
40000 O O
U O O
SC O O
QWEEK O O
ZANTAC O O
(RANITIDINE O O
HCL) O O
150MG O O
1 O O
Tablet(s) O O
PO O O
BID O O
ALLERGY: O O
NKDA O O
Physical O O
Examination: O O
VSS O O
AF-PS=1 O O
Neck: O O
no O O
nodes O O
palpable O O
HEENT: O O
No O O
thrush O O
or O O
mucositis O O
Skin: O O
no O O
rash O O
Ext: O O
without O O
edema, O O
clubbing O O
Cor: O O
S1 O O
S2 O O
Chest: O O
clear O O
lungs O O
Abdomen: O O
soft, O O
NT O O
no O O
HSM O O
Nodes: O O
neg O O
cerv, O O
sc O O
Neuro: O O
grossly O O
non-focal O O
Portacath O O
site: O O
no O O
erythema, O O
tenderness O O
Assessment O O
and O O
Plan: O O
72 O O
yo O O
M O O
with O O
lymphocyte O O
depleted O O
HD, O O
at O O
least O O
stage O O
IIIB O O
who O O
presents O O
to O O
clinic O O
today O O
for O O
cycle O O
3B O O
of O O
ABVD O O
chemotherapy. O O
He O O
continues O O
to O O
tolerate O O
his O O
therapy O O
well. O O
He O O
will O O
be O O
treated O O
today O O
with O O
Adriamycin O O
25 O O
mg/m2, O O
bleomycin O O
10 O O
U/m2, O O
vinblastine O O
6 O O
mg/m2, O O
and O O
dacarbazine O O
375 O O
mg/m2. O O
He O O
will O O
take O O
neupogen O O
480 O O
ucg O O
SC O O
QD O O
for O O
the O O
next O O
5 O O
days O O
starting O O
tomorrow. O O
His O O
DLCO O O
was O O
checked O O
prior O O
to O O
his O O
3rd O O
cycle O O
of O O
chemotherapy O O
and O O
was O O
93% O O
predicted. O O
It O O
will O O
be O O
rechecked O O
prior O O
to O O
his O O
5th O O
cycle O O
of O O
chemotherapy. O O
We O O
will O O
continue O O
to O O
check O O
his O O
INR O O
as O O
he O O
looks O O
for O O
a O O
new O O
PCP. O O
He O O
has O O
an O O
elevated O O
glucose O O
and O O
he O O
admitted O O
to O O
a O O
very O O
poor O O
diet. O O
He O O
agreed O O
to O O
improve O O
his O O
diabetic O O
diet O O
and O O
refused O O
meeting O O
with O O
a O O
dietician. O O
cc: O O

Record O O
date: O O
2083-09-10 O O
Woodstock O O
E O O
Intern O O
Admit O O
Note O O
Patient: O O
Jimenez, O O
Youssef O O
LCH O O
Unit O O
Number: O O
055 O O
47 O O
33 O O
Date O O
of O O
Admission: O O
09 O O
September O O
2083 O O
Attending O O
Physician: O O
Nathan O O
Yearwood, O O
MD O O
Room: O O
Woodstock O O
5599 O O
U O O
Code O O
Status: O O
Full O O
PCP: O O
Charles O O
Eggers, O O
MD O O
of O O
Seminole O O
Oncologist: O O
Ernest O O
Byers, O O
MD O O
Source: O O
Patient O O
Chief O O
Complaint: O O
DOE O O
History O O
of O O
The O O
Present O O
Illness: O O
Patient O O
is O O
a O O
74 O O
year-old O O
man O O
with O O
Stage O O
IIIB O O
Hodgkins O O
disease O O
s/p O O
ABVD, O O
HTN, B-HYPERTENSION O
DM, B-DIABETES O
s/p O O
CVA O O
who O O
presents O O
with O O
2-3 O O
weeks O O
of O O
DOE, O O
orthopnea, O O
and O O
PND. O O
Pt O O
denies O O
CP, O O
dyspnea O O
at O O
rest, O O
palpitations, O O
syncope, O O
lightheadedness. O O
The O O
patient O O
also O O
denies O O
F/C, O O
night O O
sweats, O O
weight O O
changes, O O
cough, O O
N/V, O O
abd O O
pain, O O
diarrhea, O O
constipation, O O
dysuria. O O
Past O O
Medical/Surgical O O
History: O O
Stage O O
IIIB O O
lyphocyte O O
depleted, O O
diffuse O O
fibrosis O O
type O O
Hodgkins O O
lymphoma O O
diagnosed O O
10/80 O O
s/P O O
6 O O
cycles O O
of O O
ABVD O O
(last O O
4/81) O O
Thyroid O O
nodule O O
(left O O
lower O O
pole) O O
s/p O O
FNA O O
no O O
malignant O O
cells O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Hyperplastic O O
colonic O O
polyp O O
and O O
internal O O
hemorrhoids O O
Lacunar O O
CVA O O
in O O
3/78 O O
for O O
which O O
he O O
is O O
maintained O O
on O O
coumadin, O O
no O O
residuals O O
50-70% O O
occlusion O O
of O O
R O O
ICA O O
HTN O O
ECHO O O
10/2080: O O
trace O O
MR, O O
trace O O
AI, O O
EF O O
67%, O O
trace O O
TR, O O
RVSP O O
31 O O
mmHg O O
Hypercholesterolemia B-HYPERLIPIDEMIA O
(10/80 O O
Chol O O
49, O O
Trig O O
148, O O
HDL O O
3, O O
LDL O O
16) O O
Allergies: O O
No O O
Known O O
Drug O O
Allergies O O
Medications: O O
Coumadin O O
8.5 O O
mg O O
QD O O
Folate O O
1 O O
mg O O
QD O O
Zantac O O
150 O O
mg O O
BID O O
Glyburide B-MEDICATION B-MEDICATION
BID O O
Social O O
History: O O
Occupation O O
- O O
retired O O
network O O
operator O O
Tobacco B-SMOKER O
- I-SMOKER O
quit B-SMOKER O
20 I-SMOKER O
years I-SMOKER O
ago, I-SMOKER O
10 I-SMOKER O
pack-yr I-SMOKER O
history I-SMOKER O
Alcohol O O
- O O
rare O O
Illicit/IV O O
Drugs O O
-denies O O
Lives O O
next O O
to O O
wife O O
(separated) O O
and O O
down O O
the O O
street O O
from O O
daughter O O
Family O O
History: O O
Non-Contributory O O
Review O O
of O O
Systems: O O
Please O O
see O O
pertinent O O
positives O O
and O O
negatives O O
in O O
HPI. O O
Physical O O
Examination: O O
97.9 O O
98 O O
180/60 B-HYPERTENSION O
22 O O
96% O O
on O O
2L O O
General O O
- O O
well O O
appearing, O O
well O O
nourished O O
patient O O
in O O
NAD, O O
appropriate O O
HEENT O O
- O O
normocephalic, O O
atraumatic, O O
PERRLA, O O
anicteric, O O
moist O O
mucous O O
membranes, O O
no O O
JVD O O
Pulmonary O O
- O O
decrease O O
BS O O
at O O
R O O
base, O O
no O O
crackles O O
Cardiac O O
- O O
regular O O
rate O O
and O O
rhythm, O O
S1 O O
and O O
S2 O O
normal, O O
no O O
murmurs O O
Abdomen O O
- O O
soft, O O
non-tender, O O
non-distended, O O
active O O
bowel O O
sounds O O
Extremity O O
- O O
no O O
cyanosis, O O
clubbing, O O
or O O
edema, O O
2+ O O
and O O
equal O O
distal O O
pulses O O
Neurology O O
- O O
AAOx3 O O
Skin O O
- O O
no O O
worrisome O O
rashes O O
or O O
lesions O O
Data: O O
Chemistries: O O
Na O O
138 O O
K O O
3.6 O O
Cl O O
106 O O
HCO3 O O
26.9 O O
BUN O O
13 O O
Cr O O
0.9 O O
Glucose O O
163 O O
Ca O O
8.8 O O
Phos O O
2.8 O O
Mg O O
1.7 O O
ALT O O
27 O O
AST O O
24 O O
AlkP O O
81 O O
Tbili O O
0.5 O O
Dbili O O
0.1 O O
Alb O O
3.5 O O
Amylase O O
25, O O
Lipase O O
3.7 O O
Blood O O
Counts: O O
WBC O O
8.8 O O
HCT O O
38.2 O O
Plts O O
264 O O
PT O O
19 O O
INR O O
2.4 O O
Microbiology: O O
U/A: O O
nitrite O O
(-), O O
0-2 O O
WBC, O O
no O O
bacteria O O
Radiology: O O
CXR: O O
Enlarged O O
cardiac O O
silhouette O O
likely O O
technically O O
related, O O
b/l O O
pleural O O
fluid O O
collections O O
R&gt;L O O
with O O
bibasilar O O
atelectasis O O
Cardiogram: O O
Atrial O O
fibrillation O O
@ O O
115 O O
BPM, O O
nl O O
interval, O O
nl O O
axis, O O
0.5 O O
mm O O
ST O O
segment O O
depressions O O
in O O
V5-V6 O O
Assessment: O O
Patient O O
is O O
a O O
74 O O
year-old O O
man O O
with O O
Stage O O
IIIB O O
Hodgkins O O
disease O O
s/p O O
ABVD, O O
HTN, O O
DM, O O
s/p O O
CVA O O
who O O
presents O O
with O O
2-3 O O
weeks O O
of O O
DOE, O O
orthopnea, O O
and O O
PND O O
with O O
new O O
onset O O
A-fib O O
with O O
RVR O O
and O O
b/l O O
pleural O O
effusions. O O
Plan: O O
1. O O
DOE: O O
Concern O O
is O O
new O O
cardiomyopathy O O
with O O
failure O O
secondary O O
to O O
adriamycin O O
toxicity, O O
nl O O
ECHO O O
in O O
2080 O O
-check O O
TTE O O
tomorrow O O
(also O O
access O O
for O O
thrombus O O
although O O
pt O O
already O O
anticoagulated) O O
-currently O O
clincially O O
euvolemic, O O
no O O
diuresis O O
for O O
now O O
2. O O
New O O
onset O O
AVR O O
with O O
RVR: O O
Possible O O
etiologies: O O
-new O O
ischemia O O
(cardiac O O
enzymes O O
neg O O
x O O
3, O O
no O O
EKG O O
changes) O O
-CHF O O
(see O O
above O O
discussion) O O
-pulm O O
disease O O
(CXR O O
w/ O O
b/l O O
small O O
pleural O O
effusions O O
), O O
could O O
be O O
pulm O O
tox O O
secondary O O
to O O
chemo O O
-thyrotoxicosis O O
(history O O
of O O
benign O O
thyroid O O
nodules O O
but O O
could O O
be O O
active O O
now) O O
check O O
TSH O O
-rate O O
controlled O O
with O O
diltiazem B-MEDICATION O
and O O
lopressor, B-MEDICATION B-MEDICATION
d/c O O
dig O O
-already O O
on O O
coumadin O O
s/p O O
CVA O O
with O O
goal O O
INR O O
2-3 O O
3. O O
s/p O O
CVA O O
-continue O O
coumadin, O O
check O O
INR O O
4. O O
Prophylaxis O O
-nexium, O O
coumadin O O
5. O O
Dispo O O
- O O
to O O
home O O
when O O
stable O O
___________________________ O O
Shaquel O O
Whitfield, O O
MD O O
Intern O O
in O O
Internal O O
Medicine O O
Pager O O
77136 O O

Record O O
date: O O
2086-09-24 O O
Patient O O
Name: O O
JIMENEZ,YOUSSEF O O
I O O
[ O O
0554733(LCH) O O
] O O
Date O O
of O O
Visit: O O
09/24/2086 O O
Reason O O
for O O
Visit O O
New O O
primary O O
care O O
Former: O O
Wesley O O
Carroll O O
MD, O O
Seminole, O O
RI O O
Chief O O
Complaint O O
'Slowing O O
down' O O
History O O
of O O
Present O O
Illness O O
Accompanied O O
by O O
daughter O O
and O O
wife, O O
from O O
whom O O
he O O
is O O
separated. O O
Complex O O
history. O O
Family O O
has O O
noted O O
slowing O O
mobility, O O
memory O O
difficulties, O O
change O O
in O O
speech, O O
over O O
past O O
year. O O
Has O O
remote O O
hx O O
stroke. O O
No O O
specific O O
recent O O
TIA O O
symptoms. O O
Still O O
driving O O
but O O
mostly O O
during O O
the O O
day O O
though O O
has O O
gotten O O
lost. O O
No O O
recent O O
accidents. O O
Gets O O
help O O
from O O
family O O
with O O
some O O
IADL's. O O
No O O
safety O O
concerns O O
around O O
meds, O O
household O O
issues. O O
Gait O O
noted O O
to O O
be O O
slower O O
and O O
more O O
deliberate. O O
No O O
falls. O O
No O O
tremor, O O
sz O O
hx. O O
No O O
etoh O O
consumption. O O
Problems O O
Hypertension B-HYPERTENSION O
Congestive O O
heart O O
failure O O
Cerebrovascular O O
accident O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Atrial O O
fibrillation O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Hodgkins O O
disease O O
: O O
Followed O O
by O O
Dr. O O
Ernest O O
Byers O O
Hyperplastic O O
polyp O O
Thyroid O O
nodule O O
: O O
Negative O O
biopsy O O
Abdominal O O
aortic O O
aneurysm O O
Medications O O
Calcium O O
+ O O
D O O
(500 O O
Elem. O O
Ca) O O
(CALCIUM O O
Carbonate O O
1250 O O
Mg O O
(500MG O O
Elem O O
Ca)/ O O
Vit O O
D O O
200 O O
Iu)) O O
1 O O
TAB O O
(500MG-200 O O
TABLET O O
) O O
PO O O
QD O O
Cardizem B-MEDICATION O
Cd I-MEDICATION O
(DILTIAZEM I-MEDICATION O
Cd I-MEDICATION O
(24 I-MEDICATION O
Hr I-MEDICATION O
Caps)) I-MEDICATION O
300 O O
MG O O
(300MG O O
CAP.SR O O
24H O O
take O O
1) O O
PO O O
QD O O
Coumadin O O
(WARFARIN O O
Sodium) O O
6 O O
MG O O
(6MG O O
TABLET O O
take O O
1) O O
PO O O
QPM O O
DIGOXIN O O
0.25 O O
MG O O
(0.25MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Doxazosin O O
(DOXAZOSIN) O O
1 O O
MG O O
(1MG O O
TABLET O O
take O O
1) O O
PO O O
q O O
hs O O
Folate O O
(FOLIC O O
Acid) O O
1MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Glucovance B-MEDICATION B-MEDICATION
(GLYBURIDE/METFORMIN) I-MEDICATION O
5/500 O O
MG O O
PO O O
BID O O
Lasix O O
(FUROSEMIDE) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Metoprolol B-MEDICATION B-MEDICATION
Tartrate I-MEDICATION O
50 O O
MG O O
(50MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Potassium O O
Chloride O O
Sustained O O
Release O O
Tab O O
40 O O
MEQ O O
(10MEQ O O
TABLET O O
SA O O
take O O
4) O O
PO O O
QD O O
Prinivil B-MEDICATION B-MEDICATION
(LISINOPRIL) I-MEDICATION O
40 O O
MG O O
(40MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
Zocor B-MEDICATION B-MEDICATION
(SIMVASTATIN) I-MEDICATION O
80 O O
MG O O
(80MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Allergies O O
NKA O O
Past O O
Medical O O
History O O
Reviewed O O
electronic O O
data O O
Reviewed O O
old O O
records O O
See O O
problem O O
list O O
Preventive O O
Health O O
History O O
See O O
Health O O
Maint. O O
Family O O
History O O
Mother- O O
Died O O
age O O
89 O O
Father-Died O O
age O O
76 O O
Colon O O
cancer O O
Siblings-Sister O O
at O O
age O O
80 O O
dementia/pneumonia O O
Social O O
History O O
Retired O O
network O O
operator/Craftperson O O
in O O
Amman. O O
Formal O O
education O O
level O O
attained- O O
HS O O
Lives O O
alone O O
in O O
private O O
home O O
near O O
wife O O
and O O
daughters. O O
Likes O O
the O O
library. O O
Needs O O
no O O
help O O
with O O
basic O O
activities O O
of O O
daily O O
living O O
Smoking B-SMOKER O
cigarettes- I-SMOKER O
See I-SMOKER O
Health I-SMOKER O
Maintenance I-SMOKER O
(HM) I-SMOKER O
or I-SMOKER O
Problem I-SMOKER O
List I-SMOKER O
(PL) I-SMOKER O
Alcohol- O O
Advance O O
Directives- O O
See O O
HM O O
Review O O
of O O
Systems O O
CONSTITUTIONAL: O O
Appetite O O
good O O
PAIN: O O
None O O
SKIN: O O
Spot O O
on O O
nose O O
EYES: O O
No O O
change O O
in O O
vision O O
HENT: O O
No O O
sores O O
HEARING: O O
Adequate O O
LYMPH: O O
No O O
swellings O O
BREASTS: O O
Inconsistent O O
self-exam O O
RESP.: O O
No O O
cough O O
CVS: O O
No O O
PND, O O
exertional O O
chest O O
pain, O O
claudication. O O
GI: O O
No O O
dyspepsia, O O
constipation O O
GU: O O
Occ. O O
incontinence, O O
nocturia O O
x O O
3 O O
MSK: O O
No O O
joint O O
pain, O O
falls O O
ENDO: O O
No O O
heat O O
or O O
cold O O
intolerance O O
PSYCH: O O
No O O
anxiety, O O
depression O O
Change O O
in O O
behavior O O
or O O
personality O O
Vital O O
Signs O O
BLOOD B-HYPERTENSION O
PRESSURE I-HYPERTENSION O
168/64 I-HYPERTENSION O
PULSE O O
60 O O
RESPIRATORY O O
RATE O O
16 O O
TEMPERATURE O O
99.2 O O
F O O
HEIGHT O O
70.5 O O
in O O
WEIGHT O O
171.6 O O
lb O O
BMI O O
24.3 O O
Physical O O
Exam O O
General O O
Appearance O O
Alert, O O
no O O
distress. O O
Skin O O
6mm O O
nodule O O
with O O
central O O
ulceration O O
bridge O O
of O O
nose. O O
Actinic O O
keratoses O O
of O O
scalp. O O
HEENT O O
HENT: O O
Canals O O
clear, O O
tympanic O O
membranes O O
intact, O O
oropharynx O O
benign O O
Neck O O
L O O
thyroid O O
nodule O O
1cm O O
Nodes/Lymphatic O O
No O O
cervical, O O
supraclavicular, O O
axillary O O
adenopathy O O
Breast O O
No O O
masses O O
Chest O O
No O O
dullness, O O
crackles O O
or O O
wheezes O O
Cor/Cardiac O O
Regular O O
rate O O
and O O
rhythm, O O
. O O
No O O
gallop. O O
L O O
carotid O O
bruit. O O
Posterior O O
tibial O O
pulses O O
full, O O
no O O
edema O O
Abdomen O O
Bowel O O
sounds O O
present, O O
non-tender, O O
no O O
organomegaly, O O
no O O
masses O O
Rectal O O
Exam O O
No O O
masses, O O
brown O O
heme O O
negative O O
stool O O
Genito-Urinary O O
No O O
prostate O O
nodules, O O
no O O
testicular O O
or O O
penile O O
lesions O O
Musc O O
Skel O O
Full O O
shoulder O O
range O O
of O O
motion, O O
hip O O
internal O O
rotation; O O
no O O
knee O O
effusions O O
Feet O O
Dec. O O
vibration O O
sense O O
in O O
stocking O O
distribution. O O
Mild O O
dec. O O
pp. O O
No O O
Deformities: O O
Gait/balance O O
disorder- O O
yes O O
/ O O
no O O
Neurological O O
EOM's O O
intact, O O
no O O
pronator O O
drift, O O
dysmmetria, O O
increased O O
tone O O
R&gt;L, O O
Bilat O O
Babinski, O O
ankle O O
jerks O O
abset; O O
gait O O
with O O
normal O O
speed O O
and O O
en O O
bloc O O
turn, O O
dec. O O
step O O
height; O O
cogent O O
conversation, O O
language O O
fluent O O
but O O
brief O O
contextual O O
responses. O O
No O O
aphasia. O O
Significant O O
visuospatial O O
disorganization. O O
2/6 O O
at O O
5 O O
mins. O O
Moderate O O
executive O O
dysfunction. O O
Mild O O
perseveration. O O
No O O
frontal O O
signs. O O
No O O
agnosia. O O
MSE: O O
See O O
separate O O
note O O
from O O
today O O
Psych O O
Euthymic O O
Assessment O O
and O O
Plan O O
Old O O
records O O
requested. O O
Numerous O O
issues. O O
Diabetes. O O
Check O O
glycohgb, O O
microalbumin. O O
Podiatry O O
and O O
ophthalmology O O
evals. O O
Cognitive O O
dysfunction. O O
Suspect O O
on O O
vascular O O
basis O O
given O O
prior O O
stroke O O
and O O
longstanding O O
severe B-HYPERTENSION O
HTN I-HYPERTENSION O
with O O
small O O
vessel O O
disease. O O
Plan O O
MRI O O
of O O
brain O O
for O O
further O O
characterization O O
? O O
SCCA O O
of O O
nose. O O
Derm O O
referral. O O
L O O
carotid O O
bruit. O O
Given O O
known O O
cerebrovascular O O
disease O O
needs O O
NICS O O
Cardiac. O O
Obtain O O
old O O
records O O
from O O
cardiologist. O O
Recent O O
ECHO O O
and O O
stress O O
evals. O O
Voiding O O
dysfunction. O O
Check O O
psa. O O
Likely O O
BPH O O
but O O
could O O
relate O O
in O O
part O O
to O O
cognitive O O
issues. O O
Begin O O
alpha O O
blocker O O
as O O
he O O
needs O O
better O O
BP O O
control O O
as O O
well. O O
Return O O
in O O
mo. O O
level O O
minutes O O
******************** O O
Confidentiality O O
notice O O
************************ O O
This O O
electronic, O O
facsimile, O O
or O O
mail O O
transmission O O
may O O
contain O O
confidential O O
information O O
which O O
is O O
protected O O
by O O
physician/patient O O
privilege. O O
This O O
information O O
is O O
intended O O
only O O
for O O
the O O
use O O
of O O
the O O
individuals O O
or O O
entities O O
named O O
above. O O
If O O
you O O
are O O
not O O
an O O
intended O O
recipient, O O
you O O
are O O
hereby O O
notified O O
that O O
any O O
disclosure, O O
copying, O O
or O O
distribution O O
of O O
this O O
information O O
is O O
strictly O O
prohibited O O
by O O
law. O O
If O O
you O O
have O O
received O O
this O O
transmission O O
in O O
error, O O
please O O
notify O O
us O O
by O O
telephone O O
at O O
once. O O
______________________________ O O
William O O
B. O O
Dodd, O O
M.D. O O

Record O O
date: O O
2087-02-20 O O
78 O O
yo O O
gentleman O O
Known O O
to O O
Dr O O
William O O
Dodd O O
Transferred O O
from O O
Duchesne O O
County O O
Hospital O O
2/19 O O
Chief O O
complaint: O O
Recurrent O O
pleural O O
effusion O O
HPI: O O
Daughter O O
present. O O
She O O
gives O O
a O O
h/o O O
father O O
being O O
unwell O O
since O O
last O O
admission O O
in O O
11/86 O O
for O O
PNA O O
and O O
pleural O O
effusion. O O
Got O O
progressively O O
more O O
SOB O O
and O O
more O O
confused. O O
Previously O O
independent, O O
was O O
becoming O O
more O O
dependent O O
for O O
ADLs. O O
Summary O O
of O O
OSH O O
course O O
as O O
per O O
Team O O
1 O O
admit O O
note. O O
I O O
spoke O O
with O O
Hospitalist, O O
Dr O O
Bates O O
about O O
patient O O
on O O
2/18. O O
Seen O O
by O O
Thoracic O O
Surgery O O
at O O
OSH O O
and O O
recommended O O
for O O
de-cortication. O O
In O O
light O O
of O O
complex O O
medical O O
history, O O
including O O
Coumadin O O
use, O O
it O O
was O O
recommended O O
that O O
transfer O O
to O O
LCH O O
was O O
appropriate. O O
Problems O O
Hypertension B-HYPERTENSION B-HYPERTENSION
Congestive O O
heart O O
failure O O
Cerebrovascular O O
accident O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Atrial O O
fibrillation O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Hodgkins O O
disease O O
: O O
Followed O O
by O O
Dr. O O
Ernest O O
Byers O O
Hyperplastic O O
polyp O O
Thyroid O O
nodule O O
: O O
Negative O O
biopsy O O
Abdominal O O
aortic O O
aneurysm O O
: O O
3.2 O O
cm O O
Medications O O
on O O
transfer: O O
1. O O
Zosyn O O
2. O O
Levofloxacin O O
IV O O
3. O O
Lisinopril B-MEDICATION B-MEDICATION
40mg O O
QD O O
4. O O
Metoprolol B-MEDICATION B-MEDICATION
XL O O
50mg O O
QD O O
5. O O
Cardizem B-MEDICATION O
300mg O O
QAM O O
6. O O
Doxazosin O O
1mg O O
QHS O O
7. O O
Lasix O O
20mg O O
PO O O
BID O O
8. O O
Digoxin O O
0.25mg O O
QD O O
9. O O
Heparin O O
gtt O O
10. O O
Simvastatin B-MEDICATION B-MEDICATION
80mg O O
QHS O O
11. O O
Glucovance B-MEDICATION B-MEDICATION
(Glipizide I-MEDICATION O
5mg/Metformin I-MEDICATION O
500mg) I-MEDICATION O
BID O O
12. O O
Folate O O
1mg O O
QD O O
13. O O
Oscal O O
+ O O
Vit O O
D O O
1 O O
tab O O
daily O O
Allergies O O
NKA O O
Health O O
Maintenance O O
Influenza O O
Vaccine O O
09/24/2086 O O
Done O O
Breast O O
Exam O O
09/24/2086 O O
No O O
masses O O
Cholesterol O O
09/24/2086 O O
143 O O
DESIRABLE: O O
&lt;200 O O
Rectal O O
exam O O
09/24/2086 O O
No O O
masses, O O
brown O O
heme O O
negative O O
stool O O
M-alb/creat O O
ratio O O
09/24/2086 O O
799.3 O O
Stool O O
Guaiac O O
09/24/2086 O O
Done O O
- O O
negative O O
Smoking O O
status O O
09/24/2086 O O
Past B-SMOKER O
smoker I-SMOKER O
No I-SMOKER O
Of I-SMOKER O
Cigarettes I-SMOKER O
Smoked I-SMOKER O
per I-SMOKER O
Day: I-SMOKER O
10-19 O O
CIG/DAY O O
(1/2-1 O O
ppd), O O
Quit O O
Date: O O
09/25/2066 O O
UA-Protein O O
02/19/2087 O O
3+ O O
Colonoscopy O O
09/13/2082 O O
see O O
report O O
in O O
Results O O
PSA O O
09/24/2086 O O
2.28 O O
Urine O O
Culture O O
09/24/2086 O O
see O O
report O O
in O O
Results O O
Triglycerides O O
09/24/2086 O O
97 O O
Cholesterol-LDL O O
09/24/2086 O O
72 O O
DESIRABLE: O O
&lt;130 O O
Microalbumin O O
09/24/2086 O O
239.8 O O
Hct O O
(Hematocrit) O O
02/20/2087 O O
34.2 O O
Prostate O O
exam O O
09/24/2086 O O
Complete O O
Physical O O
Exam O O
09/24/2086 O O
Cholesterol-HDL O O
09/24/2086 O O
52 O O
Hgb O O
(Hemoglobin) O O
02/20/2087 O O
11.4 O O
HbA1c B-DIABETES O
12/22/2086 I-DIABETES O
6.80 I-DIABETES O
GFR O O
(estimated) O O
02/20/2087 O O
&gt;60 O O
Abnormal O O
if O O
&lt;60 O O
mL/min/1.73m2. O O
If O O
patient O O
is O O
African-American, O O
multiply O O
the O O
result O O
by O O
1.21. O O
Family O O
History O O
Mother- O O
Died O O
age O O
90 O O
Father-Died O O
age O O
76 O O
Colon O O
cancer O O
Siblings-Sister O O
at O O
age O O
80 O O
dementia/pneumonia O O
Social O O
History O O
Retired O O
network O O
operator/Craftperson O O
in O O
Amman. O O
Formal O O
education O O
level O O
attained- O O
HSLives O O
alone, O O
next O O
door O O
to O O
wife O O
from O O
whom O O
he O O
is O O
separated. O O
Likes O O
the O O
library. O O
Vital O O
Signs: O O
8:00 O O
Temp O O
98.5 O O
at O O
10:15: O O
90, O O
173/84, B-HYPERTENSION O
18, O O
100 O O
(2L) O O
On O O
examination: O O
Gen: O O
appears O O
unwell, O O
plethoric O O
face O O
Psych: O O
Affect: O O
flat O O
CVS: O O
Irregular O O
irregular O O
pulse, O O
no O O
m/r/g. O O
I O O
do O O
not O O
hear O O
the O O
rub O O
documented. O O
Chest: O O
reduced O O
air O O
entry O O
to O O
mid-zone O O
of O O
right O O
lung, O O
dull O O
to O O
percussion O O
Abdo: O O
soft, O O
non-tender O O
Skin: O O
no O O
decubitus O O
Results02/20/2087 O O
NA O O
135, O O
K O O
3.2 O O
(L), O O
CL O O
96 O O
(L), O O
CO2 O O
30.6, O O
BUN O O
14, O O
CRE O O
1.00, O O
EGFR O O
&gt;60 O O
[1], O O
GLU O O
147 O O
(H)[1] O O
RESULT O O
COMMENT: O O
Abnormal O O
if O O
&lt;60 O O
mL/min/1.73m2. O O
If O O
patient O O
is O O
African-American, O O
multiply O O
theresult O O
by O O
1.21.02/19/2087 O O
NA O O
132 O O
(L), O O
K O O
3.9, O O
CL O O
96 O O
(L), O O
CO2 O O
32.0 O O
(H), O O
BUN O O
16, O O
CRE O O
1.05, O O
EGFR O O
&gt;60 O O
[1], O O
GLU O O
229 O O
(H)[1] O O
RESULT O O
COMMENT: O O
Abnormal O O
if O O
&lt;60 O O
mL/min/1.73m2. O O
If O O
patient O O
is O O
African-American, O O
multiply O O
theresult O O
by O O
1.21.02/19/2087 O O
CA O O
8.9, O O
PHOS O O
2.6, O O
MG O O
1.502/20/2087 O O
TSH O O
PEND02/20/2087 O O
WBC O O
4.4 O O
(L), O O
RBC O O
4.26 O O
(L), O O
HGB O O
11.4 O O
(L), O O
HCT O O
34.2 O O
(L), O O
MCV O O
80, O O
MCH O O
26.8, O O
MCHC O O
33.4, O O
PLT O O
315 O O
[1][1] O O
RESULT O O
COMMENT: O O
*** O O
Note: O O
New O O
normal O O
range O O
***02/19/2087 O O
WBC O O
3.4 O O
(L), O O
RBC O O
4.55, O O
HGB O O
12.2 O O
(L), O O
HCT O O
36.1 O O
(L), O O
MCV O O
79 O O
(L), O O
MCH O O
26.9, O O
MCHC O O
33.9, O O
PLT O O
319 O O
[1][1] O O
RESULT O O
COMMENT: O O
*** O O
Note: O O
New O O
normal O O
range O O
***02/20/2087 O O
RDW O O
14.002/19/2087 O O
RDW O O
14.002/20/2087 O O
DIFFR O O
RECEIVED, O O
METHOD O O
PEND, O O
%NEUT O O
PEND, O O
%LYMPH O O
PEND, O O
%MONO O O
PEND, O O
%EOS O O
PEND, O O
%BASO O O
PEND02/19/2087 O O
DIFFR O O
RECEIVED, O O
METHOD O O
Auto, O O
%NEUT O O
67 O O
(H), O O
%LYMPH O O
21 O O
(L), O O
%MONO O O
12 O O
(H), O O
%EOS O O
0, O O
%BASO O O
002/20/2087 O O
ANEUT O O
PEND, O O
ALYMP O O
PEND, O O
AMONS O O
PEND, O O
AEOSN O O
PEND, O O
ABASOP O O
PEND02/19/2087 O O
ANEUT O O
2.29, O O
ALYMP O O
0.74 O O
(L), O O
AMONS O O
0.39, O O
AEOSN O O
0.01 O O
(L), O O
ABASOP O O
0.0002/20/2087 O O
ANISO O O
PEND, O O
HYPO O O
PEND, O O
MACRO O O
PEND, O O
MICRO O O
PEND02/19/2087 O O
ANISO O O
None, O O
HYPO O O
None, O O
MACRO O O
None, O O
MICRO O O
None02/20/2087 O O
PT O O
PEND, O O
PT-INR O O
PEND, O O
PTT O O
PEND02/19/2087 O O
PT O O
15.1 O O
(H), O O
PT-INR O O
1.4, O O
PTT O O
27.302/19/2087 O O
UA-COLOR O O
RED, O O
UA-APP O O
TURBID, O O
UA-GLUC O O
2+, O O
UA-BILI O O
3+, O O
UA-KET O O
2+, O O
UA-SPGR O O
1.021, O O
UA-BLD O O
3+, O O
UA-PH O O
6.502/19/2087 O O
UA-PROT O O
3+, O O
UA-UROBI O O
Trace, O O
UA-NIT O O
POSITIVE, O O
UA-WBC O O
3+, O O
MIC-SED O O
Completed, O O
HCAST O O
None, O O
UAS-RBC O O
PACKED, O O
UAS-WBC O O
20-5002/19/2087 O O
UAS-BACT O O
NEGATIVE, O O
UAS-SQHI O O
NEGATIVE02/19/2087 O O
21:55 O O
LCH O O
RadiologyStudy O O
Name O O
Chest O O
2 O O
ViewsAccession O O
22670961Status O O
FinalExam O O
Number: O O
22670961 O O
Report O O
Status: O O
FinalType: O O
Chest O O
2 O O
ViewsDate/Time: O O
02/19/2087 O O
21:55Exam O O
Code: O O
XRCH2Ordering O O
Provider: O O
OXENDINE, O O
ODELL O O
M O O
M.D.HISTORY: O O
KNOWN O O
PNEUMONIA O O
- O O
ASSESS O O
FOR O O
INFILTRATE O O
REPORT: O O
Frontal O O
and O O
lateral O O
views O O
of O O
the O O
chest. O O
COMPARISON: O O
12/22/86 O O
FINDINGS: O O
Lines/tubes: O O
None. O O
Lungs O O
and O O
pleura: O O
There O O
is O O
continued O O
right O O
mid O O
and O O
lower O O
chest O O
opacity O O
consistent O O
with O O
loculated O O
pleural O O
fluid O O
and O O
atelectasis. O O
This O O
appearance O O
of O O
fluid O O
has O O
decreased O O
slightly O O
since O O
the O O
previous O O
study. O O
There O O
is O O
no O O
pneumothorax. O O
No O O
focal O O
consolidation O O
is O O
demonstrated O O
in O O
the O O
left O O
hemithorax. O O
There O O
may O O
be O O
a O O
small O O
posterior O O
left O O
pleural O O
effusion O O
as O O
well. O O
There O O
is O O
subtle O O
suggestion O O
of O O
Kerley O O
B O O
lines O O
at O O
the O O
lung O O
bases O O
consistent O O
with O O
mild O O
CHF. O O
Heart O O
and O O
mediastinum: O O
The O O
heart O O
and O O
the O O
mediastinum O O
are O O
unchanged O O
from O O
the O O
prior O O
study. O O
The O O
aortic O O
arch O O
is O O
calcified O O
and O O
tortuous. O O
Bones: O O
The O O
thoracic O O
skeleton O O
is O O
unchanged O O
from O O
the O O
prior O O
study. O O
IMPRESSION: O O
Continued O O
signs O O
of O O
atelectasis O O
and O O
pleural O O
fluid O O
involving O O
predominantly O O
the O O
right O O
mid O O
and O O
lower O O
hemithorax. O O
The O O
appearance O O
of O O
this O O
has O O
improved O O
slightly O O
since O O
the O O
prior O O
exam. O O
No O O
new O O
focal O O
consolidation O O
is O O
demonstrated O O
compared O O
to O O
the O O
prior O O
study. O O
There O O
is O O
subtle O O
suggestion O O
of O O
Kerley O O
B O O
lines O O
consistent O O
with O O
mild O O
CHF. O O
Plan: O O
1. O O
Recurrent O O
pleural O O
effusion: O O
for O O
repeat O O
CT O O
chest. O O
Continue O O
treatment O O
for O O
CAP. O O
2. O O
Hematuria: O O
hold O O
off O O
Coumadin O O
at O O
present. O O
Monitor O O
Foley O O
drainage. O O
Consult O O
Urology O O
if O O
no O O
resolution. O O
Otherwise O O
for O O
outpatient O O
follow-up. O O
3. O O
Hodgkin's O O
Lymphoma: O O
Alert O O
Dr O O
Joyce O O
of O O
admission O O
as O O
courtesy. O O
4. O O
A O O
Fib: O O
rate O O
controlled O O
at O O
present. O O
Hold O O
off O O
Coumadin. O O
5. O O
HTN: B-HYPERTENSION O
BP O O
poorly O O
controlled. O O
For O O
admission O O
anti-hypertensives. O O
Monitor. O O
6. O O
Psych: O O
he O O
appears O O
depressed. O O
Likely O O
reactive O O
to O O
current O O
poor O O
health. O O
I O O
will O O
alert O O
PCP. O O
7. O O
Code: O O
FULL O O
8. O O
Family: O O
Daughter O O
present O O
and O O
aware O O
of O O
plan O O
____________________________________ O O
Cincere O O
D. O O
Urban, O O
M.D. O O

Record O O
date: O O
2087-03-26 O O
Perth O O
Team O O
I O O
Admission O O
Note O O
PATIENT: O O
Youssef O O
Jimenez O O
MRN: O O
0554733 O O
ADMIT O O
DATE: O O
March O O
26, O O
2087 O O
PCP/ATTENDING: O O
William O O
Dickson O O
CONTACT: O O
Daughter O O
- O O
Yolanda O O
Jimenez O O
742-769-9436 O O
Code O O
status: O O
FULL O O
Source: O O
patient, O O
medical O O
record O O
CC: O O
wt O O
gain O O
HPI: O O
Mr. O O
Jimenez O O
is O O
a O O
78 O O
yo O O
male O O
with O O
h/o O O
Hodgkin&#8217;s O O
dz O O
s/p O O
chemo, O O
T2m, O O
HTN, B-HYPERTENSION O
AAA, O O
CHF O O
(last O O
TTE O O
2086 O O
with O O
LVEF O O
50%, O O
RVSP O O
45), O O
a O O
fib O O
on O O
coumadin, O O
recently O O
discharged O O
after O O
prolonged O O
hospital O O
stay O O
for O O
PNA O O
&amp; O O
complicated O O
pleural O O
effusion O O
requiring O O
chest O O
tube O O
placement, O O
now O O
returns O O
from O O
rehab O O
with O O
20 O O
lb O O
wt O O
gain O O
since O O
discharge O O
on O O
3/09 O O
&amp; O O
7.5 O O
lbs O O
since O O
3/20. O O
Patient O O
himself O O
is O O
without O O
complaint O O
and O O
denies O O
any O O
fevers, O O
chills, O O
SOB, O O
CP, O O
cough, O O
edema, O O
PND, O O
increasing O O
abd O O
girth, O O
orthopnea, O O
palpitations. O O
However, O O
per O O
medical O O
record O O
it O O
appears O O
that O O
patient O O
was O O
sent O O
from O O
rehab O O
day O O
PTA O O
for O O
concern O O
of O O
left O O
upper O O
ext O O
swelling. O O
Was O O
felt O O
to O O
be O O
asymptomatic O O
and O O
sent O O
back O O
to O O
rehab. O O
Today O O
was O O
sent O O
to O O
LCH O O
given O O
concern O O
for O O
his O O
left O O
upper O O
extremity O O
as O O
well O O
as O O
bilateral O O
low O O
extremity O O
swelling O O
and O O
wt O O
gain O O
with O O
concern O O
for O O
possible O O
CHF O O
flare. O O
Of O O
note, O O
on O O
day O O
of O O
d/c O O
from O O
LCH, O O
patient O O
had O O
negative O O
LUE O O
U/S O O
for O O
DVT. O O
ED O O
course: O O
In O O
the O O
ED, O O
patient O O
was O O
found O O
to O O
be O O
afebrile O O
with O O
temp O O
98.2, O O
HR O O
64, O O
BP B-HYPERTENSION O
160/61, B-HYPERTENSION O
RR O O
16, O O
&amp; O O
O2 O O
sat O O
of O O
99% O O
RA. O O
CXR O O
remarkable O O
for O O
loculated O O
right O O
pneumothorax O O
&amp; O O
interval O O
increase O O
in O O
airspace O O
density O O
suggesting O O
worsening O O
pleural O O
effusion O O
v O O
PNA. O O
His O O
WBC O O
was O O
nl O O
@ O O
4.8 O O
with O O
slight O O
left O O
shift O O
75% O O
PMNs. O O
BNP O O
slightly O O
elevated O O
at O O
2200 O O
(has O O
been O O
as O O
high O O
20K O O
in O O
past). O O
Treated O O
with O O
Vanc/Cefepime O O
&amp; O O
diuresed O O
with O O
40 O O
mg O O
IV O O
Lasix. O O
ROS: O O
As O O
per O O
HPI. O O
MEDICAL O O
HISTORY: O O
PNA O O
- O O
starting O O
in O O
9/86 O O
requiring O O
chest O O
tube O O
placement O O
for O O
loculated O O
pleural O O
effusion O O
- O O
Consideration O O
was O O
made O O
for O O
decortication O O
but O O
opted O O
for O O
medical O O
management O O
HTN O O
CHF O O
(?diastolic O O
heart O O
failure) O O
CVA O O
A O O
fib O O
Hyperlipidemia B-HYPERLIPIDEMIA B-MEDICATION
T2DM B-DIABETES O
Hodgkin&#8217;s O O
disease O O
s/p O O
chemo O O
AAA O O
FAMILY O O
HISTORY: O O
Mother- O O
Died O O
age O O
90, O O
Father-Died O O
age O O
76 O O
Colon O O
cancer O O
Siblings-Sister O O
at O O
age O O
80 O O
dementia/pneumonia O O
SOCIAL O O
HISTORY: O O
Retired O O
network O O
operator/Craftperson O O
, O O
Lives O O
alone O O
in O O
private O O
home O O
near O O
wife O O
and O O
daughters. O O
+ B-SMOKER O
Tobacco I-SMOKER O
but I-SMOKER O
quit B-SMOKER O
30 I-SMOKER O
yrs I-SMOKER O
ago. I-SMOKER O
Occasional O O
alcohol O O
ALLERGIES: O O
NKDA O O
MEDICATIONS O O
ON O O
ADMISSION: O O
1. O O
Coumadin O O
(Warfarin O O
Sodium) O O
6 O O
MG O O
PO O O
QPM O O
2. O O
Acetaminophen O O
(Tylenol O O
) O O
325-650 O O
MG O O
PO O O
Q4H O O
prn O O
3. O O
Acetylsalicylic B-MEDICATION B-MEDICATION
Acid I-MEDICATION O
(Aspirin) B-MEDICATION O
81 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
DAILY I-MEDICATION O
4. O O
Amlodipine B-MEDICATION B-MEDICATION
(Norvasc B-MEDICATION O
) I-MEDICATION O
12.5 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
DAILY I-MEDICATION O
5. O O
Calcium O O
Carbonate O O
1250 O O
Mg O O
1 O O
TAB O O
PO O O
DAILY O O
6. O O
Digoxin O O
0.125 O O
MG O O
PO O O
DAILY O O
7. O O
Folate O O
(Folic O O
Acid) O O
1 O O
MG O O
PO O O
DAILY O O
8. O O
Hydralazine B-MEDICATION O
Hcl I-MEDICATION O
50 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QID I-MEDICATION O
9. O O
Insulin B-MEDICATION O
Regular I-MEDICATION O
Inj I-MEDICATION O
Sliding I-MEDICATION O
scale I-MEDICATION O
SC I-MEDICATION O
If O O
BS O O
&lt;= O O
200 O O
give O O
0 O O
Units O O
For O O
BS O O
from O O
201 O O
to O O
250 O O
give O O
4 O O
Units O O
For O O
BS O O
from O O
251 O O
to O O
300 O O
give O O
6 O O
Units O O
For O O
BS O O
from O O
301 O O
to O O
350 O O
give O O
8 O O
Units O O
For O O
BS O O
from O O
351 O O
to O O
400 O O
give O O
10 O O
Units O O
10. O O
Insulin B-MEDICATION B-MEDICATION
Nph I-MEDICATION B-MEDICATION
Human I-MEDICATION O
6 O O
UNITS O O
SC O O
QAM O O
BEFORE O O
BREAKFAST O O
11. O O
Insulin O B-MEDICATION
Nph O B-MEDICATION
Human O O
6 O O
UNITS O O
SC O O
QHS O O
12. O O
Labetalol B-MEDICATION B-MEDICATION
Hcl I-MEDICATION O
300 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
13. O O
Prinivil B-MEDICATION B-MEDICATION
(Lisinopril) B-MEDICATION O
40 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
14. O O
Polyethylene O O
Glycol O O
(Miralax) O O
17 O O
GM O O
PO O O
DAILY O O
prn O O
15. O O
Simvastatin B-MEDICATION B-MEDICATION
(Zocor) B-MEDICATION O
80 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QHS I-MEDICATION O
16. O O
Magnesium O O
Oxide O O
400 O O
MG O O
PO O O
DAILY O O
PHYSICAL O O
EXAM: O O
VITALS: O O
T O O
97.4 O O
HR O O
66 O O
BP B-HYPERTENSION O
161/77 B-HYPERTENSION O
RR O O
16 O O
O2 O O
sat O O
98% O O
RA O O
GEN&#8217;L O O
Elderly O O
white O O
male. O O
NAD; O O
Non-toxic O O
appearing. O O
HEENT O O
MMM; O O
No O O
scleral O O
icterus; O O
No O O
pale O O
conjunctiva O O
NECK O O
Supple; O O
No O O
thyromegaly; O O
No O O
LAD. O O
JVP~7 O O
cm; O O
No O O
carotid O O
bruits O O
CV: O O
RRR O O
with O O
occasional O O
ectopy; O O
normal O O
S1, O O
S2 O O
no O O
c/r/m/g O O
LUNG: O O
Crackles O O
right O O
base O O
ABD: O O
Soft, O O
non-tender, O O
non-distended; O O
Hyperactive O O
BS. O O
No O O
HSM. O O
No O O
masses, O O
rebound. O O
No O O
CVA O O
tenderness. O O
EXT: O O
2+ O O
edema O O
bilateral O O
low O O
ext O O
to O O
shin; O O
1+ O O
left O O
upper O O
ext; O O
Warm O O
well-perfused O O
with O O
cap O O
refill O O
&lt; O O
2 O O
sec; O O
No O O
clubbing/cyanosis O O
NEURO: O O
AO O O
x O O
3; O O
CN O O
II-XII O O
grossly O O
intact O O
including O O
PERRL, O O
EOM, O O
&amp; O O
visual O O
fields; O O
Motor: O O
5/5 O O
B O O
UE/LE; O O
sensation O O
grossly O O
intact O O
to O O
light O O
touch; O O
DTRs O O
(/brachioradialis/patellar/Achilles) O O
2+ O O
&amp; O O
symmetric O O
bilaterally;Good O O
coordination O O
on O O
Finger-to-nose; O O
no O O
pronator O O
drift O O
SKIN O O
Slight O O
erythematous O O
macules O O
on O O
right O O
low O O
ext O O
anterior O O
shin; O O
no O O
warmth, O O
tenderness O O
&#183; O O
Hematology: O O
WBC O O
4.8 O O
RBC O O
3.70(L) O O
HGB O O
10.2(L) O O
HCT O O
30.0(L) O O
MCV O O
81 O O
MCH O O
27.5 O O
MCHC O O
33.9 O O
PLT O O
236 O O
RDW O O
15.6(H) O O
DIFFR O O
Received O O
METHOD O O
see O O
detail O O
%NEUT O O
75(H) O O
%LYMPH O O
14(L) O O
%MONO O O
8 O O
%EOS O O
3 O O
%BASO O O
0 O O
ANEUT O O
3.64 O O
ALYMP O O
0.64(L) O O
AMONS O O
0.38 O O
AEOSN O O
0.16 O O
ABASOP O O
0.02 O O
ANISO O O
None O O
HYPO O O
None O O
MACRO O O
None O O
MICRO O O
None O O
&#183;Chemistries: O O
NA O O
134(L) O O
K O O
4.6(T) O O
CL O O
99(L) O O
CO2 O O
26.0 O O
BUN O O
16 O O
CRE O O
0.82 O O
EGFR O O
see O O
detail O O
GLU O O
182(H) O O
ANION O O
9 O O
CA O O
8.8 O O
PHOS O O
3.4 O O
MG O O
1.7 O O
TP O O
7.5 O O
ALB O O
3.2(L) O O
GLOB O O
4.3(H) O O
ALT/SGPT O O
26 O O
AST/SGOT O O
39 O O
ALKP O O
210(H) O O
TBILI O O
0.4 O O
DBILI O O
see O O
detail O O
&#183;Cardiac O O
Enzymes: O O
NT-BNP O O
2221(HT) O O
CK-MB O O
Negative O O
TROP-I O O
Negative O O
&#183;Coags: O O
PT O O
34.9(HT) O O
PT-INR O O
3.8(T) O O
PTT O O
32.4(T) O O
&#183;Toxicology: O O
DIG O O
Refuse O O
&#183;Radiology: O O
CXR: O O
LOCULATED O O
RIGHT O O
LOWER O O
LOBE O O
PNEUMOTHORAX O O
MORE O O
APPARENT O O
ON O O
THE O O
CURRENT O O
STUDY O O
COMPARED O O
TO O O
THE O O
RADIOGRAPH O O
OF O O
3/07/87. O O
INTERVAL O O
INCREASE O O
IN O O
PATCHY O O
AIRSPACE O O
DENSITY O O
INVOLVING O O
THE O O
RIGHT O O
LOWER O O
LOBE O O
COULD O O
SUGGEST O O
WORSENING O O
NO O O
PLEURAL O O
EFFUSION O O
AND O O
OR O O
PNEUMONIA. O O
&#183;EKG: O O
A O O
fib O O
with O O
rate O O
with O O
? O O
escape O O
jxnal O O
rhythm O O
at O O
times. O O
Normal O O
axis. O O
No O O
QRS-widening. O O
No O O
ST-elevations. O O
Scooped O O
ST O O
depressions O O
V5-V6 O O
likely O O
2/2 O O
digoxin. O O
No O O
Q-waves O O
or O O
TWI. O O
QTc O O
436 O O
ASSESSMENT O O
&amp; O O
PLAN O O
Mr. O O
Jimenez O O
is O O
a O O
78 O O
yo O O
male O O
with O O
h/o O O
Hodgkin&#8217;s O O
dz O O
s/p O O
chemo, O O
T2m, O O
HTN, O O
AAA, O O
CHF O O
(last O O
TTE O O
2086 O O
with O O
LVEF O O
50%, O O
RVSP O O
45), O O
a O O
fib O O
on O O
coumadin, O O
recently O O
discharged O O
after O O
prolonged O O
hospital O O
stay O O
for O O
PNA O O
&amp; O O
complicated O O
pleural O O
effusion O O
requiring O O
chest O O
tube O O
placement, O O
now O O
returns O O
from O O
rehab O O
with O O
20 O O
lb O O
wt O O
gain O O
since O O
discharge O O
on O O
3/09 O O
&amp; O O
7.5 O O
lbs O O
since O O
3/20 O O
&amp; O O
increasing O O
pleural O O
effusion. O O
Increasing O O
wt O O
gain O O
could O O
be O O
secondary O O
to O O
low O O
ext O O
edema. O O
?right O O
heart O O
failure O O
2/2 O O
to O O
pulm O O
htn O O
or O O
perhaps O O
diastolic O O
dysfunction; O O
however O O
BNP O O
not O O
very O O
elevated. O O
Patient&#8217;s O O
albumin O O
is O O
only O O
slightly O O
below O O
3.4 O O
as O O
well. O O
Low O O
suspicion O O
for O O
DVTs O O
given O O
exam O O
with O O
bilateral O O
low O O
ext O O
swelling O O
&amp; O O
recent O O
negative O O
LUE O O
noninvasive. O O
1. O O
Low O O
ext O O
edema/wt O O
gain: O O
Patient O O
responding O O
well O O
to O O
IV O O
lasix O O
from O O
ED. O O
a. O O
Trial O O
of O O
daily O O
PO O O
lasix O O
b. O O
Strict O O
I/O/s, O O
daily O O
wt O O
c. O O
Consider O O
a O O
repeat O O
TTE, O O
but O O
recently O O
performed O O
5 O O
months O O
ago O O
so O O
expect O O
little O O
change. O O
2. O O
Loculated O O
pleural O O
effusion: O O
With O O
effusion O O
enlarging, O O
question O O
if O O
patient O O
would O O
be O O
candidate O O
for O O
decortication/pleurodesis. O O
a. O O
Consider O O
thoracic O O
surgery O O
consult O O
3. O O
ID: O O
Will O O
hold O O
on O O
further O O
antibiotics O O
at O O
this O O
time. O O
Afebrile O O
without O O
elev O O
WBC. O O
Suspect O O
CXR O O
showing O O
increasing O O
pleural O O
effusion. O O
Low O O
suspicion O O
for O O
PNA. O O
4. O O
CV: O O
a. O O
Rhythm: O O
Rate O O
control O O
with O O
digoxin, O O
labetalol. B-MEDICATION B-MEDICATION
Hold O O
coumadin O O
for O O
elevated O O
INR. O O
Restart O O
when O O
&lt;3.3. O O
b. O O
HTN: O O
Cont O O
Norvasc, O B-MEDICATION
labetalol, O B-MEDICATION
hydralazin, O B-MEDICATION
lisinopril B-MEDICATION B-MEDICATION
c. O O
PVD: O O
Cont O O
statin, O O
ASA B-MEDICATION B-MEDICATION
5. O O
T2DM: O O
Cont O O
NPH B-MEDICATION O
6 O O
units O O
BID O O
+ O O
RISS O O
F/E/N: O O
No O O
conc O O
sweets. O O
PROPHYLAXIS: O O
GI: O O
Not O O
indicated. O O
DVT: O O
Coumadin O O
BOWEL: O O
OBR O O
CODE: O O
FULL O O
__________________________________ O O
Alois O O
B. O O
Benton, O O
MDMedicine O O
Resident O O
(PGY1) O O
Pager O O
#46876 O O

Record O O
date: O O
2127-05-18 O O
May O O
18, O O
2127 O O
Robert O O
Xenakis, O O
M.D. O O
Internal O O
Medicine O O
Assoc. O O
Internal O O
Medicine O O
56th O O
Floor O O
Houston O O
Medical O O
Center O O
Hayti, O O
DE O O
69436 O O
RE: O O
MCKEE, O O
Norma O O
MR#: O O
6987776 O O
DOB: O O
7/7/75 O O
Dear O O
Robert, O O
Thank O O
you O O
for O O
allowing O O
me O O
to O O
share O O
in O O
the O O
medical O O
care O O
of O O
Ms. O O
Norma O O
Mckee, O O
a O O
51-year-old O O
female O O
patient O O
with O O
the O O
history O O
of O O
seizure O O
disorder, O O
hypertension, B-HYPERTENSION B-HYPERTENSION
borderline O O
diabetes, O O
gastroesophageal O O
reflux O O
disease O O
and O O
panic O O
related O O
symptoms, O O
and O O
depressive O O
disorder, O O
who O O
complains O O
of O O
excessive O O
daytime O O
sleepiness O O
with O O
recent O O
polysomnographic O O
abnormalities. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
As O O
you O O
already O O
know, O O
Ms. O O
Mckee O O
describes O O
a O O
longstanding O O
history O O
of O O
snoring O O
symptomatology O O
and O O
suspected O O
nocturnal O O
respiratory O O
pauses, O O
and O O
describes O O
a O O
'restless O O
sleep', O O
but O O
only O O
relatively O O
recently O O
(over O O
the O O
last O O
five O O
months, O O
particularly O O
after O O
12/26 O O
of O O
last O O
year). O O
She O O
has O O
described O O
marked O O
increased O O
daytime O O
sleepiness. O O
She O O
essentially O O
describes O O
a O O
nocturnal O O
sleep O O
pattern O O
which O O
involves O O
'sleeping O O
around O O
the O O
clock' O O
during O O
which O O
time O O
she O O
may O O
initiate O O
sleep O O
between O O
12:30 O O
and O O
1:00 O O
a.m., O O
and O O
after O O
a O O
couple O O
awakenings, O O
will O O
wake O O
up O O
at O O
10:00 O O
a.m., O O
only O O
to O O
demonstrate O O
frequent O O
and O O
often O O
prolonged O O
daytime O O
naps O O
of O O
four O O
hours O O
duration. O O
The O O
patient O O
states O O
she O O
will O O
waken O O
for O O
a O O
couple O O
of O O
hours O O
and O O
then O O
reinitiate O O
sleep O O
for O O
an O O
additional O O
four O O
hours. O O
She O O
states O O
that O O
she O O
is O O
so O O
tired O O
that O O
she O O
can O O
'fall O O
asleep O O
right O O
after O O
breakfast'. O O
She O O
then O O
would O O
get O O
up O O
for O O
lunch O O
and O O
then O O
go O O
right O O
back O O
to O O
sleep O O
and O O
sustain O O
sleep O O
until O O
3:00 O O
p.m. O O
in O O
the O O
afternoon. O O
Ms. O O
Mckee O O
also O O
demonstrates O O
a O O
history O O
of O O
seizures O O
initiated O O
at O O
3 O O
to O O
4 O O
years O O
of O O
age, O O
and O O
was O O
initially O O
started O O
on O O
phenobarbital O O
therapy. O O
She O O
later O O
switched O O
to O O
Dilantin O O
therapy, O O
but O O
more O O
recently O O
and O O
particularly O O
since O O
the O O
mid O O
10's, O O
she O O
has O O
been O O
on O O
Tegretol O O
antiepileptic O O
monotherapy O O
200 O O
mg O O
tablets, O O
four O O
tablets O O
po O O
q.a.m. O O
and O O
three O O
tablets O O
po O O
q.h.s. O O
While O O
Ms. O O
Mckee O O
also O O
demonstrates O O
both O O
daytime O O
and O O
nocturnal O O
seizures, O O
there O O
has O O
been O O
increased O O
predilections O O
for O O
nocturnal O O
seizures O O
over O O
the O O
last O O
year, O O
and O O
an O O
increased O O
amount O O
of O O
'diffuse' O O
spike O O
wave O O
discharges O O
are O O
evident O O
during O O
light O O
sleep, O O
as O O
detailed O O
during O O
a O O
recent O O
polysomnographic O O
evaluation O O
(please O O
see O O
below). O O
CURRENT O O
MEDICATIONS: O O
Remeron, O O
Celexa, O O
Zestril, B-MEDICATION B-MEDICATION
Prilosec, O O
carbamazepine O O
(200 O O
mg O O
tablets, O O
four O O
tablets O O
in O O
the O O
morning O O
and O O
three O O
tablets O O
at O O
night), O O
clonazepam, O O
hydrochlorothiazide, B-MEDICATION O
Premarin, O O
tetracycline O O
and O O
klor-con. O O
ALLERGIES: O O
No O O
adverse O O
drug O O
allergies O O
reported. O O
SLEEP O O
HISTORY: O O
Sleep O O
onset O O
intended O O
for O O
11:00 O O
p.m. O O
but O O
the O O
patient O O
does O O
not O O
often O O
sleep O O
until O O
12:30 O O
to O O
1:00 O O
a.m. O O
She O O
describes O O
one O O
to O O
two O O
early O O
morning O O
awakenings, O O
with O O
relative O O
ease O O
with O O
regards O O
to O O
subsequent O O
reinitiation O O
and O O
maintenance. O O
Sleep O O
offset O O
initially O O
occurs O O
at O O
8:30 O O
to O O
9:00 O O
a.m. O O
and O O
sometimes O O
as O O
late O O
as O O
10:00 O O
a.m. O O
The O O
patient O O
will O O
then O O
get O O
up O O
and O O
right O O
after O O
breakfast O O
fall O O
asleep O O
for O O
several O O
hours O O
in O O
duration O O
(up O O
to O O
four O O
hours). O O
The O O
patient O O
then O O
will O O
reawaken O O
and O O
have O O
lunch O O
and O O
then O O
after O O
a O O
couple O O
of O O
hours O O
of O O
sustained O O
wakefulness, O O
will O O
reinitiate O O
sleep O O
for O O
an O O
additional O O
four O O
hours O O
of O O
sleep. O O
Patient O O
may O O
sleep O O
until O O
3:00 O O
p.m. O O
on O O
certain O O
given O O
afternoons. O O
The O O
patient O O
describes O O
a O O
history O O
of O O
prominent O O
snoring O O
symptomatology O O
and O O
suspected O O
nocturnal O O
respiratory O O
pauses O O
as O O
well O O
as O O
'restless' O O
sleep. O O
She O O
denies O O
a O O
history O O
of O O
restless O O
lower O O
limb O O
sensory O O
complaints O O
of O O
nocturnal O O
lower O O
limb O O
movements O O
suggestive O O
of O O
periodic O O
limb O O
movement O O
disorder. O O
She O O
denies O O
the O O
history O O
of O O
abnormal O O
arousal O O
behaviors O O
or O O
associated O O
narcoleptic O O
symptoms. O O
PAST O O
MEDICAL O O
HISTORY: O O
1. O O
Seizure O O
disorder. O O
2. O O
Hypertension. B-HYPERTENSION B-HYPERTENSION
3. O O
Borderline O O
diabetes. O O
4. O O
Gastroesophageal O O
reflux O O
disease. O O
5. O O
Depressive O O
disorder. O O
6. O O
Panic O O
related O O
symptoms. O O
SOCIAL O O
HISTORY: O O
Patient O O
denies B-SMOKER O
active I-SMOKER O
tobacco I-SMOKER O
use. I-SMOKER O
She O O
has O O
discontinued O O
all O O
alcoholic O O
beverage O O
intake O O
due O O
to O O
her O O
reflux O O
disease. O O
She O O
averages O O
two O O
cups O O
of O O
tea O O
per O O
day. O O
While O O
describing O O
an O O
overweight O O
status, O O
she O O
has O O
increased O O
her O O
weight O O
by O O
10-20 O O
pounds O O
over O O
the O O
past O O
four O O
years. O O
PHYSICAL O O
EXAMINATION: O O
On O O
examination, O O
the O O
patient O O
demonstrates O O
a O O
mildly O O
hypersomnolent O O
facies. O O
Speech O O
is O O
clear O O
and O O
fluent. O O
Receptive O O
language O O
functioning O O
essentially O O
intact. O O
No O O
obvious O O
cranial O O
nerve O O
deficits O O
are O O
appreciated. O O
No O O
focal O O
sensory O O
motor O O
neurologic O O
deficits O O
are O O
noted. O O
No O O
significant O O
appendicular O O
dystaxias O O
or O O
dysmetrias O O
are O O
currently O O
in O O
evidence. O O
The O O
routine O O
gait O O
appears O O
to O O
be O O
normal O O
based, O O
without O O
evidence O O
of O O
significant O O
gait O O
dystaxias. O O
No O O
current O O
clinical O O
ictal O O
manifestations O O
are O O
present. O O
No O O
acute O O
evidence O O
of O O
'microsleeps' O O
are O O
noted. O O
On O O
HEENT O O
examination, O O
there O O
is O O
evidence O O
of O O
a O O
small O O
posterior O O
oropharyngeal O O
apeture, O O
with O O
increased O O
redundant O O
tissue O O
evident O O
posteriorly O O
and O O
a O O
mildly O O
elongated O O
uvula, O O
as O O
well O O
as O O
a O O
high O O
riding O O
base O O
of O O
the O O
tongue O O
and O O
mildly O O
increased O O
tonsillar O O
size. O O
Vital O O
signs O O
include O O
a O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
of I-HYPERTENSION O
144/88 B-HYPERTENSION O
(seated, I-HYPERTENSION O
left I-HYPERTENSION O
arm) I-HYPERTENSION O
and O O
a O O
heart O O
rate O O
of O O
88, O O
with O O
a O O
respiratory O O
rate O O
of O O
14. O O
IMPRESSION: O O
1. O O
Hypersomnia O O
(780.54): O O
Likely O O
to O O
be O O
a O O
result O O
of O O
frequent O O
sleep O O
disordered O O
breathing O O
events O O
and O O
their O O
associated O O
arousals. O O
Other O O
diagnostic O O
possibilities O O
include O O
the O O
presence O O
of O O
gastroesophageal O O
reflux O O
associated O O
arousals O O
as O O
well O O
as O O
nocturnal O O
sleep O O
disruptions O O
due O O
to O O
sleep O O
related O O
epilepsy O O
(although O O
seizures O O
appear O O
to O O
be O O
under O O
relatively O O
good O O
control O O
on O O
Tegretol O O
anticonvulsant O O
monotherapy). O O
2. O O
Obstructive O O
sleep O O
disordered O O
breathing O O
(780.53): O O
Patient O O
describes O O
a O O
history O O
of O O
prominent O O
snoring O O
symptomatology O O
and O O
nocturnal O O
respiratory O O
pauses O O
as O O
well O O
as O O
extremely O O
frequent O O
intermittent O O
obstructive O O
apneas O O
and O O
a O O
respiratory O O
disturbance O O
index O O
of O O
26 O O
per O O
hour O O
as O O
noted O O
during O O
a O O
recent O O
3/26/27 O O
sleep O O
study O O
with O O
associated O O
O2 O O
desaturations O O
down O O
to O O
76 O O
percent. O O
Good O O
clinical O O
response O O
to O O
nocturnal O O
CPAP O O
therapy O O
noted. O O
3. O O
Seizure O O
disorder: O O
Recent O O
literature O O
suggests O O
that O O
there O O
is O O
a O O
possible O O
association O O
between O O
treatment O O
of O O
obstructive O O
sleep O O
disorder O O
and O O
increased O O
seizure O O
frequency O O
in O O
patients O O
who O O
are O O
susceptible; O O
i.e., O O
thereby O O
giving O O
a O O
further O O
impetus O O
for O O
regular O O
ongoing O O
home O O
CPAP O O
therapy. O O
PLAN: O O
1. O O
Suggest O O
regular O O
home O O
CPAP O O
administration O O
(CPAP O O
Mallinckrodt; O O
Respironics O O
'contour O O
classic' O O
mask; O O
ramp O O
time O O
of O O
20 O O
minutes; O O
warm O O
air O O
humidification; O O
at O O
12 O O
cm O O
of O O
water O O
pressure). O O
2. O O
Pending O O
clinical O O
response, O O
will O O
reassess O O
the O O
patient's O O
level O O
of O O
alertness, O O
decrease O O
amount O O
of O O
early O O
morning O O
awakenings, O O
and O O
possibly O O
decrease O O
seizure O O
frequency O O
at O O
the O O
next O O
sleep O O
study O O
evaluation O O
in O O
12-14 O O
weeks O O
times. O O
3. O O
In O O
addition, O O
patient O O
is O O
advised O O
to O O
continue O O
efforts O O
at O O
weight O O
reduction, O O
use O O
of O O
an O O
oro-dental, O O
and/or O O
potential O O
ENT O O
surgical O O
approaches O O
may O O
also O O
help O O
to O O
improve O O
upper O O
airway O O
signs O O
and O O
symptoms. O O
4. O O
Patient O O
to O O
continue O O
on O O
Tegretol O O
anticonvulsant O O
monotherapy O O
200 O O
mg O O
tablets, O O
four O O
tablets O O
po O O
q.a.m. O O
and O O
three O O
tablets O O
po O O
q.h.s. O O
until O O
an O O
assessment O O
of O O
seizure O O
frequency O O
with O O
nocturnal O O
CPAP O O
therapy O O
has O O
been O O
made. O O
5. O O
Follow O O
up O O
neurologic O O
reevaluation O O
in O O
our O O
sleep O O
study O O
department O O
is O O
tentatively O O
scheduled O O
in O O
12-14 O O
weeks O O
time. O O
Once O O
again, O O
thank O O
you O O
for O O
allowing O O
me O O
to O O
share O O
in O O
the O O
medical O O
care O O
of O O
Ms. O O
Norma O O
Mckee. O O
I O O
hope O O
this O O
letter O O
finds O O
you O O
in O O
the O O
best O O
of O O
health. O O
Sincerely, O O
Salvador O O
B. O O
Irvin, O O
M.D. O O
Department O O
of O O
Sleep O O
Studies O O
Houston O O
Medical O O
Center O O
ADDENDUM: O O
Sleep O O
study O O
results O O
(3/26/27): O O
1. O O
Extremely O O
frequent O O
intermittent O O
obstructive O O
(82) O O
and O O
partially O O
obstructive O O
apneas O O
(63) O O
during O O
supine O O
sleep, O O
as O O
well O O
as O O
intermittent O O
hypopneas O O
(19) O O
and O O
nocturnal O O
hypoventilations, O O
intermittent O O
snore O O
arousals O O
(4) O O
and O O
episodes O O
of O O
moderate O O
snoring O O
(respiratory O O
disturbance O O
index O O
= O O
26 O O
per O O
hour) O O
with O O
associated O O
arousals O O
and O O
O2 O O
desaturations O O
down O O
to O O
76%. O O
Insofar O O
as O O
stage O O
REM O O
sleep O O
was O O
not O O
achieved, O O
the O O
actual O O
degree O O
of O O
respiratory O O
compromise O O
may O O
be O O
under O O
represented. O O
2. O O
CPAP O O
administration O O
(CPAP O O
Mallinckrodt; O O
Respironics O O
'contour O O
classic' O O
mask; O O
ramp O O
time O O
of O O
20 O O
minutes; O O
warm O O
air O O
humidification; O O
at O O
12 O O
cm O O
of O O
water O O
pressure) O O
served O O
to O O
considerably O O
reduce O O
the O O
frequency O O
of O O
these O O
nocturnal O O
respiratory O O
disturbances, O O
help O O
consolidate O O
sleep, O O
as O O
well O O
as O O
improve O O
O2 O O
saturations O O
(i.e., O O
to O O
96% O O
and O O
above, O O
even O O
during O O
REM O O
supine O O
sleep) O O
and O O
overall O O
sleep O O
stage O O
architecture. O O
3. O O
Slightly O O
increased O O
periodic O O
limb O O
movements O O
of O O
sleep, O O
activated O O
during O O
both O O
'light' O O
non-REM, O O
as O O
well O O
as O O
stage O O
REM O O
sleep O O
(index O O
= O O
8 O O
per O O
hour) O O
with O O
infrequent O O
limb O O
associated O O
arousals O O
(index O O
= O O
1 O O
per O O
hour) O O
both O O
of O O
which O O
may O O
serve O O
to O O
interfere O O
with O O
the O O
continuity O O
of O O
sleep O O
(the O O
presence O O
of O O
REM O O
related O O
nocturnal O O
lower O O
limb O O
movements O O
may O O
suggest O O
some O O
degree O O
of O O
REM O O
motor O O
disinhibition). O O
4. O O
Cardiac O O
rates O O
typically O O
ranged O O
between O O
72-87 O O
beats O O
per O O
minute; O O
average O O
80 O O
beats O O
per O O
minute. O O
5. O O
EEG O O
evidence O O
of O O
frequent O O
bursts O O
and O O
brief O O
runs O O
of O O
'diffuse' O O
spike-wave O O
discharges O O
were O O
evident O O
during O O
light O O
sleep, O O
without O O
associated O O
clinical O O
accompaniment. O O
6. O O
Inability O O
to O O
achieve O O
stage O O
REM O O
sleep O O
under O O
pre-CPAP O O
conditions, O O
but O O
with O O
prominent O O
'slow O O
wave O O
and O O
REM O O
rebounds' O O
subsequently O O
noted O O
with O O
CPAP O O
administration; O O
i.e., O O
accounting O O
for O O
more O O
than O O
41% O O
and O O
more O O
than O O
31% O O
of O O
the O O
CPAP O O
sleep O O
times, O O
respectively. O O
7. O O
Total O O
recording O O
period: O O
405 O O
minutes; O O
total O O
sleep O O
time: O O
377 O O
minutes. O O
DD:05/18/2127 O O
DT:05/20/2127 O O
RS:91294 O O
:1305 O O

Record O O
date: O O
2130-02-16 O O
INTERNAL O O
MEDICINE O O
ASSOCIATES O O
HOUSTON O O
MEDICAL O O
CENTER O O
Personal O O
data O O
and O O
overall O O
health O O
This O O
is O O
a O O
54-year-old O O
woman O O
with O O
hypertension, B-HYPERTENSION B-HYPERTENSION
hyperlipidemia, B-HYPERLIPIDEMIA O
glucose O O
intolerance, O O
depression, O O
and O O
agoraphobia. O O
Reason O O
for O O
visit O O
Extended O O
interval O O
visit. O O
Major O O
Problems O O
Depression O O
/chronic O O
mood O O
disorder O O
with O O
elements O O
of O O
paranoia/(?) O O
psychosis/agoraphobia. O O
Medicines O O
reviewed. O O
She O O
will O O
follow O O
up O O
with O O
Dr. O O
Thurston. O O
She O O
is O O
largely O O
homebound, O O
fearful O O
of O O
her O O
phone, O O
fearful O O
of O O
going O O
out, O O
overeating, O O
under O O
exercising O O
but O O
not O O
despondent O O
or O O
self-destructive. O O
She O O
does O O
have O O
support O O
from O O
sister O O
and O O
brother O O
who O O
live O O
at O O
home O O
with O O
her. O O
P: O O
Per O O
Dr. O O
Thurston. O O
Discussed O O
the O O
potential O O
of O O
transitional O O
therapist O O
if O O
she O O
relocates. O O
Family O O
history O O
risk O O
factors O O
/ O O
cad;diabetes. O O
An O O
episode O O
of O O
chest O O
discomfort O O
occurred O O
at O O
rest O O
watching O O
TV. O O
He O O
had O O
to O O
get O O
up O O
and O O
go O O
to O O
bed. O O
They O O
were O O
no O O
episymptoms O O
of O O
sweat, O O
nausea, O O
vomiting, O O
and O O
dyspnea, O O
but O O
she O O
did O O
have O O
both O O
chest O O
and O O
left O O
arm O O
discomfort, O O
the O O
duration O O
was O O
an O O
hour, O O
this O O
occurred O O
a O O
month O O
ago. O O
She O O
has O O
been O O
active O O
since O O
then O O
around O O
the O O
house O O
without O O
pain O O
and O O
had O O
no O O
pain O O
walking O O
in O O
today. O O
A: O O
Episode O O
of O O
chest O O
discomfort O O
with O O
family O O
history O O
of O O
CAD O O
and O O
multiple O O
risk O O
factors. O O
P: O O
Check O O
EKG. O O
She O O
will O O
call O O
for O O
recurrent O O
symptoms. O O
Glucose O O
intolerance O O
/family O O
history O O
of O O
diabetes. O O
Lots O O
of O O
sugars O O
and O O
carbohydrates. O O
Weight O O
is O O
up. O O
P: O O
Update O O
hemoglobin O O
A1c O O
next O O
month O O
when O O
she O O
returns O O
for O O
fasting O O
blood; O O
urine O O
microalbumin O O
today; O O
long O O
overdue O O
for O O
an O O
eye O O
exam O O
and O O
she O O
and O O
her O O
sister O O
promised O O
to O O
schedule O O
this. O O
Diet O O
reviewed O O
and O O
weight O O
program O O
urged. O O
Hiatal O O
hernia O O
Only O O
occasional O O
reflux O O
and O O
heartburn O O
but O O
one O O
episode O O
at O O
the O O
holiday O O
rather O O
vigorous O O
reflux O O
with O O
a O O
vomiting O O
episode O O
without O O
chest O O
pain. O O
There O O
was O O
vigorous O O
vomiting O O
and O O
she O O
actually O O
experienced O O
some O O
blood. O O
She O O
states O O
'one-half O O
cup.' O O
Stools O O
were O O
dark O O
for O O
several O O
days O O
thereafter, O O
then O O
cleared, O O
now O O
normal O O
and O O
she O O
has O O
had O O
no O O
satiety, O O
dysphagia, O O
or O O
recurrent O O
symptoms. O O
She O O
has O O
a O O
well O O
documented O O
GERD O O
and O O
reflux, O O
and O O
HH O O
on O O
barium O O
swallow O O
in O O
2123. O O
She O O
has O O
not O O
been O O
having O O
major O O
breakthrough O O
reflux O O
on O O
Prilosec O O
20 O O
mg. O O
A: O O
Episode O O
of O O
reflux, O O
vomiting O O
possible O O
esophageal O O
tear O O
with O O
symptoms O O
now O O
abated O O
and O O
color O O
looks O O
good. O O
She O O
does O O
not O O
appear O O
markedly O O
anemic. O O
There O O
are O O
no O O
symptoms O O
to O O
suggest O O
Barrett, O O
but O O
obviously O O
this O O
is O O
a O O
consideration. O O
P: O O
Check O O
CBC, O O
stool O O
guaiac O O
for O O
starters O O
and O O
iron O O
level. O O
If O O
she O O
significantly O O
anemic O O
and O O
these O O
symptoms O O
persist O O
an O O
EGD O O
would O O
be O O
appropriate O O
though O O
he O O
may O O
have O O
to O O
negotiate O O
this, O O
given O O
her O O
agoraphobia. O O
Minimally, O O
she O O
will O O
stay O O
on O O
Prilosec O O
one O O
or O O
two O O
a O O
day O O
in O O
the O O
meantime O O
and O O
call O O
me O O
if O O
there O O
is O O
anymore O O
vomiting, O O
bleeding, O O
or O O
black O O
stools. O O
Hypertension B-HYPERTENSION O
Blood O O
pressure O O
is O O
okay.P: O O
Continue O O
current O O
treatment. O O
02/16/2130: O O
Menstrual O O
disorder O O
/ O O
status O O
post O O
hysterectomy, O O
BSO O O
for O O
endometriomas, O O
fibroids. O O
Ran O O
out O O
of O O
Premarin O O
three O O
days O O
ago, O O
not O O
terribly O O
troubled O O
by O O
hot O O
flashes. O O
P: O O
Discontinue O O
Premarin. O O
If O O
hot O O
flashes O O
reoccur O O
badly, O O
we O O
can O O
go O O
to O O
0.3 O O
and O O
then O O
wean O O
more O O
slowly. O O
She O O
will O O
let O O
me O O
know. O O
Overweight O O
P: O O
Encouraged O O
weight O O
loss. O O
02/16/2130: O O
Sciatica O O
No O O
recurrence. O O
02/16/2130: O O
Seizure O O
disorder O O
We O O
will O O
check O O
Tegretol O O
level, O O
CBC, O O
and O O
LFTs. O O
She O O
is O O
overdue O O
and O O
had O O
episode O O
at O O
the O O
holidays O O
of O O
fainting O O
like O O
feeling O O
without O O
seizure O O
prodrome O O
or O O
seizure O O
activity. O O
P: O O
Check O O
levels. O O
Call O O
for O O
any O O
further O O
episodes. O O
Described O O
episode O O
was O O
not O O
clearly O O
arrhythmic O O
by O O
her O O
symptoms O O
and O O
she O O
had O O
no O O
post O O
ictal. O O
She O O
will O O
let O O
me O O
know O O
if O O
this O O
occurs O O
again O O
and O O
seek O O
attention O O
at O O
that O O
time. O O
Sleep O O
apnea O O
Sister O O
states O O
she O O
needs O O
a O O
new O O
sleep O O
device O O
and O O
we O O
will O O
take O O
care O O
of O O
a O O
referral O O
on O O
contact O O
from O O
her O O
supplier. O O
Gallstones O O
/ O O
status O O
post O O
cholecystectomy O O
at O O
time O O
of O O
hysterectomy. O O
The O O
episode O O
of O O
abdominal O O
discomfort O O
and O O
vomiting O O
was O O
not O O
clearly O O
colic O O
and O O
she O O
is O O
post O O
hysterectomy, O O
but O O
might O O
have O O
a O O
recurrent O O
stone. O O
No O O
obvious O O
icterus O O
today. O O
P: O O
LFT O O
profile. O O
Call O O
for O O
further O O
difficulties. O O
Chest O O
pain O O
CT O O
as O O
above. O O
P: O O
Check O O
EKG. O O
Active O O
Medications O O
Tegretol O O
200mg O O
po O O
7 O O
TABLETS O O
PER O O
DAY O O
potassium O O
chloride O O
20meq O O
po O O
QD O O
hydrochlorothiazide B-MEDICATION O
12.5 O O
mg O O
po O O
qd O O
tetracycline O O
500mg O O
po O O
QD O O
lisinopril B-MEDICATION B-MEDICATION
30 O O
mg O O
po O O
qd O O
Prilosec O O
20mg O O
po O O
QD O O
Celexa O O
20 O O
mg O O
2 O O
po O O
qd O O
Klonopin O O
0.5mg O O
po O O
1/2 O O
qd O O
Remeron O O
15 O O
mg O O
po O O
2tabs O O
qd O O
Seroquel O O
25 O O
mg O O
po O O
2tabs O O
bid O O
and O O
4 O O
ab O O
qhs O O
Flexeril O O
10 O O
mg O O
po O O
tid O O
PRN O O
muscle O O
spasm O O
Lipitor B-MEDICATION B-MEDICATION
10mg O O
po O O
qd O O
Change O O
in O O
therapies O O
and O O
Renewals O O
Tegretol O O
200mg O O
po O O
7 O O
TABLETS O O
PER O O
DAY O O
QTY:350 O O
Refills:nr O O
Start: O O
4/12/20 O O
potassium O O
chloride O O
20meq O O
po O O
QD O O
QTY:90 O O
Refills:3 O O
Start: O O
8/2/20 O O
hydrochlorothiazide O O
12.5 O O
mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
10/16/23 O O
tetracycline O O
500mg O O
po O O
QD O O
QTY:90 O O
Refills:3 O O
Start: O O
9/11/21 O O
lisinopril O B-MEDICATION
30 O O
mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
5/22/23 O O
Prilosec O O
20mg O O
po O O
QD O O
QTY:90 O O
Refills:3 O O
Start: O O
9/18/23 O O
Celexa O O
20 O O
mg O O
2 O O
po O O
qd O O
Start: O O
11/2/24 O O
Klonopin O O
0.5mg O O
po O O
1/2 O O
qd O O
Start: O O
10/18/2125 O O
Premarin O O
0.625mg O O
po O O
QD O O
QTY:90 O O
Refills:3 O O
Start: O O
10/18/2125 O O
End: O O
2/16/2130 O O
- O O
Inactivated O O
Seroquel O O
25 O O
mg O O
po O O
2tabs O O
bid O O
and O O
4 O O
ab O O
qhs O O
Start: O O
8/13/2127 O O
Lipitor O B-MEDICATION
10mg O O
po O O
qd O O
QTY:90 O O
Refills:3 O O
Start: O O
11/30/2129 O O
Procedures O O
Influenza O O
vaccine O O
STATUS O O
POST O O
left O O
arm, O O
lot# O O
N2453KM, O O
Aventis. O O
Family O O
history O O
Negative O O
in O O
the O O
interval. O O
Social O O
history O O
See O O
detail O O
above. O O
No B-SMOKER O
smoking. I-SMOKER O
No O O
alcohol. O O
No O O
risk O O
exposures. O O
Review O O
of O O
systems O O
Episode O O
of O O
chest O O
pain; O O
vomiting O O
episode; O O
faint O O
spell O O
as O O
described O O
above. O O
She O O
denies O O
blood O O
or O O
melena O O
now. O O
No O O
dysuria. O O
Not O O
much O O
activity. O O
All O O
other O O
issues O O
negative O O
except O O
as O O
above O O
- O O
eye O O
exam O O
overdue O O
and O O
she O O
promises O O
to O O
do O O
it. O O
She O O
does O O
not O O
have O O
any O O
self-breast O O
exams O O
in O O
these O O
two O O
years O O
from O O
last O O
mammogram. O O
Physical O O
examination O O
Pulse O O
70 O O
and O O
regular O O
Blood O O
pressure O O
130/88 O O
on O O
arrival, O O
repeat O O
120/78 O O
with O O
large O O
cuff O O
Weight O O
284 O O
pounds O O
Height O O
5 O O
feet O O
4-1/2 O O
inches O O
General O O
appearance O O
Flat O O
affect O O
but O O
spirits O O
are O O
no O O
worse O O
than O O
previously O O
and O O
she O O
does O O
not O O
appear O O
unusually O O
pale O O
Skin O O
Chronic O O
skin O O
changes O O
as O O
before O O
Heent O O
Negative O O
icterus O O
not O O
particularly O O
pale O O
and O O
conjunctiva. O O
Pharynx O O
benign. O O
No O O
obvious O O
bleeding O O
source O O
Neck O O
Negative. O O
No O O
jugular O O
venous O O
distension, O O
bruits O O
or O O
change O O
in O O
thyroid O O
Nodes O O
Negative O O
Breasts O O
Benign O O
Chest O O
Clear O O
Cor O O
Regular O O
rhythm. O O
S4, O O
no O O
murmur O O
Abdomen O O
Obese B-OBESE O
and O O
nontender O O
Rectal O O
exam O O
Declines O O
Genitalia O O
Genitalia, O O
deferred O O
Extrem O O
Trace O O
edema. O O
Reasonable O O
pulses O O
Musc O O
skel O O
Negative O O
Neuro O O
Normal O O
sensation O O
in O O
feet, O O
touch O O
and O O
vibration O O
Disposition O O
Flu O O
shot O O
given. O O
EKG O O
to O O
be O O
checked. O O
Urine O O
microalbumin O O
to O O
be O O
done. O O
Sister O O
will O O
schedule O O
eye O O
exam O O
and O O
confirm O O
a O O
mammogram. O O
Fasting O O
labs O O
on O O
03/09/2130 O O
when O O
she O O
sees O O
Dr. O O
Thurston O O
with O O
hemoglobin O O
A1c. O O
Prompt O O
call O O
for O O
any O O
further O O
vomiting O O
of O O
blood O O
with O O
EGD O O
as O O
next O O
step. O O
Return O O
visit O O
here O O
in O O
six O O
months O O
for O O
an O O
interval O O
visit O O
unless O O
new O O
issues O O
develop O O
in O O
the O O
meantime. O O
CC: O O
Queen O O
Thurston, O O
MD O O
Note O O
transcribed O O
by O O
outside O O
service O O
Transcription O O
errors O O
may O O
be O O
present. O O
Signed O O
electronically O O
by O O
Xenakis, O O
Robert O O
on O O
Mar O O
3, O O
2130 O O

Record O O
date: O O
2133-01-22 O O
Wise, O O
Willa O O
Internal O O
Medicine O O
Associates, O O
Suite O O
7 O O
Bayne-Jones O O
Army O O
Community O O
Hospital, O O
0th O O
Floor O O
, O O
Noom O O
038 O O
Hayti, O O
DE, O O
36349-2179 O O
RE: O O
NORMA O O
MCKEE O O
01/22/2133 O O
Admission O O
Note O O
IMA O O
COnsult O O
note O O
Covering O O
for O O
Dr O O
Robert O O
Xenakis O O
CC O O
57yo O O
with O O
multiple O O
medical, O O
psychiatric O O
problems O O
admitted O O
with O O
recurrent O O
SBO O O
and O O
acute O O
renal O O
failure O O
HPI O O
Pt O O
has O O
Hx O O
TAB/BSO, O O
appendectomy O O
and O O
cholecystectomy O O
7/2125. O O
She O O
was O O
admitted O O
8/2130 O O
with O O
SBO, O O
treated O O
conservatively O O
with O O
NG O O
suction. O O
She O O
has O O
chronic O O
constipation. O O
5 O O
days O O
ago O O
she O O
awoke O O
with O O
nausea, O O
developed O O
vomiting, O O
and O O
has O O
been O O
unable O O
to O O
keep O O
liquids O O
down. O O
She O O
has O O
severe O O
depression, O O
agorophobia, O O
and O O
did O O
not O O
want O O
to O O
come O O
in O O
to O O
the O O
hospital O O
She O O
states O O
she O O
had O O
small O O
bowel O O
movement O O
2-3 O O
days O O
ago. O O
She O O
has O O
had O O
difficulty O O
passing O O
urine, O O
with O O
a O O
very O O
small O O
amount O O
urine O O
output O O
yesterdat. O O
She O O
had O O
a O O
few O O
episodes O O
of O O
near O O
syncope O O
when O O
changing O O
from O O
sitting O O
to O O
standing, O O
but O O
no O O
syncope/ O O
LOC/ O O
falls. O O
PMHx- O O
surgery O O
as O O
above O O
Problems: O O
Chest O O
pain O O
Depression O O
followed O O
by O O
Dr O O
Kopp O O
psychiatry O O
Glucose O O
intolerance O O
Headache O O
Hematochezia O O
Hiatal O O
hernia O O
Hyperlipidemia B-HYPERLIPIDEMIA B-MEDICATION
Hypertension B-HYPERTENSION B-HYPERTENSION
Seizure O O
disorder O O
Small O O
bowel O O
obstruction O O
Hx O O
Umbilical O O
hernia O O
Easy O O
bruisability O O
Sciatica O O
Sleep O O
apnea O O
Family O O
history O O
risk O O
factors O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
Iron O O
deficiency O O
anemia O O
Obesity B-OBESE O
Acne O O
Medications: O O
vitamin O O
d O O
400 O O
units O O
po O O
daily O O
tetracycline O O
500mg O O
po O O
daily O O
Nizoral O B-MEDICATION
cream O O
2% O O
top O O
daily-bid O O
rub O O
gently O O
into O O
affected O O
area O O
once O O
to O O
twice O O
daily O O
lisinopril B-MEDICATION B-MEDICATION
30 O O
mg O O
po O O
daily O O
Prilosec O O
20mg O O
po O O
daily O O
potassium O O
chloride O O
20meq O O
po O O
daily O O
hydrochlorothiazide B-MEDICATION O
12.5 O O
mg O O
po O O
daily O O
free O O
text O O
medications O O
HEAD O O
GEAR O O
model O O
rsp1007930 O O
MiraLax O O
1 O O
pkt O O
daily O O
or O O
prn O O
simvastatin B-MEDICATION B-MEDICATION
20mg O O
po O O
qpm O O
Klonopin O O
0.5mg O O
po O O
bid O O
Celexa O O
40mg O O
po O O
daily O O
mirtazapine O B-MEDICATION
30mg O O
po O O
at O O
bedtime O O
Seroquel O O
po O O
1600 O O
mg O O
daily O O
Tegretol O O
200mg O O
po O O
7 O O
TABLETS O O
PER O O
DAY O O
CPAP O O
mask O O
Respironics O O
Comfort O O
Select O O
- O O
medium O O
Family O O
history: O O
Father O O
with O O
CAD, O O
diabetes, O O
and O O
hypertension. O O
Sister O O
with O O
hypertension, O O
diabetes, O O
and O O
hyperlipidemia. O O
Brother O O
with O O
hypertension O O
and O O
obesity. O O
Social O O
history: O O
No B-SMOKER O
tobacco. I-SMOKER O
No O O
alcohol. O O
See O O
depression O O
issues O O
above. O O
Largely O O
homebound. O O
Physical O O
Exam: O O
Blood O O
pressure: O O
100/60 O O
Pulse: O O
110 O O
Respiratory O O
rate: O O
14 O O
Temperature: O O
97.7 O O
O2 O O
sat O O
95% O O
2 O O
liters O O
General O O
appearance:Ill O O
appearing O O
Skin: O O
facial O O
acne O O
HEENT: O O
NG O O
tube O O
in O O
place. O O
mucous O O
membranes O O
dry O O
Neck: O O
no O O
adenopathy O O
Chest: O O
Clear O O
Cor: O O
S4, O O
no O O
murmur O O
Abdomen: O O
Obese.Distended B-OBESE O
Extrem: O O
There O O
is O O
1+ O O
edema. O O
Selected O O
Recent O O
Labs: O O
01/22/33 O O
Plasma O O
Sodium O O
135, O O
01/22/33 O O
Plasma O O
Potassium O O
3.7, O O
01/22/33 O O
Plasma O O
Chloride O O
78 O O
L, O O
01/22/33 O O
Plasma O O
Carbon O O
Dioxide O O
44.0 O O
H, O O
01/22/33 O O
Transaminase-SGPT O O
30, O O
01/22/33 O O
Transaminase-SGOT O O
30, O O
01/22/33 O O
Alkaline O O
Phosphatase O O
104 O O
H, O O
01/22/33 O O
Total O O
Bilirubin O O
0.7, O O
01/22/33 O O
Direct O O
Bilirubin O O
0.3, O O
12/14/14 O O
5'-Nucleotidase O O
8, O O
01/22/33 O O
Total O O
Protein O O
7.5, O O
01/22/33 O O
Albumin O O
3.8, O O
01/22/33 O O
Globulin O O
3.7, O O
03/07/31 O O
Creatine O O
Kinase O O
104, O O
01/21/33 O O
Creatine O O
Kinase O O
Isoenzymes O O
NEGATIVE, O O
01/21/33 O O
Troponin-I O O
NEGATIVE, O O
01/22/33 O O
Plasma O O
Urea O O
Nitrogen O O
67 O O
H, O O
01/22/33 O O
Calcium O O
9.7, O O
01/22/33 O O
Plasma O O
Creatinine O O
5.8 O O
H, O O
01/22/33 O O
Plasma O O
Glucose O O
200 O O
H, O O
01/22/33 O O
Lipase O O
11 O O
L, O O
01/22/33 O O
Phosphorus O O
6.7 O O
H, O O
01/22/33 O O
WBC O O
5.5, O O
01/22/33 O O
HCT O O
36.4, O O
01/22/33 O O
PLT O O
342, O O
01/21/33 O O
UA-Turbidity O O
Clear, O O
01/21/33 O O
UA-Glucose O O
NEGATIVE, O O
01/21/33 O O
Bili O O
2+, O O
01/21/33 O O
UA-Ketones O O
Trace, O O
01/21/33 O O
UA-Specific O O
Gravity O O
&gt;1.030, O O
01/21/33 O O
UA-Occult O O
Blood O O
NEGATIVE, O O
01/21/33 O O
UA-pH O O
5.0, O O
01/21/33 O O
UA-Albumin O O
2+, O O
01/21/33 O O
Urobilinogen O O
NEGATIVE, O O
01/21/33 O O
UA-Nitrite O O
NEGATIVE, O O
01/21/33 O O
UA-WBC O O
Screen O O
NEGATIVE, O O
01/21/33 O O
Hyaline O O
Cast O O
None, O O
01/21/33 O O
Granular O O
Cast O O
0-2, O O
01/21/33 O O
UA-SED-RBC O O
3-5, O O
01/21/33 O O
UA-SED-WBC O O
0-2, O O
01/21/33 O O
UA-SED-Bacteria O O
Many, O O
01/21/33 O O
Squamous O O
Cells O O
Moderate, O O
01/21/33 O O
Tubular O O
Cells O O
Few O O
Abdominal O O
CT O O
Renal O O
no O O
hydronephrosis/renal O O
masses. O O
Dilated O O
loops O O
of O O
bowel/ O O
no O O
masses/ O O
consistent O O
with O O
SBO O O
Assessment O O
and O O
plan: O O
Patient O O
with O O
recurrent O O
SBO. O O
Unfortunately O O
she O O
has O O
had O O
vomiting O O
X O O
4-5 O O
days, O O
and O O
now O O
has O O
acute O O
renal O O
failure, O O
most O O
likely O O
due O O
to O O
hypotension, O O
dehydration O O
and O O
ATN O O
Her O O
psychiatric O O
problem O O
is O O
significant. O O
Hold B-MEDICATION O
HCTZ/ I-MEDICATION O
ACE I-MEDICATION O
IV O O
hydration. O O
Renal O O
consult. O O
NG O O
suction O O
for O O
SBO. O O
Dr O O
Xenakis O O
back O O
tomorrow. O O
Willa O O
Wise, O O
MD O O
pager O O
#58824 O O
Signed O O
electronically O O
by O O
Willa O O
Wise, O O
MD O O
Document O O
Status: O O
Final O O

Record B-SMOKER O
date: O O
2134-01-05 O O
698-77-76 O O
Mckee, O O
Norma O O
January O O
5, O O
2134 O O
Endocrine/Diabetes B-DIABETES O
Present O O
Illness: O O
Ms. O O
Mckee O O
thinks O O
that O O
she O O
will O O
be O O
discharged O O
today. O O
If O O
so, O O
we O O
must O O
be O O
confident O O
that O O
she O O
is O O
able O O
to O O
draw O O
up O O
and O O
inject O O
insulin B-MEDICATION O
reliably. O O
She O O
will O O
also O O
needs O O
prescriptions O O
for O O
metformin, B-MEDICATION B-MEDICATION
insulin O O
syringes O O
(give O O
her O O
1 O O
cc O O
syringes), O O
NPH B-MEDICATION O
and O O
Regular B-MEDICATION O
insulins. I-MEDICATION O
She O O
apparently O O
has O O
glucose O O
testing O O
material O O
at O O
home. O O
Will O O
start O O
with O O
the O O
following O O
regimen, O O
in O O
addition O O
to O O
metformin O B-MEDICATION
500 O O
mg O O
bid. O O
She O O
will O O
follow O O
up O O
with O O
her O O
PCP, O O
Dr. O O
Robert O O
Xenakis. O O
Before O O
Breakfast: O O
NPH O O
30 O O
Units O O
Regular O O
8 O O
Units O O
Blood O O
Sugar O O
under O O
101 O O
10 O O
Units O O
101-150 O O
12 O O
Units O O
151-200 O O
14 O O
Units O O
201-250 O O
16 O O
Units O O
251-300 O O
18 O O
Units O O
301-350 O O
20 O O
Units O O
351-400 O O
22 O O
Units O O
Over O O
400 O O
Before O O
Supper: O O
Regular O O
8 O O
Units O O
Blood O O
Sugar O O
under O O
101 O O
10 O O
Units O O
101-150 O O
12 O O
Units O O
151-200 O O
14 O O
Units O O
201-250 O O
16 O O
Units O O
251-300 O O
18 O O
Units O O
301-350 O O
20 O O
Units O O
351-400 O O
&#183; O O
This O O
is O O
only O O
an O O
initial O O
set O O
of O O
guidelines. O O
The O O
doses O O
will O O
have O O
to O O
be O O
adjusted O O
based O O
on O O
experience, O O
diet, O O
exercise, O O
and O O
illness. O O
&#183; O O
Goal O O
is O O
to O O
have O O
blood O O
sugars O O
before O O
meals O O
in O O
the O O
90-130 O O
range O O
and O O
blood O O
sugars O O
at O O
bedtime O O
in O O
the O O
110-140 O O
range. O O
&#183; O O
Check O O
blood O O
sugars O O
initially O O
before O O
meals O O
and O O
at O O
bedtime O O
each O O
day. O O
Record O O
the O O
times, O O
blood O O
sugars, O O
insulin O O
doses O O
and O O
all O O
food O O
on O O
the O O
sheets O O
provided O O
and O O
bring O O
these O O
sheets O O
to O O
your O O
medical O O
appointments. O O
&#183; O O
Call O O
Dr. O O
Xenakis&#8217;s O O
office O O
for O O
any O O
blood O O
sugars O O
under O O
70, O O
or O O
any O O
symptoms O O
of O O
hypoglycemia O O
(low O O
blood O O
sugars). O O
&#183; O O
Also O O
call O O
if O O
blood O O
sugars O O
are O O
often O O
over O O
180. O O
Elliot O O
N. O O
Xi, O O
M.D., O O
Ph.D. O O

Record B-SMOKER O
date: O O
2135-08-03 O O
WSA O O
TEAM O O
4 O O
Surgery O O
Admission O O
Note O O
Patient: O O
Mckee, O O
Norma O O
MRN: O O
6987776 O O
Date: O O
8/3/2135 O O
PCP: O O
Dr. O O
Robert O O
Xenakis O O
Attending: O O
Dr. O O
Kirk O O
Senior: O O
Dr. O O
Huerta O O
Intern: O O
Dr. O O
Dukes O O
CC: O O
abdominal O O
pain/n/v O O
HPI: O O
60F O O
obese B-OBESE O
s/p O O
exlap/TAH/BSO/appy/chole O O
(Meyers/Hayes O O
-7/25) O O
c/b O O
ventral O O
hernia O O
and O O
recurrent O O
SBO O O
s/p O O
exlap/ventral O O
hernia O O
repair O O
with O O
alloderm O O
(Steves O O
- O O
12/33), O O
and O O
partial O O
SBO O O
managed O O
nonoperatively O O
12/34, O O
and O O
most O O
recently O O
5/23-49. O O
Pt O O
reports O O
that O O
she O O
had O O
dinner O O
last O O
night O O
about O O
6pm O O
and O O
had O O
her O O
last O O
BM O O
at O O
10pm O O
(also O O
last O O
flatus). O O
She O O
began O O
to O O
experience O O
N/V O O
at O O
about O O
11pm O O
and O O
had O O
several O O
episodes O O
of O O
NBNB O O
emesis. O O
Pt O O
reports O O
the O O
pain O O
is O O
constant, O O
and O O
located O O
adjacent O O
to O O
her O O
midline O O
incision. O O
Pt O O
felt O O
that O O
her O O
ventral O O
hernia O O
was O O
protruding O O
more. O O
She O O
denies O O
any O O
diarrhea, O O
blood O O
in O O
her O O
stools, O O
no O O
dysuria. O O
She O O
has O O
not O O
experienced O O
any O O
fevers. O O
chills, O O
CP, O O
SOB. O O
PMH: O O
Epilepsy O O
Schizophrenia O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Hypertensive B-HYPERTENSION B-HYPERTENSION
disorder I-HYPERTENSION O
Obesity B-OBESE O
Sleep O O
apnea O O
Hyperlipidemia B-HYPERLIPIDEMIA O
recurrent O O
UTI O O
s/p O O
exlap/TAH/BSO/appy/chole O O
(Meyers/Hayes) O O
(7/01) O O
c/b O O
ventral O O
hernia O O
and O O
recurrent O O
SBO O O
s/p O O
exlap/ventral O O
hernia O O
repair O O
with O O
alloderm O O
(Steves) O O
(12/33), O O
most O O
recently O O
w/pSBO O O
managed O O
nonoperatively O O
12/34 O O
duodenal O O
ulcer O O
s/p O O
EGD/clipping O O
(11/34 O O
) O O
Medications: O O
citalopram O O
90mg O O
tegretol O O
800mg O O
qam O O
600mg O O
qpm O O
colace O O
100mg O O
tid O O
hctz B-MEDICATION B-MEDICATION
25mg I-MEDICATION O
lisinopril B-MEDICATION B-MEDICATION
45mg I-MEDICATION O
mvi O O
perphenazine O O
16mg O O
bid O O
remeron O O
30 O O
bid O O
simvastatin B-MEDICATION B-MEDICATION
20mg I-MEDICATION O
qpm I-MEDICATION O
clonazepam O O
1mg O O
qam, O O
0.5mg O O
qafternoon O O
and O O
qhs O O
seroquel O O
400mg O O
qam O O
and O O
qafternoon, O O
800mg O O
qhs O O
metoprolol B-MEDICATION B-MEDICATION
25mg I-MEDICATION O
bid I-MEDICATION O
omeprazole O O
20mg O O
bid O O
vitamin O O
D O O
400mg O O
asa B-MEDICATION B-MEDICATION
81mg I-MEDICATION O
caltrate O O
600mg O O
bid O O
metformin B-MEDICATION B-MEDICATION
500mg I-MEDICATION O
bid I-MEDICATION O
potassium O O
20meq O O
insulin B-MEDICATION B-MEDICATION
NPH I-MEDICATION B-MEDICATION
18units I-MEDICATION O
qam I-MEDICATION O
insulin B-MEDICATION O
regular I-MEDICATION O
SS I-MEDICATION O
qam/qsupper I-MEDICATION O
Allergies: O O
ARIPIPRAZOLE O O
- O O
Caused O O
anger, O O
agitation,tearfulness O O
Exam: O O
VS: O O
99.4 O O
116 O O
171/79 B-HYPERTENSION O
18 O O
95% O O
RA O O
Gen: O O
NAD O O
CV: O O
RRR O O
Pulm: O O
CTAB O O
Abd: O O
soft, O O
obese O O
with O O
additionally O O
protruding O O
ventral O O
hernia; O O
well-healed O O
lower O O
midline O O
incision, O O
moderately O O
distended, O O
minimally O O
tender O O
over O O
inferior O O
incision O O
&amp; O O
to O O
the O O
right O O
of O O
it, O O
no O O
skin O O
changes; O O
hypoactive O O
BS; O O
hernia O O
is O O
reducible O O
on O O
exam O O
with O O
palpable O O
large O O
&gt;5cm O O
fascial O O
defect O O
Rectal: O O
no O O
stool O O
palpated O O
in O O
vault, O O
guaiac O O
negative, O O
no O O
masses/tenderness O O
Labs: O O
WBC O O
19.7 O O
H O O
(4.5-11.0) O O
th/cmmHCT O O
43.7 O O
(36.0-46.0) O O
%HGB O O
14.9 O O
(12.0-16.0) O O
gm/dlRBC O O
5.14 O O
(4.00-5.20) O O
mil/cmmPLT O O
464 O O
H O O
(150-400) O O
th/cummMCV O O
85 O O
(80-100) O O
flMCH O O
29.1 O O
(26.0-34.0) O O
pg/rbcMCHC O O
34.2 O O
(31.0-37.0) O O
g/dlRDW O O
14.5 O O
(11.5-14.5) O O
%Diff O O
Method O O
ManualPoly O O
63 O O
(40-70) O O
%Bands O O
28 O O
H O O
(0-10) O O
%Lymphs O O
2 O O
L O O
(22-44) O O
%Atyps O O
1 O O
H O O
(0) O O
%Monos O O
4 O O
(4-11) O O
%EOS O O
0 O O
(0-8) O O
%Basos O O
0 O O
(0-3) O O
%Metas O O
2 O O
H O O
(0) O O
%Absolute O O
Neuts O O
12.41 O O
H O O
(1.8-7.7) O O
th/cmmAbsolute O O
Bands O O
5.52 O O
th/cmmAbsolute O O
Lymphs O O
0.39 O O
L O O
(1.0-4.8) O O
th/cmmAbsolute O O
Monos O O
0.79 O O
(0.2-1.2) O O
th/mm3Absolute O O
EOS O O
0.00 O O
L O O
(0.1-0.3) O O
th/cmmAbsolute O O
Basos O O
0.00 O O
(0.0-0.3) O O
th/cmmToxic O O
Granulation O O
PRESENTAniso O O
None O O
(None)Hypo O O
None O O
(None)Macrocytes O O
None O O
(None)Microcytes O O
None O O
(None)PLT O O
Comments O O
Large O O
Forms O O
Plasma O O
Sodium O O
131 O O
L O O
(135-145) O O
mmol/LPlasma O O
Potassium O O
4.2 O O
(3.4-4.8) O O
mmol/LPlasma O O
Chloride O O
88 O O
L O O
(100-108) O O
mmol/LPlasma O O
Carbon O O
Dioxide O O
24.2 O O
(23.0-31.9) O O
mmol/LPlasma O O
Anion O O
GAP O O
19 O O
H O O
(3-15) O O
mmol/LCalcium O O
10.8 O O
H O O
(8.5-10.5) O O
mg/dlPhosphorus O O
3.7 O O
(2.6-4.5) O O
mg/dlMagnesium O O
1.7 O O
(1.4-2.0) O O
meq/LPlasma O O
Urea O O
Nitrogen O O
14 O O
(8-25) O O
mg/dlPlasma O O
Creatinine O O
1.23 O O
(0.60-1.50) O O
mg/dlPlasma O O
Glucose O O
245 O O
H O O
(70-110) O O
mg/dlTotal O O
Protein O O
8.6 O O
H O O
(6.0-8.3) O O
g/dlAlbumin O O
5.2 O O
H O O
(3.3-5.0) O O
g/dlGlobulin O O
3.4 O O
(2.3-4.1) O O
g/dlDirect O O
Bilirubin O O
0.3 O O
(0-0.4) O O
mg/dlTotal O O
Bilirubin O O
0.6 O O
(0.0-1.0) O O
mg/dlAlkaline O O
Phosphatase O O
248 O O
H O O
(30-100) O O
U/LTransaminase-SGPT O O
165 O O
H O O
(7-30) O O
U/LAmylase O O
149 O O
H O O
(3-100) O O
units/LTransaminase-SGOT O O
239 O O
H O O
(9-32) O O
U/LLipase O O
22 O O
(13-60) O O
U/L O O
Studies: O O
Abd/Pelv O O
CT: O O
Mechanical O O
small O O
bowel O O
obstruction O O
with O O
transition O O
point O O
within O O
a O O
large O O
ventral O O
hernia O O
containing O O
mostly O O
ileum. O O
There O O
is O O
a O O
significant O O
amount O O
of O O
retained O O
stool O O
within O O
the O O
colon O O
which O O
may O O
indicate O O
partial O O
or O O
early O O
obstruction. O O
Impression/Plan: O O
59F O O
p/w O O
low-grade O O
SBO O O
due O O
to O O
adhesions O O
v O O
intermittently O O
incarcerated O O
ventral O O
incisional O O
hernia. O O
Pt O O
is O O
minimally O O
tender O O
on O O
exam, O O
elevated O O
WBC; O O
CT O O
showing O O
mechanical O O
SBO O O
with O O
transition O O
point O O
at O O
ventral O O
hernia. O O
- O O
NPO/NGT O O
- O O
IVF, O O
foley, O O
strict O O
ins/outs, O O
serial O O
electrolytes. O O
- O O
Admit O O
to O O
WSA O O
Team O O
4,Attending O O
Dr. O O
Kirk. O O
- O O
RISS O O
and O O
hold O O
metformin/lisinopril O B-MEDICATION
while O O
NPO. O O
- O O
Repeat O O
CBC O O
w/diff O O
and O O
U/A O O
- O O
Cont O O
Cipro O O
for O O
UTI O O
Case O O
was O O
seen O O
and O O
discussed O O
with O O
Dr. O O
Patrizia O O
Scott, O O
senior O O
surgical O O
resident. O O
Cheryl O O
H. O O
Holland, O O
MD, O O
DMD O O
pager O O
67268 O O
PGY-2 O O
General O O
Surgery O O

Record O O
date: O O
2154-11-14 O O
Department O O
of O O
Orthopedic O O
Surgery O O
42 O O
Wood O O
St O O
OLIVE, O O
XAVIER O O
Sydney, O O
WV O O
65157 O O
26690002 O O
-------------- O O
11/14/54 O O
Michael O O
Ulrey, O O
M.D. O O
45 O O
Wood O O
St O O
Sydney, O O
WV O O
65157 O O
RE: O O
Xavier O O
Olive O O
Dear O O
Michael, O O
Mr. O O
Xavier O O
Olive O O
presents O O
for O O
evaluation, O O
thanks O O
for O O
your O O
referral. O O
As O O
you O O
recall O O
he O O
is O O
a O O
71-year-old O O
gentleman O O
who O O
is O O
status O O
post O O
angioplasty O O
on O O
the O O
left O O
for O O
high-grade O O
stenotic O O
lesions O O
of O O
the O O
distal O O
superficial O O
femoral O O
artery O O
and O O
the O O
popliteal O O
artery O O
on O O
the O O
left. O O
The O O
patient O O
presents O O
now O O
for O O
further O O
evaluation O O
of O O
his O O
'claudication O O
symptoms'. O O
The O O
patient O O
states O O
he O O
has O O
bilateral O O
lower O O
extremity O O
symptoms, O O
there O O
are O O
about O O
equivalent O O
in O O
nature. O O
He O O
has O O
very O O
minimal O O
low O O
back O O
pain. O O
He O O
states O O
it O O
seems O O
to O O
be O O
getting O O
worse O O
and O O
seems O O
to O O
be O O
associated O O
with O O
some O O
abnormal O O
gait. O O
He O O
states O O
on O O
a O O
bad O O
day O O
its O O
about O O
a O O
9/10 O O
and O O
even O O
on O O
a O O
good O O
day O O
sometimes O O
it O O
can O O
be O O
as O O
high O O
as O O
8-9/10. O O
The O O
episodes O O
are O O
almost O O
daily O O
and O O
are O O
brought O O
on O O
by O O
things O O
like O O
walking. O O
He O O
can O O
walk O O
less O O
than O O
one O O
block O O
at O O
which O O
point O O
he O O
has O O
lateral O O
calf O O
burning O O
and O O
at O O
times O O
notes O O
some O O
slow O O
shuffling O O
and O O
occasionally O O
falling. O O
When O O
he O O
is O O
having O O
severe O O
symptoms O O
he O O
notes O O
his O O
legs O O
to O O
be O O
weak. O O
He O O
denies O O
any O O
bowel O O
or O O
bladder O O
abnormalities O O
of O O
late, O O
but O O
has O O
a O O
historic O O
of O O
a O O
chronic O O
UTI O O
secondary O O
to O O
his O O
benign O O
prostatic O O
hypertrophy. O O
He O O
has O O
very O O
little O O
back O O
pain O O
associated O O
with O O
his O O
symptomatology. O O
He O O
has O O
had O O
no O O
physical O O
therapy O O
to O O
date O O
and O O
no O O
spinal O O
injections. O O
He O O
describes O O
his O O
general O O
health O O
as O O
poor, O O
but O O
when O O
specially O O
asked O O
he O O
states O O
it O O
is O O
because O O
he O O
his O O
71 O O
and O O
has O O
a O O
history O O
of O O
hypertension. B-HYPERTENSION O
Years O O
ago O O
he O O
stated O O
he O O
was O O
in O O
excellent O O
health. O O
His O O
weight O O
is O O
steady O O
at O O
200 O O
with O O
no O O
significant O O
weight O O
gain O O
or O O
loss. O O
He O O
doesn't O O
smoke O O
and O O
drinks O O
socially. O O
Quit B-SMOKER O
smoking I-SMOKER O
33 I-SMOKER O
years I-SMOKER O
ago. I-SMOKER O
He O O
does O O
not O O
think O O
he O O
will O O
ever O O
be O O
pain O O
free. O O
Review O O
of O O
Systems: O O
Reveals O O
that O O
he O O
is O O
a O O
diet B-DIABETES O
controlled I-DIABETES O
diabetic B-DIABETES O
and O O
he O O
has O O
been O O
for O O
the O O
past O O
couple O O
of O O
years. O O
He O O
has O O
difficulty O O
with O O
sleep. O O
He O O
has O O
a O O
balance O O
problem O O
and O O
also O O
has O O
benign O O
prostatic O O
hypertrophy O O
leading O O
to O O
chronic O O
urinary O O
tract O O
infection, O O
for O O
this O O
he O O
takes O O
Cardura. O O
He O O
has O O
a O O
history O O
of O O
high B-HYPERTENSION O
blood I-HYPERTENSION O
pressure. I-HYPERTENSION O
Denies O O
any O O
other O O
cardiovascular O O
abnormality. O O
No O O
respiratory O O
malfunction. O O
He O O
has O O
had O O
surgery O O
for O O
something O O
'in O O
his O O
colon' O O
he O O
has O O
also O O
had O O
a O O
bypass O O
surgery. O O
He O O
is O O
on O O
Plavix B-MEDICATION B-MEDICATION
and O O
aspirin. B-MEDICATION B-MEDICATION
Physical O O
Examination: O O
Shows O O
that O O
he O O
is O O
solid O O
built, O O
healthy O O
appearing O O
male. O O
He O O
is O O
able O O
to O O
toe O O
and O O
heel O O
walk O O
but O O
on O O
the O O
left O O
side O O
his O O
T O O
band O O
seems O O
to O O
be O O
slightly O O
weak. O O
Single O O
toe O O
raises O O
show O O
that O O
the O O
right O O
leg O O
is O O
stronger O O
than O O
the O O
left O O
leg. O O
He O O
has O O
no O O
tenderness O O
to O O
his O O
PSIS O O
and O O
he O O
has O O
no O O
Waddell O O
signs. O O
He O O
has O O
negative O O
Trendelenburg O O
bilaterally. O O
Forward O O
flexion O O
allows O O
him O O
to O O
get O O
to O O
the O O
patella. O O
Extension O O
is O O
pain O O
free O O
and O O
passive O O
hyperextension O O
does O O
not O O
reproduce O O
the O O
symptoms. O O
Motor O O
testing O O
is O O
normal O O
in O O
his O O
lower O O
extremities. O O
Sensory O O
is O O
symmetric. O O
He O O
has O O
negative O O
straight O O
leg O O
raises. O O
He O O
has O O
no O O
palpable O O
pulses. O O
He O O
is O O
hairless O O
in O O
his O O
lower O O
extremities. O O
He O O
had O O
no O O
clonus O O
or O O
Babinski O O
and O O
a O O
negative O O
Hoffman's O O
suggesting O O
that O O
he O O
is O O
not O O
myelopathic O O
despite O O
his O O
'balance O O
abnormality'. O O
He O O
is O O
on O O
multiple O O
meds O O
for O O
his O O
hypertension, O O
for O O
his O O
diabetes, B-DIABETES O
and O O
for O O
his O O
gastroesophageal O O
reflux. O O
Personal O O
review O O
of O O
his O O
plain O O
films O O
and O O
a O O
CAT O O
scan O O
indicating O O
with, O O
show O O
decent O O
residual O O
lumbar O O
lordosis O O
with O O
a O O
stent O O
noted O O
in O O
his O O
iliac O O
artery O O
on O O
the O O
right. O O
CT O O
scan O O
shows O O
lumbosacral O O
facet O O
hypertrophy. O O
At O O
this O O
point, O O
impression O O
is O O
of O O
spinal O O
stenosis O O
and O O
degenerative O O
disk O O
disease. O O
I O O
have O O
asked O O
him O O
to O O
obtain O O
an O O
MRI O O
and O O
return O O
to O O
see O O
me O O
after O O
that. O O
Thanks O O
for O O
the O O
referral. O O
______________________________ O O
Stephen O O
Nichols, O O
M.D. O O
Dictated O O
By: O O
Stephen O O
Nichols O O
eScription O O
document:6-0190274 O O
EFFocus O O
DD: O O
11/14/54 O O
DT: O O
11/14/54 O O
DV: O O
11/14/54 O O

Record B-SMOKER O
date: O O
2155-07-11 O O
July O O
11, O O
2155 O O
Name: O O
Olive, O O
Xavier O O
MRN: O O
26690002 O O
Mr. O O
Olive O O
was O O
seen O O
with O O
Dr. O O
Innis O O
in O O
general O O
neurology O O
clinic O O
on O O
07/11/55. O O
Dr. O O
Innis O O
was O O
present O O
for O O
or O O
performed O O
all O O
salient O O
aspects O O
of O O
the O O
history O O
and O O
physical O O
exam O O
and O O
together O O
we O O
discussed O O
with O O
the O O
patient O O
the O O
work-up O O
and O O
treatment O O
plan. O O
Return O O
visit. O O
Mr. O O
Olive O O
is O O
a O O
71y O O
old O O
RHM, O O
with O O
Idiopathic O O
Parkinson's O O
disease. O O
He O O
was O O
started O O
on O O
Sinemet O O
25/100mg O O
tid O O
with O O
significant O O
improvement O O
in O O
his O O
balance O O
& O O
gait O O
& O O
rest O O
tremor. O O
However O O
there O O
were O O
still O O
periods O O
of O O
shuffling O O
& O O
stumbling O O
especially O O
going O O
down O O
slope. O O
He O O
also O O
complained O O
of O O
persistant O O
fatigue O O
in O O
his O O
legs. O O
We O O
started O O
him O O
on O O
Amantadine O O
100mg O O
tid O O
during O O
his O O
last O O
visit. O O
He O O
did O O
not O O
tolerate O O
it O O
well O O
& O O
complained O O
of O O
dizziness O O
especially O O
when O O
he O O
goes O O
out, O O
even O O
with O O
reduced O O
dose O O
of O O
100mg O O
bid. O O
He O O
has O O
discontinued O O
it O O
since O O
then. O O
He O O
is O O
tolerating O O
Sinemet O O
well, O O
no O O
hallucinations, O O
on-off O O
phenomenon. O O
He O O
does O O
not O O
notice O O
any O O
wearing O O
off O O
of O O
the O O
effect O O
prior O O
to O O
next O O
dose. O O
No O O
dyskinesias. O O
No O O
new O O
Neurological O O
symptoms. O O
He O O
still O O
has O O
poor O O
balance O O
but O O
his O O
posture O O
is O O
much O O
improved. O O
PMHx: O O
HTN B-HYPERTENSION O
Hyperlipidemia B-HYPERLIPIDEMIA O
DM B-DIABETES O
type-2 I-DIABETES O
PVD O O
BPH O O
H/O O O
colon O O
cancer, O O
s/p O O
partial O O
colectomy O O
H/O O O
throat O O
surgery O O
in O O
past, O O
does O O
not O O
know O O
the O O
details O O
Medications O O
at O O
Home: O O
Sinemet O O
25/100mg O O
bid. O O
Simvastatin B-MEDICATION B-MEDICATION
10mg I-MEDICATION O
QHS I-MEDICATION O
Ranitidine O O
150mg O O
QHS O O
Metformin B-MEDICATION B-MEDICATION
850mg I-MEDICATION O
tid I-MEDICATION O
Lisinopril B-MEDICATION B-MEDICATION
2.5mg I-MEDICATION O
QD I-MEDICATION O
Gabapentin O B-MEDICATION
100mg O O
bid O O
Folic O O
acid O O
1mg O O
QD O O
Atenolol B-MEDICATION B-MEDICATION
25mg I-MEDICATION O
QD I-MEDICATION O
Glyburide B-MEDICATION B-MEDICATION
2.5mg I-MEDICATION O
QD I-MEDICATION O
Bupropion O O
150mg O O
QD O O
Ferrous O O
gluconate O B-MEDICATION
325mg O O
TID O O
Terazosin O O
4mg O O
QHS O O
Pyridoxine O O
50mg O O
QD O O
Plavix B-MEDICATION B-MEDICATION
75mg I-MEDICATION O
QD I-MEDICATION O
Allergies: O O
NKDA O O
Limited O O
physical O O
Exam: O O
Neuro: O O
MS: O O
Alert, O O
oriented, O O
appropriately O O
interactive. O O
Follows O O
all O O
commands. O O
Speech O O
is O O
fluent O O
without O O
paraphasic O O
errors. O O
Voice O O
is O O
hypophonic. O O
Facial O O
expression O O
is O O
flat. O O
CN O O
II-XII: O O
Visual O O
fields O O
full O O
to O O
confrontation; O O
PERRLA O O
3.5 O O
=&gt; O O
3.0; O O
no O O
ptosis; O O
no O O
nystagmus, O O
no O O
hypometric O O
saccades, O O
full O O
EOMI, O O
no O O
restriction O O
of O O
upgaze; O O
sensation O O
on O O
face O O
normal O O
bilaterally, O O
no O O
facial O O
asymmetry; O O
reduced O O
spontaneous O O
blinking O O
of O O
eyes; O O
good O O
smile; O O
good O O
cheek O O
puff; O O
tongue O O
and O O
palate O O
midline; O O
grossly O O
normal O O
hearing; O O
good O O
shoulder O O
shrug O O
and O O
head O O
turn. O O
Motor: O O
normal O O
bulk, O O
axial O O
rigidity O O
present. O O
Mild O O
cogwheel O O
rigidity, O O
R&gt;L O O
at O O
rest. O O
No O O
rest O O
tremor. O O
No O O
drift. O O
Strength O O
5/5 O O
throughout O O
including: O O
biceps, O O
triceps, O O
brachioradialis, O O
finger O O
flexor O O
and O O
extension, O O
hip, O O
knee O O
and O O
ankle O O
flex O O
and O O
extensions. O O
No O O
bradykinesia. O O
Sensation: O O
Decreased O O
to O O
touch, O O
temperature O O
and O O
pin O O
prick O O
bilaterally O O
in O O
feet. O O
Vibration O O
reduced O O
in O O
toes. O O
JP O O
sense O O
normal O O
bilaterally. O O
Cerebellar: O O
Good O O
FNF, O O
rapid O O
alternating O O
movements O O
Gait/Stance: O O
Gait O O
is O O
wide O O
based O O
with O O
mild O O
stooped O O
posture, O O
slightly O O
unsteady O O
but O O
no O O
festination O O
noted O O
today. O O
Decreased O O
arm O O
swing O O
noted O O
while O O
walking. O O
Not O O
able O O
to O O
tandem. O O
Rhomberg O O
negative. O O
Able O O
to O O
rise O O
and O O
sit O O
without O O
assistance. O O
Assessment O O
and O O
Plan: O O
71y O O
old O O
RHM, O O
with O O
early O O
idiopathic O O
Parkinson's O O
disease. O O
No O O
evidence O O
of O O
restricted O O
up O O
gaze O O
(PSP), O O
or O O
parkinson-plus O O
syndrome O O
at O O
this O O
time. O O
He O O
had O O
a O O
good O O
response O O
to O O
Sinemet O O
but O O
still O O
has O O
persistent O O
fatigue O O
& O O
periods O O
of O O
festination. O O
Recommend O O
increasing O O
Sinemet O O
to O O
37.5/150mg O O
tid O O
7am, O O
12noon, O O
& O O
5pm. O O
Wife O O
will O O
give O O
me O O
a O O
call O O
in O O
2wks O O
to O O
let O O
me O O
know O O
his O O
progress. O O
Follow O O
up O O
in O O
Neurology O O
clinic O O
in O O
3mths. O O
Patient O O
& O O
family O O
can O O
contact O O
me O O
in O O
interim O O
with O O
any O O
concerns. O O
Thank O O
you O O
very O O
much O O
for O O
allowing O O
me O O
to O O
participate O O
in O O
the O O
care O O
of O O
this O O
patient. O O
Sincerely, O O
___________________________________ O O
Isabella O O
Edmond, O O
M.D. O O
Resident O O
in O O
Neurology O O
Pager O O
#: O O
98768 O O
CC: O O
Michael O O
Ulrey O O
MD O O
24 O O
WOOD O O
ST O O
SYDNEY, O O
WV O O
65157 O O
Ximena O O
Keane O O
46 O O
Marshall O O
Street O O
Conneaut O O
Lake, O O
WV: O O
85486 O O

Record O O
date: O O
2157-05-17 O O
CARDIOLOGY O O
TRUMBULL O O
MEMORIAL O O
HOSPITAL O O
Reason O O
for O O
visit: O O
Second O O
opinion O O
regarding O O
painful O O
legs O O
with O O
walking O O
at O O
less O O
than O O
50 O O
yards O O
and O O
also O O
balance O O
disorder. O O
Interval O O
History: O O
Mr. O O
Xavier O O
Olive O O
is O O
a O O
73-year-old O O
gentleman O O
who O O
comes O O
into O O
Trumbull O O
Memorial O O
Vascular O O
Center O O
for O O
a O O
second O O
opinion O O
regarding O O
his O O
lower O O
extremity O O
discomfort O O
and O O
also O O
his O O
progressive O O
difficulty O O
walking O O
and O O
maintaining O O
balance. O O
His O O
referring O O
physician O O
is O O
Dr. O O
Ximena O O
Keane, O O
practicing O O
out O O
of O O
Alexandria O O
Clinic. O O
Mr. O O
Olive O O
also O O
heard O O
about O O
the O O
TMH O O
VC O O
through O O
TV O O
advertisements. O O
He O O
is O O
73 O O
years O O
old, O O
has O O
history O O
of O O
diabetes B-DIABETES O
starting O O
in O O
2135, O O
known O O
history O O
of O O
peripheral O O
artery O O
disease O O
with O O
claudication O O
and O O
calf O O
discomfort, O O
for O O
which O O
he O O
has O O
previously O O
seen O O
Dr. O O
Cain O O
at O O
Alexandria O O
Clinic, O O
and O O
also O O
has O O
been O O
evaluated O O
and O O
treated O O
at O O
the O O
Corcoran O O
District O O
Hospital. O O
Specifically, O O
he O O
describes O O
having O O
been O O
evaluated O O
by O O
Dr. O O
Cain O O
and O O
others O O
some O O
three O O
or O O
four O O
years O O
ago, O O
and O O
undergoing O O
at O O
least O O
two O O
procedures, O O
all O O
related O O
to O O
his O O
legs O O
cramping O O
up. O O
He O O
received O O
prior O O
stenting O O
to O O
his O O
right O O
common O O
iliac O O
artery O O
and O O
his O O
left O O
superficial O O
femoral O O
artery, O O
so O O
far O O
as O O
I O O
can O O
tell. O O
The O O
stents O O
were O O
placed O O
at O O
Pomeroy O O
Care O O
Center O O
(Big O O
Rapids, O O
AC) O O
and O O
also O O
he O O
had O O
evaluation O O
at O O
the O O
Corcoran O O
District O O
Hospital, O O
and O O
may O O
have O O
had O O
a O O
stenting O O
procedure O O
or O O
revascularization O O
procedure O O
there. O O
The O O
patient O O
and O O
his O O
wife O O
are O O
somewhat O O
unclear O O
about O O
the O O
dates O O
and O O
locations O O
and O O
times, O O
but O O
he O O
does O O
state O O
that O O
the O O
treatments O O
apparently O O
did O O
not O O
help O O
him O O
at O O
all. O O
Currently, O O
he O O
has O O
discomfort O O
in O O
both O O
calves O O
when O O
he O O
walks O O
too O O
far O O
or O O
too O O
fast, O O
and O O
this O O
stops O O
him O O
at O O
about O O
50 O O
yards. O O
The O O
issue O O
was O O
complicated O O
by O O
the O O
fact O O
that O O
he O O
has O O
had O O
progressive O O
parkinsonian-type O O
symptoms, O O
walking O O
in O O
a O O
shuffle, O O
tipping O O
forward, O O
and O O
occasionally O O
even O O
falling O O
forward O O
and O O
losing O O
his O O
balance O O
completely. O O
His O O
legs O O
are O O
rubbery, O O
and O O
he O O
does O O
even O O
realize O O
that O O
he O O
is O O
falling O O
forward O O
when O O
it O O
happens. O O
It O O
is O O
worse O O
when O O
he O O
is O O
carrying O O
things O O
that O O
weigh O O
anything. O O
At O O
the O O
same O O
time, O O
his O O
calves O O
do O O
cramp O O
up O O
in O O
a O O
typical O O
fashion O O
consistent O O
with O O
claudication, O O
and O O
he O O
has O O
known O O
peripheral O O
artery O O
disease. O O
Also O O
feels O O
though O O
his O O
hips O O
sometimes O O
are O O
cramping O O
up. O O
The O O
patient O O
feels O O
quite O O
disabled O O
by O O
his O O
symptoms, O O
especially O O
as O O
a O O
gentleman O O
who O O
was O O
active O O
and O O
never O O
had O O
physical O O
problems O O
of O O
this O O
nature. O O
Again, O O
there O O
is O O
some O O
degree O O
of O O
blurring O O
between O O
the O O
parkinsonian O O
symptoms O O
and O O
his O O
claudication, O O
as O O
to O O
which O O
is O O
truly O O
causing O O
his O O
disability. O O
Past O O
medical O O
history: O O
Diabetes, B-DIABETES O
onset O O
in O O
2135. O O
Parkinsonian-type O O
movement O O
disorder, O O
followed O O
by O O
Dr. O O
Jeffers O O
and O O
Innis, O O
and O O
for O O
which O O
he O O
was O O
placed O O
on O O
Sinemet, O O
presuming O O
it O O
was O O
due O O
to O O
Parkinson's. O O
The O O
patient O O
has O O
not O O
improved O O
despite O O
trying O O
the O O
medications. O O
MRI O O
at O O
AC O O
starting O O
in O O
2153 O O
has O O
shown O O
apparent O O
central O O
and O O
peripheral O O
atrophy, O O
unchanged. O O
Status O O
post O O
vertebrobasilar O O
TIA O O
by O O
report. O O
Neuropathy, O O
documented O O
by O O
EMG O O
in O O
2151 O O
with O O
no O O
spinal O O
stenosis O O
by O O
MRI. O O
Cervical O O
spondylosis. O O
Tracheal O O
tumor O O
resection O O
in O O
2128 O O
performed O O
via O O
a O O
suprasternal O O
incision. O O
Hypertension. B-HYPERTENSION O
Mild O O
renal O O
artery O O
stenosis O O
documented O O
by O O
arteriography O O
in O O
2153 O O
during O O
one O O
of O O
his O O
peripheral O O
angiograms. O O
Current O O
Medications: O O
lisinopril B-MEDICATION B-MEDICATION
2.5 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
glyburide B-MEDICATION B-MEDICATION
2.5 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
cilostazol O B-MEDICATION
100 O O
mg O O
BID O O
terazosin O O
4 O O
mg O O
QD O O
Sinemet O O
25/100 O O
mg O O
2 O O
tabs O O
TID O O
aspirin B-MEDICATION B-MEDICATION
325 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
pyridoxine O O
50 O O
mg O O
QD O O
atenolol B-MEDICATION B-MEDICATION
25 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
folic O O
acid O O
1 O O
mg O O
QD O O
gabapentin O B-MEDICATION
100 O O
mg O O
BID O O
metformin B-MEDICATION B-MEDICATION
hydrochloride I-MEDICATION B-MEDICATION
850 I-MEDICATION O
mg I-MEDICATION O
TID I-MEDICATION O
ranitidine O O
HCl O O
150 O O
mg O O
QHS O O
Zocor B-MEDICATION B-MEDICATION
10 I-MEDICATION O
mg I-MEDICATION O
QHS I-MEDICATION O
Plavix; B-MEDICATION B-MEDICATION
Dir: I-MEDICATION O
Stopped I-MEDICATION O
because I-MEDICATION O
of I-MEDICATION O
ecchymosis I-MEDICATION O
and I-MEDICATION O
epistaxis I-MEDICATION O
-stop I-MEDICATION O
Allergies: O O
No O O
known O O
allergies O O
Family O O
history: O O
Noncontributory. O O
No O O
coronary O O
artery O O
disease O O
or O O
MI. O O
Social O O
history: O O
He O O
is O O
retried O O
Motor O O
Vehicle O O
Body O O
Repairer. O O
He O O
used O O
to O O
work O O
at O O
GM. O O
He O O
lives O O
with O O
his O O
wife, O O
who O O
comes O O
in O O
today O O
with O O
him. O O
He O O
has O O
three O O
children. O O
Nondrinker. O O
He B-SMOKER O
smoked B-SMOKER O
until I-SMOKER O
30 I-SMOKER O
years I-SMOKER O
ago. I-SMOKER O
Review O O
of O O
systems: O O
Detailed O O
review O O
of O O
systems O O
was O O
carried O O
out. O O
It O O
was O O
also O O
reviewed O O
on O O
the O O
patient O O
questionnaire O O
sheet O O
that O O
the O O
patient O O
brought O O
with O O
him. O O
He O O
does O O
claim O O
to O O
have O O
some O O
dyspnea O O
with O O
exertion O O
as O O
well O O
as O O
intermittent O O
indigestion O O
consistent O O
with O O
GERD. O O
He O O
has O O
nocturia. O O
He O O
wears O O
dentures. O O
No O O
significant O O
weight O O
loss O O
or O O
anorexia. O O
No O O
visual O O
changes O O
or O O
other O O
neurologic O O
symptoms O O
other O O
than O O
the O O
gait O O
disturbance O O
and O O
neuropathy. O O
He O O
denies O O
chest O O
discomfort O O
or O O
anything O O
to O O
suggest O O
cardiac O O
ischemia. O O
Otherwise, O O
review O O
of O O
systems O O
is O O
negative O O
in O O
detail. O O
Physical O O
examination: O O
-Pulse: O O
68 O O
and O O
regular. O O
Afebrile O O
-BP: O O
105/55 O O
, O O
obtained O O
by O O
myself. O O
Equal O O
bilaterally O O
-General: O O
Well-developed O O
male O O
in O O
no O O
distress, O O
appears O O
his O O
stated O O
age. O O
Slightly O O
stooped O O
over, O O
and O O
has O O
a O O
parkinsonian-type O O
affect O O
and O O
appearance O O
-Skin: O O
Without O O
rashes O O
-Heent: O O
Normal O O
facies, O O
or O O
slightly O O
masked, O O
with O O
normal O O
extraocular O O
motions O O
and O O
reactive O O
pupils O O
-Neck: O O
Carotid O O
upstrokes O O
are O O
normal, O O
no O O
bruits. O O
No O O
JVD O O
-Chest: O O
Clear O O
-Cardiac: O O
Discloses O O
normal O O
S1 O O
and O O
S2, O O
no O O
S3 O O
or O O
S4, O O
and O O
no O O
murmurs O O
-Abdomen: O O
Moderately O O
obese, O O
protuberant, O O
soft, O O
and O O
nontender. O O
Good O O
bowel O O
sounds, O O
no O O
organomegaly, O O
no O O
enlargement O O
of O O
the O O
aorta. O O
May O O
be O O
a O O
soft O O
bruit O O
in O O
the O O
midline O O
to O O
deep O O
auscultation O O
-Extremities: O O
Femoral O O
pulses O O
are O O
2+ O O
bilaterally, O O
with O O
soft O O
bruits O O
on O O
both O O
sides. O O
Below O O
this, O O
no O O
cyanosis O O
or O O
edema O O
(perhaps O O
trace O O
to O O
1+ O O
edema), O O
and O O
posterior O O
tibial O O
pulses O O
are O O
1 O O
to O O
2+. O O
Dorsalis O O
pedis O O
pulses O O
are O O
not O O
easily O O
palpable. O O
Good O O
capillary O O
refill O O
-Neuro: O O
Gait O O
is O O
disturbed, O O
with O O
slight O O
shuffling O O
and O O
slightly O O
stooped. O O
His O O
strength O O
is O O
normal, O O
and O O
sensory O O
findings O O
are O O
slightly O O
abnormal O O
with O O
diminished O O
sensation O O
in O O
a O O
stocking-glove O O
distribution. O O
He O O
does O O
not O O
have O O
any O O
cogwheeling O O
to O O
my O O
examination. O O
Otherwise, O O
no O O
focal O O
deficits O O
Procedures: O O
Free O O
text O O
procedures O O
Exercise O O
ABIs-resting O O
ABI O O
is O O
normal O O
on O O
the O O
right O O
and O O
left O O
at O O
0. O O
92 O O
and O O
1.03, O O
respectively. O O
The O O
toe O O
brachial O O
index O O
drops O O
to O O
0.29 O O
on O O
the O O
right O O
side O O
and O O
0.91 O O
at O O
1 O O
minute O O
after O O
exercise. O O
I O O
am O O
not O O
sure O O
what O O
to O O
make O O
of O O
these O O
ABIs O O
since O O
it O O
appears O O
that O O
the O O
actual O O
ankle-brachial O O
indices O O
were O O
not O O
measured O O
following O O
exercise. O O
EKG: O O
demonstrates O O
normal O O
sinus O O
rhythm O O
or O O
sinus O O
bradycardia O O
at O O
heart O O
rate O O
of O O
55. O O
There O O
is O O
normal O O
axis O O
and O O
intervals, O O
with O O
no O O
evidence O O
of O O
prior O O
infraction, O O
and O O
perhaps O O
a O O
slight O O
right O O
ventricular O O
conduction O O
delay. O O
Other O O
Data: O O
DOB: O O
11/25/2083. O O
Assessment O O
and O O
plan: O O
Lower O O
extremity O O
arterial O O
disease O O
(PAD)-the O O
patient O O
clearly O O
has O O
history O O
of O O
PAD O O
with O O
prior O O
interventions O O
on O O
both O O
sides. O O
Currently, O O
complains O O
of O O
symptoms O O
that O O
sound O O
like O O
claudication, O O
predominantly O O
involving O O
the O O
calves O O
on O O
both O O
sides, O O
right O O
slightly O O
ahead O O
of O O
the O O
left, O O
and O O
I O O
would O O
not O O
be O O
surprised O O
if O O
he O O
has O O
significant O O
focal O O
obstructive O O
disease O O
along O O
the O O
length O O
of O O
his O O
iliac O O
of O O
SFA. O O
Since O O
his O O
ABIs O O
are O O
well O O
preserved O O
at O O
rest, O O
I O O
suspect O O
he O O
does O O
not O O
have O O
pre-occlusion O O
of O O
the O O
SFA, O O
for O O
example. O O
On O O
the O O
other O O
hand, O O
he O O
does O O
have O O
diabetes O O
and O O
his O O
ABIs O O
may O O
be O O
falsely O O
elevated. O O
His O O
major O O
limitation O O
is O O
due O O
to O O
a O O
combination O O
of O O
the O O
claudication O O
that O O
occurs O O
less O O
than O O
50 O O
yards O O
and O O
stops O O
him O O
at O O
that O O
point, O O
and O O
the O O
gait O O
disturbance O O
that O O
he O O
has O O
related O O
to O O
his O O
movement O O
disorder, O O
possible O O
Parkinson's O O
disease. O O
I O O
am O O
not O O
sure O O
that O O
this O O
latter O O
entity O O
has O O
been O O
well O O
enough O O
defined, O O
and O O
I O O
would O O
suggest O O
that O O
we O O
have O O
him O O
see O O
a O O
neurologist O O
here O O
to O O
better O O
ascertain O O
the O O
nature O O
of O O
that O O
disease, O O
and O O
as O O
to O O
whether O O
there O O
is O O
anything O O
better O O
available O O
in O O
the O O
way O O
of O O
treatment. O O
1. O O
As O O
far O O
his O O
peripheral O O
artery O O
disease, O O
it O O
would O O
be O O
extremely O O
helpful O O
to O O
obtain O O
films O O
from O O
AC O O
and/or O O
the O O
CDH, O O
to O O
better O O
define O O
what O O
procedures O O
were O O
actually O O
performed O O
and O O
where O O
stents O O
were O O
placed. O O
Given O O
that O O
it O O
has O O
been O O
a O O
year O O
or O O
more O O
since O O
his O O
last O O
intervention, O O
it O O
is O O
likely O O
he O O
will O O
need O O
another O O
angiographic O O
study O O
(or O O
MRA/CTA) O O
in O O
order O O
to O O
ascertain O O
the O O
nature O O
of O O
his O O
disease. O O
2. O O
Neurologic O O
disorder-we O O
will O O
refer O O
to O O
a O O
neurologist. O O
PLAN: O O
1. O O
Formal O O
exercise O O
ABIs. O O
2. O O
Obtain O O
angiographic O O
studies O O
from O O
AC. O O
3. O O
Followup O O
visit O O
in O O
one O O
month. O O
4. O O
Appointment O O
with O O
Dr. O O
Ruiz. O O
Changes O O
to O O
Medications O O
this O O
visit O O
lisinopril B-MEDICATION B-MEDICATION
2.5 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
glyburide B-MEDICATION B-MEDICATION
2.5 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
cilostazol O O
100 O O
mg O O
BID O O
terazosin O O
4 O O
mg O O
QD O O
Sinemet O O
25/100 O O
mg O O
2 O O
tabs O O
TID O O
aspirin B-MEDICATION B-MEDICATION
325 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
pyridoxine O O
50 O O
mg O O
QD O O
atenolol B-MEDICATION B-MEDICATION
25 I-MEDICATION O
mg I-MEDICATION O
QD I-MEDICATION O
folic O O
acid O O
1 O O
mg O O
QD O O
gabapentin O O
100 O O
mg O O
BID O O
metformin B-MEDICATION B-MEDICATION
hydrochloride I-MEDICATION O
850 I-MEDICATION O
mg I-MEDICATION O
TID I-MEDICATION O
ranitidine O O
HCl O O
150 O O
mg O O
QHS O O
Zocor B-MEDICATION B-MEDICATION
10 I-MEDICATION O
mg I-MEDICATION O
QHS I-MEDICATION O
Plavix O B-MEDICATION
Stopped O O
because O O
of O O
ecchymosis O O
and O O
epistaxis O O
- O O
InactivatedCC: O O
Outpatient O O
V O O
Chart; O O
Brittany O O
Naylor; O O
Ximena O O
Keane O O
M.D. O O
Signed O O
electronically O O
by O O
Jared O O
Xayasane O O
MD O O
on O O
Sep O O
17, O O
2157 O O

Record O O
date: O O
2158-06-08 O O
------------- O O
Parkinson's O O
Clinic O O
Trumbull O O
Memorial O O
Hospital O O
- O O
Corcoran O O
District O O
Hospital O O
(315) O O
433-0039 O O
Office O O
Visit O O
Chief O O
Complaint: O O
Increased O O
falling O O
History O O
of O O
Present O O
Illness: O O
C/O O O
increased O O
falling. O O
His O O
legs O O
buckling O O
underneath O O
him. O O
He O O
has O O
occasional O O
dizzyness. O O
Denies O O
angino, O O
or O O
sob. O O
He O O
does O O
not O O
use O O
a O O
walker. O O
He O O
arrived O O
today O O
in O O
a O O
wheel O O
chair. O O
They O O
both O O
state O O
he O O
leans O O
forward O O
and O O
the O O
he O O
falls. O O
Medications: O O
atenolol B-MEDICATION B-MEDICATION
25 I-MEDICATION O
mg: I-MEDICATION O
1 O O
tab O O
po O O
qd; O O
pyridoxine O O
100 O O
mg: O O
1 O O
tab O O
po O O
qd; O O
Sinemet O O
25/100: O O
2 O O
tab O O
po O O
qid, O O
7:30A, O O
12, O O
5, O O
9P; O O
Sinemet O O
25/100: O O
1.5 O O
tab O O
po O O
qid; O O
glyburide B-MEDICATION B-MEDICATION
2.5 I-MEDICATION O
mg: I-MEDICATION O
1 O O
tab O O
po O O
qd; O O
Zocor B-MEDICATION O
10 I-MEDICATION O
mg: I-MEDICATION O
0.5 O O
tab O O
po O O
qhs; O O
gabapentin O O
100 O O
mg: O O
1 O O
tab O O
po O O
bid; O O
folic O O
acid O O
1 O O
mg: O O
1 O O
tab O O
po O O
qd; O O
Pletal O O
100 O O
mg: O O
1 O O
tab O O
po O O
bid; O O
pyridoxine O O
50 O O
mg: O O
1 O O
tab O O
po O O
qd; O O
metformin B-MEDICATION B-MEDICATION
850 I-MEDICATION O
mg: I-MEDICATION O
1 O O
tab O O
po O O
tid; O O
ASA B-MEDICATION B-MEDICATION
81 I-MEDICATION O
mg: I-MEDICATION O
1 O O
tab O O
po O O
qd; O O
prazosin O O
4 O O
mg: O O
1 O O
tab O O
po O O
qd; O O
Lisinopril B-MEDICATION B-MEDICATION
2.5 I-MEDICATION O
mg: I-MEDICATION O
1 O O
tab O O
po O O
qd; O O
Zantac O O
150 O O
mg: O O
1 O O
tab O O
po O O
qhs. O O
Allergies: B-SMOKER O
NKDA. O O
Review O O
of O O
Systems: O O
The O O
following O O
systems O O
reviews O O
were O O
contributory: O O
endocrine O O
[pertinent O O
positives: O O
diabetes B-DIABETES O
mellitus]; I-DIABETES O
cardiovascular O O
[pertinent O O
positives: O O
hypertension, B-HYPERTENSION O
occasional O O
light O O
headed O O
ness; O O
pertinent O O
negatives: O O
chest O O
pain O O
with O O
exertion, O O
chest O O
pain O O
at O O
rest, O O
dyspnea O O
on O O
exertion, O O
peripheral O O
edema]; O O
gastrointestinal O O
[pertinent O O
positives: O O
diarrhea] O O
and O O
urinary O O
tract O O
[pertinent O O
positives: O O
nocturia, O O
urgency]. O O
The O O
following O O
systems O O
reviews O O
were O O
noncontributory: O O
general; O O
psychological O O
and O O
musculoskeletal. O O
General O O
Examination O O
------------------------------- O O
6/08/2158 O O
1:31 O O
pm: O O
In O O
his O O
right O O
arm, O O
his O O
blood O O
pressure O O
was O O
100/42 O O
and O O
his O O
pulse O O
was O O
60 O O
per O O
minute O O
when O O
lying; O O
his O O
blood O O
pressure O O
was O O
80/40 O O
and O O
his O O
pulse O O
was O O
64 O O
rrr O O
per O O
minute O O
when O O
sitting. O O
The O O
orthostatic O O
change O O
was O O
symptomatic. O O
He O O
appeared O O
well-nourished O O
and O O
well-groomed. O O
6/08/2158 O O
1:36 O O
pm: O O
In O O
his O O
right O O
arm, O O
his O O
blood O O
pressure O O
was O O
90/40 O O
when O O
sitting. O O
Rating O O
Scales: O O
UPDRS O O
Subscale O O
III O O
(Motor O O
Examination): O O
Subscale O O
total O O
score O O
was O O
22 O O
out O O
of O O
108. O O
This O O
subscale O O
was O O
completed O O
while O O
the O O
patient O O
was O O
ON. O O
Tremor O O
at O O
rest O O
was O O
rated O O
on O O
a O O
0 O O
to O O
4 O O
scale O O
(with O O
0 O O
being O O
absent): O O
0 O O
in O O
the O O
face, O O
0 O O
in O O
the O O
right O O
upper O O
extremity, O O
0 O O
in O O
the O O
left O O
upper O O
extremity, O O
0 O O
in O O
the O O
right O O
lower O O
extremity, O O
0 O O
in O O
the O O
left O O
lower O O
extremity,. O O
Action O O
or O O
postural O O
tremor O O
of O O
the O O
hands O O
was O O
rated O O
on O O
a O O
0 O O
to O O
4 O O
scale O O
(with O O
0 O O
being O O
absent): O O
0 O O
in O O
the O O
right O O
upper O O
extremity, O O
0 O O
in O O
the O O
left O O
upper O O
extremity,. O O
Rigidity O O
was O O
rated O O
on O O
a O O
0 O O
to O O
4 O O
scale O O
(with O O
0 O O
being O O
absent): O O
1 O O
in O O
the O O
right O O
upper O O
extremity, O O
1 O O
in O O
the O O
left O O
upper O O
extremity, O O
1 O O
in O O
the O O
right O O
lower O O
extremity, O O
1 O O
in O O
the O O
left O O
lower O O
extremity,. O O
The O O
following O O
movements O O
were O O
rated O O
on O O
a O O
0 O O
to O O
4 O O
scale O O
(with O O
0 O O
being O O
normal): O O
Finger O O
Taps: O O
1 O O
in O O
the O O
right O O
upper O O
extremity, O O
1 O O
in O O
the O O
left O O
upper O O
extremity; O O
Hand O O
movements: O O
1 O O
in O O
the O O
right O O
upper O O
extremity, O O
1 O O
in O O
the O O
left O O
upper O O
extremity; O O
Rapid O O
alternating O O
hand O O
movements: O O
1 O O
in O O
the O O
right O O
upper O O
extremity, O O
1 O O
in O O
the O O
left O O
upper O O
extremity; O O
Leg O O
agility: O O
1 O O
in O O
the O O
right O O
lower O O
extremity, O O
2 O O
in O O
the O O
left O O
lower O O
extremity. O O
Each O O
of O O
the O O
following O O
was O O
rated O O
on O O
a O O
0-4 O O
scale O O
(with O O
0 O O
being O O
normal): O O
Speech: O O
1 O O
(slight O O
loss O O
of O O
expression, O O
diction O O
and/or O O
volume); O O
Facial O O
expression: O O
1 O O
(minimal O O
hypomimia; O O
could O O
be O O
normal O O
'pokerface'); O O
Arising O O
from O O
a O O
chair: O O
1 O O
(slow O O
or O O
may O O
need O O
more O O
than O O
one O O
attempt); O O
Posture: O O
1 O O
(not O O
quite O O
erect, O O
slightly O O
stooped O O
posture; O O
could O O
be O O
normal O O
for O O
older O O
person); O O
Gait: O O
2 O O
(walks O O
with O O
difficulty O O
but O O
requires O O
little O O
or O O
no O O
assistance; O O
may O O
have O O
some O O
festination, O O
short O O
steps, O O
or O O
propulsion); O O
Postural O O
stability: O O
1 O O
(retropulsion, O O
but O O
recovers O O
unaided); O O
Body O O
bradykinesia O O
and O O
hypokinesia: O O
2 O O
(mild O O
degree O O
of O O
slowness O O
& O O
poverty O O
of O O
movement O O
that O O
is O O
definitely O O
abnormal; O O
alternatively, O O
some O O
reduced O O
amplitude). O O
Assessment: O O
1. O O
Parkinson's O O
Disease: O O
Parkinson O O
with O O
decline O O
in O O
strength O O
and O O
endurance. O O
It O O
is O O
possible O O
that O O
the O O
added O O
Sinemet O O
is O O
causing O O
a O O
decrease O O
in O O
his O O
blood O O
pressure. O O
I O O
made O O
a O O
referral O O
to O O
Mary O O
Darnell O O
PT O O
here O O
at O O
TMH. O O
In O O
addition O O
Dr O O
Edward O O
Nguyen O O
felt O O
a O O
slight O O
reduction O O
of O O
the O O
Sinemet O O
to O O
1.5 O O
tab O O
QID O O
may O O
help O O
his O O
blood O O
pressure O O
with O O
out O O
changing O O
his O O
motor O O
ability. O O
RTC O O
1 O O
month O O
Dr O O
Edward O O
Nguyen O O
and O O
2 O O
months O O
Genevieve O O
Noland, O O
NP O O
Recommendations: O O
Medication O O
given: O O
Sinemet O O
25/100: O O
2 O O
tab O O
po O O
qid. O O
Medication O O
changes O O
included: O O
Stopped: O O
pyridoxine O O
50 O O
mg: O O
1 O O
tab O O
po O O
qd; O O
Sinemet O O
25/100: O O
1.5 O O
tab O O
po O O
qid. O O
Started: O O
6/08/2158 O O
Sinemet O O
25/100: O O
1.5 O O
tab O O
po O O
qid. O O
This O O
patient's O O
history, O O
physical O O
examination, O O
assessment O O
and O O
recommendations O O
were O O
completed O O
by O O
Genevieve O O
Noland, O O
NP. O O

Record B-SMOKER O
date: O O
2071-08-08 O O
Reason O O
for O O
Visit O O
Mr. O O
Whitehead O O
is O O
here O O
for O O
follow-up O O
of O O
multiple O O
issues. O O
Problems O O
LOW O O
BACK O O
PAIN O O
he O O
had O O
prolonged O O
discogenic O O
back O O
pain O O
in O O
1/2070 O O
and O O
could O O
not O O
get O O
appt O O
with O O
NAMG O O
orthopedic/back O O
surgeon O O
and O O
went O O
to O O
Montreal O O
Medical O O
Center. O O
He O O
underwent O O
L4/5 O O
lamenictomy O O
in O O
2/2070. O O
He O O
has O O
persistent O O
right-lower O O
back O O
pain O O
and O O
has O O
seen O O
Dr. O O
Conley. O O
A O O
myleogram O O
done O O
on O O
8/5/71 O O
showed O O
degenerative O O
disc O O
disease O O
with O O
moderate O O
spinal O O
stenosis O O
at O O
L4/5. O O
He O O
will O O
be O O
seeing O O
Dr. O O
Sheehan. O O
Mr. O O
Whitehead O O
is O O
contemplating O O
surgery O O
as O O
he O O
cannot O O
walk O O
without O O
pain. O O
Elevated O O
blood O O
sugar O O
BS O O
was O O
191 O O
in O O
11/1/69 O O
and O O
was O O
in O O
similar O O
range O O
during O O
his O O
hospitalization O O
in O O
Montreal O O
Medical. O O
He O O
has O O
been O O
on O O
meds O O
for O O
NIDDM. B-DIABETES O
He O O
could O O
not O O
tolerate O O
high O O
dose O O
of O O
glucophage B-MEDICATION B-MEDICATION
and O O
is O O
now O O
seeing O O
endocrine. O O
His O O
HBA1c B-DIABETES O
was I-DIABETES O
7.5 I-DIABETES O
in O O
6/71 O O
on O O
glyburide B-MEDICATION B-MEDICATION
5 I-MEDICATION O
mg I-MEDICATION O
bid I-MEDICATION O
and O O
glucophage B-MEDICATION B-MEDICATION
500 I-MEDICATION O
mg I-MEDICATION O
qd. I-MEDICATION O
He O O
has O O
regular O O
optho O O
exam O O
and O O
is O O
on O O
zestoretic. B-MEDICATION O
Little O O
rationale O O
to O O
check O O
for O O
microalbuminuria O O
as O O
he O O
is O O
already O O
on O O
ace-inh. O O
His O O
lipids O O
are O O
controlled O O
with O O
diet O O
and O O
lipitor. B-MEDICATION B-MEDICATION
To O O
see O O
endocrine O O
in O O
9/71. O O
hyperlipidemia B-HYPERLIPIDEMIA O
now O O
on O O
lipitor B-MEDICATION B-MEDICATION
40 I-MEDICATION O
mg I-MEDICATION O
qhs. I-MEDICATION O
He O O
has O O
NIDDM O O
and O O
HTN. B-HYPERTENSION O
His O O
lipid O O
profile O O
from O O
4/71 O O
showed O O
a O O
LDL B-HYPERLIPIDEMIA O
of I-HYPERLIPIDEMIA O
103. I-HYPERLIPIDEMIA O
LFT O O
were O O
normal. O O
COntinue O O
med. O O
HYPERTENSION B-HYPERTENSION O
Now O O
on O O
zestoretic B-MEDICATION B-MEDICATION
20/25 I-MEDICATION O
qd I-MEDICATION O
+ O O
atenolol B-MEDICATION B-MEDICATION
50 I-MEDICATION O
mg I-MEDICATION O
qd. I-MEDICATION O
He O O
has O O
significant O O
white O O
coat O O
component. O O
It O O
is O O
again O O
high O O
at O O
170/80 B-HYPERTENSION O
in I-HYPERTENSION O
left I-HYPERTENSION O
arm. I-HYPERTENSION O
His O O
BP O O
reading O O
in O O
hospital O O
for O O
myelogram O O
this O O
week O O
was O O
130/80. O O
No O O
change. O O
h/o O O
PROSTATITIS O O
had O O
recurring O O
prostatitis O O
sx's O O
and O O
saw O O
Dr. O O
Dotson. O O
Cystoscopy O O
in O O
1/2070 O O
was O O
normal. O O
He O O
is O O
on O O
flomax O O
0.4 O O
mg O O
qd O O
and O O
doing O O
better. O O
His O O
PSA O O
was O O
2.9 O O
in O O
8/69 O O
and O O
3.2 O O
in O O
8/70. O O
To O O
see O O
Dr. O O
Dotson O O
soon. O O
Neurological O O
symptoms O O
he O O
reports O O
having O O
intolerance O O
to O O
bright O O
lights, O O
tingling O O
in O O
his O O
mid O O
anterior O O
abdomen O O
and O O
chest O O
as O O
well O O
as O O
numbness O O
in O O
his O O
left O O
middle O O
three O O
digits O O
with O O
some O O
neck O O
discomfort. O O
His O O
MRI O O
of O O
his O O
LS O O
spine O O
done O O
at O O
Montreal O O
Medical O O
in O O
early O O
2070 O O
evidently O O
showed O O
(by O O
his O O
report) O O
no O O
cord O O
abnormalities. O O
His O O
sx's O O
sound O O
like O O
left-sided O O
cervical O O
radiculopathy O O
but O O
his O O
visual O O
and O O
abdominal O O
sx's O O
makes O O
me O O
concerned O O
about O O
systemic O O
demyelinating O O
conditions. O O
Will O O
check O O
TSH, O O
B12 O O
and O O
have O O
him O O
see O O
Dr. O O
Conley. O O
[08/28/70] O O
TSH O O
and O O
B12 O O
levels O O
were O O
normal. O O
His O O
sx's O O
in O O
his O O
eyes O O
and O O
abdomen O O
have O O
essentially O O
resolved. O O
He O O
still O O
has O O
some O O
cervical O O
radiculopathy O O
syptoms. O O
He O O
will O O
see O O
Dr. O O
Conley O O
(yet O O
to O O
do O O
so). O O
[01/21/71] O O
still O O
did O O
not O O
see O O
Dr. O O
Conley. O O
He O O
now O O
has O O
right O O
neck O O
pain. O O
His O O
left O O
sided O O
numbness O O
has O O
resolved. O O
Again O O
referred O O
him O O
to O O
Dr. O O
Conley. O O
He O O
likely O O
has O O
cervical O O
radiculopathy. O O
[04/09/71] O O
c-spine O O
MRI O O
ordered O O
by O O
Dr. O O
Conley O O
showed O O
mutliple O O
levels O O
of O O
spondylothis. O O
Vital O O
Signs O O
Blood B-HYPERTENSION O
Pressure: I-HYPERTENSION O
170/70 I-HYPERTENSION O
Weight: O O
187 O O
Pounds O O
Physical O O
Exam O O
Chest O O
clear O O
Cor/Cardiac O O
s1s2 O O
s4 O O
with O O
s4 O O
Neurological O O
He O O
has O O
normal O O
motor O O
strength O O
in O O
his O O
limbs. O O
Normal O O
straight O O
leg O O
raise O O
bilaterally. O O
Medications O O
MICRONASE B-MEDICATION O
(GLYBURIDE) I-MEDICATION O
5MG O O
1 O O
Tablet(s) O O
PO O O
BID O O
Start O O
Date: O O
8/8/71 O O
ATENOLOL B-MEDICATION B-MEDICATION
50MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
ZESTORETIC B-MEDICATION B-MEDICATION
20-25 I-MEDICATION O
(LISINOPRIL/HYDROCLOROTH... O O
20/25 O O
PO O O
QD O O
Prilosec O O
SA O O
20MG O O
PO O O
BIw O O
LIPITOR B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
40MG O O
PO O O
QHS O O
GLUCOPHAGE B-MEDICATION B-MEDICATION
(METFORMIN) I-MEDICATION O
500MG O O
PO O O
QD O O
Start O O
Date: O O
2/19/71 O O
FLOMAX O O
(TAMSULOSIN) O O
0.4MG O O
PO O O
QD O O
ASPIRIN B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC I-MEDICATION O
ACID) I-MEDICATION O
81MG O O
PO O O
QD O O
MVI O O
(MULTIVITAMINS) O O
1CAPSULE O O
PO O O
QD O O
Disposition O O
and O O
Plans O O
Follow-up O O
in O O
12/71. O O
cc: O O
Dr. O O
Conley O O

Record B-SMOKER O
date: O O
2072-04-24 O O
Reason O O
for O O
Visit O O
Mr. O O
Whitehead O O
is O O
here O O
for O O
FU O O
of O O
his O O
many O O
issues. O O
Problems O O
benign O O
prostatic O O
hypertrophy O O
PSA O O
was O O
2.9 O O
in O O
8/69 O O
and O O
3.2 O O
in O O
8/70 O O
and O O
3.0 O O
in O O
2/72. O O
He O O
has O O
done O O
well O O
on O O
flomax O O
and O O
now O O
sees O O
Dr. O O
Pena. O O
hyperlipidemia B-HYPERLIPIDEMIA O
now O O
on O O
lipitor B-MEDICATION B-MEDICATION
40 I-MEDICATION O
mg I-MEDICATION O
qhs. I-MEDICATION O
He O O
has O O
NIDDM B-DIABETES O
and O O
HTN. B-HYPERTENSION O
His O O
lipid O O
profile O O
from O O
4/71 O O
showed O O
a O O
LDL B-HYPERLIPIDEMIA O
of I-HYPERLIPIDEMIA O
103. I-HYPERLIPIDEMIA O
LFT O O
were O O
normal. O O
Will O O
check O O
lab O O
work O O
and O O
continue O O
med. O O
Elevated O O
blood O O
sugar O O
BS O O
was O O
191 O O
in O O
11/1/69 O O
and O O
was O O
in O O
similar O O
range O O
during O O
his O O
hospitalization O O
in O O
Montreal O O
Medical. O O
He O O
has O O
been O O
on O O
meds O O
for O O
NIDDM. O O
He O O
could O O
not O O
tolerate O O
high O O
dose O O
of O O
glucophage B-MEDICATION B-MEDICATION
and O O
has O O
seen O O
Dr. O O
Lozano O O
in O O
diabetic O O
unit. O O
His O O
HBA1c B-DIABETES O
was I-DIABETES O
7.5 I-DIABETES O
in O O
6/71 O O
and B-DIABETES O
7.6 I-DIABETES O
in O O
9/71 O O
on O O
glyburide B-MEDICATION B-MEDICATION
5 I-MEDICATION O
mg I-MEDICATION O
bid I-MEDICATION O
and O O
glucophage B-MEDICATION B-MEDICATION
XR I-MEDICATION O
500 I-MEDICATION O
mg I-MEDICATION O
qd. I-MEDICATION O
He O O
is O O
on O O
zestoretic. B-MEDICATION O
Little O O
rationale O O
to O O
check O O
for O O
microalbuminuria O O
as O O
he O O
is O O
already O O
on O O
ace-inh. O O
His O O
lipids O O
are O O
controlled O O
with O O
diet O O
and O O
lipitor. O B-MEDICATION
He O O
has O O
no O O
neuropathic O O
sx's O O
and O O
sees O O
ophtho O O
regularly. O O
HYPERTENSION B-HYPERTENSION B-HYPERTENSION
Now O O
on O O
zestoretic B-MEDICATION O
20/25 I-MEDICATION O
bid I-MEDICATION O
+ O O
atenolol B-MEDICATION B-MEDICATION
50 I-MEDICATION O
mg I-MEDICATION O
qd. I-MEDICATION O
He O O
has O O
significant O O
white O O
coat O O
component. O O
BP B-HYPERTENSION O
is I-HYPERTENSION O
again I-HYPERTENSION O
145/80 B-HYPERTENSION O
and O O
is O O
lower O O
at O O
home. O O
Pulse O O
is O O
70 O O
but O O
it O O
again O O
sped O O
up O O
when O O
he O O
was O O
being O O
examined. O O
LOW O O
BACK O O
PAIN O O
he O O
had O O
prolonged O O
discogenic O O
back O O
pain O O
in O O
1/2070 O O
and O O
could O O
not O O
get O O
appt O O
with O O
NAMG O O
orthopedic/back O O
surgeon O O
and O O
went O O
to O O
Montreal O O
Medical O O
Center. O O
He O O
underwent O O
L4/5 O O
lamenictomy O O
in O O
2/2070. O O
He O O
has O O
persistent O O
right-lower O O
back O O
pain O O
and O O
has O O
seen O O
Drs. O O
Conley O O
and O O
Sheehan. O O
A O O
myleogram O O
done O O
on O O
8/5/71 O O
showed O O
degenerative O O
disc O O
disease O O
with O O
moderate O O
spinal O O
stenosis O O
at O O
L4/5. O O
He O O
continues O O
to O O
have O O
chronic O O
low O O
back O O
pain O O
in O O
the O O
right O O
hip O O
and O O
right O O
anterior O O
thigh. O O
He O O
exercises O O
regularly O O
and O O
has O O
not O O
benefitted O O
from O O
prior O O
epidural O O
injection. O O
Dr. O O
Sheehan O O
felt O O
that O O
pain O O
may O O
be O O
from O O
some O O
instability O O
vs O O
scar O O
tissue O O
from O O
prior O O
surgery. O O
Fusion O O
surgery O O
was O O
discussed O O
but O O
Mr. O O
Whitehead O O
is O O
not O O
too O O
keen O O
on O O
it. O O
[12/25/71] O O
still O O
has O O
back O O
pain O O
but O O
not O O
ready O O
for O O
fusion O O
surgery O O
yet. O O
Review O O
of O O
Systems O O
Otherwise O O
negative. O O
Vital O O
Signs O O
Pulse: O O
70 O O
Regular O O
Weight: O O
189 O O
Pounds O O
Blood B-HYPERTENSION O
Pressure: I-HYPERTENSION O
145/80 I-HYPERTENSION O
Left O O
Arm O O
Physical O O
Exam O O
Chest O O
clear O O
Cor/Cardiac O O
s1s2 O O
s4 O O
Abdomen O O
soft O O
and O O
nontender, O O
no O O
masses O O
or O O
organomegaly, O O
normal O O
bowel O O
sounds O O
Extremity O O
no O O
edema O O
noted, O O
pulses O O
are O O
1+ O O
Medications O O
MVI O O
(MULTIVITAMINS) O O
1CAPSULE O O
PO O O
QD O O
ASPIRIN B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC I-MEDICATION O
ACID) I-MEDICATION O
81MG O O
PO O O
QD O O
FLOMAX O O
(TAMSULOSIN) O O
0.4MG O O
PO O O
QD O O
LIPITOR B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
40MG O O
PO O O
QHS O O
ZESTORETIC B-MEDICATION B-MEDICATION
20-25 I-MEDICATION O
(LISINOPRIL/HYDROCLOROTH... O O
20/25 O O
PO O O
QD O O
GLUCOPHAGE B-MEDICATION B-MEDICATION
XR I-MEDICATION O
(METFORMIN I-MEDICATION O
XR) I-MEDICATION O
500MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
Prilosec O O
SA O O
20MG O O
PO O O
QD O O
ATENOLOL B-MEDICATION B-MEDICATION
50MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
MICRONASE B-MEDICATION O
(GLYBURIDE) I-MEDICATION O
5MG O O
1 O O
Tablet(s) O O
PO O O
BID O O
Disposition O O
and O O
Plans O O
Follow-up O O
in O O
9/72. O O
Will O O
contact O O
him O O
with O O
results O O
of O O
lab O O
work. O O

Record B-SMOKER O
date: O O
2074-03-25 O O
Reason O O
for O O
Visit O O
FU O O
of O O
several O O
issues O O
Problems O O
DVT O O
dx O O
with O O
left O O
calf O O
DVT O O
on O O
3/20/74 O O
in O O
setting O O
of O O
being O O
sedentary O O
from O O
low O O
back O O
pain. O O
Had O O
face O O
joint O O
block O O
on O O
3/09/74. O O
D-dimer O O
was O O
high O O
and O O
cxr O O
was O O
clear. O O
No O O
respiratory O O
sx's O O
to O O
suggest O O
pulmonary O O
embolism. O O
HE O O
is O O
on O O
fragmin O O
bid O O
for O O
3 O O
more O O
days. O O
INR O O
was O O
2.5 O O
on O O
3/23/74 O O
and O O
he O O
is O O
on O O
2.5 O O
mg O O
qd. O O
He O O
will O O
be O O
seeing O O
Internal O O
Medicine O O
on O O
3/28/74. O O
Will O O
treat O O
him O O
with O O
coumadin O O
for O O
six O O
months. O O
He O O
has O O
moderate O O
post-phlebitic O O
pain O O
and O O
is O O
on O O
prn O O
percocets. O O
Elevated O O
blood O O
sugar O O
BS B-DIABETES O
was I-DIABETES O
191 I-DIABETES O
in O O
11/1/69 O O
and O O
was O O
in O O
similar O O
range O O
during O O
his O O
hospitalization O O
in O O
Montreal O O
Medical. O O
He O O
has O O
been O O
on O O
meds O O
for O O
NIDDM. B-DIABETES O
His O O
glucophage B-MEDICATION O
was I-MEDICATION O
stopped I-MEDICATION O
as O O
his O O
cr O O
was O O
in O O
the O O
1.5-1.7 O O
range. O O
He O O
is O O
now O O
on O O
glyburide B-MEDICATION B-MEDICATION
10 I-MEDICATION O
mg I-MEDICATION O
bid I-MEDICATION O
and O O
his O O
sugars O O
are O O
still O O
high O O
with O O
fasting B-DIABETES O
levels I-DIABETES O
in I-DIABETES O
the I-DIABETES O
180-250 I-DIABETES O
range. I-DIABETES O
His B-DIABETES O
HBA1c B-DIABETES O
was I-DIABETES O
7 I-DIABETES O
in I-DIABETES O
11/73. I-DIABETES O
Will O O
transition B-MEDICATION O
him I-MEDICATION O
to I-MEDICATION O
insuline I-MEDICATION B-MEDICATION
with I-MEDICATION O
25 I-MEDICATION O
units I-MEDICATION O
NPH I-MEDICATION B-MEDICATION
sc O O
qhs O O
and O O
he O O
will O O
monitor O O
sugars O O
bid O O
and O O
report O O
back O O
to O O
me. O O
FU O O
in O O
one O O
month O O
to O O
recheck O O
HBA1c. O O
benign O O
prostatic O O
hypertrophy O O
PSA O O
was O O
2.9 O O
in O O
8/69 O O
and O O
3.2 O O
in O O
8/70 O O
and O O
3.0 O O
in O O
2/72. O O
PSA O O
was O O
checked O O
while O O
in O O
hospital O O
by O O
resident O O
in O O
3/74 O O
and O O
it O O
was O O
12.9. O O
Discussed O O
ramification O O
of O O
this O O
test. O O
Will O O
favor O O
rechecking O O
his O O
PSA O O
in O O
one O O
month. O O
Due O O
to O O
recent O O
DVT O O
and O O
his O O
being O O
on O O
coumadin, O O
he O O
would O O
not O O
be O O
amenable O O
to O O
undergo O O
prostate O O
biopsy O O
in O O
the O O
next O O
few O O
weeks. O O
If O O
PSA O O
remains O O
high, O O
will O O
have O O
him O O
see O O
urology. O O
Vital O O
Signs O O
Weight: O O
183 O O
Pounds O O
Blood O O
Pressure: O O
130/70 O O
Left O O
Arm O O
Physical O O
Exam O O
Extremity O O
minimal O O
swelling O O
in O O
left O O
calf O O
without O O
cords O O
Medications O O
ASPIRIN B-MEDICATION B-MEDICATION
(ACETYLSALICYLIC I-MEDICATION O
ACID) I-MEDICATION O
81MG O O
PO O O
QD O O
ATENOLOL B-MEDICATION B-MEDICATION
50MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
FLOMAX O O
(TAMSULOSIN) O O
0.4MG O O
PO O O
QD O O
INSULIN B-MEDICATION B-MEDICATION
NPH I-MEDICATION B-MEDICATION
HUMAN I-MEDICATION O
25UNITS I-MEDICATION O
SC I-MEDICATION O
QHS I-MEDICATION O
LIPITOR B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
40MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
MVI O O
(MULTIVITAMINS) O O
1CAPSULE O O
PO O O
QD O O
ZESTORETIC B-MEDICATION B-MEDICATION
20-25 I-MEDICATION O
(LISINOPRIL/HYDROCLOROTH... O O
20/25 O O
PO O O
BID O O
Disposition O O
and O O
Plans O O
FU O O
in O O
one O O
month. O O
Total O O
visit O O
time O O
was O O
40 O O
minutes. O O

Record O O
date: O O
2078-03-18 O O
Freeman O O
Internal O O
Medicine O O
Intern O O
Admission O O
Note O O
PATIENT: O O
Whitehead, O O
Aidan O O
D O O
MRN: O O
9855218 O O
ADMIT B-DIABETES O
DATE: O O
3/17/78 O O
ATTENDING: O O
Bell, O O
Charley O O
Source: O O
Patient O O
and O O
chart O O
CC: O O
Diarrhea O O
HPI: O O
1M O O
with O O
DM, O O
HTN, B-HYPERTENSION O
HL, B-HYPERLIPIDEMIA O
and O O
Parkinson's O O
disease. O O
In O O
7/77, O O
he O O
had O O
been O O
treated O O
at O O
NAMG O O
for O O
a O O
left O O
lower O O
lobe O O
PNA O O
with O O
levofloxacin, O O
and O O
developed O O
diarrhea O O
while O O
in O O
the O O
hospital. O O
After O O
discharge, O O
he O O
continued O O
to O O
have O O
profuse O O
diarrhea, O O
and O O
was O O
treated O O
with O O
IV O O
hydration O O
and O O
metronidazole O O
C. O O
diff O O
infection, O O
first O O
found O O
to O O
be O O
positive O O
on O O
7/31/77. O O
Since O O
then O O
he O O
has O O
had O O
multiple O O
episodes O O
of O O
recurrent O O
C. O O
diff. O O
Most O O
recently, O O
he O O
was O O
admitted O O
to O O
NAMG O O
for O O
treatment O O
of O O
recurrent O O
C. O O
diff O O
in O O
1/77, O O
with O O
improvement O O
after O O
receiving O O
inpatient O O
vancomycin O O
and O O
flagyl, O O
and O O
discharged O O
to O O
NAMG, O O
where O O
he O O
was O O
for O O
3 O O
weeks. O O
He O O
received O O
21 O O
days O O
of O O
flagyl. O O
After O O
about O O
two O O
weeks, O O
he O O
noticed O O
a O O
gradual O O
increase O O
in O O
his O O
stool O O
frequency. O O
Three O O
weeks O O
prior O O
to O O
admission, O O
he O O
began O O
taking O O
500 O O
mg O O
PO O O
Flagyl O O
q8h, O O
which O O
he O O
had O O
at O O
home. O O
He O O
felt O O
that O O
his O O
symptoms O O
were O O
improved O O
somewhat O O
on O O
the O O
flagyl. O O
One O O
week O O
ago, O O
he O O
saw O O
his O O
PCP, O O
where O O
a O O
C. O O
diff O O
stool O O
toxin O O
was O O
negative. O O
At O O
that O O
point, O O
he O O
stopped O O
the O O
PO O O
flagyl, O O
and O O
shortly O O
afterward O O
his O O
diarrhea O O
again O O
progressively O O
worsened. O O
Currently O O
he O O
is O O
having O O
10 O O
BM O O
per O O
day, O O
and O O
he O O
states O O
that O O
they O O
are O O
similar O O
to O O
odor, O O
color, O O
and O O
frequency O O
to O O
his O O
prior O O
C. O O
diff O O
episodes. O O
He O O
has O O
also O O
had O O
a O O
few O O
days O O
of O O
lower O O
abdominal O O
pain, O O
2-3/10, O O
with O O
no O O
clear O O
pattern, O O
and O O
noticed O O
a O O
few O O
flecks O O
of O O
blood O O
in O O
his O O
stool O O
2 O O
days O O
ago O O
on O O
one O O
occasion. O O
He O O
denies O O
other O O
symptoms O O
including O O
fever/chills, O O
n/v, O O
cp, O O
sob, O O
and O O
dizziness. O O
He O O
reports O O
that O O
when O O
he O O
had O O
taken O O
PO O O
vancomycin O O
in O O
the O O
past, O O
it O O
cost O O
$40 O O
per O O
tablet. O O
ED: O O
Afebrile, O O
HR O O
70s. O O
Hypertensive B-HYPERTENSION O
to O O
189/82. B-HYPERTENSION O
He O O
was O O
given O O
1000 O O
cc O O
NS, O O
5 O O
mg O O
PO O O
amlodipine, B-MEDICATION B-MEDICATION
20 O O
mg O O
PO O O
lisinopril, B-MEDICATION B-MEDICATION
500 O O
mg O O
IV O O
flagyl. O O
ROS: O O
Otherwise O O
negative O O
in O O
detail. O O
PMHx: O O
Lower O O
back O O
pain O O
Hypertension B-HYPERTENSION O
Hyperlipidemia B-HYPERLIPIDEMIA O
Elevated O O
blood O O
sugar O O
Parkinson&#8217;s O O
disease O O
C. O O
difficile O O
colitis O O
ALLERGIES: O O
NKDA O O
MEDICATIONS: O O
1. O O
Acetylsalicylic B-MEDICATION B-MEDICATION
Acid I-MEDICATION O
(Aspirin) B-MEDICATION O
81 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
2. O O
Amlodipine B-MEDICATION B-MEDICATION
(Norvasc) B-MEDICATION O
5 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
3. O O
Atenolol B-MEDICATION B-MEDICATION
100 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
4. O O
Atorvastatin B-MEDICATION B-MEDICATION
(Lipitor) I-MEDICATION O
20 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
5. O O
Carbidopa/Levodopa O O
25/100 O O
(Sinemet O O
25/100 O O
) O O
1.5 O O
TAB O O
PO O O
TID O O
6. O O
Citalopram O O
(Celexa) O O
20 O O
MG O O
PO O O
QD O O
7. O O
Insulin B-MEDICATION O
Nph I-MEDICATION B-MEDICATION
Human I-MEDICATION O
10 O O
UNITS O O
SC O O
QPM O O
BEFORE O O
SUPPER O O
8. O O
Insulin O B-MEDICATION
Nph O O
Human O O
5 O O
UNITS O O
SC O O
QAM O O
BEFORE O O
BREAKFAST O O
9. O O
Lactobacillus O O
PO O O
BID O O
unit O O
strength: O O
form: O O
CAPSULE O O
10. O O
Lisinopril B-MEDICATION B-MEDICATION
20 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
11. O O
Lorazepam O B-MEDICATION
(Ativan) O O
1 O O
MG O O
PO O O
as O O
directed O O
one O O
to O O
two O O
tablets O O
1-2 O O
hours O O
under O O
tongue O O
prior O O
to O O
MRI O O
and/or O O
injection O O
12. O O
Omeprazole O O
20 O O
MG O O
PO O O
QD O O
GENERIC O O
OK O O
13. O O
Tamsulosin O O
(Flomax) O O
0.4 O O
MG O O
PO O O
QHS O O
FAMILY O O
HISTORY: O O
Noncontributory O O
SOCIAL O O
HISTORY: O O
Lives O O
with O O
his O O
wife. O O
Has O O
2 O O
adult O O
stepchildren, O O
1 O O
a O O
Web O O
Technician O O
in O O
the O O
area. O O
Tob: B-SMOKER O
Denies I-SMOKER O
EtOH: O O
Denies O O
Drug O O
use: O O
Denies O O
PHYSICAL O O
EXAM O O
VITALS: O O
T O O
97.9 O O
HR O O
77 O O
BP B-HYPERTENSION O
164/70 B-HYPERTENSION O
RR O O
SpO2 O O
100 O O
GEN&#8217;L O O
: O O
Alert, O O
well O O
appearing, O O
NAD. O O
HEENT: O O
AT O O
/ O O
NC. O O
EOMI, O O
no O O
nystagmus. O O
PERRL O O
6mm O O
-&gt; O O
4mm O O
bilaterally. O O
MMM. O O
2+ O O
carotids O O
without O O
bruits. O O
No O O
lympadenopathy. O O
Heart: O O
RRR, O O
no O O
MRG O O
LUNG: O O
CTAB O O
ABD: O O
Soft, O O
NT/ND, O O
NABS. O O
No O O
organomegaly. O O
EXT: O O
WWP. O O
2+ O O
L O O
lower O O
extremity O O
edema. O O
2+ O O
DP O O
PT O O
pulses. O O
NEURO: O O
A+Ox3. O O
CN O O
II-XII, O O
speech, O O
language, O O
strength, O O
and O O
sensation O O
intact. O O
CHEMISTRIES O O
Chemistry O O
Detail O O
for O O
WHITEHEAD, O O
AIDAN O O
D O O
Plasma O O
Sodium O O
140 O O
(135-145) O O
mmol/L O O
Plasma O O
Potassium O O
3.1 O O
L O O
(3.4-4.8) O O
mmol/L O O
Plasma O O
Chloride O O
102 O O
(100-108) O O
mmol/L O O
Plasma O O
Carbon O O
Dioxide O O
30.5 O O
(23.0-31.9) O O
mmol/L O O
Plasma O O
Anion O O
GAP O O
8 O O
(3-15) O O
mmol/L O O
Calcium O O
8.8 O O
(8.5-10.5) O O
mg/dl O O
Phosphorus O O
2.4 O O
L O O
(2.6-4.5) O O
mg/dl O O
Magnesium O O
1.6 O O
(1.4-2.0) O O
meq/L O O
Plasma O O
Urea O O
Nitrogen O O
16 O O
(8-25) O O
mg/dl O O
Plasma O O
Creatinine O O
1.11 O O
(0.60-1.50) O O
mg/dl O O
eGFR O O
&gt;60 O O
mL/min/1.73m2 O O
Abnormal O O
if O O
&lt;60 O O
mL/min/1.73m2. O O
If O O
patient O O
is O O
African-American, O O
multiply O O
the O O
result O O
by O O
1.21. O O
Plasma O O
Glucose O O
135 O O
H O O
(70-110) O O
mg/dl O O
Total O O
Protein O O
7.1 O O
(6.0-8.3) O O
g/dl O O
Albumin O O
3.8 O O
(3.3-5.0) O O
g/dl O O
Globulin O O
3.3 O O
(2.6-4.1) O O
g/dl O O
Direct O O
Bilirubin O O
0.1 O O
(0-0.4) O O
mg/dl O O
Total O O
Bilirubin O O
0.5 O O
(0.0-1.0) O O
mg/dl O O
Alkaline O O
Phosphatase O O
94 O O
(45-115) O O
U/L O O
Transaminase-SGPT O O
19 O O
(10-55) O O
U/L O O
Amylase O O
32 O O
(3-100) O O
units/L O O
Transaminase-SGOT O O
12 O O
(10-40) O O
U/L O O
Lipase O O
12 O O
L O O
(13-60) O O
U/L O O
WBC O O
10.8 O O
(4.5-11.0) O O
th/cmm O O
HCT O O
36.9 O O
L O O
(41.0-53.0) O O
% O O
HGB O O
12.9 O O
L O O
(13.5-17.5) O O
gm/dl O O
RBC O O
3.96 O O
L O O
(4.50-5.90) O O
mil/cmm O O
PLT O O
244 O O
(150-400) O O
th/cumm O O
MCV O O
93 O O
(80-100) O O
fl O O
MCH O O
32.6 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
35.0 O O
(31.0-37.0) O O
g/dl O O
RDW O O
14.4 O O
(11.5-14.5) O O
% O O
DIFFERENTIAL O O
REQUEST O O
RECEIVED O O
Diff O O
Method O O
Auto O O
Poly O O
79 O O
H O O
(40-70) O O
% O O
Lymphs O O
14 O O
L O O
(22-44) O O
% O O
Monos O O
5 O O
(4-11) O O
% O O
EOS O O
2 O O
(0-8) O O
% O O
Basos O O
0 O O
(0-3) O O
% O O
Absolute O O
Neuts O O
8.50 O O
H O O
(1.8-7.7) O O
th/cmm O O
Absolute O O
Lymphs O O
1.48 O O
(1.0-4.8) O O
th/cmm O O
Absolute O O
Monos O O
0.54 O O
H O O
(0.2-0.4) O O
th/cmm O O
Absolute O O
EOS O O
0.26 O O
(0.1-0.3) O O
th/cmm O O
Absolute O O
Basos O O
0.03 O O
(0.0-0.3) O O
th/cmm O O
Aniso O O
None O O
(None) O O
Hypo O O
None O O
(None) O O
Macrocytes O O
None O O
(None) O O
Microcytes O O
None O O
(None) O O
RADIOLOGY: O O
3/17 O O
KUB. O O
Study O O
done, O O
radiology O O
read O O
pending. O O
ECG: O O
Normal O O
sinus O O
rhythm, O O
rate O O
84. O O
Normal O O
axis. O O
Normal O O
intervals. O O
No O O
ST O O
segment O O
deviation O O
or O O
T O O
wave O O
inversion. O O
ASSESSMENT O O
&amp; O O
PLAN: O O
81M O O
with O O
recurrent O O
C. O O
diff O O
infections O O
presenting O O
with O O
diarrhea. O O
Likely O O
he O O
has O O
a O O
recurrent O O
episode O O
of O O
C. O O
diff O O
infection. O O
1. O O
Diarrhea. O O
- O O
IV O O
flagyl O O
500 O O
mg O O
Q8H O O
and O O
PO O O
vancomycin O O
250 O O
mg O O
Q6H O O
- O O
stool O O
c. O O
diff O O
toxin O O
- O O
ID O O
consult O O
re: O O
appropriate O O
management O O
of O O
multiply O O
recurrent O O
C. O O
diff O O
infection O O
- O O
consider O O
social O O
services O O
consult O O
if O O
ID O O
feels O O
PO O O
vancomycin O O
is O O
the O O
only O O
viable O O
option O O
at O O
this O O
point. O O
2. O O
HTN O O
- O O
HTN O O
improved O O
s/p O O
receiving O O
his O O
home O O
regimen O O
in O O
the O O
ED. O O
- O O
will O O
replace B-MEDICATION O
atenolol B-MEDICATION B-MEDICATION
with I-MEDICATION O
metoprolol I-MEDICATION B-MEDICATION
while O O
in-patient, O O
up-titrate O O
as O O
needed, O O
starting O O
37.5mg O O
Q8h O O
3. O O
L O O
lower O O
extremity O O
edema. O O
Patient O O
states O O
he O O
was O O
evaluated O O
at O O
OSH O O
recently O O
and O O
felt O O
to O O
not O O
have O O
a O O
DVT. O O
Will O O
disuss O O
whether O O
any O O
further O O
workup O O
is O O
neeed O O
with O O
pt&#8217;s O O
PCP O O
in O O
AM. O O
3. O O
FEN. O O
PO O O
diet O O
as O O
tolerated. O O
RISS O O
/ O O
NPH. O O
4. O O
PPX. O O
Lovenox. O O
Alexander O O
X. O O
Jenks, O O
MD, O O
PhD O O
Pager O O
84261 O O

Record O O
date: O O
2064-07-26 O O
July O O
26, O O
2064 O O
Harry O O
R. O O
Lynn, O O
M.D. O O
Doraville O O
County O O
Health O O
Center O O
897 O O
Cider O O
Street O O
Platteville, O O
HI O O
79812 O O
RE: O O
Isabelle O O
Y. O O
Quick O O
ATCH: O O
655-75-45 O O
Dear O O
Harry O O
and O O
Yair: O O
My O O
thanks O O
for O O
your O O
kind O O
referral O O
of O O
the O O
above O O
noted O O
patient O O
with O O
respect O O
to O O
her O O
disabling O O
claudication O O
and O O
of O O
course O O
she O O
is O O
not O O
in O O
a O O
very O O
happy O O
circumstance. O O
As O O
you O O
know, O O
she O O
is O O
just O O
52 O O
years O O
of O O
age. O O
Her O O
cardiovascular O O
risk O O
factors O O
include O O
type B-DIABETES O
2 I-DIABETES O
diabetes B-DIABETES O
treated O O
with O O
metformin B-MEDICATION B-MEDICATION
and O O
Glyburide, B-MEDICATION B-MEDICATION
hypertension, B-HYPERTENSION B-HYPERTENSION
hyperlipidemia B-HYPERLIPIDEMIA O
and O O
she O O
is O O
a O O
former B-SMOKER O
cigarette I-SMOKER O
smoker I-SMOKER O
but O O
she O O
has O O
not B-SMOKER O
smoked I-SMOKER O
in I-SMOKER O
a I-SMOKER O
year. I-SMOKER O
She O O
spends O O
a O O
lot O O
of O O
time O O
caring O O
for O O
her O O
partially O O
disabled O O
husband. O O
She O O
has O O
known O O
and O O
impressive O O
history O O
of O O
peripheral O O
vascular O O
disease. O O
She O O
has O O
undergone O O
bilateral O O
leg O O
revascularizations. O O
On O O
the O O
left O O
side O O
initially O O
an O O
iliac O O
stent O O
was O O
tried O O
but O O
in O O
January O O
of O O
2063 O O
she O O
had O O
a O O
left O O
iliofemoral O O
endarterectomy O O
with O O
angioplasty O O
and O O
in O O
situ O O
above O O
knee O O
left O O
fem-pop O O
bypass O O
graft. O O
This O O
reconstruction O O
is O O
functioning O O
well, O O
as O O
evidenced O O
by O O
pulse O O
examination O O
and O O
she O O
certainly O O
does O O
not O O
have O O
any O O
major O O
symptoms O O
in O O
the O O
left O O
side. O O
In O O
April O O
of O O
2063 O O
she O O
had O O
a O O
right O O
common O O
femoral O O
and O O
external O O
iliac O O
endarterectomy O O
with O O
a O O
right O O
fem-pop O O
bypass O O
graft O O
to O O
the O O
above-knee O O
popliteal O O
artery O O
using O O
transposed O O
greater O O
saphenous O O
veins. O O
There O O
had O O
previously O O
been O O
a O O
right O O
iliac O O
PTA O O
and O O
stent. O O
She O O
states O O
that O O
the O O
procedure O O
in O O
the O O
right O O
leg O O
was O O
only O O
transiently O O
of O O
benefit. O O
By O O
last O O
spring, O O
i.e. O O
a O O
year O O
ago O O
she O O
again O O
had O O
rather O O
limiting O O
claudication. O O
She O O
says O O
this O O
is O O
now O O
worse O O
over O O
the O O
past O O
several O O
months O O
and O O
she O O
quantifies O O
this O O
as O O
severe O O
calf O O
pain O O
after O O
just O O
a O O
couple O O
of O O
blocks. O O
Importantly O O
she O O
does O O
not O O
have O O
ischemic O O
rest O O
pain O O
and O O
she O O
has O O
never O O
had O O
tissue O O
loss. O O
Recently O O
resting O O
ABIs O O
were O O
recorded O O
at O O
0.46 O O
on O O
the O O
right O O
and O O
0.8 O O
on O O
the O O
left. O O
Her O O
continued O O
complaints O O
led O O
to O O
a O O
repeat O O
arteriogram O O
last O O
October O O
documenting O O
a O O
superficial O O
femoral O O
artery O O
occlusion O O
(??? O O
length O O
thereof O O
- O O
she O O
did O O
not O O
bring O O
the O O
films O O
themselves) O O
and O O
a O O
patent O O
albeit O O
small O O
reconstituted O O
above-knee O O
popliteal O O
artery O O
with O O
decent O O
runoff. O O
Understandably O O
Dr. O O
Adcock O O
was O O
reluctant O O
about O O
recommending O O
further O O
revascularizations. O O
She O O
has O O
sought O O
an O O
opinion O O
here O O
in O O
this O O
regard. O O
She O O
has O O
no O O
known O O
coronary O O
artery O O
disease O O
and O O
her O O
general O O
system O O
review O O
is O O
notable O O
for O O
a O O
prior O O
hospitalization O O
in O O
2061 O O
for O O
severe O O
pancreatitis O O
requiring O O
laparotomy. O O
On O O
physical O O
examination O O
blood O O
pressure O O
was O O
140/80. O O
Pulse O O
was O O
70 O O
and O O
regular. O O
Carotid O O
upstroke O O
was O O
normal O O
and O O
there O O
were O O
no O O
major O O
carotid O O
bruits. O O
She O O
has O O
femoral O O
pulses O O
on O O
both O O
sides O O
and O O
the O O
left O O
fem-pop O O
bypass O O
graft O O
in O O
situ O O
is O O
palpable, O O
as O O
is O O
the O O
left O O
popliteal O O
pulse. O O
There O O
is O O
no O O
right O O
popliteal O O
nor O O
right O O
foot O O
pulse. O O
She O O
does O O
have O O
dependent O O
rubor O O
on O O
that O O
right O O
side O O
although O O
there O O
is O O
no O O
tissue O O
breakdown. O O
This O O
is O O
of O O
course O O
a O O
very O O
unhappy O O
situation. O O
Further O O
attempts O O
at O O
surgical O O
revascularization O O
in O O
the O O
setting O O
of O O
having O O
both O O
greater O O
saphenous O O
veins O O
harvested O O
and O O
so O O
forth O O
is O O
really O O
not O O
justified O O
for O O
claudication O O
alone O O
since O O
the O O
result O O
can O O
be O O
anticipated O O
to O O
be O O
not O O
very O O
good. O O
However O O
I O O
am O O
not O O
absolutely O O
ruling O O
this O O
out. O O
I O O
would O O
suggest O O
the O O
following. O O
Her O O
risk O O
factor O O
control O O
is O O
decent O O
and O O
she O O
should O O
certainly O O
stay O O
on O O
the O O
Lipitor, B-MEDICATION B-MEDICATION
aspirin B-MEDICATION B-MEDICATION
and O O
Plavix. B-MEDICATION O
Since O O
her O O
problem O O
is O O
claudication O O
I O O
would O O
like O O
Yair O O
to O O
institute O O
Pletal O O
at O O
full O O
dosages O O
and O O
give O O
this O O
at O O
least O O
a O O
couple O O
of O O
months O O
before O O
we O O
can O O
say O O
that O O
she O O
has O O
had O O
an O O
adequate O O
trial O O
with O O
question O O
benefit. O O
She O O
will O O
get O O
the O O
actual O O
arteriogram O O
from O O
the O O
October O O
study O O
to O O
me. O O
If O O
it O O
seems O O
reasonable O O
and O O
the O O
right O O
superficial O O
femoral O O
artery O O
block O O
is O O
not O O
too O O
long O O
an O O
attempt O O
at O O
percutaneous O O
recanalization O O
could O O
be O O
considered. O O
I O O
will O O
get O O
back O O
to O O
you O O
after O O
review O O
of O O
the O O
films O O
themselves. O O
My O O
thanks O O
once O O
again. O O
With O O
every O O
best O O
wish. O O
Sincerely, O O
Daniel O O
W. O O
Iniguez, O O
M.D. O O
cc: O O
Yair O O
K. O O
Bennett, O O
M.D., O O
208 O O
Pheasant O O
Lane, O O
Platteville, O O
HI O O
79812 O O
DWI/yim O O

Record O O
date: O O
2064-09-10 O O
Date: O O
9/10/64, O O
0857 O O
am O O
Medical O O
Record O O
Number: O O
6557545, O O
Quick, O O
Isabelle. O O
Procedure: O O
The O O
patient O O
is O O
a O O
52 O O
year O O
old O O
female O O
scheduled O O
for O O
a O O
right O O
femoral O O
popliteal O O
BPG. O O
Surgery O O
is O O
to O O
be O O
performed O O
on O O
9/17/64, O O
by O O
Dr. O O
Iyer. O O
Chief O O
Complaint O O
& O O
Present O O
Illness: O O
Patient O O
has O O
history O O
of O O
claudication O O
within O O
past O O
year. O O
She O O
underwent O O
a O O
left O O
ileofemoral O O
endarterectomy O O
1/63, O O
and O O
a O O
right O O
right O O
common O O
femoral O O
and O O
external O O
iliac O O
endarterectomy O O
with O O
right O O
fem-pop O O
4/63. O O
She O O
denies O O
any O O
relief O O
with O O
any O O
previous O O
procedures. O O
She O O
states O O
she O O
has O O
to O O
stop O O
before O O
walking O O
1 O O
block O O
due O O
to O O
pain O O
in O O
both O O
legs O O
R&gt;L. O O
Pain O O
resolves O O
with O O
rest. O O
Past O O
Medical O O
History: O O
1. O O
type B-DIABETES O
2 I-DIABETES O
diabetes B-DIABETES O
treated O O
with O O
metformin B-MEDICATION B-MEDICATION
and O O
Glyburide B-MEDICATION B-MEDICATION
2. O O
hypertension B-HYPERTENSION B-HYPERTENSION
3. O O
hyperlipidemia B-HYPERLIPIDEMIA B-HYPERTENSION
4. O O
PVD O O
5. O O
Chronic O O
pancreatitis O O
Past O O
Surgical O O
History: O O
1. O O
January O O
of O O
2063 O O
she O O
had O O
a O O
left O O
iliofemoral O O
endarterectomy O O
with O O
angioplasty O O
and O O
in O O
situ O O
above O O
knee O O
left O O
fem-pop O O
bypass O O
graft. O O
2. O O
April O O
of O O
2063 O O
she O O
had O O
a O O
right O O
common O O
femoral O O
and O O
external O O
iliac O O
endarterectomy O O
with O O
a O O
right O O
fem-pop O O
bypass O O
graft O O
to O O
the O O
above-knee O O
popliteal O O
artery O O
using O O
transposed O O
greater O O
saphenous O O
veins O O
3. O O
10/09/63, O O
aortogram O O
bilateral O O
lower O O
extremity O O
runoff O O
with O O
a O O
right O O
common O O
runoff O O
4. O O
Whipple O O
procedure O O
for O O
chronic O O
pancreatitis O O
2061 O O
Denies O O
problems O O
with O O
general O O
anesthesia O O
Family O O
History: O O
There O O
is O O
no O O
family O O
history O O
if O O
adverse O O
reactions O O
to O O
general O O
anesthesia. O O
Medications: O O
Pre-admission O O
Medication O O
List O O
for O O
QUICK,ISABELLE O O
Y O O
6557545 O O
(ATCH) O O
52 O O
F O O
Last O O
signed O O
by: O O
RICO,HELEN O O
U.,RNC O O
on O O
09/10/2064 O O
at O O
09:21 O O
1. O O
Pioglitazone B-MEDICATION B-MEDICATION
(Actos) B-MEDICATION O
15 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QAM I-MEDICATION O
2. O O
Glyburide B-MEDICATION B-MEDICATION
1.25 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QAM I-MEDICATION O
3. O O
Metformin B-MEDICATION B-MEDICATION
500 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
4. O O
Clopidogrel B-MEDICATION B-MEDICATION
(Plavix) I-MEDICATION O
75 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QAM I-MEDICATION O
dose O O
last O O
taken O O
09/10/2064 O O
5. O O
Atorvastatin B-MEDICATION B-MEDICATION
(Lipitor) I-MEDICATION O
20 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QHS I-MEDICATION O
6. O O
Atenolol B-MEDICATION B-MEDICATION
50 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QAM I-MEDICATION O
7. O O
Pantoprazole O O
(Protonix) O O
40 O O
MG O O
PO O O
QAM O O
8. O O
Cyproheptadine O O
Hcl O O
4 O O
MG O O
PO O O
BID O O
9. O O
Amitriptyline O O
Hcl O O
50 O O
MG O O
PO O O
QHS O O
10. O O
Therapeutic O O
Multivitamins O O
(Multivitamin O O
Therapeutic) O O
1 O O
TAB O O
PO O O
QHS O O
11. O O
Acetylsalicylic B-MEDICATION B-MEDICATION
Acid I-MEDICATION O
(Aspirin) B-MEDICATION O
81 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QAM I-MEDICATION O
Allergies: O O
NKDA O O
Social O O
History: O O
Smoking: B-SMOKER O
1ppd/27 I-SMOKER O
years, I-SMOKER O
quit B-SMOKER O
2 I-SMOKER O
years I-SMOKER O
ago I-SMOKER O
Alcohol O O
use: O O
none O O
Substance O O
abuse:none O O
Allergen O O
Exposure: O O
(transfusion/pregnancy): O O
none O O
in O O
last O O
3 O O
months. O O
Exercise: O O
walks O O
20 O O
minutes- O O
1/2 O O
hour O O
daily O O
Occupation: O O
none O O
Marital O O
Status: O O
married O O
Review O O
of O O
Systems: O O
General: O O
Independent O O
with O O
ADL, O O
well O O
developed, O O
well O O
nourished. O O
HEENT: O O
History O O
of O O
sinus O O
infections O O
in O O
past. O O
No O O
history O O
of O O
head O O
injury, O O
glaucoma, O O
cataracts, O O
eye O O
redness, O O
eye/nose/throat O O
pain, O O
earaches, O O
ear O O
infections, O O
nose O O
bleeds, O O
excessive O O
tearing, O O
eye/ear O O
discharge, O O
vision O O
changes O O
(including O O
double O O
vision, O O
spot, O O
specks, O O
or O O
flashing O O
lights), O O
tinnitus, O O
vertigo, O O
motion O O
sickness, O O
or O O
hearing O O
loss. O O
Respiratory: O O
Denies O O
cough O O
sputum, O O
hemoptysis, O O
wheezing, O O
asthma, O O
bronchitis, O O
emphysema, O O
pneumonia, O O
tuberculosis, O O
COPD, O O
sleep O O
apnea, O O
or O O
pleurisy. O O
Cardiovascular: O O
History O O
of O O
HTN, B-HYPERTENSION O
hypercholesterolemia. B-HYPERLIPIDEMIA O
Stress O O
test O O
9/8/64, O O
shows O O
no O O
evidence O O
for O O
myocardial O O
ischemia, O O
EF O O
70%. O O
No O O
history O O
of O O
rheumatic O O
fever, O O
MI, O O
angina, O O
syncope, O O
palpitations, O O
edema, O O
dyspnea, O O
chest O O
pain, O O
orthopnea, O O
or O O
paroxysmal O O
nocturnal O O
dyspnea. O O
GI: O O
No O O
history O O
of O O
GERD, O O
PUD, O O
bleeding, O O
changes O O
in O O
bowel O O
habits, O O
difficulty O O
swallowing, O O
appetite O O
changes, O O
nausea, O O
vomiting, O O
constipation, O O
diarrhea, O O
abdominal O O
pain, O O
food O O
intolerance, O O
excessive O O
belching O O
or O O
gas. O O
Hepatobiliary: O O
History O O
of O O
chronic O O
pancreatitis O O
s/p O O
Whipple. O O
Has O O
taken O O
protonix O O
since O O
surgery. O O
No O O
history O O
of O O
jaundice, O O
hepatitis, O O
or O O
colic. O O
GU: O O
No O O
history O O
of O O
CRF, O O
hematuria, O O
obstruction, O O
colic, O O
stones, O O
UTI, O O
polyuria, O O
nocturia, O O
decreased O O
caliber O O
or O O
force O O
of O O
urinary O O
stream, O O
hesitancy, O O
incontinence, O O
or O O
frequency O O
of O O
urination. O O
Musculoskeletal: O O
No O O
history O O
of O O
arthritis, O O
muscle O O
pain, O O
joint O O
pain, O O
stiffness, O O
gout, O O
or O O
limitations O O
with O O
ROM. O O
Neuro:History O O
of O O
right O O
inner O O
leg O O
numbness. O O
No O O
history O O
of O O
seizures, O O
stroke, O O
TIAs, O O
migraine, O O
fainting, O O
weakness, O O
paralysis, O O
tingling, O O
tremors, O O
or O O
other O O
involuntary O O
movements. O O
Peripheral O O
Vascular: O O
History O O
of O O
bilateral O O
claudication O O
R&gt;L. O O
No O O
history O O
of O O
DVT, O O
varicosities, O O
cramps, O O
or O O
ulcers. O O
Endocrine: O O
History O O
of O O
type B-DIABETES O
II I-DIABETES O
diabetes I-DIABETES O
(non I-DIABETES O
insulin I-DIABETES O
dependent) I-DIABETES O
diagnosed O O
2 O O
years O O
ago. O O
Checks O O
BS O O
regularly O O
usually O O
150 O O
-160 O O
in O O
am. O O
No O O
history O O
of O O
thyroid O O
problems, O O
heat O O
or O O
cold O O
intolerance, O O
excessive O O
sweating, O O
excessive O O
thirst O O
Heme/Onc: O O
History O O
of O O
easy O O
bruising. O O
No O O
history O O
of O O
bleeding, O O
anemia, O O
lymphadenopathy, O O
chemotherapy O O
or O O
radiation. O O
Psychiatric: O O
No O O
history O O
of O O
anxiety, O O
panic O O
attacks, O O
depression, O O
or O O
psychosis. O O
Skin: O O
No O O
history O O
of O O
rash, O O
abnormal O O
pigmentation, O O
pruritis, O O
lumps, O O
or O O
sores. O O
Physical O O
Exam: O O
SaO2: O O
100 O O
Resp: O O
16 O O
Temp:96.4 O O
Ht: O O
65in O O
Wt: O O
132.6 O O
BP: B-HYPERTENSION O
140/82 I-HYPERTENSION O
AP: O O
80 O O
General: O O
Well O O
developed, O O
thin O O
HEENT: O O
Normocephalic, O O
cranium O O
intact O O
without O O
depressions. O O
no O O
icterus, O O
thyroid O O
non-palpable, O O
neck O O
veins O O
flat, O O
carotids O O
palpable O O
without O O
bruits, O O
no O O
swelling, O O
lumps, O O
masses, O O
tenderness, O O
or O O
visible O O
pulsations. O O
Movement O O
symmetrical O O
with O O
full O O
range O O
of O O
motion. O O
Frontal O O
and O O
maxillary O O
sinuses O O
non-tender. O O
Airway: O O
Mallampatti O O
Class O O
I O O
Teeth: O O
missing O O
lower O O
molars O O
Chest: O O
Breath O O
sounds O O
clear. O O
No O O
abnormal O O
retraction O O
or O O
impairment O O
of O O
lower O O
interspaces O O
during O O
inspiration. O O
Symmetrical, O O
even O O
respiratory O O
movement. O O
Heart: O O
Regular O O
rhythm, O O
normal O O
rate, O O
no O O
murmurs, O O
rubs O O
or O O
gallops, O O
S1=S2. O O
Abdomen: O O
Soft, O O
non-tender, O O
with O O
scars, O O
no O O
distention, O O
normal O O
bowel O O
sounds, O O
no O O
organomegaly O O
or O O
palpable O O
masses. O O
Contour O O
round, O O
symmetrical, O O
without O O
lesions, O O
striae, O O
or O O
dilated O O
veins. O O
No O O
visible O O
peristalsis O O
or O O
pulsations. O O
GU/Rectal: O O
No O O
CVA O O
tenderness O O
or O O
hernias. O O
LMP O O
- O O
10 O O
years O O
ago, O O
postmenopausal O O
Lymphatics: O O
No O O
lymphadenopathy O O
Peripheral O O
Vascular: O O
No O O
edema, O O
varicosities. O O
Spider O O
veins O O
Carotids- O O
2+ O O
Radials- O O
2+ O O
Femorals- O O
2+ O O
Anterior O O
tibial- O O
not O O
palpable O O
Dorsalis O O
pedis- O O
not O O
palpable O O
Neuro: O O
CNII: O O
Visual O O
Acuity: O O
Able O O
to O O
read O O
newspaper O O
and O O
see O O
distances O O
with O O
glasses. O O
Visual O O
fields O O
full O O
to O O
confrontation. O O
CN O O
III, O O
IV, O O
and O O
VI, O O
: O O
EOMs O O
intact, O O
parallel, O O
no O O
ptosis. O O
PERRLA&A. O O
CN O O
V O O
& O O
VII: O O
Intact. O O
Temporal O O
and O O
masseter O O
muscle O O
contractions O O
equal O O
in O O
symmetry O O
and O O
strength. O O
Equal O O
sensation O O
to O O
sharp O O
stimulus O O
to O O
forehead, O O
cheek, O O
and O O
jaws. O O
CNVIII: O O
Intact. O O
No O O
loss O O
of O O
hearing O O
to O O
either O O
ear O O
via O O
whisper O O
test. O O
CN O O
IX, O O
X: O O
Intact. O O
Voice O O
without O O
hoarseness O O
or O O
nasal O O
quality. O O
Uvula O O
midline. O O
CN O O
XI: O O
Intact. O O
Equal O O
strength O O
and O O
contraction O O
to O O
trapezii O O
and O O
sternomastoid O O
muscle. O O
CN O O
XII: O O
Intact. O O
Tongue O O
movement O O
symmetrical O O
without O O
deviations O O
or O O
protrusions. O O
No O O
atrophy O O
or O O
fasciculations O O
as O O
tongue O O
lies O O
on O O
floor O O
of O O
mouth. O O
Mental O O
Status: O O
Oriented O O
x O O
3. O O
Appearance O O
neat O O
and O O
clean. O O
Pt O O
pleasant O O
and O O
cooperative O O
for O O
exam. O O
Able O O
to O O
answer O O
questions O O
appropriately O O
and O O
clearly. O O
Able O O
to O O
articulate O O
own O O
thoughts O O
and O O
questions O O
logically O O
and O O
coherently. O O
Coordination: O O
Gait O O
- O O
slow, O O
steady O O
Strength O O
and O O
Tone: O O
Tone O O
and O O
strength O O
intact O O
to O O
upper O O
and O O
lower O O
extremities. O O
Sensory: O O
Intact. O O
Reflexes: O O
not O O
tested O O
Extremities: O O
No O O
clubbing O O
or O O
cyanosis. O O
Musculoskeletal: O O
Normal O O
range O O
of O O
motion. O O
Skin: O O
Warm O O
and O O
dry O O
to O O
touch. O O
Turgor O O
intact. O O
Color O O
consistent. O O
No O O
lesions, O O
rashes, O O
or O O
edema. O O
Assessment: O O
ASA O B-MEDICATION
physical O O
status: O O
III. O O
Patient O O
is O O
a O O
52 O O
year O O
old O O
female O O
scheduled O O
for O O
a O O
right O O
femoral O O
popliteal O O
BPG. O O
Patient O O
has O O
history O O
of O O
PVD, O O
HTN O O
type O O
II O O
diabetes, O O
hyperlipidemia, O O
chronic O O
pancreatitis O O
s/p O O
Whipple, O O
and O O
no O O
problems O O
with O O
general O O
anesthesia. O O
Have O O
enclosed O O
stress O O
test O O
from O O
Hospital O O
Lafayette, O O
Platteville, O O
Hi. O O
Anesthesia O O
consent O O
form O O
and O O
tentative O O
plans O O
reviewed O O
and O O
explained. O O
Patient O O
will O O
sign O O
anesthesia O O
consent O O
form O O
day O O
of O O
surgery. O O
Plan: O O
Proposed O O
anesthetic: O O
general, O O
epidural O O
Monitors: O O
standard, O O
arterial O O
line O O
Pain O O
Management: O O
IVPCA/epidural O O
Autologous O O
Blood: O O
none O O
Premedication: O O
none O O
Usual O O
Medications: O O
Pre-admission O O
Medication O O
List O O
for O O
QUICK,ISABELLE O O
Y O O
6557545 O O
(ATCH) O O
52 O O
F O O
Last O O
signed O O
by: O O
RICO,HELEN O O
U.,RNC O O
on O O
09/10/2064 O O
at O O
09:21 O O
1. O O
Pioglitazone O B-MEDICATION
(Actos) O O
15 O O
MG O O
PO O O
QAM O O
2. O O
Glyburide O B-MEDICATION
1.25 O O
MG O O
PO O O
QAM O O
3. O O
Metformin O B-MEDICATION
500 O O
MG O O
PO O O
BID O O
4. O O
Clopidogrel O O
(Plavix) O O
75 O O
MG O O
PO O O
QAM O O
dose O O
last O O
taken O O
09/10/2064 O O
5. O O
Atorvastatin O B-MEDICATION
(Lipitor) O O
20 O O
MG O O
PO O O
QHS O O
6. O O
Atenolol O B-MEDICATION
50 O O
MG O O
PO O O
QAM O O
7. O O
Pantoprazole O O
(Protonix) O O
40 O O
MG O O
PO O O
QAM O O
8. O O
Cyproheptadine O O
Hcl O O
4 O O
MG O O
PO O O
BID O O
9. O O
Amitriptyline O O
Hcl O O
50 O O
MG O O
PO O O
QHS O O
10. O O
Therapeutic O O
Multivitamins O O
(Multivitamin O O
Therapeutic) O O
1 O O
TAB O O
PO O O
QHS O O
11. O O
Acetylsalicylic O B-MEDICATION
Acid O O
(Aspirin) O O
81 O O
MG O O
PO O O
QAM O O
Medications O O
to O O
be O O
held O O
on O O
day O O
of O O
surgery: O O
&lt;&gt; O O
Diabetic O O
Medications: O O
&lt;&gt; O O
NSAIDS: O O
Avoid O O
for O O
three O O
days O O
prior O O
to O O
surgery O O
Aspirin: O B-MEDICATION
Avoid O O
for O O
one O O
week O O
prior O O
to O O
surgery. O O
NPO: O O
&lt;&gt; O O
Ancillary O O
Studies: O O
&lt;&gt; O O
__________________________________________________________________ O O
Helen O O
Rico, O O
MSN, O O
APRN-BC, O O
FNP O O
___________________________________________________________________ O O

Record O O
date: O O
2065-08-02 O O
Vascular O O
Surgery O O
Admission O O
Note O O
Patient O O
Name: O O
Quick, O O
Isabelle O O
MRN: O O
6557545 O O
Date O O
and O O
Time: O O
8/02/65 O O
2:40PM O O
Attending: O O
Dr. O O
Iyer O O
Fellow: O O
Dr. O O
Wade O O
Junior O O
Resident: O O
Dr. O O
Joyce O O
cc: O O
thrombosed O O
R O O
fem-pop O O
BPG; O O
increasing O O
rest O O
pain O O
in O O
R O O
leg O O
HPI: O O
The O O
patient O O
is O O
a O O
53 O O
year O O
old O O
woman O O
with O O
a O O
past O O
medical O O
history O O
of O O
diabetes, B-DIABETES O
HTN, B-HYPERTENSION O
and O O
PVD O O
s/p O O
L O O
fem-pop O O
BPG O O
with O O
in-situ O O
vein O O
2063, O O
R O O
fem O O
to O O
AK O O
pop O O
BPG O O
with O O
GSV O O
2063, O O
R O O
fem-BK O O
pop O O
BPG O O
with O O
propatent O O
graft O O
9/17/64, O O
and O O
multiple O O
attempts O O
at O O
angiographic O O
intervention O O
who O O
presents O O
with O O
worsening O O
rest O O
pain O O
in O O
the O O
R O O
leg O O
X O O
1 O O
month. O O
Immediately O O
following O O
her O O
2nd O O
R O O
fem-pop O O
BPG O O
in O O
9/2064, O O
she O O
felt O O
well O O
and O O
without O O
significant O O
LE O O
pain. O O
Over O O
the O O
past O O
month, O O
however, O O
the O O
patient O O
reports O O
that O O
she O O
has O O
had O O
progressive O O
pain O O
in O O
her O O
R O O
foot O O
and O O
leg, O O
which O O
wakes O O
her O O
up O O
from O O
sleep O O
almost O O
every O O
night. O O
She O O
can O O
walk O O
less O O
than O O
one O O
block O O
without O O
disabling O O
claudication O O
which O O
improves O O
with O O
rest. O O
She O O
also O O
has O O
noticed O O
discoloration O O
of O O
her O O
R O O
foot, O O
along O O
with O O
numbness O O
and O O
paresthesias, O O
which O O
have O O
been O O
progressive O O
over O O
the O O
same O O
time O O
period. O O
She O O
denies O O
all O O
symptoms O O
other O O
than O O
RLE O O
pain O O
and O O
claudication O O
as O O
described. O O
Specifically, O O
she O O
denies O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
dizziness, O O
headache, O O
and O O
fevers/chills. O O
She O O
reports O O
that O O
her O O
left O O
leg O O
is O O
occasionally O O
painful, O O
although O O
it O O
has O O
been O O
tolerable O O
in O O
comparison O O
to O O
her O O
R O O
leg. O O
She O O
has O O
been O O
taking O O
aspirin B-MEDICATION B-MEDICATION
and O O
plavix B-MEDICATION B-MEDICATION
regularly, O O
but O O
has O O
not O O
taken O O
coumadin O O
for O O
2 O O
days O O
(last O O
dose O O
7/31/65). O O
She O O
last O O
underwent O O
arterial O O
LENIs O O
on O O
7/17/65, O O
which O O
demonstrated O O
critical O O
ischemia O O
in O O
her O O
R O O
leg O O
and O O
a O O
thrombosed O O
R O O
fem-pop O O
BPG O O
(see O O
below O O
for O O
official O O
report). O O
She O O
is O O
admitted O O
for O O
elective O O
revascularization O O
of O O
her O O
R O O
leg. O O
PMH: O O
DM B-DIABETES O
II I-DIABETES O
HTN O O
PVD O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Chronic O O
Pancreatitis O O
PSH: O O
9/20/64: O O
angio/PTA O O
L O O
proximal O O
fem-pop O O
bpg O O
and O O
L O O
SFA O O
9/17/64: O O
R O O
CFA O O
endarterectomy; O O
R O O
fem-BK O O
pop O O
BPG O O
w/ O O
propatent O O
graft O O
10/2063, O O
angio O O
w/ O O
BLE O O
runoff O O
4/2063: O O
R O O
CFA O O
and O O
EIA O O
endarterectomy; O O
R O O
fem-pop O O
BPG O O
to O O
AK O O
pop O O
using O O
transposed O O
greater O O
saphenous O O
veins O O
1/2063: O O
L O O
iliofemoral O O
endarterectomy O O
with O O
PTA O O
&amp; O O
in O O
situ O O
vein O O
AK O O
L O O
fem-pop O O
bpg O O
2061: O O
Whipple O O
procedure O O
for O O
chronic O O
pancreatitis O O
Meds: O O
1. O O
Acetylsalicylic B-MEDICATION B-MEDICATION
Acid I-MEDICATION O
(Aspirin) I-MEDICATION O
325 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
2. O O
Atenolol B-MEDICATION B-MEDICATION
50 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
3. O O
Clopidogrel B-MEDICATION O
(Plavix) I-MEDICATION O
75 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
4. O O
Cyproheptadine O O
Hcl O O
4 O O
MG O O
PO O O
BID O O
5. O O
Glipizide B-MEDICATION B-MEDICATION
2.5 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
6. O O
Metformin B-MEDICATION B-MEDICATION
500 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
TID I-MEDICATION O
7. O O
Multivitamins O O
1 O O
TAB O O
PO O O
QD O O
8. O O
Pantoprazole O O
(Protonix) O O
40 O O
MG O O
PO O O
QD O O
9. O O
Pioglitazone B-MEDICATION B-MEDICATION
(Actos) B-MEDICATION O
30 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
10. O O
Simvastatin B-MEDICATION B-MEDICATION
20 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
11. O O
Warfarin O O
Sodium O O
(Coumadin) O O
5 O O
MG O O
PO O O
QD O O
ALL: O O
NKDA O O
Social: O O
Previous B-SMOKER O
smoker, I-SMOKER O
quit I-SMOKER O
approximately I-SMOKER O
3 I-SMOKER O
years I-SMOKER O
ago I-SMOKER O
Denies O O
EtOH O O
ROS: O O
as O O
above; O O
otherwise O O
negative O O
with O O
exception O O
of O O
presenting O O
complaints O O
PE: O O
VS: O O
T O O
98.2 O O
HR O O
80 O O
BP O O
129/65 O O
RR O O
18 O O
96% O O
RA O O
NAD, O O
comfortable-appearing O O
middle-aged O O
woman, O O
NAD O O
Neck: O O
no O O
bruits O O
appreciated O O
CV: O O
RRR, O O
no O O
m/r/g O O
Pulm: O O
CTA O O
bilaterally, O O
no O O
wheezes O O
or O O
crackles O O
Abd: O O
soft, O O
non O O
tender, O O
non O O
distended; O O
R O O
vertical O O
paramedian O O
scar, O O
well-healed O O
Ext: O O
LLE O O
warm, O O
with O O
well O O
healed O O
femoral O O
and O O
L O O
knee O O
incisions, O O
normal O O
color O O
and O O
sensation O O
R O O
foot O O
cool, O O
with O O
small O O
amount O O
of O O
discoloration O O
present O O
distal O O
to O O
mid-metatarsals; O O
sensation O O
grossly O O
intact O O
although O O
subjectively O O
less O O
than O O
L O O
foot O O
Pulses: O O
Rad O O
Fem O O
Pop O O
DP O O
PT O O
R O O
2+ O O
1+ O O
NP O O
weak O O
Doppler O O
signal O O
no O O
doppler O O
signal O O
L O O
2+ O O
2+ O O
NP O O
strong O O
Doppler O O
signal O O
+ O O
Doppler O O
signal O O
PVRs O O
demonstrate O O
pulsatile O O
signals O O
in O O
LLE; O O
waveforms O O
are O O
flat O O
in O O
RLE O O
EKG: O O
normal O O
sinus O O
rhythm, O O
no O O
ischemic O O
changes O O
Labs: O O
Plasma O O
Sodium O O
139 O O
(135-145) O O
mmol/L O O
Plasma O O
Potassium O O
4.9 O O
H O O
(3.4-4.8) O O
mmol/L O O
Plasma O O
Chloride O O
101 O O
(100-108) O O
mmol/L O O
Plasma O O
Carbon O O
Dioxide O O
28.7 O O
(23.0-31.9) O O
mmol/L O O
Plasma O O
Anion O O
GAP O O
9 O O
(3-15) O O
mmol/L O O
Phosphorus O O
3.7 O O
(2.6-4.5) O O
mg/dl O O
Magnesium O O
1.6 O O
(1.4-2.0) O O
meq/L O O
Plasma O O
Urea O O
Nitrogen O O
9 O O
(8-25) O O
mg/dl O O
Plasma O O
Creatinine O O
0.94 O O
(0.60-1.50) O O
mg/dl O O
eGFR O O
&gt;60 O O
mL/min/1.73m2 O O
Plasma O O
Glucose O O
289 O O
H O O
(70-110) O O
mg/dl O O
WBC O O
8.1 O O
(4.5-11.0) O O
th/cmm O O
HCT O O
39.3 O O
(36.0-46.0) O O
% O O
HGB O O
13.8 O O
(12.0-16.0) O O
gm/dl O O
RBC O O
4.31 O O
(4.00-5.20) O O
mil/cmm O O
PLT O O
281 O O
(150-400) O O
th/cumm O O
MCV O O
91 O O
(80-100) O O
fl O O
MCH O O
31.9 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
35.0 O O
(31.0-37.0) O O
g/dl O O
RDW O O
15.6 O O
H O O
(11.5-14.5) O O
% O O
PT O O
15.8 O O
H O O
(10.3-13.2) O O
sec O O
PT-INR O O
1.4 O O
APTT O O
28.3 O O
(22.1-34.0) O O
sec O O
UA-Color O O
Yellow O O
(YELLOW) O O
UA-Turbidity O O
Clear O O
(CLEAR) O O
UA-Glucose O O
2+ O O
(NEG) O O
UA-Bili O O
NEGATIVE O O
(NEG) O O
UA-Ketones O O
NEGATIVE O O
(NEG) O O
UA-Specific O O
Gravity O O
1.005 O O
(1.001-1.035) O O
UA-Occult O O
Blood O O
NEGATIVE O O
(NEG) O O
UA-pH O O
5.0 O O
(5.0-9.0) O O
UA-Albumin O O
NEGATIVE O O
(NEG) O O
UA-Urobilinogen O O
NEGATIVE O O
(NEG) O O
UA-Nitrite O O
NEGATIVE O O
(NEG) O O
UA-WBC O O
Screen O O
NEGATIVE O O
(NEG) O O
Imaging: O O
CXR O O
8/02: O O
clear O O
lungs O O
Arterial O O
LENI O O
(7/17/65): O O
1. O O
Critical O O
peripheral O O
arterial O O
disease O O
in O O
the O O
right O O
leg O O
at O O
rest. O O
2. O O
Disease O O
is O O
located O O
in O O
the O O
aorto-iliac, O O
femoral O O
and O O
popliteal O O
segments O O
on O O
the O O
right O O
side. O O
3. O O
Mild O O
peripheral O O
arterial O O
disease O O
in O O
the O O
left O O
leg O O
at O O
rest. O O
4. O O
Disease O O
is O O
located O O
in O O
the O O
aorto-iliac O O
and O O
tibial/peroneal O O
segments O O
on O O
the O O
left O O
side. O O
5. O O
There O O
has O O
been O O
a O O
significant O O
drop O O
in O O
the O O
ankle/brachial O O
index O O
in O O
the O O
right O O
leg O O
since O O
the O O
last O O
exam, O O
from O O
0.77 O O
to O O
0.26. O O
6. O O
Occlusion O O
of O O
the O O
right O O
femoral O O
to O O
popliteal O O
PTFE O O
bypass O O
graft. O O
Assessment: O O
The O O
patient O O
is O O
a O O
53 O O
year O O
old O O
woman O O
with O O
a O O
past O O
medical O O
history O O
of O O
diabetes, O O
HTN, O O
and O O
PVD O O
s/p O O
L O O
fem-pop O O
BPG O O
with O O
in-situ O O
vein O O
2063, O O
R O O
fem O O
to O O
AK O O
pop O O
BPG O O
with O O
GSV O O
2063, O O
R O O
fem-BK O O
pop O O
BPG O O
with O O
propatent O O
graft O O
9/17/64, O O
and O O
multiple O O
attempts O O
at O O
angiographic O O
intervention O O
who O O
presents O O
with O O
worsening O O
rest O O
pain O O
in O O
the O O
R O O
leg O O
X O O
1 O O
month. O O
Given O O
her O O
progressive O O
pain, O O
worsening O O
PVRs, O O
and O O
thrombosed O O
BPG, O O
she O O
will O O
go O O
to O O
the O O
OR O O
8/03 O O
for O O
fem-pop O O
thrombectomy, O O
possible O O
fem-fem O O
bypass O O
graft, O O
and O O
angiogram O O
with O O
possible O O
angioplasty/stent. O O
Plan: O O
-Admit O O
to O O
Vascular O O
Surgery, O O
attending O O
Dr. O O
Iyer O O
-Labs, O O
EKG, O O
CXR O O
-Hold O O
Coumadin, O O
continue O O
aspirin/plavix, O B-MEDICATION
begin O O
heparin O O
drip O O
at O O
500 O O
Units/hr, O O
with O O
sliding O O
scale O O
and O O
target O O
PTT O O
40-60 O O
-Hold O O
heparin O O
drip O O
on O O
call O O
to O O
OR O O
-NPO O O
p O O
midnight, O O
IV O O
fluids O O
-Consent O O
obtained O O
and O O
placed O O
in O O
chart O O
Case O O
discussed O O
with O O
Dr. O O
David O O
Wade, O O
Vascular O O
Fellow O O
Francis O O
D. O O
Link O O
ATCH O O
Surgery O O
Pager O O
40232 O O

Record B-SMOKER O
date: O O
2062-09-18 O O
Tammy O O
Umphrey O O
PDI O O
Unit O O
No: O O
094-22-07 O O
CLEVELAND O O
PUBLIC O O
INSTITUTE O O
Internal O O
Medicine O O
Date: O O
September O O
18, O O
2062 O O
MEDICATIONS: O O
Glynase B-MEDICATION O
3 I-MEDICATION O
mg I-MEDICATION O
q.a.m., I-MEDICATION O
Glucophage B-MEDICATION B-MEDICATION
500 I-MEDICATION O
mg I-MEDICATION O
q.p.m., I-MEDICATION O
Ultram O O
50 O O
mg O O
b.i.d., O O
Synthroid O O
? O O
dose O O
q.d., O O
Premarin O O
0.625 O O
mg O O
q.d., O O
Monopril B-MEDICATION O
40 I-MEDICATION O
mg I-MEDICATION O
q.d., I-MEDICATION O
Dyazide B-MEDICATION O
1 I-MEDICATION O
q.d., I-MEDICATION O
Neurontin O O
300 O O
mg O O
q.i.d., O O
glucosamine O B-MEDICATION
chondroitin, O O
vitamin O O
E O O
400 O O
IU O O
q.d., O O
Citracal O O
2 O O
q.d., O O
Centrum O O
Silver O O
1 O O
q.d. O O
(1) O O
Diabetes B-DIABETES O
mellitus: I-DIABETES O
Went O O
on O O
cruise. O O
Ate O O
frequently O O
but O O
watched O O
portions. O O
Apparently O O
patient O O
checks O O
blood O O
sugars O O
between O O
3:00 O O
and O O
3:00 O O
and O O
when O O
she O O
has O O
shakiness. O O
She O O
was O O
under O O
the O O
impression O O
that O O
after O O
lunch O O
she O O
had O O
to O O
fast O O
for O O
three O O
hours O O
prior O O
to O O
checking O O
sugar, O O
at O O
which O O
point O O
notes O O
low O O
blood O O
sugars O O
in O O
the O O
50's O O
to O O
70's O O
with O O
shakiness, O O
for O O
which O O
she O O
takes O O
a O O
handful O O
of O O
raisins. O O
Generally O O
eats O O
breakfast O O
at O O
8:30, O O
lunch O O
12:00 O O
or O O
12:30, O O
supper O O
at O O
5:30. O O
Snacks O O
in O O
the O O
evening, O O
always O O
apple O O
and O O
yogurt. O O
Most O O
recently, O O
additionally O O
popcorn O O
and O O
saltine O O
crackers, O O
occasional O O
pretzels. O O
After O O
takes O O
raisins, O O
shakiness O O
of O O
hypoglycemic O O
symptoms O O
resolve. O O
While O O
on O O
cruise, O O
patient O O
found O O
that O O
she O O
could O O
actually O O
walk O O
more O O
than O O
she O O
thought O O
she O O
could. O O
Since O O
she O O
has O O
been O O
home, O O
has O O
not O O
been O O
walking O O
routinely. O O
(2) O O
HTN: B-HYPERTENSION O
No O O
chest O O
pain, O O
shortness O O
of O O
breath O O
or O O
palpitations. O O
(3) O O
Back O O
pain/lower O O
extremity O O
pain. O O
States O O
taking O O
glucosamine O B-MEDICATION
chondroitin. O O
Over O O
the O O
last O O
two O O
or O O
three O O
months, O O
feels O O
that O O
it O O
is O O
helping O O
with O O
decreased O O
pain. O O
Also O O
has O O
been O O
seen O O
at O O
physical O O
therapy O O
again. O O
Feels O O
that O O
this O O
is O O
helping. O O
PE: O O
Weight O O
down O O
2 O O
pounds!. O O
Blood O O
pressure, O O
right O O
arm: O O
126/68. O O
Chest O O
is O O
clear. O O
Cardiac: O O
Regular O O
rhythm O O
at O O
66, O O
no O O
murmur O O
or O O
gallop. O O
A/P: O O
(1) O O
Diabetes O O
mellitus: O O
Somewhat O O
better O O
control O O
with O O
mildly O O
elevated O O
morning O O
sugars. O O
Have O O
asked O O
patient O O
to O O
decrease O O
popcorn O O
and/or O O
crackers O O
at O O
h.s. O O
Have O O
advised O O
patient O O
to O O
take O O
small O O
handful O O
of O O
raisins O O
prior O O
to O O
onset O O
of O O
hypoglycemic O O
symptoms O O
advised O O
around O O
2:00 O O
to O O
2:30 O O
p.m. O O
Have O O
encouraged O O
patient O O
to O O
continue O O
to O O
walk O O
daily. O O
Continue O O
current O O
treatment. O O
(2) O O
Back O O
pain/lower O O
extremity O O
pain: O O
Some O O
improvement O O
with O O
PT O O
and O O
increased O O
med. O O
Continue O O
for O O
now. O O
(3) O O
HTN: O O
At O O
goal. O O
Return O O
to O O
clinic O O
at O O
the O O
beginning O O
of O O
November O O
to O O
Dr. O O
Ullom O O
to O O
resume O O
care. O O
Kathleen O O
L O O
Kuhn, O O
RNC, O O
ANP O O
KL/utz/orton O O

Record B-SMOKER O
date: O O
2063-12-13 O O
NAME: O O
Umphrey, O O
Tammy O O
MRN: O O
0942207 O O
The O O
patient O O
is O O
here O O
as O O
a O O
walk-in. O O
Her O O
spouse O O
is O O
present. O O
Patient O O
says O O
she O O
is O O
status O O
post O O
a O O
fall O O
this O O
past O O
Monday O O
at O O
home. O O
Says O O
that O O
she O O
seems O O
to O O
have O O
lost O O
her O O
balance O O
while O O
opening O O
a O O
door O O
at O O
home. O O
Denies O O
prodromal O O
symptoms O O
including O O
shortness O O
of O O
breath, O O
dizziness, O O
or O O
palpitations. O O
There O O
was O O
no O O
loss O O
of O O
consciousness. O O
Patient O O
was O O
seen O O
in O O
the O O
emergency O O
room O O
that O O
day O O
for O O
trauma O O
to O O
the O O
head. O O
Had O O
a O O
negative O O
CT O O
of O O
her O O
head O O
and O O
had O O
an O O
x-ray O O
of O O
her O O
pelvis, O O
as O O
she O O
complained O O
of O O
some O O
hip O O
pain. O O
Both O O
studies O O
were O O
negative. O O
Patient O O
was O O
then O O
sent O O
home O O
with O O
Roxicet. O O
Patient O O
was O O
seen O O
in O O
the O O
walk-in O O
clinic O O
at O O
CPI O O
yesterday, O O
after O O
noticing O O
a O O
swollen O O
tongue O O
and O O
some O O
difficulty O O
swallowing. O O
Patient O O
was O O
immediately O O
told O O
to O O
stop O O
both O O
her O O
Roxicet O O
and O O
Monopril B-MEDICATION O
and O O
was O O
treated O O
for O O
angioedema O O
with O O
Zantac O O
and O O
Claritin. O O
Today O O
patient O O
has O O
no O O
further O O
throat O O
tightness O O
or O O
tongue O O
swelling. O O
She O O
is, O O
however, O O
uncomfortable O O
continuing O O
the O O
Effexor O O
for O O
unclear O O
reasons O O
and O O
wants O O
to O O
stop O O
it. O O
Patient O O
is O O
also O O
complaining O O
of O O
severe O O
low O O
back O O
pain, O O
which O O
she O O
says O O
has O O
persisted O O
since O O
her O O
fall O O
on O O
Monday. O O
Did O O
not O O
have O O
an O O
x-ray O O
of O O
the O O
area. O O
Says O O
it O O
is O O
very O O
painful O O
to O O
sit. O O
Roxicet O O
was O O
not O O
helping. O O
She O O
is O O
off O O
her O O
Ultram O O
as O O
well. O O
PHYSICAL O O
EXAM: O O
WD/overweight O O
female O O
in O O
NAD. O O
Vital O O
signs O O
as O O
per O O
LMR, O O
WNL. O O
Weight O O
213 O O
pounds. O O
Lungs O O
- O O
clear O O
bilateral O O
breath O O
sounds. O O
Cor O O
- O O
RRR, O O
S1, O O
S2, O O
without O O
murmur O O
or O O
S3 O O
noted. O O
Back O O
- O O
slightly O O
bent O O
gait. O O
Tenderness O O
over O O
lower O O
sacrum. O O
No O O
asymmetry O O
or O O
obvious O O
deformity. O O
X-ray O O
of O O
sacrum O O
12/13/63 O O
- O O
could O O
not O O
see O O
fracture O O
as O O
per O O
my O O
reading. O O
ASSESSMENT O O
AND O O
PLAN: O O
(1) O O
Angioedema. O O
Agree O O
that O O
most O O
likely O O
culprits O O
are O O
Roxicet O O
since O O
it O O
was O O
started O O
only O O
two O O
days O O
ago, O O
and O O
ACE O O
inhibitors O O
which O O
have O O
been O O
associated O O
with O O
angioedema. O O
Currently O O
on O O
Lopressor B-MEDICATION B-MEDICATION
and O O
Dyazide, B-MEDICATION O
patient's O O
blood O O
pressure O O
is O O
WNL. O O
So O O
will O O
follow O O
for O O
now. O O
(2) O O
Low O O
back O O
pain. O O
Reviewed O O
the O O
possibility O O
of O O
a O O
coccygeal O O
fracture O O
for O O
which O O
treatment O O
would O O
not O O
be O O
any O O
different O O
than O O
pain O O
management O O
and O O
a O O
donut O O
pillow. O O
Patient O O
was O O
given O O
a O O
prescription O O
for O O
the O O
pillow. O O
She O O
was O O
told O O
to O O
look O O
out O O
for O O
signs O O
of O O
nerve O O
compression O O
and O O
to O O
go O O
to O O
the O O
ER O O
if O O
she O O
experienced O O
any O O
perianal O O
numbness O O
or O O
incontinence. O O
Will O O
notify O O
patient O O
by O O
phone O O
if O O
x-ray O O
shows O O
a O O
fracture. O O
(3) O O
Depression. O O
Did O O
not O O
feel O O
I O O
was O O
able O O
to O O
speak O O
freely O O
in O O
front O O
of O O
the O O
patient's O O
spouse. O O
Had O O
been O O
put O O
on O O
the O O
Effexor O O
by O O
Dr. O O
Zeman. O O
Advised O O
patient O O
to O O
let O O
her O O
psychiatrist O O
know O O
that O O
we O O
are O O
tapering O O
her O O
off O O
of O O
the O O
Effexor. O O
Will O O
take O O
25 O O
mg O O
q.o.d. O O
for O O
the O O
next O O
week. O O
(4) O O
Pain O O
control. O O
Will O O
switch O O
from O O
Vicodin O O
to O O
Vicodin O O
ES O O
1 O O
q. O O
6 O O
as O O
needed. O O
Knows O O
to O O
go O O
to O O
ER O O
if O O
experiences O O
any O O
symptoms O O
consistent O O
with O O
angioedema. O O
Return O O
to O O
clinic O O
in O O
approximately O O
one O O
month. O O
Susan O O
Ullom, O O
M.D. O O
SU/utz/rankin O O

Record O O
date: O O
2064-08-28 O O
Patient O O
Name: O O
UMPHREY, O O
FRANKIE; O O
MRN: O O
0942207 O O
Dictated O O
on: O O
08/28/2064 O O
by O O
WHITNEY O O
EASTERLING, O O
M.D. O O
CHIEF O O
COMPLAINT: O O
Falling O O
and O O
low O O
back O O
pain. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
is O O
a O O
66 O O
year O O
old, O O
right-handed O O
female O O
whose O O
past O O
medical O O
history O O
is O O
significant O O
for O O
status O O
post O O
laminectomy O O
at O O
L3 O O
to O O
L5 O O
in O O
January O O
of O O
2061. O O
The O O
patient O O
was O O
in O O
her O O
usual O O
state O O
of O O
health O O
with O O
some O O
residual O O
weakness O O
from O O
the O O
stenosis O O
and O O
occasional O O
buckling O O
of O O
her O O
knees O O
without O O
loss O O
of O O
consciousness O O
until O O
12/01 O O
when O O
she O O
fell O O
backwards. O O
There O O
was O O
no O O
obvious O O
leg O O
buckling. O O
She O O
said O O
she O O
just O O
came O O
off O O
balance O O
without O O
loss O O
of O O
consciousness O O
or O O
dizziness O O
or O O
preceding O O
lightheadedness. O O
Since O O
then O O
she O O
has O O
had O O
several O O
falls O O
always O O
when O O
she O O
is O O
moving. O O
MEDICATIONS: O O
Her O O
medications O O
have O O
included O O
in O O
the O O
past O O
Motrin O O
800 O O
t.i.d. O O
without O O
significant O O
effect O O
on O O
her O O
low O O
back O O
pain. O O
Ultram O O
q.i.d. O O
was O O
beneficial. O O
Neurontin O O
300 O O
q.i.d. O O
which O O
was O O
also O O
beneficial O O
without O O
side O O
effect O O
and O O
chondroitin O O
sulfate O O
which O O
she O O
feels O O
has O O
been O O
very O O
helpful O O
without O O
side O O
effect. O O
REVIEW O O
OF O O
SYSTEMS: O O
She O O
has O O
bilateral O O
dysesthesias, O O
left O O
sciatica O O
to O O
her O O
ankle. O O
She O O
has O O
had O O
weight O O
loss O O
without O O
fevers, O O
chills O O
or O O
night O O
sweat. O O
She O O
has O O
had O O
no O O
retinopathy O O
and O O
she O O
has O O
a O O
history O O
of O O
reflux O O
and O O
otherwise O O
her O O
cardiovascular, O O
pulmonary, O O
GI/GU O O
and O O
musculoskeletal O O
review O O
of O O
systems O O
are O O
unremarkable. O O
PAST O O
MEDICAL O O
HISTORY: O O
Spinal O O
stenosis O O
with O O
a O O
laminectomy O O
at O O
L3, O O
4 O O
and O O
5 O O
in O O
January O O
of O O
2061. O O
She O O
has O O
had O O
left O O
knee O O
arthroscopy. O O
She O O
had O O
mild O O
spinal O O
stenosis O O
at O O
T12 O O
to O O
L1, O O
severe O O
at O O
L3/4 O O
and O O
4/5 O O
with O O
bilateral O O
foraminal O O
disease. O O
She O O
has O O
had O O
a O O
ten O O
year O O
history O O
of O O
diabetes. B-DIABETES O
She O O
has O O
hypertension B-HYPERTENSION O
and O O
hypothyroidism. O O
MEDICATIONS: O O
Synthroid, O O
Premarin, O O
glynase, B-MEDICATION O
glucophage, B-MEDICATION B-MEDICATION
metoprolol B-MEDICATION B-MEDICATION
and O O
Effexor. O O
ALLERGIES: O O
No O O
known O O
drug O O
allergies. O O
SOCIAL O O
HISTORY: O O
She O O
is O O
married. O O
No B-SMOKER O
history I-SMOKER O
of I-SMOKER O
tobacco I-SMOKER O
or O O
alcohol. O O
FAMILY O O
HISTORY: O O
Positive O O
for O O
coronary O O
artery O O
disease, O O
breast O O
cancer O O
and O O
diabetes. O O
PHYSICAL O O
EXAMINATION: O O
She O O
is O O
a O O
well-appearing, O O
well-nourished, O O
66 O O
year O O
old O O
female. O O
Her O O
mental O O
state O O
examination O O
is O O
normal. O O
Cranial O O
nerves O O
II O O
through O O
XII O O
are O O
intact. O O
Motor O O
strength O O
is O O
significant O O
for O O
full O O
strength O O
in O O
the O O
upper O O
extremities O O
as O O
well O O
as O O
the O O
lower O O
extremities. O O
Sensation O O
is O O
intact O O
to O O
all O O
modalities O O
with O O
bilateral O O
lower O O
extremity O O
dysesthesia O O
reported O O
subjectively. O O
DTR's O O
are O O
symmetric O O
with O O
downgoing O O
toes O O
bilaterally. O O
Coordination O O
is O O
intact O O
with O O
no O O
axial O O
or O O
appendicular O O
ataxia. O O
ASSESSMENT O O
AND O O
PLAN: O O
This O O
is O O
a O O
66 O O
year O O
old O O
right-handed O O
female O O
with O O
history O O
of O O
spinal O O
stenosis O O
status O O
post O O
decompression O O
who O O
has O O
a O O
history O O
of O O
falls. O O
We O O
will O O
obtain O O
an O O
MRI O O
of O O
her O O
lumbosacral O O
to O O
evaluate O O
that O O
area O O
for O O
any O O
recurrent O O
pathology O O
or O O
new O O
changes. O O
For O O
her O O
radicular O O
pain O O
will O O
increase O O
her O O
Neurontin O O
400 O O
q.i.d. O O
We O O
would O O
like O O
to O O
obtain O O
EMG O O
with O O
nerve O O
conduction O O
studies O O
of O O
the O O
lower O O
extremities O O
to O O
evaluate O O
possible O O
need O O
for O O
reoperation. O O
The O O
patient O O
will O O
return O O
to O O
clinic O O
after O O
these O O
studies. O O
The O O
patient O O
was O O
seen O O
and O O
evaluated O O
and O O
management O O
was O O
discussed O O
with O O
the O O
attending. O O
_______________________________ O O
Whitney O O
Easterling, O O
M.D. O O
DD:08/28/2064 O O
DT:08/29/2064 O O
DT:2617 O O
:6415 O O

Record O O
date: O O
2066-08-27 O O
Team O O
A O O
Intern O O
Admit O O
Note O O
Patient O O
Name: O O
Tammy O O
Umphrey O O
MR# O O
0942207 O O
Date O O
of O O
Admission: O O
8/26/66 O O
Attending: O O
Yoel O O
Pollard O O
PCP: O O
Susan O O
Ullom O O
CC/ID: O O
70 O O
yo O O
woman O O
with O O
significant O O
disability O O
following O O
cerebral O O
aneurysm O O
rupture O O
1/ O O
66, O O
admitted O O
with O O
likely O O
UTI O O
and O O
question O O
of O O
altered O O
mental O O
status O O
HPI: O O
(As O O
summarized O O
from O O
ED O O
admit O O
note O O
and O O
computer O O
notes, O O
pt O O
is O O
not O O
able O O
to O O
give O O
history O O
and O O
family O O
is O O
not O O
present.) O O
Ms. O O
Umphrey O O
is O O
somewhat O O
cognitively O O
and O O
expressively O O
impaired O O
following O O
rupture O O
of O O
a O O
cerebral O O
aneurysm O O
1/ O O
66; O O
she O O
was O O
required O O
sub-occipital O O
craniotomy, O O
clot O O
evacuation, O O
and O O
placement O O
for O O
a O O
VP O O
shunt. O O
She O O
was O O
transferred O O
to O O
Kingsley O O
County O O
Clinic O O
2/66, O O
and O O
was O O
d/c'd O O
5/31/66. O O
Discharge O O
summary O O
indicates O O
that O O
her O O
baseline O O
at O O
that O O
time O O
included O O
being O O
able O O
to O O
follow O O
1 O O
step O O
commands O O
part O O
of O O
the O O
time O O
and O O
some O O
attempts O O
at O O
communication. O O
She O O
gets O O
nutrition O O
and O O
medication O O
through O O
a O O
G-tube O O
at O O
this O O
point, O O
and O O
has O O
had O O
an O O
indwelling O O
foley O O
catheter. O O
Computer O O
notes O O
suggest O O
that O O
prior O O
to O O
August O O
5, O O
the O O
indwelling O O
foley O O
catheter O O
had O O
been O O
removed. O O
However, O O
the O O
patient's O O
constant O O
incontinence O O
and O O
difficulty O O
keeping O O
a O O
decubitus O O
ulcer O O
dry, O O
the O O
notes O O
suggest O O
that O O
the O O
foley O O
was O O
replaced O O
8/5/66. O O
8/09/66 O O
Ms. O O
Umphrey O O
was O O
taken O O
to O O
the O O
emergency O O
room; O O
the O O
symptoms O O
she O O
was O O
having O O
at O O
that O O
time O O
are O O
not O O
clear. O O
U/A O O
was O O
suggestive O O
of O O
a O O
UTI, O O
and O O
she O O
was O O
treated O O
with O O
a O O
3-day O O
course O O
of O O
levofloxacin. O O
There O O
is O O
no O O
record O O
of O O
her O O
foley O O
catheter O O
being O O
changed O O
at O O
that O O
time, O O
and O O
urine O O
cultures O O
were O O
not O O
sent. O O
Telephone O O
notes O O
from O O
8/23 O O
suggest O O
that O O
Ms. O O
Umphrey O O
had O O
yeast O O
infection O O
and O O
foley O O
blockage; O O
8/25 O O
the O O
VNA O O
checked O O
a O O
U/A O O
at O O
home; O O
results O O
were O O
consistent O O
with O O
a O O
UTI. O O
Her O O
husband O O
reports O O
that O O
she O O
has O O
also O O
been O O
more O O
somnolent O O
and O O
less O O
herself O O
over O O
the O O
last O O
few O O
days. O O
She O O
was O O
sent O O
to O O
the O O
PDI O O
ED O O
for O O
further O O
evaluation. O O
In O O
the O O
ED, O O
repeat O O
U/A O O
was O O
consistent O O
with O O
UTI; O O
urine O O
culture O O
grew O O
abundant O O
staph O O
aureus. O O
She O O
was O O
given O O
a O O
dose O O
of O O
levofloxacin O O
500mg O O
and O O
transferred O O
to O O
the O O
floor. O O
PMH: O O
(Per O O
chart- O O
pt O O
unable O O
to O O
provide O O
history) O O
1. O O
S/P O O
aneurysm O O
rupture, O O
suboccipital O O
craniotomy O O
for O O
microsurgical O O
trapping O O
and O O
clipping O O
of O O
distal O O
PICA O O
aneurysm, O O
and O O
evacuation O O
of O O
4th O O
ventricular O O
clot. O O
2. O O
S/P O O
right O O
VP O O
shunt O O
placement. O O
3. O O
?decubitus O O
ulcer O O
3. O O
History O O
of O O
hypothyroidism. O O
4. O O
Type B-DIABETES O
II I-DIABETES O
diabetes B-DIABETES O
mellitus. I-DIABETES O
5. O O
HTN B-HYPERTENSION O
6. O O
Gastritis O O
7. O O
OA O O
in O O
hips O O
bilaterally O O
Medications: O O
Glyburide B-MEDICATION B-MEDICATION
2.5 I-MEDICATION O
mg I-MEDICATION O
qd I-MEDICATION O
Prozac O O
30mg O O
qd O O
Prevacid O O
30mg O O
qd O O
Synthroid O O
137 O O
mg O O
qd O O
Cozaar B-MEDICATION B-MEDICATION
25mg I-MEDICATION O
qd I-MEDICATION O
Ritalin O O
20mg O O
8am O O
and O O
1pm O O
Lipitor B-MEDICATION B-MEDICATION
10mg I-MEDICATION O
qhs I-MEDICATION O
MVI O O
ASA B-MEDICATION B-MEDICATION
81mg I-MEDICATION O
qd I-MEDICATION O
Colace O O
100mg O O
tid O O
Allergies: O O
finosopril, O O
percocet, O O
erythromycin O O
SH: O O
Lives O O
with O O
husband, O O
who O O
sounds O O
like O O
he O O
is O O
primary O O
caregiver. O O
Has O O
VNA O O
come O O
into O O
home O O
to O O
help O O
with O O
care. O O
Tob: B-SMOKER O
unknown I-SMOKER O
EtOH: O O
unknown O O
Illicits: O O
unknown O O
FH: O O
unknown O O
Exam: O O
VS: O O
T= O O
98.6 O O
HR= O O
80 O O
BP= O O
129/75 O O
RR= O O
20 O O
SaO2= O O
94% O O
on O O
room O O
air O O
General: O O
No O O
acute O O
distress. O O
Sleepy, O O
but O O
easily O O
arousable. O O
HEENT: O O
PER O O
3 O O
to O O
2 O O
bilaterally. O O
Slight O O
crusting O O
over O O
eyelids O O
bilaterally. O O
Anicteric O O
sclera, O O
no O O
conjunctival O O
injection. O O
EOMI. O O
Continuous O O
purposeful O O
tongue O O
movements. O O
Dry O O
mucous O O
membranes, O O
but O O
pt O O
breathes O O
solely O O
through O O
mouth. O O
Skin: O O
Telangiectasias O O
over O O
face O O
and O O
chin. O O
Neck: O O
Supple. O O
Neck O O
plethoric; O O
difficult O O
to O O
assess O O
JVD. O O
Carotids O O
2+ O O
bilaterally, O O
no O O
bruits. O O
No O O
thyromegaly, O O
no O O
cervical O O
adenopathy. O O
Chest: O O
upper O O
airway O O
sounds, O O
otherwise O O
CTA O O
bilat O O
anteriorly. O O
CVS: O O
Difficult O O
to O O
distinguish O O
over O O
upper O O
airway O O
sounds. O O
Abd: O O
Obese. B-OBESE O
Soft, O O
non-distended. O O
Does O O
not O O
appear O O
to O O
be O O
tender. O O
Extr: O O
no O O
clubbing O O
or O O
edema O O
bilaterally. O O
Neuro: O O
Sleeping O O
but O O
arousable, O O
follows O O
simple O O
commands, O O
but O O
not O O
able O O
to O O
answer O O
questions. O O
Good O O
hand O O
squeeze O O
bilaterally. O O
DTRs O O
difficult O O
to O O
elicit O O
in O O
arms, O O
2+ O O
in O O
patellae O O
bilaterally. O O
DATA O O
Chemistry: O O
Plasma O O
Sodium O O
126 O O
L O O
(135-145) O O
mmol/L O O
Plasma O O
Potassium O O
4.0 O O
(3.4-4.8) O O
mmol/L O O
Plasma O O
Chloride O O
89 O O
L O O
(100-108) O O
mmol/L O O
Plasma O O
Carbon O O
Dioxide O O
27.1 O O
(23.0-31.9) O O
mmol/L O O
Calcium O O
10.1 O O
(8.5-10.5) O O
mg/dl O O
Plasma O O
Urea O O
Nitrogen O O
14 O O
(8-25) O O
mg/dl O O
Plasma O O
Creatinine O O
0.6 O O
(0.6-1.5) O O
mg/dl O O
Plasma O O
Glucose O O
101 O O
(70-110) O O
mg/dl O O
Heme: O O
WBC O O
11.5 O O
H O O
(4.5-11.0) O O
th/cmm O O
HCT O O
38.2 O O
(36.0-46.0) O O
% O O
HGB O O
13.5 O O
(12.0-16.0) O O
gm/dl O O
RBC O O
4.53 O O
(4.00-5.20) O O
mil/cmm O O
PLT O O
474 O O
H O O
(150-350) O O
th/cumm O O
MCV O O
84 O O
(80-100) O O
fl O O
MCH O O
29.9 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
35.4 O O
(31.0-37.0) O O
g/dl O O
RDW O O
15.8 O O
H O O
(11.5-14.5) O O
% O O
DIFFERENTIAL O O
REQUEST O O
RECEIVED O O
Diff O O
Method O O
Automated O O
with O O
manual O O
review O O
Poly O O
81 O O
H O O
(40-70) O O
% O O
Lymphs O O
11 O O
L O O
(22-44) O O
% O O
Monos O O
5 O O
(4-11) O O
% O O
EOS O O
3 O O
(0-8) O O
% O O
Basos O O
0 O O
(0-3) O O
% O O
Urinalysis: O O
UA-Color O O
Yellow O O
(YELLOW) O O
UA-Turbidity O O
SLIGHT O O
(CLEAR) O O
UA-Specific O O
Gravity O O
1.010 O O
(1.005-1.035) O O
UA-pH O O
7.5 O O
(5.0-8.5) O O
UA-WBC O O
Screen O O
3+ O O
(NEG) O O
UA-Nitrite O O
POSITIVE O O
(NEG) O O
UA-Albumin O O
Trace O O
(NEG) O O
UA-Glucose O O
NEGATIVE O O
(NEG) O O
UA-Ketones O O
NEGATIVE O O
(NEG) O O
UA-Urobilinogen O O
NEGATIVE O O
(NEG) O O
UA-Bili O O
NEGATIVE O O
(NEG) O O
UA-Occult O O
Blood O O
Trace O O
(NEG) O O
UA-SED-WBC O O
20-50 O O
/hpf O O
UA-SED-RBC O O
0-2 O O
/hpf O O
UA-SED-Bacteria O O
Many O O
/hpf O O
UA-SED-Bladder O O
Cells O O
Few O O
/hpf O O
UA-SED-Amorphous O O
Crystals O O
Many O O
/hpf O O
Microbiology: O O
CXR: O O
The O O
findings O O
are O O
consistent O O
with O O
pulmonary O O
venous O O
hypertension O O
with O O
possible O O
early O O
interstitial O O
edema. O O
Head O O
CT: O O
1. O O
No O O
significant O O
change O O
compared O O
to O O
prior O O
CT O O
Brain-04/18/2066. O O
No O O
change O O
in O O
ventricle O O
size. O O
No O O
acute O O
infarct; O O
although, O O
this O O
is O O
better O O
assessed O O
with O O
MR O O
with O O
diffusion. O O
2. O O
Patchy O O
low O O
attenuation O O
areas O O
in O O
the O O
centrum O O
semiovale O O
bilaterally O O
which O O
are O O
more O O
prominent O O
now O O
and O O
most O O
likely O O
are O O
due O O
to O O
chronic O O
microangiopathic O O
changes O O
in O O
this O O
agroup. O O
EKG: O O
Normal O O
sinus O O
rhythm, O O
normal O O
axis, O O
normal O O
intervals. O O
Flattened O O
T-waves, O O
but O O
not O O
changed O O
from O O
prior O O
exam. O O
No O O
evidence O O
of O O
acute O O
ischemia. O O
Impression: O O
70 O O
yo O O
woman O O
with O O
compromised O O
baseline O O
neurologic O O
function, O O
admitted O O
with O O
complicated O O
UTI O O
and O O
possible O O
change O O
in O O
mental O O
status. O O
Mental O O
status O O
changes: O O
given O O
likely O O
undertreated O O
UTI O O
8/09/66, O O
pt O O
likely O O
has O O
recurrent O O
complicated O O
UTI O O
and O O
may O O
have O O
some O O
mental O O
status O O
alterations O O
from O O
this O O
source. O O
Important O O
to O O
rule O O
out O O
VP-shunt O O
complication O O
as O O
cause O O
of O O
mental O O
status O O
chage, O O
but O O
CT O O
appears O O
unchanged O O
from O O
4/66. O O
Hyponatremia O O
may O O
also O O
be O O
contributing O O
somewhat O O
to O O
mental O O
status O O
changes. O O
-will O O
treat O O
UTI O O
and O O
pursue O O
possibility O O
of O O
urosepsis O O
with O O
blood O O
cultures O O
-will O O
check O O
TSH O O
and O O
am O O
cortisol O O
which O O
could O O
also O O
contribute O O
to O O
mental O O
status O O
changes, O O
particularly O O
given O O
pts O O
history O O
of O O
hypothyroidism O O
UTI O O
-likely O O
UTI- O O
tx O O
-will O O
send O O
blood O O
cultures O O
to O O
assess O O
for O O
sepsis O O
from O O
urinary O O
source O O
-unclear O O
if O O
staph O O
aureus O O
is O O
true O O
urinary O O
pathogen, O O
but O O
will O O
treat O O
with O O
vancomycin O O
until O O
sensitivities O O
come O O
back, O O
then O O
treat O O
with O O
appropriate O O
antibiotic O O
-treat O O
with O O
levoquin O O
for O O
complicated O O
UTI O O
while O O
awaiting O O
final O O
microbiology O O
data O O
-change O O
foley O O
now O O
-resend O O
u/a O O
and O O
culture O O
after O O
1-2 O O
days O O
of O O
antibiotics O O
Hyponatremia- O O
may O O
be O O
contributing O O
to O O
any O O
change O O
in O O
mental O O
status O O
-volume O O
status O O
very O O
difficult O O
to O O
assess- O O
if O O
hypovolemic, O O
likely O O
hypovolemic O O
hyponatremia. O O
If O O
euvolemic, O O
likely O O
SIADH, O O
which O O
could O O
be O O
caused O O
by O O
neurologic O O
process, O O
pain, O O
or O O
infection O O
-given O O
difficulty O O
assessing O O
volume O O
status, O O
will O O
send O O
urine O O
for O O
sodium O O
and O O
osm. O O
If O O
low O O
sodium O O
high O O
osm, O O
likely O O
hypovolemic. O O
If O O
higher O O
sodium, O O
more O O
likely O O
SIADH. O O
DM B-DIABETES O
-will O O
switch O O
patient O O
to O O
ISS O O
for O O
now O O
to O O
assess O O
in-hospital O O
insulin O O
requirements O O
Hypothyroidism- O O
continue O O
levothyroxine O O
at O O
home O O
dose, O O
checking O O
TSH O O
GI/FEN- O O
ranitidine O O
BID, O O
glucerna O O
tube O O
feeds O O
per O O
KCC O O
discharge O O
summary O O
HTN-continue O O
home O O
medications O O
wound O O
care O O
consult O O
requested O O
for O O
report O O
of O O
decubitus O O
ulcer O O
_________________________________ O O
Wendy O O
Randolph O O
MD O O
#61504 O O

Record B-SMOKER O
date: O O
2067-02-12 O O
teaM O O
B O O
Intern O O
Admit O O
Note O O
Pt:Umphrey,Tammy O O
MR#: O O
0942207 O O
Date O O
of O O
Admission: O O
2/11/67 O O
Attending: O O
PCP O O
Dr. O O
Baird O O
(Cleveland O O
Public O O
Institute) O O
Source: O O
Chart O O
and O O
Pt.'s O O
husband O O
- O O
Pt O O
is O O
non-verbal O O
HPI O O
: O O
70yo O O
F O O
PMH O O
of O O
DM, B-DIABETES O
CHF, O O
bullous O O
pemphigoid O O
and O O
HTN, B-HYPERTENSION O
s/p O O
intracranial O O
aneurysm O O
rupture O O
1/66 O O
, O O
s/p O O
VP O O
shunt O O
placement. O O
Pt. O O
is O O
minimally O O
responsive O O
at O O
baseline, O O
cared O O
for O O
at O O
home O O
by O O
her O O
husband O O
with O O
the O O
assistence O O
of O O
VNA. O O
She O O
is O O
s/p O O
suprapubic O O
catheter O O
placement O O
by O O
IR O O
on O O
2/4/2067. O O
She O O
was O O
discharged O O
from O O
PDI O O
on O O
2/09/2067 O O
after O O
an O O
admission O O
for O O
occlusion O O
of O O
her O O
superpublic O O
catheter. O O
She O O
represents O O
to O O
the O O
ED O O
today O O
after O O
her O O
husband, O O
who O O
is O O
the O O
primary O O
care O O
giver O O
noted O O
on O O
the O O
morning O O
of O O
admit O O
that O O
the O O
catheter O O
was O O
not O O
draining, O O
but O O
the O O
pt. O O
was O O
incont. O O
Of O O
urine. O O
He O O
attempted O O
to O O
flush O O
the O O
catheter O O
and O O
was O O
unable O O
to. O O
VNA O O
was O O
called O O
and O O
also O O
attempted O O
to O O
flush O O
the O O
catheter. O O
The O O
VNA O O
nurse O O
noted O O
that O O
it O O
was O O
possible O O
to O O
instill O O
water, O O
but O O
not O O
possible O O
to O O
draw O O
any O O
back. O O
VNA O O
contacted O O
the O O
pts. O O
PCP O O
and O O
IR, O O
who O O
placed O O
the O O
catheter O O
on O O
her O O
previous O O
admit O O
, O O
and O O
the O O
pt. O O
was O O
brought O O
to O O
the O O
ED. O O
PMH: O O
1. O O
s/p O O
IC O O
aneurysm O O
rupture O O
1/66 O O
2. O O
Bullous O O
pemphigoid O O
-biopsy O O
proven O O
2/67 O O
3. O O
DM2 B-DIABETES O
4. O O
HTN O O
5. O O
gastritis O O
6. O O
UTI O O
7. O O
s/p O O
G O O
tube O O
placement O O
8. O O
SIADH O O
9. O O
Aspiration O O
PNA O O
- O O
To O O
complete O O
course O O
of O O
Cefpodoxime/Ceftriaxonew O O
2/16 O O
Meds: O O
Asa B-MEDICATION O
(CHILDRENS) I-MEDICATION O
81MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Mvi O O
ELIXIR O O
(MULTIVITAMIN O O
SOLUTION) O O
5 O O
ML O O
PO O O
QD O O
Colace O O
(DOCUSATE O O
SODIUM) O O
100 O O
MG O O
(100MG O O
TABLET O O
take O O
1) O O
PO O O
TID O O
Synthroid O O
(LEVOTHYROXINE O O
SODIUM) O O
137MCG O O
TABLET O O
PO O O
QD O O
Fluoxetine O O
HCL O O
20MG O O
CAPSULE O O
take O O
1 O O
Capsule(s) O O
PO O O
QD O O
Prevacid O O
(LANSOPRAZOLE) O O
30MG O O
SUSPDR O O
REC O O
JTUBE O O
QD O O
Cozaar B-MEDICATION B-MEDICATION
(LOSARTAN) I-MEDICATION O
25 I-MEDICATION O
MG I-MEDICATION O
(25MG I-MEDICATION O
TABLET I-MEDICATION O
take I-MEDICATION O
1) I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
Ritalin O O
(METHYLPHENIDATE O O
HCL) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) I-MEDICATION O
20 I-MEDICATION O
MG I-MEDICATION O
(20MG I-MEDICATION O
TABLET I-MEDICATION O
take I-MEDICATION O
1) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Ascorbic O B-MEDICATION
ACID O O
1000 O O
MG O O
(500MG/5ML O O
SYRUP O O
take O O
10 O O
ML) O O
PO O O
BID O O
Glyburide B-MEDICATION B-MEDICATION
2.5 I-MEDICATION O
MG I-MEDICATION O
(5MG I-MEDICATION O
TABLET I-MEDICATION O
take I-MEDICATION O
1) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Cefpodoxime O O
200 O O
mg O O
bid O O
x O O
4 O O
more O O
days O O
Allergies: O O
Fosinopril O O
Sodium O O
- O O
Angiodema, O O
tongue O O
swelling, O O
PERCOCET O O
- O O
Angiodema, O O
Erythromycins O O
- O O
SOB O O
levaquin O O
- O O
Rash O O
SH: O O
Pt. O O
cared O O
for O O
at O O
home O O
by O O
husband O O
with O O
VNA. O O
Minimally O O
responsive O O
at O O
baseline. O O
ROS: O O
Bullous O O
lesion O O
, O O
worst O O
along O O
left O O
flank. O O
Exam: O O
VS: O O
BP O O
118/74 O O
P O O
80 O O
T O O
97.0 O O
RR O O
18 O O
98% O O
RA O O
GEN: O O
awake, O O
responds O O
to O O
voice. O O
HEENT: O O
PERRLA, O O
supple, O O
no O O
LAD O O
Lungs: O O
CTAB O O
- O O
anterior O O
Cor: O O
RRR, O O
no O O
mumurs, O O
rubs, O O
gallops O O
Abd: O O
Soft O O
non-tender. O O
BS O O
+ O O
Extr: O O
Scattered O O
bullae O O
on O O
b/l O O
lower O O
extremities. O O
NO O O
decbus. O O
PPP. O O
Neuro: O O
. O O
Opens O O
eyes O O
to O O
voice, O O
some O O
rigidity O O
upper O O
and O O
lower O O
extremities. O O
GU: O O
Superpubic O O
tube O O
in O O
place, O O
site O O
clean O O
with O O
min. O O
erythema, O O
no O O
discharge, O O
Scant O O
drainage O O
in O O
bag. O O
Foley O O
in O O
place O O
draining O O
clear O O
urine. O O
Labs: O O
Hematology O O
Detail O O
for O O
UMPHREY, O O
TAMMY O O
U O O
PDI O O
RANDOM O O
12-Feb-2067 O O
00:27 O O
Accession# O O
8859J84563 O O
Test O O
Description O O
Result O O
Flags O O
Ref. O O
Range O O
Units O O
UA-Color O O
Yellow O O
(YELLOW) O O
UA-Turbidity O O
Clear O O
(CLEAR) O O
UA-Glucose O O
NEGATIVE O O
(NEG) O O
UA-Bili O O
NEGATIVE O O
(NEG) O O
UA-Ketones O O
NEGATIVE O O
(NEG) O O
UA-Specific O O
Gravity O O
1.020 O O
(1.001-1.035) O O
UA-Occult O O
Blood O O
NEGATIVE O O
(NEG) O O
UA-pH O O
5.5 O O
(5.0-9.0) O O
UA-Albumin O O
NEGATIVE O O
(NEG) O O
UA-Urobilinogen O O
NEGATIVE O O
(NEG) O O
UA-Nitrite O O
NEGATIVE O O
(NEG) O O
UA-WBC O O
Screen O O
2+ O O
(NEG) O O
UA-SED-RBC O O
0-2 O O
(0-2) O O
/hpf O O
UA-SED-WBC O O
20-50 O O
(0-2) O O
/hpf O O
UA-SED-Bacteria O O
Few O O
(NEG) O O
/hpf O O
Hyaline O O
Cast O O
5-10 O O
(0-5) O O
/lpf O O
Squamous O O
Cells O O
Few O O
(NEG) O O
/hpf O O
_____________________________________________________________________________________ O O
A/P: O O
70 O O
year O O
old O O
woman O O
s/p O O
IC O O
aneurysm O O
rupture, O O
now O O
with O O
minimally O O
responsive O O
state, O O
presents O O
with O O
occluded O O
superpublic O O
cathere. O O
1) O O
GU O O
- O O
Foley O O
placed O O
in O O
ED. O O
Will O O
send O O
UA/Culture. O O
Contact O O
IR O O
for O O
revision O O
of O O
tube O O
given O O
2nd O O
admission O O
this O O
month O O
for O O
occlusion. O O
2) O O
ID O O
- O O
completing O O
course O O
of O O
cefpodoxime O O
for O O
aspiration O O
pna O O
3) O O
F/E/N O O
- O O
Nocturnal O O
tube O O
feeds, O O
as O O
per O O
home O O
program O O
4) O O
HTN O O
Cozaar, O B-MEDICATION
as O O
per O O
home O O
regimen O O
5) O O
ENDO O O
- O O
RISS, O O
cont. O O
glyburide. B-MEDICATION O
6) O O
Prophy O O
- O O
Nexium, O O
fragmin O O
_______________________________ O O
G. O O
George O O
Vetter, O O
MD O O
Pager O O
05967 O O

Record O O
date: O O
2091-12-28 O O
December O O
28, O O
2091 O O
Nikkolas O O
Nancy-Jasmine O O
693-31-18-1 O O
I O O
saw O O
Nikkolas O O
Nancy-Jasmine O O
today O O
for O O
evaluation O O
concerning O O
his O O
stroke O O
in O O
August O O
2091. O O
The O O
information O O
available O O
today O O
is O O
limited O O
to O O
his O O
knowledge O O
of O O
the O O
events. O O
He O O
is O O
an O O
67-year-old O O
Honduran O O
man O O
with O O
a O O
history O O
of O O
diabetes B-DIABETES O
mellitus I-DIABETES O
and O O
HTN. B-HYPERTENSION O
In O O
August O O
he O O
suffered O O
a O O
stroke. O O
He O O
reports O O
that O O
his O O
speech O O
was O O
affected O O
and O O
that O O
he O O
developed O O
severe O O
right O O
arm O O
and O O
leg O O
weakness O O
without O O
sensory O O
loss. O O
He O O
recalls O O
no O O
problem O O
with O O
his O O
vision. O O
He O O
was O O
hospitalized O O
at O O
Dubuque O O
Obstetrics O O
Gynocology O O
Center. O O
He O O
does O O
no O O
know O O
the O O
extent O O
of O O
the O O
evaluation. O O
He O O
was O O
discharged O O
on O O
aspirin B-MEDICATION O
to O O
Mitchell O O
County O O
Hospital. O O
He O O
is O O
now O O
living O O
at O O
home O O
with O O
his O O
wife O O
and O O
son O O
with O O
visiting O O
nurse O O
assistance. O O
His O O
primary O O
care O O
physician O O
is O O
at O O
Flagler O O
Hospital. O O
He O O
has O O
severe O O
residual O O
weakness O O
of O O
the O O
right O O
arm O O
and O O
leg. O O
He O O
also O O
complains O O
of O O
dizziness O O
and O O
an O O
abnormal O O
numbness O O
in O O
his O O
mouth. O O
The O O
dizziness O O
is O O
worst O O
in O O
the O O
morning. O O
He O O
also O O
notices O O
a O O
noise O O
in O O
his O O
head O O
when O O
he O O
sleeps. O O
He O O
has O O
DM B-DIABETES O
and O O
HTN. O O
He O O
is O O
a O O
nonsmoker. B-SMOKER O
I O O
don't O O
have O O
cholesterol O O
information. O O
There O O
is O O
no O O
history O O
of O O
cardiac O O
disease. O O
There O O
is O O
no O O
history O O
of O O
alcohol O O
abuse. O O
He O O
is O O
currently O O
taking O O
aspirin, O B-MEDICATION
insulin, B-MEDICATION O
antihypertensive O O
medication O O
of O O
some O O
type O O
and O O
possibly O O
a O O
cholesterol O O
lowering O O
agent, O O
although O O
he O O
is O O
no O O
sure O O
of O O
this. O O
He O O
has O O
no O O
known O O
allergies. O O
He O O
is O O
aware O O
of O O
no O O
significant O O
family O O
history. O O
He O O
is O O
married. O O
He O O
lives O O
with O O
his O O
wife O O
and O O
22-year-old O O
son. O O
He O O
came O O
to O O
america O O
from O O
Honduras O O
in O O
2073. O O
He O O
worked O O
nights O O
in O O
construction O O
until O O
his O O
stroke. O O
Pulse O O
66, O O
regular. O O
BP B-HYPERTENSION O
186/110. B-HYPERTENSION O
There O O
are O O
no O O
cranial O O
bruits. O O
The O O
carotid O O
pulses O O
are O O
full O O
with O O
no O O
bruits. O O
The O O
lungs O O
are O O
clear. O O
The O O
heart O O
is O O
regular O O
with O O
no O O
murmur. O O
The O O
abdomen O O
is O O
benign. O O
The O O
mental O O
state O O
is O O
normal; O O
he O O
speaks O O
Spanish O O
and O O
broken O O
English. O O
He O O
is O O
able O O
to O O
name, O O
repeat, O O
and O O
comprehend O O
well. O O
His O O
fluency O O
in O O
his O O
native O O
language O O
is O O
probably O O
normal. O O
Cranial O O
nerves O O
are O O
intact. O O
There O O
is O O
severe O O
weakness O O
of O O
the O O
right O O
arm O O
and O O
leg: O O
right O O
interossei O O
and O O
finger O O
flexors O O
1/5, O O
finger O O
extensors O O
0/5, O O
biceps O O
1/5, O O
triceps O O
0-1/5, O O
deltoid O O
0-1/5. O O
(He O O
tries O O
to O O
raise O O
his O O
arm O O
proximally O O
by O O
elevating O O
the O O
shoulder.) O O
Right O O
iliopsoas O O
2/5, O O
quadriceps O O
2/5, O O
hamstrings O O
1/5, O O
distally O O
0/5. O O
The O O
tone O O
is O O
only O O
mildly O O
increased. O O
Sensation O O
is O O
intact. O O
Reflexes O O
are O O
slghtly O O
brisker O O
in O O
the O O
right O O
upper O O
extremity O O
(RUE O O
2+/4, O O
LUE O O
2/4, O O
knees O O
2+/4, O O
ankles O O
2/4). O O
The O O
right O O
plantar O O
response O O
is O O
mute; O O
he O O
withdraws O O
the O O
left. O O
Coordination O O
is O O
intact; O O
weakness O O
inhibits O O
adequate O O
testing O O
on O O
the O O
right. O O
He O O
wears O O
a O O
right O O
AFO. O O
He O O
can O O
stand O O
up O O
from O O
his O O
wheelchair O O
and O O
bear O O
weight O O
maneuvering O O
himself O O
to O O
the O O
examining O O
table, O O
but O O
he O O
cannot O O
walk O O
unsupported. O O
His O O
examination O O
is O O
most O O
consistent O O
with O O
a O O
right O O
equal O O
arm O O
and O O
leg O O
pure O O
motor O O
hemiparesis, O O
sparing O O
the O O
face. O O
This O O
was O O
likely O O
due O O
to O O
a O O
lacunar O O
infarction O O
in O O
the O O
left O O
basis O O
pontis O O
from O O
small O O
vessel O O
occlusion. O O
He O O
has O O
major O O
stroke O O
risk O O
factors, O O
including O O
DM, O O
HTN, O O
and O O
probably B-HYPERLIPIDEMIA O
hypercholesterolemia. I-HYPERLIPIDEMIA O
Currently O O
his O O
major O O
needs O O
are O O
to O O
establish O O
good O O
control O O
of O O
his O O
blood O O
pressure O O
and O O
to O O
control O O
other O O
risk O O
factors, O O
including O O
optimtal O O
glucose O O
control O O
and O O
likely O O
medication O O
for O O
hyperlipidemia, O O
and O O
to O O
continue O O
physical O O
and O O
occupational O O
therapy O O
to O O
maximize O O
his O O
functional O O
status. O O
To O O
review O O
the O O
studies O O
that O O
were O O
done O O
to O O
investigate O O
his O O
stroke O O
in O O
August, O O
I O O
will O O
request O O
the O O
record O O
of O O
that O O
hospitalization O O
from O O
DOGC. O O
I O O
will O O
also O O
request O O
his O O
records O O
from O O
his O O
physician O O
at O O
the O O
Flagler O O
Hospital. O O
He O O
will O O
certainly O O
need O O
an O O
adjustment O O
of O O
his O O
antihypertensive O O
regimen. O O
He O O
tells O O
me O O
that O O
he O O
is O O
planning O O
to O O
see O O
his O O
PCP O O
for O O
this O O
purpose. O O
I O O
asked O O
him O O
to O O
return O O
here O O
in O O
a O O
month O O
to O O
review O O
this. O O
Sincerely, O O
Patrick O O
Winn, O O
M.D. O O

Record B-SMOKER O
date: O O
2092-05-24 O O
BAYONNE O O
MEDICAL O O
CENTER O O
Internal O O
Medicine O O
15 O O
Hassell O O
Brook O O
Road O O
Daytona O O
Highridge O O
Estates, O O
AZ O O
39757 O O
Nancy-Jasmine, O O
Nikkolas O O
69331181 O O
05/24/92 O O
The O O
patient O O
is O O
a O O
67-year-old O O
man O O
with O O
hypertension, B-HYPERTENSION O
diabetes, B-DIABETES O
and O O
history O O
of O O
recent O O
stroke O O
who O O
comes O O
in O O
for O O
follow O O
up O O
and O O
for O O
evaluation O O
of O O
positive O O
PPD. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
He O O
was O O
being O O
evaluated O O
for O O
day O O
program O O
and O O
in O O
the O O
course O O
of O O
this O O
had O O
a O O
PPD O O
placed O O
which O O
was O O
positive. O O
He O O
has O O
no O O
history O O
of O O
prior O O
TB O O
testing. O O
He O O
has O O
had O O
no O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
cough, O O
fever, O O
chills, O O
weight O O
loss O O
or O O
night O O
sweats. O O
He O O
has O O
had O O
no O O
known O O
exposure O O
to O O
TB. O O
He O O
is O O
being O O
treated O O
for O O
hypertension O O
which O O
has O O
been O O
difficult O O
to O O
control O O
but O O
seems O O
recently O O
to O O
be O O
doing O O
quite O O
well O O
on O O
a O O
combination O O
of O O
HCTZ B-MEDICATION O
12.5mg, O O
metoprolol B-MEDICATION B-MEDICATION
50mg O O
b.i.d., O O
Norvasc B-MEDICATION B-MEDICATION
10mg O O
PO O O
q.d., O O
Zestril B-MEDICATION B-MEDICATION
20mg O O
PO O O
q.d. O O
Today's O O
blood O O
pressure O O
was O O
terrific O O
at O O
128/70. O O
He O O
has O O
diabetes O O
and O O
his O O
hemoglobin B-DIABETES O
A1C I-DIABETES O
came I-DIABETES O
down I-DIABETES O
from I-DIABETES O
10.4 I-DIABETES O
in I-DIABETES O
February I-DIABETES O
to I-DIABETES O
7.9 I-DIABETES O
in I-DIABETES O
May. I-DIABETES O
He O O
had O O
been O O
started O O
in O O
February O O
on O O
Glucophage B-MEDICATION B-MEDICATION
500mg O O
PO O O
b.i.d. O O
and O O
seems O O
to O O
e O O
tolerating O O
it O O
quite O O
well. O O
He O O
did O O
have O O
a O O
stroke O O
in O O
August O O
2091 O O
with O O
right-sided O O
hemiparesis. O O
He O O
is O O
able O O
to O O
walk O O
to O O
the O O
bathroom O O
with O O
a O O
cane O O
but O O
otherwise O O
uses O O
a O O
wheelchair. O O
He O O
had O O
a O O
form O O
for O O
me O O
to O O
complete O O
for O O
a O O
day O O
program O O
listing O O
his O O
typical O O
functioning. O O
PHYSICAL O O
EXAMINATION: O O
He O O
is O O
a O O
well-developed, O O
well-nourished, O O
pleasant O O
man. O O
Weight O O
was O O
not O O
done. O O
Blood O O
pressure O O
128/70. O O
HEENT: O O
throat O O
clear. O O
Neck O O
supple, O O
no O O
adenopathy O O
or O O
thyromegaly. O O
No O O
carotid O O
bruits. O O
No O O
JVD. O O
Heart: O O
no O O
murmurs. O O
Lungs O O
are O O
clear. O O
Extremities: O O
no O O
edema. O O
Neuro: O O
he O O
has O O
weakness O O
in O O
the O O
right O O
leg O O
and O O
arm. O O
ASSESSMENT O O
AND O O
PLAN: O O
1. O O
Positive O O
PPD. O O
At O O
the O O
time O O
of O O
this O O
dictation, O O
his O O
chest O O
x-ray O O
came O O
back O O
and O O
is O O
completely O O
normal. O O
Given O O
his O O
age O O
and O O
unknown O O
duration O O
of O O
his O O
positive O O
PPD, O O
will O O
not O O
treat. O O
2. O O
Hypertension. B-HYPERTENSION O
Doing O O
well O O
on O O
current O O
combination O O
of O O
medications. O O
3. O O
Diabetes, B-DIABETES O
doing O O
much O O
better O O
since O O
he O O
started O O
Glucophage. O O
At O O
his O O
next O O
visit, O O
I O O
will O O
need O O
to O O
confirm O O
when O O
his O O
last O O
eye O O
appointment O O
was. O O
4. O O
Status O O
post O O
CVA. O O
He O O
seems O O
to O O
be O O
functioning O O
well. O O
Nena O O
Quiambao, O O
M.D. O O
NQ:jaeger; O O
80-55488880.doc; O O
DD: O O
5/27/92; O O
DT: O O
5/28/92; O O
DV: O O
5/24/92 O O

Record O O
date: O O
2093-04-28 O O
BMC O O
EMERGENCY O O
DEPT O O
VISIT O O
NANCY-JASMINE,NIKKOLAS O O
693-31-18-1 O O
VISIT O O
DATE: O O
04/28/93 O O
The O O
patient O O
was O O
seen, O O
interviewed O O
and O O
examined O O
by O O
myself O O
as O O
well O O
as O O
Dr. O O
Judd O O
whose O O
note O O
I O O
have O O
reviewed, O O
and O O
whose O O
findings O O
I O O
have O O
confirmed. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
This O O
patient O O
is O O
a O O
68 O O
year-old O O
male O O
who O O
presents O O
with O O
slurred O O
speech. O O
The O O
patient O O
has O O
a O O
history O O
of O O
a O O
prior O O
cerebrovascular O O
accident O O
with O O
residual O O
right O O
sided O O
deficit. O O
One O O
day O O
prior O O
to O O
arrival, O O
the O O
patient O O
was O O
found O O
to O O
have O O
increasing O O
slurring O O
of O O
speech O O
and O O
he O O
was O O
found O O
to O O
increasing O O
weakness O O
over O O
his O O
baseline O O
on O O
the O O
right O O
side. O O
The O O
patient O O
arrives O O
without O O
acute O O
complaints O O
except O O
for O O
difficulty O O
speaking. O O
He O O
denies O O
any O O
headache. O O
He O O
also O O
does O O
complain O O
of O O
some O O
throat O O
pain. O O
REVIEW O O
OF O O
SYSTEMS: O O
Review O O
of O O
systems O O
is O O
as O O
per O O
the O O
written O O
note. O O
The O O
patient O O
denies O O
fevers, O O
chills, O O
chest O O
pain, O O
shortness O O
of O O
breath O O
or O O
dysphagia. O O
PAST O O
MEDICAL O O
HISTORY: O O
The O O
patient's O O
past O O
medical O O
history O O
is O O
significant O O
for O O
hypertension, B-HYPERTENSION O
diabetes B-DIABETES O
mellitus, I-DIABETES O
cerebrovascular O O
accident O O
and O O
otherwise O O
as O O
per O O
the O O
written O O
note. O O
MEDICATIONS: O O
The O O
patient's O O
medications O O
include O O
Tylenol, O O
aspirin, B-MEDICATION B-MEDICATION
Avenida, O O
Glucophage, B-MEDICATION B-MEDICATION
Zoloft, O O
hydrochlorothiazide, B-MEDICATION B-MEDICATION
metoprolol B-MEDICATION B-MEDICATION
and O O
otherwise O O
as O O
per O O
the O O
written O O
note. O O
ALLERGIES: O O
The O O
patient O O
has O O
no O O
known O O
drug O O
allergies. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
The O O
patient's O O
social O O
history O O
and O O
family O O
history O O
are O O
as O O
per O O
the O O
written O O
note O O
and O O
are O O
significant B-SMOKER O
for I-SMOKER O
past B-SMOKER O
tobacco I-SMOKER O
use I-SMOKER O
and O O
no O O
alcohol O O
use. O O
He O O
lives O O
with O O
family O O
and O O
goes O O
to O O
a O O
day O O
care O O
facility. O O
PHYSICAL O O
EXAMINATION: O O
GENERAL: O O
The O O
patient O O
is O O
a O O
well O O
nourished O O
male O O
in O O
no O O
acute O O
distress. O O
VITAL O O
SIGNS: O O
Temperature O O
97, O O
pulse O O
62, O O
respiratory O O
rate O O
16, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
163/96, B-HYPERTENSION O
oxygen O O
saturation O O
100% O O
on O O
room O O
air. O O
NECK: O O
Supple O O
with O O
full O O
range O O
of O O
motion. O O
No O O
nuchal O O
rigidity. O O
LUNGS: O O
Clear O O
to O O
auscultation O O
bilaterally O O
with O O
good O O
air O O
movement. O O
CARDIAC: O O
Regular O O
with O O
ectopy. O O
No O O
murmur O O
is O O
auscultated. O O
NEUROLOGIC: O O
Alert, O O
oriented O O
x O O
3, O O
dysarthric. O O
Finger O O
to O O
nose O O
is O O
within O O
normal O O
limits O O
bilaterally. O O
There O O
is O O
5/5 O O
motor O O
strength O O
throughout O O
the O O
left O O
upper O O
extremity O O
and O O
left O O
lower O O
extremity. O O
The O O
right O O
upper O O
extremity O O
and O O
right O O
lower O O
extremity O O
there O O
is O O
3/5 O O
motor O O
strength O O
throughout O O
all O O
motor O O
groups O O
tested. O O
The O O
patient O O
is O O
able O O
to O O
follow O O
all O O
commands. O O
His O O
ability O O
to O O
understand O O
appears O O
to O O
be O O
completely O O
intact. O O
Further O O
details O O
of O O
the O O
patient's O O
physical O O
examination O O
are O O
as O O
per O O
the O O
written O O
note. O O
LABORATORY O O
EVALUATION: O O
Laboratory O O
studies O O
are O O
significant O O
for O O
a O O
glucose O O
of O O
195, O O
BUN O O
of O O
14, O O
creatinine O O
of O O
1.2, O O
bicarbonate O O
of O O
26, O O
CK O O
of O O
68, O O
toxicology O O
screen O O
which O O
is O O
negative, O O
troponin O O
of O O
0.04, O O
white O O
count O O
of O O
7.4, O O
hematocrit O O
of O O
42.0, O O
platelets O O
of O O
327 O O
and O O
a O O
urinalysis O O
that O O
is O O
pending. O O
A O O
head O O
CT O O
is O O
also O O
pending. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
The O O
patient O O
was O O
interviewed O O
and O O
examined O O
in O O
the O O
emergency O O
department. O O
His O O
past O O
medical O O
records O O
were O O
reviewed. O O
The O O
patient O O
has O O
new O O
neurologic O O
findings O O
on O O
top O O
of O O
an O O
old O O
cerebrovascular O O
accident. O O
CONSULTATIONS O O
(including O O
PCP): O O
The O O
neurology O O
service O O
was O O
therefore O O
consulted O O
and O O
a O O
head O O
CT O O
was O O
ordered. O O
The O O
patient O O
will O O
be O O
admitted O O
to O O
the O O
neurology O O
service O O
for O O
further O O
work O O
up O O
and O O
he O O
will O O
likely O O
also O O
undergo O O
an O O
MRI/MRA. O O
FINAL O O
DIAGNOSIS: O O
Cerebrovascular O O
accident. O O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
The O O
patient O O
is O O
admitted O O
to O O
the O O
neurology O O
service O O
in O O
satisfactory O O
condition. O O
___________________________________ O O
KM855/90247 O O
ALISHA O O
VIOLA, O O
M.D. O O
AV51 O O
D:04/28/93 O O
T:04/28/93 O O
Dictated O O
by: O O
ALISHA O O
VIOLA, O O
M.D. O O
AV51 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record B-SMOKER O
date: O O
2093-07-03 O O
Nathan O O
D. O O
Akins, O O
MD, O O
MPH O O
BMC O O
Internal O O
Medicine O O
Associates O O
96 O O
Hassell O O
Brook O O
Road O O
Daytona O O
Highridge O O
Estates, O O
AZ O O
39757 O O
(742) O O
270-8900 O O
CC: O O
Follow-up O O
from O O
Stroke O O
69 O O
yo O O
man O O
with O O
HTN, B-HYPERTENSION O
DM, B-DIABETES O
CVA O O
in O O
5/93 O O
underwent O O
rehab O O
and O O
is O O
now O O
living O O
at O O
home O O
comes O O
in O O
for O O
follow-up O O
care. O O
He O O
is O O
under O O
the O O
care O O
of O O
Park O O
Nicollet O O
Clinic. O O
I O O
have O O
recently O O
refilled O O
all O O
of O O
his O O
medication. O O
He O O
has O O
no O O
complaints O O
today. O O
He O O
denies O O
F, O O
C, O O
N, O O
V, O O
CP, O O
SOB, O O
abd O O
pain, O O
B/B O O
changes, O O
HA O O
and O O
feels O O
he O O
is O O
getting O O
along O O
well O O
at O O
home. O O
His O O
family O O
helps O O
him O O
greatly. O O
He O O
underwent O O
PT O O
and O O
OT. O O
His O O
home O O
care O O
nurse O O
wants O O
a O O
modified O O
barrium O O
swallow O O
to O O
see O O
if O O
he O O
can O O
be O O
advanced O O
off O O
of O O
thick O O
liquids O O
to O O
solids. O O
He O O
only O O
recently O O
began O O
taking O O
TID O O
metoprolol. O B-MEDICATION
He O O
reports O O
no O O
problems O O
with O O
his O O
medication. O O
MEDICATIONS O O
AVANDIA B-MEDICATION B-MEDICATION
(ROSIGLITAZONE) O O
4 O O
MG O O
PO O O
QD O O
ZOLOFT O O
(SERTRALINE) O O
50MG O O
1 O O
Tablet(s) O O
PO O O
QD O O
EC B-MEDICATION O
ASA B-MEDICATION B-MEDICATION
(ASPIRIN I-MEDICATION O
ENTERIC I-MEDICATION O
COATED) I-MEDICATION O
325MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
GLUCOPHAGE B-MEDICATION B-MEDICATION
(METFORMIN) I-MEDICATION O
850MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
qam I-MEDICATION O
NORVASC B-MEDICATION B-MEDICATION
(AMLODIPINE) I-MEDICATION O
10MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QHS I-MEDICATION O
ZESTRIL B-MEDICATION B-MEDICATION
(LISINOPRIL) I-MEDICATION O
5MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
GLUCOPHAGE B-MEDICATION B-MEDICATION
(METFORMIN) I-MEDICATION O
500MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
qpm I-MEDICATION O
COLACE O O
(DOCUSATE O O
SODIUM) O O
100MG O O
1 O O
Capsule(s) O O
PO O O
BID O O
ZOCOR B-MEDICATION B-MEDICATION
(SIMVASTATIN) I-MEDICATION O
20MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
QHS I-MEDICATION O
PLAVIX B-MEDICATION B-MEDICATION
(CLOPIDOGREL) I-MEDICATION O
75 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
SENNA O O
TABLETS O O
2 O O
TAB O O
PO O O
QHS O O
LOPRESSOR B-MEDICATION B-MEDICATION
(METOPROLOL I-MEDICATION O
TARTRATE) I-MEDICATION O
50MG I-MEDICATION O
1 I-MEDICATION O
Tablet(s) I-MEDICATION O
PO I-MEDICATION O
TID I-MEDICATION O
PE: O O
Gen: O O
WDWN O O
in O O
NAD O O
in O O
wheelchair. O O
VS: O O
BP B-HYPERTENSION O
140/85 I-HYPERTENSION O
P70 O O
HEENT: O O
EOMI, O O
PEERL, O O
OP O O
nl, O O
conjunctiva O O
pink, O O
sclera O O
anicteric. O O
Neck: O O
Supple, O O
no O O
lymphadenopathy O O
Lungs: O O
CTA O O
B O O
CV: O O
RRR O O
no O O
M, O O
r, O O
g. O O
Abd: O O
Soft. O O
NABS, O O
NTND, O O
no O O
HSM O O
Ext: O O
No O O
c/c/e O O
Neuro: O O
Right O O
hemiparesis. O O
A/P: O O
1. O O
s/p O O
CVA: O O
although O O
he O O
has O O
a O O
dense O O
residual O O
deficit. O O
He O O
is O O
getting O O
along O O
relatively O O
well O O
at O O
home. O O
ASA, O B-MEDICATION
plavix. B-MEDICATION B-MEDICATION
Consider O O
additional O O
PT/OT O O
if O O
not O O
receiving O O
at O O
home. O O
Ordered O O
modified O O
barrium O O
swallow O O
in O O
hopes O O
of O O
advancing O O
to O O
solids. O O
2. O O
HTN: O O
elevated O O
pressure O O
today, O O
especially O O
given O O
DM. O O
If O O
remains O O
elevated O O
at O O
next O O
visit O O
would O O
intensify O O
regimen. O O
Metoprolol B-MEDICATION B-MEDICATION
50 O O
tid, O O
zestril B-MEDICATION B-MEDICATION
5 O O
qd, O O
norvasc B-MEDICATION B-MEDICATION
10 O O
qhs. O O
3. O O
DM: O O
Sugars O O
have O O
been O O
in O O
100-200 O O
range. O O
Again, O O
will O O
intensify O O
at O O
next O O
visit O O
if O O
remain O O
elevated O O
now O O
that O O
he O O
is O O
on O O
a O O
stable O O
regimen. O O
Metformin B-MEDICATION B-MEDICATION
500 O O
qpm, O O
rosiglitazone B-MEDICATION O
4 O O
qd. O O
Needs O O
A1C O O
at O O
next O O
visit. O O
4. O O
Chol: O O
on O O
zocor B-MEDICATION O
20 O O
qhs. O O
Will O O
need O O
to O O
re-check O O
fasting O O
cholesterol O O
at O O
next O O
visit. O O
5. O O
Depression: O O
Zoloft O O
50 O O
qd. O O
6. O O
HCM: O O
Deferred O O
- O O
f/u O O
with O O
me O O
in O O
1 O O
month. O O

Record O O
date: O O
2094-02-04 O O
BMC O O
NEUROLOGY O O
ED O O
NOTE O O
Date: O O
2/04/2094 O O
Name: O O
Nancy-Jasmine, O O
Nikkolas O O
MR#: O O
69331181 O O
CC: O O
1 O O
week O O
of O O
improving O O
dysarthria, O O
dysphagia, O O
and O O
vertigo, O O
and O O
persistent O O
difficulty O O
walking, O O
comes O O
in O O
today O O
for O O
medication O O
refill O O
and O O
gait O O
instability O O
HPI: O O
68yo O O
RHM O O
with O O
HTN, B-HYPERTENSION O
NIDDM, B-DIABETES O
2 O O
prior O O
strokes O O
(8/91 O O
5/93) O O
who O O
after O O
running O O
out O O
of O O
his O O
medications O O
in O O
Honduras O O
woke O O
up O O
7 O O
days O O
ago O O
with O O
dysarthria, O O
dysphagia, O O
and O O
rotatory O O
vertigo. O O
He O O
had O O
a O O
L O O
thalamocapsular O O
infarct O O
in O O
8/2091 O O
with O O
R O O
residual O O
hemiparesis, O O
and O O
a O O
R O O
thalamocapsular O O
infarct O O
5/93 O O
with O O
subsequent O O
residual O O
dysarthria. O O
During O O
his O O
May O O
hospitalization O O
he O O
had O O
dysphagia O O
for O O
which O O
he O O
briefly O O
received O O
tube O O
feeds O O
before O O
graduating O O
to O O
POs. O O
He O O
went O O
to O O
Honduras O O
approximately O O
3 O O
months O O
ago, O O
and O O
ran O O
out O O
of O O
many O O
of O O
his O O
medications O O
in O O
the O O
last O O
2 O O
weeks, O O
including O O
plavix, B-MEDICATION B-MEDICATION
lopressor, B-MEDICATION B-MEDICATION
and O O
metformin. B-MEDICATION B-MEDICATION
He O O
self-d/c'd B-MEDICATION O
zestril B-MEDICATION B-MEDICATION
for O O
new O O
nausea O O
that O O
he O O
felt O O
was O O
related. O O
Since O O
symptom O O
onset O O
7 O O
days O O
ago, O O
patient O O
has O O
noted O O
slow O O
improvement O O
in O O
both O O
dysarthria O O
and O O
dysphagia. O O
He O O
continues O O
to O O
note O O
vertigo O O
present O O
sitting, O O
worse O O
standing, O O
and O O
absent O O
supine. O O
He O O
has O O
had O O
difficulty O O
ambulating O O
as O O
well, O O
despite O O
the O O
use O O
of O O
his O O
tripod O O
cane, O O
and O O
his O O
children O O
have O O
helped O O
him O O
at O O
home. O O
He O O
returned O O
from O O
Honduras O O
3 O O
days O O
ago O O
to O O
refill O O
his O O
medications O O
and O O
get O O
his O O
symptoms O O
evaluated. O O
ROS O O
notable O O
for O O
poor O O
vision O O
bilaterally, O O
worse O O
on O O
the O O
L O O
per O O
patient. O O
Pt O O
denied O O
diplopia, O O
trouble O O
chewing, O O
numbness O O
of O O
face, O O
tinnitus. O O
No O O
HA, O O
F/C, O O
V, O O
CP/pressure, O O
SOB, O O
heartburn, O O
constipation, O O
diarrhea, O O
dysuria. O O
Of O O
note, O O
admission O O
FSBG B-DIABETES O
was I-DIABETES O
353. I-DIABETES O
PMH: O O
HTN O O
NIDDM O O
Strokes O O
as O O
above. O O
MRA O O
5/93 O O
showed O O
multifocal O O
stenoses O O
of O O
Circle O O
of O O
Willis O O
with O O
vertebrobasilar O O
insufficiency O O
Positive O O
PPD O O
MEDS: O O
ASA B-MEDICATION B-MEDICATION
325mg I-MEDICATION O
QD, I-MEDICATION O
plavix B-MEDICATION B-MEDICATION
75 I-MEDICATION O
qd I-MEDICATION O
(out), O O
lopressor B-MEDICATION B-MEDICATION
75 I-MEDICATION O
bid I-MEDICATION O
(out), O O
zestril B-MEDICATION B-MEDICATION
30 I-MEDICATION O
qd I-MEDICATION O
(self-d/c'd), O O
norvasc B-MEDICATION B-MEDICATION
10, I-MEDICATION O
metformin B-MEDICATION B-MEDICATION
850 I-MEDICATION O
qd I-MEDICATION O
(out), O O
Avandia B-MEDICATION B-MEDICATION
4 O O
qd, O O
Zoloft O O
25 O O
qd, O O
Zocor B-MEDICATION B-MEDICATION
20 I-MEDICATION O
qd I-MEDICATION O
(unclear O O
if O O
taking), O O
Zantac O O
150 O O
bid O O
ALL: O O
NKDA O O
SH: O O
Tob: B-SMOKER B-MEDICATION
no I-SMOKER O
EtOH: O O
no O O
Street O O
drugs: O O
no O O
Honduran O O
immigrant. O O
9 O O
children, O O
8 O O
live O O
with O O
pt O O
in O O
America. O O
FH: O O
CAD O O
and O O
HTN O O
VS: O O
T: O O
98.8 O O
BP: B-HYPERTENSION O
218/112 B-HYPERTENSION O
P: O O
68 O O
RR: O O
18 O O
O2 O O
sat: O O
96% O O
General: O O
WNWD, O O
NAD, O O
somewhat O O
unkempt O O
HEENT: O O
Anicteric, O O
MMM O O
without O O
lesions, O O
OP O O
clear O O
Neck: O O
Supple, O O
No O O
LAD, O O
no O O
carotid O O
bruits, O O
no O O
thyromegaly O O
CV: O O
RRR O O
s1s2 O O
no O O
m/r/g O O
Resp: O O
CTAB O O
no O O
r/w/r O O
Abd: O O
+BS O O
Soft/NT/ND O O
no O O
HSM/masses O O
Ext: O O
No O O
C/C/E, O O
Distal O O
pulses O O
intact O O
Skin: O O
No O O
rashes, O O
petechiae O O
MS: O O
A&O O O
x O O
3, O O
following O O
commands O O
Speech O O
fluent O O
w/o O O
paraphasic O O
errors O O
No O O
evidence O O
of O O
neglect O O
with O O
visual O O
or O O
tactile O O
stimulation O O
CN: O O
I O O
not O O
tested, O O
II,III O O
PERRL, O O
VFF O O
by O O
confrontation; O O
III,IV,VI O O
EOMI, O O
no O O
nystagmus O O
(supine, O O
sitting, O O
standing), O O
no O O
ptosis; O O
V- O O
sensation O O
intact O O
to O O
LT/PP, O O
masseters O O
strong O O
symmetrically; O O
VII O O
L O O
NLF O O
flattening; O O
VIII O O
hears O O
finger O O
snap; O O
IX,X O O
voice O O
with O O
mild O O
lingual O O
dysarthria, O O
palate O O
elevates O O
symmetrically, O O
gag O O
& O O
swallow O O
intact; O O
XI O O
SCM/Trapezii O O
5/5 O O
B; O O
XII O O
tongue O O
protrudes O O
midline, O O
no O O
atrophy O O
or O O
fasciculations. O O
Vertigo O O
not O O
precipitated O O
on O O
standing. O O
Motor: O O
nl O O
bulk O O
and O O
tone, O O
no O O
tremor, O O
rigidity O O
or O O
bradykinesia. O O
No O O
pronator O O
drift. O O
D O O
Bi O O
Tri O O
WF O O
WE O O
DI O O
Grip O O
Hip O O
flex O O
knee/ext O O
flex O O
dors O O
plant O O
L O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
5 O O
R O O
2 O O
3 O O
2 O O
3 O O
2 O O
1 O O
3 O O
4 O O
4 O O
4 O O
0 O O
0 O O
DTRs: O O
Bi O O
Tri O O
BR O O
Pat O O
Ach O O
Plantar O O
L O O
2 O O
2 O O
2 O O
2 O O
2 O O
up O O
R O O
3 O O
3 O O
3 O O
2 O O
2 O O
down O O
Sensory: O O
LT, O O
vibration, O O
temperature, O O
pinprick O O
intact. O O
Stereognosis O O
& O O
double O O
sim O O
stim O O
is O O
normal. O O
Coord: O O
finger O O
tap O O
rapid O O
on O O
L, O O
cannot O O
do O O
on O O
R, O O
FNF O O
intact O O
on O O
L. O O
HKS O O
intact, O O
foot O O
tap O O
rapid O O
on O O
L, O O
impaired O O
on O O
R. O O
Gait: O O
Unable O O
to O O
stand O O
with O O
legs O O
together O O
and O O
eyes O O
open, O O
retropulsing. O O
Gait O O
unstable, O O
falling O O
back. O O
Labs: O O
Lytes/Renal/Glucose O O
Sodium O O
142 O O
136-142 O O
mmol/L O O
02/04/94 O O
15:15 O O
144(*) O O
05/05/93 O O
06:20 O O
Potassium O O
4.5 O O
3.5-5.0 O O
mmol/L O O
02/04/94 O O
15:15 O O
5.4(*) O O
04/28/93 O O
11:05 O O
Chloride O O
107 O O
98-108 O O
mmol/L O O
02/04/94 O O
15:15 O O
110(*) O O
05/05/93 O O
06:20 O O
Carbon O O
Dioxide O O
26 O O
23-32 O O
mmol/L O O
02/04/94 O O
15:15 O O
21(*) O O
05/04/93 O O
08:38 O O
Blood O O
Urea O O
Nitro O O
9 O O
9-25 O O
mg/dL O O
02/04/94 O O
15:15 O O
Creatinine O O
1.1 O O
0.7-1.3 O O
mg/dL O O
02/04/94 O O
15:15 O O
Glucose B-DIABETES O
195*# I-DIABETES O
54-118 O O
mg/dL O O
02/04/94 O O
15:15 O O
195(*#) O O
02/04/94 O O
15:15 O O
Anion O O
Gap O O
9 O O
3-15 O O
mmol/L O O
02/04/94 O O
15:15 O O
General O O
Chemistries O O
Calcium O O
10.3 O O
8.8-10.5 O O
mg/dL O O
02/04/94 O O
15:15 O O
10.7(*) O O
01/25/92 O O
14:30 O O
Phosphorus O O
3.3 O O
2.4-5.0 O O
mg/dL O O
04/28/93 O O
11:05 O O
Magnesium O O
2.0 O O
1.8-2.5 O O
mg/dL O O
05/05/93 O O
06:20 O O
1.5(*) O O
04/28/93 O O
11:05 O O
Total O O
Bilirubin O O
0.3# O O
0.2-1.2 O O
mg/dL O O
07/08/93 O O
14:58 O O
0.1(*#) O O
04/28/93 O O
11:05 O O
Total O O
Protein O O
6.7 O O
6.0-8.0 O O
g/dL O O
07/08/93 O O
14:58 O O
Albumin O O
3.9 O O
3.7-5.4 O O
g/dL O O
07/08/93 O O
14:58 O O
Globulin O O
2.8 O O
2.0-4.0 O O
g/dL O O
07/08/93 O O
14:58 O O
Amylase O O
32 O O
20-70 O O
U/L O O
02/04/94 O O
15:15 O O
Lipase O O
51 O O
3-60 O O
U/L O O
07/08/93 O O
14:58 O O
Liver O O
Function O O
Tests O O
ALT O O
(SGPT) O O
10 O O
7-52 O O
U/L O O
07/08/93 O O
14:58 O O
6(*) O O
01/25/92 O O
14:30 O O
AST O O
(SGOT) O O
14 O O
9-30 O O
U/L O O
07/08/93 O O
14:58 O O
Alkaline O O
Phospha O O
39 O O
36-118 O O
U/L O O
07/08/93 O O
14:58 O O
Total O O
Bilirubin O O
0.3# O O
0.2-1.2 O O
mg/dL O O
07/08/93 O O
14:58 O O
0.1(*#) O O
04/28/93 O O
11:05 O O
Hematology O O
Complete O O
Blood O O
Count O O
WBC O O
8.05 O O
4-10 O O
K/uL O O
02/04/94 O O
15:15 O O
HCT O O
45.5# O O
40-54 O O
% O O
02/04/94 O O
15:15 O O
38.8(*) O O
07/08/93 O O
14:58 O O
HGB O O
14.9# O O
13.5-18.0 O O
g/dL O O
02/04/94 O O
15:15 O O
13.1(*) O O
07/08/93 O O
14:58 O O
RBC O O
5.40# O O
4.5-6.4 O O
M/uL O O
02/04/94 O O
15:15 O O
PLT O O
390# O O
150-450 O O
K/uL O O
02/04/94 O O
15:15 O O
MCV O O
84.2 O O
80-95 O O
um3 O O
02/04/94 O O
15:15 O O
MCH O O
27.6 O O
27-32 O O
uug O O
02/04/94 O O
15:15 O O
MCHC O O
32.8 O O
32-36 O O
g/dL O O
02/04/94 O O
15:15 O O
RDW O O
14.1 O O
10-14.5 O O
02/04/94 O O
15:15 O O
15.2(*) O O
07/08/93 O O
14:58 O O
Blood O O
Differential O O
% O O
Neutrophils O O
- O O
Au O O
57.6 O O
48-76 O O
02/04/94 O O
15:15 O O
Lymphocytes O O
- O O
Au O O
34.9 O O
18-41 O O
02/04/94 O O
15:15 O O
Monocytes O O
- O O
Auto O O
5.3 O O
2.5-8.5 O O
02/04/94 O O
15:15 O O
Eosinophils O O
- O O
Au O O
1.9 O O
0-5 O O
02/04/94 O O
15:15 O O
Basophils O O
- O O
Auto O O
0.3 O O
0-1.5 O O
02/04/94 O O
15:15 O O
Blood O O
Diff O O
- O O
Absolute O O
Abs O O
Neuts O O
Auto O O
4.63 O O
1.9-7.6 O O
02/04/94 O O
15:15 O O
Abs O O
Lymphs O O
Auto O O
2.81 O O
0.8-4.1 O O
02/04/94 O O
15:15 O O
Abs O O
Monos O O
Auto O O
0.43 O O
.10-0.8 O O
02/04/94 O O
15:15 O O
Abs O O
EOS O O
Auto O O
0.15 O O
0-0.5 O O
02/04/94 O O
15:15 O O
Abs O O
Basos O O
Auto O O
0.02 O O
0.00-0.15 O O
02/04/94 O O
15:15 O O
Hematology O O
Miscellaneous O O
HGB B-DIABETES O
A1C I-DIABETES O
8.3* I-DIABETES O
4.4-6.3 O O
% O O
07/08/93 O O
14:58 O O
8.3(*) O O
07/08/93 O O
14:58 O O
Coagulation O O
Routine O O
Coagulation O O
PT O O
13.1 O O
11.4-14.1 O O
sec O O
02/04/94 O O
15:15 O O
PT-INR O O
1.0 O O
0.9-1.1 O O
02/04/94 O O
15:15 O O
PTT O O
26.3 O O
23.8-36.6 O O
sec O O
02/04/94 O O
15:15 O O
Prior: O O
Lipid O O
Tests O O
Cholesterol O O
236 O O
140-240 O O
mg/dL O O
05/01/93 O O
12:12 O O
Triglycerides O O
187* O O
35-150 O O
mg/dL O O
05/01/93 O O
12:12 O O
187(*) O O
05/01/93 O O
12:12 O O
HDL O O
38* O O
40-60 O O
mg/dL O O
05/01/93 O O
12:12 O O
38(*) O O
05/01/93 O O
12:12 O O
Calculated B-HYPERLIPIDEMIA O
LDL I-HYPERLIPIDEMIA O
161* I-HYPERLIPIDEMIA O
50-160 O O
mg/dL O O
05/01/93 O O
12:12 O O
161(*) O O
05/01/93 O O
12:12 O O
VLDL O O
37 O O
mg/dL O O
05/01/93 O O
12:12 O O
Chemistry O O
Miscellaneous O O
HOMOCYSTEINE O O
12.5* O O
4.5-12.4 O O
umol/L O O
04/30/93 O O
06:47 O O
12.5(*) O O
04/30/93 O O
06:47 O O
LIPOa O O
67* O O
0-30 O O
mg/dL O O
04/30/93 O O
06:47 O O
67(*) O O
04/30/93 O O
06:47 O O
Urinalysis O O
Urinalysis O O
Color O O
YELLOW O O
02/04/94 O O
13:53 O O
Glucose O O
- O O
UA O O
3+ O O
0-0 O O
02/04/94 O O
13:53 O O
Bilirubin O O
NEG O O
02/04/94 O O
13:53 O O
Ketones O O
NEG O O
02/04/94 O O
13:53 O O
Specific O O
Gravity O O
1.023 O O
1.003-1.035 O O
02/04/94 O O
13:53 O O
Occult O O
Blood O O
NEG O O
02/04/94 O O
13:53 O O
pH O O
5.5 O O
4.5-8.0 O O
02/04/94 O O
13:53 O O
Protein O O
TR O O
02/04/94 O O
13:53 O O
Urobilinogen O O
NEG O O
02/04/94 O O
13:53 O O
Nitrites O O
NEG O O
02/04/94 O O
13:53 O O
WBC O O
Screen O O
NEG O O
02/04/94 O O
13:53 O O
Casts O O
NEG O O
02/04/94 O O
13:53 O O
RBC O O
- O O
Urine O O
Sed O O
NEG O O
0-2 O O
02/04/94 O O
13:53 O O
WBC O O
- O O
Urine O O
Sed O O
NEG O O
0-4 O O
02/04/94 O O
13:53 O O
Bacteria O O
NEG O O
02/04/94 O O
13:53 O O
Mucous O O
NEG O O
02/04/94 O O
13:53 O O
Squamous O O
Cells O O
NEG O O
02/04/94 O O
13:53 O O
Crystals O O
NEG O O
02/04/94 O O
13:53 O O
Amorph O O
Crystals O O
NEG O O
02/04/94 O O
13:53 O O
Other/Comments O O
NEG O O
02/04/94 O O
13:53 O O
CXR: O O
clear O O
CT O O
head: O O
bilateral O O
thalamocapsular O O
infarcts O O
CTA: O O
pending O O
MRI/MRA: O O
pending O O
Assessment: O O
68yo O O
RHM O O
with O O
history O O
of O O
bilateral O O
thalamocapsular O O
infarcts O O
and O O
multifocal O O
stenoses O O
of O O
vessels O O
of O O
Circle O O
of O O
Willis, O O
with O O
prior O O
symptoms O O
of O O
dysarthria, O O
dysphagia, O O
and O O
gait O O
instability, O O
here O O
in O O
the O O
setting O O
of O O
medication O O
noncompliance, O O
hypertensive O O
and O O
hyperglycemic, O O
with O O
1 O O
week O O
of O O
recurrent O O
symptoms. O O
Exam O O
notable O O
for O O
absence O O
of O O
vertigo O O
or O O
nystagmus, O O
as O O
well O O
as O O
retropulsing O O
stance O O
and O O
gait. O O
Hyperglycemia O O
and O O
hypertension B-HYPERTENSION O
may O O
well O O
be O O
exacerbating O O
patient's O O
prior O O
deficits. O O
However, O O
cannot O O
rule O O
out O O
possibility O O
of O O
a O O
subacute O O
infarct O O
in O O
the O O
setting O O
of O O
plavix O B-MEDICATION
and O O
antihypertensive O O
discontinuation. O O
Plan: O O
- O O
Check O O
CTA O O
to O O
assess O O
Circle O O
of O O
Willis O O
Check O O
MRI O O
brain O O
stroke O O
protocol O O
Control O O
HTN, O O
goal O O
SBP O O
~160-180 O O
Control O O
hyperglycemia O O
If O O
stroke O O
present, O O
admit O O
to O O
Neurology. O O
R/O O O
MI O O
Discussed O O
with O O
Dr. O O
Costello. O O
Thank O O
you O O
for O O
this O O
interesting O O
consult. O O
_____________________________ O O
Peter O O
Quale, O O
IJ6 O O
pgr O O
20951 O O

Record O O
date: O O
2067-08-15 O O
Neuro O O
30 O O
Caitlyn O O
Circle O O
HEATH, O O
HANNAH O O
Prestonsburg, O O
MS O O
54151 O O
91156456 O O
535-022-8716 O O
08/15/67 O O
CHIEF O O
COMPLAINT: O O
Stroke. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
is O O
a O O
72-year-old O O
right-handed O O
woman O O
with O O
a O O
history O O
of O O
hypertension, B-HYPERTENSION O
diabetes, B-DIABETES O
and O O
hypercholesterolemia B-HYPERLIPIDEMIA O
who O O
was O O
admitted O O
to O O
the O O
Neurology O O
Service O O
on O O
06/18/2067 O O
with O O
right-arm O O
weakness O O
and O O
difficulty O O
speaking. O O
She O O
presented O O
to O O
the O O
Emergency O O
Room O O
5.5 O O
hours O O
after O O
last O O
seeming O O
normal. O O
Her O O
initial O O
NI O O
stroke O O
scale O O
was O O
11. O O
She O O
was O O
admitted O O
to O O
the O O
Neurology O O
Service O O
for O O
a O O
stroke O O
workup. O O
Her O O
imaging O O
studies O O
showed O O
a O O
left O O
MCA O O
infarct O O
involving O O
the O O
left O O
corona O O
radiata, O O
head O O
of O O
the O O
caudate O O
basal O O
ganglia, O O
and O O
an O O
MI O O
cutoff O O
on O O
the O O
CTA O O
and O O
MRA O O
in O O
addition O O
to O O
a O O
left O O
ICA O O
occlusion. O O
She O O
was O O
taken O O
to O O
angiogram O O
for O O
interventional O O
neuroradiology. O O
She O O
had O O
an O O
angiogram. O O
Radiology O O
felt O O
they O O
were O O
unable O O
to O O
access O O
the O O
cause O O
and O O
no O O
intervention O O
was O O
attempted O O
and O O
the O O
patient O O
was O O
admitted O O
to O O
the O O
Neuro O O
ICU O O
for O O
blood O O
pressure O O
monitoring O O
and O O
hypertensive O O
therapy. O O
She O O
remained O O
stable O O
anti-coagulated O O
on O O
heparin. O O
During O O
the O O
hospital O O
stay, O O
she O O
spontaneously O O
converted O O
to O O
rapid O O
ventricular O O
rate O O
atrial O O
fibrillation, O O
which O O
was O O
felt O O
to O O
be O O
the O O
likely O O
source O O
of O O
her O O
stroke O O
and O O
as O O
such O O
was O O
planned O O
to O O
remain O O
anti-coagulated. O O
She O O
was O O
discharged O O
to O O
rehab O O
and O O
subsequently O O
went O O
home O O
from O O
rehab O O
on O O
08/04/2067. O O
At O O
home, O O
she O O
had O O
been O O
noted O O
to O O
have O O
elevations O O
in O O
blood O O
pressure O O
but O O
has O O
been O O
feeling O O
O.K. O O
VNA O O
sees O O
her O O
once O O
a O O
week. O O
At O O
rehab, O O
for O O
unclear O O
reasons, O O
her O O
warfarin O O
was O O
discontinued O O
and O O
in O O
speaking O O
to O O
the O O
discharging O O
physician O O
from O O
the O O
Tracy O O
Medical O O
Clinic, O O
this O O
was O O
done O O
for O O
a O O
question O O
of O O
vaginal O O
bleeding O O
although O O
the O O
patient O O
is O O
unaware O O
of O O
any O O
such O O
problems. O O
She O O
continues O O
to O O
get O O
PT O O
and O O
occupational O O
therapy O O
twice O O
per O O
week O O
and O O
complains O O
that O O
her O O
memory O O
remains O O
poor. O O
According O O
to O O
the O O
family O O
member O O
and O O
her O O
daughter O O
who O O
are O O
here O O
interpreting O O
for O O
her O O
at O O
Clinic O O
today, O O
she O O
continues O O
to O O
have O O
right-sided O O
weakness, O O
although O O
significantly O O
improved O O
and O O
decreased O O
verbal O O
output O O
although O O
her O O
daughter O O
seemed O O
to O O
be O O
able O O
to O O
communicate O O
well O O
with O O
her. O O
Since O O
her O O
discharge, O O
she O O
has O O
not O O
had O O
any O O
new O O
episodes O O
of O O
numbness, O O
weakness, O O
headaches, O O
or O O
visual O O
changes. O O
REVIEW O O
OF O O
SYSTEMS: O O
She O O
denies O O
any O O
fevers, O O
chills, O O
weight O O
loss, O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
palpitations, O O
leg O O
cramps, O O
claudication, O O
dyspnea O O
on O O
exertion, O O
cough, O O
wheezing, O O
hemoptysis, O O
heartburn, O O
abdominal O O
pain, O O
hematemesis, O O
nausea, O O
vomiting, O O
diarrhea, O O
melena, O O
dysuria, O O
changes O O
in O O
bowel O O
or O O
bladder O O
habits, O O
rashes, O O
arthralgias, O O
myalgias, O O
polyuria, O O
polydypsia, O O
breathing, O O
or O O
bleeding O O
problems. O O
Review O O
of O O
neurological O O
systems O O
as O O
above. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension, B-HYPERTENSION B-HYPERTENSION
diabetes, O O
and O O
elevated B-HYPERLIPIDEMIA O
cholesterol. I-HYPERLIPIDEMIA O
MEDICATIONS: O O
Metoprolol, B-MEDICATION B-MEDICATION
Zoloft, O O
Zocor, B-MEDICATION B-MEDICATION
and O O
Captopril. B-MEDICATION B-MEDICATION
ALLERGIES: O O
She O O
has O O
no O O
known O O
drug O O
allergies. O O
SOCIAL O O
HISTORY: O O
The O O
patient O O
lives O O
in O O
Castle O O
Rock O O
with O O
her O O
son. O O
No B-SMOKER O
history I-SMOKER O
of I-SMOKER O
tobacco I-SMOKER O
or O O
alcohol. O O
FAMILY O O
HISTORY: O O
A O O
sister O O
had O O
a O O
stroke. O O
PHYSICAL O O
EXAMINATION: O O
Her O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
was I-HYPERTENSION O
150/80, B-HYPERTENSION O
her O O
heart O O
rate O O
was O O
70, O O
respiratory O O
rate O O
of O O
12. O O
General: O O
Pleasant O O
woman O O
in O O
no O O
acute O O
distress. O O
HEENT: O O
Atraumatic, O O
normocephalic, O O
sclera O O
anicteric, O O
and O O
oropharynx O O
is O O
clear. O O
There O O
is O O
no O O
thyromegaly. O O
Neck: O O
Supple, O O
no O O
bruits, O O
with O O
2+ O O
carotids. O O
Heart: O O
Regular O O
rate O O
and O O
rhythm. O O
Lungs: O O
Clear O O
to O O
auscultation. O O
Abdomen: O O
Has O O
good O O
bowel O O
sounds, O O
soft, O O
nontender, O O
no O O
hepatosplenomegaly. O O
Extremities: O O
No O O
clubbing, O O
cyanosis, O O
or O O
edema. O O
Skin: O O
No O O
rashes O O
or O O
ulcers. O O
Neurological O O
exam O O
(conducted O O
via O O
her O O
daughter O O
and O O
the O O
interpreter): O O
She O O
is O O
alert O O
and O O
oriented. O O
She O O
is O O
attentive. O O
She O O
is O O
non-fluent O O
with O O
really O O
minimal O O
verbal O O
output. O O
She O O
has O O
decreased O O
naming O O
and O O
decreased O O
comprehension. O O
She O O
does O O
not O O
have O O
any O O
neglect O O
or O O
apraxia. O O
Registration O O
is O O
3/4. O O
Short-term O O
memory O O
is O O
0/4 O O
in O O
5 O O
minutes. O O
Pupils O O
are O O
3 O O
and O O
reactive O O
to O O
2 O O
millimeters. O O
Fundi O O
are O O
normal. O O
Extraocular O O
movements O O
are O O
intact O O
with O O
nystagmus. O O
Visual O O
fields O O
are O O
full O O
to O O
confrontation. O O
She O O
has O O
a O O
right O O
facial O O
droop. O O
Facial O O
sensation O O
is O O
intact. O O
Hearing O O
is O O
normal. O O
Motor O O
exam: O O
There O O
is O O
increased O O
muscle O O
tone O O
on O O
the O O
right O O
arm O O
and O O
leg. O O
She O O
has O O
strength O O
on O O
the O O
left O O
is O O
normal. O O
On O O
the O O
right, O O
her O O
strength O O
is O O
at O O
least O O
4/5 O O
in O O
all O O
muscle O O
groups O O
on O O
the O O
left O O
on O O
the O O
neck, O O
except O O
for O O
about O O
3/5 O O
in O O
the O O
distal O O
arm. O O
She O O
reports O O
decreased O O
pinprick O O
and O O
temperature O O
on O O
the O O
right O O
arm. O O
There O O
is O O
no O O
ataxia O O
on O O
the O O
left. O O
Gait O O
is O O
slow, O O
walks O O
with O O
a O O
cane, O O
and O O
so O O
conducts O O
the O O
right O O
leg. O O
Her O O
reflexes O O
are O O
brisker O O
on O O
the O O
right O O
at O O
about O O
3 O O
and O O
she O O
has O O
a O O
right O O
plantar O O
extensor O O
response. O O
IMAGING O O
DATA: O O
Initial O O
head O O
CT O O
on O O
06/18/2067 O O
did O O
not O O
show O O
any O O
acute O O
stroke O O
or O O
hemorrhage. O O
On O O
the O O
CT, O O
there O O
was O O
a O O
question O O
of O O
a O O
left O O
MI O O
cutoff. O O
CT O O
angiogram O O
also O O
showed O O
a O O
distal O O
left O O
ICA O O
stenosis O O
with O O
minimal O O
distal O O
interflow. O O
MRI O O
of O O
the O O
brain O O
showed O O
a O O
left O O
MCA O O
infarction O O
involving O O
the O O
left O O
corona O O
radiata, O O
head O O
of O O
the O O
caudate O O
basal O O
ganglia. O O
She O O
has O O
had O O
mild O O
to O O
moderate O O
chronic O O
small O O
vessel O O
ischemic O O
changes O O
on O O
her O O
MRI. O O
Echo O O
showed O O
a O O
normal O O
EF O O
of O O
55% O O
without O O
any O O
clot, O O
no O O
PFO. O O
IMPRESSION: O O
This O O
is O O
a O O
73-year-old O O
woman O O
with O O
significant O O
vascular O O
risk O O
factors, O O
including O O
paroxysmal O O
atrial O O
fibrillation O O
with O O
a O O
left O O
ICA O O
MCA O O
clot O O
resulting O O
in O O
a O O
left O O
MCA O O
territory O O
infarct. O O
On O O
exam, O O
she O O
has O O
residual O O
aphasia O O
involving O O
both O O
comprehension O O
and O O
fluency; O O
and O O
a O O
moderate O O
right O O
hemiparesis. O O
It O O
is O O
unclear O O
to O O
me O O
why O O
the O O
warfarin O O
was O O
discontinued O O
but O O
given O O
her O O
stroke O O
and O O
the O O
documentation O O
of O O
paroxysmal O O
atrial O O
fibrillation O O
during O O
her O O
hospital O O
stay, O O
I O O
think O O
that O O
she O O
would O O
benefit O O
from O O
anti-coagulation O O
therapy. O O
I O O
have O O
asked O O
her O O
to O O
get O O
a O O
follow O O
up O O
PCP O O
evaluation O O
at O O
the O O
OCH O O
to O O
determine O O
if O O
indeed O O
there O O
are O O
any O O
contraindications O O
to O O
anti-coagulation. O O
If O O
there O O
are O O
no O O
such O O
contraindications, O O
she O O
should O O
restart O O
on O O
warfarin. O O
In O O
addition, O O
her O O
blood O O
pressure O O
is O O
still O O
not O O
well O O
controlled O O
and O O
I O O
would O O
ask O O
her O O
to O O
increase O O
her O O
Captopril O B-MEDICATION
to O O
12.5 O O
mg O O
t.i.d. O O
and O O
to O O
maintain O O
a O O
blood O O
pressure O O
diary. O O
RECOMMENDATIONS: O O
1. O O
Continue O O
anti-hypertensive O O
and O O
increase O O
Captopril O B-MEDICATION
to O O
12.5 O O
mg O O
t.i.d. O O
2. O O
Blood O O
pressure O O
diary O O
for O O
next O O
clinic O O
appointment. O O
3. O O
Continue O O
risk O O
factor O O
modification O O
with O O
the O O
management O O
of O O
blood O O
pressure, O O
diabetes, O O
and O O
hypercholesterol O O
as O O
she O O
is O O
doing. O O
4. O O
PCP O O
evaluation O O
for O O
question O O
of O O
bleeding O O
problem O O
during O O
rehab O O
stay O O
and O O
resumption O O
of O O
warfarin O O
if O O
there O O
are O O
no O O
contraindications O O
per O O
the O O
PCP. O O
5. O O
Continue O O
physical O O
therapy O O
and O O
occupation O O
therapy O O
for O O
gait O O
training O O
and O O
language O O
rehab. O O
6. O O
Return O O
to O O
clinic O O
in O O
6 O O
months O O
or O O
sooner O O
if O O
there O O
are O O
any O O
new O O
problems. O O
More O O
than O O
50% O O
of O O
this O O
clinic O O
visit O O
was O O
spent O O
on O O
patient O O
education O O
and O O
counseling. O O
______________________________ O O
Jordan O O
Namari O O
Akers, O O
MD, O O
PHD O O
Dictated O O
By: O O
Jordan O O
Namari O O
Akers O O
eScription O O
document:7-1410500 O O
VSSten O O
Tel O O
DD: O O
09/16/67 O O
DT: O O
09/16/67 O O
DV: O O
09/16/67 O O

Record O O
date: O O
2069-05-27 O O
May O O
27, O O
2069 O O
Chad O O
Norwood, O O
MD O O
Re: O O
Hannah O O
Heath O O
OCH O O
#: O O
91156456 O O
Dear O O
Dr. O O
Norwood, O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
your O O
patient, O O
Hannah O O
Heath, O O
for O O
consultation O O
in O O
the O O
Vascular O O
dept O O
at O O
the O O
OCH. O O
As O O
you O O
know O O
she O O
is O O
a O O
72 O O
year-old O O
woman O O
with O O
prior O O
stroke. O O
I O O
will O O
review O O
his O O
medical O O
history O O
for O O
our O O
records. O O
HPI: O O
This O O
is O O
a O O
72-year-old O O
right-handed O O
woman O O
with O O
a O O
history O O
of O O
hypertension, B-HYPERTENSION B-HYPERTENSION
diabetes, B-DIABETES O
and O O
hypercholesterolemia B-HYPERLIPIDEMIA O
and O O
PAF O O
with O O
a O O
prior O O
stroke O O
(2067) O O
who O O
subsequently O O
was O O
admitted O O
to O O
the O O
OCH O O
again O O
for O O
SDH O O
with O O
supratherapeutic O O
INR O O
in O O
2068. O O
She O O
has O O
a O O
prolonged O O
hospital O O
course O O
as O O
well O O
as O O
rehab O O
stay O O
and O O
now O O
returns O O
having O O
made O O
significant O O
recovery. O O
She O O
is O O
here O O
with O O
her O O
family O O
who O O
is O O
translating. O O
She O O
ambulates O O
with O O
walker, O O
but O O
does O O
well O O
over O O
short O O
distances O O
without O O
it. O O
She O O
communicates O O
well O O
with O O
eth O O
family O O
and O O
is O O
able O O
to O O
feed O O
and O O
dress O O
herself. O O
She O O
has O O
an O O
aid O O
for O O
bathing O O
three O O
ties O O
per O O
week. O O
She O O
has O O
not O O
needed O O
the O O
PEG O O
tube O O
in O O
the O O
past O O
6 O O
months O O
and O O
is O O
eager O O
to O O
have O O
it O O
removed. O O
She O O
has O O
not O O
had O O
any O O
new O O
episodes O O
of O O
weakness, O O
numbness, O O
visual O O
or O O
language O O
changes. O O
ROS: O O
Denies O O
fevers, O O
chills, O O
chest O O
pain, O O
SOB, O O
palpitations, O O
leg O O
cramps, O O
claudication, O O
DOE, O O
cough, O O
wheezing, O O
hemoptysis, O O
heartburn, O O
abdominal O O
pain, O O
hematemesis, O O
nausea, O O
vomiting, O O
diarrhea, O O
melena, O O
dysuria, O O
changes O O
in O O
bowl O O
or O O
bladder O O
habits, O O
rashes, O O
arthralgia O O
or O O
myalgias, O O
polyuria, O O
polydipsia, O O
bruising O O
or O O
bleeding O O
problems. O O
Review O O
of O O
neurological O O
system O O
as O O
above. O O
PMH: O O
Hypertension B-HYPERTENSION B-HYPERTENSION
Diabetes B-DIABETES O
Elevated B-HYPERLIPIDEMIA O
cholesterol. I-HYPERLIPIDEMIA O
Stroke O O
SDH O O
MEDS: O O
Lipitor B-MEDICATION B-MEDICATION
10mg I-MEDICATION O
qd I-MEDICATION O
Protonix O O
40mg O O
qd O O
Diltiazem B-MEDICATION B-MEDICATION
60mg I-MEDICATION O
qd I-MEDICATION O
Metoprolol B-MEDICATION B-MEDICATION
50mg I-MEDICATION O
qd I-MEDICATION O
ALL: O O
NKDA O O
SHX: B-SMOKER O
Married O O
and O O
lives O O
with O O
her O O
husband. O O
She O O
has O O
a O O
very O O
supportive O O
family. O O
FHX: O O
Sister O O
with O O
seizures. O O
PHYSICAL O O
EXAM: O O
BP: O O
120/60 O O
HR:70 O O
RR: O O
14 O O
GEN: O O
Pleasant O O
woman O O
in O O
NAD. O O
HEENT. O O
AT/NC. O O
Sclera O O
anicteric. O O
OP O O
is O O
clear. O O
There O O
is O O
no O O
thyromegaly. O O
NECK: O O
Supple. O O
No O O
LAD. O O
Carotids O O
are O O
2+ O O
without O O
bruits. O O
HEART: O O
RRR, O O
no O O
m/r/g O O
LUNGS: O O
CTA O O
ABD: O O
+BS. O O
Soft. O O
PEG O O
site O O
inspected. O O
Slightly O O
red O O
margin. O O
No O O
significant O O
drainage O O
at O O
this O O
time. O O
No O O
odor. O O
EXT: O O
No O O
c/c/e O O
SKIN: O O
No O O
rashes O O
or O O
ulcers. O O
NEURO: O O
Cognitive O O
testing O O
limited O O
secondary O O
to O O
language O O
barrier. O O
Alert O O
and O O
oriented. O O
Interacting O O
well O O
in O O
Spanish O O
with O O
her O O
family O O
members. O O
No O O
neglect O O
or O O
apraxias. O O
Pupils O O
3-&gt;2mm. O O
Fundi O O
are O O
normal. O O
EOMI O O
without O O
nystagmus. O O
Right O O
field O O
cut. O O
Right O O
facial. O O
Tongue O O
and O O
palate O O
are O O
midline. O O
Facial O O
sensation O O
is O O
intact. O O
Hearing O O
is O O
normal. O O
On O O
motor O O
exam O O
there O O
is O O
normal O O
muscle O O
bulk, O O
but O O
increased O O
tone O O
right O O
more O O
than O O
left. O O
She O O
has O O
a O O
mild O O
right O O
HP. O O
There O O
is O O
a O O
RPD. O O
On O O
sensory O O
exam, O O
pp/temp/vib O O
are O O
symmetric. O O
There O O
is O O
distal O O
gradient O O
loss O O
of O O
sensation. O O
There O O
is O O
no O O
loss O O
of O O
cortical O O
sensation. O O
There O O
is O O
mild O O
ataxia O O
with O O
FNF O O
and O O
HTS O O
and O O
RAM O O
on O O
the O O
right. O O
Gait O O
is O O
normal O O
based O O
and O O
uses O O
a O O
walker. O O
Reflexes O O
are O O
symmetric. O O
Plantar O O
responses O O
are O O
extensor. O O
DATA: O O
MRI O O
2068: O O
old O O
right O O
MCA O O
stroke O O
CT O O
2068: O O
SDH O O
ASSESSMENT/ O O
RECOMMENDATIONS: O O
72 O O
year-old O O
woman O O
with O O
vascular O O
risk O O
factors O O
including O O
atrial O O
fibrillation O O
and O O
prior O O
stroke O O
with O O
a O O
subsequent O O
SDH O O
with O O
super O O
elevated O O
INR O O
who O O
now O O
returns O O
for O O
follow-up. O O
She O O
has O O
had O O
a O O
significant O O
recovery. O O
Our O O
goal O O
should O O
now O O
be O O
secondary O O
stroke O O
prevention O O
and O O
risk O O
factor O O
modification. O O
Given O O
that O O
her O O
bleed O O
was O O
a O O
SDH O O
and O O
in O O
the O O
setting O O
of O O
elevated O O
INR, O O
it O O
is O O
worth O O
considering O O
restarting O O
warfarin, O O
until O O
then, O O
she O O
should O O
at O O
least O O
be O O
on O O
ASA O O
and O O
I O O
have O O
communicated O O
this O O
with O O
them. O O
She O O
should O O
continue O O
with O O
her O O
BP O O
and O O
cholesterol O O
treatment O O
as O O
well. O O
She O O
is O O
eager O O
to O O
remove O O
the O O
PEG O O
and O O
I O O
will O O
refer O O
her O O
to O O
Dr O O
Queen O O
for O O
this. O O
RTC O O
as O O
needed. O O
Call O O
with O O
questions. O O
More O O
than O O
50% O O
of O O
this O O
visit O O
was O O
spent O O
on O O
patient O O
education O O
and O O
counseling. O O
Thank O O
you O O
for O O
allowing O O
me O O
to O O
participate O O
in O O
the O O
care O O
of O O
your O O
patient. O O
I O O
will O O
continue O O
to O O
follow O O
along O O
with O O
you. O O
Sincerely, O O
Jordan O O
N. O O
Akers, O O
M.D., O O
Ph.D. O O
Department O O
of O O
Neurology O O
Stroke O O
Division O O
Orange O O
City O O
Hospital O O
Prestonsburg, O O
MS O O
54151 O O

Record O O
date: O O
2070-08-28 O O
CC: O O
follow-up O O
HPI: O O
75-year-old O O
woman O O
with O O
a O O
history O O
of O O
hypertension, B-HYPERTENSION B-HYPERTENSION
diabetes, B-DIABETES O
and O O
hypercholesterolemia B-HYPERLIPIDEMIA B-MEDICATION
and O O
PAF O O
with O O
a O O
prior O O
stroke O O
(2067) O O
who O O
subsequently O O
was O O
admitted O O
to O O
the O O
OCH O O
again O O
for O O
SDH O O
with O O
supratherapeutic O O
INR O O
in O O
2068. O O
She O O
has O O
a O O
prolonged O O
hospital O O
course O O
as O O
well O O
as O O
rehab O O
stay O O
and O O
now O O
returns O O
having O O
made O O
significant O O
recovery. O O
Her O O
PEG O O
was O O
pulled-out O O
in O O
06/69. O O
She O O
is O O
here O O
with O O
her O O
husband O O
who O O
is O O
translating O O
from O O
columbian. O O
I O O
saw O O
her O O
about O O
1 O O
month O O
a O O
go O O
with O O
hiperpigmentation O O
of O O
the O O
skin, O O
which O O
I O O
felt O O
was O O
melasma, O O
and O O
treated O O
her O O
with O O
hydroquinone O O
TP, O O
sun O O
blocking O O
cream O O
and O O
avoidance O O
of O O
sun O O
exposure. O O
Both O O
she O O
and O O
her O O
husband O O
say O O
tha O O
her O O
hiperpigmentation O O
has O O
decreased O O
significantly. O O
At O O
present O O
she O O
has O O
no O O
symptoms O O
and O O
says O O
she O O
feels O O
well. O O
She O O
ambulates O O
with O O
a O O
cane, O O
and O O
she O O
is O O
planning O O
a O O
6-month O O
trip O O
to O O
Columbia O O
next O O
October O O
with O O
her O O
husband. O O
She O O
denies O O
any O O
other O O
symptoms: O O
constipation, O O
polydypsia, O O
polyuria, O O
excessive O O
fatigue, O O
weakness O O
Denies O O
fevers, O O
chills, O O
CP, O O
SOB, O O
n/v. O O
GI/GU O O
complaints. O O
PMH: O O
Hypertension B-HYPERTENSION O
Diabetes B-DIABETES O
Elevated B-HYPERLIPIDEMIA O
cholesterol. I-HYPERLIPIDEMIA O
Stroke O O
SDH O O
MEDS O O
Medications O O
(updated O O
8/28/70) O O
LISINOPRIL B-MEDICATION B-MEDICATION
10 O O
MG O O
(30MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
ATORVASTATIN B-MEDICATION B-MEDICATION
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
DILTIAZEM B-MEDICATION B-MEDICATION
60 O O
MG O O
(60MG O O
TABLET O O
take O O
1) O O
PO O O
QID O O
Lopressor B-MEDICATION B-MEDICATION
(METOPROLOL O O
Tartrate) O O
50 O O
MG O O
(50MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
Lasix O O
(FUROSEMIDE) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
ALL: O O
NKDA O O
SHX: B-SMOKER O
Originally O O
from O O
Columbia. O O
Married O O
and O O
lives O O
with O O
her O O
husband. O O
She O O
has O O
a O O
very O O
supportive O O
family. O O
FHX: O O
Sister O O
with O O
seizures. O O
PHYSICAL O O
EXAM: O O
BP: B-HYPERTENSION O
155/75 I-HYPERTENSION O
HR:75 O O
GEN: O O
Pleasant O O
woman O O
in O O
NAD. O O
Amiling, O O
in O O
a O O
wheelchair. O O
Interactve, O O
appropriate O O
reponses. O O
HEENT. O O
AT/NC. O O
Sclera O O
anicteric. O O
OP O O
is O O
clear. O O
There O O
is O O
no O O
thyromegaly. O O
NECK: O O
Supple. O O
No O O
LAD. O O
Carotids O O
are O O
2+ O O
without O O
bruits. O O
HEART: O O
RRR, O O
no O O
m/r/g O O
LUNGS: O O
CTA O O
SKIN: O O
Hyperpigmented O O
skin O O
in O O
face, O O
symmetric O O
distribution, O O
affecting O O
more O O
densely O O
more O O
cephalad O O
areas O O
of O O
her O O
face. O O
The O O
only O O
area O O
which O O
is O O
spaired O O
is O O
the O O
nasolabial O O
region. O O
ASSESSMENT/ O O
RECOMMENDATIONS: O O
No O O
evidence O O
of O O
acute O O
illness. O O
Other O O
problems: O O
1) O O
HTN: B-HYPERTENSION O
on O O
lisinopril B-MEDICATION B-MEDICATION
10 O O
mg O O
po O O
qd, O O
and O O
diltiazem. B-MEDICATION O
Her O O
BP B-HYPERTENSION O
today I-HYPERTENSION O
is I-HYPERTENSION O
slihtly I-HYPERTENSION O
elevated I-HYPERTENSION O
at I-HYPERTENSION O
150/75. I-HYPERTENSION O
I O O
will O O
increase O O
her O O
lisinorpil B-MEDICATION B-MEDICATION
dose. O O
to O O
30 O O
mg O O
po O O
qd. O O
Her O O
las O O
BMP O O
was O O
unremarkable. O O
2) O O
DM: B-DIABETES O
last B-DIABETES O
A1C B-DIABETES O
was I-DIABETES O
7.1 I-DIABETES O
in O O
07/70. O O
She O O
controlls O O
her O O
DM O O
with O O
diet. O O
Urine O O
microabuminuria, O O
UA O O
are O O
pending. O O
3) O O
Lipids: O O
will O O
re-check. O O
On O O
lipitor B-MEDICATION B-MEDICATION
10 O O
mg O O
po O O
qd. O O
5) O O
F/u O O
with O O
me O O
after O O
they O O
return O O
from O O
Columbia O O
_____________________________________________ O O
David O O
Timothy O O
Howard O O
Baldwin, O O
M.D. O O
========================== O O
Preceptor's O O
Note O O
========================== O O
Discussed O O
with O O
Dr. O O
Timothy O O
Howard O O
Baldwin. O O
Agree O O
with O O
assessment O O
and O O
plan O O
as O O
above. O O
_____________________________________________ O O
Caleb O O
N. O O
Womack, O O
M.D.,M.P.H. O O
CC: O O
follow-up O O
HPI: O O
75-year-old O O
woman O O
with O O
a O O
history O O
of O O
hypertension, O O
diabetes, O O
and O O
hypercholesterolemia O O
and O O
PAF O O
with O O
a O O
prior O O
stroke O O
(2067) O O
who O O
subsequently O O
was O O
admitted O O
to O O
the O O
OCH O O
again O O
for O O
SDH O O
with O O
supratherapeutic O O
INR O O
in O O
2068. O O
She O O
has O O
a O O
prolonged O O
hospital O O
course O O
as O O
well O O
as O O
rehab O O
stay O O
and O O
now O O
returns O O
having O O
made O O
significant O O
recovery. O O
Her O O
PEG O O
was O O
pulled-out O O
in O O
06/69. O O
She O O
is O O
here O O
with O O
her O O
husband O O
who O O
is O O
translating O O
from O O
Columbian. O O
I O O
saw O O
her O O
about O O
1 O O
month O O
a O O
go O O
with O O
hiperpigmentation O O
of O O
the O O
skin, O O
which O O
I O O
felt O O
was O O
melasma, O O
and O O
treated O O
her O O
with O O
hydroquinone O O
TP, O O
sun O O
blocking O O
cream O O
and O O
avoidance O O
of O O
sun O O
exposure. O O
Both O O
she O O
and O O
her O O
husband O O
say O O
tha O O
her O O
hiperpigmentation O O
has O O
decreased O O
significantly. O O
At O O
present O O
she O O
has O O
no O O
symptoms O O
and O O
says O O
she O O
feels O O
well. O O
She O O
ambulates O O
with O O
a O O
cane, O O
and O O
she O O
is O O
planning O O
a O O
6-month O O
trip O O
to O O
Columbia O O
next O O
October O O
with O O
her O O
husband. O O
She O O
denies O O
any O O
other O O
symptoms: O O
constipation, O O
polydypsia, O O
polyuria, O O
excessive O O
fatigue, O O
weakness O O
Denies O O
fevers, O O
chills, O O
CP, O O
SOB, O O
n/v. O O
GI/GU O O
complaints. O O
PMH: O O
Hypertension O O
Diabetes O O
Elevated O O
cholesterol. O O
Stroke O O
SDH O O
MEDS O O
Medications O O
(updated O O
8/28/70) O O
LISINOPRIL O B-MEDICATION
10 O O
MG O O
(30MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
ATORVASTATIN O B-MEDICATION
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
DILTIAZEM O B-MEDICATION
60 O O
MG O O
(60MG O O
TABLET O O
take O O
1) O O
PO O O
QID O O
Lopressor O B-MEDICATION
(METOPROLOL O O
Tartrate) O O
50 O O
MG O O
(50MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
Lasix O O
(FUROSEMIDE) O O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
ALL: O O
NKDA O O
SHX: O O
Originally O O
from O O
Columbia. O O
Married O O
and O O
lives O O
with O O
her O O
husband. O O
She O O
has O O
a O O
very O O
supportive O O
family. O O
FHX: O O
Sister O O
with O O
seizures. O O
PHYSICAL O O
EXAM: O O
BP: O O
155/75 O O
HR:75 O O
GEN: O O
Pleasant O O
woman O O
in O O
NAD. O O
Amiling, O O
in O O
a O O
wheelchair. O O
Interactve, O O
appropriate O O
reponses. O O
HEENT. O O
AT/NC. O O
Sclera O O
anicteric. O O
OP O O
is O O
clear. O O
There O O
is O O
no O O
thyromegaly. O O
NECK: O O
Supple. O O
No O O
LAD. O O
Carotids O O
are O O
2+ O O
without O O
bruits. O O
HEART: O O
RRR, O O
no O O
m/r/g O O
LUNGS: O O
CTA O O
SKIN: O O
Hyperpigmented O O
skin O O
in O O
face, O O
symmetric O O
distribution, O O
affecting O O
more O O
densely O O
more O O
cephalad O O
areas O O
of O O
her O O
face. O O
The O O
only O O
area O O
which O O
is O O
spaired O O
is O O
the O O
nasolabial O O
region. O O
ASSESSMENT/ O O
RECOMMENDATIONS: O O
No O O
evidence O O
of O O
acute O O
illness. O O
Other O O
problems: O O
1) O O
HTN: O O
on O O
lisinopril O B-MEDICATION
10 O O
mg O O
po O O
qd, O O
and O O
diltiazem. O O
Her O O
BP O O
today O O
is O O
slihtly O O
elevated O O
at O O
150/75. O O
I O O
will O O
increase O O
her O O
lisinorpil O B-MEDICATION
dose. O O
to O O
30 O O
mg O O
po O O
qd. O O
Her O O
las O O
BMP O O
was O O
unremarkable. O O
2) O O
DM: O O
last O O
A1C O O
was O O
7.1 O O
in O O
07/70. O O
She O O
controlls O O
her O O
DM O O
with O O
diet. O O
Urine O O
microabuminuria, O O
UA O O
are O O
pending. O O
3) O O
Lipids: O O
will O O
re-check. O O
On O O
lipitor O B-MEDICATION
10 O O
mg O O
po O O
qd. O O
5) O O
F/u O O
with O O
me O O
after O O
they O O
return O O
from O O
Columbian O O
_____________________________________________ O O
David O O
Timothy O O
Howard O O
Baldwin, O O
M.D. O O
========================== O O
Preceptor's O O
Note O O
========================== O O
Discussed O O
with O O
Dr. O O
Timothy O O
Howard O O
Baldwin. O O
Agree O O
with O O
assessment O O
and O O
plan O O
as O O
above. O O
_____________________________________________ O O
Caleb O O
N. O O
Womack, O O
M.D.,M.P.H. O O

Record B-SMOKER O
date: O O
2072-03-01 O O
EDVISIT^91156456^HEATH, O O
HANNAH^03/01/72^YEAGER, O O
CHRISTOPHER O O
I O O
saw O O
this O O
patient O O
with O O
Dr. O O
Rosalia O O
West. O O
I O O
confirm O O
that O O
I O O
have O O
interviewed O O
and O O
examined O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation O O
on O O
the O O
patient's O O
chart, O O
and O O
discussed O O
the O O
evaluation, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient. O O
Please O O
see O O
the O O
resident's O O
note O O
for O O
further O O
details. O O
CHIEF O O
COMPLAINT: O O
Altered O O
mental O O
status. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
76-year-old O O
female O O
with O O
history O O
of O O
prior O O
strokes, O O
hypertension, B-HYPERTENSION O
diabetes, B-DIABETES O
and O O
paroxysmal O O
atrial O O
fibrillation, O O
who O O
presents O O
with O O
altered O O
mental O O
status. O O
As O O
per O O
report, O O
the O O
patient O O
has O O
not O O
been O O
acting O O
like O O
herself O O
and O O
not O O
communicating O O
or O O
speaking O O
like O O
herself. O O
The O O
patient O O
was O O
in O O
her O O
usual O O
state O O
of O O
health O O
until O O
a O O
few O O
days O O
ago O O
where O O
she O O
started O O
to O O
develop O O
a O O
cough O O
as O O
well O O
as O O
some O O
chills. O O
The O O
patient's O O
family O O
members O O
state O O
that O O
the O O
patient O O
has O O
not O O
been O O
out O O
of O O
bed O O
and O O
has O O
been O O
unwilling O O
to O O
eat. O O
The O O
patient's O O
family O O
members O O
state O O
that O O
the O O
patient O O
is O O
not O O
acting O O
like O O
her O O
usual O O
self. O O
The O O
patient's O O
family O O
members O O
deny O O
noting O O
the O O
patient O O
complaining O O
of O O
any O O
nausea, O O
vomiting, O O
chest O O
pain O O
or O O
shortness O O
of O O
breath. O O
The O O
patient O O
was O O
actually O O
taken O O
to O O
clinic O O
yesterday O O
because O O
the O O
patient O O
was O O
starting O O
to O O
speak O O
less. O O
The O O
patient O O
was O O
seen O O
clinic O O
and O O
was O O
thought O O
to O O
be O O
depressed. O O
The O O
patient O O
has O O
a O O
known O O
history O O
of O O
a O O
facial O O
droop. O O
The O O
patient O O
was O O
incontinent O O
of O O
urine O O
today. O O
PHYSICAL O O
EXAMINATION: O O
The O O
patient's O O
vital O O
signs O O
reveal O O
the O O
following: O O
Temperature O O
was O O
102.8, O O
heart O O
rate O O
110-160 O O
beats O O
per O O
minute, O O
respiratory O O
rate O O
20, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
144/110, I-HYPERTENSION O
and O O
oxygen O O
saturation O O
was O O
95% O O
on O O
room O O
air. O O
The O O
patient's O O
oxygen O O
saturation O O
was O O
interpreted O O
as O O
borderline O O
low. O O
General: O O
No O O
acute O O
distress, O O
multiple O O
family O O
members O O
at O O
bedside. O O
HEENT: O O
The O O
patient's O O
head O O
was O O
normocephalic O O
and O O
atraumatic, O O
no O O
scalp O O
hematomas. O O
Pupils O O
were O O
equal, O O
round, O O
and O O
reactive O O
to O O
light. O O
Mucous O O
membranes O O
were O O
somewhat O O
dry, O O
right O O
facial O O
droop O O
noted, O O
no O O
drooling. O O
Neck: O O
Supple, O O
no O O
JVD, O O
no O O
carotid O O
bruits O O
appreciated. O O
There O O
was O O
no O O
meningismus. O O
Respiratory: O O
Poor O O
cooperation O O
with O O
exam. O O
Fair O O
aeration, O O
no O O
focal O O
rhonchi, O O
rales, O O
or O O
wheezes, O O
no O O
increased O O
work O O
of O O
breathing O O
or O O
use O O
of O O
accessory O O
muscles O O
was O O
noted. O O
Cardiovascular: O O
Irregularly O O
irregular, O O
tachycardic, O O
unable O O
to O O
appreciate O O
any O O
gross O O
murmurs, O O
rubs, O O
or O O
gallops. O O
GI: O O
Abdomen: O O
Soft, O O
no O O
rebound O O
or O O
guarding, O O
prior O O
well-healed O O
prior O O
G-tube O O
scar O O
noted. O O
Rectal O O
exam O O
deferred. O O
GU O O
exam: O O
The O O
patient O O
was O O
incontinent O O
of O O
urine. O O
Skin: O O
Warm O O
and O O
dry. O O
No O O
rash O O
or O O
lesions O O
were O O
noted. O O
Back: O O
The O O
patient O O
did O O
not O O
have O O
any O O
costovertebral O O
angle O O
tenderness. O O
There O O
is O O
no O O
midline O O
thoracic, O O
lumbar, O O
or O O
sacral O O
spine O O
tenderness O O
to O O
palpation. O O
Extremities: O O
Warm O O
and O O
well O O
perfused, O O
no O O
clubbing, O O
cyanosis O O
or O O
asymmetrical O O
lower O O
extremity O O
edema O O
was O O
noted. O O
There O O
were O O
no O O
palpable O O
cords. O O
Neuro: O O
The O O
patient O O
was O O
alert, O O
the O O
patient O O
was O O
a O O
verbal. O O
The O O
patient O O
grossly O O
moved O O
all O O
4 O O
extremities O O
with O O
fair O O
strength. O O
The O O
patient O O
responded O O
to O O
touch O O
appropriately. O O
The O O
patient O O
was O O
unable O O
to O O
cooperate O O
with O O
cranial O O
nerve O O
examination. O O
INITIAL O O
IMPRESSION O O
AND O O
PLAN: O O
The O O
patient O O
is O O
a O O
76-year-old O O
female O O
with O O
history O O
of O O
prior O O
stroke, O O
hypertension, O O
diabetes, O O
and O O
paroxysmal O O
atrial O O
fibrillation, O O
who O O
presents O O
with O O
altered O O
mental O O
status O O
and O O
urinary O O
incontinence. O O
Differential O O
diagnosis O O
at O O
this O O
time O O
includes O O
infectious O O
versus O O
a O O
metabolic O O
abnormality. O O
The O O
patient O O
has O O
no O O
new O O
deficits O O
on O O
neuro O O
exam O O
as O O
per O O
the O O
family O O
and O O
as O O
per O O
review O O
of O O
prior O O
notes. O O
Repeat O O
stroke O O
is O O
certainly O O
on O O
the O O
differential, O O
however, O O
I O O
have O O
a O O
lower O O
suspicion O O
then O O
for O O
a O O
metabolic O O
or O O
infectious O O
etiology. O O
The O O
patient O O
will O O
need O O
to O O
have O O
a O O
large O O
workup O O
including O O
laboratory O O
studies, O O
urine O O
studies, O O
Foley O O
catheter, O O
portable O O
chest O O
x-ray, O O
and O O
repeat O O
noncontrast O O
head O O
CT O O
scan. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
Upon O O
arrival O O
to O O
the O O
Emergency O O
Department, O O
the O O
patient O O
had O O
history O O
and O O
physical O O
exam O O
performed. O O
The O O
patient O O
was O O
noted O O
to O O
be O O
in O O
atrial O O
fibrillation O O
with O O
rapid O O
ventricular O O
response. O O
The O O
patient's O O
12-lead O O
EKG O O
revealed O O
a O O
rate O O
of O O
166 O O
beats O O
per O O
minute, O O
atrial O O
fibrillation O O
with O O
rapid O O
ventricular O O
response, O O
stable O O
T-wave O O
inversions O O
noted O O
over O O
the O O
lateral O O
leads O O
as O O
well O O
as O O
over O O
the O O
precordial O O
leads. O O
No O O
definite O O
ST O O
segment O O
abnormalities O O
were O O
noted. O O
The O O
patient O O
then O O
had O O
a O O
portable O O
chest O O
x-ray O O
and O O
as O O
per O O
report, O O
the O O
patient's O O
portable O O
chest O O
x-ray O O
did O O
not O O
reveal O O
any O O
acute O O
cardiopulmonary O O
process O O
or O O
findings. O O
The O O
patient O O
did O O
have O O
a O O
noncontrast O O
head O O
CT O O
scan O O
and O O
the O O
patient's O O
noncontrast O O
head O O
CT O O
scan O O
was O O
notable O O
for O O
some O O
right-sided O O
edema. O O
The O O
patient O O
will O O
have O O
this O O
followed O O
up O O
with O O
an O O
MRI O O
of O O
the O O
brain. O O
The O O
patient's O O
laboratory O O
studies O O
were O O
notable O O
for O O
sodium O O
of O O
131 O O
and O O
potassium O O
of O O
5.2. O O
The O O
patient's O O
lactic O O
acid O O
was O O
1.7. O O
The O O
patient's O O
white O O
blood O O
cell O O
count O O
was O O
not O O
elevated. O O
The O O
patient O O
was O O
not O O
anemic. O O
The O O
patient's O O
urinalysis O O
was O O
consistent O O
with O O
infection. O O
The O O
patient's O O
first O O
set O O
of O O
cardiac O O
markers O O
were O O
negative. O O
The O O
patient's O O
coagulation O O
studies O O
were O O
normal. O O
The O O
patient O O
was O O
treated O O
with O O
ceftriaxone O O
for O O
her O O
urinary O O
tract O O
infection. O O
The O O
patient O O
could O O
possibly O O
have O O
urosepsis O O
given O O
her O O
fever O O
and O O
tachycardia. O O
Urine O O
sepsis O O
is O O
my O O
leading O O
diagnosis O O
at O O
this O O
time. O O
The O O
patient's O O
right-sided O O
edema O O
is O O
certainly O O
concerning, O O
however, O O
I O O
do O O
not O O
feel O O
that O O
the O O
patient O O
will O O
need O O
to O O
be O O
admitted O O
to O O
Neurology O O
at O O
this O O
time. O O
The O O
patient O O
will O O
be O O
admitted O O
to O O
medicine O O
for O O
presumed O O
urosepsis. O O
The O O
patient O O
will O O
need O O
to O O
be O O
admitted O O
to O O
a O O
monitor O O
bed. O O
The O O
patient's O O
blood O O
pressure O O
is O O
normal, O O
and O O
as O O
such, O O
I O O
do O O
not O O
feel O O
that O O
the O O
patient O O
needs O O
an O O
intensive O O
care O O
unit O O
bed. O O
In O O
terms O O
the O O
patient's O O
atrial O O
fibrillation O O
with O O
rapid O O
ventricular O O
response, O O
the O O
patient O O
was O O
given O O
metoprolol O B-MEDICATION
IV. O O
The O O
patient O O
was O O
not O O
given O O
any O O
oral O O
medications O O
secondary O O
to O O
her O O
possible O O
stroke. O O
The O O
patient O O
was O O
given O O
rectal O O
Tylenol O O
as O O
well O O
as O O
rectal O O
Kayexalate O O
for O O
her O O
elevated O O
potassium O O
at O O
5.2. O O
PRIMARY O O
DIAGNOSES: O O
1. O O
Urosepsis. O O
2. O O
Atrial O O
fibrillation O O
with O O
rapid O O
ventricular O O
response. O O
3. O O
Hyponatremia. O O
4. O O
Hyperkalemia. O O
DISPOSITION: O O
The O O
patient O O
was O O
admitted O O
to O O
the O O
Medicine O O
and O O
to O O
a O O
monitor O O
bed. O O
CONDITION O O
AT O O
THE O O
TIME O O
OF O O
DISPOSITION: O O
Stable, O O
but O O
guarded. O O
______________________________ O O
YEAGER, O O
CHRISTOPHER O O
M.D. O O
D: O O
03/01/72 O O
T: O O
03/01/72 O O
Dictated O O
By: O O
YEAGER, O O
CHRISTOPHER O O
eScription O O
document:4-2135677 O O
IFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2092-08-16 O O
EDVISIT^06129040^MACK, O O
ROSE^08/16/92^GRAHAM, O O
ANGELA O O
This O O
patient's O O
visit O O
was O O
shared O O
with O O
PA, O O
Quiring. O O
I O O
also O O
personally O O
interviewed O O
and O O
examined O O
this O O
patient. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
is O O
a O O
50-year-old O O
female O O
with O O
past O O
medical O O
history O O
of O O
type B-DIABETES O
1 I-DIABETES O
diabetes, B-DIABETES O
peripheral O O
vascular O O
disease, O O
and O O
hypothyroidism O O
who O O
presents O O
for O O
evaluation O O
of O O
an O O
infected O O
left O O
heel O O
ulcer. O O
The O O
patient O O
is O O
status O O
post O O
bypass O O
grafting O O
in O O
her O O
lower O O
extremities O O
and O O
skin O O
grafting O O
of O O
a O O
nonhealing O O
ulcer O O
on O O
her O O
right O O
heel. O O
Since O O
that O O
time, O O
she O O
has O O
developed O O
a O O
chronic O O
nonhealing O O
ulcer O O
on O O
the O O
left O O
heel, O O
which O O
has O O
been O O
followed O O
closely O O
by O O
VNA. O O
Today, O O
she O O
was O O
seen O O
by O O
her O O
VNA O O
who O O
was O O
very O O
concerned O O
about O O
redness O O
and O O
swelling O O
of O O
her O O
left O O
foot O O
with O O
redness O O
that O O
extended O O
underneath O O
the O O
plantar O O
surface O O
of O O
the O O
foot O O
and O O
over O O
the O O
dorsal O O
surface O O
and O O
concern O O
for O O
infection O O
of O O
this O O
ulcer. O O
The O O
patient O O
has O O
minimal O O
sensation O O
in O O
the O O
left O O
foot. O O
She O O
states O O
sometimes O O
she O O
can O O
feel O O
a O O
pressure O O
sensation. O O
She O O
does O O
have O O
some O O
pain O O
when O O
she O O
tries O O
to O O
weightbear, O O
has O O
not O O
noted O O
any O O
fevers, O O
has O O
noted O O
some O O
chills O O
and O O
states O O
that O O
her O O
fingerstick O O
earlier O O
today O O
was O O
elevated. O O
She O O
denies O O
any O O
abdominal O O
pain, O O
nausea, O O
or O O
vomiting. O O
She O O
does O O
note O O
that O O
her O O
foot O O
does O O
appear O O
to O O
be O O
somewhat O O
slightly O O
more O O
swollen O O
but O O
has O O
not O O
noticed O O
redness O O
up O O
until O O
today. O O
PAST O O
MEDICAL O O
HISTORY: O O
Positive O O
for O O
hypothyroidism, O O
type B-DIABETES O
1 I-DIABETES O
diabetes, I-DIABETES O
and O O
peripheral O O
vascular O O
disease O O
with O O
a O O
nonhealing O O
diabetic O O
foot O O
ulcers. O O
PAST O O
SURGICAL O O
HISTORY: O O
She O O
is O O
status O O
post O O
femoral O O
bypass O O
grafting, O O
thyroidectomy, O O
skin O O
grafting O O
for O O
nonhealing O O
wounds, O O
and O O
right O O
foot O O
debridement O O
in O O
the O O
past. O O
SOCIAL O O
HISTORY: O O
She B-SMOKER O
smoked I-SMOKER O
in I-SMOKER O
the I-SMOKER O
past, I-SMOKER O
does O O
not O O
drink. O O
She O O
lives O O
with O O
family, O O
is O O
followed O O
by O O
a O O
VNA, O O
and O O
is O O
not O O
working. O O
FAMILY O O
HISTORY: O O
Reviewed O O
and O O
is O O
also O O
positive O O
for O O
diabetes. O O
REVIEW O O
OF O O
SYSTEMS: O O
All O O
other O O
systems O O
reviewed O O
and O O
otherwise O O
negative O O
except O O
per O O
the O O
HPI. O O
MEDICATIONS: O O
Insulin. B-MEDICATION O
ALLERGIES: O O
She O O
has O O
an O O
allergy O O
to O O
codeine, O O
aspirin, O B-MEDICATION
erythromycin, O O
oxycodone, O O
and O O
sulfa. O O
PHYSICAL O O
EXAMINATION: O O
Her O O
temperature O O
is O O
98.6, O O
her O O
pulse O O
105, O O
respirations O O
16, O O
blood O O
pressure O O
117/70, O O
and O O
O2 O O
saturations O O
are O O
100% O O
on O O
room O O
air. O O
The O O
patient O O
is O O
awake, O O
alert, O O
frail, O O
and O O
thin O O
female. O O
She O O
is O O
in O O
no O O
respiratory O O
distress. O O
Her O O
head O O
examination O O
is O O
normocephalic O O
and O O
atraumatic. O O
Her O O
conjunctivae O O
are O O
slightly O O
pale. O O
She O O
has O O
moist O O
mucous O O
membranes. O O
The O O
airway O O
is O O
patent. O O
Her O O
neck O O
is O O
supple O O
with O O
full O O
range O O
of O O
motion O O
without O O
any O O
pain. O O
The O O
trachea O O
is O O
midline. O O
Her O O
lungs O O
are O O
clear O O
to O O
auscultation O O
bilaterally O O
with O O
equal O O
breath O O
sounds. O O
No O O
respiratory O O
distress, O O
no O O
accessory O O
muscle O O
use, O O
and O O
no O O
chest O O
wall O O
tenderness. O O
Her O O
cardiac O O
examination O O
is O O
tachycardic O O
and O O
regular O O
at O O
about O O
100 O O
with O O
a O O
3/6 O O
systolic O O
murmur. O O
Her O O
abdomen O O
is O O
nondistended, O O
soft, O O
and O O
nontender. O O
No O O
guarding O O
and O O
no O O
peritoneal O O
signs. O O
Her O O
skin O O
is O O
remarkable O O
for O O
healing O O
superficial O O
ulcers O O
on O O
the O O
right O O
heel. O O
On O O
the O O
left O O
heel, O O
she O O
has O O
a O O
superficial O O
ulcer O O
with O O
a O O
dark O O
eschar, O O
which O O
is O O
approximately O O
4 O O
x O O
4 O O
cm O O
in O O
diameter. O O
There O O
is O O
no O O
purulent O O
discharge O O
around O O
the O O
area; O O
however, O O
the O O
skin O O
of O O
the O O
left O O
foot O O
is O O
fairly O O
violaceous O O
and O O
warm O O
on O O
the O O
plantar O O
surface O O
of O O
the O O
foot O O
surrounding O O
the O O
ulcer O O
extending O O
up O O
the O O
lateral O O
aspect O O
of O O
the O O
foot O O
to O O
the O O
anterior O O
aspect O O
of O O
the O O
left O O
ankle O O
was O O
demarcated O O
in O O
the O O
Emergency O O
Department. O O
There O O
is O O
no O O
other O O
break O O
in O O
the O O
skin O O
visualized. O O
Her O O
back O O
is O O
nontender O O
with O O
full O O
range O O
of O O
motion. O O
Extremities O O
are O O
remarkable O O
for O O
lower O O
extremity O O
atrophy. O O
She O O
does O O
have O O
1+ O O
edema O O
of O O
both O O
feet. O O
She O O
has O O
minimal O O
sensation O O
on O O
palpation O O
of O O
her O O
feet O O
with O O
no O O
obvious O O
tenderness O O
on O O
palpation O O
over O O
her O O
left O O
foot. O O
Her O O
pulses O O
are O O
trace. O O
She O O
is O O
alert O O
and O O
oriented O O
x3, O O
has O O
a O O
depressed O O
affect. O O
See O O
the O O
PA O O
note O O
for O O
remainder O O
of O O
the O O
details O O
of O O
the O O
physical O O
examination. O O
EMERGENCY O O
DEPARTMENT O O
COURSE: O O
The O O
patient O O
had O O
IV O O
access O O
initiated. O O
Laboratory O O
studies O O
were O O
sent O O
including O O
blood O O
cultures. O O
She O O
was O O
started O O
on O O
IV O O
antibiotics, O O
vancomycin, O O
and O O
gentamicin O O
and O O
was O O
consulted O O
to O O
Vascular O O
Surgery. O O
Her O O
feet O O
remained O O
elevated. O O
She O O
had O O
a O O
plain O O
x-ray O O
performed O O
of O O
her O O
foot, O O
which O O
showed O O
no O O
obvious O O
evidence O O
of O O
osteomyelitis O O
and O O
no O O
subcutaneous O O
gas. O O
Her O O
laboratory O O
studies O O
are O O
remarkable O O
for O O
hyperglycemia O O
and O O
she O O
was O O
started O O
on O O
IV O O
fluids. O O
DISPOSITION: O O
She O O
is O O
admitted O O
to O O
Surgery. O O
DIAGNOSIS: O O
Left O O
foot, O O
nonhealing O O
ulcer O O
with O O
left O O
foot O O
cellulitis, O O
and O O
peripheral O O
vascular O O
disease. O O
See O O
the O O
note O O
for O O
details. O O
______________________________ O O
GRAHAM, O O
ANGELA O O
M.D. O O
D: O O
08/16/92 O O
T: O O
08/16/92 O O
Dictated O O
By: O O
GRAHAM, O O
ANGELA O O
eScription O O
document:3-3296461 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2092-10-26 O O
SECTIONS O O
OF O O
THIS O O
NOTE O O
WERE O O
CREATED O O
WITH O O
A O O
'COPY O O
AND O O
PASTE' O O
ACTION. O O
THESE O O
SECTIONS O O
MAY O O
NOT O O
HAVE O O
COPIED O O
COMPLETELY. O O
PLEASE O O
USE O O
CAUTION O O
WHEN O O
RENDERING O O
CLINICAL O O
JUDGMENT O O
BASED O O
ON O O
THE O O
INFORMATION O O
IN O O
THIS O O
NOTE.GCC O O
Team O O
A O O
Infectious O O
Disease O O
Consultation O O
Patient: O O
Mack, O O
Rose O O
C O O
(06129040, O O
63I) O O
ID O O
Fellow: O O
Amanda O O
Qualls O O
ID O O
Attending: O O
Craig O O
Faulkner O O
Referring O O
Physician: O O
Dr. O O
Kevin O O
Katz O O
Date O O
of O O
Consult: O O
10/26/2092 O O
Reason O O
for O O
Consult: O O
DM, B-DIABETES O
chronic O O
R O O
and O O
L. O O
foot O O
ulcerations; O O
L. O O
foot O O
ulceration O O
with O O
surrounding O O
erythema, O O
pain O O
HPI: O O
50F O O
w/longstanding O O
type B-DIABETES O
I I-DIABETES O
DM I-DIABETES O
with O O
retinopathy, O O
nephropathy, O O
autonomic O O
and O O
peripheral O O
neuropathy, O O
recent O O
development O O
of O O
L. O O
heel O O
and O O
forefoot O O
ulcers, O O
here O O
with O O
a O O
few O O
days O O
of O O
pain, O O
erythema, O O
and O O
swelling O O
around O O
her O O
L. O O
forefoot O O
ulcer. O O
She O O
has O O
an O O
extremely O O
complicated O O
history O O
of O O
R O O
and O O
now O O
L. O O
foot O O
infections O O
and O O
ulcerations, O O
in O O
setting O O
of O O
here O O
severe O O
neuropathy O O
and O O
DM. O O
She O O
originally O O
sustained O O
a O O
R. O O
5th O O
metatarsal O O
fracture O O
in O O
2083, O O
with O O
poor O O
union, O O
and O O
subsequent O O
fracture O O
of O O
her O O
2nd O O
&#8211; O O
4th O O
metatarsals. O O
She O O
developed O O
a O O
chronic O O
ulcerated O O
callus O O
over O O
her O O
R. O O
lateral O O
metatarsal O O
heads, O O
with O O
underlying O O
osteomyelitis&#8212;this O O
did O O
not O O
improve O O
despite O O
multiple O O
courses O O
of O O
antibiotics. O O
She O O
underwent O O
I+D O O
of O O
her O O
R. O O
foot O O
ulceration O O
in O O
12/89, O O
OR O O
cultures O O
grew O O
P. O O
aeruginosa. O O
In O O
3/90, O O
she O O
underwent O O
debridement O O
of O O
her O O
chronic O O
R. O O
lateral O O
plantar O O
ulceration O O
and O O
skin O O
grafting. O O
In O O
6/90, O O
she O O
underwent O O
deep O O
debridement O O
of O O
her O O
ongoing O O
5th O O
metatarsal O O
osteomyelitis, O O
along O O
with O O
excision O O
of O O
her O O
5th O O
metatarsal&#8212;bone O O
cultures O O
grew O O
MSSA. O O
She O O
did O O
well O O
until O O
2/92, O O
when O O
she O O
underwent O O
R. O O
ankle O O
revision O O
for O O
an O O
equinovarus O O
deformity O O
of O O
her O O
R. O O
hindfoot O O
(calcaneal O O
osteotomy, O O
lateral O O
translation, O O
dorsiflexion O O
first O O
metatarsal O O
osteotomy, O O
and O O
Achilles O O
lengthening). O O
She O O
subsequently O O
developed O O
a O O
R. O O
heel O O
ulceration, O O
and O O
in O O
4/92, O O
underwent O O
debridement O O
of O O
this O O
ulceration, O O
removal O O
of O O
a O O
screw, O O
and O O
placement O O
of O O
a O O
vacuum O O
sponge. O O
Her O O
wound O O
continued O O
to O O
heal O O
poorly, O O
and O O
she O O
underwent O O
R. O O
SFA O O
to O O
posterior O O
tibial O O
bypass O O
grafting. O O
In O O
7/92, O O
she O O
underwent O O
debridement O O
of O O
her O O
R. O O
heel O O
wound O O
and O O
placement O O
of O O
a O O
full O O
thickness O O
skin O O
graft, O O
which O O
has O O
taken O O
well; O O
she O O
feels O O
that O O
her O O
R. O O
heel O O
has O O
been O O
healing O O
nicely. O O
During O O
her O O
long O O
hospitalization O O
in O O
4/92, O O
she O O
started O O
developing O O
L. O O
heel O O
and O O
L. O O
forefoot O O
ulcerations. O O
She O O
attributes O O
the O O
heel O O
ulcerations O O
to O O
chronic O O
pressure O O
from O O
her O O
position O O
in O O
bed, O O
and O O
the O O
forefoot O O
ulcerations O O
to O O
the O O
boots O O
that O O
were O O
used O O
to O O
relieve O O
her O O
heel O O
pressure, O O
which O O
apparently O O
abraded O O
her O O
forefoot O O
chronically. O O
These O O
ulcerations O O
continued O O
to O O
worsen O O
over O O
the O O
next O O
few O O
months, O O
and O O
she O O
presented O O
with O O
cellulitis O O
of O O
this O O
area O O
in O O
8/92. O O
She O O
received O O
vancomycin, O O
levofloxacin, O O
flagyl O O
initially, O O
then O O
augmentin, O O
with O O
persistent O O
poor O O
healing O O
of O O
her O O
wounds. O O
On O O
9/10, O O
she O O
underwent O O
operative O O
debridement O O
of O O
her O O
L. O O
plantar O O
heel O O
ulcer&#8212;she O O
was O O
found O O
to O O
have O O
extensive O O
necrotic O O
yellow-brown O O
tissue O O
underlying O O
her O O
L. O O
heel O O
eschar, O O
which O O
was O O
extensively O O
debrided; O O
she O O
received O O
a O O
course O O
of O O
linezolid O O
postoperatively. O O
She O O
had O O
an O O
angiogram O O
on O O
9/12, O O
which O O
showed O O
no O O
significant O O
flow O O
limiting O O
lesions O O
in O O
her O O
LLE, O O
and O O
good O O
flow O O
through O O
her O O
prior O O
R. O O
SFA O O
to O O
posterior O O
tibial O O
bypas O O
graft. O O
She O O
feels O O
that O O
her O O
wounds O O
have O O
been O O
healing O O
fairly O O
well O O
recently; O O
she O O
feels O O
that O O
her O O
R. O O
heel O O
is O O
almost O O
completely O O
healed, O O
and O O
that O O
her O O
L. O O
heel O O
ulcer O O
is O O
smaller O O
than O O
it O O
was O O
previously. O O
Her O O
L. O O
forefoot O O
ulcer O O
is O O
also O O
more O O
shallow O O
than O O
it O O
was O O
in O O
the O O
past. O O
Over O O
the O O
past O O
2-3 O O
days, O O
she O O
developed O O
fairly O O
acute O O
swelling, O O
erythema, O O
and O O
pain O O
around O O
her O O
forefoot O O
ulcer, O O
with O O
erythema O O
spreading O O
to O O
the O O
dorsal O O
surface O O
of O O
her O O
foot. O O
She O O
was O O
seen O O
in O O
vascular O O
surgery O O
clinic, O O
and O O
was O O
admitted O O
for O O
antibiotics O O
and O O
further O O
debridement. O O
She O O
has O O
a O O
chronic O O
&#8216;fast O O
heartbeat,&#8217; O O
denies O O
any O O
systemic O O
symptoms O O
(no O O
fevers, O O
chills, O O
sweats, O O
notable O O
weight O O
changes), O O
headaches, O O
sinus O O
symptoms, O O
sore O O
throat, O O
cough, O O
shortness O O
of O O
breath, O O
chest O O
pain, O O
nausea, O O
vomiting, O O
abdominal O O
pain, O O
diarrhea, O O
blood O O
in O O
her O O
bowel O O
movements, O O
dysuria, O O
frequency, O O
LE O O
edema, O O
rashes, O O
myalgias, O O
or O O
new O O
arthralgias. O O
She O O
feels O O
that O O
her O O
foot O O
erythema O O
has O O
improved O O
significantly O O
overnight O O
with O O
vancomycin. O O
PMH: O O
poorly O O
controlled O O
type O O
I O O
DM O O
since O O
age O O
12&#8212;complicated O O
by O O
diabetic O O
retinopathy O O
s/p O O
bilateral O O
vitrectomies O O
for O O
retinal O O
hemorrhage, O O
nephropathy, O O
peripheral O O
neuropathy, O O
autonomic O O
nephropathy O O
(gastroparesis)&#8212;on O O
an O O
insulin B-MEDICATION O
pump O O
chronic O O
foot O O
ulcerations, O O
initially O O
R, O O
now O O
L, O O
requiring O O
numerous O O
antibiotic O O
courses O O
and O O
operative O O
interventions: O O
2083: O O
R. O O
5th O O
metatarsal O O
fracture O O
in O O
2083, O O
poor O O
union, O O
subsequent O O
fracture O O
of O O
the O O
remainder O O
of O O
her O O
R. O O
metarsals O O
chronic O O
ulcerated O O
callus O O
over O O
R. O O
lateral O O
metatarsal O O
heads, O O
with O O
underlying O O
osteomyelitis, O O
no O O
improvement O O
despite O O
multiple O O
courses O O
of O O
antibiotics O O
12/89: O O
I+D O O
of O O
R. O O
foot O O
ulceration&#8212;cultures O O
grew O O
P. O O
aeruginosa O O
3/90: O O
debridement O O
of O O
chronic O O
R. O O
lateral O O
plantar O O
ulceration O O
and O O
skin O O
grafting O O
6/90: O O
deep O O
debridement O O
of O O
her O O
5th O O
metatarsal O O
osteomyelitis, O O
excision O O
of O O
her O O
5th O O
metatarsal&#8212;cultures O O
grew O O
MSSA O O
2/92: O O
calcaneal O O
osteotomy, O O
lateral O O
translation, O O
dorsiflexion O O
first O O
metatarsal O O
osteotomy, O O
and O O
Achilles O O
lengthening O O
for O O
equinovarus O O
deformity O O
of O O
her O O
R. O O
hindfoot O O
4/92: O O
subsequent O O
development O O
of O O
R. O O
heel O O
ulceration, O O
s/p O O
debridement O O
of O O
her O O
ulceration, O O
removal O O
of O O
a O O
screw, O O
vacuum O O
sponge O O
placement O O
4/92: O O
R. O O
SFA O O
to O O
posterior O O
tibial O O
bypass O O
grafting O O
7/92: O O
debridement O O
of O O
her O O
R. O O
heel O O
wound O O
and O O
full O O
thickness O O
skin O O
graft O O
(12 O O
x O O
5cm) O O
9/92: O O
development O O
of O O
L. O O
heel O O
and O O
forefoot O O
ulcerations O O
at O O
rehabilitation, O O
with O O
debridement O O
of O O
her O O
L. O O
plantar O O
heel O O
ulcer O O
on O O
9/10&#8212;found O O
to O O
have O O
extensive O O
necrotic O O
yellow-brown O O
tissue O O
underlying O O
her O O
eschar O O
PICC-associated O O
RUE O O
DVT O O
7/92, O O
on O O
coumadin O O
s/p O O
L. O O
ankle O O
fracture O O
in O O
2083 O O
R. O O
foot O O
RSD O O
s/p O O
multiple O O
R. O O
lumbar O O
sympathetic O O
blocks O O
s/p O O
R. O O
carpal O O
tunnel O O
surgery O O
hypothyroidism O O
iron O O
deficiency O O
anemia O O
depression&#8212;inpatient O O
admission O O
2090 O O
with O O
suicidal O O
ideations O O
s/p O O
subtotal O O
thyroidectomy O O
2073 O O
s/p O O
breast O O
lumpectomy O O
2078&#8212;has O O
missed O O
her O O
follow-up O O
mammogram O O
appointments O O
due O O
to O O
her O O
foot O O
issues O O
2088 O O
colonoscopy O O
with O O
&#8216;precancerous O O
polyp&#8217;&#8212;needs O O
repeat O O
evaluation O O
Home O O
Medications: O O
insulin O O
pump O O
Acetaminophen650 O O
MG O O
PO O O
Q6H O O
prn O O
Pain,Headache O O
Calcium O O
Carbonate O O
1250 O O
Mg O O
(500 O O
Mg O O
Elem O O
Ca) O O
1 O O
TAB O O
PO O O
TID O O
Clonazepam0.5 O O
MG O O
PO O O
BID O O
Clonazepam0.25 O O
MG O O
PO O O
QD O O
prn O O
Insomnia,Anxiety O O
Clotrimazole O O
1% O O
Cream O O
TOPICAL O O
TP O O
BID O O
prn O O
Itching O O
Desipramine O O
Hcl175 O O
MG O O
PO O O
HS O O
Docusate O O
Sodium O O
(Colace)100 O O
MG O O
PO O O
BID O O
Folic O O
Acid1 O O
MG O O
PO O O
QD O O
Haloperidol O O
1 O O
MG O O
PO O O
QHS O O
Hydromorphone O O
Hcl O O
(Dilaudid)4 O O
MG O O
PO O O
Q4H O O
prn O O
Levothyroxine O O
Sodium250 O O
MCG O O
PO O O
QD O O
Omeprazole40 O O
MG O O
PO O O
QD O O
Sennosides O O
Liquid2 O O
TSP O O
PO O O
QHS O O
Therapeutic O O
Multivitamins O O
(Multivitamin O O
Therapeutic)1 O O
TAB O O
PO O O
QD O O
Trazodone200 O O
MG O O
PO O O
QHS O O
Warfarin O O
Sodium5 O O
MG O O
PO O O
QPM O O
Inpatient O O
Medications: O O
Antibiotics: O O
-vancomycin O O
1g O O
IV O O
bid O O
(10/25-) O O
Immunosuppressants: O O
none O O
Others: O O
home O O
medications, O O
SC O O
heparin, O O
novolog B-MEDICATION O
sliding O O
scale O O
q6hrs O O
Allergies: O O
&#183; O O
ASA&#224;asthma O O
&#183; O O
erythromycin&#224;severe O O
nausea, O O
syncope O O
&#183; O O
sulfa&#224;rash, O O
nausea O O
&#183; O O
IV O O
contrast&#224;nausea, O O
has O O
tolerated O O
LE O O
angiogram O O
recently O O
without O O
problems O O
SocHx: O O
-was O O
walking O O
with O O
a O O
cane; O O
more O O
recently, O O
has O O
been O O
using O O
a O O
wheelchair; O O
still O O
non-weight O O
bearing O O
on O O
her O O
L. O O
foot, O O
but O O
has O O
been O O
working O O
with O O
physical O O
therapy O O
-lives O O
in O O
Girard O O
with O O
her O O
parents, O O
sister O O
-Tob: B-SMOKER O
smoked I-SMOKER O
30 I-SMOKER O
years, I-SMOKER O
rolled I-SMOKER O
her I-SMOKER O
own I-SMOKER O
cigarettes; I-SMOKER O
quit I-SMOKER O
8 I-SMOKER O
years I-SMOKER O
ago I-SMOKER O
-EtOH: O O
none O O
recently O O
-IVDU: O O
no O O
IVDU; O O
used O O
marijuana O O
in O O
the O O
past O O
FamHx: O O
sister&#8212;gestational O O
DM O O
ROS: O O
negative O O
in O O
detail O O
except O O
as O O
described O O
above O O
in O O
HPI. O O
Exam: O O
Tm O O
99.2Tc O O
97.4 O O
HR O O
96-122BP O O
120-136/50-72RR O O
16O2 O O
sat O O
99-100% O O
RA O O
Gen: O O
thin, O O
pale, O O
chronically O O
ill O O
appearing O O
woman O O
in O O
NAD O O
HEENT: O O
clear O O
oropharynx O O
without O O
thrush, O O
ulcerations; O O
few O O
cracked O O
teeth, O O
no O O
significant O O
cervical/supraclavicular O O
lymphadenopathy, O O
few O O
L. O O
axillary O O
nodes O O
Pulm: O O
lungs O O
clear O O
CV: O O
tachycardic, O O
regular, O O
II/VI O O
SEM O O
Abd: O O
soft, O O
NT, O O
+normal O O
BS, O O
no O O
HSM O O
Extr: O O
warm, O O
no O O
edema, O O
1+ O O
PT O O
pulses O O
bilaterally; O O
R. O O
heel O O
ulcer/skin O O
graft O O
site O O
healing O O
well, O O
minimal O O
drainage; O O
L. O O
heel O O
ulcer O O
fairly O O
shallow, O O
2cm O O
in O O
diameter, O O
3cm O O
L. O O
forefoot O O
ulcer O O
with O O
necrotic O O
material O O
at O O
base, O O
some O O
drainage, O O
minimal O O
surrounding O O
erythema O O
Skin: O O
no O O
rashes, O O
no O O
nail O O
changes O O
Labs: O O
(10/26) O O
WBC O O
4.35 O O
(4-10) O O
K/uL O O
LYMP O O
% O O
16.2 O O
* O O
(18-41) O O
% O O
MONO O O
% O O
5.8 O O
(2.5-8.5) O O
% O O
NEUT O O
% O O
77.8 O O
* O O
(48-76) O O
% O O
EOS O O
% O O
0 O O
(0-5) O O
% O O
BASO O O
% O O
0.2 O O
(0-1.5) O O
% O O
HCT O O
32.3 O O
* O O
(36-48) O O
% O O
PLT O O
452 O O
* O O
(150-450) O O
K/uL O O
PTT O O
54.3 O O
* O O
(23.8-36.6) O O
sec O O
PT(INR) O O
2.1 O O
* O O
(0.9-1.1) O O
GLUCOSE O O
265 O O
*# O O
(54-118) O O
mg/dL O O
UREA O O
N O O
20 O O
(9-25) O O
mg/dL O O
CREATININE O O
1.36 O O
* O O
(0.7-1.3) O O
mg/dL O O
ALT/GPT O O
11 O O
(7-52) O O
U/L O O
AST/GOT O O
9 O O
(9-30) O O
U/L O O
ALK O O
PHOS O O
113 O O
(36-118) O O
U/L O O
TOT O O
BILI O O
0.3 O O
(0.2-1.2) O O
mg/dL O O
ALBUMIN O O
3.6 O O
*# O O
(3.7-5.4) O O
g/dL O O
UA O O
(10/25): O O
sg O O
1.013, O O
1+ O O
glucose, O O
(-) O O
LE, O O
(-) O O
nitr O O
Microbiology: O O
&#183; O O
9/10: O O
L. O O
foot O O
debridement O O
cx: O O
4+ O O
CoNS O O
(ox/PCN/lev-R), O O
4+ O O
Corynebacterium O O
spp O O
&#183; O O
8/14: O O
R. O O
groin O O
wound O O
cx: O O
many O O
MRSA O O
&#183; O O
7/92: O O
R. O O
foot O O
skin O O
graft O O
cx: O O
3+ O O
CoNS, O O
3+ O O
diphtheroids O O
&#183; O O
4/92: O O
R. O O
heel O O
biopsy O O
cx: O O
few O O
S. O O
simulans O O
(ox/PCN-R, O O
vanc/tet/rif/bactr-S). O O
few O O
S. O O
epidermidis O O
(PCN/lev-R, O O
ox-S), O O
few O O
diphtheroids O O
&#183; O O
6/90: O O
rare O O
MSSA O O
(PCN-R, O O
erythro-I, O O
otherwise O O
sensitive) O O
&#183; O O
12/89: O O
R. O O
foot O O
debridement O O
cx: O O
many O O
P. O O
aeruginosa O O
(S O O
to O O
all O O
tested O O
agents) O O
&#183; O O
12/89: O O
R. O O
foot O O
wound O O
culture: O O
rare O O
MSSA, O O
rare O O
alpha-hemolytic O O
streptococci, O O
many O O
bacteroides O O
gracilis, O O
many O O
peptostreptococcus O O
prevotii, O O
few O O
fusobacterium O O
nucleatum, O O
moderate O O
anaerobic O O
GNRs O O
Radiology: O O
&#183; O O
10/25: O O
PA/lateral O O
CXR: O O
no O O
acute O O
cardiopulmonary O O
process O O
&#183; O O
9/12: O O
BLE O O
angiogram: O O
distal O O
aorta O O
and O O
iliac O O
vessels O O
without O O
stenosis, O O
R O O
CFA O O
and O O
PFA O O
widely O O
patent, O O
proximal O O
1-2cm O O
SFA O O
with O O
mild-moderate O O
stenosis, O O
without O O
flow O O
limitation; O O
remainder O O
of O O
SFA O O
above O O
bypass O O
without O O
obvious O O
stenosis, O O
R O O
mid-SFA O O
to O O
mid-PT O O
bypass O O
widely O O
patent, O O
PT O O
outflow O O
vessel O O
good O O
quality, O O
other O O
tibial O O
vessels O O
quite O O
atretic; O O
LLE: O O
L. O O
CFA O O
and O O
PFA O O
widely O O
patent, O O
L. O O
SFA O O
with O O
mild O O
eccentric O O
proximal O O
stenosis, O O
L. O O
popliteal O O
with O O
mild-moderate O O
non-flow O O
limiting O O
stenosis, O O
two O O
vessel O O
PT O O
and O O
peroneal O O
runoff O O
good O O
quality O O
&#183; O O
8/16/92: O O
L. O O
foot O O
films: O O
diffuse O O
bone O O
demineralization, O O
no O O
fracture O O
or O O
dislocation; O O
dorsal O O
talar O O
osteophyte, O O
nonspecific O O
punctate O O
calcification O O
in O O
plantar O O
aspect O O
of O O
calcaneus, O O
no O O
evidence O O
of O O
osteomyelitis, O O
soft O O
tissue O O
swelling O O
in O O
plantar O O
aspect O O
of O O
foot O O
Impression/Recommendations: O O
50F O O
w/longstanding O O
type O O
I O O
DM O O
with O O
severe O O
peripheral O O
neuropathy, O O
recent O O
development O O
of O O
L. O O
heel O O
and O O
forefoot O O
ulcers, O O
here O O
with O O
cellulitis O O
surrounding O O
her O O
L. O O
forefoot O O
ulcer, O O
improving O O
on O O
vancomycin. O O
Awaiting O O
debridement O O
today, O O
need O O
to O O
determine O O
depth O O
of O O
her O O
infection O O
and O O
whether O O
it O O
extends O O
to O O
bone: O O
&#183; O O
Continue O O
vancomycin O O
1g O O
IV O O
bid O O
for O O
now. O O
Her O O
renal O O
function O O
is O O
impaired O O
from O O
her O O
DM&#8212;would O O
check O O
a O O
vancomycin O O
trough O O
prior O O
to O O
her O O
next O O
dose. O O
&#183; O O
Please O O
send O O
biopsy O O
of O O
bone O O
underlying O O
her O O
L. O O
forefoot O O
ulcer O O
for O O
gram O O
stain, O O
aerobic O O
culture, O O
and O O
anaerobic O O
culture O O
from O O
OR O O
today. O O
&#183; O O
Needs O O
to O O
be O O
on O O
MRSA O O
contact O O
precautions&#8212;grew O O
abundant O O
MRSA O O
from O O
her O O
R. O O
groin O O
wound O O
last O O
month. O O
&#183; O O
Has O O
missed O O
her O O
follow-up O O
mammogram O O
appointments O O
and O O
colonoscopy O O
appointments O O
for O O
follow-up O O
of O O
an O O
abnormal O O
lumpectomy O O
finding O O
and O O
a O O
&#8216;precancerous O O
polyp&#8217; O O
because O O
of O O
her O O
recent O O
foot O O
issues. O O
Unable O O
to O O
stand O O
for O O
mammography O O
because O O
of O O
her O O
foot O O
issues&#8212;will O O
discuss O O
optimal O O
imaging O O
of O O
her O O
L. O O
breast O O
with O O
breast O O
radiology, O O
will O O
hopefully O O
be O O
able O O
to O O
obtain O O
this O O
study O O
during O O
this O O
hospitalization. O O
Discussed O O
with O O
Dr. O O
Craig O O
Faulkner, O O
ID O O
Attending. O O
Recommendations O O
discussed O O
with O O
Dr. O O
Zane O O
Querry O O
of O O
primary O O
team. O O
Thank O O
you O O
for O O
this O O
interesting O O
consult&#8212;we O O
will O O
continue O O
to O O
follow O O
with O O
you. O O
____________________________________ O O
Amanda O O
Qualls, O O
M.D. O O

Record O O
date: O O
2092-12-26 O O
Diabetes O O
CONSULT O O
REPORT O O
CC O O
Asked O O
by O O
Dr. O O
Katz O O
to O O
see O O
the O O
patient O O
for O O
assistance O O
with O O
management O O
of O O
hyperglycemia. O O
HPI O O
This O O
is O O
a O O
50 O O
year O O
old O O
male O O
patient O O
with O O
a O O
history O O
of O O
type B-DIABETES O
1 I-DIABETES O
diabetes B-DIABETES O
diagnosed O O
40 O O
years O O
ago O O
at O O
an O O
age O O
of O O
10. O O
Pt O O
was O O
initially O O
treated O O
with O O
insulin B-MEDICATION O
and O O
has O O
been O O
requiring B-MEDICATION O
insulin I-MEDICATION O
since I-MEDICATION O
diagnosis. O O
Pt O O
was O O
started O O
on O O
an O O
insulin O O
pump O O
in O O
2079. O O
Current O O
basal O O
rates O O
are O O
0.6 O O
units O O
from O O
12am-6am, O O
0.7 O O
units O O
from O O
6am O O
to O O
6:30pm O O
and O O
then O O
0.6 O O
units O O
at O O
6:30pm O O
again. O O
Pt O O
uses O O
a O O
carb O O
ratio O O
of O O
10:1. O O
Pt O O
cannot O O
recall O O
her O O
correction O O
factor O O
as O O
it O O
is O O
programmed O O
into O O
her O O
pump. O O
Monitors O O
her O O
blood O O
glucoses O O
at O O
least O O
4 O O
times O O
per O O
day O O
and O O
reports O O
variable O O
glucoses O O
for O O
70-&gt;200. O O
Reports O O
hypoglycemic O O
episodes O O
1-2 O O
times O O
per O O
week O O
and O O
she O O
is O O
usually O O
symptomatic O O
with O O
glucoses O O
of O O
70. O O
Reports O O
that O O
she O O
was O O
admitted O O
to O O
the O O
hospital O O
about O O
one O O
month O O
ago O O
with O O
DKA. O O
States O O
that O O
she O O
had O O
flu-like O O
symptoms O O
and O O
severe O O
vomiting O O
and O O
was O O
admitted O O
ot O O
Ames O O
Pathology O O
Center O O
for O O
treatment. O O
Had O O
never O O
had O O
DKA O O
before. O O
Pt O O
reports O O
complications O O
associated O O
with O O
diabetes. O O
Reports O O
retinopathy O O
and O O
has O O
had O O
several O O
laster O O
surgeries. O O
Reports O O
nephropathy O O
as O O
well O O
as O O
an O O
episode O O
of O O
renal O O
failure O O
related O O
to O O
a O O
hospitalization O O
this O O
summer. O O
Reports O O
peripheral O O
neuropathy O O
as O O
well O O
as O O
peripheral O O
vascular O O
disease, O O
including O O
non-healing O O
ulcers O O
that O O
have O O
lead O O
to O O
right O O
TMA. O O
Patient O O
is O O
admitted O O
for O O
stenosis O O
of O O
right O O
bypass O O
graft O O
stenosis O O
and O O
is O O
going O O
to O O
the O O
cath O O
lab O O
for O O
angiogram O O
shortly. O O
Currently O O
receiving O O
D5W O O
with O O
150 O O
meq O O
of O O
Bicarb O O
at O O
125 O O
ccs/hr O O
for O O
renal O O
protection. O O
BG O O
today O O
(with O O
IV O O
fluid O O
infusing): O O
230 O O
(4am), O O
271 O O
(9am), O O
and O O
195 O O
(11am O O
- O O
prior O O
to O O
leaving O O
for O O
cath) O O
BG O O
12/25: O O
152 O O
(1pm), O O
196 O O
(6pm), O O
172 O O
(8pm) O O
Pt O O
is O O
using O O
her O O
insulin O O
pump. O O
Allergies O O
Erythromycins O O
- O O
rash O O
Sulfa O O
- O O
rash O O
Aspirin O B-MEDICATION
- O O
rash O O
Medications O O
Diabetes O O
medications O O
at O O
home O O
included: O O
Insulin O O
pump, O O
see O O
HPI O O
Diabetes O O
medications O O
now O O
include: O O
Insulin O O
pump O O
Problems O O
Anemia O O
Anxiety O O
Deep O O
venous O O
thrombosis O O
Depression O O
Hypothyroidism O O
Palpitations O O
Right O O
TMA O O
Let O O
ankle O O
fracture O O
FHX O O
No O O
history O O
of O O
hormonal O O
disorders O O
in O O
any O O
family O O
members O O
SHX O O
and O O
Habits O O
Non-smoker B-SMOKER O
ROS O O
Patient O O
is O O
post-operative. O O
Physical O O
Examination O O
General: O O
Patient O O
is O O
in O O
no O O
apparent O O
distress. O O
Vitals: O O
BP O O
110/60, O O
HR O O
99, O O
Temp O O
HENT: O O
Inspection O O
reveals O O
no O O
abnormalities. O O
Eyes: O O
Conjunctivae, O O
sclera O O
and O O
lids O O
are O O
normal. O O
No O O
icterus. O O
Respiratory: O O
Assessment O O
of O O
respiratory O O
effort O O
reveals O O
even O O
respirations O O
without O O
use O O
of O O
accessory O O
muscles O O
Skin: O O
No O O
skin O O
rash, O O
warm O O
and O O
dry O O
skin. O O
No O O
acanthosis O O
nigricans. O O
Neurological O O
Examination: O O
Alert O O
and O O
oriented O O
to O O
person, O O
place, O O
time, O O
and O O
situation. O O
Grossly O O
nonfocal O O
exam. O O
Psychiatric: O O
Mood O O
and O O
affect O O
appropriate O O
to O O
situation. O O
Extremity O O
exam: O O
No O O
pedal O O
edema, O O
right O O
foot O O
with O O
bandage. O O
Lab O O
Results O O
12/25/2092 O O
NA O O
136, O O
K O O
4.5, O O
CL O O
107, O O
CO2 O O
22 O O
(*), O O
BUN O O
52 O O
(*), O O
CRE O O
2.11 O O
(*), O O
EGFR O O
25, O O
GLU O O
212 O O
(*)12/02/2092 O O
HGBA1C O O
9.0 O O
(H)12/25/2092 O O
WBC O O
6.55, O O
RBC O O
4.34 O O
(#), O O
HGB O O
10.5 O O
(*#), O O
HCT O O
33.5 O O
(*#), O O
MCV O O
77.2 O O
(*#), O O
MCH O O
24.2 O O
(*), O O
MCHC O O
31.4 O O
(*), O O
PLT O O
302 O O
(#) O O
Assessment O O
T1DM B-DIABETES O
- O O
Uncontrolled. O O
Pt O O
appears O O
alert, O O
oriented O O
and O O
confident O O
to O O
use O O
her O O
insulin O O
pump O O
in O O
the O O
hospital. O O
Pt O O
is O O
able O O
to O O
verbalize O O
her O O
insulin O O
doses O O
and O O
states O O
that O O
she O O
would O O
prefer O O
to O O
continue O O
with O O
pump O O
use. O O
Suspect O O
that O O
IV O O
fluids O O
are O O
contributing O O
to O O
hyperglycemia, O O
therefore O O
reluctant O O
to O O
change O O
insulin O O
doses O O
since O O
IV O O
fluids O O
will O O
likely O O
stop O O
later O O
today. O O
While O O
in O O
procedure, O O
will O O
need O O
to O O
monitor O O
blood O O
glucoses O O
more O O
closely, O O
but O O
anticipate O O
that O O
pump O O
can O O
continue O O
as O O
programmed. O O
Recommendations O O
1. O O
Continue O O
with O O
insulin O O
pump. O O
Instructed O O
pt O O
that O O
she O O
must: O O
a. O O
report O O
all O O
pre-meal O O
bolus O O
doses O O
to O O
the O O
RN O O
so O O
that O O
it O O
can O O
be O O
documented O O
on O O
the O O
flow O O
sheet. O O
b. O O
have O O
blood O O
glucoses O O
checked O O
as O O
ordered O O
using O O
the O O
hospital O O
approved O O
glucose O O
meter. O O
c. O O
alert O O
RN O O
if O O
she O O
feel O O
uncomfortable O O
using O O
insulin O O
pump. O O
RN O O
should O O
page O O
HO O O
and/or O O
diabetes O O
dept O O
immediately O O
for O O
orders O O
for O O
SC O O
insulin. O O
d. O O
agree O O
to O O
discontinue O O
insulin O O
pump O O
and O O
start O O
SC O O
insulin O O
if O O
deemed O O
necessary O O
by O O
house O O
staff. O O
Pt O O
agrees O O
to O O
all O O
of O O
the O O
above. O O
2. O O
Monitor O O
blood O O
glucoses O O
at O O
least O O
before O O
all O O
meals O O
and O O
at O O
bedtime. O O
Please O O
also O O
check O O
blood O O
glucoses O O
with O O
any O O
symptoms O O
of O O
hypoglycemia O O
or O O
at O O
pt's O O
request. O O
Be O O
sure O O
to O O
record O O
these O O
values O O
on O O
the O O
daily O O
flow O O
sheet. O O
3. O O
For O O
procedure O O
today, O O
I O O
spoke O O
with O O
Kathryn O O
Kincaid O O
and O O
asked O O
that O O
blood O O
glucoses O O
be O O
monitored O O
hourly O O
while O O
in O O
cath O O
lab O O
unless O O
BG O O
is O O
less O O
than O O
140. O O
If O O
BG O O
less O O
than O O
140, O O
monitor O O
blood O O
glucoses O O
every O O
30 O O
minutes. O O
Treat O O
BG O O
less O O
than O O
80 O O
with O O
1/2 O O
amp O O
D50 O O
and O O
continue O O
to O O
monitor O O
as O O
described O O
above. O O
Do O O
not O O
remove O O
insulin O O
pump. O O
Page O O
5-8112 O O
with O O
any O O
concerns O O
during O O
the O O
procedure. O O
Diabetes O O
dept O O
will O O
continue O O
to O O
monitor. O O
Please O O
page O O
5-8112 O O
with O O
any O O
questions O O
or O O
concerns. O O
Thank O O
you. O O
________________________ O O
Faye O O
Easley, O O
NP O O

Record O O
date: O O
2094-03-19 O O
Infectious O O
Disease O O
Consult O O
Note O O
Pt: O O
Rose O O
Mack O O
MR#: O O
06129040 O O
Consult O O
Date: O O
3/19/94 O O
CC/RFC: O O
Pt O O
is O O
a O O
52 O O
year O O
old O O
w/ O O
chronic O O
R O O
heel O O
wound, O O
now O O
w/ O O
wound O O
infection. O O
Consultation O O
was O O
requested O O
by O O
Dr. O O
Katz O O
for O O
recommendations O O
regarding O O
antibiotic O O
management. O O
HPI: O O
Pt O O
has O O
longstanding O O
DM B-DIABETES O
and O O
PVD O O
complicated O O
by O O
severe O O
R O O
foot O O
ulceration. O O
She O O
underwent O O
R O O
femoral O O
to O O
posterior O O
tibial O O
bypass O O
graft O O
in O O
5/92 O O
and O O
skin O O
grafting O O
in O O
7/92. O O
R O O
heel O O
wound O O
subsequently O O
improved O O
but O O
pt O O
developed O O
L O O
plantar O O
ulceration O O
requiring O O
debridement O O
10/92. O O
Cultures O O
grew O O
MSSA. O O
Pt O O
was O O
subsequently O O
treated O O
w/ O O
extended O O
course O O
of O O
doxycycline, O O
rifampin O O
through O O
2/93. O O
She O O
subsequently O O
did O O
well O O
until O O
developing O O
R O O
heel O O
ulcer O O
while O O
undergoing O O
psychiatric O O
hospitalization O O
in O O
mid O O
2/94. O O
She O O
was O O
initially O O
hospitalized O O
at O O
Altadena O O
Hospital, O O
where O O
she O O
underwent O O
debridement O O
of O O
wound O O
and O O
treatment O O
w/ O O
extended O O
course O O
of O O
penicillin O O
VK O O
and O O
probenicid. O O
Wound O O
failed O O
to O O
improve. O O
Pt O O
was O O
rehospitalized O O
on O O
3/18 O O
at O O
GCCfor O O
further O O
management. O O
She O O
underwent O O
incision O O
and O O
debridement O O
on O O
3/18. O O
Intraoperative O O
evaluation O O
revealed O O
ulcer O O
wound O O
tracking O O
to O O
bone. O O
Intraoperative O O
gram O O
stain O O
revealed O O
GPCs O O
in O O
pairs. O O
Intraoperative O O
cultures O O
are O O
pending. O O
Pt O O
was O O
subsequently O O
treated O O
w/ O O
vancomycin, O O
levofloxacin O O
and O O
metronidazole. O O
On O O
interview, O O
pt O O
reports O O
feeling O O
generally O O
well. O O
No O O
F/C/NS. O O
Appetite O O
normal. O O
Had O O
previously O O
noted O O
creeping O O
erythema O O
up O O
R O O
leg, O O
now O O
resolved. O O
PMH O O
(from O O
EMR) O O
DM B-DIABETES O
type I-DIABETES O
1: I-DIABETES O
c/b O O
PVD, O O
neuropathy, O O
nephropathy O O
PVD: O O
s/p O O
right O O
mid O O
superficial O O
femoral O O
artery O O
to O O
mid O O
posterior O O
tibial O O
bypass O O
graft O O
with O O
reversed O O
ipsilateral O O
greater O O
saphenous O O
vein O O
CKD O O
Hx O O
femoral O O
neck O O
fracture: O O
in O O
situ O O
screw O O
fixation O O
Anemia O O
Anxiety/Depression O O
Deep O O
venous O O
thrombosis O O
Hypothyroidism: O O
s/p O O
subtotal O O
thyroidectomy O O
74 O O
S/p O O
R O O
carpal O O
tunnel O O
surgery O O
Meds O O
on O O
Consultation O O
Plavix B-MEDICATION B-MEDICATION
Lopressor B-MEDICATION B-MEDICATION
Simvastatin B-MEDICATION B-MEDICATION
Lantus B-MEDICATION B-MEDICATION
Levoxyl O O
Abilify O O
Cogentin O O
Nortriptyline O B-MEDICATION
Trazadone O O
Probenecid O O
Neurontin O O
All O O
Erythromycins O O
cause O O
rash O O
Sulfa O O
causes O O
rash O O
Aspirin O B-MEDICATION
causes O O
rash O O
SHx B-SMOKER O
Pt O O
lives O O
at O O
home O O
w/ O O
her O O
parents O O
FHx O O
NC O O
ROS O O
Ten O O
point O O
review O O
of O O
systems O O
negative O O
except O O
as O O
noted O O
in O O
HPI. O O
Exam O O
Pt O O
is O O
a O O
tired O O
appearing O O
middle O O
aged O O
woman, O O
lying O O
comfortably O O
in O O
bed O O
VS: O O
T- O O
96.4, O O
HR- O O
84, O O
BP- B-HYPERTENSION O
153/72, B-HYPERTENSION O
RR- O O
18, O O
Sat- O O
100% O O
on O O
2L O O
HEENT: O O
MMM, O O
w/o O O
exudates O O
Chest: O O
CTAB; O O
no O O
crackles, O O
no O O
wheezes O O
CV: O O
RRR; O O
normal O O
S1S2, O O
no O O
m/r/g O O
appreciated O O
Abd: O O
NABS; O O
soft, O O
non-tender, O O
non-distended; O O
no O O
organomegaly O O
Extr: O O
R O O
heel O O
w/ O O
2 O O
x O O
2cm O O
wound O O
vac O O
dressing O O
in O O
place, O O
no O O
surrounding O O
erythema; O O
L O O
foot O O
without O O
erythem O O
or O O
ulceration O O
Neuro: O O
MS O O
nl, O O
motor O O
and O O
sensory O O
normal O O
Skin: O O
scattered O O
patchy O O
erythematous O O
rash O O
across O O
trunk O O
and O O
upper O O
extremities O O
Labs O O
Chemistry: O O
BUN: O O
19 O O
Cr: O O
1.3 O O
Tbili: O O
0.2 O O
ALT: O O
20 O O
AST: O O
22 O O
AP: O O
290 O O
Heme: O O
WBC: O O
4.7 O O
HCT: O O
33.2 O O
Plt: O O
290 O O
Impression O O
52F O O
w/ O O
DM, O O
PVD O O
and O O
hx O O
of O O
R O O
heel O O
ulceration O O
s/p O O
skin O O
grafting O O
in O O
5/92 O O
and O O
L O O
midfoot O O
MSSA O O
infection O O
in O O
9/92, O O
now O O
w/ O O
relapse O O
of O O
R O O
heel O O
ulceration. O O
Intraoperative O O
cultures O O
show O O
involvement O O
of O O
bone. O O
Clinical O O
picture O O
is O O
concerning O O
for O O
osteomyelitis. O O
Possible O O
culprit O O
organisms O O
include O O
drug O O
resistant O O
Staphylococcus O O
aureus, O O
which O O
should O O
be O O
treated O O
empirically O O
while O O
awaiting O O
cultures. O O
Pt O O
will O O
likely O O
require O O
an O O
extended O O
course O O
of O O
IV O O
therapy O O
for O O
treatment O O
of O O
osteomyelitis. O O
Recommendations O O
Follow O O
up O O
intraoperative O O
cultures O O
Continue O O
vancomycin O O
1g O O
IV O O
Q24H; O O
check O O
trough O O
prior O O
to O O
fourth O O
dose. O O
Discontinue O O
levofloxacin, O O
metronidazole. O O
_______________________________ O O
Victor O O
Reid, O O
M.D. O O
(pager O O
81625) O O
Case O O
discussed O O
with O O
infectious O O
disease O O
attending, O O
Dr. O O
Amber O O
Akins. O O

Record O O
date: O O
2082-01-28 O O
Critical O O
care O O
PULMONARY O O
FELLOW O O
ADMIT B-DIABETES O
NOTE O O
Reason O O
for O O
Admission: O O
focal O O
neurologic O O
deficits O O
HPI: O O
48 O O
yo O O
man O O
with O O
CF, O O
HTN, B-HYPERTENSION O
GERD, O O
spinal O O
stenosis, O O
DM, O O
CF O O
arthropathy, O O
h/o O O
crypto O O
meningitis O O
and O O
h/o O O
left O O
UE O O
paresthesias O O
who O O
presented O O
to O O
Sheffield O O
Care O O
Center O O
1/26 O O
with O O
complaints O O
of O O
sudden-onset O O
right O O
hand O O
paresthesias, O O
followed O O
by O O
left O O
sided O O
weakness O O
and O O
left O O
sided O O
visual O O
deficits. O O
Also O O
with O O
frontal-occipital O O
headache O O
during O O
this O O
time. O O
He O O
presented O O
to O O
the O O
Sheffield O O
Center O O
ED, O O
and O O
shortly O O
after O O
he O O
was O O
seen O O
his O O
left O O
sided O O
weakness O O
resolved, O O
although O O
his O O
visual O O
field O O
deficits O O
and O O
right O O
hand O O
paresthesia O O
as O O
well O O
as O O
his O O
headache O O
had O O
remained. O O
He O O
denies O O
F/C/N/V. O O
No O O
neck O O
stiffness. O O
He O O
had O O
a O O
noncontrast O O
head O O
CT O O
which O O
was O O
negative O O
for O O
any O O
acute O O
process O O
per O O
radiology O O
read. O O
He O O
had O O
an O O
LP O O
with O O
2 O O
WBC, O O
2 O O
RBC, O O
glucose O O
98, O O
protein O O
84, O O
appeared O O
clear. O O
Gram O O
stain O O
with O O
no O O
orgs, O O
rare O O
polys. O O
ESR O O
44, O O
crypto O O
ag O O
pending. O O
He O O
was O O
transferred O O
to O O
HSH O O
because O O
Sheffield O O
Center O O
does O O
not O O
have O O
an O O
MRI O O
machine. O O
He O O
says O O
that O O
his O O
pulmonary O O
status O O
has O O
been O O
stable, O O
and O O
produces O O
a O O
moderate O O
amount O O
of O O
yellow O O
sputum. O O
He O O
does O O
not O O
do O O
chest O O
PT O O
at O O
home. O O
He O O
has O O
a O O
h/o O O
mild O O
sinusitis, O O
but O O
he O O
says O O
that O O
it O O
hasn't O O
been O O
bothering O O
him O O
lately. O O
He O O
has O O
been O O
having O O
normal O O
bowel O O
movements O O
with O O
no O O
difficulties O O
with O O
constipation. O O
PMH: O O
CF O O
HTN O O
GERD O O
Gout O O
Spinal O O
stenosis O O
(2062) O O
CF O O
induced O O
DM O O
CF O O
arthropathy O O
Crypto O O
meningitis O O
2062 O O
Nephrotic O O
syndrome O O
Bilateral O O
cataracts O O
Current O O
Meds: O O
Lasix O O
20 O O
bid O O
Advair O O
250/50 O O
bid O O
ASA B-MEDICATION B-MEDICATION
81 I-MEDICATION O
qd I-MEDICATION O
Albuterol O O
prn O O
Pancreacarb O O
8 O O
tabs O O
with O O
meals, O O
3-5 O O
w/snacks O O
Colchicine O O
0.5mg O O
qd O O
Cozaar B-MEDICATION B-MEDICATION
50qd I-MEDICATION O
Zestril B-MEDICATION B-MEDICATION
40mg I-MEDICATION O
qd I-MEDICATION O
Accolate O O
20mg O O
bid O O
Prandin O O
2-4 O O
mg O O
tid O O
qac O O
Vit O O
E O O
and O O
D O O
Celebrex O O
100mg O O
qd O O
Vit O O
K O O
5mg O O
3x/wk O O
Protoniz O O
40mg O O
qd O O
Azithro O O
500 O O
3x/wk O O
Probenecid O O
250mg O O
bid O O
Allergies: O O
NKDA O O
Family O O
History: O O
mother O O
died O O
of O O
Hodgkins O O
dz O O
at O O
33. O O
Father O O
with O O
CVA, O O
HTN, O O
sister O O
with O O
CF O O
Social O O
History: O O
Occupation/exposures: O O
shoe O O
repairer O O
Smoking: B-SMOKER O
no B-SMOKER O
tobacco, I-SMOKER O
+occasional O O
marijuana. O O
Occasional O O
alcohol. O O
Physical O O
Exam: O O
Vitals: O O
T O O
97.9, O O
HR O O
78, O O
BP O O
118/68, O O
RR O O
20, O O
99% O O
RA O O
Gen: O O
comfortable O O
in O O
NAD O O
HEENT/neck: O O
OP O O
clear, O O
PERRL, O O
EOMI, O O
no O O
nuchal O O
rigidity O O
Lungs/chest: O O
diminished O O
breath O O
sounds O O
bilaterally, O O
no O O
crackles O O
or O O
wheezes O O
Heart: O O
RRR O O
no O O
murmurs O O
Abd: O O
soft O O
nt/nd O O
+BS O O
Extr: O O
no O O
edema O O
Neuro: O O
+left O O
unilateral O O
left-sided O O
hemianopsia. O O
OTW O O
CN O O
II-XII O O
intact. O O
5/5 O O
strength O O
throughout, O O
normal O O
sensation, O O
normal O O
cerebellar O O
exam, O O
normal O O
gait. O O
+paresthesias O O
in O O
right O O
hand O O
in O O
a O O
glove O O
distribution. O O
Lab: O O
pending O O
Imaging: O O
pending O O
Impression: O O
48 O O
yo O O
man O O
with O O
CF, O O
CF-induced O O
DM, O O
and O O
HTN, O O
who O O
presented O O
to O O
an O O
outside O O
hospital O O
with O O
focal O O
neuro O O
changes O O
of O O
unclear O O
etiology, O O
but O O
concerning O O
for O O
a O O
CVA. O O
Recommendations: O O
1. O O
Neuro: O O
Would O O
get O O
a O O
brain O O
MRI/MRA O O
to O O
further O O
evaluate. O O
After O O
the O O
MRI O O
is O O
done, O O
would O O
get O O
a O O
neurology O O
consult O O
in O O
the O O
morning. O O
Continue O O
ASA, O O
BP O O
control O O
in O O
the O O
meantime. O O
Patient O O
may O O
need O O
a O O
repeat O O
LP O O
depending O O
on O O
neuro O O
consult O O
recs. O O
2. O O
Pulm: O O
CF O O
appears O O
stable. O O
Would O O
continue O O
his O O
outpatient O O
Advair, O O
albuterol, O O
azithro. O O
3. O O
GI: O O
continue O O
enzymes, O O
vitamins. O O
High O O
calorie, O O
high O O
protein O O
CF O O
diet. O O
4. O O
Endo: O O
monitor O O
blood O O
glucose. O O
______________________ O O
Quiana O O
Titus, O O
M.D. O O
Critical O O
care O O
Fellow O O
Pager: O O
33911 O O
Lung O O
Transplant O O
Attending O O
Note: O O
I O O
have O O
seen O O
and O O
examined O O
the O O
patient O O
with O O
Dr. O O
Titus O O
and O O
I O O
agree O O
with O O
her O O
evaluation O O
and O O
plan O O
as O O
outlined O O
above. O O
Mr. O O
Aguilar O O
is O O
a O O
48 O O
yo O O
man O O
with O O
h/o O O
CF O O
with O O
mild O O
pulmonary O O
disease, O O
who O O
presented O O
to O O
an O O
OSH O O
on O O
1/26 O O
with O O
sudden O O
onset O O
of O O
right O O
upper O O
ext O O
paresthesias, O O
followed O O
by O O
a O O
loss O O
of O O
left O O
visual O O
field, O O
diplopia, O O
and O O
left O O
sided O O
weakness. O O
The O O
patient O O
denies O O
incontinence O O
but O O
had O O
some O O
gait O O
instability O O
related O O
to O O
weakness. O O
The O O
patient O O
was O O
evaluated O O
at O O
the O O
OSH O O
with O O
non-contrast O O
head O O
CT O O
and O O
L/P O O
which O O
were O O
significant O O
only O O
for O O
elevated O O
CSF O O
protein. O O
Currently O O
symptoms O O
have O O
resolved O O
other O O
than O O
persistent O O
occipital O O
headache O O
which O O
began O O
with O O
the O O
onset O O
of O O
the O O
other O O
symptoms, O O
as O O
well O O
as O O
unilateral O O
hemianopsia O O
in O O
the O O
left O O
eye O O
evident O O
on O O
exam. O O
Exam O O
also O O
notable O O
for O O
disdiadochokinesis, O O
otherwise O O
neurologic O O
exam O O
non-focal. O O
Lung O O
exam O O
notable O O
for O O
diminished O O
BS O O
but O O
no O O
wheezes O O
or O O
crackles. O O
DDX O O
for O O
above O O
includes O O
ischemic O O
process, O O
though O O
symptoms O O
appear O O
to O O
be O O
multi-focal, O O
vs. O O
mononeuritis O O
multiplex O O
related O O
to O O
inflammatory O O
process. O O
Less O O
likely O O
is O O
mass O O
lesion O O
leading O O
to O O
above O O
symptoms, O O
or O O
meningeal O O
process. O O
We O O
plan O O
to O O
obtain O O
CNS O O
MRI, O O
neuro O O
consult. O O
Will O O
await O O
MRI O O
findings O O
prior O O
to O O
pursuing O O
further O O
serologic O O
work-up. O O
Continue O O
maintenance O O
medications O O
for O O
CF. O O
_______________________ O O
Debra O O
F. O O
Mullen, O O
MD O O

Record B-SMOKER O
date: O O
2082-09-29 O O
I O O
have O O
personally O O
reviewed O O
the O O
history, O O
examined O O
the O O
patient, O O
and O O
reviewed O O
and O O
edited O O
the O O
note O O
and O O
I O O
agree O O
with O O
the O O
assessment O O
and O O
plan O O
developed O O
under O O
my O O
personal O O
supervision O O
as O O
documented O O
by O O
previosu O O
PA O O
note O O
from O O
Ursula O O
Bowers, O O
PA-C. O O
Please O O
see O O
additional O O
comments O O
below. O O
Vicente O O
Aguilar O O
is O O
a O O
49 O O
y/o O O
male O O
with O O
cystic O O
fibrosis, O O
moderate O O
to O O
severe O O
lung O O
disease, O O
colonized O O
with O O
mucoid-type O O
Pseudomonas O O
aeruginosa O O
pancreatic O O
insufficiency, O O
CF O O
related O O
DM, B-DIABETES O
HTN, B-HYPERTENSION O
renal O O
insufficiency O O
with O O
proteinuria, O O
recent O O
h/o O O
CVA, O O
gout, O O
cataracts O O
who O O
is O O
currently O O
experiencing O O
a O O
subacute O O
exacerbation O O
of O O
his O O
pulmonary O O
disease O O
requiring O O
hospitalization O O
to O O
initiate O O
IV O O
antibiotics. O O
His O O
symptoms O O
include O O
long-standing O O
fatigue, O O
increased O O
cough O O
and O O
sputum O O
production, O O
some O O
SOB O O
with O O
mild O O
chest O O
tightness O O
and O O
wheezing. O O
His O O
FEV1 O O
significantly O O
decreased O O
during O O
recent O O
clicni O O
visit. O O
He O O
also O O
reports O O
some O O
sinus O O
headaches, O O
but O O
denies O O
sinus O O
pain O O
or O O
tenderness. O O
He O O
denies O O
hemoptysis, O O
fever/chills, O O
nausea, O O
vomiting, O O
diarrhea O O
or O O
constipation. O O
Please O O
see O O
details O O
regarding O O
recent O O
MRI/MRA O O
results O O
on O O
PA O O
note O O
above, O O
as O O
well O O
as O O
medications, O O
and O O
other O O
pertinent O O
historical O O
data O O
reviewed O O
independently. O O
VSS: O O
afebrile, O O
oxygen O O
saturation O O
Gen: O O
alert, O O
NAD O O
HEENT: O O
sclera O O
clear, O O
persistent O O
visual O O
defects O O
right O O
upper O O
quadrant O O
visual O O
field, O O
neck O O
supple O O
CV: O O
regular O O
Lungs: O O
essentially O O
clear O O
with O O
good O O
aeration, O O
no O O
wheezes O O
wuth O O
few O O
scattered O O
ronchi. O O
Abdomen: O O
soft, O O
NT, O O
ND, O O
no O O
masses O O
Ext: O O
warm, O O
clubbing O O
Neuro: O O
normal O O
gait, O O
oriented O O
x O O
3. O O
Assessment/Plan: O O
Vicente O O
Aguilar O O
is O O
a O O
49 O O
y/o O O
male O O
with O O
cystic O O
fibrosism O O
noderate O O
to O O
severe O O
lung O O
disease O O
with O O
past O O
medical O O
history O O
as O O
noted O O
above O O
who O O
is O O
currently O O
experiencing O O
a O O
subacute O O
exacerbation O O
of O O
his O O
pulmonary O O
disease O O
requiring O O
hospitalization O O
to O O
initiate O O
IV O O
antibiotics O O
1. O O
PULM/ID: O O
We O O
will O O
start O O
treatment O O
with O O
tobramycin O O
700 O O
mg O O
IV O O
q O O
am, O O
as O O
well O O
as O O
Ceftazidime O O
2 O O
g O O
IV O O
q O O
8 O O
hours O O
based O O
on O O
culture O O
results. O O
We O O
will O O
continue O O
maintenance O O
pulmonary O O
medications O O
including O O
bronchodilators, O O
mucolytics O O
and O O
steroids. O O
We O O
will O O
discuss O O
hypertonic O O
saline O O
therapy O O
and O O
trial O O
its O O
use O O
if O O
agreeable. O O
We O O
will O O
send O O
a O O
new O O
sputum O O
sample O O
for O O
culture. O O
Chest O O
x-ray O O
after O O
PICC O O
placement. O O
Will O O
review O O
routine O O
admission O O
labs. O O
2. O O
CVS: O O
monitor O O
blood O O
pressure O O
assess O O
need O O
for O O
other O O
protective O O
medications. O O
Will O O
continue O O
antihypertensives, B-HYPERTENSION O
ACEi O O
and O O
ARB O O
if O O
creatinine O O
stable. O O
We O O
will O O
review O O
findings O O
from O O
recent O O
MRI/MRA. O O
Check O O
lipid O O
profile O O
if O O
not O O
done, O O
on O O
Zocor. B-MEDICATION O
3. O O
FEN/GI: O O
High O O
calorie, O O
high O O
protein O O
CF O O
diet. O O
4. O O
Renal: O O
check O O
electrolytes, O O
as O O
well O O
as O O
UA O O
with O O
random O O
protein O O
and O O
creatinine. O O
His O O
creatinine O O
was O O
elevated O O
to O O
1.6, O O
now O O
1.5 O O
and O O
was O O
1.1-1.4 O O
at O O
baseline. O O
He O O
described O O
an O O
incident O O
last O O
week O O
with O O
nausea O O
and O O
vomiting O O
that O O
likely O O
led O O
to O O
above O O
result O O
while O O
taking O O
colchicine, O O
celebrex, O O
and O O
other O O
meds. O O
This O O
is O O
probabyl O O
on O O
its O O
way O O
to O O
improvement. O O
We O O
did O O
not O O
hold O O
ACEi O O
and O O
ARB O O
at O O
this O O
time, O O
but O O
will O O
repeat O O
Cr O O
tonight. O O
He O O
will O O
drink O O
fluids O O
during O O
the O O
day O O
priro O O
to O O
PICC O O
by O O
IR. O O
He O O
does O O
not O O
have O O
a O O
nephrologist O O
adn O O
will O O
need O O
to O O
find O O
him O O
one. O O
He O O
did O O
have O O
a O O
renal O O
biopsy O O
in O O
teh O O
late O O
60s O O
adn O O
thus O O
will O O
look O O
for O O
results, O O
but O O
renal O O
disease O O
likely O O
multigfactorial. O O
We O O
will O O
tobra O O
levels O O
bvery O O
close O O
adn O O
started O O
at O O
low O O
dose O O
for O O
his O O
size. O O
Will O O
likely O O
check O O
renal O O
US O O
while O O
here. O O
5. O O
Endo: O O
continue O O
insulin B-DIABETES O
regimen. O O
He O O
will O O
check O O
blood O O
sugars O O
more O O
frequently O O
and O O
folow O O
HgA1c. O O
He O O
did O O
state O O
that O O
he O O
occasionally O O
gets O O
blood O O
sugars O O
in O O
the O O
40s O O
when O O
he O O
wakes O O
up, O O
but O O
usually O O
nto O O
when O O
he O O
is O O
sedentary, O O
ie. O O
admitted O O
to O O
hospital. O O
IF O O
BS O O
normal O O
here, O O
he O O
will O O
check O O
them O O
very O O
closely O O
at O O
home O O
as O O
well O O
and O O
make O O
adjustments O O
as O O
necesary. O O
We O O
will O O
also O O
need O O
toset O O
him O O
up O O
with O O
Endocrinologist. O O
6. O O
Access: O O
PICC O O
line O O
to O O
be O O
placed O O
in O O
IR O O
7. O O
Dispo: O O
14 O O
day O O
of O O
inpatient O O
IV O O
antibiotics O O
8. O O
Neuro: O O
He O O
was O O
last O O
seen O O
by O O
Neurologist O O
on O O
8/30 O O
and O O
was O O
discharged O O
from O O
routine O O
follow-up. O O
He O O
will O O
continue O O
anti-hypertensive O O
meds O O
and O O
ASA. B-MEDICATION O
He O O
contineu O O
sot O O
have O O
visual O O
deficit O O
in O O
R O O
upper O O
quadrant. O O
_____________________________________________ O O
Quinton O O
Israel,D.O. O O

Record O O
date: O O
2084-12-07 O O
Pulmonary O O
Service O O
Admission O O
Note O O
Vicente O O
Aguilar O O
#98179909 O O
December O O
7, O O
2084 O O
HPI O O
51 O O
y/o O O
male O O
with O O
cystic O O
fibrosis, O O
pancreatic O O
insufficency O O
and O O
CRI O O
who O O
was O O
last O O
admitted O O
for O O
cleanout O O
in O O
1/2084 O O
now O O
presenting O O
after O O
being O O
seen O O
by O O
Dr O O
Mann O O
as O O
outpatient O O
on O O
long O O
island O O
with O O
newly O O
increased O O
creatinine O O
above O O
baseline O O
and O O
to O O
initiate O O
cleanout. O O
He O O
notes O O
he O O
has O O
been O O
doing O O
fairly O O
well O O
this O O
last O O
year. O O
He O O
was O O
seen O O
for O O
a O O
physical O O
by O O
his O O
primary O O
care O O
physician O O
Dr O O
Haas O O
on O O
November O O
13th O O
at O O
which O O
time O O
he O O
reports O O
she O O
told O O
him O O
he O O
was O O
doing O O
well. O O
Dr O O
Mann O O
followed O O
up O O
with O O
her O O
on O O
his O O
lab O O
studies O O
and O O
results O O
and O O
called O O
Mr O O
Aguilar O O
on O O
friday O O
alerting O O
him O O
to O O
the O O
change O O
in O O
his O O
renal O O
function. O O
It O O
was O O
decided O O
that O O
he O O
be O O
admitted O O
for O O
renal O O
work-up O O
as O O
well O O
as O O
initiating O O
cleanout O O
as O O
he O O
does O O
his O O
cleanouts O O
yearly. O O
He O O
notes O O
he O O
has O O
felt O O
generally O O
well O O
with O O
no O O
increased O O
cough O O
or O O
sputum, O O
chest O O
pain O O
or O O
tightness. O O
He O O
notes O O
he O O
has O O
'danced O O
around' O O
some O O
cold O O
symptoms O O
earlier O O
in O O
the O O
summer O O
but O O
has O O
had O O
none O O
since. O O
He O O
denies O O
any O O
fevers O O
or O O
chills O O
and O O
notes O O
he O O
only O O
gets O O
sweats O O
if O O
he O O
has O O
a O O
low O O
blood O O
sugar. O O
He O O
denies O O
any O O
N/V, O O
diarrhea O O
or O O
constipation O O
and O O
has O O
stable O O
appetite. O O
He O O
notes O O
stable O O
weight O O
of O O
185-186 O O
lbs. O O
He O O
notes O O
he O O
has O O
had O O
erratic O O
control O O
of O O
his O O
blood O O
sugar O O
as O O
he O O
does O O
at O O
times O O
'forget' O O
to O O
give O O
himself O O
insulin. O O
He O O
does O O
monitoe O O
his O O
BS O O
four O O
times O O
per O O
day. O O
He O O
denies O O
any O O
dysuria, O O
hematuria O O
or O O
urgency. O O
he O O
does O O
note O O
frequency O O
has O O
increased O O
over O O
the O O
year, O O
he O O
now O O
urinates O O
every O O
few O O
hours. O O
He O O
denies O O
any O O
sore O O
throat O O
or O O
sinus O O
pain, O O
does O O
have O O
occasional O O
mild O O
congestion. O O
Reviwe O O
of O O
systems: O O
he O O
has O O
a O O
flu O O
shot, O O
denies O O
sick O O
contacts. O O
notes O O
his O O
prostate O O
exam O O
at O O
his O O
PCP O O
office O O
was O O
reported O O
to O O
be O O
normal. O O
denies O O
reflux O O
symptoms, O O
does O O
have O O
feeling O O
of O O
pills O O
'sticking' O O
when O O
he O O
swallows O O
them O O
occasionally. O O
PMH: O O
Cystic O O
Fibrosis O O
Pancreatic O O
insufficiency O O
CF O O
related O O
Diabetes B-DIABETES O
Mellitus I-DIABETES O
Hypertension B-HYPERTENSION O
Nephrotic O O
syndrome O O
(baseline O O
creatinine O O
1.1), O O
chart O O
dx O O
at O O
CHB O O
of O O
GN, O O
unclear O O
source O O
of O O
dx O O
Gout O O
Cataracts O O
Allergies: O O
NKDA O O
Medications: O O
Aspirin B-MEDICATION B-MEDICATION
81 I-MEDICATION O
mg I-MEDICATION O
po I-MEDICATION O
daily I-MEDICATION O
Colchicine O O
0.6 O O
mg O O
po O O
daily O O
Probenecid O O
250 O O
mg O O
po O O
bid O O
Azithromycin O O
500 O O
mg O O
po O O
q O O
thu/sat/Monday O O
simvastatin B-MEDICATION B-MEDICATION
20 I-MEDICATION O
mg I-MEDICATION O
po I-MEDICATION O
qhs I-MEDICATION O
Cozaar B-MEDICATION B-MEDICATION
50 I-MEDICATION O
mg I-MEDICATION O
po I-MEDICATION O
BID I-MEDICATION O
Accolate O O
20 O O
mg O O
po O O
bid O O
Albuterol O O
inh O O
prn O O
Plaretase O O
8000 O O
6 O O
tabs O O
po O O
qac/ O O
snacks O O
(what O O
his O O
pharmacy O O
switched O O
him O O
to O O
as O O
pancrecarb O O
not O O
available) O O
Protonix O O
40 O O
mg O O
po O O
daily O O
Lantus B-MEDICATION O
12 I-MEDICATION O
u I-MEDICATION O
qhs I-MEDICATION O
Humalog B-MEDICATION B-MEDICATION
scale I-MEDICATION O
ac I-MEDICATION O
FH/SH: O O
lives O O
on O O
long O O
island O O
with O O
partner O O
of O O
4 O O
years, O O
she O O
is O O
a O O
Notary. O O
Works O O
in O O
shoe O O
repair. O O
Denies B-SMOKER O
tobacco, I-SMOKER O
usually O O
drinks O O
daily O O
galss O O
of O O
grand O O
marnier. O O
notes O O
prior O O
daily O O
marajuana O O
smoking, O O
now O O
3-4 O O
times O O
per O O
month O O
recently. O O
PHYSICAL O O
EXAM O O
(in O O
CDIC): O O
Vitals: O O
see O O
nursing O O
flowsheet O O
GEN:NAD. O O
Pleaseant O O
male. O O
Nad. O O
HEENT: O O
PERRL, O O
op O O
moist, O O
with O O
no O O
exudates, O O
no O O
sinus O O
pain O O
or O O
tendernes, O O
no O O
LAN O O
LUNGS: O O
clear O O
to O O
auscultation O O
bilaterally, O O
no O O
wheezes O O
or O O
rhonchi O O
HEART:S1S2 O O
reg, O O
no O O
m/g/r, O O
rrr O O
ABDOMEN:soft. O O
NT/ND, O O
active O O
BS, O O
no O O
HSM O O
EXT: O O
trace O O
digital O O
clubbing O O
b/l, O O
trace O O
b/l O O
ankle O O
edema O O
NEURO:alert O O
and O O
oriented O O
x O O
3, O O
no O O
focal O O
deficits O O
DATA O O
(from O O
CHB): O O
-reported O O
BUN/Cre O O
from O O
PCP O O
office- O O
68/2.1 O O
-no O O
other O O
updated O O
data O O
Assessment/Plan: O O
Mr O O
Aguilar O O
is O O
a O O
51 O O
M O O
with O O
cystic O O
fibrosis O O
and O O
hx O O
of O O
CRI O O
who O O
presents O O
now O O
with O O
significant O O
worsening O O
of O O
his O O
renal O O
function O O
seen O O
on O O
outpatient O O
labs O O
as O O
well O O
as O O
it O O
having O O
been O O
nearly O O
one O O
year O O
since O O
prior O O
cleanout. O O
He O O
is O O
being O O
admitted O O
for O O
initiation O O
of O O
cleanout O O
and O O
evaluation O O
of O O
renal O O
dysfunction. O O
He O O
will O O
be O O
admitted O O
to O O
pulmonary O O
PA O O
service. O O
1) O O
Pulm/ID: O O
Based O O
on O O
his O O
past O O
sputum O O
culture O O
studies O O
from O O
CHB O O
and O O
his O O
renal O O
function O O
we O O
will O O
start O O
him O O
on O O
Ceftaz O O
at O O
renal O O
dose O O
of O O
2g O O
q24h O O
and O O
cipro O O
250 O O
q12h. O O
Have O O
used O O
aminoglycosides O O
in O O
the O O
past O O
but O O
given O O
his O O
renal O O
function O O
will O O
avoid O O
these O O
at O O
this O O
time. O O
Will O O
get O O
a O O
f/u O O
CXR O O
to O O
compare O O
to O O
his O O
study O O
done O O
last O O
year O O
to O O
assess O O
for O O
any O O
change. O O
Will O O
consult O O
RT O O
for O O
Chest O O
PT O O
TID O O
and O O
discuss O O
restarting O O
hypertonic O O
saline/pulmozyme. O O
Will O O
continue O O
other O O
pulmonary O O
inhalers. O O
2)FEN/GI: O O
Will O O
maintain O O
on O O
high O O
calorie, O O
high O O
protein O O
CF O O
diet O O
and O O
continue O O
current O O
regimen O O
of O O
vitamins O O
and O O
enzymes. O O
Will O O
get O O
Nutrition O O
consult O O
as O O
patient O O
has O O
not O O
been O O
seen O O
in O O
quite O O
some O O
time. O O
Will O O
monitor O O
bowels, O O
currently O O
stable. O O
3) O O
CV: O O
history O O
of O O
HTN, B-HYPERTENSION O
will O O
continue O O
home O O
cozaar B-MEDICATION B-MEDICATION
and O O
lisinopril B-MEDICATION B-MEDICATION
for O O
now O O
but O O
may O O
consider O O
alternative O O
choices O O
given O O
renal O O
dysfunction O O
if O O
needed. O O
Will O O
monitor O O
vital O O
signs. O O
4) O O
ENDO: O O
CF O O
related O O
DM: B-DIABETES O
will O O
continue O O
lantus O O
and O O
SSI O O
and O O
check O O
FSBS O O
AC/HS. O O
Will O O
send O O
HgA1c O O
given O O
his O O
report O O
of O O
erratic O O
control O O
at O O
home. O O
5) O O
Rheum: O O
Gouty O O
arthritis O O
has O O
been O O
stable, O O
will O O
contiue O O
probenecid O O
and O O
celebrex O O
6) O O
Renal: O O
Recent O O
BUN/creatinine O O
as O O
reported O O
from O O
his O O
PCP O O
is O O
significantly O O
elevated O O
from O O
his O O
prior O O
levels O O
earlier O O
this O O
year. O O
Patient O O
has O O
not O O
been O O
followed O O
regularly O O
by O O
nephrology O O
in O O
the O O
past. O O
Unclear O O
the O O
exact O O
nature O O
of O O
his O O
renal O O
dysfunction O O
and O O
the O O
etiology O O
of O O
its O O
worsening O O
of O O
late. O O
Will O O
send O O
for O O
renal O O
ultrasound O O
and O O
send O O
urine O O
lytes, O O
protein, O O
creatinine O O
and O O
eosinophils O O
to O O
begin O O
work-up O O
and O O
will O O
consider O O
renal O O
consult. O O
Will O O
start O O
gentle O O
IVF O O
hydration O O
overnight. O O
7)Access: O O
PICC O O
line O O
in O O
IR O O
today O O
8)PPX: O O
sc O O
heparin O O
, O O
PPI O O
9)Dispo: O O
TBD O O
______________________________________ O O
Francine O O
Morales, O O
PA-C O O
68626 O O

Record O O
date: O O
2085-08-29 O O
Pulmonary O O
Service O O
Admission O O
Note O O
HPI: O O
52 O O
yo O O
male O O
with O O
Cystic O O
Fibrosis, O O
CKD, O O
CF O O
related O O
Arthritis O O
presents O O
with O O
c/o O O
increased O O
cough, O O
sputum O O
production, O O
SOB O O
and O O
fatigue O O
for O O
several O O
weeks. O O
He O O
also O O
has O O
had O O
a O O
15 O O
lb O O
weight O O
loss O O
over O O
the O O
past O O
2 O O
months. O O
His O O
po O O
intake O O
has O O
been O O
decreased. O O
He O O
denies O O
fever, O O
chills, O O
night O O
sweats, O O
chest O O
tightness, O O
hemoptysis O O
or O O
blood O O
streaking. O O
PMH: O O
Cystic O O
Fibrosis O O
Pancreatic O O
insufficiency O O
CKD O O
CF B-DIABETES O
related I-DIABETES O
Diabetes B-DIABETES O
Mellitus I-DIABETES O
Hypertension B-HYPERTENSION O
Nephrotic O O
syndrome O O
(baseline O O
creatinine O O
1.1), O O
chart O O
dx O O
at O O
CHB O O
of O O
GN, O O
unclear O O
source O O
of O O
dx O O
Gout O O
Cataracts O O
Allergies: O O
NKDA O O
Medications: O O
Accolate O O
20 O O
MG O O
PO O O
BID O O
Allopurinol O O
300 O O
MG O O
daily O O
Aspirin B-MEDICATION B-MEDICATION
81 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
QD I-MEDICATION O
Azithromycin O O
500 O O
MG O O
po O O
Q O O
Thursday/Saturday/Monday O O
Colchicine O O
0.6 O O
MG O O
PO O O
Q O O
thu/sat/monday O O
HCTZ B-MEDICATION O
25 I-MEDICATION O
mg I-MEDICATION O
daily I-MEDICATION O
Humalog B-MEDICATION B-MEDICATION
SS I-MEDICATION O
q I-MEDICATION O
AC I-MEDICATION O
(approx I-MEDICATION O
20 I-MEDICATION O
units) I-MEDICATION O
Lantus B-MEDICATION B-MEDICATION
15 I-MEDICATION O
UNITS I-MEDICATION O
SC I-MEDICATION O
QHS I-MEDICATION O
Lopressor B-MEDICATION B-MEDICATION
50 I-MEDICATION O
MG I-MEDICATION O
PO I-MEDICATION O
BID I-MEDICATION O
Pancrecarb O O
MS O O
8 O O
(PANCRELIPASE O O
8,000 O O
UNITS O O
(PANCRECARB O O
MS O O
8)) O O
8 O O
TABS O O
PO O O
QAC O O
and O O
snacks O O
Probenecid O O
250 O O
MG O O
PO O O
QD O O
Prednisone O O
15 O O
MG O O
daily O O
Protonix O O
40 O O
mg O O
PO O O
QD O O
Simvastatin B-MEDICATION B-MEDICATION
20 I-MEDICATION O
MG I-MEDICATION O
po I-MEDICATION O
q I-MEDICATION O
hs I-MEDICATION O
Symbicort O O
80/4.5 O O
2 O O
PUFF O O
INH O O
BID O O
Pulmozyme O O
2.5 O O
mg O O
nebulized O O
bid O O
Hypertonic O O
Saline O O
4mL O O
inhaled O O
bid O O
FH/SH: O O
lives O O
on O O
long O O
island O O
with O O
partner O O
of O O
5 O O
years, O O
she O O
is O O
a O O
Notary. O O
Works O O
in O O
shoe O O
repair. O O
Denies B-SMOKER O
tobacco, I-SMOKER O
usually O O
drinks O O
daily O O
glass O O
of O O
grand O O
marnier. O O
notes O O
prior O O
daily O O
marajuana O O
smoking, O O
now O O
3-4 O O
times O O
per O O
month O O
recently. O O
Review O O
of O O
systems: O O
Denies O O
sick O O
contacts. O O
denies O O
reflux O O
symptoms. O O
states O O
urine O O
output O O
regular, O O
but O O
had O O
several O O
day O O
period O O
of O O
constipation O O
and O O
abdominal O O
that O O
he O O
was O O
able O O
to O O
resolve O O
with O O
prune O O
juice O O
and O O
Activia O O
yogurt. O O
PHYSICAL O O
EXAM O O
(in O O
CDIC): O O
Vitals: O O
see O O
nursing O O
flowsheet O O
GEN:NAD. O O
Pleaseant O O
male. O O
Nad. O O
HEENT: O O
PERRL, O O
op O O
moist, O O
with O O
no O O
exudates, O O
no O O
sinus O O
pain O O
or O O
tendernes, O O
no O O
LAN O O
LUNGS: O O
clear O O
to O O
auscultation O O
bilaterally, O O
no O O
wheezes O O
or O O
rhonchi O O
HEART:S1S2 O O
reg, O O
no O O
m/g/r, O O
rrr O O
ABDOMEN:soft. O O
NT/ND, O O
active O O
BS, O O
no O O
HSM O O
EXT: O O
trace O O
digital O O
clubbing O O
b/l, O O
trace O O
b/l O O
ankle O O
edema O O
NEURO:alert O O
and O O
oriented O O
x O O
3, O O
no O O
focal O O
deficits O O
DATA O O
(from O O
CHB): O O
PFT&#8217;s O O
2/01/85 O O
: O O
65/43/14 O O
12/12/84: O O
78/46/14 O O
2/4/2084: O O
90/56/18 O O
1/26/84: O O
85/53/14 O O
10/6/82: O O
45/50/20 O O
8/13/82: O O
48/33/14 O O
Sputum O O
cultures: O O
2/01/85 O O
: O O
PsA O O
(pan O O
sensitive), O O
PsA O O
(pan O O
sensitive), O O
PsA O O
(pan O O
sensitive) O O
12/8/84: O O
MRSA O O
(S: O O
linezolid, O O
synercid, O O
tetra, O O
tigecycline, O O
vanco), O O
PsA O O
#1pan O O
sensitive, O O
PsA O O
#2 O O
(S: O O
cipro, O O
zosyn, O O
tobra), O O
PsA#3 O O
(S: O O
amik, O O
azt, O O
ceft, O O
cipro, O O
gent, O O
zosyn, O O
tobra) O O
1/26/84 O O
PsA: O O
(S: O O
ceftaz, O O
cipro, O O
zosyn, O O
tobra) O O
PsA: O O
(pan O O
sensitive) O O
PsA: O O
(pan O O
sensitive) O O
Assessment/Plan: O O
Mr O O
Aguilar O O
is O O
a O O
51 O O
M O O
with O O
cystic O O
fibrosis O O
and O O
CKD O O
presenting O O
with O O
subacute O O
CF O O
exacerbation O O
for O O
IV O O
antiobiotic O O
cleanout. O O
He O O
will O O
be O O
admitted O O
to O O
pulmonary O O
PA O O
service. O O
1) O O
Pulm/ID: O O
Start O O
Ceftaz O O
2 O O
g O O
IV O O
q O O
12 O O
, O O
Cipro O O
500 O O
mg O O
po O O
q O O
12, O O
Vanco O O
1 O O
g O O
IV O O
q O O
24 O O
Sputum O O
cx O O
to O O
CHB, O O
Chest O O
xray, O O
PT O O
c/s O O
for O O
treadmill, O O
Chest O O
PT O O
BID, O O
hypertonic O O
saline, O O
pulmozyme O O
2)FEN/GI: O O
Will O O
maintain O O
on O O
high O O
calorie, O O
high O O
protein O O
CF O O
diet O O
and O O
continue O O
current O O
regimen O O
of O O
vitamins O O
and O O
enzymes. O O
Will O O
get O O
Nutrition O O
consult O O
as O O
inpatient O O
has O O
not O O
been O O
seen O O
in O O
quite O O
some O O
time. O O
Will O O
monitor O O
bowels, O O
currently O O
stable. O O
3) O O
CV: O O
History O O
of O O
HTN, B-HYPERTENSION O
will O O
continue O O
home O O
cozaar O B-MEDICATION
and O O
lisinopril O B-MEDICATION
for O O
now O O
but O O
may O O
consider O O
alternative O O
choices O O
given O O
renal O O
dysfunction O O
if O O
needed. O O
Will O O
monitor O O
vital O O
signs. O O
4) O O
ENDO: O O
CF O O
related O O
DM: O O
will O O
continue O O
lantus O B-MEDICATION
and O O
SSI O O
and O O
check O O
FSBS O O
AC/HS. O O
Will O O
send O O
HgA1c O O
given O O
his O O
report O O
of O O
erratic O O
control O O
at O O
home. O O
5) O O
Rheum: O O
Gouty O O
arthritis O O
has O O
been O O
stable, O O
will O O
contiue O O
probenecid. O O
Obtain O O
uric O O
acid O O
level.Wean O O
prednisone. O O
6) O O
Renal: O O
Followed O O
by O O
Dr O O
Esparza O O
-no O O
current O O
issues, O O
last O O
bun/cr: O O
82/1.77, O O
BP O O
maintained O O
on O O
hctz/lopressor. B-MEDICATION O
7)Access: O O
PICC O O
line O O
in O O
IR O O
today O O
8)PPX: O O
sc O O
heparin O O
, O O
PPI O O
9)Dispo: O O
TBD O O
______________________________________ O O
Ursula O O
Bowers, O O
PA-C O O
34680 O O
Pulmonary O O
Attending O O
I O O
have O O
seen O O
and O O
examined O O
Mr. O O
Aguilar O O
with O O
PA O O
Bowers O O
with O O
whose O O
note O O
I O O
agree. O O
Admission O O
for O O
'clean-out' O O
for O O
CF. O O
Increased O O
dyspnea O O
and O O
sputum O O
and O O
decrease O O
in O O
spirometry. O O
No O O
hemoptysis. O O
Plan O O
as O O
reviewed O O
with O O
team O O
is O O
to O O
start O O
Ceftazidime O O
2 O O
g O O
IV O O
q O O
12 O O
, O O
Cipro O O
500 O O
mg O O
po O O
q O O
12, O O
Vancomycin O O
1 O O
g O O
IV O O
q O O
24. O O
Sputum O O
cx O O
will O O
be O O
sent O O
to O O
CHB. O O
We O O
will O O
initiate O O
chest O O
PT O O
BID, O O
hypertonic O O
saline, O O
pulmozyme. O O
Encourage O O
ambulation. O O
He O O
is O O
on O O
prednisone O O
at O O
15 O O
mg O O
given O O
hx O O
of O O
arthritis. O O
No O O
alterations O O
in O O
dose O O
at O O
present O O
for O O
pulmonary O O
status. O O
IR O O
picc O O
pending. O O
Laboratory O O
studies O O
and O O
chest O O
x O O
ray O O
pending O O
and O O
will O O
be O O
reviewed O O
personally O O
once O O
available. O O
Disposition O O
pending. O O
Full O O
code. O O
Rachel O O
G. O O
Richardson, O O
MD O O

Record B-SMOKER O
date: O O
2112-01-27 O O
NAME: O O
Werner, O O
Brian O O
MRN: O O
4097229 O O
This O O
patient O O
reports O O
approximately O O
3-4 O O
years O O
ago O O
he O O
had O O
episodes O O
of O O
right O O
sided O O
visual O O
loss. O O
He O O
thought O O
it O O
was O O
only O O
related O O
to O O
his O O
right O O
eye. O O
What O O
he O O
describes O O
is O O
a O O
right O O
peripheral O O
hemispheric O O
visual O O
loss. O O
He O O
reports O O
having O O
a O O
history O O
of O O
headaches O O
in O O
the O O
past. O O
It O O
is O O
nothing O O
that O O
is O O
significantly O O
worse O O
than O O
usual. O O
On O O
Thursday O O
he O O
reports O O
having O O
a O O
mild O O
bitemporal O O
headache O O
and O O
then O O
later O O
that O O
day O O
ensuing O O
right O O
peripheral O O
loss O O
that O O
has O O
lasted O O
for O O
the O O
past O O
3-4 O O
days. O O
In O O
the O O
past O O
his O O
visual O O
loss O O
only O O
lasted O O
for O O
about O O
one O O
day. O O
He O O
denies O O
any O O
other O O
focal O O
neurological O O
complaints. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension. B-HYPERTENSION O
He O O
is O O
on O O
a O O
baby B-MEDICATION O
aspirin I-MEDICATION B-MEDICATION
a O O
day. O O
He O O
denies O O
any O O
further O O
headaches. O O
He O O
denies O O
any O O
numbness, O O
tingling O O
or O O
weakness O O
on O O
one O O
side O O
of O O
his O O
body O O
or O O
other. O O
He O O
has O O
chronic O O
left O O
knee O O
problems O O
from O O
an O O
old O O
injury. O O
He O O
is O O
unable O O
to O O
bend O O
the O O
leg. O O
He O O
has O O
no O O
new O O
problems O O
with O O
his O O
gait. O O
He O O
denies O O
any O O
symptoms O O
of O O
jaw O O
claudication. O O
PHYSICAL O O
EXAM: O O
His O O
exam O O
reveals O O
no O O
temporal O O
artery O O
tenderness O O
to O O
palpation. O O
His O O
funduscopic O O
exam O O
appears O O
normal O O
on O O
undilated O O
exam. O O
His O O
visual O O
fields O O
reveals O O
what O O
appears O O
to O O
be O O
consistent O O
with O O
right O O
bilateral O O
hemianopsia. O O
PERRLA. O O
EOMI. O O
Cranial O O
nerves O O
II-XII O O
are O O
otherwise O O
intact. O O
His O O
motor O O
strength O O
is O O
5/5. O O
He O O
has O O
no O O
pronator O O
drift. O O
His O O
cerebellar O O
exam O O
is O O
intact. O O
His O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
is I-HYPERTENSION O
150/100. I-HYPERTENSION O
Carotid O O
- O O
no O O
bruit. O O
Cor O O
- O O
RRR O O
no O O
MGR O O
Lungs O O
- O O
CTA O O
ASSESSMENT O O
AND O O
PLAN: O O
Question O O
bilateral O O
hemianopsia. O O
The O O
patient O O
will O O
get O O
scheduled O O
for O O
an O O
MRI/MRA O O
as O O
soon O O
as O O
possible. O O
He O O
was O O
sent O O
to O O
the O O
NDMG O O
Ophthalmology O O
Clinic O O
to O O
confirm O O
bilateral O O
vs. O O
unilateral O O
hemianopsia O O
(central O O
vs. O O
peripheral O O
etiology) O O
today O O
for O O
further O O
evaluation O O
plus/minus O O
ESR O O
and O O
CBC O O
at O O
that O O
point O O
in O O
time. O O
Ernestine O O
Phan, O O
M.D. O O
EP/gillis/cook O O

Record B-SMOKER O
date: O O
2114-09-25 O O
NAME: O O
Werner, O O
Brian O O
MRN: O O
4097229 O O
Last O O
week O O
he O O
had O O
a O O
right O O
carotid O O
endarterectomy. O O
Initially, O O
he O O
had O O
some O O
hoarseness. O O
It O O
went O O
away O O
but O O
now O O
it O O
has O O
returned. O O
He O O
did O O
have O O
a O O
period O O
of O O
100.4 O O
while O O
at O O
home O O
and O O
has O O
felt O O
a O O
little O O
chilled. O O
He O O
is O O
still O O
hoarse O O
today. O O
He O O
feels O O
a O O
little O O
achy O O
in O O
the O O
joints. O O
Medications O O
Albuterol O O
INHALER O O
1-2 O O
PUFF O O
INH O O
QID O O
PRN O O
, O O
Take O O
as O O
directed O O
Zestril B-MEDICATION B-MEDICATION
(LISINOPRIL) O O
30MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Hctz B-MEDICATION O
(HYDROCHLOROTHIAZIDE) O O
12.5MG O O
CAPSULE O O
take O O
1 O O
Capsule(s) O O
PO O O
QD O O
, O O
THIS O O
WAS O O
FAXED O O
TO O O
YOU O O
ON O O
5/8/14 O O
Coumadin O O
(WARFARIN O O
SODIUM) O O
5MG O O
TABLET O O
take O O
1.5 O O
Tablet(s) O O
PO O O
QPM O O
Salsalate O O
750MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
PRN O O
Flonase O O
NASAL O O
SPRAY O O
(FLUTICASONE O O
NASAL O O
SPRAY) O O
1-2 O O
SPRAY O O
(50MCG O O
SPRAY O O
) O O
NAS O O
BID O O
Problems O O
Hypertension B-HYPERTENSION O
Osteoathritis O O
Gastroesophageal O O
reflux O O
disease O O
Diverticulitis O O
Cerebrovascular O O
accident O O
: O O
L O O
cerebellar O O
2112, O O
s/p O O
L O O
CEA O O
Lung O O
nodule O O
: O O
Repeat O O
chest O O
CT O O
10/14. O O
Allergies O O
Penicillins O O
- O O
Rash, O O
Penicillins O O
- O O
Rash O O
Vital O O
Signs O O
BP B-HYPERTENSION O
140/78, I-HYPERTENSION O
P O O
76, O O
Temp O O
98.1 O O
F O O
On O O
exam, O O
he O O
is O O
hoarse. O O
Temperature O O
is O O
98.1, O O
however. O O
Throat O O
is O O
clear. O O
His O O
right O O
CEA O O
is O O
clean. O O
Heart: O O
Regular O O
rate O O
and O O
rhythm, O O
no O O
murmurs, O O
gallops O O
or O O
rubs. O O
Lungs O O
clear. O O
ASSESSMENT O O
AND O O
PLAN: O O
(1) O O
Bronchitis/laryngitis. O O
Chest O O
x-ray O O
today O O
is O O
clear. O O
I O O
elected O O
to O O
go O O
ahead O O
and O O
treat O O
him O O
with O O
doxycycline O O
100 O O
mg O O
b.i.d. O O
for O O
the O O
next O O
10 O O
days. O O
He O O
does O O
have O O
follow-up O O
with O O
his O O
neurosurgeon O O
in O O
the O O
next O O
10 O O
days O O
or O O
so. O O
(2) O O
Health O O
maintenance. O O
Double O O
check O O
on O O
LFTs O O
and O O
A1c O O
since O O
his O O
LFTs O O
and O O
blood O O
sugars O O
were O O
up O O
in O O
the O O
hospital. O O
Also O O
check O O
a O O
CBC. O O
Thomas O O
D. O O
Kinney, O O
M.D. O O
TDK/gillis/dougherty O O

Record O O
date: O O
2119-12-22 O O
Radiology O O
H&amp;P O O
Pt: O O
WERNER, O O
Brian O O
U O O
MRN: O O
4097229 O O
Date: O O
12/22/2119 O O
10:56h O O
CC: O O
elective O O
left O O
carotid O O
artery O O
stent O O
placement O O
HPI: O O
73yo O O
RHM O O
with O O
h/o O O
left O O
PCA O O
stroke O O
(residual O O
right O O
partial O O
visual O O
field O O
cut) O O
and O O
h/o O O
bilateral O O
carotid O O
endarterectomies O O
having O O
recurrent O O
stenosis O O
of O O
left O O
ICA O O
here O O
for O O
elective O O
left O O
ICA O O
stent O O
placement. O O
He O O
is O O
noted O O
on O O
CTA O O
head/neck O O
on O O
11/14/19 O O
to O O
have O O
a O O
'bovine' O O
variant O O
left O O
common O O
carotid O O
artery O O
takeoff O O
(origin O O
of O O
the O O
left O O
CCA O O
from O O
the O O
proximal O O
innominate O O
artery O O
- O O
anatomic O O
variant) O O
for O O
access O O
considerations. O O
ROS: O O
very O O
mild O O
chronic O O
cough, O O
denies O O
f/c/n/v, O O
denies O O
CP O O
or O O
palpitations, O O
denies O O
SOB O O
or O O
abd O O
pain, O O
no O O
recent O O
loss O O
of O O
weight O O
or O O
appetite O O
problems. O O
PMH/PSH: O O
- O O
s/p O O
left O O
CEA O O
2112 O O
, O O
s/p O O
right O O
CEA O O
2114 O O
- O O
h/o O O
left O O
PCA O O
stroke O O
2112 O O
- O O
h/o O O
vertigo O O
- O O
HTN B-HYPERTENSION O
/ O O
HL B-HYPERLIPIDEMIA O
- O O
s/p O O
LLE O O
surgery O O
for O O
fracture O O
related O O
to O O
motorcycle O O
accident O O
in O O
2068 O O
(cannot O O
bend O O
left O O
knee) O O
- O O
GERD O O
- O O
osteoarthritis O O
- O O
h/o O O
elevated O O
transaminases O O
- O O
s/p O O
biopsy O O
on O O
8mm O O
macule O O
of O O
left O O
midcalf O O
(lentigo O O
vs O O
early O O
junctional O O
nevus) O O
in O O
2116 O O
- O O
s/p O O
left O O
inguinal O O
hernia O O
repair O O
2111 O O
- O O
s/p O O
surgical O O
trigger O O
finger O O
release O O
of O O
left O O
hand O O
Dupuytren's O O
contracture O O
of O O
middle O O
finger O O
- O O
question O O
of O O
COPD O O
on O O
inhalers O O
prn, O O
with O O
smoking B-SMOKER O
history I-SMOKER O
(quit I-SMOKER O
smoking I-SMOKER O
in I-SMOKER O
2100s) I-SMOKER O
MEDICATIONS: O O
ASA B-MEDICATION B-MEDICATION
325mg O O
daily O O
(took O O
dose O O
this O O
AM) O O
Plavix B-MEDICATION B-MEDICATION
75mg O O
daily O O
(started O O
&gt;10days O O
ago, O O
took O O
dose O O
this O O
AM) O O
Albuterol O O
2puffs O O
QID O O
prn O O
SOB/wheeze O O
Flovent O O
110mcg O O
inh O O
bid O O
prn O O
SOB/wheeze O O
Nifedipine B-MEDICATION O
ER O O
60mg O O
daily O O
Niacin B-MEDICATION B-MEDICATION
ER O O
500mg O O
qhs O O
Ranitidine O O
150mg O O
BID O O
MVI O O
1tab O O
daily O O
ALLERGIES/ADR: O O
Penicillin O O
(rash) O O
Lisinopril O B-MEDICATION
(cough) O O
Atorvastatin O B-MEDICATION
(elevated O O
transaminases, O O
myalgias) O O
FMH/SH: O O
father O O
with O O
lung O O
cancer, O O
mother O O
with O O
stroke, O O
brother O O
with O O
strokes O O
in O O
age O O
50s; O O
~1ppd O O
since O O
teens, B-SMOKER O
quit I-SMOKER O
smoking I-SMOKER O
in O O
2100's; O O
rare O O
EtOH; O O
retired O O
mailman; O O
lives O O
with O O
wife O O
Javonna O O
Werner O O
026-003-5757 O O
or O O
631-133-0409 O O
in O O
Sayre O O
(KY). O O
EXAM: O O
AVSS O O
per O O
report O O
Awake/alert, O O
fully O O
oriented O O
x3, O O
appropriately O O
conversant O O
PERRL O O
/ O O
EOMI, O O
right O O
visual O O
field O O
cut O O
in O O
far O O
lateral O O
right O O
visual O O
field O O
past O O
approximately O O
60-degrees O O
(right O O
homonymous O O
hemianopsia) O O
Face O O
sensation O O
to O O
LT O O
in O O
b/l O O
V123, O O
masseters O O
strong O O
b/l, O O
face O O
strength O O
full O O
b/l, O O
hearing O O
to O O
finger O O
rub O O
b/l O O
Voice O O
clear O O
with O O
UML/TML, O O
SCM O O
&amp; O O
shoulder O O
shrugs O O
full O O
strength O O
b/l O O
No O O
pronator O O
drift, O O
full O O
strength O O
in O O
BUE/BLE O O
to O O
resistance O O
testing O O
except O O
minimal O O
bending O O
ROM O O
of O O
left O O
knee O O
joint O O
related O O
to O O
old O O
LLE O O
injury O O
from O O
motorcycle O O
accident O O
s/p O O
surgery O O
2068, O O
gait O O
with O O
LLE O O
limp O O
related O O
to O O
minimal O O
left O O
knee O O
bending O O
Sensation O O
to O O
LT O O
in O O
distal O O
BUE/BLE O O
Cardiac: O O
S1S2, O O
no O O
murmurs O O
noted O O
Lungs: O O
clear O O
to O O
auscultation O O
bilaterally O O
Abdomen: O O
soft, O O
NT/ND O O
A/P: O O
73yo O O
RHM O O
with O O
h/o O O
left O O
PCA O O
stroke O O
(residual O O
right O O
partial O O
visual O O
field O O
cut) O O
and O O
h/o O O
bilateral O O
carotid O O
endarterectomies O O
having O O
recurrent O O
stenosis O O
of O O
left O O
ICA O O
here O O
for O O
elective O O
left O O
ICA O O
stent O O
placement. O O
He O O
is O O
noted O O
on O O
CTA O O
head/neck O O
on O O
11/14/19 O O
to O O
have O O
a O O
'bovine' O O
variant O O
left O O
common O O
carotid O O
artery O O
takeoff O O
(origin O O
of O O
the O O
left O O
CCA O O
from O O
the O O
proximal O O
innominate O O
artery O O
- O O
anatomic O O
variant) O O
for O O
access O O
considerations. O O
- O O
Consent O O
with O O
discussion O O
of O O
potential O O
benefits/risks O O
&amp; O O
alternatives O O
discussed O O
with O O
opportunity O O
for O O
questions O O
provided. O O
_____________________________________ O O
Victor O O
Donovan, O O
MD O O
(Radiology O O
Fellow) O O
Discussed O O
with O O
Dr O O
Landen O O
Mccarthy O O

Record B-SMOKER O
date: O O
2120-01-20 O O
Visit O O
Note O O
Patient O O
Name: O O
WERNER, O O
BRIAN O O
U O O
MRN: O O
4097229 O O
Dictated O O
Date: O O
01/20/2120 O O
Dictated O O
by: O O
Taniya O O
Xing, O O
M.D. O O
Date O O
of O O
Visit: O O
01/20/2120 O O
Bryan O O
returns O O
for O O
followup O O
of O O
cerebrovascular O O
disease. O O
A O O
lot O O
has O O
happened O O
since O O
I O O
last O O
saw O O
him O O
in O O
10/2119. O O
A O O
CTA O O
revealed O O
severe O O
stenosis O O
of O O
his O O
left O O
ICA. O O
He O O
is O O
status O O
post O O
bilateral O O
carotid O O
endarterectomies O O
and O O
also O O
has O O
known O O
vertebral O O
disease O O
with O O
a O O
history O O
of O O
a O O
left O O
occipital O O
stroke. O O
He O O
subsequently O O
was O O
referred O O
to O O
Dr. O O
Mccarthy O O
and O O
was O O
scheduled O O
to O O
undergo O O
left O O
ICA O O
stent O O
placement O O
in O O
December. O O
In O O
November O O
1 O O
morning O O
after O O
going O O
to O O
the O O
bathroom O O
he O O
developed O O
sudden O O
onset O O
of O O
vertigo. O O
His O O
wife O O
called O O
911. O O
He O O
continued O O
to O O
have O O
positional O O
vertigo O O
in O O
the O O
emergency O O
room O O
such O O
that O O
if O O
he O O
sat O O
up O O
he O O
would O O
become O O
very O O
vertiginous O O
and O O
off O O
balance O O
but O O
if O O
he O O
laid O O
with O O
his O O
eyes O O
closed. O O
He O O
felt O O
better. O O
He O O
was O O
found O O
to O O
be O O
orthostatic O O
and O O
his O O
symptoms O O
improved O O
according O O
to O O
the O O
chart O O
by O O
the O O
next O O
day O O
though O O
according O O
to O O
the O O
patient, O O
it O O
took O O
a O O
couple O O
of O O
days O O
for O O
his O O
symptoms O O
to O O
improve O O
significantly. O O
An O O
MRI O O
of O O
the O O
brain O O
was O O
unrevealing O O
for O O
ischemia. O O
Although O O
he O O
significantly O O
improved O O
he O O
still O O
feels O O
&#34;a O O
little O O
off O O
balance&#34;. O O
He O O
is O O
fine O O
when O O
he O O
is O O
sitting O O
but O O
he O O
notes O O
when O O
he O O
stands O O
up O O
he O O
just O O
&#34;feels O O
off&#34;. O O
He O O
does O O
not O O
feel O O
acutely O O
vertiginous O O
and O O
does O O
not O O
have O O
any O O
sense O O
of O O
movement O O
but O O
does O O
not O O
feel O O
as O O
steady O O
as O O
he O O
used O O
to O O
on O O
his O O
feet. O O
He O O
has O O
seen O O
Guy O O
in O O
physical O O
therapy O O
and O O
is O O
working O O
on O O
balance O O
therapy. O O
He O O
subsequently O O
did O O
undergo O O
left O O
ICA O O
stent O O
placement O O
on O O
12/22/2119 O O
without O O
any O O
complication. O O
There O O
was O O
no O O
worsening O O
of O O
his O O
sense O O
of O O
imbalance O O
or O O
no O O
new O O
neurologic O O
symptoms. O O
Also O O
of O O
note, O O
I O O
neglected O O
to O O
mention O O
above, O O
that O O
when O O
he O O
became O O
acutely O O
vertiginous O O
in O O
November O O
there O O
were O O
no O O
other O O
accompanying O O
symptoms. O O
He O O
was O O
discharged O O
after O O
his O O
left O O
carotid O O
endarterectomy O O
on O O
Plavix B-MEDICATION B-MEDICATION
as O O
well O O
as O O
aspirin B-MEDICATION B-MEDICATION
that O O
he O O
had O O
been O O
on O O
prior O O
to O O
his O O
admission. O O
He O O
also O O
was O O
switched O O
while O O
in O O
the O O
hospital O O
from O O
hydrochlorothiazide B-MEDICATION O
to O O
Inderal B-MEDICATION O
for O O
blood O O
pressure O O
control O O
although O O
he O O
was O O
orthostatic O O
sitting O O
up. O O
Lying O O
down O O
he O O
was O O
hypertensive. O O
He O O
has O O
had O O
no O O
new O O
neurologic O O
symptoms O O
since O O
his O O
discharge O O
from O O
NDMG O O
after O O
his O O
carotid O O
endarterectomy O O
on O O
12/22/2119. O O
CURRENT O O
MEDICATIONS: O O
Aspirin, B-MEDICATION B-MEDICATION
gemfibrozil, B-MEDICATION O
nifedipine, B-MEDICATION B-MEDICATION
Plavix, O B-MEDICATION
propranolol, B-MEDICATION O
ranitidine. O O
PHYSICAL O O
EXAMINATION: O O
Pleasant, O O
healthy-appearing O O
74-year-old O O
male. O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
160/90 B-HYPERTENSION O
sitting, I-HYPERTENSION O
standing I-HYPERTENSION O
155/90. I-HYPERTENSION O
Cranial O O
nerve O O
examination O O
notable O O
for O O
right O O
homonymous O O
hemianopsia. O O
Auscultation O O
of O O
the O O
neck: O O
Unremarkable. O O
No O O
bruits. O O
There O O
are O O
bilateral O O
CEA O O
scars. O O
Motor O O
examination: O O
No O O
drift. O O
Power O O
5/5 O O
throughout. O O
Fine O O
finger O O
movements O O
intact. O O
In O O
the O O
lower O O
extremities. O O
Power O O
5/5 O O
on O O
the O O
right. O O
The O O
left O O
he O O
is O O
status O O
post O O
left O O
knee O O
fusion. O O
The O O
left O O
iliopsoas O O
and O O
dorsiflexion O O
are O O
full O O
strength. O O
His O O
gait O O
shows O O
left O O
limp O O
due O O
to O O
knee O O
fusion, O O
but O O
he O O
appears O O
steady. O O
DTRs O O
1+ O O
throughout. O O
DATA: O O
MRI O O
of O O
the O O
brain O O
in O O
11/2119 O O
shows O O
chronic O O
left O O
occipital O O
lobe O O
infarct O O
otherwise O O
unremarkable. O O
CTA O O
of O O
the O O
head O O
and O O
neck O O
11/14/2119 O O
showed O O
stable O O
left O O
PCA O O
territory O O
chronic O O
infarct O O
with O O
encephalomalacia O O
and O O
nonspecific O O
periventricular O O
white O O
matter O O
hypoattenuation O O
as O O
previously O O
described. O O
CTA O O
of O O
the O O
head O O
showed O O
stable O O
moderate O O
stenosis O O
of O O
the O O
left O O
supraclinoid O O
ICA. O O
Stable O O
occlusion O O
or O O
near O O
occlusion O O
of O O
the O O
left O O
vertebral O O
artery O O
at O O
the O O
dural O O
penetration O O
to O O
the O O
take O O
off O O
of O O
the O O
PICA. O O
There O O
is O O
reconstruction O O
of O O
contrast O O
in O O
the O O
distal O O
aspect. O O
There O O
is O O
moderate O O
stenosis O O
of O O
the O O
distal O O
left O O
interdural O O
vertebral O O
artery O O
with O O
severe O O
stenosis O O
at O O
the O O
left O O
vertebrobasilar O O
junction O O
and O O
also O O
unchanged. O O
Stable O O
moderate O O
to O O
severe O O
stenosis O O
within O O
the O O
right O O
intradural O O
vertebral O O
artery. O O
Mild O O
areas O O
of O O
stenosis O O
within O O
the O O
basilar O O
artery O O
and O O
left O O
T1 O O
and O O
T2 O O
segments O O
also O O
unchanged. O O
A O O
CTA O O
of O O
the O O
neck O O
shows O O
a O O
short O O
segment O O
of O O
severe O O
stenosis O O
of O O
the O O
proximal O O
left O O
ICA, O O
which O O
is O O
stable O O
since O O
the O O
most O O
recent O O
study. O O
The O O
right O O
carotid O O
artery O O
demonstrates O O
no O O
significant O O
stenosis. O O
Dominant O O
right O O
vertebral O O
artery O O
with O O
hypoplastic O O
left O O
vertebral O O
artery O O
demonstrates O O
moderate O O
stenosis O O
at O O
its O O
origin O O
and O O
diffuse O O
areas O O
of O O
moderate O O
stenosis O O
of O O
the O O
throughout O O
unchanged. O O
Mild O O
to O O
moderate O O
right O O
subclavian O O
artery O O
stenosis O O
just O O
proximal O O
to O O
the O O
vertebral O O
artery O O
take O O
off O O
unchanged. O O
Multiple O O
thyroid O O
nodules O O
as O O
described O O
since O O
most O O
recent O O
study. O O
New O O
ground O O
glass O O
nodule O O
in O O
the O O
lower O O
lobe O O
the O O
right O O
lung, O O
which O O
is O O
likely O O
inflammatory O O
in O O
nature. O O
Followup O O
chest O O
x-ray O O
11/14/2119 O O
was O O
unremarkable. O O
Cardiac O O
ultrasound O O
shows O O
evidence O O
of O O
a O O
PFO, O O
which O O
is O O
now O O
noted O O
following O O
performance O O
of O O
Valsalva O O
maneuver O O
not O O
previously O O
noted. O O
In O O
09/2113 O O
Holter O O
monitor O O
was O O
unremarkable. O O
IMPRESSION: O O
A O O
74-year-old O O
male O O
with O O
long-standing O O
cerebrovascular O O
disease O O
and O O
history O O
notable O O
for O O
left O O
occipital O O
lobe O O
infarct O O
with O O
vertebrobasilar O O
disease O O
as O O
described O O
above, O O
status O O
post O O
bilateral O O
carotid O O
endarterectomies O O
with O O
recent O O
restenosis O O
on O O
the O O
left O O
treated O O
with O O
stenting O O
in O O
12/2119. O O
He O O
has O O
been O O
doing O O
well O O
considering. O O
The O O
cause O O
of O O
his O O
episode O O
of O O
vertigo O O
and O O
imbalance O O
is O O
unclear. O O
It O O
is O O
difficulty O O
to O O
tease O O
out O O
whether O O
or O O
not O O
this O O
was O O
a O O
posterior O O
circulation O O
TIA O O
versus O O
small O O
stroke O O
not O O
detected O O
on O O
MRI O O
versus O O
vasovagal O O
etiology. O O
He O O
checks O O
out O O
well O O
today O O
and O O
I O O
do O O
not O O
find O O
any O O
new O O
findings O O
on O O
examination O O
and O O
his O O
walking O O
is O O
steady O O
though O O
subjectively O O
he O O
feels O O
he O O
is O O
not O O
quite O O
back O O
to O O
baseline. O O
Agree O O
with O O
Plavix O B-MEDICATION
added O O
to O O
his O O
aspirin O B-MEDICATION
dose O O
after O O
his O O
carotid O O
stent O O
placement. O O
His O O
blood O O
pressure O O
is O O
a O O
little O O
high O O
today. O O
He O O
will O O
be O O
following O O
up O O
with O O
Dr. O O
Kinney O O
in O O
2 O O
weeks. O O
Recommended O O
that O O
he O O
continue O O
to O O
work O O
with O O
Guy O O
on O O
vestibular O O
therapy. O O
Followup O O
with O O
me O O
in O O
3 O O
months. O O
___________________________ O O
Taniya O O
Xing, O O
M.D. O O
cc: O O
DD: O O
01/20/2120 O O
11:05:58 O O
TD: O O
01/21/2120 O O
07:49:40 O O
TR: O O
7038300 O O
BackJob O O
ID: O O
6183328 O O
VoiceJob O O
ID: O O
62867896 O O

Record O O
date: O O
2121-06-06 O O
Reason O O
for O O
Visit O O
Here O O
for O O
CPE O O
and O O
f/u O O
on O O
chronic O O
cough/HTN B-HYPERTENSION O
(not O O
using O O
flovent). O O
GERD O O
controlled O O
well O O
with O O
ranitidine. O O
Feeling O O
more O O
fatigued O O
recently. O O
No O O
specific O O
symptoms.Review O O
of O O
Systems O O
Denies O O
CP, O O
abd O O
pain, O O
joint O O
pains, O O
SOB/cough, O O
bowel/bladder O O
problems. O O
&#160;Remainder O O
of O O
review O O
of O O
systems O O
is O O
negative O O
in O O
detail.Allergies O O
Penicillins O O
- O O
RashLISINOPRIL O O
- O O
coughATORVASTATIN O B-MEDICATION
- O O
Elevated O O
LFTs/myalgiasMedications O O
Albuterol O O
Inhaler O O
1-2 O O
PUFF O O
INH O O
QID O O
PRN O O
, O O
Take O O
as O O
directed O O
#1 O O
Can(s)Asa B-MEDICATION O
(ACETYLSALICYLIC O O
Acid) O O
325 O O
MG O O
(325MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#Tablet(s)Diclofenac O O
1% O O
Gel O O
1 O O
% O O
GEL O O
(GM) O O
Take O O
1 O O
TOP O O
QID O O
PRN O O
, O O
Dosing O O
cards O O
supplied O O
in O O
the O O
drug O O
product O O
carton. O O
#1 O O
Month(s) O O
SupplyFlovent O O
Inhaler O O
(FLUTICASONE O O
Propionate) O O
2 O O
PUFF O O
(110MCG O O
AER O O
W/ADAP O O
) O O
INH O O
BID O O
#3 O O
Inhaler(s)Gemfibrozil B-MEDICATION O
600 O O
MG O O
TABLET O O
Take O O
0.5 O O
PO O O
QD O O
#30 O O
Tablet(s)Mvi O O
(MULTIVITAMINS) O O
1 O O
CAPSULE O O
PO O O
QDNiacin B-MEDICATION O
Extended O O
Release O O
(NICOTINIC O O
Acid O O
Extended O O
Release) O O
500 O O
MG O O
(500MG O O
TABLET O O
SA O O
Take O O
1) O O
PO O O
QHS O O
#30 O O
Tablet(s)Nifedipine B-MEDICATION O
(EXTENDED O O
Release) O O
60 O O
MG O O
(60MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#30 O O
Tablet(s)Plavix B-MEDICATION O
(CLOPIDOGREL) O O
75 O O
MG O O
(75MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s)Propranolol B-MEDICATION O
Hcl O O
20 O O
MG O O
(20 O O
MG O O
TABLET O O
Take O O
1) O O
PO O O
BID O O
#60 O O
Tablet(s)Ranitidine O O
Hcl O O
150 O O
MG O O
(150MG O O
TABLET O O
Take O O
1) O O
PO O O
BID O O
PRN O O
#Tablet(s)Problems O O
Hypertension B-HYPERTENSION O
Osteoathritis O O
Gastroesophageal O O
reflux O O
disease O O
Diverticulitis O O
Cerebrovascular O O
accident O O
: O O
L O O
cerebellar O O
2112, O O
s/p O O
L O O
CEALung O O
nodule O O
: O O
No O O
further O O
f/u O O
needed O O
per O O
CT O O
4/16.Endarterectomy O O
: O O
R, O O
2114. O O
L O O
stent O O
12/19Goiter O O
: O O
multinodular, O O
USG O O
2115Adenomatous O O
polyp O O
: O O
Repeat O O
colonoscope O O
2123Hyperlipidemia B-HYPERLIPIDEMIA O
Dupuytren's O O
contracture O O
: O O
B, O O
L O O
repairedSocial O O
History O O
Work: O O
RetiredMarital O O
status: O O
marriedChildren: O O
yesHabits: O O
Quit B-SMOKER O
cigs, I-SMOKER O
no O O
drugs. O O
Social O O
Etoh.Sexually O O
activeFamily O O
History O O
NC.Vital O O
Signs O O
BLOOD O O
PRESSURE O O
122/62PULSE O O
72WEIGHT O O
175 O O
lbPhysical O O
Exam O O
NADSkin: O O
ClearHEENT: O O
PERRLA, O O
EOMI, O O
TM's O O
and O O
Throat O O
clearNeck: O O
Supple, O O
no O O
palpable O O
thyroid O O
or O O
LN'sAxillae: O O
No O O
palpable O O
LNsLungs: O O
Clear O O
to O O
P O O
and O O
ACor: O O
RRRAbd: O O
Soft, O O
NABS, O O
no O O
bruits, O O
NT, O O
no O O
masses O O
or O O
HSMExt: O O
No O O
edema, O O
can O O
not O O
flex O O
L O O
knee, O O
chronic. O O
+ O O
R O O
Dupuytrens.Neuro: O O
Fully O O
intactAssessment O O
and O O
Plan O O
1. O O
Cough O O
- O O
use O O
flovent O O
2 O O
bid O O
- O O
has O O
helped O O
a O O
great O O
deal O O
in O O
past O O
2. O O
Hyperlipidemia O O
- O O
Taking O O
gemfibrozil B-MEDICATION O
c O O
good O O
effect O O
- O O
check O O
lipids3. O O
HTN/old O O
CVA/DM B-DIABETES O
- O O
Good O O
control, O O
cont O O
ASA/plavix. B-MEDICATION O
4. O O
Multinodular O O
goiter O O
- O O
Stable O O
5. O O
ED O O
-okay O O
with O O
levitra6. O O
GERD O O
- O O
ranitidine O O
150 O O
mg O O
p.r.n. O O
helps.7. O O
OA O O
- O O
Stable8. O O
R O O
Dupuytrens O O
- O O
Discussed, O O
follow9. O O
Fatigue O O
- O O
Check O O
chems, O O
CBC, O O
TSH. O O
DC O O
propranolol B-MEDICATION O
and O O
f/u O O
3-4 O O
wks O O
for O O
BP O O
check10. O O
Hlth O O
maint O O
- O O
colonoscopy O O
utd O O
Greater O O
than O O
25 O O
minutes O O
was O O
spent O O
in O O
direct O O
patient O O
care. O O
Greater O O
than O O
50% O O
of O O
this O O
time O O
was O O
spent O O
with O O
counseling O O
and O O
coordination O O
of O O
care. O O
Specifically O O
I O O
counseled O O
the O O
patient O O
in O O
regards O O
to O O
the O O
pathophysiology O O
of O O
his/her O O
diagnosis O O
and O O
appropriate O O
treatment O O
options. O O
F/u O O
1 O O
mnth. O O
_________________Thomas O O
D O O
Kinney, O O
MD O O

Record O O
date: O O
2082-06-29 O O
CKMC O O
EMERGENCY O O
DEPT O O
VISIT O O
UHRICH,KARSON O O
456-30-26-8 O O
VISIT O O
DATE: O O
06/29/82 O O
The O O
patient O O
was O O
seen O O
and O O
evaluated O O
with O O
the O O
medical O O
intern, O O
I O O
agree O O
with O O
the O O
medical O O
intern's O O
note. O O
PRESENTING O O
COMPLAINT: O O
The O O
patient O O
is O O
a O O
65-year-old O O
female O O
with O O
a O O
history O O
of O O
hypertension, B-HYPERTENSION O
hypercholesterolemia, B-HYPERLIPIDEMIA O
depression, O O
H O O
pylori, O O
gastric O O
reflux O O
with O O
increasing O O
back O O
pain O O
and O O
epigastric O O
pain. O O
HISTORY O O
OF O O
PRESENTING O O
COMPLAINT: O O
She O O
says O O
over O O
the O O
last O O
couple O O
of O O
days O O
it O O
is O O
unrelieved O O
with O O
food O O
but O O
not O O
exacerbated O O
by O O
food. O O
She O O
occasionally O O
has O O
a O O
pressure O O
in O O
her O O
epigastrium, O O
no O O
radiation O O
to O O
her O O
neck, O O
chest, O O
no O O
shortness O O
of O O
breath, O O
no O O
palpitations, O O
no O O
diaphoresis, O O
no O O
vomiting, O O
no O O
hematochezia, O O
or O O
melena O O
but O O
she O O
has O O
had O O
increased O O
frequency O O
of O O
her O O
BM O O
to O O
three O O
or O O
four O O
a O O
day. O O
No O O
dysuria O O
or O O
urgency. O O
She O O
describes O O
the O O
pain O O
as O O
constant. O O
PAST O O
MEDICAL O O
HISTORY: O O
Hypertension, B-HYPERTENSION O
hypercholesterolemia, O O
GERD. O O
MEDICATIONS: O O
Tetracycline, O O
Prilosec, O O
Ativan, O O
atenolol, B-MEDICATION B-MEDICATION
Zestril. B-MEDICATION B-MEDICATION
ALLERGIES: O O
Aspirin O B-MEDICATION
which O O
causes O O
upset O O
stomach. O O
SOCIAL O O
HISTORY O O
AND O O
FAMILY O O
HISTORY: O O
Nonsmoker. B-SMOKER O
PHYSICAL O O
EXAMINATION: O O
Temperature O O
98.1, O O
pulse O O
92, O O
respiratory O O
rate O O
16, O O
blood B-HYPERTENSION O
pressure I-HYPERTENSION O
196/84. B-HYPERTENSION O
Skin: O O
Warm O O
and O O
dry. O O
She O O
is O O
well-developed, O O
well-nourished O O
female O O
in O O
no O O
distress. O O
Pupils O O
are O O
equal, O O
round, O O
reactive O O
light. O O
Extraocular O O
movements O O
are O O
full. O O
Sinuses O O
nontender. O O
Oropharynx O O
clear. O O
Nasopharynx O O
clear. O O
Neck: O O
Supple, O O
full O O
range O O
of O O
motion. O O
There O O
is O O
no O O
JVD. O O
Heart: O O
Regular O O
rate O O
and O O
rhythm O O
without O O
murmur. O O
Abdomen O O
is O O
soft. O O
Lungs O O
are O O
clear. O O
Extremities: O O
There O O
is O O
no O O
clubbing, O O
cyanosis, O O
or O O
edema. O O
Rectal O O
exam O O
is O O
nontender O O
with O O
brown, O O
trace O O
guaiac O O
positive O O
stool. O O
Neurologic O O
exam O O
is O O
nonfocal. O O
LABORATORY O O
EVALUATION: O O
Patient O O
had O O
a O O
white O O
count O O
of O O
7.5, O O
hemoglobin O O
of O O
14, O O
platelet O O
count O O
of O O
259. O O
Electrolytes O O
are O O
normal. O O
Amylase O O
and O O
lipase O O
are O O
71 O O
and O O
204 O O
respectively. O O
H O O
pylori O O
IgA O O
is O O
positive O O
from O O
previous O O
studies. O O
CK O O
is O O
72, O O
troponin O O
is O O
0. O O
Chest O O
x-ray O O
is O O
reviewed O O
with O O
Radiologist O O
and O O
is O O
normal. O O
EKG O O
shows O O
normal O O
sinus O O
rhythm O O
with O O
some O O
T O O
wave O O
flattening O O
in O O
the O O
inferior O O
lateral O O
leads. O O
THERAPY O O
RENDERED/COURSE O O
IN O O
ED: O O
Patient O O
was O O
seen, O O
given O O
aspirin, B-MEDICATION B-MEDICATION
Lopressor, B-MEDICATION B-MEDICATION
and O O
nitroglycerin. B-MEDICATION B-MEDICATION
If O O
her O O
pain O O
doesn't O O
resolve O O
with O O
and O O
a O O
GI O O
cocktail O O
she O O
will O O
be O O
admitted O O
to O O
the O O
Observation O O
Unit. O O
Because O O
of O O
the O O
concern O O
that O O
her O O
pain O O
goes O O
to O O
her O O
back, O O
she O O
has O O
a O O
CT O O
scan O O
to O O
rule O O
out O O
aortic O O
dissection O O
which O O
is O O
reviewed O O
with O O
the O O
Radiologist O O
and O O
is O O
negative. O O
FINAL O O
DIAGNOSIS: O O
Atypical B-CAD O
chest I-CAD O
pain, I-CAD O
perhaps I-CAD O
consistent I-CAD O
with I-CAD O
angina. I-CAD O
DISPOSITION O O
(including O O
condition O O
upon O O
discharge): O O
Condition O O
at O O
this O O
time O O
is O O
stable. O O
___________________________________ O O
DM972/9882 O O
URIEL O O
NIX, O O
M.D. O O
UN49 O O
D:06/29/82 O O
T:06/29/82 O O
Dictated O O
by: O O
URIEL O O
NIX, O O
M.D. O O
UN49 O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2088-10-12 O O
EDVISIT^45630268^UHRICH, O O
KARSON^10/12/88^ABREU, O O
OLIVIA O O
The O O
patient O O
was O O
seen O O
primarily O O
by O O
myself. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
This O O
is O O
a O O
71-year-old O O
female O O
with O O
a O O
history O O
of O O
diabetes, B-DIABETES O
high B-HYPERTENSION O
blood I-HYPERTENSION O
pressure, I-HYPERTENSION O
and O O
hypercholesterolemia B-HYPERLIPIDEMIA B-MEDICATION
presents O O
to O O
the O O
emergency O O
room O O
with O O
some O O
right O O
thumb O O
pain O O
and O O
swelling O O
after O O
poking O O
with O O
a O O
turkey O O
bone O O
2 O O
days O O
ago. O O
Denies O O
any O O
fevers O O
or O O
chills. O O
Does O O
report O O
some O O
increased O O
redness O O
and O O
swelling O O
at O O
the O O
right O O
side. O O
Also O O
reports O O
some O O
left O O
dental O O
pain O O
that O O
started O O
this O O
morning. O O
She O O
has O O
had O O
history O O
of O O
dental O O
pain O O
in O O
the O O
past, O O
however, O O
much O O
worse O O
today. O O
No O O
fevers O O
and O O
no O O
chills. O O
Tolerating O O
secretions. O O
No O O
pain O O
on O O
swallowing. O O
No O O
recent O O
dental O O
work. O O
PAST O O
MEDICAL O O
HISTORY: O O
As O O
noted O O
above, O O
hypercholesterolemia, O O
diabetes, O O
and O O
hypertension. B-HYPERTENSION O
ALLERGIES: O O
Aspirin. O B-MEDICATION
MEDICATIONS: O O
Atenolol, B-MEDICATION B-MEDICATION
Protonix, O O
amitriptyline, O O
and O O
Lipitor. B-MEDICATION B-MEDICATION
SOCIAL O O
HISTORY: O O
Denies B-SMOKER O
any I-SMOKER O
tobacco, I-SMOKER O
alcohol, O O
or O O
IV O O
drug O O
use. O O
PAST O O
SURGICAL O O
HISTORY: O O
No O O
past O O
surgery O O
or O O
procedure. O O
REVIEW O O
OF O O
SYSTEMS: O O
Right O O
thumb O O
pain O O
and O O
left O O
tooth O O
pain. O O
PHYSICAL O O
EXAMINATION: O O
Mild O O
tachycardic O O
at O O
108 O O
and O O
low-grade O O
temperature O O
99.2. O O
Rectal O O
same. O O
She O O
is O O
an O O
elderly O O
female O O
in O O
mild O O
to O O
moderate O O
distress O O
complaining O O
significant O O
dental O O
pain. O O
Head O O
and O O
neck O O
exam, O O
post O O
dental O O
exam, O O
the O O
patient O O
has O O
pain O O
over O O
tooth O O
#16 O O
which O O
is O O
intact. O O
No O O
surrounding O O
fluctuance, O O
pus O O
discharge, O O
or O O
bleeding. O O
Tooth O O
is O O
intact O O
in O O
the O O
socket. O O
Does O O
appear O O
to O O
have O O
caries. O O
Posterior O O
pharynx O O
is O O
clear. O O
Neck O O
is O O
supple O O
with O O
full O O
range O O
of O O
motion. O O
Lungs O O
are O O
clear O O
to O O
auscultation O O
bilaterally. O O
Cardiac O O
exam O O
reveals O O
S1 O O
and O O
S2. O O
Regular O O
rate. O O
No O O
gallops, O O
rubs, O O
or O O
murmurs. O O
Abdomen O O
is O O
soft O O
and O O
nontender. O O
On O O
extremity O O
exam, O O
right O O
thumb, O O
the O O
patient O O
has O O
an O O
indurated O O
right O O
thumb O O
with O O
some O O
streaking O O
up O O
into O O
her O O
mid O O
forearm O O
on O O
the O O
lateral O O
aspect. O O
There O O
is O O
some O O
induration O O
and O O
warmth O O
to O O
touch. O O
There O O
is O O
no O O
foreign O O
body O O
visualized. O O
There O O
is O O
no O O
area O O
of O O
pus O O
discharge O O
or O O
bleeding. O O
2+ O O
radial O O
pulses. O O
LABORATORY O O
DATA: O O
Normal O O
CBC. O O
X-ray O O
of O O
the O O
right O O
hand O O
shows O O
no O O
evidence O O
of O O
foreign O O
body. O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O
IMPRESSION O O
AND O O
PLAN: O O
This O O
is O O
a O O
71-year-old O O
female O O
with O O
diabetes O O
presenting O O
with O O
cellulitis O O
and O O
some O O
streaking. O O
She O O
had O O
received O O
IV O O
Ancef O O
in O O
the O O
emergency O O
room. O O
She O O
will O O
be O O
admitted O O
for O O
continued O O
IV O O
antibiotics O O
and O O
observation. O O
______________________________ O O
ABREU, O O
OLIVIA O O
M.D. O O
D: O O
10/12/88 O O
T: O O
10/12/88 O O
Dictated O O
By: O O
ABREU, O O
OLIVIA O O
eScription O O
document:1-4087689 O O
BFFocus O O

Record O O
date: O O
2090-09-28 O O
UHRICH, O O
KARSON O O
45630268 O O
09/28/2090 O O
DATE O O
OF O O
ADMISSION: O O
09/27/2090 O O
PRIMARY O O
CARE O O
PHYSICIAN: O O
Roger O O
L. O O
Albright, O O
M.D. O O
Columbia O O
Kingwood O O
Medical O O
Center O O
57 O O
Wood O O
St, O O
Q6-24 O O
North O O
Andover, O O
KY O O
41454 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Ms. O O
Uhrich O O
is O O
a O O
73-year-old O O
woman O O
with O O
past O O
medical O O
history O O
notable O O
for O O
hypertension B-HYPERTENSION B-HYPERTENSION
and O O
dyslipidemia, B-HYPERLIPIDEMIA O
but O O
no O O
coronary O O
artery O O
disease O O
who O O
presents O O
with O O
a O O
three-day O O
history O O
of O O
progressive O O
weakness O O
and O O
lightheadedness. O O
The O O
history O O
is O O
obtained O O
in O O
Spanish O O
from O O
the O O
patient O O
and O O
through O O
her O O
daughter O O
who O O
assisted O O
with O O
translation. O O
In O O
general, O O
she O O
has O O
apparently O O
been O O
doing O O
well O O
with O O
no O O
episodes O O
of O O
chest O O
discomfort O O
or O O
exertional O O
dyspnea O O
until O O
roughly O O
three O O
days O O
ago O O
when O O
she O O
has O O
began O O
to O O
notice O O
episodic O O
problems O O
with O O
walking O O
even O O
short O O
distances O O
before O O
she O O
feels O O
as O O
though O O
she O O
might O O
pass O O
out. O O
The O O
episodes O O
have O O
occurred O O
multiple O O
times O O
per O O
day O O
and O O
after O O
a O O
particularly O O
severe O O
episode O O
this O O
morning, O O
she O O
brought O O
her O O
mother O O
to O O
the O O
emergency O O
department O O
for O O
evaluation. O O
There O O
have O O
been O O
no O O
syncopal O O
episodes O O
and O O
no O O
complaints O O
of O O
palpitations, O O
orthopnea, O O
PND, O O
or O O
lower O O
extremity O O
edema. O O
The O O
patient O O
has O O
not O O
had O O
symptoms O O
like O O
this O O
before O O
and O O
has O O
been O O
chronically O O
treated O O
with O O
atenolol B-MEDICATION B-MEDICATION
for O O
hypertension O B-HYPERTENSION
for O O
many O O
years. O O
Her O O
only O O
cardiovascular O O
evaluation O O
has O O
been O O
with O O
adenosine O O
MIBI O O
in O O
2085, O O
which O O
revealed O O
normal O O
systolic O O
function O O
and O O
no O O
evidence O O
for O O
ischemia. O O
PAST O O
MEDICAL O O
HISTORY: O O
Notable O O
for O O
hypertension, O O
hypercholesterolemia, B-HYPERLIPIDEMIA O
gastritis, O O
and O O
osteoarthritis. O O
She O O
also O O
carries O O
the O O
diagnosis O O
of O O
diabetes B-DIABETES B-MEDICATION
mellitus I-DIABETES O
but O O
is O O
not O O
currently O O
treated O O
for O O
this. O O
MEDICATIONS O O
ON O O
ADMISSION: O O
Included O O
amitriptyline O O
25 O O
mg O O
at O O
bedtime, O O
aspirin B-MEDICATION B-MEDICATION
81 O O
mg O O
daily, O O
atenolol O B-MEDICATION
25 O O
mg O O
daily, O O
Lipitor B-MEDICATION B-MEDICATION
10 O O
mg O O
at O O
bedtime, O O
hydrochlorothiazide/lisinopril B-MEDICATION B-MEDICATION
25/20 I-MEDICATION O
one O O
tablet O O
daily, O O
loratadine O B-MEDICATION
10 O O
mg O O
daily, O O
and O O
Protonix O O
40 O O
mg O O
daily. O O
She O O
developed O O
gastrointestinal O O
irritation O O
with O O
higher O O
doses O O
of O O
aspirin. O B-MEDICATION
SOCIAL B-SMOKER O
AND O O
FAMILY O O
HISTORY: O O
As O O
noted O O
in O O
the O O
housestaff O O
notes. O O
PHYSICAL O O
EXAMINATION: O O
In O O
the O O
Emergency O O
Department, O O
her O O
heart O O
rate O O
is O O
38 O O
beats O O
per O O
minute O O
and O O
her O O
blood O O
pressure O O
is O O
110/70 O O
mmHg. O O
Her O O
venous O O
pressures O O
are O O
low O O
and O O
there O O
are O O
BLANK O O
waves O O
present O O
every O O
other O O
beat. O O
The O O
chest O O
is O O
clear O O
to O O
auscultation O O
and O O
percussion O O
bilaterally. O O
Cardiovascular O O
exam O O
reveals O O
bradycardia O O
with O O
normal O O
S1, O O
wide O O
physiologically O O
split O O
S2, O O
and O O
an O O
audible O O
S4. O O
There O O
is O O
no O O
murmur. O O
The O O
abdomen O O
is O O
soft O O
and O O
nontender. O O
The O O
liver O O
is O O
not O O
palpably O O
enlarged. O O
The O O
extremities O O
are O O
warm O O
without O O
edema. O O
Electrocardiogram O O
reveals O O
sinus O O
rhythm O O
with O O
2:1 O O
AV O O
block O O
and O O
right O O
bundle-branch O O
block. O O
There O O
is O O
left O O
axis O O
deviation O O
consistent O O
with O O
left O O
anterior O O
fascicular O O
block. O O
There O O
is O O
no O O
response O O
of O O
her O O
heart O O
rate O O
to O O
mild O O
calisthenics O O
in O O
the O O
bed. O O
Laboratories O O
are O O
notable O O
for O O
normal O O
BUN O O
to O O
creatinine O O
ratio O O
of O O
23/1.2 O O
with O O
a O O
potassium O O
of O O
4.1 O O
and O O
a O O
hematocrit O O
of O O
35%. O O
Initial O O
cardiac O O
biomarkers O O
were O O
negative. O O
In O O
summary, O O
Karson O O
Uhrich O O
is O O
a O O
73-year-old O O
woman O O
with O O
hypertension O O
and O O
dyslipidemia O O
who O O
presents O O
with O O
a O O
three-day O O
history O O
of O O
presyncope O O
and O O
weakness O O
in O O
the O O
context O O
of O O
a O O
new O O
diagnosis O O
of O O
2:1 O O
AV O O
block. O O
Review O O
of O O
previous O O
electrocardiograms O O
reveals O O
no O O
right O O
bundle-branch O O
block O O
and O O
left O O
anterior O O
fascicular O O
block O O
and O O
of O O
late O O
this O O
represents O O
progression O O
of O O
her O O
underlying O O
conduction O O
system O O
disease. O O
We O O
will O O
proceed O O
to O O
permanent O O
temporary O O
pacemaker O O
implantation O O
for O O
backup O O
support O O
and O O
will O O
arrange O O
electrophysiologic O O
consultation O O
for O O
permanent O O
pacemaker O O
implantation. O O
There O O
is O O
no O O
history O O
to O O
suggest O O
an O O
ischemic O O
syndrome, O O
so O O
I O O
did O O
not O O
think O O
additional O O
pharmacologic O O
stress O O
test O O
is O O
necessary. O O
Her O O
beta-blocker O O
will O O
be O O
held O O
overnight O O
in O O
addition O O
to O O
her O O
amitriptyline O O
to O O
see O O
if O O
this O O
facilitates O O
recovery O O
of O O
her O O
AV O O
nodal O O
function. O O
Overall, O O
I O O
think O O
this O O
likely O O
represents O O
infra-hisian O O
block O O
and O O
a O O
pacemaker O O
should O O
be O O
curative O O
therapy. O O
Additional O O
plans O O
will O O
be O O
dictated O O
by O O
her O O
clinical O O
course. O O
______________________________ O O
Xavier O O
Alvin O O
Kaufman, O O
MD O O
eScription O O
document:3-6100190 O O
IFFocus O O
CC: O O
Owen O O
Quentin-Xiong O O
M.D. O O
Columbia O O
Kingwood O O
Medical O O
35 O O
Wood O O
St O O
North O O
Andover, O O
KY O O
41454 O O
DD: O O
09/28/90 O O
DT: O O
09/28/90 O O
DV: O O
09/28/90 O O

Record B-SMOKER O
date: O O
2092-05-05 O O
05/05/2092 O O
Spanish O O
81 O O
Wood O O
St O O
UHRICH, O O
KARSON O O
North O O
Andover, O O
KY O O
41454 O O
45630268 O O
(884) O O
486-9594 O O
07/01/2091 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Ms. O O
Uhrich O O
is O O
75. O O
Medical O O
issues O O
include O O
osteopenia, O O
hyperlipidemia, B-HYPERLIPIDEMIA O
hypertension, B-HYPERTENSION O
heart O O
block O O
(pacemaker O O
implanted), O O
gastritis, O O
occasional O O
joint O O
pains. O O
Medications O O
Amitriptyline O O
HCL O O
25 O O
MG O O
(25MG O O
TABLET O O
Take O O
1) O O
PO O O
QHS O O
x O O
30 O O
days O O
#30 O O
Tablet(s) O O
Asa B-MEDICATION B-MEDICATION
EC O O
ONE O O
TABLET O O
81 O O
MG O O
PO O O
qd O O
#100 O O
Tablet(s) O O
Atenolol B-MEDICATION B-MEDICATION
50 O O
MG O O
(50MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#60 O O
Tablet(s) O O
Calcium O O
+ O O
D O O
(500 O O
ELEM. O O
CA) O O
(CALCIUM O O
CARBONATE O O
1250 O O
MG O O
(500MG O O
ELEM O O
CA)/ O O
VIT O O
D O O
200 O O
IU)) O O
1 O O
TAB O O
PO O O
BID O O
#60 O O
Tablet(s) O O
Fosamax O O
(ALENDRONATE) O O
70 O O
MG O O
(70MG O O
TABLET O O
Take O O
1) O O
PO O O
Q O O
month O O
#3 O O
Month(s) O O
Supply O O
Lisinopril/hydrochlorothiazide B-MEDICATION B-MEDICATION
20MG/25MG I-MEDICATION O
1 O O
TAB O O
PO O O
QD O O
#90 O O
Tablet(s) O O
Metformin B-MEDICATION B-MEDICATION
EXTENDED O O
RELEASE O O
500 O O
MG O O
(500MG O O
TAB.SR O O
24H O O
Take O O
1) O O
PO O O
QD O O
#90 O O
TAB.SR O O
Monistat O O
3 O O
(MICONAZOLE O O
200MG O O
VAGINAL O O
SUPP) O O
1 O O
SUPP O O
PV O O
QHS O O
x O O
3 O O
days O O
#3 O O
Suppositories O O
Protonix O O
(PANTOPRAZOLE) O O
40 O O
MG O O
(40MG O O
TABLET O O
DR O O
Take O O
1) O O
PO O O
QD O O
#30 O O
Tablet(s) O O
Simvastatin B-MEDICATION B-MEDICATION
20 O O
MG O O
(20MG O O
TABLET O O
Take O O
1) O O
PO O O
QHS O O
#30 O O
Tablet(s) O O
Left O O
arm O O
pain O O
has O O
not O O
recurred. O O
When O O
tested O O
in O O
past O O
no O O
cardiac O O
cause O O
found. O O
Neurology O O
examined O O
her O O
and O O
felt O O
cause O O
had O O
probably O O
been O O
impingement, O O
no O O
further O O
follow O O
up O O
recommended. O O
She O O
has O O
been O O
pain O O
free. O O
She O O
denies O O
CP O O
or O O
pressure O O
on O O
exercise. O O
No O O
palpitation, O O
no O O
leg O O
edema. O O
Uses O O
3 O O
pillows O O
On O O
09/27/90 O O
she O O
was O O
admitted O O
to O O
the O O
hospital O O
via O O
the O O
ED O O
where O O
she O O
presented O O
with O O
2/1 O O
heartblock O O
and O O
a O O
ventricular O O
rate O O
of O O
38. O O
A O O
pacemeker O O
was O O
implanted O O
and O O
the O O
lightheadedness O O
that O O
brought O O
her O O
to O O
the O O
ED O O
disappeared. O O
She O O
is O O
under O O
the O O
care O O
of O O
Dr. O O
Ison O O
and O O
Dr. O O
Ximenez O O
in O O
Cardiology. O O
Otherwise O O
she O O
has O O
has O O
been O O
well. O O
She O O
does O O
have O O
osteoarthritis O O
of O O
the O O
knees O O
Rt. O O
&gt; O O
Lft. O O
Has O O
experienced O O
cramps O O
in O O
her O O
LE. O O
She O O
does O O
not O O
drink O O
much O O
water. O O
No O O
PND O O
or O O
ankle O O
edema. O O
No O O
significant O O
nocturia O O
(X1 O O
or O O
2). O O
No O O
cough O O
or O O
sputum, O O
no O O
chills O O
or O O
fever. O O
She O O
is O O
still O O
having O O
trouble O O
remembering O O
things O O
but O O
problem O O
is O O
not O O
worse O O
than O O
before. O O
Still O O
has O O
occaasional O O
dysuria; O O
in O O
past O O
culture O O
has O O
been O O
negative O O
PHYSICAL O O
EXAMINATION: O O
Vital O O
Signs O O
BP B-HYPERTENSION O
152/79, I-HYPERTENSION O
P O O
72, O O
Wt O O
147 O O
lb O O
FINGER O O
BLOOD O O
GLUCOSE O O
118 O O
She O O
is O O
in O O
no O O
distress. O O
Extraocular O O
movements O O
are O O
full. O O
The O O
neck O O
veins O O
are O O
flat. O O
The O O
chest O O
is O O
clear O O
to O O
auscultation. O O
The O O
heart O O
rhythm O O
is O O
regular, O O
no O O
rubs O O
or O O
gallops. O O
The O O
lower O O
extremities O O
are O O
free O O
of O O
edema.Knees O O
thickened. O O
ASSESSMENT O O
AND O O
PLAN: O O
A O O
75-year-old O O
diabetic O O
whose O O
glycemic O O
control O O
is O O
good. O O
Hemoglobin B-DIABETES O
A1 I-DIABETES O
was I-DIABETES O
6.8 I-DIABETES O
, O O
electrolytes, O O
renal O O
function, O O
and O O
calcium O O
and O O
a O O
lipid O O
panel O O
WNL O O
except O O
for O O
mild O O
triglceride O O
elevation. O O
. O O
She O O
has O O
an O O
implanted O O
pacemaker O O
which O O
if O O
functioning O O
well. O O
Adviced O O
her O O
to O O
continue O O
to O O
walk O O
and O O
watch O O
her O O
diet. O O
She O O
will O O
keep O O
appointment O O
with O O
Ophthalmologist O O
who O O
did O O
her O O
cataract O O
surgery O O
. O O
She O O
feels O O
that O O
her O O
vision O O
on O O
OD O O
is O O
diminished O O
and O O
at O O
times O O
gets O O
inflamed. O O
. O O
I O O
have O O
given O O
her O O
my O O
card O O
to O O
give O O
to O O
her O O
ophthalmologist O O
to O O
send O O
me O O
a O O
report. O O
Return O O
in O O
4 O O
months O O
or O O
prn O O
______________________________ O O
Owen O O
Quentin-Xiong, O O
M.D. O O
Results05/03/2092 O O
NA O O
139, O O
K O O
4.1, O O
CL O O
101, O O
CO2 O O
30, O O
BUN O O
20, O O
CRE O O
1.09, O O
EGFR O O
49, O O
GLU O O
10305/03/2092 O O
ANION O O
805/03/2092 O O
CA O O
9.705/03/2092 O O
ALT/SGPT O O
36 O O
(#), O O
AST/SGOT O O
41 O O
(*#)05/03/2092 O O
CHOL O O
192, O O
TRIG O O
171 O O
(*), O O
HDL O O
42 O O
(#), O O
LDLCAL O O
116, O O
VLDL O O
3405/03/2092 O O
HGBA1C O O
6.8 O O
(*)05/03/2092 O O
MALB O O
0.8, O O
MALB/CRE O O
11.805/03/2092 O O
UTIME O O
RANDOM05/03/2092 O O
UTIME O O
RANDOM, O O
U/UCRE O O
67.8 O O

Record O O
date: O O
2087-12-05 O O
Beckley O O
Appalachian O O
Regional O O
Hospital O O
040 O O
Townsend O O
West O O
MOSS, O O
DEREK O O
Espanola, O O
WI O O
85976 O O
59624156 O O
895-239-5445, O O
302-843-7619 O O
12/05/2087 O O
History O O
of O O
the O O
Present O O
Illness/Chief O O
Complaint: O O
The O O
patient O O
is O O
a O O
77-year-old O O
man O O
who O O
is O O
here O O
with O O
his O O
son O O
and O O
daughter O O
today, O O
acutely O O
ill O O
with O O
multiple O O
acute O O
medical O O
problems. O O
Medications: O O
Per O O
the O O
list O O
entered O O
on O O
the O O
computer O O
today, O O
a O O
total O O
of O O
28 O O
medications O O
and O O
accessories. O O
Allergies: O O
None. O O
Past O O
Medical O O
History O O
Surgeries O O
1. O O
Hip O O
surgery. O O
2. O O
Cholecystectomy. O O
3. O O
Lumbar O O
laminectomy. O O
4. O O
Left O O
leg O O
surgery. O O
5. O O
Bilateral O O
cataract O O
extraction. O O
6. O O
Prostate O O
biopsy O O
2086, O O
Gleason O O
grade O O
6/10. O O
7. O O
Left O O
skin O O
cancer O O
removal. O O
Medical O O
Problems O O
1. O O
Septic O O
arthritis O O
of O O
the O O
left O O
shoulder. O O
2. O O
Dislocated O O
left O O
shoulder. O O
3. O O
CHF O O
with O O
dilated O O
cardiomyopathy. O O
4. O O
Atrial O O
fibrillation. O O
5. O O
Insulin-dependent B-DIABETES O
diabetes. B-DIABETES O
6. O O
Parkinson's O O
disease. O O
7. O O
GI O O
bleed. O O
8. O O
Diffuse O O
arthritis. O O
9. O O
Prostatic O O
cancer. O O
10. O O
Prostatic O O
obstruction. O O
11. O O
Microcytic O O
anemia. O O
Family O O
History O O
Family O O
history O O
was O O
reviewed O O
and O O
is O O
notable O O
for: O O
CVD: O O
Positive. O O
Social O O
History O O
Living O O
arrangements: O O
He O O
has O O
recently O O
moved O O
from O O
Ouagadougou. O O
He O O
is O O
living O O
with O O
his O O
son O O
and O O
daughter-in-law O O
in O O
Harrisburg. O O
He O O
has O O
mostly O O
been O O
in O O
the O O
hospital O O
over O O
the O O
last O O
several O O
months. O O
Work: O O
He O O
is O O
a O O
retired O O
vocational O O
instructor. O O
He O O
had O O
been O O
with O O
the O O
city O O
of O O
Cadiz O O
for O O
32 O O
years. O O
Smoking: B-SMOKER O
None. I-SMOKER O
ETOH: O O
None. O O
Exercise: O O
None. O O
Diet: O O
Minimal, O O
poor O O
appetite. O O
Domestic O O
Violence: O O
None. O O
Health O O
Maintenance O O
Seat O O
belts: O O
Always. O O
Colonoscopy: O O
Has O O
had O O
but O O
there O O
are O O
no O O
records O O
(may O O
have O O
been O O
indadequate O O
exam). O O
Endoscopy O O
in O O
2087 O O
showed O O
gastritis. O O
Immunization O O
Td: O O
Up-to-date. O O
Review O O
of O O
Systems O O
ROS O O
reviewed O O
in O O
detail. O O
General: O O
Good O O
mood. O O
No O O
F/S/C. O O
Depressed O O
with O O
chronic O O
illness, O O
extremely O O
fatigued. O O
Skin: O O
Multiple O O
ecchymoses, O O
extremely O O
dry O O
skin. O O
HEENT: O O
no O O
sore O O
throat; O O
no O O
change O O
in O O
vision O O
or O O
blurring; O O
No O O
change O O
in O O
hearing, O O
ear O O
pain, O O
or O O
tinnitus O O
Cardiovascular: O O
History O O
of O O
substernal O O
chest O O
pain, O O
on O O
longacting O O
nitroglycerin, O O
dyspnea O O
on O O
exertion, O O
sleeps O O
with O O
the O O
bed O O
propped O O
up O O
and O O
one O O
pillow, O O
chronic O O
ankle O O
edema, O O
chronic O O
AF. O O
Respiratory: O O
Dyspnea O O
on O O
exertion. O O
GI: O O
Loose O O
bowel O O
movements O O
multiple O O
times O O
a O O
day. O O
Over O O
the O O
last O O
week O O
he O O
has O O
been O O
having O O
bright O O
red O O
blood. O O
He O O
has O O
had O O
melena O O
in O O
the O O
past, O O
most O O
recently O O
grape O O
jelly O O
like O O
clots O O
of O O
blood. O O
He O O
has O O
had O O
anorexia. O O
No O O
abdominal O O
pain, O O
no O O
vomiting. O O
Extrem: O O
Left O O
shoulder O O
pain, O O
history O O
of O O
significant O O
infection O O
in O O
the O O
left O O
shoulder, O O
torn O O
rotator O O
cuff O O
so O O
that O O
he O O
is O O
essentially O O
unable O O
to O O
use O O
the O O
left O O
arm. O O
Endocrine: O O
no O O
polyuria O O
or O O
polydipsia; O O
one O O
episode O O
of O O
sig O O
hypoglycemia O O
Neurologic: O O
no O O
HA, O O
visual O O
change, O O
seizure, O O
or O O
acute O O
neurologic O O
sxs O O
Psychiatric: O O
depression; O O
acutely O O
ill O O
Hematologic: O O
Significant O O
bruising O O
and O O
bleeding. O O
GU: O O
Urinary O O
hesitancy, O O
prostatic O O
obstruction, O O
prostatic O O
cancer. O O
Physical O O
Examination O O
General/constitutional: O O
Pleasant, O O
alert, O O
oriented, O O
in O O
acute O O
distress, O O
weak, O O
has O O
difficulty O O
moving; O O
nl O O
affect O O
Vital O O
signs: O O
Ht O O
67 O O
inches O O
Wt O O
(lbs) O O
154 O O
BMI O O
BP O O
128/68 O O
Heart O O
rate O O
84, O O
irregularly O O
irregular O O
RR12 O O
and O O
comfortable O O
w/out O O
accessory O O
muscles O O
Temp O O
96.3. O O
Skin: O O
Dry O O
skin, O O
sallow O O
pale, O O
multiple O O
ecchymoses, O O
significant O O
ulcer O O
on O O
the O O
left O O
shoulder O O
in O O
the O O
subdeltoid O O
bursa O O
area O O
with O O
pus O O
in O O
the O O
center O O
and O O
erythema O O
surrounding O O
it. O O
Lymph O O
nodes: O O
no O O
cervical, O O
supraclavicular, O O
axillary, O O
inguinal O O
lymphadenopathy O O
Neck: O O
supple; O O
carotid O O
upstroke O O
good O O
w/out O O
bruit; O O
no O O
thyromegaly O O
or O O
tenderness O O
HEENT: O O
pharynx O O
with O O
nl O O
mucosa O O
w/out O O
exudates; O O
good O O
dental O O
care; O O
conjunctivae O O
noninjected; O O
no O O
scleralicterus; O O
PERRLA; O O
EOMI O O
w/out O O
nystagmus; O O
pupils O O
pinpoint, O O
discs O O
not O O
visualized; O O
hearing O O
significantly O O
reduced; O O
TM O O
nl; O O
sinuses O O
non-tender O O
Chest: O O
w/out O O
chest O O
wall O O
tenderness; O O
clear O O
P&A O O
w/out O O
rales, O O
rhonchi, O O
or O O
wheeze O O
Cardiac: O O
In O O
AF, O O
rate O O
of O O
80, O O
palpable, O O
PMI O O
laterally O O
displaced, O O
soft O O
S2, O O
S4, O O
2/6 O O
apical O O
systolic O O
murmur O O
radiating O O
to O O
the O O
left O O
sternal O O
border O O
and O O
to O O
the O O
axilla. O O
Breast: O O
No O O
gynecomastia. O O
Abdomen: O O
nl O O
BS, O O
no O O
hepatomegaly/splenomegaly O O
or O O
mass; O O
no O O
tenderness/G/R; O O
abd O O
aorta O O
w/out O O
bruit O O
or O O
palpable O O
enlargement O O
Extremities: O O
1+ O O
pretibial O O
edema. O O
No O O
motion O O
of O O
the O O
left O O
shoulder O O
ulcer O O
as O O
noted O O
above. O O
Neurologic: O O
A&O; O O
nl O O
affect; O O
nl O O
speech; O O
weakened O O
left O O
arm; O O
reflexes O O
symmetric; O O
plantars O O
flexor O O
Rectal: O O
Copious O O
amounts O O
of O O
blood O O
in O O
the O O
rectal O O
exam, O O
loose O O
sphincter, O O
no O O
prostatic O O
mass. O O
Laboratory O O
data O O
and O O
Old O O
record O O
reviewed O O
extensive O O
records. O O
Impression: O O
Acutely O O
ill O O
gentleman O O
w/ O O
GI O O
Bleed O O
CHF O O
Hz O O
L O O
shoulder O O
infection; O O
currently O O
w/ O O
infected O O
ulcer O O
and O O
limited O O
ROM O O
due O O
to O O
rotator O O
tear O O
DM B-DIABETES O
out O O
of O O
control O O
Multiple O O
problems O O
as O O
above. O O
Long O O
discussion O O
with O O
the O O
family O O
regarding O O
previous O O
care. O O
Acute O O
problem O O
today O O
is O O
massive O O
GI O O
bleed O O
without O O
clear O O
etiology. O O
History O O
of O O
heart O O
failure O O
with O O
significant O O
weakness, O O
shortness O O
of O O
breath, O O
recent O O
chest O O
pain, O O
nonhealing O O
ulcer O O
on O O
his O O
left O O
shoulder, O O
all O O
requiring O O
emergency O O
hospitalization, O O
and O O
he O O
will O O
be O O
sent O O
to O O
the O O
BARH O O
ER O O
at O O
once. O O
Long O O
discussion O O
with O O
the O O
family O O
about O O
this O O
and O O
his O O
other O O
chronic O O
problems O O
including O O
diabetes O O
and O O
episodes O O
of O O
hypoglycemia. O O
Plan O O
Health O O
Maintenance O O
Diet O O
and O O
exercise O O
counseling O O
Further O O
evaluation O O
Medications O O
FU O O
______________________________ O O
Ursula O O
Yawn, O O
MD O O
eScription O O
document:7-3720969 O O
HFFocus O O
DD: O O
12/05/87 O O
DT: O O
12/05/87 O O
DV: O O
12/05/87 O O

Record O O
date: O O
2088-01-20 O O
Infectious O O
Disease O O
Consultation O O
Patient O O
Name: O O
Moss, O O
Derek O O
MR: O O
89659991 O O
Reason O O
for O O
consult: O O
assistance O O
with O O
management O O
of O O
possible O O
persistent O O
L O O
shoulder O O
septic O O
arthritis O O
in O O
patient O O
pre-op O O
for O O
planned O O
hip O O
replacement O O
Source: O O
patient, O O
MR O O
Counsult O O
requested O O
by: O O
Dr. O O
Everett O O
Pace O O
Date O O
of O O
consult: O O
1/20 O O
Location: O O
4E-66 O O
__________________________________________________________________ O O
HPI: O O
Mr. O O
Moss O O
is O O
a O O
77 O O
yo O O
M O O
with O O
PmHx O O
significant O O
for O O
DMII, B-DIABETES O
CHF O O
(EF O O
20-25%), O O
afib, O O
Parkinson's, O O
prostate O O
cancer O O
s/p O O
XRT O O
c/b O O
proctitis O O
and O O
GIB, O O
multiple O O
hip O O
replacements, O O
s/p O O
multiple O O
knee O O
surgeries O O
who, O O
recently O O
treated O O
for O O
S. O O
aureus O O
L O O
shoulder O O
septic O O
arthritis O O
(10/87) O O
who O O
presented O O
1/19 O O
s/p O O
fall. O O
Mr. O O
Moss O O
has O O
experienced O O
multiple O O
falls O O
recently, O O
and O O
was O O
ultimately O O
diagnosed O O
with O O
Parkinsons O O
last O O
September. O O
Following O O
the O O
diagnosis, O O
he O O
was O O
discharged O O
to O O
Bellaire O O
City O O
Hospital, O O
where O O
he O O
continued O O
to O O
experience O O
falls. O O
After O O
one O O
episode, O O
he O O
was O O
forcibly O O
picked O O
up, O O
and O O
began O O
to O O
have O O
L O O
shoulder O O
pain O O
thereafter. O O
He O O
also O O
noted O O
a O O
cut O O
over O O
the O O
L O O
elbow O O
on O O
transfer O O
to O O
the O O
NH O O
that O O
was O O
slow O O
to O O
heal. O O
After O O
several O O
weeks O O
of O O
worsening O O
shoulder O O
pain, O O
erythema, O O
and O O
warmth, O O
he O O
was O O
re-hospitalized O O
at O O
Ouagadougou, O O
where O O
he O O
underwent O O
L O O
shoulder O O
aspiration. O O
MRI O O
10/87 O O
demonstrated O O
complete O O
rupture O O
of O O
the O O
rotator O O
cuff, O O
with O O
associated O O
large O O
joint O O
effusion. O O
Of O O
note, O O
he O O
denied O O
fevers, O O
chills, O O
or O O
NS. O O
L O O
shoulder O O
aspiration O O
10/10/87 O O
demonstrated O O
purulent O O
fluid, O O
with O O
2,800,000 O O
WBC O O
(97%PMN). O O
Gram O O
stain O O
demonstrated O O
GPC O O
in O O
clusters. O O
He O O
subsequently O O
underwent O O
L O O
shoulder O O
I&D O O
10/12, O O
with O O
removal O O
of O O
300cc O O
of O O
frankly O O
purulent O O
fluid. O O
He O O
was O O
started O O
on O O
cefazolin. O O
Culture O O
results O O
returned O O
a O O
pan-sensitive O O
Staphylococcus O O
aureus O O
isolate O O
(including O O
to O O
ampicillin, O O
cefazolin, O O
clindamycin, O O
penicillin, O O
rifampin). O O
Blood O O
cultures O O
were O O
negative. O O
He O O
was O O
taken O O
back O O
to O O
the O O
OR O O
10/16 O O
for O O
arthroscopy, O O
with O O
extensive O O
debridement. O O
Interop O O
findings O O
included O O
demonstration O O
of O O
significant O O
fibrinous O O
tissue, O O
with O O
no O O
normal-appearing O O
cartiledge O O
present. O O
A O O
penrose O O
was O O
placed O O
into O O
a O O
large O O
cavity O O
down O O
the O O
subdeltoid O O
rescess, O O
and O O
a O O
second O O
in O O
the O O
subacromial O O
space. O O
He O O
was O O
transitioned O O
to O O
ampicillin O O
2g O O
q6 O O
hours O O
x O O
2 O O
weeks, O O
and O O
then O O
given O O
amoxicillin O O
(either O O
1g O O
BID O O
or O O
500mg O O
TID, O O
unsure O O
which) O O
x O O
2 O O
weeks. O O
Repeat O O
R O O
shoulder O O
MRI O O
obtained O O
12/12/87, O O
which O O
was O O
reviewed O O
with O O
staff O O
radiologist, O O
and O O
demonstrated O O
again O O
complete O O
tear O O
of O O
the O O
supra/infraspinatus/teres O O
minor/ O O
subscapularis/ O O
biceps O O
tendons, O O
with O O
also O O
persistent O O
large O O
joint O O
effusion, O O
extensive O O
synovitis, O O
and O O
full O O
thickness O O
cartiledge O O
loss O O
of O O
glenoid O O
and O O
humeral O O
head. O O
Also O O
noted O O
was O O
possible O O
AVN O O
of O O
medial O O
portion O O
of O O
the O O
humeral O O
head. O O
Overall, O O
was O O
difficult O O
to O O
tell O O
from O O
MRI O O
whether O O
findings O O
represented O O
prior O O
vs O O
active O O
disease. O O
Mr. O O
Moss O O
was O O
seen O O
in O O
the O O
ID O O
clinic O O
1/18, O O
at O O
which O O
time O O
he O O
complained O O
of O O
a O O
several O O
week O O
h/o O O
progressively O O
worsening O O
L O O
shoulder O O
discomfort O O
with O O
activity. O O
He O O
did O O
not O O
experience O O
shoulder O O
pain O O
at O O
rest, O O
and O O
had O O
not O O
recently O O
noted O O
erythema. O O
No O O
drainage. O O
Appetite O O
was O O
near O O
baseline, O O
though O O
he O O
had O O
experienced O O
fatigue. O O
Blood O O
glucoses O O
had O O
been O O
well O O
controlled. O O
His O O
daughter O O
in O O
law O O
brought O O
in O O
extensive O O
data O O
on O O
his O O
home O O
vital O O
signs, O O
which O O
revealed O O
absence O O
of O O
fever O O
except O O
for O O
a O O
single O O
isolated O O
temp O O
of O O
103, O O
with O O
stable O O
pulse/BP, O O
and O O
overall O O
well O O
controlled O O
blood O O
sugars. O O
Date O O
ESR O O
CRP O O
12/6/87 O O
88 O O
23 O O
12/19/87 O O
96 O O
28 O O
1/18/88 O O
67 O O
9.4 O O
Unfortunately, O O
Mr. O O
Moss O O
sustained O O
a O O
mechanical O O
fall O O
1/19. O O
Following O O
the O O
fall, O O
he O O
had O O
significantly O O
increased O O
hip O O
pain. O O
Hip/pelvis O O
films O O
notable O O
for O O
femoral O O
component O O
with O O
lucency O O
measuring O O
more O O
than O O
2mm O O
superolaterally O O
and O O
along O O
the O O
stem. O O
Orthopedic O O
team O O
felt O O
that O O
loosening O O
of O O
hardware O O
would O O
require O O
another O O
hip O O
revision. O O
ROS: O O
as O O
per O O
HPI. O O
Denied O O
having O O
R O O
hip O O
pain O O
prior O O
to O O
his O O
fall. O O
No O O
cough, O O
sore O O
throat, O O
chest O O
discomfort, O O
abdominal O O
pain, O O
dysuria, O O
diarrhea. O O
Extensive O O
ROS O O
otherwise O O
negative. O O
PmHx: O O
h/o O O
L O O
shoulder O O
septic O O
joint O O
s/p O O
I/D O O
in O O
10/87 O O
c/b O O
hemorrhage O O
as O O
per O O
HPI O O
CHF O O
(EF O O
20-25%) O O
s/p O O
5 O O
hip O O
surgeries, O O
s/p O O
bilateral O O
hip O O
replacements. O O
S/p O O
R O O
THA O O
with O O
revision O O
x O O
2, O O
last O O
2081 O O
(Kent), O O
s/p O O
l O O
THA O O
with O O
revision O O
x O O
1. O O
Afib, O O
maintained O O
on O O
coumadin O O
DMII, O O
diagnosed O O
~20 O O
years O O
ago. O O
Unsure O O
of O O
last O O
A1c O O
CRI O O
(baseline O O
Cr O O
~1.6-1.7) O O
HTN B-HYPERTENSION O
Parkinson's O O
disease, O O
prostate O O
ca O O
s/p O O
radiation O O
c/b O O
radiation O O
proctitis, O O
LGIB, O O
thought O O
secondary O O
to O O
radiation O O
proctitis. O O
Was O O
to O O
have O O
a O O
colonoscopy O O
this O O
week. O O
Admitted O O
with O O
GIB O O
12/87. O O
s/p O O
multiple O O
knee O O
surgeries O O
GERD O O
melanoma O O
s/p O O
excision O O
s/p O O
cholecystectomy. O O
Meds O O
on O O
admission: O O
Protonix, O O
isosorbide, O O
MVI, O O
lasix, O O
hydralazine, O O
sucralfate, O O
flomax, O O
FeSo4, O O
senna, O O
avodart, O O
sinemet, O O
coumadin, O O
quinine, O O
lantus/novolog. B-MEDICATION O
Current O O
medications: O O
Iron, O O
quinine, O O
isosorbide, O O
lasix, O O
hydral, O O
insulin, B-MEDICATION O
sinemet,flomax, O O
avodart, O O
nexium, O O
requip, O O
sucralfate O O
All/adverse O O
rxn: O O
NKDA O O
Social O O
history: O O
widowed, O O
lives O O
with O O
family, O O
who O O
are O O
very O O
involved O O
in O O
his O O
care. O O
No B-SMOKER O
tobacco, I-SMOKER O
EtOH, O O
or O O
IVDU. O O
Retired. O O
FHx: O O
Noncontributory O O
P.E. O O
VS: O O
97.4 O O
76 O O
118/97 O O
18 O O
98%RA O O
Gen: O O
found O O
lying O O
flat O O
in O O
bed, O O
in O O
no O O
acute O O
distress O O
Skin: O O
no O O
rashes. O O
Multiple O O
areas O O
of O O
ecchymoses, O O
with O O
some O O
skin O O
breakdown, O O
on O O
extremities O O
bilaterally O O
(he O O
attributes O O
this O O
to O O
multiple O O
falls) O O
HEENT: O O
anicteric, O O
conjunctiva O O
uninjected. O O
No O O
sinus O O
tenderness. O O
No O O
nasal O O
d/c. O O
No O O
sores/lesions O O
in O O
oral O O
cavity. O O
No O O
thrush O O
Neck: O O
supple, O O
no O O
JVD, O O
no O O
LAD. O O
Cor: O O
irregular O O
rhythm, O O
nl O O
S1 O O
S2, O O
II/VI O O
SEM O O
at O O
RUSB O O
Chest: O O
clear O O
to O O
auscultation O O
and O O
percussion O O
Abd: O O
soft, O O
NT/ND, O O
+BS O O
x4, O O
no O O
hepatomegaly, O O
no O O
spleen O O
tip O O
palpable. O O
Extr: O O
acyanotic, O O
nonedematous. O O
Back: O O
no O O
midline O O
or O O
CVA O O
tenderness O O
Shoulder: O O
L O O
shoulder O O
non-erythematous, O O
not O O
significantly O O
tender O O
to O O
palpation, O O
though O O
does O O
have O O
pain O O
with O O
active O O
motion. O O
No O O
exudate. O O
Can O O
forward O O
flex O O
past O O
90, O O
abduct O O
to O O
45. O O
Hip: O O
minimal O O
tenderness O O
to O O
palpation O O
of O O
R O O
hip O O
(though O O
just O O
given O O
pain O O
meds); O O
unable O O
to O O
flex O O
or O O
abduct O O
hip O O
(was O O
able O O
to O O
on O O
Wednesday O O
in O O
clinic). O O
Neuro: O O
MS: O O
awake, O O
alert, O O
oriented O O
to O O
person, O O
place, O O
time. O O
CN O O
II-XII O O
intact. O O
Motor O O
exam O O
limited O O
by O O
shoulder O O
pain, O O
though O O
strength O O
exam O O
non-focal O O
when O O
adjusted O O
for O O
injuries. O O
Mildly O O
shuffling O O
gait O O
noted O O
on O O
Wednesday O O
in O O
clinic,not O O
tested O O
today. O O
Resting O O
tremor, O O
pill O O
rolling. O O
Lines: O O
no O O
erythema. O O
Laboratory O O
Data: O O
SODIUM O O
134 O O
* O O
(136-142) O O
mmol/L O O
POTASSIUM O O
4.1 O O
(3.5-5.0) O O
mmol/L O O
CHLORIDE O O
95 O O
* O O
(98-108) O O
mmol/L O O
TOTAL O O
CO2 O O
27 O O
(23-32) O O
mmol/L O O
GLUCOSE O O
100 O O
(54-118) O O
mg/dL O O
UREA O O
N O O
99 O O
* O O
(9-25) O O
mg/dL O O
CREATININE O O
2.5 O O
* O O
(0.7-1.3) O O
mg/dL O O
WBC O O
8.66 O O
(4-10) O O
K/uL O O
HCT O O
34.1 O O
* O O
(40-54) O O
% O O
PLT O O
252 O O
(150-450) O O
K/uL O O
POLY O O
87 O O
* O O
(48-76) O O
% O O
BAND O O
4 O O
* O O
(0-3) O O
% O O
PT O O
17.9 O O
* O O
(11.8-14.6) O O
sec O O
PTT O O
33.2 O O
(23.8-36.6) O O
sec O O
PT(INR) O O
1.5 O O
* O O
(0.9-1.1) O O
Micro O O
Data: O O
None O O
recently O O
Shoulder O O
aspirate O O
as O O
per O O
HPI O O
(S O O
aureus, O O
pan O O
sensitive) O O
Imaging: O O
Pelvis/Hip O O
(right) O O
films: O O
Bilateral O O
total O O
hip O O
arthroplasties O O
without O O
any O O
acute O O
fracture O O
or O O
dislocation. O O
The O O
acetabular O O
component O O
demonstrates O O
vertical O O
inclination O O
with O O
evidence O O
of O O
polyethylene O O
wear. O O
The O O
femoral O O
component O O
demonstrates O O
lucency O O
measuring O O
more O O
than O O
2mm O O
superolaterally O O
and O O
along O O
the O O
stem O O
consistent O O
with O O
granulomatous O O
disease. O O
There O O
is O O
no O O
subsidence O O
or O O
loosening O O
based O O
on O O
Grauer's O O
classification. O O
AP O O
chest O O
film: O O
no O O
acute O O
pulmonary O O
process, O O
probable O O
cardiomegaly. O O
Assessment: O O
77 O O
yo O O
M O O
with O O
DMII, O O
CHF O O
(EF O O
20-25%), O O
afib, O O
Parkinson's, O O
prostate O O
cancer O O
s/p O O
XRT O O
c/b O O
proctitis O O
and O O
GIB, O O
multiple O O
hip O O
replacements, O O
recently O O
treated O O
for O O
S. O O
aureus O O
L O O
shoulder O O
septic O O
arthritis O O
(10/87 O O
- O O
11/87) O O
who O O
presented O O
1/19 O O
s/p O O
fall. O O
With O O
regards O O
to O O
his O O
shoulder, O O
it O O
is O O
difficult O O
to O O
know O O
whether O O
his O O
infection O O
was O O
cured O O
by O O
the O O
4-week O O
abx O O
course. O O
Though O O
his O O
shoulder O O
does O O
not O O
appear O O
to O O
be O O
grossly O O
infected O O
on O O
exam, O O
2 O O
months O O
after O O
completion O O
of O O
his O O
course, O O
it O O
is O O
too O O
early O O
to O O
determine O O
sterilization O O
of O O
the O O
shoulder O O
on O O
a O O
clinical O O
basis. O O
The O O
MRI O O
is O O
difficult O O
to O O
interpret, O O
and O O
may O O
well O O
reflect O O
prior O O
inflammatory O O
changes. O O
He O O
did O O
have O O
persistently O O
elevated O O
inflammatory O O
markers O O
(though O O
confounded O O
by O O
multiple O O
comorbidities). O O
Given O O
the O O
possibility O O
that O O
he O O
had O O
cleared O O
the O O
infection, O O
our O O
plan O O
as O O
of O O
the O O
clinic O O
visit O O
Wednesday O O
had O O
been O O
to O O
observe O O
him O O
clinically, O O
off O O
abx, O O
for O O
signs O O
of O O
recurrent O O
infection. O O
However, O O
given O O
his O O
fall O O
and O O
the O O
possibility O O
of O O
new O O
hardware O O
placement, O O
would O O
now O O
favor O O
a O O
more O O
aggressive O O
workup O O
of O O
his O O
shoulder. O O
As O O
such, O O
would O O
recommend O O
shoulder O O
aspiration O O
off O O
antibiotics. O O
The O O
source O O
for O O
the O O
L O O
shoulder O O
staph O O
infection O O
was O O
never O O
elucidated, O O
and O O
blood O O
cultures O O
were O O
negative. O O
However, O O
such O O
septic O O
arthritis O O
often O O
results O O
from O O
hematogenous O O
seeding, O O
and O O
there O O
is O O
a O O
small O O
change O O
that O O
his O O
R O O
hip O O
may O O
also O O
have O O
become O O
infected. O O
This O O
could O O
help O O
to O O
explain O O
the O O
prosthesis O O
loosening. O O
Alternatively, O O
he O O
may O O
have O O
had O O
hardware O O
mechanical O O
failure O O
in O O
setting O O
of O O
falls, O O
or O O
less O O
likely O O
involvement O O
by O O
his O O
prostatic O O
ca O O
(?read O O
of O O
granulomatous O O
disease O O
around O O
the O O
prosthesis). O O
Recommendations: O O
-hold O O
antibiotics, O O
including O O
pre-operative O O
prophylactic O O
antibiotics O O
to O O
allow O O
optimal O O
culture O O
data O O
-Aspirate O O
shoulder. O O
Send O O
fluid O O
for O O
cell O O
counts, O O
Gram O O
stain, O O
aerobic/anaerobic/fungal O O
cultures O O
-if O O
do O O
not O O
see O O
contraindication O O
to O O
proceeding O O
with O O
planned O O
hip O O
replacement O O
-would O O
obtain O O
hip O O
biopsies O O
in O O
the O O
OR, O O
again O O
off O O
abx, O O
to O O
assess O O
for O O
possible O O
hip O O
infection O O
-likewise, O O
would O O
send O O
OR O O
hip O O
specimen O O
to O O
pathology O O
to O O
assess O O
for O O
infection O O
vs. O O
neoplastic O O
involvement O O
-check O O
CK, O O
given O O
elevated O O
Cr O O
following O O
fall, O O
and O O
possible O O
rhabdo O O
Thank O O
you O O
for O O
this O O
interesting O O
consultation. O O
We O O
will O O
continue O O
to O O
follow O O
with O O
you. O O
___________ O O
Yair O O
Gillespie O O
Pager O O
#52719 O O
Infectious O O
disease O O
fellow O O

Record B-SMOKER O
date: O O
2088-09-04 O O
Beckley O O
Appalachian O O
Regional O O
Hospital O O
315 O O
Townsend O O
West O O
MOSS, O O
DEREK O O
Espanola, O O
WI O O
85976 O O
89659991 O O
895-239-5445 O O
09/04/2088 O O
REASON O O
FOR O O
VISIT: O O
Follow O O
up O O
with O O
Mr. O O
Derek O O
Moss O O
who O O
is O O
here O O
with O O
his O O
son O O
and O O
daughter-in-law O O
with O O
multiple O O
problems O O
and O O
for O O
preop O O
check O O
of O O
electrolytes. O O
Mr. O O
Moss O O
is O O
78 O O
years O O
old. O O
MEDICAL O O
PROBLEM O O
LIST: O O
1. O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2, I-DIABETES O
insulin I-DIABETES O
dependent. I-DIABETES O
2. O O
Left O O
shoulder O O
pain. O O
Scheduled O O
for O O
surgical O O
care O O
tomorrow. O O
3. O O
GI O O
bleeding, O O
ongoing. O O
4. O O
Parkinson's O O
disease. O O
5. O O
Fatigue. O O
6. O O
BCE. O O
MEDICATIONS: O O
Medication O O
list O O
updated O O
on O O
the O O
LMR. O O
Major O O
change O O
is O O
furosemide O O
now O O
60 O O
mg O O
b.i.d. O O
instead O O
of O O
80. O O
INTERIM O O
HISTORY: O O
1. O O
Hyperkalemia O O
occurred O O
on O O
higher O O
dose O O
of O O
Lasix. O O
Apparently O O
this O O
has O O
been O O
a O O
problem O O
in O O
the O O
past. O O
He O O
also O O
bumped O O
his O O
creatinine O O
to O O
2.3. O O
Potassium O O
rechecked O O
today O O
and O O
is O O
now O O
down O O
to O O
5.1, O O
stable O O
creatinine. O O
2. O O
Diabetes. O O
Blood O O
sugars O O
running O O
in O O
the O O
80s O O
in O O
the O O
morning, O O
higher O O
later O O
in O O
the O O
day O O
on O O
16 O O
units O O
of O O
Lantus B-MEDICATION O
sliding O O
scale O O
to O O
cover O O
other O O
meals. O O
Uses O O
regular O O
insulin O O
about O O
twice O O
a O O
day. O O
3. O O
GI O O
bleeding O O
ongoing O O
by O O
Mr. O O
Moss's O O
report, O O
still O O
having O O
clots O O
of O O
blood, O O
no O O
abdominal O O
pain, O O
has O O
not O O
had O O
GI O O
follow O O
up O O
recently, O O
is O O
off O O
Coumadin O O
prior O O
to O O
shoulder O O
repair. O O
3. O O
Skin O O
lesions, O O
one O O
on O O
his O O
left O O
leg, O O
one O O
on O O
his O O
right O O
medial O O
leg O O
and O O
a O O
lump O O
on O O
his O O
back O O
noticed O O
by O O
his O O
daughter O O
when O O
she O O
was O O
giving O O
him O O
a O O
therapeutic O O
massage. O O
4. O O
Left O O
shoulder O O
pain. O O
Scheduled O O
for O O
surgery O O
in O O
the O O
a.m. O O
PHYSICAL O O
EXAMINATION: O O
He O O
is O O
brighter, O O
cheerier, O O
acutely O O
oriented. O O
No O O
acute O O
pain. O O
Vital O O
Signs: O O
Blood O O
pressure O O
126/57, O O
pulse O O
66 O O
and O O
regular, O O
respirations O O
12 O O
and O O
unlabored, O O
weight O O
161. O O
Skin O O
shows O O
seborrheic O O
keratoses, O O
actinic O O
keratoses O O
on O O
the O O
right O O
leg, O O
papule O O
with O O
eschar O O
on O O
the O O
left O O
leg, O O
a O O
subcutaneous O O
nodule O O
on O O
the O O
right O O
upper O O
back. O O
Chest O O
is O O
clear O O
P&A. O O
Cardiac O O
exam O O
regular O O
rate O O
and O O
rhythm, O O
normal O O
S1, O O
S2, O O
II/IV O O
apical O O
systolic O O
murmur O O
radiating O O
to O O
the O O
left O O
sternal O O
border. O O
No O O
gallop. O O
Extremities, O O
trace O O
edema. O O
Decreased O O
ROM O O
R O O
shoulder. O O
Abdomen O O
soft. O O
Neurologic, O O
alert O O
and O O
oriented. O O
IMPRESSION O O
AND O O
PLAN: O O
Hyperkalemia O O
resolving. O O
Discussed O O
importance O O
of O O
careful O O
fluid O O
balance, O O
low-protein O O
diet O O
given O O
azotemia, O O
renal O O
follow O O
up, O O
follow O O
up O O
with O O
GI O O
for O O
GI O O
bleeding, O O
blood O O
transfusions O O
are O O
available. O O
Continue O O
lower O O
dose O O
of O O
Lasix. O O
Skin O O
lesions O O
include O O
seborrheic O O
dermatitis, O O
seborrheic O O
keratoses, O O
possible O O
lipoma, O O
although O O
lump O O
on O O
his O O
back O O
is O O
firm O O
and O O
may O O
need O O
a O O
biopsy O O
once O O
he O O
has O O
recovered O O
from O O
shoulder O O
surgery. O O
Long O O
consultation O O
with O O
him O O
and O O
his O O
daughter O O
regarding O O
home O O
care O O
after O O
surgery. O O
______________________________ O O
Ursula O O
Yawn, O O
MD O O
eScription O O
document:7-9274121 O O
EMSSten O O
Tel O O
DD: O O
09/04/88 O O
DT: O O
09/05/88 O O
DV: O O
09/04/88 O O

Record O O
date: O O
2089-03-11 O O
EDVISIT^89659991^MOSS, O O
DEREK^03/11/89^GODFREY, O O
XAVIER O O
GEORGE O O
I O O
saw O O
this O O
patient O O
with O O
the O O
resident, O O
Dr. O O
Louvinia O O
Duvall. O O
Please O O
see O O
her O O
note O O
for O O
further O O
details. O O
I O O
confirm O O
that O O
I O O
have O O
interviewed O O
and O O
examined O O
the O O
patient, O O
reviewed O O
the O O
resident's O O
documentation O O
on O O
the O O
patient's O O
chart, O O
and O O
discussed O O
the O O
evaluation, O O
plan O O
of O O
care, O O
and O O
disposition O O
with O O
the O O
patient. O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
The O O
patient O O
is O O
a O O
78-year-old O O
male O O
with O O
a O O
history O O
of O O
diabetes, B-DIABETES O
hypertension, B-HYPERTENSION O
atrial O O
fibrillation, O O
congestive O O
heart O O
failure, O O
prostate O O
cancer, O O
chronic O O
renal O O
insufficiency, O O
and O O
Parkinson O O
disease O O
previously O O
hospitalized O O
2 O O
weeks O O
prior O O
for O O
right O O
lower O O
extremity O O
cellulitis, O O
which O O
he O O
had O O
a O O
PICC O O
line O O
placed, O O
and O O
was O O
discharged O O
to O O
home O O
on O O
vancomycin. O O
Since O O
that O O
time, O O
he O O
has O O
had O O
progressively O O
increase O O
in O O
his O O
creatinines O O
despite O O
decreasing O O
doses O O
of O O
vancomycin. O O
He O O
was O O
concerned O O
and O O
requested O O
that O O
the O O
patient O O
to O O
come O O
in O O
for O O
a O O
possible O O
acute O O
renal O O
failure O O
secondary O O
to O O
the O O
antibiotic. O O
There O O
is O O
also O O
concern O O
that O O
cellulitis O O
had O O
worsened, O O
as O O
the O O
patient O O
was O O
experiencing O O
increasing O O
weakness. O O
He O O
is O O
denying O O
currently O O
any O O
fevers, O O
chills, O O
or O O
constitutional O O
symptoms. O O
His O O
baseline O O
shortness O O
of O O
breath O O
has O O
been O O
going O O
on O O
for O O
months. O O
No O O
GI O O
complaints. O O
He O O
has O O
had O O
a O O
mild O O
headache, O O
but O O
no O O
visual O O
changes, O O
no O O
focal O O
motor O O
or O O
sensory O O
loss. O O
REVIEW O O
OF O O
SYSTEMS: O O
The O O
systems O O
reviewed O O
and O O
found O O
to O O
be O O
negative. O O
MEDICATIONS: O O
He O O
has O O
a O O
long O O
list O O
of O O
medications O O
Please O O
see O O
the O O
chart. O O
ALLERGIES: O O
Morphine. O O
SOCIAL B-SMOKER O
HISTORY: O O
Reviewed O O
and O O
found O O
to O O
be O O
noncontributory. O O
FAMILY O O
HISTORY: O O
Reviewed O O
and O O
found O O
to O O
be O O
noncontributory. O O
PAST O O
SURGICAL O O
HISTORY: O O
Cholecystectomy O O
and O O
bilateral O O
total O O
hip O O
replacement. O O
PHYSICAL O O
EXAMINATION: O O
He O O
is O O
awake, O O
alert, O O
nontoxic O O
appearing, O O
and O O
in O O
no O O
acute O O
distress. O O
Vital O O
signs O O
reviewed O O
and O O
found O O
to O O
be O O
within O O
normal O O
limits. O O
Afebrile O O
at O O
95.6. O O
HEENT O O
exam O O
is O O
unremarkable. O O
Mucosal O O
membranes O O
are O O
moist. O O
Neck O O
is O O
supple. O O
Lungs O O
are O O
clear O O
bilaterally. O O
Heart O O
is O O
regular O O
rate O O
and O O
rhythm, O O
no O O
murmurs O O
or O O
gallops. O O
Abdomen: O O
Soft, O O
nondistended, O O
and O O
nontender O O
with O O
normoactive O O
bowel O O
sounds. O O
Skin O O
is O O
warm O O
and O O
dry. O O
Extremity O O
exam: O O
He O O
has O O
right O O
lower O O
extremity O O
cellulitis O O
with O O
2 O O
small O O
ulcerations O O
and O O
serosanguineous O O
drainage O O
is O O
minimal. O O
No O O
evidence O O
of O O
pus. O O
It O O
is O O
about O O
where O O
it O O
was O O
at O O
the O O
start O O
based O O
on O O
the O O
initial O O
skin O O
markings. O O
LABORATORY O O
DATA: O O
Hematocrit O O
of O O
32. O O
However, O O
his O O
BUN O O
has O O
been O O
150 O O
and O O
creatinine O O
of O O
3. O O
This O O
has O O
significantly O O
increased O O
from O O
his O O
baseline O O
of O O
1.8-2 O O
he O O
has O O
had O O
in O O
the O O
past. O O
Vancomycin O O
level O O
was O O
sent. O O
DIAGNOSIS: O O
Cellulitis O O
with O O
acute O O
renal O O
insufficiency O O
most O O
likely O O
secondary O O
to O O
vancomycin. O O
This O O
was O O
discussed O O
with O O
his O O
primary O O
care O O
provider. O O
DISPOSITION: O O
He O O
is O O
admitted O O
to O O
the O O
Medicine O O
Service. O O
______________________________ O O
GODFREY, O O
XAVIER O O
GEORGE O O
MD O O
D: O O
03/17/89 O O
T: O O
03/17/89 O O
Dictated O O
By: O O
GODFREY, O O
XAVIER O O
GEORGE O O
eScription O O
document:7-3638497 O O
BFFocus O O
******** O O
Not O O
reviewed O O
by O O
Attending O O
Physician O O
******** O O

Record O O
date: O O
2090-02-18 O O
Patient O O
Name: O O
MOSS,DEREK O O
P O O
[ O O
89659991(QMC) O O
] O O
Date O O
of O O
Visit: O O
02/18/2090 O O
Problems O O
Parkinsons O O
disease O O
Diabetes B-DIABETES O
mellitus I-DIABETES O
type I-DIABETES O
2 I-DIABETES O
Congestive O O
heart O O
failure O O
Atrial O O
fibrillation O O
Pacemaker O O
Gastroesophageal O O
reflux O O
disease O O
Hyperlipidemia B-HYPERLIPIDEMIA O
Chronic O O
renal O O
dysfunction O O
H/O O O
basal O O
cell O O
carcinoma O O
H/O O O
prostate O O
cancer O O
Chief O O
Complaint O O
Comes O O
in O O
for O O
his O O
2 O O
month O O
follow O O
up O O
visit O O
History O O
of O O
Present O O
Illness O O
79 O O
year O O
old O O
male O O
comes O O
in O O
with O O
his O O
son O O
for O O
a O O
follow O O
up. O O
He O O
reports O O
right O O
LE O O
swelling O O
and O O
redness O O
increasing O O
over O O
the O O
last O O
1 O O
week. O O
Patient O O
and O O
his O O
son O O
also O O
noted O O
right O O
big O O
toe O O
swelling O O
and O O
ulceration O O
yesterday. O O
They O O
stated O O
that O O
the O O
did O O
not O O
look O O
at O O
bilateral O O
feet O O
for O O
the O O
last O O
4-5 O O
days. O O
The O O
patient O O
reports O O
pain O O
in O O
the O O
right O O
foot O O
as O O
well. O O
He O O
has O O
no O O
h/o O O
fevers. O O
The O O
patient O O
has O O
a O O
VNA O O
nurse O O
that O O
was O O
dicontinued O O
by O O
the O O
family O O
1 O O
week O O
ago. O O
Past O O
Medical O O
History O O
Parkinson's O O
disease O O
Diabetes O O
mellitus O O
type O O
2 O O
Atrial O O
fibrillation O O
Hyperlipidemia O O
Pacemaker O O
CHF O O
(Ischemic O O
cardiomyopathy O O
with O O
an O O
EF O O
of O O
25-30%) O O
Moderate O O
AS/ O O
moderate O O
MR O O
CKD O O
GERD O O
OA O O
s/p O O
bilateral O O
hip O O
replacements O O
Prostate O O
Cancer O O
diagnosed O O
in O O
2084 O O
s/p O O
XRT O O
in O O
2085 O O
with O O
h/o O O
radiation O O
proctitis O O
Basal O O
cell O O
carcinoma O O
excision O O
Past O O
Surgical O O
History O O
Lumbar O O
laminectomy O O
in O O
the O O
2060s O O
Left O O
septic O O
shoulder O O
s/p O O
placement O O
of O O
a O O
prosthetic O O
shoulder O O
placement O O
in O O
2087 O O
Bilateral O O
THR O O
s/p O O
RH O O
revision O O
2/88 O O
H/o O O
bilateral O O
knee O O
surgeries O O
x O O
4 O O
(2 O O
surgeries O O
on O O
each O O
side) O O
Cholecystectomy O O
for O O
gall O O
stones O O
in O O
2084 O O
Social O O
History O O
Widowed O O
in O O
2081 O O
Smoking-None B-SMOKER O
Alcohol-None O O
Illicit O O
drug O O
use-None O O
Occupation-Was O O
a O O
vocational O O
instructor O O
Health O O
care O O
proxy-Yes, O O
son O O
(West) O O
Allergies O O
DUTASTERIDE O O
- O O
cough, O O
Morphine O O
- O O
Mental O O
Status O O
Change O O
Medications O O
ASA B-MEDICATION B-MEDICATION
81 O O
MG O O
PO O O
QD O O
Ferrous O O
Sulfate O O
325 O O
MG O O
(325(65)MG O O
TABLET O O
take O O
1) O O
PO O O
QD O O
FUROSEMIDE O O
80 O O
MG O O
(80MG O O
TABLET O O
take O O
1) O O
PO O O
BID O O
x O O
30 O O
days O O
Hydralazine O O
Hcl O O
10 O O
MG O O
(10MG O O
TABLET O O
take O O
1) O O
PO O O
TID O O
Imdur B-MEDICATION O
Er O O
(ISOSORBIDE O O
Mononitrate O O
(SR)) O O
120 O O
MG O O
(120MG O O
TAB.SR O O
24H O O
take O O
1) O O
PO O O
QD O O
x O O
90 O O
days, O O
pt O O
needs O O
increase O O
in O O
dose O O
for O O
afterload O O
reduction O O
for O O
severe O O
MR. O O
Substitution O O
permitted. O O
Insulin B-MEDICATION O
Regular I-MEDICATION O
Human I-MEDICATION O
6 O O
UNITS O O
SC O O
as O O
directed O O
based O O
on O O
BG O O
, O O
at O O
meals O O
pending O O
BG O O
levels O O
Lantus B-MEDICATION B-MEDICATION
(INSULIN O O
Glargine) O B-MEDICATION
16 O O
UNITS O O
SC O O
QHS O O
, O O
Lantus O B-MEDICATION
#3 O O
vials O O
3rf O O
LISINOPRIL B-MEDICATION B-MEDICATION
2.5 O O
MG O O
PO O O
QD O O
MULTIVITAMINS O O
1 O O
TAB O O
PO O O
QD O O
Nitroquick B-MEDICATION B-MEDICATION
0.3mg I-MEDICATION O
(NITROGLYCERIN I-MEDICATION O
1/200 I-MEDICATION O
(0.3 I-MEDICATION O
Mg)) I-MEDICATION O
1 O O
TAB O O
SL O O
as O O
directed O O
PRN O O
emergency O O
Procrit O O
(EPOETIN O O
Alfa) O O
6000 O O
UNITS O O
SC O O
Q O O
OTHER O O
WEEK O O
, O O
Dose O O
reduced O O
per O O
order O O
Dr. O O
Dunlap O O
Protonix O O
(PANTOPRAZOLE) O O
40 O O
MG O O
PO O O
QD O O
Requip O O
(ROPINIROLE) O O
2 O O
MG O O
(1MG O O
TABLET O O
take O O
2) O O
PO O O
TID O O
Silver O O
Sulfadiazine O O
1% O O
1 O O
APPLICATION O O
TOP O O
BID O O
PRN O O
, O O
cream O O
Toprol B-MEDICATION B-MEDICATION
Xl I-MEDICATION O
(METOPROLOL I-MEDICATION O
Succinate I-MEDICATION O
Extended I-MEDICATION O
Release) I-MEDICATION O
12.5 O O
MG O O
(25MG O O
TAB.SR O O
24H O O
take O O
0.5) O O
PO O O
QHS O O
Warfarin O O
Sodium O O
5 O O
MG O O
(2.5MG O O
TABLET O O
take O O
2) O O
PO O O
QPM O O
Zocor B-MEDICATION B-MEDICATION
(SIMVASTATIN) I-MEDICATION O
20 O O
MG O O
(20MG O O
TABLET O O
take O O
1) O O
PO O O
QHS O O
Vital O O
Signs O O
BLOOD O O
PRESSURE O O
115/55 O O
PULSE O O
70 O O
TEMPERATURE O O
96.3 O O
F O O
WEIGHT O O
152 O O
lb O O
Physical O O
Exam O O
General O O
Appearance O O
Alert, O O
sitting, O O
comfortably O O
on O O
the O O
examination O O
table, O O
oriented, O O
in O O
no O O
acute O O
distress O O
HEENT O O
PERRL/EOMI, O O
Nose-no O O
congestion, O O
Throat-clear, O O
no O O
lesions O O
Neck O O
Supple O O
Cor/Cardiac O O
S1 O O
S2 O O
+, O O
irregularly O O
irregular O O
rhythm, O O
no O O
murmurs O O
Chest O O
Clear O O
to O O
auscultation O O
bilaterally, O O
no O O
wheezing O O
Abdomen O O
Soft, O O
no O O
organomegaly, O O
BS O O
+ O O
Extremity O O
No O O
cyanosis, O O
clubbing, O O
or O O
edema. O O
Sleeves O O
on O O
all O O
4 O O
extremities O O
covering O O
dressings. O O
Improvement O O
in O O
the O O
forearm O O
abrasions. O O
Right O O
big O O
toe O O
with O O
a O O
1.5 O O
x O O
1.5 O O
cm O O
ulcer O O
with O O
granulation O O
tissue O O
and O O
surrounding O O
erythema. O O
Abscess O O
collection O O
visible O O
at O O
the O O
lateral O O
toe. O O
Erythema, O O
swelling, O O
and O O
warmth O O
noted O O
in O O
the O O
right O O
LE O O
up O O
to O O
the O O
middler O O
of O O
the O O
lower O O
leg. O O
Neurological O O
No O O
resting O O
tremor, O O
CNs O O
II-XII O O
intact, O O
increased O O
tone O O
all O O
extremities, O O
walks O O
with O O
a O O
walker, O O
has O O
bradykinesia O O
Nodes/Lymphatic O O
No O O
lymphadenopathy O O
Assessment O O
and O O
Plan O O
Right O O
foot O O
diabetic O O
ulcer O O
and O O
right O O
LE O O
cellulitis: O O
-Advised O O
to O O
go O O
to O O
the O O
QMC O O
ER O O
as O O
soon O O
as O O
possible O O
to O O
start O O
IV O O
antibiotics. O O
-Patient O O
will O O
needs O O
debridement O O
and O O
incision O O
and O O
drainage O O
of O O
his O O
right O O
big O O
toe O O
ulcer O O
and O O
abscess. O O
-Expect O O
message O O
left O O
with O O
the O O
charge O O
nurse O O
at O O
QMC. O O
RTC O O
after O O
discharge O O
from O O
the O O
hospital. O O
______________________________ O O
Frank O O
T. O O
Xuan, O O
M.D. O O

Record O O
date: O O
2083-09-22 O O
Chief O O
Complaint O O
Mrs O O
Chapman O O
is O O
here O O
to O O
follow O O
up O O
on O O
Back O O
pain, O O
HTN, B-HYPERTENSION O
S/P O O
TAH O O
and O O
DM B-DIABETES O
History O O
of O O
Present O O
Illness O O
For O O
the O O
past O O
21 O O
days O O
has O O
had O O
back O O
pain O O
since O O
she O O
was O O
involved O O
in O O
a O O
low O O
speed O O
MVA. O O
Was O O
a O O
restarined O O
passanger O O
in O O
the O O
back O O
seat O O
of O O
a O O
car, O O
that O O
wasn't O O
moving, O O
and O O
their O O
car O O
was O O
hit O O
from O O
behind. O O
She O O
developed O O
LBP O O
and O O
has O O
had O O
it O O
since. O O
The O O
next O O
day O O
she O O
had O O
the O O
TAH. O O
The O O
pain O O
is O O
constant, O O
localized O O
in O O
the O O
lower, O O
with O O
radiation O O
to O O
left O O
upper O O
or O O
left O O
lower O O
extremities. O O
NO O O
numbness, O O
tingling O O
or O O
weakness O O
on O O
upper O O
or O O
lower O O
extremities. O O
The O O
pain O O
gets O O
worse O O
with O O
movement O O
and O O
changing O O
positions. O O
Unable O O
to O O
sleep O O
at O O
night O O
with O O
the O O
pain. O O
Denies O O
any O O
urinary O O
incontinence O O
apart O O
of O O
her O O
usual, O O
when O O
sneezing O O
or O O
coughing O O
or O O
bowel O O
incontinence, O O
no O O
fever, O O
chills, O O
or O O
other O O
joint O O
aches. O O
Hasn't O O
had O O
similar O O
symptoms O O
before. O O
Hasn O O
been O O
taking O O
Tylenol O O
PRN O O
with O O
no O O
relif O O
She O O
has O O
a O O
TAH O O
and O O
BSO O O
on O O
9/2/83 O O
for O O
a O O
pelvic O O
mass, O O
found O O
to O O
be O O
serous O O
cystadenoma. O O
Feeling O O
well, O O
occasional O O
wound O O
discomfort, O O
she O O
was O O
not O O
aware O O
of O O
her O O
uterus O O
being O O
removed. O O
Review O O
of O O
Systems O O
C/P:Denies O O
chest O O
pain, O O
shortness O O
of O O
breath, O O
PND, O O
orthopnea O O
General:Denies O O
fever, O O
chills, O O
headache, O O
Has O O
lost O O
20 O O
pounds O O
since O O
6/83 O O
GI O O
:Denies O O
nausea, O O
vomiting, O O
diarrhea O O
GU: O O
Denies O O
dysuria, O O
polyuria O O
Neuro: O O
denies O O
headaches O O
HEENT: O O
no O O
cold O O
sx O O
but O O
stuffy O O
nose O O
and O O
sneezing O O
Psych: O O
was O O
very O O
depressed O O
before O O
her O O
surgery, O O
was O O
very O O
scared O O
All O O
other O O
systems O O
negative O O
Problems O O
ASTHMA O O
HYPERTENSION B-HYPERTENSION O
INSOMNIA O O
SCHIZOPHRENIA O O
DIABETES B-DIABETES O
MELLITUS I-DIABETES O
PELVIC O O
MASS O O
Allergies O O
NKDA B-SMOKER O
NONE O O
Medications O O
METAMUCIL O O
(PSYLLIUM O O
(METAMUCIL) O O
SUGAR O O
FREE) O O
1TBSP O O
PO O O
BID O O
PREMPRO O O
0.625/2.5 O O
PO O O
QD O O
LOTENSIN B-MEDICATION O
40MG O O
PO O O
BID O O
NORVASC B-MEDICATION B-MEDICATION
5MG O O
PO O O
QD O O
VANCERIL O O
2PUFFS O O
INH O O
BID O O
VENTOLIN O O
2PUFF O O
INH O O
QID O O
MULTIVITAMINS O O
PRENATAL O O
1 O O
PO O O
QD O O
PAXIL O O
40MG O O
PO O O
QHS O O
HALOPERIDOL O O
4MG O O
PO O O
QD O O
BENADRYL O O
50MG O O
PO O O
QHS O O
CALCIUM O O
CARBONATE O O
1000MG O O
PO O O
QD O O
FIORICET O O
1TAB O O
PO O O
Q4H O O
Vital O O
Signs O O
Blood O O
Pressure: O O
120/80 O O
Pulse: O O
84 O O
Respiratory O O
Rate: O O
14 O O
Weight: O O
212 O O
Pounds O O
Physical O O
Exam O O
Alert, O O
in O O
mild O O
distress, O O
able O O
to O O
sit O O
and O O
lye O O
down O O
with O O
mild O O
discomfort O O
HEENT O O
: O O
oral O O
mucosa O O
moist, O O
no O O
lesions, O O
Throat: O O
clear, O O
no O O
plaques, O O
exudates O O
or O O
erythema. O O
Rhinoscopy: O O
erythematous O O
mucosa, O O
no O O
polyps O O
Neck O O
: O O
supple, O O
no O O
masses O O
or O O
nodes, O O
no O O
JVD. O O
Lungs: O O
clear O O
anteriorly O O
and O O
posteriroly O O
to O O
auscultation, O O
no O O
rhonchi, O O
crackles O O
or O O
wheezes, O O
normal O O
percussion. O O
Heart: O O
regular,. O O
S1S2 O O
normal, O O
no O O
S3 O O
or O O
murmurs O O
Abdomen: O O
midline O O
surgical O O
scar O O
clean, O O
soft, O O
no O O
tenderness, O O
no O O
masses O O
no O O
organomegalies O O
BS(+), O O
no O O
rebound O O
Ext: O O
no O O
edema, O O
normal O O
skin O O
Back O O
exam: O O
no O O
spinal O O
deformities, O O
no O O
paraspinal O O
muscle O O
spasm, O O
no O O
sacroiliac O O
tenderness, O O
normal O O
skin O O
exam. O O
Bilateral O O
straight O O
leg O O
raising O O
test O O
negative. O O
Neurological: O O
Strenght O O
5/5 O O
bilateral O O
symmetrical, O O
Sensory O O
intact, O O
DTR O O
2++ O O
bilateral O O
symmetrical. O O
No O O
pathological O O
reflexes O O
Assessment O O
1. O O
BACK O O
PAIN O O
No O O
evidence O O
of O O
anatomical O O
or O O
neurological O O
deficit O O
Most O O
likely O O
musculoskeletal O O
origin O O
Naprosyn O O
500 O O
mg O O
po O O
BID O O
for O O
7 O O
days O O
and O O
the O O
PRN O O
#40 O O
no O O
refills O O
Soma O O
Compound O O
1 O O
tb O O
TID O O
#30 O O
no O O
refills O O
Heat O O
pads O O
TID O O
for O O
20 O O
minutes O O
each O O
time O O
Physical O O
activity O O
as O O
tolerated O O
Written O O
instructions O O
on O O
how O O
to O O
avoid O O
back O O
pain O O
and O O
exercises O O
to O O
performed O O
three O O
times O O
per O O
week O O
given O O
and O O
start O O
the O O
exercises O O
in O O
a O O
month O O
time O O
Use O O
a O O
pillow O O
under O O
the O O
knees O O
to O O
decreased O O
the O O
back O O
pain O O
2. O O
S/P O O
TAH O O
BSO O O
Explained O O
to O O
her O O
the O O
procedure O O
and O O
she O O
understood. O O
Will O O
start O O
Premarin O O
0.625 O O
mg O O
po O O
QD O O
#30 O O
6 O O
refills O O
and O O
D/C O O
Prempro O O
Continue O O
MVI O O
and O O
calcium O O
3. O O
ALLERGIC O O
RHINITIS O O
Rhinocort O O
nasal O O
spray O O
2 O O
puffs O O
BID O O
1 O O
and O O
6 O O
refills O O
4. O O
HYPERTENSION O O
Well O O
controlled, O O
continue O O
same O O
meds O O
5. O O
DIABETES O O
MELLITUS O O
Prescr O O
for O O
Accucheck O O
glucometer, O O
strips O O
and O O
lancets O O
Plan O O
Follow O O
up O O
with O O
me O O
in O O
2 O O
months O O
for O O
flu O O
shot O O
or O O
before O O
PRN O O

Record O O
date: O O
2086-11-17 O O
Chilton O O
County O O
Hospital O O
Nursing O O
Home O O
427 O O
Ohio O O
Street O O
CHAPMAN, O O
NOOR O O
Weston, O O
VT O O
36112 O O
45479406 O O
(324) O O
090-7704 O O
11/17/86 O O
REASON O O
FOR O O
VISIT: O O
Ms. O O
Chapman O O
is O O
a O O
58-year-old O O
woman O O
who O O
comes O O
in O O
complaining O O
of O O
allergy O O
symptoms O O
with O O
nasal O O
congestion, O O
runny O O
nose, O O
sneezing. O O
She O O
also O O
has O O
a O O
bit O O
of O O
a O O
cough O O
and O O
trouble O O
breathing O O
because O O
of O O
the O O
congestion O O
and O O
allergies. O O
She O O
has O O
no O O
fevers, O O
sweats O O
or O O
chills, O O
no O O
chest O O
pain. O O
Her O O
sugars O O
have O O
been O O
in O O
the O O
180 O O
and O O
200 O O
range O O
at O O
home. O O
No O O
dysuria. O O
No O O
abdominal O O
symptoms. O O
REVIEW O O
OF O O
SYSTEMS: O O
Otherwise O O
negative O O
in O O
detail. O O
MEDICATIONS: O O
Ativan O O
1 O O
mg O O
q.d., O O
lisinopril B-MEDICATION B-MEDICATION
10 O O
mg O O
q.d., O O
metformin B-MEDICATION B-MEDICATION
500 O O
mg O O
b.i.d., O O
Serzone O O
b.i.d., O O
Zyprexa O B-MEDICATION
q.h.s., O O
atenolol B-MEDICATION B-MEDICATION
25 O O
mg O O
q.d., O O
enteric B-MEDICATION O
coated I-MEDICATION O
aspirin I-MEDICATION B-MEDICATION
325 O O
mg O O
q.d., O O
Vanceril O O
inhaler, O O
Ventolin O O
inhaler O O
everyday O O
and O O
also O O
occasionally O O
at O O
night O O
Paxil O O
40 O O
mg O O
q.h.s. O O
She O O
notes O O
she O O
has O O
not O O
used O O
any O O
sublingual O O
nitroglycerin. O B-MEDICATION
ALLERGIES: O O
None O O
known. O O
SOCIAL O O
HISTORY: O O
She B-SMOKER O
has I-SMOKER O
never B-SMOKER O
smoked, I-SMOKER O
used O O
alcohol O O
or O O
street O O
drugs. O O
PHYSICAL O O
EXAMINATION: O O
Well O O
developed, O O
well O O
nourished O O
in O O
no O O
acute O O
distress. O O
Blood O O
pressure O O
136/72, O O
pulse O O
84, O O
weight O O
229 O O
pounds, O O
afebrile, O O
pleasant, O O
Spanish O O
speaking O O
woman. O O
She O O
has O O
an O O
8 O O
mm O O
in O O
diameter O O
irregular O O
hyperpigmented O O
nodular O O
lesion O O
on O O
her O O
right O O
forefoot. O O
Mouth O O
and O O
pharynx O O
without O O
erythema O O
or O O
exudate. O O
No O O
adenopathy O O
or O O
tenderness O O
in O O
the O O
submandibular, O O
cervical, O O
posterior O O
cervical, O O
supraclavicular O O
or O O
axillary O O
area. O O
Thyroid O O
is O O
nontender O O
and O O
nonnodular. O O
Neck: O O
Supple. O O
No O O
spine O O
or O O
flank O O
tenderness. O O
No O O
bruits, O O
no O O
stridor. O O
Heart O O
sounds: O O
S1 O O
and O O
S2 O O
regular O O
rate O O
and O O
rhythm. O O
No O O
murmur, O O
rub O O
or O O
gallop. O O
Her O O
chest O O
is O O
clear O O
to O O
auscultation O O
anteriorly O O
and O O
posteriorly O O
with O O
no O O
rales O O
wheezes O O
or O O
rhonchi. O O
She O O
is O O
clear O O
to O O
percussion. O O
Normal O O
bowel O O
sounds. O O
Abdomen O O
is O O
soft O O
and O O
nontender. O O
No O O
mass O O
or O O
organomegaly. O O
No O O
guarding O O
or O O
rebound. O O
Extremities O O
are O O
without O O
edema, O O
cyanosis O O
or O O
clubbing. O O
No O O
calf O O
tenderness. O O
Reflexes O O
are O O
normal. O O
Pedal O O
pulses O O
are O O
present O O
bilaterally. O O
There O O
is O O
no O O
rash O O
or O O
erythema, O O
maceration O O
on O O
her O O
feet. O O
No O O
lesion O O
on O O
her O O
foot. O O
LABORATORY O O
STUDIES: O O
An O O
MRI O O
from O O
September O O
18 O O
showed O O
a O O
left O O
kidney O O
mass, O O
cystic. O O
Hemoglobin B-DIABETES O
A1c I-DIABETES O
from I-DIABETES O
August I-DIABETES O
was I-DIABETES O
6.5 I-DIABETES O
and O O
the O O
LDL B-HYPERLIPIDEMIA O
was I-HYPERLIPIDEMIA O
125. I-HYPERLIPIDEMIA O
IMPRESSION O O
AND O O
PLAN: O O
1. O O
Diabetes: B-DIABETES O
Her O O
diabetes B-DIABETES O
has O O
been O O
extremely O O
well O O
controlled. O O
We O O
will O O
continue O O
her O O
current O O
regimen. O O
We O O
will O O
check O O
glucose, O O
hemoglobin O O
A1c, O O
U/A, O O
urine, O O
microalbuminuria. O O
She O O
recently O O
went O O
to O O
the O O
ophthalmologist. O O
2. O O
Elevated O O
cholesterol. O O
Our O O
goal O O
is O O
an O O
LDL O O
of O O
100. O O
We O O
will O O
start B-MEDICATION O
Lipitor B-MEDICATION B-MEDICATION
10 O O
mg O O
p.o. O O
q.d. O O
She O O
will O O
return O O
in O O
six O O
weeks O O
for O O
follow O O
up O O
of O O
this. O O
3. O O
Hypertension. B-HYPERTENSION O
Her O O
blood O O
pressure O O
is O O
acceptable. O O
We O O
will O O
continue O O
her O O
current O O
regimen. O O
Results O O
were O O
given O O
as O O
needed. O O
4. O O
Allergy O O
symptoms. O O
I O O
gave O O
her O O
Rhinocort O O
AQ O O
nasal O O
spray. O O
Explained O O
how O O
to O O
use O O
it. O O
5. O O
Nodular O O
hyperpigmented O O
lesion O O
on O O
her O O
forefeet. O O
I O O
will O O
refer O O
her O O
to O O
Dermatology O O
for O O
evaluation O O
of O O
this O O
lesion, O O
but O O
the O O
patient O O
says O O
that O O
it O O
has O O
been O O
there O O
for O O
as O O
long O O
as O O
she O O
can O O
remember O O
but O O
it O O
is O O
quite O O
atypical O O
to O O
my O O
exam. O O
6. O O
Left O O
renal O O
cystic O O
mass. O O
She O O
has O O
been O O
scheduled O O
for O O
a O O
follow-up O O
MRI O O
for O O
December O O
13. O O
7. O O
Asthma: O O
She O O
is O O
doing O O
stably O O
in O O
this O O
regard O O
and O O
I O O
believe O O
that O O
nasal O O
spray O O
will O O
help O O
substantially O O
with O O
her O O
symptoms. O O
labs O O
great, O O
letter O O
sent O O
______________________________ O O
Sandra O O
Jewell, O O
M.D. O O
Dictated O O
By: O O
Sandra O O
Jewell O O
eScription O O
document:5-7786571 O O
EMSSten O O
Tel O O
DD: O O
11/18/86 O O
DT: O O
11/19/86 O O
DV: O O
11/18/86 O O

Record B-SMOKER O
date: O O
2087-06-16 O O
Chief O O
Complaint O O
Mrs O O
Chapman O O
is O O
here O O
today O O
to O O
follow O O
up O O
on O O
HTN, B-HYPERTENSION O
DM B-DIABETES O
History O O
of O O
Present O O
Illness O O
I O O
saw O O
her O O
2/24/87 O O
for O O
HTN O O
and O O
DM. O O
BP B-HYPERTENSION O
was I-HYPERTENSION O
high I-HYPERTENSION O
and O O
increased O O
Lisinopril B-MEDICATION B-MEDICATION
to O O
20 O O
mg O O
QD O O
Restarted O O
Lipitpr B-MEDICATION B-MEDICATION
but O O
she O O
still O O
is O O
not O O
taking O O
it. O O
The O O
pharmacy O O
didn't O O
give O O
it O O
to O O
her. O O
Her B-HYPERLIPIDEMIA O
LDL B-HYPERLIPIDEMIA O
is I-HYPERLIPIDEMIA O
116 I-HYPERLIPIDEMIA O
ono I-HYPERLIPIDEMIA O
2/87 I-HYPERLIPIDEMIA O
and O O
has O O
DM, O O
goal O O
&lt;100. O O
Feels O O
well. O O
Had O O
an O O
ETT O O
MIBI O O
few O O
weeks O O
ago O O
and O O
no O O
evidence O O
of O O
ischemia. O O
Denies O O
CP, O O
SOB, O O
palpitations O O
Started O O
walking O O
daily O O
around O O
Woodstown O O
about O O
3.5 O O
miles O O
and O O
has O O
lost O O
7 O O
pounds O O
since O O
I O O
saw O O
her. O O
Also O O
eating O O
more O O
vegetables O O
and O O
fruits O O
and O O
less O O
carbohydrates. O O
Third, O O
she O O
had O O
a O O
renal O O
U/S O O
done O O
for O O
hematuria O O
and O O
showed O O
small O O
left O O
renal O O
mass. O O
Had O O
a O O
CT O O
scan O O
later O O
that O O
showed O O
the O O
same O O
and O O
recommended O O
an O O
MRI. O O
She O O
had O O
it O O
done O O
few O O
9/86. O O
Recommended O O
to O O
repeat O O
it O O
soon. O O
Left O O
lower O O
pole O O
renal O O
lesion O O
with O O
MRI O O
signal O O
characteristics O O
consistent O O
with O O
a O O
cystic, O O
septated, O O
unenhancing O O
renal O O
lesion O O
or O O
bosniak O O
grade O O
2. O O
However, O O
when O O
compared O O
to O O
prior O O
CT O O
examination O O
demonstrating O O
late O O
filling O O
of O O
this O O
lesion, O O
follow O O
up O O
is O O
warranted O O
to O O
exclude O O
a O O
cystic O O
renal O O
neoplasm O O
making O O
this O O
an O O
overall O O
bosniak O O
grade O O
2F. O O
Review O O
of O O
Systems O O
C/P: O O
Denies O O
PND, O O
orthopnea. O O
Leg O O
swelling O O
after O O
walking O O
around O O
the O O
pond O O
General: O O
Denies O O
fever, O O
chills O O
HEENT O O
: O O
No O O
cold O O
sx O O
GI O O
: O O
Denies O O
nausea, O O
vomiting, O O
diarrhea. O O
Psych: O O
follow O O
with O O
therapist O O
and O O
psychiatry. O O
Taking O O
all O O
her O O
psych O O
meds O O
GU: O O
Denies O O
dysuria, O O
polyuria O O
Neuro: O O
denies O O
Skin O O
: O O
denies O O
All O O
other O O
systems O O
negative O O
Problems O O
ASTHMA O O
HYPERTENSION B-HYPERTENSION O
INSOMNIA O O
SCHIZOPHRENIA O O
DIABETES B-DIABETES O
MELLITUS I-DIABETES O
10/08/85 O O
R O O
breast O O
u/s O O
with O O
likely O O
lipoma O O
and O O
simple O O
cyst O O
at O O
8 O O
o'clock, O O
repeat O O
u/s O O
in O O
6 O O
months O O
and O O
mammography O O
in O O
01/2086 O O
Renal O O
mass O O
OBESITY B-OBESE O
: I-OBESE O
Type I-OBESE O
3 I-OBESE O
- O O
BMI B-OBESE O
44 I-OBESE O
Allergies O O
NKDA O O
NONE O O
Medications O O
Paxil O O
40 O O
MG O O
PO O O
QHS O O
Ntg B-MEDICATION O
1/150 I-MEDICATION O
(NITROGLYCERIN B-MEDICATION O
1/150 I-MEDICATION O
(0.4 I-MEDICATION O
MG)) I-MEDICATION O
1 I-MEDICATION O
TAB I-MEDICATION O
SL I-MEDICATION O
Not O O
taking O O
it O O
Ativan O O
(LORAZEPAM) O O
1MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
Ventolin O O
2 O O
PUFF O O
INH O O
QID O O
PRN O O
Shortness O O
of O O
breath O O
, O O
PRNNot O O
taking O O
it O O
Vanceril O O
2 O O
PUFFS O O
INH O O
BID O O
Not O O
taking O O
it O O
Rhinocort O O
AQUA O O
(BUDESONIDE O O
NASAL B-MEDICATION O
INHALER) O O
2 O O
SPRAY O O
NAS O O
qd O O
Not O O
taking O O
it O O
Zyprexa O O
(OLANZAPINE) O O
7.5MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QHS O O
Serzone O O
(NEFAZODONE) O O
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QHS O O
Calcium O O
CARBONATE O O
1250 O O
MG O O
(1.25G O O
TABLET O O
) O O
PO O O
QD O O
Multivitamins O O
1 O O
CAPSULE O O
PO O O
QD O O
Not O O
taking O O
it O O
Ecasa B-MEDICATION B-MEDICATION
(ASPIRIN O O
ENTERIC O O
COATED) O O
325MG O O
TABLET O O
EC O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Metformin B-MEDICATION B-MEDICATION
500MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
BID O O
Lisinopril O B-MEDICATION
20MG O O
TABLET O O
take O O
1 O O
PO O O
QD O O
Atenolol B-MEDICATION B-MEDICATION
50MG O O
TABLET O O
take O O
1 O O
PO O O
QD O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
Not O O
taking O O
it O O
Vital O O
signs O O
BP O O
128/88, O O
P O O
76, O O
RR O O
14, O O
Ht O O
61.5 O O
in, O O
Wt O O
224 O O
lb O O
Physical O O
Exam O O
Alert, O O
in O O
no O O
distress O O
obese B-OBESE O
HEENT O O
: O O
oral O O
mucosa O O
moist, O O
no O O
lesions, O O
Throat: O O
clear, O O
no O O
plaques, O O
exudates O O
or O O
erythema. O O
Neck O O
: O O
supple, O O
no O O
masses O O
or O O
nodes, O O
no O O
JVD. O O
Lungs: O O
clear O O
anteriorly O O
and O O
posteriroly O O
to O O
auscultation, O O
no O O
rhonchi, O O
crackles O O
or O O
wheezes O O
Heart: O O
regular,. O O
S1S2 O O
normal, O O
no O O
S3 O O
or O O
murmurs O O
Abdomen: O O
soft, O O
no O O
tenderness, O O
no O O
masses O O
no O O
organomegalies O O
BS(+), O O
no O O
rebound O O
Ext: O O
no O O
edema, O O
normal O O
skin O O
Feet O O
exam: O O
normal O O
skin, O O
no O O
lesions, O O
normal O O
DP, O O
good O O
capillary O O
filling, O O
thick O O
toenails, O O
microfilament O O
test O O
normal O O
Assessment/Plan O O
1. O O
HYPERTENSION O O
Borderline O O
controlled O O
on O O
current O O
therapy O O
Will O O
increase O O
Atenolol O B-MEDICATION
to O O
100 O O
mg O O
QD O O
30 O O
Increase O O
Lisinopril O B-MEDICATION
to O O
40 O O
mg O O
QD O O
30 O O
and O O
6 O O
refills O O
Low O O
salt O O
diet O O
See O O
me O O
in O O
12 O O
weeks O O
Congratulated O O
her O O
for O O
exercise O O
and O O
weigth O O
loss O O
2. O O
CHEST O O
PAIN O O
Asymptomatic O O
for O O
weeks O O
Negative O O
ETT O O
MIBI O O
Needs O O
to O O
take O O
ASA O B-MEDICATION
QD O O
Already O O
on O O
BBlockers, O O
ASA O B-MEDICATION
3. O O
DIABETES O O
MELLITUS O O
On O O
Metformin O B-MEDICATION
500 O O
mg O O
BID O O
60 O O
and O O
6 O O
refills O O
Recomm O O
low O O
fat O O
and O O
low O O
carb O O
diet O O
and O O
increase O O
physical O O
activity, O O
return O O
to O O
walking O O
QD O O
Wil O O
check O O
HbA1C O O
and O O
glucose O O
Restart B-MEDICATION O
Lipitor I-MEDICATION B-MEDICATION
10 O O
mg O O
QHS O O
30 O O
and O O
6 O O
refills O O
LDL O O
goal O O
&lt;100 O O
Chedck O O
Lipid O O
profile O O
4. O O
ASTHMA O O
Stable O O
for O O
months O O
5. O O
RENAL O O
MASS O O
Needs O O
to O O
repeat O O
MRI O O
soon. O O
Will O O
schedule O O
6.SCHIZOPHRENIA O O
Follow O O
up O O
with O O
Psych O O
See O O
me O O
in O O
12 O O
weeks O O

Record B-SMOKER O
date: O O
2088-06-24 O O
Patient O O
Name: O O
CHAPMAN,NOOR O O
[ O O
MRN: O O
45479406HBMC O O
] O O
Date O O
of O O
Visit: O O
6/24/2088 O O
Chief O O
Complaint O O
Mrs O O
Chapman O O
is O O
here O O
today O O
to O O
follow O O
up O O
on O O
HTN, B-HYPERTENSION O
DM B-DIABETES O
History O O
of O O
Present O O
Illness O O
She O O
has O O
been O O
feeling O O
well. O O
Seen O O
by O O
orthopedics O O
few O O
days O O
ago O O
for O O
shopulder O O
pain. O O
Offered O O
steroid O O
injection O O
but O O
she O O
declined. O O
Instead O O
started O O
NSAIDs O O
and O O
will O O
follow O O
up O O
in O O
4 O O
weeks. O O
Still O O
has O O
pain O O
on O O
her O O
left O O
shoulder. O O
She O O
is O O
checking O O
glucose O O
sometimes O O
and O O
has O O
been O O
in O O
the O O
high O O
90s. O O
Not B-MEDICATION O
taking I-MEDICATION O
Metformin B-MEDICATION B-MEDICATION
for I-MEDICATION O
1 I-MEDICATION O
month, I-MEDICATION O
was O O
told O O
insurance O O
won't O O
pay O O
for O O
it. O O
Has O O
been O O
doing O O
well O O
overall. O O
Eye O O
exam O O
scheduled O O
for O O
next O O
month O O
Depression O O
is O O
stable. O O
Taking O O
all O O
her O O
meds O O
as O O
directed O O
Needs O O
refills O O
for O O
meds O O
Walking O O
1 O O
hour O O
every O O
day O O
Review O O
of O O
Systems O O
C/P: O O
Denies O O
PND, O O
orthopnea O O
General: O O
Denies O O
fever, O O
chills O O
HEENT O O
: O O
No O O
cold O O
sx O O
GI O O
: O O
Denies O O
nausea, O O
vomiting, O O
diarrhea. O O
Psych: O O
follow O O
with O O
therapist O O
and O O
psychiatry. O O
Taking O O
all O O
her O O
psych O O
meds O O
GU: O O
Denies O O
dysuria, O O
polyuria O O
Neuro: O O
headaches O O
Skin O O
: O O
no O O
rashes O O
All O O
other O O
systems O O
negative O O
Problems O O
ASTHMA O O
HYPERTENSION B-HYPERTENSION O
INSOMNIA O O
SCHIZOPHRENIA O O
DIABETES B-DIABETES O
MELLITUS I-DIABETES O
10/08/85 O O
R O O
breast O O
u/s O O
with O O
likely O O
lipoma O O
and O O
simple O O
cyst O O
at O O
8 O O
o'clock, O O
repeat O O
u/s O O
in O O
6 O O
months O O
and O O
mammography O O
in O O
01/2086 O O
Renal O O
mass O O
OBESITY B-OBESE O
: I-OBESE O
Type I-OBESE O
3 I-OBESE O
- O O
BMI B-OBESE O
44 I-OBESE O
Allergies O O
NKA O O
Medications O O
ATENOLOL B-MEDICATION B-MEDICATION
100MG O O
TABLET O O
take O O
1 O O
PO O O
QD O O
ATIVAN O O
(LORAZEPAM) O O
1MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
CALCIUM O O
CARBONATE O O
1250 O O
MG O O
(1.25G O O
TABLET) O O
PO O O
QD O O
CLOBETASOL O O
PROPIONATE O O
0.05% O O
1 O O
APPLICATION O O
TOP O O
BID O O
ECASA B-MEDICATION B-MEDICATION
(ASPIRIN O O
ENTERIC O O
COATED) O O
325MG O O
TABLET O O
EC O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
IBUPROFEN O O
800 O O
MG O O
PO O O
TID O O
PRN O O
shoulder O O
pain O O
LIPITOR B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
10MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QD O O
LISINOPRIL B-MEDICATION B-MEDICATION
40MG O O
TABLET O O
take O O
1 O O
PO O O
QD O O
METFORMIN B-MEDICATION B-MEDICATION
500MG O O
TABLET O O
take O O
1 O O
PO O O
BID O O
(Not O O
taking O O
it) O O
MULTIVITAMINS O O
1 O O
CAPSULE O O
PO O O
QD O O
NASACORT O O
2 O O
PUFF O O
NA O O
QHS O O
, O O
2 O O
puffs O O
in O O
each O O
nostril O O
QHS O O
PAXIL O O
40 O O
MG O O
PO O O
QHS O O
PREMARIN O O
(CONJUGATED O O
ESTROGENS) O O
1 O O
GM O O
PV O O
Q72H O O
SERZONE O O
(NEFAZODONE) O O
100MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QHS O O
VENTOLIN O O
2 O O
PUFF O O
INH O O
QID O O
PRN O O
Shortness O O
of O O
breath, O O
PRN O O
ZYPREXA O O
(OLANZAPINE) O O
7.5MG O O
TABLET O O
take O O
1 O O
Tablet(s) O O
PO O O
QHS O O
Vital O O
Signs O O
Blood B-HYPERTENSION O
Pressure: I-HYPERTENSION O
-- I-HYPERTENSION O
140/80 I-HYPERTENSION O
[Left I-HYPERTENSION O
Arm] I-HYPERTENSION O
[Sitting] I-HYPERTENSION O
Pulse: O O
-- O O
68 O O
[Regular] O O
[Radial] O O
Respiratory O O
Rate: O O
-- O O
14 O O
[Regular] O O
Weight: O O
-- O O
225 O O
[Pounds] O O
Physical O O
Exam O O
Alert, O O
in O O
no O O
distress O O
obese B-OBESE O
HEENT O O
: O O
PEERL, O O
EOMI, O O
oral O O
mucosa O O
moist, O O
no O O
lesions, O O
Throat: O O
clear, O O
no O O
plaques, O O
exudates O O
or O O
erythema. O O
Neck O O
: O O
supple, O O
no O O
masses O O
or O O
nodes, O O
no O O
JVD. O O
Lungs: O O
clear O O
anteriorly O O
and O O
posteriroly O O
to O O
auscultation, O O
no O O
rhonchi, O O
crackles O O
or O O
wheezes O O
Heart: O O
regular,. O O
S1S2 O O
normal, O O
no O O
S3 O O
or O O
murmurs O O
Abdomen: O O
soft, O O
no O O
tenderness, O O
no O O
masses O O
no O O
organomegalies O O
BS(+), O O
no O O
rebound O O
Ext: O O
no O O
edema, O O
normal O O
skin O O
Feet O O
exam: O O
thick O O
toenails, O O
good O O
DP, O O
good O O
capillary O O
filling, O O
normal O O
microfillament O O
test O O
Assessment/Plan O O
1. O O
HYPERTENSION O O
Well O O
controlled O O
on O O
current O O
therapy O O
Atenolol B-MEDICATION B-MEDICATION
to O O
100 O O
mg O O
QD O O
30 O O
and O O
6 O O
refills O O
Lisinopril B-MEDICATION B-MEDICATION
40 O O
mg O O
QD O O
30 O O
and O O
6 O O
refills O O
2. O O
DIABETES O B-MEDICATION
MELLITUS O O
On B-MEDICATION O
Metformin I-MEDICATION B-MEDICATION
500 I-MEDICATION O
mg I-MEDICATION O
BID I-MEDICATION O
60 I-MEDICATION O
and I-MEDICATION O
6 I-MEDICATION O
refills. I-MEDICATION O
AllMed I-MEDICATION O
Insurance I-MEDICATION O
covers I-MEDICATION O
for I-MEDICATION O
it I-MEDICATION O
Check O O
glucose O O
QAM O O
Recomm O O
low O O
fat O O
and O O
low O O
carb O O
diet O O
and O O
increase O O
physical O O
activity, O O
continue O O
walking O O
QD O O
Last B-DIABETES O
HbA1C I-DIABETES O
in I-DIABETES O
5/88 I-DIABETES O
7.4 I-DIABETES O
LDL O O
69 O O
5/88 O O
Lipitor O B-MEDICATION
10 O O
mg O O
QHS O O
30 O O
and O O
6 O O
refills O O
Needs O O
eye O O
exam O O
3. O O
ASTHMA O O
Stable O O
for O O
months O O
See O O
me O O
in O O
4 O O
months O O
______________________________ O O
Cynthia O O
Nancy-Nesmith, O O
M.D. O O

Record O O
date: O O
2081-03-22 O O
Chief O O
Complaint O O
of: O O
Nephrolithiasis O O
2/28/81 O O
cysto, O O
left O O
stent, O O
ESWL,meatal O O
dilatation O O
History O O
of O O
Present O O
Illness: O O
50 O O
yo O O
male O O
here O O
for O O
removal O O
of O O
his O O
stent. O O
He O O
denies O O
fevers, O O
nausea, O O
chest O O
pain, O O
shortness O O
of O O
breadth O O
(at O O
baseline), O O
and O O
vomiting. O O
Voiding O O
symptoms: O O
hesitancy, O O
intermittency, O O
nocturia O O
x1 O O
3/week, O O
no O O
frequency, O O
and O O
intermittent O O
urgency. O O
Reports O O
erectile O O
dysfunction-difficulty O O
maintaining O O
erections. O O
Past O O
Medical O O
History: O O
NIDDM, B-DIABETES O
neurofibromatosis, O O
Hodgkins O O
disease-chemo O O
and O O
XRT O O
(bleomycin, O O
adriamycin, O O
vincristine, O O
DTIC) O O
Past O O
Surgical O O
History: O O
left O O
axillary O O
biopsy, O O
pectus O O
excavatum, O O
neck O O
surgery O O
Medications: O O
metformin, B-MEDICATION O
urocit O O
K, O O
ibuprofen O O
PRN O O
Allergies: O O
he O O
reports O O
an O O
allergy O O
to O O
contrast O O
in O O
the O O
past O O
but O O
did O O
well O O
with O O
his O O
last O O
CT O O
scan. O O
Social O O
History: O O
Single O O
Does B-SMOKER O
not I-SMOKER O
smoke I-SMOKER O
No O O
alcohol O O
use O O
Retired O O
from O O
dc O O
comics O O
Family O O
Hx: O O
No O O
history O O
of O O
stones O O
Mother O O
- O O
died O O
of O O
sarcoma O O
Father O O
-died O O
of O O
an O O
MI O O
Sister O O
with O O
ITP O O
Review O O
of O O
Systems: O O
No O O
interval O O
change O O
Genitourinary O O
Review O O
of O O
Systems O O
No O O
Kidney O O
stones O O
in O O
the O O
past O O
No O O
Urinary O O
tract O O
infections O O
No O O
Sexually O O
transmitted O O
diseases O O
Physical O O
Examination: O O
General O O
Examination: O O
Vital O O
Signs: O O
Morbid B-OBESE O
obesity I-OBESE O
BP B-HYPERTENSION O
154/82 I-HYPERTENSION O
cor O O
RRR O O
lung O O
CTAB O O
abd O O
soft O O
No O O
CVAT O O
LE O O
no O O
calf O O
tenderness O O
cystoscopy O O
Patient O O
was O O
placed O O
in O O
the O O
supine O O
position O O
and O O
prepped O O
and O O
draped O O
in O O
the O O
standard O O
sterile O O
fashion. O O
Lidocaine O O
jelly O O
was O O
inserted O O
into O O
the O O
meatus O O
for O O
local O O
anaesthesia. O O
A O O
flexible O O
cystoscope O O
was O O
inserted O O
into O O
the O O
meatus. O O
The O O
urethra O O
was O O
without O O
lesions. O O
The O O
lateral O O
lobes O O
of O O
the O O
prostate O O
coapted O O
at O O
the O O
midline. O O
The O O
stent O O
was O O
identified O O
and O O
using O O
alligator O O
forceps O O
the O O
distal O O
portion O O
was O O
grasped. O O
It O O
was O O
removed O O
intact. O O
The O O
patient O O
tolerated O O
the O O
procedure O O
and O O
was O O
discharged O O
from O O
the O O
clinic O O
after O O
receiving O O
ciprofloxacin. O O
Laboratory O O
Values: O O
An O O
independent O O
review O O
of O O
a O O
urinalysis O O
shows: O O
No O O
WBC's O O
+ O O
RBC's O O
No O O
Glucose O O
No O O
Protein O O
Nitrite O O
Negative O O
pH O O
7.0 O O
Abdomen O O
Single O O
22-Mar-2081 O O
REPORT: O O
History: O O
As O O
above. O O
Comparison:Noncontrast O O
CT O O
abdomen O O
and O O
pelvis O O
3/14/81. O O
Findings: O O
There O O
is O O
a O O
left O O
ureteral O O
stent. O O
Tiny O O
residual O O
stones O O
seen O O
on O O
prior O O
CT O O
are O O
not O O
identified O O
on O O
this O O
KUB.The O O
bowel O O
gas O O
pattern O O
is O O
nonobstructive. O O
The O O
bones O O
are O O
unremarkable O O
in O O
appearance. O O
The O O
visualized O O
lung O O
bases O O
are O O
unremarkable. O O
IMPRESSION: O O
LEFT O O
URETERAL O O
STENT. O O
NO O O
ABNORMAL O O
CALCIFICATIONS O O
IDENTIFIED. O O
Impression: O O
50 O O
yo O O
male O O
treated O O
for O O
a O O
1.1 O O
cm O O
symptomatic O O
left O O
renal O O
stone. O O
His O O
post-operative O O
KUB O O
does O O
not O O
show O O
any O O
calcifications. O O
The O O
stent O O
was O O
removed O O
intact O O
without O O
difficulty. O O
He O O
is O O
to O O
have O O
a O O
follow O O
up O O
CT O O
in O O
June O O
with O O
and O O
without O O
contrast O O
for O O
further O O
evaluation O O
of O O
a O O
renal O O
lesion O O
seen O O
on O O
a O O
previous O O
CT O O
scan. O O
He O O
did O O
have O O
a O O
post-operative O O
CT O O
that O O
showed O O
a O O
subcapsular O O
hematoma O O
for O O
which O O
his O O
blood O O
pressure O O
will O O
be O O
followed. O O
That O O
study O O
also O O
showed O O
the O O
stone O O
which O O
is O O
no O O
longer O O
visualized O O
on O O
todays O O
KUB. O O
The O O
imaging O O
in O O
June O O
will O O
again O O
assess O O
his O O
stone O O
burden. O O
Plan: O O
1 O O
CT O O
abd/pelvis O O
I-/I+ O O
in O O
June O O
Follow O O
Up: O O
in O O
June O O
Patricia O O
Barajas, O O
MD O O
Urology- O O
Gila O O
Regional O O
Hospital O O
Please O O
note: O O
This O O
email O O
may O O
contain O O
confidential O O
patient O O
information O O
which O O
is O O
legally O O
protected O O
by O O
patient-physician O O
privilege. O O
If O O
you O O
are O O
not O O
the O O
intended O O
recipient, O O
you O O
are O O
hereby O O
notified O O
that O O
any O O
disclosure, O O
copying, O O
or O O
distribution O O
of O O
this O O
information O O
is O O
strictly O O
prohibited O O
by O O
law. O O
If O O
you O O
have O O
received O O
this O O
communication O O
in O O
error, O O
please O O
notify O O
us O O
by O O
telephone O O
at O O
once O O
and O O
destroy O O
any O O
electronic O O
or O O
paper O O
copies. O O
We O O
apologize O O
for O O
any O O
inconvenience. O O
cc: O O

Record O O
date: O O
2084-04-28 O O
Medicine O O
&#8211; O O
Mediquik O O
6 O O
Intern O O
Admission O O
Note O O
PATIENT: O O
Gillespie, O O
Patrick O O
MRN: O O
2571454 O O
ADMIT O O
DATE: O O
Tuesday O O
4/28/84 O O
PCP: O O
Dr. O O
Yakov O O
Xie O O
ATTENDING: O O
Ward O O
(Dr. O O
Wiggins O O
/ O O
Dr. O O
Stone) O O
CONTACT: O O
sister O O
Snow O O
241-904-0696 O O
SOURCE: O O
patient O O
and O O
records O O
CC/ID: O O
cough O O
HPI O O
Mr O O
Gillespie O O
is O O
a O O
53 O O
yo O O
man O O
with O O
a O O
history O O
of O O
NIDDM B-DIABETES O
and O O
hypertension B-HYPERTENSION O
who O O
presented O O
to O O
House O O
Of O O
Calvary O O
Hospital O O
today O O
with O O
a O O
chief O O
complaint O O
of O O
cough O O
for O O
the O O
last O O
5 O O
days. O O
He O O
was O O
in O O
his O O
usual O O
state O O
of O O
health O O
prior O O
to O O
that. O O
Cough O O
has O O
been O O
dry; O O
also O O
notes O O
shortness O O
of O O
breath O O
with O O
exertion O O
and O O
diaphoresis. O O
He O O
notes O O
intermittent O O
palpitations O O
and O O
mild O O
lightheadedness O O
during O O
the O O
last O O
few O O
days. O O
He O O
has O O
had O O
pneumonia O O
several O O
times O O
in O O
the O O
past. O O
He O O
denies O O
fever, O O
chills, O O
SOB O O
at O O
rest, O O
orthopnea, O O
PND, O O
chest O O
pain, O O
wheezing, O O
hemoptysis, O O
and O O
sick O O
contacts. O O
He O O
reports O O
compliance O O
with O O
his O O
medications O O
and O O
no O O
recent O O
change O O
in O O
diet. O O
At O O
Calvary, O O
CXR O O
was O O
interpreted O O
as O O
bilateral O O
pneumonia O O
L&gt;R. O O
EKG O O
revealed O O
atrial O O
fibrillation, O O
of O O
which O O
he O O
had O O
no O O
known O O
history. O O
He O O
was O O
referred O O
to O O
the O O
GRH O O
ED O O
for O O
further O O
evaluation. O O
In O O
the O O
ED O O
he O O
was O O
afebrile, O O
HR O O
130s-140s O O
(atrial O O
fibrillation) O O
SBP B-HYPERTENSION O
140s I-HYPERTENSION O
O2 O O
sat O O
99-100%. O O
On O O
exam O O
he O O
had O O
fine O O
bibasilar O O
crackles. O O
He O O
was O O
given O O
levofloxacin O O
750 O O
mg O O
po, O O
dalteparin O O
5000 O O
units, O O
diltiazem B-MEDICATION O
10 O O
mg O O
iv O O
and O O
30 O O
mg O O
po O O
with O O
lowering O O
of O O
HR O O
to O O
90s, O O
and O O
NS O O
500 O O
cc. O O
He O O
was O O
admitted O O
to O O
Medicine O O
&#8211; O O
Mediquik O O
77 O O
for O O
further O O
management. O O
REVIEW O O
OF O O
SYSTEMS O O
General O O
&#8211; O O
+sweats, O O
no O O
weight O O
loss/gain, O O
no O O
fever, O O
no O O
chills, O O
no O O
change O O
in O O
appetite O O
HEENT O O
&#8211; O O
no O O
neck O O
swelling, O O
no O O
neck O O
stiffness, O O
no O O
hoarseness, O O
no O O
hearing O O
loss O O
Pulmonary O O
&#8211; O O
per O O
HPI, O O
no O O
hemoptysis, O O
no O O
wheezing O O
Cardiac O O
&#8211; O O
+palpitations, O O
no O O
chest O O
pain/pressure, O O
no O O
PND O O
Gastrointestinal O O
&#8211; O O
no O O
N/V, O O
no O O
diarrhea, O O
no O O
constipation, O O
no O O
BRBPR, O O
no O O
melena, O O
no O O
abd O O
pain O O
Genitourinary O O
&#8211; O O
no O O
hematuria, O O
no O O
dysuria, O O
no O O
polyuria, O O
no O O
nocturia O O
Extremity O O
&#8211; O O
no O O
leg O O
swelling O O
Musculoskeletal O O
&#8211; O O
no O O
back O O
pain, O O
no O O
neck O O
pain, O O
no O O
leg O O
pain, O O
no O O
arm O O
pain, O O
no O O
joint O O
pain O O
Hematologic O O
&#8211; O O
no O O
bruising, O O
no O O
bleeding O O
Neuro O O
&#8211; O O
no O O
seizures, O O
no O O
headache, O O
no O O
weakness, O O
no O O
numbness/tingling O O
Skin O O
&#8211; O O
no O O
new O O
concerning O O
rashes O O
or O O
lesions O O
Exposures O O
&#8211; O O
no O O
sick O O
contacts, O O
no O O
recent O O
travel O O
PAST O O
MEDICAL O O
HISTORY O O
NIDDM O O
&#8211; O O
A1c O O
6.4 O O
last O O
month O O
Hypertension B-HYPERTENSION O
Hyperlipidemia B-HYPERLIPIDEMIA O
Nephrolithiasis O O
Neurofibromatosis O O
Pectus O O
excavatum O O
Hodgkin&#8217;s O O
disease O O
&#8211; O O
diagnosed O O
in O O
2070; O O
s/p O O
XRT, O O
chemo O O
(bleomycin, O O
adriamycin, O O
vincristine, O O
DTIC), O O
and O O
surgical O O
Resection; O O
oncologist O O
Dr. O O
Bass O O
at O O
MAC O O
Pneumonia O O
&#8211; O O
multiple O O
times O O
in O O
past O O
PAST O O
SURGICAL O O
HISTORY O O
Left O O
axillary O O
biopsy O O
L O O
neck/shoulder O O
surgery O O
(to O O
remove O O
Hodgkin&#8217;s O O
tumor) O O
Surgery O O
for O O
pectus O O
excavatum O O
RECENT O O
DIAGNOSTIC O O
STUDIES O O
Adeno-MIBI O O
2082: O O
negative O O
for O O
ischemia, O O
maybe O O
a O O
small O O
inferior O O
wall O O
scar, O O
LV O O
fxn O O
at O O
lower O O
limit O O
of O O
normal O O
Chest O O
CT O O
3/25/84: O O
Homogeneous O O
soft O O
tissue O O
mass O O
in O O
the O O
right O O
apical O O
paraspinal O O
region O O
that O O
is O O
slightly O O
fusiform O O
in O O
morphology O O
(2.6 O O
x O O
2.6 O O
cm O O
x O O
4 O O
cm) O O
with O O
imaging O O
features O O
suggestive O O
of O O
a O O
neurogenic O O
tumor O O
(ganglioneuroma, O O
neurofibroma, O O
schwannoma). O O
No O O
evidence O O
of O O
associated O O
osseous O O
change O O
or O O
extension O O
into O O
the O O
neural O O
foramina. O O
MEDICATIONS O O
ON O O
ADMISSION O O
ASA B-MEDICATION B-MEDICATION
81 O O
mg O O
daily O O
Metformin B-MEDICATION B-MEDICATION
1000 O O
mg O O
bid O O
Lisinopril B-MEDICATION B-MEDICATION
10 O O
mg O O
daily O O
Simvastatin B-MEDICATION B-MEDICATION
&#8211; O O
not O O
sure O O
of O O
dose O O
Flovent O O
2 O O
puffs O O
bid O O
(started O O
1 O O
month O O
ago O O
for O O
cough) O O
ALLERGIES/ADVERSE O O
REACTIONS O O
IV O O
contrast O O
&#8211; O O
SOB, O O
nausea O O
FAMILY O O
HISTORY O O
Mother O O
&#8211; O O
DM, O O
died O O
of O O
sarcoma, O O
Father O O
- O O
died O O
of O O
an O O
MI, O O
Sister O O
with O O
ITP, O O
Brother O O
and O O
Sister O O
have O O
neurofibromatosis O O
SOCIAL O O
HISTORY O O
Native O O
of O O
Edgefield. O O
Lives O O
in O O
Edgefield O O
with O O
his O O
brother. O O
On O O
disability. O O
Volunteers O O
- O O
animal O O
rescue. O O
No B-SMOKER O
current I-SMOKER O
or I-SMOKER O
previous I-SMOKER O
tobacco. I-SMOKER O
Rare O O
EtOH. O O
No O O
illicits. O O
PHYSICAL O O
EXAMINATION O O
Vitals O O
97.7 O O
92 O O
141/69 B-HYPERTENSION O
18 O O
98% O O
3L O O
General O O
&#8211; O O
obese, B-OBESE O
breathing O O
comfortably O O
HEENT O O
&#8211; O O
sclerae O O
anicteric, O O
MMM O O
Neck O O
&#8211; O O
supple, O O
no O O
LAD O O
Pulmonary O O
&#8211; O O
good O O
air O O
movement, O O
no O O
crackles O O
or O O
wheezes, O O
decreased O O
breath O O
sounds O O
at O O
L O O
base O O
Cardiac O O
&#8211; O O
irreg O O
irreg O O
rhythm, O O
no O O
m/g/r, O O
nl O O
LV O O
heave; O O
pectus O O
excavatum O O
Abdomen O O
&#8211; O O
+BS, O O
obese, O O
soft, O O
nontender, O O
nondistended O O
Extremity O O
&#8211; O O
warm, O O
2+ O O
DP O O
pulses O O
bilaterally, O O
trace O O
bilateral O O
lower O O
extremity O O
edema, O O
no O O
foot O O
ulcers O O
Neuro O O
&#8211; O O
CNs O O
2-12 O O
grossly O O
intact, O O
normal O O
sensation O O
to O O
light O O
touch, O O
5/5 O O
strength O O
bilaterally O O
Skin O O
&#8211; O O
multiple O O
5mm O O
elevated O O
round O O
vesicular O O
lesions O O
on O O
face, O O
chest, O O
and O O
back O O
LABS O O
143 O O
/ O O
4.3 O O
/ O O
100 O O
/ O O
32.4 O O
/ O O
17 O O
/ O O
1.07 O O
/ O O
117 O O
8.9 O O
/ O O
3.6 O O
/ O O
1.7 O O
LFTs O O
wnl O O
12.8 O O
&gt; O O
39.8 O O
&lt; O O
405 O O
83% O O
polys O O
INR O O
1.2 O O
MICROBIOLOGY O O
Blood O O
culture O O
pending O O
(sent) O O
RADIOLOGICAL O O
STUDIES O O
CXR O O
&#8211; O O
no O O
acute O O
abnormalities, O O
severe O O
pectus O O
excavatum O O
and O O
rib O O
deformities O O
noted, O O
unchanged O O
from O O
the O O
prior O O
studies O O
EKG O O
Atrial O O
fibrillation, O O
L O O
axis O O
deviation, O O
narrow O O
QRS, O O
QTc O O
438, O O
incomplete O O
RBBB, O O
no O O
concerning O O
ST O O
segment O O
or O O
T O O
wave O O
changes O O
ASSESSMENT O O
AND O O
PLAN O O
53 O O
yo O O
man O O
with O O
NIDDM O O
and O O
HTN B-HYPERTENSION O
presents O O
with O O
5 O O
days O O
of O O
cough O O
and O O
mild O O
SOB, O O
CXR O O
reveals O O
possible O O
pneumonia, O O
also O O
noted O O
to O O
have O O
new O O
atrial O O
fibrillation. O O
###ATRIAL O O
FIBRILLATION O O
&#8211; O O
per O O
patient, O O
no O O
history O O
of O O
a O O
fib. O O
May O O
have O O
been O O
triggered O O
by O O
pneumonia. O O
No O O
chest O O
pain O O
to O O
suggest O O
recent O O
MI. O O
No O O
sign O O
of O O
PE. O O
Hemodynamically O O
stable. O O
CHADS2 O O
score O O
2, O O
so O O
warfarin O O
is O O
indicated O O
for O O
anticoagulation. O O
Unclear O O
when O O
this O O
rhythm O O
started, O O
so O O
will O O
hold O O
off O O
on O O
cardioversion. O O
- O O
Rate O O
control O O
with O O
po O O
diltiazem O O
- O O
Warfarin O O
for O O
anticoagulation; O O
follow O O
INR O O
- O O
Check O O
TTE, O O
TSH O O
###PNEUMONIA O O
&#8211; O O
afebrile, O O
but O O
has O O
elevated O O
WBC O O
count; O O
also O O
symptomatic O O
cough O O
and O O
SOB, O O
and O O
history O O
of O O
pneumonia O O
several O O
times. O O
Will O O
treat O O
for O O
community-acquired O O
pneumonia. O O
- O O
Levofloxacin O O
750 O O
mg O O
daily; O O
plan O O
for O O
10 O O
day O O
course O O
(4/28-5/7) O O
- O O
Check O O
sputum O O
and O O
blood O O
cultures O O
###DIABETES B-DIABETES O
MELLITUS I-DIABETES O
&#8211; O O
RISS, O O
FSG; O O
hold B-MEDICATION O
metformin I-MEDICATION B-MEDICATION
###HYPERTENSION B-HYPERTENSION O
&#8211; O O
will O O
switch B-MEDICATION O
lisinopril I-MEDICATION B-MEDICATION
to I-MEDICATION O
captopril B-MEDICATION B-MEDICATION
12.5 O O
mg O O
tid; O O
also O O
getting O O
diltiazem O O
as O O
above O O
###DYSLIPIDEMIA B-HYPERLIPIDEMIA O
&#8211; O O
simvastatin B-MEDICATION B-MEDICATION
20 O O
mg O O
daily O O
(does O O
not O O
know O O
home O O
dose) O O
###PROPHYLAXIS: O O
GI: O O
none O O
DVT: O O
dalteparin O O
BOWEL: O O
Colace/Senna O O
prn O O
FEN: O O
Cardiac, O O
ADA O O
1800 O O
calorie O O
DISPO: O O
to O O
home O O
once O O
HR O O
controlled O O
CODE: O O
Full O O
(confirmed O O
&#8211; O O
does O O
not O O
want O O
prolonged O O
intubation) O O
___________________________________ O O
Marion O O
Costa, O O
MD O O
Internal O O
Medicine O O
PGY-1 O O
Pager O O
67531 O O

Record B-SMOKER O
date: O O
2084-06-09 O O
Medicine O O
Attending O O
Admit O O
Note O O
June O O
9, O O
2084 O O
1340 O O
h O O
I O O
interviewed O O
and O O
examined O O
the O O
patient O O
on O O
rounds O O
this O O
morning O O
with O O
Dr. O O
Lilly O O
and O O
with O O
Team O O
E O O
and O O
we O O
reviewed O O
the O O
relevant O O
data O O
and O O
discussed O O
the O O
case O O
in O O
detail. O O
I O O
agree O O
with O O
the O O
findings O O
and O O
recommendations O O
in O O
Dr. O O
Lilly's O O
note, O O
with O O
any O O
small O O
exceptions O O
or O O
points O O
of O O
emphasis O O
noted O O
below. O O
Please O O
refer O O
to O O
it O O
for O O
details O O
of O O
HPI, O O
PMH, O O
medications O O
and O O
allergies, O O
family O O
and O O
social O O
history, O O
laboratory O O
and O O
other O O
data, O O
and O O
ROS. O O
I O O
would O O
only O O
add/emphasize O O
the O O
following: O O
Mr. O O
Gillespie O O
is O O
a O O
53 O O
year-old O O
man O O
with O O
medical O O
history O O
that O O
includes: O O
h/p O O
Hodgkin&#8217;s O O
lymphoma, O O
2070-2071, O O
treated O O
with O O
local O O
resection, O O
bleomycin, O O
adriamycin, O O
and O O
other O O
agents, O O
XRT O O
to O O
a O O
wide O O
chest O O
field O O
Atrial O O
fibrillation O O
- O O
diagnosed O O
in O O
3/84; O O
on O O
warfarin, O O
metoprolol B-MEDICATION B-MEDICATION
Pectus O O
excavatum O O
&#8211; O O
repair O O
failed O O
as O O
a O O
child O O
Pneumonia O O
several O O
times O O
in O O
the O O
past O O
Central B-OBESE O
obesity I-OBESE O
&#8211; O O
weighs O O
about O O
315#, O O
down O O
from O O
a O O
high O O
of O O
360# O O
Type B-DIABETES O
II I-DIABETES O
diabetes I-DIABETES O
mellitus, I-DIABETES O
last O O
A1C O O
6.4, O O
on O O
metformin B-MEDICATION B-MEDICATION
only, O O
1000 O O
mg O O
BID O O
Hypertension, B-HYPERTENSION O
on O O
lisinopril B-MEDICATION B-MEDICATION
10 O O
mg, O O
Toprol B-MEDICATION B-MEDICATION
XL I-MEDICATION O
Elevated B-HYPERLIPIDEMIA O
lipids I-HYPERLIPIDEMIA O
- O O
on O O
statin B-MEDICATION O
Neurofibromatosis O O
(Soft O O
tissue O O
mass O O
in O O
right O O
apex O O
noted O O
on O O
3/84 O O
CT O O
may O O
be O O
neurogenic O O
tumor.) O O
Kidney O O
stones O O
Patent O O
foramen O O
ovale O O
He O O
presents O O
with O O
dyspnea, O O
orthopnea, O O
and O O
palpitations O O
as O O
described O O
by O O
Dr. O O
Lilly, O O
and O O
was O O
found O O
to O O
be O O
in O O
atrial O O
fibrillation/flutter O O
with O O
rapid O O
ventricular O O
response. O O
He O O
has O O
improved O O
with O O
heart O O
rate O O
control. O O
Exam O O
VS O O
- O O
as O O
noted O O
General O O
- O O
pleasant O O
obese B-OBESE O
white O O
man O O
with O O
severe O O
pectus O O
deformity. O O
Breathing O O
with O O
abdominal O O
muscles O O
tensed O O
on O O
expiration. O O
CV O O
- O O
heart O O
with O O
regular O O
rhythm, O O
normal O O
S1, O O
prominent O O
S2, O O
and O O
no O O
murmurs, O O
rubs, O O
or O O
gallops O O
Lungs O O
- O O
clear O O
Abdomen O O
- O O
obese O O
Extremities O O
- O O
minimal O O
edema O O
Data O O
- O O
reviewed O O
in O O
detail O O
and O O
are O O
as O O
in O O
Dr. O O
Lilly's O O
note. O O
Bicarb O O
31, O O
BNP O O
2050, O O
WBC O O
15, O O
INR O O
3.1. O O
Impression: O O
Poorly O O
tolerated O O
atrial O O
fibrillation/flutter O O
with O O
RVR, O O
needing O O
better O O
rate O O
control. O O
Given O O
the O O
severe O O
pectus O O
deformity O O
as O O
well O O
as O O
his O O
history O O
of O O
lung-toxic O O
chemotherapy O O
drugs O O
and O O
XRT, O O
he O O
may O O
have O O
some O O
restrictive O O
lung O O
disease O O
that O O
would O O
limit O O
his O O
cardiopulmonary O O
reserve. O O
I O O
would O O
not O O
be O O
surprised O O
if O O
he O O
additionally O O
has O O
obstructive O O
lung O O
disease, O O
given O O
the O O
'belly O O
breathing' O O
and O O
the O O
wheezing O O
he O O
had O O
last O O
admission. O O
Recommendations: O O
Increase O O
metoprolol O B-MEDICATION
dose. O O
May O O
need O O
Toprol O B-MEDICATION
XL O O
100 O O
BID. O O
Best O O
to O O
maximize O O
utility O O
of O O
BB O O
prior O O
to O O
adding O O
other O O
agents. O O
Filter O O
all O O
IVs O O
(PFO) O O
PFTs O O
and O O
Pulmonology O O
consult O O
as O O
an O O
outpatient O O
Balance O O
of O O
plan O O
per O O
Dr. O O
Lilly. O O
Peter O O
Wiggins, O O
MD, O O
PhD O O
pager O O
32089 O O

Record O O
date: O O
2084-06-15 O O
PATIENT: O O
Patrick O O
Gillespie O O
MRN: O O
2571454 O O
ADMIT B-DIABETES O
DATE: O O
6/13/84 O O
TRANSFER O O
DATE: O O
6/15/84 O O
ATTN: O O
Wright O O
Reason O O
for O O
admission/transfer: O O
aflutter O O
starting O O
on O O
sotalol B-MEDICATION O
HPI O O
Please O O
see O O
admission O O
note O O
for O O
full O O
details. O O
In O O
brief, O O
this O O
is O O
a O O
54 O O
y/o O O
M O O
hx O O
neurofibromatosis, O O
Hodgkin's O O
lymphoma O O
s/p O O
chemo/XRT O O
in O O
the O O
70s, O O
DMII B-DIABETES O
(A1c O O
6.5 O O
in O O
03/84), O O
HTN, B-HYPERTENSION O
obesity B-OBESE O
and O O
new O O
diagnosis O O
of O O
Afib, O O
recently O O
discharged O O
from O O
the O O
Mediquik O O
2 O O
days O O
prior O O
to O O
readmission O O
6/13 O O
where O O
he O O
was O O
being O O
treated O O
for O O
AF O O
w/ O O
RVR. O O
His O O
toprol B-MEDICATION O
was O O
increased O O
from O O
100mg O O
dily O O
to O O
100mg O O
BID O O
at O O
that O O
time. O O
Prior O O
w/u O O
w/ O O
fairly O O
nl O O
TTE O O
and O O
nl O O
TSH. O O
Now O O
returned O O
for O O
his O O
third O O
admission O O
with O O
AF O O
w/ O O
RVR, O O
rates O O
into O O
the O O
140s. O O
He O O
is O O
considerably O O
symptomatic O O
with O O
the O O
AF O O
w/ O O
palpitations, O O
lightheadedness, O O
dyspnea, O O
and O O
diaphoresis. O O
HD O O
stable. O O
He O O
has O O
been O O
on O O
increasing O O
doses O O
of O O
Toprol B-MEDICATION O
without O O
effect O O
given O O
this O O
is O O
his O O
third O O
admission. O O
MEDICAL O O
HISTORY O O
NIDDM B-DIABETES O
HTN O O
HL B-HYPERLIPIDEMIA O
Neurofibromatosis O O
Pectus O O
excavatum O O
H/o O O
Hodgkin's O O
disease O O
- O O
diagnosed O O
in O O
2070; O O
s/p O O
XRT, O O
chemo O O
(bleomycin, O O
adriamycin, O O
vincristine, O O
DTIC), O O
and O O
surgical O O
resection; O O
oncologist O O
Dr. O O
Bass O O
at O O
MAC O O
ALLERGIES: O O
IV O O
contrast O O
For O O
social B-SMOKER O
history/ O O
family O O
history/ O O
meds O O
on O O
admission O O
please O O
see O O
admission O O
note. O O
HOSPITAL O O
COURSE: O O
PAF/ O O
Flutter: O O
In O O
the O O
Ed, O O
he O O
had O O
been O O
given O O
IV O O
lopressor B-MEDICATION B-MEDICATION
5mg O O
w/ O O
25mg O O
PO O O
lopressor O B-MEDICATION
w/o O O
improvement O O
and O O
then O O
was O O
given O O
10mg O O
IV O O
dilt B-MEDICATION O
which O O
brought O O
HR O O
down O O
to O O
90s. O O
He O O
was O O
also O O
given O O
0.5mg O O
digoxin O O
for O O
possible O O
dig O O
load. O O
Given O O
he O O
was O O
failing O O
on O O
Toprol O B-MEDICATION
100mg O O
BID O O
his O O
medications O O
were O O
switched O O
to O O
diltiazem B-MEDICATION O
60mg O O
q6hr O O
to O O
see O O
if O O
a O O
different O O
drug O O
class O O
might O O
help. O O
Cardiology/ O O
EP O O
was O O
consulted O O
for O O
the O O
possibility O O
of O O
ablation O O
given O O
this O O
was O O
his O O
third O O
admission O O
and O O
he O O
is O O
so O O
symptomatic. O O
EP O O
decided O O
to O O
start O O
the O O
patient O O
on O O
sotalol O O
80-mg O O
BID O O
with O O
the O O
plan O O
to O O
increase O O
sotalol O O
to O O
120mg O O
BID O O
on O O
6/15 O O
if O O
Qtc O O
remains O O
stable O O
( O O
&lt;500 O O
msec). O O
He O O
is O O
planned O O
to O O
received O O
5 O O
doses O O
of O O
sotalol O O
prior O O
to O O
dispo O O
and O O
if O O
he O O
remained O O
in O O
aflutter O O
through O O
6/15 O O
is O O
to O O
get O O
DCCV O O
on O O
6/16. O O
He O O
received O O
his O O
first O O
and O O
only O O
dose O O
in O O
the O O
pm O O
6/14. O O
Overnight O O
he O O
was O O
bradycardic O O
into O O
the O O
40s O O
while O O
sleeping. O O
He O O
had O O
a O O
3.5 O O
second O O
pause O O
however O O
on O O
telemetry. O O
His O O
heart O O
rates O O
have O O
ranged O O
from O O
45-60 O O
in O O
AFlutter. O O
BPs O O
90s O O
systolic. O O
Per O O
EP, O O
as O O
pt O O
asleep, O O
will O O
con't O O
sotalol. O O
He O O
is O O
on O O
coumadin O O
for O O
anticoagulation. O O
INR O O
goal O O
2-3. O O
EP(Dr. O O
Moody= O O
fellow) O O
and O O
cards O O
(PRM O O
wright) O O
are O O
following. O O
PUMP: O O
echo O O
04/84 O O
which O O
demonstrated O O
an O O
elongated O O
LA O O
sLVH, O O
EF O O
61%, O O
tr O O
TR, O O
RSVP O O
41, O O
RV O O
nl. O O
On O O
ACEI. O O
PULM: O O
CXR O O
in O O
ED O O
with O O
pulm O O
edema. O O
Given O O
20mg O O
PO O O
lasix O O
x1 O O
for O O
gentle O O
diuresis. O O
On O O
1 O O
L O O
O2 O O
as O O
of O O
am O O
6/15 O O
and O O
lasix O O
10mg O O
Iv O O
x O O
1 O O
again O O
this O O
am O O
6/15. O O
Felt O O
to O O
be O O
related O O
to O O
his O O
AF. O O
He O O
does O O
have O O
a O O
h/o O O
repeated O O
PNAs. O O
On O O
xopenex, O O
flovent. O O
FEN: O O
Mild O O
hyperK O O
in O O
the O O
ED O O
to O O
5.3. O O
Received O O
30g O O
kayexelate. O O
Normalized. O O
NPO O O
at O O
midnight O O
6/15 O O
for O O
possibel O O
DCCV O O
if O O
still O O
planned O O
by O O
E. O O
Isabella O O
Glenn O O
Mathews, O O
MD O O
MSc, O O
Pager O O
43771 O O

Record B-SMOKER O
date: O O
2071-05-31 O O
Walk-in O O
clinic O O
Xian, O O
Imogene O O
81376761 O O
5-31-71 O O
HPI: O O
Ms. O O
Xian O O
is O O
a O O
74-year-old O O
female O O
who O O
presented O O
to O O
clinic O O
this O O
evening O O
for O O
follow O O
up O O
of O O
her O O
diabetes. B-DIABETES O
Patient O O
was O O
last O O
seen O O
in O O
clinic O O
in O O
11-70 O O
after O O
which O O
time O O
she O O
left O O
for O O
Ghana O O
for O O
the O O
past O O
six O O
months. O O
She O O
returned O O
this O O
past O O
Friday O O
but O O
has O O
since O O
run O O
out O O
of O O
insulin. B-MEDICATION O
She O O
states O O
that O O
she O O
has O O
been O O
feeling O O
well O O
and O O
has O O
not O O
had O O
any O O
problems O O
but O O
does O O
not O O
know O O
the O O
amount O O
of O O
insulin O O
that O O
she O O
has O O
been O O
taking. O O
It O O
has O O
been O O
administered O O
to O O
her O O
by O O
a O O
friend O O
in O O
Ghana. O O
Our O O
records O O
show O O
that O O
when O O
she O O
left O O
Ghana O O
she O O
was O O
on O O
a O O
70/30 B-MEDICATION O
of I-MEDICATION O
Humulin, I-MEDICATION O
20 O O
units O O
per O O
day O O
and O O
also O O
600mg O O
of O O
Rezulin B-MEDICATION O
and O O
20mg O O
q.d. O O
of O O
Lipitor. B-MEDICATION B-MEDICATION
REVIEW O O
OF O O
SYSTEMS: O O
Review O O
of O O
systems O O
is O O
positive O O
for O O
insulin B-DIABETES O
dependent I-DIABETES O
diabetes I-DIABETES O
mellitus I-DIABETES O
but O O
other O O
than O O
that O O
Ms. O O
Xian O O
is O O
a O O
fairly O O
healthy O O
woman. O O
PHYSICAL O O
EXAMINATION: O O
On O O
physical O O
exam O O
this O O
evening O O
her O O
pulse O O
is O O
80. O O
Blood B-HYPERTENSION O
pressure I-HYPERTENSION O
was I-HYPERTENSION O
152/80 B-HYPERTENSION O
in I-HYPERTENSION O
her I-HYPERTENSION O
left I-HYPERTENSION O
arm. I-HYPERTENSION O
Blood O O
sugar O O
was O O
262. O O
It O O
should O O
be O O
noted O O
that O O
she O O
has O O
not O O
had O O
any O O
insulin O O
since O O
Sunday. O O
Her O O
weight O O
was O O
116 O O
1/2 O O
which O O
reflects O O
a O O
1/2 O O
lb. O O
weight O O
loss O O
since O O
11-70. O O
Tonight O O
her O O
heart O O
had O O
a O O
regular O O
rate O O
and O O
rhythm O O
at O O
80. O O
Her O O
neck O O
veins O O
were O O
flat. O O
Her O O
lungs O O
were O O
clear O O
to O O
auscultation O O
bilaterally O O
and O O
there O O
was O O
no O O
evidence O O
of O O
peripheral O O
edema. O O
ASSESSMENT: O O
Insulin B-DIABETES O
dependent I-DIABETES O
diabetes I-DIABETES O
mellitus. I-DIABETES O
PLAN: O O
LFTs, O O
A1C, O O
basic O O
panel O O
this O O
evening. O O
Glucotrol O B-MEDICATION
10mg O O
dispense O O
No. O O
60 O O
with O O
1 O O
refill O O
b.i.d. O O
A O O
VNA O O
referral O O
for O O
medication O O
management O O
and O O
patient O O
was O O
instructed O O
to O O
return O O
to O O
the O O
clinic O O
on O O
Saturday O O
6-05 O O
for O O
repeat O O
blood O O
sugar O O
and O O
also O O
to O O
bring O O
her O O
glucometer O O
at O O
that O O
time O O
so O O
that O O
it O O
could O O
be O O
calibrated O O
correctly. O O
________________________________ O O
Grace O O
Vann, O O
R.N.P. O O
DG:WA:1749 O O
DD:5-31-71 O O
DT:6-1-71 O O
DV:5-31-71 O O

Record B-SMOKER O
date: O O
2072-07-30 O O
SCHLESWIG O O
COUNTY O O
CLINIC O O
Walk-in O O
clinic O O
24 O O
Weld O O
St O O
Grandview, O O
NE O O
13472 O O
Xian, O O
Imogene O O
64187177 O O
07/30/72 O O
CHIEF O O
COMPLAINT: O O
Ms. O O
Xian O O
is O O
a O O
75-year-old O O
female O O
who O O
presented O O
to O O
the O O
walk-in O O
clinic O O
this O O
evening O O
as O O
a O O
walk-in O O
with O O
a O O
chief O O
complaint O O
of O O
bilateral O O
foot O O
pain O O
especially O O
in O O
the O O
toe O O
area, O O
and O O
she O O
says O O
that O O
this O O
has O O
been O O
going O O
on O O
for O O
approximately O O
two O O
months. O O
ALLERGIES: O O
She O O
denies O O
any O O
known O O
drug O O
allergies. O O
MEDICATIONS: O O
At O O
present, O O
she O O
is O O
taking O O
Glucophage B-MEDICATION B-MEDICATION
500 O O
mg O O
one O O
p.o. O O
q.a.m, O O
two O O
p.o. O O
q.p.m., O O
Avandia B-MEDICATION B-MEDICATION
2 O O
mg O O
one O O
p.o. O O
q.a.m., O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
one O O
p.o. O O
q.d., O O
glipizide B-MEDICATION B-MEDICATION
5 O O
mg O O
two O O
p.o. O O
q.a.m., O O
and O O
two O O
p.o. O O
q.p.m., O O
and O O
Lipitor B-MEDICATION B-MEDICATION
20 O O
mg O O
q.d. O O
REVIEW O O
OF O O
SYSTEMS: O O
The O O
patient O O
states O O
that O O
she O O
has O O
had O O
constant O O
pain O O
in O O
her O O
toes O O
and O O
at O O
times O O
with O O
a O O
feeling O O
of O O
tingling. O O
Otherwise, O O
she O O
states O O
she O O
has O O
been O O
feeling O O
well. O O
She O O
denies O O
any O O
chest O O
pain O O
or O O
heart O O
palpitation. O O
She O O
denies O O
any O O
shortness O O
of O O
breath. O O
She O O
denies O O
any O O
nausea, O O
vomiting O O
or O O
diarrhea. O O
She O O
denies O O
any O O
frequency, O O
dysuria O O
or O O
thirst. O O
She O O
has O O
a O O
history O O
of O O
non- B-DIABETES O
insulin-dependent I-DIABETES O
diabetes B-DIABETES O
at O O
this O O
time. O O
PHYSICAL O O
EXAMINATION: O O
Her O O
temperature O O
was O O
98.5 O O
degrees O O
p.o., O O
her O O
pulse O O
was O O
80, O O
her O O
blood O O
pressure O O
was O O
118/60 O O
in O O
her O O
right O O
arm. O O
Her O O
weight O O
was O O
117 O O
pounds, O O
which O O
reflects O O
a O O
one-pound O O
weight O O
loss O O
since O O
her O O
last O O
visit. O O
Her O O
blood O O
sugar, O O
which O O
was O O
random, O O
was O O
159, O O
her O O
last O O
meal O O
being O O
at O O
12 O O
noon. O O
Her O O
son, O O
who O O
accompanied O O
her O O
states O O
that O O
it O O
is O O
questionable O O
whether O O
she O O
is O O
taking O O
her O O
medications O O
as O O
instructed O O
and O O
voiced O O
an O O
interest O O
in O O
having O O
his O O
mother O O
take O O
insulin, O O
which O O
she O O
has O O
taken O O
in O O
the O O
past. O O
Her O O
heart O O
had O O
a O O
regular O O
rate O O
and O O
rhythm O O
at O O
80. O O
There O O
was O O
no O O
evidence O O
of O O
any O O
peripheral O O
edema. O O
Examination O O
of O O
her O O
toes O O
revealed O O
presence O O
of O O
some O O
tinea O O
interdigitally. O O
ASSESSMENT: O O
1. O O
Non-insulin-dependent B-DIABETES O
diabetes I-DIABETES O
mellitus, I-DIABETES O
moderate O O
control. O O
2. O O
Tinea O O
pedis. O O
PLAN: O O
Medication O O
refills O O
were O O
given O O
for O O
Glucotrol B-MEDICATION B-MEDICATION
5 O O
mg O O
dispensed O O
No. O O
120 O O
with O O
two O O
refills, O O
two O O
p.o. O O
q.a.m., O O
two O O
p.o. O O
q.p.m., O O
Glucophage O B-MEDICATION
500 O O
mg O O
No. O O
90 O O
one O O
p.o. O O
q.a.m., O O
two O O
p.o. O O
q.p.m., O O
and O O
Avandia O B-MEDICATION
2 O O
mg O O
No. O O
30 O O
with O O
two O O
refills O O
one O O
p.o. O O
q.a.m., O O
and O O
a O O
new O O
prescription O O
for O O
Lotrimin O O
AF O O
1% O O
cream O O
dispensed O O
12 O O
g O O
with O O
one O O
refill, O O
apply O O
to O O
the O O
affected O O
area O O
b.i.d. O O
for O O
up O O
to O O
four O O
weeks. O O
Xian, O O
Imogene O O
64187177 O O
07/30/72 O O
Page O O
2 O O
The O O
patient O O
has O O
an O O
appointment O O
scheduled O O
with O O
her O O
primary O O
care O O
provider O O
Dr. O O
Paul O O
Shaw O O
for O O
8/16/72, O O
and O O
was O O
advised O O
to O O
keep O O
that O O
appointment. O O
Grace O O
Vann, O O
N.P. O O
GV:arreola:06:278:08;37-60093.doc;DD:07/30/72;DT:08/01/72;DV:07/30/72; O O

Record B-SMOKER O
date: O O
2073-05-29 O O
Internal O O
Medicine O O
97 O O
Weld O O
St O O
Xian, O O
Imogene O O
Grandview, O O
NE O O
13472 O O
81376761 O O
(552) O O
598-5590 O O
05/29/73 O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS: O O
Ms. O O
Xian O O
is O O
75 O O
years O O
of O O
age. O O
She O O
has O O
adult-onset B-DIABETES O
diabetes, B-DIABETES O
which O O
in O O
the O O
past O O
has O O
required O O
treatment O O
with O O
insulin. B-MEDICATION O
She O O
has O O
been O O
managed O O
with O O
oral O O
hypoglycemics O O
because O O
of O O
her O O
reticence O O
to O O
using O O
injections. O O
She O O
also O O
has O O
a O O
history O O
of O O
CVA. O O
I O O
last O O
saw O O
her O O
in O O
August O O
of O O
last O O
year. O O
She O O
was O O
seen O O
by O O
Ms. O O
Vann, O O
our O O
nurse O O
practitioner O O
in O O
early O O
May. O O
CURRENT O O
MEDICATIONS: O O
Glipizide B-MEDICATION B-MEDICATION
5 O O
mg O O
two O O
in O O
the O O
morning O O
and O O
two O O
in O O
the O O
evening, O O
Plavix B-MEDICATION B-MEDICATION
75 O O
mg O O
one O O
p.o. O O
q.d., O O
and O O
Avandia B-MEDICATION O
2 O O
mg O O
one O O
p.o. O O
q.a.m. O O
According O O
to O O
Ms. O O
Vann's O O
note O O
of O O
Apr O O
29, O O
2073, O O
she O O
is O O
also O O
supposed O O
to O O
be O O
taking O O
metformin B-MEDICATION B-MEDICATION
500 O O
mg O O
one O O
in O O
the O O
morning O O
and O O
two O O
with O O
the O O
evening O O
meal O O
as O O
was O O
prescribed O O
back O O
in O O
2072. O O
The O O
patient O O
and O O
her O O
son O O
today O O
are O O
not O O
sure O O
that O O
she O O
is O O
taking O O
this O O
medication. O O
In O O
fact, O O
they O O
believe O O
that O O
she O O
is O O
not. O O
There O O
has O O
been O O
moderate O O
polyuria O O
and O O
polydipsia. O O
Control O O
of O O
diabetes O O
has O O
been O O
erratic. O O
Hemoglobin O O
A1c O O
has O O
been O O
elevated. O O
On O O
Apr O O
29, O O
2073, O O
blood O O
glucose O O
was O O
274, O O
BUN O O
was O O
25, O O
creatinine O O
1.0, O O
electrolytes O O
within O O
normal O O
limits O O
as O O
was O O
calcium. O O
Cholesterol B-HYPERLIPIDEMIA O
was I-HYPERLIPIDEMIA O
315. I-HYPERLIPIDEMIA O
Hemoglobin B-DIABETES O
A1c I-DIABETES O
10.6. I-DIABETES O
The O O
patient O O
has O O
not O O
experienced O O
chest O O
pain, O O
palpitations O O
but O O
she O O
is O O
moderately O O
short O O
of O O
breath O O
when O O
climbing O O
stairs. O O
There O O
has O O
been O O
no O O
orthopnea O O
and O O
no O O
PND. O O
She O O
denies O O
dysuria O O
and O O
urgency O O
and O O
has O O
not O O
experienced O O
near O O
syncope. O O
She O O
denies O O
nausea, O O
vomiting, O O
diarrhea, O O
and O O
constipation. O O
PHYSICAL O O
EXAMINATION: O O
On O O
physical O O
examination O O
today, O O
she O O
appears O O
well. O O
Blood O O
pressure O O
122/66. O O
The O O
heart O O
rate O O
is O O
90 O O
and O O
regular, O O
weight O O
113 O O
pounds, O O
approximately O O
five O O
pounds O O
less O O
than O O
last O O
year. O O
Random O O
blood O O
glucose O O
was O O
224. O O
The O O
patient O O
suffered O O
a O O
minor O O
CVA O O
back O O
in O O
September O O
2071. O O
She O O
denies O O
any O O
recurrence O O
of O O
motor O O
deficits O O
or O O
symptoms O O
suggestive O O
of O O
TIA. O O
The O O
patient O O
has O O
a O O
past O O
history O O
of O O
hyperthyroidism O O
that O O
was O O
treated O O
with O O
iodine O O
131. O O
She O O
has O O
not O O
been O O
hypothyroid O O
since O O
then. O O
In O O
fact, O O
the O O
last O O
TSH O O
level O O
was O O
0.05 O O
in O O
August O O
of O O
last O O
year, O O
just O O
prior O O
to O O
her O O
departure O O
to O O
Ghana. O O
She O O
denies O O
heat O O
intolerance O O
as O O
well O O
as O O
palpitations. O O
On O O
physical O O
examination, O O
she O O
is O O
a O O
small O O
lady O O
in O O
no O O
acute O O
distress. O O
The O O
neck O O
veins O O
are O O
flat. O O
The O O
extraocular O O
movements O O
are O O
full. O O
There O O
are O O
no O O
symptoms O O
of O O
hyperthyroidism. O O
The O O
chest O O
is O O
clear O O
to O O
auscultation. O O
The O O
heart O O
sounds O O
are O O
regular. O O
There O O
are O O
no O O
rubs O O
or O O
gallops. O O
The O O
lower O O
extremities O O
are O O
free O O
of O O
edema O O
and O O
now O O
her O O
toes O O
are O O
free O O
of O O
fungi O O
but O O
the O O
nails O O
are O O
overgrown O O
and O O
require O O
attention. O O
ASSESSMENT O O
AND O O
PLAN: O O
A O O
76 O O
year O O
old O O
woman O O
with O O
a O O
past O O
history O O
of O O
hyperthyroidism, O O
which O O
was O O
treated O O
with O O
I-131 O O
with O O
good O O
results O O
who, O O
last O O
year O O
before O O
she O O
left O O
the O O
country, O O
had O O
a O O
subnormal O O
TSH. O O
She O O
does O O
not O O
have O O
obvious O O
symptoms O O
of O O
hyperthyroidism O O
but O O
today O O
I O O
have O O
obtained O O
a O O
repeat O O
TSH O O
as O O
well O O
as O O
T3 O O
and O O
T4. O O
Diabetes B-DIABETES O
continues O O
to O O
be O O
a O O
problem. O O
Glycemic O O
control O O
continues O O
to O O
be O O
difficult O O
to O O
achieve. O O
Today, O O
I O O
have O O
reinstated B-MEDICATION O
metformin I-MEDICATION B-MEDICATION
at O O
500 O O
mg O O
p.o. O O
q.d. O O
The O O
son O O
is O O
going O O
to O O
check O O
on O O
the O O
medications O O
to O O
make O O
certain O O
that O O
indeed O O
she O O
is O O
not O O
taking O O
this O O
medicine O O
at O O
this O O
point. O O
The O O
other O O
medications O O
were O O
continued. O O
It O O
is O O
indeed O O
possible O O
that O O
she O O
will O O
need O O
insulin O O
in O O
the O O
near O O
future. O O
I O O
plan O O
close O O
followup O O
and O O
will O O
see O O
her O O
again O O
in O O
six O O
weeks' O O
time. O O
If O O
she O O
is O O
hyperthyroid, O O
this O O
may O O
also O O
explain O O
the O O
difficulty O O
in O O
achieving O O
glycemic O O
control. O O
Against O O
this O O
is O O
the O O
high O O
cholesterol. O O
She O O
used B-MEDICATION O
to I-MEDICATION O
be I-MEDICATION O
on I-MEDICATION O
Lipitor, I-MEDICATION B-MEDICATION
which O O
was O O
discontinued O O
during O O
her O O
trip O O
to O O
Ghana. O O
I O O
have O O
reinstated B-MEDICATION O
the I-MEDICATION O
Lipitor I-MEDICATION B-MEDICATION
today O O
20 O O
mg O O
p.o. O O
q.d. O O
I O O
have O O
also O O
added O O
a O O
small O O
dose O O
of O O
enalapril B-MEDICATION O
2.5 O O
mg O O
p.o. O O
q.d. O O
to O O
protect O O
her O O
kidneys O O
even O O
though O O
she O O
is O O
not O O
hypertensive. O O
______________________________ O O
Kevin O O
Shamar-Trevino, O O
M.D. O O
eScription O O
document:0-389401 O O
NFFocus O O
DD: O O
05/29/73 O O
DT: O O
05/30/73 O O
DV: O O
05/29/73 O O

Record O O
date: O O
2080-06-15 O O
Walk-in O O
visit O O
because O O
of O O
Pt O O
of O O
Dr O O
Shamar O O
Seen O O
in O O
the O O
EW O O
bo O O
HA O O
, O O
work O O
up O O
negative. O O
Basicallty O O
the O O
diagnosis O O
was O O
anxiety. O O
It O O
seems O O
she's O O
very O O
lonely O O
here, O O
lives O O
with O O
son O O
who O O
works O O
long O O
hours. O O
In O O
the O O
EW O O
it O O
was O O
recommended O O
she O O
antecipates O O
her O O
trip O O
to O O
Ghana O O
because O O
she O O
feels O O
much O O
better O O
there. O O
Sent O O
for O O
fup O O
with O O
pcp O O
. O O
Symtpoms O O
all O O
resolved O O
. O O
Son O O
needs O O
a O O
letter O O
to O O
antecipate O O
her O O
airplane O O
ticket O O
She O O
ahs O O
no O O
new O O
complaints. O O
Problems O O
TOXIC O O
NODULAR O O
GOITER O O
ARTHRITIS O O
CVA O O
: O O
In O O
year O O
2071. O O
Hyperthyroidism O O
: O O
I-131 O O
5 O O
years O O
ago. O O
Insulin B-DIABETES O
dependent I-DIABETES O
diabetic I-DIABETES O
Hyperlipidemia B-HYPERLIPIDEMIA O
Hypertension B-HYPERTENSION O
h/o O O
urosepsis O O
Medications O O
Actos B-MEDICATION B-MEDICATION
(PIOGLITAZONE) O O
15 O O
MG O O
(15MG O O
TABLET O O
Take O O
1) O O
PO O O
q.d. O O
#90 O O
Tablet(s) O O
Calcium O O
+ O O
D O O
(600 O O
MG O O
ELEM O O
CA) O O
(CALCIUM O O
CARBONATE O O
1500 O O
MG O O
(600 O O
MG O O
ELEM O O
CA)/ O O
VIT O O
D O O
200 O O
IU) O O
1 O O
TAB O O
PO O O
BID O O
#3 O O
Month(s) O O
Supply O O
Enteric O O
COATED O O
ASPIRIN B-MEDICATION B-MEDICATION
(ASPIRIN O O
ENTERIC O O
COATED) O O
81 O O
MG O O
(81MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s) O O
Insulin O B-MEDICATION
NPH B-MEDICATION B-MEDICATION
HUMAN O O
17 O O
UNITS O O
SC O O
as O O
directed O O
, O O
15 O O
units O O
in O O
the O O
morning O O
and O O
5 O O
units O O
at O O
night O O
#3 O O
Month(s) O O
Supply O O
Lancets O O
ONE O O
UNIT O O
(Take O O
1) O O
PO O O
bid O O
x O O
90 O O
days O O
#180 O O
units O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20 O O
MG O O
(20MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s) O O
Lisinopril B-MEDICATION B-MEDICATION
10 O O
MG O O
(20MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
x O O
90 O O
days O O
#90 O O
Tablet(s) O O
Lopressor B-MEDICATION B-MEDICATION
(METOPROLOL O O
TARTRATE) O O
25 O O
MG O O
(25MG O O
TABLET O O
Take O O
1) O O
PO O O
BID O O
#3 O O
Month(s) O O
Supply O O
Micronase B-MEDICATION O
5 O O
MG O O
PO O O
QD O O
#90 O O
Tablet(s) O O
Motrin O O
(IBUPROFEN) O O
400 O O
MG O O
(400MG O O
TABLET O O
Take O O
1) O O
PO O O
BID O O
#30 O O
Tablet(s) O O
Onetocuh O O
Ultra O O
Soft O O
Lancets O O
ONE O O
TOP O O
As O O
directed O O
, O O
Use O O
as O O
directed O O
#1 O O
Box(es) O O
Onetouch O O
Test O O
Strips O O
ONE O O
TOP O O
as O O
directed O O
, O O
Use O O
as O O
directed O O
#1 O O
Box(es) O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
PO O O
QD O O
#90 O O
Tablet(s) O O
Social B-SMOKER O
history: I-SMOKER O
smoking B-SMOKER O
( I-SMOKER O
- I-SMOKER O
) I-SMOKER O
ROS: O O
Constitutional: O O
Feels O O
well. O O
Energy: O O
good. O O
Wt: O O
stable O O
ENT: O O
no O O
hearing O O
loss, O O
no O O
ear O O
pain, O O
no O O
nasal O O
discharge O O
Skin: O O
no O O
rashes, O O
itching O O
CV: O O
no O O
chest O O
pain, O O
no O O
SOB, O O
PND, O O
DOE, O O
no O O
edema O O
Respir: O O
no O O
cough, O O
no O O
wheezing O O
GI: O O
no O O
nausea, O O
no O O
vomiting, O O
no O O
abdominal O O
pain, O O
heart O O
burn, O O
nl O O
BM O O
GU: O O
no O O
dysuria, O O
no O O
frequency, O O
no O O
urgency. O O
PE: O O
Appears O O
well. O O
Legally O O
blind. O O
Vital O O
Signs O O
BP B-HYPERTENSION O
151/68, I-HYPERTENSION O
P O O
88, O O
Wt O O
140 O O
lb O O
FINGER O O
BLOOD O O
GLUCOSE O O
90 O O
O2 O O
sat O O
99 O O
HEENT: O O
NCAT, O O
EOMI O O
Neck: O O
no O O
cervical O O
adenopathy O O
Lungs: O O
clear O O
bilaterally O O
Heart: O O
regular, O O
normal O O
S1 O O
and O O
S2. O O
Abd: O O
Soft, O O
non-tender. O O
Extr: O O
no O O
edema. O O
ASSESMENT O O
AND O O
PLAN: O O
labs O O
reviwed O O
DM B-DIABETES O
: O O
check O O
A!C O O
today O O
HTn B-HYPERTENSION O
: O O
increase O O
lisinopril B-MEDICATION B-MEDICATION
to O O
20 O O
mg, O O
check O O
chem O O
HL; B-HYPERLIPIDEMIA O
check O O
cho O O
profile O O
on O O
lipitor. B-MEDICATION B-MEDICATION
Anxxiety: O O
letter O O
to O O
antecipate O O
her O O
trip O O

Record O O
date: O O
2081-09-06 O O
09/06/81 O O
Follow O O
up O O
after O O
long O O
absence. O O
Pt O O
was O O
seen O O
last O O
week O O
by O O
Dr.Anderson O O
and O O
prior O O
to O O
that O O
she O O
was O O
at O O
Chesterfield O O
ED O O
and O O
prior O O
to O O
that O O
her O O
son O O
reports O O
that O O
she O O
had O O
been O O
in O O
Ghanna. O O
I O O
suspect O O
she O O
has O O
been O O
under O O
someone O O
else's O O
care O O
since O O
I O O
never O O
prescribed O O
Glyburide, B-MEDICATION B-MEDICATION
Actos B-MEDICATION B-MEDICATION
and O O
Insulin. B-MEDICATION B-MEDICATION
The O O
last O O
time O O
I O O
saw O O
her O O
in O O
January O O
I O O
discontinued B-MEDICATION O
Metformin B-MEDICATION B-MEDICATION
because O O
of O O
GI O O
intolerance O O
and O O
her O O
regimen O O
was O O
Insulin O O
only. O O
She O O
did O O
not O O
keep O O
subsequent O O
appointments. O O
She O O
was O O
seen O O
at O O
Chesterfield O O
ED O O
because O O
of O O
pyelonephritis/UTI O O
treated O O
with O O
ceftriaxone O O
and O O
discharged O O
on O O
Nitrofurantoin. O B-MEDICATION
She O O
has O O
now O O
completed O O
the O O
treatment. O O
She O O
feels O O
better O O
although O O
there O O
is O O
still O O
mild O O
dysuria, O O
denies O O
chills O O
and O O
fever. O O
course O O
Problems O O
TOXIC O O
NODULAR O O
GOITER O O
ARTHRITIS O O
CVA O O
: O O
In O O
year O O
2071. O O
Hyperthyroidism O O
: O O
I-131 O O
5 O O
years O O
ago. O O
Insulin B-DIABETES O
dependent I-DIABETES O
diabetic I-DIABETES O
Hyperlipidemia B-HYPERLIPIDEMIA O
Hypertension B-HYPERTENSION O
h/o O O
urosepsis O O
Medications O O
Actos O B-MEDICATION
(PIOGLITAZONE) O O
15 O O
MG O O
(15MG O O
TABLET O O
Take O O
1) O O
PO O O
q.d. O O
#30 O O
Tablet(s) O O
Calcium O O
+ O O
D O O
(600 O O
Mg O O
Elem O O
Ca) O O
(CALCIUM O O
Carbonate O O
1500 O O
Mg O O
(600 O O
Mg O O
Elem O O
Ca)/ O O
Vit O O
D O O
200 O O
Iu) O O
1 O O
TAB O O
PO O O
BID O O
#3 O O
Month(s) O O
Supply O O
Clotrimazole O O
1% O O
Cream O O
1 O O
APPLICATION O O
TOP O O
BID, O O
Apply O O
between O O
toes O O
left O O
foot O O
#15 O O
GM O O
TUBE O O
Enteric O O
Coated O O
Aspirin B-MEDICATION B-MEDICATION
(ASPIRIN O O
Enteric O O
Coated) O O
81 O O
MG O O
(81MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s) O O
Insulin O B-MEDICATION
Nph B-MEDICATION B-MEDICATION
Human O O
17 O O
UNITS O O
SC O O
as O O
directed, O O
15 O O
units O O
in O O
the O O
morning O O
and O O
5 O O
units O O
at O O
night O O
#3 O O
Month(s) O O
Supply O O
Lancets O O
ONE O O
UNIT O O
(Take O O
1) O O
PO O O
bid O O
x O O
90 O O
days O O
#180 O O
units O O
Levofloxacin O O
500 O O
MG O O
(500MG O O
TABLET O O
Take O O
1) O O
PO O O
Q48H O O
#3 O O
Tablet(s) O O
Lipitor B-MEDICATION B-MEDICATION
(ATORVASTATIN) O O
20 O O
MG O O
(20MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
#90 O O
Tablet(s) O O
Lisinopril B-MEDICATION B-MEDICATION
20 O O
MG O O
(20MG O O
TABLET O O
Take O O
1) O O
PO O O
QD O O
x O O
90 O O
days O O
#90 O O
Tablet(s) O O
Lopressor B-MEDICATION B-MEDICATION
(METOPROLOL O O
Tartrate) O O
25 O O
MG O O
(25MG O O
TABLET O O
Take O O
1) O O
PO O O
BID O O
#3 O O
Month(s) O O
Supply O O
Micronase B-MEDICATION O
5 O O
MG O O
PO O O
QD O O
#30 O O
Tablet(s) O O
Motrin O O
(IBUPROFEN) O O
400 O O
MG O O
(400MG O O
TABLET O O
Take O O
1) O O
PO O O
BID O O
#30 O O
Tablet(s) O O
One O O
Touch O O
Glucometer O O
1 O O
(Take O O
1) O O
PO O O
bid O O
#1 O O
Unit O O
Onetocuh O O
Ultra O O
Soft O O
Lancets O O
ONE O O
TOP O O
As O O
directed, O O
Use O O
as O O
directed O O
#1 O O
Box(es) O O
Plavix B-MEDICATION B-MEDICATION
(CLOPIDOGREL) O O
75 O O
MG O O
PO O O
QD O O
#90 O O
Tablet(s) O O
Soc O O
Hx: O O
Smoking B-SMOKER O
(-) I-SMOKER O
ROS: O O
all O O
other O O
systems O O
were O O
reviewed O O
and O O
are O O
negative. O O
PE: O O
Appears O O
elderly O O
but O O
in O O
no O O
distress.. O O
Comes O O
accompanied O O
by O O
son. O O
Lungs: O O
clear O O
bilaterally O O
Heart: O O
regular, O O
normal O O
S1 O O
and O O
S2. O O
Abd: O O
Soft, O O
non-tender, O O
no O O
CVA O O
tenderness O O
ASSESMENT O O
AND O O
PLAN: O O
UTI: O O
Reculture O O
now O O
post O O
Rx O O
DM: B-DIABETES O
she O O
did O O
not O O
tolerate O O
Metformin. O B-MEDICATION
I O O
have O O
DC B-MEDICATION O
Actos I-MEDICATION O
and O O
kept B-MEDICATION O
her I-MEDICATION O
on I-MEDICATION O
Glyburide I-MEDICATION O
and O O
current O O
dose O O
of O O
insulin. B-MEDICATION O
Instructed O O
son O O
to O O
call O O
if O O
hypoglycemic O O
or O O
if O O
Sx O O
of O O
UTI O O
reccur. O O
Plan O O
to O O
see O O
her O O
in O O
one O O
week O O
and O O
will O O
then O O
DC O O
Glyburide. O O
Son O O
denies O O
taking O O
her O O
to O O
another O O
MD. O O
I O O
will O O
obtain O O
a O O
second O O
urine O O
culture O O
and O O
sensitivities O O
. O O
Kevin O O
P. O O
Shamar O O
MD O O

Record B-SMOKER O
date: O O
2129-08-20 O O
July O O
06, O O
2129 O O
Robert O O
Trejo, O O
M.D. O O
17 O O
Unicorn O O
Way O O
Suite O O
353 O O
Chickasha, O O
NC O O
75156 O O
RE: O O
Tyler O O
Pearson O O
WMC#727-19-02 O O
Dear O O
Doctor O O
Trejo: O O
I O O
had O O
the O O
pleasure O O
of O O
seeing O O
our O O
mutual O O
patient, O O
Mr. O O
Tyler O O
Pearson, O O
in O O
follow O O
up O O
evaluation O O
in O O
our O O
vascular O O
surgery O O
clinic O O
here O O
today. O O
As O O
you O O
will O O
remember O O
he O O
recently O O
underwent O O
right O O
carotid O O
endarterectomy O O
with O O
Dacron O O
patch O O
angioplasty O O
after O O
treatment O O
of O O
a O O
severe O O
underlying O O
pneumonia. O O
He O O
returns O O
today O O
reporting O O
that O O
he O O
is O O
doing O O
well O O
from O O
a O O
neurologic O O
standpoint. O O
He O O
has O O
had O O
no O O
focal, O O
motor, O O
sensory O O
deficits, O O
and O O
no O O
amaurosis O O
fugax. O O
A O O
follow O O
up O O
duplex O O
examination O O
performed O O
in O O
our O O
vascular O O
laboratory O O
reveals O O
mild O O
right O O
ICA O O
disease O O
after O O
his O O
carotid O O
endarterectomy O O
with O O
moderate O O
left O O
ICA O O
stenosis O O
which O O
should O O
be O O
followed O O
over O O
time. O O
Assessment O O
and O O
plan: O O
Overall, O O
I O O
am O O
extremely O O
pleased O O
with O O
Mr. O O
Pearson's O O
outcome O O
given O O
his O O
high O O
risk O O
pulmonary O O
status. O O
It O O
would O O
be O O
prudent O O
to O O
see O O
him O O
again O O
in O O
follow O O
up O O
evaluation O O
in O O
six O O
months' O O
time O O
with O O
a O O
repeat O O
carotid O O
duplex O O
examination. O O
I O O
would O O
be O O
happy O O
to O O
assist O O
in O O
the O O
management O O
of O O
this O O
or O O
any O O
of O O
your O O
other O O
patients O O
as O O
you O O
deem O O
necessary O O
in O O
the O O
future. O O
Thank O O
you O O
again O O
for O O
allowing O O
me O O
to O O
assist O O
in O O
his O O
care. O O
If O O
I O O
can O O
be O O
of O O
any O O
further O O
assistance, O O
please O O
feel O O
free O O
to O O
contact O O
either O O
myself O O
or O O
one O O
of O O
my O O
partners O O
directly. O O
Sincerely, O O
Steven O O
E. O O
Land, O O
M.D. O O
SEL:kerns O O

Record O O
date: O O
2132-05-27 O O
Date O O
5/27/32 O O
Time O O
4am O O
Team O O
E O O
Admission O O
Note O O
Patient: O O
Pearson, O O
Tyler O O
Medical O O
Record O O
Number: O O
727 O O
19 O O
02 O O
Room: O O
J8845I O O
Date O O
of O O
Admission: O O
5/26/32 O O
PCP: O O
Yale O O
Triplett O O
(Turner O O
Clinic) O O
Attending O O
Physician: O O
Arias/Wesley O O
Admitting O O
Intern: O O
Jaquan O O
Mahoney O O
Code O O
Status: O O
FULL O O
CODE O O
Source: O O
Patient, O O
Medical O O
Record O O
ID/CC: O O
87yoM O O
h/o O O
COPD, O O
DM2, B-DIABETES O
CVA O O
p/w O O
SOB, O O
cough. O O
History O O
of O O
Present O O
Illness: O O
Patient O O
w/ O O
severe O O
COPD O O
(PFT O O
not O O
available). O O
Reports O O
coughing O O
x O O
3wks, O O
productive O O
of O O
light, O O
white O O
sputum. O O
Has O O
had O O
intermittent, O O
fluctuating O O
symptoms O O
of O O
cough/DOE O O
since O O
then. O O
10d O O
prior, O O
seen O O
at O O
VGH O O
ED O O
and O O
was O O
discharged O O
w/ O O
prednisone O O
(7d O O
course). O O
He O O
reports O O
that O O
his O O
symptoms O O
never O O
improved O O
on O O
prednisone. O O
At O O
baseline, O O
he O O
is O O
able O O
to O O
walk O O
40-50y O O
flat O O
ground O O
and O O
several O O
flights O O
of O O
stairs; O O
limited O O
by O O
dyspnea. O O
Now, O O
has O O
dyspnea O O
at O O
rest O O
and O O
cannot O O
climb O O
1 O O
flight O O
of O O
stairs. O O
Saw O O
his O O
PCPs O O
NP O O
on O O
the O O
day O O
of O O
admission O O
and O O
was O O
referred O O
to O O
WMC. O O
Denies O O
clear O O
precipitant, O O
denies O O
sick O O
contacts, O O
h/o O O
seasonal O O
allergies. O O
In O O
the O O
ED, O O
VS: O O
T O O
98.1 O O
HR O O
100-114 O O
BP95/55-172/79 B-HYPERTENSION O
RR24-36 O O
O2sat O O
96%4L. O O
He O O
was O O
noted O O
to O O
be O O
visibly O O
dyspneic, O O
wheezes O O
on O O
exam O O
w/ O O
an O O
irregular O O
heartbeat. O O
He O O
was O O
transferred O O
to O O
trauma O O
for O O
close O O
observation O O
of O O
respiratory O O
status, O O
although O O
he O O
did O O
not O O
require O O
PPV O O
or O O
ABG. O O
BNP O O
136, O O
cardiac O O
markers O O
neg O O
x O O
1. O O
WBC O O
returned O O
at O O
17.5. O O
AP O O
CXR O O
was O O
indeterminate O O
for O O
clear O O
PNA. O O
Patient O O
was O O
started O O
on O O
albuterol/atrovent O O
nebs, O O
solumedrol O O
125mg, O O
ceftriaxone/azithromycin O O
for O O
possible O O
PNA. O O
Review O O
of O O
Systems: O O
Chest O O
pressure O O
sensation, O O
muscle O O
tightness O O
, O O
L O O
sided, O O
intermittent O O
lasting O O
only O O
minutes, O O
nonradiating, O O
non-exertional, O O
nonpleuritic, O O
non-positional. O O
Patient O O
denies O O
the O O
following O O
symptoms. O O
CONSTITUTIONAL: O O
f/c/r/sweats, O O
anorexia/weight-loss O O
HEENT: O O
h/a/ear O O
pain/sore O O
throat/rhinorrhea O O
PULM:cough/SOB/DOE O O
CV: O O
chest O O
pain/palpitations/LH O O
dness/LOC/PND/LE O O
swelling O O
ABD:abd O O
px/n/v/constipation/diarrhea/melena/BPR/ O O
bloating O O
GU: O O
dysuria/frequency/urgency O O
SKIN: O O
rash, O O
bruising, O O
mucosal O O
bleeding O O
NEURO: O O
unilateral O O
weakness/paresthesia/dysphasia/dysphagia/visual O O
change. O O
Past O O
Medical/Surgical O O
History: O O
COPD O O
PFTs O O
not O O
in O O
CAS O O
Home O O
O2: O O
2L O O
at O O
baseline O O
(used O O
continuously) O O
No O O
history O O
of O O
intubation O O
Cerebrovascular O O
Disease O O
R O O
ICA O O
stenosis O O
S/p O O
R O O
CEA O O
for O O
symptoms O O
L O O
ICA O O
stenosis O O
F/b O O
Steven O O
Land O O
Avoiding O O
CEA O O
given O O
severe O O
pulmonary O O
disease O O
On O O
ASA, B-MEDICATION O
suggesting O O
addition O O
of O O
plavix O B-MEDICATION
(not O O
currently O O
on) O O
DM2 O O
BPH O O
PTSD O O
Lung O O
CA O O
S/p O O
L O O
lobectomy. O O
Allergies: O O
Tetracycline O O
- O O
unknown O O
Bactrim O O
- O O
unknown O O
Medications O O
(on O O
PCP O O
note O O
as O O
of O O
5/3/32): O O
Tylenol O O
prn O O
Albuterol O O
inh O O
qid O O
prn O O
Albuterol O O
neb O O
qid O O
ECASA B-MEDICATION B-MEDICATION
325 O O
qd O O
Ca O O
+ O O
D O O
250/125 O O
bid O O
Advair O O
250/50 O O
bid O O
Lasix O O
10mg O O
qd O O
Neurontin O O
300mg O O
tid O O
Guaifenesin O O
300mg O O
tid O O
Atrovent O O
inhaler O O
2 O O
puff O O
qid O O
Loratidine O O
10 O O
qd O O
Losartan B-MEDICATION B-MEDICATION
50 O O
qd O O
Zantac O O
150 O O
bid O O
Senna O O
prn O O
Simvastatin B-MEDICATION B-MEDICATION
20 O O
qd O O
Travoprost O O
0.004% O O
OS O O
qhs O O
Social O O
History: O O
Lives O O
in O O
North O O
Wilkesboro O O
w/ O O
wife. O O
Son O O
lives O O
first O O
floor O O
of O O
same O O
house. O O
Wife O O
and O O
family O O
split O O
responsibilities O O
for O O
his O O
care-taking. O O
Has O O
VNA. O O
Former O O
civil O O
engineer, O O
supervisor, O O
consultant. O O
+ O O
asbestos O O
exposure. O O
TOB:3-4ppd B-SMOKER O
x I-SMOKER O
40y. I-SMOKER O
stopped I-SMOKER O
40y I-SMOKER O
prior I-SMOKER O
ETOH: O O
social O O
ILLICITS: O O
none O O
Family O O
History: O O
Denies O O
colon/prostate O O
CA, O O
DM, O O
CVD. O O
Physical O O
Examination: O O
GEN: O O
appropriate, O O
mildly O O
dyspneic, O O
worse O O
with O O
standing O O
up O O
VS: O O
T O O
98.1 O O
P O O
111 O O
BP B-HYPERTENSION O
183/90 I-HYPERTENSION O
RR O O
28 O O
O2SAT O O
94%4L O O
HEENT: O O
MMM, O O
JVP O O
base O O
of O O
neck. O O
Conjunctiva O O
clear. O O
PULM: O O
partially O O
broken O O
sentences; O O
mildly-moderately O O
dyspneic. O O
incr O O
expiratory:inspiratory O O
ratio. O O
Quiet O O
BS O O
bilaterally. O O
Wheezing O O
scattered. O O
CV: O O
no O O
bruits O O
auscultated. O O
Tachy, O O
regular, O O
S1 O O
and O O
S2 O O
normal, O O
no O O
murmurs O O
ABD: O O
soft, O O
NT/ND/NM/NHSM. O O
BS O O
active O O
EXT: O O
no O O
c/c/e, O O
DPs O O
2+ O O
NEURO: O O
MS O O
A&Ox3 O O
SKIN: O O
no O O
rash, O O
good O O
skin O O
turgor O O
Data: O O
NA O O
139 O O
K O O
3.6 O O
CL O O
101 O O
CO2 O O
33.9(H) O O
BUN O O
22 O O
CRE O O
1.2 O O
GLU O O
131(H) O O
CA O O
8.7 O O
PHOS O O
2.7 O O
MG O O
1.6 O O
TBILI O O
0.4 O O
DBILI O O
0.1 O O
TP O O
8.0 O O
ALB O O
3.3 O O
GLOB O O
4.7(H) O O
AMY O O
72 O O
LIPS O O
2.1 O O
ALT/SGPT O O
25 O O
AST/SGOT O O
21 O O
ALKP O O
67 O O
NT-BNP O O
136(T) O O
CK O O
30(L) O O
CK-MB O O
2.9 O O
Negative O O
CKMBRI O O
see O O
detail O O
TROP-I O O
Negative O O
TROP-T O O
&lt;0.01 O O
WBC O O
17.5(H) O O
RBC O O
5.31 O O
HGB O O
14.8 O O
HCT O O
47.1 O O
MCV O O
89 O O
MCH O O
27.9 O O
MCHC O O
31.4 O O
PLT O O
332 O O
RDW O O
15.8(H) O O
DIFFR O O
Received O O
METHOD O O
Auto O O
%NEUT O O
83(H) O O
%LYMPH O O
12(L) O O
%MONO O O
4 O O
%EOS O O
1 O O
%BASO O O
0 O O
ANEUT O O
14.77(H) O O
ALYMP O O
2.02 O O
AMONS O O
0.64(H) O O
AEOSN O O
0.08(L) O O
ABASOP O O
0.03 O O
ANISO O O
None O O
HYPO O O
None O O
MACRO O O
None O O
MICRO O O
None O O
PT O O
13.6(T) O O
PT-INR O O
1.1 O O
PTT O O
25.3 O O
EKG O O
tachycardia, O O
at O O
least O O
two O O
atrial O O
foci. O O
RBBB. O O
CXR O O
L O O
lower O O
lung O O
opacity. O O
Poor O O
film. O O
Impression/Plan: O O
87yoM O O
h/o O O
COPD, O O
vascular O O
disease O O
p/w O O
SOB, O O
cough. O O
Likely O O
COPD O O
flare. O O
High O O
WBC O O
may O O
be O O
steroids, O O
but O O
CXR O O
too O O
poor O O
to O O
rule O O
out O O
PNA. O O
Otherwise, O O
no O O
clear O O
precipitant. O O
Failed O O
steroids O O
as O O
outpatient O O
(dosing O O
unclear). O O
Given O O
level O O
of O O
dyspnea, O O
will O O
treat O O
w/ O O
solumedrol O O
for O O
now, O O
and O O
transition O O
to O O
prednisone O O
when O O
improvement/trajectory O O
is O O
clear. O O
Patient O O
may O O
need O O
a O O
longer O O
taper O O
than O O
over O O
10d. O O
SOB: O O
COPD O O
flare O O
+/- O O
PNA. O O
-repeat O O
CXR O O
in O O
AM. O O
-solumedrol O O
125mg O O
q6 O O
for O O
now. O O
Transition O O
to O O
prednisone O O
1mg/kg O O
when O O
clinically O O
stable. O O
Follow O O
trend, O O
decide O O
on O O
length O O
of O O
taper O O
at O O
later O O
date. O O
-advair, O O
spiriva. O O
Standing O O
albuterol O O
nebs O O
q4 O O
for O O
now. O O
Space O O
nebs O O
when O O
improvement O O
demonstrated. O O
-keep O O
O2 O O
sats O O
88-92% O O
CHEST O O
PRESSURE: O O
follow O O
for O O
now. O O
Would O O
deserve O O
stress. O O
Unless O O
has O O
more O O
activity/symptoms O O
while O O
here, O O
would O O
defer O O
to O O
be O O
done O O
as O O
outpatient. O O
Does O O
have O O
significant O O
risk O O
factors. O O
-ROMI O O
by O O
markers. O O
-telemetry. O O
-ASA, O O
ARB, O O
statin. O O
-start O O
low O O
dose O O
beta-blocker O O
to O O
see O O
if O O
he O O
tolerates. O O
HTN: B-HYPERTENSION O
likely O O
exacerbated O O
by O O
steroids. O O
Will O O
be O O
moving O O
target O O
in O O
setting O O
of O O
changing O O
steroid O O
dose. O O
-c/w O O
home O O
ARB. O O
-start O O
lopressor O B-MEDICATION
25 O O
tid O O
for O O
now. O O
-hydralazine O O
25mg O O
q6h O O
for O O
immediate O O
decrease O O
in O O
BP O O
now. O O
Taper O O
off O O
when O O
able. O O
DM2: O O
no O O
meds O O
from O O
home O O
-RISS, O O
FS O O
qid. O O
-check O O
A1c. O O
FEN: O O
no O O
added O O
salt, O O
low O O
cholesterol/fat, O O
no O O
conc O O
sweets O O
PROPHY: O O
fragmin, O O
zantac. O O
CODE: O O
full O O
code O O
(confirmed O O
w/ O O
patient) O O
DISPO: O O
PT O O
eval. O O
Jaquan O O
Mahoney, O O
MD O O
Pager: O O
#84464 O O

Record O O
date: O O
2132-06-14 O O
Internal O O
Medicine O O
Intern O O
Admission O O
Note O O
Name: O O
Tyler O O
Pearson O O
MR#: O O
7271902 O O
Date O O
of O O
admission: O O
14 O O
June O O
2132 O O
Admitting O O
Intern: O O
Noah O O
Rosario O O
Admitting O O
Junior: O O
Raymond O O
Pack O O
Attending: O O
Frank O O
Ash O O
Chief O O
Complaint: O O
shortness O O
of O O
breath O O
History O O
of O O
Present O O
Illness: O O
Mr. O O
Pearson O O
is O O
a O O
an O O
87 O O
year O O
old O O
gentleman O O
with O O
COPD O O
on O O
home O O
oxygen, O O
CVA, O O
DM, B-DIABETES O
and O O
history O O
of O O
lung O O
cancer O O
s/p O O
resection O O
without O O
chemotherapy O O
who O O
presented O O
to O O
the O O
ED O O
with O O
acute O O
shortness O O
of O O
breath. O O
Of O O
note, O O
he O O
was O O
hospitalized O O
from O O
May O O
26 O O
until O O
May O O
29 O O
for O O
a O O
COPD O O
flare, O O
and O O
was O O
discharged O O
home O O
at O O
that O O
time O O
on O O
a O O
prednisone O O
taper, O O
which O O
he O O
completed O O
about O O
one O O
week O O
ago. O O
He O O
was O O
in O O
his O O
usual O O
state O O
of O O
good O O
health O O
and O O
had O O
even O O
spent O O
the O O
past O O
weekend O O
with O O
family O O
in O O
Connecticut O O
camping. O O
But O O
on O O
the O O
evening O O
of O O
June O O
13 O O
he O O
began O O
to O O
feel O O
short O O
of O O
breath, O O
without O O
cough O O
or O O
chest O O
pain, O O
and O O
the O O
dyspnea O O
was O O
made O O
worse O O
with O O
exertion. O O
Not O O
made O O
worse O O
with O O
lying O O
down. O O
He O O
also O O
had O O
a O O
fever O O
to O O
103, O O
without O O
mental O O
status O O
changes. O O
EMS O O
was O O
called O O
and O O
in O O
the O O
field O O
he O O
was O O
noted O O
to O O
be O O
breathing O O
at O O
a O O
rate O O
in O O
the O O
40s; O O
he O O
was O O
given O O
a O O
dose O O
of O O
IV O O
lasix O O
and O O
he O O
put O O
out O O
600cc O O
of O O
urine. O O
He O O
was O O
then O O
brought O O
to O O
the O O
WMC O O
ED O O
where O O
he O O
continued O O
to O O
display O O
labored O O
breathing, O O
breathing O O
in O O
the O O
40s, O O
afebrile, O O
tachycardic O O
to O O
147bpm. O O
An O O
ABG O O
on O O
BIPAP O O
showed O O
7.35/53/100. O O
His O O
blood O O
pressure O O
dropped O O
from O O
systolic O O
130s O O
to O O
70/50, O O
and O O
so O O
he O O
was O O
subsequently O O
intubated, O O
and O O
a O O
central O O
and O O
arterial O O
lines O O
placed. O O
He O O
was O O
given O O
approximately O O
2L O O
of O O
NS O O
with O O
resultant O O
CVP O O
of O O
11. O O
He O O
was O O
also O O
started O O
on O O
dopamine, O O
which O O
was O O
eventually O O
transitioned O O
to O O
norepinephrine. O O
He O O
was O O
given O O
vancomycin, O O
levaquin, O O
and O O
flagyl, O O
as O O
well O O
as O O
a O O
dose O O
of O O
solumedrol. O O
He O O
was O O
then O O
transferred O O
to O O
the O O
Internal O O
Medicine. O O
Review O O
of O O
Systems: O O
per O O
HPI; O O
no O O
changes O O
in O O
mental O O
status; O O
no O O
cough, O O
chest O O
pain, O O
palpitations; O O
no O O
N/V/C/D; O O
no O O
BRBPR O O
or O O
melena; O O
no O O
sick O O
contacts. O O
Past O O
Medical O O
History O O
COPD O O
on O O
home O O
O2 O O
2LNC O O
at O O
all O O
times, O O
never O O
been O O
intubated O O
Cerebrovascular O O
disease: O O
s/p O O
R O O
CEA, O O
and O O
with O O
L O O
ICA O O
on O O
aspirin B-MEDICATION B-MEDICATION
DM2 B-DIABETES O
Lung O O
cancer: O O
s/p O O
L O O
partial O O
resection O O
BPH O O
PTSD O O
Medications O O
on O O
Admission O O
Albuterol O O
and O O
atrovent O O
nebulizers O O
prn O O
Advair O O
250/50 O O
2puffs O O
bid O O
ASA B-MEDICATION B-MEDICATION
325mg O O
po O O
qd O O
Calcium O O
and O O
vitamin O O
D O O
250mg O O
po O O
bid O O
Lasix O O
10mg O O
po O O
qd O O
Neurontin O O
300mg O O
po O O
tid O O
Guaifenasin O O
10mL O O
tid O O
Zantac O O
150mg O O
po O O
bid O O
Senna O O
2tabs O O
bid O O
Zocor B-MEDICATION B-MEDICATION
20mg O O
po O O
qhs O O
Losartan B-MEDICATION B-MEDICATION
100mg O O
po O O
qd O O
Toprol B-MEDICATION B-MEDICATION
XL O O
100mg O O
po O O
qd O O
Loratidine O B-MEDICATION
10mg O O
po O O
qd O O
Allergies: O O
bactrim O O
and O O
tetracycline, O O
reactions O O
unknown O O
Social O O
History: O O
retired O O
Civil O O
Engineer, O O
positive O O
asbestos O O
exposure; O O
quit B-SMOKER O
smoking I-SMOKER O
30 I-SMOKER O
years I-SMOKER O
ago; I-SMOKER O
no O O
EtOH O O
or O O
illicits O O
Family O O
History: O O
denies O O
any O O
known O O
family O O
history O O
of O O
lung O O
disease, O O
COPD, O O
CAD, O O
or O O
cancer O O
Physical O O
Exam O O
Gen: O O
NAD, O O
appears O O
comfortable O O
VS: O O
T96.1 O O
bp118/60 O O
without O O
pressors O O
P93 O O
CVP O O
6-9 O O
O2sat O O
97% O O
on O O
mechanical O O
ventilation O O
HEENT: O O
R O O
eye O O
not O O
reactive O O
to O O
light; O O
L O O
eye O O
3 O O
2mm O O
with O O
light; O O
EOMI O O
Neck: O O
supple, O O
JVP O O
flat O O
Pulm: O O
ronchi O O
bilaterally O O
without O O
wheezing O O
or O O
crackles O O
Cor: O O
regular, O O
nls1s2, O O
no O O
mumurs O O
Abd: O O
soft, O O
NTND, O O
+BS, O O
no O O
HSM O O
Ext: O O
trace O O
lower O O
edema O O
bilaterally; O O
warm, O O
DP O O
2+ O O
B O O
Neuro: O O
no O O
focal O O
findings, O O
pt O O
appropriate; O O
CN O O
2-12 O O
intact, O O
tongue O O
midlines, O O
strength O O
5/5 O O
all O O
extremities, O O
toes O O
downgoing O O
Labs O O
Date/Time O O
NA O O
K O O
CL O O
CO2 O O
06/14/2132 O O
4.3 O O
06/14/2132 O O
138 O O
4.1 O O
101 O O
29.1 O O
Date/Time O O
BUN O O
CRE O O
GLU O O
06/14/2132 O O
132 O O
(H) O O
06/14/2132 O O
30 O O
(H) O O
1.6 O O
(H) O O
123 O O
(H) O O
Date/Time O O
CA O O
PHOS O O
MG O O
TBILI O O
06/14/2132 O O
9.4 O O
4.1 O O
1.4 O O
0.9 O O
Date/Time O O
DBILI O O
TP O O
ALB O O
GLOB O O
06/14/2132 O O
0.0 O O
6.7 O O
3.4 O O
3.3 O O
Date/Time O O
LACT O O
06/14/2132 O O
1.2 O O
Date/Time O O
TEMP O O
FIO2 O O
bPO2 O O
bPCO2 O O
06/14/2132 O O
37.0 O O
1.00 O O
100 O O
(H) O O
53 O O
(H) O O
Date/Time O O
bPH O O
06/14/2132 O O
7.35 O O
Date/Time O O
ALT/SGPT O O
AST/SGOT O O
ALKP O O
TBILI O O
06/14/2132 O O
16 O O
22 O O
54 O O
0.9 O O
Date/Time O O
NT-BNP O O
CK-MB O O
TROP-I O O
06/14/2132 O O
NEGATIVE O O
NEGATIVE O O
06/14/2132 O O
325 O O
Date/Time O O
PT O O
PT-INR O O
PTT O O
06/14/2132 O O
12.8 O O
1.0 O O
26.8 O O
Date/Time O O
WBC O O
RBC O O
HGB O O
HCT O O
06/14/2132 O O
22.9 O O
(H) O O
4.89 O O
14.1 O O
42.9 O O
Date/Time O O
MCV O O
MCH O O
MCHC O O
PLT O O
06/14/2132 O O
88 O O
28.9 O O
32.9 O O
190 O O
Date/Time O O
DIFFR O O
METHOD O O
%NEUT O O
%LYMPH O O
06/14/2132 O O
RECEIVED O O
Auto O O
82 O O
(H) O O
15 O O
(L) O O
Date/Time O O
UA-GLUC O O
UA-KET O O
UA-SPGR O O
UA-BLD O O
06/14/2132 O O
NEGATIVE O O
NEGATIVE O O
1.015 O O
NEGATIVE O O
Date/Time O O
UA-PH O O
UA-PROT O O
UA-NIT O O
UA-WBC O O
06/14/2132 O O
5.0 O O
NEGATIVE O O
NEGATIVE O O
NEGATIVE O O
06/14/2132 O O
07:10 O O
CXR O O
Right O O
upper O O
lobe O O
and O O
right O O
middle O O
lobe O O
opacity, O O
new O O
since O O
5/27/2132, O O
suspicious O O
for O O
pneumonia. O O
Lines O O
and O O
tubes O O
as O O
described O O
above, O O
without O O
evidence O O
of O O
pneumothorax O O
following O O
left O O
IJ O O
placement. O O
EKG: O O
sinus O O
tachycardia O O
at O O
134bpm; O O
right O O
ventricular O O
hypertrophy; O O
0.5mm O O
ST O O
depression O O
V6 O O
Assessment O O
and O O
Plan O O
Mr. O O
Pearson O O
is O O
a O O
pleasant O O
87 O O
year O O
old O O
gentleman O O
with O O
a O O
history O O
of O O
COPD, O O
never O O
intubated, O O
who O O
presented O O
with O O
one O O
day O O
of O O
dyspnea. O O
He O O
had O O
a O O
fever O O
to O O
103, O O
and O O
presented O O
with O O
hypotension O O
and O O
respiratory O O
distress O O
requiring O O
intubation. O O
He O O
has O O
an O O
elevated O O
wbc O O
and O O
an O O
increased O O
creatinine O O
to O O
1.6; O O
his O O
chest O O
x-ray O O
is O O
consistent O O
with O O
a O O
RUL O O
and O O
RML O O
pneumonia, O O
and O O
he O O
has O O
a O O
low O O
bnp O O
negative O O
for O O
cardiac O O
stretching. O O
His O O
presentation O O
is O O
consistent O O
with O O
sepsis O O
secondary O O
to O O
pneumonia. O O
Sepsis: O O
continue O O
EGDT, O O
with O O
goal O O
MAP&gt;65 O O
and O O
goal O O
CVP O O
of O O
8-12 O O
a. O O
IVF O O
with O O
NS O O
for O O
goal O O
CVP O O
8-12 O O
b. O O
pressors O O
as O O
needed O O
(vasopressin O O
+/- O O
levophed) O O
for O O
goal O O
MAP&gt;65 O O
(currently O O
off O O
pressors) O O
c. O O
monitor O O
urine O O
output O O
d. O O
measure O O
central O O
venous O O
oxygen O O
saturation O O
e. O O
antibiotics O O
for O O
pneumonia: O O
would O O
treat O O
with O O
vancomycin O O
and O O
cefepime, O O
check O O
vancomycin O O
trough O O
tomorrow O O
am O O
f. O O
f/u O O
all O O
culture O O
data O O
g. O O
continue O O
advair O O
250/50 O O
h. O O
no O O
need O O
for O O
steroids O O
currently, O O
and O O
will O O
not O O
check O O
cort-stim O O
in O O
setting O O
of O O
having O O
received O O
solumedrol O O
in O O
ED O O
i. B-MEDICATION O
hold I-MEDICATION O
antihypertensives I-MEDICATION O
(losartan I-MEDICATION O
100mg I-MEDICATION O
qd I-MEDICATION O
and I-MEDICATION O
toprol I-MEDICATION B-MEDICATION
100mg I-MEDICATION O
qd) I-MEDICATION O
in I-MEDICATION O
setting I-MEDICATION O
of I-MEDICATION O
hypotension I-MEDICATION O
ARF: O O
creatinine O O
up O O
to O O
1.6 O O
from O O
baseline O O
of O O
1.1, O O
likely O O
pre-renal O O
etiology O O
in O O
setting O O
of O O
sepsis; O O
will O O
give O O
trial O O
hydration O O
Ppx: O O
ranitidine O O
and O O
heparin O O
_______________________________ O O
Noah O O
G. O O
Rosario O O
Pager O O
81251 O O
PGY-1 O O

Record O O
date: O O
2134-10-28 O O
Team O O
IV O O
Attending O O
Admission O O
Note O O
PT O O
Name: O O
Pearson, O O
Tyler O O
MR# O O
7271902 O O
Date O O
of O O
Admission: O O
10/28/34 O O
at O O
1930 O O
CC: O O
shortness O O
of O O
breath O O
HPI: O O
Mr. O O
Pearson O O
is O O
a O O
89 O O
year O O
old O O
male O O
with O O
past O O
medical O O
history O O
of O O
COPD, O O
s/p O O
CVA, O O
AODM, B-DIABETES O
BPH, O O
CRI O O
who O O
presented O O
to O O
WMC O O
complaining O O
about O O
shortness O O
of O O
breath. O O
The O O
patient O O
was O O
admitted O O
to O O
the O O
Ross O O
Medical O O
Center O O
with O O
pneumonia O O
on O O
three O O
occasions O O
in O O
the O O
last O O
6 O O
weeks. O O
He O O
was O O
discharged O O
home O O
and O O
completed O O
the O O
most O O
recent O O
course O O
of O O
antibiotics O O
today. O O
He O O
has O O
noted O O
increasing O O
shortness O O
of O O
breath, O O
wheezing, O O
decreased O O
exercise O O
tolerance O O
prompting O O
him O O
to O O
seek O O
medical O O
attention. O O
The O O
patient O O
denied O O
fever, O O
productive O O
cough, O O
nausea, O O
vomiting, O O
diaphoresis, O O
chest O O
pain. O O
ROS: O O
all O O
systems O O
are O O
negative O O
in O O
detail O O
except O O
as O O
noted O O
above O O
PMH: O O
COPD O O
on O O
home O O
O2 O O
2LNC O O
at O O
all O O
times O O
Cerebrovascular O O
disease: O O
s/p O O
R O O
CEA O O
6/2129 O O
L O O
ICA O O
stenosis, O O
followed O O
medically O O
with O O
serial O O
ultrasound, O O
on O O
aspirin B-MEDICATION B-MEDICATION
DM2 B-DIABETES O
Lung O O
cancer: O O
s/p O O
L O O
partial O O
resection O O
2106&#8217;s O O
BPH O O
PTSD O O
Artificial O O
R O O
eye O O
(s/p O O
trauma O O
2069) O O
CRI O O
(baseline O O
1.1 O O
&#8211; O O
1.3) O O
Medications O O
(from O O
discharge O O
notes): O O
Acetylsalicylic B-MEDICATION O
Acid I-MEDICATION O
(Aspirin B-MEDICATION O
) O O
PO O O
325 O O
MG O O
QD O O
Fluticasone O O
Propionate/salmeterol O O
250/50 O O
(Advair O O
Diskus O O
250/50 O O
) O O
INH O O
1 O O
PUFF O O
BID O O
Simvastatin B-MEDICATION B-MEDICATION
(Zocor B-MEDICATION O
) O O
PO O O
40 O O
MG O O
QD O O
Losartan B-MEDICATION B-MEDICATION
PO O O
100 O O
MG O O
QD O O
Ipratropium O O
Nebulizer O O
(Atrovent O O
Nebulizer O O
) O O
NEB O O
0.5 O O
MG O O
QID O O
Calcium O O
Carbonate/vitd O O
(250mg O O
Ca++/125u O O
Vitd) O O
PO O O
250 O O
MG O O
TID O O
Gabapentin O O
(Neurontin O O
) O O
PO O O
300 O O
MG O O
TID O O
Albuterol O O
Nebulizer O O
NEB O O
2.5 O O
MG O O
Q4H O O
prn O O
Metoprolol B-MEDICATION B-MEDICATION
PO O O
12.5 O O
MG O O
BID O O
Furosemide O O
(Lasix O O
) O O
PO O O
10 O O
MG O O
QD O O
Loratadine O B-MEDICATION
PO O O
10 O O
MG O O
QD O O
MVI O O
Brimonidine O O
one O O
gtt O O
OS O O
BID O O
Tamsulosin O O
0.4 O O
mg O O
QHS O O
Prednisone O O
40 O O
mg O O
QD O O
Allergies: O O
Bactrim/Tetracycline O O
FH: O O
noncontributory O O
SH: O O
retired O O
Civil O O
Engineer; O O
(-) O O
ETOH O O
(-) O O
illicit O O
drugs O O
(+) B-SMOKER O
tobacco I-SMOKER O
&#8211; I-SMOKER O
stopped B-SMOKER O
30 I-SMOKER O
years I-SMOKER O
ago; I-SMOKER O
30 I-SMOKER O
pack I-SMOKER O
year I-SMOKER O
history I-SMOKER O
Exam: O O
VS: O O
T=99 O O
HR=112 O O
BP= O O
139/57 O O
RR=28; O O
96% O O
after O O
neb O O
in O O
ER O O
General: O O
well O O
nourished/well O O
developed O O
male O O
in O O
no O O
acute O O
distress O O
HEENT: O O
NC/AT O O
Neck: O O
Supple; O O
JVP O O
flat O O
Chest: O O
diffuse O O
expiratory O O
wheezes O O
CVS: O O
distant O O
heart O O
sounds O O
(difficult O O
to O O
appreciate O O
over O O
breath O O
sounds) O O
Abd: O O
soft, O O
nontender, O O
nondistended, O O
normoactive O O
BS O O
Extr: O O
no O O
C/C/E O O
Neuro: O O
nonfocal O O
Skin: O O
no O O
rashes O O
DATA: O O
Chemistry: O O
Plasma O O
Sodium O O
135 O O
(135-145) O O
mmol/L O O
Plasma O O
Potassium O O
4.5 O O
(3.4-4.8) O O
mmol/L O O
Plasma O O
Chloride O O
96 O O
L O O
(100-108) O O
mmol/L O O
Plasma O O
Carbon O O
Dioxide O O
31.5 O O
(23.0-31.9) O O
mmol/L O O
Plasma O O
Anion O O
GAP O O
8 O O
(3-15) O O
mmol/L O O
Calcium O O
9.6 O O
(8.5-10.5) O O
mg/dl O O
Phosphorus O O
3.0 O O
(2.6-4.5) O O
mg/dl O O
Magnesium O O
1.8 O O
(1.4-2.0) O O
meq/L O O
Plasma O O
Urea O O
Nitrogen O O
15 O O
(8-25) O O
mg/dl O O
Plasma O O
Creatinine O O
1.38 O O
(0.60-1.50) O O
mg/dl O O
eGFR O O
51 O O
mL/min/1.73m2 O O
Abnormal O O
if O O
&lt;60 O O
mL/min/1.73m2. O O
If O O
patient O O
is O O
African-American, O O
multiply O O
the O O
result O O
by O O
1.21. O O
Plasma O O
Glucose O O
124 O O
H O O
(70-110) O O
mg/dl O O
Creatine O O
Kinase O O
Isoenzymes O O
NEGATIVE O O
(NEG) O O
Troponin-I O O
NEGATIVE O O
(NEG) O O
NT-proBNP O O
398 O O
(0-1800) O O
pg/ml O O
Hematology: O O
WBC O O
14.4 O O
H O O
(4.5-11.0) O O
th/cmm O O
HCT O O
36.9 O O
L O O
(41.0-53.0) O O
% O O
HGB O O
12.7 O O
L O O
(13.5-17.5) O O
gm/dl O O
RBC O O
4.07 O O
L O O
(4.50-5.90) O O
mil/cmm O O
PLT O O
354 O O
(150-400) O O
th/cumm O O
MCV O O
91 O O
(80-100) O O
fl O O
MCH O O
31.3 O O
(26.0-34.0) O O
pg/rbc O O
MCHC O O
34.5 O O
(31.0-37.0) O O
g/dl O O
RDW O O
13.7 O O
(11.5-14.5) O O
% O O
PT O O
14.7 O O
H O O
(10.3-13.2) O O
sec O O
PT-INR O O
1.3 O O
DIFFERENTIAL O O
REQUEST O O
RECEIVED O O
Diff O O
Method O O
Auto O O
Poly O O
81 O O
H O O
(40-70) O O
% O O
Lymphs O O
11 O O
L O O
(22-44) O O
% O O
Monos O O
5 O O
(4-11) O O
% O O
EOS O O
3 O O
(0-8) O O
% O O
Basos O O
0 O O
(0-3) O O
% O O
Absolute O O
Neuts O O
11.75 O O
H O O
(1.8-7.7) O O
th/cmm O O
Absolute O O
Lymphs O O
1.60 O O
(1.0-4.8) O O
th/cmm O O
Absolute O O
Monos O O
0.70 O O
(0.2-1.2) O O
th/mm3 O O
Absolute O O
EOS O O
0.36 O O
H O O
(0.1-0.3) O O
th/cmm O O
Absolute O O
Basos O O
0.01 O O
(0.0-0.3) O O
th/cmm O O
Aniso O O
None O O
(None) O O
Hypo O O
None O O
(None) O O
Macrocytes O O
None O O
(None) O O
Microcytes O O
None O O
(None) O O
Chest O O
x-ray: O O
diffuse O O
interstitial O O
opacities O O
likely O O
representing O O
interstitial O O
fibrosis; O O
no O O
definite O O
focal O O
consolidation O O
EKG: O O
sinus O O
tach O O
at O O
111; O O
nl O O
axis; O O
RBBB; O O
___________________________________________ O O
Impression: O O
89 O O
year O O
old O O
male O O
with O O
past O O
medical O O
history O O
of O O
COPD O O
on O O
home O O
O2, O O
HTN, B-HYPERTENSION O
AODM, O O
hyperlipidemia, B-HYPERLIPIDEMIA O
remote O O
CVA, O O
CRI O O
admitted O O
with O O
COPD O O
exacerbation O O
after O O
recent O O
admission O O
to O O
Ross O O
Hospital O O
with O O
pneumonia. O O
Plan: O O
1. O O
COPD O O
exacerbation O O
-- O O
Patient O O
appears O O
comfortable O O
after O O
nebulizer O O
treatments O O
in O O
the O O
ER. O O
He O O
has O O
completed O O
his O O
course O O
of O O
oral O O
antibiotics O O
and O O
remains O O
on O O
oral O O
Prednisone. O O
Will O O
continue O O
oral O O
Prednisone O O
and O O
continue O O
aggressive O O
nebulizer O O
treatments. O O
He O O
may O O
require O O
higher O O
dose O O
of O O
oral O O
steroids O O
and O O
subsequent O O
taper. O O
His O O
chest O O
x-ray O O
does O O
NOT O O
demonstrate O O
a O O
focal O O
area O O
of O O
consolidation O O
at O O
this O O
time. O O
2. O O
HTN O O
&#8211; O O
continue O O
Lasix, O O
Losartan, O O
and O O
Lasix O O
3. O O
diabetes B-DIABETES O
&#8211; O O
Patient O O
reportedly O O
does O O
NOT O O
require O O
medication O O
for O O
management. O O
Will O O
check O O
BS O O
BID O O
now O O
that O O
he O O
is O O
on O O
oral O O
Prednisone O O
4. O O
Glaucoma O O
&#8211; O O
continue O O
Brimonidine O O
BID O O
______________________ O O
Gennaro O O
B. O O
Norwood, O O
MD O O
Medical O O
Team O O
4 O O
Team O O
4 O O
Beeper O O
#07736 O O

